PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Bernard, MA; Zhao, H; Yue, SC; Anandaiah, A; Koziel, H; Tachado, SD				Bernard, Mark A.; Zhao, Hui; Yue, Simon C.; Anandaiah, Asha; Koziel, Henry; Tachado, Souvenir D.			Novel HIV-1 MiRNAs Stimulate TNF alpha Release in Human Macrophages via TLR8 Signaling Pathway	PLOS ONE			English	Article							SMALL NONCODING RNAS; IMMUNE ACTIVATION; ANTIRETROVIRAL THERAPY; ALVEOLAR MACROPHAGES; HAIRPIN STRUCTURE; GENE-EXPRESSION; POLYADENYLATION; IDENTIFICATION; TRANSCRIPTION; MICRORNAS	Purpose: To determine whether HIV-1 produces microRNAs and elucidate whether these miRNAs can induce inflammatory response in macrophages (independent of the conventional miRNA function in RNA interference) leading to chronic immune activation. Methods: Using sensitive quantitative Real Time RT-PCR and sequencing, we detected novel HIV-derived miRNAs in the sera of HIV+ persons, and associated with exosomes. Release of TNF alpha by macrophages challenged with HIV miRNAs was measured by ELISA. Results: HIV infection of primary alveolar macrophages produced elevated levels of viral microRNAs vmiR88, vmiR99 and vmiR-TAR in cell extracts and in exosome preparations from conditioned medium. Furthermore, these miRNAs were also detected in exosome fraction of sera from HIV-infected persons. Importantly, vmiR88 and vmiR99 (but not vmiR-TAR) stimulated human macrophage TNFa release, which is dependent on macrophage TLR8 expression. These data support a potential role for HIV-derived vmiRNAs released from infected macrophages as contributing to chronic immune activation in HIV-infected persons, and may represent a novel therapeutic target to limit AIDS pathogenesis. Conclusion: Novel HIV vmiR88 and vmiR99 are present in the systemic circulation of HIV+ persons and could exhibit biological function (independent of gene silencing) as ligands for TLR8 signaling that promote macrophage TNFa release, and may contribute to chronic immune activation. Targeting novel HIV-derived miRNAs may represent a therapeutic strategy to limit chronic immune activation and AIDS progression.	[Bernard, Mark A.; Zhao, Hui; Yue, Simon C.; Anandaiah, Asha; Koziel, Henry; Tachado, Souvenir D.] Beth Israel Deaconess Med Ctr, Div Pulm Crit Care & Sleep Med, Boston, MA 02215 USA; [Bernard, Mark A.; Zhao, Hui; Yue, Simon C.; Anandaiah, Asha; Koziel, Henry; Tachado, Souvenir D.] Harvard Univ, Sch Med, Boston, MA USA; [Zhao, Hui] Shanxi Med Univ, Hosp 2, Dept Resp Med, Taiyuan, Shanxi, Peoples R China	Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School; Shanxi Medical University	Tachado, SD (corresponding author), Beth Israel Deaconess Med Ctr, Div Pulm Crit Care & Sleep Med, Boston, MA 02215 USA.	stachado@bidmc.harvard.edu		Tachado, Souvenir/0000-0002-8368-6102; Bernard, Mark/0000-0001-7141-2975	National Institutes of Health Grant [R01-HL092811]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL092811] Funding Source: NIH RePORTER	National Institutes of Health Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	National Institutes of Health Grant R01-HL092811 to SDT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Althaus CF, 2012, RETROVIROLOGY, V9, DOI 10.1186/1742-4690-9-27; Anthony KB, 2003, JAIDS-J ACQ IMM DEF, V33, P125, DOI 10.1097/00126334-200306010-00002; Aquaro S, 2002, J MED VIROL, V68, P479, DOI 10.1002/jmv.10245; Bennasser Y, 2005, IMMUNITY, V22, P607, DOI 10.1016/j.immuni.2005.03.010; BERKHOUT B, 1995, VIROLOGY, V207, P276, DOI 10.1006/viro.1995.1077; Bernard MA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104039; BOHNLEIN S, 1989, J VIROL, V63, P421; Bosinger SE, 2011, CURR OPIN HIV AIDS, V6, P411, DOI 10.1097/COH.0b013e3283499cf6; Brenchley JM, 2006, NAT MED, V12, P1365, DOI 10.1038/nm1511; Brown BD, 2007, NAT BIOTECHNOL, V25, P1457, DOI 10.1038/nbt1372; Bunn RC, 2010, CARDIOVASC DIABETOL, V9, DOI 10.1186/1475-2840-9-73; Calin GA, 2006, NAT REV CANCER, V6, P857, DOI 10.1038/nrc1997; Das AT, 1999, J VIROL, V73, P81, DOI 10.1128/JVI.73.1.81-91.1999; Dolken L, 2007, J VIROL, V81, P13771, DOI 10.1128/JVI.01313-07; Forsbach A, 2008, J IMMUNOL, V180, P3729, DOI 10.4049/jimmunol.180.6.3729; Garbati MR, 2013, BLOOD, V122, P3197, DOI 10.1182/blood-2013-02-484816; Hamm S, 2010, IMMUNOBIOLOGY, V215, P559, DOI 10.1016/j.imbio.2009.09.003; Han XB, 2012, J BIOL CHEM, V287, P13778, DOI 10.1074/jbc.M112.342683; Hasegawa A, 2009, BLOOD, V114, P2917, DOI 10.1182/blood-2009-02-204263; KINTER AL, 1990, J VIROL, V64, P4306, DOI 10.1128/JVI.64.9.4306-4312.1990; Klase Z, 2009, RETROVIROLOGY, V6, DOI 10.1186/1742-4690-6-18; Klasens BIF, 1999, NUCLEIC ACIDS RES, V27, P446, DOI 10.1093/nar/27.2.446; Klebanoff SJ, 1997, AIDS RES HUM RETROV, V13, P1221, DOI 10.1089/aid.1997.13.1221; Koziel H, 1998, J CLIN INVEST, V102, P1332, DOI 10.1172/JCI560; Lehmann SM, 2012, NAT NEUROSCI, V15, P827, DOI 10.1038/nn.3113; Markham Nicholas R., 2008, V453, P3, DOI 10.1007/978-1-60327-429-6_1; Morelli AE, 2004, BLOOD, V104, P3257, DOI 10.1182/blood-2004-03-0824; Narayanan A, 2013, J BIOL CHEM, V288, P20014, DOI 10.1074/jbc.M112.438895; Ouellet DL, 2013, RETROVIROLOGY, V10, DOI 10.1186/1742-4690-10-86; Pasternak AO, 2012, J INFECT DIS, V206, P1443, DOI 10.1093/infdis/jis502; Pegtel DM, 2010, P NATL ACAD SCI USA, V107, P6328, DOI 10.1073/pnas.0914843107; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Pfeffer S, 2005, NAT METHODS, V2, P269, DOI 10.1038/NMETH746; Robbins M, 2007, MOL THER, V15, P1663, DOI 10.1038/sj.mt.6300240; Schopman NCT, 2012, VIRUS RES, V169, P438, DOI 10.1016/j.virusres.2012.06.017; Schopman NCT, 2012, NUCLEIC ACIDS RES, V40, P414, DOI 10.1093/nar/gkr719; Silvestri G, 2003, J CLIN INVEST, V112, P821, DOI 10.1172/JCI200319799; Sodora DL, 2008, AIDS, V22, P439, DOI 10.1097/QAD.0b013e3282f2dbe7; STROYNOWSKI I, 1983, P NATL ACAD SCI-BIOL, V80, P2206, DOI 10.1073/pnas.80.8.2206; Tachado SD, 2005, AM J RESP CELL MOL, V33, P610, DOI 10.1165/rcmb.2004-0341OC; Tachado SD, 2010, BLOOD, V115, P3606, DOI 10.1182/blood-2009-10-250787; Tanji H, 2013, SCIENCE, V339, P1426, DOI 10.1126/science.1229159; Turnbough CL, 2008, MICROBIOL MOL BIOL R, V72, P266, DOI 10.1128/MMBR.00001-08; Virtue A, 2012, J HEMATOL ONCOL, V5, DOI 10.1186/1756-8722-5-66; Wagschal A, 2012, CELL, V150, P1147, DOI 10.1016/j.cell.2012.08.004; Whisnant AW, 2013, MBIO, V4, DOI 10.1128/mBio.00193-13; Yanofsky C, 2000, J BACTERIOL, V182, P1, DOI 10.1128/JB.182.1.1-8.2000; Yeung ML, 2009, NUCLEIC ACIDS RES, V37, P6575, DOI 10.1093/nar/gkp707	48	58	64	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2014	9	9							e106006	10.1371/journal.pone.0106006	http://dx.doi.org/10.1371/journal.pone.0106006			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ1IR	25191859	Green Published, Green Submitted, gold			2022-12-27	WOS:000347993600013
J	Chueasiri, C; Chunthong, K; Pitnjam, K; Chakhonkaen, S; Sangarwut, N; Sangsawang, K; Suksangpanomrung, M; Michaelson, LV; Napier, JA; Muangprom, A				Chueasiri, Chutharat; Chunthong, Ketsuwan; Pitnjam, Keasinee; Chakhonkaen, Sriprapai; Sangarwut, Numphet; Sangsawang, Kanidta; Suksangpanomrung, Malinee; Michaelson, Louise V.; Napier, Johnathan A.; Muangprom, Amorntip			Rice ORMDL Controls Sphingolipid Homeostasis Affecting Fertility Resulting from Abnormal Pollen Development	PLOS ONE			English	Article							PLANT SPHINGOLIPIDS; GENETIC-VARIANTS; BIOSYNTHESIS; ASTHMA; IDENTIFICATION; INVOLVEMENT; PERFORMANCE; PATHWAY; MARKERS; CELLS	The orosomucoids (ORM) are ER-resisdent polypeptides encoded by ORM and ORMDL (ORM-like) genes. In humans, ORMDL3 was reported as genetic risk factor associated to asthma. In yeast, ORM proteins act as negative regulators of sphingolipid synthesis. Sphingolipids are important molecules regulating several processes including stress responses and apoptosis. However, the function of ORM/ORMDL genes in plants has not yet been reported. Previously, we found that temperature sensitive genetic male sterility (TGMS) rice lines controlled by tms2 contain a deletion of about 70 kb in chromosome 7. We identified four genes expressed in panicles, including an ORMDL ortholog, as candidates for tms2. In this report, we quantified expression of the only two candidate genes normally expressed in anthers of wild type plants grown in controlled growth rooms for fertile and sterile conditions. We found that only the ORMDL gene (LOC_Os07g26940) showed differential expression under these conditions. To better understand the function of rice ORMDL genes, we generated RNAi transgenic rice plants suppressing either LOC_Os07g26940, or all three ORMDL genes present in rice. We found that the RNAi transgenic plants with low expression of either LOC_Os07g26940 alone or all three ORMDL genes were sterile, having abnormal pollen morphology and staining. In addition, we found that both sphingolipid metabolism and expression of genes involved in sphingolipid synthesis were perturbed in the tms2 mutant, analogous to the role of ORMs in yeast. Our results indicated that plant ORMDL proteins influence sphingolipid homeostasis, and deletion of this gene affected fertility resulting from abnormal pollen development.	[Chueasiri, Chutharat; Chunthong, Ketsuwan; Pitnjam, Keasinee; Chakhonkaen, Sriprapai; Sangarwut, Numphet; Sangsawang, Kanidta; Suksangpanomrung, Malinee; Muangprom, Amorntip] Natl Ctr Genet Engn & Biotechnol, Klongluang, Pathumthani, Thailand; [Michaelson, Louise V.; Napier, Johnathan A.] Rothamsted Res, Dept Biol Chem, Harpenden, Herts, England	National Science & Technology Development Agency - Thailand; National Center Genetic Engineering & Biotechnology (BIOTEC); UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Rothamsted Research	Muangprom, A (corresponding author), Natl Ctr Genet Engn & Biotechnol, Thailand Sci Pk, Klongluang, Pathumthani, Thailand.	amorntip.mua@biotec.or.th		Michaelson, Louise/0000-0001-5621-4495; Napier, Johnathan/0000-0003-3580-3607	National Science and Technology Development Agency [P-00-20101]; BBSRC [BBS/E/C/00005207] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BBS/E/C/00005207] Funding Source: researchfish	National Science and Technology Development Agency; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by National Science and Technology Development Agency; grant numbers P-00-20101. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aubert A, 2011, PLANT J, V65, P958, DOI 10.1111/j.1365-313X.2011.04481.x; Breslow DK, 2010, NATURE, V463, P1048, DOI 10.1038/nature08787; Caldana C, 2007, PLANT METHODS, V3, DOI 10.1186/1746-4811-3-7; Cantero-Recasens G, 2010, HUM MOL GENET, V19, P111, DOI 10.1093/hmg/ddp471; Chao DY, 2011, PLANT CELL, V23, P1061, DOI 10.1105/tpc.110.079095; Chen M, 2008, PLANT CELL, V20, P1862, DOI 10.1105/tpc.107.057851; Chen M, 2012, PLANT J, V69, P769, DOI 10.1111/j.1365-313X.2011.04829.x; Chen RZ, 2007, PLANT CELL, V19, P847, DOI 10.1105/tpc.106.044123; Coursol S, 2003, NATURE, V423, P651, DOI 10.1038/nature01643; Dietrich CR, 2008, PLANT J, V54, P284, DOI 10.1111/j.1365-313X.2008.03420.x; Fang QR, 2011, BMC MED GENET, V12, DOI 10.1186/1471-2350-12-133; Galanter J, 2008, AM J RESP CRIT CARE, V177, P1194, DOI 10.1164/rccm.200711-1644OC; Guo L, 2012, J BIOL CHEM, V287, P8286, DOI 10.1074/jbc.M111.274274; Han SM, 2010, P NATL ACAD SCI USA, V107, P5851, DOI 10.1073/pnas.0911617107; Hjelmqvist L, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-6-research0027; Imamura T, 2007, PLANT CELL PHYSIOL, V48, P1108, DOI 10.1093/pcp/pcm084; Liu M, 2012, J CELL SCI, V125, P2428, DOI 10.1242/jcs.100578; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lopez MT, 2003, CROP SCI, V43, P2267, DOI 10.2135/cropsci2003.2267; Lynch DV, 2004, NEW PHYTOL, V161, P677, DOI 10.1111/j.1469-8137.2004.00992.x; Markham JE, 2007, RAPID COMMUN MASS SP, V21, P1304, DOI 10.1002/rcm.2962; Markham JE, 2011, PLANT CELL, V23, P2362, DOI 10.1105/tpc.110.080473; Moffatt MF, 2007, NATURE, V448, P470, DOI 10.1038/nature06014; Pitnjam K, 2008, PLANTA, V228, P813, DOI 10.1007/s00425-008-0784-3; Shi LH, 2007, CELL RES, V17, P1030, DOI 10.1038/cr.2007.100; Spassieva S, 2003, PLANT BIOLOGY, V5, P125, DOI 10.1055/s-2003-40726; Sperling P, 2003, BBA-MOL CELL BIOL L, V1632, P1, DOI 10.1016/S1388-1981(03)00033-7; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Teng C, 2008, PLANT PHYSIOL, V146, P1322, DOI 10.1104/pp.107.113506; Ternes P, 2006, J BIOL CHEM, V281, P5582, DOI 10.1074/jbc.M512864200; Verlaan DJ, 2009, AM J HUM GENET, V85, P377, DOI 10.1016/j.ajhg.2009.08.007; Virmani S. S., 2004, International Rice Research Notes, V29, P10; Wang M, 2004, PLANT MOL BIOL REP, V22, P409, DOI 10.1007/BF02772683; Wang XL, 2009, PLANT J, V57, P473, DOI 10.1111/j.1365-313X.2008.03700.x; Wu H, 2009, ALLERGY, V64, P629, DOI 10.1111/j.1398-9995.2008.01912.x; Yamaguchi Y, 1997, BREEDING SCI, V47, P371; Zauner S, 2010, ADV EXP MED BIOL, V688, P249	37	17	19	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2014	9	9							e106386	10.1371/journal.pone.0106386	http://dx.doi.org/10.1371/journal.pone.0106386			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ1IR	25192280	Green Submitted, gold, Green Published			2022-12-27	WOS:000347993600022
J	Dodderi, SK; Kumar, AMV; Naik, BR; Kanchar, A; Rewari, BB; Harries, AD				Dodderi, Sunil Kumar; Kumar, Ajay M. V.; Naik, Balaji R.; Kanchar, Avinash; Rewari, B. B.; Harries, Anthony D.			How Many People Living with HIV Will Be Additionally Eligible for Antiretroviral Treatment in Karnataka State, India as per the World Health Organization 2013 Guidelines?	PLOS ONE			English	Article								Background: The National AIDS control programme (NACP) in India is currently following the World Health Organization (WHO) 2010 antiretroviral therapy (ART) guidelines. In 2013, the WHO revised its recommendations for initiating ART among people living with HIV (PLHIV) by increasing the threshold for ART initiation to a CD4 count <= 500 cells/uL. For certain patient groups, ART is recommended irrespective of CD4 count (PLHIV with active tuberculosis, hepatitis B virus infection, pregnant and breast feeding women, children aged under five years and those living in a sero-discordant relationship). In this operational research, we assess the effect of applying this recommendation on the number of PLHIV additionally eligible for ART. Methods: This was a cross-sectional analysis of routinely collected programme data from all PLHIV registered in Karnataka State (population 60 million), India in 2012. Results: Of 37,044 PLHIV, 27,074 (73%) were eligible for initiating ART as per WHO-2010 criteria. As per the WHO-2013 criteria (CD4 count <= 500 and all pregnant women and under-five children irrespective of CD4 count), an additional 5104 (14%) HIV-infected people would be eligible for initiating ART. There were no data to inform the additional patient load due to sero-discordance. Conclusion: Adopting the WHO-2013 guidelines for India has important resource implications. However, given the significant patient and programmatic benefits of adopting the new guidelines, this has been considered favourably by the NACP in India and steps are being planned to integrate ART care into the general health system to cope with the increased numbers of patients.	[Dodderi, Sunil Kumar] Karnataka State AIDS Prevent Soc, Bangalore, Karnataka, India; [Dodderi, Sunil Kumar; Rewari, B. B.] Govt India, Minist Hlth & Family Welf, Natl AIDS Control Org, New Delhi, India; [Kumar, Ajay M. V.] Int Union TB & Lung Dis, South East Asia Off, New Delhi, India; [Naik, Balaji R.] World Hlth Org Country Off India, New Delhi, India; [Kanchar, Avinash] World Hlth Org, Geneva, Switzerland; [Kumar, Ajay M. V.; Harries, Anthony D.] Int Union TB & Lung Dis, Paris, France; [Harries, Anthony D.] London Sch Hyg & Trop Med, Dept Infect & Trop Dis, London WC1, England	World Health Organization; World Health Organization; University of London; London School of Hygiene & Tropical Medicine	Naik, BR (corresponding author), World Hlth Org Country Off India, New Delhi, India.	naikb@rntcp.org		Madhugiri Venkatachalaiah, Ajay Kumar/0000-0003-1011-8531	Department for International Development (DFID), UK	Department for International Development (DFID), UK	The authors thank the Department for International Development (DFID), UK, for supporting the publication of this article in an open access journal and supporting Ajay MV Kumar as senior operational research fellow. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2007, ANT THER GUID HIV IN; Arora P, 2011, SEX TRANSM INFECT, V87, P516, DOI 10.1136/sextrans-2011-050203; IDF (International Diabetes Federation), 2021, CONSOLIDATED GUIDELI, V10th ed.; Konings E, 2012, B WORLD HEALTH ORGAN, V90, P659, DOI 10.2471/BLT.11.089599; *NAT AIDS CONTR OR, 2013, TECHN REP IND HIV ES; National AIDS Control Organization, 2008, OP GUID INT COUNS TE; National AIDS Control Organization, 2014, GN AZ LAUNCH NAT AID; Raguenaud ME, 2009, BMC PEDIATR, V9, DOI 10.1186/1471-2431-9-54; Saggurti N, 2009, AIDS BEHAV, V13, P921, DOI 10.1007/s10461-009-9564-8; WHO, 2013, GLOB UPD HIV TREATM; World Health Organization, 2010, 1145 WHO	11	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2014	9	9							e107136	10.1371/journal.pone.0107136	http://dx.doi.org/10.1371/journal.pone.0107136			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ1IR	25192338	gold, Green Submitted, Green Published, Green Accepted			2022-12-27	WOS:000347993600100
J	Escudero-Abarca, BI; Suh, SH; Moore, MD; Dwivedi, HP; Jaykus, LA				Escudero-Abarca, Blanca I.; Suh, Soo Hwan; Moore, Matthew D.; Dwivedi, Hari P.; Jaykus, Lee-Ann			Selection, Characterization and Application of Nucleic Acid Aptamers for the Capture and Detection of Human Norovirus Strains	PLOS ONE			English	Article							LINKED-IMMUNOSORBENT-ASSAY; REVERSE TRANSCRIPTION-PCR; REAL-TIME PCR; MAGNETIC BEADS; IMMUNOMAGNETIC SEPARATION; UNITED-STATES; DNA APTAMERS; SAMPLES; GASTROENTERITIS; VIRUS	Human noroviruses (HuNoV) are the leading cause of acute viral gastroenteritis and an important cause of foodborne disease. Despite their public health significance, routine detection of HuNoV in community settings, or food and environmental samples, is limited, and there is a need to develop alternative HuNoV diagnostic reagents to complement existing ones. The purpose of this study was to select and characterize single-stranded (ss) DNA aptamers with binding affinity to HuNoV. The utility of these aptamers was demonstrated in their use for capture and detection of HuNoV in outbreak-derived fecal samples and a representative food matrix. SELEX (Systematic Evolution of Ligands by EXponential enrichment) was used to isolate ssDNA aptamer sequences with broad reactivity to the prototype GII.2 HuNoV strain, Snow Mountain Virus (SMV). Four aptamer candidates (designated 19, 21, 25 and 26) were identified and screened for binding affinity to 14 different virus-like particles (VLPs) corresponding to various GI and GII HuNoV strains using an Enzyme-Linked Aptamer Sorbant Assay (ELASA). Collectively, aptamers 21 and 25 showed affinity to 13 of the 14 VLPs tested, with strongest binding to GII.2 (SMV) and GII. 4 VLPs. Aptamer 25 was chosen for further study. Its binding affinity to SMV-VLPs was equivalent to that of a commercial antibody within a range of 1 to 5 mg/ml. Aptamer 25 also showed binding to representative HuNoV strains present in stool specimens obtained from naturally infected individuals. Lastly, an aptamer magnetic capture (AMC) method using aptamer 25 coupled with RT-qPCR was developed for recovery and detection of HuNoV in artificially contaminated lettuce. The capture efficiency of the AMC was 2.5-36% with an assay detection limit of 10 RNA copies per lettuce sample. These ssDNA aptamer candidates show promise as broadly reactive reagents for use in HuNoV capture and detection assays in various sample types.	[Escudero-Abarca, Blanca I.; Suh, Soo Hwan; Moore, Matthew D.; Dwivedi, Hari P.; Jaykus, Lee-Ann] N Carolina State Univ, Dept Food Bioproc & Nutr Sci, Raleigh, NC 27695 USA	University of North Carolina; North Carolina State University	Escudero-Abarca, BI (corresponding author), N Carolina State Univ, Dept Food Bioproc & Nutr Sci, Raleigh, NC 27695 USA.	biescude@ncsu.edu	Dwivedi, Hari/AAK-5866-2021; Moore, Matthew/H-9345-2019	Moore, Matthew/0000-0002-5393-0733	Merieux Research Grants Program; USDA National Institute of Food and Agriculture [2011-68003-30395]	Merieux Research Grants Program; USDA National Institute of Food and Agriculture(United States Department of Agriculture (USDA))	This work was supported in part by the Merieux Research Grants Program. Funding was also provided by Agriculture and Food Research Initiative Competitive Grant no. 2011-68003-30395 from the USDA National Institute of Food and Agriculture. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed SM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075922; Beier R, 2014, FEMS MICROBIOL LETT, V351, P162, DOI 10.1111/1574-6968.12366; Chen ZC, 2013, J VIROL, V87, P9547, DOI 10.1128/JVI.01376-13; Costantini V, 2010, J CLIN MICROBIOL, V48, P2770, DOI 10.1128/JCM.00654-10; Dwivedi HP, 2010, APPL MICROBIOL BIOT, V87, P2323, DOI 10.1007/s00253-010-2728-7; Ebel GD, 2002, EMERG INFECT DIS, V8, P979, DOI 10.3201/eid0809.020152; Escudero BI, 2012, J FOOD PROTECT, V75, P927, DOI 10.4315/0362-028X.JFP-11-460; FRIGUET B, 1985, J IMMUNOL METHODS, V77, P305, DOI 10.1016/0022-1759(85)90044-4; Fuchs H, 1995, J IMMUNOL METHODS, V188, P197, DOI 10.1016/0022-1759(95)00202-2; Giamberardino A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079087; Glass RI, 2009, NEW ENGL J MED, V361, P1776, DOI 10.1056/NEJMra0804575; Hall AJ, 2013, EMERG INFECT DIS, V19, P1198, DOI 10.3201/eid1908.130465; Imai T, 2011, BMC BIOTECHNOL, V11, DOI 10.1186/1472-6750-11-123; Joshi R, 2009, MOL CELL PROBE, V23, P20, DOI 10.1016/j.mcp.2008.10.006; Jothikumar N, 2005, APPL ENVIRON MICROB, V71, P1870, DOI 10.1128/AEM.71.4.1870-1875.2005; Kageyama T, 2003, J CLIN MICROBIOL, V41, P1548, DOI 10.1128/JCM.41.4.1548-1557.2003; Kato T, 2000, NUCLEIC ACIDS RES, V28, P1963, DOI 10.1093/nar/28.9.1963; Kaur H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031196; Kele B, 2011, DIAGN MICR INFEC DIS, V70, P475, DOI 10.1016/j.diagmicrobio.2011.04.002; Kim YS, 2014, BIOSENS BIOELECTRON, V54, P195, DOI 10.1016/j.bios.2013.11.003; Knight A, 2013, CRIT REV MICROBIOL, V39, P295, DOI 10.3109/1040841X.2012.709820; Lee HM, 2013, J FOOD PROTECT, V76, P707, DOI 10.4315/0362-028X.JFP-12-343; Leggitt PR, 2000, J FOOD PROTECT, V63, P1738, DOI 10.4315/0362-028X-63.12.1738; Lindesmith LC, 2008, PLOS MED, V5, P269, DOI 10.1371/journal.pmed.0050031; Morton V, 2009, APPL ENVIRON MICROB, V75, P4641, DOI 10.1128/AEM.00202-09; Ozalp VC, 2014, ANAL BIOCHEM, V447, P119, DOI 10.1016/j.ab.2013.11.022; Pan LW, 2012, FOOD MICROBIOL, V30, P420, DOI 10.1016/j.fm.2011.12.026; Park Y, 2008, APPL ENVIRON MICROB, V74, P4226, DOI 10.1128/AEM.00013-08; Patel MM, 2008, EMERG INFECT DIS, V14, P1224, DOI 10.3201/eid1408.071114; Rodriguez-Lazaro D, 2004, FEMS MICROBIOL LETT, V233, P257, DOI 10.1111/j.1574-6968.2004.tb09490.x; Rogers JD, 2013, J CLIN MICROBIOL, V51, P1803, DOI 10.1128/JCM.00295-13; Scallan E, 2011, EMERG INFECT DIS, V17, P16, DOI [10.3201/eid1701.P21101, 10.3201/eid1701.091101p2]; Shin GA, 2008, WATER RES, V42, P4562, DOI 10.1016/j.watres.2008.08.001; Suh SH, 2013, WOODHEAD PUBL FOOD S, V259, P173, DOI 10.1533/9780857098740.3.173; Tian P, 2008, APPL ENVIRON MICROB, V74, P4271, DOI 10.1128/AEM.00539-08; Tian P, 2011, INT J FOOD MICROBIOL, V147, P223, DOI 10.1016/j.ijfoodmicro.2011.04.013; Yao L, 2009, LETT APPL MICROBIOL, V49, P173, DOI 10.1111/j.1472-765X.2009.02638.x; Zheng DP, 2006, VIROLOGY, V346, P312, DOI 10.1016/j.virol.2005.11.015; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	39	64	64	1	65	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2014	9	9							e106805	10.1371/journal.pone.0106805	http://dx.doi.org/10.1371/journal.pone.0106805			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ1IR	25192421	gold, Green Published, Green Submitted			2022-12-27	WOS:000347993600064
J	Hill, NT; Gracia-Maldonado, GH; Leonard, MK; Harper, AR; Tober, KL; Oberyszyn, TM; Kadakia, MP				Hill, Natasha T.; Gracia-Maldonado, Gabriel H.; Leonard, Mary K.; Harper, Amanda R.; Tober, Kathleen L.; Oberyszyn, Tatiana M.; Kadakia, Madhavi P.			Role of Vitamin D3 in Modulation of Delta Np63 alpha Expression during UVB Induced Tumor Formation in SKH-1 Mice	PLOS ONE			English	Article							NONMELANOMA SKIN-CANCER; BASAL-CELL CARCINOMAS; D-RECEPTOR; SIGNALING PATHWAYS; P63 EXPRESSION; HAIR FOLLICLE; P53 HOMOLOG; D SYSTEM; RADIATION; CALCIUM	Delta Np63 alpha, a proto-oncogene, is up-regulated in non-melanoma skin cancers and directly regulates the expression of both Vitamin D receptor (VDR) and phosphatase and tensin homologue deleted on chromosome ten (PTEN). Since Delta Np63 alpha has been shown to inhibit cell invasion via regulation of VDR, we wanted to determine whether dietary Vitamin D-3 protected against UVB induced tumor formation in SKH-1 mice, a model for squamous cell carcinoma development. We examined whether there was a correlation between dietary Vitamin D-3 and Delta Np63 alpha, VDR or PTEN expression in vivo in SKH-1 mice chronically exposed to UVB radiation and fed chow containing increasing concentrations of dietary Vitamin D-3. Although we observed differential effects of the Vitamin D-3 diet on Delta Np63 alpha and VDR expression in chronically irradiated normal mouse skin as well as UVB induced tumors, Vitamin D-3 had little effect on PTEN expression in vivo. While low-grade papillomas in mice exposed to UV and fed normal chow displayed increased levels of Delta Np63 alpha, expression of both Delta Np63 alpha and VDR was reduced in invasive tumors. Interestingly, in mice fed high Vitamin D-3 chow, elevated levels of Delta Np63 alpha were observed in both local and invasive tumors but not in normal skin suggesting that oral supplementation with Vitamin D-3 may increase the proliferative potential of skin tumors by increasing Delta Np63 alpha levels.	[Hill, Natasha T.; Gracia-Maldonado, Gabriel H.; Leonard, Mary K.; Kadakia, Madhavi P.] Wright State Univ, Boonshoft Sch Med, Dept Biochem & Mol Biol, Dayton, OH 45435 USA; [Harper, Amanda R.; Tober, Kathleen L.; Oberyszyn, Tatiana M.] Ohio State Univ, Dept Pathol, Columbus, OH 43210 USA	University System of Ohio; Wright State University Dayton; University System of Ohio; Ohio State University	Kadakia, MP (corresponding author), Wright State Univ, Boonshoft Sch Med, Dept Biochem & Mol Biol, Dayton, OH 45435 USA.	madhavi.kadakia@wright.edu		Hill, Natasha/0000-0001-9043-4643; LEONARD, M. Kathryn/0000-0002-8432-6803; Oberyszyn, Tatiana/0000-0002-5308-0855	National Institutes of Health [1R01CA154715]; Ohio State Cancer Center [P30 CA016058]; NATIONAL CANCER INSTITUTE [R01CA154715, P30CA016058] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ohio State Cancer Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by grant1R01CA154715 (MK) from the National Institutes of Health and P30 CA016058 (TO) Ohio State Cancer Center. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARBOUR NC, 1993, MOL ENDOCRINOL, V7, P1307, DOI 10.1210/me.7.10.1307; Backman SA, 2004, P NATL ACAD SCI USA, V101, P1725, DOI 10.1073/pnas.0308217100; Benavides F, 2009, J DERMATOL SCI, V53, P10, DOI 10.1016/j.jdermsci.2008.08.012; Bircan S, 2006, J CUTAN PATHOL, V33, P293, DOI 10.1111/j.0303-6987.2006.00436.x; Burns EM, 2013, J SKIN CANCER, V2013, DOI 10.1155/2013/246848; Burns EM, 2013, CARCINOGENESIS, V34, P370, DOI 10.1093/carcin/bgs349; Choi HR, 2002, HUM PATHOL, V33, P158, DOI 10.1053/hupa.2002.30722; Chung M, 2011, ANN INTERN MED, V155, P827, DOI 10.7326/0003-4819-155-12-201112200-00005; Deeb KK, 2007, NAT REV CANCER, V7, P684, DOI 10.1038/nrc2196; Di Como CJ, 2002, CLIN CANCER RES, V8, P494; Dixon KM, 2011, CANCER PREV RES, V4, P1485, DOI 10.1158/1940-6207.CAPR-11-0165; Eide MJ, 2011, ARCH DERMATOL, V147, P1379, DOI 10.1001/archdermatol.2011.231; Faurschou A, 2007, EXP DERMATOL, V16, P485, DOI 10.1111/j.1600-0625.2007.00551.x; Fleet JC, 2008, J NUTR, V138, P1114, DOI 10.1093/jn/138.6.1114; Fortmann SP, 2013, ANN INTERN MED, V159, P824, DOI 10.7326/0003-4819-159-12-201312170-00729; Fukushima H, 2009, CANCER RES, V69, P9263, DOI 10.1158/0008-5472.CAN-09-1188; Gandini S, 2011, INT J CANCER, V128, P1414, DOI 10.1002/ijc.25439; Hibi K, 2000, P NATL ACAD SCI USA, V97, P5462, DOI 10.1073/pnas.97.10.5462; Kommagani R, 2006, ONCOGENE, V25, P3745, DOI 10.1038/sj.onc.1209412; Kommagani R, 2009, J CELL SCI, V122, P2828, DOI 10.1242/jcs.049619; Koster MI, 2004, GENE DEV, V18, P126, DOI 10.1101/gad.1165104; Kraemer A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083392; Krishnan AV, 2013, J STEROID BIOCHEM, V136, P289, DOI 10.1016/j.jsbmb.2012.08.005; Langberg M, 2009, BRIT J DERMATOL, V160, P151, DOI 10.1111/j.1365-2133.2008.08797.x; Leonard MK, 2011, CELL DEATH DIFFER, V18, P1924, DOI 10.1038/cdd.2011.73; Liefer KM, 2000, CANCER RES, V60, P4016; Lutzow-Holm C, 1993, Exp Dermatol, V2, P113, DOI 10.1111/j.1600-0625.1993.tb00018.x; Mills AA, 1999, NATURE, V398, P708, DOI 10.1038/19531; Ming M, 2010, ONCOGENE, V29, P492, DOI 10.1038/onc.2009.357; Mitschele T, 2004, LAB INVEST, V84, P693, DOI 10.1038/labinvest.3700096; Morris RJ, 2000, CANCER RES, V60, P226; Ogawa E, 2008, J BIOL CHEM, V283, P34241, DOI 10.1074/jbc.M804101200; Pan LN, 2010, FEBS J, V277, P989, DOI 10.1111/j.1742-4658.2009.07542.x; Rebel HG, 2012, CARCINOGENESIS, V33, P714, DOI 10.1093/carcin/bgs004; Reichrath J, 2004, J CUTAN PATHOL, V31, P224, DOI 10.1111/j.0303-6987.2003.00183.x; Sakiz D, 2009, PATHOL RES PRACT, V205, P589, DOI 10.1016/j.prp.2009.01.010; Scragg R, 2011, PUBLIC HEALTH NUTR, V14, P1515, DOI 10.1017/S1368980011001455; Suzuki A, 2003, CANCER RES, V63, P674; Syed DN, 2012, PHOTOCHEM PHOTOBIOL, V88, P1184, DOI 10.1111/j.1751-1097.2012.01115.x; Tang JY, 2010, CANCER CAUSE CONTROL, V21, P387, DOI 10.1007/s10552-009-9470-4; Thomas-Ahner JM, 2007, CANCER RES, V67, P3468, DOI 10.1158/0008-5472.CAN-06-3798; Urist MJ, 2002, AM J PATHOL, V161, P1199, DOI 10.1016/S0002-9440(10)64396-9; van Dam RM, 2000, AM J CLIN NUTR, V71, P135; Westfall MD, 2005, CELL CYCLE, V4, P710, DOI 10.4161/cc.4.5.1685; Yang A, 1999, NATURE, V398, P714, DOI 10.1038/19539; Yang AN, 1998, MOL CELL, V2, P305, DOI 10.1016/S1097-2765(00)80275-0; Zineb R, 1998, ENDOCRINOLOGY, V139, P1844, DOI 10.1210/en.139.4.1844; Zinser GM, 2002, CARCINOGENESIS, V23, P2103, DOI 10.1093/carcin/23.12.2103	48	7	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2014	9	9							e107052	10.1371/journal.pone.0107052	http://dx.doi.org/10.1371/journal.pone.0107052			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ1IR	25191969	Green Published, gold			2022-12-27	WOS:000347993600092
J	Huston, RK; Christensen, JM; Karnpracha, C; Rosa, JE; Clark, SM; Migaki, EA; Wu, YX				Huston, Robert K.; Christensen, J. Mark; Karnpracha, Chanida; Rosa, Jill E.; Clark, Sara M.; Migaki, Evelyn A.; Wu, YingXing			Calcium Chloride in Neonatal Parenteral Nutrition: Compatibility Studies Using Laser Methodology	PLOS ONE			English	Article							INORGANIC-PHOSPHATE SALTS; ORGANIC CALCIUM; ALUMINUM CONTAMINATION; PHYSICAL COMPATIBILITY; NUTRIENT ADMIXTURES; SODIUM-PHOSPHATE; PRECIPITATION; TROPHAMINE; STABILITY; GLUCONATE	Introduction: We have previously reported results of precipitation studies for neonatal parenteral nutrition solutions containing calcium chloride and sodium phosphate using visual methods to determine compatibility. The purpose of this study was to do further testing of compatibility for solutions containing calcium chloride using more sensitive methods. Methods: Solutions of Trophamine (Braun Medical Inc, Irvine, CA) and Premasol (Baxter Pharmaceuticals, Deerfield, IL) were compounded with calcium chloride and potassium phosphate. Controls contained no calcium or phosphate. After incubation at 37 degrees for 24 hours solutions without visual precipitation were analyzed to determine mean particle size using dynamic light scattering from a laser light source. Results: Particle sizes were similar for control solutions and those without visual precipitation and a mean particle size <1000 nm. Compatible solutions were defined as those with added calcium and phosphate with no visual evidence of precipitation and mean particle size <1000 nm. In solutions containing 2.5-3% amino acids and 10 mmol/L of calcium chloride the maximum amount of potassium phosphate that was compatible was 7.5 mmol/L. Conclusion: Maximum amounts of phosphate that could be added to parenteral nutrition solutions containing Trophamine and calcium chloride were about 7.5-10 mmol/L less for a given concentration of calcium based upon laser methodology compared to visual techniques to determine compatibility. There were minor differences in compatibility when adding calcium chloride and potassium phosphate to Premasol versus Trophamine.	[Huston, Robert K.] Northwest Newborn Specialists, PC & Pediatrix Med Grp, Portland, OR 97227 USA; [Christensen, J. Mark; Karnpracha, Chanida] Oregon State Univ, Coll Pharm, Dept Pharmaceut Sci, Corvallis, OR 97331 USA; [Rosa, Jill E.] Denver Vet Affairs Med Ctr, Dept Pharm, Denver, CO USA; [Clark, Sara M.; Migaki, Evelyn A.] Neonatal Pharm Providence St Vincent Med Ctr, Portland, OR USA; [Wu, YingXing] Med Data Res Ctr, Portland, OR USA	Oregon State University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Veterans Affairs Medical Center - Denver	Huston, RK (corresponding author), Northwest Newborn Specialists, PC & Pediatrix Med Grp, Portland, OR 97227 USA.	Robert_Huston@pediatrix.com			Northwest Newborn Specialists PC; RKH at Providence Health Services, Portland OR	Northwest Newborn Specialists PC; RKH at Providence Health Services, Portland OR	Funding was provided by Northwest Newborn Specialists PC. Funding was sent directly to the research account of RKH at Providence Health Services, Portland OR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bishop NJ, 1997, NEW ENGL J MED, V336, P1557, DOI 10.1056/NEJM199705293362203; Bohrer D, 2002, JPEN-PARENTER ENTER, V26, P382, DOI 10.1177/0148607102026006382; Bouchoud L, 2010, JPEN-PARENTER ENTER, V34, P542, DOI 10.1177/0148607110374615; CHAIEB SD, 2006, EJHP SCI, V12, P35; Driscoll DF, 2012, JPEN-PARENTER ENTER, V36, P497, DOI 10.1177/0148607112455064; DRISCOLL DF, 1995, AM J HEALTH-SYST PH, V52, P623, DOI 10.1093/ajhp/52.6.623; Driscoll DF, 2001, INT J PHARM, V219, P21, DOI 10.1016/S0378-5173(01)00626-3; Fewtrell MS, 2009, PEDIATRICS, V124, P1372, DOI 10.1542/peds.2009-0783; FITZGERALD KA, 1986, AM J HOSP PHARM, V43, P88, DOI 10.1093/ajhp/43.1.88; Food and Drug Administration, 2002, FED REGISTER, V67, P70691; Frey OR, 2000, ANN PHARMACOTHER, V34, P811, DOI 10.1345/aph.19306; HAUW JJ, 1975, CELL TISSUE RES, V163, P133; HENRY RS, 1980, AM J HOSP PHARM, V37, P673, DOI 10.1093/ajhp/37.5.673; Hoie EB, 1996, J PEDIAT PHARM PRACT, V1, P163; Huston R. K., 2012, ICAN: Infant, Child & Adolescent Nutrition, V4, P137, DOI 10.1177/1941406412443553; Huston RK, 2012, JPEN-PARENTER ENTER, V36, P498, DOI 10.1177/0148607112456297; KAMINSKI MV, 1974, AM J HOSP PHARM, V31, P244, DOI 10.1093/ajhp/31.3.244; Kerner, 1983, MANUAL PEDIAT PARENT, P177; KOO WWK, 1986, JPEN-PARENTER ENTER, V10, P591, DOI 10.1177/0148607186010006591; Migaki EA, 2012, JPEN-PARENTER ENTER, V36, P470, DOI 10.1177/0148607111420154; Nicoli DF, 1995, AM LAB, V4, P41; Parikh MJ, 2005, AM J HEALTH-SYST PH, V62, P1177, DOI 10.1093/ajhp/62.11.1177; Pluhator-Murton MM, 1999, JPEN-PARENTER ENTER, V23, P222, DOI 10.1177/0148607199023004222; Pohlandt F., 2005, NUTR PRETERM INFANT, V2nd, P245; Poole RL, 2008, JPEN-PARENTER ENTER, V32, P242, DOI 10.1177/0148607108316187; Singh H, 2009, PEDIATR CRIT CARE ME, V10, P213, DOI 10.1097/PCC.0b013e31819a3bf4; Smith BS, 2007, AM J HEALTH-SYST PH, V64, P730, DOI 10.2146/ajhp060163; Trissel LA., 2007, HDB INJECTABLE DRUGS, V14th, P1720; United States Pharmacopeia, 2008, US PHARMACOPEIA 31 N, V26, P311	29	5	11	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2014	9	9							e106825	10.1371/journal.pone.0106825	http://dx.doi.org/10.1371/journal.pone.0106825			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ1IR	25192060	Green Published, gold, Green Submitted			2022-12-27	WOS:000347993600069
J	Morard, I; Clement, S; Calmy, A; Mangia, A; Cerny, A; De Gottardi, A; Gorgievski, M; Heim, M; Malinverni, R; Moradpour, D; Mullhaupt, B; Semela, D; Pascarella, S; Bochud, PY; Negro, F				Morard, Isabelle; Clement, Sophie; Calmy, Alexandra; Mangia, Alessandra; Cerny, Andrea; De Gottardi, Andrea; Gorgievski, Meri; Heim, Markus; Malinverni, Raffaele; Moradpour, Darius; Muellhaupt, Beat; Semela, David; Pascarella, Stephanie; Bochud, Pierre-Yves; Negro, Franco		Swiss Hepatitis C Cohort Study Grp	Clinical Significance of the CCR5delta32 Allele in Hepatitis C	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; HCV INFECTION; CCR5-DELTA-32 MUTATION; GENETIC-VARIATION; SPONTANEOUS CLEARANCE; INTERFERON-ALPHA; PREDICTIVE-VALUE; VIRUS-INFECTION; SINGLE-SOURCE; IL28B	Background: The CCR5 receptor, expressed on Th1 cells, may influence clinical outcomes of HCV infection. We explored a possible link between a CCR5 32-base deletion (CCR5delta32), resulting in the expression of a non-functioning receptor, and clinical outcomes of HCV infection. Methods: CCR5 and HCV-related phenotypes were analysed in 1,290 chronically infected patients and 160 patients with spontaneous clearance. Results: Carriage of the CCR5delta32 allele was observed in 11% of spontaneous clearers compared to 17% of chronically infected patients (OR = 0.59, 95% CI interval 0.35-0.99, P = 0.047). Carriage of this allele also tended to be observed more frequently among patients with liver inflammation (19%) compared to those without inflammation (15%, OR = 1.38, 95% CI interval 0.99-1.95, P = 0.06). The CCR5delta32 was not associated with sustained virological response (P = 0.6), fibrosis stage (P = 0.8), or fibrosis progression rate (P = 0.4). Conclusions: The CCR5delta32 allele appears to be associated with a decreased rate of spontaneous HCV eradication, but not with hepatitis progression or response to antiviral therapy.	[Morard, Isabelle; Negro, Franco] Univ Hosp Geneva, Div Gastroenterol & Hepatol, Geneva, Switzerland; [Clement, Sophie; Negro, Franco] Univ Hosp Geneva, Div Clin Pathol, Geneva, Switzerland; [Calmy, Alexandra] Univ Hosp Geneva, Div Infect Dis, Geneva, Switzerland; [Mangia, Alessandra] IRCCS Casa Sollievo Sofferenza, Liver Unit, San Giovanni Rotondo, Italy; [Cerny, Andrea] Clin Moncucco, Serv Hepatol, Lugano, Switzerland; [De Gottardi, Andrea] Univ Hosp Bern, Div Hepatol, CH-3010 Bern, Switzerland; [Gorgievski, Meri] Univ Hosp Bern, Div Infect Dis, CH-3010 Bern, Switzerland; [Heim, Markus] Univ Hosp Bern, Div Gastroenterol & Hepatol, CH-3010 Bern, Switzerland; [Malinverni, Raffaele] Pourtales Hosp, Div Infect Dis, Neuchatel, Switzerland; [Moradpour, Darius] Univ Lausanne Hosp, Div Gastroenterol & Hepatol, Lausanne, Switzerland; [Moradpour, Darius; Bochud, Pierre-Yves] Univ Lausanne, Lausanne, Switzerland; [Muellhaupt, Beat] Univ Zurich Hosp, Div Gastroenterol & Hepatol, CH-8091 Zurich, Switzerland; [Semela, David] Canton Hosp, Div Gastroenterol, St Gallen, Switzerland; [Pascarella, Stephanie] Univ Geneva, Dept Pathol & Immunol, Geneva, Switzerland; [Bochud, Pierre-Yves] Univ Lausanne Hosp, Div Infect Dis, Lausanne, Switzerland	University of Geneva; University of Geneva; University of Geneva; IRCCS Casa Sollievo Della Sofferenza; University of Bern; University Hospital of Bern; University of Bern; University Hospital of Bern; University of Bern; University Hospital of Bern; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Lausanne; University of Zurich; University Zurich Hospital; Kantonsspital St. Gallen; University of Geneva; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV)	Morard, I (corresponding author), Univ Hosp Geneva, Div Gastroenterol & Hepatol, Geneva, Switzerland.	isabelle.morard@hcuge.ch	Mangia, A/AAL-5357-2020; De Gottardi, Andrea/AAN-7512-2020; Semela, David/D-1988-2010; Bochud, Pierre-Yves/ABE-5979-2020; Negro, Francesco/E-2183-2012; Heim, Markus/A-7526-2008; Moradpour, Darius/G-7918-2017; Mullhaupt, Beat/O-3744-2016	Mangia, A/0000-0002-2600-3555; De Gottardi, Andrea/0000-0002-4401-2340; Heim, Markus/0000-0002-7523-4894; Moradpour, Darius/0000-0003-1977-6792; Bochud, Pierre-Yves/0000-0002-2208-4757; Mullhaupt, Beat/0000-0002-9020-8192	Swiss National Science Foundation [3347C0-108782/1, 33CS30_148417/1]; European Union [260844]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); European Union(European Commission)	This work was supported by Swiss National Science Foundation grants 3347C0-108782/1 and 33CS30_148417/1 to the Swiss Hepatitis C Cohort Study; European Union's Seventh Framework Programme for research, technological development and demonstration: grant agreement no 260844 to the Swiss Hepatitis C Cohort Study; and Swiss National Science Foundation grant 33CS30_148417/1 to FN. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahlenstiel G, 2003, J HEPATOL, V39, P245, DOI 10.1016/S0168-8278(03)00193-4; Ajuebor MN, 2006, J IMMUNOL, V177, P2039, DOI 10.4049/jimmunol.177.4.2039; BEDOSSA P, 1994, HEPATOLOGY, V20, P15; Bochud PY, 2009, J HEPATOL, V51, P655, DOI 10.1016/j.jhep.2009.05.016; Bruno R, 2010, GUT, V59, P513, DOI 10.1136/gut.2008.163287; El-Moamly AAR, 2013, PARASITOL RES, V112, P2745, DOI 10.1007/s00436-013-3380-9; Fatkenheuer G, 2008, NEW ENGL J MED, V359, P1442, DOI 10.1056/NEJMoa0803154; Fatkenheuer G, 2010, JAIDS-J ACQ IMM DEF, V53, P78, DOI 10.1097/QAI.0b013e3181bb28dc; Ge DL, 2009, NATURE, V461, P399, DOI 10.1038/nature08309; Glas J, 2003, CLIN IMMUNOL, V108, P46, DOI 10.1016/S1521-6616(03)00059-7; Goulding C, 2005, GUT, V54, P1157, DOI 10.1136/gut.2004.055699; Goyal A, 2006, WORLD J GASTROENTERO, V12, P4721, DOI 10.3748/wjg.v12.i29.4721; Gruener NH, 2001, J VIROL, V75, P5550, DOI 10.1128/JVI.75.12.5550-5558.2001; Hanafiah KM, 2013, HEPATOLOGY, V57, P1333, DOI 10.1002/hep.26141; Hellier S, 2003, HEPATOLOGY, V38, P1468, DOI [10.1016/j.hep.2003.09.027, 10.1053/jhep.2003.09027]; Kunkel EJ, 2002, AM J PATHOL, V160, P347, DOI 10.1016/S0002-9440(10)64378-7; Larrubia JR, 2007, J HEPATOL, V47, P632, DOI 10.1016/j.jhep.2007.04.009; Lazzarin A, 2012, HIV CLIN TRIALS, V13, P83, DOI 10.1310/hct1302-83; Lechner F, 2001, REV MED VIROL, V11, P11, DOI 10.1002/rmv.295; Lechner F, 2000, EUR J IMMUNOL, V30, P2479, DOI 10.1002/1521-4141(200009)30:9<2479::AID-IMMU2479>3.0.CO;2-B; Loetscher P, 1998, NATURE, V391, P344, DOI 10.1038/34814; Macias J, 2012, EUR J CLIN MICROBIOL, V31, P2083, DOI 10.1007/s10096-012-1546-5; Nattermann J, 2011, J HEPATOL, V55, P1201, DOI 10.1016/j.jhep.2011.03.011; Patin E, 2012, GASTROENTEROLOGY, V143, P1244, DOI 10.1053/j.gastro.2012.07.097; Prasad L, 2007, INT J EPIDEMIOL, V36, P731, DOI 10.1093/ije/dym096; Promrat K, 2003, GASTROENTEROLOGY, V124, P352, DOI 10.1053/gast.2003.50061; Rauch A, 2010, GASTROENTEROLOGY, V138, P1338, DOI 10.1053/j.gastro.2009.12.056; Seki E, 2009, J CLIN INVEST, V119, P1858, DOI 10.1172/JCI37444; Suppiah V, 2013, GENES IMMUN, V14, P286, DOI 10.1038/gene.2013.15; Suppiah V, 2009, NAT GENET, V41, P1100, DOI 10.1038/ng.447; Tanaka Y, 2009, NAT GENET, V41, P1105, DOI 10.1038/ng.449; Thomas DL, 2009, NATURE, V461, P798, DOI 10.1038/nature08463; Urabe Y, 2013, J HEPATOL, V58, P875, DOI 10.1016/j.jhep.2012.12.024; Vincent T, 2005, JAIDS-J ACQ IMM DEF, V38, P305; Wendt A, 2014, CLIN PHARMACOL-ADV A, V6, P1, DOI 10.2147/CPAA.S30338; Woitas RP, 2002, GASTROENTEROLOGY, V122, P1721, DOI 10.1053/gast.2002.33660; Yang YF, 2001, J CLIN IMMUNOL, V21, P402, DOI 10.1023/A:1013173610032	37	5	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2014	9	9							e106424	10.1371/journal.pone.0106424	http://dx.doi.org/10.1371/journal.pone.0106424			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ1IR	25191700	Green Submitted, Green Accepted, Green Published, gold			2022-12-27	WOS:000347993600024
J	Ongo, G; Ricoult, SG; Kennedy, TE; Juncker, D				Ongo, Grant; Ricoult, Sebastien G.; Kennedy, Timothy E.; Juncker, David			Ordered, Random, Monotonic and Non-Monotonic Digital Nanodot Gradients	PLOS ONE			English	Article							GENE-EXPRESSION; GROWTH; GUIDANCE; DIFFERENTIATION; MOLECULES; PROTEIN; MECHANISMS; HAPTOTAXIS; GENERATION; RESPONSES	Cell navigation is directed by inhomogeneous distributions of extracellular cues. It is well known that noise plays a key role in biology and is present in naturally occurring gradients at the micro-and nanoscale, yet it has not been studied with gradients in vitro. Here, we introduce novel algorithms to produce ordered and random gradients of discrete nanodots called digital nanodot gradients (DNGs) -according to monotonic and non-monotonic density functions. The algorithms generate continuous DNGs, with dot spacing changing in two dimensions along the gradient direction according to arbitrary mathematical functions, with densities ranging from 0.02% to 44.44%. The random gradient algorithm compensates for random nanodot overlap, and the randomness and spatial homogeneity of the DNGs were confirmed with Ripley's K function. An array of 100 DNGs, each 400x400 mm(2), comprising a total of 57 million 200x200 nm(2) dots was designed and patterned into silicon using electron-beam lithography, then patterned as fluorescently labeled IgGs on glass using lift-off nanocontact printing. DNGs will facilitate the study of the effects of noise and randomness at the micro-and nanoscales on cell migration and growth.	[Ongo, Grant; Juncker, David] McGill Univ, Dept Biomed Engn, Montreal, PQ, Canada; [Ongo, Grant; Ricoult, Sebastien G.; Juncker, David] McGill Univ, Montreal, PQ, Canada; [Ongo, Grant; Ricoult, Sebastien G.; Juncker, David] McGill Univ, Genome Quebec Innovat Ctr, Montreal, PQ, Canada; [Ricoult, Sebastien G.; Kennedy, Timothy E.; Juncker, David] McGill Univ, Montreal Neurol Inst, Dept Neurol & Neurosurg, McGill Program Neuroengn, Montreal, PQ H3A 2B4, Canada	McGill University; McGill University; McGill University; McGill University	Juncker, D (corresponding author), McGill Univ, Dept Biomed Engn, Montreal, PQ, Canada.	david.juncker@mcgill.ca	Ricoult, Sebastien/L-3081-2013; Juncker, David/C-2351-2009	Ricoult, Sebastien/0000-0002-3226-8058; Juncker, David/0000-0002-7313-1162	Canadian Institutes of Health Research (CHIR); Imperial-McGill collaboration in Neurotechnology; Canadian Foundation for Innovation (CFI); McGill Nanotools Microfabrication Laboratory - CFI; CFI; McGill University; Natural Sciences and Engineering Research Council (NSERC); Neuroengineering Training Program (NTP) at McGill University; CIHR; Molson Foundation; Biomedical Engineering Department at McGill University; Killam Foundation Scholar Award; Chercheur National Award from the Fonds de la Recherche en Sante du Quebec; McGill Nanotools Microfabrication Laboratory - McGill University	Canadian Institutes of Health Research (CHIR)(Canadian Institutes of Health Research (CIHR)); Imperial-McGill collaboration in Neurotechnology; Canadian Foundation for Innovation (CFI)(Canada Foundation for Innovation); McGill Nanotools Microfabrication Laboratory - CFI; CFI(Canada Foundation for Innovation); McGill University; Natural Sciences and Engineering Research Council (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Neuroengineering Training Program (NTP) at McGill University; CIHR(Canadian Institutes of Health Research (CIHR)); Molson Foundation; Biomedical Engineering Department at McGill University; Killam Foundation Scholar Award; Chercheur National Award from the Fonds de la Recherche en Sante du Quebec(Fonds de la Recherche en Sante du Quebec); McGill Nanotools Microfabrication Laboratory - McGill University	The authors acknowledge support from the Canadian Institutes of Health Research (CHIR, Regenerative and Nanomedicine Grant), the Imperial-McGill collaboration in Neurotechnology, the Canadian Foundation for Innovation (CFI) and the McGill Nanotools Microfabrication Laboratory (funded by CFI and McGill University). G.O. and S.G.R. were supported by the Natural Sciences and Engineering Research Council (NSERC) Collaborative Research and Training Experience (CREATE) grants for Integrated Sensors and Systems (ISS) and Neuroengineering Training Program (NTP) at McGill University. The NTP is also funded through CIHR and The Molson Foundation. G.O. was supported by the Biomedical Engineering Department at McGill University. T.E.K. was supported by a Killam Foundation Scholar Award and a Chercheur National Award from the Fonds de la Recherche en Sante du Quebec. D.J. holds a Canada Research Chair. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chang JG, 2005, J APPL PHYS, V98; Chung BG, 2005, LAB CHIP, V5, P401, DOI 10.1039/b417651k; Coyer SR, 2007, ANGEW CHEM INT EDIT, V46, P6837, DOI 10.1002/anie.200700989; Dalal IL, 2008, IEEE INT CONF ASAP, P108, DOI 10.1109/ASAP.2008.4580163; Dalby MJ, 2007, NAT MATER, V6, P997, DOI 10.1038/nmat2013; Derby B, 2012, SCIENCE, V338, P921, DOI 10.1126/science.1226340; Dertinger SKW, 2002, P NATL ACAD SCI USA, V99, P12542, DOI 10.1073/pnas.192457199; DEV P, 1975, INT J MAN MACH STUD, V7, P511, DOI 10.1016/S0020-7373(75)80030-7; DICKINSON RB, 1993, J MATH BIOL, V31, P563, DOI 10.1007/BF00161199; Goodman CS, 1996, ANNU REV NEUROSCI, V19, P341, DOI 10.1146/annurev.ne.19.030196.002013; Gurdon JB, 2001, NATURE, V413, P797, DOI 10.1038/35101500; Imamichi T, 2011, WINT SIMUL C PROC, P2414, DOI 10.1109/WSC.2011.6147951; Kantawong F, 2009, BIOMATERIALS, V30, P4723, DOI 10.1016/j.biomaterials.2009.05.040; Keenan TM, 2008, LAB CHIP, V8, P34, DOI 10.1039/b711887b; Kim BK, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2247; Kiskowski MA, 2009, BIOPHYS J, V97, P1095, DOI 10.1016/j.bpj.2009.05.039; Lander AD, 2002, DEV BIOL, V247, P471; Mai J, 2009, J NEUROSCI, V29, P7450, DOI 10.1523/JNEUROSCI.1121-09.2009; McLaughlin T, 2005, ANNU REV NEUROSCI, V28, P327, DOI 10.1146/annurev.neuro.28.061604.135714; Ming GL, 2002, NATURE, V417, P411, DOI 10.1038/nature745; PAPPAS TN, 1994, ICPS '94: THE PHYSICS AND CHEMISTRY OF IMAGING SYSTEMS - IS&T'S 47TH ANNUAL CONFERENCE, VOLS I AND II, P468; Raser JM, 2005, SCIENCE, V309, P2010, DOI 10.1126/science.1105891; Ricoult SG, 2014, BIOMATERIALS, V35, P727, DOI 10.1016/j.biomaterials.2013.10.023; Ricoult SG, 2013, SMALL, V9, P3308, DOI 10.1002/smll.201202915; Smith JT, 2006, EXP CELL RES, V312, P2424, DOI 10.1016/j.yexcr.2006.04.005; SWEETSER DA, 1988, GENE DEV, V2, P1318, DOI 10.1101/gad.2.10.1318; Tonazzini I, 2013, BIOMATERIALS, V34, P6027, DOI 10.1016/j.biomaterials.2013.04.039; Ulichney R., 1987, DIGITAL HALFTONING; Von Philipsborn AC, 2006, NAT PROTOC, V1, P1322, DOI 10.1038/nprot.2006.251; von Philipsborn AC, 2006, DEVELOPMENT, V133, P2487, DOI 10.1242/dev.02412; Wang CJ, 2008, LAB CHIP, V8, P227, DOI 10.1039/b713945d; Weber M, 2013, SCIENCE, V339, P328, DOI 10.1126/science.1228456	32	4	5	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2014	9	9							e106541	10.1371/journal.pone.0106541	http://dx.doi.org/10.1371/journal.pone.0106541			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ1IR	25192173	Green Published, gold, Green Submitted			2022-12-27	WOS:000347993600033
J	Bhojani, U; Devedasan, N; Mishra, A; De Henauw, S; Kolsteren, P; Criel, B				Bhojani, Upendra; Devedasan, Narayanan; Mishra, Arima; De Henauw, Stefaan; Kolsteren, Patrick; Criel, Bart			Health System Challenges in Organizing Quality Diabetes Care for Urban Poor in South India	PLOS ONE			English	Article							CHRONIC DISEASES; RISK-FACTORS; PREVALENCE; MANAGEMENT	Background: Weak health systems in low-and middle-income countries are recognized as the major constraint in responding to the rising burden of chronic conditions. Despite recognition by global actors for the need for research on health systems, little attention has been given to the role played by local health systems. We aim to analyze a mixed local health system to identify the main challenges in delivering quality care for diabetes mellitus type 2. Methods: We used the health system dynamics framework to analyze a health system in KG Halli, a poor urban neighborhood in South India. We conducted semi-structured interviews with healthcare providers located in and around the neighborhood who provide care to diabetes patients: three specialist and 13 non-specialist doctors, two pharmacists, and one laboratory technician. Observations at the health facilities were recorded in a field diary. Data were analyzed through thematic analysis. Result: There is a lack of functional referral systems and a considerable overlap in provision of outpatient care for diabetes across the different levels of healthcare services in KG Halli. Inadequate use of patients' medical records and lack of standard treatment protocols affect clinical decision-making. The poor regulation of the private sector, poor systemic coordination across healthcare providers and healthcare delivery platforms, widespread practice of bribery and absence of formal grievance redress platforms affect effective leadership and governance. There appears to be a trust deficit among patients and healthcare providers. The private sector, with a majority of healthcare providers lacking adequate training, operates to maximize profit, and healthcare for the poor is at best seen as charity. Conclusions: Systemic impediments in local health systems hinder the delivery of quality diabetes care to the urban poor. There is an urgent need to address these weaknesses in order to improve care for diabetes and other chronic conditions.	[Bhojani, Upendra; Devedasan, Narayanan] Inst Publ Hlth, Bangalore, Karnataka, India; [Bhojani, Upendra; Kolsteren, Patrick; Criel, Bart] Inst Trop Med, Dept Publ Hlth, B-2000 Antwerp, Belgium; [Bhojani, Upendra; De Henauw, Stefaan] Univ Ghent, Dept Publ Hlth, B-9000 Ghent, Belgium; [Mishra, Arima] Azim Premji Univ, Bangalore, Karnataka, India	Institute of Tropical Medicine (ITM); Ghent University	Bhojani, U (corresponding author), Inst Publ Hlth, Bangalore, Karnataka, India.	upendra@iphindia.org	BHOJANI, UPENDRA/AAP-7846-2021	BHOJANI, UPENDRA/0000-0002-9179-6248; Devadasan, N./0000-0001-5774-2337	Institute of Tropical Medicine, Antwerp, Belgium	Institute of Tropical Medicine, Antwerp, Belgium	This study was funded through the PhD scholarship received by UB from the Institute of Tropical Medicine, Antwerp, Belgium (www.itg.be). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alliance for Health Policy and Systems Research, 2004, STRENGTH HLTH SYST R; Anand K, 2007, NATL MED J INDIA, V20, P115; Bhojani U, 2013, GLOBAL HEALTH ACTION, V6, DOI 10.3402/gha.v6i0.22258; Bhojani U, 2013, BMC HEALTH SERV RES, V13, DOI 10.1186/1472-6963-13-306; Bhojani U, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-990; Brashier B, 2012, OPEN J RESP DIS, V02, P73, DOI DOI 10.4236/OJRD.2012.23011; Chenge F, 2010, TRAINING MED DOCTORS; Dans A, 2011, LANCET, V377, P680, DOI 10.1016/S0140-6736(10)61506-1; Deepa Mohan, 2011, J Diabetes Sci Technol, V5, P918; Department of AYUSH, 2010, SYST AYUSH; Directorate General of Health Services, 2014, NAT PROGR PREV CONTR; Elloker S, 2012, CRISES ROUTINES INNO, P161; Gilson L, 2003, SOC SCI MED, V56, P1453, DOI 10.1016/S0277-9536(02)00142-9; International Diabetes Federation, 2013, IDF DIABETES ATLAS; Kar SS, 2010, NATL MED J INDIA, V23, P206; Kar SS, 2013, INT J MED PUBLIC HEA, V3, P215; Ministry of Health and Family Welfare, 2013, NAT URB HLTH MISS FR; Misra A, 2001, INT J OBESITY, V25, P1722, DOI 10.1038/sj.ijo.0801748; Nishtar S, 2010, B WORLD HEALTH ORGAN, V88, P74, DOI 10.2471/BLT.09.067868; Olmen J. van, 2012, Health, Culture and Society, V2, P1; Planning Commission of India, 1951, HLTH 1 5 YEAR PLAN 1; Planning Commission of India, 1974, HLTH FAM PLANN NUTR; Planning Commission of India, 1961, HLTH FAM PLANN 3 5 Y; Planning Commission of India, 1985, HLTH FAM WELF 7 5 YE, V2; Planning Commission of India, 1956, HLTH 2 5 YEAR PLAN; Planning Commission of India, 1969, HLTH FAM PLANN 4 5 Y; Pongsupap Y, 2010, EXPERIENCES PEOPLE C; Reddy KS, 2005, LANCET, V366, P1744, DOI [10.1016/s0140-6736(05)67343-6, 10.1016/S0140-6736(05)67343-6]; Samb B, 2010, LANCET, V376, P1785, DOI 10.1016/S0140-6736(10)61353-0; Sheikh K, 2015, HEALTH POLICY PLANN, V30, P39, DOI 10.1093/heapol/czt095; Srinivasan S, 2013, EC POLIT WKLY, VXLVIII, P14; Sunil Nandraj, 2012, Economic and Political Weekly, V47, P12; Task Force on Health Systems Research, 2005, MILL DEV GOALS WILL; The World Bank, 1992, MEM REC PRES INT DEV; The World Bank, 1988, MEM REC PRES INT DEV; van Olmen J., 2010, ANAL HLTH SYSTEMS MA; Venkataraman K, 2009, INT J DIABETES DEV C, V29, P103, DOI 10.4103/0973-3930.54286; WHO, 2007, EV BUS STRENGTH HLTH	38	24	24	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 4	2014	9	9							e106522	10.1371/journal.pone.0106522	http://dx.doi.org/10.1371/journal.pone.0106522			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3XV	25188582	Green Published, gold, Green Submitted			2022-12-27	WOS:000341271500049
J	Patel, DA; Snedecor, SJ; Tang, WY; Sudharshan, L; Lim, JW; Cuffe, R; Pulgar, S; Gilchrist, KA; Camejo, RR; Stephens, J; Nichols, G				Patel, Dipen A.; Snedecor, Sonya J.; Tang, Wing Yu; Sudharshan, Lavanya; Lim, Jessica W.; Cuffe, Robert; Pulgar, Sonia; Gilchrist, Kim A.; Camejo, Rodrigo Refoios; Stephens, Jennifer; Nichols, Garrett			48-Week Efficacy and Safety of Dolutegravir Relative to Commonly Used Third Agents in Treatment-Naive HIV-1-Infected Patients: A Systematic Review and Network Meta-Analysis	PLOS ONE			English	Review							REVERSE-TRANSCRIPTASE INHIBITOR; TENOFOVIR DISOPROXIL FUMARATE; TWICE-DAILY LOPINAVIR/RITONAVIR; ONCE-DAILY ATAZANAVIR/RITONAVIR; CO-FORMULATED ELVITEGRAVIR; HIV TYPE-1 INFECTION; ANTIRETROVIRAL-NAIVE; INITIAL TREATMENT; DOUBLE-BLIND; DAILY DARUNAVIR/RITONAVIR	Background: A network meta-analysis can provide estimates of relative efficacy for treatments not directly studied in head-to- head randomized controlled trials. We estimated the relative efficacy and safety of dolutegravir (DTG) versus third agents currently recommended by guidelines, including ritonavir-boosted atazanavir (ATV/r), ritonavir-boosted darunavir (DRV/r), efavirenz (EFV), cobicistat-boosted elvitegravir (EVG/c), ritonavir-boosted lopinavir (LPV/r), raltegravir (RAL), and rilpivirine (RPV), in treatment-naive HIV-1-infected patients. Methods: A systematic review of published literature was conducted to identify phase 3/4 randomized controlled clinical trials (up to August 2013) including at least one third agent of interest in combination with a backbone nucleoside reverse transcriptase inhibitor (NRTI) regimen. Bayesian fixed-effect network meta-analysis models adjusting for the type of nucleoside reverse transcriptase inhibitor backbone (tenofovir disoproxil fumarate/emtricitabine [TDF/FTC] or abacavir/lamivudine [ABC/3TC]) were used to evaluate week 48 efficacy (HIV-RNA suppression to <50 copies/mL and change in CD4+ cells/mu L) and safety (lipid changes, adverse events, and discontinuations due to adverse events) of DTG relative to all other treatments. Sensitivity analyses assessing the impact of NRTI treatment adjustment and random-effects models were performed. Results: Thirty-one studies including 17,000 patients were combined in the analysis. Adjusting for the effect of NRTI backbone, treatment with DTG resulted in significantly higher odds of virologic suppression (HIV RNA<50 copies/mL) and increase in CD4+ cells/mu L versus ATV/r, DRV/r, EFV, LPV/r, and RPV. Dolutegravir had better or equivalent changes in total cholesterol, LDL, triglycerides, and lower odds of adverse events and discontinuation due to adverse events compared to all treatments. Random-effects and unadjusted models resulted in similar conclusions. Conclusion: Three clinical trials of DTG have demonstrated comparable or superior efficacy and safety to DRV, RAL, and EFV in HIV-1-infected treatment-naive patients. This network meta-analysis suggests DTG is also favorable or comparable to other commonly used third agents (ATV/r, LPV/r, RPV, and EVG/c).	[Patel, Dipen A.; Snedecor, Sonya J.; Tang, Wing Yu; Sudharshan, Lavanya; Stephens, Jennifer] Pharmerit Int, Bethesda, MD 20814 USA; [Lim, Jessica W.] GlaxoSmithKline, Stockley Pk, Middx, England; [Cuffe, Robert] ViiV Healthcare, Brentford, Middx, England; [Gilchrist, Kim A.] GlaxoSmithKline, Renaissance, PA USA; [Camejo, Rodrigo Refoios] GlaxoSmithKline, Brentford, Middx, England; [Pulgar, Sonia; Nichols, Garrett] GlaxoSmithKline, Res Triangle Pk, NC USA	GlaxoSmithKline; GlaxoSmithKline; GlaxoSmithKline; GlaxoSmithKline; GlaxoSmithKline	Snedecor, SJ (corresponding author), Pharmerit Int, Bethesda, MD 20814 USA.	ssnedecor@pharmerit.com			ViiV Healthcare; Pharmerit International; GlaxoSmithKline	ViiV Healthcare; Pharmerit International; GlaxoSmithKline(GlaxoSmithKline)	This study was funded by ViiV Healthcare. Pharmerit International, ViiV Healthcare and GlaxoSmithKline provided support in the form of salaries for all authors as employees but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aberg JA, 2012, AIDS RES HUM RETROV, V28, P1184, DOI 10.1089/aid.2011.0327; Andersson LM, 2013, SCAND J INFECT DIS, V45, P543, DOI 10.3109/00365548.2012.756985; [Anonymous], 2014, GUIDELINES USE ANTIR, P1; Bartlett JA, 2006, JAIDS-J ACQ IMM DEF, V43, P284, DOI 10.1097/01.qai.0000243092.40490.26; Behrens G, 2012, ANTIVIR THER, V17, P1011, DOI 10.3851/IMP2305; Berenguer J, 2008, CLIN INFECT DIS, V47, P1083, DOI 10.1086/592114; Bonnet M, 2013, LANCET INFECT DIS, V13, P303, DOI 10.1016/S1473-3099(13)70007-0; Bucher HC, 1997, J CLIN EPIDEMIOL, V50, P683, DOI 10.1016/S0895-4356(97)00049-8; Campbell TB, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001290; Clotet B, 2014, LANCET, V383, P2222, DOI 10.1016/S0140-6736(14)60084-2; Cohen C, 2013, 7 AIS C HIV APTH TE; Cohen CJ, 2011, LANCET, V378, P229, DOI 10.1016/S0140-6736(11)60983-5; Daar ES, 2011, ANN INTERN MED, V154, DOI 10.7326/0003-4819-154-7-201104050-00316; DeJesus E, 2004, CLIN INFECT DIS, V39, P1038, DOI 10.1086/424009; DeJesus E, 2004, CLIN INFECT DIS, V39, P411, DOI 10.1086/422143; DeJesus E, 2011, INT J CLIN PRACT, V65, P1240, DOI 10.1111/j.1742-1241.2011.02807.x; DeJesus E, 2012, LANCET, V379, P2429, DOI 10.1016/S0140-6736(12)60918-0; Despiegel N, 2014, VALUE HEALTH, V17, pA273, DOI 10.1016/j.jval.2014.03.1589; Despiegel N, 2013, 14 HIV EUR AIDS C; deWolf F, 1997, AIDS, V11, P1799, DOI 10.1097/00002030-199715000-00003; Dias S, 2013, MED DECIS MAKING, V33, P657, DOI 10.1177/0272989X13485155; Dias S, 2013, MED DECIS MAKING, V33, P597, DOI 10.1177/0272989X13487604; Dias S, 2013, MED DECIS MAKING, V33, P607, DOI 10.1177/0272989X12458724; Dore GJ, 2004, J INFECT DIS, V189, P1185, DOI 10.1086/380398; Echeverria P, 2010, ANTIVIR RES, V85, P403, DOI 10.1016/j.antiviral.2009.11.008; Joseph E, 2006, LANCET, V368, P476, DOI 10.1016/S0140-6736(06)69155-1; European AIDS Clinical Society, 2013, GUID VERS 7 0; Fong R, 2013, SEX HEALTH, V10, P442, DOI 10.1071/SH13043; Gallant JE, 2006, NEW ENGL J MED, V354, P251, DOI 10.1056/NEJMoa051871; Gallant JE, 2004, JAMA-J AM MED ASSOC, V292, P191, DOI 10.1001/jama.292.2.191; Goujard C, 2006, CLIN INFECT DIS, V42, P709, DOI 10.1086/500213; Gulick RM, 2006, JAMA-J AM MED ASSOC, V296, P769, DOI 10.1001/jama.296.7.769; Higgins J, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.ED000049; Hogg R, 2013, 7 IAS C HIV PATH TRE; Huedo-Medina TB, 2006, PSYCHOL METHODS, V11, P193, DOI 10.1037/1082-989X.11.2.193; Jemsek JG, 2006, CLIN INFECT DIS, V42, P273, DOI 10.1086/498505; Lennox JL, 2009, LANCET, V374, P796, DOI 10.1016/S0140-6736(09)60918-1; Lockman S, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001236; Lu G, 2004, STAT MED, V23, P3105, DOI 10.1002/sim.1875; Lunn DJ, 2000, STAT COMPUT, V10, P325, DOI 10.1023/A:1008929526011; Maggiolo F, 2003, CLIN INFECT DIS, V37, P41, DOI 10.1086/375598; Mankhatitham Wiroj, 2012, Journal of the Medical Association of Thailand, V95, P163; Mannheimer S, 2002, CLIN INFECT DIS, V34, P1115, DOI 10.1086/339074; Manosuthi W, 2009, CLIN INFECT DIS, V48, P1752, DOI 10.1086/599114; Martin S, 2007, 4 IAS C HIV PATH TRE; Mills AM, 2009, AIDS, V23, P1679, DOI 10.1097/QAD.0b013e32832d7350; Moher David, 2009, Open Med, V3, pe123; Molina JM, 2008, LANCET, V372, P646, DOI 10.1016/S0140-6736(08)61081-8; Molina JM, 2013, AIDS, V27, P889, DOI 10.1097/QAD.0b013e32835e1554; Molina JM, 2011, LANCET, V378, P238, DOI 10.1016/S0140-6736(11)60936-7; Montaner Julio S G, 2006, MedGenMed, V8, P36; Nelson MR, 2013, HIV CLIN TRIALS, V14, P81, DOI 10.1310/hct1403-81; Nelson M, 2012, J ANTIMICROB CHEMOTH, V67, P2020, DOI 10.1093/jac/dks130; Malan DR, 2008, JAIDS-J ACQ IMM DEF, V47, P161, DOI 10.1097/QAI.0b013e31815ace6a; Nishijima T, 2013, INTERNAL MED, V52, P735, DOI 10.2169/internalmedicine.52.9155; Ortiz R, 2008, AIDS, V22, P1389, DOI 10.1097/QAD.0b013e32830285fb; Paterson DL, 2000, ANN INTERN MED, V133, P21, DOI 10.7326/0003-4819-133-1-200007040-00004; Phillips AN, 2006, CURR OPIN HIV AIDS, V1, P43, DOI 10.1097/01.COH.0000194106.12816.b1; Pinola M., 2010, J ANTIVIRALS ANTIRET, V2, P56, DOI [10.4172/jaa.1000024, DOI 10.4172/JAA.1000024]; Post FA, 2010, JAIDS-J ACQ IMM DEF, V55, P49, DOI 10.1097/QAI.0b013e3181dd911e; Puls RL, 2010, CLIN INFECT DIS, V51, P855, DOI 10.1086/656363; Raffi F, 2013, LANCET, V381, P735, DOI 10.1016/S0140-6736(12)61853-4; Riddler SA, 2008, NEW ENGL J MED, V358, P2095, DOI 10.1056/NEJMoa074609; Rockstroh JK, 2013, JAIDS-J ACQ IMM DEF, V63, P77, DOI 10.1097/QAI.0b013e31828ace69; Rodger AJ, 2013, AIDS, V27, P973, DOI 10.1097/QAD.0b013e32835cae9c; Sax PE, 2012, LANCET, V379, P2439, DOI 10.1016/S0140-6736(12)60917-9; Sierra-Madero J, 2010, JAIDS-J ACQ IMM DEF, V53, P582, DOI 10.1097/QAI.0b013e3181cae4a1; Smith Kimberly Y, 2008, AIDS Res Ther, V5, P5, DOI 10.1186/1742-6405-5-5; Smith KY, 2009, AIDS, V23, P1547, DOI 10.1097/QAD.0b013e32832cbcc2; Solem CT, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098152; Soriano V, 2011, ANTIVIR THER, V16, P339, DOI 10.3851/IMP1745; Squires K, 2004, JAIDS-J ACQ IMM DEF, V36, P1011, DOI 10.1097/00126334-200408150-00003; US Department of Health and Human Services  U.S. Department of Health and Human Services, 2013, GUID IND HUM IMM VIR; Uy J, 2011, AIDS CARE, V23, P1500, DOI 10.1080/09540121.2011.565033; van Leth F, 2004, ANTIVIR THER, V9, P721; Fernandez-Montero JV, 2014, EXPERT OPIN PHARMACO, V15, P1051, DOI 10.1517/14656566.2014.913023; Vieira MC, 2011, HIV CLIN TRIALS, V12, P175, DOI [10.1310/hct1204-175, 10.1310/HCT1204-175]; Vrouenraets SME, 2011, HIV MED, V12, P620, DOI 10.1111/j.1468-1293.2011.00941.x; Walmsley S, 2002, NEW ENGL J MED, V346, P2039, DOI 10.1056/NEJMoa012354; Walmsley S, 2009, JAIDS-J ACQ IMM DEF, V50, P367, DOI 10.1097/QAI.0b013e318198a815; Walmsley SL, 2013, NEW ENGL J MED, V369, P1807, DOI 10.1056/NEJMoa1215541; Wester CW, 2010, AIDS, V24, pS27, DOI 10.1097/01.aids.0000366080.91192.55; Yeni P, 2006, LANCET, V368, P287, DOI 10.1016/S0140-6736(06)69074-0	83	52	55	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 4	2014	9	9							e105653	10.1371/journal.pone.0105653	http://dx.doi.org/10.1371/journal.pone.0105653			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3XV	25188312	gold, Green Submitted, Green Published			2022-12-27	WOS:000341271500011
J	Radeloff, D; Ciaramidaro, A; Siniatchkin, M; Hainz, D; Schlitt, S; Weber, B; Poustka, F; Bolte, S; Walter, H; Freitag, CM				Radeloff, Daniel; Ciaramidaro, Angela; Siniatchkin, Michael; Hainz, Daniela; Schlitt, Sabine; Weber, Bernhard; Poustka, Fritz; Boelte, Sven; Walter, Henrik; Freitag, Christine Margarete			Structural Alterations of the Social Brain: A Comparison between Schizophrenia and Autism	PLOS ONE			English	Article							MEDIAL PREFRONTAL CORTEX; LIKELIHOOD ESTIMATION METAANALYSIS; FUNCTIONAL MAGNETIC-RESONANCE; CEREBRAL-BLOOD-FLOW; SPECTRUM DISORDERS; AUDITORY HALLUCINATIONS; NEURAL SYSTEMS; ASPERGER-SYNDROME; 1ST-EPISODE SCHIZOPHRENIA; INSULAR DYSFUNCTION	Autism spectrum disorder and schizophrenia share a substantial number of etiologic and phenotypic characteristics. Still, no direct comparison of both disorders has been performed to identify differences and commonalities in brain structure. In this voxel based morphometry study, 34 patients with autism spectrum disorder, 21 patients with schizophrenia and 26 typically developed control subjects were included to identify global and regional brain volume alterations. No global gray matter or white matter differences were found between groups. In regional data, patients with autism spectrum disorder compared to typically developed control subjects showed smaller gray matter volume in the amygdala, insula, and anterior medial prefrontal cortex. Compared to patients with schizophrenia, patients with autism spectrum disorder displayed smaller gray matter volume in the left insula. Disorder specific positive correlations were found between mentalizing ability and left amygdala volume in autism spectrum disorder, and hallucinatory behavior and insula volume in schizophrenia. Results suggest the involvement of social brain areas in both disorders. Further studies are needed to replicate these findings and to quantify the amount of distinct and overlapping neural correlates in autism spectrum disorder and schizophrenia.	[Radeloff, Daniel; Ciaramidaro, Angela; Siniatchkin, Michael; Hainz, Daniela; Schlitt, Sabine; Poustka, Fritz; Boelte, Sven; Freitag, Christine Margarete] Goethe Univ Frankfurt, Dept Child & Adolescent Psychiat Psychosomat & Ps, D-60054 Frankfurt, Germany; [Weber, Bernhard; Walter, Henrik] Goethe Univ Frankfurt, Dept Psychiat Psychosomat & Psychotherapy, D-60054 Frankfurt, Germany; [Boelte, Sven] Karolinska Inst KIND, Ctr Neurodev Disorders, Dept Womens & Childrens Hlth, Stockholm, Sweden; [Walter, Henrik] Charite, Dept Psychiat & Psychotherapy, Div Mind & Brain Res, D-13353 Berlin, Germany; [Weber, Bernhard] Univ Basel, Psychiat Univ Clin, Basel, Switzerland	Goethe University Frankfurt; Goethe University Frankfurt; Karolinska Institutet; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; University of Basel	Radeloff, D (corresponding author), Goethe Univ Frankfurt, Dept Child & Adolescent Psychiat Psychosomat & Ps, D-60054 Frankfurt, Germany.	daniel.radeloff@kgu.de	Radeloff, Daniel/I-8354-2015; Bölte, Sven/AAH-8675-2019; Walter, Henrik/O-2612-2013	Radeloff, Daniel/0000-0002-8430-8306; Bölte, Sven/0000-0002-4579-4970; Walter, Henrik/0000-0002-9403-6121; Freitag, Christine Margarete/0000-0001-9676-4782; Ciaramidaro, Angela/0000-0003-1157-6702	Swedish Research Council [523-2009-7054]; LOEWE-Program 'Neuronal Coordination Research Focus Frankfurt' (NeFF)	Swedish Research Council(Swedish Research CouncilEuropean Commission); LOEWE-Program 'Neuronal Coordination Research Focus Frankfurt' (NeFF)	The study was partly supported by the Swedish Research Council (grant nr. 523-2009-7054) and by the LOEWE-Program 'Neuronal Coordination Research Focus Frankfurt' (NeFF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achenbach T. M., 1991, MANUAL SELF REPORT 1; Achenbach TM, 1997, MANUAL YOUNG ADULT S, DOI DOI 10.1126/science.aap8757; Adolphs R, 2003, NAT REV NEUROSCI, V4, P165, DOI 10.1038/nrn1056; Amodio DM, 2006, NAT REV NEUROSCI, V7, P268, DOI 10.1038/nrn1884; [Anonymous], 1991, MANUAL CHILD BEHAV C; Ashburner J, 2010, VBM TUTORIAL; Aylward EH, 1999, NEUROLOGY, V53, P2145, DOI 10.1212/WNL.53.9.2145; Baron-Cohen S, 2001, J CHILD PSYCHOL PSYC, V42, P241, DOI 10.1017/S0021963001006643; Baron-Cohen S, 2000, NEUROSCI BIOBEHAV R, V24, P355, DOI 10.1016/S0149-7634(00)00011-7; Bauman ML, 2005, INT J DEV NEUROSCI, V23, P183, DOI 10.1016/j.ijdevneu.2004.09.006; Bolte S., 2006, DIAGNOSTISCHES INTER; Bora E, 2011, SCHIZOPHR RES, V127, P46, DOI 10.1016/j.schres.2010.12.020; Borgwardt SJ, 2007, BIOL PSYCHIAT, V61, P1148, DOI 10.1016/j.biopsych.2006.08.009; Brieber S, 2007, J CHILD PSYCHOL PSYC, V48, P1251, DOI 10.1111/j.1469-7610.2007.01799.x; Brune M, 2009, BEHAV BRAIN FUNCT, V5, DOI 10.1186/1744-9081-5-6; Brunet E, 2003, NEUROPSYCHOLOGIA, V41, P1574, DOI 10.1016/S0028-3932(03)00119-2; Burns J, 2006, WORLD PSYCHIATRY, V5, P77; Carr L, 2003, P NATL ACAD SCI USA, V100, P5497, DOI 10.1073/pnas.0935845100; Castelli F, 2002, BRAIN, V125, P1839, DOI 10.1093/brain/awf189; Chan RCK, 2010, SCHIZOPHR B, V37, P177; Cheung C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012233; Ciaramidaro A, 2013, SOCIAL COGNITIVE AFF; Copolov DL, 2003, PSYCHIAT RES-NEUROIM, V122, P139, DOI 10.1016/S0925-4927(02)00121-X; Courchesne E, 2011, JAMA-J AM MED ASSOC, V306, P2001, DOI 10.1001/jama.2011.1638; Craig AD, 2009, NAT REV NEUROSCI, V10, P59, DOI 10.1038/nrn2555; Craig AD, 2003, CURR OPIN NEUROBIOL, V13, P500, DOI 10.1016/S0959-4388(03)00090-4; Critchley HD, 2004, NAT NEUROSCI, V7, P189, DOI 10.1038/nn1176; Critchley HD, 2000, BRAIN, V123, P2203, DOI 10.1093/brain/123.11.2203; Critchley HD, 2002, NEUROIMAGE, V16, P909, DOI 10.1006/nimg.2002.1147; Das P, 2012, SCHIZOPHR RES, V134, P158, DOI 10.1016/j.schres.2011.08.019; Deichmann R, 2004, NEUROIMAGE, V21, P757, DOI 10.1016/j.neuroimage.2003.09.062; Devue C, 2007, BRAIN RES, V1143, P169, DOI 10.1016/j.brainres.2007.01.055; Di Martino A, 2009, BIOL PSYCHIAT, V65, P63, DOI 10.1016/j.biopsych.2008.09.022; Dickstein DP, 2013, J AM ACAD CHILD PSY, V52, P279, DOI 10.1016/j.jaac.2012.12.012; Diederen KMJ, 2010, AM J PSYCHIAT, V167, P427, DOI 10.1176/appi.ajp.2009.09040456; Doyle-Thomas KAR, 2013, J CHILD NEUROL, V28, P729, DOI 10.1177/0883073812451496; Duerden EG, 2012, AUTISM RES, V5, P49, DOI 10.1002/aur.235; Duvernoy H. M., 1991, HUMAN BRAIN SURFACE; Dziobek I, 2006, NEUROPSYCHOLOGIA, V44, P1891, DOI 10.1016/j.neuropsychologia.2006.02.005; Ebisch SJH, 2011, HUM BRAIN MAPP, V32, P1013, DOI 10.1002/hbm.21085; Ellison-Wright I, 2008, AM J PSYCHIAT, V165, P1015, DOI 10.1176/appi.ajp.2008.07101562; Ellison-Wright I, 2009, SCHIZOPHR RES, V108, P3, DOI 10.1016/j.schres.2008.11.021; Ford JM, 2004, J PSYCHIATR RES, V38, P37, DOI 10.1016/S0022-3956(03)00095-5; Fornito A, 2009, SCHIZOPHR RES, V108, P104, DOI 10.1016/j.schres.2008.12.011; Frith CD, 2006, BRAIN RES, V1079, P36, DOI 10.1016/j.brainres.2005.12.126; FRITH CD, 1988, BRIT J PSYCHIAT, V153, P437, DOI 10.1192/bjp.153.4.437; Frith CD, 2007, CURR BIOL, V17, pR724, DOI 10.1016/j.cub.2007.05.068; Frith U, 2003, PHILOS T R SOC B, V358, P459, DOI 10.1098/rstb.2002.1218; Gallagher HL, 2002, NEUROIMAGE, V16, P814, DOI 10.1006/nimg.2002.1117; Glahn DC, 2008, BIOL PSYCHIAT, V64, P774, DOI 10.1016/j.biopsych.2008.03.031; Guilmatre A, 2009, ARCH GEN PSYCHIAT, V66, P947, DOI 10.1001/archgenpsychiatry.2009.80; Harrison PJ, 2003, SCHIZOPHR RES, V64, P25, DOI 10.1016/S0920-9964(02)00502-9; Hoffman RE, 2008, BRIT J PSYCHIAT, V193, P424, DOI 10.1192/bjp.bp.107.040501; Honaga E, 2010, NEUROSCI LETT, V478, P141, DOI 10.1016/j.neulet.2010.05.004; Honea R, 2005, AM J PSYCHIAT, V162, P2233, DOI 10.1176/appi.ajp.162.12.2233; Jabbi M, 2007, NEUROIMAGE, V34, P1744, DOI 10.1016/j.neuroimage.2006.10.032; Jardri R, 2011, AM J PSYCHIAT, V168, P73, DOI 10.1176/appi.ajp.2010.09101522; Johnston PJ, 2005, EUR J NEUROSCI, V22, P1221, DOI 10.1111/j.1460-9568.2005.04294.x; Kampe KKW, 2003, J NEUROSCI, V23, P5258; Kana RK, 2014, SOC COGN AFFECT NEUR, V9, P98, DOI 10.1093/scan/nss106; KAY SR, 1989, BRITISH JOURNAL OF PSYCHIATRY, VOL 155, SUPP NO. 7, P59, DOI 10.1192/S0007125000291514; Kleinhans NM, 2011, NEUROIMAGE, V54, P697, DOI 10.1016/j.neuroimage.2010.07.037; Kratzmeier H, 1988, STANDARD PROGR MATRI, P2; Lee SK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090792; Lombardo MV, 2011, NEUROIMAGE, V56, P1832, DOI 10.1016/j.neuroimage.2011.02.067; Lord C, 2001, AUTISM DIAGNOSTIC SC; Lovero KL, 2009, NEUROIMAGE, V45, P976, DOI 10.1016/j.neuroimage.2008.12.070; Machado CJ, 2006, BEHAV NEUROSCI, V120, P761, DOI 10.1037/0735-7044.120.4.761; Manoliu A, 2014, SCHIZOPHRENIA BULL, V40, P428, DOI 10.1093/schbul/sbt037; Manoliu A, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00216; May A, 2006, CURR OPIN NEUROL, V19, P407, DOI 10.1097/01.wco.0000236622.91495.21; McAlonan GM, 2008, J CHILD PSYCHOL PSYC, V49, P1287, DOI 10.1111/j.1469-7610.2008.01933.x; Menon V, 2010, BRAIN STRUCT FUNCT, V214, P655, DOI 10.1007/s00429-010-0262-0; Nickl-Jockschat T, 2012, HUM BRAIN MAPP, V33, P1470, DOI 10.1002/hbm.21299; Nieminen-von Wendt T, 2003, EUR CHILD ADOLES PSY, V12, P178, DOI 10.1007/s00787-003-0337-z; Ochsner KN, 2008, SOC COGN AFFECT NEUR, V3, P144, DOI 10.1093/scan/nsn006; Olabi B, 2011, BIOL PSYCHIAT, V70, P88, DOI 10.1016/j.biopsych.2011.01.032; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Palaniyappan L, 2013, NEURON, V79, P814, DOI 10.1016/j.neuron.2013.06.027; Palaniyappan L, 2012, SCHIZOPHR RES, V137, P169, DOI 10.1016/j.schres.2012.01.038; Palaniyappan L, 2012, J PSYCHIATR NEUROSCI, V37, P17, DOI 10.1503/jpn.100176; Pantelis C, 2003, LANCET, V361, P281, DOI 10.1016/S0140-6736(03)12323-9; Pedersen A, 2012, SCHIZOPHR RES, V137, P224, DOI 10.1016/j.schres.2012.02.022; Pelphrey KA, 2005, BRAIN, V128, P1038, DOI 10.1093/brain/awh404; Pelphrey KA, 2011, J CHILD PSYCHOL PSYC, V52, P631, DOI 10.1111/j.1469-7610.2010.02349.x; Pierce K, 2001, BRAIN, V124, P2059, DOI 10.1093/brain/124.10.2059; Pinkham AE, 2008, SCHIZOPHR RES, V99, P164, DOI 10.1016/j.schres.2007.10.024; Pol HEH, 2008, SCHIZOPHRENIA BULL, V34, P354, DOI 10.1093/schbul/sbm168; Quadflieg S, 2008, BIOL PSYCHOL, V78, P129, DOI 10.1016/j.biopsycho.2008.01.014; Rinaldi T, 2008, FRONT NEURAL CIRCUIT, V2, DOI 10.3389/neuro.04.004.2008; Ruahl D., 2004, DIAGNOSTISCHE BEOBAC; Rutter M, 2003, AUTISM DIAGNOSTIC IN; Saarela MV, 2007, CEREB CORTEX, V17, P230, DOI 10.1093/cercor/bhj141; Sasson NJ, 2011, J NEURODEV DISORD, V3, P87, DOI 10.1007/s11689-010-9068-x; Saxe R, 2006, CURR OPIN NEUROBIOL, V16, P235, DOI 10.1016/j.conb.2006.03.001; Schilbach L, 2010, J COGNITIVE NEUROSCI, V22, P2702, DOI 10.1162/jocn.2009.21401; Shenton ME, 2001, SCHIZOPHR RES, V49, P1, DOI 10.1016/S0920-9964(01)00163-3; Shepherd AM, 2012, BIOL PSYCHIAT, V72, P775, DOI 10.1016/j.biopsych.2012.04.020; Shepherd AM, 2012, NEUROSCI BIOBEHAV R, V36, P1342, DOI 10.1016/j.neubiorev.2011.12.015; Shergill SS, 2004, BRIT J PSYCHIAT, V185, P516, DOI 10.1192/bjp.185.6.516; Shergill SS, 2000, ARCH GEN PSYCHIAT, V57, P1033, DOI 10.1001/archpsyc.57.11.1033; Siegal M, 2002, NAT REV NEUROSCI, V3, P463, DOI 10.1038/nrn844; Singer T, 2004, SCIENCE, V303, P1157, DOI 10.1126/science.1093535; Stanfield AC, 2008, EUR PSYCHIAT, V23, P289, DOI 10.1016/j.eurpsy.2007.05.006; Steen RG, 2007, AM J NEURORADIOL, V28, P1119, DOI 10.3174/ajnr.A0537; Steen RG, 2006, BRIT J PSYCHIAT, V188, P510, DOI 10.1192/bjp.188.6.510; Sugranyes G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025322; Suzuki K, 2011, ARCH GEN PSYCHIAT, V68, P306, DOI 10.1001/archgenpsychiatry.2011.4; Talairach I., 1988, COPLANAR STEREOTACTI; Testa-Silva G, 2012, CEREB CORTEX, V22, P1333, DOI 10.1093/cercor/bhr224; Toyomaki A, 2013, JPN PSYCHOL RES, V55, P175, DOI 10.1111/jpr.12012; Uddin LQ, 2009, NEUROSCI BIOBEHAV R, V33, P1198, DOI 10.1016/j.neubiorev.2009.06.002; Umeda S, 2010, SOC NEUROSCI-UK, V5, P19, DOI 10.1080/17470910902990584; Via E, 2011, ARCH GEN PSYCHIAT, V68, P409, DOI 10.1001/archgenpsychiatry.2011.27; Vita A, 2006, SCHIZOPHR RES, V82, P75, DOI 10.1016/j.schres.2005.11.004; Walter H, 2004, J COGNITIVE NEUROSCI, V16, P1854, DOI 10.1162/0898929042947838; Walter H, 2009, SOC COGN AFFECT NEUR, V4, P166, DOI 10.1093/scan/nsn047; Wang AT, 2007, ARCH GEN PSYCHIAT, V64, P698, DOI 10.1001/archpsyc.64.6.698; Wang AT, 2004, J AM ACAD CHILD PSY, V43, P481, DOI 10.1097/00004583-200404000-00015; Wicker B, 2003, NEURON, V40, P655, DOI 10.1016/S0896-6273(03)00679-2; Woods SW, 2003, J CLIN PSYCHIAT, V64, P663, DOI 10.4088/JCP.v64n0607; Wright IC, 2000, AM J PSYCHIAT, V157, P16, DOI 10.1176/ajp.157.1.16; Wylie KP, 2010, SCHIZOPHR RES, V123, P93, DOI 10.1016/j.schres.2010.08.027	123	42	42	0	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 4	2014	9	9							e106539	10.1371/journal.pone.0106539	http://dx.doi.org/10.1371/journal.pone.0106539			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3XV	25188200	Green Published, Green Submitted, gold			2022-12-27	WOS:000341271500051
J	Betancor, MB; McStay, E; Minghetti, M; Migaud, H; Tocher, DR; Davie, A				Betancor, Monica B.; McStay, Elsbeth; Minghetti, Matteo; Migaud, Herve; Tocher, Douglas R.; Davie, Andrew			Daily Rhythms in Expression of Genes of Hepatic Lipid Metabolism in Atlantic Salmon (Salmo salar L.)	PLOS ONE			English	Article							CIRCADIAN CLOCK; RECEPTOR LXR; FISH-OIL; LIVER; ALPHA; BRAIN; LIGHT; MICROARRAY; MELATONIN; ONTOGENY	In mammals, several genes involved in liver lipid and cholesterol homeostasis are rhythmically expressed with expression shown to be regulated by clock genes via Rev-erb 1 alpha. In order to elucidate clock gene regulation of genes involved in lipid metabolism in Atlantic salmon (Salmo salar L.), the orphan nuclear receptor Rev-erb 1a was cloned and 24 h expression of clock genes, transcription factors and genes involved in cholesterol and lipid metabolism determined in liver of parr acclimated to a long-day photoperiod, which was previously shown to elicit rhythmic clock gene expression in the brain. Of the 31 genes analysed, significant daily expression was demonstrated in the clock gene Bmal1, transcription factor genes Srebp1, Lxr, Ppar alpha and Pparc, and several lipid metabolism genes Hmgcr, Ipi, ApoCII and El. The possible regulatory mechanisms and pathways, and the functional significance of these patterns of expression were discussed. Importantly and in contrast to mammals, Per1, Per2, Fas, Srebp2, Cyp71 alpha and Rev-erb 1 alpha did not display significant daily rhythmicity in salmon. The present study is the first report characterising 24 h profiles of gene expression in liver of Atlantic salmon. However, more importantly, the predominant role of lipids in the nutrition and metabolism of fish, and of feed efficiency in determining farming economics, means that daily rhythmicity in the regulation of lipid metabolism will be an area of considerable interest for future research in commercially important species.	[Betancor, Monica B.; McStay, Elsbeth; Minghetti, Matteo; Migaud, Herve; Tocher, Douglas R.; Davie, Andrew] Univ Stirling, Sch Nat Sci, Inst Aquaculture, Stirling FK9 4LA, Scotland	University of Stirling	Betancor, MB (corresponding author), Univ Stirling, Sch Nat Sci, Inst Aquaculture, Stirling FK9 4LA, Scotland.	m.b.betancor@stir.ac.uk	Davie, Andrew/A-2247-2009; Migaud, Herve/C-5647-2009; Tocher, Douglas R/C-5652-2011	Davie, Andrew/0000-0002-9524-618X; Tocher, Douglas R/0000-0002-8603-9410; Betancor, Monica/0000-0003-1626-7458; Migaud, Herve/0000-0002-5404-7512				Akhtar RA, 2002, CURR BIOL, V12, P540, DOI 10.1016/S0960-9822(02)00759-5; Allendorf F.W., 1984, P1; Amundsen PA, 1999, J FISH BIOL, V54, P58, DOI 10.1111/j.1095-8649.1999.tb00612.x; Canaple L, 2006, MOL ENDOCRINOL, V20, P1715, DOI 10.1210/me.2006-0052; Cermakian N, 2000, P NATL ACAD SCI USA, V97, P4339, DOI 10.1073/pnas.97.8.4339; Cho HK, 2012, GEN COMP ENDOCR, V175, P39, DOI 10.1016/j.ygcen.2011.08.026; Cunha I, 2013, COMP BIOCHEM PHYS B, V164, P247, DOI 10.1016/j.cbpb.2013.01.003; Damiola F, 2000, GENE DEV, V14, P2950, DOI 10.1101/gad.183500; Davie A, 2011, CHRONOBIOL INT, V28, P177, DOI 10.3109/07420528.2010.550407; Davie A, 2009, CHRONOBIOL INT, V26, P379, DOI 10.1080/07420520902820947; Dunlap JC, 1999, CELL, V96, P271, DOI 10.1016/S0092-8674(00)80566-8; Evans RM, 2004, NAT MED, V10, P355, DOI 10.1038/nm1025; FAO (Food and Agriculture Organization of the United Nations), 2012, STAT WORLD FISH AQ; Feliciano A, 2011, J BIOL RHYTHM, V26, P24, DOI 10.1177/0748730410388600; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Lopez-Olmeda JF, 2010, BIOLOGICAL CLOCK IN FISH, P155; Paredes JF, 2014, CHRONOBIOL INT, V31, P613, DOI 10.3109/07420528.2014.881837; Gervois P, 1999, MOL ENDOCRINOL, V13, P400, DOI 10.1210/me.13.3.400; Hardin PE, 2013, CURR OPIN NEUROBIOL, V23, P724, DOI 10.1016/j.conb.2013.02.018; Horton JD, 2003, P NATL ACAD SCI USA, V100, P12027, DOI 10.1073/pnas.1534923100; Huang TS, 2010, CHRONOBIOL INT, V27, P1715, DOI 10.3109/07420528.2010.521272; JONES PJH, 1990, J LIPID RES, V31, P667; Ko CH, 2006, HUM MOL GENET, V15, pR271, DOI 10.1093/hmg/ddl207; Kornmann B, 2007, COLD SPRING HARB SYM, V72, P319, DOI 10.1101/sqb.2007.72.041; Le Martelot G, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000181; Leaver MJ, 2007, J MOL ENDOCRINOL, V38, P391, DOI 10.1677/JME-06-0043; Leaver MJ, 2008, REV FISH SCI, V16, P73, DOI 10.1080/10641260802325278; Lehmann JM, 1997, J BIOL CHEM, V272, P3137, DOI 10.1074/jbc.272.6.3137; Patino MAL, 2011, CHRONOBIOL INT, V28, P381, DOI 10.3109/07420528.2011.566398; Marchler-Bauer A, 2011, NUCLEIC ACIDS RES, V39, pD225, DOI 10.1093/nar/gkq1189; McStay E, 2014, COMP BIOCHEM PHYS A, V169, P77, DOI 10.1016/j.cbpa.2013.12.011; Migaud H, 2010, J FISH BIOL, V76, P27, DOI 10.1111/j.1095-8649.2009.02500.x; Minghetti M, 2011, BBA-MOL CELL BIOL L, V1811, P194, DOI 10.1016/j.bbalip.2010.12.008; Morais S, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-255; Refinetti R., 2006, CIRCADIAN PHYSL, V2nd; Repa JJ, 2000, GENE DEV, V14, P2819, DOI 10.1101/gad.844900; Rey G, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000595; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Sargent John R., 2002, P181; Sato R, 2010, ARCH BIOCHEM BIOPHYS, V501, P177, DOI 10.1016/j.abb.2010.06.004; Schibler U, 2010, SIGNALING PATHWAYS IN LIVER DISEASES, SECOND EDITION, P501, DOI 10.1007/978-3-642-00150-5_34; Schmutz I, 2012, MOL CELL ENDOCRINOL, V349, P38, DOI 10.1016/j.mce.2011.05.007; Schultz JR, 2000, GENE DEV, V14, P2831, DOI 10.1101/gad.850400; Shimba S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025231; Sierk ML, 2001, BIOCHEMISTRY-US, V40, P12833, DOI 10.1021/bi011086r; Tacon AGJ, 2008, AQUACULTURE, V285, P146, DOI 10.1016/j.aquaculture.2008.08.015; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tocher D., 2009, Lipid Technology, V21, P13, DOI 10.1002/lite.200800079; Tocher DR, 2010, AQUAC RES, V41, P717, DOI 10.1111/j.1365-2109.2008.02150.x; Tocher DR, 2003, REV FISH SCI, V11, P107, DOI 10.1080/713610925; Vera LM, 2013, CHRONOBIOL INT, V30, P649, DOI 10.3109/07420528.2013.775143; Vollmers C, 2009, P NATL ACAD SCI USA, V106, P21453, DOI 10.1073/pnas.0909591106; Wang NN, 2008, CELL METAB, V8, P482, DOI 10.1016/j.cmet.2008.10.009; Yang XY, 2006, CELL, V126, P801, DOI 10.1016/j.cell.2006.06.050	55	33	33	3	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 3	2014	9	9							e106739	10.1371/journal.pone.0106739	http://dx.doi.org/10.1371/journal.pone.0106739			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3TB	25184355	gold, Green Published			2022-12-27	WOS:000341257700113
J	Mohapatra, PK; Sarma, DK; Prakash, A; Bora, K; Ahmed, MA; Sarma, B; Goswami, BK; Bhattacharyya, DR; Mahanta, J				Mohapatra, Pradyumna Kishore; Sarma, Devojit Kumar; Prakash, Anil; Bora, Khukumoni; Ahmed, Md Atique; Sarma, Bibhas; Goswami, Basanta Kumar; Bhattacharyya, Dibya Ranjan; Mahanta, Jagadish			Molecular Evidence of Increased Resistance to Anti-Folate Drugs in Plasmodium falciparum in North-East India: A Signal for Potential Failure of Artemisinin Plus Sulphadoxine-Pyrimethamine Combination Therapy	PLOS ONE			English	Article							CAR-NICOBAR ISLAND; DIHYDROFOLATE-REDUCTASE; CHLOROQUINE RESISTANCE; MALARIA PARASITES; DIHYDROPTEROATE SYNTHETASE; MUTATIONS; PREVALENCE; PFCRT; MECHANISMS; EMERGENCE	North-east India, being a corridor to South-east Asia, is believed to play an important role in transmitting drug resistant Plasmodium falciparum malaria to India and South Asia. North-east India was the first place in India to record the emergence of drug resistance to chloroquine as well as sulphadoxine/pyrimethamine. Presently chloroquine resistance is widespread all over the North-east India and resistance to other anti-malarials is increasing. In this study both in vivo therapeutic efficacy and molecular assays were used to screen the spectrum of drug resistance to chloroquine and sulphadoxine/pyrimethamine in the circulating P. falciparum strains. A total of 220 P. falciparum positives subjects were enrolled in the study for therapeutic assessment of chloroquine and sulphadoxine/pyrimethamine and assessment of point mutations conferring resistances to these drugs were carried out by genotyping the isolates following standard methods. Overall clinical failures in sulphadoxine/pyrimethamine and chloroquine were found 12.6 and 69.5% respectively, while overall treatment failures recorded were 13.7 and 81.5% in the two arms. Nearly all (99.0%) the isolates had mutant pfcrt genotype (76T), while 68% had mutant pfmdr-1 genotype (86Y). Mutation in dhps 437 codon was the most prevalent one while dhfr codon 108 showed 100% mutation. A total of 23 unique haplotypes at the dhps locus and 7 at dhfr locus were found while dhps-dhfr combined loci revealed 49 unique haplotypes. Prevalence of double, triple and quadruple mutations were common while 1 haplotype was found with all five mutated codons (F/AGEGS/T) at dhps locus. Detection of quadruple mutants (51I/59R/108N/164L) in the present study, earlier recorded from Car Nicobar Island, India only, indicates the presence of high levels of resistance to sulphadoxine/pyrimethamine in north-east India. Associations between resistant haplotypes and the clinical outcomes and emerging resistance in sulphadoxine/pyrimethamine in relation to the efficacy of the currently used artemisinin combination therapy are discussed.	[Mohapatra, Pradyumna Kishore; Sarma, Devojit Kumar; Prakash, Anil; Bora, Khukumoni; Ahmed, Md Atique; Sarma, Bibhas; Goswami, Basanta Kumar; Bhattacharyya, Dibya Ranjan; Mahanta, Jagadish] NE Reg ICMR, Reg Med Res Ctr, Dibrugarh, Assam, India; [Prakash, Anil] Natl Inst Res Environm Hlth ICMR, Bhopal, Madhya Pradesh, India	Indian Council of Medical Research (ICMR); ICMR - Regional Medical Research Centre, North East Region (RMRC NE); Indian Council of Medical Research (ICMR); ICMR - National Institute for Research in Environmental Health (NIREH)	Mahanta, J (corresponding author), NE Reg ICMR, Reg Med Res Ctr, Dibrugarh, Assam, India.	jmahanta@gmail.com	Ahmed, Atique/L-7820-2015; Sarma, Dr. Devojit Kumar/AAE-3003-2022; Sarma, Devojit Kumar/D-4337-2013	Ahmed, Md Atique/0000-0002-3407-7220; Sarma, Devojit Kumar/0000-0002-2749-4114	Indian Council of Medical Research, Government of India	Indian Council of Medical Research, Government of India(Indian Council of Medical Research (ICMR))	The study was funded by Indian Council of Medical Research, Government of India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed A, 2006, ANTIMICROB AGENTS CH, V50, P1546, DOI 10.1128/AAC.50.4.1546-1549.2006; Ahmed A, 2004, ANTIMICROB AGENTS CH, V48, P879, DOI 10.1128/AAC.48.3.879-889.2004; Ahmed A, 2006, ANTIMICROB AGENTS CH, V50, P3934, DOI 10.1128/AAC.00732-06; Anderson AC, 2005, DRUG DISCOV TODAY, V10, P121, DOI 10.1016/S1359-6446(04)03308-2; [Anonymous], NAT DRUG POL MAL; Biswas S, 2000, TROP MED INT HEALTH, V5, P737, DOI 10.1046/j.1365-3156.2000.00632.x; Biswas S, 2004, J Postgrad Med, V50, P17; BJORKMAN A, 1990, T ROY SOC TROP MED H, V84, P177, DOI 10.1016/0035-9203(90)90246-B; Das S., 1981, Indian Journal of Malariology, V18, P109; Dhillon GPS., 1997, DRUG RESISTANCE CHEM, P14; Dondorp AM, 2009, NEW ENGL J MED, V361, P455, DOI 10.1056/NEJMoa0808859; Farooq Umar, 2004, Journal of Vector Borne Diseases, V41, P45; Fernandes N, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-35; Fidock DA, 2000, MOL CELL, V6, P861, DOI 10.1016/S1097-2765(05)00077-8; Figueiredo P, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-236; Goswami D, 2014, J INFECT DEV COUNTR, V8, P768, DOI 10.3855/jidc.3398; Gregson A, 2005, PHARMACOL REV, V57, P117, DOI 10.1124/pr.57.1.4; Lin Jessica T, 2010, Curr Infect Dis Rep, V12, P165, DOI 10.1007/s11908-010-0099-y; Lumb V, 2009, J INFECT DIS, V199, P1064, DOI 10.1086/597206; Lynch C, 2008, J INFECT DIS, V197, P1598, DOI 10.1086/587845; Mohapatra PK, 2005, TROP MED INT HEALTH, V10, P478, DOI 10.1111/j.1365-3156.2005.01401.x; Mohapatra PK, 2003, INDIAN J MED RES, V118, P71; Ndiaye D, 2005, TROP MED INT HEALTH, V10, P1176, DOI 10.1111/j.1365-3156.2005.01506.x; NVBDCP, 2013, MAL SIT IND; O'Brien C, 2011, CURR OPIN INFECT DIS, V24, P570, DOI 10.1097/QCO.0b013e32834cd3ed; Ouellette M, 2001, TROP MED INT HEALTH, V6, P874, DOI 10.1046/j.1365-3156.2001.00777.x; Pickard AL, 2003, ANTIMICROB AGENTS CH, V47, P2418, DOI 10.1128/AAC.47.8.2418-2423.2003; Plowe CV, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-121; Sa JM, 2009, P NATL ACAD SCI USA, V106, P18883, DOI 10.1073/pnas.0911317106; SEHGAL P N, 1973, Journal of Communicable Diseases, V5, P175; Shah NK, 2011, LANCET INFECT DIS, V11, P57, DOI 10.1016/S1473-3099(10)70214-0; Sharma YD, 2012, CURR SCI INDIA, V102, P696; SNOUNOU G, 1993, MOL BIOCHEM PARASIT, V61, P315, DOI 10.1016/0166-6851(93)90077-B; Triglia T, 1997, P NATL ACAD SCI USA, V94, P13944, DOI 10.1073/pnas.94.25.13944; Warhurst DC, 1999, INFECTION, V27, pS55, DOI 10.1007/BF02561674; Wellems TE, 2001, J INFECT DIS, V184, P770, DOI 10.1086/322858; WERNSDORFER WH, 1991, PHARMACOL THERAPEUT, V50, P95, DOI 10.1016/0163-7258(91)90074-V; WHO, 2003, WHO ASS MON ANT DRUG; World Health Organization, 2009, REP TECHN CONS DEF V; Wu YM, 1996, P NATL ACAD SCI USA, V93, P1130, DOI 10.1073/pnas.93.3.1130; YOUNG MD, 1961, AM J TROP MED HYG, V10, P317, DOI 10.4269/ajtmh.1961.10.317; Zakeri S, 2008, AM J TROP MED HYG, V78, P633, DOI 10.4269/ajtmh.2008.78.633	42	23	23	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 3	2014	9	9							e105562	10.1371/journal.pone.0105562	http://dx.doi.org/10.1371/journal.pone.0105562			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3TB	25184337	gold, Green Submitted, Green Published			2022-12-27	WOS:000341257700020
J	Powers, TW; Neely, BA; Shao, Y; Tang, HY; Troyer, DA; Mehta, AS; Haab, BB; Drake, RR				Powers, Thomas W.; Neely, Benjamin A.; Shao, Yuan; Tang, Huiyuan; Troyer, Dean A.; Mehta, Anand S.; Haab, Brian B.; Drake, Richard R.			MALDI Imaging Mass Spectrometry Profiling of N-Glycans in Formalin-Fixed Paraffin Embedded Clinical Tissue Blocks and Tissue Microarrays	PLOS ONE			English	Article							PROTEOMIC ANALYSIS; LINKED GLYCAN; CANCER; VALIDATION; EXPRESSION; WORKFLOW; SAMPLES; IMPACT	A recently developed matrix-assisted laser desorption/ionization imaging mass spectrometry (MALDI-IMS) method to spatially profile the location and distribution of multiple N-linked glycan species in frozen tissues has been extended and improved for the direct analysis of glycans in clinically derived formalin-fixed paraffin-embedded (FFPE) tissues. Formalinfixed tissues from normal mouse kidney, human pancreatic and prostate cancers, and a human hepatocellular carcinoma tissue microarray were processed by antigen retrieval followed by on-tissue digestion with peptide N-glycosidase F. The released N-glycans were detected by MALDI-IMS analysis, and the structural composition of a subset of glycans could be verified directly by on-tissue collision-induced fragmentation. Other structural assignments were confirmed by off-tissue permethylation analysis combined with multiple database comparisons. Imaging of mouse kidney tissue sections demonstrates specific tissue distributions of major cellular N-linked glycoforms in the cortex and medulla. Differential tissue distribution of N-linked glycoforms was also observed in the other tissue types. The efficacy of using MALDI-IMS glycan profiling to distinguish tumor from non-tumor tissues in a tumor microarray format is also demonstrated. This MALDI-IMS workflow has the potential to be applied to any FFPE tissue block or tissue microarray to enable higher throughput analysis of the global changes in N-glycosylation associated with cancers.	[Powers, Thomas W.; Neely, Benjamin A.; Drake, Richard R.] Med Univ S Carolina, Dept Cell & Mol Pharmacol & Expt Therapeut, Charleston, SC 29425 USA; [Powers, Thomas W.; Neely, Benjamin A.; Drake, Richard R.] Med Univ S Carolina, MUSC Prote Ctr, Charleston, SC 29425 USA; [Shao, Yuan; Drake, Richard R.] Med Univ S Carolina, Hollings Canc Ctr Biorepository & Tissue Anal Res, Charleston, SC 29425 USA; [Troyer, Dean A.] Eastern Virginia Med Sch, Dept Pathol & Microbiol, Norfolk, VA 23501 USA; [Troyer, Dean A.] Eastern Virginia Med Sch, Dept Mol Cell Biol, Norfolk, VA 23501 USA; [Mehta, Anand S.] Drexel Univ, Coll Med, Dept Microbiol & Immunol, Doylestown, PA USA; [Mehta, Anand S.] Drexel Inst Biotechnol & Virol, Doylestown, PA USA; [Tang, Huiyuan; Haab, Brian B.] Van Andel Res Inst, Lab Canc Immunodiagnost, Grand Rapids, MI USA	Medical University of South Carolina; Medical University of South Carolina; Medical University of South Carolina; Eastern Virginia Medical School; Eastern Virginia Medical School; Drexel University; Drexel University; Van Andel Institute	Drake, RR (corresponding author), Med Univ S Carolina, Dept Cell & Mol Pharmacol & Expt Therapeut, Charleston, SC 29425 USA.	draker@musc.edu	Neely, Benjamin/AGR-8303-2022	Neely, Benjamin/0000-0001-6120-7695	National Institutes of Health/National Cancer Institute [R21CA137704, R01CA135087, U01CA168896]; state of South Carolina SmartState Endowed Research program; Biorepository & Tissue Analysis Shared Resource, Hollings Cancer Center [P30 CA138313]; South Carolina Clinical & Translational Research (SCTR) Institute [UL1 RR029882, UL1 TR000062]; National Cancer Institute (NCI) [R01 CA120206, U01 CA168856]; Hepatitis B Foundation; Commonwealth of Pennsylvania; NATIONAL CANCER INSTITUTE [R01CA120206, U01CA168856, R21CA137704, R01CA135087, U01CA168896, P30CA138313] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000062] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR029882] Funding Source: NIH RePORTER	National Institutes of Health/National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); state of South Carolina SmartState Endowed Research program; Biorepository & Tissue Analysis Shared Resource, Hollings Cancer Center; South Carolina Clinical & Translational Research (SCTR) Institute; National Cancer Institute (NCI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Hepatitis B Foundation; Commonwealth of Pennsylvania; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported by grants from the National Institutes of Health/National Cancer Institute grants R21CA137704 and R01CA135087, and the state of South Carolina SmartState Endowed Research program to R. R. D. Additional resources and support were from the Biorepository & Tissue Analysis Shared Resource, Hollings Cancer Center (P30 CA138313), and by the South Carolina Clinical & Translational Research (SCTR) Institute (UL1 RR029882 & UL1 TR000062) for R. R. D. This work was supported by grants R01 CA120206 and U01 CA168856 from the National Cancer Institute (NCI), the Hepatitis B Foundation, and an appropriation from The Commonwealth of Pennsylvania to A. M. This work was supported by a grant from the National Institutes of Health/National Cancer Institute, U01CA168896, to B.B.H. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Berry KAZ, 2011, CHEM REV, V111, P6491, DOI 10.1021/cr200280p; Camp RL, 2008, J CLIN ONCOL, V26, P5630, DOI 10.1200/JCO.2008.17.3567; Casadonte R, 2011, NAT PROTOC, V6, P1695, DOI 10.1038/nprot.2011.388; Castellino S, 2011, BIOANALYSIS, V3, P2427, DOI [10.4155/bio.11.232, 10.4155/BIO.11.232]; Cazares LH, 2009, CLIN CANCER RES, V15, P5541, DOI 10.1158/1078-0432.CCR-08-2892; Ceroni A, 2008, J PROTEOME RES, V7, P1650, DOI 10.1021/pr7008252; Chaurand P, 2006, J PROTEOME RES, V5, P2889, DOI 10.1021/pr060346u; Chaurand P, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.O110.004259; Chen CY, 2013, P NATL ACAD SCI USA, V110, P630, DOI 10.1073/pnas.1220425110; Cornett DS, 2008, ANAL CHEM, V80, P5648, DOI 10.1021/ac800617s; Craven RA, 2013, PROTEOM CLIN APPL, V7, P273, DOI 10.1002/prca.201200065; Franco R, 2011, EXPERT REV ANTICANC, V11, P859, DOI [10.1586/ERA.11.65, 10.1586/era.11.65]; Groseclose MR, 2008, PROTEOMICS, V8, P3715, DOI 10.1002/pmic.200800495; Harvey DJ, 2005, PROTEOMICS, V5, P1774, DOI 10.1002/pmic.200401248; Hewitt SM, 2006, METHOD ENZYMOL, V410, P400, DOI 10.1016/S0076-6879(06)10020-8; Kobayashi M, 2010, METHOD ENZYMOL, V479, P271, DOI 10.1016/S0076-6879(10)79016-9; Ludwig JA, 2005, NAT REV CANCER, V5, P845, DOI 10.1038/nrc1739; Magdeldin S, 2012, PROTEOMICS, V12, P1045, DOI 10.1002/pmic.201100550; Mehta A, 2012, CANCER EPIDEM BIOMAR, V21, P925, DOI 10.1158/1055-9965.EPI-11-1183; Miwa HE, 2012, GLYCOCONJUGATE J, V29, P609, DOI 10.1007/s10719-012-9373-6; Nilsson A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011411; Quaas A, 2013, HISTOPATHOLOGY, V63, P455, DOI 10.1111/his.12193; Schultz MJ, 2012, CANCER METAST REV, V31, P501, DOI 10.1007/s10555-012-9359-7; Shi CJ, 2014, LAB INVEST, V94, P409, DOI 10.1038/labinvest.2014.10; Takikita M, 2007, CURR OPIN BIOTECH, V18, P318, DOI 10.1016/j.copbio.2007.05.007; Thompson SM, 2013, PROTEOM CLIN APPL, V7, P241, DOI 10.1002/prca.201200086; van Cruijsen H, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-180; Wisniewski JR, 2013, PROTEOM CLIN APPL, V7, P225, DOI 10.1002/prca.201200046	29	154	155	0	61	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 3	2014	9	9							e106255	10.1371/journal.pone.0106255	http://dx.doi.org/10.1371/journal.pone.0106255			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3TB	25184632	gold, Green Published, Green Submitted			2022-12-27	WOS:000341257700045
J	Kloth, N; Shields, SE; Rhodes, G				Kloth, Nadine; Shields, Susannah E.; Rhodes, Gillian			On the Other Side of the Fence: Effects of Social Categorization and Spatial Grouping on Memory and Attention for Own-Race and Other-Race Faces	PLOS ONE			English	Article							GROUP MEMBERSHIP; RECOGNITION; BIAS; MODEL; INDIVIDUATION; EXPERTISE; CONTACT; ACCOUNT	The term "own-race bias'' refers to the phenomenon that humans are typically better at recognizing faces from their own than a different race. The perceptual expertise account assumes that our face perception system has adapted to the faces we are typically exposed to, equipping it poorly for the processing of other-race faces. Sociocognitive theories assume that other-race faces are initially categorized as out-group, decreasing motivation to individuate them. Supporting sociocognitive accounts, a recent study has reported improved recognition for other-race faces when these were categorized as belonging to the participants' in-group on a second social dimension, i.e., their university affiliation. Faces were studied in groups, containing both own-race and other-race faces, half of each labeled as in-group and out-group, respectively. When study faces were spatially grouped by race, participants showed a clear own-race bias. When faces were grouped by university affiliation, recognition of other-race faces from the social in-group was indistinguishable from own-race face recognition. The present study aimed at extending this singular finding to other races of faces and participants. Forty Asian and 40 European Australian participants studied Asian and European faces for a recognition test. Faces were presented in groups, containing an equal number of own-university and other-university Asian and European faces. Between participants, faces were grouped either according to race or university affiliation. Eye tracking was used to study the distribution of spatial attention to individual faces in the display. The race of the study faces significantly affected participants' memory, with better recognition of own-race than other-race faces. However, memory was unaffected by the university affiliation of the faces and by the criterion for their spatial grouping on the display. Eye tracking revealed strong looking biases towards both own-race and own-university faces. Results are discussed in light of the theoretical accounts of the own-race bias.	[Kloth, Nadine; Shields, Susannah E.; Rhodes, Gillian] Univ Western Australia, Sch Psychol, Australian Res Council Ctr Excellence Cognit & Di, Crawley, WA, Australia; [Kloth, Nadine; Rhodes, Gillian] Univ Jena, DFG Res Unit Person Percept, Jena, Germany	University of Western Australia; Friedrich Schiller University of Jena	Kloth, N (corresponding author), Univ Western Australia, Sch Psychol, Australian Res Council Ctr Excellence Cognit & Di, Crawley, WA, Australia.	nadine.kloth@uwa.edu.au	Kloth, Nadine/H-5207-2014	Kloth, Nadine/0000-0003-1473-303X; Rhodes, Gillian/0000-0002-3631-8518	Australian Research Council Centre of Excellence in Cognition and its Disorders [CE110001021]; ARC [DP0877379]; ARC Discovery Outstanding Researcher Award [DP130102300]	Australian Research Council Centre of Excellence in Cognition and its Disorders(Australian Research Council); ARC(Australian Research Council); ARC Discovery Outstanding Researcher Award(Australian Research Council)	This research was supported by the Australian Research Council Centre of Excellence in Cognition and its Disorders (CE110001021), an ARC Professorial Fellowship to Rhodes (DP0877379), and an ARC Discovery Outstanding Researcher Award to Rhodes (DP130102300). For detailed information about the funding agency, see http://www.arc.gov.au. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bernstein MJ, 2007, PSYCHOL SCI, V18, P706, DOI 10.1111/j.1467-9280.2007.01964.x; Burke C, 2013, TOP 5 DIFFERENCES U; Caharel S, 2011, INT J PSYCHOPHYSIOL, V79, P266, DOI 10.1016/j.ijpsycho.2010.10.018; Correll J, 2011, J EXP SOC PSYCHOL, V47, P1162, DOI 10.1016/j.jesp.2011.04.001; de Heering A, 2010, DEVELOPMENTAL SCI, V13, P181, DOI 10.1111/j.1467-7687.2009.00876.x; DeGutis J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058253; Hancock KJ, 2008, BRIT J PSYCHOL, V99, P45, DOI 10.1348/000712607X199981; Hayward WG, 2008, COGNITION, V106, P1017, DOI 10.1016/j.cognition.2007.04.002; Hayward WG, 2013, VIS COGN, V21, P1224, DOI 10.1080/13506285.2013.824530; Hehman E, 2011, J EXP SOC PSYCHOL, V47, P1262, DOI 10.1016/j.jesp.2011.05.014; Hehman E, 2010, J EXP SOC PSYCHOL, V46, P445, DOI 10.1016/j.jesp.2009.11.008; Heron-Delaney M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019858; Hourihan KL, 2013, MEM COGNITION, V41, P1021, DOI 10.3758/s13421-013-0316-7; Hugenberg K., 2011, OXFORD HDB FACE PERC, P245; Hugenberg K, 2007, J EXP SOC PSYCHOL, V43, P334, DOI 10.1016/j.jesp.2006.02.010; Hugenberg K, 2013, VIS COGN, V21, P1392, DOI 10.1080/13506285.2013.821429; Hugenberg K, 2010, PSYCHOL REV, V117, P1168, DOI 10.1037/a0020463; Kelly DJ, 2007, PSYCHOL SCI, V18, P1084, DOI 10.1111/j.1467-9280.2007.02029.x; Levin DT, 1996, J EXP PSYCHOL LEARN, V22, P1364, DOI 10.1037/0278-7393.22.6.1364; Levin DT, 2000, J EXP PSYCHOL GEN, V129, P559, DOI 10.1037//0096-3445.129.4.559; MACMILLAN NA, 1990, PSYCHOL BULL, V107, P401, DOI 10.1037/0033-2909.107.3.401; MALPASS RS, 1969, J PERS SOC PSYCHOL, V13, P330, DOI 10.1037/h0028434; Meissner CA, 2001, PSYCHOL PUBLIC POL L, V7, P3, DOI 10.1037//1076-8971.7.1.3; Minear M, 2004, BEHAV RES METH INS C, V36, P630, DOI 10.3758/BF03206543; Mondloch CJ, 2010, PERCEPTION, V39, P1065, DOI 10.1068/p6608; Rhodes G, 2009, BRIT J PSYCHOL, V100, P717, DOI 10.1348/000712608X396503; Rossion B., 2011, OXFORD HDB FACE PERC, P215, DOI DOI 10.1093/OXFORDHB/9780199559053.013.0012; Sangrigoli S, 2005, PSYCHOL SCI, V16, P440; Shriver ER, 2008, PERS SOC PSYCHOL B, V34, P260, DOI 10.1177/0146167207310455; Sporer SL, 2001, PSYCHOL PUBLIC POL L, V7, P36, DOI 10.1038//1076-8971.7.1.36; Stahl J, 2008, NEUROREPORT, V19, P583, DOI 10.1097/WNR.0b013e3282f97b4d; Stanislaw H, 1999, BEHAV RES METH INS C, V31, P137, DOI 10.3758/BF03207704; Tanaka JW, 2013, VIS COGN, V21, P1183, DOI 10.1080/13506285.2013.826315; VALENTINE T, 1992, Q J EXP PSYCHOL-A, V44, P671, DOI 10.1080/14640749208401305; VALENTINE T, 1991, Q J EXP PSYCHOL-A, V43, P161, DOI 10.1080/14640749108400966; Van Bavel JJ, 2012, PERS SOC PSYCHOL B, V38, P1566, DOI 10.1177/0146167212455829; Wiese H, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00898; Wiese H, 2009, BIOL PSYCHOL, V81, P103, DOI 10.1016/j.biopsycho.2009.03.002; Wilson JP, 2014, PLOS ONE, V9; Young SG, 2012, PERS SOC PSYCHOL REV, V16, P116, DOI 10.1177/1088868311418987	40	13	13	0	62	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2014	9	9							e105979	10.1371/journal.pone.0105979	http://dx.doi.org/10.1371/journal.pone.0105979			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AO3LR	25180902	gold, Green Published, Green Submitted			2022-12-27	WOS:000341231500042
J	Seebacher, F; Grigaltchik, VS				Seebacher, Frank; Grigaltchik, Veronica S.			Embryonic Developmental Temperatures Modulate Thermal Acclimation of Performance Curves in Tadpoles of the Frog Limnodynastes peronii	PLOS ONE			English	Article							LOCOMOTOR PERFORMANCE; INCUBATION-TEMPERATURE; METABOLIC-RESPONSES; NATURAL-SELECTION; EVOLUTION; TIME; TOLERANCE; CAPACITY; VARIES; GROWTH	Performance curves of physiological rates are not fixed, and determining the extent to which thermal performance curves can change in response to environmental signals is essential to understand the effect of climate variability on populations. The aim of this study was to determine whether and how temperatures experienced during early embryonic development affect thermal performance curves of later life history stages in the frog Limnodynastes peronii. We tested the hypotheses that a) the embryonic environment affects mean trait values only; b) temperature at which performance of tadpoles is maximal shifts with egg incubation temperatures so that performance is maximised at the incubation temperatures, and c) incubation temperatures modulate the capacity for reversible acclimation in tadpoles. Growth rates were greater in warm (25 degrees C) compared to cold (15 degrees C) acclimated (6 weeks) tadpoles regardless of egg developmental temperatures (15 degrees C or 25 degrees C, representing seasonal means). The breadth of the performance curve of burst locomotor performance (measured at 10, 15, 20, 25, and 30 degrees C, representing annual range) is greatest when egg developmental and acclimation temperatures coincide. The mode of the performance curves shifted with acclimation conditions and maximum performance was always at higher temperatures than acclimation conditions. Performance curves of glycolytic (lactate dehydrogenase activities) and mitochondrial (citrate synthase and cytochrome c oxidase) enzymes were modulated by interactions between egg incubation and acclimation temperatures. Lactate dehydrogenase activity paralleled patterns seen in burst locomotor performance, but oxygen consumption rates and mitochondrial enzyme activities did not mirror growth or locomotor performance. We show that embryonic developmental conditions can modulate performance curves of later life-history stages, thereby conferring flexibilty to respond to environmental conditions later in life.	[Seebacher, Frank; Grigaltchik, Veronica S.] Univ Sydney, Sch Biol Sci, Sydney, NSW 2006, Australia	University of Sydney	Seebacher, F (corresponding author), Univ Sydney, Sch Biol Sci, Sydney, NSW 2006, Australia.	frank.seebacher@sydney.edu.au		Seebacher, Frank/0000-0002-2281-9311	Australian Research Council Discovery [DP120101215]	Australian Research Council Discovery(Australian Research Council)	Australian Research Council Discovery Grant DP120101215 (www.arc.gov.au) to FS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altwegg R, 2003, EVOLUTION, V57, P872; Angilletta MJ, 2006, J THERM BIOL, V31, P541, DOI 10.1016/j.jtherbio.2006.06.002; Bateson P, 2001, INT J EPIDEMIOL, V30, P928, DOI 10.1093/ije/30.5.928; Bonduriansky R, 2012, EVOL APPL, V5, P192, DOI 10.1111/j.1752-4571.2011.00213.x; Bonduriansky R, 2009, ANNU REV ECOL EVOL S, V40, P103, DOI 10.1146/annurev.ecolsys.39.110707.173441; Calmettes G, 2012, J PHYSIOL-LONDON, V590, P3403, DOI 10.1113/jphysiol.2012.239376; Chevin LM, 2010, EVOLUTION, V64, P1143, DOI 10.1111/j.1558-5646.2009.00875.x; Daxinger L, 2012, NAT REV GENET, V13, P153, DOI 10.1038/nrg3188; DeAngelis JT, 2008, MOL BIOTECHNOL, V38, P179, DOI 10.1007/s12033-007-9010-y; Drummond GB, 2012, J PHYSIOL-LONDON, V590, P235, DOI 10.1113/jphysiol.2011.225235; Eliason EJ, 2011, SCIENCE, V332, P109, DOI 10.1126/science.1199158; FRY FEJ, 1958, ANNU REV PHYSIOL, V20, P207, DOI 10.1146/annurev.ph.20.030158.001231; Gabriel W, 2005, AM NAT, V166, P339, DOI 10.1086/432558; Gosner K. L., 1960, Herpetologica, V16, P183; Greer EL, 2012, NAT REV GENET, V13, P343, DOI 10.1038/nrg3173; Guderley H, 2004, BIOL REV, V79, P409, DOI 10.1017/S1464793103006328; Guderley H, 2004, COMP BIOCHEM PHYS B, V139, P371, DOI 10.1016/j.cbpc.2004.04.001; Hallsson LR, 2012, J EVOLUTION BIOL, V25, P1275, DOI 10.1111/j.1420-9101.2012.02512.x; Ho DH, 2010, J EXP BIOL, V213, P3, DOI 10.1242/jeb.019752; Huey RB, 1999, AM ZOOL, V39, P323; Husak JF, 2006, EVOLUTION, V60, P2122, DOI 10.1111/j.0014-3820.2006.tb01849.x; Izem R, 2005, AM NAT, V166, P277, DOI 10.1086/431314; JONES PL, 1982, J EXP ZOOL, V219, P163, DOI 10.1002/jez.1402190205; Kaplan RH, 2006, EVOLUTION, V60, P142; Kawecki TJ, 2000, EVOLUTION, V54, P1, DOI 10.1111/j.0014-3820.2000.tb00001.x; Kern P, 2014, J EXP BIOL, V217, P1246, DOI 10.1242/jeb.097006; Lane SJ, 2002, J ANIM ECOL, V71, P780, DOI 10.1046/j.1365-2656.2002.00644.x; Laurila A, 2001, OIKOS, V95, P451, DOI 10.1034/j.1600-0706.2001.950310.x; Lee WS, 2010, J EXP BIOL, V213, P3289, DOI 10.1242/jeb.043083; LEVINS RICHARD, 1968; Martin N, 2009, COMP BIOCHEM PHYS A, V152, P599, DOI 10.1016/j.cbpa.2009.01.010; Moran R, 2010, FRESHWATER BIOL, V55, P315, DOI 10.1111/j.1365-2427.2009.02276.x; Reik W, 2001, SCIENCE, V293, P1089, DOI 10.1126/science.1063443; Rogers KD, 2004, COMP BIOCHEM PHYS A, V137, P731, DOI 10.1016/j.cbpb.2004.02.008; Rogers KD, 2007, J EXP BIOL, V210, P2932, DOI 10.1242/jeb.008391; Schauble CS, 2004, BIOL J LINN SOC, V82, P39, DOI 10.1111/j.1095-8312.2004.00315.x; Schell C. B., 2003, Australian Zoologist, V32, P401; Scott GR, 2012, P NATL ACAD SCI USA, V109, P14247, DOI 10.1073/pnas.1205012109; Seebacher F, 2014, J EXP BIOL, V217, P1940, DOI 10.1242/jeb.101147; Seebacher F, 2014, FUNCT ECOL, V28, P137, DOI 10.1111/1365-2435.12156; Sinclair ELE, 2006, J EXP MAR BIOL ECOL, V335, P131, DOI 10.1016/j.jembe.2006.03.010; Suarez RK, 2012, J EXP BIOL, V215, P2351, DOI 10.1242/jeb.059725; Teperino R, 2010, CELL METAB, V12, P321, DOI 10.1016/j.cmet.2010.09.004; Tyler MJ, 2011, FIELD GUIDE FROGS AU; VANDAMME R, 1992, HERPETOLOGICA, V48, P220; Watkins TB, 2006, PHYSIOL BIOCHEM ZOOL, V79, P140, DOI 10.1086/498182; Wilson RS, 1999, J COMP PHYSIOL B, V169, P445, DOI 10.1007/s003600050241; Wilson RS, 2000, COMP BIOCHEM PHYS A, V127, P21, DOI 10.1016/S1095-6433(00)00238-5; Wilson RS, 2001, J EXP BIOL, V204, P4227	49	31	31	2	62	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2014	9	9							e106492	10.1371/journal.pone.0106492	http://dx.doi.org/10.1371/journal.pone.0106492			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3LR	25181291	Green Submitted, Green Published, gold			2022-12-27	WOS:000341231500104
J	Kysenius, K; Brunello, CA; Huttunen, HJ				Kysenius, Kai; Brunello, Cecilia A.; Huttunen, Henri J.			Mitochondria and NMDA Receptor-Dependent Toxicity of Berberine Sensitizes Neurons to Glutamate and Rotenone Injury	PLOS ONE			English	Article							APOPTOSIS-INDUCING FACTOR; CELL-DEATH; RAT MODEL; IN-VITRO; K+ CHANNELS; EXCITOTOXICITY; DYSFUNCTION; IMPAIRMENT; EXPRESSION; COPTIDIS	The global incidence of metabolic and age-related diseases, including type 2 diabetes and Alzheimer's disease, is on the rise. In addition to traditional pharmacotherapy, drug candidates from complementary and alternative medicine are actively being pursued for further drug development. Berberine, a nutraceutical traditionally used as an antibiotic, has recently been proposed to act as a multi-target protective agent against type 2 diabetes, dyslipidemias, ischemic brain injury and neurodegenerative diseases, such as Parkinson's and Alzheimer's disease. However, the safety profile of berberine remains controversial, as isolated reports suggest risks with acute toxicity, bradycardia and exacerbation of neurodegeneration. We report that low micromolar berberine causes rapid mitochondria-dependent toxicity in primary neurons characterized by mitochondrial swelling, increased oxidative stress, decreased mitochondrial membrane potential and depletion of ATP content. Berberine does not induce caspase-3 activation and the resulting neurotoxicity remains unaffected by pan-caspase inhibitor treatment. Interestingly, inhibition of NMDA receptors by memantine and MK-801 completely blocked berberine-induced neurotoxicity. Additionally, subtoxic nanomolar concentrations of berberine were sufficient to sensitize neurons to glutamate excitotoxicity and rotenone injury. Our study highlights the need for further safety assessment of berberine, especially due to its tendency to accumulate in the CNS and the risk of potential neurotoxicity as a consequence of increasing bioavailability of berberine.	[Kysenius, Kai; Brunello, Cecilia A.; Huttunen, Henri J.] Univ Helsinki, Neurosci Ctr, Helsinki, Finland	University of Helsinki	Huttunen, HJ (corresponding author), Univ Helsinki, Neurosci Ctr, Helsinki, Finland.	Henri.Huttunen@helsinki.fi	Kysenius, Kai/U-6388-2019	Kysenius, Kai/0000-0003-1038-2850; Huttunen, Henri/0000-0002-9867-4438; Brunello, Cecilia Anna/0000-0002-0301-8965	Academy of Finland [218081, 263762]; FGSN/Brain Mind; GPBM/Integrative Life Science doctoral programs; University of Helsinki	Academy of Finland(Academy of Finland); FGSN/Brain Mind; GPBM/Integrative Life Science doctoral programs; University of Helsinki	Research was funded by grants from the Academy of Finland (HJH) (grant numbers 218081 and 263762), the FGSN/Brain & Mind (KK) and GPBM/Integrative Life Science (CAB) doctoral programs and the University of Helsinki (KK, CAB, HJH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu-Amero KK, 2005, ARCH PATHOL LAB MED, V129, P1295; Asai M, 2007, BIOCHEM BIOPH RES CO, V352, P498, DOI 10.1016/j.bbrc.2006.11.043; Bae J, 2013, MOL CELLS, V35, P151, DOI 10.1007/s10059-013-2298-5; Barnes DE, 2011, LANCET NEUROL, V10, P819, DOI 10.1016/S1474-4422(11)70072-2; Benaissa F, 2009, ACTA PHYSIOL HUNG, V96, P213, DOI 10.1556/APhysiol.96.2009.2.6; Betarbet R, 2000, NAT NEUROSCI, V3, P1301, DOI 10.1038/81834; BORODINA VM, 1977, TSITOLOGIYA+, V19, P1067; Budd SL, 1996, J NEUROCHEM, V67, P2282; Cannillo M, 2013, WORLD J CARDIOL, V5, P261, DOI 10.4330/wjc.v5.i7.261; Carlsson CM, 2010, J ALZHEIMERS DIS, V20, P711, DOI 10.3233/JAD-2010-100012; CHAN E, 1993, BIOL NEONATE, V63, P201; Colombo D, 2014, J TOXICOL-US, V2014, DOI 10.1155/2014/145325; Cui HS, 2009, BIOL PHARM BULL, V32, P79, DOI 10.1248/bpb.32.79; Danaei G, 2011, LANCET, V378, P31, DOI 10.1016/S0140-6736(11)60679-X; Derosa G, 2012, EXPERT OPIN BIOL TH, V12, P1113, DOI 10.1517/14712598.2012.704014; Durairajan SSK, 2012, NEUROBIOL AGING, V33, P2903, DOI 10.1016/j.neurobiolaging.2012.02.016; Edwards MA, 2007, NEUROTOXICOLOGY, V28, P876, DOI 10.1016/j.neuro.2007.04.006; Fukui M, 2012, TOXICOL APPL PHARM, V262, P156, DOI 10.1016/j.taap.2012.04.030; Godugu C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089919; Goldberg I, 2012, J NEUROL SCI, V322, P250, DOI 10.1016/j.jns.2012.02.021; Gomez C, 2007, FRONT BIOSCI-LANDMRK, V12, P1079, DOI 10.2741/2128; Greenamyre JT, 1999, BIOCHEM SOC SYMP, V66, P85, DOI 10.1042/bss0660085; Hausenloy DJ, 2012, BRIT J PHARMACOL, V165, P1235, DOI 10.1111/j.1476-5381.2011.01700.x; Hsu YY, 2013, TOXICOL APPL PHARM, V272, P787, DOI 10.1016/j.taap.2013.08.008; Hsu YY, 2012, EUR J PHARM SCI, V46, P415, DOI 10.1016/j.ejps.2012.03.004; Hwang JM, 2006, ARCH TOXICOL, V80, P62, DOI 10.1007/s00204-005-0014-8; Imanshahidi M, 2008, PHYTOTHER RES, V22, P999, DOI 10.1002/ptr.2399; Isaev NK, 2004, NEUROREPORT, V15, P2227, DOI 10.1097/00001756-200410050-00017; Jantova S, 2003, J PHARM PHARMACOL, V55, P1143, DOI 10.1211/002235703322277186; Ji HF, 2011, MOLECULES, V16, P6732, DOI 10.3390/molecules16086732; Johnson-Cadwell LI, 2007, J NEUROCHEM, V101, P1619, DOI 10.1111/j.1471-4159.2007.04516.x; Jung HA, 2009, BIOL PHARM BULL, V32, P1433, DOI 10.1248/bpb.32.1433; Kwon IH, 2010, NEUROSCI LETT, V486, P29, DOI 10.1016/j.neulet.2010.09.038; Kysenius K, 2012, CELL MOL LIFE SCI, V69, P1903, DOI 10.1007/s00018-012-0977-6; Lau CW, 2001, CARDIOVASC DRUG REV, V19, P234; Lee Taehwan, 2010, Exp Neurobiol, V19, P140, DOI 10.5607/en.2010.19.3.140; Li CY, 2004, AM J PHYSIOL-CELL PH, V286, pC893, DOI 10.1152/ajpcell.00127.2003; Linn YC, 2012, PHYTOTHER RES, V26, P682, DOI 10.1002/ptr.3617; Ma BL, 2010, J ETHNOPHARMACOL, V128, P357, DOI 10.1016/j.jep.2010.01.047; McGill JB, 2012, CURR DIABETES REV, V8, P257, DOI 10.2174/157339912800840541; MIKES V, 1983, BIOCHIM BIOPHYS ACTA, V723, P231, DOI 10.1016/0005-2728(83)90122-6; Nemoto Y, 1999, EMBO J, V18, P2991, DOI 10.1093/emboj/18.11.2991; Nicholls DG, 2007, J NEUROSCI RES, V85, P3206, DOI 10.1002/jnr.21290; Nicholls DG, 2008, ANN NY ACAD SCI, V1147, P53, DOI 10.1196/annals.1427.002; Nicholls DG, 2000, PHYSIOL REV, V80, P315, DOI 10.1152/physrev.2000.80.1.315; Nunnari J, 2012, CELL, V148, P1145, DOI 10.1016/j.cell.2012.02.035; Pereira CV, 2008, TOXICOL SCI, V105, P408, DOI 10.1093/toxsci/kfn131; Pereira GC, 2007, J PHARMACOL EXP THER, V323, P636, DOI 10.1124/jpet.107.128017; Polster BM, 2005, J BIOL CHEM, V280, P6447, DOI 10.1074/jbc.M413269200; Rodriguez-Menchaca A, 2006, J CARDIOVASC PHARM, V47, P21, DOI 10.1097/01.fjc.0000191564.52242.00; SanchezChapula J, 1996, BRIT J PHARMACOL, V117, P1427, DOI 10.1111/j.1476-5381.1996.tb15302.x; Schulz JB, 1996, NEUROSCIENCE, V71, P1043, DOI 10.1016/0306-4522(95)00527-7; Serafim TL, 2008, CANCER CHEMOTH PHARM, V61, P1007, DOI 10.1007/s00280-007-0558-9; Shin KS, 2013, ARCH PHARM RES, V36, P759, DOI 10.1007/s12272-013-0051-4; Tanner CM, 2011, ENVIRON HEALTH PERSP, V119, P866, DOI 10.1289/ehp.1002839; Turner N, 2008, DIABETES, V57, P1414, DOI 10.2337/db07-1552; Vesikansa A, 2012, SCI REP-UK, V2, DOI 10.1038/srep00310; Volbracht C, 2006, EUR J NEUROSCI, V23, P2611, DOI 10.1111/j.1460-9568.2006.04787.x; Wang HM, 2004, J NEUROSCI, V24, P10963, DOI 10.1523/JNEUROSCI.3461-04.2004; Wang LH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036418; Wang XL, 2005, LIFE SCI, V77, P3058, DOI 10.1016/j.lfs.2005.02.033; Wang YX, 1996, EUR J PHARMACOL, V316, P307, DOI 10.1016/S0014-2999(96)00663-2; Ward MW, 2000, J NEUROSCI, V20, P7208; Wu J, 1997, BRAIN RES, V775, P214, DOI 10.1016/S0006-8993(97)00960-8; Yao J., 2013, SCI CHINA LIFE SCI; Ye MZ, 2009, J PHARM PHARMACOL, V61, P831, DOI [10.1211/jpp.61.07.0001, 10.1211/jpp/61.07.0001]; Yoo KY, 2006, BIOL PHARM BULL, V29, P623, DOI 10.1248/bpb.29.623; Yu SW, 2003, NEUROBIOL DIS, V14, P303, DOI 10.1016/j.nbd.2003.08.008; Yuan JY, 2000, NATURE, V407, P802, DOI 10.1038/35037739; Zhang Q, 2012, ACTA PHYSIOL HUNG, V99, P311, DOI 10.1556/APhysiol.99.2012.3.8; Zhou XQ, 2008, NEUROSCI LETT, V447, P31, DOI 10.1016/j.neulet.2008.09.064; Zhu FQ, 2006, BMC NEUROSCI, V7, DOI 10.1186/1471-2202-7-78	72	45	48	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2014	9	9							e107129	10.1371/journal.pone.0107129	http://dx.doi.org/10.1371/journal.pone.0107129			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ1IR	25192195	Green Published, gold, Green Submitted			2022-12-27	WOS:000347993600099
J	Muurinen, C; Laine, M; Pentti, J; Virtanen, M; Salo, P; Kivimaki, M; Vahtera, J; Oksanen, T				Muurinen, Charlotte; Laine, Matti; Pentti, Jaana; Virtanen, Marianna; Salo, Paula; Kivimaki, Mika; Vahtera, Jussi; Oksanen, Tuula			Vertical and Horizontal Trust at Work as Predictors of Retirement Intentions: The Finnish Public Sector Study	PLOS ONE			English	Article							LONGITUDINAL ANALYSIS; DISABILITY; LEADERSHIP; MODEL; RISK; PERFORMANCE; EMPLOYEES; DECISION; STRESS; HEALTH	This prospective cohort study aimed to examine the associations of trust towards the supervisor (vertical trust) and trust towards co-workers (horizontal trust) with retirement intentions. The participants were 14 840 women and men working in the municipal sector in 2000-12 (Finnish Public Sector Study). Trust (vertical trust towards the supervisor and horizontal trust towards co-workers) and retirement intentions were assessed in repeated surveys. Multivariable multinomial logistic regression analyses were conducted to assess the association between baseline trust and retirement intentions at 3.7 years of follow-up. Demographic characteristics, health, psychological distress, health risk behaviors, personality factors, and psychosocial factors were included as covariates. Of the participants, 67.0% trusted their supervisor and 54.9% trusted their co-workers. Employees who trusted their supervisor (odds ratio (OR) 0.60, 95% confidence interval (CI) 0.53-0.67) and employees who trusted their co-workers (odds ratio 0.62, 95% confidence interval 0.55-0.70) at baseline were less likely to have strong retirement intentions at follow-up compared to those who did not trust. These associations largely persisted after adjusting for all covariates and taking into account baseline retirement intentions. In conclusion, trust in the supervisor and co-workers predicted retirement intentions. These observational findings suggest that increasing trust in the workplace may contribute to lengthening working careers and preventing early retirement.	[Muurinen, Charlotte; Pentti, Jaana; Virtanen, Marianna; Salo, Paula; Kivimaki, Mika; Vahtera, Jussi; Oksanen, Tuula] Finnish Inst Occupat Hlth Dev Work & Org, Turku, Finland; [Muurinen, Charlotte; Pentti, Jaana; Virtanen, Marianna; Salo, Paula; Kivimaki, Mika; Vahtera, Jussi; Oksanen, Tuula] Finnish Inst Occupat Hlth Dev Work & Org, Helsinki, Finland; [Muurinen, Charlotte; Laine, Matti] Abo Akad Univ, Dept Psychol & Logoped, Turku, Finland; [Salo, Paula] Univ Turku, Dept Behav Sci & Philosophy, Psychol Sect, Turku, Finland; [Kivimaki, Mika] UCL, Dept Epidemiol & Publ Hlth, London, England; [Kivimaki, Mika] Univ Helsinki, Inst Behav Sci, Helsinki, Finland; [Vahtera, Jussi] Univ Turku, Dept Publ Hlth, Turku, Finland; [Vahtera, Jussi] Turku Univ Hosp, FIN-20520 Turku, Finland	Finnish Institute of Occupational Health; Finnish Institute of Occupational Health; Abo Akademi University; University of Turku; University of London; University College London; University of Helsinki; University of Turku; University of Turku	Muurinen, C (corresponding author), Finnish Inst Occupat Hlth Dev Work & Org, Turku, Finland.	cmuurine@abo.fi	Oksanen, Tuula/AAK-5599-2021; Salo, Paula/D-6649-2013; Kivimaki, Mika/B-3607-2012	Salo, Paula/0000-0002-0812-277X; Kivimaki, Mika/0000-0002-4699-5627; Vahtera, Jussi/0000-0002-6036-061X	EU - Academy of Finland [264944]; Foundation for Municipal Development (Hallintososionomien rahaston apuraha); Academy of Finland [258598, 265174]; Economic and Social Research Council, UK	EU - Academy of Finland; Foundation for Municipal Development (Hallintososionomien rahaston apuraha); Academy of Finland(Academy of Finland); Economic and Social Research Council, UK(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC))	The Finnish Public Sector Study is supported by the EU ERA-AGE2 programme funded by the Academy of Finland (project 264944) and the participating organizations. CM was supported by The Foundation for Municipal Development (Hallintososionomien rahaston apuraha). MV was supported by the Academy of Finland (grants 258598, 265174). MK is supported by a professorial fellowship from the Economic and Social Research Council, UK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aida J, 2013, J EPIDEMIOL COMMUN H, V67, P42, DOI 10.1136/jech-2011-200307; Barnes-Farrell JL, 2003, RETIREMENT: REASONS, PROCESSES, AND RESULTS, P159; Beehr T, 1986, PERS PSYCHOL, V39; Blau P. M., 2006, EXCHANGE POWER SOCIA; Blekesaune M, 2012, EUR J AGEING, V9, P199, DOI 10.1007/s10433-011-0212-6; Borsch-Supan A, 2005, 1 FINN CTR PENS; Burke CS, 2007, LEADERSHIP QUART, V18, P606, DOI 10.1016/j.leaqua.2007.09.006; Colquitt JA, 2007, J APPL PSYCHOL, V92, P909, DOI 10.1037/0021-9010.92.4.909; Dirks KT, 2001, ORGAN SCI, V12, P450, DOI 10.1287/orsc.12.4.450.10640; Dirks KT, 2002, J APPL PSYCHOL, V87, P611, DOI 10.1037/0021-9010.87.4.611; Dittrich D, 2011, OLDER WORKERS SUSTAI; DRISCOLL JW, 1978, ACAD MANAGE J, V21, P44, DOI 10.2307/255661; Elovainio M, 2003, J OCCUP ENVIRON MED, V45, P433, DOI 10.1097/01.jom.0000058334.05741.7a; FELDMAN DC, 1994, ACAD MANAGE REV, V19, P285, DOI 10.2307/258706; Finnish Centre for Pensions, 2013, PENS PART SOC SEC; Fulmer CA, 2012, J MANAGE, V38, P1167, DOI 10.1177/0149206312439327; Giordano GN, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-665; Goldberg D, 1998, USERS GUIDE GEN HLTH; Gould R, 2008, DIMENSIONS WORK ABIL, P139; Harkonmaki K, 2007, J EPIDEMIOL COMMUN H, V61, P479, DOI 10.1136/jech.2006.052670; Harkonmaki K, 2009, SCAND J PUBLIC HEALT, V37, P252, DOI 10.1177/1403494808100273; Holi MM, 2003, NORD J PSYCHIAT, V57, P233, DOI 10.1080/08039480310001418; Innocenti L, 2011, HUM RESOUR MANAG J, V21, P303, DOI 10.1111/j.1748-8583.2010.00151.x; Jagger C, 2008, LANCET, V372, P2124, DOI 10.1016/S0140-6736(08)61594-9; Karasek R, 1990, HLTH WORK STRESS PRO; Kauhanen M, 2012, IMPACT NEAR SUPERIOR; Kirkpatrick SA, 1996, J APPL PSYCHOL, V81, P36, DOI 10.1037/0021-9010.81.1.36; Kouvonen A, 2008, OCCUP ENVIRON MED, V65, P44, DOI 10.1136/oem.2007.032755; Kujala UM, 2002, AM J EPIDEMIOL, V156, P985, DOI 10.1093/aje/kwf151; Lewicki RJ, 2006, J MANAGE, V32, P991, DOI 10.1177/0149206306294405; MANTYNIEMI A, 2012, J OCCUP ENVIRON MED, V69, P574; MAYER RC, 1995, ACAD MANAGE REV, V20, P709, DOI 10.2307/258792; Mein G, 2000, AGE AGEING, V29, P529, DOI 10.1093/ageing/29.6.529; Mielonen A, 2012, VAESTON IKAANTYMISEN; Moore DP, 2011, GEND MANAG, V26, P220, DOI 10.1108/17542411111130981; MOORMAN RH, 1991, J APPL PSYCHOL, V76, P845, DOI 10.1037/0021-9010.76.6.845; OECD, 2013, PENS GLANC 2013 RET; Oksanen T, 2012, EUR J AGEING, V9, P221, DOI 10.1007/s10433-012-0243-7; Pienta AM, 2003, J APPL GERONTOL, V22, P340, DOI 10.1177/0733464803253587; Rechel B, 2013, LANCET, V381, P1312, DOI 10.1016/S0140-6736(12)62087-X; Rich GA, 1997, J ACAD MARKET SCI, V25, P319, DOI 10.1177/0092070397254004; ROTTER JB, 1967, J PERS, V35, P651, DOI 10.1111/j.1467-6494.1967.tb01454.x; SCHEIER MF, 1994, J PERS SOC PSYCHOL, V67, P1063, DOI 10.1037/0022-3514.67.6.1063; Schils T, 2008, EUR SOCIOL REV, V24, P315, DOI 10.1093/esr/jcn009; Siegrist J, 2007, EUR J PUBLIC HEALTH, V17, P62, DOI 10.1093/eurpub/ckl084; Spielberger C. D., 1973, MANUAL STATE TRAIT I; Statistics Finland, 1987, CLASS OCC; Sutinen R, 2005, WORK STRESS, V19, P177, DOI 10.1080/02678370500151760; Suzuki E, 2010, SOC SCI MED, V70, P1367, DOI 10.1016/j.socscimed.2010.01.014; Topa G, 2009, J VOCAT BEHAV, V75, P38, DOI 10.1016/j.jvb.2009.03.002; Tsutsumi A, 2004, SOC SCI MED, V59, P2335, DOI 10.1016/j.socscimed.2004.03.030; van Gunsteren H., 1991, TIME RETIREMENT COMP; Virtanen M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088695; von Bonsdorff ME, 2010, OCCUP MED-OXFORD, V60, P94, DOI 10.1093/occmed/kqp126; Wang M, 2010, J MANAGE, V36, P172, DOI 10.1177/0149206309347957; WHO, 2000, WHO TECHNICAL REPORT, V894	56	7	7	2	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2014	9	9							e106956	10.1371/journal.pone.0106956	http://dx.doi.org/10.1371/journal.pone.0106956			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AZ1IR	25191745	Green Published, gold, Green Submitted			2022-12-27	WOS:000347993600084
J	Qi, ZP; Li, L; Wang, XF; Gao, X; Wang, X; Wei, HM; Zhang, J; Sun, R; Tian, ZG				Qi, Ziping; Li, Lu; Wang, Xuefu; Gao, Xiang; Wang, Xin; Wei, Haiming; Zhang, Jian; Sun, Rui; Tian, Zhigang			Bone Marrow Transplantation Concurrently Reconstitutes Donor Liver and Immune System across Host Species Barrier in Mice	PLOS ONE			English	Article							HEPATITIS-B-VIRUS; HEMATOPOIETIC STEM-CELLS; HUMANIZED MOUSE MODELS; CORD BLOOD; HUMAN HEPATOCYTES; IN-VIVO; MYELOMONOCYTIC CELLS; XENOGENEIC GVHD; TRANSGENIC MICE; CD34(+) CELLS	Liver immunopathologic mechanisms during hepatotropic infection, malignant transformation, and autoimmunity are still unclear. Establishing a chimeric mouse with a reconstituted liver and immune system derived from a single donor across species is critical to study regional donor immune responses in recipient liver. Using a strain of mice deficient in tyrosine catabolic enzyme fumarylacetoacetate hydrolase (fah(-/-)) and bone marrow transplantation (BMT), we reconstituted the donor's hepatocytes and immune cells across host species barrier. Syngeneic, allogeneic or even xenogeneic rat BMT rescued most recipient fah(-/-) mice against liver failure by donor BM-derived FAH(+) hepatocytes. Importantly, immune system developed normally in chimeras, and the immune cells together with organ architecture were intact and functional. Thus, donor BM can across host species barrier and concurrently reconstitutes MHC-identical response between immune cells and hepatocytes, giving rise to a new simple and convenient small animal model to study donor's liver immune response in mice.	[Qi, Ziping; Li, Lu; Wang, Xuefu; Wei, Haiming; Sun, Rui; Tian, Zhigang] Univ Sci & Technol China, Sch Life Sci, Dept Immunol, Hefei 230026, Anhui, Peoples R China; [Li, Lu; Wei, Haiming; Sun, Rui; Tian, Zhigang] Hefei Natl Lab Phys Sci Microscale, Hefei, Anhui, Peoples R China; [Gao, Xiang] Nanjing Univ, Model Anim Res Ctr, Nanjing 210008, Jiangsu, Peoples R China; [Wang, Xin] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Biochem & Cell Biol, Shanghai, Peoples R China; [Zhang, Jian] Shandong Univ, Sch Pharmaceut Sci, Jinan 250100, Peoples R China; [Tian, Zhigang] Collaborat Innovat Ctr Diag & Treatment Infect Di, Hangzhou, Zhejiang, Peoples R China	Chinese Academy of Sciences; University of Science & Technology of China, CAS; Nanjing University; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Shandong University; Collaborative Innovation Center for Diagnosis & Treatment of Infectious Diseases	Tian, ZG (corresponding author), Univ Sci & Technol China, Sch Life Sci, Dept Immunol, Hefei 230026, Anhui, Peoples R China.	tzg@ustc.edu.cn	Zhang, Jian/AAQ-3068-2021; Tian, Zhigang/J-3512-2013	Wang, Xuefu/0000-0001-7212-7156	Ministry of Science & Technology of China [2013CB531503, 2013CB944902]; Natural Science Foundation of China [31390433]; National Science & Technology Major Projects [2012ZX10002006]	Ministry of Science & Technology of China(Ministry of Science and Technology, China); Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Science & Technology Major Projects	This work was supported by Ministry of Science & Technology of China (Basic Science Project #2013CB531503, #2013CB944902), Natural Science Foundation of China (#31390433), and National Science & Technology Major Projects(#2012ZX10002006). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABE K, 1992, HEPATOLOGY, V15, P690, DOI 10.1002/hep.1840150423; Azuma H, 2007, NAT BIOTECHNOL, V25, P903, DOI 10.1038/nbt1326; Bissig KD, 2010, J CLIN INVEST, V120, P924, DOI 10.1172/JCI40094; Camargo FD, 2004, J CLIN INVEST, V113, P1266, DOI 10.1172/JCI200421301; Chen QF, 2009, P NATL ACAD SCI USA, V106, P21783, DOI 10.1073/pnas.0912274106; Chen YY, 2007, HEPATOLOGY, V46, P706, DOI 10.1002/hep.21872; Droetto S, 2004, FASEB J, V18, P1273, DOI 10.1096/fj.03-1444fje; GROMPE M, 1995, NAT GENET, V10, P453, DOI 10.1038/ng0895-453; GUIDOTTI LG, 1995, J VIROL, V69, P6158, DOI 10.1128/JVI.69.10.6158-6169.1995; Guidotti LG, 1999, SCIENCE, V284, P825, DOI 10.1126/science.284.5415.825; Guidotti LG, 2006, ANNU REV PATHOL-MECH, V1, P23, DOI 10.1146/annurev.pathol.1.110304.100230; He ZY, 2010, AM J PATHOL, V177, P1311, DOI 10.2353/ajpath.2010.091154; Hippen KL, 2012, BLOOD, V119, P619, DOI 10.1182/blood-2011-07-368027; Huang LR, 2006, P NATL ACAD SCI USA, V103, P17862, DOI 10.1073/pnas.0608578103; Ishikawa F, 2004, FASEB J, V18, P1958, DOI 10.1096/fj.04-2396fje; Ishikawa F, 2005, BLOOD, V106, P1565, DOI 10.1182/blood-2005-02-0516; Ishikawa F, 2006, FASEB J, V20, P950, DOI 10.1096/fj.05-4863fje; Ito M, 2002, BLOOD, V100, P3175, DOI 10.1182/blood-2001-12-0207; Ito R, 2012, CELL MOL IMMUNOL, V9, P208, DOI 10.1038/cmi.2012.2; Jaruga B, 2003, J IMMUNOL, V171, P3233, DOI 10.4049/jimmunol.171.6.3233; Kakinuma S, 2003, STEM CELLS, V21, P217, DOI 10.1634/stemcells.21-2-217; Kumar P, 2008, CELL, V134, P577, DOI 10.1016/j.cell.2008.06.034; Lagasse E, 2000, NAT MED, V6, P1229, DOI 10.1038/81326; Legrand N, 2006, J IMMUNOL, V176, P2053, DOI 10.4049/jimmunol.176.4.2053; Legrand N, 2009, CELL HOST MICROBE, V6, P5, DOI 10.1016/j.chom.2009.06.006; Lutgehetmann M, 2012, HEPATOLOGY, V55, P685, DOI 10.1002/hep.24758; Luznik L, 2010, BLOOD, V115, P3224, DOI 10.1182/blood-2009-11-251595; MARION PL, 1980, P NATL ACAD SCI-BIOL, V77, P2941, DOI 10.1073/pnas.77.5.2941; MASON WS, 1980, J VIROL, V36, P829, DOI 10.1128/JVI.36.3.829-836.1980; Mercer DF, 2001, NAT MED, V7, P927, DOI 10.1038/90968; Quintana-Bustamante O, 2006, HEPATOLOGY, V43, P108, DOI 10.1002/hep.21005; Schiedner G, 2003, MOL THER, V7, P35, DOI 10.1016/S1525-0016(02)00017-5; Shultz LD, 2005, J IMMUNOL, V174, P6477, DOI 10.4049/jimmunol.174.10.6477; Shultz LD, 2010, P NATL ACAD SCI USA, V107, P13022, DOI 10.1073/pnas.1000475107; Sugiyama M, 2007, HEPATOLOGY, V45, P929, DOI 10.1002/hep.21584; SUMMERS J, 1978, P NATL ACAD SCI USA, V75, P4533, DOI 10.1073/pnas.75.9.4533; Sun ZF, 2007, J EXP MED, V204, P705, DOI 10.1084/jem.20062411; Taguchi A, 2004, J CLIN INVEST, V114, P330, DOI 10.1172/jci200420622; Tateno C, 2004, AM J PATHOL, V165, P901, DOI 10.1016/S0002-9440(10)63352-4; Torrente Y, 2004, J CLIN INVEST, V114, P182, DOI 10.1172/JCI200420325; Traggiai E, 2004, SCIENCE, V304, P104, DOI 10.1126/science.1093933; Vassilopoulos G, 2003, NATURE, V422, P901, DOI 10.1038/nature01539; Wang X, 2003, NATURE, V422, P897, DOI 10.1038/nature01531; Washburn ML, 2011, GASTROENTEROLOGY, V140, P1334, DOI 10.1053/j.gastro.2011.01.001; Willenbring H, 2004, NAT MED, V10, P744, DOI 10.1038/nm1062; Wunderlich M, 2014, BLOOD, V123, pE134, DOI 10.1182/blood-2014-02-556340; Zhang LG, 2012, CELL MOL IMMUNOL, V9, P237, DOI 10.1038/cmi.2012.7	47	1	1	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2014	9	9							e106791	10.1371/journal.pone.0106791	http://dx.doi.org/10.1371/journal.pone.0106791			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ1IR	25191899	Green Submitted, gold, Green Published			2022-12-27	WOS:000347993600061
J	Stoeck, CT; Kalinowska, A; von Deuster, C; Harmer, J; Chan, RW; Niemann, M; Manka, R; Atkinson, D; Sosnovik, DE; Mekkaoui, C; Kozerke, S				Stoeck, Christian T.; Kalinowska, Aleksandra; von Deuster, Constantin; Harmer, Jack; Chan, Rachel W.; Niemann, Markus; Manka, Robert; Atkinson, David; Sosnovik, David E.; Mekkaoui, Choukri; Kozerke, Sebastian			Dual-Phase Cardiac Diffusion Tensor Imaging with Strain Correction	PLOS ONE			English	Article							MAGNETIC-RESONANCE; IN-VIVO; FIBER ARCHITECTURE; HISTOLOGICAL VALIDATION; LAMINAR STRUCTURE; HUMAN HEART; MRI; MYOCARDIUM; MOTION; QUANTIFICATION	Purpose: In this work we present a dual-phase diffusion tensor imaging (DTI) technique that incorporates a correction scheme for the cardiac material strain, based on 3D myocardial tagging. Methods: In vivo dual-phase cardiac DTI with a stimulated echo approach and 3D tagging was performed in 10 healthy volunteers. The time course of material strain was estimated from the tagging data and used to correct for strain effects in the diffusion weighted acquisition. Mean diffusivity, fractional anisotropy, helix, transverse and sheet angles were calculated and compared between systole and diastole, with and without strain correction. Data acquired at the systolic sweet spot, where the effects of strain are eliminated, served as a reference. Results: The impact of strain correction on helix angle was small. However, large differences were observed in the transverse and sheet angle values, with and without strain correction. The standard deviation of systolic transverse angles was significantly reduced from 35.9 +/- 3.9 degrees to 27.8 degrees +/- 3.5 degrees (p<0.001) upon strain-correction indicating more coherent fiber tracks after correction. Myocyte aggregate structure was aligned more longitudinally in systole compared to diastole as reflected by an increased transmural range of helix angles (71.8 degrees +/- 3.9 degrees systole vs. 55.6 degrees +/- 5.6 degrees, p<0.001 diastole). While diastolic sheet angle histograms had dominant counts at high sheet angle values, systolic histograms showed lower sheet angle values indicating a reorientation of myocyte sheets during contraction. Conclusion: An approach for dual-phase cardiac DTI with correction for material strain has been successfully implemented. This technique allows assessing dynamic changes in myofiber architecture between systole and diastole, and emphasizes the need for strain correction when sheet architecture in the heart is imaged with a stimulated echo approach.	[Stoeck, Christian T.; von Deuster, Constantin; Niemann, Markus; Manka, Robert; Kozerke, Sebastian] Univ Zurich, Inst Biomed Engn, Zurich, Switzerland; [Stoeck, Christian T.; von Deuster, Constantin; Niemann, Markus; Manka, Robert; Kozerke, Sebastian] ETH, Zurich, Switzerland; [Kalinowska, Aleksandra] MIT, Dept Mech & Biomed Engn, Cambridge, MA 02139 USA; [von Deuster, Constantin; Harmer, Jack; Kozerke, Sebastian] Kings Coll London, London WC2R 2LS, England; [Chan, Rachel W.; Atkinson, David] UCL, Ctr Med Imaging, London, England; [Niemann, Markus; Manka, Robert] Univ Zurich Hosp, Dept Cardiol, CH-8091 Zurich, Switzerland; [Manka, Robert] Univ Zurich Hosp, Dept Radiol, CH-8091 Zurich, Switzerland; [Sosnovik, David E.; Mekkaoui, Choukri] Harvard Univ, Sch Med, Dept Radiol, Athinoula A Martinos Ctr Biomed Imaging,Massachus, Boston, MA 02115 USA; [Sosnovik, David E.] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Cardiovasc Res Ctr,Cardiol Div, Boston, MA USA; [Mekkaoui, Choukri] Univ Hosp Ctr Nimes, Dept Radiol, EA 2415, Nimes, France; [Mekkaoui, Choukri] Univ Montpellier I, Fac Med, Montpellier, France	University of Zurich; Swiss Federal Institutes of Technology Domain; ETH Zurich; Massachusetts Institute of Technology (MIT); University of London; King's College London; University of London; University College London; University of Zurich; University Zurich Hospital; University of Zurich; University Zurich Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Massachusetts General Hospital; Universite de Montpellier; CHU de Nimes; Universite de Montpellier	Kozerke, S (corresponding author), Univ Zurich, Inst Biomed Engn, Zurich, Switzerland.	kozerke@biomed.ee.ethz.ch	Kozerke, Sebastian/J-3209-2015; Atkinson, David/C-2270-2008; Kalinowska, Ola/AAP-4610-2021; Stoeck, Christian T/S-6280-2016	Kozerke, Sebastian/0000-0003-3725-8884; Atkinson, David/0000-0003-1124-6666; Kalinowska, Ola/0000-0002-0530-2863; Stoeck, Christian/0000-0001-8670-0929	Swiss National Science Foundation [CR3213_132671/1]; UK EPSRC [EP/I018808/1]; Adult Congenital Heart Disease Service GSTT; National Institute for Health Research (NIHR) Biomedical Research Centre at Guy's and St Thomas' NHS Foundation Trust; King's College London; National Institutes of Health [5R01HL112831]; EPSRC [EP/I018700/1, EP/I018808/1] Funding Source: UKRI; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL112831] Funding Source: NIH RePORTER; Engineering and Physical Sciences Research Council [EP/I018700/1, EP/I018808/1] Funding Source: researchfish	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); UK EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Adult Congenital Heart Disease Service GSTT; National Institute for Health Research (NIHR) Biomedical Research Centre at Guy's and St Thomas' NHS Foundation Trust; King's College London; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	This work was supported by the Swiss National Science Foundation, grant #CR3213_132671/1; UK EPSRC (EP/I018808/1), Adult Congenital Heart Disease Service GSTT and the National Institute for Health Research (NIHR) Biomedical Research Centre at Guy's and St Thomas' NHS Foundation Trust and King's College London; and the National Institutes of Health (5R01HL112831). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander AL, 2006, NEUROIMAG CLIN N AM, V16, P299, DOI 10.1016/j.nic.2006.02.006; Bammer R, 2002, MAGNET RESON MED, V48, P128, DOI 10.1002/mrm.10184; Bammer R, 2001, MAGN RESON MED, V46, P548, DOI 10.1002/mrm.1226; Breuer FA, 2005, MAGNET RESON MED, V53, P684, DOI 10.1002/mrm.20401; Chen JJ, 2005, AM J PHYSIOL-HEART C, V289, pH1898, DOI 10.1152/ajpheart.00041.2005; Chen JJ, 2003, AM J PHYSIOL-HEART C, V285, pH946, DOI 10.1152/ajpheart.00889.2002; Chen Y, 2013, PROGRESSIVE MYOCARDI, P3077; Cheng YJ, 2012, AM J PHYSIOL-HEART C, V303, pH559, DOI 10.1152/ajpheart.00321.2012; Costa KD, 1999, AM J PHYSIOL-HEART C, V276, pH595, DOI 10.1152/ajpheart.1999.276.2.H595; Dou JG, 2002, MAGNET RESON MED, V48, P105, DOI 10.1002/mrm.10188; EDELMAN RR, 1994, MAGNET RESON MED, V32, P423, DOI 10.1002/mrm.1910320320; Eggen MD, 2012, MAGN RESON MED, V67, P1703, DOI 10.1002/mrm.23194; Ennis DB, 2005, MAGNET RESON MED, V53, P169, DOI 10.1002/mrm.20318; FEINBERG DA, 1985, RADIOLOGY, V156, P743, DOI 10.1148/radiology.156.3.4023236; Ferreira P., 2014, J CARDIOVASC MAGN RE, V16, pP338; Ferreira PF, 2014, J CARDIOVASC MAGN R, V16, DOI 10.1186/s12968-014-0087-8; FISCHER SE, 1993, MAGNET RESON MED, V30, P191, DOI 10.1002/mrm.1910300207; Gamper U, 2007, MAGN RESON MED, V57, P331, DOI 10.1002/mrm.21127; Geerts L, 2002, AM J PHYSIOL-HEART C, V283, pH139, DOI 10.1152/ajpheart.00968.2001; GREENBAUM RA, 1981, BRIT HEART J, V45, P248; Hales PW, 2012, PROG BIOPHYS MOL BIO, V110, P319, DOI 10.1016/j.pbiomolbio.2012.07.014; Hales PW, 2011, NMR BIOMED, V24, P836, DOI 10.1002/nbm.1629; Harmer J, 2013, INVIVO DIFFUSION TEN; Helm PA, 2005, MAGN RESON MED, V54, P850, DOI 10.1002/mrm.20622; Hess AT, 2009, MAGN RESON MED, V62, P77, DOI 10.1002/mrm.21984; Hsu EW, 1998, AM J PHYSIOL-HEART C, V274, pH1627, DOI 10.1152/ajpheart.1998.274.5.H1627; Jones DK, 1999, MAGNET RESON MED, V42, P515, DOI 10.1002/(SICI)1522-2594(199909)42:3<515::AID-MRM14>3.0.CO;2-Q; Klein S, 2010, IEEE T MED IMAGING, V29, P196, DOI 10.1109/TMI.2009.2035616; Kristoffersen A, 2007, J MAGN RESON, V187, P293, DOI 10.1016/j.jmr.2007.05.004; Kung GL, 2011, J MAGN RESON IMAGING, V34, P1080, DOI 10.1002/jmri.22725; Lau AZ, 2014, MAGN RESON MED; LEGRICE IJ, 1995, AM J PHYSIOL-HEART C, V269, pH571, DOI 10.1152/ajpheart.1995.269.2.H571; Lustig M, 2007, MAGN RESON MED, V58, P1182, DOI 10.1002/mrm.21391; McGill LA, 2012, J CARDIOVASC MAGN R, V14, DOI 10.1186/1532-429X-14-86; Mekkaoui C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072795; Mekkaoui C, 2012, J CARDIOVASC MAGN R, V14, DOI 10.1186/1532-429X-14-70; Menzel MI, 2011, MAGN RESON MED, V66, P1226, DOI 10.1002/mrm.23064; Myronenko A, 2010, IEEE T PATTERN ANAL, V32, P2262, DOI 10.1109/TPAMI.2010.46; Nguyen C, 2013, MAGN RESON MED; Nielles-Vallespin S, 2013, TIME RESOLVED VIVO C; Nielles-Vallespin S, 2013, MAGN RESON MED, V70, P454, DOI 10.1002/mrm.24488; Pope AJ, 2008, AM J PHYSIOL-HEART C, V295, pH1243, DOI 10.1152/ajpheart.00484.2008; REESE TG, 1995, MAGNET RESON MED, V34, P786, DOI 10.1002/mrm.1910340603; Reese TG, 1996, J MAGN RESON SER B, V112, P253, DOI 10.1006/jmrb.1996.0139; Reischauer C, 2011, EUR J RADIOL, V80, pE34, DOI 10.1016/j.ejrad.2010.06.038; Rutz AK, 2008, MAGN RESON MED, V59, P755, DOI 10.1002/mrm.21363; Schar M, 2003, CONSIDERATIONS SHIMM; Schmid P, 2005, EUR J CARDIO-THORAC, V27, P468, DOI 10.1016/j.ejcts.2004.11.036; Scollan DF, 1998, AM J PHYSIOL-HEART C, V275, pH2308, DOI 10.1152/ajpheart.1998.275.6.H2308; Smerup M, 2013, ANAT REC, V296, P1724, DOI 10.1002/ar.22787; Sosnovik DE, 2014, CIRCULATION, V129, P1731, DOI 10.1161/CIRCULATIONAHA.113.005841; Sosnovik DE, 2009, CIRC-CARDIOVASC IMAG, V2, P206, DOI 10.1161/CIRCIMAGING.108.815050; STREETER DD, 1969, CIRC RES, V24, P339, DOI 10.1161/01.RES.24.3.339; Strijkers GJ, 2009, NMR BIOMED, V22, P182, DOI 10.1002/nbm.1299; Toussaint N, 2013, MED IMAGE ANAL; Toussaint N, 2010, LECT NOTES COMPUT SC, V6361, P418; Tseng WI, 1999, MAGNET RESON MED, V42, P393, DOI 10.1002/(SICI)1522-2594(199908)42:2<393::AID-MRM22>3.0.CO;2-F; Tseng WYI, 2003, J MAGN RESON IMAGING, V17, P31, DOI 10.1002/jmri.10223; vonDeuster C, 2013, CONCURRENT DUAL SLIC; Wang H, 2013, IEEE ENG MED BIO, P4386, DOI 10.1109/EMBC.2013.6610518; Wu EX, 2007, MAGN RESON MED, V58, P687, DOI 10.1002/mrm.21350; Wu MT, 2006, CIRCULATION, V114, P1036, DOI 10.1161/CIRCULATIONAHA.105.545863; Wu Y, 2009, J MAGN RESON IMAGING, V29, P305, DOI 10.1002/jmri.21598; Young AA, 1998, J MICROSC-OXFORD, V192, P139, DOI 10.1046/j.1365-2818.1998.00414.x	64	63	63	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2014	9	9							e107159	10.1371/journal.pone.0107159	http://dx.doi.org/10.1371/journal.pone.0107159			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ1IR	25191900	Green Published, Green Accepted, gold			2022-12-27	WOS:000347993600103
J	Wiest, R; Abela, E; Missimer, J; Schroth, G; Hess, CW; Sturzenegger, M; Wang, DJJ; Weder, B; Federspiel, A				Wiest, Roland; Abela, Eugenio; Missimer, John; Schroth, Gerhard; Hess, Christian W.; Sturzenegger, Matthias; Wang, Danny J. J.; Weder, Bruno; Federspiel, Andrea			Interhemispheric Cerebral Blood Flow Balance during Recovery of Motor Hand Function after Ischemic Stroke-A Longitudinal MRI Study Using Arterial Spin Labeling Perfusion	PLOS ONE			English	Article							COST FUNCTION MASKING; SUBCORTICAL STROKE; FMRI; CONNECTIVITY; CORTEX; ACTIVATION; NETWORKS; TASK; NORMALIZATION; NEUROSCIENCE	Background: Unilateral ischemic stroke disrupts the well balanced interactions within bilateral cortical networks. Restitution of interhemispheric balance is thought to contribute to post-stroke recovery. Longitudinal measurements of cerebral blood flow (CBF) changes might act as surrogate marker for this process. Objective: To quantify longitudinal CBF changes using arterial spin labeling MRI (ASL) and interhemispheric balance within the cortical sensorimotor network and to assess their relationship with motor hand function recovery. Methods: Longitudinal CBF data were acquired in 23 patients at 3 and 9 months after cortical sensorimotor stroke and in 20 healthy controls using pulsed ASL. Recovery of grip force and manual dexterity was assessed with tasks requiring power and precision grips. Voxel-based analysis was performed to identify areas of significant CBF change. Region-of-interest analyses were used to quantify the interhemispheric balance across nodes of the cortical sensorimotor network. Results: Dexterity was more affected, and recovered at a slower pace than grip force. In patients with successful recovery of dexterous hand function, CBF decreased over time in the contralesional supplementary motor area, paralimbic anterior cingulate cortex and superior precuneus, and interhemispheric balance returned to healthy control levels. In contrast, patients with poor recovery presented with sustained hypoperfusion in the sensorimotor cortices encompassing the ischemic tissue, and CBF remained lateralized to the contralesional hemisphere. Conclusions: Sustained perfusion imbalance within the cortical sensorimotor network, as measured with task-unrelated ASL, is associated with poor recovery of dexterous hand function after stroke. CBF at rest might be used to monitor recovery and gain prognostic information.	[Wiest, Roland; Abela, Eugenio; Schroth, Gerhard; Weder, Bruno] Inselspital Bern, Univ Hosp, Inst Diagnost & Intervent Neuroradiol, SCAN, CH-3010 Bern, Switzerland; [Wiest, Roland; Abela, Eugenio; Schroth, Gerhard; Hess, Christian W.; Sturzenegger, Matthias; Weder, Bruno; Federspiel, Andrea] Univ Bern, Bern, Switzerland; [Weder, Bruno] Kantonsspital St Gallen, Dept Neurol, St Gallen, Switzerland; [Missimer, John] Paul Scherrer Inst, Lab Biomol Res, Villigen, Switzerland; [Abela, Eugenio; Hess, Christian W.; Sturzenegger, Matthias; Weder, Bruno] Inselspital Bern, Univ Hosp, Dept Neurol, CH-3010 Bern, Switzerland; [Wang, Danny J. J.] Univ Calif Los Angeles, Dept Neurol, Ahmanson Lovelace Brain Mapping Ctr, Los Angeles, CA 90024 USA; [Federspiel, Andrea] Univ Hosp Psychiat, Dept Psychiat Neurophysiol, Bern, Switzerland	University of Bern; University Hospital of Bern; University of Bern; Kantonsspital St. Gallen; Swiss Federal Institutes of Technology Domain; Paul Scherrer Institute; University of Bern; University Hospital of Bern; University of California System; University of California Los Angeles; University of Bern; University Hospital of Bern	Wiest, R (corresponding author), Inselspital Bern, Univ Hosp, Inst Diagnost & Intervent Neuroradiol, SCAN, CH-3010 Bern, Switzerland.	roland.wiest@insel.ch	Wang, Danny JJ/O-2482-2018	Wang, Danny JJ/0000-0002-0840-7062; Weder, Bruno/0000-0002-8106-9899; Abela, Eugenio/0000-0002-9356-1450	Swiss National Foundation Grant (SNF) [3200B0-118018]; Swiss National Foundation Grant (SPUM) [124114]	Swiss National Foundation Grant (SNF); Swiss National Foundation Grant (SPUM)	This study was granted by the Swiss National Foundation Grant (SNF 3200B0-118018) to BW and Swiss National Foundation Grant (SPUM 124114) to GS (www.snf.ch). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abela E, 2014, BRAIN STRUCT FUNCT; Abela E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031275; ADAMS HP, 1993, STROKE, V24, P35, DOI 10.1161/01.STR.24.1.35; Alsop D. C., 2014, MAGN RESON MED; Andersen SM, 2010, NEUROIMAGE, V53, P78, DOI 10.1016/j.neuroimage.2010.06.003; Ashburner J, 2005, NEUROIMAGE, V26, P839, DOI 10.1016/j.neuroimage.2005.02.018; Binkofski F, 2004, BRAIN LANG, V89, P362, DOI 10.1016/S0093-934X(03)00358-4; Bokkers RPH, 2012, STROKE, V43, P1290, DOI 10.1161/STROKEAHA.110.589234; Brett M, 2001, NEUROIMAGE, V14, P486, DOI 10.1006/nimg.2001.0845; Calautti C, 2001, NEUROREPORT, V12, P3883, DOI 10.1097/00001756-200112210-00005; Calautti C, 2007, NEUROIMAGE, V34, P322, DOI 10.1016/j.neuroimage.2006.08.026; Carter AR, 2010, ANN NEUROL, V67, P365, DOI 10.1002/ana.21905; Castiello U, 2005, NAT REV NEUROSCI, V6, P726, DOI 10.1038/nrn1744; Cavanna AE, 2006, BRAIN, V129, P564, DOI 10.1093/brain/awl004; Cramer SC, 1997, STROKE, V28, P2518, DOI 10.1161/01.STR.28.12.2518; Dai WY, 2008, MAGN RESON MED, V60, P1488, DOI 10.1002/mrm.21790; Deichmann R, 2004, NEUROIMAGE, V21, P757, DOI 10.1016/j.neuroimage.2003.09.062; Detre JA, 2009, CURR OPIN NEUROL, V22, P348, DOI 10.1097/WCO.0b013e32832d9505; Donahue MJ, 2014, J MAGN RESON IMAGING, V39, P377, DOI 10.1002/jmri.24150; Ehrsson HH, 2001, J NEUROPHYSIOL, V85, P2613, DOI 10.1152/jn.2001.85.6.2613; Enzinger C, 2008, STROKE, V39, P1507, DOI 10.1161/STROKEAHA.107.501999; Fan FM, 2013, HUM BRAIN MAPP, V34, P1872, DOI 10.1002/hbm.22034; Federspiel A, 2006, J NEURAL TRANSM, V113, P1403, DOI 10.1007/s00702-006-0434-5; Fox MD, 2007, NAT REV NEUROSCI, V8, P700, DOI 10.1038/nrn2201; GOLDMANRAKIC PS, 1988, ANNU REV NEUROSCI, V11, P137, DOI 10.1146/annurev.neuro.11.1.137; Grefkes C, 2008, ANN NEUROL, V63, P236, DOI 10.1002/ana.21228; Hartmann S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003831; Hendrikse J, 2012, NEUROIMAG CLIN N AM, V22, P259, DOI 10.1016/j.nic.2012.02.003; Hillis AE, 2004, BRAIN LANG, V89, P524, DOI 10.1016/j.bandl.2004.01.007; Hillis AE, 2006, J NEUROSCI, V26, P8069, DOI 10.1523/JNEUROSCI.2088-06.2006; INFELD B, 1995, STROKE, V26, P90, DOI 10.1161/01.STR.26.1.90; Inman CS, 2012, NEUROIMAGE, V59, P227, DOI 10.1016/j.neuroimage.2011.07.083; JEBSEN R H, 1971, Archives of Physical Medicine and Rehabilitation, V52, P170; JEBSEN R H, 1969, Archives of Physical Medicine and Rehabilitation, V50, P311; Kagi G, 2010, BEHAV BRAIN FUNCT, V6, DOI 10.1186/1744-9081-6-71; Khurshid S, 2012, CORTEX, V48, P530, DOI 10.1016/j.cortex.2011.01.003; Lee MH, 2013, AM J NEURORADIOL, V34, P1866, DOI 10.3174/ajnr.A3263; Leichnetz GR, 2001, ANAT RECORD, V263, P215, DOI 10.1002/ar.1082; Lyden P, 1999, STROKE, V30, P2347, DOI 10.1161/01.STR.30.11.2347; Lyden P D, 1998, J Stroke Cerebrovasc Dis, V7, P113; Marshall RS, 2009, ANN NEUROL, V65, P596, DOI 10.1002/ana.21636; Marshall RS, 2000, STROKE, V31, P656, DOI 10.1161/01.STR.31.3.656; MATHIOWETZ V, 1984, J HAND SURG-AM, V9A, P222, DOI 10.1016/S0363-5023(84)80146-X; Matteis M, 2003, J NEUROL, V250, P810, DOI 10.1007/s00415-003-1082-4; Mosier K, 2011, J NEUROPHYSIOL, V105, P1295, DOI 10.1152/jn.00757.2010; Nhan H, 2004, J CEREBR BLOOD F MET, V24, P756, DOI 10.1097/01.WCB.0000122744.72175.9C; Park CH, 2011, STROKE, V42, P1357, DOI 10.1161/STROKEAHA.110.596155; Paus T, 2001, EUR J NEUROSCI, V14, P1405, DOI 10.1046/j.0953-816x.2001.01757.x; Rehme AK, 2013, J PHYSIOL-LONDON, V591, P17, DOI 10.1113/jphysiol.2012.243469; Rehme AK, 2011, CEREB CORTEX, V21, P756, DOI 10.1093/cercor/bhq140; Richardson JD, 2011, BEHAV NEUROL, V24, P117, DOI [10.3233/BEN-2011-0283, 10.1155/2011/380810]; Seifritz E, 2000, PSYCHIAT RES-NEUROIM, V99, P1, DOI 10.1016/S0925-4927(00)00054-8; Seitz R J, 1990, Neuroreport, V1, P57, DOI 10.1097/00001756-199009000-00016; Seitz Rudiger J, 2003, Adv Neurol, V93, P281; Silvestrini M, 1998, NEUROLOGY, V50, P191, DOI 10.1212/WNL.50.1.191; STERN EB, 1992, AM J OCCUP THER, V46, P647, DOI 10.5014/ajot.46.7.647; Wang JJ, 2003, MAGN RESON MED, V50, P599, DOI 10.1002/mrm.10559; Wang JJ, 2003, MAGN RESON MED, V49, P796, DOI 10.1002/mrm.10437; Wang JJ, 2002, MAGN RESON MED, V48, P242, DOI 10.1002/mrm.10211; Wang L, 2010, BRAIN, V133, P1224, DOI 10.1093/brain/awq043; Ward NS, 2004, ANN NEUROL, V55, P829, DOI 10.1002/ana.20099; Ward NS, 2003, BRAIN, V126, P1430, DOI 10.1093/brain/awg145; Ward NS, 2003, BRAIN, V126, P2476, DOI 10.1093/brain/awg245; Wenderoth N, 2005, EUR J NEUROSCI, V22, P235, DOI 10.1111/j.1460-9568.2005.04176.x; Wu WC, 2007, MAGN RESON MED, V58, P1020, DOI 10.1002/mrm.21403	65	18	20	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2014	9	9							e106327	10.1371/journal.pone.0106327	http://dx.doi.org/10.1371/journal.pone.0106327			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ1IR	25191858	Green Published, gold, Green Submitted			2022-12-27	WOS:000347993600019
J	Koehrer, P; Saab, S; Berdeaux, O; Isaico, R; Gregoire, S; Cabaret, S; Bron, AM; Creuzot-Garcher, CP; Bretillon, L; Acar, N				Koehrer, Philippe; Saab, Sarah; Berdeaux, Olivier; Isaico, Rodica; Gregoire, Stephane; Cabaret, Stephanie; Bron, Alain M.; Creuzot-Garcher, Catherine P.; Bretillon, Lionel; Acar, Niyazi			Erythrocyte Phospholipid and Polyunsaturated Fatty Acid Composition in Diabetic Retinopathy	PLOS ONE			English	Article							DOCOSAHEXAENOIC ACID; INSULIN SENSITIVITY; LIPIDS; DEFORMABILITY; EXPRESSION; STORAGE; RETINA; BOVINE; MUSCLE	Background: Long chain polyunsaturated fatty acids (LCPUFAs) including docosahexaenoic acid and arachidonic acid are suspected to play a key role in the pathogenesis of diabetes. LCPUFAs are known to be preferentially concentrated in specific phospholipids termed as plasmalogens. This study was aimed to highlight potential changes in the metabolism of phospholipids, and particularly plasmalogens, and LCPUFAs at various stages of diabetic retinopathy in humans. Methodology and Principal Findings: We performed lipidomic analyses on red blood cell membranes from controls and mainly type 2 diabetes mellitus patients with or without retinopathy. The fatty acid composition of erythrocytes was determined by gas chromatography and the phospholipid structure was determined by liquid chromatography equipped with an electrospray ionisation source and coupled with a tandem mass spectrometer (LC-ESI-MS/MS). A significant decrease in levels of docosahexaenoic acid and arachidonic acid in erythrocytes of diabetic patients with or without retinopathy was observed. The origin of this decrease was a loss of phosphatidyl-ethanolamine phospholipids esterified with these LCPUFAs. In diabetic patients without retinopathy, this change was balanced by an increase in the levels of several phosphatidyl-choline species. No influence of diabetes nor of diabetic retinopathy was observed on the concentrations of plasmalogen-type phospholipids. Conclusions and Significance: Diabetes and diabetic retinopathy were associated with a reduction of erythrocyte LCPUFAs in phosphatidyl-ethanolamines. The increase of the amounts of phosphatidyl-choline species in erythrocytes of diabetic patients without diabetic retinopathy might be a compensatory mechanism for the loss of LC-PUFA-rich phosphatidyl-ethanolamines.	[Koehrer, Philippe; Isaico, Rodica; Bron, Alain M.; Creuzot-Garcher, Catherine P.] Univ Hosp, Dept Ophthalmol, Dijon, France; [Saab, Sarah; Berdeaux, Olivier; Gregoire, Stephane; Cabaret, Stephanie; Bron, Alain M.; Creuzot-Garcher, Catherine P.; Bretillon, Lionel; Acar, Niyazi] INRA, UMR1324, Ctr Sci Gout & Alimentat, F-21034 Dijon, France; [Saab, Sarah; Berdeaux, Olivier; Gregoire, Stephane; Cabaret, Stephanie; Bron, Alain M.; Creuzot-Garcher, Catherine P.; Bretillon, Lionel; Acar, Niyazi] CNRS, UMR6265, Ctr Sci Gout & Alimentat, Dijon, France; [Saab, Sarah; Berdeaux, Olivier; Gregoire, Stephane; Cabaret, Stephanie; Bron, Alain M.; Creuzot-Garcher, Catherine P.; Bretillon, Lionel; Acar, Niyazi] Univ Bourgogne, UMR, Ctr Sci Gout & Alimentat, Dijon, France	CHU Dijon Bourgogne; INRAE; Institut Agro; AgroSup Dijon; Centre National de la Recherche Scientifique (CNRS); Universite de Bourgogne; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut Agro; AgroSup Dijon; Universite de Bourgogne; Institut Agro; AgroSup Dijon; Centre National de la Recherche Scientifique (CNRS); Universite de Bourgogne	Acar, N (corresponding author), INRA, UMR1324, Ctr Sci Gout & Alimentat, F-21034 Dijon, France.	acar@dijon.inra.fr	Bron, Alain/AAP-8010-2020	Bron, Alain/0000-0002-7265-931X; Bretillon, Lionel/0000-0002-6957-100X	French National Institute for Agricultural Research (INRA); Regional Council of Burgundy (France); French Government grant [ANR-11-LABX-0021]; European Funding for Regional Economical Development (FEDER); Abbott Laboratories (Dijon, France)	French National Institute for Agricultural Research (INRA); Regional Council of Burgundy (France)(Region Bourgogne-Franche-Comte); French Government grant; European Funding for Regional Economical Development (FEDER); Abbott Laboratories (Dijon, France)	The authors acknowledge the French National Institute for Agricultural Research (INRA) and the Regional Council of Burgundy (France) for funding a PhD fellowship to SS. This work was supported by a French Government grant managed by the French National Research Agency (ANR) under the program "Investissements d'Avenir'' (ANR-11-LABX-0021), the European Funding for Regional Economical Development (FEDER), and Abbott Laboratories (Dijon, France). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acar N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035102; Acar N, 2009, EXP EYE RES, V89, P840, DOI 10.1016/j.exer.2009.07.008; Akinkuolie AO, 2011, CLIN NUTR, V30, P702, DOI 10.1016/j.clnu.2011.08.013; BARNES AJ, 1977, LANCET, V2, P789; BARTLETT EM, 1970, ANAL BIOCHEM, V36, P159, DOI 10.1016/0003-2697(70)90343-X; Berdeaux O, 2010, J CHROMATOGR A, V1217, P7738, DOI 10.1016/j.chroma.2010.10.039; Berry KAZ, 2004, J AM SOC MASS SPECTR, V15, P1499, DOI 10.1016/j.jasms.2004.07.009; BORKMAN M, 1993, NEW ENGL J MED, V328, P238, DOI 10.1056/NEJM199301283280404; Brenner RR, 2003, PROSTAG LEUKOTR ESS, V68, P151, DOI 10.1016/S0952-3278(02)00265-X; Bretillon L, 2008, EXP EYE RES, V87, P521, DOI 10.1016/j.exer.2008.08.010; Brownlee M, 2001, NATURE, V414, P813, DOI 10.1038/414813a; Caimi G, 2004, ACTA DIABETOL, V41, P99, DOI 10.1007/s00592-004-0151-1; Chen WQ, 2005, INVEST OPHTH VIS SCI, V46, P4342, DOI 10.1167/iovs.05-0601; Cho Young I, 2008, J Diabetes Sci Technol, V2, P1130; de Wilde MC, 2002, BRAIN RES, V947, P166, DOI 10.1016/S0006-8993(02)02695-1; El-Seweidy MM, 2002, PHARMACOL RES, V45, P391, DOI 10.1006/phrs.2002.0979; FLIESLER SJ, 1983, PROG LIPID RES, V22, P79; FORD DA, 1989, CIRC RES, V64, P173, DOI 10.1161/01.RES.64.1.173; FORD DA, 1989, P NATL ACAD SCI USA, V86, P3479, DOI 10.1073/pnas.86.10.3479; Han XL, 2000, BIOCHEM J, V352, P79, DOI 10.1042/0264-6021:3520079; HUGHES WF, 1991, EXP EYE RES, V53, P573, DOI 10.1016/0014-4835(91)90215-Z; JUANEDA P, 1985, LIPIDS, V20, P40, DOI 10.1007/BF02534360; KLEIN R, 1984, OPHTHALMOLOGY, V91, P1; Komatsu W, 2003, FREE RADICAL BIO MED, V34, P1006, DOI 10.1016/S0891-5849(03)00027-3; Koya D, 1998, DIABETES, V47, P859, DOI 10.2337/diabetes.47.6.859; Kuroki T, 1998, BIOCHEM BIOPH RES CO, V247, P473, DOI 10.1006/bbrc.1998.8814; Lee AG, 2004, BBA-BIOMEMBRANES, V1666, P62, DOI 10.1016/j.bbamem.2004.05.012; MALECAZE F, 1994, ARCH OPHTHALMOL-CHIC, V112, P1476, DOI 10.1001/archopht.1994.01090230090028; McHowat J, 2000, AM J PHYSIOL-ENDOC M, V279, pE25, DOI 10.1152/ajpendo.2000.279.1.E25; Min Y, 2004, DIABETOLOGIA, V47, P75, DOI 10.1007/s00125-003-1275-5; MOILANEN T, 1981, CLIN CHIM ACTA, V114, P111, DOI 10.1016/0009-8981(81)90235-7; MORRISON WR, 1964, J LIPID RES, V5, P600; Nagan N, 2001, PROG LIPID RES, V40, P199, DOI 10.1016/S0163-7827(01)00003-0; Rinaldi B, 2002, LIFE SCI, V71, P993, DOI 10.1016/S0024-3205(02)01792-7; SanGiovanni JP, 2005, PROG RETIN EYE RES, V24, P87, DOI 10.1016/j.preteyeres.2004.06.002; Shin S, 2007, INDIAN J EXP BIOL, V45, P121; SUGIURA T, 1983, J BIOCHEM-TOKYO, V94, P1719; Tikhonenko M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055177; Tikhonenko M, 2010, DIABETES, V59, P219, DOI 10.2337/db09-0728; Weijers RNM, 2012, CURR DIABETES REV, V8, P390, DOI 10.2174/157339912802083531	40	35	35	1	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 4	2014	9	9							e106912	10.1371/journal.pone.0106912	http://dx.doi.org/10.1371/journal.pone.0106912			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3XV	25188352	Green Submitted, Green Published, gold			2022-12-27	WOS:000341271500096
J	Perez, E; Turner, M; Fisher, A; Lockwood, J; Daley, D				Perez, Elvira; Turner, Melody; Fisher, Anthony; Lockwood, Joanna; Daley, David			Linguistic Analysis of the Preschool Five Minute Speech Sample: What the Parents of Preschool Children with Early Signs of ADHD Say and How They Say It?	PLOS ONE			English	Article							ATTENTION-DEFICIT/HYPERACTIVITY-DISORDER; DEFICIT HYPERACTIVITY DISORDER; ASSESSING EXPRESSED EMOTION; NONPHARMACOLOGICAL INTERVENTIONS; MATERNAL DEPRESSION; BEHAVIOR PROBLEMS; YOUNG-CHILDREN; MENTAL-HEALTH; MOTHERS; PSYCHOPATHOLOGY	A linguistic analysis was performed on the Preschool Five Minute Speech Sample (PFMSS) of 42 parents. PFMSS is a validated measure for Expressed Emotion (EE) to assess parent-child relationship. Half of these parents (n = 21, clinical group) had preschool children with early symptoms of attention deficit hyperactivity disorder (ADHD), the rest had typically developing children. Early symptoms of ADHD were identified with the Werry-Weiss Peters Rating Scale. The linguistic component of the PFMSS was analysed with keyword and linguistic pattern identification. The results of these two complementary analyses (i.e., EE and linguistic analysis) provided relevant recommendations that may improve the efficacy of psychological treatment for ADHD such as parenting interventions. We discuss the practical implications of these findings.	[Perez, Elvira; Turner, Melody; Lockwood, Joanna; Daley, David] Univ Nottingham, Sch Med, Nottingham, England; [Fisher, Anthony] Univ Nottingham, Sch English, Nottingham NG7 2RD, England	University of Nottingham; University of Nottingham	Perez, E (corresponding author), Univ Nottingham, Sch Med, Nottingham, England.	elvira.perez@nottingham.ac.uk	Turner, Melody/AAD-6274-2020	Daley, David/0000-0002-3597-0408; Turner, Melody/0000-0001-9759-210X; Perez Vallejos, Elvira/0000-0002-0258-9440	Economic and Social Research Council [ES/M00161X/1] Funding Source: researchfish; Engineering and Physical Sciences Research Council [EP/G065802/1] Funding Source: researchfish; EPSRC [EP/G065802/1] Funding Source: UKRI; ESRC [ES/M00161X/1] Funding Source: UKRI	Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC))		Adolphs S, 2004, INT J APPL LINGUISTI, V1, P44; AINSWORTH MDS, 1989, AM PSYCHOL, V44, P709, DOI 10.1037/0003-066X.44.4.709; AINSWORTH MDS, 1979, AM PSYCHOL, V34, P932, DOI 10.1037/0003-066X.34.10.932; Arns M, 2009, CLIN EEG NEUROSCI, V40, P180, DOI 10.1177/155005940904000311; Baker BL, 2000, J CHILD PSYCHOL PSYC, V41, P907, DOI 10.1017/S0021963099006125; Baker P., 2006, USING CORPORA DISCOU; Banaschewski T, 2006, EUR CHILD ADOLES PSY, V15, P476, DOI 10.1007/s00787-006-0549-0; Barkley RA, 1988, BEHAV ASSESSMENT CHI, P69; Beck A, 2004, J INTELL DISABIL RES, V48, P628, DOI 10.1111/j.1365-2788.2003.00564.x; Berger I, 2008, J CHILD NEUROL, V23, P1036, DOI 10.1177/0883073808317726; Biederman J, 2006, PSYCHOL MED, V36, P167, DOI 10.1017/S0033291705006410; Bloch MH, 2011, J AM ACAD CHILD PSY, V50, P991, DOI 10.1016/j.jaac.2011.06.008; Bor W, 2002, J ABNORM CHILD PSYCH, V30, P571, DOI 10.1023/A:1020807613155; Bradley RH, 2002, ANNU REV PSYCHOL, V53, P371, DOI 10.1146/annurev.psych.53.100901.135233; Brown B, 2009, SOCIOL HEALTH ILL, V31, P508, DOI 10.1111/j.1467-9566.2008.01147.x; Brown R, 2012, ANN REPORT CTR MENTA; Bussing R, 2006, SOC SCI MED, V63, P871, DOI 10.1016/j.socscimed.2006.03.014; Cartwright KL, 2011, J AM ACAD CHILD PSY, V50, P1042, DOI 10.1016/j.jaac.2011.07.006; Chronis AM, 2003, J AM ACAD CHILD PSY, V42, P1424, DOI 10.1097/00004583-200312000-00009; Cohen J.E., 1988, STAT POWER ANAL BEHA; Crawford P, 2008, HEALTH RISK SOC, V10, P331, DOI 10.1080/13698570802167397; Crawford P, 2013, QUAL HEALTH RES, V23, P719, DOI 10.1177/1049732313482190; Cussen A, 2012, EUR J PEDIATR, V171, P271, DOI 10.1007/s00431-011-1524-4; Daley D, 2003, BRIT J CLIN PSYCHOL, V42, P53, DOI 10.1348/014466503762842011; Daley D, 2014, J AM ACAD CHILD PSY, V53, P835, DOI 10.1016/j.jaac.2014.05.013; Deault LC, 2010, CHILD PSYCHIAT HUM D, V41, P168, DOI 10.1007/s10578-009-0159-4; Ermisch J., 2010, CAUSAL EFFECTS PAREN; Fabiano GA, 2009, CLIN PSYCHOL REV, V29, P129, DOI 10.1016/j.cpr.2008.11.001; Fiks AG, 2011, PATIENT EDUC COUNS, V84, P236, DOI 10.1016/j.pec.2010.07.035; Gerdes AC, 2007, J ABNORM CHILD PSYCH, V35, P705, DOI 10.1007/s10802-007-9134-3; Goodman SH, 1999, PSYCHOL REV, V106, P458, DOI 10.1037/0033-295X.106.3.458; Goodman SH, 2011, CLIN CHILD FAM PSYCH, V14, P1, DOI 10.1007/s10567-010-0080-1; Graham J, 2011, EUR CHILD ADOLES PSY, V20, P17, DOI 10.1007/s00787-010-0140-6; Haidet P, 2008, PATIENT EDUC COUNS, V73, P232, DOI 10.1016/j.pec.2008.07.007; Harvey K, 2008, FAM PRACT, V25, P1; Hermansen M, 2008, CLIN CHIROPRACTIC, V11, P182; HILL MS, 1987, SOC SCI RES, V16, P39, DOI 10.1016/0049-089X(87)90018-4; HOOLEY JM, 1985, CLIN PSYCHOL REV, V5, P119, DOI 10.1016/0272-7358(85)90018-2; Hughes C, 2011, INFANT CHILD DEV, V20, P251, DOI 10.1002/icd.736; Johnston C, 2001, CLIN CHILD FAM PSYCH, V4, P183, DOI 10.1023/A:1017592030434; Johnston C, 1996, J ABNORM CHILD PSYCH, V24, P85, DOI 10.1007/BF01448375; Johnston C, 2002, J ABNORM CHILD PSYCH, V30, P77, DOI 10.1023/A:1014235200174; Keown L, 2011, INT J BEHAV DEV, V35, P161, DOI 10.1177/0165025410380982; Klassen AF, 2004, PEDIATRICS, V114, pE541, DOI 10.1542/peds.2004-0844; Kohls G, 2009, DEVELOPMENTAL SCI, V12, P614, DOI 10.1111/j.1467-7687.2009.00816.x; Lench H, 2011, J ATTEN DISORD, V17, P141, DOI DOI 10.1177/1087054711427401; Liddle EB, 2011, J CHILD PSYCHOL PSYC, V52, P761, DOI 10.1111/j.1469-7610.2010.02333.x; Loe IM, 2007, J PEDIATR PSYCHOL, V32, P643, DOI 10.1093/jpepsy/jsl054; Lovejoy MC, 2000, CLIN PSYCHOL REV, V20, P561, DOI 10.1016/S0272-7358(98)00100-7; MAGANA AB, 1986, PSYCHIAT RES, V17, P203, DOI 10.1016/0165-1781(86)90049-1; Markomichali P, 2009, ADV ADHD, V3, P89; MASH EJ, 1983, J CONSULT CLIN PSYCH, V51, P86, DOI 10.1037/0022-006X.51.1.86; Milteer RM, 2012, PEDIATRICS, V129, pE204, DOI 10.1542/peds.2011-2953; Nigg JT, 2012, J AM ACAD CHILD PSY, V51, P86, DOI 10.1016/j.jaac.2011.10.015; Partington A., 2004, CORPORA DISCOURSE; Pelham W, 2010, 1 2 3 MAGIC EFFECTIV; Pelham WE, 1999, ALCOHOL RES HEALTH, V23, P292; Pelham WE, 2007, J PEDIATR PSYCHOL, V32, P711, DOI 10.1093/jpepsy/jsm022; Polanczyk G, 2007, CURR OPIN PSYCHIATR, V20, P386, DOI 10.1097/YCO.0b013e3281568d7a; Psychogiou L, 2007, EUR CHILD ADOLES PSY, V16, P458, DOI 10.1007/s00787-007-0619-y; Richards JS, 2014, J AM ACAD CHILD PSY, V53, P311, DOI 10.1016/j.jaac.2013.11.011; Rogosch FA, 2004, DEV PSYCHOPATHOL, V16, P689, DOI 10.1017/S0954579404004730; Routh D, 1978, PSYCHOL MANAGEMENT P; Rutter M, 2006, J CHILD PSYCHOL PSYC, V47, P226, DOI 10.1111/j.1469-7610.2005.01557.x; Scott M., 2012, WORDSMITH TOOLS VERS; Shaver PR, 2010, J SOC PERS RELAT, V27, P163, DOI 10.1177/0265407509360899; Simpson JA, 2010, J SOC PERS RELAT, V27, P173, DOI 10.1177/0265407509360909; Sonuga-Barke EJS, 2013, AM J PSYCHIAT, V170, P275, DOI 10.1176/appi.ajp.2012.12070991; Sonuga-Barke EJS, 2011, J CHILD PSYCHOL PSYC, V52, P917, DOI 10.1111/j.1469-7610.2011.02444.x; Sonuga-Barke EJS, 2010, J AM ACAD CHILD PSY, V49, P345, DOI 10.1016/j.jaac.2009.12.018; Sonuga-Barke EJS, 2008, AM J MED GENET B, V147B, P1359, DOI 10.1002/ajmg.b.30860; Sonuga-Barke EJS, 2006, INFANT YOUNG CHILD, V19, P142, DOI 10.1097/00001163-200604000-00007; Sonuga-Barke EJS, 2004, BRIT J CLIN PSYCHOL, V43, P449, DOI 10.1348/0144665042388973; Sonuga-Barke S, 2013, J AM ACAD CHILD ADOL, V50, P547; SonugaBarke EJS, 1997, PSYCHOL MED, V27, P909, DOI 10.1017/S0033291797005291; SONUGABARKE EJS, 1992, J CHILD PSYCHOL PSYC, V33, P387, DOI 10.1111/j.1469-7610.1992.tb00874.x; STUBBE DE, 1993, J CHILD PSYCHOL PSYC, V34, P139, DOI 10.1111/j.1469-7610.1993.tb00976.x; Swanson JM, 1998, LANCET, V351, P429, DOI 10.1016/S0140-6736(97)11450-7; Taylor E, 2004, EUROPEAN CHILD ADOLE, V15, P476; Thapar A, 2012, ARCH DIS CHILD, V97, P260, DOI 10.1136/archdischild-2011-300482; Thompson MJJ, 2009, EUR CHILD ADOLES PSY, V18, P605, DOI 10.1007/s00787-009-0020-0; Thompson MJJ, 1996, BRIT J PSYCHIAT, V168, P16, DOI 10.1192/bjp.168.1.16; Toplak M, 2005, J ABNORM CHILD PSYCH, V33, P639, DOI 10.1007/s10802-005-6743-6; Toplak ME, 2006, J NEUROSCI METH, V151, P15, DOI 10.1016/j.jneumeth.2005.09.018; van de Loo-Neus GHH, 2011, EUR NEUROPSYCHOPHARM, V21, P584, DOI 10.1016/j.euroneuro.2011.03.008; Van Meel CS, 2005, J AM ACAD CHILD PSY, V44, P451, DOI 10.1097/01.chi.0000155326.22394.e6; Wearden AJ, 2000, CLIN PSYCHOL REV, V20, P633, DOI 10.1016/S0272-7358(99)00008-2; Webster-Stratton C, 2012, J CLIN CHILD ADOLESC, V65, P93	88	6	6	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 3	2014	9	9							e106231	10.1371/journal.pone.0106231	http://dx.doi.org/10.1371/journal.pone.0106231			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AO3TB	25184287	Green Submitted, gold, Green Published			2022-12-27	WOS:000341257700041
J	Lee, EJ; Park, HJ; Lee, IJ; Kim, WW; Ha, SJ; Suh, YG; Seong, J				Lee, Eun-Jung; Park, Hyo Jin; Lee, Ik-Jae; Kim, Won Woo; Ha, Sang-Jun; Suh, Yang-Gun; Seong, Jinsil			Inhibition of IL-17A Suppresses Enhanced-Tumor Growth in Low Dose Pre-Irradiated Tumor Beds	PLOS ONE			English	Article							RADIATION-THERAPY; UP-REGULATION; CELLS; CARCINOMA; METASTASIS; IL-6; RADIOTHERAPY; INFLAMMATION; INDUCTION; APOPTOSIS	Ionizing radiation induces modification of the tumor microenvironment such as tumor surrounding region, which is relevant to treatment outcome after radiotherapy. In this study, the effects of pre-irradiated tumor beds on the growth of subsequently implanted tumors were investigated as well as underlying mechanism. The experimental model was set up by irradiating the right thighs of C3H/HeN mice with 5 Gy, followed by the implantation of HCa-I and MIH-2. Both implanted tumors in the pre-irradiated bed showed accelerated-growth compared to the control. Tumor-infiltrated lymphocyte (TIL) levels were increased, as well as pro-tumor factors such as IL-6 and transforming growth factor-beta1 (TGF-beta 1) in the pre-irradiated group. In particular, the role of pro-tumor cytokine interleukin-17A (IL-17A) was investigated as a possible target mechanism because IL-6 and TGF-beta are key factors in Th17 cells differentiation from naive T cells. IL-17A expression was increased not only in tumors, but also in CD4+ T cells isolated from the tumor draining lymph nodes. The effect of IL-17A on tumor growth was confirmed by treating tumors with IL-17A antibody, which abolished the acceleration of tumor growth. These results indicate that the upregulation of IL-17A seems to be a key factor for enhancing tumor growth in pre-irradiated tumor beds.	[Lee, Eun-Jung; Lee, Ik-Jae; Kim, Won Woo; Suh, Yang-Gun; Seong, Jinsil] Yonsei Univ, Coll Med, Dept Radiat Oncol, Seoul, South Korea; [Park, Hyo Jin; Ha, Sang-Jun] Yonsei Univ, Dept Biochem, Seoul 120749, South Korea	Yonsei University; Yonsei University Health System; Yonsei University	Seong, J (corresponding author), Yonsei Univ, Coll Med, Dept Radiat Oncol, Seoul, South Korea.	jsseong@yuhs.ac		Lee, Ik Jae/0000-0001-7165-3373; Ha, Sang-Jun/0000-0002-1192-6031	National Research Foundation of Korea (NRF) - Ministry of Science, ICT and Future planning [2010-001854]; Korean Health Technology R&D Project, Ministry of Health &Welfare, Republic of Korea [A121982]	National Research Foundation of Korea (NRF) - Ministry of Science, ICT and Future planning; Korean Health Technology R&D Project, Ministry of Health &Welfare, Republic of Korea	This study was supported by the National Nuclear R&D Program through a National Research Foundation of Korea (NRF) grant (2010-001854) funded by the Ministry of Science, ICT and Future planning. This study was also supported by a grant of the Korean Health Technology R&D Project (A121982), Ministry of Health & Welfare, Republic of Korea. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ao XP, 2009, J HEMATOL ONCOL, V2, DOI 10.1186/1756-8722-2-6; Bae SH, 2012, INT J RADIAT ONCOL, V82, pE603, DOI 10.1016/j.ijrobp.2011.09.053; Basanta D, 2009, CANCER RES, V69, P7111, DOI 10.1158/0008-5472.CAN-08-3957; Chou CH, 2009, INT J RADIAT ONCOL, V75, P1553, DOI 10.1016/j.ijrobp.2009.08.034; Fujikawa K, 2000, J UROLOGY, V164, P673, DOI 10.1016/S0022-5347(05)67278-3; Hasselle MD, 2012, J THORAC ONCOL, V7, P376, DOI 10.1097/JTO.0b013e31824166a5; Hodge DR, 2005, EUR J CANCER, V41, P2502, DOI 10.1016/j.ejca.2005.08.016; Horiguchi A, 2002, KIDNEY INT, V61, P926, DOI 10.1046/j.1523-1755.2002.00206.x; Irie M, 2004, INT J CANCER, V111, P238, DOI 10.1002/ijc.20247; Kim W, 2011, J RADIAT RES, V52, P646, DOI 10.1269/jrr.10185; Kryczek I, 2009, BLOOD, V114, P357, DOI 10.1182/blood-2008-09-177360; Kuang DM, 2010, HEPATOLOGY, V51, P154, DOI 10.1002/hep.23291; Kuonen F, 2012, CLIN CANCER RES, V18, P5196, DOI 10.1158/1078-0432.CCR-11-1758; Li J, 2011, PLOS ONE, V6; Maehara Y, 1999, J CLIN ONCOL, V17, P607, DOI 10.1200/JCO.1999.17.2.607; Milross CG, 1996, JNCI-J NATL CANCER I, V88, P1308, DOI 10.1093/jnci/88.18.1308; Miyamoto Y, 2001, ANTICANCER RES, V21, P2449; Morishima N, 2009, BIOCHEM BIOPH RES CO, V386, P105, DOI 10.1016/j.bbrc.2009.05.140; Moseley TA, 2003, CYTOKINE GROWTH F R, V14, P155, DOI 10.1016/S1359-6101(03)00002-9; Numasaki M, 2003, BLOOD, V101, P2620, DOI 10.1182/blood-2002-05-1461; Park H, 2005, NAT IMMUNOL, V6, P1133, DOI 10.1038/ni1261; Park HJ, 2012, CELL IMMUNOL, V278, P76, DOI 10.1016/j.cellimm.2012.07.001; Pogrlbny I, 2005, MOL CANCER RES, V3, P553, DOI 10.1158/1541-7786.MCR-05-0074; Purdy JA, 2008, HEALTH PHYS, V95, P666, DOI 10.1097/01.HP.0000326342.47348.06; Rofstad EK, 2005, CANCER RES, V65, P2387, DOI 10.1158/0008-5472.CAN-04-3039; Romano M, 1997, IMMUNITY, V6, P315, DOI 10.1016/S1074-7613(00)80334-9; SAEKI Y, 1971, RADIOLOGY, V101, P175, DOI 10.1148/101.1.175; STENSTROM KW, 1955, RADIAT RES, V2, P180, DOI 10.2307/3570322; van den Berg WB, 2009, NAT REV RHEUMATOL, V5, P549, DOI 10.1038/nrrheum.2009.179; Wang Wei-wei, 2010, Zhonghua Zhong Liu Za Zhi, V32, P757; Zhang JP, 2009, J HEPATOL, V50, P980, DOI 10.1016/j.jhep.2008.12.033; Zou WP, 2010, NAT REV IMMUNOL, V10, P248, DOI 10.1038/nri2742	32	16	17	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2014	9	9							e106423	10.1371/journal.pone.0106423	http://dx.doi.org/10.1371/journal.pone.0106423			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3LR	25181290	gold, Green Published, Green Submitted			2022-12-27	WOS:000341231500094
J	Calvente, I; Davila-Arias, C; Ocon-Hernandez, O; Perez-Lobato, R; Ramos, R; Artacho-Cordon, F; Olea, N; Nunez, MI; Fernandez, MF				Calvente, Irene; Davila-Arias, Cristina; Ocon-Hernandez, Olga; Perez-Lobato, Rocio; Ramos, Rosa; Artacho-Cordon, Francisco; Olea, Nicolas; Isabel Nunez, Maria; Fernandez, Mariana F.			Characterization of Indoor Extremely Low Frequency and Low Frequency Electromagnetic Fields in the INMA-Granada Cohort	PLOS ONE			English	Article							MAGNETIC-FIELDS; POOLED ANALYSIS; EXPOSURE ASSESSMENT; PERSONAL EXPOSURE; LEUKEMIA; EMF	Objective: To characterize the exposure to electric fields and magnetic fields of non-ionizing radiation in the electromagnetic spectrum (15 Hz to 100 kHz) in the dwellings of children from the Spanish Environment and Childhood-"INMA" population-based birth cohort. Methodology: The study sample was drawn from the INMA-Granada cohort. Out of 300 boys participating in the 9-10 year follow-up, 123 families agreed to the exposure assessment at home and completed a specific ad hoc questionnaire gathering information on sources of non-ionizing radiation electric and magnetic fields inside the homes and on patterns of use. Long-term indoor measurements were carried out in the living room and bedroom. Results: Survey data showed a low exposure in the children's homes according to reference levels of the International Commission on Non-Ionizing Radiation Protection but with large differences among homes in mean and maximum values. Daytime electrostatic and magnetic fields were below the quantification limit in 78.6% (92 dwellings) and 92.3% (108 dwellings) of houses, with an arithmetic mean value (+/- standard deviation) of 7.31 +/- 9.32 V/m and 162.30 +/- 91.16 nT, respectively. Mean magnetic field values were 1.6 lower during the night than the day. Nocturnal electrostatic values were not measured. Exposure levels were influenced by the area of residence (higher values in urban/semi-urban versus rural areas), type of dwelling, age of dwelling, floor of the dwelling, and season. Conclusion: Given the greater sensitivity to extremely low-frequency electromagnetic fields of children and following the precautionary principle, preventive measures are warranted to reduce their exposure.	[Calvente, Irene; Perez-Lobato, Rocio; Artacho-Cordon, Francisco; Olea, Nicolas; Isabel Nunez, Maria; Fernandez, Mariana F.] Univ Granada, San Cecilio Univ Hosp, Inst Invest Biosanitaria Ibs Granada, Granada, Spain; [Calvente, Irene; Davila-Arias, Cristina; Ocon-Hernandez, Olga; Perez-Lobato, Rocio; Ramos, Rosa] San Cecilio Univ Hosp, Unit Res Support, Inst Invest Biosanitaria Ibs Granada, Granada, Spain; [Artacho-Cordon, Francisco; Olea, Nicolas; Isabel Nunez, Maria; Fernandez, Mariana F.] Univ Granada, Dept Radiol, Granada, Spain; [Olea, Nicolas; Fernandez, Mariana F.] CIBER Epidemiol & Salud Publ CIBERESP, Madrid, Spain	Hospital Universitario San Cecilio; Instituto de Investigacion Biosanitaria IBS Granada; University of Granada; Hospital Universitario San Cecilio; Instituto de Investigacion Biosanitaria IBS Granada; University of Granada; CIBER - Centro de Investigacion Biomedica en Red; CIBERESP	Fernandez, MF (corresponding author), Univ Granada, San Cecilio Univ Hosp, Inst Invest Biosanitaria Ibs Granada, Granada, Spain.	marieta@ugr.es	Núñez, María Isabel/L-9924-2014; Fernandez, Mariana F./C-9877-2012; Olea, Nicolas/H-3198-2014; Ocón-Hernández, Olga/H-7477-2015; Artacho-Cordon, Francisco/A-3166-2015	Núñez, María Isabel/0000-0001-8159-7969; Fernandez, Mariana F./0000-0001-6417-8914; Olea, Nicolas/0000-0002-8938-3743; Ocón-Hernández, Olga/0000-0002-8113-3651; Artacho-Cordon, Francisco/0000-0003-3850-6173	Spanish Ministry of Health (CIBERESP); Spanish Ministry of Health [FIS PI11/0610]; Andalusia Regional Government; Council of Innovation, Science and Enterprise [P09-CTS-5488]; Council of Health [SAS PI-0675-2010]	Spanish Ministry of Health (CIBERESP); Spanish Ministry of Health(Instituto de Salud Carlos IIISpanish Government); Andalusia Regional Government; Council of Innovation, Science and Enterprise; Council of Health	This work was supported by the Spanish Ministry of Health (CIBERESP and FIS PI11/0610) and the Andalusia Regional Government, Council of Innovation, Science and Enterprise (Excellence Project P09-CTS-5488) and Council of Health (SAS PI-0675-2010). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahlbom A, 1998, HEALTH PHYS, V74, P494; Ahlbom A, 2000, BRIT J CANCER, V83, P692, DOI 10.1054/bjoc.2000.1376; Alonso A, 2012, RADIAT PROT DOSIM, V151, P426, DOI 10.1093/rpd/ncs026; BioInitiative Working Group, 2012, BIOINITIATIVE REP RA; Brix J, 2001, BIOELECTROMAGNETICS, V22, P323, DOI 10.1002/bem.57; Burgi A, 2010, BIOELECTROMAGNETICS, V31, P226, DOI 10.1002/bem.20552; Dieval C, 2012, REV MED INTERNE, V33, P76, DOI 10.1016/j.revmed.2011.11.017; Foliart DE, 2002, J EXPO ANAL ENV EPID, V12, P441, DOI 10.1038/sj.jea.7500245; Frei P, 2010, ENVIRON INT, V36, P714, DOI 10.1016/j.envint.2010.05.005; Freire C, 2009, SCI TOTAL ENVIRON, V407, P1562, DOI 10.1016/j.scitotenv.2008.10.068; Greenland S, 2000, EPIDEMIOLOGY, V11, P624, DOI 10.1097/00001648-200011000-00003; Grellier J, 2014, ENVIRON INT, V62, P55, DOI 10.1016/j.envint.2013.09.017; Guxens M, 2012, INT J EPIDEMIOL, V41, P930, DOI 10.1093/ije/dyr054; Heinavaara S, 2011, ENVIRON HEALTH-GLOB, V10, DOI 10.1186/1476-069X-10-14; Huang JL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067284; Int Commission Non-Ionizing, 2010, HEALTH PHYS, V99, P818, DOI 10.1097/HP.0b013e3181f06c86; International Agency for Research on Cancer (IARC), 2002, NON RAD 1; Kheifets L, 2010, BRIT J CANCER, V103, P1128, DOI 10.1038/sj.bjc.6605838; Kundi M, 2009, ENVIRON HEALTH PERSP, V117, pA484, DOI 10.1289/ehp.0901111; Lauer O, 2012, BIOELECTROMAGNETICS, V33, P75, DOI 10.1002/bem.20687; Neskovic N, 2012, RADIAT PROT DOSIM, V149, P238, DOI 10.1093/rpd/ncr248; Palmquist E, 2014, INT J HYG ENVIR HEAL, V217, P427, DOI 10.1016/j.ijheh.2013.08.005; Repacholi M, 2012, SCI TOTAL ENVIRON, V426, P454, DOI 10.1016/j.scitotenv.2012.03.030; Roosli M, 2011, SCI TOTAL ENVIRON, V409, P3364, DOI 10.1016/j.scitotenv.2011.05.041; Rudant J, 2010, AM J EPIDEMIOL, V172, P1015, DOI 10.1093/aje/kwq233; Straume A, 2008, BIOELECTROMAGNETICS, V29, P20, DOI 10.1002/bem.20357; Teepen JC, 2012, INT J CANCER, V131, P769, DOI 10.1002/ijc.27542; Tomitsch J, 2012, RADIAT PROT DOSIM, V149, P384, DOI 10.1093/rpd/ncr325; Tomitsch J, 2010, BIOELECTROMAGNETICS, V31, P200, DOI 10.1002/bem.20548; Valic B., 2014, RADIAT PROT DOSIM, P1; Vistnes AI, 2001, RAD HOME OUTDOORS WO, P286; Vulevic B, 2012, 1 INT C RAD DOS VAR, P1; WHO-World Health Organization, 2004, EL FIELDS EMF SUMM H; World Health Organization, 2007, ENV HLTH CRIT, V238	34	15	15	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2014	9	9							e106666	10.1371/journal.pone.0106666	http://dx.doi.org/10.1371/journal.pone.0106666			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ1IR	25192253	Green Submitted, gold, Green Published			2022-12-27	WOS:000347993600052
J	Gibson-Corley, KN; Bockenstedt, MM; Li, HJ; Boggiatto, PM; Phanse, Y; Petersen, CA; Bellaire, BH; Jones, DE				Gibson-Corley, Katherine N.; Bockenstedt, Marie M.; Li, Huijuan; Boggiatto, Paola M.; Phanse, Yashdeep; Petersen, Christine A.; Bellaire, Bryan H.; Jones, Douglas E.			An In Vitro Model of Antibody-Enhanced Killing of the Intracellular Parasite Leishmania amazonensis	PLOS ONE			English	Article							NADPH OXIDASE ACTIVITY; CIRCULATING IMMUNE-COMPLEXES; CD4(+) T-CELLS; FC-GAMMA-RI; B-CELLS; NITRIC-OXIDE; INFECTION; MICE; RESPONSES; ACTIVATION	Footpad infection of C3HeB/FeJ mice with Leishmania amazonensis leads to chronic lesions accompanied by large parasite loads. Co-infecting these animals with L. major leads to induction of an effective Th1 immune response that can resolve these lesions. This cross-protection can be recapitulated in vitro by using immune cells from L. major-infected animals to effectively activate L. amazonensis-infected macrophages to kill the parasite. We have shown previously that the B cell population and their IgG2a antibodies are required for effective cross-protection. Here we demonstrate that, in contrast to L. major, killing L. amazonensis parasites is dependent upon FcR gamma common-chain and NADPH oxidase-generated superoxide from infected macrophages. Superoxide production coincided with killing of L. amazonensis at five days post-activation, suggesting that opsonization of the parasites was not a likely mechanism of the antibody response. Therefore we tested the hypothesis that non-specific immune complexes could provide a mechanism of FcR gamma common-chain/NADPH oxidase dependent parasite killing. Macrophage activation in response to soluble IgG2a immune complexes, IFN-gamma and parasite antigen was effective in significantly reducing the percentage of macrophages infected with L. amazonensis. These results define a host protection mechanism effective during Leishmania infection and demonstrate for the first time a novel means by which IgG antibodies can enhance killing of an intracellular pathogen.	[Gibson-Corley, Katherine N.; Bockenstedt, Marie M.; Li, Huijuan; Boggiatto, Paola M.; Petersen, Christine A.; Jones, Douglas E.] Iowa State Univ, Coll Vet Med, Dept Vet Pathol, Ames, IA 50011 USA; [Phanse, Yashdeep; Bellaire, Bryan H.] Iowa State Univ, Coll Vet Med, Dept Vet Microbiol & Prevent Med, Ames, IA USA	Iowa State University; Iowa State University	Jones, DE (corresponding author), Iowa State Univ, Coll Vet Med, Dept Vet Pathol, Ames, IA 50011 USA.	jonesdou@iastate.edu	Petersen, Christine/M-1881-2014; Bellaire, Bryan/GNP-5200-2022	Petersen, Christine/0000-0002-7285-4254; Bellaire, Bryan/0000-0002-4034-6482; Gibson-Corley, Katherine/0000-0002-1846-1580; Phanse, Yashdeep/0000-0002-2943-7113	National Institutes of Health, National Institute of Allergy and Infectious Disease [KO8 AI076616]; CVM; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K08AI076616] Funding Source: NIH RePORTER	National Institutes of Health, National Institute of Allergy and Infectious Disease(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); CVM; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the National Institutes of Health, National Institute of Allergy and Infectious Disease, KO8 AI076616 (KNGC), and a CVM seed grant (DEJ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AFONSO LCC, 1993, INFECT IMMUN, V61, P2952, DOI 10.1128/IAI.61.7.2952-2959.1993; Almeida TF, 2012, PARASITE IMMUNOL, V34, P492, DOI 10.1111/j.1365-3024.2012.01384.x; Ambarus CA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035994; Anderson CF, 2005, J IMMUNOL, V174, P2934, DOI 10.4049/jimmunol.174.5.2934; Boggiatto PM, 2009, AM J PATHOL, V174, P1818, DOI 10.2353/ajpath.2009.080905; Bonetto S, 2009, FASEB J, V23, P575, DOI 10.1096/fj.08-117069; Buxbaum LU, 2008, IMMUNOL RES, V42, P197, DOI 10.1007/s12026-008-8074-5; Casadevall A, 2012, NAT IMMUNOL, V13, P21, DOI 10.1038/ni.2184; Courret N, 2003, INT J PARASITOL, V33, P1373, DOI 10.1016/S0020-7519(03)00179-6; de Souza VL, 2000, MICROBES INFECT, V2, P1807, DOI 10.1016/S1286-4579(00)01340-X; Elshafie AI, 2007, J IMMUNOL, V178, P5383, DOI 10.4049/jimmunol.178.8.5383; Elshafie AI, 2006, AM J TROP MED HYG, V75, P864, DOI 10.4269/ajtmh.2006.75.864; Gallo P, 2010, IMMUNOL LETT, V133, P70, DOI 10.1016/j.imlet.2010.07.004; Gibson-Corley KN, 2012, AM J PATHOL, V180, P2009, DOI 10.1016/j.ajpath.2012.01.012; Gibson-Corley KN, 2010, INT J PARASITOL, V40, P157, DOI 10.1016/j.ijpara.2009.11.010; Gomes IN, 2003, MICROBES INFECT, V5, P251, DOI 10.1016/S1286-4579(03)00025-X; Gonzalez-Lombana CZ, 2008, ACTA TROP, V106, P27, DOI 10.1016/j.actatropica.2007.12.012; Huang J, 2009, P NATL ACAD SCI USA, V106, P6226, DOI 10.1073/pnas.0811045106; Ji HX, 2003, INFECT IMMUN, V71, P4278, DOI 10.1128/IAI.71.8.4278-4288.2003; Ji JX, 2002, AM J TROP MED HYG, V66, P338, DOI 10.4269/ajtmh.2002.66.338; Jonsson F, 2013, J LEUKOCYTE BIOL, V94, P643, DOI 10.1189/jlb.1212623; Jones DE, 2002, INFECT IMMUN, V70, P2151, DOI 10.1128/IAI.70.4.2151-2158.2002; Kawai T, 2011, IMMUNITY, V34, P637, DOI 10.1016/j.immuni.2011.05.006; Kennedy AD, 2008, BLOOD, V112, P4788, DOI 10.1182/blood-2008-09-179135; KHARAZMI A, 1982, T ROY SOC TROP MED H, V76, P793, DOI 10.1016/0035-9203(82)90110-9; Lodge R, 2006, CELL MICROBIOL, V8, P1922, DOI 10.1111/j.1462-5822.2006.00758.x; Mancardi DA, 2013, BLOOD, V121, P1563, DOI 10.1182/blood-2012-07-442541; MARY C, 1993, AM J TROP MED HYG, V49, P492, DOI 10.4269/ajtmh.1993.49.492; Miles SA, 2005, J EXP MED, V201, P747, DOI 10.1084/jem.20041470; Mukbel R, 2006, MICROBES INFECT, V8, P2547, DOI 10.1016/j.micinf.2006.07.005; Mukbel RM, 2007, AM J TROP MED HYG, V76, P669, DOI 10.4269/ajtmh.2007.76.669; Nimmerjahn Falk, 2008, V415, P151, DOI 10.1007/978-1-59745-570-1_9; Nish S, 2011, IMMUNITY, V34, P629, DOI 10.1016/j.immuni.2011.05.009; PFEFFERKORN LC, 1990, MOL IMMUNOL, V27, P263, DOI 10.1016/0161-5890(90)90139-Q; PFEFFERKORN LC, 1989, J BIOL CHEM, V264, P14112; Pham NK, 2005, INFECT IMMUN, V73, P8322, DOI 10.1128/IAI.73.12.8322-8333.2005; Phanse Y, 2012, JOVE-J VIS EXP, DOI 10.3791/3884; Porrozzi R, 2004, AM J TROP MED HYG, V71, P297, DOI 10.4269/ajtmh.2004.71.297; Qi H, 2004, INFECT IMMUN, V72, P988, DOI 10.1128/IAI.72.2.988-995.2004; Qi H, 2001, J IMMUNOL, V167, P4534, DOI 10.4049/jimmunol.167.8.4534; Ramer AE, 2006, INFECT IMMUN, V74, P1547, DOI 10.1128/IAI.74.3.1547-1554.2006; Rodriguez-Pinto D, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-108; Sacks D, 2002, NAT REV IMMUNOL, V2, P845, DOI 10.1038/nri933; Saha S, 2006, INDIAN J MED RES, V123, P245; Solano-Gallego L, 2009, VET PARASITOL, V165, P1, DOI 10.1016/j.vetpar.2009.05.022; Stenger S, 1996, J EXP MED, V183, P1501, DOI 10.1084/jem.183.4.1501; Suh CI, 2006, J EXP MED, V203, P1915, DOI 10.1084/jem.20052085; Veras PST, 2006, EXP PARASITOL, V113, P201, DOI 10.1016/j.exppara.2006.01.008; Tian W, 2008, BLOOD, V112, P3867, DOI 10.1182/blood-2007-11-126029; TRIPP CS, 1995, J CLIN INVEST, V95, P1628, DOI 10.1172/JCI117837; Vanloubbeeck Y, 2004, AM J TROP MED HYG, V71, P407, DOI 10.4269/ajtmh.2004.71.407; Vanloubbeeck YF, 2004, INFECT IMMUN, V72, P4455, DOI 10.1128/IAI.72.8.4455-4463.2004; Veras PST, 1999, MEM I OSWALDO CRUZ, V94, P491, DOI 10.1590/S0074-02761999000400011; VOULDOUKIS I, 1995, P NATL ACAD SCI USA, V92, P7804, DOI 10.1073/pnas.92.17.7804; Vouldoukis I, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018289; Wanasen N, 2008, INT J PARASITOL, V38, P417, DOI 10.1016/j.ijpara.2007.08.010; Woelbing F, 2006, J EXP MED, V203, P177, DOI 10.1084/jem.20052288; Yuan H, 2009, BIOORG MED CHEM LETT, V19, P4223, DOI 10.1016/j.bmcl.2009.05.105	58	18	18	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2014	9	9							e106426	10.1371/journal.pone.0106426	http://dx.doi.org/10.1371/journal.pone.0106426			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ1IR	25191842	Green Published, gold, Green Submitted			2022-12-27	WOS:000347993600025
J	Gomez, JF; Cardona, K; Romero, L; Ferrero, JM; Trenor, B				Gomez, Juan F.; Cardona, Karen; Romero, Lucia; Ferrero, Jose M., Jr.; Trenor, Beatriz			Electrophysiological and Structural Remodeling in Heart Failure Modulate Arrhythmogenesis. 1D Simulation Study	PLOS ONE			English	Article							FAILING HUMAN HEART; ALTERED CONNEXIN43 EXPRESSION; NONFAILING HUMAN MYOCARDIUM; HUMAN VENTRICULAR MYOCYTES; ACTION-POTENTIAL DURATION; SARCOPLASMIC-RETICULUM; CARDIAC MYOCYTES; TRANSMURAL HETEROGENEITY; REENTRANT ARRHYTHMIAS; IMPULSE PROPAGATION	Background: Heart failure is a final common pathway or descriptor for various cardiac pathologies. It is associated with sudden cardiac death, which is frequently caused by ventricular arrhythmias. Electrophysiological remodeling, intercellular uncoupling, fibrosis and autonomic imbalance have been identified as major arrhythmogenic factors in heart failure etiology and progression. Objective: In this study we investigate in silico the role of electrophysiological and structural heart failure remodeling on the modulation of key elements of the arrhythmogenic substrate, i.e., electrophysiological gradients and abnormal impulse propagation. Methods: Two different mathematical models of the human ventricular action potential were used to formulate models of the failing ventricular myocyte. This provided the basis for simulations of the electrical activity within a transmural ventricular strand. Our main goal was to elucidate the roles of electrophysiological and structural remodeling in setting the stage for malignant life-threatening arrhythmias. Results: Simulation results illustrate how the presence of M cells and heterogeneous electrophysiological remodeling in the human failing ventricle modulate the dispersion of action potential duration and repolarization time. Specifically, selective heterogeneous remodeling of expression levels for the Na+/Ca2+ exchanger and SERCA pump decrease these heterogeneities. In contrast, fibroblast proliferation and cellular uncoupling both strongly increase repolarization heterogeneities. Conduction velocity and the safety factor for conduction are also reduced by the progressive structural remodeling during heart failure. Conclusion: An extensive literature now establishes that in human ventricle, as heart failure progresses, gradients for repolarization are changed significantly by protein specific electrophysiological remodeling (either homogeneous or heterogeneous). Our simulations illustrate and provide new insights into this. Furthermore, enhanced fibrosis in failing hearts, as well as reduced intercellular coupling, combine to increase electrophysiological gradients and reduce electrical propagation. In combination these changes set the stage for arrhythmias.	[Gomez, Juan F.; Cardona, Karen; Romero, Lucia; Ferrero, Jose M., Jr.; Trenor, Beatriz] Univ Politecn Valencia, Inst Invest Ingn Biomed, E-46071 Valencia, Spain	Universitat Politecnica de Valencia	Trenor, B (corresponding author), Univ Politecn Valencia, Inst Invest Ingn Biomed, E-46071 Valencia, Spain.	btrenor@gbio.i3bh.es	Trenor, Beatriz/H-1716-2015; Gomez, Juan F/B-5228-2017; Romero, Lucia/H-6815-2015; Ferrero, Jose M/I-2034-2015; Gómez, Juan F/ABA-8500-2020	Trenor, Beatriz/0000-0001-9166-6112; Gomez, Juan F/0000-0003-0253-4842; Romero, Lucia/0000-0003-4605-8630; Ferrero, Jose M/0000-0003-4200-9225; Gómez, Juan F/0000-0003-0253-4842	"VI Plan Nacional de Investigacion Cientifica, Desarrollo e Innovacion Tecnologica" from the Ministerio de Economia y Competitividad of Spain [TIN2012-37546-C03-01]; European Commission (European Regional Development Funds - ERDF - FEDER); Direccion General de Politica Cientifica de la Generalitat Valenciana [GV/2013/119]; Programa Prometeo de la Conselleria d'Educacio Formacio I Ocupacio, Generalitat Valenciana [PROMETEO/2012/030]	"VI Plan Nacional de Investigacion Cientifica, Desarrollo e Innovacion Tecnologica" from the Ministerio de Economia y Competitividad of Spain; European Commission (European Regional Development Funds - ERDF - FEDER); Direccion General de Politica Cientifica de la Generalitat Valenciana; Programa Prometeo de la Conselleria d'Educacio Formacio I Ocupacio, Generalitat Valenciana	This work was partially supported by (i) the "VI Plan Nacional de Investigacion Cientifica, Desarrollo e Innovacion Tecnologica" from the Ministerio de Economia y Competitividad of Spain (grant number TIN2012-37546-C03-01) and the European Commission (European Regional Development Funds - ERDF - FEDER), (ii) the Direccion General de Politica Cientifica de la Generalitat Valenciana (grant number GV/2013/119), and (iii) Programa Prometeo (PROMETEO/2012/030) de la Conselleria d'Educacio Formacio I Ocupacio, Generalitat Valenciana. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akar FG, 2007, AM J PHYSIOL-HEART C, V293, pH1223, DOI 10.1152/ajpheart.00079.2007; Akar FG, 2003, CIRC RES, V93, P638, DOI 10.1161/01.RES.0000092248.59479.AE; Akar FG, 2002, CIRCULATION, V105, P1247, DOI 10.1161/hc1002.105231; Ambrosi CM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054635; Antoons G, 2007, J ELECTROCARDIOL, V40, pS8, DOI 10.1016/j.jelectrocard.2007.05.022; Antzelevitch C, 2010, CIRC RES, V106, P815, DOI 10.1161/CIRCRESAHA.109.216226; Armoundas AA, 2003, CIRC RES, V93, P46, DOI 10.1161/01.RES.0000080932.98903.D8; Bers DM, 2006, ANN NY ACAD SCI, V1080, P165, DOI 10.1196/annals.1380.015; BEUCKELMANN DJ, 1992, CIRCULATION, V85, P1046, DOI 10.1161/01.CIR.85.3.1046; BEUCKELMANN DJ, 1993, CIRC RES, V73, P379, DOI 10.1161/01.RES.73.2.379; Boyle PM, 2010, BIOPHYS J, V98, pL57, DOI 10.1016/j.bpj.2010.03.018; Bundgaard H, 1996, MOL CELL BIOCHEM, V164, P277, DOI 10.1007/BF00408668; Chilton L, 2005, AM J PHYSIOL-HEART C, V288, pH2931, DOI 10.1152/ajpheart.01220.2004; Clayton RH, 2011, PROG BIOPHYS MOL BIO, V104, P22, DOI 10.1016/j.pbiomolbio.2010.05.008; Coronel R, 2013, BBA-MOL BASIS DIS, V1832, P2432, DOI 10.1016/j.bbadis.2013.04.002; Coronel R, 2001, CARDIOVASC RES, V50, P419, DOI 10.1016/S0008-6363(01)00284-X; Coronel R, 2009, HEART RHYTHM, V6, P537, DOI 10.1016/j.hrthm.2009.01.013; Curran J, 2010, J MOL CELL CARDIOL, V49, P25, DOI 10.1016/j.yjmcc.2010.03.013; Cutler MJ, 2007, J ELECTROCARDIOL, V40, pS1, DOI 10.1016/j.jelectrocard.2007.05.027; DELGADO C, 1990, CIRC RES, V67, P97, DOI 10.1161/01.RES.67.1.97; Dupont E, 2001, J MOL CELL CARDIOL, V33, P359, DOI 10.1006/jmcc.2000.1308; Elshrif MM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084401; Fast VG, 1996, CIRC RES, V79, P115, DOI 10.1161/01.RES.79.1.115; Fontes M.S., 2011, BIOCH BIOPHYS ACTA; Gaudesius G, 2003, CIRC RES, V93, P421, DOI 10.1161/01.RES.0000089258.40661.0C; George CH, 2008, CARDIOVASC RES, V77, P302, DOI 10.1093/cvr/cvm006; Gima K, 2002, CIRC RES, V90, P889, DOI 10.1161/01.RES.0000016960.61087.86; Glukhov AV, 2012, CIRCULATION, V125, P1835, DOI 10.1161/CIRCULATIONAHA.111.047274; Glukhov AV, 2010, CIRC RES, V106, P981, DOI 10.1161/CIRCRESAHA.109.204891; Gomez JF, 2013, COMPUT CARDIOL CONF, V40, P49; Gomez JF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103273; Gomez JF, 2012, COMPUT CARDIOL CONF, V39, P233; Gonzalez A, 2011, J AM COLL CARDIOL, V58, P1833, DOI 10.1016/j.jacc.2011.06.058; Grandi E, 2010, J MOL CELL CARDIOL, V48, P112, DOI 10.1016/j.yjmcc.2009.09.019; HASENFUSS G, 1994, CIRC RES, V75, P434, DOI 10.1161/01.RES.75.3.434; Heidenreich EA, 2010, ANN BIOMED ENG, V38, P2331, DOI 10.1007/s10439-010-9997-2; Hobai IA, 2001, CIRCULATION, V103, P1577; Holzem KM, 2012, EUROPACE, V14, pV50, DOI 10.1093/europace/eus275; Iyer V, 2012, J APPL PHYSIOL, V112, P944, DOI 10.1152/japplphysiol.00609.2011; Jacquemet V, 2008, AM J PHYSIOL-HEART C, V294, pH2040, DOI 10.1152/ajpheart.01298.2007; Jacquemet V, 2007, EUROPACE, V9, P29, DOI 10.1093/europace/eum207; Janse MJ, 2004, CARDIOVASC RES, V61, P208, DOI 10.1016/j.cardiores.2003.11.018; Kawara T, 2001, CIRCULATION, V104, P3069, DOI 10.1161/hc5001.100833; Kohl P, 2005, J ELECTROCARDIOL, V38, P45, DOI 10.1016/j.jelectrocard.2005.06.096; Kostin S, 2003, MOL CELL BIOCHEM, V242, P135, DOI 10.1023/A:1021154115673; Lou Q, 2012, AM J PHYSIOL-HEART C, V303, pH1426, DOI 10.1152/ajpheart.00457.2012; Lou Q, 2011, CIRCULATION, V123, P1881, DOI 10.1161/CIRCULATIONAHA.110.989707; MacCannell KA, 2007, BIOPHYS J, V92, P4121, DOI 10.1529/biophysj.106.101410; Majumder R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045040; Maltsev VA, 2007, EUR J HEART FAIL, V9, P219, DOI 10.1016/j.ejheart.2006.08.007; Marx SO, 2001, CIRC RES, V88, P1151, DOI 10.1161/hh1101.091268; McDowell KS, 2011, BIOPHYS J, V101, P1307, DOI 10.1016/j.bpj.2011.08.009; McSpadden LC, 2009, AM J PHYSIOL-CELL PH, V297, pC339, DOI 10.1152/ajpcell.00024.2009; Miragoli M, 2006, CIRC RES, V98, P801, DOI 10.1161/01.RES.0000214537.44195.a3; Miragoli M, 2007, CIRC RES, V101, P755, DOI 10.1161/CIRCRESAHA.107.160549; Moreno JD, 2013, CIRC RES, V113, pE50, DOI 10.1161/CIRCRESAHA.113.301971; Nayak AR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072950; O'Hara T, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002061; O'Rourke B, 1999, CIRC RES, V84, P562, DOI 10.1161/01.RES.84.5.562; OHLER A, 1994, N-S ARCH PHARMACOL, V349, P602, DOI 10.1007/BF01258466; Piacentino V, 2003, CIRC RES, V92, P651, DOI 10.1161/01.RES.0000062469.83985.9B; Pieske B, 1999, CIRC RES, V85, P38; Poelzing S, 2004, AM J PHYSIOL-HEART C, V287, pH1762, DOI 10.1152/ajpheart.00346.2004; Prestle L, 1999, CARDIOVASC RES, V43, P323, DOI 10.1016/S0008-6363(99)00119-4; Priebe L, 1998, CIRC RES, V82, P1206, DOI 10.1161/01.RES.82.11.1206; Qu ZL, 2004, AM J PHYSIOL-HEART C, V286, pH1310, DOI 10.1152/ajpheart.00561.2003; Reinecke H, 1996, CARDIOVASC RES, V31, P48, DOI 10.1016/0008-6363(95)00176-X; Remy-Jardin M, 2014, INTEGRATED CARDIOTHO; Rohr S, 2004, CARDIOVASC RES, V62, P309, DOI 10.1016/j.cardiores.2003.11.035; Romero L, 2009, ANN BIOMED ENG, V37, P1560, DOI 10.1007/s10439-009-9721-2; ROOK MB, 1992, AM J PHYSIOL, V263, pC959, DOI 10.1152/ajpcell.1992.263.5.C959; Sachse FB, 2009, ANN BIOMED ENG, V37, P874, DOI 10.1007/s10439-009-9667-4; Sah R, 2002, CIRC RES, V90, P165, DOI 10.1161/hh0202.103315; SCHWINGER RHG, 1995, CIRCULATION, V92, P3220, DOI 10.1161/01.CIR.92.11.3220; Shaw RM, 1997, CARDIOVASC RES, V35, P256, DOI 10.1016/S0008-6363(97)00093-X; Soltysinska E, 2009, PFLUG ARCH EUR J PHY, V459, P11, DOI 10.1007/s00424-009-0718-3; Sossalla S, 2011, BASIC RES CARDIOL, V106, P263, DOI 10.1007/s00395-010-0136-x; Spach MS, 1997, PACE, V20, P397, DOI 10.1111/j.1540-8159.1997.tb06199.x; Taggart P, 2000, J MOL CELL CARDIOL, V32, P621, DOI 10.1006/jmcc.2000.1105; Tanaka K, 2007, CIRC RES, V101, P839, DOI 10.1161/CIRCRESAHA.107.153858; Thompson SA, 2011, CIRCULATION, V123, P2083, DOI 10.1161/CIRCULATIONAHA.110.015057; Tomaselli GF, 2004, CIRC RES, V95, P754, DOI 10.1161/01.RES.0000145047.14691.db; Tomaselli GF, 1999, CARDIOVASC RES, V42, P270, DOI 10.1016/S0008-6363(99)00017-6; Trenor B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032659; Undrovinas AI, 1999, CELL MOL LIFE SCI, V55, P494, DOI 10.1007/s000180050306; Undrovinas Albertas I, 2006, J Cardiovasc Electrophysiol, V17 Suppl 1, pS169; Vasquez C, 2004, COMPUT CARDIOL, V31, P349, DOI 10.1109/CIC.2004.1442944; Vigmond E, 2009, EXP PHYSIOL, V94, P563, DOI 10.1113/expphysiol.2008.044073; Walmsley J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056359; Wiegerinck RF, 2008, HEART RHYTHM, V5, P1178, DOI 10.1016/j.hrthm.2008.04.026; Winslow RL, 1999, CIRC RES, V84, P571, DOI 10.1161/01.RES.84.5.571; WIT AL, 1993, AM J CARDIOL, V72, pF3, DOI 10.1016/0002-9149(93)90958-F; Xie YF, 2009, HEART RHYTHM, V6, P1641, DOI 10.1016/j.hrthm.2009.08.003; Xiong W, 2005, CIRC RES, V97, P207, DOI 10.1161/01.RES.0000175935.08283.27; Yano M, 2000, CIRCULATION, V102, P2131, DOI 10.1161/01.CIR.102.17.2131; Zlochiver S, 2008, BIOPHYS J, V95, P4469, DOI 10.1529/biophysj.108.136473	96	36	37	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2014	9	9							e106602	10.1371/journal.pone.0106602	http://dx.doi.org/10.1371/journal.pone.0106602			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ1IR	25191998	Green Published, gold			2022-12-27	WOS:000347993600044
J	Kumar, A; Dougherty, M; Findlay, GM; Geisheker, M; Klein, J; Lazar, J; Machkovech, H; Resnick, J; Resnick, R; Salter, AI; Talebi-Liasi, F; Arakawa, C; Baudin, J; Bogaard, A; Salesky, R; Zhou, Q; Smith, K; Clark, JI; Shendure, J; Horwitz, MS				Kumar, Akash; Dougherty, Max; Findlay, Gregory M.; Geisheker, Madeleine; Klein, Jason; Lazar, John; Machkovech, Heather; Resnick, Jesse; Resnick, Rebecca; Salter, Alexander I.; Talebi-Liasi, Faezeh; Arakawa, Christopher; Baudin, Jacob; Bogaard, Andrew; Salesky, Rebecca; Zhou, Qian; Smith, Kelly; Clark, John I.; Shendure, Jay; Horwitz, Marshall S.			Genome Sequencing of Idiopathic Pulmonary Fibrosis in Conjunction with a Medical School Human Anatomy Course	PLOS ONE			English	Article							MUC5B PROMOTER POLYMORPHISM; NONSPECIFIC INTERSTITIAL PNEUMONIA; MUTATIONS; FRAMEWORK; VARIANTS; SUSCEPTIBILITY; ASSOCIATION; EXPRESSION; SMOKING; DISEASE	Even in cases where there is no obvious family history of disease, genome sequencing may contribute to clinical diagnosis and management. Clinical application of the genome has not yet become routine, however, in part because physicians are still learning how best to utilize such information. As an educational research exercise performed in conjunction with our medical school human anatomy course, we explored the potential utility of determining the whole genome sequence of a patient who had died following a clinical diagnosis of idiopathic pulmonary fibrosis (IPF). Medical students performed dissection and whole genome sequencing of the cadaver. Gross and microscopic findings were more consistent with the fibrosing variant of nonspecific interstitial pneumonia (NSIP), as opposed to IPF per se. Variants in genes causing Mendelian disorders predisposing to IPF were not detected. However, whole genome sequencing identified several common variants associated with IPF, including a single nucleotide polymorphism (SNP), rs35705950, located in the promoter region of the gene encoding mucin glycoprotein MUC5B. The MUC5B promoter polymorphism was recently found to markedly elevate risk for IPF, though a particular association with NSIP has not been previously reported, nor has its contribution to disease risk previously been evaluated in the genome-wide context of all genetic variants. We did not identify additional predicted functional variants in a region of linkage disequilibrium (LD) adjacent to MUC5B, nor did we discover other likely risk-contributing variants elsewhere in the genome. Whole genome sequencing thus corroborates the association of rs35705950 with MUC5B dysregulation and interstitial lung disease. This novel exercise additionally served a unique mission in bridging clinical and basic science education.	[Kumar, Akash; Dougherty, Max; Findlay, Gregory M.; Geisheker, Madeleine; Klein, Jason; Lazar, John; Machkovech, Heather; Resnick, Jesse; Resnick, Rebecca; Salter, Alexander I.; Talebi-Liasi, Faezeh; Arakawa, Christopher; Baudin, Jacob; Bogaard, Andrew; Salesky, Rebecca; Zhou, Qian] Univ Washington, Sch Med, Seattle, WA 98195 USA; [Kumar, Akash; Dougherty, Max; Findlay, Gregory M.; Geisheker, Madeleine; Klein, Jason; Lazar, John; Machkovech, Heather; Resnick, Rebecca; Salter, Alexander I.; Arakawa, Christopher; Baudin, Jacob; Bogaard, Andrew] Univ Washington, Med Sci Training Program, Seattle, WA 98195 USA; [Kumar, Akash; Dougherty, Max; Findlay, Gregory M.; Klein, Jason; Machkovech, Heather; Shendure, Jay] Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA; [Smith, Kelly; Horwitz, Marshall S.] Univ Washington, Dept Pathol, Seattle, WA 98195 USA; [Clark, John I.] Univ Washington, Dept Biol Struct, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Horwitz, MS (corresponding author), Univ Washington, Dept Pathol, Seattle, WA 98195 USA.	horwitz@uw.edu	Shendure, Jay/AAU-3684-2021; Findlay, Gregory/AAX-9029-2020	Findlay, Gregory/0000-0002-7767-8608; Dougherty, Max/0000-0002-0841-0675; Geisheker, Madeleine/0000-0002-4166-3236; Arakawa, Christopher/0000-0001-9322-174X; Baudin, Jacob/0000-0001-5233-7084; Resnick, Jesse/0000-0003-2108-4074; Salter, Alexander/0000-0003-3820-0895; Horwitz, Marshall/0000-0002-1683-1680; Shendure, Jay/0000-0002-1516-1865; Kumar, Akash/0000-0001-9442-3597; Resnick, Rebecca/0000-0001-5804-4418	University of Washington School of Medicine; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007266] Funding Source: NIH RePORTER	University of Washington School of Medicine; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This study was funded by University of Washington School of Medicine institutional funds designated for educational activities for medical students. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abou Taam R, 2009, PEDIATR PULM, V44, P167, DOI 10.1002/ppul.20970; Aquino-Galvez A, 2009, HUM GENET, V125, P639, DOI 10.1007/s00439-009-0666-1; Armanios MY, 2007, NEW ENGL J MED, V356, P1317, DOI 10.1056/NEJMoa066157; Ashley EA, 2010, LANCET, V375, P1525, DOI 10.1016/S0140-6736(10)60452-7; Baumgartner KB, 1997, AM J RESP CRIT CARE, V155, P242, DOI 10.1164/ajrccm.155.1.9001319; Borie R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070621; Boucher RC, 2011, NEW ENGL J MED, V364, P1560, DOI 10.1056/NEJMe1014191; Cameron HS, 2005, J PEDIATR-US, V146, P370, DOI 10.1016/j.jpeds.2004.10.028; Campo I, 2014, RESP RES, V15, DOI 10.1186/1465-9921-15-43; Cooper GM, 2011, NAT REV GENET, V12, P628, DOI 10.1038/nrg3046; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; Dixon-Salazar TJ, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003544; du Bois R, 2007, THORAX, V62, P1008, DOI 10.1136/thx.2004.031039; Erlich H, 2012, TISSUE ANTIGENS, V80, P1, DOI 10.1111/j.1399-0039.2012.01881.x; Fernandez BA, 2012, RESP RES, V13, DOI 10.1186/1465-9921-13-64; Fingerlin TE, 2013, NAT GENET, V45, P613, DOI 10.1038/ng.2609; Guillot L, 2009, J MED GENET, V46, P490, DOI 10.1136/jmg.2009.066829; Herazo-Maya JD, 2012, BIOMARK MED, V6, P529, DOI [10.2217/bmm.12.38, 10.2217/BMM.12.38]; Hunninghake GM, 2013, NEW ENGL J MED, V368, P2192, DOI 10.1056/NEJMoa1216076; Ito I, 2005, AM J RESP CRIT CARE, V171, P632, DOI 10.1164/rccm.200403-417OC; Johnson AD, 2008, BIOINFORMATICS, V24, P2938, DOI 10.1093/bioinformatics/btn564; Kim TS, 1998, AM J ROENTGENOL, V171, P1645, DOI 10.2214/ajr.171.6.9843306; Kircher M, 2014, NAT GENET, V46, P310, DOI 10.1038/ng.2892; Kortmann GL, 2010, AM J MED GENET B, V153B, P17, DOI 10.1002/ajmg.b.30978; Kropski JA, 2013, DIS MODEL MECH, V6, P9, DOI 10.1242/dmm.010736; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Lupski JR, 2010, NEW ENGL J MED, V362, P1181, DOI 10.1056/NEJMoa0908094; Marrone A, 2007, HAEMATOLOGICA, V92, P1013, DOI 10.3324/haematol.11407; Marten K, 2009, EUR RADIOL, V19, P1679, DOI 10.1007/s00330-009-1308-7; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Ng SB, 2009, NATURE, V461, P272, DOI 10.1038/nature08250; Noble PW, 2012, J CLIN INVEST, V122, P2756, DOI 10.1172/JCI60323; Nogee LM, 2001, NEW ENGL J MED, V344, P573, DOI 10.1056/NEJM200102223440805; Noth I, 2013, LANCET RESP MED, V1, P309, DOI 10.1016/S2213-2600(13)70045-6; Ono S, 2011, EUR RESPIR J, V38, P861, DOI 10.1183/09031936.00143610; Papa V, 2013, SCI WORLD J, DOI 10.1155/2013/310348; Peljto AL, 2013, JAMA-J AM MED ASSOC, V309, P2232, DOI 10.1001/jama.2013.5827; Poletti V, 2012, SEMIN RESP CRIT CARE, V33, P440, DOI 10.1055/s-0032-1325155; Roy MG, 2014, NATURE, V505, P412, DOI 10.1038/nature12807; Sano Y, 2005, TRANSPLANT P, V37, P1371, DOI 10.1016/j.transproceed.2004.12.205; Seibold MA, 2011, NEW ENGL J MED, V364, P1503, DOI 10.1056/NEJMoa1013660; Selman M, 2003, HUM GENET, V113, P542, DOI 10.1007/s00439-003-1015-4; Selman M, 2001, RESP RES, V3, DOI 10.1186/rr175; Smits Jacqueline M A, 2003, Clin Transpl, P89; Stergachis AB, 2013, SCIENCE, V342, P1367, DOI 10.1126/science.1243490; Thomas AQ, 2002, AM J RESP CRIT CARE, V165, P1322, DOI 10.1164/rccm.200112-123OC; Topol EJ, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004126; Tsakiri KD, 2007, P NATL ACAD SCI USA, V104, P7552, DOI 10.1073/pnas.0701009104; Turner J, 2009, BIOCHEM SOC T, V37, P877, DOI 10.1042/BST0370877; van Moorsel CHM, 2010, AM J RESP CRIT CARE, V182, P1419, DOI 10.1164/rccm.200906-0953OC; Wang Y, 2009, AM J HUM GENET, V84, P52, DOI 10.1016/j.ajhg.2008.11.010; Worthey EA, 2011, GENET MED, V13, P255, DOI 10.1097/GIM.0b013e3182088158; Yang IV, 2013, THORAX, V68, P1114, DOI 10.1136/thoraxjnl-2012-202943; Zhang YZ, 2011, NEW ENGL J MED, V364, P1576, DOI 10.1056/NEJMc1013504	54	7	8	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2014	9	9							e106744	10.1371/journal.pone.0106744	http://dx.doi.org/10.1371/journal.pone.0106744			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ1IR	25192356	Green Submitted, gold, Green Published			2022-12-27	WOS:000347993600058
J	Maeda, M; Harris, AW; Kingham, BF; Lumpkin, CJ; Opdenaker, LM; McCahan, SM; Wang, W; Butchbach, MER				Maeda, Miho; Harris, Ashlee W.; Kingham, Brewster F.; Lumpkin, Casey J.; Opdenaker, Lynn M.; McCahan, Suzanne M.; Wang, Wenlan; Butchbach, Matthew E. R.			Transcriptome Profiling of Spinal Muscular Atrophy Motor Neurons Derived from Mouse Embryonic Stem Cells	PLOS ONE			English	Article							ACID-BINDING PROTEIN; ACTIN MESSENGER-RNA; SMN2 COPY NUMBER; RETINOIC-ACID; GROWTH CONES; NEUROMUSCULAR-JUNCTIONS; PRENATAL-DIAGNOSIS; SINGLE NUCLEOTIDE; REDUCED SURVIVAL; GENE-EXPRESSION	Proximal spinal muscular atrophy (SMA) is an early onset, autosomal recessive motor neuron disease caused by loss of or mutation in SMN1 (survival motor neuron 1). Despite understanding the genetic basis underlying this disease, it is still not known why motor neurons (MNs) are selectively affected by the loss of the ubiquitously expressed SMN protein. Using a mouse embryonic stem cell (mESC) model for severe SMA, the RNA transcript profiles (transcriptomes) between control and severe SMA (SMN2(+/+); mSmn(-/-)) mESC-derived MNs were compared in this study using massively parallel RNA sequencing (RNA-Seq). The MN differentiation efficiencies between control and severe SMA mESCs were similar. RNA-Seq analysis identified 3,094 upregulated and 6,964 downregulated transcripts in SMA mESC-derived MNs when compared against control cells. Pathway and network analysis of the differentially expressed RNA transcripts showed that pluripotency and cell proliferation transcripts were significantly increased in SMA MNs while transcripts related to neuronal development and activity were reduced. The differential expression of selected transcripts such as Crabp1, Crabp2 and Nkx2.2 was validated in a second mESC model for SMA as well as in the spinal cords of low copy SMN2 severe SMA mice. Furthermore, the levels of these selected transcripts were restored in high copy SMN2 rescue mouse spinal cords when compared against low copy SMN2 severe SMA mice. These findings suggest that SMN deficiency affects processes critical for normal development and maintenance of MNs.	[Maeda, Miho; Harris, Ashlee W.; Lumpkin, Casey J.; Wang, Wenlan; Butchbach, Matthew E. R.] Nemours Alfred I duPont Hosp Children, Ctr Appl Clin Gen Nemours Biomed Res, Wilmington, DE 19803 USA; [McCahan, Suzanne M.; Wang, Wenlan; Butchbach, Matthew E. R.] Nemours Alfred I duPont Hosp Children, Ctr Pediat Res Nemours Biomed Res, Wilmington, DC USA; [McCahan, Suzanne M.] Nemours Alfred I duPont Hosp Children, Bioinformat Core Facil, Wilmington, DC USA; [Maeda, Miho; Lumpkin, Casey J.; Wang, Wenlan; Butchbach, Matthew E. R.] Univ Delaware, Dept Biol Sci, Newark, DE USA; [Kingham, Brewster F.] Univ Delaware, Sequencing & Genotyping Ctr, Newark, DE USA; [Opdenaker, Lynn M.] Univ Delaware, Ctr Translat Canc Res, Newark, DE USA; [McCahan, Suzanne M.; Butchbach, Matthew E. R.] Thomas Jefferson Univ, Dept Pediat, Philadelphia, PA 19107 USA	Nemours Alfred I. duPont Hospital for Children; Nemours Alfred I. duPont Hospital for Children; Nemours Alfred I. duPont Hospital for Children; University of Delaware; University of Delaware; University of Delaware; Jefferson University	Butchbach, MER (corresponding author), Nemours Alfred I duPont Hosp Children, Ctr Appl Clin Gen Nemours Biomed Res, Wilmington, DE 19803 USA.	butchbach@nemoursresearch.org		Butchbach, Matthew/0000-0003-2912-6400	Institutional Development Award (IDeA) Networks of Biomedical Research Excellence (INBRE) [P20GM103446]; Centers of Biomedical Research Excellence (COBRE) [P20GM103464]; programs of the National Institute of General Medical Sciences of the National Institutes of Health; Nemours Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103464, P20GM103446] Funding Source: NIH RePORTER	Institutional Development Award (IDeA) Networks of Biomedical Research Excellence (INBRE); Centers of Biomedical Research Excellence (COBRE)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); programs of the National Institute of General Medical Sciences of the National Institutes of Health; Nemours Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This project was supported by an Institutional Development Award (IDeA) Networks of Biomedical Research Excellence (INBRE; grant number P20GM103446 to W.W. and M.E.R.B.) and Centers of Biomedical Research Excellence (COBRE; grant number P20GM103464 to M.E.R.B., S.M.M. and W.W.) programs of the National Institute of General Medical Sciences of the National Institutes of Health as well as the Nemours Foundation (M.E.R.B. and W.W.). The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Anderson KN, 2004, NEUROMUSCULAR DISORD, V14, P711, DOI 10.1016/j.nmd.2004.08.009; Appel B, 2003, NEURON, V40, P461, DOI 10.1016/S0896-6273(03)00688-3; Arber S, 1999, NEURON, V23, P659, DOI 10.1016/S0896-6273(01)80026-X; Azzouz M, 2004, J CLIN INVEST, V114, P1726, DOI 10.1172/JCI200422922; Barrett T, 2013, NUCLEIC ACIDS RES, V41, pD991, DOI 10.1093/nar/gks1193; Bassell GJ, 1998, J NEUROSCI, V18, P251; Ben-Shachar S, 2011, GENET MED, V13, P110, DOI 10.1097/GIM.0b013e3182017c05; Boyer LA, 2005, CELL, V122, P947, DOI 10.1016/j.cell.2005.08.020; Boyne LJ, 1996, INT J DEV NEUROSCI, V14, P739, DOI 10.1016/S0736-5748(96)00053-6; Briscoe J, 1999, NATURE, V398, P622, DOI 10.1038/19315; Burghes AHM, 2009, NAT REV NEUROSCI, V10, P597, DOI 10.1038/nrn2670; Butchbach MER, 2007, J NEUROSCI METH, V161, P285, DOI 10.1016/j.jneumeth.2006.11.002; Butchbach MER, 2010, HUM MOL GENET, V19, P454, DOI 10.1093/hmg/ddp510; Caraballo-Miralles V, 2013, INT J MOL SCI, V14, P11424, DOI 10.3390/ijms140611424; Carrel TL, 2006, J NEUROSCI, V26, P11014, DOI 10.1523/JNEUROSCI.1637-06.2006; Chang HCH, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003209; Chang T, 2011, STEM CELLS, V29, P2090, DOI 10.1002/stem.749; Cheever TR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017768; Cho SC, 2010, GENE DEV, V24, P438, DOI 10.1101/gad.1884910; Coovert DD, 1997, HUM MOL GENET, V6, P1205, DOI 10.1093/hmg/6.8.1205; Corti S, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004108; Crawford TO, 1996, NEUROBIOL DIS, V3, P97, DOI 10.1006/nbdi.1996.0010; Cusco I, 2002, BJOG-INT J OBSTET GY, V109, P1244, DOI 10.1016/S1470-0328(02)02983-X; DELCORRAL RD, 2003, NEURON, V40, P65, DOI DOI 10.1016/S0896-6273(03)00565-8; DENCKER L, 1990, DEVELOPMENT, V110, P343; Dominguez E, 2011, HUM MOL GENET, V20, P681, DOI 10.1093/hmg/ddq514; Ebert AD, 2009, NATURE, V457, P277, DOI 10.1038/nature07677; Elsheikh B, 2009, MUSCLE NERVE, V40, P652, DOI 10.1002/mus.21350; Fang ZD, 2011, BRIEF BIOINFORM, V12, P280, DOI 10.1093/bib/bbr004; Foust KD, 2010, NAT BIOTECHNOL, V28, P271, DOI 10.1038/nbt.1610; Gabanella F, 2005, HUM MOL GENET, V14, P3629, DOI 10.1093/hmg/ddi390; Garcia EL, 2013, RNA, V19, P1510, DOI 10.1261/rna.038919.113; Gavrilina TO, 2008, HUM MOL GENET, V17, P1063, DOI 10.1093/hmg/ddm379; Gogliotti RG, 2013, HUM MOL GENET, V22, P4084, DOI 10.1093/hmg/ddt258; Gogliotti RG, 2012, J NEUROSCI, V32, P3818, DOI 10.1523/JNEUROSCI.5775-11.2012; HOSLER BA, 1989, MOL CELL BIOL, V9, P5623, DOI 10.1128/MCB.9.12.5623; Hsieh-Li HM, 2000, NAT GENET, V24, P66, DOI 10.1038/71709; Hua YM, 2011, NATURE, V478, P123, DOI 10.1038/nature10485; Jablonka S, 2000, HUM MOL GENET, V9, P341, DOI 10.1093/hmg/9.3.341; Juknat A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061462; Kariya S, 2008, HUM MOL GENET, V17, P2552, DOI 10.1093/hmg/ddn156; Kim SK, 2005, STEM CELLS, V23, P458, DOI 10.1634/stemcells.2004-0245; Kong LL, 2009, J NEUROSCI, V29, P842, DOI 10.1523/JNEUROSCI.4434-08.2009; Kramer A, 2014, BIOINFORMATICS, V30, P523, DOI 10.1093/bioinformatics/btt703; Le TT, 2005, HUM MOL GENET, V14, P845, DOI 10.1093/hmg/ddi078; Lefebvre S, 1997, NAT GENET, V16, P265, DOI 10.1038/ng0797-265; LEFEBVRE S, 1995, CELL, V80, P155, DOI 10.1016/0092-8674(95)90460-3; Lim LS, 2007, MOL BIOL CELL, V18, P1348, DOI 10.1091/mbc.E06-07-0624; Liu H, 2010, J NEUROSCI RES, V88, P111, DOI 10.1002/jnr.22189; Lorson CL, 1999, P NATL ACAD SCI USA, V96, P6307, DOI 10.1073/pnas.96.11.6307; Lorson CL, 2000, HUM MOL GENET, V9, P259, DOI 10.1093/hmg/9.2.259; Lyahyai J, 2012, GENET TEST MOL BIOMA, V16, P215, DOI 10.1089/gtmb.2011.0149; Makhortova NR, 2011, NAT CHEM BIOL, V7, P544, DOI [10.1038/NCHEMBIO.595, 10.1038/nchembio.595]; Martin M, 2011, EMBNET J, V17, P10, DOI [10.14806/ej.17.1.200, 10.10.14806/ej.17.1.200, DOI 10.14806/EJ.17.1.200]; Martinez TL, 2012, J NEUROSCI, V32, P8703, DOI 10.1523/JNEUROSCI.0204-12.2012; Masui S, 2008, BMC DEV BIOL, V8, DOI 10.1186/1471-213X-8-45; McAndrew PE, 1997, AM J HUM GENET, V60, P1411, DOI 10.1086/515465; McGovern VL, 2008, HUM MOL GENET, V17, P2900, DOI 10.1093/hmg/ddn189; McWhorter ML, 2003, J CELL BIOL, V162, P919, DOI 10.1083/jcb.200303168; Michaud M, 2010, NEUROBIOL DIS, V38, P125, DOI 10.1016/j.nbd.2010.01.006; Miles GB, 2004, J NEUROSCI, V24, P7848, DOI 10.1523/JNEUROSCI.1972-04.2004; Monani UR, 1999, HUM MOL GENET, V8, P1177, DOI 10.1093/hmg/8.7.1177; Monani UR, 2000, HUM MOL GENET, V9, P333, DOI 10.1093/hmg/9.3.333; Mourelatos Z, 2001, EMBO J, V20, P5443, DOI 10.1093/emboj/20.19.5443; Murray LM, 2010, HUM MOL GENET, V19, P420, DOI 10.1093/hmg/ddp506; Novitch BG, 2003, NEURON, V40, P81, DOI 10.1016/j.neuron.2003.08.006; Pagliardini S, 2000, HUM MOL GENET, V9, P47, DOI 10.1093/hmg/9.1.47; Papetti M, 2011, J CELL PHYSIOL, V226, P785, DOI 10.1002/jcp.22399; Park GH, 2010, J NEUROSCI, V30, P12005, DOI 10.1523/JNEUROSCI.2208-10.2010; Passini MA, 2010, J CLIN INVEST, V120, P1253, DOI 10.1172/JCI41615; PEARN J, 1978, J MED GENET, V15, P409, DOI 10.1136/jmg.15.6.409; PEREZCASTRO AV, 1989, P NATL ACAD SCI USA, V86, P8813, DOI 10.1073/pnas.86.22.8813; Pfaff SL, 1996, CELL, V84, P309, DOI 10.1016/S0092-8674(00)80985-X; Pierfelice T, 2011, NEURON, V69, P840, DOI 10.1016/j.neuron.2011.02.031; Prior TW, 2004, AM J MED GENET A, V130A, P307, DOI 10.1002/ajmg.a.30251; Redmond LC, 2011, BLOOD CELL MOL DIS, V47, P1, DOI 10.1016/j.bcmd.2011.03.002; Rossoll W, 2003, J CELL BIOL, V163, P801, DOI 10.1083/jcb.200304128; Sareen D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039113; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Schrank B, 1997, P NATL ACAD SCI USA, V94, P9920, DOI 10.1073/pnas.94.18.9920; See K, 2014, HUM MOL GENET, V23, P1754, DOI 10.1093/hmg/ddt567; Su YN, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017067; Sugarman EA, 2012, EUR J HUM GENET, V20, P27, DOI 10.1038/ejhg.2011.134; Sultan M, 2008, SCIENCE, V321, P956, DOI 10.1126/science.1160342; Swoboda KJ, 2005, ANN NEUROL, V57, P704, DOI 10.1002/ana.20473; Tiziano FD, 2007, NEUROMUSCULAR DISORD, V17, P400, DOI 10.1016/j.nmd.2007.02.006; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Valori CF, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000830; Van Meerbeke JP, 2013, HUM MOL GENET, V22, P4074, DOI 10.1093/hmg/ddt257; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Wan LL, 2005, MOL CELL BIOL, V25, P5543, DOI 10.1128/MCB.25.13.5543-5551.2005; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Wichterle H, 2002, CELL, V110, P385, DOI 10.1016/S0092-8674(02)00835-8; Winkler C, 2005, GENE DEV, V19, P2320, DOI 10.1101/gad.342005; Wirth B, 2006, HUM GENET, V119, P422, DOI 10.1007/s00439-006-0156-7; Wu CY, 2012, JOVE-J VIS EXP, DOI 10.3791/3813; Wu CY, 2011, BMC NEUROSCI, V12, DOI 10.1186/1471-2202-12-25; Zhang HL, 2006, J NEUROSCI, V26, P8622, DOI 10.1523/JNEUROSCI.3967-05.2006; Zhang W, 2006, NUCLEIC ACIDS RES, V34, P4780, DOI 10.1093/nar/gkl631; Zhang Z, 2008, CELL, V133, P585, DOI 10.1016/j.cell.2008.03.031; Zhang ZX, 2013, P NATL ACAD SCI USA, V110, P19348, DOI 10.1073/pnas.1319280110	103	28	28	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2014	9	9							e106818	10.1371/journal.pone.0106818	http://dx.doi.org/10.1371/journal.pone.0106818			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ1IR	25191843	Green Published, gold, Green Submitted			2022-12-27	WOS:000347993600067
J	Stathopoulou, A; Lucchiari, G; Ooi, SKT				Stathopoulou, Athanasia; Lucchiari, Giulia; Ooi, Steen K. T.			DNA Methylation Is Dispensable for Suppression of the Agouti viable yellow Controlling Element in Murine Embryonic Stem Cells	PLOS ONE			English	Article							HISTONE H3; ENDOGENOUS RETROVIRUSES; TRANSPOSABLE ELEMENTS; MOUSE EMBRYOS; GENES; MICE; METHYLTRANSFERASE; EXPRESSION; MUTATIONS; BINDING	The agouti viable (A(vy)) locus is considered a model to understand how retroelements function as controlling elements in mammals. Epigenetic factors, principally CpG methylation, are widely held to play a dominant regulatory role in controlling the locus' activity. The purpose of this study was to examine its behavior in ES cells and determine if this locus could be exploited for use in screen-based investigations. We have derived multiple A(vy) ES cell lines from the C57BL/6 strain and generated a cell line carrying a GFP-reporter gene (A(vy)/A(GFP)). Use of the DNA demethylating drug 5-azacitidine on various ES cell lines does not induce either agouti or GFP expression. Methylation analysis reveals that although most lines display normal methylation at IAP elements in general, the A(vy) IAP element is essentially unmethylated. In addition, we find that different repeat compartments are epigenetically unstable in a number of derived cell lines.	[Stathopoulou, Athanasia; Lucchiari, Giulia; Ooi, Steen K. T.] UCL, Inst Canc, Dept Canc Biol, London, England	University of London; University College London	Ooi, SKT (corresponding author), UCL, Inst Canc, Dept Canc Biol, London, England.	s.ooi@ucl.ac.uk		Stathopoulou, Athanasia/0000-0001-8579-7706	Biotechnology and Biological Sciences Research Council (BBSRC) David Phillips Fellowship [BB/H022546/1]; European Research Council (ERC) Starting Grant [281784-XXDNAM]; BBSRC [BB/H022546/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/H022546/1] Funding Source: researchfish	Biotechnology and Biological Sciences Research Council (BBSRC) David Phillips Fellowship(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); European Research Council (ERC) Starting Grant(European Research Council (ERC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by the Biotechnology and Biological Sciences Research Council (BBSRC) David Phillips Fellowship (BB/H022546/1), awarded to SKTO (http://www.bbsrc.ac.uk/pa/grants/AwardDetails.aspx?FundingReference = BB/H022546/1) and the European Research Council (ERC) Starting Grant (281784-XXDNAM), awarded to SKTO and supporting AS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARAKI K, 1995, P NATL ACAD SCI USA, V92, P160, DOI 10.1073/pnas.92.1.160; Auerbach W, 2000, BIOTECHNIQUES, V29, P1024, DOI 10.2144/00295st04; Blewitt ME, 2006, PLOS GENET, V2, P399, DOI 10.1371/journal.pgen.0020049; Bourc'his D, 2004, NATURE, V431, P96, DOI 10.1038/nature02886; Bourque G, 2008, GENOME RES, V18, P1752, DOI 10.1101/gr.080663.108; Cropley JE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009055; Damelin M, 2007, MOL CELL BIOL, V27, P3891, DOI 10.1128/MCB.00036-07; Dean W, 1998, DEVELOPMENT, V125, P2273; DICKIES MM, 1962, J HERED, V53, P84, DOI 10.1093/oxfordjournals.jhered.a107129; DUHL DMJ, 1994, NAT GENET, V8, P59, DOI 10.1038/ng0994-59; Dupressoir A, 1996, MOL CELL BIOL, V16, P4495; EVANS MJ, 1981, NATURE, V292, P154, DOI 10.1038/292154a0; Feng SH, 2010, SCIENCE, V330, P622, DOI 10.1126/science.1190614; Humpherys D, 2001, SCIENCE, V293, P95, DOI 10.1126/science.1061402; Kano H, 2009, GENE DEV, V23, P1303, DOI 10.1101/gad.1803909; Karimi MM, 2011, CELL STEM CELL, V8, P676, DOI 10.1016/j.stem.2011.04.004; Klose RJ, 2006, TRENDS BIOCHEM SCI, V31, P89, DOI 10.1016/j.tibs.2005.12.008; Kuramochi-Miyagawa S, 2008, GENE DEV, V22, P908, DOI 10.1101/gad.1640708; Lachner M, 2001, NATURE, V410, P116, DOI 10.1038/35065132; Lehnertz B, 2003, CURR BIOL, V13, P1192, DOI 10.1016/S0960-9822(03)00432-9; Liu PT, 2003, GENOME RES, V13, P476, DOI 10.1101/gr.749203; MARTIN GR, 1981, P NATL ACAD SCI-BIOL, V78, P7634, DOI 10.1073/pnas.78.12.7634; Matsui T, 2010, NATURE, V464, P927, DOI 10.1038/nature08858; Morgan HD, 1999, NAT GENET, V23, P314, DOI 10.1038/15490; Ooi SKT, 2007, NATURE, V448, P714, DOI 10.1038/nature05987; Ooi SKT, 2010, EPIGENET CHROMATIN, V3, DOI 10.1186/1756-8935-3-17; Rebollo R, 2012, GENOME BIOL, V13, DOI [10.1186/gb-2012-13-10-R89, 10.1186/gb-2012-13-10-r89]; Rowe HM, 2010, NATURE, V463, P237, DOI 10.1038/nature08674; Schmidt D, 2012, CELL, V148, P335, DOI 10.1016/j.cell.2011.11.058; Schultz DC, 2002, GENE DEV, V16, P919, DOI 10.1101/gad.973302; Sharif J, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2011.0340; Thomas JH, 2011, GENOME RES, V21, P1800, DOI 10.1101/gr.121749.111; Walsh CP, 1998, NAT GENET, V20, P116, DOI 10.1038/2413; Ward CM, 2004, EXP CELL RES, V293, P229, DOI 10.1016/j.yexcr.2003.10.017; Ware CB, 2003, TRANSGENIC RES, V12, P743, DOI 10.1023/B:TRAG.0000005246.35812.c8; Waterland RA, 2003, MOL CELL BIOL, V23, P5293, DOI 10.1128/MCB.23.15.5293-5300.2003; Waterston RH, 2002, NATURE, V420, P520, DOI 10.1038/nature01262; Zhang Y, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000007	38	1	1	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2014	9	9							e107355	10.1371/journal.pone.0107355	http://dx.doi.org/10.1371/journal.pone.0107355			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ1IR	25191835	Green Published, gold			2022-12-27	WOS:000347993600109
J	Stratford, JM; Thompson, JA				Stratford, Jennifer M.; Thompson, John A.			Beta-Galactosidase Staining in the Nucleus of the Solitary Tract of Fos-Tau-LacZ Mice Is Unaffected by Monosodium Glutamate Taste Stimulation	PLOS ONE			English	Article							C-FOS; BRAIN; RAT; ORGANIZATION; EXPRESSION; REVEAL	Fos-Tau-LacZ (FTL) transgenic mice are used to visualize the anatomical connectivity of neurons that express c-Fos, an immediate early gene, in response to activation. In contrast to typical c-Fos protein expression, which is localized to the nucleus of stimulated neurons, activation of the c-Fos gene results in beta galactosidase (beta-gal) expression throughout the entire cytoplasm of activated cells in FTL mice; thereby making it possible to discern the morphology of c-Fos expressing cells. This can be an especially important tool in brain areas in which function may be related to cell morphology, such as the primary taste/viscerosensory brainstem nucleus of the solitary tract (nTS). Thus, to further characterize FTL activity in the brain, the current study quantified both beta-gal enzymatic activity as well as c-Fos protein expression in the nTS under a variety of experimental conditions (no stimulation, no stimulation with prior overnight food and water restriction, monosodium glutamate taste stimulation, and monosodium glutamate taste stimulation with perfusion 5 h post stimulation). Contrary to previous research, we found that beta-gal activity (both labeled cell bodies and overall number of labeled pixels) was unchanged across all experimental conditions. However, traditional c-Fos protein activity (both cell bodies and number of activated pixels) varied significantly across experimental conditions, with the greatest amount of c-Fos protein label found in the group that received monosodium glutamate taste stimulation. Interestingly, although many c-Fos positive cells were also beta-gal positive in the taste stimulated group, some c-Fos protein labeled cells were not colabeled with beta-gal. Together, these data suggest that beta-gal staining within the nTS reflects a stable population of beta-gal-positive neurons whose pattern of expression is unaffected by experimental condition.	[Stratford, Jennifer M.] Univ Colorado, Sch Med, Dept Cell & Dev Biol, Rocky Mt Taste & Smell Ctr, Aurora, CO 80045 USA; [Thompson, John A.] Univ Colorado, Sch Med, Dept Neurosurg, Aurora, CO USA	University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus	Stratford, JM (corresponding author), Univ Colorado, Sch Med, Dept Cell & Dev Biol, Rocky Mt Taste & Smell Ctr, Aurora, CO 80045 USA.	jennifer.stratford@ucdenver.edu	Thompson, John A/T-6194-2019	Thompson, John A/0000-0003-2991-5194	NIH [5F32DC012025-03]; Rocky Mountain Taste and Smell Center [P30 DC04657];  [1R01DC012931-01]; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [F32DC012025, P30DC004657, R01DC012931] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Rocky Mountain Taste and Smell Center; ; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported by an NIH grant to JMS (5F32DC012025-03) with additional support from Dr. Thomas E. Finger (1R01DC012931-01), and the Rocky Mountain Taste and Smell Center (P30 DC04657). With the exception of the NIH grant to JMS, the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali AEA, 2009, NEUROBIOL LEARN MEM, V92, P381, DOI 10.1016/j.nlm.2009.05.004; Archer S, 1999, BIOCHEM BIOPH RES CO, V257, P687, DOI 10.1006/bbrc.1999.0445; Barraco IRA, 1994, NUCL SOLITARY TRACT; CALLAHAN CA, 1994, P NATL ACAD SCI USA, V91, P5972, DOI 10.1073/pnas.91.13.5972; CHIBA T, 1978, BRAIN RES, V151, P323, DOI 10.1016/0006-8993(78)90888-0; Corson JA, 2010, CHEM SENSES, V35, P630; Greferath U, 2004, NEUROIMAGE, V23, P1027, DOI 10.1016/j.neuroimage.2004.06.044; GUTHRIE KM, 1993, P NATL ACAD SCI USA, V90, P3329, DOI 10.1073/pnas.90.8.3329; King MS, 2007, ROLE NUCL SOLITARY T, P17; Murphy M, 2007, BIOL PROCED ONLINE, V9, P1, DOI 10.1251/bpo128; Niblock MM, 2010, BRAIN RES, V1311, P51, DOI 10.1016/j.brainres.2009.11.037; SHAPIRO RE, 1985, J COMP NEUROL, V238, P473, DOI 10.1002/cne.902380411; Stratford JM, 2011, J NEUROSCI, V31, P9101, DOI 10.1523/JNEUROSCI.0404-11.2011; TRAVERS SP, 1995, J NEUROPHYSIOL, V73, P2144, DOI 10.1152/jn.1995.73.6.2144; WATSON RE, 1986, PEPTIDES, V7, P155, DOI 10.1016/0196-9781(86)90076-8; Wilson Y, 2002, P NATL ACAD SCI USA, V99, P3252, DOI 10.1073/pnas.042701199; Zangenehpour S, 2002, MOL BRAIN RES, V109, P221, DOI 10.1016/S0169-328X(02)00556-9	17	1	1	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2014	9	9							e107238	10.1371/journal.pone.0107238	http://dx.doi.org/10.1371/journal.pone.0107238			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ1IR	25192442	Green Published, Green Submitted, gold			2022-12-27	WOS:000347993600107
J	Tops, W; Callens, M; Desoete, A; Stevens, M; Brysbaert, M				Tops, Wim; Callens, Maaike; Desoete, Annemie; Stevens, Michael; Brysbaert, Marc			Metacognition for Spelling in Higher Education Students with Dyslexia: Is There Evidence for the Dual Burden Hypothesis?	PLOS ONE			English	Article							COLLEGE-STUDENTS; SKILLS; DIFFICULTIES; MOTIVATION; COGNITION; CHILDREN; UNAWARE	We examined whether academic and professional bachelor students with dyslexia are able to compensate for their spelling deficits with metacognitive experience. Previous research suggested that students with dyslexia may suffer from a dual burden. Not only do they perform worse on spelling but in addition they are not as fully aware of their difficulties as their peers without dyslexia. According to some authors, this is the result of a worse feeling of confidence, which can be considered as a form of metacognition (metacognitive experience). We tried to isolate this metacognitive experience by asking 100 students with dyslexia and 100 matched control students to rate their feeling of confidence in a word spelling task and a proofreading task. Next, we used Signal Detection Analysis to disentangle the effects of proficiency and criterion setting. We found that students with dyslexia showed lower proficiencies but not suboptimal response biases. They were as good at deciding when they could be confident or not as their peers without dyslexia. They just had more cases in which their spelling was wrong. We conclude that the feeling of confidence in our students with dyslexia is as good as in their peers without dyslexia. These findings go against the Dual Burden theory (Kruger & Dunning, 1999), which assumes that people with a skills problem suffer twice as a result of insufficiently developed metacognitive competence. As a result, there is no gain to be expected from extra training of this metacognitive experience in higher education students with dyslexia.	[Tops, Wim; Callens, Maaike; Desoete, Annemie; Stevens, Michael; Brysbaert, Marc] Univ Ghent, B-9000 Ghent, Belgium; [Tops, Wim] Univ Groningen, Groningen, Netherlands	Ghent University; University of Groningen	Tops, W (corresponding author), Univ Ghent, B-9000 Ghent, Belgium.	wimtops@gmail.com	Brysbaert, Marc/A-3910-2011; Desoete, Annemie/A-4876-2015	Brysbaert, Marc/0000-0002-3645-3189; Desoete, Annemie/0000-0001-6663-7440; tops, funnel/0000-0003-3116-4203; Tops, Wim/0000-0002-7889-8610	Odysseus Grant - Flemish Government	Odysseus Grant - Flemish Government	This study was made possible by an Odysseus Grant, which was awarded to MB by the Flemish Government. The funders however had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American psychiatric association, 2013, DIAGNOSTIC STAT MANU, DOI 10.1176/appi.books.9780890425596; [Anonymous], 2009, HDB METACOGNITION ED; Badian NA, 1999, J LEARN DISABIL, V32, P138, DOI 10.1177/002221949903200204; Borgwaldt S, 2004, AUST J PSYCHOL, V56, P106; Brus B, 1991, EEN MINUUT TEST VORM; Butler D. L., 1998, LEARNING LEARNING DI, P277; Callens M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038081; CHI MTH, 1989, COGNITIVE SCI, V13, P145, DOI 10.1207/s15516709cog1302_1; Christensen R., 2013, R PACKAGE VERSION 20, P08; Cope N, 2005, AM J HUM GENET, V76, P581, DOI 10.1086/429131; De Pessemier P, 2009, TEST GEVORDERD LEZEN; De Smedt B, 2010, NEUROPSYCHOLOGIA, V48, P3973, DOI 10.1016/j.neuropsychologia.2010.10.018; DeCarlo LT, 1998, PSYCHOL METHODS, V3, P186, DOI 10.1037/1082-989X.3.2.186; Dekker R, 2004, KAUFMAN ADOLESCENT A; Dijkstra KA, 2013, J BEHAV DECIS MAKING, V26, P285, DOI 10.1002/bdm.1759; Efklides A., 2002, METACOGNITION PROCES, P19, DOI [DOI 10.1007/978-1-4615-1099-4_2, 10.1007/978-1-4615-1099-4_2]; Efklides A, 2011, EDUC PSYCHOL-US, V46, P6, DOI 10.1080/00461520.2011.538645; Efklides A, 2008, EUR PSYCHOL, V13, P277, DOI 10.1027/1016-9040.13.4.277; Efklides A, 2009, PSICOTHEMA, V21, P76; Flavell J.H., 1976, NATURE INTELLIGENCE, P231, DOI DOI 10.1038/HDY.1976.85; FLAVELL JH, 1979, AM PSYCHOL, V34, P906, DOI 10.1037/0003-066X.34.10.906; Gobel SM, 2010, Q J EXP PSYCHOL, V63, P1361, DOI 10.1080/17470210903359206; Hacker DJ., 2009, HDB METACOGNITION ED, P154, DOI [10.4324/9780203876428, DOI 10.4324/9780203876428]; Hanley JR, 2004, Q J EXP PSYCHOL-A, V57, P1393, DOI 10.1080/02724980343000819; Hatcher J, 2002, BRIT J EDUC PSYCHOL, V72, P119, DOI 10.1348/000709902158801; Job JM, 2012, CONTEMP EDUC PSYCHOL, V37, P162, DOI 10.1016/j.cedpsych.2011.05.001; Kirby JR, 2008, J LEARN DISABIL-US, V41, P85, DOI 10.1177/0022219407311040; Kleijnen R., 2008, DIAGNOSE BEHANDELING; Kruger J, 1999, J PERS SOC PSYCHOL, V77, P1121, DOI 10.1037/0022-3514.77.6.1121; Kruger J, 2002, J PERS SOC PSYCHOL, V82, P189, DOI 10.1037//0022-3514.82.2.189; LINDGREN SD, 1985, CHILD DEV, V56, P1404, DOI 10.1111/j.1467-8624.1985.tb00206.x; LOFTUS GR, 1978, MEM COGNITION, V6, P312, DOI 10.3758/BF03197461; Maniscalco B, 2012, CONSCIOUS COGN, V21, P422, DOI 10.1016/j.concog.2011.09.021; Mason A, 2005, PEDIATR CLIN N AM, V52, P61, DOI 10.1016/j.pcl.2004.11.001; Mortimore T, 2006, STUD HIGH EDUC, V31, P235, DOI 10.1080/03075070600572173; Perfect T. J., 2002, APPL METACOGNITION; Pressley M., 2006, METACOGN LEARN, V1, P99, DOI [10.1007/s11409-006-7263-7, DOI 10.1007/S11409-006-7263-7]; Rose LT, 2012, MIND BRAIN EDUC, V6, P1, DOI 10.1111/j.1751-228X.2011.01135.x; Schneider W, 2008, MIND BRAIN EDUC, V2, P114, DOI 10.1111/j.1751-228X.2008.00041.x; Sideridis GD, 2006, J LEARN DISABIL-US, V39, P215, DOI 10.1177/00222194060390030301; Son LK, 2012, EDUC PSYCHOL REV, V24, P379, DOI 10.1007/s10648-012-9206-y; Szmalec A, 2011, J EXP PSYCHOL LEARN, V37, P1270, DOI 10.1037/a0023820; Tops W, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064484; Tops W, 2012, ANN DYSLEXIA, V62, P186, DOI 10.1007/s11881-012-0072-6; Trainin G, 2005, LEARN DISABILITY Q, V28, P261, DOI 10.2307/4126965; van den Bos K, 1999, KLEPEL VORM A B TEST; Vanderswalmen R, 2010, TRENDS AND PROSPECTS IN METACOGNITION RESEARCH, P367, DOI 10.1007/978-1-4419-6546-2_17; Vaughn S., 2003, LEARNING DISABILITIE, V18, P137, DOI [10.1111/1540-5826.00070, DOI 10.1111/1540-5826.00070]; Weinert F.E., 1987, METACOGNITION MOTIVA, P65; Winne PH, 1998, EDUC PSYCHOL SER, P277; Wong BYL, 1996, ADCS LEARNING DISABI; Zhang L. J., 2001, LANG AWARE, V10, P268, DOI DOI 10.1080/09658410108667039	52	4	4	1	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2014	9	9							e106550	10.1371/journal.pone.0106550	http://dx.doi.org/10.1371/journal.pone.0106550			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AZ1IR	25192428	Green Submitted, Green Published, gold			2022-12-27	WOS:000347993600035
J	Cholley, P; Ka, R; Guyeux, C; Thouverez, M; Guessennd, N; Ghebremedhin, B; Frank, T; Bertrand, X; Hocquet, D				Cholley, Pascal; Ka, Roughyatou; Guyeux, Christophe; Thouverez, Michelle; Guessennd, Nathalie; Ghebremedhin, Beniam; Frank, Thierry; Bertrand, Xavier; Hocquet, Didier			Population Structure of Clinical Pseudomonas aeruginosa from West and Central African Countries	PLOS ONE			English	Article							FIELD GEL-ELECTROPHORESIS; EXTENDED-SPECTRUM OXACILLINASES; METALLO-BETA-LACTAMASE; MOLECULAR EPIDEMIOLOGY; RESISTANCE MECHANISMS; STRAINS; HOSPITALS; IDENTIFICATION; OUTBREAK; FRANCE	Background: Pseudomonas aeruginosa (PA) has a non-clonal, epidemic population with a few widely distributed and frequently encountered sequence types (STs) called 'high-risk clusters'. Clinical P. aeruginosa (clinPA) has been studied in all inhabited continents excepted in Africa, where a very few isolates have been analyzed. Here, we characterized a collection of clinPA isolates from four countries of West and Central Africa. Methodology: 184 non-redundant isolates of clinPA from hospitals of Senegal, Ivory Coast, Nigeria, and Central African Republic were genotyped by MLST. We assessed their resistance level to antibiotics by agar diffusion and identified the extended-spectrum beta-lactamases (ESBLs) and metallo-beta-lactamases (MBLs) by sequencing. The population structure of the species was determined by a nucleotide-based analysis of the entire PA MLST database and further localized on the phylogenetic tree (i) the sequence types (STs) of the present collection, (ii) the STs by continents, (iii) ESBL- and MBL-producing STs from the MLST database. Principal Findings: We found 80 distinct STs, of which 24 had no relationship with any known STs. 'High-risk' international clonal complexes (CC155, CC244, CC235) were frequently found in West and Central Africa. The five VIM-2-producing isolates belonged to CC233 and CC244. GES-1 and GES-9 enzymes were produced by one CC235 and one ST1469 isolate, respectively. We showed the spread of 'high-risk' international clonal complexes, often described as multidrug-resistant on other continents, with a fully susceptible phenotype. The MBL- and ESBL-producing STs were scattered throughout the phylogenetic tree and our data suggest a poor association between a continent and a specific phylogroup. Conclusions: ESBL-and MBL-encoding genes are borne by both successful international clonal complexes and distinct local STs in clinPA of West and Central Africa. Furthermore, our data suggest that the spread of a ST could be either due to its antibiotic resistance or to features independent from the resistance to antibiotics.	[Cholley, Pascal; Thouverez, Michelle; Bertrand, Xavier; Hocquet, Didier] Univ Franche Comte, Ctr Hosp Univ, UMR 6249 CNRS Chronoenvironnement, Lab Hyg Hosp, F-25030 Besancon, France; [Ka, Roughyatou] Ctr Hosp Natl Univ Fann, Lab Bacteriol, Dakar, Senegal; [Guyeux, Christophe] Univ Franche Comte, CNRS, UMR 6174, Dept Informat Syst Complexes, Belfort, France; [Guessennd, Nathalie] Inst Pasteur, Abidjan, Cote Ivoire; [Ghebremedhin, Beniam] Otto Von Guericke Univ, Magdeburg, Germany; [Frank, Thierry] Inst Pasteur, Bangui, Cent Afr Republ; [Hocquet, Didier] CHU Besancon, Ctr Ressources Biol Ferdinand Cabanne Filiere Mic, F-25030 Besancon, France	Universite de Franche-Comte; CHU Besancon; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute for Engineering & Systems Sciences (INSIS); Universite de Franche-Comte; Universite de Technologie de Belfort-Montbeliard (UTBM); Otto von Guericke University; Universite de Franche-Comte; CHU Besancon	Hocquet, D (corresponding author), Univ Franche Comte, Ctr Hosp Univ, UMR 6249 CNRS Chronoenvironnement, Lab Hyg Hosp, F-25030 Besancon, France.	dhocquet@chu-besancon.fr	Guyeux, Christophe/C-2153-2011; Bertrand, Xavier/AAL-3809-2021; Ghebremedhin, Beniam/AAX-3103-2021; Hocquet, Didier/AAK-9107-2020; Bertrand, Xavier/AAK-3270-2021	Guyeux, Christophe/0000-0003-0195-4378; Hocquet, Didier/0000-0002-4192-7238; Bertrand, Xavier/0000-0002-8028-1396	University Hospital of Besancon (Delegation a la Recherche Clinique et l'Innovation, Commission des Examens de Laboratoire et d'Innovation Analytique, project P. aeruginosa in Sub-Saharan Africa)	University Hospital of Besancon (Delegation a la Recherche Clinique et l'Innovation, Commission des Examens de Laboratoire et d'Innovation Analytique, project P. aeruginosa in Sub-Saharan Africa)	PC, MT, XB and XB were granted by the University Hospital of Besancon (Delegation a la Recherche Clinique et l'Innovation, Commission des Examens de Laboratoire et d'Innovation Analytique, project P. aeruginosa in Sub-Saharan Africa 2012). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Breidenstein EBM, 2011, TRENDS MICROBIOL, V19, P419, DOI 10.1016/j.tim.2011.04.005; Cabot G, 2012, ANTIMICROB AGENTS CH, V56, P6349, DOI 10.1128/AAC.01388-12; Cholley P, 2011, J CLIN MICROBIOL, V49, P2578, DOI 10.1128/JCM.00102-11; Curran B, 2004, J CLIN MICROBIOL, V42, P5644, DOI 10.1128/JCM.42.12.5644-5649.2004; DEFLAUN MF, 1990, APPL ENVIRON MICROB, V56, P112, DOI 10.1128/AEM.56.1.112-119.1990; Edelstein MV, 2013, LANCET INFECT DIS, V13, P867, DOI 10.1016/S1473-3099(13)70168-3; Empel J, 2007, J CLIN MICROBIOL, V45, P2829, DOI 10.1128/JCM.00997-07; Fernandez-Olmos A, 2013, J CLIN MICROBIOL, V51, P2761, DOI 10.1128/JCM.00802-13; Fournier D, 2013, J ANTIMICROB CHEMOTH, V68, P1772, DOI 10.1093/jac/dkt098; Garcia-Castillo M, 2012, J CLIN MICROBIOL, V50, P1777, DOI 10.1128/JCM.05478-11; Garcia-Castillo M, 2011, J CLIN MICROBIOL, V49, P2905, DOI 10.1128/JCM.00753-11; Hocquet D, 2003, ANTIMICROB AGENTS CH, V47, P1887, DOI 10.1128/AAC.47.6.1887-1894.2003; Hocquet D, 2011, J CLIN MICROBIOL, V49, P2262, DOI 10.1128/JCM.02585-10; Hocquet D, 2010, ANTIMICROB AGENTS CH, V54, P3512, DOI 10.1128/AAC.01646-09; Huson DH, 2012, SYST BIOL, V61, P1061, DOI 10.1093/sysbio/sys062; Jeannot K, 2013, J ANTIMICROB CHEMOTH, V68, P2952, DOI 10.1093/jac/dkt296; Jolley KA, 2001, BIOINFORMATICS, V17, P1230, DOI 10.1093/bioinformatics/17.12.1230; Jolley KA, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-595; Kung VL, 2010, MICROBIOL MOL BIOL R, V74, P621, DOI 10.1128/MMBR.00027-10; Libisch B, 2009, CURR MICROBIOL, V58, P111, DOI 10.1007/s00284-008-9285-7; Lopez-Causape C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071001; Lyczak JB, 2000, MICROBES INFECT, V2, P1051, DOI 10.1016/S1286-4579(00)01259-4; Maatallah M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025617; Magiorakos AP, 2012, CLIN MICROBIOL INFEC, V18, P268, DOI 10.1111/j.1469-0691.2011.03570.x; Mesaros N, 2007, CLIN MICROBIOL INFEC, V13, P560, DOI 10.1111/j.1469-0691.2007.01681.x; Mulet M, 2010, ENVIRON MICROBIOL, V12, P1513, DOI 10.1111/j.1462-2920.2010.02181.x; Perez-Losada M, 2013, INFECT GENET EVOL, V16, P38, DOI 10.1016/j.meegid.2013.01.009; Pirnay JP, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007740; Poirel L, 2005, ANTIMICROB AGENTS CH, V49, P3593, DOI 10.1128/AAC.49.8.3593-3597.2005; Poole K, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00065; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Pournaras S, 2013, J ANTIMICROB CHEMOTH, V68, P1271, DOI 10.1093/jac/dkt004; Samuelsen O, 2010, ANTIMICROB AGENTS CH, V54, P346, DOI 10.1128/AAC.00824-09; Santella G, 2010, J CLIN MICROBIOL, V48, P4342, DOI 10.1128/JCM.00614-10; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Talon D, 1996, J HOSP INFECT, V32, P135, DOI 10.1016/S0195-6701(96)90055-9; TENOVER FC, 1995, J CLIN MICROBIOL, V33, P2233, DOI 10.1128/JCM.33.9.2233-2239.1995; University of Oxford, PSEUD AER MLST DAT; Van Mansfeld R, 2009, J CLIN MICROBIOL, V47, P4096, DOI 10.1128/JCM.01462-09; Vatcheva-Dobrevska R, 2013, MICROB DRUG RESIST, V19, P355, DOI 10.1089/mdr.2013.0004; Viedma E, 2009, ANTIMICROB AGENTS CH, V53, P4930, DOI 10.1128/AAC.00900-09; Walsh TR, 2010, INT J ANTIMICROB AG, V36, pS8, DOI 10.1016/S0924-8579(10)70004-2; Wiehlmann L, 2007, P NATL ACAD SCI USA, V104, P8101, DOI 10.1073/pnas.0609213104; Wieser A, 2012, APPL MICROBIOL BIOT, V93, P965, DOI 10.1007/s00253-011-3783-4; Woodford N, 2011, FEMS MICROBIOL REV, V35, P736, DOI 10.1111/j.1574-6976.2011.00268.x	45	20	20	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 4	2014	9	9							e107008	10.1371/journal.pone.0107008	http://dx.doi.org/10.1371/journal.pone.0107008			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3XV	25187957	Green Published, gold, Green Submitted			2022-12-27	WOS:000341271500106
J	Gong, T; Lundholm, C; Rejno, G; Mood, C; Langstrom, N; Almqvist, C				Gong, Tong; Lundholm, Cecilia; Rejno, Gustaf; Mood, Carina; Langstrom, Niklas; Almqvist, Catarina			Parental Socioeconomic Status, Childhood Asthma and Medication Use - A Population-Based Study	PLOS ONE			English	Article							ENVIRONMENTAL EXPOSURE; HEALTH; SENSITIZATION; ADHERENCE; SEVERITY; RHINITIS; FAMILY; IMPACT; INCOME; COHORT	Background: Little is known about how parental socioeconomic status affects offspring asthma risk in the general population, or its relation to healthcare and medication use among diagnosed children. Methods: This register-based cohort study included 211,520 children born between April 2006 and December 2008 followed until December 2010. Asthma diagnoses were retrieved from the National Patient Register, and dispensed asthma medications from the Prescribed Drug Register. Parental socioeconomic status (income and education) were retrieved from Statistics Sweden. The associations between parental socioeconomic status and outcomes were estimated by Cox proportional hazard regression. Results: Compared to the highest parental income level, children exposed to all other levels had increased risk of asthma during their first year of life (e.g. hazard ratio, HR 1.19, 95% confidence interval, CI 1.09-1.31 for diagnosis and HR 1.17, 95% CI 1.08-1.26 for medications for the lowest quintile) and the risk was decreased after the first year, especially among children from the lowest parental income quintile (HR 0.84, 95% CI 0.77-0.92 for diagnosis, and HR 0.80, 95% CI 0.74-0.86 for medications). Further, compared to children with college-educated parents, those whose parents had lower education had increased risk of childhood asthma regardless of age. Children with the lowest parental education had increased risk of an inpatient (HR 2.07, 95% CI 1.61-2.65) and outpatient (HR 1.32, 95% CI 1.18-1.47) asthma diagnosis. Among diagnosed children, those from families with lower education used fewer controller medications than those whose parents were college graduates. Conclusions: Our findings indicate an age-varying association between parental income and childhood asthma and consistent inverse association regardless of age between parental education and asthma incidence, dispensed controller medications and inpatient care which should be further investigated and remedied.	[Gong, Tong; Lundholm, Cecilia; Rejno, Gustaf; Langstrom, Niklas; Almqvist, Catarina] Karolinska Inst, Dept Med Epidemiol & Biostat, Stockholm, Sweden; [Mood, Carina] Stockholm Univ, Swedish Inst Social Res, S-10691 Stockholm, Sweden; [Almqvist, Catarina] Karolinska Univ Hosp, Astrid Lindgren Childrens Hosp, Lung & Allergy Unit, Stockholm, Sweden	Karolinska Institutet; Stockholm University; Karolinska Institutet; Karolinska University Hospital	Gong, T (corresponding author), Karolinska Inst, Dept Med Epidemiol & Biostat, Stockholm, Sweden.	tong.gong@ki.se	Rejnö, Gustaf/N-7198-2014; Langstrom, Niklas/C-5615-2009; Gong, Tong/HDM-8653-2022	Rejnö, Gustaf/0000-0002-8095-5629; Langstrom, Niklas/0000-0002-2686-6799; Lundholm, Cecilia/0000-0002-6546-3650	Swedish Research Council [2011-3060]; Swedish Initiative for Research on Microdata in the Social And Medical Sciences (SIMSAM) [340-2013-5867]; Swedish Heart Lung foundation; Strategic Research Program in Epidemiology at Karolinska Institutet; Stockholm County Council; Karolinska Institutet	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Initiative for Research on Microdata in the Social And Medical Sciences (SIMSAM); Swedish Heart Lung foundation(Swedish Heart-Lung Foundation); Strategic Research Program in Epidemiology at Karolinska Institutet; Stockholm County Council(Stockholm County Council); Karolinska Institutet(Karolinska Institutet)	Financial support was provided from the Swedish Research Council (grant no 2011-3060) and through the Swedish Initiative for Research on Microdata in the Social And Medical Sciences (SIMSAM) framework grant no 340-2013-5867, the Swedish Heart Lung foundation, the Strategic Research Program in Epidemiology at Karolinska Institutet, and through the regional agreement on medical training and clinical research (ALF) between Stockholm County Council and Karolinska Institutet. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almqvist C, 2005, CLIN EXP ALLERGY, V35, P612, DOI 10.1111/j.1365-2222.2005.02243.x; [Anonymous], 2012, TAX SWED ENGL SUMM T; [Anonymous], DISP INC PER CONS WE; Asher MI, 2006, LANCET, V368, P733, DOI 10.1016/S0140-6736(06)69283-0; Bateman ED, 2008, EUR RESPIR J, V31, P143, DOI 10.1183/09031936.00138707; Bloomberg GR, 2009, PEDIATRICS, V123, P829, DOI 10.1542/peds.2008-0504; Braback L, 2005, EUR RESPIR J, V26, P1064, DOI 10.1183/09031936.05.00022105; Braman SS, 2006, CHEST, V130, p4S, DOI 10.1378/chest.130.1_suppl.4S; Braun-Fahrlander C, 2002, NEW ENGL J MED, V347, P869, DOI 10.1056/NEJMoa020057; Braveman PA, 2005, JAMA-J AM MED ASSOC, V294, P2879, DOI 10.1001/jama.294.22.2879; Cesaroni G, 2003, EUR RESPIR J, V22, P619, DOI 10.1183/09031936.03.00091202; Crighton EJ, 2010, INT J CIRCUMPOL HEAL, V69, P138, DOI 10.3402/ijch.v69i2.17435; Curtis LM, 2012, J ASTHMA, V49, P178, DOI 10.3109/02770903.2011.648297; Drotar D, 2009, J DEV BEHAV PEDIATR, V30, P574, DOI 10.1097/DBP.0b013e3181c3c3bb; FERGUSSON DM, 1986, J EPIDEMIOL COMMUN H, V40, P50, DOI 10.1136/jech.40.1.50; Fiks AG, 2010, PEDIATRICS, V126, P306, DOI 10.1542/peds.2010-0526; Fleming L, 2007, CURR OPIN ALLERGY CL, V7, P190, DOI 10.1097/ACI.0b013e3280895d0c; Greenland S, 1999, EPIDEMIOLOGY, V10, P37, DOI 10.1097/00001648-199901000-00008; Hafkamp-de Groen E, 2012, J EPIDEMIOL COMMUN H, V66, P1017, DOI 10.1136/jech-2011-200333; Halldorsson M, 2002, J EPIDEMIOL COMMUN H, V56, P200, DOI 10.1136/jech.56.3.200; Hancox RJ, 2004, THORAX, V59, P376, DOI 10.1136/thx.2003.010363; Kozyrskyj AL, 2010, AM J PUBLIC HEALTH, V100, P540, DOI 10.2105/AJPH.2008.150771; Kull I, 2002, ARCH DIS CHILD, V87, P478, DOI 10.1136/adc.87.6.478; Lindbaek M, 2003, EUR RESPIR J, V21, P105, DOI 10.1183/09031936.02.00241802; Mangrio E, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-891; Martel MJ, 2009, AM J EPIDEMIOL, V169, P195, DOI 10.1093/aje/kwn309; Melen E, 2001, ALLERGY, V56, P646, DOI 10.1034/j.1398-9995.2001.00387.x; Midodzi WK, 2010, J ASTHMA, V47, P7, DOI 10.3109/02770900903380996; Mielck A, 1996, INT J EPIDEMIOL, V25, P388, DOI 10.1093/ije/25.2.388; MITCHELL EA, 1989, INT J EPIDEMIOL, V18, P888, DOI 10.1093/ije/18.4.888; Morse RB, 2011, JAMA-J AM MED ASSOC, V306, P1454, DOI 10.1001/jama.2011.1385; Ortqvist AK, 2013, PHARMACOEPIDEM DR S, V22, P850, DOI 10.1002/pds.3465; Osterberg L, 2005, NEW ENGL J MED, V353, P487, DOI 10.1056/NEJMra050100; Poyser MA, 2002, EUR RESPIR J, V19, P892, DOI 10.1183/09031936.02.00238402; Riksbanken, ANN AV EXCH RAT AGGR; Rona RJ, 2000, THORAX, V55, P239, DOI 10.1136/thorax.55.3.239; Seguin L, 2005, J EPIDEMIOL COMMUN H, V59, P42, DOI 10.1136/jech.2004.020438; Seguin L, 2007, PEDIATRICS, V119, pE1063, DOI 10.1542/peds.2006-1750; Socialstyrelsen, 2004, GUID CAR ASTHM CHRON; Socialstyrelsen, 2005, MED BIRTH REG 2003; Spencer N, 2005, J EPIDEMIOL COMMUN H, V59, P842, DOI 10.1136/jech.2005.036301; The Dental and Pharmaceutical Benefits Agency, 2007, SWED PHARM REIMB SYS; To T, 2010, AM J RESP CRIT CARE, V181, P337, DOI 10.1164/rccm.200907-1035OC; Ungar WJ, 2011, ANN ALLERG ASTHMA IM, V106, P17, DOI 10.1016/j.anai.2010.10.006; Violato M, 2009, SOC SCI MED, V69, P955, DOI 10.1016/j.socscimed.2009.06.036; Wallby T, 2011, ACTA PAEDIATR, V100, P1495, DOI 10.1111/j.1651-2227.2011.02344.x	46	48	48	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 4	2014	9	9							e106579	10.1371/journal.pone.0106579	http://dx.doi.org/10.1371/journal.pone.0106579			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AO3XV	25188036	gold, Green Published			2022-12-27	WOS:000341271500058
J	Hudson, WH; Youn, C; Ortlund, EA				Hudson, William H.; Youn, Christine; Ortlund, Eric A.			Crystal Structure of the Mineralocorticoid Receptor DNA Binding Domain in Complex with DNA	PLOS ONE			English	Article							GLUCOCORTICOID-RECEPTOR; PROGESTERONE-RECEPTOR; MESSENGER-RNAS; CROSS-TALK; MUTATIONS; ESTROGEN; ACID; LOCALIZATION; ALDOSTERONE; MECHANISMS	The steroid hormone receptors regulate important physiological functions such as reproduction, metabolism, immunity, and electrolyte balance. Mutations within steroid receptors result in endocrine disorders and can often drive cancer formation and progression. Despite the conserved three-dimensional structure shared among members of the steroid receptor family and their overlapping DNA binding preference, activation of individual steroid receptors drive unique effects on gene expression. Here, we present the first structure of the human mineralocorticoid receptor DNA binding domain, in complex with a canonical DNA response element. The overall structure is similar to the glucocorticoid receptor DNA binding domain, but small changes in the mode of DNA binding and lever arm conformation may begin to explain the differential effects on gene regulation by the mineralocorticoid and glucocorticoid receptors. In addition, we explore the structural effects of mineralocorticoid receptor DNA binding domain mutations found in type I pseudohypoaldosteronism and multiple types of cancer.	[Hudson, William H.; Youn, Christine; Ortlund, Eric A.] Emory Univ, Sch Med, Dept Biochem, Atlanta, GA 30322 USA; [Hudson, William H.; Youn, Christine; Ortlund, Eric A.] Emory Univ, Sch Med, Winship Canc Inst, Atlanta, GA USA	Emory University; Emory University	Ortlund, EA (corresponding author), Emory Univ, Sch Med, Dept Biochem, Atlanta, GA 30322 USA.	eortlun@emory.edu	Hudson, William/E-6622-2012; Ortlund, Eric Anthony/F-4672-2014; Ortlund, Eric Anthony/P-3121-2019	Hudson, William/0000-0002-2513-1213; Ortlund, Eric Anthony/0000-0001-8855-3029; Ortlund, Eric Anthony/0000-0001-8855-3029; Youn, Christine/0000-0002-0022-2848	AHA [13PRE16920012]; NIH [5T32GM008602-14]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008602] Funding Source: NIH RePORTER	AHA(American Heart Association); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the AHA 13PRE16920012 and NIH 5T32GM008602-14. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Arora VK, 2013, CELL, V155, P1309, DOI 10.1016/j.cell.2013.11.012; Barnes PJ, 1998, CLIN SCI, V94, P557, DOI 10.1042/cs0940557; Berger S, 1998, P NATL ACAD SCI USA, V95, P9424, DOI 10.1073/pnas.95.16.9424; Boyer M, 2000, NUCLEIC ACIDS RES, V28, P2494, DOI 10.1093/nar/28.13.2494; Bridgham JT, 2006, SCIENCE, V312, P97, DOI 10.1126/science.1123348; CALDENHOVEN E, 1995, MOL ENDOCRINOL, V9, P401, DOI 10.1210/me.9.4.401; Caprio M, 2008, CIRC RES, V102, P1359, DOI 10.1161/CIRCRESAHA.108.174235; Cerami E, 2012, CANCER DISCOV, V2, P401, DOI 10.1158/2159-8290.CD-12-0095; Chantong B, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-260; Daniel AR, 2011, EXPERT REV ENDOCRINO, V6, P359, DOI 10.1586/EEM.11.25; DeRijk RH, 2006, J CLIN ENDOCR METAB, V91, P5083, DOI 10.1210/jc.2006-0915; Di Fabio F, 2007, J GASTROINTEST SURG, V11, P1521, DOI 10.1007/s11605-007-0234-8; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Falkenstein E, 2000, PHARMACOL REV, V52, P513; Faresse N, 2014, J STEROID BIOCHEM, V143, P334, DOI 10.1016/j.jsbmb.2014.04.015; Fuse H, 2000, MOL ENDOCRINOL, V14, P889, DOI 10.1210/me.14.6.889; Gao JJ, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004088; Geller DS, 2000, SCIENCE, V289, P119, DOI 10.1126/science.289.5476.119; HERMAN JP, 1989, MOL ENDOCRINOL, V3, P1886, DOI 10.1210/mend-3-11-1886; Hudson WH, 2013, NAT STRUCT MOL BIOL, V20, P53, DOI 10.1038/nsmb.2456; Ivanes F, 2012, EUR HEART J, V33, P191, DOI 10.1093/eurheartj/ehr176; Jeong Y, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000378; Joels M, 2008, TRENDS NEUROSCI, V31, P1, DOI 10.1016/j.tins.2007.10.005; John S, 2011, NAT GENET, V43, P264, DOI 10.1038/ng.759; Kim S, 2013, SCIENCE, V339, P816, DOI 10.1126/science.1229223; Kino T, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000568; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Leo JCL, 2004, ENDOCRINOLOGY, V145, P1314, DOI 10.1210/en.2003-0732; Liang J, 2013, ANNU REV PHYSIOL, V75, P225, DOI 10.1146/annurev-physiol-030212-183708; Liu WH, 1995, P NATL ACAD SCI USA, V92, P12480, DOI 10.1073/pnas.92.26.12480; LOMBES M, 1992, CIRC RES, V71, P503, DOI 10.1161/01.RES.71.3.503; Lonergan Peter E, 2011, J Carcinog, V10, P20, DOI 10.4103/1477-3163.83937; Lu XJ, 2003, NUCLEIC ACIDS RES, V31, P5108, DOI 10.1093/nar/gkg680; MARVER D, 1974, P NATL ACAD SCI USA, V71, P1431, DOI 10.1073/pnas.71.4.1431; McGraw AP, 2013, CURR ATHEROSCLER REP, V15, DOI 10.1007/s11883-013-0340-x; Meijsing SH, 2009, SCIENCE, V324, P407, DOI 10.1126/science.1164265; MUNE T, 1995, NAT GENET, V10, P394, DOI 10.1038/ng0895-394; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pitt B, 1999, NEW ENGL J MED, V341, P709, DOI 10.1056/NEJM199909023411001; Pujo L, 2007, HUM MUTAT, V28, P33, DOI 10.1002/humu.20371; Rastinejad F, 2013, J MOL ENDOCRINOL, V51, pT1, DOI 10.1530/JME-13-0173; Reddy TE, 2009, GENOME RES, V19, P2163, DOI 10.1101/gr.097022.109; Rickard AJ, 2012, HYPERTENSION, V60, P1443, DOI 10.1161/HYPERTENSIONAHA.112.203158; Sartorato P, 2004, MOL ENDOCRINOL, V18, P2151, DOI 10.1210/me.2003-0408; Sartorato P, 2003, J CLIN ENDOCR METAB, V88, P2508, DOI 10.1210/jc.2002-021932; SCHENA M, 1989, GENE DEV, V3, P1590, DOI 10.1101/gad.3.10.1590; SCHWABE JWR, 1993, CELL, V75, P567, DOI 10.1016/0092-8674(93)90390-C; Sherry ST, 2001, NUCLEIC ACIDS RES, V29, P308, DOI 10.1093/nar/29.1.308; Surjit M, 2011, CELL, V145, P224, DOI 10.1016/j.cell.2011.03.027; Thomas-Chollier M, 2013, P NATL ACAD SCI USA, V110, P17826, DOI 10.1073/pnas.1316235110; Tiberio L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059410; TSAI MJ, 1994, ANNU REV BIOCHEM, V63, P451, DOI 10.1146/annurev.bi.63.070194.002315; Ueda K, 2014, BIOCHEM BIOPH RES CO, V445, P132, DOI 10.1016/j.bbrc.2014.01.125; VANEEKELEN JAM, 1988, J NEUROSCI RES, V21, P88, DOI 10.1002/jnr.490210113; Vilasco M, 2011, BREAST CANCER RES TR, V130, P1, DOI 10.1007/s10549-011-1689-6; Walther RF, 2005, J BIOL CHEM, V280, P17549, DOI 10.1074/jbc.M501548200; Watson LC, 2013, NAT STRUCT MOL BIOL, V20, P876, DOI 10.1038/nsmb.2595; Young MJ, 2008, CURR OPIN NEPHROL HY, V17, P174, DOI 10.1097/MNH.0b013e3282f56854; ZILLIACUS J, 1994, P NATL ACAD SCI USA, V91, P4175, DOI 10.1073/pnas.91.10.4175	60	29	29	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 4	2014	9	9							e107000	10.1371/journal.pone.0107000	http://dx.doi.org/10.1371/journal.pone.0107000			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3XV	25188500	Green Published, gold, Green Submitted			2022-12-27	WOS:000341271500105
J	Kelsey, L; Katoch, P; Ray, A; Mitra, S; Chakraborty, S; Lin, MF; Mehta, PP				Kelsey, Linda; Katoch, Parul; Ray, Anuttoma; Mitra, Shalini; Chakraborty, Souvik; Lin, Ming-Fong; Mehta, Parmender P.			Vitamin D-3 Regulates the Formation and Degradation of Gap Junctions in Androgen-Responsive Human Prostate Cancer Cells	PLOS ONE			English	Article							RETINOIC ACID; 1-ALPHA,25-DIHYDROXYVITAMIN D-3; INTERCELLULAR COMMUNICATION; INTRAEPITHELIAL NEOPLASIA; TRANSFORMED-CELLS; GROWTH-INHIBITION; CARCINOMA-CELLS; TIGHT JUNCTIONS; E-CADHERIN; 1,25-DIHYDROXYVITAMIN D-3	1 alpha-25(OH)(2) vitamin D-3 (1-25D), an active hormonal form of Vitamin D-3, is a well-known chemopreventive and pro-differentiating agent. It has been shown to inhibit the growth of several prostate cancer cell lines. Gap junctions, formed of proteins called connexins (Cx), are ensembles of cell-cell channels, which permit the exchange of small growth regulatory molecules between adjoining cells. Cell-cell communication mediated by gap junctional channels is an important homeostatic control mechanism for regulating cell growth and differentiation. We have investigated the effect of 1-25D on the formation and degradation of gap junctions in an androgen-responsive prostate cancer cell line, LNCaP, which expresses retrovirally-introduced Cx32. Connexin32 is expressed by the luminal and well-differentiated cells of normal prostate and prostate tumors. Our results document that 1-25D enhances the expression of Cx32 and its subsequent assembly into gap junctions. Our results further show that 1-25D prevents androgen-regulated degradation of Cx32, post-translationally, independent of androgen receptor (AR)-mediated signaling. Finally, our findings document that formation of gap junctions sensitizes Cx32-expressing LNCaP cells to the growth inhibitory effects of 1-25D and alters their morphology. These findings suggest that the growth-inhibitory effects of 1-25D in LNCaP cells may be related to its ability to modulate the assembly of Cx32 into gap junctions.	[Kelsey, Linda; Katoch, Parul; Ray, Anuttoma; Mitra, Shalini; Chakraborty, Souvik; Lin, Ming-Fong; Mehta, Parmender P.] Univ Nebraska Med Ctr, Dept Biochem & Mol Biol, Omaha, NE 68198 USA	University of Nebraska System; University of Nebraska Medical Center	Mehta, PP (corresponding author), Univ Nebraska Med Ctr, Dept Biochem & Mol Biol, Omaha, NE 68198 USA.	pmehta@unmc.edu			National Institutes of Health [CA113903]; DOD PCRP [PC-081198, PC-111867]; Nebraska State Grant [LB506, R01DE12308]; NATIONAL CANCER INSTITUTE [R01CA113903] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE012308] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); DOD PCRP; Nebraska State Grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This research was supported by National Institutes of Health CA113903, DOD PCRP PC-081198 and PC-111867, Nebraska State Grant LB506 and R01DE12308. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abate-Shen C, 2000, GENE DEV, V14, P2410, DOI 10.1101/gad.819500; Aboseif SR, 1997, PROSTATE, V31, P161; Ahn J, 2008, JNCI-J NATL CANCER I, V100, P796, DOI 10.1093/jnci/djn152; Banach-Petrosky W, 2006, CLIN CANCER RES, V12, P5895, DOI 10.1158/1078-0432.CCR-06-1039; Bertram JS, 1999, NUTR REV, V57, P182, DOI 10.1111/j.1753-4887.1999.tb06941.x; Beyer Eric C., 2009, P3, DOI 10.1007/978-1-59745-489-6_1; Blutt SE, 1997, ENDOCRINOLOGY, V138, P1491, DOI 10.1210/en.138.4.1491; Bosco D, 2011, PHYSIOL REV, V91, P1393, DOI 10.1152/physrev.00027.2010; Bostwick DG, 2004, MODERN PATHOL, V17, P360, DOI 10.1038/modpathol.3800053; BOSTWICK DG, 1992, J CELL BIOCHEM, P10; Chakraborty S, 2010, J BIOL CHEM, V285, P10761, DOI 10.1074/jbc.M109.053348; CHEN SC, 1995, CELL GROWTH DIFFER, V6, P681; Christov KT, 2002, CANCER RES, V62, P5178; Crespin Sophie, 2009, P529, DOI 10.1007/978-1-59745-489-6_27; CUNHA GR, 1987, ENDOCR REV, V8, P338, DOI 10.1210/edrv-8-3-338; Deeb KK, 2007, NAT REV CANCER, V7, P684, DOI 10.1038/nrc2196; Farla P, 2005, J CELL SCI, V118, P4187, DOI 10.1242/jcs.02546; Fleet JC, 2012, BIOCHEM J, V441, P61, DOI 10.1042/BJ20110744; Francis R, 2012, PLOS ONE, V6, P1; GLOVER JF, 1988, CANCER RES, V48, P3693; Goodenough DA, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a002576; Govindarajan R, 2002, J BIOL CHEM, V277, P50087, DOI 10.1074/jbc.M202652200; Govindarajan R, 2010, MOL BIOL CELL, V21, P4089, DOI 10.1091/mbc.E10-05-0403; Habermann H, 2002, J UROLOGY, V167, P655, DOI 10.1016/S0022-5347(01)69118-3; Habermann H, 2001, ENDOCRINOLOGY, V142, P359, DOI 10.1210/en.142.1.359; Hirschi KK, 1996, CELL GROWTH DIFFER, V7, P861; Igawa T, 2002, PROSTATE, V50, P222, DOI 10.1002/pros.10054; Iversen P, 2002, UROLOGY, V60, P64, DOI 10.1016/S0090-4295(02)01576-5; Johnson KE, 2013, MOL BIOL CELL, V24, P715, DOI 10.1091/mbc.E12-07-0537; Kardami E, 2007, PROG BIOPHYS MOL BIO, V94, P245, DOI 10.1016/j.pbiomolbio.2007.03.009; Kelsey L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032846; Kemppainen JA, 1996, UROLOGY, V48, P157, DOI 10.1016/S0090-4295(96)00117-3; King TJ, 2005, BBA-BIOMEMBRANES, V1719, P146, DOI 10.1016/j.bbamem.2005.08.012; King TJ, 2004, CARCINOGENESIS, V25, P669, DOI 10.1093/carcin/bgh071; King TJ, 2005, CELL COMMUN ADHES, V12, P293, DOI 10.1080/15419060500514168; King TJ, 2005, ONCOGENE, V24, P1718, DOI 10.1038/sj.onc.1208355; Kojima T, 2001, EXP CELL RES, V263, P193, DOI 10.1006/excr.2000.5103; Kojima T, 2002, EXP CELL RES, V276, P40, DOI 10.1006/excr.2002.5511; Kojima T, 2007, J MEMBRANE BIOL, V217, P13, DOI 10.1007/s00232-007-9021-4; Kokai Y, 2011, J MEMBRANE BIOL, V217, P13; Konety BR, 1996, CELL GROWTH DIFFER, V7, P1563; Krishnan AV, 2010, ENDOCR-RELAT CANCER, V17, pR19, DOI 10.1677/ERC-09-0139; Laird DW, 2010, TRENDS CELL BIOL, V20, P92, DOI 10.1016/j.tcb.2009.11.001; Laird DW, 2006, BIOCHEM J, V394, P527, DOI 10.1042/BJ20051922; Langlois S, 2007, J BIOL CHEM, V282, P30171, DOI 10.1074/jbc.M703623200; Langlois S, 2010, CANCER RES, V70, P4222, DOI 10.1158/0008-5472.CAN-09-3281; LASNITZKI I, 1974, CANCER RES, V34, P1564; LASNITZKI I, 1976, BRIT J CANCER, V34, P239, DOI 10.1038/bjc.1976.158; Lin MF, 1998, J BIOL CHEM, V273, P5939, DOI 10.1074/jbc.273.10.5939; Lin MF, 2000, CELL BIOL INT, V24, P681, DOI 10.1006/cbir.2000.0433; Lokeshwar BL, 1999, CANCER EPIDEM BIOMAR, V8, P241; Manual M, 2006, ANNU REV PHARMACOL, V46, P451; Mao AJ, 2000, J BIOL CHEM, V275, P34407, DOI 10.1074/jbc.M003917200; Marker PC, 2003, DEV BIOL, V253, P165, DOI 10.1016/S0012-1606(02)00031-3; McLachlan E, 2006, CANCER RES, V66, P9886, DOI 10.1158/0008-5472.CAN-05-4302; Mehta P, 1999, DEV GENET, V24, P91, DOI 10.1002/(SICI)1520-6408(1999)24:1/2<91::AID-DVG10>3.0.CO;2-#; MEHTA PP, 1989, J CELL BIOL, V108, P1053, DOI 10.1083/jcb.108.3.1053; MEHTA PP, 1986, CELL, V44, P187, DOI 10.1016/0092-8674(86)90497-6; MEHTA PP, 1991, J CELL BIOL, V113, P371, DOI 10.1083/jcb.113.2.371; Mitra S, 2006, MOL BIOL CELL, V17, P5400, DOI 10.1091/mbc.E06-04-0280; MUSIL LS, 1990, J CELL BIOL, V111, P2077, DOI 10.1083/jcb.111.5.2077; Naus CC, 2010, NAT REV CANCER, V10, P435, DOI 10.1038/nrc2841; Palmer HG, 2001, J CELL BIOL, V154, P369, DOI 10.1083/jcb.200102028; Paluch E, 2009, CURR BIOL, V19, pR790, DOI 10.1016/j.cub.2009.07.029; Peehl DM, 2003, ENDOCR-RELAT CANCER, V10, P131, DOI 10.1677/erc.0.0100131; Plante I, 2011, ONCOGENE, V30, P1681, DOI 10.1038/onc.2010.551; Salbreux G, 2012, TRENDS CELL BIOL, V22, P536, DOI 10.1016/j.tcb.2012.07.001; SCHWARTZ GG, 1990, ANTICANCER RES, V10, P1307; SCHWARTZ GG, 1995, UROLOGY, V46, P365, DOI 10.1016/S0090-4295(99)80221-0; Shen MM, 2010, GENE DEV, V24, P1967, DOI 10.1101/gad.1965810; Shen RQ, 2000, ENDOCRINOLOGY, V141, P1699, DOI 10.1210/en.141.5.1699; SKOWRONSKI RJ, 1993, ENDOCRINOLOGY, V132, P1952, DOI 10.1210/en.132.5.1952; Swami S, 2012, ENDOCRINOLOGY, V153, P2576, DOI 10.1210/en.2011-1600; Swami S, 2011, MOL CELL ENDOCRINOL, V347, P61, DOI 10.1016/j.mce.2011.05.010; Thevenin AF, 2013, PHYSIOLOGY, V28, P93, DOI 10.1152/physiol.00038.2012; Trosko JE, 2006, ANN NY ACAD SCI, V1089, P36, DOI 10.1196/annals.1386.018; Trosko JE, 2007, J MEMBRANE BIOL, V218, P93, DOI 10.1007/s00232-007-9072-6; Trosko JE, 2006, NUTR CANCER, V54, P102, DOI 10.1207/s15327914nc5401_12; Trosko JE, 2001, MUTAT RES-FUND MOL M, V480, P219, DOI 10.1016/S0027-5107(01)00181-6; Vanslyke JK, 2000, MOL BIOL CELL, V11, P1933, DOI 10.1091/mbc.11.6.1933; VanSlyke JK, 2000, METHODS, V20, P156, DOI 10.1006/meth.1999.0933; Vezina CM, 2008, DEV DYNAM, V237, P1321, DOI 10.1002/dvdy.21526; Wang M, 2007, J CELL SCI, V120, P320, DOI 10.1242/jcs.03343; Wei CJ, 2004, ANNU REV CELL DEV BI, V20, P811, DOI 10.1146/annurev.cellbio.19.111301.144309; Xu J, 2013, BBA-BIOMEMBRANES, V1828, P167, DOI 10.1016/j.bbamem.2012.06.024; Yang ES, 2003, J BIOL CHEM, V278, P46862, DOI 10.1074/jbc.M306340200; Yang ES, 2002, MOL CELL ENDOCRINOL, V186, P69, DOI 10.1016/S0303-7207(01)00671-2; Zhao XY, 2000, ENDOCRINOLOGY, V141, P2548, DOI 10.1210/en.141.7.2548; Zhao XY, 1999, ENDOCRINOLOGY, V140, P1205, DOI 10.1210/en.140.3.1205; Zhuang SH, 1998, ENDOCRINOLOGY, V139, P1197, DOI 10.1210/en.139.3.1197; Zhuang SH, 1997, MOL CELL ENDOCRINOL, V126, P83, DOI 10.1016/S0303-7207(96)03974-3	91	13	13	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 4	2014	9	9							e106437	10.1371/journal.pone.0106437	http://dx.doi.org/10.1371/journal.pone.0106437			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3XV	25188420	gold, Green Published, Green Submitted			2022-12-27	WOS:000341271500034
J	Kumar, AS; Bryan, JN; Kumar, SR				Kumar, Ashwath S.; Bryan, Jeffrey N.; Kumar, Senthil R.			Bacterial Quorum Sensing Molecule N-3-Oxo-Dodecanoyl-L-Homoserine Lactone Causes Direct Cytotoxicity and Reduced Cell Motility in Human Pancreatic Carcinoma Cells	PLOS ONE			English	Article							HOMOSERINE LACTONE; EXPRESSION; APOPTOSIS; THERAPY; IQGAP1; GROWTH; CANCER	In spite of chemotherapeutic and surgical advances, pancreatic cancer continues to have a dismal prognosis. Metastasis due to tumor cell migration remains the most critical challenge in treating pancreatic cancer, and conventional chemotherapy is rarely curative. In the quest for more novel molecules to fight this disease, we tested the hypothesis that the Pseudomonas aeruginosa quorum sensing signal molecule N-3-oxo-dodecanoyl-L-homoserine lactone (O-DDHSL) would be cytotoxic to and reduce mobility of pancreatic carcinoma cells (Panc-1 and Aspc-1). Results showed a decrease in cell viability from apoptosis, diminished colony formation, and inhibition of migration of the evaluated pancreatic carcinoma cell lines. Also, cell viability decreased in the presence of O-DDHSL when cells were grown in matrigel basement membrane matrix. While messenger RNA for IQGAP-1 decreased in Panc-1 and HPDE cells upon exposure to O-DDHSL, no change was observed in Aspc-1 cells. Cofilin mRNA expression was found to be increased in both HPDE and Panc-1 cells with marginal decrease in Aspc-1 cells. RhoC, a Rho-family GTPase involved in cell motility, increased in the presence of O-DDHSL, suggesting a possible compensatory response to alteration in other migration associated genes. Our results indicate that O-DDHSL could be an effective biomolecule in eukaryotic systems with multimodal function for essential molecular targeting in pancreatic cancer.	[Kumar, Ashwath S.; Bryan, Jeffrey N.; Kumar, Senthil R.] Univ Missouri, Comparat Oncol & Epigenet Lab, Columbia, MO 65211 USA; [Kumar, Senthil R.] Harry S Truman Vet Hosp, Columbia, MO USA	University of Missouri System; University of Missouri Columbia; US Department of Veterans Affairs; Veterans Health Administration (VHA); Harry S. Truman Memorial Veterans' Hospital	Kumar, SR (corresponding author), Univ Missouri, Comparat Oncol & Epigenet Lab, Columbia, MO 65211 USA.	kumars@missouri.edu		Bryan, Jeffrey/0000-0002-6820-9850				Almhanna K, 2008, ONCOLOGY-NY, V22, P1176; Axelrod M, 2013, ONCOTARGET, V4, P622, DOI 10.18632/oncotarget.938; Bensenor LB, 2007, J CELL SCI, V120, P658, DOI 10.1242/jcs.03376; Clark EA, 2000, NATURE, V406, P532, DOI 10.1038/35020106; Davis BM, 2012, PLOS ONE, V5; Delorme V, 2007, DEV CELL, V13, P646, DOI 10.1016/j.devcel.2007.08.011; Fisher WE, 2011, WORLD J SURG, V35, P1766, DOI 10.1007/s00268-010-0949-7; Franken NAP, 2006, NAT PROTOC, V1, P2315, DOI 10.1038/nprot.2006.339; Geissmann Q, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054072; Gioeli D, 2011, MOL CANCER THER, V10, P1581, DOI 10.1158/1535-7163.MCT-10-1033; Henke JM, 2004, J BACTERIOL, V186, P6902, DOI 10.1128/JB.186.20.6902-6914.2004; Jahoor A, 2008, J BACTERIOL, V190, P4408, DOI 10.1128/JB.01444-07; Karlsson T, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002953; Lee GY, 2007, NAT METHODS, V4, P359, DOI 10.1038/NMETH1015; Li L, 2004, ONCOGENE, V23, P4894, DOI 10.1038/sj.onc.1207612; Liu N, 1998, AM J PATHOL, V153, P263, DOI 10.1016/S0002-9440(10)65567-8; McCleary-Wheeler AL, 2013, CANCER LETT, V328, P212, DOI 10.1016/j.canlet.2012.10.005; Noritake J, 2004, MOL BIOL CELL, V15, P1065, DOI 10.1091/mbc.E03-08-0582; Ortori CA, 2011, ANAL BIOANAL CHEM, V399, P839, DOI 10.1007/s00216-010-4341-0; Pacheco AR, 2009, CURR OPIN MICROBIOL, V12, P192, DOI 10.1016/j.mib.2009.01.006; Pearson JP, 1999, J BACTERIOL, V181, P1203, DOI 10.1128/JB.181.4.1203-1210.1999; Ritchie AJ, 2007, IMMUNOL CELL BIOL, V85, P596, DOI 10.1038/sj.icb.7100090; Rogers S, 2008, BIOINFORMATICS, V24, P2894, DOI 10.1093/bioinformatics/btn553; Schneider L, 2010, CELL PHYSIOL BIOCHEM, V25, P279, DOI 10.1159/000276562; Schwarzer C, 2012, CELL MICROBIOL, V14, P698, DOI 10.1111/j.1462-5822.2012.01753.x; Shiner Erin K, 2004, Biol Proced Online, V6, P268, DOI 10.1251/bpo98; Suwa H, 1998, BRIT J CANCER, V77, P147, DOI 10.1038/bjc.1998.23; Swift S, 2001, ADV MICROB PHYSIOL, V45, P199, DOI 10.1016/S0065-2911(01)45005-3; Tateda K, 2003, INFECT IMMUN, V71, P5785, DOI 10.1128/IAI.71.10.5785-5793.2003; Telford G, 1998, INFECT IMMUN, V66, P36, DOI 10.1128/IAI.66.1.36-42.1998; Vogel C, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.59; Wang YF, 2011, ONCOL REP, V26, P1595, DOI 10.3892/or.2011.1447; Williams P, 2009, CURR OPIN MICROBIOL, V12, P182, DOI 10.1016/j.mib.2009.01.005; Yates EA, 2002, INFECT IMMUN, V70, P5635, DOI 10.1128/IAI.70.10.5635-5646.2002	34	17	17	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 4	2014	9	9							e106480	10.1371/journal.pone.0106480	http://dx.doi.org/10.1371/journal.pone.0106480			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3XV	25188245	Green Submitted, Green Published, gold			2022-12-27	WOS:000341271500038
J	Yan, B; Kuick, CH; Lim, M; Venkataraman, K; Tennakoon, C; Loh, E; Lian, D; Leong, MY; Lakshmanan, M; Tergaonkar, V; Sung, WK; Soh, SY; Chang, KTE				Yan, Benedict; Kuick, Chik Hong; Lim, Malcolm; Venkataraman, Kavita; Tennakoon, Chandana; Loh, Eva; Lian, Derrick; Leong, May Ying; Lakshmanan, Manikandan; Tergaonkar, Vinay; Sung, Wing-Kin; Soh, Shui Yen; Chang, Kenneth T. E.			Platform Comparison for Evaluation of ALK Protein Immunohistochemical Expression, Genomic Copy Number and Hotspot Mutation Status in Neuroblastomas	PLOS ONE			English	Article							IN-SITU-HYBRIDIZATION; CELL LUNG-CANCER; ACTIVATING MUTATIONS; KINASE; GENE; REARRANGEMENT; LYMPHOMA; IDENTIFICATION; AMPLIFICATION; RECEPTOR	ALK is an established causative oncogenic driver in neuroblastoma, and is likely to emerge as a routine biomarker in neuroblastoma diagnostics. At present, the optimal strategy for clinical diagnostic evaluation of ALK protein, genomic and hotspot mutation status is not well-studied. We evaluated ALK immunohistochemical (IHC) protein expression using three different antibodies (ALK1, 5A4 and D5F3 clones), ALK genomic status using single-color chromogenic in situ hybridization (CISH), and ALK hotspot mutation status using conventional Sanger sequencing and a next-generation sequencing platform (Ion Torrent Personal Genome Machine (IT-PGM)), in archival formalin-fixed, paraffin-embedded neuroblastoma samples. We found a significant difference in IHC results using the three different antibodies, with the highest percentage of positive cases seen on D5F3 immunohistochemistry. Correlation with ALK genomic and hotspot mutational status revealed that the majority of D5F3 ALK-positive cases did not possess either ALK genomic amplification or hotspot mutations. Comparison of sequencing platforms showed a perfect correlation between conventional Sanger and IT-PGM sequencing. Our findings suggest that D5F3 immunohistochemistry, single-color CISH and IT-PGM sequencing are suitable assays for evaluation of ALK status in future neuroblastoma clinical trials.	[Yan, Benedict; Kuick, Chik Hong; Lim, Malcolm; Loh, Eva; Lian, Derrick; Leong, May Ying; Chang, Kenneth T. E.] KK Womens & Childrens Hosp, Dept Pathol & Lab Med, Singapore, Singapore; [Venkataraman, Kavita] Natl Univ Singapore, Saw Swee Hock Sch Publ Hlth, Singapore 117548, Singapore; [Venkataraman, Kavita] Natl Univ Hlth Syst, Singapore, Singapore; [Tennakoon, Chandana; Sung, Wing-Kin] Genome Inst Singapore, Singapore, Singapore; [Lakshmanan, Manikandan; Tergaonkar, Vinay] Natl Univ Singapore, Inst Mol & Cell Biol, Mouse Models Human Canc Unit, Singapore 117548, Singapore; [Sung, Wing-Kin] Natl Univ Singapore, Sch Comp, Singapore 117548, Singapore; [Soh, Shui Yen] KK Womens & Childrens Hosp, Dept Paediat Subspecialties, Haematol Oncol Serv, Singapore, Singapore	KK Women's & Children's Hospital; National University of Singapore; National University of Singapore; Agency for Science Technology & Research (A*STAR); A*STAR - Genome Institute of Singapore (GIS); Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Molecular & Cell Biology (IMCB); National University of Singapore; National University of Singapore; KK Women's & Children's Hospital	Yan, B (corresponding author), KK Womens & Childrens Hosp, Dept Pathol & Lab Med, Singapore, Singapore.	tranceblues@gmail.com; Kenneth.chang.te@kkh.com.sg	Venkataraman, Kavita/Q-8956-2019	Venkataraman, Kavita/0000-0002-3139-6998; Lim, Malcolm/0000-0003-3691-4368; Sung, Wing-Kin/0000-0001-7806-7086	National Medical Research Council [NMRC/CNIG/1095/2012]	National Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	Funding support was provided by a grant from the National Medical Research Council (NMRC/CNIG/1095/2012). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Azarova AM, 2011, SEMIN CANCER BIOL, V21, P267, DOI 10.1016/j.semcancer.2011.09.005; Benjamini Y, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks001; Bresler SC, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002950; Caren H, 2008, BIOCHEM J, V416, P153, DOI 10.1042/BJ20081834; Cazes A, 2013, CANCER RES, V73, P195, DOI 10.1158/0008-5472.CAN-12-1242; Chen YY, 2008, NATURE, V455, P971, DOI 10.1038/nature07399; Cheung NKV, 2012, JAMA-J AM MED ASSOC, V307, P1062, DOI 10.1001/jama.2012.228; Conklin CMJ, 2013, J THORAC ONCOL, V8, P45, DOI 10.1097/JTO.0b013e318274a83e; De Brouwer S, 2010, CLIN CANCER RES, V16, P4353, DOI 10.1158/1078-0432.CCR-09-2660; Duijkers FAM, 2012, AM J PATHOL, V180, P1223, DOI 10.1016/j.ajpath.2011.12.003; Gargis AS, 2012, NAT BIOTECHNOL, V30, P1033, DOI 10.1038/nbt.2403; George RE, 2008, NATURE, V455, P975, DOI 10.1038/nature07397; Hallberg B, 2013, NAT REV CANCER, V13, P685, DOI 10.1038/nrc3580; Hasan MK, 2013, SCI REP-UK, V3, DOI 10.1038/srep03450; Huang M, 2013, CSH PERSPECT MED, V3, DOI 10.1101/cshperspect.a014415; Janoueix-Lerosey I, 2008, NATURE, V455, P967, DOI 10.1038/nature07398; Kim H, 2011, J THORAC ONCOL, V6, P1359, DOI 10.1097/JTO.0b013e31821cfc73; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Li Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069016; McCourt CM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069604; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Mino-Kenudson M, 2010, CLIN CANCER RES, V16, P1561, DOI 10.1158/1078-0432.CCR-09-2845; Molenaar JJ, 2012, NATURE, V483, P589, DOI 10.1038/nature10910; Mosse YP, 2008, NATURE, V455, P930, DOI 10.1038/nature07261; Mosse YP, 2013, LANCET ONCOL, V14, P472, DOI 10.1016/S1470-2045(13)70095-0; Okubo J, 2012, ONCOGENE, V31, P4667, DOI 10.1038/onc.2011.616; Passoni L, 2009, CANCER RES, V69, P7338, DOI 10.1158/0008-5472.CAN-08-4419; Pugh TJ, 2013, NAT GENET, V45, P279, DOI 10.1038/ng.2529; Pulford K, 1997, BLOOD, V89, P1394, DOI 10.1182/blood.V89.4.1394; Rehm HL, 2013, GENET MED, V15, P733, DOI 10.1038/gim.2013.92; Ross MG, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-5-r51; Sausen M, 2013, NAT GENET, V45, P12, DOI 10.1038/ng.2493; Schildhaus HU, 2013, MODERN PATHOL, V26, P1468, DOI 10.1038/modpathol.2013.95; Selinger CI, 2013, MODERN PATHOL, V26, P1545, DOI 10.1038/modpathol.2013.87; Singh RR, 2013, J MOL DIAGN, V15, P607, DOI 10.1016/j.jmoldx.2013.05.003; Thorvaldsdottir H, 2013, BRIEF BIOINFORM, V14, P178, DOI 10.1093/bib/bbs017; Wang M, 2013, EXP MOL PATHOL, V95, P124, DOI 10.1016/j.yexmp.2013.06.002; Weickhardt AJ, 2013, CANCER-AM CANCER SOC, V119, P1467, DOI 10.1002/cncr.27913; Wolff AC, 2013, J CLIN ONCOL, V31, P3997, DOI 10.1200/JCO.2013.50.9984; Yan Benedict, 2013, J Clin Pathol, V66, P985, DOI 10.1136/jclinpath-2012-201375; Yan B, 2010, J CLIN PATHOL, V63, P839, DOI 10.1136/jcp.2010.076570; Ying J, 2013, ANN ONCOL, V24, P2589, DOI 10.1093/annonc/mdt295	42	12	13	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 4	2014	9	9							e106575	10.1371/journal.pone.0106575	http://dx.doi.org/10.1371/journal.pone.0106575			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3XV	25188507	Green Submitted, Green Published, gold			2022-12-27	WOS:000341271500056
J	Zaferani, A; Talsma, DT; Yazdani, S; Celie, JWAM; Aikio, M; Heljasvaara, R; Navis, GJ; Pihlajaniemi, T; van den Born, J				Zaferani, Azadeh; Talsma, Ditmer T.; Yazdani, Saleh; Celie, Johanna W. A. M.; Aikio, Mari; Heljasvaara, Ritva; Navis, Gerjan J.; Pihlajaniemi, Taina; van den Born, Jacob			Basement Membrane Zone Collagens XV and XVIII/Proteoglycans Mediate Leukocyte Influx in Renal Ischemia/Reperfusion	PLOS ONE			English	Article							MONOCYTE CHEMOATTRACTANT PROTEIN-1; ACUTE KIDNEY INJURY; XVIII COLLAGEN; L-SELECTIN; EXTRACELLULAR-MATRIX; HUMAN TISSUES; EXPRESSION; ENDOSTATIN; PATHOPHYSIOLOGY; ALPHA-1(XVIII)	Collagen type XV and XVIII are proteoglycans found in the basement membrane zones of endothelial and epithelial cells, and known for their cryptic anti-angiogenic domains named restin and endostatin, respectively. Mutations or deletions of these collagens are associated with eye, muscle and microvessel phenotypes. We now describe a novel role for these collagens, namely a supportive role in leukocyte recruitment. We subjected mice deficient in collagen XV or collagen XVIII, and their compound mutant, as well as the wild-type control mice to bilateral renal ischemia/reperfusion, and evaluated renal function, tubular injury, and neutrophil and macrophage influx at different time points after ischemia/reperfusion. Five days after ischemia/reperfusion, the collagen XV, collagen XVIII and the compound mutant mice showed diminished serum urea levels compared to wild-type mice (all p<0.05). Histology showed reduced tubular damage, and decreased inflammatory cell influx in all mutant mice, which were more pronounced in the compound mutant despite increased expression of MCP-1 and TNF-alpha in double mutant mice compared to wildtype mice. Both type XV and type XVIII collagen bear glycosaminoglycan side chains and an in vitro approach with recombinant collagen XVIII fragments with variable glycanation indicated a role for these side chains in leukocyte migration. Thus, basement membrane zone collagen/proteoglycan hybrids facilitate leukocyte influx and tubular damage after renal ischemia/reperfusion and might be potential intervention targets for the reduction of inflammation in this condition.	[Zaferani, Azadeh; Talsma, Ditmer T.; Yazdani, Saleh; Navis, Gerjan J.; van den Born, Jacob] Univ Groningen, Univ Med Ctr Groningen, Groningen, Netherlands; [Celie, Johanna W. A. M.] Vrije Univ Amsterdam, Med, Amsterdam, Netherlands; [Aikio, Mari; Heljasvaara, Ritva; Pihlajaniemi, Taina] Univ Oulu, Bioctr Oulu, Oulu Ctr Cell Matrix Res, Oulu, Finland; [Aikio, Mari; Heljasvaara, Ritva; Pihlajaniemi, Taina] Univ Oulu, Fac Biochem & Mol Med, Oulu, Finland	University of Groningen; Vrije Universiteit Amsterdam; University of Oulu; University of Oulu	Zaferani, A (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Groningen, Netherlands.	a.zaferani@umcg.nl	Yazdani, Saleh/K-9640-2015	Yazdani, Saleh/0000-0002-5162-9904; Pihlajaniemi, Taina/0000-0002-1664-9045; Heljasvaara, Ritva/0000-0003-4763-3844	Dutch Kidney foundation [C06.2163]; Health Science Council of the Academy of Finland [138866]; Sigrid Juselius Foundation; NWO [40-00506-98-9021, 175-010-2009-023]; Health Science Council of the Academy of Finland (Centre of Excellence) [251314]	Dutch Kidney foundation; Health Science Council of the Academy of Finland(Academy of Finland); Sigrid Juselius Foundation(Sigrid Juselius Foundation); NWO(Netherlands Organization for Scientific Research (NWO)); Health Science Council of the Academy of Finland (Centre of Excellence)	This work was funded by Dutch Kidney foundation (C06.2163), by the Health Science Council of the Academy of Finland (Grant 138866 and Centre of Excellence 2012-2017 Grant 251314), and by Sigrid Juselius Foundation. Part of the work was performed at University Medical Center Groningen, Imaging and Microscopy Center (UMIC), which is sponsored by NWO-grants 40-00506-98-9021 and 175-010-2009-023. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amenta PS, 2005, J HISTOCHEM CYTOCHEM, V53, P165, DOI 10.1369/jhc.4A6376.2005; Bellini MH, 2007, NEPHROLOGY, V12, P459, DOI 10.1111/j.1440-1797.2007.00850.x; Bonventre JV, 2011, J CLIN INVEST, V121, P4210, DOI 10.1172/JCI45161; Celie JWAM, 2007, AM J PATHOL, V170, P1865, DOI 10.2353/ajpath.2007.070061; Celie JWAM, 2005, J BIOL CHEM, V280, P26965, DOI 10.1074/jbc.M502188200; Eklund L, 2001, P NATL ACAD SCI USA, V98, P1194, DOI 10.1073/pnas.031444798; Erickson AC, 2000, J HISTOCHEM CYTOCHEM, V48, P1291, DOI 10.1177/002215540004801001; Fukai N, 2002, EMBO J, V21, P1535, DOI 10.1093/emboj/21.7.1535; Hagg PM, 1997, AM J PATHOL, V150, P2075; Hamano Y, 2010, J AM SOC NEPHROL, V21, P1445, DOI 10.1681/ASN.2009050492; Hurskainen M, 2010, J BIOL CHEM, V285, P5258, DOI 10.1074/jbc.M109.033787; Hynes RO, 2009, SCIENCE, V326, P1216, DOI 10.1126/science.1176009; Jang HR, 2009, J MOL MED, V87, P859, DOI 10.1007/s00109-009-0491-y; Kalluri R, 2003, NAT REV CANCER, V3, P422, DOI 10.1038/nrc1094; Kawashima H, 2003, J BIOL CHEM, V278, P13069, DOI 10.1074/jbc.M212244200; Kinnunen AI, 2011, J BIOL CHEM, V286, P7755, DOI 10.1074/jbc.M110.166132; Korpos E, 2010, CELL TISSUE RES, V339, P47, DOI 10.1007/s00441-009-0853-3; Kruegel J, 2010, CELL MOL LIFE SCI, V67, P2879, DOI 10.1007/s00018-010-0367-x; Li Q, 2011, J CELL BIOCHEM, V112, P1585, DOI 10.1002/jcb.23074; Marneros AG, 2005, FASEB J, V19, P716, DOI 10.1096/fj.04-2134rev; Meyer F, 2009, DEV GROWTH DIFFER, V51, P483, DOI 10.1111/j.1440-169X.2009.01111.x; Momota R, 2011, MATRIX BIOL, V30, P258, DOI 10.1016/j.matbio.2011.03.008; Oertli B, 1998, J IMMUNOL, V161, P3431; Ortega N, 2002, J CELL SCI, V115, P4201, DOI 10.1242/jcs.00106; Petrini G, 2002, MOL CELL BIOCHEM, V241, P21, DOI 10.1023/A:1020878919459; Ramchandran R, 1999, BIOCHEM BIOPH RES CO, V255, P735, DOI 10.1006/bbrc.1999.0248; Rasi K, 2010, CIRC RES, V107, P1241, DOI 10.1161/CIRCRESAHA.110.222133; REHN M, 1994, J BIOL CHEM, V269, P13929; REHN M, 1995, J BIOL CHEM, V270, P4705, DOI 10.1074/jbc.270.9.4705; REHN M, 1994, P NATL ACAD SCI USA, V91, P4234, DOI 10.1073/pnas.91.10.4234; Rienstra H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009095; Saarela J, 1998, AM J PATHOL, V153, P611, DOI 10.1016/S0002-9440(10)65603-9; Schlesinger M, 2009, THROMB HAEMOSTASIS, V102, P816, DOI 10.1160/TH09-01-0061; Seppinen L, 2011, MATRIX BIOL, V30, P83, DOI 10.1016/j.matbio.2010.11.001; Sertie AL, 2000, HUM MOL GENET, V9, P2051, DOI 10.1093/hmg/9.13.2051; Utriainen A, 2004, HUM MOL GENET, V13, P2089, DOI 10.1093/hmg/ddh213; Voisin MB, 2010, AM J PATHOL, V176, P482, DOI 10.2353/ajpath.2010.090510; Wen XY, 2010, CONTRIB NEPHROL, V165, P39, DOI 10.1159/000313743; Ylikarppa R, 2003, MATRIX BIOL, V22, P443, DOI 10.1016/S0945-053X(03)00074-X; Yurchenco PD, 2009, CURR PHARM DESIGN, V15, P1277, DOI 10.2174/138161209787846766; Zen K, 2003, CURR OPIN CELL BIOL, V15, P557, DOI 10.1016/S0955-0674(03)00103-0	41	19	19	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 4	2014	9	9							e106732	10.1371/journal.pone.0106732	http://dx.doi.org/10.1371/journal.pone.0106732			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3XV	25188209	gold, Green Submitted, Green Published			2022-12-27	WOS:000341271500079
J	Cooper, CB; Shirk, J; Zuckerberg, B				Cooper, Caren B.; Shirk, Jennifer; Zuckerberg, Benjamin			The Invisible Prevalence of Citizen Science in Global Research: Migratory Birds and Climate Change	PLOS ONE			English	Article							DATA-INTENSIVE SCIENCE; SCALE; QUALITY; TOOL	Citizen science is a research practice that relies on public contributions of data. The strong recognition of its educational value combined with the need for novel methods to handle subsequent large and complex data sets raises the question: Is citizen science effective at science? A quantitative assessment of the contributions of citizen science for its core purpose scientific research - is lacking. We examined the contribution of citizen science to a review paper by ornithologists in which they formulated ten central claims about the impact of climate change on avian migration. Citizen science was never explicitly mentioned in the review article. For each of the claims, these ornithologists scored their opinions about the amount of research effort invested in each claim and how strongly the claim was supported by evidence. This allowed us to also determine whether their trust in claims was, unwittingly or not, related to the degree to which the claims relied primarily on data generated by citizen scientists. We found that papers based on citizen science constituted between 24 and 77% of the references backing each claim, with no evidence of a mistrust of claims that relied heavily on citizen-science data. We reveal that many of these papers may not easily be recognized as drawing upon volunteer contributions, as the search terms "citizen science'' and "volunteer'' would have overlooked the majority of the studies that back the ten claims about birds and climate change. Our results suggest that the significance of citizen science to global research, an endeavor that is reliant on long-term information at large spatial scales, might be far greater than is readily perceived. To better understand and track the contributions of citizen science in the future, we urge researchers to use the keyword "citizen science'' in papers that draw on efforts of non-professionals.	[Cooper, Caren B.; Shirk, Jennifer] Cornell Lab Ornithol, Ithaca, NY 14850 USA; [Zuckerberg, Benjamin] Univ Wisconsin, Madison, WI USA	Cornell University; University of Wisconsin System; University of Wisconsin Madison	Cooper, CB (corresponding author), Cornell Lab Ornithol, Ithaca, NY 14850 USA.	caren.cooper@cornell.edu	Zuckerberg, Benjamin/AAL-9623-2021	Cooper, Caren/0000-0001-6263-8892				Bates AJ, 2013, ENTOMOL EXP APPL, V146, P386, DOI 10.1111/eea.12038; Bonilla NO, 2012, FRONT ECOL ENVIRON, V93, P340; Bonney R, 2009, PUBLIC PARTICIPATION; Bonney R, 2009, BIOSCIENCE, V59, P977, DOI 10.1525/bio.2009.59.11.9; Bonter DN, 2012, FRONT ECOL ENVIRON, V10, P305, DOI 10.1890/110273; Both C, 2007, CLIM RES, V35, P93, DOI 10.3354/cr00716; Both C, 2010, CURR BIOL, V20, P243, DOI 10.1016/j.cub.2009.11.074; Cooper C. B., 2012, CITIZEN SCI PUBLIC P, P99; Cooper CB, 2014, INT J BIOME IN PRESS; Cornwell ML, 2012, SOC STUD SCI, V42, P101, DOI 10.1177/0306312711430440; Danielsen F, 2014, BIOSCIENCE, V64, P236, DOI 10.1093/biosci/biu001; Danielsen F, 2010, J APPL ECOL, V47, P1166, DOI 10.1111/j.1365-2664.2010.01874.x; Devictor V, 2010, DIVERS DISTRIB, V16, P354, DOI 10.1111/j.1472-4642.2009.00615.x; Dickinson JL, 2010, ANNU REV ECOL EVOL S, V41, P149, DOI 10.1146/annurev-ecolsys-102209-144636; Engel Sarah R., 2002, American Entomologist, V48, P164; Fink D, 2010, ECOL APPL, V20, P2131, DOI 10.1890/09-1340.1; Galloway AWE, 2006, WILDLIFE SOC B, V34, P1425, DOI 10.2193/0091-7648(2006)34[1425:TROCSA]2.0.CO;2; Gardiner MM, 2012, FRONT ECOL ENVIRON, V10, P471, DOI 10.1890/110185; Genet KS, 2003, WILDLIFE SOC B, V31, P703; Gill JA, 2001, NATURE, V412, P436, DOI 10.1038/35086568; Gollan J, 2012, ENVIRON MANAGE, V50, P969, DOI 10.1007/s00267-012-9924-4; Hochachka WM, 2012, TRENDS ECOL EVOL, V27, P130, DOI 10.1016/j.tree.2011.11.006; Jordan RC, 2012, ENVIRON MANAGE, V49, P425, DOI 10.1007/s00267-011-9789-y; Kelling S, 2009, BIOSCIENCE, V59, P613, DOI 10.1525/bio.2009.59.7.12; Knudsen E, 2011, BIOL REV, V86, P928, DOI 10.1111/j.1469-185X.2011.00179.x; Kremen C, 2011, CONSERV BIOL, V25, P607, DOI 10.1111/j.1523-1739.2011.01657.x; Kyba CCM, 2013, SCI REP-UK, V3, DOI 10.1038/srep01835; Lawrence A, 2009, GLOBAL ENVIRON CHANG, V19, P173, DOI 10.1016/j.gloenvcha.2009.01.006; McCormick S, 2012, ECOL SOC, V17, DOI 10.5751/ES-05263-170431; Miller DAW, 2012, ECOL APPL, V22, P1665; Miller-Rushing A, 2013, B ECOL SOC AM, V94, P112, DOI DOI 10.1890/0012-9623-94.1.112; Moyer-Horner L, 2012, J WILDLIFE MANAGE, V76, P1472, DOI 10.1002/jwmg.373; Newman G, 2011, ECOL INFORM, V6, P217, DOI 10.1016/j.ecoinf.2011.03.002; Parsons J, 2011, NATURE, V471, P37, DOI 10.1038/471037a; Roy HE, 2012, UNDERSTANDING CITIZE; Silvertown J, 2009, TRENDS ECOL EVOL, V24, P467, DOI 10.1016/j.tree.2009.03.017; Sullivan BL, 2014, BIOL CONSERV, V169, P31, DOI 10.1016/j.biocon.2013.11.003; Switzer A, 2012, FRONT ECOL ENVIRON, V10, P334, DOI 10.1890/110276; Tregidgo DJ, 2013, ENVIRON POLLUT, V182, P448, DOI 10.1016/j.envpol.2013.03.034	39	113	117	5	149	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 3	2014	9	9							e106508	10.1371/journal.pone.0106508	http://dx.doi.org/10.1371/journal.pone.0106508			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3TB	25184755	Green Submitted, Green Published, gold			2022-12-27	WOS:000341257700080
J	Huang, H; Kang, RY; Zhao, ZD				Huang, He; Kang, Rongyan; Zhao, Zhendong			Is Hepatitis C Associated with Atherosclerotic Burden? A Systematic Review and Meta-Analysis	PLOS ONE			English	Article							CORONARY-ARTERY-DISEASE; HIV-INFECTED PATIENTS; CHRONIC HCV INFECTION; NON-HODGKIN-LYMPHOMA; VIRUS-INFECTION; SUBCLINICAL ATHEROSCLEROSIS; CAROTID ATHEROSCLEROSIS; RISK; SEROPOSITIVITY; EPIDEMIOLOGY	Background and Aims: Increasing evidence demonstrates that hepatitis C virus (HCV) infection is associated with atherosclerosis. However, there are contrasting findings in several studies that the atherosclerotic burden is not associated with HCV infections. Therefore, we performed a meta-analysis to clarify if HCV infection is associated with atherosclerosis compared to non-infected people. Methods: Standard guidelines for performance of meta-analysis were followed. Results: A thorough database search performed by two independent investigators identified 14 eligible studies for analysis. The data from 11 studies were synthesized to report unadjusted odds ratios (ORs) for carotid atherosclerosis; the pooled unadjusted OR (95% confidence interval (CI)) was 1.65 (1.21, 2.09). By synthesizing the data from 8 studies to report adjusted ORs for carotid atherosclerosis the pooled multi-confounder adjusted OR (95% CI) was 1.76 (1.20, 2.32). However, the numbers of studies on coronary or femoral atherosclerosis were limited and not enough for analysis. Conclusions: Our meta-analysis indicats that HCV infection is associated with carotid atherosclerosis independent of classical risk factors. Therefore, we would recommend for HCV infected patients to be counseled on their risk for carotid atherosclerosis.	[Zhao, Zhendong] Chinese Acad Med Sci, Inst Pathogen Biol, MOH Key Lab Syst Biol Pathogens, Beijing 100730, Peoples R China; Peking Union Med Coll, Beijing 100021, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Pathogen Biology - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College	Zhao, ZD (corresponding author), Chinese Acad Med Sci, Inst Pathogen Biol, MOH Key Lab Syst Biol Pathogens, Beijing 100730, Peoples R China.	zhaozhendong661028@gmail.com	huang, he/GLT-7903-2022	Huang, He/0000-0002-4887-2671	National Natural Science Foundation of China [81301440]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China (no. 81301440, http://www.nsfc.gov.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adinolfi LE, 2014, WORLD J GASTROENTERO, V20, P3410, DOI 10.3748/wjg.v20.i13.3410; Adinolfi LE, 2013, ATHEROSCLEROSIS, V231, P22, DOI 10.1016/j.atherosclerosis.2013.08.003; Adinolfi LE, 2012, ATHEROSCLEROSIS, V221, P496, DOI 10.1016/j.atherosclerosis.2012.01.051; Alyan O, 2008, CIRC J, V72, P1960, DOI 10.1253/circj.CJ-08-0459; Aslam F, 2010, ATHEROSCLEROSIS, V209, P340, DOI 10.1016/j.atherosclerosis.2009.10.006; Bilora F, 2008, ANGIOLOGY, V59, P717, DOI 10.1177/0003319707311536; Blake GJ, 2001, CIRC RES, V89, P763, DOI 10.1161/hh2101.099270; Boddi Maria, 2007, Dig Liver Dis, V39 Suppl 1, pS55; Boddi M, 2010, J CLIN VIROL, V47, P72, DOI 10.1016/j.jcv.2009.10.005; Butt AA, 2009, CLIN INFECT DIS, V49, P225, DOI 10.1086/599371; Caliskan Y, 2009, CLIN NEPHROL, V71, P147; Daghestani L, 1999, AM J MED, V106, P347, DOI 10.1016/S0002-9343(99)00014-5; De Sanjose S, 2008, CLIN GASTROENTEROL H, V6, P451, DOI 10.1016/j.cgh.2008.02.011; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; EASTERBROOK PJ, 1991, LANCET, V337, P867, DOI 10.1016/0140-6736(91)90201-Y; Fukui M, 2003, JAMA-J AM MED ASSOC, V289, P1245, DOI 10.1001/jama.289.10.1245-b; Giordano TP, 2007, JAMA-J AM MED ASSOC, V297, P2010, DOI 10.1001/jama.297.18.2010; Guiltinan AM, 2008, AM J EPIDEMIOL, V167, P743, DOI 10.1093/aje/kwm370; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Higgins J, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.ED000049; Huang H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081305; Ishizaka N, 2002, LANCET, V359, P133, DOI 10.1016/S0140-6736(02)07339-7; Ishizaka Y, 2003, CIRC J, V67, P26, DOI 10.1253/circj.67.26; Kakinami L, 2013, INT J CLIN PRACT, V67, P6, DOI 10.1111/j.1742-1241.2012.02953.x; Lee MH, 2009, J HEPATOL, V50, pS153, DOI 10.1016/S0168-8278(09)60408-6; Louie KS, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-86; Masia M, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-265; Momiyama Y, 2005, ATHEROSCLEROSIS, V181, P211, DOI 10.1016/j.atherosclerosis.2005.02.027; Mostafa A, 2010, GUT, V59, P1135, DOI 10.1136/gut.2009.202317; Normand SLT, 1999, STAT MED, V18, P321, DOI 10.1002/(SICI)1097-0258(19990215)18:3<321::AID-SIM28>3.0.CO;2-P; Oliveira CPMS, 2013, INT J CARDIOL, V164, P221, DOI 10.1016/j.ijcard.2011.07.016; Pateria P, 2013, J GASTROEN HEPATOL, V28, P161; Petta S, 2012, HEPATOLOGY, V55, P1317, DOI 10.1002/hep.25508; Roed T, 2014, VASC HEALTH RISK MAN, V10, P55, DOI 10.2147/VHRM.S53557; Roed T, 2012, CLIN PHYSIOL FUNCT I, V32, P421, DOI 10.1111/j.1475-097X.2012.01152.x; Sosner P, 2012, ATHEROSCLEROSIS, V222, P274, DOI 10.1016/j.atherosclerosis.2012.02.027; Stroup DF, 2000, JAMA-J AM MED ASSOC, V283, P2008, DOI 10.1001/jama.283.15.2008; Targher G, 2007, J HEPATOL, V46, P1126, DOI 10.1016/j.jhep.2007.01.021; Tien PC, 2009, AIDS, V23, P1781, DOI 10.1097/QAD.0b013e32832d7aa8; Tomiyama H, 2003, ATHEROSCLEROSIS, V166, P401, DOI 10.1016/S0021-9150(02)00388-X; Volzke H, 2004, ATHEROSCLEROSIS, V174, P99, DOI 10.1016/j.atherosclerosis.2004.01.010; Wasley A, 2000, SEMIN LIVER DIS, V20, P1, DOI 10.1055/s-2000-9506; White DL, 2008, J HEPATOL, V49, P831, DOI 10.1016/j.jhep.2008.08.006; Wong RJ, 2014, DIGEST DIS SCI, V59, P1586, DOI 10.1007/s10620-014-3222-3; Zein CO, 2005, AM J GASTROENTEROL, V100, P48, DOI 10.1111/j.1572-0241.2005.40429.x	45	28	30	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 3	2014	9	9							e106376	10.1371/journal.pone.0106376	http://dx.doi.org/10.1371/journal.pone.0106376			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3TB	25184517	gold, Green Submitted, Green Published			2022-12-27	WOS:000341257700064
J	Olausson, KH; Maire, CL; Haidar, S; Ling, J; Learner, E; Nister, M; Ligon, KL				Olausson, Karl Holmberg; Maire, Cecile L.; Haidar, Sam; Ling, Jason; Learner, Emily; Nister, Monica; Ligon, Keith L.			Prominin-1 (CD133) Defines Both Stem and Non-Stem Cell Populations in CNS Development and Gliomas	PLOS ONE			English	Article							NEURAL PROGENITOR CELLS; HUMAN BRAIN; PROSPECTIVE IDENTIFICATION; SPLICE VARIANTS; CANCER GENOMICS; GLIOBLASTOMA; EXPRESSION; PROTEIN; TUMORS; MARKER	Prominin-1 (CD133) is a commonly used cancer stem cell marker in central nervous system (CNS) tumors including glioblastoma (GBM). Expression of Prom1 in cancer is thought to parallel expression and function in normal stem cells. Using RNA in situ hybridization and antibody tools capable of detecting multiple isoforms of Prom1, we find evidence for two distinct Prom1 cell populations in mouse brain. Prom1 RNA is first expressed in stem/progenitor cells of the ventricular zone in embryonic brain. Conversely, in adult mouse brain Prom1 RNA is low in SVZ/SGZ stem cell zones but high in a rare but widely distributed cell population (Prom1(hi)). Lineage marker analysis reveals Prom1(hi) cells are Olig2+Sox2+glia but Olig1/2 knockout mice lacking oligodendroglia retain Prom1(hi) cells. Bromodeoxyuridine labeling identifies Prom1 hi as slow-dividing distributed progenitors distinct from NG2+Olig2+oligodendrocyte progenitors. In adult human brain, PROM1 cells are rarely positive for OLIG2, but express astroglial markers GFAP and SOX2. Variability of PROM1 expression levels in human GBM and patient-derived xenografts (PDX) - from no expression to strong, uniform expression - highlights that PROM1 may not always be associated with or restricted to cancer stem cells. TCGA and PDX data show that high expression of PROM1 correlates with poor overall survival. Within proneural subclass tumors, high PROM1 expression correlates inversely with IDH1 (R132H) mutation. These findings support PROM1 as a tumor cell-intrinsic marker related to GBM survival, independent of its stem cell properties, and highlight potentially divergent roles for this protein in normal mouse and human glia.	[Olausson, Karl Holmberg; Maire, Cecile L.; Haidar, Sam; Ling, Jason; Learner, Emily; Ligon, Keith L.] Dana Farber Canc Inst, Dept Med Oncol, Ctr Mol Oncol Pathol, Boston, MA 02115 USA; [Olausson, Karl Holmberg; Nister, Monica] Karolinska Inst, Dept Oncol Pathol, Stockholm, Sweden; [Ligon, Keith L.] Boston Childrens Hosp, Dept Pathol, Boston, MA USA; [Ligon, Keith L.] Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA; [Ligon, Keith L.] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA	Harvard University; Dana-Farber Cancer Institute; Karolinska Institutet; Harvard University; Boston Children's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School	Ligon, KL (corresponding author), Dana Farber Canc Inst, Dept Med Oncol, Ctr Mol Oncol Pathol, Boston, MA 02115 USA.	keith_ligon@dfci.harvard.edu		Learner, Emily/0000-0003-3778-8631	NIH [R01 RO1CA170592]; Sontag Foundation; Karolinska Institutet; Swedish Childhood Cancer Foundation; Swedish Cancer Society; Swedish Research Council; NATIONAL CANCER INSTITUTE [P50CA165962, P01CA095616, R01CA170592, P01CA142536] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [K08NS047213] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Sontag Foundation; Karolinska Institutet(Karolinska Institutet); Swedish Childhood Cancer Foundation(European Commission); Swedish Cancer Society(Swedish Cancer Society); Swedish Research Council(Swedish Research CouncilEuropean Commission); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	Financial support for this study was provided by NIH R01 RO1CA170592 (KLL, CLM) the Sontag Foundation (KLL) and PhD-funding from the Karolinska Institutet (KHO) as well as additional financial support from the Swedish Childhood Cancer Foundation, The Swedish Cancer Society and The Swedish Research Council (MN). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; Arndt K, 2013, P NATL ACAD SCI USA, V110, P5582, DOI 10.1073/pnas.1215438110; Bao SD, 2006, NATURE, V444, P756, DOI 10.1038/nature05236; Beckervordersandforth R, 2010, CELL STEM CELL, V7, P744, DOI 10.1016/j.stem.2010.11.017; Beier D, 2007, CANCER RES, V67, P4010, DOI 10.1158/0008-5472.CAN-06-4180; Brennan CW, 2013, CELL, V155, P462, DOI 10.1016/j.cell.2013.09.034; Buffo A, 2005, P NATL ACAD SCI USA, V102, P18183, DOI 10.1073/pnas.0506535102; Cerami E, 2012, CANCER DISCOV, V2, P401, DOI 10.1158/2159-8290.CD-12-0095; Chen RH, 2010, CANCER CELL, V17, P362, DOI 10.1016/j.ccr.2009.12.049; Chin L, 2008, NATURE, V455, P1061, DOI 10.1038/nature07385; Codega P, 2014, NEURON, V82, P545, DOI 10.1016/j.neuron.2014.02.039; Corbeil D, 1998, BLOOD, V91, P2625, DOI 10.1182/blood.V91.7.2625.2625_2625_2626; Corbeil D, 2009, GLIA, V57, P860, DOI 10.1002/glia.20812; Coskun V, 2008, P NATL ACAD SCI USA, V105, P1026, DOI 10.1073/pnas.0710000105; Ding BS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062150; Fargeas CA, 2004, J CELL SCI, V117, P4301, DOI 10.1242/jcs.01315; Gao JJ, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004088; Gotz M, 2005, NAT REV MOL CELL BIO, V6, P777, DOI 10.1038/nrm1739; Griguer CE, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003655; Guerrero-Cazares H, 2011, J COMP NEUROL, V519, P1165, DOI 10.1002/cne.22566; Gurudev N, 2013, ADV EXP MED BIOL, V777, P55, DOI 10.1007/978-1-4614-5894-4_4; Kemper K, 2010, CANCER RES, V70, P719, DOI 10.1158/0008-5472.CAN-09-1820; Khatri P, 2014, SCI REP-UK, V4, DOI 10.1038/srep03803; Laks DR, 2009, STEM CELLS, V27, P980, DOI 10.1002/stem.15; LAPIDOT T, 1994, NATURE, V367, P645, DOI 10.1038/367645a0; Lee A, 2005, NAT NEUROSCI, V8, P723, DOI 10.1038/nn1473; Ligon KL, 2006, P NATL ACAD SCI USA, V103, P7853, DOI 10.1073/pnas.0511001103; Lu QR, 2002, CELL, V109, P75, DOI 10.1016/S0092-8674(02)00678-5; Miraglia S, 1997, BLOOD, V90, P5013, DOI 10.1182/blood.V90.12.5013.5013_5013_5021; Missol-Kolka E, 2011, PROSTATE, V71, P254, DOI 10.1002/pros.21239; Sanai N, 2011, NATURE, V478, P382, DOI 10.1038/nature10487; SASAKI A, 1988, ACTA NEUROPATHOL, V76, P128, DOI 10.1007/BF00688096; Singh SK, 2004, ONCOGENE, V23, P7267, DOI 10.1038/sj.onc.1207946; Singh SK, 2003, CANCER RES, V63, P5821; Singh SK, 2004, NATURE, V432, P396, DOI 10.1038/nature03128; Strausberg RL, 2002, P NATL ACAD SCI USA, V99, P16899, DOI 10.1073/pnas.242603899; Tramontin AD, 2003, CEREB CORTEX, V13, P580, DOI 10.1093/cercor/13.6.580; Uchida N, 2000, P NATL ACAD SCI USA, V97, P14720, DOI 10.1073/pnas.97.26.14720; van den Berge SA, 2010, AGING CELL, V9, P313, DOI 10.1111/j.1474-9726.2010.00556.x; Verhaak RGW, 2010, CANCER CELL, V17, P98, DOI 10.1016/j.ccr.2009.12.020; Walker TL, 2013, J NEUROSCI, V33, P3010, DOI 10.1523/JNEUROSCI.3363-12.2013; Wang J, 2008, INT J CANCER, V122, P761, DOI 10.1002/ijc.23130; Wang J, 2013, STEM CELLS DEV, V22, P2121, DOI 10.1089/scd.2013.0003; Weigmann A, 1997, P NATL ACAD SCI USA, V94, P12425, DOI 10.1073/pnas.94.23.12425; Zeppernick F, 2008, CLIN CANCER RES, V14, P123, DOI 10.1158/1078-0432.CCR-07-0932; Zhang C, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0056772, 10.1371/journal.pone.0081049]; Zhou Q, 2002, CELL, V109, P61, DOI 10.1016/S0092-8674(02)00677-3	47	25	25	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 3	2014	9	9							e106694	10.1371/journal.pone.0106694	http://dx.doi.org/10.1371/journal.pone.0106694			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3TB	25184684	Green Published, Green Submitted, gold			2022-12-27	WOS:000341257700107
J	Panpradist, N; Toley, BJ; Zhang, XH; Byrnes, S; Buser, JR; Englund, JA; Lutz, BR				Panpradist, Nuttada; Toley, Bhushan J.; Zhang, Xiaohong; Byrnes, Samantha; Buser, Joshua R.; Englund, Janet A.; Lutz, Barry R.			Swab Sample Transfer for Point-Of-Care Diagnostics: Characterization of Swab Types and Manual Agitation Methods	PLOS ONE			English	Article							RESISTANT STAPHYLOCOCCUS-AUREUS; REAL-TIME PCR; NASAL SWABS; CHLAMYDIA-TRACHOMATIS; MRSA; SPECIMENS; CULTURE; ASSAY; WOMEN	Background: The global need for disease detection and control has increased effort to engineer point-of-care (POC) tests that are simple, robust, affordable, and non-instrumented. In many POC tests, sample collection involves swabbing the site (e.g., nose, skin), agitating the swab in a fluid to release the sample, and transferring the fluid to a device for analysis. Poor performance in sample transfer can reduce sensitivity and reproducibility. Methods: In this study, we compared bacterial release efficiency of seven swab types using manual-agitation methods typical of POC devices. Transfer efficiency was measured using quantitative PCR (qPCR) for Staphylococcus aureus under conditions representing a range of sampling scenarios: 1) spiking low-volume samples onto the swab, 2) submerging the swab in excess-volume samples, and 3) swabbing dried sample from a surface. Results: Excess-volume samples gave the expected recovery for most swabs (based on tip fluid capacity); a polyurethane swab showed enhanced recovery, suggesting an ability to accumulate organisms during sampling. Dry samples led to recovery of similar to 20-30% for all swabs tested, suggesting that swab structure and volume is less important when organisms are applied to the outer swab surface. Low-volume samples led to the widest range of transfer efficiencies between swab types. Rayon swabs (63 mu L capacity) performed well for excess-volume samples, but showed poor recovery for low-volume samples. Nylon (100 mu L) and polyester swabs (27 mu L) showed intermediate recovery for low-volume and excess-volume samples. Polyurethane swabs (16 mu L) showed excellent recovery for all sample types. This work demonstrates that swab transfer efficiency can be affected by swab material, structure, and fluid capacity and details of the sample. Results and quantitative analysis methods from this study will assist POC assay developers in selecting appropriate swab types and transfer methods.	[Panpradist, Nuttada; Toley, Bhushan J.; Zhang, Xiaohong; Byrnes, Samantha; Buser, Joshua R.; Lutz, Barry R.] Univ Washington, Dept Bioengn, Seattle, WA 98195 USA; [Englund, Janet A.] Fred Hutchinson Canc Res Ctr, Div Clin Res, Program Infect Dis, Seattle, WA 98104 USA; [Englund, Janet A.] Univ Washington, Dept Pediat, Seattle Childrens Res Inst, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; Fred Hutchinson Cancer Center; Seattle Children's Hospital; University of Washington; University of Washington Seattle	Englund, JA (corresponding author), Fred Hutchinson Canc Res Ctr, Div Clin Res, Program Infect Dis, 1124 Columbia St, Seattle, WA 98104 USA.	janet.englund@seattlechildrens.org; blutz@uw.edu	Panpradist, Nuttada/AAX-4821-2021; Toley, Bhushan/X-8571-2019; Panpradist, Nuttada/AAZ-2189-2021	Toley, Bhushan/0000-0003-0119-2350; Lutz, Barry/0000-0003-4298-4901; Panpradist, Nuttada/0000-0002-2733-4110	Defense Advanced Research Projects Agency Defense Sciences Office [HR0011-11-2-0007]	Defense Advanced Research Projects Agency Defense Sciences Office(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA))	The work presented in this paper was carried out in part with support from the Defense Advanced Research Projects Agency Defense Sciences Office under a grant to the University of Washington (grant number HR0011-11-2-0007, PI Paul Yager) with collaborators at PATH, GE Global Research, and ElitechGroup North America Inc./Epoch Biosciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alere Scarborough Maine USA, 2012, AL BINAXNOW RSV CARD; Campbell AP, 2013, J CLIN MICROBIOL, V51, P324, DOI 10.1128/JCM.02871-12; Freitas AI, 2014, J BASIC MICROB, V54, P750, DOI 10.1002/jobm.201200603; Gao X, 2007, J CLIN MICROBIOL, V45, P1185, DOI 10.1128/JCM.02076-06; Goodell CK, 2013, VET MICROBIOL, V166, P450, DOI 10.1016/j.vetmic.2013.06.029; Gustavsson L, 2011, J CLIN VIROL, V51, P275, DOI 10.1016/j.jcv.2011.05.025; Harry K. H., 2013, African Journal of Microbiology Research, V7, P4039; Hassanzadeh P, 2013, IRAN RED CRESCENT ME, V15, P207, DOI 10.5812/ircmj.3726; Hollingsworth MA, 2004, NAT REV CANCER, V4, P45, DOI 10.1038/nrc1251; Instant Technologies I, 2011, ISTREP INSTR CLIN DI; Jerris R, 2005, ASM 105 GEN CONV ATL; Jonas D, 2002, J CLIN MICROBIOL, V40, P1821, DOI 10.1128/JCM.40.5.1821-1823.2002; Komaromy A, 2008, P SOC PHOTO-OPT INS, V6799, pU125, DOI 10.1117/12.762416; Landers TF, 2010, J CLIN MICROBIOL, V48, P2235, DOI 10.1128/JCM.01958-09; Matheson A, 2012, INFECT CONT HOSP EP, V33, P803, DOI 10.1086/666639; Mikalova L, 2013, BMC MICROBIOL, V13, DOI 10.1186/1471-2180-13-178; Ostergaard L, 1997, GENITOURIN MED, V73, P493; Patel PA, 2011, J CLIN MICROBIOL, V49, P2266, DOI [10.1128/JCM.02431-10, 10.1128/JCM.00698-11]; Paule SM, 2009, AM J CLIN PATHOL, V131, P532, DOI 10.1309/AJCP18ONZUTDUGAQ; Peterson LR, 2010, J CLIN MICROBIOL, V48, P1661, DOI 10.1128/JCM.00003-10; Ratner B, 2009, BIOMEDICAL ENG E MEG, P305; Rossney AS, 2008, J CLIN MICROBIOL, V46, P3285, DOI 10.1128/JCM.02487-07; Rubin LG, 2008, J CLIN MICROBIOL, V46, P2635, DOI 10.1128/JCM.01903-07; Sheeler Robert D, 2002, J Am Board Fam Pract, V15, P261; SPARHAM PD, 1978, J CLIN PATHOL, V31, P913, DOI 10.1136/jcp.31.10.913; Spyridaki IS, 2009, J VIROL METHODS, V156, P102, DOI 10.1016/j.jviromet.2008.10.027; Turner JC, 2010, 26 CLIN VIR S FLOR U; van der Schee C, 1999, J CLIN MICROBIOL, V37, P4127, DOI 10.1128/JCM.37.12.4127-4130.1999; Verhoeven P, 2010, J CLIN MICROBIOL, V48, P4242, DOI 10.1128/JCM.01425-10; Waris ME, 2007, ARCH DIS CHILD, V92, P1046, DOI 10.1136/adc.2006.113514; Wu LT, 2013, J CLIN MICROBIOL, V51, P3031, DOI 10.1128/JCM.00740-13; Yam WC, 2013, J CLIN MICROBIOL, V51, P2869, DOI 10.1128/JCM.00488-13	32	26	27	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2014	9	9							e105786	10.1371/journal.pone.0105786	http://dx.doi.org/10.1371/journal.pone.0105786			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3LR	25181250	Green Published, gold, Green Submitted			2022-12-27	WOS:000341231500034
J	Xiao, D; Ye, CY; Zhang, HF; Kan, B; Lu, JX; Xu, JG; Jiang, XG; Zhao, F; You, YH; Yan, XM; Wang, DC; Hu, Y; Zhang, MJ; Zhang, JZ				Xiao, Di; Ye, Changyun; Zhang, Huifang; Kan, Biao; Lu, Jingxing; Xu, Jianguo; Jiang, Xiugao; Zhao, Fei; You, Yuanhai; Yan, Xiaomei; Wang, Duochun; Hu, Yuan; Zhang, Maojun; Zhang, Jianzhong			The Construction and Evaluation of Reference Spectra for the Identification of Human Pathogenic Microorganisms by MALDI-TOF MS	PLOS ONE			English	Article							FLIGHT MASS-SPECTROMETRY; DESORPTION-IONIZATION-TIME; SPECIES IDENTIFICATION; RAPID IDENTIFICATION; ANAEROBIC-BACTERIA; STREPTOCOCCUS; DATABASE; SYSTEMS	Matrix-assisted laser desorption/ionization time-of-flight mass spectrometry (MALDI-TOF MS) is an emerging technique for the rapid and high-throughput identification of microorganisms. There remains a dearth of studies in which a large number of pathogenic microorganisms from a particular country or region are utilized for systematic analyses. In this study, peptide mass reference spectra (PMRS) were constructed and evaluated from numerous human pathogens (a total of 1019 strains from 94 species), including enteric (46 species), respiratory (21 species), zoonotic (17 species), and nosocomial pathogens (10 species), using a MALDI-TOF MS Biotyper system (MBS). The PMRS for 380 strains of 52 species were new contributions to the original reference database (ORD). Compared with the ORD, the new reference database (NRD) allowed for 28.2% (from 71.5% to 99.7%) and 42.3% (from 51.3% to 93.6%) improvements in identification at the genus and species levels, respectively. Misidentification rates were 91.7% and 57.1% lower with the NRD than with the ORD for genus and species identification, respectively. Eight genera and 25 species were misidentified. For genera and species that are challenging to accurately identify, identification results must be manually determined and adjusted in accordance with the database parameters. Through augmentation, the MBS demonstrated a high identification accuracy and specificity for human pathogenic microorganisms. This study sought to provide theoretical guidance for using PMRS databases in various fields, such as clinical diagnosis and treatment, disease control, quality assurance, and food safety inspection.	[Xiao, Di; Ye, Changyun; Zhang, Huifang; Kan, Biao; Lu, Jingxing; Xu, Jianguo; Jiang, Xiugao; Zhao, Fei; You, Yuanhai; Yan, Xiaomei; Wang, Duochun; Hu, Yuan; Zhang, Maojun; Zhang, Jianzhong] Chinese Ctr Dis Control & Prevent, Natl Inst Communicable Dis Control & Prevent, State Key Lab Infect Dis Prevent & Control, Beijing, Peoples R China; [Xiao, Di; Ye, Changyun; Zhang, Huifang; Kan, Biao; Lu, Jingxing; Xu, Jianguo; Jiang, Xiugao; Zhao, Fei; You, Yuanhai; Yan, Xiaomei; Wang, Duochun; Hu, Yuan; Zhang, Maojun; Zhang, Jianzhong] Collaborat Innovat Ctr Diag & Treatment Infect Di, Hangzhou, Zhejiang, Peoples R China	Chinese Center for Disease Control & Prevention; National Institute for Communicable Disease Control & Prevention, Chinese Center for Disease Control & Prevention; Collaborative Innovation Center for Diagnosis & Treatment of Infectious Diseases	Zhang, JZ (corresponding author), Chinese Ctr Dis Control & Prevent, Natl Inst Communicable Dis Control & Prevent, State Key Lab Infect Dis Prevent & Control, Beijing, Peoples R China.	zhangjianzhong@icdc.cn	Zhang, Hui/HHN-8494-2022; Zhang, Jianzhong/AAM-6179-2021; zhang, hui/GXH-6098-2022	Zhang, Jianzhong/0000-0001-7056-8206; 	national key program for infectious disease of China [2013ZX10004216-002]; national key scientific instrument and equipment development projects [2012YQ18011709]; Mega Project of Research on HIV/AIDS, Viral Hepatitis Infectious Disease [2013ZX10004-101]	national key program for infectious disease of China; national key scientific instrument and equipment development projects; Mega Project of Research on HIV/AIDS, Viral Hepatitis Infectious Disease	This work was supported by the national key program for infectious disease of China (Contract No. 2013ZX10004216-002), the national key scientific instrument and equipment development projects (Contract No. 2012YQ18011709), Mega Project of Research on HIV/AIDS, Viral Hepatitis Infectious Disease (Contract No. 2013ZX10004-101). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alispahic M, 2011, INT J MED MICROBIOL, V301, P513, DOI 10.1016/j.ijmm.2011.03.001; Bessede E, 2011, CLIN MICROBIOL INFEC, V17, P533, DOI 10.1111/j.1469-0691.2010.03274.x; Bizzini A, 2010, J CLIN MICROBIOL, V48, P1549, DOI 10.1128/JCM.01794-09; Christensen JJ, 2012, J CLIN MICROBIOL, V50, P1787, DOI 10.1128/JCM.06339-11; Coulibaly O, 2011, MED MYCOL, V49, P621, DOI 10.3109/13693786.2011.555424; De Carolis E, 2012, CLIN MICROBIOL INFEC, V18, P475, DOI 10.1111/j.1469-0691.2011.03599.x; Dubois D, 2010, J CLIN MICROBIOL, V48, P941, DOI 10.1128/JCM.00413-09; Fedorko DP, 2012, EUR J CLIN MICROBIOL, V31, P2257, DOI 10.1007/s10096-012-1563-4; Ferreira L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020223; Hijazin M, 2012, VET MICROBIOL, V157, P243, DOI 10.1016/j.vetmic.2011.12.022; Ilina EN, 2009, J MOL DIAGN, V11, P75, DOI 10.2353/jmoldx.2009.080079; Justesen US, 2011, J CLIN MICROBIOL, V49, P4314, DOI 10.1128/JCM.05788-11; Khot PD, 2013, J CLIN MICROBIOL, V51, P3711, DOI 10.1128/JCM.01526-13; Manchanda V, 2010, J GLOB INFECT DIS, V2, P291, DOI 10.4103/0974-777X.68538; Mellmann A, 2008, J CLIN MICROBIOL, V46, P1946, DOI 10.1128/JCM.00157-08; Murugaiyan J, 2012, CLIN MICROBIOL INFEC, V18, P461, DOI 10.1111/j.1469-0691.2011.03593.x; Putignani L, 2011, MOL BIOSYST, V7, P620, DOI 10.1039/c0mb00138d; Risch M, 2010, SWISS MED WKLY, V140, P37, DOI 10.4414/smw.2010/13095; Saffert RT, 2011, J CLIN MICROBIOL, V49, P887, DOI 10.1128/JCM.01890-10; Sogawa K, 2012, ANAL BIOANAL CHEM, V403, P1811, DOI 10.1007/s00216-011-5656-1; Sogawa K, 2011, ANAL BIOANAL CHEM, V400, P1905, DOI 10.1007/s00216-011-4877-7; Sparbier K, 2012, EUR J CLIN MICROBIOL, V31, P767, DOI 10.1007/s10096-011-1373-0; Suh MJ, 2005, PROTEOMICS, V5, P4818, DOI 10.1002/pmic.200402111; van Veen SQ, 2010, J CLIN MICROBIOL, V48, P900, DOI 10.1128/JCM.02071-09; Verroken A, 2010, J CLIN MICROBIOL, V48, P4015, DOI 10.1128/JCM.01234-10; Wang J, 2012, ANAL CHIM ACTA, V716, P133, DOI 10.1016/j.aca.2011.12.016; Xiao D, 2013, INFECT GENET EVOL, V14, P320, DOI 10.1016/j.meegid.2012.12.007; Xiao D, 2012, DIAGN MICR INFEC DIS, V73, P301, DOI 10.1016/j.diagmicrobio.2012.04.004; Zhu BQ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056139	29	10	10	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2014	9	9							e106312	10.1371/journal.pone.0106312	http://dx.doi.org/10.1371/journal.pone.0106312			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3LR	25181391	Green Published, Green Submitted, gold			2022-12-27	WOS:000341231500075
J	Tsujimura, Y; Inada, H; Yoneda, M; Fujita, T; Matsuo, K; Yasutomi, Y				Tsujimura, Yusuke; Inada, Hiroyasu; Yoneda, Misao; Fujita, Tomoyuki; Matsuo, Kazuhiro; Yasutomi, Yasuhiro			Effects of Mycobacteria Major Secretion Protein, Ag85B, on Allergic Inflammation in the Lung	PLOS ONE			English	Article							DELTA-T-CELLS; TISSUE HOMEOSTASIS; IMMUNE-RESPONSES; BCG VACCINATION; INFECTION; IL-22; INNATE; IL-17; TUBERCULOSIS; MODEL	Many epidemiological studies have suggested that the recent increase in prevalence and severity of allergic diseases such as asthma is inversely correlated with Mycobacterium bovis bacillus Calmette Guerin (BCG) vaccination. However, the underlying mechanisms by which mycobacterial components suppress allergic diseases are not yet fully understood. Here we showed the inhibitory mechanisms for development of allergic airway inflammation by using highly purified recombinant Ag85B (rAg85B), which is one of the major protein antigens secreted from M. tuberculosis. Ag85B is thought to be a single immunogenic protein that can elicit a strong Th1-type immune response in hosts infected with mycobacteria, including individuals vaccinated with BCG. Administration of rAg85B showed a strong inhibitory effect on the development of allergic airway inflammation with induction of Th1-response and IL-17 and IL-22 production. Both cytokines induced by rAg85B were involved in the induction of Th17-related cytokine-production innate immune cells in the lung. Administration of neutralizing antibodies to IL-17 or IL-22 in rAg85B-treated mice revealed that IL-17 induced the infiltration of neutrophils in BAL fluid and that allergen-induced bronchial eosinophilia was inhibited by IL-22. Furthermore, enhancement of the expression of genes associated with tissue homeostasis and wound healing was observed in bronchial tissues after rAg85B administration in a Th17-related cytokine dependent manner. The results of this study provide evidence for the potential usefulness of rAg85B as a novel approach for anti-allergic effect and tissue repair other than the role as a conventional TB vaccine.	[Tsujimura, Yusuke; Yasutomi, Yasuhiro] Tsukuba Primate Res Ctr, Natl Inst Biomed Innovat, Lab Immunoregulat & Vaccine Res, Tsukuba, Ibaraki, Japan; [Inada, Hiroyasu] Suzuka Univ Med Sci, Dept Pharmaceut Sci, Suzuka, Mie, Japan; [Yoneda, Misao] Mie Univ, Grad Sch Med, Inst Mol & Expt Med, Dept Pathol Oncol,Fac Med, Tsu, Mie 514, Japan; [Fujita, Tomoyuki] Maruho Co Ltd, Kyoto R&D Ctr, Res Labs, Shimogyo ku, Kyoto, Japan; [Matsuo, Kazuhiro] Japan BCG Lab, Dept Res & Dev, Tokyo, Japan; [Yasutomi, Yasuhiro] Mie Univ, Dept Immunoregulat, Grad Sch Med, Tsu, Mie 514, Japan	National Institute of Health Sciences - Japan; Mie University; Mie University	Yasutomi, Y (corresponding author), Tsukuba Primate Res Ctr, Natl Inst Biomed Innovat, Lab Immunoregulat & Vaccine Res, Tsukuba, Ibaraki, Japan.	yasutomi@nibio.go.jp		Matsuo, Keitaro/0000-0003-1761-6314	Health Science Research Grants from the Ministry of Health, Labor, and Welfare of Japan; Ministry of Education, Culture, Sports, Science, and Technology of Japan	Health Science Research Grants from the Ministry of Health, Labor, and Welfare of Japan; Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by Health Science Research Grants from the Ministry of Health, Labor, and Welfare of Japan and the Ministry of Education, Culture, Sports, Science, and Technology of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS DO, 1976, AM J PATHOL, V84, P164; Adams JFA, 1999, LANCET, V353, P2030, DOI 10.1016/S0140-6736(98)08510-9; Cavallo GP, 2002, ARCH OTOLARYNGOL, V128, P1058, DOI 10.1001/archotol.128.9.1058; Cella M, 2009, NATURE, V457, P722, DOI 10.1038/nature07537; Choi IS, 2002, ANN ALLERG ASTHMA IM, V88, P584, DOI 10.1016/S1081-1206(10)61890-X; Cui JQ, 1999, J EXP MED, V190, P783, DOI 10.1084/jem.190.6.783; DETOGNI P, 1994, SCIENCE, V264, P703, DOI 10.1126/science.8171322; Dieli F, 2000, EUR J IMMUNOL, V30, P1512, DOI 10.1002/(SICI)1521-4141(200005)30:5<1512::AID-IMMU1512>3.0.CO;2-3; Dieli F, 2003, J IMMUNOL, V170, P463, DOI 10.4049/jimmunol.170.1.463; Graf R, 2006, J SURG RES, V133, P113, DOI 10.1016/j.jss.2005.09.030; Grenier A, 2002, BLOOD, V99, P2997, DOI 10.1182/blood.V99.8.2997; Griffiths KL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023463; Guilloteau K, 2010, J IMMUNOL; Harada M, 2006, J EXP MED, V203, P2929, DOI 10.1084/jem.20062206; Herz U, 1998, J ALLERGY CLIN IMMUN, V102, P867, DOI 10.1016/S0091-6749(98)70030-2; Holgate ST, 2012, NAT MED, V18, P673, DOI 10.1038/nm.2731; Karamatsu K, 2012, J ASTHMA ALLERGY, V5, P71, DOI 10.2147/JAA.S37667; Korn T, 2009, ANNU REV IMMUNOL, V27, P485, DOI 10.1146/annurev.immunol.021908.132710; Lambrecht BN, 2012, NAT MED, V18, P684, DOI 10.1038/nm.2737; Li ZJ, 2006, INVEST OPHTH VIS SCI, V47, P4794, DOI 10.1167/iovs.06-0381; Li ZJ, 2011, FASEB J, V25, P2659, DOI 10.1096/fj.11-184804; Li ZJ, 2011, AM J PATHOL, V178, P1106, DOI 10.1016/j.ajpath.2010.12.001; Lockhart E, 2006, J IMMUNOL, V177, P4662, DOI 10.4049/jimmunol.177.7.4662; Monticelli LA, 2011, NAT IMMUNOL, V12, P1045, DOI [10.1038/ni.2131, 10.1031/ni.2131]; Mori H, 2009, ARCH DERMATOL RES, V301, P151, DOI 10.1007/s00403-008-0873-y; Planus E, 1999, J CELL SCI, V112, P243; Robinson DS, 2004, J CLIN INVEST, V114, P1389, DOI 10.1172/JCI200423595; Sandor M, 2003, TRENDS IMMUNOL, V24, P44, DOI 10.1016/S1471-4906(02)00006-6; Schnyder B, 2010, CYTOKINE, V50, P220, DOI 10.1016/j.cyto.2010.02.003; Sonnenberg GF, 2011, NAT IMMUNOL, V12, P383, DOI 10.1038/ni.2025; Sonnenberg GF, 2010, J EXP MED, V207, P1293, DOI 10.1084/jem.20092054; Stassen M, 2004, J IMMUNOL, V173, P267, DOI 10.4049/jimmunol.173.1.267; Stirling DP, 2009, J NEUROSCI, V29, P753, DOI 10.1523/JNEUROSCI.4918-08.2009; Sugimoto K, 2008, J CLIN INVEST, V118, P534, DOI [10.1172/JC133194, 10.1172/JCI33194]; Takamura S, 2005, J IMMUNOL, V175, P2541, DOI 10.4049/jimmunol.175.4.2541; Takatori H, 2009, J EXP MED, V206, P35, DOI 10.1084/jem.20072713; Taniguchi M, 2003, ANNU REV IMMUNOL, V21, P483, DOI 10.1146/annurev.immunol.21.120601.141057; Torrado E, 2010, CYTOKINE GROWTH F R, V21, P455, DOI 10.1016/j.cytogfr.2010.10.004; Yoshida YO, 2010, J IMMUNOL, V184, P4414, DOI 10.4049/jimmunol.0903332; Zuany-Amorim C, 2002, NAT MED, V8, P625, DOI 10.1038/nm0602-625	40	13	14	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2014	9	9							e106807	10.1371/journal.pone.0106807	http://dx.doi.org/10.1371/journal.pone.0106807			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ1IR	25192550	Green Published, gold, Green Submitted			2022-12-27	WOS:000347993600065
J	Voigt, W; Hoellthaler, J; Magnani, T; Corrao, V; Valdagni, R				Voigt, Wieland; Hoellthaler, Josef; Magnani, Tiziana; Corrao, Vito; Valdagni, Riccardo			'Act on Oncology' as a New Comprehensive Approach to Assess Prostate Cancer Centres - Method Description and Results of a Pilot Study	PLOS ONE			English	Article							MULTIDISCIPLINARY CARE; BREAST CENTERS; MANAGEMENT; SURVEILLANCE; REQUIREMENTS; IMPROVEMENT; UNIT	Background: Multidisciplinary care of prostate cancer is increasingly offered in specialised cancer centres. It requires the optimisation of medical and operational processes and the integration of the different medical and non-medical stakeholders. Objective: To develop a standardised operational process assessment tool basing on the capability maturity model integration (CMMI) able to implement multidisciplinary care and improve process quality and efficiency. Design, Setting, and Participants: Information for model development was derived from medical experts, clinical guidelines, best practice elements of renowned cancer centres, and scientific literature. Data were organised in a hierarchically structured model, consisting of 5 categories, 30 key process areas, 172 requirements, and more than 1500 criteria. Compliance with requirements was assessed through structured on-site surveys covering all relevant clinical and management processes. Comparison with best practice standards allowed to recommend improvements. 'Act On Oncology'(AoO) was applied in a pilot study on a prostate cancer unit in Europe. Results and Limitations: Several best practice elements such as multidisciplinary clinics or advanced organisational measures for patient scheduling were observed. Substantial opportunities were found in other areas such as centre management and infrastructure. As first improvements the evaluated centre administration described and formalised the organisation of the prostate cancer unit with defined personnel assignments and clinical activities and a formal agreement is being worked on to have structured access to First-Aid Posts. Conclusions: In the pilot study, the AoO approach was feasible to identify opportunities for process improvements. Measures were derived that might increase the operational process quality and efficiency.	[Voigt, Wieland; Hoellthaler, Josef] Siemens AG, H CX CRM VA HCC ONC, Healthcare Sect, Customer Solut Div, Erlangen, Germany; [Magnani, Tiziana; Corrao, Vito; Valdagni, Riccardo] Fdn IRCCS, Ist Nazl Tumori, Milan, Italy	Siemens AG; Siemens Germany; Fondazione IRCCS Istituto Nazionale Tumori Milan	Voigt, W (corresponding author), Siemens AG, H CX CRM VA HCC ONC, Healthcare Sect, Customer Solut Div, Erlangen, Germany.	wieland.voigt@siemens.com	Valdagni, Riccardo/K-1361-2016	Valdagni, Riccardo/0000-0001-5140-9728	Siemens AG Healthcare Sector	Siemens AG Healthcare Sector(Siemens AG)	This study was funded by Siemens AG Healthcare Sector. Co-authors Wieland Voigt and Josef Hoellthaler are employed by Siemens AG Healthcare Sector. Siemens AG Healthcare Sector provided support in the form of salaries for authors Wieland Voigt and Josef Hoellthaler, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section."	Aizer AA, 2013, SEMIN RADIAT ONCOL, V23, P157, DOI 10.1016/j.semradonc.2013.01.001; Aizer AA, 2012, J CLIN ONCOL, V30, P3071, DOI 10.1200/JCO.2012.42.8466; Anand N, 2007, ORGAN DYN, V36, P329, DOI 10.1016/j.orgdyn.2007.06.001; Basler Joseph W, 2005, Curr Urol Rep, V6, P228, DOI 10.1007/s11934-005-0012-7; Beckmann MW, 2011, ONKOLOGIE, V34, P362, DOI 10.1159/000329601; Bellardita L, 2011, J ONCOL PRACT, V7, pE1, DOI 10.1200/JOP.2010.000020; Brucker SY, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-228; Bul M, 2013, EUR UROL, V63, P597, DOI 10.1016/j.eururo.2012.11.005; Chrissis M, 2006, CMMI GUIDELINES PROC; Cornish JA, 2011, SURG ONCOL, V20, pE72, DOI 10.1016/j.suronc.2010.10.005; Cox J, 2008, CURR OPIN UROL, V18, P275, DOI 10.1097/MOU.0b013e3282fba5f2; Forrester E, 2011, CMMI SERVICES GUIDEL, P2; Gabel M, 1997, CANCER, V79, P2380; Gemmel P, 2007, WORKING PAPER; Gomella LG, 2011, EUR UROL, V60, P1197, DOI 10.1016/j.eururo.2011.08.023; Gomella LG, 2010, J ONCOL PRACT, V6, pE5, DOI 10.1200/JOP.2010.000071; Goncalves PD, 2013, BMC HEALTH SERV RES, V13, DOI 10.1186/1472-6963-13-475; Greiling M, 2010, ORTHOPADE, V39, P752, DOI 10.1007/s00132-010-1623-3; Heidenreich A., 2013, EUR UROL; Hopmeier T, 2012, SENOLOGIE, V9, pA70; JUNOR EJ, 1994, BRIT J CANCER, V70, P363, DOI 10.1038/bjc.1994.307; Kesson EM, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e2718; Krebsgesellschaft D, 2010, ERH PROST; Lordick F, 2010, ONKOLOGISCHE CHIRURG, P201; Lotz J, 2011, DEV PROCESS MATURITY; Magnani T, 2012, BJU INT, V110, P998, DOI 10.1111/j.1464-410X.2012.10970.x; Network NCC, 2011, NCCN GUID VERS 1 201; Parker C, 2004, LANCET ONCOL, V5, P101, DOI 10.1016/S1470-2045(04)01384-1; Raghupathi W, 2002, COMMUN ACM, V45, P56, DOI 10.1145/585597.585602; Ray-Coquard I, 2004, ANN ONCOL, V15, P307, DOI 10.1093/annonc/mdh058; Ruhstaller T, 2006, EUR J CANCER, V42, P2459, DOI 10.1016/j.ejca.2006.03.034; Scott JA, 2013, J CLIN ONCOL, V31; Seidel RP, 2013, BREAST CARE, V8, P41, DOI 10.1159/000348356; Spencer BA, 2008, J CLIN ONCOL, V26, P3735, DOI 10.1200/JCO.2007.13.2555; Steffens JA, 2010, UROLOGE, V49, P910, DOI 10.1007/s00120-010-2301-0; Strebel RT, 2013, SUPPORT CARE CANCER, V21, P2327, DOI 10.1007/s00520-013-1791-x; Valdagni R, 2005, INT J RADIAT ONCOL, V63, P309, DOI 10.1016/j.ijrobp.2005.04.055; Valdagni R, 2011, EUR J CANCER, V47, P1, DOI 10.1016/j.ejca.2010.10.029; van Lent WAM, 2010, BMC HEALTH SERV RES, V10, DOI 10.1186/1472-6963-10-253; Weikert S, 2011, UROLOGE, V50, P1083, DOI 10.1007/s00120-011-2629-0; Wilson ARM, 2013, EUR J CANCER, V49, P3579, DOI 10.1016/j.ejca.2013.07.017	41	6	6	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2014	9	9							e106743	10.1371/journal.pone.0106743	http://dx.doi.org/10.1371/journal.pone.0106743			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ1IR	25192213	Green Published, Green Submitted, gold			2022-12-27	WOS:000347993600057
J	Chou, CJ; Peng, SY; Wu, MH; Yang, CC; Lin, YS; Cheng, WTK; Wu, SC; Lin, YP				Chou, Chih-Jen; Peng, Shao-Yu; Wu, Mei-Han; Yang, Cho-Chen; Lin, Yu-Sheng; Cheng, Winston Teng-Kui; Wu, Shinn-Chih; Lin, Yao-Ping			Generation and Characterization of a Transgenic Pig Carrying a DsRed-Monomer Reporter Gene	PLOS ONE			English	Article							RED FLUORESCENT PROTEIN; SWINE GENOME; CELLS; MOUSE; MODEL; CORAL; MICE	Background: Pigs are an optimal animal for conducting biomedical research because of their anatomical and physiological resemblance to humans. In contrast to the abundant resources available in the study of mice, few fluorescent protein-harboring porcine models are available for preclinical studies. In this paper, we report the successful generation and characterization of a transgenic DsRed-Monomer porcine model. Methods: The transgene comprised a CMV enhancer/chicken-beta actin promoter and DsRed monomeric cDNA. Transgenic pigs were produced by using pronuclear microinjection. PCR and Southern blot analyses were applied for identification of the transgene. Histology, blood examinations and computed tomography were performed to study the health conditions. The pig amniotic fluid progenitor/stem cells were also isolated to examine the existence of red fluorescence and differentiation ability. Results: Transgenic pigs were successfully generated and transmitted to offspring at a germ-line transmission rate of 43.59% (17/39). Ubiquitous expression of red fluorescence was detected in the brain, eye, tongue, heart, lung, liver, pancreas, spleen, stomach, small intestine, large intestine, kidney, testis, and muscle; this was confirmed by histology and western blot analyses. In addition, we confirmed the differentiation potential of amniotic fluid progenitor stem cells isolated from the transgenic pig. Conclusions: This red fluorescent pig can serve as a host for other fluorescent-labeled cells in order to study cell-microenvironment interactions, and can provide optimal red-fluorescent-labeled cells and tissues for research in developmental biology, regenerative medicine, and xenotransplantation.	[Chou, Chih-Jen; Peng, Shao-Yu; Wu, Shinn-Chih] Natl Taiwan Univ, Inst Biotechnol, Taipei 10764, Taiwan; [Wu, Mei-Han] Taipei Vet Gen Hosp, Dept Radiol, Taipei, Taiwan; [Yang, Cho-Chen] Natl Chiayi Univ, Dept Anim Sci, Chiayi, Taiwan; [Lin, Yu-Sheng; Cheng, Winston Teng-Kui; Wu, Shinn-Chih] Natl Taiwan Univ, Dept Anim Sci & Technol, Taipei 10764, Taiwan; [Cheng, Winston Teng-Kui] Tunghai Univ, Dept Anim Sci & Biotechnol, Taichung 40704, Taiwan; [Lin, Yao-Ping] Taipei Vet Gen Hosp, Div Nephrol, Dept Med, Taipei, Taiwan; [Wu, Mei-Han; Lin, Yao-Ping] Natl Yang Ming Univ, Dept Med, Taipei 112, Taiwan	National Taiwan University; Taipei Veterans General Hospital; National Chiayi University; National Taiwan University; Tunghai University; Taipei Veterans General Hospital; National Yang Ming Chiao Tung University	Wu, SC (corresponding author), Natl Taiwan Univ, Inst Biotechnol, Taipei 10764, Taiwan.	scw01@ntu.edu.tw; linyp@vghtpe.gov.tw	Chou, Chih-Jen/AAF-6939-2020	Wu, Shinn-Chih/0000-0001-8881-1550	National Taiwan University [97R-99R0066-41]; Council of Agriculture, Executive Yuan, R. O. C. (Taiwan) [99AS-1.2.3-ST-aM]	National Taiwan University(National Taiwan University); Council of Agriculture, Executive Yuan, R. O. C. (Taiwan)	This work was supported by a grant from National Taiwan University (Grant 97R-99R0066-41) and the Council of Agriculture, Executive Yuan, R. O. C. (Taiwan) (Grant 99AS-1.2.3-ST-aM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe T, 2013, DEV GROWTH DIFFER, V55, P390, DOI 10.1111/dgd.12062; Baird GS, 2000, P NATL ACAD SCI USA, V97, P11984, DOI 10.1073/pnas.97.22.11984; Campbell RE, 2002, P NATL ACAD SCI USA, V99, P7877, DOI 10.1073/pnas.082243699; Gross LA, 2000, P NATL ACAD SCI USA, V97, P11990, DOI 10.1073/pnas.97.22.11990; Hadjantonakis AK, 2004, BMC BIOTECHNOL, V4, DOI 10.1186/1472-6750-4-33; Hadjantonakis Anna-Katerina, 2002, BMC Biotechnol, V2, P11, DOI 10.1186/1472-6750-2-11; Hirabayashi M, 2001, EXP ANIM TOKYO, V50, P125, DOI 10.1538/expanim.50.125; Hsiao FSH, 2011, J ANIM SCI, V89, P3460, DOI 10.2527/jas.2011-3889; Lu Y, 2013, GENESIS, V51, P575, DOI 10.1002/dvg.22399; Matsunari H, 2008, CLONING STEM CELLS, V10, P313, DOI 10.1089/clo.2008.0024; Matz MV, 1999, NAT BIOTECHNOL, V17, P969, DOI 10.1038/13657; Murakami Takashi, 2012, Methods Mol Biol, V872, P177, DOI 10.1007/978-1-61779-797-2_12; Okabe M, 1997, FEBS LETT, V407, P313, DOI 10.1016/S0014-5793(97)00313-X; Reinecke H, 2008, CIRC RES, V103, P1058, DOI 10.1161/CIRCRESAHA.108.180588; Schook LB, 2005, COMP FUNCT GENOM, V6, P251, DOI 10.1002/cfg.479; Sommer JR, 2012, TRANSGENIC RES, V21, P383, DOI 10.1007/s11248-011-9542-6; Sprangers B, 2008, KIDNEY INT, V74, P14, DOI 10.1038/ki.2008.135; Vintersten K, 2004, GENESIS, V40, P241, DOI 10.1002/gene.20095; Walters EM, 2012, BMC MED GENOMICS, V5, DOI 10.1186/1755-8794-5-55; Yanushevich YG, 2002, FEBS LETT, V511, P11, DOI 10.1016/S0014-5793(01)03263-X; Zhou J, 2011, FEBS LETT, V585, P821, DOI 10.1016/j.febslet.2011.02.013	21	6	7	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 4	2014	9	9							e106864	10.1371/journal.pone.0106864	http://dx.doi.org/10.1371/journal.pone.0106864			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3XV	25187950	Green Published, gold, Green Submitted			2022-12-27	WOS:000341271500092
J	Lu, HY				Lu, Hung-Yi			Application of Optimal Designs to Item Calibration	PLOS ONE			English	Article							BINARY DATA; SEQUENTIAL DESIGNS; LOGISTIC-REGRESSION; PARAMETERS; MODELS	In computerized adaptive testing (CAT), examinees are presented with various sets of items chosen from a precalibrated item pool. Consequently, the attrition speed of the items is extremely fast, and replenishing the item pool is essential. Therefore, item calibration has become a crucial concern in maintaining item banks. In this study, a two-parameter logistic model is used. We applied optimal designs and adaptive sequential analysis to solve this item calibration problem. The results indicated that the proposed optimal designs are cost effective and time efficient.	Fu Jen Catholic Univ, Dept Stat & Informat Sci, New Taipei City, Taiwan	Fu Jen Catholic University	Lu, HY (corresponding author), Fu Jen Catholic Univ, Dept Stat & Informat Sci, New Taipei City, Taiwan.	069201@mail.fju.edu.tw						ABDELBASIT KM, 1983, J AM STAT ASSOC, V78, P90; [Anonymous], 1968, STAT THEORIES MENTAL; ATKINSON AC, 1982, BIOMETRIKA, V69, P61, DOI 10.1093/biomet/69.1.61; BERGER MPF, 1994, J EDUC STAT, V19, P43, DOI 10.3102/10769986019001043; Birnbaum A, 1958, ANN MATH STAT, V29; Birnbaum A, 1957, EFFICIENT DESIGN USE, P26; Buyske SG, 1998, OPTIMAL DES IN PRESS; Buyske S, 2005, APPLIED OPTIMAL DESIGNS, P1, DOI 10.1002/0470857005.ch1; Chang YC, 2013, ARXIV12064189; Chang YC, 2006, MAXIMUM QUASILIKELIH; CHANG YCI, 1992, ANN STAT, V20, P1953, DOI 10.1214/aos/1176348897; Chang YCI, 2010, VOX SANG, V98, P140, DOI 10.1007/S11336-009-9133-0; Eggen TJHM, 1999, APPL PSYCH MEAS, V23, P249, DOI 10.1177/01466219922031365; Fedorov VV., 1972, THEORY OPTIMAL EXPT; John RS, 1975, TECHNOMETRICS, V17, P15; JONES DH, 1994, PSYCHOMETRIKA, V59, P59, DOI 10.1007/BF02294265; Kalish LA, 1978, 33 PENNS STAT U DEP; Kalish LA, 1978, OPTIMAL DESIGN ESTIM; Lazarsfeld P.F., 1968, LATENT STRUCTURE ANA; Lord F.M., 1952, PSYCHOMETRIKA MONOGR, V7, DOI DOI 10.1039/TF9524800166; Lord F. M., 1968, STAT THEORIES MENTAL; LORD FM, 1970, PSYCHOMETRIKA, V35, P43, DOI 10.1007/BF02290592; Mathew T, 2001, J STAT PLAN INFER, V93, P295, DOI 10.1016/S0378-3758(00)00173-7; McBride JR, 1983, RELIABILITY VALIDITY, P223; MINKIN S, 1987, J AM STAT ASSOC, V82, P1098, DOI 10.2307/2289386; Mulder J, 2009, PSYCHOMETRIKA, V74, P273, DOI 10.1007/s11336-008-9097-5; Pukelsheim F., 1993, OPTIMAL DESIGN EXPT; Rasch G., 1960, PROBABILISTIC MODELS; Sands WA, 1999, HUMRROFREADD9626; Silvey S.D, 1980, OPTIMAL DESIGN INTRO; SITTER RR, 1993, SCAND J STAT, V20, P329; van der Aalst W, 2014, IEEE INT ENTERP DIST, P1, DOI 10.1109/EDOC.2014.11; van der Linden WJ, 2000, APPL MEAS EDUC, V13, P35, DOI 10.1207/s15324818ame1301_2; van der Linden WJ, 1998, APPL PSYCH MEAS, V22, P195, DOI 10.1177/01466216980223001; WEISS DJ, 1984, APPL PSYCH MEAS, V8, P273, DOI 10.1177/014662168400800303; WU CFJ, 1985, J AM STAT ASSOC, V80, P974, DOI 10.2307/2288563; Yang M, 2008, J STAT PLAN INFER, V138, P624, DOI 10.1016/j.jspi.2006.12.007; Ying ZL, 1997, STAT SINICA, V7, P75	39	5	5	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 4	2014	9	9							e106747	10.1371/journal.pone.0106747	http://dx.doi.org/10.1371/journal.pone.0106747			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3XV	25188318	Green Published, gold, Green Submitted			2022-12-27	WOS:000341271500081
J	McCoy, RC; Taylor, RW; Blauwkamp, TA; Kelley, JL; Kertesz, M; Pushkarev, D; Petrov, DA; Fiston-Lavier, AS				McCoy, Rajiv C.; Taylor, Ryan W.; Blauwkamp, Timothy A.; Kelley, Joanna L.; Kertesz, Michael; Pushkarev, Dmitry; Petrov, Dmitri A.; Fiston-Lavier, Anna-Sophie			Illumina TruSeq Synthetic Long-Reads Empower De Novo Assembly and Resolve Complex, Highly-Repetitive Transposable Elements	PLOS ONE			English	Article							DROSOPHILA-MELANOGASTER; LARGE GENOMES; GC CONTENT; GENERATION; SEQUENCE; DNA; ALGORITHMS; ALIGNMENT; QUALITY; IMPACT	High-throughput DNA sequencing technologies have revolutionized genomic analysis, including the de novo assembly of whole genomes. Nevertheless, assembly of complex genomes remains challenging, in part due to the presence of dispersed repeats which introduce ambiguity during genome reconstruction. Transposable elements (TEs) can be particularly problematic, especially for TE families exhibiting high sequence identity, high copy number, or complex genomic arrangements. While TEs strongly affect genome function and evolution, most current de novo assembly approaches cannot resolve long, identical, and abundant families of TEs. Here, we applied a novel Illumina technology called TruSeq synthetic long-reads, which are generated through highly-parallel library preparation and local assembly of short read data and which achieve lengths of 1.5-18.5 Kbp with an extremely low error rate (similar to 0.03% per base). To test the utility of this technology, we sequenced and assembled the genome of the model organism Drosophila melanogaster (reference genome strain y; cn, bw, sp) achieving an N50 contig size of 69.7 Kbp and covering 96.9% of the euchromatic chromosome arms of the current reference genome. TruSeq synthetic long-read technology enables placement of individual TE copies in their proper genomic locations as well as accurate reconstruction of TE sequences. We entirely recovered and accurately placed 4,229 (77.8%) of the 5,434 annotated transposable elements with perfect identity to the current reference genome. As TEs are ubiquitous features of genomes of many species, TruSeq synthetic long-reads, and likely other methods that generate long-reads, offer a powerful approach to improve de novo assemblies of whole genomes.	[McCoy, Rajiv C.; Taylor, Ryan W.; Petrov, Dmitri A.; Fiston-Lavier, Anna-Sophie] Stanford Univ, Dept Biol, Stanford, CA 94305 USA; [Blauwkamp, Timothy A.] Illumina Inc, San Diego, CA USA; [Kelley, Joanna L.] Washington State Univ, Sch Biol Sci, Pullman, WA 99164 USA; [Kertesz, Michael] Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA; [Pushkarev, Dmitry] Stanford Univ, Dept Phys, Stanford, CA 94305 USA; [Fiston-Lavier, Anna-Sophie] Inst Sci Evolut Montpellier, Montpellier, France	Stanford University; Illumina; Washington State University; Stanford University; Stanford University; Centre National de la Recherche Scientifique (CNRS); Institut de Recherche pour le Developpement (IRD); Universite de Montpellier	McCoy, RC (corresponding author), Stanford Univ, Dept Biol, Stanford, CA 94305 USA.	rmccoy@stanford.edu	Kelley, Joanna L/H-1693-2012; Fiston-Lavier, Anna-Sophie/ABC-4950-2020; McCoy, Rajiv/AEW-9951-2022	Kelley, Joanna L/0000-0002-7731-605X; Fiston-Lavier, Anna-Sophie/0000-0002-7306-6532; McCoy, Rajiv/0000-0003-0615-146X; Petrov, Dmitri/0000-0002-3664-9130	National Institutes of Health [R01 GM100366, R01 GM097415, R01 GM089926]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM089926, R01GM097415, R01GM100366] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health grants R01 GM100366, R01 GM097415, and R01 GM089926 to DAP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams M., 2002, GENOME BIOL, V3, DOI DOI 10.1186/GB-2002; Adams MD, 2000, SCIENCE, V287, P2185, DOI 10.1126/science.287.5461.2185; Alkan C, 2011, NAT METHODS, V8, P61, DOI 10.1038/NMETH.1527; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; BDGP, D MEL GEN REL 5 NOT; Benjamini Y, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks001; Bradnam KR, 2013, GIGASCIENCE, V2, DOI 10.1186/2047-217X-2-10; Brown C.T., 2012, ARXIV12034802; Casacuberta E, 2013, MOL ECOL, V22, P1503, DOI 10.1111/mec.12170; Chen ZX, 2014, GENOME RES, V24, P1209, DOI 10.1101/gr.159384.113; Clark AG, 2007, NATURE, V450, P203, DOI 10.1038/nature06341; Clarke J, 2009, NAT NANOTECHNOL, V4, P265, DOI [10.1038/NNANO.2009.12, 10.1038/nnano.2009.12]; Cordaux R, 2009, NAT REV GENET, V10, P691, DOI 10.1038/nrg2640; de Koning APJ, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002384; Delcher AL, 2002, NUCLEIC ACIDS RES, V30, P2478, DOI 10.1093/nar/30.11.2478; Duret L, 2001, MOL BIOL EVOL, V18, P757, DOI 10.1093/oxfordjournals.molbev.a003858; Feschotte C, 2002, NAT REV GENET, V3, P329, DOI 10.1038/nrg793; Fiston-Lavier A, FLYTE TRANSPOSABLE E; Fiston-Lavier AS, 2007, GENOME RES, V17, P1458, DOI 10.1101/gr.6208307; Fiston-Lavier AS, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkq1291; Glenn TC, 2011, MOL ECOL RESOUR, V11, P759, DOI 10.1111/j.1755-0998.2011.03024.x; Gonzalez J, 2009, GENE, V448, P124, DOI 10.1016/j.gene.2009.06.008; Gonzalez J, 2009, MOL BIOL EVOL, V26, P1949, DOI 10.1093/molbev/msp107; Gonzalez J, 2008, PLOS BIOL, V6, P2109, DOI 10.1371/journal.pbio.0060251; Gurevich A, 2013, BIOINFORMATICS, V29, P1072, DOI 10.1093/bioinformatics/btt086; Haynes KA, 2007, GENETICS, V175, P1539, DOI 10.1534/genetics.106.066407; Hoskins RA, 2007, SCIENCE, V316, P1625, DOI 10.1126/science.1139816; Hu TT, 2013, GENOME RES, V23, P89, DOI 10.1101/gr.141689.112; Huddleston J, 2014, GENOME RES, V24, P688, DOI 10.1101/gr.168450.113; HURLBERT SH, 1984, ECOL MONOGR, V54, P187, DOI 10.2307/1942661; Jiao X, 2013, J DATA MINING GENOMI, V4; Keane TM, 2013, BIOINFORMATICS, V29, P389, DOI 10.1093/bioinformatics/bts697; Kidwell MG, 2001, EVOLUTION, V55, P1, DOI 10.1111/j.0014-3820.2001.tb01268.x; Kofler R, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002487; Koren S, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-9-r101; Koren S, 2012, NAT BIOTECHNOL, V30, P692, DOI 10.1038/nbt.2280; Kuleshov V, 2014, NAT BIOTECHNOL, V32, P261, DOI 10.1038/nbt.2833; Kurtz S, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-2-r12; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Landolin J, 2014, INITIAL NOVO ASSEMBL; Langley CH, 2011, GENETICS, V188, P239, DOI 10.1534/genetics.111.127530; Lee E, 2012, SCIENCE, V337, P967, DOI 10.1126/science.1222077; Levy Samuel, 2007, PLoS Biol, V5, pe254, DOI 10.1371/journal.pbio.0050254; Li H, 2009, BIOINFORMATICS, V25, P1094, DOI [10.1093/bioinformatics/btp100, 10.1093/bioinformatics/btp324]; Li RQ, 2010, GENOME RES, V20, P265, DOI 10.1101/gr.097261.109; Lindenbaum P, 2014, SAM2TSV UTILITY JVAR; Linheiro RS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030008; Mackay TFC, 2012, NATURE, V482, P173, DOI 10.1038/nature10811; Miller JR, 2010, GENOMICS, V95, P315, DOI 10.1016/j.ygeno.2010.03.001; Myers EW, 2000, SCIENCE, V287, P2196, DOI 10.1126/science.287.5461.2196; Nagarajan N, 2013, NAT REV GENET, V14, P157, DOI 10.1038/nrg3367; Nekrutenko A, 2001, TRENDS GENET, V17, P619, DOI 10.1016/S0168-9525(01)02445-3; Osoegawa K, 2007, GENOMICS, V89, P291, DOI 10.1016/j.ygeno.2006.10.002; Platzer Alexander, 2012, Biology (Basel), V1, P395, DOI 10.3390/biology1020395; Quesneville H, 2005, PLOS COMPUT BIOL, V1, P166, DOI 10.1371/journal.pcbi.0010022; Quesneville H, 2003, J MOL EVOL, V57, pS50, DOI 10.1007/s00239-003-0007-2; R Core Team, 2021, R LANGUAGE ENV STAT; Rebollo R, 2012, ANNU REV GENET, V46, P21, DOI 10.1146/annurev-genet-110711-155621; Robb SMC, 2013, G3-GENES GENOM GENET, V3, P949, DOI 10.1534/g3.112.005348; Roberts RJ, 2013, GENOME BIOL, V14, DOI [10.1186/gb-2013-14-7-405, 10.1186/gb-2013-14-6-405]; Salzberg SL, 2012, GENOME RES, V22, P557, DOI 10.1101/gr.131383.111; Scheipl F., 2020, LINEAR MIXED EFFECTS, DOI 10.18637/jss.v067.i01; Simpson JT, 2012, GENOME RES, V22, P549, DOI 10.1101/gr.126953.111; Sommer DD, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-64; Voskoboynik A, 2013, ELIFE, V2, DOI 10.7554/eLife.00569; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; Ye L, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-3-r31; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107	68	129	156	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 4	2014	9	9							e106689	10.1371/journal.pone.0106689	http://dx.doi.org/10.1371/journal.pone.0106689			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3XV	25188499	Green Submitted, Green Published, gold			2022-12-27	WOS:000341271500070
J	Tang, QS; An, YL; Liu, DF; Liu, PD; Zhang, DS				Tang, Qiusha; An, Yanli; Liu, Dongfang; Liu, Peidang; Zhang, Dongsheng			Folate/NIR 797-Conjugated Albumin Magnetic Nanospheres: Synthesis, Characterisation, and In Vitro and In Vivo Targeting Evaluation	PLOS ONE			English	Article							IRON-OXIDE NANOPARTICLES; DRUG-DELIVERY; CANCER THERANOSTICS; BREAST-CANCER; THERAPY; NANOCARRIERS; RELEASE; SYSTEMS; PROBES	A practical and effective strategy for synthesis of Folate-NIR 797-conjugated Magnetic Albumin Nanospheres (FA-NIR 797-MAN) was developed. For this strategy, Magnetic Albumin Nanospheres (MAN), composed of superparamagnetic iron oxide nanoparticles (SPIONs) and bovine serum albumin (BSA), were covalently conjugated with folic acid (FA) ligands to enhance the targeting capability of the particles to folate receptor (FR) over-expressing tumours. Subsequently, a near-infrared (NIR) fluorescent dye NIR 797 was conjugated with FA-conjugated MAN for in vivo fluorescence imaging. The FA-NIR 797-MAN exhibited low toxicity to a human nasopharyngeal epidermal carcinoma cell line (KB cells). Additionally, in vitro and in vivo evaluation of the dynamic behaviour and targeting ability of FA-NIR 797-MAN to KB tumours validated the highly selective affinity of FA-NIR 797-MAN for FR-positive tumours. In summary, the FA-NIR 797-MAN prepared here exhibited great potential for tumour imaging, since the near-infrared fluorescence contrast agents target cells via FR-mediated endocytosis. The high fluorescence intensity together with the targeting effect makes FA-NIR 797-MAN a promising candidate for imaging, monitoring, and early diagnosis of cancer at the molecular and cellular levels.	[Tang, Qiusha; Liu, Peidang; Zhang, Dongsheng] Southeast Univ, Sch Med, Nanjing, Jiangsu, Peoples R China; [An, Yanli; Liu, Dongfang] Southeast Univ, Zhongda Hosp, Sch Med, Dept Radiol,Jiangsu Key Lab Mol & Funct Imaging, Nanjing, Jiangsu, Peoples R China	Southeast University - China; Southeast University - China	Zhang, DS (corresponding author), Southeast Univ, Sch Med, Nanjing, Jiangsu, Peoples R China.	b7712900@jlonline.com			National Key Basic Research Program of China (973 Program) [2013 CB933904, 2013 CB733803]; National Natural Science Foundation of China [81271635, 81071881, 81301270, 81101139]	National Key Basic Research Program of China (973 Program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Key Basic Research Program of China (973 Program) (Grant No. 2013 CB933904, 2013 CB733803), National Natural Science Foundation of China (81271635, 81071881, 81301270, 81101139). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alencar H, 2007, RADIOLOGY, V244, P232, DOI 10.1148/radiol.2441052114; Cao J, 2013, BIOMATERIALS, V34, P6272, DOI 10.1016/j.biomaterials.2013.05.008; Chen HY, 2012, NANOSCALE, V4, P6050, DOI 10.1039/c2nr31616a; Corbin IR, 2013, NANOMEDICINE-UK, V8, P875, DOI [10.2217/nnm.12.137, 10.2217/NNM.12.137]; Du CL, 2013, BIOMATERIALS, V34, P3087, DOI 10.1016/j.biomaterials.2013.01.041; Du Y, 2009, COGN AFFECT BEHAV NE, V9, P44, DOI 10.3758/CABN.9.1.44; Elzoghby AO, 2012, J CONTROL RELEASE, V157, P168, DOI 10.1016/j.jconrel.2011.07.031; Franchini MC, 2010, SMALL, V6, P366, DOI 10.1002/smll.200901689; Guaragna A, 2012, BIOCONJUGATE CHEM, V23, P84, DOI 10.1021/bc200410d; Guo MA, 2011, BIOMATERIALS, V32, P185, DOI 10.1016/j.biomaterials.2010.09.077; Hayashi K, 2013, THERANOSTICS, V3, P366, DOI 10.7150/thno.5860; Laurent S, 2011, INT J MOL EPIDEMIOL, V2, P367; Li YT, 2011, INT J NANOMED, V6, P2805, DOI 10.2147/IJN.S24596; Liu DF, 2011, ADV FUNCT MATER, V21, P1498, DOI 10.1002/adfm.201001658; Liu DF, 2012, NANOSCALE, V4, P2306, DOI 10.1039/c2nr11918h; Liu F, 2010, MOL IMAGING BIOL, V12, P595, DOI 10.1007/s11307-010-0305-1; Liu X, 2013, BIOMATERIALS, V34, P817, DOI 10.1016/j.biomaterials.2012.10.017; Mahajan S, 2013, NANOTECHNOLOGY, V24, DOI 10.1088/0957-4484/24/1/015603; Meng H, 2011, J BIOL INORG CHEM, V16, P117, DOI 10.1007/s00775-010-0709-z; Rastogi R, 2011, COLLOID SURFACE B, V82, P160, DOI 10.1016/j.colsurfb.2010.08.037; Retnakumari A, 2010, NANOTECHNOLOGY, V21, DOI 10.1088/0957-4484/21/5/055103; Santhosh PB, 2013, CANCER LETT, V336, P8, DOI 10.1016/j.canlet.2013.04.032; Saxena V, 2012, COLLOID SURFACE B, V94, P274, DOI 10.1016/j.colsurfb.2012.02.001; Wahajuddin, 2012, INT J NANOMED, V7, P3445, DOI 10.2147/IJN.S30320; Wang X, 2011, ACS NANO, V5, P6184, DOI 10.1021/nn200739q; Wang ZJ, 2008, PEDIATR RADIOL, V38, P529, DOI 10.1007/s00247-008-0764-6; Zhang J, 2010, PHARM RES-DORDR, V27, P46, DOI 10.1007/s11095-009-0005-1; Zhang LK, 2010, ARCH PHARM RES, V33, P1193, DOI 10.1007/s12272-010-0809-x; Zhang LM, 2010, SMALL, V6, P537, DOI 10.1002/smll.200901680; Zhao LY, 2013, J NANOSCI NANOTECHNO, V13, P741, DOI 10.1166/jnn.2013.6080; Zheng CF, 2012, BIOMATERIALS, V33, P5603, DOI 10.1016/j.biomaterials.2012.04.044	31	14	15	0	61	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 4	2014	9	9							e106483	10.1371/journal.pone.0106483	http://dx.doi.org/10.1371/journal.pone.0106483			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3XV	25188308	Green Submitted, Green Published, gold			2022-12-27	WOS:000341271500039
J	Wen, XR; Wang, K; Zhao, ZM; Zhang, YF; Sun, TT; Zhang, F; Wu, J; Fu, YY; Du, Y; Zhang, L; Sun, Y; Liu, YH; Ma, K; Liu, HZ; Song, YJ				Wen, Xiangru; Wang, Kai; Zhao, Ziming; Zhang, Yifang; Sun, Tingting; Zhang, Fang; Wu, Jian; Fu, Yanyan; Du, Yang; Zhang, Lei; Sun, Ying; Liu, YongHai; Ma, Kai; Liu, Hongzhi; Song, Yuanjian			Brain-Targeted Delivery of Trans-Activating Transcriptor-Conjugated Magnetic PLGA/Lipid Nanoparticles	PLOS ONE			English	Article							GENE DELIVERY; POLYMERIC LIPOSOMES; CNS DELIVERY; THERAPY; BARRIER; DRUG; MANIPULATION; NANOCARRIER; CHITOSAN; PROTEIN	Magnetic poly (D, L-lactide-co-glycolide) (PLGA)/lipid nanoparticles (MPLs) were fabricated from PLGA, L-alpha-phosphatidyl-ethanolamine (DOPE), 1,2-distearoyl-sn-glycero-3-phosphoethanolamine-N-amino (polyethylene glycol) (DSPE-PEG-NH2), and magnetic nanoparticles (NPs), and then conjugated to trans-activating transcriptor (TAT) peptide. The TAT-MPLs were designed to target the brain by magnetic guidance and TAT conjugation. The drugs hesperidin (HES), naringin (NAR), and glutathione (GSH) were encapsulated in MPLs with drug loading capacity (>10%) and drug encapsulation efficiency (>90%). The therapeutic efficacy of the drug-loaded TAT-MPLs in bEnd.3 cells was compared with that of drug-loaded MPLs. The cells accumulated higher levels of TAT-MPLs than MPLs. In addition, the accumulation of QD-loaded fluorescein isothiocyanate (FITC)-labeled TAT-MPLs in bEnd.3 cells was dose and time dependent. Our results show that TAT-conjugated MPLs may function as an effective drug delivery system that crosses the blood brain barrier to the brain.	[Wen, Xiangru; Song, Yuanjian] Xuzhou Med Coll, Jiangsu Key Lab Brain Dis Bioinformat, Xuzhou, Jiangsu, Peoples R China; [Wang, Kai; Zhang, Yifang; Sun, Tingting] Yunnan Agr Univ, Coll Anim Sci & Technol, Yunnan, Kunming Provinc, Peoples R China; [Zhao, Ziming] Xuzhou Med Coll, Sch Pharm, Xuzhou, Jiangsu, Peoples R China; [Zhang, Fang; Wu, Jian; Fu, Yanyan; Du, Yang; Liu, Hongzhi; Song, Yuanjian] Xuzhou Med Coll, Neurobiol Res Ctr, Xuzhou, Jiangsu, Peoples R China; [Zhang, Fang; Wu, Jian; Fu, Yanyan; Du, Yang; Liu, Hongzhi; Song, Yuanjian] Xuzhou Med Coll, Dept Neurobiol, Xuzhou, Jiangsu, Peoples R China; [Wen, Xiangru; Ma, Kai] Xuzhou Med Coll, Sch Basic Educ Sci, Xuzhou, Jiangsu, Peoples R China; [Zhang, Lei; Sun, Ying; Liu, YongHai] Xuzhou Med Coll, Affiliated Hosp, Dept Neurol, Xuzhou, Jiangsu, Peoples R China; [Ma, Kai] Xuzhou Med Coll, Dept Med Informat, Xuzhou, Jiangsu, Peoples R China	Xuzhou Medical University; Yunnan Agricultural University; Xuzhou Medical University; Xuzhou Medical University; Xuzhou Medical University; Xuzhou Medical University; Xuzhou Medical University; Xuzhou Medical University	Liu, HZ (corresponding author), Xuzhou Med Coll, Neurobiol Res Ctr, Xuzhou, Jiangsu, Peoples R China.	xzmclhz@126.com; biosongyuanjian@126.com		wang, kai/0000-0002-1373-579X	Jiangsu Key Laboratory of Brain Disease Bioinformation [Jsbl1102]; Priority Academic Program Development of Jiangsu Higher Education Institutions; Education Departmental Natural Science Research Funds of Jiangsu Provincial Higher School of China [13KJB310021]; National Natural Science Foundation of China [31100762, 81371300]; Foundation of President of Xuzhou Medical College [2012KJZ06]; Qing Lan Project of Jiangsu Province	Jiangsu Key Laboratory of Brain Disease Bioinformation; Priority Academic Program Development of Jiangsu Higher Education Institutions; Education Departmental Natural Science Research Funds of Jiangsu Provincial Higher School of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Foundation of President of Xuzhou Medical College; Qing Lan Project of Jiangsu Province	This work was supported by Jiangsu Key Laboratory of Brain Disease Bioinformation (Jsbl1102), the Priority Academic Program Development of Jiangsu Higher Education Institutions, the Education Departmental Natural Science Research Funds of Jiangsu Provincial Higher School of China (13KJB310021), the National Natural Science Foundation of China ( 31100762, 81371300), the Foundation of President of Xuzhou Medical College (2012KJZ06), and the Qing Lan Project of Jiangsu Province. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott NJ, 2010, NEUROBIOL DIS, V37, P13, DOI 10.1016/j.nbd.2009.07.030; Aichberger KJ, 2007, EUR J CLIN INVEST, V37, P808, DOI 10.1111/j.1365-2362.2007.01859.x; Akhtari M, 2008, EPILEPSIA, V49, P1419, DOI 10.1111/j.1528-1167.2008.01615.x; Andreu A, 2008, CHEMBIOCHEM, V9, P219, DOI 10.1002/cbic.200700277; Chavanpatil MD, 2007, MOL PHARM, V4, P730, DOI 10.1021/mp070024d; Choi KM, 2011, ACS NANO, V5, P8690, DOI 10.1021/nn202597c; Costantino L, 2005, J CONTROL RELEASE, V108, P84, DOI 10.1016/j.jconrel.2005.07.013; Cui YN, 2013, BIOMATERIALS, V34, P8511, DOI 10.1016/j.biomaterials.2013.07.075; Dobson J, 2006, GENE THER, V13, P283, DOI 10.1038/sj.gt.3302720; Gabizon AA, 2001, CLIN CANCER RES, V7, P223; Garbuzenko O, 2005, CHEM PHYS LIPIDS, V135, P117, DOI 10.1016/j.chemphyslip.2005.02.003; Kievit FM, 2011, ADV MATER, V23, pH217, DOI 10.1002/adma.201102313; Krack M, 2008, J AM CHEM SOC, V130, P7315, DOI 10.1021/ja077398k; Laurent S, 2008, CHEM REV, V108, P2064, DOI 10.1021/cr068445e; Lazar AN, 2013, NANOMED-NANOTECHNOL, V9, P712, DOI 10.1016/j.nano.2012.11.004; Li LH, 2008, BIOMATERIALS, V29, P1509, DOI 10.1016/j.biomaterials.2007.11.014; Liang XF, 2008, LANGMUIR, V24, P7147, DOI 10.1021/la703775a; Liang XF, 2013, LANGMUIR, V29, P8683, DOI 10.1021/la401166v; Liang XF, 2010, J NANOPART RES, V12, P1723, DOI 10.1007/s11051-010-9896-3; Liang XF, 2009, J BIOMAT SCI-POLYM E, V20, P115, DOI 10.1163/156856208X393536; Liu F, 2014, CHEM COMMUN, V50, P6200, DOI 10.1039/c4cc01266f; Lu W, 2005, INT J PHARMACEUT, V295, P247, DOI 10.1016/j.ijpharm.2005.01.043; Malhotra M, 2013, BIOMATERIALS, V34, P1270, DOI 10.1016/j.biomaterials.2012.10.013; Pan BF, 2007, CANCER RES, V67, P8156, DOI 10.1158/0008-5472.CAN-06-4762; Pan Y, 2012, CHEM SOC REV, V41, P2912, DOI 10.1039/c2cs15315g; Pulkkinen M, 2008, EUR J PHARM BIOPHARM, V70, P66, DOI 10.1016/j.ejpb.2008.04.018; Rao KS, 2008, BIOMATERIALS, V29, P4429, DOI 10.1016/j.biomaterials.2008.08.004; Salman HH, 2007, VACCINE, V25, P8123, DOI 10.1016/j.vaccine.2007.09.044; Santra S, 2005, CHEM COMMUN, P3144, DOI 10.1039/b503234b; Schwarze SR, 1999, SCIENCE, V285, P1569, DOI 10.1126/science.285.5433.1569; Shin J, 2014, INTEGR BIOL-UK, V6, P532, DOI 10.1039/c3ib40195b; Teixido M, 2008, J PEPT SCI, V14, P163, DOI 10.1002/psc.983; Tian XH, 2013, INT J NANOMED, V8, P865, DOI 10.2147/IJN.S39951; Tiwari Sandip B., 2006, Current Drug Delivery, V3, P219, DOI 10.2174/156720106776359230; Torchilin VP, 2008, BIOPOLYMERS, V90, P604, DOI 10.1002/bip.20989; Yamanouchi D, 2008, BIOMATERIALS, V29, P3269, DOI 10.1016/j.biomaterials.2008.04.026; Yu ZQ, 2013, J AM CHEM SOC, V135, P2883, DOI 10.1021/ja311090e; Zhao AJ, 2005, J MAGN MAGN MATER, V295, P37, DOI 10.1016/j.jmmm.2004.12.044	38	41	42	1	80	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 4	2014	9	9							e106652	10.1371/journal.pone.0106652	http://dx.doi.org/10.1371/journal.pone.0106652			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3XV	25187980	Green Published, gold, Green Submitted			2022-12-27	WOS:000341271500065
J	Aydin, S; Dekairelle, AF; Ambroise, J; Durant, JF; Heusterspreute, M; Guiot, Y; Cosyns, JP; Gala, JL				Aydin, Selda; Dekairelle, Anne-France; Ambroise, Jerome; Durant, Jean-Francois; Heusterspreute, Michel; Guiot, Yves; Cosyns, Jean-Pierre; Gala, Jean-Luc			Unambiguous Detection of Multiple TP53 Gene Mutations in AAN-Associated Urothelial Cancer in Belgium Using Laser Capture Microdissection	PLOS ONE			English	Article							ARISTOLOCHIC ACID NEPHROPATHY; TRANSITIONAL-CELL CARCINOMA; CHINESE HERBS NEPHROPATHY; DNA-ADDUCTS; ENDEMIC NEPHROPATHY; SIGNATURE; TISSUE; POLYMORPHISM; DIAGNOSIS; ETIOLOGY	In the Balkan and Taiwan, the relationship between exposure to aristolochic acid and risk of urothelial neoplasms was inferred from the A>T genetic hallmark in TP53 gene from malignant cells. This study aimed to characterize the TP53 mutational spectrum in urothelial cancers consecutive to Aristolochic Acid Nephropathy in Belgium. Serial frozen tumor sections from female patients (n = 5) exposed to aristolochic acid during weight-loss regimen were alternatively used either for p53 immunostaining or laser microdissection. Tissue areas with at least 60% p53-positive nuclei were selected for microdissecting sections according to p53-positive matching areas. All areas appeared to be carcinoma in situ. After DNA extraction, mutations in the TP53 hot spot region (exons 5-8) were identified using nested-PCR and sequencing. False-negative controls consisted in microdissecting fresh-frozen tumor tissues both from a patient with a Li-Fraumeni syndrome who carried a p53 constitutional mutation, and from KRas mutated adenocarcinomas. To rule out false-positive results potentially generated by microdissection and nested-PCR, a phenacetin-associated urothelial carcinoma and normal fresh ureteral tissues (n = 4) were processed with high laser power. No unexpected results being identified, molecular analysis was pursued on malignant tissues, showing at least one mutation in all (six different mutations in two) patients, with 13/16 exonic (nonsense, 2; missense, 11) and 3/16 intronic (one splice site) mutations. They were distributed as transitions (n = 7) or transversions (n = 9), with an equal prevalence of A>T and G>T (3/16 each). While current results are in line with A>T prevalence previously reported in Balkan and Taiwan studies, they also demonstrate that multiple mutations in the TP53 hot spot region and a high frequency of G>T transversion appear as a complementary signature reflecting the toxicity of a cumulative dose of aristolochic acid ingested over a short period of time.	[Aydin, Selda; Guiot, Yves; Cosyns, Jean-Pierre] UCL, IREC, CUSL, Dept Pathol, Brussels, Belgium; [Dekairelle, Anne-France; Ambroise, Jerome; Durant, Jean-Francois; Heusterspreute, Michel; Gala, Jean-Luc] UCL, IREC, CUSL, Ctr Appl Mol Technol CTMA, Brussels, Belgium	Universite Catholique Louvain; Cliniques Universitaires Saint-Luc; Universite Catholique Louvain	Gala, JL (corresponding author), UCL, IREC, CUSL, Ctr Appl Mol Technol CTMA, Brussels, Belgium.	jean-luc.gala@uclouvain.be						Arlt VM, 2002, MUTAGENESIS, V17, P265, DOI 10.1093/mutage/17.4.265; Arlt VM, 2001, MUTAT RES-GEN TOX EN, V494, P143, DOI 10.1016/S1383-5718(01)00188-7; Besaratinia A, 2010, FASEB J, V24, P2612, DOI 10.1096/fj.10-157263; Bieler CA, 1997, CARCINOGENESIS, V18, P1063, DOI 10.1093/carcin/18.5.1063; Chen CH, 2013, INT J CANCER, V133, P14, DOI 10.1002/ijc.28013; Chen CH, 2012, P NATL ACAD SCI USA, V109, P8241, DOI 10.1073/pnas.1119920109; Cosyns JP, 2003, DRUG SAFETY, V26, P33, DOI 10.2165/00002018-200326010-00004; COSYNS JP, 1994, KIDNEY INT, V45, P1680, DOI 10.1038/ki.1994.220; Cosyns JP, 1999, AM J KIDNEY DIS, V33, P1011, DOI 10.1016/S0272-6386(99)70136-8; Dekairelle AF, 2005, CLIN CANCER RES, V11, P4724, DOI 10.1158/1078-0432.CCR-05-0140; DEPIERREUX M, 1994, AM J KIDNEY DIS, V24, P172, DOI 10.1016/S0272-6386(12)80178-8; Feldmeyer N, 2006, MUTAT RES-GEN TOX EN, V608, P163, DOI 10.1016/j.mrgentox.2006.02.017; Gao JP, 2000, INT J ONCOL, V16, P469; Gokmen MR, 2013, ANN INTERN MED, V158, P469, DOI 10.7326/0003-4819-158-6-201303190-00006; Grollman AP, 2007, P NATL ACAD SCI USA, V104, P12129, DOI 10.1073/pnas.0701248104; Grollman AP, 2013, ENVIRON MOL MUTAGEN, V54, P1, DOI 10.1002/em.21756; Hermans MP, 2006, DIABETIC MED, V23, P529, DOI 10.1111/j.1464-5491.2006.01841.x; Hodges KB, 2010, HUM PATHOL, V41, P155, DOI 10.1016/j.humpath.2009.07.002; Hranjec T, 2005, CROAT MED J, V46, P116; Iwata I, 1999, DIABETES, V48, P416, DOI 10.2337/diabetes.48.2.416; Jelakovic B, 2012, KIDNEY INT, V81, P559, DOI 10.1038/ki.2011.371; Kanaan N, 2003, NEPHROL DIAL TRANSPL, V18, P440, DOI 10.1093/ndt/18.2.440; Lord GM, 2004, AM J KIDNEY DIS, V43, DOI 10.1053/j.ajkd.2003.11.024; Mei N, 2006, MUTAT RES-FUND MOL M, V602, P83, DOI 10.1016/j.mrfmmm.2006.08.004; Moriya M, 2011, INT J CANCER, V129, P1532, DOI 10.1002/ijc.26077; Nedelko T, 2009, INT J CANCER, V124, P987, DOI 10.1002/ijc.24006; Nortier JL, 2000, NEW ENGL J MED, V342, P1686, DOI 10.1056/NEJM200006083422301; Olivier M, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a001008; PETERSEN I, 1993, CARCINOGENESIS, V14, P2119, DOI 10.1093/carcin/14.10.2119; Petitjean A, 2007, HUM MUTAT, V28, P622, DOI 10.1002/humu.20495; Pfeifer GP, 2003, MUTAT RES-FUND MOL M, V526, P39, DOI 10.1016/S0027-5107(03)00013-7; Sauter G, 2004, WHO CLASSIFICATION T, P110; SCHMEISER HH, 1991, CANCER LETT, V59, P139, DOI 10.1016/0304-3835(91)90178-K; Schmeiser HH, 1996, CANCER RES, V56, P2025; STIBOROVA M, 1994, CARCINOGENESIS, V15, P1187, DOI 10.1093/carcin/15.6.1187; VANHAELEN M, 1994, LANCET, V343, P174, DOI 10.1016/S0140-6736(94)90964-4; VANHERWEGHEM JL, 1993, LANCET, V341, P387, DOI 10.1016/0140-6736(93)92984-2; Verhoest G, 2012, UROL ONCOL-SEMIN ORI, V30, P469, DOI 10.1016/j.urolonc.2010.07.005	38	15	17	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 3	2014	9	9							e106301	10.1371/journal.pone.0106301	http://dx.doi.org/10.1371/journal.pone.0106301			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3TB	25184754	Green Published, gold, Green Submitted			2022-12-27	WOS:000341257700052
J	Hu, MB; Liu, SH; Jiang, HW; Bai, PD; Ding, Q				Hu, Meng-Bo; Liu, Sheng-Hua; Jiang, Hao-Wen; Bai, Pei-De; Ding, Qiang			Obesity Affects the Biopsy-Mediated Detection of Prostate Cancer, Particularly High-Grade Prostate Cancer: A Dose-Response Meta-Analysis of 29,464 Patients	PLOS ONE			English	Article							BODY-MASS INDEX; RISK-FACTOR; MEN; ANTIGEN; HEMODILUTION; PSA; ASSOCIATION; PREDICTOR; DISEASE; COHORT	Background and Objectives: In previous studies, obesity (measured according to the body mass index) has correlated inconsistently with the risk of biopsy-measured prostate cancer, and specifically high-grade prostate cancer. This meta-analysis aimed to clarify these correlations. Methods: A comprehensive literature search of the MEDLINE and EMBASE databases was conducted for relevant studies published through January 2014. The pooled estimates of odds ratios (OR) and confidence intervals (CI) were computed, and the meta-analysis was performed with the STATA software according to a random effects approach. Results: A total of 11 studies that included 29,464 individuals were identified. A 5-kg/m(2) increase in body mass index was associated with a 15% (OR, 1.15; 95% CI, 0.98-1.34) higher risk of prostate cancer detection and a 37% (OR, 1.37; 95% CI, 1.19-1.57) higher risk of high-grade prostate cancer detection at biopsy. There were no differences among the results of studies conducted in the USA, Europe or Asia. We also found that studies that had adjusted for prostate-specific antigen levels, digital rectal examination results, and prostate volumes obtained positive significant outcomes (OR, 1.27; 95% CI, 1.12-1.44), whereas studies that did not adjust for the above-mentioned confounding variables obtained negative results (OR, 0.92; 95% CI, 0.68-1.25). Moreover, the positive correlation between body mass index and the detection of both prostate cancer and high-grade diseases tended to be stronger as the number of biopsy cores increased. Conclusion: The present meta-analysis demonstrated that a high body mass index correlated positively with prostate cancer detection, especially high-grade prostate cancer detection. The adoption of a modified and possibly more aggressive biopsy strategy was suggested for obese populations.	[Hu, Meng-Bo; Liu, Sheng-Hua; Jiang, Hao-Wen; Bai, Pei-De; Ding, Qiang] Fudan Univ, Huashan Hosp, Dept Urol, Shanghai 200433, Peoples R China; [Hu, Meng-Bo; Liu, Sheng-Hua; Jiang, Hao-Wen; Bai, Pei-De; Ding, Qiang] Fudan Univ, Urol Res Inst, Shanghai 200433, Peoples R China	Fudan University; Fudan University	Jiang, HW (corresponding author), Fudan Univ, Huashan Hosp, Dept Urol, Shanghai 200433, Peoples R China.	haowenj@gmail.com; qiangd_urol@126.com	Hu, Meng-Bo/HDL-7502-2022		National Natural Science Foundation of China [81272835]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by funds from National Natural Science Foundation of China (Grant No. 81272835, http://www.nsfc.gov.cn). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashwell M, 2012, OBES REV, V13, P275, DOI 10.1111/j.1467-789X.2011.00952.x; Banez LL, 2007, JAMA-J AM MED ASSOC, V298, P2275, DOI 10.1001/jama.298.19.2275; Calle EE, 2003, NEW ENGL J MED, V348, P1625, DOI 10.1056/NEJMoa021423; De Nunzio C, 2011, EJSO-EUR J SURG ONC, V37, P1025, DOI 10.1016/j.ejso.2011.09.036; De Nunzio C, 2013, UROL ONCOL-SEMIN ORI, V31, P997, DOI 10.1016/j.urolonc.2011.08.007; Deurenberg P, 2002, Obes Rev, V3, P141, DOI 10.1046/j.1467-789X.2002.00065.x; Discacciati A, 2012, ANN ONCOL, V23, P1665, DOI 10.1093/annonc/mdr603; Fowke JH, 2011, CANCER RES, V71, DOI 10.1158/1538-7445.AM2011-944; Fowke JH, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-23; Freedland SJ, 2009, PROSTATE CANCER P D, V12, P259, DOI 10.1038/pcan.2009.11; Freedland SJ, 2006, J UROLOGY, V175, P500, DOI 10.1016/S0022-5347(05)00162-X; Freedland S, 2011, J UROLOGY, V185, pE66, DOI 10.1016/j.juro.2011.02.225; Freedland SJ, 2008, UROLOGY, V72, P1102, DOI 10.1016/j.urology.2008.05.044; Gong Z, 2006, CANCER EPIDEM BIOMAR, V15, P1977; Grubb RL, 2009, CANCER EPIDEM BIOMAR, V18, P748, DOI 10.1158/1055-9965.EPI-08-0938; Harbord RM, 2009, STATA J, V9, P197, DOI 10.1177/1536867X0900900202; Hekal IA, 2010, PROSTATE CANCER P D, V13, P186, DOI 10.1038/pcan.2009.53; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Hu MB, 2014, MED ONCOL, V31, DOI 10.1007/s12032-013-0829-8; Isom-Batz G, 2005, J UROLOGY, V173, P1935, DOI 10.1097/01.ju.0000158040.33531.e7; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Jeon KP, 2012, KOREAN J UROL, V53, P593, DOI 10.4111/kju.2012.53.9.593; Kim YJ, 2007, INT J UROL, V14, P1009, DOI 10.1111/j.1442-2042.2007.01879.x; Kobayashi T, 2005, UROLOGY, V66, P130, DOI 10.1016/j.urology.2005.01.041; MacInnis RJ, 2006, CANCER CAUSE CONTROL, V17, P989, DOI 10.1007/s10552-006-0049-z; Mallah KN, 2005, CANCER-AM CANCER SOC, V103, P2030, DOI 10.1002/cncr.20991; Masuda H, 2013, INT J UROL, V20, P701, DOI 10.1111/iju.12023; Nandeesha H, 2009, INT UROL NEPHROL, V41, P267, DOI 10.1007/s11255-008-9440-x; Oh JJ, 2013, BJU INT, V112, pE265, DOI 10.1111/j.1464-410X.2012.11766.x; Orsini N, 2006, STATA J, V6, P40, DOI 10.1177/1536867X0600600103; Parekh N, 2010, AM J MED, V123, P829, DOI 10.1016/j.amjmed.2010.05.011; Park J, 2013, BJU INT IN PRESS; Price RS, 2012, PROSTATE CANCER P D, V15, P135, DOI 10.1038/pcan.2011.54; Vazquez JP, 2012, MED ONCOL, V29, P1956, DOI 10.1007/s12032-011-0036-4; Remzi M, 2005, J UROLOGY, V174, P1256, DOI 10.1097/01.ju.0000173924.83392.cc; Roobol MJ, 2012, EUR UROL, V61, P577, DOI 10.1016/j.eururo.2011.11.012; Rundle A, 2008, PROSTATE, V68, P373, DOI 10.1002/pros.20704; Rundle A, 2009, CANCER EPIDEM BIOMAR, V18, P2343, DOI 10.1158/1055-9965.EPI-09-0441; Werny DM, 2007, CANCER EPIDEM BIOMAR, V16, P70, DOI 10.1158/1055-9965.EPI-06-0588	39	34	38	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 3	2014	9	9							e106677	10.1371/journal.pone.0106677	http://dx.doi.org/10.1371/journal.pone.0106677			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3TB	25184215	Green Published, gold, Green Submitted			2022-12-27	WOS:000341257700102
J	Myczek, K; Yeung, ST; Castello, N; Baglietto-Vargas, D; LaFerla, FM				Myczek, Kristoffer; Yeung, Stephen T.; Castello, Nicholas; Baglietto-Vargas, David; LaFerla, Frank M.			Hippocampal Adaptive Response Following Extensive Neuronal Loss in an Inducible Transgenic Mouse Model	PLOS ONE			English	Article							TRAUMATIC BRAIN-INJURY; NEURAL STEM-CELLS; ENDOTHELIAL GROWTH-FACTOR; ROSTRAL MIGRATORY STREAM; TEMPORAL-LOBE EPILEPSY; CENTRAL-NERVOUS-SYSTEM; ALZHEIMERS-DISEASE; DENTATE GYRUS; ADULT NEUROGENESIS; SUBVENTRICULAR ZONE	Neuronal loss is a common component of a variety of neurodegenerative disorders (including Alzheimer's, Parkinson's, and Huntington's disease) and brain traumas (stroke, epilepsy, and traumatic brain injury). One brain region that commonly exhibits neuronal loss in several neurodegenerative disorders is the hippocampus, an area of the brain critical for the formation and retrieval of memories. Long-lasting and sometimes unrecoverable deficits caused by neuronal loss present a unique challenge for clinicians and for researchers who attempt to model these traumas in animals. Can these deficits be recovered, and if so, is the brain capable of regeneration following neuronal loss? To address this significant question, we utilized the innovative CaM/Tet-DTA mouse model that selectively induces neuronal ablation. We found that we are able to inflict a consistent and significant lesion to the hippocampus, resulting in hippocampally-dependent behavioral deficits and a long-lasting upregulation in neurogenesis, suggesting that this process might be a critical part of hippocampal recovery. In addition, we provide novel evidence of angiogenic and vasculature changes following hippocampal neuronal loss in CaM/Tet-DTA mice. We posit that angiogenesis may be an important factor that promotes neurogenic upregulation following hippocampal neuronal loss, and both factors, angiogenesis and neurogenesis, can contribute to the adaptive response of the brain for behavioral recovery.	[LaFerla, Frank M.] Univ Calif Irvine, Dept Neurobiol & Behav, Irvine, CA 92697 USA; Univ Calif Irvine, Inst Memory Impairments & Neurol Disorders, Irvine, CA USA	University of California System; University of California Irvine; University of California System; University of California Irvine	LaFerla, FM (corresponding author), Univ Calif Irvine, Dept Neurobiol & Behav, Irvine, CA 92697 USA.	laferla@uci.edu	Baglietto-Vargas, David DBV/B-1425-2018; Yeung, Stephen/J-8910-2016; Baglietto, David/I-2572-2019	Baglietto-Vargas, David DBV/0000-0003-1441-3175; Yeung, Stephen/0000-0002-9710-5567; Baglietto, David/0000-0003-1441-3175	National Institutes of Health (NIH): NIH/NIA [AG027544-06, OD010420]; Larry Hillblom foundation [2013-A-016-FEL]; NATIONAL INSTITUTE ON AGING [R01AG027544] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [S10OD010420] Funding Source: NIH RePORTER	National Institutes of Health (NIH): NIH/NIA; Larry Hillblom foundation; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This study was supported by grants from the National Institutes of Health (NIH): NIH/NIA AG027544-06, OD010420 (FML), and by The Larry Hillblom foundation #2013-A-016-FEL (DBV). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akers KG, 2014, SCIENCE, V344, P598, DOI 10.1126/science.1248903; Backman L, 2005, NEUROPSYCHOLOGY, V19, P520, DOI 10.1037/0894-4105.19.4.520; Baglietto-Vargas D, 2010, J ALZHEIMERS DIS, V21, P119, DOI 10.3233/JAD-2010-100066; Bakker A, 2008, SCIENCE, V319, P1640, DOI 10.1126/science.1152882; BARNES CA, 1979, J COMP PHYSIOL PSYCH, V93, P74, DOI 10.1037/h0077579; Bauer R, 2004, EXP TOXICOL PATHOL, V56, P65, DOI 10.1016/j.etp.2004.04.002; Beauchamp MH, 2011, INT J DEV NEUROSCI, V29, P137, DOI 10.1016/j.ijdevneu.2010.12.003; Beauchamp M, 2011, DEV NEUROPSYCHOL, V36, P578, DOI 10.1080/87565641.2011.555572; Bell BD, 2007, NEUROPSYCHOL REV, V17, P455, DOI 10.1007/s11065-007-9049-3; Bengzon J, 1997, P NATL ACAD SCI USA, V94, P10432, DOI 10.1073/pnas.94.19.10432; BERKOVIC SF, 1991, ANN NEUROL, V29, P175, DOI 10.1002/ana.410290210; BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; Blurton-Jones M, 2006, J COMP NEUROL, V499, P603, DOI 10.1002/cne.21122; Brozzi F, 2009, J BIOL CHEM, V284, P8788, DOI 10.1074/jbc.M805897200; Cameron HA, 2001, J COMP NEUROL, V435, P406, DOI 10.1002/cne.1040; Campanella M, 2002, STROKE, V33, P586, DOI 10.1161/hs0202.103399; Castello NA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091453; Castro AA, 2013, BRAIN RES, V1513, P103, DOI 10.1016/j.brainres.2013.03.029; Chehrehasa F, 2009, J NEUROSCI METH, V177, P122, DOI 10.1016/j.jneumeth.2008.10.006; Chen XH, 2003, J NEUROTRAUM, V20, P623, DOI 10.1089/089771503322144545; Clelland CD, 2009, SCIENCE, V325, P210, DOI 10.1126/science.1173215; Clinton LK, 2010, J NEUROSCI, V30, P7281, DOI 10.1523/JNEUROSCI.0490-10.2010; Crews L, 2010, J NEUROSCI, V30, P12252, DOI 10.1523/JNEUROSCI.1305-10.2010; Cross MJ, 2001, TRENDS PHARMACOL SCI, V22, P201, DOI 10.1016/S0165-6147(00)01676-X; Dash PK, 2001, J NEUROSCI RES, V63, P313, DOI 10.1002/1097-4547(20010215)63:4<313::AID-JNR1025>3.0.CO;2-4; Deng W, 2009, J NEUROSCI, V29, P13532, DOI 10.1523/JNEUROSCI.3362-09.2009; Drapeau E, 2003, P NATL ACAD SCI USA, V100, P14385, DOI 10.1073/pnas.2334169100; Elmore MRP, 2014, NEURON, V82, P380, DOI 10.1016/j.neuron.2014.02.040; Eriksson PS, 1998, NAT MED, V4, P1313, DOI 10.1038/3305; Fisher A, 2000, NEUROSCIENCE, V95, P97; Fox NC, 1996, BRAIN, V119, P2001, DOI 10.1093/brain/119.6.2001; Friocourt G, 2003, CEREB CORTEX, V13, P620, DOI 10.1093/cercor/13.6.620; Fritz HG, 2004, EXP TOXICOL PATHOL, V56, P91, DOI 10.1016/j.etp.2004.04.001; Gage FH, 2000, SCIENCE, V287, P1433, DOI 10.1126/science.287.5457.1433; Gage FH, 2002, J NEUROSCI, V22, P612, DOI 10.1523/JNEUROSCI.22-03-00612.2002; Ge SY, 2008, J PHYSIOL-LONDON, V586, P3759, DOI 10.1113/jphysiol.2008.155655; Gil JMAC, 2005, NEUROBIOL DIS, V20, P744, DOI 10.1016/j.nbd.2005.05.006; Hayashi T, 2003, J CEREBR BLOOD F MET, V23, P166, DOI 10.1097/00004647-200302000-00004; Hendriks MPH, 2002, EPILEPSY BEHAV, V3, P165, DOI 10.1006/ebeh.2002.0320; HICKS RR, 1993, J NEUROTRAUM, V10, P405, DOI 10.1089/neu.1993.10.405; Hoeben A, 2004, PHARMACOL REV, V56, P549, DOI 10.1124/pr.56.4.3; Imayoshi I, 2008, NAT NEUROSCI, V11, P1153, DOI 10.1038/nn.2185; JACKSON GD, 1990, NEUROLOGY, V40, P1869, DOI 10.1212/WNL.40.12.1869; Jeltsch H, 2001, NEUROBIOL LEARN MEM, V76, P81, DOI 10.1006/nlme.2000.3986; Jessberger S, 2008, NAT NEUROSCI, V11, P888, DOI 10.1038/nn.2148; Jessberger S, 2009, LEARN MEMORY, V16, P147, DOI 10.1101/lm.1172609; JESTE DV, 1992, AM J PSYCHIAT, V149, P184; Jin KL, 2004, P NATL ACAD SCI USA, V101, P343, DOI 10.1073/pnas.2634794100; Kempermann G, 2002, EUR J NEUROSCI, V16, P129, DOI 10.1046/j.1460-9568.2002.02042.x; Lamm O, 2014, J COMP NEUROL, V522, P2817, DOI 10.1002/cne.23607; Lazic SE, 2004, NEUROREPORT, V15, P811, DOI 10.1097/00001756-200404090-00014; Lee P, 1998, P NATL ACAD SCI USA, V95, P11371, DOI 10.1073/pnas.95.19.11371; Leventhal C, 1999, MOL CELL NEUROSCI, V13, P450, DOI 10.1006/mcne.1999.0762; LOWENSTEIN DH, 1992, J NEUROSCI, V12, P4846; Marxreiter F, 2013, CELL MOL LIFE SCI, V70, P459, DOI 10.1007/s00018-012-1062-x; Mayford M, 1996, SCIENCE, V274, P1678, DOI 10.1126/science.274.5293.1678; MORRIS RGM, 1982, NATURE, V297, P681, DOI 10.1038/297681a0; MOSER E, 1993, J NEUROSCI, V13, P3916; Nagamoto-Combs K, 2007, J NEUROTRAUM, V24, P1719, DOI 10.1089/neu.2007.0377; Newsome MR, 2010, NEUROPSYCHOLOGY, V24, P139, DOI 10.1037/a0017432; Ohl F, 1999, COGNITIVE BRAIN RES, V7, P379, DOI 10.1016/S0926-6410(98)00042-1; OPPENHEIM RW, 1991, ANNU REV NEUROSCI, V14, P453, DOI 10.1146/annurev.ne.14.030191.002321; Palacios EM, 2013, JAMA NEUROL, V70, P845, DOI 10.1001/jamaneurol.2013.38; Raber J, 2004, RADIAT RES, V162, P39, DOI 10.1667/RR3206; RAKIC P, 1974, SCIENCE, V183, P425, DOI 10.1126/science.183.4123.425; Rakic P, 2002, NAT REV NEUROSCI, V3, P65, DOI 10.1038/nrn700; Reetz K, 2010, NEUROBIOL DIS, V39, P402, DOI 10.1016/j.nbd.2010.05.006; Reijmer YD, 2012, J AM GERIATR SOC, V60, P1426, DOI 10.1111/j.1532-5415.2012.04081.x; Schanzer A, 2004, BRAIN PATHOL, V14, P237; Scharfman HE, 2000, J NEUROSCI, V20, P6144, DOI 10.1523/JNEUROSCI.20-16-06144.2000; Schuff N, 2009, ALZHEIMERS DEMENT, V5, P454, DOI 10.1016/j.jalz.2009.04.1233; Shors TJ, 2001, NATURE, V410, P372, DOI 10.1038/35066584; Snapyan M, 2009, J NEUROSCI, V29, P4172, DOI 10.1523/JNEUROSCI.4956-08.2009; Snyder JS, 2005, NEUROSCIENCE, V130, P843, DOI 10.1016/j.neuroscience.2004.10.009; Song SH, 2002, NATURE, V417, P39, DOI 10.1038/417039a; Spalding KL, 2013, CELL, V153, P1219, DOI 10.1016/j.cell.2013.05.002; SQUIRE LR, 1992, PSYCHOL REV, V99, P195, DOI 10.1037/0033-295X.99.2.195; Sun D, 2009, EXP NEUROL, V216, P56, DOI 10.1016/j.expneurol.2008.11.011; Taupin P, 2002, J NEUROSCI RES, V69, P745, DOI 10.1002/jnr.10378; Thompson PM, 2003, J NEUROSCI, V23, P994; Thored P, 2006, STEM CELLS, V24, P739, DOI 10.1634/stemcells.2005-0281; Tomaiuolo F, 2004, J NEUROL NEUROSUR PS, V75, P1314, DOI 10.1136/jnnp.2003.017046; TREVES A, 1994, HIPPOCAMPUS, V4, P374, DOI 10.1002/hipo.450040319; van Praag H, 1999, NAT NEUROSCI, V2, P266, DOI 10.1038/6368; West MJ, 2004, NEUROBIOL AGING, V25, P1205, DOI 10.1016/j.neurobiolaging.2003.12.005; Whitman MC, 2009, J COMP NEUROL, V516, P94, DOI 10.1002/cne.22093; Wittko IM, 2009, J NEUROSCI, V29, P8704, DOI 10.1523/JNEUROSCI.5527-08.2009; Yamasaki TR, 2007, J NEUROSCI, V27, P11925, DOI 10.1523/JNEUROSCI.1627-07.2007; Yamashita T, 2006, J NEUROSCI, V26, P6627, DOI 10.1523/JNEUROSCI.0149-06.2006; Yeung ST, 2014, NEUROSCIENCE, V259, P214, DOI 10.1016/j.neuroscience.2013.11.054; Zhang CL, 2008, NATURE, V451, P1004, DOI 10.1038/nature06562; Zhang RL, 2001, NEUROSCIENCE, V105, P33, DOI 10.1016/S0306-4522(01)00117-8	92	5	5	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 3	2014	9	9							e106009	10.1371/journal.pone.0106009	http://dx.doi.org/10.1371/journal.pone.0106009			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3TB	25184527	Green Published, gold			2022-12-27	WOS:000341257700030
J	Wen, YF; Wei, JCC; Hsu, YW; Chiou, HY; Wong, HSC; Wong, RH; Ikegawa, S; Chang, WC				Wen, Ya-Feng; Wei, James Cheng-Chung; Hsu, Yu-Wen; Chiou, Hung-Yi; Wong, Henry Sung-Ching; Wong, Ruey-Hong; Ikegawa, Shiro; Chang, Wei-Chiao			rs10865331 Associated with Susceptibility and Disease Severity of Ankylosing Spondylitis in a Taiwanese Population	PLOS ONE			English	Article							HLA-B27; ERAP1; SPONDYLOARTHRITIS; CHINESE; POLYMORPHISM; METAANALYSIS; VARIANTS; RECEPTOR; IL23R; LOCI	Ankylosing spondylitis (AS) is a highly familial rheumatic disorder and is considered as a chronic inflammatory disease. Genetic factors are involved in the pathogenesis of AS. To identify genes which render people susceptible to AS in a Taiwanese population, we selected six single-nucleotide polymorphisms (SNPs) from previous genome-wide association studies (GWASs) which were associated with AS in European descendants and Han Chinese. To assess whether the six SNPs contributed to AS susceptibility and severity in Taiwanese population, 475 AS patients fulfilling the modified New York Criteria and 527 healthy subjects were recruited. We found that rs10865331 was significantly associated with AS susceptibility and with Bath AS Function Index (BASFI). The AA and AG genotypes of rs10865331 were also significantly associated with a higher erythrocyte sedimentation rate. Our findings provided evidence that rs10865331 is associated AS susceptibility and with disease activity (BASFI) in a Taiwanese population.	[Wen, Ya-Feng; Hsu, Yu-Wen; Chang, Wei-Chiao] Taipei Med Univ, Sch Pharm, Dept Clin Pharm, Taipei, Taiwan; [Wei, James Cheng-Chung] Chung Shan Med Univ Hosp, Div Allergy Immunol & Rheumatol, Dept Med, Taichung, Taiwan; [Wei, James Cheng-Chung] Chung Shan Med Univ, Inst Med, Taichung, Taiwan; [Chiou, Hung-Yi] Taipei Med Univ, Sch Publ Hlth, Taipei, Taiwan; [Wong, Ruey-Hong] Chung Shan Med Univ, Dept Publ Hlth, Taichung, Taiwan; [Chang, Wei-Chiao] Taipei Med Univ, Wanfang Hosp, Dept Pharm, Taipei, Taiwan; [Wen, Ya-Feng; Hsu, Yu-Wen; Chiou, Hung-Yi; Wong, Henry Sung-Ching; Ikegawa, Shiro; Chang, Wei-Chiao] Taipei Med Univ, Sch Pharm, Master Program Clin Pharmacogen & Pharmacoprote, Taipei, Taiwan; [Ikegawa, Shiro] RIKEN Ctr Integrat Med Sci, Lab Bone & Joint Dis, Yokohama, Kanagawa, Japan	Taipei Medical University; Chung Shan Medical University; Chung Shan Medical University Hospital; Chung Shan Medical University; Taipei Medical University; Chung Shan Medical University; Taipei Medical University; Taipei Municipal WanFang Hospital; Taipei Medical University; RIKEN	Chang, WC (corresponding author), Taipei Med Univ, Sch Pharm, Dept Clin Pharm, Taipei, Taiwan.	wcc@tmu.edu.tw	Ikegawa, Shiro/N-6895-2015; Wei, James Cheng-Chung/AAL-8947-2020	Ikegawa, Shiro/0000-0003-0316-2147; Wei, James Cheng-Chung/0000-0002-1235-0679; Chang, Wei-Chiao/0000-0002-8573-5924; Wen, Ya-Feng/0000-0001-5090-4153; Chiou, Hung Yi/0000-0002-4545-9697	Excellence for Cancer Research Center grant, Department of Health, Executive Yuan, Taiwan, R.O.C. [DOH102-TD-C-111-002]; National Science Council, Taiwan, ROC [NSC101-2628-B038-001-MY2, NSC101-2320-B038-029-MY3]	Excellence for Cancer Research Center grant, Department of Health, Executive Yuan, Taiwan, R.O.C.; National Science Council, Taiwan, ROC(Ministry of Science and Technology, Taiwan)	This work was supported by the funding from an Excellence for Cancer Research Center grant, Department of Health, Executive Yuan, Taiwan, R.O.C. (DOH102-TD-C-111-002) and grants from the National Science Council, Taiwan, ROC (NSC101-2628-B038-001-MY2; NSC101-2320-B038-029-MY3). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bang SY, 2011, J RHEUMATOL, V38, P322, DOI 10.3899/jrheum.100652; Brown MA, 2000, ANN RHEUM DIS, V59, P883, DOI 10.1136/ard.59.11.883; Brown MA, 1997, ARTHRITIS RHEUM, V40, P1823, DOI 10.1002/art.1780401015; Chen C, 2012, RHEUMATOL INT, V32, P15, DOI 10.1007/s00296-010-1566-3; Chen R, 2012, RHEUMATOL INT, V32, P909, DOI 10.1007/s00296-010-1712-y; Chou CT, 2001, J IMMUNOL METHODS, V255, P15, DOI 10.1016/S0022-1759(01)00414-8; Colbert RA, 2010, IMMUNOL REV, V233, P181, DOI 10.1111/j.0105-2896.2009.00865.x; Cortes A, 2013, NAT GENET, V45, P730, DOI 10.1038/ng.2667; Cui XL, 2003, J IMMUNOL, V171, P6814, DOI 10.4049/jimmunol.171.12.6814; Davidson SI, 2011, ANN RHEUM DIS, V70, P289, DOI 10.1136/ard.2010.133322; Davidson SI, 2009, ARTHRITIS RHEUM-US, V60, P3263, DOI 10.1002/art.24933; Evans DM, 2011, NAT GENET, V43, P761, DOI 10.1038/ng.873; Karaderi T, 2009, RHEUMATOLOGY, V48, P386, DOI 10.1093/rheumatology/ken501; Kenny EE, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002559; Lee YH, 2012, INFLAMM RES, V61, P143, DOI 10.1007/s00011-011-0398-2; Lin ZM, 2012, NAT GENET, V44, P73, DOI 10.1038/ng.1005; Newport M, 2007, NAT GENET, V39, P1329, DOI 10.1038/ng.2007.17; Reveille JD, 2011, AM J MED SCI, V341, P284, DOI 10.1097/MAJ.0b013e31820f8c99; Reveille JD, 2010, NAT GENET, V42, P123, DOI 10.1038/ng.513; Sanchez A, 2010, J RHEUMATOL, V37, P2345, DOI 10.3899/jrheum.100211; Suzuki T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061045; Tremelling M, 2007, GASTROENTEROLOGY, V132, P1657, DOI 10.1053/j.gastro.2007.02.051; Trinchieri G, 2003, IMMUNITY, V19, P641, DOI 10.1016/S1074-7613(03)00296-6; Wang CM, 2012, ARTHRITIS RES THER, V14, DOI 10.1186/ar3855; Wei JCC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052801; Wei JCC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020426; Wei JCC, 2004, RHEUMATOLOGY, V43, P839, DOI 10.1093/rheumatology/keh193; Wei J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047979; Yang KL, 2004, TISSUE ANTIGENS, V63, P476, DOI 10.1111/j.0001-2815.2004.00197.x; Zochling J, 2010, BEST PRACT RES CL RH, V24, P747, DOI 10.1016/j.berh.2011.02.002	30	10	10	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 3	2014	9	9							e104525	10.1371/journal.pone.0104525	http://dx.doi.org/10.1371/journal.pone.0104525			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3TB	25184745	Green Submitted, Green Published, gold			2022-12-27	WOS:000341257700010
J	Sharif-Askari, FS; Sulaiman, SAS; Sharif-Askari, NS; Hussain, AAS; Railey, MJ				Sharif-Askari, Fatemeh Saheb; Sulaiman, Syed Azhar Syed; Sharif-Askari, Narjes Saheb; Hussain, Ali Al Sayed; Railey, Mohammad Jaffar			Adverse Outcomes of Anticoagulant Use among Hospitalized Patients with Chronic Kidney Disease: A Comparison of the Rates of Major Bleeding Events between Unfractionated Heparin and Enoxaparin	PLOS ONE			English	Article							MOLECULAR-WEIGHT HEPARIN; SUBCUTANEOUS ENOXAPARIN; PREVALENCE; PREVENTION; EFFICACY; SAFETY; RISK	Background: Anticoagulation therapy is usually required in patients with chronic kidney disease (CKD) for treatment or prevention of thromboembolic diseases. However, this benefit could easily be offset by the risk of bleeding. Objectives: To determine the incidence of adverse outcomes of anticoagulants in hospitalized patients with CKD, and to compare the rates of major bleeding events between the unfractionated heparin (UFH) and enoxaparin users. Methods: One year prospective observational study was conducted in patients with CKD stages 3 to 5 (estimated GFR, 1059 ml/min/1.73 m(2)) who were admitted to the renal unit of Dubai Hospital. Propensity scores for the use of anticoagulants, estimated for each of the 488 patients, were used to identify a cohort of 117 pairs of patients. Cox regression method was used to estimate association between anticoagulant use and adverse outcomes. Results: Major bleeding occurred in 1 in 3 patients who received anticoagulation during hospitalization (hazard ratio [HR], 4.61 [95% confidence interval [CI], 2.05-10.35]). Compared with enoxaparin users, patients who received anticoagulation with unfractionated heparin had a lower mean [SD] serum level of platelet counts (139.95 [113]x10(3)/mu L vs 205.56 [123]x10(3)/mu L; P<0.001), and had a higher risk of major bleeding (HR, 4.79 [95% CI, 1.85-12.36]). Furthermore, compared with those who did not receive anticoagulants, patients who did had a higher in-hospital mortality (HR, 2.54 [95% CI, 1.03-6.25]); longer length of hospitalization (HR, 1.04 [95% CI, 1.01-1.06]); and higher hospital readmission at 30 days (HR, 1.79 [95% CI, 1.10-2.91]). Conclusions: Anticoagulation among hospitalized patients with CKD was significantly associated with an increased risk of bleeding and in-hospital mortality. Hence, intensive monitoring and preventive measures such as laboratory monitoring and/or dose adjustment are warranted.	[Sharif-Askari, Fatemeh Saheb; Sulaiman, Syed Azhar Syed; Sharif-Askari, Narjes Saheb] Univ Sains Malaysia, Sch Pharm, George Town, Malaysia; [Hussain, Ali Al Sayed] Dubai Hlth Author, Dept Pharm, Dubai, U Arab Emirates; [Railey, Mohammad Jaffar] Dubai Hosp, Nephrol Unit, Dubai, U Arab Emirates	Universiti Sains Malaysia; Dubai Hospital	Sharif-Askari, FS (corresponding author), Univ Sains Malaysia, Sch Pharm, George Town, Malaysia.	dr.fatemeh.askari@gmail.com	Sharif-Askari, Narjes Saheb/I-1743-2019	Sharif-Askari, Narjes Saheb/0000-0003-0482-6777; Syed Sulaiman, Syed Azhar/0000-0002-0775-859X				Antman EM, 2006, NEW ENGL J MED, V354, P1477, DOI 10.1056/NEJMoa060898; Antman EM, 1999, CIRCULATION, V100, P1593, DOI 10.1161/01.CIR.100.15.1593; Austin PC, 2007, STAT MED, V26, P734, DOI 10.1002/sim.2580; Bazzino O, 1998, NEW ENGL J MED, V338, P1488; Blazing MA, 2004, JAMA-J AM MED ASSOC, V292, P55, DOI 10.1001/jama.292.1.55; Boccardo P, 2004, SEMIN THROMB HEMOST, V30, P579, DOI 10.1055/s-2004-835678; British Medical Association, 2012, BRIT NATL FORMULARY; Brookhart MA, 2006, AM J EPIDEMIOL, V163, P1149, DOI 10.1093/aje/kwj149; Chan KE, 2013, KIDNEY INT, V84, P555, DOI 10.1038/ki.2013.152; Cohen M, 1997, NEW ENGL J MED, V337, P447, DOI 10.1056/NEJM199708143370702; Coresh J, 2007, JAMA-J AM MED ASSOC, V298, P2038, DOI 10.1001/jama.298.17.2038; Dager WE, 2010, ADV CHRONIC KIDNEY D, V17, P420, DOI 10.1053/j.ackd.2010.06.002; Decousus H, 1998, NEW ENGL J MED, V338, P409, DOI 10.1056/NEJM199802123380701; DEYO RA, 1992, J CLIN EPIDEMIOL, V45, P613, DOI 10.1016/0895-4356(92)90133-8; Hallan SI, 2006, J AM SOC NEPHROL, V17, P2275, DOI 10.1681/ASN.2005121273; Hirsh J, 2008, CHEST, V133, p141S, DOI 10.1378/chest.08-0689; Jalal DI, 2010, SEMIN THROMB HEMOST, V36, P34, DOI 10.1055/s-0030-1248722; Koo S, 2004, ARCH INTERN MED, V164, P1557, DOI 10.1001/archinte.164.14.1557; Levine M, 1996, NEW ENGL J MED, V334, P677, DOI 10.1056/NEJM199603143341101; Merli G, 2001, ANN INTERN MED, V134, P191, DOI 10.7326/0003-4819-134-3-200102060-00009; Pisters R, 2010, CHEST, V138, P1093, DOI 10.1378/chest.10-0134; Rubin DB, 2001, HLTH SERV OUTCOME RE, V2, P169, DOI 10.1023/A:1020363010465; Schulman S, 2008, CHEST, V133, p257S, DOI 10.1378/chest.08-0674; Sherman DG, 2007, LANCET, V369, P1347, DOI 10.1016/S0140-6736(07)60633-3; Thoemmes F, 2012, PROPENSITY SCORE MAT; Thorevska N, 2004, CHEST, V125, P856, DOI 10.1378/chest.125.3.856; Verbeeck RK, 2009, EUR J CLIN PHARMACOL, V65, P757, DOI 10.1007/s00228-009-0678-8; Zhang LX, 2008, AM J KIDNEY DIS, V51, P373, DOI 10.1053/j.ajkd.2007.11.009	28	10	10	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2014	9	9							e106517	10.1371/journal.pone.0106517	http://dx.doi.org/10.1371/journal.pone.0106517			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3LR	25181525	Green Submitted, Green Published, gold			2022-12-27	WOS:000341231500107
J	Zarrouk, M; Finlay, DK; Foretz, M; Viollet, B; Cantrell, DA				Zarrouk, Marouan; Finlay, David K.; Foretz, Marc; Viollet, Benoit; Cantrell, Doreen A.			Adenosine-Mono-Phosphate-Activated Protein Kinase-Independent Effects of Metformin in T Cells	PLOS ONE			English	Article							ENERGY SENSOR; DIFFERENTIATION; METABOLISM; MEMORY; LYMPHOCYTES; INHIBITION; TRANSPORT; NUTRIENT; SYSTEM; AMPK	The anti-diabetic drug metformin regulates T-cell responses to immune activation and is proposed to function by regulating the energy-stress-sensing adenosine-monophosphate-activated protein kinase (AMPK). However, the molecular details of how metformin controls T cell immune responses have not been studied nor is there any direct evidence that metformin acts on T cells via AMPK. Here, we report that metformin regulates cell growth and proliferation of antigen-activated T cells by modulating the metabolic reprogramming that is required for effector T cell differentiation. Metformin thus inhibits the mammalian target of rapamycin complex I signalling pathway and prevents the expression of the transcription factors c-Myc and hypoxia-inducible factor 1 alpha. However, the inhibitory effects of metformin on T cells did not depend on the expression of AMPK in T cells. Accordingly, experiments with metformin inform about the importance of metabolic reprogramming for T cell immune responses but do not inform about the importance of AMPK.	[Zarrouk, Marouan; Cantrell, Doreen A.] Univ Dundee, Coll Life Sci, Div Cell Signalling & Immunol, Dundee, Scotland; [Finlay, David K.] Trinity Coll Dublin, Trinity Biomed Sci Inst, Sch Biochem & Immunol, Dublin, Ireland; [Finlay, David K.] Trinity Coll Dublin, Trinity Biomed Sci Inst, Sch Pharm & Pharmaceut Sci, Dublin, Ireland; [Foretz, Marc; Viollet, Benoit] INSERM, Inst Cochin, Unite 1016, Paris, France; [Foretz, Marc; Viollet, Benoit] CNRS, Unites Mixtes Rech 8104, Paris, France; [Foretz, Marc; Viollet, Benoit] Univ Paris 05, Sorbonne Paris Cite, Paris, France	University of Dundee; Trinity College Dublin; Trinity College Dublin; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite	Cantrell, DA (corresponding author), Univ Dundee, Coll Life Sci, Div Cell Signalling & Immunol, Dundee, Scotland.	d.a.cantrell@dundee.ac.uk	FORETZ, Marc/O-7334-2017; Viollet, Benoit/N-2397-2019; Finlay, David/H-5840-2018; Zarrouk, Marouan/K-7541-2019; Viollet, Benoit/O-6927-2017	FORETZ, Marc/0000-0001-7017-9032; Viollet, Benoit/0000-0002-0121-0224; Finlay, David/0000-0003-2716-6679; Viollet, Benoit/0000-0002-0121-0224; Zarrouk, Marouan/0000-0002-3259-6123	Wellcome Trust Principal Research Fellowship [097418/Z/11Z];  [065975/Z/01/A]	Wellcome Trust Principal Research Fellowship(Wellcome Trust); 	The work presented here was supported by a Wellcome Trust Principal Research Fellowship [097418/Z/11Z] and Program Grant [065975/Z/01/A] to DAC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Araki K, 2009, NATURE, V460, P108, DOI 10.1038/nature08155; Ben Sahra I, 2011, CANCER RES, V71, P4366, DOI 10.1158/0008-5472.CAN-10-1769; Finlay DK, 2012, J EXP MED, V209, P2441, DOI 10.1084/jem.20112607; Foretz M, 2010, J CLIN INVEST, V120, P2355, DOI 10.1172/JCI40671; Green AS, 2010, BLOOD, V116, P4262, DOI 10.1182/blood-2010-02-269837; Hardie DG, 2012, NAT REV MOL CELL BIO, V13, P251, DOI 10.1038/nrm3311; He S, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0028291, 10.1371/journal.pone.0020107]; HOLMAN GD, 1990, J BIOL CHEM, V265, P18172; Kang KY, 2013, INT IMMUNOPHARMACOL, P1, DOI [10.1016/j.in-timp.2013.03.020, DOI 10.1016/J.IN-TIMP.2013.03.020]; Macintyre AN, 2011, IMMUNITY, V34, P224, DOI 10.1016/j.immuni.2011.01.012; MacIver NJ, 2013, ANNU REV IMMUNOL, V31, P259, DOI 10.1146/annurev-immunol-032712-095956; MacIver NJ, 2011, J IMMUNOL, V187, P4187, DOI 10.4049/jimmunol.1100367; Michalek RD, 2011, J IMMUNOL, V186, P3299, DOI 10.4049/jimmunol.1003613; Miller RA, 2013, NATURE, V494, P256, DOI 10.1038/nature11808; Nath N, 2009, J IMMUNOL, V182, P8005, DOI 10.4049/jimmunol.0803563; Owen MR, 2000, BIOCHEM J, V348, P607, DOI 10.1042/0264-6021:3480607; Pearce Erika L, 2013, Science, V342, P1242454, DOI 10.1126/science.1242454; Pearce EL, 2009, NATURE, V460, P103, DOI 10.1038/nature08097; Powell JD, 2010, IMMUNITY, V33, P301, DOI 10.1016/j.immuni.2010.09.002; Rolf J, 2013, EUR J IMMUNOL, V43, P889, DOI 10.1002/eji.201243008; Rosilio CL, 2013, CANC LETT, P1, DOI [10.1016/j.canlet.2013.04.015, DOI 10.1016/J.CAN-LET.2013.04.015]; Sinclair LV, 2008, NAT IMMUNOL, V9, P513, DOI 10.1038/ni.1603; Sinclair LV, 2013, NAT IMMUNOL, V14, P500, DOI 10.1038/ni.2556; Tamas P, 2006, J EXP MED, V203, P1665, DOI 10.1084/jem.20052469; Wang RN, 2012, NAT IMMUNOL, V13, P907, DOI 10.1038/ni.2386; Wang RN, 2011, IMMUNITY, V35, P871, DOI 10.1016/j.immuni.2011.09.021; Zarrouk M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060217; Zhang N, 2011, IMMUNITY, V35, P161, DOI 10.1016/j.immuni.2011.07.010	28	26	29	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2014	9	9							e106710	10.1371/journal.pone.0106710	http://dx.doi.org/10.1371/journal.pone.0106710			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3LR	25181053	Green Published, Green Submitted, gold			2022-12-27	WOS:000341231500123
J	LaBute, MX; Zhang, XH; Lenderman, J; Bennion, BJ; Wong, SE; Lightstone, FC				LaBute, Montiago X.; Zhang, Xiaohua; Lenderman, Jason; Bennion, Brian J.; Wong, Sergio E.; Lightstone, Felice C.			Adverse Drug Reaction Prediction Using Scores Produced by Large-Scale Drug-Protein Target Docking on High-Performance Computing Machines	PLOS ONE			English	Article							GENERALIZED BORN MODEL; MOLECULAR DOCKING; BREAST-CANCER; MATRIX METALLOPROTEINASE-1; TISSUE INHIBITOR; LIGAND DOCKING; MM-PBSA; BINDING; IDENTIFICATION; EXPRESSION	Late-stage or post-market identification of adverse drug reactions (ADRs) is a significant public health issue and a source of major economic liability for drug development. Thus, reliable in silico screening of drug candidates for possible ADRs would be advantageous. In this work, we introduce a computational approach that predicts ADRs by combining the results of molecular docking and leverages known ADR information from DrugBank and SIDER. We employed a recently parallelized version of AutoDock Vina (VinaLC) to dock 906 small molecule drugs to a virtual panel of 409 DrugBank protein targets. L1-regularized logistic regression models were trained on the resulting docking scores of a 560 compound subset from the initial 906 compounds to predict 85 side effects, grouped into 10 ADR phenotype groups. Only 21% (87 out of 409) of the drug-protein binding features involve known targets of the drug subset, providing a significant probe of off-target effects. As a control, associations of this drug subset with the 555 annotated targets of these compounds, as reported in DrugBank, were used as features to train a separate group of models. The Vina off-target models and the DrugBank on-target models yielded comparable median area-under-the-receiver-operating-characteristic-curves (AUCs) during 10-fold cross-validation (0.60-0.69 and 0.61-0.74, respectively). Evidence was found in the PubMed literature to support several putative ADR-protein associations identified by our analysis. Among them, several associations between neoplasm-related ADRs and known tumor suppressor and tumor invasiveness marker proteins were found. A dual role for interstitial collagenase in both neoplasms and aneurysm formation was also identified. These associations all involve off-target proteins and could not have been found using available drug/on-target interaction data. This study illustrates a path forward to comprehensive ADR virtual screening that can potentially scale with increasing number of CPUs to tens of thousands of protein targets and millions of potential drug candidates.	[LaBute, Montiago X.; Lenderman, Jason] Lawrence Livermore Natl Lab, Computat Engn Div, Livermore, CA USA; [Zhang, Xiaohua; Bennion, Brian J.; Wong, Sergio E.; Lightstone, Felice C.] Lawrence Livermore Natl Lab, Biosci & Biotechnol Div, Livermore, CA 94550 USA	United States Department of Energy (DOE); Lawrence Livermore National Laboratory; United States Department of Energy (DOE); Lawrence Livermore National Laboratory	Lightstone, FC (corresponding author), Lawrence Livermore Natl Lab, Biosci & Biotechnol Div, Livermore, CA 94550 USA.	lightstone1@llnl.gov	Zhang, Xiaohua/N-2622-2014	Zhang, Xiaohua/0000-0003-0102-6352	Laboratory Directed Research and Development (LDRD) [004-SI-012]	Laboratory Directed Research and Development (LDRD)	Funding was provided by Laboratory Directed Research and Development (LDRD) (004-SI-012). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baron JA, 2008, LANCET, V372, P1756, DOI 10.1016/S0140-6736(08)61490-7; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Beuming T, 2009, PROTEIN SCI, V18, P1609, DOI 10.1002/pro.177; Bolton EE, 2010, ANN REP COMP CHEM, V4, P217, DOI 10.1016/S1574-1400(08)00012-1; Bonferroni CE, 1935, STUDI ONORE PROFESSO, P13; Bowes J, 2012, NAT REV DRUG DISCOV, V11, P909, DOI 10.1038/nrd3845; Brown EG, 1999, DRUG SAFETY, V20, P109, DOI 10.2165/00002018-199920020-00002; Brylinski M, 2011, PROTEINS, V79, P735, DOI 10.1002/prot.22913; Cami A, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002774; Campillos M, 2008, SCIENCE, V321, P263, DOI 10.1126/science.1158140; Case D., 2012, AMBER12 AMBERTOOLS13; Case DA, 2005, J COMPUT CHEM, V26, P1668, DOI 10.1002/jcc.20290; Chen Xian-liang, 2011, Chinese Journal of Pathology, V40, P805, DOI 10.3760/cma.j.issn.0529-5807.2011.12.004; Chimal-Ramirez GK, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/279505; Cobanoglu MC, 2013, J CHEM INF MODEL, V53, P3399, DOI 10.1021/ci400219z; Dowling P, 2012, INT J CANCER, V131, P911, DOI 10.1002/ijc.26462; Englebienne P, 2007, PROTEINS, V69, P160, DOI 10.1002/prot.21479; Ernst F R, 2001, J Am Pharm Assoc (Wash), V41, P192; Fliri AF, 2005, NAT CHEM BIOL, V1, P389, DOI 10.1038/nchembio747; Food And Drug Administration, 2014, OR BOOK APPR DRUG PR; Friedman J, 2010, J STAT SOFTW, V33, P1, DOI 10.18637/jss.v033.i01; Gasso P, 2014, J PSYCHIATR RES, V48, P94, DOI 10.1016/j.jpsychires.2013.09.017; Giacomini KM, 2007, NATURE, V446, P975, DOI 10.1038/446975a; Gunther S, 2008, NUCLEIC ACIDS RES, V36, pD919, DOI 10.1093/nar/gkm862; Guimaraes CRW, 2008, J CHEM INF MODEL, V48, P958, DOI 10.1021/ci800004w; Halgren TA, 2009, J CHEM INF MODEL, V49, P377, DOI 10.1021/ci800324m; Harris MA, 2004, NUCLEIC ACIDS RES, V32, pD258, DOI 10.1093/nar/gkh036; Hattori N, 2005, SARCOIDOSIS VASC DIF, V22, P27; Herman WH, 2013, DIABETES CARE, V36, P775, DOI 10.2337/dc13-0270; Huang LC, 2013, PROTEOMICS, V13, P313, DOI 10.1002/pmic.201200337; Huang LC, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-S5-S11; Huang N, 2006, J MED CHEM, V49, P6789, DOI 10.1021/jm0608356; Kanehisa M, 2002, NOVART FDN SYMP, V247, P91; Kim HW, 2010, NEUROBIOL DIS, V37, P596, DOI 10.1016/j.nbd.2009.11.010; Kirkpatrick P, 2004, NATURE, V432, P823, DOI 10.1038/432823a; Kirshner DA, 2013, NUCLEIC ACIDS RES, V41, pW256, DOI 10.1093/nar/gkt403; Komajda M, 2010, EUR HEART J, V31, P824, DOI 10.1093/eurheartj/ehp604; Konstandin MH, 2009, BASIC RES CARDIOL, V104, P341, DOI 10.1007/s00395-008-0770-8; Korematsu S, 2012, PEDIATR INFECT DIS J, V31, P973, DOI 10.1097/INF.0b013e31825ba6b3; Kuhn M, 2013, MOL SYST BIOL, V9, DOI 10.1038/msb.2013.10; Kuhn M, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2009.98; KUNTZ ID, 1982, J MOL BIOL, V161, P269, DOI 10.1016/0022-2836(82)90153-X; Layton T, 2009, AM J PATHOL, V175, P2625, DOI 10.2353/ajpath.2009.090543; Lenselink EB, 2014, J CHEM INF MODEL, V54, P1737, DOI 10.1021/ci5000455; Li XL, 2014, MOL CARCINOGEN, V53, P659, DOI 10.1002/mc.22020; Lin Y, 2013, CHINESE MED J-PEKING, V126, P4295, DOI 10.3760/cma.j.issn.0366-6999.20131765; Liu M, 2012, J AM MED INFORM ASSN, V19, pE28, DOI 10.1136/amiajnl-2011-000699; Lounkine E, 2012, NATURE, V486, P361, DOI 10.1038/nature11159; Mizutani S, 2012, BIOINFORMATICS, V28, pI522, DOI 10.1093/bioinformatics/bts383; Moitessier N, 2008, BRIT J PHARMACOL, V153, pS7, DOI 10.1038/sj.bjp.0707515; Mongan J, 2007, J CHEM THEORY COMPUT, V3, P156, DOI 10.1021/ct600085e; Mysinger MM, 2012, J MED CHEM, V55, P6582, DOI 10.1021/jm300687e; Nilmeier JP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062535; Onufriev A, 2004, PROTEINS, V55, P383, DOI 10.1002/prot.20033; Pauwels E, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-169; PERE J J, 1990, Encephale, V16, P143; Poongavanam V, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098659; Raha K, 2007, DRUG DISCOV TODAY, V12, P725, DOI 10.1016/j.drudis.2007.07.006; Rastelli G, 2010, J COMPUT CHEM, V31, P797, DOI 10.1002/jcc.21372; Reardon S, 2013, NATURE, V503, P449, DOI 10.1038/503449a; Repana K, 2006, ANTICANCER RES, V26, P4949; RICHARDS FM, 1977, ANNU REV BIOPHYS BIO, V6, P151, DOI 10.1146/annurev.bb.06.060177.001055; Romeo G, 2004, FASEB J, V18, P725, DOI 10.1096/fj.03-0841fje; Sousa SF, 2013, CURR MED CHEM, V20, P2296, DOI 10.2174/0929867311320180002; Sousa SF, 2006, PROTEINS, V65, P15, DOI 10.1002/prot.21082; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Stuijver DJF, 2012, THROMB HAEMOSTASIS, V108, P1077, DOI 10.1160/TH12-07-0496; Tatonetti NP, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-9-238; Thompson DC, 2008, J CHEM INF MODEL, V48, P1081, DOI 10.1021/ci700470c; Tibshirani R, 1996, J ROY STAT SOC B MET, V58, P267, DOI 10.1111/j.2517-6161.1996.tb02080.x; Wallach I, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012063; Wang RX, 2003, J MED CHEM, V46, P2287, DOI 10.1021/jm0203783; Warren GL, 2006, J MED CHEM, V49, P5912, DOI 10.1021/jm050362n; Whitebread S, 2005, DRUG DISCOV TODAY, V10, P1421, DOI 10.1016/S1359-6446(05)03632-9; Wilgenhof S, 2012, ANTICANCER RES, V32, P1355; Wong SE, 2011, EXPERT OPIN DRUG DIS, V6, P65, DOI 10.1517/17460441.2011.534452; Wu TT, 2009, BIOINFORMATICS, V25, P714, DOI 10.1093/bioinformatics/btp041; Xie L, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000387; Yamanishi Y, 2012, J CHEM INF MODEL, V52, P3284, DOI 10.1021/ci2005548; Yang L, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000441; Yang Y, 2013, EXPERT OPIN DRUG DIS, V8, P277, DOI 10.1517/17460441.2013.749853; Zhang XH, 2014, J CHEM INF MODEL, V54, P324, DOI 10.1021/ci4005145; Zhang XH, 2013, J COMPUT CHEM, V34, P915, DOI 10.1002/jcc.23214; Zhang XH, 2010, J CHEM INF MODEL, V50, P651, DOI 10.1021/ci9003333; Zhang XY, 2009, MOL CANCER RES, V7, P634, DOI 10.1158/1541-7786.MCR-08-0371	86	46	46	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2014	9	9							e106298	10.1371/journal.pone.0106298	http://dx.doi.org/10.1371/journal.pone.0106298			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ1IR	25191698	Green Submitted, Green Published, gold			2022-12-27	WOS:000347993600018
J	Gingras, J; Smith, S; Matson, DJ; Johnson, D; Nye, K; Couture, L; Feric, E; Yin, RY; Moyer, BD; Peterson, ML; Rottman, JB; Beiler, RJ; Malmberg, AB; McDonough, SI				Gingras, Jacinthe; Smith, Sarah; Matson, David J.; Johnson, Danielle; Nye, Kim; Couture, Lauren; Feric, Elma; Yin, Ruoyuan; Moyer, Bryan D.; Peterson, Matthew L.; Rottman, James B.; Beiler, Rudolph J.; Malmberg, Annika B.; McDonough, Stefan I.			Global Nav1.7 Knockout Mice Recapitulate the Phenotype of Human Congenital Indifference to Pain	PLOS ONE			English	Article							GATED SODIUM-CHANNEL; CLOSED-STATE INACTIVATION; OF-FUNCTION MUTATIONS; NA(V)1.7; RAT; SCN9A; CURRENTS; NEURONS; MOUSE; GENE	Clinical genetic studies have shown that loss of Nav1.7 function leads to the complete loss of acute pain perception. The global deletion is reported lethal in mice, however, and studies of mice with promoter-specific deletions of Nav1.7 have suggested that the role of Nav1.7 in pain transduction depends on the precise form of pain. We developed genetic and animal husbandry strategies that overcame the neonatal-lethal phenotype and enabled construction of a global Nav1.7 knockout mouse. Knockouts were anatomically normal, reached adulthood, and had phenotype wholly analogous to human congenital indifference to pain (CIP): compared to littermates, knockouts showed no defects in mechanical sensitivity or overall movement yet were completely insensitive to painful tactile, thermal, and chemical stimuli and were anosmic. Knockouts also showed no painful behaviors resulting from peripheral injection of nonselective sodium channel activators, did not develop complete Freund's adjuvant-induced thermal hyperalgesia, and were insensitive to intra-dermal histamine injection. Tetrodotoxin-sensitive sodium current recorded from cell bodies of isolated sensory neurons and the mechanically-evoked spiking of C-fibers in a skin-nerve preparation each were reduced but not eliminated in tissue from knockouts compared to littermates. Results support a role for Nav1.7 that is conserved between rodents and humans and suggest several possibly translatable biomarkers for the study of Nav1.7-targeted therapeutics. Results further suggest that Nav1.7 may retain its key role in persistent as well as acute forms of pain.	[Gingras, Jacinthe; Smith, Sarah; Matson, David J.; Johnson, Danielle; Nye, Kim; Couture, Lauren; Feric, Elma; Yin, Ruoyuan; Moyer, Bryan D.; Malmberg, Annika B.; McDonough, Stefan I.] Amgen Inc, Dept Neurosci, Cambridge, MA 02141 USA; [Peterson, Matthew L.] Amgen Inc, Dept Pharmaceut Res & Dev, Cambridge, MA USA; [Rottman, James B.] Amgen Inc, Dept Pathol, Cambridge, MA USA; [Beiler, Rudolph J.] Amgen Inc, Dept Comparat Anim Res, Cambridge, MA USA	Amgen; Amgen; Amgen; Amgen	McDonough, SI (corresponding author), Amgen Inc, Dept Neurosci, Cambridge, MA 02141 USA.	stefanm@amgen.com			Amgen Inc.	Amgen Inc.(Amgen)	The authors were all Amgen employees at the time when the work was performed. No specific funding was received for this work. This work was fully supported by Amgen Inc. Amgen Inc. provided support in the form of salaries for all authors, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Ahmad S, 2007, HUM MOL GENET, V16, P2114, DOI 10.1093/hmg/ddm160; Akopian AN, 1999, NAT NEUROSCI, V2, P541, DOI 10.1038/9195; Amaya F, 2006, J NEUROSCI, V26, P12852, DOI 10.1523/JNEUROSCI.4015-06.2006; AUESTAD N, 1989, BRIT J NUTR, V61, P495, DOI 10.1079/BJN19890139; Black JA, 2012, MOL PAIN, V8, DOI 10.1186/1744-8069-8-82; Black JA, 2008, ANN NEUROL, V64, P644, DOI 10.1002/ana.21527; Blair NT, 2003, J NEUROSCI, V23, P10338; Brooks J, 2005, TCE-THE CHEM ENG, P19; CATTERALL WA, 1980, ANNU REV PHARMACOL, V20, P15, DOI 10.1146/annurev.pa.20.040180.000311; CATTERALL WA, 1975, P NATL ACAD SCI USA, V72, P1782, DOI 10.1073/pnas.72.5.1782; Catterall WA, 2005, PHARMACOL REV, V57, P397, DOI 10.1124/pr.57.4.4; CHAPLAN SR, 1994, J NEUROSCI METH, V53, P55, DOI 10.1016/0165-0270(94)90144-9; Cox JJ, 2006, NATURE, V444, P894, DOI 10.1038/nature05413; Cummins TR, 1998, J NEUROSCI, V18, P9607; Devigili G, 2014, PAIN; Dib-Hajj SD, 2013, NAT REV NEUROSCI, V14, P49, DOI 10.1038/nrn3404; DICKENSON AH, 1987, PAIN, V30, P349, DOI 10.1016/0304-3959(87)90023-6; Eisener-Dorman AF, 2009, BRAIN BEHAV IMMUN, V23, P318, DOI 10.1016/j.bbi.2008.09.001; ELLIOTT AA, 1993, J PHYSIOL-LONDON, V463, P39, DOI 10.1113/jphysiol.1993.sp019583; Estacion M, 2011, MOL PAIN, V7, DOI 10.1186/1744-8069-7-92; Faber CG, 2012, P NATL ACAD SCI USA, V109, P19444, DOI 10.1073/pnas.1216080109; Faber CG, 2012, ANN NEUROL, V71, P26, DOI 10.1002/ana.22485; Fertleman CR, 2007, NEUROLOGY, V69, P586, DOI 10.1212/01.wnl.0000268065.16865.5f; Fertleman CR, 2006, NEURON, V52, P767, DOI 10.1016/j.neuron.2006.10.006; George AL, 2005, J CLIN INVEST, V115, P1990, DOI 10.1172/JCI25505; Gingras J, 2012, World Intellectual Property Organization, Patent No. [2012/099983 A1, 2012099983]; Goldberg YP, 2007, CLIN GENET, V71, P311, DOI 10.1111/j.1399-0004.2007.00790.x; Hains BC, 2003, J NEUROSCI, V23, P8881; Herzog RI, 2003, J PHYSIOL-LONDON, V551, P741, DOI 10.1113/jphysiol.2003.047357; Hille B., 2001, ION CHANNELS EXCITAB, V3rd Edn; HONDEGHEM LM, 1984, ANNU REV PHARMACOL, V24, P387, DOI 10.1146/annurev.pa.24.040184.002131; Jukic M, 2014, CURR MED CHEM, V21, P164; KLUGBAUER N, 1995, EMBO J, V14, P1084, DOI 10.1002/j.1460-2075.1995.tb07091.x; Lee JH, 2014, CELL, V157, P1393, DOI 10.1016/j.cell.2014.03.064; Lennertz RC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043597; Leo S, 2010, BEHAV BRAIN RES, V208, P149, DOI 10.1016/j.bbr.2009.11.023; Malmberg AB, 2004, PROG PAIN RES MANAG, V28, P21; Meisler MH, 2005, J CLIN INVEST, V115, P2010, DOI 10.1172/JCI25466; Minett MS, 2014, CELL REP, V6, P301, DOI 10.1016/j.celrep.2013.12.033; Minett MS, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1795; Mogil JS, 1999, P NATL ACAD SCI USA, V96, P7744, DOI 10.1073/pnas.96.14.7744; Nassar MA, 2004, P NATL ACAD SCI USA, V101, P12706, DOI 10.1073/pnas.0404915101; Nassar MA, 2006, MOL PAIN, V2, DOI 10.1186/1744-8069-2-33; OGATA N, 1992, PFLUG ARCH EUR J PHY, V420, P590, DOI 10.1007/BF00374638; Priest BT, 2005, P NATL ACAD SCI USA, V102, P9382, DOI 10.1073/pnas.0501549102; Reimann F, 2010, P NATL ACAD SCI USA, V107, P5148, DOI 10.1073/pnas.0913181107; Rowe AH, 2013, SCIENCE, V342, P441, DOI 10.1126/science.1236451; ROY ML, 1992, J NEUROSCI, V12, P2104; Scadding J. W., 2013, WALL MELZACKS TXB PA, P926, DOI DOI 10.1016/B0-443-07287-6/50067-9; Schmalhofer WA, 2008, MOL PHARMACOL, V74, P1476, DOI 10.1124/mol.108.047670; Shields SD, 2012, J NEUROSCI, V32, P10819, DOI 10.1523/JNEUROSCI.0304-12.2012; TAKAGI H, 1966, JPN J PHARMACOL, V16, P287, DOI 10.1254/jjp.16.287; THRUSH DC, 1973, BRAIN, V96, P369, DOI 10.1093/brain/96.2.369; ToledoAral JJ, 1997, P NATL ACAD SCI USA, V94, P1527, DOI 10.1073/pnas.94.4.1527; Vasylyev DV, 2012, J NEUROPHYSIOL, V108, P729, DOI 10.1152/jn.00091.2012; Wang W, 2011, MOL PAIN, V7, DOI 10.1186/1744-8069-7-16; Weiss J, 2011, NATURE, V472, P186, DOI 10.1038/nature09975; Whiteside GT, 2008, NEUROPHARMACOLOGY, V54, P767, DOI 10.1016/j.neuropharm.2008.01.001; Widmark J, 2011, MOL BIOL EVOL, V28, P859, DOI 10.1093/molbev/msq257; WOOLF CJ, 1984, PAIN, V18, P325, DOI 10.1016/0304-3959(84)90045-9; Yajima M, 2006, EXP ANIM TOKYO, V55, P391, DOI 10.1538/expanim.55.391; Yang Mu, 2009, Curr Protoc Neurosci, VChapter 8, DOI 10.1002/0471142301.ns0824s48; Yang Y, 2004, J MED GENET, V41, P171, DOI 10.1136/jmg.2003.012153; Yeomans DC, 2005, HUM GENE THER, V16, P271, DOI 10.1089/hum.2005.16.271	64	108	114	2	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 4	2014	9	9							e105895	10.1371/journal.pone.0105895	http://dx.doi.org/10.1371/journal.pone.0105895			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3XV	25188265	gold, Green Published, Green Submitted			2022-12-27	WOS:000341271500017
J	Hill, A; Duran, J; Purcell, P				Hill, Adele; Duran, Juanita; Purcell, Patricia			Lubricin Protects the Temporomandibular Joint Surfaces from Degeneration	PLOS ONE			English	Article							VARA-PERICARDITIS SYNDROME; ARTICULAR-CARTILAGE; DEFICIENT MICE; OSTEOARTHRITIS; DISORDERS; BONE	The temporomandibular joint (TMJ) is a specialized synovial joint essential for the mobility and function of the mammalian jaw. The TMJ is composed of the mandibular condyle, the glenoid fossa of the temporal bone, and a fibrocartilagenous disc interposed between these bones. A fibrous capsule, lined on the luminal surface by the synovial membrane, links these bones and retains synovial fluid within the cavity. The major component of synovial fluid is lubricin, a glycoprotein encoded by the gene proteoglycan 4 (Prg4), which is synthesized by chondrocytes at the surface of the articular cartilage and by synovial lining cells. We previously showed that in the knee joint, Prg4 is crucial for maintenance of cartilage surfaces and for regulating proliferation of the intimal cells in the synovium. Consequently, the objective of this study was to determine the role of lubricin in the maintenance of the TMJ. We found that mice lacking lubricin have a normal TMJ at birth, but develop degeneration resembling TMJ osteoarthritis by 2 months, increasing in severity over time. Disease progression in Prg4(-/-) mice results in synovial hyperplasia, deterioration of cartilage in the condyle, disc and fossa with an increase in chondrocyte number and their redistribution in clusters with loss of superficial zone chondrocytes. All articular surfaces of the joint had a prominent layer of protein deposition. Compared to the knee joint, the osteoarthritis-like phenotype was more severe and manifested earlier in the TMJ. Taken together, the lack of lubricin in the TMJ causes osteoarthritis-like degeneration that affects the articular cartilage as well as the integrity of multiple joint tissues. Our results provide the first molecular evidence of the role of lubricin in the TMJ and suggest that Prg4(-/-) mice might provide a valuable new animal model for the study of the early events of TMJ osteoarthritis.	[Hill, Adele] Boston Childrens Hosp, Dept Orthopaed Surg, Boston, MA USA; [Hill, Adele] Harvard Univ, Sch Med, Dept Genet, Boston, MA USA; [Duran, Juanita; Purcell, Patricia] Boston Childrens Hosp, Dept Plast & Oral Surg, Boston, MA 02115 USA; [Duran, Juanita; Purcell, Patricia] Harvard Univ, Sch Med, Boston, MA USA	Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School	Purcell, P (corresponding author), Boston Childrens Hosp, Dept Plast & Oral Surg, Boston, MA 02115 USA.	ppurcell@post.harvard.edu		Hill, Adele/0000-0003-2696-0731	National Institute of Arthritis and Musculoskeletal and Skin Diseases [R01AR050180]; Boston Plastic and Oral Surgery Foundation, Inc; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR050180] Funding Source: NIH RePORTER	National Institute of Arthritis and Musculoskeletal and Skin Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); Boston Plastic and Oral Surgery Foundation, Inc; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	AH was supported by the National Institute of Arthritis and Musculoskeletal and Skin Diseases R01AR050180 (Drs. M. Warman and G. Jay; co-PIs) and The Boston Plastic and Oral Surgery Foundation, Inc supported PP and JD. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ameye L, 2002, FASEB J, V16, DOI 10.1096/fj.01-0848com; Ameye LG, 2006, CURR OPIN RHEUMATOL, V18, P537, DOI 10.1097/01.bor.0000240369.39713.af; AVERY JK, 2001, ORAL DEV HISTOLOGY, P435; Bahabri SA, 1998, ARTHRITIS RHEUM, V41, P730, DOI 10.1002/1529-0131(199804)41:4<730::AID-ART22>3.0.CO;2-Y; Chen J, 2009, ARCH ORAL BIOL, V54, P1091, DOI 10.1016/j.archoralbio.2009.10.001; Embree M, 2011, J DENT RES, V90, P1331, DOI 10.1177/0022034511421930; Franz T, 2001, OSTEOARTHR CARTILAGE, V9, P582, DOI 10.1053/joca.2001.0418; Gynther GW, 1997, INT J ORAL MAX SURG, V26, P10, DOI 10.1016/S0901-5027(97)80838-7; Ingawale S, 2009, ANN BIOMED ENG, V37, P976, DOI 10.1007/s10439-009-9659-4; Jay GD, 2007, P NATL ACAD SCI USA, V104, P6194, DOI 10.1073/pnas.0608558104; Kumar D, 2013, OSTEOARTHR CARTILAGE, V21, P86, DOI 10.1016/j.joca.2012.09.014; Kure-Hattori I, 2012, ARCH ORAL BIOL, V57, P987, DOI 10.1016/j.archoralbio.2012.01.006; LANG TC, 1993, J ORAL MAXIL SURG, V51, P1115, DOI 10.1016/S0278-2391(10)80451-3; Lotz M, 2014, POSTGRAD MED J, V90, P171, DOI 10.1136/postgradmedj-2013-203726rep; Marcelino J, 1999, NAT GENET, V23, P319, DOI 10.1038/15496; Ochiai T, 2010, J DENT RES, V89, P349, DOI 10.1177/0022034510363078; Purcell P, 2012, J DENT RES, V91, P387, DOI 10.1177/0022034512438401; Purcell P, 2009, P NATL ACAD SCI USA, V106, P18297, DOI 10.1073/pnas.0908836106; Rhee DK, 2005, J CLIN INVEST, V115, P622, DOI 10.1172/JCI200522263; Rintala M, 1997, J ANAT, V190, P201, DOI 10.1046/j.1469-7580.1997.19020201.x; Romero-Reyes M, 2014, J PAIN RES, V7, P99, DOI 10.2147/JPR.S37593; Scrivani SJ, 2008, NEW ENGL J MED, V359, P2693, DOI 10.1056/NEJMra0802472; Sellam J, 2010, NAT REV RHEUMATOL, V6, P625, DOI 10.1038/nrrheum.2010.159; Sylvester DC, 2011, CRANIO, V29, P117, DOI 10.1179/crn.2011.020; Tanaka E, 2008, J DENT RES, V87, P296, DOI 10.1177/154405910808700406; Wadhwa S, 2005, CELLS TISSUES ORGANS, V181, P136, DOI 10.1159/000091375; Wadhwa S, 2005, OSTEOARTHR CARTILAGE, V13, P817, DOI 10.1016/j.joca.2005.04.016; Wang XD, 2012, J DENT RES, V91, P499, DOI 10.1177/0022034512441946; Xu L, 2003, ARTHRITIS RHEUM, V48, P2509, DOI 10.1002/art.11233; Xu L, 2007, ARTHRITIS RHEUM, V56, P2663, DOI 10.1002/art.22761	30	26	26	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 4	2014	9	9							e106497	10.1371/journal.pone.0106497	http://dx.doi.org/10.1371/journal.pone.0106497			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3XV	25188282	gold, Green Published, Green Submitted			2022-12-27	WOS:000341271500045
J	Holmner, A; Ebi, KL; Lazuardi, L; Nilsson, M				Holmner, Asa; Ebi, Kristie L.; Lazuardi, Lutfan; Nilsson, Maria			Carbon Footprint of Telemedicine Solutions - Unexplored Opportunity for Reducing Carbon Emissions in the Health Sector	PLOS ONE			English	Article							GREENHOUSE-GAS EMISSIONS; CLIMATE-CHANGE; CARE; TRAVEL; TIME; TELEREHABILITATION; TELEHEALTH; MEETINGS; ENERGY; COSTS	Background: The healthcare sector is a significant contributor to global carbon emissions, in part due to extensive travelling by patients and health workers. Objectives: To evaluate the potential of telemedicine services based on videoconferencing technology to reduce travelling and thus carbon emissions in the healthcare sector. Methods: A life cycle inventory was performed to evaluate the carbon reduction potential of telemedicine activities beyond a reduction in travel related emissions. The study included two rehabilitation units at Umea University Hospital in Sweden. Carbon emissions generated during telemedicine appointments were compared with care-as-usual scenarios. Upper and lower bound emissions scenarios were created based on different teleconferencing solutions and thresholds for when telemedicine becomes favorable were estimated. Sensitivity analyses were performed to pinpoint the most important contributors to emissions for different set-ups and use cases. Results: Replacing physical visits with telemedicine appointments resulted in a significant 40-70 times decrease in carbon emissions. Factors such as meeting duration, bandwidth and use rates influence emissions to various extents. According to the lower bound scenario, telemedicine becomes a greener choice at a distance of a few kilometers when the alternative is transport by car. Conclusions: Telemedicine is a potent carbon reduction strategy in the health sector. But to contribute significantly to climate change mitigation, a paradigm shift might be required where telemedicine is regarded as an essential component of ordinary health care activities and not only considered to be a service to the few who lack access to care due to geography, isolation or other constraints.	[Holmner, Asa] Umea Univ, Dept Radiat Sci, Umea, Sweden; [Ebi, Kristie L.] ClimAdapt LLC, Seattle, WA USA; [Lazuardi, Lutfan] Gadjah Mada Univ, Fac Med, Dept Publ Hlth, Yogyakarta, Indonesia; [Nilsson, Maria] Umea Univ, Dept Publ Hlth & Clin Med Epidemiol & Global Hlth, Umea, Sweden	Umea University; Gadjah Mada University; Umea University	Holmner, A (corresponding author), Umea Univ, Dept Radiat Sci, Umea, Sweden.	Asa.Holmner-Rocklov@vll.se	Lazuardi, Lutfan/K-6812-2019	Lazuardi, Lutfan/0000-0001-5146-8162	FAS; Swedish Council for Working Life and Social Research [2006-1512]; Swedish International Development Cooperation Agency (SIDA).	FAS; Swedish Council for Working Life and Social Research(Swedish Research CouncilSwedish Research Council for Health Working Life & Welfare (Forte)); Swedish International Development Cooperation Agency (SIDA).	This work was partly undertaken within the Umea Centre for Global Health Research, with support from FAS, the Swedish Council for Working Life and Social Research (grant no. 2006-1512). The work was also supported in part by funding from the Swedish International Development Cooperation Agency (SIDA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnfalk P, 2003, J CLEAN PROD, V11, P859, DOI 10.1016/S0959-6526(02)00158-0; Barkenbus JN, 2010, ENERG POLICY, V38, P762, DOI 10.1016/j.enpol.2009.10.021; Borggren C, 2013, J CLEAN PROD, V41, P126, DOI 10.1016/j.jclepro.2012.09.003; Broens THF, 2007, J TELEMED TELECARE, V13, P303, DOI 10.1258/135763307781644951; Christensen MC, 2009, J HEALTH POLIT POLIC, V34, P1011, DOI 10.1215/03616878-2009-034; Connor A, 2011, HEMODIAL INT, V15, P39, DOI 10.1111/j.1542-4758.2010.00523.x; Fujitsu, 2011, WHIT PAP LIF CYCL AS; Hilty DM, 2013, TELEMED E-HEALTH, V19, P444, DOI 10.1089/tmj.2013.0075; Holmner A., 2012, GLOB HLTH ACTION, V5; Johansson T, 2011, J TELEMED TELECARE, V17, P1, DOI 10.1258/jtt.2010.100105; Kairy D, 2009, DISABIL REHABIL, V31, P427, DOI 10.1080/09638280802062553; Kendall A, 2012, INT J LIFE CYCLE ASS, V17, P1042, DOI 10.1007/s11367-012-0436-5; Kendall A, 2012, ENVIRON SCI TECHNOL, V46, P2557, DOI 10.1021/es203098j; Koch S, 2006, INT J MED INFORM, V75, P565, DOI 10.1016/j.ijmedinf.2005.09.002; Leduc G, 2010, TRANSPORT POLICY, V17, P409, DOI 10.1016/j.tranpol.2010.04.008; Lenzen M, 1999, TRANSPORT RES D-TR E, V4, P265, DOI 10.1016/S1361-9209(99)00009-7; Lewis D, 2009, J TELEMED TELECARE, V15, P137, DOI 10.1258/jtt.2009.003010; Malmodin J, 2010, J IND ECOL, V14, P770, DOI 10.1111/j.1530-9290.2010.00278.x; McMichael AJ, 2013, NEW ENGL J MED, V368, P1335, DOI 10.1056/NEJMra1109341; Mistry H, 2012, J TELEMED TELECARE, V18, P1, DOI 10.1258/jtt.2011.110505; NHS (National Health Service), 2009, SAV CARB IMPR HLTH N; Ong D, 2012, 2012 IEEE ONLINE CONFERENCE ON GREEN COMMUNICATIONS (GREENCOM), P50, DOI 10.1109/GreenCom.2012.6519615; Pencheon David, 2009, N S W Public Health Bull, V20, P173, DOI 10.1071/NB09044; Raghavan B., 2011, P 10 ACM WORKSHOP HO, P1, DOI [10.1145/2070562.2070571, DOI 10.1145/2070562.2070571]; Rozenblum R, 2013, INT J MED INFORM, V82, P141, DOI 10.1016/j.ijmedinf.2012.12.008; Schmidt S, 2009, BUNDESGESUNDHEITSBLA, V52, P270, DOI 10.1007/s00103-009-0794-8; Woodward A, 2014, LANCET, V383, P1185, DOI 10.1016/S0140-6736(14)60576-6; Wootton R, 2011, BMC HEALTH SERV RES, V11, DOI 10.1186/1472-6963-11-185; Wootton R, 2010, J TELEMED TELECARE, V16, P215, DOI 10.1258/jtt.2010.004015; Yellowlees PM, 2010, TELEMED J E-HEALTH, V16, P230, DOI 10.1089/tmj.2009.0105; Zapka J, 2013, BMC HEALTH SERV RES, V13, DOI 10.1186/1472-6963-13-33	31	67	67	2	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 4	2014	9	9							e105040	10.1371/journal.pone.0105040	http://dx.doi.org/10.1371/journal.pone.0105040			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AO3XV	25188322	Green Published, Green Submitted, gold			2022-12-27	WOS:000341271500004
J	Wang, LF; Lin, KJ; Chen, C; Fu, S; Xue, FS				Wang, LiuFeng; Lin, KeJian; Chen, Chao; Fu, Shu; Xue, FangSen			Diapause Induction and Termination in the Small Brown Planthopper, Laodelphax striatellus (Hemiptera: Delphacidae)	PLOS ONE			English	Article							REPRODUCTIVE DIAPAUSE; LEPIDOPTERA-NOCTUIDAE; GEOGRAPHIC-VARIATION; PINE CATERPILLAR; COTTON BOLLWORM; PUPAL DIAPAUSE; TEMPERATURE; PHOTOPERIOD; POPULATION; INTENSITY	The small brown planthopper, Laodelphax striatellus (Fallen) enters the photoperiodic induction of diapause as 3rd or 4th instar nymphs. The photoperiodic response curves in this planthopper showed a typical long-day response type with a critical daylength of approximately 11 h at 25 degrees C, 12 h at 22 and 20 degrees C and 12.5 h at 18 degrees C, and diapause induction was almost abrogated at 28 degrees C. The third stage was the most sensitive stage to photoperiod. The photoperiodic response curve at 20 degrees C showed a gradual decline in diapause incidence in ultra-long nights, and continuous darkness resulted in 100% development. The required number of days for a 50% response was distinctly different between the short-and long-night cycles, showing that the effect of one short night was equivalent to the effect of three long nights at 18 degrees C. The rearing day length of 12 h evoked a weaker intensity of diapause than did 10 and 11 h. The duration of diapause was significantly longer under the short daylength of 11 h than it was under the long daylength of 15 h. The optimal temperature for diapause termination was 26 and 28 degrees C. Chilling at 5 degrees C for different times did not shorten the duration of diapause but significantly lengthened it when chilling period was included. In autumn, 50% of the nymphs that hatched from late September to mid-October entered diapause in response to temperatures below 20 degrees C. The critical daylength in the field was between 12 h 10 min and 12 h 32 min (including twilight), which was nearly identical to the critical daylength of 12.5 h at 18 degrees C. In spring, overwintering nymphs began to emerge in early March-late March when the mean daily temperature rose to 10 degrees C or higher.	[Wang, LiuFeng; Chen, Chao; Fu, Shu; Xue, FangSen] Jiangxi Agr Univ, Inst Entomol, Nanchang, Jiangxi, Peoples R China; [Lin, KeJian] Chinese Acad Agr Sci, State Key Lab Biol Plant Dis & Insect Pests, Inst Plant Protect, Beijing 100193, Peoples R China	Jiangxi Agricultural University; Chinese Academy of Agricultural Sciences; Institute of Plant Protection, CAAS	Lin, KJ (corresponding author), Chinese Acad Agr Sci, State Key Lab Biol Plant Dis & Insect Pests, Inst Plant Protect, Beijing 100193, Peoples R China.	kjlin@ippcaas.cn; xue_fangsen@hotmail.com	lin, ke/GZM-8300-2022		National Natural Science Foundation of PR China [31272042]; Sci-Tech Landing Projection of Higher Education of Jiangxi Province [KJLD14030]	National Natural Science Foundation of PR China(National Natural Science Foundation of China (NSFC)); Sci-Tech Landing Projection of Higher Education of Jiangxi Province	The research was supported by a grant from National Natural Science Foundation of PR China (31272042) and the Sci-Tech Landing Projection of Higher Education of Jiangxi Province (KJLD14030). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Broufas GD, 2006, ENVIRON ENTOMOL, V35, P1216, DOI 10.1603/0046-225X(2006)35[1216:EOCEAP]2.0.CO;2; Cai BH, 1964, ACTA ENTOMOL SINICA, V13, P552; Chen C, 2014, B ENTOMOL RES, V104, P12, DOI 10.1017/S0007485313000266; Chen YS, 2013, J INSECT PHYSIOL, V59, P855, DOI 10.1016/j.jinsphys.2013.06.002; Danilevskii A.S., 1965, PHOTOPERIODISM SEASO; Danks HV, 1987, INSECT DORMANCY ECOL; Denlinger DL, 2002, ANNU REV ENTOMOL, V47, P93, DOI 10.1146/annurev.ento.47.091201.145137; Han R, 2005, J APPL ENTOMOL, V129, P105, DOI 10.1111/j.1439-0418.2005.00941.x; He Yuan, 2012, Chinese Journal of Rice Science, V26, P109, DOI 10.3969/j.issn.1001-7216.2012.01.0.17; HODEK I, 1988, ENTOMOL EXP APPL, V49, P153, DOI 10.1007/BF00188248; Hodek I, 2002, EUR J ENTOMOL, V99, P163, DOI 10.14411/eje.2002.024; Hua A, 2005, J INSECT PHYSIOL, V51, P1287, DOI 10.1016/j.jinsphys.2005.07.007; Huang LL, 2005, ENTOMOL EXP APPL, V117, P127, DOI 10.1111/j.1570-7458.2005.00345.x; Johansen TJ, 2014, INSECT SCI, V21, P103, DOI 10.1111/1744-7917.12013; KIMURA MT, 1990, J INSECT PHYSIOL, V36, P147, DOI 10.1016/0022-1910(90)90115-V; KIMURA MT, 1983, PHYSIOL ENTOMOL, V8, P181, DOI 10.1111/j.1365-3032.1983.tb00347.x; KISIMOTO R, 1989, APPL ENTOMOL ZOOL, V24, P157, DOI 10.1303/aez.24.157; KISIMOTO R., 1958, JAPANESE JOUR APPL ENT AND ZOOL, V2, P128, DOI 10.1303/jjaez.2.128; Kostal V, 1997, J INSECT PHYSIOL, V43, P767, DOI 10.1016/S0022-1910(97)00032-2; Kroon A, 1997, PHYSIOL ENTOMOL, V22, P357, DOI 10.1111/j.1365-3032.1997.tb01180.x; Li WX, 2008, ANN ENTOMOL SOC AM, V101, P613, DOI 10.1603/0013-8746(2008)101[613:ROPATI]2.0.CO;2; Lin ZW, 2004, J HEILONGJIANG BAYI, V16, P15; Liu Xiang-Dong, 2006, Chinese Bulletin of Entomology, V43, P141; MASAKI S, 1981, BIOL CLOCKS SEASONAL, P101; Nakamura K, 2000, EUR J ENTOMOL, V97, P19, DOI 10.14411/eje.2000.004; Noda H, 1992, JAPAN AGR RES Q, V6, P124; Otuka A, 2010, APPL ENTOMOL ZOOL, V45, P259, DOI 10.1303/aez.2010.259; Purple Mountain Observatory Chinese Academy of Sciences, 2011, 2012 CHIN ASTR CAL, P595; SAUNDERS DS, 1983, J INSECT PHYSIOL, V29, P399, DOI 10.1016/0022-1910(83)90067-7; SAUNDERS DS, 1971, J INSECT PHYSIOL, V17, P801, DOI 10.1016/0022-1910(71)90098-9; Saunders DS, 2002, INSECT CLOCKS; SPIETH HR, 1995, J INSECT PHYSIOL, V41, P77, DOI 10.1016/0022-1910(94)00072-O; SUGIKI T, 1972, Kontyu, V40, P269; Takeda M, 2006, APPL ENTOMOL ZOOL, V41, P429, DOI 10.1303/aez.2006.429; Tauber M.J., 1986, SEASONAL ADAPTATIONS; TAUBER MJ, 1976, CAN J ZOOL, V54, P260, DOI 10.1139/z76-029; Wang Liu-Feng, 2013, Acta Entomologica Sinica, V56, P1430; Wang XP, 2009, PHYSIOL ENTOMOL, V34, P158, DOI 10.1111/j.1365-3032.2008.00668.x; Xiao HJ, 2010, J INSECT PHYSIOL, V56, P1558, DOI 10.1016/j.jinsphys.2010.05.012; Xue FS, 1997, J INSECT PHYSIOL, V43, P701, DOI 10.1016/S0022-1910(97)00053-X; Yoshida MT, 1995, J INSECT PHYSL, V41, P217	41	13	14	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 4	2014	9	9							e107030	10.1371/journal.pone.0107030	http://dx.doi.org/10.1371/journal.pone.0107030			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3XV	25188306	Green Published, Green Submitted, gold			2022-12-27	WOS:000341271500109
J	Berbari, NF; Malarkey, EB; Yazdi, SMZR; McNair, AD; Kippe, JM; Croyle, MJ; Kraft, TW; Yoder, BK				Berbari, Nicolas F.; Malarkey, Erik B.; Yazdi, S. M. Zaki R.; McNair, Andrew D.; Kippe, Jordyn M.; Croyle, Mandy J.; Kraft, Timothy W.; Yoder, Bradley K.			Hippocampal and Cortical Primary Cilia Are Required for Aversive Memory in Mice	PLOS ONE			English	Article							BIEDL-SYNDROME PROTEINS; INTRAFLAGELLAR TRANSPORT; NEURONAL CILIA; MOUSE MODEL; DEFECTS; LOCALIZATION; RECEPTORS; MEMBRANE; POLARIS; OBESITY	It has been known for decades that neurons throughout the brain possess solitary, immotile, microtubule based appendages called primary cilia. Only recently have studies tried to address the functions of these cilia and our current understanding remains poor. To determine if neuronal cilia have a role in behavior we specifically disrupted ciliogenesis in the cortex and hippocampus of mice through conditional deletion of the Intraflagellar Transport 88 (Ift88) gene. The effects on learning and memory were analyzed using both Morris Water Maze and fear conditioning paradigms. In comparison to wild type controls, cilia mutants displayed deficits in aversive learning and memory and novel object recognition. Furthermore, hippocampal neurons from mutants displayed an altered paired-pulse response, suggesting that loss of IFT88 can alter synaptic properties. A variety of other behavioral tests showed no significant differences between conditional cilia mutants and controls. This type of conditional allele approach could be used to distinguish which behavioral features of ciliopathies arise due to defects in neural development and which result from altered cell physiology. Ultimately, this could lead to an improved understanding of the basis for the cognitive deficits associated with human cilia disorders such as Bardet-Biedl syndrome, and possibly more common ailments including depression and schizophrenia.	[Berbari, Nicolas F.; Malarkey, Erik B.; Yazdi, S. M. Zaki R.; McNair, Andrew D.; Kippe, Jordyn M.; Croyle, Mandy J.; Yoder, Bradley K.] Univ Alabama Birmingham, Dept Cell Dev & Integrat Biol, Birmingham, AL 35294 USA; [Kraft, Timothy W.] Univ Alabama Birmingham, Dept Vis Sci, Birmingham, AL USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham	Yoder, BK (corresponding author), Univ Alabama Birmingham, Dept Cell Dev & Integrat Biol, Birmingham, AL 35294 USA.	byoder@uab.edu		Berbari, Nicolas/0000-0003-2863-1069	National Institutes of Health [RO1 DK075996]; UAB Neuroscience Behavioral Assessment Core [P30 NS47466]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK065655, R01DK075996, P30DK074038] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P30NS047466] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); UAB Neuroscience Behavioral Assessment Core; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	Funding provided by National Institutes of Health RO1 (RO1 DK075996) to BKY and UAB Neuroscience Behavioral Assessment Core (P30 NS47466). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agassandian K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093484; Amador-Arjona A, 2011, J NEUROSCI, V31, P9933, DOI 10.1523/JNEUROSCI.1062-11.2011; Antunes M, 2012, COGN PROCESS, V13, P93, DOI 10.1007/s10339-011-0430-z; Barnett S, 2002, J Med Genet, V39, pe76, DOI 10.1136/jmg.39.12.e76; Berbari NF, 2008, P NATL ACAD SCI USA, V105, P4242, DOI 10.1073/pnas.0711027105; Berbari NF, 2011, DEV BIOL, V360, P66, DOI 10.1016/j.ydbio.2011.09.001; Berbari NF, 2009, CURR BIOL, V19, pR526, DOI 10.1016/j.cub.2009.05.025; Bishop GA, 2007, J COMP NEUROL, V505, P562, DOI 10.1002/cne.21510; Brailov I, 2000, BRAIN RES, V872, P271, DOI 10.1016/S0006-8993(00)02519-1; Carter CS, 2012, NAT MED, V18, P1797, DOI 10.1038/nm.2996; Chakravarthy B, 2010, BIOCHEM BIOPH RES CO, V401, P458, DOI 10.1016/j.bbrc.2010.09.081; Chizhikov VV, 2007, J NEUROSCI, V27, P9780, DOI 10.1523/JNEUROSCI.5586-06.2007; Crawley JN, 2007, BRAIN PATHOL, V17, P448, DOI 10.1111/j.1750-3639.2007.00096.x; Davenport JR, 2007, CURR BIOL, V17, P1586, DOI 10.1016/j.cub.2007.08.034; Davis RE, 2007, P NATL ACAD SCI USA, V104, P19422, DOI 10.1073/pnas.0708571104; DeCaen PG, 2013, NATURE, V504, P315, DOI 10.1038/nature12832; Delling M, 2013, NATURE, V504, P311, DOI 10.1038/nature12833; Domire JS, 2011, CELL MOL LIFE SCI, V68, P2951, DOI 10.1007/s00018-010-0603-4; Eichers ER, 2006, HUM GENET, V120, P211, DOI 10.1007/s00439-006-0197-y; Einstein EB, 2010, J NEUROSCI, V30, P4306, DOI 10.1523/JNEUROSCI.5295-09.2010; Guo HL, 2000, BIOCHEM BIOPH RES CO, V273, P661, DOI 10.1006/bbrc.2000.2870; Handel M, 1999, NEUROSCIENCE, V89, P909, DOI 10.1016/S0306-4522(98)00354-6; Haycraft CJ, 2007, DEVELOPMENT, V134, P307, DOI 10.1242/dev.02732; Higginbotham H, 2013, NAT NEUROSCI, V16, P1000, DOI 10.1038/nn.3451; Higginbotham H, 2012, DEV CELL, V23, P925, DOI 10.1016/j.devcel.2012.09.019; Jin H, 2010, CELL, V141, P1208, DOI 10.1016/j.cell.2010.05.015; Kamiya A, 2008, ARCH GEN PSYCHIAT, V65, P996, DOI 10.1001/archpsyc.65.9.996; Li C, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000044; Marley A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046647; Marley A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010902; Pedersen LB, 2008, CURR TOP DEV BIOL, V85, P23, DOI 10.1016/S0070-2153(08)00802-8; Rosenbaum JL, 2002, NAT REV MOL CELL BIO, V3, P813, DOI 10.1038/nrm952; Seo SJ, 2009, HUM MOL GENET, V18, P1323, DOI 10.1093/hmg/ddp031; Sharma N, 2008, CURR TOP DEV BIOL, V85, P371, DOI 10.1016/S0070-2153(08)00813-2; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; Su S, 2013, NAT METHODS, V10, P1105, DOI [10.1038/NMETH.2647, 10.1038/nmeth.2647]; Tan PL, 2007, P NATL ACAD SCI USA, V104, P17524, DOI 10.1073/pnas.0706618104; Taulman PD, 2001, MOL BIOL CELL, V12, P589, DOI 10.1091/mbc.12.3.589; Whitfield J.F., 2012, NEUROGENESIS RES, P137; Whitfield JF, 2009, CELL SIGNAL, V21, P1351, DOI 10.1016/j.cellsig.2009.02.013; Yoder BK, 2002, AM J PHYSIOL-RENAL, V282, pF541, DOI 10.1152/ajprenal.00273.2001	41	31	31	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 3	2014	9	9							e106576	10.1371/journal.pone.0106576	http://dx.doi.org/10.1371/journal.pone.0106576			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3TB	25184295	gold, Green Published, Green Submitted			2022-12-27	WOS:000341257700090
J	Dun, W; Wright, P; Danilo, P; Mohler, PJ; Boyden, PA				Dun, Wen; Wright, Patrick; Danilo, Peter, Jr.; Mohler, Peter J.; Boyden, Penelope A.			SAP97 and Cortactin Remodeling in Arrhythmogenic Purkinje Cells	PLOS ONE			English	Article							HUMAN ATRIAL-FIBRILLATION; ANCHORING PROTEIN SAP97; CARDIAC MYOCYTES; K+ CURRENT; POTASSIUM CHANNELS; INFARCTED HEART; PLASMA-MEMBRANE; KV1.5; EXPRESSION; CURRENTS	Because structural remodeling of several proteins, including ion channels, may underlie the abnormal action potentials of Purkinje cells (PCs) that survive in the 48 hr infarcted zone of the canine heart (IZPCs), we sought to determine the subcellular structure and function of the KV1.5 (KCNA5) protein in single IZPCs. Clustering of the Kv1.5 subunit in axons is regulated by a synapse-associated protein, SAP97, and is linked to an actin-binding protein, cortactin, and an intercellular adhesion molecule, N-cadherin. To understand the functional remodeling of the Kv1.5 channel and its regulation in IZPCs, Kv1.5 currents in PCs were measured as the currents blocked by 10 mu M RSD1379 using patch-clamp techniques. Immunocytochemistry and confocal imaging were used for both single and aggregated IZPCs vs normal PCs (NZPCs) to determine the relationship of Kv1.5 with SAP-97, cortactin and N-cadherin. In IZPCs, both the sarcolemma (SL) and intercalated disk (ID) Kv1.5 protein are abundant, and the amount of cytosolic Kv1.5 protein is greatly increased. SAP-97 is also increased at IDs and has notable cytosolic localization suggesting that SAP-97 may regulate the functional expression and stabilization of Kv1.5 channels in IZPCs. Cortactin, which is located with N-cadherin at IDs in NZPCs, remains at IDs but begins to dissociate from N-cadherin, often forming ring structures and colocalizing with Kv1.5 within IZPCs. At the same time, cortactin/Kv1.5 colocalization is increased at the ID, suggesting an ongoing active process of membrane trafficking of the channel protein. Finally, the Kv1.5 current, measured as the RSD1379-sensitive current, at + 40 mV did not differ between NZPCs (0.81 +/- 0.24 pA/pF, n = 14) and IZPCs (0.83 +/- 0.21 pA/pF, n = 13, NS). In conclusion, the subcellular structural remodeling of Kv1.5, SAP97 and cortactin maintained and normalized the function of the Kv1.5 channel in Purkinje cells that survived myocardial infarction.	[Dun, Wen; Danilo, Peter, Jr.; Boyden, Penelope A.] Columbia Univ, Dept Pharmacol, Ctr Mol Therapeut, New York, NY 10027 USA; [Wright, Patrick; Mohler, Peter J.] Ohio State Univ, Wexner Med Ctr, Dorothy M Davis Heart & Lung Res Inst, Columbus, OH 43210 USA; [Mohler, Peter J.] Ohio State Univ, Wexner Med Ctr, Dept Internal Med, Columbus, OH 43210 USA; [Mohler, Peter J.] Ohio State Univ, Wexner Med Ctr, Dept Physiol & Cell Biol, Columbus, OH 43210 USA	Columbia University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University	Boyden, PA (corresponding author), Columbia Univ, Dept Pharmacol, Ctr Mol Therapeut, New York, NY 10027 USA.	pab4@columbia.edu			National Institutes of Health [HL105983, HL066140, HL114383, HL084583, HL083422]; Saving Tiny Hearts Society; American Heart Association; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL114383, R01HL066140, R01HL105983, R01HL083422, R01HL084583] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Saving Tiny Hearts Society; American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This study was supported by the National Institutes of Health [HL105983, HL066140, HL114383 to PAB];[HL084583, HL083422, HL114383 to PJM]; Saving Tiny Hearts Society (PJM), American Heart Association (PJM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abi-Char J, 2008, AM J PHYSIOL-HEART C, V294, pH1851, DOI 10.1152/ajpheart.01045.2007; Balse E, 2012, PHYSIOL REV, V92, P1317, DOI 10.1152/physrev.00041.2011; Boycott HE, 2013, P NATL ACAD SCI USA, V110, pE3955, DOI 10.1073/pnas.1309896110; BOYDEN PA, 1989, CIRC RES, V65, P955, DOI 10.1161/01.RES.65.4.955; Cheng L, 2011, J BIOL CHEM, V286, P20478, DOI 10.1074/jbc.M111.218560; Coronel R., 2010, NOVEL THERAPEUTIC TA; Dou Y, 2010, AM J PHYSIOL-CELL PH, V298, pC1343, DOI 10.1152/ajpcell.00005.2010; Dun W, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078087; El-Haou S, 2009, CIRC RES, V104, P758, DOI 10.1161/CIRCRESAHA.108.191007; Eldstrom J, 2003, FEBS LETT, V547, P205, DOI 10.1016/S0014-5793(03)00668-9; Fedida D, 2003, CIRC RES, V93, P744, DOI 10.1161/01.RES.0000096362.60730.AE; Feng JL, 1997, CIRC RES, V80, P572, DOI 10.1161/01.RES.80.4.572; Folco EJ, 2004, AM J PHYSIOL-HEART C, V287, pH681, DOI 10.1152/ajpheart.00152.2004; Godreau D, 2002, CARDIOVASC RES, V56, P433, DOI 10.1016/S0008-6363(02)00602-8; Han SP, 2014, J BIOL CHEM, V289, P7764, DOI 10.1074/jbc.M113.544478; HARRIS AS, 1950, CIRCULATION, V1, P1318, DOI 10.1161/01.CIR.1.6.1318; Herrmann S, 2012, J BIOL CHEM, V287, P44151, DOI 10.1074/jbc.M112.372540; JECK C, 1995, CIRCULATION, V92, P465, DOI 10.1161/01.CIR.92.3.465; Li JF, 2005, CIRC RES, V97, P474, DOI 10.1161/01.RES.0000181132.11393.18; Mathur R, 2006, BIOCHEM BIOPH RES CO, V342, P1, DOI 10.1016/j.bbrc.2006.01.110; Murata M, 2001, AM J PHYSIOL-HEART C, V281, pH2575, DOI 10.1152/ajpheart.2001.281.6.H2575; Olson TM, 2006, HUM MOL GENET, V15, P2185, DOI 10.1093/hmg/ddl143; Petitprez S, 2011, CIRC RES, V108, P294, DOI 10.1161/CIRCRESAHA.110.228312; Pinto JMB, 1998, J CARDIOVASC ELECTR, V9, P299, DOI 10.1111/j.1540-8167.1998.tb00915.x; Schumacher-Bass SM, 2014, CIRC RES, V114, P982, DOI 10.1161/CIRCRESAHA.114.302711; Sridhar A, 2007, BRIT J PHARMACOL, V152, P870, DOI 10.1038/sj.bjp.0707403; VanWagoner DR, 1997, CIRC RES, V80, P772	27	3	3	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 3	2014	9	9							e106830	10.1371/journal.pone.0106830	http://dx.doi.org/10.1371/journal.pone.0106830			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3TB	25184222	Green Published, gold, Green Submitted			2022-12-27	WOS:000341257700123
J	Malaviya, P; Hasker, E; Picado, A; Mishra, M; Van Geertruyden, JP; Das, ML; Boelaert, M; Sundar, S				Malaviya, Paritosh; Hasker, Epco; Picado, Albert; Mishra, Mukesh; Van Geertruyden, Jean-Pierre; Das, Murari Lal; Boelaert, Marleen; Sundar, Shyam			Exposure to Phlebotomus argentipes (Diptera, Psychodidae, Phlebotominae) Sand Flies in Rural Areas of Bihar, India: The Role of Housing Conditions	PLOS ONE			English	Article							LASTING INSECTICIDAL NETS; VISCERAL LEISHMANIASIS; RISK-FACTOR; KALA-AZAR; TRANSMISSION; ELIMINATION; SANDFLIES; ECOLOGY; POVERTY; LEVEL	Background: Visceral Leishmaniasis (VL) is a vector-borne infectious disease, caused by the protozoan Leishmania donovani, which is transmitted by phlebotomine sand flies. In an earlier study in Bihar, India, we found an association between incidence of VL and housing conditions. In the current study we investigated the influence of housing structure and conditions in and around the house on the indoor abundance of Phlebotomus argentipes, the vector of VL in this area. Methods: In each of 50 study villages in Muzaffarpur district, we randomly selected 10 houses. Light traps were installed in each house for one night during three annual peaks of sand fly density over two successive years. Sand flies captured were morphologically identified and segregated by species, sex and feeding status. Data on housing conditions and socioeconomic status were also collected. We fitted a linear mixed-effects regression model with log-transformed P. argentipes counts as outcome variable and village as random effect. Results: P. argentipes was found in all but four of the 500 households. There was considerable variability between the years and the seasons. On bivariate analysis, housing structure, dampness of the floor, keeping animals inside, presence of animal dung around the house, and socio-economic status were all significantly associated with sand fly density. Highest sand fly densities were observed in thatched houses. In the multivariate model only the housing structure and socio-economic status remained significant. Conclusions: Better housing conditions are associated with lower sand fly densities, independent of other socio-economic conditions. However, in this area in Bihar even in the better-built houses sand flies are present.	[Malaviya, Paritosh; Mishra, Mukesh; Boelaert, Marleen; Sundar, Shyam] Banaras Hindu Univ, Inst Med Sci, Varanasi 221005, Uttar Pradesh, India; [Malaviya, Paritosh; Hasker, Epco] Inst Trop Med, Dept Publ Hlth, B-2000 Antwerp, Belgium; [Picado, Albert] Univ Barcelona, Hosp Clin, CRESIB, Ctr Recerca Salut Int Barcelona, Barcelona, Spain; [Malaviya, Paritosh; Van Geertruyden, Jean-Pierre] Univ Antwerp, Int Hlth Unit, B-2020 Antwerp, Belgium; [Das, Murari Lal] BP Koirala Inst Hlth Sci, Dharan, Nepal	Banaras Hindu University (BHU); Institute of Tropical Medicine (ITM); ISGlobal; CRESIB; University of Barcelona; Hospital Clinic de Barcelona; University of Antwerp; B.P. Koirala Institute of Health Sciences	Sundar, S (corresponding author), Banaras Hindu Univ, Inst Med Sci, Varanasi 221005, Uttar Pradesh, India.	drshyamsundar@hotmail.com	Das, Murari/AAK-9157-2021; Malaviya, Paritosh/B-1819-2012; Van geertruyden, Jean-Pierre/S-3254-2019; Boelaert, Marleen/E-2698-2012; Van geertruyden, Jean-Pierre/K-6425-2014	Malaviya, Paritosh/0000-0002-7558-152X; Van geertruyden, Jean-Pierre/0000-0001-5006-6364; Boelaert, Marleen/0000-0001-8051-6776; Van geertruyden, Jean-Pierre/0000-0001-5006-6364; Picado, Albert/0000-0001-7344-628X; Das, Murari/0000-0001-6816-2389	National Institute for Allergy and Infectious Diseases, National Institutes of Health, TMRC Grant [P50AI074321]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P50AI074321] Funding Source: NIH RePORTER	National Institute for Allergy and Infectious Diseases, National Institutes of Health, TMRC Grant; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the National Institute for Allergy and Infectious Diseases, National Institutes of Health, TMRC Grant no. P50AI074321. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander B, 2000, MED VET ENTOMOL, V14, P109, DOI 10.1046/j.1365-2915.2000.00237.x; Alvar J, 2006, TRENDS PARASITOL, V22, P552, DOI 10.1016/j.pt.2006.09.004; Alvar J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035671; Bern C, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000599; Bhattacharya SK, 2006, INDIAN J MED RES, V123, P195; Bhattarai NR, 2010, EMERG INFECT DIS, V16, P231, DOI 10.3201/eid1602.090623; Boelaert M, 2009, TROP MED INT HEALTH, V14, P639, DOI 10.1111/j.1365-3156.2009.02279.x; CHANIOTIS BN, 1971, J MED ENTOMOL, V8, P339, DOI 10.1093/jmedent/8.4.339; Dinesh DS, 2008, TROP MED INT HEALTH, V13, P953, DOI 10.1111/j.1365-3156.2008.02096.x; Chaves LF, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-164; Chaves LF, 2010, J MED ENTOMOL, V47, P291, DOI 10.1603/ME09250; Ghosh K, 1999, J MED ENTOMOL, V36, P588, DOI 10.1093/jmedent/36.5.588; Hasker E, 2012, EMERG INFECT DIS, V18, P1662, DOI 10.3201/eid1810.111083; Joshi A., 2008, Journal of Vector Borne Diseases, V45, P105; Kalra NL., 1988, MANUALS ENTOMOLOGY V; Kesari S, 2010, PARASITE VECTOR, V3, DOI 10.1186/1756-3305-3-94; Lewis D.J., 1982, Bulletin of the British Museum (Natural History) Entomology, V45, P121; Lewis D.J., 1978, BULLETIN OF THE BRITISH MUSEUM (NATURAL HISTORY) ENTOMOLOGY SUPPLEMENT, V37, P217; Malafaia G, 2009, PARASITE IMMUNOL, V31, P587, DOI 10.1111/j.1365-3024.2009.01117.x; Merlo J, 2005, J EPIDEMIOL COMMUN H, V59, P729, DOI 10.1136/jech.2004.023929; MUKHOPADHYAY AK, 1987, INDIAN J MED RES, V86, P475; Picado A, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c6760; Picado A, 2010, J MED ENTOMOL, V47, P283, DOI 10.1603/ME09175; Poche D, 2011, J VECTOR ECOL, V36, pS106, DOI 10.1111/j.1948-7134.2011.00119.x; Poche RM, 2012, J VECTOR ECOL, V37, P148, DOI 10.1111/j.1948-7134.2012.00211.x; Quinnell RJ, 2009, PARASITOLOGY, V136, P1915, DOI 10.1017/S0031182009991156; QUINNELL RJ, 1992, MED VET ENTOMOL, V6, P195, DOI 10.1111/j.1365-2915.1992.tb00606.x; Singh A, 2008, J ECOPHYSIOLOGY OCCU, V8; Singh R, 2008, ACTA TROP, V107, P117, DOI 10.1016/j.actatropica.2008.04.025	29	17	18	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 3	2014	9	9							e106771	10.1371/journal.pone.0106771	http://dx.doi.org/10.1371/journal.pone.0106771			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3TB	25184542	Green Published, Green Submitted, gold			2022-12-27	WOS:000341257700119
J	Nevozhay, D				Nevozhay, Dmitry			Cheburator Software for Automatically Calculating Drug Inhibitory Concentrations from In Vitro Screening Assays	PLOS ONE			English	Article							METHOTREXATE CONJUGATE; ANTITUMOR-ACTIVITY; TOXICITY; CARRIER	In the process of new cancer drug development, as the first step of their assessment, their activities are usually studied in vitro against a panel of cancer cell lines. The results of these in vitro drug screening assays are commonly expressed as inhibitory concentration 50% (IC50): the concentration of the tested agent that inhibits the proliferation of the cancer cell population to 50% of the theoretically possible effect (absolute IC50) or maximum effect practically achieved by the drug (relative IC50). The currently available software for calculating IC50 values requires manual data entry, is time consuming, and is prone to calculation errors. Thus, we have developed open source, free, easy-to-use software for performing standardized data evaluations and automatically calculating the IC50. This software eliminates the laborious and error-prone manual entry of data, substantially reduces the amount of time spent for data analysis. It has been extensively used in our department as the main tool for in vitro data processing during the past several years and can be useful for other research groups working in the area of anticancer drug discovery, either alone or combined with other software packages. The current version of our program, Cheburator, together with sample data, source code, and documentation, is freely available at the following URL: http://www.cheburator.nevozhay.com (it is free for academic use, but a license is required for commercial use).	[Nevozhay, Dmitry] Univ Texas MD Anderson Canc Ctr, Dept Syst Biol, Unit 950, Houston, TX 77030 USA; [Nevozhay, Dmitry] Polish Acad Sci, Inst Immunol & Expt Therapy, Dept Expt Oncol, PL-53114 Wroclaw, Poland; [Nevozhay, Dmitry] Far Eastern Fed Univ, Sch Biomed, Vladivostok, Russia	University of Texas System; UTMD Anderson Cancer Center; Polish Academy of Sciences; Hirszfeld Institute of Immunology & Experimental Therapy of the Polish Academy of Sciences; Far Eastern Federal University	Nevozhay, D (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Syst Biol, Unit 950, Houston, TX 77030 USA.	dnevozhay@gmail.com	Nevozhay, Dmitry/D-7251-2017		Jozef Mianowski Fund; Foundation for Polish Science; Ministry of Education and Science, Russian Federation [1326]	Jozef Mianowski Fund; Foundation for Polish Science(Foundation for Polish ScienceEuropean Commission); Ministry of Education and Science, Russian Federation(Ministry of Education and Science, Russian FederationRussian Federation)	This work was supported by a joint fellowship from the Jozef Mianowski Fund and the Foundation for Polish Science to Dmitry Nevozhay and by Program #1326 from the Ministry of Education and Science, Russian Federation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bindslev N., 2008, DRUG ACCEPTOR INTERA; Budzynska R, 2007, ONCOL RES, V16, P415, DOI 10.3727/000000007783980837; Carpenter J, 2000, STAT MED, V19, P1141, DOI 10.1002/(SICI)1097-0258(20000515)19:9<1141::AID-SIM479>3.0.CO;2-F; Goszczynski T, 2013, BBA-GEN SUBJECTS, V1830, P2526, DOI 10.1016/j.bbagen.2012.11.005; Jagiello M, 2010, ACTA BIOCHIM POL, V57, P83; Kenakin TP., 1993, PHARM ANAL DRUG RECE, V2; Le CT, 2005, J BIOPHARM STAT, V15, P903, DOI 10.1080/10543400500265595; MEDDINGS JB, 1989, AM J PHYSIOL, V257, pG982, DOI 10.1152/ajpgi.1989.257.6.G982; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Neubig RR, 2003, PHARMACOL REV, V55, P597, DOI 10.1124/pr.55.4.4; Nevozhay D, 2006, ANTICANCER RES, V26, P1135; Nevozhay D, 2006, ANTICANCER RES, V26, P2179; PARELLADA J, 1995, J NAT PRODUCTS, V58, P823, DOI 10.1021/np50120a001; REED L. J., 1938, AMER JOUR HYG, V27, P493; Sebaugh JL, 2011, PHARM STAT, V10, P128, DOI 10.1002/pst.426; Shoemaker RH, 2006, NAT REV CANCER, V6, P813, DOI 10.1038/nrc1951; SKEHAN P, 1990, J NATL CANCER I, V82, P1107, DOI 10.1093/jnci/82.13.1107; [No title captured]	18	75	74	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 3	2014	9	9							e106186	10.1371/journal.pone.0106186	http://dx.doi.org/10.1371/journal.pone.0106186			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3TB	25184280	gold, Green Published, Green Submitted			2022-12-27	WOS:000341257700034
J	Pourabdolhossein, F; Mozafari, S; Morvan-Dubois, G; Mirnajafi-Zadeh, J; Lopez-Juarez, A; Pierre-Simons, J; Demeneix, BA; Javan, M				Pourabdolhossein, Fereshteh; Mozafari, Sabah; Morvan-Dubois, Ghislaine; Mirnajafi-Zadeh, Javad; Lopez-Juarez, Alejandra; Pierre-Simons, Jacqueline; Demeneix, Barbara A.; Javan, Mohammad			Nogo Receptor Inhibition Enhances Functional Recovery following Lysolecithin-Induced Demyelination in Mouse Optic Chiasm	PLOS ONE			English	Article							EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; MYELIN-ASSOCIATED GLYCOPROTEIN; STEM-CELL NICHE; OLIGODENDROCYTE DIFFERENTIATION; SUBVENTRICULAR ZONE; MULTIPLE-SCLEROSIS; SPINAL-CORD; ADULT-RAT; AXONAL REGENERATION; PROGENITOR CELLS	Background: Inhibitory factors have been implicated in the failure of remyelination in demyelinating diseases. Myelin associated inhibitors act through a common receptor called Nogo receptor (NgR) that plays critical inhibitory roles in CNS plasticity. Here we investigated the effects of abrogating NgR inhibition in a non-immune model of focal demyelination in adult mouse optic chiasm. Methodology/Principal Findings: A focal area of demyelination was induced in adult mouse optic chiasm by microinjection of lysolecithin. To knock down NgR levels, siRNAs against NgR were intracerebroventricularly administered via a permanent cannula over 14 days, Functional changes were monitored by electrophysiological recording of latency of visual evoked potentials (VEPs). Histological analysis was carried out 3, 7 and 14 days post demyelination lesion. To assess the effect of NgR inhibition on precursor cell repopulation, BrdU was administered to the animals prior to the demyelination induction. Inhibition of NgR significantly restored VEPs responses following optic chiasm demyelination. These findings were confirmed histologically by myelin specific staining. siNgR application resulted in a smaller lesion size compared to control. NgR inhibition significantly increased the numbers of BrdU+/Olig2+ progenitor cells in the lesioned area and in the neurogenic zone of the third ventricle. These progenitor cells (Olig2+ or GFAP+) migrated away from this area as a function of time. Conclusions/Significance: Our results show that inhibition of NgR facilitate myelin repair in the demyelinated chiasm, with enhanced recruitment of proliferating cells to the lesion site. Thus, antagonizing NgR function could have therapeutic potential for demyelinating disorders such as Multiple Sclerosis.	[Pourabdolhossein, Fereshteh; Mozafari, Sabah; Mirnajafi-Zadeh, Javad; Javan, Mohammad] Tarbiat Modares Univ, Fac Med Sci, Dept Physiol, Tehran, Iran; [Pourabdolhossein, Fereshteh; Morvan-Dubois, Ghislaine; Lopez-Juarez, Alejandra; Pierre-Simons, Jacqueline; Demeneix, Barbara A.] Museum Natl Hist Nat, Dept Regulat Dev & Divers Mol, CNRS, UMR 7221, F-75231 Paris, France; [Javan, Mohammad] ACECR, Royan Inst Stem Cell Biol & Technol, Cell Sci Res Ctr, Dept Stem Cells & Dev Biol, Tehran, Iran	Tarbiat Modares University; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Museum National d'Histoire Naturelle (MNHN); Academic Center for Education, Culture & Research (ACECR)	Javan, M (corresponding author), Tarbiat Modares Univ, Fac Med Sci, Dept Physiol, Tehran, Iran.	mjavan@modares.ac.ir	Mirnajafi-Zadeh, Javad/W-5379-2019; Mirnajafi-Zadeh, Javad/AAD-4822-2022; Javan, Mohammad/C-6758-2008; morvan-dubois, ghislaine/AAI-1765-2019; Lopez Juarez, Silvia Alejandra/D-2617-2017	Mirnajafi-Zadeh, Javad/0000-0003-3946-9052; Javan, Mohammad/0000-0003-2045-6171; Mozafari, Sabah/0000-0002-8166-2465; Lopez Juarez, Silvia Alejandra/0000-0001-9443-6531; Morvan-Dubois, ghislaine/0000-0003-1285-9130	Tarbiat Modares University, Tehran, Iran; EU program (FP6, Crescendo); AFM (Association Francaise contre les Myopathies); CNRS; MNHN	Tarbiat Modares University, Tehran, Iran; EU program (FP6, Crescendo); AFM (Association Francaise contre les Myopathies)(Association Francaise contre les Myopathies); CNRS(Centre National de la Recherche Scientifique (CNRS)); MNHN	This study was supported by a grant from Tarbiat Modares University, Tehran, Iran. The work in B. A. Demeneix's lab, Paris France, was supported by the EU program (FP6, Crescendo), the AFM (Association Francaise contre les Myopathies) and grants from the CNRS and MNHN. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bibollet-Bahena Olivia, 2009, Central Nervous System Agents in Medicinal Chemistry, V9, P95; Cantley LC, 2002, SCIENCE, V296, P1655, DOI 10.1126/science.296.5573.1655; Chen Z, 2001, CHEM REV, V101, P2449, DOI 10.1021/cr000241p; Chitnis T, 2007, AM J PATHOL, V170, P1695, DOI 10.2353/ajpath.2007.060677; Chong SYC, 2012, P NATL ACAD SCI USA, V109, P1299, DOI 10.1073/pnas.1113540109; COLELLO RJ, 1995, J NEUROSCI, V15, P7665; Dahiya S, 2011, J NEUROPATH EXP NEUR, V70, P622, DOI 10.1097/NEN.0b013e31822200aa; de Castro F, 2005, BRAIN RES REV, V49, P227, DOI 10.1016/j.brainresrev.2004.12.034; Decherf S, 2010, P NATL ACAD SCI USA, V107, P4471, DOI 10.1073/pnas.0905190107; Decker L, 2002, J NEUROSCI RES, V69, P763, DOI 10.1002/jnr.10411; Dehghan S, 2012, J MOL NEUROSCI, V48, P77, DOI 10.1007/s12031-012-9777-6; Edgar JM, 2004, J NEUROSCI RES, V76, P593, DOI 10.1002/jnr.20063; Ernst C, 2005, EUR J NEUROSCI, V22, P3059, DOI 10.1111/j.1460-9568.2005.04499.x; Fontoura P, 2004, J IMMUNOL, V173, P6981, DOI 10.4049/jimmunol.173.11.6981; Fournier AE, 2001, NATURE, V409, P341, DOI 10.1038/35053072; Fry EJ, 2007, NEURON, V53, P649, DOI 10.1016/j.neuron.2007.02.009; Gao LM, 2006, J NEUROSCI, V26, P7619, DOI 10.1523/JNEUROSCI.0855-06.2006; GrandPre T, 2000, NATURE, V403, P439, DOI 10.1038/35000226; Griffiths I, 1998, SCIENCE, V280, P1610, DOI 10.1126/science.280.5369.1610; Harvey PA, 2009, J NEUROSCI, V29, P6285, DOI 10.1523/JNEUROSCI.5885-08.2009; Hu JG, 2008, NEUROSCIENCE, V151, P138, DOI 10.1016/j.neuroscience.2007.10.050; Huang JY, 2012, BRAIN RES, V1437, P1, DOI 10.1016/j.brainres.2011.12.008; Hunt D, 2002, MOL CELL NEUROSCI, V20, P537, DOI 10.1006/mcne.2002.1153; Irvine KA, 2008, BRAIN, V131, P1464, DOI 10.1093/brain/awn080; Ishikawa T, 2008, EPILEPSY RES, V79, P146, DOI 10.1016/j.eplepsyres.2008.01.001; Jepson S, 2012, J BIOL CHEM, V287, P22184, DOI 10.1074/jbc.M112.366179; Jiang W, 2009, TRANSL RES, V154, P40, DOI 10.1016/j.trsl.2009.04.005; Kandel ES, 1999, EXP CELL RES, V253, P210, DOI 10.1006/excr.1999.4690; Karnezis T, 2004, NAT NEUROSCI, V7, P736, DOI 10.1038/nn1261; Klistorner A, 2007, INVEST OPHTH VIS SCI, V48, P4549, DOI 10.1167/iovs.07-0381; Kotter MR, 2001, GLIA, V35, P204, DOI 10.1002/glia.1085; Kuroda K, 2009, EUR J PHARMACOL, V602, P294, DOI 10.1016/j.ejphar.2008.11.048; Lappe-Siefke C, 2003, NAT GENET, V33, P366, DOI 10.1038/ng1095; Lee HJ, 2008, J NEUROSCI, V28, P2753, DOI 10.1523/JNEUROSCI.5586-07.2008; Lee JY, 2013, NEUROSCIENTIST, V19, P394, DOI 10.1177/1073858413477207; Liao H, 2004, J NEUROCHEM, V90, P1156, DOI 10.1111/j.1471-4159.2004.02573.x; Liedtke W, 1998, AM J PATHOL, V152, P251; LOIS C, 1994, SCIENCE, V264, P1145, DOI 10.1126/science.8178174; Lopez-Juarez A, 2012, CELL STEM CELL, V10, P531, DOI 10.1016/j.stem.2012.04.008; Mathis C, 2010, CEREB CORTEX, V20, P2380, DOI 10.1093/cercor/bhp307; McDonald CL, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-113; MCKERRACHER L, 1994, NEURON, V13, P805, DOI 10.1016/0896-6273(94)90247-X; Mi S, 2005, NAT NEUROSCI, V8, P745, DOI 10.1038/nn1460; Mi S, 2007, NAT MED, V13, P1228, DOI 10.1038/nm1664; Miron VE, 2013, NAT NEUROSCI, V16, P1211, DOI 10.1038/nn.3469; Mozafari S, 2011, NEUROMOL MED, V13, P138, DOI 10.1007/s12017-011-8143-0; Mozafari S, 2010, BRAIN RES, V1351, P50, DOI 10.1016/j.brainres.2010.07.026; Nait-Oumesmar B, 1999, EUR J NEUROSCI, V11, P4357, DOI 10.1046/j.1460-9568.1999.00873.x; Ono K, 1997, NEURON, V19, P283, DOI 10.1016/S0896-6273(00)80939-3; Paxinos G, 2004, MOUSE BRAIN STEREOTA; Petratos S, 2012, BRAIN, V135, P1794, DOI 10.1093/brain/aws100; Picard-Riera N, 2002, P NATL ACAD SCI USA, V99, P13211, DOI 10.1073/pnas.192314199; Remaud S, 2013, MOL THER-NUCL ACIDS, V2, DOI 10.1038/mtna.2013.8; Satarian L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071855; Satoh JI, 2005, J NEUROPATH EXP NEUR, V64, P129, DOI 10.1093/jnen/64.2.129; Schwab ME, 2010, NAT REV NEUROSCI, V11, P799, DOI 10.1038/nrn2936; Steinbach K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026341; Su ZD, 2007, J CELL SCI, V120, P1877, DOI 10.1242/jcs.03448; Syed YA, 2008, NEUROSURG FOCUS, V24, DOI 10.3171/FOC/2008/24/3-4/E4; Talbott JF, 2005, EXP NEUROL, V192, P11, DOI 10.1016/j.expneurol.2004.05.038; Wang B, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001856; Wang F, 2008, NEUROSCIENCE, V151, P74, DOI 10.1016/j.neuroscience.2007.10.034; Wang KC, 2002, NATURE, V420, P74, DOI 10.1038/nature01176; Wang TZ, 2010, BRAIN RES, V1360, P147, DOI 10.1016/j.brainres.2010.08.101; Xu Y, 2005, EXP NEUROL, V192, P251, DOI 10.1016/j.expneurol.2004.12.021; Yan J, 2012, J NEUROCHEM, V120, P721, DOI 10.1111/j.1471-4159.2011.07619.x; Yang YH, 2010, ANN NEUROL, V67, P498, DOI 10.1002/ana.21935; You YY, 2011, INVEST OPHTH VIS SCI, V52, P6911, DOI 10.1167/iovs.11-7434; Yu PP, 2008, NEUROBIOL DIS, V32, P535, DOI 10.1016/j.nbd.2008.09.012	69	36	39	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 3	2014	9	9							e106378	10.1371/journal.pone.0106378	http://dx.doi.org/10.1371/journal.pone.0106378			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3TB	25184636	gold, Green Published, Green Submitted			2022-12-27	WOS:000341257700065
J	Liu, CC; Hwang, CS; Yang, WS; Tsai, DC; Wu, SH; Chou, AH; Chow, YH; Wu, SC; Wang, JR; Chiang, JR; Huang, CC; Pan, CH; Chong, P				Liu, Chia-Chyi; Hwang, Chyi-Sing; Yang, Wun-Syue; Tsai, Dan-Chin; Wu, Sze-Hsien; Chou, Ai-Hsiang; Chow, Yen-Hung; Wu, Suh-Chin; Wang, Jen-Ren; Chiang, Jen-Ron; Huang, Chin-Cheng; Pan, Chien-Hsiung; Chong, Pele			Long-Term Immunogenicity Studies of Formalin-Inactivated Enterovirus 71 Whole-Virion Vaccine in Macaques	PLOS ONE			English	Article							VIRUS-LIKE PARTICLES; VP1 CAPSID PROTEIN; NEUTRALIZING ANTIBODIES; MOLECULAR EPIDEMIOLOGY; INTERFERON-GAMMA; RHESUS-MONKEYS; EV71 VACCINE; DOUBLE-BLIND; PHASE-I; INFECTION	Enterovirus 71 (EV71) has caused epidemics of hand, foot and mouth diseases in Asia during the past decades and no vaccine is available. A formalin-inactivated EV71 candidate vaccine (EV71vac) based on B4 subgenotype has previously been developed and found to elicit strong neutralizing antibody responses in mice and humans. In this study, we evaluated the long-term immunogenicity and safety of this EV71vac in a non-human primate model. Juvenile macaques were immunized at 0, 3 and 6 weeks either with 10 or 5 mu g doses of EV71vac formulated with AlPO4 adjuvant, or PBS as control. During the 56 weeks of studies, no fever nor local redness and swelling at sites of injections was observed in the immunized macaques. After single immunization, 100% seroconversion based on 4-fold increased in neutralization titer (Nt) was detected in EV71vac immunized monkeys but not PBS controls. A dose-dependent IgG antibody response was observed in monkeys receiving EV71vac immunization. The Nt of EV71vac immunized macaques had reached the peak after 3 vaccinations, then decreased gradually; however, the GMT of neutralizing antibody in the EV71vac immunized macaques were still above 100 at the end of the study. Correspondingly, both dose-and time-dependent interferon-gamma and CD4(+) T cell responses were detected in monkeys receiving EV71vac. Interestingly, similar to human responses, the dominant T cell epitopes of macaques were identified mainly in VP2 and VP3 regions. In addition, strong cross-neutralizing antibodies against most EV71 subgenotypes except some C2 and C4b strains, and Coxsackievirus A16 were observed. In summary, our results indicate that EV71vac elicits dose-dependent T-cell and antibody responses in macaques that could be a good animal model for evaluating the long-term immune responses elicited by EV71 vaccines.	[Liu, Chia-Chyi; Yang, Wun-Syue; Tsai, Dan-Chin; Wu, Sze-Hsien; Chou, Ai-Hsiang; Chow, Yen-Hung; Wang, Jen-Ren; Pan, Chien-Hsiung; Chong, Pele] Natl Hlth Res Inst, Natl Inst Infect Dis & Vaccinol, Zhunan Town, Miaoli County, Taiwan; [Hwang, Chyi-Sing; Huang, Chin-Cheng] Council Agr, Anim Hlth Res Inst, Tamsui, Taiwan; [Wu, Suh-Chin] Natl Tsing Hua Univ, Inst Biotechnol, Dept Life Sci, Hsinchu, Taiwan; [Chiang, Jen-Ron] Ctr Dis Control, Taipei, Taiwan; [Pan, Chien-Hsiung; Chong, Pele] China Med Univ, Grad Inst Immunol, Taichung, Taiwan	National Health Research Institutes - Taiwan; National Tsing Hua University; Centers For Disease Control - Taiwan; China Medical University Taiwan	Pan, CH (corresponding author), Natl Hlth Res Inst, Natl Inst Infect Dis & Vaccinol, Zhunan Town, Miaoli County, Taiwan.	cpan@nhri.org.tw; pelechong@nhri.org.tw	Chong, Pele/E-3855-2010; Wang, Jen-Ren/F-5254-2011; Wu, Suh-Chin/AAV-6233-2021; Pan, Chien-Hsiung/E-3857-2010; Liu, Chia-Chyi/A-8215-2012; Chow, Yen-Hung/E-3863-2010	Liu, Chia-Chyi/0000-0002-6257-0389; Wang, Jen-Ren/0000-0002-4127-4046	Ministry of Health and Welfare; Taiwan CDC; National Science Council [NSC 99A1-VCSP01-014, NSC 100A1-VCSP01-014]; National Health Research Institutes, Taiwan [01A1-IVSP17-014, 01A1-IVPP33-014, 02A1-IVPP12-014]	Ministry of Health and Welfare(Ministry of Health, Labour and Welfare, Japan); Taiwan CDC; National Science Council(Ministry of Science and Technology, Taiwan); National Health Research Institutes, Taiwan(National Health Research Institutes - Taiwan)	This work was supported by the Ministry of Health and Welfare, the Taiwan CDC, National Science Council (NSC 99A1-VCSP01-014 and NSC 100A1-VCSP01-014) and the National Health Research Institutes (01A1-IVSP17-014, 01A1-IVPP33-014 and 02A1-IVPP12-014), Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arita M, 2007, J VIROL, V81, P9386, DOI 10.1128/JVI.02856-06; Brown BA, 1999, J VIROL, V73, P9969, DOI 10.1128/JVI.73.12.9969-9975.1999; Caine EA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059501; Cello J, 1996, J GEN VIROL, V77, P2097, DOI 10.1099/0022-1317-77-9-2097; Chang LY, 2006, PEDIATR RES, V60, P466, DOI 10.1203/01.pdr.0000238247.86041.19; Chang LY, 2004, JAMA-J AM MED ASSOC, V291, P222, DOI 10.1001/jama.291.2.222; Chang LY, 2002, PEDIATRICS, V109, DOI 10.1542/peds.109.6.e88; Chen HL, 2008, VACCINE, V26, P2882, DOI 10.1016/j.vaccine.2008.03.041; Chen HW, 2013, ARCH VIROL, V158, P1523, DOI 10.1007/s00705-013-1639-1; Cheng A, 2013, VACCINE, V31, P2471, DOI 10.1016/j.vaccine.2013.03.015; Chong P, 2012, HUM VACC IMMUNOTHER, V8, P1775, DOI 10.4161/hv.21739; Chou AH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079783; Chou AH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034834; Chung YC, 2006, WORLD J GASTROENTERO, V12, P921, DOI 10.3748/wjg.v12.i6.921; Dong CH, 2011, VACCINE, V29, P6269, DOI 10.1016/j.vaccine.2011.06.044; Dong CH, 2010, HUM VACCINES, V6, P1028, DOI 10.4161/hv.6.12.12982; DRAKE JW, 1993, P NATL ACAD SCI USA, V90, P4171, DOI 10.1073/pnas.90.9.4171; Foo DGW, 2007, MICROBES INFECT, V9, P1299, DOI 10.1016/j.micinf.2007.06.002; Guang D, 2007, VIRUS RES, V125, P61, DOI 10.1016/j.virusres.2006.12.005; Ho MT, 1999, NEW ENGL J MED, V341, P929, DOI 10.1056/NEJM199909233411301; Huang SW, 2009, J CLIN MICROBIOL, V47, P3653, DOI 10.1128/JCM.00630-09; Huang SC, 2008, VIRUS RES, V131, P250, DOI 10.1016/j.virusres.2007.10.002; KIRKEGAARD K, 1986, CELL, V47, P433, DOI 10.1016/0092-8674(86)90600-8; Klingel K, 2003, AM J PATHOL, V162, P1709, DOI 10.1016/S0002-9440(10)64305-2; KUTUBUDDIN M, 1992, J VIROL, V66, P3042, DOI 10.1128/JVI.66.5.3042-3047.1992; Li YP, 2012, VACCINE, V30, P3295, DOI 10.1016/j.vaccine.2012.03.010; Lin YL, 2012, VACCINE, V30, P1305, DOI 10.1016/j.vaccine.2011.12.081; Lin YW, 2009, J VIROL, V83, P6477, DOI 10.1128/JVI.00434-09; Lukashev AN, 2003, J VIROL, V77, P10423, DOI 10.1128/JVI.77.19.10423-10431.2003; McMinn PC, 2012, CURR OPIN VIROL, V2, P199, DOI 10.1016/j.coviro.2012.02.009; Shen FH, 2013, J GEN VIROL, V94, P1019, DOI 10.1099/vir.0.046383-0; Tan CS, 2007, ARCH VIROL, V152, P1069, DOI 10.1007/s00705-007-0941-1; Tan SG, 2013, J IMMUNOL, V191, P1637, DOI 10.4049/jimmunol.1301439; Xu J, 2010, VACCINE, V28, P3516, DOI 10.1016/j.vaccine.2010.03.003; Yi LN, 2011, CRIT REV MICROBIOL, V37, P313, DOI 10.3109/1040841X.2011.580723; Yoke-Fun C, 2006, BMC MICROBIOL, V6, DOI 10.1186/1471-2180-6-74; Zhang Y, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0059086, 10.1371/journal.pone.0056341]; Zhu FC, 2013, LANCET, V381, P2024, DOI 10.1016/S0140-6736(13)61049-1	38	8	10	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2014	9	9							e106756	10.1371/journal.pone.0106756	http://dx.doi.org/10.1371/journal.pone.0106756			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4JX	25197967	Green Submitted, gold, Green Published			2022-12-27	WOS:000341304700046
J	Benova, L; Cumming, O; Gordon, BA; Magoma, M; Campbell, OMR				Benova, Lenka; Cumming, Oliver; Gordon, Bruce A.; Magoma, Moke; Campbell, Oona M. R.			Where There Is No Toilet: Water and Sanitation Environments of Domestic and Facility Births in Tanzania	PLOS ONE			English	Article							MATERNAL MORTALITY; SOUTHERN TANZANIA; PUERPERAL SEPSIS; RURAL TANZANIA; HEALTH; CARE; CHILDBIRTH	Background: Inadequate water and sanitation during childbirth are likely to lead to poor maternal and newborn outcomes. This paper uses existing data sources to assess the water and sanitation (WATSAN) environment surrounding births in Tanzania in order to interrogate whether such estimates could be useful for guiding research, policy and monitoring initiatives. Methods: We used the most recent Tanzania Demographic and Health Survey (DHS) to characterise the delivery location of births occurring between 2005 and 2010. Births occurring in domestic environments were characterised as WATSAN-safe if the home fulfilled international definitions of improved water and improved sanitation access. We used the 2006 Service Provision Assessment survey to characterise the WATSAN environment of facilities that conduct deliveries. We combined estimates from both surveys to describe the proportion of all births occurring in WATSAN-safe environments and conducted an equity analysis based on DHS wealth quintiles and eight geographic zones. Results: 42.9% (95% confidence interval: 41.6%-44.2%) of all births occurred in the woman's home. Among these, only 1.5% (95% confidence interval: 1.2%-2.0%) were estimated to have taken place in WATSAN-safe conditions. 74% of all health facilities conducted deliveries. Among these, only 44% of facilities overall and 24% of facility delivery rooms were WATSAN-safe. Combining the estimates, we showed that 30.5% of all births in Tanzania took place in a WATSAN-safe environment (range of uncertainty 25%-42%). Large wealth-based inequalities existed in the proportion of births occurring in domestic environments based on wealth quintile and geographical zone. Conclusion: Existing data sources can be useful in national monitoring and prioritisation of interventions to improve poor WATSAN environments during childbirth. However, a better conceptual understanding of potentially harmful exposures and better data are needed in order to devise and apply more empirical definitions of WATSAN-safe environments, both at home and in facilities.	[Benova, Lenka; Campbell, Oona M. R.] London Sch Hyg & Trop Med, Fac Epidemiol & Populat Hlth, London WC1, England; [Cumming, Oliver] London Sch Hyg & Trop Med, Fac Infect & Trop Dis, London WC1, England; [Gordon, Bruce A.] World Hlth Org, Geneva, Switzerland; [Magoma, Moke] Bugando Med Ctr & Teaching Hosp, Evidence Act E4A, Dept Obstet & Gynaecol, Mwanza, Tanzania	University of London; London School of Hygiene & Tropical Medicine; University of London; London School of Hygiene & Tropical Medicine; World Health Organization	Benova, L (corresponding author), London Sch Hyg & Trop Med, Fac Epidemiol & Populat Hlth, London WC1, England.	lenka.benova@lshtm.ac.uk		Cumming, Oliver/0000-0002-5074-8709; Campbell, Oona/0000-0002-9311-0115	World Health Organization [001] Funding Source: Medline	World Health Organization(World Health Organization)		Adams J., 2008, ESSENTIAL ENV HLTH S; Benova L, 2014, TROP MED INT HEALTH, V19, P368, DOI 10.1111/tmi.12275; Campbell OMR, 2006, LANCET, V368, P1284, DOI 10.1016/S0140-6736(06)69381-1; Filmer D, 2001, DEMOGRAPHY, V38, P115, DOI 10.2307/3088292; Gordon AA., 1795, TREATISE EPIDEMIC PU; Gould IM, 2010, LANCET INFECT DIS, V10, P275, DOI 10.1016/S1473-3099(09)70304-4; Hanson Claudia, 2013, BMC Res Notes, V6, P435, DOI 10.1186/1756-0500-6-435; Henderson LN, 2008, HUM RESOUR HEALTH, V6, DOI 10.1186/1478-4491-6-18; Hussein J, 2004, INT J GYNECOL OBSTET, V85, pS52, DOI 10.1016/j.ijgo.2004.01.010; Kengia JT, 2013, TOHOKU J EXP MED, V230, P241, DOI 10.1620/tjem.230.241; Kruk ME, 2014, B WORLD HEALTH ORGAN, V92, P246, DOI 10.2471/BLT.13.126417; Kruk ME, 2010, HEALTH POLICY, V97, P209, DOI 10.1016/j.healthpol.2010.05.002; Kruk ME, 2009, AM J PUBLIC HEALTH, V99, P1666, DOI 10.2105/AJPH.2008.146209; National Bureau of Statistics (NBS/Tanzania) ICF Macro, 2011, TANZ DEM HLTH SURV 2; National Bureau of Statistics Tanzania and Macro International, 2007, TANZ SERV PROV ASS S; Penfold S, 2013, BMC HEALTH SERV RES, V13, DOI 10.1186/1472-6963-13-61; Scott B, 2007, HEALTH POLICY PLANN, V22, P225, DOI 10.1093/heapol/czm016; Semmelweis I., 1983, ETIOLOGY CONCEPT PRO; Spangler SA, 2010, SOC SCI MED, V71, P760, DOI 10.1016/j.socscimed.2010.05.025; Stanton CK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060694; Tanzanian Ministry of Health and Social Welfare, 2014, WOM CHILDR 1 COUNTD; UNICEF and WHO, 2012, PROGR DRINKING WATER; Urassa Earnest, 1995, Afr J Health Sci, V2, P242; WHO/UNICEF, 2012, COUNTD 2015 BUILD FU; WHO & UNICEF, 2013, PROGR SAN DRINK WAT; WHO UNICEF UNFPA Bank W & UNDP, 2014, TRENDS MAT MORT 1990; WHO (World Health Organization), 2012, UN WAT GLOB ANN ASS; World Health Organization, 2012, HAND HYG OUTP HOM BA; World Health Organization, 2009, WHO GUID HAND HYG HL; World Health Organization (WHO), 1996, CAR NORM BIRTH PRACT; Zaidi AKM, 2005, LANCET, V365, P1175, DOI 10.1016/S0140-6736(05)71881-X	31	27	27	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2014	9	9							e106738	10.1371/journal.pone.0106738	http://dx.doi.org/10.1371/journal.pone.0106738			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ1IR	25191753	Green Published, Green Accepted, gold, Green Submitted			2022-12-27	WOS:000347993600054
J	Horlin, C; Falkmer, M; Parsons, R; Albrecht, MA; Falkmer, T				Horlin, Chiara; Falkmer, Marita; Parsons, Richard; Albrecht, Matthew A.; Falkmer, Torbjorn			The Cost of Autism Spectrum Disorders	PLOS ONE			English	Article							BEHAVIORAL TREATMENT; MEDIATION ANALYSIS; CHILDREN; INTERVENTION; DIAGNOSIS; FAMILIES; PARENTS; ADOS; AGE	Objective: A diagnosis of an autism spectrum disorders is usually associated with substantial lifetime costs to an individual, their family and the community. However, there remains an elusive factor in any cost-benefit analysis of ASD diagnosis, namely the cost of not obtaining a diagnosis. Given the infeasibility of estimating the costs of a population that, by its nature, is inaccessible, the current study compares expenses between families whose children received a formal ASD diagnosis immediately upon suspecting developmental atypicality and seeking advice, with families that experienced a delay between first suspicion and formal diagnosis. Design: A register based questionnaire study covering all families with a child with ASD in Western Australia. Participants: Families with one or more children diagnosed with an ASD, totalling 521 children diagnosed with an ASD; 317 records were able to be included in the final analysis. Results: The median family cost of ASD was estimated to be AUD $ 34,900 per annum with almost 90% of the sum ($ 29,200) due to loss of income from employment. For each additional symptom reported, approximately $ 1,400 cost for the family per annum was added. While there was little direct influence on costs associated with a delay in the diagnosis, the delay was associated with a modest increase in the number of ASD symptoms, indirectly impacting the cost of ASD. Conclusions: A delay in diagnosis was associated with an indirect increased financial burden to families. Early and appropriate access to early intervention is known to improve a child's long-term outcomes and reduce lifetime costs to the individual, family and society. Consequently, a per symptom dollar value may assist in allocation of individualised funding amounts for interventions rather than a nominal amount allocated to all children below a certain age, regardless of symptom presentation, as is the case in Western Australia.	[Horlin, Chiara; Falkmer, Marita; Parsons, Richard; Falkmer, Torbjorn] Curtin Univ, Sch Occupat Therapy & Social Work, Perth, WA 6845, Australia; [Falkmer, Marita] Jonkoping Univ, Inst Disabil Res, Sch Educ & Commun, CHILD Programme, Jonkoping, Sweden; [Albrecht, Matthew A.] Curtin Univ, Sch Psychol, CHIRI, Perth, WA 6845, Australia; [Falkmer, Torbjorn] Linkoping Univ, Fac Hlth Sci, Dept Med & Hlth Sci IMH, Linkoping, Sweden; [Falkmer, Torbjorn] Pain & Rehabil Ctr, Linkoping, Sweden; [Falkmer, Torbjorn] La Trobe Univ, Sch Occupat Therapy, Melbourne, Vic, Australia	Curtin University; Jonkoping University; Curtin University; Linkoping University; La Trobe University	Falkmer, T (corresponding author), Curtin Univ, Sch Occupat Therapy & Social Work, Perth, WA 6845, Australia.	T.Falkmer@curtin.edu.au	Albrecht, Matthew/H-5918-2019	Albrecht, Matthew/0000-0002-6540-5979; horlin, chiara/0000-0003-4233-2030	Department of Social Services (DSS); Australian Government's Cooperative Research Centres Program; DSS [RES-HEA-CRD-TB-50940]	Department of Social Services (DSS); Australian Government's Cooperative Research Centres Program(Australian GovernmentDepartment of Industry, Innovation and ScienceCooperative Research Centres (CRC) Programme); DSS	This study was funded by the Department of Social Services (DSS), formerly the Department of Families, Housing, Community Services and Indigenous Affairs (FaHCSIA), with in-kind support of the Autism CRC, established and supported under the Australian Government's Cooperative Research Centres Program. The research was also conducted in collaboration with Disabilities Services Commission Western Australia (DSC). DSS had no active role in the design, implementation, data collection, analysis or interpretation of the study. DSC collaborated with the authors and assisted in data collection by in-kind contribution of its employee's time in some aspects of the study. Writing of the report and the decision to submit this manuscript were solely the role and responsibility of the authors. However, approval to submit this study for publication was sought from CRC Living with Autism Spectrum Disorders, DSS and DSC. All researchers are independent from both DSS and DSC and take full responsibility for the integrity of the data and the accuracy of the analyses. (DSS grant number - RES-HEA-CRD-TB-50940 http://www.dss.gov.au/)	Australian Government, 2013, HELP CHILDR AUT; Consulting SE, 2007, SYNERGIES EC CONSULT; FENSKE EC, 1985, ANAL INTERVEN DEVEL, V5, P49, DOI 10.1016/S0270-4684(85)80005-7; Ganz M. L., 2006, THE COSTS OF AUTISM, P475; Ganz ML, 2007, ARCH PEDIAT ADOL MED, V161, P343, DOI 10.1001/archpedi.161.4.343; Harris SL, 2000, J AUTISM DEV DISORD, V30, P137, DOI 10.1023/A:1005459606120; Hartley SL, 2010, J FAM PSYCHOL, V24, P449, DOI 10.1037/a0019847; Hayes AF, 2009, COMMUN MONOGR, V76, P408, DOI 10.1080/03637750903310360; Keenan M, 2010, J APPL RES INTELLECT, V23, P390, DOI 10.1111/j.1468-3148.2010.00555.x; Le Couteur A, 2008, J AUTISM DEV DISORD, V38, P362, DOI 10.1007/s10803-007-0403-3; LOVAAS OI, 1987, J CONSULT CLIN PSYCH, V55, P3, DOI 10.1037/0022-006X.55.1.3; MacKinnon DP, 2007, ANNU REV PSYCHOL, V58, P593, DOI 10.1146/annurev.psych.58.110405.085542; Matson JL, 2008, RES DEV DISABIL, V29, P537, DOI 10.1016/j.ridd.2007.09.006; MCEACHIN JJ, 1993, AM J MENT RETARD, V97, P359; Montes G, 2008, PEDIATRICS, V121, pE821, DOI 10.1542/peds.2007-1594; Parish SL, 2012, INTELLECT DEV DISAB, V50, P441, DOI 10.1352/1934-9556-50.06.441; Phelps KW, 2009, J INTELLECT DEV DIS, V34, P27, DOI 10.1080/13668250802690930; Remington B, 2007, AM J MENT RETARD, V112, P418, DOI 10.1352/0895-8017(2007)112[418:EIBIOF]2.0.CO;2; Rogers SJ, 1996, J AUTISM DEV DISORD, V26, P243, DOI 10.1007/BF02172020; Sharpe DL, 2007, J FAM ECON ISS, V28, P247, DOI 10.1007/s10834-007-9059-6; Shattuck PT, 2007, MENT RETARD DEV D R, V13, P129, DOI 10.1002/mrdd.20143; Sikora DM, 2008, J AUTISM DEV DISORD, V38, P440, DOI 10.1007/s10803-007-0407-z; South M, 2002, J AUTISM DEV DISORD, V32, P593, DOI 10.1023/A:1021211232023; Woolfenden S, 2012, RES AUTISM SPECT DIS, V6, P345, DOI 10.1016/j.rasd.2011.06.008	24	107	109	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2014	9	9							e106552	10.1371/journal.pone.0106552	http://dx.doi.org/10.1371/journal.pone.0106552			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AZ1IR	25191755	Green Submitted, Green Accepted, Green Published, gold			2022-12-27	WOS:000347993600036
J	Pal, G; Lovas, G; Dobolyi, A				Pal, Gabriella; Lovas, Gabor; Dobolyi, Arpad			Induction of Transforming Growth Factor Beta Receptors following Focal Ischemia in the Rat Brain	PLOS ONE			English	Article							III TGF-BETA; CEREBRAL-ISCHEMIA; KINASE 1; MESSENGER-RNA; ALTERNATIVE ACTIVATION; PERMANENT OCCLUSION; EXPRESSION; GROWTH-FACTOR-BETA-1; BETAGLYCAN; MICROGLIA	Transforming growth factor-beta s (TGF-beta s) regulate cellular proliferation, differentiation, and survival. TGF-beta s bind to type I (TGF-beta RI) and II receptors (TGF-beta RII), which are transmembrane kinase receptors, and an accessory type III receptor (TGF-beta RIII). TGF-beta may utilize another type I receptor, activin-like kinase receptor (Alk1). TGF-beta is neuroprotective in the middle cerebral artery occlusion (MCAO) model of stroke. Recently, we reported the expression pattern of TGF-beta 1-3 after MCAO. To establish how TGF-beta s exert their actions following MCAO, the present study describes the induction of TGF-beta RI, RII, RIII and Alk1 at 24 h, 72 h and 1 mo after transient 1 h MCAO as well as following 24 h permanent MCAO using in situ hybridization histochemistry. In intact brain, only TGF-beta RI had significant expression: neurons in cortical layer IV contained TGF-beta RI. At 24 h after the occlusion, no TGF-beta receptors showed induction. At 72 h following MCAO, all four types of TGF-beta receptors were induced in the infarct area, while TGF-beta RI and RII also appeared in the penumbra. Most cells with elevated TGF-beta RI mRNA levels were microglia. TGF-beta RII co-localized with both microglial and endothelial markers while TGF-beta RIII and Alk1 were present predominantly in endothels. All four TGF-beta receptors were induced within the lesion 1 mo after the occlusion. In particular, TGF-beta RIII was further induced as compared to 72 h after MCAO. At this time point, TGF-beta RIII signal was predominantly not associated with blood vessels suggesting its microglial location. These data suggest that TGF-beta receptors are induced after MCAO in a timely and spatially regulated fashion. TGF-beta receptor expression is preceded by increased TGF-beta expression. TGF-beta RI and RII are likely to be co-expressed in microglial cells while Alk1, TGF-beta RII, and RIII in endothels within the infarct where TGF-beta 1 may be their ligand. At later time points, TGF-beta RIII may also appear in glial cells to potentially affect signal transduction via TGF-beta RI and RII.	[Pal, Gabriella; Dobolyi, Arpad] Semmelweis Univ, Dept Anat Histol & Embryol, Neuromorphol Lab, H-1085 Budapest, Hungary; [Lovas, Gabor] Semmelweis Univ, Dept Neurol, H-1085 Budapest, Hungary; [Lovas, Gabor] Jahn Ferenc Teaching Hosp, Dept Neurol, Budapest, Hungary; [Dobolyi, Arpad] Hungarian Acad Sci, Inst Biol, Lab Mol & Syst Neurobiol, Budapest, Hungary; [Dobolyi, Arpad] Eotvos Lorand Univ, Budapest, Hungary	Semmelweis University; Semmelweis University; Hungarian Academy of Sciences; Eotvos Lorand University	Dobolyi, A (corresponding author), Semmelweis Univ, Dept Anat Histol & Embryol, Neuromorphol Lab, H-1085 Budapest, Hungary.	dobolyi@ana.sote.hu	Dobolyi, Arpad/AAE-5913-2020		Hungarian Scientific Research Fund [OTKA K100319]; Bolyai Janos Fellowship Grant of the Hungarian Academy of Sciences;  [KTIA_NAP_B_13-2-2014-0004]	Hungarian Scientific Research Fund(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA)); Bolyai Janos Fellowship Grant of the Hungarian Academy of Sciences; 	Support was provided by Hungarian Scientific Research Fund Research Grant OTKA K100319, the KTIA_NAP_B_13-2-2014-0004 Program, and the Bolyai Janos Fellowship Grant of the Hungarian Academy of Sciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe K, 1996, BRAIN RES, V723, P206, DOI 10.1016/0006-8993(96)00253-3; Akhurst RJ, 2012, NAT REV DRUG DISCOV, V11, P790, DOI 10.1038/nrd3810; Albinana V, 2011, MOL PHARMACOL, V79, P833, DOI 10.1124/mol.110.067447; Arighi CN, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-S5-S3; Ata KA, 1999, ACTA NEUROPATHOL, V97, P447, DOI 10.1007/s004010051013; Barone FC, 2010, NEUROPHARMACOLOGY, V59, P650, DOI 10.1016/j.neuropharm.2010.08.016; Bilandzic M, 2012, MOL CELL ENDOCRINOL, V359, P13, DOI 10.1016/j.mce.2012.03.020; Blobe GC, 2001, J BIOL CHEM, V276, P24627, DOI 10.1074/jbc.M100188200; Bloom BB, 1996, BBA-MOL CELL RES, V1312, P243, DOI 10.1016/0167-4889(96)00043-2; Bottner M, 2000, J NEUROCHEM, V75, P2227, DOI 10.1046/j.1471-4159.2000.0752227.x; CHAO CC, 1995, CLIN IMMUNOL IMMUNOP, V77, P358, DOI 10.1006/clin.1995.1163; Chopp M, 1996, ACT NEUR S, V66, P21; DACUNHA A, 1993, J NEUROIMMUNOL, V42, P71, DOI 10.1016/0165-5728(93)90214-J; De Groot CJA, 1999, J NEUROPATH EXP NEUR, V58, P174, DOI 10.1097/00005072-199902000-00007; Deng XB, 1999, CELL GROWTH DIFFER, V10, P11; Dhandapani KM, 2003, CELL BIOCHEM BIOPHYS, V39, P13, DOI 10.1385/CBB:39:1:13; Dobolyi A, 2012, INT J MOL SCI, V13, P8219, DOI 10.3390/ijms13078219; Farnworth PG, 2007, ENDOCRINOLOGY, V148, P5355, DOI 10.1210/en.2007-0155; Feng Z, 2008, J NEUROSCI, V28, P9599, DOI 10.1523/JNEUROSCI.2589-08.2008; FLANDERS KC, 1991, DEVELOPMENT, V113, P183; Flanders KC, 1998, PROG NEUROBIOL, V54, P71, DOI 10.1016/S0301-0082(97)00066-X; Garrido-Martin EM, 2013, CIRC RES, V112, P113, DOI 10.1161/CIRCRESAHA.112.275586; Gault J, 2004, NEUROSURGERY, V55, P1, DOI 10.1227/01.NEU.0000126872.23715.E5; GEHRMANN J, 1995, NEUROPATH APPL NEURO, V21, P277, DOI 10.1111/j.1365-2990.1995.tb01062.x; Gordon S, 2003, NAT REV IMMUNOL, V3, P23, DOI 10.1038/nri978; Goumans MJ, 2003, MOL CELL, V12, P817, DOI 10.1016/S1097-2765(03)00386-1; GROSS CE, 1993, STROKE, V24, P558, DOI 10.1161/01.STR.24.4.558; Guegan C, 2000, BRAIN RES, V856, P93, DOI 10.1016/S0006-8993(99)02347-1; Hawinkels LJAC, 2013, EXPERT OPIN INV DRUG, V22, P1371, DOI 10.1517/13543784.2013.837884; Hempel N, 2008, CARCINOGENESIS, V29, P905, DOI 10.1093/carcin/bgn049; Huang F, 2012, CELL BIOSCI, V2, DOI 10.1186/2045-3701-2-9; Imai Y, 2002, GLIA, V40, P164, DOI 10.1002/glia.10149; Jones LL, 1998, BRAIN RES, V795, P301, DOI 10.1016/S0006-8993(98)00325-4; Konig HG, 2005, J CELL BIOL, V168, P1077, DOI 10.1083/jcb.200407027; Lagord C, 2002, MOL CELL NEUROSCI, V20, P69, DOI 10.1006/mcne.2002.1121; Lawrence DA, 1996, EUR CYTOKINE NETW, V7, P363; Lee NY, 2009, MOL BIOL CELL, V20, P4362, DOI 10.1091/mbc.E09-07-0539; Lewis KA, 2000, NATURE, V404, P411, DOI 10.1038/35006129; Li JJ, 2008, NEUROSCIENCE, V156, P662, DOI 10.1016/j.neuroscience.2008.07.061; LONGA EZ, 1989, STROKE, V20, P84, DOI 10.1161/01.STR.20.1.84; LOPEZCASILLAS F, 1993, CELL, V73, P1435, DOI 10.1016/0092-8674(93)90368-Z; Lux A, 1999, J BIOL CHEM, V274, P9984, DOI 10.1074/jbc.274.15.9984; Mabuchi T, 2000, STROKE, V31, P1735, DOI 10.1161/01.STR.31.7.1735; MacConell LA, 2002, ENDOCRINOLOGY, V143, P1066, DOI 10.1210/en.143.3.1066; Manaenko A, 2014, INHIBITION TRANSFORM; Marin-Teva J.L., 2012, NEURON GLIA BIOL, P1; Massague J, 2000, GENE DEV, V14, P627; Mathieu P, 2010, NEUROIMMUNOMODULAT, V17, P200, DOI 10.1159/000258723; Morgan TE, 2000, NEUROSCIENCE, V101, P313, DOI 10.1016/S0306-4522(00)00387-0; Namura S, 1998, J NEUROSCI, V18, P3659; Oh SP, 2000, P NATL ACAD SCI USA, V97, P2626, DOI 10.1073/pnas.97.6.2626; Pal G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046731; Paxinos G., 2005, RAT BRAIN STEREOTAXI, V5th Edn, DOI 10.1016/c2009-0-63235-9; Popp A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004764; PREHN JHM, 1993, J CEREBR BLOOD F MET, V13, P521, DOI 10.1038/jcbfm.1993.67; PREHN JHM, 1993, J NEUROCHEM, V60, P1665, DOI 10.1111/j.1471-4159.1993.tb13389.x; Ramos-Cabrer P, 2011, STROKE, V42, pS7, DOI 10.1161/STROKEAHA.110.596684; Roberts AB, 1998, MINER ELECTROL METAB, V24, P111, DOI 10.1159/000057358; Ruocco A, 1999, J CEREBR BLOOD F MET, V19, P1345, DOI 10.1097/00004647-199912000-00008; Schachtrup C, 2010, J NEUROSCI, V30, P5843, DOI 10.1523/JNEUROSCI.0137-10.2010; Schilling M, 2003, EXP NEUROL, V183, P25, DOI 10.1016/S0014-4886(03)00082-7; Seki T, 2003, CIRC RES, V93, P682, DOI 10.1161/01.RES.0000095246.40391.3B; Sharp FR, 2000, J CEREBR BLOOD F MET, V20, P1011, DOI 10.1097/00004647-200007000-00001; Slotkin TA, 1997, DEV BRAIN RES, V99, P61, DOI 10.1016/S0165-3806(96)00199-X; Townsend TA, 2012, CELL SIGNAL, V24, P247, DOI 10.1016/j.cellsig.2011.09.006; TSUNAWAKI S, 1988, NATURE, V334, P260, DOI 10.1038/334260a0; UNSICKER K, 1991, NEUROSCIENCE, V44, P613, DOI 10.1016/0306-4522(91)90082-Y; Unsicker K, 1996, J NEUROBIOL, V29, P262, DOI 10.1002/(SICI)1097-4695(199602)29:2<262::AID-NEU10>3.0.CO;2-D; van Meeteren LA, 2012, J BIOL CHEM, V287, P18551, DOI 10.1074/jbc.M111.338103; Vivien D, 1998, J NEUROCHEM, V70, P2296; Vogel T, 2010, CEREB CORTEX, V20, P661, DOI 10.1093/cercor/bhp134; WANG XF, 1991, CELL, V67, P797, DOI 10.1016/0092-8674(91)90074-9; Weiss A, 2013, WIRES DEV BIOL, V2, P47, DOI 10.1002/wdev.86; Wick W, 2006, CURR PHARM DESIGN, V12, P341, DOI 10.2174/138161206775201901; WRANA JL, 1994, NATURE, V370, P341, DOI 10.1038/370341a0; Wrighton KH, 2009, CELL RES, V19, P8, DOI 10.1038/cr.2008.327; Xiao BG, 1997, NEUROSCI LETT, V226, P71, DOI 10.1016/S0304-3940(97)00234-6; Yamashita K, 1999, BRAIN RES, V836, P139, DOI 10.1016/S0006-8993(99)01626-1; Yin JR, 2009, BRAIN RES, V1263, P10, DOI 10.1016/j.brainres.2009.01.042; Zhou XL, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-210; Zhu Y, 2002, J NEUROSCI, V22, P3898, DOI 10.1523/JNEUROSCI.22-10-03898.2002	81	26	27	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2014	9	9							e106544	10.1371/journal.pone.0106544	http://dx.doi.org/10.1371/journal.pone.0106544			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ1IR	25192322	Green Published, Green Accepted, gold			2022-12-27	WOS:000347993600034
J	Shenton, F; Bewick, GS; Banks, RW				Shenton, Fiona; Bewick, Guy S.; Banks, Robert W.			A Study of the Expression of Small Conductance Calcium-Activated Potassium Channels (SK1-3) in Sensory Endings of Muscle Spindles and Lanceolate Endings of Hair Follicles in the Rat	PLOS ONE			English	Article							K+ CHANNELS; MODULATION; MECHANOTRANSDUCTION; COLOCALIZATION; LOCALIZATION; TERMINALS; GANGLION; SYSTEM; CELLS	Processes underlying mechanotransduction and its regulation are poorly understood. Inhibitors of Ca2+-activated K+ channels cause a dramatic increase in afferent output from stretched muscle spindles. We used immunocytochemistry to test for the presence and location of small conductance Ca2+-activated K+ channels (SK1-3) in primary endings of muscle spindles and lanceolate endings of hair follicles in the rat. Tissue sections were double immunolabelled with antibodies to one of the SK channel isoforms and to either synaptophysin (SYN, as a marker of synaptic like vesicles (SLV), present in many mechanosensitive endings) or S100 (a Ca2+-binding protein present in glial cells). SK channel immunoreactivity was also compared to immunolabelling for the Na+ ion channel ASIC2, previously reported in both spindle primary and lanceolate endings. SK1 was not detected in sensory terminals of either muscle spindles or lanceolate endings. SK2 was found in the terminals of both muscle spindles and lanceolate endings, where it colocalised with the SLV marker SYN (spindles and lanceolates) and the satellite glial cell (SGC) marker S100 (lanceolates). SK3 was not detected in muscle spindles; by contrast it was present in hair follicle endings, expressed predominantly in SGCs but perhaps also in the SGC: terminal interface, as judged by colocalisation statistical analysis of SYN and S100 immunoreactivity. The possibility that all three isoforms might be expressed in pre-terminal axons, especially at heminodes, cannot be ruled out. Differential distribution of SK channels is likely to be important in their function of responding to changes in intracellular [Ca2+] thereby modulating mechanosensory transduction by regulating the excitability of the sensory terminals. In particular, the presence of SK2 throughout the sensory terminals of both kinds of mechanoreceptor indicates an important role for an outward Ca2+-activated K+ current in the formation of the receptor potential in both types of ending.	[Shenton, Fiona; Banks, Robert W.] Univ Durham, Sch Biol & Biomed Sci, Durham, England; [Bewick, Guy S.] Univ Aberdeen, Sch Med Sci, Aberdeen, Scotland	Durham University; University of Aberdeen	Bewick, GS (corresponding author), Univ Aberdeen, Sch Med Sci, Aberdeen, Scotland.	g.s.bewick@abdn.ac.uk	Bewick, Guy/AAL-8214-2021	Bewick, Guy/0000-0001-8266-7797; Banks, Robert/0000-0003-1614-6488	Medical Research Council [G0601253]; MRC [G0601253] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	Funding came from a Medical Research Council grant (G0601253 - http://www.mrc.ac.uk/) to GSB and RWB. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDRES KH, 1966, Z ZELLFORSCH MIK ANA, V75, P339, DOI 10.1007/BF00407165; Armstrong WE, 2005, J COMP NEUROL, V491, P175, DOI 10.1002/cne.20679; Banks RW, 2013, J PHYSIOL-LONDON, V591, P2523, DOI 10.1113/jphysiol.2012.243659; Berkefeld H, 2010, PHYSIOL REV, V90, P1437, DOI 10.1152/physrev.00049.2009; Bewick GS, 2005, J PHYSIOL-LONDON, V562, P381, DOI 10.1113/jphysiol.2004.074799; Cabo R, 2013, NEUROSCI LETT, V555, P62, DOI 10.1016/j.neulet.2013.09.026; Costes SV, 2004, BIOPHYS J, V86, P3993, DOI [10.1529/biophysj.103.038422, 10.1529/biophysi.103.038422]; Delmas P, 2011, NAT REV NEUROSCI, V12, P139, DOI 10.1038/nrn2993; Garcia-Anoveros J, 2001, J NEUROSCI, V21, P2678, DOI 10.1523/JNEUROSCI.21-08-02678.2001; Hulliger M, 2009, J NEUROSCI METH, V178, P103, DOI 10.1016/j.jneumeth.2008.12.002; HUNT CC, 1978, J GEN PHYSIOL, V71, P683, DOI 10.1085/jgp.71.6.683; KRUSE MN, 1991, EXP BRAIN RES, V86, P359; MANDERS EMM, 1993, J MICROSC-OXFORD, V169, P375, DOI 10.1111/j.1365-2818.1993.tb03313.x; Mongan LC, 2005, NEUROSCIENCE, V131, P161, DOI 10.1016/j.neuroscience.2004.09.062; POPPELE RE, 1981, NEUROSCIENCE, V6, P1157, DOI 10.1016/0306-4522(81)90080-4; Rice FL, 1997, J COMP NEUROL, V385, P149; Rousse I, 2006, GLIA, V54, P691, DOI 10.1002/glia.20388; Scholz A, 1998, J PHYSIOL-LONDON, V513, P55, DOI 10.1111/j.1469-7793.1998.055by.x; Simon A, 2009, P PHYSL SOC, V15, p28P; Simon A, 2009, BRIT NEUROSCI ASS AB, V20, P95; Simon A, 2010, J PHYSIOL-LONDON, V588, P171, DOI 10.1113/jphysiol.2009.182683; Takahashi-Iwanaga H, 2008, J COMP NEUROL, V510, P68, DOI 10.1002/cne.21756; Vit JP, 2006, NEURON GLIA BIOL, V2, P247, DOI 10.1017/S1740925X07000427; Zelena J, 1994, NERVES MECHANORECEPT	24	10	10	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2014	9	9							e107073	10.1371/journal.pone.0107073	http://dx.doi.org/10.1371/journal.pone.0107073			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ1IR	25191752	Green Accepted, Green Published, gold, Green Submitted			2022-12-27	WOS:000347993600096
J	Yang, JQ; Ran, P; Chen, JY; He, YT; Li, LW; Tan, N; Li, G; Sun, SO; Liu, Y; Zhan, JX; Zheng, JY; Zhou, YL				Yang, Jun-qing; Ran, Peng; Chen, Ji-yan; He, Yi-ting; Li, Li-wen; Tan, Ning; Li, Guang; Sun, Shuo; Liu, Yong; Zhan, Jia-xin; Zheng, Jian-yi; Zhou, Ying-ling			Development of Contrast-Induced Acute Kidney Injury after Elective Contrast Media Exposure in Patients with Type 2 Diabetes Mellitus: Effect of Albuminuria	PLOS ONE			English	Article							PERCUTANEOUS CORONARY INTERVENTION; ACUTE-RENAL-FAILURE; GLOMERULAR-FILTRATION-RATE; PROXIMAL TUBULAR CELLS; INDUCED NEPHROPATHY; SODIUM-BICARBONATE; KAPPA-B; PREVENTION; PROTEINURIA; MORTALITY	Background: The influence of albuminuria and urinary pH on the development of contrast-induced acute kidney disease (CI-AKI) in patients with type 2 diabetes mellitus (T2DM) after elective coronary angiography (CAG) or percutaneous coronary intervention (PCI) is unknown. Methods: CI-AKI was defined as an increase in serum creatinine >26.4 mu mol/L or >50% of baseline value within 48 hours after contrast media exposure. Demographics, traditional risk factors, clinical outcomes and CI-AKI incidence were compared between groups. Univariate analysis and multivariate logistic regression were performed to assess risk factors of CI-AKI. Results: We observed 597 patients with T2DM after CAG or PCI. Patients were divided into 3 groups based on early morning urinary albumin: negative group (urine dipstick negative, n = 483), trace group (urine dipstick trace, n = 60), and positive group (urine dipstick >= 1+, n = 54). CI-AKI occurred in 33 (5.5%) patients, including 19 (3.9%) in the negativealbuminuria group, 4 (6.7%) in the trace group, and 10 (18.5%) in the positive group (p < 0.001), respectively. After adjusting for potential confounding risk factors, positive albuminuria (OR = 3.8, 95% CI: 1.5 to 9.2, p = 0.004) and urinary pH, 6 (OR = 2.4, 95% CI: 1.1 to 5.1, p = 0.020) remained significantly associated with CI-AKI. Conclusion: Preprocedural albuminuria and urinary pH,6 are independent risk factors of CI-AKI in patients with T2DM undergoing elective cardiac catheterization, and may be used to identify patients at high risk of post-procedural CI-AKI.	[Yang, Jun-qing; Ran, Peng; Chen, Ji-yan; Li, Li-wen; Tan, Ning; Li, Guang; Sun, Shuo; Liu, Yong; Zhan, Jia-xin; Zheng, Jian-yi; Zhou, Ying-ling] Guangdong Acad Med Sci, Guangdong Gen Hosp, Guangdong Cardiovasc Inst, Dept Cardiol, Guangzhou, Guangdong, Peoples R China; [He, Yi-ting] Shunde first Hosp, Dept Cardiol, Foshan, Guangdong, Peoples R China	Guangdong Academy of Medical Sciences & Guangdong General Hospital	Chen, JY (corresponding author), Guangdong Acad Med Sci, Guangdong Gen Hosp, Guangdong Cardiovasc Inst, Dept Cardiol, Guangzhou, Guangdong, Peoples R China.	gdphospital@163.com; gdghospital@163.com			Science and Technology Planning Project of Guangdong Province, Guangdong Cardiovascular Institute [2008A030201002]; Guangdong Provincial Cardiovascular Clinical Medicine Research Fund, Guangzhou, China [2009X41]	Science and Technology Planning Project of Guangdong Province, Guangdong Cardiovascular Institute; Guangdong Provincial Cardiovascular Clinical Medicine Research Fund, Guangzhou, China	The work was supported by Science and Technology Planning Project of Guangdong Province (grant NO.: 2008A030201002), Guangdong Cardiovascular Institute; and Guangdong Provincial Cardiovascular Clinical Medicine Research Fund (grant NO.: 2009X41), Guangzhou, China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbate M, 1999, NEPHROL DIAL TRANSPL, V14, P304, DOI 10.1093/ndt/14.2.304; Arici M, 2003, J AM SOC NEPHROL, V14, P17, DOI 10.1097/01.ASN.0000042167.66685.EA; ATKINS JL, 1986, NEPHRON, V44, P70, DOI 10.1159/000183915; Birn H, 2006, KIDNEY INT, V69, P440, DOI 10.1038/sj.ki.5000141; Briguori C, 2007, CIRCULATION, V115, P1211, DOI 10.1161/CIRCULATIONAHA.106.687152; Brown AS, 2010, DIMENS CRIT CARE NUR, V29, P112, DOI 10.1097/DCC.0b013e3181d24b62; CAMERON JS, 1990, AM J NEPHROL, V10, P81; Dangas G, 2005, AM J CARDIOL, V95, P13, DOI 10.1016/j.amjcard.2004.08.056; de Brito-Ashurst I, 2009, J AM SOC NEPHROL, V20, P2075, DOI 10.1681/ASN.2008111205; Eknoyan G, 2002, AM J KIDNEY DIS, V39, pS14, DOI 10.1053/ajkd.2002.30939; Erkan E, 2001, AM J PHYSIOL-RENAL, V280, pF1107, DOI 10.1152/ajprenal.2001.280.6.F1107; Gavi S, 2009, GERIATRICS-US, V64, P12; Grams ME, 2010, J AM SOC NEPHROL, V21, P1757, DOI 10.1681/ASN.2010010128; Gupta R, 2005, CATHETER CARDIO INTE, V64, P442, DOI 10.1002/ccd.20316; Hemmelgarn BR, 2010, JAMA-J AM MED ASSOC, V303, P423, DOI 10.1001/jama.2010.39; Heyman SN, 2010, INVEST RADIOL, V45, P188, DOI 10.1097/RLI.0b013e3181d2eed8; Hillege HL, 2002, CIRCULATION, V106, P1777, DOI 10.1161/01.CIR.0000031732.78052.81; Hingorani SR, 2008, BIOL BLOOD MARROW TR, V14, P1365, DOI 10.1016/j.bbmt.2008.09.015; Hogan SE, 2008, AM HEART J, V156, P414, DOI 10.1016/j.ahj.2008.05.014; Huang TM, 2011, J AM SOC NEPHROL, V22, P156, DOI 10.1681/ASN.2010050553; James MT, 2010, LANCET, V376, P2096, DOI 10.1016/S0140-6736(10)61271-8; KAMDAR A, 1977, DIABETES, V26, P643, DOI 10.2337/diabetes.26.7.643; Kanaguchi Y, 2011, NEPHROL DIAL TRANSPL, V26, P3465, DOI 10.1093/ndt/gfr110; Klima T, 2012, EUR HEART J, V33, P2071, DOI 10.1093/eurheartj/ehr501; Levine GN, 2011, J AM COLL CARDIOL, V58, pE44, DOI 10.1016/j.jacc.2011.08.007; Lindsay J, 2004, AM J CARDIOL, V94, P786, DOI 10.1016/j.amjcard.2004.06.007; Gorriz JL, 2012, TRANSPLANT REV-ORLAN, V26, P3, DOI 10.1016/j.trre.2011.10.002; Markota D, 2013, EUR HEART J, V34, P2362, DOI 10.1093/eurheartj/eht009; McCullough PA, 1997, AM J MED, V103, P368, DOI 10.1016/S0002-9343(97)00150-2; McCullough PA, 2006, REV CARDIOVASC MED, V7, P177; Mehran R, 2004, J AM COLL CARDIOL, V44, P1393, DOI 10.1016/j.jacc.2004.06.068; Meier P, 2009, BMC MED, V7, DOI 10.1186/1741-7015-7-23; Merten GJ, 2004, JAMA-J AM MED ASSOC, V291, P2328, DOI 10.1001/jama.291.19.2328; Morigi M, 2002, J AM SOC NEPHROL, V13, P1179; National Collaborating Centre for Chronic Conditions, 2008, CHRON KIDN DIS NAT C; Navaneethan SD, 2009, AM J KIDNEY DIS, V53, P617, DOI 10.1053/j.ajkd.2008.08.033; Ninomiya T, 2009, J AM SOC NEPHROL, V20, P1813, DOI 10.1681/ASN.2008121270; Ohse T, 2006, KIDNEY INT, V70, P1447, DOI 10.1038/sj.ki.5001704; Parfrey P, 2005, CARDIOVASC INTER RAD, V28, pS3, DOI 10.1007/s00270-005-0196-8; Pflueger A, 2009, MED SCI MONITOR, V15, pRA125; Piskinpasa S, 2013, RENAL FAILURE, V35, P62, DOI 10.3109/0886022X.2012.741646; Recio-Mayoral A, 2007, J AM COLL CARDIOL, V49, P1283, DOI 10.1016/j.jacc.2006.11.034; Rihal CS, 2002, CIRCULATION, V105, P2259, DOI 10.1161/01.CIR.0000016043.87291.33; Smulders YM, 1996, ARCH INTERN MED, V156, P1629, DOI 10.1001/archinte.156.15.1629; Stacul F, 2011, EUR RADIOL, V21, P2527, DOI 10.1007/s00330-011-2225-0; Tang S, 2003, J CLIN INVEST, V111, P515, DOI [10.1172/JCI16079, 10.1172/JCI200316079]; Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS), 2010, Eur Heart J, V31, P2501, DOI 10.1093/eurheartj/ehq277; Toprak O, 2007, NEPHROL DIAL TRANSPL, V22, P819, DOI 10.1093/ndt/gfl636; Tublin ME, 1998, AM J ROENTGENOL, V171, P933, DOI 10.2214/ajr.171.4.9762972; Wang YP, 1999, J AM SOC NEPHROL, V10, P1204; Weisbord SD, 2006, J AM SOC NEPHROL, V17, P2871, DOI 10.1681/ASN.2006030301; Yang ZK, 2013, INT J CARDIOL, V165, P76, DOI 10.1016/j.ijcard.2011.07.074; Zoja C, 1995, AM J KIDNEY DIS, V26, P934, DOI 10.1016/0272-6386(95)90058-6	53	13	13	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2014	9	9							e106454	10.1371/journal.pone.0106454	http://dx.doi.org/10.1371/journal.pone.0106454			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ1IR	25192238	Green Published, gold, Green Submitted			2022-12-27	WOS:000347993600028
J	Baesi, K; Moallemi, S; Farrokhi, M; Alinaghi, SAS; Truong, HHM				Baesi, Kazem; Moallemi, Samaneh; Farrokhi, Molood; Alinaghi, Seyed Ahmad Seyed; Truong, Hong-Ha M.			Subtype Classification of Iranian HIV-1 Sequences Registered in the HIV Databases, 2006-2013	PLOS ONE			English	Article							INJECTING DRUG-USERS; TYPE-1 SUBTYPE; RESISTANCE; DIVERSITY; EPIDEMIC; CRF35-AD; SURVEILLANCE; AFGHANISTAN; INFECTION; GAG	Background: The rate of human immunodeficiency virus type 1 (HIV-1) infection in Iran has increased dramatically in the past few years. While the earliest cases were among hemophiliacs, injection drug users (IDUs) fuel the current epidemic. Previous molecular epidemiological analysis found that subtype A was most common among IDUs but more recent studies suggest CRF_35AD may be more prevalent now. To gain a better understanding of the molecular epidemiology of HIV-1 infection in Iran, we analyzed all Iranian HIV sequence data from the Los Alamos National Laboratory. Methods: All Iranian HIV sequences from subtyping studies with pol, gag, env and full-length HIV-1 genome sequences registered in the HIV databases (www.hiv.lanl.gov) between 2006 and 2013 were downloaded. Phylogenetic trees of each region were constructed using Neighbor-Joining (NJ) and Maximum Parsimony methods. Results: A total of 475 HIV sequences were analyzed. Overall, 78% of sequences were CRF_35AD. By gene region, CRF_35AD comprised 83% of HIV-1 pol, 62% of env, 78% of gag, and 90% of full-length genome sequences analyzed. There were 240 sequences re-categorized as CRF_ AD. The proportion of CRF_35AD sequences categorized by the present study is nearly double the proportion of what had been reported. Conclusions: Phylogenetic analysis indicates HIV-1 subtype CRF_ 35AD is the predominant circulating strain in Iran. This result differed from previous studies that reported subtype A as most prevalent in HIV-infected patients but confirmed other studies which reported CRF_ 35AD as predominant among IDUs. The observed epidemiological connection between HIV strains circulating in Iran and Afghanistan may be due to drug trafficking and/or immigration between the two countries. This finding suggests the possible origins and transmission dynamics of HIV/AIDS within Iran and provides useful information for designing control and intervention strategies.	[Baesi, Kazem; Moallemi, Samaneh; Farrokhi, Molood; Alinaghi, Seyed Ahmad Seyed] Univ Tehran Med Sci, Iranian Res Ctr HIV AIDS, Iranian Inst Reduct High Risk Behav, Tehran, Iran; [Truong, Hong-Ha M.] Univ Calif San Francisco, San Francisco, CA 94143 USA; [Truong, Hong-Ha M.] Gladstone Inst Virol & Immunol, San Francisco, CA USA	Tehran University of Medical Sciences; University of California System; University of California San Francisco; University of California System; University of California San Francisco; The J David Gladstone Institutes	Truong, HHM (corresponding author), Univ Calif San Francisco, San Francisco, CA 94143 USA.	Hong-Ha.Truong@ucsf.edu	Baesi, Kazem/J-9066-2017; SeyedAlinaghi, SeyedAhmad/M-2938-2017	Baesi, Kazem/0000-0001-5483-0008; SeyedAlinaghi, SeyedAhmad/0000-0003-3210-7905				Baesi K, 2010, SCI J IRAN BLOOD TRA, V7, P94; Baesi K, 2014, J MED VIROL, V86, P1093, DOI 10.1002/jmv.23898; Brenner BG, 2012, MOL BIOL INT, V2012, DOI DOI 10.1155/2012/256982; Castro-Nallar E, 2012, MOL PHYLOGENET EVOL, V62, P777, DOI 10.1016/j.ympev.2011.11.019; Hamkar R, 2010, AIDS, V24, pS85, DOI 10.1097/01.aids.0000386738.32919.67; Hu DJ, 1996, JAMA-J AM MED ASSOC, V275, P210, DOI 10.1001/jama.275.3.210; Jahanbakhsh F, 2013, AIDS RES HUM RETROV, V29, P198, DOI [10.1089/AID.2012.0186, 10.1089/aid.2012.0186]; Jahanbakhsh F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061864; Kurle S, 2004, AIDS RES HUM RETROV, V20, P1113, DOI 10.1089/aid.2004.20.1113; Lessells RJ, 2012, CURR OPIN VIROL, V2, P636, DOI 10.1016/j.coviro.2012.08.006; Luft LM, 2011, INT J INFECT DIS, V15, pE661, DOI 10.1016/j.ijid.2011.05.013; Lynch RM, 2009, AIDS RES HUM RETROV, V25, P237, DOI 10.1089/aid.2008.0219; Mir-Nasseri MM, 2011, HEPAT MON, V11, P19; Mousavi SM, 2010, ARCH VIROL, V155, P329, DOI 10.1007/s00705-009-0583-6; Naderi H R, 2006, Infect Agent Cancer, V1, P4, DOI 10.1186/1750-9378-1-4; National AIDS Committee Secretariat Ministry of Health and Medical Education, 2013, ISL REP IR AIDS PROG; Sanders-Buell E, 2007, AIDS RES HUM RETROV, V23, P834, DOI 10.1089/aid.2006.0299; Sanders-Buell E, 2010, AIDS RES HUM RETROV, V26, P605, DOI 10.1089/aid.2009.0226; Sarrami-Forooshani R, 2006, J MED VIROL, V78, P853, DOI 10.1002/jmv.20634; Soheilli ZS, 2009, AIDS RES HUM RETROV, V25, P123, DOI 10.1089/aid.2008.0199; Tagliamonte M, 2007, AIDS RES HUM RETROV, V23, P1569, DOI 10.1089/aid.2007.0169; Tongo M, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-29	22	20	24	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 4	2014	9	9							e105098	10.1371/journal.pone.0105098	http://dx.doi.org/10.1371/journal.pone.0105098			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3XV	25188443	Green Submitted, Green Published, gold			2022-12-27	WOS:000341271500006
J	Lee, YF; Nimura, K; Lo, WN; Saga, K; Kaneda, Y				Lee, Yu Fei; Nimura, Keisuke; Lo, Wan Ning; Saga, Kotaro; Kaneda, Yasufumi			Histone H3 Lysine 36 Methyltransferase Whsc1 Promotes the Association of Runx2 and p300 in the Activation of Bone-Related Genes	PLOS ONE			English	Article							WOLF-HIRSCHHORN-SYNDROME; OSTEOBLAST DIFFERENTIATION; CELL-DIFFERENTIATION; OSTEOCALCIN PROMOTER; METHYLATION; TRANSCRIPTION; CHROMATIN; ACETYLATION; HYPB/SETD2; PHENOTYPE	The orchestration of histone modifiers is required to establish the epigenomic status that regulates gene expression during development. Whsc1 (Wolf-Hirschhorn Syndrome candidate 1), a histone H3 lysine 36 (H3K36) trimethyltransferase, is one of the major genes associated with Wolf-Hirshhorn syndrome, which is characterized by skeletal abnormalities. However, the role of Whsc1 in skeletal development remains unclear. Here, we show that Whsc1 regulates gene expression through Runt-related transcription factor (Runx) 2, a transcription factor central to bone development, and p300, a histone acetyltransferase, to promote bone differentiation. Whsc1(-/-) embryos exhibited defects in ossification in the occipital bone and sternum. Whsc1 knockdown in pre-osteoblast cells perturbed histone modification patterns in bone-related genes and led to defects in bone differentiation. Whsc1 increased the association of p300 with Runx2, activating the bone-related genes Osteopontin (Opn) and Collagen type Ia (Col1a1), and Whsc1 suppressed the overactivation of these genes via H3K36 trimethylation. Our results suggest that Whsc1 fine-tunes the expression of bone-related genes by acting as a modulator in balancing H3K36 trimethylation and histone acetylation. Our results provide novel insight into the mechanisms by which this histone methyltransferase regulates gene expression.	[Lee, Yu Fei; Nimura, Keisuke; Lo, Wan Ning; Saga, Kotaro; Kaneda, Yasufumi] Osaka Univ, Grad Sch Med, Div Gene Therapy Sci, Osaka, Japan	Osaka University	Nimura, K (corresponding author), Osaka Univ, Grad Sch Med, Div Gene Therapy Sci, Osaka, Japan.	nimura@gts.med.osaka-u.ac.jp	Nimura, Keisuke/AAE-9925-2020		MEXT KAKENHI Grant [23710224, 24116514]; Osaka University	MEXT KAKENHI Grant(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Osaka University	Funding came from MEXT KAKENHI Grant Nos. 23710224 and 24116514 and the Osaka University Program for the Support of Networking among Present and Future Researchers. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen EF, 2014, EUR J HUM GENET, V22, P464, DOI 10.1038/ejhg.2013.192; BARRON BJ, 1994, J NUCL MED, V35, P1167; Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Bergemann AD, 2005, TRENDS GENET, V21, P188, DOI 10.1016/j.tig.2005.01.008; Boumah CE, 2009, MOL ENDOCRINOL, V23, P1255, DOI 10.1210/me.2008-0217; Cantone I, 2013, NAT STRUCT MOL BIOL, V20, P282, DOI 10.1038/nsmb.2489; Carrozza MJ, 2005, CELL, V123, P581, DOI 10.1016/j.cell.2005.10.023; Chuang LSH, 2013, INT J CANCER, V132, P1260, DOI 10.1002/ijc.27964; Czekanska EM, 2012, EUR CELLS MATER, V24, P1; Ducy P, 1997, CELL, V89, P747, DOI 10.1016/S0092-8674(00)80257-3; Edmunds JW, 2008, EMBO J, V27, P406, DOI 10.1038/sj.emboj.7601967; Grunstein M, 1997, NATURE, V389, P349, DOI 10.1038/38664; Hu M, 2010, P NATL ACAD SCI USA, V107, P2956, DOI 10.1073/pnas.0915033107; Javed A, 1999, MOL CELL BIOL, V19, P7491; Kato S, 2010, IBMS BONEKEY, V7, P314, DOI [10.1138/20100464, DOI 10.1138/20100464]; Kimura A, 2010, DEVELOPMENT, V137, P1159, DOI 10.1242/dev.045005; Kitabayashi I, 1998, EMBO J, V17, P2994, DOI 10.1093/emboj/17.11.2994; Komori T, 1997, CELL, V89, P755, DOI 10.1016/S0092-8674(00)80258-5; Komori T, 2006, J CELL BIOCHEM, V99, P1233, DOI 10.1002/jcb.20958; Lee M, 2010, J BIOL CHEM, V285, P38014, DOI 10.1074/jbc.M110.142141; Liakhovitskaia A, 2010, DEV BIOL, V340, P539, DOI 10.1016/j.ydbio.2010.02.005; Lou Y, 2009, HUM MOL GENET, V18, P556, DOI 10.1093/hmg/ddn383; Lucio-Eterovic AK, 2010, P NATL ACAD SCI USA, V107, P16952, DOI 10.1073/pnas.1002653107; Mazzeu JF, 2007, GENET MOL BIOL, V30, P339, DOI 10.1590/S1415-47572007000300007; Mikkelsen TS, 2007, NATURE, V448, P553, DOI 10.1038/nature06008; Miyazono K, 2004, ONCOGENE, V23, P4232, DOI 10.1038/sj.onc.1207131; Nimura K, 2006, GENES CELLS, V11, P1225, DOI 10.1111/j.1365-2443.2006.01012.x; Nimura K, 2009, NATURE, V460, P287, DOI 10.1038/nature08086; PINNEY DF, 1989, ENVIRON HEALTH PERSP, V80, P221, DOI 10.2307/3430747; Schroeder TM, 2004, J BIOL CHEM, V279, P41998, DOI 10.1074/jbc.M403702200; Skinner MK, 2011, BIRTH DEFECTS RES C, V93, P51, DOI 10.1002/bdrc.20199; Takeichi M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057829; Venkatesh S, 2012, NATURE, V489, P452, DOI 10.1038/nature11326; Wang YJ, 2005, J BONE MINER RES, V20, P1624, DOI 10.1359/JBMR.050516; Yoh SM, 2008, GENE DEV, V22, P3422, DOI 10.1101/gad.1720008; Zhang SQ, 2009, J BONE MINER RES, V24, P1889, DOI [10.1359/JBMR.090502, 10.1359/jbmr.090502]; Zollino M, 2008, AM J MED GENET C, V148C, P257, DOI 10.1002/ajmg.c.30190	37	19	19	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 4	2014	9	9							e106661	10.1371/journal.pone.0106661	http://dx.doi.org/10.1371/journal.pone.0106661			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3XV	25188294	Green Published, Green Submitted, gold			2022-12-27	WOS:000341271500067
J	Franco, DG; Markus, RP				Franco, Daiane Gil; Markus, Regina P.			The Cellular State Determines the Effect of Melatonin on the Survival of Mixed Cerebellar Cell Culture	PLOS ONE			English	Article							FACTOR-KAPPA-B; NITRIC-OXIDE SYNTHASE; DELTA-AMINOLEVULINIC-ACID; OUTWARD K+ CURRENT; GRANULE CELLS; SIGNALING PATHWAYS; INDUCIBLE ISOFORM; OXIDATIVE DAMAGE; MICROGLIAL CELLS; RAT CEREBELLUM	The constitutive activation of nuclear factor-kappa B (NF-kappa B), a key transcription factor involved in neuroinflammation, is essential for the survival of neurons in situ and of cerebellar granule cells in culture. Melatonin is known to inhibit the activation of NF-kappa B and has a cytoprotective function. In this study, we evaluated whether the cytoprotective effect of melatonin depends on the state of activation of a mixed cerebellar culture that is composed predominantly of granule cells; we tested the effect of melatonin on cultured rat cerebellar cells stimulated or not with lipopolysaccharide (LPS). The addition of melatonin (0.1 nM-1 mu M) reduced the survival of naive cells while inhibiting LPS-induced cell death. Melatonin (100 nM) transiently (15 min) inhibited the nuclear translocation of both NF-kappa B dimers (p50/p50, p50/RelA) and, after 60 min, increased the activation of p50/RelA. Melatonin-induced p50/RelA activity in naive cells resulted in the transcription of inducible nitric oxide synthase (iNOS) and the production of NO. Otherwise, in cultures treated with LPS, melatonin blocked the LPS-induced activation of p50/RelA and the reduction in p50/p50 levels and inhibited iNOS expression and NO synthesis. Therefore, melatonin in vehicle-treated cells induces cell death, while it protects against LPS-induced cytotoxicity. In summary, we confirmed that melatonin is a neuroprotective drug when cerebellar cells are challenged; however, melatonin can also lead to cell death when the normal balance of the NF-kappa B pathway is disturbed. Our data provide a mechanistic basis for understanding the influence of cell context on the final output response of melatonin.	[Franco, Daiane Gil; Markus, Regina P.] Univ Sao Paulo, Inst Biosci, Lab Chronopharmacol, Sao Paulo, Brazil	Universidade de Sao Paulo	Markus, RP (corresponding author), Univ Sao Paulo, Inst Biosci, Lab Chronopharmacol, Sao Paulo, Brazil.	rpmarkus@usp.br	Markus, Regina P./AAC-1505-2021; Markus, Regina P/K-2954-2012	Markus, Regina P./0000-0003-4606-6120; Markus, Regina P/0000-0003-4606-6120	Sao Paulo Research Foundation - FAPESP [2007/078716]; National Council for Science Technology and Innovation (CNPq) [480097/2013-5]; Coordination for Support of Higher Education (CAPES-MEC)	Sao Paulo Research Foundation - FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); National Council for Science Technology and Innovation (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordination for Support of Higher Education (CAPES-MEC)	Financial support to RPM was provided by the following: Sao Paulo Research Foundation - FAPESP 2007/078716, National Council for Science Technology and Innovation (CNPq, 480097/2013-5), and Coordination for Support of Higher Education (CAPES-MEC). DGF is PhD fellow of FAPESP (2009/17800-4). RPM (305378/2009-0) and Debora Aparecida Moura (377855/2013-8) are senior and technical fellows of CNPq. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamah-Biassi E, 2013, J HISTOCHEM IN PRESS; Al-Ghoul WM, 1998, NEUROREPORT, V9, P4063, DOI 10.1097/00001756-199812210-00011; Alonso M, 2006, J PINEAL RES, V41, P8, DOI 10.1111/j.1600-079X.2006.00323.x; Bejarano I, 2011, BASIC CLIN PHARMACOL, V108, P14, DOI 10.1111/j.1742-7843.2010.00619.x; Bekyarova G, 2012, INT J IMMUNOPATH PH, V25, P591, DOI 10.1177/039463201202500305; Bhakar AL, 2002, J NEUROSCI, V22, P8466; Blask DE, 2005, ENDOCRINE, V27, P179, DOI 10.1385/ENDO:27:2:179; Bruck R, 2004, J HEPATOL, V40, P86, DOI 10.1016/S0168-8278(03)00504-X; Carneiro RCG, 1998, NEUROSCIENCE, V82, P293; Cristofanon S, 2009, ANN NY ACAD SCI, V1171, P472, DOI 10.1111/j.1749-6632.2009.04896.x; Cruz-Machado SD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040142; delaTorre A, 1999, J IMMUNOL, V162, P4101; Esparza JL, 2005, J PINEAL RES, V39, P129, DOI 10.1111/j.1600-079X.2005.00225.x; Ferrari MFR, 2008, J MOL NEUROSCI, V35, P151, DOI 10.1007/s12031-007-9025-7; Ferreira ZS, 2005, J PINEAL RES, V38, P182, DOI 10.1111/j.1600-079X.2004.00191.x; Fridmacher V, 2003, J NEUROSCI, V23, P9403; GALLI C, 1995, J NEUROSCI, V15, P1172; GALLO V, 1987, J NEUROSCI, V7, P2203; GALLO V, 1990, J NEUROCHEM, V54, P1619, DOI 10.1111/j.1471-4159.1990.tb01213.x; GAUDET S, 1991, BRAIN RES, V539, P355, DOI 10.1016/0006-8993(91)91645-H; Gepdiremen A, 2000, JPN J PHARMACOL, V84, P467, DOI 10.1254/jjp.84.467; Gilad E, 1998, FASEB J, V12, P685, DOI 10.1096/fasebj.12.9.685; Grilli M, 1999, BIOCHEM PHARMACOL, V57, P1, DOI 10.1016/S0006-2952(98)00214-7; Hardeland R, 2012, SCI WORLD J, DOI 10.1100/2012/640389; Hayden MS, 2004, GENE DEV, V18, P2195, DOI 10.1101/gad.1228704; Hill SM, 2011, J MAMMARY GLAND BIOL, V16, P235, DOI 10.1007/s10911-011-9222-4; Imbesi M, 2008, BRAIN RES, V1227, P19, DOI 10.1016/j.brainres.2008.06.082; Jimenez-Jorge S, 2007, J PINEAL RES, V42, P240, DOI 10.1111/j.1600-079X.2006.00411.x; Kaltschmidt B, 2005, BBA-MOL CELL RES, V1745, P287, DOI 10.1016/j.bbamcr.2005.05.009; Kaltschmidt B, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a001271; Kaur C, 2006, GLIA, V54, P826, DOI 10.1002/glia.20420; Kawamoto EM, 2008, J NEUROSCI RES, V86, P845, DOI 10.1002/jnr.21548; LASHER RS, 1972, BRAIN RES, V41, P482, DOI 10.1016/0006-8993(72)90521-5; LAUDON M, 1988, NEUROENDOCRINOLOGY, V48, P577, DOI 10.1159/000125066; Lax P, 2008, J PINEAL RES, V44, P70, DOI 10.1111/j.1600-079X.2007.00481.x; Lezoualc'h F, 1998, J PINEAL RES, V24, P168, DOI 10.1111/j.1600-079X.1998.tb00530.x; Lilienbaum A, 2003, MOL CELL BIOL, V23, P2680, DOI 10.1128/MCB.23.8.2680-2698.2003; Liu LY, 2007, J NEUROCHEM, V102, P333, DOI 10.1111/j.1471-4159.2007.04669.x; Liu YJ, 2007, J PINEAL RES, V43, P232, DOI 10.1111/j.1600-079X.2007.00466.x; Luchetti F, 2010, FASEB J, V24, P3603, DOI 10.1096/fj.10-154450; Malek R, 2007, PHARMACOL REP, V59, P25; Markus RP, 2003, J PHARMACOL EXP THER, V305, P525, DOI 10.1124/jpet.102.045625; Matthews JR, 1996, NUCLEIC ACIDS RES, V24, P2236, DOI 10.1093/nar/24.12.2236; Meffert MK, 2005, TRENDS NEUROSCI, V28, P37, DOI 10.1016/j.tins.2004.11.002; Min KJ, 2012, J PINEAL RES, V52, P296, DOI 10.1111/j.1600-079X.2011.00943.x; Ohashi R, 2014, DEV NEUROBIOL, V74, P467, DOI 10.1002/dneu.22139; Ortiz GG, 2008, CURR NEUROPHARMACOL, V6, P203, DOI 10.2174/157015908785777201; Pablos MI, 1997, J APPL PHYSIOL, V83, P354, DOI 10.1152/jappl.1997.83.2.354; Pandi-Perumal SR, 2013, NEUROTOX RES, V23, P267, DOI 10.1007/s12640-012-9337-4; PARK SK, 1994, BIOCHEM BIOPH RES CO, V201, P762, DOI 10.1006/bbrc.1994.1766; Park SW, 2005, MOL CELL PROTEOMICS, V4, P300, DOI 10.1074/mcp.M400195-MCP200; PENG HB, 1995, J BIOL CHEM, V270, P14214, DOI 10.1074/jbc.270.23.14214; Piccioli P, 2001, J NEUROSCI RES, V66, P1064, DOI 10.1002/jnr.1251.abs; Pinato L, BRAIN STRUC IN PRESS; Pizzi M, 2006, EUR J PHARMACOL, V545, P22, DOI 10.1016/j.ejphar.2006.06.027; Pizzi M, 2009, FEBS J, V276, P27, DOI 10.1111/j.1742-4658.2008.06767.x; Polazzi E, 2001, GLIA, V36, P271, DOI 10.1002/glia.1115; Princ FG, 1997, J PINEAL RES, V23, P40, DOI 10.1111/j.1600-079X.1997.tb00333.x; Reiter RJ, 2007, J PHYSIOL PHARMACOL, V58, P5; Reynaert NL, 2004, P NATL ACAD SCI USA, V101, P8945, DOI 10.1073/pnas.0400588101; Sainz RM, 2003, CELL MOL LIFE SCI, V60, P1407, DOI 10.1007/s00018-003-2319-1; Sato I, 1996, NEUROSCI LETT, V205, P45, DOI 10.1016/0304-3940(96)12377-6; Tamura EK, 2006, J PINEAL RES, V41, P267, DOI 10.1111/j.1600-079X.2006.00366.x; Tamura EK, 2009, J PINEAL RES, V46, P268, DOI 10.1111/j.1600-079X.2008.00657.x; Tan DX, 2010, CURR NEUROPHARMACOL, V8, P162, DOI 10.2174/157015910792246263; Togashi H, 1997, P NATL ACAD SCI USA, V94, P2676, DOI 10.1073/pnas.94.6.2676; Tripathi DN, 2010, J PINEAL RES, V48, P324, DOI 10.1111/j.1600-079X.2010.00756.x; Uz T, 2002, NEUROSCI RES, V42, P309, DOI 10.1016/S0168-0102(02)00011-1; Xiao WH, 2004, CELL MOL IMMUNOL, V1, P425; Zhou MO, 2003, BRAIN RES, V970, P169, DOI 10.1016/S0006-8993(03)02332-1	70	18	18	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 3	2014	9	9							e106332	10.1371/journal.pone.0106332	http://dx.doi.org/10.1371/journal.pone.0106332			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3TB	25184316	gold, Green Published, Green Submitted			2022-12-27	WOS:000341257700055
J	Rideau Batista Novais, A; Crouzin, N; Cavalier, M; Boubal, M; Guiramand, J; Cohen-Solal, C; Ferreira, MCD; Cambonie, G; Vignes, M; Barbanel, G				Rideau Batista Novais, Aline; Crouzin, Nadine; Cavalier, Melanie; Boubal, Mathilde; Guiramand, Janique; Cohen-Solal, Catherine; Ferreira, Marie-Celeste de Jesus; Cambonie, Gilles; Vignes, Michel; Barbanel, Gerard			Tiagabine Improves Hippocampal Long-Term Depression in Rat Pups Subjected to Prenatal Inflammation	PLOS ONE			English	Article							IMMUNE CHALLENGE; AREA CA1; INFECTION; ACTIVATION; MECHANISMS; INDUCTION; EXPOSURE; NEURONS; FETAL; GABA	Maternal inflammation during pregnancy is associated with the later development of cognitive and behavioral impairment in the offspring, reminiscent of the traits of schizophrenia or autism spectrum disorders. Hippocampal long-term potentiation and long-term depression of glutamatergic synapses are respectively involved in memory formation and consolidation. In male rats, maternal inflammation with lipopolysaccharide (LPS) led to a premature loss of long-term depression, occurring between 12 and 25 postnatal days instead of after the first postnatal month, and aberrant occurrence of long-term potentiation. We hypothesized this would be related to GABAergic system impairment. Sprague Dawley rats received either LPS or isotonic saline ip on gestational day 19. Male offspring's hippocampus was studied between 12 and 25 postnatal days. Morphological and functional analyses demonstrated that prenatal LPS triggered a deficit of hippocampal GABAergic interneurons, associated with presynaptic GABAergic transmission deficiency in male offspring. Increasing ambient GABA by impairing GABA reuptake with tiagabine did not interact with the low frequency-induced long-term depression in control animals but fully prevented its impairment in male offspring of LPS-challenged dams. Tiagabine furthermore prevented the aberrant occurrence of paired-pulse triggered long-term potentiation in these rats. Deficiency in GABA seems to be central to the dysregulation of synaptic plasticity observed in juvenile in utero LPS-challenged rats. Modulating GABAergic tone may be a possible therapeutic strategy at this developmental stage.	[Rideau Batista Novais, Aline; Cavalier, Melanie; Boubal, Mathilde; Guiramand, Janique; Cohen-Solal, Catherine; Ferreira, Marie-Celeste de Jesus; Cambonie, Gilles; Vignes, Michel; Barbanel, Gerard] Univ Montpellier 2, Univ Montpellier 1, CNRS, Lab IBMM UMR Inst Biomol Max Mousseron 5247, Montpellier, France; [Rideau Batista Novais, Aline; Boubal, Mathilde; Cambonie, Gilles] Montpellier Univ Hosp, Neonatal Intens Care Unit, Montpellier, France; [Crouzin, Nadine] Aix Marseille Univ, CNRS, Lab NICN Neurobiol Interact Cellulaires & Neuroph, Marseille, France	Centre National de la Recherche Scientifique (CNRS); Universite de Montpellier; Universite de Montpellier; CHU de Montpellier; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite	Barbanel, G (corresponding author), Univ Montpellier 2, Univ Montpellier 1, CNRS, Lab IBMM UMR Inst Biomol Max Mousseron 5247, Montpellier, France.	gerard.barbanel@univ-montp2.fr	Vignes, Michel/AAA-7693-2019	Vignes, Michel/0000-0003-0969-2966; CAMBONIE, GILLES/0000-0002-1360-7915	Ministere de l'Enseignement Superieur et de la Recherche; Centre National de la Recherche Scientifique; University of Montpellier 2; Groupe d'Etudes de Neonatalogie-Languedoc Roussillon	Ministere de l'Enseignement Superieur et de la Recherche; Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS)); University of Montpellier 2; Groupe d'Etudes de Neonatalogie-Languedoc Roussillon	ARBN was the recipient of a fellowship from the "Ministere de l'Enseignement Superieur et de la Recherche". This work was supported in part by the Centre National de la Recherche Scientifique and University of Montpellier 2 and with the financial support of Groupe d'Etudes de Neonatalogie-Languedoc Roussillon. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atack JR, 2010, PHARMACOL THERAPEUT, V125, P11, DOI 10.1016/j.pharmthera.2009.09.001; Atladottir HO, 2010, J AUTISM DEV DISORD, V40, P1423, DOI 10.1007/s10803-010-1006-y; Baharnoori M, 2009, SCHIZOPHR RES, V107, P99, DOI 10.1016/j.schres.2008.10.003; Belforte JE, 2010, NAT NEUROSCI, V13, P76, DOI 10.1038/nn.2447; Benes FM, 1998, BIOL PSYCHIAT, V44, P88, DOI 10.1016/S0006-3223(98)00138-3; Benes FM, 2007, P NATL ACAD SCI USA, V104, P10164, DOI 10.1073/pnas.0703806104; Boksa P, 2010, BRAIN BEHAV IMMUN, V24, P881, DOI 10.1016/j.bbi.2010.03.005; Brown AS, 2010, AM J PSYCHIAT, V167, P261, DOI 10.1176/appi.ajp.2009.09030361; Buchanan RW, 2011, BIOL PSYCHIAT, V69, P442, DOI 10.1016/j.biopsych.2010.09.052; Cambonie G, 2004, J NEUROSCI RES, V75, P125, DOI 10.1002/jnr.10823; DUDEK SM, 1992, P NATL ACAD SCI USA, V89, P4363, DOI 10.1073/pnas.89.10.4363; Escobar M, 2011, BIOL PSYCHIAT, V70, P992, DOI 10.1016/j.biopsych.2011.01.009; Gandal MJ, 2012, TRANSL PSYCHIAT, V2, DOI 10.1038/tp.2012.69; Ge YA, 2010, P NATL ACAD SCI USA, V107, P16697, DOI 10.1073/pnas.1008200107; Gonzalez-Burgos G, 2010, ADV PHARMACOL, V58, P175, DOI 10.1016/S1054-3589(10)58008-6; Hagberg H, 2012, ANN NEUROL, V71, P444, DOI 10.1002/ana.22620; Harvey L, 2012, NEUROPHARMACOLOGY, V62, P1767, DOI 10.1016/j.neuropharm.2011.11.022; Kemp N, 1999, NEUROPHARMACOLOGY, V38, P495, DOI 10.1016/S0028-3908(98)00222-6; Knable MB, 2004, MOL PSYCHIATR, V9, P609, DOI 10.1038/sj.mp.4001471; Lante F, 2008, HIPPOCAMPUS, V18, P602, DOI 10.1002/hipo.20421; Lante F, 2007, FREE RADICAL BIO MED, V42, P1231, DOI 10.1016/j.freeradbiomed.2007.01.027; Manahan-Vaughan D, 2000, CEREB CORTEX, V10, P482, DOI 10.1093/cercor/10.5.482; Meyer U, 2008, BRAIN BEHAV IMMUN, V22, P469, DOI 10.1016/j.bbi.2007.09.012; MULKEY RM, 1992, NEURON, V9, P967, DOI 10.1016/0896-6273(92)90248-C; Nouel D, 2012, EUR NEUROPSYCHOPHARM, V22, P300, DOI 10.1016/j.euroneuro.2011.08.001; O'Donnell P, 2011, SCHIZOPHRENIA BULL, V37, P484, DOI 10.1093/schbul/sbr028; Paxinos G, 1998, RAT BRAIN IN STEREOTAXIC COORDINATES, FOURTH ED., pix; PEARCE RA, 1995, J PHYSIOL-LONDON, V484, P425, DOI 10.1113/jphysiol.1995.sp020675; Rana SA, 2012, HORM BEHAV, V62, P228, DOI 10.1016/j.yhbeh.2012.03.015; Richetto J, 2014, SCHIZOPHRENIA BULL, V40, P351, DOI 10.1093/schbul/sbs195; Rideau Batista Novais A, 2013, PEDIATR RES, V73, P750, DOI 10.1038/pr.2013.40; Samuelsson AM, 2006, AM J PHYSIOL-REG I, V290, pR1345, DOI 10.1152/ajpregu.00268.2005; Shao LR, 2009, J PHYSIOL-LONDON, V587, P5907, DOI 10.1113/jphysiol.2009.179887; Todtenkopf MS, 1998, SYNAPSE, V29, P323, DOI 10.1002/(SICI)1098-2396(199808)29:4<323::AID-SYN4>3.0.CO;2-7; Uusi-Oukari M, 2010, PHARMACOL REV, V62, P97, DOI 10.1124/pr.109.002063; WAGNER JJ, 1995, J NEUROSCI, V15, P1577; Waldmeier PC, 2008, J NEURAL TRANSM, V115, P1401, DOI 10.1007/s00702-008-0095-7; Whitlock JR, 2006, SCIENCE, V313, P1093, DOI 10.1126/science.1128134; Zhang Y, 2012, NEUROPHARMACOLOGY, V62, P1299, DOI 10.1016/j.neuropharm.2011.02.022	39	13	13	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 3	2014	9	9							e106302	10.1371/journal.pone.0106302	http://dx.doi.org/10.1371/journal.pone.0106302			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3TB	25184226	Green Published, gold, Green Submitted			2022-12-27	WOS:000341257700053
J	Yang, JJ; Huang, CH; Liu, CE; Tang, HJ; Yang, CJ; Lee, YC; Lee, KY; Tsai, MS; Lin, SW; Chen, YH; Lu, PL; Hung, CC				Yang, Jen-Jia; Huang, Chung-Hao; Liu, Chun-Eng; Tang, Hung-Jen; Yang, Chia-Jui; Lee, Yi-Chien; Lee, Kuan-Yeh; Tsai, Mao-Song; Lin, Shu-Wen; Chen, Yen-Hsu; Lu, Po-Liang; Hung, Chien-Ching			Multicenter Study of Trimethoprim/Sulfamethoxazole-Related Hepatotoxicity: Incidence and Associated Factors among HIV-Infected Patients Treated for Pneumocystis jirovecii Pneumonia	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; INDUCED LIVER-INJURY; SULFAMETHOXAZOLE HYDROXYLAMINE FORMATION; DEPENDENT FLUCONAZOLE HEPATOTOXICITY; TRIMETHOPRIM-SULFAMETHOXAZOLE; CAUSALITY ASSESSMENT; CARINII-PNEUMONIA; ADVERSE REACTIONS; UNITED-STATES; AIDS	The incidence of hepatotoxicity related to trimethoprim/sulfamethoxazole (TMP/SMX) administered at a therapeutic dose may vary among study populations of different ethnicities and hepatotoxic metabolites of TMP/SMX may be decreased by drug-drug interaction with fluconazole. We aimed to investigate the incidence of hepatotoxicity and the role of concomitant use of fluconazole in HIV-infected patients receiving TMP/SMX for Pneumocystis jirovecii pneumonia. We reviewed medical records to collect clinical characteristics and laboratory data of HIV-infected patients who received TMP/SMX for treatment of P. jirovecii pneumonia at 6 hospitals around Taiwan between September 2009 and February 2013. Hepatotoxicity was defined as 2-fold or greater increase of aminotransferase or total bilirubin level from baselines. Roussel UCLAF Causality Assessment Method (RUCAM) was used to analyze the causality of drug-induced liver injuries. NAT1 and NAT2 acetylator types were determined with the use of polymerase-chain-reaction (PCR) restriction fragment length polymorphism to differentiate common single-nucleotide polymorphisms (SNPs) predictive of the acetylator phenotypes in a subgroup of patients. During the study period, 286 courses of TMP/SMX treatment administered to 284 patients were analyzed. One hundred and fifty-two patients (53.1%) developed hepatotoxicity, and TMP/SMX was considered causative in 47 (16.4%) who had a RUCAM score of 6 or greater. In multivariate analysis, concomitant use of fluconazole for candidiasis was the only factor associated with reduced risk for hepatotoxicity (adjusted odds ratio, 0.372; 95% confidence interval, 0.145-0.957), while serostatus of hepatitis B or C virus, NAT1 and NAT2 acetylator types, or receipt of combination antiretroviral therapy was not. The incidence of hepatotoxicity decreased with an increasing daily dose of fluconazole up to 4.0 mg/kg. We conclude that the incidence of TMP/SMX-related hepatotoxicity was 16.4% in HIV-infected Taiwanese patients who received TMP/SMX for pneumocystosis. Concomitant use of fluconazole was associated with decreased risk for TMP/SMX-related hepatotoxicity.	[Yang, Jen-Jia; Hung, Chien-Ching] Natl Taiwan Univ Hosp, Dept Internal Med, Taipei 100, Taiwan; [Yang, Jen-Jia; Hung, Chien-Ching] Natl Taiwan Univ, Coll Med, Taipei 10764, Taiwan; [Yang, Jen-Jia] Po Jen Gen Hosp, Dept Internal Med, Taipei, Taiwan; [Huang, Chung-Hao; Chen, Yen-Hsu; Lu, Po-Liang] Kaohsiung Med Univ Hosp, Dept Internal Med, Kaohsiung, Taiwan; [Huang, Chung-Hao; Chen, Yen-Hsu; Lu, Po-Liang] Kaohsiung Med Univ, Kaohsiung, Taiwan; [Liu, Chun-Eng] Changhua Christian Hosp, Dept Internal Med, Changhua, Taiwan; [Tang, Hung-Jen] Chi Mei Med Ctr, Dept Internal Med, Tainan, Taiwan; [Yang, Chia-Jui; Tsai, Mao-Song] Far Eastern Mem Hosp, Dept Internal Med, New Taipei City, Taiwan; [Lee, Yi-Chien] Chia Yi Christian Hosp, Ditmanson Med Fdn, Dept Internal Med, Chiayi, Taiwan; [Lee, Kuan-Yeh] Natl Taiwan Univ Hosp, Dept Internal Med, Hsin Chu Branch, Hsinchu, Taiwan; [Lin, Shu-Wen] Natl Taiwan Univ, Grad Inst Clin Pharm, Taipei 10764, Taiwan; [Lin, Shu-Wen] Natl Taiwan Univ Hosp, Dept Pharm, Taipei, Taiwan; [Lin, Shu-Wen] Natl Taiwan Univ, Coll Med, Taipei 10764, Taiwan; [Hung, Chien-Ching] China Med Univ Hosp, Dept Med Res, Taichung, Taiwan; [Hung, Chien-Ching] China Med Univ, Taichung, Taiwan	National Taiwan University; National Taiwan University Hospital; National Taiwan University; Kaohsiung Medical University; Kaohsiung Medical University Hospital; Kaohsiung Medical University; Changhua Christian Hospital; Chi Mei Hospital; Far Eastern Memorial Hospital; National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University; National Taiwan University Hospital; National Taiwan University; China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan	Lu, PL (corresponding author), Kaohsiung Med Univ Hosp, Dept Internal Med, Kaohsiung, Taiwan.	idpaul@gmail.com; hcc0401@ntu.edu.tw	Lu, Po-Liang/D-4499-2009	Lu, Po-Liang/0000-0002-7423-6783; Chen, Yen-hsu/0000-0002-8667-4844; LIN, SHU-WEN/0000-0002-9940-0850; Hung, Chien-Ching/0000-0001-7345-0836	Centers for Disease Control, Taiwan [DOH102-DC-1401]	Centers for Disease Control, Taiwan	This study was supported by grants from the Centers for Disease Control, Taiwan (grant number DOH102-DC-1401 to C.-C. H.). The funding source played no role in study design and conduct, data collection, analysis or interpretation, writing of the manuscript, or the decision to submit it for publication.	Abrescia N, 2005, CURR PHARM DESIGN, V11, P3697, DOI 10.2174/138161205774580804; Andrade RJ, 2005, GASTROENTEROLOGY, V129, P512, DOI 10.1053/j.gastro.2005.05.006; Bell Tara L, 2010, Pharmacotherapy, V30, P539, DOI 10.1592/phco.30.5.539; BENICHOU C, 1990, J HEPATOL, V11, P272; Berg P A, 1987, Infection, V15 Suppl 5, pS259, DOI 10.1007/BF01643200; Bernstein L S, 1975, Can Med Assoc J, V112, P96; Bjornsson E, 2005, HEPATOLOGY, V42, P481, DOI 10.1002/hep.20800; Bronstein JA, 1997, CLIN INFECT DIS, V25, P1266, DOI 10.1086/516975; Chalasani N, 2008, GASTROENTEROLOGY, V135, P1924, DOI 10.1053/j.gastro.2008.09.011; CRIBB AE, 1995, DRUG METAB DISPOS, V23, P406; DANAN G, 1993, J CLIN EPIDEMIOL, V46, P1323, DOI 10.1016/0895-4356(93)90101-6; Deitz AC, 1997, ANAL BIOCHEM, V253, P219, DOI 10.1006/abio.1997.2379; DEWIT S, 1989, LANCET, V1, P746; Garcia-Cortes M, 2011, J HEPATOL, V55, P683, DOI 10.1016/j.jhep.2011.02.007; Hein DW, 2012, PHARMACOGENOMICS, V13, P31, DOI [10.2217/pgs.11.122, 10.2217/PGS.11.122]; Hellden A, 2010, EUR J CLIN PHARMACOL, V66, P791, DOI 10.1007/s00228-010-0820-7; HUGHES WT, 1995, J INFECT DIS, V171, P1295, DOI 10.1093/infdis/171.5.1295; JICK H, 1995, PHARMACOTHERAPY, V15, P428; Kantola T, 2000, EUR J CLIN PHARMACOL, V56, P225, DOI 10.1007/s002280000127; Kaplan JE, 2000, CLIN INFECT DIS, V30, pS5, DOI 10.1086/313843; KLEIN NC, 1992, AIDS, V6, P301, DOI 10.1097/00002030-199203000-00007; LAWSON DH, 1982, REV INFECT DIS, V4, P429; LEE BL, 1994, CLIN PHARMACOL THER, V56, P184, DOI 10.1038/clpt.1994.122; Lee KY, 2012, J ANTIMICROB CHEMOTH, V67, P2749, DOI 10.1093/jac/dks283; Lee KY, 2012, J MICROBIOL IMMUNOL; Lemoine M, 2012, CURR OPIN INFECT DIS, V25, P10, DOI 10.1097/QCO.0b013e32834ef599; Mainra Rahul Rai, 2003, Can J Clin Pharmacol, V10, P175; Masters PA, 2003, ARCH INTERN MED, V163, P402, DOI 10.1001/archinte.163.4.402; Miljkovic MM, 2012, J CLIN PHARM THER, V37, P196, DOI 10.1111/j.1365-2710.2011.01282.x; Miller RF, 2013, CLIN CHEST MED, V34, P229, DOI 10.1016/j.ccm.2013.02.001; Mitra AK, 1996, CLIN PHARMACOL THER, V59, P332, DOI 10.1016/S0009-9236(96)80011-7; Novelli V, 1999, ANTIMICROB AGENTS CH, V43, P1955, DOI 10.1128/AAC.43.8.1955; SATTLER FR, 1988, ANN INTERN MED, V109, P280, DOI 10.7326/0003-4819-109-4-280; Schwarz UI, 2003, EUR J CLIN INVEST, V33, P23, DOI 10.1046/j.1365-2362.33.s2.6.x; Smith CL, 1997, CLIN INFECT DIS, V25, P1477, DOI 10.1086/516993; STEVENS RC, 1991, ANTIMICROB AGENTS CH, V35, P1884, DOI 10.1128/AAC.35.9.1884; von Moltke LL, 2001, J CLIN PHARMACOL, V41, P85, DOI 10.1177/00912700122009728; Vyas PM, 2006, J PHARMACOL EXP THER, V319, P488, DOI 10.1124/jpet.106.105858; Wang D, 2012, BMC MED GENOMICS, V5, DOI 10.1186/1755-8794-5-32; Wang JL, 2010, ANTIMICROB AGENTS CH, V54, P2409, DOI 10.1128/AAC.01657-09; WELLS C, 1992, J INFECTION, V24, P111, DOI 10.1016/0163-4453(92)91346-D; Winter HR, 2004, CLIN PHARMACOL THER, V76, P313, DOI 10.1016/j.clpt.2004.06.002; Xie HG, 1997, PHARMACOGENETICS, V7, P503, DOI 10.1097/00008571-199712000-00009	43	28	30	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 3	2014	9	9							e106141	10.1371/journal.pone.0106141	http://dx.doi.org/10.1371/journal.pone.0106141			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3TB	25184238	Green Published, Green Submitted, gold			2022-12-27	WOS:000341257700033
J	Meza-Sosa, KF; Perez-Garcia, EI; Camacho-Concha, N; Lopez-Gutierrez, O; Pedraza-Alva, G; Perez-Martinez, L				Meza-Sosa, Karla F.; Perez-Garcia, Erick I.; Camacho-Concha, Nohemi; Lopez-Gutierrez, Oswaldo; Pedraza-Alva, Gustavo; Perez-Martinez, Leonor			MiR-7 Promotes Epithelial Cell Transformation by Targeting the Tumor Suppressor KLF4	PLOS ONE			English	Article							TRANSCRIPTION FACTOR KLF4; KRUPPEL-LIKE FACTOR-4; CYCLIN D1 PROMOTER; DOWN-REGULATION; IN-VITRO; CANCER; DIFFERENTIATION; EXPRESSION; GROWTH; KRUPPEL-LIKE-FACTOR-4	MicroRNAs (miRNAs) are endogenous small non-coding RNAs that have a pivotal role in the post-transcriptional regulation of gene expression and their misregulation is common in different types of cancer. Although it has been shown that miR-7 plays an oncogenic role in different cellular contexts, the molecular mechanisms by which miR-7 promotes cell transformation are not well understood. Here we show that the transcription factor KLF4 is a direct target of miR-7 and present experimental evidence indicating that the regulation of KLF4 by miR-7 has functional implications in epithelial cell transformation. Stable overexpression of miR-7 into lung and skin epithelial cells enhanced cell proliferation, cell migration and tumor formation. Alteration of these cellular functions by miR-7 resulted from misregulation of KLF4 target genes involved in cell cycle control. miR-7-induced tumors showed decreased p21 and increased Cyclin D levels. Taken together, these findings indicate that miR-7 acts as an oncomiR in epithelial cells in part by directly regulating KLF4 expression. Thus, we conclude that miR-7 acts as an oncomiR in the epithelial cellular context, where through the negative regulation of KLF4-dependent signaling pathways, miR-7 promotes cellular transformation and tumor growth.	[Meza-Sosa, Karla F.; Perez-Garcia, Erick I.; Camacho-Concha, Nohemi; Lopez-Gutierrez, Oswaldo; Pedraza-Alva, Gustavo; Perez-Martinez, Leonor] Univ Nacl Autonoma Mexico, Inst Biotecnol, Dept Med Mol & Bioproc, Lab Neuroinmunobiol, Cuernavaca 62191, Morelos, Mexico	Universidad Nacional Autonoma de Mexico	Perez-Martinez, L (corresponding author), Univ Nacl Autonoma Mexico, Inst Biotecnol, Dept Med Mol & Bioproc, Lab Neuroinmunobiol, Cuernavaca 62191, Morelos, Mexico.	leonor@ibt.unam.mx	Meza-Sosa, Karla F/V-1439-2017	Meza-Sosa, Karla F/0000-0002-0095-2357	Consejo Nacional de Ciencia y Tecnologia (CONACyT) [155290, 154542]; DGAPA-PAPIIT [IN209212, IN227510]; CONACyT Graduate Scholarship	Consejo Nacional de Ciencia y Tecnologia (CONACyT)(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); DGAPA-PAPIIT(Programa de Apoyo a Proyectos de Investigacion e Innovacion Tecnologica (PAPIIT)); CONACyT Graduate Scholarship	This work was supported by the Consejo Nacional de Ciencia y Tecnologia (CONACyT) [grant numbers 155290 to L.P.-M. and 154542 to G.P.-A.], by the DGAPA-PAPIIT [grant numbers IN209212 L.P.-M. and IN227510 to G.P.-A.] and by a CONACyT Graduate Scholarship to K.F.M.-S. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Bianchi F, 2004, CLIN CANCER RES, V10, P6023, DOI 10.1158/1078-0432.CCR-04-0619; Camacho-Concha N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080806; Cao XW, 2006, ANNU REV NEUROSCI, V29, P77, DOI 10.1146/annurev.neuro.29.051605.112839; Chen CZ, 2004, SCIENCE, V303, P83, DOI 10.1126/science.1091903; Chen HY, 2012, CANCER RES, V72, P3631, DOI 10.1158/0008-5472.CAN-12-0667; Chiambaretta F, 2004, MOL VIS, V10, P901; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2; Chou YT, 2010, CANCER RES, V70, P8822, DOI 10.1158/0008-5472.CAN-10-0638; Dang D, 2009, INT J BIOCHEM, V32, P1103; De Smaele E, 2010, BRAIN RES, V1338, P100, DOI 10.1016/j.brainres.2010.03.103; Deyrieux AF, 2007, CYTOTECHNOLOGY, V54, P77, DOI 10.1007/s10616-007-9076-1; Evans PM, 2008, ACTA BIOCH BIOPH SIN, V40, P554, DOI 10.1111/j.1745-7270.2008.00439.x; Fang Y, 2012, ARTERIOSCL THROM VAS, V32, P979, DOI 10.1161/ATVBAHA.111.244053; Foster KW, 2000, CANCER RES, V60, P6488; Ghaleb AM, 2005, CELL RES, V15, P92, DOI 10.1038/sj.cr.7290271; Ghaleb AM, 2007, CANCER RES, V67, P7147, DOI 10.1158/0008-5472.CAN-07-1302; Griffiths-Jones S, 2006, NUCLEIC ACIDS RES, V34, pD140, DOI 10.1093/nar/gkj112; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hawryluk EB, 2013, J CUTAN PATHOL, V40, P61, DOI 10.1111/cup.12024; Hubbard T, 2002, NUCLEIC ACIDS RES, V30, P38, DOI 10.1093/nar/30.1.38; Ivey KN, 2010, CELL STEM CELL, V7, P36, DOI 10.1016/j.stem.2010.06.012; John B, 2004, PLOS BIOL, V2, P1862, DOI 10.1371/journal.pbio.0020363; Johnson DG, 1999, ANNU REV PHARMACOL, V39, P295, DOI 10.1146/annurev.pharmtox.39.1.295; Kaldis P, 2009, DEV CELL, V17, P749, DOI 10.1016/j.devcel.2009.12.001; Katz JP, 2005, GASTROENTEROLOGY, V128, P935, DOI 10.1053/j.gastro.2005.02.022; Katz JP, 2002, DEVELOPMENT, V129, P2619; Kertesz M, 2007, NAT GENET, V39, P1278, DOI 10.1038/ng2135; Kharas MG, 2007, BLOOD, V109, P747, DOI 10.1182/blood-2006-03-011106; Klein ME, 2005, CURR OPIN NEUROBIOL, V15, P507, DOI 10.1016/j.conb.2005.08.011; Komatsu S, 2013, ANTICANCER RES, V33, P271; Krek A, 2005, NAT GENET, V37, P495, DOI 10.1038/ng1536; Ky N, 2009, APOPTOSIS, V14, P1095, DOI 10.1007/s10495-009-0368-0; Lee JM, 2013, MOL CANCER RES, V11, P43, DOI 10.1158/1541-7786.MCR-12-0355; Lewis BP, 2003, CELL, V115, P787, DOI 10.1016/S0092-8674(03)01018-3; Li HX, 2010, J BIOL CHEM, V285, P17846, DOI 10.1074/jbc.M109.076992; Li J, 2012, CARCINOGENESIS, V33, P1239, DOI 10.1093/carcin/bgs143; Li XK, 2010, NAT REV NEUROSCI, V11, P329, DOI 10.1038/nrn2739; LIEBER M, 1976, INT J CANCER, V17, P62, DOI 10.1002/ijc.2910170110; Lin ZS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043593; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Luo AP, 2004, ONCOGENE, V23, P1291, DOI 10.1038/sj.onc.1207218; Luo LL, 2012, J CELL SCI, V125, P3124, DOI 10.1242/jcs.096412; Mahatan CS, 1999, NUCLEIC ACIDS RES, V27, P4562, DOI 10.1093/nar/27.23.4562; Marshall OJ, 2004, BIOINFORMATICS, V20, P2471, DOI 10.1093/bioinformatics/bth254; McConnell B, 2008, CANCER, V29, P549; Meza-Sosa KF, 2012, J NEUROSCI RES, V90, P1, DOI 10.1002/jnr.22701; Mohan N, 2013, MOL ONCOL, V7, P464, DOI 10.1016/j.molonc.2012.12.002; Nickenig G, 2002, FASEB J, V16, P1077, DOI 10.1096/fj.01-0570com; Ohnishi S, 2003, BIOCHEM BIOPH RES CO, V308, P251, DOI 10.1016/S0006-291X(03)01356-1; Okuda H, 2013, CANCER RES, V73, P1434, DOI 10.1158/0008-5472.CAN-12-2037; Olsen PH, 1999, DEV BIOL, V216, P671, DOI 10.1006/dbio.1999.9523; Pallante P, 2006, ENDOCR-RELAT CANCER, V13, P497, DOI 10.1677/erc.1.01209; Parasramka MA, 2012, CLIN EPIGENETICS, V4, DOI 10.1186/1868-7083-4-16; Perez-Martinez L, 2005, J NEUROSCI, V25, P4917, DOI 10.1523/JNEUROSCI.5066-04.2005; Rehmsmeier M, 2004, RNA, V10, P1507, DOI 10.1261/rna.5248604; Rhodes N, 1997, ONCOGENE, V14, P3017, DOI 10.1038/sj.onc.1201158; Rozen S, 2000, Methods Mol Biol, V132, P365; Sanchez N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065671; Segre JA, 1999, NAT GENET, V22, P356, DOI 10.1038/11926; Sengupta S, 2009, STEM CELLS, V27, P1524, DOI 10.1002/stem.84; Shie JL, 1999, GASTROENTEROLOGY, V116, pA520; Shie JL, 2000, NUCLEIC ACIDS RES, V28, P2969, DOI 10.1093/nar/28.15.2969; Shields JM, 1996, J BIOL CHEM, V271, P20009, DOI 10.1074/jbc.271.33.20009; Strauss WM, 2006, MAMM GENOME, V17, P833, DOI 10.1007/s00335-006-0025-7; Sun SG, 2011, EMBO REP, V12, P56, DOI 10.1038/embor.2010.172; Tian YY, 2010, J BIOL CHEM, V285, P7986, DOI 10.1074/jbc.M109.062877; Tsitsiou E, 2009, CURR OPIN PHARMACOL, V9, P514, DOI 10.1016/j.coph.2009.05.003; Varkonyi-Gasic E, 2007, PLANT METHODS, V3, DOI 10.1186/1746-4811-3-12; Wang N, 2002, WORLD J GASTROENTERO, V8, P966, DOI 10.3748/wjg.v8.i6.966; Wang XY, 2009, BRAIN RES BULL, V80, P268, DOI 10.1016/j.brainresbull.2009.08.006; Wei DY, 2005, CANCER RES, V65, P2746, DOI 10.1158/0008-5472.CAN-04-3619; Xie CQ, 2011, STEM CELLS DEV, V20, P205, DOI 10.1089/scd.2010.0283; Xiong SD, 2011, INT J BIOL SCI, V7, P805, DOI 10.7150/ijbs.7.805; Xu N, 2009, CELL, V137, P647, DOI 10.1016/j.cell.2009.02.038; Yasunaga J, 2004, CANCER RES, V64, P6002, DOI 10.1158/0008-5472.CAN-04-1422; Yoon HS, 2005, ONCOGENE, V24, P4017, DOI 10.1038/sj.onc.1208576; Yoon HS, 2004, J BIOL CHEM, V279, P5035, DOI 10.1074/jbc.M307631200; Yori JL, 2010, J BIOL CHEM, V285, P16854, DOI 10.1074/jbc.M110.114546; Yoshida T, 2010, J BIOL CHEM, V285, P21175, DOI 10.1074/jbc.M110.112482; Yu F, 2011, ONCOGENE, V30, P2161, DOI 10.1038/onc.2010.591; Yu ZH, 2013, J MOL HISTOL, V44, P669, DOI 10.1007/s10735-013-9516-5; Zhang W, 2006, MOL CELL BIOL, V26, P2055, DOI 10.1128/MCB.26.6.2055-2064.2006; Zhang WQ, 2000, J BIOL CHEM, V275, P18391, DOI 10.1074/jbc.C000062200; Zhang YY, 2012, ASIAN PAC J CANCER P, V13, P2437, DOI 10.7314/APJCP.2012.13.6.2437; Zhao XH, 2010, NEURON, V65, P612, DOI 10.1016/j.neuron.2010.02.018	86	43	44	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2014	9	9							e103987	10.1371/journal.pone.0103987	http://dx.doi.org/10.1371/journal.pone.0103987			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3LR	25181544	Green Submitted, gold, Green Published			2022-12-27	WOS:000341231500007
J	Qu, HC; Zhang, W; Yan, S; Liu, YL; Wang, P				Qu, Hong-Chen; Zhang, Wei; Yan, Shi; Liu, Yi-Li; Wang, Ping			Urinary Nerve Growth Factor Could Be a Biomarker for Interstitial Cystitis/Painful Bladder Syndrome: A Meta-Analysis	PLOS ONE			English	Article							CYSTITIS/BLADDER PAIN SYNDROME; BOTULINUM-TOXIN-A; OVERACTIVE BLADDER; EXPRESSION; HETEROGENEITY; PREVALENCE; PATHWAYS; NGF	To examine whether urinary nerve growth factor (NGF) could serve as a biomarker for interstitial cystitis/painful bladder syndrome (IC/PBS), we conducted a comprehensive meta-analysis of 9 studies. Among the studies considered, patients with IC/PBS had higher urinary NGF and NGF/Cr levels compared to those of healthy people (SMD = 1.94, 95% CI = 0.79-3.08, P = 0.0009 and SMD = 1.79, 95% CI = 0.65-2.93, P = 0.002, respectively). In addition, there was a significant difference between patients with IC/PBS and patients with overactive bladder (OAB) symptoms with respect to the urinary NGF and NGF/Cr levels (SMD = -0.62, 95% CI = -1.00- -0.24, P = 0.001 and SMD = -0.70, 95% CI = -1.01- -0.39, P<0.0001, respectively). Furthermore, patients had a significantly lower urinary NGF level after successful treatment (SMD = 1.74, 95% CI = 0.32-3.17, P = 0.02). In conclusion, urinary NGF could be a useful biomarker for the diagnosis of OAB, a urinary biomarker for the differential diagnosis of IC/PBS and OAB (when a critical urinary NGF or NGF/Cr level is needed), and a predictive biomarker to help guide treatment.	[Qu, Hong-Chen; Liu, Yi-Li; Wang, Ping] China Med Univ, Affiliated Hosp 4, Dept Urol Surg, Shenyang, Liaoning, Peoples R China; [Zhang, Wei] China Med Univ, Dent Affiliated Hosp, Dept Orthodont, Shenyang, Liaoning, Peoples R China; [Yan, Shi] Third Hosp Shenyang, Dept Urol Surg, Shenyang, Liaoning, Peoples R China	China Medical University; China Medical University	Wang, P (corresponding author), China Med Univ, Affiliated Hosp 4, Dept Urol Surg, Shenyang, Liaoning, Peoples R China.	cmu4h_wangping@126.com						Amaya F, 2004, EUR J NEUROSCI, V20, P2303, DOI 10.1111/j.1460-9568.2004.03701.x; Bhide AA, 2013, INT UROGYNECOL J, V24, P1065, DOI 10.1007/s00192-012-2027-1; Chuang YC, 2001, J UROLOGY, V165, P975, DOI 10.1016/S0022-5347(05)66587-1; Chung SD, 2011, NEUROUROL URODYNAM, V30, P417, DOI 10.1002/nau.20938; Clemens JQ, 2005, J UROLOGY, V174, P576, DOI 10.1097/01.ju.0000165170.43617.be; Corcoran AT, 2013, WORLD J UROL, V31, P241, DOI 10.1007/s00345-012-0852-y; Dupont MC, 2001, J UROLOGY, V166, P1111, DOI 10.1016/S0022-5347(05)65931-9; Erickson DR, 2002, J UROLOGY, V167, P2461, DOI 10.1016/S0022-5347(05)65005-7; Hanno PM, 1999, J UROLOGY, V161, P553, DOI 10.1016/S0022-5347(01)61948-7; Hanno PM, 2001, UROLOGY, V57, P2, DOI 10.1016/S0090-4295(01)01112-8; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Jiang YH, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0091609, 10.1371/journal.pone.0093563, 10.1371/journal.pone.0105989]; Kuo HC, 2010, NEUROUROL URODYNAM, V29, P482, DOI 10.1002/nau.20741; Lamb K, 2004, J PAIN, V5, P150, DOI 10.1016/j.jpain.2004.01.001; Liu HT, 2007, UROLOGY, V70, P463, DOI 10.1016/j.urology.2007.04.038; Liu HT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044687; Liu HT, 2010, BJU INT, V106, P1681, DOI 10.1111/j.1464-410X.2009.08851.x; Liu HT, 2009, BJU INT, V104, P1476, DOI 10.1111/j.1464-410X.2009.08675.x; Lowe EM, 1997, BRIT J UROL, V79, P572, DOI 10.1046/j.1464-410X.1997.00097.x; MESSING EM, 1987, UROLOGY, V29, P4; Murphy GK, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-544; Ogawa T, 2010, J UROLOGY, V183, P1206, DOI 10.1016/j.juro.2009.11.007; Okragly AJ, 1999, J UROLOGY, V161, P438, DOI 10.1016/S0022-5347(01)61915-3; Peters JL, 2006, JAMA-J AM MED ASSOC, V295, P676, DOI 10.1001/jama.295.6.676; Pinto R, 2010, EUR UROL, V58, P360, DOI 10.1016/j.eururo.2010.02.031; Rachaneni S, 2013, INT UROGYNECOL J, V24, P1603, DOI 10.1007/s00192-013-2104-0; Saini Rajiv, 2008, Curr Urol Rep, V9, P314, DOI 10.1007/s11934-008-0054-8; Steers WD, 2006, NAT CLIN PRACT UROL, V3, P101, DOI 10.1038/ncpuro0408; STEERS WD, 1991, J CLIN INVEST, V88, P1709, DOI 10.1172/JCI115488; Steers William D, 2002, Rev Urol, V4 Suppl 4, pS7; Stewart WF, 2002, WORLD J UROL, V20, P327, DOI 10.1007/s00345-002-0301-4; TUTTLE JB, 1994, J AUTONOM NERV SYST, V49, P147, DOI 10.1016/0165-1838(94)90134-1; Tyagi P, 2012, J UROLOGY, V187, P2243, DOI 10.1016/j.juro.2012.01.034; Vizzard MA, 2001, J CHEM NEUROANAT, V21, P125, DOI 10.1016/S0891-0618(00)00115-0; Vizzard MA, 2000, AM J PHYSIOL-REG I, V278, pR1027, DOI 10.1152/ajpregu.2000.278.4.R1027; von Elm E, 2007, EPIDEMIOLOGY, V18, P800, DOI 10.1097/EDE.0b013e3181577654; Zintzaras E, 2005, GENET EPIDEMIOL, V28, P123, DOI 10.1002/gepi.20048	37	23	25	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2014	9	9							e106321	10.1371/journal.pone.0106321	http://dx.doi.org/10.1371/journal.pone.0106321			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3LR	25181532	gold, Green Published, Green Submitted			2022-12-27	WOS:000341231500077
J	Samur, MK				Samur, Mehmet Kemal			RTCGAToolbox: A New Tool for Exporting TCGA Firehose Data	PLOS ONE			English	Article							CANCER GENOME ATLAS; SIGNATURES; LANDSCAPE; PROFILES; CIRCOS	Background & Objective: Managing data from large-scale projects (such as The Cancer Genome Atlas (TCGA)) for further analysis is an important and time consuming step for research projects. Several efforts, such as the Firehose project, make TCGA pre-processed data publicly available via web services and data portals, but this information must be managed, downloaded and prepared for subsequent steps. We have developed an open source and extensible R based data client for pre-processed data from the Firehouse, and demonstrate its use with sample case studies. Results show that our RTCGAToolbox can facilitate data management for researchers interested in working with TCGA data. The RTCGAToolbox can also be integrated with other analysis pipelines for further data processing.	[Samur, Mehmet Kemal] Dana Farber Canc Inst, Dept Biostat & Computat Biol, Boston, MA 02115 USA; [Samur, Mehmet Kemal] Harvard Univ, Sch Publ Hlth, Boston, MA 02115 USA; [Samur, Mehmet Kemal] Dana Farber Canc Inst, Inst Myeloma Therapeut, Boston, MA 02115 USA; [Samur, Mehmet Kemal] Dana Farber Canc Inst, Jerome Lipper Multiple Myeloma Ctr, Boston, MA 02115 USA; [Samur, Mehmet Kemal] Harvard Univ, Sch Med, Boston, MA USA	Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Dana-Farber Cancer Institute; Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School	Samur, MK (corresponding author), Dana Farber Canc Inst, Dept Biostat & Computat Biol, Boston, MA 02115 USA.	samur@jimmy.harvard.edu		Samur, Mehmet/0000-0002-9978-5682	National Institutes of Health [PO1CA155258, P50CA100707, PO1CA78378, RO1-124929]; NATIONAL CANCER INSTITUTE [P01CA155258, P01CA078378, P50CA100707] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work is supported by grants from the National Institutes of Health, Grants: PO1CA155258, P50CA100707, PO1CA78378, and RO1-124929. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexandrov LB, 2013, NATURE, V500, P415, DOI 10.1038/nature12477; Buetow KH, 2009, DRUG DISCOV TODAY, V14, P605, DOI 10.1016/j.drudis.2009.03.011; Cerami E, 2012, CANCER DISCOV, V2, P401, DOI 10.1158/2159-8290.CD-12-0095; Chin L, 2008, NATURE, V455, P1061, DOI 10.1038/nature07385; Ciriello G, 2013, NAT GENET, V45, P1127, DOI 10.1038/ng.2762; Cline MS, 2013, SCI REP-UK, V3, DOI 10.1038/srep02652; Gadaleta E, 2011, BRIEF BIOINFORM, V12, P52, DOI 10.1093/bib/bbq010; Gao JJ, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004088; Gehlenborg N, 2013, BIOINFORMATICS, V29, P1089, DOI 10.1093/bioinformatics/btt085; Guberman JM, 2011, DATABASE-OXFORD, DOI 10.1093/database/bar041; Guo Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071462; Haider S, 2009, NUCLEIC ACIDS RES, V37, pW23, DOI 10.1093/nar/gkp265; Krzywinski M, 2009, GENOME RES, V19, P1639, DOI 10.1101/gr.092759.109; Law CW, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-2-r29; Mermel CH, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-4-r41; Omberg L, 2013, NAT GENET, V45, P1121, DOI 10.1038/ng.2761; Pennisi E, 2011, SCIENCE, V331, P666, DOI 10.1126/science.331.6018.666; Rhodes DR, 2007, NEOPLASIA, V9, P166, DOI 10.1593/neo.07112; Robbins DE, 2013, BIOINFORMATICS, V29, P1333, DOI 10.1093/bioinformatics/btt141; Saltz J, 2006, BIOINFORMATICS, V22, P1910, DOI 10.1093/bioinformatics/btl272; Samur MK, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-672; Samur MK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056228; Sean D, 2007, BIOINFORMATICS, V23, P1846, DOI 10.1093/bioinformatics/btm254; Shapovalov MV, 2007, BIOINFORMATICS, V23, P1437, DOI 10.1093/bioinformatics/btm120; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; Weinstein JN, 2013, NAT GENET, V45, P1113, DOI 10.1038/ng.2764; Zhang HE, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-244	27	99	103	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2014	9	9							e106397	10.1371/journal.pone.0106397	http://dx.doi.org/10.1371/journal.pone.0106397			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3LR	25181531	Green Published, Green Submitted, gold			2022-12-27	WOS:000341231500087
J	Gomes, CLR; Leao, CL; Venturotti, C; Barreira, AL; Guimaraes, G; Fonseca, RJC; Fortunato, RS; Mourao, PAS; Delgado, AG; Takiya, CM; Leite, M				Gomes, Conrado L. R.; Leao, Cristina L.; Venturotti, Carolina; Barreira, Andre L.; Guimaraes, Gabriela; Fonseca, Roberto J. C.; Fortunato, Rodrigo S.; Mourao, Paulo A. S.; Delgado, Alvimar G.; Takiya, Christina M.; Leite, Maurilo, Jr.			The Protective Role of Fucosylated Chondroitin Sulfate, a Distinct Glycosaminoglycan, in a Murine Model of Streptozotocin-Induced Diabetic Nephropathy	PLOS ONE			English	Article							GLOMERULAR-BASEMENT-MEMBRANE; MOLECULAR-WEIGHT HEPARIN; HIGH GLUCOSE; KIDNEY-DISEASE; STRUCTURAL ALTERATION; EPITHELIAL-CELLS; GENE-EXPRESSION; ORAL SULODEXIDE; TGF-BETA; HEPARANASE	Background: Heparanase-1 activation, albuminuria, and a decrease in glomerular heparan sulfate (HS) have been described in diabetic nephropathy (DN). Glycosaminoglycan (GAG)-based drugs have been shown to have renoprotective effects in this setting, although recent trials have questioned their clinical effectiveness. Here, we describe the effects of fucosylated chondroitin sulfate (FCS), a novel GAG extracted from a marine echinoderm, in experimentally induced DN compared to a widely used GAG, enoxaparin (ENX). Methods: Diabetes mellitus (DM) was induced by streptozotocin in male Wistar rats divided into three groups: DM (without treatment), FCS (8 mg/kg), and ENX (4 mg/kg), administered subcutaneously. After 12 weeks, we measured blood glucose, blood pressure, albuminuria, and renal function. The kidneys were evaluated for mesangial expansion and collagen content. Immunohistochemical quantifications of macrophages, TGF-beta, nestin and immunofluorescence analysis of heparanase-1 and glomerular basement membrane (GBM) HS content was also performed. Gene expression of proteoglycan core proteins and enzymes involved in GAG assembly/degradation were analyzed by TaqMan real-time PCR. Results: Treatment with GAGs prevented albuminuria and did not affect the glucose level or other functional aspects. The DM group exhibited increased mesangial matrix deposition and tubulointerstitial expansion, and prevention was observed in both GAG groups. TGF-beta expression and macrophage infiltration were prevented by the GAG treatments, and podocyte damage was halted. The diabetic milieu resulted in the down-regulation of agrin, perlecan and collagen XVIII mRNAs, along with the expression of enzymes involved in GAG biosynthesis. Treatment with FCS and ENX positively modulated such changes. Heparanase-1 expression was significantly reduced after GAG treatment without affecting the GBM HS content, which was uniformly reduced in all of the diabetic animals. Conclusions: Our results demonstrate that the administration of FCS prevented several pathological features of ND in rats. This finding should stimulate further research on GAG treatment for this complication of diabetes.	[Gomes, Conrado L. R.; Leao, Cristina L.; Venturotti, Carolina; Barreira, Andre L.; Guimaraes, Gabriela; Delgado, Alvimar G.; Takiya, Christina M.; Leite, Maurilo, Jr.] Univ Fed Rio de Janeiro, Dept Clin Med, Serv Disciplina Nefrol, Rio De Janeiro, Brazil; [Gomes, Conrado L. R.; Leao, Cristina L.; Venturotti, Carolina; Barreira, Andre L.; Guimaraes, Gabriela; Fonseca, Roberto J. C.; Mourao, Paulo A. S.; Delgado, Alvimar G.; Takiya, Christina M.; Leite, Maurilo, Jr.] Univ Fed Rio de Janeiro, Hosp Univ Clementino Fraga Filho, Rio De Janeiro, Brazil; [Guimaraes, Gabriela; Takiya, Christina M.] Univ Fed Rio de Janeiro, Inst Ciencias Biomed, Rio De Janeiro, Brazil; [Fonseca, Roberto J. C.; Mourao, Paulo A. S.] Univ Fed Rio de Janeiro, Inst Bioquim Med, Lab Tecido Conjunt, Rio De Janeiro, Brazil; [Fortunato, Rodrigo S.] Univ Fed Rio de Janeiro, Inst Biofis Carlos Chagas Filho, Lab Radiobiol Mol, Rio De Janeiro, Brazil	Universidade Federal do Rio de Janeiro; Universidade Federal do Rio de Janeiro; Universidade Federal do Rio de Janeiro; Universidade Federal do Rio de Janeiro; Universidade Federal do Rio de Janeiro	Leite, M (corresponding author), Univ Fed Rio de Janeiro, Dept Clin Med, Serv Disciplina Nefrol, Rio De Janeiro, Brazil.	mleitejr@hucff.ufrj.br	FONSECA, ROBERTO/C-1761-2015; Fortunato, Rodrigo/AAM-9931-2020; Mourao, Paulo/AAA-5386-2020; Takiya, Christina/AAU-5959-2021; Fortunato, Rodrigo/F-2020-2014	Takiya, Christina/0000-0002-8019-628X; CASTRO FONSECA, ROBERTO JOSE/0000-0001-7500-1348; Fortunato, Rodrigo/0000-0003-3497-8173; Gomes, Conrado/0000-0001-6711-9469	Rio de Janeiro State Research Supporting Foundation (FAPERJ); Coordination for the Improvement of Higher Education Personnel (CAPES)	Rio de Janeiro State Research Supporting Foundation (FAPERJ)(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); Coordination for the Improvement of Higher Education Personnel (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	This study was partially supported by Rio de Janeiro State Research Supporting Foundation (FAPERJ) and Coordination for the Improvement of Higher Education Personnel (CAPES). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2008, MES IND QUANT; Atkins RC, 2010, NEPHROL DIAL TRANSPL, V25, P331, DOI 10.1093/ndt/gfp757; Bacilieri M, 2011, GLYCOBIOLOGY, V21, P1029, DOI 10.1093/glycob/cwr038; Granqvist ABR, 2006, AM J PHYSIOL-RENAL, V291, pF722, DOI 10.1152/ajprenal.00433.2005; Blouza S, 2010, J NEPHROL, V23, P415; Borsig L, 2007, J BIOL CHEM, V282, P14984, DOI 10.1074/jbc.M610560200; Ceol M, 2003, J NEPHROL, V16, P210; Ceol M, 2000, J AM SOC NEPHROL, V11, P2324, DOI 10.1681/ASN.V11122324; Chen J, 2006, J AM SOC NEPHROL, V17, P1283, DOI 10.1681/ASN.2005101032; Chen S, 2008, KIDNEY INT, V74, P289, DOI 10.1038/ki.2008.159; DECKERT T, 1989, DIABETOLOGIA, V32, P219, DOI 10.1007/BF00285287; Dedov I, 1997, NEPHROL DIAL TRANSPL, V12, P2295, DOI 10.1093/ndt/12.11.2295; Edge ASB, 2000, DIABETOLOGIA, V43, P1056, DOI 10.1007/s001250051489; Gambaro G, 2002, J AM SOC NEPHROL, V13, DOI 10.1097/01.ASN.0000014254.87188.E5; GAMBARO G, 1994, KIDNEY INT, V46, P797, DOI 10.1038/ki.1994.335; Gambaro G, 2012, AM J KIDNEY DIS, V60, P169, DOI 10.1053/j.ajkd.2012.01.029; Gambaro G, 2010, J NEPHROL, V23, P244; Garsen M, 2014, NEPHROL DIAL TRANSPL, V29, P49, DOI 10.1093/ndt/gft410; Gil N, 2012, DIABETES, V61, P208, DOI 10.2337/db11-1024; Girardin EP, 2005, J BIOL CHEM, V280, P38059, DOI 10.1074/jbc.M507997200; Goldberg S, 2009, NEPHROL DIAL TRANSPL, V24, P2044, DOI 10.1093/ndt/gfn758; Han J, 2013, VASC PHARMACOL, V59, P112, DOI 10.1016/j.vph.2013.08.001; Haraldsson B, 2008, PHYSIOL REV, V88, P451, DOI 10.1152/physrev.00055.2006; Harvey SJ, 2007, AM J PATHOL, V171, P139, DOI 10.2353/ajpath.2007.061116; Ishikawa Y, 1999, KIDNEY INT, V56, P954, DOI 10.1046/j.1523-1755.1999.00639.x; Jeansson M, 2006, DIABETOLOGIA, V49, P2200, DOI 10.1007/s00125-006-0319-z; Jefferson JA, 2008, KIDNEY INT, V74, P22, DOI 10.1038/ki.2008.128; Jiang P, 2002, J BIOL CHEM, V277, P8989, DOI 10.1074/jbc.M105682200; Joladarashi D, 2011, GLYCOBIOLOGY, V21, P960, DOI 10.1093/glycob/cwr029; KANWAR YS, 1980, J CELL BIOL, V86, P688, DOI 10.1083/jcb.86.2.688; Lewis EJ, 2011, AM J KIDNEY DIS, V58, P729, DOI 10.1053/j.ajkd.2011.06.020; Masola V, 2012, J TRANSL MED, V10, DOI 10.1186/1479-5876-10-213; Maxhimer JB, 2005, DIABETES, V54, P2172, DOI 10.2337/diabetes.54.7.2172; Melo NM, 2010, AM J PHYSIOL-RENAL, V299, pF1299, DOI 10.1152/ajprenal.00217.2010; Mogyorosi A, 1998, AM J PHYSIOL-RENAL, V275, pF827, DOI 10.1152/ajprenal.1998.275.5.F827; Mourao PAS, 1998, BRIT J HAEMATOL, V101, P647, DOI 10.1046/j.1365-2141.1998.00769.x; Packham DK, 2012, J AM SOC NEPHROL, V23, P123, DOI 10.1681/ASN.2011040378; Pecly IMD, 2006, NEPHROL DIAL TRANSPL, V21, P1212, DOI 10.1093/ndt/gfk076; Reine TM, 2013, J HISTOCHEM CYTOCHEM, V61, P606, DOI 10.1369/0022155413494392; Rops ALWMM, 2014, KIDNEY INT, V86, P932, DOI 10.1038/ki.2014.115; Rops ALWMM, 2012, NEPHROL DIAL TRANSPL, V27, P2853, DOI 10.1093/ndt/gfr732; Schrijvers BF, 2004, ENDOCR REV, V25, P971, DOI 10.1210/er.2003-0018; Shafat I, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017312; Singh A, 2011, AM J PHYSIOL-RENAL, V300, pF40, DOI 10.1152/ajprenal.00103.2010; Strunz CMC, 2011, CARDIOVASC DIABETOL, V10, DOI 10.1186/1475-2840-10-35; TAMSMA JT, 1994, DIABETOLOGIA, V37, P313, DOI 10.1007/BF00398060; TEMPLETON DM, 1989, LAB INVEST, V61, P202; van den Hoven MJ, 2008, KIDNEY INT, V73, P278, DOI 10.1038/sj.ki.5002706; van den Hoven MJ, 2006, KIDNEY INT, V70, P2100, DOI 10.1038/sj.ki.5001985; van den Hoven MJ, 2009, NEPHROL DIAL TRANSPL, V24, P2637, DOI 10.1093/ndt/gfp182; VANDENBORN J, 1992, KIDNEY INT, V41, P115, DOI 10.1038/ki.1992.15; Vlodavsky I, 2012, CANCER MICROENVIRON, V5, P115, DOI 10.1007/s12307-011-0082-7; Weigert C, 2001, KIDNEY INT, V60, P935, DOI 10.1046/j.1523-1755.2001.060003935.x; Weil EJ, 2012, KIDNEY INT, V82, P1010, DOI 10.1038/ki.2012.234; Wijnhoven TJM, 2008, DIABETOLOGIA, V51, P372, DOI 10.1007/s00125-007-0879-6; Wijnhoven TJM, 2007, J AM SOC NEPHROL, V18, P823, DOI 10.1681/ASN.2006070692; Wolf G, 2005, DIABETES, V54, P1626, DOI 10.2337/diabetes.54.6.1626; Yard BA, 2001, EXP NEPHROL, V9, P214; Yung SS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054501	59	14	15	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2014	9	9							e106929	10.1371/journal.pone.0106929	http://dx.doi.org/10.1371/journal.pone.0106929			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ1IR	25192337	Green Published, gold, Green Submitted			2022-12-27	WOS:000347993600082
J	Koehler, BC; Scherr, AL; Lorenz, S; Elssner, C; Kautz, N; Welte, S; Jaeger, D; Urbanik, T; Schulze-Bergkamen, H				Koehler, Bruno Christian; Scherr, Anna-Lena; Lorenz, Stephan; Elssner, Christin; Kautz, Nicole; Welte, Stefan; Jaeger, Dirk; Urbanik, Toni; Schulze-Bergkamen, Henning			Pan-Bcl-2 Inhibitor Obatoclax Delays Cell Cycle Progression and Blocks Migration of Colorectal Cancer Cells	PLOS ONE			English	Article							ACUTE LYMPHOBLASTIC-LEUKEMIA; BH3 MIMETICS; E-CADHERIN; PHASE-I; APOPTOSIS; AUTOPHAGY; GX15-070; EXPRESSION; MCL-1; RESISTANCE	Despite the fact that new treatment regimes have improved overall survival of patients challenged by colorectal cancer (CRC), prognosis in the metastatic situation is still restricted. The Bcl-2 family of proteins has been identified as promising anti cancer drug target. Even though small molecules targeting Bcl-2 proteins are in clinical trials, little is known regarding their effects on CRC. The aim of this study was to preclinically investigate the value of ABT-737 and Obatoclax as anticancer drugs for CRC treatment. The effects of the BH3-mimetics ABT-737 and Obatoclax on CRC cells were assessed using viability and apoptosis assays. Wound healing migration and boyden chamber invasion assays were applied. 3-dimensional cell cultures were used for long term assessment of invasion and proliferation. Clinically relevant concentrations of pan-Bcl-2 inhibitor Obatoclax did not induce cell death. In contrast, the BH3-mimetic ABT-737 induced apoptosis in a dose dependent manner. Obatoclax caused a cell line specific slowdown of CRC cell growth. Furthermore, Obatoclax, but not ABT-737, recovered E-Cadherin expression and led to impaired migration and invasion of CRC cells. The proliferative capacity and invasiveness of CRC cells was strikingly inhibited by low dose Obatoclax in long term 3-dimensional cell cultures. Obatoclax, but not ABT-737, caused a G1-phase arrest accompanied by a downregulation of Cyclin D1 and upregulation of p27 and p21. Overexpression of Mcl-1, Bcl-xL or Bcl-2 reversed the inhibitory effect of Obatoclax on migration but failed to restore the proliferative capacity of Obatoclax-treated CRC cells. The data presented indicate broad and multifaceted antitumor effects of the pan-Bcl-2 inhibitor Obatoclax on CRC cells. In contrast to ABT-737, Obatoclax inhibited migration, invasion and proliferation in sublethal doses. In summary, this study recommends pan-Bcl-2 inhibition as a promising approach for clinical trials in CRC.	[Koehler, Bruno Christian; Scherr, Anna-Lena; Lorenz, Stephan; Elssner, Christin; Kautz, Nicole; Welte, Stefan; Jaeger, Dirk; Urbanik, Toni; Schulze-Bergkamen, Henning] Univ Heidelberg Hosp, Natl Ctr Tumor Dis, Dept Med Oncol, Heidelberg, Germany	Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg	Koehler, BC (corresponding author), Univ Heidelberg Hosp, Natl Ctr Tumor Dis, Dept Med Oncol, Heidelberg, Germany.	Bruno.koehler@nct-heidelberg.de			Medical Faculty of the University of Heidelberg, Germany; German Research Foundation (Deutsche Forschungsgemeinschaft) [DFG SCHU 1443/4-1]	Medical Faculty of the University of Heidelberg, Germany; German Research Foundation (Deutsche Forschungsgemeinschaft)(German Research Foundation (DFG))	This study was supported by a Postdoctoral-Fellowship granted to BCK from the Medical Faculty of the University of Heidelberg, Germany (http://www.medizinische-fakultaet-hd.uni-heidelberg.de), and grants to HSB from the German Research Foundation (Deutsche Forschungsgemeinschaft, http://www.dfg.de/, DFG SCHU 1443/4-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Azmi AS, 2011, EXPERT OPIN EMERG DR, V16, P59, DOI 10.1517/14728214.2010.515210; Backus HHJ, 2001, ANN ONCOL, V12, P779, DOI 10.1023/A:1011112227044; Bodur C, 2012, CURR MED CHEM, V19, P1804, DOI 10.2174/092986712800099839; Crawford N, 2011, APOPTOSIS, V16, P311, DOI 10.1007/s10495-010-0561-1; Espona-Fiedler M, 2012, BIOCHEM PHARMACOL, V83, P489, DOI 10.1016/j.bcp.2011.11.027; Even-Ram S, 2005, CURR OPIN CELL BIOL, V17, P524, DOI 10.1016/j.ceb.2005.08.015; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Fujise K, 2000, J BIOL CHEM, V275, P39458, DOI 10.1074/jbc.M006626200; Gravdal K, 2007, CLIN CANCER RES, V13, P7003, DOI 10.1158/1078-0432.CCR-07-1263; Harrison LRE, 2011, J CLIN INVEST, V121, P1075, DOI 10.1172/JCI43505; Hazan RB, 2004, ANN NY ACAD SCI, V1014, P155, DOI 10.1196/annals.1294.016; Heidari N, 2010, CELL DEATH DIS, V1, DOI 10.1038/cddis.2010.53; Hermiston ML, 1996, GENE DEV, V10, P985, DOI 10.1101/gad.10.8.985; Huang SB, 2010, AUTOPHAGY, V6, P256, DOI 10.4161/auto.6.2.11124; Hwang JJ, 2010, CLIN CANCER RES, V16, P4038, DOI 10.1158/1078-0432.CCR-10-0822; Jain HV, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0081582; Janumyan YM, 2003, EMBO J, V22, P5459, DOI 10.1093/emboj/cdg533; Kim JK, 2009, J CELL PHYSIOL, V220, P292, DOI 10.1002/jcp.21791; Koehler BC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076446; Labi V, 2008, CELL DEATH DIFFER, V15, P977, DOI 10.1038/cdd.2008.37; Liang CC, 2007, NAT PROTOC, V2, P329, DOI 10.1038/nprot.2007.30; Martinez-Paniagua MA, 2011, CELL CYCLE, V10, P2792, DOI 10.4161/cc.10.16.16952; Mazumder S, 2012, CANCER RES, V72, P3069, DOI 10.1158/0008-5472.CAN-11-4106; McCoy F, 2010, CELL DEATH DIS, V1, DOI 10.1038/cddis.2010.86; Mehlen P, 2006, NAT REV CANCER, V6, P449, DOI 10.1038/nrc1886; NICOLETTI I, 1991, J IMMUNOL METHODS, V139, P271, DOI 10.1016/0022-1759(91)90198-O; Paik PK, 2010, CANCER CHEMOTH PHARM, V66, P1079, DOI 10.1007/s00280-010-1265-5; Pan JX, 2010, CANCER LETT, V293, P167, DOI 10.1016/j.canlet.2010.01.006; Raats DAE, 2011, CELL ONCOL, V34, P307, DOI 10.1007/s13402-011-0026-8; Schneider MR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014325; Schoenwaelder SM, 2011, BLOOD, V118, P1663, DOI 10.1182/blood-2011-04-347849; Schulze-Bergkamen H, 2008, WORLD J GASTROENTERO, V14, P3829, DOI 10.3748/wjg.14.3829; Sherr CJ, 1999, GENE DEV, V13, P1501, DOI 10.1101/gad.13.12.1501; Sieghart W, 2006, J HEPATOL, V44, P151, DOI 10.1016/j.jhep.2005.09.010; Urbanik T, 2012, J HEPATOL, V57, P995, DOI 10.1016/j.jhep.2012.06.017; Urtishak KA, 2013, BLOOD, V121, P2689, DOI 10.1182/blood-2012-04-425033; Vermeulen K, 2003, CELL PROLIFERAT, V36, P131, DOI 10.1046/j.1365-2184.2003.00266.x; Vick B, 2009, HEPATOLOGY, V49, P627, DOI 10.1002/hep.22664; Wanebo HJ, 2012, CLIN EXP METASTAS, V29, P821, DOI 10.1007/s10585-012-9517-x; Wei Y, 2010, CLIN CANCER RES, V16, P3923, DOI 10.1158/1078-0432.CCR-10-0032; Wheelock MJ, 2008, J CELL SCI, V121, P727, DOI 10.1242/jcs.000455; Wroblewski D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084073; Yamaguchi H, 2005, CURR OPIN CELL BIOL, V17, P559, DOI 10.1016/j.ceb.2005.08.002; Yang JS, 2011, ACTA HISTOCHEM, V113, P810, DOI 10.1016/j.acthis.2011.01.002; Zhai D, 2006, CELL DEATH DIFFER, V13, P1419, DOI 10.1038/sj.cdd.4401937; Zhang YL, 2008, WORLD J GASTROENTERO, V14, P3069, DOI 10.3748/wjg.14.3069; Zinkel SS, 2008, METHOD ENZYMOL, V442, P231, DOI 10.1016/S0076-6879(08)01412-2	47	24	24	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2014	9	9							e106571	10.1371/journal.pone.0106571	http://dx.doi.org/10.1371/journal.pone.0106571			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ1IR	25192188	gold, Green Published, Green Submitted			2022-12-27	WOS:000347993600039
J	Park, J; Stanley, D; Kim, Y				Park, Jiyeong; Stanley, David; Kim, Yonggyun			Roles of Peroxinectin in PGE(2)-Mediated Cellular Immunity in Spodoptera exigua	PLOS ONE			English	Article							TOBACCO HORNWORM; BEET ARMYWORM; PROSTAGLANDIN BIOSYNTHESIS; EICOSANOID BIOSYNTHESIS; MALPIGHIAN TUBULES; ARACHIDONIC-ACID; GENE-EXPRESSION; HOUSE CRICKET; HEMOCYTES; ADHESION	Background: Prostaglandins (PGs) mediate insect immune responses to infections and invasions. Although the presence of PGs has been confirmed in several insect species, their biosynthesis in insects remains a conundrum because orthologs of the mammalian cyclooxygenases (COXs) have not been found in the known insect genomes. PG-mediated immune reactions have been documented in the beet armyworm, Spodoptera exigua. The purpose of this research is to identify the source of PGs in S. exigua. Principal Findings: Peroxidases (POXs) are a sister group of COX genes. Ten putative POXs (SePOX-A, SePOX-J) were expressed in S. exigua. Expressions of SePOX-F and -H were induced by bacterial challenge and expressed in the hemocytes and the fat body. RNAi of each POX was performed by hemocoelic injection of their specific double-stranded RNAs. dsPOX-F or, separately, dsPOX-H, but not the other eight dsRNA constructs, specifically suppressed hemocyte-spreading behavior and nodule formation; these two reactions were also inhibited by aspirin, a COX inhibitor. PGE(2), but not arachidonic acid, treatment rescued the immunosuppression. Sequence analysis indicated that both POX genes were clustered with peroxinectin (Pxt) and their cognate proteins shared some conserved domains corresponding to the Pxt of Drosophila melanogaster. Conclusions: SePOX-F and -H are Pxt-like genes associated with PG biosynthesis in S. exigua.	[Park, Jiyeong; Kim, Yonggyun] Andong Natl Univ, Dept Bioresource Sci, Andong, South Korea; [Stanley, David] USDA ARS, Biol Control Insects Res Lab, Columbia, MO 65205 USA	Andong National University; United States Department of Agriculture (USDA)	Kim, Y (corresponding author), Andong Natl Univ, Dept Bioresource Sci, Andong, South Korea.	hosanna@andong.ac.kr			National Research Foundation of Korea [2013R1A1A2A10058197]	National Research Foundation of Korea(National Research Foundation of Korea)	This work was supported by the National Research Foundation of Korea (www.nrf.re.kr), Grant # 2013R1A1A2A10058197. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beckage NE, 2008, INSECT IMMUNOLOGY, P1; Burke JE, 2009, J LIPID RES, V50, pS237, DOI 10.1194/jlr.R800033-JLR200; Buyukguzel K, 2002, INSECT BIOCHEM MOLEC, V32, P435, DOI 10.1016/S0965-1748(01)00121-7; Cerenius L, 2008, TRENDS IMMUNOL, V29, P263, DOI 10.1016/j.it.2008.02.009; DESTEPHANO DB, 1974, PROSTAG OTH LIPID M, V6, P71, DOI 10.1016/S0090-6980(74)80042-0; GADELHAK GG, 1995, INSECT BIOCHEM MOLEC, V25, P743, DOI 10.1016/0965-1748(95)00014-M; Gillespie JP, 1997, ANNU REV ENTOMOL, V42, P611, DOI 10.1146/annurev.ento.42.1.611; GOH H G, 1990, Korean Journal of Applied Entomology, V29, P180; JOHANSSON MW, 1989, INSECT BIOCHEM, V19, P573, DOI 10.1016/0020-1790(89)90022-X; Jurenka RA, 1999, ARCH INSECT BIOCHEM, V41, P225, DOI 10.1002/(SICI)1520-6327(1999)41:4&lt;225::AID-ARCH6&gt;3.0.CO;2-0; Kim GS, 2009, ARCH INSECT BIOCHEM, V70, P162, DOI 10.1002/arch.20286; KOBAYASHI M, 1990, CELL TISSUE RES, V260, P13, DOI 10.1007/BF00297485; Lemaitre B, 2007, ANNU REV IMMUNOL, V25, P697, DOI 10.1146/annurev.immunol.25.022106.141615; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; LOHER W, 1981, P NATL ACAD SCI-BIOL, V78, P7835, DOI 10.1073/pnas.78.12.7835; Machado E, 2007, INSECT BIOCHEM MOLEC, V37, P876, DOI 10.1016/j.ibmb.2007.04.003; Marmaras VJ, 2009, CELL SIGNAL, V21, P186, DOI 10.1016/j.cellsig.2008.08.014; MURTAUGH MP, 1982, INSECT BIOCHEM, V12, P599, DOI 10.1016/0020-1790(82)90046-4; Park B, 2011, BMB REP, V44, P393, DOI 10.5483/BMBRep.2011.44.6.393; Park JM, 2013, BIORESOURCE TECHNOL, V135, P1, DOI 10.1016/j.biortech.2013.03.132; Park JW, 2010, ANNU REV ENTOMOL, V70, P162; PETZEL DH, 1993, INSECT BIOCHEM MOLEC, V23, P431, DOI 10.1016/0965-1748(93)90050-3; Phelps PK, 2003, COMP BIOCHEM PHYS A, V136, P409, DOI 10.1016/S1095-6433(03)00199-5; RADALLAH D, 1995, J INSECT PHYSIOL, V41, P7, DOI 10.1016/0022-1910(94)00081-Q; Rowley AF, 2005, J EXP BIOL, V208, P3, DOI 10.1242/jeb.01275; Ryu YS, 2003, BBA-GENE STRUCT EXPR, V1628, P206, DOI 10.1016/S0167-4781(03)00143-X; SAS Institute, 1989, SAS STAT US GUID; Schleusener DR, 1996, ARCH INSECT BIOCHEM, V33, P63, DOI 10.1002/(SICI)1520-6327(1996)33:1&lt;63::AID-ARCH5&gt;3.0.CO;2-Y; Shrestha S, 2008, INSECT BIOCHEM MOLEC, V38, P99, DOI 10.1016/j.ibmb.2007.09.013; Shrestha S, 2010, J INSECT PHYSIOL, V56, P324, DOI 10.1016/j.jinsphys.2009.11.008; Shrestha S, 2009, BIOSCI BIOTECH BIOCH, V73, P2077, DOI 10.1271/bbb.90272; Srikanth K, 2011, ARCH INSECT BIOCHEM, V78, P145, DOI 10.1002/arch.20450; Stanley D., 2000, EICOSANOIDS INVERTEB; Stanley D, 2006, BBA-MOL CELL BIOL L, V1761, P1383, DOI 10.1016/j.bbalip.2006.05.011; Stanley D, 2014, CRIT REV PLANT SCI, V33, P20, DOI 10.1080/07352689.2014.847631; Stanley DW, 2008, INSECT BIOCHEM MOLEC, V38, P275, DOI 10.1016/j.ibmb.2007.11.004; STANLEYSAMUELSON DW, 1994, INSECT BIOCHEM MOLEC, V24, P481, DOI 10.1016/0965-1748(94)90043-4; Strand MR, 2008, INSECT IMMUNOLOGY, P25, DOI 10.1016/S0965-1748(02)00092-9; THORNQVIST PO, 1994, DEV COMP IMMUNOL, V18, P3, DOI 10.1016/0145-305X(94)90247-X; TOBE SS, 1983, INSECT BIOCHEM, V13, P137, DOI 10.1016/0020-1790(83)90076-8; Tootle TL, 2008, DEVELOPMENT, V135, P839, DOI 10.1242/dev.017590; Tootle TL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019943; Valentin E, 2000, BIOCHIMIE, V82, P815, DOI 10.1016/S0300-9084(00)01168-8; VANKERKHOVE E, 1995, J INSECT PHYSIOL, V41, P435, DOI 10.1016/0022-1910(94)00109-T; Varvas K, 1999, J BIOL CHEM, V274, P9923, DOI 10.1074/jbc.274.15.9923; Varvas K, 2009, INSECT BIOCHEM MOLEC, V39, P851, DOI 10.1016/j.ibmb.2009.10.002; Vizzini A, 2013, DEV COMP IMMUNOL, V41, P59, DOI 10.1016/j.dci.2013.03.015; Wakayama EJ, 1986, INSECT BIOCHEM, V15, P367	48	34	37	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2014	9	9							e105717	10.1371/journal.pone.0105717	http://dx.doi.org/10.1371/journal.pone.0105717			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ1IR	25191834	Green Published, Green Submitted, gold			2022-12-27	WOS:000347993600007
J	Slovak, M; Kucera, J; Zaveska, E; Vd'acny, P				Slovak, Marek; Kucera, Jaromir; Zaveska, Eliska; Vd'acny, Peter			Dealing with Discordant Genetic Signal Caused by Hybridisation, Incomplete Lineage Sorting and Paucity of Primary Nucleotide Homologies: A Case Study of Closely Related Members of the Genus Picris Subsection Hieracioides (Compositae)	PLOS ONE			English	Article							NUCLEAR RIBOSOMAL DNA; RETICULATE EVOLUTION; PHYLOGENETIC INFERENCE; ALLOZYME VARIATION; GLACIAL REFUGIA; HYBRID ORIGINS; SPECIES TREE; RED CAMPION; CHLOROPLAST; ASTERACEAE	We investigated genetic variation and evolutionary history of closely related taxa of Picris subsect. Hieracioides with major focus on the widely distributed P. hieracioides and its closely related congeners, P. hispidissima, P. japonica, P. olympica, and P. nuristanica. Accessions from 140 sample sites of the investigated Picris taxa were analyzed on the infra-and the interspecific level using nuclear (ITS1-5.8S-ITS2 region) and chloroplast (rpl32-trnL (UAG) region) DNA sequences. Genetic patterns of P. hieracioides, P. hispidissima, and P. olympica were shown to be incongruent and, in several cases, both plastid and nuclear alleles transcended borders of the taxa and genetic lineages. The widespread P. hieracioides was genetically highly variable and non-monophyletic across both markers, with allele groups having particular geographic distributions. Generally, all gene trees and networks displayed only a limited and statistically rather unsupported resolution among ingroup taxa causing their phylogenetic relationships to remain rather unresolved. More light on these intricate evolutionary relationships was cast by the Bayesian coalescent-based analysis, although some relationships were still left unresolved. A combination of suite of phylogenetic analyses revealed the ingroup taxa to represent a complex of genetically closely related and morphologically similar entities that have undergone a highly dynamic and recent evolution. This has been especially affected by the extensive and recurrent gene flow among and within the studied taxa and/or by the maintenance of ancestral variation. Paucity of phylogenetically informative signal further hampers the reconstruction of relationships on the infra-as well as on the inter-specific level. In the present study, we have demonstrated that a combination of various phylogenetic analyses of datasets with extremely complex and incongruent phylogenetic signal may shed more light on the interrelationships and evolutionary history of analysed species groups.	[Slovak, Marek; Kucera, Jaromir] Slovak Acad Sci, Inst Bot, Bratislava, Slovakia; [Zaveska, Eliska] Charles Univ Prague, Dept Bot, Prague, Czech Republic; [Vd'acny, Peter] Comenius Univ, Dept Zool, Bratislava, Slovakia	Slovak Academy of Sciences; Charles University Prague; Comenius University Bratislava	Slovak, M (corresponding author), Slovak Acad Sci, Inst Bot, Bratislava, Slovakia.	marek.slovak@savba.sk	Zaveska, Eliska/E-4650-2012; Slovák, Marek/T-7304-2017; Kučera, Jaromír/G-4363-2011; Vdacny, Peter/U-3382-2017	Zaveska, Eliska/0000-0003-2992-2941; Slovák, Marek/0000-0001-9917-3099; Kučera, Jaromír/0000-0002-9983-7630; Vdacny, Peter/0000-0003-4877-0234	Research and Development Support Agency, Bratislava, Slovakia [APVV-0239-09, APVV-032-010]	Research and Development Support Agency, Bratislava, Slovakia(Slovak Research and Development Agency)	Funding for this study was provided by The Research and Development Support Agency, Bratislava, Slovakia ( grants no. APVV-0239-09 and APVV-032-010 to Karol Marhold). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilar JF, 1999, SYST BIOL, V48, P735, DOI 10.1080/106351599259997; Aguilar JF, 2003, MOL PHYLOGENET EVOL, V28, P430, DOI 10.1016/S1055-7903(02)00301-9; Aguilar JF, 1999, MOL ECOL, V8, P1341, DOI 10.1046/j.1365-294X.1999.00690.x; Alvarez I, 2003, MOL PHYLOGENET EVOL, V29, P417, DOI 10.1016/S1055-7903(03)00208-2; [Anonymous], 2014, TRACER V1 6; Baack EJ, 2007, CURR OPIN GENET DEV, V17, P513, DOI 10.1016/j.gde.2007.09.001; BALDWIN BG, 1995, ANN MO BOT GARD, V82, P247, DOI 10.2307/2399880; Bardy KE, 2010, MOL PHYLOGENET EVOL, V57, P771, DOI 10.1016/j.ympev.2010.06.025; Chapman MA, 2007, THEOR APPL GENET, V115, P747, DOI 10.1007/s00122-007-0605-2; Clement M, 2000, MOL ECOL, V9, P1657, DOI 10.1046/j.1365-294x.2000.01020.x; Comes HP, 2001, EVOLUTION, V55, P1943, DOI 10.1111/j.0014-3820.2001.tb01312.x; Duvall MR, 2004, MOL PHYLOGENET EVOL, V30, P97, DOI 10.1016/S1055-7903(03)00187-8; ENNOS RA, 1994, HEREDITY, V72, P250, DOI 10.1038/hdy.1994.35; FARRIS JS, 1994, CLADISTICS, V10, P315, DOI 10.1111/j.1096-0031.1996.tb00196.x; Feliner GN, 2004, ANN BOT-LONDON, V93, P189, DOI 10.1093/aob/mch027; Flagel LE, 2008, AM J BOT, V95, P756, DOI 10.3732/ajb.0800049; Frajman B, 2007, MOL PHYLOGENET EVOL, V43, P140, DOI 10.1016/j.ympev.2006.11.003; Frajman B, 2009, SYST BIOL, V58, P328, DOI 10.1093/sysbio/syp030; Francisco-Ortega J, 1999, MOL PHYLOGENET EVOL, V11, P361, DOI 10.1006/mpev.1998.0592; Funk DJ, 2003, ANNU REV ECOL EVOL S, V34, P397, DOI 10.1146/annurev.ecolsys.34.011802.132421; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Hall T.A., 1999, NUCL ACIDS S SER, V41, P95; Heled J, 2010, MOL BIOL EVOL, V27, P570, DOI 10.1093/molbev/msp274; Hewitt GM, 2004, PHILOS T R SOC B, V359, P183, DOI 10.1098/rstb.2003.1388; Holland BR, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-202; Huck S, 2009, J BIOGEOGR, V36, P1588, DOI 10.1111/j.1365-2699.2009.02096.x; Hudson R.R., 1990, Oxford Surveys in Evolutionary Biology, V7, P1; Huson DH, 2006, MOL BIOL EVOL, V23, P254, DOI 10.1093/molbev/msj030; Jang CG, 2005, BOT J LINN SOC, V148, P175, DOI 10.1111/j.1095-8339.2005.00406.x; Joly S, 2012, MOL ECOL RESOUR, V12, P179, DOI 10.1111/j.1755-0998.2011.03065.x; Joly S, 2009, AM NAT, V174, pE54, DOI 10.1086/600082; Koopman WJM, 2005, SYST BIOL, V54, P197, DOI 10.1080/10635150590924181; Kramp K, 2009, PLANT BIOLOGY, V11, P392, DOI 10.1111/j.1438-8677.2008.00130.x; Kubatko LS, 2009, BIOINFORMATICS, V25, P971, DOI 10.1093/bioinformatics/btp079; Kucera J, 2010, TAXON, V59, P148, DOI 10.1002/tax.591015; LACK HW, 1979, PLANT SYST EVOL, V131, P35, DOI 10.1007/BF00984121; Lack HW, 1974, THESIS U VIENNA AUST; Lack HW, 1975, FLORA TURKEY E AEGEA, P678; Linder CR, 2004, AM J BOT, V91, P1700, DOI 10.3732/ajb.91.10.1700; Maddison D.R., 2000, MACCLADE4 ANAL PHYLO; Malm JU, 2002, BIOL J LINN SOC, V77, P23, DOI 10.1046/j.1095-8312.1999.00079.x; Medail F, 2009, J BIOGEOGR, V36, P1333, DOI 10.1111/j.1365-2699.2008.02051.x; Miller M.A., 2010, P GAT COMP ENV WORKS; Moody ML, 2012, MOL PHYLOGENET EVOL, V64, P145, DOI 10.1016/j.ympev.2012.03.012; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Prentice HC, 2008, PLANT SYST EVOL, V272, P23, DOI 10.1007/s00606-007-0629-8; Ramsey J, 2008, EVOLUTION, V62, P639, DOI 10.1111/j.1558-5646.2007.00264.x; Rauscher JT, 2002, MOL ECOL, V11, P2691, DOI 10.1046/j.1365-294X.2002.01640.x; Rebernig CA, 2010, MOL ECOL, V19, P3421, DOI 10.1111/j.1365-294X.2010.04754.x; Resetnik I, 2014, MOL PHYLOGEN EVOL, V74; Rieseberg LH, 1997, ANNU REV ECOL SYST, V28, P359, DOI 10.1146/annurev.ecolsys.28.1.359; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Samuel R, 2006, AM J BOT, V93, P1193, DOI 10.3732/ajb.93.8.1193; Schmidt-Lebuhn AN, 2012, MOL PHYLOGENET EVOL, V65, P23, DOI 10.1016/j.ympev.2012.05.015; Schonswetter P, 2009, TAXON, V58, P1326, DOI 10.1002/tax.584020; Shaw J, 2005, AM J BOT, V92, P142, DOI 10.3732/ajb.92.1.142; Shaw J, 2007, AM J BOT, V94, P275, DOI 10.3732/ajb.94.3.275; Shimodaira H, 2001, BIOINFORMATICS, V17, P1246, DOI 10.1093/bioinformatics/17.12.1246; Shimodaira H, 2002, SYST BIOL, V51, P492, DOI 10.1080/10635150290069913; Silvestro D, 2012, ORG DIVERS EVOL, V12, P335, DOI 10.1007/s13127-011-0056-0; Slovak M, 2008, NORD J BOT, V28, P238; Slovak M, 2009, J BIOGEOGR, V36, P372, DOI 10.1111/j.1365-2699.2008.02005.x; Slovak M, 2007, PHYTON-ANN REI BOT A, V47, P73; Slovak M, 2012, SYST BOT, V37, P258, DOI 10.1600/036364412X616828; Slovak M, 2009, PLANT SYST EVOL, V278, P187, DOI 10.1007/s00606-008-0137-5; Small RL, 2004, AUST SYST BOT, V17, P145, DOI 10.1071/SB03015; Swofford DL., 2001, PAUP PHYLOGENETIC AN; TEMPLETON AR, 1992, GENETICS, V132, P619; Timme RE, 2007, AM J BOT, V94, P302, DOI 10.3732/ajb.94.3.302; Tyler T, 2002, J BIOGEOGR, V29, P919, DOI 10.1046/j.1365-2699.2002.00698.x; Tyler T, 2002, PLANT SYST EVOL, V233, P47, DOI 10.1007/s006060200054; van der Niet T, 2008, MOL PHYLOGENET EVOL, V47, P154, DOI 10.1016/j.ympev.2007.12.008; Wagele JW, 1998, MOL PHYLOGENET EVOL, V9, P358, DOI 10.1006/mpev.1998.0501; Wendel J.F., 1998, MOL SYSTEMATICS PLAN, P265, DOI 10.1007/978-1-4615-5419-6_10; White TJ., 1990, PCR PROTOCOLS GUIDE, P315; Wiens JJ, 2000, SYST BIOL, V49, P143, DOI 10.1080/10635150050207447; Willyard A, 2009, MOL PHYLOGENET EVOL, V52, P498, DOI 10.1016/j.ympev.2009.02.011; Yu WB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074828; Yu Y, 2011, SYST BIOL, V60, P138, DOI 10.1093/sysbio/syq084; Zaveska E, 2012, TAXON, V61, P747, DOI 10.1002/tax.614004	81	12	12	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2014	9	9							e104929	10.1371/journal.pone.0104929	http://dx.doi.org/10.1371/journal.pone.0104929			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ1IR	25192431	Green Submitted, Green Published, gold			2022-12-27	WOS:000347993600005
J	Atta, EH; de Oliveira, DCM; Bouzas, LF; Nucci, M; Abdelhay, E				Atta, Elias Hallack; Muniz de Oliveira, Danielli Cristina; Bouzas, Luis Fernando; Nucci, Marcio; Abdelhay, Eliana			Less Graft-Versus-Host Disease after Rabbit Antithymocyte Globulin Conditioning in Unrelated Bone Marrow Transplantation for Leukemia and Myelodysplasia: Comparison with Matched Related Bone Marrow Transplantation	PLOS ONE			English	Article							STEM-CELL TRANSPLANTATION; HLA-IDENTICAL SIBLINGS; SEVERE APLASTIC-ANEMIA; QUALITY-OF-LIFE; T-CELL; THYMOCYTE GLOBULIN; MYELOID-LEUKEMIA; RANDOMIZED-TRIAL; DONOR MARROW; PROPHYLAXIS	One of the major drawbacks for unrelated donor (UD) bone marrow transplantation (BMT) is graft-versus-host disease (GVHD). Despite results from randomized trials, antithymocyte globulin (ATG) is not routinely included for GVHD prophylaxis in UD BMT by many centers. One of ways to demonstrate the usefulness of rabbit ATG in UD BMT is to evaluate how its results approximate to those observed in matched related (MRD) BMT. Therefore, we compared the outcomes between UD BMT with rabbit ATG (Thymoglobulin) for GVHD prophylaxis (n = 25) and MRD BMT (n = 91) for leukemia and myelodysplasia. All but one patient received a myeloablative conditioning regimen. Grades II-IV acute GVHD were similar (39.5% vs. 36%, p = 0.83); however, MRD BMT recipients developed more moderate-severe chronic GVHD (36.5% vs. 8.6%, p = 0.01) and GVHD-related deaths (32.5% vs. 5.6%, p = 0.04). UD BMT independently protected against chronic GVHD (hazard ratio 0.23, p = 0.04). The 6-month transplant-related mortality, 1-year relapse incidence, and 5-year survival rates were similar between patients with non-advanced disease in the MRD and UD BMT groups, 13.8% vs. 16.6% (p = 0.50), 20.8% vs. 16.6% (p = 0.37), and 57% vs. 50% (p = 0.67), respectively. Stable full donor chimerism was equally achieved (71.3% vs. 71.4%, p = 1). Incorporation of rabbit ATG in UD BMT promotes less GVHD, without jeopardizing chimerism evolution, and may attain similar survival outcomes as MRD BMT for leukemia and myelodysplasia especially in patients without advanced disease.	[Atta, Elias Hallack; Muniz de Oliveira, Danielli Cristina; Bouzas, Luis Fernando; Abdelhay, Eliana] CEMO, Inst Nacl Canc, Rio De Janeiro, Brazil; [Nucci, Marcio] Univ Fed Rio de Janeiro, Univ Hosp, Rio De Janeiro, Brazil	National Cancer Institute (Inca); Universidade Federal do Rio de Janeiro	Atta, EH (corresponding author), CEMO, Inst Nacl Canc, Rio De Janeiro, Brazil.	elias.atta@inca.gov.br	Atta, Elias/AAQ-7134-2021; Nucci, Marcio/G-4515-2012	Nucci, Marcio/0000-0003-4867-0014				Appelbaum FR, 2012, BIOL BLOOD MARROW TR, V18, pS111, DOI 10.1016/j.bbmt.2011.11.002; Bacigalupo A, 2006, BIOL BLOOD MARROW TR, V12, P560, DOI 10.1016/j.bbmt.2005.12.034; Bacigalupo A, 2001, BLOOD, V98, P2942, DOI 10.1182/blood.V98.10.2942; Basara N, 2005, BONE MARROW TRANSPL, V35, P1011, DOI 10.1038/sj.bmt.1704957; BEATTY PG, 1991, TRANSPLANTATION, V51, P443, DOI 10.1097/00007890-199102000-00034; Byrne JL, 2000, BONE MARROW TRANSPL, V25, P411, DOI 10.1038/sj.bmt.1702165; Champlin RE, 2000, BLOOD, V95, P3996; De Pauw B, 2008, CLIN INFECT DIS, V46, P1813, DOI 10.1086/588660; Duggan P, 2002, BONE MARROW TRANSPL, V30, P681, DOI 10.1038/sj.bmt.1703674; Filipovich AH, 2005, BIOL BLOOD MARROW TR, V11, P945, DOI 10.1016/j.bbmt.2005.09.004; Finke J, 2000, BRIT J HAEMATOL, V111, P303, DOI 10.1046/j.1365-2141.2000.02305.x; Finke J, 2009, LANCET ONCOL, V10, P855, DOI 10.1016/S1470-2045(09)70225-6; Hoegh-Petersen M, 2013, BONE MARROW TRANSPL, V48, P105, DOI 10.1038/bmt.2012.99; Lee SJ, 2007, BLOOD, V110, P4576, DOI 10.1182/blood-2007-06-097386; Ljungman P, 2002, CLIN INFECT DIS, V34, P1094, DOI 10.1086/339329; Meijer E, 2003, EXP HEMATOL, V31, P1026, DOI 10.1016/S0301-472X(03)00204-2; Mullighan C, 2004, TRANSPLANTATION, V77, P587, DOI 10.1097/01.TP.0000111769.45088.A2; Na IK, 2013, HAEMATOL-HEMATOL J, V98, P23, DOI 10.3324/haematol.2012.067611; Pidala J, 2011, BIOL BLOOD MARROW TR, V17, P1237, DOI 10.1016/j.bbmt.2010.12.705; Pidala J, 2009, BLOOD, V114, P7, DOI 10.1182/blood-2008-10-182592; Portier DA, 2012, BONE MARROW TRANSPL, V47, P1513, DOI 10.1038/bmt.2012.81; PRZEPIORKA D, 1995, BONE MARROW TRANSPL, V15, P825; Remberger M, 2004, TRANSPLANTATION, V78, P122, DOI 10.1097/01.TP.0000133513.29923.44; Remberger M, 2008, EUR J HAEMATOL, V80, P419, DOI 10.1111/j.1600-0609.2008.01047.x; Remberger M, 2013, CLIN TRANSPLANT, V27, pE368, DOI 10.1111/ctr.12131; Ruutu T, 2012, BONE MARROW TRANSPL, V47, P1459, DOI 10.1038/bmt.2012.45; Saber W, 2013, BLOOD, V122, P1974, DOI 10.1182/blood-2013-04-496778; Saber W, 2012, BLOOD, V119, P3908, DOI 10.1182/blood-2011-09-381699; Scheinberg P, 2007, BLOOD, V109, P3219, DOI 10.1182/blood-2006-09-045625; Scrucca L, 2007, BONE MARROW TRANSPL, V40, P381, DOI 10.1038/sj.bmt.1705727; Socie G, 2011, BLOOD, V117, P6375, DOI 10.1182/blood-2011-01-329821; Soiffer RJ, 2011, BLOOD, V117, P6963, DOI 10.1182/blood-2011-01-332007; SPENCER A, 1995, BLOOD, V86, P3590, DOI 10.1182/blood.V86.9.3590.bloodjournal8693590; Svahn BM, 2006, TRANSPLANTATION, V81, P1600, DOI 10.1097/01.tp.0000210324.44633.b1; Terasako K, 2010, HEMATOLOGY, V15, P165, DOI 10.1179/102453309X12583347113852; THOMAS FT, 1984, TRANSPLANT P, V16, P1561; Walker Tim, 2011, Clin Transpl, P55; Yu ZP, 2012, BIOL BLOOD MARROW TR, V18, P593, DOI 10.1016/j.bbmt.2011.08.009; Zander AR, 1999, BONE MARROW TRANSPL, V23, P889, DOI 10.1038/sj.bmt.1701745	39	5	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 4	2014	9	9							e107155	10.1371/journal.pone.0107155	http://dx.doi.org/10.1371/journal.pone.0107155			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3XV	25188326	Green Published, gold, Green Submitted			2022-12-27	WOS:000341271500116
J	Bluhm, K; Otte, JC; Yang, LX; Zinsmeister, C; Legradi, J; Keiter, S; Kosmehl, T; Braunbeck, T; Strahle, U; Hollert, H				Bluhm, Kerstin; Otte, Jens C.; Yang, Lixin; Zinsmeister, Christian; Legradi, Jessica; Keiter, Steffen; Kosmehl, Thomas; Braunbeck, Thomas; Straehle, Uwe; Hollert, Henner			Impacts of Different Exposure Scenarios on Transcript Abundances in Danio rerio Embryos when Investigating the Toxicological Burden of Riverine Sediments	PLOS ONE			English	Article							ARYL-HYDROCARBON RECEPTOR; SETTLING PARTICULATE MATTER; KILLER-ENHANCING FACTOR; UPPER DANUBE RIVER; ZEBRAFISH EMBRYOS; COMET ASSAY; DEVELOPMENTAL TOXICITY; CAENORHABDITIS-ELEGANS; GENE-EXPRESSION; RISK-ASSESSMENT	Purpose: Recently, a proof-of-concept study revealed the suitability of transcriptome analyses to obtain and assess changes in the abundance of transcripts in zebrafish (Danio rerio) embryos after exposure to organic sediment extracts. The present study investigated changes in the transcript abundance in zebrafish embryos exposed to whole sediment samples and corresponding organic extracts in order to identify the impact of different exposure pathways on sediment toxicity. Materials and Methods: Danio rerio embryos were exposed to sublethal concentrations of three sediment samples from the Danube River, Germany. The sediment samples were investigated both as freeze-dried samples and as organic extracts. Silica dust and a process control of the extraction procedure were used as references. After exposure, mRNA was isolated and changes in profiles of gene expression levels were examined by an oligonucleotide microarray. The microarray results were compared with bioassays, chemical analysis of the sediments and profiles of gene expression levels induced by several single substances. Results and Discussion: The microarray approach elucidated significant changes in the abundance of transcripts in exposed zebrafish embryos compared to the references. Generally, results could be related to Ah-receptor-mediated effects as confirmed by bioassays and chemical analysis of dioxin-like contaminants, as well as to exposure to stress-inducing compounds. Furthermore, the results indicated that mixtures of chemicals, as present in sediment and extract samples, result in complex changes of gene expression level profiles difficult to compare with profiles induced by single chemical substances. Specifically, patterns of transcript abundances were less influenced by the chemical composition at the sampling site compared t the method of exposure (sediment/extract). This effect might be related to different bioavailability of chemicals. Conclusions: The apparent difference between the exposure scenarios is an important aspect that needs to be addressed when conducting analyses of alterations in the expression level of mRNA.	[Bluhm, Kerstin; Keiter, Steffen; Hollert, Henner] Rhein Westfal TH Aachen, Inst Environm Res Aachen Biol & Biotechnol, Dept Ecosyst Anal, Aachen, Germany; [Otte, Jens C.; Yang, Lixin; Zinsmeister, Christian; Legradi, Jessica; Straehle, Uwe] Karlsruhe Inst Technol, Inst Toxicol & Genet, D-76021 Karlsruhe, Germany; [Legradi, Jessica] Vrije Univ Amsterdam, Inst Environm Studies, Amsterdam, Netherlands; [Kosmehl, Thomas; Braunbeck, Thomas] Heidelberg Univ, Ctr Organismal Studies, Aquat Ecol & Toxicol Grp, Heidelberg, Germany; [Hollert, Henner] Nanjing Univ, Sch Environm, Nanjing 210008, Jiangsu, Peoples R China; [Hollert, Henner] Tongji Univ, Coll Environm Sci & Engn, Key Lab Yangtze River Environm, Educ Minist China, Shanghai 200092, Peoples R China; [Hollert, Henner] Chongqing Univ, Coll Resources & Environm Sci, Chongqing 630044, Peoples R China	RWTH Aachen University; Helmholtz Association; Karlsruhe Institute of Technology; Vrije Universiteit Amsterdam; Ruprecht Karls University Heidelberg; Nanjing University; Tongji University; Chongqing University	Hollert, H (corresponding author), Rhein Westfal TH Aachen, Inst Environm Res Aachen Biol & Biotechnol, Dept Ecosyst Anal, Aachen, Germany.	henner.hollert@bio5.rwth-aachen.de	Legradi, Jessica/V-9449-2019; yang, lixin/AAW-5386-2021; Hollert, Henner/A-1027-2009; yang, lixin/GSO-1670-2022; Straehle, Uwe/K-7054-2013	Legradi, Jessica/0000-0003-0388-860X; yang, lixin/0000-0003-3377-1998; Hollert, Henner/0000-0001-5776-5619; yang, lixin/0000-0003-3377-1998; Keiter, Steffen/0000-0002-2356-6686	German Federal Ministry of Education and Research [02WU1053-01]; European commission [242048, LSHG-CT/2003/503496]	German Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); European commission(European CommissionEuropean Commission Joint Research Centre)	The authors acknowledge financial support by the German Federal Ministry of Education and Research (grant 02WU1053-01). The present study was part of the research funding priority DanTox (DanTox-a novel joint research project using zebrafish (Danio rerio) to identify specific toxicity and molecular modes of action of sediment-bound pollutants). Additional funding was given by the European commission IP ZF-Health grant (No 242048) and IP ZF Models (LSHG-CT/2003/503496). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AARTS JMMJG, 1995, EUR J PHARM-ENVIRON, V293, P463; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; BIRNBAUM LS, 1994, ENVIRON HEALTH PERSP, V102, P157, DOI 10.1289/ehp.94102s9157; Boettcher M, 2010, MUTAT RES-GEN TOX EN, V700, P11, DOI 10.1016/j.mrgentox.2010.04.016; Bruschweiler BJ, 1996, ARCH ENVIRON CON TOX, V31, P475, DOI 10.1007/s002449900134; Dalton TP, 2002, CHEM-BIOL INTERACT, V141, P77, DOI 10.1016/S0009-2797(02)00067-4; Engwall M, 1996, ENVIRON TOXICOL CHEM, V15, P213, DOI 10.1002/etc.5620150220; Flach CF, 2006, INFLAMM BOWEL DIS, V12, P837, DOI 10.1097/01.mib.0000232469.23574.11; Garrison PM, 1996, FUND APPL TOXICOL, V30, P194, DOI 10.1006/faat.1996.0056; Goksoyr A, 1995, Arch Toxicol Suppl, V17, P80; Grund S, 2010, DIS AQUAT ORGAN, V88, P235, DOI 10.3354/dao02159; Guo Y, 2002, ONCOGENE, V21, P7545, DOI 10.1038/sj.onc.1205907; Guo YF, 2008, ACTA BIOCH BIOPH SIN, V40, P426, DOI 10.1111/j.1745-7270.2008.00418.x; Hallare AV, 2011, J SOIL SEDIMENT, V11, P141, DOI 10.1007/s11368-010-0302-7; Hawliczek A, 2012, REPROD TOXICOL, V33, P213, DOI 10.1016/j.reprotox.2011.11.001; Heimann W, 2011, J SOIL SEDIMENT, V11, P1279, DOI 10.1007/s11368-011-0416-6; Higley E, 2012, ENVIRON TOXICOL CHEM, V31, P1053, DOI 10.1002/etc.1777; Hollert H, 2000, ENVIRON TOXICOL CHEM, V19, P528, DOI 10.1002/etc.5620190302; Hollert Henner, 2003, Journal of Soils and Sediments, V3, P197, DOI 10.1065/jss2003.09.085; Incardona JP, 2006, TOXICOL APPL PHARM, V217, P308, DOI 10.1016/j.taap.2006.09.018; Jimenez GS, 1999, ONCOGENE, V18, P7656, DOI 10.1038/sj.onc.1203013; Keiter S, 2007, THESIS U HEIDELBERG; Keiter S, 2008, ANAL BIOANAL CHEM, V390, P2009, DOI 10.1007/s00216-007-1652-x; Keiter S, 2010, J SOIL SEDIMENT, V10, P714, DOI 10.1007/s11368-010-0221-7; Keiter S, 2009, J SOIL SEDIMENT, V9, P168, DOI 10.1007/s11368-009-0087-8; Kikuchi H, 1996, ARCH BIOCHEM BIOPHYS, V334, P235, DOI 10.1006/abbi.1996.0451; Kim AT, 1997, TOXICOL APPL PHARM, V147, P135, DOI 10.1006/taap.1997.8270; Kosmehl T, 2007, J SOIL SEDIMENT, V7, P377, DOI 10.1065/jss2007.11.261; Kosmehl T, 2006, ENVIRON TOXICOL CHEM, V25, P2097, DOI 10.1897/05-460R.1; Kosmehl T, 2012, REPROD TOXICOL, V33, P245, DOI 10.1016/j.reprotox.2012.01.005; Lam SH, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000121; Lammer E, 2009, COMP BIOCHEM PHYS C, V149, P196, DOI 10.1016/j.cbpc.2008.11.006; Leaver MJ, 2010, AQUAT TOXICOL, V96, P234, DOI 10.1016/j.aquatox.2009.10.025; LEE LEJ, 1993, CELL BIOL TOXICOL, V9, P279, DOI 10.1007/BF00755606; Menzel R, 2005, ENVIRON SCI TECHNOL, V39, P8324, DOI 10.1021/es050884s; Menzel R, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-160; Merilainen PS, 2007, ENVIRON TOXICOL CHEM, V26, P1827, DOI 10.1897/06-521R.1; Moens LN, 2007, CHEMOSPHERE, V67, P2293, DOI 10.1016/j.chemosphere.2006.09.092; Nuwaysir EF, 1999, MOL CARCINOGEN, V24, P153, DOI 10.1002/(SICI)1098-2744(199903)24:3<153::AID-MC1>3.0.CO;2-P; Otte JC, 2008, ENVIRON INT, V34, P1176, DOI 10.1016/j.envint.2008.05.004; Pina B, 2011, AQUAT TOXICOL, V105, P40, DOI 10.1016/j.aquatox.2011.06.006; Rise ML, 2004, PHYSIOL GENOMICS, V20, P21, DOI 10.1152/physiolgenomics.00036.2004; SAURI H, 1995, BIOCHEM BIOPH RES CO, V208, P964, DOI 10.1006/bbrc.1995.1428; Seitz N, 2008, MUTAT RES-GEN TOX EN, V652, P38, DOI 10.1016/j.mrgentox.2007.12.004; Shou J, 2005, BIOMARKERS, V10, P310, DOI 10.1080/13547500500218583; Snape JR, 2004, AQUAT TOXICOL, V67, P143, DOI 10.1016/j.aquatox.2003.11.011; Strmac M, 2002, J FISH BIOL, V61, P24, DOI [10.1111/j.1095-8649.2002.tb01734.x, 10.1006/jfbi.2002.1919]; Wahl M, 2008, CHEMOSPHERE, V73, P209, DOI 10.1016/j.chemosphere.2008.05.025; Westerfield M., 1993, ZEBRAFISH BOOK GUIDE; Williams TD, 2003, AQUAT TOXICOL, V65, P141, DOI 10.1016/S0166-445X(03)00119-X; Yang LX, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-10-r227; Zhou JG, 2003, MOL PHARMACOL, V63, P915, DOI 10.1124/mol.63.4.915; Zielke H, 2011, J SOIL SEDIMENT, V11, P352, DOI 10.1007/s11368-010-0317-0	53	11	11	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 4	2014	9	9							e106523	10.1371/journal.pone.0106523	http://dx.doi.org/10.1371/journal.pone.0106523			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3XV	25187966	Green Submitted, Green Published, gold			2022-12-27	WOS:000341271500050
J	Buxton, CD; Hartmann, K; Kearney, R; Gardner, C				Buxton, Colin D.; Hartmann, Klaas; Kearney, Robert; Gardner, Caleb			When Is Spillover from Marine Reserves Likely to Benefit Fisheries?	PLOS ONE			English	Article							PROTECTED AREAS; SPINY LOBSTER; REEF FISHES; LONG-TERM; PALINURUS-ELEPHAS; LARVAL DISPERSAL; ADJACENT FISHERY; NEW-ZEALAND; APO ISLAND; ADULT FISH	The net movement of individuals from marine reserves (also known as no-take marine protected areas) to the remaining fishing grounds is known as spillover and is frequently used to promote reserves to fishers on the grounds that it will benefit fisheries. Here we consider how mismanaged a fishery must be before spillover from a reserve is able to provide a net benefit for a fishery. For our model fishery, density of the species being harvested becomes higher in the reserve than in the fished area but the reduction in the density and yield of the fished area was such that the net effect of the closure was negative, except when the fishery was mismanaged. The extent to which effort had to exceed traditional management targets before reserves led to a spillover benefit varied with rates of growth and movement of the model species. In general, for well-managed fisheries, the loss of yield from the use of reserves was less for species with greater movement and slower growth. The spillover benefit became more pronounced with increasing mis-management of the stocks remaining available to the fishery. This model-based result is consistent with the literature of field-based research where a spillover benefit from reserves has only been detected when the fishery is highly depleted, often where traditional fisheries management controls are absent. We conclude that reserves in jurisdictions with well-managed fisheries are unlikely to provide a net spillover benefit.	[Buxton, Colin D.; Hartmann, Klaas; Gardner, Caleb] Univ Tasmania, Inst Marine & Antarctic Studies, Fisheries Aquaculture & Coasts Ctr, Hobart, Tas, Australia; [Kearney, Robert] Univ Canberra, Inst Appl Ecol, Canberra, ACT 2601, Australia	University of Tasmania; University of Canberra	Buxton, CD (corresponding author), Univ Tasmania, Inst Marine & Antarctic Studies, Fisheries Aquaculture & Coasts Ctr, Hobart, Tas, Australia.	colin.buxton@utas.edu.au	Buxton, Colin/AAV-3489-2021; Gardner, Caleb/I-7086-2013	Gardner, Caleb/0000-0003-0324-4337; Buxton, Colin/0000-0002-3256-5220	Fisheries Research and Development Corporation [FRDC 2010/226]	Fisheries Research and Development Corporation	This work was supported by the Fisheries Research and Development Corporation (FRDC 2010/226). http://frdc.com.au/Pages/home.aspx. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abesamis RA, 2005, ECOL APPL, V15, P1798, DOI 10.1890/05-0174; Abesamis RA, 2006, FISH B-NOAA, V104, P360; Abesamis RA, 2006, AQUAT CONSERV, V16, P349, DOI 10.1002/aqc.730; Apostolaki P, 2002, CAN J FISH AQUAT SCI, V59, P405, DOI 10.1139/F02-018; Ashworth JS, 2005, BIOL CONSERV, V121, P333, DOI 10.1016/j.biocon.2004.05.006; Barnes B, 2013, ECOL MODEL, V269, P113, DOI 10.1016/j.ecolmodel.2013.08.012; Bohnsack JA, 1998, AUST J ECOL, V23, P298, DOI 10.1111/j.1442-9993.1998.tb00734.x; Cole RG, 2000, AQUAT CONSERV, V10, P421, DOI 10.1002/1099-0755(200011/12)10:6<421::AID-AQC423>3.0.CO;2-E; Costello C, 2008, SCIENCE, V321, P1678, DOI 10.1126/science.1159478; Davidson RJ, 2002, AQUAT CONSERV, V12, P213, DOI 10.1002/aqc.505; DEH, 2003, INF PAP COMM DEP ENV; DEMARTINI EE, 1993, FISH B-NOAA, V91, P414; Edgar GJ, 2009, ECOL APPL, V19, P1967, DOI 10.1890/09-0610.1; Follesa MC, 2009, SCI MAR, V73, P499, DOI 10.3989/scimar.2009.73n3499; Forcada A, 2009, MAR ECOL PROG SER, V379, P197, DOI 10.3354/meps07892; Gell FR, 2003, TRENDS ECOL EVOL, V18, P448, DOI 10.1016/S0169-5347(03)00189-7; Goni R, 2006, MAR ECOL PROG SER, V308, P207, DOI 10.3354/meps308207; Goni R, 2010, MAR ECOL PROG SER, V400, P233, DOI 10.3354/meps08419; Grafton RQ, 2007, SCIENCE, V318, P1601, DOI 10.1126/science.1146017; Grafton RQ, 2006, ECON REC, V82, P469, DOI 10.1111/j.1475-4932.2006.00360.x; Halpern BS, 2009, ENVIRON CONSERV, V36, P268, DOI 10.1017/S0376892910000032; Halpern BS, 2002, ECOL LETT, V5, P361, DOI 10.1046/j.1461-0248.2002.00326.x; Harrison HB, 2012, CURR BIOL, V22, P1023, DOI 10.1016/j.cub.2012.04.008; Hart DR, 2006, CAN J FISH AQUAT SCI, V63, P1445, DOI 10.1139/F06-071; Hilborn R, 2006, CAN J FISH AQUAT SCI, V63, P642, DOI 10.1139/f05-243; Kelly S, 2002, COAST MANAGE, V30, P153, DOI 10.1080/089207502753504689; Kerwath SE, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3347; Le Quesne WJF, 2009, ICES J MAR SCI, V66, P122, DOI 10.1093/icesjms/fsn202; Lester SE, 2009, MAR ECOL PROG SER, V384, P33, DOI 10.3354/meps08029; McClanahan TR, 1996, CONSERV BIOL, V10, P1187, DOI 10.1046/j.1523-1739.1996.10041187.x; McClanahan TR, 2000, ECOL APPL, V10, P1792, DOI 10.2307/2641239; NOAA, 2011, BEN NAT SYST MAR PRO; Nowlis JS, 1999, FISH B-NOAA, V97, P604; Nowlis JS, 2000, B MAR SCI, V66, P651; Pillans S, 2005, MAR ECOL PROG SER, V295, P201, DOI 10.3354/meps295201; Polacheck T., 1990, NAT RESOUR MODEL, V4, P327; Ralston S, 2008, CAN J FISH AQUAT SCI, V65, P588, DOI 10.1139/F07-174; Revenga S., 2008, OPTIONS MEDITERRAN B, P107; Roberts CM, 2001, SCIENCE, V294, P1920, DOI 10.1126/science.294.5548.1920; Roberts CM, 1997, TRENDS ECOL EVOL, V12, P35, DOI 10.1016/S0169-5347(96)20109-0; Rowe S, 2001, CAN J FISH AQUAT SCI, V58, P1336, DOI 10.1139/cjfas-58-7-1336; Russ GR, 2011, ECOL APPL, V21, P241, DOI 10.1890/09-1197.1; Russ Garry R., 2002, P421, DOI 10.1016/B978-012615185-5/50024-4; Russ GR, 1996, MAR ECOL PROG SER, V132, P1, DOI 10.3354/meps132001; Steele JH, 2003, P ROY SOC B-BIOL SCI, V270, pS230, DOI 10.1098/rsbl.2003.0074; Stobart B, 2009, MAR ECOL PROG SER, V384, P47, DOI 10.3354/meps08007; Stockhausen WT, 2000, B MAR SCI, V66, P957; Tewfik A, 2003, AQUAT CONSERV, V13, P473, DOI 10.1002/aqc.562; Tupper MH, 2007, FISH B-NOAA, V105, P527; Vandeperre F, 2011, FISH FISH, V12, P412, DOI 10.1111/j.1467-2979.2010.00401.x; Wakefield CB, 2010, J FISH BIOL, V77, P1359, DOI 10.1111/j.1095-8649.2010.02756.x; White JW, 2011, OIKOS, V120, P1151, DOI 10.1111/j.1600-0706.2010.19226.x; Yamazaki S, 2014, FISH FISH, V15, P196, DOI 10.1111/faf.12008; Zeller D, 2003, MAR ECOL PROG SER, V254, P269, DOI 10.3354/meps254269	54	49	51	1	81	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 4	2014	9	9							e107032	10.1371/journal.pone.0107032	http://dx.doi.org/10.1371/journal.pone.0107032			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3XV	25188380	gold, Green Published, Green Submitted			2022-12-27	WOS:000341271500110
J	Wen, XY; Ding, LM; Hunter, E; Spearman, P				Wen, Xiaoyun; Ding, Lingmei; Hunter, Eric; Spearman, Paul			An siRNA Screen of Membrane Trafficking Genes Highlights Pathways Common to HIV-1 and M-PMV Virus Assembly and Release	PLOS ONE			English	Article							PFIZER MONKEY VIRUS; CELLULAR-PROTEINS; HOST PROTEINS; GAG; PHOSPHATIDYLINOSITOL-(4,5)-BISPHOSPHATE; IDENTIFICATION; POLYPEPTIDES; DIRECTS; TSG101; DOMAIN	The assembly and release of retroviruses from the host cells requires a coordinated series of interactions between viral structural proteins and cellular trafficking pathways. Although a number of cellular factors involved in retrovirus assembly have been identified, it is likely that retroviruses utilize additional trafficking factors to expedite their assembly and budding that have not yet been defined. We performed a screen using an siRNA library targeting host membrane trafficking genes in order to identify new host factors that contribute to retrovirus assembly or release. We utilized two retroviruses that follow very distinct assembly pathways, HIV-1 and Mason-Pfizer monkey virus (M-PMV) in order to identify host pathways that are generally applicable in retrovirus assembly versus those that are unique to HIV or M-PMV. Here we report the identification of 24 host proteins identified in the screen and subsequently validated in follow-up experiments as contributors to the assembly or release of both viruses. In addition to identifying a number of previously unsuspected individual trafficking factors, we noted multiple hits among proteins involved in modulation of the actin cytoskeleton, clathrin-mediated transport pathways, and phosphoinositide metabolism. Our study shows that distant genera of retroviruses share a number of common interaction strategies with host cell trafficking machinery, and identifies new cellular factors involved in the late stages of retroviral replication.	[Wen, Xiaoyun; Ding, Lingmei; Spearman, Paul] Emory Univ, Sch Med & Childrens Healthcare Atlanta, Dept Pediat, Atlanta, GA 30322 USA; [Hunter, Eric] Emory Univ, Emory Vaccine Ctr, Yerkes Natl Primate Res Ctr, Atlanta, GA 30322 USA	Children's Healthcare of Atlanta (CHOA); Emory University; Emory University	Spearman, P (corresponding author), Emory Univ, Sch Med & Childrens Healthcare Atlanta, Dept Pediat, Atlanta, GA 30322 USA.	paul.spearman@emory.edu			National Institutes of Health [GM-111027, CA-27834]; Children's Healthcare of Atlanta; Children's Center for Immunology and Vaccines; Emory Center for AIDS Research [P30 AI050409]; NATIONAL CANCER INSTITUTE [R01CA027834, R37CA027834] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI058828, P30AI050409] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM111027] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P51OD011132] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Children's Healthcare of Atlanta; Children's Center for Immunology and Vaccines; Emory Center for AIDS Research; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by National Institutes of Health grant GM-111027 (PS) and CA-27834 (EH). Supporting infrastructure was provided by funds from Children's Healthcare of Atlanta, the Children's Center for Immunology and Vaccines, and the Emory Center for AIDS Research (P30 AI050409). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Batonick M, 2005, VIROLOGY, V342, P190, DOI 10.1016/j.virol.2005.08.001; Bieniasz PD, 2006, VIROLOGY, V344, P55, DOI 10.1016/j.virol.2005.09.044; BRADAC J, 1984, VIROLOGY, V138, P260, DOI 10.1016/0042-6822(84)90350-7; Brass AL, 2008, SCIENCE, V319, P921, DOI 10.1126/science.1152725; BURNS JC, 1993, P NATL ACAD SCI USA, V90, P8033, DOI 10.1073/pnas.90.17.8033; Caillet M, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002347; Campbell S, 2001, P NATL ACAD SCI USA, V98, P10875, DOI 10.1073/pnas.191224698; Camus G, 2007, MOL BIOL CELL, V18, P3193, DOI 10.1091/mbc.E06-12-1147; Carlson LA, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001173; Chung HY, 2008, J VIROL, V82, P4884, DOI 10.1128/JVI.02667-07; Clark J, 2014, PLOS ONE IN PRESS; Dong XH, 2005, CELL, V120, P663, DOI 10.1016/j.cell.2004.12.023; Dziuba N, 2012, AIDS RES HUM RETROV, V28, P1329, DOI 10.1089/aid.2011.0358; Franceschini A, 2013, NUCLEIC ACIDS RES, V41, pD808, DOI 10.1093/nar/gks1094; Friedrich BM, 2011, RETROVIROLOGY, V8, DOI 10.1186/1742-4690-8-32; Garrus JE, 2001, CELL, V107, P55, DOI 10.1016/S0092-8674(01)00506-2; GELDERBLOM HR, 1989, ARCH VIROL, V106, P1, DOI 10.1007/BF01311033; Konig R, 2008, CELL, V135, P49, DOI 10.1016/j.cell.2008.07.032; Liu L, 2011, RETROVIROLOGY, V8, DOI 10.1186/1742-4690-8-94; Liu L, 2012, J VIROL, V86, P11242, DOI 10.1128/JVI.00544-12; Machesky LM, 1998, CURR BIOL, V8, P1347, DOI 10.1016/S0960-9822(98)00015-3; Miki H, 1998, EMBO J, V17, P6932, DOI 10.1093/emboj/17.23.6932; Ono A, 2004, P NATL ACAD SCI USA, V101, P14889, DOI 10.1073/pnas.0405596101; Ott DE, 1996, J VIROL, V70, P7734, DOI 10.1128/JVI.70.11.7734-7743.1996; Ott DE, 2000, VIROLOGY, V266, P42, DOI 10.1006/viro.1999.0075; Prchal J, 2012, J MOL BIOL, V423, P427, DOI 10.1016/j.jmb.2012.07.021; Saad JS, 2006, P NATL ACAD SCI USA, V103, P11364, DOI 10.1073/pnas.0602818103; SASAKI H, 1995, P NATL ACAD SCI USA, V92, P2026, DOI 10.1073/pnas.92.6.2026; Sfakianos JN, 2003, TRAFFIC, V4, P660, DOI 10.1034/j.1600-0854.2003.00125.x; Stauffer S, 2014, J VIROL, V88, P7893, DOI 10.1128/JVI.00428-14; Strack B, 2003, CELL, V114, P689, DOI 10.1016/S0092-8674(03)00653-6; Szklarczyk D, 2011, NUCLEIC ACIDS RES, V39, pD561, DOI 10.1093/nar/gkq973; Usami Y, 2009, BIOCHEM SOC T, V37, P181, DOI 10.1042/BST0370181; VerPlank L, 2001, P NATL ACAD SCI USA, V98, P7724, DOI 10.1073/pnas.131059198; Vlach J, 2008, P NATL ACAD SCI USA, V105, P10565, DOI 10.1073/pnas.0801765105; Votteler J, 2013, CELL HOST MICROBE, V14, P232, DOI 10.1016/j.chom.2013.08.012; Wen XY, 2014, J VIROL, V88, P6906, DOI 10.1128/JVI.00023-14; WILLS JW, 1991, AIDS, V5, P639, DOI 10.1097/00002030-199106000-00002; Yeung ML, 2009, J BIOL CHEM, V284, P19463, DOI 10.1074/jbc.M109.010033; Zhang FW, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002119; Zhou HL, 2008, CELL HOST MICROBE, V4, P495, DOI 10.1016/j.chom.2008.10.004	41	5	5	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 4	2014	9	9							e106151	10.1371/journal.pone.0106151	http://dx.doi.org/10.1371/journal.pone.0106151			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3XV	25187981	Green Published, Green Submitted, gold			2022-12-27	WOS:000341271500023
J	Cooper, JJ; Cracknell, N; Hardiman, J; Wright, H; Mills, D				Cooper, Jonathan J.; Cracknell, Nina; Hardiman, Jessica; Wright, Hannah; Mills, Daniel			The Welfare Consequences and Efficacy of Training Pet Dogs with Remote Electronic Training Collars in Comparison to Reward Based Training	PLOS ONE			English	Article							SALIVA CORTISOL; CANIS-FAMILIARIS; RESPONSES; BEHAVIOR; STRESS; SITUATIONS; STIMULI	This study investigated the welfare consequences of training dogs in the field with manually operated electronic devices (e-collars). Following a preliminary study on 9 dogs, 63 pet dogs referred for recall related problems were assigned to one of three Groups: Treatment Group A were trained by industry approved trainers using e-collars; Control Group B trained by the same trainers but without use of e-collars; and Group C trained by members of the Association of Pet Dog Trainers, UK again without e-collar stimulation (n = 21 for each Group). Dogs received two 15 minute training sessions per day for 4-5 days. Training sessions were recorded on video for behavioural analysis. Saliva and urine were collected to assay for cortisol over the training period. During preliminary studies there were negative changes in dogs' behaviour on application of electric stimuli, and elevated cortisol post-stimulation. These dogs had generally experienced high intensity stimuli without pre-warning cues during training. In contrast, in the subsequent larger, controlled study, trainers used lower settings with a pre-warning function and behavioural responses were less marked. Nevertheless, Group A dogs spent significantly more time tense, yawned more often and engaged in less environmental interaction than Group C dogs. There was no difference in urinary corticosteroids between Groups. Salivary cortisol in Group A dogs was not significantly different from that in Group B or Group C, though Group C dogs showed higher measures than Group B throughout sampling. Following training 92% of owners reported improvements in their dog's referred behaviour, and there was no significant difference in reported efficacy across Groups. Owners of dogs trained using e-collars were less confident of applying the training approach demonstrated. These findings suggest that there is no consistent benefit to be gained from e-collar training but greater welfare concerns compared with positive reward based training.	[Cooper, Jonathan J.; Cracknell, Nina; Hardiman, Jessica; Wright, Hannah; Mills, Daniel] Lincoln Univ, Sch Life Sci, Anim Behav Cognit & Welf Res Grp, Lincoln, England	University of Lincoln	Cooper, JJ (corresponding author), Lincoln Univ, Sch Life Sci, Anim Behav Cognit & Welf Res Grp, Lincoln, England.	jcooper@lincoln.ac.uk		Cooper, Jonathan/0000-0002-9014-4395	defra of UK government [AW1402, AW1402a]	defra of UK government	The research project was commissioned and funded by defra of UK government AW1402 and AW1402a to provide scientific evidence on which to base animal welfare policy (url: http://www.defra.gov.uk/). The project team did receive input from defra regarding project design and timescales, but ultimately the project team was responsible for design of study. Defra also provided feedback on project reports from an independent anonymous review panel, and this feedback has been taken into account in the final project report, from which this paper has been derived. The authors have support of the funding body to publish findings of study following independent peer review.	[Anonymous], 2013, STUDIES ASSESS EFFEC; Beerda B, 1998, APPL ANIM BEHAV SCI, V58, P365, DOI 10.1016/S0168-1591(97)00145-7; Beerda B, 1997, APPL ANIM BEHAV SCI, V52, P307, DOI 10.1016/S0168-1591(96)01131-8; Beerda B, 1996, HORM BEHAV, V30, P272, DOI 10.1006/hbeh.1996.0033; Benjamini Y, 2000, J EDUC BEHAV STAT, V25, P60, DOI 10.3102/10769986025001060; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Blackwell EJ, 2006, APPL ANIM BEHAV SCI, V85, P319; Blackwell EJ, 2012, BMC VET RES, V8, DOI 10.1186/1746-6148-8-93; Companion Animal Behaviour Therapy Study Group, 2003, J SMALL ANIM PRAC, V44, P95; Companion Animal Welfare Council , 2012, US EL PULS TRAIN AID; Dale AR, 2013, APPL ANIM BEHAV SCI, V146, P107, DOI 10.1016/j.applanim.2013.04.006; Dogtra, 1200 SER TRAIN MAN; Dreschel NA, 2009, HORM BEHAV, V55, P163, DOI 10.1016/j.yhbeh.2008.09.010; Electronic Collar Manufacturers Association, TRAIN GUID; Hennessy MB, 2013, APPL ANIM BEHAV SCI, V149, P1, DOI 10.1016/j.applanim.2013.09.004; Hiby EF, 2004, ANIM WELFARE, V13, P63; Hiby EF, 2006, PHYSIOL BEHAV, V89, P385, DOI 10.1016/j.physbeh.2006.07.012; KEMPPAINEN RJ, 1984, J ENDOCRINOL, V103, P219, DOI 10.1677/joe.0.1030219; Klein D, 2000, THESIS U MUENSTER; Kobelt AJ, 2003, RES VET SCI, V75, P157, DOI 10.1016/S0034-5288(03)00080-8; Kopyoma T, 2003, HORM METAB RES, V35, P355; Kovelska J, 2003, ACT VET BRNO, V72, P599; Ligout S, 2009, P 7 IVBM ED 2009, P134; Lindsay S, 2001, HDB APPL DOG BEHAV T, V2; Lindsay SR, 2005, HANDBOOK OF APPLIED DOG BEHAVIOR AND TRAINING, VOL 3: PROCEDURES AND PROTOCOLS, P1, DOI 10.1002/9780470344514; Lines JA, 2013, VET REC, V172, DOI 10.1136/vr.101144; Marschark ED, 2002, ANTHROZOOS, V15, P51, DOI 10.2752/089279302786992685; Mills D.S., 2010, J VET BEHAV, V1, P60, DOI [DOI 10.1016/J.JVEB.2009.09.006, 10.1016/j.jveb.2009.09.006]; Mills DS, 2006, APPL ANIM BEHAV SCI, V98, P114, DOI 10.1016/j.applanim.2005.08.012; Petsafe, OP GUID REM TRAIN 25; Pongracz P, 2005, J COMP PSYCHOL, V119, P136, DOI 10.1037/0735-7036.119.2.136; Rooney NJ, 2007, PHYSIOL BEHAV, V92, P847, DOI 10.1016/j.physbeh.2007.06.011; Schalke E, 2007, APPL ANIM BEHAV SCI, V105, P369, DOI 10.1016/j.applanim.2006.11.002; Schilder MBH, 2004, APPL ANIM BEHAV SCI, V85, P319, DOI 10.1016/j.applanim.2003.10.004; Sportdog, SD 1825E TRAIN MAN; Voith VL, 1996, READINGS COMPANION A, P140	36	27	27	5	122	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 3	2014	9	9							e102722	10.1371/journal.pone.0102722	http://dx.doi.org/10.1371/journal.pone.0102722			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3TB	25184218	Green Submitted, gold, Green Accepted, Green Published			2022-12-27	WOS:000341257700004
J	Hartig, F; Munkemuller, T; Johst, K; Dieckmann, U				Hartig, Florian; Muenkemueller, Tamara; Johst, Karin; Dieckmann, Ulf			On the Sympatric Evolution and Evolutionary Stability of Coexistence by Relative Nonlinearity of Competition	PLOS ONE			English	Article							LONG-TERM COEXISTENCE; CHARACTER DISPLACEMENT; DENSITY-DEPENDENCE; COMMUNITY ECOLOGY; DYNAMICS; DISTURBANCE; SELECTION; RESOURCE; BIODIVERSITY; ENVIRONMENT	If two species exhibit different nonlinear responses to a single shared resource, and if each species modifies the resource dynamics such that this favors its competitor, they may stably coexist. This coexistence mechanism, known as relative nonlinearity of competition, is well understood theoretically, but less is known about its evolutionary properties and its prevalence in real communities. We address this challenge by using adaptive dynamics theory and individual-based simulations to compare community stabilization and evolutionary stability of species that coexist by relative nonlinearity. In our analysis, evolution operates on the species' density-compensation strategies, and we consider a trade-off between population growth rates at high and low resource availability. We confirm previous findings that, irrespective of the particular model of density dependence, there are many combinations of overcompensating and undercompensating density-compensation strategies that allow stable coexistence by relative nonlinearity. However, our analysis also shows that most of these strategy combinations are not evolutionarily stable and will be outcompeted by an intermediate density-compensation strategy. Only very specific trade-offs lead to evolutionarily stable coexistence by relative nonlinearity. As we find no reason why these particular trade-offs should be common in nature, we conclude that the sympatric evolution and evolutionary stability of relative nonlinearity, while possible in principle, seems rather unlikely. We speculate that this may, at least in part, explain why empirical demonstrations of this coexistence mechanism are rare, noting, however, that the difficulty to detect relative nonlinearity in the field is an equally likely explanation for the current lack of empirical observations, and that our results are limited to communities with non-overlapping generations and constant resource supply. Our study highlights the need for combining ecological and evolutionary perspectives for gaining a better understanding of community assembly and biogeographic patterns.	[Hartig, Florian; Muenkemueller, Tamara; Johst, Karin] UFZ Helmholtz Ctr Environm Res, Dept Ecol Modelling, Leipzig, Germany; [Hartig, Florian] Univ Freiburg, D-79106 Freiburg, Germany; [Muenkemueller, Tamara] Univ Grenoble Alpes, La Ecol Alpine, Grenoble, France; [Muenkemueller, Tamara] Ctr Natl Rech Sci, La Ecol Alpine, Grenoble, France; [Dieckmann, Ulf] Int Inst Appl Syst Anal, Evolut & Ecol Program, A-2361 Laxenburg, Austria	Helmholtz Association; Helmholtz Center for Environmental Research (UFZ); University of Freiburg; Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA); Centre National de la Recherche Scientifique (CNRS); International Institute for Applied Systems Analysis (IIASA)	Hartig, F (corresponding author), UFZ Helmholtz Ctr Environm Res, Dept Ecol Modelling, Leipzig, Germany.	florian.hartig@biom.uni-freiburg.de	Johst, Karin/D-5309-2015; Münkemüller, Tamara/AAQ-1670-2020; Hartig, Florian/G-4510-2010; Dieckmann, Ulf/E-1424-2011	Johst, Karin/0000-0003-0798-2361; Hartig, Florian/0000-0002-6255-9059; Dieckmann, Ulf/0000-0001-7089-0393	ERC [233066]; European Community [281422]; European Commission; European Science Foundation; Austrian Science Fund; Austrian Ministry for Science and Research; Vienna Science and Technology Fund	ERC(European Research Council (ERC)European Commission); European Community(European Commission); European Commission(European CommissionEuropean Commission Joint Research Centre); European Science Foundation(European Science Foundation (ESF)European Commission); Austrian Science Fund(Austrian Science Fund (FWF)); Austrian Ministry for Science and Research; Vienna Science and Technology Fund	FH acknowledges support from the ERC Advanced Grant 233066. TM received funding from the European Community's Seventh Framework Programme (FP7/2007-2013) under grant agreement no 281422 (TEEMBIO). UD gratefully acknowledges financial support by the European Commission, the European Science Foundation, the Austrian Science Fund, the Austrian Ministry for Science and Research, and the Vienna Science and Technology Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrams PA, 2004, ECOLOGY, V85, P372, DOI 10.1890/02-0684; Abrams PA, 2013, EVOLUTION, V67, P315, DOI 10.1111/j.1558-5646.2012.01756.x; ADLER FR, 1990, J MATH BIOL, V28, P695, DOI 10.1007/BF00160232; Adler PB, 2006, P NATL ACAD SCI USA, V103, P12793, DOI 10.1073/pnas.0600599103; [Anonymous], 2014, R LANG ENV STAT COMP; ARMSTRONG RA, 1980, AM NAT, V115, P151, DOI 10.1086/283553; Banitz T, 2008, THEOR ECOL-NETH, V1, P231, DOI 10.1007/s12080-008-0023-3; Berkley HA, 2010, ECOL LETT, V13, P360, DOI 10.1111/j.1461-0248.2009.01427.x; Bever JD, 2010, TRENDS ECOL EVOL, V25, P468, DOI 10.1016/j.tree.2010.05.004; Chave J, 2004, ECOL LETT, V7, P241, DOI 10.1111/j.1461-0248.2003.00566.x; CHESSON P, 1994, THEOR POPUL BIOL, V45, P227, DOI 10.1006/tpbi.1994.1013; Chesson P, 2003, THEOR POPUL BIOL, V64, P345, DOI 10.1016/S0040-5809(03)00095-9; Chesson P, 2000, THEOR POPUL BIOL, V58, P211, DOI 10.1006/tpbi.2000.1486; Chesson P, 2000, ANNU REV ECOL SYST, V31, P343, DOI 10.1146/annurev.ecolsys.31.1.343; Coyne J.A., 2004, SPECIATION; Crawley MJ, 2004, ECOLOGY, V85, P3277, DOI 10.1890/03-0804; Descamps-Julien B, 2005, ECOLOGY, V86, P2815, DOI 10.1890/04-1700; Dieckmann U, 1997, TRENDS ECOL EVOL, V12, P128, DOI 10.1016/S0169-5347(97)01004-5; Dieckmann U., 2004, ADAPTIVE SPECIATION; Dieckmann Ulf, 2004, P188, DOI 10.1017/CBO9780511542022.015; Dislich C, 2010, ECOL MODEL, V221, P2227, DOI 10.1016/j.ecolmodel.2010.06.011; DOEBELI M, 1995, P ROY SOC B-BIOL SCI, V260, P119, DOI 10.1098/rspb.1995.0068; dos Santos FAS, 2011, ECOL LETT, V14, P653, DOI 10.1111/j.1461-0248.2011.01626.x; FELSENSTEIN J, 1979, AM NAT, V113, P499, DOI 10.1086/283409; Gavrilets S, 2004, FITNESS LANDSCAPES O; Geritz SAH, 2007, THEOR POPUL BIOL, V71, P424, DOI 10.1016/j.tpb.2007.03.006; Getz WM, 1996, ECOLOGY, V77, P2014, DOI 10.2307/2265697; Gravel D, 2011, ECOL LETT, V14, P828, DOI 10.1111/j.1461-0248.2011.01643.x; HASSELL MP, 1975, J ANIM ECOL, V44, P283, DOI 10.2307/3863; Hubbell Stephen P., 2001, V32, pi; Huisman J, 1999, NATURE, V402, P407, DOI 10.1038/46540; HUTCHINSON GE, 1959, AM NAT, V93, P145, DOI 10.1086/282070; HUTCHINSON GE, 1961, AM NAT, V95, P137, DOI 10.1086/282171; Hutchinson GE, 1969, ECOLOGICAL THEATER E; JANZEN DH, 1970, AM NAT, V104, P501, DOI 10.1086/282687; Johnson MTJ, 2007, TRENDS ECOL EVOL, V22, P250, DOI 10.1016/j.tree.2007.01.014; Johst K, 1999, P ROY SOC B-BIOL SCI, V266, P1147, DOI 10.1098/rspb.1999.0756; Johst K, 2008, POPUL ECOL, V50, P79, DOI 10.1007/s10144-007-0061-5; Kisdi E, 2006, J EVOLUTION BIOL, V19, P49, DOI 10.1111/j.1420-9101.2005.00993.x; Kneitel JM, 2004, ECOL LETT, V7, P69, DOI 10.1046/j.1461-0248.2003.00551.x; Loso JB, 2000, P NATL ACAD SCI USA, V97, P5693, DOI 10.1073/pnas.97.11.5693; M'Gonigle LK, 2012, NATURE, V484, P506, DOI 10.1038/nature10971; Mangan SA, 2010, NATURE, V466, P752, DOI 10.1038/nature09273; Mathias A, 2013, THEOR POPUL BIOL, V84, P56, DOI 10.1016/j.tpb.2012.11.009; Matthews B, 2011, ECOL LETT, V14, P690, DOI 10.1111/j.1461-0248.2011.01627.x; Metcalf CJE, 2008, P NATL ACAD SCI USA, V105, P10466, DOI 10.1073/pnas.0800777105; Mougi A, 2006, J THEOR BIOL, V241, P467, DOI 10.1016/j.jtbi.2005.12.017; Munkemuller T, 2009, J THEOR BIOL, V259, P109, DOI 10.1016/j.jtbi.2009.03.010; Packer A, 2000, NATURE, V404, P278, DOI 10.1038/35005072; Pfennig DW, 2010, AM NAT, V176, pS26, DOI 10.1086/657056; Purves DW, 2010, J ANIM ECOL, V79, P1215, DOI 10.1111/j.1365-2656.2010.01738.x; RAND DA, 1995, P ROY SOC B-BIOL SCI, V259, P55, DOI 10.1098/rspb.1995.0009; RICKER W. E., 1954, JOUR FISH RES BD CANADA, V11, P559; Schluter D, 2009, SCIENCE, V323, P737, DOI 10.1126/science.1160006; Shoresh N, 2008, P NATL ACAD SCI USA, V105, P12365, DOI 10.1073/pnas.0803032105; SMITH JM, 1973, ECOLOGY, V54, P384, DOI 10.2307/1934346; Snyder RE, 2011, AM NAT, V178, pE76, DOI 10.1086/661905; TILMAN D, 1994, ECOLOGY, V75, P2, DOI 10.2307/1939377; Turchin Peter, 2003, Monographs in Population Biology, V35, pi; TURELLI M, 1980, P NATL ACAD SCI-BIOL, V77, P7501, DOI 10.1073/pnas.77.12.7501; Wiens JJ, 2010, ECOL LETT, V13, P1310, DOI 10.1111/j.1461-0248.2010.01515.x; Wilensky U., 1999, NETLOGO; Wilson WG, 2005, AM NAT, V165, P193, DOI 10.1086/427733; Yu DW, 2001, AM NAT, V158, P49, DOI 10.1086/320865	64	7	7	0	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 3	2014	9	9							e94454	10.1371/journal.pone.0094454	http://dx.doi.org/10.1371/journal.pone.0094454			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3TB	25184813	Green Submitted, Green Accepted, Green Published, gold			2022-12-27	WOS:000341257700001
J	Nouri, M; Bredberg, A; Westrom, B; Lavasani, S				Nouri, Mehrnaz; Bredberg, Anders; Westrom, Bjorn; Lavasani, Shahram			Intestinal Barrier Dysfunction Develops at the Onset of Experimental Autoimmune Encephalomyelitis, and Can Be Induced by Adoptive Transfer of Auto-Reactive T Cells	PLOS ONE			English	Article							CENTRAL-NERVOUS-SYSTEM; INFLAMMATORY-BOWEL-DISEASE; MULTIPLE-SCLEROSIS; TIGHT JUNCTIONS; TH17 CELLS; PERMEABILITY; PATHOGENESIS; ZONULIN; MECHANISMS; MODEL	Multiple sclerosis (MS) is a chronic inflammatory demyelinating disease of the central nervous system with a pathogenesis involving a dysfunctional blood-brain barrier and myelin-specific, autoreactive T cells. Although the commensal microbiota seems to affect its pathogenesis, regulation of the interactions between luminal antigens and mucosal immune elements remains unclear. Herein, we investigated whether the intestinal mucosal barrier is also targeted in this disease. Experimental autoimmune encephalomyelitis (EAE), the prototypic animal model of MS, was induced either by active immunization or by adoptive transfer of autoreactive T cells isolated from these mice. We show increased intestinal permeability, overexpression of the tight junction protein zonulin and alterations in intestinal morphology (increased crypt depth and thickness of the submucosa and muscularis layers). These intestinal manifestations were seen at 7 days (i.e., preceding the onset of neurological symptoms) and at 14 days (i.e., at the stage of paralysis) after immunization. We also demonstrate an increased infiltration of proinflammatory Th1/Th17 cells and a reduced regulatory T cell number in the gut lamina propria, Peyer's patches and mesenteric lymph nodes. Adoptive transfer to healthy mice of encephalitogenic T cells, isolated from EAE-diseased animals, led to intestinal changes similar to those resulting from the immunization procedure. Our findings show that disruption of intestinal homeostasis is an early and immune-mediated event in EAE. We propose that this intestinal dysfunction may act to support disease progression, and thus represent a potential therapeutic target in MS. In particular, an increased understanding of the regulation of tight junctions at the blood-brain barrier and in the intestinal wall may be crucial for design of future innovative therapies.	[Nouri, Mehrnaz] Lund Univ, Dept Clin Sci, Clin Res Ctr, Surg Res Unit, Malmo, Sweden; [Nouri, Mehrnaz; Westrom, Bjorn; Lavasani, Shahram] Lund Univ, Dept Biol, Lund, Sweden; [Bredberg, Anders; Lavasani, Shahram] ImmuneBiotech AB, Lund Life Sci Incubator, Lund, Sweden; [Bredberg, Anders] Lund Univ, Dept Lab Med, Sect Med Microbiol, Malmo, Sweden	Lund University; Lund University; Lund University	Lavasani, S (corresponding author), Lund Univ, Dept Biol, Lund, Sweden.	Shahram.Lavasani@biol.lu.se	Weström, Björn R/N-2232-2016	Weström, Björn R/0000-0001-9296-2845; Lavasani, Shahram/0000-0003-4922-9351	Royal Physiographic Society in Lund, Sweden; Lund University faculty grants	Royal Physiographic Society in Lund, Sweden; Lund University faculty grants	This project is partially financed by grants from the Royal Physiographic Society in Lund, Sweden. The rest of the funding has come from Lund University faculty grants. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alkhawajah MM, 2013, MULT SCLER J, V19, P259, DOI 10.1177/1352458512461393; Arrieta MC, 2006, GUT, V55, DOI 10.1136/gut.2005.085373; Bennett J, 2010, J NEUROIMMUNOL, V229, P180, DOI 10.1016/j.jneuroim.2010.08.011; Berer K, 2011, NATURE, V479, P538, DOI 10.1038/nature10554; Croxford AL, 2011, BBA-MOL BASIS DIS, V1812, P177, DOI 10.1016/j.bbadis.2010.06.010; de Kort S, 2011, OBES REV, V12, P449, DOI 10.1111/j.1467-789X.2010.00845.x; Fasano A, 2005, NAT CLIN PRACT GASTR, V2, P416, DOI 10.1038/ncpgasthep0259; Fasano A, 1997, J CLIN INVEST, V99, P1158, DOI 10.1172/JCI119271; Fasano A, 2011, PHYSIOL REV, V91, P151, DOI 10.1152/physrev.00003.2008; Goverman J, 2009, NAT REV IMMUNOL, V9, P393, DOI 10.1038/nri2550; Goverman JM, 2011, IMMUNOL REV, V241, P228, DOI 10.1111/j.1600-065X.2011.01016.x; Harhaj NS, 2004, INT J BIOCHEM CELL B, V36, P1206, DOI 10.1016/j.biocel.2003.08.007; Kebir H, 2007, NAT MED, V13, P1173, DOI 10.1038/nm1651; Kunz M, 2009, MEDIAT INFLAMM, V2009, DOI 10.1155/2009/979258; Langer-Gould A, 2010, MULT SCLER J, V16, P855, DOI 10.1177/1352458510369146; Lavasani S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009009; Lee YK, 2009, CURR OPIN IMMUNOL, V21, P274, DOI 10.1016/j.coi.2009.05.021; Liu ZJ, 2009, WORLD J GASTROENTERO, V15, P5784, DOI 10.3748/wjg.15.5784; Mazmanian SK, 2011, P NATL ACAD SCI USA, V108, P14615; Neu J, 2005, J PEDIATR GASTR NUTR, V40, P589, DOI 10.1097/01.MPG.0000159636.19346.C1; O'Connor RA, 2008, J IMMUNOL, V181, P3750, DOI 10.4049/jimmunol.181.6.3750; Ochoa-Reparaz J, 2009, J IMMUNOL, V183, P6041, DOI 10.4049/jimmunol.0900747; Panwala CM, 1998, J IMMUNOL, V161, P5733; Sapone A, 2006, DIABETES, V55, P1443, DOI 10.2337/db05-1593; Sawcer S, 2011, NATURE, V476, P214, DOI 10.1038/nature10251; Veldhoen M, 2006, IMMUNITY, V24, P179, DOI 10.1016/j.immuni.2006.01.001; Visser J, 2009, ANN NY ACAD SCI, V1165, P195, DOI 10.1111/j.1749-6632.2009.04037.x; Watts T, 2005, P NATL ACAD SCI USA, V102, P2916, DOI 10.1073/pnas.0500178102; Westerholm-Ormio M, 2003, DIABETES, V52, P2287, DOI 10.2337/diabetes.52.9.2287; Yacyshyn B, 1996, DIGEST DIS SCI, V41, P2493, DOI 10.1007/BF02100148; Zephir H, 2013, MULTIPLE SCLEROSIS	31	108	110	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 3	2014	9	9							e106335	10.1371/journal.pone.0106335	http://dx.doi.org/10.1371/journal.pone.0106335			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3TB	25184418	Green Published, gold, Green Submitted			2022-12-27	WOS:000341257700056
J	Zou, SY; He, XY; Liu, YF; Chen, DL; Luo, YB; Huang, KL; Zhang, W; Xu, WT				Zou, Shiying; He, Xiaoyun; Liu, Yifei; Chen, Delong; Luo, Yunbo; Huang, Kunlun; Zhang, Wei; Xu, Wentao			Toxicological Evaluation of Lactase Derived from Recombinant Pichia pastoris	PLOS ONE			English	Article							BETA-GALACTOSIDASE; LACTOSE-INTOLERANCE; ORAL TOXICITY; SAFETY EVALUATION; PERSISTENCE; EXPRESSION; CHILDREN; INFANTS; LINKAGE; LEVEL	A recombinant lactase was expressed in Pichia pastoris, resulting in enzymatic activity of 3600 U/mL in a 5 L fermenter. The lactase product was subjected to a series of toxicological tests to determine its safety for use as an enzyme preparation in the dairy industry. This recombinant lactase had the highest activity of all recombinant strains reported thus far. Acute oral toxicity, mutagenicity, genotoxic, and subchronic toxicity tests performed in rats and mice showed no death in any groups. The lethal dose 50% (LD50) based on the acute oral toxicity study is greater than 30 mL/kg body weight, which is in accordance with the 1500 L milk consumption of a 50 kg human daily. The lactase showed no mutagenic activity in the Ames test or a mouse sperm abnormality test at levels of up to 5 mg/plate and 1250 mg/kg body weight, respectively. It also showed no genetic toxicology in a bone marrow cell micronucleus test at levels of up to 1250 mg/kg body weight. A 90-day subchronic repeated toxicity study via the diet with lactase levels up to 1646 mg/kg (1000-fold greater than the mean human exposure) did not show any treatment-related significant toxicological effects on body weight, food consumption, organ weights, hematological and clinical chemistry, or histopathology compared to the control groups. This toxicological evaluation system is comprehensive and can be used in the safety evaluation of other enzyme preparations. The lactase showed no acute, mutagenic, genetic, or subchronic toxicity under our evaluation system.	[Zou, Shiying; He, Xiaoyun; Liu, Yifei; Chen, Delong; Luo, Yunbo; Huang, Kunlun; Xu, Wentao] China Agr Univ, Coll Food Sci & Nutr Engn, Lab Food Safety & Mol Biol, Beijing 100094, Peoples R China; [Zou, Shiying; He, Xiaoyun; Luo, Yunbo; Huang, Kunlun; Xu, Wentao] Minist Agr, Supervis Inspect & Testing Ctr Genetically Modifi, Beijing, Peoples R China; [Zhang, Wei] Chinese Acad Agr Sci, Biotechnol Res Inst, Beijing 100193, Peoples R China	China Agricultural University; Ministry of Agriculture & Rural Affairs; Chinese Academy of Agricultural Sciences; Biotechnology Research Institute, CAAS	Zhang, W (corresponding author), Chinese Acad Agr Sci, Biotechnol Res Inst, Beijing 100193, Peoples R China.	zwcaas@hotmail.com; xuwentaoboy@sina.com		Kunlun, Huang/0000-0002-2350-5859	National GMO Cultivation Major Project of New Varieties [2013ZX08011-006, 2009ZX08019-001B]	National GMO Cultivation Major Project of New Varieties	The work was supported by the National GMO Cultivation Major Project of New Varieties (2013ZX08011-006 and 2009ZX08019-001B). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adrio JL, 2003, INT MICROBIOL, V6, P191, DOI 10.1007/s10123-003-0133-0; Bakoma B, 2013, FOOD CHEM TOXICOL, V52, P176, DOI 10.1016/j.fct.2012.11.021; BERKA RM, 1998, Patent No. 5736374; Cereghino JL, 2000, FEMS MICROBIOL REV, V24, P45, DOI 10.1111/j.1574-6976.2000.tb00532.x; Coenen TMM, 2000, FOOD CHEM TOXICOL, V38, P671, DOI 10.1016/S0278-6915(00)00053-3; Domingues L, 2000, APPL MICROBIOL BIOT, V54, P97, DOI 10.1007/s002530000358; Fang L, 2012, HUM GENET, V131, P1153, DOI 10.1007/s00439-012-1140-z; FLAMM EL, 1991, BIO-TECHNOL, V9, P349, DOI 10.1038/nbt0491-349; Gulsen N, 2002, ARCH ANIM NUTR, V56, P131, DOI 10.1080/00039420214186; Hayes J, 2009, MUTAGENESIS, V24, P419, DOI 10.1093/mutage/gep024; He XY, 2009, FOOD CHEM TOXICOL, V47, P425, DOI 10.1016/j.fct.2008.11.032; Heyman MB, 2006, PEDIATRICS, V118, P1279, DOI 10.1542/peds.2006-1721; Ibrahim SA, 2000, J DAIRY SCI, V83, P923, DOI 10.3168/jds.S0022-0302(00)74955-1; ITOH T, 1982, AGR BIOL CHEM TOKYO, V46, P899, DOI 10.1080/00021369.1982.10865183; Kim SJ, 2010, SAF HEALTH WORK, V1, P80, DOI 10.5491/SHAW.2010.1.1.80; KRUSE TA, 1988, FEBS LETT, V240, P123, DOI 10.1016/0014-5793(88)80352-1; KRZANOWSKA H, 1976, GENET RES, V28, P189, DOI 10.1017/S0016672300016864; Lokki AI, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-9; Nie CM, 2013, PROTEIN EXPRES PURIF, V92, P88, DOI 10.1016/j.pep.2013.08.019; No OT, 1997, BACTERIAL REVERSE MU; OECD, 1998, HLTH EFF REP DOS 408; Oecd T, 1997, OECD GUIDELINE TESTI, P474; Pariza MW, 2001, REGUL TOXICOL PHARM, V33, P173, DOI 10.1006/rtph.2001.1466; Poulter M, 2003, ANN HUM GENET, V67, P298, DOI 10.1046/j.1469-1809.2003.00048.x; Rayburn SR, 1990, SAFETY REGULATIONS S, P267; Schauss AG, 2010, TOXICOLOGY, V278, P46, DOI 10.1016/j.tox.2010.04.017; STYRNA J, 1991, GENET RES, V57, P135, DOI 10.1017/S0016672300029207; Swallow DM, 2003, ANNU REV GENET, V37, P197, DOI 10.1146/annurev.genet.37.110801.143820; Travis RC, 2013, INT J CANCER, V132, P1901, DOI 10.1002/ijc.27836; Walum E, 1998, ENVIRON HEALTH PERSP, V106, P497, DOI 10.2307/3433801; Wang YX, 1998, GASTROENTEROLOGY, V114, P1230, DOI 10.1016/S0016-5085(98)70429-9; Wilt Timothy J, 2010, Evid Rep Technol Assess (Full Rep), P1; Yoshikawa Y, 2013, J TOXICOL SCI, V38, P459, DOI 10.2131/jts.38.459; Yuan DT, 2010, AM FAM PHYSICIAN, V81, P933; Zhang W, 2012, China patent, Patent No. [CN102776215 A, 102776215]; Zhou C, 2011, DRUG CHEM TOXICOL, V34, P359, DOI 10.3109/01480545.2010.542465	36	7	8	0	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 3	2014	9	9							e106470	10.1371/journal.pone.0106470	http://dx.doi.org/10.1371/journal.pone.0106470			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3TB	25184300	Green Published, Green Submitted, gold			2022-12-27	WOS:000341257700076
J	Altamirano, F; Perez, CF; Liu, M; Widrick, J; Barton, ER; Allen, PD; Adams, JA; Lopez, JR				Altamirano, Francisco; Perez, Claudio F.; Liu, Min; Widrick, Jeffrey; Barton, Elisabeth R.; Allen, Paul D.; Adams, Jose A.; Lopez, Jose R.			Whole Body Periodic Acceleration Is an Effective Therapy to Ameliorate Muscular Dystrophy in mdx Mice	PLOS ONE			English	Article							NITRIC-OXIDE SYNTHASE; SKELETAL-MUSCLE FIBERS; L-ARGININE; MOUSE MUSCLE; CALCIUM-RELEASE; SATELLITE CELLS; IN-VIVO; EXPRESSION; UTROPHIN; PROTEIN	Duchenne muscular dystrophy (DMD) is a genetic disorder caused by the absence of dystrophin in both skeletal and cardiac muscles. This leads to severe muscle degeneration, and dilated cardiomyopathy that produces patient death, which in most cases occurs before the end of the second decade. Several lines of evidence have shown that modulators of nitric oxide (NO) pathway can improve skeletal muscle and cardiac function in the mdx mouse, a mouse model for DMD. Whole body periodic acceleration (pGz) is produced by applying sinusoidal motion to supine humans and in standing conscious rodents in a headward-footward direction using a motion platform. It adds small pulses as a function of movement frequency to the circulation thereby increasing pulsatile shear stress to the vascular endothelium, which in turn increases production of NO. In this study, we examined the potential therapeutic properties of pGz for the treatment of skeletal muscle pathology observed in the mdx mouse. We found that pGz (480 cpm, 8 days, 1 hr per day) decreased intracellular Ca2+ and Na+ overload, diminished serum levels of creatine kinase (CK) and reduced intracellular accumulation of Evans Blue. Furthermore, pGz increased muscle force generation and expression of both utrophin and the carboxy-terminal PDZ ligand of nNOS (CAPON). Likewise, pGz (120 cpm, 12 h) applied in vitro to skeletal muscle myotubes reduced Ca2+ and Na+ overload, diminished abnormal sarcolemmal Ca2+ entry and increased phosphorylation of endothelial NOS. Overall, this study provides new insights into the potential therapeutic efficacy of pGz as a non-invasive and non-pharmacological approach for the treatment of DMD patients through activation of the NO pathway.	[Altamirano, Francisco; Allen, Paul D.; Lopez, Jose R.] Univ Calif Davis, Sch Vet Med, Dept Mol Biosci, Davis, CA 95616 USA; [Perez, Claudio F.; Allen, Paul D.; Lopez, Jose R.] Harvard Univ, Brigham & Womens Hosp, Sch Med, Dept Anesthesiol Perioperat & Pain Med, Boston, MA 02115 USA; [Liu, Min] Univ Penn, Perleman Sch Med, Dept Physiol, Philadelphia, PA 19104 USA; [Widrick, Jeffrey] Harvard Univ, Sch Med, Dept Genet, Boston Childrens Hosp, Boston, MA USA; [Widrick, Jeffrey] Harvard Univ, Sch Med, Boston Childrens Hosp, Program Gen, Boston, MA USA; [Barton, Elisabeth R.] Univ Penn, Sch Dent Med, Philadelphia, PA 19104 USA; [Adams, Jose A.] Mt Sinai Med Ctr, Div Neonatol, Miami, FL USA	University of California System; University of California Davis; Harvard University; Brigham & Women's Hospital; Harvard Medical School; University of Pennsylvania; Pennsylvania Medicine; Harvard University; Boston Children's Hospital; Harvard Medical School; Harvard University; Boston Children's Hospital; Harvard Medical School; University of Pennsylvania; Mount Sinai Medical Center	Lopez, JR (corresponding author), Univ Calif Davis, Sch Vet Med, Dept Mol Biosci, Davis, CA 95616 USA.	jrlopez@ucdavis.edu	Adams, Jose Antonio/ABC-2699-2021; Adams, Jose Antonio/AAI-2342-2020; Altamirano, Francisco/I-1928-2013	Adams, Jose Antonio/0000-0002-9401-2226; Adams, Jose Antonio/0000-0002-9401-2226; Altamirano, Francisco/0000-0002-1612-2729	(EB) Wellstone Muscular Dystrophy Cooperative Center Physiological Assessment Core [U54-AR052646]; National Institutes of Health [AR43140, AR052534]; Florida Heart Research Institute; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [U54AR052646, R01AR043140, P01AR052354] Funding Source: NIH RePORTER	(EB) Wellstone Muscular Dystrophy Cooperative Center Physiological Assessment Core; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Florida Heart Research Institute; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported by (EB) Wellstone Muscular Dystrophy Cooperative Center Physiological Assessment Core (U54-AR052646; ERB); National Institutes of Health AR43140 (JRL and PDA), AR052534 (JRL and PDA), the Florida Heart Research Institute (JAA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams BD, 2009, J AM CHEM SOC, V131, P6930, DOI 10.1021/ja901798u; Adams JA, 2000, J APPL PHYSIOL, V89, P2447, DOI 10.1152/jappl.2000.89.6.2447; Adams JA, 2001, CRIT CARE MED, V29, P1983, DOI 10.1097/00003246-200110000-00022; Adams JA, 2009, PEPTIDES, V30, P373, DOI 10.1016/j.peptides.2008.10.014; Allen DG, 2010, CAN J PHYSIOL PHARM, V88, P83, DOI 10.1139/Y09-058; Altamirano F, 2014, BIOPHYS J, V106, p116a; Altamirano F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081222; Altamirano F, 2012, J BIOL CHEM, V287, P20876, DOI 10.1074/jbc.M112.344929; Anderson JE, 2000, MOL BIOL CELL, V11, P1859, DOI 10.1091/mbc.11.5.1859; Anderson JE, 2003, NEUROMUSCULAR DISORD, V13, P388, DOI 10.1016/S0960-8966(03)00029-4; Angelini C, 2007, MUSCLE NERVE, V36, P424, DOI 10.1002/mus.20812; AWOLESI MA, 1995, J CLIN INVEST, V96, P1449, DOI 10.1172/JCI118181; Bachrach E, 2004, P NATL ACAD SCI USA, V101, P3581, DOI 10.1073/pnas.0400373101; Barton ER, 2005, MUSCLE NERVE, V32, P751, DOI 10.1002/mus.20425; Bellinger AM, 2009, NAT MED, V15, P325, DOI 10.1038/nm.1916; Blake DJ, 2002, PHYSIOL REV, V82, P291, DOI 10.1152/physrev.00028.2001; BRAUND KG, 1980, EXP NEUROL, V68, P50, DOI 10.1016/0014-4886(80)90066-7; BRENMAN JE, 1995, CELL, V82, P743, DOI 10.1016/0092-8674(95)90471-9; Burr AR, 2014, MOL CELL BIOL, V34, P1991, DOI 10.1128/MCB.00339-14; Burr AR, 2014, MOL CELL BIOL; Capote J, 2010, AM J PHYSIOL-CELL PH, V298, pC1077, DOI 10.1152/ajpcell.00428.2009; Chang KC, 2008, P NATL ACAD SCI USA, V105, P4477, DOI 10.1073/pnas.0709118105; Chang WJ, 1996, P NATL ACAD SCI USA, V93, P9142, DOI 10.1073/pnas.93.17.9142; Chaubourt E, 1999, NEUROBIOL DIS, V6, P499, DOI 10.1006/nbdi.1999.0256; Chen ML, 2008, J MOL NEUROSCI, V34, P89, DOI 10.1007/s12031-007-9005-y; Coirault C, 1999, AM J PHYSIOL-CELL PH, V277, pC1170, DOI 10.1152/ajpcell.1999.277.6.C1170; DARDEVET D, 1995, J CLIN INVEST, V96, P2113, DOI 10.1172/JCI118264; Davies KE, 2006, NAT REV MOL CELL BIO, V7, P762, DOI 10.1038/nrm2024; DUNN JF, 1993, J NEUROL SCI, V114, P76, DOI 10.1016/0022-510X(93)90052-Z; Eltit JM, 2013, FASEB J, V27, P991, DOI 10.1096/fj.12-218354; Emery A E, 1991, Neuromuscul Disord, V1, P19, DOI 10.1016/0960-8966(91)90039-U; Gilbert T, 1999, HUM GENE THER, V10, P1299, DOI 10.1089/10430349950017987; Goyenvalle A, 2004, SCIENCE, V306, P1796, DOI 10.1126/science.1104297; Guerron AD, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011220; Hamer PW, 2002, J ANAT, V200, P69, DOI 10.1046/j.0021-8782.2001.00008.x; Hirn C, 2008, J GEN PHYSIOL, V132, P199, DOI 10.1085/jgp.200810024; Hnia K, 2008, AM J PATHOL, V172, P1509, DOI 10.2353/ajpath.2008.071009; HOFFMAN EP, 1989, NEURON, V2, P1019, DOI 10.1016/0896-6273(89)90226-2; HOFFMAN EP, 1987, CELL, V51, P919, DOI 10.1016/0092-8674(87)90579-4; Jaffrey SR, 2002, P NATL ACAD SCI USA, V99, P3199, DOI 10.1073/pnas.261705799; Jasmin BJ, 2002, J PHYSIOL-PARIS, V96, P31, DOI 10.1016/S0928-4257(01)00078-X; Khurana TS, 2003, NAT REV DRUG DISCOV, V2, P379, DOI 10.1038/nrd1085; Lai Y, 2009, J CLIN INVEST, V119, P624, DOI 10.1172/JCI36612; LOPEZ JR, 1987, ACTA CIENT VENEZ, V38, P503; Manzur AY, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003725.pub3; Marques MJ, 2010, ACTA BIOL HUNG, V61, P168, DOI 10.1556/ABiol.61.2010.2.5; MATSUMURA K, 1992, NATURE, V360, P588, DOI 10.1038/360588a0; Mizunoya W, 2011, AM J PHYSIOL-CELL PH, V300, pC1065, DOI 10.1152/ajpcell.00482.2010; MONACO AP, 1986, NATURE, V323, P646, DOI 10.1038/323646a0; Persichini T, 2006, ANTIOXID REDOX SIGN, V8, P1897, DOI 10.1089/ars.2006.8.1897; Persichini T, 2006, ANTIOXID REDOX SIGN, V8, P949, DOI 10.1089/ars.2006.8.949; Pitsillides AA, 1995, FASEB J, V9, P1614, DOI 10.1096/fasebj.9.15.8529841; Rokutanda T, 2011, ARTERIOSCL THROM VAS, V31, P2872, DOI 10.1161/ATVBAHA.111.229773; Sackner MA, 2005, CHEST, V128, P2794, DOI 10.1378/chest.128.4.2794; Sackner MA, 2005, CHEST, V127, P30, DOI 10.1378/chest.127.1.30; Segalat L, 2005, EXP CELL RES, V302, P170, DOI 10.1016/j.yexcr.2004.09.007; Serravite DH, 2014, INT J SPORTS PHYSL P; Squire S, 2002, HUM MOL GENET, V11, P3333, DOI 10.1093/hmg/11.26.3333; Thomas GD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049350; Tidball JG, 1999, J BIOL CHEM, V274, P33155, DOI 10.1074/jbc.274.46.33155; Tinsley J, 1998, NAT MED, V4, P1441, DOI 10.1038/4033; TURNER PR, 1988, NATURE, V335, P735, DOI 10.1038/335735a0; Uematsu M, 1995, AM J PHYSIOL-CELL PH, V269, pC1371, DOI 10.1152/ajpcell.1995.269.6.C1371; Vandebrouck C, 2002, J CELL BIOL, V158, P1089, DOI 10.1083/jcb.200203091; Vianello S, 2013, FASEB J, V27, P2256, DOI 10.1096/fj.12-215723; Wehling M, 2001, J CELL BIOL, V155, P123, DOI 10.1083/jcb.200105110; Wehling-Henricks M, 2005, HUM MOL GENET, V14, P1921, DOI 10.1093/hmg/ddi197; Woods CE, 2004, J PHYSIOL-LONDON, V557, P59, DOI 10.1113/jphysiol.2004.061291	68	16	16	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2014	9	9							e106590	10.1371/journal.pone.0106590	http://dx.doi.org/10.1371/journal.pone.0106590			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3LR	25181488	Green Published, gold, Green Submitted			2022-12-27	WOS:000341231500116
J	Angrisano, T; Schiattarella, GG; Keller, S; Pironti, G; Florio, E; Magliulo, F; Bottino, R; Pero, R; Lembo, F; Avvedimento, EV; Esposito, G; Trimarco, B; Chiariotti, L; Perrino, C				Angrisano, Tiziana; Schiattarella, Gabriele Giacomo; Keller, Simona; Pironti, Gianluigi; Florio, Ermanno; Magliulo, Fabio; Bottino, Roberta; Pero, Raffaela; Lembo, Francesca; Avvedimento, Enrico Vittorio; Esposito, Giovanni; Trimarco, Bruno; Chiariotti, Lorenzo; Perrino, Cinzia			Epigenetic Switch at Atp2a2 and Myh7 Gene Promoters in Pressure Overload-Induced Heart Failure	PLOS ONE			English	Article							CHROMATIN MODIFICATIONS; CARDIAC DYSFUNCTION; DNA METHYLATION; MECHANICAL-STRESS; EXPRESSION; HYPERTROPHY; DISEASE	Re-induction of fetal genes and/or re-expression of postnatal genes represent hallmarks of pathological cardiac remodeling, and are considered important in the progression of the normal heart towards heart failure (HF). Whether epigenetic modifications are involved in these processes is currently under investigation. Here we hypothesized that histone chromatin modifications may underlie changes in the gene expression program during pressure overload-induced HF. We evaluated chromatin marks at the promoter regions of the sarcoplasmic reticulum Ca2+ ATPase (SERCA-2A) and beta-myosin-heavy chain (beta-MHC) genes (Atp2a2 and Myh7, respectively) in murine hearts after one or eight weeks of pressure overload induced by transverse aortic constriction (TAC). As expected, all TAC hearts displayed a significant reduction in SERCA-2A and a significant induction of beta-MHC mRNA levels. Interestingly, opposite histone H3 modifications were identified in the promoter regions of these genes after TAC, including H3 dimethylation (me2) at lysine (K) 4 (H3K4me2) and K9 (H3K9me2), H3 trimethylation (me3) at K27 (H3K27me3) and dimethylation (me2) at K36 (H3K36me2). Consistently, a significant reduction of lysine-specific demethylase KDM2A could be found after eight weeks of TAC at the Atp2a2 promoter. Moreover, opposite changes in the recruitment of DNA methylation machinery components (DNA methyltransferases DNMT1 and DNMT3b, and methyl CpG binding protein 2 MeCp2) were found at the Atp2a2 or Myh7 promoters after TAC. Taken together, these results suggest that epigenetic modifications may underlie gene expression reprogramming in the adult murine heart under conditions of pressure overload, and might be involved in the progression of the normal heart towards HF.	[Angrisano, Tiziana; Keller, Simona; Florio, Ermanno; Pero, Raffaela; Lembo, Francesca; Avvedimento, Enrico Vittorio; Chiariotti, Lorenzo] Univ Naples Federico II, Dept Mol Med & Med Biotechnol, Naples, Italy; [Angrisano, Tiziana] Univ Naples Federico II, Dept Biol, Naples, Italy; [Schiattarella, Gabriele Giacomo; Pironti, Gianluigi; Magliulo, Fabio; Bottino, Roberta; Esposito, Giovanni; Trimarco, Bruno; Perrino, Cinzia] Univ Naples Federico II, Dept Adv Biomed Sci, Naples, Italy; [Pironti, Gianluigi] Duke Univ, Med Ctr, Dept Med, Durham, NC USA	University of Naples Federico II; University of Naples Federico II; University of Naples Federico II; Duke University	Chiariotti, L (corresponding author), Univ Naples Federico II, Dept Mol Med & Med Biotechnol, Naples, Italy.	chiariot@unina.it; perrino@unina.it	Perrino, Cinzia/K-3183-2016; Pero, Raffaela/L-1461-2015; Pironti, Gianluigi/D-9449-2018; Schiattarella, Gabriele/Z-2624-2019; Schiattarella, Gabriele G/M-9506-2017; Angrisano, Tiziana/AAC-5353-2022; Trimarco, Bruno BT/K-7851-2016; Bottino, Roberta/AAQ-4135-2021; Bottino, Roberta/AAM-7711-2021; Chiariotti, Lorenzo/AAC-5262-2022; ESPOSITO, Giovanni/F-2880-2010	Perrino, Cinzia/0000-0002-2274-0048; Pero, Raffaela/0000-0003-2182-5530; Pironti, Gianluigi/0000-0001-9401-3029; Schiattarella, Gabriele/0000-0002-7582-7171; Schiattarella, Gabriele G/0000-0002-7582-7171; Trimarco, Bruno BT/0000-0002-0701-6449; Bottino, Roberta/0000-0002-2938-4728; ESPOSITO, Giovanni/0000-0003-0565-7127; FLORIO, ERMANNO/0000-0001-6961-0059; CHIARIOTTI, Lorenzo/0000-0001-6097-4171; Magliulo, Fabio/0000-0003-3387-8517; Angrisano, Tiziana/0000-0002-5940-5278	Italian Ministry of Health [GR-2009-1596220]; Italian Ministry of University, Research and Technology [RBFR124FEN]; Programma Operativo Regionale Campania Fondo Sociale Europeo; "CREME Epigenomics Flagship Project" , EPIGEN, C.N.R; Programmi di ricerca di rilevante interesse nazionale [200956L784]	Italian Ministry of Health(Ministry of Health, Italy); Italian Ministry of University, Research and Technology(Ministry of Education, Universities and Research (MIUR)); Programma Operativo Regionale Campania Fondo Sociale Europeo; "CREME Epigenomics Flagship Project" , EPIGEN, C.N.R; Programmi di ricerca di rilevante interesse nazionale(Ministry of Education, Universities and Research (MIUR)Research Projects of National Relevance (PRIN))	This work was supported by grants to C. P. [Italian Ministry of Health, GR-2009-1596220; Italian Ministry of University, Research and Technology, RBFR124FEN] and by "Programma Operativo Regionale Campania Fondo Sociale Europeo 2007-2013'', "CREME Epigenomics Flagship Project'', EPIGEN, C. N. R. and "Programmi di ricerca di rilevante interesse nazionale 2009'' grants to L. C. [200956L784]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Backs J, 2006, CIRC RES, V98, P15, DOI 10.1161/01.RES.0000197782.21444.8f; Blackledge NP, 2010, MOL CELL, V38, P179, DOI 10.1016/j.molcel.2010.04.009; Chambliss AB, 2013, FASEB J, V27, P2667, DOI 10.1096/fj.12-227108; Dirkx E, 2013, BBA-MOL BASIS DIS, V1832, P2414, DOI 10.1016/j.bbadis.2013.07.023; Egger G, 2004, NATURE, V429, P457, DOI 10.1038/nature02625; Esposito G, 2002, CIRCULATION, V105, P85, DOI 10.1161/hc0102.101365; FRANCIS GS, 1995, CURR OPIN CARDIOL, V10, P260, DOI 10.1097/00001573-199505000-00005; Gusterson RJ, 2003, J BIOL CHEM, V278, P6838, DOI 10.1074/jbc.M211762200; Haas J, 2013, EMBO MOL MED, V5, P413, DOI 10.1002/emmm.201201553; Hang CT, 2010, NATURE, V466, P62, DOI 10.1038/nature09130; Herron TJ, 2002, CIRC RES, V90, P1150, DOI 10.1161/01.RES.0000022879.57270.11; HO KKL, 1993, J AM COLL CARDIOL  S, V22, P6; Kaneda R, 2009, GENES CELLS, V14, P69, DOI 10.1111/j.1365-2443.2008.01252.x; Kho C, 2011, NATURE, V477, P601, DOI 10.1038/nature10407; KOMURO I, 1993, ANNU REV PHYSIOL, V55, P55, DOI 10.1146/annurev.ph.55.030193.000415; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Lipskaia L, 2010, EXPERT OPIN BIOL TH, V10, P29, DOI 10.1517/14712590903321462; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Movassagh M, 2011, CIRCULATION, V124, P2411, DOI 10.1161/CIRCULATIONAHA.111.040071; Movassagh M, 2011, EPIGENOMICS-UK, V3, P103, DOI 10.2217/EPI.10.70; Olson Eric N, 2006, Novartis Found Symp, V274, P3; Papait R, 2013, P NATL ACAD SCI USA, V110, P20164, DOI 10.1073/pnas.1315155110; Papait R, 2013, BASIC RES CARDIOL, V108, DOI 10.1007/s00395-013-0361-1; Perillo B, 2008, SCIENCE, V319, P202, DOI 10.1126/science.1147674; Perrino C, 2006, VASC PHARMACOL, V45, P77, DOI 10.1016/j.vph.2006.01.018; Perrino C, 2006, J CLIN INVEST, V116, P1547, DOI 10.1172/JCI25397; Sadoshima J, 1997, ANNU REV PHYSIOL, V59, P551, DOI 10.1146/annurev.physiol.59.1.551; Schwarzbauer K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047924; Shilatifard A, 2006, ANNU REV BIOCHEM, V75, P243, DOI 10.1146/annurev.biochem.75.103004.142422; Tingare A, 2013, BIOCHEM SOC T, V41, P789, DOI 10.1042/BST20130012; Vire E, 2006, NATURE, V439, P871, DOI 10.1038/nature04431; WEI CM, 1993, CIRCULATION, V88, P1004, DOI 10.1161/01.CIR.88.3.1004; Zhang CL, 2002, CELL, V110, P479, DOI 10.1016/S0092-8674(02)00861-9	33	24	26	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2014	9	9							e106024	10.1371/journal.pone.0106024	http://dx.doi.org/10.1371/journal.pone.0106024			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3LR	25181347	Green Accepted, Green Published, gold			2022-12-27	WOS:000341231500044
J	Bean, DM; Heimbach, J; Ficorella, L; Micklem, G; Oliver, SG; Favrin, G				Bean, Daniel M.; Heimbach, Joshua; Ficorella, Lorenzo; Micklem, Gos; Oliver, Stephen G.; Favrin, Giorgio			esyN: Network Building, Sharing and Publishing	PLOS ONE			English	Article							INTERACTION DATABASE; CRISPONI-SYNDROME; ALZHEIMERS; GENE; PROTEOSTASIS; INTEGRATION; EXPRESSION; PATHWAY; BIOLOGY; SYSTEMS	The construction and analysis of networks is increasingly widespread in biological research. We have developed esyN ("easy networks'') as a free and open source tool to facilitate the exchange of biological network models between researchers. esyN acts as a searchable database of user-created networks from any field. We have developed a simple companion web tool that enables users to view and edit networks using data from publicly available databases. Both normal interaction networks (graphs) and Petri nets can be created. In addition to its basic tools, esyN contains a number of logical templates that can be used to create models more easily. The ability to use previously published models as building blocks makes esyN a powerful tool for the construction of models and network graphs. Users are able to save their own projects online and share them either publicly or with a list of collaborators. The latter can be given the ability to edit the network themselves, allowing online collaboration on network construction. esyN is designed to facilitate unrestricted exchange of this increasingly important type of biological information. Ultimately, the aim of esyN is to bring the advantages of Open Source software development to the construction of biological networks.	[Bean, Daniel M.; Heimbach, Joshua; Ficorella, Lorenzo; Micklem, Gos; Oliver, Stephen G.; Favrin, Giorgio] Univ Cambridge, Cambridge Syst Biol Ctr, Cambridge, England; [Bean, Daniel M.; Ficorella, Lorenzo; Oliver, Stephen G.; Favrin, Giorgio] Univ Cambridge, Dept Biochem, Cambridge CB2 1QW, England; [Ficorella, Lorenzo] Univ Pisa, Dipartimento Biochim, Pisa, Italy; [Micklem, Gos] Univ Cambridge, Dept Genet, Cambridge CB2 3EH, England	University of Cambridge; University of Cambridge; University of Pisa; University of Cambridge	Favrin, G (corresponding author), Univ Cambridge, Cambridge Syst Biol Ctr, Cambridge, England.	gf247@cam.ac.uk	Oliver, Stephen/AAQ-5992-2021; Bean, Daniel/AFQ-4601-2022	Oliver, Stephen/0000-0003-3410-6439; Micklem, Gos/0000-0002-6883-6168; Bean, Daniel/0000-0002-8594-7804; Favrin, Giorgio/0000-0002-1884-7352	Wellcome Trust/MRC [089703/Z/09/Z]; BBSRC [BB/K011138/1] Funding Source: UKRI; MRC [MC_G1000734] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/K011138/1] Funding Source: researchfish; Medical Research Council [MC_G1000734] Funding Source: researchfish	Wellcome Trust/MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)Wellcome Trust); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by the Wellcome Trust/MRC (grant code: 089703/Z/09/Z) (http://www.wellcome.ac.uk/ and http://www.mrc.ac.uk/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altay G, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-296; [Anonymous], 2013, NUCL ACIDS RES; Balakrishnan R, 2012, DATABASE-OXFORD, DOI 10.1093/database/bar062; Balch WE, 2008, SCIENCE, V319, P916, DOI 10.1126/science.1141448; Bandyopadhyay S, 2010, SCIENCE, V330, P1385, DOI 10.1126/science.1195618; Ben-Zvi A, 2009, P NATL ACAD SCI USA, V106, P14914, DOI 10.1073/pnas.0902882106; Chatr-aryamontri A, 2013, NUCLEIC ACIDS RES, V41, pD816, DOI 10.1093/nar/gks1158; Contrino S, 2012, NUCLEIC ACIDS RES, V40, pD1082, DOI 10.1093/nar/gkr921; Crisponi L, 2007, AM J HUM GENET, V80, P971, DOI 10.1086/516843; Croft D, 2014, NUCLEIC ACIDS RES, V42, pD472, DOI 10.1093/nar/gkt1102; Cruchaga C, 2014, NATURE, V505, P550, DOI 10.1038/nature12825; Forabosco P, 2013, NEUROBIOL AGING, V34, P2699, DOI 10.1016/j.neurobiolaging.2013.05.001; Goss PJE, 1998, P NATL ACAD SCI USA, V95, P6750, DOI 10.1073/pnas.95.12.6750; Harold D, 2009, NAT GENET, V41, P1088, DOI 10.1038/ng.440; Hernandez F, 2013, J ALZHEIMERS DIS, V33, pS141, DOI 10.3233/JAD-2012-129025; Ideker T, 2012, MOL SYST BIOL, V8, DOI 10.1038/msb.2011.99; Jonsson T, 2013, NEW ENGL J MED, V368, P107, DOI 10.1056/NEJMoa1211103; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kauwe JSK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015918; Khwaja A, 1999, NATURE, V401, P33, DOI 10.1038/43354; Lambert JC, 2013, NAT GENET, V45, P1452, DOI 10.1038/ng.2802; Li C, 2010, BMC SYST BIOL, V4, DOI [10.1186/1752-0509-4-39, 10.1186/1752-0509-4-92]; Ling SC, 2013, NEURON, V79, P416, DOI 10.1016/j.neuron.2013.07.033; Lyne M, 2013, DATABASE-OXFORD, DOI 10.1093/database/bat060; Lyne R, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-7-r129; MURATA T, 1989, P IEEE, V77, P541, DOI 10.1109/5.24143; Nishimura D, 2001, BIOTECH SOFTWARE INT, V2, P117, DOI DOI 10.1089/152791601750294344; Ogishima S, 2013, CLIN PHARMACOL THER, V93, P399, DOI 10.1038/clpt.2013.37; Razick S, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-405; Rhinn H, 2013, NATURE, V500, P45, DOI 10.1038/nature12415; Rohr C, 2010, BIOINFORMATICS, V26, P974, DOI 10.1093/bioinformatics/btq050; Shang H, 2014, MOL NEUROBIOL; Smith RN, 2012, BIOINFORMATICS, V28, P3163, DOI 10.1093/bioinformatics/bts577; Smoot ME, 2011, BIOINFORMATICS, V27, P431, DOI 10.1093/bioinformatics/btq675; Uzunalic N, 2013, GENET COUNSEL, V24, P161; Vasquez JB, 2013, NEUROSCI LETT, V556, P58, DOI 10.1016/j.neulet.2013.09.058; Walter P, 2011, SCIENCE, V334, P1081, DOI 10.1126/science.1209038; Zhang B, 2013, CELL, V153, P707, DOI 10.1016/j.cell.2013.03.030; Zhang YW, 2011, MOL BRAIN, V4, DOI 10.1186/1756-6606-4-3	39	42	42	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2014	9	9							e106035	10.1371/journal.pone.0106035	http://dx.doi.org/10.1371/journal.pone.0106035			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3LR	25181461	Green Published, gold			2022-12-27	WOS:000341231500045
J	Ma, HF; Hu, JH; Xi, J; Shen, W; Ge, JQ; Geng, F; Wu, YT; Guo, JJ; Yao, DZ				Ma, Hengfen; Hu, Jiehui; Xi, Jie; Shen, Wen; Ge, Jianqiao; Geng, Feng; Wu, Yuntao; Guo, Jinjin; Yao, Dezhong			Bilingual Cognitive Control in Language Switching: An fMRI Study of English-Chinese Late Bilinguals	PLOS ONE			English	Article							MEDIAL FRONTAL-CORTEX; BASAL GANGLIA; ANTERIOR CINGULATE; INHIBITORY CONTROL; BRAIN; REPRESENTATION; ORGANIZATION; MECHANISMS; SELECTION; AREAS	The present study explored the bilingual cognitive control mechanism by comparing Chinese-English bilinguals' language switching in a blocked picture naming paradigm against three baseline conditions, namely the control condition (a fixation cross, low-level baseline), single L1 production (Chinese naming, high-level baseline), and single L2 production (English naming, high-level baseline). Different activation patterns were observed for language switching against different baseline conditions. These results indicate that different script bilingual language control involves a fronto-parietal-subcortical network that extends to the precentral gyrus, the Supplementary Motor Area, the Supra Marginal Gyrus, and the fusiform. The different neural correlates identified across different comparisons supported that bilingual language switching involves high-level cognitive processes that are not specific to language processing. Future studies adopting a network approach are crucial in identifying the functional connectivity among regions subserving language control.	[Ma, Hengfen; Geng, Feng; Wu, Yuntao; Guo, Jinjin] Civil Aviat Univ China, Sch Foreign Languages, Tianjin, Peoples R China; [Hu, Jiehui; Yao, Dezhong] Univ Elect Sci & Technol China, Sch Life Sci & Technol, Key Lab NeuroInformat, Minist Educ, Chengdu 610054, Peoples R China; [Hu, Jiehui] Univ Elect Sci & Technol China, Sch Foreign Languages, Chengdu 610054, Peoples R China; [Xi, Jie] Chinese Acad Sci, Inst Psychol, Key Lab Behav Sci, Beijing 100101, Peoples R China; [Shen, Wen] Tianjin First Ctr Hosp, Dept Radiol, Tianjin, Peoples R China; [Ge, Jianqiao] Peking Univ, Ctr MRI Res, Acad Adv Interdisciplinary Studies, Beijing 100871, Peoples R China	Civil Aviation University of China; University of Electronic Science & Technology of China; University of Electronic Science & Technology of China; Chinese Academy of Sciences; Institute of Psychology, CAS; Peking University	Hu, JH (corresponding author), Univ Elect Sci & Technol China, Sch Life Sci & Technol, Key Lab NeuroInformat, Minist Educ, Chengdu 610054, Peoples R China.	jerrywho@163.com			National Science Foundation of China [81271550]; Fundamental Research Funding for the Central Universities [ZYGX2011YB031]; Sichuan Social Science Foundation [SC13WY14]	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funding for the Central Universities; Sichuan Social Science Foundation	The study is supported by the National Science Foundation of China (81271550), the Fundamental Research Funding for the Central Universities (ZYGX2011YB031), and the Sichuan Social Science Foundation (SC13WY14). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abutalebi J, 2008, CEREB CORTEX, V18, P1496, DOI 10.1093/cercor/bhm182; Abutalebi J, 2008, LANG COGNITIVE PROC, V23, P557, DOI 10.1080/01690960801920602; Abutalebi J, 2007, J NEUROLINGUIST, V20, P242, DOI 10.1016/j.jneuroling.2006.10.003; Backman L, 2006, NEUROSCI BIOBEHAV R, V30, P791, DOI 10.1016/j.neubiorev.2006.06.005; Bialystok E., 2007, INT J BILING EDUC BI, V10, P210, DOI [10.2167/beb441.0, DOI 10.2167/BEB441.0]; Bialystok E, 2009, BILING-LANG COGN, V12, P3, DOI 10.1017/S1366728908003477; Bobb SC, 2013, J COGN PSYCHOL, V25, P493, DOI 10.1080/20445911.2013.822724; Bookheimer S, 2002, ANNU REV NEUROSCI, V25, P151, DOI 10.1146/annurev.neuro.25.112701.142946; COLLINS DL, 1994, J COMPUT ASSIST TOMO, V18, P192, DOI 10.1097/00004728-199403000-00005; Costa A., 1999, BILINGUAL LANG COGNI, V2, P231, DOI [10.1017/S1366728999000334, 10.1017/s1366728999000334, DOI 10.1017/S1366728999000334]; De Bleser R, 2003, J NEUROLINGUIST, V16, P439, DOI 10.1016/S0911-6044(03)00022-8; de Bruin A, 2014, NEUROIMAGE, V90, P348, DOI 10.1016/j.neuroimage.2013.12.049; Dronkers NF, 1996, NATURE, V384, P159, DOI 10.1038/384159a0; Duque J, 2013, J COGNITIVE NEUROSCI, V25, P1634, DOI 10.1162/jocn_a_00421; Friederici AD, 2003, NEUROPSYCHOLOGY, V17, P133, DOI 10.1037/0894-4105.17.1.133; Friston KJ, 1994, HUMAN BRAIN MAPPING, V2, P189, DOI DOI 10.1002/HBM.460020402; Guo TM, 2011, NEUROIMAGE, V56, P2300, DOI 10.1016/j.neuroimage.2011.03.049; Hedden T, 2010, NEUROIMAGE, V51, P421, DOI 10.1016/j.neuroimage.2010.01.089; Hernandez A, 2005, TRENDS COGN SCI, V9, P220, DOI 10.1016/j.tics.2005.03.003; Hernandez AE, 2000, BRAIN LANG, V73, P421, DOI 10.1006/brln.1999.2278; Hernandez AE, 2001, NEUROIMAGE, V14, P510, DOI 10.1006/nimg.2001.0810; Hernandez AE, 2006, BILING-LANG COGN, V9, P177, DOI 10.1017/S1366728906002525; Hernandez AE, 2009, BRAIN LANG, V109, P133, DOI 10.1016/j.bandl.2008.12.005; Hickok G, 2012, NAT REV NEUROSCI, V13, P135, DOI 10.1038/nrn3158; Hosoda C, 2013, J NEUROSCI, V33, P13663, DOI 10.1523/JNEUROSCI.0410-13.2013; Hosoda C, 2012, J NEUROLINGUIST, V25, P44, DOI 10.1016/j.jneuroling.2011.08.007; Jaeger Antonio, 2013, Psychol. Neurosci., V6, P23, DOI 10.3922/j.psns.2013.1.05; Jahfari S, 2012, J NEUROSCI, V32, P10870, DOI 10.1523/JNEUROSCI.0902-12.2012; Kroll J.F., 2005, HDB BILINGUALISM PSY; Li YQ, 2013, BRAIN LANG, V127, P452, DOI 10.1016/j.bandl.2013.09.005; Liu HY, 2010, BRAIN RES, V1316, P75, DOI 10.1016/j.brainres.2009.12.030; Longworth CE, 2005, BRAIN, V128, P584, DOI 10.1093/brain/awh387; Luk G, 2012, LANG COGNITIVE PROC, V27, P1479, DOI 10.1080/01690965.2011.613209; Luk G, 2010, BRAIN COGNITION, V74, P347, DOI 10.1016/j.bandc.2010.09.004; McCormick LM, 2006, NEUROIMAGE, V32, P1167, DOI 10.1016/j.neuroimage.2006.04.227; Mink JW, 1996, PROG NEUROBIOL, V50, P381, DOI 10.1016/S0301-0082(96)00042-1; Mink JW, 2003, ARCH NEUROL-CHICAGO, V60, P1365, DOI 10.1001/archneur.60.10.1365; Nachev P, 2008, NAT REV NEUROSCI, V9, P856, DOI 10.1038/nrn2478; Price CJ, 2010, ANN NY ACAD SCI, V1191, P62, DOI 10.1111/j.1749-6632.2010.05444.x; Price CJ, 1997, J COGNITIVE NEUROSCI, V9, P727, DOI 10.1162/jocn.1997.9.6.727; Ridderinkhof KR, 2004, SCIENCE, V306, P443, DOI 10.1126/science.1100301; Seeley WW, 2007, J NEUROSCI, V27, P2349, DOI 10.1523/JNEUROSCI.5587-06.2007; Toro R, 2008, CEREB CORTEX, V18, P2553, DOI 10.1093/cercor/bhn014; Velanova K, 2008, CEREB CORTEX, V18, P2505, DOI 10.1093/cercor/bhn012; Wang YP, 2007, NEUROIMAGE, V35, P862, DOI 10.1016/j.neuroimage.2006.09.054; Wang YP, 2009, NEUROIMAGE, V47, P414, DOI 10.1016/j.neuroimage.2008.12.055; Welander-Vatn A, 2013, NEUROSCI LETT, V549, P51, DOI 10.1016/j.neulet.2013.06.010	47	10	10	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2014	9	9							e106468	10.1371/journal.pone.0106468	http://dx.doi.org/10.1371/journal.pone.0106468			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3LR	25180974	Green Submitted, Green Published, gold			2022-12-27	WOS:000341231500103
J	Cohen, JR; Gallen, CL; Jacobs, EG; Lee, TG; D'Esposito, M				Cohen, Jessica R.; Gallen, Courtney L.; Jacobs, Emily G.; Lee, Taraz G.; D'Esposito, Mark			Quantifying the Reconfiguration of Intrinsic Networks during Working Memory	PLOS ONE			English	Article							FUNCTIONAL BRAIN NETWORKS; CONNECTIVITY NETWORKS; TASK; PERFORMANCE; ARCHITECTURES; WORKSPACE; COGNITION; DYNAMICS	Rapid, flexible reconfiguration of connections across brain regions is thought to underlie successful cognitive control. Two intrinsic networks in particular, the cingulo-opercular (CO) and fronto-parietal (FP), are thought to underlie two operations critical for cognitive control: task-set maintenance/tonic alertness and adaptive, trial-by-trial updating. Using functional magnetic resonance imaging, we directly tested whether the functional connectivity of the CO and FP networks was related to cognitive demands and behavior. We focused on working memory because of evidence that during working memory tasks the entire brain becomes more integrated. When specifically probing the CO and FP cognitive control networks, we found that individual regions of both intrinsic networks were active during working memory and, as expected, integration across the two networks increased during task blocks that required cognitive control. Crucially, increased integration between each of the cognitive control networks and a task-related, non-cognitive control network (the hand somatosensory-motor network; SM) was related to increased accuracy. This implies that dynamic reconfiguration of the CO and FP networks so as to increase their inter-network communication underlies successful working memory.	[Cohen, Jessica R.] Kennedy Krieger Inst, Baltimore, MD 21205 USA; [Cohen, Jessica R.] Johns Hopkins Univ, Sch Med, Dept Neurol, Baltimore, MD 21205 USA; [Gallen, Courtney L.; D'Esposito, Mark] Univ Calif Berkeley, Helen Wills Neurosci Inst, Berkeley, CA 94720 USA; [Jacobs, Emily G.] Harvard Univ, Sch Med, Dept Psychiat, Boston, MA 02115 USA; [Jacobs, Emily G.] Brigham & Womens Hosp, Dept Psychiat & Med, Div Womens Hlth, Boston, MA 02115 USA; [Lee, Taraz G.] Univ Calif Santa Barbara, Dept Psychol & Brain Sci, Santa Barbara, CA 93106 USA; [D'Esposito, Mark] Univ Calif Berkeley, Dept Psychol, Berkeley, CA 94720 USA	Kennedy Krieger Institute; Johns Hopkins University; University of California System; University of California Berkeley; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; University of California System; University of California Santa Barbara; University of California System; University of California Berkeley	Cohen, JR (corresponding author), Kennedy Krieger Inst, Baltimore, MD 21205 USA.	CohenJe@kennedykrieger.org		Lee, Taraz/0000-0002-3186-8625	National Institutes of Health [NS79698, MH63901]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH063901] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS079698] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by National Institutes of Health grants NS79698 and MH63901 to MD. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arbabshirani MR, 2013, HUM BRAIN MAPP, V34, P2959, DOI 10.1002/hbm.22118; Bassett DS, 2011, P NATL ACAD SCI USA, V108, P7641, DOI 10.1073/pnas.1018985108; Bressler SL, 2001, TRENDS COGN SCI, V5, P26, DOI 10.1016/S1364-6613(00)01564-3; Chang C, 2010, FILM COMMENT, V46, P81; Cole DM, 2010, FRONT SYST NEUROSCI, V4, DOI 10.3389/fnsys.2010.00008; Cole MW, 2014, NEURON, V83, P238, DOI 10.1016/j.neuron.2014.05.014; Dehaene S, 1998, P NATL ACAD SCI USA, V95, P14529, DOI 10.1073/pnas.95.24.14529; DEsposito M, 2014, CEREB CORTE IN PRESS; Dosenbach NUF, 2008, TRENDS COGN SCI, V12, P99, DOI 10.1016/j.tics.2008.01.001; Dosenbach NUF, 2007, P NATL ACAD SCI USA, V104, P11073, DOI 10.1073/pnas.0704320104; Dosenbach NUF, 2006, NEURON, V50, P799, DOI 10.1016/j.neuron.2006.04.031; Fornito A, 2012, P NATL ACAD SCI USA, V109, P12788, DOI 10.1073/pnas.1204185109; Fox MD, 2010, FRONT SYST NEUROSCI, V4, DOI [10.3389/fnsys.2010.00019, 10.3389/fnsys.2010.0001]; Giessing C, 2013, J NEUROSCI, V33, P5903, DOI 10.1523/JNEUROSCI.4854-12.2013; Gordon EM, 2012, HUM BRAIN MAPP, V33, P1536, DOI 10.1002/hbm.21306; Jacobs E, 2011, J NEUROSCI, V31, P5286, DOI 10.1523/JNEUROSCI.6394-10.2011; Jones DT, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0039731, 10.1371/journal.pone.0044294]; Kitzbichler MG, 2011, J NEUROSCI, V31, P8259, DOI 10.1523/JNEUROSCI.0440-11.2011; Lee TG, 2012, J NEUROSCI, V32, P15458, DOI 10.1523/JNEUROSCI.0627-12.2012; McIntosh AR, 1999, MEMORY, V7, P523, DOI 10.1080/096582199387733; Mennes M, 2013, CEREB CORTEX, V23, P223, DOI 10.1093/cercor/bhs010; Mumford JA, 2012, NEUROIMAGE, V59, P2636, DOI 10.1016/j.neuroimage.2011.08.076; Nomura EM, 2010, P NATL ACAD SCI USA, V107, P12017, DOI 10.1073/pnas.1002431107; Power JD, 2011, NEURON, V72, P665, DOI 10.1016/j.neuron.2011.09.006; Power JD, 2010, NEURON, V67, P735, DOI 10.1016/j.neuron.2010.08.017; Repovs G, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00137; Rissman J, 2004, NEUROIMAGE, V23, P752, DOI 10.1016/j.neuroimage.2004.06.035; Seeley WW, 2007, J NEUROSCI, V27, P2349, DOI 10.1523/JNEUROSCI.5587-06.2007; Shehzad Z, 2009, CEREB CORTEX, V19, P2209, DOI 10.1093/cercor/bhn256; van den Heuvel MP, 2009, J NEUROSCI, V29, P7619, DOI 10.1523/JNEUROSCI.1443-09.2009; Woolrich M, 2008, NEUROIMAGE, V41, P286, DOI 10.1016/j.neuroimage.2008.02.042; Woolrich MW, 2001, NEUROIMAGE, V14, P1370, DOI 10.1006/nimg.2001.0931; Yeo BTT, 2014, FUNCTIONAL IN PRESS	33	27	27	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2014	9	9							e106636	10.1371/journal.pone.0106636	http://dx.doi.org/10.1371/journal.pone.0106636			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ1IR	25191704	Green Submitted, Green Published, gold			2022-12-27	WOS:000347993600048
J	Schoetz, U; Deliolanis, NC; Ng, D; Pauli, J; Resch-Genger, U; Kuhn, E; Heuer, S; Beisker, W; Koster, RW; Zitzelsberger, H; Caldwell, RB				Schoetz, Ulrike; Deliolanis, Nikolaos C.; Ng, David; Pauli, Jutta; Resch-Genger, Ute; Kuehn, Enrico; Heuer, Steffen; Beisker, Wolfgang; Koester, Reinhard W.; Zitzelsberger, Horst; Caldwell, Randolph B.			Usefulness of a Darwinian System in a Biotechnological Application: Evolution of Optical Window Fluorescent Protein Variants under Selective Pressure	PLOS ONE			English	Article							GENE CONVERSION; HYPERMUTATION; EXPRESSION	With rare exceptions, natural evolution is an extremely slow process. One particularly striking exception in the case of protein evolution is in the natural production of antibodies. Developing B cells activate and diversify their immunoglobulin (Ig) genes by recombination, gene conversion (GC) and somatic hypermutation (SHM). Iterative cycles of hypermutation and selection continue until antibodies of high antigen binding specificity emerge (affinity maturation). The avian B cell line DT40, a cell line which is highly amenable to genetic manipulation and exhibits a high rate of targeted integration, utilizes both GC and SHM. Targeting the DT40's diversification machinery onto transgenes of interest inserted into the Ig loci and coupling selective pressure based on the desired outcome mimics evolution. Here we further demonstrate the usefulness of this platform technology by selectively pressuring a large shift in the spectral properties of the fluorescent protein eqFP615 into the highly stable and advanced optical imaging expediting fluorescent protein Amrose. The method is advantageous as it is time and cost effective and no prior knowledge of the outcome protein's structure is necessary. Amrose was evolved to have high excitation at 633 nm and excitation/emission into the far-red, which is optimal for whole-body and deep tissue imaging as we demonstrate in the zebrafish and mouse model.	[Schoetz, Ulrike; Heuer, Steffen; Zitzelsberger, Horst; Caldwell, Randolph B.] German Res Ctr Environm Hlth GmbH, Helmholtz Ctr Munich, Res Unit Radiat Cytogenet, Dept Radiat Sci, Munich, Germany; [Deliolanis, Nikolaos C.] German Res Ctr Environm Hlth GmbH, Helmholtz Ctr Munich, Inst Biol & Med Imaging, Munich, Germany; [Ng, David] Max Planck Inst Neurobiol, Res Grp Cellular Dynam, D-82152 Martinsried, Germany; [Pauli, Jutta; Resch-Genger, Ute] BAM Fed Inst Mat Res & Testing, Div Biophoton, Berlin, Germany; [Kuehn, Enrico; Koester, Reinhard W.] German Res Ctr Environm Hlth GmbH, Helmholtz Ctr Munich, Inst Dev Genet, Munich, Germany; [Beisker, Wolfgang] German Res Ctr Environm Hlth GmbH, Helmholtz Ctr Munich, Inst Toxicol, Munich, Germany	Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Max Planck Society; Federal Institute for Materials Research & Testing; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health	Caldwell, RB (corresponding author), German Res Ctr Environm Hlth GmbH, Helmholtz Ctr Munich, Res Unit Radiat Cytogenet, Dept Radiat Sci, Munich, Germany.	randolph.caldwell@helmholtz-muenchen.de	Resch-Genger, Ute/B-8369-2009; SchÃtz, Ulrike/ABF-3818-2020	Resch-Genger, Ute/0000-0002-0944-1115; Caldwell, Randolph/0000-0003-3933-3243; Deliolanis, Nikolaos/0000-0002-6392-3035; Schotz, Ulrike/0000-0001-8118-3977; Koster, Reinhard/0000-0001-6593-8196	Marie Curie Intra-European Fellowship within the 7th European Community Framework Programme; KVSF (Kompetenzverbund fur Strahlenforschung) - BMBF (Federal Ministry of Education and Research, Germany) [02NUK001E]	Marie Curie Intra-European Fellowship within the 7th European Community Framework Programme(European Commission); KVSF (Kompetenzverbund fur Strahlenforschung) - BMBF (Federal Ministry of Education and Research, Germany)(Federal Ministry of Education & Research (BMBF))	NCD acknowledges support from a Marie Curie Intra-European Fellowship within the 7th European Community Framework Programme. This work was also funded in part by a KVSF (Kompetenzverbund fur Strahlenforschung, 02NUK001E) grant supported by the BMBF (Federal Ministry of Education and Research, Germany). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arakawa H, 2004, PLOS BIOL, V2, P967, DOI 10.1371/journal.pbio.0020179; Arakawa H, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkm616; BABA TW, 1985, VIROLOGY, V144, P139, DOI 10.1016/0042-6822(85)90312-5; Bachl J, 2007, CYTOGENET GENOME RES, V117, P189, DOI 10.1159/000103179; Blagodatski A, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000332; Boder ET, 1997, NAT BIOTECHNOL, V15, P553, DOI 10.1038/nbt0697-553; Deliolanis NC, 2009, J BIOMED OPT, V14, DOI 10.1117/1.3149854; Deliolanis NC, 2008, J BIOMED OPT, V13, DOI 10.1117/1.2967184; Kanayama N, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gnj013; Lakowicz J.R., 2006, PRINCIPLES FLUORESCE; Lin MZ, 2009, CHEM BIOL, V16, P1169, DOI 10.1016/j.chembiol.2009.10.009; Morozova KS, 2010, BIOPHYS J, V99, pL13, DOI 10.1016/j.bpj.2010.04.025; PARRISH JA, 1981, J INVEST DERMATOL, V77, P45, DOI 10.1111/1523-1747.ep12479235; Petersen J, 2003, J BIOL CHEM, V278, P44626, DOI 10.1074/jbc.M307896200; Pletnev S, 2008, J BIOL CHEM, V283, P28980, DOI 10.1074/jbc.M800599200; Pletneva NV, 2011, PROTEIN SCI, V20, P1265, DOI 10.1002/pro.654; Razansky D, 2009, NAT PHOTONICS, V3, P412, DOI 10.1038/NPHOTON.2009.98; Resch-Genger U, 2005, J FLUORESC, V15, P315, DOI 10.1007/s10895-005-2629-9; RUPP RAW, 1994, GENE DEV, V8, P1311, DOI 10.1101/gad.8.11.1311; Saribasak H, 2006, J IMMUNOL, V176, P365, DOI 10.4049/jimmunol.176.1.365; Schoetz U, 2006, J IMMUNOL, V177, P395, DOI 10.4049/jimmunol.177.1.395; Seo H, 2006, NAT PROTOC, V1, P1502, DOI 10.1038/nprot.2006.248; Shcherbo D, 2007, NAT METHODS, V4, P741, DOI 10.1038/NMETH1083; Shcherbo D, 2010, NAT METHODS, V7, P827, DOI [10.1038/NMETH.1501, 10.1038/nmeth.1501]; Shcherbo D, 2009, BIOCHEM J, V418, P567, DOI 10.1042/BJ20081949; Shu XK, 2009, SCIENCE, V324, P804, DOI 10.1126/science.1168683; Wang L, 2004, P NATL ACAD SCI USA, V101, P16745, DOI 10.1073/pnas.0407752101; Wang L, 2006, NAT PROTOC, V1, P1346, DOI 10.1038/nprot.2006.243; Wiedenmann J, 2002, P NATL ACAD SCI USA, V99, P11646, DOI 10.1073/pnas.182157199; Winding P, 2001, J IMMUNOL METHODS, V249, P1, DOI 10.1016/S0022-1759(00)00333-1; Wurth C, 2013, NAT PROTOC, V8, P1535, DOI 10.1038/nprot.2013.087; Wurth C, 2011, ANAL CHEM, V83, P3431, DOI 10.1021/ac2000303	32	2	2	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2014	9	9							e107069	10.1371/journal.pone.0107069	http://dx.doi.org/10.1371/journal.pone.0107069			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ1IR	25192257	Green Published, Green Submitted, gold			2022-12-27	WOS:000347993600094
J	Chauhan, A				Chauhan, Ashok			Unperturbed Posttranscriptional Regulatory Rev Protein Function and HIV-1 Replication in Astrocytes	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; RNA-BINDING PROTEIN; TRANSCRIPTION ELONGATION COMPLEX; LASER CAPTURE MICRODISSECTION; LONG TERMINAL REPEAT; TAR RNA; NUCLEAR EXPORT; P-TEFB; MESSENGER-RNA; HIV-1-ASSOCIATED DEMENTIA	Astrocytes protect neurons, but also evoke proinflammatory responses to injury and viral infections, including HIV. There is a prevailing notion that HIV-1 Rev protein function in astrocytes is perturbed, leading to restricted viral replication. In earlier studies, our finding of restricted viral entry into astrocytes led us to investigate whether there are any intracellular restrictions, including crippled Rev function, in astrocytes. Despite barely detectable levels of DDX3 (Rev-supporting RNA helicase) and TRBP (anti-PKR) in primary astrocytes compared to astrocytic cells, Rev function was unperturbed in wild-type, but not DDX3-ablated astrocytes. As in permissive cells, after HIV-1 entry bypass in astrocytes, viral-encoded Tat and Rev proteins had robust regulatory activities, leading to efficient viral replication. Productive HIV-1 infection in astrocytes persisted for several weeks. Our findings on HIV-1 entry bypass in astrocytes demonstrated that the intracellular environment is conducive to viral replication and that Tat and Rev functions are unperturbed.	[Chauhan, Ashok] Univ S Carolina, Sch Med, Dept Pathol Microbiol & Immunol, Columbia, SC 29208 USA; [Chauhan, Ashok] Univ S Carolina, Sch Med, Dept Pharmacol Physiol & Neurosci, Columbia, SC USA	University of South Carolina; University of South Carolina System; University of South Carolina Columbia; University of South Carolina; University of South Carolina System; University of South Carolina Columbia	Chauhan, A (corresponding author), Univ S Carolina, Sch Med, Dept Pathol Microbiol & Immunol, Columbia, SC 29208 USA.	Ashok.Chauhan@uscmed.sc.edu			National Institutes of Health (NIH) [RO1 NS0064]; University of South Carolina School of Medicine	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of South Carolina School of Medicine	The work was supported by National Institutes of Health (NIH) grant RO1 NS0064 (AC) and internal funding from the University of South Carolina School of Medicine. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADACHI A, 1986, J VIROL, V59, P284, DOI 10.1128/JVI.59.2.284-291.1986; Askjaer P, 1998, J BIOL CHEM, V273, P33414, DOI 10.1074/jbc.273.50.33414; Bencheikh M, 1999, J NEUROVIROL, V5, P115, DOI 10.3109/13550289909021993; Bivalkar-Mehla S, 2011, VIRUS RES, V155, P1, DOI 10.1016/j.virusres.2010.10.003; Boutet A, 2001, GLIA, V34, P165, DOI 10.1002/glia.1051.abs; Brack-Werner R, 1999, AIDS, V13, P1, DOI 10.1097/00002030-199901140-00003; Bres V, 2005, GENE DEV, V19, P1211, DOI 10.1101/gad.1291705; Canki M, 2001, J VIROL, V75, P7925, DOI 10.1128/JVI.75.17.7925-7933.2001; Chauhan A, 2003, J BIOL CHEM, V278, P13512, DOI 10.1074/jbc.M209381200; Chauhan A, 2007, FASEB J, V21, P777, DOI 10.1096/fj.06-7054com; Chauhan A, 2007, J CONTROL RELEASE, V117, P148, DOI 10.1016/j.jconrel.2006.10.031; Chauhan A, 2014, VIROLOGY, V456, P1, DOI 10.1016/j.virol.2014.03.002; Chou S, 2013, P NATL ACAD SCI USA, V110, pE123, DOI 10.1073/pnas.1216971110; Churchill MJ, 2006, J NEUROVIROL, V12, P146, DOI 10.1080/13550280600748946; Churchill MJ, 2009, ANN NEUROL, V66, P253, DOI 10.1002/ana.21697; D'Orso I, 2012, MOL CELL BIOL, V32, P4780, DOI 10.1128/MCB.00206-12; Daecke J, 2005, J VIROL, V79, P1581, DOI 10.1128/JVI.79.3.1581-1594.2005; Daher A, 2001, J BIOL CHEM, V276, P33899, DOI 10.1074/jbc.M103584200; Daher A, 2009, MOL CELL BIOL, V29, P254, DOI 10.1128/MCB.01030-08; Daniels SM, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-38; DEWHURST S, 1987, J VIROL, V61, P3774, DOI 10.1128/JVI.61.12.3774-3782.1987; Fang JH, 2005, VIROLOGY, V336, P299, DOI 10.1016/j.virol.2005.03.017; FISCHER U, 1994, EMBO J, V13, P4105, DOI 10.1002/j.1460-2075.1994.tb06728.x; Fornerod M, 1997, CELL, V90, P1051, DOI 10.1016/S0092-8674(00)80371-2; Fredericksen BL, 2002, J VIROL, V76, P11440, DOI 10.1128/JVI.76.22.11440-11446.2002; Fujii R, 2001, J BIOL CHEM, V276, P5445, DOI 10.1074/jbc.M006892200; Garber ME, 1998, COLD SPRING HARB SYM, V63, P371, DOI 10.1101/sqb.1998.63.371; Gatignol A, 2005, RETROVIROLOGY, V2, DOI 10.1186/1742-4690-2-65; GATIGNOL A, 1991, SCIENCE, V251, P1597, DOI 10.1126/science.2011739; Gorry P, 1998, J NEUROVIROL, V4, P377, DOI 10.3109/13550289809114536; Gorry PR, 2003, CURR HIV RES, V1, P463, DOI 10.2174/1570162033485122; Gorry PR, 1999, J VIROL, V73, P352, DOI 10.1128/JVI.73.1.352-361.1999; Hamby ME, 2006, J NEUROSCI METH, V150, P128, DOI 10.1016/j.jneumeth.2005.06.016; Herrmann CH, 2001, J CELL SCI, V114, P1491; Ishaq M, 2008, MOL BIOTECHNOL, V39, P231, DOI 10.1007/s12033-008-9040-0; Jeang KT, 2006, NUCLEIC ACIDS RES, V34, P4198, DOI 10.1093/nar/gkl398; Keen NJ, 1997, EMBO J, V16, P5260, DOI 10.1093/emboj/16.17.5260; Kutsch O, 2002, J VIROL, V76, P8776, DOI 10.1128/JVI.76.17.8776-8786.2002; Li JZ, 1999, P NATL ACAD SCI USA, V96, P709, DOI 10.1073/pnas.96.2.709; LI YX, 1992, J VIROL, V66, P6587, DOI 10.1128/JVI.66.11.6587-6600.1992; LI YX, 1991, J VIROL, V65, P3973, DOI 10.1128/JVI.65.8.3973-3985.1991; MALIM MH, 1989, NATURE, V338, P254, DOI 10.1038/338254a0; Mehla R, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-239; Mehla R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011160; Miyauchi K, 2009, CELL, V137, P433, DOI 10.1016/j.cell.2009.02.046; Modem S, 2005, NUCLEIC ACIDS RES, V33, P873, DOI 10.1093/nar/gki231; Modem S, 2008, J CELL PHYSIOL, V214, P14, DOI 10.1002/jcp.21305; MUESING MA, 1987, CELL, V48, P691, DOI 10.1016/0092-8674(87)90247-9; Nashchekin D, 2006, J BIOL CHEM, V281, P14263, DOI 10.1074/jbc.M600262200; NATH A, 1995, J NEUROPATH EXP NEUR, V54, P320, DOI 10.1097/00005072-199505000-00005; NEUMANN M, 1995, J VIROL, V69, P2159, DOI 10.1128/JVI.69.4.2159-2167.1995; Neumann M, 2001, J CELL SCI, V114, P1717; Neville M, 1997, CURR BIOL, V7, P767, DOI 10.1016/S0960-9822(06)00335-6; Noguchi K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051393; Ong CL, 2005, J VIROL, V79, P12763, DOI 10.1128/JVI.79.20.12763-12772.2005; PARK HS, 1994, P NATL ACAD SCI USA, V91, P4713, DOI 10.1073/pnas.91.11.4713; Qian S, 2009, P NATL ACAD SCI USA, V106, P605, DOI 10.1073/pnas.0806822106; Ramanathan Y, 1999, J VIROL, V73, P5448, DOI 10.1128/JVI.73.7.5448-5458.1999; Reddy TR, 1999, NAT MED, V5, P635, DOI 10.1038/9479; Reddy TR, 2002, J BIOL CHEM, V277, P5778, DOI 10.1074/jbc.M106836200; Sanghvi VR, 2011, J VIROL, V85, P12614, DOI 10.1128/JVI.05240-11; Schweighardt B, 2001, AIDS RES HUM RETROV, V17, P1133, DOI 10.1089/088922201316912745; SELBY MJ, 1989, GENE DEV, V3, P547, DOI 10.1101/gad.3.4.547; Sheridan PL, 1997, GENE DEV, V11, P3327, DOI 10.1101/gad.11.24.3327; Shun MC, 2008, J VIROL, V82, P11555, DOI 10.1128/JVI.01561-08; Sobhian B, 2010, MOL CELL, V38, P439, DOI 10.1016/j.molcel.2010.04.012; Soros VB, 2001, J VIROL, V75, P8203, DOI 10.1128/JVI.75.17.8203-8215.2001; Steger DJ, 1998, P NATL ACAD SCI USA, V95, P12924, DOI 10.1073/pnas.95.22.12924; Tahirov TH, 2010, NATURE, V465, P747, DOI 10.1038/nature09131; TORNATORE C, 1991, J VIROL, V65, P6094, DOI 10.1128/JVI.65.11.6094-6100.1991; Treand C, 2006, EMBO J, V25, P1690, DOI 10.1038/sj.emboj.7601074; Trillo-Pazos G, 2003, BRAIN PATHOL, V13, P144; Vijaykumar TS, 2008, VIROLOGY, V381, P1, DOI 10.1016/j.virol.2008.07.039; Weinberger LS, 2005, CELL, V122, P169, DOI 10.1016/j.cell.2005.06.006; Wiley CA, 1997, AIDS, V11, P252; Wolff B, 1997, CHEM BIOL, V4, P139, DOI 10.1016/S1074-5521(97)90257-X; Yedavalli VSRK, 2004, CELL, V119, P381, DOI 10.1016/j.cell.2004.09.029; Zhang J, 2000, J BIOL CHEM, V275, P34314, DOI 10.1074/jbc.M006804200; Zhang RN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015620	79	10	10	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 4	2014	9	9							e106910	10.1371/journal.pone.0106910	http://dx.doi.org/10.1371/journal.pone.0106910			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3XV	25188302	Green Submitted, Green Published, gold			2022-12-27	WOS:000341271500095
J	Chavez, RO; Clevers, JGPW; Verbesselt, J; Naulin, PI; Herold, M				Chavez, Roberto O.; Clevers, Jan G. P. W.; Verbesselt, Jan; Naulin, Paulette I.; Herold, Martin			Detecting Leaf Pulvinar Movements on NDVI Time Series of Desert Trees: A New Approach for Water Stress Detection	PLOS ONE			English	Article							PAMPA DEL TAMARUGAL; ATACAMA DESERT; PROSOPIS-TAMARUGO; CANOPY STRUCTURE; NORTHERN CHILE; PHOTOINHIBITION; LANDSAT; PLANTS; TERRA; LIFE	Heliotropic leaf movement or leaf 'solar tracking' occurs for a wide variety of plants, including many desert species and some crops. This has an important effect on the canopy spectral reflectance as measured from satellites. For this reason, monitoring systems based on spectral vegetation indices, such as the normalized difference vegetation index (NDVI), should account for heliotropic movements when evaluating the health condition of such species. In the hyper-arid Atacama Desert, Northern Chile, we studied seasonal and diurnal variations of MODIS and Landsat NDVI time series of plantation stands of the endemic species Prosopis tamarugo Phil., subject to different levels of groundwater depletion. As solar irradiation increased during the day and also during the summer, the paraheliotropic leaves of Tamarugo moved to an erectophile position (parallel to the sun rays) making the NDVI signal to drop. This way, Tamarugo stands with no water stress showed a positive NDVI difference between morning and midday (Delta NDVImo-mi) and between winter and summer (Delta NDVIW-S). In this paper, we showed that the Delta NDVImo-mi of Tamarugo stands can be detected using MODIS Terra and Aqua images, and the Delta NDVIW-S using Landsat or MODIS Terra images. Because pulvinar movement is triggered by changes in cell turgor, the effects of water stress caused by groundwater depletion can be assessed and monitored using Delta NDVImo-mi and Delta NDVIW-S. For an 11-year time series without rainfall events, Landsat Delta NDVIW-S of Tamarugo stands showed a positive linear relationship with cumulative groundwater depletion. We conclude that both Delta NDVImo-mi and Delta NDVIW-S have potential to detect early water stress of paraheliotropic vegetation.	[Chavez, Roberto O.; Clevers, Jan G. P. W.; Verbesselt, Jan; Herold, Martin] Wageningen Univ, Lab Geo Informat Sci & Remote Sensing, NL-6700 AP Wageningen, Netherlands; [Naulin, Paulette I.] Univ Chile, Dept Silvicultura & Conservac Nat, Lab Biol Plantas, Santiago, Chile	Wageningen University & Research; Universidad de Chile	Chavez, RO (corresponding author), Wageningen Univ, Lab Geo Informat Sci & Remote Sensing, NL-6700 AP Wageningen, Netherlands.	roberto.chavez@wur.nl	Naulin, Paulette/D-8234-2014; Clevers, Jan/N-1278-2014; Chávez, Roberto O./ABC-3608-2021; Herold, Martin/F-8553-2012; Verbesselt, Jan/B-9044-2012	Naulin, Paulette/0000-0002-2166-2789; Clevers, Jan/0000-0002-0046-082X; Chávez, Roberto O./0000-0001-6782-3579; Herold, Martin/0000-0003-0246-6886; Verbesselt, Jan/0000-0001-7923-4309	CONICYT (Chile)-Wageningen University scholarship [281/2009]	CONICYT (Chile)-Wageningen University scholarship	This work has been funded by the CONICYT (Chile)-Wageningen University scholarship (Res. Ex. N. 281/2009). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALPERT P, 2002, DESICCATION SURVIVAL, P4; Altamirano H, 2006, ESPECIES ARBOREAS BO, P534; [Anonymous], 2010, PLANT PHYSL 5 EDITIO; Aravena R, 1985, CURRENT STATE KNOWLE; Baret F, 2007, J EXP BOT, V58, P869, DOI 10.1093/jxb/erl231; Birdsey R, 2013, CARBON MANAG, V4, P519, DOI [10.4155/CMT.13.49, 10.4155/cmt.13.49]; Chavez RO, 2013, INT J APPL EARTH OBS, V21, P53, DOI 10.1016/j.jag.2012.08.013; Chavez RO, 2013, REMOTE SENS-BASEL, V5, P5064, DOI 10.3390/rs5105064; Cohen WB, 2004, BIOSCIENCE, V54, P535, DOI 10.1641/0006-3568(2004)054[0535:LRIEAO]2.0.CO;2; CONAMA (Consejo Nacional del Medio Ambiente), 2008, BIOD CHIL PATR DES; de Chile Gobierno, 1997, PLAN MAN RES NAC PAM, P425; EHLERINGER J, 1980, SCIENCE, V210, P1094, DOI 10.1126/science.210.4474.1094; Estades CF, 1996, WILSON BULL, V108, P268; Gajardo R., 1994, VEGETACION NATURAL C; GAMON JA, 1995, ECOL APPL, V5, P28, DOI 10.2307/1942049; Houston J, 2003, INT J CLIMATOL, V23, P1453, DOI 10.1002/joc.938; Houston J, 2006, J HYDROL, V330, P402, DOI 10.1016/j.jhydrol.2006.03.036; KIMES DS, 1983, INT J REMOTE SENS, V4, P257, DOI 10.1080/01431168308948545; KOLLER D, 1990, PLANT CELL ENVIRON, V13, P615, DOI 10.1111/j.1365-3040.1990.tb01079.x; Koller D, 2001, COMPREHENSIVE SERIES, P833; Masek JG, 2006, IEEE GEOSCI REMOTE S, V3, P68, DOI 10.1109/LGRS.2005.857030; McKay CP, 2003, ASTROBIOLOGY, V3, P393, DOI 10.1089/153110703769016460; MOONEY HA, 1980, OECOLOGIA, V44, P177, DOI 10.1007/BF00572676; MORAN MS, 1989, REMOTE SENS ENVIRON, V29, P251, DOI 10.1016/0034-4257(89)90004-7; Morton DC, 2014, NATURE, V506, P221, DOI 10.1038/nature13006; Navarro-Gonzalez R, 2003, SCIENCE, V302, P1018, DOI 10.1126/science.1089143; Pastenes C, 2005, J EXP BOT, V56, P425, DOI 10.1093/jxb/eri061; Pastenes C, 2004, J PLANT PHYSIOL, V161, P1315, DOI 10.1016/j.jplph.2003.09.002; Ramirez-Leyton G., 2005, FAUNA ALTIPLANO DESI; Riedemann P., 2006, FLORA NATIVA VALOR O; Rojas R, 2007, HYDROGEOL J, V15, P537, DOI 10.1007/s10040-006-0084-6; Soudani K, 2014, NATURE, V506, P165, DOI 10.1038/nature13052; Sudzuki F., 1985, CURRENT STATE KNOWLE, P11; Trobok S., 1985, CURRENT STATE KNOWLE; Verbesselt J, 2012, REMOTE SENS ENVIRON, V123, P98, DOI 10.1016/j.rse.2012.02.022; Verbesselt J, 2009, FOREST ECOL MANAG, V258, P1166, DOI 10.1016/j.foreco.2009.06.011; Wang J, 2007, INT GEOSCI REMOTE SE, P3390, DOI 10.1109/IGARSS.2007.4423572; Williams DL, 2006, PHOTOGRAMM ENG REM S, V72, P1171, DOI 10.14358/PERS.72.10.1171; Wolfe RE, 2002, REMOTE SENS ENVIRON, V83, P31, DOI 10.1016/S0034-4257(02)00085-8; Wu A, 2008, INT J REMOTE SENS, V29, P1997, DOI 10.1080/01431160701355272; ZELADA L, 1986, FOREST ECOL MANAG, V16, P15, DOI 10.1016/0378-1127(86)90004-6	41	9	9	1	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 4	2014	9	9							e106613	10.1371/journal.pone.0106613	http://dx.doi.org/10.1371/journal.pone.0106613			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3XV	25188305	Green Published, Green Submitted, gold			2022-12-27	WOS:000341271500060
J	DaCosta, JM; Sorenson, MD				DaCosta, Jeffrey M.; Sorenson, Michael D.			Amplification Biases and Consistent Recovery of Loci in a Double-Digest RAD-seq Protocol	PLOS ONE			English	Article							POPULATION GENETIC-STRUCTURE; PCR AMPLIFICATION; GENOME; GENERATION; DISCOVERY; DIVERGENCE; ALIGNMENT; MARKERS; SEARCH	A growing variety of "genotype-by-sequencing'' (GBS) methods use restriction enzymes and high throughput DNA sequencing to generate data for a subset of genomic loci, allowing the simultaneous discovery and genotyping of thousands of polymorphisms in a set of multiplexed samples. We evaluated a "double-digest'' restriction-site associated DNA sequencing (ddRAD-seq) protocol by 1) comparing results for a zebra finch (Taeniopygia guttata) sample with in silico predictions from the zebra finch reference genome; 2) assessing data quality for a population sample of indigobirds (Vidua spp.); and 3) testing for consistent recovery of loci across multiple samples and sequencing runs. Comparison with in silico predictions revealed that 1) over 90% of predicted, single-copy loci in our targeted size range (178-328 bp) were recovered; 2) short restriction fragments (38-178 bp) were carried through the size selection step and sequenced at appreciable depth, generating unexpected but nonetheless useful data; 3) amplification bias favored shorter, GC-rich fragments, contributing to among locus variation in sequencing depth that was strongly correlated across samples; 4) our use of restriction enzymes with a GC-rich recognition sequence resulted in an up to four-fold overrepresentation of GC-rich portions of the genome; and 5) star activity (i.e., non-specific cutting) resulted in thousands of "extra'' loci sequenced at low depth. Results for three species of indigobirds show that a common set of thousands of loci can be consistently recovered across both individual samples and sequencing runs. In a run with 46 samples, we genotyped 5,996 loci in all individuals and 9,833 loci in 42 or more individuals, resulting in <1% missing data for the larger data set. We compare our approach to similar methods and discuss the range of factors (fragment library preparation, natural genetic variation, bioinformatics) influencing the recovery of a consistent set of loci among samples.	[DaCosta, Jeffrey M.; Sorenson, Michael D.] Boston Univ, Dept Biol, Boston, MA 02215 USA	Boston University	DaCosta, JM (corresponding author), Boston Univ, Dept Biol, 5 Cummington St, Boston, MA 02215 USA.	dacostaj@bu.edu	Sorenson, Michael/D-8065-2011	Sorenson, Michael/0000-0001-5375-2917; DaCosta, Jeffrey/0000-0002-8590-2083	National Science Foundation [DEB 0640759, DEB 1011517]	National Science Foundation(National Science Foundation (NSF))	This study was funded by the National Science Foundation (DEB 0640759 and DEB 1011517). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aird D, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-2-r18; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Andolfatto P, 2011, GENOME RES, V21, P610, DOI 10.1101/gr.115402.110; Axelsson E, 2005, GENOME RES, V15, P120, DOI 10.1101/gr.3021305; Baird NA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003376; Buerkle CA, 2013, MOL ECOL, V22, P3028, DOI 10.1111/mec.12105; Catchen J, 2013, MOL ECOL, V22, P2864, DOI 10.1111/mec.12330; Coyne KJ, 2004, APPL ENVIRON MICROB, V70, P5298, DOI 10.1128/AEM.70.9.5298-5304.2004; Davey JL, 2010, BRIEF FUNCT GENOMICS, V9, P416, DOI 10.1093/bfgp/elq031; Davey JW, 2013, MOL ECOL, V22, P3151, DOI 10.1111/mec.12084; Davey JW, 2011, NAT REV GENET, V12, P499, DOI 10.1038/nrg3012; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Ekblom R, 2011, HEREDITY, V107, P1, DOI 10.1038/hdy.2010.152; Ellegren H, 2007, CYTOGENET GENOME RES, V117, P120, DOI 10.1159/000103172; Elshire RJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019379; Fair J., 2010, ORNITHOLOGICAL COUNC; Fedurco M, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gnj023; Gautier M, 2013, MOL ECOL, V22, P3165, DOI 10.1111/mec.12089; Gompert Z, 2010, MOL ECOL, V19, P2455, DOI 10.1111/j.1365-294X.2010.04666.x; Hamady M, 2008, NAT METHODS, V5, P235, DOI 10.1038/NMETH.1184; Han E, 2014, MOL BIOL EVOL, V31, P723, DOI 10.1093/molbev/mst229; Hohenlohe PA, 2012, PHILOS T R SOC B, V367, P395, DOI 10.1098/rstb.2011.0245; Kamps-Hughes N, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt257; LYNCH M, 1994, MOL ECOL, V3, P91, DOI 10.1111/j.1365-294X.1994.tb00109.x; McCormack JE, 2013, MOL PHYLOGENET EVOL, V66, P526, DOI 10.1016/j.ympev.2011.12.007; Narum SR, 2013, MOL ECOL, V22, P2841, DOI 10.1111/mec.12350; Parchman TL, 2012, MOL ECOL, V21, P2991, DOI 10.1111/j.1365-294X.2012.05513.x; Peterson BK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037135; Poland JA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032253; Quail MA, 2008, NAT METHODS, V5, P1005, DOI 10.1038/nmeth.1270; Sefc KM, 2005, MOL ECOL, V14, P1407, DOI 10.1111/j.1365-294X.2005.02492.x; Sorenson MD, 2003, NATURE, V424, P928, DOI 10.1038/nature01863; Truong HT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037565; van Orsouw NJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001172; Wahlund S, 1928, HEREDITAS, V11, P65, DOI 10.1111/j.1601-5223.1928.tb02483.x; Walsh P S, 1992, PCR Methods Appl, V1, P241, DOI 10.1101/gr.1.4.241; Wang S, 2012, NAT METHODS, V9, P808, DOI [10.1038/nmeth.2023, 10.1038/NMETH.2023]	38	112	113	0	144	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 4	2014	9	9							e106713	10.1371/journal.pone.0106713	http://dx.doi.org/10.1371/journal.pone.0106713			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3XV	25188270	gold, Green Published, Green Submitted			2022-12-27	WOS:000341271500073
J	Farid, NDN; Aziz, NA; Al-Sadat, N; Jamaludin, M; Dahlui, M				Farid, Nik Daliana Nik; Aziz, Norlaili Abdul; Al-Sadat, Nabilla; Jamaludin, Mariam; Dahlui, Maznah			Clinical Breast Examination As the Recommended Breast Cancer Screening Modality in a Rural Community in Malaysia; What Are the Factors That Could Enhance Its Uptake?	PLOS ONE			English	Article							SERVICE	Breast cancer is the most common cause of deaths and the most frequently diagnosed cancer among women worldwide. This study aimed to determine the prevalence of breast cancer screening, specifically on clinical breast examination, and the predictors of its uptake among women in Malaysia. A cross-sectional study was carried out in five selected districts whereby women aged between 20 to 64 years old, from a total of 1000 households were interviewed. A total of 1192 women responded to the survey of which 53.3% reported had ever done clinical breast examination. Significant associations with clinical breast examination were noted for income and distance from the hospital. These factors should be considered in developing interventions aimed at promoting clinical breast examination. In particular, healthcare providers should be proactive in raising awareness about clinical breast examination among women in Malaysia.	[Farid, Nik Daliana Nik; Aziz, Norlaili Abdul; Jamaludin, Mariam] Univ Malaya, Fac Med, Dept Social & Prevent Med, Kuala Lumpur, Malaysia; [Al-Sadat, Nabilla] Univ Malaya, Fac Med, Ctr Populat Hlth, Dept Social & Prevent Med, Kuala Lumpur, Malaysia; [Dahlui, Maznah] Univ Malaya, Fac Med, Julius Ctr, Dept Social & Prevent Med, Kuala Lumpur, Malaysia	Universiti Malaya; Universiti Malaya; Universiti Malaya	Farid, NDN (corresponding author), Univ Malaya, Fac Med, Dept Social & Prevent Med, Kuala Lumpur, Malaysia.	daliana@ummc.edu.my	Daliana, Nik/I-6196-2015; DAHLUI, MAZNAH/B-8976-2010; Dahlui, Maznah/F-9665-2010	Daliana, Nik/0000-0001-5303-558X; DAHLUI, MAZNAH/0000-0003-4923-9410; 	Faculty of Medicine, University of Malaya [RG410/12HTM]	Faculty of Medicine, University of Malaya	Financial support to MD by the Faculty of Medicine, University of Malaya (Grant Number: RG410/12HTM), is gratefully acknowledged. URL: medicine.um.edu.my. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdullah NN, 2011, ASIAN PAC J CANCER P, V12, P2643; Ahmadian M, 2012, LIFE SCI J, V9, P585; American Cancer Society, 2014, CLIN BREAST EX; Bancej C, 2003, J MED SCREEN, V10, P16, DOI 10.1258/096914103321610761; Bhoo-Pathy N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030995; Cancer Australia, EARL DET BREAST CANC; Dahlui M., 2011, ASIAN PAC J CANCER P, V12, P1; Dahlui M, 2012, ASIAN PAC J CANCER P, V13, P3443, DOI 10.7314/APJCP.2012.13.7.3443; Department of Statistics Malaysia, 2010, TOT POP ETHN GROUP M; Family Health Development Division Ministry of Health Malaysia, 2014, SERV PROV; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; GCC Lim, 2003, 1 NAT CANC REG, P138; Henf LC, 2007, HLTH CARE MALAYSIA D; Hisham Abdullah N, 2004, Asian J Surg, V27, P130, DOI 10.1016/S1015-9584(09)60326-2; IARC IAfcR, 2013, LAT WORLD CANC STAT; Institute for Public Health, 2006, WOM HLTH BREAST HLTH; Khan H, 2013, BRIT SOC BREAST RAD; Linking Health Communication with Social Support, 2011, DEF SOC SUPP; Linsell L, 2010, J MED SCREEN, V17, P176, DOI 10.1258/jms.2010.010037; Maheswaran R, 2006, J EPIDEMIOL COMMUN H, V60, P208, DOI 10.1136/jech.200X.038398; Miller AB, 2000, JNCI-J NATL CANCER I, V92, P1490, DOI 10.1093/jnci/92.18.1490; Ministry of Health Malaysia, 2010, CLIN PRACT GUID MAN; Norlaili AA, 2013, ASIAN PAC J CANCER P, V14, P7161, DOI 10.7314/APJCP.2013.14.12.7161; Pahang Tourism, 2014, AB PAH; Paul M., 2012, FACTORS INFLUENCE UP; Saslow D, 2004, CA-CANCER J CLIN, V54, P327, DOI 10.3322/canjclin.54.6.327; WHO, 2014, BREAST CANC PREV CON	27	14	14	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 4	2014	9	9							e106469	10.1371/journal.pone.0106469	http://dx.doi.org/10.1371/journal.pone.0106469			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3XV	25188003	Green Published, Green Submitted, gold			2022-12-27	WOS:000341271500037
J	Khuntirat, B; Yoon, IK; Chittaganpitch, M; Krueger, WS; Supawat, K; Blair, PJ; Putnam, SD; Gibbons, RV; Buddhari, D; Sawanpanyalert, P; Heil, GL; Friary, JA; Gray, GC				Khuntirat, Benjawan; Yoon, In-Kyu; Chittaganpitch, Malinee; Krueger, Whitney S.; Supawat, Krongkaew; Blair, Patrick J.; Putnam, Shannon D.; Gibbons, Robert V.; Buddhari, Darunee; Sawanpanyalert, Pathom; Heil, Gary L.; Friary, John A.; Gray, Gregory C.			High Rate of A(H1N1)pdm09 Infections among Rural Thai Villagers, 2009-2010	PLOS ONE			English	Article							A H1N1 VIRUS; APRIL-MAY 2009; NEW-YORK-CITY; INFLUENZA-A; PANDEMIC INFLUENZA; HOUSEHOLD TRANSMISSION; CLINICAL-DIAGNOSIS; SEASONAL INFLUENZA; OUTBREAK; ANTIBODY	Background: Pandemic influenza A(H1N1)pdm09 emerged in Thailand in 2009. A prospective longitudinal adult cohort and household transmission study of influenza-like illness (ILI) was ongoing in rural Thailand at the time of emergence. Symptomatic and subclinical A(H1N1)pdm09 infection rates in the cohort and among household members were evaluated. Methods: A cohort of 800 Thai adults underwent active community-based surveillance for ILI from 2008-2010. Acute respiratory samples from ILI episodes were tested for A(H1N1)pdm09 by qRT-PCR; acute and 60-day convalescent blood samples were tested by A(H1N1)pdm09 hemagglutination inhibition assay (HI). Enrollment, 12-month and 24-month followup blood samples were tested for A(H1N1)pdm09 seroconversion by HI. Household members of influenza A-infected cohort subjects with ILI were enrolled in household transmission investigations in which day 0 and 60 blood samples and acute respiratory samples were tested by either qRT-PCR or HI for A(H1N1)pdm09. Seroconversion between annual blood samples without A(H1N1)pdm09-positive ILI was considered as subclinical infection. Results: The 2-yr cumulative incidence of A(H1N1)pdm09 infection in the cohort in 2009/2010 was 10.8% (84/781) with an annual incidence of 1.2% in 2009 and 9.7% in 2010; 83.3% of infections were subclinical (50% in 2009 and 85.9% in 2010). The 2-yr cumulative incidence was lowest (5%) in adults born <= 1957. The A(H1N1) pdm09 secondary attack rate among household contacts was 47.2% (17/36); 47.1% of these infections were subclinical. The highest A(H1N1)pdm09 secondary attack rate among household contacts (70.6%, 12/17) occurred among children born between 1990 and 2003. Conclusion: Subclinical A(H1N1)pdm09 infections in Thai adults occurred frequently and accounted for a greater proportion of all A(H1N1)pdm09 infections than previously estimated. The role of subclinical infections in A(H1N1)pdm09 transmission has important implications in formulating strategies to predict and prevent the spread of A(H1N1)pdm09 and other influenza virus strains.	[Khuntirat, Benjawan; Yoon, In-Kyu; Gibbons, Robert V.; Buddhari, Darunee] Armed Forces Res Inst Med Sci, Dept Virol, Bangkok 10400, Thailand; [Chittaganpitch, Malinee; Supawat, Krongkaew; Sawanpanyalert, Pathom] Minist Publ Hlth, Natl Inst Hlth, Nonthaburi, Thailand; [Krueger, Whitney S.; Heil, Gary L.; Friary, John A.; Gray, Gregory C.] Univ Florida, Coll Publ Hlth & Hlth Profess, Gainesville, FL USA; [Krueger, Whitney S.; Heil, Gary L.; Friary, John A.; Gray, Gregory C.] Univ Florida, Emerging Pathogens Inst, Gainesville, FL USA; [Blair, Patrick J.] Naval Med Res Ctr Asia, Singapore, Singapore; [Putnam, Shannon D.] Naval Hlth Res Ctr, San Diego, CA USA	United States Department of Defense; United States Army; Walter Reed Army Institute of Research (WRAIR); Armed Forces Research Institute of Medical Science (AFRIMS); Ministry of Public Health - Thailand; State University System of Florida; University of Florida; State University System of Florida; University of Florida; United States Department of Defense; United States Navy; Naval Medical Research Center (NMRC); Naval Health Research Center (NHRC)	Gray, GC (corresponding author), Duke Univ, Sch Med, Duke Infect Dis, Durham, NC 27705 USA.	gcgray2@gmail.com	Gray, Gregory C./ABF-1298-2020	Gray, Gregory/0000-0002-4628-5908	US Armed Forces Health Surveillance Center - Global Emerging Infections Surveillance and Response System; National Institute of Allergy and Infectious Diseases [R01 AI068803]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI068803] Funding Source: NIH RePORTER	US Armed Forces Health Surveillance Center - Global Emerging Infections Surveillance and Response System; National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the US Armed Forces Health Surveillance Center - Global Emerging Infections Surveillance and Response System (multiple grants to GCG, PJB, SDP, and IKY) and National Institute of Allergy and Infectious Diseases (R01 AI068803 to GCG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achonu C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026427; AHO M, 2010, EURO SURVEILL, V15; Babcock HM, 2008, INFECT CONT HOSP EP, V29, P921, DOI 10.1086/590663; Bandaranayake D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013211; Boivin G, 2000, CLIN INFECT DIS, V31, P1166, DOI 10.1086/317425; Call SA, 2005, JAMA-J AM MED ASSOC, V293, P987, DOI 10.1001/jama.293.8.987; Capuano AW, 2007, INFLUENZA OTHER RESP, V1, P87, DOI 10.1111/j.1750-2659.2007.00014.x; Cauchemez S, 2009, NEW ENGL J MED, V361, P2619, DOI 10.1056/NEJMoa0905498; Chen MIC, 2010, JAMA-J AM MED ASSOC, V303, P1383, DOI 10.1001/jama.2010.404; Cowling BJ, 2010, NEW ENGL J MED, V362, P2175, DOI 10.1056/NEJMoa0911530; Cox CM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029301; France AM, 2010, J INFECT DIS, V201, P984, DOI 10.1086/651145; Gilbert GL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012562; GREENBERG SB, 1974, AM J EPIDEMIOL, V100, P209, DOI 10.1093/oxfordjournals.aje.a112029; Grills N, 2010, AUST NZ J PUBL HEAL, V34, P228, DOI 10.1111/j.1753-6405.2010.00518.x; Hancock K, 2009, NEW ENGL J MED, V361, P1945, DOI 10.1056/NEJMoa0906453; Harper SA, 2009, CLIN INFECT DIS, V48, P1003, DOI 10.1086/598513; Horby P, 2012, AM J EPIDEMIOL, V175, P1062, DOI 10.1093/aje/kws121; Hsu SB, 2008, B MATH BIOL, V70, P134, DOI 10.1007/s11538-007-9245-6; Iamsirithaworn S., 2011, Siriraj Medical Journal, V63, P64; Jackson ML, 2011, CLIN INFECT DIS, V53, P455, DOI 10.1093/cid/cir437; Kayali G, 2008, J CLIN VIROL, V43, P73, DOI 10.1016/j.jcv.2008.04.013; Khaokham CB, 2013, INFLUENZA OTHER RESP, V7, P791, DOI 10.1111/irv.12100; Khuntirat BP, 2011, CLIN INFECT DIS, V53, pE107, DOI 10.1093/cid/cir525; Krueger WS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072196; Kyriakis CS, 2010, EMERG INFECT DIS, V16, P96, DOI 10.3201/eid1601.091190; LARSON HE, 1978, J HYG-CAMBRIDGE, V80, P243, DOI 10.1017/S0022172400053596; Lerdsamran H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016164; McVernon J, 2010, EURO SURVEILL, V15, pii; Miller E, 2010, LANCET, V375, P1100, DOI 10.1016/S0140-6736(09)62126-7; Morgan OW, 2010, EMERG INFECT DIS, V16, P631, DOI 10.3201/eid1604.091658; Odaira F, 2009, EURO SURVEILL, V14; Ong AK, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008453; Papenburg J, 2010, CLIN INFECT DIS, V51, P1033, DOI 10.1086/656582; PEREIRA MS, 1972, BMJ-BRIT MED J, V4, P701, DOI 10.1136/bmj.4.5842.701; POTTER CW, 1977, J INFECT DIS, V135, P423, DOI 10.1093/infdis/135.3.423; Riley S, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1000442; Simmerman JM, 2009, PLOS ONE, V4, pA107, DOI 10.1371/journal.pone.0007776; Suess T, 2010, AM J EPIDEMIOL, V171, P1157, DOI 10.1093/aje/kwq071; Tandale BV, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-255; Zambon M, 2001, ARCH INTERN MED, V161, P2116, DOI 10.1001/archinte.161.17.2116; Zhang X, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023034	42	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 4	2014	9	9							e106751	10.1371/journal.pone.0106751	http://dx.doi.org/10.1371/journal.pone.0106751			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3XV	25188434	Green Published, gold, Green Submitted			2022-12-27	WOS:000341271500083
J	Arnulf, JK; Larsen, KR; Martinsen, OL; Bong, CH				Arnulf, Jan Ketil; Larsen, Kai Rune; Martinsen, Oyvind Lund; Bong, Chih How			Predicting Survey Responses: How and Why Semantics Shape Survey Statistics on Organizational Behaviour	PLOS ONE			English	Article							SELF-REPORTS; PERFORMANCE; LEADERSHIP; CONSTRUCT; INFORMATION; VALIDATION; COMMITMENT; EXCHANGE; CRITERIA; WORDNET	Some disciplines in the social sciences rely heavily on collecting survey responses to detect empirical relationships among variables. We explored whether these relationships were a priori predictable from the semantic properties of the survey items, using language processing algorithms which are now available as new research methods. Language processing algorithms were used to calculate the semantic similarity among all items in state-of-the-art surveys from Organisational Behaviour research. These surveys covered areas such as transformational leadership, work motivation and work outcomes. This information was used to explain and predict the response patterns from real subjects. Semantic algorithms explained 60-86% of the variance in the response patterns and allowed remarkably precise prediction of survey responses from humans, except in a personality test. Even the relationships between independent and their purported dependent variables were accurately predicted. This raises concern about the empirical nature of data collected through some surveys if results are already given a priori through the way subjects are being asked. Survey response patterns seem heavily determined by semantics. Language algorithms may suggest these prior to administering a survey. This study suggests that semantic algorithms are becoming new tools for the social sciences, opening perspectives on survey responses that prevalent psychometric theory cannot explain.	[Arnulf, Jan Ketil; Martinsen, Oyvind Lund] BI Norwegian Business Sch, Dept Leadership & Org Behav, Oslo, Norway; [Larsen, Kai Rune] Univ Colorado Boulder, Leeds Sch Business, Management & Entrepreneurship Div, Boulder, CO USA; [Bong, Chih How] Univ Malaysia Sarawak, Fac Comp Sci & Informat Technol, Sarawak, Malaysia	BI Norwegian Business School; University of Colorado System; University of Colorado Boulder; University of Malaysia Sarawak	Arnulf, JK (corresponding author), BI Norwegian Business Sch, Dept Leadership & Org Behav, Oslo, Norway.	jan.k.arnulf@bi.no	Arnulf, Jan Ketil/K-7654-2013; Larsen, Kai/AAF-7117-2021	Arnulf, Jan Ketil/0000-0002-3798-1477; Bong, Chih How/0000-0002-2612-3493; Martinsen, Oyvind Lund/0000-0002-7968-4497	United States National Science Foundation [NSF 0965338]; National Institutes of Health through Colorado Clinical and Translational Sciences Institute [NIH/CTSI 5 UL1 RR025780]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001082] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025780] Funding Source: NIH RePORTER	United States National Science Foundation(National Science Foundation (NSF)); National Institutes of Health through Colorado Clinical and Translational Sciences Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	The authors thank the United States National Science Foundation for research support under grant NSF 0965338 and the National Institutes of Health through Colorado Clinical and Translational Sciences Institute for research support under NIH/CTSI 5 UL1 RR025780. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], OXFORD HDB HUMAN ACT; Avolio B., 1995, MLQ MULTIFACTOR LEAD; Bagozzi RP, 2011, MIS QUART, V35, P261; Bass B., 1994, IMPROVING ORG EFFECT; Bernerth JB, 2007, J ORGAN BEHAV, V28, P979, DOI 10.1002/job.443; Bollen K.A., 1993, TESTING STRUCTURAL E, DOI DOI 10.1093/SF/73.3.1161; Cammann C., 1979, MICHIGAN ORG ASSESSM; COOMBS CH, 1960, PSYCHOMETRIKA, V25, P219, DOI 10.1007/BF02289726; Coombs CH, 1964, THEORY DATA, DOI 10.1177/001316446502500236; Costa PT, 2007, REVISED NEO PERSONAL; Dennis S., 2003, 25 ANN M COGN SCI SO; DIGMAN JM, 1990, ANNU REV PSYCHOL, V41, P417, DOI 10.1146/annurev.psych.41.1.417; Dumais S. T., 1988, USING LATENT SEMANTI, P281; DUMAIS ST, 1991, BEHAV RES METH INS C, V23, P229, DOI 10.3758/BF03203370; Dumdum UR, 2013, MONOGR LEAD MANAGE, V2, P39, DOI 10.1108/S1479-3571(2013)0000005008; FELDMAN JM, 1988, J APPL PSYCHOL, V73, P421, DOI 10.1037/0021-9010.73.3.421; Fellbaum C, 2010, THEORY AND APPLICATIONS OF ONTOLOGY: COMPUTER APPLICATIONS, P231, DOI 10.1007/978-90-481-8847-5_10; House RJ, 1997, J MANAGE, V23, P409, DOI 10.1016/S0149-2063(97)90037-4; Hu LT, 1999, STRUCT EQU MODELING, V6, P1, DOI 10.1080/10705519909540118; Judge TA, 2004, J APPL PSYCHOL, V89, P755, DOI 10.1037/0021-9010.89.5.755; Kahneman D., 2011, THINKING FAST SLOW; Kline P., 2000, HDB PSYCHOL TESTING; Kuvaas B, 2006, J ORGAN BEHAV, V27, P365, DOI 10.1002/job.377; Kuvaas B, 2006, INT J HUM RESOUR MAN, V17, P504, DOI 10.1080/09585190500521581; Landauer TK, 1998, DISCOURSE PROCESS, V25, P259, DOI 10.1080/01638539809545028; Larsen KG, 2008, PRINCIPLES OF MODEL CHECKING, P1, DOI 10.1145/1753196.1753211; Larsen KR, 2004, SOCIOL METHODOL, V34, P349, DOI 10.1111/j.0081-1750.2004.00156.x; Larsen KR, 2013, LEEDS SCH WORKING PA, P1; Leacock C, 1998, COMPUT LINGUIST, V24, P147; Likert R., 1932, ARCH PSYCHOL, V140, P1, DOI DOI 10.1111/J.1540-5834.2010.00585.X; MacKenzie SB, 2011, MIS QUART, V35, P293; Martinsen O. L., 2003, NORSKE VERSJONER NEO; MEYER JP, 1993, J APPL PSYCHOL, V78, P538, DOI 10.1037/0021-9010.78.4.538; MICHELL J, 1994, J MATH PSYCHOL, V38, P244, DOI 10.1006/jmps.1994.1016; Michell J, 2013, NEW IDEAS PSYCHOL, V31, P13, DOI 10.1016/j.newideapsych.2011.02.004; Mihalcea R., 2006, AAAI, P775; MILLER GA, 1995, COMMUN ACM, V38, P39, DOI 10.1145/219717.219748; Mohler M., 2009, TEXT TO TEXT SEMANTI, P567; Nakov P, 2001, WEIGHT FUNCTIONS IMP, P187; Nunnally K, 2010, PSYCHOMETRIC THEORY, V3rd; Parks-Stamm EJ, 2010, J EXP SOC PSYCHOL, V46, P531, DOI 10.1016/j.jesp.2010.02.004; Piccolo RF, 2012, LEADERSHIP QUART, V23, P567, DOI 10.1016/j.leaqua.2011.12.008; Podsakoff PM, 2012, ANNU REV PSYCHOL, V63, P539, DOI 10.1146/annurev-psych-120710-100452; PODSAKOFF PM, 1986, J MANAGE, V12, P531, DOI 10.1177/014920638601200408; Schwarz N, 1999, AM PSYCHOL, V54, P93, DOI 10.1037/0003-066X.54.2.93; Shore LM, 2006, J APPL SOC PSYCHOL, V36, P837, DOI 10.1111/j.0021-9029.2006.00046.x; Slaney KL, 2013, NEW IDEAS PSYCHOL, V31, P1, DOI 10.1016/j.newideapsych.2011.02.010; SMEDSLUND J, 1994, SCAND J PSYCHOL, V35, P1, DOI 10.1111/j.1467-9450.1994.tb00928.x; SMEDSLUND J, 1988, SCAND J PSYCHOL, V29, P148, DOI 10.1111/j.1467-9450.1988.tb00785.x; Spearman C, 1904, AM J PSYCHOL, V15, P201, DOI 10.2307/1412107; Stogdill R. M., 1963, MANUAL LEADER BEHAV; Thurstone LL, 1947, MULTIPLE FACTOR ANAL; Van Dyne L, 1998, ACAD MANAGE J, V41, P108, DOI 10.2307/256902; Van Knippenberg D, 2013, ACAD MANAG ANN, V7, P1, DOI 10.1080/19416520.2013.759433; VANSCHUUR WH, 1994, APPL PSYCH MEAS, V18, P97, DOI 10.1177/014662169401800201; Wang G, 2011, GROUP ORGAN MANAGE, V36, P223, DOI 10.1177/1059601111401017	56	54	54	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 3	2014	9	9							e106361	10.1371/journal.pone.0106361	http://dx.doi.org/10.1371/journal.pone.0106361			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AO3TB	25184672	Green Published, Green Accepted, gold			2022-12-27	WOS:000341257700058
J	Hasnain, S; McClendon, CL; Hsu, MT; Jacobson, MP; Bandyopadhyay, P				Hasnain, Sabeeha; McClendon, Christopher L.; Hsu, Monica T.; Jacobson, Matthew P.; Bandyopadhyay, Pradipta			A New Coarse-Grained Model for E. coli Cytoplasm: Accurate Calculation of the Diffusion Coefficient of Proteins and Observation of Anomalous Diffusion	PLOS ONE			English	Article							BROWNIAN DYNAMICS SIMULATIONS; GREEN FLUORESCENT PROTEIN; CONCENTRATED PROTEIN; PHOTOBLEACHING RECOVERY; STABILITY; MOBILITY; CELLS; MOLECULES; CROWDERS; VOLUME	A new coarse-grained model of the E. coli cytoplasm is developed by describing the proteins of the cytoplasm as flexible units consisting of one or more spheres that follow Brownian dynamics (BD), with hydrodynamic interactions (HI) accounted for by a mean-field approach. Extensive BD simulations were performed to calculate the diffusion coefficients of three different proteins in the cellular environment. The results are in close agreement with experimental or previously simulated values, where available. Control simulations without HI showed that use of HI is essential to obtain accurate diffusion coefficients. Anomalous diffusion inside the crowded cellular medium was investigated with Fractional Brownian motion analysis, and found to be present in this model. By running a series of control simulations in which various forces were removed systematically, it was found that repulsive interactions (volume exclusion) are the main cause for anomalous diffusion, with a secondary contribution from HI.	[Hasnain, Sabeeha; Bandyopadhyay, Pradipta] Jawaharlal Nehru Univ, Sch Computat & Integrat Sci, New Delhi 110067, India; [McClendon, Christopher L.] Univ Calif San Diego, Skaggs Sch Pharm & Pharmaceut Sci, San Diego, CA 92103 USA; [Hsu, Monica T.] Univ Calif San Diego, Grad Grp Biophys, San Diego, CA 92103 USA; [Jacobson, Matthew P.] Univ Calif San Diego, Dept Pharmaceut Chem, San Diego, CA 92103 USA	Jawaharlal Nehru University, New Delhi; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego	Bandyopadhyay, P (corresponding author), Jawaharlal Nehru Univ, Sch Computat & Integrat Sci, New Delhi 110067, India.	praban07@gmail.com	Jacobson, Matthew/Y-5161-2018	Jacobson, Matthew/0000-0001-6262-655X				Ando T, 2013, J CHEM PHYS, V139, DOI 10.1063/1.4817660; Ando T, 2010, P NATL ACAD SCI USA, V107, P18457, DOI 10.1073/pnas.1011354107; Andrews SS, 2004, PHYS BIOL, V1, P137, DOI 10.1088/1478-3967/1/3/001; AXELROD D, 1976, BIOPHYS J, V16, P1055, DOI 10.1016/S0006-3495(76)85755-4; Banks DS, 2005, BIOPHYS J, V89, P2960, DOI 10.1529/biophysj.104.051078; Bicout DJ, 1996, J PHYS CHEM-US, V100, P2489, DOI 10.1021/jp9525191; BRADY JF, 1988, ANNU REV FLUID MECH, V20, P111, DOI 10.1146/annurev.fl.20.010188.000551; Brown EB, 1999, BIOPHYS J, V77, P2837, DOI 10.1016/S0006-3495(99)77115-8; Burov S, 2011, PHYS CHEM CHEM PHYS, V13, P1800, DOI 10.1039/c0cp01879a; CAYLEY S, 1991, J MOL BIOL, V222, P281, DOI 10.1016/0022-2836(91)90212-O; Cheung MS, 2005, P NATL ACAD SCI USA, V102, P4753, DOI 10.1073/pnas.0409630102; Dix JA, 2008, ANNU REV BIOPHYS, V37, P247, DOI 10.1146/annurev.biophys.37.032807.125824; DWYER JD, 1993, BIOPHYS J, V65, P1810, DOI 10.1016/S0006-3495(93)81235-9; Ellis RJ, 2006, BIOL CHEM, V387, P485, DOI 10.1515/BC.2006.064; Ellis RJ, 2001, TRENDS BIOCHEM SCI, V26, P597, DOI 10.1016/S0968-0004(01)01938-7; Elowitz MB, 1999, J BACTERIOL, V181, P197, DOI 10.1128/JB.181.1.197-203.1999; ERMAK DL, 1978, J CHEM PHYS, V69, P1352, DOI 10.1063/1.436761; Feig M, 2013, J MOL GRAPH MODEL, V45, P144, DOI 10.1016/j.jmgm.2013.08.017; Golding I, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.098102; Hall D, 2003, BBA-PROTEINS PROTEOM, V1649, P127, DOI 10.1016/S1570-9639(03)00167-5; Heyes DM, 1996, MOL PHYS, V87, P287, DOI 10.1080/00268979650027450; KAO HP, 1993, J CELL BIOL, V120, P175, DOI 10.1083/jcb.120.1.175; Kerr RA, 2008, SIAM J SCI COMPUT, V30, P3126, DOI 10.1137/070692017; Klann M, 2012, INT J MOL SCI, V13, P7798, DOI 10.3390/ijms13067798; Konopka MC, 2006, J BACTERIOL, V188, P6115, DOI 10.1128/JB.01982-05; Kues T, 2001, BIOPHYS J, V80, P2954, DOI 10.1016/S0006-3495(01)76261-3; Lipkow K, 2005, J BACTERIOL, V187, P45, DOI 10.1128/JB.187.1.45-53.2005; Lopez-Campistrous A, 2005, MOL CELL PROTEOMICS, V4, P1205, DOI 10.1074/mcp.D500006-MCP200; Luby-Phelps K, 2000, INT REV CYTOL, V192, P189; McGuffee SR, 2006, J AM CHEM SOC, V128, P12098, DOI 10.1021/ja0614058; McGuffee SR, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000694; Mereghetti P, 2012, J PHYS CHEM B, V116, P8523, DOI 10.1021/jp212532h; Minton AP, 2006, J CELL SCI, V119, P2863, DOI 10.1242/jcs.03063; Minton AP, 2005, J PHARM SCI-US, V94, P1668, DOI 10.1002/jps.20417; Predeus AV, 2012, J PHYS CHEM B, V116, P8610, DOI 10.1021/jp300129u; Ridgway D, 2008, BIOPHYS J, V94, P3748, DOI 10.1529/biophysj.107.116053; Rivas German, 2004, EMBO Reports, V5, P23, DOI 10.1038/sj.embor.7400056; Roberts E, 2009, P 2009 IEEE INT S PA; SAXTON MJ, 1994, BIOPHYS J, V66, P394, DOI 10.1016/S0006-3495(94)80789-1; Sewitz S, 2013, CURRENT CHEM BIOL, V7, P214, DOI [10.2174/221279680703140508101810, DOI 10.2174/221279680703140508101810]; Sterpone F, 2014, CHEM SOC REV, V43, P4871, DOI 10.1039/c4cs00048j; Sun J, 2007, J CHEM PHYS, V127, DOI 10.1063/1.2789434; Swaminathan R, 1997, BIOPHYS J, V72, P1900, DOI 10.1016/S0006-3495(97)78835-0; Szymanski J, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.038102; TERRY BR, 1995, BIOCHEM BIOPH RES CO, V217, P21, DOI 10.1006/bbrc.1995.2740; TOKUYAMA M, 1994, PHYS REV E, V50, pR16, DOI 10.1103/PhysRevE.50.R16; Trovato F, 2013, MACROMOLECULES, V46, P8311, DOI 10.1021/ma401843h; Villalba GU, 2003, PHYS REV E, V68; Wachsmuth M, 2000, J MOL BIOL, V298, P677, DOI 10.1006/jmbi.2000.3692; Wang Q, 2012, BIOPHYS J, V102, P2353, DOI 10.1016/j.bpj.2012.04.010; Weber SC, 2010, PHYS REV E, V82, DOI 10.1103/PhysRevE.82.011913; Weiss M, 2003, BIOPHYS J, V84, P4043, DOI 10.1016/S0006-3495(03)75130-3; Weiss M, 2004, BIOPHYS J, V87, P3518, DOI 10.1529/biophysj.104.044263; Weiss M, 2013, PHYS REV E, V88, DOI 10.1103/PhysRevE.88.010101; Zhou HX, 2008, ARCH BIOCHEM BIOPHYS, V469, P76, DOI 10.1016/j.abb.2007.07.013; Zhou HX, 2004, ACCOUNTS CHEM RES, V37, P123, DOI 10.1021/ar0302282; Zhou HX, 2004, BIOCHEMISTRY-US, V43, P2141, DOI 10.1021/bi036269n; ZIMMERMAN SB, 1991, J MOL BIOL, V222, P599, DOI 10.1016/0022-2836(91)90499-V	58	26	26	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2014	9	9							e106466	10.1371/journal.pone.0106466	http://dx.doi.org/10.1371/journal.pone.0106466			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3LR	25180859	gold, Green Published, Green Submitted			2022-12-27	WOS:000341231500102
J	Qi, L; Li, SH; Si, LB; Lu, M; Tian, H				Qi, Lei; Li, Shu-hai; Si, Li-bo; Lu, Ming; Tian, Hui			Expression of THOP1 and Its Relationship to Prognosis in Non-Small Cell Lung Cancer	PLOS ONE			English	Article							THIMET OLIGOPEPTIDASE; EC 3.4.24.15; BREAST-CANCER; TUMOR-GROWTH; ANGIOGENESIS; NEUROLYSIN; BRADYKININ; DOXORUBICIN; SECRETION; MEMBRANE	Background: The study was designed to detect the expression level of thimet oligopeptidase (THOP1) protein in non-small cell lung cancer (NSCLC) and investigate its correlation with clinicopathologic features and prognosis. Methods: Immunohistochemical staining was used to determine the expression of THOP1 protein in 120 NSCLC specimens and 53 distant normal lung tissues. Quantitative real-time PCR and western blotting were employed to measure the expression of THOP1 in 16 pairs of primary NSCLC and corresponding normal tissues. Results: Analysis of immunohistochemical staining suggested low THOP1 expression was found in 71 (59.2%) of the 120 NSCLC specimens and significantly correlated with positive lymph node metastasis (P = 0.048). However, low THOP1 expression was found in 22 (41.5%) of the 53 normal lung tissues. Chi-square test suggested that the expression of THOP1 was significantly higher in the normal lung tissues than that in the NSCLC specimens (P = 0.032). Real-Time PCR and western blotting showed that NSCLC specimens had decreased THOP1 mRNA and protein expression compared to corresponding normal tissues. Univariate analysis demonstrated that low THOP1 expression significantly predicted decreased 5-year disease-free survival (P = 0.038) and overall survival (P = 0.017). In addition, positive lymph node metastasis (P = 0.025) and advanced TNM stage (P = 0.009) significantly predicted decreased 5-year overall survival. However, multivariate Cox regression analysis showed that only low THOP1 expression retained its significance as an independent prognostic factor for unfavorable 5-year disease-free survival (P = 0.046) and overall survival (P = 0.021). Conclusions: THOP1 may have clinical potentials to be employed as a promising biomarker to identify individuals with better prognosis and a novel antitumor agent for therapy of patients with NSCLC.	[Qi, Lei; Li, Shu-hai; Si, Li-bo; Lu, Ming; Tian, Hui] Shandong Univ, Qi Lu Hosp, Dept Thorac Surg, Jinan 250100, Shandong, Peoples R China	Shandong University	Tian, H (corresponding author), Shandong Univ, Qi Lu Hosp, Dept Thorac Surg, Jinan 250100, Shandong, Peoples R China.	tianhuiy@sohu.com		Qi, Lei/0000-0002-5787-3772	National Natural Science Foundation of China [30571844]; Science and Technology Development Foundation of Shandong Province [2009GG10002007]; National Natural Science Foundation of Shandong Province [ZR2009CM090]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Development Foundation of Shandong Province; National Natural Science Foundation of Shandong Province	This project was supported by the National Natural Science Foundation of China (No. 30571844), the Science and Technology Development Foundation of Shandong Province (No. 2009GG10002007), and the National Natural Science Foundation of Shandong Province (No. ZR2009CM090). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ACKER GR, 1987, J NEUROCHEM, V48, P284, DOI 10.1111/j.1471-4159.1987.tb13160.x; BARRETT AJ, 1995, METHOD ENZYMOL, V248, P529; Camargo ACM, 1997, BIOCHEM J, V324, P517, DOI 10.1042/bj3240517; Crack PJ, 1999, BRAIN RES, V835, P113, DOI 10.1016/S0006-8993(99)01494-8; Dubois V, 2006, EUR J CANCER, V42, P3049, DOI 10.1016/j.ejca.2005.10.030; FERRO ES, 1993, BIOCHEM BIOPH RES CO, V191, P275, DOI 10.1006/bbrc.1993.1213; Ferro ES, 1999, DNA CELL BIOL, V18, P781, DOI 10.1089/104454999314926; Hayashi I, 2002, LAB INVEST, V82, P871, DOI 10.1097/01.LAB.0000018885.36823.D6; Ikeda Y, 2004, CANCER RES, V64, P5178, DOI 10.1158/0008-5472.CAN-03-3589; Ishihara K, 2002, INT IMMUNOPHARMACOL, V2, P499, DOI 10.1016/S1567-5769(01)00193-X; Jemal A, 2009, CA-CANCER J CLIN, V59, P225, DOI 10.3322/caac.20006; Kamangar F, 2006, J CLIN ONCOL, V24, P2137, DOI 10.1200/JCO.2005.05.2308; Kessler JH, 2011, NAT IMMUNOL, V12, P45, DOI 10.1038/ni.1974; Krause DR, 1997, J CELL BIOCHEM, V66, P297, DOI 10.1002/(SICI)1097-4644(19970901)66:3<297::AID-JCB3>3.0.CO;2-K; Massarelli EE, 1999, BRAIN RES, V851, P261, DOI 10.1016/S0006-8993(99)02135-6; Montiel JL, 1997, J NEUROCHEM, V68, P354; Nomoto S, 2014, ANN SURG ONCOL; Oliveira V, 2001, BIOCHEMISTRY-US, V40, P4417, DOI 10.1021/bi002715k; Paschoalin T, 2007, MOL CANCER, V6, DOI 10.1186/1476-4598-6-44; Pisters KMW, 2007, J CLIN ONCOL, V25, P5506, DOI 10.1200/JCO.2007.14.1226; Ravel D, 2008, CLIN CANCER RES, V14, P1258, DOI 10.1158/1078-0432.CCR-07-1165; Shrimpton CN, 2002, ENDOCR REV, V23, P647, DOI 10.1210/er.2001-0032; Vamesu S, 2008, ROM J MORPHOL EMBRYO, V49, P181; Vermeulen PB, 2010, CANCER-AM CANCER SOC, V116, P2748, DOI 10.1002/cncr.25169; Wolf D, 2005, CLIN CANCER RES, V11, P8326, DOI 10.1158/1078-0432.CCR-05-1244; Yang WH, 2010, J CELL BIOCHEM, V109, P82, DOI 10.1002/jcb.22383	26	12	12	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2014	9	9							e106665	10.1371/journal.pone.0106665	http://dx.doi.org/10.1371/journal.pone.0106665			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3LR	25180910	Green Published, gold, Green Submitted			2022-12-27	WOS:000341231500122
J	Tsun, JGS; Yung, SS; Chau, MKM; Shiu, SWM; Chan, TM; Tan, KCB				Tsun, Joseph G. S.; Yung, Susan; Chau, Mel K. M.; Shiu, Sammy W. M.; Chan, Tak Mao; Tan, Kathryn C. B.			Cellular Cholesterol Transport Proteins in Diabetic Nephropathy	PLOS ONE			English	Article							RENAL CORTICAL CHOLESTEROL; LIPID-ACCUMULATION; MESANGIAL CELLS; HUMAN KIDNEY; METABOLISM; ABCA1; GLOMERULOSCLEROSIS; DYSREGULATION; MACROPHAGES; EXPRESSION	Background: Lipid accumulation has been shown to accelerate renal injury, and the intracellular accumulation of lipids may be caused by alterations in synthesis as well as lipid uptake and efflux. We have investigated the role of cellular cholesterol transport proteins including adenosine triphosphate binding cassette transporter A1 (ABCA1), G1 (ABCG1) and scavenger receptor class B type I (SR-BI) in diabetic nephropathy. Methods: Protein expression and the ability to mediate cholesterol efflux of ABCA1, ABCG1 and SR-BI was determined in human renal mesangial cells and proximal tubular epithelial cells cultured under normal or high glucose conditions. Renal expression of these cholesterol transporters was examined in a murine model of streptozotocin-induced type 1 diabetes. Results: ABCA1, ABCG1 and SR-BI were expressed in both human renal mesangial cells and proximal tubular epithelial cells, and mediated cholesterol efflux to apolipoprotein AI and HDL. In vitro, hyperglycemia reduced the expression and the ability to mediate cholesterol efflux of all three cholesterol transporters (p<0.05). In vivo studies showed that intra-renal accumulation of lipids was increased in diabetic mice, particularly in mice with nephropathy. This was associated with a significant reduction in the expression of ABCA1, ABCG1 and SR-BI in the kidneys. These changes were already seen in diabetic mice without nephropathy and preceded the development of nephropathy. Diabetic mice with nephropathy had the lowest level of these cholesterol transporters. Conclusion: Inducing diabetes with streptozotocin significantly reduced renal expression of ABCA1, ABCG1 and SR-BI. Defects in cholesterol export pathway in renal cells could therefore promote cholesterol accumulation and might contribute to the development of diabetic nephropathy.	[Tsun, Joseph G. S.; Yung, Susan; Chau, Mel K. M.; Shiu, Sammy W. M.; Chan, Tak Mao; Tan, Kathryn C. B.] Univ Hong Kong, Dept Med, Hong Kong, Hong Kong, Peoples R China	University of Hong Kong	Tan, KCB (corresponding author), Univ Hong Kong, Dept Med, Hong Kong, Hong Kong, Peoples R China.	kcbtan@hkucc.hku.hk	; /C-4468-2009	Chan, Tak Mao/0000-0002-3495-4051; /0000-0003-3124-1328	Hong Kong Research Grants Council Research Fund [HKU 776709M]	Hong Kong Research Grants Council Research Fund(Hong Kong Research Grants Council)	This study is supported by funding from the Hong Kong Research Grants Council Research Fund (HKU 776709M). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrass CK, 2006, CONTRIB NEPHROL, V151, P106, DOI 10.1159/000095323; Adorni MP, 2007, J LIPID RES, V48, P2453, DOI 10.1194/jlr.M700274-JLR200; Anami Y, 1997, ATHEROSCLEROSIS, V135, P225, DOI 10.1016/S0021-9150(97)00166-4; Grone HJ, 1996, KIDNEY INT, V49, pS18; Jandeleit-Dahm K, 1999, KIDNEY INT, V56, pS31, DOI 10.1046/j.1523-1755.1999.07109.x; Johnson ACM, 2003, AM J PATHOL, V162, P283, DOI 10.1016/S0002-9440(10)63819-9; Kim HJ, 2009, AM J PHYSIOL-RENAL, V296, pF1297, DOI 10.1152/ajprenal.90761.2008; Kim HJ, 2009, AM J NEPHROL, V29, P607, DOI 10.1159/000193631; LEE HS, 1991, CLIN NEPHROL, V36, P67; MOORHEAD JF, 1982, LANCET, V2, P1309; Nieland TJF, 2002, P NATL ACAD SCI USA, V99, P15422, DOI 10.1073/pnas.222421399; Proctor G, 2006, DIABETES, V55, P2502, DOI 10.2337/db05-0603; Rosenson RS, 2012, CIRCULATION, V125, P1905, DOI 10.1161/CIRCULATIONAHA.111.066589; Ruan XZ, 2003, J AM SOC NEPHROL, V14, P593, DOI 10.1097/01.ASN.0000050414.52908.DA; RYAN MJ, 1994, KIDNEY INT, V45, P48, DOI 10.1038/ki.1994.6; SCHLONDORFF D, 1993, AM J KIDNEY DIS, V22, P72, DOI 10.1016/S0272-6386(12)70171-3; Song KH, 2012, TRANSPL P, V44, P1021, DOI 10.1016/j.transproceed.2012.03.018; Sun LJ, 2002, J BIOL CHEM, V277, P18919, DOI 10.1074/jbc.M110650200; TAKEMURA T, 1993, KIDNEY INT, V43, P918, DOI 10.1038/ki.1993.129; Tang CR, 2010, J LIPID RES, V51, P1719, DOI 10.1194/jlr.M003525; Wang ZW, 2005, DIABETES, V54, P2328, DOI 10.2337/diabetes.54.8.2328; WHEELER DC, 1993, MINER ELECTROL METAB, V19, P149; Yung S, 2006, KIDNEY INT, V69, P272, DOI 10.1038/sj.ki.5000042; Yung S, 2009, ARTHRITIS RHEUM-US, V60, P2071, DOI 10.1002/art.24573; Zager RA, 2003, AM J PATHOL, V163, P313, DOI 10.1016/S0002-9440(10)63655-3; Zager RA, 2001, KIDNEY INT, V60, P2299, DOI 10.1046/j.1523-1755.2001.00071.x	26	32	36	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2014	9	9							e105787	10.1371/journal.pone.0105787	http://dx.doi.org/10.1371/journal.pone.0105787			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3LR	25181357	Green Published, gold, Green Submitted			2022-12-27	WOS:000341231500035
J	Inohara, T; Kohsaka, S; Sato, N; Kajimoto, K; Keida, T; Mizuno, M; Takano, T				Inohara, Taku; Kohsaka, Shun; Sato, Naoki; Kajimoto, Katsuya; Keida, Takehiko; Mizuno, Masayuki; Takano, Teruo		ATTEND Investigators	Prognostic Impact of Renal Dysfunction Does Not Differ According to the Clinical Profiles of Patients: Insight from the Acute Decompensated Heart Failure Syndromes (ATTEND) Registry	PLOS ONE			English	Article							INITIATE LIFESAVING TREATMENT; CENTRAL VENOUS-PRESSURE; IN-HOSPITAL MORTALITY; CONSENSUS CONFERENCE; RISK STRATIFICATION; ORGANIZED PROGRAM; PREDICTORS; HEMODYNAMICS; CLASSIFICATION; CONGESTION	Background: Renal dysfunction associated with acute decompensated heart failure (ADHF) is associated with impaired outcomes. Its mechanism is attributed to renal arterial hypoperfusion or venous congestion, but its prognostic impact based on each of these clinical profiles requires elucidation. Methods and Results: ADHF syndromes registry subjects were evaluated (N = 4,321). Logistic regression modeling calculated adjusted odds ratios (OR) for in-hospital mortality for patients with and without renal dysfunction. Renal dysfunction risk was calculated for subgroups with hypoperfusion-dominant (eg. cold extremities, a low mean blood pressure or a low proportional pulse pressure) or congestion-dominant clinical profiles (eg. peripheral edema, jugular venous distension, or elevated brain natriuretic peptide) to evaluate renal dysfunction's prognostic impact in the context of the two underlying mechanisms. On admission, 2,150 (49.8%) patients aged 73.3 +/- 613.6 years had renal dysfunction. Compared with patients without renal dysfunction, those with renal dysfunction were older and had dominant ischemic etiology jugular venous distension, more frequent cold extremities, and higher brain natriuretic peptide levels. Renal dysfunction was associated with in-hospital mortality (OR 2.36; 95% confidence interval 1.75-3.18, p<0.001), and the prognostic impact of renal dysfunction was similar in subgroup of patients with hypoperfusion-or congestion-dominant clinical profiles (p-value for the interaction ranged from 0.104-0.924, and was always >0.05). Conclusions: Baseline renal dysfunction was significantly associated with in-hospital mortality in ADHF patients. The prognostic impact of renal dysfunction was the same, regardless of its underlying etiologic mechanism.	[Inohara, Taku; Kohsaka, Shun] Keio Univ, Sch Med, Dept Cardiol, Tokyo, Japan; [Sato, Naoki] Kosugi Hosp, Nippon Med Sch Musashi, Internal Med Cardiol & Intens Care Unit, Kawasaki, Kanagawa, Japan; [Kajimoto, Katsuya] Sensoji Hosp, Dept Cardiol, Tokyo, Japan; [Keida, Takehiko] Edogawa Hosp, Dept Cardiol, Tokyo, Japan; [Mizuno, Masayuki] Tokyo Womens Med Univ, Dept Cardiol, Tokyo, Japan; [Takano, Teruo] Nippon Med Univ, Dept Internal Med, Tokyo, Japan	Keio University; Tokyo Women's Medical University; Nippon Medical School	Kohsaka, S (corresponding author), Keio Univ, Sch Med, Dept Cardiol, Tokyo, Japan.	kohsaka@cpnet.med.keio.ac.jp	Abe, Yukio/AAW-8428-2020	Kohsaka, Shun/0000-0003-3779-2972	Japan Heart Foundation	Japan Heart Foundation	This study was supported by the Japan Heart Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham WT, 2008, J AM COLL CARDIOL, V52, P347, DOI 10.1016/j.jacc.2008.04.028; Antonelli M, 2007, INTENS CARE MED, V33, P575, DOI 10.1007/s00134-007-0531-4; Braam B, 2012, HEART FAIL REV, V17, P161, DOI 10.1007/s10741-011-9246-2; Cioffi G, 2013, INT J CARDIOL, V168, P3691, DOI 10.1016/j.ijcard.2013.06.020; Damman K, 2009, J AM COLL CARDIOL, V53, P582, DOI 10.1016/j.jacc.2008.08.080; Fonarow GC, 2005, JAMA-J AM MED ASSOC, V293, P572, DOI 10.1001/jama.293.5.572; Forman DE, 2004, J AM COLL CARDIOL, V43, P61, DOI 10.1016/j.jacc.2003.07.031; Gheorghiade M, 2010, EUR J HEART FAIL, V12, P423, DOI 10.1093/eurjhf/hfq045; Gheorghiade M, 2009, J AM COLL CARDIOL, V53, P557, DOI 10.1016/j.jacc.2008.10.041; Haase M, 2013, CONTRIB NEPHROL, V182, P99, DOI 10.1159/000349969; Harjola VP, 2010, EUR J HEART FAIL, V12, P239, DOI 10.1093/eurjhf/hfq002; Heywood JT, 2007, J CARD FAIL, V13, P422, DOI 10.1016/j.cardfail.2007.03.011; Kajimoto K, 2013, INT J CARDIOL, V168, P554, DOI 10.1016/j.ijcard.2013.01.187; Levey AS, 2003, ANN INTERN MED, V139, P137, DOI 10.7326/0003-4819-139-2-200307150-00013; Mebazaa Alexandre, 2008, Crit Care Med, V36, pS129, DOI 10.1097/01.CCM.0000296274.51933.4C; Mullens W, 2009, J AM COLL CARDIOL, V53, P589, DOI 10.1016/j.jacc.2008.05.068; Nohria A, 2003, J AM COLL CARDIOL, V41, P1797, DOI 10.1016/S0735-1097(03)00309-7; Nohria A, 2008, J AM COLL CARDIOL, V51, P1268, DOI 10.1016/j.jacc.2007.08.072; O'Connor CM, 2008, AM HEART J, V156, P662, DOI 10.1016/j.ahj.2008.04.030; Pascual-Figal DA, 2011, EUR J HEART FAIL, V13, P718, DOI 10.1093/eurjhf/hfr047; Rehman SU, 2008, J AM COLL CARDIOL, V52, P1458, DOI 10.1016/j.jacc.2008.07.042; Ronco C, 2010, EUR HEART J, V31, P703, DOI 10.1093/eurheartj/ehp507; Sato N, 2010, AM HEART J, V159, P949, DOI 10.1016/j.ahj.2010.03.019; Schrier RW, 1999, NEW ENGL J MED, V341, P577, DOI 10.1056/NEJM199908193410806; STEVENSON LW, 1989, JAMA-J AM MED ASSOC, V261, P884, DOI 10.1001/jama.261.6.884; Takagi A, 2010, J CARDIOL, V55, P317, DOI 10.1016/j.jjcc.2009.12.005; Uthoff H, 2011, EUR J HEART FAIL, V13, P432, DOI 10.1093/eurjhf/hfq195	27	10	11	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2014	9	9							e105596	10.1371/journal.pone.0105596	http://dx.doi.org/10.1371/journal.pone.0105596			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4JX	25197833	Green Published, Green Submitted, gold			2022-12-27	WOS:000341304700015
J	Junjie, RK; Browne, NK; Erftemeijer, PLA; Todd, PA				Junjie, Reef K.; Browne, Nicola K.; Erftemeijer, Paul L. A.; Todd, Peter A.			Impacts of Sediments on Coral Energetics: Partitioning the Effects of Turbidity and Settling Particles	PLOS ONE			English	Article							GREAT-BARRIER-REEF; COMMUNITY STRUCTURE; SCLERACTINIAN CORALS; LIGHT; PHOTOSYNTHESIS; FLUORESCENCE; ORGANISMS; REJECTION; INSHORE; ZOOXANTHELLAE	Sediment loads have long been known to be deleterious to corals, but the effects of turbidity and settling particles have not previously been partitioned. This study provides a novel approach using inert silicon carbide powder to partition and quantify the mechanical effects of sediment settling versus reduced light under a chronically high sedimentary regime on two turbid water corals commonly found in Singapore (Galaxea fascicularis and Goniopora somaliensis). Coral fragments were evenly distributed among three treatments: an open control (30% ambient PAR), a shaded control (15% ambient PAR) and sediment treatment (15% ambient PAR; 26.4 mg cm(-2) day(-1)). The rate of photosynthesis and respiration, and the dark-adapted quantum yield were measured once a week for four weeks. By week four, the photosynthesis to respiration ratio (P/R ratio) and the photosynthetic yield (F-v/F-m) had fallen by 14% and 3-17% respectively in the shaded control, contrasting with corals exposed to sediments whose P/R ratio and yield had declined by 21% and 18-34% respectively. The differences in rates between the shaded control and the sediment treatment were attributed to the mechanical effects of sediment deposition. The physiological response to sediment stress differed between species with G. fascicularis experiencing a greater decline in the net photosynthetic yield (13%) than G. somaliensis (9.5%), but a smaller increase in the respiration rates (G. fascicularis = 9.9%, G. somaliensis = 14.2%). These different physiological responses were attributed, in part, to coral morphology and highlighted key physiological processes that drive species distribution along high to low turbidity and depositional gradients.	[Junjie, Reef K.; Todd, Peter A.] Natl Univ Singapore, Expt Marine & Ecol Lab, Dept Biol Sci, Singapore 117548, Singapore; [Browne, Nicola K.] Curtin Univ, Dept Environm & Agr, Perth, WA 6845, Australia; [Erftemeijer, Paul L. A.] SKM, Perth, WA, Australia; [Erftemeijer, Paul L. A.] Univ Western Australia, UWA Oceans Inst, Crawley, Australia; [Todd, Peter A.] Natl Univ Singapore, Trop Marine Sci Inst, Singapore 117548, Singapore	National University of Singapore; Curtin University; University of Western Australia; National University of Singapore	Browne, NK (corresponding author), Curtin Univ, Dept Environm & Agr, Perth, WA 6845, Australia.	Nicola.browne@my.jcu.edu.au	browne, Nicola/W-6612-2019; Todd, Peter A/H-8410-2012; Erftemeijer, Paul/U-7485-2018	Erftemeijer, Paul/0000-0002-2904-7422; Browne, nicola/0000-0002-7160-6865	Singapore-Delfte Water Alliance Marine & Coastal Research Program (Theme 2) [R-264-001-001-272]; National Parks	Singapore-Delfte Water Alliance Marine & Coastal Research Program (Theme 2); National Parks	This research was carried out as part of Singapore-Delfte Water Alliance Marine & Coastal Research Program (Theme 2): "Dredging and infrastructure development near critical marine ecosystems" (R-264-001-001-272) with additional support from the National Parks-funded project: "Impacts of ship-wake-induced sediment resuspension on coral reefs and seagrass in Singapore." The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdel-Salam H.A., 1988, P285; Al-Horani FA, 2003, MAR BIOL, V142, P419, DOI 10.1007/s00227-002-0981-8; Anthony KRN, 1999, LIMNOL OCEANOGR, V44, P1415, DOI 10.4319/lo.1999.44.6.1415; Anthony KRN, 2000, CORAL REEFS, V19, P59, DOI 10.1007/s003380050227; Anthony KRN, 2004, LIMNOL OCEANOGR, V49, P2201, DOI 10.4319/lo.2004.49.6.2201; Anthony KRN, 2004, OECOLOGIA, V141, P373, DOI 10.1007/s00442-004-1647-7; Anthony KRN, 2003, OECOLOGIA, V134, P23, DOI 10.1007/s00442-002-1095-1; Anthony KRN, 2000, J EXP MAR BIOL ECOL, V252, P221, DOI 10.1016/S0022-0981(00)00237-9; BAK RPM, 1978, MAR POLLUT BULL, V9, P14, DOI 10.1016/0025-326X(78)90275-8; Beer S, 1998, MAR ECOL PROG SER, V174, P293, DOI 10.3354/meps174293; Browne NK, 2013, CORAL REEFS, V32, P195, DOI 10.1007/s00338-012-0965-1; Browne NK, 2010, CORAL REEFS, V29, P683, DOI 10.1007/s00338-010-0640-3; Bruno JF, 2003, ECOL LETT, V6, P1056, DOI 10.1046/j.1461-0248.2003.00544.x; Chan LT, 1980, THESIS NATL U SINGAP; CHOU L M, 1988, Galaxea, V7, P101; Chou L. M., 1996, Galaxea, V13, P85; Chou LM, 2006, ENVIRONMENT IN ASIA PACIFIC HARBOURS, P377, DOI 10.1007/1-4020-3655-8_22; Crabbe MJC, 2005, CORAL REEFS, V24, P437, DOI 10.1007/s00338-005-0004-6; DeVantier LM, 2006, CORAL REEFS, V25, P329, DOI 10.1007/s00338-006-0115-8; Dikou A, 2006, MAR POLLUT BULL, V52, P1340, DOI 10.1016/j.marpolbul.2006.02.011; Done T, 1986, FRING REEF WORKSH SC, V9, P34; Done T.J., 1982, Coral Reefs, V1, P95, DOI 10.1007/BF00301691; Erftemeijer PLA, 2012, MAR POLLUT BULL, V64, P1737, DOI 10.1016/j.marpolbul.2012.05.008; Fabricius K, 2005, MAR POLLUT BULL, V51, P384, DOI 10.1016/j.marpolbul.2004.10.041; Fabricius KE, 2008, LIMNOL OCEANOGR, V53, P690, DOI 10.4319/lo.2008.53.2.0690; Fabricius KE, 2005, MAR POLLUT BULL, V50, P125, DOI 10.1016/j.marpolbul.2004.11.028; Fabricius KE, 2000, ESTUAR COAST SHELF S, V50, P115, DOI 10.1006/ecss.1999.0538; Falkowski P.G., 1990, P89; Hennige SJ, 2010, J EXP MAR BIOL ECOL, V391, P143, DOI 10.1016/j.jembe.2010.06.019; Hill R, 2008, SYMBIOSIS, V46, P45; Hilton MJ, 1995, ENVIRON CONSERV, V22, P307, DOI 10.1017/S0376892900034883; Hoogenboom MO, 2006, MAR ECOL PROG SER, V313, P1, DOI 10.3354/meps313001; Huang DW, 2009, RAFFLES B ZOOL, P69; Lane D.J.W, 1991, P REGIONAL S LIVING, P97; Larcombe P, 1999, CORAL REEFS, V18, P163, DOI 10.1007/s003380050174; LASKER HR, 1980, J EXP MAR BIOL ECOL, V47, P77, DOI 10.1016/0022-0981(80)90139-2; Lesser MP, 2001, MAR ECOL PROG SER, V212, P69, DOI 10.3354/meps212069; Low J. K. Y., 1994, P 3 ASEAN AUSTR S LI, P697; Low JKY, 1995, 2 WORKSH EAS 35 PROJ; LOYA Y, 1976, B MAR SCI, V26, P450; Lui GCY, 2012, RAFFLES B ZOOL, V60, P525; Mass T, 2010, J EXP BIOL, V213, P4084, DOI 10.1242/jeb.039891; Naumann MS, 2009, CORAL REEFS, V28, P109, DOI 10.1007/s00338-008-0459-3; Nugues MM, 2003, CORAL REEFS, V22, P507, DOI 10.1007/s00338-003-0338-x; Orpin AR, 1999, AUST J EARTH SCI, V46, P883, DOI 10.1046/j.1440-0952.1999.00751.x; Piniak GA, 2008, ESTUAR COAST SHELF S, V77, P56, DOI 10.1016/j.ecss.2007.08.023; Piniak GA, 2007, MAR ENVIRON RES, V64, P456, DOI 10.1016/j.marenvres.2007.04.001; Pocock YP, 1972, GEOL RUNDSCH, V61, P598, DOI DOI 10.1007/BF01896337; RIEGL B, 1995, J EXP MAR BIOL ECOL, V186, P259, DOI 10.1016/0022-0981(94)00164-9; Rodolfo-Metalpa R, 2008, J EXP BIOL, V211, P1579, DOI 10.1242/jeb.016345; ROGERS CS, 1990, MAR ECOL PROG SER, V62, P185, DOI 10.3354/meps062185; Schreiber U, 2004, ADV PHOTO RESPIRAT, V19, P279; Sofonia J.J., 2006, THESIS J COOK U TOWN; Sofonia JJ, 2008, ESTUAR COAST SHELF S, V78, P748, DOI 10.1016/j.ecss.2008.02.025; STAFFORDSMITH MG, 1993, MAR BIOL, V115, P229, DOI 10.1007/BF00346340; STAFFORDSMITH MG, 1992, AUST J MAR FRESH RES, V43, P683, DOI 10.1071/MF9920683; Stambler N, 1998, SYMBIOSIS, V24, P127; Sweatman H, 2011, CORAL REEFS, V30, P521, DOI 10.1007/s00338-010-0715-1; Sweatman H., 2007, STATUS NEARSHORE REE; TELESNICKI GJ, 1995, B MAR SCI, V57, P527; Todd PA, 2004, MAR ECOL PROG SER, V271, P167, DOI 10.3354/meps271167; Todd PA, 2004, J EXP MAR BIOL ECOL, V299, P97, DOI 10.1016/j.jembe.2003.09.005; Tun K., 2012, THESIS NATL U SINGAP; Ulstrup KE, 2006, MAR BIOL, V149, P1325, DOI 10.1007/s00227-006-0286-4; Veron J.E.N., 2000, CORALS WORLD, V1-3; WALKER DI, 1982, MAR POLLUT BULL, V13, P21, DOI 10.1016/0025-326X(82)90492-1; Weber M, 2006, J EXP MAR BIOL ECOL, V336, P18, DOI 10.1016/j.jembe.2006.04.007; Weber M, 2012, P NATL ACAD SCI USA, V109, pE1558, DOI 10.1073/pnas.1100715109; Woolfe KJ, 1999, MAR GEOL, V155, P331, DOI 10.1016/S0025-3227(98)00131-5	69	41	42	2	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2014	9	9							e107195	10.1371/journal.pone.0107195	http://dx.doi.org/10.1371/journal.pone.0107195			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4JX	25197883	gold, Green Published, Green Submitted			2022-12-27	WOS:000341304700095
J	O'Grady, TJ; Kitahara, CM; DiRienzo, AG; Boscoe, FP; Gates, MA				O'Grady, Thomas J.; Kitahara, Cari M.; DiRienzo, A. Gregory; Boscoe, Francis P.; Gates, Margaret A.			Randomization to Screening for Prostate, Lung, Colorectal and Ovarian Cancers and Thyroid Cancer Incidence in Two Large Cancer Screening Trials	PLOS ONE			English	Article							PAPILLARY MICROCARCINOMA; INCREASING INCIDENCE; CARCINOMA; TRENDS; MANAGEMENT	Background: Thyroid cancer incidence has increased significantly over the past three decades due, in part, to incidental detection. We examined the association between randomization to screening for lung, prostate, colorectal and/or ovarian cancers and thyroid cancer incidence in two large prospective randomized screening trials. Methods: We assessed the association between randomization to low-dose helical CT scan versus chest x-ray for lung cancer screening and risk of thyroid cancer in the National Lung Screening Trial (NLST). In the Prostate Lung Colorectal and Ovarian Cancer Screening Trial (PLCO), we assessed the association between randomization to regular screening for said cancers versus usual medical care and thyroid cancer risk. Over a median 6 and 11 years of follow-up in NLST and PLCO, respectively, we identified 60 incident and 234 incident thyroid cancer cases. Cox proportional hazards regression was used to calculate the cause specific hazard ratios (HR) and 95% confidence intervals (CI) for thyroid cancer. Results: In NLST, randomization to lung CT scan was associated with a non-significant increase in thyroid cancer risk (HR = 1.61; 95% CI: 0.96-2.71). This association was stronger during the first 3 years of follow-up, during which participants were actively screened (HR = 2.19; 95% CI: 1.07-4.47), but not subsequently (HR = 1.08; 95% CI: 0.49-2.37). In PLCO, randomization to cancer screening compared with usual care was associated with a significant decrease in thyroid cancer risk for men (HR = 0.61; 95% CI: 0.49-0.95) but not women (HR = 0.91; 95% CI: 0.66-1.26). Similar results were observed when restricting to papillary thyroid cancer in both NLST and PLCO. Conclusion: Our study suggests that certain medical encounters, such as those using low-dose helical CT scan for lung cancer screening, may increase the detection of incidental thyroid cancer.	[O'Grady, Thomas J.; DiRienzo, A. Gregory; Boscoe, Francis P.; Gates, Margaret A.] SUNY Albany, Sch Publ Hlth, Rensselaer, NY 12144 USA; [Kitahara, Cari M.] NCI, Div Canc Epidemiol & Genet, NIH, Rockville, MD USA	State University of New York (SUNY) System; State University of New York (SUNY) Albany; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	O'Grady, TJ (corresponding author), SUNY Albany, Sch Publ Hlth, Rensselaer, NY 12144 USA.	togrady@albany.edu	Kitahara, Cari M/R-8267-2016	Kitahara, Cari M/0000-0001-6416-4432; Gates Kuliszewski, Margaret/0000-0002-2111-6227	Intramural Research Program of the National Cancer Institute, National Institutes of Health; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R24HD044943] Funding Source: NIH RePORTER	Intramural Research Program of the National Cancer Institute, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported in part by the Intramural Research Program of the National Cancer Institute, National Institutes of Health. There was no additional funding or support for this work. The funders had no role in the study design, data collection and analysis, decision to publish, or preperation of the manuscript.	Aberle DR, 2010, JNCI-J NATL CANCER I, V102, P1771, DOI 10.1093/jnci/djq434; Brito JP, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f4706; Burgess JR, 2006, THYROID, V16, P47, DOI 10.1089/thy.2006.16.47; Burgess JR, 2000, J CLIN ENDOCR METAB, V85, P1513, DOI 10.1210/jc.85.4.1513; Cheema Y, 2006, J SURG RES, V134, P160, DOI 10.1016/j.jss.2006.04.014; COX DR, 1972, J R STAT SOC B, V34, P187; Cramer JD, 2010, SURGERY, V148, P1147, DOI 10.1016/j.surg.2010.10.016; Davies L, 2006, JAMA-J AM MED ASSOC, V295, P2164, DOI 10.1001/jama.295.18.2164; Esserman LJ, 2014, LANCET ONCOL, V15, pE234, DOI 10.1016/S1470-2045(13)70598-9; Esserman LJ, 2013, JAMA-J AM MED ASSOC, V310, P797, DOI 10.1001/jama.2013.108415; Fritz A, 2000, INT CLASSIFICATION D; Gatsonis CA, 2011, RADIOLOGY, V258, P243, DOI 10.1148/radiol.10091808; Hall SF, 2009, WORLD J SURG, V33, P2567, DOI 10.1007/s00268-009-0226-9; Haymart MR, 2009, ANN SURG ONCOL, V16, P3132, DOI 10.1245/s10434-009-0647-6; Ito Y, 2003, THYROID, V13, P381, DOI 10.1089/105072503321669875; Jemal A, 2013, JNCI-J NATL CANCER I, V105, P175, DOI 10.1093/jnci/djs491; Kaffenberger SD, 2014, UROL CLIN N AM, V41, P249, DOI 10.1016/j.ucl.2014.01.004; Kahn C, 2012, CANCER CAUSE CONTROL, V23, P35, DOI 10.1007/s10552-011-9852-2; Kent WDT, 2007, CAN MED ASSOC J, V177, P1357, DOI 10.1503/cmaj.061730; Klein JP, 2005, SURVIVAL ANAL TECHNI, P98; Lee JC, 2013, CANCER-AM CANCER SOC, V119, P4358, DOI 10.1002/cncr.28254; Leenhardt L, 2004, EUR J ENDOCRINOL, V150, P133, DOI 10.1530/eje.0.1500133; LIN DY, 1993, BIOMETRIKA, V80, P557, DOI 10.2307/2337177; Liu S, 2001, BRIT J CANCER, V85, P1335, DOI 10.1054/bjoc.2001.2061; Luster M, 2014, NAT REV ENDOCRINOL; Malone MK, 2013, THYROID; Melck AL, 2010, ONCOLOGIST, V15, P1285, DOI 10.1634/theoncologist.2010-0156; National Cancer Istitute, 2012, NAT LUNG SCREEN TRIA; Neuhold N, 2011, ANN SURG ONCOL, V18, P3430, DOI 10.1245/s10434-011-1663-x; Nishiyama RH, 1977, PREVELANCE SMALL PAP; Pacini F, 2006, EUR J ENDOCRINOL, V154, P787, DOI 10.1530/eje.1.02158; Pearce EN, 2004, J CLIN ENDOCR METAB, V89, P3710, DOI 10.1210/jc.2004-1189; Piersanti M, 2003, ENDOCR PATHOL, V14, P183, DOI 10.1385/EP:14:3:183; Prorok PC, 2000, CONTROL CLIN TRIALS, V21, p273S, DOI 10.1016/S0197-2456(00)00098-2; Roche L. M., 2011, J ENV PUBLIC HLTH, V2011; Ron E, 2006, CANC EPIDEMIOLOGY PR; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Smith BR, 2006, THYROID, V16, P109, DOI 10.1089/thy.2006.16.109; Sprague BL, 2008, CANCER CAUSE CONTROL, V19, P585, DOI 10.1007/s10552-008-9122-0; Verkooijen HM, 2003, CANCER CAUSE CONTROL, V14, P13, DOI 10.1023/A:1022593923603; Xing MZ, 2009, ANN SURG ONCOL, V16, P801, DOI 10.1245/s10434-008-0298-z; Yoon DY, 2008, J COMPUT ASSIST TOMO, V32, P810, DOI 10.1097/RCT.0b013e318157fd38; Yousem DM, 1997, AM J NEURORADIOL, V18, P1423; Yu XM, 2011, ANN SURG, V254, P653, DOI 10.1097/SLA.0b013e318230036d	44	5	5	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2014	9	9							e106880	10.1371/journal.pone.0106880	http://dx.doi.org/10.1371/journal.pone.0106880			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ1IR	25192282	gold, Green Published, Green Submitted			2022-12-27	WOS:000347993600076
J	Shimelmitz, R; Kuhn, SL; Ronen, A; Weinstein-Evron, M				Shimelmitz, Ron; Kuhn, Steven L.; Ronen, Avraham; Weinstein-Evron, Mina			Predetermined Flake Production at the Lower/Middle Paleolithic Boundary: Yabrudian Scraper-Blank Technology	PLOS ONE			English	Article							TABUN CAVE; GEOMETRIC INDEX; CORE TECHNOLOGY; QESEM CAVE; MIDDLE; TRANSITION; REDUCTION; ORIGINS; LEVANT; CARMEL	While predetermined debitage technologies are recognized beginning with the middle Acheulian, the Middle Paleolithic is usually associated with a sharp increase in their use. A study of scraper-blank technology from three Yabrudian assemblages retrieved from the early part of the Acheulo-Yabrudian complex of Tabun Cave (ca. 415-320 kyr) demonstrates a calculated and preplanned production, even if it does not show the same complexity and elaboration as in the Levallois technology. These scraper dominated assemblages show an organization of production based on an intensive use of predetermination blank technology already in place at the end of the Lower Paleolithic of the Levant. These results provide a novel perspective on the differences and similarities between the Lower and Middle Paleolithic industries. We suggest that there was a change in the paradigm in the way hominins exploited stone tools: in many Middle Paleolithic assemblages the potential of the stone tools for hafting was a central feature, in the Lower Paleolithic ergonometric considerations of manual prehension were central to the design of blanks and tools.	[Shimelmitz, Ron; Ronen, Avraham; Weinstein-Evron, Mina] Univ Haifa, Zinman Inst Archaeol, IL-31999 Haifa, Israel; [Kuhn, Steven L.] Univ Arizona, Sch Anthropol, Tucson, AZ USA	University of Haifa; University of Arizona	Shimelmitz, R (corresponding author), Univ Haifa, Zinman Inst Archaeol, IL-31999 Haifa, Israel.	ronishim@gmail.com		Shimelmitz, Ron/0000-0002-0395-9036; Weinstein-Evron, Mina/0000-0001-7699-5647	Irene Levi Sala CARE Archaeological Foundation; University of Arizona Libraries	Irene Levi Sala CARE Archaeological Foundation; University of Arizona Libraries	The study was supported by the Irene Levi Sala CARE Archaeological Foundation and the open access publishing fund of the University of Arizona Libraries. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al Qadi A, 2011, LOWER MIDDLE PALAEOL; Andrefsky W., 2005, CAMB MAN ARCHAEOL, DOI DOI 10.1017/CBO9780511810244; Barham L, HAND HANDLE 1 IND RE; Barkai R., 2009, HUM EVOL, V24, P57; Barkai R., 2011, LOWER MIDDLE PALEOLI, V126, P121; Barkai R., 2010, ANTIQUITY, V84; Bocda E., 1990, PALEO, V2, P43; Boeda E, 1996, NATURE, V380, P336, DOI 10.1038/380336a0; Boeda E, 2008, ANTIQUITY, V82, P853, DOI 10.1017/S0003598X00097623; Bordes F, 1955, ANTHROPOLOGIE, V59, P486; Bordes F., 1984, LECONS PALEOLITHIQUE; Coolidge F, 2011, RISE HOMOSAPIENS EVO; Copel L., 1989, COPELAND L, P213; Copeland L., 1975, PROBLEMS PREHISTORY, P317; Copeland L., 1995, DEFINITION INTERPRET, P171; Copeland L., 1983, PALE ORIENT, V9, P21; Copeland L., 1978, PALEORIENT, V4, P33; Copeland L., 1983, ADLUN STONE AGE, P89; Cretin C, 1996, PALEO, V8, P243; DeBono H, 2001, J ISRAEL PREHISTORIC, V31, P9; Dibble E., 1995, DEFINITION INTERPRET, P41; Dibble H.L., 1995, DEFINITION INTERPRET; Dibble Harold L., 1995, J ARCHAEOL METHOD TH, V2, P299, DOI [10.1007/BF02229003, DOI 10.1007/BF02229003]; DIBBLE HL, 1981, J ARCHAEOL SCI, V8, P283, DOI 10.1016/0305-4403(81)90004-2; Druck D., 2004, THESIS U HAIFA; Eren MI, 2008, J HUM EVOL, V55, P952, DOI 10.1016/j.jhevol.2008.07.009; Gallotti R, 2013, J HUM EVOL, V65, P594, DOI 10.1016/j.jhevol.2013.07.001; Garrod DA, 1937, STONE AGE MOUNT CARM, DOI DOI 10.1038/140186D0; Garrod DAE, 1956, QUATERNARIA; Gisis I, 1974, PALEORIENT, V2, P175, DOI [10.3406/paleo.1974.4180, DOI 10.3406/PALEO.1974.4180]; Gisis I., 2008, THESIS U HAIFA; Gisis I, 2006, AXE AGE ACHEULIAN TO, P137; Goldberg P, 1973, THESIS U MICHIGAN; Goldberg P., 1973, PALEORIENT, V1, P151, DOI DOI 10.3406/PALEO.1973.4163; Gopehr A, 2010, QUAT GEOCHRONOL, V5, P644; Goren-Inbar N, 2011, J ARCHAEOL SCI, V38, P1901, DOI 10.1016/j.jas.2011.03.037; Goren-Inbar N, 2011, VERTEBR PALEOBIOL PA, P89, DOI 10.1007/978-94-007-0492-3_8; Gowlett J.A.J, 2014, LUCY LANGUAGE BENCHM, P409; Hiscock P, 2005, J ARCHAEOL SCI, V32, P1015, DOI 10.1016/j.jas.2005.02.002; HOWELL F. CLARK, 1959, PROC AMER PHIL SOC, V103, P1; Inizan Marie -Louise, 1999, PRE HIST PIERRE TAIL; Jelinek A.J., 1982, TRANSITION LOWER MID, V151, P57; Jelinek A. J., 1990, EMERGENCE MODERN HUM, P81; JELINEK AJ, 1982, SCIENCE, V216, P1369, DOI 10.1126/science.216.4553.1369; Julien CK, 1994, ANCIENT MIND ELEMENT, P152, DOI DOI 10.1017/CBO9780511598388.016; Kirkbride D., 1961, B MUSEE BEYROUTH, VXXIII, P7; KUHN SL, 1990, J ARCHAEOL SCI, V17, P583, DOI 10.1016/0305-4403(90)90038-7; Lahr MM, 2001, HUMAN ROOTS AFRICA A, P23; Le Tensorer J.-M., 2011, LOWER MIDDLE PALAEOL, P235; Le Tensorer JM, 2007, GEOARCHAEOLOGY, V22, P621, DOI 10.1002/gea.20177; Lemorini C, 2006, J ARCHAEOL SCI, V33, P921, DOI 10.1016/j.jas.2005.10.019; Lenoir M., 1995, DEFINITION INTERPRET, P249; Lev Z., 2010, THESIS TEL AVIV U; McPherron SP, 2003, MULTIPLE APPROACHES, P55; Meignen L, 2012, ARCHAEOL ETHNOL ANTH, V40, P12, DOI 10.1016/j.aeae.2012.11.003; Meignen L., 1994, IND LAMINAIRES PALE, V18, P125; Meignen L, 2009, LITHIC MAT PALEOLITH, P15, DOI DOI 10.1002/9781444311976.CH2; Mercier N, 2000, CR ACAD SCI II A, V330, P731, DOI 10.1016/S1251-8050(00)00193-2; Mercier N, 2003, J HUM EVOL, V45, P401, DOI 10.1016/j.jhevol.2003.09.004; Monigal K., 2002, THESIS SO METHODIST; Monnier G, 2006, INTERD CONTRIB ARCH, P57, DOI 10.1007/0-387-24661-4_4; Nishiaki Y., 2011, LOWER MIDDLE PALAEOL, V126, P67; Nishiaki Y., 1989, PALE ORIENT, V15, P215, DOI DOI 10.3406/paleo.1989.4497; Nowell A, 2010, STONE TOOLS AND THE EVOLUTION OF HUMAN COGNITION, P67; Pelcin AW, 1997, J ARCHAEOL SCI, V24, P749, DOI 10.1006/jasc.1996.0156; Peresani M., 2003, DISCOID LITHIC TECHN, P19; Richter J, 2011, VERTEBR PALEOBIOL PA, P7, DOI 10.1007/978-94-007-0415-2_2; Rink WJ, 2004, J ARCHAEOL SCI, V31, P15, DOI 10.1016/S0305-4403(03)00080-3; Roe D, 1983, BAR INT SERIES, V159, P433; Roebroeks W, 2011, P NATL ACAD SCI USA, V108, P5209, DOI 10.1073/pnas.1018116108; Rolland N., 1995, DEFINITION INTERPRET, P333; Rollefson G.O., 1978, THESIS U ARIZONA; Rollefson GO, 2006, NEAR EAST ARCHAEOL, V69, P61, DOI 10.1086/NEA25067649; Ronen A., 2011, LOWER MIDDLE PALEOLI, P121; Ronen A., 2000, BAR INT SERIES, V850, P97; Rots V, 2011, J HUM EVOL, V60, P637, DOI 10.1016/j.jhevol.2011.01.001; Rust A, 1958, HUNDERT JAHRE NEANDE, P290; Rust A., 1950, HOHLENFUNDE JABRUD S; Saragusti I, 2002, THESIS HEBREW U JERU; Sharon G, 2011, J HUM EVOL, V60, P387, DOI 10.1016/j.jhevol.2009.11.012; Sharon G, 2009, CURR ANTHROPOL, V50, P335, DOI 10.1086/598849; Shea J.J., 2013, TRANSITIONS, DOI 10.1017/CBO9781139026314; Shifroni A., 2000, BAR INT SERIES, V850, P119; Shimelmitz R., 2013, PALEOANTHROPOLOGY, P1, DOI [10.4207/PA.2013.ART77, DOI 10.4207/PA.2013.ART77]; Shimelmitz R., 2009, THESIS TEL AVIV U; Shimelmitz R, 2011, J HUM EVOL, V61, P458, DOI 10.1016/j.jhevol.2011.06.003; Shipton C, 2013, J HUM EVOL, V65, P93, DOI 10.1016/j.jhevol.2013.03.007; Shmookler L., 1983, MASLOUKH REVIS UNPUB; Skinner J.H., 1970, B MUSE E BEYROUTH, VXXIII, P143; Slimak L., 2003, DISCOID LITHIC TECHN, P33; Tryon C. A., 2005, AFR ARCHAEOL REV, V22, P199, DOI [10.1007/s10437-006-9002-5, DOI 10.1007/S10437-006-9002-5]; Tsatskin A., 2000, BAR INT SERIES, VS850, P133; Valladas H, 2013, J HUM EVOL, V65, P585, DOI 10.1016/j.jhevol.2013.07.005; Vaquero M., 2003, BAR INT SERIES, V1120, P67; Verri G, 2005, J ARCHAEOL SCI, V32, P207, DOI 10.1016/j.jas.2004.09.001; Weinstein-Evron M., 2000, BAR INT SERIES, V850, P145; Weinstein-Evron M, 2003, EURASIAN PREHISTORY, V1, P31; White M, 2003, CURR ANTHROPOL, V44, P598, DOI 10.1086/377653; Wright GA., 1966, PAP MICHIGAN ACAD SC, V407-23, P407; Zaidner Y., 2006, AXE AGE ACHEULIAN TO, P243; Zaidner Y., 2005, J ISR PREHIST SOC, V35, P93	101	24	24	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2014	9	9							e106293	10.1371/journal.pone.0106293	http://dx.doi.org/10.1371/journal.pone.0106293			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Arts &amp; Humanities Citation Index (A&amp;HCI)	Science & Technology - Other Topics	AZ1IR	25192429	Green Published, Green Submitted, gold			2022-12-27	WOS:000347993600017
J	Veach, AM; Dodds, WK; Skibbe, A				Veach, Allison M.; Dodds, Walter K.; Skibbe, Adam			Fire and Grazing Influences on Rates of Riparian Woody Plant Expansion along Grassland Streams	PLOS ONE			English	Article							TALLGRASS PRAIRIE; SHRUB EXPANSION; JUNIPERUS-VIRGINIANA; FOREST EXPANSION; MESIC GRASSLAND; GALLERY FOREST; CARBON-DIOXIDE; GREAT-PLAINS; VEGETATION; ENCROACHMENT	Grasslands are threatened globally due to the expansion of woody plants. The few remaining headwater streams within tallgrass prairies are becoming more like typical forested streams due to rapid conversion of riparian zones from grassy to wooded. Forestation can alter stream hydrology and biogeochemistry. We estimated the rate of riparian woody plant expansion within a 30 m buffer zone surrounding the stream bed across whole watersheds at Konza Prairie Biological Station over 25 years from aerial photographs. Watersheds varied with respect to experimentally-controlled fire and bison grazing. Fire frequency, presence or absence of grazing bison, and the historical presence of woody vegetation prior to the study time period (a proxy for proximity of propagule sources) were used as independent variables to predict the rate of riparian woody plant expansion between 1985 and 2010. Water yield was estimated across these years for a subset of watersheds. Riparian woody encroachment rates increased as burning became less frequent than every two years. However, a higher fire frequency (1-2 years) did not reverse riparian woody encroachment regardless of whether woody vegetation was present or not before burning regimes were initiated. Although riparian woody vegetation cover increased over time, annual total precipitation and average annual temperature were variable. So, water yield over 4 watersheds under differing burn frequencies was quite variable and with no statistically significant detected temporal trends. Overall, burning regimes with a frequency of every 1-2 years will slow the conversion of tallgrass prairie stream ecosystems to forested ones, yet over long time periods, riparian woody plant encroachment may not be prevented by fire alone, regardless of fire frequency.	[Veach, Allison M.; Dodds, Walter K.] Kansas State Univ, Div Biol, Manhattan, KS 66506 USA; [Skibbe, Adam] Univ Iowa, Dept Geog & Sustainabil Sci, Iowa City, IA USA	Kansas State University; University of Iowa	Veach, AM (corresponding author), Kansas State Univ, Div Biol, Ackert Hall, Manhattan, KS 66506 USA.	amveach@ksu.edu		Veach, Allison/0000-0001-9845-3558; Dodds, Walter/0000-0002-6666-8930	National Science Foundation's Konza Prairie Long Term Ecological Research (Award) [DEB-0823341]; Kansas Experimental Program to Stimulate Competitive Research (Award) [EPS-0919443]; Kansas State University Open Access Publishing Fund	National Science Foundation's Konza Prairie Long Term Ecological Research (Award); Kansas Experimental Program to Stimulate Competitive Research (Award); Kansas State University Open Access Publishing Fund	This research was supported by the National Science Foundation's Konza Prairie Long Term Ecological Research (Award # DEB-0823341) and the Kansas Experimental Program to Stimulate Competitive Research (Award # EPS-0919443) both of which were awarded to Walter Dodds. Publication of this article was funded in part by the Kansas State University Open Access Publishing Fund. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARCHER S, 1995, CLIMATIC CHANGE, V29, P91, DOI 10.1007/BF01091640; Arthur MA, 1998, J TORREY BOT SOC, V125, P225, DOI 10.2307/2997220; Blinn CR, 2001, J FOREST, V99, P11; Bond WJ, 2012, PHILOS T R SOC B, V367, P601, DOI 10.1098/rstb.2011.0182; BRAGG TB, 1976, J RANGE MANAGE, V29, P19, DOI 10.2307/3897682; Briggs JM, 2005, BIOSCIENCE, V55, P243, DOI 10.1641/0006-3568(2005)055[0243:AEITCA]2.0.CO;2; Briggs JM, 2002, AM MIDL NAT, V147, P287, DOI 10.1674/0003-0031(2002)147[0287:EOWPIT]2.0.CO;2; Brown AE, 2005, J HYDROL, V310, P28, DOI 10.1016/j.jhydrol.2004.12.010; Dodds WK, 2012, BIOSCIENCE, V62, P709, DOI 10.1525/bio.2012.62.8.4; Dodds WK, 1996, HYDROBIOLOGIA, V333, P151, DOI 10.1007/BF00013429; Dodds WK, 2004, BIOSCIENCE, V54, P205, DOI 10.1641/0006-3568(2004)054[0205:LOTETE]2.0.CO;2; Dodds WK, 1997, J N AM BENTHOL SOC, V16, P162, DOI 10.2307/1468248; Eckhardt HC, 2000, AFR J ECOL, V38, P108, DOI 10.1046/j.1365-2028.2000.00217.x; Ehleringer JR, 1997, OECOLOGIA, V112, P285, DOI 10.1007/s004420050311; Eldridge DJ, 2011, ECOL LETT, V14, P709, DOI 10.1111/j.1461-0248.2011.01630.x; Fremont JC, 1886, MEMOIRS MY LIFE TIME; Garvey JE, 1998, ECOLOGY, V79, P442; GEHRING JL, 1992, AM MIDL NAT, V128, P209, DOI 10.2307/2426455; Hayden B., 1998, GRASSLAND DYNAMICS L, P19; Heisler JL, 2003, AM J BOT, V90, P423, DOI 10.3732/ajb.90.3.423; House JI, 2003, TELLUS B, V55, P345, DOI 10.1034/j.1600-0889.2003.00037.x; Huxman TE, 2005, ECOLOGY, V86, P308, DOI 10.1890/03-0583; Jackson RB, 2002, NATURE, V418, P623, DOI 10.1038/nature00910; Knapp AK, 1999, BIOSCIENCE, V49, P39, DOI 10.2307/1313492; KNIGHT CL, 1994, LANDSCAPE ECOL, V9, P117; Kochy M, 2001, J ECOL, V89, P807, DOI 10.1046/j.0022-0477.2001.00600.x; Konza Prairie LTER, 2013, KONZ DAT; Konza Prairie LTER, 2013, KONZ PRAIR BURN HIST; Larson DM, 2013, FRESHW SCI, V32, P779, DOI 10.1899/12-118.1; Lett MS, 2003, J VEG SCI, V14, P487, DOI 10.1111/j.1654-1103.2003.tb02175.x; McCarron JK, 2003, AM J BOT, V90, P1496, DOI 10.3732/ajb.90.10.1496; McKinley DC, 2008, ECOSYSTEMS, V11, P454, DOI 10.1007/s10021-008-9133-4; Oviatt C. G., 1998, GRASSLAND DYNAMICS L, P35; Peterson DW, 2001, ECOL APPL, V11, P914, DOI 10.1890/1051-0761(2001)011[0914:PFIOSF]2.0.CO;2; Ratajczak Z, ECOLOGY IN PRESS; Ratajczak Z, 2011, ECOSPHERE, V2, DOI 10.1890/ES11-00212.1; Ratajczak Z, 2012, ECOLOGY, V93, P697, DOI 10.1890/11-1199.1; Reisinger AJ, 2013, ECOSYSTEMS, V16, P547, DOI 10.1007/s10021-012-9630-3; Riley AJ, 2012, FRESHWATER BIOL, V57, P1138, DOI 10.1111/j.1365-2427.2012.02778.x; Ruthven DC, 2003, J RANGE MANAGE, V56, P159, DOI 10.2307/4003900; Sankaran M, 2008, GLOBAL ECOL BIOGEOGR, V17, P236, DOI 10.1111/j.1466-8238.2007.00360.x; Saunders DL, 2002, CONSERV BIOL, V16, P30, DOI 10.1046/j.1523-1739.2002.99562.x; Scholes RJ, 1997, ANNU REV ECOL SYST, V28, P517, DOI 10.1146/annurev.ecolsys.28.1.517; Scott RL, 2006, GLOBAL CHANGE BIOL, V12, P311, DOI 10.1111/j.1365-2486.2005.01093.x; Ungerer MC, 2013, J HERED, V104, P182, DOI 10.1093/jhered/ess095; Van Auken OW, 2009, J ENVIRON MANAGE, V90, P2931, DOI 10.1016/j.jenvman.2009.04.023; Van Auken OW, 2000, ANNU REV ECOL SYST, V31, P197, DOI 10.1146/annurev.ecolsys.31.1.197; Wine ML, 2012, FOREST ECOL MANAG, V266, P170, DOI 10.1016/j.foreco.2011.11.014; Zhang L, 2001, WATER RESOUR RES, V37, P701, DOI 10.1029/2000WR900325	49	28	29	3	60	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2014	9	9							e106922	10.1371/journal.pone.0106922	http://dx.doi.org/10.1371/journal.pone.0106922			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ1IR	25192194	gold, Green Published, Green Submitted			2022-12-27	WOS:000347993600081
J	Bonato, A; Gleich, DF; Kim, M; Mitsche, D; Pralat, P; Tian, YH; Young, SJ				Bonato, Anthony; Gleich, David F.; Kim, Myunghwan; Mitsche, Dieter; Pralat, Pawel; Tian, Yanhua; Young, Stephen J.			Dimensionality of Social Networks Using Motifs and Eigenvalues	PLOS ONE			English	Article							DYNAMICS; GRAPHS	We consider the dimensionality of social networks, and develop experiments aimed at predicting that dimension. We find that a social network model with nodes and links sampled from an m-dimensional metric space with power-law distributed influence regions best fits samples from real-world networks when m scales logarithmically with the number of nodes of the network. This supports a logarithmic dimension hypothesis, and we provide evidence with two different social networks, Facebook and LinkedIn. Further, we employ two different methods for confirming the hypothesis: the first uses the distribution of motif counts, and the second exploits the eigenvalue distribution.	[Bonato, Anthony; Pralat, Pawel] Ryerson Univ, Dept Math, Toronto, ON, Canada; [Gleich, David F.] Purdue Univ, Dept Comp Sci, W Lafayette, IN 47907 USA; [Kim, Myunghwan] Stanford Univ, Dept Elect Engn, Stanford, CA 94305 USA; [Mitsche, Dieter] Univ Nice Sophia Antipolis, Lab JA Dieudonne, F-06189 Nice, France; [Tian, Yanhua] York Univ, Dept Math & Stat, Toronto, ON M3J 2R7, Canada; [Young, Stephen J.] Univ Louisville, Dept Math, Louisville, KY 40292 USA	Toronto Metropolitan University; Purdue University System; Purdue University; Purdue University West Lafayette Campus; Stanford University; UDICE-French Research Universities; Universite Cote d'Azur; York University - Canada; University of Louisville	Bonato, A (corresponding author), Ryerson Univ, Dept Math, Toronto, ON, Canada.	abonato@ryerson.ca; dgleich@purdue.edu		Gleich, David/0000-0002-8107-6474	NSERC DG grants; NSF CAREER award [CCF-1149756]	NSERC DG grants(Natural Sciences and Engineering Research Council of Canada (NSERC)); NSF CAREER award(National Science Foundation (NSF)NSF - Office of the Director (OD))	NSERC DG grants; NSF CAREER award CCF-1149756; MITACS for hosting the authors' research team at the Advances in Network Analysis and its Applications Workshop held at the University of British Colombia in July 2012. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Banerjee A, 2012, BIOSYSTEMS, V107, P186, DOI 10.1016/j.biosystems.2011.11.004; Banerjee A, 2009, DISCRETE APPL MATH, V157, P2425, DOI 10.1016/j.dam.2008.06.033; Barabasi AL, 1999, SCIENCE, V286, P509, DOI 10.1126/science.286.5439.509; Bonato A, 2012, INTERNET MATH, V8, P2, DOI 10.1080/15427951.2012.625246; Chung F.R.K., 1992, SPECTRAL GRAPH THEOR; Clauset A, 2009, SIAM REV, V51, P661, DOI 10.1137/070710111; Csardi G., 2005, INTERJ COMPLEX SYST, P1695; Dhillon I.S, 1997, THESIS U CALIFORNIA; Dhillon IS, 2006, ACM T MATH SOFTWARE, V32, P533, DOI 10.1145/1186785.1186788; Estrada E, 2006, EUROPHYS LETT, V73, P649, DOI 10.1209/epl/i2005-10441-3; Faloutsos M, 1999, COMP COMM R, V29, P251, DOI 10.1145/316194.316229; Gleich DF, 2012, INTERNET MATH, V8, P232, DOI 10.1080/15427951.2012.680824; Kim M, 2012, INTERNET MATH, V8, P113, DOI 10.1080/15427951.2012.625257; Kolda TG, 2013, CSSI13026636 ARXIV; Krioukov D, 2013, PHYS REV E, V88, DOI 10.1103/PhysRevE.88.022808; Krioukov D, 2012, SCI REP-UK, V2, DOI 10.1038/srep00793; Krioukov D, 2010, PHYS REV E, V82, DOI 10.1103/PhysRevE.82.036106; Kumar R, 2000, ANN IEEE SYMP FOUND, P57, DOI 10.1109/SFCS.2000.892065; Leskovec J, 2009, INTERNET MATH, V6, P29, DOI 10.1080/15427951.2009.10129177; Leskovec J, 2010, J MACH LEARN RES, V11, P985; Leskovec J, 2007, ACM T WEB, V1, DOI 10.1145/1232722.1232727; MCPHERSON JM, 1991, SOC FORCES, V70, P19, DOI 10.2307/2580060; McPherson M, 2001, ANNU REV SOCIOL, V27, P415, DOI 10.1146/annurev.soc.27.1.415; Memisevic V, 2010, J INTEGR BIOINFORM, V7, P120; Moreno S, 2013, 19TH ACM SIGKDD INTERNATIONAL CONFERENCE ON KNOWLEDGE DISCOVERY AND DATA MINING (KDD'13), P1052; Nepusz T, 2012, PLFIT SOFTWARE; Palmer C.R., 2002, SIGKDD, P81, DOI DOI 10.1145/775047.775059; Patro R, 2012, BIOINFORMATICS, V28, P3105, DOI 10.1093/bioinformatics/bts592; SEIDMAN SB, 1983, SOC NETWORKS, V5, P269, DOI 10.1016/0378-8733(83)90028-X; Sweeney L, 2000, LIDAPWP4 CARN MELL U; Traud AL, 2011, CSSI11022166 ARXIV; Vomel C, 2010, ACM T MATH SOFTWARE, V37, DOI 10.1145/1644001.1644002; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; Wernicke S, 2006, IEEE ACM T COMPUT BI, V3, P347, DOI 10.1109/TCBB.2006.51; Witten I. H., 2005, DATA MINING PRACTICA; Zhang ZZ, 2006, J PHYS A-MATH GEN, V39, P1811, DOI 10.1088/0305-4470/39/8/003; Zhao XH, 2011, COLLABORATECOM, P77, DOI 10.4108/icst.collaboratecom.2011.247162	37	23	23	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 4	2014	9	9							e106052	10.1371/journal.pone.0106052	http://dx.doi.org/10.1371/journal.pone.0106052			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AO3XV	25188391	Green Submitted, gold, Green Published			2022-12-27	WOS:000341271500019
J	Chen, KH; Hsu, HH; Lee, CC; Yen, TH; Ko, YC; Yang, CW; Hung, CC				Chen, Kuan-Hsing; Hsu, Hsiang-Hao; Lee, Cheng-Chia; Yen, Tzu-Hai; Ko, Yi-Ching; Yang, Chih-Wei; Hung, Cheng-Chieh			The AMPK Agonist AICAR Inhibits TGF-beta 1 Induced Activation of Kidney Myofibroblasts	PLOS ONE			English	Article							PROTEIN-KINASE ACTIVATION; TGF-BETA; OBSTRUCTIVE NEPHROPATHY; FIBROBLAST ACTIVATION; INTERSTITIAL FIBROSIS; RENAL FIBROSIS; METABOLISM; DISEASE; CELLS; GLUCOSE	Activation of interstitial myofibroblasts and excessive production of extracellular matrix proteins are common pathways that contribute to chronic kidney disease. In a number of tissues, AMP-activated kinase (AMPK) activation has been shown to inhibit fibrosis. Here, we examined the inhibitory effect of the AMPK activator, 5-aminoimidazole-4-carboxyamide ribonucleoside (AICAR), on renal fibrosis in vivo and TGF-beta 1-induced renal fibroblasts activation in vitro. A unilateral ureteral obstruction (UUO) model was induced in male BALB/c mice. Mice with UUO were administered AICAR (500 mg/Kg/day) or saline intraperitoneally 1 day before UUO surgery and daily thereafter. Both kidneys were harvested 7 days after surgery for further analysis. For the in vitro studies, NRK-49F rat fibroblasts were pre-incubated with AICAR before TGF-beta 1 stimulation. The inhibitory effects of AICAR on signaling pathways down-stream of TGF-beta 1 were analyzed. In UUO model mice, administration of AICAR attenuated extracellular matrix protein deposition and the expression of alpha-smooth muscle actin (alpha-SMA), type I collagen and fibronectin. Pre-incubation of NRK-49F cells with AICAR inhibited TGF-beta 1-induced myofibroblast activation. Silencing of AMPK alpha 1 by siRNA or by blocking AMPK activation with Compound C diminished the inhibitory effect of AICAR. Moreover, the inhibitory effects of AICAR on TGF-beta 1-mediated myofibroblast activation were associated with down-regulation of ERK 1/2 and STAT3. Our results suggest that AICAR reduces tubulointerstitial fibrosis in UUO mice and inhibits TGF-beta 1-induced kidney myofibroblast activation. AMPK activation by AICAR may have therapeutic potential for the treatment of renal tubulointerstitial fibrosis.	[Chen, Kuan-Hsing; Hsu, Hsiang-Hao; Lee, Cheng-Chia; Yen, Tzu-Hai; Ko, Yi-Ching; Yang, Chih-Wei; Hung, Cheng-Chieh] Chang Gung Univ, Sch Med, Chang Gung Mem Hosp, Kidney Res Ctr, Taoyuan, Taiwan	Chang Gung Memorial Hospital; Chang Gung University	Hung, CC (corresponding author), Chang Gung Univ, Sch Med, Chang Gung Mem Hosp, Kidney Res Ctr, Taoyuan, Taiwan.	cchung9651@yahoo.com		Lee, Cheng-Chia/0000-0002-6973-5908	National Science Council of Taiwan [NMRPG5A0031]	National Science Council of Taiwan(Ministry of Science and Technology, Taiwan)	This work was supported by grants from the National Science Council of Taiwan (NMRPG5A0031). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bijland S, 2013, CLIN SCI, V124, P491, DOI 10.1042/CS20120536; Bondi CD, 2010, J AM SOC NEPHROL, V21, P93, DOI 10.1681/ASN.2009020146; Bottinger EP, 2002, J AM SOC NEPHROL, V13, P2600, DOI 10.1097/01.ASN.0000033611.79556.AE; Bottinger EP, 2007, SEMIN NEPHROL, V27, P309, DOI 10.1016/j.semnephrol.2007.02.009; Carling D, 2004, TRENDS BIOCHEM SCI, V29, P18, DOI 10.1016/j.tibs.2003.11.005; DOWNER G, 1988, J CLIN INVEST, V82, P998, DOI 10.1172/JCI113710; Fox Melissa M, 2013, Genes Cancer, V4, P3, DOI 10.1177/1947601913486346; Fraser D, 2003, AM J PATHOL, V163, P2565, DOI 10.1016/S0002-9440(10)63611-5; Gonzalez-Girones DM, 2013, APOPTOSIS, V18, P1008, DOI 10.1007/s10495-013-0850-6; Grande MT, 2009, NAT REV NEPHROL, V5, P319, DOI 10.1038/nrneph.2009.74; Handy JA, 2010, J CELL BIOCHEM, V110, P1195, DOI 10.1002/jcb.22634; Hasenour CM, 2014, J BIOL CHEM, V289, P5950, DOI 10.1074/jbc.M113.528232; Hawley SA, 2005, CELL METAB, V2, P9, DOI 10.1016/j.cmet.2005.05.009; Hawley SA, 1996, J BIOL CHEM, V271, P27879, DOI 10.1074/jbc.271.44.27879; Hoogendijk AJ, 2013, J BIOL CHEM, V288, P7047, DOI 10.1074/jbc.M112.413138; Hurley RL, 2005, J BIOL CHEM, V280, P29060, DOI 10.1074/jbc.M503824200; Kim IY, 2013, FRONT ONCOL, V3, DOI 10.3389/fonc.2013.00175; Kodiha M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088087; Kuratsune M, 2007, NEPHROLOGY, V12, P565, DOI 10.1111/j.1440-1797.2007.00881.x; Lanner JT, 2012, NAT MED, V18, P244, DOI 10.1038/nm.2598; Lee JH, 2013, AM J PHYSIOL-RENAL, V304, pF686, DOI 10.1152/ajprenal.00148.2012; Lempiainen J, 2012, BRIT J PHARMACOL, V166, P1905, DOI 10.1111/j.1476-5381.2012.01895.x; Lim CP, 2009, J INVEST DERMATOL, V129, P851, DOI 10.1038/jid.2008.337; Lim JY, 2012, J CELL PHYSIOL, V227, P1081, DOI 10.1002/jcp.22824; Liu SX, 2007, MOL BIOL CELL, V18, P2169, DOI 10.1091/mbc.E06-12-1121; Liu XN, 2014, P NATL ACAD SCI USA, V111, pE435, DOI 10.1073/pnas.1311121111; Liu YH, 2006, KIDNEY INT, V69, P213, DOI 10.1038/sj.ki.5000054; Lopez-Hernandez FJ, 2012, CELL TISSUE RES, V347, P141, DOI 10.1007/s00441-011-1275-6; Massague J, 1998, ANNU REV BIOCHEM, V67, P753, DOI 10.1146/annurev.biochem.67.1.753; Meran S, 2011, INT J EXP PATHOL, V92, P158, DOI 10.1111/j.1365-2613.2011.00764.x; Merrill GF, 1997, AM J PHYSIOL-ENDOC M, V273, pE1107, DOI 10.1152/ajpendo.1997.273.6.E1107; Mishra R, 2008, J BIOL CHEM, V283, P10461, DOI 10.1074/jbc.M800902200; Moustakas A, 2005, J CELL SCI, V118, P3573, DOI 10.1242/jcs.02554; Namgaladze D, 2013, CARDIOVASC RES, V98, P479, DOI 10.1093/cvr/cvt073; Nath N, 2005, J IMMUNOL, V175, P566, DOI 10.4049/jimmunol.175.1.566; Neilson EG, 2006, NAT CLIN PRACT NEPHR, V2, P101, DOI 10.1038/ncpneph0093; O'Neill LAJ, 2013, NATURE, V493, P346, DOI 10.1038/nature11862; Pang MY, 2010, KIDNEY INT, V78, P257, DOI 10.1038/ki.2010.154; SABINA RL, 1985, J BIOL CHEM, V260, P6107; Salt IP, 2012, EXPERT OPIN INV DRUG, V21, P1155, DOI 10.1517/13543784.2012.696609; Satriano J, 2013, AM J PHYSIOL-RENAL, V305, pF727, DOI 10.1152/ajprenal.00293.2013; Srivastava RAK, 2012, J LIPID RES, V53, P2490, DOI 10.1194/jlr.R025882; Su RY, 2007, MOL CANCER THER, V6, P1562, DOI 10.1158/1535-7163.MCT-06-0800; Suzuki Hitoe, 2004, Clin Exp Nephrol, V8, P188; Tian YC, 2003, J AM SOC NEPHROL, V14, P631, DOI 10.1097/01.ASN.0000053418.56286.5E; Vij N, 2008, MOL VIS, V14, P1020; Vitzel KF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062190; Wynn TA, 2008, J PATHOL, V214, P199, DOI 10.1002/path.2277; Yamamoto T, 2001, FEBS LETT, V492, P247, DOI 10.1016/S0014-5793(01)02258-X; Yang CW, 2002, J AM SOC NEPHROL, V13, P2037, DOI 10.1097/01.ASN.0000022007.91733.62; Zhang YE, 2009, CELL RES, V19, P128, DOI 10.1038/cr.2008.328; Zhao X, 2008, AM J PHYSIOL-LUNG C, V295, pL497, DOI 10.1152/ajplung.90210.2008	52	46	48	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 4	2014	9	9							e106554	10.1371/journal.pone.0106554	http://dx.doi.org/10.1371/journal.pone.0106554			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3XV	25188319	gold, Green Published, Green Submitted			2022-12-27	WOS:000341271500053
J	He, J; Guo, SX; Liu, JM; Zhang, M; Ding, YS; Zhang, JY; Li, SG; Xu, SZ; Niu, Q; Guo, H; Ma, RL				He, Jia; Guo, Shuxia; Liu, Jiaming; Zhang, Mei; Ding, Yusong; Zhang, Jingyu; Li, Shugang; Xu, Shangzhi; Niu, Qiang; Guo, Heng; Ma, Rulin			Ethnic Differences in Prevalence of General Obesity and Abdominal Obesity among Low-Income Rural Kazakh and Uyghur Adults in Far Western China and Implications in Preventive Public Health	PLOS ONE			English	Article							BODY-MASS INDEX; RISK-FACTORS; CHRONIC DISEASE; UNITED-STATES; US ADULTS; OVERWEIGHT; TRENDS; ASSOCIATIONS; POPULATIONS; EPIDEMIC	Background: The global pandemic of obesity has become a disastrous public health issue that needs urgent attention. Previous studies have concentrated in high-income urban settings and few cover low-income rural settings especially nomadic residents in mountain areas. This study focused on low-income rural and nomadic minority people residing in China's far west and investigated their prevalence and ethnic differences of obesity. Methods: A questionnaire-based survey and physical examination of 8,036 individuals were conducted during 2009-2010, using stratified cluster random sampling method in nomadic Kazakhs and rural Uyghur residents (>= 18 years old) in 18 villages, Xinjiang, China, about 4,407 km away from capital Beijing. Obesity was defined by BMI and WC. Results: The overall prevalence of general and abdominal obesity in Kazakh adults were 18.3% and 60.0%, respectively and in Uyghur, 7.6% and 54.5%, respectively. Female's prevalence of obesity was higher than male's for general obesity (45-54 age group in Uyghur, P = 0.041) and abdominal obesity (>= 55 years in Kazakhs, P-55 similar to = 0.010, P-65 similar to = 0.001; and >= 18 years in Uyghurs, P < 0.001). Kazakh's prevalence of obesity was higher than Uyghur's (general obesity: >= 35 years, P < 0.001; abdominal obesity: >= 25 years in males and >= 65 years in females, P < 0.01). The prevalence of obesity increased after 18 years old and subsequently decreased after 55 years old. Meat consumption, older age, and female gender had a higher risk of obesity in these two minorities. Conclusions: Both general and abdominal obesity were common in rural ethnic Kazakhs and Uyghurs. The prevalence rates were different in these two minorities depending on ethnicity, gender, and age. Kazakhs, females and elderly people may be prioritized in prevention of obesity in western China. Because of cost-effectiveness in measuring BMI and WC, we recommend that BMI and WC be integrated into local preventive policies in public health toward screening obesity and related diseases in low-income rural minorities.	[He, Jia; Guo, Shuxia; Liu, Jiaming; Zhang, Mei; Ding, Yusong; Zhang, Jingyu; Li, Shugang; Xu, Shangzhi; Niu, Qiang; Guo, Heng; Ma, Rulin] Shihezi Univ, Sch Med, Dept Prevent Med, Shihezi, Xinjiang, Peoples R China	Shihezi University	Guo, SX (corresponding author), Shihezi Univ, Sch Med, Dept Prevent Med, Shihezi, Xinjiang, Peoples R China.	pge888@sina.com			National Key Technology R&D Program of China [2009BAI82B04]	National Key Technology R&D Program of China(National Key Technology R&D Program)	This research was supported by the National Key Technology R&D Program of China (Grant No. 2009BAI82B04). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agyemang C, 2011, INT J OBESITY, V35, P1334, DOI 10.1038/ijo.2010.281; Baghaei F, 2003, OBES RES, V11, P578, DOI 10.1038/oby.2003.81; Cai ZJ, 1999, WHO TECH REP SER, V887, P1; Chang CJ, 2003, INT J OBESITY, V27, P253, DOI 10.1038/sj.ijo.802197; Chau JY, 2012, PREV MED, V54, P195, DOI 10.1016/j.ypmed.2011.12.020; Chen CM, 2008, OBES REV, V9, P14, DOI 10.1111/j.1467-789X.2007.00433.x; Chen Chunming, 2004, Biomed Environ Sci, V17 Suppl, P1; Cong L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090262; Deurenberg P, 1998, INT J OBESITY, V22, P1164, DOI 10.1038/sj/ijo/0800741; Elobeid MA, 2007, OBESITY, V15, P2380, DOI 10.1038/oby.2007.282; Finucane MM, 2011, LANCET, V377, P557, DOI 10.1016/S0140-6736(10)62037-5; Flegal KM, 2012, JAMA-J AM MED ASSOC, V307, P491, DOI 10.1001/jama.2012.39; Flegal KM, 2010, JAMA-J AM MED ASSOC, V303, P235, DOI 10.1001/jama.2009.2014; Ford ES, 2011, INT J OBESITY, V35, P736, DOI 10.1038/ijo.2010.186; Gao Y, 2006, BMC PUBLIC HEALTH, V11, P919; Gutierrez-Fisac JL, 2012, OBES REV, V13, P388, DOI 10.1111/j.1467-789X.2011.00964.x; Hamer M, 2012, J CLIN ENDOCR METAB, V97, P2482, DOI 10.1210/jc.2011-3475; Hou XH, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-389; Kaidar-Person O, 2011, OBES SURG, V21, P1792, DOI 10.1007/s11695-011-0490-2; Katsuyama Y, 1998, HUM HERED, V48, P126, DOI 10.1159/000022793; Kershaw KN, 2013, AM J EPIDEMIOL, V177, P299, DOI 10.1093/aje/kws372; Kim J, 2002, AM J CLIN NUTR, V76, P378, DOI 10.1093/ajcn/76.2.378; Ko GT, 2010, EUR J CLIN NUTR, V64, P549, DOI 10.1038/ejcn.2010.49; Kwan ML, 2014, AM J EPIDEMIOL, V179, P95, DOI 10.1093/aje/kwt233; Linhares RD, 2012, CAD SAUDE PUBLICA, V28, P438, DOI 10.1590/S0102-311X2012000300004; Lorig K, 2013, HEALTH EDUC BEHAV, V40, P67, DOI 10.1177/1090198112436969; Martinez-Ros MT, 2001, INT J OBESITY, V25, P1372, DOI 10.1038/sj.ijo.0801684; McLellan F, 2002, LANCET, V359, P1412, DOI 10.1016/S0140-6736(02)08397-6; Nystad T, 2010, SCAND J PUBLIC HEALT, V38, P17, DOI 10.1177/1403494809354791; Ogden CL, 2006, JAMA-J AM MED ASSOC, V295, P1549, DOI 10.1001/jama.295.13.1549; Pi-Sunyer FX, 1998, OBES RES, V6, p51S; Population Census Office under the State Council and Department of Population Social Science and Technology Statistics, 2002, TAB 2000 POP CENS PE; Reynolds K, 2007, OBESITY, V15, P10, DOI 10.1038/oby.2007.527; Tian HG, 2009, PREV MED, V48, P59, DOI 10.1016/j.ypmed.2008.10.020; Wang H, 2012, BMC PUBLIC HEALTH, V12, DOI [10.1186/1471-2458-12-967, 10.1186/1471-2407-12-528]; Wang Y, 2007, INT J OBESITY, V31, P177, DOI 10.1038/sj.ijo.0803354; WHO, 2003, WHO TECH REP SER, V916, P1; WHO, 2008, GLOB START DIET PHYS; World Health Organization, 2012, WORLD HLTH STAT; Xi B, 2012, OBES REV, V13, P287, DOI 10.1111/j.1467-789X.2011.00944.x; Xu SH, 2008, AM J HUM GENET, V82, P883, DOI 10.1016/j.ajhg.2008.01.017; Zhang WJ, 2013, NAT BIOTECHNOL, V31, P590, DOI 10.1038/nbt.2631	42	27	33	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 4	2014	9	9							e106723	10.1371/journal.pone.0106723	http://dx.doi.org/10.1371/journal.pone.0106723			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3XV	25188373	Green Published, Green Submitted, gold			2022-12-27	WOS:000341271500075
J	Kim, N; Zheng, Z; Elmetwaly, S; Schlick, T				Kim, Namhee; Zheng, Zhe; Elmetwaly, Shereef; Schlick, Tamar			RNA Graph Partitioning for the Discovery of RNA Modularity: A Novel Application of Graph Partition Algorithm to Biology	PLOS ONE			English	Article							IN-VITRO SELECTION; MOTIFS; POOLS; ANNOTATION; TOPOLOGIES; SEQUENCES; NETWORKS; RESOURCE; TREES; RAG	Graph representations have been widely used to analyze and design various economic, social, military, political, and biological networks. In systems biology, networks of cells and organs are useful for understanding disease and medical treatments and, in structural biology, structures of molecules can be described, including RNA structures. In our RNA-As-Graphs (RAG) framework, we represent RNA structures as tree graphs by translating unpaired regions into vertices and helices into edges. Here we explore the modularity of RNA structures by applying graph partitioning known in graph theory to divide an RNA graph into subgraphs. To our knowledge, this is the first application of graph partitioning to biology, and the results suggest a systematic approach for modular design in general. The graph partitioning algorithms utilize mathematical properties of the Laplacian eigenvector (mu 2) corresponding to the second eigenvalues (lambda 2) associated with the topology matrix defining the graph: lambda 2 describes the overall topology, and the sum of mu 2's components is zero. The three types of algorithms, termed median, sign, and gap cuts, divide a graph by determining nodes of cut by median, zero, and largest gap of mu 2's components, respectively. We apply these algorithms to 45 graphs corresponding to all solved RNA structures up through 11 vertices (similar to 220 nucleotides). While we observe that the median cut divides a graph into two similar-sized subgraphs, the sign and gap cuts partition a graph into two topologically-distinct subgraphs. We find that the gap cut produces the best biologically-relevant partitioning for RNA because it divides RNAs at less stable connections while maintaining junctions intact. The iterative gap cuts suggest basic modules and assembly protocols to design large RNA structures. Our graph substructuring thus suggests a systematic approach to explore the modularity of biological networks. In our applications to RNA structures, subgraphs also suggest design strategies for novel RNA motifs.	[Schlick, Tamar] NYU, Dept Chem, New York, NY 10012 USA; NYU, Courant Inst Math Sci, New York, NY USA	New York University; New York University	Schlick, T (corresponding author), NYU, Dept Chem, New York, NY 10012 USA.	schlick@nyu.edu	Elmetwaly, Shereef/H-5678-2019; Elmetwaly, Shereef/D-8097-2016	Elmetwaly, Shereef/0000-0002-0615-7071; Elmetwaly, Shereef/0000-0002-0615-7071; Schlick, Tamar/0000-0002-2392-2062	National Science Foundation [DMS-0201160, CCF-0727001]; National Institute of Health [GM100469, GM081410]; NSF REU fellowship for the Biophysics program [NSF MCB-0316771]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM100469, R01GM081410] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF REU fellowship for the Biophysics program; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work is supported by the National Science Foundation (DMS-0201160, CCF-0727001) and the National Institute of Health (GM100469, GM081410). Zhe Zheng was supported by an NSF REU fellowship for the Biophysics program NSF MCB-0316771. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afonin KA, 2010, NAT NANOTECHNOL, V5, P676, DOI [10.1038/NNANO.2010.160, 10.1038/nnano.2010.160]; Bakhtin Y, 2009, B MATH BIOL, V71, P84, DOI 10.1007/s11538-008-9353-y; Barabasi AL, 2003, SCI AM, V288, P60, DOI 10.1038/scientificamerican0503-60; Biggs N., 1993, ALGEBRAIC GRAPH THEO; Bray D, 2003, SCIENCE, V301, P1864, DOI 10.1126/science.1089118; Breaker RR, 2010, COLD SPRING HARB PER; CHASTAIN M, 1991, PROG NUCLEIC ACID RE, V41, P131; Eddy SR, 2001, NAT REV GENET, V2, P919, DOI 10.1038/35103511; Fera D, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-88; FIEDLER M, 1973, CZECH MATH J, V23, P298; Gopal A, 2012, RNA, V18, P284, DOI 10.1261/rna.027557.111; Guo PX, 2010, NAT NANOTECHNOL, V5, P833, DOI [10.1038/nnano.2010.231, 10.1038/NNANO.2010.231]; Hamada M, 2006, BIOINFORMATICS, V22, P2480, DOI 10.1093/bioinformatics/btl431; Haynes T, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-108; Izzo JA, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-219; Kalir S, 2004, CELL, V117, P713, DOI 10.1016/j.cell.2004.05.010; Kim N, 2004, J MOL BIOL, V341, P1129, DOI 10.1016/j.jmb.2004.06.054; Kim N, 2012, BIOPHYSICS RNA FOLDI; Kim N, 2013, WSEAS T MATH, V12, P941; Kim N, 2007, BIOINFORMATICS, V23, P2959, DOI 10.1093/bioinformatics/btm439; Kim N, 2007, RNA, V13, P478, DOI 10.1261/rna.374907; Kim N, 2014, P NATL ACAD SCI USA, V111, P4079, DOI 10.1073/pnas.1318893111; Kim N, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq282; Koessler DR, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-S6-S21; Laing C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071947; Laserson U, 2005, NUCLEIC ACIDS RES, V33, P6057, DOI 10.1093/nar/gki911; Leontis NB, 2002, COMP FUNCT GENOM, V3, P518, DOI 10.1002/cfg.213; Mohar B, 2004, TOPICS ALGEBRAIC GRA; Nudler E, 2006, CELL, V126, P19, DOI 10.1016/j.cell.2006.06.024; Petingi L, 1998, DISCRETE MATH, V179, P155, DOI 10.1016/S0012-365X(97)00034-4; Quarta G, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002368; Quarta G, 2009, J MOL BIOL, V393, P993, DOI 10.1016/j.jmb.2009.08.062; Que-Gewirth NS, 2007, GENE THER, V14, P283, DOI 10.1038/sj.gt.3302900; SHAPIRO BA, 1990, COMPUT APPL BIOSCI, V6, P309; Spielman DA, 2007, LINEAR ALGEBRA APPL, V421, P284, DOI 10.1016/j.laa.2006.07.020; Waterman M.S., 1978, ADV MATH SUPPLEMENTA, V1, P167; Xin YR, 2008, RNA, V14, P2465, DOI 10.1261/rna.1249208; Yook SH, 2002, P NATL ACAD SCI USA, V99, P13382, DOI 10.1073/pnas.172501399	38	13	13	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 4	2014	9	9							e106074	10.1371/journal.pone.0106074	http://dx.doi.org/10.1371/journal.pone.0106074			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3XV	25188578	Green Submitted, Green Published, gold			2022-12-27	WOS:000341271500021
J	Rogers, EE; Backus, EA				Rogers, Elizabeth E.; Backus, Elaine A.			Anterior Foregut Microbiota of the Glassy-Winged Sharpshooter Explored Using Deep 16S rRNA Gene Sequencing from Individual Insects	PLOS ONE			English	Article							XYLELLA-FASTIDIOSA; WOLBACHIA-PIPIENTIS; PIERCES DISEASE; COLONIZATION; VECTORS; CICADELLIDAE; DIVERSITY; SYMBIONTS; HEMIPTERA; ENDOSYMBIONTS	The glassy-winged sharpshooter (GWSS) is an invasive insect species that transmits Xylella fastidiosa, the bacterium causing Pierce's disease of grapevine and other leaf scorch diseases. X. fastidiosa has been shown to colonize the anterior foregut (cibarium and precibarium) of sharpshooters, where it may interact with other naturally-occurring bacterial species. To evaluate such interactions, a comprehensive list of bacterial species associated with the sharpshooter cibarium and precibarium is needed. Here, a survey of microbiota associated with the GWSS anterior foregut was conducted. Ninety-six individual GWSS, 24 from each of 4 locations (Bakersfield, CA; Ojai, CA; Quincy, FL; and a laboratory colony), were characterized for bacteria in dissected sharpshooter cibaria and precibaria by amplification and sequencing of a portion of the 16S rRNA gene using Illumina MiSeq technology. An average of approximately 150,000 sequence reads were obtained per insect. The most common genus detected was Wolbachia; sequencing of the Wolbachia ftsZ gene placed this strain in supergroup B, one of two Wolbachia supergroups most commonly associated with arthropods. X. fastidiosa was detected in all 96 individuals examined. By multilocus sequence typing, both X. fastidiosa subspecies fastidiosa and subspecies sandyi were present in GWSS from California and the colony; only subspecies fastidiosa was detected in GWSS from Florida. In addition to Wolbachia and X. fastidiosa, 23 other bacterial genera were detected at or above an average incidence of 0.1%; these included plant-associated microbes (Methylobacterium, Sphingomonas, Agrobacterium, and Ralstonia) and soil-or water-associated microbes (Anoxybacillus, Novosphingobium, Caulobacter, and Luteimonas). Sequences belonging to species of the family Enterobacteriaceae also were detected but it was not possible to assign these to individual genera. Many of these species likely interact with X. fastidiosa in the cibarium and precibarium.	[Rogers, Elizabeth E.; Backus, Elaine A.] ARS, USDA, San Joaquin Valley Agr Sci Ctr, Parlier, CA 93648 USA	United States Department of Agriculture (USDA)	Rogers, EE (corresponding author), ARS, USDA, San Joaquin Valley Agr Sci Ctr, Parlier, CA 93648 USA.	elizabeth.rogers@ars.usda.gov	Rogers, Elizabeth/AAB-3643-2021; Rogers, Elizabeth E/D-2087-2009; Backus, Elaine/AAG-2272-2019	Rogers, Elizabeth/0000-0002-0545-4744; Rogers, Elizabeth E/0000-0002-0545-4744; 	USDA-ARS [5302-22000-010-00D]	USDA-ARS(United States Department of Agriculture (USDA)USDA Agricultural Research Service)	Funding for this research was from USDA-ARS appropriated project 5302-22000-010-00D. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alix B, 2012, NUCLEIC ACIDS RES, V40, pW573, DOI 10.1093/nar/gks485; Almeida RPP, 2006, ANN ENTOMOL SOC AM, V99, P884, DOI 10.1603/0013-8746(2006)99[884:POXFCO]2.0.CO;2; BACKUS EA, 1982, J MORPHOL, V172, P361, DOI 10.1002/jmor.1051720310; Backus EA, VECTOR MEDIATED TRAN; Backus EA, 2011, PHYTOPATHOLOGY, V101, P912, DOI 10.1094/PHYTO-09-10-0231; Baldo L, 2006, APPL ENVIRON MICROB, V72, P7098, DOI 10.1128/AEM.00731-06; Bextine B, 2004, CURR MICROBIOL, V48, P327, DOI 10.1007/s00284-003-4178-2; BRLANSKY RH, 1983, PHYTOPATHOLOGY, V73, P530, DOI 10.1094/Phyto-73-530; Casiraghi M, 2005, MICROBIOL-SGM, V151, P4015, DOI 10.1099/mic.0.28313-0; Casiraghi M, 2001, PARASITOLOGY, V122, P93, DOI 10.1017/S0031182000007149; Engel P, 2013, FEMS MICROBIOL REV, V37, P699, DOI 10.1111/1574-6976.12025; Fagen Jennie R, 2012, Open Microbiol J, V6, P29, DOI 10.2174/1874285801206010029; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Hail D, 2011, ENVIRON ENTOMOL, V40, P23, DOI 10.1603/EN10115; HILL BL, 1995, PHYTOPATHOLOGY, V85, P209, DOI 10.1094/Phyto-85-209; Kozich JJ, 2013, APPL ENVIRON MICROB, V79, P5112, DOI 10.1128/AEM.01043-13; Lacava Paulo Teixeira, 2007, Entomological Research, V37, P261, DOI 10.1111/j.1748-5967.2007.00123.x; Ledbetter CA, 2009, HORTSCIENCE, V44, P1928, DOI 10.21273/HORTSCI.44.7.1928; Curley CM, 2007, ANN ENTOMOL SOC AM, V100, P345, DOI 10.1603/0013-8746(2007)100[345:EFFEOG]2.0.CO;2; Moran NA, 2005, APPL ENVIRON MICROB, V71, P8802, DOI 10.1128/AEM.71.12.8802-8810.2005; Moran NA, 2003, ENVIRON MICROBIOL, V5, P116, DOI 10.1046/j.1462-2920.2003.00391.x; Newman KL, 2003, APPL ENVIRON MICROB, V69, P7319, DOI 10.1128/AEM.69.12.7319-7327.2003; PURCELL AH, 1979, SCIENCE, V206, P839, DOI 10.1126/science.206.4420.839; Redak RA, 2004, ANNU REV ENTOMOL, V49, P243, DOI 10.1146/annurev.ento.49.061802.123403; Scally M, 2005, APPL ENVIRON MICROB, V71, P8491, DOI 10.1128/AEM.71.12.8491-8499.2005; Schloss PD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027310; Takiya DM, 2006, MOL ECOL, V15, P4175, DOI 10.1111/j.1365-294X.2006.03071.x; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Turner TR, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-6-209; Yuan X, 2010, PHYTOPATHOLOGY, V100, P601, DOI 10.1094/PHYTO-100-6-0601	30	17	18	0	55	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 3	2014	9	9							e106215	10.1371/journal.pone.0106215	http://dx.doi.org/10.1371/journal.pone.0106215			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3TB	25184624	Green Submitted, gold, Green Published			2022-12-27	WOS:000341257700038
J	Stavropoulos, KKM; Carver, LJ				Stavropoulos, Katherine K. M.; Carver, Leslie J.			Effect of Familiarity on Reward Anticipation in Children with and without Autism Spectrum Disorders	PLOS ONE			English	Article							EVENT-RELATED POTENTIALS; STIMULUS-PRECEDING NEGATIVITY; FUSIFORM FACE AREA; TYPICAL DEVELOPMENT; FACIAL EXPRESSIONS; YOUNG-CHILDREN; RECOGNITION; PERCEPTION; ATTACHMENT; PUNISHMENT	Background: Previous research on the reward system in autism spectrum disorders (ASD) suggests that children with ASD anticipate and process social rewards differently than typically developing (TD) children-but has focused on the reward value of unfamiliar face stimuli. Children with ASD process faces differently than their TD peers. Previous research has focused on face processing of unfamiliar faces, but less is known about how children with ASD process familiar faces. The current study investigated how children with ASD anticipate rewards accompanied by familiar versus unfamiliar faces. Methods: The stimulus preceding negativity (SPN) of the event-related potential (ERP) was utilized to measure reward anticipation. Participants were 6- to 10-year-olds with (N = 14) and without (N = 14) ASD. Children were presented with rewards accompanied by incidental face or non-face stimuli that were either familiar (caregivers) or unfamiliar. All non-face stimuli were composed of scrambled face elements in the shape of arrows, controlling for visual properties. Results: No significant differences between familiar versus unfamiliar faces were found for either group. When collapsing across familiarity, TD children showed larger reward anticipation to face versus non-face stimuli, whereas children with ASD did not show differential responses to these stimulus types. Magnitude of reward anticipation to faces was significantly correlated with behavioral measures of social impairment in the ASD group. Conclusions: The findings do not provide evidence for differential reward anticipation for familiar versus unfamiliar face stimuli in children with or without ASD. These findings replicate previous work suggesting that TD children anticipate rewards accompanied by social stimuli more than rewards accompanied by non-social stimuli. The results do not support the idea that familiarity normalizes reward anticipation in children with ASD. Our findings also suggest that magnitude of reward anticipation to faces is correlated with levels of social impairment for children with ASD.	[Stavropoulos, Katherine K. M.; Carver, Leslie J.] Univ Calif San Diego, Dept Psychol, La Jolla, CA 92093 USA	University of California System; University of California San Diego	Stavropoulos, KKM (corresponding author), Univ Calif San Diego, Dept Psychol, La Jolla, CA 92093 USA.	kmeltzoff@gmail.com			Autism Speaks Dennis Weatherstone Predoctoral Fellowship [7844]	Autism Speaks Dennis Weatherstone Predoctoral Fellowship	This work was supported by an Autism Speaks Dennis Weatherstone Predoctoral Fellowship awarded to KKMS (grant 7844). The funders had no rule in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brunia CHM, 2011, CLIN NEUROPHYSIOL, V122, P858, DOI 10.1016/j.clinph.2010.12.039; Charman T, 1998, INF MENTAL HLTH J, V19, P260, DOI 10.1002/(SICI)1097-0355(199822)19:2<260::AID-IMHJ12>3.0.CO;2-W; Chevallier C, 2012, TRENDS COGN SCI, V16, P231, DOI 10.1016/j.tics.2012.02.007; Constantino JN., 2012, SRS2 SOCIAL RESPONSI, V2nd ed; COURCHESNE E, 1978, ELECTROEN CLIN NEURO, V45, P468, DOI 10.1016/0013-4694(78)90291-2; Dawson G, 2002, CHILD DEV, V73, P700, DOI 10.1111/1467-8624.00433; Dawson G, 2005, DEV PSYCHOPATHOL, V17, P679, DOI 10.1017/S0954579405050327; Dawson G, 2004, DEVELOPMENTAL SCI, V7, P340, DOI 10.1111/j.1467-7687.2004.00352.x; Dawson G, 2008, DEV PSYCHOPATHOL, V20, P775, DOI 10.1017/S0954579408000370; de Haan M, 2003, INT J PSYCHOPHYSIOL, V51, P45, DOI 10.1016/S0167-8760(03)00152-1; Dichter GS, 2012, J AUTISM DEV DISORD, V42, P147, DOI 10.1007/s10803-011-1221-1; Grelotti DJ, 2002, DEV PSYCHOBIOL, V40, P213, DOI 10.1002/dev.10028; Groen Y, 2008, CLIN NEUROPHYSIOL, V119, P2476, DOI 10.1016/j.clinph.2008.08.004; Gunji A, 2013, BRAIN DEV-JPN, V35, P293, DOI 10.1016/j.braindev.2012.12.008; Gunji A, 2009, BRAIN DEV-JPN, V31, P139, DOI 10.1016/j.braindev.2008.04.011; Haxby JV, 2000, TRENDS COGN SCI, V4, P223, DOI 10.1016/S1364-6613(00)01482-0; Kohls G, 2011, J AUTISM DEV DISORD, V41, P1523, DOI 10.1007/s10803-011-1177-1; Kotani Y, 2003, PSYCHOPHYSIOLOGY, V40, P818, DOI 10.1111/1469-8986.00082; Kylliainen A, 2012, J CHILD PSYCHOL PSYC, V53, P790, DOI 10.1111/j.1469-7610.2011.02522.x; Larson MJ, 2011, PSYCHIAT RES, V187, P198, DOI 10.1016/j.psychres.2010.11.006; Lopez-Calderon J, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00213; Lord C., 2012, AUTISM DIAGNOSTIC OB, V2nd; Luyster RJ, 2011, BRAIN TOPOGR, V24, P220, DOI 10.1007/s10548-011-0176-z; McPartland J, 2004, J CHILD PSYCHOL PSYC, V45, P1235, DOI 10.1111/j.1469-7610.2004.00318.x; McPartland JC, 2012, J NEURODEV DISORD, V4, DOI 10.1186/1866-1955-4-16; MUNDY P, 1986, J CHILD PSYCHOL PSYC, V27, P657, DOI 10.1111/j.1469-7610.1986.tb00190.x; Ohgami Y, 2006, PSYCHOPHYSIOLOGY, V43, P227, DOI 10.1111/j.1469-8986.2006.00396.x; Pankert A, 2014, J NEURAL TRANSM, V121, P1199, DOI 10.1007/s00702-014-1210-6; Pierce K, 2004, BRAIN, V127, P2703, DOI 10.1093/brain/awh289; Pierce K, 2001, BRAIN, V124, P2059, DOI 10.1093/brain/124.10.2059; Pierce K, 2008, BIOL PSYCHIAT, V64, P552, DOI 10.1016/j.biopsych.2008.05.013; Rutgers AH, 2007, J ABNORM CHILD PSYCH, V35, P859, DOI 10.1007/s10802-007-9139-y; Schultz RT, 2005, INT J DEV NEUROSCI, V23, P125, DOI 10.1016/j.ijdevneu.2004.12.012; Schultz RT, 2000, ARCH GEN PSYCHIAT, V57, P331, DOI 10.1001/archpsyc.57.4.331; Scott-Van Zeeland AA, 2010, AUTISM RES, V3, P53, DOI 10.1002/aur.122; SIGMAN M, 1984, J AUTISM DEV DISORD, V14, P231, DOI 10.1007/BF02409576; SIGMAN M, 1989, J AM ACAD CHILD PSY, V28, P74, DOI 10.1097/00004583-198901000-00014; Stavropoulos KKM, 2014, J CHILD PSYCHOL PSYC, V55, P1398, DOI 10.1111/jcpp.12270; Stavropoulos KKM, 2014, SOC COGN AFFECT NEUR, V9, P1569, DOI 10.1093/scan/nst149; Tottenham N, 2009, PSYCHIAT RES, V168, P242, DOI 10.1016/j.psychres.2008.05.006; van Boxtel GJM, 2004, J PSYCHOPHYSIOL, V18, P61, DOI 10.1027/0269-8803.18.23.61; WALTERS AS, 1990, RES DEV DISABIL, V11, P303, DOI 10.1016/0891-4222(90)90015-Z; Webb SJ, 2010, INT J PSYCHOPHYSIOL, V77, P106, DOI 10.1016/j.ijpsycho.2010.04.011; Webb SJ, 2011, CHILD DEV, V82, P1868, DOI 10.1111/j.1467-8624.2011.01656.x; Webb SJ, 2005, DEVELOPMENTAL SCI, V8, P605, DOI 10.1111/j.1467-7687.2005.00452.x; Wechsler D., 2011, WASI 2 WECHSLER ABBR	46	9	9	2	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 3	2014	9	9							e106667	10.1371/journal.pone.0106667	http://dx.doi.org/10.1371/journal.pone.0106667			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AO3TB	25184524	gold, Green Published			2022-12-27	WOS:000341257700099
J	Ali, S; Steinmetz, G; Montillet, G; Perrard, MH; Loundou, A; Durand, P; Guichaoua, MR; Prat, O				Ali, Sazan; Steinmetz, Gerard; Montillet, Guillaume; Perrard, Marie-Helene; Loundou, Anderson; Durand, Philippe; Guichaoua, Marie-Roberte; Prat, Odette			Exposure to Low-Dose Bisphenol A Impairs Meiosis in the Rat Seminiferous Tubule Culture Model: A Physiotoxicogenomic Approach	PLOS ONE			English	Article							SYNAPTONEMAL COMPLEX DAMAGE; ENDOCRINE-DISRUPTING CHEMICALS; INDICATE WIDESPREAD EXPOSURE; MEIOTIC PROGRESSION; ESTROGENIC CHEMICALS; IN-VITRO; SPERM PRODUCTION; DNA-DAMAGE; GERM-CELLS; CHROMOSOME	Background: Bisphenol A (BPA) is one of the most widespread chemicals in the world and is suspected of being responsible for male reproductive impairments. Nevertheless, its molecular mode of action on spermatogenesis is unclear. This work combines physiology and toxicogenomics to identify mechanisms by which BPA affects the timing of meiosis and induces germ-cell abnormalities. Methods: We used a rat seminiferous tubule culture model mimicking the in vivo adult rat situation. BPA (1 nM and 10 nM) was added to the culture medium. Transcriptomic and meiotic studies were performed on the same cultures at the same exposure times (days 8, 14, and 21). Transcriptomics was performed using pangenomic rat microarrays. Immunocytochemistry was conducted with an anti-SCP3 antibody. Results: The gene expression analysis showed that the total number of differentially expressed transcripts was time but not dose dependent. We focused on 120 genes directly involved in the first meiotic prophase, sustaining immunocytochemistry. Sixty-two genes were directly involved in pairing and recombination, some of them with high fold changes. Immunocytochemistry indicated alteration of meiotic progression in the presence of BPA, with increased leptotene and decreased diplotene spermatocyte percentages and partial meiotic arrest at the pachytene checkpoint. Morphological abnormalities were observed at all stages of the meiotic prophase. The prevalent abnormalities were total asynapsis and apoptosis. Transcriptomic analysis sustained immunocytological observations. Conclusion: We showed that low doses of BPA alter numerous genes expression, especially those involved in the reproductive system, and severely impair crucial events of the meiotic prophase leading to partial arrest of meiosis in rat seminiferous tubule cultures.	[Ali, Sazan; Guichaoua, Marie-Roberte] Aix Marseille Univ, Fac Med, IRD 237, CNRS,UMR 7263,IMBE, Marseille, France; [Steinmetz, Gerard; Prat, Odette] French Alternat Energy & Atom Energy Commiss CEA, IBEB, Div Life Sci, Bagnols Sur Ceze, France; [Montillet, Guillaume; Perrard, Marie-Helene; Durand, Philippe] CNRS, IGFL, INRA, UMR 5242,ENS, Lyon, France; [Loundou, Anderson] Aix Marseille Univ, Fac Med, Unite DAide Methodol Rech Clin, Marseille, France	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; Aix-Marseille Universite; Institut de Recherche pour le Developpement (IRD); CEA; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); INRAE; UDICE-French Research Universities; Universite Claude Bernard Lyon 1; CHU Lyon; Ecole Normale Superieure de Lyon (ENS de LYON); UDICE-French Research Universities; Aix-Marseille Universite	Prat, O (corresponding author), French Alternat Energy & Atom Energy Commiss CEA, IBEB, Div Life Sci, Bagnols Sur Ceze, France.	odette.prat@cea.fr	Perrard, Marie-Hélène/R-7864-2017		Research Consortium ECCOREV (Ecosystemes Continentaux et Risques Environnementaux) [3098]; CNRS/Aix-Marseille Universite	Research Consortium ECCOREV (Ecosystemes Continentaux et Risques Environnementaux); CNRS/Aix-Marseille Universite	The Research Consortium ECCOREV no 3098 (Ecosystemes Continentaux et Risques Environnementaux) CNRS/Aix-Marseille Universite funded this study (AOI 2010, grant number 7). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aikawa H, 2004, CELL TISSUE RES, V315, P119, DOI 10.1007/s00441-003-0806-1; Al-Hiyasat AS, 2002, EUR J ORAL SCI, V110, P163, DOI 10.1034/j.1600-0722.2002.11201.x; Allard P, 2010, P NATL ACAD SCI USA, V107, P20405, DOI 10.1073/pnas.1010386107; ALLEN JW, 1988, CELL BIOL TOXICOL, V4, P487, DOI 10.1007/BF00117776; ALLEN JW, 1988, MUTAT RES, V201, P313, DOI 10.1016/0027-5107(88)90020-6; Ashby J, 2003, TOXICOL SCI, V74, P129, DOI 10.1093/toxsci/kfg093; BACKER LC, 1988, MUTAT RES, V203, P317, DOI 10.1016/0165-1161(88)90021-0; Baudat F, 2010, M S-MED SCI, V26, P468, DOI 10.1051/medsci/2010265468; Brieno-Enriquez MA, 2011, HUM REPROD, V26, P2807, DOI 10.1093/humrep/der249; Can A, 2005, MOL HUM REPROD, V11, P389, DOI 10.1093/molehr/gah179; Chalmel F, 2007, P NATL ACAD SCI USA, V104, P8346, DOI 10.1073/pnas.0701883104; CLERMONT Y, 1972, PHYSIOL REV, V52, P198, DOI 10.1152/physrev.1972.52.1.198; Della Seta D, 2006, HORM BEHAV, V50, P301, DOI 10.1016/j.yhbeh.2006.03.015; Eichenlaub-Ritter U, 2008, MUTATRES, V651, P64; Eichenlaub-Ritter U, 2008, MUTAT RES-GEN TOX EN, V651, P82, DOI 10.1016/j.mrgentox.2007.10.014; Fiorini C, 2004, REPROD TOXICOL, V18, P413, DOI 10.1016/j.reprotox.2004.01.002; Fisichella M, 2012, PART FIBRE TOXICOL, V9, P1743; Geoffroy-Siraudin C, 2012, TOXICOL APPL PHARM, V262, P238, DOI 10.1016/j.taap.2012.04.033; Geoffroy-Siraudin C, 2010, TOXICOL SCI, V116, P286, DOI 10.1093/toxsci/kfq099; Gilleron J, 2009, INT J BIOCHEM CELL B, V41, P1381, DOI 10.1016/j.biocel.2008.12.008; Godet M, 2008, DEV BIOL, V315, P173, DOI 10.1016/j.ydbio.2007.12.019; Guichaoua MR, 2005, HUM REPROD, V20, P1897, DOI 10.1093/humrep/deh868; Guyton KZ, 2009, MUTAT RES-REV MUTAT, V681, P230, DOI 10.1016/j.mrrev.2008.10.001; Hartung T, 2011, ALTEX-ALTERN ANIM EX, V28, P83, DOI 10.14573/altex.2011.2.083; Howdeshell KL, 2008, TOXICOL SCI, V102, P371, DOI 10.1093/toxsci/kfm306; Hunt PA, 2003, CURR BIOL, V13, P546, DOI 10.1016/S0960-9822(03)00189-1; Hunt PA, 2009, BIOL REPROD, V81, P807, DOI 10.1095/biolreprod.109.077008; Iida H, 2003, REPROD TOXICOL, V17, P457, DOI 10.1016/S0890-6238(03)00034-0; Ikezuki Y, 2002, HUM REPROD, V17, P2839, DOI 10.1093/humrep/17.11.2839; Kortenkamp A, 2011, STATE ART ASSESSMENT; Kuiper GGJM, 1998, ENDOCRINOLOGY, V139, P4252, DOI 10.1210/en.139.10.4252; LaRocca J, 2011, BIRTH DEFECTS RES B, V92, P526, DOI 10.1002/bdrb.20336; Lenie S, 2008, MUTAT RES-GEN TOX EN, V651, P71, DOI 10.1016/j.mrgentox.2007.10.017; Li MWM, 2010, P NATL ACAD SCI USA, V107, P17998, DOI 10.1073/pnas.1007047107; Liu C, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.203; Liu C, 2014, CELL TISSUE RES, V355, P223, DOI 10.1007/s00441-013-1723-6; Lobenhofer EK, 2004, TOXICOL PATHOL, V32, P482, DOI 10.1080/01926230490483324; Longepied G, 2010, HUM REPROD, V25, P2655, DOI 10.1093/humrep/deq209; Lopez-Casas PP, 2012, REPROD TOXICOL, V33, P106, DOI 10.1016/j.reprotox.2011.12.012; Ludwig S, 2011, TOXICOL SCI, V122, P52, DOI 10.1093/toxsci/kfr099; Mark M, 2008, J CELL SCI, V121, P3233, DOI 10.1242/jcs.035071; Meeker JD, 2010, REPROD TOXICOL, V30, P532, DOI 10.1016/j.reprotox.2010.07.005; Metzler-Guillemain C, 2000, FERTIL STERIL, V74, P916, DOI 10.1016/S0015-0282(00)01551-X; Miyawaki J, 2007, J ATHEROSCLER THROMB, V14, P245, DOI 10.5551/jat.E486; Naciff JM, 2005, TOXICOL SCI, V86, P396, DOI 10.1093/toxsci/kfi198; Pfaffl MW, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.9.e36; Pittman DL, 1998, MOL CELL, V1, P697, DOI 10.1016/S1097-2765(00)80069-6; Prat O, 2010, TOXICOL IN VITRO, V24, P160, DOI 10.1016/j.tiv.2009.07.035; Qiu LL, 2013, TOXICOL LETT, V219, P116, DOI 10.1016/j.toxlet.2013.03.011; Raj A, 2006, PLOS BIOL, V4, P1707, DOI 10.1371/journal.pbio.0040309; Roeder GS, 2000, TRENDS GENET, V16, P395, DOI 10.1016/S0168-9525(00)02080-1; Rubin BS, 2011, J STEROID BIOCHEM, V127, P27, DOI 10.1016/j.jsbmb.2011.05.002; Rubin BS, 2009, MOL CELL ENDOCRINOL, V304, P55, DOI 10.1016/j.mce.2009.02.023; Shin BS, 2004, J TOXICOL ENV HEAL A, V67, P1971, DOI 10.1080/15287390490514615; Sohoni P, 1998, J ENDOCRINOL, V158, P327, DOI 10.1677/joe.0.1580327; Staub C, 2000, EXP CELL RES, V260, P85, DOI 10.1006/excr.2000.4998; Susiarjo M, 2007, PLOS GENET, V3, DOI 10.1371/journal.pgen.0030005; Tainaka H, 2012, J TOXICOL SCI, V37, P539; Takeuchi T, 2004, BIOCHEM BIOPH RES CO, V325, P549, DOI 10.1016/j.bbrc.2004.10.073; Takeuchi T, 2002, BIOCHEM BIOPH RES CO, V291, P76, DOI 10.1006/bbrc.2002.6407; Takeuchi T, 2004, ENDOCR J, V51, P165, DOI 10.1507/endocrj.51.165; Tohei A, 2001, EXP BIOL MED, V226, P216, DOI 10.1177/153537020122600309; Tyl RW, 2002, TOXICOL SCI, V68, P121, DOI 10.1093/toxsci/68.1.121; Vandenberg Laura N., 2013, Reviews on Environmental Health, V28, P37, DOI 10.1515/reveh-2012-0034; Vandenberg LN, 2012, ENDOCR REV, V33, P378, DOI 10.1210/er.2011-1050; Vandenberg LN, 2012, CIENC SAUDE COLETIVA, V17, P407, DOI 10.1590/S1413-81232012000200015; Vandenberg LN, 2010, ENVIRON HEALTH PERSP, V118, P1055, DOI 10.1289/ehp.0901716; Vandenberg LN, 2009, ENDOCR REV, V30, P75, DOI 10.1210/er.2008-0021; Vom Saal FS, 1998, TOXICOL IND HEALTH, V14, P239, DOI 10.1177/074823379801400115; Welshons WV, 2003, ENVIRON HEALTH PERSP, V111, P994, DOI 10.1289/ehp.5494; Wright WR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030120; Wu HJ, 2013, MUTAT RES-GEN TOX EN, V752, P57, DOI 10.1016/j.mrgentox.2013.01.005; Zhang HQ, 2012, MOL BIOL REP, V39, P5651, DOI 10.1007/s11033-011-1372-3; Zickler D, 1998, ANNU REV GENET, V32, P619, DOI 10.1146/annurev.genet.32.1.619	74	44	45	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2014	9	9							e106245	10.1371/journal.pone.0106245	http://dx.doi.org/10.1371/journal.pone.0106245			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3LR	25181051	Green Published, gold, Green Submitted			2022-12-27	WOS:000341231500063
J	Brinkhuizen, T; Weijzen, CAH; Eben, J; Thissen, MR; van Marion, AM; Lohman, BG; Winnepenninckx, VJL; Nelemans, PJ; van Steensel, MAM				Brinkhuizen, Tjinta; Weijzen, Chantal A. H.; Eben, Jonathan; Thissen, Monique R.; van Marion, Arienne M.; Lohman, Bjorn G.; Winnepenninckx, Veronique J. L.; Nelemans, Patty J.; van Steensel, Maurice A. M.			Immunohistochemical Analysis of the Mechanistic Target of Rapamycin and Hypoxia Signalling Pathways in Basal Cell Carcinoma and Trichoepithelioma	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; MAMMALIAN TARGET; MTOR; EXPRESSION; SKIN; ACTIVATION; PROTEINS; RECEPTOR; BIOLOGY; ORIGIN	Background: Basal cell carcinoma (BCC) is the most common cancer in Caucasians. Trichoepithelioma (TE) is a benign neoplasm that strongly resembles BCC. Both are hair follicle (HF) tumours. HFs are hypoxic microenvironments, therefore we hypothesized that hypoxia-induced signalling pathways could be involved in BCC and TE as they are in other human malignancies. Hypoxia-inducible factor 1 (HIF1) and mechanistic/mammalian target of rapamycin (mTOR) are key players in these pathways. Objectives: To determine whether HIF1/mTOR signalling is involved in BCC and TE. Methods: We used immunohistochemical staining of formalin-fixed paraffin-embedded BCC (n = 45) and TE (n = 35) samples to assess activity of HIF1, mTORC1 and their most important target genes. The percentage positive tumour cells was assessed manually in a semi-quantitative manner and categorized (0%, <30%, 30-80% and >80%). Results: Among 45 BCC and 35 TE examined, expression levels were respectively 81% and 57% (BNIP3), 73% and 75% (CAIX), 79% and 86% (GLUT1), 50% and 19% (HIF1 alpha), 89% and 88% (pAKT), 55% and 61% (pS6), 15% and 25% (pMTOR), 44% and 63% (PHD2) and 44% and 49% (VEGF-A). CAIX, Glut1 and PHD2 expression levels were significantly higher in TE when only samples with at least 80% expression were included. Conclusions: HIF and mTORC1 signalling seems active in both BCC and TE. There are no appreciable differences between the two with respect to pathway activity. At this moment immunohistochemical analyses of HIF, mTORC1 and their target genes does not provide a reliable diagnostic tool for the discrimination of BCC and TE.	[Brinkhuizen, Tjinta; Weijzen, Chantal A. H.; Thissen, Monique R.; van Steensel, Maurice A. M.] Maastricht Univ, Med Ctr, Dept Dermatol, Maastricht, Netherlands; [Eben, Jonathan; Winnepenninckx, Veronique J. L.] Maastricht Univ, Med Ctr, Dept Pathol, Maastricht, Netherlands; [Nelemans, Patty J.] Maastricht Univ, Med Ctr, Dept Epidemiol, Maastricht, Netherlands; [van Steensel, Maurice A. M.] Maastricht Univ, Med Ctr, Dept Clin Genet, Maastricht, Netherlands; [Brinkhuizen, Tjinta; Weijzen, Chantal A. H.; Eben, Jonathan; Thissen, Monique R.; Winnepenninckx, Veronique J. L.; Nelemans, Patty J.; van Steensel, Maurice A. M.] Maastricht Univ, Med Ctr, Sch Oncol & Dev Biol, GROW, Maastricht, Netherlands; [van Marion, Arienne M.] VieCuri Med Ctr, Dept Pathol, Venlo, Netherlands; [Lohman, Bjorn G.] Laurentius Hosp, Dept Pathol, Roermond, Netherlands; [van Steensel, Maurice A. M.] Inst Med Biol, Singapore, Singapore	Maastricht University; Maastricht University; Maastricht University; Maastricht University; Maastricht University; VieCuri Medical Center; Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Medical Biology (IMB)	Brinkhuizen, T (corresponding author), Maastricht Univ, Med Ctr, Dept Dermatol, Maastricht, Netherlands.	t.brinkhuizen@mumc.nl	van Steensel, Maurice A.M./V-3852-2019	van Steensel, Maurice/0000-0002-7507-2442	Dutch Cancer Society [KWF UM2009-4609, KWF UM2009-4352]	Dutch Cancer Society(KWF Kankerbestrijding)	This work was supported by the Dutch Cancer Society, grants to TB (KWF UM2009-4609) and MVS (KWF UM2009-4352). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arits AHMM, 2011, EUR J DERMATOL, V21, P870, DOI 10.1684/ejd.2011.1504; Arsham AM, 2003, J BIOL CHEM, V278, P29655, DOI 10.1074/jbc.M212770200; Bowden J, 2002, J CUTAN PATHOL, V29, P585, DOI 10.1034/j.1600-0560.2002.291003.x; Brugarolas J, 2004, GENE DEV, V18, P2893, DOI 10.1101/gad.1256804; Chan DA, 2010, BRIT J CANCER, V103, P1, DOI 10.1038/sj.bjc.6605682; Chen S, 2009, BRIT J DERMATOL, V161, P357, DOI 10.1111/j.1365-2133.2009.09179.x; Chen SJ, 2009, BRIT J DERMATOL, V160, P442, DOI 10.1111/j.1365-2133.2008.08903.x; Chiang GG, 2005, J BIOL CHEM, V280, P25485, DOI 10.1074/jbc.M501707200; Chinnadurai G, 2008, ONCOGENE, V27, pS114, DOI 10.1038/onc.2009.49; D'Angelo G, 2003, J BIOL CHEM, V278, P38183, DOI 10.1074/jbc.M302244200; Dodd K.M., 2014, ONCOGENE; Duvel K, 2010, MOL CELL, V39, P171, DOI 10.1016/j.molcel.2010.06.022; Evans SM, 2006, J INVEST DERMATOL, V126, P2596, DOI 10.1038/sj.jid.5700451; Flohil SC, 2013, J INVEST DERMATOL, V133, P913, DOI 10.1038/jid.2012.431; Fruman DA, 2014, NAT REV DRUG DISCOV, V13, P140, DOI 10.1038/nrd4204; Hardie DG, 2005, CURR OPIN CELL BIOL, V17, P167, DOI 10.1016/j.ceb.2005.01.006; Jee SH, 2002, J INVEST DERMATOL, V119, P1121, DOI 10.1046/j.1523-1747.2002.19503.x; Jokilehto T, 2006, CLIN CANCER RES, V12, P1080, DOI 10.1158/1078-0432.CCR-05-2022; Karayannopoulou G, 2013, ANTICANCER RES, V33, P3711; Kasper M, 2012, J CLIN INVEST, V122, P455, DOI 10.1172/JCI58779; Krahl D, 2010, BRIT J DERMATOL, V163, P138, DOI 10.1111/j.1365-2133.2010.09711.x; Liu LS, 2013, INT J DERMATOL, V52, P654, DOI 10.1111/ijd.12017; Nakayama K, 2009, J BIOCHEM, V146, P757, DOI 10.1093/jb/mvp167; Nys K, 2011, BBA-REV CANCER, V1816, P1, DOI 10.1016/j.bbcan.2011.02.001; Rathman-Josserand M, 2013, J INVEST DERMATOL; Rippey JJ, 1998, HISTOPATHOLOGY, V32, P393; Ruan K, 2009, J CELL BIOCHEM, V107, P1053, DOI 10.1002/jcb.22214; Sadlecki P, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/616850; Sedlakova O, 2014, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00400; Semenza GL, 2010, ONCOGENE, V29, P625, DOI 10.1038/onc.2009.441; Toth T, 2000, HUM PATHOL, V31, P955; van Steensel MAM, 2009, EXP DERMATOL, V18, P185, DOI 10.1111/j.1600-0625.2008.00808.x; Vasudev NS, 2014, ANGIOGENESIS, V17, P471, DOI 10.1007/s10456-014-9420-y; WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309; Weedon D, 2009, SKIN PATHOLOGY; Weninger W, 1996, LAB INVEST, V75, P647; Wouters BG, 2008, NAT REV CANCER, V8, P851, DOI 10.1038/nrc2501; Wykoff CC, 2000, CANCER RES, V60, P7075; Yang YZ, 2013, J CELL BIOCHEM, V114, P967, DOI 10.1002/jcb.24438; Youssef KK, 2010, NAT CELL BIOL, V12, P299, DOI 10.1038/ncb2031; Zhang HM, 2003, APOPTOSIS, V8, P229, DOI 10.1023/A:1023616620970	41	10	12	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2014	9	9							e106427	10.1371/journal.pone.0106427	http://dx.doi.org/10.1371/journal.pone.0106427			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3LR	25181405	gold, Green Published, Green Submitted			2022-12-27	WOS:000341231500095
J	Cocker, F; Nicholson, JM; Graves, N; Oldenburg, B; Palmer, AJ; Martin, A; Scott, J; Venn, A; Sanderson, K				Cocker, Fiona; Nicholson, Jan M.; Graves, Nicholas; Oldenburg, Brian; Palmer, Andrew J.; Martin, Angela; Scott, Jenn; Venn, Alison; Sanderson, Kristy			Depression in Working Adults: Comparing the Costs and Health Outcomes of Working When Ill	PLOS ONE			English	Article							2007 NATIONAL-SURVEY; PRIMARY-CARE; MENTAL-DISORDERS; PRODUCTIVITY; PRESENTEEISM; ABSENTEEISM; PREVALENCE; WOMEN; MODEL; SICK	Objective: Working through a depressive illness can improve mental health but also carries risks and costs from reduced concentration, fatigue, and poor on-the-job performance. However, evidence-based recommendations for managing work attendance decisions, which benefit individuals and employers, are lacking. Therefore, this study has compared the costs and health outcomes of short-term absenteeism versus working while ill ("presenteeism") amongst employed Australians reporting lifetime major depression. Methods: Cohort simulation using state-transition Markov models simulated movement of a hypothetical cohort of workers, reporting lifetime major depression, between health states over one- and five-years according to probabilities derived from a quality epidemiological data source and existing clinical literature. Model outcomes were health service and employment-related costs, and quality-adjusted-life-years (QALYs), captured for absenteeism relative to presenteeism, and stratified by occupation (blue versus white-collar). Results: Per employee with depression, absenteeism produced higher mean costs than presenteeism over one- and five-years ($42,573/5-years for absenteeism, $37,791/5-years for presenteeism). However, overlapping confidence intervals rendered differences non-significant. Employment-related costs (lost productive time, job turnover), and antidepressant medication and service use costs of absenteeism and presenteeism were significantly higher for white-collar workers. Health outcomes differed for absenteeism versus presenteeism amongst white-collar workers only. Conclusions: Costs and health outcomes for absenteeism and presenteeism were not significantly different; service use costs excepted. Significant variation by occupation type was identified. These findings provide the first occupation-specific cost evidence which can be used by clinicians, employees, and employers to review their management of depression-related work attendance, and may suggest encouraging employees to continue working is warranted.	[Cocker, Fiona; Oldenburg, Brian] Univ Melbourne, Sch Populat & Global Hlth, Melbourne, Vic, Australia; [Nicholson, Jan M.] La Trobe Univ, Judith Lumley Ctr, Melbourne, Vic, Australia; [Graves, Nicholas] Queensland Univ Technol, Sch Publ Hlth, Brisbane, Qld 4001, Australia; [Cocker, Fiona; Palmer, Andrew J.; Venn, Alison; Sanderson, Kristy] Univ Tasmania, Menzies Res Inst Tasmania, Hobart, Tas, Australia; [Martin, Angela] Univ Tasmania, Tasmanian Sch Business & Econ, Hobart, Tas, Australia; [Scott, Jenn] Univ Tasmania, Sch Psychol, Hobart, Tas, Australia	University of Melbourne; La Trobe University; Queensland University of Technology (QUT); University of Tasmania; University of Tasmania; University of Tasmania	Cocker, F (corresponding author), Univ Melbourne, Sch Populat & Global Hlth, Melbourne, Vic, Australia.	fiona.cocker@unimelb.edu.au	Venn, Alison J/J-2803-2013; Martin, Angela/J-7183-2014; Sanderson, Kristy/J-2796-2013; Palmer, Andrew/J-7289-2014	Martin, Angela/0000-0003-0109-1218; Oldenburg, Brian/0000-0002-7712-5413; Sanderson, Kristy/0000-0002-3132-2745; scott, jenn/0000-0002-6955-4015; Nicholson, Jan/0000-0002-0305-0017; Cocker, Fiona/0000-0002-2889-2114; Palmer, Andrew/0000-0002-9703-7891; Graves, Nicholas/0000-0002-5559-3267	Australian Research Council Strategic Research Scholarship (ARC) [LP0990010]; National Health and Medical Research Council (NHMRC) [ID490018]; Australian Research Council Future Fellowship [FT991524]	Australian Research Council Strategic Research Scholarship (ARC)(Australian Research Council); National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Australian Research Council Future Fellowship(Australian Research Council)	Dr. Cocker completed this work whilst in receipt of a Pro Vice Chancellor (Research) Australian Research Council Strategic Research Scholarship (ARC Linkage Project LP0990010). This work was funded by a National Health and Medical Research Council (NHMRC) Project Grant (ID490018) awarded to Associate Professor Sanderson who was funded by an Australian Research Council Future Fellowship (FT991524). Professor Palmer has received advisory board payments in the area of diabetes from Jansen, Johnson and Johnson, sanofi Aventis, and Novo Nordisk. The listed funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aronsson G, 2005, J OCCUP ENVIRON MED, V47, P958, DOI 10.1097/01.jom.0000177219.75677.17; Aronsson G, 2000, J EPIDEMIOL COMMUN H, V54, P502, DOI 10.1136/jech.54.7.502; Australian Bureau of Statistics, 2006, AUSTR NZ STAND CLASS; Australian Federal Department of Education Employment and Workplace Relations, 2008, EV WORK FAM STRAT YO; Bergstrom G, 2009, INT ARCH OCC ENV HEA, V82, P1179, DOI 10.1007/s00420-009-0433-6; Bergstrom G, 2009, J OCCUP ENVIRON MED, V51, P629, DOI [10.1097/JOM.0b913e3181a8281b, 10.1097/JOM.0b013e3181a8281b]; Birnbaum HG, 2003, J AFFECT DISORDERS, V74, P15, DOI 10.1016/S0165-0327(02)00427-5; Braithwaite RS, 2007, ANN INTERN MED, V146, P133, DOI 10.7326/0003-4819-146-2-200701160-00008; Briggs AH, 2000, PHARMACOECONOMICS, V17, P479, DOI 10.2165/00019053-200017050-00006; Burgess PM, 2009, AUST NZ J PSYCHIAT, V43, P615, DOI 10.1080/00048670902970858; Cox A, 2010, INT PERSPECTIVES DEP; Dowden J, 2008, THERAPEUTIC GUIDELIN; Gold MR, 1996, COST EFFECTIVENESS H; Hawthorne G, 2005, AUST NZ J PUBL HEAL, V29, P136, DOI 10.1111/j.1467-842X.2005.tb00063.x; Hawthorne G, 1999, QUAL LIFE RES, V8, P209, DOI 10.1023/A:1008815005736; Headspace, 2020, HEADSP NAT YOUTH MEN; Hilton MF, 2008, J OCCUP ENVIRON MED, V50, P1228, DOI 10.1097/JOM.0b013e31818c30a8; Kausto J, 2008, SCAND J WORK ENV HEA, V34, P239, DOI 10.5271/sjweh.1266; Kausto J, 2010, BMC PUBLIC HEALTH, V10, P1, DOI 10.1186/1471-2458-10-361; Kivimaki M, 2005, AM J PUBLIC HEALTH, V95, P98, DOI 10.2105/AJPH.2003.035873; Kruijshaar ME, 2005, EUR J EPIDEMIOL, V20, P103, DOI 10.1007/s10654-004-1009-0; LaMontagne AD., 2010, ESTIMATING EC BENEFI; Leineweber C, 2012, INT ARCH OCC ENV HEA, V85, P905, DOI 10.1007/s00420-012-0735-y; Lerner D, 2004, PSYCHIAT SERV, V55, P1371, DOI 10.1176/appi.ps.55.12.1371; Loerch B, 2000, J PSYCHIAT RES, V34, P211, DOI 10.1016/S0022-3956(00)00005-4; Markussen S, 2010, CASE PRESENTEEISM; Martin A, 2010, HUM RESOUR MANAGE-US, V49, P647, DOI 10.1002/hrm.20370; Rost K, 2004, MED CARE, V42, P1202, DOI 10.1097/00005650-200412000-00007; Sanderson K, 2006, CAN J PSYCHIAT, V51, P63, DOI 10.1177/070674370605100202; Sanderson K, 2004, QUAL LIFE RES, V13, P1255, DOI 10.1023/B:QURE.0000037482.92757.82; Sanderson K, 2007, J AFFECT DISORDERS, V101, P65, DOI 10.1016/j.jad.2006.10.024; Simon GE, 2000, GEN HOSP PSYCHIAT, V22, P153, DOI 10.1016/S0163-8343(00)00072-4; SPITZER RL, 1994, JAMA-J AM MED ASSOC, V272, P1749, DOI 10.1001/jama.272.22.1749; Stewart WF, 2003, JAMA-J AM MED ASSOC, V289, P3135, DOI 10.1001/jama.289.23.3135; Teesson M, 2009, AUST NZ J PSYCHIAT, V43, P606, DOI 10.1080/00048670902970908; Vaananen A, 2003, SOC SCI MED, V57, P807, DOI 10.1016/S0277-9536(02)00450-1; Wang PS, 2006, ARCH GEN PSYCHIAT, V63, P1345, DOI 10.1001/archpsyc.63.12.1345	37	19	20	0	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2014	9	9							e105430	10.1371/journal.pone.0105430	http://dx.doi.org/10.1371/journal.pone.0105430			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AO3LR	25181469	gold, Green Published, Green Submitted			2022-12-27	WOS:000341231500025
J	d'Albis, H; Esso, LJ; Arolas, HPI				d'Albis, Hippolyte; Esso, Loesse Jacques; Pifarre i Arolas, Hector			Persistent Differences in Mortality Patterns across Industrialized Countries	PLOS ONE			English	Article							CONVERGENCE; LIFE	The epidemiological transition has provided the theoretical background for the expectation of convergence in mortality patterns. We formally test and reject the convergence hypothesis for a sample of industrialized countries in the period from 1960 to 2008. After a period of convergence in the decade of 1960 there followed a sustained process of divergence with a pronounced increase at the end of the 1980's, explained by trends within former Socialist countries (Eastern countries). While Eastern countries experienced abrupt divergence after the dissolution of the Soviet Union, differences within Western countries remained broadly constant for the whole period. Western countries transitioned from a strong correlation between life expectancy and variance in 1960 to no association between both moments in 2008 while Eastern countries experienced the opposite evolution. Taken together, our results suggest that convergence can be better understood when accounting for shared structural similarities amongst groups of countries rather than through global convergence.	[d'Albis, Hippolyte] Univ Paris 01, Paris Sch Econ, F-75231 Paris 05, France; [Esso, Loesse Jacques] ENSEA, Abidjan, Cote Ivoire; [Pifarre i Arolas, Hector] Univ Toulouse 1, Toulouse Sch Econ, F-31042 Toulouse, France	heSam Universite; Universite Pantheon-Sorbonne; Paris School of Economics; Institut Polytechnique de Paris; Universite de Toulouse; Universite Toulouse 1 Capitole; Toulouse School of Economics	d'Albis, H (corresponding author), Univ Paris 01, Paris Sch Econ, F-75231 Paris 05, France.	hdalbis@psemail.eu		d'Albis, Hippolyte/0000-0002-6409-4320; , Hector/0000-0002-6056-3636	European Research Council	European Research Council(European Research Council (ERC)European Commission)	Funding provided to HA: European Research Council http://erc.europa.eu/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barro R. J., 2003, EC GROWTH; Becker GS, 2005, AM ECON REV, V95, P277, DOI 10.1257/0002828053828563; Bloom DE, 2007, P NATL ACAD SCI USA, V104, P16044, DOI 10.1073/pnas.0702012104; Cutler D, 2006, J ECON PERSPECT, V20, P97, DOI 10.1257/jep.20.3.97; Edwards RD, 2005, POPUL DEV REV, V31, P645, DOI 10.1111/j.1728-4457.2005.00092.x; Gillespie DOS, 2014, DEMOGRAPHY, V51, P1003, DOI 10.1007/s13524-014-0287-8; Leon DA, 2007, LANCET, V369, P2001, DOI 10.1016/S0140-6736(07)60941-6; McMichael AJ, 2004, LANCET, V363, P1155, DOI 10.1016/S0140-6736(04)15902-3; Mesle, 2004, DEMRES SPECIAL, V2, P45, DOI DOI 10.4054/DEMRES.2004.S2.3]; OMRAN AR, 1971, MILBANK MEML FUND Q, V49, P509, DOI 10.2307/3349375; ROBINE J.M., 2001, POPULATION ENGLISH S, V13, P173, DOI DOI 10.2307/3030265; University of California Berkeley (USA) and Max Planck Institute for Demographic Research (Germany), DAT HUM MORT DAB; Vallin J, 2004, DEMRES SPECIAL, V2, P593; Vaupel JW, 2011, BMJ OPEN, V1, DOI 10.1136/bmjopen-2011-000128; Wilmoth JR, 1998, POPUL DEV REV, V24, P593, DOI 10.2307/2808156; Wilson C, 2001, POPUL DEV REV, V27, P155, DOI 10.1111/j.1728-4457.2001.00155.x	16	4	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2014	9	9							e106176	10.1371/journal.pone.0106176	http://dx.doi.org/10.1371/journal.pone.0106176			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AO3LR	25181447	gold, Green Published			2022-12-27	WOS:000341231500055
J	Dalaba, MA; Akweongo, P; Williams, J; Saronga, HP; Tonchev, P; Sauerborn, R; Mensah, N; Blank, A; Kaltschmidt, J; Loukanova, S				Dalaba, Maxwell Ayindenaba; Akweongo, Patricia; Williams, John; Saronga, Happiness Pius; Tonchev, Pencho; Sauerborn, Rainer; Mensah, Nathan; Blank, Antje; Kaltschmidt, Jens; Loukanova, Svetla			Costs Associated with Implementation of Computer-Assisted Clinical Decision Support System for Antenatal and Delivery Care: Case Study of Kassena-Nankana District of Northern Ghana	PLOS ONE			English	Article							PHYSICIAN ORDER ENTRY; HEALTH; OUTCOMES; QUALITY	Objective: This study analyzed cost of implementing computer-assisted Clinical Decision Support System (CDSS) in selected health care centres in Ghana. Methods: A descriptive cross sectional study was conducted in the Kassena-Nankana district (KND). CDSS was deployed in selected health centres in KND as an intervention to manage patients attending antenatal clinics and the labour ward. The CDSS users were mainly nurses who were trained. Activities and associated costs involved in the implementation of CDSS (pre-intervention and intervention) were collected for the period between 2009-2013 from the provider perspective. The ingredients approach was used for the cost analysis. Costs were grouped into personnel, trainings, overheads (recurrent costs) and equipment costs (capital cost). We calculated cost without annualizing capital cost to represent financial cost and cost with annualizing capital costs to represent economic cost. Results: Twenty-two trained CDSS users (at least 2 users per health centre) participated in the study. Between April 2012 and March 2013, users managed 5,595 antenatal clients and 872 labour clients using the CDSS. We observed a decrease in the proportion of complications during delivery (pre-intervention 10.74% versus post-intervention 9.64%) and a reduction in the number of maternal deaths (pre-intervention 4 deaths versus post-intervention 1 death). The overall financial cost of CDSS implementation was US$23,316, approximately US$1,060 per CDSS user trained. Of the total cost of implementation, 48% (US$11,272) was pre-intervention cost and intervention cost was 52% (US$12,044). Equipment costs accounted for the largest proportion of financial cost: 34% (US$7,917). When economic cost was considered, total cost of implementation was US$17,128-lower than the financial cost by 26.5%. Conclusions: The study provides useful information in the implementation of CDSS at health facilities to enhance health workers' adherence to practice guidelines and taking accurate decisions to improve maternal health care.	[Dalaba, Maxwell Ayindenaba; Saronga, Happiness Pius; Sauerborn, Rainer; Loukanova, Svetla] Heidelberg Univ, Inst Publ Hlth, Heidelberg, Germany; [Dalaba, Maxwell Ayindenaba; Williams, John; Mensah, Nathan] Navrongo Hlth Res Ctr, Navrongo, Ghana; [Akweongo, Patricia] Univ Ghana, Sch Publ Hlth, Accra, Ghana; [Saronga, Happiness Pius] Muhimbili Univ Hlth & Allied Sci, Sch Publ Hlth & Social Sci, Dept Behav Sci, Dar Es Salaam, Tanzania; [Tonchev, Pencho] Med Univ, Surg Clin, Pleven, Bulgaria; [Mensah, Nathan; Blank, Antje; Kaltschmidt, Jens] Univ Heidelberg Hosp, Dept Clin Pharmacol & Pharmacoepidemiol, Med Klin, Krehl Klin, Heidelberg, Germany	Ruprecht Karls University Heidelberg; Navrongo Health Research Center; University of Ghana; Muhimbili University of Health & Allied Sciences; Medical University Pleven; Ruprecht Karls University Heidelberg	Dalaba, MA (corresponding author), Heidelberg Univ, Inst Publ Hlth, Bergheimer Str 58, Heidelberg, Germany.	madalaba@yahoo.com	Mensah, Nathan/GYR-0802-2022; Tonchev, Pencho/E-7836-2012; Saronga, Happiness/AGP-6824-2022	Tonchev, Pencho/0000-0002-9213-748X; Saronga, Happiness/0000-0002-1946-4855; Dalaba, Maxwell/0000-0002-7101-769X; Blank, Antje/0000-0001-8743-5194; AKWEONGO, PATRICIA/0000-0001-6728-3365	European Union [22982]	European Union(European Commission)	The study is part of the main QUALMAT research project funded as part of the 7th Framework Programme of the European Union (grant agreement 22982). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akazili J, 2011, AFRICAN J HLTH SCI, V18, P62; Anokwa Y., 2012, P 5 INT C INF COMM T, P13, DOI DOI 10.1145/2160673.2160676; [Anonymous], 2014, CANADIAN J NURSING I; Baker U, 2012, IMPLEMENT SCI, V7, DOI 10.1186/1748-5908-7-31; Blanchard AK, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-234; Blaya JA, 2010, HEALTH AFFAIR, V29, P244, DOI 10.1377/hlthaff.2009.0894; Bosman RJ, 2009, BEST PRACT RES-CLIN, V23, P15, DOI 10.1016/j.bpa.2008.10.001; Dalaba MA, 2013, BMC HEALTH SERV RES, V13, DOI 10.1186/1472-6963-13-287; Deribe K, 2010, ETHIOP J HLTH SCI, V20; Drummond MF., 2005, METHODS EC EVALUATIO, P55; Duysburgh E, 2013, TROP MED INT HEALTH, V18, P534, DOI 10.1111/tmi.12076; Evans MG, 2003, BRIT MED J, V327, P163, DOI 10.1136/bmj.327.7407.163-b; Field TS, 2008, J AM MED INFORM ASSN, V15, P466, DOI 10.1197/jamia.M2589; Gagliardi AR, 2009, IMPLEMENT SCI, V4, DOI 10.1186/1748-5908-4-36; Galanter WL, 2005, J AM MED INFORM ASSN, V12, P269, DOI 10.1197/jamia.M1727; Garg AX, 2005, JAMA-J AM MED ASSOC, V293, P1223, DOI 10.1001/jama.293.10.1223; Ghana Health Service, 2008, NAT SAF MOTH SERV PR; Grimshaw J, 2006, J GEN INTERN MED, V21, pS14, DOI 10.1111/j.1525-1497.2006.00357.x; Hussain M Latif M (n.d.), CLIN DECISION SUPPOR; Jao CS, 2010, DECISION SUPPORT SYS; Joubert G, 2007, EPIDEMIOLOGY RES MAN; Karsh B-T., 2009, CLIN PRACTICE IMPROV; Kaushal R, 2003, ARCH INTERN MED, V163, P1409, DOI 10.1001/archinte.163.12.1409; Khan KS, 2006, LANCET, V367, P1066, DOI 10.1016/S0140-6736(06)68397-9; Kirigia Joses M, 2006, Afr J Health Sci, V13, P86; Kuperman GJ, 2003, ANN INTERN MED, V139, P31, DOI 10.7326/0003-4819-139-1-200307010-00010; Kyei NNA, 2012, BMC PREGNANCY CHILDB, V12, DOI 10.1186/1471-2393-12-151; Ministry Of Health T, 2005, HLTH SECT ICT POL ST; Musen MA, 2006, BIOMEDICAL INFORM CO, P698, DOI DOI 10.1007/0-387-36278-920; Oduro AR, 2012, INT J EPIDEMIOL, V41, P968, DOI 10.1093/ije/dys111; Ofori-Adjei David, 2007, Ghana Med J, V41, P94; Osheroff JA, 2007, J AM MED INFORM ASSN, V14, P141, DOI 10.1197/jamia.M2334; Pearson L, 2006, CHILDBIRTH CARE OPPO; Poley MJ, 2007, CLIN CHEM, V53, P213, DOI 10.1373/clinchem.2006.073908; Ronsmans C, 2006, LANCET, V368, P1189, DOI 10.1016/S0140-6736(06)69380-X; Rotich JK, 2003, J AM MED INFORM ASSN, V10, P295, DOI 10.1197/jamia.M1301; Trivedi MH, 2009, BMC MED INFORM DECIS, V9, DOI 10.1186/1472-6947-9-6; World Health Organization, 2006, PREGN CHILDB POSTP N; Zakane SA, 2014, INT J MED INFORM, V83, P459, DOI 10.1016/j.ijmedinf.2014.01.013; Zere E, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-252	40	12	12	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2014	9	9							e106416	10.1371/journal.pone.0106416	http://dx.doi.org/10.1371/journal.pone.0106416			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AO3LR	25180831	Green Submitted, gold, Green Published			2022-12-27	WOS:000341231500092
J	Milgroom, MG; Jimenez-Gasco, MD; Olivares-Garcia, C; Drott, MT; Jimenez-Diaz, RM				Milgroom, Michael G.; Jimenez-Gasco, Maria del Mar; Olivares-Garcia, Concepcio; Drott, Milton T.; Jimenez-Diaz, Rafael M.			Recombination between Clonal Lineages of the Asexual Fungus Verticillium dahliae Detected by Genotyping by Sequencing	PLOS ONE			English	Article							VEGETATIVE COMPATIBILITY; LENGTH POLYMORPHISM; MOLECULAR MARKERS; SEED TRANSMISSION; CANDIDA-ALBICANS; WILT; EVOLUTION; VIRULENCE; SEX; PATHOGENICITY	Most asexual species of fungi have either lost sexuality recently, or they experience recombination by cryptic sexual reproduction. Verticillium dahliae is a plant-pathogenic, ascomycete fungus with no known sexual stage, even though related genera have well-described sexual reproduction. V. dahliae reproduces mitotically and its population structure is highly clonal. However, previously described discrepancies in phylogenetic relationships among clonal lineages may be explained more parsimoniously by recombination than mutation; therefore, we looked for evidence of recombination within and between clonal lineages. Genotyping by sequencing was performed on 141 V. dahliae isolates from diverse geographic and host origins, resulting in 26,748 single-nucleotide polymorphisms (SNPs). We found a strongly clonal population structure with the same lineages as described previously by vegetative compatibility groups (VCGs) and molecular markers. We detected 443 recombination events, evenly distributed throughout the genome. Most recombination events detected were between clonal lineages, with relatively few recombinant haplotypes detected within lineages. The only three isolates with mating type MAT1-1 had recombinant SNP haplotypes; all other isolates had mating type MAT1-2. We found homologs of eight meiosis-specific genes in the V. dahliae genome, all with conserved or partially conserved protein domains. The extent of recombination and molecular signs of sex in (mating-type and meiosis-specific genes) suggest that V. dahliae clonal lineages arose by recombination, even though the current population structure is markedly clonal. Moreover, the detection of new lineages may be evidence that sexual reproduction has occurred recently and may potentially occur under some circumstances. We speculate that the current clonal population structure, despite the sexual origin of lineages, has arisen, in part, as a consequence of agriculture and selection for adaptation to agricultural cropping systems.	[Milgroom, Michael G.; Drott, Milton T.] Cornell Univ, Dept Plant Pathol & Plant Microbe Biol, Ithaca, NY 14850 USA; [Jimenez-Gasco, Maria del Mar] Penn State Univ, Dept Plant Pathol & Environm Microbiol, University Pk, PA 16802 USA; [Olivares-Garcia, Concepcio; Jimenez-Diaz, Rafael M.] Univ Cordoba, Coll Agr & Forestry, Cordoba, Spain; [Olivares-Garcia, Concepcio; Jimenez-Diaz, Rafael M.] Univ Cordoba, Inst Sustainable Agr, CSIC, Cordoba, Spain	Cornell University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Universidad de Cordoba; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Agricultura Sostenible (IAS); Universidad de Cordoba	Milgroom, MG (corresponding author), Cornell Univ, Dept Plant Pathol & Plant Microbe Biol, Ithaca, NY 14850 USA.	mgm5@cornell.edu	Drott, Milton/W-7159-2019; del Mar Jimenez-Gasco, Maria/A-9701-2011; Jimenez Diaz, Rafael/H-9159-2018	Drott, Milton/0000-0001-9715-2200; del Mar Jimenez-Gasco, Maria/0000-0001-7329-0211; Jimenez Diaz, Rafael/0000-0003-2411-1955	Ministerio de Economia y Competitividad, Spain [AGL2011-24935]; European Union	Ministerio de Economia y Competitividad, Spain; European Union(European Commission)	This work was supported by Grant AGL2011-24935 (Vertigen project) from Ministerio de Economia y Competitividad, Spain, and co-financed with European Regional Development Funds from the European Union. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amyotte SG, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-314; Atallah ZK, 2011, PLANT DIS, V95, P784, DOI 10.1094/PDIS-01-11-0075; Atallah ZK, 2010, FUNGAL GENET BIOL, V47, P416, DOI 10.1016/j.fgb.2010.02.003; BejaranoAlcazar J, 1996, PLANT DIS, V80, P1233, DOI 10.1094/PD-80-1233; Bell G, 1982, MASTERPIECE NATURE E; Bennett RJ, 2003, MOL CELL BIOL, V23, P8189, DOI 10.1128/MCB.23.22.8189-8201.2003; Berbegal M, 2010, PLANT DIS, V94, P396, DOI 10.1094/PDIS-94-4-0396; Bhat RG, 2003, PLANT DIS, V87, P789, DOI 10.1094/PDIS.2003.87.7.789; Bruen TC, 2006, GENETICS, V172, P2665, DOI 10.1534/genetics.105.048975; Burt A, 1996, P NATL ACAD SCI USA, V93, P770, DOI 10.1073/pnas.93.2.770; BUTTERFIELD EJ, 1977, PHYTOPATHOLOGY, V67, P1073, DOI 10.1094/Phyto-67-1073; CAMBARERI EB, 1989, SCIENCE, V244, P1571, DOI 10.1126/science.2544994; Cirulli M, 2010, PLANT DIS, V94, P1176, DOI 10.1094/PDIS-12-09-0852; Collado-Romero M, 2008, PHYTOPATHOLOGY, V98, P1019, DOI 10.1094/PHYTO-98-9-1019; Collado-Romero M, 2006, PHYTOPATHOLOGY, V96, P485, DOI 10.1094/PHYTO-96-0485; Collins A, 2005, PLANT PATHOL, V54, P549, DOI 10.1111/j.1365-3059.2005.01240.x; Couch BC, 2000, PHYTOPATHOLOGY, V90, P514, DOI 10.1094/PHYTO.2000.90.5.514; Croll D, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-13; Crouch JA, 2008, FUNGAL GENET BIOL, V45, P190, DOI 10.1016/j.fgb.2007.08.004; de Jonge R, 2013, GENOME RES, V23, P1271, DOI 10.1101/gr.152660.112; Debuchy R, 2006, MYCOTA, P293, DOI DOI 10.1007/3-540-28135-5_15; den Bakker HC, 2010, MOL BIOL EVOL, V27, P2474, DOI 10.1093/molbev/msq155; Dobinson KF, 1998, MYCOL RES, V102, P1089, DOI 10.1017/S0953756297006035; Douhan LI, 2001, PLANT DIS, V85, P297, DOI 10.1094/PDIS.2001.85.3.297; du Toit LJ, 2005, PLANT DIS, V89, P4, DOI 10.1094/PD-89-0004; Dung JKS, 2013, PHYTOPATHOLOGY, V103, P445, DOI 10.1094/PHYTO-06-12-0133-R; Elshire RJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019379; FELSENSTEIN J, 1974, GENETICS, V78, P737; FINCHAM JRS, 1979, FUNGAL GENETICS; Geiser DM, 1998, P NATL ACAD SCI USA, V95, P388, DOI 10.1073/pnas.95.1.388; Glass NL, 2000, ANNU REV GENET, V34, P165, DOI 10.1146/annurev.genet.34.1.165; Gore ME, 2011, PHYTOPARASITICA, V39, P285, DOI 10.1007/s12600-011-0163-7; Halary Sebastien, 2011, Genome Biol Evol, V3, P950, DOI 10.1093/gbe/evr089; Halkett F, 2005, TRENDS ECOL EVOL, V20, P194, DOI 10.1016/j.tree.2005.01.001; Heitman J., 2007, SEX FUNGI MOL DETERM; Heitman J, 2013, MYCOLOGIA, V105, P1, DOI 10.3852/12-253; Hiemstra J. A., 1998, COMPENDIUM VERTICILL, P5; Hull CM, 2000, SCIENCE, V289, P307, DOI 10.1126/science.289.5477.307; Huson DH, 2006, MOL BIOL EVOL, V23, P254, DOI 10.1093/molbev/msj030; Inderbitzin P, 2014, PHYTOPATHOLOGY, V104, P564, DOI 10.1094/PHYTO-11-13-0315-IA; Inderbitzin P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018260; Jany JL, 2010, AM NAT, V175, P424, DOI 10.1086/650725; Jimenez-Diaz RM, 2012, PLANT DIS, V96, P304, DOI 10.1094/PDIS-06-11-0496; Jimenez-Diaz RM, 2006, PHYTOPATHOLOGY, V96, P288, DOI 10.1094/PHYTO-96-0288; Jimenez-Gasco MDM, 2014, PHYTOPATHOLOGY, V104, P650, DOI 10.1094/PHYTO-07-13-0180-R; JOAQUIM TR, 1991, PHYTOPATHOLOGY, V81, P552, DOI 10.1094/Phyto-81-552; KISTLER HC, 1992, ANNU REV PHYTOPATHOL, V30, P131, DOI 10.1146/annurev.py.30.090192.001023; Klosterman SJ, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002137; Klosterman SJ, 2009, ANNU REV PHYTOPATHOL, V47, P39, DOI 10.1146/annurev-phyto-080508-081748; KOHN LM, 1995, CAN J BOT, V73, pS1231, DOI 10.1139/b95-383; Korolev N, 2008, EUR J PLANT PATHOL, V122, P603, DOI 10.1007/s10658-008-9330-1; LESLIE JF, 1993, ANNU REV PHYTOPATHOL, V31, P127, DOI 10.1146/annurev.py.31.090193.001015; Malcolm GM, 2013, PHYTOPATHOLOGY, V103, P538, DOI 10.1094/PHYTO-08-12-0192-LE; Marston AL, 2004, NAT REV MOL CELL BIO, V5, P983, DOI 10.1038/nrm1526; Martin DP, 2011, MOL ECOL RESOUR, V11, P943, DOI 10.1111/j.1755-0998.2011.03026.x; Martin DP, 2010, BIOINFORMATICS, V26, P2462, DOI 10.1093/bioinformatics/btq467; Martin FN, 2010, PHYTOPATHOLOGY, V100, P1231, DOI 10.1094/PHYTO-12-09-0352; Mercado-Blanco J, 2003, PLANT DIS, V87, P1487, DOI 10.1094/PDIS.2003.87.12.1487; Milgroom MG, 1996, ANNU REV PHYTOPATHOL, V34, P457, DOI 10.1146/annurev.phyto.34.1.457; Milgroom MG, 2009, FUNGAL GENET BIOL, V46, P849, DOI 10.1016/j.fgb.2009.07.007; MULLER HJ, 1964, MUTAT RES, V1, P2, DOI 10.1016/0027-5107(64)90047-8; Nierman WC, 2005, NATURE, V438, P1151, DOI 10.1038/nature04332; Oliver SG., 1981, FUNGAL NUCLEUS, P191; Omer MA, 2008, PLANT DIS, V92, P1127, DOI 10.1094/PDIS-92-7-1127; Paoletti M, 2005, CURR BIOL, V15, P1242, DOI 10.1016/j.cub.2005.05.045; Pegg GF, 2002, VERTICILLUM WILTS, DOI [DOI 10.1079/9780851995298.0000, 10.1079/9780851995298.0000]; Poggeler S, 2002, CURR GENET, V42, P153, DOI 10.1007/s00294-002-0338-3; Posada D, 2001, TRENDS ECOL EVOL, V16, P37, DOI 10.1016/S0169-5347(00)02026-7; PUHALLA JE, 1974, GENETICS, V76, P411; Ramirez-Prado JH, 2008, FUNGAL GENET BIOL, V45, P1292, DOI 10.1016/j.fgb.2008.06.007; Riley R, 2014, NEW PHYTOL, V201, P254, DOI 10.1111/nph.12462; Riley R, 2013, FUNGAL ECOL, V6, P44, DOI 10.1016/j.funeco.2012.01.010; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Saleh D, 2012, MOL ECOL, V21, P1330, DOI 10.1111/j.1365-294X.2012.05469.x; Schurko AM, 2008, BIOESSAYS, V30, P579, DOI 10.1002/bies.20764; Schurko AM, 2009, TRENDS ECOL EVOL, V24, P208, DOI 10.1016/j.tree.2008.11.010; Seidl MF, 2014, BIOESSAYS, V36, P335, DOI 10.1002/bies.201300155; SMITH JM, 1993, P NATL ACAD SCI USA, V90, P4384, DOI 10.1073/pnas.90.10.4384; SMITH JM, 1978, EVOLUTION SEX; STRAUSBAUGH CA, 1993, PHYTOPATHOLOGY, V83, P1253, DOI 10.1094/Phyto-83-1253; TALBOYS P. W., 1960, PLANT PATHOL, V9, P57, DOI 10.1111/j.1365-3059.1960.tb01147.x; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Taylor JW, 1999, ANNU REV PHYTOPATHOL, V37, P197, DOI 10.1146/annurev.phyto.37.1.197; Usami T, 2008, PHYSIOL MOL PLANT P, V73, P133, DOI 10.1016/j.pmpp.2009.04.002; Usami T, 2009, J GEN PLANT PATHOL, V75, P422, DOI 10.1007/s10327-009-0197-6; Vallad GE, 2005, PLANT DIS, V89, P317, DOI 10.1094/PD-89-0317; ZOLAN ME, 1995, MICROBIOL REV, V59, P686, DOI 10.1128/MMBR.59.4.686-698.1995	87	73	75	1	59	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2014	9	9							e106740	10.1371/journal.pone.0106740	http://dx.doi.org/10.1371/journal.pone.0106740			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3LR	25181515	Green Published, gold			2022-12-27	WOS:000341231500126
J	Breuninger, M; van Ginneken, B; Philipsen, RHHM; Mhimbira, F; Hella, JJ; Lwilla, F; van den Hombergh, J; Ross, A; Jugheli, L; Wagner, D; Reither, K				Breuninger, Marianne; van Ginneken, Bram; Philipsen, Rick H. H. M.; Mhimbira, Francis; Hella, Jerry J.; Lwilla, Fred; van den Hombergh, Jan; Ross, Amanda; Jugheli, Levan; Wagner, Dirk; Reither, Klaus			Diagnostic Accuracy of Computer-Aided Detection of Pulmonary Tuberculosis in Chest Radiographs: A Validation Study from Sub-Saharan Africa	PLOS ONE			English	Article								Background: Chest radiography to diagnose and screen for pulmonary tuberculosis has limitations, especially due to interreader variability. Automating the interpretation has the potential to overcome this drawback and to deliver objective and reproducible results. The CAD4TB software is a computer-aided detection system that has shown promising preliminary findings. Evaluation studies in different settings are needed to assess diagnostic accuracy and practicability of use. Methods: CAD4TB was evaluated on chest radiographs of patients with symptoms suggestive of pulmonary tuberculosis enrolled in two cohort studies in Tanzania. All patients were characterized by sputum smear microscopy and culture including subsequent antigen or molecular confirmation of Mycobacterium tuberculosis (M.tb) to determine the reference standard. Chest radiographs were read by the software and two human readers, one expert reader and one clinical officer. The sensitivity and specificity of CAD4TB was depicted using receiver operating characteristic (ROC) curves, the area under the curve calculated and the performance of the software compared to the results of human readers. Results: Of 861 study participants, 194 (23%) were culture-positive for M.tb. The area under the ROC curve of CAD4TB for the detection of culture-positive pulmonary tuberculosis was 0.84 (95% CI 0.80-0.88). CAD4TB was significantly more accurate for the discrimination of smear-positive cases against non TB patients than for smear-negative cases (p-value < 0.01). It differentiated better between TB cases and non TB patients among HIV-negative compared to HIV-positive individuals (p < 0.01). CAD4TB significantly outperformed the clinical officer, but did not reach the accuracy of the expert reader (p = 0.02), for a tuberculosis specific reading threshold. Conclusion: CAD4TB accurately distinguished between the chest radiographs of culture-positive TB cases and controls. Further studies on cost-effectiveness, operational and ethical aspects should determine its place in diagnostic and screening algorithms.	[Breuninger, Marianne; Ross, Amanda; Jugheli, Levan; Reither, Klaus] Swiss Trop & Publ Hlth Inst, Basel, Switzerland; [Breuninger, Marianne; Mhimbira, Francis; Hella, Jerry J.; Lwilla, Fred; Jugheli, Levan; Reither, Klaus] Ifakara Hlth Inst, Bagamoyo, Tanzania; [Breuninger, Marianne; Wagner, Dirk] Univ Hosp Freiburg, Ctr Infect Dis & Travel Med, Freiburg, Germany; [van Ginneken, Bram; Philipsen, Rick H. H. M.] Radboud Univ Nijmegen, Med Ctr, Diagnost Image Anal Grp, NL-6525 ED Nijmegen, Netherlands; [van den Hombergh, Jan] PharmAccess Int, Dar Es Salaam, Tanzania; [Ross, Amanda; Jugheli, Levan; Reither, Klaus] Univ Basel, Basel, Switzerland	University of Basel; Swiss Tropical & Public Health Institute; Ifakara Health Institute; University of Freiburg; Radboud University Nijmegen; University of Basel	Breuninger, M (corresponding author), Swiss Trop & Publ Hlth Inst, Basel, Switzerland.	marianne.breuninger@venus.uni-freiburg.de	van Ginneken, Bram/A-3728-2012; Wagner, Dirk/D-9778-2016; Hella, Jerry/I-6738-2017	van Ginneken, Bram/0000-0003-2028-8972; Wagner, Dirk/0000-0002-3271-5815; Reither, Klaus/0000-0001-6195-8237; Hella, Jerry/0000-0003-2392-8592; Mhimbira, Francis/0000-0001-8989-6832	European and Developing Countries Clinical Trials Partnership (EDCTP) as part of the project "Evaluation of new and emerging diagnostics for childhood tuberculosis in high burden countries" (TB CHILD) [IP.2009.32040.007]; EDCTP as part of the project "Evaluation of Multiple Novel and Emerging Technologies for TB Diagnosis in Smear negative and HIV infected Persons in High-burden Countries" (TB NEAT study) [IP.09.32040.009]; Delft Imaging Systems (CAD4TBII)	European and Developing Countries Clinical Trials Partnership (EDCTP) as part of the project "Evaluation of new and emerging diagnostics for childhood tuberculosis in high burden countries" (TB CHILD); EDCTP as part of the project "Evaluation of Multiple Novel and Emerging Technologies for TB Diagnosis in Smear negative and HIV infected Persons in High-burden Countries" (TB NEAT study); Delft Imaging Systems (CAD4TBII)	This study was supported by the European and Developing Countries Clinical Trials Partnership (EDCTP) as part of the project "Evaluation of new and emerging diagnostics for childhood tuberculosis in high burden countries" (TB CHILD) [IP.2009.32040.007]. The development of the CAD4TB software was supported by the EDCTP as part of the project "Evaluation of Multiple Novel and Emerging Technologies for TB Diagnosis in Smear negative and HIV infected Persons in High-burden Countries" (TB NEAT study) [IP.09.32040.009]. Delft Imaging Systems (CAD4TBII, http://www.delftimagingsystems.com/tb-solutions/cad4tb) provided a research grant to Bram van Ginneken and Rick HHM Philipsen for the development of CAD4TB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aliyu G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063170; Balabanova Y, 2005, BMJ-BRIT MED J, V331, P379, DOI 10.1136/bmj.331.7513.379; Buijtels PCAM, 2009, EMERG INFECT DIS, V15, P242, DOI 10.3201/eid1502.080006; Conners R. W., 1982, Proceedings of the 6th International Conference on Pattern Recognition, P1152; DELONG ER, 1988, BIOMETRICS, V44, P837, DOI 10.2307/2531595; den Boon S, 2006, INT J TUBERC LUNG D, V10, P876; Den Boon S, 2005, INT J TUBERC LUNG D, V9, P1088; Division of Leprosy Tuberculosis and Lung Disease, 2009, GUID MAN LEPR TUB; FOURIE PB, 1980, TUBERCLE, V61, P71, DOI 10.1016/0041-3879(80)90013-6; Ginneken B van, 2012, ANN M RAD SOC N AM; Graham S, 2002, INT J TUBERC LUNG D, V6, P137; Griffith D, 2006, OFFICIAL ATS IDSA ST; Hogeweg L, 2011, ANN M RAD SOC N AM 2; Hogeweg L, 2010, LECT NOTES COMPUT SC, V6363, P650; ICAP Columbia University, 2014, RESOURCES; Jaeger S, 2013, QUANT IMAG MED SURG, V3, P89, DOI 10.3978/j.issn.2223-4292.2013.04.03; Lemon J., 2006, R R NEWS; Maduskar P, 2013, INT J TUBERC LUNG D, V17, P1613, DOI 10.5588/ijtld.13.0325; Ministry of Health and Social Services Namibia, 2011, NAT GUID MAN TUB; Ministry of Health and Social Welfare, 2006, MAN NAT TUB LEPR PRO; Ministry of Health Uganda, 2010, MAN NAT TUB LEPR PRO; National Department of Health South Africa, 2008, NAT TUB MAN GUID; R Core Team, 2021, R LANGUAGE ENV STAT; Robin X, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-77; Samulski M, 2010, EUR RADIOL, V20, P2323, DOI 10.1007/s00330-010-1821-8; Siddiqi K, 2003, LANCET INFECT DIS, V3, P288, DOI 10.1016/S1473-3099(03)00609-1; Stevenson M, 2013, EPIR R PACKAGE ANAL; Story A, 2012, INT J TUBERC LUNG D, V16, P1461, DOI 10.5588/ijtld.11.0773; The National Tuberculosis and Leprosy Programme Zambia, 2008, TB MAN; Tuberculosis Leprosy and TB/HIV Prevention and Control Programme, 2008, TUB LEPR TB HIV PREV; Uplekar M, 2013, INT J TUBERC LUNG D, V17, P1248, DOI 10.5588/ijtld.13.0199; van Cleeff MRA, 2005, BMC INFECT DIS, V5, DOI 10.1186/1471-2334-5-111; van Ginneken B, 2011, RADIOLOGY, V261, P719, DOI 10.1148/radiol.11091710; van Leth F, 2013, 1 TUBERCULOSIS PREVA; van't Hoog AH, 2011, INT J TUBERC LUNG D, V15, P1308, DOI 10.5588/ijtld.11.0004; WHO, 2013, WORKSH SCAL IMPL COL; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; Wickham H, 2007, J STAT SOFTW, V21, P1; World Health Organization, 2013, SYST SCREEN ACT TUB; Zellweger JP, 2006, INT J TUBERC LUNG D, V10, P1123; Zennaro F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073939; Zimbabwe National Tuberculosis Control Programme, 2010, NAT TB GUID	42	47	47	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2014	9	9							e106381	10.1371/journal.pone.0106381	http://dx.doi.org/10.1371/journal.pone.0106381			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ1IR	25192172	Green Published, gold, Green Accepted			2022-12-27	WOS:000347993600021
J	Chen, Q; Zhang, X; Li, WM; Ji, YQ; Cao, HZ; Zheng, PS				Chen, Qing; Zhang, Xin; Li, Wei-Min; Ji, Yu-Qiang; Cao, Hao-Zhe; Zheng, Pengsheng			Prognostic Value of LGR5 in Colorectal Cancer: A Meta-Analysis	PLOS ONE			English	Article							PROTEIN-COUPLED RECEPTOR; STEM-CELL MARKER; RECTAL-CANCER; COLON-CANCER; EXPRESSION; OVEREXPRESSION; SURVIVAL; RECURRENCE; INTESTINE; CARCINOMA	Objective: Leucine-rich repeat-containing G protein-coupled receptor 5 (LGR5) has recently been reported to be a marker of cancer stem cells (CSCs) in colorectal cancer (CRC), and the prognostic value of LGR5 in CRC has been evaluated in several studies. However, the conclusions remain controversial. In this study, we aimed to evaluate the association between the expression of LGR5 and the outcome of CRC patients by performing a meta-analysis. Methods: We systematically searched for relevant studies published up to February 2014 using the PubMed, Web of Science, EMBASE and Wangfang databases. Only articles in which LGR5 expression was detected by immunohistochemistry were included. A meta-analysis was performed using STATA 12.0, and pooled hazard ratios (HRs) with 95% confidence intervals (CIs) were used to estimate the strength of the association between LGR5 expression and the prognosis of CRC patients. Results: A total of 7 studies comprising 1833 CRC patients met the inclusion criteria, including 6 studies comprising 1781 patients for overall survival (OS) and 3 studies comprising 528 patients for disease-free survival (DFS). Our results showed that high LGR5 expression was significantly associated with poor prognosis in terms of OS (HR: 1.87, 95% CI: 1.23-2.84; P = 0.003) and DFS (HR: 2.44, 95% CI: 1.49-3.98; P<0.001). Further subgroup analysis revealed that many factors, including the study region, number of patients, follow-up duration and cutoff value, affected the significance of the association between LGR5 expression and a worse prognosis in patients with CRC. In addition, there was no evidence of publication bias, as suggested by Begg's and Egger's tests. Conclusions: The present meta-analysis indicated that high LGR5 expression was associated with poor prognosis in patients with CRC and that LGR5 is an efficient prognostic factor in CRC.	[Chen, Qing; Cao, Hao-Zhe; Zheng, Pengsheng] Xi An Jiao Tong Univ, Sch Med, Affiliated Hosp 1, Dept Reprod Med, Xian, Peoples R China; [Zhang, Xin] Xi An Jiao Tong Univ, Sch Med, Affiliated Hosp 2, Dept Obstet & Gynaecol, Xian, Peoples R China; [Li, Wei-Min] Xi An Jiao Tong Univ, Sch Med, Affiliated Hosp 1, Dept Nutr, Xian, Peoples R China; [Ji, Yu-Qiang] First Hosp Xian, Inst Cardiovasc Res, Xian, Peoples R China	Xi'an Jiaotong University; Xi'an Jiaotong University; Xi'an Jiaotong University	Zheng, PS (corresponding author), Xi An Jiao Tong Univ, Sch Med, Affiliated Hosp 1, Dept Reprod Med, Xian, Peoples R China.	zp_sheng@163.com			National Natural Science Fund for Distinguished Young Scientists [30725043]; National Natural Science Foundation of China [31201118]	National Natural Science Fund for Distinguished Young Scientists(National Natural Science Foundation of China (NSFC)); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by a grant from the National Natural Science Fund for Distinguished Young Scientists (No. 30725043) and a grant from the National Natural Science Foundation of China (No. 31201118). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahlquist DA, 2012, GASTROENTEROLOGY, V142, P248, DOI 10.1053/j.gastro.2011.10.031; Barker N, 2007, NATURE, V449, P1003, DOI 10.1038/nature06196; Becker L, 2008, THESCIENTIFICWORLDJO, V8, P1168, DOI 10.1100/tsw.2008.148; BEGG CB, 1994, BIOMETRICS, V50, P1088, DOI 10.2307/2533446; Chai Ningli, 2013, Nan Fang Yi Ke Da Xue Xue Bao, V33, P972; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Fan XS, 2010, INT J COLORECTAL DIS, V25, P583, DOI 10.1007/s00384-010-0903-z; Gerger A, 2011, CLIN CANCER RES, V17, P6934, DOI 10.1158/1078-0432.CCR-11-1180; Haegebarth A, 2009, AM J PATHOL, V174, P715, DOI 10.2353/ajpath.2009.080758; Handoll HH, 2006, ARCH PHYS MED REHAB, V87, P875, DOI 10.1016/j.apmr.2006.04.006; He S, 2014, BIOMEDICINE PHARMACO; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Hsu HC, 2013, INT J COLORECTAL DIS, V28, P1535, DOI 10.1007/s00384-013-1721-x; Hsu SY, 1998, MOL ENDOCRINOL, V12, P1830, DOI 10.1210/me.12.12.1830; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Kleist B, 2012, AM J TRANSL RES, V4, P279; Kleist B, 2011, INT J CLIN EXP PATHO, V4, P327; Kobayashi H, 2007, SURGERY, V141, P67, DOI 10.1016/j.surg.2006.07.020; Liu Z, 2014, NEOPLASMA, V61, P177, DOI 10.4149/neo_2014_016; McClanahan T, 2006, CANCER BIOL THER, V5, P419, DOI 10.4161/cbt.5.4.2521; Merlos-Suarez A, 2011, CELL STEM CELL, V8, P511, DOI 10.1016/j.stem.2011.02.020; Nakata S, 2013, BRAIN PATHOL, V23, P60, DOI 10.1111/j.1750-3639.2012.00618.x; Peng L, 2010, MODERN DIGESTION INT, V15, P284; Pitule P, 2013, ANTICANCER RES, V33, P4855; Reya T, 2001, NATURE, V414, P105, DOI 10.1038/35102167; Saigusa S, 2013, J CANCER RES CLIN, V139, P131, DOI 10.1007/s00432-012-1308-x; Saigusa S, 2012, INT J ONCOL, V41, P1643, DOI 10.3892/ijo.2012.1598; Stang A, 2010, EUR J EPIDEMIOL, V25, P603, DOI 10.1007/s10654-010-9491-z; Takahashi H, 2011, ANN SURG ONCOL, V18, P1166, DOI 10.1245/s10434-010-1373-9; Tanese K, 2008, AM J PATHOL, V173, P835, DOI 10.2353/ajpath.2008.071091; Uchida H, 2010, CANCER SCI, V101, P1731, DOI 10.1111/j.1349-7006.2010.01571.x; Valladares-Ayerbes M, 2012, INT J MOL SCI, V13, P4367, DOI 10.3390/ijms13044367; Visvader JE, 2008, NAT REV CANCER, V8, P755, DOI 10.1038/nrc2499; Wu XS, 2012, WORLD J SURG ONCOL, V10, DOI 10.1186/1477-7819-10-244; Yamamoto Y, 2003, HEPATOLOGY, V37, P528, DOI 10.1053/jhep.2003.50029; Yamanoi K, 2013, PATHOL INT, V63, P13, DOI 10.1111/pin.12013; Ziskin JL, 2012, GUT	38	20	22	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2014	9	9							e107013	10.1371/journal.pone.0107013	http://dx.doi.org/10.1371/journal.pone.0107013			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ1IR	25192390	Green Published, gold, Green Submitted			2022-12-27	WOS:000347993600089
J	Sebina, I; Biraro, IA; Dockrell, HM; Elliott, AM; Cose, S				Sebina, Ismail; Biraro, Irene A.; Dockrell, Hazel M.; Elliott, Alison M.; Cose, Stephen			Circulating B-Lymphocytes as Potential Biomarkers of Tuberculosis Infection Activity	PLOS ONE			English	Article							BLOOD MONONUCLEAR-CELLS; MYCOBACTERIUM-TUBERCULOSIS; LATENT TUBERCULOSIS; IMMUNE-RESPONSE; HUMORAL IMMUNITY; PLASMA-CELLS; MEMORY; ANTIBODIES; PRESERVATION; VACCINATION	Accurate biomarkers of Mycobacterium tuberculosis infection activity would significantly improve early diagnosis, treatment and management of M. tuberculosis infection. We hypothesised that circulating B-lymphocytes may be useful biomarkers of tuberculosis (TB) infection status in highly TB-endemic settings. Ex-vivo and in-vitro mycobacteria-specific B-cell ELISPOT assays were used to examine the plasmablast (PB) and memory B-cell (MBC) responses in the peripheral blood of adult, healthy, community controls (n = 151) and of active TB patients (n = 48) living in Uganda. Frequencies of mycobacteria-specific PBs were markedly higher in active TB patients compared to healthy controls, and, conversely, MBCs were markedly higher in the healthy controls compared to active TB patients. In addition, the community controls with evidence of latent TB infection had higher peripheral blood PB and MBC responses than those without evidence of TB infection. These data demonstrate that peripheral blood B-cell responses are differentially modulated during latent and active M. tuberculosis infection, and suggest that the PB to MBC ratio may be a useful biomarker of TB infection activity.	[Sebina, Ismail; Biraro, Irene A.; Elliott, Alison M.; Cose, Stephen] Uganda Virus Res Inst, MRC, Uganda Res Unit AIDS, Coinfect Studies Programme, Entebbe, Uganda; [Biraro, Irene A.; Elliott, Alison M.] Makerere Univ Kampala, Coll Hlth Sci, Dept Internal Med, Kampala, Uganda; [Dockrell, Hazel M.; Elliott, Alison M.] London Sch Hyg & Trop Med, Dept Immunol & Infect, London WC1, England; [Elliott, Alison M.; Cose, Stephen] London Sch Hyg & Trop Med, Dept Clin Res, London WC1, England	Uganda Virus Research Institute; Makerere University; University of London; London School of Hygiene & Tropical Medicine; University of London; London School of Hygiene & Tropical Medicine	Sebina, I (corresponding author), QIMR Berghofer Med Res Inst, Malaria Immunol Lab, Brisbane, Qld, Australia.	ismail.sebina@qimrberghofer.edu.au; stephen.cose@mrcuganda.org	Cose, Stephen/H-4851-2019	Cose, Stephen/0000-0002-5156-037X; Elliott, Alison/0000-0003-2818-9549; Sebina, Ismail/0000-0003-3232-3472; Dockrell, Hazel/0000-0003-1869-9107	Wellcome Trust [092779, 084344]	Wellcome Trust(Wellcome TrustEuropean Commission)	This work was supported by a Wellcome Trust Masters Training Fellowship awarded to IS (grant number 092779) and a Wellcome Trust Uganda PhD Fellowship in Infection and Immunity held by IAB, funded by a Wellcome Trust Strategic Award (grant number 084344). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aliyu G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063170; Amanna IJ, 2007, NEW ENGL J MED, V357, P1903, DOI 10.1056/NEJMoa066092; Barry CE, 2009, NAT REV MICROBIOL, V7, P845, DOI 10.1038/nrmicro2236; Bernasconi NL, 2002, SCIENCE, V298, P2199, DOI 10.1126/science.1076071; Berry MPR, 2010, NATURE, V466, P973, DOI 10.1038/nature09247; Blanchard-Rohner G, 2009, BLOOD, V114, P4998, DOI 10.1182/blood-2009-03-211052; Cliff JM, 2013, J INFECT DIS, V207, P18, DOI 10.1093/infdis/jis499; Joosten SA, 2012, GENES IMMUN, V13, P71, DOI 10.1038/gene.2011.64; Kelly DF, 2005, JAMA-J AM MED ASSOC, V294, P3019, DOI 10.1001/jama.294.23.3019; Khan IH, 2008, CLIN VACCINE IMMUNOL, V15, P433, DOI 10.1128/CVI.00354-07; Kozakiewicz L, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003472; Kozakiewicz L, 2013, ADV EXP MED BIOL, V783, P225, DOI 10.1007/978-1-4614-6111-1_12; Kyu SY, 2009, J IMMUNOL METHODS, V340, P42, DOI 10.1016/j.jim.2008.09.025; Lalvani A, 2005, LANCET INFECT DIS, V5, P322, DOI 10.1016/S1473-3099(05)70118-3; Lin PL, 2010, J IMMUNOL, V185, P15, DOI 10.4049/jimmunol.0903856; Maertzdorf J, 2012, INT J TUBERC LUNG D, V16, P1140, DOI 10.5588/ijtld.12.0246; Maertzdorf J, 2011, GENES IMMUN, V12, P15, DOI 10.1038/gene.2010.51; Maglione PJ, 2009, EUR J IMMUNOL, V39, P676, DOI 10.1002/eji.200839148; Mallone R, 2011, CLIN EXP IMMUNOL, V163, P33, DOI 10.1111/j.1365-2249.2010.04272.x; O'Garra A, 2013, ANNU REV IMMUNOL, V31, P475, DOI 10.1146/annurev-immunol-032712-095939; Odendahl M, 2005, BLOOD, V105, P1614, DOI 10.1182/blood-2004-07-2507; Ottenhoff THM, 2012, TUBERCULOSIS, V92, pS17, DOI 10.1016/S1472-9792(12)70007-0; Pai M, 2010, NAT REV MICROBIOL, V8, P242, DOI 10.1038/nrmicro2236-c1; Phuah JY, 2012, AM J PATHOL, V181, P508, DOI 10.1016/j.ajpath.2012.05.009; Pinna D, 2009, EUR J IMMUNOL, V39, P1260, DOI 10.1002/eji.200839129; Raqib R, 2009, CLIN VACCINE IMMUNOL, V16, P521, DOI 10.1128/CVI.00391-08; Reimann KA, 2000, CLIN DIAGN LAB IMMUN, V7, P352, DOI 10.1128/CDLI.7.3.352-359.2000; Rosado MM, 2011, EUR J IMMUNOL, V41, P1800, DOI 10.1002/eji.201041187; Sebina I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051381; Sridhar S, 2011, FUTURE MICROBIOL, V6, P1021, DOI [10.2217/FMB.11.82, 10.2217/fmb.11.82]; Tarlinton D, 2008, CURR OPIN IMMUNOL, V20, P162, DOI 10.1016/j.coi.2008.03.016; Torrado E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061681; Truck J, 2014, HUM VACC IMMUNOTHER, P10; Wallis RS, 2013, LANCET INFECT DIS, V13, P362, DOI 10.1016/S1473-3099(13)70034-3; Walzl G, 2011, NAT REV IMMUNOL, V11, P343, DOI 10.1038/nri2960; Whitworth HS, 2013, BIOMARK MED, V7, P349, DOI [10.2217/BMM.13.53, 10.2217/bmm.13.53]; Young DB, 2009, TRENDS MICROBIOL, V17, P183, DOI 10.1016/j.tim.2009.02.005; Zhang MX, 2012, CELL IMMUNOL, V274, P89, DOI 10.1016/j.cellimm.2012.01.007	38	18	18	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2014	9	9							e106796	10.1371/journal.pone.0106796	http://dx.doi.org/10.1371/journal.pone.0106796			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ1IR	25192196	Green Submitted, Green Published, gold, Green Accepted			2022-12-27	WOS:000347993600063
J	Silva, P; Travassos, B; Vilar, L; Aguiar, P; Davids, K; Araujo, D; Garganta, J				Silva, Pedro; Travassos, Bruno; Vilar, Luis; Aguiar, Paulo; Davids, Keith; Araujo, Duarte; Garganta, Julio			Numerical Relations and Skill Level Constrain Co-Adaptive Behaviors of Agents in Sports Teams	PLOS ONE			English	Article							NEUROBIOLOGICAL SYSTEMS; DYNAMICS; AFFORDANCES; MOVEMENT; COORDINATION; PERFORMANCE; KNOWLEDGE; COMPLEX; MODELS; PART	Similar to other complex systems in nature (e.g., a hunting pack, flocks of birds), sports teams have been modeled as social neurobiological systems in which interpersonal coordination tendencies of agents underpin team swarming behaviors. Swarming is seen as the result of agent co-adaptation to ecological constraints of performance environments by collectively perceiving specific possibilities for action (affordances for self and shared affordances). A major principle of invasion team sports assumed to promote effective performance is to outnumber the opposition (creation of numerical overloads) during different performance phases (attack and defense) in spatial regions adjacent to the ball. Such performance principles are assimilated by system agents through manipulation of numerical relations between teams during training in order to create artificially asymmetrical performance contexts to simulate overloaded and underloaded situations. Here we evaluated effects of different numerical relations differentiated by agent skill level, examining emergent inter-individual, intra-and inter-team coordination. Groups of association football players (national - NLP and regional-level - RLP) participated in small-sided and conditioned games in which numerical relations between system agents were manipulated (5v5, 5v4 and 5v3). Typical grouping tendencies in sports teams (major ranges, stretch indices, distances of team centers to goals and distances between the teams' opposing line-forces in specific team sectors) were recorded by plotting positional coordinates of individual agents through continuous GPS tracking. Results showed that creation of numerical asymmetries during training constrained agents' individual dominant regions, the underloaded teams' compactness and each team's relative position on-field, as well as distances between specific team sectors. We also observed how skill level impacted individual and team coordination tendencies. Data revealed emergence of co-adaptive behaviors between interacting neurobiological social system agents in the context of sport performance. Such observations have broader implications for training design involving manipulations of numerical relations between interacting members of social collectives.	[Silva, Pedro; Garganta, Julio] Univ Porto, Fac Desporto, Ctr Res Educ Innovat & Intervent Sport CIFI2D, P-4100 Oporto, Portugal; [Travassos, Bruno] Univ Beira Interior, Dept Sport Sci, CIDESD, Covilha, Portugal; [Vilar, Luis] Lusofona Univ Humanities & Technol, Fac Phys Educ & Sports, Lisbon, Portugal; [Vilar, Luis; Araujo, Duarte] Univ Nova Lisboa, CIPER, Fac Motricidade Humana, P-1200 Lisbon, Portugal; [Aguiar, Paulo] Univ Porto, Fac Ciencias, Ctr Math, P-4100 Oporto, Portugal; [Davids, Keith] Sheffield Hallam Univ, Ctr Sports Engn Res, Sheffield S1 1WB, S Yorkshire, England; [Davids, Keith] Univ Jyvaskyla, FiDiPro Programme, Jyvaskyla, Finland	Universidade do Porto; Universidade da Beira Interior; Lusofona University; Universidade de Lisboa; Universidade Nova de Lisboa; Universidade do Porto; Sheffield Hallam University; University of Jyvaskyla	Silva, P (corresponding author), Univ Porto, Fac Desporto, Ctr Res Educ Innovat & Intervent Sport CIFI2D, Rua Campo Alegre 823, P-4100 Oporto, Portugal.	psilv@fade.up.pt	Aguiar, Paulo/AAD-2462-2020; Travassos, Bruno/G-4478-2013; Araújo, Duarte/M-2044-2017; Araújo, Duarte/F-4161-2011; Vilar, Luis/E-6970-2013	Aguiar, Paulo/0000-0003-4164-5713; Travassos, Bruno/0000-0002-2165-2687; Araújo, Duarte/0000-0001-7932-3192; Araújo, Duarte/0000-0001-7932-3192; Vilar, Luis/0000-0002-1397-0933; Davids, Keith/0000-0003-1398-6123	Foundation for Science and Technology (FCT, Portugal) [SFRH/BD/73463/2010]	Foundation for Science and Technology (FCT, Portugal)(Portuguese Foundation for Science and Technology)	This work was supported by the Foundation for Science and Technology (FCT, Portugal), through the grant SFRH/BD/73463/2010 awarded to the first author. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Araujo D, 2004, SKILL ACQUISITION SP, P409; Araujo D, ROTLEDGE HD IN PRESS; Button C, 2012, COMPLEXITY THINKING, P135; Chatfield C., 2003, ANAL TIME SERIES INT, V6, DOI 10.4324/9780203491683; Chow JY, 2011, NEW IDEAS PSYCHOL, V29, P189, DOI 10.1016/j.newideapsych.2010.10.001; Cohen J.E., 1988, STAT POWER ANAL BEHA; Coutts AJ, 2010, J SCI MED SPORT, V13, P133, DOI 10.1016/j.jsams.2008.09.015; Davids K, 2006, ADAPT BEHAV, V14, P73, DOI 10.1177/105971230601400103; Davids K, 2013, EXERC SPORT SCI REV, V41, P154, DOI 10.1097/JES.0b013e318292f3ec; Duarte R, 2013, COMPLEX SYSTEMS SPOR; Duarte R., 2010, OPEN SPORTS SCI J, V3, P16, DOI [DOI 10.2174/1875399X01003010016, 10.2174/1875399X01003010016]; Duarte R, 2013, J SYST SCI COMPLEX, V26, P62, DOI 10.1007/s11424-013-2290-3; Duarte R, 2012, SPORTS MED, V42, P633, DOI 10.2165/11632450-000000000-00000; Eccles D., 2010, INT REV SPORT EXER P, V3, P154, DOI [10.1080/1750984X.2010.519400, DOI 10.1080/1750984X.2010.519400]; Edelman GM, 2001, P NATL ACAD SCI USA, V98, P13763, DOI 10.1073/pnas.231499798; Fonseca S, 2012, HUM MOVEMENT SCI, V31, P1652, DOI 10.1016/j.humov.2012.04.006; Frencken W, 2011, EUR J SPORT SCI, V11, P215, DOI 10.1080/17461391.2010.499967; GIBSON James J., 1979, ECOLOGICAL APPROACH; Grehaigne J, 1988, SCI FOOTBALL, V1, P316; Grehaigne JF, 1997, J SPORT SCI, V15, P137, DOI 10.1080/026404197367416; GREHAIGNE JF, 1995, QUEST, V47, P490, DOI 10.1080/00336297.1995.10484171; Hristovski R, 2011, NONLIN DYNAM PSYCHOL, V15, P175; HUGHES C, 1994, FOOTBALL ASS COACHIN; Johnston RJ, 2013, INT J PERF ANAL SPOR, V13, P262, DOI 10.1080/24748668.2013.11868646; Kesebir S, 2012, PERS SOC PSYCHOL REV, V16, P233, DOI 10.1177/1088868311430834; Mark LS, 2007, ECOL PSYCHOL, V19, P107; Marsh KL, 2006, ECOL PSYCHOL, V18, P1, DOI 10.1207/s15326969eco1801_1; Passos P, 2008, J SPORT SCI, V26, P1421, DOI 10.1080/02640410802208986; Passos P, 2013, SPORTS MED, V43, P1, DOI 10.1007/s40279-012-0001-1; Passos P, 2011, J MOTOR BEHAV, V43, P155, DOI 10.1080/00222895.2011.552078; Passos P, 2009, J MOTOR BEHAV, V41, P445, DOI 10.3200/35-08-061; Rampinini E, 2007, J SPORT SCI, V25, P659, DOI 10.1080/02640410600811858; Richardson MJ, 2007, HUM MOVEMENT SCI, V26, P867, DOI 10.1016/j.humov.2007.07.002; Riley MA, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00038; Schmidt RC, 2008, UNDERST COMPLEX SYST, P281, DOI 10.1007/978-3-540-74479-5_14; Sebanz N, 2006, TRENDS COGN SCI, V10, P70, DOI 10.1016/j.tics.2005.12.009; Silva P, INT J SPORT IN PRESS; Silva P, 2013, SPORTS MED, V43, P765, DOI 10.1007/s40279-013-0070-9; SINNOTT RW, 1984, SKY TELESCOPE, V68, P159; Stearns SC, 2007, EVOLUTION, V61, P2275, DOI 10.1111/j.1558-5646.2007.00202.x; Stoffregen TA, 1999, J EXP PSYCHOL HUMAN, V25, P120, DOI 10.1037/0096-1523.25.1.120; Sumpter DJT, 2006, PHILOS T R SOC B, V361, P5, DOI 10.1098/rstb.2005.1733; Teodorescu L, 1977, THEORIE METHODOLOGIE; Travassos B, 2012, HUM MOVEMENT SCI, V31, P932, DOI 10.1016/j.humov.2011.10.004; Travassos B, 2012, PSYCHOL SPORT EXERC, V13, P216, DOI 10.1016/j.psychsport.2011.11.009; Travassos B, 2011, HUM MOVEMENT SCI, V30, P1245, DOI 10.1016/j.humov.2011.04.003; Vilar L, 2013, J SYST SCI COMPLEX, V26, P73, DOI 10.1007/s11424-013-2286-z; Withagen R, 2012, NEW IDEAS PSYCHOL, V30, P250, DOI 10.1016/j.newideapsych.2011.12.003; Witt JK, 2012, J EXP PSYCHOL HUMAN, V38, P1202, DOI 10.1037/a0026512; Witt JK, 2012, J EXP PSYCHOL HUMAN, V38, P715, DOI 10.1037/a0026261; Worthington E, 1974, LEARNING TEACHING SO; Yue ZY, 2008, STUD APPL MATH, V121, P223, DOI 10.1111/j.1467-9590.2008.00413.x	52	77	77	0	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2014	9	9							e107112	10.1371/journal.pone.0107112	http://dx.doi.org/10.1371/journal.pone.0107112			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AZ1IR	25191870	Green Published, Green Accepted, gold			2022-12-27	WOS:000347993600097
J	Qi, H; An, HZ; Hao, XQ; Zhong, WQ; Zhang, YB				Qi, Hai; An, Haizhong; Hao, Xiaoqing; Zhong, Weiqiong; Zhang, Yanbing			Analyzing the International Exergy Flow Network of Ferrous Metal Ores	PLOS ONE			English	Article							RESOURCE ANALYSIS; SYSTEMS ACCOUNT; ENERGY; SECTOR; TRADE; CHINA; SUSTAINABILITY; EVOLUTION	This paper employs an un-weighted and weighted exergy network to study the properties of ferrous metal ores in countries worldwide and their evolution from 2002 to 2012. We find that there are few countries controlling most of the ferrous metal ore exports in terms of exergy and that the entire exergy flow network is becoming more heterogeneous though the addition of new nodes. The increasing of the average clustering coefficient indicates that the formation of an international exergy flow system and regional integration is improving. When we contrast the average out strength of exergy and the average out strength of currency, we find both similarities and differences. Prices are affected largely by human factors; thus, the growth rate of the average out strength of currency has fluctuated acutely in the eleven years from 2002 to 2012. Exergy is defined as the maximum work that can be extracted from a system and can reflect the true cost in the world, and this parameter fluctuates much less. Performing an analysis based on the two aspects of exergy and currency, we find that the network is becoming uneven.	[Qi, Hai; An, Haizhong; Hao, Xiaoqing; Zhong, Weiqiong] China Univ Geosci, Sch Humanities & Econ Management, Beijing, Peoples R China; [Qi, Hai; An, Haizhong; Hao, Xiaoqing; Zhong, Weiqiong] Minist Land & Resources, Key Lab Carrying Capac Assessment Resource & Envi, Beijing, Peoples R China; [Qi, Hai; Zhang, Yanbing] Hebei Univ Sci & Technol, Dept Teaching Affairs, Shijiazhuang, Peoples R China; [Qi, Hai; An, Haizhong; Hao, Xiaoqing; Zhong, Weiqiong] China Univ Geosci, Lab Resources & Environm Management, Beijing, Peoples R China	China University of Geosciences; Ministry of Natural Resources of the People's Republic of China; Hebei University of Science & Technology; China University of Geosciences	An, HZ (corresponding author), China Univ Geosci, Sch Humanities & Econ Management, Beijing, Peoples R China.	ahz369@163.com			National Natural Science Foundation of China [71173199]; Ministry of Education, Humanities and Social Sciences Planning Fund [10YJA630001]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Education, Humanities and Social Sciences Planning Fund	This work was funded by the National Natural Science Foundation of China (Grant No. 71173199) and the Ministry of Education, Humanities and Social Sciences Planning Fund (Grant No. 10YJA630001). Prof. Haizhong An is the author received the funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An HZ, 2014, PHYSICA A, V393, P382, DOI 10.1016/j.physa.2013.08.055; Ayres RU, 2003, ENERGY, V28, P219, DOI 10.1016/S0360-5442(02)00089-0; Ayres RU, 1998, ENERGY, V23, P355, DOI 10.1016/S0360-5442(97)00076-5; Bajardi P, 2011, PLOS ONE, V6; Banavar JR, 1999, NATURE, V399, P130, DOI 10.1038/20144; Barabasi AL, 1999, PHYSICA A, V272, P173, DOI 10.1016/S0378-4371(99)00291-5; Barabasi AL, 1999, SCIENCE, V286, P509, DOI 10.1126/science.286.5439.509; Chen B, 2007, ENERG POLICY, V35, P2079, DOI 10.1016/j.enpol.2006.08.004; Chen B, 2007, ENERG POLICY, V35, P2051, DOI 10.1016/j.enpol.2006.07.001; Chen B, 2007, ENERG POLICY, V35, P2065, DOI 10.1016/j.enpol.2006.07.007; Chen B, 2007, ECOL ECON, V61, P355, DOI 10.1016/j.ecolecon.2006.03.009; Chen B, 2006, ECOL MODEL, V196, P313, DOI 10.1016/j.ecolmodel.2006.02.019; Chen B, 2006, ENERGY, V31, P1115, DOI 10.1016/j.energy.2005.06.003; Chen GQ, 2007, ECOL MODEL, V208, P102, DOI 10.1016/j.ecolmodel.2007.04.017; Chen GQ, 2007, ENERG POLICY, V35, P2087, DOI 10.1016/j.enpol.2006.08.012; Chen GQ, 2007, ENERG POLICY, V35, P2038, DOI 10.1016/j.enpol.2006.06.009; Chen GQ, 2009, ENERGY, V34, P1127, DOI 10.1016/j.energy.2009.04.023; Chen G.Q., 2006, COMMUN NONLINEAR SCI, V11, P531, DOI DOI 10.1016/J.CNSNS.2004.11.009; [程淑佳 Cheng Shujia], 2011, [地理科学, Scientia Geographica Sinica], V31, P1342; CISIY, 2003, CHINA IRON STEEL IND; CNMY, 2003, CHINA NONFERROUS MET; Dai J, 2012, RENEW SUST ENERG REV, V16, P4796, DOI 10.1016/j.rser.2012.04.027; Dincer I, 2002, ENERG POLICY, V30, P137, DOI 10.1016/S0301-4215(01)00079-9; Dincer I, 2004, INT J ENERG RES, V28, P205, DOI 10.1002/er.962; Dincer I, 2003, P I MECH ENG A-J POW, V217, P481, DOI 10.1243/095765003322407539; Dincer I, 2004, APPL THERM ENG, V24, P525, DOI 10.1016/j.applthermaleng.2003.10.011; Dincer I, 2005, ENERG POLICY, V33, P1461, DOI 10.1016/j.enpol.2004.01.004; Dincer I, 2004, ENERG SOURCE, V26, P1239, DOI 10.1080/00908310490441566; Dincer I, 2004, ENERG POLICY, V32, P1615, DOI 10.1016/80301-4215(03)00132-0; Ertesvag IS, 2000, ENERGY, V25, P957, DOI 10.1016/S0360-5442(00)00025-6; Ertesvag IS, 2005, ENERGY, V30, P649, DOI 10.1016/j.energy.2004.05.025; Fagiolo G, 2010, J EVOL ECON, V20, P479, DOI 10.1007/s00191-009-0160-x; Finnveden G, 1997, ENERGY, V22, P923, DOI 10.1016/S0360-5442(97)00022-4; Gao XY, 2014, ENERGY, V73, P380, DOI 10.1016/j.energy.2014.06.028; Gao XN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055481; Garlaschelli D, 2005, PHYSICA A, V355, P138, DOI 10.1016/j.physa.2005.02.075; Gasparatos A, 2009, RENEW SUST ENERG REV, V13, P1074, DOI 10.1016/j.rser.2008.03.004; Gasparatos A, 2009, RENEW SUST ENERG REV, V13, P956, DOI 10.1016/j.rser.2008.03.005; Haibo WDGH, 2006, SYSTEMS ENG THEORY P, V2006, P49; Hao X.Q., 2013, ECON GEOGR, V33, P92; JORGENSEN S E, 1977, Ecological Modelling, V3, P39, DOI 10.1016/0304-3800(77)90023-0; JORGENSEN SE, 1995, ECOL MODEL, V77, P99, DOI 10.1016/0304-3800(93)E0080-M; Latora V, 2003, EUR PHYS J B, V32, P249, DOI 10.1140/epjb/e2003-00095-5; Li HJ, 2014, PHYSICA A, V406, P80, DOI 10.1016/j.physa.2014.03.041; Li X, 2003, PHYSICA A, V328, P287, DOI 10.1016/S0378-4371(03)00567-3; Milia D, 2006, ENERGY, V31, P100, DOI 10.1016/j.energy.2004.04.046; MORRIS DR, 1986, ENERGY, V11, P733, DOI 10.1016/0360-5442(86)90013-7; Nakicenovic N, 1996, ENERGY, V21, P223, DOI 10.1016/0360-5442(96)00001-1; Newman MEJ, 1999, PHYS LETT A, V263, P341, DOI 10.1016/S0375-9601(99)00757-4; Newman MEJ, 2003, SIAM REV, V45, P167, DOI 10.1137/S003614450342480; Newman MEJ, 2002, PHYS REV LETT, V89, P4; quan Dwqlb, 2011, RES MEASUREMENT EVOL; REISTAD GM, 1975, J ENG POWER-T ASME, V97, P429, DOI 10.1115/1.3446026; Schiavo S, 2010, QUANT FINANC, V10, P389, DOI 10.1080/14697680902882420; Schweitzer F, 2009, SCIENCE, V325, P422, DOI 10.1126/science.1173644; Serrano MA, 2003, PHYS REV E, V68, P4; Szargut J, 2002, ENERGY, V27, P379, DOI 10.1016/S0360-5442(01)00092-5; SZARGUT J, 1989, APPL ENERG, V32, P269, DOI 10.1016/0306-2619(89)90016-0; SZARGUT J, 1985, B POL ACAD SCI-TECH, V33, P292; Szargut J., 1987, EXERGY ANAL THERMAL, DOI 10.1016/0142-727X(89)90062-3; Szargut J, 1965, EXERGY; [谭跃进 Tan Yuejin], 2004, [系统工程理论与实践, Systems Engineering-Theory & Practice], V24, P1; Utlu Z, 2007, RENEW SUST ENERG REV, V11, P1, DOI 10.1016/j.rser.2004.12.005; Vazquez A, 2002, PHYS REV E, V65, P12; Wall, 1977, 7742 I THEOR PHYS; Wall, 1986, THESIS U TECHNOLOGY; WALL G, 1987, RESOUR ENERG, V9, P55, DOI 10.1016/0165-0572(87)90023-5; WALL G, 1990, ENERGY, V15, P435, DOI 10.1016/0360-5442(90)90040-9; WALL G, 1994, ENERGY, V19, P1267, DOI 10.1016/0360-5442(94)90030-2; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; Zhang B, 2010, RENEW SUST ENERG REV, V14, P1527, DOI 10.1016/j.rser.2010.01.021; Zhong WQ, 2014, PHYSICA A, V413, P42, DOI 10.1016/j.physa.2014.06.055	72	19	19	0	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 4	2014	9	9							e106617	10.1371/journal.pone.0106617	http://dx.doi.org/10.1371/journal.pone.0106617			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3XV	25188407	gold, Green Submitted, Green Published			2022-12-27	WOS:000341271500062
J	Dias, FMV; Ribeiro, RF; Fernandes, AA; Fiorim, J; Travaglia, TCF; Vassallo, DV; Stefanon, I				Vargas Dias, Fernanda Moura; Ribeiro Junior, Rogerio Faustino; Fernandes, Aurelia Araujo; Fiorim, Jonaina; Francischetto Travaglia, Teresa Cristina; Vassallo, Dalton Valentim; Stefanon, Ivanita			Na+K+-ATPase Activity and K+ Channels Differently Contribute to Vascular Relaxation in Male and Female Rats	PLOS ONE			English	Article							SMOOTH-MUSCLE-CELLS; NITRIC-OXIDE; GENDER-DIFFERENCES; HYPERTENSIVE-RATS; ENDOTHELIAL DYSFUNCTION; POTASSIUM CHANNELS; PHYSIOLOGICAL ROLES; SEX-HORMONES; SODIUM-PUMP; REACTIVITY	Gender associated differences in vascular reactivity regulation might contribute to the low incidence of cardiovascular disease in women. Cardiovascular protection is suggested to depend on female sex hormones' effects on endothelial function and vascular tone regulation. We tested the hypothesis that potassium (K+) channels and Na+K+-ATPase may be involved in the gender-based vascular reactivity differences. Aortic rings from female and male rats were used to examine the involvement of K+ channels and Na+K+-ATPase in vascular reactivity. Acetylcholine (ACh)-induced relaxation was analyzed in the presence of L-NAME (100 mM) and the following K+ channels blockers: tetraethylammonium (TEA, 2 mM), 4-aminopyridine (4-AP, 5 mM), iberiotoxin (IbTX, 30 nM), apamin (0.5 mu M) and charybdotoxin (ChTX, 0.1 mu M). The AChinduced relaxation sensitivity was greater in the female group. After incubation with 4-AP the ACh-dependent relaxation was reduced in both groups. However, the dAUC was greater in males, suggesting that the voltage-dependent K+ channel (K-v) participates more in males. Inhibition of the three types of Ca2+-activated K+ channels induced a greater reduction in R-max in females than in males. The functional activity of the Na+K+-ATPase was evaluated by KCl-induced relaxation after L-NAME and OUAincubation. OUA reduced K+-induced relaxation in female and male groups, however, it was greater in males, suggesting a greater Na+K+-ATPase functional activity. L-NAME reduced K+-induced relaxation only in the female group, suggesting that nitric oxide (NO) participates more in their functional Na+K+-ATPase activity. These results suggest that the K+ channels involved in the gender-based vascular relaxation differences are the large conductance Ca2+-activated K+ channels (BKCa) in females and K-v in males and in the K+-induced relaxation and the Na+K+-ATPase vascular functional activity is greater in males.	[Vargas Dias, Fernanda Moura; Ribeiro Junior, Rogerio Faustino; Fernandes, Aurelia Araujo; Fiorim, Jonaina; Francischetto Travaglia, Teresa Cristina; Vassallo, Dalton Valentim; Stefanon, Ivanita] Univ Fed Espirito Santo, Dept Ciencias Fisiol, Vitoria, Espirito Santo, Brazil	Universidade Federal do Espirito Santo	Stefanon, I (corresponding author), Univ Fed Espirito Santo, Dept Ciencias Fisiol, Vitoria, Espirito Santo, Brazil.	ivanitaufes@hotmail.com	Ribeiro, Rogerio/F-7116-2012; Vassallo, Dalton/K-8289-2016	Ribeiro, Rogerio/0000-0002-9725-3869; Stefanon, Ivanita/0000-0003-2638-5183; Vassallo, Dalton/0000-0002-4463-4174	CAPES; CNPq; FAPES/FUNCITEC	CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); FAPES/FUNCITEC	This study was supported by grants from CAPES; CNPq; and FAPES/FUNCITEC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bianchi PR, 2006, LIFE SCI, V78, P875, DOI 10.1016/j.lfs.2005.05.086; Blanco G, 1998, AM J PHYSIOL-RENAL, V275, pF633, DOI 10.1152/ajprenal.1998.275.5.F633; BLAUSTEIN MP, 1993, AM J PHYSIOL, V264, pC1367, DOI 10.1152/ajpcell.1993.264.6.C1367; BOLOTINA VM, 1994, NATURE, V368, P850, DOI 10.1038/368850a0; Bondarenko A, 2006, BRIT J PHARMACOL, V149, P958, DOI 10.1038/sj.bjp.0706913; Briones AM, 2009, J HYPERTENS, V27, P83, DOI 10.1097/HJH.0b013e328317a7cf; Callera GE, 2004, J PHARMACOL EXP THER, V309, P1036, DOI 10.1124/jpet.103.062810; Chatterjee A, 2008, VASC PHARMACOL, V49, P134, DOI 10.1016/j.vph.2008.06.008; Cheong A, 2002, J VASC RES, V39, P122, DOI 10.1159/000057761; Dalle Lucca JJ, 2000, HUM REPROD, V15, P961; Dantas APV, 2004, CARDIOVASC RES, V61, P22, DOI 10.1016/j.cardiores.2003.10.010; Darkow DJ, 1997, AM J PHYSIOL-HEART C, V272, pH2765, DOI 10.1152/ajpheart.1997.272.6.H2765; EDWARDS JG, 1985, J APPL PHYSIOL, V58, P1683, DOI 10.1152/jappl.1985.58.5.1683; Feletou M, 2006, ARTERIOSCL THROM VAS, V26, P1215, DOI 10.1161/01.ATV.0000217611.81085.c5; Feletou M, 2009, BRIT J PHARMACOL, V156, P545, DOI 10.1111/j.1476-5381.2009.00052.x; Fiorim J, 2012, TOXICOL APPL PHARM, V262, P22, DOI 10.1016/j.taap.2012.04.015; Forstermann U, 2006, CIRCULATION, V113, P1708, DOI 10.1161/CIRCULATIONAHA.105.602532; Garland CJ, 2011, BRIT J PHARMACOL, V164, P839, DOI 10.1111/j.1476-5381.2010.01148.x; GISCLARD V, 1988, J PHARMACOL EXP THER, V244, P19; GRUWEL MLH, 1995, AM J PHYSIOL-HEART C, V268, pH351, DOI 10.1152/ajpheart.1995.268.1.H351; GUPTA S, 1994, AM J PHYSIOL, V266, pH2146, DOI 10.1152/ajpheart.1994.266.5.H2146; HERRINGTON DM, 1994, AM J CARDIOL, V73, P951, DOI 10.1016/0002-9149(94)90136-8; Jamieson DG, 2010, CURR ATHEROSCLER REP, V12, P236, DOI 10.1007/s11883-010-0118-3; Kim Kyung Hee, 2005, Sci STKE, V2005, ppe28; Ko Eun A., 2008, Journal of Smooth Muscle Research, V44, P65, DOI 10.1540/jsmr.44.65; LAWLER KA, 1995, PSYCHOSOM MED, V57, P357, DOI 10.1097/00006842-199507000-00007; Lucca JJD, 2000, HUM REPROD, V15, P2496, DOI 10.1093/humrep/15.12.2496; Marin J, 1999, PHARMACOL THERAPEUT, V84, P249, DOI 10.1016/S0163-7258(99)00037-6; McKee AP, 2003, AM J PHYSIOL-HEART C, V284, pH1737, DOI 10.1152/ajpheart.00779.2002; Mendelsohn ME, 1999, NEW ENGL J MED, V340, P1801, DOI 10.1056/NEJM199906103402306; MONCADA S, 1991, PHARMACOL REV, V43, P109; NELSON MT, 1995, AM J PHYSIOL-CELL PH, V268, pC799, DOI 10.1152/ajpcell.1995.268.4.C799; OIKE M, 1993, PFLUG ARCH EUR J PHY, V424, P301, DOI 10.1007/BF00384356; Orshal JM, 2004, AM J PHYSIOL-REG I, V286, pR233, DOI 10.1152/ajpregu.00338.2003; Palacios J, 2004, AM J PHYSIOL-HEART C, V286, pH1793, DOI 10.1152/ajpheart.00990.2003; Poreba R, 2011, HUM EXP TOXICOL, V30, P1174, DOI 10.1177/0960327110391383; Rossoni LV, 2002, BRIT J PHARMACOL, V135, P771, DOI 10.1038/sj.bjp.0704501; Sartori TE, 2010, VASC HEALTH RISK MAN, V6, P431; Schoner W, 2000, EXP CLIN ENDOCR DIAB, V108, P449, DOI 10.1055/s-2000-8140; SKAUG N, 1981, AM J PHYSIOL, V241, pH217, DOI 10.1152/ajpheart.1981.241.2.H217; Standen NB, 1998, ACTA PHYSIOL SCAND, V164, P549; Tammaro P, 2004, BRIT J PHARMACOL, V143, P303, DOI 10.1038/sj.bjp.0705957; Therien AG, 2000, AM J PHYSIOL-CELL PH, V279, pC541, DOI 10.1152/ajpcell.2000.279.3.C541; Thompson J, 2003, CLIN EXP PHARMACOL P, V30, P1, DOI 10.1046/j.1440-1681.2003.03790.x; Triggle Chris R., 2003, Journal of Smooth Muscle Research, V39, P249, DOI 10.1540/jsmr.39.249; Vitale C, 2009, NAT REV CARDIOL, V6, P532, DOI 10.1038/nrcardio.2009.105; WEBB RC, 1978, BLOOD VESSELS, V15, P198; Yang Y, 2007, AM J PHYSIOL-HEART C, V293, pH1553, DOI 10.1152/ajpheart.00151.2007; Zahler R, 1996, AM J PHYSIOL-CELL PH, V270, pC361, DOI 10.1152/ajpcell.1996.270.1.C361	49	15	15	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 4	2014	9	9							e106345	10.1371/journal.pone.0106345	http://dx.doi.org/10.1371/journal.pone.0106345			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3XV	25187951	Green Submitted, Green Published, gold			2022-12-27	WOS:000341271500029
J	Yang, JL; Zhang, T; Wan, XF				Yang, Jialiang; Zhang, Tong; Wan, Xiu-Feng			Sequence-Based Antigenic Change Prediction by a Sparse Learning Method Incorporating Co-Evolutionary Information	PLOS ONE			English	Article							INFLUENZA; SUBSTITUTIONS; REGRESSION; VARIANTS; RESIDUES	Rapid identification of influenza antigenic variants will be critical in selecting optimal vaccine candidates and thus a key to developing an effective vaccination program. Recent studies suggest that multiple simultaneous mutations at antigenic sites accumulatively enhance antigenic drift of influenza A viruses. However, pre-existing methods on antigenic variant identification are based on analyses from individual sites. Because the impacts of these co-evolved sites on influenza antigenicity may not be additive, it will be critical to quantify the impact of not only those single mutations but also multiple simultaneous mutations or co-evolved sites. Here, we developed and applied a computational method, AntigenCO, to identify and quantify both single and co-evolutionary sites driving the historical antigenic drifts. AntigenCO achieved an accuracy of up to 90.05% for antigenic variant prediction, significantly outperforming methods based on single sites. AntigenCO can be useful in antigenic variant identification in influenza surveillance.	[Yang, Jialiang; Wan, Xiu-Feng] Mississippi State Univ, Coll Vet Med, Dept Basic Sci, Starkville, MS 39759 USA; [Zhang, Tong] Rutgers State Univ, Dept Stat, Piscataway, NJ USA	Mississippi State University; Rutgers State University New Brunswick	Wan, XF (corresponding author), Mississippi State Univ, Coll Vet Med, Dept Basic Sci, Starkville, MS 39759 USA.	wan@cvm.msstate.edu		Yang, Jialiang/0000-0003-4689-8672	National Institutes of Health National Institute of Allergy and Infectious Diseases [RC1AI086830, P20GM103646]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [RC1AI086830] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103646] Funding Source: NIH RePORTER	National Institutes of Health National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Funding provided by National Institutes of Health National Institute of Allergy and Infectious Diseases RC1AI086830 and P20GM103646. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barnett JL, 2012, BIOINFORMATICS, V28, P1292, DOI 10.1093/bioinformatics/bts105; Cai ZP, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000949; Du XJ, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1710; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; HOERL AE, 1970, TECHNOMETRICS, V12, P55, DOI 10.1080/00401706.1970.10488634; Huang JW, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-S1-S41; Koel BF, 2013, SCIENCE, V342, P976, DOI 10.1126/science.1244730; Liao YC, 2008, BIOINFORMATICS, V24, P505, DOI 10.1093/bioinformatics/btm638; Martin LC, 2005, BIOINFORMATICS, V21, P4116, DOI 10.1093/bioinformatics/bti671; Pollock DD, 1999, J MOL BIOL, V287, P187, DOI 10.1006/jmbi.1998.2601; Shih ACC, 2007, P NATL ACAD SCI USA, V104, P6283, DOI 10.1073/pnas.0701396104; Sjostrand K., 2005, MATLAB IMPLEMENTATIO; Smith DJ, 2004, SCIENCE, V305, P371, DOI 10.1126/science.1097211; Sun HL, 2013, MBIO, V4, DOI 10.1128/mBio.00230-13; Tibshirani R, 1996, J ROY STAT SOC B MET, V58, P267, DOI 10.1111/j.2517-6161.1996.tb02080.x	15	14	14	2	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 4	2014	9	9							e106660	10.1371/journal.pone.0106660	http://dx.doi.org/10.1371/journal.pone.0106660			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3XV	25188236	Green Submitted, Green Published, gold			2022-12-27	WOS:000341271500066
J	Yang, JH; Wang, XY; Song, SH; Liu, F; Fu, ZR; Wang, QX				Yang, Jinghui; Wang, Xiaoyu; Song, Shaohua; Liu, Fang; Fu, Zhiren; Wang, Quanxing			Near-Term Anti-CD25 Monoclonal Antibody Administration Protects Murine Liver from Ischemia-Reperfusion Injury Due to Reduced Numbers of CD4(+) T Cells	PLOS ONE			English	Article							LYMPHOCYTES; TRANSPLANTATION; BASILIXIMAB; CONTRIBUTE; INDUCTION; INNATE; IMMUNOSUPPRESSION; METAANALYSIS; INSIGHTS; THERAPY	Background: CD4(+) T cell is acknowledged as a key factor in the initiation phase of liver ischemia reperfusion injury. The purpose of current study is to demonstrate the effect of antecedent near-term anti-CD25 monoclonal antibody treatment on IR-induced liver injury by modulation of CD4(+) T cells. Methods: 70% liver warm IR was induced in male C57BL/6 mice after anti-CD25 mAb or non-specific IgG administration. Liver function, histological damage, in vitro Proliferation, FACS, cytokine production, and immunofluorescence were assessed to evaluate the impact of antecedent near-term PC61 treatment on IR-induced liver injury. Results: After 70% liver ischemia, mice preconditioned with PC61 displayed significantly preserved liver function as characterized by less histological damage and reduced serum enzymes level. Mechanistic studies revealed that the protection effect of anti-CD25 mAb was associated with ameliorated intrahepatic inflammatory milieu and reduced CD4(+) T lymphocytes as manifested by the decrease of proinflammatory cytokine production (less expression of TNF-alpha, IFN-gamma, IL-2, and IL-6) and the lower CD4/CD8 proportion. Conclusions: Our results provide first line of evidence indicating that near-term treatment with anti-CD25 monoclonal antibody might provide protection for livers against IR-induced injury by reducing CD4(+) T cells, but not influencing functional Treg population. Therefore, our results demonstrate a potential function of anti-CD25 monoclonal antibody which was neglected in the past, and may be helpful in various clinical conditions, particularly in liver and kidney transplantations.	[Yang, Jinghui; Wang, Xiaoyu; Song, Shaohua; Liu, Fang; Fu, Zhiren] Second Mil Med Univ, Shanghai ChangZheng Hosp, Dept Organ Transplantat, Shanghai, Peoples R China; [Wang, Quanxing] Second Mil Med Univ, Natl Key Lab Med Immunol, Shanghai, Peoples R China	Naval Medical University; Naval Medical University	Fu, ZR (corresponding author), Second Mil Med Univ, Shanghai ChangZheng Hosp, Dept Organ Transplantat, Shanghai, Peoples R China.	zhirenf@sh163.net; wangqx64@hotmail.com	Yang, Jinghui/ABH-5641-2020		National High Technology Research and Development Program 863 [2012AA021001]; National Natural Science Foundation of China [81270550]; Foundation of the Ministry of Health [2012(1274)-MA(121)-6(88)]	National High Technology Research and Development Program 863(National High Technology Research and Development Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Foundation of the Ministry of Health	This work was supported by funds from the National High Technology Research and Development Program 863 (2012AA021001) and the National Natural Science Foundation of China (81270550) and the Foundation of the Ministry of Health (2012(1274)-MA(121)-6(88)). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adu D, 2003, BRIT MED J, V326, P789, DOI 10.1136/bmj.326.7393.789; Benghiat FS, 2005, TRANSPLANTATION, V79, P648, DOI 10.1097/01.TP.0000155179.61445.78; Brea D, 2014, J CELL MOL MED; Burne MJ, 2001, J CLIN INVEST, V108, P1283, DOI 10.1172/JCI200112080; Burne-Taney MJ, 2006, J IMMUNOL, V176, P7015, DOI 10.4049/jimmunol.176.11.7015; Casey KA, 2012, J IMMUNOL, V188, P4866, DOI 10.4049/jimmunol.1200402; Datta G, 2013, WORLD J GASTROENTERO, V19, P1683, DOI 10.3748/wjg.v19.i11.1683; de Perrot M, 2003, J IMMUNOL, V171, P4995, DOI 10.4049/jimmunol.171.10.4995; de Sandes-Freitas TV, 2013, INT UROL NEPHROL, V45, P537, DOI 10.1007/s11255-012-0298-6; Devey LR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049647; Dostert C, 2013, CURR OPIN IMMUNOL, V25, P359, DOI 10.1016/j.coi.2013.02.008; Fondevilla C, 2003, EXP MOL PATHOL, V74, P86, DOI 10.1016/S0014-4800(03)00008-X; Friedewald JJ, 2004, KIDNEY INT, V66, P486, DOI 10.1111/j.1523-1755.2004.761_3.x; Gandolfo MT, 2007, KIDNEY INT, V71, P1193, DOI 10.1038/sj.ki.5002285; Hardinger KL, 2012, TRANSPL INT; Horie Y, 1999, MICROCIRCULATION, V6, P267; Huang P, 2013, EXP EYE RES, V115, P131, DOI 10.1016/j.exer.2013.06.015; Huang YF, 2007, CELL IMMUNOL, V248, P4, DOI 10.1016/j.cellimm.2007.03.009; Johnston JA, 1996, J LEUKOCYTE BIOL, V60, P441, DOI 10.1002/jlb.60.4.441; Khandoga A, 2006, HEPATOLOGY, V43, P306, DOI 10.1002/hep.21017; Kim MG, 2013, J AM SOC NEPHROL, V24, P1529, DOI 10.1681/ASN.2012080784; Kinsey GR, 2009, J AM SOC NEPHROL, V20, P1744, DOI 10.1681/ASN.2008111160; Leite-De-Moraes MC, 1999, J IMMUNOL, V163, P5871; Li PY, 2013, STROKE, V44, P3509, DOI 10.1161/STROKEAHA.113.002637; Martin-Mateos RM, 2012, TRANSPL P, V44, P2570, DOI 10.1016/j.transproceed.2012.09.109; Meier-Kriesche HU, 2004, AM J TRANSPLANT, V4, P378, DOI 10.1111/j.1600-6143.2004.00332.x; Outerelo C, 2013, TRANSPL P, V45, P1076, DOI 10.1016/j.transproceed.2013.03.010; Rabb H, 2002, KIDNEY INT, V61, P1935, DOI 10.1046/j.1523-1755.2002.00378.x; Rochman Y, 2009, NAT REV IMMUNOL, V9, P480, DOI 10.1038/nri2580; Tanaka T, 2012, ANNU REV PHARMACOL, V52, P199, DOI 10.1146/annurev-pharmtox-010611-134715; Turner AP, 2013, TRANSPL INT, V26, P673, DOI 10.1111/tri.12100; van Golen RF, 2012, CYTOKINE GROWTH F R, V23, P69, DOI 10.1016/j.cytogfr.2012.04.006; Van Meirvenne S, 2005, MOL THER, V12, P922, DOI 10.1016/j.ymthe.2005.02.029; Webster AC, 2004, TRANSPLANTATION, V77, P166, DOI 10.1097/01.TP.0000109643.32659.C4; Yang XK, 2013, J SURG RES, V184, P832, DOI 10.1016/j.jss.2013.05.014; Zwacka RM, 1997, J CLIN INVEST, V100, P279, DOI 10.1172/JCI119533	36	7	7	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 4	2014	9	9							e106892	10.1371/journal.pone.0106892	http://dx.doi.org/10.1371/journal.pone.0106892			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3XV	25188007	Green Published, gold, Green Submitted			2022-12-27	WOS:000341271500093
J	Chan, WK; Sthaneshwar, P; Mustapha, NRN; Mahadeva, S				Chan, Wah-Kheong; Sthaneshwar, Pavai; Mustapha, Nik Raihan Nik; Mahadeva, Sanjiv			Limited Utility of Plasma M30 in Discriminating Non-Alcoholic Steatohepatitis from Steatosis - A Comparison with Routine Biochemical Markers	PLOS ONE			English	Article							FATTY LIVER-DISEASE; BIOMARKER PANEL; APOPTOSIS; CYTOKERATIN-18; FIBROSIS; NASH	Introduction: The utility of Cytokeratin-18 fragment, namely CK18Asp396 (M30), for the diagnosis of non-alcoholic steatohepatitis (NASH) is currently uncertain. We aimed to provide further data in this area among multi-ethnic Asian subjects with NAFLD. Materials and Methods: The accuracy of M30 for detecting NASH was compared with serum alanine aminotransferase (ALT), aspartate aminotransferase (AST) and gamma glutamyl transpeptidase (GGT) levels in consecutive adult subjects with biopsy-proven non-alcoholic fatty liver disease (NAFLD). Results: Data for 93 NAFLD subjects (mean age 51.0 +/- 11.1 years old and 51.6% males) and 20 healthy controls (mean age 50.2 +/- 16.4 years old and 33.3% males) were analyzed. There were 39 NASH subjects (41.9%) and 54 non-NASH subjects (58.1%) among the NAFLD subjects. Plasma M30 (349 U/L vs. 162 U/L), and serum ALT (70 IU/L vs. 26 IU/L), AST (41 IU/L vs. 20 IU/L) and GGT (75 IU/L vs. 33 IU/L) were significantly higher in NAFLD subjects than in healthy controls. Serum ALT (86 IU/L vs. 61 IU/L), AST (58 IU/L vs. 34 IU/L) and GGT (97 IU/L vs. 56 IU/L) were significantly higher in NASH subjects compared to non-NASH subjects, but no significant difference was observed with plasma M30 (435 U/L vs. 331 U/L). The accuracy of plasma M30, and serum ALT, AST and GGT was good for predicting NAFLD (AUROC 0.91, 0.95, 0.87 and 0.85, respectively) but less so for NASH (AUROC 0.59, 0.64, 0.75 and 0.68, respectively). Serum ALT and AST, but not plasma M30 showed a significant trend with increasing grades of ballooning and lobular inflammation. Conclusion: The utility of M30 in the detection of NASH in clinical practice appears limited, in comparison to routine biochemical markers.	[Chan, Wah-Kheong; Mahadeva, Sanjiv] Univ Malaya, Fac Med, Dept Med, Gastroenterol & Hepatol Unit,Gastrointestinal End, Kuala Lumpur, Malaysia; [Sthaneshwar, Pavai] Univ Malaya, Div Lab Med, Dept Pathol, Fac Med, Kuala Lumpur, Malaysia; [Mustapha, Nik Raihan Nik] Hosp Alor Setar, Dept Pathol, Alor Setar, Kedah, Malaysia	Universiti Malaya; Universiti Malaya	Chan, WK (corresponding author), Univ Malaya, Fac Med, Dept Med, Gastroenterol & Hepatol Unit,Gastrointestinal End, Kuala Lumpur, Malaysia.	wahkheong2003@hotmail.com	Mahadeva, Sanjiv/E-1711-2011; STHANESHWAR, PAVAI/B-9489-2010; Chan, Wah-Kheong/H-2329-2016; Chan, Wah Kheong/AGA-6636-2022	Mahadeva, Sanjiv/0000-0001-5824-0590; STHANESHWAR, PAVAI/0000-0002-7518-4217; Chan, Wah-Kheong/0000-0002-9105-5837; Chan, Wah Kheong/0000-0002-9105-5837	University of Malaya [RG536-13HTM]	University of Malaya(Universiti Malaya)	This study was funded by the University of Malaya Research Grant. Project No.: RG536-13HTM. URL: http://umresearch.um.edu.my/mainpage.php?module=Maklumat&kategori=86&id=62&papar=1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chalasani N, 2012, HEPATOLOGY, V55, P2005, DOI 10.1002/hep.25762; Cusi K, 2014, J HEPATOL, V60, P167, DOI 10.1016/j.jhep.2013.07.042; Diab DL, 2008, CLIN GASTROENTEROL H, V6, P1249, DOI 10.1016/j.cgh.2008.07.016; Ekstedt M, 2006, HEPATOLOGY, V44, P865, DOI 10.1002/hep.21327; Feldstein AE, 2003, GASTROENTEROLOGY, V125, P437, DOI 10.1016/S0016-5085(03)00907-7; Feldstein AE, 2009, HEPATOLOGY, V50, P1072, DOI 10.1002/hep.23050; Kleiner DE, 2005, HEPATOLOGY, V41, P1313, DOI 10.1002/hep.20701; PICCININO F, 1986, J HEPATOL, V2, P165, DOI 10.1016/S0168-8278(86)80075-7; Sanyal AJ, 2006, HEPATOLOGY, V43, P682, DOI 10.1002/hep.21103; Shen J, 2012, ALIMENT PHARM THER, V36, P1057, DOI 10.1111/apt.12091; Shen JY, 2012, J HEPATOL, V56, P1363, DOI 10.1016/j.jhep.2011.12.025; Suzuki A, 2006, LIVER INT, V26, P1209, DOI 10.1111/j.1478-3231.2006.01362.x; Tamimi TIAR, 2011, J HEPATOL, V54, P1224, DOI 10.1016/j.jhep.2010.08.023; Wah-Kheong C, 2013, HEPATOL INT, V7, P65, DOI 10.1007/s12072-012-9384-1; Wieckowska A, 2006, HEPATOLOGY, V44, P27, DOI 10.1002/hep.21223; Yilmaz Y, 2007, WORLD J GASTROENTERO, V13, P837, DOI 10.3748/wjg.v13.i6.837; Yilmaz Y, 2012, CLIN CHIM ACTA, V414, P154, DOI 10.1016/j.cca.2012.08.005; Younossi ZM, 2011, OBES SURG, V21, P431, DOI 10.1007/s11695-010-0204-1	18	18	18	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 3	2014	9	9							e105903	10.1371/journal.pone.0105903	http://dx.doi.org/10.1371/journal.pone.0105903			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3TB	25184298	gold, Green Submitted, Green Published			2022-12-27	WOS:000341257700028
J	Nazemi, S; Rahbek, M; Parhamifar, L; Moghimi, SM; Babamoradi, H; Mehrdana, F; Klaerke, DA; Knight, CH				Nazemi, Sasan; Rahbek, Mette; Parhamifar, Ladan; Moghimi, Seyed Moein; Babamoradi, Hamid; Mehrdana, Foojan; Klaerke, Dan Arne; Knight, Christopher H.			Reciprocity in the Developmental Regulation of Aquaporins 1, 3 and 5 during Pregnancy and Lactation in the Rat	PLOS ONE			English	Article							WATER CHANNELS; MILK SECRETION; EXPRESSION; SUPERAQUAPORINS; EVOLUTION; PROTEIN; GLANDS	Milk secretion involves significant flux of water, driven largely by synthesis of lactose within the Golgi apparatus. It has not been determined whether this flux is simply a passive consequence of the osmotic potential between cytosol and Golgi, or whether it involves regulated flow. Aquaporins (AQPs) are membrane water channels that regulate water flux. AQP1, AQP3 and AQP5 have previously been detected in mammary tissue, but evidence of developmental regulation (altered expression according to the developmental and physiological state of the mammary gland) is lacking and their cellular/subcellular location is not well understood. In this paper we present evidence of developmental regulation of all three of these AQPs. Further, there was evidence of reciprocity since expression of the rather abundant AQP3 and less abundant AQP1 increased significantly from pregnancy into lactation, whereas expression of the least abundant AQP5 decreased. It would be tempting to suggest that AQP3 and AQP1 are involved in the secretion of water into milk. Paradoxically, however, it was AQP5 that demonstrated most evidence of expression located at the apical (secretory) membrane. The possibility is discussed that AQP5 is synthesized during pregnancy as a stable protein that functions to regulate water secretion during lactation. AQP3 was identified primarily at the basal and lateral membranes of the secretory cells, suggesting a possible involvement in regulated uptake of water and glycerol. AQP1 was identified primarily at the capillary and secretory cell cytoplasmic level and may again be more concerned with uptake and hence milk synthesis, rather than secretion. The fact that expression was developmentally regulated supports, but does not prove, a regulatory involvement of AQPs in water flux through the milk secretory cell.	[Nazemi, Sasan; Rahbek, Mette; Klaerke, Dan Arne; Knight, Christopher H.] Univ Copenhagen, Fac Hlth & Med Sci, Dept Vet Clin & Anim Sci IKVH, Copenhagen, Denmark; [Parhamifar, Ladan; Moghimi, Seyed Moein] Univ Copenhagen, Fac Hlth & Med Sci, Dept Pharm, Ctr Pharmaceut Nanotechnol & Nanotoxicol, Copenhagen, Denmark; [Babamoradi, Hamid] Univ Copenhagen, Fac Sci, Dept Food Sci, Spect & Chemometr Sect, Copenhagen, Denmark; [Mehrdana, Foojan] Univ Copenhagen, Fac Hlth & Med Sci, Dept Vet Dis Biol IVS Parasitol & Aquat Dis, Copenhagen, Denmark	University of Copenhagen; University of Copenhagen; University of Copenhagen; University of Copenhagen	Nazemi, S (corresponding author), Univ Copenhagen, Fac Hlth & Med Sci, Dept Vet Clin & Anim Sci IKVH, Copenhagen, Denmark.	sasan.n@gmail.com	Parhamifar, Ladan/C-5145-2016; Babamoradi, Hamid/E-6200-2015	Parhamifar, Ladan/0000-0003-4374-5734; Babamoradi, Hamid/0000-0002-0451-7686; Moghimi, Seyed Moein/0000-0003-0836-926X; Gjerdrum, Lise Mette Rahbek/0000-0003-4377-3209				Benoit JB, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002517; Branes MC, 2005, AM J PHYSIOL-CELL PH, V288, pC1048, DOI 10.1152/ajpcell.00420.2003; Carbrey Jennifer M, 2009, Handb Exp Pharmacol, P3, DOI 10.1007/978-3-540-79885-9_1; Deen PMT, 2002, AM J PHYSIOL-RENAL, V282, pF330, DOI 10.1152/ajprenal.0168.2001; Delporte C, 2006, BBA-BIOMEMBRANES, V1758, P1061, DOI 10.1016/j.bbamem.2006.01.022; Endo M, 1999, MICROVASC RES, V58, P89, DOI 10.1006/mvre.1999.2158; FLEET IR, 1975, J PHYSIOL-LONDON, V251, P763, DOI 10.1113/jphysiol.1975.sp011120; GARTON GA, 1963, J LIPID RES, V4, P237; Gresz V, 2001, AM J PHYSIOL-GASTR L, V281, pG247, DOI 10.1152/ajpgi.2001.281.1.G247; Ishibashi K, 2014, BBA-GEN SUBJECTS, V1840, P1507, DOI 10.1016/j.bbagen.2013.10.039; Ishibashi K, 2009, CLIN EXP NEPHROL, V13, P107, DOI 10.1007/s10157-008-0118-6; Ishikawa Y, 2006, J PHARMACOL SCI, V100, P495, DOI 10.1254/jphs.CRJ06007X; Janosi L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059897; Klein C, 2013, REPROD DOMEST ANIM, V48, P529, DOI 10.1111/rda.12116; Lindsay LA, 2006, REPRODUCTION, V131, P369, DOI 10.1530/rep.1.00914; Maeda N, 2012, MOL ASPECTS MED, V33, P665, DOI 10.1016/j.mam.2012.02.004; Magni F, 2006, PROTEOMICS, V6, P5637, DOI 10.1002/pmic.200600212; Matsuzaki T, 2005, HISTOCHEM CELL BIOL, V123, P501, DOI 10.1007/s00418-005-0753-x; McClellan HL, 2008, NUTR RES REV, V21, P97, DOI 10.1017/S0954422408100749; Mobasheri A, 2014, J MAMMARY GLAND BIOL, V19, P91, DOI 10.1007/s10911-013-9312-6; Mobasheri A, 2011, ACTA HISTOCHEM, V113, P137, DOI 10.1016/j.acthis.2009.09.005; Morishita Y, 2004, J PHARMACOL SCI, V96, P276, DOI 10.1254/jphs.FMJ04004X7; NICHOLAS KR, 1988, BIOCHEM BIOPH RES CO, V154, P529, DOI 10.1016/0006-291X(88)90172-6; Oftedal OT, 2012, ANIMAL, V6, P355, DOI 10.1017/S1751731111001935; Ohashi Y, 2008, CURR EYE RES, V33, P621, DOI 10.1080/02713680802262819; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Sachdeva R, 2014, PROG BIOPHYS MOL BIO, V114, P69, DOI 10.1016/j.pbiomolbio.2014.01.002; Shennan DB, 2000, PHYSIOL REV, V80, P925, DOI 10.1152/physrev.2000.80.3.925; Tian W, 2004, CANCER SCI, V95, P491, DOI 10.1111/j.1349-7006.2004.tb03238.x; Truchet S, 2014, J MAMMARY GLAND BIOL, V19, P119, DOI 10.1007/s10911-013-9311-7	30	6	6	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 3	2014	9	9							e106809	10.1371/journal.pone.0106809	http://dx.doi.org/10.1371/journal.pone.0106809			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3TB	25184686	Green Published, Green Accepted, Green Submitted, gold			2022-12-27	WOS:000341257700120
J	Novinec, M; Lenarcic, B; Baici, A				Novinec, Marko; Lenarcic, Brigita; Baici, Antonio			Probing the Activity Modification Space of the Cysteine Peptidase Cathepsin K with Novel Allosteric Modifiers	PLOS ONE			English	Article							HEPARIN-LIKE GLYCOSAMINOGLYCANS; INHIBITORS; LIBERATOR; SULFATE; COMPLEX	Targeting allosteric sites is gaining increasing recognition as a strategy for modulating the activity of enzymes, especially in drug design. Here we investigate the mechanisms of allosteric regulation of cathepsin K as a representative of cysteine cathepsins and a promising drug target for the treatment of osteoporosis. Eight novel modifiers are identified by computational targeting of predicted allosteric sites on the surface of the enzyme. All act via hyperbolic kinetic mechanisms in presence of low molecular mass substrates, as expected for allosteric effectors. Two compounds have sizable effects on enzyme activity using interstitial collagen as a natural substrate of cathepsin K and four compounds show a significantly stabilizing effect on cathepsin K. The concept of activity modification space is introduced to obtain a global perspective of the effects elicited by the modifiers. Analysis of the activity modification space reveals that the activity of cathepsin K is regulated via multiple, different allosteric mechanisms.	[Novinec, Marko; Lenarcic, Brigita] Univ Ljubljana, Dept Chem & Biochem, Fac Chem & Chem Technol, Ljubljana, Slovenia; [Novinec, Marko; Baici, Antonio] Univ Zurich, Dept Biochem, Zurich, Switzerland; [Lenarcic, Brigita] Jozef Stefan Inst, Dept Biochem & Mol & Struct Biol, Ljubljana, Slovenia	University of Ljubljana; University of Zurich; Slovenian Academy of Sciences & Arts (SASA); Jozef Stefan Institute	Novinec, M (corresponding author), Univ Ljubljana, Dept Chem & Biochem, Fac Chem & Chem Technol, Ljubljana, Slovenia.	marko.novinec@fkkt.uni-lj.si; abaici@bioc.uzh.ch	Novinec, Marko/J-9789-2019	Novinec, Marko/0000-0003-1824-1649; Lenarcic, Brigita/0000-0002-2508-3776; Baici, Antonio/0000-0002-2980-0541	Slovenian Research agency [Z1-4077, P1-0140]; Olga Mayenfisch Foundation; Novartis Foundation	Slovenian Research agency(Slovenian Research Agency - Slovenia); Olga Mayenfisch Foundation; Novartis Foundation(Novartis)	This work was supported by the Slovenian Research agency (grant Z1-4077 to MN), the Slovenian Research Agency - program group P1-0140 (MN and BL), the Olga Mayenfisch Foundation (grant to AB), and the Novartis Foundation (grant to AB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almeida PC, 2001, J BIOL CHEM, V276, P944, DOI 10.1074/jbc.M003820200; Almeida PC, 1999, J BIOL CHEM, V274, P30433, DOI 10.1074/jbc.274.43.30433; BAICI A, 1981, EUR J BIOCHEM, V119, P9, DOI 10.1111/j.1432-1033.1981.tb05570.x; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; BOTTS J, 1953, T FARADAY SOC, V49, P696, DOI 10.1039/tf9534900696; Fenton AW, 2008, TRENDS BIOCHEM SCI, V33, P420, DOI 10.1016/j.tibs.2008.05.009; Halabi N, 2009, CELL, V138, P774, DOI 10.1016/j.cell.2009.07.038; Irwin JJ, 2005, J CHEM INF MODEL, V45, P177, DOI 10.1021/ci049714+; KELETI T, 1967, J THEOR BIOL, V16, P337, DOI 10.1016/0022-5193(67)90060-4; Li ZQ, 2008, J MOL BIOL, V383, P78, DOI 10.1016/j.jmb.2008.07.038; Li ZQ, 2004, J BIOL CHEM, V279, P5470, DOI 10.1074/jbc.M310349200; Li ZQ, 2002, J BIOL CHEM, V277, P28669, DOI 10.1074/jbc.M204004200; Li ZQ, 2000, BIOCHEMISTRY-US, V39, P529, DOI 10.1021/bi992251u; Mannervik B, 2010, FEBS LETT, V584, P2565, DOI 10.1016/j.febslet.2010.04.024; MONOD J, 1965, J MOL BIOL, V12, P88, DOI 10.1016/S0022-2836(65)80285-6; Morris GM, 2009, J COMPUT CHEM, V30, P2785, DOI 10.1002/jcc.21256; Novinec Marko, 2013, Biomol Concepts, V4, P287, DOI 10.1515/bmc-2012-0054; Novinec M, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4287; Novinec M, 2013, BIOL CHEM, V394, P1163, DOI 10.1515/hsz-2013-0134; Novinec M, 2012, FEBS LETT, V586, P1062, DOI 10.1016/j.febslet.2012.03.004; Novinec M, 2012, PROTEIN EXPRES PURIF, V82, P1, DOI 10.1016/j.pep.2011.11.002; Novinec M, 2010, BIOCHEM J, V429, P379, DOI 10.1042/BJ20100337; Nussinov R, 2014, TRENDS PHARMACOL SCI, V35, P256, DOI 10.1016/j.tips.2014.03.006; Nussinov R, 2013, CELL, V153, P293, DOI 10.1016/j.cell.2013.03.034; Palmier MO, 2007, ANAL BIOCHEM, V371, P43, DOI 10.1016/j.ab.2007.07.008; Ringner M, 2008, NAT BIOTECHNOL, V26, P303, DOI 10.1038/nbt0308-303; Tsai CJ, 2008, J MOL BIOL, V378, P1, DOI 10.1016/j.jmb.2008.02.034; Wahlberg E, 2012, NAT BIOTECHNOL, V30, P283, DOI 10.1038/nbt.2121	28	15	15	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 3	2014	9	9							e106642	10.1371/journal.pone.0106642	http://dx.doi.org/10.1371/journal.pone.0106642			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3TB	25184245	gold, Green Submitted, Green Published, Green Accepted			2022-12-27	WOS:000341257700096
J	Chi, XY; Hu, RB; Zhang, XW; Chen, MN; Chen, N; Pan, LJ; Wang, T; Wang, MA; Yang, Z; Wang, QF; Yu, SL				Chi, Xiaoyuan; Hu, Ruibo; Zhang, Xiaowen; Chen, Mingna; Chen, Na; Pan, Lijuan; Wang, Tong; Wang, Mian; Yang, Zhen; Wang, Quanfu; Yu, Shanlin			Cloning and Functional Analysis of Three Diacylglycerol Acyltransferase Genes from Peanut (Arachis hypogaea L.)	PLOS ONE			English	Article							COA-CHOLESTEROL ACYLTRANSFERASE; FATTY-ACID-COMPOSITION; SEED OIL CONTENT; ARABIDOPSIS-THALIANA; TRIACYLGLYCEROL BIOSYNTHESIS; THALASSIOSIRA-PSEUDONANA; OVER-EXPRESSION; ACYL-COENZYME; KEY ENZYME; WAX-ESTER	Diacylglycerol acyltransferase (DGAT) catalyzes the final and only committed acylation step in the synthesis of triacylglycerols. In this study, three novel AhDGATs genes were identified and isolated from peanut. Quantitative realtime RT-PCR analysis indicated that the AhDGAT1-2 transcript was more abundant in roots, seeds, and cotyledons, whereas the transcript abundances of AhDGAT1-1 and AhDGAT3-3 were higher in flowers than in the other tissues examined. During seed development, transcript levels of AhDGAT1-1 remained relatively low during the initial developmental stage but increased gradually during later stages, peaking at 50 days after pegging (DAP). Levels of AhDGAT1-2 transcripts were higher at 10 and 60 DAPs and much lower during other stages, whereas AhDGAT3-3 showed higher expression levels at 20 and 50 DAPs. In addition, AhDGAT transcripts were differentially expressed following exposure to abiotic stresses or abscisic acid. The activity of the three AhDGAT genes was confirmed by heterologous expression in a Saccharomyces cerevisiae TAG-deficient quadruple mutant. The recombinant yeasts restored lipid body formation and TAG biosynthesis, and preferentially incorporated unsaturated C18 fatty acids into lipids. The present study provides significant information useful in modifying the oil deposition of peanut through molecular breeding.	[Chi, Xiaoyuan; Chen, Mingna; Chen, Na; Pan, Lijuan; Wang, Tong; Wang, Mian; Yang, Zhen; Yu, Shanlin] Shandong Peanut Res Inst, Qingdao, Peoples R China; [Chi, Xiaoyuan] Chinese Acad Agr Sci, Oil Crops Res Inst, Key Lab Biol & Genet Improvement Oil Crops, Minist Agr, Wuhan, Peoples R China; [Hu, Ruibo] Chinese Acad Sci, QIBEBT, Qingdao, Peoples R China; [Zhang, Xiaowen] Chinese Acad Fishery Sci, Yellow Sea Fisheries Res Inst, Qingdao, Peoples R China; [Wang, Quanfu] Harbin Inst Technol, Sch Marine & Technol, Weihai, Peoples R China	Chinese Academy of Agricultural Sciences; Oil Crops Research Institute, CAAS; Ministry of Agriculture & Rural Affairs; Chinese Academy of Sciences; Chinese Academy of Fishery Sciences; Yellow Sea Fisheries Research Institute, CAFS; Harbin Institute of Technology	Wang, QF (corresponding author), Harbin Inst Technol, Sch Marine & Technol, Weihai, Peoples R China.	wangquanfu2000@126.com; yshanlin1956@163.com	Hu, Ruibo/P-3471-2018; wang, quan fu/K-9703-2018	Hu, Ruibo/0000-0001-6299-5320; wang, quan fu/0000-0002-3885-5464	China Agriculture Research System [CARS-14]; National Natural Science Foundation of China [31000728, 31100205, 31200211]; Natural Science Fund of Shangdong Province [ZR2009DQ004, ZR2011CQ036, ZR2012CQ031]; Qingdao Municipal Science and Technology Plan Project [11-2-3-26-nsh, 12-1-4-11-(2)-jch]; Fund of Key Laboratory of Biology and Genetic Improvement of Oil Crops, Ministry of Agriculture [2014010]	China Agriculture Research System; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Fund of Shangdong Province; Qingdao Municipal Science and Technology Plan Project; Fund of Key Laboratory of Biology and Genetic Improvement of Oil Crops, Ministry of Agriculture	This study was supported by grants from China Agriculture Research System (CARS-14), the National Natural Science Foundation of China (31000728, 31100205, 31200211), the Natural Science Fund of Shangdong Province (ZR2009DQ004, ZR2011CQ036, ZR2012CQ031), Qingdao Municipal Science and Technology Plan Project (11-2-3-26-nsh, 12-1-4-11-(2)-jch), the Fund of Key Laboratory of Biology and Genetic Improvement of Oil Crops, Ministry of Agriculture (2014010). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrianov V, 2010, PLANT BIOTECHNOL J, V8, P277, DOI 10.1111/j.1467-7652.2009.00458.x; Bouvier-Nave P, 2000, EUR J BIOCHEM, V267, P85, DOI 10.1046/j.1432-1327.2000.00961.x; BROWSE J, 1986, ANAL BIOCHEM, V152, P141, DOI 10.1016/0003-2697(86)90132-6; Burgal J, 2008, PLANT BIOTECHNOL J, V6, P819, DOI 10.1111/j.1467-7652.2008.00361.x; Cases S, 1998, J BIOL CHEM, V273, P26755, DOI 10.1074/jbc.273.41.26755; Cases S, 1998, P NATL ACAD SCI USA, V95, P13018, DOI 10.1073/pnas.95.22.13018; Chen JE, 2012, J BIOTECHNOL, V162, P28, DOI 10.1016/j.jbiotec.2012.05.009; Chen X, 2011, PLANT SIGNAL BEHAV, V6, P1695, DOI 10.4161/psb.6.11.17777; Chi XiaoYuan, 2014, Research on Crops, V15, P141; Chi XY, 2012, MOL GENET GENOMICS, V287, P167, DOI 10.1007/s00438-011-0665-5; Chi XY, 2011, PLANT CELL REP, V30, P1393, DOI 10.1007/s00299-011-1048-4; Cui YL, 2013, J APPL PHYCOL, V25, P1509, DOI 10.1007/s10811-013-9991-9; Daniel J, 2004, J BACTERIOL, V186, P5017, DOI 10.1128/jb.186.15.5017-5030.2004; Durrett TP, 2010, P NATL ACAD SCI USA, V107, P9464, DOI 10.1073/pnas.1001707107; Halford NG, 1998, PLANT MOL BIOL, V37, P735, DOI 10.1023/A:1006024231305; He XH, 2004, LIPIDS, V39, P311, DOI 10.1007/s11745-004-1234-2; Hobbs DH, 1999, FEBS LETT, V452, P145, DOI 10.1016/S0014-5793(99)00646-8; Hofmann K, 2000, TRENDS BIOCHEM SCI, V25, P111, DOI 10.1016/S0968-0004(99)01539-X; Hsieh TH, 2002, PLANT PHYSIOL, V129, P1086, DOI 10.1104/pp.003442; Jako C, 2001, PLANT PHYSIOL, V126, P861, DOI 10.1104/pp.126.2.861; Kalscheuer R, 2003, J BIOL CHEM, V278, P8075, DOI 10.1074/jbc.M210533200; KATAVIC V, 1995, PLANT PHYSIOL, V108, P399, DOI 10.1104/pp.108.1.399; King A, 2007, PLANTA, V226, P381, DOI 10.1007/s00425-007-0489-z; Klein W, 1999, J BACTERIOL, V181, P5341, DOI 10.1128/JB.181.17.5341-5349.1999; Kohlwein SD, 2010, J BIOL CHEM, V285, P15663, DOI 10.1074/jbc.R110.118356; Kroon JTM, 2006, PHYTOCHEMISTRY, V67, P2541, DOI 10.1016/j.phytochem.2006.09.020; Lardizabal K, 2008, PLANT PHYSIOL, V148, P89, DOI 10.1104/pp.108.123042; Lewin TM, 1999, BIOCHEMISTRY-US, V38, P5764, DOI 10.1021/bi982805d; Li F, 2008, PLANT PHYSIOL, V148, P97, DOI 10.1104/pp.108.123471; Li RZ, 2010, LIPIDS, V45, P145, DOI 10.1007/s11745-010-3385-4; Li RZ, 2010, PLANT BIOTECHNOL J, V8, P184, DOI 10.1111/j.1467-7652.2009.00476.x; Hernandez ML, 2012, PLANT PHYSIOL, V160, P215, DOI 10.1104/pp.112.201541; McCartney AW, 2004, PLANT J, V37, P156, DOI 10.1111/j.1365-313X.2004.01949.x; MOORE KM, 1989, J HERED, V80, P252, DOI 10.1093/oxfordjournals.jhered.a110845; Mou SL, 2012, J APPL PHYCOL, V24, P1169, DOI 10.1007/s10811-011-9746-4; MURATA N, 1995, BIOCHEM J, V308, P1; Niu YF, 2013, MAR DRUGS, V11, P4558, DOI 10.3390/md11114558; Nykiforuk CL, 2002, BBA-MOL CELL BIOL L, V1580, P95, DOI 10.1016/S1388-1981(01)00200-1; Oelkers P, 1998, J BIOL CHEM, V273, P26765, DOI 10.1074/jbc.273.41.26765; OHLROGGE J, 1995, PLANT CELL, V7, P957, DOI 10.1105/tpc.7.7.957; Peng ZY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061363; Saha S, 2006, PLANT PHYSIOL, V141, P1533, DOI 10.1104/pp.106.082198; Sakamoto T, 1998, ARCH MICROBIOL, V169, P20; Sandager L, 2002, J BIOL CHEM, V277, P6478, DOI 10.1074/jbc.M109109200; Sandager L, 2000, BIOCHEM SOC T, V28, P700; Sanjaya, 2013, PLANT CELL, V25, P677, DOI 10.1105/tpc.112.104752; Shockey JM, 2006, PLANT CELL, V18, P2294, DOI 10.1105/tpc.106.043695; Szalontai B, 2000, BBA-BIOMEMBRANES, V1509, P409, DOI 10.1016/S0005-2736(00)00323-0; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Taylor DC, 2009, BOTANY, V87, P533, DOI 10.1139/B08-101; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Turchetto-Zolet AC, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-263; Wagner M, 2010, PLANT PHYSIOL BIOCH, V48, P407, DOI 10.1016/j.plaphy.2010.03.008; Wang HW, 2006, THEOR APPL GENET, V112, P1086, DOI 10.1007/s00122-006-0210-9; Xu JY, 2008, PLANT BIOTECHNOL J, V6, P799, DOI 10.1111/j.1467-7652.2008.00358.x; Xu JY, 2013, FEBS J, V280, P6162, DOI 10.1111/febs.12537; Xu JY, 2009, BOTANY, V87, P544, DOI 10.1139/B08-145; Yamada K, 2003, SCIENCE, V302, P842, DOI 10.1126/science.1088305; Zhang FY, 2005, PLANT SCI, V169, P689, DOI 10.1016/j.plantsci.2005.05.019; Zhang M, 2009, PLANT CELL, V21, P3885, DOI 10.1105/tpc.109.071795; Zhu JH, 2007, CURR OPIN PLANT BIOL, V10, P290, DOI 10.1016/j.pbi.2007.04.010; Zou JT, 1999, PLANT J, V19, P645, DOI 10.1046/j.1365-313x.1999.00555.x	62	28	36	0	56	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2014	9	9							e105834	10.1371/journal.pone.0105834	http://dx.doi.org/10.1371/journal.pone.0105834			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3LR	25181516	Green Published, Green Submitted, gold			2022-12-27	WOS:000341231500037
J	D'Souza, DV; Jonckers, E; Bruns, A; Kunnecke, B; von Kienlin, M; Van der Linden, A; Mueggler, T; Verhoye, M				D'Souza, Dany V.; Jonckers, Elisabeth; Bruns, Andreas; Kuennecke, Basil; von Kienlin, Markus; Van der Linden, Annemie; Mueggler, Thomas; Verhoye, Marleen			Preserved Modular Network Organization in the Sedated Rat Brain	PLOS ONE			English	Article							STATE FUNCTIONAL CONNECTIVITY; RESTING-STATE; DEFAULT-MODE; SPONTANEOUS FLUCTUATIONS; ANESTHESIA; CORRELATE; SIGNALS; CORTEX; FMRI	Translation of resting-state functional connectivity (FC) magnetic resonance imaging (rs-fMRI) applications from human to rodents has experienced growing interest, and bears a great potential in pre-clinical imaging as it enables assessing non-invasively the topological organization of complex FC networks (FCNs) in rodent models under normal and various pathophysiological conditions. However, to date, little is known about the organizational architecture of FCNs in rodents in a mentally healthy state, although an understanding of the same is of paramount importance before investigating networks under compromised states. In this study, we characterized the properties of resting-state FCN in an extensive number of Sprague-Dawley rats (n = 40) under medetomidine sedation by evaluating its modular organization and centrality of brain regions and tested for reproducibility. Fully-connected large-scale complex networks of positively and negatively weighted connections were constructed based on Pearson partial correlation analysis between the time courses of 36 brain regions encompassing almost the entire brain. Applying recently proposed complex network analysis measures, we show that the rat FCN exhibits a modular architecture, comprising six modules with a high between subject reproducibility. In addition, we identified network hubs with strong connections to diverse brain regions. Overall our results obtained under a straight medetomidine protocol show for the first time that the community structure of the rat brain is preserved under pharmacologically induced sedation with a network modularity contrasting from the one reported for deep anesthesia but closely resembles the organization described for the rat in conscious state.	[D'Souza, Dany V.; Bruns, Andreas; Kuennecke, Basil; von Kienlin, Markus; Mueggler, Thomas] F Hoffmann La Roche & Co Ltd, Neurosci Discovery, CH-4002 Basel, Switzerland; [Jonckers, Elisabeth; Van der Linden, Annemie; Verhoye, Marleen] Univ Antwerp, Bio Imaging Lab, B-2020 Antwerp, Belgium	Roche Holding; University of Antwerp	Jonckers, E (corresponding author), Univ Antwerp, Bio Imaging Lab, B-2020 Antwerp, Belgium.	elisabeth.jonckers@uantwerpen.be	Bruns, Andreas/B-7330-2015; Van der Linden, Annemie/L-7855-2017; Mueggler, Thomas/AAC-7998-2020	Bruns, Andreas/0000-0001-6965-641X; Van der Linden, Annemie/0000-0003-2941-6520; Verhoye, Marleen/0000-0002-6267-0611; von Kienlin, Markus/0000-0002-7972-3003	Roche Postdoctoral Fellowship (RPF), Switzerland	Roche Postdoctoral Fellowship (RPF), Switzerland	This work was funded by the Roche Postdoctoral Fellowship (RPF), Switzerland. The funder provided support in the form of salaries for authors DVD, AB, BK, MvK and TM, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Achard S, 2007, PLOS COMPUT BIOL, V3, P174, DOI 10.1371/journal.pcbi.0030017; Anderson JS, 2011, CEREB CORTEX, V21, P1134, DOI 10.1093/cercor/bhq190; Anderson JS, 2011, HUM BRAIN MAPP, V32, P919, DOI 10.1002/hbm.21079; Becerra L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025701; Bifone A, 2010, MAGN RESON IMAGING, V28, P1200, DOI 10.1016/j.mri.2010.07.001; BISWAL B, 1995, MAGNET RESON MED, V34, P537, DOI 10.1002/mrm.1910340409; Bullmore ET, 2009, NAT REV NEUROSCI, V10, P186, DOI 10.1038/nrn2575; Chang C, 2009, NEUROIMAGE, V47, P1381, DOI 10.1016/j.neuroimage.2009.04.048; Chhatwal JP, 2013, NEUROLOGY, V81, P736, DOI 10.1212/WNL.0b013e3182a1aafe; De Groof G, 2013, BEHAV BRAIN RES, V239, P43, DOI 10.1016/j.bbr.2012.10.044; Fox MD, 2007, NAT REV NEUROSCI, V8, P700, DOI 10.1038/nrn2201; Fox MD, 2006, P NATL ACAD SCI USA, V103, P10046, DOI 10.1073/pnas.0604187103; Greicius MD, 2004, P NATL ACAD SCI USA, V101, P4637, DOI 10.1073/pnas.0308627101; Greicius MD, 2003, P NATL ACAD SCI USA, V100, P253, DOI 10.1073/pnas.0135058100; Hampson M, 2002, HUM BRAIN MAPP, V15, P247, DOI 10.1002/hbm.10022; HENNIG J, 1986, MAGNET RESON MED, V3, P823, DOI 10.1002/mrm.1910030602; Hutchison RM, 2010, J NEUROPHYSIOL, V103, P3398, DOI 10.1152/jn.00141.2010; Jiang TZ, 2004, HUM BRAIN MAPP, V22, P63, DOI 10.1002/hbm.20012; Jonckers E, 2014, MAGN RESON MED, V72, P1103, DOI 10.1002/mrm.24990; Jonckers E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018876; Kalthoff D, 2013, NMR BIOMED, V26, P638, DOI 10.1002/nbm.2908; Kalthoff D, 2011, NEUROIMAGE, V54, P2828, DOI 10.1016/j.neuroimage.2010.10.053; Kannurpatti SS, 2008, NEUROIMAGE, V40, P1738, DOI 10.1016/j.neuroimage.2007.05.061; Keilholz S, 2012, BRAIN CONNECT; Liang ZF, 2012, J NEUROSCI, V32, P10183, DOI 10.1523/JNEUROSCI.1020-12.2012; Liang ZF, 2012, NEUROIMAGE, V59, P1190, DOI 10.1016/j.neuroimage.2011.08.009; Liang ZF, 2011, J NEUROSCI, V31, P3776, DOI 10.1523/JNEUROSCI.4557-10.2011; Liu WC, 2008, BRAIN RES, V1223, P42, DOI 10.1016/j.brainres.2008.05.054; Lu H, 2007, P NATL ACAD SCI USA, V104, P18265, DOI 10.1073/pnas.0705791104; Lu HB, 2012, P NATL ACAD SCI USA, V109, P3979, DOI [10.1073/pnas.1101934108, 10.1073/pnas.1200506109]; Majeed W, 2009, J MAGN RESON IMAGING, V30, P384, DOI 10.1002/jmri.21848; Mishra AM, 2013, EPILEPSIA, V54, P1214, DOI 10.1111/epi.12227; Nakamura T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008220; Nallasamy N, 2011, NEUROSCIENTIST, V17, P94, DOI 10.1177/1073858410374126; Nasrallah FA, 2012, NEUROIMAGE, V60, P436, DOI 10.1016/j.neuroimage.2011.12.026; Nelson LE, 2003, ANESTHESIOLOGY, V98, P428, DOI 10.1097/00000542-200302000-00024; Orliac F, 2013, SCHIZOPHR RES; Pan WJ, 2011, BRAIN CONNECT, V1, P119, DOI 10.1089/brain.2011.0014; Pawela CP, 2008, MAGN RESON MED, V59, P1021, DOI 10.1002/mrm.21524; Pawela CP, 2010, NEUROIMAGE, V49, P2467, DOI 10.1016/j.neuroimage.2009.09.054; Pawela CP, 2009, NEUROIMAGE, V46, P1137, DOI 10.1016/j.neuroimage.2009.03.004; Raichle ME, 2001, P NATL ACAD SCI USA, V98, P676, DOI 10.1073/pnas.98.2.676; Rubinov M, 2011, NEUROIMAGE, V56, P2068, DOI 10.1016/j.neuroimage.2011.03.069; Sakoglu U, 2011, BIOCHEM PHARMACOL, V81, P1374, DOI 10.1016/j.bcp.2010.12.029; Schwarz AJ, 2013, BRAIN CONNECT, V3, P503, DOI 10.1089/brain.2013.0168; Schwarz AJ, 2009, NEUROIMAGE, V47, P302, DOI 10.1016/j.neuroimage.2009.03.064; Seminowicz DA, 2012, J NEUROSCI, V32, P15843, DOI 10.1523/JNEUROSCI.2927-12.2012; Shah D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084241; Shim WH, 2013, J NEUROPHYSIOL, V109, P238, DOI 10.1152/jn.00332.2012; Stam Cornelis J, 2007, Nonlinear Biomed Phys, V1, P3, DOI 10.1186/1753-4631-1-3; Supekar K, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000100; van den Heuvel MP, 2008, NEUROIMAGE, V43, P528, DOI 10.1016/j.neuroimage.2008.08.010; van den Heuvel MP, 2013, TRENDS COGN SCI, V17, P683, DOI 10.1016/j.tics.2013.09.012; van den Heuvel MP, 2010, EUR NEUROPSYCHOPHARM, V20, P519, DOI 10.1016/j.euroneuro.2010.03.008; van Meer MPA, 2012, J NEUROSCI, V32, P4495, DOI 10.1523/JNEUROSCI.3662-11.2012; van Zijl P. C., 2013, SCHIZOPHR B; Wang JH, 2010, FRONT SYST NEUROSCI, V4, DOI 10.3389/fnsys.2010.00016; Watson C, 2006, RAT BRAIN STEREOTAXI; Williams KA, 2010, MAGN RESON IMAGING, V28, P995, DOI 10.1016/j.mri.2010.03.007; Yu QB, 2011, FRONT SYST NEUROSCI, V5, DOI [10.3389/fnsys.2011.00007, 10.3389/fnsys.2011.00103]; Zhao FQ, 2008, NEUROIMAGE, V39, P248, DOI 10.1016/j.neuroimage.2007.07.063	61	25	25	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2014	9	9							e106156	10.1371/journal.pone.0106156	http://dx.doi.org/10.1371/journal.pone.0106156			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3LR	25181007	Green Submitted, Green Published, gold			2022-12-27	WOS:000341231500053
J	Sugimoto, T; Shinozaki, T; Naruse, T; Miyamoto, Y				Sugimoto, Takashi; Shinozaki, Tomohiro; Naruse, Takashi; Miyamoto, Yuki			Who Was Concerned about Radiation, Food Safety, and Natural Disasters after the Great East Japan Earthquake and Fukushima Catastrophe? A Nationwide Cross-Sectional Survey in 2012	PLOS ONE			English	Article							NUCLEAR-POWER-PLANT; PSYCHOLOGICAL DISTRESS; ACCIDENT; DETERMINANTS; DEPRESSION; PREVALENCE; EXPOSURE	Background: Disaster-related concerns by sub-populations have not been clarified after the great East Japan earthquake and the Fukushima nuclear power plant incidents. This paper assesses who was concerned about radiation, food safety, and natural disasters among the general population in order to buffer such concerns effectively. Methods: The hypothesis that women, parents, and family caregivers were most concerned about radiation, food safety, and natural disaster was tested using a varying-intercept multivariable logistic regression with 5809 responses from a nationwide cross-sectional survey random-sampled in March 2012. Results: Many people were at least occasionally concerned about radiation (53.5%), food safety (47.3%), and about natural disaster (69.5%). Women were more concerned than men about radiation (OR = 1.67; 95% CI = 1.35-2.06), food safety (1.70; 1.38-2.10), and natural disasters (1.74; 1.39-2.19). Parents and family care needs were not significant. Married couples were more concerned about radiation (1.53; 1.33-1.77), food safety (1.38; 1.20-1.59), and natural disasters (1.30; 1.12-1.52). Age, child-cohabitation, college-completion, retirement status, homemaker status, and the house-damage certificate of the last disaster were also associated with at least one concern. Participants from the Kanto region were more concerned about radiation (2.08; 1.58-2.74) and food safety (1.30; 1.07-1.59), which demonstrate similar positive associations to participants from Tohoku where a disaster relief act was invoked (3.36; 2.25-5.01 about radiation, 1.49; 1.08-2.06 about food safety). Conclusions: Sectioning the populations by gender and other demographics will clarify prospective targets for interventions, allow for a better understanding of post-disaster concerns, and help communicate relevant information effectively.	[Sugimoto, Takashi] Univ Tokyo, Grad Sch Publ Policy, Dept Hlth Technol Assessment & Publ Policy, Tokyo, Japan; [Shinozaki, Tomohiro] Univ Tokyo, Grad Sch Med, Dept Biostat, Tokyo, Japan; [Naruse, Takashi] Univ Tokyo, Grad Sch Med, Dept Community Hlth Nursing, Tokyo, Japan; [Miyamoto, Yuki] Univ Tokyo, Grad Sch Med, Dept Psychiat Nursing, Tokyo, Japan	University of Tokyo; University of Tokyo; University of Tokyo; University of Tokyo	Sugimoto, T (corresponding author), Univ Tokyo, Grad Sch Publ Policy, Dept Hlth Technol Assessment & Publ Policy, Tokyo, Japan.	t-sugimoto@pp.u-tokyo.ac.jp	Miyamoto, Yuki/J-3732-2019; Naruse, Takashi/AAI-8322-2020	Miyamoto, Yuki/0000-0002-2192-0469; SUGIMOTO, TAKASHI/0000-0002-0911-4157; Shinozaki, Tomohiro/0000-0003-3395-9691				A Research Unit, 2012, COMP SURV QUAL LIF O; Bromet EJ, 2011, CLIN ONCOL-UK, V23, P297, DOI 10.1016/j.clon.2011.01.501; Bromet EJ, 2002, ENVIRON HEALTH PERSP, V110, P625, DOI 10.1289/ehp.02110s4625; Chiu S, 2010, J AFFECT DISORDERS, V121, P212, DOI 10.1016/j.jad.2009.05.028; Douglas B., 2014, LME4 LINEAR MIXED EF; Editorial, 2013, NUCL ERROR JAPAN SHO; Fujii S., 2007, Kobe Journal of Medical Sciences, V53, P375; Gelman A., 2007, DATA ANAL USING REGR; Gelman A., 2013, ARM DATA ANAL USING; Goodwin R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037690; Haworth Abigail, 2013, GUARDIAN; Hongo Jun, 2013, JAPAN TIMES; Kuwabara H, 2008, PSYCHIAT CLIN NEUROS, V62, P503, DOI 10.1111/j.1440-1819.2008.01842.x; Matsuda N, 2013, RADIAT RES, V179, P663, DOI 10.1667/RR3232.1; Matsuoka Y, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-249; Mcneill D, 2013, INDEPENDENT; Ministry of Health Labour and Welfare Japan, 2012, RESP GREAT E JAP EAR; Naoi Yutaka, 2013, Am J Disaster Med, V8, P87, DOI 10.5055/ajdm.2013.0114; Nomura S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060192; Norris CM, 2006, J CLIN EPIDEMIOL, V59, P448, DOI 10.1016/j.jclinepi.2005.09.007; Orita M, 2013, RADIAT PROT DOSIM, V156, P383, DOI 10.1093/rpd/nct082; Qu ZY, 2014, J NERV MENT DIS, V202, P275, DOI 10.1097/NMD.0000000000000118; R Core Team, 2013, R LANG ENV STAT COMP; Rubin GJ, 2012, BRIT J PSYCHIAT, V201, P400, DOI 10.1192/bjp.bp.112.111575; Shibuya K, 2014, LANCET, V383, P1883, DOI 10.1016/S0140-6736(14)60909-0; Shindo M, 2012, PSYCHIAT CLIN NEUROS, V66, P454, DOI 10.1111/j.1440-1819.2012.02366.x; Su YS, 2011, J STAT SOFTW, V45, P1; Sugimoto A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065331; Sugimoto Amina, 2014, ENV HLTH PERSPECT; Sugimoto T, 2013, INTERACT J MED RES, V2, P46, DOI 10.2196/ijmr.2585; Thomas W, 2013, VGAM VECTOR GEN LINE; Tsubokura M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100302; Uchida T, 2013, NATURE	33	15	15	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2014	9	9							e106377	10.1371/journal.pone.0106377	http://dx.doi.org/10.1371/journal.pone.0106377			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3LR	25181292	Green Submitted, gold, Green Published			2022-12-27	WOS:000341231500084
J	Sun, ZF; Zhang, YH; Guo, JF; Sun, QY; Mei, JP; Zhou, HL; Guan, LP; Tian, JY; Hu, ZM; Li, JD; Xia, K; Yan, XX; Tang, BS				Sun, Zhan-fang; Zhang, Yu-han; Guo, Ji-feng; Sun, Qi-ying; Mei, Jun-pu; Zhou, Han-lin; Guan, Li-ping; Tian, Jin-yong; Hu, Zheng-mao; Li, Jia-da; Xia, Kun; Yan, Xin-xiang; Tang, Bei-sha			Genetic Diagnosis of Two Dopa-Responsive Dystonia Families by Exome Sequencing	PLOS ONE			English	Article							CLINICAL CHARACTERISTICS; DIURNAL FLUCTUATION; PARKINSONS-DISEASE; POINT MUTATION; DEFICIENCY	Dopa-responsive dystonia, a rare disorder typically presenting in early childhood with lower limb dystonia and gait abnormality, responds well to levodopa. However, it is often misdiagnosed with the wide spectrum of phenotypes. By exome sequencing, we make a rapid genetic diagnosis for two atypical dopa-responsive dystonia pedigrees. One pedigree, presented with prominent parkinsonism, was misdiagnosed as Parkinson's disease until a known mutation in GCH1 (GTP cyclohydrolase 1) gene (NM_000161.2: c.631_632delAT, p.Met211ValfsX38) was found. The other pedigree was detected with a new compound heterozygous mutation in TH (tyrosine hydroxylase) gene [(NM_000360.3: c.911C>T, p.Ala304Val) and (NM_000360.3: c.1358G>A, p.Arg453His)], whose proband, a pregnant woman, required a rapid and less-biased genetic diagnosis. In conclusion, we demonstrated that exome sequencing could provide a precise and rapid genetic testing in the diagnosis of Mendelian diseases, especially for diseases with wide phenotypes.	[Sun, Zhan-fang; Zhang, Yu-han; Guo, Ji-feng; Sun, Qi-ying; Tian, Jin-yong; Yan, Xin-xiang; Tang, Bei-sha] Cent S Univ, Xiangya Hosp, Dept Neurol, Changsha, Hunan, Peoples R China; [Guo, Ji-feng; Yan, Xin-xiang; Tang, Bei-sha] Cent S Univ, Key Lab Hunan Prov Neurodegenerat Disorders, Changsha, Hunan, Peoples R China; [Hu, Zheng-mao; Li, Jia-da; Xia, Kun; Tang, Bei-sha] Cent S Univ, State Key Lab Med Genet, Changsha, Hunan, Peoples R China; [Mei, Jun-pu; Zhou, Han-lin; Guan, Li-ping] BGI Shenzhen, Shenzhen, Peoples R China	Central South University; Central South University; Central South University; Beijing Genomics Institute (BGI)	Tang, BS (corresponding author), Cent S Univ, Xiangya Hosp, Dept Neurol, Changsha, Hunan, Peoples R China.	bstang7398@163.com	XIA, KUN/AAO-3525-2020	Li, Jia-Da/0000-0002-4236-3518	Major State Basic Research Development Program of China (973 Program) [2011CB510000]; State Key Program of National Natural Science Foundation of China [81130021]; public industry research and special projects from National Health and Family Planning Commission of China [201302001]; Graduate Innovation Project in Hunan province	Major State Basic Research Development Program of China (973 Program)(National Basic Research Program of China); State Key Program of National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); public industry research and special projects from National Health and Family Planning Commission of China; Graduate Innovation Project in Hunan province	This study was supported by the Major State Basic Research Development Program of China (973 Program) (grant number 2011CB510000 to Bei-sha Tang), the State Key Program of National Natural Science Foundation of China (grant number 81130021 to Bei-sha Tang), and the public industry research and special projects from National Health and Family Planning Commission of China (grant number 201302001 to Bei-sha Tang), and Graduate Innovation Project in Hunan province (to Zhan-fang Sun). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bonafe L, 2001, AM J HUM GENET, V69, P269, DOI 10.1086/321970; Choi M, 2009, P NATL ACAD SCI USA, V106, P19096, DOI 10.1073/pnas.0910672106; Clot F, 2009, BRAIN, V132, P1753, DOI 10.1093/brain/awp084; Eggers C, 2012, PARKINSONISM RELAT D, V18, P666, DOI 10.1016/j.parkreldis.2011.10.003; Foo JN, 2012, NAT REV NEUROL, V8, P508, DOI 10.1038/nrneurol.2012.148; Furukawa Y, 1998, NEUROLOGY, V50, P1015, DOI 10.1212/WNL.50.4.1015; Furukawa Y, 1999, MOVEMENT DISORD, V14, P709, DOI 10.1002/1531-8257(199909)14:5<709::AID-MDS1001>3.0.CO;2-T; Geyer HL, 2006, LANCET NEUROL, V5, P780, DOI 10.1016/S1474-4422(06)70547-6; Grotzsch H, 2004, NEUROLOGY, V62, P637, DOI 10.1212/01.WNL.0000110192.27794.E8; [桂江 Gui Jiang], 2012, [分析试验室, Chinese Journal of Analysis Laboratory], V31, P29; Hammer MB, 2013, EUR J NEUROL, V20, P486, DOI 10.1111/j.1468-1331.2012.03883.x; Hanihara T, 1997, MOVEMENT DISORD, V12, P408, DOI 10.1002/mds.870120321; HARWOOD G, 1994, J NEUROL NEUROSUR PS, V57, P460, DOI 10.1136/jnnp.57.4.460; Hjermind LE, 2006, MOVEMENT DISORD, V21, P679, DOI 10.1002/mds.20773; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; ICHINOSE H, 1994, NAT GENET, V8, P236, DOI 10.1038/ng1194-236; Khan NL, 2003, BRAIN, V126, P1279, DOI 10.1093/brain/awg142; Ku CS, 2012, EXPERT REV MOL DIAGN, V12, P211, DOI [10.1586/ERM.12.3, 10.1586/erm.12.3]; LUDECKE B, 1995, HUM GENET, V95, P123; Ludecke B, 1996, HUM MOL GENET, V5, P1023, DOI 10.1093/hmg/5.7.1023; Momma K, 2009, PARKINSONISM RELAT D, V15, P160, DOI 10.1016/j.parkreldis.2007.12.010; NYGAARD TG, 1992, ANN NEUROL, V32, P603, DOI 10.1002/ana.410320502; Phukan J, 2011, LANCET NEUROL, V10, P1074, DOI 10.1016/S1474-4422(11)70232-0; Segawa M, 1976, Adv Neurol, V14, P215; Shi Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081884; Sun M, 2006, ARCH NEUROL-CHICAGO, V63, P826, DOI 10.1001/archneur.63.6.826; Tadic V., 2012, ARCH NEUROL-CHICAGO, V17, P1; Tarsy D, 2006, NEW ENGL J MED, V355, P818, DOI 10.1056/NEJMra055549; Trender-Gerhard I, 2009, J NEUROL NEUROSUR PS, V80, P839, DOI 10.1136/jnnp.2008.155861; Wang JL, 2011, BRAIN, V134, P3490, DOI 10.1093/brain/awr289	30	3	6	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2014	9	9							e106388	10.1371/journal.pone.0106388	http://dx.doi.org/10.1371/journal.pone.0106388			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3LR	25181484	Green Published, gold, Green Submitted			2022-12-27	WOS:000341231500086
J	Wisgrill, L; Schuller, S; Bammer, M; Berger, A; Pollak, A; Radke, TF; Kogler, G; Spittler, A; Helmer, H; Husslein, P; Gortner, L				Wisgrill, Lukas; Schueller, Simone; Bammer, Markus; Berger, Angelika; Pollak, Arnold; Radke, Teja Falk; Koegler, Gesine; Spittler, Andreas; Helmer, Hanns; Husslein, Peter; Gortner, Ludwig			Hematopoietic Stem Cells in Neonates: Any Differences between Very Preterm and Term Neonates?	PLOS ONE			English	Article							UMBILICAL-CORD BLOOD; INDUCED LUNG INJURY; PROGENITOR CELLS; REPOPULATING CELLS; CD34(+) CELLS; MARROW; ANGIOGENESIS; PREECLAMPSIA; ASSOCIATION; POPULATION	Background: In the last decades, human full-term cord blood was extensively investigated as a potential source of hematopoietic stem and progenitor cells (HSPCs). Despite the growing interest of regenerative therapies in preterm neonates, only little is known about the biological function of HSPCs from early preterm neonates under different perinatal conditions. Therefore, we investigated the concentration, the clonogenic capacity and the influence of obstetric/perinatal complications and maternal history on HSPC subsets in preterm and term cord blood. Methods: CD34+ HSPC subsets in UCB of 30 preterm and 30 term infants were evaluated by flow cytometry. Clonogenic assays suitable for detection of the proliferative potential of HSPCs were conducted. Furthermore, we analyzed the clonogenic potential of isolated HSPCs according to the stem cell marker CD133 and aldehyde dehydrogenase (ALDH) activity. Results: Preterm cord blood contained a significantly higher concentration of circulating CD34+ HSPCs, especially primitive progenitors, than term cord blood. The clonogenic capacity of HSPCs was enhanced in preterm cord blood. Using univariate analysis, the number and clonogenic potential of circulating UCB HSPCs was influenced by gestational age, birth weight and maternal age. Multivariate analysis showed that main factors that significantly influenced the HSPC count were maternal age, gestational age and white blood cell count. Further, only gestational age significantly influenced the clonogenic potential of UCB HSPCs. Finally, isolated CD34+/CD133+, CD34+/CD133- and ALDH high HSPC obtained from preterm cord blood showed a significantly higher clonogenic potential compared to term cord blood. Conclusion: We demonstrate that preterm cord blood exhibits a higher HSPC concentration and increased clonogenic capacity compared to term neonates. These data may imply an emerging use of HSPCs in autologous stem cell therapy in preterm neonates.	[Wisgrill, Lukas; Schueller, Simone; Bammer, Markus; Berger, Angelika; Pollak, Arnold] Med Univ Vienna, Dept Pediat & Adolescent Med, Div Neonatol Paediat Intens Care & Neuropaediat, Vienna, Austria; [Radke, Teja Falk; Koegler, Gesine] Univ Dusseldorf, Med Ctr, Inst Transplantat Diagnost & Cell Therapeut, Dusseldorf, Germany; [Spittler, Andreas] Med Univ Vienna, Dept Surg, Res Labs, Vienna, Austria; [Spittler, Andreas] Med Univ Vienna, Dept Surg, Core Facil Flow Cytometry, Vienna, Austria; [Helmer, Hanns; Husslein, Peter] Med Univ Vienna, Dept Obstet & Gynecol, Vienna, Austria; [Gortner, Ludwig] Univ Saarland, Dept Pediat & Neonatol, Homburg, Saar, Germany	Medical University of Vienna; Heinrich Heine University Dusseldorf; Medical University of Vienna; Medical University of Vienna; Medical University of Vienna; Saarland University	Gortner, L (corresponding author), Univ Saarland, Dept Pediat & Neonatol, Homburg, Saar, Germany.	Ludwig.Gortner@uniklinikum-saarland.de	Wisgrill, Lukas/V-3682-2019	Schuller, Simone/0000-0003-0344-8786; Wisgrill, Lukas/0000-0001-9833-9499; Berger, Angelika/0000-0001-8775-2405; Spittler, Andreas/0000-0003-2657-6836; Helmer, Hanns/0000-0003-3623-2180; Radke, Teja Falk/0000-0002-1839-156X	University Saarland [HOMFOR2011]	University Saarland	This study was funded by the University Saarland (HOMFOR2011). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Baik I, 2005, CANCER RES, V65, P358; Bailey AS, 2004, BLOOD, V103, P13, DOI 10.1182/blood-2003-05-1684; Ballen KK, 2001, BONE MARROW TRANSPL, V27, P7, DOI 10.1038/sj.bmt.1702729; Bonab MAM, 2004, TRANSFUSION, V44, P690, DOI 10.1111/j.1537-2995.2004.03227.x; Cervera A, 2006, AM J HEMATOL, V81, P397, DOI 10.1002/ajh.20598; Chang YS, 2009, CELL TRANSPLANT, V18, P869, DOI 10.3727/096368909X471189; CLAPP DW, 1989, J LAB CLIN MED, V113, P422; Cotten CM, 2014, J PEDIATR-US, V164, P973, DOI 10.1016/j.jpeds.2013.11.036; Dalous J, 2013, STEM CELLS DEV, V22, P169, DOI 10.1089/scd.2012.0183; de Wynter EA, 1998, STEM CELLS, V16, P387, DOI 10.1002/stem.160387; Donega V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0051253; Eglitis MA, 1997, P NATL ACAD SCI USA, V94, P4080, DOI 10.1073/pnas.94.8.4080; Elkhafif N, 2011, APMIS, V119, P66, DOI 10.1111/j.1600-0463.2010.02693.x; Fenton TR, 2013, BMC PEDIATR, V13, DOI 10.1186/1471-2431-13-59; Franceschini V, 2009, STEM CELLS, V27, P825, DOI 10.1002/stem.11; Gasparoni A, 2000, PEDIATR RES, V47, P825, DOI 10.1203/00006450-200006000-00024; Gluckman E, 2000, EXP HEMATOL, V28, P1197, DOI 10.1016/S0301-472X(00)00540-3; Gortner L, 2012, KLIN PADIATR, V224, P233, DOI 10.1055/s-0032-1316296; Grewal SS, 2003, BLOOD, V101, P4233, DOI 10.1182/blood-2002-08-2510; Handgretinger R, 2013, ADV EXP MED BIOL, V777, P99, DOI 10.1007/978-1-4614-5894-4_7; Hassanein SMA, 2011, J MATERN-FETAL NEO M, V24, P229, DOI 10.3109/14767058.2010.482606; Hess DA, 2004, BLOOD, V104, P1648, DOI 10.1182/blood-2004-02-0448; Horbar JD, 2012, PEDIATRICS, V129, P1019, DOI 10.1542/peds.2011-3028; Ishikawa F, 2003, ANN NY ACAD SCI, V996, P174, DOI 10.1111/j.1749-6632.2003.tb03245.x; Kogler G, 2009, BONE MARROW TRANSPL, V44, P683, DOI 10.1038/bmt.2009.287; Kogler G, 2005, EXP HEMATOL, V33, P573, DOI 10.1016/j.exphem.2005.01.012; Krause DS, 2001, CELL, V105, P369, DOI 10.1016/S0092-8674(01)00328-2; Lim FTH, 2000, AM J OBSTET GYNECOL, V183, P1144, DOI 10.1067/mob.2000.108848; Manegold G, 2008, TRANSFUSION, V48, P871, DOI 10.1111/j.1537-2995.2007.01617.x; McGuckin CP, 2007, EARLY HUM DEV, V83, P733, DOI 10.1016/j.earlhumdev.2007.09.001; Nakajima M, 2009, BIOCHEM BIOPH RES CO, V389, P290, DOI 10.1016/j.bbrc.2009.08.139; Omori A, 2008, TOHOKU J EXP MED, V215, P23, DOI 10.1620/tjem.215.23; Peichev M, 2000, BLOOD, V95, P952, DOI 10.1182/blood.V95.3.952.003k27_952_958; Polin RA, 2012, PEDIATRICS, V129, P1006, DOI 10.1542/peds.2012-0541; Putman DM, 2012, STEM CELLS, V30, P2248, DOI 10.1002/stem.1206; Salven P, 2003, BLOOD, V101, P168, DOI 10.1182/blood-2002-03-0755; Sun J, 2010, TRANSFUSION, V50, P1980, DOI 10.1111/j.1537-2995.2010.02720.x; Surbek DV, 2001, AM J OBSTET GYNECOL, V185, P725, DOI 10.1067/mob.2001.117343; Taguchi A, 2004, J CLIN INVEST, V114, P330, DOI 10.1172/jci200420622; Wahid FSA, 2012, J OBSTET GYNAECOL RE, V38, P490, DOI 10.1111/j.1447-0756.2011.01740.x; Wyrsch A, 1999, EXP HEMATOL, V27, P1338, DOI 10.1016/S0301-472X(99)00059-4; Yin AH, 1997, BLOOD, V90, P5002, DOI 10.1182/blood.V90.12.5002.5002_5002_5012; Zhang XY, 2012, CELL BIOL INT, V36, P589, DOI 10.1042/CBI20110447	43	20	20	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2014	9	9							e106717	10.1371/journal.pone.0106717	http://dx.doi.org/10.1371/journal.pone.0106717			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3LR	25181353	Green Published, Green Submitted, gold			2022-12-27	WOS:000341231500124
J	Holz, E; Lass-Hennemann, J; Streb, M; Pfaltz, M; Michael, T				Holz, Elena; Lass-Hennemann, Johanna; Streb, Markus; Pfaltz, Monique; Michael, Tanja			Effects of Acute Cortisol Administration on Perceptual Priming of Trauma-Related Material	PLOS ONE			English	Article							POSTTRAUMATIC-STRESS-DISORDER; DECLARATIVE MEMORY RETRIEVAL; PSYCHOSOCIAL STRESS; NEUTRAL STIMULI; HAIR CORTISOL; SEPTIC SHOCK; HYDROCORTISONE; CONSOLIDATION; INDIVIDUALS; ACTIVATION	Intrusive memories are a hallmark symptom of posttraumatic stress disorder (PTSD). They reflect excessive and uncontrolled retrieval of the traumatic memory. Acute elevations of cortisol are known to impair the retrieval of already stored memory information. Thus, continuous cortisol administration might help in reducing intrusive memories in PTSD. Strong perceptual priming for neutral stimuli associated with a "traumatic" context has been shown to be one important learning mechanism that leads to intrusive memories. However, the memory modulating effects of cortisol have only been shown for explicit declarative memory processes. Thus, in our double blind, placebo controlled study we aimed to investigate whether cortisol influences perceptual priming of neutral stimuli that appeared in a "traumatic" context. Two groups of healthy volunteers (N = 160) watched either neutral or "traumatic" picture stories on a computer screen. Neutral objects were presented in between the pictures. Memory for these neutral objects was tested after 24 hours with a perceptual priming task and an explicit memory task. Prior to memory testing half of the participants in each group received 25 mg of cortisol, the other half received placebo. In the placebo group participants in the "traumatic" stories condition showed more perceptual priming for the neutral objects than participants in the neutral stories condition, indicating a strong perceptual priming effect for neutral stimuli presented in a "traumatic" context. In the cortisol group this effect was not present: Participants in the neutral stories and participants in the "traumatic" stories condition in the cortisol group showed comparable priming effects for the neutral objects. Our findings show that cortisol inhibits perceptual priming for neutral stimuli that appeared in a "traumatic" context. These findings indicate that cortisol influences PTSD-relevant memory processes and thus further support the idea that administration of cortisol might be an effective treatment strategy in reducing intrusive reexperiencing.	[Holz, Elena; Lass-Hennemann, Johanna; Streb, Markus; Michael, Tanja] Univ Saarland, Div Clin Psychol & Psychotherapy, Dept Psychol, D-66123 Saarbrucken, Germany; [Pfaltz, Monique] Univ Zurich Hosp, Div Psychiat & Psychotherapy, CH-8091 Zurich, Switzerland	Saarland University; University of Zurich; University Zurich Hospital	Michael, T (corresponding author), Univ Saarland, Div Clin Psychol & Psychotherapy, Dept Psychol, D-66123 Saarbrucken, Germany.	t.michael@mx.uni-saarland.de	Pfalz, Monique/N-7508-2018; Michael, Tanja/AAG-9160-2020	Pfaltz, Monique/0000-0002-4030-4514; Michael, Tanja/0000-0002-2409-3817	German Research Foundation (Deutsche Forschungsgemeinschaft, DFG) [MI 1537-1]	German Research Foundation (Deutsche Forschungsgemeinschaft, DFG)(German Research Foundation (DFG))	This research was funded by the German Research Foundation (Deutsche Forschungsgemeinschaft, DFG) Grant number: MI 1537-1 (www.dfg.de). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackermann S, 2013, J COGNITIVE NEUROSCI, V25, P1896, DOI 10.1162/jocn_a_00440; Aerni A, 2004, AM J PSYCHIAT, V161, P1488, DOI 10.1176/appi.ajp.161.8.1488; Amir N, 2010, COGNITIVE THER RES, V34, P49, DOI 10.1007/s10608-008-9211-0; Arntz A, 2005, J BEHAV THER EXP PSY, V36, P19, DOI 10.1016/j.jbtep.2004.11.003; Cahill L, 2003, LEARN MEMORY, V10, P270, DOI 10.1101/lm.62403; Czock D, 2005, CLIN PHARMACOKINET, V44, P61, DOI 10.2165/00003088-200544010-00003; de Quervain DJF, 2003, EUR J NEUROSCI, V17, P1296, DOI 10.1046/j.1460-9568.2003.02542.x; De Quervain DJF, 2007, PROG BRAIN RES, V167, P239, DOI 10.1016/S0079-6123(07)67017-4; de Quervain DJF, 2009, FRONT NEUROENDOCRIN, V30, P358, DOI 10.1016/j.yfrne.2009.03.002; De Quervain DJF, 2006, ANN NY ACAD SCI, V1071, P216, DOI 10.1196/annals.1364.016; Delahanty DL, 2013, CNS SPECTRUMS, V18, P103, DOI 10.1017/S1092852913000096; DRESSENDORFER RA, 1992, J STEROID BIOCHEM, V43, P683, DOI 10.1016/0960-0760(92)90294-S; Ehlers A, 2006, MEMORY, V14, P316, DOI 10.1080/09658210500305876; Ehlers A, 2004, MEMORY, V12, P403, DOI 10.1080/09658210444000025; Ehlers A, 2000, BEHAV RES THER, V38, P319, DOI 10.1016/S0005-7967(99)00123-0; Ehlers A, 1995, Behav Cogn Psychother, V23, P217, DOI 10.1017/S135246580001585X; Ehlers A, 2012, J BEHAV THER EXP PSY, V43, pS67, DOI 10.1016/j.jbtep.2010.12.009; Ehring T, 2011, J ABNORM PSYCHOL, V120, P234, DOI 10.1037/a0021080; Het S, 2005, PSYCHONEUROENDOCRINO, V30, P771, DOI 10.1016/j.psyneuen.2005.03.005; Hidalgo V, 2012, STRESS, V15, P329, DOI 10.3109/10253890.2011.624224; Holmes EA, 2005, J BEHAV THER EXP PSY, V36, P3, DOI 10.1016/j.jbtep.2004.11.002; Holmes EA, 2008, ACTA PSYCHOL, V127, P553, DOI 10.1016/j.actpsy.2007.11.002; Jacoby LL, 1993, J EXP PSYCHOL GEN, V133, P3; Klaassens ER, 2012, PSYCHONEUROENDOCRINO, V37, P317, DOI 10.1016/j.psyneuen.2011.07.003; Kleim B, 2012, PSYCHOL MED, V42, P173, DOI 10.1017/S0033291711001048; Kuhlmann S, 2005, NEUROBIOL LEARN MEM, V83, P158, DOI 10.1016/j.nlm.2004.09.001; Kuhlmann S, 2005, J NEUROSCI, V25, P2977, DOI 10.1523/JNEUROSCI.5139-04.2005; Kuhlmann S, 2006, NEUROSCI LETT, V399, P268, DOI 10.1016/j.neulet.2006.02.007; Lass-Hennemann J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016389; Luethi M, 2009, FRONT BEHAV NEUROSCI, V3, DOI 10.3389/neuro.08.005.2008; Luo HR, 2012, BIOL PSYCHIAT, V72, P65, DOI 10.1016/j.biopsych.2011.12.020; Michael T, 2007, BEHAV RES THER, V45, P341, DOI 10.1016/j.brat.2006.03.012; Michael T, 2005, BEHAV RES THER, V43, P613, DOI 10.1016/j.brat.2004.04.006; Michael T, 2005, EMOTION, V5, P103, DOI 10.1037/1528-3542.5.1.103; Morris MC, 2012, CLIN PSYCHOL REV, V32, P301, DOI 10.1016/j.cpr.2012.02.002; Oei NYL, 2007, BRAIN IMAGING BEHAV, V1, P31, DOI 10.1007/s11682-007-9003-2; Preuss Diana, 2009, Stress, V12, P379, DOI 10.1080/10253890802524592; Rimmele U, 2010, LEARN MEMORY, V17, P186, DOI 10.1101/lm.1728510; Romer S, 2011, PSYCHOPHARMACOLOGY, V215, P33, DOI 10.1007/s00213-010-2112-4; Schelling G, 2004, BIOL PSYCHIAT, V55, P627, DOI 10.1016/j.biopsych.2003.09.014; Schelling G, 2001, BIOL PSYCHIAT, V50, P978, DOI 10.1016/S0006-3223(01)01270-7; Schelling G, 1999, CRIT CARE MED, V27, P2678, DOI 10.1097/00003246-199912000-00012; Smeets T, 2008, PSYCHONEUROENDOCRINO, V33, P1378, DOI 10.1016/j.psyneuen.2008.07.009; SQUIRE LR, 1992, P NATL ACAD SCI USA, V89, P1837, DOI 10.1073/pnas.89.5.1837; Steudte S, 2013, BIOL PSYCHIAT, V74, P639, DOI 10.1016/j.biopsych.2013.03.011; Steudte S, 2011, PSYCHONEUROENDOCRINO, V36, P1193, DOI 10.1016/j.psyneuen.2011.02.012; Sundermann O, 2013, J BEHAV THER EXP PSY, V44, P213, DOI 10.1016/j.jbtep.2012.10.001; Wahbeh H, 2013, J TRAUMA STRESS, V26, P241, DOI 10.1002/jts.21798; Wolf OT, 2004, ANN NY ACAD SCI, V1032, P195, DOI 10.1196/annals.1314.019; Yehuda R, 2009, ANN NY ACAD SCI, V1179, P56, DOI 10.1111/j.1749-6632.2009.04979.x	50	16	16	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2014	9	9							e104864	10.1371/journal.pone.0104864	http://dx.doi.org/10.1371/journal.pone.0104864			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ1IR	25192334	Green Published, Green Accepted, gold			2022-12-27	WOS:000347993600004
J	House, BR; Silk, JB; Lambeth, SP; Schapiro, SJ				House, Bailey R.; Silk, Joan B.; Lambeth, Susan P.; Schapiro, Steven J.			Task Design Influences Prosociality in Captive Chimpanzees (Pan troglodytes)	PLOS ONE			English	Article							WILD CHIMPANZEES; INEQUITY AVERSION; CAPUCHIN MONKEYS; NATIONAL-PARK; FOOD; COOPERATION; RECIPROCITY; ALTRUISM; QUANTITY; BEHAVIOR	Chimpanzees confer benefits on group members, both in the wild and in captive populations. Experimental studies of how animals allocate resources can provide useful insights about the motivations underlying prosocial behavior, and understanding the relationship between task design and prosocial behavior provides an important foundation for future research exploring these animals' social preferences. A number of studies have been designed to assess chimpanzees' preferences for outcomes that benefit others (prosocial preferences), but these studies vary greatly in both the results obtained and the methods used, and in most cases employ procedures that reduce critical features of naturalistic social interactions, such as partner choice. The focus of the current study is on understanding the link between experimental methodology and prosocial behavior in captive chimpanzees, rather than on describing these animals' social motivations themselves. We introduce a task design that avoids isolating subjects and allows them to freely decide whether to participate in the experiment. We explore key elements of the methods utilized in previous experiments in an effort to evaluate two possibilities that have been offered to explain why different experimental designs produce different results: (a) chimpanzees are less likely to deliver food to others when they obtain food for themselves, and (b) evidence of prosociality may be obscured by more "complex" experimental apparatuses (e.g., those including more components or alternative choices). Our results suggest that the complexity of laboratory tasks may generate observed variation in prosocial behavior in laboratory experiments, and highlights the need for more naturalistic research designs while also providing one example of such a paradigm.	[House, Bailey R.] Univ Calif Los Angeles, Dept Anthropol, Los Angeles, CA 90024 USA; [Silk, Joan B.] Arizona State Univ, Sch Human Evolut & Social Change, Tempe, AZ USA; [Lambeth, Susan P.; Schapiro, Steven J.] Univ Texas MD Anderson Canc Ctr, Michale E Keeling Ctr Comparat Med & Res, Bastrop, TX USA	University of California System; University of California Los Angeles; Arizona State University; Arizona State University-Tempe; University of Texas System; UTMD Anderson Cancer Center	House, BR (corresponding author), Univ Calif Los Angeles, Dept Anthropol, Los Angeles, CA 90024 USA.	bhouse80@ucla.edu	House, Bailey R/Q-2125-2017	House, Bailey R/0000-0002-4023-9724; Schapiro, Steven J./0000-0001-5406-1739				BOESCH C, 1989, AM J PHYS ANTHROPOL, V78, P547, DOI 10.1002/ajpa.1330780410; Boesch C, 2006, COOPERATION IN PRIMATES AND HUMANS: MECHANISMS AND EVOLUTIONS, P139, DOI 10.1007/3-540-28277-7_8; Boysen ST, 1996, J EXP PSYCHOL-ANIM B, V22, P76, DOI 10.1037/0097-7403.22.1.76; Boysen ST, 2001, J COMP PSYCHOL, V115, P106, DOI 10.1037/0735-7036.115.1.106; Brauer J, 2012, SOC JUSTICE RES, V25, P256, DOI 10.1007/s11211-012-0159-6; Brauer J, 2009, AM J PRIMATOL, V71, P175, DOI 10.1002/ajp.20639; Brosnan SF, 2011, FRONT NEUROSCI-SWITZ, V5, DOI 10.3389/fnins.2011.00043; Brosnan SF, 2010, ANIM BEHAV, V79, P1229, DOI 10.1016/j.anbehav.2010.02.019; Brosnan SF, 2009, ANIM COGN, V12, P587, DOI 10.1007/s10071-009-0218-z; Camerer C.F., 2003, BEHAV GAME THEORY EX, DOI 10.1257/jep.9.2.209; CHALMEAU R, 1994, PRIMATES, V35, P385, DOI 10.1007/BF02382735; Chalmeau R, 1996, PRIMATES, V37, P39, DOI 10.1007/BF02382918; Cronin KA, EVOL HUM BE IN PRESS; Cronin KA, 2012, ANIM BEHAV, V84, P1085, DOI 10.1016/j.anbehav.2012.08.009; de Waal FBM, 1997, EVOL HUM BEHAV, V18, P375, DOI 10.1016/S1090-5138(97)00085-8; de Waal FBM, 2008, P NATL ACAD SCI USA, V105, P13685, DOI 10.1073/pnas.0807060105; Fletcher GE, 2008, AM J PRIMATOL, V70, P901, DOI 10.1002/ajp.20576; Gilby IC, 2008, ANIM BEHAV, V75, P351, DOI 10.1016/j.anbehav.2007.06.008; Gilby IC, 2010, J HUM EVOL, V59, P44, DOI 10.1016/j.jhevol.2010.02.006; Gilby IC, 2006, ANIM BEHAV, V71, P953, DOI 10.1016/j.anbehav.2005.09.009; Gomes CM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005116; Gomes CM, 2009, P ROY SOC B-BIOL SCI, V276, P699, DOI 10.1098/rspb.2008.1324; Greenberg JR, 2010, ANIM BEHAV, V80, P873, DOI 10.1016/j.anbehav.2010.08.008; Henrich J, 2006, SCIENCE, V312, P60, DOI 10.1126/science.1126398; Henrich J, 2005, BEHAV BRAIN SCI, V28, P795, DOI 10.1017/S0140525X05000142; Henrich J, 2004, NATURE, V428, P139, DOI 10.1038/428139a; Heyes C, 2012, PHILOS T R SOC B, V367, P2695, DOI 10.1098/rstb.2012.0217; Horner V, 2011, P NATL ACAD SCI USA, V108, P13847, DOI 10.1073/pnas.1111088108; Jaeggi AV, 2013, EVOL HUM BEHAV, V34, P69, DOI 10.1016/j.evolhumbehav.2012.09.005; Jaeggi AV, 2010, PHILOS T R SOC B, V365, P2723, DOI 10.1098/rstb.2010.0118; Jensen K, 2006, P ROY SOC B-BIOL SCI, V273, P1013, DOI 10.1098/rspb.2005.3417; Jensen K, 2007, SCIENCE, V318, P107, DOI 10.1126/science.1145850; Jensen K, 2007, P NATL ACAD SCI USA, V104, P13046, DOI 10.1073/pnas.0705555104; Lakshminarayanan VR, 2008, CURR BIOL, V18, pR999, DOI 10.1016/j.cub.2008.08.057; Langergraber KE, 2007, P NATL ACAD SCI USA, V104, P7786, DOI 10.1073/pnas.0611449104; Massen JJM, 2011, PRIMATES, V52, P237, DOI 10.1007/s10329-011-0244-8; Massen JJM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009734; Melis AP, 2011, P ROY SOC B-BIOL SCI, V278, P1405, DOI 10.1098/rspb.2010.1735; Melis AP, 2010, PHILOS T R SOC B, V365, P2663, DOI 10.1098/rstb.2010.0157; Melis AP, 2006, SCIENCE, V311, P1297, DOI 10.1126/science.1123007; Mitani JC, 2001, ANIM BEHAV, V61, P915, DOI 10.1006/anbe.2000.1681; Mitani JC, 2006, COOPERATION IN PRIMATES AND HUMANS: MECHANISMS AND EVOLUTIONS, P107, DOI 10.1007/3-540-28277-7_6; Mitani JC, 2009, ANIM BEHAV, V77, P633, DOI 10.1016/j.anbehav.2008.11.021; Nishida T, 1996, INT J PRIMATOL, V17, P947, DOI 10.1007/BF02735296; Price SA, 2012, SOC JUSTICE RES, V25, P140, DOI 10.1007/s11211-012-0153-z; Proctor D, 2013, P NATL ACAD SCI USA, V110, P2070, DOI 10.1073/pnas.1220806110; Silk JB, 2005, NATURE, V437, P1357, DOI 10.1038/nature04243; Tan JZ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0051922; Tomasello M, 2011, SCIENCE, V334, P1227, DOI 10.1126/science.1213443; Vonk J, 2008, ANIM BEHAV, V75, P1757, DOI 10.1016/j.anbehav.2007.09.036; Warneken F, 2007, PLOS BIOL, V5, P1414, DOI 10.1371/journal.pbio.0050184; Watts DP, 2001, BEHAVIOUR, V138, P299, DOI 10.1163/15685390152032488; Watts DP, 1998, BEHAV ECOL SOCIOBIOL, V44, P43, DOI 10.1007/s002650050513; Yamamoto S, 2012, SOC JUSTICE RES, V25, P233, DOI 10.1007/s11211-012-0160-0; Yamamoto S, 2012, P NATL ACAD SCI USA, V109, P3588, DOI 10.1073/pnas.1108517109; Yamamoto S, 2010, ANIM BEHAV, V79, P595, DOI 10.1016/j.anbehav.2009.11.034; Yamamoto S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007416; Yamamoto S, 2009, INTERACT STUD, V10, P150, DOI 10.1075/is.10.2.04yam	58	40	40	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2014	9	9							e103422	10.1371/journal.pone.0103422	http://dx.doi.org/10.1371/journal.pone.0103422			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ1IR	25191860	Green Published, gold, Green Accepted			2022-12-27	WOS:000347993600001
J	He, G; Cerin, E; Huang, WY; Wong, SH				He, Gang; Cerin, Ester; Huang, Wendy Y.; Wong, Stephen H.			Understanding Neighborhood Environment Related to Hong Kong Children's Physical Activity: A Qualitative Study Using Nominal Group Technique	PLOS ONE			English	Article							BUILT ENVIRONMENT; PERCEPTIONS; RELIABILITY; WALKING; BEHAVIORS; WALKABILITY; ATTRIBUTES; YOUTH; NEWS; PLAY	Background: Relationships between the neighborhood environment and children's physical activity have been well documented in Western countries but are less investigated in ultra-dense Asian cities. The aim of this study was to identify the environmental facilitators and barriers of physical activity behaviors among Hong Kong Chinese children using nominal group technique. Methods: Five nominal groups were conducted among 34 children aged 10-11 years from four types of neighborhoods varying in socio-economic status and walkability in Hong Kong. Environmental factors were generated by children in response to the question "What neighborhood environments do you think would increase or decrease your willingness to do physical activity?'' Factors were prioritized in order of their importance to children's physical activity. Results: Sixteen unique environmental factors, which were perceived as the most important to children's physical activity, were identified. Factors perceived as physical activity-facilitators included "Sufficient lighting'', "Bridge or tunnel'', "Few cars on roads'', "Convenient transportation'', "Subway station'', "Recreation grounds'', "Shopping malls with air conditioning'', "Fresh air'', "Interesting animals'', and "Perfume shop''. Factors perceived as physical activity-barriers included "People who make me feel unsafe'', "Crimes nearby'', "Afraid of being taken or hurt at night'', "Hard to find toilet in shopping mall'', "Too much noise'', and "Too many people in recreation grounds''. Conclusions: Specific physical activity-related environmental facilitators and barriers, which are unique in an ultra-dense city, were identified by Hong Kong children. These initial findings can inform future examinations of the physical activity-environment relationship among children in Hong Kong and similar Asian cities.	[He, Gang; Huang, Wendy Y.; Wong, Stephen H.] Chinese Univ Hong Kong, Dept Sports Sci & Phys Educ, Hong Kong, Peoples R China; [He, Gang; Cerin, Ester] Deakin Univ, Sch Exercise & Nutr Sci, Geelong, Vic 3217, Australia; [Cerin, Ester] Univ Hong Kong, Inst Human Performance, Hong Kong, Peoples R China; [Huang, Wendy Y.] Hong Kong Baptist Univ, Dept Phys Educ, Hong Kong, Peoples R China	Chinese University of Hong Kong; Deakin University; University of Hong Kong; Hong Kong Baptist University	Wong, SH (corresponding author), Chinese Univ Hong Kong, Dept Sports Sci & Phys Educ, Hong Kong, Peoples R China.	hsswong@cuhk.edu.hk	Cerin, Ester/Z-2011-2019; Cerin, Ester/L-1271-2015	Cerin, Ester/0000-0002-7599-165X; Cerin, Ester/0000-0002-7599-165X; Wong, Stephen H./0000-0002-6821-4545; He, Gang/0000-0003-0493-9368; Huang, Wendy/0000-0003-3995-1121				[Anonymous], 2003, SOC SCI MED, DOI DOI 10.1016/S0277-9536(02)00163-6; Brownson RC, 2009, AM J PREV MED, V36, pS99, DOI 10.1016/j.amepre.2009.01.005; Carson V, 2010, CAN J PUBLIC HEALTH, V101, P124, DOI 10.1007/BF03404356; Cerin E, 2011, HEALTH PLACE, V17, P937, DOI 10.1016/j.healthplace.2011.04.005; Cerin E, 2010, INT J BEHAV NUTR PHY, V7, DOI 10.1186/1479-5868-7-84; Davison KK, 2006, INT J BEHAV NUTR PHY, V3, DOI 10.1186/1479-5868-3-19; De Meester F, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-7; de Vet E, 2011, OBES REV, V12, pe130, DOI 10.1111/j.1467-789X.2010.00784.x; Ding D, 2011, AM J PREV MED, V41, P442, DOI 10.1016/j.amepre.2011.06.036; Evenson KR, 2006, INT J BEHAV NUTR PHY, V3, DOI 10.1186/1479-5868-3-28; Frank LD, 2010, BRIT J SPORT MED, V44, P924, DOI 10.1136/bjsm.2009.058701; GALLAGHER M, 1993, FAM PRACT, V10, P76, DOI 10.1093/fampra/10.1.76; Gebel K, 2009, ANN BEHAV MED, V37, P228, DOI 10.1007/s12160-009-9098-3; Gerdes KE, 1995, SOCIAL WORK ED, V17, P139; Giles-Corti Billie, 2012, INCREASING DENSITY A; Huang SJ, 2010, HEALTH PLACE, V16, P470, DOI 10.1016/j.healthplace.2009.12.004; Huang YJ, 2011, INT J BEHAV NUTR PHY, V8, DOI 10.1186/1479-5868-8-16; Hume C, 2007, AM J HEALTH PROMOT, V21, P201, DOI 10.4278/0890-1171-21.3.201; Janssen I, 2010, INT J BEHAV NUTR PHY, V7, DOI 10.1186/1479-5868-7-40; Lam JWK, 2010, PREV MED, V51, P96, DOI 10.1016/j.ypmed.2010.04.017; Leisure and Cultural Services Department of Hong Kong Government, 2012, PHYS FITN TEST COMM; Maddison R, 2009, INT J BEHAV NUTR PHY, V6, DOI 10.1186/1479-5868-6-19; McMurray A R, 1994, J Nurs Staff Dev, V10, P62; Nabors L, 2003, J SCHOOL HEALTH, V73, P216, DOI 10.1111/j.1746-1561.2003.tb06563.x; Owen CG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030932; Page AS, 2010, INT J BEHAV NUTR PHY, V7, DOI 10.1186/1479-5868-7-17; Riley AW, 2004, AMBUL PEDIATR, V4, P371, DOI 10.1367/A03-178R.1; Ronen GM, 2001, QUAL LIFE RES, V10, P71, DOI 10.1023/A:1016659917227; Rosenberg D, 2009, PREV MED, V49, P213, DOI 10.1016/j.ypmed.2009.07.011; Scott MM, 2007, J URBAN HEALTH, V84, P346, DOI 10.1007/s11524-007-9179-1; Stokols D, 1996, AM J HEALTH PROMOT, V10, P282, DOI 10.4278/0890-1171-10.4.282; Timperio A, 2006, AM J PREV MED, V30, P45, DOI 10.1016/j.amepre.2005.08.047; Timperio A, 2004, PREV MED, V38, P39, DOI 10.1016/j.ypmed.2003.09.026; Troiano RP, 2008, MED SCI SPORT EXER, V40, P181, DOI 10.1249/mss.0b013e31815a51b3; VANDEVEN AH, 1972, AM J PUBLIC HEALTH N, V62, P337, DOI 10.2105/AJPH.62.3.337; Veitch J, 2006, HEALTH PLACE, V12, P383, DOI 10.1016/j.healthplace.2005.02.009; Veitch J, 2011, ANN BEHAV MED, V41, P333, DOI 10.1007/s12160-011-9260-6; WHO, 2010, GLOB REC PHYS ACT HL, V1st, P15	38	16	17	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 4	2014	9	9							e106578	10.1371/journal.pone.0106578	http://dx.doi.org/10.1371/journal.pone.0106578			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AO3XV	25187960	Green Published, gold			2022-12-27	WOS:000341271500057
J	Bedran, TBL; Mayer, MPA; Spolidorio, DP; Grenier, D				Lombardo Bedran, Telma Blanca; Alves Mayer, Marcia Pinto; Spolidorio, Denise Palomari; Grenier, Daniel			Synergistic Anti-Inflammatory Activity of the Antimicrobial Peptides Human Beta-Defensin-3 (hBD-3) and Cathelicidin (LL-37) in a Three-Dimensional Co-Culture Model of Gingival Epithelial Cells and Fibroblasts	PLOS ONE			English	Article							MONOCYTE CHEMOATTRACTANT PROTEIN-1; HUMAN BETA-DEFENSINS; PORPHYROMONAS-GINGIVALIS; INFLAMMATORY MEDIATORS; STAPHYLOCOCCUS-AUREUS; PERIODONTAL-DISEASE; EXPRESSION; INNATE; LIPOPOLYSACCHARIDE; ALPHA	Given the spread of antibiotic resistance in bacterial pathogens, antimicrobial peptides that can also modulate the immune response may be a novel approach for effectively controlling periodontal infections. In the present study, we used a three-dimensional (3D) co-culture model of gingival epithelial cells and fibroblasts stimulated with Aggregatibacter actinomycetemcomitans lipopolysaccharide (LPS) to investigate the anti-inflammatory properties of human beta-defensin-3 (hBD-3) and cathelicidin (LL-37) and to determine whether these antimicrobial peptides can act in synergy. The 3D co-culture model composed of gingival fibroblasts embedded in a collagen matrix overlaid with gingival epithelial cells had a synergistic effect with respect to the secretion of IL-6 and IL-8 in response to LPS stimulation compared to fibroblasts and epithelial cells alone. The 3D co-culture model was stimulated with non-cytotoxic concentrations of hBD-3 (10 and 20 mu M) and LL-37 (0.1 and 0.2 mu M) individually and in combination in the presence of A. actinomycetemcomitans LPS. A multiplex ELISA assay was used to quantify the secretion of 41 different cytokines. hBD-3 and LL-37 acted in synergy to reduce the secretion of GRO-alpha, G-CSF, IP-10, IL-6, and MCP-1, but only had an additive effect on reducing the secretion of IL-8 in response to A. actinomycetemcomitans LPS stimulation. The present study showed that hBD-3 acted in synergy with LL-37 to reduce the secretion of cytokines by an LPS-stimulated 3D model of gingival mucosa. This combination of antimicrobial peptides thus shows promising potential as an adjunctive therapy for treating inflammatory periodontitis.	[Lombardo Bedran, Telma Blanca] State Univ Sao Paulo, Araraquara Dent Sch, Dept Oral Diag & Surg, Sao Paulo, Brazil; [Alves Mayer, Marcia Pinto] Univ Sao Paulo, Inst Biomed Sci, Dept Microbiol, Sao Paulo, Brazil; [Spolidorio, Denise Palomari] State Univ Sao Paulo, Araraquara Dent Sch, Dept Physiol & Pathol, Sao Paulo, Brazil; [Grenier, Daniel] Univ Laval, Fac Dent, Oral Ecol Res Grp, Quebec City, PQ, Canada	Universidade Estadual Paulista; Universidade de Sao Paulo; Universidade Estadual Paulista; Laval University	Grenier, D (corresponding author), Univ Laval, Fac Dent, Oral Ecol Res Grp, Quebec City, PQ, Canada.	daniel.grenier@greb.ulaval.ca	Mayer, Marcia/D-4645-2012; Grenier, Daniel/E-5557-2015; Spolidorio, Denise Madalena Palomari/P-3530-2016	Mayer, Marcia/0000-0002-5910-8433; Grenier, Daniel/0000-0003-0878-4674; Spolidorio, Denise Madalena Palomari/0000-0003-2376-1024	Canadian Institutes of Health Research; Laboratoire de Controle Microbiologique de l'Universite Laval	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Laboratoire de Controle Microbiologique de l'Universite Laval	This study was supported by the Canadian Institutes of Health Research and the Laboratoire de Controle Microbiologique de l'Universite Laval. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almasri A, 2007, J PERIODONTOL, V78, P533, DOI 10.1902/jop.2007.060296; Bachrach G, 2006, J DENT RES, V85, P933, DOI 10.1177/154405910608501012; Bodet C, 2006, J DENT RES, V85, P235, DOI 10.1177/154405910608500306; BOUKAMP P, 1990, DIFFERENTIATION, V44, P150, DOI 10.1111/j.1432-0436.1990.tb00548.x; Brandenburg LO, 2012, POLYMERS-BASEL, V4, P539, DOI 10.3390/polym4010539; Carlisle MD, 2009, J INNATE IMMUN, V1, P118, DOI 10.1159/000181015; Cederlund A, 2011, FEBS J, V278, P3942, DOI 10.1111/j.1742-4658.2011.08302.x; Chen XJ, 2005, J DERMATOL SCI, V40, P123, DOI 10.1016/j.jdermsci.2005.03.014; Chung WO, 2007, CURR PHARM DESIGN, V13, P3073, DOI 10.2174/138161207782110435; DARVEAU RP, 1983, J BACTERIOL, V155, P831, DOI 10.1128/JB.155.2.831-838.1983; DongariBagtzoglou AI, 1996, J PERIODONTAL RES, V31, P90, DOI 10.1111/j.1600-0765.1996.tb00469.x; Doss M, 2010, J LEUKOCYTE BIOL, V87, P79, DOI 10.1189/jlb.0609382; Dunsche A, 2002, EUR J ORAL SCI, V110, P121, DOI 10.1034/j.1600-0722.2002.11186.x; Durr UHN, 2006, BBA-BIOMEMBRANES, V1758, P1408, DOI 10.1016/j.bbamem.2006.03.030; Fives-Taylor PM, 1999, PERIODONTOL 2000, V20, P136, DOI 10.1111/j.1600-0757.1999.tb00161.x; Gamonal J, 2001, J PERIODONTAL RES, V36, P194, DOI 10.1034/j.1600-0765.2001.360309.x; Giannobile WV, 2008, J PERIODONTOL, V79, P1592, DOI 10.1902/jop.2008.080174; Golec M, 2007, ANN AGR ENV MED, V14, P1; Gorr SU, 2012, FRONT ORAL BIOL, V15, P84, DOI 10.1159/000329673; Gorr SU, 2011, J CLIN PERIODONTOL, V38, P126, DOI 10.1111/j.1600-051X.2010.01664.x; Gorr SU, 2009, PERIODONTOL 2000, V51, P152, DOI 10.1111/j.1600-0757.2009.00310.x; Gron B, 2002, APMIS, V110, P892, DOI 10.1034/j.1600-0463.2002.1101208.x; Gursoy U.K., 2012, J ORAL MICROBIOL, V4, P1, DOI 10.3402/jom.v4i0.15127; Gursoy UK, 2012, J PERIODONTOL, V83, P242, DOI 10.1902/jop.2011.110177; Inomata M, 2010, EUR J ORAL SCI, V118, P574, DOI 10.1111/j.1600-0722.2010.00775.x; Into T, 2010, CELL IMMUNOL, V264, P104, DOI 10.1016/j.cellimm.2010.05.005; Ji S, 2007, J PERIODONTAL RES, V42, P503, DOI 10.1111/j.1600-0765.2007.00974.x; Joly S, 2004, J CLIN MICROBIOL, V42, P1024, DOI 10.1128/JCM.42.3.1024-1029.2004; Jonsson D, 2012, J PERIODONTAL RES, V47, P330, DOI 10.1111/j.1600-0765.2011.01436.x; Komatsuzawa H, 2007, CURR PHARM DESIGN, V13, P3084, DOI 10.2174/138161207782110426; Kurtis B, 2005, J PERIODONTOL, V76, P1849, DOI 10.1902/jop.2005.76.11.1849; Kusumoto Y, 2004, J PERIODONTOL, V75, P370, DOI 10.1902/jop.2004.75.3.370; LARRICK JW, 1995, INFECT IMMUN, V63, P1291, DOI 10.1128/IAI.63.4.1291-1297.1995; Lee SH, 2012, J ENDODONT, V38, P351, DOI 10.1016/j.joen.2011.12.026; Lee SH, 2010, INT J ANTIMICROB AG, V35, P138, DOI 10.1016/j.ijantimicag.2009.09.024; Liu RK, 2001, J PERIODONTOL, V72, P1545, DOI 10.1902/jop.2001.72.11.1545; Loesche WJ, 2001, CLIN MICROBIOL REV, V14, P727, DOI 10.1128/CMR.14.4.727-752.2001; Lu Q, 2005, J PERIODONTAL RES, V40, P474, DOI 10.1111/j.1600-0765.2005.00827.x; Madeira MFM, 2013, MOL ORAL MICROBIOL, V28, P415, DOI 10.1111/omi.12034; Maisetta G, 2003, ANTIMICROB AGENTS CH, V47, P3349, DOI 10.1128/AAC.47.10.3349-3351.2003; Maisetta G, 2011, PEPTIDES, V32, P1073, DOI 10.1016/j.peptides.2011.02.003; McCormick TS, 2010, PERIODONTOL 2000, V54, P195, DOI 10.1111/j.1600-0757.2010.00373.x; Midorikawa K, 2003, INFECT IMMUN, V71, P3730, DOI 10.1128/IAI.71.7.3730-3739.2003; Mookherjee N, 2006, J IMMUNOL, V176, P2455, DOI 10.4049/jimmunol.176.4.2455; MUNDY GR, 1991, J PERIODONTAL RES, V26, P213, DOI 10.1111/j.1600-0765.1991.tb01647.x; Nagaoka I, 2000, INFLAMM RES, V49, P73, DOI 10.1007/s000110050561; Nijnik A, 2009, CURR OPIN HEMATOL, V16, P41, DOI 10.1097/MOH.0b013e32831ac517; Pingel LC, 2008, IMMUNOL CELL BIOL, V86, P643, DOI 10.1038/icb.2008.56; Pradeep AR, 2009, J PERIODONTOL, V80, P1454, DOI 10.1902/jop.2009.090117; Rosenfeld Y, 2006, J BIOL CHEM, V281, P1636, DOI 10.1074/jbc.M504327200; Sager R, 1992, Cytokines, V4, P96; Saitoh M, 2004, ARCH ORAL BIOL, V49, P799, DOI 10.1016/j.archoralbio.2004.04.012; Scott MG, 2002, J IMMUNOL, V169, P3883, DOI 10.4049/jimmunol.169.7.3883; Scott MG, 1999, INFECT IMMUN, V67, P2005; Semple F, 2010, EUR J IMMUNOL, V40, P1073, DOI 10.1002/eji.200940041; Slots J, 1999, PERIODONTOL 2000, V20, P82, DOI 10.1111/j.1600-0757.1999.tb00159.x; SMOLA H, 1993, J CELL BIOL, V122, P417, DOI 10.1083/jcb.122.2.417; Sochacki KA, 2011, P NATL ACAD SCI USA, V108, pE77, DOI 10.1073/pnas.1101130108; Socransky SS, 2005, PERIODONTOL 2000, V38, P135, DOI 10.1111/j.1600-0757.2005.00107.x; Suphasiriroj W, 2013, J PERIODONTOL, V84, P256, DOI 10.1902/jop.2012.110652; Tao RC, 2005, ANTIMICROB AGENTS CH, V49, P3883, DOI 10.1128/AAC.49.9.3883-3888.2005; Thunell DH, 2010, J PERIODONTAL RES, V45, P148, DOI 10.1111/j.1600-0765.2009.01204.x; Vankeerberghen A, 2005, J PERIODONTOL, V76, P1293, DOI 10.1902/jop.2005.76.8.1293; Walters SM, 2010, PEPTIDES, V31, P1649, DOI 10.1016/j.peptides.2010.06.001; Wendell KJ, 2001, J PERIODONTOL, V72, P1038, DOI 10.1902/jop.2001.72.8.1038; Yoshimura A, 1997, J PERIODONTAL RES, V32, P279, DOI 10.1111/j.1600-0765.1997.tb00535.x; Yucel-Lindberg T, 2013, EXPERT REV MOL MED, V15, DOI 10.1017/erm.2013.8	67	35	39	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 4	2014	9	9							e106766	10.1371/journal.pone.0106766	http://dx.doi.org/10.1371/journal.pone.0106766			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3XV	25187958	Green Submitted, Green Published, gold			2022-12-27	WOS:000341271500085
J	Montero, M; Rahimpour, M; Viale, AM; Almagro, G; Eydallin, G; Sevilla, A; Canovas, M; Bernal, C; Lozano, AB; Munoz, FJ; Baroja-Fernandez, E; Bahaji, A; Mori, H; Codoner, FM; Pozueta-Romero, J				Montero, Manuel; Rahimpour, Mehdi; Viale, Alejandro M.; Almagro, Goizeder; Eydallin, Gustavo; Sevilla, Angel; Canovas, Manuel; Bernal, Cristina; Belen Lozano, Ana; Jose Munoz, Francisco; Baroja-Fernandez, Edurne; Bahaji, Abdellatif; Mori, Hirotada; Codoner, Francisco M.; Pozueta-Romero, Javier			Systematic Production of Inactivating and Non-Inactivating Suppressor Mutations at the relA Locus That Compensate the Detrimental Effects of Complete spoT Loss and Affect Glycogen Content in Escherichia coli	PLOS ONE			English	Article							STRESS-RESPONSE; PPGPP SYNTHESIS; RNA-POLYMERASE; RIBOSOMAL-RNA; PROTEIN; GENES; METABOLISM; STRINGENT; MUTANTS; ACID	In Escherichia coli, ppGpp is a major determinant of growth and glycogen accumulation. Levels of this signaling nucleotide are controlled by the balanced activities of the ppGpp RelA synthetase and the dual-function hydrolase/synthetase SpoT. Here we report the construction of spoT null (Delta spoT) mutants obtained by transducing a Delta spoT allele from Delta relA Delta spoT double mutants into relA(+) cells. Iodine staining of randomly selected transductants cultured on a rich complex medium revealed differences in glycogen content among them. Sequence and biochemical analyses of 8 Delta spoT clones displaying glycogen-deficient phenotypes revealed different inactivating mutations in relA and no detectable ppGpp when cells were cultured on a rich complex medium. Remarkably, although the co-existence of Delta spoT with relA proficient alleles has generally been considered synthetically lethal, we found that 11 Delta spoT clones displaying high glycogen phenotypes possessed relA mutant alleles with non-inactivating mutations that encoded stable RelA proteins and ppGpp contents reaching 45-85% of those of wild type cells. None of the Delta spoT clones, however, could grow on M9-glucose minimal medium. Both Sanger sequencing of specific genes and high-throughput genome sequencing of the Delta spoT clones revealed that suppressor mutations were restricted to the relA locus. The overall results (a) defined in around 4 nmoles ppGpp/g dry weight the threshold cellular levels that suffice to trigger net glycogen accumulation, (b) showed that mutations in relA, but not necessarily inactivating mutations, can be selected to compensate total SpoT function(s) loss, and (c) provided useful tools for studies of the in vivo regulation of E. coli RelA ppGpp synthetase.	[Montero, Manuel; Rahimpour, Mehdi; Viale, Alejandro M.; Almagro, Goizeder; Eydallin, Gustavo; Jose Munoz, Francisco; Baroja-Fernandez, Edurne; Bahaji, Abdellatif; Pozueta-Romero, Javier] UPNA CSIC Gobierno Navarra, Inst Agrobiotecnol, Mutiloabeti, Nafarroa, Spain; [Viale, Alejandro M.] Univ Nacl Rosario, Fac Ciencias Bioquim & Farmaceut, Dept Microbiol, Inst Biol Mol & Celular Rosario IBR,CONICET, RA-2000 Rosario, Santa Fe, Argentina; [Sevilla, Angel; Canovas, Manuel; Bernal, Cristina; Belen Lozano, Ana] Univ Murcia, Fac Quim, Dept Bioquim & Biol Mol & Inmunol, Murcia, Spain; [Mori, Hirotada] Nara Inst Sci & Technol, Grad Sch Biol Sci, Nara 6300101, Japan; [Codoner, Francisco M.] Lifesequencing SL, Valencia, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC-GN-UPNA - Instituto de Agrobiotecnologia (IDAB); Universidad Publica de Navarra; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); National University of Rosario; University of Murcia; Nara Institute of Science & Technology	Viale, AM (corresponding author), UPNA CSIC Gobierno Navarra, Inst Agrobiotecnol, Mutiloabeti, Nafarroa, Spain.	viale@ibr-conicet.gov.ar; javier.pozueta@unavarra.es	Montero, Manuel/K-7166-2013; Canovas, Manuel/K-3860-2014; Pozueta-Romero, Javier/G-3766-2011; Edurne, Baroja-Fernandez/I-4037-2012; Almagro, Goizeder/Y-9900-2019; Pozueta-Romero, Javier/AAP-9341-2021; Bahaji, Abdellatif/C-4105-2015; Muñoz, Francisco/I-3547-2012; Rahimpour, Mehdi/M-4042-2017	Montero, Manuel/0000-0002-8036-8758; Canovas, Manuel/0000-0003-3254-1736; Pozueta-Romero, Javier/0000-0002-0335-9663; Edurne, Baroja-Fernandez/0000-0003-0049-6045; Almagro, Goizeder/0000-0001-7035-9965; Pozueta-Romero, Javier/0000-0002-0335-9663; Bahaji, Abdellatif/0000-0002-5270-497X; Muñoz, Francisco/0000-0002-0426-2118; 	Comision Interministerial de Ciencia y Tecnologia; Fondo Europeo de Desarrollo Regional (Spain) [BIO2010-18239, BIO2011-29233-002-01]; Fundacion Seneca [08660/P1/08]; JSPS (Japan Society for the Promotion of Science) KAKENHI [22241050]; Public University of Navarra; JAE fellowship from the Consejo Superior de Investigaciones Cientificas; Programa Campus Ibericus de Excelencia Internacional; Ministerio de Educacion, Spain; Public University of Navarra, Pamplona, Spain; Proyecto financiado por el Ministerio de Educacion en el marco del Programa Campus de Excelencia Internacional	Comision Interministerial de Ciencia y Tecnologia(Consejo Interinstitucional de Ciencia y Tecnologia (CICYT)); Fondo Europeo de Desarrollo Regional (Spain)(European Commission); Fundacion Seneca(Fundacion Seneca); JSPS (Japan Society for the Promotion of Science) KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Public University of Navarra; JAE fellowship from the Consejo Superior de Investigaciones Cientificas; Programa Campus Ibericus de Excelencia Internacional; Ministerio de Educacion, Spain; Public University of Navarra, Pamplona, Spain; Proyecto financiado por el Ministerio de Educacion en el marco del Programa Campus de Excelencia Internacional	This research was partially supported by the Comision Interministerial de Ciencia y Tecnologia and Fondo Europeo de Desarrollo Regional (Spain) [grant numbers BIO2010-18239 and BIO2011-29233-002-01], the Fundacion Seneca [grant number 08660/P1/08] and JSPS (Japan Society for the Promotion of Science) KAKENHI Grant-in-Aid for Scientific Research (A) [grant number 22241050]. GA and GE acknowledge fellowships from the Public University of Navarra. MR acknowledges a pre-doctoral JAE fellowship from the Consejo Superior de Investigaciones Cientificas. AMV is grateful to the funding of the Programa Campus Ibericus de Excelencia Internacional, Ministerio de Educacion, Spain. His 2-months visit (January-March 2014) to the Institute of Agrobiotechnology, Public University of Navarra, Pamplona, Spain, was included into the Proyecto financiado por el Ministerio de Educacion en el marco del Programa Campus de Excelencia Internacional. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; AN G, 1979, J BACTERIOL, V137, P1100, DOI 10.1128/JB.137.3.1100-1110.1979; Baba T, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100050; Bajad SU, 2006, J CHROMATOGR A, V1125, P76, DOI 10.1016/j.chroma.2006.05.019; Balsalobre C, 2011, MOL MICROBIOL, V79, P827, DOI 10.1111/j.1365-2958.2010.07521.x; Battesti A, 2006, MOL MICROBIOL, V62, P1048, DOI 10.1111/j.1365-2958.2006.05442.x; BD Bionutrients, 2006, TECHN MAN ADV BIOPRO; Cashel M., 1996, ESCHERICHIA COLI SAL, P1458; Chatterji D, 2007, FEMS MICROBIOL LETT, V267, P51, DOI 10.1111/j.1574-6968.2006.00532.x; Dalebroux ZD, 2012, NAT REV MICROBIOL, V10, P203, DOI 10.1038/nrmicro2720; Darling AE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011147; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Durfee T, 2008, J BACTERIOL, V190, P1084, DOI 10.1128/JB.01092-07; Eydallin G, 2007, FEBS LETT, V581, P2947, DOI 10.1016/j.febslet.2007.05.044; Eydallin G, 2010, DNA RES, V17, P61, DOI 10.1093/dnares/dsp028; Faijes M, 2007, MICROB CELL FACT, V6, DOI 10.1186/1475-2859-6-27; Ferenci T, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-62; Fructuoso Sergio, 2012, BMC Res Notes, V5, P428, DOI 10.1186/1756-0500-5-428; Gentry DR, 1996, MOL MICROBIOL, V19, P1373, DOI 10.1111/j.1365-2958.1996.tb02480.x; GENTRY DR, 1993, J BACTERIOL, V175, P7982, DOI 10.1128/JB.175.24.7982-7989.1993; GOVONS S, 1969, J BACTERIOL, V97, P970, DOI 10.1128/JB.97.2.970-972.1969; Gropp M, 2001, J BACTERIOL, V183, P570, DOI 10.1128/JB.183.2.570-579.2001; Hogg T, 2004, CELL, V117, P57, DOI 10.1016/S0092-8674(04)00260-0; Jiang MX, 2007, J BACTERIOL, V189, P6140, DOI 10.1128/JB.00315-07; Kanehisa M, 2012, NUCLEIC ACIDS RES, V40, pD109, DOI 10.1093/nar/gkr988; Kitagawa M, 2005, DNA RES, V12, P291, DOI 10.1093/dnares/dsi012; KUO MS, 1986, CARBOHYD RES, V156, P173, DOI 10.1016/S0008-6215(00)90109-5; LAZZARINI RA, 1971, J BIOL CHEM, V246, P4381; LEHMAN IR, 1958, J BIOL CHEM, V233, P163; METZGER S, 1989, J BIOL CHEM, V264, P21146; Montero M, 2011, BIOCHEM J, V433, P107, DOI 10.1042/BJ20101186; Montero M, 2009, BIOCHEM J, V424, P129, DOI 10.1042/BJ20090980; Persky NS, 2009, MOL MICROBIOL, V73, P253, DOI 10.1111/j.1365-2958.2009.06767.x; Potrykus K, 2008, ANNU REV MICROBIOL, V62, P35, DOI 10.1146/annurev.micro.62.081307.162903; Powell BS, 1998, J BACTERIOL, V180, P1053, DOI 10.1128/JB.180.5.1053-1062.1998; Preinerstorfer B, 2010, J CHROMATOGR A, V1217, P312, DOI 10.1016/j.chroma.2009.11.051; Preiss J, 2009, ECOSAL ESCHERICHIA C, DOI [DOI 10.1128/ECOSAL.4.7.4, 10.1128/ecosal.4.7.4]; Rahimpour M, 2013, BIOCHEM J, V452, P559, DOI 10.1042/BJ20130154; REITZER L, 1996, ESCHERICHIA COLI SAL; RYALS J, 1982, J BACTERIOL, V151, P1261, DOI 10.1128/JB.151.3.1261-1268.1982; Sajish M, 2007, J BIOL CHEM, V282, P34977, DOI 10.1074/jbc.M704828200; Sajish M, 2009, J BIOL CHEM, V284, P9115, DOI 10.1074/jbc.M807187200; Saksinchai S, 2001, WORLD J MICROB BIOT, V17, P307, DOI 10.1023/A:1016717428583; SARUBBI E, 1988, MOL GEN GENET, V213, P214, DOI 10.1007/BF00339584; Schadel F, 2011, APPL MICROBIOL BIOT, V92, P1261, DOI 10.1007/s00253-011-3377-1; Sezonov G, 2007, J BACTERIOL, V189, P8746, DOI 10.1128/JB.01368-07; SOKAWA Y, 1975, CELL, V5, P69, DOI 10.1016/0092-8674(75)90093-8; Srivatsan A, 2008, CURR OPIN MICROBIOL, V11, P100, DOI 10.1016/j.mib.2008.02.001; Srivatsan A, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000139; TEDIN K, 1992, J BIOL CHEM, V267, P2337; Terui Y, 2012, INT J BIOCHEM CELL B, V44, P412, DOI 10.1016/j.biocel.2011.11.017; TETU C, 1980, EUR J BIOCHEM, V103, P117, DOI 10.1111/j.1432-1033.1980.tb04295.x; Traxler MF, 2011, MOL MICROBIOL, V79, P830, DOI 10.1111/j.1365-2958.2010.07498.x; Wilson WA, 2010, FEMS MICROBIOL REV, V34, P952, DOI 10.1111/j.1574-6976.2010.00220.x; XIAO H, 1991, J BIOL CHEM, V266, P5980; Yamamotoya T, 2012, BBA-PROTEINS PROTEOM, V1824, P1442, DOI 10.1016/j.bbapap.2012.06.010	56	14	16	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 4	2014	9	9							e106938	10.1371/journal.pone.0106938	http://dx.doi.org/10.1371/journal.pone.0106938			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3XV	25188023	Green Published, gold			2022-12-27	WOS:000341271500100
J	Radeva, MY; Kugelmann, D; Spindler, V; Waschke, J				Radeva, Mariya Y.; Kugelmann, Daniela; Spindler, Volker; Waschke, Jens			PKA Compartmentalization via AKAP220 and AKAP12 Contributes to Endothelial Barrier Regulation	PLOS ONE			English	Article							KINASE-ANCHORING PROTEIN; SIGNALING COMPLEX; PHOSPHODIESTERASE 4D; CAMP LEVELS; IN-VIVO; RAC 1; CELLS; ACTIVATION; ADHESION; VASP	cAMP-mediated PKA signaling is the main known pathway involved in maintenance of the endothelial barrier. Tight regulation of PKA function can be achieved by discrete compartmentalization of the enzyme via physical interaction with A-kinase anchoring proteins (AKAPs). Here, we investigated the role of AKAPs 220 and 12 in endothelial barrier regulation. Analysis of human and mouse microvascular endothelial cells as well as isolated rat mesenteric microvessels was performed using TAT-Ahx-AKAPis peptide, designed to competitively inhibit PKA-AKAP interaction. In vivo microvessel hydraulic conductivity and in vitro transendothelial electrical resistance measurements showed that this peptide destabilized endothelial barrier properties, and dampened the cAMP-mediated endothelial barrier stabilization induced by forskolin and rolipram. Immunofluorescence analysis revealed that TAT-Ahx-AKAPis led to both adherens junctions and actin cytoskeleton reorganization. Those effects were paralleled by redistribution of PKA and Rac1 from endothelial junctions and by Rac1 inactivation. Similarly, membrane localization of AKAP220 was also reduced. In addition, depletion of either AKAP12 or AKAP220 significantly impaired endothelial barrier function and AKAP12 was also shown to interfere with cAMP-mediated barrier enhancement. Furthermore, immunoprecipitation analysis demonstrated that AKAP220 interacts not only with PKA but also with VE-cadherin and beta-catenin. Taken together, these results indicate that AKAP-mediated PKA subcellular compartmentalization is involved in endothelial barrier regulation. More specifically, AKAP220 and AKAP12 contribute to endothelial barrier function and AKAP12 is required for cAMP-mediated barrier stabilization.	[Radeva, Mariya Y.; Kugelmann, Daniela; Spindler, Volker; Waschke, Jens] Univ Munich, Inst Anat & Cell Biol, Munich, Germany	University of Munich	Waschke, J (corresponding author), Univ Munich, Inst Anat & Cell Biol, Munich, Germany.	jens.waschke@med.uni-muenchen.de	Spindler, Volker/G-1704-2019	Spindler, Volker/0000-0002-1302-5421	Deutsche Forschungsgemeinschaft [SFB 688]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by a grant from the Deutsche Forschungsgemeinschaft (SFB 688, TP A4) (http://www.sfb688.de/). JW received the funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamson RH, 2002, J PHYSIOL-LONDON, V539, P295, DOI 10.1113/jphysiol.2001.013117; Aird WC, 2007, CIRC RES, V100, P158, DOI 10.1161/01.RES.0000255691.76142.4a; Barth N LA, 2009, ACTA PHYSL 2009 S669, V195; Bauman AL, 2004, NEUROPHARMACOLOGY, V46, P299, DOI 10.1016/j.neuropharm.2003.09.016; Bauman AL, 2006, MOL CELL, V23, P925, DOI 10.1016/j.molcel.2006.07.025; Baumer Y, 2008, HISTOCHEM CELL BIOL, V129, P765, DOI 10.1007/s00418-008-0422-y; Baumer Y, 2009, J CELL PHYSIOL, V220, P716, DOI 10.1002/jcp.21819; Beckers CML, 2010, THROMB HAEMOSTASIS, V103, P40, DOI 10.1160/TH09-06-0403; Birukova AA, 2010, MICROVASC RES, V79, P128, DOI 10.1016/j.mvr.2009.11.007; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Choi YK, 2008, FEBS J, V275, P2338, DOI 10.1111/j.1742-4658.2008.06387.x; Choi YK, 2007, J NEUROSCI, V27, P4472, DOI 10.1523/JNEUROSCI.5368-06.2007; Cinel I, 2007, CURR OPIN INFECT DIS, V20, P345, DOI 10.1097/QCO.0b013e32818be70a; Cioffi DL, 2002, J CELL BIOL, V157, P1267, DOI 10.1083/jcb.200204022; Dessauer CW, 2009, MOL PHARMACOL, V76, P935, DOI 10.1124/mol.109.059345; Dodge KL, 2001, EMBO J, V20, P1921, DOI 10.1093/emboj/20.8.1921; Dodge-Kafka KL, 2005, NATURE, V437, P574, DOI 10.1038/nature03966; DRENCKHAHN D, 1997, VASCULAR ENDOTHELIUM, P1; Duchardt F, 2007, TRAFFIC, V8, P848, DOI 10.1111/j.1600-0854.2007.00572.x; Faruque OM, 2009, AM J PHYSIOL-CELL PH, V296, pC306, DOI 10.1152/ajpcell.00216.2008; Fischmeister R, 2006, CIRC RES, V98, P582, DOI 10.1161/01.RES.0000215564.22445.7e; Gorski JA, 2005, MOL BIOL CELL, V16, P3574, DOI 10.1091/mbc.E05-02-0134; Hoshi Senji, 2003, Int J Clin Oncol, V8, P118, DOI 10.1007/s101470300021; Jarnaess E, 2007, BIOCHEM SOC T, V35, P931, DOI 10.1042/BST0350931; Kapiloff MS, 2009, J BIOL CHEM, V284, P23540, DOI 10.1074/jbc.M109.030072; Kwon HB, 2012, EXP MOL MED, V44, P225, DOI 10.3858/emm.2012.44.3.017; Logue JS, 2009, FASEB J, V23; Logue JS, 2011, J BIOL CHEM, V286, P22113, DOI 10.1074/jbc.M111.232660; Mehta D, 2006, PHYSIOL REV, V86, P279, DOI 10.1152/physrev.00012.2005; MICHEL CC, 1974, Q J EXP PHYSIOL CMS, V59, P283, DOI 10.1113/expphysiol.1974.sp002275; Michel CC, 1999, PHYSIOL REV, V79, P703, DOI 10.1152/physrev.1999.79.3.703; Michel JJC, 2002, ANNU REV PHARMACOL, V42, P235, DOI 10.1146/annurev.pharmtox.42.083101.135801; Oldenburger A, 2012, PHARMACEUTICALS, V5, P1291, DOI 10.3390/ph5121291; Qiao J, 2003, AM J PHYSIOL-LUNG C, V284, pL972, DOI 10.1152/ajplung.00429.2002; Rampersad SN, 2010, J BIOL CHEM, V285, P33614, DOI 10.1074/jbc.M110.140004; Reinton N, 2000, DEV BIOL, V223, P194, DOI 10.1006/dbio.2000.9725; Rich TC, 2001, P NATL ACAD SCI USA, V98, P13049, DOI 10.1073/pnas.221381398; Sayner SL, 2006, CIRC RES, V98, P675, DOI 10.1161/01.RES.0000209516.84815.3e; Schillace RV, 1999, CURR BIOL, V9, P321, DOI 10.1016/S0960-9822(99)80141-9; Schillace RV, 2001, J BIOL CHEM, V276, P12128, DOI 10.1074/jbc.M010398200; Schlegel N, 2008, AM J PHYSIOL-CELL PH, V294, pC178, DOI 10.1152/ajpcell.00273.2007; Schlegel N, 2014, CELL TISSUE RES, V355, P587, DOI 10.1007/s00441-013-1755-y; Schlegel N, 2010, CARDIOVASC RES, V87, P1, DOI 10.1093/cvr/cvq093; Schlegel N, 2009, CRIT CARE MED, V37, P1735, DOI 10.1097/CCM.0b013e31819deb6a; Schlegel N, 2009, J CELL PHYSIOL, V220, P357, DOI 10.1002/jcp.21772; Schlegel N, 2009, AM J PHYSIOL-CELL PH, V296, pC453, DOI 10.1152/ajpcell.00360.2008; Sehrawat S, 2011, BLOOD, V117, P708, DOI 10.1182/blood-2010-02-268870; Spindler V, 2011, AM J PATHOL, V178, P2424, DOI 10.1016/j.ajpath.2011.01.014; Spindler V, 2010, CARDIOVASC RES, V87, P243, DOI 10.1093/cvr/cvq086; Tanji C, 2002, J BIOL CHEM, V277, P36955, DOI 10.1074/jbc.M206210200; Tasken K, 2004, PHYSIOL REV, V84, P137, DOI 10.1152/physrev.00021.2003; Tasken KA, 2001, J BIOL CHEM, V276, P21999, DOI 10.1074/jbc.C000911200; Waschke J, 2004, AM J PHYSIOL-HEART C, V287, pH704, DOI 10.1152/ajpheart.01076.2003; Waschke J, 2004, AM J PHYSIOL-HEART C, V286, pH394, DOI 10.1152/ajpheart.00221.2003; Werthmann RC, 2009, J PHYSIOL-LONDON, V587, P4091, DOI 10.1113/jphysiol.2009.172957; Wojciak-Stothard B, 2002, VASC PHARMACOL, V39, P187, DOI 10.1016/S1537-1891(03)00008-9; Wong W, 2004, NAT REV MOL CELL BIO, V5, P959, DOI 10.1038/nrm1527	57	29	30	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 4	2014	9	9							e106733	10.1371/journal.pone.0106733	http://dx.doi.org/10.1371/journal.pone.0106733			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3XV	25188285	gold, Green Submitted, Green Published			2022-12-27	WOS:000341271500080
J	Richey, JE; Phillips, JS; Schunn, CD; Schneider, W				Richey, J. Elizabeth; Phillips, Jeffrey S.; Schunn, Christian D.; Schneider, Walter			Is the Link from Working Memory to Analogy Causal? No Analogy Improvements following Working Memory Training Gains	PLOS ONE			English	Article							INTELLIGENCE; CAPACITY; SPAN; ACQUISITION; PLASTICITY; CHILDREN; MODEL; TERM	Analogical reasoning has been hypothesized to critically depend upon working memory through correlational data [1], but less work has tested this relationship through experimental manipulation [2]. An opportunity for examining the connection between working memory and analogical reasoning has emerged from the growing, although somewhat controversial, body of literature suggests complex working memory training can sometimes lead to working memory improvements that transfer to novel working memory tasks. This study investigated whether working memory improvements, if replicated, would increase analogical reasoning ability. We assessed participants' performance on verbal and visual analogy tasks after a complex working memory training program incorporating verbal and spatial tasks [3,4]. Participants' improvements on the working memory training tasks transferred to other short-term and working memory tasks, supporting the possibility of broad effects of working memory training. However, we found no effects on analogical reasoning. We propose several possible explanations for the lack of an impact of working memory improvements on analogical reasoning.	[Richey, J. Elizabeth; Schunn, Christian D.; Schneider, Walter] Univ Pittsburgh, Ctr Learning Res & Dev, Dept Psychol, Pittsburgh, PA 15260 USA; [Phillips, Jeffrey S.] Univ Penn, Dept Neurol, Philadelphia, PA 19104 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of Pennsylvania	Richey, JE (corresponding author), Univ Pittsburgh, Ctr Learning Res & Dev, Dept Psychol, Pittsburgh, PA 15260 USA.	jes1235@pitt.edu	Richey, J. Elizabeth/AAE-2783-2020; Schunn, Christian D./H-2468-2011	Richey, J. Elizabeth/0000-0002-0045-6855; Schunn, Christian D./0000-0003-3589-297X; Phillips, Jeffrey/0000-0003-0079-9441	Defense Advanced Research Projects Agency [NBCH090053]	Defense Advanced Research Projects Agency(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA))	This study was supported by the Defense Advanced Research Projects Agency (NBCH090053, http://www.darpa.mil/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson JR, 1981, COGNITIVE SKILLS THE, P191; Baddeley A., 1974, PSYCHOL LEARNING MOT, V8; Beilock SL, 2007, J EXP PSYCHOL LEARN, V33, P983, DOI 10.1037/0278-7393.33.6.983; Blanchette I, 2000, MEM COGNITION, V28, P108, DOI 10.3758/BF03211580; CATRAMBONE R, 1989, J EXP PSYCHOL LEARN, V15, P1147, DOI 10.1037/0278-7393.15.6.1147; Catrambone R, 2006, MEM COGNITION, V34, P1126, DOI 10.3758/BF03193258; Chein JM, 2010, PSYCHON B REV, V17, P193, DOI 10.3758/PBR.17.2.193; Cho S, 2007, MEM COGNITION, V35, P1445, DOI 10.3758/BF03193614; Dahlin E, 2008, PSYCHOL AGING, V23, P720, DOI 10.1037/a0014296; ERICSSON KA, 1980, SCIENCE, V208, P1181, DOI 10.1126/science.7375930; FORBUS KD, 1995, COGNITIVE SCI, V19, P141, DOI 10.1016/0364-0213(95)90016-0; Gentner D, 2003, J EDUC PSYCHOL, V95, P393, DOI 10.1037/0022-0663.95.2.393; GICK ML, 1983, COGNITIVE PSYCHOL, V15, P1, DOI 10.1016/0010-0285(83)90002-6; Gmeindl L, 2011, MEM COGNITION, V39, P37, DOI 10.3758/s13421-010-0012-9; Green AE, 2010, CEREB CORTEX, V20, P70, DOI 10.1093/cercor/bhp081; Jaeggi SM, 2008, P NATL ACAD SCI USA, V105, P6829, DOI 10.1073/pnas.0801268105; Jaeggi SM, 2010, INTELLIGENCE, V38, P625, DOI 10.1016/j.intell.2010.09.001; Jausovec N, 2012, BRAIN COGNITION, V79, P96, DOI 10.1016/j.bandc.2012.02.007; Kane MJ, 2004, J EXP PSYCHOL GEN, V133, P189, DOI 10.1037/0096-3445.133.2.189; KEANE MT, 1994, COGNITIVE SCI, V18, P387, DOI 10.1207/s15516709cog1803_2; Klingberg T, 2002, J CLIN EXP NEUROPSYC, V24, P781, DOI 10.1076/jcen.24.6.781.8395; Klingberg T, 2005, J AM ACAD CHILD PSY, V44, P177, DOI 10.1097/00004583-200502000-00010; Klingberg T, 2010, TRENDS COGN SCI, V14, P317, DOI 10.1016/j.tics.2010.05.002; KYLLONEN PC, 1990, INTELLIGENCE, V14, P389, DOI 10.1016/S0160-2896(05)80012-1; MARKMAN AB, 1993, COGNITIVE PSYCHOL, V25, P431, DOI 10.1006/cogp.1993.1011; Melby-Lervag M, 2013, DEV PSYCHOL, V49, P270, DOI 10.1037/a0028228; Morrison AB, 2011, PSYCHON B REV, V18, P46, DOI 10.3758/s13423-010-0034-0; Morrison R. G., 2001, P 23 ANN C COGNITIVE, P663; Morrison RG, 2004, J COGNITIVE NEUROSCI, V16, P260, DOI 10.1162/089892904322984553; NOVICK LR, 1991, J EXP PSYCHOL LEARN, V17, P398, DOI 10.1037/0278-7393.17.3.398; PIROLLI PL, 1985, CAN J PSYCHOL, V39, P240, DOI 10.1037/h0080061; Redick TS, 2013, J EXP PSYCHOL GEN, V142, P359, DOI 10.1037/a0029082; Richland LE, 2004, COGNITION INSTRUCT, V22, P37, DOI 10.1207/s1532690Xci2201_2; ROSS BH, 1984, COGNITIVE PSYCHOL, V16, P371, DOI 10.1016/0010-0285(84)90014-8; Schmiedek F, 2010, FRONT AGING NEUROSCI, V2, DOI 10.3389/fnagi.2010.00027; Schunn CD, 1998, PSYCHOL LEARN MOTIV, P115; Shipstead Z, 2010, PSYCHOL BELG, V50, P245, DOI 10.5334/pb-50-3-4-245; Siegler RS, 1996, IMPLICIT MEMORY META, P79; STERNBERG RJ, 1977, PSYCHOL REV, V84, P353, DOI 10.1037/0033-295X.84.4.353; Unsworth N, 2007, PSYCHOL BULL, V133, P1038, DOI 10.1037/0033-2909.133.6.1038; Verstynen T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047336; Waltz JA, 2000, MEM COGNITION, V28, P1205, DOI 10.3758/BF03211821; Westerberg H, 2007, BRAIN INJURY, V21, P21, DOI 10.1080/02699050601148726; Westerberg H, 2007, PHYSIOL BEHAV, V92, P186, DOI 10.1016/j.physbeh.2007.05.041; Wiley J, 2012, PSYCHOL LEARN MOTIV, V56, P185, DOI 10.1016/B978-0-12-394393-4.00006-6; Wiley J, 2011, J EXP PSYCHOL LEARN, V37, P256, DOI 10.1037/a0021613; Wykes T, 1999, SCHIZOPHRENIA BULL, V25, P291, DOI 10.1093/oxfordjournals.schbul.a033379	47	6	7	3	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 4	2014	9	9							e106616	10.1371/journal.pone.0106616	http://dx.doi.org/10.1371/journal.pone.0106616			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AO3XV	25188356	Green Submitted, Green Published, gold			2022-12-27	WOS:000341271500061
J	Simons, NK; Gossner, MM; Lewinsohn, TM; Boch, S; Lange, M; Muller, J; Pasalic, E; Socher, SA; Turke, M; Fischer, M; Weisser, WW				Simons, Nadja K.; Gossner, Martin M.; Lewinsohn, Thomas M.; Boch, Steffen; Lange, Markus; Mueller, Joerg; Pasalic, Esther; Socher, Stephanie A.; Tuerke, Manfred; Fischer, Markus; Weisser, Wolfgang W.			Resource-Mediated Indirect Effects of Grassland Management on Arthropod Diversity	PLOS ONE			English	Article							LAND-USE INTENSITY; LANDSCAPE COMPOSITION; SPECIES COMPOSITION; PLANT DIVERSITY; BIODIVERSITY; COMMUNITIES; INVERTEBRATES; CONSERVATION; ABUNDANCE; RESPONSES	Intensive land use is a driving force for biodiversity decline in many ecosystems. In semi-natural grasslands, land-use activities such as mowing, grazing and fertilization affect the diversity of plants and arthropods, but the combined effects of different drivers and the chain of effects are largely unknown. In this study we used structural equation modelling to analyse how the arthropod communities in managed grasslands respond to land use and whether these responses are mediated through changes in resource diversity or resource quantity (biomass). Plants were considered resources for herbivores which themselves were considered resources for predators. Plant and arthropod (herbivores and predators) communities were sampled on 141 meadows, pastures and mown pastures within three regions in Germany in 2008 and 2009. Increasing land-use intensity generally increased plant biomass and decreased plant diversity, mainly through increasing fertilization. Herbivore diversity decreased together with plant diversity but showed no response to changes in plant biomass. Hence, land-use effects on herbivore diversity were mediated through resource diversity rather than quantity. Land-use effects on predator diversity were mediated by both herbivore diversity (resource diversity) and herbivore quantity (herbivore biomass), but indirect effects through resource quantity were stronger. Our findings highlight the importance of assessing both direct and indirect effects of land-use intensity and mode on different trophic levels. In addition to the overall effects, there were subtle differences between the different regions, pointing to the importance of regional land-use specificities. Our study underlines the commonly observed strong effect of grassland land use on biodiversity. It also highlights that mechanistic approaches help us to understand how different land-use modes affect biodiversity.	[Simons, Nadja K.; Gossner, Martin M.; Pasalic, Esther; Tuerke, Manfred; Weisser, Wolfgang W.] Tech Univ Munich, Sch Life Sci Weihenstephan, Dept Ecol & Ecosyst Management, Terr Ecol Res Grp, Freising Weihenstephan, Germany; [Lewinsohn, Thomas M.] Univ Estadual Campinas, Inst Biol, Dept Anim Biol, Campinas, SP, Brazil; [Boch, Steffen; Socher, Stephanie A.; Fischer, Markus] Univ Bern, Inst Plant Sci, Bern, Switzerland; [Lange, Markus] Max Planck Inst Biogeochem, D-07745 Jena, Germany; [Mueller, Joerg] Univ Potsdam, Inst Biochem & Biol, Potsdam, Germany; [Fischer, Markus] Senckenberg Gesell Nat Forsch, Biodivers & Climate Res Ctr, Frankfurt, Germany	Technical University of Munich; Universidade de Sao Paulo; Universidade Estadual de Campinas; University of Bern; Max Planck Society; University of Potsdam; Senckenberg Gesellschaft fur Naturforschung (SGN)	Simons, NK (corresponding author), Tech Univ Munich, Sch Life Sci Weihenstephan, Dept Ecol & Ecosyst Management, Terr Ecol Res Grp, Freising Weihenstephan, Germany.	nadja.simons@tum.de	Weisser, Wolfgang W/B-9718-2014; Lewinsohn, Thomas M/D-5880-2012; Türke, Manfred/AFE-8308-2022; Fischer, Markus/C-6411-2008; Simons, Nadja K./H-4227-2019; Boch, Steffen/L-5436-2016; Gossner, Martin M./J-2730-2015	Weisser, Wolfgang W/0000-0002-2757-8959; Lewinsohn, Thomas M/0000-0001-5950-5343; Türke, Manfred/0000-0002-8957-5454; Fischer, Markus/0000-0002-5589-5900; Simons, Nadja K./0000-0002-2718-7050; Gossner, Martin M./0000-0003-1516-6364; Socher, Stephanie/0000-0002-0090-4005	DFG [DFG-WE 3081/21-1]; DAAD (Project TUMBRA); German Research Foundation (DFG); Technische Universitat Munchen	DFG(German Research Foundation (DFG)); DAAD (Project TUMBRA); German Research Foundation (DFG)(German Research Foundation (DFG)); Technische Universitat Munchen	The work was funded by the DFG Priority Program 1374 "Infrastructure-Biodiversity-Exploratories" (DFG-WE 3081/21-1.). www.dfg.de/spp/en. Additional funds for exchange visits to analyze data were provided by Unicamp (PRP/Faepex) for TML and MMG and by DAAD (Project TUMBRA) for NKH. www.toek.wzw.tum.de/index.php?id = 117. This work was supported by the German Research Foundation (DFG) and the Technische Universitat Munchen within the funding programme Open Access Publishing. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allan E, 2014, P NATL ACAD SCI USA, V111, P308, DOI 10.1073/pnas.1312213111; Andreasen C, 2002, WEED TECHNOL, V16, P873, DOI 10.1614/0890-037X(2002)016[0873:ROWSAC]2.0.CO;2; [Anonymous], 1998, STANDARDLISTE FARN B; Becklin KM, 2006, CAN J BOT, V84, P1298, DOI 10.1139/B06-099; Bell JR, 2001, J ZOOL, V255, P377, DOI 10.1017/S0952836901001479; Bluthgen N, 2012, BASIC APPL ECOL, V13, P207, DOI 10.1016/j.baae.2012.04.001; Borer ET, 2012, ECOL LETT, V15, P1457, DOI 10.1111/ele.12006; Brook AJ, 2008, J APPL ECOL, V45, P1357, DOI 10.1111/j.1365-2664.2008.01530.x; Buffington ML, 1998, J INSECT CONSERV, V2, P99, DOI 10.1023/A:1009653021706; Chamberlain DE, 2000, J APPL ECOL, V37, P771, DOI 10.1046/j.1365-2664.2000.00548.x; Dennis P, 2008, J APPL ECOL, V45, P279, DOI 10.1111/j.1365-2664.2007.01378.x; Di Giulio M, 2001, J APPL ECOL, V38, P310, DOI 10.1046/j.1365-2664.2001.00605.x; Doxon ED, 2011, J FIELD ORNITHOL, V82, P60, DOI 10.1111/j.1557-9263.2010.00308.x; Fischer M, 2010, BASIC APPL ECOL, V11, P473, DOI 10.1016/j.baae.2010.07.009; Geiger F, 2010, BASIC APPL ECOL, V11, P97, DOI 10.1016/j.baae.2009.12.001; Grace J.B., 2006, STRUCT EQ MOD NAT; Haddad NM, 2009, ECOL LETT, V12, P1029, DOI 10.1111/j.1461-0248.2009.01356.x; Haddad NM, 2001, AM NAT, V158, P17, DOI 10.1086/320866; Hopkins A, 2006, J AGR SCI-CAMBRIDGE, V144, P503, DOI 10.1017/S0021859606006496; Humbert JY, 2009, AGR ECOSYST ENVIRON, V130, P1, DOI 10.1016/j.agee.2008.11.014; HUTCHINSON GE, 1959, AM NAT, V93, P145, DOI 10.1086/282070; Lavorel S, 2013, J VEG SCI, V24, P942, DOI 10.1111/jvs.12083; Lewinsohn TM, 2008, ECOL LETT, V11, P398, DOI 10.1111/j.1461-0248.2008.01155.x; Littlewood NA, 2012, INSECT CONSERV DIVER, V5, P1, DOI 10.1111/j.1752-4598.2011.00174.x; Marini L, 2008, J APPL ECOL, V45, P361, DOI 10.1111/j.1365-2664.2007.01402.x; Marion B, 2010, ECOSCIENCE, V17, P229, DOI 10.2980/17-3-3315; MORRIS MG, 1979, J APPL ECOL, V16, P77, DOI 10.2307/2402730; Nickel H, 2003, AGR ECOSYST ENVIRON, V98, P183, DOI 10.1016/S0167-8809(03)00080-X; R Core Team, 2021, R LANGUAGE ENV STAT; ROGERS LE, 1976, ANN ENTOMOL SOC AM, V69, P387, DOI 10.1093/aesa/69.2.387; Rook AJ, 2004, BIOL CONSERV, V119, P137, DOI 10.1016/j.biocon.2003.11.010; Ryder C, 2005, BIODIVERS CONSERV, V14, P187, DOI 10.1007/s10531-005-5045-1; Scohier A, 2012, ANIMAL, V6, P1129, DOI 10.1017/S1751731111002618; Sjodin NE, 2008, J APPL ECOL, V45, P763, DOI 10.1111/j.1365-2664.2007.01443.x; Socher SA, 2012, J ECOL, V100, P1391, DOI 10.1111/j.1365-2745.2012.02020.x; SOUTHWOOD TRE, 1979, BIOL J LINN SOC, V12, P327, DOI 10.1111/j.1095-8312.1979.tb00063.x; Spafford RD, 2013, ECOL EVOL, V3, P3347, DOI 10.1002/ece3.688; Srivastava DS, 1998, AM NAT, V152, P510, DOI 10.1086/286187; Standen V, 2000, J APPL ECOL, V37, P884, DOI 10.1046/j.1365-2664.2000.00532.x; Strong D., 1984, INSECTS PLANTS COMMU; van den Berg LJL, 2011, GLOBAL CHANGE BIOL, V17, P1871, DOI 10.1111/j.1365-2486.2010.02345.x; Watkinson AR, 2001, J APPL ECOL, V38, P233, DOI 10.1046/j.1365-2664.2001.00621.x; Weiner CN, 2011, BASIC APPL ECOL, V12, P292, DOI 10.1016/j.baae.2010.08.006; Woodcock BA, 2009, J APPL ECOL, V46, P920, DOI 10.1111/j.1365-2664.2009.01675.x	44	29	30	3	78	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 4	2014	9	9							e107033	10.1371/journal.pone.0107033	http://dx.doi.org/10.1371/journal.pone.0107033			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3XV	25188423	Green Published, gold, Green Submitted			2022-12-27	WOS:000341271500111
J	Bergman, EJ; Doherty, PF; Bishop, CJ; Wolfe, LL; Banulis, BA				Bergman, Eric J.; Doherty, Paul F., Jr.; Bishop, Chad J.; Wolfe, Lisa L.; Banulis, Bradley A.			Herbivore Body Condition Response in Altered Environments: Mule Deer and Habitat Management	PLOS ONE			English	Article							WHITE-TAILED DEER; WESTERN JUNIPER; NUTRITIONAL CONDITION; POPULATION-DYNAMICS; DETECTING PREGNANCY; PREDICTIVE MODELS; NET-GUN; MOOSE; ULTRASONOGRAPHY; FAT	The relationships between habitat, body condition, life history characteristics, and fitness components of ungulates are interwoven and of interest to researchers as they strive to understand the impacts of a changing environment. With the increased availability of portable ultrasound machines and the refinement of hormonal assays, assessment of ungulate body condition has become an accessible monitoring strategy. We employed body condition scoring, estimation of % ingesta-free body fat (%IFBF), assessment of free thyroid hormones (FT4 and FT3), and assessment of pregnancy, as metrics to determine if landscape-level habitat treatments affected body condition of adult (>= 1.5 years old) female mule deer (Odocoileus hemionus). All body condition related metrics were measured on 2 neighboring study areas - a reference area that had received no habitat treatments and a treatment study area that had received mechanical removal of pinyon pine (Pinyus edulis) - Utah juniper (Juniperus osteosperma) forest, chemical control of weeds, and reseeding with preferred mule deer browse species. A consistent trend of higher %IFBF was observed in the treatment study area ((%) over bar IFBF = 7: 38, SD = 1.31) than in the reference study area ((%) over bar IFBF = 6.97, SD = 2.16), although variation of estimates was larger than hypothesized. A similar pattern was observed with higher thyroid hormones concentrations being observed in the treatment study area, but large amounts of variation within concentration estimates were also observed. The consistent pattern of higher body condition related estimates in our treatment study area provides evidence that large mammalian species are sensitive to landscape change, although variation within estimates underlie the challenge in detecting population level impacts stemming from environmental change.	[Bergman, Eric J.; Bishop, Chad J.; Wolfe, Lisa L.] Colorado Pk & Wildlife, Mammals Res, Ft Collins, CO 80523 USA; [Doherty, Paul F., Jr.] Colorado State Univ, Dept Fish Wildlife & Conservat Biol, Ft Collins, CO 80523 USA; [Banulis, Bradley A.] Colorado Pk & Wildlife, Terr Programs, Montrose, CO USA	Colorado State University	Bergman, EJ (corresponding author), Colorado Pk & Wildlife, Mammals Res, Ft Collins, CO 80523 USA.	eric.bergman@state.co.us			Colorado Parks and Wildlife Game Cash Funds; USFWS Federal Aid Research Grants; Colorado Parks and Wildlife Habitat Partnership Program; Mule Deer Foundation; Colorado Parks and Wildlife Big Game Auction and Raffle Grants	Colorado Parks and Wildlife Game Cash Funds; USFWS Federal Aid Research Grants; Colorado Parks and Wildlife Habitat Partnership Program; Mule Deer Foundation; Colorado Parks and Wildlife Big Game Auction and Raffle Grants	Funding for this research was provided by Colorado Parks and Wildlife Game Cash Funds, USFWS Federal Aid Research Grants, Colorado Parks and Wildlife Habitat Partnership Program, the Mule Deer Foundation, and Colorado Parks and Wildlife Big Game Auction and Raffle Grants. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barbieri MM, 2004, ANN STAT, V32, P870, DOI 10.1214/009053604000000238; Bates JD, 2000, J RANGE MANAGE, V53, P119, DOI 10.2307/4003402; Bates JD, 1998, GREAT BASIN NAT, V58, P363; Bergman EJ, 2014, J WILDLIFE MANAGE, V78, P448, DOI 10.1002/jwmg.683; Bishop C. J., 2009, WILDLIFE MONOGRAPHS, V172; Bishop CJ, 2009, J WILDLIFE MANAGE, V73, P462, DOI 10.2193/2008-015; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Cook RC, 2007, J WILDLIFE MANAGE, V71, P1934, DOI 10.2193/2006-262; Cook RC, 2010, J WILDLIFE MANAGE, V74, P880, DOI 10.2193/2009-031; Cook RC, 2001, J WILDLIFE MANAGE, V65, P973, DOI 10.2307/3803046; Doherty PF, 2012, J ORNITHOL, V152, pS317, DOI 10.1007/s10336-010-0598-5; EBERHARDT L L, 1977, Wildlife Society Bulletin, V5, P162; EBERHARDT L L, 1977, Environmental Conservation, V4, P205; Feldman E. C., 2004, CANINE FELINE ENDOCR; Gaillard JM, 2013, ECOLOGY, V94, P1261, DOI 10.1890/12-0710.1; Gaillard JM, 1998, TRENDS ECOL EVOL, V13, P58, DOI 10.1016/S0169-5347(97)01237-8; Gaillard JM, 2000, ANNU REV ECOL SYST, V31, P367, DOI 10.1146/annurev.ecolsys.31.1.367; Hamlin KL, 2000, J WILDLIFE MANAGE, V64, P441, DOI 10.2307/3803242; Houston EW, 2001, J ZOO WILDLIFE MED, V32, P366, DOI 10.1638/1042-7260(2001)032[0366:MPIBBB]2.0.CO;2; Jacques CN, 2009, J WILDLIFE MANAGE, V73, P1282, DOI 10.2193/2009-039; Keech MA, 2000, J WILDLIFE MANAGE, V64, P450, DOI 10.2307/3803243; Massey J, 2013, ECOLOGY, V94, P1271, DOI 10.1890/12-0708.1; Meyer DJ., 2004, VET LAB MED INTERPRE; Miller RF, 2000, J RANGE MANAGE, V53, P574, DOI 10.2307/4003150; ROBINETTE W. LESLIE, 1957, JOUR WILDLIFE MANAGEMENT, V21, P134, DOI 10.2307/3797579; SEVERINGHAUS CW, 1949, J WILDLIFE MANAGE, V13, P195, DOI 10.2307/3796089; SMITH RB, 1982, J WILDLIFE MANAGE, V46, P1089, DOI 10.2307/3808248; STEPHENSON TR, 1993, ALCES N AM, V29, P115; Stephenson TR, 2002, WILDLIFE SOC B, V30, P557; Stephenson TR, 1998, CAN J ZOOL, V76, P717, DOI 10.1139/cjz-76-4-717; Vahtiala S, 2004, THERIOGENOLOGY, V61, P785, DOI 10.1016/S0093-691X(03)00253-X; Watkins B, 2007, HABITAT GUIDELINES M; WATKINS BE, 1983, CAN J ZOOL, V61, P1116, DOI 10.1139/z83-146; WATKINS BE, 1982, CAN J ZOOL, V60, P1331, DOI 10.1139/z82-180; Webb SL, 2008, J WILDLIFE MANAGE, V72, P310, DOI 10.2193/2007-101; WOOD AK, 1986, J WILDLIFE MANAGE, V50, P684, DOI 10.2307/3800981; YOUNG JA, 1985, WEED SCI, V33, P513, DOI 10.1017/S0043174500082758	37	13	13	0	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 3	2014	9	9							e106374	10.1371/journal.pone.0106374	http://dx.doi.org/10.1371/journal.pone.0106374			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3TB	25184410	Green Submitted, Green Published, gold			2022-12-27	WOS:000341257700063
J	Li, PF; Cheng, ZG; Ma, BL; Palta, JA; Kong, HY; Mo, F; Wang, JY; Zhu, Y; Lv, GC; Batool, A; Bai, X; Li, FM; Xiong, YC				Li, Pu-Fang; Cheng, Zheng-Guo; Ma, Bao-Luo; Palta, Jairo A.; Kong, Hai-Yan; Mo, Fei; Wang, Jian-Yong; Zhu, Ying; Lv, Guang-Chao; Batool, Asfa; Bai, Xue; Li, Feng-Min; Xiong, You-Cai			Dryland Wheat Domestication Changed the Development of Aboveground Architecture for a Well-Structured Canopy	PLOS ONE			English	Article							WATER-USE EFFICIENCY; SPRING WHEAT; COMPETITIVE ABILITY; GENETIC-IMPROVEMENT; DROUGHT TOLERANCE; GRAIN-YIELD; LEAF SIZE; GROWTH; EVOLUTION; NITROGEN	We examined three different-ploidy wheat species to elucidate the development of aboveground architecture and its domesticated mechanism under environment-controlled field conditions. Architecture parameters including leaf, stem, spike and canopy morphology were measured together with biomass allocation, leaf net photosynthetic rate and instantaneous water use efficiency (WUEi). Canopy biomass density was decreased from diploid to tetraploid wheat, but increased to maximum in hexaploid wheat. Population yield in hexaploid wheat was higher than in diploid wheat, but the population fitness and individual competition ability was higher in diploid wheats. Plant architecture was modified from a compact type in diploid wheats to an incompact type in tetraploid wheats, and then to a more compact type of hexaploid wheats. Biomass accumulation, population yield, harvest index and the seed to leaf ratio increased from diploid to tetraploid and hexaploid, associated with heavier specific internode weight and greater canopy biomass density in hexaploid and tetraploid than in diploid wheat. Leaf photosynthetic rate and WUEi were decreased from diploid to tetraploid and increased from tetraploid to hexaploid due to more compact leaf type in hexaploid and diploid than in tetraploid. Grain yield formation and WUEi were closely associated with spatial stance of leaves and stems. We conclude that the ideotype of dryland wheats could be based on spatial reconstruction of leaf type and further exertion of leaf photosynthetic rate.	[Li, Pu-Fang; Cheng, Zheng-Guo; Kong, Hai-Yan; Mo, Fei; Wang, Jian-Yong; Zhu, Ying; Lv, Guang-Chao; Batool, Asfa; Bai, Xue; Li, Feng-Min; Xiong, You-Cai] Lanzhou Univ, Sch Life Sci, Inst Arid Agroecol, State Key Lab Grassland Agroecosyst, Lanzhou 730000, Peoples R China; [Li, Pu-Fang; Ma, Bao-Luo] Agr & Agri Food Canada, ECORC, Ottawa, ON, Canada; [Palta, Jairo A.] CSIRO Plant Ind, Canberra, ACT, Australia; [Palta, Jairo A.] Univ Western Australia, Fac Nat & Agr Sci, Sch Plant Biol, Perth, WA 6009, Australia	Lanzhou University; Agriculture & Agri Food Canada; Commonwealth Scientific & Industrial Research Organisation (CSIRO); University of Western Australia	Xiong, YC (corresponding author), Lanzhou Univ, Sch Life Sci, Lanzhou 730000, Peoples R China.	xiongyc@lzu.edu.cn	Palta, Jairo/F-4652-2011; mo, fei/B-5253-2018; Li, Fengmin/K-8740-2012; Xiong, You-Cai/HDL-8596-2022; Batool, Asfa/V-9416-2019; LI, feng/HIR-1703-2022; Mo, Fei/R-5645-2017	Li, Fengmin/0000-0002-2144-3498; Xiong, You-Cai/0000-0002-4394-8331; Mo, Fei/0000-0002-7538-0453; Palta, Jairo/0000-0002-4116-7670	Natural Science Foundation of China [31070372, 31350110219]; Meteorological Industrial Program [GYHY201106029 -2]; Fundamental Research Funds for the Central Universities of China [lzujbky-2012-220]; International Cooperation Program of Ministry of Science and Technology of China [2010DFA32790]; Oversea Master Program of Ministry of Education [Ms2011LZDX059]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Meteorological Industrial Program; Fundamental Research Funds for the Central Universities of China(Fundamental Research Funds for the Central Universities); International Cooperation Program of Ministry of Science and Technology of China; Oversea Master Program of Ministry of Education	This research was funded in part by the Natural Science Foundation of China (31070372 and 31350110219), National Meteorological Industrial Program (GYHY201106029 -2), the Fundamental Research Funds for the Central Universities of China (lzujbky-2012-220), International Cooperation Program of Ministry of Science and Technology of China (2010DFA32790) and the Oversea Master Program of Ministry of Education (Ms2011LZDX059). This is a joint contribution between Lanzhou University and Agriculture and Agri-Food Canada. AAFC-ECORC contribution no. is 13-517. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], [No title captured]; Bertin N, 1998, ANN BOT-LONDON, V82, P71, DOI 10.1006/anbo.1998.0647; Brooks TJ, 2000, PHOTOSYNTH RES, V66, P97, DOI 10.1023/A:1010634521467; Canevara M. G., 1994, European Journal of Agronomy, V3, P175, DOI 10.1016/S1161-0301(14)80081-6; Cattivelli L, 2008, FIELD CROP RES, V105, P1, DOI 10.1016/j.fcr.2007.07.004; CHAPIN FS, 1980, ANNU REV ECOL SYST, V11, P233, DOI 10.1146/annurev.es.11.110180.001313; COPELAND PJ, 1985, CROP SCI, V25, P843, DOI 10.2135/cropsci1985.0011183X002500050028x; Craine JM, 2006, PLANT SOIL, V285, P171, DOI 10.1007/s11104-006-9002-x; Cruz-Aguado JA, 1999, ANN BOT-LONDON, V83, P655, DOI 10.1006/anbo.1999.0869; DEWEY WG, 1985, CROP SCI, V25, P245, DOI 10.2135/cropsci1985.0011183X002500020011x; Donald C. M., 1981, WHEAT SCI TODAY TOMO; DONALD CM, 1968, EUPHYTICA, V17, P385, DOI 10.1007/BF00056241; Dubcovsky J, 2007, SCIENCE, V316, P1862, DOI 10.1126/science.1143986; Dvorak J, 1998, THEOR APPL GENET, V97, P657, DOI 10.1007/s001220050942; Falster DS, 2003, NEW PHYTOL, V158, P509, DOI 10.1046/j.1469-8137.2003.00765.x; FELDMAN M, 1981, SCI AM, V244, P102, DOI 10.1038/scientificamerican0181-102; Fischer RA, 2008, FIELD CROP RES, V105, P15, DOI 10.1016/j.fcr.2007.04.002; Fischer RA, 2007, J AGR SCI-CAMBRIDGE, V145, P99, DOI 10.1017/S0021859607006843; Fu ZL, 2001, THESIS CHINA AGR U; Fuller DQ, 2007, ANN BOT-LONDON, V100, P903, DOI 10.1093/aob/mcm048; Gastal F, 2002, J EXP BOT, V53, P789, DOI 10.1093/jexbot/53.370.789; GAUDET CL, 1988, NATURE, V334, P242, DOI 10.1038/334242a0; Gelang J, 2001, ENVIRON EXP BOT, V46, P155, DOI 10.1016/S0098-8472(01)00092-2; Guo TC, 2001, ACTA AGRONOMICA SINI, V27, P633; HARLAN JR, 1966, SCIENCE, V153, P1074, DOI 10.1126/science.153.3740.1074; HARLAN JR, 1973, EVOLUTION, V27, P311, DOI [10.2307/2406971, 10.1111/j.1558-5646.1973.tb00676.x]; Huang ZhongWen, 2009, Acta Agronomica Sinica, V35, P1483; Hunt HW, 1998, ANN BOT-LONDON, V81, P489, DOI 10.1006/anbo.1998.0584; HURD EA, 1974, AGR METEOROL, V14, P39, DOI 10.1016/0002-1571(74)90009-0; Jiang GM, 2000, PHOTOSYNTHETICA, V38, P227, DOI 10.1023/A:1007222016017; Kihara H, 1944, AGR HORTIC, V19, P889; KOSHKIN EI, 1989, FIELD CROP RES, V22, P297, DOI 10.1016/0378-4290(89)90029-4; Kramer PJ, 1969, PLANT SOIL WATER REL; Li FM, 2001, AGR WATER MANAGE, V49, P163, DOI 10.1016/S0378-3774(01)00088-9; Ma SC, 2008, FIELD CROP RES, V105, P56, DOI 10.1016/j.fcr.2007.07.005; Ma SC, 2010, FIELD CROP RES, V115, P158, DOI 10.1016/j.fcr.2009.10.017; Ma SC, 2009, PLANT GROWTH REGUL, V57, P233, DOI 10.1007/s10725-008-9340-1; McIntyre BD, 1996, AGR FOREST METEOROL, V81, P31, DOI 10.1016/0168-1923(95)02303-8; Niklas KJ, 2006, NEW PHYTOL, V171, P27, DOI 10.1111/j.1469-8137.2006.01760.x; Olesen JE, 2004, FIELD CROP RES, V89, P263, DOI 10.1016/j.fcr.2004.02.005; Palta JA, 2007, FIELD CROP RES, V104, P52, DOI 10.1016/j.fcr.2007.03.015; [潘晓云 Pan Xiaoyun], 2002, [植物生态学报, Acta Phytoecologica Sinica], V26, P177; Richards RA, 2000, J EXP BOT, V51, P447, DOI 10.1093/jexbot/51.suppl_1.447; Salamini F, 2002, NAT REV GENET, V3, P429, DOI 10.1038/nrg817; Sandana P, 2011, FIELD CROP RES, V120, P311, DOI 10.1016/j.fcr.2010.11.005; Shearman VJ, 2005, CROP SCI, V45, P175; [史竹叶 Shi Zhuye], 2003, [干旱地区农业研究, Agricultural Research in the Arid Areas], V21, P101; Slafer GA, 2005, ANN APPL BIOL, V146, P61, DOI 10.1111/j.1744-7348.2005.04048.x; Slafer GA, 2003, ANN APPL BIOL, V142, P117, DOI 10.1111/j.1744-7348.2003.tb00237.x; Slafer GA, 2009, CROP PHYSIOLOGY: APPLICATIONS FOR GENETIC IMPROVEMENT AND AGRONOMY, P277, DOI 10.1016/B978-0-12-374431-9.00012-8; Song YH, 2008, FUNCT PLANT BIOL, V35, P925, DOI 10.1071/FP08055; WAINES JG, 1992, HEREDITAS, V116, P207, DOI 10.1111/j.1601-5223.1992.tb00143.x; WARDLAW IF, 1993, PLANT CELL ENVIRON, V16, P1029, DOI 10.1111/j.1365-3040.1996.tb02054.x; Wardlaw IF, 1961, PHOTOSYNTHESIS CEREA; Weiner J, 1990, AGROECOLOGY; Weinig C, 2000, EVOLUTION, V54, P124, DOI 10.1111/j.0014-3820.2000.tb00013.x; Xiong YC, 2007, ENVIRON EXP BOT, V59, P193, DOI 10.1016/j.envexpbot.2005.12.003; You-Cai X, 2006, PLANTA, V224, P710, DOI 10.1007/s00425-006-0252-x; Yang DM, 2010, ANN BOT-LONDON, V105, P71, DOI 10.1093/aob/mcp262; Yu Bo-Lan, 2001, Acta Genetica Sinica, V28, P635; Zhang DY, 1999, FIELD CROP RES, V61, P179, DOI 10.1016/S0378-4290(98)00156-7; Zhang X, 2002, CHINESE SCI BULL, V47, P1321, DOI 10.1360/02tb9293; Zhou Y, 2007, EUPHYTICA, V157, P465, DOI 10.1007/s10681-007-9376-8; Zohary D, 2000, DOMESTICATION PLANTS, DOI DOI 10.1006/ANBO.2001.1505	64	17	18	0	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2014	9	9							e95825	10.1371/journal.pone.0095825	http://dx.doi.org/10.1371/journal.pone.0095825			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3LR	25181037	gold, Green Published, Green Submitted			2022-12-27	WOS:000341231500003
J	Yamasaki, T; Suzuki, A; Hasebe, R; Horiuchi, M				Yamasaki, Takeshi; Suzuki, Akio; Hasebe, Rie; Horiuchi, Motohiro			Comparison of the Anti-Prion Mechanism of Four Different Anti-Prion Compounds, Anti-PrP Monoclonal Antibody 44B1, Pentosan Polysulfate, Chlorpromazine, and U18666A, in Prion-Infected Mouse Neuroblastoma Cells	PLOS ONE			English	Article							PROTEIN; LOCALIZATION; ACCUMULATION; ENDOCYTOSIS; INHIBITION; QUINACRINE; CLEARANCE; LYSOSOMES; INDUCTION; AUTOPHAGY	Molecules that inhibit the formation of an abnormal isoform of prion protein (PrPSc) in prion-infected cells are candidate therapeutic agents for prion diseases. Understanding how these molecules inhibit PrPSc formation provides logical basis for proper evaluation of their therapeutic potential. In this study, we extensively analyzed the effects of the anti-PrP monoclonal antibody (mAb) 44B1, pentosan polysulfate (PPS), chlorpromazine (CPZ) and U18666A on the intracellular dynamics of a cellular isoform of prion protein (PrPC) and PrPSc in prion-infected mouse neuroblastoma cells to re-evaluate the effects of those agents. MAb 44B1 and PPS rapidly reduced PrPSc levels without altering intracellular distribution of PrPSc. PPS did not change the distribution and levels of PrPC, whereas mAb 44B1 appeared to inhibit the trafficking of cell surface PrPC to organelles in the endocytic-recycling pathway that are thought to be one of the sites for PrPSc formation. In contrast, CPZ and U18666A initiated the redistribution of PrPSc from organelles in the endocytic-recycling pathway to late endosomes/lysosomes without apparent changes in the distribution of PrPC. The inhibition of lysosomal function by monensin or bafilomycin A1 after the occurrence of PrPSc redistribution by CPZ or U18666A partly antagonized PrPSc degradation, suggesting that the transfer of PrPSc to late endosomes/lysosomes, possibly via alteration of the membrane trafficking machinery of cells, leads to PrPSc degradation. This study revealed that precise analysis of the intracellular dynamics of PrPC and PrPSc provides important information for understanding the mechanism of anti-prion agents.	[Yamasaki, Takeshi; Suzuki, Akio; Hasebe, Rie; Horiuchi, Motohiro] Hokkaido Univ, Grad Sch Vet Med, Lab Vet Hyg, Kita Ku, Sapporo, Hokkaido, Japan	Hokkaido University	Horiuchi, M (corresponding author), Hokkaido Univ, Grad Sch Vet Med, Lab Vet Hyg, Kita Ku, Sapporo, Hokkaido, Japan.	horiuchi@vetmed.hokudai.ac.jp		HASEBE, Rie/0000-0003-2009-0595	Program for Leading Graduate Schools [F01]; Japan Initiative for Global Research Network on Infectious Diseases (JGRID); Ministry of Education, Culture, Sports, Science, and Technology, Japan; Ministry of Health, Labour and Welfare of Japan;  [23248050];  [H26-Shokuhin-Ippan-003]	Program for Leading Graduate Schools; Japan Initiative for Global Research Network on Infectious Diseases (JGRID)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Education, Culture, Sports, Science, and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Health, Labour and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); ; 	T.Y. was supported by a Grant-in-Aid for JSPS Fellows (no. 22.4181). This work was supported by a Grant-in-Aid for Science Research (A) (grant no. 23248050), a grant from the Program for Leading Graduate Schools (F01), and the Japan Initiative for Global Research Network on Infectious Diseases (JGRID), from the Ministry of Education, Culture, Sports, Science, and Technology, Japan. This work was also supported by grants for TSE research (H26-Shokuhin-Ippan-003) and Research on Measures for Intractable Diseases from the Ministry of Health, Labour and Welfare of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguib Y, 2009, AUTOPHAGY, V5, P361, DOI 10.4161/auto.5.3.7662; Aguzzi A, 2009, PHYSIOL REV, V89, P1105, DOI 10.1152/physrev.00006.2009; Bate C, 2004, J BIOL CHEM, V279, P14983, DOI 10.1074/jbc.M313061200; Bone I, 2008, EUR J NEUROL, V15, P458, DOI 10.1111/j.1468-1331.2008.02108.x; Bujny MV, 2007, J CELL SCI, V120, P2010, DOI 10.1242/jcs.003111; CAUGHEY B, 1993, J VIROL, V67, P643, DOI 10.1128/JVI.67.2.643-650.1993; Cheung NS, 2004, BIOCHEM BIOPH RES CO, V315, P408, DOI 10.1016/j.bbrc.2004.01.066; Forloni G, 2013, CURR TOP MED CHEM, V13, P2465; Futerman AH, 2004, NAT REV MOL CELL BIO, V5, P554, DOI 10.1038/nrm1423; Geschwind MD, 2013, NEUROLOGY, V81, P2015, DOI 10.1212/WNL.0b013e3182a9f3b4; Gilch S, 2009, CELL MOL LIFE SCI, V66, P3979, DOI 10.1007/s00018-009-0158-4; Heiseke A, 2009, J NEUROCHEM, V109, P25, DOI 10.1111/j.1471-4159.2009.05906.x; Hui C, 2006, CELL SIGNAL, V18, P1844, DOI 10.1016/j.cellsig.2006.04.006; Ikonen E, 2008, NAT REV MOL CELL BIO, V9, P125, DOI 10.1038/nrm2336; Kim CL, 2004, J GEN VIROL, V85, P3473, DOI 10.1099/vir.0.80113-0; Kim CL, 2004, VIROLOGY, V320, P40, DOI 10.1016/j.virol.2003.10.026; Klingenstein R, 2006, J NEUROCHEM, V98, P748, DOI 10.1111/j.1471-4159.2006.03889.x; Korth C, 2001, P NATL ACAD SCI USA, V98, P9836, DOI 10.1073/pnas.161274798; Lingwood D, 2010, SCIENCE, V327, P46, DOI 10.1126/science.1174621; Luzio JP, 2007, NAT REV MOL CELL BIO, V8, P622, DOI 10.1038/nrm2217; Marijanovic Z, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000426; Marzo L, 2013, J CELL SCI, V126, P1345, DOI 10.1242/jcs.114801; MCKINLEY MP, 1991, LAB INVEST, V65, P622; Mizushima N, 2007, GENE DEV, V21, P2861, DOI 10.1101/gad.1599207; Moreno JA, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3006767; Nakagaki T, 2013, AUTOPHAGY, V9, P1386, DOI 10.4161/auto.25381; Nakamitsu S, 2010, J GEN VIROL, V91, P563, DOI 10.1099/vir.0.016287-0; Naslavsky N, 1997, J BIOL CHEM, V272, P6324, DOI 10.1074/jbc.272.10.6324; ODA K, 1991, BIOCHEM BIOPH RES CO, V178, P369, DOI 10.1016/0006-291X(91)91823-U; Pimpinelli F, 2005, EUR J NEUROSCI, V21, P2063, DOI 10.1111/j.1460-9568.2005.04049.x; POHLMANN R, 1984, BIOCHEM J, V217, P649, DOI 10.1042/bj2170649; Relano-Gines A, 2011, J INFECT DIS, V204, P1038, DOI 10.1093/infdis/jir484; Rouvinski A, 2014, J CELL BIOL, V204, P423, DOI 10.1083/jcb.201308028; SHYNG SL, 1995, J BIOL CHEM, V270, P30221; Sim Valerie L., 2012, Infectious Disorders - Drug Targets, V12, P144; Sim Valerie L., 2009, Infectious Disorders - Drug Targets, V9, P81; Sobo K, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000851; Song CH, 2009, J VIROL, V83, P5918, DOI 10.1128/JVI.00165-09; Supattapone S, 1999, P NATL ACAD SCI USA, V96, P14529, DOI 10.1073/pnas.96.25.14529; TARABOULOS A, 1995, J CELL BIOL, V129, P121, DOI 10.1083/jcb.129.1.121; Tomiyama Y, 2004, CELL TISSUE RES, V317, P253, DOI 10.1007/s00441-004-0941-3; Tsuboi Y, 2009, NEUROPATHOLOGY, V29, P632, DOI 10.1111/j.1440-1789.2009.01058.x; Uryu M, 2007, MICROBIOL IMMUNOL, V51, P661, DOI 10.1111/j.1348-0421.2007.tb03954.x; Veith NM, 2009, EUR J CELL BIOL, V88, P45, DOI 10.1016/j.ejcb.2008.08.001; Whittle IR, 2006, ACTA NEUROCHIR, V148, P677, DOI 10.1007/s00701-006-0772-y; Yamaguchi S, 2006, BIOCHEM BIOPH RES CO, V349, P485, DOI 10.1016/j.bbrc.2006.08.072; Yamasaki T, 2014, VIROLOGY, V450, P324, DOI 10.1016/j.virol.2013.11.007; Yamasaki T, 2012, J GEN VIROL, V93, P668, DOI 10.1099/vir.0.037101-0	48	24	25	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2014	9	9							e106516	10.1371/journal.pone.0106516	http://dx.doi.org/10.1371/journal.pone.0106516			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3LR	25181483	gold, Green Published			2022-12-27	WOS:000341231500106
J	Akaishi, T; Yamaguchi, T; Suzuki, Y; Nagane, Y; Suzuki, S; Murai, H; Imai, T; Motomura, M; Fujihara, K; Aoki, M; Utsugisawa, K				Akaishi, Tetsuya; Yamaguchi, Takuhiro; Suzuki, Yasushi; Nagane, Yuriko; Suzuki, Shigeaki; Murai, Hiroyuki; Imai, Tomihiro; Motomura, Masakatsu; Fujihara, Kazuo; Aoki, Masashi; Utsugisawa, Kimiaki			Insights into the Classification of Myasthenia Gravis	PLOS ONE			English	Article							CLUSTER-ANALYSIS	Background and Purpose: Myasthenia gravis (MG) is often categorized into thymoma-associated MG, early-onset MG with onset age,50 years, and late-onset MG with onset age >= 50 years. However, the boundary age of 50 years old between early-and late-onset MG remains controversial, and each category contains further subtypes. We attempted to classify MG from a statistical perspective. Methods: We analyzed 640 consecutive MG patients using two-step cluster analysis with clinical variables and discrimination analysis, using onset age as a variable. Results: Two-step cluster analyses categorized MG patients into the following five subtypes: ocular MG; MG with thymic hyperplasia (THMG); generalized anti-acetylcholine receptor antibody (AChR-Ab)-negative MG; thymoma-associated MG; and generalized AChR-Ab-positive (SP) MG without thymic abnormalities. Among these 5 subtypes, THMG showed a distribution of onset age skewed toward a younger age (p < 0.01), whereas ocular MG and SPMG without thymic abnormalities showed onset age skewed toward an older age (p < 0.001 and p < 0.0001, respectively). The other 2 subtypes showed normal distributions. THMG appeared as the main component of early-onset MG, and ocular MG and SPMG without thymic abnormalities as the main components of late-onset MG. Discrimination analyses between THMG and ocular MG and/or SPMG without thymic abnormalities demonstrated a boundary age of 45 years old. Conclusions: From a statistical perspective, the boundary age between early-and late-onset MG is about 45 years old.	[Akaishi, Tetsuya; Fujihara, Kazuo; Aoki, Masashi] Tohoku Univ, Grad Sch Med, Dept Neurol, Sendai, Miyagi 980, Japan; [Yamaguchi, Takuhiro] Tohoku Univ, Grad Sch Med, Div Biostat, Sendai, Miyagi 980, Japan; [Suzuki, Yasushi] Sendai Med Ctr, Dept Neurol, Sendai, Miyagi, Japan; [Nagane, Yuriko; Utsugisawa, Kimiaki] Hanamaki Gen Hosp, Dept Neurol, Hanamaki, Japan; [Suzuki, Shigeaki] Keio Univ, Sch Med, Dept Neurol, Tokyo, Japan; [Murai, Hiroyuki] Kyushu Univ, Grad Sch Med Sci, Neurol Inst, Dept Neurol, Fukuoka 812, Japan; [Murai, Hiroyuki] Sapporo Med Univ, Sch Hlth Sci, Sapporo, Hokkaido, Japan; [Motomura, Masakatsu] Nagasaki Inst Appl Sci, Fac Engn, Dept Engn, Med Engn Course, Nagasaki, Japan	Tohoku University; Tohoku University; Keio University; Kyushu University; Sapporo Medical University; Nagasaki Institute of Applied Science	Utsugisawa, K (corresponding author), Hanamaki Gen Hosp, Dept Neurol, Hanamaki, Japan.	kutsugi@s4.dion.ne.jp	Suzuki, Shigeaki/N-9555-2013; Akaishi, Tetsuya/ABI-7460-2022		Japan MG registry study group; Neuroimmunological Disease Research Committee Grant from the Japanese Ministry of Health, Labour, and Welfare	Japan MG registry study group; Neuroimmunological Disease Research Committee Grant from the Japanese Ministry of Health, Labour, and Welfare	This work was supported by a fund of the Japan MG registry study group and by a Neuroimmunological Disease Research Committee Grant from the Japanese Ministry of Health, Labour, and Welfare. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aarli JA, 1999, ARCH NEUROL-CHICAGO, V56, P25, DOI 10.1001/archneur.56.1.25; Jaretzki A, 2000, NEUROLOGY, V55, P16, DOI 10.1212/WNL.55.1.16; Marx A, 2013, AUTOIMMUN REV, V12, P875, DOI 10.1016/j.autrev.2013.03.007; Meriggioli MN, 2009, LANCET NEUROL, V8, P475, DOI 10.1016/S1474-4422(09)70063-8; Murai H., 2014, CLIN EXP NEUROIMMUNO, V5, P84, DOI [10.1111/cen3.12091, DOI 10.1111/CEN3.12091]; Olsen SF, 1996, BRIT MED J, V313, P863; ROUSSEEUW PJ, 1987, J COMPUT APPL MATH, V20, P53, DOI 10.1016/0377-0427(87)90125-7; Suzuki S, 2013, J NEUROL NEUROSUR PS, V84, P989, DOI 10.1136/jnnp-2012-304057; Utsugisawa K, 2014, MUSCLE NERV IN PRESS	9	14	16	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2014	9	9							e106757	10.1371/journal.pone.0106757	http://dx.doi.org/10.1371/journal.pone.0106757			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ1IR	25192469	Green Submitted, Green Published, gold			2022-12-27	WOS:000347993600059
J	Lorenz, J; Seebach, E; Hackmayer, G; Greth, C; Bauer, RJ; Kleinschmidt, K; Bettenworth, D; Bohm, M; Grifka, J; Grassel, S				Lorenz, Julia; Seebach, Elisabeth; Hackmayer, Gerit; Greth, Carina; Bauer, Richard J.; Kleinschmidt, Kerstin; Bettenworth, Dominik; Boehm, Markus; Grifka, Joachim; Graessel, Susanne			Melanocortin 1 Receptor-Signaling Deficiency Results in an Articular Cartilage Phenotype and Accelerates Pathogenesis of Surgically Induced Murine Osteoarthritis	PLOS ONE			English	Article							INTERCELLULAR-ADHESION MOLECULE-1; MELANOCYTE-STIMULATING HORMONE; SUBCHONDRAL BONE; ALPHA-MSH; CHONDROCYTES; PROOPIOMELANOCORTIN; PEPTIDES; MODEL; HYALURONAN; EXPRESSION	Proopiomelanocortin-derived peptides exert pleiotropic effects via binding to melanocortin receptors (MCR). MCR-subtypes have been detected in cartilage and bone and mediate an increasing number of effects in diathrodial joints. This study aims to determine the role of MC1-receptors (MC1) in joint physiology and pathogenesis of osteoarthritis (OA) using MC1-signaling deficient mice (Mc1re/e). OA was surgically induced in Mc1re/e and wild-type (WT) mice by transection of the medial meniscotibial ligament. Histomorphometry of Safranin O stained articular cartilage was performed with non-operated controls (11 weeks and 6 months) and 4/8 weeks past surgery. mu CT-analysis for assessing epiphyseal bone architecture was performed as a longitudinal study at 4/8 weeks after OA-induction. Collagen II, ICAM-1 and MC1 expression was analysed by immunohistochemistry. Mc1re/e mice display less Safranin O and collagen II stained articular cartilage area compared to WT prior to OA-induction without signs of spontaneous cartilage surface erosion. This MC1-signaling deficiency related cartilage phenotype persisted in 6 month animals. At 4/8 weeks after OA-induction cartilage erosions were increased in Mc1re/e knees paralleled by weaker collagen II staining. Prior to OA-induction, Mc1re/e mice do not differ from WT with respect to bone parameters. During OA, Mc1re/e mice developed more osteophytes and had higher epiphyseal bone density and mass. Trabecular thickness was increased while concomitantly trabecular separation was decreased in Mc1re/e mice. Numbers of ICAM-positive chondrocytes were equal in non-operated 11 weeks Mc1re/e and WT whereas number of positive chondrocytes decreased during OA-progression. Unchallenged Mc1re/e mice display smaller articular cartilage covered area without OA-related surface erosions indicating that MC1-signaling is critical for proper cartilage matrix integrity and formation. When challenged with OA, Mc1re/e mice develop a more severe OA-pathology. Our data suggest that MC1-signaling protects against cartilage degradation and subchondral bone sclerosis in OA indicating a beneficial role of the POMC system in joint pathophysiology.	[Lorenz, Julia; Hackmayer, Gerit; Bauer, Richard J.; Graessel, Susanne] Univ Hosp Regensburg, Regensburg, Bavaria, Germany; [Seebach, Elisabeth; Greth, Carina] Orthoped Univ Hosp Heidelberg, Res Ctr Expt Orthoped, Heidelberg, Baden Wurttembe, Germany; [Kleinschmidt, Kerstin] Merck Serono Global Res & Dev, TIP Immunol, Darmstadt, Hessen, Germany; [Hackmayer, Gerit; Bettenworth, Dominik; Boehm, Markus] Univ Hosp Munster, Munster, North Rhine Wes, Germany; [Lorenz, Julia; Grifka, Joachim; Graessel, Susanne] Univ Hosp Regensburg, Bad Abbach, Bavaria, Germany	University of Regensburg; Ruprecht Karls University Heidelberg; University of Munster; University of Regensburg	Grassel, S (corresponding author), Univ Hosp Regensburg, Regensburg, Bavaria, Germany.	susanne.graessel@klinik.uni-regensburg.de		Bettenworth, Dominik/0000-0002-1435-4825	DFG [GR1301/9-1]	DFG(German Research Foundation (DFG))	This work was funded by the DFG, and the grant No. GR1301/9-1 was assigned to SG and MB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bettica P, 2002, ARTHRITIS RHEUM, V46, P3178, DOI 10.1002/art.10630; Bohm M, 2012, ENDOCR REV, V33, P623, DOI 10.1210/er.2011-1016; Bohm M, 1999, ANN NY ACAD SCI, V885, P372; Botter SM, 2008, OSTEOARTHR CARTILAGE, V16, P506, DOI 10.1016/j.joca.2007.08.005; Botter SM, 2011, ARTHRITIS RHEUM-US, V63, P2690, DOI 10.1002/art.30307; Brzoska T, 2008, ENDOCR REV, V29, P581, DOI 10.1210/er.2007-0027; Burr DB, 2004, J RHEUMATOL, V31, P77; Ceriani Giuliana, 1994, Neuroimmunomodulation, V1, P28, DOI 10.1159/000097087; Cornish J, 2003, AM J PHYSIOL-ENDOC M, V284, pE1181, DOI 10.1152/ajpendo.00412.2002; DAVIES ME, 1991, CONNECT TISSUE RES, V26, P207, DOI 10.3109/03008209109152439; Dreier R, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar3117; Dumont LM, 2005, PEPTIDES, V26, P1929, DOI 10.1016/j.peptides.2004.12.034; Evans JF, 2004, BONE, V35, P96, DOI 10.1016/j.bone.2004.03.015; Felson DT, 2004, ARTHRITIS RHEUM-US, V50, P341, DOI 10.1002/art.20051; Friedrich-Rust M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077927; Glasson SS, 2007, OSTEOARTHR CARTILAGE, V15, P1061, DOI 10.1016/j.joca.2007.03.006; Glasson SS, 2010, OSTEOARTHR CARTILAGE, V18, pS17, DOI 10.1016/j.joca.2010.05.025; Glasson SS, 2005, NATURE, V434, P644, DOI 10.1038/nature03369; Goldring MB, 2007, J CELL PHYSIOL, V213, P626, DOI 10.1002/jcp.21258; Goldring MB, 2010, ANN NY ACAD SCI, V1192, P230, DOI 10.1111/j.1749-6632.2009.05240.x; Goldring MB, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2592; Grassel S, 2009, ARTHRITIS RHEUM-US, V60, P3017, DOI 10.1002/art.24846; Karsdal MA, 2008, OSTEOARTHR CARTILAGE, V16, P638, DOI 10.1016/j.joca.2008.01.014; Lisignoli G, 2001, ARTHRITIS RHEUM-US, V44, P1800, DOI 10.1002/1529-0131(200108)44:8<1800::AID-ART317>3.0.CO;2-1; MCCOURT PAG, 1994, J BIOL CHEM, V269, P30081; PARFITT AM, 1987, J BONE MINER RES, V2, P595, DOI 10.1002/jbmr.5650020617; Pitsillides AA, 2011, NAT REV RHEUMATOL, V7, P654, DOI 10.1038/nrrheum.2011.129; ROBBINS LS, 1993, CELL, V72, P827, DOI 10.1016/0092-8674(93)90572-8; Schioth HB, 2001, VITAM HORM, V63, P195, DOI 10.1016/S0083-6729(01)63007-3; Sinusas K, 2012, AM FAM PHYSICIAN, V85, P49; Slominski A, 2000, PHYSIOL REV, V80, P979, DOI 10.1152/physrev.2000.80.3.979; van den Berg WB, 2011, OSTEOARTHR CARTILAGE, V19, P338, DOI 10.1016/j.joca.2011.01.022; van der Kraan PM, 2007, OSTEOARTHR CARTILAGE, V15, P237, DOI 10.1016/j.joca.2006.11.006; Vessillier S, 2012, ANN RHEUM DIS, V71, P143, DOI 10.1136/annrheumdis-2011-200100; Yasuda T, 2012, J PHARMACOL SCI, V118, P25, DOI 10.1254/jphs.11044FP; Yasuda T, 2010, CLIN RHEUMATOL, V29, P1259, DOI 10.1007/s10067-010-1512-5; Yoon SW, 2008, OSTEOARTHR CARTILAGE, V16, P115, DOI 10.1016/j.joca.2007.05.026; Zhong Q, 2005, BONE, V36, P820, DOI 10.1016/j.bone.2005.01.020	38	19	21	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2014	9	9							e105858	10.1371/journal.pone.0105858	http://dx.doi.org/10.1371/journal.pone.0105858			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ1IR	25191747	Green Submitted, Green Published, gold			2022-12-27	WOS:000347993600012
J	Wu, YP; Cao, C; Wu, YF; Zhang, C; Zhu, C; Ying, SM; Chen, ZH; Shen, HH; Li, W				Wu, Yanping; Cao, Chao; Wu, Yinfang; Zhang, Chao; Zhu, Chen; Ying, Songmin; Chen, Zhihua; Shen, Huahao; Li, Wen			TNF-alpha-308G/A Polymorphism Contributes to Obstructive Sleep Apnea Syndrome Risk: Evidence Based on 10 Case-Control Studies	PLOS ONE			English	Article							NECROSIS-FACTOR-ALPHA; C-REACTIVE PROTEIN; GENE POLYMORPHISM; TNF-ALPHA; HYPOPNEA SYNDROME; PROMOTER POLYMORPHISM; METAANALYSIS; LIPOPOLYSACCHARIDE; ASSOCIATION; POPULATION	Objective: The aim of our study was to investigate the association between the TNF-alpha-308G/A polymorphism and obstructive sleep apnea syndrome (OSAS). Method: The Medline, Web of Science, EMBASE, Chinese National Knowledge Infrastructure (CNKI), and Cochrane Central Register of Controlled Trials were searched. Pooled odds ratios (ORs) and 95% confidence intervals (CIs) were calculated to study TNF-alpha-308G/A polymorphism and risk of OSAS. Result: 10 case-control studies were included in our meta-analysis. The results from our study showed that the TNF-a-308G/A polymorphism was significantly associated with risk of OSAS (A vs. G: OR = 1.67, 95% CI = 1.43-1.95). In the subgroup analysis by ethnicity, the statistical similar results were observed both in European (A vs. G: OR = 1.68, 95% CI = 1.35-2.08) and Asian population (A vs. G: OR = 2.02, 95% CI = 1.50-2.71). When stratified by age, a significantly increased risk was observed in adult carries A allele compared with G allele (OR = 1.79, 95% CI = 1.50-2.13), whereas no association was found in children (OR = 1.09, 95% CI = 0.70-1.69). Conclusion: Our study suggested that the TNF-alpha- 308G/A polymorphism contributed to the susceptibility to the risk of OSAS. Additional well-designed large studies are needed to validate our findings.	[Wu, Yanping; Cao, Chao; Wu, Yinfang; Zhang, Chao; Zhu, Chen; Ying, Songmin; Chen, Zhihua; Shen, Huahao; Li, Wen] Zhejiang Univ, Sch Med, Affiliated Hosp 2, Dept Resp & Crit Care Med, Hangzhou 310003, Zhejiang, Peoples R China; [Cao, Chao] Ningbo Univ, Sch Med, Affiliated Hosp, Dept Resp Med, Ningbo 315211, Zhejiang, Peoples R China	Zhejiang University; Ningbo University	Li, W (corresponding author), Zhejiang Univ, Sch Med, Affiliated Hosp 2, Dept Resp & Crit Care Med, Hangzhou 310003, Zhejiang, Peoples R China.	liwenzjhz0408@163.com			National Natural Science Foundation of China [81170037, 81370126]; Natural Science Foundation of Ningbo [2012A610257]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Ningbo	This work was supported by grant of National Natural Science Foundation of China (No. 81170037 and No. 81370126) and Natural Science Foundation of Ningbo (No. 2012A610257). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almpanidou P, 2012, HIPPOKRATIA, V16, P217; [Anonymous], 2016, NEWCASTLEOTTAWA SCAL; Bhushan B, 2009, RESP MED, V103, P386, DOI 10.1016/j.rmed.2008.10.001; Brand E, 2001, INT J OBESITY, V25, P581, DOI 10.1038/sj.ijo.0801576; Ciftci TU, 2004, CYTOKINE, V28, P87, DOI 10.1016/j.cyto.2004.07.003; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Eckert Danny J, 2008, Proc Am Thorac Soc, V5, P144, DOI 10.1513/pats.200707-114MG; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Guan Jian YH, 2013, CHLN ARCH OTOLARYNGO, V20; Hiestand DM, 2006, CHEST, V130, P780, DOI 10.1378/chest.130.3.780; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Hoffstedt J, 2000, DIABETOLOGIA, V43, P117, DOI 10.1007/s001250050015; Huang J, 2012, GENET TEST MOL BIOMA, V16, P246, DOI 10.1089/gtmb.2011.0170; Karkucak M, 2012, TURK KLIN TIP BILIM, V32, P1368, DOI 10.5336/medsci.2012-28126; Khalyfa A, 2011, J PEDIATR-US, V158, P81, DOI 10.1016/j.jpeds.2010.07.032; Kielb SA, 2012, NEUROMOL MED, V14, P180, DOI 10.1007/s12017-012-8182-1; Kroeger KM, 2000, CYTOKINE, V12, P110, DOI 10.1006/cyto.1999.0529; Krueger JM, 2008, CURR PHARM DESIGN, V14, P3408, DOI 10.2174/138161208786549281; Lau J, 1997, ANN INTERN MED, V127, P820, DOI 10.7326/0003-4819-127-9-199711010-00008; Li F, 2006, TUMOR NECROSIS FACTO; Li NF, 2010, CLIN EXP HYPERTENS, V32, P54, DOI 10.3109/10641960902993087; Li T, 2013, ACAD J CHINESE PLA M, V34; Liu Hui-guo, 2006, Zhonghua Jiehe He Huxi Zazhi, V29, P596; Louis E, 1998, CLIN EXP IMMUNOL, V113, P401; MANTEL N, 1959, J NATL CANCER I, V22, P719; Popko K, 2008, J PHYSIOL PHARMACOL, V59, P607; Raabe T, 1998, J BIOL CHEM, V273, P974, DOI 10.1074/jbc.273.2.974; Riha RL, 2005, EUR RESPIR J, V26, P673, DOI 10.1183/09031936.05.00130804; Shamsuzzaman ASM, 2002, CIRCULATION, V105, P2462, DOI 10.1161/01.CIR.0000018948.95175.03; Teramoto S, 2003, CIRCULATION, V107, pE40, DOI 10.1161/01.CIR.0000053956.46188.5F; WILSON A, 1992, J ROY SOC MED, V85, P1; Wilson AG, 1997, P NATL ACAD SCI USA, V94, P3195, DOI 10.1073/pnas.94.7.3195; Young T, 2002, AM J RESP CRIT CARE, V165, P1217, DOI 10.1164/rccm.2109080; Zamarron C, 2008, EUR J INTERN MED, V19, P390, DOI 10.1016/j.ejim.2007.12.006	35	13	15	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2014	9	9							e106183	10.1371/journal.pone.0106183	http://dx.doi.org/10.1371/journal.pone.0106183			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ1IR	25192323	gold, Green Published, Green Submitted			2022-12-27	WOS:000347993600016
J	Bednarek, I; Manka, R; Pienkos, M				Bednarek, Ilona; Manka, Ryszard; Pienkos, Monika			The Influence of the Enhanced Vector Meson Sector on the Properties of the Matter of Neutron Stars	PLOS ONE			English	Article							EQUATION-OF-STATE; MEAN-FIELD-THEORY; LAMBDA-HYPERNUCLEI; UNSTABLE NUCLEI; MODEL; HYPERONS; MASS	This paper gives an overview of the model of a neutron star with non-zero strangeness constructed within the framework of the nonlinear realization of the chiral SU(3)(L) x SU(3)(R) symmetry. The emphasis is put on the physical properties of the matter of a neutron star as well as on its internal structure. The obtained solution is particularly aimed at the problem of the construction of a theoretical model of a neutron star matter with hyperons that will give high value of the maximum mass.	[Bednarek, Ilona; Pienkos, Monika] Silesian Univ, Inst Phys, Dept Astrophys & Cosmol, PL-40007 Katowice, Poland; [Manka, Ryszard] Independent Researcher, Katowice, Poland	University of Silesia in Katowice	Bednarek, I (corresponding author), Silesian Univ, Inst Phys, Dept Astrophys & Cosmol, Uniwersytecka 4, PL-40007 Katowice, Poland.	ilona.bednarek@us.edu.pl						Agrawal BK, 2010, PHYS REV C, V81, DOI 10.1103/PhysRevC.81.034323; Antoniadis J, 2013, SCIENCE, V340, DOI 10.1126/science.1233232; Baldo M, 1998, PHYS REV C, V58, P3688, DOI 10.1103/PhysRevC.58.3688; BAYM G, 1971, ASTROPHYS J, V170, P299, DOI 10.1086/151216; BAYM G, 1971, NUCL PHYS A, VA175, P225, DOI 10.1016/0375-9474(71)90281-8; Bednarek I, 2012, ASTRON ASTROPHYS, V543, DOI 10.1051/0004-6361/201118560; Bednarek I, 2006, PHYS REV C, V73, DOI 10.1103/PhysRevC.73.045804; Bednarek I, 2011, ACTA PHYS POL B, V42, P2211, DOI 10.5506/APhysPolB.42.2211; Bednarek I, 2011, ACTA PHYS POL B, V42, P2221, DOI 10.5506/APhysPolB.42.2221; Bednarek I, 2009, ACTA PHYS POL B, V40, P3071; Bednarek I, 2009, J PHYS G NUCL PARTIC, V36, DOI 10.1088/0954-3899/36/9/095201; BODMER AR, 1989, NUCL PHYS A, V505, P123, DOI 10.1016/0375-9474(89)90419-3; BOGUTA J, 1977, NUCL PHYS A, V292, P413, DOI 10.1016/0375-9474(77)90626-1; Bombaci I, 2009, PHYS LETT B, V680, P448, DOI 10.1016/j.physletb.2009.09.039; Bonanno L, 2012, ASTRON ASTROPHYS, V539, DOI 10.1051/0004-6361/201117832; Buballa M, 2005, PHYS REP, V407, P205, DOI 10.1016/j.physrep.2004.11.004; Carriere J, 2003, ASTROPHYS J, V593, P463, DOI 10.1086/376515; Chamel N, 2008, LIVING REV RELATIV, V11, DOI 10.12942/lrr-2008-10; Colucci G, 2013, PHYS REV C, V87, DOI 10.1103/PhysRevC.87.055806; Del Estal M, 2001, PHYS REV C, V63, DOI 10.1103/PhysRevC.63.024314; Demorest PB, 2010, NATURE, V467, P1081, DOI 10.1038/nature09466; DOVER CB, 1983, ANN PHYS-NEW YORK, V146, P309, DOI 10.1016/0003-4916(83)90036-2; Fukuda T, 1998, PHYS REV C, V58, P1306, DOI 10.1103/PhysRevC.58.1306; Furnstahl RJ, 1996, NUCL PHYS A, V598, P539, DOI 10.1016/0375-9474(95)00488-2; Furnstahl RJ, 1997, NUCL PHYS A, V615, P441, DOI 10.1016/S0375-9474(96)00472-1; Hasegawa T, 1996, PHYS REV C, V53, P1210, DOI 10.1103/PhysRevC.53.1210; Horowitz CJ, 2001, PHYS REV LETT, V86, P5647, DOI 10.1103/PhysRevLett.86.5647; Hotchi H, 2001, PHYS REV C, V64, DOI 10.1103/PhysRevC.64.044302; Khaustov P, 2000, PHYS REV C, V61, DOI 10.1103/PhysRevC.61.054603; Klahn T, 2013, PHYS REV D, V88, DOI 10.1103/PhysRevD.88.085001; Lalazissis GA, 1997, PHYS REV C, V55, P540, DOI 10.1103/PhysRevC.55.540; Lattimer JM, 2013, ASTROPHYS J, V771, DOI 10.1088/0004-637X/771/1/51; Logoteta D, 2012, PHYS REV C, V85, DOI 10.1103/PhysRevC.85.055807; Manka R, 2002, NEW J PHYS, V4, DOI 10.1088/1367-2630/4/1/314; Manka R, 2001, J PHYS G NUCL PARTIC, V27, P1975, DOI 10.1088/0954-3899/27/10/302; Miyatsu T, 2013, PHYS REV C, V88, DOI 10.1103/PhysRevC.88.015802; Nagae T, 1998, PHYS REV LETT, V80, P1605, DOI 10.1103/PhysRevLett.80.1605; NAGELS MM, 1977, PHYS REV D, V15, P2547, DOI 10.1103/PhysRevD.15.2547; Noumi H, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.072301; Ozel F, 2006, NATURE, V441, P1115, DOI 10.1038/nature04858; Papazoglou P, 1999, PHYS REV C, V59, P411, DOI 10.1103/PhysRevC.59.411; Papazoglou P, 1998, PHYS REV C, V57, P2576, DOI 10.1103/PhysRevC.57.2576; Piekarewicz J, 2009, PHYS REV C, V79, DOI 10.1103/PhysRevC.79.054311; Schaffner J, 1996, PHYS REV C, V53, P1416, DOI 10.1103/PhysRevC.53.1416; Schulze HJ, 1998, PHYS REV C, V57, P704, DOI 10.1103/PhysRevC.57.704; SEDRAKIAN AD, 1994, PHYS LETT B, V338, P111, DOI 10.1016/0370-2693(94)91352-8; SEROT BD, 1986, ADV NUCL PHYS, V16, P1; Singh SK, 2013, J PHYS G NUCL PARTIC, V40, DOI 10.1088/0954-3899/40/8/085104; SLADKOWSKI J, 1992, PHYS REV D, V45, P1701, DOI 10.1103/PhysRevD.45.1701; SUGAHARA Y, 1994, NUCL PHYS A, V579, P557, DOI 10.1016/0375-9474(94)90923-7; SUGAHARA Y, 1994, PROG THEOR PHYS, V92, P803, DOI 10.1143/PTP.92.803; Takahashi H, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.212502; Todd-Rutel BG, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.122501; TOKI H, 1995, NUCL PHYS A, V588, pC357, DOI 10.1016/0375-9474(95)00161-S; Vidana I, 2000, PHYS REV C, V61, DOI 10.1103/PhysRevC.61.025802; Vidana I, 2011, EPL-EUROPHYS LETT, V94, DOI 10.1209/0295-5075/94/11002; Walecka J.D., 2004, THEORETICAL NUCL SUB, DOI 10.1142/5500; Weissenborn S, 2013, NUCL PHYS A, V914, P421, DOI 10.1016/j.nuclphysa.2013.04.003; Weissenborn S, 2012, PHYS REV C, V85, DOI 10.1103/PhysRevC.85.065802; Weissenborn S, 2012, NUCL PHYS A, V881, P62, DOI 10.1016/j.nuclphysa.2012.02.012; WIRINGA RB, 1988, PHYS REV C, V38, P1010, DOI 10.1103/PhysRevC.38.1010; Zuo W, 2002, NUCL PHYS A, V706, P418, DOI 10.1016/S0375-9474(02)00750-9	62	7	7	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 4	2014	9	9							e106368	10.1371/journal.pone.0106368	http://dx.doi.org/10.1371/journal.pone.0106368			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3XV	25188304	Green Submitted, Green Published, gold			2022-12-27	WOS:000341271500032
J	Godden, KE; Landry, JP; Slepneva, N; Migues, PV; Pompeiano, M				Godden, Kyle E.; Landry, Jeremy P.; Slepneva, Natalya; Migues, Paola V.; Pompeiano, Maria			Early Expression of Hypocretin/Orexin in the Chick Embryo Brain	PLOS ONE			English	Article							MELANIN-CONCENTRATING HORMONE; OREXIN-A; PREPRO-OREXIN; GENE-EXPRESSION; RAT-BRAIN; INTRACEREBROVENTRICULAR INJECTION; OREXIN/HYPOCRETIN NEURONS; SYNAPTIC INNERVATION; ENERGY HOMEOSTASIS; MOLECULAR-CLONING	Hypocretin/Orexin (H/O) neuropeptides are released by a discrete group of neurons in the vertebrate hypothalamus which play a pivotal role in the maintenance of waking behavior and brain state control. Previous studies have indicated that the H/O neuronal development differs between mammals and fish; H/O peptide-expressing cells are detectable during the earliest stages of brain morphogenesis in fish, but only towards the end of brain morphogenesis (by similar to 85% of embryonic development) in rats. The developmental emergence of H/O neurons has never been previously described in birds. With the goal of determining whether the chick developmental pattern was more similar to that of mammals or of fish, we investigated the emergence of H/O-expressing cells in the brain of chick embryos of different ages using immunohistochemistry. Post-natal chick brains were included in order to compare the spatial distribution of H/O cells with that of other vertebrates. We found that H/O-expressing cells appear to originate from two separate places in the region of the diencephalic proliferative zone. These developing cells express the H/O neuropeptide at a comparatively early age relative to rodents (already visible at 14% of the way through fetal development), thus bearing a closer resemblance to fish. The H/O-expressing cell population proliferates to a large number of cells by a relatively early embryonic age. As previously suggested, the distribution of H/O neurons is intermediate between that of mammalian and non-mammalian vertebrates. This work suggests that, in addition to its roles in developed brains, the H/O peptide may play an important role in the early embryonic development of non-mammalian vertebrates.	[Godden, Kyle E.; Landry, Jeremy P.; Slepneva, Natalya; Migues, Paola V.; Pompeiano, Maria] McGill Univ, Dept Psychol, Montreal, PQ, Canada	McGill University	Pompeiano, M (corresponding author), McGill Univ, Dept Psychol, Montreal, PQ, Canada.	maria.pompeiano@mcgill.ca		Pompeiano, Maria/0000-0001-9418-3896	G. W. Stairs Fund; McGill Startup funds; Human Frontiers Science Program [RGP0004/2013]	G. W. Stairs Fund; McGill Startup funds; Human Frontiers Science Program(Human Frontier Science Program)	This work was supported by the G. W. Stairs Fund, the McGill Startup funds and the RGP0004/2013 Human Frontiers Science Program grant to MP. The funders have no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTMAN J, 1986, ADV ANAT EMBRYOL CEL, V100, P1; Amiot C, 2005, EUR J NEUROSCI, V22, P531, DOI 10.1111/j.1460-9568.2005.04224.x; ArnoldAldea SA, 1996, J NEUROBIOL, V31, P103, DOI 10.1002/(SICI)1097-4695(199609)31:1<103::AID-NEU9>3.0.CO;2-6; Boratyn GM, 2012, BIOL DIRECT, V7, DOI 10.1186/1745-6150-7-12; Carter ME, 2012, P NATL ACAD SCI USA, V109, pE2635, DOI 10.1073/pnas.1202526109; Charvet CJ, 2010, P ROY SOC B-BIOL SCI, V277, P3469, DOI 10.1098/rspb.2010.0811; Darras VM, 2009, GEN COMP ENDOCR, V163, P58, DOI 10.1016/j.ygcen.2008.11.014; De Groef B, 2008, MOL CELL ENDOCRINOL, V293, P17, DOI 10.1016/j.mce.2008.06.002; De Lecea L, 1998, P NATL ACAD SCI USA, V95, P322, DOI 10.1073/pnas.95.1.322; Dickinson H, 2008, NEUROSCI LETT, V436, P1, DOI 10.1016/j.neulet.2007.12.043; Dominguez L, 2010, J CHEM NEUROANAT, V39, P20, DOI 10.1016/j.jchemneu.2009.07.007; Ellestad LE, 2011, GEN COMP ENDOCR, V171, P82, DOI 10.1016/j.ygcen.2010.12.006; Fabris C, 2004, J COMP NEUROL, V471, P113, DOI 10.1002/cne.20007; Faraco JH, 2006, J BIOL CHEM, V281, P29753, DOI 10.1074/jbc.M605811200; Galas L, 2001, J COMP NEUROL, V429, P242, DOI 10.1002/1096-9861(20000108)429:2<242::AID-CNE5>3.0.CO;2-Z; Gilthorpe JD, 2002, DEVELOPMENT, V129, P4719; Girault EM, 2012, PROG BRAIN RES, V198, P47, DOI 10.1016/B978-0-444-59489-1.00005-7; Golden JA, 1997, DEVELOPMENT, V124, P3525; GRAY EG, 1962, J ANAT, V96, P79; Hagan JJ, 1999, P NATL ACAD SCI USA, V96, P10911, DOI 10.1073/pnas.96.19.10911; Hahn JD, 2010, NEUROSCI LETT, V468, P12, DOI 10.1016/j.neulet.2009.10.047; Harrison TA, 1999, NEUROSCI LETT, V273, P17, DOI 10.1016/S0304-3940(99)00611-4; Heinonen MV, 2008, ACTA PHYSIOL, V192, P471, DOI 10.1111/j.1748-1716.2008.01836.x; Horvath TL, 1999, J COMP NEUROL, V415, P145; Huesa G, 2005, J COMP NEUROL, V488, P476, DOI 10.1002/cne.20610; Kaminski T, 2012, VITAM HORM, V89, P61, DOI 10.1016/B978-0-12-394623-2.00004-4; Kaslin J, 2004, J NEUROSCI, V24, P2678, DOI 10.1523/JNEUROSCI.4908-03.2004; Katayama S, 2010, COMP BIOCHEM PHYS A, V157, P132, DOI 10.1016/j.cbpa.2010.05.018; Katayama S, 2010, NEUROSCI LETT, V484, P157, DOI 10.1016/j.neulet.2010.08.043; Kilduff TS, 2000, TRENDS NEUROSCI, V23, P359, DOI 10.1016/S0166-2236(00)01594-0; Kruger JL, 2010, J CHEM NEUROANAT, V40, P256, DOI 10.1016/j.jchemneu.2010.07.004; Landry JP, 2014, DEV NEUROBIOL, V74, P1030, DOI 10.1002/dneu.22182; Lee MG, 2005, J NEUROSCI, V25, P6716, DOI 10.1523/JNEUROSCI.1887-05.2005; Li JC, 2014, BRIT J PHARMACOL, V171, P332, DOI 10.1111/bph.12415; Li Y, 2013, J NEUROPHYSIOL, V109, P1571, DOI 10.1152/jn.00522.2012; Lopez JM, 2009, PEPTIDES, V30, P873, DOI 10.1016/j.peptides.2009.01.013; Madarasz E, 2013, NEURAL STEM CELLS NE, P45, DOI [10.5772/55678, DOI 10.5772/55678]; Madden Christopher J, 2012, Biomol Concepts, V3, P381; Makela KA, 2010, ACTA PHYSIOL, V198, P237, DOI 10.1111/j.1748-1716.2009.02068.x; Matsuda K, 2012, VITAM HORM, V89, P341, DOI 10.1016/B978-0-12-394623-2.00018-4; McCIennan KM, 2006, FRONT NEUROENDOCRIN, V27, P193; Mellor DJ, 2007, NEW ZEAL VET J, V55, P51, DOI 10.1080/00480169.2007.36742; Mikrouli E, 2011, NEUROPEPTIDES, V45, P401, DOI 10.1016/j.npep.2011.07.010; MILEWSKI N, 1989, J NEUROENDOCRINOL, V1, P473, DOI 10.1111/j.1365-2826.1989.tb00149.x; Mileykovskiy BY, 2005, NEURON, V46, P787, DOI 10.1016/j.neuron.2005.04.035; Modirrousta M, 2005, EUR J NEUROSCI, V21, P2807, DOI 10.1111/j.1460-9568.2005.04104.x; Nambu T, 1999, BRAIN RES, V827, P243, DOI 10.1016/S0006-8993(99)01336-0; Ohkubo T, 2003, J MOL ENDOCRINOL, V31, P499, DOI 10.1677/jme.0.0310499; Ohkubo T, 2002, BBA-GENE STRUCT EXPR, V1577, P476, DOI 10.1016/S0167-4781(02)00483-9; Osmon, 2005, ATLAS CHICK DEV; Panula P, 2010, ACTA PHYSIOL, V198, P381, DOI 10.1111/j.1748-1716.2009.02038.x; Phillips-Singh D, 2003, CELL TISSUE RES, V313, P217, DOI 10.1007/s00441-003-0755-8; Porkka-Heiskanen T, 2004, NEUROBIOL AGING, V25, P231, DOI 10.1016/S0197-4580(03)00043-5; Prober DA, 2006, J NEUROSCI, V26, P13400, DOI 10.1523/JNEUROSCI.4332-06.2006; Puelles L., 2007, CHICK BRAIN STEREOTA, V1st; RIGATTO H, 1986, J APPL PHYSIOL, V61, P160, DOI 10.1152/jappl.1986.61.1.160; Russo F, 2008, ANAT REC, V291, P169, DOI 10.1002/ar.20641; Sakurai T, 1998, CELL, V92, P573, DOI 10.1016/S0092-8674(00)80949-6; Saper CB, 2005, J COMP NEUROL, V493, P477, DOI 10.1002/cne.20839; Sawai N, 2010, NEUROSCI LETT, V468, P51, DOI 10.1016/j.neulet.2009.10.061; SCHAGGER H, 1987, ANAL BIOCHEM, V166, P368, DOI 10.1016/0003-2697(87)90587-2; Siegel S, 1988, NONPARAMETRIC STAT B, V2; Singletary KG, 2006, J CHEM NEUROANAT, V32, P81, DOI 10.1016/j.jchemneu.2006.05.003; Sinton CM, 2011, SLEEP MED REV, V15, P197, DOI 10.1016/j.smrv.2010.12.003; Sokolowska P, 2012, NEUROSCI LETT, V506, P303, DOI 10.1016/j.neulet.2011.11.028; Song ZG, 2013, GEN COMP ENDOCR, V190, P112, DOI 10.1016/j.ygcen.2013.05.006; Steininger TL, 2004, J CHEM NEUROANAT, V27, P165, DOI 10.1016/j.jchemneu.2004.02.007; Stoyanova II, 2012, CELL MOL NEUROBIOL, V32, P49, DOI 10.1007/s10571-011-9733-y; Szarek E, 2010, MOL CELL ENDOCRINOL, V323, P115, DOI 10.1016/j.mce.2010.04.002; Takahashi K, 2008, NEUROSCIENCE, V153, P860, DOI 10.1016/j.neuroscience.2008.02.058; Tsujino N, 2013, FRONT BEHAV NEUROSCI, V7, DOI 10.3389/fnbeh.2013.00028; van den Pol AN, 2001, J COMP NEUROL, V433, P349, DOI 10.1002/cne.1144; Volkoff H, 2012, VITAM HORM, V89, P315, DOI 10.1016/B978-0-12-394623-2.00017-2; Walter I, 2010, J EXP BIOL, V213, P3167, DOI 10.1242/jeb.043349; Wang QP, 2005, REGUL PEPTIDES, V126, P35, DOI 10.1016/j.regpep.2004.08.030; Wechsler W, 1967, Prog Brain Res, V26, P93; Wong KKY, 2011, GEN COMP ENDOCR, V171, P124, DOI 10.1016/j.ygcen.2011.01.001; Xu MY, 2007, MOL CELL ENDOCRINOL, V271, P28, DOI 10.1016/j.mce.2007.03.003; Yamamoto Y, 2000, MOL BRAIN RES, V78, P108, DOI 10.1016/S0169-328X(00)00080-2; Yan AF, 2011, PEPTIDES, V32, P1363, DOI 10.1016/j.peptides.2011.05.004; Yuan LX, 2009, BRAIN RES, V1273, P18, DOI 10.1016/j.brainres.2009.03.052	81	7	8	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 4	2014	9	9							e106977	10.1371/journal.pone.0106977	http://dx.doi.org/10.1371/journal.pone.0106977			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3XV	25188307	Green Published, Green Submitted, gold			2022-12-27	WOS:000341271500102
J	Yang, WW; Li, QH; Pan, ZF				Yang, Weiwei; Li, Qinghua; Pan, Zhifang			Sphingosine-1-Phosphate Promotes Extravillous Trophoblast Cell Invasion by Activating MEK/ERK/MMP-2 Signaling Pathways via S1P/S1PR1 Axis Activation	PLOS ONE			English	Article							PROTEIN-COUPLED RECEPTOR; EARLY HUMAN-PREGNANCY; SPHINGOSINE 1-PHOSPHATE; RHO/RHO-KINASE; HUMAN DECIDUA; CANCER CELLS; MIGRATION; EXPRESSION; PROLIFERATION; APOPTOSIS	Successful placentation depends on the proper invasion of extravillous trophoblast (EVT) cells into maternal tissues. Previous reports demonstrated that S1P receptors are expressed in the EVT cells and S1P could regulate migration and function of trophoblast cells via S1P receptors. However, little is known about roles of S1P in the invasion of EVT cells. Our study was performed to investigate S1P effect on the invasion of EVT cells. We used the extravillous trophoblast cell line HTR8/SVneo cells to evaluate the effect. In vitro invasion assay was employed to determine the invasion of HTR8/SVneo cells induced by S1P. MMP-2 enzyme activity and relative level in the supernatants of HTR8/SVneo was assessed by gelatin zymography and western blot. Based on the above, siRNA and specific inhibitors were used for the intervention and study of potential signal pathways, and Real-time qPCR and western blot were used to test the mRNA and protein level of potential signal targets. We found that S1P could promote HTR8/SVneo cell invasion and upregulates activity and level of MMP-2. The promotion requires activation of MEK-ERK and is dependent on the axis of S1P/S1PR1. Our investigation of S1P may provide new insights into the molecular mechanisms of EVT invasion.	[Yang, Weiwei; Pan, Zhifang] Weifang Med Univ, Pharm & Biol Sci Sch, Weifang, Peoples R China; [Li, Qinghua] Weifang Med Univ, Sch Publ Hlth, Weifang, Peoples R China	Weifang Medical University; Weifang Medical University	Yang, WW (corresponding author), Weifang Med Univ, Pharm & Biol Sci Sch, Weifang, Peoples R China.	yangweiwei0127@gmail.com			Natural Science Foundation of Shandong Province [ZR2013CM032]; Weifang Medical University [K1302021]; Weifang Science and Technology Bureau [201301078]	Natural Science Foundation of Shandong Province(Natural Science Foundation of Shandong Province); Weifang Medical University; Weifang Science and Technology Bureau	This work was supported by grants from the Natural Science Foundation of Shandong Province (ZR2013CM032), Weifang Medical University (No. K1302021) and Weifang Science and Technology Bureau (No. 201301078). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Saghir K, 2013, PLACENTA, V34, pA97, DOI 10.1016/j.placenta.2013.06.290; Alsaghir DA K., 2010, P PHYSL SOC, V19, pPC246; Anin Sheba Anin, 2004, Hum Fertil (Camb), V7, P169, DOI 10.1080/14647270400006911; Arikawa K, 2003, J BIOL CHEM, V278, P32841, DOI 10.1074/jbc.M305024200; Bai Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038875; Ball E, 2006, J PATHOL, V208, P535, DOI 10.1002/path.1927; Bao MY, 2012, LIVER INT, V32, P331, DOI 10.1111/j.1478-3231.2011.02666.x; Brinkmann V, 2002, J BIOL CHEM, V277, P21453, DOI 10.1074/jbc.C200176200; Brocklyn James R Van, 2010, World J Biol Chem, V1, P307, DOI 10.4331/wjbc.v1.i10.307; Champion H, 2012, MOL HUM REPROD, V18, P391, DOI 10.1093/molehr/gas010; Crosley EJ, 2013, PLACENTA, V34, P127, DOI 10.1016/j.placenta.2012.12.001; Cuvillier O, 2001, BLOOD, V98, P2828, DOI 10.1182/blood.V98.9.2828; Davaille J, 2002, J BIOL CHEM, V277, P37323, DOI 10.1074/jbc.M202798200; Dunlap KA, 2010, BIOL REPROD, V82, P876, DOI 10.1095/biolreprod.109.081604; Goyal P, 2013, MOL HUM REPROD, V19, P528, DOI 10.1093/molehr/gat023; GRAHAM CH, 1993, EXP CELL RES, V206, P204, DOI 10.1006/excr.1993.1139; GRAHAM CH, 1991, J CELL PHYSIOL, V148, P228, DOI 10.1002/jcp.1041480207; Guo L, 2013, REPROD SCI; Hannun YA, 2008, NAT REV MOL CELL BIO, V9, P139, DOI 10.1038/nrm2329; Harada J, 2004, J NEUROCHEM, V88, P1026, DOI 10.1046/j.1471-4159.2003.02219.x; Jauniaux E, 2005, PLACENTA, V26, P114, DOI 10.1016/j.placenta.2004.05.011; Johnstone ED, 2005, J LIPID RES, V46, P1833, DOI 10.1194/jlr.M500095-JLR200; KHONG TY, 1986, BRIT J OBSTET GYNAEC, V93, P1049, DOI 10.1111/j.1471-0528.1986.tb07830.x; Kim DS, 2004, CELL SIGNAL, V16, P89, DOI 10.1016/S0898-6568(03)00114-1; Kim ES, 2011, J CELL SCI, V124, P2220, DOI 10.1242/jcs.076794; Kunkel GT, 2013, NAT REV DRUG DISCOV, V12, P688, DOI 10.1038/nrd4099; Lash GE, 2006, FASEB J, V20, P2512, DOI 10.1096/fj.06-6616com; Lepley D, 2005, CANCER RES, V65, P3788, DOI 10.1158/0008-5472.CAN-04-2311; Liu X, 2012, MOL CELL BIOCHEM, V363, P21, DOI 10.1007/s11010-011-1154-1; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Maceyka M, 2002, BBA-MOL CELL BIOL L, V1585, P193, DOI 10.1016/S1388-1981(02)00341-4; Maceyka M, 2012, TRENDS CELL BIOL, V22, P50, DOI 10.1016/j.tcb.2011.09.003; Paik JH, 2001, J BIOL CHEM, V276, P11830, DOI 10.1074/jbc.M009422200; Park KS, 2007, BIOCHEM BIOPH RES CO, V356, P239, DOI 10.1016/j.bbrc.2007.02.112; Paugh SW, 2003, FEBS LETT, V554, P189, DOI 10.1016/S0014-5793(03)01168-2; PIJNENBORG R, 1983, PLACENTA, V4, P397, DOI 10.1016/S0143-4004(83)80043-5; PIJNENBORG R, 1980, PLACENTA, V1, P3, DOI 10.1016/S0143-4004(80)80012-9; Pyne NJ, 2010, NAT REV CANCER, V10, P489, DOI 10.1038/nrc2875; Sebire NJ, 2002, HUM REPROD, V17, P1067, DOI 10.1093/humrep/17.4.1067; Singh AT, 2012, REPROD BIOMED ONLINE, V24, P224, DOI 10.1016/j.rbmo.2011.10.012; Steegers EAP, 2010, LANCET, V376, P631, DOI 10.1016/S0140-6736(10)60279-6; Sun HY, 2010, BIOCHEM BIOPH RES CO, V395, P361, DOI 10.1016/j.bbrc.2010.04.019; Tapia A, 2008, HUM REPROD, V23, P1724, DOI 10.1093/humrep/den121; Tse WK, 2002, PLACENTA, V23, P699, DOI 10.1053/plac.2002.0866; Yamamoto Y, 2010, BIOL REPROD, V82, P628, DOI 10.1095/biolreprod.109.081497; Yamashita H, 2006, J SURG RES, V130, P80, DOI 10.1016/j.jss.2005.08.004; Yang YY, 2012, J CLIN ENDOCR METAB, V97, pE1390, DOI 10.1210/jc.2012-1150; Young N, 2009, MOL CANCER RES, V7, P23, DOI 10.1158/1541-7786.MCR-08-0061; Zhu Jia-Yu, 2012, Rev Obstet Gynecol, V5, pe137	49	28	29	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 4	2014	9	9							e106725	10.1371/journal.pone.0106725	http://dx.doi.org/10.1371/journal.pone.0106725			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3XV	25188412	Green Published, Green Submitted, gold			2022-12-27	WOS:000341271500076
J	Kumar, L; Chhibber, S; Harjai, K				Kumar, Lokender; Chhibber, Sanjay; Harjai, Kusum			Zingerone Suppresses Liver Inflammation Induced by Antibiotic Mediated Endotoxemia through Down Regulating Hepatic mRNA Expression of Inflammatory Markers in Pseudomonas aeruginosa Peritonitis Mouse Model	PLOS ONE			English	Article							NECROSIS-FACTOR-ALPHA; KAPPA-B; ESCHERICHIA-COLI; NITRIC-OXIDE; TUMOR PROMOTION; PROTEIN-2; RELEASE; ACTIVATION; GENERATION; APOPTOSIS	Antibiotic-induced endotoxin release is associated with high mortality rate even when appropriate antibiotics are used for the treatment of severe infections in intensive care units. Since liver is involved in systemic clearance and detoxification of endotoxin hence it becomes a primary target organ for endotoxin mediated inflammation. Currently available anti-inflammatory drugs give rise to serious side effects. Hence, there is an urgent need for safe and effective anti-inflammatory therapy. It is likely that anti-inflammatory phytochemicals and neutraceutical agents may have the potential to reduce the endotoxin mediated inflammation and complications associated with endotoxin release. Keeping this in mind, the present study was planned to evaluate the hepatoprotective potential of zingerone (active compound of zingiber officinale) against liver inflammation induced by antibiotic mediated endotoxemia. The selected antibiotics capable of releasing high content of endotoxin were employed for their in vivo efficacy in P. aeruginosa peritonitis model. Released endotoxin induced inflammation and zingerone as co-anti-inflammatory therapy significantly reduced inflammatory response. Improved liver histology and reduced inflammatory markers MDA, RNI, MPO, tissue damage markers (AST, ALT, ALP) and inflammatory cytokines (MIP-2, IL-6 and TNF-alpha) were indicative of therapeutic potential of zingerone. The mechanism of action of zingerone may be related to significant inhibition of the mRNA expression of inflammatory markers (TLR4, RelA, NF-kB2, TNF-alpha, iNOS, COX-2) indicating that zingerone interferes with cell signalling pathway and suppresses hyper expression of cell signaling molecules of inflammatory pathway. Zingerone therapy significantly protected liver from endotoxin induced inflammatory damage by down regulating biochemical as well as molecular markers of inflammation. In conclusion, this study provides evidence that zingerone is a potent anti-inflammatory phytomedicine against hepatic inflammation induced by antibiotic mediated endotoxemia. These results thus suggest that zingerone treatment can be used as a co-therapy with antibiotics to reduced endotoxin induced inflammation during treatment of severe P. aeruginosa infections.	[Kumar, Lokender; Chhibber, Sanjay; Harjai, Kusum] Panjab Univ, Dept Microbiol, Chandigarh 160014, India	Panjab University	Harjai, K (corresponding author), Panjab Univ, Dept Microbiol, BMS Block, Chandigarh 160014, India.	kusum_harjai@hotmail.com	Kumar, Lokender/AAY-6862-2020	Kumar, Lokender/0000-0002-0692-0137	Department of Science and technology (DST) Govt of India	Department of Science and technology (DST) Govt of India(Department of Science & Technology (India))	The authors acknowledge the financial support by INSPIRE programme of Department of Science and technology (DST) Govt of India in the form of a Senior Research Fellowship to the first author. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn SI, 2009, MOL CELLS, V27, P211, DOI 10.1007/s10059-009-0026-y; Anjaneyulu M, 2004, AM J NEPHROL, V24, P488, DOI 10.1159/000080722; [Anonymous], 2002, INT J TOXICOL, V21, P95, DOI 10.1080/10915810290096522; Basak S, 2008, MOL CELL BIOL, V28, P3139, DOI 10.1128/MCB.01469-07; Bautista AP, 1997, HEPATOLOGY, V25, P335, DOI 10.1002/hep.510250214; CHALKLEY LJ, 1985, ANTIMICROB AGENTS CH, V28, P331, DOI 10.1128/AAC.28.2.331; Choi YY, 2013, EVIDENCE BASED COMPL, V2013; Correia JD, 2001, J BIOL CHEM, V276, P21129, DOI 10.1074/jbc.M009164200; Davis MR, 2013, J BACTERIOL, V195, P1504, DOI 10.1128/JB.01999-12; De Francischi JN, 2009, MEDIATORS INFLAMMATI, V2009; GALANOS C, 1979, P NATL ACAD SCI USA, V76, P5939, DOI 10.1073/pnas.76.11.5939; Hang L, 1999, J IMMUNOL, V162, P3037; Holzheimer RG, 1996, J ENDOTOXIN RES, V3, P261, DOI 10.1177/096805199600300312; HORROW JC, 1985, ANESTH ANALG, V64, P348; Jain L, 2013, J GASTROEN HEPATOL, V28, P1187, DOI 10.1111/jgh.12160; KATO Y, 1995, FEMS IMMUNOL MED MIC, V12, P195, DOI 10.1016/0928-8244(95)00067-8; Kim MK, 2010, EXP GERONTOL, V45, P419, DOI 10.1016/j.exger.2010.03.005; Kwon DH, 2006, ANTIMICROB AGENTS CH, V50, P1623, DOI 10.1128/AAC.50.5.1623-1627.2006; Lamp KC, 1996, ANTIMICROB AGENTS CH, V40, P247, DOI 10.1128/AAC.40.1.247; Le BV, 2012, EUR J CLIN MICROBIOL, V31, P1983, DOI 10.1007/s10096-011-1530-5; Li QT, 2002, NAT REV IMMUNOL, V2, P725, DOI 10.1038/nri910; Marshall JC, 2001, CRIT CARE MED, V29, pS99, DOI 10.1097/00003246-200107001-00032; MASUYOSHI S, 1981, ARZNEIMITTEL-FORSCH, V31-2, P1070; May MJ, 1997, SEMIN CANCER BIOL, V8, P63, DOI 10.1006/scbi.1997.0057; McIsaac SM, 2012, J LEUKOCYTE BIOL, V92, P977, DOI 10.1189/jlb.0811410; Mehta S, 2005, VASC PHARMACOL, V43, P390, DOI 10.1016/j.vph.2005.08.013; Mordmuller B, 2003, EMBO REP, V4, P82, DOI 10.1038/embor710; Nakano M, 1996, J ENDOTOXIN RES, V3, P195, DOI 10.1177/096805199600300305; Pan MH, 2006, BIOCHEM PHARMACOL, V72, P1293, DOI 10.1016/j.bcp.2006.07.039; Park KK, 1998, CANCER LETT, V129, P139, DOI 10.1016/S0304-3835(98)00081-0; RAETZ CRH, 1991, FASEB J, V5, P2652, DOI 10.1096/fasebj.5.12.1916089; Rao BN, 2009, MUTAT RES-GEN TOX EN, V677, P33, DOI 10.1016/j.mrgentox.2009.05.004; Rao BN, 2011, EUR J PHARMACOL, V657, P59, DOI 10.1016/j.ejphar.2011.02.002; ROCKETT KA, 1994, PARASITE IMMUNOL, V16, P243, DOI 10.1111/j.1365-3024.1994.tb00346.x; Rosenthal C, 1998, CRIT CARE MED, V26, P912, DOI 10.1097/00003246-199805000-00027; Scheidereit C, 2006, ONCOGENE, V25, P6685, DOI 10.1038/sj.onc.1209934; Sener G, 2003, LIFE SCI, V72, P2707, DOI 10.1016/S0024-3205(03)00187-5; Shen FM, 2004, SHOCK, V21, P556, DOI 10.1097/01.shk.0000126647.51109.5c; Sies H, 1997, Adv Pharmacol, V38, P229; STANDIFORD TJ, 1995, J IMMUNOL, V155, P2222; TANIMURA F, 1993, EUR ARCH OTO-RHINO-L, V250, P412; Tukov FF, 2007, TOXICOL SCI, V100, P267, DOI 10.1093/toxsci/kfm209; Xie XX, 2014, INT IMMUNOPHARMACOL, V19, P103, DOI 10.1016/j.intimp.2013.12.028; Zhou X, 2011, DETERMINATION GLUCOS, V2011	44	9	11	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 3	2014	9	9							e106536	10.1371/journal.pone.0106536	http://dx.doi.org/10.1371/journal.pone.0106536			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3TB	25184525	gold, Green Submitted, Green Published			2022-12-27	WOS:000341257700085
J	Li, M; Li, PW; Wu, H; Zhang, Q; Ma, F; Zhang, ZW; Ding, XX; Wang, HL				Li, Min; Li, Peiwu; Wu, Hui; Zhang, Qi; Ma, Fei; Zhang, Zhaowei; Ding, Xiaoxia; Wang, Hengling			An Ultra-Sensitive Monoclonal Antibody-Based Competitive Enzyme Immunoassay for Sterigmatocystin in Cereal and Oil Products	PLOS ONE			English	Article								Sterigmatocystin (STG), a biosynthesis precursor of aflatoxin B-1, is well known for its toxic and carcinogenic effects in humans and animals. STG derivatives and protein conjugates are needed for generation of monoclonal antibodies (mAbs). This work describes a reliable and fast synthesis of novel STG derivatives, based on which novel STG bovine serum albumin conjugates were prepared. With the novel STG bovine serum albumin conjugates, three sensitive and specific mAbs against STG, named VerA 3, VerA 4, and VerA 6, were prepared by semi-solid hypoxanthine/aminopterin/thymidine (HAT) medium using a modified two-step screening procedure. They exhibited high affinity for STG and no cross-reactivity (CR) with aflatoxins B-1, B-2, G(1), G(2), and M-1. Based on the most sensitive antibody VerA 3, an ultra-sensitive competitive enzyme-linked immunosorbent assay (ELISA) was developed for STG in wheat, maize, and peanuts. Assays were performed in the STG-GA-BSA-coated (0.5 mu g.mL(-1)) ELISA format, in which the antibody was diluted to 1:80,000. Several physicochemical factors influencing assay performance, such as pH, ionic strength, blocking solution, and diluting solution, were optimized. The final results showed that the assays had the detection limits of 0.08 ng.g(-1) for wheat, 0.06 ng.g(-1) for maize, and 0.1 ng.g(-1) for peanuts, inter-assay and intra-assay variations of less than 10%, and recoveries ranging from 83% to 110%. These recoveries were in good agreement with those obtained by using HPLC-MS/MS method (90-104%), indicating the importance of the mAb VerA 3 in the study of STG in crude agricultural products.	[Li, Min; Li, Peiwu; Wu, Hui; Zhang, Qi; Ma, Fei; Zhang, Zhaowei; Ding, Xiaoxia; Wang, Hengling] Chinese Acad Agr Sci, Oil Crops Res Inst, Wuhan, Peoples R China; [Wu, Hui; Zhang, Qi; Ma, Fei; Zhang, Zhaowei; Wang, Hengling] Minist Agr, Key Lab Biol & Genet Improvement Oil Crops, Wuhan, Peoples R China; [Li, Min; Li, Peiwu; Ma, Fei; Zhang, Zhaowei; Wang, Hengling] Minist Agr, Key Lab Detect Mycotoxins, Wuhan, Peoples R China; [Li, Min; Li, Peiwu; Ding, Xiaoxia; Wang, Hengling] Minist Agr, Lab Risk Assessment Oilseeds Prod Wuhan, Wuhan, Peoples R China; [Li, Peiwu] Minist Agr, Qual Inspect & Test Ctr Oilseeds Prod, Wuhan, Peoples R China	Chinese Academy of Agricultural Sciences; Oil Crops Research Institute, CAAS; Ministry of Agriculture & Rural Affairs; Ministry of Agriculture & Rural Affairs; Ministry of Agriculture & Rural Affairs; Ministry of Agriculture & Rural Affairs	Li, PW (corresponding author), Chinese Acad Agr Sci, Oil Crops Res Inst, Wuhan, Peoples R China.	peiwuli@oilcrops.cn; zhangqi521x@yahoo.cn		, Zhaowei/0000-0002-6686-2995	Project of National Science & Technology Pillar Plan [2012BAB19B09]; Special Fund for Agro-scientific Research in the Public Interest [201303088]; National Natural Science Foundation of China [31171702]	Project of National Science & Technology Pillar Plan; Special Fund for Agro-scientific Research in the Public Interest; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the Project of National Science & Technology Pillar Plan (2012BAB19B09), the Special Fund for Agro-scientific Research in the Public Interest (201303088), and the National Natural Science Foundation of China (31171702). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2004, 500923 GBT CHIN STAN, P203; BERRY CL, 1988, J PATHOL, V154, P301, DOI 10.1002/path.1711540405; Cervino C, 2007, MOLECULES, V12, P641, DOI 10.3390/12030641; Guan D, 2011, FOOD CHEM, V125, P1359, DOI 10.1016/j.foodchem.2010.10.006; Jurjevic Z, 2013, MYCOTOXIN RES, V29, P141, DOI 10.1007/s12550-013-0160-4; SHANNON GM, 1976, J ASSOC OFF ANA CHEM, V59, P963; Tang XQ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102963; Versilovskis A, 2009, FOOD ADDIT CONTAM A, V26, P127, DOI 10.1080/02652030802342497; Versilovskis A, 2008, FOOD CHEM, V109, P243, DOI 10.1016/j.foodchem.2007.12.066; Versilovskis A, 2007, J CHROMATOGR A, V1157, P467, DOI 10.1016/j.chroma.2007.05.022; Versilovskis A, 2010, MOL NUTR FOOD RES, V54, P136, DOI 10.1002/mnfr.200900345; Wang GM, 2011, J CHROMATOGR SCI, V49, P276, DOI 10.1093/chrsci/49.4.276; Zhang DH, 2009, ANAL CHIM ACTA, V636, P63, DOI 10.1016/j.aca.2009.01.010	13	14	17	0	69	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 3	2014	9	9							e106415	10.1371/journal.pone.0106415	http://dx.doi.org/10.1371/journal.pone.0106415			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3TB	25184275	Green Submitted, Green Published, gold			2022-12-27	WOS:000341257700068
J	Lin, LH; Hua, L; Qu, YF; Gao, JF; Ji, X				Lin, Long-Hui; Hua, Lei; Qu, Yan-Fu; Gao, Jian-Fang; Ji, Xiang			The Phylogeographical Pattern and Conservation of the Chinese Cobra (Naja atra) across Its Range Based on Mitochondrial Control Region Sequences	PLOS ONE			English	Article							POPULATION-GROWTH; DNA-SEQUENCES; GENE FLOW; EVOLUTION; ELAPIDAE; DIVERGENCE; SERPENTES; SOFTWARE; MODEL	The vulnerable Chinese cobra (Naja atra) ranges from southeastern China south of the Yangtze River to northern Vietnam and Laos. Large mountain ranges and water bodies may influence the pattern of genetic diversity of this species. We sequenced the mitochondrial DNA control region (1029 bp) using 285 individuals collected from 23 localities across the species' range and obtained 18 sequences unique to Taiwan from GenBank for phylogenetic and population analysis. Two distinct clades were identified, one including haplotypes from the two westernmost localities (Hekou and Miyi) and the other including haplotypes from all sampling sites except Miyi. A strong population structure was found (Phi st = 0.76, P < 0.0001) with high haplotype diversity (h = 1.00) and low nucleotide diversity (pi = 0.0049). The Luoxiao and Nanling Mountains act as historical geographical barriers limiting gene exchange. In the haplotype network there were two "star'' clusters. Haplotypes from populations east of the Luoxiao Mountains were represented within one cluster and haplotypes from populations west of the mountain range within the other, with haplotypes from populations south of the Nanling Mountains in between. Lineage sorting between mainland and island populations is incomplete. It remains unknown as to how much adaptive differentiation there is between population groups or within each group. We caution against long-distance transfers within any group, especially when environmental differences are apparent.	[Lin, Long-Hui; Gao, Jian-Fang] Hangzhou Normal Univ, Hangzhou Key Lab Anim Adaptat & Evolut, Sch Life Sci, Hangzhou, Zhejiang, Peoples R China; [Hua, Lei; Qu, Yan-Fu; Ji, Xiang] Nanjing Normal Univ, Jiangsu Key Lab Biodivers & Biotechnol, Coll Life Sci, Nanjing, Jiangsu, Peoples R China	Hangzhou Normal University; Nanjing Normal University	Ji, X (corresponding author), Nanjing Normal Univ, Jiangsu Key Lab Biodivers & Biotechnol, Coll Life Sci, Nanjing, Jiangsu, Peoples R China.	xji@mail.hz.zj.cn			National Natural Science Foundation of China [31070339, 31101635, 31200283, 31272294]; Priority Academic Program Development of Jiangsu Higher Education Institutions [CXLX11_0885]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Priority Academic Program Development of Jiangsu Higher Education Institutions	The work was supported by the National Natural Science Foundation of China (31070339, 31101635, 31200283 and 31272294) and Priority Academic Program Development of Jiangsu Higher Education Institutions (CXLX11_0885). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Avise J. C., 2000, PHYLOGEOGRAPHY HIST; AVISE JC, 1987, ANNU REV ECOL SYST, V18, P489, DOI 10.1146/annurev.es.18.110187.002421; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Bouzat JL, 1998, CONSERV BIOL, V12, P836, DOI 10.1046/j.1523-1739.1998.97164.x; Cai Y, 2012, J ZOOL SYST EVOL RES, V50, P137, DOI 10.1111/j.1439-0469.2012.00655.x; Cassens I, 2003, MOL ECOL, V12, P1781, DOI 10.1046/j.1365-294X.2003.01876.x; Chiucchi JE, 2010, MOL ECOL, V19, P5345, DOI 10.1111/j.1365-294X.2010.04860.x; Ding L, 2011, MOL ECOL, V20, P1905, DOI 10.1111/j.1365-294X.2011.05060.x; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Forcina G, 2012, MOL PHYLOGENET EVOL, V65, P523, DOI 10.1016/j.ympev.2012.07.006; Fu YX, 1997, GENETICS, V147, P915; HARPENDING HC, 1994, HUM BIOL, V66, P591; Huang Song, 2003, Acta Zoologica Sinica, V49, P854; Huang S, 2007, MOL PHYLOGENET EVOL, V44, P942, DOI 10.1016/j.ympev.2007.05.019; Huang S, 2009, MOL PHYLOGENET EVOL, V51, P438, DOI 10.1016/j.ympev.2009.02.013; Ineich Ivan, 1996, Bulletin de la Societe Herpetologique de France, V75-76, P7; Ji Xiang, 2002, Acta Zoologica Sinica, V48, P591; Kumar S, 2004, BRIEF BIOINFORM, V5, P150, DOI 10.1093/bib/5.2.150; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Lin Chi-Xian, 2007, Acta Zoologica Sinica, V53, P437; Lin HC, 2008, CONSERV GENET, V9, P1089, DOI 10.1007/s10592-007-9418-8; Lin LH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036334; Lin LH, 2008, ZOOL SCI, V25, P888, DOI 10.2108/zsj.25.888; Minton S.A., 1986, P3; Nei M., 1987, MOL EVOLUTIONARY GEN; Posada D, 2001, TRENDS ECOL EVOL, V16, P37, DOI 10.1016/S0169-5347(00)02026-7; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; ROGERS AR, 1995, EVOLUTION, V49, P608, DOI 10.1111/j.1558-5646.1995.tb02297.x; ROGERS AR, 1992, MOL BIOL EVOL, V9, P552; Sallaberry-Pincheira N, 2011, DIVERS DISTRIB, V17, P152, DOI 10.1111/j.1472-4642.2010.00729.x; SLATKIN M, 1991, GENETICS, V129, P555; Slowinski JB, 2000, HERPETOLOGICA, V56, P257; Swofford D, 2002, PAUP PHYLOGENETIC AN, DOI 10.1111/J.0014-3820.2002.TB00191.X; TAJIMA F, 1989, GENETICS, V123, P585; TAMURA K, 1993, MOL BIOL EVOL, V10, P512, DOI 10.1093/oxfordjournals.molbev.a040023; TAYLOR AC, 1994, MOL ECOL, V3, P277, DOI 10.1111/j.1365-294X.1994.tb00068.x; Templeton AR, 1998, MOL ECOL, V7, P381, DOI 10.1046/j.1365-294x.1998.00308.x; Wallach V, 2009, ZOOTAXA, P26, DOI 10.11646/zootaxa.2236.1.2; Wisely SM, 2002, J HERED, V93, P231, DOI 10.1093/jhered/93.4.231; WUSTER W, 1992, HERPETOLOGICA, V48, P69; Wuster W, 2007, MOL PHYLOGENET EVOL, V45, P437, DOI 10.1016/j.ympev.2007.07.021; Wuster Wolfgang, 1996, Snake, V27, P85; Yan J, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-569; Zhao EM, 1998, CHINA RED DATA BOOK, P274; Zink RM, 2013, AUK, V130, P449, DOI 10.1525/auk.2013.12241	47	28	29	3	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 3	2014	9	9							e106944	10.1371/journal.pone.0106944	http://dx.doi.org/10.1371/journal.pone.0106944			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3TB	25184236	Green Published, Green Submitted, gold			2022-12-27	WOS:000341257700130
J	Liu, XF; Hu, XS; Keller, MA; Zhao, HY; Wu, YF; Liu, TX				Liu, Xiao-Feng; Hu, Xiang-Shun; Keller, Mike A.; Zhao, Hui-Yan; Wu, Yun-Feng; Liu, Tong-Xian			Tripartite Interactions of Barley Yellow Dwarf Virus, Sitobion avenae and Wheat Varieties	PLOS ONE			English	Article							ENGLISH GRAIN APHID; CROP LOSS ASSESSMENT; RED WINTER-WHEAT; CHERRY-OAT APHID; YIELD COMPONENTS; CEREAL APHIDS; METOPOLOPHIUM-DIRHODUM; INSECT BEHAVIOR; SPRING WHEAT; F HOMOPTERA	The tripartite interactions in a pathosystem involving wheat (Triticum aestivum L.), the Barley yellow dwarf virus (BYDV), and the BYDV vector aphid Sitobion avenae were studied under field conditions to determine the impact of these interactions on aphid populations, virus pathology and grain yield. Wheat varietal resistance to BYDV and aphids varied among the three wheat varieties studied over two consecutive years. The results demonstrated that (1) aphid peak number (APN) in the aphid + BYDV (viruliferous aphid) treatment was greater and occurred earlier than that in the non-viruliferous aphid treatment. The APN and the area under the curve of population dynamics (AUC) on a S. avenae-resistant variety 98-10-30 was significantly lower than on two aphid-susceptible varieties Tam200(13) G and Xiaoyan6. (2) The production of alatae (PA) was greater on the variety 98-10-30 than on the other varieties, and PA was greater in the aphid + BYDV treatment on 98-1030 than in the non-viruliferous aphid treatment, but this trend was reversed on Tam200(13) G and Xiaoyan6. (3) The BYDV disease incidence (DIC) on the variety 98-10-30 was greater than that on the other two varieties in 2012, and the disease index (DID) on Tam200(13) G was lower than on the other varieties in the aphid + BYDV and BYDV treatments in 2012, but not in 2011 when aphid vector numbers were generally lower. (4) Yield loss in the aphid + BYDV treatment tended to be greater than that in the aphid or BYDV alone treatments across varieties and years. We suggested that aphid population development and BYDV transmission tend to promote each other under field conditions. The aphids + BYDV treatment caused greater yield reductions than non-viruliferous aphids or virus treatment. Wheat varietal resistance in 98-10-30 affects the aphid dispersal, virus transmission and wheat yield loss though inhibits aphid populations from increasing.	[Liu, Xiao-Feng; Hu, Xiang-Shun; Zhao, Hui-Yan; Wu, Yun-Feng; Liu, Tong-Xian] Northwest A&F Univ, State Key Lab Crop Stress Biol Arid Areas, Yangling, Shaanxi, Peoples R China; [Liu, Xiao-Feng; Hu, Xiang-Shun; Keller, Mike A.; Zhao, Hui-Yan; Wu, Yun-Feng; Liu, Tong-Xian] Northwest A&F Univ, Key Lab Crop Pest Management Northwest Loess Plat, Minist Agr, Yangling, Shaanxi, Peoples R China; [Keller, Mike A.] Univ Adelaide, Sch Agr Food & Wine, Adelaide, SA, Australia	Northwest A&F University - China; Ministry of Agriculture & Rural Affairs; Northwest A&F University - China; University of Adelaide	Wu, YF (corresponding author), Northwest A&F Univ, State Key Lab Crop Stress Biol Arid Areas, Yangling, Shaanxi, Peoples R China.	wuyf@nwsuaf.edu.cn; txliu@nwsuaf.edu.cn	Keller, Michael A/A-8371-2008; Hu, Xiangshun/M-9935-2013	Keller, Michael A/0000-0003-0721-9753; 	The Youth Foundation [080807, 08080252]; Basic Research Foundation of Northwest AF University [Z111020915, Z109021122]; National Department Public Benefit Research Foundation of China [nyhyzx201303021]; Education Ministry of China [B07049]	The Youth Foundation; Basic Research Foundation of Northwest AF University; National Department Public Benefit Research Foundation of China; Education Ministry of China(Ministry of Education, China)	This study was financially supported by The Youth Foundation (080807, 08080252), the Basic Research Foundation of Northwest A&F University (Z111020915, Z109021122), the National Department Public Benefit Research Foundation of China (grant no. nyhyzx201303021), and the 111 Project from the Education Ministry of China (grant no. B07049). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AJAYI O, 1986, ANN APPL BIOL, V108, P145, DOI 10.1111/j.1744-7348.1986.tb01975.x; Ajayi O, 1983, ANN APPL BIOL, V10, P1; Araya JE, 1987, J PLANT DIS PROTECT, V94, P195; BASEDOW T, 1994, Z PFLANZENK PFLANZEN, V101, P337; Bosque-Perez NA, 2011, VIRUS RES, V159, P201, DOI 10.1016/j.virusres.2011.04.020; CARRIGAN LL, 1981, CROP SCI, V21, P377, DOI 10.2135/cropsci1981.0011183X002100030006x; CARTER N, 1989, CROP PROT, V8, P271, DOI 10.1016/0261-2194(89)90012-4; CISAR G, 1982, CROP SCI, V22, P474, DOI 10.2135/cropsci1982.0011183X002200030009x; [代锦 Dai Jin], 2010, [西北农业学报, Acat Agriculturae Boreali-Occidentalis Sinica], V19, P165; Daugherty MP, 2010, ECOL ENTOMOL, V35, P360, DOI 10.1111/j.1365-2311.2010.01189.x; Dedryver CA, 2005, EUR J PLANT PATHOL, V111, P341, DOI 10.1007/s10658-004-4890-1; Dogimont C, 2010, CR BIOL, V333, P566, DOI 10.1016/j.crvi.2010.04.003; DOODSON JK, 1970, ANN APPL BIOL, V66, P361, DOI 10.1111/j.1744-7348.1970.tb04615.x; FERERES A, 1990, J APPL ENTOMOL, V109, P29, DOI 10.1111/j.1439-0418.1990.tb00015.x; FERERES A, 1988, ENVIRON ENTOMOL, V17, P596, DOI 10.1093/ee/17.3.596; FERERES A, 1989, ENVIRON ENTOMOL, V18, P388, DOI 10.1093/ee/18.3.388; Fereres A, 2009, VIRUS RES, V141, P158, DOI 10.1016/j.virusres.2008.10.020; Fiebig M, 2004, ENTOMOL EXP APPL, V110, P11, DOI 10.1111/j.0013-8703.2004.00115.x; FITZGERA.PJ, 1967, CROP SCI, V7, P337, DOI 10.2135/cropsci1967.0011183X000700040018x; GEORGE KS, 1974, ANN APPL BIOL, V77, P67, DOI 10.1111/j.1744-7348.1974.tb01389.x; GEORGE KS, 1979, PLANT PATHOL, V28, P143, DOI 10.1111/j.1365-3059.1979.tb02630.x; GILDOW FE, 1993, PHYTOPATHOLOGY, V83, P270, DOI 10.1094/Phyto-83-270; GILDOW FE, 1980, ANN ENTOMOL SOC AM, V73, P343, DOI 10.1093/aesa/73.3.343; GILL C C, 1980, Plant Disease, V64, P197; Herbert DA, 1999, J PROD AGRIC, V12, P105, DOI 10.2134/jpa1999.0105; HODGSON CJ, 1981, ANN APPL BIOL, V98, P1, DOI 10.1111/j.1744-7348.1981.tb00417.x; Hoffman TK, 1998, PLANT DIS, V82, P620, DOI 10.1094/PDIS.1998.82.6.620; [胡亮 HU Liang], 2009, [麦类作物学报, Journal of Triticeae Crops], V29, P721; Hu XS, 2013, J ECON ENTOMOL, V106, P1894, DOI 10.1603/EC13071; Hu XiangShun, 2004, Acta Botanica Boreali-Occidentalia Sinica, V24, P1221; Huang J, 2003, PLANTA, V217, P767, DOI 10.1007/s00425-003-1039-y; Ingwell LL, 2012, SCI REP-UK, V2, DOI 10.1038/srep00578; JENSEN SG, 1971, CROP SCI, V11, P775, DOI 10.2135/cropsci1971.0011183X001100060001x; JENSEN SG, 1972, PHYTOPATHOLOGY, V62, P290, DOI 10.1094/Phyto-62-290; Jimenez-Martinez ES, 2004, J ECON ENTOMOL, V97, P203, DOI 10.1603/0022-0493-97.2.203; KOLBE W, 1969, Pflanzenschutz-Nachr. Bayer (Ger. Ed.), V22, P171; KOLBE W, 1974, ANN APPL BIOL, V77, P85, DOI 10.1111/j.1744-7348.1974.tb01392.x; Lai You-Peng, 2011, Chinese Journal of Applied Entomology, V48, P1688; Larsson H, 2005, CROP PROT, V24, P397, DOI 10.1016/j.cropro.2004.08.011; Li R, 2003, J SHANXI AGR U, V23, P312; LIU SY, 1986, J ECON ENTOMOL, V79, P1688, DOI 10.1093/jee/79.6.1688; Luo RW, 1990, ACTA PHYTOPHY SIN, V17, P209; Mann RS, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002610; Matsuura S, 2009, APPL ENTOMOL ZOOL, V44, P143, DOI 10.1303/aez.2009.143; Mauck K, 2012, FUNCT ECOL, V26, P1162, DOI 10.1111/j.1365-2435.2012.02026.x; Mauck KE, 2010, P NATL ACAD SCI USA, V107, P3600, DOI 10.1073/pnas.0907191107; Mayer CJ, 2008, J CHEM ECOL, V34, P1518, DOI 10.1007/s10886-008-9564-6; Mitchell PL, 2004, NEOTROP ENTOMOL, V33, P519, DOI 10.1590/S1519-566X2004000500001; Moreno-Delafuente A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061543; Neil KA, 1997, CAN ENTOMOL, V129, P1079, DOI 10.4039/Ent1291079-6; OAKLEY JN, 1994, ANN APPL BIOL, V124, P195, DOI 10.1111/j.1744-7348.1994.tb04128.x; PAPP M, 1993, EUPHYTICA, V67, P49, DOI 10.1007/BF00022724; Perry KL, 2000, PHYTOPATHOLOGY, V90, P1043, DOI 10.1094/PHYTO.2000.90.9.1043; Qian Y. T., 1986, Acta Phytophylactica Sinica, V13, P159; QUIROZ C, 1991, J ECON ENTOMOL, V84, P1920, DOI 10.1093/jee/84.6.1920; Ren CG, 1998, CHINESE BULL ENTOMOL, V35, P16; Ren ZY, 1990, ACTA PHYTOPATHOL SIN, V20, P13; Riedell WE, 1999, CROP SCI, V39, P158, DOI 10.2135/cropsci1999.0011183X003900010025x; Roossinck MJ, 2011, NAT REV MICROBIOL, V9, P99, DOI 10.1038/nrmicro2491; Rubinstein G, 1997, J GEN VIROL, V78, P2683, DOI 10.1099/0022-1317-78-10-2683; Sanderson FR, 1969, NZ WEED PEST CONTR C, V22, P227; SMITH HARVEY C., 1963, NEW ZEALAND JOUR AGRIC RES, V6, P229; SMITH PR, 1982, AUST J AGR RES, V33, P179, DOI 10.1071/AR9820179; Tang Q., 2007, DPS DATA PROCESSING; THIRAKHUPT V, 1992, Z PFLANZENK PFLANZEN, V99, P420; Wang M. F., 2010, HENAN AGR SCI, V4, P16; WEBSTER JA, 1999, EC ENV SOCIAL BENEFI, P87; WRATTEN SD, 1975, ANN APPL BIOL, V79, P27, DOI 10.1111/j.1744-7348.1975.tb01518.x; Wu BL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016896; Wu RJ, 1986, PLANT PROT, V6, p[2, 23]; [杨菲 Yang Fei], 2012, [植物保护, Plant Protection], V38, P117; YOUNT DJ, 1985, PLANT DIS, V69, P487, DOI 10.1094/PD-69-487; Yu XQ, 2010, J TRITICEAE CROPS, V10, P1053; Zhang Q F, 1983, PLANT DIS, V67, P895; ZHOU GH, 1984, PLANT DIS, V68, P710, DOI 10.1094/PD-69-710; Zhou Guanghe, 1986, Acta Phytopathologica Sinica, V16, P17	76	22	31	1	67	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 3	2014	9	9							e106639	10.1371/journal.pone.0106639	http://dx.doi.org/10.1371/journal.pone.0106639			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3TB	25184214	Green Published, Green Submitted, gold			2022-12-27	WOS:000341257700095
J	Cerame, B; Cox, JA; Brumfield, RT; Tucker, JW; Taylor, SS				Cerame, Blain; Cox, James A.; Brumfield, Robb T.; Tucker, James W.; Taylor, Sabrina S.			Adaptation to Ephemeral Habitat May Overcome Natural Barriers and Severe Habitat Fragmentation in a Fire-Dependent Species, the Bachman's Sparrow (Peucaea aestivalis)	PLOS ONE			English	Article							GENETIC POPULATION-STRUCTURE; RED-COCKADED WOODPECKERS; COMPUTER-PROGRAM; UNITED-STATES; PHYLOGEOGRAPHY; DNA; EVOLUTIONARY; LANDSCAPE; SOFTWARE; DISTANCE	Bachman's Sparrow (Peucaea aestivalis) is a fire-dependent species that has undergone range-wide population declines in recent decades. We examined genetic diversity in Bachman's Sparrows to determine whether natural barriers have led to distinct population units and to assess the effect of anthropogenic habitat loss and fragmentation. Genetic diversity was examined across the geographic range by genotyping 226 individuals at 18 microsatellite loci and sequencing 48 individuals at mitochondrial and nuclear genes. Multiple analyses consistently demonstrated little genetic structure and high levels of genetic variation, suggesting that populations are panmictic. Based on these genetic data, separate management units/subspecies designations or translocations to promote gene flow among fragmented populations do not appear to be necessary. Panmixia in Bachman's Sparrow may be a consequence of an historical range expansion and retraction. Alternatively, high vagility in Bachman's Sparrow may be an adaptation to the ephemeral, fire-mediated habitat that this species prefers. In recent times, high vagility also appears to have offset inbreeding and loss of genetic diversity in highly fragmented habitat.	[Cerame, Blain; Taylor, Sabrina S.] Louisiana State Univ, Ctr Agr, Sch Renewable Nat Resources, Baton Rouge, LA 70803 USA; [Cox, James A.] Tall Timbers Res Stn & Land Conservancy, Tallahassee, FL USA; [Brumfield, Robb T.] Louisiana State Univ, Museum Nat Sci, Baton Rouge, LA 70803 USA; [Brumfield, Robb T.] Louisiana State Univ, Dept Biol Sci, Baton Rouge, LA 70803 USA; [Tucker, James W.] Archbold Biol Stn, Venus, FL USA	Louisiana State University System; Louisiana State University; Louisiana State University System; Louisiana State University; Louisiana State University System; Louisiana State University	Taylor, SS (corresponding author), Louisiana State Univ, Ctr Agr, Sch Renewable Nat Resources, Baton Rouge, LA 70803 USA.	staylor@lsu.edu	Brumfield, Robb T/K-6108-2015; Tucker, James W/B-7671-2014	Brumfield, Robb T/0000-0003-2307-0688; Taylor, Sabrina/0000-0002-0118-9883	Louisiana Board of Regents Research Competitiveness Subprogram [LEQSF(2011-13)-RD-A-02]; Louisiana State University AgCenter; US Army Medical Research and Material Command [W81XWH-06-2-0026]; Archbold Biological Station under supervision of Reed Bowman	Louisiana Board of Regents Research Competitiveness Subprogram; Louisiana State University AgCenter; US Army Medical Research and Material Command(United States Department of DefenseUnited States ArmyU.S. Army Medical Research & Materiel Command (USAMRMC)); Archbold Biological Station under supervision of Reed Bowman	Financial support was provided to SST by the Louisiana Board of Regents Research Competitiveness Subprogram LEQSF(2011-13)-RD-A-02 and the Louisiana State University AgCenter. Sampling by JWT at Avon Park Air Force Range was supported by funding from the US Army Medical Research and Material Command under Cooperative Agreement No. W81XWH-06-2-0026 with Archbold Biological Station under supervision of Reed Bowman. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allendorf F, 2013, CONSERV GENET, V2nd; American Ornithologists' Union (AOU), 1957, AM ORN UN CHECK LIST; [Anonymous], 2013, INS PESTS POT GLOB, DOI DOI 10.1016/B978-0-12-386895-4.00005-3; Arguedas N, 2000, CONDOR, V102, P517, DOI 10.1650/0010-5422(2000)102[0517:SMAGPS]2.0.CO;2; Belkhir K., 1999, GENETIX LOGICIEL WIN; Brant SV, 2002, MOL PHYLOGENET EVOL, V22, P163, DOI 10.1006/mpev.2001.1057; Brohede J, 2002, NUCLEIC ACIDS RES, V30, P1997, DOI 10.1093/nar/30.9.1997; Brooks M., 1938, Wilson Bulletin, V50, P86; Brooks ME, 2011, WILSON J ORNITHOL, V123, P65, DOI 10.1676/10-039.1; Brown SM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059732; Brunsfeld S., 2001, INTEGRATING ECOLOGY, V14, P319; Burbrink FT, 2008, MOL PHYLOGENET EVOL, V47, P274, DOI 10.1016/j.ympev.2007.10.020; Burbrink FT, 2000, EVOLUTION, V54, P2107, DOI 10.1554/0014-3820(2000)054[2107:MDPOTP]2.0.CO;2; Clement M, 2000, MOL ECOL, V9, P1657, DOI 10.1046/j.1365-294x.2000.01020.x; Clostio RW, 2012, ANIM CONSERV, V15, P613, DOI 10.1111/j.1469-1795.2012.00557.x; Cornuet JM, 1996, GENETICS, V144, P2001; Cox JA, 2004, J FIELD ORNITHOL, V75, P359, DOI 10.1648/0273-8570-75.4.359; Cox JA, 2007, J FIELD ORNITHOL, V78, P263, DOI 10.1111/j.1557-9263.2007.00113.x; Cox JA, 2010, CONDOR, V112, P663, DOI 10.1525/cond.2010.100024; Croteau EK, 2007, CONSERV GENET, V8, P1453, DOI 10.1007/s10592-007-9296-0; Dor R, 2012, J HERED, V103, P55, DOI 10.1093/jhered/esr114; DUNNING JB, 1990, AUK, V107, P463; DUNNING JB, 1995, CONSERV BIOL, V9, P542, DOI 10.1046/j.1523-1739.1995.09030542.x; Dunning Jr J. B., 2006, BIRDS N AM; Eifrig G., 1915, Auk Cambridge Mass, V32; Engstrom R. Todd, 2005, Studies in Avian Biology, V30, P147; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Falush D, 2003, GENETICS, V164, P1567; Francois O, 2010, MOL ECOL RESOUR, V10, P773, DOI 10.1111/j.1755-0998.2010.02868.x; Gaggiotti O.E., 2004, ECOLOGY GENETICS EVO; Gamble T, 2008, MOL PHYLOGENET EVOL, V48, P112, DOI 10.1016/j.ympev.2008.03.015; Gilbert KJ, 2012, MOL ECOL, V21, P4925, DOI 10.1111/j.1365-294X.2012.05754.x; Goudet J, 1995, J HERED, V86, P485, DOI 10.1093/oxfordjournals.jhered.a111627; Guillot G, 2005, MOL ECOL NOTES, V5, P712, DOI 10.1111/j.1471-8286.2005.01031.x; GUO SW, 1992, AM J HUM GENET, V51, P1111; Hackett SJ, 1996, MOL PHYLOGENET EVOL, V5, P368, DOI 10.1006/mpev.1996.0032; HAIG SM, 1994, MOL ECOL, V3, P581, DOI 10.1111/j.1365-294X.1994.tb00089.x; Haig SM, 1996, MOL ECOL, V5, P725, DOI 10.1111/j.1365-294X.1996.tb00369.x; HELLBERG ME, 1994, EVOLUTION, V48, P1829, DOI 10.1111/j.1558-5646.1994.tb02218.x; Hubisz MJ, 2009, MOL ECOL RESOUR, V9, P1322, DOI 10.1111/j.1755-0998.2009.02591.x; Jackson ND, 2010, EVOLUTION, V64, P409, DOI 10.1111/j.1558-5646.2009.00840.x; Jensen JL, 2005, BMC GENET, V6, DOI 10.1186/1471-2156-6-13; Johnson KP, 1998, MOL PHYLOGENET EVOL, V10, P82, DOI 10.1006/mpev.1997.0481; Jones CD, 2013, WILSON J ORNITHOL, V125, P293, DOI 10.1676/12-119.1; Kalinowski ST, 2011, HEREDITY, V106, P625, DOI 10.1038/hdy.2010.95; Koopman MM, 2010, CONSERV GENET, V11, P2027, DOI 10.1007/s10592-010-0095-7; LANDE R, 1988, SCIENCE, V241, P1455, DOI 10.1126/science.3420403; Latch EK, 2008, J HERED, V99, P265, DOI 10.1093/jhered/esn009; Lee PLM, 2001, MOL ECOL, V10, P1633, DOI 10.1046/j.1365-294X.2001.01305.x; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; LIU JG, 1995, CONSERV BIOL, V9, P62, DOI 10.1046/j.1523-1739.1995.09010062.x; LOUIS EJ, 1987, BIOMETRICS, V43, P805, DOI 10.2307/2531534; Mayer C, 2009, MOL ECOL, V18, P2353, DOI 10.1111/j.1365-294X.2009.04200.x; McKay BD, 2009, J AVIAN BIOL, V40, P181, DOI 10.1111/j.1600-048X.2009.04503.x; MCPEEK MA, 1992, AM NAT, V140, P1010, DOI 10.1086/285453; Michalakis Y, 1996, GENETICS, V142, P1061; Mitchell RJ, 2006, CAN J FOREST RES, V36, P2724, DOI 10.1139/X06-100; NEI M, 1972, AM NAT, V106, P283, DOI 10.1086/282771; NEI M, 1975, EVOLUTION, V29, P1, DOI 10.2307/2407137; Nei M., 1987, MOL EVOLUTIONARY GEN; Ortego J, 2008, MUTAT RES-FUND MOL M, V648, P82, DOI 10.1016/j.mrfmmm.2008.09.012; Paradis E, 1998, EVOL ECOL, V12, P235, DOI 10.1023/A:1006539930788; Pauly GB, 2007, MOL ECOL, V16, P415, DOI 10.1111/j.1365-294X.2006.03149.x; Pereoglou F, 2013, MOL ECOL, V22, P1267, DOI 10.1111/mec.12172; Piry S, 2004, J HERED, V95, P536, DOI 10.1093/jhered/esh074; Piry S, 1999, J HERED, V90, P502, DOI 10.1093/jhered/90.4.502; Primmer CR, 2002, MOL ECOL, V11, P603, DOI 10.1046/j.0962-1083.2001.01452.x; Pritchard JK, 2000, GENETICS, V155, P945; Rannala B, 1997, P NATL ACAD SCI USA, V94, P9197, DOI 10.1073/pnas.94.17.9197; Raymond M, 1995, EVOLUTION, V49, P1280, DOI 10.1111/j.1558-5646.1995.tb04456.x; RICE WR, 1989, EVOLUTION, V43, P223, DOI 10.1111/j.1558-5646.1989.tb04220.x; Rousset F, 2008, MOL ECOL RESOUR, V8, P103, DOI 10.1111/j.1471-8286.2007.01931.x; Schrey AW, 2011, MOL ECOL, V20, P56, DOI 10.1111/j.1365-294X.2010.04925.x; SEUTIN G, 1991, CAN J ZOOL, V69, P82, DOI 10.1139/z91-013; Shriver WG, 2001, J WILDLIFE MANAGE, V65, P470, DOI 10.2307/3803099; Sibley David Allen, 2000, SIBLEY GUIDE BIRDS; Soltis DE, 2006, MOL ECOL, V15, P4261, DOI 10.1111/j.1365-294X.2006.03061.x; Spear SF, 2010, BIOL CONSERV, V143, P778, DOI 10.1016/j.biocon.2009.12.021; STANGEL PW, 1992, CONSERV BIOL, V6, P283, DOI 10.1046/j.1523-1739.1992.620283.x; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Templeton AR, 2001, P NATL ACAD SCI USA, V98, P5426, DOI 10.1073/pnas.091093098; Templeton AR, 2004, MOL ECOL, V13, P789, DOI 10.1046/j.1365-294X.2003.02041.x; Templeton AR, 1998, MOL ECOL, V7, P381, DOI 10.1046/j.1365-294x.1998.00308.x; TEMPLETON AR, 1992, GENETICS, V132, P619; Tucker JW, 2006, WILSON J ORNITHOL, V118, P131, DOI 10.1676/05-022.1; Tucker JW, 2004, J WILDLIFE MANAGE, V68, P1114, DOI 10.2193/0022-541X(2004)068[1114:IOFOBS]2.0.CO;2; Van Oosterhout C, 2004, MOL ECOL NOTES, V4, P535, DOI 10.1111/j.1471-8286.2004.00684.x; Veit ML, 2005, CONSERV GENET, V6, P159, DOI 10.1007/s10592-004-7831-9; Watts Bryan D., 1998, Raven, V69, P9; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI 10.1111/j.1558-5646.1984.tb05657.x; Widener B., 2008, TALL TIMBERS RES STA, V17; Willi Y, 2006, ANNU REV ECOL EVOL S, V37, P433, DOI 10.1146/annurev.ecolsys.37.091305.110145	93	8	9	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2014	9	9							e105782	10.1371/journal.pone.0105782	http://dx.doi.org/10.1371/journal.pone.0105782			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3LR	25180939	gold, Green Published			2022-12-27	WOS:000341231500033
J	Chen, J; Liu, TW; Hu, WJ; Simon, M; Wang, WH; Chen, J; Liu, X; Zheng, HL				Chen, Juan; Liu, Ting-Wu; Hu, Wen-Jun; Simon, Martin; Wang, Wen-Hua; Chen, Juan; Liu, Xiang; Zheng, Hai-Lei			Comparative Proteomic Analysis of Differentially Expressed Proteins Induced by Hydrogen Sulfide in Spinacia oleracea Leaves	PLOS ONE			English	Article							STRESS-RESPONSIVE PROTEINS; WRKY TRANSCRIPTION FACTORS; GLYCINE-RICH PROTEINS; NITRIC-OXIDE; GEL-ELECTROPHORESIS; NITRATE REDUCTASE; DROUGHT TOLERANCE; SEED-GERMINATION; STOMATAL DENSITY; PHYTOCHROME	Hydrogen sulfide (H2S), as a potential gaseous messenger molecule, has been suggested to play important roles in a wide range of physiological processes in plants. The aim of present study was to investigate which set of proteins is involved in H2S-regulated metabolism or signaling pathways. Spinacia oleracea seedlings were treated with 100 mu M NaHS, a donor of H2S. Changes in protein expression profiles were analyzed by 2-D gel electrophoresis coupled with MALDI-TOF MS. Over 1000 protein spots were reproducibly resolved, of which the abundance of 92 spots was changed by at least 2-fold (sixtyfive were up-regulated, whereas 27 were down-regulated). These proteins were functionally divided into 9 groups, including energy production and photosynthesis, cell rescue, development and cell defense, substance metabolism, protein synthesis and folding, cellular signal transduction. Further, we found that these proteins were mainly localized in cell wall, plasma membrane, chloroplast, mitochondria, nucleus, peroxisome and cytosol. Our results demonstrate that H2S is involved in various cellular and physiological activities and has a distinct influence on photosynthesis, cell defense and cellular signal transduction in S. oleracea leaves. These findings provide new insights into proteomic responses in plants under physiological levels of H2S.	[Chen, Juan] Northwest A&F Univ, State Key Lab Soil Eros & Dryland Farming Loess P, Yangling, Shanxi, Peoples R China; [Chen, Juan; Liu, Ting-Wu; Hu, Wen-Jun; Simon, Martin; Wang, Wen-Hua; Chen, Juan; Liu, Xiang; Zheng, Hai-Lei] Xiamen Univ, MOE Coll Environm & Ecol, Key Lab Subtrop Wetland Ecosyst Res MOE, Xiamen, Fujian, Peoples R China; [Liu, Ting-Wu] Huaiyin Normal Univ, Dept Biol, Huaian, Jiangsu, Peoples R China	Northwest A&F University - China; Xiamen University; Huaiyin Normal University	Zheng, HL (corresponding author), Xiamen Univ, MOE Coll Environm & Ecol, Key Lab Subtrop Wetland Ecosyst Res MOE, Xiamen, Fujian, Peoples R China.	zhenghl@xmu.edu.cn	Zheng, Hai-Lei/G-3432-2010	Zheng, Hai-Lei/0000-0001-8588-1529	Natural Science Foundation of China (NSFC) [30930076, 31300505, 31260057, 30770192, 30670317]; Foundation of the Chinese Ministry of Education [20070384033]; Program for New Century Excellent Talents in Xiamen University (NCETXMU) [X07115]; foundation of doctoral scientific research in Northwest AF University [2013BSJJ090]	Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Foundation of the Chinese Ministry of Education(Ministry of Education, China); Program for New Century Excellent Talents in Xiamen University (NCETXMU)(Program for New Century Excellent Talents in University (NCET)); foundation of doctoral scientific research in Northwest AF University	This study was financially supported by the Natural Science Foundation of China (NSFC Nos 30930076, 31300505, 31260057, 30770192, 30670317), the Foundation of the Chinese Ministry of Education (20070384033), the Program for New Century Excellent Talents in Xiamen University (NCETXMU No X07115), the foundation of doctoral scientific research in Northwest A&F University (2013BSJJ090). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Askari H, 2006, PROTEOMICS, V6, P2542, DOI 10.1002/pmic.200500328; Bachmann M, 1996, FEBS LETT, V398, P26, DOI 10.1016/S0014-5793(96)01188-X; Bai XG, 2011, J PROTEOME RES, V10, P4349, DOI 10.1021/pr200333f; Balasubramanian S, 2006, NAT GENET, V38, P711, DOI 10.1038/ng1818; BJELLQVIST B, 1982, J BIOCHEM BIOPH METH, V6, P317, DOI 10.1016/0165-022X(82)90013-6; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Carpentier SC, 2005, PROTEOMICS, V5, P2497, DOI 10.1002/pmic.200401222; Carvalho RF, 2011, J INTEGR PLANT BIOL, V53, P920, DOI 10.1111/j.1744-7909.2011.01081.x; Chen J, 2013, PLANT SOIL, V362, P301, DOI 10.1007/s11104-012-1275-7; Chen J, 2011, J EXP BOT, V62, P4481, DOI 10.1093/jxb/err145; Chen YF, 2005, ANN BOT-LONDON, V95, P901, DOI 10.1093/aob/mci100; Delledonne M, 2005, CURR OPIN PLANT BIOL, V8, P390, DOI 10.1016/j.pbi.2005.05.002; Desikan R, 2002, P NATL ACAD SCI USA, V99, P16314, DOI 10.1073/pnas.252461999; Devoto A, 2005, PHYSIOL PLANTARUM, V123, P161, DOI 10.1111/j.1399-3054.2004.00418.x; Doughty J, 1998, PLANT CELL, V10, P1333, DOI 10.1105/tpc.10.8.1333; Eulgem T, 2007, CURR OPIN PLANT BIOL, V10, P366, DOI 10.1016/j.pbi.2007.04.020; Faivre-Nitschke SE, 2001, EUR J BIOCHEM, V268, P1332, DOI 10.1046/j.1432-1327.2001.01999.x; Fang XL, 2013, J PROTEOME RES, V12, P1772, DOI 10.1021/pr301117a; Farras R, 2001, EMBO J, V20, P2742, DOI 10.1093/emboj/20.11.2742; Garcia-Mata C, 2010, NEW PHYTOL, V188, P977, DOI 10.1111/j.1469-8137.2010.03465.x; Hosoki R, 1997, BIOCHEM BIOPH RES CO, V237, P527, DOI 10.1006/bbrc.1997.6878; Hu LY, 2012, J AGR FOOD CHEM, V60, P8684, DOI 10.1021/jf300728h; Jiang Y, 2007, J EXP BOT, V58, P3591, DOI 10.1093/jxb/erm207; Jin ZP, 2011, BIOCHEM BIOPH RES CO, V414, P481, DOI 10.1016/j.bbrc.2011.09.090; La Camera S, 2011, PLANT J, V68, P507, DOI 10.1111/j.1365-313X.2011.04706.x; [李东波 Li Dongbo], 2010, [植物学报, Chinese Bulletin of Botany], V45, P354; Li L, 2012, BIOMETALS, V25, P617, DOI 10.1007/s10534-012-9551-9; Li L, 2011, ANNU REV PHARMACOL, V51, P169, DOI 10.1146/annurev-pharmtox-010510-100505; Li SP, 2014, J AGR FOOD CHEM, V62, P1119, DOI 10.1021/jf4047122; LICHTENTHALER HK, 1987, METHOD ENZYMOL, V148, P350; LIN G, 1992, AUST J PLANT PHYSIOL, V19, P509, DOI 10.1071/PP9920509; Lisjak M, 2010, PLANT PHYSIOL BIOCH, V48, P931, DOI 10.1016/j.plaphy.2010.09.016; Liu J, 2012, PLANT MOL BIOL, V78, P289, DOI 10.1007/s11103-011-9860-3; Liu TW, 2011, PROTEOMICS, V11, P2079, DOI 10.1002/pmic.201000307; Lum HK, 2005, NITRIC OXIDE-BIOL CH, V12, P220, DOI 10.1016/j.niox.2005.03.002; Majeran W, 2005, PLANT CELL, V17, P3111, DOI 10.1105/tpc.105.035519; Mayfield JD, 2012, J EXP BOT, V63, P3061, DOI 10.1093/jxb/ers022; MCGARVEY DJ, 1992, J BIOL CHEM, V267, P5964; Meng YY, 2011, J PROTEOME RES, V10, P5416, DOI 10.1021/pr200671d; Mousavi A, 2005, APPL BIOCHEM BIOTECH, V120, P169, DOI 10.1385/ABAB:120:3:169; Ndimba BK, 2005, PROTEOMICS, V5, P4185, DOI 10.1002/pmic.200401282; Oliveira AP, 2008, J AGR FOOD CHEM, V56, P5216, DOI 10.1021/jf800563w; OREN A, 1979, BIOCHIM BIOPHYS ACTA, V546, P270, DOI 10.1016/0005-2728(79)90045-8; Ottmann C, 2007, MOL CELL, V25, P427, DOI 10.1016/j.molcel.2006.12.017; Pandey SP, 2009, PLANT PHYSIOL, V150, P1648, DOI 10.1104/pp.109.138990; Porta H, 2002, PLANT PHYSIOL, V130, P15, DOI 10.1104/pp.010787; Ratnaparkhe MB, 2011, NEW PHYTOL, V192, P164, DOI 10.1111/j.1469-8137.2011.03800.x; RENNENBERG H, 1983, PHYTOCHEMISTRY, V22, P1557, DOI 10.1016/0031-9422(83)80088-0; Ringli C, 2001, CELL MOL LIFE SCI, V58, P1430, DOI 10.1007/PL00000786; Rostoks N, 2003, THEOR APPL GENET, V107, P1094, DOI 10.1007/s00122-003-1351-8; Sakai H, 1998, PLANT CELL PHYSIOL, V39, P1232, DOI 10.1093/oxfordjournals.pcp.a029325; SEKIYA J, 1982, PLANT PHYSIOL, V70, P430, DOI 10.1104/pp.70.2.430; Sun J, 2013, PLANT PHYSIOL BIOCH, V65, P67, DOI 10.1016/j.plaphy.2013.01.003; Toroser D, 1998, FEBS LETT, V435, P110, DOI 10.1016/S0014-5793(98)01048-5; Wang BL, 2010, PLANTA, V231, P1301, DOI 10.1007/s00425-010-1134-9; Wang R, 2002, FASEB J, V16, P1792, DOI 10.1096/fj.02-0211hyp; Wang YQ, 2012, PLANT SOIL, V351, P107, DOI 10.1007/s11104-011-0936-2; Wang YH, 2009, NEW PHYTOL, V182, P851, DOI 10.1111/j.1469-8137.2009.02820.x; WILSON LG, 1978, PLANT PHYSIOL, V61, P184, DOI 10.1104/pp.61.2.184; [肖强 Xiao Qiang], 2005, [生态学杂志, Chinese Journal of Ecology], V24, P711; Xu YH, 2012, J EXP BOT, V63, P1095, DOI 10.1093/jxb/err315; Xuan W, 2008, PLANT PHYSIOL, V148, P881, DOI 10.1104/pp.108.125567; Yang GD, 2008, SCIENCE, V322, P587, DOI 10.1126/science.1162667; Yoo CY, 2010, PLANT CELL, V22, P4128, DOI 10.1105/tpc.110.078691; Zhang H, 2010, BIOL PLANTARUM, V54, P743, DOI 10.1007/s10535-010-0133-9; Zhang H, 2008, J INTEGR PLANT BIOL, V50, P1518, DOI 10.1111/j.1744-7909.2008.00769.x; Zhang H, 2011, POSTHARVEST BIOL TEC, V60, P251, DOI 10.1016/j.postharvbio.2011.01.006; Zhang H, 2009, PLANT GROWTH REGUL, V58, P243, DOI 10.1007/s10725-009-9372-1; Zhao WM, 2001, EMBO J, V20, P6008, DOI 10.1093/emboj/20.21.6008; [侯智慧 Zhihui Hou], 2011, [植物学报, Chinese Bulletin of Botany], V46, P396; Zhou GK, 2007, PLANT CELL PHYSIOL, V48, P689, DOI 10.1093/pcp/pcm037; Zhou LA, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-290; 刘菁, 2011, [科学通报, Chinese Science Bulletin], V56, P2515	73	11	13	2	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2014	9	9							e105400	10.1371/journal.pone.0105400	http://dx.doi.org/10.1371/journal.pone.0105400			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3LR	25181351	Green Published, gold			2022-12-27	WOS:000341231500024
J	Courtois, P; Figuieres, C; Mulier, C				Courtois, Pierre; Figuieres, Charles; Mulier, Chloe			Conservation Priorities when Species Interact: The Noah's Ark Metaphor Revisited	PLOS ONE			English	Article							MODELS	This note incorporates ecological interactions into the Noah's Ark problem. In doing so, we arrive at a general model for ranking in situ conservation projects accounting for species interrelations and provide an operational cost-effectiveness method for the selection of best preserving diversity projects under a limited budget constraint.	[Courtois, Pierre; Figuieres, Charles; Mulier, Chloe] INRA, LAMETA, F-34060 Montpellier, France	INRAE; Institut Agro; Montpellier SupAgro; Centre National de la Recherche Scientifique (CNRS); Universite de Montpellier	Figuieres, C (corresponding author), INRA, LAMETA, F-34060 Montpellier, France.	figuiere@supagro.inra.fr		courtois, pierre/0000-0002-3997-828X	ONEMA program	ONEMA program	This study was supported by the ONEMA program 2013-2015. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAUMGARTNER S, 2004, ECOHEALTH, V1, P101, DOI DOI 10.1007/S10393-004-0003-Z; BAUMOL WJ, 1967, ECONOMETRICA, V35, P447, DOI 10.2307/1905648; Burgman MA, 1993, RISK ASSESSMENT CONS, P44; Elith J, 2009, ANNU REV ECOL EVOL S, V40, P677, DOI 10.1146/annurev.ecolsys.110308.120159; Eppink FV, 2007, ECOL ECON, V61, P284, DOI 10.1016/j.ecolecon.2006.01.013; Garnett ST, 2000, ACTION PLAN AUSTR BI; Guisan A, 2005, ECOL LETT, V8, P993, DOI 10.1111/j.1461-0248.2005.00792.x; Hauser CE, 2009, ECOL LETT, V12, P638; Joseph LN, 2009, CONSERV BIOL, V23, P328, DOI 10.1111/j.1523-1739.2008.01124.x; McCarthy MA, 2008, J APPL ECOL, V45, P1428, DOI 10.1111/j.1365-2664.2008.01521.x; Simianer H, 2008, CONSERV GENET, V9, P171, DOI 10.1007/s10592-007-9319-x; van der Heide CM, 2005, ECOL ECON, V55, P218, DOI 10.1016/j.ecolecon.2004.12.018; Weitzman ML, 1998, ECONOMETRICA, V66, P1279, DOI 10.2307/2999617; Witting L, 2000, ECOL MODEL, V125, P123, DOI 10.1016/S0304-3800(99)00177-5	14	8	8	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2014	9	9							e106073	10.1371/journal.pone.0106073	http://dx.doi.org/10.1371/journal.pone.0106073			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AO3LR	25181514	Green Published, Green Submitted, gold			2022-12-27	WOS:000341231500046
J	Lauer, F; Prost, K; Gerlach, R; Patzold, S; Wolf, M; Urmersbach, S; Lehndorff, E; Eckmeier, E; Amelung, W				Lauer, Franziska; Prost, Katharina; Gerlach, Renate; Paetzold, Stefan; Wolf, Mareike; Urmersbach, Sarah; Lehndorff, Eva; Eckmeier, Eileen; Amelung, Wulf			Organic Fertilization and Sufficient Nutrient Status in Prehistoric Agriculture? - Indications from Multi-Proxy Analyses of Archaeological Topsoil Relicts	PLOS ONE			English	Article							NATURAL N-15 ABUNDANCE; D-AMINO ACIDS; BLACK CARBON; FECAL STEROLS; BILE-ACIDS; MANAGEMENT-PRACTICES; ISOTOPIC COMPOSITION; MOLECULAR MARKERS; CENTRAL AMAZON; SOIL	Neolithic and Bronze Age topsoil relicts revealed enhanced extractable phosphorus (P) and plant available inorganic P fractions, thus raising the question whether there was targeted soil amelioration in prehistoric times. This study aimed (i) at assessing the overall nutrient status and the soil organic matter content of these arable topsoil relicts, and (ii) at tracing ancient soil fertilizing practices by respective stable isotope and biomarker analyses. Prehistoric arable topsoils were preserved in archaeological pit fillings, whereas adjacent subsoils served as controls. One Early Weichselian humic zone represented the soil status before the introduction of agriculture. Recent topsoils served as an additional reference. The applied multi-proxy approach comprised total P and micronutrient contents, stable N isotope ratios, amino acid, steroid, and black carbon analyses as well as soil color measurements. Total contents of P and selected micronutrients (I, Cu, Mn, Mo, Se, Zn) of the arable soil relicts were above the limits for which nutrient deficiencies could be assumed. All pit fillings exhibited elevated delta N-15 values close to those of recent topsoils (delta N-15>6 to 7 parts per thousand), giving first hints for prehistoric organic N-input. Ancient legume cultivation as a potential source for N input could not be verified by means of amino acid analysis. In contrast, bile acids as markers for faecal input exhibited larger concentrations in the pit fillings compared with the reference and control soils indicating faeces (i.e. manure) input to Neolithic arable topsoils. Also black carbon contents were elevated, amounting up to 38% of soil organic carbon, therewith explaining the dark soil color in the pit fillings and pointing to inputs of burned biomass. The combination of different geochemical analyses revealed a sufficient nutrient status of prehistoric arable soils, as well as signs of amelioration (inputs of organic material like charcoal and faeces-containing manure).	[Lauer, Franziska; Prost, Katharina; Paetzold, Stefan; Wolf, Mareike; Urmersbach, Sarah; Lehndorff, Eva; Eckmeier, Eileen; Amelung, Wulf] Univ Bonn, Inst Crop Sci & Resource Conservat Soil Sci & So, Bonn, Germany; [Gerlach, Renate] Archaeol Heritage Management Rhineland, LVR Amt Bodendenkmalpflege Rheinland, Bonn, Germany; [Eckmeier, Eileen] Rhein Westfal TH Aachen, Dept Geog, Aachen, Germany	University of Bonn; RWTH Aachen University	Prost, K (corresponding author), Univ Bonn, Inst Crop Sci & Resource Conservat Soil Sci & So, Bonn, Germany.	kprost@uni-bonn.de	Eckmeier, Eileen/M-8524-2015; Lehndorff, Eva/H-1230-2013; Pätzold, Stefan/J-6521-2016; Amelung, Wulf/H-2136-2013; Prost, Katharina/AAC-4023-2020	Eckmeier, Eileen/0000-0003-3053-8226; Amelung, Wulf/0000-0002-4920-4667; Prost, Katharina/0000-0003-2225-6069	German Research Foundation (DFG) [SFB 806, D2]; Stiftung zur Forderung der Archaologie im rheinischen Braunkohlenrevier [216]	German Research Foundation (DFG)(German Research Foundation (DFG)); Stiftung zur Forderung der Archaologie im rheinischen Braunkohlenrevier	This study was funded by the German Research Foundation (DFG; SFB 806, D2) and the Stiftung zur Forderung der Archaologie im rheinischen Braunkohlenrevier (216). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abel H, 2004, INHALTSSTOFFE FUTTER; Ad-hoc AG Boden (Ad-hoc-Arbeitsgruppe der Staatlichen Geologischen Dienste und der Bundesanstalt fur Geowissenschaften und Rohstoffe), 2005, BOD KART; Amelung W, 2008, ADV AGRON, V100, P155, DOI 10.1016/S0065-2113(08)00606-8; Amelung W, 2003, J PLANT NUTR SOIL SC, V166, P677, DOI 10.1002/jpln.200321274; Amelung W, 2001, SOIL BIOL BIOCHEM, V33, P553, DOI 10.1016/S0038-0717(00)00195-4; Amundson R, 2003, GLOBAL BIOGEOCHEM CY, V17, DOI 10.1029/2002GB001903; [Anonymous], 2009, 11277 ISO; [Anonymous], 1995, 11466 ISO; [Anonymous], 1994, 10693 ISO; Arrhenius O, 1931, Z PFLANZENERNAHRUNG, V10, P185; Atkinson CJ, 2010, PLANT SOIL, V337, P1, DOI 10.1007/s11104-010-0464-5; Bais HP, 2006, ANNU REV PLANT BIOL, V57, P233, DOI 10.1146/annurev.arplant.57.032905.105159; Bellhoff G, 2004, INHALTSSTOFFE FUTTER; BETHELL PH, 1994, J ARCHAEOL SCI, V21, P619, DOI 10.1006/jasc.1994.1061; Birk JJ, 2012, J CHROMATOGR A, V1242, P1, DOI 10.1016/j.chroma.2012.04.027; Birk JJ, 2011, J ARCHAEOL SCI, V38, P1209, DOI 10.1016/j.jas.2010.12.015; BJORKHEM I, 1973, EUR J BIOCHEM, V37, P143, DOI 10.1111/j.1432-1033.1973.tb02968.x; Bol R, 2005, RAPID COMMUN MASS SP, V19, P3216, DOI 10.1002/rcm.2156; Bol R, 2004, ISOT ENVIRON HEALT S, V40, P243, DOI 10.1080/10256010412331305607; Brenner DL, 2001, GEOCHIM COSMOCHIM AC, V65, P4171, DOI 10.1016/S0016-7037(01)00699-8; Brodowski S, 2005, ORG GEOCHEM, V36, P1299, DOI 10.1016/j.orggeochem.2005.03.011; Brodowski S, 2004, BIOGEOCHEMISTRY, V71, P17, DOI 10.1007/s10533-004-5733-z; Brodowski S, 2007, GEODERMA, V139, P220, DOI 10.1016/j.geoderma.2007.02.004; Bull I, 2012, MANURE MATTERS: HISTORICAL, ARCHAEOLOGICAL AND ETHNOGRAPHIC PERSPECTIVES, P61; Bull ID, 2003, ARCHAEOMETRY, V45, P149, DOI 10.1111/1475-4754.00101; Bull ID, 2002, ENVIRON INT, V27, P647, DOI 10.1016/S0160-4120(01)00124-6; Bull ID, 2001, GEOARCHAEOLOGY, V16, P223, DOI 10.1002/1520-6548(200102)16:2<223::AID-GEA1002>3.0.CO;2-7; Bull ID, 1999, ANTIQUITY, V73, P86, DOI 10.1017/S0003598X0008786X; CAMPBELL CA, 1991, SOIL SCI SOC AM J, V55, P739, DOI 10.2136/sssaj1991.03615995005500030017x; Daniau AL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009157; DAUNCEY K. D. M., 1952, Advanc. Sci., V9, P33; Dohle H.-J., 2010, BEITRAGE ARCHAOZOOLO, V8, P35; Eckmeier E, 2007, BIOGEOSCIENCES, V4, P377, DOI 10.5194/bg-4-377-2007; Eckmeier E, 2010, GEODERMA, V159, P147, DOI 10.1016/j.geoderma.2010.07.006; Eckmeier E, 2008, CHARRED ORGANIC MATT; Eckmeier E, 2007, HOLOCENE, V17, P539, DOI 10.1177/0959683607077041; Eckmeier E, 2009, J ARCHAEOL SCI, V36, P1590, DOI 10.1016/j.jas.2009.03.021; Ehrmann O, 2009, PRAEHIST Z, V84, P44, DOI 10.1515/PZ.2009.003; EIDT RC, 1977, SCIENCE, V197, P1327, DOI 10.1126/science.197.4311.1327; Ekmekcioglu C, 2006, ESSENTIELLE SPURENEL, V1; Elhmmali MM, 1997, ENVIRON SCI TECHNOL, V31, P3663, DOI 10.1021/es9704040; Elhmmali MM, 2000, ENVIRON SCI TECHNOL, V34, P39, DOI 10.1021/es990076z; Evershed RP, 1996, ACS SYM SER, V625, P157, DOI 10.1021/bk-1996-0625.ch013; EYSSEN HJ, 1973, EUR J BIOCHEM, V36, P411, DOI 10.1111/j.1432-1033.1973.tb02926.x; Fischer P., 2012, EISZEITALT GGW, V61, P48, DOI DOI 10.3285/eg.61.1.04; FRANK H, 1982, ANAL CHEM, V54, P715, DOI 10.1021/ac00241a027; Friedel JK, 2002, SOIL BIOL BIOCHEM, V34, P315, DOI 10.1016/S0038-0717(01)00185-7; Friederich S, 2011, THESIS; GASKELL SJ, 1975, NATURE, V254, P209, DOI 10.1038/254209b0; Genssler L, 2010, 27 LANUV; Gerlach R, 2012, QUATERN INT, V265, P191, DOI 10.1016/j.quaint.2011.10.007; Gerlach R, 2011, UMWELTARCHAOLOGIE NA, P27; Gerlach R, 2006, GEODERMA, V136, P38, DOI 10.1016/j.geoderma.2006.01.011; Glaser B, 2000, ORG GEOCHEM, V31, P669, DOI 10.1016/S0146-6380(00)00044-9; Glaser B, 1999, BAYREUTHER BODENKUND, V68, P196; Glaser B, 1998, ORGANIC GEOCHEMISTRY, V29, P911; Goldammer JG, 1996, FIRE ECOSYSTEMS BORE, V1; GRIMALT JO, 1990, ENVIRON SCI TECHNOL, V24, P357, DOI 10.1021/es00073a011; Heizer R. E., 1965, STUDIES CHEM ANAL AR; Hogberg P, 1997, NEW PHYTOL, V137, P179, DOI 10.1046/j.1469-8137.1997.00808.x; HOGBERG P, 1993, PLANT SOIL, V157, P147, DOI 10.1007/BF02390237; Holliday VT, 2007, J ARCHAEOL SCI, V34, P301, DOI 10.1016/j.jas.2006.05.004; ISO, 1995, 10694 ISO; [ISO] International Organization for Standardization, 2005, 10390 ISO; Johnston AE, 2004, MICRONUTRIENTS SOIL; Kalis AJ, 1999, PFLANZENSPUREN ARCHA, P129; Kircher M, 1998, BIOL UNSERER ZEIT, V28, P281; Kleber M, 2003, SOIL SCI, V168, P292, DOI 10.1097/00010694-200304000-00006; KNIGHTS BA, 1983, J ARCHAEOL SCI, V10, P139, DOI 10.1016/0305-4403(83)90048-1; Kolstrup E, 1994, EISZEITALTER GEGENWA, V44, P16; Kriszan M, 2014, AGR ECOSYST ENVIRON, V184, P158, DOI 10.1016/j.agee.2013.11.028; Kriszan M, 2009, PLANT SOIL, V325, P157, DOI 10.1007/s11104-009-9965-5; KROPP J., 2009, KLIMAWANDEL SACHSEN; Krull ES, 2003, GEODERMA, V112, P1, DOI 10.1016/S0016-7061(02)00291-4; KVENVOLDEN KA, 1970, SCIENCE, V169, P1079, DOI 10.1126/science.169.3950.1079; Lang G, 1994, QUARTARE VEGETATIONS; Lauer F, 2013, GEODERMA, V207, P111, DOI 10.1016/j.geoderma.2013.05.005; Leeming R, 1996, WATER RES, V30, P2893, DOI 10.1016/S0043-1354(96)00011-5; Lehmann J, 2003, PLANT SOIL, V249, P343, DOI 10.1023/A:1022833116184; Lehmann J., 2004, AMAZONIAN DARK EARTH; Lehmann J, 2011, SOIL BIOL BIOCHEM, V43, P1812, DOI 10.1016/j.soilbio.2011.04.022; Leopold M, 2011, QUATERN INT, P1; Lindsay W. L., 1979, Chemical equilibria in soils.; LIU Z, 1983, SOIL SCI, V135, P40, DOI 10.1097/00010694-198301000-00009; Lloyd CEM, 2012, ORG GEOCHEM, V43, P56, DOI 10.1016/j.orggeochem.2011.11.001; Lombardo U, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072746; Lorch VW, 1940, NATURWISSENSCHAFTEN, V28, P633; Luning J., 2000, UNIVERSITATSFORSCHUN, V58; Marshall JD, 2007, ECOL METHOD CONCEPT, P22, DOI 10.1002/9780470691854.ch2; Martinelli LA, 1999, BIOGEOCHEMISTRY, V46, P45, DOI 10.1023/A:1006100128782; Mikutta R, 2010, GEOCHIM COSMOCHIM AC, V74, P2142, DOI 10.1016/j.gca.2010.01.006; MOORE PD, 1983, NATURE, V304, P122, DOI 10.1038/304122a0; Nagata Y, 1998, BBA-GEN SUBJECTS, V1379, P76, DOI 10.1016/S0304-4165(97)00084-6; Oliver MA, 1997, EUR J SOIL SCI, V48, P573, DOI 10.1046/j.1365-2389.1997.00124.x; Peri PL, 2012, GLOBAL CHANGE BIOL, V18, P311, DOI 10.1111/j.1365-2486.2011.02494.x; Prost K, 2013, J ENVIRON QUAL, V42, P164, DOI 10.2134/jeq2012.0064; Proudfoot B., 1976, GEOARCHAEOLOGY, P93; Pyne S, 1996, INTRO WILDLAND FIRE; Rejsek K, 2010, SOIL AMINO ACIDS QUA, P15; Rogge WF, 2006, ATMOS ENVIRON, V40, P27, DOI 10.1016/j.atmosenv.2005.07.076; Rosch M, 2002, VEG HIST ARCHAEOBOT, V11, P143, DOI 10.1007/s003340200016; Schier W, 2009, PRAEHIST Z, V84, P15, DOI 10.1515/PZ.2009.002; Schlummer M, 2014, EARTH-SCI REV, V131, P22, DOI 10.1016/j.earscirev.2014.01.004; Schmid EM, 2001, SOIL SCI, V166, P569, DOI 10.1097/00010694-200109000-00001; Schneider MPW, 2010, ORG GEOCHEM, V41, P1082, DOI 10.1016/j.orggeochem.2010.07.001; Schulten H.-R., 1998, Biology and Fertility of Soils, V26, P1, DOI 10.1007/s003740050335; Semmel A, 1968, FRANKFURTER GEOGRAPH, V45, P1; Senbayram M, 2008, RAPID COMMUN MASS SP, V22, P1735, DOI 10.1002/rcm.3548; SHEARER G, 1986, AUST J PLANT PHYSIOL, V13, P699, DOI 10.1071/PP9860699; Shearer G., 1989, Ecological Studies, V68, P342; Shillito LM, 2011, J ARCHAEOL SCI, V38, P1869, DOI 10.1016/j.jas.2011.03.031; Simpson IA, 1999, HOLOCENE, V9, P223, DOI 10.1191/095968399666898333; Simpson IA, 1999, RAPID COMMUN MASS SP, V13, P1315, DOI 10.1002/(SICI)1097-0231(19990715)13:13<1315::AID-RCM629>3.0.CO;2-0; Singh B, 2010, AUST J SOIL RES, V48, P516, DOI 10.1071/SR10058; Spielvogel S, 2004, J PLANT NUTR SOIL SC, V167, P545, DOI 10.1002/jpln.200421424; STEELE KW, 1981, NEW ZEAL J AGR RES, V24, P167, DOI 10.1080/00288233.1981.10420885; Stevenson F.J., 1994, ORGANIC FORMS SOIL N, P59; Stevenson FJ, 1999, CYCLES SOIL CARBON N, P368; Tate R.K., 1982, ARCHAOLOGISCHE INFOR, V14, P191; Taube PS, 2013, ORG GEOCHEM, V58, P96, DOI 10.1016/j.orggeochem.2013.02.004; TAYLOR CD, 1981, GEOCHIM COSMOCHIM AC, V45, P2161, DOI 10.1016/0016-7037(81)90068-5; Terry RE, 2004, J ARCHAEOL SCI, V31, P1237, DOI 10.1016/j.jas.2004.03.017; Tinner W, 1999, J ECOL, V87, P273, DOI 10.1046/j.1365-2745.1999.00346.x; Tyagi P, 2008, WATER AIR SOIL POLL, V187, P263, DOI 10.1007/s11270-007-9514-x; VIRGINIA RA, 1982, OECOLOGIA, V54, P317, DOI 10.1007/BF00380000; Vranova V, 2012, PLANT SOIL, V354, P21, DOI 10.1007/s11104-011-1059-5; Watzka M, 2006, SOIL BIOL BIOCHEM, V38, P1564, DOI 10.1016/j.soilbio.2005.11.007; Wells EC, 2000, J ARCHAEOL SCI, V27, P449, DOI 10.1006/jasc.1999.0490; Wilson CA, 2008, J ARCHAEOL SCI, V35, P1; Wolf M, 2014, ORG GEOCHEM, V70, P44, DOI 10.1016/j.orggeochem.2014.03.002; Wolf M, 2013, ORG GEOCHEM, V55, P11, DOI 10.1016/j.orggeochem.2012.11.002; Yoneyama T, 1996, MASS SPECTROMETRY SO, P206; Zimmermann A, 2005, BONNER JB, V205, P1	133	17	17	1	63	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2014	9	9							e106244	10.1371/journal.pone.0106244	http://dx.doi.org/10.1371/journal.pone.0106244			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Arts &amp; Humanities Citation Index (A&amp;HCI)	Science & Technology - Other Topics	AO3LR	25180911	Green Submitted, gold, Green Published			2022-12-27	WOS:000341231500062
J	Park, CH; Jeong, YH; Jeong, YI; Kwon, JW; Shin, T; Hyun, SH; Jeung, EB; Kim, NH; Seo, SK; Lee, CK; Hwang, WS				Park, Chi-Hun; Jeong, Young-Hee; Jeong, Yeun-Ik; Kwon, Jeong-Woo; Shin, Taeyoung; Hyun, Sang-Hwan; Jeung, Eui-Bae; Kim, Nam-Hyung; Seo, Sang-Kyo; Lee, Chang-Kyu; Hwang, Woo-Suk			Amino Acid Supplementation Affects Imprinted Gene Transcription Patterns in Parthenogenetic Porcine Blastocysts	PLOS ONE			English	Article							PREIMPLANTATION MOUSE EMBRYOS; IN-VITRO; EXPRESSION; CULTURE; METABOLISM; METHYLATION; VIABILITY; TRANSPORT; REGION; FLUIDS	To determine whether exogenous amino acids affect gene transcription patterns in parthenogenetic porcine embryos, we investigated the effects of amino acid mixtures in culture medium. Parthenogenetic embryos were cultured in PZM3 medium under four experimental conditions: 1) control (no amino acids except L-glutamine and taurine); 2) nonessential amino acids (NEAA); 3) essential amino acids (EAA); and 4) NEAA and EAA. The rate of development of embryos to the four-cell stage was not affected by treatment. However, fewer (P<0.05) embryos cultured with EAA (12.8%) reached the blastocyst stage as compared with the control group (25.6%) and NEAA group (30.3%). Based on these findings, we identified genes with altered expression in parthenogenetic embryos exposed to medium with or without EAAs. The results indicated that EAA influenced gene expression patterns, particularly those of imprinted genes (e.g., H19, IGF2R, PEG1, XIST). However, NEAAs did not affect impaired imprinted gene expressions induced by EAA. The results also showed that mechanistic target of rapamycin (MTOR) mRNA expression was significantly increased by EAA alone as compared with control cultures, and that the combined treatment with NEAA and EAA did not differ significantly from those of control cultures. Our results revealed that gene transcription levels in porcine embryos changed differentially depending on the presence of EAA or NEAA. However, the changes in the H19 mRNA observed in the parthenogenetic blastocysts expression level was not related to the DNA methylation status in the IGF2/H19 domain. The addition of exogenous amino acid mixtures affected not only early embryonic development, but also gene transcription levels, particularly those of imprinted genes. However, this study did not reveal how amino acids affect expression of imprinted genes under the culture conditions used. Further studies are thus required to fully evaluate how amino acids affect transcriptional regulation in porcine embryos.	[Park, Chi-Hun; Jeong, Young-Hee; Jeong, Yeun-Ik; Shin, Taeyoung; Hwang, Woo-Suk] Sooam Biotech Res Fdn, Seoul, South Korea; [Kwon, Jeong-Woo; Kim, Nam-Hyung] Chungbuk Natl Univ, Coll Vet Med, Dept Anim Sci, Cheongju, Chungbuk, South Korea; [Hyun, Sang-Hwan; Jeung, Eui-Bae] Chungbuk Natl Univ, Coll Vet Med, Cheongju, Chungbuk, South Korea; [Seo, Sang-Kyo] Anim Quarantine Div, Suwon, Gyeonggi Do, South Korea; [Lee, Chang-Kyu] Seoul Natl Univ, Dept Agr Biotechnol, Seoul, South Korea; [Lee, Chang-Kyu] Seoul Natl Univ, Res Inst Agr & Life Sci, Seoul, South Korea	Chungbuk National University; Chungbuk National University; Seoul National University (SNU); Seoul National University (SNU)	Hwang, WS (corresponding author), Sooam Biotech Res Fdn, Seoul, South Korea.	hwangws@sooam.org	Park, Chi-Hun/J-1258-2019	Park, Chi-Hun/0000-0002-7618-9028	Next-Generation BioGreen 21 Program Rural Development Administration [PJ00832303]; Research Program Gyeonggi-do Project, Republic of Korea [307-02]	Next-Generation BioGreen 21 Program Rural Development Administration; Research Program Gyeonggi-do Project, Republic of Korea	This work was supported by a grant of Next-Generation BioGreen 21 Program (No. PJ00832303) Rural Development Administration, and also by a grant of Research Program (No. 307-02) Gyeonggi-do Project, Republic of Korea. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARTOLOMEI MS, 1993, GENE DEV, V7, P1663, DOI 10.1101/gad.7.9.1663; BAVISTER BD, 1990, MOL REPROD DEV, V25, P45, DOI 10.1002/mrd.1080250109; Beebe LFS, 2009, J REPROD DEVELOP, V55, P373, DOI 10.1262/jrd.20176; Booth PJ, 2005, REPRODUCTION, V130, P655, DOI 10.1530/rep.1.00727; Brasse-Lagnel C, 2009, FEBS J, V276, P1826, DOI 10.1111/j.1742-4658.2009.06920.x; Constancia M, 2005, P NATL ACAD SCI USA, V102, P19219, DOI 10.1073/pnas.0504468103; DeRisi JL, 1997, SCIENCE, V278, P680, DOI 10.1126/science.278.5338.680; Doherty AS, 2000, BIOL REPROD, V62, P1526, DOI 10.1095/biolreprod62.6.1526; Dugimont T, 1998, ONCOGENE, V16, P2395, DOI 10.1038/sj.onc.1201742; EAGLE H, 1959, SCIENCE, V130, P432, DOI 10.1126/science.130.3373.432; Fafournoux P, 2000, BIOCHEM J, V351, P1, DOI 10.1042/0264-6021:3510001; Fauque P, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-116; Fernandez-Gonzalez R, 2004, P NATL ACAD SCI USA, V101, P5880, DOI 10.1073/pnas.0308560101; Fernandez-Gonzalez R, 2009, REPRODUCTION, V137, P271, DOI 10.1530/REP-08-0265; Gangloff YG, 2004, MOL CELL BIOL, V24, P9508, DOI 10.1128/MCB.24.21.9508-9516.2004; GARDNER DK, 1993, BIOL REPROD, V48, P377, DOI 10.1095/biolreprod48.2.377; GARDNER DK, 1993, HUM REPROD, V8, P288, DOI 10.1093/oxfordjournals.humrep.a138039; Gonzalez IM, 2012, DEV BIOL, V361, P286, DOI 10.1016/j.ydbio.2011.10.021; HO YG, 1995, MOL REPROD DEV, V41, P232, DOI 10.1002/mrd.1080410214; Houghton FD, 2002, HUM REPROD, V17, P999, DOI 10.1093/humrep/17.4.999; IRITANI A, 1974, J ANIM SCI, V39, P582, DOI 10.2527/jas1974.393582x; Khosla S, 2001, BIOL REPROD, V64, P918, DOI 10.1095/biolreprod64.3.918; Kim J, 2013, BIOL REPROD, V88, DOI 10.1095/biolreprod.112.105080; Kong XF, 2012, J NUTR BIOCHEM, V23, P1178, DOI 10.1016/j.jnutbio.2011.06.012; Lane M, 2001, J ASSIST REPROD GEN, V18, P519, DOI 10.1023/A:1016657228171; Lane M, 1998, HUM REPROD, V13, P991, DOI 10.1093/humrep/13.4.991; Lane M, 2007, BEST PRACT RES CL OB, V21, P83, DOI 10.1016/j.bpobgyn.2006.09.009; LAU MMH, 1994, GENE DEV, V8, P2953, DOI 10.1101/gad.8.24.2953; Leese HJ, 2008, REPROD FERT DEVELOP, V20, P1, DOI 10.1071/RD07153; Leese HJ, 2002, BIOESSAYS, V24, P845, DOI 10.1002/bies.10137; Li RF, 2007, MOL REPROD DEV, V74, P1228, DOI 10.1002/mrd.20682; Liu Z, 1995, HUM REPROD, V10, P2985, DOI 10.1093/oxfordjournals.humrep.a135834; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Martin PM, 2001, DEV BIOL, V240, P182, DOI 10.1006/dbio.2001.0461; Park CH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051398; Park CH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022216; Park CH, 2009, GENOMICS, V93, P179, DOI 10.1016/j.ygeno.2008.10.002; Pietz J, 1999, J CLIN INVEST, V103, P1169, DOI 10.1172/JCI5017; Reik W, 2003, THERIOGENOLOGY, V59, P21, DOI 10.1016/S0093-691X(02)01269-4; Rinaudo P, 2004, REPRODUCTION, V128, P301, DOI 10.1530/rep.1.00297; Scaglia F, 2004, J NUTR, V134, p2775S, DOI 10.1093/jn/134.10.2775S; Sturmey RG, 2003, REPRODUCTION, V126, P197, DOI 10.1530/rep.0.1260197; Summers MC, 2003, HUM REPROD UPDATE, V9, P557, DOI 10.1093/humupd/dmg039; Tremblay KD, 1997, MOL CELL BIOL, V17, P4322, DOI 10.1128/MCB.17.8.4322; Van Thuan N, 2002, BIOL REPROD, V67, P1688, DOI 10.1095/biolreprod.102.004812; Van Winkle LJ, 2001, BIOL REPROD, V64, P1, DOI 10.1095/biolreprod64.1.1; VANWINKLE LJ, 1995, BIOL REPROD, V52, P96, DOI 10.1095/biolreprod52.1.96; WHITTEN WK, 1968, J REPROD FERTIL, V17, P399, DOI 10.1530/jrf.0.0170399; Wu GY, 2009, AMINO ACIDS, V37, P1, DOI 10.1007/s00726-009-0269-0	49	5	5	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2014	9	9							e106549	10.1371/journal.pone.0106549	http://dx.doi.org/10.1371/journal.pone.0106549			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3LR	25180972	Green Published, Green Submitted, gold			2022-12-27	WOS:000341231500113
J	Su, M; Zhu, LC; Wei, HP; Luo, WH; Lin, RF; Zou, CL				Su, Meng; Zhu, Lu-Cheng; Wei, Hang-Ping; Luo, Wen-Hua; Lin, Rui-Fang; Zou, Chang-Lin			S-1-Based versus Capecitabine-Based Preoperative Chemoradiotherapy in the Treatment of Locally Advanced Rectal Cancer: A Matched-Pair Analysis	PLOS ONE			English	Article							ORAL FLUOROPYRIMIDINE CARBAMATE; TOTAL MESORECTAL EXCISION; ANTITUMOR-ACTIVITY; 5-FLUOROURACIL; RADIOTHERAPY; S-1; CHEMORADIATION; FLUOROURACIL; TOXICITY; LIVER	Objective: The aim of this paper was to compare the efficacy and safety of S-1-based and capecitabine-based preoperative chemoradiotherapy regimens in patients with locally advanced rectal cancer through a retrospective matched-pair analysis. Materials and methods: Between Jan 2010 and Mar 2014, 24 patients with locally advanced rectal cancer who received preoperative radiotherapy concurrently with S-1 were individually matched with 24 contemporary patients with locally advanced rectal cancer who received preoperative radiotherapy concurrently with capecitabine according to clinical stage (as determined by pelvic magnetic resonance imaging and computed tomography) and age (within five years). All these patients performed mesorectal excision 4-8 weeks after the completion of chemoradiotherapy. Results: The tumor volume reduction rates were 55.9 +/- 15.1% in the S-1 group and 53.8 +/- 16.0% in the capecitabine group (p = 0.619). The overall downstaging, including both T downstaging and N downstaging, occurred in 83.3% of the S-1 group and 70.8% of the capecitabine group (p = 0.508). The significant tumor regression, including regression grade I and II, occurred in 33.3% of S-1 patients and 25.0% of capecitabine patients (p = 0.754). In the two groups, Grade 4 adverse events were not observed and Grade 3 consisted of only two cases of diarrhea, and no patient suffered hematologic adverse event of Grade 2 or higher. However, the incidence of diarrhea (62.5% vs 33.3%, p = 0.014) and hand-foot syndrome (29.2% vs 0%, p = 0.016) were higher in capecitabine group. Other adverse events did not differ significantly between two groups. Conclusions: The two preoperative chemoradiotherapy regimens were effective and safe for patients of locally advanced rectal cancer, but regimen with S-1 exhibited a lower incidence of adverse events.	[Su, Meng; Zhu, Lu-Cheng; Wei, Hang-Ping; Luo, Wen-Hua; Lin, Rui-Fang; Zou, Chang-Lin] Wenzhou Med Univ, Affiliated Hosp 1, Dept Radiat Oncol & Chemotherapy, Wenzhou, Peoples R China	Wenzhou Medical University	Zou, CL (corresponding author), Wenzhou Med Univ, Affiliated Hosp 1, Dept Radiat Oncol & Chemotherapy, Wenzhou, Peoples R China.	zcl19670115@163.com		Zhu, Lucheng/0000-0001-7298-4166				Bosset JF, 2006, NEW ENGL J MED, V355, P1114, DOI 10.1056/NEJMoa060829; Ceelen W, 2009, INT J CANCER, V124, P2966, DOI 10.1002/ijc.24247; De Caluwe L, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006041.pub3; Edge S, 2010, AJCC CANC STAGING MA, V7th; Gerard JP, 2006, J CLIN ONCOL, V24, P4620, DOI 10.1200/JCO.2006.06.7629; Gray R, 2001, LANCET, V358, P1291; Ishikawa T, 1998, BIOL PHARM BULL, V21, P713; Ishikawa T, 1998, BIOCHEM PHARMACOL, V55, P1091, DOI 10.1016/S0006-2952(97)00682-5; Kim DY, 2007, INT J RADIAT ONCOL, V67, P378, DOI 10.1016/j.ijrobp.2006.08.063; Kim JC, 2005, INT J RADIAT ONCOL, V63, P346, DOI 10.1016/j.ijrobp.2005.02.046; Kim JS, 2002, INT J RADIAT ONCOL, V54, P403, DOI 10.1016/S0360-3016(02)02856-0; Krishnan S, 2006, INT J RADIAT ONCOL, V66, P762, DOI 10.1016/j.ijrobp.2006.05.063; MANDARD AM, 1994, CANCER, V73, P2680, DOI 10.1002/1097-0142(19940601)73:11<2680::AID-CNCR2820731105>3.0.CO;2-C; Miwa M, 1998, EUR J CANCER, V34, P1274, DOI 10.1016/S0959-8049(98)00058-6; Nakata E, 2006, ONCOL REP, V16, P465; Rich TA, 2004, J CLIN ONCOL, V22, P2214, DOI 10.1200/JCO.2004.08.009; Sadahiro S, 2011, ONCOLOGY-BASEL, V81, P306, DOI 10.1159/000334580; Sauer R, 2004, NEW ENGL J MED, V351, P1731, DOI 10.1056/NEJMoa040694; Schoffski P, 2004, ANTI-CANCER DRUG, V15, P85, DOI 10.1097/01.cad.0000114631.91268.39; Shirasaka T, 1996, ANTI-CANCER DRUG, V7, P548, DOI 10.1097/00001813-199607000-00010; SHIRASAKA T, 1993, CANCER RES, V53, P4004; Takechi T, 1997, CANCER CHEMOTH PHARM, V39, P205; TATSUMI K, 1987, JPN J CANCER RES, V78, P748; Therasse P, 2000, J NATL CANCER I, V92, P205, DOI 10.1093/jnci/92.3.205; Trotti A, 2003, SEMIN RADIAT ONCOL, V13, P176, DOI 10.1016/S1053-4296(03)00031-6; Ulrich A, 2009, INT J RADIAT ONCOL, V75, P129, DOI 10.1016/j.ijrobp.2008.10.051; Van Cutsem E, 2000, J CLIN ONCOL, V18, P1337, DOI 10.1200/JCO.2000.18.6.1337; van Gijn W, 2011, LANCET ONCOL, V12, P575, DOI 10.1016/S1470-2045(11)70097-3	28	8	8	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2014	9	9							e106162	10.1371/journal.pone.0106162	http://dx.doi.org/10.1371/journal.pone.0106162			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3LR	25181318	Green Published, gold, Green Submitted			2022-12-27	WOS:000341231500054
J	Thompson, JR; Kamath, N; Perry, KL				Thompson, Jeremy R.; Kamath, Nitin; Perry, Keith L.			An Evolutionary Analysis of the Secoviridae Family of Viruses	PLOS ONE			English	Article							GRAPEVINE-FANLEAF-VIRUS; PICORNA-LIKE VIRUS; INTERSPECIES RECOMBINATION EVENTS; COMPLETE NUCLEOTIDE-SEQUENCE; RNA VIRUSES; SELECTION PRESSURE; GENETIC-STRUCTURE; COMPUTER-PROGRAM; SPHERICAL VIRUS; MOTTLE VIRUS	The plant-infecting Secoviridae family of viruses forms part of the Picornavirales order, an important group of non-enveloped viruses that infect vertebrates, arthropods, plants and algae. The impact of the secovirids on cultivated crops is significant, infecting a wide range of plants from grapevine to rice. The overwhelming majority are transmitted by ecdysozoan vectors such as nematodes, beetles and aphids. In this study, we have applied a variety of computational methods to examine the evolutionary traits of these viruses. Strong purifying selection pressures were calculated for the coat protein (CP) sequences of nine species, although for two species evidence of both codon specific and episodic diversifying selection were found. By using Bayesian phylogenetic reconstruction methods CP nucleotide substitution rates for four species were estimated to range from between 9.29x10(-3) to 2.74x10(-3) (subs/site/year), values which are comparable with the short-term estimates of other related plant-and animal-infecting virus species. From these data, we were able to construct a time-measured phylogeny of the subfamily Comovirinae that estimated divergence of ninety-four extant sequences occurred less than 1,000 years ago with present virus species diversifying between 50 and 250 years ago; a period coinciding with the intensification of agricultural practices in industrial societies. Although recombination (modularity) was limited to closely related taxa, significant and often unique similarities in the protein domains between secovirid and animal infecting picorna-like viruses, especially for the protease and coat protein, suggested a shared ancestry. We discuss our results in a wider context and find tentative evidence to indicate that some members of the Secoviridae might have their origins in insects, possibly colonizing plants in a number of founding events that have led to speciation. Such a scenario; virus infection between species of different taxonomic kingdoms, has significant implications for virus emergence.	[Thompson, Jeremy R.; Kamath, Nitin; Perry, Keith L.] Cornell Univ, Dept Plant Pathol & Plant Microbe Biol, Ithaca, NY 14850 USA; [Kamath, Nitin] NIAID, Lab Malaria & Vector Res, Bethesda, MD 20892 USA	Cornell University; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Thompson, JR (corresponding author), Cornell Univ, Dept Plant Pathol & Plant Microbe Biol, Ithaca, NY 14850 USA.	jrt36@cornell.edu	Thompson, Jeremy R./Q-9370-2019	Thompson, Jeremy R./0000-0003-4015-4058	Cornell University College of Agriculture and Life Sciences	Cornell University College of Agriculture and Life Sciences	This study was supported by Cornell University College of Agriculture and Life Sciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahlquist P, 2003, J VIROL, V77, P8181, DOI 10.1128/JVI.77.15.8181-8186.2003; Alfaro-Fernandez A, 2010, J PHYTOPATHOL, V158, P457, DOI 10.1111/j.1439-0434.2009.01639.x; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; [Anonymous], 2011, VIRUS TAXONOMY; Aravind L, 1999, J MOL BIOL, V287, P1023, DOI 10.1006/jmbi.1999.2653; Azzam O, 2000, ARCH VIROL, V145, P1183, DOI 10.1007/s007050070118; Ban L, 2007, J VIROL METHODS, V142, P136, DOI 10.1016/j.jviromet.2007.01.014; Campbell Bruce C., 1994, Insect Molecular Biology, V3, P73, DOI 10.1111/j.1365-2583.1994.tb00154.x; Chancellor TCB, 2006, ADV VIRUS RES, V66, P1, DOI 10.1016/S0065-3527(06)66001-6; Chare ER, 2004, J GEN VIROL, V85, P3149, DOI 10.1099/vir.0.80134-0; Chen YP, 2012, INSECT PATHOLOGY, 2ND EDITION, P133, DOI 10.1016/B978-0-12-384984-7.00005-1; Dasgupta R, 2001, P NATL ACAD SCI USA, V98, P4910, DOI 10.1073/pnas.081288198; Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI [10.1093/molbev/msi103, 10.1093/molbev/mss075]; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Drummond AJ, 2009, PHYLOGENETIC HANDBOOK: A PRACTICAL APPROACH TO PHYLOGENETIC ANALYSIS AND HYPOTHESIS TESTING, 2ND EDITION, P564; Duffy S, 2008, NAT REV GENET, V9, P267, DOI 10.1038/nrg2323; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Elbeaino T, 2012, VIRUS RES, V166, P136, DOI 10.1016/j.virusres.2012.03.011; Fargette D, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000125; Ferrer RM, 2011, ARCH VIROL, V156, P1445, DOI 10.1007/s00705-011-0990-3; Gibbs AJ, 2010, J GEN VIROL, V91, P13, DOI 10.1099/vir.0.015925-0; Gibbs AJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002523; Gibbs MJ, 1999, P NATL ACAD SCI USA, V96, P8022, DOI 10.1073/pnas.96.14.8022; GILDOW FE, 1988, PHYTOPATHOLOGY, V78, P811, DOI 10.1094/Phyto-78-811; Harper SJ, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00093; Hicks AL, 2011, J VIROL, V85, P7942, DOI 10.1128/JVI.02535-10; Holmes EC, 2009, ANNU REV ECOL EVOL S, V40, P353, DOI 10.1146/annurev.ecolsys.110308.120248; Ivanov KI, 2012, CURR OPIN VIROL, V2, P712, DOI 10.1016/j.coviro.2012.10.001; Iwanami T, 1999, J GEN VIROL, V80, P793, DOI 10.1099/0022-1317-80-3-793; KISHINO H, 1989, J MOL EVOL, V29, P170, DOI 10.1007/BF02100115; Koonin EV, 2008, NAT REV MICROBIOL, V6, P925, DOI 10.1038/nrmicro2030; KOONIN EV, 1993, CRIT REV BIOCHEM MOL, V28, P375, DOI 10.3109/10409239309078440; Kuzmin IV, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002786; Lamprecht RL, 2012, VIRUS GENES, V45, P406, DOI 10.1007/s11262-012-0765-2; LE GALL O, 1995, J GEN VIROL, V76, P1285, DOI 10.1099/0022-1317-76-5-1285; Le Gall O, 2008, ARCH VIROL, V153, P715, DOI 10.1007/s00705-008-0041-x; Leconte AM, 2013, BIOCHEMISTRY-US, V52, P1490, DOI 10.1021/bi3016185; Li CJ, 2000, J GEN VIROL, V81, P541, DOI 10.1099/0022-1317-81-2-541; Li JL, 2014, MBIO, V5; Martelli GP, 2006, OPTIONS MEDITERRANEE; Martin DP, 2010, BIOINFORMATICS, V26, P2462, DOI 10.1093/bioinformatics/btq467; Mekuria TA, 2009, PHYTOPATHOLOGY, V99, P1394, DOI 10.1094/PHYTO-99-12-1394; Melcher U, 2000, J GEN VIROL, V81, P257, DOI 10.1099/0022-1317-81-1-257; Murray GGR, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.0965; Murrell B, 2013, MOL BIOL EVOL, V30, P1196, DOI 10.1093/molbev/mst030; Nolasco G, 2006, ARCH VIROL, V151, P83, DOI 10.1007/s00705-005-0611-0; Oliver JE, 2010, VIRUS RES, V152, P30, DOI 10.1016/j.virusres.2010.05.017; Pagan I, 2010, J VIROL, V84, P6177, DOI 10.1128/JVI.02160-09; Pond SLK, 2006, BIOINFORMATICS, V22, P3096, DOI 10.1093/bioinformatics/btl474; Pond SLK, 2011, MOL BIOL EVOL, V28, P3033, DOI 10.1093/molbev/msr125; Pond SLK, 2005, BIOINFORMATICS, V21, P2531, DOI 10.1093/bioinformatics/bti320; Pond SLK, 2005, BIOINFORMATICS, V21, P676, DOI 10.1093/bioinformatics/bti079; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Rehm P, 2011, MOL PHYLOGENET EVOL, V61, P880, DOI 10.1016/j.ympev.2011.09.003; Roossinck MJ, 2011, J GEN VIROL, V92, P2674, DOI 10.1099/vir.0.034702-0; Sanfacon H., 2012, VIRUS TAXONOMY, P881, DOI DOI 10.1016/B978-0-12-384684-6.00075-6; Sanfacon H, 2009, ARCH VIROL, V154, P899, DOI 10.1007/s00705-009-0367-z; Sun BJ, 2013, PHYTOPATHOLOGY, V103, P949, DOI 10.1094/PHYTO-01-13-0013-R; SWOFFORD DL, 1993, J GEN PHYSIOL, V102, pA9; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Thompson JR, 2012, VIRUS RES, V163, P19, DOI 10.1016/j.virusres.2011.08.006; Thompson JR, 2004, ARCH VIROL, V149, P2141, DOI 10.1007/s00705-004-0362-3; Thompson JR, 2002, J GEN VIROL, V83, P229, DOI 10.1099/0022-1317-83-1-229; Tugume AK, 2010, J GEN VIROL, V91, P1092, DOI 10.1099/vir.0.016089-0; Tuthill TJ, 2010, CURR TOP MICROBIOL, V343, P43, DOI 10.1007/82_2010_37; Tzanetakis IE, 2006, VIRUS RES, V121, P199, DOI 10.1016/j.virusres.2006.06.001; Verbeek M, 2008, ARCH VIROL, V153, P127, DOI 10.1007/s00705-007-1076-0; Verbeek M, 2007, ARCH VIROL, V152, P881, DOI 10.1007/s00705-006-0917-6; Vigne E, 2008, ARCH VIROL, V153, P1771, DOI 10.1007/s00705-008-0182-y; Vigne E, 2004, J GEN VIROL, V85, P2435, DOI 10.1099/vir.0.79904-0; Vigne E, 2009, VIRUS RES, V144, P154, DOI 10.1016/j.virusres.2009.04.018; Wertheim JO, 2012, MOL BIOL EVOL, V29, P451, DOI 10.1093/molbev/msr266; Wertheim JO, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000377; Woelk CH, 2002, MOL BIOL EVOL, V19, P2333, DOI 10.1093/oxfordjournals.molbev.a004059; Xia X, 2001, J HERED, V92, P371, DOI 10.1093/jhered/92.4.371; Zhang CQ, 2007, PHYTOPATHOLOGY, V97, P1255, DOI 10.1094/PHYTO-97-10-1255	76	19	19	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2014	9	9							e106305	10.1371/journal.pone.0106305	http://dx.doi.org/10.1371/journal.pone.0106305			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3LR	25180860	gold, Green Submitted, Green Published			2022-12-27	WOS:000341231500072
J	Wei, FY; Leung, KS; Li, G; Qin, JH; Chow, SKH; Huang, S; Sun, MH; Qin, L; Cheung, WH				Wei, Fang-Yuan; Leung, Kwok-Sui; Li, Gang; Qin, Jianghui; Chow, Simon Kwoon-Ho; Huang, Shuo; Sun, Ming-Hui; Qin, Ling; Cheung, Wing-Hoi			Low Intensity Pulsed Ultrasound Enhanced Mesenchymal Stem Cell Recruitment through Stromal Derived Factor-1 Signaling in Fracture Healing	PLOS ONE			English	Article							HUMAN PERIOSTEAL CELLS; BONE-MARROW; RAT MODEL; OSTEOGENIC DIFFERENTIATION; COMPUTED-TOMOGRAPHY; CHEMOKINE RECEPTOR; GENE-EXPRESSION; REPAIR; VITRO; STIMULATION	Low intensity pulsed ultrasound (LIPUS) has been proven effective in promoting fracture healing but the underlying mechanisms are not fully depicted. We examined the effect of LIPUS on the recruitment of mesenchymal stem cells (MSCs) and the pivotal role of stromal cell-derived factor-1/C-X-C chemokine receptor type 4 (SDF-1/CXCR4) pathway in response to LIPUS stimulation, which are essential factors in bone fracture healing. For in vitro study, isolated rat MSCs were divided into control or LIPUS group. LIPUS treatment was given 20 minutes/day at 37 degrees C for 3 days. Control group received sham LIPUS treatment. After treatment, intracellular CXCR4 mRNA, SDF-1 mRNA and secreted SDF-1 protein levels were quantified, and MSCs migration was evaluated with or without blocking SDF-1/CXCR4 pathway by AMD3100. For in vivo study, fractured 8-week-old young rats received intracardiac administration of MSCs were assigned to LIPUS treatment, LIPUS+AMD3100 treatment or vehicle control group. The migration of transplanted MSC to the fracture site was investigated by ex vivo fluorescent imaging. SDF-1 protein levels at fracture site and in serum were examined. Fracture healing parameters, including callus morphology, micro-architecture of the callus and biomechanical properties of the healing bone were investigated. The in vitro results showed that LIPUS upregulated SDF-1 and CXCR4 expressions in MSCs, and elevated SDF-1 protein level in the conditioned medium. MSCs migration was promoted by LIPUS and partially inhibited by AMD3100. In vivo study demonstrated that LIPUS promoted MSCs migration to the fracture site, which was associated with an increase of local and serum SDF-1 level, the changes in callus formation, and the improvement of callus microarchitecture and mechanical properties; whereas the blockade of SDF-1/CXCR4 signaling attenuated the LIPUS effects on the fractured bones. These results suggested SDF-1 mediated MSCs migration might be one of the crucial mechanisms through which LIPUS exerted influence on fracture healing.	[Wei, Fang-Yuan; Leung, Kwok-Sui; Li, Gang; Qin, Jianghui; Chow, Simon Kwoon-Ho; Huang, Shuo; Sun, Ming-Hui; Qin, Ling; Cheung, Wing-Hoi] Chinese Univ Hong Kong, Dept Orthopaed & Traumatol, Shatin, Hong Kong, Peoples R China; [Leung, Kwok-Sui; Qin, Ling; Cheung, Wing-Hoi] Chinese Acad Sci, Shenzhen Inst Adv Technol, Inst Biomed & Hlth Engn, Translat Med Res & Dev Ctr, Shenzhen, Peoples R China	Chinese University of Hong Kong; Chinese Academy of Sciences; Shenzhen Institute of Advanced Technology, CAS	Cheung, WH (corresponding author), Chinese Univ Hong Kong, Dept Orthopaed & Traumatol, Clin Sci Bldg, Shatin, Hong Kong, Peoples R China.	louis@ort.cuhk.edu.hk	Cheung, Wing-Hoi/J-2150-2018; Li, Gang/J-7830-2018; Chow, Simon Kwoon-ho/J-1554-2018; Qin, Ling/J-9047-2018	Cheung, Wing-Hoi/0000-0003-3247-8255; Li, Gang/0000-0002-3981-2239; Chow, Simon Kwoon-ho/0000-0003-1742-980X; Qin, Ling/0000-0001-6173-6167	AO Grant [S-11-10C]; OTC Foundation Research Fund [2009-WHLG]	AO Grant; OTC Foundation Research Fund	This research project was supported by an AO Grant (Ref: S-11-10C) and partially by OTC Foundation Research Fund (Ref: 2009-WHLG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnsdorf EJ, 2009, J CELL SCI, V122, P546, DOI 10.1242/jcs.036293; Augat P, 1997, CALCIFIED TISSUE INT, V60, P194, DOI 10.1007/s002239900213; Azuma Y, 2001, J BONE MINER RES, V16, P671, DOI 10.1359/jbmr.2001.16.4.671; Bastian O, 2011, J LEUKOCYTE BIOL, V89, P669, DOI 10.1189/jlb.0810446; Bhakta S, 2006, CARDIOVASC REVASCULA, V7, P19, DOI 10.1016/j.carrev.2005.10.008; CAPLAN AI, 1991, J ORTHOP RES, V9, P641, DOI 10.1002/jor.1100090504; Caplan AI, 2006, J CELL BIOCHEM, V98, P1076, DOI 10.1002/jcb.20886; Carter DR, 1996, BONE, V18, pS5, DOI 10.1016/8756-3282(95)00373-8; Cencioni C, 2012, CARDIOVASC RES, V94, P400, DOI 10.1093/cvr/cvs132; Cheng M, 2012, PROG MOL BIOL TRANSL, V111, P243, DOI 10.1016/B978-0-12-398459-3.00011-3; Cheung WH, 2013, ULTRASOUND MED BIOL, V39, P117, DOI 10.1016/j.ultrasmedbio.2012.08.015; Cheung WH, 2012, J ORTHOP RES, V30, P129, DOI 10.1002/jor.21487; Cheung WH, 2011, ULTRASOUND MED BIOL, V37, P231, DOI 10.1016/j.ultrasmedbio.2010.11.016; Claes L, 2012, NAT REV RHEUMATOL, V8, P133, DOI 10.1038/nrrheum.2012.1; Dai KR, 2007, ADVANCED BIOIMAGING TECHNOLOGIES IN ASSESSMENT OF THE QUALITY OF BONE AND SCAFFOLD MATERIALS: TECHNIQUES AND APPLICATIONS, P531, DOI 10.1007/978-3-540-45456-4_33; Dar A, 2005, NAT IMMUNOL, V6, P1038, DOI 10.1038/ni1251; De Clercq E, 2003, NAT REV DRUG DISCOV, V2, P581, DOI 10.1038/nrd1134; Dominici M, 2006, CYTOTHERAPY, V8, P315, DOI 10.1080/14653240600855905; DUARTE LR, 1983, ARCH ORTHOP TRAUM SU, V101, P153, DOI 10.1007/BF00436764; Dyson M, 1983, Ultrasound Med Biol, VSuppl 2, P61; EKELAND A, 1982, ACTA ORTHOP SCAND, V53, P527, DOI 10.3109/17453678208992252; Ernstrom GG, 2002, ANNU REV GENET, V36, P411, DOI 10.1146/annurev.genet.36.061802.101708; Favaro-Pipi E, 2010, ULTRASOUND MED BIOL, V36, P2057, DOI 10.1016/j.ultrasmedbio.2010.07.012; Fricker SP, 2006, BIOCHEM PHARMACOL, V72, P588, DOI 10.1016/j.bcp.2006.05.010; Fung CH, 2012, ULTRASOUND MED BIOL, V38, P745, DOI 10.1016/j.ultrasmedbio.2012.01.022; Furlani D, 2009, CELL TRANSPLANT, V18, P319, DOI 10.3727/096368909788534906; Garlet TP, 2008, CYTOKINE, V42, P330, DOI 10.1016/j.cyto.2008.03.003; Granero-Molto F, 2009, STEM CELLS, V27, P1887, DOI 10.1002/stem.103; Guo Y, 2005, STEM CELLS, V23, P1324, DOI 10.1634/stemcells.2005-0085; Hadjiargyrou M, 1998, CLIN ORTHOP RELAT R, pS216, DOI 10.1097/00003086-199810001-00022; Houthuijzen J, 2012, BRIT J CANCER, V106, P1901, DOI 10.1038/bjc.2012.201; Hsu HC, 2007, CELL SIGNAL, V19, P2317, DOI 10.1016/j.cellsig.2007.07.006; Huang S, 1999, NAT CELL BIOL, V1, pE131, DOI 10.1038/13043; Iwai T, 2007, J BONE MINER METAB, V25, P392, DOI 10.1007/s00774-007-0777-5; Jing DH, 2010, HAEMATOL-HEMATOL J, V95, P542, DOI 10.3324/haematol.2009.010736; Jung Y, 2006, BONE, V38, P497, DOI 10.1016/j.bone.2005.10.003; Kasper G, 2007, STEM CELLS, V25, P1985, DOI 10.1634/stemcells.2006-0676; Katayama Y, 2006, CELL, V124, P407, DOI 10.1016/j.cell.2005.10.041; Katsumi A, 2004, J BIOL CHEM, V279, P12001, DOI 10.1074/jbc.R300038200; Khan Y, 2008, J BONE JOINT SURG AM, V90A, P138, DOI 10.2106/JBJS.G.01218; Kitaori T, 2009, ARTHRITIS RHEUM-US, V60, P813, DOI 10.1002/art.24330; Kolar P, 2011, CLIN ORTHOP RELAT R, V469, P3118, DOI 10.1007/s11999-011-1865-3; Kristiansen TK, 1997, J BONE JOINT SURG AM, V79A, P961, DOI 10.2106/00004623-199707000-00002; Kumagai K, 2012, J ORTHOP RES, V30, P1516, DOI 10.1002/jor.22103; Lai CH, 2010, ULTRASOUND MED BIOL, V36, P1022, DOI 10.1016/j.ultrasmedbio.2010.03.014; Leung KS, 2004, CLIN ORTHOP RELAT R, P253; Leung KS, 2004, ULTRASOUND MED BIOL, V30, P389, DOI 10.1016/j.ultrasmedbio.2003.11.008; Leung KS, 2009, J ORTHOP RES, V27, P458, DOI 10.1002/jor.20753; Li F, 2009, BIOCHEM BIOPH RES CO, V386, P247, DOI 10.1016/j.bbrc.2009.06.025; Li JK, 2003, BIOMATERIALS, V24, P2379, DOI 10.1016/S0142-9612(03)00033-4; Li YJ, 2004, J ORTHOP RES, V22, P1283, DOI 10.1016/j.orthres.2004.04.002; Liu XQ, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0054077, 10.1371/journal.pone.0077367, 10.1371/journal.pone.0058489]; Ponte AL, 2007, STEM CELLS, V25, P1737, DOI 10.1634/stemcells.2007-0054; Luu YK, 2009, J BONE MINER RES, V24, P50, DOI [10.1359/jbmr.080817, 10.1359/JBMR.080817]; Ma M, 2011, CANCER LETT, V312, P1, DOI 10.1016/j.canlet.2011.06.028; Mehta S, 1997, ULTRASOUND MED BIOL, V23, P1123, DOI 10.1016/S0301-5629(97)00023-9; Meirelles LD, 2009, CYTOKINE GROWTH F R, V20, P419, DOI 10.1016/j.cytogfr.2009.10.002; Minguell JJ, 2001, EXP BIOL MED, V226, P507, DOI 10.1177/153537020122600603; Murata K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037163; Nagaya N, 2005, CIRCULATION, V112, P1128, DOI 10.1161/CIRCULATIONAHA.104.500447; Naruse K, 2003, J BONE MINER RES, V18, P360, DOI 10.1359/jbmr.2003.18.2.360; Nyman JS, 2009, J BIOMECH, V42, P891, DOI 10.1016/j.jbiomech.2009.01.016; Peled A, 2000, BLOOD, V95, P3289, DOI 10.1182/blood.V95.11.3289.011k33_3289_3296; Ponomaryov T, 2000, J CLIN INVEST, V106, P1331, DOI 10.1172/JCI10329; Pounder NM, 2008, ULTRASONICS, V48, P330, DOI 10.1016/j.ultras.2008.02.005; Rawool NM, 2003, J ULTRAS MED, V22, P145, DOI 10.7863/jum.2003.22.2.145; Rui YF, 2010, TISSUE ENG PT A, V16, P1549, DOI 10.1089/ten.TEA.2009.0529; Sant'Anna EF, 2005, J ORTHOP RES, V23, P646, DOI 10.1016/j.orthres.2004.09.007; Schindeler A, 2008, SEMIN CELL DEV BIOL, V19, P459, DOI 10.1016/j.semcdb.2008.07.004; Schwartz MA, 2001, J CELL SCI, V114, P2553; Sena K, 2011, ULTRASONICS, V51, P639, DOI 10.1016/j.ultras.2011.01.007; Shi HF, 2010, BONE, V46, P1299, DOI 10.1016/j.bone.2009.11.028; Short B, 2003, ARCH MED RES, V34, P565, DOI 10.1016/j.arcmed.2003.09.007; Son BR, 2006, STEM CELLS, V24, P1254, DOI 10.1634/stemcells.2005-0271; Sun JS, 2001, J BIOMED MATER RES, V57, P449, DOI 10.1002/1097-4636(20011205)57:3<449::AID-JBM1188>3.0.CO;2-0; Sun MH, 2012, J ORTHOP RES, V30, P137, DOI 10.1002/jor.21490; Tam KF, 2008, ULTRASOUND MED BIOL, V34, P1957, DOI 10.1016/j.ultrasmedbio.2008.06.005; Toupadakis CA, 2012, J ORTHOP RES, V30, P1853, DOI 10.1002/jor.22145; Walter MNM, 2010, EXP CELL RES, V316, P1271, DOI 10.1016/j.yexcr.2010.02.026; WANG SJ, 1994, J ORTHOP RES, V12, P40, DOI 10.1002/jor.1100120106; Wang YXJ, 2010, J MAGN RESON IMAGING, V31, P1508, DOI 10.1002/jmri.22173; Whitney NP, 2012, ULTRASOUND MED BIOL; Wynn RF, 2004, BLOOD, V104, P2643, DOI 10.1182/blood-2004-02-0526; Xu LL, 2012, INT J BIOCHEM CELL B, V44, P612, DOI 10.1016/j.biocel.2011.12.018; Yamaguchi J, 2003, CIRCULATION, V107, P1322, DOI 10.1161/01.CIR.0000055313.77510.22; Yang KH, 1996, J ORTHOP RES, V14, P802, DOI 10.1002/jor.1100140518; Yang RS, 2005, BONE, V36, P276, DOI 10.1016/j.bone.2004.10.009	87	86	94	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2014	9	9							e106722	10.1371/journal.pone.0106722	http://dx.doi.org/10.1371/journal.pone.0106722			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3LR	25181476	gold, Green Submitted, Green Published			2022-12-27	WOS:000341231500125
J	Xu, WJ; Lopez-Guzman, M; Schoen, C; Fitzgerald, S; Lauer, SL; Nixon, RA; Levy, E; Wilson, DA				Xu, Wenjin; Lopez-Guzman, Mirielle; Schoen, Chelsea; Fitzgerald, Shane; Lauer, Stephanie L.; Nixon, Ralph A.; Levy, Efrat; Wilson, Donald A.			Spared Piriform Cortical Single-Unit Odor Processing and Odor Discrimination in the Tg2576 Mouse Model of Alzheimer's Disease	PLOS ONE			English	Article							MILD COGNITIVE IMPAIRMENT; OLFACTORY-BULB; TRANSGENIC MICE; AMYLOID-BETA; DEFICITS; RATS; CORTEX; MEMORY; IDENTIFICATION; HABITUATION	Alzheimer's disease is a neurodegenerative disorder that is the most common cause of dementia in the elderly today. One of the earliest reported signs of Alzheimer's disease is olfactory dysfunction, which may manifest in a variety of ways. The present study sought to address this issue by investigating odor coding in the anterior piriform cortex, the primary cortical region involved in higher order olfactory function, and how it relates to performance on olfactory behavioral tasks. An olfactory habituation task was performed on cohorts of transgenic and age-matched wild-type mice at 3, 6 and 12 months of age. These animals were then anesthetized and acute, single-unit electrophysiology was performed in the anterior piriform cortex. In addition, in a separate group of animals, a longitudinal odor discrimination task was conducted from 3-12 months of age. Results showed that while odor habituation was impaired at all ages, Tg2576 performed comparably to age-matched wild-type mice on the olfactory discrimination task. The behavioral data mirrored intact anterior piriform cortex single-unit odor responses and receptive fields in Tg2576, which were comparable to wild-type at all age groups. The present results suggest that odor processing in the olfactory cortex and basic odor discrimination is especially robust in the face of amyloid beta precursor protein (A beta PP) over-expression and advancing amyloid beta (A beta) pathology. Odor identification deficits known to emerge early in Alzheimer's disease progression, therefore, may reflect impairments in linking the odor percept to associated labels in cortical regions upstream of the primary olfactory pathway, rather than in the basic odor processing itself.	[Xu, Wenjin; Lopez-Guzman, Mirielle; Schoen, Chelsea; Fitzgerald, Shane; Lauer, Stephanie L.; Wilson, Donald A.] Nathan S Kline Inst Psychiat Res, Emot Brain Inst, Orangeburg, NY 10962 USA; [Xu, Wenjin; Wilson, Donald A.] NYU, Sch Med, Dept Child & Adolescent Psychiat, New York, NY USA; [Fitzgerald, Shane; Lauer, Stephanie L.; Nixon, Ralph A.; Levy, Efrat] Nathan S Kline Inst Psychiat Res, Ctr Dementia Res, Orangeburg, NY 10962 USA; [Levy, Efrat] NYU, Sch Med, Dept Psychiat, New York, NY USA; [Nixon, Ralph A.] NYU, Sch Med, Dept Cell Biol, New York, NY USA; [Levy, Efrat] NYU, Sch Med, Dept Biochem & Mol Pharmacol, New York, NY USA; [Wilson, Donald A.] NYU, Sch Med, Dept Neurosci & Physiol, New York, NY USA	Nathan Kline Institute for Psychiatric Research; New York University; Nathan Kline Institute for Psychiatric Research; New York University; New York University; New York University; New York University	Xu, WJ (corresponding author), Nathan S Kline Inst Psychiat Res, Emot Brain Inst, Orangeburg, NY 10962 USA.	wenxu817@gmail.com		Wilson, Donald/0000-0001-8918-2151	National Institute of Aging [R01-AG037693]; NATIONAL INSTITUTE ON AGING [R01AG037693, P01AG017617] Funding Source: NIH RePORTER	National Institute of Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	The work was funded by grant R01-AG037693 to EL, RAN and DAW from the National Institute of Aging. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albers MW, 2006, CURR NEUROL NEUROSCI, V6, P379, DOI 10.1007/s11910-996-0018-7; Arnold SE, 2010, ANN NEUROL, V67, P462, DOI 10.1002/ana.21910; Bahar-Fuchs A, 2011, INT PSYCHOGERIATR, V23, P1097, DOI 10.1017/S1041610210002371; Barnes DC, 2008, NAT NEUROSCI, V11, P1378, DOI 10.1038/nn.2217; Berens P, 2009, J STAT SOFTW, V31, P1, DOI 10.18637/jss.v031.i10; Best AR, 2005, J NEUROSCI, V25, P2513, DOI 10.1523/JNEUROSCI.5298-04.2005; Born HA, 2014, J NEUROSCI, V34, P3826, DOI 10.1523/JNEUROSCI.5171-13.2014; Braak H, 1996, ACTA NEUROL SCAND, V93, P3; Braak H, 2011, J NEUROPATH EXP NEUR, V70, P960, DOI 10.1097/NEN.0b013e318232a379; Calhoun-Haney R, 2005, BRAIN COGNITION, V58, P178, DOI 10.1016/j.bandc.2004.10.004; Callahan MJ, 2001, AM J PATHOL, V158, P1173, DOI 10.1016/S0002-9440(10)64064-3; Chapuis J, 2013, J NEUROSCI, V33, P13449, DOI 10.1523/JNEUROSCI.1387-13.2013; Chapuis J, 2012, NAT NEUROSCI, V15, P155, DOI 10.1038/nn.2966; Chen CFF, 2011, J NEUROPHYSIOL, V106, P3136, DOI 10.1152/jn.00721.2011; Cheng N, 2013, J NEUROSCI, V33, P12208, DOI 10.1523/JNEUROSCI.0291-13.2013; Chishti MA, 2001, J BIOL CHEM, V276, P21562, DOI 10.1074/jbc.M100710200; Choi GB, 2011, CELL, V146, P1003, DOI 10.1016/j.cell.2011.07.041; Conti MZ, 2013, ARCH CLIN NEUROPSYCH, V28, P391, DOI 10.1093/arclin/act032; COYLE JT, 1983, SCIENCE, V219, P1184, DOI 10.1126/science.6338589; Cramer PE, 2012, SCIENCE, V335, P1503, DOI 10.1126/science.1217697; Devanand DP, 2008, BIOL PSYCHIAT, V64, P871, DOI 10.1016/j.biopsych.2008.06.020; Devanand DP, 2000, AM J PSYCHIAT, V157, P1399, DOI 10.1176/appi.ajp.157.9.1399; Djordjevic J, 2008, NEUROBIOL AGING, V29, P693, DOI 10.1016/j.neurobiolaging.2006.11.014; Fletcher ML, 2010, LEARN MEMORY, V17, P561, DOI 10.1101/lm.941510; Franklin K.B.J., 2008, MOUSE BRAIN STEREOTA; Gheusi C, 2000, P NATL ACAD SCI USA, V97, P1823, DOI 10.1073/pnas.97.4.1823; Gottfried JA, 2010, NAT REV NEUROSCI, V11, P628, DOI 10.1038/nrn2883; Guerin D, 2009, NEUROBIOL AGING, V30, P272, DOI 10.1016/j.neurobiolaging.2007.05.020; Hsiao K, 1996, SCIENCE, V274, P99, DOI 10.1126/science.274.5284.99; Janus C, 2000, NATURE, V408, P979, DOI 10.1038/35050110; Kawarabayashi T, 2001, J NEUROSCI, V21, P372, DOI 10.1523/JNEUROSCI.21-02-00372.2001; Kimura R, 2009, NEUROBIOL DIS, V33, P229, DOI 10.1016/j.nbd.2008.10.006; Kovacs T, 1999, NEUROPATH APPL NEURO, V25, P481; Kovacs T, 2001, NEUROREPORT, V12, P285, DOI 10.1097/00001756-200102120-00021; Li W, 2010, BRAIN, V133, P2714, DOI 10.1093/brain/awq209; Linster C, 2009, LEARN MEMORY, V16, P452, DOI 10.1101/lm.1403509; Lovitz AM, 2012, CHEM SENSES, V37, P533, DOI 10.1093/chemse/bjs006; Mandairon N, 2008, EUR J NEUROSCI, V27, P1210, DOI 10.1111/j.1460-9568.2008.06101.x; Mandairon N, 2006, P NATL ACAD SCI USA, V103, P13543, DOI 10.1073/pnas.0602750103; McBride K, 2006, J NEUROSCI, V26, P9892, DOI 10.1523/JNEUROSCI.0504-06.2006; Morales-Corraliza J, 2013, NEUROBIOL AGING, V34, P137, DOI 10.1016/j.neurobiolaging.2012.04.007; Murphy C, 1999, PHYSIOL BEHAV, V66, P177, DOI 10.1016/S0031-9384(98)00262-5; Nusser Z, 2001, J NEUROPHYSIOL, V86, P2823, DOI 10.1152/jn.2001.86.6.2823; Oakley H, 2006, J NEUROSCI, V26, P10129, DOI 10.1523/JNEUROSCI.1202-06.2006; Palop JJ, 2007, NEURON, V55, P697, DOI 10.1016/j.neuron.2007.07.025; Phillips M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019567; Rahayel S, 2012, BEHAV BRAIN RES, V231, P60, DOI 10.1016/j.bbr.2012.02.047; Razani J, 2010, NEUROPSYCHOLOGY, V24, P291, DOI 10.1037/a0018269; Rey NL, 2012, NEUROBIOL AGING, V33, p[426, e421]; Schoenbaum G, 1999, J NEUROSCI, V19, P1876; Slotnick B, 2004, J NEUROSCI, V24, P9195, DOI 10.1523/JNEUROSCI.1936-04.2004; SLOTNICK BM, 1980, BRAIN RES BULL, V5, P141, DOI 10.1016/0361-9230(80)90186-0; SLOTNICK BM, 1985, BEHAV NEUROSCI, V99, P956, DOI 10.1037/0735-7044.99.5.956; TALAMO BR, 1991, ANN NY ACAD SCI, V640, P1; Verret L, 2012, CELL, V149, P708, DOI 10.1016/j.cell.2012.02.046; Vloeberghs E, 2008, BEHAV NEUROSCI, V122, P491, DOI 10.1037/0735-7044.122.3.491; Wesson DW, 2013, BEHAV BRAIN RES, V237, P96, DOI 10.1016/j.bbr.2012.09.019; Wesson DW, 2011, J NEUROSCI, V31, P15962, DOI 10.1523/JNEUROSCI.2085-11.2011; Wesson DW, 2010, J NEUROSCI, V30, P505, DOI 10.1523/JNEUROSCI.4622-09.2010; Wilson DA, 2003, NEUROSCI BIOBEHAV R, V27, P307, DOI 10.1016/S0149-7634(03)00050-2; Wilson DA, 2011, NEURON, V72, P506, DOI 10.1016/j.neuron.2011.10.027; Xu W, 2012, NEUROSCIENCE, V223, P12, DOI 10.1016/j.neuroscience.2012.07.067; Young JW, 2009, NEUROBIOL AGING, V30, P1430, DOI 10.1016/j.neurobiolaging.2007.11.018; YOUNGENTOB SL, 1990, PHYSIOL BEHAV, V47, P1053, DOI 10.1016/0031-9384(90)90352-5; YOUNGENTOB SL, 1991, PHYSIOL BEHAV, V49, P1293, DOI 10.1016/0031-9384(91)90366-V	65	12	12	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2014	9	9							e106431	10.1371/journal.pone.0106431	http://dx.doi.org/10.1371/journal.pone.0106431			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3LR	25181487	Green Submitted, Green Published, gold			2022-12-27	WOS:000341231500096
J	Zhang, M; Li, MF; Sun, L				Zhang, Min; Li, Mo-fei; Sun, Li			NKLP27: A Teleost NK-Lysin Peptide that Modulates Immune Response, Induces Degradation of Bacterial DNA, and Inhibits Bacterial and Viral Infection	PLOS ONE			English	Article							ANTIMICROBIAL PEPTIDE; CYNOGLOSSUS-SEMILAEVIS; SYNTHETIC PEPTIDE; EXPRESSION; CELLS; IDENTIFICATION; GRANULYSIN; DEFENSE; INNATE; FISH	NK-lysin is an antimicrobial protein produced by cytotoxic T lymphocytes and natural killer cells. In this study, we examined the biological property of a peptide, NKLP27, derived from tongue sole (Cynoglossus semilaevis) NK-lysin. NKLP27 is composed of 27 amino acids and shares little sequence identity with known NK-lysin peptides. NKLP27 possesses bactericidal activity against both Gram-negative and Gram-positive bacteria including common aquaculture pathogens. The bactericidal activity of NKLP27 was dependent on the C-terminal five residues, deletion of which dramatically reduced the activity of NKLP27. During its interaction with the target bacterial cells, NKLP27 destroyed cell membrane integrity, penetrated into the cytoplasm, and induced degradation of genomic DNA. In vivo study showed that administration of tongue sole with NKLP27 before bacterial and viral infection significantly reduced pathogen dissemination and replication in tissues. Further study revealed that fish administered with NKLP27 exhibited significantly upregulated expression of the immune genes including those that are known to be involved in antibacterial and antiviral defense. These results indicate that NKLP27 is a novel antimicrobial against bacterial and viral pathogens, and that the observed effect of NKLP27 on bacterial DNA and host gene expression adds new insights to the action mechanism of fish antimicrobial peptides.	[Zhang, Min; Li, Mo-fei; Sun, Li] Chinese Acad Sci, Inst Oceanol, Key Lab Expt Marine Biol, Qingdao, Peoples R China; [Zhang, Min] Qingdao Agr Univ, Coll Marine Sci & Engn, Qingdao, Peoples R China; [Sun, Li] Zhejiang Univ, Collaborat Innovat Ctr Deep Sea Biol, Hangzhou 310003, Zhejiang, Peoples R China; [Li, Mo-fei] Chinese Acad Sci, Grad Univ, Beijing, Peoples R China	Chinese Academy of Sciences; Institute of Oceanology, CAS; Qingdao Agricultural University; Zhejiang University; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Sun, L (corresponding author), Chinese Acad Sci, Inst Oceanol, Key Lab Expt Marine Biol, Qingdao, Peoples R China.	lsun@qdio.ac.cn			National Natural Science Foundation of China [31101925]; National Basic Research Program of China [2012CB114406]; Taishan Scholar Program of Shandong Province	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China(National Basic Research Program of China); Taishan Scholar Program of Shandong Province	This work was supported by the grants of the National Natural Science Foundation of China (31101925), the National Basic Research Program of China (2012CB114406), and the Taishan Scholar Program of Shandong Province. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andra J, 1996, FEBS LETT, V385, P96, DOI 10.1016/0014-5793(96)00359-6; Andra J, 1999, MED MICROBIOL IMMUN, V188, P117, DOI 10.1007/s004300050113; Andra J, 2007, J BIOL CHEM, V282, P14719, DOI 10.1074/jbc.M608920200; Andreu D, 1999, BIOCHEM J, V344, P845, DOI 10.1042/0264-6021:3440845; Bhan U, 2007, J IMMUNOL, V179, P3937, DOI 10.4049/jimmunol.179.6.3937; Bruhn H, 2003, BIOCHEM J, V375, P737, DOI 10.1042/BJ20030250; Chen YY, 2013, FISH SHELLFISH IMMUN, V35, P399, DOI 10.1016/j.fsi.2013.04.049; Chen YX, 2007, ANTIMICROB AGENTS CH, V51, P1398, DOI 10.1128/AAC.00925-06; Cheng C, 2012, DEV COMP IMMUNOL, V39, P399; Cheng S, 2010, VACCINE, V28, P2636, DOI 10.1016/j.vaccine.2010.01.016; Corrales J, 2010, DEV COMP IMMUNOL, V34, P331, DOI 10.1016/j.dci.2009.11.004; Endsley JJ, 2004, J IMMUNOL, V173, P2607, DOI 10.4049/jimmunol.173.4.2607; Fjell CD, 2012, NAT REV DRUG DISCOV, V11, P37, DOI 10.1038/nrd3591; Frantz AL, 2012, MUCOSAL IMMUNOL, V5, P501, DOI 10.1038/mi.2012.23; Gao PP, 2012, WATER RES, V46, P2355, DOI 10.1016/j.watres.2012.02.004; Guggemoos S, 2008, J IMMUNOL, V180, P438, DOI 10.4049/jimmunol.180.1.438; Hirono I, 2007, FISH SHELLFISH IMMUN, V22, P567, DOI 10.1016/j.fsi.2006.08.003; Hong YH, 2008, AVIAN DIS, V52, P302, DOI 10.1637/8083-072307-ResNote.1; Hong YH, 2006, VET IMMUNOL IMMUNOP, V110, P339, DOI 10.1016/j.vetimm.2005.11.002; Hsu CH, 2005, NUCLEIC ACIDS RES, V33, P4053, DOI 10.1093/nar/gki725; Izadpanah A, 2005, J AM ACAD DERMATOL, V52, P381, DOI 10.1016/j.jaad.2004.08.026; Jacobs T, 2003, ANTIMICROB AGENTS CH, V47, P607, DOI 10.1128/AAC.47.2.607-613.2003; Jang WS, 2006, FEBS LETT, V580, P1490, DOI 10.1016/j.febslet.2006.01.041; Krieg AM, 2002, ANNU REV IMMUNOL, V20, P709, DOI 10.1146/annurev.immunol.20.100301.064842; Lee MO, 2012, P NATL ACAD SCI USA, V109, P12087, DOI 10.1073/pnas.1209161109; Lee SH, 2013, VET PARASITOL, V197, P113, DOI 10.1016/j.vetpar.2013.04.020; Li H, 2013, FISH SHELLFISH IMMUN, V35, P1030, DOI 10.1016/j.fsi.2013.07.001; Li YX, 2012, DEV COMP IMMUNOL, V37, P55, DOI 10.1016/j.dci.2011.12.007; Li YX, 2011, FISH SHELLFISH IMMUN, V31, P446, DOI 10.1016/j.fsi.2011.06.017; Lin HJ, 2012, ZOOL SCI, V29, P327, DOI 10.2108/zsj.29.327; Linde CMA, 2005, INFECT IMMUN, V73, P6332, DOI 10.1128/IAI.73.10.6332-6339.2005; Neela FA, 2007, J MICROBIOL, V45, P64; Pan CY, 2007, DNA CELL BIOL, V26, P403, DOI 10.1089/dna.2006.0564; Park CB, 1997, FEBS LETT, V411, P173, DOI 10.1016/S0014-5793(97)00684-4; Park IY, 1998, FEBS LETT, V437, P258, DOI 10.1016/S0014-5793(98)01238-1; Salerno G, 2007, COMP BIOCHEM PHYS B, V146, P521, DOI 10.1016/j.cbpb.2006.12.007; Schroder-Borm H, 2003, BBA-BIOMEMBRANES, V1612, P164, DOI 10.1016/S0005-2736(03)00115-9; Scott MG, 2002, J IMMUNOL, V169, P3883, DOI 10.4049/jimmunol.169.7.3883; Sitaram N, 2003, BIOCHEM BIOPH RES CO, V309, P879, DOI 10.1016/j.bbrc.2003.08.095; Wang HR, 2009, VACCINE, V27, P4047, DOI 10.1016/j.vaccine.2009.04.023; Wang KR, 2009, CANCER LETT, V278, P65, DOI 10.1016/j.canlet.2008.12.027; Wang W, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044884; Wang Z, 2004, NUCLEIC ACIDS RES, V32, pD590, DOI 10.1093/nar/gkh025; Yan JX, 2012, BIOCHIMIE, V94, P184, DOI 10.1016/j.biochi.2011.10.005; Yan JX, 2013, ANTIMICROB AGENTS CH, V57, P220, DOI 10.1128/AAC.01619-12; ZAKY M. M. M., 2010, J BACTERIOLOGY RES L, V2, P30; Zasloff M, 2002, NATURE, V415, P389, DOI 10.1038/415389a; Zhang M, 2008, MICROBIOL-SGM, V154, P2060, DOI 10.1099/mic.0.2008/017343-0; Zhang M, 2013, DEV COMP IMMUNOL, V40, P258, DOI 10.1016/j.dci.2013.03.005; Zhang M, 2012, FISH SHELLFISH IMMUN, V33, P1192, DOI 10.1016/j.fsi.2012.09.010; Zhang M, 2012, AQUAC RES, V43, P556, DOI 10.1111/j.1365-2109.2011.02861.x; Zhang YA, 2004, VET IMMUNOL IMMUNOP, V101, P259, DOI 10.1016/j.vetimm.2004.05.005; Zheng WJ, 2011, FISH SHELLFISH IMMUN, V30, P638, DOI 10.1016/j.fsi.2010.12.014; Zheng WJ, 2010, FISH SHELLFISH IMMUN, V28, P829, DOI 10.1016/j.fsi.2010.01.013; Zhou SH, 2005, EUR J IMMUNOL, V35, P822, DOI 10.1002/eji.200425730	55	64	66	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2014	9	9							e106543	10.1371/journal.pone.0106543	http://dx.doi.org/10.1371/journal.pone.0106543			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3LR	25180858	gold, Green Published, Green Submitted			2022-12-27	WOS:000341231500112
J	Wei, JK; Zhang, XJ; Yu, Y; Huang, H; Li, FH; Xiang, JH				Wei, Jiankai; Zhang, Xiaojun; Yu, Yang; Huang, Hao; Li, Fuhua; Xiang, Jianhai			Comparative Transcriptomic Characterization of the Early Development in Pacific White Shrimp Litopenaeus vannamei	PLOS ONE			English	Article							RNA-SEQ; LARVAL DEVELOPMENT; MUSCLE DEVELOPMENT; ENZYME-ACTIVITY; MESSENGER-RNA; BOONE; TOOL; METAMORPHOSIS; VISUALIZATION; TEMPERATURE	Penaeid shrimp has a distinctive metamorphosis stage during early development. Although morphological and biochemical studies about this ontogeny have been developed for decades, researches on gene expression level are still scarce. In this study, we have investigated the transcriptomes of five continuous developmental stages in Pacific white shrimp (Litopenaeus vannamei) with high throughput Illumina sequencing technology. The reads were assembled and clustered into 66,815 unigenes, of which 32,398 have putative homologues in nr database, 14,981 have been classified into diverse functional categories by Gene Ontology (GO) annotation and 26,257 have been associated with 255 pathways by KEGG pathway mapping. Meanwhile, the differentially expressed genes (DEGs) between adjacent developmental stages were identified and gene expression patterns were clustered. By GO term enrichment analysis, KEGG pathway enrichment analysis and functional gene profiling, the physiological changes during shrimp metamorphosis could be better understood, especially histogenesis, diet transition, muscle development and exoskeleton reconstruction. In conclusion, this is the first study that characterized the integrated transcriptomic profiles during early development of penaeid shrimp, and these findings will serve as significant references for shrimp developmental biology and aquaculture research.	[Wei, Jiankai; Zhang, Xiaojun; Yu, Yang; Li, Fuhua; Xiang, Jianhai] Chinese Acad Sci, Inst Oceanol, Key Lab Expt Marine Biol, Qingdao, Peoples R China; [Wei, Jiankai; Yu, Yang] Univ Chinese Acad Sci, Beijing, Peoples R China; [Huang, Hao] Hainan Guandtop Ocean Breeding Co Ltd, Haikou, Peoples R China	Chinese Academy of Sciences; Institute of Oceanology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Xiang, JH (corresponding author), Chinese Acad Sci, Inst Oceanol, Key Lab Expt Marine Biol, Qingdao, Peoples R China.	jhxiang@qdio.ac.cn	zhang, jin/GXV-9154-2022		National High-Tech Research and Development Program of China (863 program) [2012AA10A404, 2012AA092205]; National Natural Science Foundation of China [31172396, 31072203]; Hainan Guandtop Ocean Breeding Co. Ltd.	National High-Tech Research and Development Program of China (863 program)(National High Technology Research and Development Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Hainan Guandtop Ocean Breeding Co. Ltd.	This work was supported by National High-Tech Research and Development Program of China (863 program) (2012AA10A404 and 2012AA092205) and National Natural Science Foundation of China (31172396 and 31072203). Co-author Hao Huang is employed by Hainan Guandtop Ocean Breeding Co. Ltd. Hainan Guandtop Ocean Breeding Co. Ltd. provided support in the form of salary for author Hao Huang and shrimp samples, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of this author is articulated in the 'author contributions' section. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Artavanis-Tsakonas S, 1999, SCIENCE, V284, P770, DOI 10.1126/science.284.5415.770; Bachere E, 2000, AQUACULTURE, V191, P3, DOI 10.1016/S0044-8486(00)00413-0; Barckmann B, 2013, BBA-GENE REGUL MECH, V1829, P714, DOI 10.1016/j.bbagrm.2012.12.011; Brito R, 2004, AQUACULTURE, V237, P517, DOI 10.1016/j.aquaculture.2004.05.012; Carrillo-Farnes O, 2007, CRUSTACEANA, V80, P257, DOI 10.1163/156854007780162424; Charles JP, 2010, INSECT BIOCHEM MOLEC, V40, P205, DOI 10.1016/j.ibmb.2009.12.005; Chen XQ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067120; Chu KH, 1996, CRUSTACEANA, V69, P368, DOI 10.1163/156854096X00961; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Cornman RS, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-22; DALL W, 1990, ADV MAR BIOL, V27, P1; de Hoon MJL, 2004, BIOINFORMATICS, V20, P1453, DOI 10.1093/bioinformatics/bth078; Discovering statistics using R, 2012, CHOICE REV ONLINE, V50, DOI [10.5860/choice.50-2114, DOI 10.5860/CHOICE.50-2114]; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Hertzler PL, 2009, ARTHROPOD STRUCT DEV, V38, P235, DOI 10.1016/j.asd.2008.12.003; Ingham PW, 2001, GENE DEV, V15, P3059, DOI 10.1101/gad.938601; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Karouzou MV, 2007, INSECT BIOCHEM MOLEC, V37, P754, DOI 10.1016/j.ibmb.2007.03.007; Kiatmetha P, 2011, AQUACULT INT, V19, P599, DOI 10.1007/s10499-010-9375-y; Kiernan DA, 2006, EVOL DEV, V8, P537, DOI 10.1111/j.1525-142X.2006.00126.x; Kumlu M, 2000, AQUACULTURE, V188, P167, DOI 10.1016/S0044-8486(00)00330-6; Landsverk ML, 2005, CELL MOL LIFE SCI, V62, P2270, DOI 10.1007/s00018-005-5176-2; Le Vay L, 2001, COMP BIOCHEM PHYS A, V128, P623; Lee CY, 2003, CURR BIOL, V13, P350, DOI 10.1016/S0960-9822(03)00085-X; Li C., 2012, PLOS ONE, V7; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Maqbool T, 2007, J MUSCLE RES CELL M, V28, P397, DOI 10.1007/s10974-008-9133-1; Martin L, 2012, AQUACULTURE, V358, P234, DOI 10.1016/j.aquaculture.2012.05.005; Mayeuf A, 2011, M S-MED SCI, V27, P521, DOI 10.1051/medsci/2011275018; Medina M, 2009, MOL ECOL, V18, P763, DOI 10.1111/j.1365-294X.2008.04079.x; Mill C, 2012, CARDIOVASC RES, V95, P233, DOI 10.1093/cvr/cvs141; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Muhammad F, 2012, ITAL J ZOOL, V79, P77, DOI 10.1080/11250003.2011.590534; Panganiban G, 2000, DEV DYNAM, V218, P554, DOI 10.1002/1097-0177(200008)218:4<554::AID-DVDY1023>3.0.CO;2-#; Pertea G, 2003, BIOINFORMATICS, V19, P651, DOI 10.1093/bioinformatics/btg034; Preston N., 1985, P31; Puello-Cruz AC, 2002, AQUAC RES, V33, P333, DOI 10.1046/j.1365-2109.2002.00676.x; Racotta IS, 2004, AQUACULTURE, V233, P181, DOI 10.1016/j.aquaculture.2003.09.031; Rapaport F, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-9-r95; Rocha J, 2012, AQUACULTURE, V330, P111, DOI 10.1016/j.aquaculture.2011.12.024; Saldanha AJ, 2004, BIOINFORMATICS, V20, P3246, DOI 10.1093/bioinformatics/bth349; Schier AF, 2007, SCIENCE, V316, P406, DOI 10.1126/science.1140693; Sookruksawong S, 2013, DEV COMP IMMUNOL, V41, P523, DOI 10.1016/j.dci.2013.07.020; Tan MH, 2013, GENOME RES, V23, P201, DOI 10.1101/gr.141424.112; Tatusov RL, 1997, SCIENCE, V278, P631, DOI 10.1126/science.278.5338.631; Team R. D. C., 2005, R LANG ENV STAT COMP; THUMMEL CS, 1995, CELL, V83, P871, DOI 10.1016/0092-8674(95)90203-1; Tracy K, 2013, CURR TOP DEV BIOL, V103, P101, DOI 10.1016/B978-0-12-385979-2.00004-6; Truman JW, 2002, ANNU REV ENTOMOL, V47, P467, DOI 10.1146/annurev.ento.47.091201.145230; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Watanabe T, 2006, FISHERIES SCI, V72, P452, DOI 10.1111/j.1444-2906.2006.01171.x; Weiss A, 1996, ANNU REV CELL DEV BI, V12, P417, DOI 10.1146/annurev.cellbio.12.1.417; Wodarz A, 1998, ANNU REV CELL DEV BI, V14, P59, DOI 10.1146/annurev.cellbio.14.1.59; Xue SX, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076718; Ye J, 2006, NUCLEIC ACIDS RES, V34, pW293, DOI 10.1093/nar/gkl031; Zacharia S, 2004, AQUACULTURE, V232, P373, DOI 10.1016/S0044-8486(03)00538-6; Zeng D.G., 2013, PLOS ONE, V8	58	71	74	0	62	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2014	9	9							e106201	10.1371/journal.pone.0106201	http://dx.doi.org/10.1371/journal.pone.0106201			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4JX	25197823	Green Submitted, gold, Green Published			2022-12-27	WOS:000341304700025
J	Chen, WH; Xin, PL; Pan, QX; Chen, YY; Wang, CR; Zhang, ZS; Chen, YF; Zhang, CY; Cai, WJ				Chen, Wan-Hua; Xin, Pei-Ling; Pan, Qun-Xiong; Chen, Ya-Yun; Wang, Cong-Ren; Zhang, Zhi-Shan; Chen, Yi-Feng; Zhang, Chao-Yang; Cai, Wen-Jie			ERCC1 Single Nucleotide Polymorphism C8092A, but Not Its Expression Is Associated with Survival of Esophageal Squamous Cell Carcinoma Patients from Fujian Province, China	PLOS ONE			English	Article							MINOR HISTOPATHOLOGICAL RESPONSE; NEOADJUVANT RADIOCHEMOTHERAPY; GENETIC POLYMORPHISMS; EXCISION-REPAIR; PREDICTS RESPONSE; BLADDER-CANCER; RNA EXPRESSION; CHEMOTHERAPY; RISK; CHEMORADIOTHERAPY	Esophageal carcinoma is one of the world's deadliest cancers. Esophageal squamous cell carcinoma (ESCC) is more frequent than adenocarcenoma (AC) in China. Platinum-based chemotherapy with surgical resection is a common treatment approach for ESCC; however, the treatment response is uncertain. Evidence suggests polymorphisms in genes encoding excision repair cross-complementing group 1 (ERCC1), a protein involved in nuclear excision repair (NER), may help predict response to cisplatin and other platinum-based chemotherapeutics. Multiple ERCC1 single nucleotide polymorphisms (SNPs) have been associated with platinum chemotherapy response. Two common SNPs occur at the C8092A and C118T loci. Our study aimed to determine if 1) an association exists between ERCC1 tumor expression and patient survival, 2) whether adjuvant therapy influence on survival is related to histological ERCC1 presence in tumor cell nuclei, and 3) whether other clinicopathological characteristics in a cohort of patients following surgery for various stages of ESCC are associated with tumor ERCC1 expression. One hundred eight patients were included in the study, and tumor biopsy was collected for genotyping and immunohistochemical analysis of ERCC1. Sixty-seven patients (62%) received no adjuvant therapy, and the rest had either platinum-based chemotherapy (28.5%), radiotherapy (6.5%) or both treatments (2.8%). Logrank analysis revealed no significant connection between tumor ERCC1 expression (P = 0.12) or adjuvant therapy (P = 0.56) on patient survival. Also, non-parametric Mann-Whitney analysis showed no significant link between tumor size or nodus tumor formation and ERCC1 presence in patients in the study. Interestingly, C8092A SNP showed significant association with patient survival (P = 0.01), with patients homozygous for the mutant allele showing the most significantly reduced survival (P = 0.04) compared to those homozygous for the dominant allele (CC). Our results provide novel insight into the genotypic variation of patients from Quanzhou, Fujian province China.	[Chen, Wan-Hua; Chen, Ya-Yun; Zhang, Zhi-Shan] Fujian Med Univ, Hosp Quanzhou 1, Dept Clin Lab, Quanzhou, Fujian, Peoples R China; [Xin, Pei-Ling; Zhang, Chao-Yang; Cai, Wen-Jie] Fujian Med Univ, Hosp Quanzhou 1, Dept Radiat Oncol, Quanzhou, Fujian, Peoples R China; [Pan, Qun-Xiong; Wang, Cong-Ren] Fujian Med Univ, Hosp Quanzhou 1, Dept Surg Oncol, Quanzhou, Fujian, Peoples R China; [Chen, Yi-Feng] Fujian Med Univ, Hosp Quanzhou 1, Dept Pathol, Quanzhou, Fujian, Peoples R China	Fujian Medical University; Fujian Medical University; Fujian Medical University; Fujian Medical University	Cai, WJ (corresponding author), Fujian Med Univ, Hosp Quanzhou 1, Dept Radiat Oncol, Quanzhou, Fujian, Peoples R China.	wenjiecai918@yahoo.com	Chen, Yi/HIR-2608-2022; Zhang, zs/GXN-3521-2022		Quanzhou Science and Technology Project [2010Z83]; Fujian Province Innovative Medical Research, People's Republic of China [2011-CXB-30]	Quanzhou Science and Technology Project; Fujian Province Innovative Medical Research, People's Republic of China	This project was funded under the Quanzhou Science and Technology Project (#2010Z83) and Fujian Province Innovative Medical Research 2011-CXB-30, People's Republic of China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Haddad S, 1999, AM J PATHOL, V155, P2057, DOI 10.1016/S0002-9440(10)65524-1; Benhamou S, 2004, INT J CANCER, V112, P901, DOI 10.1002/ijc.20474; Brabender J, 2008, J GASTROINTEST SURG, V12, P1815, DOI 10.1007/s11605-008-0668-7; Cui Tong-Jian, 2012, Zhongguo Zhong Xi Yi Jie He Za Zhi, V32, P628; da Costa Miranda V, 2013, J GASTROINTEST CANC; Edge SB, 2010, ANN SURG ONCOL, V17, P1471, DOI 10.1245/s10434-010-0985-4; Fareed KR, 2010, BRIT J CANCER, V102, P1600, DOI 10.1038/sj.bjc.6605686; Furuta T, 2002, CANCER RES, V62, P4899; Gao R, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2012-002030; Gao ZQ, 2011, EXP THER MED, V2, P811, DOI 10.3892/etm.2011.276; Gebski V, 2007, LANCET ONCOL, V8, P226, DOI 10.1016/S1470-2045(07)70039-6; Hu Zhi-Jian, 2010, Zhonghua Liu Xing Bing Xue Za Zhi, V31, P1288; Huang J, 2013, MED ONCOL, V30, DOI 10.1007/s12032-012-0343-4; Joshi MBM, 2005, CLIN CANCER RES, V11, P2215; Lee JM, 2001, INT J CANCER, V95, P240, DOI 10.1002/1097-0215(20010720)95:4<240::AID-IJC1041>3.0.CO;2-1; Li S, 2014, ANTI-CANCER DRUG, V25, P106, DOI 10.1097/CAD.0000000000000021; Ma WJ, 2010, WORLD J GASTROENTERO, V16, P641, DOI 10.3748/wjg.v16.i5.641; Metzger R, 2012, J GASTROINTEST SURG, V16, P26, DOI 10.1007/s11605-011-1700-x; Natsugoe S, 2006, DIS ESOPHAGUS, V19, P468, DOI 10.1111/j.1442-2050.2006.00615.x; NAUNHEIM KS, 1992, J THORAC CARDIOV SUR, V103, P887; Ni M, 2014, SCI REP-UK, V4, DOI 10.1038/srep04112; Olaussen KA, 2007, CURR OPIN PULM MED, V13, P284, DOI 10.1097/MCP.0b013e32816b5c63; Ozcan MF, 2013, UROL ONCOL-SEMIN ORI, V31, P1709, DOI 10.1016/j.urolonc.2012.06.014; Rodriguez S, 2009, AM J EPIDEMIOL, V169, P505, DOI 10.1093/aje/kwn359; Rumiato E, 2013, PHARMACOGENET GENOM, V23, P597, DOI 10.1097/FPC.0b013e3283653afc; Tanaka K, 2009, MOL MED REP, V2, P903, DOI 10.3892/mmr_00000190; Tantraworasin Apichat, 2013, Cancer Manag Res, V5, P327, DOI 10.2147/CMAR.S52073; Wang X, 2010, MED ONCOL, V27, P484, DOI 10.1007/s12032-009-9239-3; Wang Y, 2011, ONCOL REP, V25, P1047, DOI 10.3892/or.2011.1170; Warnecke-Eberz U, 2004, CLIN CANCER RES, V10, P3794, DOI 10.1158/1078-0432.CCR-03-0079; Warnecke-Eberz U, 2009, J GASTROINTEST SURG, V13, P1411, DOI 10.1007/s11605-009-0881-z; Wei SZ, 2011, MED ONCOL, V28, P315, DOI 10.1007/s12032-010-9443-1; Wu XF, 2006, J CLIN ONCOL, V24, P3789, DOI 10.1200/JCO.2005.03.6640; Yang YM, 2013, TISSUE BARRIERS, V1, DOI 10.4161/tisb.23494; Zhang LQ, 2012, MUTAGENESIS, V27, P67, DOI 10.1093/mutage/ger062; Zhang ZY, 2012, ASIAN PAC J CANCER P, V13, P2583, DOI 10.7314/APJCP.2012.13.6.2583; Zhou Songwen, 2008, Zhongguo Fei Ai Za Zhi, V11, P251, DOI 10.3779/j.issn.1009-3419.2008.02.030	37	7	8	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2014	9	9							e106600	10.1371/journal.pone.0106600	http://dx.doi.org/10.1371/journal.pone.0106600			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ1IR	25191856	Green Published, Green Submitted, gold			2022-12-27	WOS:000347993600043
J	Jang, TH; Lee, DS; Choi, K; Jeong, EM; Kim, IG; Kim, YW; Chun, JN; Jeon, JH; Park, HH				Jang, Tae-Ho; Lee, Dong-Sup; Choi, Kihang; Jeong, Eui Man; Kim, In-Gyu; Kim, Young Whan; Chun, Jung Nyeo; Jeon, Ju-Hong; Park, Hyun Ho			Crystal Structure of Transglutaminase 2 with GTP Complex and Amino Acid Sequence Evidence of Evolution of GTP Binding Site	PLOS ONE			English	Article							TISSUE TRANSGLUTAMINASE; CROSS-LINKING; PROTEIN COMPLEXES; IDENTIFICATION; RAT; TRANSAMIDATION; LOCALIZATION; MUTATION; MATRIX; CELLS	Transglutaminase2 (TG2) is a multi-functional protein involved in various cellular processes, including apoptosis, differentiation, wound healing, and angiogenesis. The malfunction of TG2 causes many human disease including inflammatory disease, celiac disease, neurodegenerative diseases, tissue fibrosis, and cancers. Protein cross-linking activity, which is representative of TG2, is activated by calcium ions and suppressed by GTP. Here, we elucidated the structure of TG2 in complex with its endogenous inhibitor, GTP. Our structure showed why GTP is the optimal nucleotide for interacting with and inhibiting TG2. In addition, sequence comparison provided information describing the evolutionary scenario of GTP usage for controlling the activity of TG2.	[Jang, Tae-Ho; Park, Hyun Ho] Yeungnam Univ, Sch Biotechnol, Gyongsan, South Korea; [Jang, Tae-Ho; Park, Hyun Ho] Yeungnam Univ, Grad Sch Biochem, Gyongsan, South Korea; [Lee, Dong-Sup] Seoul Natl Univ, Coll Med, Dept Physiol & Biophys, Seoul, South Korea; [Choi, Kihang] Korea Univ, Dept Chem, Seoul 136701, South Korea; [Jeong, Eui Man; Kim, In-Gyu] Seoul Natl Univ, Coll Med, AARC, Dept Biochem & Mol Biol, Seoul, South Korea; [Kim, Young Whan] Seoul Natl Univ, Coll Med, Dept Internal Med, Div Pulm & Crit Care Med, Seoul 151, South Korea; [Kim, Young Whan] Seoul Natl Univ, Coll Med, Med Res Ctr, Lung Inst, Seoul, South Korea; [Chun, Jung Nyeo; Jeon, Ju-Hong] Seoul Natl Univ, Coll Med, Dept Biomed Sci, Dept Physiol, Seoul, South Korea; [Chun, Jung Nyeo; Jeon, Ju-Hong] Seoul Natl Univ, Coll Med, Inst Dermatol Sci, Seoul, South Korea	Yeungnam University; Yeungnam University; Seoul National University (SNU); Korea University; Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU)	Jeon, JH (corresponding author), Seoul Natl Univ, Coll Med, Dept Biomed Sci, Dept Physiol, Seoul, South Korea.	jhjeon2@snu.ac.kr; hyunho@ynu.ac.k		park, hyun ho/0000-0001-9928-0847; Jeon, Ju-Hong/0000-0002-5603-2955; Jeong, Eui Man/0000-0003-0692-2033	Korea Healthcare Technology R&D Project, Ministry of Health and Welfare, Republic of Korea [A100190]	Korea Healthcare Technology R&D Project, Ministry of Health and Welfare, Republic of Korea	This study was supported by a grant from the Korea Healthcare Technology R&D Project, Ministry of Health and Welfare, Republic of Korea (A100190). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ACHYUTHAN KE, 1987, J BIOL CHEM, V262, P1901; BARNES RN, 1985, CARCINOGENESIS, V6, P459, DOI 10.1093/carcin/6.3.459; Begg GE, 2006, J BIOL CHEM, V281, P12603, DOI 10.1074/jbc.M600146200; Begg GE, 2006, P NATL ACAD SCI USA, V103, P19683, DOI 10.1073/pnas.0609283103; Birckbichler PJ, 2000, CANCER-AM CANCER SOC, V89, P412, DOI 10.1002/1097-0142(20000715)89:2<412::AID-CNCR29>3.0.CO;2-O; BIRCKBICHLER PJ, 1977, CANCER RES, V37, P1340; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Dieterich W, 1997, NAT MED, V3, P797, DOI 10.1038/nm0797-797; DUDEK SM, 1994, BRAIN RES, V651, P129, DOI 10.1016/0006-8993(94)90688-2; Dzivenu OK, 2004, PROTEIN EXPRES PURIF, V38, P1, DOI 10.1016/j.pep.2004.07.016; EITAN S, 1994, SCIENCE, V264, P1764, DOI 10.1126/science.7911602; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Grenard P, 2001, J BIOL CHEM, V276, P33066, DOI 10.1074/jbc.M102553200; GRIFFIN M, 1979, BRIT J EXP PATHOL, V60, P653; Griffin M, 2002, BIOCHEM J, V368, P377, DOI 10.1042/BJ20021234; Haroon ZA, 1999, FASEB J, V13, P1787, DOI 10.1096/fasebj.13.13.1787; Hitomi K, 2000, BIOSCI BIOTECH BIOCH, V64, P657, DOI 10.1271/bbb.64.657; Hitomi K, 2000, BIOSCI BIOTECH BIOCH, V64, P2128, DOI 10.1271/bbb.64.2128; Hitomi K, 1999, J BIOCHEM-TOKYO, V125, P1048, DOI 10.1093/oxfordjournals.jbchem.a022385; Hoffner G, 2005, FRONT BIOSCI-LANDMRK, V10, P3078, DOI 10.2741/1764; Im MJ, 1997, CELL SIGNAL, V9, P477, DOI 10.1016/S0898-6568(97)00049-1; Ishizawa T, 2003, J NEUROPATH EXP NEUR, V62, P389, DOI 10.1093/jnen/62.4.389; JOHNSON TS, 1994, ONCOGENE, V9, P2935; Jones RA, 2006, CELL DEATH DIFFER, V13, P1442, DOI 10.1038/sj.cdd.4401816; Kim SY, 2006, FRONT BIOSCI-LANDMRK, V11, P3026, DOI 10.2741/2030; Lesort M, 2000, PROG NEUROBIOL, V61, P439, DOI 10.1016/S0301-0082(99)00052-0; Lesort M, 1998, J BIOL CHEM, V273, P11991, DOI 10.1074/jbc.273.20.11991; Liu SP, 2002, P NATL ACAD SCI USA, V99, P2743, DOI 10.1073/pnas.042454899; Lorand L, 2003, NAT REV MOL CELL BIO, V4, P140, DOI 10.1038/nrm1014; Mangala LS, 2005, PROG EXP TUMOR RES, V38, P125; McCoy AJ, 2007, ACTA CRYSTALLOGR D, V63, P32, DOI 10.1107/S0907444906045975; Murthy SNP, 2002, P NATL ACAD SCI USA, V99, P2738, DOI 10.1073/pnas.052715799; Nemes Z, 1997, J BIOL CHEM, V272, P20577, DOI 10.1074/jbc.272.33.20577; Norlund MA, 1999, BRAIN RES, V851, P154, DOI 10.1016/S0006-8993(99)02179-4; Oliverio S, 1997, MOL CELL BIOL, V17, P6040, DOI 10.1128/MCB.17.10.6040; PIACENTINI M, 1991, EUR J CELL BIOL, V54, P246; Pinkas DM, 2007, PLOS BIOL, V5, P2788, DOI 10.1371/journal.pbio.0050327; Porzio O, 2007, Hum Mutat, V28, P1150, DOI 10.1002/humu.9511; Ruan QM, 2008, INT J CLIN EXP MED, V1, P248; Spina AM, 1999, BIOCHEM BIOPH RES CO, V260, P351, DOI 10.1006/bbrc.1999.0914; Stamnaes J, 2010, J BIOL CHEM, V285, P25402, DOI 10.1074/jbc.M109.097162; UPCHURCH HF, 1991, J CELL PHYSIOL, V149, P375, DOI 10.1002/jcp.1041490304; Vagin AA, 2004, ACTA CRYSTALLOGR D, V60, P2184, DOI 10.1107/S0907444904023510; Wang DS, 2008, INT J CLIN EXP PATHO, V1, P5	44	31	31	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2014	9	9							e107005	10.1371/journal.pone.0107005	http://dx.doi.org/10.1371/journal.pone.0107005			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ1IR	25192068	Green Published, gold, Green Submitted			2022-12-27	WOS:000347993600087
J	Li, JM; Zhang, YO; Ren, YA; Liu, BG; Lin, X; Yang, J; Zhao, HC; Wang, YJ; Song, L				Li, Jia-mou; Zhang, Yao; Ren, Yuan; Liu, Bao-ge; Lin, Xin; Yang, Jiang; Zhao, Hu-cheng; Wang, Ya-jie; Song, Lei			Uniaxial Cyclic Stretch Promotes Osteogenic Differentiation and Synthesis of BMP2 in the C3H10T1/2 Cells with BMP2 Gene Variant of rs2273073 (T/G)	PLOS ONE			English	Article							POSTERIOR LONGITUDINAL LIGAMENT; SPINAL LIGAMENT; OSSIFICATION; BONE; POLYMORPHISM; MYELOPATHY; ASSOCIATION; EXPRESSION; BETA; INVOLVEMENT	Ossification of the posterior longitudinal ligament of the cervical spine (OPLL) is characterized by the replacement of ligament tissues with ectopic bone formation, and this result is strongly affected by genetic and local factors. Two single nucleotide polymorphisms (SNPs) of rs2273073 (T/G) and rs235768 (A/T) of bone morphogenetic protein 2 (BMP2) gene which are associated with OPLL have been reported in our previous report. In this study, we confirmed the connection in 18 case samples analysis of BMP2 gene in OPLL patients; additionally, it was also shown from the OPLL patients with ligament tissues that enchondral ossification and expression of BMP2 were significantly higher compared with the non-OPLL patients by histological examination, immunohistochemistry and Western blotting analysis. To investigate the underlying mechanism, we studied the effect of SNPs in cell model. The C3H10T1/2 cells with different BMP2 gene variants were constructed and then subjected to uniaxial cyclic stretch (0.5 Hz, 10% stretch). In the presence of mechanical stress, the expression of BMP2 protein in C3H10T1/2 cells transfected by BMP2 (rs2273073 (T/G)) and BMP2 (rs2273073 (T/G), rs235768 (A/T)) were significantly higher than the corresponding static groups (P < 0.05). In conclusion, these results suggested that BMP2 gene variant of rs2273073 (T/G) could not only increase cell susceptibility to bone transformation similar to pre-OPLL change, but also increase the sensibility to mechanical stress which might play an important role during the progression of OPLL.	[Li, Jia-mou; Zhang, Yao; Liu, Bao-ge; Lin, Xin; Yang, Jiang; Song, Lei] Capital Med Univ, Beijing Tian Tan Hosp, Dept Orthoped, Beijing, Peoples R China; [Ren, Yuan; Wang, Ya-jie] Capital Med Univ, Beijing Tian Tan Hosp, CoreLab Clin Med Res, Beijing, Peoples R China; [Zhao, Hu-cheng] Tsinghua Univ, Dept Engn Mech, Beijing 100084, Peoples R China	Capital Medical University; Capital Medical University; Tsinghua University	Song, L (corresponding author), Capital Med Univ, Beijing Tian Tan Hosp, Dept Orthoped, Beijing, Peoples R China.	tiantansongl@163.com			Basic Research-Clinic Foundation of Capital Medical University [12JL-L08]	Basic Research-Clinic Foundation of Capital Medical University	This research was supported by grants from the Basic Research-Clinic Foundation of Capital Medical University (NO. 12JL-L08). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAYLINK DJ, 1993, J BONE MINER RES, V8, pS565; BOLANDER ME, 1992, P SOC EXP BIOL MED, V200, P165; Ding J, 2001, CYTOTECHNOLOGY, V36, P125, DOI 10.1023/A:1014056012278; Fujimaki S, 2013, STEM CELLS INT, V2013, DOI 10.1155/2013/420164; Furukawa K, 2006, J PHARMACOL SCI, V100, P201, DOI 10.1254/jphs.FMJ05004X4; Furushima K, 2002, J BONE MINER RES, V17, P128, DOI 10.1359/jbmr.2002.17.1.128; Inaba K, 1996, IN VIVO, V10, P445; Iwasaki K, 2004, CALCIFIED TISSUE INT, V74, P448, DOI 10.1007/s00223-002-0021-1; Iwasawa T, 2006, CALCIFIED TISSUE INT, V79, P422, DOI 10.1007/s00223-006-0147-7; Jun JK, 2012, J KOREAN NEUROSURG S, V52, P7, DOI 10.3340/jkns.2012.52.1.7; KAWAGUCHI H, 1992, SPINE, V17, pS33; Kawaguchi Y, 2003, SPINE, V28, P1424, DOI 10.1097/00007632-200307010-00013; Key G.A., 1839, GUYS HOSP REP, V3, P17; Kim YH, 2013, MED ENG PHYS, V35, P1266, DOI 10.1016/j.medengphy.2013.01.006; KINGSLEY DM, 1994, GENE DEV, V8, P133, DOI 10.1101/gad.8.2.133; Koga H, 1998, AM J HUM GENET, V62, P1460, DOI 10.1086/301868; Kon T, 1997, CALCIFIED TISSUE INT, V60, P291, DOI 10.1007/s002239900231; Koshizuka Y, 2002, J BONE MINER RES, V17, P138, DOI 10.1359/jbmr.2002.17.1.138; Lee J, 1999, NATURE, V400, P382, DOI 10.1038/22578; Liu Y, 2010, CLIN ORTHOP RELAT R, V468, P3333, DOI 10.1007/s11999-010-1511-5; Maeda S, 2001, J BONE MINER RES, V16, P948, DOI 10.1359/jbmr.2001.16.5.948; Matsunaga S, 1996, SPINE, V21, P184, DOI 10.1097/00007632-199601150-00005; MATSUNAGA S, 1994, CLIN ORTHOP RELAT R, P168; Matsunaga S, 2008, SPINE, V33, P2648, DOI 10.1097/BRS.0b013e31817f988c; Miyauchi A, 2000, J BIOL CHEM, V275, P3335, DOI 10.1074/jbc.275.5.3335; Nakamura H, 1994, Nihon Seikeigeka Gakkai Zasshi, V68, P725; Naruse K, 1998, AM J PHYSIOL-HEART C, V274, pH1532; Numasawa T, 1999, J BONE MINER RES, V14, P500, DOI 10.1359/jbmr.1999.14.4.500; Ohishi H, 2003, J PHARMACOL EXP THER, V305, P818, DOI 10.1124/jpet.102.047142; Okamoto K, 2004, J BONE MINER METAB, V22, P612, DOI 10.1007/s00774-004-0531-1; Onari K, 2001, SPINE, V26, P488, DOI 10.1097/00007632-200103010-00011; Oppenheimer A., 1942, RADIOLOGY, V38, P160, DOI [10.1148/38.2.160, DOI 10.1148/38.2.160]; Saeed H, 2012, STEM CELL REV REP, V8, P318, DOI 10.1007/s12015-011-9315-x; Stapleton CJ, 2011, NEUROSURG FOCUS, V30, DOI 10.3171/2010.12.FOCUS10271; Tanaka H, 2001, RHEUMATOLOGY, V40, P1163, DOI 10.1093/rheumatology/40.10.1163; Tanno M, 2003, BONE, V33, P475, DOI 10.1016/S8756-3282(03)00204-7; Tsukimoto H., 1960, ARCH JPN CHIR, V29, P1003; TSUYAMA N, 1984, CLIN ORTHOP RELAT R, P71; Urist MR, 2009, CLIN ORTHOP RELAT R, V467, P3051, DOI 10.1007/s11999-009-1068-3; URIST MR, 1971, J DENT RES, V50, P1392, DOI 10.1177/00220345710500060601; URIST MR, 1965, SCIENCE, V150, P893, DOI 10.1126/science.150.3698.893; Wang H, 2008, EUR SPINE J, V17, P956, DOI 10.1007/s00586-008-0651-8; Wang PN, 1999, SPINE, V24, P142, DOI 10.1097/00007632-199901150-00010; Wilson JR, 2013, SPINE, V38, pS123, DOI 10.1097/BRS.0b013e3182a7f478; Xue H, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0068926, 10.1371/journal.pone.0074366]; Yan L, 2013, CHINESE MED J-PEKING, V126, P1112, DOI 10.3760/cma.j.issn.0366-6999.20123323; Yang HS, 2011, EUR SPINE J, V20, P1459, DOI 10.1007/s00586-011-1767-9; Zhang RR, 2013, BONE, V52, P145, DOI 10.1016/j.bone.2012.09.029	48	13	14	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2014	9	9							e106598	10.1371/journal.pone.0106598	http://dx.doi.org/10.1371/journal.pone.0106598			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ1IR	25191703	Green Submitted, Green Published, gold			2022-12-27	WOS:000347993600042
J	Rao, VR; Neogi, U; Eugenin, E; Prasad, VR				Rao, Vasudev R.; Neogi, Ujjwal; Eugenin, Eliseo; Prasad, Vinayaka R.			The gp120 Protein Is a Second Determinant of Decreased Neurovirulence of Indian HIV-1C Isolates Compared to Southern African HIV-1C Isolates	PLOS ONE			English	Article							CLADE-SPECIFIC DIFFERENCES; TAT PROTEIN; NEUROTOXICITY; DISORDERS; INDUCTION	Regional differences in neurovirulence have been documented among subtype/clade-C HIV-1 isolates in India and Southern Africa. We previously demonstrated that a C31S substitution in Clade-C Tat dicysteine motif reduces monocyte recruitment, cytokine induction and direct neurotoxicity. Therefore, this polymorphism is considered to be a causative factor for these differences in neurovirulence. We previously reported on the genotypic differences in Tat protein between clade-C and rest of the clades showing that approximately 90% of clade-C HIV-1 Tat sequences worldwide contained this C31S polymorphism, while 99% of non-clade C isolates lacked this Tat polymorphism at C31 residue (Ranga et al. (2004) J Virol 78: 2586-2590). Subsequently, we documented intra-clade-C differences in the frequency of Tat dicysteine variants between India and Southern Africa, as the basis for differential disease severity and showed the importance of the Tat dicysteine motif for neuropathogenesis using small animal models. We have now examined if determinants of neurovirulence besides Tat are different between the clade-C HIV-1 isolates from Southern Africa and India. Envelope glycoprotein gp120 is a well-documented contributor to neurotoxicity. We found that gp120 sequences of HIV-1 isolates from these two regions are genetically distinct. In order to delineate the contribution of gp120 to neurovirulence, we compared direct in vitro neurotoxicity of HIV-infected supernatants of a representative neurovirulent US clade-B isolate with two isolates each from Southern Africa and India using primary human neurons and SH-SY5Y neuroblastoma cells. Immunodepletion of gp120 of both US clade B and the Southern African clade C isolates revealed robust decreases in neurotoxicity, while that of the Indian isolates showed minimal effect on neurotoxicity. The gp120 as a cause of differential neurotoxicity was further confirmed using purified recombinant gp120 from HIV isolates from these regions. We conclude that gp120 is one of the key factors responsible for the decreased neurovirulence of Indian clade C HIV-1 isolates when compared to South African clade C HIV-1.	[Rao, Vasudev R.; Prasad, Vinayaka R.] Albert Einstein Coll Med, Dept Microbiol & Immunol, Bronx, NY 10467 USA; [Neogi, Ujjwal] Karolinska Inst, Dept Lab Med, Div Clin Microbiol, Stockholm, Sweden; [Eugenin, Eliseo] Rutgers State Univ, Publ Hlth Res Inst, New Jersey Med Sch, Newark, NJ 07102 USA; [Eugenin, Eliseo] Rutgers State Univ, New Jersey Med Sch, Newark, NJ 07102 USA	Yeshiva University; Albert Einstein College of Medicine; Karolinska Institutet; Rutgers State University Newark; Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers State University Newark; Rutgers State University New Brunswick; Rutgers State University Medical Center	Prasad, VR (corresponding author), Albert Einstein Coll Med, Dept Microbiol & Immunol, Bronx, NY 10467 USA.	vinayaka.prasad@einstein.yu.edu	Neogi, Ujjwal/E-4274-2012; Prasad, Vinayaka R./A-1029-2011; Neogi, Ujjwal/ABF-1172-2021	Neogi, Ujjwal/0000-0002-0844-3338; Prasad, Vinayaka/0000-0002-9461-0189	NIH [R01 MH083579, R37 AI030861, R01 MH096625]; FOGARTY INTERNATIONAL CENTER [D43TW001403] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI030861, P30AI051519] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH096625, R01MH083579] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was mainly supported by NIH R01 MH083579 and R37 AI030861 (to V.R.P.). The work was also supported by NIH R01 MH096625 (to E.A.E.). V.R.R. and V.R.P wish to thank the Einstein/Montefiore Center for AIDS Research (P30 AI051519) for the use of BSL3/Clinical Virology Core services. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bachis A, 2012, J NEUROSCI, V32, P9477, DOI 10.1523/JNEUROSCI.0865-12.2012; Bennett BA, 1995, BRAIN RES, V705, P168, DOI 10.1016/0006-8993(95)01166-8; Campbell GR, 2007, J VIROL, V81, P5919, DOI 10.1128/JVI.01938-06; Chen LN, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025994; Clifford DB, 2007, J NEUROVIROL, V13, P67, DOI 10.1080/13550280601169837; Fau Diop Ag, TETRODOTOXIN BLOCKS; Fau Sindou P, PREVENTION HIV COAT; Gandhi N, 2009, AIDS RES HUM RETROV, V25, P691, DOI 10.1089/aid.2008.0299; Heaton RK, 2011, J NEUROVIROL, V17, P3, DOI 10.1007/s13365-010-0006-1; Holguin A, 2011, AIDS BEHAV, V15, P1895, DOI 10.1007/s10461-011-9988-9; Holman AG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049538; Joska JA, 2011, AIDS BEHAV, V15, P1197, DOI 10.1007/s10461-010-9744-6; Joska JA, 2010, AIDS BEHAV, V14, P371, DOI 10.1007/s10461-009-9538-x; Langford TD, 2003, BRAIN PATHOL, V13, P195; LANNUZEL A, 1995, EUR J NEUROSCI, V7, P2285, DOI 10.1111/j.1460-9568.1995.tb00649.x; Lawler K, 2010, J INT AIDS SOC, V13, DOI 10.1186/1758-2652-13-15; Li WX, 2008, J NEUROSCI, V28, P12190, DOI 10.1523/JNEUROSCI.3019-08.2008; Mishra M, 2008, ANN NEUROL, V63, P366, DOI 10.1002/ana.21292; Neogi U, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039819; Ranga U, 2004, J VIROL, V78, P2586, DOI 10.1128/JVI.78.5.2586-2590.2004; Rao VR, 2008, J NEUROSCI, V28, P10010, DOI 10.1523/JNEUROSCI.2955-08.2008; Rao VR, 2013, RETROVIROLOGY, V10, DOI 10.1186/1742-4690-10-61; Rao VR, 2009, HIV PROTOCOLS; Sacktor N, 2001, NEUROLOGY, V56, P257, DOI 10.1212/WNL.56.2.257; Satishchandra P, 2000, INDIAN J MED RES, V111, P14; Shankarappa R, 2001, J VIROL, V75, P10479, DOI 10.1128/JVI.75.21.10479-10487.2001; SINDOU P, 1994, J NEUROL SCI, V126, P133, DOI 10.1016/0022-510X(94)90262-3; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Wong JK, 2010, J BIOL CHEM, V285, P18319, DOI 10.1074/jbc.M110.120840; Xu HX, 2011, J NEUROSCI, V31, P17074, DOI 10.1523/JNEUROSCI.4072-11.2011	30	8	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 4	2014	9	9							e107074	10.1371/journal.pone.0107074	http://dx.doi.org/10.1371/journal.pone.0107074			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3XV	25188269	Green Submitted, Green Published, gold			2022-12-27	WOS:000341271500115
J	Gallo, SA; Carpenter, AS; Irwin, D; McPartland, CD; Travis, J; Reynders, S; Thompson, LA; Glisson, SR				Gallo, Stephen A.; Carpenter, Afton S.; Irwin, David; McPartland, Caitlin D.; Travis, Joseph; Reynders, Sofie; Thompson, Lisa A.; Glisson, Scott R.			The Validation of Peer Review through Research Impact Measures and the Implications for Funding Strategies	PLOS ONE			English	Article							SCIENCE; CHANCE; HEART; LUNG	There is a paucity of data in the literature concerning the validation of the grant application peer review process, which is used to help direct billions of dollars in research funds. Ultimately, this validation will hinge upon empirical data relating the output of funded projects to the predictions implicit in the overall scientific merit scores from the peer review of submitted applications. In an effort to address this need, the American Institute of Biological Sciences (AIBS) conducted a retrospective analysis of peer review data of 2,063 applications submitted to a particular research program and the bibliometric output of the resultant 227 funded projects over an 8-year period. Peer review scores associated with applications were found to be moderately correlated with the total time-adjusted citation output of funded projects, although a high degree of variability existed in the data. Analysis over time revealed that as average annual scores of all applications (both funded and unfunded) submitted to this program improved with time, the average annual citation output per application increased. Citation impact did not correlate with the amount of funds awarded per application or with the total annual programmatic budget. However, the number of funded applications per year was found to correlate well with total annual citation impact, suggesting that improving funding success rates by reducing the size of awards may be an efficient strategy to optimize the scientific impact of research program portfolios. This strategy must be weighed against the need for a balanced research portfolio and the inherent high costs of some areas of research. The relationship observed between peer review scores and bibliometric output lays the groundwork for establishing a model system for future prospective testing of the validity of peer review formats and procedures.	[Gallo, Stephen A.; Carpenter, Afton S.; Irwin, David; McPartland, Caitlin D.; Reynders, Sofie; Thompson, Lisa A.; Glisson, Scott R.] Amer Inst Biol Sci, Sci Peer Advisory & Review Serv Div, Reston, VA 20191 USA; [Travis, Joseph] Florida State Univ, Dept Biol Sci, Tallahassee, FL 32306 USA	State University System of Florida; Florida State University	Gallo, SA (corresponding author), Amer Inst Biol Sci, Sci Peer Advisory & Review Serv Div, Reston, VA 20191 USA.	sgallo@aibs.org		Gallo, Stephen/0000-0001-6043-2153				Berg J, 2013, ASBMB TODAY, V12, P3; Berg JM, 2013, MOL BIOL CELL, V24, P3273, DOI 10.1091/mbc.E13-07-0400; Bornmann L, 2004, BIF FUTURA, V19, P7; Braun T, 2010, NATURE, V465, P870, DOI 10.1038/465870a; Cabezas-Clavijo A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068258; Claveria LE, 2000, SCIENTOMETRICS, V47, P11, DOI 10.1023/A:1005609624130; COLE S, 1981, SCIENCE, V214, P881, DOI 10.1126/science.7302566; Danthi N, 2014, CIRC RES, V114, P600, DOI 10.1161/CIRCRESAHA.114.302656; de Winter JCF, 2014, SCIENTOMETRICS, V98, P1547, DOI 10.1007/s11192-013-1089-2; Demicheli V, 2007, COCHRANE DB SYST REV, V2; Dwan K, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003081; Escobar-Alvarez SN, 2013, ACAD MED, V88, P1740, DOI 10.1097/ACM.0b013e3182a7a38e; Fang D, 2003, ACAD MED, V78, P1271, DOI 10.1097/00001888-200312000-00017; Fortin JM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065263; Galis ZS, 2012, AM J RESP CRIT CARE, V186, P575, DOI 10.1164/rccm.201208-1437ED; Gallo SA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071693; Glenn JF, 2010, TECHNOL INNOV, V12, P241, DOI 10.3727/194982410X12895770314195; Graves N, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d4797; Ioannidis JPA, 2011, NATURE, V477, P529, DOI 10.1038/477529a; Jackson JL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022475; Lane J, 2010, NATURE, V464, P488, DOI 10.1038/464488a; Lauer MS, 2014, CIRC RES, V114, P1080, DOI 10.1161/CIRCRESAHA.114.303627; MARKOWITZ HM, 1991, J FINANC, V46, P469, DOI 10.2307/2328831; Mayo NE, 2006, J CLIN EPIDEMIOL, V59, P842, DOI 10.1016/j.jclinepi.2005.12.007; Mervis J, 2013, SCIENCE, V340, P670, DOI 10.1126/science.340.6133.670; Van Noorden R, 2010, NATURE, V465, P864, DOI 10.1038/465864a; van Raan AFJ, 2004, HANDBOOK OF QUANTITATIVE SCIENCE AND TECHNOLOGY RESEARCH: THE USE OF PUBLICATION AND PATENT STATISTICS IN STUDIES OF S&T SYSTEMS, P19; Van Raan AFJ, 2006, SCIENTOMETRICS, V67, P491, DOI 10.1556/Scient.67.2006.3.10; Wadman M, 2010, NATURE, V468, P355; Wood F., 2003, PEER REV HLTH SCI, V2nd ed., P14	30	25	26	0	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 3	2014	9	9							e106474	10.1371/journal.pone.0106474	http://dx.doi.org/10.1371/journal.pone.0106474			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AO3TB	25184367	Green Published, Green Submitted, gold			2022-12-27	WOS:000341257700077
J	He, DY; Wang, JC; Yi, L; Guo, XJ; Guo, SC; Guo, G; Tu, WZ; Wu, WY; Yang, L; Xiao, R; Li, Y; Chu, HY; Lai, SL; Jin, L; Zou, HJ; Reveille, JD; Assassi, S; Mayes, MD; Zhou, XD				He, Dongyi; Wang, Jiucun; Yi, Lin; Guo, Xinjian; Guo, Shicheng; Guo, Gang; Tu, Wenzhen; Wu, Wenyu; Yang, Li; Xiao, Rong; Li, Yuan; Chu, Haiyan; Lai, Syeling; Jin, Li; Zou, Hejian; Reveille, John D.; Assassi, Shervin; Mayes, Maureen D.; Zhou, Xiaodong			Association of the HLA-DRB1 with Scleroderma in Chinese Population	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; CLASS-II GENES; SYSTEMIC-SCLEROSIS; SUSCEPTIBILITY; GENETICS; MHC; AUTOANTIBODIES; HAPLOTYPES; FEATURES; LOCI	Multiple alleles of the Human leukocyte antigen (HLA) DRB1 have been strongly associated with systemic sclerosis (SSc) and its clinical or serological subsets. However, the associations vary in different ethnic populations. To define SSc-risk and/or protective alleles of HLA-DRB1 in Chinese population, we studied a Han Chinese cohort containing 585 patients with SSc and 458 gender-matched, unrelated controls. The HLA-DRB1 genotyping was performed with sequence-based typing method. Exact p-values were obtained (Fisher's test) from 262 tables of allele frequency and disease status. The major SSc risk allele subtypes of HLA-DRB1 are the DRB1*15:02 and *16:02 in this Chinese cohort. Particularly, DRB1*15: 02 was most significantly associated with anti-centromere autoantibodies (ACA) positive, and DRB1*16:02 with anti-topoisomerase I autoantibodies (ATA) positive patients. On the other hand, DRB1*01:01 and *04:06 were strong SSc-protective alleles in Chinese, especially in patients who were ACA positive and had diffuse cutaneous SSc (dcSSc), respectively. In addition, DRB1*11 and *07:01 also showed significant association with SSc as a risk for and protection from SSc, respectively, and which is consistent with the studies of Spanish, US Caucasian and Hispanic populations. DRB1*15 was associated with ATA positive Chinese SSc that is consistent with Black South African and Korean SSc. These findings of HLA-DRB1 alleles in association with Chinese SSc provide the growing knowledge of genetics of SSc, and indicate that the genetic heterogeneity among ethnicities may significantly impact the complex trait of SSc.	[He, Dongyi; Guo, Xinjian; Reveille, John D.; Assassi, Shervin; Mayes, Maureen D.; Zhou, Xiaodong] Univ Texas Med Sch Houston, Div Rheumatol & Clin Immunogenet, Houston, TX 77030 USA; [He, Dongyi] Guanghua Integrat Med Hosp, Inst Arthrit Res, Shanghai Acad Chinese Med Sci, Shanghai, Peoples R China; [Wang, Jiucun; Guo, Shicheng; Li, Yuan; Chu, Haiyan; Jin, Li] Fudan Univ, Minist Educ MOE Key Lab Contemporary Anthropol, Sch Life Sci, Shanghai 200433, Peoples R China; [Wang, Jiucun; Guo, Shicheng; Li, Yuan; Chu, Haiyan; Jin, Li] Fudan Univ, State Key Lab Genet Engn, Shanghai 200433, Peoples R China; [Wang, Jiucun; Zou, Hejian] Fudan Univ, Inst Rheumatol Immunol & Allergy, Shanghai 200433, Peoples R China; [Yi, Lin] Gansu Coll Tradit Chinese Med, Lanzhou, Gansu, Peoples R China; [Guo, Gang] Yiling Hosp, Shijiazhuang, Hebei Province, Peoples R China; [Tu, Wenzhen] Shanghai Tradit Chinese Med Integrated Hosp, Shanghai, Peoples R China; [Wu, Wenyu] Fudan Univ, Div Dermatol, Huashan Hosp, Shanghai 200433, Peoples R China; [Yang, Li] Teaching Hosp Chengdu Univ TCM, Div Rheumatol, Chengdu, Sichuan, Peoples R China; [Xiao, Rong] Cent S Univ, Dept Dermatol, Xiangya Hosp 2, Changsha, Hunan, Peoples R China; [Lai, Syeling] Michael E DeBakey VA Med Ctr, Dept Pathol, Baylor Coll Med, Houston, TX USA; [Zou, Hejian] Fudan Univ, Div Rheumatol, Huashan Hosp, Shanghai 200433, Peoples R China	University of Texas System; University of Texas Health Science Center Houston; Fudan University; Fudan University; Fudan University; Gansu University of Chinese Medicine; Fudan University; Chengdu University of Traditional Chinese Medicine; Central South University; Baylor College of Medicine; Fudan University	Zhou, XD (corresponding author), Univ Texas Med Sch Houston, Div Rheumatol & Clin Immunogenet, Houston, TX 77030 USA.	xiaodong.zhou@uth.tmc.edu	Jin, Li/M-5063-2019; Wang, Jiucun/J-8744-2012; Guo, Shicheng/A-1204-2016; Jin, Li/C-1468-2009	Wang, Jiucun/0000-0003-2765-0620; Guo, Shicheng/0000-0002-7047-9972; Jin, Li/0000-0002-4546-2415	US NIH NIAID UO1 [1U01AI09090]; International S&T Cooperation Program of China [2013DFA30870]; National Science Foundation of China [81270120]; Ministry of Science and Technology [2011BAI09B00]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR055258] Funding Source: NIH RePORTER	US NIH NIAID UO1; International S&T Cooperation Program of China; National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	The studies were supported by research grants from the US NIH NIAID UO1, 1U01AI09090, International S&T Cooperation Program of China (2013DFA30870), the National Science Foundation of China (81270120), and the Ministry of Science and Technology (2011BAI09B00). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allanore Y, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002091; [Anonymous], 1980, ARTHRITIS RHEUM, V23, P581, DOI 10.1002/art.1780230510; Arnett FC, 2010, ANN RHEUM DIS, V69, P822, DOI 10.1136/ard.2009.111906; Beretta L, 2012, RHEUMATOLOGY, V51, P52, DOI 10.1093/rheumatology/ker335; Broen JCA, 2012, CURR RHEUMATOL REP, V14, P11, DOI 10.1007/s11926-011-0221-7; Bunn CC, 1999, CLIN EXP IMMUNOL, V117, P207; Erlich H, 2008, DIABETES, V57, P1084, DOI 10.2337/db07-1331; Furukawa H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033133; Gilchrist FC, 2001, GENES IMMUN, V2, P76, DOI 10.1038/sj.gene.6363734; Gorlova O, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002178; Kang SH, 2001, J RHEUMATOL, V28, P1577; Kuwana M, 1999, INTERNAL MED, V38, P336, DOI 10.2169/internalmedicine.38.336; LEROY EC, 1988, J RHEUMATOL, V15, P202; Louthrenoo W, 2013, RHEUMATOL INT, V33, P2069, DOI 10.1007/s00296-013-2686-3; Mayes MD, 2014, AM J HUM GENET, V94, P47, DOI 10.1016/j.ajhg.2013.12.002; Newton JL, 2004, GENES IMMUN, V5, P151, DOI 10.1038/sj.gene.6364045; Radstake TRDJ, 2010, NAT GENET, V42, P426, DOI 10.1038/ng.565; Raychaudhuri S, 2012, NAT GENET, V44, P291, DOI 10.1038/ng.1076; Reveille JD, 2006, BEST PRACT RES CL RH, V20, P601, DOI 10.1016/j.berh.2006.03.004; Romano E, 2011, CLIN EXP RHEUMATOL, V29, pS75; Simeon CP, 2009, J RHEUMATOL, V36, P2733, DOI 10.3899/jrheum.090377; Steen VD, 2005, SEMIN ARTHRITIS RHEU, V35, P35, DOI 10.1016/j.semarthrit.2005.03.005; Tikly M, 2004, TISSUE ANTIGENS, V63, P487, DOI 10.1111/j.0001-2815.2004.00199.x; Varga J, 2007, J CLIN INVEST, V117, P557, DOI 10.1172/JCI31139; Wang JC, 2013, CLIN RHEUMATOL, V32, P617, DOI 10.1007/s10067-012-2145-7; Yunis EJ, 2003, TISSUE ANTIGENS, V62, P1, DOI 10.1034/j.1399-0039.2003.00098.x; Zhou XD, 2013, INT J IMMUNOPATH PH, V26, P747, DOI 10.1177/039463201302600318; Zhou XD, 2009, ARTHRITIS RHEUM-US, V60, P3807, DOI 10.1002/art.24982	28	16	16	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 3	2014	9	9							e106939	10.1371/journal.pone.0106939	http://dx.doi.org/10.1371/journal.pone.0106939			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3TB	25184637	Green Published, Green Submitted, gold			2022-12-27	WOS:000341257700129
J	Li, H; Li, YD; Cui, L; Wang, BY; Cui, WL; Li, MH; Cheng, YS				Li, Hui; Li, Yongdong; Cui, Lei; Wang, Biyuan; Cui, Wenli; Li, Minghua; Cheng, Yingsheng			Monitoring Pancreatic Carcinogenesis by the Molecular Imaging of Cathepsin E In Vivo Using Confocal Laser Endomicroscopy	PLOS ONE			English	Article							GROWTH-FACTOR RECEPTOR; DUCTAL ADENOCARCINOMA; FLUORESCENT-PROBE; CANCER; MICE; NEOPLASIA; DIAGNOSIS; CLASSIFICATION; VISUALIZATION; STRICTURES	The monitoring of pancreatic ductal adenocarcinoma (PDAC) in high-risk populations is essential. Cathepsin E (CTSE) is specifically and highly expressed in PDAC and pancreatic intraepithelial neoplasias (PanINs), and its expression gradually increases along with disease progression. In this study, we first established an in situ 7,12-dimethyl-1,2-benzanthracene (DMBA)-induced rat model for PanINs and PDAC and then confirmed that tumorigenesis properties in this model were consistent with those of human PDAC in that CTSE expression gradually increased with tumor development using histology and immunohistochemistry. Then, using in vivo imaging of heterotopically implanted tumors generated from CTSE-overexpressing cells (PANC-1-CTSE) in nude mice and in vitro imaging of PanINs and PDAC in DMBA-induced rats, the specificity of the synthesized CTSE-activatable probe was verified. Quantitative determination identified that the fluorescence signal ratio of pancreatic tumor to normal pancreas gradually increased in association with progressive pathological grades, with the exception of no significant difference between PanIN-II and PanIN-III grades. Finally, we monitored pancreatic carcinogenesis in vivo using confocal laser endomicroscopy (CLE) in combination with the CTSE-activatable probe. A prospective double-blind control study was performed to evaluate the accuracy of this method in diagnosing PDAC and PanINs of all grades (>82.7%). This allowed us to establish effective diagnostic criteria for CLE in PDAC and PanINs to facilitate the monitoring of PDAC in high-risk populations.	[Li, Hui; Li, Yongdong; Wang, Biyuan; Li, Minghua; Cheng, Yingsheng] Shanghai Jiao Tong Univ, Dept Radiol, Affiliated Peoples Hosp 6, Shanghai 200030, Peoples R China; [Cui, Lei] Univ Shanghai Sci & Technol, Coll Sci, Shanghai, Peoples R China; [Cui, Wenli] Fudan Univ, Dept Pathol, Shanghai Canc Ctr, Shanghai 200433, Peoples R China	Shanghai Jiao Tong University; University of Shanghai for Science & Technology; Fudan University	Cheng, YS (corresponding author), Shanghai Jiao Tong Univ, Dept Radiol, Affiliated Peoples Hosp 6, Shanghai 200030, Peoples R China.	yingsheng_cheng@163.com	Cui, Lei/F-6368-2014	Cui, lei/0000-0003-2510-0895				Abd-Elgaliel WR, 2013, J CONTROL RELEASE, V167, P221, DOI 10.1016/j.jconrel.2013.02.007; Abd-Elgaliel WR, 2011, MOL BIOSYST, V7, P3207, DOI 10.1039/c1mb05215b; Abd-Elgaliel WR, 2010, BBA-GEN SUBJECTS, V1800, P1002, DOI 10.1016/j.bbagen.2010.06.005; Baudy AR, 2011, MOL IMAGING BIOL, V13, P462, DOI 10.1007/s11307-010-0376-z; Bersch VP, 2009, PANCREAS, V38, P65, DOI 10.1097/MPA.0b013e318184d330; Buchner AM, 2010, GASTROENTEROLOGY, V138, pS95, DOI 10.1053/j.gastro.2009.10.053; Canto MI, 2006, CLIN GASTROENTEROL H, V4, P766, DOI 10.1016/j.cgh.2006.02.005; Chu D, 2010, J PANCREAS, V11, P203; Cruz-Monserrate Z, 2012, GUT, V61, P1315, DOI 10.1136/gutjnl-2011-300544; Eser S, 2011, P NATL ACAD SCI USA, V108, P9945, DOI 10.1073/pnas.1100890108; Harsha HC, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000046; Hruban RH, 2007, GASTROENTEROL CLIN N, V36, P831, DOI 10.1016/j.gtc.2007.08.012; Keliher EJ, 2013, NEOPLASIA, V15, P684, DOI 10.1593/neo.13276; Klapman Jason, 2008, Cancer Control, V15, P280; Konda VJA, 2011, GASTROINTEST ENDOSC, V74, P1049, DOI 10.1016/j.gie.2011.07.018; Leong RWL, 2008, GASTROENTEROLOGY, V135, P1870, DOI 10.1053/j.gastro.2008.08.054; Lichtenstein P, 2000, NEW ENGL J MED, V343, P78, DOI 10.1056/NEJM200007133430201; Liu J, 2013, CANCER LETT, V330, P200, DOI 10.1016/j.canlet.2012.11.044; Matthaei Hanno, 2013, Methods Mol Biol, V980, P1, DOI 10.1007/978-1-62703-287-2_1; McKinney KQ, 2011, J PROTEOMICS, V74, P79, DOI 10.1016/j.jprot.2010.08.006; Meining A, 2012, ENDOSCOPY, V44, P251, DOI 10.1055/s-0031-1291545; Meining A, 2008, CLIN GASTROENTEROL H, V6, P1057, DOI 10.1016/j.cgh.2008.04.014; Meining A, 2007, CLIN GASTROENTEROL H, V5, P1261, DOI 10.1016/j.cgh.2007.05.019; Meining A, 2011, GASTROINTEST ENDOSC, V74, P961, DOI 10.1016/j.gie.2011.05.009; Mennone A, 2011, GASTROINTEST ENDOSC, V73, P338, DOI 10.1016/j.gie.2010.10.002; Nakai Y, 2012, J PHYSIOL PHARMACOL, V63, P577; Niedergethmann M, 2004, PANCREAS, V29, P204, DOI 10.1097/00006676-200410000-00005; Poruk KE, 2013, ANN SURG, V257, P17, DOI 10.1097/SLA.0b013e31825ffbfb; Raimondi S, 2009, NAT REV GASTRO HEPAT, V6, P699, DOI 10.1038/nrgastro.2009.177; Rivera JA, 1997, SURGERY, V122, P82, DOI 10.1016/S0039-6060(97)90268-3; Rulyak SJ, 2003, GASTROENTEROLOGY, V124, P1292, DOI 10.1016/S0016-5085(03)00272-5; Tuveson DA, 2006, CANCER RES, V66, P242, DOI 10.1158/0008-5472.CAN-05-2305; Uno K, 2000, J GASTROEN HEPATOL, V15, P1333, DOI 10.1046/j.1440-1746.2000.02351.x; Zhang SJ, 2013, BIOCONJUGATE CHEM, V24, P1907, DOI 10.1021/bc400328m; Zhang YQ, 2013, BBA-REV CANCER, V1835, P110, DOI 10.1016/j.bbcan.2012.11.001	35	17	19	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 3	2014	9	9							e106566	10.1371/journal.pone.0106566	http://dx.doi.org/10.1371/journal.pone.0106566			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3TB	25184278	gold, Green Submitted, Green Published			2022-12-27	WOS:000341257700089
J	Saeed, AM; Duffort, S; Ivanov, D; Wang, H; Laird, JM; Salomon, RG; Cruz-Guilloty, F; Perez, VL				Saeed, Ali M.; Duffort, Stephanie; Ivanov, Dmitry; Wang, Hua; Laird, James M.; Salomon, Robert G.; Cruz-Guilloty, Fernando; Perez, Victor L.			The Oxidative Stress Product Carboxyethylpyrrole Potentiates TLR2/TLR1 Inflammatory Signaling in Macrophages	PLOS ONE			English	Article							CHLAMYDIA-PNEUMONIAE INFECTION; LOW-DENSITY-LIPOPROTEIN; TOLL-LIKE RECEPTORS; MACULAR DEGENERATION; PATTERN-RECOGNITION; TOLL-LIKE-RECEPTOR-2; ATHEROSCLEROSIS; IDENTIFICATION; EPITOPES; LIGANDS	Oxidative stress is key in the pathogenesis of several diseases including age-related macular degeneration (AMD), atherosclerosis, diabetes, and Alzheimer's disease. It has previously been established that a lipid peroxidation product, carboxyethylpyrrole (CEP), accumulates in the retinas of AMD patients. Retinal infiltrating macrophages also accumulate in the retinas of both AMD patients and in a murine model of AMD. We therefore investigated the ability of CEP-adducts to activate innate immune signaling in murine bone-marrow derived macrophages (BMDMs). We found that CEP specifically synergizes with low-dose TLR2-agonists (but not agonists for other TLRs) to induce production of inflammatory cytokines. Moreover, CEP selectively augments TLR2/TLR1-signaling instead of TLR2/TLR6-signaling. These studies uncover a novel synergistic inflammatory relationship between an endogenously produced oxidation molecule and a pathogen-derived product, which may have implications in the AMD disease process and other oxidative stress-driven pathologies.	[Saeed, Ali M.] Univ Miami, Miller Sch Med, Sheila & David Fuente Program Canc Biol, Miami, FL 33136 USA; [Duffort, Stephanie; Ivanov, Dmitry; Cruz-Guilloty, Fernando; Perez, Victor L.] Univ Miami, Miller Sch Med, Dept Ophthalmol, Bascom Palmer Eye Inst, Miami, FL 33136 USA; [Wang, Hua; Laird, James M.; Salomon, Robert G.] Case Western Reserve Univ, Dept Chem, Cleveland, OH 44106 USA; [Cruz-Guilloty, Fernando; Perez, Victor L.] Univ Miami, Miller Sch Med, Dept Microbiol & Immunol, Miami, FL 33136 USA	University of Miami; Bascom Palmer Eye Institute; University of Miami; Case Western Reserve University; University of Miami	Cruz-Guilloty, F (corresponding author), Immucor Inc, Norcross, GA 30071 USA.	Fcruzguilloty@gmail.com; Vperez4@med.miami.edu	Wang, Hua/N-9400-2015; Perez, Victor L./AAY-8633-2020	Wang, Hua/0000-0002-2109-5497; Ivanov, Dmitry/0000-0002-5573-4402; Salomon, Robert/0000-0001-9456-3557	Edward N. & Della L. Thome Memorial Foundation Bank of America N.A. Trustee Award Program in Macular Degeneration Research; NIH [P30EY14801, R01-GM21249]; Research to Prevent Blindness; Sheila and David Fuente Graduate Program in Cancer Biology, Sylvester Comprehensive Cancer Center; Howard Hughes Medical Institute Fellowship of the Life Sciences Research Foundation; NATIONAL EYE INSTITUTE [R01EY016813, P30EY014801] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM021249] Funding Source: NIH RePORTER	Edward N. & Della L. Thome Memorial Foundation Bank of America N.A. Trustee Award Program in Macular Degeneration Research; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Research to Prevent Blindness(Research to Prevent Blindness (RPB)); Sheila and David Fuente Graduate Program in Cancer Biology, Sylvester Comprehensive Cancer Center; Howard Hughes Medical Institute Fellowship of the Life Sciences Research Foundation(Howard Hughes Medical Institute); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by The Edward N. & Della L. Thome Memorial Foundation Bank of America N.A. Trustee Award Program in Macular Degeneration Research (VLP), NIH P30EY14801 (Center Grant), Research to Prevent Blindness (Unrestricted Grant to the Bascom Palmer Eye Institute), NIH R01-GM21249 (RGS). AMS acknowledges partial support and assistance from the Sheila and David Fuente Graduate Program in Cancer Biology, Sylvester Comprehensive Cancer Center. FCG was supported by a Howard Hughes Medical Institute Fellowship of the Life Sciences Research Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bagchi A, 2007, J IMMUNOL, V178, P1164, DOI 10.4049/jimmunol.178.2.1164; Beckett EL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039460; Brzozowska Aleksandra, 2012, Klin Oczna, V114, P29; Cao F, 2007, INFECT IMMUN, V75, P753, DOI 10.1128/IAI.01386-06; Cao XG, 2011, PATHOL INT, V61, P528, DOI 10.1111/j.1440-1827.2011.02695.x; Cheng K, 2012, ANGEW CHEM INT EDIT, V51, P12246, DOI 10.1002/anie.201204910; Chou MY, 2008, J INTERN MED, V263, P479, DOI 10.1111/j.1365-2796.2008.01968.x; Crabb JW, 2002, P NATL ACAD SCI USA, V99, P14682, DOI 10.1073/pnas.222551899; Cruz-Guilloty F, 2013, INT J INFLAMM, V2013, DOI 10.1155/2013/503725; Cruz-Guilloty F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088201; Darveau RP, 2004, INFECT IMMUN, V72, P5041, DOI 10.1128/IAI.72.9.5041-5051.2004; Doyle SL, 2012, NAT MED; Edfeldt K, 2002, CIRCULATION, V105, P1158, DOI 10.1161/circ.105.10.1158; Evans T. A., 2008, AM J BIOCH BIOTECHNO, V4, P61, DOI DOI 10.3844/AJBBSP.2008.61.72; Forner L, 2006, J CLIN PERIODONTOL, V33, P401, DOI 10.1111/j.1600-051X.2006.00924.x; Fujimoto T, 2010, INVEST OPHTH VIS SCI, V51, P4694, DOI 10.1167/iovs.09-4464; Gibson FC, 2006, J DENT RES, V85, P106, DOI 10.1177/154405910608500202; Gu JY, 2009, MOL CELL PROTEOMICS, V8, P1338, DOI 10.1074/mcp.M800453-MCP200; Gu XR, 2003, J BIOL CHEM, V278, P42027, DOI 10.1074/jbc.M305460200; Haas P, 2009, EYE, V23, P2228, DOI 10.1038/eye.2008.422; Handa JT, 2012, MOL ASPECTS MED, V33, P418, DOI 10.1016/j.mam.2012.03.006; Hayashi C, 2010, J INNATE IMMUN, V2, P334, DOI 10.1159/000314686; Hollyfield JG, 2008, NAT MED, V14, P194, DOI 10.1038/nm1709; Hreggvidsdottir HS, 2009, J LEUKOCYTE BIOL, V86, P655, DOI 10.1189/jlb.0908548; Imai Y, 2008, CELL, V133, P235, DOI 10.1016/j.cell.2008.02.043; Jimenez-Dalmaroni MJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007411; Kadl A, 2010, CIRC RES, V107, P737, DOI 10.1161/CIRCRESAHA.109.215715; Kalayoglu MV, 2005, GRAEF ARCH CLIN EXP, V243, P1080, DOI 10.1007/s00417-005-1169-y; Kalayoglu MV, 2003, ARCH OPHTHALMOL-CHIC, V121, P478, DOI 10.1001/archopht.121.4.478; Kalayoglu MV, 2002, JAMA-J AM MED ASSOC, V288, P2724, DOI 10.1001/jama.288.21.2724; Laman JD, 2002, AM J CARDIOL, V90, P119, DOI 10.1016/S0002-9149(02)02432-3; Lappin DF, 2011, J CLIN PERIODONTOL, V38, P318, DOI 10.1111/j.1600-051X.2011.01702.x; Lin TA, 2010, J INFECT DIS, V202, P624, DOI 10.1086/654929; Lu L, 2009, BIOORGAN MED CHEM, V17, P7548, DOI 10.1016/j.bmc.2009.09.009; Maharaj B, 2012, CARDIOVASC J AFR, V23, P340, DOI 10.5830/CVJA-2012-016; McLaughlin RW, 2002, J CLIN MICROBIOL, V40, P4771, DOI 10.1128/JCM.40.12.4771-4775.2002; Miller YI, 2005, ARTERIOSCL THROM VAS, V25, P1213, DOI 10.1161/01.ATV.0000159891.73193.31; Miller YI, 2011, CIRC RES, V108, P235, DOI 10.1161/CIRCRESAHA.110.223875; Monaco C, 2009, CIRCULATION, V120, P2462, DOI 10.1161/CIRCULATIONAHA.109.851881; Mosser DM, 2008, NAT REV IMMUNOL, V8, P958, DOI 10.1038/nri2448; Mullick AE, 2005, J CLIN INVEST, V115, P3149, DOI 10.1172/JCI25482; Napolitani G, 2005, NAT IMMUNOL, V6, P769, DOI 10.1038/ni1223; Nikkari S, 2001, J CLIN MICROBIOL, V39, P1956, DOI 10.1128/JCM.39.5.1956-1959.2001; Nilsen NJ, 2008, J LEUKOCYTE BIOL, V84, P280, DOI 10.1189/jlb.0907656; Ozinsky A, 2000, P NATL ACAD SCI USA, V97, P13766, DOI 10.1073/pnas.250476497; Panigrahi S, 2013, CIRC RES, V112, P103, DOI 10.1161/CIRCRESAHA.112.274241; Prebeck S, 2001, J IMMUNOL, V167, P3316, DOI 10.4049/jimmunol.167.6.3316; Salomon RG, 2011, CHEM RES TOXICOL, V24, P1803, DOI 10.1021/tx200206v; Schumann RR, 2007, EUR J IMMUNOL, V37, P2059, DOI 10.1002/eji.200737604; Shen D, 2009, BRIT J OPHTHALMOL, V93, P405, DOI 10.1136/bjo.2008.145383; Stutz A, 2009, J CLIN INVEST, V119, P3502, DOI 10.1172/JCI40599; Travassos LH, 2004, EMBO REP, V5, P1000, DOI 10.1038/sj.embor.7400248; Weismann D, 2012, BBA-BIOMEMBRANES, V1818, P2465, DOI 10.1016/j.bbamem.2012.01.018; Weismann D, 2011, NATURE, V478, P76, DOI 10.1038/nature10449; West XZ, 2010, NATURE, V467, P972, DOI 10.1038/nature09421; Wetzler LM, 2003, VACCINE, V21, pS55, DOI 10.1016/S0264-410X(03)00201-9; Wiesner P, 2010, CIRC RES, V107, P56, DOI 10.1161/CIRCRESAHA.110.218420; Yang X, 2005, ARTERIOSCL THROM VAS, V25, P2308, DOI 10.1161/01.ATV.0000187468.00675.a3; Zhu Q, 2008, P NATL ACAD SCI USA, V105, P16260, DOI 10.1073/pnas.0805325105	59	24	24	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 3	2014	9	9							e106421	10.1371/journal.pone.0106421	http://dx.doi.org/10.1371/journal.pone.0106421			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3TB	25184331	gold, Green Submitted, Green Published			2022-12-27	WOS:000341257700069
J	Zheng, GW; Tian, B; Li, WQ				Zheng, Guowei; Tian, Bo; Li, Weiqi			Membrane Lipid Remodelling of Meconopsis racemosa after Its Introduction into Lowlands from an Alpine Environment	PLOS ONE			English	Article							ARABIDOPSIS-THALIANA; PHOSPHATE DEPRIVATION; FATTY-ACIDS; SEED PLANTS; TEMPERATURE; ADAPTATION; TOLERANCE; GALACTOLIPIDS; DOMESTICATION; ACCLIMATION	Membrane lipids, which determine the integrity and fluidity of membranes, are sensitive to environmental changes. The influence of stresses, such as cold and phosphorus deficiency, on lipid metabolism is well established. However, little is known about how plant lipid profiles change in response to environmental changes during introduction, especially when plants are transferred from extreme conditions to moderate ones. Using a lipidomics approach, we profiled the changes in glycerolipid molecules upon the introduction of the alpine ornamental species Meconopsis racemosa from the alpine region of Northwest Yunnan to the lowlands of Kunming, China. We found that the ratios of digalactosyldiacylglycerol/monogalactosyldiacylglycerol (DGDG/MGDG) and phosphatidylcholine/phosphatidylethanolamine (PC/PE) remained unchanged. Introduction of M. racemosa from an alpine environment to a lowland environment results in two major effects. The first is a decline in the level of plastidic lipids, especially galactolipids. The second, which concerns a decrease of the double-bond index (DBI) and could make the membrane more gel-like, is a response to high temperatures. Changes in the lipidome after M. racemosa was introduced to a lowland environment were the reverse of those that occur when plants are exposed to phosphorus deficiency or cold stress.	[Zheng, Guowei; Li, Weiqi] Chinese Acad Sci, Kunming Inst Bot, Key Lab Plant Divers & Biogeog East Asia, Kunming, Yunnan, Peoples R China; [Tian, Bo] Chinese Acad Sci, Key Lab Trop Plant Resource & Sustainable Use, Xishuangbanna Trop Bot Garden, Kunming, Peoples R China; [Zheng, Guowei; Li, Weiqi] Chinese Acad Sci, Kunming Inst Bot, Plant Germplasm & Genom Ctr, Germplasm Bank Wild Species, Kunming, Yunnan, Peoples R China	Chinese Academy of Sciences; Kunming Institute of Botany, CAS; Chinese Academy of Sciences; Xishuangbanna Tropical Botanical Garden, CAS; Chinese Academy of Sciences; Kunming Institute of Botany, CAS	Li, WQ (corresponding author), Chinese Acad Sci, Kunming Inst Bot, Key Lab Plant Divers & Biogeog East Asia, Kunming, Yunnan, Peoples R China.	weiqili@mail.kib.ac.cn		zheng, guowei/0000-0001-9820-5685	NSFC [30670474, 30870571, 31371661]; West Light Foundation of the Chinese Academy of Sciences (CAS); Germplasm Bank of Wild Species; CAS Innovation Program of Kunming Institute [540806321211]; 100 Talents Program, CAS	NSFC(National Natural Science Foundation of China (NSFC)); West Light Foundation of the Chinese Academy of Sciences (CAS)(Chinese Academy of Sciences); Germplasm Bank of Wild Species; CAS Innovation Program of Kunming Institute; 100 Talents Program, CAS	The study was supported by grants from NSFC 30670474 & 30870571, West Light Foundation of the Chinese Academy of Sciences (CAS), Germplasm Bank of Wild Species, the CAS Innovation Program of Kunming Institute (540806321211) and the "100 Talents Program, CAS". The study was also supported by grants from (NSFC 31371661). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson MX, 2003, FEBS LETT, V537, P128, DOI 10.1016/S0014-5793(03)00109-1; Bakht J, 2006, J EXP BOT, V57, P3707, DOI 10.1093/jxb/erl120; Buchanan B. B., 2002, BIOCH MOL BIOL PLANT; Burgos A, 2011, PLANT J, V66, P656, DOI 10.1111/j.1365-313X.2011.04531.x; Chen JP, 2006, PLANT CELL ENVIRON, V29, P1437, DOI 10.1111/j.1365-3040.2006.01527.x; Chintalapati S, 2004, CELL MOL BIOL, V50, P631; Denich TJ, 2003, J MICROBIOL METH, V52, P149, DOI 10.1016/S0167-7012(02)00155-0; Diamond J, 2002, NATURE, V418, P700, DOI 10.1038/nature01019; Dormann P, 2002, TRENDS PLANT SCI, V7, P112, DOI 10.1016/S1360-1385(01)02216-6; Falcone Deane L., 2004, BMC Plant Biology, V4, P17, DOI 10.1186/1471-2229-4-17; Garcia-Palacios P, 2013, NEW PHYTOL, V198, P504, DOI 10.1111/nph.12127; Hartel H, 2000, P NATL ACAD SCI USA, V97, P10649, DOI 10.1073/pnas.180320497; HAZEL JR, 1990, PROG LIPID RES, V29, P167, DOI 10.1016/0163-7827(90)90002-3; Jia YX, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065687; Jouhet J, 2004, J CELL BIOL, V167, P863, DOI 10.1083/jcb.200407022; Korner C, 1999, ALPINE PLANT LIFE FU; Levitt J, 1980, CHILLING FREEZING HI; Li H, 2003, BAIMA SNOW MOUNTAIN, P42; Li W, 2008, J BIOL CHEM, V283, P461, DOI 10.1074/jbc.M706692200; Lutz C, 2012, PLANTS IN ALPINE REGIONS: CELL PHYSIOLOGY OF ADAPTION AND SURVIVAL STRATEGIES, P1, DOI 10.1007/978-3-7091-0136-0; Moellering ER, 2010, SCIENCE, V330, P226, DOI 10.1126/science.1191803; Murakami Y, 2000, SCIENCE, V287, P476, DOI 10.1126/science.287.5452.476; Murphy D. J., 2005, PLANT LIPIDS BIOL UT; Nakamura Y, 2013, PROG LIPID RES, V52, P43, DOI 10.1016/j.plipres.2012.07.002; Nakamura Y, 2009, P NATL ACAD SCI USA, V106, P20978, DOI 10.1073/pnas.0907173106; Penfield S, 2008, NEW PHYTOL, V179, P615, DOI 10.1111/j.1469-8137.2008.02478.x; Prasch CM, 2013, PLANT PHYSIOL, V162, P1849, DOI 10.1104/pp.113.221044; Sakai A., 1987, FROST SURVIVAL PLANT, P124, DOI [10.1007/978-3-642-71745-1, DOI 10.1007/978-3-642-71745-1]; UEMURA M, 1995, PLANT PHYSIOL, V109, P15, DOI 10.1104/pp.109.1.15; Wahid A, 2007, ENVIRON EXP BOT, V61, P199, DOI 10.1016/j.envexpbot.2007.05.011; Wallis JG, 2002, PROG LIPID RES, V41, P254, DOI 10.1016/S0163-7827(01)00027-3; Welti R, 2002, J BIOL CHEM, V277, P31994, DOI 10.1074/jbc.M205375200; Welti R, 2007, FRONT BIOSCI-LANDMRK, V12, P2494, DOI 10.2741/2250; Zhang SB, 2008, BOT STUD, V49, P225; Zhang SB, 2010, BOT STUD, V51, P457; Zheng GW, 2011, PLANT CELL ENVIRON, V34, P1431, DOI 10.1111/j.1365-3040.2011.02341.x	36	5	5	2	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 3	2014	9	9							e106614	10.1371/journal.pone.0106614	http://dx.doi.org/10.1371/journal.pone.0106614			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3TB	25184635	Green Published, gold, Green Submitted			2022-12-27	WOS:000341257700093
J	Maleki, K; Hamadeh, RR; Gholami, J; Mandil, A; Hamid, S; Butt, ZA; Bin Saeed, A; El Kheir, DYM; Saleem, M; Maqsoud, S; Safi, N; Abdul-Majeed, BA; Majdzadeh, R				Maleki, Katayoun; Hamadeh, Randah R.; Gholami, Jaleh; Mandil, Ahmed; Hamid, Saima; Butt, Zahid Ahmad; Bin Saeed, Abdulaziz; El Kheir, Dalia Y. M.; Saleem, Mohammed; Maqsoud, Sahar; Safi, Najibullah; Abdul-Majeed, Ban A.; Majdzadeh, Reza			The Knowledge Translation Status in Selected Eastern-Mediterranean Universities and Research Institutes	PLOS ONE			English	Article							HEALTH RESEARCH; PRIORITIES; CAPACITY; NEED	Background: A serious worldwide effort to strengthen research based knowledge translation (KT) has begun in recent years and some countries, particularly developed ones, are trying to incorporate KT in their health and health research systems. Keeping in mind the recent economic depression and the need to perform more efficient research, we aimed to assess and compare the KT status of selected health research institutes in the Eastern Mediterranean Regions' countries, and to identify their strengths and weaknesses in the field. Methods: After finding the focal points that would steer the focus group discussions (FGDs) and help complete the 'Self Assessment Tool for Research Institutes' (SATORI) tool, each focal point held two FGDs in which researchers, research authorities and other individuals specified in detail further in the study were held. The scores obtained by each institute were evaluated quantitatively, and the transcriptions were analyzed qualitatively with OpenCode software. Results: For ease of analysis the 50 items of the SATORI were classified into 7 main domains: 'priority setting', 'research quality and timeliness', 'researchers' KT capacities', 'facilities and pre-requisites of KT', 'processes and regulations supporting KT', 'interaction with research users', and 'promoting and evaluating the use of knowledge'. Based on the scoring system, the strongest domain was 'research quality and timeliness'. 'Priority setting' was the weakest domain of all. The remaining domains were more or less equal in strength and were not in a favorable state. The qualitative findings confirmed the quantitative findings. Conclusions: The main problem, it seems, is that a KT climate does not exist in the region. And despite the difference in the contexts, there are many similarities in the region's institutes included in this study. Collaborative efforts can play a role in creating this climate by steering countries towards KT and suggesting regional strategic directions according to their needs.	[Maleki, Katayoun; Gholami, Jaleh; Majdzadeh, Reza] Tehran Univ Med Sci, Knowledge Utilizat Res Ctr, Tehran, Iran; [Hamadeh, Randah R.] AGU, Coll Med & Med Sci, Manama, Bahrain; [Mandil, Ahmed] KSU, Coll Med, Riyadh, Saudi Arabia; [Hamid, Saima; Butt, Zahid Ahmad] Hlth Serv Acad, MoH, Islamabad, Pakistan; [Bin Saeed, Abdulaziz] KSU, Dept Family & Community Med, Riyadh, Saudi Arabia; [El Kheir, Dalia Y. M.] Univ Khartoum, Fac Med, Khartoum, Sudan; [Saleem, Mohammed] Univ Alexandria, High Inst Publ Hlth, Alexandria, Egypt; [Maqsoud, Sahar] Univ Alexandria, Prevent Affairs Dept, Students Clin & Hosp, Alexandria, Egypt; [Safi, Najibullah] WHO Country Off, Kabul, Afghanistan; [Abdul-Majeed, Ban A.] Al Nahrain Univ, Coll Med, Baghdad, Iraq	Tehran University of Medical Sciences; Arabian Gulf University; King Saud University; Health Services Academy; King Saud University; University of Khartoum; Egyptian Knowledge Bank (EKB); Alexandria University; Egyptian Knowledge Bank (EKB); Alexandria University; Al-Nahrain University	Majdzadeh, R (corresponding author), Tehran Univ Med Sci, Knowledge Utilizat Res Ctr, Tehran, Iran.	rezamajd@tums.ac.ir	Butt, Zahid Ahmad/W-4292-2017; Hamadeh, Randah R./AAE-9720-2020	Butt, Zahid Ahmad/0000-0002-2486-4781; Hamadeh, Randah R./0000-0002-4205-1354; Gholami, Jaleh/0000-0002-3248-6207; Mandil, Ahmed/0000-0002-0903-3277	WHO/EMRO	WHO/EMRO(World Health Organization)	The underlying investigation received financial support from WHO/EMRO. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2008, LANCET, V372, P1855, DOI 10.1016/S0140-6736(08)61789-4; Birdsell J, 2003, NETWORKS THEIR ROLE; Canadian Institutes of Health Research, 2004, INN ACT KNOWL TRANSL; Conklin J, 2013, IMPLEMENT SCI, V8, DOI 10.1186/1748-5908-8-7; Contandriopoulos D, MILBANK Q, V88, P444; Creech H., 2001, STRATEGIC INTENTIONS; Dobbins M, 2007, IMPLEMENT SCI, V2, DOI 10.1186/1748-5908-2-20; El-Jardali F, 2012, IMPLEMENT SCI, V7, DOI 10.1186/1748-5908-7-2; Ghaffar A, 2009, INDIAN J MED RES, V129, P368; Gholami J, 2013, HEALTH RES POLICY SY, V11, DOI 10.1186/1478-4505-11-43; Gholami J, 2011, HEALTH RES POLICY SY, V9, DOI 10.1186/1478-4505-9-10; Hofmeyer Anne, 2007, Health Res Policy Syst, V5, P5, DOI 10.1186/1478-4505-5-5; Innvaer Simon, 2002, J Health Serv Res Policy, V7, P239, DOI 10.1258/135581902320432778; Jacobson N, 2004, SCI COMMUN, V25, P246, DOI 10.1177/1075547003262038; Kennedy A., 2008, Eastern Mediterranean Health Journal, V14, P502; Kobus K, 2007, NICOTINE TOB RES S4, V9, pS571; Lavis JN, 2006, B WORLD HEALTH ORGAN, V84, P620, DOI 10.2471/BLT.06.030312; Lavis JN, 2009, HEALTH RES POLICY SY, V7, DOI 10.1186/1478-4505-7-S1-S3; Majdzadeh R, 2009, J MED HYPOTHESES IDE, V3, P18; Majdzadeh R, 2009, IRAN J PUBLIC HLTH, V38; Majdzadeh R, 2012, HEALTH POLICY PLANN, V27, P499, DOI 10.1093/heapol/czr072; Mendizibal E, 2006, UNDERSTANDING NETWOR; Miller J, 2009, RURAL REMOTE HEALTH, V9; Montorzi G, 2010, PRIORITY SETTING RES; Muntaner C, 2012, J URBAN HEALTH, V89, P915, DOI 10.1007/s11524-012-9699-1; Nuyens Y, 2007, B WORLD HEALTH ORGAN, V85, P319, DOI 10.2471/BLT.06.032375; Pablos-Mendez A, 2005, B WORLD HEALTH ORGAN, V83, P723; Patino R, 2009, J AM ASSOC LAB ANIM, V48, P138; Report of The Regional Committee for the Eastern Mediterranean, EMRC6012EEMRC6012E; SCImago, 2007, SJR SCIMAGO J COUNTR; Secretariat GFHR, 1999, 10 90 REP HLTH RES 1; Straus SE, 2009, CAN MED ASSOC J, V181, P165, DOI 10.1503/cmaj.081229; The Commission on Health Research for Development, 1990, HLTH RES ESS LINK EQ; Wahabi HA, 2011, BMC MED EDUC, V11, DOI 10.1186/1472-6920-11-85; Ward Vicky, 2009, Evid Policy, V5, P267; WHO, 2009, INT C PRIM HLTH CAR; WHO Evidence-informed policy-making, WHO EV INF POL MAK E; World Health Organization, 2011, STRAT DIR SCAL RES H; World Health Organization, 2004, WORLD REP KNOWL BETT, pxvi; World Health Organization, EV INF POL MAK	40	10	10	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2014	9	9							e103732	10.1371/journal.pone.0103732	http://dx.doi.org/10.1371/journal.pone.0103732			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4JX	25197834	Green Published, gold, Green Submitted			2022-12-27	WOS:000341304700005
J	Card, DC; Schield, DR; Reyes-Velasco, J; Fujita, MK; Andrew, AL; Oyler-McCance, SJ; Fike, JA; Tomback, DF; Ruggiero, RP; Castoe, TA				Card, Daren C.; Schield, Drew R.; Reyes-Velasco, Jacobo; Fujita, Matthew K.; Andrew, Audra L.; Oyler-McCance, Sara J.; Fike, Jennifer A.; Tomback, Diana F.; Ruggiero, Robert P.; Castoe, Todd A.			Two Low Coverage Bird Genomes and a Comparison of Reference-Guided versus De Novo Genome Assemblies	PLOS ONE			English	Article							HOMOMORPHIC SEX-CHROMOSOMES; GUNNISON SAGE-GROUSE; AVIAN GENOME; BLISTER RUST; EVOLUTION; SEQUENCE; REVEALS; DISCOVERY; DIVERGENCE; LANDSCAPES	As a greater number and diversity of high-quality vertebrate reference genomes become available, it is increasingly feasible to use these references to guide new draft assemblies for related species. Reference-guided assembly approaches may substantially increase the contiguity and completeness of a new genome using only low levels of genome coverage that might otherwise be insufficient for de novo genome assembly. We used low-coverage (similar to 3.5-5.5x) Illumina paired-end sequencing to assemble draft genomes of two bird species (the Gunnison Sage-Grouse, Centrocercus minimus, and the Clark's Nutcracker, Nucifraga columbiana). We used these data to estimate de novo genome assemblies and reference-guided assemblies, and compared the information content and completeness of these assemblies by comparing CEGMA gene set representation, repeat element content, simple sequence repeat content, and GC isochore structure among assemblies. Our results demonstrate that even lower-coverage genome sequencing projects are capable of producing informative and useful genomic resources, particularly through the use of reference-guided assemblies.	[Card, Daren C.; Schield, Drew R.; Reyes-Velasco, Jacobo; Fujita, Matthew K.; Andrew, Audra L.; Castoe, Todd A.] Univ Texas Arlington, Dept Biol, Arlington, TX 76019 USA; [Oyler-McCance, Sara J.; Fike, Jennifer A.] US Geol Survey, Ft Collins Sci Ctr, Ft Collins, CO USA; [Tomback, Diana F.] Univ Colorado, Dept Integrat Biol, Denver, CO 80202 USA; [Ruggiero, Robert P.] Univ Colorado, Dept Biochem & Mol Genet, Sch Med, Aurora, CO USA	University of Texas System; University of Texas Arlington; United States Department of the Interior; United States Geological Survey; University of Colorado System; University of Colorado Denver; University of Colorado System; University of Colorado Anschutz Medical Campus	Castoe, TA (corresponding author), Univ Texas Arlington, Dept Biol, Arlington, TX 76019 USA.	todd.castoe@uta.edu	Card, Daren/AAY-1777-2021	Card, Daren/0000-0002-1629-5726; Oyler-McCance, Sara/0000-0003-1599-8769	University of Texas at Arlington; CRISP Award; development funds (University of Colorado Denver); NATIONAL LIBRARY OF MEDICINE [T15LM009451] Funding Source: NIH RePORTER	University of Texas at Arlington; CRISP Award; development funds (University of Colorado Denver); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	Support was provided from startup funds from the University of Texas at Arlington to TAC (computational analysis) and from a CRISP Award and development funds (University of Colorado Denver) to DFT and SJOM (data generation). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alfoldi J, 2011, NATURE, V477, P587, DOI 10.1038/nature10390; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; ANSARI HA, 1988, CYTOGENET CELL GENET, V47, P185, DOI 10.1159/000132545; Barker FK, 2015, MITOCHONDR DNA, V26, P384, DOI 10.3109/19401736.2013.840588; Barringer LE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037663; Bouckaert R, 2013, PLOS COMPUTATIONAL B, V10; Card DC, 2014, DRYAD DIGITAL REPOSI, DOI [10.5061/dryad.qn1n2, DOI 10.5061/DRYAD.QN1N2]; Castoe TA, 2013, P NATL ACAD SCI USA, V110, P20645, DOI 10.1073/pnas.1314475110; Castoe TA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030953; Castoe TA, 2011, GENOME BIOL EVOL, V3, P641, DOI 10.1093/gbe/evr043; Dalloul RA, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000475; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Ellegren H, 2005, TRENDS ECOL EVOL, V20, P180, DOI 10.1016/j.tree.2005.01.015; Ellegren H, 2012, NATURE, V491, P756, DOI 10.1038/nature11584; Ericson PGP, 2005, J AVIAN BIOL, V36, P222, DOI 10.1111/j.0908-8857.2001.03409.x; Fujita MK, 2011, GENOME BIOL EVOL, V3, P974, DOI 10.1093/gbe/evr072; Gregory T. R., 2013, ANIMAL GENOME SIZE D; Gunnison Sage-Grouse Rangewide Steering Committee, 2004, GUNN SAG GROUS RANG; Hansmann T, 2009, CYTOGENET GENOME RES, V126, P281, DOI 10.1159/000251965; Hillier LW, 2004, NATURE, V432, P695, DOI 10.1038/nature03154; Huang YH, 2013, NAT GENET, V45, P776, DOI 10.1038/ng.2657; Jurka J, 2005, CYTOGENET GENOME RES, V110, P462, DOI 10.1159/000084979; Kan XZ, 2010, AFR J BIOTECHNOL, V9, P3073; Koren S, 2012, NAT BIOTECHNOL, V30, P692, DOI 10.1038/nbt.2280; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Lanfear R, 2012, MOL BIOL EVOL, V29, P1695, DOI 10.1093/molbev/mss020; Li RQ, 2010, NATURE, V463, P311, DOI 10.1038/nature08696; Mellmann A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022751; Nanda I, 2008, CYTOGENET GENOME RES, V122, P150, DOI 10.1159/000163092; Nishito Y, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-243; Ogawa A, 1998, P NATL ACAD SCI USA, V95, P4415, DOI 10.1073/pnas.95.8.4415; Oleksyk TK, 2012, GIGASCIENCE, V1, DOI 10.1186/2047-217X-1-14; Organ C.L., 2011, LIVING DINOSAURS EVO, P325; Oyler-McCance SJ, 2005, J WILDLIFE MANAGE, V69, P630, DOI 10.2193/0022-541X(2005)069[0630:PGOGSI]2.0.CO;2; Pagan HJT, 2012, GENOME BIOL EVOL, V4, P575, DOI 10.1093/gbe/evs038; Parchman TL, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-180; Parra G, 2007, BIOINFORMATICS, V23, P1061, DOI 10.1093/bioinformatics/btm071; Pereira SL, 2006, MOL BIOL EVOL, V23, P1731, DOI 10.1093/molbev/msl038; Phillips MJ, 2010, SYST BIOL, V59, P90, DOI 10.1093/sysbio/syp079; Pokorna M, 2012, CHROMOSOMA, V121, P409, DOI 10.1007/s00412-012-0371-z; Primmer CR, 1997, GENOME RES, V7, P471, DOI 10.1101/gr.7.5.471; Qu Y, 2013, NATURE COMMUNICATION, V4; Rands CM, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-95; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Schneeberger K, 2011, P NATL ACAD SCI USA, V108, P10249, DOI 10.1073/pnas.1107739108; Schoettle AW, 2007, J FOREST RES-JPN, V12, P327, DOI 10.1007/s10310-007-0024-x; Shaffer HB, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-3-r28; Shapiro MD, 2013, SCIENCE, V339, P1063, DOI 10.1126/science.1230422; Shedlock AM, 2007, P NATL ACAD SCI USA, V104, P2767, DOI 10.1073/pnas.0606204104; Shetty S, 2002, CYTOGENET GENOME RES, V99, P245, DOI 10.1159/000071600; Shetty S, 1999, CHROMOSOME RES, V7, P289, DOI 10.1023/A:1009278914829; Smit A. F. A., 2008, REPEATMASKER OPEN 3; St John JA, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-1-415; Stiver JR, 2008, BIOL CONSERV, V141, P472, DOI 10.1016/j.biocon.2007.10.018; Sun C, 2012, GENOME BIOL EVOL, V4, P168, DOI 10.1093/gbe/evr139; TAKAGI N, 1974, CHROMOSOMA, V46, P91, DOI 10.1007/BF00332341; Tomback D., 2001, WHITEBARK PINE COMMU, P3; Tomback DF, 2010, FOREST PATHOL, V40, P186, DOI 10.1111/j.1439-0329.2010.00655.x; TOMBACK DF, 1982, J ANIM ECOL, V51, P451, DOI 10.2307/3976; Vaidya G, 2011, CLADISTICS, V27, P171, DOI 10.1111/j.1096-0031.2010.00329.x; Vicoso B, 2013, P NATL ACAD SCI USA, V110, P6453, DOI 10.1073/pnas.1217027110; Warren WC, 2010, NATURE, V464, P757, DOI 10.1038/nature08819; Zhan XJ, 2013, NAT GENET, V45, P563, DOI 10.1038/ng.2588	63	21	21	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2014	9	9							e106649	10.1371/journal.pone.0106649	http://dx.doi.org/10.1371/journal.pone.0106649			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ1IR	25192061	Green Published, gold, Green Submitted			2022-12-27	WOS:000347993600051
J	George, BP; Schneider, EB; Venkatesan, A				George, Benjamin P.; Schneider, Eric B.; Venkatesan, Arun			Encephalitis Hospitalization Rates and Inpatient Mortality in the United States, 2000-2010	PLOS ONE			English	Article							HERPES-SIMPLEX ENCEPHALITIS; LENGTH-OF-STAY; NMDA-RECEPTOR ENCEPHALITIS; NILE-VIRUS-DISEASE; PROGNOSTIC-FACTORS; TRENDS; EPIDEMIOLOGY; ETIOLOGIES; MORBIDITY; BURDEN	Background: Encephalitis rates by etiology and acute-phase outcomes for encephalitis in the 21st century are largely unknown. We sought to evaluate cause-specific rates of encephalitis hospitalizations and predictors of inpatient mortality in the United States. Methods: Using the Nationwide Inpatient Sample (NIS) from 2000 to 2010, a retrospective observational study of 238,567 patients (mean [SD] age, 44.8 [24.0] years) hospitalized within non-federal, acute care hospitals in the U. S. with a diagnosis of encephalitis was conducted. Hospitalization rates were calculated using population-level estimates of disease from the NIS and population estimates from the United States Census Bureau. Adjusted odds of mortality were calculated for patients included in the study. Results: In the U.S. from 2000-2010, there were 7.3 +/- 0.2 encephalitis hospitalizations per 100,000 population (95% CI: 7.1-7.6). Encephalitis hospitalization rates were highest among females (7.660.2 per 100,000) and those <1 year and >65 years of age with rates of 13.5 +/- 0.9 and 14.1 +/- 0.4 per 100,000, respectively. Etiology was unknown for approximately 50% of cases. Among patients with identified etiology, viral causes were most common (48.2%), followed by Other Specified causes (32.5%), which included predominantly autoimmune conditions. The most common infectious agents were herpes simplex virus, toxoplasma, and West Nile virus. Comorbid HIV infection was present in 7.7% of hospitalizations. Average length of stay was 11.2 days with mortality of 5.6%. In regression analysis, patients with comorbid HIV/AIDS or cancer had increased odds of mortality (odds ratio [OR] = 1.70; 95% CI: 1.30-2.22 and OR = 2.26; 95% CI: 1.88-2.71, respectively). Enteroviral, postinfectious, toxic, and Other Specified causes were associated with lower odds vs. herpes simplex encephalitis. Conclusions: While encephalitis and encephalitis-related mortality impose a considerable burden in the U.S. in the 21st Century, the reported demographics of hospitalized encephalitis patients may be changing.	[George, Benjamin P.; Schneider, Eric B.] Ctr Surg Trials & Outcomes Res, Johns Hopkins Sch Med, Dept Surg, Baltimore, MD 21287 USA; [George, Benjamin P.] Univ Rochester, Sch Med & Dent, Rochester, NY USA; [Venkatesan, Arun] Johns Hopkins Encephalitis Ctr, Johns Hopkins Sch Med, Dept Neurol, Baltimore, MD USA	Johns Hopkins University; Johns Hopkins Medicine; University of Rochester; Johns Hopkins University; Johns Hopkins Medicine	Schneider, EB (corresponding author), Ctr Surg Trials & Outcomes Res, Johns Hopkins Sch Med, Dept Surg, Baltimore, MD 21287 USA.	eschnei1@jhmi.edu; avenkat2@jhmi.edu						[Anonymous], 2010, INTRO HCUP NAT INP S; Barbadoro P, 2012, EPIDEMIOL INFECT, V140, P753, DOI 10.1017/S0950268811001002; Bernard S, 2012, EPIDEMIOL INFECT, V141, P1; Branco RG, 2010, CURR TREAT OPTION NE, V12, P464, DOI 10.1007/s11940-010-0086-5; Bueno H, 2010, JAMA-J AM MED ASSOC, V303, P2141, DOI 10.1001/jama.2010.748; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Cohn AC, 2010, CLIN INFECT DIS, V50, P184, DOI 10.1086/649209; Dalmau J, 2008, LANCET NEUROL, V7, P327, DOI 10.1016/S1474-4422(08)70060-7; Dalmau J, 2011, LANCET NEUROL, V10, P63, DOI 10.1016/S1474-4422(10)70253-2; Dalmau J, 2008, LANCET NEUROL, V7, P1091, DOI 10.1016/S1474-4422(08)70224-2; Davison KL, 2003, EMERG INFECT DIS, V9, P234; De Cock KM, 2012, AIDS, V26, P1205, DOI 10.1097/QAD.0b013e328354622a; Emig M, 2004, CLIN INFECT DIS, V38, P289, DOI 10.1086/380458; Fuchs VR, 2012, NEW ENGL J MED, V366, P973, DOI 10.1056/NEJMp1200478; Gable MS, 2012, CLIN INFECT DIS, V54, P899, DOI 10.1093/cid/cir1038; Glaser CA, 2006, CLIN INFECT DIS, V43, P1565, DOI 10.1086/509330; Haut ER, 2012, JAMA-J AM MED ASSOC, V307, P2589, DOI 10.1001/jama.2012.6626; Howitz M, 2009, EPIDEMIOL INFECT, V137, P1631, DOI 10.1017/S0950268809002428; Huppatz C, 2009, EMERG INFECT DIS, V15, P1359, DOI 10.3201/eid1509.081540; Kalra AD, 2010, J GEN INTERN MED, V25, P930, DOI 10.1007/s11606-010-1370-5; Khetsuriani N, 2007, EPIDEMIOL INFECT, V135, P583, DOI 10.1017/S0950268806007163; Khetsuriani N, 2002, CLIN INFECT DIS, V35, P175, DOI 10.1086/341301; Kulkarni MA, 2013, EPIDEMIOL INFECT, V141, P2243, DOI 10.1017/S095026881200252X; Langford TD, 2003, BRAIN PATHOL, V13, P195; Lansky A, 2010, JAIDS-J ACQ IMM DEF, V55, pS64, DOI 10.1097/QAI.0b013e3181fbbe15; Lindsey Nicole P., 2010, Morbidity and Mortality Weekly Report, V59, P1; Mailles A, 2009, CLIN INFECT DIS, V49, P1838, DOI 10.1086/648419; McGrath N, 1997, J NEUROL NEUROSUR PS, V63, P321, DOI 10.1136/jnnp.63.3.321; Quan HD, 2005, MED CARE, V43, P1130, DOI 10.1097/01.mlr.0000182534.19832.83; Raschilas F, 2002, CLIN INFECT DIS, V35, P254, DOI 10.1086/341405; Rosenfeld Myrna R, 2012, Continuum (Minneap Minn), V18, P366, DOI 10.1212/01.CON.0000413664.42798.aa; Saczynski JS, 2010, AM J MED, V123, P1007, DOI 10.1016/j.amjmed.2010.05.018; Tan IL, 2012, NEUROLOGY, V79, P2125, DOI 10.1212/WNL.0b013e3182752ceb; Thakur KT, 2013, NEUROLOGY, V81, P793, DOI 10.1212/WNL.0b013e3182a2cc6d; Titulaer MJ, 2013, LANCET NEUROL, V12, P157, DOI 10.1016/S1474-4422(12)70310-1; Vincent A, 2004, BRAIN, V127, P701, DOI 10.1093/brain/awh077; Vora NM, 2014, NEUROLOGY, V82, P443, DOI 10.1212/WNL.0000000000000086; Washington A Eugene, 2011, N Engl J Med, V365, pe31, DOI 10.1056/NEJMp1109407; Whitley RJ, 2006, ANTIVIR RES, V71, P141, DOI 10.1016/j.antiviral.2006.04.002; Zuliani L, 2012, J NEUROL NEUROSUR PS, V83, P638, DOI 10.1136/jnnp-2011-301237	40	122	127	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2014	9	9							e104169	10.1371/journal.pone.0104169	http://dx.doi.org/10.1371/journal.pone.0104169			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ1IR	25192177	Green Published, Green Submitted, gold			2022-12-27	WOS:000347993600003
J	Jiang, YJ; Du, ZG; Yang, F; Di, Y; Li, J; Zhou, ZW; Pillarisetty, VG; Fu, DL				Jiang, Yongjian; Du, Zunguo; Yang, Feng; Di, Yang; Li, Ji; Zhou, Zhongwen; Pillarisetty, Venu G.; Fu, Deliang			FOXP3(+) Lymphocyte Density in Pancreatic Cancer Correlates with Lymph Node Metastasis	PLOS ONE			English	Article							REGULATORY T-CELLS; TUMOR MICROENVIRONMENT; PERIPHERAL-BLOOD; ADENOCARCINOMA; PROGRESSION; PREVALENCE; CARCINOMA; SURGERY; HEAD	Objective: To determine if the density of FOXP3(+) lymphocytes in primary tumors and lymph nodes in pancreatic cancer correlates with the presence of lymph node metastases. Methods: FOXP3(+) lymphocyte density in primary pancreatic cancer tissue and draining lymph nodes was measured using immunohistochemistry. We analyzed the clinical and pathological aspects associated with the accumulation of FOXP3(+) lymphocytes in pancreatic cancer. We also analyzed the correlation of density of FOXP3(+) lymphocytes in lymph nodes with the nodal status and distance from the primary tumor. Results: FOXP3(+) lymphocyte density in pancreatic cancer was significantly higher than in paratumoral pancreatic tissue. The density of FOXP3(+) lymphocytes in local tumor tissue correlated significantly with the histological grade and overall lymph node status. Furthermore, FOXP3(+) lymphocyte density was significantly higher in positive lymph nodes than in negative ones, while it had no correlation with the distance of the lymph node from the primary tumor. Conclusion: FOXP3(+) lymphocyte density in primary tumor tissue in patients with pancreatic cancer correlates with lymph node metastasis. Lymph nodes containing metastases having higher FOXP3(+) lymphocyte densities than do negative lymph nodes.	[Jiang, Yongjian; Yang, Feng; Di, Yang; Li, Ji; Fu, Deliang] Fudan Univ, Huashan Hosp, Dept Pancreat Surg, Shanghai 200433, Peoples R China; [Du, Zunguo; Zhou, Zhongwen] Fudan Univ, Huashan Hosp, Dept Pathol, Shanghai 200433, Peoples R China; [Pillarisetty, Venu G.] Univ Washington, Dept Surg, Seattle, WA 98195 USA	Fudan University; Fudan University; University of Washington; University of Washington Seattle	Fu, DL (corresponding author), Fudan Univ, Huashan Hosp, Dept Pancreat Surg, Shanghai 200433, Peoples R China.	surgeonfu@163.com	Pillarisetty, Venu/AAF-4425-2020	Pillarisetty, Venu/0000-0002-1162-9643	Shanghai Municipal Natural Science Foundation [11ZR1405500]; Shanghai Municipal Science and Technology Commission [13140902401]	Shanghai Municipal Natural Science Foundation; Shanghai Municipal Science and Technology Commission(Science & Technology Commission of Shanghai Municipality (STCSM))	This study was supported by grants from Shanghai Municipal Natural Science Foundation (11ZR1405500) and grants from Shanghai Municipal Science and Technology Commission (13140902401). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Azuma T, 2003, CANCER RES, V63, P4516; Chen ML, 2005, P NATL ACAD SCI USA, V102, P419, DOI 10.1073/pnas.0408197102; Deng LF, 2010, CLIN CANCER RES, V16, P4105, DOI 10.1158/1078-0432.CCR-10-1073; Feig C, 2012, CLIN CANCER RES, V18, P4266, DOI 10.1158/1078-0432.CCR-11-3114; Fujita T, 2010, PANCREAS, V39, pE48, DOI 10.1097/MPA.0b013e3181bd5cfa; Hiraoka N, 2006, CLIN CANCER RES, V12, P5423, DOI 10.1158/1078-0432.CCR-06-0369; Huang Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094376; Ikemoto T, 2006, PANCREAS, V33, P386, DOI 10.1097/01.mpa.0000240275.68279.13; Ino Y, 2013, BRIT J CANCER, V108, P914, DOI 10.1038/bjc.2013.32; Kondo S., 2010, PANCREATIC CANC, P1035; Liang BT, 2008, J IMMUNOL, V180, P5916, DOI 10.4049/jimmunol.180.9.5916; Liyanage UK, 2002, J IMMUNOL, V169, P2756, DOI 10.4049/jimmunol.169.5.2756; Massucco P, 2009, ANN SURG ONCOL, V16, P3323, DOI 10.1245/s10434-009-0672-5; Nentwich MF, 2012, ANTICANCER RES, V32, P1999; Obong AE, 2013, GASTROENTEROLOGY, V145, P1121; Sakai M, 2005, SURGERY, V137, P606, DOI 10.1016/j.surg.2005.02.009; Shibuya KC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096565; Swartz MA, 2012, NAT REV CANCER, V12, P210, DOI 10.1038/nrc3186; Tang YC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091551; Wachsmann MB, 2012, J INVEST MED, V60, P643, DOI 10.2310/JIM.0b013e31824a4d79; Yamada S, 2009, PANCREAS, V38, pE13, DOI 10.1097/MPA.0b013e3181889e2d; Yuan XL, 2010, CLIN IMMUNOL, V134, P277, DOI 10.1016/j.clim.2009.10.005	22	32	33	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2014	9	9							e106741	10.1371/journal.pone.0106741	http://dx.doi.org/10.1371/journal.pone.0106741			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ1IR	25191901	Green Submitted, gold, Green Published			2022-12-27	WOS:000347993600055
J	Zhang, YC; Qu, EZ; Ren, J; Zhang, Q; Zheng, RQ; Yang, Y; Chen, GH				Zhang, Ying-cai; Qu, En-ze; Ren, Jie; Zhang, Qi; Zheng, Rong-qin; Yang, Yang; Chen, Gui-hua			New Diagnosis and Therapy Model for Ischemic-Type Biliary Lesions following Liver Transplantation-A Retrospective Cohort Study	PLOS ONE			English	Article							CONTRAST-ENHANCED ULTRASOUND; MR CHOLANGIOGRAPHY; BILE-DUCTS; COMPLICATIONS; STRICTURES; EXPERIENCE; MANAGEMENT; RECIPIENTS; INJURY	Ischemic-type biliary lesions (ITBLs) are a major cause of graft loss and mortality after orthotopic liver transplantation (OLT). Impaired blood supply to the bile ducts may cause focal or extensive damage, resulting in intra-or extrahepatic bile duct strictures or dilatations that can be detected by ultrasonography, computed tomography, magnetic resonance cholangiopancreatography, and cholangiography. However, the radiographic changes occur at an advanced stage, after the optimal period for therapeutic intervention. Endoscopic retrograde cholangio-pancreatography (ERCP) and percutaneous transhepatic cholangiodrainage (PTCD) are the gold standard methods of detecting ITBLs, but these procedures cannot be used for continuous monitoring. Traditional methods of follow-up and diagnosis result in delayed diagnosis and treatment of ITBLs. Our center has used the early diagnosis and intervention model (EDIM) for the diagnosis and treatment of ITBLs since February 2008. This model mainly involves preventive medication to protect the epithelial cellular membrane of the bile ducts, regular testing of liver function, and weekly monitor of contrast-enhanced ultrasonography (CEUS) to detect ischemic changes to the bile ducts. If the liver enzyme levels become abnormal or CEUS shows low or no enhancement of the wall of the hilar bile duct during the arterial phase, early ERCP and PTCD are performed to confirm the diagnosis and to maintain biliary drainage. Compared with patients treated by the traditional model used prior to February 2008, patients in the EDIM group had a lower incidence of biliary tract infection (28.6% vs. 48.6%, P = 0.04), longer survival time of liver grafts (24 +/- 9.6 months vs. 17 +/- 12.3 months, P = 0.02), and better outcomes after treatment of ITBLs.	[Zhang, Ying-cai; Yang, Yang; Chen, Gui-hua] Sun Yat Sen Univ, Affiliated Hosp 3, Dept Liver Transplantat, Guangzhou 510275, Guangdong, Peoples R China; [Qu, En-ze; Ren, Jie; Zheng, Rong-qin] Sun Yat Sen Univ, Affiliated Hosp 3, Dept Med Ultrason, Guangzhou 510275, Guangdong, Peoples R China; [Zhang, Qi] Guangdong Prov Key Lab Liver Dis, Guangzhou, Guangdong, Peoples R China	Sun Yat Sen University; Sun Yat Sen University	Yang, Y (corresponding author), Sun Yat Sen Univ, Affiliated Hosp 3, Dept Liver Transplantat, Guangzhou 510275, Guangdong, Peoples R China.	yysysu@163.com; chgh1955@263.net	yang, yang/GVT-5210-2022; yang, yang/HGT-7999-2022; Lang, Ming/HIK-0758-2022	Zhang, Qi/0000-0001-9916-8919	National Natural Science Foundation of China [81170451, 81300365, 81370575]; Sci-tech Research Development Program of Guangdong Province [2010B050700003, 2011B031800103]; Guangdong Natural Science Foundation [9251008901000020]; Sci-tech Research Development Program of Guangzhou [2011Y1-00033]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Sci-tech Research Development Program of Guangdong Province; Guangdong Natural Science Foundation(National Natural Science Foundation of Guangdong Province); Sci-tech Research Development Program of Guangzhou	This work was supported by grants from National Natural Science Foundation of China (81170451, 81300365, 81370575), Sci-tech Research Development Program of Guangdong Province (2010B050700003, 2011B031800103, http://pro.gdstc.gov.cn), Guangdong Natural Science Foundation (9251008901000020), and Sci-tech Research Development Program of Guangzhou (2011Y1-00033, http://www.gzsi.gov.cn). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ben Qian Y, 2004, ARCH SURG-CHICAGO, V139, P1101, DOI 10.1001/archsurg.139.10.1101; Boraschi P, 2004, TRANSPLANT P, V36, P2744, DOI 10.1016/j.transproceed.2004.09.038; Boraschi P, 2004, ABDOM IMAGING, V29, P189, DOI 10.1007/s00261-003-0109-8; Boraschi P, 2001, MAGN RESON IMAGING, V19, P1097, DOI 10.1016/S0730-725X(01)00443-X; Buis CI, 2006, J HEPATO-BILIARY-PAN, V13, P517, DOI 10.1007/s00534-005-1080-2; CAMPBELL WL, 1994, RADIOLOGY, V191, P735, DOI 10.1148/radiology.191.3.8184054; DOPPMAN JL, 1978, RADIOLOGY, V128, P577, DOI 10.1148/128.3.577; Feller RB, 1996, J GASTROEN HEPATOL, V11, P21, DOI 10.1111/j.1440-1746.1996.tb00005.x; Geuken E, 2004, J HEPATOL, V41, P1017, DOI 10.1016/j.jhep.2004.08.023; Guichelaar MMJ, 2003, AM J TRANSPLANT, V3, P885, DOI 10.1034/j.1600-6143.2003.00165.x; Herold C, 2001, ABDOM IMAGING, V26, P597, DOI 10.1007/s00261-001-0064-1; Hertl M, 2000, LIVER TRANSPLANT, V6, P207, DOI 10.1002/lt.500060201; Hoekstra H, 2006, HEPATOLOGY, V43, P1022, DOI 10.1002/hep.21169; Isozaki T, 2003, RADIOLOGY, V229, P798, DOI 10.1148/radiol.2293020858; Kok T, 1996, J CLIN ULTRASOUND, V24, P103, DOI 10.1002/(SICI)1097-0096(199603)24:3<103::AID-JCU1>3.0.CO;2-L; Leen E, 1996, CLIN RADIOL, V51, P35; OTTO G, 1995, ZBL CHIR, V120, P450; Park JY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042754; Ren J, 2013, ULTRASOUND MED BIOL, V39, P753, DOI 10.1016/j.ultrasmedbio.2012.12.004; Ren J, 2009, LIVER TRANSPLANT, V15, P1703, DOI 10.1002/lt.21910; Rizk RS, 1998, GASTROINTEST ENDOSC, V47, P128, DOI 10.1016/S0016-5107(98)70344-X; SANCHEZURDAZPAL L, 1992, HEPATOLOGY, V16, P49, DOI 10.1002/hep.1840160110; SANCHEZURDAZPAL L, 1993, HEPATOLOGY, V17, P605, DOI 10.1002/hep.1840170413; Sawyer RG, 1998, TRANSPLANTATION, V66, P1201, DOI 10.1097/00007890-199811150-00015; Schlosser T, 2003, ULTRASOUND MED BIOL, V29, P985, DOI 10.1016/S0301-5629(03)00890-1; SHERMAN S, 1991, PANCREAS, V6, P350, DOI 10.1097/00006676-199105000-00013; Sidhu PS, 2004, EUR RADIOL, V14, P21, DOI 10.1007/s00330-003-1981-x; Takasaki S, 2001, J HEPATOL, V34, P455, DOI 10.1016/S0168-8278(00)00058-1; Turrion VS, 1999, TRANSPLANT P, V31, P2392, DOI 10.1016/S0041-1345(99)00396-6; WARD EM, 1990, RADIOLOGY, V177, P259, DOI 10.1148/radiology.177.1.2399328; Ward J, 2004, RADIOLOGY, V231, P101, DOI 10.1148/radiol.2311030017; WORTHY SA, 1994, J CLIN ULTRASOUND, V22, P461, DOI 10.1002/jcu.1870220711	32	5	7	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2014	9	9							e105795	10.1371/journal.pone.0105795	http://dx.doi.org/10.1371/journal.pone.0105795			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ1IR	25192214	Green Published, gold, Green Submitted			2022-12-27	WOS:000347993600010
J	Bozza, WP; Di, X; Takeda, K; Rosado, LAR; Pariser, S; Zhang, BL				Bozza, William P.; Di, Xu; Takeda, Kazuyo; Rosado, Leslie A. Rivera; Pariser, Sarah; Zhang, Baolin			The Use of a Stably Expressed FRET Biosensor for Determining the Potency of Cancer Drugs	PLOS ONE			English	Article							INDUCED APOPTOSIS; CASPASE ACTIVATION; LIVING CELLS; ASSAY; PATHWAYS; DYNAMICS; SCREEN; LINES	Many cancer drugs are intended to kill cancer cells by inducing apoptosis. However, the potency assays used for measuring the bioactivity of these products are generally cell viability assays which do not distinguish between cell death and growth inhibition. Here we describe a cell-based fluorescence resonance energy transfer (FRET) biosensor designed to measure the bioactivity of apoptosis inducing cancer drugs. The biosensor contains cyan fluorescent protein (CFP) linked via caspase 3 and caspase 8 specific cleavage recognition sequences to yellow fluorescent protein (YFP). Upon caspase activation, as in the case of apoptosis induction, the linker is cleaved abolishing the cellular FRET signal. This assay closely reflects the mechanism of action of cancer drugs, in killing cancer cells and therefore can function as a potency test for different cancer drugs. We rigorously demonstrate this through characterization of a class of proteins targeting the death receptors. The one-step assay appears to be superior to other apoptosis-based assays because of its simplicity, convenience, and robustness.	[Bozza, William P.; Di, Xu; Rosado, Leslie A. Rivera; Pariser, Sarah; Zhang, Baolin] US FDA, Div Therapeut Prot, Off Biotechnol Prod, Ctr Drug Evaluat & Res, Silver Spring, MD 20903 USA; [Takeda, Kazuyo] US FDA, Microscopy & Imaging Core Facil, Ctr Biol Evaluat & Res, Silver Spring, MD USA; [Pariser, Sarah] Brown Univ, Providence, RI 02912 USA	US Food & Drug Administration (FDA); US Food & Drug Administration (FDA); Brown University	Zhang, BL (corresponding author), US FDA, Div Therapeut Prot, Off Biotechnol Prod, Ctr Drug Evaluat & Res, Silver Spring, MD 20903 USA.	Baolin.zhang@fda.hhs.gov			Food and Drug Administration, Center for Drug Evaluation and Research, Critical Path Initiative fund; Food and Drug Administration, Center for Drug Evaluation and Research, Medical Countermeasure Initiative fund	Food and Drug Administration, Center for Drug Evaluation and Research, Critical Path Initiative fund; Food and Drug Administration, Center for Drug Evaluation and Research, Medical Countermeasure Initiative fund	This work was supported by the Food and Drug Administration, Center for Drug Evaluation and Research, Critical Path Initiative fund; and the Food and Drug Administration, Center for Drug Evaluation and Research, Medical Countermeasure Initiative fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdulghani J, 2010, EXPERT OPIN THER TAR, V14, P1091, DOI 10.1517/14728222.2010.519701; ALLEY MC, 1988, CANCER RES, V48, P589; Brunelle JK, 2010, DRUG RESIST UPDATE, V13, P172, DOI 10.1016/j.drup.2010.09.001; Clegg R.M., 1996, FLUORESCENCE IMAGING, V137, P179; Demchenko A. P., 2012, Experimental Oncology, V34, P263; Gordon GW, 1998, BIOPHYS J, V74, P2702, DOI 10.1016/S0006-3495(98)77976-7; Hagg M, 2002, INVEST NEW DRUG, V20, P253, DOI 10.1023/A:1016249728664; He LS, 2004, AM J PATHOL, V164, P1901, DOI 10.1016/S0002-9440(10)63751-0; Johnstone RW, 2008, NAT REV CANCER, V8, P782, DOI 10.1038/nrc2465; Jones J, 2000, J BIOMOL SCREEN, V5, P307, DOI 10.1177/108705710000500502; Kaufmann S H, 2001, Curr Protoc Cell Biol, VChapter 18, DOI 10.1002/0471143030.cb1802s11; Kawai H, 2005, J PHARMACOL SCI, V97, P361, DOI 10.1254/jphs.FP0040592; Kroemer G, 2009, CELL DEATH DIFFER, V16, P3, DOI 10.1038/cdd.2008.150; Krysko DV, 2008, METHODS, V44, P205, DOI 10.1016/j.ymeth.2007.12.001; Li YB, 2013, ONCOL LETT, V6, P156, DOI 10.3892/ol.2013.1352; Luo KQ, 2003, BIOCHEM BIOPH RES CO, V304, P217, DOI 10.1016/S0006-291X(03)00559-X; Luo KQ, 2001, BIOCHEM BIOPH RES CO, V283, P1054, DOI 10.1006/bbrc.2001.4896; Masters A, 2014, PLATELETS, V25, P175, DOI 10.3109/09537104.2013.801947; Muppidi Jagan, 2004, Curr Protoc Immunol, VChapter 3, DOI 10.1002/0471142735.im0317s59; Nieves-Neira W, 1999, INT J CANCER, V82, P396, DOI 10.1002/(SICI)1097-0215(19990730)82:3<396::AID-IJC13>3.0.CO;2-Z; Prasuhn DE, 2010, ACS NANO, V4, P5487, DOI 10.1021/nn1016132; Shoemaker RH, 2006, NAT REV CANCER, V6, P813, DOI 10.1038/nrc1951; Smith GST, 2012, JOVE-J VIS EXP, DOI 10.3791/3422; Stepczynska A, 2001, ONCOGENE, V20, P1193, DOI 10.1038/sj.onc.1204221; van RJ, 2004, BIOPHYS J, V86, P2517, DOI [10.1016/S0006-3495(04)74307-6, DOI 10.1016/S0006-3495(04)74307-6]; Walczak H, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a008698; Waldman SA, 2002, ANN ALLERG ASTHMA IM, V89, P7, DOI 10.1016/S1081-1206(10)61904-7; Wang ZQ, 2005, BIOORG MED CHEM LETT, V15, P2335, DOI 10.1016/j.bmcl.2005.02.081; Wu XL, 2006, CYTOM PART A, V69A, P477, DOI 10.1002/cyto.a.20300; Xia ZP, 2001, BIOPHYS J, V81, P2395, DOI 10.1016/S0006-3495(01)75886-9; Zhang BL, 2005, CANCER RES, V65, P6054, DOI 10.1158/0008-5472.CAN-05-0175; Zhang YQ, 2009, J BIOL CHEM, V284, P12956, DOI 10.1074/jbc.M807845200; Zhang YQ, 2008, MOL CANCER RES, V6, P1861, DOI 10.1158/1541-7786.MCR-08-0313; Zhou LL, 2011, CANCER BIOL THER, V12, P335, DOI 10.4161/cbt.12.4.17174; Zhu XM, 2012, BIOCHEM BIOPH RES CO, V418, P641, DOI 10.1016/j.bbrc.2012.01.066	35	9	9	2	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 4	2014	9	9							e107010	10.1371/journal.pone.0107010	http://dx.doi.org/10.1371/journal.pone.0107010			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3XV	25188024	Green Submitted, Green Published, gold			2022-12-27	WOS:000341271500107
J	Cousijn, J; Zanolie, K; Munsters, RJM; Kleibeuker, SW; Crone, EA				Cousijn, Janna; Zanolie, Kiki; Munsters, Robbert J. M.; Kleibeuker, Sietske W.; Crone, Eveline A.			The Relation between Resting State Connectivity and Creativity in Adolescents before and after Training	PLOS ONE			English	Article							INDEPENDENT COMPONENT ANALYSIS; DIVERGENT THINKING; WORKING-MEMORY; BRAIN ACTIVITY; FUNCTIONAL CONNECTIVITY; EXECUTIVE FUNCTION; FMRI; PATTERNS; CHILDREN; ROBUST	An important component of creativity is divergent thinking, which involves the ability to generate novel and useful problem solutions. In this study, we tested the relation between resting-state functional connectivity of brain areas activated during a divergent thinking task (i.e., supramarginal gyrus, middle temporal gyrus, medial frontal gyrus) and the effect of practice in 32 adolescents aged 15-16. Over a period of two weeks, an experimental group (n = 16) conducted an 8-session Alternative Uses Task (AUT) training and an active control group (n = 16) conducted an 8-session rule switching training. Resting-state functional connectivity was measured before (pre-test) and after (post-test) training. Across groups at pre-test, stronger connectivity between the middle temporal gyrus and bilateral postcentral gyrus was associated with better divergent thinking performance. The AUT-training, however, did not significantly change functional connectivity. Post hoc analyses showed that change in divergent thinking performance over time was predicted by connectivity between left supramarginal gyrus and right occipital cortex. These results provide evidence for a relation between divergent thinking and resting-state functional connectivity in a task-positive network, taking an important step towards understanding creative cognition and functional brain connectivity.	[Cousijn, Janna; Zanolie, Kiki; Munsters, Robbert J. M.; Kleibeuker, Sietske W.; Crone, Eveline A.] Leiden Univ, Dept Physiol, Brain & Dev Lab, Leiden, Netherlands; [Zanolie, Kiki; Kleibeuker, Sietske W.; Crone, Eveline A.] Leiden Inst Brain & Cognit, Leiden, Netherlands; [Cousijn, Janna] Univ Utrecht, Dept Dev & Expt Psychol, Utrecht, Netherlands	Leiden University; Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Utrecht University	Cousijn, J (corresponding author), Leiden Univ, Dept Physiol, Brain & Dev Lab, Leiden, Netherlands.	j.cousijn@gmail.com		Cousijn, Janna/0000-0002-7699-2582; Zanolie, Kiki/0000-0001-6101-1000; Crone, Eveline/0000-0002-7508-6078	NWO [400-08-023]	NWO(Netherlands Organization for Scientific Research (NWO))	This study was supported by a grant from NWO (open competition program; grant nr. 400-08-023) awarded to E. A. Crone. NWO has no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ACHENBACH TM, 1991, MONOGR SOC RES CHILD, V56, pR5; Arden R, 2010, BEHAV BRAIN RES, V214, P143, DOI 10.1016/j.bbr.2010.05.015; Beckmann CF, 2004, IEEE T MED IMAGING, V23, P137, DOI 10.1109/TMI.2003.822821; Beckmann CF, 2005, PHILOS T R SOC B, V360, P1001, DOI 10.1098/rstb.2005.1634; Blakemore SJ, 2014, ANNU REV PSYCHOL, V65, P187, DOI 10.1146/annurev-psych-010213-115202; Carlsson I, 2000, NEUROPSYCHOLOGIA, V38, P873, DOI 10.1016/S0028-3932(99)00128-1; Chavez-Eakle RA, 2007, NEUROIMAGE, V38, P519, DOI 10.1016/j.neuroimage.2007.07.059; Cohen JR, 2010, NAT NEUROSCI, V13, P669, DOI 10.1038/nn.2558; Damoiseaux JS, 2006, P NATL ACAD SCI USA, V103, P13848, DOI 10.1073/pnas.0601417103; De Dreu CKW, 2008, J PERS SOC PSYCHOL, V95, P648, DOI 10.1037/0022-3514.95.3.648; Dietrich A, 2010, PSYCHOL BULL, V136, P822, DOI 10.1037/a0019749; Filippini N, 2009, P NATL ACAD SCI USA, V106, P7209, DOI 10.1073/pnas.0811879106; Fink A, 2006, EUR J NEUROSCI, V23, P2241, DOI 10.1111/j.1460-9568.2006.04751.x; Fink A, 2014, NEUROSCI BIOBEHAV R, V44, P111, DOI 10.1016/j.neubiorev.2012.12.002; Fink A, 2010, NEUROIMAGE, V52, P1687, DOI 10.1016/j.neuroimage.2010.05.072; Fink A, 2009, HUM BRAIN MAPP, V30, P734, DOI 10.1002/hbm.20538; Folley BS, 2005, SCHIZOPHR RES, V80, P271, DOI 10.1016/j.schres.2005.06.016; Fox MD, 2007, NAT REV NEUROSCI, V8, P700, DOI 10.1038/nrn2201; Friedman RS, 2001, J PERS SOC PSYCHOL, V81, P1001, DOI 10.1037/0022-3514.81.6.1001; Gibson C, 2009, BRAIN COGNITION, V69, P162, DOI 10.1016/j.bandc.2008.07.009; Guilford J.P., 1967, NATURE HUMAN INTELLI; Huizinga M, 2006, NEUROPSYCHOLOGIA, V44, P2017, DOI 10.1016/j.neuropsychologia.2006.01.010; Huizinga M, 2011, CHILD NEUROPSYCHOL, V17, P51, DOI 10.1080/09297049.2010.509715; Hyvarinen A, 1999, IEEE T NEURAL NETWOR, V10, P626, DOI 10.1109/72.761722; Jenkinson M, 2002, NEUROIMAGE, V17, P825, DOI 10.1006/nimg.2002.1132; Jolles DD, 2013, HUM BRAIN MAPP, V34, P396, DOI 10.1002/hbm.21444; Karbach J, 2009, DEVELOPMENTAL SCI, V12, P978, DOI 10.1111/j.1467-7687.2009.00846.x; Kelly AMC, 2009, CEREB CORTEX, V19, P640, DOI 10.1093/cercor/bhn117; Kim KH, 2008, J CREATIVE BEHAV, V42, P106, DOI 10.1002/j.2162-6057.2008.tb01290.x; Kleibeuker SW, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00905; Klingberg T, 2010, TRENDS COGN SCI, V14, P317, DOI 10.1016/j.tics.2010.05.002; Koyama MS, 2011, J NEUROSCI, V31, P8617, DOI 10.1523/JNEUROSCI.4865-10.2011; Luna B, 2001, NEUROIMAGE, V13, P786, DOI 10.1006/nimg.2000.0743; Luna B, 2010, BRAIN COGNITION, V72, P101, DOI 10.1016/j.bandc.2009.08.005; Mackey AP, 2013, J NEUROSCI, V33, P4796, DOI 10.1523/JNEUROSCI.4141-12.2013; Mcnab F, 2008, NEUROPSYCHOLOGIA, V46, P2668, DOI 10.1016/j.neuropsychologia.2008.04.023; Owen AM, 2010, NATURE, V465, P775, DOI 10.1038/nature09042; Qin YL, 2004, P NATL ACAD SCI USA, V101, P5686, DOI 10.1073/pnas.0401227101; Sawyer, 2004, ED RES, V33, P12, DOI DOI 10.3102/0013189X033002012; Scott G, 2004, CREATIVITY RES J, V16, P361, DOI 10.1207/s15326934crj1604_1; Shattuck DW, 2008, NEUROIMAGE, V39, P1064, DOI 10.1016/j.neuroimage.2007.09.031; Singer J.D., 2003, APPL LONGITUDINAL DA, DOI 10.1093/acprof:oso/9780195152968.001.0001; Smith SM, 2002, HUM BRAIN MAPP, V17, P143, DOI 10.1002/hbm.10062; Smith SM, 2009, NEUROIMAGE, V44, P83, DOI 10.1016/j.neuroimage.2008.03.061; Somerville LH, 2010, CURR OPIN NEUROBIOL, V20, P236, DOI 10.1016/j.conb.2010.01.006; Takeuchi H, 2012, CEREB CORTEX, V22, P2921, DOI 10.1093/cercor/bhr371; Thorell LB, 2009, DEVELOPMENTAL SCI, V12, P106, DOI 10.1111/j.1467-7687.2008.00745.x; Van Dam A. G., 2006, CAT CREATIEVE AANLEG; van den Heuvel MP, 2010, EUR NEUROPSYCHOPHARM, V20, P519, DOI 10.1016/j.euroneuro.2010.03.008; Van Wesel F, 2006, CREATIEVE AANLEG TES; Vartanian O, 2013, NEUROSCIENCE, V236, P186, DOI 10.1016/j.neuroscience.2012.12.060; Wechsler D., 2004, WISC 4 WECHSLER INTE, DOI 10.1037/t15174-000; Woolrich MW, 2001, NEUROIMAGE, V14, P1370, DOI 10.1006/nimg.2001.0931; Worsley K.J., 2001, FUNCTIONAL MRI AN IN, P251, DOI [10.1093/acprof:oso/ 9780192630711.003.0014, DOI 10.1093/ACPROF:OSO/9780192630711.003.0014]	54	26	28	1	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 4	2014	9	9							e105780	10.1371/journal.pone.0105780	http://dx.doi.org/10.1371/journal.pone.0105780			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AO3XV	25188416	Green Published, gold			2022-12-27	WOS:000341271500013
J	Mahan, ED; Zaveri, T; Ziegler, GR; Hayes, JE				Mahan, Ellen D.; Zaveri, Toral; Ziegler, Gregory R.; Hayes, John E.			Relationships between Perceptual Attributes and Rheology in Over-the-Counter Vaginal Products: A Potential Tool for Microbicide Development	PLOS ONE			English	Article							SENSORY PROPERTIES; WOMEN; ACCEPTABILITY; TEXTURE; GEL; EXPERIENCES; PACKAGE; HIV	Vaginal microbicides are believed to have substantial potential to empower women to protect themselves from HIV, although clinical trials to date have had mixed results at best. Issues with patient adherence in these trials suggest additional emphasis should be placed on optimizing acceptability. Acceptability is driven, in part, by the sensory properties of the microbicide, so better understanding of the relationships between sensory properties and the physical and rheological properties of microbicides should facilitate the simultaneous optimization of sensory properties in parallel with the biophysical properties required for drug deployment. Recently, we have applied standard methods to assess the potential acceptability of microbicide prototypes ex vivo and to quantify the sensory properties of microbicide surrogates. Here, we link quantitative perceptual data to the rheological properties of 6 over-the counter (OTC) vaginal products used as ex vivo microbicide surrogates. Shear-thinning behavior (n) and tan delta (10 rad/ s) showed no relationship with any perceptual attributes while shear storage modulus, G' (10 rad/ s) was correlated with some attributes, but did not appear to be a strong predictor of sensory properties. Conversely, the storage loss modulus, G '' (10 rad/ s) and the consistency coefficient, K, were correlated with several sensory attributes: stickiness, rubberiness, and uniform thickness for G '' and stickiness, rubberiness, and peaking for K. Although these relationships merit confirmation in later studies, this pilot study suggests rheological principles can be used to understand the sensory properties evoked by microbicide surrogates assessed ex vivo. Additional work is needed to determine if these findings would apply for microbicides in vivo.	[Mahan, Ellen D.; Zaveri, Toral; Hayes, John E.] Penn State Univ, Coll Agr Sci, Sensory Evaluat Ctr, University Pk, PA 16802 USA; [Mahan, Ellen D.; Zaveri, Toral; Ziegler, Gregory R.; Hayes, John E.] Penn State Univ, Coll Agr Sci, Dept Food Sci, University Pk, PA 16802 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Hayes, JE (corresponding author), Penn State Univ, Coll Agr Sci, Sensory Evaluat Ctr, University Pk, PA 16802 USA.	jeh40@psu.edu	Hayes, John E/A-5893-2008	Hayes, John E/0000-0001-9065-6326; Ziegler, Gregory/0000-0002-3881-649X	Pennsylvania State University; National Institute of Allergy and Infectious Diseases [R33AI094514]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R33AI094514] Funding Source: NIH RePORTER	Pennsylvania State University; National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by seed funds from the Pennsylvania State University and a grant from the National Institute of Allergy and Infectious Diseases [R33AI094514] to JEH and GRZ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrews GP, 2009, BIOMACROMOLECULES, V10, P2427, DOI 10.1021/bm9003332; [Anonymous], 1980, VISCOELASTIC PROPERT; AVAC, 2012, ONG PLANN CLIN TRIAL; Basu S, 2010, J FOOD ENG, V100, P357, DOI 10.1016/j.jfoodeng.2010.04.022; Bentley ME, 2004, AM J PUBLIC HEALTH, V94, P1159, DOI 10.2105/AJPH.94.7.1159; Bourne MC, 2002, CORRELATION PHYS MEA, P293; Brighenti M, 2008, J DAIRY SCI, V91, P4501, DOI 10.3168/jds.2008-1322; Buckheit RW, 2010, ANTIVIR RES, V85, P142, DOI 10.1016/j.antiviral.2009.10.013; Civille GV, 1991, COSMET TOILETRIES, V106; CUSSLER EL, 1977, PERCEPT PSYCHOPHYS, V21, P504, DOI 10.3758/BF03198730; das Neves Jose, 2009, Current Drug Delivery, V6, P83; DEMARTINE ML, 1975, J PHARM SCI, V64, P976, DOI 10.1002/jps.2600640618; Giguere R, 2012, CULT HEALTH SEX, V14, P151, DOI 10.1080/13691058.2011.630099; Hess SJ, 1997, J DAIRY SCI, V80, P252, DOI 10.3168/jds.S0022-0302(97)75933-2; Hoffman S, 2010, ARCH SEX BEHAV, V39, P748, DOI 10.1007/s10508-009-9509-3; Karim QA, 2010, SCIENCE, V329, P1168, DOI 10.1126/science.1193748; Lawless H. T., 2010, SENSORY EVALUATION F; Le S, 2008, J SENS STUD, V23, P14, DOI 10.1111/j.1745-459X.2007.00137.x; Le S, 2008, J STAT SOFTW, V25, P1, DOI 10.18637/jss.v025.i01; Lee IS, 2005, J SENS STUD, V20, P421, DOI 10.1111/j.1745-459X.2005.00037.x; Li BD, 2013, ANTIVIR RES, V97, P280, DOI 10.1016/j.antiviral.2012.12.024; Li BD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054975; Mahan ED, 2011, CONTRACEPTION, V84, P184, DOI 10.1016/j.contraception.2010.11.012; Mezger T., 2006, RHEOLOGY HDB USERS R; Morrow K, 2003, J WOMENS HEALTH, V12, P655, DOI 10.1089/154099903322404302; Morrow KM, 2014, ARCH SEX BEHAV, V43, P1459, DOI 10.1007/s10508-013-0235-5; Morrow KM, 2014, AIDS RES HUM RETROV, V30, P78, DOI [10.1089/aid.2013.0099, 10.1089/AID.2013.0099]; Morrow KM, 2010, ANTIVIR RES, V88, pS40, DOI 10.1016/j.antiviral.2010.09.008; Murray JM, 2001, FOOD RES INT, V34, P461, DOI 10.1016/S0963-9969(01)00070-9; Owen DH, 2000, CONTRACEPTION, V62, P321, DOI 10.1016/S0010-7824(00)00184-0; Pages J., 2004, REV COLOMB ESTAD, V27, P1; Parente ME, 2005, J COSMET SCI, V56, P175; Stone A, 2002, NAT REV DRUG DISCOV, V1, P977, DOI 10.1038/nrd959; Szczesniak AS, 2002, FOOD QUAL PREFER, V13, P215, DOI 10.1016/S0950-3293(01)00039-8; SZCZESNIAK AS, 1963, J FOOD SCI, V28, P385, DOI 10.1111/j.1365-2621.1963.tb00219.x; SZCZESNIAK AS, 1987, J TEXTURE STUD, V18, P1, DOI 10.1111/j.1745-4603.1987.tb00566.x; Tabilo-Munizaga G, 2005, J FOOD ENG, V67, P147, DOI 10.1016/j.jfoodeng.2004.05.062; Tasoglu S, 2013, PHYS FLUIDS, V25, DOI 10.1063/1.4793598; van den Berg JJ, 2014, AIDS BEHAV, V18, P862, DOI 10.1007/s10461-013-0652-4; van der Straten A, 2012, AIDS, V26, pF13, DOI 10.1097/QAD.0b013e3283522272; Verguet S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015501; Zaveri T, 2014, PHARMA IN PRESS; Zubowicz EA, 2006, J WOMENS HEALTH, V15, P952, DOI 10.1089/jwh.2006.15.952	43	8	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 4	2014	9	9							e105614	10.1371/journal.pone.0105614	http://dx.doi.org/10.1371/journal.pone.0105614			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3XV	25188244	Green Submitted, Green Published, gold			2022-12-27	WOS:000341271500010
J	Wang, H; Ji, RR; Meng, J; Cui, QQ; Zou, WX; Li, L; Wang, GL; Sun, L; Li, ZH; Huo, L; Fan, YX; Penny, DJ				Wang, Hu; Ji, Ruirui; Meng, Jie; Cui, Qiqiong; Zou, Wenxin; Li, Lei; Wang, Guoliang; Sun, Li; Li, Zhaohui; Huo, Lei; Fan, Yuxin; Penny, Daniel J.			Functional Changes in Pulmonary Arterial Endothelial Cells Associated with BMPR2 Mutations	PLOS ONE			English	Article							BONE MORPHOGENETIC PROTEIN; GERMLINE MUTATIONS; BETA-RECEPTOR; HYPERTENSION; GENE; SUFFICIENT; EXPRESSION; MECHANISM; MEDIATOR; LOCUS	Pulmonary arterial hypertension (PAH) is a devastating disease characterized by abnormal remodeling of small, peripheral pulmonary arteries. Germline mutations in the bone morphogenetic protein receptor type 2 (BMPR2) gene are a major risk factor for developing PAH. At present, the correlation between the BMPR2 mutation and the patient's prognosis remains controversial despite several investigations. In this study, we explored the functional effects of four BMPR2 mutations to dissect the functional significance of the BMPR2 gene defect. Cellular immunofluorescence assay of four mutants (Tyr67Cys, Thr268fs, Ser863Asn, and Gln433X) revealed that the BMPR2 protein containing Thr268fs, Ser863Asn, or Gln433X exhibited abnormal subcellular localization. The BrdU incorporation and TUNEL assay suggested that any of the BMPR2 mutations Thr268fs, Ser863Asn, or Gln433X could improve endothelial cell apoptosis and decrease cell proliferation. All of the four mutants could inhibit nitric oxide (NO) synthesis in HLMVE cells, and ET-1 levels increased in the cells transfected with mutant Ser863Asn. Our results will improve the understanding of the genotype-phenotype correlations and mechanisms associated with BMPR2 mutations.	[Wang, Hu; Ji, Ruirui; Meng, Jie; Zou, Wenxin; Li, Lei; Wang, Guoliang; Li, Zhaohui; Fan, Yuxin; Penny, Daniel J.] Texas Childrens Hosp, Baylor Coll Med, Dept Pediat, Cardiol Sect, Houston, TX 77030 USA; [Cui, Qiqiong] Texas Childrens Hosp, Baylor Coll Med, Cardiovasc Clin Res Core, Houston, TX 77030 USA; [Sun, Li; Huo, Lei] Univ Texas MD Anderson Canc Ctr, Dept Pathol, Houston, TX 77030 USA	Baylor College of Medicine; Baylor College of Medicine; University of Texas System; UTMD Anderson Cancer Center	Fan, YX (corresponding author), Texas Childrens Hosp, Baylor Coll Med, Dept Pediat, Cardiol Sect, Houston, TX 77030 USA.	yuxinf@bcm.edu			Abby Glaser Children's Heart Fund; National Natural Science Foundation of China [81170093]	Abby Glaser Children's Heart Fund; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by Abby Glaser Children's Heart Fund and National Natural Science Foundation of China (81170093). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atkinson C, 2002, CIRCULATION, V105, P1672, DOI 10.1161/01.CIR.0000012754.72951.3D; Austin ED, 2009, RESP RES, V10, DOI 10.1186/1465-9921-10-87; Cogan JD, 2006, AM J RESP CRIT CARE, V174, P590, DOI 10.1164/rccm.200602-165OC; De Caestecker M, 2001, RESPIR RES, V2, P193; Deng ZM, 2000, AM J HUM GENET, V67, P737, DOI 10.1086/303059; Dias-Junior Carlos Alan, 2008, J. bras. pneumol., V34, P412, DOI 10.1590/S1806-37132008000600012; Elliott CG, 2006, CIRCULATION, V113, P2509, DOI 10.1161/CIRCULATIONAHA.105.601930; Finkenzeller G, 2012, MICROVASC RES, V84, P81, DOI 10.1016/j.mvr.2012.03.010; Gaine SP, 1998, LANCET, V352, P719, DOI 10.1016/S0140-6736(98)02111-4; Gangopahyay A, 2011, J BIOL CHEM, V286, P33134, DOI 10.1074/jbc.M111.274100; Girerd B, 2010, RESP RES, V11, DOI 10.1186/1465-9921-11-73; Harrison RE, 2005, CIRCULATION, V111, P435, DOI 10.1161/01.CIR.0000153798.78540.87; Hong KH, 2008, CIRCULATION, V118, P722, DOI 10.1161/CIRCULATIONAHA.107.736801; Humbert M, 2004, J AM COLL CARDIOL, V43, p13S, DOI 10.1016/j.jacc.2004.02.029; Humbert M, 2004, NEW ENGL J MED, V351, P1425, DOI 10.1056/NEJMra040291; Kawabata M, 1998, CYTOKINE GROWTH F R, V9, P49, DOI 10.1016/S1359-6101(97)00036-1; Khajavi M, 2006, EUR J HUM GENET, V14, P1074, DOI 10.1038/sj.ejhg.5201649; Lane KB, 2000, NAT GENET, V26, P81, DOI 10.1038/79226; Langleben D, 2007, CLIN CHEST MED, V28, P117, DOI 10.1016/j.ccm.2006.11.002; Leung JWC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026994; Li HY, 2013, CELL PHYSIOL BIOCHEM, V32, P1354, DOI 10.1159/000356574; Machado RD, 2005, CIRCULATION, V111, P607, DOI 10.1161/01.CIR.0000154543.07679.08; Machado RD, 2001, AM J HUM GENET, V68, P92, DOI 10.1086/316947; McLaughlin VV, 2006, CIRCULATION, V114, P1417, DOI 10.1161/CIRCULATIONAHA.104.503540; McLaughlin VV, 2004, CHEST, V126, p78S, DOI 10.1378/chest.126.1_suppl.78S; Miyazono K, 2000, CYTOKINE GROWTH F R, V11, P15, DOI 10.1016/S1359-6101(99)00025-8; Morrell NW, 2009, J AM COLL CARDIOL, V54, pS20, DOI 10.1016/j.jacc.2009.04.018; Morse JH, 1997, CIRCULATION, V95, P2603, DOI 10.1161/01.CIR.95.12.2603; Neu-Yilik G, 2008, ADV GENET, V62, P185, DOI 10.1016/S0065-2660(08)00604-4; Nichols WC, 1997, NAT GENET, V15, P277, DOI 10.1038/ng0397-277; Rosenzweig EB, 2008, J HEART LUNG TRANSPL, V27, P668, DOI 10.1016/j.healun.2008.02.009; Song YL, 2005, CIRCULATION, V112, P553, DOI 10.1161/CIRCULATIONAHA.104.492488; Star GP, 2013, MICROVASC RES, V85, P46, DOI 10.1016/j.mvr.2012.10.012; Star GP, 2010, MICROVASC RES, V80, P349, DOI 10.1016/j.mvr.2010.05.010; STEWART DJ, 1991, ANN INTERN MED, V114, P464, DOI 10.7326/0003-4819-114-6-464; Sztrymf B, 2008, AM J RESP CRIT CARE, V177, P1377, DOI 10.1164/rccm.200712-1807OC; Takahashi K, 2007, PEDIATR RES, V61, P392, DOI 10.1203/pdr.0b013e3180332cba; Teichert-Kuliszewska K, 2006, CIRC RES, V98, P209, DOI 10.1161/01.RES.0000200180.01710.e6; Thomson JR, 2000, J MED GENET, V37, P741, DOI 10.1136/jmg.37.10.741; Tuder RM, 2009, J AM COLL CARDIOL, V54, pS3, DOI 10.1016/j.jacc.2009.04.009; Valdimarsdottir G, 2002, CIRCULATION, V106, P2263, DOI 10.1161/01.CIR.0000033830.36431.46; West J, 2008, AM J PHYSIOL-LUNG C, V295, pL744, DOI 10.1152/ajplung.90255.2008	42	7	10	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 4	2014	9	9							e106703	10.1371/journal.pone.0106703	http://dx.doi.org/10.1371/journal.pone.0106703			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3XV	25187962	Green Published, Green Submitted, gold			2022-12-27	WOS:000341271500071
J	Zhu, PL; Huang, F; Lin, F; Li, QW; Yuan, Y; Gao, ZH; Chen, FL				Zhu, Pengli; Huang, Feng; Lin, Fan; Li, Qiaowei; Yuan, Yin; Gao, Zhonghai; Chen, Falin			The Relationship of Retinal Vessel Diameters and Fractal Dimensions with Blood Pressure and Cardiovascular Risk Factors	PLOS ONE			English	Article							CORONARY-HEART-DISEASE; VASCULAR CALIBER; MICROVASCULAR ABNORMALITIES; DIABETIC-RETINOPATHY; URIC-ACID; ATHEROSCLEROSIS RISK; ARTERIOLAR DIAMETER; METABOLIC SYNDROME; VENULAR CALIBER; OLDER PERSONS	Background: This study aimed to investigate the correlation between quantitative retinal vascular parameters such as central retinal arteriolar equivalent (CRAE) and retinal vascular fractal dimension (D(f)), and cardiovascular risk factors in the Chinese Han population residing in the in islands of southeast China. Methodology/Principle Findings: In this cross-sectional study, fundus photographs were collected and semi-automated analysis software was used to analyze retinal vessel diameters and fractal dimensions. Cardiovascular risk factors such as relevant medical history, blood pressure (BP), lipids, and blood glucose data were collected. Subjects had a mean age of 51.9 +/- 12.0 years and included 812 (37.4%) males and 1,357 (62.6%) females. Of the subjects, 726 (33.5%) were overweight, 226 (10.4%) were obese, 272 (12.5%) had diabetes, 738 (34.0%) had hypertension, and 1,156 (53.3%) had metabolic syndrome. After controlling for the effects of potential confounders, multivariate analyses found that age (beta = 0.06, P = 0.008), sex (beta = 1.33, P = 0.015), mean arterial blood pressure (beta = -0.12, P<0.001), high-sensitivity C-reactive protein (beta = -0.22, P = 0.008), and CRVE (beta = 0.23, P<0.001) were significantly associated with CRAE. Age (beta = -0.0012, P<0.001), BP classification (prehypertension: beta = -0.0075, P = 0.014; hypertension: beta = -0.0131, P = 0.002), and hypertension history (beta = -0.0007, P = 0.009) were significantly associated with D(f). Conclusions/Significance: D(f) exhibits a stronger association with BP than CRAE. Thus, D(f) may become a useful indicator of cardiovascular risk.	[Zhu, Pengli; Huang, Feng; Lin, Fan; Li, Qiaowei; Yuan, Yin] Fujian Med Univ, Fujian Prov Inst Clin Geriatr, Fujian Prov Hosp, Dept Geriatr Med, Fuzhou, Peoples R China; [Gao, Zhonghai] Fujian Prov Hosp, Dept Ophthalmol, Fuzhou, Peoples R China; [Chen, Falin] Fujian Prov Hosp, Clin Lab Ctr, Fuzhou, Peoples R China	Fujian Medical University; Fujian Provincial Hospital; Fujian Provincial Hospital; Fujian Provincial Hospital	Zhu, PL (corresponding author), Fujian Med Univ, Fujian Prov Inst Clin Geriatr, Fujian Prov Hosp, Dept Geriatr Med, Fuzhou, Peoples R China.	zpl7755@gmail.com		Lin, Fan/0000-0002-9435-5181; Zhu, Pengli/0000-0001-9922-5717	Fujian Major Program of Basic Science Project Foundation entitled "Epidemiologic survey of hypertension and prehypertension intervention research in HaiDao County of Fujian Province'' [2010Y0013]; The Predictive Value of Retinal Quantitative Parameters and Cardiovascular Risk Factors Relativity on Subclinical Arteriosclerosis: a Prospective Study [2013Y0023]	Fujian Major Program of Basic Science Project Foundation entitled "Epidemiologic survey of hypertension and prehypertension intervention research in HaiDao County of Fujian Province''; The Predictive Value of Retinal Quantitative Parameters and Cardiovascular Risk Factors Relativity on Subclinical Arteriosclerosis: a Prospective Study	This study was supported by the Fujian Major Program of Basic Science Project Foundation entitled "Epidemiologic survey of hypertension and prehypertension intervention research in HaiDao County of Fujian Province'' [2010Y0013] and The Predictive Value of Retinal Quantitative Parameters and Cardiovascular Risk Factors Relativity on Subclinical Arteriosclerosis: a Prospective Study [2013Y0023]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberti KGMM, 2005, LANCET, V366, P1059, DOI 10.1016/S0140-6736(05)67402-8; Avery CL, 2012, ATHEROSCLEROSIS, V225, P412, DOI 10.1016/j.atherosclerosis.2012.10.034; Azemin MZC, 2012, NEUROBIOL AGING, V33, DOI 10.1016/j.neurobiolaging.2010.04.010; Basevi V, 2011, DIABETES CARE, V34, P1887, DOI 10.2337/dc11-s011; Cheung CY, 2012, AM J OPHTHALMOL, V154, P663, DOI 10.1016/j.ajo.2012.04.016; Cheung CY, 2011, J HYPERTENS, V29, P1380, DOI 10.1097/HJH.0b013e328347266c; Cheung CYL, 2012, HYPERTENSION, V60, P1094, DOI 10.1161/HYPERTENSIONAHA.111.189142; Cheung Carol Yim-lui, 2012, J Diabetes Sci Technol, V6, P595; Cheung CYL, 2011, OPHTHALMOLOGY, V118, P812, DOI 10.1016/j.ophtha.2010.08.045; Cheung N, 2009, DIABETES CARE, V32, P106, DOI 10.2337/dc08-1233; Cheung N, 2010, ANN NEUROL, V68, P107, DOI 10.1002/ana.22011; Chobanian AV., 2003, HYPERTENSION, V42, P1206, DOI [10.1161/01.HYP.0000107251, DOI 10.1161/01.HYP.9.2_PT_2.II36, DOI 10.1161/01.HYP.0000107251.49515.C2]; Coutinho TD, 2007, J HUM HYPERTENS, V21, P610, DOI 10.1038/sj.jhh.1002193; Crosby-Nwaobi R, 2012, OPHTHALMOLOGICA, V228, P84, DOI 10.1159/000337252; DAXER A, 1993, GRAEF ARCH CLIN EXP, V231, P681, DOI 10.1007/BF00919281; Erdogan D, 2006, CORONARY ARTERY DIS, V17, P7, DOI 10.1097/00019501-200602000-00002; Feig DI, 2008, NEW ENGL J MED, V359, P1811, DOI 10.1056/NEJMra0800885; FODOR JG, 1973, CAN MED ASSOC J, V108, P1365; Gepstein R, 2012, BLOOD PRESSURE, V21, P191, DOI 10.3109/08037051.2012.645336; Gullu H, 2007, EUR J HEART FAIL, V9, P466, DOI 10.1016/j.ejheart.2006.10.019; Huang Feng, 2013, Zhonghua Xin Xue Guan Bing Za Zhi, V41, P876; Ikram MK, 2006, NEUROLOGY, V66, P1339, DOI 10.1212/01.wnl.0000210533.24338.ea; Ikram MK, 2004, INVEST OPHTH VIS SCI, V45, P2129, DOI 10.1167/iovs.03-1390; Kawasaki R, 2011, NEUROLOGY, V76, P1766, DOI 10.1212/WNL.0b013e31821a7d7d; Kawasaki R, 2006, OPHTHALMOLOGY, V113, P1378, DOI 10.1016/j.ophtha.2006.02.052; Kirkutis A, 2004, P W PHARMACOL SOC, P71; Knudtson MD, 2003, CURR EYE RES, V27, P143, DOI 10.1076/ceyr.27.3.143.16049; Leung H, 2004, J HYPERTENS, V22, P1543, DOI 10.1097/01.hjh.0000125455.28861.3f; Liew G, 2008, OPHTHALMOLOGY, V115, P1951, DOI 10.1016/j.ophtha.2008.05.029; Liew G, 2008, ARCH OPHTHALMOL-CHIC, V126, P1404, DOI 10.1001/archopht.126.10.1404; Liew G, 2011, EUR HEART J, V32, P422, DOI 10.1093/eurheartj/ehq431; Lim SW, 2009, DIABETES CARE, V32, P2081, DOI 10.2337/dc09-0719; Lopes R, 2009, MED IMAGE ANAL, V13, P634, DOI 10.1016/j.media.2009.05.003; Roger VL, 2012, CIRCULATION, V125, pE2, DOI 10.1161/CIR.0b013e31823ac046; Roy MS, 2012, ARCH OPHTHALMOL-CHIC, V130, P561, DOI 10.1001/archophthalmol.2011.2725; Smith W, 2004, HYPERTENSION, V44, P442, DOI 10.1161/01.HYP.0000140772.40322.ec; Sng CCA, 2010, NEPHROL DIAL TRANSPL, V25, P2252, DOI 10.1093/ndt/gfq007; Sun C, 2008, INVEST OPHTH VIS SCI, V49, P1784, DOI 10.1167/iovs.07-1450; Talu S., 2013, HVM Bioflux, V5, P52; Torres FS, 2013, ATHEROSCLEROSIS, V229, P134, DOI 10.1016/j.atherosclerosis.2013.04.019; Tsai ASH, 2011, DIABETES RES CLIN PR, V94, P291, DOI 10.1016/j.diabres.2011.07.032; Wang JJ, 2007, EUR HEART J, V28, P1984, DOI 10.1093/eurheartj/ehm221; Wang SA, 2007, CLIN EXP OPHTHALMOL, V35, P800, DOI 10.1111/j.1442-9071.2007.01627.x; Wong TY, 2006, ARCH INTERN MED, V166, P2388, DOI 10.1001/archinte.166.21.2388; Wong TY, 2006, INVEST OPHTH VIS SCI, V47, P2341, DOI 10.1167/iovs.05-1539; Wong TY, 2004, BMJ-BRIT MED J, V329, P79, DOI 10.1136/bmj.38124.682523.55; Wong TY, 2004, ANN INTERN MED, V140, P248, DOI 10.7326/0003-4819-140-4-200402170-00006; Wong TY, 2003, OPHTHALMOLOGY, V110, P933, DOI 10.1016/S0161-6420(03)00084-8; Wong TY, 2003, OPHTHALMOLOGY, V110, P658, DOI 10.1016/S0161-6420(02)01931-0; Wong TY, 2002, JAMA-J AM MED ASSOC, V287, P1153, DOI 10.1001/jama.287.9.1153; Wong TY, 2001, LANCET, V358, P1134, DOI 10.1016/S0140-6736(01)06253-5; Yuan Y, 2012, INTERN MED J, V42, P1014, DOI 10.1111/j.1445-5994.2011.02470.x; Yuan YZ, 2011, BIOMED ENVIRON SCI, V24, P146, DOI 10.3967/0895-3988.2011.02.009	53	30	30	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 4	2014	9	9							e106551	10.1371/journal.pone.0106551	http://dx.doi.org/10.1371/journal.pone.0106551			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3XV	25188273	Green Submitted, gold, Green Published			2022-12-27	WOS:000341271500052
J	Morin, C; Aubin, A				Morin, Chantal; Aubin, Andree			Primary Reasons for Osteopathic Consultation: A Prospective Survey in Quebec	PLOS ONE			English	Article							PROFILE; POPULATION; PREVALENCE; MEDICINE; IMPACT; PAIN	Background: Osteopathy is an increasingly popular health care modality to address pain and function in the musculoskeletal system, organs and the head region, as well as functional somatic syndromes. Although osteopathy is recommended principally in guidelines for management of back pain, osteopaths' scope of practice is wide, albeit poorly defined. In order to understand better the practice of osteopathy, this study aimed to investigate the most common reasons for osteopathic consultations in clinical settings in Quebec. Methods: A prospective survey of members of the Registre des osteopathes du Quebec was conducted to examine demographics in osteopathic practices, as well as patients' primary reasons for consultations over a two-week period. The questionnaire was devised following a literature review and refined and verified with two stages of expert input. Results: 277 osteopaths (60.1% response rate) responded to the survey notice. 14,002 patients' primary reasons for consultations were reported in completed questionnaires and returned by practicing osteopaths. Musculoskeletal pain located in the spine, thorax, pelvis and limbs was the most common reason for consultations (61.9%), with females consulting most commonly for cervical pain and males for lumbar pain. Perinatal and paediatric (11.8%), head (9.1%), visceral (5.0%) and general concerns (4.8%) were the other most common reasons for consultations. Preventive care represented the remaining 0.3%. Interpretation: The nature of primary reasons for osteopathic consultations, coupled with documented satisfaction of patients with this approach, suggest a future for multidisciplinary collaborative health care including osteopathy. Results of this survey may contribute to informing physicians and others pending regulation of Quebec osteopaths, and also provide direction for future clinical research and guidelines development.	[Morin, Chantal; Aubin, Andree] Ctr Osteopath Quebec, Montreal, PQ, Canada; [Morin, Chantal] Univ Sherbrooke, Fac Med & Hlth Sci, Sch Rehabil, Sherbrooke, PQ J1K 2R1, Canada	University of Sherbrooke	Morin, C (corresponding author), Ctr Osteopath Quebec, Montreal, PQ, Canada.	Chantal.Morin@USherbrooke.ca			Osteopathie Quebec; Fonds de recherche en sante du Quebec; Faculty of Medicine and Health Sciences of the Universitede Sherbrooke	Osteopathie Quebec; Fonds de recherche en sante du Quebec(Fonds de la Recherche en Sante du Quebec); Faculty of Medicine and Health Sciences of the Universitede Sherbrooke	This study received funding from the Registre des osteopathes du Quebec (now Osteopathie Quebec); the first author received PhD scholarships from the Fonds de recherche en sante du Quebec and the Faculty of Medicine and Health Sciences of the Universitede Sherbrooke; and Osteopathie Quebec provided a grant to authors for publication. The funders had no role in the study concept and design, data collection and analysis, decision to publish, or preparation of the manuscript for submission.	Airaksinen O, 2006, EUR SPINE J, V15, pS192, DOI 10.1007/s00586-006-1072-1; Beaudet N, 2013, BMC MUSCULOSKEL DIS, V14, DOI 10.1186/1471-2474-14-151; Burke SR, 2013, BMC MUSCULOSKEL DIS, V14, DOI 10.1186/1471-2474-14-227; Cheshire A, 2011, BMC FAMILY PRACTICE, P1; Chou R, 2007, ANN INTERN MED, V147, P478, DOI 10.7326/0003-4819-147-7-200710020-00006; Cooke LJ, 2010, CAN J NEUROL SCI, V37, P580, DOI 10.1017/S0317167100010738; Dubois T, 2012, OSTEOPATHY FRANCE DE; Esmail N, 2007, COMPLEMENTARY ALTERN, P53; Fanuele JC, 2000, SPINE, V25, P1509, DOI 10.1097/00007632-200006150-00009; Fawkes C, 2010, STANDARDISED DATA CO, P1; Fawkes CA, 2014, MANUAL THER, V19, P125, DOI 10.1016/j.math.2013.09.001; Fawkes CA, 2014, MANUAL THER, V19, P119, DOI 10.1016/j.math.2013.08.006; Fiore F, 2013, MED QUEBEC, V48, P14; Foster NE, 2012, ARTHRITIS RES THER, V14, DOI 10.1186/ar3743; Gurden Mark, 2012, Prim Health Care Res Dev, V13, P204, DOI 10.1017/S1463423611000648; Health Do, 2006, MUSC SERV FRAM JOINT; Hogg-Johnson S, 2008, SPINE, V33, pS39, DOI 10.1097/BRS.0b013e31816454c8; Jean D, 2007, PEDIATRICS, V120, pE138, DOI 10.1542/peds.2006-3105; Lund G, 2010, J AM OSTEOPATH ASSOC, V110, P376; McIlwraith B, 2003, J OSTEOPATH MED, V6, P7; Meana M, 2004, BMC WOMENS HEALTH, V4, P1, DOI DOI 10.1186/1472-6874-4-S1-S17; Metcalfe A, 2010, BMC COMPLEM ALTERN M, V10, DOI 10.1186/1472-6882-10-58; O'Connor D, 2009, ETUDE PERSPECTIVES O; OBRIEN B, 1994, INT J EPIDEMIOL, V23, P1020, DOI 10.1093/ije/23.5.1020; OIA, 2014, OST OST MED GLOB VIE; OIA, 2012, HIST CURR CONT OST P; Orrock PJ, 2009, INT J OSTEOPATH MED, V12, P128, DOI 10.1016/j.ijosm.2009.06.001; Pelissier-Simard L, 2008, MED QUEBEC, V43, P23; Savigny P., 2009, LOND NATL COLLAB CEN; Strutt R, 2008, MANUAL THER, V13, P456, DOI 10.1016/j.math.2007.05.013; van Tulder M, 2006, EUR SPINE J, V15, pS169, DOI 10.1007/s00586-006-1071-2; WHO, 2010, BENCHM TRAIN TRAD CO; Williams N, 2008, BMC FAM PRACT, V9, DOI 10.1186/1471-2296-9-30	33	34	34	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 3	2014	9	9							e106259	10.1371/journal.pone.0106259	http://dx.doi.org/10.1371/journal.pone.0106259			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3TB	25184204	gold, Green Published, Green Submitted			2022-12-27	WOS:000341257700046
J	Nieradka, A; Ufer, C; Thiadens, K; Grech, G; Horos, R; van Coevorden-Hameete, M; van den Akker, E; Sofi, S; Kuhn, H; von Lindern, M				Nieradka, Andrzej; Ufer, Christoph; Thiadens, Klaske; Grech, Godfrey; Horos, Rastislav; van Coevorden-Hameete, Marleen; van den Akker, Emile; Sofi, Sajad; Kuhn, Hartmut; von Lindern, Marieke			Grsf1-Induced Translation of the SNARE Protein Use1 Is Required for Expansion of the Erythroid Compartment	PLOS ONE			English	Article							STEM-CELL FACTOR; MESSENGER-RNA TRANSLATION; 5' UNTRANSLATED REGION; C-KIT; GLUCOCORTICOID-RECEPTOR; SECONDARY STRUCTURE; MOLECULAR ANALYSIS; IDENTIFICATION; PROGENITORS; EXPRESSION	Induction of cell proliferation requires a concomitant increase in the synthesis of glycosylated lipids and membrane proteins, which is dependent on ER-Golgi protein transport by CopII-coated vesicles. In this process, retrograde transport of ER resident proteins from the Golgi is crucial to maintain ER integrity, and allows for anterograde transport to continue. We previously showed that expression of the CopI specific SNARE protein Use1 (Unusual SNARE in the ER 1) is tightly regulated by eIF4E-dependent translation initiation of Use1 mRNA. Here we investigate the mechanism that controls Use1 mRNA translation. The 5'UTR of mouse Use1 contains a 156 nt alternatively spliced intron. The non-spliced form is the predominantly translated mRNA. The alternatively spliced sequence contains G-repeats that bind the RNA-binding protein G-rich sequence binding factor 1 (Grsf1) in RNA band shift assays. The presence of these G-repeats rendered translation of reporter constructs dependent on the Grsf1 concentration. Down regulation of either Grsf1 or Use1 abrogated expansion of erythroblasts. The 5'UTR of human Use1 lacks the splice donor site, but contains an additional upstream open reading frame in close proximity of the translation start site. Similar to mouse Use1, also the human 5'UTR contains G-repeats in front of the start codon. In conclusion, Grsf1 controls translation of the SNARE protein Use1, possibly by positioning the 40S ribosomal subunit and associated translation factors in front of the translation start site.	[Nieradka, Andrzej; Horos, Rastislav; van Coevorden-Hameete, Marleen; von Lindern, Marieke] Erasmus MC, Dept Hematol, Rotterdam, Netherlands; [Ufer, Christoph; Sofi, Sajad; Kuhn, Hartmut] Univ Med Berlin Charite, Inst Biochem, Berlin, Germany; [Thiadens, Klaske; van den Akker, Emile; von Lindern, Marieke] Sanquin Res, Dept Hematopoiesis, Amsterdam, Netherlands; [Thiadens, Klaske; van den Akker, Emile; von Lindern, Marieke] Landsteiner Lab AMC UvA, Amsterdam, Netherlands; [Grech, Godfrey] Univ Malta, Sch Med, Dept Pathol, Msida, Malta	Erasmus University Rotterdam; Erasmus MC; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; University of Malta	von Lindern, M (corresponding author), Erasmus MC, Dept Hematol, Rotterdam, Netherlands.	m.vonlindern@sanquin.nl	Grech, Godfrey/AAD-1303-2020; Grech, Godfrey/A-4684-2013; von Lindern, Marieke/AAH-2350-2020	Grech, Godfrey/0000-0003-4502-8237; Grech, Godfrey/0000-0003-4502-8237; Sofi, Sajad/0000-0001-8354-1694; Horos, Rastislav/0000-0001-7730-9557	Marie Curie Research Training Network Eurythron Grant [005499]; Deutsche Forschungsgemeinschaft [IRTG1673]	Marie Curie Research Training Network Eurythron Grant; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by grants from the Marie Curie Research Training Network Eurythron Grant 005499 to M. v. L., A.N. and R. H., and by the Deutsche Forschungsgemeinschaft to H. K. and C. U. (IRTG1673). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwala P, 2013, BIOCHEMISTRY-US, V52, P1528, DOI 10.1021/bi301365g; Antonicka H, 2013, CELL METAB, V17, P386, DOI 10.1016/j.cmet.2013.02.006; Bakker WJ, 2004, J CELL BIOL, V164, P175, DOI 10.1083/jcb.200307056; Bauer A, 1999, GENE DEV, V13, P2996, DOI 10.1101/gad.13.22.2996; Beaudoin JD, 2014, NUCLEIC ACIDS RES, V42, P1209, DOI 10.1093/nar/gkt904; Beaudoin JD, 2010, NUCLEIC ACIDS RES, V38, P7022, DOI 10.1093/nar/gkq557; Beghini A, 2000, BLOOD, V95, P726, DOI 10.1182/blood.V95.2.726; Belgareh-Touze N, 2003, TRAFFIC, V4, P607, DOI 10.1034/j.1600-0854.2003.00116.x; Bi XP, 2002, NATURE, V419, P271, DOI 10.1038/nature01040; Blazquez-Domingo M, 2005, MOL CELL BIOL, V25, P8496, DOI 10.1128/MCB.25.19.8496-8506.2005; Bonifacino JS, 2004, CELL, V116, P153, DOI 10.1016/S0092-8674(03)01079-1; Broudy VC, 1996, BLOOD, V88, P75; BROXMEYER HE, 1991, BLOOD, V77, P2142; Bugaut A, 2012, NUCLEIC ACIDS RES, V40, P4727, DOI 10.1093/nar/gks068; Buratti E, 2004, MOL CELL BIOL, V24, P10505, DOI 10.1128/MCB.24.24.10505-10514.2004; Burri L, 2003, P NATL ACAD SCI USA, V100, P9873, DOI 10.1073/pnas.1734000100; Cassetti MC, 2001, VIROLOGY, V289, P180, DOI 10.1006/viro.2001.1149; Castillon GA, 2009, TRAFFIC, V10, P186, DOI 10.1111/j.1600-0854.2008.00857.x; Del Prete MJ, 2007, RNA, V13, P414, DOI 10.1261/rna.79407; Dilcher M, 2003, EMBO J, V22, P3664, DOI 10.1093/emboj/cdg339; Dolznig H, 2001, FASEB J, V15, P1442, DOI 10.1096/fj.00-0705fje; Graff JR, 2003, CLIN EXP METASTAS, V20, P265, DOI 10.1023/A:1022943419011; Grech G, 2008, BLOOD, V112, P2750, DOI 10.1182/blood-2008-01-133140; Iolascon A, 2009, HAEMATOLOGICA; Jefferies HBJ, 1997, EMBO J, V16, P3693, DOI 10.1093/emboj/16.12.3693; Jiao XF, 2002, BIOL REPROD, V66, P475, DOI 10.1095/biolreprod66.2.475; Joosten M, 2004, J BIOL CHEM, V279, P38169, DOI 10.1074/jbc.M401283200; Jourdain AA, 2013, CELL METAB, V17, P399, DOI 10.1016/j.cmet.2013.02.005; Kash JC, 2002, J VIROL, V76, P10417, DOI 10.1128/JVI.76.20.10417-10426.2002; Kim TW, 2004, CLIN CANCER RES, V10, P3076, DOI 10.1158/1078-0432.CCR-03-0581; Kolbus A, 2003, BLOOD, V102, P3136, DOI 10.1182/blood-2003-03-0923; KOROMILAS AE, 1992, EMBO J, V11, P4153, DOI 10.1002/j.1460-2075.1992.tb05508.x; Lee MCS, 2004, ANNU REV CELL DEV BI, V20, P87, DOI 10.1146/annurev.cellbio.20.010403.105307; Li Y, 2004, J BIOCHEM BIOPH METH, V60, P85, DOI 10.1016/j.jbbm.2004.03.008; Li Y, 2013, FRAGILE X PROTEINS S; Lickert H, 2005, DEVELOPMENT, V132, P2599, DOI 10.1242/dev.01842; Looijenga LHJ, 2003, CANCER RES, V63, P7674; Matsuda A, 2003, ONCOGENE, V22, P3307, DOI 10.1038/sj.onc.1206406; Mikulits W, 1997, DNA CELL BIOL, V16, P849, DOI 10.1089/dna.1997.16.849; Moffat J, 2006, CELL, V124, P1283, DOI 10.1016/j.cell.2006.01.040; Okumura AJ, 2006, J BIOL CHEM, V281, P4495, DOI 10.1074/jbc.M509715200; Park YW, 1999, P NATL ACAD SCI USA, V96, P6694, DOI 10.1073/pnas.96.12.6694; Perez Castro C, 2007, J CELL SCI, V120, P2454, DOI 10.1242/jcs.004200; Rahim G, 2012, MOL CELL BIOL, V32, P1745, DOI 10.1128/MCB.06751-11; Resch AM, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-162; Ryder Sean P., 2008, V488, P99, DOI 10.1007/978-1-60327-475-3_7; Sampath P, 2008, CELL STEM CELL, V2, P448, DOI 10.1016/j.stem.2008.03.013; Satchwell TJ, 2013, HAEMATOLOGICA, V98, P1788, DOI 10.3324/haematol.2013.085522; Thoreen CC, 2012, NATURE, V485, P109, DOI 10.1038/nature11083; Uemura T, 2009, MOL CELL BIOL, V29, P1869, DOI 10.1128/MCB.01089-08; Ufer C, 2008, GENE DEV, V22, P1838, DOI 10.1101/gad.466308; Ufer C, 2012, CURR PROTEIN PEPT SC, V13, P347, DOI 10.2174/138920312801619457; van Dijk TB, 2000, BLOOD, V96, P3406; Verrier SE, 2008, EUR J CELL BIOL, V87, P863, DOI 10.1016/j.ejcb.2008.07.003; von Lindern M, 2001, ONCOGENE, V20, P3651, DOI 10.1038/sj.onc.1204494; Weng HY, 2012, RNA BIOL, V9, P1099, DOI 10.4161/rna.21210; Zheng R, 2004, LEUKEMIA RES, V28, P121, DOI 10.1016/S0145-2126(03)00184-X; Zhong XY, 2009, MOL CELL, V35, P1, DOI 10.1016/j.molcel.2009.06.016	58	15	16	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 3	2014	9	9							e104631	10.1371/journal.pone.0104631	http://dx.doi.org/10.1371/journal.pone.0104631			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3TB	25184340	Green Submitted, Green Published, gold			2022-12-27	WOS:000341257700013
J	Normanton, M; Alvarenga, H; Hamerschlak, N; Ribeiro, A; Kondo, A; Rizzo, LV; Marti, LC				Normanton, Marilia; Alvarenga, Heliene; Hamerschlak, Nelson; Ribeiro, Andreza; Kondo, Andrea; Rizzo, Luiz Vicente; Marti, Luciana Cavalheiro			Interleukin 7 Plays a Role in T Lymphocyte Apoptosis Inhibition Driven by Mesenchymal Stem Cell without Favoring Proliferation and Cytokines Secretion	PLOS ONE			English	Article							MARROW STROMAL CELLS; MECHANISMS; SUPPRESSION; RESPONSES; SURVIVAL; PROMOTE; NAIVE; IL-7	Since 2004, when a case report describing the use of human mesenchymal stem cells (hMSCs) infusion as a therapy for GVHD after bone marrow transplantation, a new perspective in MSC function emerged. Since then hMSCs immunomodulatory potential became the target of several studies. Although great progress has been made in our understanding of hMSCs, their effect on T cell remains obscure. Our study has confirmed the already described effect of hMSCs on lymphocytes proliferation and survival. We also show that the impairment of lymphocyte proliferation and apoptosis is contact-independent and occurs in a prostaglandin-independent manner. A potential correlation between IL-7 and hMSCs effect is suggested, as we observed an increase in IL-7 receptors (CD127) on lymphocyte membrane in MSC presence. Additionally, blocking IL-7 in hMSCs-lymphocytes co-cultures increased lymphocytes apoptosis and we also have demonstrated that hMSCs are able to produce this interleukin. Moreover, we found that during Th1/Th17 differentiation in vitro, hMSCs presence leads to Th1/Th17 cells with reduced capacity of INF-y and IL-17 secretion respectively, regardless of having several pro-inflammatory cytokines in culture. We did not confirm an increment of Treg in these cultures, but a reduced percentage of INF-y/IL-17 secreting cells was observed, suggesting that the ratio between anti and pro-inflammatory cells changed. This changed ratio is very important to GvHD therapy and links hMSCs to an anti-inflammatory role. Taken together, our findings provide important preliminary results on the lymphocyte pathway modulated by MSCs and may contribute for developing novel treatments and therapeutic targets for GvHD and others autoimmune diseases.	[Normanton, Marilia; Alvarenga, Heliene; Rizzo, Luiz Vicente; Marti, Luciana Cavalheiro] Hosp Israelita Albert Einstein, Inst Israelita Ensino & Pesquisa Albert Einstein, Sao Paulo, Brazil; [Hamerschlak, Nelson] Hosp Israelita Albert Einstein, Bone Marrow Transplant Program, Sao Paulo, Brazil; [Ribeiro, Andreza] Hosp Israelita Albert Einstein, Dept Oncol, Sao Paulo, Brazil; [Kondo, Andrea] Hosp Israelita Albert Einstein, Blood Bank Dept, Sao Paulo, Brazil; [Normanton, Marilia; Alvarenga, Heliene; Marti, Luciana Cavalheiro] Univ Sao Paulo FMUSP, Fac Med, Programa Posgrad Alergia & Imunopatol, Sao Paulo, Brazil	Hospital Israelita Albert Einstein; Hospital Israelita Albert Einstein; Hospital Israelita Albert Einstein; Hospital Israelita Albert Einstein; Universidade de Sao Paulo	Marti, LC (corresponding author), Hosp Israelita Albert Einstein, Inst Israelita Ensino & Pesquisa Albert Einstein, Sao Paulo, Brazil.	lmarti@einstein.br	Marti, Luciana/E-8242-2010; Rizzo, Luiz Vicente/B-4458-2009; Hamerschlak, Nelson/M-8060-2015; Marti, Luciana Cavalheiro/Z-2555-2019	Marti, Luciana/0000-0002-3890-0827; Hamerschlak, Nelson/0000-0002-5140-5310; Marti, Luciana Cavalheiro/0000-0002-3890-0827	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [2011/02027-4]	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) funded this project through the grant number 2011/02027-4. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal S, 2005, BLOOD, V105, P1815, DOI 10.1182/blood-2004-04-1559; Al-Rawi MAA, 2003, HISTOL HISTOPATHOL, V18, P911, DOI 10.14670/HH-18.911; Benvenuto F, 2007, STEM CELLS, V25, P1753, DOI 10.1634/stemcells.2007-0068; Bernardo ME, 2013, CELL STEM CELL, V13, P392, DOI 10.1016/j.stem.2013.09.006; Beyer Nardi N, 2006, HANDB EXP PHARM, V174, P249; Boomsma RA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035685; Danial NN, 2004, CELL, V116, P205, DOI 10.1016/S0092-8674(04)00046-7; de Deus GC, 2012, EINSTEIN-SAO PAULO, V10, P296, DOI 10.1590/S1679-45082012000300007; De Miguel MP, 2012, CURR MOL MED, V12, P574; Di Nicola M, 2002, BLOOD, V99, P3838, DOI 10.1182/blood.V99.10.3838; Ding DC, 2011, CELL TRANSPLANT, V20, P5, DOI 10.3727/096368910X; Dominici M, 2006, CYTOTHERAPY, V8, P315, DOI 10.1080/14653240600855905; Francois M, 2012, MOL THER, V20, P187, DOI 10.1038/mt.2011.189; FRIEDENSTEIN AJ, 1974, EXP HEMATOL, V2, P83; Ghannam S, 2013, J IMMUNOL, V191, P5777, DOI 10.4049/jimmunol.1390061; Hofmeister R, 1999, CYTOKINE GROWTH F R, V10, P41, DOI 10.1016/S1359-6101(98)00025-2; Jacobs SR, 2010, J IMMUNOL, V184, P3461, DOI 10.4049/jimmunol.0902593; Khaled AR, 2002, NAT REV IMMUNOL, V2, P817, DOI 10.1038/nri931; Khubutiya MS, 2014, CYTOTHERAPY, V16, P579, DOI 10.1016/j.jcyt.2013.07.017; Kim J, 2009, EXP HEMATOL, V37, P1445, DOI 10.1016/j.exphem.2009.09.004; Krampera M, 2003, BLOOD, V101, P3722, DOI 10.1182/blood-2002-07-2104; Le Blanc K, 2004, LANCET, V363, P1439, DOI 10.1016/S0140-6736(04)16104-7; Marti LC, 2014, MEM I OSWALDO CRUZ, V109, P70, DOI 10.1590/0074-0276130252; Meisel R, 2004, BLOOD, V103, P4619, DOI 10.1182/blood-2003-11-3909; Mendez-Ferrer S, 2010, NATURE, V466, P829, DOI 10.1038/nature09262; Nemeth K, 2009, NAT MED, V15, P42, DOI 10.1038/nm.1905; Normanton M, 2013, EINSTEIN-SAO PAULO, V11, P237, DOI 10.1590/S1679-45082013000200019; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Prockop DJ, 1997, SCIENCE, V276, P71, DOI 10.1126/science.276.5309.71; Ramasamy R, 2007, LEUKEMIA, V21, P304, DOI 10.1038/sj.leu.2404489; Ren GW, 2009, STEM CELLS, V27, P1954, DOI 10.1002/stem.118; Rodriguez-Pardo VM, 2013, CELL MOL BIOL LETT, V18, P11, DOI 10.2478/s11658-012-0036-1; Ryan JM, 2007, CLIN EXP IMMUNOL, V149, P353, DOI 10.1111/j.1365-2249.2007.03422.x; Sato K, 2007, BLOOD, V109, P228, DOI 10.1182/blood-2006-02-002246; Tan JT, 2001, P NATL ACAD SCI USA, V98, P8732, DOI 10.1073/pnas.161126098	35	11	13	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 3	2014	9	9							e106673	10.1371/journal.pone.0106673	http://dx.doi.org/10.1371/journal.pone.0106673			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3TB	25184791	Green Submitted, Green Published, gold			2022-12-27	WOS:000341257700101
J	Zhang, JW; He, LJ; Cao, SJ; Yang, Q; Yang, SW; Zhou, YJ				Zhang, Jian-wei; He, Ling-jie; Cao, Shu-jun; Yang, Qing; Yang, Shi-wei; Zhou, Yu-jie			Association of Serum Uric Acid and Coronary Artery Disease in Premenopausal Women	PLOS ONE			English	Article							DENSITY-LIPOPROTEIN CHOLESTEROL; C-REACTIVE PROTEIN; HEART-DISEASE; ATHEROSCLEROTIC BURDEN; METABOLIC SYNDROME; RISK; HYPERURICEMIA; EVENTS	Objective: To date, no study in the published literature has investigated the role of various serum uric acid (SUA) concentrations in the development of angiographically-proven coronary artery disease (CAD) in premenopausal women. Therefore, the aim of this study was to investigate the role SUA levels may play in the prevalence, severity, and prognosis of CAD in premenopausal women. Methods: This cross-sectional retrospective study included 607 premenopausal women who had undergone coronary angiography. The CAD diagnosis was based upon stenosis affecting >= 50% of the luminal diameter. Association of the SUA levels with CAD prevalence, severity, and clinical outcomes were assessed by statistical analysis. Results: In total, 369 (60.8%) of the patients were diagnosed with CAD. The CAD patients had significantly higher SUA levels than those without CAD (5.3 +/- 1.9 vs. 4.8 +/- 1.7 mg/dL, P = 0.001). The SUA levels were found to be significantly associated with CAD prevalence (P = 0.013). Patients with higher levels of SUA also showed increased rates of multivessel disease and composite end-points, such as major adverse cardiac events. Furthermore, multivariate analysis identified abnormally high levels of uric acid (hyperuricemia) as an independent risk factor for CAD (OR 1.51 (1.11-2.53), P<0.05). Conclusions: The SUA levels are significantly associated with the prevalence of CAD. The SUA levels may be a predictor for incidence of major cardiovascular events in premenopausal women.	[Zhang, Jian-wei; Yang, Qing; Yang, Shi-wei; Zhou, Yu-jie] Capital Med Univ, Key Lab Remodeling Related Cardiovasc Dis, Beijing Inst Heart Lung & Blood Vessel Dis, Beijing Anzhen Hosp,Dept Cardiol,Minist Educ, Beijing, Peoples R China; [He, Ling-jie] Capital Med Univ, Beijing Friendship Hosp, Dept Emergency, Beijing, Peoples R China; [Cao, Shu-jun] Capital Med Univ, Beijing Daxing Hosp, Dept Cardiol, Beijing, Peoples R China	Capital Medical University; Capital Medical University; Capital Medical University	Zhou, YJ (corresponding author), Capital Med Univ, Key Lab Remodeling Related Cardiovasc Dis, Beijing Inst Heart Lung & Blood Vessel Dis, Beijing Anzhen Hosp,Dept Cardiol,Minist Educ, Beijing, Peoples R China.	azzyj12@163.com	Zhou, Yu/HHN-3071-2022		Beijing Municipal High-Level Talent Foundation of Health System [2011-1-5)]; Beijing Municipal Administration of Hospitals'; Medicine Development of Special Funding Support [ZY201303]; National Key Clinical Specialty Construction Project	Beijing Municipal High-Level Talent Foundation of Health System; Beijing Municipal Administration of Hospitals'; Medicine Development of Special Funding Support; National Key Clinical Specialty Construction Project	This work was supported by grants from the Beijing Municipal High-Level Talent Foundation of Health System (No. 2011-1-5), the Beijing Municipal Administration of Hospitals' Clinical This work was supported bu Medicine Development of Special Funding Support (No. ZY201303), and the National Key Clinical Specialty Construction Project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali NS, 2002, WOMEN HEALTH, V35, P83, DOI 10.1300/J013v35n01_06; Ansell BJ, 2007, CURR OPIN LIPIDOL, V18, P427, DOI 10.1097/MOL.0b013e3282364a17; Ansell Benjamin J, 2006, Curr Atheroscler Rep, V8, P405, DOI 10.1007/s11883-006-0038-4; Athyros VG, 2007, NEPHROL DIAL TRANSPL, V22, P118, DOI 10.1093/ndt/gfl538; Calvo RY, 2014, AM J CARDIOL, V113, P1153, DOI 10.1016/j.amjcard.2013.12.022; Corsetti JP, 2010, ARTERIOSCL THROM VAS, V30, P1657, DOI 10.1161/ATVBAHA.110.207977; Dou KF, 2008, CHINESE MED J-PEKING, V121, P2392, DOI 10.1097/00029330-200812010-00006; Dullaart RPF, 2010, ARTERIOSCL THROM VAS, V30, P1502, DOI 10.1161/ATVBAHA.110.209544; Espinola-Klein C, 2007, ATHEROSCLEROSIS, V195, pE126, DOI 10.1016/j.atherosclerosis.2007.01.021; Espinola-Klein C, 2007, AM J CARDIOL, V99, P1623, DOI 10.1016/j.amjcard.2007.01.049; Feig DI, 2008, NEW ENGL J MED, V359, P1811, DOI 10.1056/NEJMra0800885; Heinig M, 2006, CLEV CLIN J MED, V73, P1059, DOI 10.3949/ccjm.73.12.1059; Jayachandran M, 2011, J CARDIOVASC TRANSL, V4, P811, DOI 10.1007/s12265-011-9296-9; Jin M, 2012, FRONT BIOSCI-LANDMRK, V17, P656, DOI 10.2741/3950; Kanbay M, 2013, HEART, V99, P759, DOI 10.1136/heartjnl-2012-302535; Katsiki N, 2013, J CARDIOVASC MED, V14, P397, DOI 10.2459/JCM.0b013e3283595adc; Keidar S, 2009, J CLIN LIPIDOL, V3, P345, DOI 10.1016/j.jacl.2009.08.003; Kim SY, 2010, ARTHRIT CARE RES, V62, P170, DOI 10.1002/acr.20065; King KB, 2002, HEART LUNG, V31, P246, DOI 10.1067/mhl.2002.126522; Lin GM, 2013, J CARDIOL, V61, P122, DOI 10.1016/j.jjcc.2012.09.004; Luster AD, 1998, NEW ENGL J MED, V338, P436, DOI 10.1056/NEJM199802123380706; Navab M, 2006, NAT CLIN PRACT ENDOC, V2, P504, DOI 10.1038/ncpendmet0245; Ndrepepa G, 2013, NUTR METAB CARDIOVAS, V23, P1195, DOI 10.1016/j.numecd.2013.03.005; Ndrepepa G, 2013, EUR J CLIN INVEST, V43, P256, DOI 10.1111/eci.12039; Ndrepepa G, 2013, CLIN SCI, V124, P259, DOI 10.1042/CS20120336; Oliver-McNeil S, 2002, AM J CRIT CARE, V11, P221, DOI 10.4037/ajcc2002.11.3.221; Pai JK, 2006, ATHEROSCLEROSIS, V186, P132, DOI 10.1016/j.atherosclerosis.2005.06.041; Veeranna V, 2013, J AM COLL CARDIOLOGY, V61	28	23	24	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 3	2014	9	9							e106130	10.1371/journal.pone.0106130	http://dx.doi.org/10.1371/journal.pone.0106130			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3TB	25184207	gold, Green Submitted, Green Published			2022-12-27	WOS:000341257700032
J	Mansano, ESB; de Morais, GR; Moratto, EM; Sato, F; Neto, AM; Svidzinski, TIE; Baesso, ML; Hernandes, L				Benites Mansano, Elaine Sciuniti; de Morais, Gutierrez Rodrigues; Moratto, Edilaine Martins; Sato, Francielle; Neto, Antonio Medina; Estivalet Svidzinski, Terezinha Ines; Baesso, Mauro Luciano; Hernandes, Luzmarina			Correlation between Histopathological and FT-Raman Spectroscopy Analysis of the Liver of Swiss Mice Infected with Paracoccidioides brasiliensis	PLOS ONE			English	Article							METHENAMINE-SILVER NITRATE; PULMONARY PARACOCCIDIOIDOMYCOSIS; TISSUE; PHAGOCYTOSIS; EXPRESSION; RESISTANCE; MECHANISM; DIAGNOSIS; RESPONSES; ADHESIN	Paracoccidioidomycosis is the most important systemic mycosis in Latin America. The main entrance of the fungus is the airway. It primarily occurs in the lung, but in its disseminated form may affect any organ. The liver is one of the organs afflicted by this disease and its homeostasis may be impaired. The aim of the present study was to evaluate the evolution of paracoccidioidomycosis in the liver of Swiss mice and correlate morphological factors with the expression of gp43 and with physicochemical analysis via FT-Raman of the infected organ. According to colony forming unit (CFU) and granuloma counting, the first and second weeks were the periods when infection was most severe. Tissue response was characterized by the development of organized granulomas and widespread infection, with yeasts located within the macrophages and isolated hepatocytes. The gp43 molecule was distributed throughout the hepatic parenchyma, and immunostaining was constant in all observed periods. The main physicochemical changes of the infected liver were observed in the spectral ranges between 1700-1530 cm(-1) and 1370 - 1290 cm(-1), a peak shifting center attributed to phenylalanine and area variation of -CH2 and -CH3 compounds associated to collagen, respectively. Over time, there was a direct proportional relationship between the number of CFUs, the number of granulomas and the physicochemical changes in the liver of mice infected with Paracoccidioides brasiliensis. The expression of gp43 was similar in all observed periods.	[Benites Mansano, Elaine Sciuniti; Moratto, Edilaine Martins; Hernandes, Luzmarina] Univ Estadual Maringa, Dept Morphol Sci, Maringa, Parana, Brazil; [de Morais, Gutierrez Rodrigues; Sato, Francielle; Neto, Antonio Medina; Baesso, Mauro Luciano] Univ Estadual Maringa, Dept Phys, Maringa, Parana, Brazil; [Estivalet Svidzinski, Terezinha Ines] Univ Estadual Maringa, Dept Clin Anal & Biomed, Maringa, Parana, Brazil	Universidade Estadual de Maringa; Universidade Estadual de Maringa; Universidade Estadual de Maringa	Sato, F (corresponding author), Univ Estadual Maringa, Dept Phys, Maringa, Parana, Brazil.	fsato@uem.br	Sato, Francielle/H-2485-2017; Sato, Francielle/ABC-4278-2021; Sato, Francielle/ABC-4501-2021; Medina, Antonio N/H-3244-2012; Hernandes, Luzmarina/AAV-6934-2020	Sato, Francielle/0000-0002-8273-2891; Sato, Francielle/0000-0002-8273-2891; Medina, Antonio N/0000-0003-2885-457X; Hernandes, Luzmarina/0000-0003-4284-4394	Brazilian agency Fundacao Araucaria [114/2010]; Brazilian agency CNPq [114/2010]	Brazilian agency Fundacao Araucaria(Fundacao Araucaria de Apoio ao Desenvolvimento Cientifico e Tecnologico do Estado do Parana FA); Brazilian agency CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This study received financial support from Brazilian agencies Fundacao Araucaria and CNPq, under the Project PRONEX 114/2010 - "Nucleus of Excellency in Advanced Optics for Biophysical and Biomedical Applications''. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acorci MJ, 2009, SCAND J IMMUNOL, V69, P73, DOI 10.1111/j.1365-3083.2008.02199.x; Andreotti PF, 2005, MICROBES INFECT, V7, P875, DOI 10.1016/j.micinf.2005.02.005; Apte M, 2013, J NANOBIOTECHNOL, V11, DOI 10.1186/1477-3155-11-2; BARBOSA WILLIAM, 1968, REV INST MED TROP SAO PAULO, V10, P16; Bertini S, 2007, CLIN VACCINE IMMUNOL, V14, P150, DOI 10.1128/CVI.00285-06; Bertoni TA, 2012, CLIN VACCINE IMMUNOL, V19, P1887, DOI 10.1128/CVI.00252-12; Bocalandro I, 1960, REV PAUL MED, V56, P350; Borges-Walmsley MI, 2002, TRENDS MICROBIOL, V10, P80, DOI 10.1016/S0966-842X(01)02292-2; Braga GD, 2014, HISTOPATHOLOGY, V64, P256, DOI 10.1111/his.12244; Cheng WT, 2005, MICROSC RES TECHNIQ, V68, P75, DOI 10.1002/jemt.20229; Costa PF, 2010, MYCOPATHOLOGIA, V169, P37, DOI 10.1007/s11046-009-9228-2; Coutinho Ziadir Francisco, 2002, Cad. Saúde Pública, V18, P1441, DOI 10.1590/S0102-311X2002000500037; Da Silva FC, 2009, AM J TROP MED HYG, V80, P798, DOI 10.4269/ajtmh.2009.80.798; Da Silva JF, 2013, PLOS ONE, V8, P1; da Silva MB, 2009, MEM I OSWALDO CRUZ, V104, P644, DOI 10.1590/S0074-02762009000400019; da Silva MB, 2006, MICROBES INFECT, V8, P197, DOI 10.1016/j.micinf.2005.06.018; de Brito T, 1968, Rev Inst Med Trop Sao Paulo, V10, P188; de Matos WB, 2012, REV SOC BRAS MED TRO, V45, P385, DOI 10.1590/S0037-86822012000300020; de Oliveira AF, 2010, ACTA CIR BRAS, V25, P434, DOI 10.1590/S0102-86502010000500009; de Paulo LF, 2013, J BIOMED OPT, V18, DOI 10.1117/1.JBO.18.9.095004; DEFAVERI J, 1982, MYCOPATHOLOGIA, V77, P3, DOI 10.1007/BF00588649; DEFAVERI J, 1992, MYCOPATHOLOGIA, V119, P1; DEFAVERI J, 1989, MYCOPATHOLOGIA, V105, P53, DOI 10.1007/BF00443831; Nogueira MGD, 2006, REV SOC BRAS MED TRO, V39, P478, DOI 10.1590/S0037-86822006000500011; Fortes RM, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-84; Gonzalez A, 2008, INT J EXP PATHOL, V89, P106, DOI 10.1111/j.1365-2613.2008.00573.x; GREEN CJ, 1981, LAB ANIM, V15, P163, DOI 10.1258/002367781780959107; GROCOTT RG, 1955, AM J CLIN PATHOL, V25, P975, DOI 10.1093/ajcp/25.8_ts.0975; Hanna SA, 2000, MICROBES INFECT, V2, P877, DOI 10.1016/S1286-4579(00)00390-7; Hawi SR, 1996, CANCER LETT, V110, P35, DOI 10.1016/S0304-3835(96)04455-2; Huang NY, 2011, OPT EXPRESS, V19, P22892, DOI 10.1364/OE.19.022892; HUPPERT M, 1978, J CLIN MICROBIOL, V8, P598; Lenzi HL, 2000, MED MYCOL, V38, P115; Lien-Vien D, 1991, HDB IR RAMAN CHARACT, P155; Lorincz A, 2004, J PEDIATR SURG, V39, P953, DOI 10.1016/j.jpedsurg.2004.02.043; Malini R, 2006, BIOPOLYMERS, V81, P179, DOI 10.1002/bip.20398; MCMAHON JP, 1995, J CLIN INVEST, V96, P1010, DOI 10.1172/JCI118086; Mendes-Giannini MJS, 2000, MED MYCOL, V38, P113, DOI 10.1080/mmy.38.s1.113.123; Morato EM, 2013, PHOTOCHEM PHOTOBIOL, V89, P1170, DOI 10.1111/php.12110; Nemecek JC, 2006, SCIENCE, V312, P583, DOI 10.1126/science.1124105; Nimrichter L, 2005, MICROBES INFECT, V7, P789, DOI 10.1016/j.micinf.2005.03.002; Nogueira SV, 2010, INFECT IMMUN, V78, P4040, DOI 10.1128/IAI.00221-10; Oshima Y, 2010, J BIOMED OPT, V15, DOI 10.1117/1.3316296; Fortes MRP, 2011, AN BRAS DERMATOL, V86, P516, DOI 10.1590/S0365-05962011000300014; Pereira LA, 2007, FEMS YEAST RES, V7, P1381, DOI 10.1111/j.1567-1364.2007.00292.x; Pereira M, 2009, MEM I OSWALDO CRUZ, V104, P486, DOI 10.1590/S0074-02762009000300015; Perenha-Viana MCZ, 2012, CLIN VACCINE IMMUNOL, V19, P616, DOI 10.1128/CVI.05693-11; Popi AF, 2002, CELL IMMUNOL, V218, P87, DOI 10.1016/S0008-8749(02)00576-2; RESTREPO A, 1980, J CLIN MICROBIOL, V12, P279, DOI 10.1128/JCM.12.2.279-281.1980; Rocha AA, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-277; Shikanai-Yasuda MA, 2006, REV SOC BRAS MED TRO, V39, P297, DOI 10.1590/S0037-86822006000300017; SINGERVERMES LM, 1994, CLIN EXP IMMUNOL, V97, P113, DOI 10.1111/j.1365-2249.1994.tb06588.x; Socrates G, 2001, MACROMOLECULES INFRA; Takahachi G, 2006, BRAZ ARCH BIOL TECHN, V49, P897, DOI 10.1590/S1516-89132006000700006; Vargas J, 2009, REV ENFERM INFECC TR, V1, P49; Villalobos-Duno H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066853; Wanke B, 2009, J BRAS PNEUMOL, V35, P1245, DOI 10.1590/S1806-37132009001200013	57	6	6	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2014	9	9							e106256	10.1371/journal.pone.0106256	http://dx.doi.org/10.1371/journal.pone.0106256			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3LR	25181524	Green Submitted, Green Published, gold			2022-12-27	WOS:000341231500066
J	Hepojoki, S; Nurmi, V; Vaheri, A; Hedman, K; Vapalahti, O; Hepojoki, J				Hepojoki, Satu; Nurmi, Visa; Vaheri, Antti; Hedman, Klaus; Vapalahti, Olli; Hepojoki, Jussi			A Protein L -Based Immunodiagnostic Approach Utilizing Time-Resolved Forster Resonance Energy Transfer	PLOS ONE			English	Article							CHAIN VARIABLE DOMAIN; LIGHT; IMMUNOASSAYS; PRINCIPLES; TERBIUM; BINDING; ASSAY; SERUM; TOOL	Chelated lanthanides such as europium (Eu) have uniquely long fluorescence emission half-lives permitting their use in time-resolved fluorescence (TRF) assays. In Forster resonance energy transfer (FRET) a donor fluorophore transfers its emission energy to an acceptor fluorophore if in sufficiently close proximity. The use of time-resolved (TR) FRET minimizes the autofluorescence of molecules present in biological samples. In this report, we describe a homogenous immunoassay prototype utilizing TR-FRET for detection of antibodies in solution. The assay is based on labeled protein L, a bacterial protein that binds to immunoglobulin (Ig) light chain, and labeled antigen, which upon association with the same Ig molecule produce a TR-FRET active complex. We show that the approach is functional and can be utilized for both mono- and polyvalent antigens. We also compare the assay performance to that of another homogenous TR-FRET immunoassay reported earlier. This novel assay may have wide utility in infectious disease point-of-care diagnostics.	[Hepojoki, Satu; Nurmi, Visa; Vaheri, Antti; Hedman, Klaus; Vapalahti, Olli; Hepojoki, Jussi] Univ Helsinki, Dept Virol, Helsinki, Finland; [Vaheri, Antti; Hedman, Klaus; Vapalahti, Olli] Univ Helsinki, Cent Hosp, Hosp Dist Helsinki & Uusimaa, Lab Serv,HUSLAB, Helsinki, Finland; [Vapalahti, Olli] Univ Helsinki, Dept Vet Biosci, Helsinki, Finland	University of Helsinki; University of Helsinki; Helsinki University Central Hospital; University of Helsinki	Hepojoki, J (corresponding author), Univ Helsinki, Dept Virol, Helsinki, Finland.	jussi.hepojoki@helsinki.fi	Hepojoki, Jussi/W-4667-2017; Hedman, Klaus/D-5379-2009; Vaheri, Antti/AAV-1523-2020	Hepojoki, Jussi/0000-0001-5699-214X; Vapalahti, Olli/0000-0003-2270-6824; Hedman, Klaus/0000-0003-1779-7960; Nurmi, Visa/0000-0001-8052-5592; Hepojoki, Satu/0000-0002-0696-1879	Finnish Funding Agency for Technology and Innovation [440071, 440118]; Kliinisen Kemian tutkimussaatio; Foundation for Finnish Inventions; Integrative Life Science doctoral program; Laboratoriolaaketieteen edistamissaatio	Finnish Funding Agency for Technology and Innovation(Finnish Funding Agency for Technology & Innovation (TEKES)); Kliinisen Kemian tutkimussaatio; Foundation for Finnish Inventions; Integrative Life Science doctoral program; Laboratoriolaaketieteen edistamissaatio	Finnish Funding Agency for Technology and Innovation grant numbers 440071 and 440118. KH received these funds (http://www.tekes.fi/en/tekes/). Kliinisen Kemian tutkimussaatio (SH), The Foundation for Finnish Inventions (KH), Integrative Life Science doctoral program (SH), and Laboratoriolaaketieteen edistamissaatio (SH) provided smaller funds. Grant numbers do not apply. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKERSTROM B, 1989, J BIOL CHEM, V264, P19740; Bazin H, 2001, SPECTROCHIM ACTA A, V57, P2197, DOI 10.1016/S1386-1425(01)00493-0; BJORCK L, 1988, J IMMUNOL, V140, P1194; Blomberg K, 1999, CLIN CHEM, V45, P855; DECHATEAU M, 1993, SCAND J IMMUNOL, V37, P399; DIAMANDIS EP, 1988, CLIN BIOCHEM, V21, P139, DOI 10.1016/S0009-9120(88)80104-8; DIAMANDIS EP, 1990, ANAL CHEM, V62, pA1149, DOI 10.1021/ac00221a001; EKINS RP, 1985, PURE APPL CHEM, V57, P473, DOI 10.1351/pac198557030473; Forster T, 1948, ANN PHYS, V437; Gabourdes M, 2004, ANAL BIOCHEM, V333, P105, DOI 10.1016/j.ab.2004.06.006; GAILLARD O, 1994, ANN BIOL CLIN-PARIS, V52, P751; Hildebrandt N, 2007, J BIOMED BIOTECHNOL, DOI 10.1155/2007/79169; Klostermeier D, 2001, BIOPOLYMERS, V61, P159; Maple PAC, 2014, J CLIN MICROBIOL, V52, P947, DOI 10.1128/JCM.02613-13; NILSON BHK, 1992, J BIOL CHEM, V267, P2234; NILSON BHK, 1993, J IMMUNOL METHODS, V164, P33, DOI 10.1016/0022-1759(93)90273-A; Saraheimo S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062739; Stenroos K, 1998, CYTOKINE, V10, P495, DOI 10.1006/cyto.1997.0321; STOOP JW, 1969, CLIN EXP IMMUNOL, V4, P101; Zheng ZL, 2012, J TRANSL MED, V10, DOI 10.1186/1479-5876-10-29	20	9	10	3	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2014	9	9							e106432	10.1371/journal.pone.0106432	http://dx.doi.org/10.1371/journal.pone.0106432			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3LR	25181527	Green Published, Green Submitted, gold			2022-12-27	WOS:000341231500097
J	Szitenberg, A; Koutsovoulos, G; Blaxter, ML; Lunt, DH				Szitenberg, Amir; Koutsovoulos, Georgios; Blaxter, Mark L.; Lunt, David H.			The Evolution of Tyrosine-Recombinase Elements in Nematoda	PLOS ONE			English	Article							UNIFIED CLASSIFICATION-SYSTEM; TRANSPOSABLE ELEMENTS; DATABASE; GENOMES; DIRS-1; BLAST; MAFFT	Transposable elements can be categorised into DNA and RNA elements based on their mechanism of transposition. Tyrosine recombinase elements (YREs) are relatively rare and poorly understood, despite sharing characteristics with both DNA and RNA elements. Previously, the Nematoda have been reported to have a substantially different diversity of YREs compared to other animal phyla: the Dirs1-like YRE retrotransposon was encountered in most animal phyla but not in Nematoda, and a unique Pat1-like YRE retrotransposon has only been recorded from Nematoda. We explored the diversity of YREs in Nematoda by sampling broadly across the phylum and including 34 genomes representing the three classes within Nematoda. We developed a method to isolate and classify YREs based on both feature organization and phylogenetic relationships in an open and reproducible workflow. We also ensured that our phylogenetic approach to YRE classification identified truncated and degenerate elements, informatively increasing the number of elements sampled. We identified Dirs1-like elements (thought to be absent from Nematoda) in the nematode classes Enoplia and Dorylaimia indicating that nematode model species do not adequately represent the diversity of transposable elements in the phylum. Nematode Pat1-like elements were found to be a derived form of another Pat1-like element that is present more widely in animals. Several sequence features used widely for the classification of YREs were found to be homoplasious, highlighting the need for a phylogenetically-based classification scheme. Nematode model species do not represent the diversity of transposable elements in the phylum.	[Szitenberg, Amir; Lunt, David H.] Univ Hull, Evolutionary Biol Grp, Sch Biol Biomed & Environm Sci, Kingston Upon Hull HU6 7RX, N Humberside, England; [Koutsovoulos, Georgios; Blaxter, Mark L.] Univ Edinburgh, Inst Evolutionary Biol, Edinburgh, Midlothian, Scotland	University of Hull; University of Edinburgh	Szitenberg, A (corresponding author), Univ Hull, Evolutionary Biol Grp, Sch Biol Biomed & Environm Sci, Kingston Upon Hull HU6 7RX, N Humberside, England.	A.Szitenberg@hull.ac.uk	Szitenberg, Amir/T-7070-2019; Blaxter, Mark/O-2535-2019; Blaxter, Mark L/B-4113-2010; Szitenberg, Amir/AAA-4169-2020	Blaxter, Mark L/0000-0003-2861-949X; Koutsovoulos, Georgios/0000-0003-3406-3715; Lunt, David H/0000-0002-9000-7470; Szitenberg, Amir/0000-0002-7309-2845	The National Environmental Research Council (NERC) [R8/H10/56, NE/J011355/1]; The Medical Research Council (MRC) [G0900740]; The Biotechnology and Biological Science Research Council; Medical Research Council [G0900740] Funding Source: researchfish; Natural Environment Research Council [NE/J011355/1, NE/J009423/1, NBAF010003] Funding Source: researchfish; MRC [G0900740] Funding Source: UKRI; NERC [NE/J009423/1, NBAF010003, NE/J011355/1] Funding Source: UKRI	The National Environmental Research Council (NERC); The Medical Research Council (MRC)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); The Biotechnology and Biological Science Research Council; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	The National Environmental Research Council (NERC, http://www.nerc.ac.uk/) supports MLB with award R8/H10/56. They also support AS, MLB and DHL with award NE/J011355/1. The Medical Research Council (MRC, http://www.mrc.ac.uk/index.htm) supports MLB with award G0900740. The Biotechnology and Biological Science Research Council (http://www.bbsrc.ac.uk/home/home.aspx) supports GK with a Research Studentship award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Anisimova M, 2011, SYST BIOL, V60, P685, DOI 10.1093/sysbio/syr041; Badyaev AV, 2005, P ROY SOC B-BIOL SCI, V272, P877, DOI 10.1098/rspb.2004.3045; Bessereau Jean-Louis, 2006, WormBook, P1; Camacho C, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-421; Capella-Gutierrez S, 2009, BIOINFORMATICS, V25, P1972, DOI 10.1093/bioinformatics/btp348; CAPPELLO J, 1984, MOL CELL BIOL, V4, P2207, DOI 10.1128/MCB.4.10.2207; Carr M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050978; CHARLESWORTH D, 1995, GENETICS, V140, P415; COLLINS J, 1987, NATURE, V328, P726, DOI 10.1038/328726a0; De Ley Paul, 2002, P1; DECHASTONAY Y, 1992, NUCLEIC ACIDS RES, V20, P1623, DOI 10.1093/nar/20.7.1623; DOAK TG, 1994, P NATL ACAD SCI USA, V91, P942, DOI 10.1073/pnas.91.3.942; Dolgin ES, 2006, GENETICS, V174, P817, DOI 10.1534/genetics.106.060434; Duncan L, 2002, GENETICS, V162, P1617; Eads BD, 2012, P NATL ACAD SCI USA, V109, P858, DOI 10.1073/pnas.1119667109; Finnegan DJ, 2012, CURR BIOL, V22, pR432, DOI 10.1016/j.cub.2012.04.025; Goodwin TJD, 2004, MOL BIOL EVOL, V21, P746, DOI 10.1093/molbev/msh072; Goodwin TJD, 2003, MICROBIOL-SGM, V149, P3099, DOI 10.1099/mic.0.26529-0; Goodwin TJD, 2001, MOL BIOL EVOL, V18, P2067, DOI 10.1093/oxfordjournals.molbev.a003748; Guerillot R, 2014, GENOME BIOL EVOL, V6, P260, DOI 10.1093/gbe/evu010; Iyer LM, 2014, P NATL ACAD SCI USA, V111, P1676, DOI 10.1073/pnas.1321818111; Jacobs ME, 2003, EUKARYOT CELL, V2, P103, DOI 10.1128/EC.2.1.103-114.2003; Jurka J, 2005, CYTOGENET GENOME RES, V110, P462, DOI 10.1159/000084979; Jurka J, 2007, ANNU REV GENOM HUM G, V8, P241, DOI 10.1146/annurev.genom.8.080706.092416; Kapitonov VV, 2003, P NATL ACAD SCI USA, V100, P6569, DOI 10.1073/pnas.0732024100; Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436; Katoh K, 2013, MOL BIOL EVOL, V30, P772, DOI 10.1093/molbev/mst010; Kawakami T, 2010, HEREDITY, V104, P341, DOI 10.1038/hdy.2009.182; Kiontke K, 2013, CURR BIOL, V23, pR862, DOI 10.1016/j.cub.2013.08.009; Kojima KK, 2011, MOBILE DNA-UK, V2, DOI 10.1186/1759-8753-2-12; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Lorenzi HA, 2006, MOL BIOCHEM PARASIT, V145, P184, DOI 10.1016/j.molbiopara.2005.10.002; Muszewska A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076319; Nakayashiki H, 2011, GENES CELLS, V16, P827, DOI 10.1111/j.1365-2443.2011.01533.x; Okonechnikov K, 2012, BIOINFORMATICS, V28, P1166, DOI 10.1093/bioinformatics/bts091; Piednoel M, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-621; Piednoel M, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-86; Poulter RTM, 2005, CYTOGENET GENOME RES, V110, P575, DOI 10.1159/000084991; Price MN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009490; Seberg O, 2009, NAT REV GENET, V10, P276, DOI 10.1038/nrg2165-c3; Shimodaira H, 2001, BIOINFORMATICS, V17, P1246, DOI 10.1093/bioinformatics/17.12.1246; Sorek R, 2002, GENOME RES, V12, P1060, DOI 10.1101/gr.229302; Wessler SR, 2006, IMPLICIT GENOME, P138; Wicker T, 2007, NAT REV GENET, V8, P973, DOI 10.1038/nrg2165; Wright S, 2001, CURR BIOL, V11, pR296, DOI 10.1016/S0960-9822(01)00168-3; Wright SI, 2001, GENETICS, V158, P1279; 1998, SCIENCE, V282, P2018	48	2	2	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2014	9	9							e106630	10.1371/journal.pone.0106630	http://dx.doi.org/10.1371/journal.pone.0106630			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4JX	25197791	Green Submitted, Green Published, gold			2022-12-27	WOS:000341304700035
J	Leong, TL; Marini, KD; Rossello, FJ; Jayasekara, SN; Russell, PA; Prodanovic, Z; Kumar, B; Ganju, V; Alamgeer, M; Irving, LB; Steinfort, DP; Peacock, CD; Cain, JE; Szczepny, A; Watkins, DN				Leong, Tracy L.; Marini, Kieren D.; Rossello, Fernando J.; Jayasekara, Samantha N.; Russell, Prudence A.; Prodanovic, Zdenka; Kumar, Beena; Ganju, Vinod; Alamgeer, Muhammad; Irving, Louis B.; Steinfort, Daniel P.; Peacock, Craig D.; Cain, Jason E.; Szczepny, Anette; Watkins, D. Neil			Genomic Characterisation of Small Cell Lung Cancer Patient-Derived Xenografts Generated from Endobronchial Ultrasound-Guided Transbronchial Needle Aspiration Specimens	PLOS ONE			English	Article							TUMOR XENOGRAFTS; MODELS; HETEROGENEITY; EXPRESSION; MUTATIONS; EVOLUTION; SAMPLES; GENE	Patient-derived xenograft (PDX) models generated from surgical specimens are gaining popularity as preclinical models of cancer. However, establishment of PDX lines from small cell lung cancer (SCLC) patients is difficult due to very limited amount of available biopsy material. We asked whether SCLC cells obtained from endobronchial ultrasound-guided transbronchial needle aspiration (EBUS-TBNA) could generate PDX lines that maintained the phenotypic and genetic characteristics of the primary tumor. Following successful EBUS-TBNA sampling for diagnostic purposes, we obtained an extra sample for cytologic analysis and implantation into the flanks of immunodeficient mice. Animals were monitored for engraftment for up to 6 months. Histopathologic and immunohistochemical analysis, and targeted next-generation re-sequencing, were then performed in both the primary sample and the derivative PDX line. A total of 12 patients were enrolled in the study. EBUS-TBNA aspirates yielded large numbers of viable tumor cells sufficient to inject between 18,750 and 1,487,000 cells per flank, and to yield microgram quantities of high-quality DNA. Of these, samples from 10 patients generated xenografts (engraftment rate 83%) with a mean latency of 104 days (range 63-188). All but one maintained a typical SCLC phenotype that closely matched the original sample. Identical mutations that are characteristic of SCLC were identified in both the primary sample and xenograft line. EBUS-TBNA has the potential to be a powerful tool in the development of new targeting strategies for SCLC patients by providing large numbers of viable tumor cells suitable for both xenografting and complex genomic analysis.	[Leong, Tracy L.; Marini, Kieren D.; Jayasekara, Samantha N.; Ganju, Vinod; Alamgeer, Muhammad; Cain, Jason E.; Szczepny, Anette; Watkins, D. Neil] MIMR PHI Inst, Clayton, Vic, Australia; [Leong, Tracy L.; Marini, Kieren D.; Rossello, Fernando J.; Ganju, Vinod; Alamgeer, Muhammad; Cain, Jason E.; Szczepny, Anette; Watkins, D. Neil] Monash Univ, Clayton, Vic, Australia; [Rossello, Fernando J.] Victorian Life Sci Computat Initiat, Life Sci Computat Ctr, Carlton, Vic, Australia; [Russell, Prudence A.] St Vincents Hosp, Dept Anat Pathol, Melbourne, Vic, Australia; [Prodanovic, Zdenka; Kumar, Beena] Monash Hlth, Dept Pathol, Clayton, Vic, Australia; [Ganju, Vinod; Alamgeer, Muhammad] Monash Hlth, Dept Med Oncol, East Bentleigh, Vic, Australia; [Irving, Louis B.; Steinfort, Daniel P.] Royal Melbourne Hosp, Dept Resp Med, Parkville, Vic 3050, Australia; [Peacock, Craig D.] Cleveland Clin, Translat Hematol & Oncol Res, Cleveland, OH 44106 USA; [Watkins, D. Neil] St Vincents Hosp, Garvan Inst Med Res, Kinghorn Canc Ctr, Darlinghurst, NSW 2010, Australia	Prince Henry's Institute of Medical Research; Monash University; St Vincent's Hospital Melbourne; Royal Melbourne Hospital; Cleveland Clinic Foundation; Garvan Institute of Medical Research; St Vincents Hospital Sydney	Szczepny, A (corresponding author), MIMR PHI Inst, Clayton, Vic, Australia.	anette.szczepny@monash.edu; n.watkins@garvan.org.au	Alamgeer, Muhammad/AAM-4784-2021; Steinfort, Daniel/AAO-6898-2020; Rossello, Fernando/B-1208-2015	Steinfort, Daniel/0000-0002-8998-2949; Rossello, Fernando/0000-0003-3885-8777; Leong, Tracy/0000-0002-1950-1505	Victorian Cancer Agency; National Health and Medical Research Council of Australia; Victorian Government Operational Infrastructure Support Program	Victorian Cancer Agency; National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Victorian Government Operational Infrastructure Support Program	This work was supported by the Victorian Cancer Agency (www.victoriancanceragency.org.au), the National Health and Medical Research Council of Australia (www.nhmrc.gov.au), and the Victorian Government Operational Infrastructure Support Program (www.business.vic.gov.au/grants-and-assistance/programs/medical-research-operational-infrastructure-program). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alamgeer M, 2013, THORAX, V68, P1095, DOI 10.1136/thoraxjnl-2012-203021; British Thoracic Society Bronchoscopy Guidelines Committee, 2001, THORAX S1, V56, DOI [10.1136/thorax.56.suppl_1.i1, DOI 10.1136/THX.56.SUPPL1.IL]; Burrell RA, 2013, NATURE, V501, P338, DOI 10.1038/nature12625; Chen Z, 2012, NATURE, V483, P613, DOI 10.1038/nature10937; Cutz JC, 2006, CLIN CANCER RES, V12, P4043, DOI 10.1158/1078-0432.CCR-06-0252; Danecek P, 2011, BIOINFORMATICS, V27, P2156, DOI 10.1093/bioinformatics/btr330; Daniel VC, 2009, CANCER RES, V69, P3364, DOI 10.1158/0008-5472.CAN-08-4210; Dong X, 2010, CLIN CANCER RES, V16, P1442, DOI 10.1158/1078-0432.CCR-09-2878; Gerlinger M, 2014, NAT GENET, V46, P225, DOI 10.1038/ng.2891; Hann CL, 2008, CANCER RES, V68, P2321, DOI 10.1158/0008-5472.CAN-07-5031; Hodgkinson CL, 2014, NAT MED, V20, P897, DOI 10.1038/nm.3600; John T, 2011, CLIN CANCER RES, V17, P134, DOI 10.1158/1078-0432.CCR-10-2224; Kumar P, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-290; Lawrence MS, 2013, NATURE, V499, P214, DOI 10.1038/nature12213; Liu XM, 2013, HUM MUTAT, V34, pE2393, DOI 10.1002/humu.22376; Mountain CF, 1997, CHEST, V111, P1718, DOI 10.1378/chest.111.6.1718; Nakajima T, 2011, J BRONCHOL INTERN PU, V18, P301, DOI 10.1097/LBR.0b013e31823302b7; Nakajima T, 2011, CHEST, V140, P1319, DOI 10.1378/chest.10-3186; Navani N, 2012, AM J RESP CRIT CARE, V185, P1316, DOI 10.1164/rccm.201202-0294OC; Peifer M, 2012, NAT GENET, V44, P1104, DOI 10.1038/ng.2396; Quintana E, 2012, SCI TRANSL MED, V4, DOI [10.1126/sci-translmed.3004599, DOI 10.1126/SCI-TRANSLMED.3004599]; Rossello FJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074432; Rossi A, 2013, CANCER TREAT REV, V39, P498, DOI 10.1016/j.ctrv.2012.09.006; Ruden DM, 2012, SNPSIFT, V1-9, DOI [10.3389/fgene.2012.00035/abstract, DOI 10.3389/FGENE.2012.00035/ABSTRACT]; Rudin CM, 2012, NAT GENET, V44, P1111, DOI 10.1038/ng.2405; Santis G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025191; Schmid-Bindert G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077948; Sgambato A, 2013, EXPERT OPIN PHARMACO, V14, P2019, DOI 10.1517/14656566.2013.823401; Siolas D, 2013, CANCER RES, V73, P5315, DOI 10.1158/0008-5472.CAN-13-1069; Steinfort DP, 2011, INTERN MED J, V41, P815, DOI 10.1111/j.1445-5994.2009.02142.x; Stigt JA, 2013, J THORAC ONCOL, V8, P1012, DOI 10.1097/JTO.0b013e31829ce93e; Tentler JJ, 2012, NAT REV CLIN ONCOL, V9, P338, DOI 10.1038/nrclinonc.2012.61; van Eijk R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017791; van Meerbeeck JP, 2011, LANCET, V378, P1741, DOI 10.1016/S0140-6736(11)60165-7; Williams SA, 2013, LAB INVEST, V93, P970, DOI 10.1038/labinvest.2013.92; Zhang RF, 2013, EUR J CANCER, V49, P1860, DOI 10.1016/j.ejca.2013.02.008	36	28	30	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2014	9	9							e106862	10.1371/journal.pone.0106862	http://dx.doi.org/10.1371/journal.pone.0106862			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ1IR	25191746	Green Published, gold			2022-12-27	WOS:000347993600072
J	Matsui, Y; Satoi, S; Kaibori, M; Toyokawa, H; Yanagimoto, H; Matsui, K; Ishizaki, M; Kwon, AH				Matsui, Yoichi; Satoi, Sohei; Kaibori, Masaki; Toyokawa, Hideyoshi; Yanagimoto, Hiroaki; Matsui, Kosuke; Ishizaki, Morihiko; Kwon, A-Hon			Antibiotic Prophylaxis in Laparoscopic Cholecystectomy: A Randomized Controlled Trial	PLOS ONE			English	Article							POSTOPERATIVE INFECTION COMPLICATION; LOW-RISK PATIENTS; METAANALYSIS; IMPACT; NEED	Background: Recent meta-analyses concluded that antibiotic prophylaxis is not warranted in low-risk laparoscopic cholecystectomy. However, most trials in the meta-analyses had a relatively small sample size and were statistically underpowered. In addition, many of the trials mentioned potential cost savings owing to the elimination of prophylactic antibiotics. However, no trial has statistically estimated the cost effectiveness. To evaluate the results of meta-analyses, we conducted a randomized controlled trial on the role of prophylactic antibiotics in low-risk laparoscopic cholecystectomy with an adequate sample size. Methods: From March 2007 to May 2013, at the Department of Surgery, Kansai Medical University, patients who were scheduled for elective laparoscopic cholecystectomy were randomly assigned to one of two arms: those who were and were not administered prophylactic antibiotics. The primary endpoint was the occurrence of postoperative infections and secondary endpoints were postoperative hospital stay and medical costs. Findings: During the study period, 518 patients were assigned to the Antibiotics group and 519 to the No antibiotics group. Occurrences of surgical site infections, distant infections and overall infections were significantly lower in the Antibiotics group than in the No antibiotics group (0.8 vs. 3.7%, p = 0.001, OR: 0.205 (95% CI: 0.069 to 0.606); 0.4 vs. 3.1%, p = 0.0004, OR: 0.122 (95% CI: 0.028 to 0.533); 1.2 vs. 6.7%; p < 0.0001, OR: 0.162 (95% CI: 0.068 to 0.389), respectively). The postoperative hospital stay was significantly shorter in the Antibiotics group (mean, SD: 3.69 +/- 1.56 vs. 4.07 +/- 3.00; p = 0.01) and the postoperative medical costs were significantly lower in the Antibiotics group (mean, SD: $766 +/- 341 vs. 8326670; p = 0.047). Multivariable analysis showed that independent risk factors for postoperative infectious complications were no prophylactic antibiotics (p < 0.0001) and age 65 or older (p = 0.006). Conclusions: Perioperative administration of prophylactic antibiotics should be recommended in laparoscopic cholecystectomy to prevent postoperative infectious complications and to reduce medical costs.	[Matsui, Yoichi; Satoi, Sohei; Kaibori, Masaki; Toyokawa, Hideyoshi; Yanagimoto, Hiroaki; Matsui, Kosuke; Ishizaki, Morihiko; Kwon, A-Hon] Kansai Med Univ, Dept Surg, Hirakata, Osaka, Japan	Kansai Medical University	Matsui, Y (corresponding author), Kansai Med Univ, Dept Surg, Hirakata, Osaka, Japan.	matsui@hirakata.kmu.ac.jp	Matsui, Yoichi/Q-9966-2019	Matsui, Yoichi/0000-0002-7353-958X				Al-Ghnaniem R, 2003, BRIT J SURG, V90, P365, DOI 10.1002/bjs.4033; Ammori BJ, 2004, SURG ENDOSC, V18, P565, DOI 10.1007/s00464-003-9141-6; Barie PS, 2012, ANN SURG, V255, P1030, DOI 10.1097/SLA.0b013e3182574dd3; Burdiles, 1995, REV CHIL CIR, V47, P145; Catarci M, 2004, SURG ENDOSC, V18, P638, DOI 10.1007/s00464-003-9090-0; Chang WT, 2006, AM J SURG, V191, P721, DOI 10.1016/j.amjsurg.2006.01.050; Chen WJ, 2000, ZHEJIANG MED J, V22, P684; Choudhary A, 2008, J GASTROINTEST SURG, V12, P1847, DOI 10.1007/s11605-008-0681-x; Dobay KJ, 1999, AM SURGEON, V65, P226; Enochsson L, 2013, JAMA SURG, V148, P471, DOI 10.1001/jamasurg.2013.1221; Fang ZH, 2006, J LAPAROSCO SURG, V11, P250; Harling R, 2000, ANN ROY COLL SURG, V82, P408; Higgins A, 1999, ARCH SURG-CHICAGO, V134, P611, DOI 10.1001/archsurg.134.6.611; Illig KA, 1997, J AM COLL SURGEONS, V184, P353; Koc M, 2003, SURG ENDOSC, V17, P1716, DOI 10.1007/s00464-002-8866-y; Kuthe Sachin Anant, 2006, Trop Gastroenterol, V27, P54; Mahatharadol Virachai, 2001, Journal of the Medical Association of Thailand, V84, P105; Marschall J, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f3147; Sanabria A, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005265.pub2; Sarveswaran J, 2008, AM J SURG, V195, P135, DOI 10.1016/j.amjsurg.2006.09.034; Sharma N, 2010, SURG INFECT, V11, P367, DOI 10.1089/sur.2008.084; Shi HX, 2001, J SURG CONC PRAC, V6, P403; Tocchi A, 2000, ARCH SURG-CHICAGO, V135, P67, DOI 10.1001/archsurg.135.1.67; Uludag M, 2009, JSLS-J SOC LAPAROEND, V13, P337; Wang B, 2007, CLIN ED GEN PRAC, V5, P124; Yan RC, 2011, J LAPAROENDOSC ADV S, V21, P301, DOI 10.1089/lap.2010.0436; Yd H, 2003, CLIN MED, V23, P4; Yidiz B, 2009, HEPATO-GASTROENTEROL, V56, P589; Zhou H, 2009, ALIMENT PHARM THER, V29, P1086, DOI 10.1111/j.1365-2036.2009.03977.x; 王林波, 2002, [中华医院感染学杂志, Chinese Journal of Nosocomiology], V12, P845; 胡明秋, 2004, [中华普通外科杂志, Chinese Journal of General Surgery], V19, P639	31	31	35	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2014	9	9							e106702	10.1371/journal.pone.0106702	http://dx.doi.org/10.1371/journal.pone.0106702			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ1IR	25192389	Green Published, Green Submitted, gold			2022-12-27	WOS:000347993600053
J	Clarke, A; Martin, D; Jones, D; Schofield, P; Anthony, G; McNamee, P; Gray, D; Smith, BH				Clarke, Amanda; Martin, Denis; Jones, Derek; Schofield, Patricia; Anthony, Geraldine; McNamee, Paul; Gray, Denise; Smith, Blair H.			"I Try and Smile, I Try and Be Cheery, I Try Not to Be Pushy. I Try to Say 'I'm Here for Help' but I Leave Feeling... Worried'': A Qualitative Study of Perceptions of Interactions with Health Professionals by Community-Based Older Adults with Chronic Pain	PLOS ONE			English	Article							LOW-BACK-PAIN; PEOPLE; MANAGEMENT; CARE; EPIDEMIOLOGY; EXPERIENCES; DIAGNOSIS; ACCOUNTS; PATIENT; LIFE	Background: Over 50% of community-dwelling older adults experience chronic pain, which threatens their quality of life. Of importance to their pain management is older people's interaction with health professionals that, if unsatisfactory, may impair the outcome. Aims: To add to the limited research specific to older people living with chronic pain in the community, we explored how they perceive their experiences of interacting with health professionals, seeking factors that might optimise these interactions. Methods: Purposive sampling was used to recruit men and women >65 years with self-reported musculoskeletal chronic pain. Qualitative individual interviews and one group interview were undertaken with 23 participants. Data were transcribed verbatim and underwent Framework Analysis. Results: Three themes were identified. Seeking help illustrates issues around why older people in the community may or may not seek help for chronic pain, and highlights the potential involvement of social comparison. Importance of diagnosis illustrates the desire for professional validation of their condition and an aversion to vague explanations based on the person's age. Being listened to and being heard illustrates the importance of empathic communication and understanding expectations, with due respect for the person's age. Conclusions: In common with people of all ages, an effective partnership between an older person in pain and health professionals is essential if pain is to be reported, appropriately assessed and managed, because of the subjective nature of pain and its treatment responses. For older people with pain, perception about their age, by both parties in the partnership, is an additional factor that can unnecessarily interfere with the effectiveness of this partnership. Health professionals should engage with older adults to clarify their expectations about pain and its management, which may be influenced by perceptions about age; and to encourage expression of their concerns, which may also be affected by perceptions about age.	[Clarke, Amanda; Jones, Derek] Northumbria Univ, Sch Hlth Community & Educ Studies, Newcastle Upon Tyne NE1 8ST, Tyne & Wear, England; [Martin, Denis] Univ Teesside, Hlth & Social Care Inst, Middlesbrough, Cleveland, England; [Schofield, Patricia] Univ Greenwich, Sch Hlth & Social Care, London SE18 6PF, England; [Anthony, Geraldine; Smith, Blair H.] Univ Dundee, Med Res Inst, Dundee, Scotland; [McNamee, Paul; Gray, Denise] Univ Aberdeen, Sch Med & Dent, Aberdeen, Scotland	Northumbria University; University of Teesside; University of Greenwich; University of Dundee; University of Aberdeen	Martin, D (corresponding author), Univ Teesside, Hlth & Social Care Inst, Middlesbrough, Cleveland, England.	d.martin@tees.ac.uk	Schofield, Patricia/U-8534-2019; Smith, Blair/G-2834-2012	Clarke, Amanda/0000-0001-5701-7733; McNamee, Paul/0000-0002-4540-8718; Smith, Blair/0000-0002-5362-9430	Medical Research Council as part of the Lifelong Health and Wellbeing programme; MRC [G0900684] Funding Source: UKRI; Medical Research Council [G0900684] Funding Source: researchfish; Chief Scientist Office [HERU1] Funding Source: researchfish	Medical Research Council as part of the Lifelong Health and Wellbeing programme(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Chief Scientist Office	This study was funded by the Medical Research Council as part of the Lifelong Health and Wellbeing programme. The funders had no role in the design, execution, analysis and interpretation of the data, or writing of the study.	Breivik H, 2006, EUR J PAIN, V10, P287, DOI 10.1016/j.ejpain.2005.06.009; Clarke A, 2012, BMC GERIATR, V12, DOI 10.1186/1471-2318-12-78; Cooper K, 2008, PHYSIOTHERAPY, V94, P244, DOI 10.1016/j.physio.2007.10.006; Corbett M, 2007, SOC SCI MED, V65, P1584, DOI 10.1016/j.socscimed.2007.06.008; Elliott AM, 1999, LANCET, V354, P1248, DOI 10.1016/S0140-6736(99)03057-3; Gagliese L, 2009, J PAIN, V10, P343, DOI 10.1016/j.jpain.2008.10.013; Gignac MAM, 2006, ARTHRIT RHEUM-ARTHR, V55, P905, DOI 10.1002/art.22338; Grime J, 2010, BRIT J GEN PRACT, V60, P597, DOI 10.3399/bjgp10X515106; Helme RD, 2001, CLIN GERIATR MED, V17, P417, DOI 10.1016/S0749-0690(05)70078-1; Hill J, 2007, RHEUMATOLOGY, V46, P796, DOI 10.1093/rheumatology/kel407; IASP, 2009, GLOB YEAR PAIN 2009; Jackson T, 2011, EUR J PAIN, V15, P1081, DOI 10.1016/j.ejpain.2011.04.008; Jakobsson U, 2003, J PAIN SYMPTOM MANAG, V26, P625, DOI 10.1016/S0885-3924(03)00145-3; JENSEN MP, 1992, COGNITIVE THER RES, V16, P297, DOI 10.1007/BF01183283; Jutel A, 2009, SOCIOL HEALTH ILL, V31, P278, DOI 10.1111/j.1467-9566.2008.01152.x; Kristiansson MH, 2011, BMC FAM PRACT, V12, DOI 10.1186/1471-2296-12-31; Kumar A, 2008, PAIN OLDER PEOPLE RE; Kvale S, 1996, INTERVIEWS INTRO QUA; Leung KK, 2004, QUAL LIFE RES, V13, P179, DOI 10.1023/B:QURE.0000015291.79826.a8; Mercer SW, 2004, PATIENT EDUC COUNS, V53, P13, DOI 10.1016/S0738-3991(03)00242-8; Mercer SW, 2001, BRIT MED J, V322, P865, DOI 10.1136/bmj.322.7290.865; Ong BN, 2011, INT J QUAL STUD HEAL, V6, DOI 10.3402/qhw.v6i3.7035; Ong BN, 2006, SOCIOL HEALTH ILL, V28, P203, DOI 10.1111/j.1467-9566.2006.00488.x; Ritchie J, 1994, ANAL QUALITATIVE DAT, P172; Roberto KA, 2002, J WOMEN AGING, V14, P5, DOI 10.1300/J074v14n03_02; Sanders C, 2002, SOCIOL HEALTH ILL, V24, P227, DOI 10.1111/1467-9566.00292; Schofield P, 2011, AGING HLTH, V7, P551, DOI DOI 10.2217/AHE.11.41]; Sofaer B, 2005, AGE AGEING, V34, P462, DOI 10.1093/ageing/afi139; Sofaer-Bennett B, 2012, GERIATRIC MED MIDLIF, V42, P13; Sofaer-Bennett B, 2007, PAIN MED, V8, P271, DOI 10.1111/j.1526-4637.2007.00297.x; Stannard C, 2003, CURR MED RES OPIN, V19, P703, DOI 10.1185/030079903125002478; Toye F, 2011, PRIM HEALTH CARE RES, V13, P72; Walker J, 1999, PAIN, V80, P621, DOI 10.1016/S0304-3959(98)00254-1; Zalon M L, 1997, Image J Nurs Sch, V29, P21, DOI 10.1111/j.1547-5069.1997.tb01135.x	34	30	30	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 4	2014	9	9							e105450	10.1371/journal.pone.0105450	http://dx.doi.org/10.1371/journal.pone.0105450			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AO3XV	25187952	gold, Green Accepted, Green Published			2022-12-27	WOS:000341271500008
J	Fatima, K; Mathew, S; Suhail, M; Ali, A; Damanhouri, G; Azhar, E; Qadri, I				Fatima, Kaneez; Mathew, Shilu; Suhail, Mohd; Ali, Ashraf; Damanhouri, Ghazi; Azhar, Esam; Qadri, Ishtiaq			Docking Studies of Pakistani HCV NS3 Helicase: A Possible Antiviral Drug Target	PLOS ONE			English	Article							HEPATITIS-C VIRUS; RNA HELICASE; CRYSTAL-STRUCTURE; ACRIDONE DERIVATIVES; PROTEIN MODELS; INHIBITORS; REPLICATION; MECHANISM; ACCURACY; DOMAIN	The nonstructural protein 3 (NS3) of hepatitis C virus (HCV) helicase is believed to be essential for viral replication and has become an attractive target for the development of antiviral drugs. The study of helicase is useful for elucidating its involvement in positive sense single-stranded RNA virus replication and to serve as templates for the design of novel antiviral drugs. In recent years, several models have been proposed on the conformational change leading to protein movement and RNA unwinding. Some compounds have been recently reported to inhibit the helicase and these include small molecules, RNA aptamers and antibodies. The current study is designed to help gain insights for the consideration of potential inhibitors for Pakistani HCV NS3 helicase protein. We have cloned, expressed and purified HCV NS3 helicase from Pakistani HCV serum samples and determined its 3D structure and employed it further in computational docking analysis to identify inhibitors against HCV genotype 3a (GT3a), including six antiviral key molecules such as quercetin, beta-carotene, resveratrol, catechins, lycopene and lutein. The conformation obtained after docking showed good hydrogen bond (HBond) interactions with best docking energy for quercetin and catechins followed by resveratrol and lutein. These anti-helicase key molecules will offer an alternative attraction to target the viral helicase, due to the current limitation with the interferon resistance treatment and presences of high rate of resistance in anti-protease inhibitor classes.	[Fatima, Kaneez] IQ Inst Infect & Immun, Lahore, Punjab, Pakistan; [Mathew, Shilu] King Abdulaziz Univ, Ctr Excellence Genom Med Res, Jeddah, Saudi Arabia; [Suhail, Mohd; Ali, Ashraf; Damanhouri, Ghazi; Azhar, Esam; Qadri, Ishtiaq] King Abdulaziz Univ, King Fahd Med Res Ctr, Jeddah, Saudi Arabia	King Abdulaziz University; King Abdulaziz University	Qadri, I (corresponding author), King Abdulaziz Univ, King Fahd Med Res Ctr, Jeddah, Saudi Arabia.	ishtiaq80262@yahoo.com	Suhail, Mohd/H-9626-2012; Suhail, Mohd/K-2086-2014; Azhar, Esam/ABI-1044-2020; Damanhouri, Ghazi/Q-7901-2019; Ali, Ashraf/H-9630-2012; Qadri, Ishtiaq/I-6889-2013; Ali, Ashraf/HDM-9287-2022	Suhail, Mohd/0000-0002-1641-4633; Ali, Ashraf/0000-0001-5267-2608; Azhar, Esam/0000-0002-1736-181X; Qadri, Ishtiaq/0000-0003-4334-0585	IQ Institute of Infection and Immunity (IQI3); Miraj Foundation	IQ Institute of Infection and Immunity (IQI3); Miraj Foundation	This work was funded by IQ Institute of Infection and Immunity (IQI3) and Miraj Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashfaq UA, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-161; Ashfaq Usman Ali, 2011, Genet Vaccines Ther, V9, P7, DOI 10.1186/1479-0556-9-7; BARTENSCHLAGER R, 1994, J VIROL, V68, P5045, DOI 10.1128/JVI.68.8.5045-5055.1994; Belon CA, 2010, BIOCHEMISTRY-US, V49, P1822, DOI 10.1021/bi901974a; Belon CA, 2009, FUTURE VIROL, V4, P277, DOI 10.2217/FVL.09.7; BOWIE JU, 1991, SCIENCE, V253, P164, DOI 10.1126/science.1853201; Calland N, 2012, VIRUSES-BASEL, V4, P2197, DOI 10.3390/v4102197; Campagna M, 2010, BIOCHEM SOC T, V38, P50, DOI 10.1042/BST0380050; Chen CS, 2009, J MED CHEM, V52, P2716, DOI 10.1021/jm8011905; Cho HS, 1998, J BIOL CHEM, V273, P15045, DOI 10.1074/jbc.273.24.15045; Dahl G, 2007, FEBS J, V274, P5979, DOI 10.1111/j.1742-4658.2007.06120.x; ElHefnawi M, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-S17-S5; Fatima K, 2011, VIRUS RES, V160, P230, DOI 10.1016/j.virusres.2011.06.020; Fiser A, 2000, PROTEIN SCI, V9, P1753, DOI 10.1110/ps.9.9.1753; Frick DN, 2007, CURR ISSUES MOL BIOL, V9, P1; Gemma S, 2011, BIOORG MED CHEM LETT, V21, P2776, DOI 10.1016/j.bmcl.2010.09.002; Gu MG, 2010, P NATL ACAD SCI USA, V107, P521, DOI 10.1073/pnas.0913380107; Hamid S., 2004, JPMA Journal of the Pakistan Medical Association, V54, P146; Jones DM, 2010, J BIOL CHEM, V285, P22732, DOI 10.1074/jbc.R110.133017; KAUL TN, 1985, J MED VIROL, V15, P71, DOI 10.1002/jmv.1890150110; Khachatoorian R, 2012, VIROLOGY, V433, P346, DOI 10.1016/j.virol.2012.08.029; KHACHIK F, 1995, J CELL BIOCHEM, P236; Khan M, 2013, BIOINFORMATION, V9; Khan M, 2013, BIOINFORMATION, V9, P978, DOI 10.6026/97320630009978; KIM DW, 1995, BIOCHEM BIOPH RES CO, V215, P160, DOI 10.1006/bbrc.1995.2447; Kim JL, 1998, STRUCTURE, V6, P89, DOI 10.1016/S0969-2126(98)00010-0; Krawczyk M, 2009, BIOL CHEM, V390, P351, DOI 10.1515/BC.2009.040; Li KL, 2012, J MED CHEM, V55, P3319, DOI 10.1021/jm300021v; Lopez-Labrador Francesc-Xavier, 2008, Recent Pat Antiinfect Drug Discov, V3, P157, DOI 10.2174/157489108786242369; LUTHY R, 1992, NATURE, V356, P83, DOI 10.1038/356083a0; Maiti R, 2004, NUCLEIC ACIDS RES, V32, pW590, DOI 10.1093/nar/gkh477; Manfroni G, 2009, J MED CHEM, V52, P3354, DOI 10.1021/jm801608u; Marti-Renom MA, 2000, ANNU REV BIOPH BIOM, V29, P291, DOI 10.1146/annurev.biophys.29.1.291; Mastrangelo E, 2012, J ANTIMICROB CHEMOTH, V67, P1884, DOI 10.1093/jac/dks147; Mathew S, 2014, INFECT GENET EVOL; Naggie Susanna, 2012, Top Antivir Med, V20, P154; Najda-Bernatowicz A, 2010, BIOORGAN MED CHEM, V18, P5129, DOI 10.1016/j.bmc.2010.05.066; Pang R, 2010, PHYTOTHER RES, V24, P1627, DOI 10.1002/ptr.3155; Perchyonok VTSZO T, 2013, OPEN NANOSCIENCE J, V7; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Phoon CW, 2001, BIOORG MED CHEM LETT, V11, P1647, DOI 10.1016/S0960-894X(01)00263-3; Piccininni S, 2002, J BIOL CHEM, V277, P45670, DOI 10.1074/jbc.M204124200; Ranji A, 2010, RNA BIOL, V7, P775, DOI 10.4161/rna.7.6.14249; SANTOS E, 1989, FASEB J, V3, P2151, DOI 10.1096/fasebj.3.10.2666231; Santos MS, 1996, AM J CLIN NUTR, V64, P772, DOI 10.1093/ajcn/64.5.772; Song JM, 2005, ANTIVIR RES, V68, P66, DOI 10.1016/j.antiviral.2005.06.010; Stankiewicz-Drogon A, 2010, J MED CHEM, V53, P3117, DOI 10.1021/jm901741p; Thomsen R, 2006, J MED CHEM, V49, P3315, DOI 10.1021/jm051197e; Tunitskaya VL, 2011, BIOORG MED CHEM LETT, V21, P5331, DOI 10.1016/j.bmcl.2011.07.018; Vlachakis D, 2013, PEERJ, V1, DOI 10.7717/peerj.85; Webb Benjamin, 2016, Curr Protoc Protein Sci, V86, DOI [10.1002/cpbi.3, 10.1002/0471250953.bi0506s15, 10.1002/0471140864.ps0209s50, 10.1002/cpps.20]; Xu D, 2011, BIOPHYS J, V101, P2525, DOI 10.1016/j.bpj.2011.10.024; Yao NH, 1999, STRUCTURE, V7, P1353, DOI 10.1016/S0969-2126(00)80025-8; Yao NH, 1997, NAT STRUCT BIOL, V4, P463, DOI 10.1038/nsb0697-463	54	12	14	2	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 4	2014	9	9							e106339	10.1371/journal.pone.0106339	http://dx.doi.org/10.1371/journal.pone.0106339			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3XV	25188400	Green Published, Green Submitted, gold			2022-12-27	WOS:000341271500027
J	Kim, BC; Joo, J; Chang, HJ; Yeo, HY; Yoo, BC; Park, B; Park, JW; Sohn, DK; Hong, CW; Han, KS				Kim, Byung Chang; Joo, Jungnam; Chang, Hee Jin; Yeo, Hyun Yang; Yoo, Byong Chul; Park, Boram; Park, Ji Won; Sohn, Dae Kyung; Hong, Chang Won; Han, Kyung Su			A Predictive Model Combining Fecal Calgranulin B and Fecal Occult Blood Tests Can Improve the Diagnosis of Colorectal Cancer	PLOS ONE			English	Article							INTESTINAL INFLAMMATION; PROTEIN MARKERS; CALPROTECTIN; RISK; SPECIFICITY; SENSITIVITY; COMBINATION; PERFORMANCE; LIMITATIONS; STATISTICS	Aim: Current fecal screening tools for colorectal cancer (CRC), such as fecal occult blood tests (FOBT), are limited by their low sensitivity. Calgranulin B (CALB) was previously reported as a candidate fecal marker for CRC. This study investigated whether a combination of the FOBT and fecal CALB has increased sensitivity and specificity for a diagnosis of CRC. Materials and Methods: Patients with CRC (n = 175), and healthy individuals (controls; n = 151) were enrolled into the development (81 cases and 51 controls) and validation (94 cases and 100 controls) sets. Stool samples were collected before bowel preparation. CALB levels were determined by western blotting. FOBT and fecal CALB results were used to develop a predictive model based on logistic regression analysis. The benefit of adding CALB to a model with only FOBT was evaluated as an increased area under the receiver operating curve (AUC), partial AUC, and reclassification improvement (RI) in cases and controls, and net reclassification improvement (NRI). Results: Mean CALB level was significantly higher in CRC patients than in controls (P < 0.001). CALB was not associated with tumor stage or cancer site, but positivity on the FOBT was significantly higher in advanced than in earlier tumor stages. At a specificity of 90%, the cross-validated AUC and sensitivity were 89.81% and 82.72%, respectively, in the development set, and 92.74% and 79.79%, respectively, in the validation set. The incremental benefit of adding CALB to the model, as shown by the increase in AUC, had a p-value of 0.0499. RI in cases and controls and NRI all revealed that adding CALB significantly improved the prediction model. Conclusion: A predictive model using a combination of FOBT and CALB may have greater sensitivity and specificity and AUC for predicting CRC than models using a single marker.	[Kim, Byung Chang; Chang, Hee Jin; Park, Ji Won; Sohn, Dae Kyung; Hong, Chang Won; Han, Kyung Su] Natl Canc Ctr, Ctr Colorectal Canc, Goyang, Gyeonggi, South Korea; [Kim, Byung Chang; Sohn, Dae Kyung; Hong, Chang Won; Han, Kyung Su] Natl Canc Ctr, Ctr Canc Prevent & Detect, Goyang, Gyeonggi, South Korea; [Joo, Jungnam; Park, Boram] Natl Canc Ctr, Biometr Res Branch, Goyang, Gyeonggi, South Korea; [Chang, Hee Jin; Yeo, Hyun Yang; Yoo, Byong Chul; Park, Ji Won; Sohn, Dae Kyung] Natl Canc Ctr, Res Inst & Hosp, Goyang, Gyeonggi, South Korea	National Cancer Center - Korea (NCC); National Cancer Center - Korea (NCC); National Cancer Center - Korea (NCC); National Cancer Center - Korea (NCC)	Chang, HJ (corresponding author), Natl Canc Ctr, Ctr Colorectal Canc, Goyang, Gyeonggi, South Korea.	heejincmd@yahoo.com		Park, Boram/0000-0003-2683-8795	National Cancer Center of Korea [NCC-1240830-1]; Converging Research Center Program - Ministry of Education, Science and Technology [2013K000271]	National Cancer Center of Korea; Converging Research Center Program - Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea)	Supportive foundations: This research was supported by grant from the National Cancer Center of Korea (NCC-1240830-1), and by the Converging Research Center Program funded by the Ministry of Education, Science and Technology (Project No. 2013K000271). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahlquist DA, 1997, GASTROENTEROL CLIN N, V26, P41, DOI 10.1016/S0889-8553(05)70282-X; Ahlquist DA, 1996, DIGEST DIS, V14, P132, DOI 10.1159/000171545; ALLISON JE, 1990, ANN INTERN MED, V112, P328, DOI 10.7326/0003-4819-112-5-328; Dabritz J, 2014, WORLD J GASTROENTERO, V20, P363, DOI 10.3748/wjg.v20.i2.363; Davies RJ, 2005, NAT REV CANCER, V5, P199, DOI 10.1038/nrc1569; DELONG ER, 1988, BIOMETRICS, V44, P837, DOI 10.2307/2531595; FEARON ER, 1990, CELL, V61, P759, DOI 10.1016/0092-8674(90)90186-I; Flahault A, 2005, J CLIN EPIDEMIOL, V58, P859, DOI 10.1016/j.jclinepi.2004.12.009; Foell D, 2008, J PATHOL, V216, P183, DOI 10.1002/path.2394; Foell D, 2009, GUT, V58, P859, DOI 10.1136/gut.2008.170019; Greene FL, 2002, AJCC CANC STAGING MA, DOI DOI 10.1007/978-1-4757-3656-4; Greenland P, 2005, ARCH INTERN MED, V165, P2454, DOI 10.1001/archinte.165.21.2454; Hamilton SR, 2000, WHO CLASSIFICATION T; Hoff G, 2004, GUT, V53, P1329, DOI 10.1136/gut.2004.039032; IMAN RL, 1979, TECHNOMETRICS, V21, P499, DOI 10.2307/1268289; Jung KW, 2009, J KOREAN MED SCI, V24, P995, DOI 10.3346/jkms.2009.24.6.995; Karl J, 2008, CLIN GASTROENTEROL H, V6, P1122, DOI 10.1016/j.cgh.2008.04.021; Kronborg O, 2000, GUT, V46, P795, DOI 10.1136/gut.46.6.795; Langhorst J, 2008, AM J GASTROENTEROL, V103, P162, DOI 10.1111/j.1572-0241.2007.01556.x; Lieberman DA, 2000, NEW ENGL J MED, V343, P162, DOI 10.1056/NEJM200007203430301; MANDEL JS, 1993, NEW ENGL J MED, V328, P1365, DOI 10.1056/NEJM199305133281901; Mor G, 2005, P NATL ACAD SCI USA, V102, P7677, DOI 10.1073/pnas.0502178102; Osborn NK, 2005, GASTROENTEROLOGY, V128, P192, DOI 10.1053/j.gastro.2004.10.041; Pencina MJ, 2008, STAT MED, V27, P157, DOI 10.1002/sim.2929; Pepe MS, 2004, AM J EPIDEMIOL, V159, P882, DOI 10.1093/aje/kwh101; Rhodes JM, 2000, GUT, V46, P746, DOI 10.1136/gut.46.6.746; Schroder O, 2007, ALIMENT PHARM THER, V26, P1035, DOI 10.1111/j.1365-2036.2007.03457.x; Shitrit ABG, 2007, DIS COLON RECTUM, V50, P2188, DOI 10.1007/s10350-007-9038-x; Simon R, 2003, BRIT J CANCER, V89, P1599, DOI 10.1038/sj.bjc.6601326; STJOHN DJB, 1992, ANN INTERN MED, V117, P376, DOI 10.7326/0003-4819-117-5-376; Takai T, 2009, CANCER EPIDEM BIOMAR, V18, P1888, DOI 10.1158/1055-9965.EPI-08-0937; Tibble J, 2001, GUT, V49, P402, DOI 10.1136/gut.49.3.402; Ware JH, 2006, NEW ENGL J MED, V355, P2615, DOI 10.1056/NEJMp068249; Yoo BC, 2008, DIS COLON RECTUM, V51, P1703, DOI 10.1007/s10350-008-9381-6	34	11	12	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 4	2014	9	9							e106182	10.1371/journal.pone.0106182	http://dx.doi.org/10.1371/journal.pone.0106182			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3XV	25188229	Green Submitted, gold, Green Published			2022-12-27	WOS:000341271500024
J	Spisak, T; Jakab, A; Kis, SA; Opposits, G; Aranyi, C; Berenyi, E; Emri, M				Spisak, Tamas; Jakab, Andras; Kis, Sandor A.; Opposits, Gabor; Aranyi, Csaba; Berenyi, Ervin; Emri, Miklos			Voxel-Wise Motion Artifacts in Population-Level Whole-Brain Connectivity Analysis of Resting-State fMRI	PLOS ONE			English	Article							GLOBAL SIGNAL REGRESSION; FUNCTIONAL CONNECTIVITY; CEREBRAL-CORTEX; HEAD MOTION; AUTISM; REGISTRATION; IMPACT; ROBUST; MRI; OPTIMIZATION	Functional Magnetic Resonance Imaging (fMRI) based brain connectivity analysis maps the functional networks of the brain by estimating the degree of synchronous neuronal activity between brain regions. Recent studies have demonstrated that "resting-state'' fMRI-based brain connectivity conclusions may be erroneous when motion artifacts have a differential effect on fMRI BOLD signals for between group comparisons. A potential explanation could be that in-scanner displacement, due to rotational components, is not spatially constant in the whole brain. However, this localized nature of motion artifacts is poorly understood and is rarely considered in brain connectivity studies. In this study, we initially demonstrate the local correspondence between head displacement and the changes in the resting-state fMRI BOLD signal. Than, we investigate how connectivity strength is affected by the population-level variation in the spatial pattern of regional displacement. We introduce Regional Displacement Interaction (RDI), a new covariate parameter set for second-level connectivity analysis and demonstrate its effectiveness in reducing motion related confounds in comparisons of groups with different voxel-vise displacement pattern and preprocessed using various nuisance regression methods. The effect of using RDI as second-level covariate is than demonstrated in autism-related group comparisons. The relationship between the proposed method and some of the prevailing subject-level nuisance regression techniques is evaluated. Our results show that, depending on experimental design, treating in-scanner head motion as a global confound may not be appropriate. The degree of displacement is highly variable among various brain regions, both within and between subjects. These regional differences bias correlation-based measures of brain connectivity. The inclusion of the proposed second-level covariate into the analysis successfully reduces artifactual motion-related group differences and preserves real neuronal differences, as demonstrated by the autism-related comparisons.	[Spisak, Tamas; Kis, Sandor A.; Opposits, Gabor; Aranyi, Csaba; Emri, Miklos] Univ Debrecen, Med & Hlth Sci Ctr, Dept Nucl Med, Debrecen, Hungary; [Jakab, Andras] Med Univ Vienna, Dept Radiol, Vienna, Austria; [Berenyi, Ervin] Univ Debrecen, Med & Hlth Sci Ctr, Dept Biomed Lab & Imaging Sci, Debrecen, Hungary	University of Debrecen; Medical University of Vienna; University of Debrecen	Spisak, T (corresponding author), Univ Debrecen, Med & Hlth Sci Ctr, Dept Nucl Med, Debrecen, Hungary.	tspisak@pet.dote.hu	Opposits, Gabor/AAO-2526-2020; Opposits, Gábor/AAD-6265-2020; Spisak, Tamas/GWQ-9005-2022; Emri, Miklós/AAK-3515-2020; Jakab, András/U-9436-2019	Opposits, Gabor/0000-0002-0065-224X; Emri, Miklós/0000-0001-9884-9202; Jakab, András/0000-0001-6291-9889; Aranyi, Sandor Csaba/0000-0001-9569-5404	European Union; European Social Fund through project "Supercomputer, the national virtual lab'' [TAMOP-4.2.2.C-11/1/KONV-2012-0010]; State of Hungary - European Social Fund through project "Basic and applied research to assist the development of speech for the deaf" [TAMOP 4.2.2.C-11/1/KONV]; State of Hungary through the National Brain Research Program [KTIA_13_NAP-A-II/3]; European Commission, 7th European Community Framework Programme, Marie Curie IEF Research grant FABRIC - "exploring the Formation and Adaptation of the Brain Connectome'' [2012-PIEF-GA-33003]; State of Hungary - European Social Fund 'National Excellence Program' [TAMOP-4.2.4.A/2-11/1-2012-0001]	European Union(European Commission); European Social Fund through project "Supercomputer, the national virtual lab''; State of Hungary - European Social Fund through project "Basic and applied research to assist the development of speech for the deaf"; State of Hungary through the National Brain Research Program; European Commission, 7th European Community Framework Programme, Marie Curie IEF Research grant FABRIC - "exploring the Formation and Adaptation of the Brain Connectome''; State of Hungary - European Social Fund 'National Excellence Program'	The study was partially supported by the European Union and the European Social Fund through project "Supercomputer, the national virtual lab'' (grant. no.: TAMOP-4.2.2.C-11/1/KONV-2012-0010). The work was supported by the European Union and the State of Hungary, co-financed by the European Social Fund through project "Basic and applied research to assist the development of speech for the deaf'' (TAMOP 4.2.2.C-11/1/KONV). The project was supported by the State of Hungary through the National Brain Research Program ("Charting the normal and pathological macro-scale brain connectome by in vivo neuroimaging'', KTIA_13_NAP-A-II/3). T. S. was supported by the European Union and the State of Hungary, co-financed by the European Social Fund in the framework of TAMOP-4.2.4.A/2-11/1-2012-0001 'National Excellence Program'. A.J. was supported by the European Commission, 7th European Community Framework Programme, Marie Curie IEF Research grant FABRIC - "exploring the Formation and Adaptation of the Brain Connectome'', 2012-PIEF-GA-33003. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLISON PD, 1977, AM J SOCIOL, V83, P144, DOI 10.1086/226510; [Anonymous], 2004, STAT ANAL DATA DISPL; Behzadi Y, 2007, NEUROIMAGE, V37, P90, DOI 10.1016/j.neuroimage.2007.04.042; Belmonte MK, 2004, J NEUROSCI, V24, P9228, DOI 10.1523/JNEUROSCI.3340-04.2004; Breheny P., 2012, VISUALIZATION REGRES; Cordes D, 2001, AM J NEURORADIOL, V22, P1326; Courchesne E, 2005, CURR OPIN NEUROBIOL, V15, P225, DOI 10.1016/j.conb.2005.03.001; Deen Ben, 2012, Nature, V491, pS20; Desikan RS, 2006, NEUROIMAGE, V31, P968, DOI 10.1016/j.neuroimage.2006.01.021; Di Martino A, 2014, MOL PSYCHIATR, V19, P659, DOI 10.1038/mp.2013.78; Dobson A. J., 2010, INTRO GEN LINEAR MOD, V2nd; Fair DA, 2013, FRONT SYST NEUROSCI, V6, DOI 10.3389/fnsys.2012.00080; Fox MD, 2009, J NEUROPHYSIOL, V101, P3270, DOI 10.1152/jn.90777.2008; Freire L, 2001, NEUROIMAGE, V14, P709, DOI 10.1006/nimg.2001.0869; Friston KJ, 1996, MAGNET RESON MED, V35, P346, DOI 10.1002/mrm.1910350312; Friston KJ, 1994, HUMAN BRAIN MAPPING, V2, P189, DOI DOI 10.1002/HBM.460020402; Ginestet CE, 2011, NEUROIMAGE, V55, P688, DOI 10.1016/j.neuroimage.2010.11.030; Glover GH, 2000, MAGNET RESON MED, V44, P162, DOI 10.1002/1522-2594(200007)44:1<162::AID-MRM23>3.0.CO;2-E; Gotts SJ, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00356; Imperati D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023437; Jakab A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060982; Jenkinson M, 2002, NEUROIMAGE, V17, P825, DOI 10.1006/nimg.2002.1132; Jenkinson M, 2001, MED IMAGE ANAL, V5, P143, DOI 10.1016/S1361-8415(01)00036-6; Jenkinson M, 2012, NEUROIMAGE, V62, P782, DOI 10.1016/j.neuroimage.2011.09.015; Jo HJ, 2013, J APPL MATH, DOI 10.1155/2013/935154; Jo HJ, 2010, NEUROIMAGE, V52, P571, DOI 10.1016/j.neuroimage.2010.04.246; Kim B, 1999, MAGN RESON MED, V41, P964, DOI 10.1002/(SICI)1522-2594(199905)41:5<964::AID-MRM16>3.0.CO;2-D; Klaus B, 2013, FDRTOOL ESTIMATION L; Koyama MS, 2011, J NEUROSCI, V31, P8617, DOI 10.1523/JNEUROSCI.4865-10.2011; Lemieux L, 2007, MAGN RESON IMAGING, V25, P894, DOI 10.1016/j.mri.2007.03.009; Muller RA, 2011, CEREB CORTEX, V21, P2233, DOI 10.1093/cercor/bhq296; Murphy K, 2009, NEUROIMAGE, V44, P893, DOI 10.1016/j.neuroimage.2008.09.036; Niazy RK, 2011, PROG BRAIN RES, V193, P259, DOI 10.1016/B978-0-444-53839-0.00017-X; Power JD, 2012, NEUROIMAGE, V76; Power JD, 2012, NEUROIMAGE, V59, P2142, DOI 10.1016/j.neuroimage.2011.10.018; R Core Team, 2021, R LANGUAGE ENV STAT; Saad ZS, 2012, BRAIN CONNECT, V2, P25, DOI 10.1089/brain.2012.0080; Satterthwaite TD, 2013, NEUROIMAGE, V64, P240, DOI 10.1016/j.neuroimage.2012.08.052; Satterthwaite TD, 2012, NEUROIMAGE, V60, P623, DOI 10.1016/j.neuroimage.2011.12.063; Smith SM, 2002, HUM BRAIN MAPP, V17, P143, DOI 10.1002/hbm.10062; Smyser CD, 2010, CEREB CORTEX, V20, P2852, DOI 10.1093/cercor/bhq035; Spisak T, 2012, MAGN RESON MATER PHY, V25, P616; STINE RA, 1995, AM STAT, V49, P53, DOI 10.2307/2684812; Strimmer K, 2008, BIOINFORMATICS, V24, P1461, DOI 10.1093/bioinformatics/btn209; Van Dijk KRA, 2012, NEUROIMAGE, V59, P431, DOI 10.1016/j.neuroimage.2011.07.044; Venables William N, 1994, MODERN APPL STAT S P, V250; Yan CG, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00910; Yan CG, 2013, NEUROIMAGE, V76, P183, DOI 10.1016/j.neuroimage.2013.03.004; Zotev V, 2012, NEUROIMAGE, V63, P698, DOI 10.1016/j.neuroimage.2012.07.031	49	18	18	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 4	2014	9	9							e104947	10.1371/journal.pone.0104947	http://dx.doi.org/10.1371/journal.pone.0104947			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3XV	25188284	Green Submitted, Green Published, gold			2022-12-27	WOS:000341271500003
J	Stenberg, TA; Kildal, AB; Sanden, E; How, OJ; Hagve, M; Ytrehus, K; Larsen, TS; Myrmel, T				Stenberg, Thor Allan; Kildal, Anders Benjamin; Sanden, Espen; How, Ole-Jakob; Hagve, Martin; Ytrehus, Kirsti; Larsen, Terje S.; Myrmel, Truls			The Acute Phase of Experimental Cardiogenic Shock Is Counteracted by Microcirculatory and Mitochondrial Adaptations	PLOS ONE			English	Article							MYOCARDIAL-INFARCTION; HEART-FAILURE; OXIDATIVE-PHOSPHORYLATION; EARLY REVASCULARIZATION; RESPIRATION; HYPOXIA; BEDSIDE; EFFICIENCY; MORTALITY; BENCH	The mechanisms contributing to multiorgan dysfunction during cardiogenic shock are poorly understood. Our goal was to characterize the microcirculatory and mitochondrial responses following >= 10 hours of severe left ventricular failure and cardiogenic shock. We employed a closed-chest porcine model of cardiogenic shock induced by left coronary microembolization (n = 12) and a time-matched control group (n = 6). Hemodynamics and metabolism were measured hourly by intravascular pressure catheters, thermodilution, arterial and organ specific blood gases. Echocardiography and assessment of the sublingual microcirculation by sidestream darkfield imaging were performed at baseline, 2 +/- 1 and 13 +/- 3 (mean +/- SD) hours after coronary microembolization. Upon hemodynamic decompensation, cardiac, renal and hepatic mitochondria were isolated and evaluated by high-resolution respirometry. Low cardiac output, hypotension, oliguria and severe reductions in mixed-venous and hepatic O-2 saturations were evident in cardiogenic shock. The sublingual total and perfused vessel densities were fully preserved throughout the experiments. Cardiac mitochondrial respiration was unaltered, whereas state 2, 3 and 4 respiration of renal and hepatic mitochondria were increased in cardiogenic shock. Mitochondrial viability (RCR; state 3/state 4) and efficiency (ADP/O ratio) were unaffected. Our study demonstrates that the microcirculation is preserved in a porcine model of untreated cardiogenic shock despite vital organ hypoperfusion. Renal and hepatic mitochondrial respiration is upregulated, possibly through demand-related adaptations, and the endogenous shock response is thus compensatory and protective, even after several hours of global hypoperfusion.	[Stenberg, Thor Allan; Sanden, Espen; Myrmel, Truls] Univ Tromso, Fac Hlth Sci, Dept Clin Med, Cardiovasc Res Grp, Tromso, Norway; [Kildal, Anders Benjamin; How, Ole-Jakob; Hagve, Martin; Ytrehus, Kirsti; Larsen, Terje S.] Univ Tromso, Fac Hlth Sci, Dept Med Biol, Cardiovasc Res Grp, Tromso, Norway; [Stenberg, Thor Allan; Kildal, Anders Benjamin; Myrmel, Truls] Univ Hosp North Norway, Dept Cardiothorac & Vasc Surg, Tromso, Norway	UiT The Arctic University of Tromso; UiT The Arctic University of Tromso; UiT The Arctic University of Tromso; University Hospital of North Norway	Sanden, E (corresponding author), Univ Tromso, Fac Hlth Sci, Dept Clin Med, Cardiovasc Res Grp, Tromso, Norway.	espen.sanden@uit.no; truls.myrmel@uit.no		Kildal, Anders Benjamin/0000-0002-1319-6511	Northern Norway Regional Health Authority; Norwegian Health Association, Norwegian Council on Cardiovascular Diseases	Northern Norway Regional Health Authority; Norwegian Health Association, Norwegian Council on Cardiovascular Diseases	This work was financially supported by the Northern Norway Regional Health Authority and the Norwegian Health Association, Norwegian Council on Cardiovascular Diseases. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AGRESS CM, 1957, J APPL PHYSIOL, V10, P469, DOI 10.1152/jappl.1957.10.3.469; Almsherqi ZA, 2006, CELL RES, V16, P297, DOI 10.1038/sj.cr.7310037; Berger PB, 1999, CIRCULATION, V99, P873, DOI 10.1161/01.CIR.99.7.873; Boerma EC, 2005, CRIT CARE, V9, pR601, DOI 10.1186/cc3809; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; CHANCE B, 1955, J BIOL CHEM, V217, P409; D'hooge J, 2000, Eur J Echocardiogr, V1, P154, DOI 10.1053/euje.2000.0031; Daussin FN, 2012, MED SCI SPORT EXER, V44, P217, DOI 10.1249/MSS.0b013e31822b0bd4; De Backer D, 2004, AM HEART J, V147, P91, DOI 10.1016/j.ahj.2003.07.006; De Backer D, 2007, CRIT CARE, V11, DOI 10.1186/cc6118; den Uil CA, 2010, EUR HEART J, V31, P3032, DOI 10.1093/eurheartj/ehq324; DUAN JM, 1989, MOL CELL BIOCHEM, V90, P47; Fink MP, 2002, CRIT CARE, V6, P491, DOI 10.1186/cc1824; Fukuda R, 2007, CELL, V129, P111, DOI 10.1016/j.cell.2007.01.047; FULLER EO, 1985, J MOL CELL CARDIOL, V17, P71, DOI 10.1016/S0022-2828(85)80093-6; Guzun R, 2009, BBA-BIOENERGETICS, V1787, P1089, DOI 10.1016/j.bbabio.2009.03.024; Hafstad AD, 2011, J APPL PHYSIOL, V111, P1235, DOI 10.1152/japplphysiol.00594.2011; Heusch G, 2009, CIRCULATION, V120, P1822, DOI 10.1161/CIRCULATIONAHA.109.888784; Hochman JS, 1999, NEW ENGL J MED, V341, P625, DOI 10.1056/NEJM199908263410901; Hollenberg SM, 1999, ANN INTERN MED, V131, P47, DOI 10.7326/0003-4819-131-1-199907060-00010; Ince C, 2005, CRIT CARE, V9, pS13, DOI 10.1186/cc3753; INCE C, 1993, AM J PHYSIOL, V264, pH294, DOI 10.1152/ajpheart.1993.264.2.H294; JIN MB, 1995, J SURG RES, V58, P509, DOI 10.1006/jsre.1995.1080; Johansen D, 2011, ACTA PHYSIOL, V201, P435, DOI 10.1111/j.1748-1716.2010.02221.x; Kaasik A, 2004, FASEB J, V18, P1219, DOI 10.1096/fj.04-1508com; Kirschenbaum LA, 2000, CRIT CARE MED, V28, P1290, DOI 10.1097/00003246-200005000-00005; Krumholz HM, 2006, CIRCULATION, V113, P732, DOI 10.1161/CIRCULATIONAHA.106.172860; LEMMI CAE, 1989, AM J PHYSIOL, V257, pF837, DOI 10.1152/ajprenal.1989.257.5.F837; Lim N, 2003, CHEST, V124, P1885, DOI 10.1378/chest.124.5.1885; Lowenstein JM, 1969, METHOD ENZYMOL, P3, DOI [10.1016/0076-6879(69)13005-0, DOI 10.1016/0076-6879(69)13005-0]; Mukae S, 1997, JPN HEART J, V38, P515; Munsterman LDH, 2010, CRIT CARE, V14, DOI 10.1186/cc9242; Nieminen MS, 2006, EUR HEART J, V27, P2725, DOI 10.1093/eurheartj/ehl193; Okuda M, 2006, SHOCK, V25, P557, DOI 10.1097/01.shk.0000209546.06801.d7; PALMER JW, 1977, J BIOL CHEM, V252, P8731; PARK CD, 1973, J SURG RES, V14, P139; PELIKAN PCD, 1987, CIRC RES, V61, P880, DOI 10.1161/01.RES.61.6.880; Reynolds HR, 2008, CIRCULATION, V117, P686, DOI 10.1161/CIRCULATIONAHA.106.613596; Rosca M, 2011, BBA-BIOENERGETICS, V1807, P1373, DOI 10.1016/j.bbabio.2011.02.003; Rosca MG, 2008, CARDIOVASC RES, V80, P30, DOI 10.1093/cvr/cvn184; Semenza GL, 2007, BIOCHEM J, V405, P1, DOI 10.1042/BJ20070389; Singer M, 2004, LANCET, V364, P545, DOI 10.1016/S0140-6736(04)16815-3; Spronk PE, 2005, UPD INT CAR, V42, P47; Tatsumi T, 2000, J AM COLL CARDIOL, V35, P1338, DOI 10.1016/S0735-1097(00)00526-X; Timohhina N, 2009, J BIOENERG BIOMEMBR, V41, P259, DOI 10.1007/s10863-009-9224-8; Tsai AG, 2003, AM J PHYSIOL-HEART C, V285, pH1537, DOI 10.1152/ajpheart.00176.2003; Westaby S, 2012, NAT REV CARDIOL, V9, P158, DOI 10.1038/nrcardio.2011.194; Zannad F, 2006, EUR J HEART FAIL, V8, P697, DOI 10.1016/j.ejheart.2006.01.001; Zeymer U, 2004, EUR HEART J, V25, P322, DOI 10.1016/j.ehj.2003.12.008	49	12	12	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 4	2014	9	9							e105213	10.1371/journal.pone.0105213	http://dx.doi.org/10.1371/journal.pone.0105213			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3XV	25188581	Green Published, Green Submitted, gold			2022-12-27	WOS:000341271500007
J	Baggini, C; Salomidi, M; Voutsinas, E; Bray, L; Krasakopoulou, E; Hall-Spencer, JM				Baggini, Cecilia; Salomidi, Maria; Voutsinas, Emanuela; Bray, Laura; Krasakopoulou, Eva; Hall-Spencer, Jason M.			Seasonality Affects Macroalgal Community Response to Increases in pCO(2)	PLOS ONE			English	Article							ELEVATED CARBON-DIOXIDE; OCEAN ACIDIFICATION; CLIMATE-CHANGE; MARINE MACROALGAE; HEAVY-METALS; AEGEAN SEA; CO2; ASSEMBLAGES; SEAWEED; SHIFTS	Ocean acidification is expected to alter marine systems, but there is uncertainty about its effects due to the logistical difficulties of testing its large-scale and long-term effects. Responses of biological communities to increases in carbon dioxide can be assessed at CO2 seeps that cause chronic exposure to lower seawater pH over localised areas of seabed. Shifts in macroalgal communities have been described at temperate and tropical pCO(2) seeps, but temporal and spatial replication of these observations is needed to strengthen confidence our predictions, especially because very few studies have been replicated between seasons. Here we describe the seawater chemistry and seasonal variability of macroalgal communities at CO2 seeps off Methana (Aegean Sea). Monitoring from 2011 to 2013 showed that seawater pH decreased to levels predicted for the end of this century at the seep site with no confounding gradients in Total Alkalinity, salinity, temperature or wave exposure. Most nutrient levels were similar along the pH gradient; silicate increased significantly with decreasing pH, but it was not limiting for algal growth at all sites. Metal concentrations in seaweed tissues varied between sites but did not consistently increase with pCO(2). Our data on the flora are consistent with results from laboratory experiments and observations at Mediterranean CO2 seep sites in that benthic communities decreased in calcifying algal cover and increased in brown algal cover with increasing pCO(2). This differs from the typical macroalgal community response to stress, which is a decrease in perennial brown algae and proliferation of opportunistic green algae. Cystoseira corniculata was more abundant in autumn and Sargassum vulgare in spring, whereas the articulated coralline alga Jania rubens was more abundant at reference sites in autumn. Diversity decreased with increasing CO2 regardless of season. Our results show that benthic community responses to ocean acidification are strongly affected by season.	[Baggini, Cecilia; Bray, Laura; Hall-Spencer, Jason M.] Univ Plymouth, Marine Biol & Ecol Res Ctr, Plymouth PL4 8AA, Devon, England; [Salomidi, Maria; Voutsinas, Emanuela; Bray, Laura; Krasakopoulou, Eva] Hellen Ctr Marine Res, Inst Oceanog, Anavissos, Attica, Greece; [Krasakopoulou, Eva] Univ Aegean, Dept Marine Sci, Lesvos, Greece	University of Plymouth; Hellenic Centre for Marine Research; University of Aegean	Baggini, C (corresponding author), Univ Plymouth, Marine Biol & Ecol Res Ctr, Plymouth PL4 8AA, Devon, England.	cecilia.baggini@plymouth.ac.uk	Hall-Spencer, Jason/AFN-7866-2022	Hall-Spencer, Jason/0000-0002-6915-2518; Salomidi, Maria/0000-0002-7514-3562; Krasakopoulou, Evangelia/0000-0002-1948-3482; Bray, Laura/0000-0001-9486-9169	MARES Grant; EU [265103]	MARES Grant; EU(European Commission)	This work was funded through a MARES Grant to CB. MARES is a Joint Doctorate programme selected under Erasmus Mundus coordinated by Ghent University (FPA 2011-0016). Check www.mares-eu.org for extra information. Part of the sampling was funded by the EU FP7 project 'Mediterranean Sea Acidification under a changing climate' (grant agreement no. 265103). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdallah AMA, 2005, CHEM ECOL, V21, P399, DOI 10.1080/02757540500290222; Ainsworth EA, 2005, NEW PHYTOL, V165, P351, DOI 10.1111/j.1469-8137.2004.01224.x; Airoldi L, 2007, OCEANOGR MAR BIOL, V45, P345; Amaral V, 2011, ESTUAR COAST SHELF S, V93, P460, DOI 10.1016/j.ecss.2011.05.024; Ballesteros E, 2007, MAR POLLUT BULL, V55, P172, DOI 10.1016/j.marpolbul.2006.08.038; Belegratis MR, 1999, HYDROBIOLOGIA, V412, P67, DOI 10.1023/A:1003852300198; BENDSCHNEIDER K, 1952, J MAR RES, V11, P87; Boatta F, 2013, MAR POLLUT BULL, V73, P485, DOI 10.1016/j.marpolbul.2013.01.029; Bowden H, 1997, ROUGH ROCKY PLACE, P77; Briffa M, 2012, MAR POLLUT BULL, V64, P1519, DOI 10.1016/j.marpolbul.2012.05.032; BRYAN GW, 1973, J MAR BIOL ASSOC UK, V53, P705, DOI 10.1017/S0025315400058902; Caldeira K, 2005, J GEOPHYS RES-OCEANS, V110, DOI 10.1029/2004JC002671; Cheminee A, 2013, J EXP MAR BIOL ECOL, V442, P70, DOI 10.1016/j.jembe.2013.02.003; Cigliano M, 2010, MAR BIOL, V157, P2489, DOI 10.1007/s00227-010-1513-6; Clarke K.R., 2006, PRIMER V6 USER MANUA; CLINE JD, 1969, LIMNOL OCEANOGR, V14, P454, DOI 10.4319/lo.1969.14.3.0454; Connell SD, 2008, MAR ECOL PROG SER, V360, P63, DOI 10.3354/meps07526; Connell SD, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2012.0442; Connell SD, 2010, P ROY SOC B-BIOL SCI, V277, P1409, DOI 10.1098/rspb.2009.2069; Cornwall CE, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.2201; Crook ED, 2012, CORAL REEFS, V31, P239, DOI 10.1007/s00338-011-0839-y; D'Alessandro W, 2008, J VOLCANOL GEOTH RES, V178, P818, DOI 10.1016/j.jvolgeores.2008.09.014; Dando PR, 2000, PHYS CHEM EARTH PT B, V25, P1, DOI 10.1016/S1464-1909(99)00112-4; DETHIER MN, 1993, MAR ECOL PROG SER, V96, P93, DOI 10.3354/meps096093; Dias BB, 2010, J GEOL SOC LONDON, V167, P843, DOI 10.1144/0016-76492010-050; Doney SC, 2009, ANNU REV MAR SCI, V1, P169, DOI 10.1146/annurev.marine.010908.163834; Engelen AH, 2008, EUR J PHYCOL, V43, P275, DOI 10.1080/09670260801979279; Fabricius KE, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2013.2479; Fabricius KE, 2011, NAT CLIM CHANGE, V1, P165, DOI 10.1038/NCLIMATE1122; Falkenberg LJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033841; Fraschetti S, 2005, MAR ECOL PROG SER, V296, P13, DOI 10.3354/meps296013; Friligos N, 1991, WATER ENV; Garrard SL, 2013, MAR BIOL, V160, P1789, DOI 10.1007/s00227-012-2033-3; Gilpin LC, 2004, J SEA RES, V51, P21, DOI 10.1016/j.seares.2003.05.005; Godbold JA, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2013.0186; Hale R, 2011, OIKOS, V120, P661, DOI 10.1111/j.1600-0706.2010.19469.x; Hall-Spencer JM, 2008, NATURE, V454, P96, DOI 10.1038/nature07051; Harley CDG, 2012, J PHYCOL, V48, P1064, DOI 10.1111/j.1529-8817.2012.01224.x; Hofmann GE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028983; Hofmann LC, 2012, MAR ECOL PROG SER, V464, P89, DOI 10.3354/meps09892; Howes DE, 1994, BRIT COLUMBIA PHYS S, P1; Hubner A, 2004, CHEM ERDE-GEOCHEM, V64, P75, DOI 10.1016/j.chemer.2003.10.001; Inoue S, 2013, NAT CLIM CHANGE, V3, P683, DOI [10.1038/nclimate1855, 10.1038/NCLIMATE1855]; Johnson VR, 2012, GLOBAL CHANGE BIOL, V18, P2792, DOI 10.1111/j.1365-2486.2012.02716.x; Kamenos NA, 2013, GLOBAL CHANGE BIOL, V19, P3621, DOI 10.1111/gcb.12351; Karageorgis AP, 2005, APPL GEOCHEM, V20, P69, DOI 10.1016/j.apgeochem.2004.07.008; Kerrison P, 2011, ESTUAR COAST SHELF S, V94, P129, DOI 10.1016/j.ecss.2011.05.025; Kletou D, 2012, MARINE ECOSYSTEMS, P1; Koch M, 2013, GLOBAL CHANGE BIOL, V19, P103, DOI 10.1111/j.1365-2486.2012.02791.x; Koroleff F., 1970, INT COUNCIL EXPLORAT, P19; Kroeker KJ, 2013, GLOBAL CHANGE BIOL, V19, P1884, DOI 10.1111/gcb.12179; Kroeker KJ, 2013, NAT CLIM CHANGE, V3, P156, DOI [10.1038/NCLIMATE1680, 10.1038/nclimate1680]; Lejeusne C, 2010, TRENDS ECOL EVOL, V25, P250, DOI 10.1016/j.tree.2009.10.009; Lewis ER, 1998, ESS-DIVE, DOI 10.15485/1464255; MAHER WA, 1984, MAR POLLUT BULL, V15, P111, DOI 10.1016/0025-326X(84)90447-8; Mangialajo L, 2007, MAR POLLUT BULL, V55, P30, DOI 10.1016/j.marpolbul.2006.08.022; Martin S, 2008, BIOL LETTERS, V4, P689, DOI 10.1098/rsbl.2008.0412; McDermid KJ, 2003, J APPL PHYCOL, V15, P513, DOI 10.1023/B:JAPH.0000004345.31686.7f; MULLIN JB, 1955, ANAL CHIM ACTA, V12, P162, DOI 10.1016/S0003-2670(00)87825-3; MURPHY J, 1962, ANAL CHIM ACTA, V26, P31; Orfanidis S, 2011, MEDITERR MAR SCI, V12, P199, DOI 10.12681/mms.60; Piazzi L, 2004, BOT MAR, V47, P105, DOI 10.1515/BOT.2004.010; Pinedo S, 2007, MAR POLLUT BULL, V55, P126, DOI 10.1016/j.marpolbul.2006.08.044; PINGREE RD, 1976, J MAR BIOL ASSOC UK, V56, P845, DOI 10.1017/S0025315400020919; Porzio L, 2011, J EXP MAR BIOL ECOL, V400, P278, DOI 10.1016/j.jembe.2011.02.011; Raman D, 2013, INT J MODERN CHEM AP, V1, P12; Riebesell U., 2011, GUIDE BEST PRACTICES, DOI DOI 10.2777/58454; Riebesell U, 2008, NATURE, V454, P46, DOI 10.1038/454046a; Ries JB, 2009, GEOLOGY, V37, P1131, DOI 10.1130/G30210A.1; Rodolfo-Metalpa R, 2011, NAT CLIM CHANGE, V1, P308, DOI 10.1038/NCLIMATE1200; Sala E, 1997, J EXP MAR BIOL ECOL, V212, P25, DOI 10.1016/S0022-0981(96)02745-1; Scherner F, 2013, MAR POLLUT BULL, V76, P106, DOI 10.1016/j.marpolbul.2013.09.019; Schiel D.R., 2001, SCIENCE CONSERV, P5; Shannon C.E, 1949, MATH THEORY COMMUNIC, V1st; Spatharis S, 2011, ESTUAR COAST SHELF S, V91, P298, DOI 10.1016/j.ecss.2010.10.032; Spicer JI, 2014, J EXP BIOL, V217, P46, DOI 10.1242/jeb.090365; Swanson AK, 2007, GLOBAL CHANGE BIOL, V13, P1696, DOI 10.1111/j.1365-2486.2007.01384.x; Tarasov VG, 2005, CHEM GEOL, V224, P5, DOI 10.1016/j.chemgeo.2005.07.021; Taskin E., 2012, MEDITERRANEAN CYSTOS, P1; Thomsen J, 2010, BIOGEOSCIENCES, V7, P3879, DOI 10.5194/bg-7-3879-2010; Thomsen J, 2013, GLOBAL CHANGE BIOL, V19, P1017, DOI 10.1111/gcb.12109; Tilman D, 1997, ECOLOGY, V78, P81, DOI 10.1890/0012-9658(1997)078[0081:CIRLAG]2.0.CO;2; Tsiamis K, 2013, MAR ECOL PROG SER, V472, P73, DOI 10.3354/meps10060; Vizzini S, 2013, ESTUAR COAST SHELF S, V134, P19, DOI 10.1016/j.ecss.2013.09.015; Zohary T, 1998, LIMNOL OCEANOGR, V43, P387, DOI 10.4319/lo.1998.43.3.0387	85	49	50	0	109	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 3	2014	9	9							e106520	10.1371/journal.pone.0106520	http://dx.doi.org/10.1371/journal.pone.0106520			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3TB	25184242	gold, Green Submitted, Green Published			2022-12-27	WOS:000341257700082
J	Brabec, M; Honek, A; Pekar, S; Martinkova, Z				Brabec, Marek; Honek, Alois; Pekar, Stano; Martinkova, Zdenka			Population Dynamics of Aphids on Cereals: Digging in the Time-Series Data to Reveal Population Regulation Caused by Temperature	PLOS ONE			English	Article							RHOPALOSIPHUM-PADI L; SITOBION-AVENAE F; METOPOLOPHIUM-DIRHODUM HEMIPTERA; LIFE-HISTORY TRAITS; ROSE GRAIN APHID; WINTER-WHEAT; CLIMATE-CHANGE; SPRING MIGRATION; SOWING DATE; HOMOPTERA	Aphid populations show periodic fluctuations and many causes are attributed to their dynamic. We investigated the regulation by temperature of the aphid populations composed of Metopolophium dirhodum, Sitobion avenae, and Rhopalosiphum padi on winter wheat using a 24 years long time series data. We computed the sum of daily temperatures above 5 degrees C, the threshold temperature for aphid development, and the sum of daily temperatures within the [0(threshold for wheat development),5]degrees C interval. Applying Generalised Additive Model framework we tested influences of temperature history expressed via degree days before the start of the aphid immigration on the length of their occurrence. We aimed to estimate the magnitude and direction of this influence, and how far to the past before the start of the aphid season the temperature effect goes and then identify processes responsible for the effect. We fitted four models that differed in the way of correcting for abundance in the previous year and in specification of temperature effects. Abundance in the previous year did not affect the length of period of aphid population growth on wheat. The temperature effect on the period length increased up to 123 days before the start of the current season, i.e. when wheat completed vernalization. Increased sum of daily temperatures above 5 degrees C and the sum of daily temperatures within the [0,5]degrees C interval both shortened the length of period of aphid population growth. Stronger effect of the latter suggests that wheat can escape from aphid attacks if during winter temperatures range from 0 to 5 degrees C. The temperature influence was not homogeneous in time. The strongest effect of past temperature was about 50 to 80 and 90 to 110 days before the beginning of the current aphid season indicating important role of termination of aphid egg dormancy and egg hatching.	[Brabec, Marek] Acad Sci Czech Republ, Inst Comp Sci, Dept Nonlinear Modeling, Prague, Bohemia, Czech Republic; [Honek, Alois; Martinkova, Zdenka] Crop Res Inst, Dept Invertebrate & Plant Biodivers Agrosyst, Prague, Bohemia, Czech Republic; [Pekar, Stano; Martinkova, Zdenka] Masaryk Univ, Fac Sci, Dept Bot & Zool, CS-61137 Brno, Czech Republic	Czech Academy of Sciences; Institute of Analytical Chemistry of the Czech Academy of Sciences; Institute of Computer Science of the Czech Academy of Sciences; Czech Crop Research Institute (CRI); Masaryk University Brno	Honek, A (corresponding author), Crop Res Inst, Dept Invertebrate & Plant Biodivers Agrosyst, Prague, Bohemia, Czech Republic.	honek@vurv.cz	Pekar, Stano/F-4148-2010; Brabec, Marek/F-9816-2012	Pekar, Stano/0000-0002-0197-5040; Brabec, Marek/0000-0001-6367-5791	Institute of the Computer Science [RVO 67985807]; Ministry of Agriculture of the Czech Republic [RO 0414]	Institute of the Computer Science; Ministry of Agriculture of the Czech Republic(Ministry of Agriculture, Czech Republic)	This work received support from these sources: Long-term strategic development financing of the Institute of the Computer Science project no. RVO 67985807 (MB); Ministry of Agriculture of the Czech Republic project no. RO 0414 (AH and ZM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; ALMON S, 1965, ECONOMETRICA, V33, P178, DOI 10.2307/1911894; AMMAN GD, 1968, ANN ENTOMOL SOC AM, V61, P1606, DOI 10.1093/aesa/61.6.1606; ANKERSMIT GW, 1981, NETH J PLANT PATHOL, V87, P71, DOI 10.1007/BF01976641; Asin L, 2001, ENVIRON ENTOMOL, V30, P1127, DOI 10.1603/0046-225X-30.6.1127; Barndorff-Nielsen O. E., 1994, INFERENCE ASYMPTOTIC; Belcari A., 1985, Frustula Entomologica, V6, P413; Blackman RL, 1984, APHIDS WORLD CROPS; BODE E, 1980, Z ANGEW ENTOMOL, V89, P363; Bommarco R, 2007, J APPL ECOL, V44, P1013, DOI 10.1046/j.0021-8901.2007.01332.x; CANNON RJC, 1984, B ENTOMOL RES, V74, P33, DOI 10.1017/S0007485300009913; Carter Nick, 1994, P129; DEAN GJ, 1974, B ENTOMOL RES, V63, P401, DOI 10.1017/S0007485300040888; DEDRYVER CA, 1984, AGRONOMIE, V4, P711, DOI 10.1051/agro:19840802; Dedryver CA, 1998, ECOL ENTOMOL, V23, P123, DOI 10.1046/j.1365-2311.1998.00113.x; Dedryver CA, 2010, CR BIOL, V333, P539, DOI 10.1016/j.crvi.2010.03.009; Dixon A.F.G., 1987, Agricultural Zoology Reviews, V2, P1; Dixon AFG, 1997, ENTOMOPHAGA, V42, P71, DOI 10.1007/BF02769882; Dong ZK, 2013, AGR ECOSYST ENVIRON, V181, P144, DOI 10.1016/j.agee.2013.09.009; ENTWISTLE JC, 1989, ANN APPL BIOL, V114, P397, DOI 10.1111/j.1744-7348.1989.tb03355.x; FENG MG, 1992, PAN-PAC ENTOMOL, V68, P248; GASTON KJ, 1988, NATURE, V331, P709, DOI 10.1038/331709a0; GASTON KJ, 1988, OIKOS, V53, P49, DOI 10.2307/3565662; Gosselke U, 2001, ECOL MODEL, V145, P143, DOI 10.1016/S0304-3800(01)00386-6; HAND SC, 1983, ENTOMOL EXP APPL, V33, P220, DOI 10.1111/j.1570-7458.1983.tb03259.x; HAND SC, 1986, NETH J PLANT PATHOL, V92, P137, DOI 10.1007/BF01999795; Hansen LM, 2006, AGR FOREST ENTOMOL, V8, P83, DOI 10.1111/j.1461-9563.2006.00289.x; HOLLER C, 1990, J APPL ENTOMOL, V109, P21, DOI 10.1111/j.1439-0418.1990.tb00014.x; Honek A, 2006, B ENTOMOL RES, V96, P269, DOI 10.1079/BER2006427; Honek A, 2005, EUR J ENTOMOL, V102, P443, DOI 10.14411/eje.2005.063; Honek A, 2004, B ENTOMOL RES, V94, P19, DOI 10.1079/BER2003280; HONEK A, 1991, B ENTOMOL RES, V81, P57, DOI 10.1017/S0007485300053244; Honek A, 1999, EUR J ENTOMOL, V96, P135; Hoover JK, 2004, GLOBAL CHANGE BIOL, V10, P1197, DOI 10.1111/j.1529-8817.2003.00796.x; HOWARD MT, 1990, ANN APPL BIOL, V117, P9, DOI 10.1111/j.1744-7348.1990.tb04190.x; HULLE M, 1994, J APPL ECOL, V31, P49, DOI 10.2307/2404598; Jeffs CT, 2014, ENTOMOL EXP APPL, V150, P240, DOI 10.1111/eea.12160; KIECKHEFER RW, 1989, ANN ENTOMOL SOC AM, V82, P701, DOI 10.1093/aesa/82.6.701; KINDLMANN P, 1989, FUNCT ECOL, V3, P531, DOI 10.2307/2389567; KIRBY EJM, 1992, J AGR SCI, V118, P271, DOI 10.1017/S0021859600070635; Klueken AM, 2009, J PLANT DIS PROTECT, V116, P129, DOI 10.1007/BF03356299; LEATHER SR, 1993, J APPL ENTOMOL, V116, P217, DOI 10.1111/j.1439-0418.1993.tb01192.x; LEATHER SR, 1984, Z ANGEW ENTOMOL, V97, P431; Leslie TW, 2009, AGR FOREST ENTOMOL, V11, P73, DOI 10.1111/j.1461-9563.2008.00405.x; Ma G, 2012, J INSECT PHYSIOL, V58, P1456, DOI 10.1016/j.jinsphys.2012.08.012; Masterman AJ, 1996, J APPL ECOL, V33, P23, DOI 10.2307/2405012; Matis JH, 2008, MATH BIOSCI, V215, P137, DOI 10.1016/j.mbs.2008.07.007; Maudsley MJ, 1996, ANN APPL BIOL, V128, P453, DOI 10.1111/j.1744-7348.1996.tb07106.x; MCGRATH PF, 1990, ANN APPL BIOL, V117, P31, DOI 10.1111/j.1744-7348.1990.tb04192.x; McMaster GS, 2005, J AGR SCI-CAMBRIDGE, V143, P137, DOI 10.1017/S0021859605005083; Newman JA, 2005, GLOBAL CHANGE BIOL, V11, P940, DOI 10.1111/j.1365-2486.2005.00946.x; Newman JA, 2004, GLOBAL CHANGE BIOL, V10, P5, DOI 10.1111/j.1365-2486.2003.00709.x; Papura D, 2003, HEREDITY, V90, P397, DOI 10.1038/sj.hdy.6800262; PARISH WEG, 1993, ANN APPL BIOL, V122, P9, DOI 10.1111/j.1744-7348.1993.tb04009.x; Porter JR, 1999, EUR J AGRON, V10, P23, DOI 10.1016/S1161-0301(98)00047-1; Prasil IT, 2005, BIOL PLANTARUM, V49, P195, DOI 10.1007/s10535-005-5200-2; R Core Team, 2021, R LANGUAGE ENV STAT; REDFEARN A, 1988, ECOL MONOGR, V58, P39, DOI 10.2307/1942633; Robertson MJ, 1996, ANN BOT-LONDON, V78, P371, DOI 10.1006/anbo.1996.0132; SENGONCA C, 1994, J APPL ENTOMOL, V117, P224; SLAFER GA, 1995, PLANT CELL ENVIRON, V18, P671, DOI 10.1111/j.1365-3040.1995.tb00568.x; Spaldon E, 1982, PLANT PRODUCTION; SPITZER K, 1984, OECOLOGIA, V62, P91, DOI 10.1007/BF00377379; STORCKWEYHERMULLER S, 1988, ENTOMOL GEN, V13, P189; VICKERMAN GP, 1979, B ENTOMOL RES, V69, P1, DOI 10.1017/S0007485300017855; von Blotzheim Glutz, 2010, Anzeiger des Vereins Thueringer Ornithologen, V7, P29; Wetzel T., 2004, INTEGRIERTER PFLANZE; Wood S.N., 2017, GEN ADDITIVE MODELS, V2nd ed., DOI [10.1201/9781315370279, DOI 10.1201/9781315370279]; ZHOU X, 1992, ANN APPL BIOL, V121, P27, DOI 10.1111/j.1744-7348.1992.tb03984.x	69	21	25	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 3	2014	9	9							e106228	10.1371/journal.pone.0106228	http://dx.doi.org/10.1371/journal.pone.0106228			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3TB	25184219	Green Submitted, gold, Green Published			2022-12-27	WOS:000341257700039
J	Genre, F; Lopez-Mejias, R; Garcia-Bermudez, M; Castaneda, S; Gonzalez-Juanatey, C; Llorca, J; Corrales, A; Ubilla, B; Miranda-Filloy, JA; Pina, T; Gomez-Vaquero, C; Rodriguez-Rodriguez, L; Fernandez-Gutierrez, B; Balsa, A; Pascual-Salcedo, D; Lopez-Longo, FJ; Carreira, P; Blanco, R; Gonzalez-Alvaro, I; Martin, J; Gonzalez-Gay, MA				Genre, Fernanda; Lopez-Mejias, Raquel; Garcia-Bermudez, Mercedes; Castaneda, Santos; Gonzalez-Juanatey, Carlos; Llorca, Javier; Corrales, Alfonso; Ubilla, Begona; Miranda-Filloy, Jose A.; Pina, Trinitario; Gomez-Vaquero, Carmen; Rodriguez-Rodriguez, Luis; Fernandez-Gutierrez, Benjamin; Balsa, Alejandro; Pascual-Salcedo, Dora; Lopez-Longo, Francisco J.; Carreira, Patricia; Blanco, Ricardo; Gonzalez-Alvaro, Isidoro; Martin, Javier; Gonzalez-Gay, Miguel A.			Osteoprotegerin CGA Haplotype Protection against Cerebrovascular Complications in Anti-CCP Negative Patients with Rheumatoid Arthritis	PLOS ONE			English	Article							PLASMA OSTEOPROTEGERIN; CARDIOVASCULAR EVENTS; CAROTID ATHEROSCLEROSIS; VASCULAR CALCIFICATION; GENE POLYMORPHISMS; KIDNEY-FUNCTION; RISK-FACTOR; ASSOCIATION; DISEASE; MORTALITY	Introduction: Rheumatoid arthritis is an inflammatory disease with high incidence of cardiovascular disease due to accelerated atherosclerosis. Osteoprotegerin (OPG) has been associated with increased risk of atherosclerotic disease in the general population. Several polymorphisms in the OPG gene with functional effects on cardiovascular disease in non-rheumatic individuals have been described. Therefore, we aimed to analyze the effect of three of these functional OPG polymorphisms on the risk of cardiovascular disease in a large and well-characterized cohort of Spanish patients with rheumatoid arthritis. Methods: Three OPG gene variants (rs3134063, rs2073618 and rs3134069) were genotyped by TaqMan assays in 2027 Spanish patients with rheumatoid arthritis. Anti-cyclic citrullinated peptide (anti-CCP) antibody testing was positive in 997 of 1714 tested. Also, 18.3% of the whole series had experienced cardiovascular events, including 5.4% with cerebrovascular accidents. The relationship between OPG variants and cardiovascular events was assessed using Cox regression. Results: No association between OPG gene variants and cardiovascular disease was observed in the whole group of rheumatoid arthritis patients or in anti-CCP positive patients. Nevertheless, a protective effect of CGA haplotype on the risk of cardiovascular disease in general, and specifically in the risk of cerebrovascular complications after adjusting for sex, age at disease diagnosis and traditional cardiovascular risk factors was disclosed in anti-CCP negative patients (HR = 0.54; 95% CI: 0.31-0.95; p = 0.032 and HR = 0.17; 95% CI: 0.04-0.78; p = 0.022, respectively). Conclusion: Our results indicate a protective effect of the OPG CGA haplotype on cardiovascular risk, mainly due to a protective effect against cerebrovascular events in anti-CCP negative rheumatoid arthritis patients.	[Genre, Fernanda; Lopez-Mejias, Raquel; Corrales, Alfonso; Ubilla, Begona; Pina, Trinitario; Blanco, Ricardo; Gonzalez-Gay, Miguel A.] IDIVAL, Div Rheumatol, Genet & Atherosclerosis Res Grp System Inflammato, Santander, Spain; [Garcia-Bermudez, Mercedes; Martin, Javier] IPBLN CSIC, Inst Parasitol & Biomed Lopez Neyra, Granada, Spain; [Castaneda, Santos; Gonzalez-Alvaro, Isidoro] Hosp Univ Princesa, IIS Princesa, Dept Rheumatol, Madrid, Spain; [Gonzalez-Juanatey, Carlos] Hosp Univ Lucus Augusti, Div Cardiol, Lugo, Spain; [Llorca, Javier] Univ Cantabria, Sch Med, Dept Epidemiol & Computat Biol, E-39005 Santander, Spain; [Llorca, Javier] IDIVAL, CIBER Epidemiol & Salud Publ CIBERESP, Santander, Spain; [Miranda-Filloy, Jose A.] Hosp Univ Lucus Augusti, Div Rheumatol, Lugo, Spain; [Gomez-Vaquero, Carmen] Hosp Univ Bellvitge, Dept Rheumatol, Barcelona, Spain; [Rodriguez-Rodriguez, Luis; Fernandez-Gutierrez, Benjamin] Hosp Clin San Carlos, Dept Rheumatol, Madrid, Spain; [Balsa, Alejandro; Pascual-Salcedo, Dora] Hosp Univ La Paz, Dept Rheumatol, Madrid, Spain; [Lopez-Longo, Francisco J.] Hosp Gen Univ Gregorio Maranon, Dept Rheumatol, Madrid, Spain; [Carreira, Patricia] Hosp Univ 12 Octubre, Dept Rheumatol, Madrid, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Parasitologia y Biomedicina Lopez-Neyra (IPBLN); Hospital de La Princesa; Hospital Universitario Lucus Augusti-Lugo; Universidad de Cantabria; CIBER - Centro de Investigacion Biomedica en Red; CIBERESP; Hospital Universitario Lucus Augusti-Lugo; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); Bellvitge University Hospital; University of Barcelona; Hospital Clinico San Carlos; Hospital Universitario La Paz; General University Gregorio Maranon Hospital; Hospital Universitario 12 de Octubre	Gonzalez-Gay, MA (corresponding author), IDIVAL, Div Rheumatol, Genet & Atherosclerosis Res Grp System Inflammato, Santander, Spain.	miguelaggay@hotmail.com	blanco, ricardo/AAA-1248-2020; Rodriguez-Rodriguez, Luis/H-5880-2013; Llorca, Javier/F-7371-2011; García-Bermúdez, Mercedes/E-7708-2013; Martín, María/HDL-9512-2022; Balsa, Alejandro/ABF-6456-2020; Martin, Javier/B-8141-2008; Fernandez-Gutierrez, Benjamin/AAM-9063-2020; Carreira, Patricia E/D-4429-2018; González-Gay, Miguel A./B-2306-2008; Martín, Javier/AAV-5209-2021	blanco, ricardo/0000-0003-2344-2285; Rodriguez-Rodriguez, Luis/0000-0002-2869-7861; Llorca, Javier/0000-0001-8569-861X; García-Bermúdez, Mercedes/0000-0002-2643-5956; Martin, Javier/0000-0002-2202-0622; Carreira, Patricia E/0000-0001-8279-3806; González-Gay, Miguel A./0000-0002-7924-7406; Pina Murcia, Trinitario/0000-0001-8097-7695	European Union FEDER funds; "Fondo de Investigacion Sanitaria'' (Spain) [PI06/0024, PS09/00748, PI12/00060]; RETICS Programs (RIER) from "Instituto de Salud Carlos III'' (ISCIII) (Spain); European IMI BTCure Program; RETICS Program (RIER) [RD12/0009/0013]; Sara Borrell postdoctoral fellowship from the "Instituto de Salud Carlos III'' at the Spanish Ministry of Health (Spain)	European Union FEDER funds(European Commission); "Fondo de Investigacion Sanitaria'' (Spain)(Instituto de Salud Carlos III); RETICS Programs (RIER) from "Instituto de Salud Carlos III'' (ISCIII) (Spain); European IMI BTCure Program; RETICS Program (RIER); Sara Borrell postdoctoral fellowship from the "Instituto de Salud Carlos III'' at the Spanish Ministry of Health (Spain)	This study was supported by European Union FEDER funds and "Fondo de Investigacion Sanitaria'' (grants PI06/0024, PS09/00748 and PI12/00060) (Spain). This work was also partially supported by RETICS Programs RD12/0009 (RIER) from "Instituto de Salud Carlos III'' (ISCIII) (Spain), and in part by grants from the European IMI BTCure Program. FG and BU are supported by funds from the RETICS Program (RIER) (RD12/0009/0013). RLM is a recipient of a Sara Borrell postdoctoral fellowship from the "Instituto de Salud Carlos III'' at the Spanish Ministry of Health (Spain). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aletaha D, 2010, ARTHRITIS RHEUM-US, V62, P2569, DOI 10.1002/art.27584; Anand DV, 2006, J AM COLL CARDIOL, V47, P1850, DOI 10.1016/j.jacc.2005.12.054; ARNETT FC, 1988, ARTHRITIS RHEUM, V31, P315, DOI 10.1002/art.1780310302; Avina-Zubieta JA, 2012, ANN RHEUM DIS, V71, P1524, DOI 10.1136/annrheumdis-2011-200726; Biscetti F, 2013, HUM GENET, V132, P49, DOI 10.1007/s00439-012-1224-9; Bjerre M, 2013, SPRINGERPLUS, V2, DOI 10.1186/2193-1801-2-658; Callegari A, 2013, ARTERIOSCL THROM VAS, V33, P2491, DOI 10.1161/ATVBAHA.113.301755; Chen WJY, 2011, CARDIOVASC DIABETOL, V10, DOI 10.1186/1475-2840-10-67; del Rincon I, 2003, ARTHRITIS RHEUM, V48, P1833, DOI 10.1002/art.11078; del Rincon I, 2001, ARTHRITIS RHEUM-US, V44, P2737, DOI 10.1002/1529-0131(200112)44:12<2737::AID-ART460>3.0.CO;2-#; Del Val Del Amno N, 2006, CLIN EXP RHEUMATOL, V24, P281; Dessein PH, 2005, J RHEUMATOL, V32, P435; Dessein PH, 2014, J RHEUMATOL, V41, P429, DOI 10.3899/jrheum.131037; Di Bartolo BA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074211; Drysdale CM, 2000, P NATL ACAD SCI USA, V97, P10483, DOI 10.1073/pnas.97.19.10483; Garcia-Bermudez M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077695; Genre F, 2014, CLIN EXP RH IN PRESS; Gonzalez-Gay MA, 2005, SEMIN ARTHRITIS RHEU, V35, P8, DOI 10.1016/j.semarthrit.2005.03.004; Gonzalez-Gay MA, 2005, J RHEUMATOL, V32, P1219; Gonzalez-Gay MA, 2007, ARTHRIT RHEUM-ARTHR, V57, P125, DOI 10.1002/art.22482; Gonzalez-Juanatey C, 2009, SEMIN ARTHRITIS RHEU, V38, P366, DOI 10.1016/j.semarthrit.2008.01.012; Goodson N, 2005, ANN RHEUM DIS, V64, P1595, DOI 10.1136/ard.2004.034777; Hofbauer LC, 2004, JAMA-J AM MED ASSOC, V292, P490, DOI 10.1001/jama.292.4.490; Jorsal A, 2008, DIABETOLOGIA, V51, P2100, DOI 10.1007/s00125-008-1123-8; Kiechl S, 2004, CIRCULATION, V109, P2175, DOI 10.1161/01.CIR.0000127957.43874.BB; Lopez-Mejias R, 2012, ATHEROSCLEROSIS, V224, P426, DOI 10.1016/j.atherosclerosis.2012.06.008; Martin ER, 2000, AM J HUM GENET, V67, P383, DOI 10.1086/303003; Morony S, 2008, CIRCULATION, V117, P411, DOI 10.1161/CIRCULATIONAHA.107.707380; Morris RW, 2002, GENET EPIDEMIOL, V23, P221, DOI 10.1002/gepi.10200; Peters MJL, 2009, ARTHRIT RHEUM-ARTHR, V61, P1571, DOI 10.1002/art.24836; Ramus SM, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/364073; Rasmussen LM, 2006, EUR J ENDOCRINOL, V154, P75, DOI 10.1530/eje.1.02049; Rodriguez-Rodriguez L, 2012, MEDIAT INFLAMM, V2012, DOI 10.1155/2012/574817; Roshandel D, 2011, CALCIFIED TISSUE INT, V89, P446, DOI 10.1007/s00223-011-9532-y; Secchiero P, 2013, CLIN CANCER RES, V19, P1949, DOI 10.1158/1078-0432.CCR-12-3027; Secchiero P, 2010, ATHEROSCLEROSIS, V210, P274, DOI 10.1016/j.atherosclerosis.2009.11.005; Solomon DH, 2003, CIRCULATION, V107, P1303, DOI 10.1161/01.CIR.0000054612.26458.B2; Soufi M, 2004, J CLIN ENDOCR METAB, V89, P3764, DOI 10.1210/jc.2003-032054; Straface G, 2011, STROKE, V42, P3022, DOI 10.1161/STROKEAHA.111.619288; Van Campenhout A, 2009, ATHEROSCLEROSIS, V204, P321, DOI 10.1016/j.atherosclerosis.2008.09.033; van der Helm-van Mil AHM, 2005, ARTHRITIS RES THER, V7, pR949, DOI 10.1186/ar1767; van Gaalen FA, 2004, ARTHRITIS RHEUM, V50, P2113, DOI 10.1002/art.20316; van Halm VP, 2009, ANN RHEUM DIS, V68, P1395, DOI 10.1136/ard.2008.094151; Wolfe F, 2003, J RHEUMATOL, V30, P36; Zhao HY, 2003, PHARMACOGENOMICS, V4, P171, DOI 10.1517/phgs.4.2.171.22636	45	9	9	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 3	2014	9	9							e106823	10.1371/journal.pone.0106823	http://dx.doi.org/10.1371/journal.pone.0106823			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3TB	25184828	gold, Green Published, Green Submitted			2022-12-27	WOS:000341257700122
J	Just, J; Kristensen, RM; Olesen, J				Just, Jean; Kristensen, Reinhardt Mobjerg; Olesen, Jorgen			Dendrogramma, New Genus, with Two New Non-Bilaterian Species from the Marine Bathyal of Southeastern Australia (Animalia, Metazoa incertae sedis) - with Similarities to Some Medusoids from the Precambrian Ediacara	PLOS ONE			English	Article							EVOLUTION; VENDOBIONTA; ORIGINS; LIFE; TREE	A new genus, Dendrogramma, with two new species of multicellular, non-bilaterian, mesogleal animals with some bilateral aspects, D. enigmatica and D. discoides, are described from the south-east Australian bathyal (400 and 1000 metres depth). A new family, Dendrogrammatidae, is established for Dendrogramma. These mushroom-shaped organisms cannot be referred to either of the two phyla Ctenophora or Cnidaria at present, because they lack any specialised characters of these taxa. Resolving the phylogenetic position of Dendrogramma depends much on how the basal metazoan lineages (Ctenophora, Porifera, Placozoa, Cnidaria, and Bilateria) are related to each other, a question still under debate. At least Dendrogramma must have branched off before Bilateria and is possibly related to Ctenophora and/or Cnidaria. Dendrogramma, therefore, is referred to Metazoa incertae sedis. The specimens were fixed in neutral formaldehyde and stored in 80% ethanol and are not suitable for molecular analysis. We recommend, therefore, that attempts be made to secure new material for further study. Finally similarities between Dendrogramma and a group of Ediacaran (Vendian) medusoids are discussed.	[Just, Jean; Kristensen, Reinhardt Mobjerg; Olesen, Jorgen] Univ Copenhagen, Zool Museum, Nat Hist Museum Denmark, Sect Biosystemat, DK-2100 Copenhagen, Denmark	University of Copenhagen	Just, J (corresponding author), Univ Copenhagen, Zool Museum, Nat Hist Museum Denmark, Sect Biosystemat, DK-2100 Copenhagen, Denmark.	jean-just@mail.dk	Olesen, Jørgen/A-3353-2013; Kristensen, Reinhardt M/A-8772-2013	Olesen, Jørgen/0000-0001-9582-7083; Kristensen, Reinhardt M/0000-0001-9549-1188; Olesen, Jes/0000-0002-6712-2702	Australian Marine Science and Technology/Australian Research Council grant	Australian Marine Science and Technology/Australian Research Council grant	This work was supported by an Australian Marine Science and Technology/Australian Research Council grant. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BUSS LW, 1994, PALEOBIOLOGY, V20, P1, DOI 10.1017/S0094837300011088; Dohrmann M, 2013, INTEGR COMP BIOL, V53, P503, DOI 10.1093/icb/ict008; Dunn CW, 2008, NATURE, V452, P745, DOI 10.1038/nature06614; Edgecombe GD, 2011, ORG DIVERS EVOL, V11, P151, DOI 10.1007/s13127-011-0044-4; Fedonkin MA., 1984, STRATIGRAFIYA PALEON, P30; Finnerty JR, 2003, INT J DEV BIOL, V47, P523; Giribet G, 2007, ZOOTAXA, P61, DOI 10.11646/zootaxa.1668.1.8; Glaessner M.F., 1984, DAWN ANIMAL LIFE BIO; Harrison F.W., 1991, MICROSCOPIC ANATOMY, V2; Hejnol A, 2009, P ROY SOC B-BIOL SCI, V276, P4261, DOI 10.1098/rspb.2009.0896; Moroz LL, 2014, NATURE, V510, P109, DOI 10.1038/nature13400; Nielsen C, 2012, ANIMAL EVOLUTION: INTERRELATIONSHIPS OF THE LIVING PHYLA, 3RD EDITION, P1; Nosenko T, 2013, MOL PHYLOGENET EVOL, V67, P223, DOI 10.1016/j.ympev.2013.01.010; Philippe H, 2009, CURR BIOL, V19, P706, DOI 10.1016/j.cub.2009.02.052; Pick KS, 2010, MOL BIOL EVOL, V27, P1983, DOI 10.1093/molbev/msq089; Ryan JF, 2013, SCIENCE, V342, P1336, DOI 10.1126/science.1242592; Seilacher A, 2007, GEOL SOC SPEC PUBL, V286, P387, DOI 10.1144/SP286.28; SEILACHER A, 1989, LETHAIA, V22, P229, DOI 10.1111/j.1502-3931.1989.tb01332.x; SEILACHER A, 1992, J GEOL SOC LONDON, V149, P607, DOI 10.1144/gsjgs.149.4.0607; Seilacher A, 1984, PATTERNS CHANGE EART, P158; Solon CM, 2013, GEOL SOC AM GSA 125; Sperling EA, 2010, EVOL DEV, V12, P201, DOI 10.1111/j.1525-142X.2010.00404.x; Tang F, 2011, EVOL DEV, V13, P408, DOI 10.1111/j.1525-142X.2011.00499.x; Technau U, 2011, DEVELOPMENT, V138, P1447, DOI 10.1242/dev.048959; Vickers-Rich, 2008, RISE ANIMALS EVOLUTI	25	14	16	2	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 3	2014	9	9							e102976	10.1371/journal.pone.0102976	http://dx.doi.org/10.1371/journal.pone.0102976			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3TB	25184248	Green Published, Green Submitted, gold			2022-12-27	WOS:000341257700005
J	Spedden, E; Wiens, MR; Demirel, MC; Staii, C				Spedden, Elise; Wiens, Matthew R.; Demirel, Melik C.; Staii, Cristian			Effects of Surface Asymmetry on Neuronal Growth	PLOS ONE			English	Article							NEURITE OUTGROWTH; AXONAL OUTGROWTH; HIPPOCAMPAL-NEURONS; GUIDANCE; CONES; CHEMOTAXIS; CUES	Detailed knowledge of how the surface physical properties, such as mechanics, topography and texture influence axonal outgrowth and guidance is essential for understanding the processes that control neuron development, the formation of functional neuronal connections and nerve regeneration. Here we synthesize asymmetric surfaces with well-controlled topography and texture and perform a systematic experimental and theoretical investigation of axonal outgrowth on these substrates. We demonstrate unidirectional axonal bias imparted by the surface ratchet-based topography and quantify the topographical guidance cues that control neuronal growth. We describe the growth cone dynamics using a general stochastic model (Fokker-Planck formalism) and use this model to extract two key dynamical parameters: diffusion (cell motility) coefficient and asymmetric drift coefficient. The drift coefficient is identified with the torque caused by the asymmetric ratchet topography. We relate the observed directional bias in axonal outgrowth to cellular contact guidance behavior, which results in an increase in the cell-surface coupling with increased surface anisotropy. We also demonstrate that the disruption of cytoskeletal dynamics through application of Taxol (stabilizer of microtubules) and Blebbistatin (inhibitor of myosin II activity) greatly reduces the directional bias imparted by these asymmetric surfaces. These results provide new insight into the role played by topographical cues in neuronal growth and could lead to new methods for stimulating neuronal regeneration and the engineering of artificial neuronal tissue.	[Spedden, Elise; Wiens, Matthew R.; Staii, Cristian] Tufts Univ, Dept Phys & Astron, Medford, MA 02155 USA; [Spedden, Elise; Wiens, Matthew R.; Staii, Cristian] Tufts Univ, Ctr Nanoscop Phys, Medford, MA 02155 USA; [Demirel, Melik C.] Penn State Univ, Mat Res Inst, University Pk, PA 16802 USA; [Demirel, Melik C.] Penn State Univ, Dept Engn Sci, University Pk, PA 16802 USA	Tufts University; Tufts University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Staii, C (corresponding author), Tufts Univ, Dept Phys & Astron, Medford, MA 02155 USA.	cstaii01@tufts.edu	Demirel, Melik C/E-3775-2016	Demirel, Melik/0000-0003-0466-7649	National Science Foundation [CBET 1067093]; US National Institutes of Health [1R21HL112114-01]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R21HL112114] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by the National Science Foundation, grant CBET 1067093 (E.S., C.S.). M.C.D. was supported by US National Institutes of Health (grant 1R21HL112114-01). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beighley R, 2012, APPL PHYS LETT, V101, DOI 10.1063/1.4755837; Betz T, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.098103; Cetinkaya M, 2007, POLYMER, V48, P4130, DOI 10.1016/j.polymer.2007.05.015; Cetinkaya M, 2008, J POLYM SCI POL PHYS, V46, P640, DOI 10.1002/polb.21399; Dickson BJ, 2002, SCIENCE, V298, P1959, DOI 10.1126/science.1072165; Dowell-Mesfin NM, 2004, J NEURAL ENG, V1, P78, DOI 10.1088/1741-2560/1/2/003; Fan YW, 2002, J NEUROSCI METH, V120, P17, DOI 10.1016/S0165-0270(02)00181-4; Fozdar DY, 2011, INT J NANOMED, V6, P45, DOI 10.2147/IJN.S12376; Francisco H, 2007, BIOMATERIALS, V28, P3398, DOI 10.1016/j.biomaterials.2007.04.015; Frank T, 1996, FOKKER PLANCK EQUATI; Franze K, 2013, DEVELOPMENT, V140, P3069, DOI 10.1242/dev.079145; Franze K, 2010, REP PROG PHYS, V73, DOI 10.1088/0034-4885/73/9/094601; Frey MT, 2006, BIOPHYS J, V90, P3774, DOI 10.1529/biophysj.105.074526; GRULER H, 1990, Z NATURFORSCH C, V45, P1241; Hancock MJ, 2012, ADV FUNCT MATER, V22, P2223, DOI 10.1002/adfm.201103017; Hart SR, 2013, LAB CHIP, V13, P562, DOI 10.1039/c2lc41166k; Hill NA, 1997, J THEOR BIOL, V186, P503, DOI 10.1006/jtbi.1997.0421; Huber AB, 2003, ANNU REV NEUROSCI, V26, P509, DOI 10.1146/annurev.neuro.26.010302.081139; Johansson F, 2006, BIOMATERIALS, V27, P1251, DOI 10.1016/j.biomaterials.2005.07.047; Kam L, 2001, BIOMATERIALS, V22, P1049, DOI 10.1016/S0142-9612(00)00352-5; Koch D, 2012, BIOPHYS J, V102, P452, DOI 10.1016/j.bpj.2011.12.025; Kundu A, 2013, LAB CHIP, V13, P3070, DOI 10.1039/c3lc50174d; Li NZ, 2005, EXP CELL RES, V311, P307, DOI 10.1016/j.yexcr.2005.10.007; Lowery LA, 2009, NAT REV MOL CELL BIO, V10, P332, DOI 10.1038/nrm2679; Malvadkar NA, 2010, NAT MATER, V9, P1023, DOI 10.1038/NMAT2864; Micholt L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066170; Moore SW, 2011, DEV NEUROBIOL, V71, P1090, DOI 10.1002/dneu.20947; PATEL N, 1982, J NEUROSCI, V2, P483; Rajnicek AM, 1997, J CELL SCI, V110, P2915; Riveline D, 2001, J CELL BIOL, V153, P1175, DOI 10.1083/jcb.153.6.1175; Rizzo DJ, 2013, PHYS REV E, V88, DOI 10.1103/PhysRevE.88.042707; Rosoff WJ, 2004, NAT NEUROSCI, V7, P678, DOI 10.1038/nn1259; SCHIENBEIN M, 1993, B MATH BIOL, V55, P585, DOI 10.1016/S0092-8240(05)80241-1; Schlosshauer B, 2006, NEUROSURGERY, V59, P740, DOI 10.1227/01.NEU.0000235197.36789.42; Smeal RM, 2008, EXP NEUROL, V213, P281, DOI 10.1016/j.expneurol.2008.05.026; So E, 2010, J PHYS D APPL PHYS, V43, DOI 10.1088/0022-3727/43/4/045403; Song M, 2007, ANN BIOMED ENG, V35, P1812, DOI 10.1007/s10439-007-9348-0; Spedden E, 2013, PHYS BIOL, V10, DOI 10.1088/1478-3975/10/5/056002; Spedden E, 2012, BIOPHYS J, V103, P868, DOI 10.1016/j.bpj.2012.08.005; Staii C, 2011, LANGMUIR, V27, P233, DOI 10.1021/la102331x; TessierLavigne M, 1996, SCIENCE, V274, P1123, DOI 10.1126/science.274.5290.1123; Wen ZX, 2006, CURR OPIN NEUROBIOL, V16, P52, DOI 10.1016/j.conb.2005.12.005; Zhang N, 2005, BRAIN RES REV, V49, P48, DOI 10.1016/j.brainresrev.2004.11.002; ZHENG JQ, 1994, NATURE, V368, P140, DOI 10.1038/368140a0	44	22	22	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 3	2014	9	9							e106709	10.1371/journal.pone.0106709	http://dx.doi.org/10.1371/journal.pone.0106709			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3TB	25184796	Green Published, gold, Green Submitted			2022-12-27	WOS:000341257700108
J	Stenfeldt, C; Pacheco, JM; Rodriguez, LL; Arzt, J				Stenfeldt, Carolina; Pacheco, Juan M.; Rodriguez, Luis L.; Arzt, Jonathan			Early Events in the Pathogenesis of Foot-and-Mouth Disease in Pigs; Identification of Oropharyngeal Tonsils as Sites of Primary and Sustained Viral Replication	PLOS ONE			English	Article							KIDNEY-CELL LINE; NATURAL AEROSOLS; HOST-RANGE; VIRUS; SWINE; CATTLE; TRANSMISSION; INFECTION; ANTIBODY; CONTACT	A time-course study was performed to elucidate the early events of foot-and-mouth disease virus (FMDV) infection in pigs subsequent to simulated natural, intra-oropharyngeal, inoculation. The earliest detectable event was primary infection in the lingual and paraepiglottic tonsils at 6 hours post inoculation (hpi) characterized by regional localization of viral RNA, viral antigen, and infectious virus. At this time FMDV antigen was localized in cytokeratin-positive epithelial cells and CD172a-expressing leukocytes of the crypt epithelium of the paraepiglottic tonsils. De novo replication of FMDV was first detected in oropharyngeal swab samples at 12 hpi and viremia occurred at 18-24 hpi, approximately 24 hours prior to the appearance of vesicular lesions. From 12 through 78 hpi, microscopic detection of FMDV was consistently localized to cytokeratin-positive cells within morphologically characteristic segments of oropharyngeal tonsil crypt epithelium. During this period, leukocyte populations expressing CD172a, SLA-DQ class II and/or CD8 were found in close proximity to infected epithelial cells, but with little or no co-localization with viral proteins. Similarly, M-cells expressing cytokeratin-18 did not co-localize with FMDV proteins. Intra-epithelial micro-vesicles composed of acantholytic epithelial cells expressing large amounts of structural and non-structural FMDV proteins were present within crypts of the tonsil of the soft palate during peak clinical infection. These findings inculpate the paraepiglottic tonsils as the primary site of FMDV infection in pigs exposed via the gastrointestinal tract. Furthermore, the continuing replication of FMDV in the oropharyngeal tonsils during viremia and peak clinical infection with no concurrent amplification of virus occurring in the lower respiratory tract indicates that these sites are the major source of shedding of FMDV from pigs.	[Stenfeldt, Carolina; Pacheco, Juan M.; Rodriguez, Luis L.; Arzt, Jonathan] ARS, Plum Isl Anim Dis Ctr, Foreign Anim Dis Res Unit, USDA, Greenport, NY 11944 USA; [Stenfeldt, Carolina] Oak Ridge Inst Sci & Educ, PIADC Res Participat Program, Oak Ridge, TN USA	United States Department of Agriculture (USDA); Oak Ridge Associated Universities; United States Department of Energy (DOE); Oak Ridge Institute for Science & Education	Arzt, J (corresponding author), ARS, Plum Isl Anim Dis Ctr, Foreign Anim Dis Res Unit, USDA, Greenport, NY 11944 USA.	Jonathan.Arzt@ars.usda.gov	Stenfeldt, Carolina/AAG-7940-2021	Pacheco, Juan/0000-0001-5477-0201; Stenfeldt, Carolina/0000-0002-2074-3886; Arzt, Jonathan/0000-0002-7517-7893	ARS-CRIS Project [1940-32000-057-00D]; Science and Technology Directorate of the U.S. Department of Homeland Security [HSHQDC-11-X-00189]; Plum Island Animal Disease Center Research Participation Program fellowship; National Pork Board (NPB project) [11-174]; NPB	ARS-CRIS Project; Science and Technology Directorate of the U.S. Department of Homeland Security(United States Department of Homeland Security (DHS)); Plum Island Animal Disease Center Research Participation Program fellowship; National Pork Board (NPB project); NPB	This research was funded in part by ARS-CRIS Project 1940-32000-057-00D and an interagency agreement with the Science and Technology Directorate of the U.S. Department of Homeland Security (award number HSHQDC-11-X-00189). CS is a recipient of a Plum Island Animal Disease Center Research Participation Program fellowship, administered by the Oak Ridge Institute for Science and Education (ORISE; www.orau.org) through an interagency agreement with the US Department of Energy. Additional funding was received from the National Pork Board (NPB project identification number: 11-174; www.pork.org), a government-owned corporation that administers a competitive peer-reviewed grants process with the objective to select and fund projects researching areas of importance to the pork industry. None of the contributing authors are employed by NPB, nor professionally evaluated by this entity. The funding received from NPB does not alter our adherence to PLOS ONE policies on sharing data and materials. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexandersen S, 2005, CURR TOP MICROBIOL, V288, P9; Alexandersen S, 2003, J COMP PATHOL, V129, P268, DOI 10.1016/S0021-9975(03)00045-8; Alexandersen S, 2003, J COMP PATHOL, V129, P1, DOI 10.1016/S0021-9975(03)00041-0; Alexandersen S, 2002, EPIDEMIOL INFECT, V128, P313, DOI 10.1017/S0950268801006501; Alexandersen S, 2001, J GEN VIROL, V82, P747, DOI 10.1099/0022-1317-82-4-747; Arzt J, 2011, TRANSBOUND EMERG DIS, V58, P305, DOI 10.1111/j.1865-1682.2011.01236.x; Arzt J, 2010, VET PATHOL, V47, P1048, DOI 10.1177/0300985810372509; Arzt J, 2009, J VET DIAGN INVEST, V21, P779, DOI 10.1177/104063870902100604; BAXT B, 1989, J VIROL, V63, P2143, DOI 10.1128/JVI.63.5.2143-2151.1989; Belz GT, 1996, ANAT RECORD, V245, P102; BROWN CC, 1995, J COMP PATHOL, V113, P51, DOI 10.1016/S0021-9975(05)80068-4; Callahan JD, 2002, J AM VET MED ASSOC, V220, P1636, DOI 10.2460/javma.2002.220.1636; Donaldson AI, 2001, VET REC, V148, P602, DOI 10.1136/vr.148.19.602; Donaldson AI, 2001, VET REC, V148, P600, DOI 10.1136/vr.148.19.600; DONALDSON AI, 1980, RES VET SCI, V29, P315, DOI 10.1016/S0034-5288(18)32634-1; Dunn CS, 1997, VET REC, V141, P174, DOI 10.1136/vr.141.7.174; FAO/OIE, 2012, GLOB FOOT AND MOUTH; GEBERT A, 1994, CELL TISSUE RES, V276, P213, DOI 10.1007/BF00306106; Grubman MJ, 2004, CLIN MICROBIOL REV, V17, P465, DOI 10.1128/CMR.17.2.465-493.2004; Harwood LJ, 2008, J VIROL, V82, P6379, DOI 10.1128/JVI.00021-08; Horter Dennis C., 2003, Animal Health Research Reviews, V4, P143, DOI 10.1079/AHRR200358; LaRocco M, 2013, J CLIN MICROBIOL, V51, P1714, DOI 10.1128/JCM.03370-12; Liebler-Tenorio EM, 2006, VET RES, V37, P257, DOI 10.1051/vetres:2006001; Murphy C, 2010, VET REC, V166, P10, DOI 10.1136/vr.b5583; Pacheco JM, 2003, J VIROL, V77, P13017, DOI 10.1128/JVI.77.24.13017-13027.2003; Pacheco JM, 2013, VIROLOGY, V446, P260, DOI 10.1016/j.virol.2013.08.003; Pacheco JM, 2012, VET J, V193, P456, DOI 10.1016/j.tvjl.2012.01.012; Pacheco JM, 2010, J VET SCI, V11, P133, DOI 10.4142/jvs.2010.11.2.133; Pacheco JM, 2010, VET J, V183, P46, DOI 10.1016/j.tvjl.2008.08.023; Piriou-Guzylack L, 2008, VET RES, V39, DOI 10.1051/vetres:2008030; Robinson L, 2011, J VIROL, V85, P2212, DOI 10.1128/JVI.02180-10; Schummer A, 1979, VISCERA DOMESTIC MAM, P51; Sergeant E., 2015, EPITOOLS EPIDEMIOLOG; Siebers A, 1996, TRENDS MICROBIOL, V4, P22, DOI 10.1016/0966-842X(96)81501-0; Stenfeldt C, 2016, TRANSBOUND EMERG DIS, V63, P152, DOI 10.1111/tbed.12235; Stenfeldt C, 2014, RES VET SCI, V96, P396, DOI 10.1016/j.rvsc.2014.01.009; SWANEY LM, 1988, VET MICROBIOL, V18, P1, DOI 10.1016/0378-1135(88)90111-3; Terpstra C, 1972, Bull Off Int Epizoot, V77, P859; Yang M, 2007, J IMMUNOL METHODS, V321, P174, DOI 10.1016/j.jim.2007.01.016; Yang PC, 1999, VET REC, V145, P731, DOI 10.1136/vr.145.25.731	40	31	31	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 3	2014	9	9							e106859	10.1371/journal.pone.0106859	http://dx.doi.org/10.1371/journal.pone.0106859			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3TB	25184288	Green Submitted, gold, Green Published			2022-12-27	WOS:000341257700125
J	Yoshioka, K; Ishii, K; Kuramoto, T; Nagai, S; Funao, H; Ishihama, H; Shiono, Y; Sasaki, A; Aizawa, M; Okada, Y; Koyasu, S; Toyama, Y; Matsumoto, M				Yoshioka, Kenji; Ishii, Ken; Kuramoto, Tetsuya; Nagai, Shigenori; Funao, Haruki; Ishihama, Hiroko; Shiono, Yuta; Sasaki, Aya; Aizawa, Mamoru; Okada, Yasunori; Koyasu, Shigeo; Toyama, Yoshiaki; Matsumoto, Morio			A Novel Mouse Model of Soft-Tissue Infection Using Bioluminescence Imaging Allows Noninvasive, Real-Time Monitoring of Bacterial Growth	PLOS ONE			English	Article							IN-VIVO; ALKALINE PROTEASE; MURINE MODEL; ANTIBIOTICS; OSTEOMYELITIS; VALIDATION; KINETICS; MICE; SKIN	Musculoskeletal infections, including surgical-site and implant-associated infections, often cause progressive inflammation and destroy areas of the soft tissue. Treating infections, especially those caused by multi-antibiotic resistant bacteria such as methicillin-resistant Staphylococcus aureus (MRSA) remains a challenge. Although there are a few animal models that enable the quantitative evaluation of infection in soft tissues, these models are not always reproducible or sustainable. Here, we successfully established a real-time, in vivo, quantitative mouse model of soft-tissue infection in the superficial gluteus muscle (SGM) using bioluminescence imaging. A bioluminescent strain of MRSA was inoculated into the SGM of BALB/c adult male mice, followed by sequential measurement of bacterial photon intensity and serological and histological analyses of the mice. The mean photon intensity in the mice peaked immediately after inoculation and remained stable until day 28. The serum levels of interleukin-6, interleukin-1 and C-reactive protein at 12 hours after inoculation were significantly higher than those prior to inoculation, and the C-reactive protein remained significantly elevated until day 21. Histological analyses showed marked neutrophil infiltration and abscesses containing necrotic and fibrous tissues in the SGM. With this SGM mouse model, we successfully visualized and quantified stable bacterial growth over an extended period of time with bioluminescence imaging, which allowed us to monitor the process of infection without euthanizing the experimental animals. This model is applicable to in vivo evaluations of the long-term efficacy of novel antibiotics or antibacterial implants.	[Yoshioka, Kenji; Ishii, Ken; Kuramoto, Tetsuya; Funao, Haruki; Ishihama, Hiroko; Shiono, Yuta; Toyama, Yoshiaki; Matsumoto, Morio] Keio Univ, Sch Med, Dept Orthoped Surg, Shinjuku Ku, Tokyo, Japan; [Nagai, Shigenori; Koyasu, Shigeo] Keio Univ, Sch Med, Dept Microbiol & Immunol, Shinjuku Ku, Tokyo, Japan; [Sasaki, Aya; Okada, Yasunori] Keio Univ, Sch Med, Dept Pathol, Shinjuku Ku, Tokyo 160, Japan; [Aizawa, Mamoru] Meiji Univ, Sch Sci & Technol, Dept Appl Chem, Kawasaki, Kanagawa, Japan; [Ishii, Ken; Aizawa, Mamoru] KAST, Kawasaki, Kanagawa, Japan; [Nagai, Shigenori] Japan Sci & Technol Agcy JST, CREST, Tokyo, Japan; [Nagai, Shigenori] Tokyo Med & Dent Univ, Grad Sch Med & Dent Sci, Dept Mol Immunol, Tokyo, Japan; [Koyasu, Shigeo] RIKEN Ctr Integrat Med Sci IMS, Lab Immune Cell Syst, Yokohama, Kanagawa, Japan	Keio University; Keio University; Keio University; Meiji University; Kanagawa Academy Science & Technology; Japan Science & Technology Agency (JST); Tokyo Medical & Dental University (TMDU); RIKEN	Ishii, K (corresponding author), Keio Univ, Sch Med, Dept Orthoped Surg, Shinjuku Ku, Tokyo, Japan.	keni8888@z7.keio.jp	Okada, Yasunori/B-5550-2014; Koyasu, Shigeo/J-5583-2015	Okada, Yasunori/0000-0001-9208-4755; Koyasu, Shigeo/0000-0001-9585-3038; Nagai, Shigenori/0000-0002-5018-5942; ISHII, KEN/0000-0003-0094-7918	Ministry of Education and Science, Kanagawa Academy of Science and Technology (KAST); General Insurance Association of Japan; Private Universities Foundation for the Development of Fundamental Research Strategies; Development of Next-generation Regenerative Medicine Process Using Biomaterials with Life Function on the Basis of Vertical Integration System; Keio Gijuku Academic Development Funds; Research for Promoting Technological Seeds; Grants-in-Aid for Scientific Research [26293400, 22229004] Funding Source: KAKEN	Ministry of Education and Science, Kanagawa Academy of Science and Technology (KAST); General Insurance Association of Japan; Private Universities Foundation for the Development of Fundamental Research Strategies; Development of Next-generation Regenerative Medicine Process Using Biomaterials with Life Function on the Basis of Vertical Integration System; Keio Gijuku Academic Development Funds; Research for Promoting Technological Seeds(Japan Science & Technology Agency (JST)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by scientific research fund of Ministry of Education and Science, Kanagawa Academy of Science and Technology (KAST), a medical research grant on traffic accident from The General Insurance Association of Japan, Private Universities Foundation for the Development of Fundamental Research Strategies, Development of Next-generation Regenerative Medicine Process Using Biomaterials with Life Function on the Basis of Vertical Integration System, Keio Gijuku Academic Development Funds, and Research for Promoting Technological Seeds. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bernthal NM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012580; Cavanaugh DL, 2009, J BONE JOINT SURG AM, V91A, P1907, DOI 10.2106/JBJS.G.01237; Contag CH, 1995, MOL MICROBIOL, V18, P593, DOI 10.1111/j.1365-2958.1995.mmi_18040593.x; Costa GL, 2001, J IMMUNOL, V167, P2379, DOI 10.4049/jimmunol.167.4.2379; Engelsman AF, 2009, J BIOMED MATER RES B, V88B, P123, DOI 10.1002/jbm.b.31158; Engleberg NC, 2001, J INFECT DIS, V183, P1043, DOI 10.1086/319291; Francis KP, 2000, INFECT IMMUN, V68, P3594, DOI 10.1128/IAI.68.6.3594-3600.2000; Funao H, 2012, INFECT IMMUN, V80, P733, DOI 10.1128/IAI.06166-11; Guo Y, 2013, ANTIMICROB AGENTS CH, V57, P855, DOI 10.1128/AAC.01003-12; Hidalgo-Grass C, 2004, LANCET, V363, P696, DOI 10.1016/S0140-6736(04)15643-2; Hirai M, 2010, CONTRAST MEDIA MOL I, V5, P70, DOI 10.1002/cmmi.367; Hsiao AL, 2005, CURR OPIN PEDIATR, V17, P56, DOI 10.1097/01.mop.0000151781.13635.70; Kadurugamuwa Jagath L, 2005, Mol Imaging, V4, P137; Kim DE, 2004, STROKE, V35, P952, DOI 10.1161/01.STR.0000120308.21946.5D; Kumar EV, 2011, BIOPROC BIOSYST ENG, V34, P403, DOI 10.1007/s00449-010-0483-x; Li D, 2008, J ORTHOP RES, V26, P96, DOI 10.1002/jor.20452; Mandl S, 2002, J CELL BIOCHEM, P239, DOI 10.1002/jcb.10454; Massey S, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00174; Okada S, 2005, FASEB J, V19, P1839, DOI 10.1096/fj.05-4082fje; Peltola H, 1984, Duodecim, V100, P390; Pillon A, 2005, ANAL BIOCHEM, V340, P295, DOI 10.1016/j.ab.2005.02.032; Pribaz JR, 2012, J ORTHOP RES, V30, P335, DOI 10.1002/jor.21519; Rocchetta HL, 2001, ANTIMICROB AGENTS CH, V45, P129, DOI 10.1128/AAC.45.1.129-137.2001; Sever D, 2011, FASEB J, V25, P676, DOI 10.1096/fj.10-158121; Sivasubramanian S, 2008, CHEMOSPHERE, V70, P1025, DOI 10.1016/j.chemosphere.2007.07.084; Sweeney TJ, 1999, P NATL ACAD SCI USA, V96, P12044, DOI 10.1073/pnas.96.21.12044; Tseng CW, 2011, JOVE-J VIS EXP, DOI 10.3791/2528; Wang XL, 2003, BLOOD, V102, P3478, DOI 10.1182/blood-2003-05-1432; Xiong YQ, 2005, ANTIMICROB AGENTS CH, V49, P380, DOI 10.1128/AAC.49.1.380-387.2005; Zhang H, 2008, IN VIVO, V22, P667	30	8	9	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 3	2014	9	9							e106367	10.1371/journal.pone.0106367	http://dx.doi.org/10.1371/journal.pone.0106367			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3TB	25184249	gold, Green Submitted, Green Published			2022-12-27	WOS:000341257700061
J	Zhang, ZT; Zhang, ZH; Wang, HC; Zhang, GX; Hu, D; Xiong, J; Xiong, NA; Wang, T; Cao, XB; Mao, L				Zhang, Zhentao; Zhang, Zhaohui; Wang, Hongcai; Zhang, Guoxin; Hu, Dan; Xiong, Jing; Xiong, Nian; Wang, Tao; Cao, Xuebing; Mao, Ling			Proliferating Cell Nuclear Antigen Binds DNA Polymerase-beta and Mediates 1-Methyl-4-Phenylpyridinium-Induced Neuronal Death	PLOS ONE			English	Article							ALZHEIMERS-DISEASE BRAIN; PARKINSONS-DISEASE; CYCLE EVENTS; REPLICATION; PATHWAYS; INSIGHTS; PCNA	The mechanisms leading to dopaminergic neuronal loss in the substantia nigra of patients with Parkinson disease (PD) remain poorly understood. We recently reported that aberrant DNA replication mediated by DNA polymerase-beta (DNA pol-beta) plays a causal role in the death of postmitotic neurons in an in vitro model of PD. In the present study, we show that both proliferating cell nuclear antigen (PCNA) and DNA pol-beta are required for MPP+-induced neuronal death. PCNA binds to the catalytic domain of DNA pol-beta in MPP+-treated neurons and in post-mortem brain tissues of PD patients. The PCNA-DNA pol-beta complex is loaded into DNA replication forks and mediates DNA replication in postmitotic neurons. The aberrant DNA replication mediated by the PCNA-DNA pol-beta complex induces p53-dependent neuronal cell death. Our results indicate that the interaction of PCNA and DNA pol-beta contributes to neuronal death in PD.	[Zhang, Zhentao; Zhang, Zhaohui; Hu, Dan; Xiong, Jing] Wuhan Univ, Dept Neurol, Renmin Hosp, Wuhan 430072, Peoples R China; [Wang, Hongcai; Zhang, Guoxin; Xiong, Nian; Wang, Tao; Cao, Xuebing; Mao, Ling] Huazhong Univ Sci & Technol, Union Hosp, Dept Neurol, Tongji Med Coll, Wuhan 430074, Peoples R China	Wuhan University; Huazhong University of Science & Technology	Mao, L (corresponding author), Huazhong Univ Sci & Technol, Union Hosp, Dept Neurol, Tongji Med Coll, Wuhan 430074, Peoples R China.	maoling13096@163.com	zhang, zh/GWV-4677-2022	Zhang, Zhentao/0000-0001-6708-1472	National Natural Science Foundation of China [81100958, 81101905]; Ministry of Education of China [20110141120061]; Natural Science Foundation of Hubei Provence [2011CBD480]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Education of China(Ministry of Education, China); Natural Science Foundation of Hubei Provence	This study was supported by National Natural Science Foundation of China (Grant no. 81100958, ZZ and 81101905, LM), Doctoral Fund of Ministry of Education of China (http://www.cutech.edu.cn/, Grant no. 20110141120061, ZZ), and Natural Science Foundation of Hubei Provence (http://www.hbstd.gov.cn/, Grant no. 2011CBD480, ZZ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aparicio OM, 1999, P NATL ACAD SCI USA, V96, P9130, DOI 10.1073/pnas.96.16.9130; Arendt T, 2010, AM J PATHOL, V177, P15, DOI 10.2353/ajpath.2010.090955; Busser J, 1998, J NEUROSCI, V18, P2801; Cabeza-Arvelaiz Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044700; Canitrot Y, 1999, FASEB J, V13, P1107, DOI 10.1096/fasebj.13.9.1107; Copani A, 2002, FASEB J, V16, P2006, DOI 10.1096/fj.02-0422fje; Copani A, 2006, J NEUROSCI, V26, P10949, DOI 10.1523/JNEUROSCI.2793-06.2006; D'Amelio M, 2009, ANN NY ACAD SCI, V1155, P324, DOI 10.1111/j.1749-6632.2008.03681.x; Herrup K, 2011, FRONT BIOSCI ELITE E, V4, P2101; Herrup K, 2013, CURR OPIN CELL BIOL, V25, P711, DOI 10.1016/j.ceb.2013.08.001; Hoglinger GU, 2007, P NATL ACAD SCI USA, V104, P3585, DOI 10.1073/pnas.0611671104; Katsel P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068361; Kedar PS, 2002, J BIOL CHEM, V277, P31115, DOI 10.1074/jbc.M201497200; Levy OA, 2009, APOPTOSIS, V14, P478, DOI 10.1007/s10495-008-0309-3; Li J, 2013, P NATL ACAD SCI USA, V110, P7672, DOI 10.1073/pnas.1222241110; Mosch B, 2007, J NEUROSCI, V27, P6859, DOI 10.1523/JNEUROSCI.0379-07.2007; Osheroff WP, 1999, J BIOL CHEM, V274, P3642, DOI 10.1074/jbc.274.6.3642; Rodriguez-Blanco J, 2008, J NEUROCHEM, V107, P127, DOI 10.1111/j.1471-4159.2008.05588.x; Roos WP, 2013, CANCER LETT, V332, P237, DOI 10.1016/j.canlet.2012.01.007; Scholzen T, 2000, J CELL PHYSIOL, V182, P311, DOI 10.1002/(SICI)1097-4652(200003)182:3<311::AID-JCP1>3.0.CO;2-9; Sobol RW, 1996, NATURE, V379, P183, DOI 10.1038/379183a0; Strzalka W, 2011, ANN BOT-LONDON, V107, P1127, DOI 10.1093/aob/mcq243; Vaithiyalingam S, 2014, J MOL BIOL, V426, P558, DOI 10.1016/j.jmb.2013.11.007; Walter J, 2000, MOL CELL, V5, P617, DOI 10.1016/S1097-2765(00)80241-5; Xu XJ, 2013, NUCLEIC ACIDS RES, V41, P10020, DOI 10.1093/nar/gkt810; Yang Y, 2001, J NEUROSCI, V21, P2661, DOI 10.1523/JNEUROSCI.21-08-02661.2001; Yang Y, 2003, J NEUROSCI, V23, P2557; Yurov YB, 2011, THESCIENTIFICWORLDJO, V11, P2602, DOI 10.1100/2011/625690; Zhang LY, 2012, P NATL ACAD SCI USA, V109, P20041, DOI 10.1073/pnas.1212914109; Zhang ZT, 2014, NEUROPSYCHOPHARMACOL, V39, P638, DOI 10.1038/npp.2013.243; Zhang ZT, 2010, CELL BIOL INT, V34, P1181, DOI 10.1042/CBI20090079; Zhang ZT, 2010, APOPTOSIS, V15, P105, DOI 10.1007/s10495-009-0425-8	32	3	4	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 3	2014	9	9							e106669	10.1371/journal.pone.0106669	http://dx.doi.org/10.1371/journal.pone.0106669			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3TB	25184665	Green Published, Green Submitted, gold			2022-12-27	WOS:000341257700100
J	Pappens, M; Schroijen, M; Sutterlin, S; Smets, E; Van den Bergh, O; Thayer, JF; Van Diest, I				Pappens, Meike; Schroijen, Mathias; Sutterlin, Stefan; Smets, Elyn; Van den Bergh, Omer; Thayer, Julian F.; Van Diest, Ilse			Resting Heart Rate Variability Predicts Safety Learning and Fear Extinction in an Interoceptive Fear Conditioning Paradigm	PLOS ONE			English	Article							VENTROMEDIAL PREFRONTAL CORTEX; POSTTRAUMATIC-STRESS; ESTROGEN-LEVELS; ANXIETY; STARTLE; AMYGDALA; HUMANS; THREAT; PERFORMANCE; INHIBITION	This study aimed to investigate whether interindividual differences in autonomic inhibitory control predict safety learning and fear extinction in an interoceptive fear conditioning paradigm. Data from a previously reported study (N = 40) were extended (N = 17) and re-analyzed to test whether healthy participants' resting heart rate variability (HRV) - a proxy of cardiac vagal tone - predicts learning performance. The conditioned stimulus (CS) was a slight sensation of breathlessness induced by a flow resistor, the unconditioned stimulus (US) was an aversive short-lasting suffocation experience induced by a complete occlusion of the breathing circuitry. During acquisition, the paired group received 6 paired CS-US presentations; the control group received 6 explicitly unpaired CS-US presentations. In the extinction phase, both groups were exposed to 6 CS-only presentations. Measures included startle blink EMG, skin conductance responses (SCR) and US-expectancy ratings. Resting HRV significantly predicted the startle blink EMG learning curves both during acquisition and extinction. In the unpaired group, higher levels of HRV at rest predicted safety learning to the CS during acquisition. In the paired group, higher levels of HRV were associated with better extinction. Our findings suggest that the strength or integrity of prefrontal inhibitory mechanisms involved in safety-and extinction learning can be indexed by HRV at rest.	[Pappens, Meike; Schroijen, Mathias; Sutterlin, Stefan; Smets, Elyn; Van den Bergh, Omer; Van Diest, Ilse] Katholieke Univ Leuven, Res Grp Hlth Psychol, Leuven, Belgium; [Sutterlin, Stefan] Lillehammer Univ Coll, Psychol Sect, Lillehammer, Norway; [Sutterlin, Stefan] Oslo Univ Hosp, Dept Psychosomat Med, Div Surg & Clin Neurosci, Rikshosp, Oslo, Norway; [Thayer, Julian F.] Ohio State Univ, Dept Psychol, Columbus, OH 43210 USA	KU Leuven; Inland Norway University of Applied Sciences; University of Oslo; National Hospital Norway; University System of Ohio; Ohio State University	Van Diest, I (corresponding author), Katholieke Univ Leuven, Res Grp Hlth Psychol, Leuven, Belgium.	Ilse.VanDiest@ppw.kuleuven.be	Thayer, Julian/AAA-1161-2020	Thayer, Julian/0000-0001-9385-3421; Sutterlin, Stefan/0000-0002-4337-1296; Van den Bergh, Omer/0000-0001-6394-7363; Van Diest, Ilse/0000-0002-0048-774X	Fund for Scientific Research, Flanders (FWO, Vlaanderen); KULeuven Center for Excellence Research Grant	Fund for Scientific Research, Flanders (FWO, Vlaanderen)(FWO); KULeuven Center for Excellence Research Grant	Meike Pappens and Elyn Smets could contribute to this study thanks to grants from the Fund for Scientific Research, Flanders (FWO, Vlaanderen). The research was also supported by a KULeuven Center for Excellence Research Grant (I. Van Diest, O. Van den Bergh, M. Schroijen). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvares GA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070468; Appelhans BM, 2006, REV GEN PSYCHOL, V10, P229, DOI 10.1037/1089-2680.10.3.229; Baeken C, 2010, BEHAV BRAIN RES, V214, P450, DOI 10.1016/j.bbr.2010.06.029; BENARROCH EE, 1993, MAYO CLIN PROC, V68, P988, DOI 10.1016/S0025-6196(12)62272-1; Bertsch K, 2012, PSYCHOPHYSIOLOGY, V49, P672, DOI 10.1111/j.1469-8986.2011.01341.x; Blumenthal TD, 2005, PSYCHOPHYSIOLOGY, V42, P1, DOI 10.1111/j.1469-8986.2005.00271.x; Bos MGN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062661; Bouton ME, 2002, BIOL PSYCHIAT, V52, P976, DOI 10.1016/S0006-3223(02)01546-9; Britton JC, 2013, AM J PSYCHIAT, V170, P1195, DOI 10.1176/appi.ajp.2013.12050651; Buchheit M, 2007, AM J PHYSIOL-HEART C, V293, pH8, DOI 10.1152/ajpheart.00335.2007; Delgado LC, 2010, BEHAV RES THER, V48, P873, DOI 10.1016/j.brat.2010.05.012; Craske MG, 2008, BEHAV RES THER, V46, P5, DOI 10.1016/j.brat.2007.10.003; Davis M, 2010, NEUROPSYCHOPHARMACOL, V35, P105, DOI 10.1038/npp.2009.109; De Clercq A, 2006, BEHAV RES METHODS, V38, P504, DOI 10.3758/BF03192805; Friedman BH, 2007, BIOL PSYCHOL, V74, P185, DOI 10.1016/j.biopsycho.2005.08.009; Gillie BL, PSYCHOL SCI IN PRESS; Glover EM, 2013, J PSYCHIATR NEUROSCI, V38, P341, DOI 10.1503/jpn.120129; Glover EM, 2012, BIOL PSYCHIAT, V72, P19, DOI 10.1016/j.biopsych.2012.02.031; Gorka SM, 2013, J PSYCHOPHYSIOL, V27, P95, DOI 10.1027/0269-8803/a000091; Hansen AL, 2013, J PSYCHOPHYSIOL, V27, P67, DOI 10.1027/0269-8803/a000088; Hansen AL, 2010, J PSYCHOPHYSIOL, V24, P41, DOI 10.1027/0269-8803/a000005; Iellamo F, 2000, CIRCULATION, V102, P2588; Kaufmann T, 2012, INT J PSYCHOPHYSIOL, V83, P336, DOI 10.1016/j.ijpsycho.2011.11.018; Kaufmann T, 2011, BEHAV RES METHODS, V43, P1161, DOI 10.3758/s13428-011-0107-7; Koval P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081536; Lau JY, 2011, P NATL ACAD SCI USA, V108, P4500, DOI 10.1073/pnas.1005494108; Li ZB, 2009, INT J PSYCHOPHYSIOL, V73, P212, DOI 10.1016/j.ijpsycho.2009.03.002; Lissek S, 2005, BEHAV RES THER, V43, P1391, DOI 10.1016/j.brat.2004.10.007; Lissek S, 2010, AM J PSYCHIAT, V167, P47, DOI 10.1176/appi.ajp.2009.09030410; Lissek S, 2009, BEHAV RES THER, V47, P111, DOI 10.1016/j.brat.2008.10.017; Melzig CA, 2009, INT J PSYCHOPHYSIOL, V71, P109, DOI 10.1016/j.ijpsycho.2008.07.013; Michael T, 2007, J ABNORM PSYCHOL, V116, P612, DOI 10.1037/0021-843X.116.3.612; Milad MR, 2010, NEUROSCIENCE, V168, P652, DOI 10.1016/j.neuroscience.2010.04.030; Milad MR, 2005, P NATL ACAD SCI USA, V102, P10706, DOI 10.1073/pnas.0502441102; Milad MR, 2002, NATURE, V420, P70, DOI 10.1038/nature01138; Mineka S, 2008, ACTA PSYCHOL, V127, P567, DOI 10.1016/j.actpsy.2007.11.007; Nunan D, 2010, PACE, V33, P1407, DOI 10.1111/j.1540-8159.2010.02841.x; Pappens M, 2012, PSYCHOPHYSIOLOGY, V49, P821, DOI 10.1111/j.1469-8986.2012.01357.x; Pappens M, 2011, INT J PSYCHOPHYSIOL, V80, P161, DOI 10.1016/j.ijpsycho.2011.02.015; Pappens M, 2010, BIOL PSYCHOL, V84, P98, DOI 10.1016/j.biopsycho.2010.02.006; Park G, PSYCHOPHYSI IN PRESS; Park G, 2013, PSYCHOPHYSIOLOGY, V50, P398, DOI 10.1111/psyp.12029; Parsons RG, 2013, NAT NEUROSCI, V16, P146, DOI 10.1038/nn.3296; Pena DF, 2013, BIOL PSYCHIAT, V73, P1071, DOI 10.1016/j.biopsych.2012.10.021; Phelps EA, 2004, NEURON, V43, P897, DOI 10.1016/j.neuron.2004.08.042; Porges S W, 1994, Monogr Soc Res Child Dev, V59, P167, DOI 10.2307/1166144; Porges SW, 2007, BIOL PSYCHOL, V74, P116, DOI 10.1016/j.biopsycho.2006.06.009; Porges Stephen W, 2009, Cleve Clin J Med, V76 Suppl 2, pS86, DOI 10.3949/ccjm.76.s2.17; Porges SW, 2001, INT J PSYCHOPHYSIOL, V42, P123, DOI 10.1016/S0167-8760(01)00162-3; Price JL, 2005, J COMP NEUROL, V493, P132, DOI 10.1002/cne.20750; Quirk GJ, 2008, NEUROPSYCHOPHARMACOL, V33, P56, DOI 10.1038/sj.npp.1301555; Quirk GJ, 2006, BIOL PSYCHIAT, V60, P337, DOI 10.1016/j.biopsych.2006.03.010; Rauch SL, 2006, BIOL PSYCHIAT, V60, P376, DOI 10.1016/j.biopsych.2006.06.004; Rauch SL, 2005, NEUROREPORT, V16, P1909, DOI 10.1097/01.wnr.0000186599.66243.50; Ritz T, 2006, PSYCHOSOM MED, V68, P617, DOI 10.1097/01.psy.0000228010.96408.ed; Ruiz-Padial E, 2003, PSYCHOPHYSIOLOGY, V40, P306, DOI 10.1111/1469-8986.00032; SAKAKIBARA M, 1994, PSYCHOPHYSIOLOGY, V31, P223, DOI 10.1111/j.1469-8986.1994.tb02210.x; Schmitz A, 2012, NAT PROTOC, V7, P527, DOI 10.1038/nprot.2012.001; Sehlmeyer C, 2011, PSYCHOL MED, V41, P789, DOI 10.1017/S0033291710001248; Spruyt A, 2010, EXP PSYCHOL, V57, P36, DOI 10.1027/1618-3169/a000005; Sutterlin S, 2011, SOC NEUROSCI-UK, V6, P169, DOI 10.1080/17470919.2010.495883; Thayer Julian F., 2006, Dose-Response, V4, P2, DOI 10.2203/dose-response.004.01.002.Thayer; Thayer JF, 2012, NEUROSCI BIOBEHAV R, V36, P747, DOI 10.1016/j.neubiorev.2011.11.009; Thayer JF, 2009, ANN BEHAV MED, V37, P141, DOI 10.1007/s12160-009-9101-z; Thayer JF, 2009, NEUROSCI BIOBEHAV R, V33, P81, DOI 10.1016/j.neubiorev.2008.08.004; Urry HL, 2006, J NEUROSCI, V26, P4415, DOI 10.1523/JNEUROSCI.3215-05.2006; Vansteenwegen D, 2008, BIOL PSYCHOL, V77, P39, DOI 10.1016/j.biopsycho.2007.08.012; Villa B, 2002, PHARMACOL RES, V45, P475, DOI 10.1006/phrs.2002.0989	68	55	55	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2014	9	9							e105054	10.1371/journal.pone.0105054	http://dx.doi.org/10.1371/journal.pone.0105054			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AO3LR	25181542	Green Published, Green Submitted, gold			2022-12-27	WOS:000341231500017
J	Pillans, RD; Bearham, D; Boomer, A; Downie, R; Patterson, TA; Thomson, DP; Babcock, RC				Pillans, Richard D.; Bearham, Douglas; Boomer, Andrew; Downie, Ryan; Patterson, Toby A.; Thomson, Damian P.; Babcock, Russel C.			Multi Year Observations Reveal Variability in Residence of a Tropical Demersal Fish, Lethrinus nebulosus: Implications for Spatial Management	PLOS ONE			English	Article							MARINE PROTECTED AREA; HOME-RANGE SIZE; MOVEMENT PATTERNS; SITE FIDELITY; LIFE-HISTORY; HABITAT UTILIZATION; SPANGLED EMPEROR; PAGRUS-AURATUS; REEF FISHES; RESERVES	Off the Ningaloo coast of North West Western Australia, Spangled Emperor Lethrinus nebulosus are among the most highly targeted recreational fish species. The Ningaloo Reef Marine Park comprises an area of 4,566 km(2) of which 34% is protected from fishing by 18 no-take sanctuary zones ranging in size from 0.08-44.8 km(2). To better understand Spangled Emperor movements and the adequacy of sanctuary zones within the Ningaloo Reef Marine Park for this species, 84 Spangled Emperor of a broad spectrum of maturity and sex were tagged using internal acoustic tags in a range of lagoon and reef slope habitats both inside and adjacent to the Mangrove Bay Sanctuary zone. Kernel Utilisation Distribution (KUD) was calculated for 39 resident individuals that were detected for more than 30 days. There was no relationship with fish size and movement or site fidelity. Average home range (95% KUD) for residents was 8.5 +/- 0.5 km(2) compared to average sanctuary zone size of 30 km(2). Calculated home range was stable over time resulting in resident animals tagged inside the sanctuary zone spending similar to 80% of time within the sanctuary boundaries. The number of fish remaining within the array of receivers declined steadily over time and after one year more than 60% of tagged fish had moved outside the sanctuary zone and also beyond the 28 km(2) array of receivers. Long term monitoring identified the importance of shifting home range and was essential for understanding overall residency within protected areas and also for identifying spawning related movements. This study indicates that despite exhibiting stable and small home ranges over periods of one to two years, more than half the population of spangled emperor move at scales greater than average sanctuary size within the Ningaloo Reef Marine Park.	[Pillans, Richard D.; Babcock, Russel C.] CSIRO Marine & Atmospher Res, Brisbane, Qld, Australia; [Downie, Ryan; Patterson, Toby A.] CSIRO Marine & Atmospher Res, Hobart, Tas, Australia; [Bearham, Douglas; Thomson, Damian P.] CSIRO Marine & Atmospher Res, Perth, WA, Australia; [Boomer, Andrew] SIMS, IMOS Anim Tagging & Monitoring, Mosman, NSW, Australia	Commonwealth Scientific & Industrial Research Organisation (CSIRO); Commonwealth Scientific & Industrial Research Organisation (CSIRO); Commonwealth Scientific & Industrial Research Organisation (CSIRO); Sydney Institute of Marine Science	Pillans, RD (corresponding author), CSIRO Marine & Atmospher Res, Brisbane, Qld, Australia.	Richard.Pillans@csiro.au	Babcock, Russell C/A-3794-2012; Pillans, Richard/F-2458-2012; Bearham, Douglas/AAW-1776-2020; Thomson, Damian P/C-3047-2014; Bearham, Doug/G-8689-2011	Babcock, Russell C/0000-0002-7756-1290; Bearham, Doug/0000-0002-2977-2843; Pillans, Richard/0000-0001-6234-8764; Patterson, Toby/0000-0002-7150-9205; Thomson, Damian/0000-0001-5485-1562	Ocean Flagship of CSIRO; Western Australia Marine Science Institute (WAMSI); CSIRO; Australian Animal Tracking and Monitoring System (AATAMS); facility of Australia's Integrated Marine Observing System (IMOS)	Ocean Flagship of CSIRO(Commonwealth Scientific & Industrial Research Organisation (CSIRO)); Western Australia Marine Science Institute (WAMSI); CSIRO(Commonwealth Scientific & Industrial Research Organisation (CSIRO)); Australian Animal Tracking and Monitoring System (AATAMS); facility of Australia's Integrated Marine Observing System (IMOS)	This study was funded by the Wealth from Ocean Flagship of CSIRO and the Western Australia Marine Science Institute (WAMSI). The Australian Institute of Marine Science provided in kind vessel support. The Ningaloo Reef Ecosystem Tracking Array is a fully co-invested installation co-funded by CSIRO and the Australian Animal Tracking and Monitoring System (AATAMS), a facility of Australia's Integrated Marine Observing System (IMOS) whose support made this project possible. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS PB, 1980, FISH B-NOAA, V78, P1; ANDREWS PLR, 1993, PHILOS T ROY SOC B, V342, P363, DOI 10.1098/rstb.1993.0165; Attwood CG, 1995, S AFR J MARINE SCI, V16, P227; Babcock RC, 2010, P NATL ACAD SCI USA, V107, P18256, DOI 10.1073/pnas.0908012107; Babcock RC., 2008, FINAL ANAL RECOMM, V2007, P100; Babcock RC, 2012, ENVIRON CONSERV, V39, P282, DOI 10.1017/S0376892912000148; Bellwood DR, 1985, THESIS J COOK U TOWN; CALM MPRA, 2005, MAN PLAN NING MAR PA; Carpenter KE, 2001, FAO SPECIES IDENTI 3, V5, P3037; Chateau O, 2008, J MAR BIOL ASSOC UK, V88, P825, DOI 10.1017/S0025315408001434; Chateau O, 2007, ENVIRON BIOL FISH, V80, P503, DOI 10.1007/s10641-006-9149-6; Chateau O, 2009, ICES J MAR SCI, V66, P50, DOI 10.1093/icesjms/fsn165; Claudet J, 2010, ECOL APPL, V20, P830, DOI 10.1890/08-2131.1; Cooke SJ, 2004, TRENDS ECOL EVOL, V19, P334, DOI 10.1016/j.tree.2004.04.003; DEMARTINI EE, 1993, FISH B-NOAA, V91, P414; Egli DP, 2004, ICES J MAR SCI, V61, P1137, DOI 10.1016/j.icesjms.2004.07.004; Gerber LR, 2002, BIOL CONSERV, V106, P11, DOI 10.1016/S0006-3207(01)00224-5; Goni R, 2006, MAR ECOL PROG SER, V308, P207, DOI 10.3354/meps308207; Green KM, 2011, MAR ECOL PROG SER, V436, P219, DOI 10.3354/meps09263; Halpern BS, 2003, ECOL APPL, V13, pS117; Harrison HB, 2012, CURR BIOL, V22, P1023, DOI 10.1016/j.cub.2012.04.008; Heupel MR, 2003, J FISH BIOL, V63, P1357, DOI 10.1046/j.1095-8649.2003.00250.x; Hobday AJ, 2009, REV-METHODS TECHNOL, V9, P381, DOI 10.1007/978-1-4020-9640-2_23; Horne JS, 2007, ECOLOGY, V88, P2354, DOI 10.1890/06-0957.1; Kernohan Brian J., 2001, P125, DOI 10.1016/B978-012497781-5/50006-2; Kramer DL, 1999, ENVIRON BIOL FISH, V55, P65, DOI 10.1023/A:1007481206399; Lester SE, 2009, MAR ECOL PROG SER, V384, P33, DOI 10.3354/meps08029; Lindholm J, 2006, NMSP0606; Lindholm J., 2005, MARINE SANCTUARIES C; Lindholm J, 2006, CARIBB J SCI, V42, P138; Lowe CG, 2003, MAR ECOL PROG SER, V256, P205, DOI 10.3354/meps256205; March D, 2011, ESTUAR COAST SHELF S, V92, P581, DOI 10.1016/j.ecss.2011.02.015; Marriott RJ, 2011, FISHERIES MANAG ECOL, V18, P89, DOI 10.1111/j.1365-2400.2010.00754.x; Marriott RJ, 2010, J FISH BIOL, V76, P1396, DOI 10.1111/j.1095-8649.2010.02571.x; Marshell A, 2011, CORAL REEFS, V30, P631, DOI 10.1007/s00338-011-0770-2; Meyer CG, 2007, MAR BIOL, V151, P2133, DOI 10.1007/s00227-007-0647-7; Meyer CG, 2010, MAR BIOL, V157, P1499, DOI 10.1007/s00227-010-1424-6; Meyer CG, 2005, ENVIRON BIOL FISH, V73, P201, DOI 10.1007/s10641-005-0559-7; Micheli F, 2004, ECOL APPL, V14, P1709, DOI 10.1890/03-5260; Moran M, 1993, FISHERIES BIOL EMP L; Nanami A, 2009, FISHERIES SCI, V75, P1109, DOI 10.1007/s12562-009-0136-7; Nowlis JS, 1999, FISH B-NOAA, V97, P604; OGDEN JC, 1973, ECOLOGY, V54, P589, DOI 10.2307/1935344; PARENT S, 1995, CAN J FISH AQUAT SCI, V52, P1768, DOI 10.1139/f95-769; Parsons DM, 2010, BIOL CONSERV, V143, P2039, DOI 10.1016/j.biocon.2010.05.009; Pedersen MW, 2013, METHODS ECOL EVOL, V4, P920, DOI 10.1111/2041-210X.12086; Polacheck T., 1990, NAT RESOUR MODEL, V4, P327; Rakitin A, 1996, MAR ECOL PROG SER, V131, P97, DOI 10.3354/meps131097; Rhodes KL, 2012, CORAL REEFS, V31, P443, DOI 10.1007/s00338-012-0875-2; Simpfendorfer CA, 2002, CAN J FISH AQUAT SCI, V59, P23, DOI 10.1139/F01-191; Starr RM, 2004, CAN J FISH AQUAT SCI, V61, P1083, DOI 10.1139/F04-054; Sumner NR, 2002, 139 DEP FISH WA; vanRooij JM, 1996, ENVIRON BIOL FISH, V47, P353, DOI 10.1007/BF00005050; VANWINKLE W, 1975, J WILDLIFE MANAGE, V39, P118; Welsh JQ, 2012, CORAL REEFS, V31, P55, DOI 10.1007/s00338-011-0813-8; Westera M, 2003, J EXP MAR BIOL ECOL, V294, P145, DOI 10.1016/S0022-0981(03)00268-5; White C, 2008, ECOL LETT, V11, P370, DOI 10.1111/j.1461-0248.2007.01151.x; White G.C., 1990, ANAL WILDLIFE RADIO; Worm B, 2003, P NATL ACAD SCI USA, V100, P9884, DOI 10.1073/pnas.1333941100; WORTON BJ, 1989, ECOLOGY, V70, P164, DOI 10.2307/1938423; Zeller DC, 1998, MAR ECOL PROG SER, V162, P253, DOI 10.3354/meps162253; Zeller DC, 1997, MAR ECOL PROG SER, V154, P65, DOI 10.3354/meps154065	62	26	27	1	56	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2014	9	9							e105507	10.1371/journal.pone.0105507	http://dx.doi.org/10.1371/journal.pone.0105507			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3LR	25181537	Green Published, gold, Green Submitted			2022-12-27	WOS:000341231500027
J	Toonen, EJM; Laskewitz, AJ; van Dijk, TH; Bleeker, A; Grefhorst, A; Schouten, AE; Bastiaanssen, EAJ; Ballak, DB; Koenders, MI; van Doorn, C; van der Vleuten, MAJ; van Lierop, MJC; Groen, AK; Dokter, WHA				Toonen, Erik J. M.; Laskewitz, Anke J.; van Dijk, Theo H.; Bleeker, Aycha; Grefhorst, Aldo; Schouten, Annelies E.; Bastiaanssen, Ellen A. J.; Ballak, Dov B.; Koenders, Marije I.; van Doorn, Cindy; van der Vleuten, Monique A. J.; van Lierop, Marie-Jose C.; Groen, Albert K.; Dokter, Wim H. A.			Glucose Kinetics in the Collagen-Induced Arthritis Model: An All-in-One Model to Assess Both Efficacy and Metabolic Side Effects of Glucocorticoids	PLOS ONE			English	Article							DEXAMETHASONE-INDUCED HYPERGLYCEMIA; PANCREATIC BETA-CELL; INSULIN SENSITIVITY; RHEUMATOID-ARTHRITIS; ALPHA; MICE; MECHANISMS; INTOLERANCE; RESISTANCE; INDUCTION	Prednisolone and other glucocorticoids (GCs) are potent anti-inflammatory drugs, but chronic use is hampered by metabolic side effects. Therefore, there is an urgent medical need for improved GCs that are as effective as classical GCs but have a better safety profile. A well-established model to assess anti-inflammatory efficacy is the chronic collagen-induced arthritis (CIA) model in mice, a model with features resembling rheumatoid arthritis. Models to quantify undesired effects of glucocorticoids on glucose kinetics are less well-established. Recently, we have described a model to quantify basal blood glucose kinetics using stably-labeled glucose. In the present study, we have integrated this blood glucose kinetic model in the CIA model to enable quantification of both efficacy and adverse effects in one animal model. Arthritis scores were decreased after treatment with prednisolone, confirming the anti-inflammatory properties of GCs. Both inflammation and prednisolone induced insulin resistance as insulin secretion was strongly increased whereas blood glucose concentrations and hepatic glucose production were only slightly decreased. This insulin resistance did not directly resulted in hyperglycemia, indicating a highly adaptive compensatory mechanism in these mice. In conclusion, this 'all-in-one' model allows for studying effects of (novel) GC compounds on the development of arthritis and glucose kinetics in a single animal. This integrative model provides a valuable tool for investigating (drug-induced) metabolic dysregulation in an inflammatory setting.	[Toonen, Erik J. M.; Ballak, Dov B.] Radboud Univ Nijmegen, Med Ctr, Dept Internal Med, NL-6525 ED Nijmegen, Netherlands; [Laskewitz, Anke J.; Bleeker, Aycha; Groen, Albert K.] Univ Groningen, Univ Med Ctr Groningen, Dept Pediat, Groningen, Netherlands; [van Dijk, Theo H.; Groen, Albert K.] Univ Groningen, Univ Med Ctr Groningen, Dept Lab Med, Groningen, Netherlands; [Grefhorst, Aldo] Univ Med Ctr Rotterdam, Erasmus MC, Dept Internal Med, Rotterdam, Netherlands; [Schouten, Annelies E.; Bastiaanssen, Ellen A. J.; van Doorn, Cindy; van der Vleuten, Monique A. J.; van Lierop, Marie-Jose C.; Dokter, Wim H. A.] MSD Res Labs, Dept Immune Therapeut, Oss, Netherlands; [Koenders, Marije I.] Radboud Univ Nijmegen, Med Ctr, RIMLS, Dept Expt Rheumatol, NL-6525 ED Nijmegen, Netherlands	Radboud University Nijmegen; University of Groningen; University of Groningen; Erasmus University Rotterdam; Erasmus MC; Merck & Company; Radboud University Nijmegen	Toonen, EJM (corresponding author), Radboud Univ Nijmegen, Med Ctr, Dept Internal Med, NL-6525 ED Nijmegen, Netherlands.	eriktoonen@hotmail.com	Toonen, Erik/G-7337-2015; Ballak, Dov B/E-1188-2017; Koenders, Marije I/A-1341-2012	Koenders, Marije I/0000-0001-5845-8362; Toonen, Erik/0000-0001-9039-635X	Dutch Top Institute Pharma [T1-106]; MSD	Dutch Top Institute Pharma; MSD	This research is supported by Dutch Top Institute Pharma; project T1-106 (www.tipharma.nl). The authors AS, EB, CvD, MvdV and MJvL and WD were previously employed by MSD and received salary from MSD to fund part of this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ader M, 1997, J CLIN INVEST, V99, P1187, DOI 10.1172/JCI119275; BERGMAN RN, 1987, J CLIN INVEST, V79, P790, DOI 10.1172/JCI112886; Bernal-Mizrachi C, 2003, NAT MED, V9, P1069, DOI 10.1038/nm898; Best JD, 1996, DIABETES CARE, V19, P1018, DOI 10.2337/diacare.19.9.1018; Clee SM, 2007, ENDOCR REV, V28, P48, DOI 10.1210/er.2006-0035; COMPTON MM, 1986, ENDOCRINOLOGY, V118, P38, DOI 10.1210/endo-118-1-38; COURTENAY JS, 1980, NATURE, V283, P666, DOI 10.1038/283666a0; DEFRONZO RA, 1979, AM J PHYSIOL, V237, pE214; den Uyl D, 2012, ARTHRITIS RHEUM-US, V64, P639, DOI 10.1002/art.33378; Dessein PH, 2004, J RHEUMATOL, V31, P867; Donath MY, 2009, PHYSIOLOGY, V24, P325, DOI 10.1152/physiol.00032.2009; Dulos J, 2004, ARTHRITIS RHEUM-US, V50, P3346, DOI 10.1002/art.20509; Dulos J, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar3032; GILL AM, 1994, DIABETES, V43, P999, DOI 10.2337/diabetes.43.8.999; Gounarides JS, 2008, ENDOCRINOLOGY, V149, P758, DOI 10.1210/en.2007-1214; Gulliford MC, 2006, DIABETES CARE, V29, P2728, DOI 10.2337/dc06-1499; Gurzov EN, 2010, J BIOL CHEM, V285, P19910, DOI 10.1074/jbc.M110.122374; HALLGREN R, 1983, ACTA MED SCAND, V213, P351; Hillier SG, 2007, J ENDOCRINOL, V195, P1, DOI 10.1677/JOE-07-0309; Hwang JY, 2008, INT J NANOMED, V3, P359; Joosten LAB, 1999, J IMMUNOL, V163, P5049; Kokkola R, 2003, ARTHRITIS RHEUM, V48, P2052, DOI 10.1002/art.11161; Laskewitz AJ, 2010, ENDOCRINOLOGY, V151, P2171, DOI 10.1210/en.2009-1374; LEE WNP, 1991, BIOL MASS SPECTROM, V20, P451, DOI 10.1002/bms.1200200804; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Miner JN, 2007, P NATL ACAD SCI USA, V104, P19244, DOI 10.1073/pnas.0705517104; Monzillo LU, 2003, NUTR REV, V61, P397, DOI 10.1301/nr.2003.dec.397-412; Muniyappa R, 2008, AM J PHYSIOL-ENDOC M, V294, pE15, DOI 10.1152/ajpendo.00645.2007; Myers LK, 1997, LIFE SCI, V61, P1861, DOI 10.1016/S0024-3205(97)00480-3; ORLAND MJ, 1987, DIABETOLOGIA, V30, P934, DOI 10.1007/BF00295877; Pacini G, 2001, AM J PHYSIOL-ENDOC M, V281, pE693, DOI 10.1152/ajpendo.2001.281.4.E693; Plater-Zyberk C, 2008, ARTHRITIS RHEUM, V58, pS163; Rhen T, 2005, NEW ENGL J MED, V353, P1711, DOI 10.1056/NEJMra050541; Schacke H, 2002, PHARMACOL THERAPEUT, V96, P23, DOI 10.1016/S0163-7258(02)00297-8; Schaecke H, 2007, MOL CELL ENDOCRINOL, V275, P109, DOI 10.1016/j.mce.2007.05.014; STUART JM, 1982, J CLIN INVEST, V69, P673, DOI 10.1172/JCI110495; SVENSON KLG, 1987, METABOLISM, V36, P944, DOI 10.1016/0026-0495(87)90129-6; Thomas CR, 1998, BIOCHEM PHARMACOL, V56, P1145, DOI 10.1016/S0006-2952(98)00151-8; Thompson CS, 2008, CURR PHARM DESIGN, V14, P309, DOI 10.2174/138161208783497679; van Dijk TH, 2003, ANAL BIOCHEM, V322, P1, DOI 10.1016/j.ab.2003.07.008; van Dijk TH, 2013, LAB ANIM; van Raalte DH, 2009, EUR J CLIN INVEST, V39, P81, DOI 10.1111/j.1365-2362.2008.02067.x; van Raalte DH, 2010, EUR J ENDOCRINOL, V162, P729, DOI 10.1530/EJE-09-1034; van Tuyl LHD, 2010, ANN RHEUM DIS, V69, P807, DOI 10.1136/ard.2009.108027; Wallace TM, 2004, DIABETES CARE, V27, P1487, DOI 10.2337/diacare.27.6.1487; Wolfe F, 2004, J RHEUMATOL, V31, P695; YEN TT, 1992, INT J OBESITY, V16, P923; Zhao RY, 2011, DIABETES METAB SYNDR, V4, P61, DOI 10.2147/DMSO.S15510	48	4	6	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2014	9	9							e98684	10.1371/journal.pone.0098684	http://dx.doi.org/10.1371/journal.pone.0098684			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3LR	25181348	Green Published, gold, Green Submitted			2022-12-27	WOS:000341231500004
J	Yoneda, A; Kuo, HWD; Ishihara, M; Azadi, P; Yu, SM; Ho, THD				Yoneda, Aki; Kuo, Hsion-Wen David; Ishihara, Mayumi; Azadi, Parastoo; Yu, Su-May; Ho, Tuan-hua David			Glycosylation Variants of a beta-Glucosidase Secreted by a Taiwanese Fungus, Chaetomella raphigera, Exhibit Variant-Specific Catalytic and Biochemical Properties	PLOS ONE			English	Article							N-LINKED OLIGOSACCHARIDES; O-GLYCOSYLATION; PROTEIN GLYCOSYLATION; ENZYMATIC-ACTIVITY; PICHIA-PASTORIS; THERMOSTABILITY; MANNOSYLATION; LOCALIZATION; PURIFICATION; TECHNOLOGIES	Cellulosic biomass is an abundant and promising energy source. To make cellulosic biofuels competitive against conventional fuels, conversion of rigid plant materials into sugars must become efficient and cost-effective. During cellulose degradation, cellulolytic enzymes generate cellobiose (beta-(1 -> 4)-glucose dimer) molecules, which in turn inhibit such enzymes by negative feedback. beta-Glucosidases (BGLs) cleave cellobiose into glucose monomers, assisting overall cellulolytic activities. Therefore, BGLs are essential for efficient conversion of cellulosic biomass into biofuels, and it is important to characterize newly isolated BGLs for useful traits. Here, we report our discovery that the indigenous Taiwanese fungus Chaetomella raphigera strain D2 produces two molecular weight variants of a single BGL, D2-BGL (shortened to "D2"), which differ in O-glycosylation. The more extensively O-glycosylated form of native D2 (nD2L) has increased activity toward the natural substrate, cellobiose, compared to the less O-glycosylated form (nD2S). nD2L is more stable at 60 degrees C, in acidic pH, and in the presence of the ionic detergent sodium dodecyl sulfate than nD2S. Furthermore, unlike nD2S, nD2L does not display substrate inhibition by an artificial substrate p-nitrophenyl glucopyranoside (pNPG), and the glucose feedback inhibition kinetics of nD2L is competitive (while it is non-competitive for nD2S), suggesting that these two glycovariants of D2 bind substrates differently. Interestingly, D2 produced in a heterologous system, Pichia pastoris, closely mimics properties of nD2S. Our studies suggest that O-glycosylation of D2 is important in determining its catalytic and biochemical properties.	[Yoneda, Aki; Ho, Tuan-hua David] Washington Univ, Dept Biol, St Louis, MO 63130 USA; [Yoneda, Aki] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO USA; [Kuo, Hsion-Wen David] Tunghai Univ, Dept Environm Sci & Engn, Taichung 40704, Taiwan; [Ishihara, Mayumi; Azadi, Parastoo] Univ Georgia, Complex Carbohydrate Res Ctr, Athens, GA 30602 USA; [Yu, Su-May] Acad Sinica, Nankang, Inst Mol Biol, Taipei, Taiwan; [Yu, Su-May; Ho, Tuan-hua David] Natl Chung Hsing Univ, Agr Biotechnol Ctr, Taichung 40227, Taiwan; [Yu, Su-May; Ho, Tuan-hua David] Natl Chung Hsing Univ, Dept Life Sci, Taichung 40227, Taiwan; [Ho, Tuan-hua David] Acad Sinica, Nankang, Inst Plant & Microbial Biol, Taipei, Taiwan	Washington University (WUSTL); Washington University (WUSTL); Tunghai University; University System of Georgia; University of Georgia; Academia Sinica - Taiwan; National Chung Hsing University; National Chung Hsing University; Academia Sinica - Taiwan	Ho, THD (corresponding author), Washington Univ, Dept Biol, Campus Box 1137, St Louis, MO 63130 USA.	tho@sinica.edu.tw	Yu, Su-May/ABB-6950-2021	Yu, Su-May/0000-0001-8744-9246; Aoki, Mayumi/0000-0002-8368-8546	International Center for Advanced Research in Energy and Sustainability, Washington University; Ministry of Science and Technology, Taiwan, Republic of China [103-3113-P-008 -001]	International Center for Advanced Research in Energy and Sustainability, Washington University; Ministry of Science and Technology, Taiwan, Republic of China	This work was supported by the International Center for Advanced Research in Energy and Sustainability, Washington University (http://icares.wustl.edu/Pages/Home.aspx) to TDH, and Ministry of Science and Technology, Taiwan, Republic of China (http://www.most.gov.tw) grant #103-3113-P-008 -001 to TDH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aebi M, 2013, BBA-MOL CELL RES, V1833, P2430, DOI 10.1016/j.bbamcr.2013.04.001; Alvira P, 2010, BIORESOURCE TECHNOL, V101, P4851, DOI 10.1016/j.biortech.2009.11.093; ANUMULA KR, 1992, ANAL BIOCHEM, V203, P101, DOI 10.1016/0003-2697(92)90048-C; Aoki-Kinoshita Kiyoko F, 2013, Methods Mol Biol, V951, P257, DOI 10.1007/978-1-62703-146-2_17; Beckham GT, 2012, CURR OPIN BIOTECH, V23, P338, DOI 10.1016/j.copbio.2011.11.030; Bhatia Y, 2002, CRIT REV BIOTECHNOL, V22, P375, DOI 10.1080/07388550290789568; Blanch HW, 2011, BIOTECHNOL J, V6, P1086, DOI 10.1002/biot.201000180; Bretthauer RK, 1999, BIOTECHNOL APPL BIOC, V30, P193; CARLSON DM, 1968, J BIOL CHEM, V243, P616; Chen L, 2014, P NATL ACAD SCI US; Chen VP, 2011, J BIOL CHEM, V286, P32948, DOI 10.1074/jbc.M111.261248; Chi YH, 2010, COMP BIOCHEM PHYS B, V156, P40, DOI 10.1016/j.cbpb.2010.01.017; Chill L, 2009, BIOTECHNOL BIOENG, V102, P828, DOI 10.1002/bit.22099; De Schutter K, 2009, NAT BIOTECHNOL, V27, P561, DOI 10.1038/nbt.1544; Ecker M, 2003, EMBO REP, V4, P628, DOI 10.1038/sj.embor.embor864; Endo T, 2004, GLYCOCONJUGATE J, V21, P3, DOI 10.1023/B:GLYC.0000043740.26062.2c; Gao L, 2012, J BIOL CHEM, V287, P15906, DOI 10.1074/jbc.M111.332890; Gelfand I, 2013, NATURE, V493, P514, DOI 10.1038/nature11811; Goto M, 2007, BIOSCI BIOTECH BIOCH, V71, P1415, DOI 10.1271/bbb.70080; Grass J, 2011, J BIOL CHEM, V286, P5977, DOI 10.1074/jbc.M110.191304; Haan C, 2007, J IMMUNOL METHODS, V318, P11, DOI 10.1016/j.jim.2006.07.027; Jeoh T, 2008, BIOTECHNOL BIOFUELS, V1, DOI 10.1186/1754-6834-1-10; Kazenwadel C, 2013, APPL MICROBIOL BIOT, V97, P7215, DOI 10.1007/s00253-012-4579-x; Kemmer G, 2010, NAT PROTOC, V5, P267, DOI 10.1038/nprot.2009.182; KERN G, 1993, PROTEIN SCI, V2, P1862, DOI 10.1002/pro.5560021108; KORNFELD R, 1985, ANNU REV BIOCHEM, V54, P631, DOI 10.1146/annurev.biochem.54.1.631; Koseki T, 2006, BIOSCI BIOTECH BIOCH, V70, P2476, DOI 10.1271/bbb.60207; KUKURUZINSKA MA, 1987, ANNU REV BIOCHEM, V56, P915, DOI 10.1146/annurev.biochem.56.1.915; Kuo M, 2008, FEBS LETT, V582, P829, DOI 10.1016/j.febslet.2008.02.010; Liebminger E, 2013, J BIOL CHEM, V288, P22270, DOI 10.1074/jbc.M113.475558; Lin Y, 2001, DRUG METAB DISPOS, V29, P368; Loibl M, 2013, BBA-MOL CELL RES, V1833, P2438, DOI 10.1016/j.bbamcr.2013.02.008; Lynd LR, 2008, NAT BIOTECHNOL, V26, P169, DOI 10.1038/nbt0208-169; Lynd LR, 2002, MICROBIOL MOL BIOL R, V66, P506, DOI 10.1128/MMBR.66.3.506-577.2002; Morelle W, 2005, EUKARYOT CELL, V4, P1308, DOI 10.1128/EC.4.7.1308-1316.2005; NAIM HY, 1992, J BIOL CHEM, V267, P25494; Ng IS, 2011, BIORESOURCE TECHNOL, V102, P6073, DOI 10.1016/j.biortech.2010.12.110; OLSEN O, 1991, J GEN MICROBIOL, V137, P579, DOI 10.1099/00221287-137-3-579; Raju TS, 2006, BIOCHEM BIOPH RES CO, V341, P797, DOI 10.1016/j.bbrc.2006.01.030; Sola RJ, 2009, J PHARM SCI-US, V98, P1223, DOI 10.1002/jps.21504; TAKAYANAGI T, 1994, CARBOHYD RES, V256, P149, DOI 10.1016/0008-6215(94)84234-5; Tilbeurgh H, 1982, FEBS LETT, V149, P152; van Zyl WH, 2011, INTERFACE FOCUS, V1, P196, DOI 10.1098/rsfs.2010.0017; Wallecha A, 2003, BBA-PROTEINS PROTEOM, V1649, P74, DOI 10.1016/S1570-9639(03)00163-8; Wallis GLF, 2001, EUR J BIOCHEM, V268, P4134, DOI 10.1046/j.1432-1327.2001.02322.x; Wang P, 2013, SCIENCE, V342, P1357, DOI 10.1126/science.1245095; Ward OP, 2012, BIOTECHNOL ADV, V30, P1119, DOI 10.1016/j.biotechadv.2011.09.012; WILLIAMSON G, 1992, BIOCHEM J, V282, P423, DOI 10.1042/bj2820423; Yanez E, 1998, BIOCHEM J, V329, P65, DOI 10.1042/bj3290065; Yusa A, 2006, J BIOL CHEM, V281, P20393, DOI 10.1074/jbc.M600140200	50	7	8	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2014	9	9							e106306	10.1371/journal.pone.0106306	http://dx.doi.org/10.1371/journal.pone.0106306			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3LR	25180973	Green Submitted, Green Published, gold			2022-12-27	WOS:000341231500073
J	Cornelissen, R; Lievense, LA; Maat, AP; Hendriks, RW; Hoogsteden, HC; Bogers, AJ; Hegmans, JP; Aerts, JG				Cornelissen, Robin; Lievense, Lysanne A.; Maat, Alexander P.; Hendriks, Rudi W.; Hoogsteden, Henk C.; Bogers, Ad J.; Hegmans, Joost P.; Aerts, Joachim G.			Ratio of Intratumoral Macrophage Phenotypes Is a Prognostic Factor in Epithelioid Malignant Pleural Mesothelioma	PLOS ONE			English	Article							TUMOR-ASSOCIATED MACROPHAGES; PHASE-III; CANCER; CELLS; EXPRESSION; SURVIVAL; POLARIZATION; CHEMOTHERAPY; INHIBITION; CISPLATIN	Hypothesis: The tumor micro-environment and especially the different macrophage phenotypes appear to be of great influence on the behavior of multiple tumor types. M1 skewed macrophages possess anti-tumoral capacities, while the M2 polarized macrophages have pro-tumoral capacities. We analyzed if the macrophage count and the M2 to total macrophage ratio is a discriminative marker for outcome after surgery in malignant pleural mesothelioma (MPM) and studied the prognostic value of these immunological cells. Methods: 8 MPM patients who received induction chemotherapy and surgical treatment were matched on age, sex, tumor histology, TNM stage and EORTC score with 8 patients who received chemotherapy only. CD8 positive T-cells and the total macrophage count, using the CD68 pan-macrophage marker, and CD163 positive M2 macrophage count were determined in tumor specimens prior to treatment. Results: The number of CD68 and CD163 cells was comparable between the surgery and the non-surgery group, and was not related to overall survival (OS) in both the surgery and non-surgery group. However, the CD163/CD68 ratio did correlate with OS in both in the total patient group (Pearson r-0.72, p < 0.05). No correlation between the number of CD8 cells and prognosis was found. Conclusions: The total number of macrophages in tumor tissue did not correlate with OS in both groups, however, the CD163/CD68 ratio correlates with OS in the total patient group. Our data revealed that the CD163/CD68 ratio is a potential prognostic marker in epithelioid mesothelioma patients independent of treatment but cannot be used as a predictive marker for outcome after surgery.	[Cornelissen, Robin; Lievense, Lysanne A.; Hendriks, Rudi W.; Hoogsteden, Henk C.; Hegmans, Joost P.; Aerts, Joachim G.] Erasmus MC Canc Inst, Dept Pulm Med, Rotterdam, Netherlands; [Maat, Alexander P.; Bogers, Ad J.] Erasmus MC Canc Inst, Dept Cardiothorac Surg, Rotterdam, Netherlands	Erasmus University Rotterdam; Erasmus MC; Erasmus MC Cancer Institute; Erasmus University Rotterdam; Erasmus MC; Erasmus MC Cancer Institute	Aerts, JG (corresponding author), Erasmus MC Canc Inst, Dept Pulm Med, Rotterdam, Netherlands.	j.aerts@erasmusmc.nl	Cornelissen, Robin/AAQ-8098-2021; Aerts, Joachim GJV/I-7885-2018	Cornelissen, Robin/0000-0002-4289-3092; Bogers, Ad/0000-0001-6200-1998	Stichting Asbestkanker Rotterdam; Mesothelioma Applied Research Foundation (MARF) - Larry Davis Memorial Grant	Stichting Asbestkanker Rotterdam; Mesothelioma Applied Research Foundation (MARF) - Larry Davis Memorial Grant	Stichting Asbestkanker Rotterdam, Mesothelioma Applied Research Foundation (MARF) - Larry Davis Memorial Grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander HR, 2013, SURGERY, V153, P779, DOI 10.1016/j.surg.2013.01.001; Anraku M, 2008, J THORAC CARDIOV SUR, V135, P823, DOI 10.1016/j.jtcvs.2007.10.026; Beatty GL, 2011, SCIENCE, V331, P1612, DOI 10.1126/science.1198443; Becker M, 2013, HISTOL HISTOPATHOL; Biswas SK, 2010, NAT IMMUNOL, V11, P889, DOI 10.1038/ni.1937; Bremnes RM, 2011, J THORAC ONCOL, V6, P824, DOI 10.1097/JTO.0b013e3182037b76; Brower V, 2012, J NATL CANCER I, V104, P649, DOI 10.1093/jnci/djs235; Buhtoiarov IN, 2011, IMMUNOLOGY, V132, P226, DOI 10.1111/j.1365-2567.2010.03357.x; Burt BM, 2011, CANCER-AM CANCER SOC, V117, P5234, DOI 10.1002/cncr.26143; Chuang CM, 2010, J BIOMED SCI, V17, DOI 10.1186/1423-0127-17-32; Cornelissen R, 2012, CLIN DEV IMMUNOL, DOI 10.1155/2012/927240; Cui YL, 2013, ASIAN PAC J CANCER P, V14, P1003, DOI 10.7314/APJCP.2013.14.2.1003; de Kleijn S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072249; Edin S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047045; Fennell DA, 2005, J CLIN ONCOL, V23, P184, DOI 10.1200/JCO.2005.07.050; Flores RM, 2008, J THORAC CARDIOV SUR, V135, P620, DOI 10.1016/j.jtcvs.2007.10.054; Fong CHY, 2008, J EXP MED, V205, P1269, DOI 10.1084/jem.20080124; Fridlender ZG, 2011, AM J RESP CELL MOL, V44, P230, DOI 10.1165/rcmb.2010-0080OC; Gordon GJ, 2009, JNCI-J NATL CANCER I, V101, P678, DOI 10.1093/jnci/djp061; Guiducci C, 2005, CANCER RES, V65, P3437, DOI 10.1158/0008-5472.CAN-04-4262; Haas AR, 2013, CLIN CHEST MED, V34, P99, DOI 10.1016/j.ccm.2012.12.005; Hagemann T, 2008, J EXP MED, V205, P1261, DOI 10.1084/jem.20080108; Hegmans JPJJ, 2006, EUR RESPIR J, V27, P1086, DOI 10.1183/09031936.06.00135305; Herwig MC, 2013, EXP EYE RES, V107, P52, DOI 10.1016/j.exer.2012.11.012; Heusinkveld M, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-216; Kaimala S, 2014, CANCER IMMUNOL IMMUN, V63, P587, DOI 10.1007/s00262-014-1543-x; Lan C, 2012, TECHNOL CANC RES TRE; Lievense LA, 2013, LUNG CANCER, DOI [10.1016/j.lung-can.2013.02.017, DOI 10.1016/J.LUNG-CAN.2013.02.017]; Mantovani A, 2010, CURR OPIN IMMUNOL, V22, P231, DOI 10.1016/j.coi.2010.01.009; Medrek C, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-306; Niino D, 2010, PATHOL INT, V60, P278, DOI 10.1111/j.1440-1827.2010.02514.x; Pantano F, 2013, J CELL MOL MED, V17, P1415, DOI 10.1111/jcmm.12109; Popivanova BK, 2009, CANCER RES, V69, P7884, DOI 10.1158/0008-5472.CAN-09-1451; Pyonteck SM, 2013, NAT MED, V19, P1264, DOI 10.1038/nm.3337; Rogers TL, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-177; Ruffell B, 2012, TRENDS IMMUNOL, V33, P119, DOI 10.1016/j.it.2011.12.001; Scherpereel A, 2010, EUR RESPIR J, V35, P479, DOI [10.3779/j.issn.1009-3419.2010.10.14, 10.1183/09031936.00063109]; Schmid MC, 2010, J ONCOL, V2010, DOI 10.1155/2010/201026; Soini Y, 2000, BRIT J CANCER, V83, P880, DOI 10.1054/bjoc.2000.1384; Suzuki K, 2011, CANCER IMMUNOL IMMUN, V60, P1721, DOI 10.1007/s00262-011-1073-8; Tanaka S, 1998, J CLIN INVEST, V102, P445, DOI 10.1172/JCI3169; Tang XQ, 2013, IMMUNOLOGY, V138, P93, DOI 10.1111/imm.12023; Taube JM, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003689; Topalian SL, 2012, CURR OPIN IMMUNOL, V24, P207, DOI 10.1016/j.coi.2011.12.009; van Meerbeeck JP, 2005, J CLIN ONCOL, V23, P6881, DOI 10.1200/JCO.20005.14.589; Veltman JD, 2010, BRIT J CANCER, V103, P629, DOI 10.1038/sj.bjc.6605814; Vogelzang NJ, 2003, J CLIN ONCOL, V21, P2636, DOI 10.1200/JCO.2003.11.136; Yamada N, 2010, CANCER IMMUNOL IMMUN, V59, P1543, DOI 10.1007/s00262-010-0881-6	48	68	71	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2014	9	9							e106742	10.1371/journal.pone.0106742	http://dx.doi.org/10.1371/journal.pone.0106742			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ1IR	25192022	Green Published, Green Submitted, gold			2022-12-27	WOS:000347993600056
J	Deng, XH; Zheng, XX; Yang, HM; Moreira, JMA; Brunner, N; Christensen, H				Deng, Xiaohong; Zheng, Xuxu; Yang, Huanming; Moreira, Jose Manuel Afonso; Brunner, Nils; Christensen, Henrik			Comparative Analysis of Evolutionarily Conserved Motifs of Epidermal Growth Factor Receptor 2 (HER2) Predicts Novel Potential Therapeutic Epitopes	PLOS ONE			English	Article							BREAST-CANCER; TYROSINE KINASE; ZINC-FINGER; CRYSTAL-STRUCTURE; IN-SITU; TRASTUZUMAB; PERTUZUMAB; BINDING; DOMAIN; RESISTANCE	Overexpression of human epidermal growth factor receptor 2 (HER2) is associated with tumor aggressiveness and poor prognosis in breast cancer. With the availability of therapeutic antibodies against HER2, great strides have been made in the clinical management of HER2 overexpressing breast cancer. However, de novo and acquired resistance to these antibodies presents a serious limitation to successful HER2 targeting treatment. The identification of novel epitopes of HER2 that can be used for functional/region-specific blockade could represent a central step in the development of new clinically relevant anti-HER2 antibodies. In the present study, we present a novel computational approach as an auxiliary tool for identification of novel HER2 epitopes. We hypothesized that the structurally and linearly evolutionarily conserved motifs of the extracellular domain of HER2 (ECD HER2) contain potential druggable epitopes/targets. We employed the PROSITE Scan to detect structurally conserved motifs and PRINTS to search for linearly conserved motifs of ECD HER2. We found that the epitopes recognized by trastuzumab and pertuzumab are located in the predicted conserved motifs of ECD HER2, supporting our initial hypothesis. Considering that structurally and linearly conserved motifs can provide functional specific configurations, we propose that by comparing the two types of conserved motifs, additional druggable epitopes/targets in the ECD HER2 protein can be identified, which can be further modified for potential therapeutic application. Thus, this novel computational process for predicting or searching for potential epitopes or key target sites may contribute to epitope-based vaccine and function-selected drug design, especially when x-ray crystal structure protein data is not available.	[Deng, Xiaohong; Zheng, Xuxu] Chongqing Technol & Business Univ, Chongqing Key Lab Catalysis & Funct Organ Mol, Chongqing, Peoples R China; [Deng, Xiaohong; Moreira, Jose Manuel Afonso; Brunner, Nils] Univ Copenhagen, Fac Hlth & Med Sci, Inst Vet Dis Biol, Sect Mol Dis Biol, Copenhagen, Denmark; [Deng, Xiaohong; Moreira, Jose Manuel Afonso; Brunner, Nils] Univ Copenhagen, Fac Hlth & Med Sci, Inst Vet Dis Biol, Sinodanish Breast Canc Res Ctr, Copenhagen, Denmark; [Christensen, Henrik] Univ Copenhagen, Inst Vet Dis Biol, Fac Hlth & Med Sci, Copenhagen, Denmark; [Deng, Xiaohong; Yang, Huanming] Beijing Genom Inst, Shenzhen, Peoples R China; [Deng, Xiaohong; Yang, Huanming] Sinodanish Breast Canc Res Ctr, Shenzhen, Peoples R China	Chongqing Technology & Business University; University of Copenhagen; University of Copenhagen; University of Copenhagen; Beijing Genomics Institute (BGI)	Deng, XH (corresponding author), Chongqing Technol & Business Univ, Chongqing Key Lab Catalysis & Funct Organ Mol, Chongqing, Peoples R China.	irenedeng77@gmail.com		Moreira, Jose/0000-0002-9944-1214; Christensen, Henrik/0000-0003-4238-4658	National Natural Science Foundation of China; Danish National Research Foundation; National Science and Technology Ministry of China [2010ZX09401-306-2-22]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Danish National Research Foundation(Danmarks Grundforskningsfond); National Science and Technology Ministry of China	The study was financially supported by the National Natural Science Foundation of China and the Danish National Research Foundation, and by National Science and Technology Ministry of China (No. 2010ZX09401-306-2-22). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baselga J, 2012, NEW ENGL J MED, V366, P109, DOI 10.1056/NEJMoa1113216; Baselga J, 2010, J CLIN ONCOL, V28, P1138, DOI 10.1200/JCO.2009.24.2024; Ben-Kasus T, 2007, MOL ONCOL, V1, P42, DOI 10.1016/j.molonc.2007.01.003; Berezov A, 2002, J BIOL CHEM, V277, P28330, DOI 10.1074/jbc.M202880200; Bessiere D, 2008, J BIOL CHEM, V283, P4352, DOI 10.1074/jbc.M707537200; Burgess AW, 2003, MOL CELL, V12, P541, DOI 10.1016/S1097-2765(03)00350-2; Carlsson J, 2004, BRIT J CANCER, V90, P2344, DOI 10.1038/sj.bjc.6601881; CARTER P, 1992, P NATL ACAD SCI USA, V89, P4285, DOI 10.1073/pnas.89.10.4285; Cho HS, 2003, NATURE, V421, P756, DOI 10.1038/nature01392; Clementi N, 2013, DRUG DISCOV TODAY, V18, P464, DOI 10.1016/j.drudis.2012.11.006; Cortes J, 2012, J CLIN ONCOL, V30, P1594, DOI 10.1200/JCO.2011.37.4207; de Castro E, 2006, NUCLEIC ACIDS RES, V34, pW362, DOI 10.1093/nar/gkl124; de Vega S, 2007, J BIOL CHEM, V282, P30878, DOI 10.1074/jbc.M705847200; Edwards TA, 2003, GENE DEV, V17, P2508, DOI 10.1101/gad.1119403; Esteva FJ, 2010, NAT REV CLIN ONCOL, V7, P98, DOI 10.1038/nrclinonc.2009.216; Franklin MC, 2004, CANCER CELL, V5, P317, DOI 10.1016/S1535-6108(04)00083-2; Garrett JT, 2011, CANCER BIOL THER, V11, P793, DOI 10.4161/cbt.11.9.15045; Garrett TPJ, 2003, MOL CELL, V11, P495, DOI 10.1016/S1097-2765(03)00048-0; Gershoni JM, 2007, BIODRUGS, V21, P145, DOI 10.2165/00063030-200721030-00002; Geyer CE, 2006, NEW ENGL J MED, V355, P2733, DOI 10.1056/NEJMoa064320; Harbeck N, 2013, BREAST CARE, V8, P49, DOI 10.1159/000346837; Ivanciuc O, 2009, REGUL TOXICOL PHARM, V54, pS11, DOI 10.1016/j.yrtph.2008.11.007; Kaufman B, 2009, LANCET ONCOL, V10, P581, DOI 10.1016/S1470-2045(09)70087-7; Latta EK, 2002, MODERN PATHOL, V15, P1318, DOI 10.1097/01.MP.0000038462.62634.B1; LEE MS, 1989, SCIENCE, V245, P635, DOI 10.1126/science.2503871; Li LY, 2011, CANCER RES, V71, P4269, DOI 10.1158/0008-5472.CAN-10-3504; Loer B, 2008, NAT CELL BIOL, V10, P422, DOI 10.1038/ncb1704; Nahta R, 2006, BREAST CANCER RES, V8, DOI 10.1186/bcr1612; Nahta R, 2006, NAT CLIN PRACT ONCOL, V3, P269, DOI 10.1038/ncponc0509; Owens Marilyn A, 2004, Clin Breast Cancer, V5, P63, DOI 10.3816/CBC.2004.n.011; PAVLETICH NP, 1991, SCIENCE, V252, P809, DOI 10.1126/science.2028256; Portera CC, 2008, CLIN CANCER RES, V14, P2710, DOI 10.1158/1078-0432.CCR-07-4636; Press MF, 1997, J CLIN ONCOL, V15, P2894, DOI 10.1200/JCO.1997.15.8.2894; REID KBM, 1989, IMMUNOL TODAY, V10, P177, DOI 10.1016/0167-5699(89)90317-4; Revannasiddaiah S, 2012, NEW ENGL J MED, V366, P1349, DOI 10.1056/NEJMc1201462; Roussigne M, 2003, TRENDS BIOCHEM SCI, V28, P66, DOI 10.1016/S0968-0004(02)00013-0; Saxon ML, 1999, J BIOL CHEM, V274, P28356, DOI 10.1074/jbc.274.40.28356; Scaltriti M, 2007, J NATL CANCER I, V99, P628, DOI 10.1093/jnci/djk134; Schlessinger J, 2000, CELL, V103, P211, DOI 10.1016/j.cell.2010.06.011; Schymkowitz J, 2005, NUCLEIC ACIDS RES, V33, pW382, DOI 10.1093/nar/gki387; Slack FJ, 1998, TRENDS BIOCHEM SCI, V23, P474, DOI 10.1016/S0968-0004(98)01299-7; SLAMON DJ, 1989, SCIENCE, V244, P707, DOI 10.1126/science.2470152; SLAMON DJ, 1987, SCIENCE, V235, P177, DOI 10.1126/science.3798106; Souri M, 2008, BIOCHEMISTRY-US, V47, P8656, DOI 10.1021/bi8006143; Spector NL, 2009, J CLIN ONCOL, V27, P5838, DOI 10.1200/JCO.2009.22.1507; Vogel CL, 2002, J CLIN ONCOL, V20, P719, DOI 10.1200/JCO.20.3.719; Wang SC, 2004, CANCER CELL, V6, P251, DOI 10.1016/j.ccr.2004.07.012; Wei XQ, 2001, J IMMUNOL, V167, P277, DOI 10.4049/jimmunol.167.1.277; Xia WL, 2011, MOL CANCER THER, V10, P1367, DOI 10.1158/1535-7163.MCT-10-0991; XIE YM, 1994, BIOCHEM BIOPH RES CO, V203, P1589, DOI 10.1006/bbrc.1994.2368; Yaziji H, 2004, JAMA-J AM MED ASSOC, V291, P1972, DOI 10.1001/jama.291.16.1972	51	3	5	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2014	9	9							e106448	10.1371/journal.pone.0106448	http://dx.doi.org/10.1371/journal.pone.0106448			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ1IR	25192037	Green Published, Green Submitted, gold			2022-12-27	WOS:000347993600027
J	Bradley, JM; Koker, P; Deng, Q; Moroni-Zentgraf, P; Ratjen, F; Geller, DE; Elborn, JS				Bradley, Judy M.; Koker, Paul; Deng, Qiqi; Moroni-Zentgraf, Petra; Ratjen, Felix; Geller, David E.; Elborn, J. Stuart		Tiotropium Cystic Fibrosis Study G	Testing Two Different Doses of Tiotropium Respimat (R) in Cystic Fibrosis: Phase 2 Randomized Trial Results	PLOS ONE			English	Article							QUALITY-OF-LIFE; BRONCHODILATORS; SALMETEROL; EFFICACY; MANNITOL; CHILDREN; INHALER; GROWTH	Background: Tiotropium is a once-daily, long-acting anticholinergic bronchodilator with the potential to alleviate airway obstruction in cystic fibrosis. Our objective was to evaluate the efficacy and safety of 2.5 and 5 mu g once-daily tiotropium delivered via the Respimat Soft Mist Inhaler vs. placebo in people with cystic fibrosis. Methods: This phase 2, 12-week, randomized, double-blind, placebo-controlled parallel-group study of tiotropium Respimat as add-on to usual cystic fibrosis maintenance therapy included people with cystic fibrosis with pre-bronchodilator forced expiratory volume in 1 second (FEV1) >= 25% predicted. Co-primary efficacy end points were change from baseline in percent-predicted FEV1 area under the curve from 0 to 4 hours (FEV1 AUC(0-4h)), and trough FEV1 at the end of week 12. Findings: A total of 510 subjects with cystic fibrosis aged 5-69 years were randomized. Both doses of tiotropium resulted in significant improvement compared with placebo in the co-primary efficacy end points at the end of week 12 (change from baseline in percent-predicted FEV1 AUC(0-4h): 2.5 mu g: 2.94%, 95% confidence interval 1.19-4.70, p = 0.001; 5 mu g: 3.39%, 95% confidence interval 1.67-5.12, p = 0.0001; in percent-predicted trough FEV1: 2.5 mu g: 2.24%, p = 0.2; 5 mu g: 2.22%, p = 0.02). There was a greater benefit with tiotropium 5 vs. 2.5 mu g. No treatment-related adverse events or unexpected safety findings were observed in patients taking tiotropium. Conclusions: Tiotropium significantly improved lung function in people with cystic fibrosis. The improvement was greater with the higher dose than the lower dose, with no difference in adverse events.	[Bradley, Judy M.] Univ Ulster, Inst Nursing & Hlth Res, Ulster, North Ireland; [Koker, Paul; Deng, Qiqi] Boehringer Ingelheim Pharmaceut Inc, Ridgefield, CT 06877 USA; [Moroni-Zentgraf, Petra] Boehringer Ingelheim Pharma GmbH & Co KG, Ingelheim, Germany; [Ratjen, Felix] Hosp Sick Children, Toronto, ON M5G 1X8, Canada; [Geller, David E.] Florida State Univ, Coll Med, Orlando, FL USA; [Elborn, J. Stuart] Queens Univ Belfast, Ctr Infect & Immun, Belfast, Antrim, North Ireland	Ulster University; Boehringer Ingelheim; Boehringer Ingelheim; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); State University System of Florida; Florida State University; Queens University Belfast	Elborn, JS (corresponding author), Queens Univ Belfast, Ctr Infect & Immun, Belfast, Antrim, North Ireland.	s.elborn@qub.ac.uk	Leroy, Sylvie SL/A-6903-2017; Deng, Qiqi/HII-7423-2022	Leroy, Sylvie SL/0000-0002-3465-8180; Herth, Felix/0000-0002-7638-2506; Middleton, Peter G/0000-0003-3361-4941; Bradley, Judy/0000-0002-7423-135X; Milavetz, Mary/0000-0001-9989-3010; elborn, joseph/0000-0002-2323-442X; Smyth, Alan/0000-0001-5494-5438; Ratjen, Felix/0000-0003-4057-6592	Boehringer Ingelheim	Boehringer Ingelheim(Boehringer Ingelheim)	This study was funded by Boehringer Ingelheim. Boehringer Ingelheim was involved in the study design, data collection and analysis, decision to publish, and preparation of the manuscript.	Aitken ML, 2012, AM J RESP CRIT CARE, V185, P645, DOI 10.1164/rccm.201109-1666OC; AVITAL A, 1992, PEDIATR PULM, V13, P34, DOI 10.1002/ppul.1950130109; Bateman Eric, 2010, Int J Chron Obstruct Pulmon Dis, V5, P197; Bilton D, 2013, J CYST FIBROS, V12, P367, DOI 10.1016/j.jcf.2012.11.002; Colombo JL, 2003, CURR OPIN PULM MED, V9, P504, DOI 10.1097/00063198-200311000-00010; Cropp GJ, 1996, AM J MED, V100, pS19, DOI 10.1016/S0002-9343(96)80049-0; Davis PB, 1996, AM J RESP CRIT CARE, V154, P1229, DOI 10.1164/ajrccm.154.5.8912731; Elkins MR, 2006, NEW ENGL J MED, V354, P229, DOI 10.1056/NEJMoa043900; Farrell PM, 2008, J PEDIATR-US, V153, pS4, DOI 10.1016/j.jpeds.2008.05.005; Goss CH, 2007, THORAX, V62, P360, DOI 10.1136/thx.2006.060889; Halfhide C, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003428.pub2; Henry B, 2003, QUAL LIFE RES, V12, P63, DOI 10.1023/A:1022037320039; Hordvik NL, 2002, PEDIATR PULM, V34, P287, DOI 10.1002/ppul.10162; Hordvik NL, 1999, PEDIATR PULM, V27, P43, DOI 10.1002/(SICI)1099-0496(199901)27:1<43::AID-PPUL9>3.0.CO;2-E; Ichinose M, 2010, RESP MED, V104, P228, DOI 10.1016/j.rmed.2009.11.011; Johnson C, 2003, CHEST, V123, P20, DOI 10.1378/chest.123.1.20; Kamin W, 2010, AM J RESP CRIT CARE, V181; Kamin W, 2011, INT SOC AER MED C 18; Kesser KC, 2009, RESP CARE, V54, P754, DOI 10.4187/002013209790983250; KNUDSON RJ, 1983, AM REV RESPIR DIS, V127, P725; Koker P, 2007, RANDOMIZED DOUBLE BL; Konstan MW, 1999, PEDIATR PULM, V28, P248, DOI 10.1002/(SICI)1099-0496(199910)28:4<248::AID-PPUL3>3.0.CO;2-N; Lymp J, 2009, PEDIATR PULM, V23, pA221; Miller MR, 2005, EUR RESPIR J, V26, P319, DOI 10.1183/09031936.05.00034805; Moher D, 2001, BMC Med Res Methodol, V1, P2, DOI 10.1186/1471-2288-1-2; Ratjen F, 2013, J CYST FIBROS S1, V12, pS64; Royce FH, 2011, CURR OPIN PEDIATR, V23, P535, DOI 10.1097/MOP.0b013e32834a7829; Salvatore D, 2002, PEDIATR PULM, V34, P11, DOI 10.1002/ppul.10117; Spiriva RESPIMAT, 2010, SUMM PROD CHAR 2010; van Noord JA, 2009, RESP MED, V103, P22, DOI 10.1016/j.rmed.2008.10.002; VanDyke Rhonda D, 2013, Ann Am Thorac Soc, V10, P205, DOI 10.1513/AnnalsATS.201209-082OC; Voshaar T, 2008, RESP MED, V102, P32, DOI 10.1016/j.rmed.2007.08.009; WANG XB, 1993, AM REV RESPIR DIS, V148, P1502, DOI 10.1164/ajrccm/148.6_Pt_1.1502; Whittaker ET, 1967, CALCULUS OBSERVATION, P156	34	16	16	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 4	2014	9	9							e106195	10.1371/journal.pone.0106195	http://dx.doi.org/10.1371/journal.pone.0106195			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3XV	25188297	Green Submitted, Green Published, gold			2022-12-27	WOS:000341271500025
J	Kelley, MR; Jiang, YL; Guo, CL; Reed, A; Meng, HD; Vasko, MR				Kelley, Mark R.; Jiang, Yanlin; Guo, Chunlu; Reed, April; Meng, Hongdi; Vasko, Michael R.			Role of the DNA Base Excision Repair Protein, APE1 in Cisplatin, Oxaliplatin, or Carboplatin Induced Sensory Neuropathy	PLOS ONE			English	Article							ROOT GANGLION NEURONS; INDUCED PERIPHERAL NEUROTOXICITY; SMALL-MOLECULE INHIBITOR; STRAND BREAK REPAIR; APURINIC/APYRIMIDINIC ENDONUCLEASE; CELL-CYCLE; INDUCED APOPTOSIS; OXIDATIVE STRESS; PLATINUM NEUROTOXICITY; NERVOUS-SYSTEM	Although chemotherapy-induced peripheral neuropathy (CIPN) is a dose-limiting side effect of platinum drugs, the mechanisms of this toxicity remain unknown. Previous work in our laboratory suggests that cisplatin-induced CIPN is secondary to DNA damage which is susceptible to base excision repair (BER). To further examine this hypothesis, we studied the effects of cisplatin, oxaliplatin, and carboplatin on cell survival, DNA damage, ROS production, and functional endpoints in rat sensory neurons in culture in the absence or presence of reduced expression of the BER protein AP endonuclease/redox factor-1 (APE1). Using an in situ model of peptidergic sensory neuron function, we examined the effects of the platinum drugs on hind limb capsaicin-evoked vasodilatation. Exposing sensory neurons in culture to the three platinum drugs caused a concentration-dependent increase in apoptosis and cell death, although the concentrations of carboplatin were 10 fold higher than cisplatin. As previously observed with cisplatin, oxaliplatin and carboplatin also increased DNA damage as indicated by an increase in phospho-H2AX and reduced the capsaicin-evoked release of CGRP from neuronal cultures. Both cisplatin and oxaliplatin increased the production of ROS as well as 8-oxoguanine DNA adduct levels, whereas carboplatin did not. Reducing levels of APE1 in neuronal cultures augmented the cisplatin and oxaliplatin induced toxicity, but did not alter the effects of carboplatin. Using an in vivo model, systemic injection of cisplatin (3 mg/kg), oxaliplatin (3 mg/kg), or carboplatin (30 mg/kg) once a week for three weeks caused a decrease in capsaicin-evoked vasodilatation, which was delayed in onset. The effects of cisplatin on capsaicin-evoked vasodilatation were attenuated by chronic administration of E3330, a redox inhibitor of APE1 that serendipitously enhances APE1 DNA repair activity in sensory neurons. These outcomes support the importance of the BER pathway, and particularly APE1, in sensory neuropathy caused by cisplatin and oxaliplatin, but not carboplatin and suggest that augmenting DNA repair could be a therapeutic target for CIPN.	[Kelley, Mark R.; Jiang, Yanlin; Reed, April] Herman B Wells Ctr Pediat Res, Dept Pediat, Indianapolis, IN 46202 USA; [Kelley, Mark R.; Guo, Chunlu; Meng, Hongdi; Vasko, Michael R.] Indiana Univ, Sch Med, Dept Pharmacol & Toxicol, Indianapolis, IN 46202 USA	Indiana University System; Indiana University-Purdue University Indianapolis	Kelley, MR (corresponding author), Herman B Wells Ctr Pediat Res, Dept Pediat, Indianapolis, IN 46202 USA.	mkelley@iu.edu		Kelley, Mark/0000-0002-6120-9532	National Institutes of Health, National Cancer Institute [CA121168, CA121168S1, CA167291]; Riley Children's Foundation; NATIONAL CANCER INSTITUTE [R01CA121168, R01CA167291] Funding Source: NIH RePORTER	National Institutes of Health, National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Riley Children's Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by grants from the National Institutes of Health, National Cancer Institute CA121168, CA121168S1, to MRK and MRV and CA167291 and the Riley Children's Foundation to MRK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amptoulach Sousana, 2011, Chemother Res Pract, V2011, P843019, DOI 10.1155/2011/843019; Bapat A, 2010, J PHARMACOL EXP THER, V334, P988, DOI 10.1124/jpet.110.169128; Bapat A, 2009, ANTIOXID REDOX SIGN, V11, P651, DOI [10.1089/ars.2008.2218, 10.1089/ARS.2008.2218]; Blisard K S, 1992, J Exp Pathol, V6, P65; Boyette-Davis J, 2011, PAIN, V152, P308, DOI 10.1016/j.pain.2010.10.030; Carozzi VA, 2010, CURR CANCER DRUG TAR, V10, P670; Cavaletti G, 1998, ANN ONCOL, V9, P443, DOI 10.1023/A:1008231925889; Cavaletti G, 2010, NAT REV NEUROL, V6, P657, DOI 10.1038/nrneurol.2010.160; Chvalova K, 2007, NUCLEIC ACIDS RES, V35, P1812, DOI 10.1093/nar/gkm032; David SS, 2007, NATURE, V447, P941, DOI 10.1038/nature05978; Duarte DB, 2012, DNA REPAIR IN CANCER THERAPY: MOLECULAR TARGETS AND CLINICAL APPLICATIONS, P283, DOI 10.1016/B978-0-12-384999-1.10013-7; Dzagnidze A, 2007, J NEUROSCI, V27, P9451, DOI 10.1523/JNEUROSCI.0523-07.2007; Earley JN, 2011, ANTIOXID REDOX SIGNA; El-Khamisy SF, 2007, NEUROSCIENCE, V145, P1260, DOI 10.1016/j.neuroscience.2006.08.048; Englander EW, 2013, DNA REPAIR, V12, P685, DOI 10.1016/j.dnarep.2013.04.020; Feghali JG, 2001, LARYNGOSCOPE, V111, P1147, DOI 10.1097/00005537-200107000-00005; Ferroni P, 2011, REJUV RES, V14, P293, DOI 10.1089/rej.2010.1141; Fischer SJ, 2001, NEUROBIOL DIS, V8, P1027, DOI 10.1006/nbdi.2001.0426; Fishel ML, 2007, MOL ASPECTS MED, V28, P375, DOI 10.1016/j.mam.2007.04.005; Fishel ML, 2007, MUTAT RES-FUND MOL M, V614, P24, DOI 10.1016/j.mrfmmm.2006.06.007; Fishel ML, 2011, MOL CANCER THER, V10, P1698, DOI 10.1158/1535-7163.MCT-11-0107; Fung H, 2005, MOL CELL, V17, P463, DOI 10.1016/j.molcel.2004.12.029; Gamelin E, 2002, SEMIN ONCOL, V29, P21, DOI 10.1053/sonc.2002.35525; Georgiadis M, 2012, BIOORGANIC MED CHEM; Gill JS, 1998, J CLIN INVEST, V101, P2842, DOI 10.1172/JCI1130; Go RS, 1999, J CLIN ONCOL, V17, P409, DOI 10.1200/JCO.1999.17.1.409; Gracias NG, 2011, NEUROTOXICOLOGY, V32, P140, DOI 10.1016/j.neuro.2010.09.006; GREGG RW, 1992, J CLIN ONCOL, V10, P795, DOI 10.1200/JCO.1992.10.5.795; Heinzlef O, 1998, J NEUROL NEUROSUR PS, V64, P667, DOI 10.1136/jnnp.64.5.667; Hershman DL, 2014, J CLIN ONCOL, V32, P1941, DOI 10.1200/JCO.2013.54.0914; HOLZER P, 1988, NEUROSCIENCE, V24, P739, DOI 10.1016/0306-4522(88)90064-4; Jiang YL, 2008, CANCER RES, V68, P6425, DOI 10.1158/0008-5472.CAN-08-1173; Jiang YL, 2010, CANCER INVEST, V28, P885, DOI 10.3109/07357907.2010.512816; Jiang YL, 2009, DNA REPAIR, V8, P1273, DOI 10.1016/j.dnarep.2009.08.003; Kelley Mark R, 2012, Curr Mol Pharmacol, V5, P36; Kim HJ, 2010, J NEUROSCI, V30, P3933, DOI 10.1523/JNEUROSCI.6054-09.2010; Kim YJ, 2011, CURR MOL PHARM; Kinoshita A, 2002, CARCINOGENESIS, V23, P341, DOI 10.1093/carcin/23.2.341; Kopke RD, 1997, AM J OTOL, V18, P559; Kothandapani A., 2013, NUCL ACIDS RES; Krishnan AV, 2005, MUSCLE NERVE, V32, P51, DOI 10.1002/mus.20340; Lehky RJ, 2004, MUSCLE NERVE, V29, P387, DOI 10.1002/mus.10559; Liu CC, 2010, MOL PAIN, V6, DOI 10.1186/1744-8069-6-76; Luo MH, 2012, BIOCHEMISTRY-US, V51, P695, DOI 10.1021/bi201034z; Luo MH, 2004, ANTICANCER RES, V24, P2127; Madhusudan S, 2005, NUCLEIC ACIDS RES, V33, P4711, DOI 10.1093/nar/gki781; McDonald ES, 2005, NEUROBIOL DIS, V18, P305, DOI 10.1016/j.nbd.2004.09.013; McWhinney SR, 2009, MOL CANCER THER, V8, P10, DOI 10.1158/1535-7163.MCT-08-0840; Meijer C, 1999, NEUROTOXICOLOGY, V20, P883; Mohammed MZ, 2011, BRIT J CANCER, V104, P653, DOI 10.1038/sj.bjc.6606058; Nyland RL, 2010, J MED CHEM, V53, P1200, DOI 10.1021/jm9014857; Pak JH, 2011, CANCER INVEST, V29, P21, DOI 10.3109/07357907.2010.535056; Pusztai L, 2004, CYTOKINE, V25, P94, DOI 10.1016/j.cyto.2003.10.004; Raymond E, 1998, ANN ONCOL, V9, P1053, DOI 10.1023/A:1008213732429; Rendell MS, 1998, MICROVASC RES, V55, P3, DOI 10.1006/mvre.1997.2049; Richardson JD, 2002, J PHARMACOL EXP THER, V302, P839, DOI 10.1124/jpet.102.032797; ROSENBERG B, 1985, CANCER, V55, P2303, DOI 10.1002/1097-0142(19850515)55:10<2303::AID-CNCR2820551002>3.0.CO;2-L; RYBAK LP, 1995, FUND APPL TOXICOL, V26, P293, DOI 10.1006/faat.1995.1100; Schulze C, 2011, CLIN COLORECTAL CANC, V10, P126, DOI 10.1016/j.clcc.2011.03.010; Screnci D, 1999, J INORG BIOCHEM, V77, P105, DOI 10.1016/S0162-0134(99)00135-X; Su DG, 2010, BIOCHEMISTRY; Sultana R, 2012, INT J CANCER, V131, P2433, DOI 10.1002/ijc.27512; Ta LE, 2006, NEUROTOXICOLOGY, V27, P992, DOI 10.1016/j.neuro.2006.04.010; Tell G, 2009, ANTIOXID REDOX SIGN, V11, P601, DOI 10.1089/ars.2008.2194; Todd RC, 2009, METALLOMICS, V1, P280, DOI 10.1039/b907567d; Turchi JJ, 2012, DNA REPAIR IN CANCER THERAPY: MOLECULAR TARGETS AND CLINICAL APPLICATIONS, P109, DOI 10.1016/B978-0-12-384999-1.10006-X; van den Berg JH, 2006, CANC TREAT REV; Vascotto C, 2012, DNA REPAIR IN CANCER THERAPY: MOLECULAR TARGETS AND CLINICAL APPLICATIONS, P29, DOI 10.1016/B978-0-12-384999-1.10003-4; Vasko MR, 2011, DNA REPAIR, V10, P942, DOI 10.1016/j.dnarep.2011.06.004; Vasko MR, 2005, DNA REPAIR, V4, P367, DOI 10.1016/j.dnarep.2004.11.006; Verdu E, 1999, MUSCLE NERVE, V22, P329, DOI 10.1002/(SICI)1097-4598(199903)22:3<329::AID-MUS5>3.0.CO;2-8; Wang D, 2005, NAT REV DRUG DISCOV, V4, P307, DOI 10.1038/nrd1691; Wang D, 2004, MOL CANCER THER, V3, P679; Wilson RH, 2002, J CLIN ONCOL, V20, P1767, DOI 10.1200/JCO.2002.07.056; Windebank AJ, 2008, J PERIPHER NERV SYST, V13, P27, DOI 10.1111/j.1529-8027.2008.00156.x; Zhang HH, 2007, CARCINOGENESIS, V28, P1629, DOI 10.1093/carcin/bgm072; Zhang J, 2013, BIOCHEMISTRY-US, V52, P2955, DOI 10.1021/bi400179m; Zheng HE, 2011, EXP NEUROL, V232, P154, DOI 10.1016/j.expneurol.2011.08.016	78	72	72	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 4	2014	9	9							e106485	10.1371/journal.pone.0106485	http://dx.doi.org/10.1371/journal.pone.0106485			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3XV	25188410	Green Submitted, Green Published, gold			2022-12-27	WOS:000341271500041
J	Felmingham, KL; Falconer, EM; Williams, L; Kemp, AH; Allen, A; Peduto, A; Bryant, RA				Felmingham, Kim L.; Falconer, Erin M.; Williams, Leanne; Kemp, Andrew H.; Allen, Adrian; Peduto, Anthony; Bryant, Richard A.			Reduced Amygdala and Ventral Striatal Activity to Happy Faces in PTSD Is Associated with Emotional Numbing	PLOS ONE			English	Article							POSTTRAUMATIC-STRESS-DISORDER; HUMAN ORBITOFRONTAL CORTEX; FUNCTIONAL NEUROANATOMY; DORSAL STRIATUM; RESPONSES; REWARD; METAANALYSIS; ACTIVATION; NEUROSCIENCE; VETERANS	There has been a growing recognition of the importance of reward processing in PTSD, yet little is known of the underlying neural networks. This study tested the predictions that (1) individuals with PTSD would display reduced responses to happy facial expressions in ventral striatal reward networks, and (2) that this reduction would be associated with emotional numbing symptoms. 23 treatment-seeking patients with Posttraumatic Stress Disorder were recruited from the treatment clinic at the Centre for Traumatic Stress Studies, Westmead Hospital, and 20 trauma-exposed controls were recruited from a community sample. We examined functional magnetic resonance imaging responses during the presentation of happy and neutral facial expressions in a passive viewing task. PTSD participants rated happy facial expression as less intense than trauma-exposed controls. Relative to controls, PTSD participants revealed lower activation to happy (-neutral) faces in ventral striatum and and a trend for reduced activation in left amygdala. A significant negative correlation was found between emotional numbing symptoms in PTSD and right ventral striatal regions after controlling for depression, anxiety and PTSD severity. This study provides initial evidence that individuals with PTSD have lower reactivity to happy facial expressions, and that lower activation in ventral striatal-limbic reward networks may be associated with symptoms of emotional numbing.	[Felmingham, Kim L.] Univ New S Wales, Sch Psychol, Sydney, NSW, Australia; [Felmingham, Kim L.; Falconer, Erin M.; Williams, Leanne; Allen, Adrian; Bryant, Richard A.] Westmead Hosp, Westmead Millennium Inst, Brain Dynam Ctr, Sydney, NSW, Australia; [Felmingham, Kim L.; Allen, Adrian; Bryant, Richard A.] Univ Tasmania, Sch Psychol, Hobart, Tas, Australia; [Williams, Leanne] Univ Sydney, Western Clin Sch, Sydney, NSW 2006, Australia; [Kemp, Andrew H.] Univ Sydney, Sch Psychol, Sydney, NSW 2006, Australia; [Peduto, Anthony] Westmead Hosp, Dept Radiol, MRI Unit, Sydney, NSW, Australia	University of New South Wales Sydney; University of Sydney; Westmead Institute for Medical Research; University of Tasmania; University of Sydney; University of Sydney; University of Sydney	Felmingham, KL (corresponding author), Univ New S Wales, Sch Psychol, Sydney, NSW, Australia.	Kim.Felmingham@utas.edu.au	Kemp, Andrew Haddon/C-7984-2012; Williams, Leanne/GLU-4975-2022; Bryant, Richard/AAA-6479-2019	Kemp, Andrew Haddon/0000-0003-1146-3791; Williams, Leanne/0000-0001-9987-7360; Bryant, Richard/0000-0002-9607-819X	National Health and Medical Research Council (NHMRC) [300304]; Australian Research Council [LP0212048]; NHMRC [1050848]	National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Australian Research Council(Australian Research Council); NHMRC(National Health and Medical Research Council (NHMRC) of Australia)	This research was supported by a National Health and Medical Research Council (NHMRC) Program Grant (300304), and Australian Research Council Linkage Grant (LP0212048), and an NHMRC Project Grant (1050848). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Addington J, 2010, J PSYCHIATR NEUROSCI, V35, P49, DOI 10.1503/jpn.080039; Balleine BW, 2007, J NEUROSCI, V27, P8161, DOI 10.1523/JNEUROSCI.1554-07.2007; Berns GS, 2001, J NEUROSCI, V21, P2793, DOI 10.1523/JNEUROSCI.21-08-02793.2001; Berridge KC, 2008, PSYCHOPHARMACOLOGY, V199, P457, DOI 10.1007/s00213-008-1099-6; Blake D. D., 1990, BEHAV THERAPIST, V18, P187, DOI DOI 10.1007/BF02105408; Breiter HC, 1996, NEURON, V17, P875, DOI 10.1016/S0896-6273(00)80219-6; Costafreda SG, 2008, BRAIN RES REV, V58, P57, DOI 10.1016/j.brainresrev.2007.10.012; Davis M, 2001, MOL PSYCHIATR, V6, P13, DOI 10.1038/sj.mp.4000812; Elliott R, 2000, J NEUROSCI, V20, P6159, DOI 10.1523/JNEUROSCI.20-16-06159.2000; Elman I, 2005, PSYCHIAT RES, V135, P179, DOI 10.1016/j.psychres.2005.04.002; Elman I, 2009, BIOL PSYCHIAT, V66, P1083, DOI 10.1016/j.biopsych.2009.06.006; Ernst M, 2005, NEUROIMAGE, V25, P1279, DOI 10.1016/j.neuroimage.2004.12.038; Ferry AT, 2000, EXP BRAIN RES, V131, P320, DOI 10.1007/s002219900240; Frewen PA, 2006, ANN NY ACAD SCI, V1071, P110, DOI 10.1196/annals.1364.010; Fusar-Poli P, 2009, J PSYCHIATR NEUROSCI, V34, P418; Galvan A, 2005, J NEUROSCI, V25, P8650, DOI 10.1523/JNEUROSCI.2431-05.2005; Gordon Evian, 2008, Journal of Integrative Neuroscience, V7, P345, DOI 10.1142/S0219635208001927; Gur RC, 2002, J NEUROSCI METH, V115, P137, DOI 10.1016/S0165-0270(02)00006-7; Hooper JW, 2008, J PSYCHIATR RES, V42, P802, DOI 10.1016/j.jpsychires.2007.10.008; Jatzko A, 2006, EUR ARCH PSY CLIN N, V256, P112, DOI 10.1007/s00406-005-0617-3; Kashdan TB, 2006, BEHAV RES THER, V44, P457, DOI 10.1016/j.brat.2005.03.001; Killgore WDS, 2004, NEUROIMAGE, V21, P1215, DOI 10.1016/j.neuroimage.2003.12.033; Kringelbach ML, 2004, PROG NEUROBIOL, V72, P341, DOI 10.1016/j.pneurobio.2004.03.006; Litz BT, 2002, AUST NZ J PSYCHIAT, V36, P198, DOI 10.1046/j.1440-1614.2002.01002.x; Lovibond SH, 1995, MANUAL DEPRESSION AN, V2nd; Mai JK, 2004, ATLAS HUMAN BRAIN; Milad MR, 2007, ANN NY ACAD SCI, V1121, P546, DOI 10.1196/annals.1401.006; Monk CS, 2008, AM J PSYCHIAT, V165, P266; Nitschke JB, 2006, NEUROIMAGE, V29, P106, DOI 10.1016/j.neuroimage.2005.06.068; Norman SB, 2007, J NERV MENT DIS, V195, P48, DOI 10.1097/01.nmd.0000252135.25114.02; North CS, 2009, AM J PSYCHIAT, V166, P34, DOI 10.1176/appi.ajp.2008.08050644; O'Doherty J, 2003, NEUROPSYCHOLOGIA, V41, P147, DOI 10.1016/S0028-3932(02)00145-8; O'Doherty J, 2004, SCIENCE, V304, P452, DOI 10.1126/science.1094285; Phan KL, 2002, NEUROIMAGE, V16, P331, DOI 10.1006/nimg.2002.1087; Pizzagalli DA, 2009, AM J PSYCHIAT, V166, P702, DOI 10.1176/appi.ajp.2008.08081201; Robbins L, 1998, ARCHIVES OF GENERAL, V45, P1069; Rolls ET, 2004, BRAIN COGNITION, V55, P11, DOI 10.1016/s0278-2626(03)00277-x; Romero MC, 2008, NEUROREPORT, V19, P1141, DOI 10.1097/WNR.0b013e328307c3fc; Ruscio AM, 2002, J TRAUMA STRESS, V15, P351, DOI 10.1023/A:1020125006371; Sailer U, 2008, NEUROPSYCHOLOGIA, V46, P2836, DOI 10.1016/j.neuropsychologia.2008.05.022; Shin LM, 2005, ARCH GEN PSYCHIAT, V62, P273, DOI 10.1001/archpsyc.62.3.273; Somerville LH, 2004, BIOL PSYCHIAT, V55, P897, DOI 10.1016/j.biopsych.2004.01.007; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; Ursu S, 2005, COGNITIVE BRAIN RES, V23, P51, DOI 10.1016/j.cogbrainres.2005.01.004; Williams LM, 2006, J NEUROSCI, V26, P9264, DOI 10.1523/JNEUROSCI.1016-06.2006; Williams LM, 2006, NEUROIMAGE, V29, P347, DOI 10.1016/j.neuroimage.2005.03.047; Winston JS, 2007, NEUROPSYCHOLOGIA, V45, P195, DOI 10.1016/j.neuropsychologia.2006.05.009	47	67	67	1	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 3	2014	9	9							e103653	10.1371/journal.pone.0103653	http://dx.doi.org/10.1371/journal.pone.0103653			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AO3TB	25184336	Green Published, gold			2022-12-27	WOS:000341257700007
J	Fornari, C; Beccuti, M; Lanzardo, S; Conti, L; Balbo, G; Cavallo, F; Calogero, RA; Cordero, F				Fornari, Chiara; Beccuti, Marco; Lanzardo, Stefania; Conti, Laura; Balbo, Gianfranco; Cavallo, Federica; Calogero, Raffaele A.; Cordero, Francesca			A Mathematical-Biological Joint Effort to Investigate the Tumor-Initiating Ability of Cancer Stem Cells	PLOS ONE			English	Article							POPULATION-DYNAMICS; MAMMARY-CANCER; SELF-RENEWAL; MODEL; DIFFERENTIATION; LINEAGES; NICHE	The involvement of Cancer Stem Cells (CSCs) in tumor progression and tumor recurrence is one of the most studied subjects in current cancer research. The CSC hypothesis states that cancer cell populations are characterized by a hierarchical structure that affects cancer progression. Due to the complex dynamics involving CSCs and the other cancer cell subpopulations, a robust theory explaining their action has not been established yet. Some indications can be obtained by combining mathematical modeling and experimental data to understand tumor dynamics and to generate new experimental hypotheses. Here, we present a model describing the initial phase of ErbB2(+) mammary cancer progression, which arises from a joint effort combing mathematical modeling and cancer biology. The proposed model represents a new approach to investigate the CSC-driven tumorigenesis and to analyze the relations among crucial events involving cancer cell subpopulations. Using in vivo and in vitro data we tuned the model to reproduce the initial dynamics of cancer growth, and we used its solution to characterize observed cancer progression with respect to mutual CSC and progenitor cell variation. The model was also used to investigate which association occurs among cell phenotypes when specific cell markers are considered. Finally, we found various correlations among model parameters which cannot be directly inferred from the available biological data and these dependencies were used to characterize the dynamics of cancer subpopulations during the initial phase of ErbB2(+) mammary cancer progression.	[Fornari, Chiara; Beccuti, Marco; Balbo, Gianfranco; Cordero, Francesca] Univ Turin, Dept Comp Sci, Turin, Italy; [Fornari, Chiara; Lanzardo, Stefania; Conti, Laura; Cavallo, Federica; Calogero, Raffaele A.] Univ Turin, Dept Mol Biotechnol & Hlth Sci, Ctr Mol Biotechnol, Turin, Italy	University of Turin; University of Turin	Cordero, F (corresponding author), Univ Turin, Dept Comp Sci, Turin, Italy.	fcordero@di.unito.it	Calogero, Raffaele/K-9428-2019; Cordero, Francesca/AAB-3655-2019; CONTI, LAURA/A-9005-2017; Conti, Laura/AAL-8272-2020; Cavallo, Federica/C-5666-2011	Calogero, Raffaele/0000-0002-2848-628X; Cordero, Francesca/0000-0002-3143-3330; CONTI, LAURA/0000-0003-1780-098X; Beccuti, Marco/0000-0001-6125-9460; Cavallo, Federica/0000-0003-4571-1060	Italian Association for Cancer Research [IG 11675]; Fondazione Ricerca Molinette Onlus, the University of Torino; Compagnia di San Paolo (Progetti di Ricerca Ateneo/CSP); Epigenomics Flagship Project EPIGEN; MIUR-CNR; King Abdulaziz University of Saudi Arabia [10-15-1432/HICI]; Fondazione Veronesi Pink is Good grant	Italian Association for Cancer Research(Fondazione AIRC per la ricerca sul cancro); Fondazione Ricerca Molinette Onlus, the University of Torino; Compagnia di San Paolo (Progetti di Ricerca Ateneo/CSP)(Compagnia di San Paolo); Epigenomics Flagship Project EPIGEN; MIUR-CNR(Ministry of Education, Universities and Research (MIUR)Consiglio Nazionale delle Ricerche (CNR)); King Abdulaziz University of Saudi Arabia; Fondazione Veronesi Pink is Good grant(Fondazione Umberto Veronesi)	This work was partially supported by the following grants: the Italian Association for Cancer Research (IG 11675) for F. Cavallo; Fondazione Ricerca Molinette Onlus, the University of Torino; the Compagnia di San Paolo (Progetti di Ricerca Ateneo/CSP); the Epigenomics Flagship Project EPIGEN; MIUR-CNR and by project grant Nr. 10-15-1432/HICI from the King Abdulaziz University of Saudi Arabia. Moreover, L. C. is supported by a Fondazione Veronesi Pink is Good grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alarcon T, 2011, DISCRETE CONT DYN-A, V31, P32; Berettal E, 2012, MATH MODEL NAT PHENO, V7, P1; Bjerkvig R, 2005, NAT REV CANCER, V5, P899, DOI 10.1038/nrc1740; Boggio K, 1998, J EXP MED, V188, P589, DOI 10.1084/jem.188.3.589; Chaffer C, 2011, PNAS, V108; Chou CS, 2010, BIOPHYS J, V99, P3145, DOI 10.1016/j.bpj.2010.09.034; Cicalese A, 2009, CELL, V138, P1083, DOI 10.1016/j.cell.2009.06.048; Clarke MF, 2006, CELL, V124, P1111, DOI 10.1016/j.cell.2006.03.011; Conti L, 2013, FASEB J, V27, P4731, DOI 10.1096/fj.13-230201; Conti L, 2013, CONTRAST MEDIA MOL I, V8, P350, DOI 10.1002/cmmi.1529; Cordero F, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-S6-S11; D'Onofrio A, 2012, SEMA SIMAI SPRINGER; d'Onofrio A, 2007, J THEOR BIOL, V244, P367, DOI 10.1016/j.jtbi.2006.08.022; Dingli D, 2007, PLOS COMPUT BIOL, V3; Enderling H, 2009, CANCER RES, V69, P8814, DOI 10.1158/0008-5472.CAN-09-2115; Frank NY, 2010, J CLIN INVEST, V120, P41, DOI 10.1172/JCI41004; Grange C, 2008, NEOPLASIA, V10, P1433, DOI 10.1593/neo.08902; Gupta PB, 2011, CELL, V146, P633, DOI 10.1016/j.cell.2011.07.026; Heffernan JM, 2005, J R SOC INTERFACE, V2, P281, DOI 10.1098/rsif.2005.0042; Helton JC, 2003, RELIAB ENG SYST SAFE, V81, P23, DOI 10.1016/S0951-8320(03)00058-9; Hu YJ, 2013, MED HYPOTHESES, V80, P649, DOI 10.1016/j.mehy.2013.01.009; Johnston MD, 2007, P NATL ACAD SCI USA, V104, P4008, DOI 10.1073/pnas.0611179104; Johnston MD, 2007, CELL CYCLE, V6, P2106, DOI 10.4161/cc.6.17.4649; Johnston MD, 2010, J THEOR BIOL, V266, P708, DOI 10.1016/j.jtbi.2010.07.031; Kern SE, 2007, CANCER RES, V67, P8985, DOI 10.1158/0008-5472.CAN-07-1971; Lander A, 2009, PLOS BIOL, V10; Lathia JD, 2011, CELL DEATH DIS, V2, DOI 10.1038/cddis.2011.80; Lo WC, 2009, MATH BIOSCI ENG, V6, P59, DOI 10.3934/mbe.2009.6.59; MACKILLOP WJ, 1983, J NATL CANCER I, V70, P9; Marciniak-Czochra A, 2009, STEM CELLS DEV, V18, P377, DOI 10.1089/scd.2008.0143; Michor F, 2004, CELL CYCLE, V3, P358; Michor F, 2004, NAT REV CANCER, V4, P197, DOI 10.1038/nrc1295; Mirams G, 2013, J THEOR BIOL, P143; Molina-Pena R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0026233; Morton CI, 2011, THEOR BIOL MED MODEL, V8, DOI 10.1186/1742-4682-8-48; Murray, 2002, MATH BIOL I INTRO IN; Nakata Y, 2011, J BIOL DYNAM, P2; Nguyen LV, 2012, NAT REV CANCER, V12, P133, DOI 10.1038/nrc3184; Nowak MA, 2003, P NATL ACAD SCI USA, V100, P14966, DOI 10.1073/pnas.2535419100; Ovadia J, 2013, BIOPHYS J, V104, P237, DOI 10.1016/j.bpj.2012.11.3807; Pardal R, 2003, NAT REV CANCER, V3, P895, DOI 10.1038/nrc1232; Pierre N, 1992, DYNAMICAL SYSTEMS IN; Tang DG, 2012, CELL RES, V22, P457, DOI 10.1038/cr.2012.13; TOMLINSON IPM, 1995, P NATL ACAD SCI USA, V92, P11130, DOI 10.1073/pnas.92.24.11130; Turner C, 2010, J THEOR BIOL, V265, P329, DOI 10.1016/j.jtbi.2010.05.024; Tyson DR, 2012, NAT METHODS, V9, P923, DOI 10.1038/nmeth.2138; Valent P, 2012, NAT REV CANCER, V12, P767, DOI 10.1038/nrc3368; Visvader JE, 2008, NAT REV CANCER, V8, P755, DOI 10.1038/nrc2499; Youssefpour H, 2012, J THEOR BIOL, V304, P39, DOI 10.1016/j.jtbi.2012.02.030; Zhang L, 2012, BMC SYST BIOL, V6, DOI 10.1186/1752-0509-6-93; Zhu XW, 2011, J THEOR BIOL, V269, P138, DOI 10.1016/j.jtbi.2010.10.016	51	10	10	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 3	2014	9	9							e106193	10.1371/journal.pone.0106193	http://dx.doi.org/10.1371/journal.pone.0106193			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3TB	25184361	Green Submitted, Green Published, gold			2022-12-27	WOS:000341257700036
J	Golkar, A; Johansson, E; Kasahara, M; Osika, W; Perski, A; Savic, I				Golkar, Armita; Johansson, Emilia; Kasahara, Maki; Osika, Walter; Perski, Aleksander; Savic, Ivanka			The Influence of Work-Related Chronic Stress on the Regulation of Emotion and on Functional Connectivity in the Brain	PLOS ONE			English	Article							SALIVARY CORTISOL; INDIVIDUAL-DIFFERENCES; CHRONIC BURNOUT; STARTLE REFLEX; SUPPRESSION; RESPONSES; CHILDHOOD; ASYMMETRY; CONFLICT; AROUSAL	Despite mounting reports about the negative effects of chronic occupational stress on cognitive and emotional functions, the underlying mechanisms are unknown. Recent findings from structural MRI raise the question whether this condition could be associated with a functional uncoupling of the limbic networks and an impaired modulation of emotional stress. To address this, 40 subjects suffering from burnout symptoms attributed to chronic occupational stress and 70 controls were investigated using resting state functional MRI. The participants' ability to up-regulate, down-regulate, and maintain emotion was evaluated by recording their acoustic startle response while viewing neutral and negatively loaded images. Functional connectivity was calculated from amygdala seed regions, using explorative linear correlation analysis. Stressed subjects were less capable of down-regulating negative emotion, but had normal acoustic startle responses when asked to up-regulate or maintain emotion and when no regulation was required. The functional connectivity between the amygdala and the anterior cingulate cortex correlated with the ability to down-regulate negative emotion. This connectivity was significantly weaker in the burnout group, as was the amygdala connectivity with the dorsolateral prefrontal cortex and the motor cortex, whereas connectivity from the amygdala to the cerebellum and the insular cortex were stronger. In subjects suffering from chronic occupational stress, the functional couplings within the emotion-and stress-processing limbic networks seem to be altered, and associated with a reduced ability to down-regulate the response to emotional stress, providing a biological substrate for a further facilitation of the stress condition.	[Golkar, Armita; Johansson, Emilia; Kasahara, Maki; Osika, Walter] Karolinska Inst, Dept Clin Neurosci, Stockholm, Sweden; [Osika, Walter] Karolinska Inst, Ctr Social Sustainabil, Dept Neurobiol Care Sci & Soc, Stockholm, Sweden; [Perski, Aleksander] Stockholm Univ, Stress Res Inst, S-10691 Stockholm, Sweden; [Savic, Ivanka] Karolinska Inst & Hosp, Dept Womens & Childrens Hlth, Stockholm, Sweden; [Savic, Ivanka] Karolinska Inst & Hosp, Neurol Clin, Stockholm, Sweden	Karolinska Institutet; Karolinska Institutet; Stockholm University; Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; Karolinska University Hospital	Savic, I (corresponding author), Karolinska Inst & Hosp, Dept Womens & Childrens Hlth, Stockholm, Sweden.	ivanka.savic-berglund@ki.se	Osika, Walter/AAH-7966-2020	Osika, Walter/0000-0002-1583-7319; Golkar, Armita/0000-0003-3077-0391	Swedish Council for Working Life and Social Research (FAS); Swedish Research Council; VINNOVA	Swedish Council for Working Life and Social Research (FAS)(Swedish Research CouncilSwedish Research Council for Health Working Life & Welfare (Forte)); Swedish Research Council(Swedish Research CouncilEuropean Commission); VINNOVA(Vinnova)	The Swedish Council for Working Life and Social Research (FAS), the Swedish Research Council, and VINNOVA are acknowledged for their financial support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahola K, 2006, SOC PSYCH PSYCH EPID, V41, P11, DOI 10.1007/s00127-005-0011-5; Anderson CM, 2002, PSYCHONEUROENDOCRINO, V27, P231, DOI 10.1016/S0306-4530(01)00047-6; Backstrom T, 2013, PSYCHONEUROENDOCRINO, V38, P1078, DOI 10.1016/j.psyneuen.2012.10.014; Baldacara L, 2011, J PSYCHIATR RES, V45, P1627, DOI 10.1016/j.jpsychires.2011.07.013; BISWAL B, 1995, MAGNET RESON MED, V34, P537, DOI 10.1002/mrm.1910340409; Blix E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064065; Bradley MM, 2001, EMOTION, V1, P276, DOI 10.1037//1528-3542.1.3.276; BRADLEY MM, 1990, PSYCHOPHYSIOLOGY, V27, P513, DOI 10.1111/j.1469-8986.1990.tb01966.x; Brown VM, 2014, NEUROPSYCHOPHARMACOL, V39, P351, DOI 10.1038/npp.2013.197; Chida Y, 2009, BIOL PSYCHOL, V80, P265, DOI 10.1016/j.biopsycho.2008.10.004; Copertaro A, 2010, MED LAV, V101, P427; Copertaro A, 2007, G Ital Med Lav Ergon, V29, P350; DAVIS M, 1982, SCIENCE, V218, P688, DOI 10.1126/science.7134967; De Bellis MD, 2006, BIOL PSYCHIAT, V60, P697, DOI 10.1016/j.biopsych.2006.04.035; Deykin EY, 2001, PSYCHOSOM MED, V63, P835, DOI 10.1097/00006842-200109000-00018; Dillon DG, 2005, BEHAV NEUROSCI, V119, P1118, DOI 10.1037/0735-7044.119.4.1118; Egner T, 2008, CEREB CORTEX, V18, P1475, DOI 10.1093/cercor/bhm179; EISLER RM, 1971, J NERV MENT DIS, V153, P227, DOI 10.1097/00005053-197110000-00001; Etkin A, 2006, NEURON, V51, P871, DOI 10.1016/j.neuron.2006.07.029; Fernandez Torres B, 2006, Rev Esp Anestesiol Reanim, V53, P359; Fries E, 2009, INT J PSYCHOPHYSIOL, V72, P67, DOI 10.1016/j.ijpsycho.2008.03.014; Galbois A, 2010, J HEPATOL, V52, P839, DOI 10.1016/j.jhep.2010.01.026; Gerra G, 2014, PROG NEURO-PSYCHOPH, V48, P220, DOI 10.1016/j.pnpbp.2013.10.011; Gianaros PJ, 2008, J NEUROSCI, V28, P990, DOI 10.1523/JNEUROSCI.3606-07.2008; Girdler SS, 2007, PHARMACOL THERAPEUT, V116, P125, DOI 10.1016/j.pharmthera.2007.05.006; Goldin PR, 2008, BIOL PSYCHIAT, V63, P577, DOI 10.1016/j.biopsych.2007.05.031; Golkar A, 2013, BEHAV NEUROSCI, V127, P59, DOI 10.1037/a0030892; Golkar A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048107; Gounko NV, 2013, MOL PSYCHIATR, V18, P86, DOI 10.1038/mp.2012.43; Grossi G, 2005, J PSYCHOSOM RES, V59, P103, DOI 10.1016/j.jpsychores.2005.02.009; Grossi G, 2003, J PSYCHOSOM RES, V55, P309, DOI 10.1016/S0022-3999(02)00633-5; HOLMES TH, 1967, J PSYCHOSOM RES, V11, P213, DOI 10.1016/0022-3999(67)90010-4; Hong JY, 2013, J NEUROSCI, V33, P11994, DOI 10.1523/JNEUROSCI.5733-12.2013; Jackson DC, 2003, PSYCHOL SCI, V14, P612, DOI 10.1046/j.0956-7976.2003.psci_1473.x; Jackson DC, 2000, PSYCHOPHYSIOLOGY, V37, P515, DOI 10.1111/1469-8986.3740515; Jovanovic H, 2011, NEUROIMAGE, V55, P1178, DOI 10.1016/j.neuroimage.2010.12.060; Kalia M, 2002, METABOLISM, V51, P49, DOI 10.1053/meta.2002.33193; Karlamangla AS, 2013, PSYCHONEUROENDOCRINO, V38, P2585, DOI 10.1016/j.psyneuen.2013.06.010; Kasckow JW, 2001, PEPTIDES, V22, P845, DOI 10.1016/S0196-9781(01)00399-0; Koenigsberg HW, 2010, NEUROPSYCHOLOGIA, V48, P1813, DOI 10.1016/j.neuropsychologia.2010.03.002; Lang P. J., 1997, NIMH CTR STUDY EMOTI, P39; LANG PJ, 1990, PSYCHOL REV, V97, P377, DOI 10.1037/0033-295X.97.3.377; Langelaan S, 2007, INT J BEHAV MED, V14, P213, DOI 10.1007/BF03002995; LeDoux JE, 2000, ANNU REV NEUROSCI, V23, P155, DOI 10.1146/annurev.neuro.23.1.155; Levesque J, 2003, BIOL PSYCHIAT, V53, P502, DOI 10.1016/S0006-3223(02)01817-6; Melamed S, 1999, J PSYCHOSOM RES, V46, P591, DOI 10.1016/S0022-3999(99)00007-0; Moch SL, 2003, ENDOCRINE, V21, P267, DOI 10.1385/ENDO:21:3:267; Mommersteeg PMC, 2006, HEALTH PSYCHOL, V25, P243, DOI 10.1037/0278-6133.25.2.243; Mommersteeg PMC, 2006, PSYCHONEUROENDOCRINO, V31, P216, DOI 10.1016/j.psyneuen.2005.07.003; MONTGOMERY S, 1978, ACTA PSYCHIAT SCAND, P33; Ochsner KN, 2002, J COGNITIVE NEUROSCI, V14, P1215, DOI 10.1162/089892902760807212; Ochsner KN, 2004, NEUROIMAGE, V23, P483, DOI 10.1016/j.neuroimage.2004.06.030; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Pezawas L, 2005, NAT NEUROSCI, V8, P828, DOI 10.1038/nn1463; Phillips ML, 2003, BIOL PSYCHIAT, V54, P504, DOI 10.1016/S0006-3223(03)00168-9; Pruessner JC, 1999, PSYCHOSOM MED, V61, P197, DOI 10.1097/00006842-199903000-00012; Rabinak Christine A, 2011, Front Psychiatry, V2, P62, DOI 10.3389/fpsyt.2011.00062; Raio CM, 2013, P NATL ACAD SCI USA, V110, P15139, DOI 10.1073/pnas.1305706110; Rydrnark I, 2006, BIOL PSYCHIAT, V60, P867, DOI 10.1016/j.biopsych.2006.04.029; Sandstrom A, 2005, BIOL PSYCHOL, V69, P271, DOI 10.1016/j.biopsycho.2004.08.003; Sang L, 2012, NEUROIMAGE, V61, P1213, DOI 10.1016/j.neuroimage.2012.04.011; Savic I., 2013, CEREB CORTEX; Savic I, 2008, P NATL ACAD SCI USA, V105, P9403, DOI 10.1073/pnas.0801566105; SCHAUFELI WB, 1995, PSYCHOL REP, V76, P1083, DOI 10.2466/pr0.1995.76.3c.1083; Sheehan DV, 1998, J CLIN PSYCHIAT, V59, P34, DOI 10.4088/JCP.09m05305whi; Sripada RK, 2012, J PSYCHIATR NEUROSCI, V37, P241, DOI 10.1503/jpn.110069; Stenlund T, 2007, SCAND J PUBLIC HEALT, V35, P516, DOI 10.1080/14034940701271874; Wager TD, 2008, NEURON, V59, P1037, DOI 10.1016/j.neuron.2008.09.006; Weber K, 2009, PSYCHOPHYSIOLOGY, V46, P1234, DOI 10.1111/j.1469-8986.2009.00871.x; Weike AI, 2007, PSYCHOPHYSIOLOGY, V44, P170, DOI 10.1111/j.1469-8986.2006.00469.x; Weissenbacher A, 2009, NEUROIMAGE, V47, P1408, DOI 10.1016/j.neuroimage.2009.05.005; Yeomans JS, 1995, BRAIN RES REV, V21, P301, DOI 10.1016/0165-0173(96)00004-5	72	83	84	5	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 3	2014	9	9							e104550	10.1371/journal.pone.0104550	http://dx.doi.org/10.1371/journal.pone.0104550			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AO3TB	25184294	Green Published, gold			2022-12-27	WOS:000341257700012
J	Su, YP; Chang, CK; Hayes, RD; Perera, G; Broadbent, M; To, D; Hotopf, M; Stewart, R				Su, Yu-Ping; Chang, Chin-Kuo; Hayes, Richard D.; Perera, Gayan; Broadbent, Matthew; To, David; Hotopf, Matthew; Stewart, Robert			Mini-Mental State Examination as a Predictor of Mortality among Older People Referred to Secondary Mental Healthcare	PLOS ONE			English	Article							ALL-CAUSE MORTALITY; COGNITIVE IMPAIRMENT; EXCESS MORTALITY; SOUTH LONDON; FOLLOW-UP; SURVIVAL; DEPRESSION; RISK; DISORDERS; DEMENTIA	Background: Lower levels of cognitive function have been found to be associated with higher mortality in older people, particularly in dementia, but the association in people with other mental disorders is still inconclusive. Methods and Findings: Data were analysed from a large mental health case register serving a geographic catchment of 1.23 million residents, and associations were investigated between cognitive function measured by the Mini-Mental State Examination (MMSE) and survival in patients aged 65 years old and over. Cox regressions were carried out, adjusting for age, gender, psychiatric diagnosis, ethnicity, marital status, and area-level socioeconomic index. A total of 6,704 subjects were involved, including 3,368 of them having a dementia diagnosis and 3,336 of them with depression or other diagnoses. Descriptive outcomes by Kaplan-Meier curves showed significant differences between those with normal and impaired cognitive function (MMSE score<25), regardless of a dementia diagnosis. As a whole, the group with lower cognitive function had an adjusted hazard ratio (HR) of 1.42 (95% CI: 1.28, 1.58) regardless of diagnosis. An HR of 1.23 (95% CI: 1.18, 1.28) per quintile increment of MMSE was also estimated after confounding control. A linear trend of MMSE in quintiles was observed for the subgroups of dementia and other non-dementia diagnoses (both p-values<0.001). However, a threshold effect of MMSE score under 20 was found for the specific diagnosis subgroups of depression. Conclusion: Current study identified an association between cognitive impairment and increased mortality in older people using secondary mental health services regardless of a dementia diagnosis. Causal pathways between this exposure and outcome (for example, suboptimal healthcare) need further investigation.	[Su, Yu-Ping; Chang, Chin-Kuo; Hayes, Richard D.; Perera, Gayan; To, David; Hotopf, Matthew; Stewart, Robert] Kings Coll London, Inst Psychiat, London WC2R 2LS, England; [Su, Yu-Ping] Cathay Gen Hosp, Dept Psychiat, Taipei, Taiwan; [Su, Yu-Ping] Fu Jen Catholic Univ, Sch Med, Taipei, Taiwan; [Broadbent, Matthew] South London & Maudsley NHS Fdn Trust, London, England	University of London; King's College London; Cathay General Hospital; Fu Jen Catholic University; South London & Maudsley NHS Trust	Chang, CK (corresponding author), Kings Coll London, Inst Psychiat, London WC2R 2LS, England.	chin-kuo.chang@kcl.ac.uk	Hotopf, Matthew/E-4971-2010; Stewart, Robert/B-1667-2010; Hayes, Richard/D-2382-2010; Su, Yu-Ping/J-7534-2012; Chang, Chin-Kuo/E-4991-2010	Stewart, Robert/0000-0002-4435-6397; Su, Yu-Ping/0000-0002-9200-3756; Chang, Chin-Kuo/0000-0002-8338-7196; Hayes, Richard/0000-0003-4453-244X; Perera, Gayan/0000-0002-3414-303X; Hotopf, Matthew/0000-0002-3980-4466	National Institute for Health Research (NIHR) Mental Health Biomedical Research Centre at South London and Maudsley NHS Foundation Trust; National Institute for Health Research (NIHR) Mental Health Biomedical Research Centre at King's College London; Guy's and St Thomas' Charity; Maudsley Charity; Medical Research Council [MR/J01219X/1] Funding Source: researchfish; MRC [MR/J01219X/1] Funding Source: UKRI	National Institute for Health Research (NIHR) Mental Health Biomedical Research Centre at South London and Maudsley NHS Foundation Trust; National Institute for Health Research (NIHR) Mental Health Biomedical Research Centre at King's College London; Guy's and St Thomas' Charity; Maudsley Charity; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This research was supported by the Biomedical Research Nucleus data management and informatics facility at South London and Maudsley NHS Foundation Trust, which is funded by the National Institute for Health Research (NIHR) Mental Health Biomedical Research Centre at South London and Maudsley NHS Foundation Trust and King's College London and a joint infrastructure grant from Guy's and St Thomas' Charity and the Maudsley Charity. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bassuk SS, 2000, AM J EPIDEMIOL, V151, P676; Borjesson-Hanson A, 2007, NEUROLOGY, V69, P2069, DOI 10.1212/01.wnl.0000280464.59322.af; Bosworth HB, 1999, J GERONTOL B-PSYCHOL, V54, pP273, DOI 10.1093/geronb/54B.5.P273; Bowen JD, 1996, NEUROLOGY, V47, P433, DOI 10.1212/WNL.47.2.433; BRUCE ML, 1995, J GERONTOL B-PSYCHOL, V50, pP289, DOI 10.1093/geronb/50B.6.P289; Chang CK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019590; Chang CK, 2010, BMC PSYCHIATRY, V10, DOI 10.1186/1471-244X-10-77; Fernandes AC, 2013, BMC MED INFORM DECIS, V13, DOI 10.1186/1472-6947-13-71; Gale CR, 1996, BRIT MED J, V312, P608; Hannerz H, 2001, PUBLIC HEALTH, V115, P328; Hayes RD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044613; JAGGER C, 1988, INT J EPIDEMIOL, V17, P111, DOI 10.1093/ije/17.1.111; Jorm AF, 2000, GERONTOLOGY, V46, P219, DOI 10.1159/000022163; Kane KD, 2010, PSYCHOL AGING, V25, P446, DOI 10.1037/a0019032; KELMAN HR, 1994, AM J PUBLIC HEALTH, V84, P1255, DOI 10.2105/AJPH.84.8.1255; Khan A, 2013, JAMA PSYCHIAT, V70, P1091, DOI 10.1001/jamapsychiatry.2013.149; Lavretsky H, 2010, AM J PSYCHIAT, V167, P589, DOI 10.1176/appi.ajp.2009.09020280; Lee M, 2009, J AM MED DIR ASSOC, V10, P466, DOI 10.1016/j.jamda.2009.03.014; Lefevre T, 2012, EUR J PUBLIC HEALTH, V22, P643, DOI 10.1093/eurpub/ckr103; Lemogne C, 2013, J PSYCHIATR RES, V47, P851, DOI 10.1016/j.jpsychires.2013.03.015; LIU IY, 1990, AM J EPIDEMIOL, V132, P136, DOI 10.1093/oxfordjournals.aje.a115625; Neale R, 2001, INT J EPIDEMIOL, V30, P1383, DOI 10.1093/ije/30.6.1383; Nguyen HT, 2003, J AM GERIATR SOC, V51, P178, DOI 10.1046/j.1532-5415.2003.51055.x; Paradise M, 2009, INT J GERIATR PSYCH, V24, P739, DOI 10.1002/gps.2190; Park B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079460; Park MH, 2012, ACTA PSYCHIAT SCANDI; Sachs GA, 2011, ANN INTERN MED, V155, P300, DOI 10.7326/0003-4819-155-5-201109060-00007; Schaufele M, 1999, INT J GERIATR PSYCH, V14, P946, DOI 10.1002/(SICI)1099-1166(199911)14:11<946::AID-GPS45>3.0.CO;2-9; Schoevers RA, 2009, INT J GERIATR PSYCH, V24, P169, DOI 10.1002/gps.2088; Sinforiani E, 2007, ARCH GERONTOL GERIAT, V44, P375, DOI 10.1016/j.archger.2007.01.052; Smits CHM, 1999, AM J EPIDEMIOL, V150, P978; Steenland K, 2010, NEUROEPIDEMIOLOGY, V35, P28, DOI 10.1159/000306055; Stewart R, 2009, BMC PSYCHIATRY, V9, DOI 10.1186/1471-244X-9-51; Stump TE, 2001, J AM GERIATR SOC, V49, P934, DOI 10.1046/j.1532-5415.2001.49184.x; Todd S, 2013, INT J GERIATR PSYCH, V28, P1109, DOI 10.1002/gps.3946; Vilalta-Franch J, 2012, INT J GERIATR PSYCH, V27, P67, DOI 10.1002/gps.2691; WALSH JS, 1990, ANN INTERN MED, V113, P429, DOI 10.7326/0003-4819-113-6-429; Wilson RS, 2009, ARCH NEUROL-CHICAGO, V66, P767, DOI 10.1001/archneurol.2009.80; Wolfe CDA, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001033; Wolfson C, 2001, NEW ENGL J MED, V344, P1111, DOI 10.1056/NEJM200104123441501; Wu CY, 2012, PSYCHOL MED, V42, P1581, DOI 10.1017/S0033291711002698; Zahodne LB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073645; Zanetti O, 2009, ARCH GERONTOL GERIAT, V49, P237, DOI 10.1016/j.archger.2009.09.035	43	22	22	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 3	2014	9	9							e105312	10.1371/journal.pone.0105312	http://dx.doi.org/10.1371/journal.pone.0105312			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AO3TB	25184819	Green Published, Green Submitted, gold			2022-12-27	WOS:000341257700017
J	Opstad, TB; Arnesen, H; Pettersen, AA; Seljeflot, I				Opstad, Trine B.; Arnesen, Harald; Pettersen, Alf A.; Seljeflot, Ingebjorg			The MMP-9-1562 C/T Polymorphism in the Presence of Metabolic Syndrome Increases the Risk of Clinical Events in Patients with Coronary Artery Disease	PLOS ONE			English	Article							MATRIX METALLOPROTEINASE INDUCER; ACUTE MYOCARDIAL-INFARCTION; HEART-DISEASE; FUNCTIONAL POLYMORPHISM; CARDIOVASCULAR-DISEASE; GENETIC-VARIATION; TISSUE INHIBITOR; MATRIX-METALLOPROTEINASE-9; EXPRESSION; PROMOTER	Background and Objectives: Elevated levels of matrix metalloproteinase (MMP)-9 have been associated with the metabolic syndrome (MetS) and cardiovascular events. The MMP-9 -1562 C/T polymorphism has furthermore been shown as a risk factor for coronary artery disease (CAD). The non-favourable cardiometabolic state in MetS may increase the risk. We aimed to investigate the influence of MMP-9 -1562 C/T polymorphism in subjects with CAD and MetS. Methods: Patients (n = 1000) with verified CAD stratified in Mets +/- (n = 244/756), were analyzed for the MMP-9 21562 C/T polymorphism and related to clinical events after 2 years follow-up. Serum levels of total MMP-9 and tissue inhibitor of matrix metalloproteinases (TIMP)-1 were analyzed in all, whereas MMP-9 activity, extracellular matrix metalloproteinase inducer (EMMPRIN), and expression of the two genes were analyzed in a subset of 240 randomly selected patients. Results: Totally, 106 clinical endpoints were recorded. In MetS; the T-allele associated with 5.5 fold increase in event rate (p < 0.0001), increased with number of MetS components, a 117% increase in total MMP-9 levels (TT homozygous, p = 0.05), significantly higher total-and endogenous active MMP-9 and TIMP-1 levels (p < 0.01 all), and EMMPRIN was inversely correlated with pro-and endogenous active MMP-9 (p < 0.05, both). In non-MetS; the T-allele was not associated with new events, nor higher MMP-9 levels. EMMPRIN was significantly correlated with total MMP-9 and TIMP-1 (p < 0.01, both) and the two genes were inter-correlated (p < 0.001). Conclusion: In CAD patients with MetS, the MMP-9 T-allele increased the risk of clinical events, probably mediated through elevated MMP-9 levels and altered MMP-9 regulation.	[Opstad, Trine B.; Arnesen, Harald; Pettersen, Alf A.; Seljeflot, Ingebjorg] Univ Oslo, Hosp Ulleval, Ctr Clin Heart Res, Oslo, Norway; [Opstad, Trine B.; Arnesen, Harald; Pettersen, Alf A.; Seljeflot, Ingebjorg] Oslo Univ Hosp, Ctr Heart Failure Res, Oslo, Norway; [Opstad, Trine B.; Arnesen, Harald; Seljeflot, Ingebjorg] Univ Oslo, Fac Med, Oslo, Norway	University of Oslo; University of Oslo; University of Oslo	Opstad, TB (corresponding author), Univ Oslo, Hosp Ulleval, Ctr Clin Heart Res, Oslo, Norway.	trineoa@medisin.uio.no		Pettersen, Alf-Age R/0000-0001-7543-475X	Stein Erik Hagen Foundation for Clinical Heart Research, Oslo, Norway	Stein Erik Hagen Foundation for Clinical Heart Research, Oslo, Norway	The work was funded by Stein Erik Hagen Foundation for Clinical Heart Research, Oslo, Norway. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bao W, 2010, AM J PHYSIOL-CELL PH, V299, pC1212, DOI 10.1152/ajpcell.00228.2010; Belo VA, 2012, INT J OBESITY, V36, P69, DOI 10.1038/ijo.2011.169; Berg G, 2011, CLIN CHIM ACTA, V412, P1731, DOI 10.1016/j.cca.2011.06.013; Blankenberg S, 2003, CIRCULATION, V107, P1579, DOI 10.1161/01.CIR.0000058700.41738.12; Demacq C, 2008, CLIN CHEM LAB MED, V46, P57, DOI 10.1515/CCLM.2008.014; Derosa G, 2006, ENDOTHELIUM-J ENDOTH, V13, P227, DOI 10.1080/10623320600780942; Furenes EB, 2008, SCAND J CLIN LAB INV, V68, P177, DOI 10.1080/00365510701663350; GALIS ZS, 1994, J CLIN INVEST, V94, P2493, DOI 10.1172/JCI117619; Galis ZS, 2002, CIRC RES, V90, P251, DOI 10.1161/res.90.3.251; Hopps E, 2012, EUR J INTERN MED, V23, P99, DOI 10.1016/j.ejim.2011.09.012; Hopps E, 2013, J INVEST MED, V61, P978, DOI 10.2310/JIM.0b013e318294e9da; Koh YS, 2008, INT J CARDIOL, V127, P430, DOI 10.1016/j.ijcard.2007.04.107; Li JY, 2013, CARDIOLOGY, V124, P53, DOI 10.1159/000345772; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Malik S, 2004, CIRCULATION, V110, P1245, DOI 10.1161/01.CIR.0000140677.20606.0E; Medley TL, 2004, ARTERIOSCL THROM VAS, V24, P1479, DOI 10.1161/01.ATV.0000135656.49158.95; Opstad TB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074498; Opstad TB, 2012, CLIN CHIM ACTA, V413, P113, DOI 10.1016/j.cca.2011.09.004; Pettersen AAR, 2004, SCAND CARDIOVASC J, V38, P353, DOI 10.1080/14017430410024324; Pettersen AAR, 2012, J AM HEART ASSOC, V1, DOI 10.1161/JAHA.112.000703; Schmidt R, 2006, CIRCULATION, V113, P834, DOI 10.1161/CIRCULATIONAHA.105.568162; Tayebjee MH, 2005, AM J CARDIOL, V96, P339, DOI 10.1016/j.amjcard.2005.03.072; Wang YY, 2005, SHOCK, V24, P214, DOI 10.1097/01.shk.0000174935.13786.6c; Weiss TW, 2010, THROMB HAEMOSTASIS, V103, P679, DOI 10.1160/TH09-05-0317; Yasmin, 2005, ARTERIOSCL THROM VAS, V25, P372, DOI 10.1161/01.ATV.0000151373.33830.41; Yoon YW, 2005, ATHEROSCLEROSIS, V180, P37, DOI 10.1016/j.atherosclerosis.2004.11.021; Zhang BP, 1999, CIRCULATION, V99, P1788, DOI 10.1161/01.CIR.99.14.1788	27	25	26	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2014	9	9							e106816	10.1371/journal.pone.0106816	http://dx.doi.org/10.1371/journal.pone.0106816			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ1IR	25191702	Green Published, Green Submitted, gold			2022-12-27	WOS:000347993600066
J	Slaughter, JL; Stenger, MR; Reagan, PB; Jadcherla, SR				Slaughter, Jonathan L.; Stenger, Michael R.; Reagan, Patricia B.; Jadcherla, Sudarshan R.			Utilization of Inhaled Corticosteroids for Infants with Bronchopulmonary Dysplasia	PLOS ONE			English	Article							BECLOMETHASONE DIPROPIONATE; CONTROLLED-TRIAL; PRETERM; THERAPY; GLUCOCORTICOIDS; INHALATION; CHILDHOOD; STEROIDS; HARMS	Objective: To determine demographic and clinical variables associated with inhaled corticosteroid administration and to evaluate between-hospital variation in inhaled steroid use for infants with bronchopulmonary dysplasia (BPD). Design: Retrospective Cohort Study. Setting: Neonatal units of 35 US children's hospitals; as recorded in the Pediatric Health Information System (PHIS) database. Patients: 1429 infants with evolving BPD at 28 days who were born at,29 weeks gestation with birth weight,1500 grams, admitted within the first 7 postnatal days, and discharged between January 2007-June 2011. Results: Inhaled steroids were prescribed to 25% (n = 352) of the cohort with use steadily increasing during the first two months of hospitalization. The most frequently prescribed steroid was beclomethasone (n = 194, 14%), followed by budesonide (n = 125, 9%), and then fluticasone (n = 90, 6%). Birth gestation,24 weeks, birth weight 500-999 grams, and prolonged ventilation all increased the adjusted odds of ever receiving inhaled corticosteroids (p, 0.05). Wide variations between hospitals in the frequency of infants ever receiving inhaled steroids (range: 0-60%) and the specific drug prescribed were noted. This variation persisted, even after controlling for observed confounders. Conclusions: Inhaled corticosteroid administration to infants with BPD is common in neonatal units within U.S. Children's hospitals. However, its utilization varies markedly between centers from no treatment at some institutions to the majority of infants with BPD being treated at others. This supports the need for further research to identify the benefits and potential risks of inhaled steroid usage in infants with BPD.	[Slaughter, Jonathan L.; Stenger, Michael R.; Jadcherla, Sudarshan R.] Ohio State Univ, Coll Med, Dept Pediat, Columbus, OH 43210 USA; [Slaughter, Jonathan L.; Stenger, Michael R.; Jadcherla, Sudarshan R.] Nationwide Childrens Hosp, Columbus, OH USA; [Slaughter, Jonathan L.; Stenger, Michael R.; Reagan, Patricia B.; Jadcherla, Sudarshan R.] Nationwide Childrens Hosp, Ctr Perinatal Res, Res Inst, Columbus, OH USA; [Jadcherla, Sudarshan R.] Nationwide Childrens Hosp, Neonatal & Infant Feeding Disorders Res Program, Columbus, OH USA; [Reagan, Patricia B.] Ohio State Univ, Dept Econ, Columbus, OH 43210 USA; [Reagan, Patricia B.] Ohio State Univ, Ctr Human Resource Res, Columbus, OH 43210 USA	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; Nationwide Childrens Hospital; University System of Ohio; Ohio State University; Nationwide Childrens Hospital; Research Institute at Nationwide Children's Hospital; University System of Ohio; Ohio State University; Nationwide Childrens Hospital; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University	Slaughter, JL (corresponding author), Ohio State Univ, Coll Med, Dept Pediat, Columbus, OH 43210 USA.	slaughter.84@osu.edu	Slaughter, Jonathan L/E-4102-2011; Jadcherla, Sudarshan/AAE-5178-2020	Slaughter, Jonathan L/0000-0001-6831-7520; 	National Heart, Lung, And Blood Institute of the National Institutes of Health [K08HL121182]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K08HL121182] Funding Source: NIH RePORTER	National Heart, Lung, And Blood Institute of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Research reported in this publication was supported by the National Heart, Lung, And Blood Institute of the National Institutes of Health under Award Number K08HL121182. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnon S, 1996, PEDIATR PULM, V21, P231; Bancalari EH, 2012, J PEDIATR-US, V161, P585, DOI 10.1016/j.jpeds.2012.05.054; Barnes PJ, 1998, AM J RESP CRIT CARE, V157, pS1, DOI 10.1164/ajrccm.157.3.157315; Bassler D, 2010, NEONATOLOGY, V97, P52, DOI 10.1159/000227294; Buzzi E, 2013, EARLY HUM DEV, V89, pS62, DOI 10.1016/S0378-3782(13)70018-5; Chou R, 2010, J CLIN EPIDEMIOL, V63, P502, DOI 10.1016/j.jclinepi.2008.06.007; Cole C H, 2001, Semin Neonatol, V6, P343, DOI 10.1053/siny.2001.0069; Cole CH, 1999, NEW ENGL J MED, V340, P1005, DOI 10.1056/NEJM199904013401304; Cole CH, 1999, J PEDIATR-US, V135, P65, DOI 10.1016/S0022-3476(99)70329-X; Dugas MA, 2005, PEDIATRICS, V115, pE566, DOI 10.1542/peds.2004-0951; Ehrenkranz RA, 2005, PEDIATRICS, V116, P1353, DOI 10.1542/peds.2005-0249; Farney KD, 2013, RESP CARE; Halliday HL, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001146.pub3; Kelly HW, 2008, PEDIATRICS, V122, pE53, DOI 10.1542/peds.2007-3381; Kelly HW, 2012, NEW ENGL J MED, V367, P904, DOI 10.1056/NEJMoa1203229; Kohler E, 2008, ARCH DIS CHILD-FETAL, V93, pF275, DOI 10.1136/adc.2007.121285; LAFORCE WR, 1993, J PEDIATR-US, V122, P285, DOI 10.1016/S0022-3476(06)80134-4; LINDER N, 1995, J PEDIATR-US, V127, P651, DOI 10.1016/S0022-3476(95)70133-8; Lister P, 2000, COCHRANE DB SYST REV; Maas C, 2010, NEONATOLOGY, V98, P404, DOI 10.1159/000316978; Mazela J, 2011, EUR J PEDIATR, V170, P433, DOI 10.1007/s00431-010-1292-6; McKeever T, 2013, CHEST; Moore CD, 2013, DRUG METAB DISPOS, V41, P379, DOI 10.1124/dmd.112.046318; Ng PC, 1998, J CLIN ENDOCR METAB, V83, P2390, DOI 10.1210/jc.83.7.2390; Onland W, 2012, COCHRANE DB SYST REV, V4; Pappagallo M, 1998, Indian J Pediatr, V65, P273, DOI 10.1007/BF02752304; Porter Kalen B, 2005, J Pediatr Pharmacol Ther, V10, P90, DOI 10.5863/1551-6776-10.2.90; Roberts JK, 2013, J PHARMACOL EXP THER, V345, P308, DOI 10.1124/jpet.112.202556; Shah SS, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002058.pub2; Shah SS, 2012, COCHRANE DB SYST REV, V5; Shah VS, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001969.pub3; Slaughter JL, 2013, PEDIATRICS, V131, P716, DOI 10.1542/peds.2012-1835; Stockmann C, 2013, J PEDIATR-US, V162, P1222, DOI 10.1016/j.jpeds.2012.11.031; Vandenbroucke JP, 2006, CAN MED ASSOC J, V174, P645, DOI 10.1503/cmaj.051484; Walsh MC, 2006, PEDIATRICS, V117, pS52, DOI 10.1542/peds.2005-0620I; WATTERBERG KL, 1991, PEDIATR PULM, V10, P136, DOI 10.1002/ppul.1950100217; Watterberg K, 2012, CLIN PERINATOL, V39, P47, DOI 10.1016/j.clp.2011.12.017	37	28	33	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2014	9	9							e106838	10.1371/journal.pone.0106838	http://dx.doi.org/10.1371/journal.pone.0106838			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ1IR	25192252	gold, Green Published, Green Submitted			2022-12-27	WOS:000347993600070
J	Watanabe, T; Shino, A; Akashi, K; Kikuchi, J				Watanabe, Taiji; Shino, Amiu; Akashi, Kinya; Kikuchi, Jun			Chemical Profiling of Jatropha Tissues under Different Torrefaction Conditions: Application to Biomass Waste Recovery	PLOS ONE			English	Article							ALPHA-AMINO-ACIDS; THERMAL-DECOMPOSITION; ARABIDOPSIS-THALIANA; NMR ANALYSIS; CELLULOSE; STATE; KINETICS; LIGNIN; ENERGY; LIGNOCELLULOSE	Gradual depletion of the world petroleum reserves and the impact of environmental pollution highlight the importance of developing alternative energy resources such as plant biomass. To address these issues, intensive research has focused on the plant Jatropha curcas, which serves as a rich source of biodiesel because of its high seed oil content. However, producing biodiesel from Jatropha generates large amounts of biomass waste that are difficult to use. Therefore, the objective of our research was to analyze the effects of different conditions of torrefaction on Jatropha biomass. Six different types of Jatropha tissues (seed coat, kernel, stem, xylem, bark, and leaf) were torrefied at four different temperature conditions (200 degrees C, 250 degrees C, 300 degrees C, and 350 degrees C), and changes in the metabolite composition of the torrefied products were determined by Fourier transform-infrared spectroscopy and nuclear magnetic resonance analyses. Cellulose was gradually converted to oligosaccharides in the temperature range of 200 degrees C-300 degrees C and completely degraded at 350 degrees C. Hemicellulose residues showed different degradation patterns depending on the tissue, whereas glucuronoxylan efficiently decomposed between 300 degrees C and 350 degrees C. Heat-induced depolymerization of starch to maltodextrin started between 200 degrees C and 250 degrees C, and oligomer sugar structure degradation occurred at higher temperatures. Lignin degraded at each temperature, e. g., syringyl (S) degraded at lower temperatures than guaiacyl (G). Finally, the toxic compound phorbol ester degraded gradually starting at 235 degrees C and efficiently just below 300 degrees C. These results suggest that torrefaction is a feasible treatment for further processing of residual biomass to biorefinery stock or fertilizer.	[Watanabe, Taiji; Kikuchi, Jun] Yokohama City Univ, Grad Sch Med Life Sci, Tsurumi Ku, Yokohama, Kanagawa 232, Japan; [Shino, Amiu; Kikuchi, Jun] RIKEN Ctr Sustainable Resource Sci, Tsurumi Ku, Yokohama, Kanagawa, Japan; [Akashi, Kinya] Tottori Univ, Fac Agr, Tottori 680, Japan; [Kikuchi, Jun] RIKEN Ctr Sustainable Resource Sci, Biomass Engn Program, Tsurumi Ku, Yokohama, Kanagawa, Japan; [Kikuchi, Jun] Nagoya Univ, Grad Sch Bioagr Sci, Chikusa Ku, Nagoya, Aichi 4648601, Japan; [Kikuchi, Jun] Nagoya Univ, Sch Agr Sci, Chikusa Ku, Nagoya, Aichi 4648601, Japan	Yokohama City University; RIKEN; Tottori University; RIKEN; Nagoya University; Nagoya University	Kikuchi, J (corresponding author), Yokohama City Univ, Grad Sch Med Life Sci, Tsurumi Ku, Yokohama, Kanagawa 232, Japan.	jun.kikuchi@riken.jp	Akashi, Kinya/C-4575-2019; Kikuchi, Jun/M-5512-2015; Kikuchi, Jun/O-4725-2019	Akashi, Kinya/0000-0002-9991-5766; Kikuchi, Jun/0000-0002-6809-394X; Kikuchi, Jun/0000-0002-6809-394X	JST/JICA; JSPS, Japan	JST/JICA(Japan Science & Technology Agency (JST)); JSPS, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This research was supported in part by Grants-in-Aid for Science and Technology Research Partnership for Sustainable Development (SATREPS to J.K., K. A.) from JST/JICA, and Grants-in-Aid for Scientific Research (C) (J.K.) from JSPS, Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asakura T, 2014, ANAL CHEM, V86, P5425, DOI 10.1021/ac5005037; Bates RB, 2012, BIORESOURCE TECHNOL, V124, P460, DOI 10.1016/j.biortech.2012.07.018; Brebu M, 2010, CELL CHEM TECHNOL, V44, P353; Bridgwater AV, 2012, BIOMASS BIOENERG, V38, P68, DOI 10.1016/j.biombioe.2011.01.048; Campbell JE, 2009, SCIENCE, V324, P1055, DOI 10.1126/science.1168885; Chen JB, 2013, ANAL BIOANAL CHEM, V405, P9385, DOI 10.1007/s00216-013-7366-3; Chen WH, 2012, BIORESOURCE TECHNOL, V118, P195, DOI 10.1016/j.biortech.2012.04.101; Chen WH, 2012, BIORESOURCE TECHNOL, V111, P433, DOI 10.1016/j.biortech.2012.01.163; Chen WH, 2011, ENERGY, V36, P6451, DOI 10.1016/j.energy.2011.09.022; Chikayama E, 2010, ANAL CHEM, V82, P1653, DOI 10.1021/ac9022023; Chikayama E, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003805; Date Y, 2012, J PROTEOME RES, V11, P5602, DOI 10.1021/pr3008682; Fisher EM, 2012, BIORESOURCE TECHNOL, V119, P157, DOI 10.1016/j.biortech.2012.05.109; Fukuda S, 2011, NATURE, V469, P543, DOI 10.1038/nature09646; Fukuda S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004893; Furusawa Y, NATURE IN PRESS; Gunaseelan VN, 2009, BIOMASS BIOENERG, V33, P589, DOI 10.1016/j.biombioe.2008.09.002; Ito K, 2014, ANAL CHEM, V86, P1098, DOI 10.1021/ac402869b; Ke J, 2011, BIOMACROMOLECULES, V12, P1610, DOI 10.1021/bm2000132; Kikuchi J, 2004, PLANT CELL PHYSIOL, V45, P1099, DOI 10.1093/pcp/pch117; KIKUCHI J., 2011, J ECOSYSTEM ECOGRA S, VS2, P1, DOI DOI 10.4172/2157-7625.S2-001; Kikuchi Jun, 2007, V358, P273, DOI 10.1007/978-1-59745-244-1_15; Komatsu T, 2013, ANAL CHEM, V85, P8857, DOI 10.1021/ac402197h; Lee JW, 2012, BIORESOURCE TECHNOL, V116, P471, DOI 10.1016/j.biortech.2012.03.122; Liang YG, 2011, CHEM ENG J, V168, P544, DOI 10.1016/j.cej.2011.01.020; Lin YC, 2009, J PHYS CHEM C, V113, P20097, DOI 10.1021/jp906702p; Liu XX, 2008, POLYM DEGRAD STABIL, V93, P260, DOI 10.1016/j.polymdegradstab.2007.09.004; Lu KM, 2012, BIORESOURCE TECHNOL, V123, P98, DOI 10.1016/j.biortech.2012.07.096; Melkior T, 2012, FUEL, V92, P271, DOI 10.1016/j.fuel.2011.06.042; Miura K, 2001, ENERG FUEL, V15, P599, DOI 10.1021/ef0001787; Mori T, 2012, CARBOHYD POLYM, V90, P1197, DOI 10.1016/j.carbpol.2012.06.027; Murata K, 2012, J ANAL APPL PYROL, V94, P75, DOI 10.1016/j.jaap.2011.11.008; Ogata Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030263; Ogura T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066919; Okushita K, 2012, BIOMACROMOLECULES, V13, P1323, DOI 10.1021/bm300537k; Phanphanich M, 2011, BIORESOURCE TECHNOL, V102, P1246, DOI 10.1016/j.biortech.2010.08.028; Ragauskas AJ, 2006, SCIENCE, V311, P484, DOI 10.1126/science.1114736; Raschip IE, 2013, INT J BIOL MACROMOL, V54, P230, DOI 10.1016/j.ijbiomac.2012.12.036; RODANTE F, 1992, THERMOCHIM ACTA, V194, P197, DOI 10.1016/0040-6031(92)80018-R; RODANTE F, 1990, THERMOCHIM ACTA, V171, P15, DOI 10.1016/0040-6031(90)87002-T; Sekiyama Y, 2011, ANAL CHEM, V83, P719, DOI 10.1021/ac102097u; Sekiyama Y, 2010, ANAL CHEM, V82, P1643, DOI 10.1021/ac9019076; Sen A, 2012, IND CROP PROD, V38, P132, DOI 10.1016/j.indcrop.2012.01.018; Seshadri V, 2012, J PHYS CHEM A, V116, P11997, DOI 10.1021/jp3085099; Sidhu OP, 2010, PLANTA, V232, P85, DOI 10.1007/s00425-010-1159-0; Tian C, 2007, J BIOL CHEM, V282, P18532, DOI 10.1074/jbc.M700549200; TROCKENBRODT M, 1995, ANN BOT-LONDON, V75, P281, DOI 10.1006/anbo.1995.1022; Vassilev SV, 2010, FUEL, V89, P913, DOI 10.1016/j.fuel.2009.10.022; Watanabe T, 2012, PLANT BIOTECHNOL-NAR, V29, P163, DOI 10.5511/plantbiotechnology.12.0222a; Wesolowski M, 2005, J THERM ANAL CALORIM, V82, P307, DOI 10.1007/s10973-005-0895-z; Yamamura M, 2013, PLANT BIOTECHNOL-NAR, V30, P25, DOI 10.5511/plantbiotechnology.12.1127a; Yamazawa A, 2014, METABOLITES, V4, P36, DOI 10.3390/metabo4010036; Yamazawa A, 2013, MOLECULES, V18, P9021, DOI 10.3390/molecules18089021; Zheng AQ, 2013, BIORESOURCE TECHNOL, V128, P370, DOI 10.1016/j.biortech.2012.10.067	54	18	18	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2014	9	9							e106893	10.1371/journal.pone.0106893	http://dx.doi.org/10.1371/journal.pone.0106893			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ1IR	25191879	Green Submitted, Green Published, gold			2022-12-27	WOS:000347993600079
J	Wiman, NG; Walton, VM; Dalton, DT; Anfora, G; Burrack, HJ; Chiu, JC; Daane, KM; Grassi, A; Miller, B; Tochen, S; Wang, XG; Ioriatti, C				Wiman, Nik G.; Walton, Vaughn M.; Dalton, Daniel T.; Anfora, Gianfranco; Burrack, Hannah J.; Chiu, Joanna C.; Daane, Kent M.; Grassi, Alberto; Miller, Betsey; Tochen, Samantha; Wang, Xingeng; Ioriatti, Claudio			Integrating Temperature-Dependent Life Table Data into a Matrix Projection Model for Drosophila suzukii Population Estimation	PLOS ONE			English	Article							SPOTTED-WING DROSOPHILA; CODLING MOTH LEPIDOPTERA; DIPTERA DROSOPHILIDAE; CHERRY; DISTRIBUTIONS; INFESTATION; PREDICTION; TOLERANCE; EMERGENCE; VINEGAR	Temperature-dependent fecundity and survival data was integrated into a matrix population model to describe relative Drosophila suzukii Matsumura (Diptera: Drosophilidae) population increase and age structure based on environmental conditions. This novel modification of the classic Leslie matrix population model is presented as a way to examine how insect populations interact with the environment, and has application as a predictor of population density. For D. suzukii, we examined model implications for pest pressure on crops. As case studies, we examined model predictions in three small fruit production regions in the United States (US) and one in Italy. These production regions have distinctly different climates. In general, patterns of adult D. suzukii trap activity broadly mimicked seasonal population levels predicted by the model using only temperature data. Age structure of estimated populations suggest that trap and fruit infestation data are of limited value and are insufficient for model validation. Thus, we suggest alternative experiments for validation. The model is advantageous in that it provides stage-specific population estimation, which can potentially guide management strategies and provide unique opportunities to simulate stage-specific management effects such as insecticide applications or the effect of biological control on a specific life-stage. The two factors that drive initiation of the model are suitable temperatures (biofix) and availability of a suitable host medium (fruit). Although there are many factors affecting population dynamics of D. suzukii in the field, temperature-dependent survival and reproduction are believed to be the main drivers for D. suzukii populations.	[Wiman, Nik G.; Walton, Vaughn M.; Dalton, Daniel T.; Miller, Betsey; Tochen, Samantha] Oregon State Univ, Dept Hort, Corvallis, OR 97331 USA; [Anfora, Gianfranco; Grassi, Alberto; Ioriatti, Claudio] Fdn Edmund Mach, Res & Innovat Ctr, San Michele All Adige, Trento, Italy; [Anfora, Gianfranco; Grassi, Alberto; Ioriatti, Claudio] Fdn Edmund Mach, Technol Transfer Ctr, San Michele All Adige, Trento, Italy; [Burrack, Hannah J.] N Carolina State Univ, Dept Entomol, Raleigh, NC 27695 USA; [Chiu, Joanna C.] Univ Calif Davis, Dept Entomol & Nematol, Davis, CA 95616 USA; [Daane, Kent M.; Wang, Xingeng] Univ Calif Berkeley, Dept Environm Sci Policy & Management, Berkeley, CA 94720 USA	Oregon State University; Fondazione Edmund Mach; Fondazione Edmund Mach; University of North Carolina; North Carolina State University; University of California System; University of California Davis; University of California System; University of California Berkeley	Walton, VM (corresponding author), Oregon State Univ, Dept Hort, Corvallis, OR 97331 USA.	vaughn.walton@oregonstate.edu	Dalton, Daniel/AFR-7270-2022; Dalton, Daniel/X-5783-2019; Dalton, Daniel/AAM-1954-2020; Burrack, Hannah/CAJ-5730-2022; Wiman, Nik/J-4998-2019; ioriatti, claudio/H-5938-2019	Dalton, Daniel/0000-0001-8267-1155; Wiman, Nik/0000-0003-0890-5050; ioriatti, claudio/0000-0002-8919-9217; Chiu, Joanna/0000-0001-7613-8127; Burrack, Hannah/0000-0002-8460-8245; ANFORA, Gianfranco/0000-0003-2545-1409	United States Department of Agriculture National Institue for Food and Agriculture award [2010-51181-21167]; Autonomous Province of Trento (Italy), Research funds for Grandi Progetti, Project LExEM (Laboratory of excellence for epidemiology and modeling)	United States Department of Agriculture National Institue for Food and Agriculture award; Autonomous Province of Trento (Italy), Research funds for Grandi Progetti, Project LExEM (Laboratory of excellence for epidemiology and modeling)	Funding for research in the USA was provided by the United States Department of Agriculture National Institue for Food and Agriculture award #2010-51181-21167. In Italy, this work was partly funded by the Autonomous Province of Trento (Italy), Research funds for Grandi Progetti, Project LExEM (Laboratory of excellence for epidemiology and modeling, http://www.lexem.eu). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aghdam HR, 2009, ENVIRON ENTOMOL, V38, P885, DOI 10.1603/022.038.0343; Allen L.J.S., 2010, INTRO STOCHASTIC PRO; Anonymous, 2013, Bulletin OEPP, V43, P417, DOI 10.1111/epp.12059; Beers EH, 2011, PEST MANAG SCI, V67, P1386, DOI 10.1002/ps.2279; Bruck DJ, 2011, PEST MANAG SCI, V67, P1375, DOI 10.1002/ps.2242; Carey JR, 2001, ANNU REV ENTOMOL, V46, P79, DOI 10.1146/annurev.ento.46.1.79; Carey JR, 1993, APPL DEMOGRAPHY BIOL, P43; Castillo-Chavez C., 2011, MATH MODELS POPULATI; Caswell, 2000, MATRIX POPULATION MO; Cha DH, 2012, J CHEM ECOL, V38, P1419, DOI 10.1007/s10886-012-0196-5; Cianci D, 2013, J MED ENTOMOL, V50, P533, DOI 10.1603/ME12126; Cini A, 2012, B INSECTOL, V65, P149; Dalton DT, 2011, PEST MANAG SCI, V67, P1368, DOI 10.1002/ps.2280; de Almeida SJ, 2010, ENVIRON MODELL SOFTW, V25, P1490, DOI 10.1016/j.envsoft.2010.04.021; Fangue NA, 2006, J EXP BIOL, V209, P2859, DOI 10.1242/jeb.02260; Ferguson NM, 2003, NATURE, V425, P681, DOI 10.1038/nature02007; FOCKS DA, 1995, AM J TROP MED HYG, V53, P489, DOI 10.4269/ajtmh.1995.53.489; Goodhue RE, 2011, PEST MANAG SCI, V67, P1396, DOI 10.1002/ps.2259; Hamby KA, 2013, PLOS ONE, DOI [10.1371/journal.-pone.0068472, DOI 10.1371/JOURNAL.-PONE.0068472]; Jones VP, 2012, POPUL ECOL, V54, P421, DOI 10.1007/s10144-012-0315-8; Kanzawa T, 1939, REV APPL ENTOMOLOGY, V29, p[49, 622]; Kawase S, 2007, PLANT PROT, V61, P205; Kimura MT, 2004, OECOLOGIA, V140, P442, DOI 10.1007/s00442-004-1605-4; Landolt PJ, 2012, J APPL ENTOMOL, V136, P148, DOI 10.1111/j.1439-0418.2011.01646.x; Lee JC, 2012, J ECON ENTOMOL, V105, P1350, DOI 10.1603/EC12132; Lee JC, 2011, PEST MANAG SCI, V67, P1358, DOI 10.1002/ps.2225; LESLIE PH, 1948, BIOMETRIKA, V35, P213, DOI 10.2307/2332342; LESLIE PH, 1945, BIOMETRIKA, V33, P183, DOI 10.2307/2332297; Lourenco PM, 2011, J VECTOR ECOL, V36, P279, DOI 10.1111/j.1948-7134.2011.00168.x; Mitsui H, 2007, J NAT HIST, V41, P1731, DOI 10.1080/00222930701504797; Mitsui H, 2006, POPUL ECOL, V48, P233, DOI 10.1007/s10144-006-0260-5; Park JJ, 2010, J ECON ENTOMOL, V103, P1474, DOI 10.1603/EC10003; Pianka ER, 2011, EVOLUTIONARY ECOLOGY, P7; Quesada-Moraga E, 2012, ENVIRON ENTOMOL, V41, P966, DOI 10.1603/EN12029; R Development Core Team, 2013, R: A Language and Environment for Statistical Computing; Rahmandad H, 2008, MANAGE SCI, V54, P998, DOI 10.1287/mnsc.1070.0787; REISSIG WH, 1979, ENVIRON ENTOMOL, V8, P51, DOI 10.1093/ee/8.1.51; ROCK GC, 1983, ENVIRON ENTOMOL, V12, P831, DOI 10.1093/ee/12.3.831; Southeast Regional Climate Center, 2014, CRONOS DAT; Statsoft Inc, 2005, STAT 7 1; Teixeira LAF, 2001, ENVIRON ENTOMOL, V30, P925, DOI 10.1603/0046-225X-30.5.925; Tochen S, 2014, ENVIRON ENTOMOL, V43, P501, DOI 10.1603/EN13200; University of California Agriculture and Natural Resources (UCANR), 2014, WEATH MOD DEGR DAYS; University of California Agriculture and Natural Resources (UCANR), 2014, CAL WEATH DAT DAIL W; Walsh DB, 2011, J INTEGR PEST MANAG, V2, DOI 10.1603/IPM10010; Williams CR, 2008, J MED ENTOMOL, V45, P1173, DOI 10.1603/0022-2585(2008)45[1173:REOAAP]2.0.CO;2; Yang HM, 2011, BIOSYSTEMS, V103, P360, DOI 10.1016/j.biosystems.2010.11.002	47	103	106	2	107	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2014	9	9							e106909	10.1371/journal.pone.0106909	http://dx.doi.org/10.1371/journal.pone.0106909			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ1IR	25192013	gold, Green Submitted, Green Published			2022-12-27	WOS:000347993600080
J	Zieger, M; Ahnelt, PK; Uhrin, P				Zieger, Marina; Ahnelt, Peter K.; Uhrin, Pavel			CX3CL1 (Fractalkine) Protein Expression in Normal and Degenerating Mouse Retina: In Vivo Studies	PLOS ONE			English	Article							MEMBRANE-ANCHORED CHEMOKINE; RAT HIPPOCAMPAL-NEURONS; MICROGLIAL ACTIVATION; GANGLION-CELLS; RD10 MOUSE; AMACRINE CELLS; BETA-SUBUNIT; BRAIN; CX(3)CR1; PIGMENTOSA	We aimed to investigate fractalkine (CX3CL1) protein expression in wild type (wt) retina and its alterations during retinal degeneration in mouse model (rd10) of retinitis pigmentosa. Forms of retinal protein CX3CL1, total protein and mRNA levels of CX3CL1 were analyzed at postnatal days (P) 5, 10, 14, 22, 30, 45, and 60 by Western blotting and real-time PCR. Cellular sources of CX3CL1 were investigated by in situ hybridization histochemistry (ISH) and using transgenic (CX3CL1cherry) mice. The immunoblots revealed that in both, wt and rd10 retinas, a membrane integrated similar to 100 kDa CX3CL1 form and a cleaved similar to 85 kDa CX3CL1 form were present at P5. At P10, accumulation of another presumably intra-neuronal,95 kDa form and a decrease in the similar to 85-kDa form were observed. From P14, a similar to 95 kDa form became principal in wt retina, while in rd10 retinas a soluble similar to 85 kDa form increased at P45 and P60. In comparison, retinas of rd10 mice had significantly lower levels of total CX3CL1 protein (from P10 onwards) and lower CX3CL1 mRNA levels (from P14), even before the onset of primary rod degeneration. ISH and mCherry reporter fluorescence showed neurons in the inner retina layers as principal sites of CX3CL1 synthesis both in wt and rd10 retinas. In conclusion, our results demonstrate that CX3CL1 has a distinctive course of expression and functional regulation in rd10 retina starting at P10. The biological activity of CX3CL1 is regulated by conversion of a membrane integrated to a soluble form during neurogenesis and in response to pathologic changes in the adult retinal milieu. Viable mature neurons in the inner retina likely exhibit a dynamic intracellular storage depot of CX3CL1.	[Zieger, Marina; Ahnelt, Peter K.] Med Univ Vienna, Ctr Physiol & Pharmacol, Dept Neurophysiol & Neuropharmacol, Vienna, Austria; [Uhrin, Pavel] Med Univ Vienna, Ctr Physiol & Pharmacol, Dept Vasc Biol & Thrombosis Res, Vienna, Austria; [Zieger, Marina] Univ Massachusetts, Sch Med, Dept Ophthalmol, Worcester, MA USA; [Zieger, Marina] Univ Massachusetts, Sch Med, Gene Therapy Ctr, Worcester, MA USA	Medical University of Vienna; Medical University of Vienna; University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester	Zieger, M (corresponding author), Med Univ Vienna, Ctr Physiol & Pharmacol, Dept Neurophysiol & Neuropharmacol, Vienna, Austria.	Marina.Zieger@umassmed.edu; Pavel.Uhrin@meduniwien.ac.at	Zieger, Marina/AAF-3355-2020	Zieger, Marina/0000-0003-2693-3901; Uhrin, Pavel/0000-0002-9792-3420; Ahnelt, Peter/0000-0003-0784-8891	Austrian Science Fund (FWF) [I 433-B13]; Austrian Science Fund (FWF) [I 433] Funding Source: researchfish	Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	Project supported by the Austrian Science Fund (FWF) I 433-B13 (www.fwf.ac.at) granted to PKA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrzejewski MG, 2010, BIOCHEM BIOPH RES CO, V395, P178, DOI 10.1016/j.bbrc.2010.03.139; Bachstetter AD, 2011, NEUROBIOL AGING, V32, P2030, DOI 10.1016/j.neurobiolaging.2009.11.022; Barhoum R, 2008, NEUROSCIENCE, V155, P698, DOI 10.1016/j.neuroscience.2008.06.042; Bazan JF, 1997, NATURE, V385, P640, DOI 10.1038/385640a0; Biber K, 2007, TRENDS NEUROSCI, V30, P596, DOI 10.1016/j.tins.2007.08.007; Birnbacher R, 1998, PEDIATR RES, V43, P614, DOI 10.1203/00006450-199805000-00009; BLANKS JC, 1974, J COMP NEUROL, V156, P81, DOI 10.1002/cne.901560107; Boehme SA, 2000, J IMMUNOL, V165, P397, DOI 10.4049/jimmunol.165.1.397; BREITSCHOPF H, 1992, ACTA NEUROPATHOL, V84, P581; Cardona AE, 2006, NAT NEUROSCI, V9, P917, DOI 10.1038/nn1715; Chang B, 2007, VISION RES, V47, P624, DOI 10.1016/j.visres.2006.11.020; Chapman GA, 2000, J NEUROSCI, V20, DOI 10.1523/JNEUROSCI.20-15-j0004.2000; Clark AK, 2012, EXP NEUROL, V234, P283, DOI 10.1016/j.expneurol.2011.09.012; Combadiere C, 2007, J CLIN INVEST, V117, P2920, DOI 10.1172/JCI31692; Cook A, 2010, J BIOL CHEM, V285, P10563, DOI 10.1074/jbc.M109.035477; Farrar GJ, 2002, EMBO J, V21, P857, DOI 10.1093/emboj/21.5.857; FISHER LJ, 1979, J COMP NEUROL, V187, P359, DOI 10.1002/cne.901870207; Fuller AD, 2008, J NEUROIMMUNE PHARM, V3, P246, DOI 10.1007/s11481-008-9118-2; Gargini C, 2007, J COMP NEUROL, V500, P222, DOI 10.1002/cne.21144; Garton KJ, 2001, J BIOL CHEM, V276, P37993; Garton KJ, 2006, J LEUKOCYTE BIOL, V79, P1105, DOI 10.1189/jlb.0106038; Gemma C, 2010, AGING DIS, V1, P232; Harrison JK, 1998, P NATL ACAD SCI USA, V95, P10896, DOI 10.1073/pnas.95.18.10896; Hatori K, 2002, J NEUROSCI RES, V69, P418, DOI 10.1002/jnr.10304; Hellwig S, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00071; Hermand P, 2008, J BIOL CHEM, V283, P30225, DOI 10.1074/jbc.M802638200; HINDS JW, 1978, J COMP NEUROL, V179, P277, DOI 10.1002/cne.901790204; Hoarau JJ, 2011, CNS NEUROL DISORD-DR, V10, P25, DOI 10.2174/187152711794488601; Huang LB, 2013, OCUL IMMUNOL INFLAMM, V21, P276, DOI 10.3109/09273948.2013.791925; Huang YW, 2009, J BIOL CHEM, V284, P29644, DOI 10.1074/jbc.M109.045682; Hundhausen C, 2003, BLOOD, V102, P1186, DOI 10.1182/blood-2002-12-3775; Jones BW, 2012, JPN J OPHTHALMOL, V56, P289, DOI 10.1007/s10384-012-0147-2; Jung S, 2000, MOL CELL BIOL, V20, P4106, DOI 10.1128/MCB.20.11.4106-4114.2000; Kim KW, 2011, BLOOD, V118, pE156, DOI 10.1182/blood-2011-04-348946; Kraft AD, 2011, INT J ENV RES PUB HE, V8, P2980, DOI 10.3390/ijerph8072980; Lauro C, 2008, J IMMUNOL, V180, P7590, DOI 10.4049/jimmunol.180.11.7590; Lauro C, 2006, J IMMUNOL, V177, P7599, DOI 10.4049/jimmunol.177.11.7599; Limatola C, 2005, J NEUROIMMUNOL, V166, P19, DOI 10.1016/j.jneuroim.2005.03.023; Liu GY, 2005, J BIOL CHEM, V280, P19858, DOI 10.1074/jbc.M413073200; Lucas AD, 2001, AM J PATHOL, V158, P855, DOI 10.1016/S0002-9440(10)64034-5; MADREPERLA SA, 1990, ARCH OPHTHALMOL-CHIC, V108, P358, DOI 10.1001/archopht.1990.01070050056030; Marc RE, 2003, PROG RETIN EYE RES, V22, P607, DOI 10.1016/S1350-9462(03)00039-9; Mazzoni F, 2008, J NEUROSCI, V28, P14282, DOI 10.1523/JNEUROSCI.4968-08.2008; MCLAUGHLIN ME, 1993, NAT GENET, V4, P130, DOI 10.1038/ng0693-130; Mizoue LS, 1999, BIOCHEMISTRY-US, V38, P1402, DOI 10.1021/bi9820614; Mizuno T, 2003, BRAIN RES, V979, P65, DOI 10.1016/S0006-8993(03)02867-1; Morganti JM, 2012, J NEUROSCI, V32, P14592, DOI 10.1523/JNEUROSCI.0539-12.2012; Muller LPD, 2007, J COMP NEUROL, V505, P177, DOI 10.1002/cne.21487; Nishiyori A, 1998, FEBS LETT, V429, P167, DOI 10.1016/S0014-5793(98)00583-3; Noda M, 2011, J BIOL CHEM, V286, P2308, DOI 10.1074/jbc.M110.169839; OLNEY JW, 1968, INVEST OPHTH VISUAL, V7, P250; Pan Y, 1997, NATURE, V387, P611, DOI 10.1038/42491; Pang JJ, 2011, INVEST OPHTH VIS SCI, V52, P4886, DOI 10.1167/iovs.10-5921; Paolicelli RC, 2011, SCIENCE, V333, P1456, DOI 10.1126/science.1202529; Peng B, 2014, J NEUROSCI, V34, P8139, DOI 10.1523/JNEUROSCI.5200-13.2014; Phillips MJ, 2010, J COMP NEUROL, V518, P2071, DOI 10.1002/cne.22322; Prinz M, 2011, NAT NEUROSCI, V14, P1227, DOI 10.1038/nn.2923; Prinz M, 2010, J NEUROIMMUNOL, V224, P80, DOI 10.1016/j.jneuroim.2010.05.015; Puthussery T, 2009, EUR J NEUROSCI, V29, P1533, DOI 10.1111/j.1460-9568.2009.06728.x; Ragozzino D, 2006, J NEUROSCI, V26, P10488, DOI 10.1523/JNEUROSCI.3192-06.2006; Ransohoff RM, 2007, INT REV NEUROBIOL, V82, P187, DOI 10.1016/S0074-7742(07)82010-1; Ransohoff RM, 2013, GLIA, V61, P1, DOI 10.1002/glia.22439; Rogers JT, 2011, J NEUROSCI, V31, P16241, DOI 10.1523/JNEUROSCI.3667-11.2011; Samardzija M, 2012, EXP EYE RES, V99, P17, DOI 10.1016/j.exer.2012.04.004; Schafer DP, 2012, NEURON, V74, P691, DOI 10.1016/j.neuron.2012.03.026; Schlamp CL, 2013, MOL VIS, V19, P1387; Silverman MD, 2003, INVEST OPHTH VIS SCI, V44, P1608, DOI 10.1167/iovs.02-0233; Sunnemark D, 2005, J NEUROINFLAMM, V2, DOI 10.1186/1742-2094-2-17; Tole S, 2010, AM J PHYSIOL-CELL PH, V298, pC1469, DOI 10.1152/ajpcell.00380.2009; Tsou CL, 2001, J BIOL CHEM, V276, P44622, DOI 10.1074/jbc.M107327200; Vukovic J, 2012, J NEUROSCI, V32, P6435, DOI 10.1523/JNEUROSCI.5925-11.2012; Wolf Y, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00026; Zeng HY, 2005, INVEST OPHTH VIS SCI, V46, P2992, DOI 10.1167/iovs.05-0118; Zujovic V, 2000, GLIA, V29, P305, DOI 10.1002/(SICI)1098-1136(20000215)29:4<305::AID-GLIA2>3.0.CO;2-V	74	26	26	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2014	9	9							e106562	10.1371/journal.pone.0106562	http://dx.doi.org/10.1371/journal.pone.0106562			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ1IR	25191897	gold, Green Published, Green Submitted			2022-12-27	WOS:000347993600037
J	Elluri, S; Enow, C; Vdovikova, S; Rompikuntal, PK; Dongre, M; Carlsson, S; Pal, A; Uhlin, BE; Wai, SN				Elluri, Sridhar; Enow, Constance; Vdovikova, Svitlana; Rompikuntal, Pramod K.; Dongre, Mitesh; Carlsson, Sven; Pal, Amit; Uhlin, Bernt Eric; Wai, Sun Nyunt			Outer Membrane Vesicles Mediate Transport of Biologically Active Vibrio cholerae Cytolysin (VCC) from V-cholerae Strains	PLOS ONE			English	Article							ENTEROTOXIGENIC ESCHERICHIA-COLI; CYTOLETHAL DISTENDING TOXIN; STRUCTURAL GENE HLYA; PORE-FORMING TOXIN; BIOTYPE EL-TOR; NUCLEOTIDE-SEQUENCE; VIRULENCE FACTORS; ACTINOBACILLUS-ACTINOMYCETEMCOMITANS; MOLECULAR ANALYSIS; CELL VACUOLATION	Background: Outer membrane vesicles (OMVs) released from Gram-negative bacteria can serve as vehicles for the translocation of virulence factors. Vibrio cholerae produce OMVs but their putative role in translocation of effectors involved in pathogenesis has not been well elucidated. The V. cholerae cytolysin (VCC), is a pore-forming toxin that lyses target eukaryotic cells by forming transmembrane oligomeric beta-barrel channels. It is considered a potent toxin that contributes to V. cholerae pathogenesis. The mechanisms involved in the secretion and delivery of the VCC have not been extensively studied. Methodology/Principal Findings: OMVs from V. cholerae strains were isolated and purified using a differential centrifugation procedure and Optiprep centrifugation. The ultrastructure and the contents of OMVs were examined under the electron microscope and by immunoblot analyses respectively. We demonstrated that VCC from V. cholerae strain V: 5/04 was secreted in association with OMVs and the release of VCC via OMVs is a common feature among V. cholerae strains. The biological activity of OMV-associated VCC was investigated using contact hemolytic assay and epithelial cell cytotoxicity test. It showed toxic activity on both red blood cells and epithelial cells. Our results indicate that the OMVs architecture might play a role in stability of VCC and thereby can enhance its biological activities in comparison with the free secreted VCC. Furthermore, we tested the role of OMV-associated VCC in host cell autophagy signalling using confocal microscopy and immunoblot analysis. We observed that OMV-associated VCC triggered an autophagy response in the target cell and our findings demonstrated for the first time that autophagy may operate as a cellular defence mechanism against an OMV-associated bacterial virulence factor. Conclusion/Significance: Biological assays of OMVs from the V. cholerae strain V: 5/04 demonstrated that OMV-associated VCC is indeed biologically active and induces toxicity on mammalian cells and furthermore can induce autophagy.	[Elluri, Sridhar; Enow, Constance; Vdovikova, Svitlana; Rompikuntal, Pramod K.; Dongre, Mitesh; Uhlin, Bernt Eric; Wai, Sun Nyunt] Umea Univ, Dept Mol Biol, Lab Mol Infect Med Sweden MIMS, Umea, Sweden; [Elluri, Sridhar; Pal, Amit] Natl Inst Cholera & Enter Dis, Div Pathophysiol, Kolkata, W Bengal, India; [Carlsson, Sven] Umea Univ, Dept Med Biochem, Umea, Sweden	Umea University; Indian Council of Medical Research (ICMR); ICMR - National Institute of Cholera & Enteric Diseases (NICED); Umea University	Wai, SN (corresponding author), Umea Univ, Dept Mol Biol, Lab Mol Infect Med Sweden MIMS, Umea, Sweden.	sun.nyunt.wai@molbiol.umu.se	rompikuntal, pramod/C-6917-2015; Uhlin, Bernt Eric/AAO-6292-2021	rompikuntal, pramod/0000-0002-4754-4676; Uhlin, Bernt Eric/0000-0002-2991-8072; dongre, mitesh/0000-0002-7151-1137; Wai, Sun Nyunt/0000-0003-4793-4671	Swedish Research Council [2006-4702, 2013-2392, 353-2010-7074, 2010-3031, 2012-4638, 349-2007-8673]; Swedish Foundation for International Cooperation in Research and Higher Education [IG2008-2049]; Umea University	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Foundation for International Cooperation in Research and Higher Education; Umea University	SNW was supported by the Swedish Research Council project grants 2006-4702 (VR-NT), 2013-2392 (VR-MH), and the Swedish Foundation for International Cooperation in Research and Higher Education IG2008-2049 (STINT). BEU was supported by the Swedish Research Council project grants 2010-3031 (VR-MH) and 2012-4638 (VR-NT). The Laboratory for Molecular Infection Medicine Sweden (MIMS) is supported by Umea University and the Swedish Research Council (353-2010-7074). This work was performed as part of the Umea Centre for Microbial Research (UCMR) Linnaeus Program supported by Umea University and the Swedish Research Council (349-2007-8673). Funding website: URL: http://www.vr.se. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Saka HA, 2008, MICROB PATHOGENESIS, V44, P118, DOI 10.1016/j.micpath.2007.08.013; ALM RA, 1988, MOL MICROBIOL, V2, P481; ALM RA, 1991, VACCINE, V9, P588, DOI 10.1016/0264-410X(91)90247-4; Awasthi SP, 2013, INFECT IMMUN, V81, P531, DOI 10.1128/IAI.00982-12; Balsalobre C, 2006, MOL MICROBIOL, V59, P99, DOI 10.1111/j.1365-2958.2005.04938.x; Bauer ME, 1997, INFECT IMMUN, V65, P2218, DOI 10.1128/IAI.65.6.2218-2224.1997; Beveridge TJ, 1999, J BACTERIOL, V181, P4725, DOI 10.1128/JB.181.16.4725-4733.1999; BLIGHT MA, 1994, TRENDS BIOTECHNOL, V12, P450, DOI 10.1016/0167-7799(94)90020-5; BOLIVAR F, 1977, GENE, V2, P95, DOI 10.1016/0378-1119(77)90000-2; CASADABAN MJ, 1980, J BACTERIOL, V143, P971, DOI 10.1128/JB.143.2.971-980.1980; CHATTERJ.SN, 1967, J GEN MICROBIOL, V49, P1; Cheng LW, 2000, J BACTERIOL, V182, P3183, DOI 10.1128/JB.182.11.3183-3190.2000; COELHO A, 1995, J CLIN MICROBIOL, V33, P114, DOI 10.1128/JCM.33.1.114-118.1995; DONNENBERG MS, 1991, INFECT IMMUN, V59, P4310, DOI 10.1128/IAI.59.12.4310-4317.1991; Faruque SM, 1998, MICROBIOL MOL BIOL R, V62, P1301, DOI 10.1128/MMBR.62.4.1301-1314.1998; Figueroa-Arredondo P, 2001, INFECT IMMUN, V69, P1613, DOI 10.1128/IAI.69.3.1613-1624.2001; FURSTE JP, 1986, GENE, V48, P119, DOI 10.1016/0378-1119(86)90358-6; Gutierrez MG, 2007, P NATL ACAD SCI USA, V104, P1829, DOI 10.1073/pnas.0601437104; Galka F, 2008, INFECT IMMUN, V76, P1825, DOI 10.1128/IAI.01396-07; Ganguly S, 2014, J BIOL CHEM, V289, P4001, DOI 10.1074/jbc.M113.522284; HANAHAN D, 1983, J MOL BIOL, V166, P557, DOI 10.1016/S0022-2836(83)80284-8; Horstman AL, 2000, J BIOL CHEM, V275, P12489, DOI 10.1074/jbc.275.17.12489; ICHINOSE Y, 1987, INFECT IMMUN, V55, P1090, DOI 10.1128/IAI.55.5.1090-1093.1987; Johansson J, 2000, CELL, V102, P475, DOI 10.1016/S0092-8674(00)00052-0; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; KADURUGAMUWA JL, 1995, J BACTERIOL, V177, P3998, DOI 10.1128/jb.177.14.3998-4008.1995; KAPER JB, 1995, CLIN MICROBIOL REV, V8, P48, DOI 10.1128/CMR.8.1.48; Kato S, 2002, MICROB PATHOGENESIS, V32, P1, DOI 10.1006/mpat.2001.0474; Kesty NC, 2004, EMBO J, V23, P4538, DOI 10.1038/sj.emboj.7600471; KONDO K, 1993, MICROBIOL IMMUNOL, V37, P149, DOI 10.1111/j.1348-0421.1993.tb03192.x; Krasilnikov OV, 2007, BIOCHIMIE, V89, P271, DOI 10.1016/j.biochi.2006.12.003; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lear JD, 2000, BBA-PROTEIN STRUCT M, V1476, P350, DOI 10.1016/S0167-4838(99)00241-1; Levine B, 2008, CELL, V132, P27, DOI 10.1016/j.cell.2007.12.018; Lindmark B, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-220; Lohner S, 2009, FASEB J, V23, P2521, DOI 10.1096/fj.08-127688; Luo Y, 2013, BMC MICROBIOL, V13, DOI 10.1186/1471-2180-13-52; MEKALANOS JJ, 1983, NATURE, V306, P551, DOI 10.1038/306551a0; Mestre MB, 2013, CURR MOL MED, V13, P241; MILLER VL, 1988, J BACTERIOL, V170, P2575, DOI 10.1128/JB.170.6.2575-2583.1988; Mizushima N, 2005, CELL DEATH DIFFER, V12, P1535, DOI 10.1038/sj.cdd.4401728; Moschioni M, 2002, CELL MICROBIOL, V4, P397, DOI 10.1046/j.1462-5822.2002.00199.x; Mostowy S, 2013, CELL MICROBIOL, V15, P395, DOI 10.1111/cmi.12063; Nagamune K, 1997, J BIOL CHEM, V272, P1338, DOI 10.1074/jbc.272.2.1338; Nesper J, 2000, J BACTERIOL, V182, P5097, DOI 10.1128/JB.182.18.5097-5104.2000; Nesper J, 2002, INFECT IMMUN, V70, P2419, DOI 10.1128/IAI.70.5.2419-2433.2002; Ni HM, 2011, AUTOPHAGY, V7, P188, DOI 10.4161/auto.7.2.14181; Olivier V, 2007, INFECT IMMUN, V75, P5035, DOI 10.1128/IAI.00506-07; Oscarsson J, 1999, MOL MICROBIOL, V32, P1226, DOI 10.1046/j.1365-2958.1999.01435.x; Ou GW, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007806; Pal A, 1999, INDIAN J MED RES, V109, P208; Pantano S, 2006, TOXICON, V47, P35, DOI 10.1016/j.toxicon.2005.09.007; Ricci V, 2005, BIOCHEM BIOPH RES CO, V337, P173, DOI 10.1016/j.bbrc.2005.09.035; Rompikuntal PK, 2012, INFECT IMMUN, V80, P31, DOI 10.1128/IAI.06069-11; Saha PK, 1996, J CLIN MICROBIOL, V34, P1114, DOI 10.1128/JCM.34.5.1114-1117.1996; Sikora AE, 2011, J BIOL CHEM, V286, P16555, DOI 10.1074/jbc.M110.211078; Skorupski K, 1996, GENE, V169, P47, DOI 10.1016/0378-1119(95)00793-8; Soloaga A, 1998, BIOCHEMISTRY-US, V37, P6387, DOI 10.1021/bi9730994; Thungapathra M, 2002, ANTIMICROB AGENTS CH, V46, P2948, DOI 10.1128/AAC.46.9.2948-2955.2002; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; Vaitkevicius K, 2006, P NATL ACAD SCI USA, V103, P9280, DOI 10.1073/pnas.0601754103; Valeru SP, 2009, INFECT IMMUN, V77, P935, DOI 10.1128/IAI.00929-08; WAI SN, 1995, MICROBIOL IMMUNOL, V39, P451, DOI 10.1111/j.1348-0421.1995.tb02228.x; Wai SN, 2003, CELL, V115, P25, DOI 10.1016/S0092-8674(03)00754-2; Wai SN, 1998, APPL ENVIRON MICROB, V64, P3648; YAMAMOTO K, 1990, INFECT IMMUN, V58, P4106, DOI 10.1128/IAI.58.12.4106-4116.1990; Zhu J, 2002, P NATL ACAD SCI USA, V99, P3129, DOI 10.1073/pnas.052694299; Zitzer A, 1999, J BIOL CHEM, V274, P1375, DOI 10.1074/jbc.274.3.1375	68	43	48	2	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 4	2014	9	9							e106731	10.1371/journal.pone.0106731	http://dx.doi.org/10.1371/journal.pone.0106731			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3XV	25187967	Green Published, Green Submitted, gold			2022-12-27	WOS:000341271500078
J	George, DT; Behm, CA; Hall, DH; Mathesius, U; Rug, M; Nguyen, KCQ; Verma, NK				George, Divya T.; Behm, Carolyn A.; Hall, David H.; Mathesius, Ulrike; Rug, Melanie; Nguyen, Ken C. Q.; Verma, Naresh K.			Shigella flexneri Infection in Caenorhabditis elegans: Cytopathological Examination and Identification of Host Responses	PLOS ONE			English	Article							OUTER-MEMBRANE VESICLES; GRAM-NEGATIVE BACTERIA; PSEUDOMONAS-AERUGINOSA; C. ELEGANS; SALMONELLA-TYPHIMURIUM; PATHOGEN INTERACTION; CYTOSOLIC ACONITASE; MICROBIAL VIRULENCE; ESCHERICHIA-COLI; LIFE-SPAN	The Gram-negative bacterium Shigella flexneri is the causative agent of shigellosis, a diarrhoeal disease also known as bacillary dysentery. S. flexneri infects the colonic and rectal epithelia of its primate host and induces a cascade of inflammatory responses that culminates in the destruction of the host intestinal lining. Molecular characterization of host-pathogen interactions in this infection has been challenging due to the host specificity of S. flexneri strains, as it strictly infects humans and non-human primates. Recent studies have shown that S. flexneri infects the soil dwelling nematode Caenorhabditis elegans, however, the interactions between S. flexneri and C. elegans at the cellular level and the cause of nematode death are unknown. Here we attempt to gain insight into the complex host-pathogen interactions between S. flexneri and C. elegans. Using transmission electron microscopy, we show that live S. flexneri cells accumulate in the nematode intestinal lumen, produce outer membrane vesicles and invade nematode intestinal cells. Using two-dimensional differential in-gel electrophoresis we identified host proteins that are differentially expressed in response to S. flexneri infection. Four of the identified genes, aco-1, cct-2, daf-19 and hsp-60, were knocked down using RNAi and ACO-1, CCT-2 and DAF-19, which were identified as up-regulated in response to S. flexneri infection, were found to be involved in the infection process. aco-1 RNAi worms were more resistant to S. flexneri infection, suggesting S. flexneri-mediated disruption of host iron homeostasis. cct-2 and daf-19 RNAi worms were more susceptible to infection, suggesting that these genes are induced as a protective mechanism by C. elegans. These observations further our understanding of the processes involved in S. flexneri infection of C. elegans, which is immensely beneficial to the routine use of this new in vivo model to study S. flexneri pathogenesis.	[George, Divya T.; Behm, Carolyn A.; Verma, Naresh K.] Australian Natl Univ, Res Sch Biol, Div Biomed Sci & Biochem, Canberra, ACT, Australia; [Hall, David H.; Nguyen, Ken C. Q.] Albert Einstein Coll Med, Ctr C Elegans Anat, Dept Neurosci, Bronx, NY 10467 USA; [Mathesius, Ulrike] Australian Natl Univ, Res Sch Biol, Div Plant Sci, Canberra, ACT, Australia; [Rug, Melanie] Australian Natl Univ, Ctr Adv Microscopy, Canberra, ACT, Australia	Australian National University; Yeshiva University; Albert Einstein College of Medicine; Australian National University; Australian National University	Verma, NK (corresponding author), Australian Natl Univ, Res Sch Biol, Div Biomed Sci & Biochem, Canberra, ACT, Australia.	Naresh.Verma@anu.edu.au	Verma, Naresh/C-9161-2009; Behm, Carolyn A/A-2102-2008; Rug, Melanie/B-5417-2015; Mathesius, Ulrike/C-9767-2009	Verma, Naresh/0000-0001-8109-2215; Behm, Carolyn A/0000-0002-0603-221X; Mathesius, Ulrike/0000-0002-3557-0105	NIH [NIH OD010943]; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [R24OD010943] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	DH gratefully acknowledges support of the NIH grant (NIH OD010943). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aballay A, 2000, CURR BIOL, V10, P1539, DOI 10.1016/S0960-9822(00)00830-7; Alegado RA, 2003, CELL MICROBIOL, V5, P435, DOI 10.1046/j.1462-5822.2003.00287.x; Amano A, 2010, MICROBES INFECT, V12, P791, DOI 10.1016/j.micinf.2010.05.008; Ashida H, 2009, CURR TOP MICROBIOL, V337, P231, DOI 10.1007/978-3-642-01846-6_8; Balla KM, 2013, CELL MICROBIOL, V15, P1313, DOI 10.1111/cmi.12152; Bomberger JM, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000382; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BRENNER S, 1974, GENETICS, V77, P71; Burton EA, 2006, APPL ENVIRON MICROB, V72, P5043, DOI 10.1128/AEM.00558-06; Darby C, 2005, INTERACTIONS MICROBI; DUPONT HL, 1989, J INFECT DIS, V159, P1126, DOI 10.1093/infdis/159.6.1126; Dutta S, 2004, MICROBIOL IMMUNOL, V48, P965, DOI 10.1111/j.1348-0421.2004.tb03626.x; Fiocca R, 1999, J PATHOL, V188, P220, DOI 10.1002/(SICI)1096-9896(199906)188:2<220::AID-PATH307>3.0.CO;2-C; Fritz JA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005117; Furuta N, 2009, INFECT IMMUN, V77, P4761, DOI 10.1128/IAI.00841-09; Gourley BL, 2003, J BIOL CHEM, V278, P3227, DOI 10.1074/jbc.M210333200; GRENIER D, 1992, INFECT IMMUN, V60, P1854, DOI 10.1128/IAI.60.5.1854-1857.1992; Hall DH, 2012, METHOD CELL BIOL, V107, P93, DOI 10.1016/B978-0-12-394620-1.00004-7; Hsiao JY, 2013, J MICROBIOL, V51, P367, DOI 10.1007/s12275-013-2589-8; Jennison AV, 2004, FEMS MICROBIOL REV, V28, P43, DOI 10.1016/j.femsre.2003.07.002; Joshua GWP, 2003, MICROBIOL-SGM, V149, P3221, DOI 10.1099/mic.0.26475-0; Kadurugamuwa JL, 1999, MICROBIOL-SGM, V145, P2051, DOI 10.1099/13500872-145-8-2051; Kamath RS, 2003, METHODS, V30, P313, DOI 10.1016/S1046-2023(03)00050-1; Kesika P, 2011, SCAND J INFECT DIS, V43, P286, DOI 10.3109/00365548.2010.548400; Kim YI, 2004, J MOL BIOL, V342, P421, DOI 10.1016/j.jmb.2004.07.036; Kirienko NV, 2013, CELL HOST MICROBE, V13, P406, DOI 10.1016/j.chom.2013.03.003; Kuehn MJ, 2005, GENE DEV, V19, P2645, DOI 10.1101/gad.1299905; Kurz CL, 2007, CURR OPIN MICROBIOL, V10, P10, DOI 10.1016/j.mib.2006.12.001; Kurz CL, 2000, TRENDS MICROBIOL, V8, P142, DOI 10.1016/S0966-842X(99)01691-1; Labrousse A, 2000, CURR BIOL, V10, P1543, DOI 10.1016/S0960-9822(00)00833-2; MALLETT CP, 1993, VACCINE, V11, P190, DOI 10.1016/0264-410X(93)90016-Q; Mathesius U, 2001, J EXP BOT, V52, P419, DOI 10.1093/jexbot/52.suppl_1.419; MAURELLI AT, 1984, INFECT IMMUN, V43, P397, DOI 10.1128/IAI.43.1.397-401.1984; McBroom AJ, 2007, MOL MICROBIOL, V63, P545, DOI 10.1111/j.1365-2958.2006.05522.x; McGee MD, 2011, AGING CELL, V10, P699, DOI 10.1111/j.1474-9726.2011.00713.x; Murphy CT, 2003, NATURE, V424, P277, DOI 10.1038/nature01789; Negrete-Abascal E, 2000, FEMS MICROBIOL LETT, V191, P109, DOI 10.1111/j.1574-6968.2000.tb09326.x; Ogawa M, 2008, NAT REV MICROBIOL, V6, P11, DOI 10.1038/nrmicro1814; Powell Jennifer R., 2008, V415, P403, DOI 10.1007/978-1-59745-570-1_24; Reith W, 2001, ANNU REV IMMUNOL, V19, P331, DOI 10.1146/annurev.immunol.19.1.331; ROSEN G, 1995, INFECT IMMUN, V63, P3973, DOI 10.1128/IAI.63.10.3973-3979.1995; Schertzer JW, 2013, J MOL MICROB BIOTECH, V23, P118, DOI 10.1159/000346770; SERENY B, 1955, Acta Microbiol Acad Sci Hung, V2, P293; Sifri CD, 2005, TRENDS MICROBIOL, V13, P119, DOI 10.1016/j.tim.2005.01.003; Sugimoto T, 2008, EXP CELL RES, V314, P103, DOI 10.1016/j.yexcr.2007.08.015; Sulston J., 1988, METHODS NEMATODE CAE; Tan MW, 1999, P NATL ACAD SCI USA, V96, P2408, DOI 10.1073/pnas.96.5.2408; Tan MW, 1999, P NATL ACAD SCI USA, V96, P715, DOI 10.1073/pnas.96.2.715; VANDEVERG LL, 1995, INFECT IMMUN, V63, P1947, DOI 10.1128/IAI.63.5.1947-1954.1995; VOINOYASENETSKY MV, 1962, ACTA MORPHOL HUNG, V11, P439; WAI SN, 1995, MICROBIOL IMMUNOL, V39, P451, DOI 10.1111/j.1348-0421.1995.tb02228.x; Wai SN, 2003, J BACTERIOL, V185, P5491, DOI 10.1128/JB.185.18.5491-5499.2003; Wang JG, 2010, MAGNETIC FRINGE FIELDS AND INTERFERENCE IN HIGH INTENSITY ACCELERATORS, P1; WASSEF JS, 1989, INFECT IMMUN, V57, P858, DOI 10.1128/IAI.57.3.858-863.1989; Xie YS, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003324	55	13	15	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 4	2014	9	9							e106085	10.1371/journal.pone.0106085	http://dx.doi.org/10.1371/journal.pone.0106085			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3XV	25187942	Green Published, gold, Green Submitted			2022-12-27	WOS:000341271500022
J	Czernik, C; Rhode, S; Helfer, S; Schmalisch, G; Buhrer, C; Schmitz, L				Czernik, Christoph; Rhode, Stefanie; Helfer, Sven; Schmalisch, Gerd; Buehrer, Christoph; Schmitz, Lothar			Development of Left Ventricular Longitudinal Speckle Tracking Echocardiography in Very Low Birth Weight Infants with and without Bronchopulmonary Dysplasia during the Neonatal Period	PLOS ONE			English	Article							PATENT DUCTUS-ARTERIOSUS; RESPIRATORY-DISTRESS-SYNDROME; STRAIN-RATE; PULMONARY-HYPERTENSION; MYOCARDIAL-FUNCTION; PRETERM INFANTS; SYSTEMIC HYPERTENSION; REFERENCE VALUES; TISSUE DOPPLER; COHORT	Objectives: In preterm infants, postnatal myocardial adaptation may be complicated by bronchopulmonary dysplasia (BPD). We aimed to describe the development of left ventricular function by serial 2D, Doppler, and speckle tracking echocardiography (2D-STE) in infants with and without BPD during the neonatal period and compare these to anthropometric and conventional hemodynamic parameters. Study Design: Prospective echocardiography on day of life (DOL) 1, 7, 14, and 28 in 119 preterm infants,1500 g birth weight of whom 36 developed BPD (need for oxygen supplementation at 36 weeks gestational age). Non-BPD and BPD infants differed significantly in median (IQR) gestational age (25.5(24-26.5) weeks vs. 29(27-30) weeks, p<0.001) and birth weight (661(552-871) g vs. 1100(890-1290) g, p<0.001). Results: The intra-and inter-observer variability of the 2D-STE parameters measured did not depend on time of measurement, although there were significant differences in the reproducibility of the parameters. Low intra-and inter-observer variability was seen for longitudinal systolic strain and strain rate mid septum with a median CV (coefficient of variation) of <4.6%. Much higher CVs (>10%) were seen for the apical segment. While anthropometric parameters show rapid development during the first 4 weeks of life, the speckle tracking parameters did not differ statistically significantly during the neonatal period. Infants with and without BPD differed significantly (p<0.001) in the development of anthropometric parameters, conventional hemodynamic parameters except for heart rate, and 2D-STE parameters: global longitudinal systolic strain rate (GLSSR) and longitudinal systolic strain for the mid left wall (LSSR). The largest differences were seen at DOL 1 and 7 in GLSSR (p<0.001) and in LSSR (p<0.01). Conclusions: Reproducible 2D-STE measurements are possible in preterm infants,1500 g. Cardiac deformation reveals early (DOL 1 and 7) ventricular changes (GLSSR and LSSR) in very low birth weight infants who develop BPD.	[Czernik, Christoph; Schmalisch, Gerd; Buehrer, Christoph] Charite Univ Med Ctr, Dept Neonatol, Berlin, Germany; [Rhode, Stefanie; Helfer, Sven; Schmitz, Lothar] Charite Univ Med Ctr, Dept Pediat Cardiol, Berlin, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Czernik, C (corresponding author), Charite Univ Med Ctr, Dept Neonatol, Berlin, Germany.	christoph.czernik@charite.de		Helfer, Sven/0000-0003-4623-6353				Aase SA, 2008, EUR J ECHOCARDIOGR, V9, P555, DOI 10.1093/ejechocard/jen120; Alagappan A, 1998, AM J PERINAT, V15, P3, DOI 10.1055/s-2007-993889; Amundsen BH, 2009, EUR J ECHOCARDIOGR, V10, P229, DOI 10.1093/ejechocard/jen201; ANDERSON AH, 1993, AM J PERINAT, V10, P190; Berkelhamer SK, 2013, SEMIN PERINATOL, V37, P124, DOI 10.1053/j.semperi.2013.01.009; Cameli M, 2012, CARDIOVASC ULTRASOUN, V10, DOI 10.1186/1476-7120-10-4; Chock VY, 2014, PEDIATR RES, V75, P570, DOI 10.1038/pr.2013.253; Christou Helen, 2005, J Intensive Care Med, V20, P76, DOI 10.1177/0885066604273494; CLYMAN RI, 1987, J PEDIATR-US, V111, P579, DOI 10.1016/S0022-3476(87)80126-9; Czernik C, 2013, ULTRASOUND MED BIOL, V39, P1343, DOI 10.1016/j.ultrasmedbio.2013.03.024; Czernik C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038352; Dandel M, 2009, INT J CARDIOL, V132, P11, DOI 10.1016/j.ijcard.2008.06.091; Dragulescu A, 2010, ARCH CARDIOVASC DIS, V103, P603, DOI 10.1016/j.acvd.2010.09.004; Fine NM, 2013, CIRC-CARDIOVASC IMAG, V6, P711, DOI 10.1161/CIRCIMAGING.113.000640; Friedberg MK, 2008, AM J CARDIOL, V102, P335, DOI 10.1016/j.amjcard.2008.03.064; FRIEDMAN AH, 1993, SEMIN PERINATOL, V17, P106; Fukuda Y, 2011, J AM SOC ECHOCARDIOG, V24, P1101, DOI 10.1016/j.echo.2011.06.005; Gorcsan J, 2011, J AM COLL CARDIOL, V58, P1401, DOI 10.1016/j.jacc.2011.06.038; Greenberg NL, 2002, CIRCULATION, V105, P99, DOI 10.1161/hc0102.101396; Hammerstingl C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038519; Hardegree EL, 2013, CIRC-HEART FAIL, V6, P748, DOI 10.1161/CIRCHEARTFAILURE.112.000098; LINDNER W, 1990, PEDIATR RES, V27, P278, DOI 10.1203/00006450-199003000-00015; Lorch SM, 2008, J AM SOC ECHOCARDIOG, V21, P1207, DOI 10.1016/j.echo.2008.08.011; Madurga A, 2013, AM J PHYSIOL-LUNG C, V305, pL893, DOI 10.1152/ajplung.00267.2013; Marcus KA, 2011, J AM SOC ECHOCARDIOG, V24, P625, DOI 10.1016/j.echo.2011.01.021; Marcus KA, 2011, MITOCHONDRION, V11, P405, DOI 10.1016/j.mito.2010.12.005; Mondillo S, 2011, J ULTRAS MED, V30, P71, DOI 10.7863/jum.2011.30.1.71; Nestaas E, 2014, EARLY HUM DEV, V90, P247, DOI 10.1016/j.earlhumdev.2014.01.014; Nestaas E, 2011, CARDIOL YOUNG, V21, P1, DOI 10.1017/S1047951109991314; Rudolph AM, 2010, ARCH DIS CHILD-FETAL, V95, pF132, DOI 10.1136/adc.2007.128777; Schmalisch G, 2012, BMC PEDIATR, V12, DOI 10.1186/1471-2431-12-37; Schmitz L, 2004, EARLY HUM DEV, V76, P101, DOI 10.1016/j.earlhumdev.2003.11.003; Schneider DJ, 2006, CIRCULATION, V114, P1873, DOI 10.1161/CIRCULATIONAHA.105.592063; Sehgal A, 2011, EUR J PEDIATR, V170, P1237, DOI 10.1007/s00431-011-1435-4; SHIMADA S, 1994, J PEDIATR-US, V125, P270, DOI 10.1016/S0022-3476(94)70210-1; Shimada S, 2003, PEDIATR INT, V45, P255, DOI 10.1046/j.1442-200X.2003.01713.x; Skinner J, 2001, Semin Neonatol, V6, P49, DOI 10.1053/siny.2000.0037; Weidemann F, 2002, AM J PHYSIOL-HEART C, V283, pH792, DOI 10.1152/ajpheart.00025.2002; Yilmaz R, 2005, J AM SOC ECHOCARDIOG, V18, P873, DOI 10.1016/j.echo.2005.01.016	39	19	19	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 3	2014	9	9							e106504	10.1371/journal.pone.0106504	http://dx.doi.org/10.1371/journal.pone.0106504			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3TB	25184634	gold, Green Submitted, Green Published			2022-12-27	WOS:000341257700079
J	Herr, MJ; Mabry, SE; Jennings, LK				Herr, Michael J.; Mabry, Scott E.; Jennings, Lisa K.			Tetraspanin CD9 Regulates Cell Contraction and Actin Arrangement via RhoA in Human Vascular Smooth Muscle Cells	PLOS ONE			English	Article							NEOINTIMAL FORMATION; BETA(1) INTEGRINS; PROTEIN-KINASE; ACTIVATION; FIBRONECTIN; ADHESION; BETA-1-INTEGRIN; DIFFERENTIATION; GTPASES; INJURY	The most prevalent cardiovascular diseases arise from alterations in vascular smooth muscle cell (VSMC) morphology and function. Tetraspanin CD9 has been previously implicated in regulating vascular pathologies; however, insight into how CD9 may regulate adverse VSMC phenotypes has not been provided. We utilized a human model of aortic smooth muscle cells to understand the consequences of CD9 deficiency on VSMC phenotypes. Upon knocking down CD9, the cells developed an abnormally small and rounded morphology. We determined that this morphological change was due to a lack of typical parallel actin arrangement. We also found similar total RhoA but decreased GTP-bound (active) RhoA levels in CD9 deficient cells. As a result, cells lacking a full complement of CD9 were less contractile than their control treated counterparts. Upon restoration of RhoA activity in the CD9 deficient cells, the phenotype was reversed and cell contraction was restored. Conversely, inhibition of RhoA activity in the control cells mimicked the CD9-deficient cell phenotype. Thus, alteration in CD9 expression was sufficient to profoundly disrupt cellular actin arrangement and endogenous cell contraction by interfering with RhoA signaling. This study provides insight into how CD9 may regulate previously described vascular smooth muscle cell pathophysiology.	[Herr, Michael J.; Mabry, Scott E.; Jennings, Lisa K.] Univ Tennessee, Ctr Hlth Sci, Vasc Biol Ctr Excellence, Memphis, TN 38163 USA; [Herr, Michael J.; Mabry, Scott E.; Jennings, Lisa K.] Univ Tennessee, Ctr Hlth Sci, Dept Internal Med, Memphis, TN 38163 USA; [Herr, Michael J.; Jennings, Lisa K.] Univ Tennessee, Ctr Hlth Sci, Dept Microbiol Immunol & Biochem, Memphis, TN 38163 USA; [Jennings, Lisa K.] Univ Tennessee, Ctr Hlth Sci, Dept Surg, Memphis, TN 38163 USA; [Jennings, Lisa K.] Univ Tennessee, Ctr Hlth Sci, Joint Program Biomed Engn, Memphis, TN 38163 USA; [Jennings, Lisa K.] Univ Memphis, Memphis, TN 38152 USA; [Herr, Michael J.; Jennings, Lisa K.] CirQuest Labs LLC, Memphis, TN USA	University of Tennessee System; University of Tennessee Health Science Center; University of Tennessee System; University of Tennessee Health Science Center; University of Tennessee System; University of Tennessee Health Science Center; University of Tennessee System; University of Tennessee Health Science Center; University of Tennessee System; University of Tennessee Health Science Center; University of Memphis	Jennings, LK (corresponding author), Univ Tennessee, Ctr Hlth Sci, Vasc Biol Ctr Excellence, Memphis, TN 38163 USA.	ljennings@uthsc.edu			American Heart Association [11GRNT7590037, 13MSRF14940000]; Vascular Biology Support Fund at the University of Tennessee Health Science Center; CirQuest Labs, LLC.	American Heart Association(American Heart Association); Vascular Biology Support Fund at the University of Tennessee Health Science Center; CirQuest Labs, LLC.	This work was supported by the American Heart Association grant 11GRNT7590037 and summer research fellowship 13MSRF14940000 awarded to Dr. Lisa K. Jennings, and the Vascular Biology Support Fund at the University of Tennessee Health Science Center. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. CirQuest Labs, LLC. provided support in the form of salaries for authors MJH and LKJ, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Benink HA, 2005, J CELL BIOL, V168, P429, DOI 10.1083/jcb.200411109; Bi D, 2005, CIRC RES, V96, P890, DOI 10.1161/01.RES.0000163018.66460.85; Bishop AL, 2000, BIOCHEM J, V348, P241, DOI 10.1042/0264-6021:3480241; Carloni V, 2013, ONCOGENE, V32, P2649, DOI 10.1038/onc.2012.268; Charrin S, 2009, BIOCHEM J, V420, P133, DOI 10.1042/BJ20082422; Chen CN, 2006, P NATL ACAD SCI USA, V103, P2665, DOI 10.1073/pnas.0510973103; Churchman AT, 2009, J CELL MOL MED, V13, P2282, DOI 10.1111/j.1582-4934.2009.00874.x; Cook GA, 2002, BLOOD, V100, P4502, DOI 10.1182/blood.V100.13.4502; Costa P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074659; Delaguillaumie A, 2002, J CELL SCI, V115, P433; Eto Y, 2000, AM J PHYSIOL-HEART C, V278, pH1744, DOI 10.1152/ajpheart.2000.278.6.H1744; Flatau G, 1997, NATURE, V387, P729, DOI 10.1038/42743; Gu JG, 2001, J BIOL CHEM, V276, P27090, DOI 10.1074/jbc.M102284200; Hart MJ, 1998, SCIENCE, V280, P2112, DOI 10.1126/science.280.5372.2112; HEDIN U, 1988, J CELL BIOL, V107, P307, DOI 10.1083/jcb.107.1.307; Herr MJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067766; Hong IK, 2012, J BIOL CHEM, V287, P32027, DOI 10.1074/jbc.M111.314443; JENNINGS LK, 1990, J BIOL CHEM, V265, P3815; Johnson JL, 2009, J CELL SCI, V122, P2263, DOI 10.1242/jcs.045997; Kotha J, 2008, EXP CELL RES, V314, P1811, DOI 10.1016/j.yexcr.2008.01.024; Kotha J, 2009, ATHEROSCLEROSIS, V203, P377, DOI 10.1016/j.atherosclerosis.2008.07.036; Little KD, 2004, MOL BIOL CELL, V15, P2375, DOI 10.1091/mbc.E03-12-0886; Moiseeva EP, 2001, CARDIOVASC RES, V52, P372, DOI 10.1016/S0008-6363(01)00399-6; Novitskaya V., 2013, ONCOGENE; Orr AW, 2009, ARTERIOSCL THROM VAS, V29, P225, DOI 10.1161/ATVBAHA.108.178749; Owens GK, 2004, PHYSIOL REV, V84, P767, DOI 10.1152/physrev.00041.2003; Pickering JG, 2000, AM J PATHOL, V156, P453, DOI 10.1016/S0002-9440(10)64750-5; Powner D, 2011, BIOCHEM SOC T, V39, P563, DOI 10.1042/BST0390563; Ren XD, 1999, EMBO J, V18, P578, DOI 10.1093/emboj/18.3.578; Rensen SSM, 2007, NETH HEART J, V15, P100, DOI 10.1007/BF03085963; Sawada N, 2000, CIRCULATION, V101, P2030, DOI 10.1161/01.CIR.101.17.2030; Scherberich A, 1998, ARTERIOSCL THROM VAS, V18, P1691, DOI 10.1161/01.ATV.18.11.1691; Scherberich A, 2002, THROMB HAEMOSTASIS, V87, P1043, DOI 10.1055/s-0037-1613130; Schuliga M, 2013, AM J RESP CELL MOL, V48, P346, DOI 10.1165/rcmb.2012-0151OC; Shi W, 2000, J CELL BIOL, V148, P591, DOI 10.1083/jcb.148.3.591; Shields MA, 2012, J BIOL CHEM, V287, P6218, DOI 10.1074/jbc.M111.308940; Tang YF, 2010, J BIOL CHEM, V285, P17556, DOI 10.1074/jbc.M109.076414; Turlo KA, 2013, ARTERIOSCL THROM VAS, V33, P2325, DOI 10.1161/ATVBAHA.112.300648; Uehata M, 1997, NATURE, V389, P990, DOI 10.1038/40187; Wang L, 2010, CIRC RES, V106, P514, DOI 10.1161/CIRCRESAHA.109.202762; Yanez-Mo M, 2009, TRENDS CELL BIOL, V19, P434, DOI 10.1016/j.tcb.2009.06.004; Zhang F, 2009, CARDIOVASC RES, V83, P7, DOI 10.1093/cvr/cvp080; Zhang WW, 2012, J BIOL CHEM, V287, P33996, DOI 10.1074/jbc.M112.369603; Zhang XA, 2001, J BIOL CHEM, V276, P25005, DOI 10.1074/jbc.M102156200	44	11	11	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 3	2014	9	9							e106999	10.1371/journal.pone.0106999	http://dx.doi.org/10.1371/journal.pone.0106999			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3TB	25184334	Green Submitted, gold, Green Published			2022-12-27	WOS:000341257700133
J	Jia, XJ; Mi, SF; Wang, JZ; Qiao, WB; Peng, XW; Han, YJ				Jia, Xiaojing; Mi, Shuofu; Wang, Jinzhi; Qiao, Weibo; Peng, Xiaowei; Han, Yejun			Insight into Glycoside Hydrolases for Debranched Xylan Degradation from Extremely Thermophilic Bacterium Caldicellulosiruptor lactoaceticus	PLOS ONE			English	Article							CELLULASE-FREE XYLANASE; HIGHLY THERMOSTABLE XYLANASE; ALPHA-GLUCURONIDASE; BIOCHEMICAL-CHARACTERIZATION; SCHIZOPHYLLUM-COMMUNE; STRUCTURAL INSIGHTS; NEUTRAL XYLANASE; PURIFICATION; HYDROLYSIS; EXPRESSION	Caldicellulosiruptor lactoaceticus 6A, an anaerobic and extremely thermophilic bacterium, uses natural xylan as carbon source. The encoded genes of C. lactoaceticus 6A for glycoside hydrolase (GH) provide a platform for xylan degradation. The GH family 10 xylanase (Xyn10A) and GH67 alpha-glucuronidase (Agu67A) from C. lactoaceticus 6A were heterologously expressed, purified and characterized. Both Xyn10A and Agu67A are predicted as intracellular enzymes as no signal peptides identified. Xyn10A and Agu67A had molecular weight of 47.0 kDa and 80.0 kDa respectively as determined by SDS-PAGE, while both appeared as homodimer when analyzed by gel filtration. Xyn10A displayed the highest activity at 80 degrees C and pH 6.5, as 75 degrees C and pH 6.5 for Agu67A. Xyn10A had good stability at 75 degrees C, 80 degrees C, and pH 4.5-8.5, respectively, and was sensitive to various metal ions and reagents. Xyn10A possessed hydrolytic activity towards xylo-oligosaccharides (XOs) and beechwood xylan. At optimum conditions, the specific activity of Xyn10A was 44.6 IU/mg with beechwood xylan as substrate, and liberated branched XOs, xylobiose, and xylose. Agu67A was active on branched XOs with methyl-glucuronic acids (MeGlcA) sub-chains, and primarily generated XOs equivalents and MeGlcA. The specific activity of Agu67A was 1.3 IU/mg with aldobiouronic acid as substrate. The synergistic action of Xyn10A and Agu67A was observed with MeGlcA branched XOs and xylan as substrates, both backbone and branched chain of substrates were degraded, and liberated xylose, xylobiose, and MeGlcA. The synergism of Xyn10A and Agu67A provided not only a thermophilic method for natural xylan degradation, but also insight into the mechanisms for xylan utilization of C. lactoaceticus.	[Jia, Xiaojing; Mi, Shuofu; Qiao, Weibo; Peng, Xiaowei; Han, Yejun] Chinese Acad Sci, Natl Key Lab Biochem Engn, Inst Proc Engn, Beijing, Peoples R China; [Wang, Jinzhi] Chinese Acad Agr Sci, Inst Agrofood Sci & Technol, Beijing 100193, Peoples R China; [Qiao, Weibo] Shenyang Agr Univ, Coll Biosci & Biotechnol, Shenyang 110161, Peoples R China	Chinese Academy of Sciences; Institute of Process Engineering, CAS; Chinese Academy of Agricultural Sciences; Shenyang Agricultural University	Han, YJ (corresponding author), Chinese Acad Sci, Natl Key Lab Biochem Engn, Inst Proc Engn, Beijing, Peoples R China.	yejunhan09@gmail.com	Han, Yejun/AAC-7411-2019		National High Technology Research and Development Program of China (863 Project) [2014AA021905]; 100 Talents Program of Institute of Process Engineering, Chinese Academy of Sciences	National High Technology Research and Development Program of China (863 Project)(National High Technology Research and Development Program of China); 100 Talents Program of Institute of Process Engineering, Chinese Academy of Sciences	This work was funded by the National High Technology Research and Development Program of China (863 Project, No. 2014AA021905), and 100 Talents Program of Institute of Process Engineering, Chinese Academy of Sciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blumer-Schuette SE, 2011, J BACTERIOL, V193, P1483, DOI 10.1128/JB.01515-10; Choi ID, 2000, BIOSCI BIOTECH BIOCH, V64, P2530, DOI 10.1271/bbb.64.2530; Chong SL, 2011, APPL MICROBIOL BIOT, V90, P1323, DOI 10.1007/s00253-011-3157-y; Collins T, 2005, FEMS MICROBIOL REV, V29, P3, DOI 10.1016/j.femsre.2004.06.005; de Vries RP, 1998, J BACTERIOL, V180, P243, DOI 10.1128/JB.180.2.243-249.1998; Guo B, 2009, APPL MICROBIOL BIOT, V84, P1107, DOI 10.1007/s00253-009-2056-y; Han YJ, 2012, J BIOL CHEM, V287, P34946, DOI 10.1074/jbc.M112.391532; Hung KS, 2011, PROCESS BIOCHEM, V46, P1257, DOI 10.1016/j.procbio.2011.02.009; Jiang ZQ, 2005, ENZYME MICROB TECH, V36, P923, DOI 10.1016/j.enzmictec.2005.01.023; Kim DY, 2010, BIORESOURCE TECHNOL, V101, P8814, DOI 10.1016/j.biortech.2010.06.023; Kolenova K, 2006, J BIOTECHNOL, V121, P338, DOI 10.1016/j.jbiotec.2005.08.001; Kulkarni N, 1999, FEMS MICROBIOL REV, V23, P411, DOI 10.1111/j.1574-6976.1999.tb00407.x; Kumar V, 2013, EXTREMOPHILES, V17, P797, DOI 10.1007/s00792-013-0565-1; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LEVER M, 1972, ANAL BIOCHEM, V47, P273, DOI 10.1016/0003-2697(72)90301-6; Li LT, 2006, ENZYME MICROB TECH, V38, P780, DOI 10.1016/j.enzmictec.2005.08.007; Li XT, 2010, BIOCHEM ENG J, V52, P71, DOI 10.1016/j.bej.2010.07.006; Li XT, 2005, BIORESOURCE TECHNOL, V96, P1370, DOI 10.1016/j.biortech.2004.11.006; Luo HY, 2010, APPL MICROBIOL BIOT, V86, P1829, DOI 10.1007/s00253-009-2410-0; Manikandan K, 2006, PROTEIN SCI, V15, P1951, DOI 10.1110/ps.062220206; McPhillips K, 2014, APPL BIOCHEM BIOTECH, V172, P1747, DOI 10.1007/s12010-013-0640-1; MLADENOVSKA Z, 1995, ARCH MICROBIOL, V163, P223, DOI [10.1007/s002030050196, 10.1007/BF00305357]; Parkkinen T, 2004, ACTA CRYSTALLOGR D, V60, P542, DOI 10.1107/S0907444903029123; Pradeep GC, 2013, PROCESS BIOCHEM, V48, P1188, DOI 10.1016/j.procbio.2013.06.007; PULS J, 1987, ENZYME MICROB TECH, V9, P83, DOI 10.1016/0141-0229(87)90147-5; Ratanachomsri U, 2006, J BIOCHEM MOL BIOL, V39, P105; Ryabova O, 2009, FEBS LETT, V583, P1457, DOI 10.1016/j.febslet.2009.03.057; Sapre MP, 2005, J GEN APPL MICROBIOL, V51, P327, DOI 10.2323/jgam.51.327; Shi H, 2013, BIOTECHNOL BIOFUELS, V6, DOI 10.1186/1754-6834-6-26; Taibi Z, 2012, APPL BIOCHEM BIOTECH, V166, P663, DOI 10.1007/s12010-011-9457-y; Tenkanen M, 2000, J BIOTECHNOL, V78, P149, DOI 10.1016/S0168-1656(99)00240-0; Wang JS, 2011, WORLD J MICROB BIOT, V27, P207, DOI 10.1007/s11274-010-0445-0; WOOD PJ, 1988, METHOD ENZYMOL, V160, P59; Yeoman CJ, 2010, ADV APPL MICROBIOL, V70, P1, DOI 10.1016/S0065-2164(10)70001-0; Zaide G, 2001, EUR J BIOCHEM, V268, P3006, DOI 10.1046/j.1432-1327.2001.02193.x; Zhang JH, 2011, BIOTECHNOL BIOFUELS, V4, DOI 10.1186/1754-6834-4-12; Zheng F, 2013, J IND MICROBIOL BIOT, V40, P1083, DOI 10.1007/s10295-013-1312-4; Zheng J, 2013, BIOTECHNOL LETT, V35, P1433, DOI 10.1007/s10529-013-1220-8	38	13	15	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 3	2014	9	9							e106482	10.1371/journal.pone.0106482	http://dx.doi.org/10.1371/journal.pone.0106482			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3TB	25184498	gold, Green Submitted, Green Published			2022-12-27	WOS:000341257700078
J	Kowalewska, PM; Patrick, AL; Fox-Robichaud, AE				Kowalewska, Paulina M.; Patrick, Amanda L.; Fox-Robichaud, Alison E.			Syndecan-1 in the Mouse Parietal Peritoneum Microcirculation in Inflammation	PLOS ONE			English	Article							LEUKOCYTE-ENDOTHELIAL INTERACTIONS; NECROSIS-FACTOR-ALPHA; TOLL-LIKE RECEPTOR-4; HEPARAN-SULFATE; CELL-SURFACE; DIALYSIS; EXPRESSION; RECRUITMENT; GLYCOCALYX; GROWTH	Background: The heparan sulfate proteoglycan syndecan-1 (CD138) was shown to regulate inflammatory responses by binding chemokines and cytokines and interacting with adhesion molecules, thereby modulating leukocyte trafficking to tissues. The objectives of this study were to examine the expression of syndecan-1 and its role in leukocyte recruitment and chemokine presentation in the microcirculation underlying the parietal peritoneum. Methods: Wild-type BALB/c and syndecan-1 null mice were stimulated with an intraperitoneal injection of Staphylococcus aureus LTA, Escherichia coli LPS or TNF alpha and the microcirculation of the parietal peritoneum was examined by intravital microscopy after 4 hours. Fluorescence confocal microscopy was used to examine syndecan-1 expression in the peritoneal microcirculation using fluorescent antibodies. Blocking antibodies to adhesion molecules were used to examine the role of these molecules in leukocyte-endothelial cell interactions in response to LTA. To determine whether syndecan-1 co-localizes with chemokines in vivo, fluorescent antibodies to syndecan-1 were co-injected intravenously with anti-MIP-2 (CXCL2), anti-KC (CXCL1) or anti-MCP-1 (CCL2). Results and Conclusion: Syndecan-1 was localized to the subendothelial region of peritoneal venules and the mesothelial layer. Leukocyte rolling was significantly decreased with LPS treatment while LTA and TNFa significantly increased leukocyte adhesion compared with saline control. Leukocyte-endothelial cell interactions were not different in syndecan-1 null mice. Antibody blockade of beta(2) integrin (CD18), ICAM-1 (CD54) and VCAM-1 (CD106) did not decrease leukocyte adhesion in response to LTA challenge while blockade of P-selectin (CD62P) abrogated leukocyte rolling. Lastly, MIP-2 expression in the peritoneal venules was not dependent on syndecan-1 in vivo. Our data suggest that syndecan-1 is expressed in the parietal peritoneum microvasculature but does not regulate leukocyte recruitment and is not necessary for the presentation of the chemokine MIP-2 in this tissue.	[Kowalewska, Paulina M.] McMaster Univ, Med Sci Grad Program, Hamilton, ON, Canada; [Patrick, Amanda L.; Fox-Robichaud, Alison E.] McMaster Univ, Thrombosis & Atherosclerosis Res Inst, Hamilton, ON, Canada; [Patrick, Amanda L.; Fox-Robichaud, Alison E.] McMaster Univ, Dept Med, Hamilton, ON, Canada	McMaster University; McMaster University; McMaster University	Fox-Robichaud, AE (corresponding author), McMaster Univ, Thrombosis & Atherosclerosis Res Inst, Hamilton, ON, Canada.	afoxrob@mcmaster.ca			Baxter Corporation; Department of Medicine, McMaster University; Ontario Graduate Scholarship	Baxter Corporation; Department of Medicine, McMaster University; Ontario Graduate Scholarship(Ontario Graduate Scholarship)	The study was supported by Baxter Corporation and Internal Funding from the Department of Medicine, McMaster University. PMK was supported by the Ontario Graduate Scholarship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALBELDA SM, 1991, J CELL BIOL, V114, P1059, DOI 10.1083/jcb.114.5.1059; Alexander CM, 2000, NAT GENET, V25, P329, DOI 10.1038/77108; Andonegui G, 2003, J CLIN INVEST, V111, P1011, DOI 10.1172/JCI200316510; Carulli S, 2012, J BIOL CHEM, V287, P12204, DOI 10.1074/jbc.M111.300061; Chaudhary K, 2010, CLIN J AM SOC NEPHRO, V5, P723, DOI 10.2215/CJN.05720809; Chen Y, 2007, J BIOL CHEM, V282, P159, DOI 10.1074/jbc.M608542200; CizmeciSmith G, 1997, ARTERIOSCL THROM VAS, V17, P2609, DOI 10.1161/01.ATV.17.11.2609; Day RM, 2003, CYTOKINE, V21, P224, DOI 10.1016/S1043-4666(03)00091-7; Flessner MF, 2007, J AM SOC NEPHROL, V18, P2294, DOI 10.1681/ASN.2006121417; Flessner MF, 2010, PERITON DIALYSIS INT, V30, P284, DOI 10.3747/pdi.2009.00100; Fox-Robichaud A, 2000, HEPATOLOGY, V31, P1123, DOI 10.1053/he.2000.6961; Fresenius Medical Care, 2008, FRES MED CAR ANN REP; Gotte M, 2005, CURR EYE RES, V30, P417, DOI 10.1080/02713680590956289; Gotte M, 2002, INVEST OPHTH VIS SCI, V43, P1135; Hayashida A, 2011, J BIOL CHEM, V286, P3288, DOI 10.1074/jbc.M110.185165; Hayashida K, 2008, J BIOL CHEM, V283, P19895, DOI 10.1074/jbc.M801614200; Hayashida K, 2009, BLOOD, V114, P3033, DOI 10.1182/blood-2009-02-204966; Haynes A, 2005, INFECT IMMUN, V73, P7914, DOI 10.1128/IAI.73.12.7914-7921.2005; Haywood-Watson RJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023530; Johansson PI, 2011, ANN SURG, V254, P194, DOI 10.1097/SLA.0b013e318226113d; Kainulainen V, 1996, J BIOL CHEM, V271, P18759, DOI 10.1074/jbc.271.31.18759; KATO M, 1995, MOL BIOL CELL, V6, P559, DOI 10.1091/mbc.6.5.559; Kato S, 2004, J AM SOC NEPHROL, V15, P1289; Kavanagh D, 2004, NEPHROL DIAL TRANSPL, V19, P2584, DOI 10.1093/ndt/gfh386; Kowalewska PM, 2011, MICROCIRCULATION; Li QL, 2002, CELL, V111, P635, DOI 10.1016/S0092-8674(02)01079-6; Mactier R, 2009, PERITON DIALYSIS INT, V29, P262; Maday S, 2008, TRAFFIC, V9, P1915, DOI 10.1111/j.1600-0854.2008.00805.x; Marshall LJ, 2003, J IMMUNOL, V171, P2057, DOI 10.4049/jimmunol.171.4.2057; Masola V, 2012, J BIOL CHEM, V287, P1478, DOI 10.1074/jbc.M111.279836; Masouleh BK, 2009, J IMMUNOL, V182, P4985, DOI 10.4049/jimmunol.0800574; Massena S, 2010, BLOOD, V116, P1924, DOI 10.1182/blood-2010-01-266072; MIETTINEN HM, 1994, MOL BIOL CELL, V5, P1325, DOI 10.1091/mbc.5.12.1325; Oh JH, 2010, INT J GYNECOL CANCER, V20, P751, DOI 10.1111/IGC.0b013e3181e02faa; Park PW, 2004, J BIOL CHEM, V279, P251, DOI 10.1074/jbc.M308537200; Park PW, 2001, NATURE, V411, P98, DOI 10.1038/35075100; Patrick AL, 2007, AM J PHYSIOL-GASTR L, V293, pG663, DOI 10.1152/ajpgi.00070.2007; Pries AR, 2000, PFLUG ARCH EUR J PHY, V440, P653, DOI 10.1007/s004240000307; Rehm M, 2007, CIRCULATION, V116, P1896, DOI 10.1161/CIRCULATIONAHA.106.684852; Rops AL, 2007, KIDNEY INT, V72, P1204, DOI 10.1038/sj.ki.5002514; RUBIN J, 1987, J LAB CLIN MED, V110, P448; RUBIN J, 1986, AM J MED SCI, V292, P203, DOI 10.1097/00000441-198610000-00004; Rubin J, 1988, ASAIO Trans, V34, P912; RUBIN J, 1989, AM J MED SCI, V298, P383, DOI 10.1097/00000441-198912000-00005; SALMIVIRTA M, 1992, J BIOL CHEM, V267, P17606; SANANTONIO JD, 1994, GLYCOBIOLOGY, V4, P327; Savery MD, 2013, MICROVASC RES, V87, P83, DOI 10.1016/j.mvr.2013.02.001; Schellings MWM, 2010, HYPERTENSION, V55, P249, DOI 10.1161/HYPERTENSIONAHA.109.137885; Slimani H, 2003, GLYCOBIOLOGY, V13, P623, DOI 10.1093/glycob/cwg083; Spillmann D, 1998, J BIOL CHEM, V273, P15487, DOI 10.1074/jbc.273.25.15487; Stepp MA, 2002, J CELL SCI, V115, P4517, DOI 10.1242/jcs.00128; Stoler-Barak L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085699; Williams JD, 2002, J AM SOC NEPHROL, V13, P470, DOI 10.1681/ASN.V132470; Xu J, 2005, J IMMUNOL, V174, P5758, DOI 10.4049/jimmunol.174.9.5758; Yipp BG, 2002, J IMMUNOL, V168, P4650, DOI 10.4049/jimmunol.168.9.4650; Zarbock A, 2009, CURR TOP MICROBIOL, V334, P129, DOI 10.1007/978-3-540-93864-4_6; Zhang XL, 2013, J IMMUNOL, V191, P4551, DOI 10.4049/jimmunol.1300931	57	5	5	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 3	2014	9	9							e104537	10.1371/journal.pone.0104537	http://dx.doi.org/10.1371/journal.pone.0104537			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3TB	25184228	gold, Green Submitted, Green Published			2022-12-27	WOS:000341257700011
J	Potpara, TS; Polovina, MM; Djikic, D; Marinkovic, JM; Kocev, N; Lip, GYH				Potpara, Tatjana S.; Polovina, Marija M.; Djikic, Dijana; Marinkovic, Jelena M.; Kocev, Nikola; Lip, Gregory Y. H.			The Association of CHA(2)DS(2)-VASc Score and Blood Biomarkers with Ischemic Stroke Outcomes: The Belgrade Stroke Study	PLOS ONE			English	Article							RISK STRATIFICATION SCHEMES; CARDIAC TROPONIN-I; ATRIAL-FIBRILLATION PATIENTS; ACUTE CORONARY SYNDROMES; PREDICTING STROKE; NATIONWIDE COHORT; PROGNOSTIC VALUE; HEART-FAILURE; MORTALITY; CHADS(2)	Background: Many blood biomarkers have a positive association with stroke outcome, but adding blood biomarkers to the National Institutes of Health Stroke Scale (NIHSS) did not significantly improve its discriminatory ability. We investigated the association of the CHA(2)DS(2)-VASc score with unfavourable functional outcome (defined as a 30-day modified Rankin Scale [mRS] >= 3) in patients presenting with acute ischemic stroke (AIS), and examined whether the addition of blood biomarkers (troponin I [TnI], fibrinogen, C-reactive protein [CRP]) affects the model discriminatory ability. Methods: We conducted an observational single-centre study of consecutive patients with AIS. All patients were admitted to hospital within 24 hours from the neurological symptoms onset. Results: Of 240 patients (mean age 70.0 +/- 8.9 years), unfavourable 30-day outcome occurred in 92 (38.3%). Patients with mRS >= 3 were older and more likely to have atrial fibrillation or other comorbidities (all p < 0.001). They had higher levels of CRP, fibrinogen, TnI and higher CHA(2)DS(2)-VASc and CHADS(2) scores (all p < 0.05). The adjusted CHA(2)DS(2)-VASc score had excellent predictive ability for poor stroke outcome (c-statistic 0.982; 95% CI, 0.964-1.000, p < 0.001). Whilst CRP had the highest sensitivity (83.7%), cardiac TnI was the most specific (97.3%) for prediction of poor stroke outcome (cut-off: > 0.09 mu g/L). Compared with each of these biomarkers, CHA(2)DS(2)-VASc score had significantly better predictive ability for poor stroke outcome (c-statistic for CRP, Fibrinogen and TnI was 0.853; 95% CI, 0.802-0.895, 0.848; 95% CI, 0.796-0.891, and 0.792; 95% CI, 0.736-0.842, all p < 0.001, respectively, versus 0.932; 95% CI, 0.892-0.960, p < 0.001 for the CHA(2)DS(2)-VASc, all p for the comparisons, 0.01). There was no significant difference in the predictive ability of the CHA(2)DS(2)-VASc score vs. combinations of the CHA(2)DS(2)-VASc and TnI or TnI, fibrinogen and CRP (z statistic 0.369, p = 0.7119; integrated discrimination index 0.00801 and 0.00172, respectively, both p > 0.05). Conclusions: The CHA(2)DS(2)-VASc score alone reliably predicts 30-day unfavourable outcome of stroke. Adding blood biomarkers to the CHA(2)DS(2)-VASc score did not significantly increase the predictive ability of the model.	[Potpara, Tatjana S.; Lip, Gregory Y. H.] Univ Belgrade, Fac Med, Belgrade, Serbia; [Potpara, Tatjana S.; Polovina, Marija M.; Djikic, Dijana] Clin Ctr Serbia, Cardiol Clin, Belgrade, Serbia; [Djikic, Dijana] Univ Clin Ctr Gracanica, Kosovo, Serbia; [Marinkovic, Jelena M.; Kocev, Nikola] Univ Belgrade, Inst Med Stat & Informat, Belgrade, Serbia; [Lip, Gregory Y. H.] Univ Birmingham, Ctr Cardiovasc Sci, City Hosp, Birmingham, W Midlands, England	University of Belgrade; Clinical Centre of Serbia; University of Belgrade; University of Birmingham	Potpara, TS (corresponding author), Univ Belgrade, Fac Med, Belgrade, Serbia.	tanjapotpara@gmail.com						Agewall S, 2011, EUR HEART J, V32, P404, DOI 10.1093/eurheartj/ehq456; Antman EM, 1996, NEW ENGL J MED, V335, P1342, DOI 10.1056/NEJM199610313351802; Ay H, 2006, NEUROLOGY, V66, P1325, DOI 10.1212/01.wnl.0000206077.13705.6d; Camm AJ, 2012, EUROPACE, V14, P1385, DOI [10.1093/europace/eus305, 10.1093/eurheartj/ehs253]; CANDELISE L, 1995, LANCET, V346, P1509; Christensen H, 2004, CEREBROVASC DIS, V18, P194, DOI 10.1159/000079941; Counsell C, 2004, J NEUROL NEUROSUR PS, V75, P401, DOI 10.1136/jnnp.2003.018085; Deguchi I, 2013, J STROKE CEREBROVASC, V22, pE343, DOI 10.1016/j.jstrokecerebrovasdis.2013.02.018; DELONG ER, 1988, BIOMETRICS, V44, P837, DOI 10.2307/2531595; Di Angelantonio E, 2005, J NEUROL NEUROSUR PS, V76, P76, DOI 10.1136/jnnp.2004.041491; Dixit S, 2000, ARCH INTERN MED, V160, P3153, DOI 10.1001/archinte.160.20.3153; Easton JD, 2009, STROKE, V40, P2276, DOI 10.1161/STROKEAHA.108.192218; Faiz KW, 2014, J STROKE CEREBROVASC, V23, P241, DOI 10.1016/j.jstrokecerebrovasdis.2013.01.005; Fonarow GC, 2012, JAMA-J AM MED ASSOC, V308, P257, DOI 10.1001/jama.2012.7870; Freda BJ, 2002, J AM COLL CARDIOL, V40, P2065, DOI 10.1016/S0735-1097(02)02608-6; Giralt-Steinhauer E, 2012, J NEUROL, V259, P745, DOI 10.1007/s00415-011-6259-7; Hasan N, 2012, BRIT J CLIN PHARMACO, V74, P230, DOI 10.1111/j.1365-2125.2012.04212.x; Heuschmann PU, 2004, ARCH INTERN MED, V164, P1761, DOI 10.1001/archinte.164.16.1761; Hijazi Z, 2013, EUR HEART J, V34, P1475, DOI 10.1093/eurheartj/eht024; Hijazi Z, 2012, CIRCULATION, V125, P1605, DOI 10.1161/CIRCULATIONAHA.111.038729; Hommel M, 1996, NEW ENGL J MED, V335, P145; Horwich TB, 2003, CIRCULATION, V108, P833, DOI 10.1161/01.CIR.0000084543.79097.34; James P, 2000, BRIT MED J, V320, P1502, DOI 10.1136/bmj.320.7248.1502; Jensen JK, 2007, AM J CARDIOL, V99, P108, DOI 10.1016/j.amjcard.2006.07.071; Jeremias A, 2005, ANN INTERN MED, V142, P786, DOI 10.7326/0003-4819-142-9-200505030-00015; Kerr G, 2009, CEREBROVASC DIS, V28, P220, DOI 10.1159/000226773; Lip GYH, 2013, CEREBROVASC DIS, V36, P281, DOI 10.1159/000355981; Lip GYH, 2013, INT J CARDIOL, V168, P414, DOI 10.1016/j.ijcard.2012.09.148; Lip GYH, 2013, EUR HEART J, V34, P1041, DOI 10.1093/eurheartj/ehs435; Lip GYH, 2010, CHEST, V137, P263, DOI 10.1378/chest.09-1584; Mahajan VS, 2011, CIRCULATION, V124, P2350, DOI 10.1161/CIRCULATIONAHA.111.023697; Montaner J, 2012, CEREBROVASC DIS, V34, P240, DOI 10.1159/000341858; Ntaios G, 2013, NEUROLOGY, V80, P1009, DOI 10.1212/WNL.0b013e318287281b; Olesen JB, 2012, THROMB HAEMOSTASIS, V107, P1172, DOI 10.1160/TH12-03-0175; Olesen JB, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d124; Omland T, 2009, NEW ENGL J MED, V361, P2538, DOI 10.1056/NEJMoa0805299; Pencina MJ, 2008, STAT MED, V27, P207, DOI 10.1002/sim.3106; Perini AP, 2014, EUROPACE, V16, P71, DOI 10.1093/europace/eut190; Potpara TS, 2012, CIRC-ARRHYTHMIA ELEC, V5, P319, DOI 10.1161/CIRCEP.111.966713; Salat D, 2013, CEREBROVASC DIS, V35, P220, DOI 10.1159/000346591; Scheitz JF, 2011, BMC NEUROL, V11, DOI 10.1186/1471-2377-11-98; Smith EE, 2010, CIRCULATION, V122, P1496, DOI 10.1161/CIRCULATIONAHA.109.932822; Tu HTH, 2013, CEREBROVASC DIS, V36, P273, DOI 10.1159/000353670; van Staa TP, 2011, J THROMB HAEMOST, V9, P39, DOI 10.1111/j.1538-7836.2010.04085.x; VANSWIETEN JC, 1988, STROKE, V19, P604, DOI 10.1161/01.STR.19.5.604; Weimar C, 2004, STROKE, V35, P158, DOI 10.1161/01.STR.0000106761.94985.8B; Whiteley W, 2012, STROKE, V43, P86, DOI 10.1161/STROKEAHA.111.634089; Whiteley W, 2009, STROKE, V40, pE380, DOI 10.1161/STROKEAHA.108.528752	48	15	17	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 3	2014	9	9							e106439	10.1371/journal.pone.0106439	http://dx.doi.org/10.1371/journal.pone.0106439			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3TB	25184809	Green Published, Green Submitted, gold			2022-12-27	WOS:000341257700073
J	Ratzinger, F; Dedeyan, M; Rammerstorfer, M; Perkmann, T; Burgmann, H; Makristathis, A; Dorffner, G; Lotsch, F; Blacky, A; Ramharter, M				Ratzinger, Franz; Dedeyan, Michel; Rammerstorfer, Matthias; Perkmann, Thomas; Burgmann, Heinz; Makristathis, Athanasios; Dorffner, Georg; Loetsch, Felix; Blacky, Alexander; Ramharter, Michael			A Risk Prediction Model for Screening Bacteremic Patients: A Cross Sectional Study	PLOS ONE			English	Article							OPERATING CHARACTERISTIC CURVES; BLOOD CULTURE CONTAMINATION; POPULATION-BASED ASSESSMENT; ONE-DEPENDENCE ESTIMATORS; ADULT PATIENTS; EMERGENCY-DEPARTMENT; ACQUIRED BACTEREMIA; COST-EFFECTIVENESS; STREAM INFECTIONS; NAIVE BAYES	Background: Bacteraemia is a frequent and severe condition with a high mortality rate. Despite profound knowledge about the pre-test probability of bacteraemia, blood culture analysis often results in low rates of pathogen detection and therefore increasing diagnostic costs. To improve the cost-effectiveness of blood culture sampling, we computed a risk prediction model based on highly standardizable variables, with the ultimate goal to identify via an automated decision support tool patients with very low risk for bacteraemia. Methods: In this retrospective hospital-wide cohort study evaluating 15,985 patients with suspected bacteraemia, 51 variables were assessed for their diagnostic potency. A derivation cohort (n = 14.699) was used for feature and model selection as well as for cut-off specification. Models were established using the A2DE classifier, a supervised Bayesian classifier. Two internally validated models were further evaluated by a validation cohort (n = 1,286). Results: The proportion of neutrophile leukocytes in differential blood count was the best individual variable to predict bacteraemia (ROC-AUC: 0.694). Applying the A2DE classifier, two models, model 1 (20 variables) and model 2 (10 variables) were established with an area under the receiver operating characteristic curve (ROC-AUC) of 0.767 and 0.759, respectively. In the validation cohort, ROC-AUCs of 0.800 and 0.786 were achieved. Using predefined cut-off points, 16% and 12% of patients were allocated to the low risk group with a negative predictive value of more than 98.8%. Conclusion: Applying the proposed models, more than ten percent of patients with suspected blood stream infection were identified having minimal risk for bacteraemia. Based on these data the application of this model as an automated decision support tool for physicians is conceivable leading to a potential increase in the cost-effectiveness of blood culture sampling. External prospective validation of the model's generalizability is needed for further appreciation of the usefulness of this tool.	[Ratzinger, Franz; Perkmann, Thomas] Med Univ Vienna, Dept Lab Med, Div Med & Chem Lab Diagnost, Vienna, Austria; [Dedeyan, Michel; Rammerstorfer, Matthias; Burgmann, Heinz; Loetsch, Felix; Ramharter, Michael] Med Univ Vienna, Div Infect Dis & Trop Med, Dept Med 1, Vienna, Austria; [Makristathis, Athanasios] Med Univ Vienna, Dept Lab Med, Div Clin Microbiol, Vienna, Austria; [Dorffner, Georg] Med Univ Vienna, Sect Artificial Intelligence, Ctr Med Stat Informat & Intelligent Syst, Vienna, Austria; [Blacky, Alexander] Med Univ Vienna, Clin Inst Hosp Hyg, Vienna, Austria; [Ramharter, Michael] Univ Tubingen, Inst Tropenmed, Tubingen, Germany	Medical University of Vienna; Medical University of Vienna; Medical University of Vienna; Medical University of Vienna; Medical University of Vienna; Eberhard Karls University of Tubingen	Ramharter, M (corresponding author), Med Univ Vienna, Div Infect Dis & Trop Med, Dept Med 1, Vienna, Austria.	michael.ramharter@meduniwien.ac.at	Perkmann, Thomas/F-3074-2012; Dorffner, Georg/AAQ-1455-2020; Ramharter, Michael/C-5273-2013	Lotsch, Felix/0000-0002-6938-9523; Dorffner, Georg/0000-0002-3181-2576; Ramharter, Michael/0000-0002-9259-1885; Perkmann, Thomas/0000-0002-7976-0285; Burgmann, Heinz/0000-0002-2114-0999; Ratzinger, Franz/0000-0002-1910-1018				Akobeng AK, 2007, ACTA PAEDIATR, V96, P644, DOI 10.1111/j.1651-2227.2006.00178.x; Alahmadi YM, 2011, J HOSP INFECT, V77, P233, DOI 10.1016/j.jhin.2010.09.033; [Anonymous], 2005, P 22 INT C MACH LEAR; BATES DW, 1990, ANN INTERN MED, V113, P495, DOI 10.7326/0003-4819-113-7-495; Bates DW, 1997, J INFECT DIS, V176, P1538, DOI 10.1086/514153; BATES DW, 1991, JAMA-J AM MED ASSOC, V265, P365, DOI 10.1001/jama.265.3.365; Bearman GML, 2005, ARCH MED RES, V36, P646, DOI 10.1016/j.arcmed.2005.02.005; Carpenter J, 2000, STAT MED, V19, P1141, DOI 10.1002/(SICI)1097-0258(20000515)19:9<1141::AID-SIM479>3.0.CO;2-F; Coburn B, 2012, JAMA-J AM MED ASSOC, V308, P502, DOI 10.1001/jama.2012.8262; De Ferrari L, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-277; DELONG ER, 1988, BIOMETRICS, V44, P837, DOI 10.2307/2531595; Fluss R, 2005, BIOMETRICAL J, V47, P458, DOI 10.1002/bimj.200410135; Garcia-Jimenez B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009969; Hall KK, 2006, CLIN MICROBIOL REV, V19, P788, DOI 10.1128/CMR.00062-05; Hall M.A, 1999, CORRELATION BASED FE; HANLEY JA, 1983, RADIOLOGY, V148, P839, DOI 10.1148/radiology.148.3.6878708; Jaimes F, 2004, CLIN INFECT DIS, V38, P357, DOI 10.1086/380967; Jin SJ, 2013, SCAND J INFECT DIS, V45, P672, DOI 10.3109/00365548.2013.799287; Kohavi R, 1997, ARTIF INTELL, V97, P273, DOI 10.1016/S0004-3702(97)00043-X; Kundu S, 2011, EUR J EPIDEMIOL, V26, P261, DOI 10.1007/s10654-011-9567-4; Kuppermann N, 1998, ANN EMERG MED, V31, P679, DOI 10.1016/S0196-0644(98)70225-2; Kurz DJ, 2009, HEART, V95, P662, DOI 10.1136/hrt.2008.145904; Lark RL, 2001, DIAGN MICR INFEC DIS, V41, P15, DOI 10.1016/S0732-8893(01)00284-X; Laupland KB, 2013, EPIDEMIOL INFECT, V141, P2149, DOI 10.1017/S0950268812002725; Laupland KB, 2002, CRIT CARE MED, V30, P2462, DOI 10.1097/00003246-200211000-00010; Lee CC, 2012, DIAGN MICR INFEC DIS, V73, P168, DOI 10.1016/j.diagmicrobio.2012.02.009; Liao L, 2003, J AM COLL CARDIOL, V42, P851, DOI 10.1016/S0735-1097(03)00836-2; Little JR, 1997, INFECT CONT HOSP EP, V18, P200; Moonesinghe SR, 2013, ANESTHESIOLOGY, V119, P959, DOI 10.1097/ALN.0b013e3182a4e94d; Nakamura T, 2006, J EVAL CLIN PRACT, V12, P692, DOI 10.1111/j.1365-2753.2006.00637.x; Perl B, 1999, CLIN INFECT DIS, V29, P1483, DOI 10.1086/313525; PFITZENMEYER P, 1995, J AM GERIATR SOC, V43, P230, DOI 10.1111/j.1532-5415.1995.tb07327.x; Pien BC, 2010, AM J MED, V123, P819, DOI 10.1016/j.amjmed.2010.03.021; Qamruddin A, 2008, J CLIN PATHOL, V61, P509, DOI 10.1136/jcp.2007.047647; Raoult D, 2010, J EMERG MED, V39, P501, DOI 10.1016/j.jemermed.2009.01.019; Robin X, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-77; Roth A, 2010, J CLIN MICROBIOL, V48, P4552, DOI 10.1128/JCM.00877-10; Shapiro NI, 2008, J EMERG MED, V35, P255, DOI 10.1016/j.jemermed.2008.04.001; Shapiro NI, 2010, J EMERG MED, V39, P501, DOI 10.1016/j.jemermed.2010.03.002; Su CP, 2011, J MICROBIOL IMMUNOL, V44, P449, DOI 10.1016/j.jmii.2011.04.006; Tudela P, 2010, MED CLIN-BARCELONA, V135, P685, DOI 10.1016/j.medcli.2010.04.009; van der Heijden YF, 2011, INFECT CONT HOSP EP, V32, P623, DOI 10.1086/660096; Webb GI, 2012, MACH LEARN, V86, P233, DOI 10.1007/s10994-011-5263-6; Webb GI, 2005, MACH LEARN, V58, P5, DOI 10.1007/s10994-005-4258-6; Yoshida T, 2005, INTERNAL MED, V44, P1157, DOI 10.2169/internalmedicine.44.1157; Zaidi Nayyar A., 2013, Advances in Knowledge Discovery and Data Mining. 17th Pacific-Asia Conference, PAKDD 2013. Proceedings, P149, DOI 10.1007/978-3-642-37453-1_13; Zheng F, 2007, LECT NOTES ARTIF INT, V4701, P490; Zwang O, 2006, J HOSP MED, V1, P272, DOI 10.1002/jhm.115	48	13	13	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 3	2014	9	9							e106765	10.1371/journal.pone.0106765	http://dx.doi.org/10.1371/journal.pone.0106765			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3TB	25184209	Green Submitted, gold, Green Published			2022-12-27	WOS:000341257700116
J	Hughes, VA; Meklemburg, R; Bottomley, SP; Wintrode, PL				Hughes, Victoria A.; Meklemburg, Robert; Bottomley, Stephen P.; Wintrode, Patrick L.			The Z Mutation Alters the Global Structural Dynamics of alpha(1)-Antitrypsin	PLOS ONE			English	Article							EXCHANGE-MASS-SPECTROMETRY; HYDROGEN-EXCHANGE; SERPIN POLYMERIZATION; ALPHA-1-ANTITRYPSIN; MECHANISM; DISEASE; CONFORMATION; DEFICIENCY	alpha(1)-Antitrypsin (alpha(1)AT) deficiency, the most common serpinopathy, results in both emphysema and liver disease. Over 90% of all clinical cases of alpha(1)AT deficiency are caused by the Z variant in which Glu342, located at the top of s5A, is replaced by a Lys which results in polymerization both in vivo and in vitro. The Glu342Lys mutation removes a salt bridge and a hydrogen bond but does not effect the thermodynamic stability of Z alpha(1)AT compared to the wild type protein, M alpha(1)AT, and so it is unclear why Z alpha(1)AT has an increased polymerization propensity. We speculated that the loss of these interactions would make the native state of Z alpha(1)AT more dynamic than M alpha(1)AT and that this change renders the protein more polymerization prone. We have used hydrogen/deuterium exchange combined with mass spectrometry (HXMS) to determine the structural and dynamic differences between native Z and M alpha(1)AT to reveal the molecular basis of Z alpha(1)AT polymerization. Our HXMS data shows that the Z mutation significantly perturbs the region around the site of mutation. Strikingly the Z mutation also alters the dynamics of regions distant to the mutation such as the B, D and I helices and specific regions of each beta-sheet. These changes in global dynamics may lead to an increase in the likelihood of Z alpha(1)AT sampling a polymerogenic structure thereby causing disease.	[Hughes, Victoria A.; Bottomley, Stephen P.] Monash Univ, Dept Biochem & Mol Biol, Clayton, Vic, Australia; [Meklemburg, Robert; Wintrode, Patrick L.] Univ Maryland, Sch Pharm, Dept Pharmaceut Sci, Baltimore, MD 21201 USA	Monash University; University System of Maryland; University of Maryland Baltimore	Wintrode, PL (corresponding author), Univ Maryland, Sch Pharm, Dept Pharmaceut Sci, Baltimore, MD 21201 USA.	pwintrode@rx.umaryland.edu			National Health and Medical Research Council (NHMRC)	National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia)	This work was funded by the The National Health and Medical Research Council (NHMRC) (Aus). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baek JH, 2009, MOL CELL PROTEOMICS, V8, P1072, DOI 10.1074/mcp.M800365-MCP200; BAI YW, 1993, PROTEINS, V17, P75, DOI 10.1002/prot.340170110; Blanco I, 2001, CLIN GENET, V60, P31, DOI 10.1034/j.1399-0004.2001.600105.x; Cabrita LD, 2004, BIOCHEMISTRY-US, V43, P9834, DOI 10.1021/bi0491346; Chang WSW, 1996, BIOCHEM J, V314, P647, DOI 10.1042/bj3140647; Deng YZ, 1999, ANAL BIOCHEM, V276, P150, DOI 10.1006/abio.1999.4347; Elliott PR, 1998, J MOL BIOL, V275, P419, DOI 10.1006/jmbi.1997.1458; Fregonese L, 2008, ORPHANET J RARE DIS, V3, DOI 10.1186/1750-1172-3-16; Gooptu B, 2009, ANNU REV BIOCHEM, V78, P147, DOI 10.1146/annurev.biochem.78.082107.133320; James EL, 1998, ARCH BIOCHEM BIOPHYS, V356, P296, DOI 10.1006/abbi.1998.0751; Kass I, 2012, BIOPHYS J, V102, P2856, DOI 10.1016/j.bpj.2012.05.023; Knaupp AS, 2011, J MOL BIOL, V413, P888, DOI 10.1016/j.jmb.2011.09.013; Knaupp AS, 2010, J MOL BIOL, V396, P375, DOI 10.1016/j.jmb.2009.11.048; Knaupp AS, 2009, IUBMB LIFE, V61, P1, DOI 10.1002/iub.127; Krishnan B, 2011, NAT STRUCT MOL BIOL, V18, P222, DOI 10.1038/nsmb.1976; Levina V, 2009, PROTEIN EXPRES PURIF, V68, P226, DOI 10.1016/j.pep.2009.06.011; LOMAS DA, 1993, BIOCHEMISTRY-US, V32, P500, DOI 10.1021/bi00053a014; LOMAS DA, 1992, NATURE, V357, P605, DOI 10.1038/357605a0; Mahadeva R, 2002, J BIOL CHEM, V277, P6771, DOI 10.1074/jbc.C100722200; Tew DJ, 2001, J MOL BIOL, V313, P1161, DOI 10.1006/jmbi.2001.5104; Tsutsui Y, 2008, J BIOL CHEM, V283, P30804, DOI 10.1074/jbc.M804048200; Tsutsui Y, 2006, BIOCHEMISTRY-US, V45, P6561, DOI 10.1021/bi060431f; Wales TE, 2006, MASS SPECTROM REV, V25, P158, DOI 10.1002/mas.20064; YU MH, 1995, NAT STRUCT BIOL, V2, P363, DOI 10.1038/nsb0595-363	24	12	14	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2014	9	9							e102617	10.1371/journal.pone.0102617	http://dx.doi.org/10.1371/journal.pone.0102617			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3LR	25181470	Green Submitted, Green Published, gold			2022-12-27	WOS:000341231500005
J	Arya, GC; Kumar, R; Bisht, NC				Arya, Gulab C.; Kumar, Roshan; Bisht, Naveen C.			Evolution, Expression Differentiation and Interaction Specificity of Heterotrimeric G-Protein Subunit Gene Family in the Mesohexaploid Brassica rapa	PLOS ONE			English	Article							ALPHA-SUBUNIT; NECROTROPHIC PATHOGENS; GAMMA-SUBUNITS; ARABIDOPSIS; ACID; DIVERSITY; ROLES; DEP1; SEED; POLYPLOIDY	Heterotrimeric G-proteins, comprising of G alpha, G beta, and G gamma subunits, are important signal transducers which regulate many aspects of fundamental growth and developmental processes in all eukaryotes. Initial studies in model plants Arabidopsis and rice suggest that the repertoire of plant G-protein is much simpler than that observed in metazoans. In order to assess the consequence of whole genome triplication events within Brassicaceae family, we investigated the multiplicity of G-protein subunit genes in mesohexaploid Brassica rapa, a globally important vegetable and oilseed crop. We identified one G alpha (Br alpha A.G beta 1), three G beta (Br alpha A.G beta 1, Br alpha A.G beta 2, and Br alpha A.G beta 3), and five G gamma (Br alpha A.G gamma 1, Br alpha A.G gamma 2, Br alpha A.G gamma 3, Br alpha A.G gamma 4, and Br alpha A.G gamma 5) genes from B. rapa, with a possibility of 15 G alpha beta gamma heterotrimer combinations. Our analysis suggested that the process of genome triplication coupled with gene-loss (gene-fractionation) phenomenon have shaped the quantitative and sequence diversity of G-protein subunit genes in the extant B. rapa genome. Detailed expression analysis using qRT-PCR assays revealed that the G-protein genes have retained ubiquitous but distinct expression profiles across plant development. The expression of multiple G-protein genes was differentially regulated during seed-maturation and germination stages, and in response to various phytohormone treatments and stress conditions. Yeast-based interaction analysis showed that G-protein subunits interacted in most of the possible combinations, with some degree of subunit-specific interaction specificity, to control the functional selectivity of G-protein heterotrimer in different cell and tissue-types or in response to different environmental conditions. Taken together, this research identifies a highly diverse G-protein signaling network known to date from B. rapa, and provides a clue about the possible complexity of G-protein signaling networks present across globally important Brassica species.	[Arya, Gulab C.; Kumar, Roshan; Bisht, Naveen C.] Natl Inst Plant Genome Res, New Delhi, India	Department of Biotechnology (DBT) India; National Institute of Plant Genome Research (NIPGR)	Bisht, NC (corresponding author), Natl Inst Plant Genome Res, New Delhi, India.	ncbisht@nipgr.ac.in	Arya, Gulab Chand/GRE-9108-2022	Arya, Gulab Chand/0000-0001-5222-0601; Kumar, Roshan/0000-0002-0346-9125	National Institute of Plant Genome Research, India; Council of Scientific and Industrial Research (CSIR, India); University Grant Commission (UGC, India)	National Institute of Plant Genome Research, India; Council of Scientific and Industrial Research (CSIR, India)(Council of Scientific & Industrial Research (CSIR) - India); University Grant Commission (UGC, India)(University Grants Commission, India)	This work was supported by the core research grant from National Institute of Plant Genome Research, India. GCA and RK were supported by a Junior Research Fellowship from Council of Scientific and Industrial Research (CSIR, India) and University Grant Commission (UGC, India), respectively. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson DJ, 2007, PLANT CELL REP, V26, P1469, DOI 10.1007/s00299-007-0356-1; Ashikari M, 1999, P NATL ACAD SCI USA, V96, P10284, DOI 10.1073/pnas.96.18.10284; Augustine R, 2013, J EXP BOT, V64, P4907, DOI 10.1093/jxb/ert280; Bisht NC, 2011, NEW PHYTOL, V190, P35, DOI 10.1111/j.1469-8137.2010.03581.x; Cabrera-Vera TM, 2003, ENDOCR REV, V24, P765, DOI 10.1210/er.2000-0026; Chandna R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036918; Chen JG, 2006, PLANT PHYSIOL, V141, P887, DOI 10.1104/pp.106.079202; Chen Y, 2006, PLANT PHYSIOL, V140, P302, DOI 10.1104/pp.105.069872; Chen YL, 2004, PLANT PHYSIOL, V136, P4096, DOI 10.1104/pp.104.047837; Cheng F, 2013, PLANT CELL, V25, P1541, DOI 10.1105/tpc.113.110486; Cheng F, 2012, FRONT PLANT SCI, V3, DOI 10.3389/fpls.2012.00198; Choudhury SR, 2014, PLANT BIOTECHNOL J, V12, P49, DOI 10.1111/pbi.12115; Choudhury SR, 2013, PLANT PHYSIOL, V162, P522, DOI 10.1104/pp.113.215400; Choudhury SR, 2012, PLANT SIGNAL BEHAV, V7, P1114, DOI 10.4161/psb.21298; Choudhury SR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023361; Flagel LE, 2009, NEW PHYTOL, V183, P557, DOI 10.1111/j.1469-8137.2009.02923.x; Fujisawa Y, 1999, P NATL ACAD SCI USA, V96, P7575, DOI 10.1073/pnas.96.13.7575; Gao Y, 2010, MOL BIOL REP, V37, P3957, DOI 10.1007/s11033-010-0054-x; Gao Y, 2010, PLANT MOL BIOL REP, V28, P450, DOI 10.1007/s11105-009-0169-1; Huang XZ, 2009, NAT GENET, V41, P494, DOI 10.1038/ng.352; Izawa Y, 2010, PLANT CELL PHYSIOL, V51, P271, DOI 10.1093/pcp/pcp186; Koch MA, 2000, MOL BIOL EVOL, V17, P1483, DOI 10.1093/oxfordjournals.molbev.a026248; Kunihiro S, 2013, J EXP BOT, V64, P4517, DOI 10.1093/jxb/ert267; Lease KA, 2001, PLANT CELL, V13, P2631, DOI 10.1105/tpc.13.12.2631; Li SJ, 2012, PLANT SIGNAL BEHAV, V7, P1357, DOI 10.4161/psb.21620; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Liu SL, 2010, MOL BIOL EVOL, V27, P2817, DOI 10.1093/molbev/msq169; Liu ZL, 2007, CURR BIOL, V17, P1669, DOI 10.1016/j.cub.2007.08.030; Mun JH, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-10-r111; Nilson SE, 2010, NEW PHYTOL, V185, P734, DOI 10.1111/j.1469-8137.2009.03120.x; Obrdlik P, 2004, P NATL ACAD SCI USA, V101, P12242, DOI 10.1073/pnas.0404467101; Oki K, 2005, PLANT CELL PHYSIOL, V46, P381, DOI 10.1093/pcp/pci036; Ostergaard L, 2008, PLANT METHODS, V4, DOI 10.1186/1746-4811-4-10; Pandey S, 2006, PLANT PHYSIOL, V141, P243, DOI 10.1104/pp.106.079038; Panjabi P, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-113; Perfus-Barbeoch L, 2004, CURR OPIN PLANT BIOL, V7, P719, DOI 10.1016/j.pbi.2004.09.013; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Temple BRS, 2007, ANNU REV PLANT BIOL, V58, P249, DOI 10.1146/annurev.arplant.58.032806.103827; Trusov Y, 2006, PLANT PHYSIOL, V140, P210, DOI 10.1104/pp.105.069625; Trusov Y, 2007, PLANT CELL, V19, P1235, DOI 10.1105/tpc.107.050096; Trusov Yuri, 2012, BMC Res Notes, V5, P608, DOI 10.1186/1756-0500-5-608; Trusov Y, 2009, PLANT J, V58, P69, DOI 10.1111/j.1365-313X.2008.03755.x; U. N., 1935, Japanese Journal of Botany, V7, P389; Ullah H, 2002, PLANT PHYSIOL, V129, P897, DOI 10.1104/pp.005017; Ullah H, 2001, SCIENCE, V292, P2066, DOI 10.1126/science.1059040; Urano D, 2013, OPEN BIOL, V3, DOI 10.1098/rsob.120186; Urano D, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002756; Wang XW, 2011, NAT GENET, V43, P1035, DOI 10.1038/ng.919; Wang XQ, 2001, SCIENCE, V292, P2070, DOI 10.1126/science.1059046; Warpeha KM, 2008, PLANT CELL ENVIRON, V31, P1756, DOI 10.1111/j.1365-3040.2008.01878.x; WARPEHA KMF, 1991, P NATL ACAD SCI USA, V88, P8925, DOI 10.1073/pnas.88.20.8925	51	14	15	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2014	9	9							e105771	10.1371/journal.pone.0105771	http://dx.doi.org/10.1371/journal.pone.0105771			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ1IR	25191920	gold, Green Submitted, Green Published			2022-12-27	WOS:000347993600008
J	Campilongo, R; Di Martino, ML; Marcocci, L; Pietrangeli, P; Leuzzi, A; Grossi, M; Casalino, M; Nicoletti, M; Micheli, G; Colonna, B; Prosseda, G				Campilongo, Rosaria; Di Martino, Maria Letizia; Marcocci, Lucia; Pietrangeli, Paola; Leuzzi, Adriano; Grossi, Milena; Casalino, Mariassunta; Nicoletti, Mauro; Micheli, Gioacchino; Colonna, Bianca; Prosseda, Gianni			Molecular and Functional Profiling of the Polyamine Content in Enteroinvasive E. coli: Looking into the Gap between Commensal E. coli and Harmful Shigella	PLOS ONE			English	Article							VIRULENCE GENE ICSA; ESCHERICHIA-COLI; CONVERGENT EVOLUTION; H-NS; SPP.; PATHOGENICITY; PROMOTER; SEQUENCE; FLEXNERI; ORIGINS	Polyamines are small molecules associated with a wide variety of physiological functions. Bacterial pathogens have developed subtle strategies to exploit polyamines or manipulate polyamine-related processes to optimize fitness within the host. During the transition from its innocuous E. coli ancestor, Shigella, the aetiological agent of bacillary dysentery, has undergone drastic genomic rearrangements affecting the polyamine profile. A pathoadaptation process involving the speG gene and the cad operon has led to spermidine accumulation and loss of cadaverine. While a higher spermidine content promotes the survival of Shigella within infected macrophages, the lack of cadaverine boosts the pathogenic potential of the bacterium in host tissues. Enteroinvasive E. coli (EIEC) display the same pathogenicity process as Shigella, but have a higher infectious dose and a higher metabolic activity. Pathoadaption events affecting the cad locus have occurred also in EIEC, silencing cadaverine production. Since EIEC are commonly regarded as evolutionary intermediates between E. coli and Shigella, we investigated on their polyamine profile in order to better understand which changes have occurred along the path to pathogenicity. By functional and molecular analyses carried out in EIEC strains belonging to different serotypes, we show that speG has been silenced in one strain only, favouring resistance to oxidative stress conditions and survival within macrophages. At the same time, we observe that the content of spermidine and putrescine, a relevant intermediate in the synthesis of spermidine, is higher in all strains as compared to E. coli. This may represent an evolutionary response to the lack of cadaverine. Indeed, restoring cadaverine synthesis decreases the expression of the speC gene, whose product affects putrescine production. In the light of these results, we discuss the possible impact of pathoadaptation events on the evolutionary emergence of a polyamine profile favouring to the pathogenic lifestyle of Shigella and EIEC.	[Campilongo, Rosaria; Di Martino, Maria Letizia; Leuzzi, Adriano; Grossi, Milena; Colonna, Bianca; Prosseda, Gianni] Univ Roma La Sapienza, Dipartimento Biol & Biotecnol C Darwin, Ist Pasteur Fdn Cenci Bolognetti, I-00185 Rome, Italy; [Di Martino, Maria Letizia; Casalino, Mariassunta] Univ Roma Tre, Dipartimento Sci, Rome, Italy; [Marcocci, Lucia; Pietrangeli, Paola] Univ Roma La Sapienza, Dipartimento Biochim, I-00185 Rome, Italy; [Nicoletti, Mauro] Univ G DAnnunzio, Dipartimento Sci Sperimentali & Clin, Chieti, Italy; [Micheli, Gioacchino] CNR, Ist Biol Med Mol & NanoBiotecnol, Rome, Italy	Fondazione Cenci Bolognetti; Sapienza University Rome; Roma Tre University; Sapienza University Rome; G d'Annunzio University of Chieti-Pescara; Consiglio Nazionale delle Ricerche (CNR)	Prosseda, G (corresponding author), Univ Roma La Sapienza, Dipartimento Biol & Biotecnol C Darwin, Ist Pasteur Fdn Cenci Bolognetti, Piazzale Aldo Moro 5, I-00185 Rome, Italy.	gianni.prosseda@uniroma1.it	Micheli, Gioacchino/G-5797-2013; Di Martino, Maria Letizia/L-7066-2019; Nicoletti, Mauro/AAI-7702-2020	Micheli, Gioacchino/0000-0002-4133-8492; Di Martino, Maria Letizia/0000-0002-9491-4000; Marcocci, Lucia/0000-0003-2301-7166; PROSSEDA, Gianni/0000-0001-5235-0086; Campilongo, Rosaria/0000-0003-4319-5453	Istituto Pasteur Fondazione Cenci Bolognetti; Universita Roma Tre; Ministero della Ricerca e dell'Istruzione [PRIN 2012/WWJSX8K]; Ministero della Ricerca e dell'Istruzione (FIRB); Sapienza Universita di Roma	Istituto Pasteur Fondazione Cenci Bolognetti(Istituto Pasteur Italia Fondazione Cenci Bolognetti); Universita Roma Tre; Ministero della Ricerca e dell'Istruzione; Ministero della Ricerca e dell'Istruzione (FIRB); Sapienza Universita di Roma	RC is supported by fellowships of the Istituto Pasteur Fondazione Cenci Bolognetti. MLDM was supported by a post-doc grant from Universita Roma Tre. This work was supported by grants from Ministero della Ricerca e dell'Istruzione (PRIN 2012/WWJSX8K and FIRB), and by grants of Sapienza Universita di Roma. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barbagallo M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027226; Bliven KA, 2012, INFECT IMMUN, V80, P4061, DOI 10.1128/IAI.00740-12; Casalino M, 2005, INT J MED MICROBIOL, V294, P503, DOI 10.1016/j.ijmm.2004.11.001; Casalino M, 2003, INFECT IMMUN, V71, P5472, DOI 10.1128/IAI.71.10.5472-5479.2003; Casalino M, 2010, INT J MED MICROBIOL, V300, P289, DOI 10.1016/j.ijmm.2009.10.008; Chaturvedi R, 2010, GASTROENTEROLOGY, V139, P1686, DOI 10.1053/j.gastro.2010.06.060; Tran CN, 2011, NUCLEIC ACIDS RES, V39, P8122, DOI 10.1093/nar/gkr521; Croxen MA, 2013, CLIN MICROBIOL REV, V26, P822, DOI 10.1128/CMR.00022-13; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Day WA, 2001, INFECT IMMUN, V69, P7471, DOI 10.1128/IAI.69.12.7471-7480.2001; De Carolis E, 2011, INT J MED MICROBIOL, V301, P273, DOI 10.1016/j.ijmm.2010.10.001; Di Martino ML, 2013, INT J MED MICROBIOL, V303, P651, DOI 10.1016/j.ijmm.2013.09.007; Di Martino ML, 2013, INT J MED MICROBIOL, V303, P484, DOI 10.1016/j.ijmm.2013.06.008; Feng Y, 2011, PLOS ONE, V6; FUKUCHI JI, 1995, J BIOL CHEM, V270, P18831, DOI 10.1074/jbc.270.32.18831; Giangrossi M, 2010, NUCLEIC ACIDS RES, V38, P3362, DOI 10.1093/nar/gkq025; Iarashi K, 2010, INT J BIOCHEM CELL B, V42, P39, DOI 10.1016/j.biocel.2009.07.009; Jelsbak L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036149; Joshi GS, 2011, MOL MICROBIOL, V82, P9, DOI 10.1111/j.1365-2958.2011.07809.x; Kaper JB, 2004, NAT REV MICROBIOL, V2, P123, DOI 10.1038/nrmicro818; Keseler IM, 2011, NUCLEIC ACIDS RES, V39, pD583, DOI 10.1093/nar/gkq1143; Lan R, 2004, INFECT IMMUN, V72, P5080, DOI 10.1128/IAI.72.9.5080-5088.2004; Lan RT, 2002, MICROBES INFECT, V4, P1125, DOI 10.1016/S1286-4579(02)01637-4; Leimbach A, 2013, CURR TOP MICROBIOL, V358, P3, DOI 10.1007/82_2012_303; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Madhubala R, 1998, METHODS MOL BIOL POL, V79; MATES JM, 1992, AGENTS ACTIONS, V36, P17, DOI 10.1007/BF01991222; Maurelli AT, 1998, P NATL ACAD SCI USA, V95, P3943, DOI 10.1073/pnas.95.7.3943; MENG SY, 1992, J BACTERIOL, V174, P2659, DOI 10.1128/jb.174.8.2659-2669.1992; NAKATA N, 1993, MOL MICROBIOL, V9, P459, DOI 10.1111/j.1365-2958.1993.tb01707.x; NGO TT, 1987, ANAL BIOCHEM, V160, P290, DOI 10.1016/0003-2697(87)90049-2; Ochman H, 2001, SCIENCE, V292, P1096, DOI 10.1126/science.1058543; Parsot C, 2005, FEMS MICROBIOL LETT, V252, P11, DOI 10.1016/j.femsle.2005.08.046; Peng JP, 2009, INFECT GENET EVOL, V9, P147, DOI 10.1016/j.meegid.2008.10.003; Prosseda G, 1998, RES MICROBIOL, V149, P15, DOI 10.1016/S0923-2508(97)83619-4; Prosseda G, 2002, RES MICROBIOL, V153, P461, DOI 10.1016/S0923-2508(02)01346-3; Prosseda G, 2007, RES MICROBIOL, V158, P487, DOI 10.1016/j.resmic.2007.05.001; Prosseda G, 2006, J BACTERIOL, V188, P4681, DOI 10.1128/JB.00332-06; Prosseda G, 2012, RES MICROBIOL, V163, P399, DOI 10.1016/j.resmic.2012.07.004; Prosseda G, 2010, BIOCHEMISTRY-US, V49, P2778, DOI 10.1021/bi902003g; Prunier AL, 2007, MICROBIOL-SGM, V153, P2363, DOI 10.1099/mic.0.2007/006916-0; Pupo GM, 2000, P NATL ACAD SCI USA, V97, P10567, DOI 10.1073/pnas.180094797; Moreno ACR, 2009, FEMS MICROBIOL LETT, V301, P156, DOI 10.1111/j.1574-6968.2009.01815.x; Sansonetti PJ, 2006, PLOS MED, V3, P1465, DOI 10.1371/journal.pmed.0030354; SANSONETTI PJ, 1982, ANN INST PASTEUR MIC, VA133, P351; Scribano D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090230; Shah P, 2008, MOL MICROBIOL, V68, P4, DOI 10.1111/j.1365-2958.2008.06126.x; SILVA RM, 1980, J CLIN MICROBIOL, V11, P441, DOI 10.1128/JCM.11.5.441-444.1980; TABOR CW, 1985, MICROBIOL REV, V49, P81, DOI 10.1128/MMBR.49.1.81-99.1985; Touchon M, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000344	50	31	31	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2014	9	9							e106589	10.1371/journal.pone.0106589	http://dx.doi.org/10.1371/journal.pone.0106589			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ1IR	25192335	Green Published, gold, Green Submitted			2022-12-27	WOS:000347993600040
J	Duan, JG; Chen, XY; Lau, A; Wong, A; Thomas, GN; Tomlinson, B; Liu, R; Chan, JCN; Leung, TW; Mok, V; Wong, KS				Duan, Jian Gang; Chen, Xiang Yan; Lau, Alex; Wong, Adrian; Thomas, G. Neil; Tomlinson, Brian; Liu, Roxanna; Chan, Juliana C. N.; Leung, Thomas W.; Mok, Vincent; Wong, Ka Sing			Long-Term Risk of Cardiovascular Disease among Type 2 Diabetic Patients with Asymptomatic Intracranial Atherosclerosis: A Prospective Cohort Study	PLOS ONE			English	Article							C-REACTIVE PROTEIN; CEREBRAL-ARTERY STENOSIS; CORONARY-HEART-DISEASE; VASCULAR-DISEASE; TRANSCRANIAL DOPPLER; ISCHEMIC-STROKE; INFLAMMATION; PROGRESSION; MORTALITY; MELLITUS	Objective: To investigate whether asymptomatic middle cerebral artery (MCA) stenosis is associated with risk of cardiovascular disease (CVD) in Chinese with type 2 diabetes. Methods: In this prospective cohort study, 2,144 Hong Kong Chinese with type 2 diabetes and without history of stroke or atrial fibrillation were recruited in 1994-1996 and followed up for a median of 14.51 years. Participants were assessed at baseline for MCA stenosis using transcranial Doppler. We performed survival analysis to assess the association between asymptomatic MCA stenosis and first CVD event, defined as ischemic stroke, acute coronary syndrome (ACS) or cardiovascular death. Results: Of the 2,144 subjects, MCA stenosis at baseline was detected in 264 (12.3%). Rates of stroke, ACS and cardiovascular death per 100 were, respectively, 2.24, 2.92 and 1.11 among participants with stenosis, higher than among those without stenosis. Ten-year cumulative occurrence of stroke, ACS and cardiovascular death in subjects with MCA stenosis was 20%, 24% and 10%, respectively, higher than the corresponding values for subjects without stenosis(all P < 0.001). After adjusting for covariates, MCA stenosis was found to be an independent predictor of stroke [ hazard ratio (HR) 1.40, 95% CI 1.05-1.86; P = 0.02], ACS (HR 1.35, 95% CI 1.04-1.75; P = 0.02) and cardiovascular death(HR 1.56, 95% CI 1.04-2.33; P = 0.03). Conclusions: Asymptomatic MCA stenosis is a risk factor for CVD in Chinese with type 2 diabetes, and detection of asymptomatic MCA stenosis by transcranial Doppler can identify diabetic individuals at high risk of future CVD. This finding is particularly important for diabetic individuals in Asia, where intracranial atherosclerosis is common.	[Duan, Jian Gang] Capital Med Univ, Xuanwu Hosp, Dept Emergency, Beijing, Peoples R China; [Duan, Jian Gang; Chen, Xiang Yan; Lau, Alex; Tomlinson, Brian; Liu, Roxanna; Chan, Juliana C. N.; Leung, Thomas W.; Mok, Vincent; Wong, Ka Sing] Chinese Univ Hong Kong, Prince Wales Hosp, Dept Med & Therapeut, Shatin, Hong Kong, Peoples R China; [Wong, Adrian] Hong Kong Inst Educ, Dept Psychol Studies, Hong Kong, Hong Kong, Peoples R China; [Wong, Adrian] Hong Kong Inst Educ, Ctr Psychosocial Hlth & Aging, Hong Kong, Hong Kong, Peoples R China; [Thomas, G. Neil] Univ Birmingham, Dept Publ Hlth Epidemiol & Biostat, Birmingham, W Midlands, England	Capital Medical University; Chinese University of Hong Kong; Prince of Wales Hospital; Education University of Hong Kong (EdUHK); Education University of Hong Kong (EdUHK); University of Birmingham	Wong, KS (corresponding author), Chinese Univ Hong Kong, Prince Wales Hosp, Dept Med & Therapeut, Shatin, Hong Kong, Peoples R China.	ks-wong@cuhk.edu.hk	Tomlinson, Brian/P-5365-2015; Tomlinson, Brian/AAD-9404-2019; Leung, Thomas W/AAU-6475-2021; Chan, Juliana/B-7918-2016; Leung, Thomas W. H./O-8567-2015; Chen, Xiang Yan/O-8602-2015; Wong, Ka Sing Lawrence/N-3434-2015; Mok, Vincent/N-6421-2015; Wong, Adrian/K-4859-2014; Lau, Alexander Y/N-2485-2015; Thomas, G. Neil/A-1879-2013	Tomlinson, Brian/0000-0001-6717-5444; Leung, Thomas W/0000-0001-8193-0709; Chan, Juliana/0000-0003-1325-1194; Wong, Ka Sing Lawrence/0000-0002-2031-9866; Mok, Vincent/0000-0002-8102-8835; Wong, Adrian/0000-0002-7859-3956; Lau, Alexander Y/0000-0002-5933-9290; Thomas, G. Neil/0000-0002-2777-1847	Direct Grant for Research [2005.1.082]; S. H. Ho Cardiovascular and Stroke Center of the Chinese University of Hong Kong; Croucher Senior Medical Research Fellowships	Direct Grant for Research; S. H. Ho Cardiovascular and Stroke Center of the Chinese University of Hong Kong; Croucher Senior Medical Research Fellowships	This study was partly funded by a Direct Grant for Research (reference no. 2005.1.082) and supported by the S. H. Ho Cardiovascular and Stroke Center of the Chinese University of Hong Kong. Professor KS Lawrence Wong was supported in part by the Croucher Senior Medical Research Fellowships 2011-2012. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amer Diabet Assoc, 2014, DIABETES CARE, V37, pS14, DOI 10.2337/dc14-S014; [Anonymous], 2012, DIABETES CARE S1, V35, pS4, DOI DOI 10.2337/DC12-S004; Arenillas JF, 2008, STROKE, V39, P1456, DOI 10.1161/STROKEAHA.107.498600; Arenillas Juan F, 2005, Cerebrovasc Dis, V20 Suppl 2, P75, DOI 10.1159/000089359; Beckman JA, 2002, JAMA-J AM MED ASSOC, V287, P2570, DOI 10.1001/jama.287.19.2570; Biasucci LM, 1999, CIRCULATION, V99, P855, DOI 10.1161/01.CIR.99.7.855; Chen XY, 2010, CEREBROVASC DIS, V30, P374, DOI 10.1159/000319570; Gao S, 2002, J NEUROIMAGING, V12, P213, DOI 10.1177/10528402012003001; Gavin JR, 1999, DIABETES CARE, V22, pS5; Gaziano TA, 2005, CIRCULATION, V112, P3547, DOI 10.1161/CIRCULATIONAHA.105.591792; Kern R, 2005, NEUROLOGY, V65, P859, DOI 10.1212/01.wnl.0000175983.76110.59; Koenig W, 1999, CIRCULATION, V99, P237, DOI 10.1161/01.CIR.99.2.237; Leng XY, 2013, STROKE, V44, P68, DOI 10.1161/STROKEAHA.112.675652; Lopez-Cancio E, 2012, STROKE, V43, P2712, DOI 10.1161/STROKEAHA.112.661702; Luitse MJA, 2012, LANCET NEUROL, V11, P261, DOI 10.1016/S1474-4422(12)70005-4; Mohr JP, 1997, STROKE, V28, P1501; Mugabo Y, 2010, CURR DIABETES REV, V6, P27, DOI 10.2174/157339910790442628; Ni J, 2011, J NEUROL SCI, V301, P63, DOI 10.1016/j.jns.2010.10.029; Oh MS, 2011, BMC NEUROL, V11, DOI 10.1186/1471-2377-11-138; Plutzky J, 2004, REV ENDOCR METAB DIS, V5, P255, DOI 10.1023/B:REMD.0000032414.17672.5c; Rost NS, 2001, STROKE, V32, P2575, DOI 10.1161/hs1101.098151; Sanon S, 2012, AM J CARDIOL, V110, p13B, DOI 10.1016/j.amjcard.2012.08.035; Sarwar N, 2010, LANCET, V375, P2215, DOI 10.1016/S0140-6736(10)60484-9; Schulze MB, 2004, DIABETES CARE, V27, P889, DOI 10.2337/diacare.27.4.889; Soino M, 2006, DIABETES CARE, V29, P329, DOI 10.2337/diacare.29.02.06.dc05-1700; Thomas GN, 2008, CEREBROVASC DIS, V25, P261, DOI 10.1159/000116303; Thomas GN, 2004, DIABETES CARE, V27, P1121, DOI 10.2337/diacare.27.5.1121; Thomas GN, 2001, CLIN NEPHROL, V55, P7; van der Meer IM, 2002, STROKE, V33, P2750, DOI 10.1161/01.STR.0000044168.00485.02; Viles-Gonzalez JF, 2004, EUR HEART J, V25, P1197, DOI 10.1016/j.ehj.2004.03.011; Virmani R, 2006, J AM COLL CARDIOL, V47, pC13, DOI 10.1016/j.jacc.2005.10.065; Winbeck K, 2002, STROKE, V33, P2459, DOI 10.1161/01.STR.0000029828.51413.82; Wong KS, 2000, STROKE, V31, P2641, DOI 10.1161/01.STR.31.11.2641	33	7	8	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2014	9	9							e106623	10.1371/journal.pone.0106623	http://dx.doi.org/10.1371/journal.pone.0106623			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ1IR	25192283	gold, Green Published, Green Submitted			2022-12-27	WOS:000347993600046
J	Lee, YJ; Moon, KC; Jeong, CW; Kwak, C; Kim, HH; Ku, JH				Lee, Young Ju; Moon, Kyung Chul; Jeong, Chang Wook; Kwak, Cheol; Kim, Hyeon Hoe; Ku, Ja Hyeon			Impact of Squamous and Glandular Differentiation on Oncologic Outcomes in Upper and Lower Tract Urothelial Carcinoma	PLOS ONE			English	Article							RADICAL CYSTECTOMY; BLADDER-CANCER; HISTOLOGICAL VARIANTS; CELL-CARCINOMA; EXTERNAL VALIDATION; CLINICAL-OUTCOMES; SURVIVAL; RECURRENCE; UPDATE	Purpose: To investigate the prognostic significance of squamous and/or glandular differentiation in urothelial carcinoma (UC). Materials and Methods: Among 800 consecutive patients who underwent radical cystectomy or nephroureterectomy at our institution from January 1990 to December 2010, 696 patients were included for the analysis. Clinicopathologic variables were compared according to the presence of squamous and/or glandular differentiation and the tumor location. Results: A total of 51 (7.3%) patients had squamous and/or glandular differentiation. Patients with squamous and/or glandular differentiation had higher pathological T stage (p<0.001) and grade (p<0.001) than those with pure form of UC. After the median follow-up of 55.2 months, 84 (24.6%) and 82 (23.1%) died of upper urinary tract UC and UC of bladder, respectively. Patients with squamous and/or glandular differentiation in upper urinary tract UC showed poorer cancer-specific survival (CSS) (p<0.001) and overall survival (OS) (p<0.001) than those with pure form in upper urinary tract UC (p<0.001), but not in UC of bladder (p = 0.178 for CSS and p = 0.172 for OS). On multivariate Cox regression analysis, squamous and/or glandular differentiation was an independent predictor of CSS (hazard ratio [HR] 1.76; 95% confidence interval [CI] 1.08-2.85, p = 0.023), but it was not associated with OS (HR 1.52; 95% CI 1.00-2.32, p = 0.051). Conclusions: The presence of variant histology could be associated with poorer survival outcome in patients with UC. Squamous and/or glandular differentiation is associated with features of biologically aggressive disease and an independent predictor of CSS.	[Lee, Young Ju; Jeong, Chang Wook; Kwak, Cheol; Kim, Hyeon Hoe; Ku, Ja Hyeon] Seoul Natl Univ, Coll Med, Dept Urol, Seoul, South Korea; [Moon, Kyung Chul] Seoul Natl Univ, Coll Med, Dept Pathol, Seoul 151, South Korea	Seoul National University (SNU); Seoul National University (SNU)	Ku, JH (corresponding author), Seoul Natl Univ, Coll Med, Dept Urol, Seoul, South Korea.	kuuro70@snu.ac.kr	Ku, Ja Hyeon/E-6682-2016					Amin MB, 2009, MODERN PATHOL, V22, pS96, DOI 10.1038/modpathol.2009.26; Antunes Alberto A., 2007, Int. braz j urol., V33, P339, DOI 10.1590/S1677-55382007000300006; Blacks PC, 2009, UROL ONCOL-SEMIN ORI, V27, P3, DOI 10.1016/j.urolonc.2007.07.010; EBLE JN, 2004, WHO CLASSIFICATION T, P90; Ehdaie B, 2012, J UROLOGY, V187, P74, DOI 10.1016/j.juro.2011.09.056; Erdemir F, 2007, INT UROL NEPHROL, V39, P803, DOI 10.1007/s11255-006-9151-0; Honma I, 2004, UROLOGY, V64, P744, DOI 10.1016/j.urology.2004.05.003; Kim SP, 2012, J UROLOGY, V188, P405, DOI 10.1016/j.juro.2012.04.020; Ku JH, 2013, BRIT J CANCER, V109, P1130, DOI 10.1038/bjc.2013.462; LOGOTHETIS CJ, 1988, J CLIN ONCOL, V6, P1590, DOI 10.1200/JCO.1988.6.10.1590; Lopez-Beltran A, 2006, HUM PATHOL, V37, P1371, DOI 10.1016/j.humpath.2006.05.009; Moon KC, 2014, ANN SURG ONCOL, V21, P3132, DOI 10.1245/s10434-014-3561-5; Mostofi FK, 1973, HIST TYPING URINARY; Munoz JJ, 2000, J UROLOGY, V164, P1523, DOI 10.1016/S0022-5347(05)67019-X; Nishiyama H, 2004, EUR UROL, V45, P176, DOI 10.1016/j.eururo.2003.09.011; Perez-Montiel D, 2006, MODERN PATHOL, V19, P494, DOI 10.1038/modpathol.3800559; Ploeg M, 2010, J UROLOGY, V183, P915, DOI 10.1016/j.juro.2009.11.018; Pons F, 2011, CURR ONCOL REP, V13, P216, DOI 10.1007/s11912-011-0161-4; Rink M, 2012, EUR UROL, V62, P677, DOI 10.1016/j.eururo.2012.02.018; Rink M, 2012, J UROLOGY, V188, P398, DOI 10.1016/j.juro.2012.04.009; Rogers CG, 2006, J UROLOGY, V175, P2048, DOI 10.1016/S0022-5347(06)00317-X; Roupret M, 2013, EUR UROL, V63, P1059, DOI 10.1016/j.eururo.2013.03.032; Scosyrev E, 2011, BJU INT, V108, P693, DOI 10.1111/j.1464-410X.2010.09900.x; Scosyrev E, 2009, UROLOGY, V73, P822, DOI 10.1016/j.urology.2008.11.042; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Sobin, 2009, UICC TNM CLASSIFICAT; Xylinas E, 2013, EUR J CANCER, V49, P1889, DOI 10.1016/j.ejca.2013.02.001	27	17	18	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2014	9	9							e107027	10.1371/journal.pone.0107027	http://dx.doi.org/10.1371/journal.pone.0107027			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ1IR	25191845	Green Published, Green Submitted, gold			2022-12-27	WOS:000347993600091
J	Pan, XD; Chen, ZW; Yang, XY; Liu, GQ				Pan, Xiaodi; Chen, Ziwei; Yang, Xueyong; Liu, Guoqin			Arabidopsis Voltage-Dependent Anion Channel 1 (AtVDAC1) Is Required for Female Development and Maintenance of Mitochondrial Functions Related to Energy-Transaction	PLOS ONE			English	Article							PERMEABILITY TRANSITION PORE; OVULE DEVELOPMENT; GAMETOPHYTE DEVELOPMENT; CELL-DEATH; EXPRESSION LEVEL; CYTOCHROME-C; BCL-2 FAMILY; WILD-TYPE; VDAC; PROTEIN	The voltage-dependent anion channels (VDACs), prominently localized in the outer mitochondrial membrane, play important roles in the metabolite exchange, energy metabolism and mitochondria-mediated apoptosis process in mammalian cells. However, relatively little is known about the functions of VDACs in plants. To further investigate the function of AtVDAC1 in Arabidopsis, we analyzed a T-DNA insertion line for the AtVDAC1 gene. The knock-out mutant atvdac1 showed reduced seed set due to a large number of undeveloped ovules in siliques. Genetic analyses indicated that the mutation of AtVDAC1 affected female fertility and belonged to a sporophytic mutation. Abnormal ovules in the process of female gametogenesis were observed using a confocal laser scanning microscope. Interestingly, both mitochondrial transmembrane potential (Delta Psi) and ATP synthesis rate were obviously reduced in the mitochondria isolated from atvdac1 plants.	[Pan, Xiaodi; Chen, Ziwei; Yang, Xueyong; Liu, Guoqin] China Agr Univ, Coll Biol Sci, State Key Lab Plant Physiol & Biochem, Beijing 100094, Peoples R China	China Agricultural University	Liu, GQ (corresponding author), China Agr Univ, Coll Biol Sci, State Key Lab Plant Physiol & Biochem, Beijing 100094, Peoples R China.	liu@cau.edu.cn		Yang, Xueyong/0000-0003-0453-2023	National Natural Science Foundation of China [31071259]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by grants from the National Natural Science Foundation of China (Project 31071259). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu-Hamad S, 2006, P NATL ACAD SCI USA, V103, P5787, DOI 10.1073/pnas.0600103103; Al Bitar F, 2003, BBA-GENE STRUCT EXPR, V1625, P43, DOI 10.1016/S0167-4781(02)00590-0; Al Bitar F, 2002, BBA-GENE STRUCT EXPR, V1579, P133, DOI 10.1016/S0167-4781(02)00532-8; Anflous K, 2001, J BIOL CHEM, V276, P1954, DOI 10.1074/jbc.M006587200; Anflous-Pharayra K, 2007, BBA-BIOENERGETICS, V1767, P136, DOI 10.1016/j.bbabio.2006.11.013; Baker SC, 1997, GENETICS, V145, P1109; Blachly-Dyson E, 2001, IUBMB LIFE, V52, P113; BLUMENTHAL A, 1993, PLANT PHYSIOL, V101, P579, DOI 10.1104/pp.101.2.579; Boateng KA, 2008, MOL PLANT, V1, P620, DOI 10.1093/mp/ssn030; Brenner C, 2006, ONCOGENE, V25, P4744, DOI 10.1038/sj.onc.1209609; Carlsson J, 2008, MITOCHONDRION, V8, P74, DOI 10.1016/j.mito.2007.09.006; Christensen CA, 1997, SEX PLANT REPROD, V10, P49, DOI 10.1007/s004970050067; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Crompton M, 1998, EUR J BIOCHEM, V258, P729, DOI 10.1046/j.1432-1327.1998.2580729.x; DAY DA, 1978, PLANT SCI LETT, V11, P99, DOI 10.1016/0304-4211(78)90112-8; Drews GN, 2002, ANNU REV GENET, V36, P99, DOI 10.1146/annurev.genet.36.040102.131941; Elkeles A, 1997, J BIOL CHEM, V272, P6252, DOI 10.1074/jbc.272.10.6252; ELKELES A, 1995, PLANT MOL BIOL, V29, P109, DOI 10.1007/BF00019123; Elliott RC, 1996, PLANT CELL, V8, P155, DOI 10.1105/tpc.8.2.155; Graham BH, 2010, J BIOL CHEM, V285, P11143, DOI 10.1074/jbc.M109.080317; HEINS L, 1994, J BIOL CHEM, V269, P26402; Homble F, 2012, BBA-BIOMEMBRANES, V1818, P1486, DOI 10.1016/j.bbamem.2011.11.028; Hoogenboom BW, 2007, J MOL BIOL, V370, P246, DOI 10.1016/j.jmb.2007.04.073; Howden R, 1998, GENETICS, V149, P621; Jurgens G, 2005, ANNU REV PLANT BIOL, V56, P281, DOI 10.1146/annurev.arplant.55.031903.141636; Klucher KM, 1996, PLANT CELL, V8, P137, DOI 10.1105/tpc.8.2.137; Kull FJ, 2013, J CELL SCI, V126, P9, DOI 10.1242/jcs.103911; Lee SM, 2009, MOL CELLS, V27, P321, DOI 10.1007/s10059-009-0041-z; Leon G, 2007, PLANT PHYSIOL, V143, P1534, DOI 10.1104/pp.106.095158; Linke B, 2005, MITOCHONDRION, V5, P389, DOI 10.1016/j.mito.2005.10.001; MANNELLA CA, 1975, BIOCHIM BIOPHYS ACTA, V413, P226, DOI 10.1016/0005-2736(75)90106-6; Marmagne A, 2004, MOL CELL PROTEOMICS, V3, P675, DOI 10.1074/mcp.M400001-MCP200; Meyer EH, 2009, PLANT PHYSIOL, V151, P603, DOI 10.1104/pp.109.141770; MITCHELL P, 1965, NATURE, V208, P147, DOI 10.1038/208147a0; MITCHELL P, 1965, NATURE, V208, P1205, DOI 10.1038/2081205a0; Motamayor JC, 2000, SEX PLANT REPROD, V12, P209, DOI 10.1007/s004970050002; Narita M, 1998, P NATL ACAD SCI USA, V95, P14681, DOI 10.1073/pnas.95.25.14681; Pedersen PL, 2007, J BIOENERG BIOMEMBR, V39, P211, DOI 10.1007/s10863-007-9094-x; Portereiko MF, 2006, PLANT PHYSIOL, V141, P957, DOI 10.1104/pp.106.079319; Robert N, 2012, PLANT MOL BIOL, V78, P431, DOI 10.1007/s11103-012-9874-5; ROBINSONBEERS K, 1992, PLANT CELL, V4, P1237, DOI 10.1105/tpc.4.10.1237; Roosens N, 2000, BBA-BIOMEMBRANES, V1463, P470, DOI 10.1016/S0005-2736(99)00246-1; Rostovtseva TK, 1998, BIOPHYS J, V74, P2365, DOI 10.1016/S0006-3495(98)77945-7; Saccone C, 2003, J MOL EVOL, V57, pS277, DOI 10.1007/s00239-003-0037-9; Sampson MJ, 2001, J BIOL CHEM, V276, P39206, DOI 10.1074/jbc.M104724200; Schneitz K, 1997, DEVELOPMENT, V124, P1367; Shi DQ, 2005, PLANT CELL, V17, P2340, DOI 10.1105/tpc.105.033563; Shimizu S, 1999, NATURE, V399, P483, DOI 10.1038/20959; Shimizu S, 2000, ONCOGENE, V19, P4309, DOI 10.1038/sj.onc.1203788; Shimizu S, 2001, J CELL BIOL, V152, P237, DOI 10.1083/jcb.152.2.237; Skinner DJ, 2001, PLANT CELL, V13, P2719, DOI 10.1105/tpc.13.12.2719; SMACK DP, 1985, PLANT PHYSIOL, V79, P1094, DOI 10.1104/pp.79.4.1094; Takahashi Y, 2013, APOPTOSIS, V18, P917, DOI 10.1007/s10495-013-0845-3; Tan XY, 2010, PLANT CELL PHYSIOL, V51, P635, DOI 10.1093/pcp/pcq029; Tateda C, 2009, PLANT CELL REP, V28, P41, DOI 10.1007/s00299-008-0630-x; Tateda C, 2011, J EXP BOT, V62, P4773, DOI 10.1093/jxb/err113; Tsujimoto Y, 2000, CELL DEATH DIFFER, V7, P1174, DOI 10.1038/sj.cdd.4400780; Tsujimoto Y, 2007, APOPTOSIS, V12, P835, DOI 10.1007/s10495-006-0525-7; Vianello A, 2007, PHYSIOL PLANTARUM, V129, P242, DOI 10.1111/j.1399-3054.2006.00767.x; Wandrey M, 2004, PLANT PHYSIOL, V134, P182, DOI 10.1104/pp.103.031484; Wang YB, 2012, PLANT J, V69, P227, DOI 10.1111/j.1365-313X.2011.04785.x; Weeber EJ, 2002, J BIOL CHEM, V277, P18891, DOI 10.1074/jbc.M201649200; Yang SL, 2003, PLANT CELL, V15, P2792, DOI 10.1105/tpc.016618; Yang WC, 1999, GENE DEV, V13, P2108, DOI 10.1101/gad.13.16.2108; Yang XY, 2011, PLANT CELL, V23, P1093, DOI 10.1105/tpc.110.082420; Young MJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-31; ZALMAN LS, 1980, J BIOL CHEM, V255, P1771; ZIZI M, 1994, J BIOL CHEM, V269, P1614	68	14	14	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2014	9	9							e106941	10.1371/journal.pone.0106941	http://dx.doi.org/10.1371/journal.pone.0106941			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ1IR	25192453	Green Published, gold, Green Submitted			2022-12-27	WOS:000347993600083
J	Villarroya, A; Barros, AC; Kiesecker, J				Villarroya, Ana; Barros, Ana Cristina; Kiesecker, Joseph			Policy Development for Environmental Licensing and Biodiversity Offsets in Latin America	PLOS ONE			English	Article							CONSERVATION; FRAMEWORK; SCALE; SITES	Attempts to meet biodiversity goals through application of the mitigation hierarchy have gained wide traction globally with increased development of public policy, lending standards, and corporate practices. With interest in biodiversity offsets increasing in Latin America, we seek to strengthen the basis for policy development through a review of major environmental licensing policy frameworks in Argentina, Brazil, Chile, Colombia, Mexico, Peru and Venezuela. Here we focused our review on an examination of national level policies to evaluate to which degree current provisions promote positive environmental outcomes. All the surveyed countries have national-level Environmental Impact Assessment laws or regulations that cover the habitats present in their territories. Although most countries enable the use of offsets only Brazil, Colombia, Mexico and Peru explicitly require their implementation. Our review has shown that while advancing quite detailed offset policies, most countries do not seem to have strong requirements regarding impact avoidance. Despite this deficiency most countries have a strong foundation from which to develop policy for biodiversity offsets, but several issues require further guidance, including how best to: (1) ensure conformance with the mitigation hierarchy; (2) identify the most environmentally preferable offsets within a landscape context; (3) determine appropriate mitigation replacement ratios; and (4) ensure appropriate time and effort is given to monitor offset performance.	[Villarroya, Ana] Nature Conservancy, Boulder, CO 80307 USA; [Barros, Ana Cristina] Nature Conservancy, Brasilia, DF, Brazil; [Kiesecker, Joseph] Nature Conservancy, Ft Collins, CO USA	Nature Conservancy; Nature Conservancy; Nature Conservancy	Villarroya, A (corresponding author), Nature Conservancy, Boulder, CO 80307 USA.	ana.villarroya@tnc.org	Ballarin, Ana Villarroya/Y-7191-2019; Villarroya, Ana/GSD-2644-2022	Ballarin, Ana Villarroya/0000-0001-8008-0423; Villarroya, Ana/0000-0001-8008-0423	Grantham Foundation; Anne Ray Charitable Trust; Nature Conservancy	Grantham Foundation; Anne Ray Charitable Trust; Nature Conservancy	Funding was provided by the Grantham Foundation, the Anne Ray Charitable Trust and The Nature Conservancy. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alternative Latin Investor, 2011, INFR INV LAT AM 2011; Arponen A, 2007, CONSERV BIOL, V21, P527, DOI 10.1111/j.1523-1739.2006.00607.x; Astorga A, 2006, ESTUDIO COMP SISTEMA; Barbero JA, 2012, INFRASTRUCTURE DEV L; Barrick, 2010, BARR BUILD VAL EV WE; BBOP, 2012, STAND BIOD OFFS; Bekessy SA, 2010, CONSERV LETT, V3, P151, DOI 10.1111/j.1755-263X.2010.00110.x; Brownlie S., 2009, IMPACT ASSESS PROJ A, V27, P227, DOI DOI 10.3152/146155109X465968; Bull JW, 2013, ORYX, V47, P369, DOI 10.1017/S003060531200172X; Burgin S, 2008, BIODIVERS CONSERV, V17, P807, DOI 10.1007/s10531-008-9319-2; Business and and Biodiversity Offsets Programme (BBOP), 2013, NO NET LOSS OV BUS B; Business and Biodiversity Offsets Programme (BBOP), 2012, GUID NOT STAND BIOD; Clare S, 2011, WETL ECOL MANAG, V19, P165, DOI 10.1007/s11273-011-9209-3; Climate Community and Biodiversity Alliance, 2008, CCB STAND; CONAFOR, 2013, PROGR COMP AMB CAMB; Council on Environmental Quality, 2000, PROT ENV; Dickie I, 2010, TECHNICAL REPORT; Doswald N., 2012, BIODIVERSITY OFFSETS; Equator Principles, 2013, EQ PRINC; Espinoza G, 2001, REV ENV IMPACT ASSES; *EUR COMM, 1999, GUID ASS IND CUM IMP; European Bank for Reconstruction and Development, 2008, ENV SOC POL; Ferraro PJ, 2006, PLOS BIOL, V4, P482, DOI 10.1371/journal.pbio.0040105; Gardner TA, 2013, CONSERV BIOL, V27, P1254, DOI 10.1111/cobi.12118; Glasson J, 2000, ENVIRON IMPACT ASSES, V20, P191, DOI 10.1016/S0195-9255(99)00043-8; Hayes N., 2007, IMPACT ASSESS PROJ A, V25, P209, DOI [10.3152/146155107x227126, DOI 10.3152/146155107X227126]; Hilderbrand RH, 2005, ECOL SOC, V10; International Finance Corporation, 2012, PERF STAND ENV SOC S; Jesus de J, 2013, IAIA FASTIPS; Kiesecker J.M., 2013, ENCY BIODIVERSITY, Vsecond, P495; Kiesecker JM, 2010, FRONT ECOL ENVIRON, V8, P261, DOI 10.1890/090005; Kiesecker JM, 2009, BIOSCIENCE, V59, P77, DOI 10.1525/bio.2009.59.1.11; Latimer W, 2007, PLAN PRACT RES, V22, P155, DOI 10.1080/02697450701584337; Lawrence DP, 2003, ENV IMPACT ASSESSMEN; MADSEN B., 2011, 2011 UPDATE STATE BI; Maron M, 2012, BIOL CONSERV, V155, P141, DOI 10.1016/j.biocon.2012.06.003; McElfish Jr JM, 1995, ELR, V25, P10003; McKenney BA, 2010, ENVIRON MANAGE, V45, P165, DOI 10.1007/s00267-009-9396-3; Moilanen A, 2013, WILDLIFE RES, V40, P153, DOI 10.1071/WR12083; Moilanen A, 2009, RESTOR ECOL, V17, P470, DOI 10.1111/j.1526-100X.2008.00382.x; Morgan RK, 2012, IMPACT ASSESS PROJ A, V30, P5, DOI 10.1080/14615517.2012.661557; Morris R. K. A., 2006, Journal for Nature Conservation (Jena), V14, P106, DOI 10.1016/j.jnc.2006.01.003; Norton DA, 2009, ENVIRON MANAGE, V43, P698, DOI 10.1007/s00267-008-9192-5; Overton JM, 2013, AMBIO, V42, P100, DOI 10.1007/s13280-012-0342-x; Pilgrim JD, 2013, CONSERV LETT, V6, P376, DOI 10.1111/conl.12002; Pinto-Ferreira L, 1989, COMENTARIOS CONSTITU, V1; Pritchard D, 1993, ECOS, V14, P3; Quetier F, 2011, BIOL CONSERV, V144, P2991, DOI 10.1016/j.biocon.2011.09.002; Regnery B, 2013, CONSERV BIOL, V27, P1335, DOI 10.1111/cobi.12123; Saborio-Coze A, 2009, REV ENV IMPACT ASSES; Saenz S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081831; Saenz S, 2013, SUSTAINABILITY-BASEL, V5, P4961, DOI 10.3390/su5124961; Sanchez-Triana E, 2007, ANN C INT ASS IMP AS, P100; Tanaka A, 2010, CITY PLAN MAG, V59, P18; Teck Resources Limited, 2013, TECKS BIOD STRAT; The Biodiversity Consultancy, 2013, GOV POL BIOD OFFS; Tinto Rio, 2004, RIO TINTOS BIODIVERS; Villarroya A, 2013, ENVIRON IMPACT ASSES, V42, P87, DOI 10.1016/j.eiar.2012.11.002; Walker S, 2009, CONSERV LETT, V2, P149, DOI 10.1111/j.1755-263X.2009.00061.x; Wende W., 2005, Impact Assessment and Project Appraisal, V23, P101, DOI 10.3152/147154605781765652; Wood C., 2013, ENVIRON IMPACT ASSES, V2nd, DOI [10.4324/9781315838953, DOI 10.4324/9781315838953]	61	59	62	2	65	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2014	9	9							e107144	10.1371/journal.pone.0107144	http://dx.doi.org/10.1371/journal.pone.0107144			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ1IR	25191758	Green Published, Green Submitted, gold			2022-12-27	WOS:000347993600102
J	Yu, MX; Mo, C; Mo, L				Yu, Mengxia; Mo, Ce; Mo, Lei			The Role of Phoneme in Mandarin Chinese Production: Evidence from ERPs	PLOS ONE			English	Article							SPEECH PRODUCTION; TIME-COURSE; LANGUAGE PRODUCTION; BRAIN POTENTIALS; FUNCTIONAL UNIT; LEXICAL ACCESS; WORD RETRIEVAL; SEGMENTS; REPRESENTATION; INTERFERENCE	Established linguistic theoretical frameworks propose that alphabetic language speakers use phonemes as phonological encoding units during speech production whereas Mandarin Chinese speakers use syllables. This framework was challenged by recent neural evidence of facilitation induced by overlapping initial phonemes, raising the possibility that phonemes also contribute to the phonological encoding process in Chinese. However, there is no evidence of non-initial phoneme involvement in Chinese phonological encoding among representative Chinese speakers, rendering the functional role of phonemes in spoken Chinese controversial. Here, we addressed this issue by systematically investigating the word-initial and non-initial phoneme repetition effect on the electrophysiological signal using a picture-naming priming task in which native Chinese speakers produced disyllabic word pairs. We found that overlapping phonemes in both the initial and noninitial position evoked more positive ERPs in the 180-to 300-ms interval, indicating position-invariant repetition facilitation effect during phonological encoding. Our findings thus revealed the fundamental role of phonemes as independent phonological encoding units in Mandarin Chinese.	[Yu, Mengxia; Mo, Ce; Mo, Lei] S China Normal Univ, Ctr Study Appl Psychol, Guangzhou, Guangdong, Peoples R China	South China Normal University	Mo, L (corresponding author), S China Normal Univ, Ctr Study Appl Psychol, Guangzhou, Guangdong, Peoples R China.	molei@scnu.edu.cn			National Natural Science Foundation of China [31200785]; National Basic Research Program of China (973 Program) [2012CB720704]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China (973 Program)(National Basic Research Program of China)	This research was supported by National Natural Science Foundation of China (31200785) and National Basic Research Program of China (973 Program 2012CB720704). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alario FX, 2007, COGNITION, V102, P464, DOI 10.1016/j.cognition.2006.02.002; Chen JY, 2002, J MEM LANG, V46, P751, DOI 10.1006/jmla.2001.2825; Chen TM, 2013, PSYCHON B REV, V20, P154, DOI 10.3758/s13423-012-0326-7; Costa A, 2009, P NATL ACAD SCI USA, V106, P21442, DOI 10.1073/pnas.0908921106; Damian MF, 2007, J MEM LANG, V57, P195, DOI 10.1016/j.jml.2006.11.001; Damian MF, 2009, LANG COGNITIVE PROC, V24, P685, DOI 10.1080/01690960802351260; Damian MF, 2003, J MEM LANG, V49, P119, DOI 10.1016/S0749-596X(03)00008-1; DELL GS, 1984, J EXP PSYCHOL LEARN, V10, P222, DOI 10.1037/0278-7393.10.2.222; Dell'Acqua R, 2010, FRONT PSYCHOL, V1, DOI 10.3389/fpsyg.2010.00177; FORSTER KI, 1991, J MEM LANG, V30, P1, DOI 10.1016/0749-596X(91)90008-8; Jescheniak JRD, 2002, J COGNITIVE NEUROSCI, V14, P951, DOI 10.1162/089892902760191162; Kinoshita S, 2000, PSYCHON B REV, V7, P133, DOI 10.3758/BF03210732; Kureta Y, 2006, J EXP PSYCHOL LEARN, V32, P1102, DOI 10.1037/0278-7393.32.5.1102; Levelt WJM, 1999, BEHAV BRAIN SCI, V22, P1; MACKAY DG, 1972, COGNITIVE PSYCHOL, V3, P210, DOI 10.1016/0010-0285(72)90004-7; Maess B, 2002, J COGNITIVE NEUROSCI, V14, P455, DOI 10.1162/089892902317361967; MEYER AS, 1991, J MEM LANG, V30, P69, DOI 10.1016/0749-596X(91)90011-8; MEYER AS, 1990, J MEM LANG, V29, P524, DOI 10.1016/0749-596X(90)90050-A; O'Seaghdha PG, 2013, P NATL ACAD SCI USA, V110, pE3, DOI 10.1073/pnas.1217032110; O'Seaghdha PG, 2010, COGNITION, V115, P282, DOI 10.1016/j.cognition.2010.01.001; Qu QQ, 2013, P NATL ACAD SCI USA, V110, pE4, DOI 10.1073/pnas.1217601110; Qu QQ, 2012, P NATL ACAD SCI USA, V109, P14265, DOI 10.1073/pnas.1200632109; READ C, 1986, COGNITION, V24, P31, DOI 10.1016/0010-0277(86)90003-X; Schiller NO, 2004, J MEM LANG, V50, P477, DOI 10.1016/j.jml.2004.02.004; Schiller NO, 2003, COGNITIVE BRAIN RES, V17, P819, DOI 10.1016/S0926-6410(03)00204-0; Strijkers K, 2010, CEREB CORTEX, V20, P912, DOI 10.1093/cercor/bhp153; Sullivan MP, 1999, LANG COGNITIVE PROC, V14, P15, DOI 10.1080/016909699386365; Verdonschot RG, 2011, J EXP PSYCHOL LEARN, V37, P1458, DOI 10.1037/a0024491; Verdonschot RG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061454; Wheeldon L, 2003, LANG COGNITIVE PROC, V18, P81, DOI 10.1080/01690960143000470; You WP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046595; [张清芳 Zhang Qingfang], 2003, [心理学报, Acta Psychologica Sinica], V35, P447	32	20	21	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2014	9	9							e106486	10.1371/journal.pone.0106486	http://dx.doi.org/10.1371/journal.pone.0106486			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AZ1IR	25191857	Green Published, Green Submitted, gold			2022-12-27	WOS:000347993600031
J	Nery, LR; Eltz, NS; Hackman, C; Fonseca, R; Altenhofen, S; Guerra, HN; Freitas, VM; Bonan, CD; Vianna, MRMR				Nery, Laura Roesler; Eltz, Natalia Silva; Hackman, Cristiana; Fonseca, Raphaela; Altenhofen, Stefani; Guerra, Heydi Noriega; Freitas, Vanessa Morais; Bonan, Carla Denise; Moreira Roca Vianna, Monica Ryff			Brain Intraventricular Injection of Amyloid-beta in Zebrafish Embryo Impairs Cognition and Increases Tau Phosphorylation, Effects Reversed by Lithium	PLOS ONE			English	Article							ALZHEIMERS-DISEASE; DIMETHYL-SULFOXIDE; CELL-DEATH; APOPTOSIS; PROTEIN; OLIGOMERS; MEMORY; INHIBITION; TAUOPATHY; CATENIN	Alzheimer's disease (AD) is a devastating neurodegenerative disorder with no effective treatment and commonly diagnosed only on late stages. Amyloid-beta (A beta) accumulation and exacerbated tau phosphorylation are molecular hallmarks of AD implicated in cognitive deficits and synaptic and neuronal loss. The A beta and tau connection is beginning to be elucidated and attributed to interaction with different components of common signaling pathways. Recent evidences suggest that non-fibrillary A beta forms bind to membrane receptors and modulate GSK-3 beta activity, which in turn phosphorylates the microtubule-associated tau protein leading to axonal disruption and toxic accumulation. Available AD animal models, ranging from rodent to invertebrates, significantly contributed to our current knowledge, but complementary platforms for mechanistic and candidate drug screenings remain critical for the identification of early stage biomarkers and potential disease-modifying therapies. Here we show that A beta 1-42 injection in the hindbrain ventricle of 24 hpf zebrafish embryos results in specific cognitive deficits and increased tau phosphorylation in GSK-3 beta target residues at 5dpf larvae. These effects are reversed by lithium incubation and not accompanied by apoptotic markers. We believe this may represent a straightforward platform useful to identification of cellular and molecular mechanisms of early stage AD-like symptoms and the effects of neuroactive molecules in pharmacological screenings.	[Nery, Laura Roesler; Eltz, Natalia Silva; Hackman, Cristiana; Fonseca, Raphaela; Altenhofen, Stefani; Bonan, Carla Denise; Moreira Roca Vianna, Monica Ryff] Pontificia Univ Catolica Rio Grande do Sul, Fac Biociencias, ZebLab, Porto Alegre, RS, Brazil; [Nery, Laura Roesler; Eltz, Natalia Silva; Hackman, Cristiana; Fonseca, Raphaela; Moreira Roca Vianna, Monica Ryff] Pontificia Univ Catolica Rio Grande do Sul, Fac Biociencias, Lab Biol & Desenvolvimento Sistem Nervoso, Porto Alegre, RS, Brazil; [Altenhofen, Stefani; Bonan, Carla Denise] Pontificia Univ Catolica Rio Grande do Sul, Fac Biociencias, Lab Neuroquim & Psicofarmacol, Porto Alegre, RS, Brazil; [Guerra, Heydi Noriega; Freitas, Vanessa Morais] Univ Sao Paulo, Inst Biomed Sci, Dept Cell & Dev Biol, Sao Paulo, Brazil	Pontificia Universidade Catolica Do Rio Grande Do Sul; Pontificia Universidade Catolica Do Rio Grande Do Sul; Pontificia Universidade Catolica Do Rio Grande Do Sul; Universidade de Sao Paulo	Vianna, MRMR (corresponding author), Pontificia Univ Catolica Rio Grande do Sul, Fac Biociencias, ZebLab, Porto Alegre, RS, Brazil.	monica.vianna@pucrs.br	Vianna, Monica R M R/G-3520-2012; Bonan, Carla Denise/J-7899-2015; Vianna, Monica Ryff Moreira Roca/O-3348-2019; Freitas, Vanessa M/D-7897-2012; Altenhofen, Stefani/V-6370-2018	Vianna, Monica R M R/0000-0002-1881-127X; Bonan, Carla Denise/0000-0001-9715-6244; Vianna, Monica Ryff Moreira Roca/0000-0002-1881-127X; Freitas, Vanessa M/0000-0001-9613-8626; Altenhofen, Stefani/0000-0001-7229-6494	CNPq fellowships; CAPES; CS byFAPERGS; CNPq [305060/2009-0, 567483/2008-8]; DECIT/SCTIE-MS/CNPq-FAPERGS [10/0036-5 700545/2008-PRONEX]	CNPq fellowships(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); CS byFAPERGS; CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); DECIT/SCTIE-MS/CNPq-FAPERGS	MRV, RF, NES and CDB received CNPq fellowships, LRN and SA were supported by CAPES and CS byFAPERGS; This work was supported by CNPq(305060/2009-0, 567483/2008-8) and DECIT/SCTIE-MS/CNPq-FAPERGS (10/0036-5 700545/2008-PRONEX). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benilova I, 2012, NAT NEUROSCI, V15, P349, DOI 10.1038/nn.3028; Blazina AR, 2013, ZEBRAFISH, V10, P480, DOI 10.1089/zeb.2012.0860; Brunden KR, 2009, NAT REV DRUG DISCOV, V8, P783, DOI 10.1038/nrd2959; Cameron DJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039598; Campioni S, 2010, NAT CHEM BIOL, V6, P140, DOI [10.1038/NCHEMBIO.283, 10.1038/nchembio.283]; Cleary JP, 2005, NAT NEUROSCI, V8, P79, DOI 10.1038/nn1372; Cole LK, 2001, DEV BIOL, V240, P123, DOI 10.1006/dbio.2001.0432; Cunvong K, 2013, INVEST OPHTH VIS SCI, V54, P1516, DOI 10.1167/iovs.12-10821; D'MELLO SR, 1994, EXP CELL RES, V211, P332, DOI 10.1006/excr.1994.1095; Dumurgier J, 2013, NEUROBIOL DIS, V54, P486, DOI 10.1016/j.nbd.2013.01.023; Forlenza OV, 2011, J PSYCHIATR RES, V45, P220, DOI 10.1016/j.jpsychires.2010.06.002; Fraysse B, 2006, ECOTOX ENVIRON SAFE, V63, P253, DOI 10.1016/j.ecoenv.2004.10.015; Golde TE, 2000, BBA-MOL BASIS DIS, V1502, P172, DOI 10.1016/S0925-4439(00)00043-0; Gutzman Jennifer H, 2009, J Vis Exp, DOI 10.3791/1218; Hanslick JL, 2009, NEUROBIOL DIS, V34, P1, DOI 10.1016/j.nbd.2008.11.006; Harkany T, 1998, BEHAV BRAIN RES, V90, P133, DOI 10.1016/S0166-4328(97)00091-0; Holtzman DM, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002369; Hoover BR, 2010, NEURON, V68, P1067, DOI 10.1016/j.neuron.2010.11.030; Howe K, 2013, NATURE, V496, P498, DOI 10.1038/nature12111; Jenkins JL, 2010, NAT CHEM BIOL, V6, P172, DOI 10.1038/nchembio.320; Jung H, 2012, J APPL TOXICOL, V32, P654, DOI 10.1002/jat.1665; Kramer T., 2012, INT J ALZHEIMERS DIS, V2012, DOI DOI 10.1155/2012/381029; Leng Y, 2008, J NEUROSCI, V28, P2576, DOI 10.1523/JNEUROSCI.5467-07.2008; Lenz S, 2013, J NEUROCHEM, V127, P453, DOI 10.1111/jnc.12446; Lesne S, 2006, NATURE, V440, P352, DOI 10.1038/nature04533; Li J, 2013, EXP NEUROL, V250, P94, DOI 10.1016/j.expneurol.2013.09.024; Liu F, 2006, FEBS LETT, V580, P6269, DOI 10.1016/j.febslet.2006.10.033; Liu J, 2001, INT IMMUNOPHARMACOL, V1, P63, DOI 10.1016/S1567-5769(00)00016-3; Magdesian MH, 2008, J BIOL CHEM, V283, P9359, DOI 10.1074/jbc.M707108200; Maguschak KA, 2008, NAT NEUROSCI, V11, P1319, DOI 10.1038/nn.2198; Matsebatlela T, 2012, BIOL TRACE ELEM RES, V149, P323, DOI 10.1007/s12011-012-9438-1; Mazanetz MP, 2007, NAT REV DRUG DISCOV, V6, P464, DOI 10.1038/nrd2111; Mc Donald JM, 2010, BRAIN, V133, P1328, DOI 10.1093/brain/awq065; Newman M, 2011, BBA-MOL BASIS DIS, V1812, P346, DOI 10.1016/j.bbadis.2010.09.012; Noble W, 2005, P NATL ACAD SCI USA, V102, P6990, DOI 10.1073/pnas.0500466102; Nocjar C, 2007, NEUROSCIENCE, V150, P774, DOI 10.1016/j.neuroscience.2007.09.063; Paquet D, 2010, NEURODEGENER DIS, V7, P99, DOI 10.1159/000285515; Paquet D, 2009, J CLIN INVEST, V119, P1382, DOI 10.1172/JCI37537; Pelkowski SD, 2011, BEHAV BRAIN RES, V223, P135, DOI 10.1016/j.bbr.2011.04.033; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Rankin CA, 2005, MOL BRAIN RES, V138, P84, DOI 10.1016/j.molbrainres.2005.04.012; RYAN JJ, 1994, LEUKEMIA RES, V18, P617, DOI 10.1016/0145-2126(94)90043-4; Sakono M, 2010, FEBS J, V277, P1348, DOI 10.1111/j.1742-4658.2010.07568.x; Santos NC, 2003, BIOCHEM PHARMACOL, V65, P1035, DOI 10.1016/S0006-2952(03)00002-9; Selkoe DJ, 2011, NAT MED, V17, P1060, DOI 10.1038/nm.2460; Shahpasand K, 2012, J NEUROSCI, V32, P2430, DOI 10.1523/JNEUROSCI.5927-11.2012; Shankar GM, 2008, NAT MED, V14, P837, DOI 10.1038/nm1782; Shipton OA, 2011, J NEUROSCI, V31, P1688, DOI 10.1523/JNEUROSCI.2610-10.2011; Tang RY, 2007, ACTA BIOCH BIOPH SIN, V39, P384, DOI 10.1111/j.1745-7270.2007.00283.x; Van Dam D, 2011, BRIT J PHARMACOL, V164, P1285, DOI 10.1111/j.1476-5381.2011.01299.x; van Gijn ME, 2001, EXP CELL RES, V265, P46, DOI 10.1006/excr.2001.5174; Voytovych H, 2012, NEUROPHARMACOLOGY, V63, P274, DOI 10.1016/j.neuropharm.2012.03.023; Westerfield M, 2000, ZEBRAFISH BOOK GUIDE; Wu YY, 2013, J ALZHEIMERS DIS, V37, P515, DOI 10.3233/JAD-130521; Xi YW, 2011, CURR NEUROL NEUROSCI, V11, P274, DOI 10.1007/s11910-011-0182-2; Xia WM, 2010, J ALZHEIMERS DIS, V20, P981, DOI 10.3233/JAD-2010-1412; Yamada M, 2005, BEHAV BRAIN RES, V474, P86; Yu Y, 2009, J NEUROCHEM, V108, P1480, DOI 10.1111/j.1471-4159.2009.05882.x; Zhang WV, 2005, APOPTOSIS, V10, P75, DOI 10.1007/s10495-005-6063-x	60	55	58	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 4	2014	9	9							e105862	10.1371/journal.pone.0105862	http://dx.doi.org/10.1371/journal.pone.0105862			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3XV	25187954	gold, Green Published, Green Submitted			2022-12-27	WOS:000341271500015
J	Premi, E; Cauda, F; Gasparotti, R; Diano, M; Archetti, S; Padovani, A; Borroni, B				Premi, Enrico; Cauda, Franco; Gasparotti, Roberto; Diano, Matteo; Archetti, Silvana; Padovani, Alessandro; Borroni, Barbara			Multimodal fMRI Resting-State Functional Connectivity in Granulin Mutations: The Case of Fronto-Parietal Dementia	PLOS ONE			English	Article							FRONTOTEMPORAL LOBAR DEGENERATION; VOXEL-BASED MORPHOMETRY; DEFAULT MODE NETWORK; ALZHEIMERS-DISEASE; REGIONAL HOMOGENEITY; MOLECULAR NEXOPATHIES; DIAGNOSTIC-CRITERIA; BEHAVIORAL VARIANT; TISSUE PATHOLOGY; SUBJECT MOTION	Background: Monogenic dementias represent a great opportunity to trace disease progression from preclinical to symptomatic stages. Frontotemporal Dementia related to Granulin (GRN) mutations presents a specific framework of brain damage, involving fronto-temporal regions and long inter-hemispheric white matter bundles. Multimodal resting-state functional MRI (rs-fMRI) is a promising tool to carefully describe disease signature from the earliest disease phase. Objective: To define local connectivity alterations in GRN related pathology moving from the presymptomatic (asymptomatic GRN mutation carriers) to the clinical phase of the disease (GRN-related Frontotemporal Dementia). Methods: Thirty-one GRN Thr272fs mutation carriers (14 patients with Frontotemporal Dementia and 17 asymptomatic carriers) and 38 healthy controls were recruited. Local connectivity measures (Regional Homogeneity (ReHo), Fractional Amplitude of Low Frequency Fluctuation (fALFF) and Degree Centrality (DC)) were computed, considering age and gender as nuisance variables as well as the influence of voxel-level gray matter atrophy. Results: Asymptomatic GRN carriers had selective reduced ReHo in the left parietal region and increased ReHo in frontal regions compared to healthy controls. Considering Frontotemporal Dementia patients, all measures (ReHo, fALFF and DC) were reduced in inferior parietal, frontal lobes and posterior cingulate cortex. Considering GRN mutation carriers, an inverse correlation with age in the posterior cingulate cortex, inferior parietal lobule and orbitofrontal cortex was found. Conclusions: GRN pathology is characterized by functional brain network alterations even decades before the clinical onset; they involve the parietal region primarily and then spread to the anterior regions of the brain, supporting the concept of molecular nexopathies.	[Premi, Enrico; Padovani, Alessandro; Borroni, Barbara] Univ Brescia, Neurol Unit, Ctr Ageing Brain & Neurodegenerat Disorders, Brescia, Italy; [Cauda, Franco; Diano, Matteo] Koelliker Hosp, Clin & Expt Ctr Funct Magnet Resonance Imaging, Turin, Italy; [Cauda, Franco; Diano, Matteo] Univ Turin, Dept Psychol, Turin, Italy; [Gasparotti, Roberto] Univ Brescia, Neuroradiol Unit, Brescia, Italy; [Gasparotti, Roberto] Brescia Hosp, Lab Anal 3, Brescia, Italy	University of Brescia; University of Turin; University of Brescia; Hospital Spedali Civili Brescia	Borroni, B (corresponding author), Univ Brescia, Neurol Unit, Ctr Ageing Brain & Neurodegenerat Disorders, Brescia, Italy.	bborroni@inwind.it	Gasparotti, Roberto/K-5165-2018; Padovani, Alessandro/ABI-7312-2020; Borroni, Barbara/AAN-4105-2020; Cauda, Franco/G-5021-2010; Diano, Matteo/U-4333-2017; Premi, Enrico/J-9854-2018	Gasparotti, Roberto/0000-0002-2591-2415; Padovani, Alessandro/0000-0002-0119-3639; Cauda, Franco/0000-0003-1526-8475; Diano, Matteo/0000-0001-7024-5183; Premi, Enrico/0000-0002-4342-6963				Ashburner J, 2005, NEUROIMAGE, V26, P839, DOI 10.1016/j.neuroimage.2005.02.018; Ashburner J, 2001, NEUROIMAGE, V14, P1238, DOI 10.1006/nimg.2001.0961; Baker M, 2006, NATURE, V442, P916, DOI 10.1038/nature05016; Borroni B, 2008, REJUV RES, V11, P585, DOI 10.1089/rej.2007.0623; Borroni B, 2010, EUR J NEUROL, V17, P703, DOI 10.1111/j.1468-1331.2009.02911.x; Borroni B, 2008, NEUROGENETICS, V9, P197, DOI 10.1007/s10048-008-0127-3; Borroni B, 2012, NEUROBIOL AGING, V33, P2506, DOI 10.1016/j.neurobiolaging.2011.10.031; Buckner RL, 2009, J NEUROSCI, V29, P1860, DOI 10.1523/JNEUROSCI.5062-08.2009; Buzsaki G, 2004, SCIENCE, V304, P1926, DOI 10.1126/science.1099745; Cabral J, 2011, NEUROIMAGE, V57, P130, DOI 10.1016/j.neuroimage.2011.04.010; Casanova R, 2007, NEUROIMAGE, V34, P137, DOI 10.1016/j.neuroimage.2006.09.011; Chhatwal JP, 2013, NEUROLOGY, V81, P736, DOI 10.1212/WNL.0b013e3182a1aafe; Chow Tiffany W, 2013, Continuum (Minneap Minn), V19, P438, DOI 10.1212/01.CON.0000429173.35439.9c; Cruts M, 2006, NATURE, V442, P920, DOI 10.1038/nature05017; Deco G, 2011, NAT REV NEUROSCI, V12, P43, DOI 10.1038/nrn2961; Di X, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00118; Dopper EGP, 2013, NEUROLOGY, V80, P814, DOI 10.1212/WNL.0b013e31828407bc; Farb NAS, 2013, CORTEX, V49, P1856, DOI 10.1016/j.cortex.2012.09.008; Filippi M, 2013, HUM BRAIN MAPP, V34, P1330, DOI 10.1002/hbm.21514; Friston KJ, 1996, MAGNET RESON MED, V35, P346, DOI 10.1002/mrm.1910350312; Garibotto V, 2008, NEUROLOGY, V71, P1342, DOI 10.1212/01.wnl.0000327670.62378.c0; Gorno-Tempini ML, 2011, NEUROLOGY, V76, P1006, DOI 10.1212/WNL.0b013e31821103e6; Hayasaka S, 2004, NEUROIMAGE, V22, P676, DOI 10.1016/j.neuroimage.2004.01.041; He Y, 2007, NEUROIMAGE, V35, P488, DOI 10.1016/j.neuroimage.2006.11.042; Jacova C, 2013, NEUROLOGY, V81, P1322, DOI 10.1212/WNL.0b013e3182a8237e; Kendall M.G., 1990, RANK CORRELATION MET, V5th; Long XY, 2008, J NEUROSCI METH, V171, P349, DOI 10.1016/j.jneumeth.2008.03.021; Mackenzie IRA, 2010, ACTA NEUROPATHOL, V119, P1, DOI 10.1007/s00401-009-0612-2; Maximo JO, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00605; McKhann GM, 2001, ARCH NEUROL-CHICAGO, V58, P1803, DOI 10.1001/archneur.58.11.1803; Mesmoudi S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067444; Mesulam MM, 1998, BRAIN, V121, P1013, DOI 10.1093/brain/121.6.1013; Mevel K, 2013, NEUROBIOL AGING, V34, P1292, DOI 10.1016/j.neurobiolaging.2012.08.018; Moreno F, 2013, NEUROBIOL AGING, V34, P1462, DOI 10.1016/j.neurobiolaging.2012.11.005; Mowinckel AM, 2012, NEUROIMAGE, V63, P1364, DOI 10.1016/j.neuroimage.2012.08.004; Neary D, 1998, NEUROLOGY, V51, P1546, DOI 10.1212/WNL.51.6.1546; Oakes TR, 2007, NEUROIMAGE, V34, P500, DOI 10.1016/j.neuroimage.2006.10.007; Onoda K, 2012, J COGNITIVE NEUROSCI, V24, P2186, DOI 10.1162/jocn_a_00269; Pereira JMS, 2009, NEUROLOGY, V72, P1653, DOI 10.1212/WNL.0b013e3181a55fa2; Petersson KM, 1999, PHILOS T R SOC B, V354, P1261, DOI 10.1098/rstb.1999.0478; Pievani M, 2014, ALZHEIMERS DEMENT; Poldrack RA, 2008, NEUROIMAGE, V40, P409, DOI 10.1016/j.neuroimage.2007.11.048; Power JD, 2012, NEUROIMAGE, V59, P2142, DOI 10.1016/j.neuroimage.2011.10.018; Premi E, 2013, JAMA NEUROL; Premi E, 2013, J NUCL MED, V54, P1066, DOI 10.2967/jnumed.112.111773; Rademakers R, 2012, NAT REV NEUROL, V8, P423, DOI 10.1038/nrneurol.2012.117; Rascovsky K, 2011, BRAIN, V134, P2456, DOI 10.1093/brain/awr179; Rohrer JD, 2009, NEUROLOGY, V72, P1562, DOI 10.1212/WNL.0b013e3181a4124e; Rohrer JD, 2011, BRAIN, V134, P2565, DOI 10.1093/brain/awr198; Rytty R, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00461; Sieben A, 2012, ACTA NEUROPATHOL, V124, P353, DOI 10.1007/s00401-012-1029-x; Smieskova R, 2012, HUM BRAIN MAPP, V33, P2281, DOI 10.1002/hbm.21360; Song JY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063727; Song XW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025031; Tang W, 2011, SCIENCE, V332, P478, DOI 10.1126/science.1199214; Tian LX, 2012, NEUROIMAGE, V60, P539, DOI 10.1016/j.neuroimage.2011.11.098; Toh H, 2011, J MOL NEUROSCI, V45, P538, DOI 10.1007/s12031-011-9569-4; Turner JA, 2013, FRONT NEUROSCI-SWITZ, V7, DOI 10.3389/fnins.2013.00137; Van Damme P, 2008, J CELL BIOL, V181, P37, DOI 10.1083/jcb.200712039; van den Heuvel MP, 2013, J NEUROSCI, V33, P14489, DOI 10.1523/JNEUROSCI.2128-13.2013; Wang JH, 2010, FRONT SYST NEUROSCI, V4, DOI 10.3389/fnsys.2010.00016; Wang ZQ, 2011, HUM BRAIN MAPP, V32, P1720, DOI 10.1002/hbm.21140; Warren JD, 2013, TRENDS NEUROSCI, V36, P561, DOI 10.1016/j.tins.2013.06.007; Warren JD, 2012, NEURON, V73, P1060, DOI 10.1016/j.neuron.2012.03.006; Whitwell JL, 2009, NEUROLOGY, V72, P813, DOI 10.1212/01.wnl.0000343851.46573.67; Whitwell JL, 2007, ARCH NEUROL-CHICAGO, V64, P371, DOI 10.1001/archneur.64.3.371; Whitwell JL, 2005, ARCH NEUROL-CHICAGO, V62, P1402, DOI 10.1001/archneur.62.9.1402; Yang X, 2011, NEUROIMAGE, V57, P423, DOI 10.1016/j.neuroimage.2011.04.046; Zang YF, 2004, NEUROIMAGE, V22, P394, DOI 10.1016/j.neuroimage.2003.12.030; Zhang ZQ, 2012, NEUROIMAGE, V59, P1429, DOI 10.1016/j.neuroimage.2011.08.049; Zhou J, 2010, BRAIN, V133, P1352, DOI 10.1093/brain/awq075; Zou QH, 2008, J NEUROSCI METH, V172, P137, DOI 10.1016/j.jneumeth.2008.04.012; Zuo XN, 2013, NEUROIMAGE, V65, P374, DOI 10.1016/j.neuroimage.2012.10.017; Zuo XN, 2012, CEREB CORTEX, V22, P1862, DOI 10.1093/cercor/bhr269; Zuo XN, 2010, NEUROIMAGE, V49, P1432, DOI 10.1016/j.neuroimage.2009.09.037	75	49	49	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 4	2014	9	9							e106500	10.1371/journal.pone.0106500	http://dx.doi.org/10.1371/journal.pone.0106500			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3XV	25188321	Green Published, Green Submitted, gold			2022-12-27	WOS:000341271500046
J	Takano, K; Yatabe, MS; Abe, A; Suzuki, Y; Sanada, H; Watanabe, T; Kimura, J; Yatabe, J				Takano, Kozue; Yatabe, Midori Sasaki; Abe, Asami; Suzuki, Yu; Sanada, Hironobu; Watanabe, Tsuyoshi; Kimura, Junko; Yatabe, Junichi			Characteristic Expressions of GABA Receptors and GABA Producing/Transporting Molecules in Rat Kidney	PLOS ONE			English	Article							GAMMA-AMINOBUTYRIC-ACID; BLOOD-PRESSURE; IDENTIFICATION; SUBUNITS; DOPAMINE; CLONING; RABBIT	Gamma-aminobutyric acid (GABA) is an important neurotransmitter, but recent reports have revealed the expression of GABAergic components in peripheral, non-neural tissues. GABA administration induces natriuresis and lowers blood pressure, suggesting renal GABA targets. However, systematic evaluation of renal GABAergic components has not been reported. In this study, kidney cortices of Wistar-Kyoto rats (WKY) were used to assay for messenger RNAs of GABA-related molecules using RT-PCR. In WKY kidney cortex, GABA(A) receptor subunits, alpha 1, beta 3, delta, epsilon and pi, in addition to both types of GABA(B) receptors, R1 and R2, and GABA(C) receptor rho 1 and rho 2 subunit mRNAs were detected. Kidney cortex also expressed mRNAs of glutamate decarboxylase (GAD) 65, GAD67, 4-aminobutyrate aminotransferase and GABA transporter, GAT2. Western blot and/or immunohistochemistry were performed for those molecules detected by RT-PCR. By immunofluorescent observation, co-staining of alpha 1, beta 3, and pi subunits was observed mainly on the apical side of cortical tubules, and immunoblot of kidney protein precipitated with pi subunit antibody revealed alpha 1 and beta 3 subunit co-assembly. This is the first report of GABA(A) receptor pi subunit in the kidney. In summary, unique set of GABA receptor subunits and subtypes were found in rat kidney cortex. As GABA producing enzymes, transporters and degrading enzyme were also detected, a possible existence of local renal GABAergic system with an autocrine/paracrine mechanism is suggested.	[Takano, Kozue; Yatabe, Midori Sasaki; Abe, Asami; Suzuki, Yu; Kimura, Junko; Yatabe, Junichi] Fukushima Med Univ, Sch Med, Dept Pharmacol, Fukushima, Japan; [Watanabe, Tsuyoshi; Yatabe, Junichi] Fukushima Med Univ, Sch Med, Dept Nephrol Hypertens Diabetol Endocrinol & Meta, Fukushima, Japan; [Sanada, Hironobu] Fukushima Welf Federat Agr Cooperat, Div Hlth Sci Res, Fukushima, Japan	Fukushima Medical University; Fukushima Medical University	Yatabe, MS (corresponding author), Fukushima Med Univ, Sch Med, Dept Pharmacol, Fukushima, Japan.	msasaki@fmu.ac.jp; jyatabe@fmu.ac.jp			KAKENHI [23790949]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK081943] Funding Source: NIH RePORTER	KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This study was supported by KAKENHI (Grant-in-Aid for Young Scientists (B) (23790949)). URL: http://www.jsps.go.jp/english/index.html. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BERMAN JA, 1994, J NEUROCHEM, V63, P1948; BORDEN LA, 1992, J BIOL CHEM, V267, P21098; Braun M, 2010, DIABETES, V59, P1694, DOI 10.2337/db09-0797; Chintagari NR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014171; Christiansen B, 2007, J BIOL CHEM, V282, P19331, DOI 10.1074/jbc.M702111200; ERDO SL, 1984, BIOCHEM BIOPH RES CO, V125, P18, DOI 10.1016/S0006-291X(84)80327-7; ERDO SL, 1991, EXPERIENTIA, V47, P227; Frolund Bente, 2002, Current Topics in Medicinal Chemistry, V2, P817, DOI 10.2174/1568026023393525; GRIGORENKO EV, 1994, VISUAL NEUROSCI, V11, P379, DOI 10.1017/S0952523800001723; Hayakawa K, 2004, BRIT J NUTR, V92, P411, DOI 10.1079/BJN20041221; Hedblom E, 1997, J BIOL CHEM, V272, P15346, DOI 10.1074/jbc.272.24.15346; Hu JH, 2002, NEUROCHEM RES, V27, P195, DOI 10.1023/A:1014876303062; Hussain T, 2003, EXP BIOL MED, V228, P134, DOI 10.1177/153537020322800202; Jose PA, 2010, BBA-MOL BASIS DIS, V1802, P1259, DOI 10.1016/j.bbadis.2010.02.004; Kobuchi S, 2009, EUR J PHARMACOL, V623, P113, DOI 10.1016/j.ejphar.2009.09.023; Kontani Y, 1999, EUR J BIOCHEM, V264, P218, DOI 10.1046/j.1432-1327.1999.00612.x; Liu ZH, 1996, NEPHRON, V72, P662, DOI 10.1159/000188956; Mizuta K, 2008, AM J RESP CELL MOL, V39, P296, DOI 10.1165/rcmb.2007-0414OC; Monasterolo LA, 1996, J PHARMACOL EXP THER, V279, P602; Neelands TR, 1999, MOL PHARMACOL, V56, P598, DOI 10.1124/mol.56.3.598; Neusser MA, 2010, AM J PATHOL, V176, P594, DOI 10.2353/ajpath.2010.090268; PARDUCZ A, 1992, J HISTOCHEM CYTOCHEM, V40, P675, DOI 10.1177/40.5.1573248; PARRAMON M, 1994, NEUROSCI LETT, V168, P243, DOI 10.1016/0304-3940(94)90460-X; Sarang SS, 2008, J PHARMACOL EXP THER, V324, P376, DOI 10.1124/jpet.107.129957; Sarang SS, 2001, J AM SOC NEPHROL, V12, P1107, DOI 10.1681/ASN.V1261107; SHERIF FM, 1994, PROG NEURO-PSYCHOPH, V18, P1219, DOI 10.1016/0278-5846(94)90089-2; Slugg RM, 2003, J PHYSIOL-LONDON, V551, P295, DOI 10.1113/jphysiol.2003.041319; Tao WC, 2013, J NEUROSCI, V33, P3738, DOI 10.1523/JNEUROSCI.4829-12.2013; Whiting PJ, 1997, J NEUROSCI, V17, P5027; Woroniecka KI, 2011, DIABETES, V60, P2354, DOI 10.2337/db10-1181; Yamakoshi J, 2007, BIOSCI BIOTECH BIOCH, V71, P165, DOI 10.1271/bbb.60424	31	17	19	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 4	2014	9	9							e105835	10.1371/journal.pone.0105835	http://dx.doi.org/10.1371/journal.pone.0105835			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3XV	25188493	Green Submitted, gold, Green Published			2022-12-27	WOS:000341271500014
J	Wu, CM; Luan, H; Zhang, X; Wang, S; Zhang, XP; Sun, XB; Guo, P				Wu, Chongming; Luan, Hong; Zhang, Xue; Wang, Shuai; Zhang, Xiaopo; Sun, Xiaobo; Guo, Peng			Chlorogenic Acid Protects against Atherosclerosis in ApoE(-/-) Mice and Promotes Cholesterol Efflux from RAW264.7 Macrophages	PLOS ONE			English	Article							FOAM CELL-FORMATION; CARDIOVASCULAR-DISEASE; COFFEE CONSUMPTION; GENE-EXPRESSION; RECEPTOR-ALPHA; CAFFEIC ACID; RATS; ACTIVATION; PATHWAY; GLUCOSE	Chlorogenic acid (CGA) is one of the most abundant polyphenols in the human diet and is suggested to be a potential antiatherosclerotic agent due to its proposed hypolipidemic, anti-inflammatory and antioxidative properties. The aim of this study was to evaluate the effect of CGA on atherosclerosis development in ApoE(-/-) mice and its potential mechanism. ApoE(-/-) mice were fed a cholesterol-rich diet without (control) or with CGA (200 and 400 mg/kg) or atorvastatin (4 mg/kg) for 12 weeks. During the study plasma lipid and inflammatory parameters were determined. Treatment with CGA (400 mg/ kg) reduced atherosclerotic lesion area and vascular dilatation in the aortic root, comparable to atorvastatin. CGA (400 mg/kg) also significantly decreased plasma levels of total cholesterol, triglycerides and low-density lipoprotein-cholesterol as well as inflammatory markers. Supplementation with CGA or CGA metabolites-containing serum suppressed oxidized lowdensity lipoprotein (oxLDL)-induced lipid accumulation and stimulated cholesterol efflux from RAW264.7 cells. CGA significantly increased the mRNA levels of PPARc, LXRa, ABCA1 and ABCG1 as well as the transcriptional activity of PPARc. Cholesterol efflux assay showed that three major metabolites, caffeic, ferulic and gallic acids, significantly stimulated cholesterol efflux from RAW264.7 cells. These results suggest that CGA potently reduces atherosclerosis development in ApoE(-/-) mice and promotes cholesterol efflux from RAW264.7 macrophages. Caffeic, ferulic and gallic acids may be the potential active compounds accounting for the in vivo effect of CGA.	[Guo, Peng] Chinese Acad Med Sci, Pharmacol & Toxicol Res Ctr, Inst Med Plant Dev, Beijing 100730, Peoples R China; Peking Union Med Coll, Beijing 100730, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Medicinal Plant Development - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College	Guo, P (corresponding author), Chinese Acad Med Sci, Pharmacol & Toxicol Res Ctr, Inst Med Plant Dev, Beijing 100730, Peoples R China.	pguo@implad.ac.cn	Wu, Chongming/GOJ-9081-2022; Guo, Peng/GWC-0572-2022; Wu, Chongming/AAQ-9085-2021; guo, peng/AAG-4052-2019	Wu, Chongming/0000-0003-2898-370X	National Natural Sciences Foundation of China [81001437, 81202994]	National Natural Sciences Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the following grants: 81001437 and 81202994 from National Natural Sciences Foundation of China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Azuma K, 2000, J AGR FOOD CHEM, V48, P5496, DOI 10.1021/jf000483q; Berbee JFP, 2013, J NUTR BIOCHEM, V24, P1423, DOI 10.1016/j.jnutbio.2012.11.009; Chinetti G, 2001, NAT MED, V7, P53, DOI 10.1038/83348; Choi JM, 2012, MOL CELLS, V33, P217, DOI 10.1007/s10059-012-2297-y; dos Santos MD, 2006, BIOL PHARM BULL, V29, P2236, DOI 10.1248/bpb.29.2236; de Haan W, 2008, CIRCULATION, V117, P2515, DOI 10.1161/CIRCULATIONAHA.107.761965; Ding L, 2012, CELL METAB, V15, P861, DOI 10.1016/j.cmet.2012.04.020; Erk T, 2012, MOL NUTR FOOD RES, V56, P1488, DOI 10.1002/mnfr.201200222; Frostegard J, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-117; Goff DC, 2006, CIRCULATION, V113, P647, DOI 10.1161/CIRCULATIONAHA.105.552737; Gu L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065477; Guo P, 2010, J PHARMACOL SCI, V113, P395, DOI 10.1254/jphs.10041FP; Jain SK, 2009, ANTIOXID REDOX SIGN, V11, P241, DOI 10.1089/ars.2008.2140; Jeong HW, 2011, DIABETES, V60, P496, DOI 10.2337/db09-1145; Johnston KL, 2003, AM J CLIN NUTR, V78, P728, DOI 10.1093/ajcn/78.4.728; Kennedy MA, 2005, CELL METAB, V1, P121, DOI 10.1016/j.cmet.2005.01.002; Lee SM, 2013, NUTR RES, V33, P136, DOI 10.1016/j.nutres.2012.11.010; Lee TS, 2010, J CELL BIOCHEM, V111, P104, DOI 10.1002/jcb.22667; Liu YJ, 2013, MOL MED REP, V8, P1106, DOI 10.3892/mmr.2013.1652; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Loke WM, 2010, ARTERIOSCL THROM VAS, V30, P749, DOI 10.1161/ATVBAHA.109.199687; Monteiro M, 2007, J NUTR, V137, P2196, DOI 10.1093/jn/137.10.2196; Moore KJ, 2011, CELL, V145, P341, DOI 10.1016/j.cell.2011.04.005; Ohashi R, 2005, QJM-INT J MED, V98, P845, DOI 10.1093/qjmed/hci136; Ohnishi R, 2006, BIOSCI BIOTECH BIOCH, V70, P2560, DOI 10.1271/bbb.60243; Ong KW, 2013, BIOCHEM PHARMACOL, V85, P1341, DOI 10.1016/j.bcp.2013.02.008; Ong KW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032718; Park SH, 2011, J NUTR, V141, P1931, DOI 10.3945/jn.111.144816; Sato Y, 2011, INT J PHARMACEUT, V403, P136, DOI 10.1016/j.ijpharm.2010.09.035; Shan JH, 2009, INT IMMUNOPHARMACOL, V9, P1042, DOI 10.1016/j.intimp.2009.04.011; Shi HT, 2013, INFLAMM RES, V62, P581, DOI 10.1007/s00011-013-0610-7; Shi HT, 2013, TOXICOLOGY, V303, P107, DOI 10.1016/j.tox.2012.10.025; Sirimarco G, 2013, STROKE, V44, P373, DOI 10.1161/STROKEAHA.112.673129; Suzuki A, 2006, J HYPERTENS, V24, P1065, DOI 10.1097/01.hjh.0000226196.67052.c0; Tall AR, 2008, CELL METAB, V7, P365, DOI 10.1016/j.cmet.2008.03.001; Upadhyay R, 2013, CRIT REV FOOD SCI, V53, P968, DOI 10.1080/10408398.2011.576319; Uto-Kondo H, 2010, CIRC RES, V106, P779, DOI 10.1161/CIRCRESAHA.109.206615; Wan CW, 2013, PHYTOTHER RES, V27, P545, DOI 10.1002/ptr.4751; Wang M, 2013, ATHEROSCLEROSIS, V229, P62, DOI 10.1016/j.atherosclerosis.2013.01.017; Wu CM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035764; Wu ZH, 2009, PHARMACOLOGY, V84, P282, DOI 10.1159/000242999; Xu JG, 2012, J AGR FOOD CHEM, V60, P11625, DOI 10.1021/jf303771s; Yusuf S, 2014, EUR HEART J, V35, P353, DOI 10.1093/eurheartj/eht407; Zhang J, 2011, ASSAY DRUG DEV TECHN, V9, P136, DOI 10.1089/adt.2010.0288; Zhang XP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061922	45	57	62	1	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 4	2014	9	9							e95452	10.1371/journal.pone.0095452	http://dx.doi.org/10.1371/journal.pone.0095452			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3XV	25187964	Green Submitted, gold, Green Published			2022-12-27	WOS:000341271500001
J	Antu, KA; Riya, MP; Mishra, A; Anilkumar, KS; Chandrakanth, CK; Tamrakar, AK; Srivastava, AK; Raghu, KG				Antu, Kalathookunnel Antony; Riya, Mariam Philip; Mishra, Arvind; Anilkumar, Karunakaran S.; Chandrakanth, Chandrasekharan K.; Tamrakar, Akhilesh K.; Srivastava, Arvind K.; Raghu, K. Gopalan			Antidiabetic Property of Symplocos cochinchinensis Is Mediated by Inhibition of Alpha Glucosidase and Enhanced Insulin Sensitivity	PLOS ONE			English	Article							OLEANOLIC ACID; IN-VITRO; DIABETES-MELLITUS; OXIDATIVE STRESS; AGE INHIBITORS; BETA-CELL; TYPE-2; ANTIOXIDANT; RESISTANCE; FAT	The study is designed to find out the biochemical basis of antidiabetic property of Symplocos cochinchinensis (SC), the main ingredient of 'Nisakathakadi' an Ayurvedic decoction for diabetes. Since diabetes is a multifactorial disease, ethanolic extract of the bark (SCE) and its fractions (hexane, dichloromethane, ethyl acetate and 90% ethanol) were evaluated by in vitro methods against multiple targets relevant to diabetes such as the alpha glucosidase inhibition, glucose uptake, adipogenic potential, oxidative stress, pancreatic beta cell proliferation, inhibition of protein glycation, protein tyrosine phosphatase-1B (PTP-1B) and dipeptidyl peptidase-IV (DPP-IV). Among the extracts, SCE exhibited comparatively better activity like alpha glucosidase inhibition (IC50 value-82.07 +/- 2.10 mu g/mL), insulin dependent glucose uptake (3 fold increase) in L6 myotubes, pancreatic beta cell regeneration in RIN-m5F (3.5 fold increase) and reduced triglyceride accumulation (22% decrease) in 3T3L1 cells, protection from hyperglycemia induced generation of reactive oxygen species in HepG2 cells (59.57% decrease) with moderate antiglycation and PTP-1B inhibition. Chemical characterization by HPLC revealed the superiority of SCE over other extracts due to presence and quantity of bioactives (beta-sitosterol, phloretin 2' glucoside, oleanolic acid) in addition to minerals like magnesium, calcium, potassium, sodium, zinc and manganese. So SCE has been subjected to oral sucrose tolerance test to evaluate its antihyperglycemic property in mild diabetic and diabetic animal models. SCE showed significant antihyperglycemic activity in in vivo diabetic models. We conclude that SC mediates the antidiabetic activity mainly via alpha glucosidase inhibition, improved insulin sensitivity, with moderate antiglycation and antioxidant activity.	[Antu, Kalathookunnel Antony; Riya, Mariam Philip; Chandrakanth, Chandrasekharan K.; Raghu, K. Gopalan] NIIST, CSIR, Agroproc & Nat Prod Div, Thiruvananthapuram, Kerala, India; [Mishra, Arvind; Srivastava, Arvind K.] CDRI, CSIR, Div Biochem, Lucknow, Uttar Pradesh, India; [Anilkumar, Karunakaran S.] CDRI, CSIR, Div Med Chem, Lucknow, Uttar Pradesh, India; [Tamrakar, Akhilesh K.] CDRI, CSIR, Div Pharmacol, Lucknow, Uttar Pradesh, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - National Institute Interdisciplinary Science & Technology (NIIST); Council of Scientific & Industrial Research (CSIR) - India; CSIR - Central Drug Research Institute (CDRI); Council of Scientific & Industrial Research (CSIR) - India; CSIR - Central Drug Research Institute (CDRI); Council of Scientific & Industrial Research (CSIR) - India; CSIR - Central Drug Research Institute (CDRI)	Raghu, KG (corresponding author), NIIST, CSIR, Agroproc & Nat Prod Div, Thiruvananthapuram, Kerala, India.	raghukgopal2009@rediffmail.com	Kalathookunnel Antony, Antu/AAH-2517-2022; Kalathookunnel Antony, Antu/AFM-0173-2022; Raghu, K G/AAT-8042-2021		Indian Council of Medical Research, Govt. of India [3/1/3/JRF-2009/MPD-34 (21404)]	Indian Council of Medical Research, Govt. of India(Indian Council of Medical Research (ICMR))	The funder for this work was the Indian Council of Medical Research, Govt. of India, as Research Fellowship (3/1/3/JRF-2009/MPD-34 (21404)) of Antu KA. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbasi MA, 2004, THESIS U KARACHI PAK; Ahmed N, 2005, DIABETES RES CLIN PR, V67, P3, DOI 10.1016/j.diabres.2004.09.004; Ali MS, 2002, PHYTOCHEMISTRY, V60, P295, DOI 10.1016/S0031-9422(02)00104-8; Antu KA, 2014, EXP TOXICOL PATHOL, V66, P281, DOI 10.1016/j.etp.2014.05.004; Apostolidis E, 2007, INNOV FOOD SCI EMERG, V8, P46, DOI 10.1016/j.ifset.2006.06.001; Atanasov AG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061755; Bailey C.J., 2004, PRACT DIABETES INT, V21, P115, DOI [DOI 10.1002/PDI.606, 10.1002/pdi.606]; BAILEY CJ, 1989, DIABETES CARE, V12, P553, DOI 10.2337/diacare.12.8.553; Brindis F, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/591313; Castellano JM, 2013, DIABETES, V62, P1791, DOI 10.2337/db12-1215; Chai JW, 2011, GENES NUTR, V6, P181, DOI 10.1007/s12263-010-0196-4; Chang CC, 2002, J FOOD DRUG ANAL, V10, P178; Cheng AYY, 2005, CAN MED ASSOC J, V172, P213, DOI 10.1503/cmaj.1031414; Chiasson JL, 2004, DIABETES, V53, pS34, DOI 10.2337/diabetes.53.suppl_3.S34; CHIASSON JL, 1994, ANN INTERN MED, V121, P928, DOI 10.7326/0003-4819-121-12-199412150-00004; Drucker DJ, 2006, LANCET, V368, P1696, DOI 10.1016/S0140-6736(06)69705-5; Evans JL, 2002, ENDOCR REV, V23, P599, DOI 10.1210/er.2001-0039; Fowler MJ, 2008, CLIN DIABETES, V26, P77, DOI [DOI 10.2337/DIACLIN.26.2.77, 10.2337/diaclin.26.2.77]; Graziose Rocky, 2010, Curr Drug Discov Technol, V7, P2; Gupta R, 2011, J DIABETES, V3, P29, DOI 10.1111/j.1753-0407.2010.00107.x; HALLIWELL B, 1987, ANAL BIOCHEM, V165, P215, DOI 10.1016/0003-2697(87)90222-3; Hanfeld M, 2008, TYPE 2 DIABETES PRIN, P121; Jones William P, 2012, Methods Mol Biol, V864, P341, DOI 10.1007/978-1-61779-624-1_13; Kadowaki T, 2006, J CLIN INVEST, V116, P1784, DOI 10.1172/JCI29126; Krishnanvaidyan KV, 2000, SAHASRAYOGAM SUJANAP; Lebovitz HE, 2001, J CLIN ENDOCR METAB, V86, P280, DOI 10.1210/jc.86.1.280; Leonti M, 2013, FRONT PHARMACOL, V4, DOI 10.3389/fphar.2013.00092; Li SS, 2009, JAMA-J AM MED ASSOC, V302, P179, DOI 10.1001/jama.2009.976; MAKKAR HPS, 1993, J SCI FOOD AGR, V61, P161, DOI 10.1002/jsfa.2740610205; Martini LA, 2010, NUTR REV, V68, P341, DOI 10.1111/j.1753-4887.2010.00296.x; Masumoto S, 2009, J AGR FOOD CHEM, V57, P4651, DOI 10.1021/jf9008197; Meena AK, 2009, ASIAN J TRADIT MED, V4, P152; Moller DE, 2001, NATURE, V414, P821, DOI 10.1038/414821a; Nagai R, 2012, DIABETES, V61, P549, DOI 10.2337/db11-1120; Najafian M, 2012, MOL BIOL REP, V39, P5299, DOI 10.1007/s11033-011-1328-7; Nerurkar PV, 2010, BMC COMPLEM ALTERN M, V10, DOI 10.1186/1472-6882-10-34; Nishikawa T, 2000, NATURE, V404, P787, DOI 10.1038/35008121; Nugent C, 2001, MOL ENDOCRINOL, V15, P1729, DOI 10.1210/me.15.10.1729; Osonoi T, 2010, METABOLISM, V59, P1816, DOI 10.1016/j.metabol.2010.06.006; Pellati F, 2012, J CHROMATOGR A, V1242, P43, DOI 10.1016/j.chroma.2012.04.025; Porasuphatana S, 2012, ASIA PAC J CLIN NUTR, V21, P12; Riya MP, 2014, J SCI FOOD AGR, V94, P943, DOI 10.1002/jsfa.6340; Ross SA, 2004, CHEM REV, V104, P1255, DOI 10.1021/cr0204653; Sankar V, 2013, J CARDIOVASC PHARM, V61, P23, DOI 10.1097/FJC.0b013e3182756ad3; Shi CM, 2008, J TISSUE ENG REGEN M, V2, P482, DOI 10.1002/term.120; Shilpa K, 2009, BIOTECHNOL LETT, V31, P1837, DOI 10.1007/s10529-009-0105-3; SHIMADA K, 1992, J AGR FOOD CHEM, V40, P945, DOI 10.1021/jf00018a005; Singh AB, 2009, NAT PROD RES, V23, P876, DOI 10.1080/14786410802420416; SINGLETON V. L., 1965, AMER J ENOL VITICULT, V16, P144; Soumyanath A., 2006, TRADITIONAL MED MODE; STOOKEY LL, 1970, ANAL CHEM, V42, P779, DOI 10.1021/ac60289a016; Sunil C, 2012, FOOD CHEM TOXICOL, V50, P1547, DOI 10.1016/j.fct.2012.01.029; Sunil C, 2011, J ETHNOPHARMACOL, V134, P298, DOI 10.1016/j.jep.2010.12.018; Tamrakar AK, 2010, ENDOCRINOLOGY, V151, P5624, DOI 10.1210/en.2010-0437; Tchinda AT, 2007, CHEM PHARM BULL, V55, P1402, DOI 10.1248/cpb.55.1402; Thomson M, 2007, FASEB J, V21; Tontonoz P, 2008, ANNU REV BIOCHEM, V77, P289, DOI 10.1146/annurev.biochem.77.061307.091829; Trease GE, 1989, PHARMACOGNOSY; Vasan S, 2001, EXPERT OPIN INV DRUG, V10, P1977, DOI 10.1517/13543784.10.11.1977; Vetere A, 2014, NAT REV DRUG DISCOV, V13, P278, DOI 10.1038/nrd4231; Viollet B, 2012, CLIN SCI, V122, P253, DOI 10.1042/CS20110386; Wang X, 2013, MOL CELL ENDOCRINOL, V376, P70, DOI 10.1016/j.mce.2013.06.014; Winiarska K, 2004, MOL CELL BIOCHEM, V261, P91, DOI 10.1023/B:MCBI.0000028742.83086.43; Yamazaki T, 2005, J BIOL CHEM, V280, P21506, DOI 10.1074/jbc.M412989200; Yu YH, 2002, J BIOL CHEM, V277, P50876, DOI 10.1074/jbc.M207353200; Zimmet P, 2001, NATURE, V414, P782, DOI 10.1038/414782a; Zou Chenhui, 2007, Journal of Pharmacological and Toxicological Methods, V56, P63, DOI 10.1016/j.vascn.2007.01.002	67	19	19	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 3	2014	9	9							e105829	10.1371/journal.pone.0105829	http://dx.doi.org/10.1371/journal.pone.0105829			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3TB	25184241	Green Submitted, gold, Green Published			2022-12-27	WOS:000341257700026
J	Berge, O; Monteil, CL; Bartoli, C; Chandeysson, C; Guilbaud, C; Sands, DC; Morris, CE				Berge, Odile; Monteil, Caroline L.; Bartoli, Claudia; Chandeysson, Charlotte; Guilbaud, Caroline; Sands, David C.; Morris, Cindy E.			A User's Guide to a Data Base of the Diversity of Pseudomonas syringae and Its Application to Classifying Strains in This Phylogenetic Complex	PLOS ONE			English	Article							SAVASTANOI PV. SAVASTANOI; NATURALLY LACKING; SPECIES COMPLEX; CAUSAL AGENT; GENE; POPULATIONS; VIRULENCE; EVOLUTION; PATHOGEN; GENOME	The Pseudomonas syringae complex is composed of numerous genetic lineages of strains from both agricultural and environmental habitats including habitats closely linked to the water cycle. The new insights from the discovery of this bacterial species in habitats outside of agricultural contexts per se have led to the revelation of a wide diversity of strains in this complex beyond what was known from agricultural contexts. Here, through Multi Locus Sequence Typing (MLST) of 216 strains, we identified 23 clades within 13 phylogroups among which the seven previously described P. syringae phylogroups were included. The phylogeny of the core genome of 29 strains representing nine phylogroups was similar to the phylogeny obtained with MLST thereby confirming the robustness of MLST-phylogroups. We show that phenotypic traits rarely provide a satisfactory means for classification of strains even if some combinations are highly probable in some phylogroups. We demonstrate that the citrate synthase (cts) housekeeping gene can accurately predict the phylogenetic affiliation for more than 97% of strains tested. We propose a list of cts sequences to be used as a simple tool for quickly and precisely classifying new strains. Finally, our analysis leads to predictions about the diversity of P. syringae that is yet to be discovered. We present here an expandable framework mainly based on cts genetic analysis into which more diversity can be integrated.	[Berge, Odile; Monteil, Caroline L.; Bartoli, Claudia; Chandeysson, Charlotte; Guilbaud, Caroline; Morris, Cindy E.] INRA, Pathol Vegetale UR0407, F-84143 Montfavet, France; [Bartoli, Claudia] Univ Tuscia, Dept Sci & Technol Agr Forestry Nat & Energy DAFN, Viterbo, Italy; [Sands, David C.; Morris, Cindy E.] Montana State Univ, Dept Plant Sci & Plant Pathol, Bozeman, MT 59717 USA	INRAE; Tuscia University; Montana State University System; Montana State University Bozeman	Morris, CE (corresponding author), INRA, Pathol Vegetale UR0407, F-84143 Montfavet, France.	cindy.morris@avignon.inra.fr	MONTEIL, Caroline L./AAU-8284-2021; Bartoli, Claudia/F-4961-2017	MONTEIL, Caroline L./0000-0002-2834-6834; Bartoli, Claudia/0000-0003-1461-2983	Institut National de la Recherche Agronomique (INRA); Research Federation "Ecosystemes Continentaux et Risques Environnementaux" (ECCOREV) funds; Epicurus Fund	Institut National de la Recherche Agronomique (INRA); Research Federation "Ecosystemes Continentaux et Risques Environnementaux" (ECCOREV) funds; Epicurus Fund	This work was supported by internal funds from Institut National de la Recherche Agronomique (INRA), by the Research Federation "Ecosystemes Continentaux et Risques Environnementaux" (ECCOREV) funds for a research project to isolate strains from irrigation canals and by a contribution from the Epicurus Fund at Donors Trust to support publication fees. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almeida NF, 2010, PHYTOPATHOLOGY, V100, P208, DOI 10.1094/PHYTO-100-3-0208; Baltrus DA, 2014, MOL PLANT PATHOL, V15, P461, DOI 10.1111/mpp.12103; Baltrus DA, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002132; Bartoli C, 2014, MOL PLANT P IN PRESS; Bartoli C, 2014, ENVIRON MICROBIOL, V16, P2301, DOI 10.1111/1462-2920.12433; BILLING E, 1970, J APPL BACTERIOL, V33, P492, DOI 10.1111/j.1365-2672.1970.tb02225.x; Bodilis J, 2006, MICROBIOL-SGM, V152, P1075, DOI 10.1099/mic.0.28656-0; Bull CT, 2011, PHYTOPATHOLOGY, V101, P847, DOI 10.1094/PHYTO-11-10-0318; Clarke CR, 2010, MOL PLANT MICROBE IN, V23, P198, DOI 10.1094/MPMI-23-2-0198; Cottyn B, 2011, PLANT PATHOL, V60, P453, DOI 10.1111/j.1365-3059.2010.02388.x; Diallo MD, 2012, ISME J, V6, P1325, DOI 10.1038/ismej.2011.202; Gardan L, 1999, INT J SYST BACTERIOL, V49, P469, DOI 10.1099/00207713-49-2-469; Gerhardt P, 1981, MANUAL METHODS GEN B; Green S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010224; Gutierrez-Barranquero JA, 2013, PHYTOPATHOLOGY, V103, P1115, DOI 10.1094/PHYTO-04-13-0093-R; Hildebrand DC, 1988, PSEUDOMONAS, P60; Hockett KL, 2014, MOL PLANT MICROBE IN, V27, P923, DOI 10.1094/MPMI-11-13-0354-R; Hu FP, 1998, J APPL MICROBIOL, V85, P365; Humphrey PT, 2014, MOL ECOL, V23, P1497, DOI 10.1111/mec.12657; Hwang MSH, 2005, APPL ENVIRON MICROB, V71, P5182, DOI 10.1128/AEM.71.9.5182-5191.2005; Jakob K, 2002, MOL PLANT MICROBE IN, V15, P1195, DOI 10.1094/MPMI.2002.15.12.1195; Janse JD, 1996, SYST APPL MICROBIOL, V19, P589, DOI 10.1016/S0723-2020(96)80030-0; Joly M, 2013, ATMOS ENVIRON, V70, P392, DOI 10.1016/j.atmosenv.2013.01.027; KING EO, 1954, J LAB CLIN MED, V44, P301; Lamichhane JR, 2013, PLANT PATHOL, V62, P624, DOI 10.1111/j.1365-3059.2012.02670.x; Lamichhane JR, 2014, ADV AGRON, V126, P235, DOI 10.1016/B978-0-12-800132-5.00004-3; Maiden MCJ, 1998, P NATL ACAD SCI USA, V95, P3140, DOI 10.1073/pnas.95.6.3140; Marakeby H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089142; Marchi G, 2005, EUR J PLANT PATHOL, V112, P101, DOI 10.1007/s10658-005-0804-0; McCullagh P, 1989, GEN LINEAR MODELS; Miller CM, 1998, J APPL MICROBIOL, V84, P937; MISAGHI I, 1969, PHYTOPATHOLOGY, V59, P1436; Monteil CL, 2014, ISME J, V8, P2290, DOI 10.1038/ismej.2014.55; Monteil CL, 2013, NEW PHYTOL, V199, P800, DOI 10.1111/nph.12316; Monteil CL, 2011, ENVIRON MICROBIOL, V22, P2099; Morris CE, 2010, MBIO, V1, DOI 10.1128/mBio.00107-10; Morris CE, 2000, PHYTOPATHOLOGY, V90, P636, DOI 10.1094/PHYTO.2000.90.6.636; Morris CE, 2008, ISME J, V2, P321, DOI 10.1038/ismej.2007.113; Morris CE, 2007, INFECT GENET EVOL, V7, P84, DOI 10.1016/j.meegid.2006.05.002; Mucyn TS, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1003807; Mulet M, 2010, ENVIRON MICROBIOL, V12, P1513, DOI 10.1111/j.1462-2920.2010.02181.x; Natalini E, 2006, J PLANT PATHOL, V88, P219; O'Brien HE, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-141; ORSER C, 1985, J BACTERIOL, V164, P359, DOI 10.1128/JB.164.1.359-366.1985; Parkinson N, 2011, PLANT PATHOL, V60, P338, DOI 10.1111/j.1365-3059.2010.02366.x; Rodriguez-Palenzuela P, 2010, ENVIRON MICROBIOL, V12, P1604, DOI 10.1111/j.1462-2920.2010.02207.x; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Sarkar SF, 2004, APPL ENVIRON MICROB, V70, P1999, DOI 10.1128/AEM.70.4.1999-2012.2004; Sawada H, 1999, J MOL EVOL, V49, P627, DOI 10.1007/PL00006584; Sawada H, 1997, APPL ENVIRON MICROB, V63, P282, DOI 10.1128/AEM.63.1.282-288.1997; SCHAAD NW, 1979, ANNU REV PHYTOPATHOL, V17, P123, DOI 10.1146/annurev.py.17.090179.001011; Scortichini M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075794; Sulthana S, 2011, APPL ENVIRON MICROB, V77, P7896, DOI 10.1128/AEM.05683-11; Trantas EA, 2013, EUR J PLANT PATHOL, V137, P477, DOI 10.1007/s10658-013-0258-8; Van Hall CJJ, 1902, THESIS AMSTERDAM, V8, P372; WILSON M, 1994, APPL ENVIRON MICROB, V60, P4468, DOI 10.1128/AEM.60.12.4468-4477.1994; Xia X, 2013, MOL BIOL EVOL; Young JM, 2010, J PLANT PATHOL, V92, pS5	58	139	140	0	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 3	2014	9	9							e105547	10.1371/journal.pone.0105547	http://dx.doi.org/10.1371/journal.pone.0105547			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3TB	25184292	Green Submitted, Green Published, gold			2022-12-27	WOS:000341257700019
J	Herring, G; Eagles-Smith, CA; Gawlik, DE; Beerens, JM; Ackerman, JT				Herring, Garth; Eagles-Smith, Collin A.; Gawlik, Dale E.; Beerens, James M.; Ackerman, Joshua T.			Physiological Condition of Juvenile Wading Birds in Relation to Multiple Landscape Stressors in the Florida Everglades: Effects of Hydrology, Prey Availability, and Mercury Bioaccumulation	PLOS ONE			English	Article							IBISES EUDOCIMUS-ALBUS; CORTICOSTERONE LEVELS; WHITE IBIS; METHYLMERCURY; EXPOSURE; PROTEINS; BLOOD; EGRETS; TOXICOKINETICS; CONTAMINATION	The physiological condition of juvenile birds can be influenced by multiple ecological stressors, and few studies have concurrently considered the effects of environmental contaminants in combination with ecological attributes that can influence foraging conditions and prey availability. Using three temporally distinct indices of physiological condition, we compared the physiological response of nestling great egrets (Ardea alba) and white ibises (Eudocimus albus) to changing prey availability, hydrology (water depth, recession rate), and mercury exposure in the Florida Everglades. We found that the physiological response of chicks varied between species and among environmental variables. Chick body condition (short-term index) and fecal corticosterone levels (medium-term) were influenced by wetland water depth, prey availability, region, and age, but not by mercury contamination. However, mercury exposure did influence heat shock protein 70 (HSP70) in egret chicks, indicating a longer-term physiological response to contamination. Our results indicate that the physiological condition of egret and ibis chicks were influenced by several environmental stressors, and the time frame of the effect may depend on the specialized foraging behavior of the adults provisioning the chicks.	[Herring, Garth; Eagles-Smith, Collin A.] US Geol Survey, Forest & Rangeland Ecosyst Sci Ctr, Corvallis, OR 97330 USA; [Gawlik, Dale E.; Beerens, James M.] Florida Atlantic Univ, Dept Biol Sci, Boca Raton, FL 33431 USA; [Ackerman, Joshua T.] US Geol Survey, Western Ecol Res Ctr, Dixon Field Stn, Dixon, CA USA	United States Department of the Interior; United States Geological Survey; State University System of Florida; Florida Atlantic University; United States Department of the Interior; United States Geological Survey	Herring, G (corresponding author), US Geol Survey, Forest & Rangeland Ecosyst Sci Ctr, Corvallis, OR 97330 USA.	gherring@usgs.gov	Ackerman, Joshua T./AAF-9503-2019; Eagles-Smith, Collin/T-8580-2019; Herring, Garth/AAF-6604-2019; Eagles-Smith, Collin/AAH-3811-2019	Eagles-Smith, Collin/0000-0003-1329-5285; Ackerman, Josh/0000-0002-3074-8322	Fish and Wildlife Service [401815G028]; U.S. Geological Survey	Fish and Wildlife Service(US Fish & Wildlife Service); U.S. Geological Survey(United States Geological Survey)	Financial or inkind support was provided by the U.S. This work received support from the Fish and Wildlife Service (grant/contract number: 401815G028) and U.S. Geological Survey. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams EM, 2009, ENVIRON TOXICOL CHEM, V28, P982, DOI 10.1897/08-253.1; [Anonymous], [No title captured]; ASTHEIMER LB, 1992, ORNIS SCAND, V23, P355, DOI 10.2307/3676661; Beaulieu M, 2009, BEHAV ECOL, V20, P878, DOI 10.1093/beheco/arp076; Beerens JM, 2011, AUK, V128, P651, DOI 10.1525/auk.2011.10165; Benson Jeb, 2003, Marine Ornithology, V31, P181; Bierkens JGEA, 2000, TOXICOLOGY, V153, P61, DOI 10.1016/S0300-483X(00)00304-8; Brkljacic J, 2007, J APPL TOXICOL, V27, P43, DOI 10.1002/jat.1182; Butler MW, 2010, PHYSIOL BIOCHEM ZOOL, V83, P78, DOI 10.1086/648483; Chen JW, 2011, EPIDEMIOLOGY, V22, pS289, DOI 10.1097/01.ede.0000392589.40145.ae; Day RD, 2007, ENVIRON HEALTH PERSP, V115, P1421, DOI 10.1289/ehp.9918; DesRochers DW, 2009, COMP BIOCHEM PHYS A, V152, P46, DOI 10.1016/j.cbpa.2008.08.034; Dorn NJ, 2011, IBIS, V153, P323, DOI 10.1111/j.1474-919X.2011.01101.x; Fournier F, 2002, COMP BIOCHEM PHYS A, V133, P703, DOI 10.1016/S1095-6433(02)00140-X; Franceschini MD, 2009, ECOTOXICOLOGY, V18, P514, DOI 10.1007/s10646-009-0309-2; Franzellitti S, 2006, BIOCHEM BIOPH RES CO, V351, P719, DOI 10.1016/j.bbrc.2006.10.089; Frederick PC, 1999, ENVIRON TOXICOL CHEM, V18, P1940, DOI [10.1002/etc.5620180912, 10.1897/1551-5028(1999)018&lt;1940:EOGEAA&gt;2.3.CO;2]; FREDERICK PC, 1989, AUK, V106, P625; Frederick PC, 2002, ENVIRON TOXICOL CHEM, V21, P163, DOI 10.1897/1551-5028(2002)021<0163:WBABOM>2.0.CO;2; Frederick P, 2011, P ROY SOC B-BIOL SCI, V278, P1851, DOI 10.1098/rspb.2010.2189; Frederick Peter C., 1994, P659; GAUNT AS, 1997, ORNITHOLOGICAL COUNC; Gawlik DE, 2002, ECOL MONOGR, V72, P329, DOI 10.1890/0012-9615(2002)072[0329:TEOPAO]2.0.CO;2; Gray CM, 2001, ANIM BEHAV, V62, P705, DOI 10.1006/anbe.2001.1813; Hahn TP, 1998, ECOLOGY, V79, P2365, DOI 10.1890/0012-9658(1998)079[2365:RSIAOB]2.0.CO;2; Hall BD, 2004, ENVIRON POLLUT, V154, P124; Heath JA, 2005, AUK, V122, P255, DOI 10.1642/0004-8038(2005)122[0255:RAMCHA]2.0.CO;2; Herring G, 2009, SCI TOTAL ENVIRON, V407, P2641, DOI 10.1016/j.scitotenv.2008.12.043; Herring G, 2007, THESCIENTIFICWORLDJO, V7, P1596, DOI 10.1100/tsw.2007.242; Herring G, 2013, SCI TOTAL ENVIRON, V458, P637, DOI 10.1016/j.scitotenv.2013.04.036; Herring G, 2013, J WILDLIFE MANAGE, V77, P58, DOI 10.1002/jwmg.445; Herring G, 2012, ENVIRON SCI TECHNOL, V46, P6339, DOI 10.1021/es300668c; Herring G, 2011, FUNCT ECOL, V25, P682, DOI 10.1111/j.1365-2435.2010.01792.x; Herring G, 2010, AUK, V127, P660, DOI 10.1525/auk.2010.09144; Herring G, 2009, J WILDLIFE MANAGE, V73, P1010, DOI 10.2193/2008-398; Hoffman DJ, 2011, ENVIRON TOXICOL CHEM, V30, P920, DOI 10.1002/etc.459; Hwang GW, 2012, BIOL PHARM BULL, V35, P1881, DOI 10.1248/bpb.b212019; Jackson AK, 2011, AUK, V128, P759, DOI 10.1525/auk.2011.11106; Jayasena N, 2011, AQUAT TOXICOL, V105, P321, DOI 10.1016/j.aquatox.2011.07.003; *JMP, 2001, GUID STAT DAT AN US; KACELNIK A, 1984, J ANIM ECOL, V53, P283, DOI 10.2307/4357; Kern M, 2001, PHYSIOL BIOCHEM ZOOL, V74, P651, DOI 10.1086/322927; Khan MZ, 2002, GEN COMP ENDOCR, V128, P57, DOI 10.1016/S0016-6480(02)00063-1; Kitaysky AS, 2003, HORM BEHAV, V43, P140, DOI 10.1016/S0018-506X(02)00030-2; Kitaysky AS, 1999, J COMP PHYSIOL B, V169, P303, DOI 10.1007/s003600050225; Kitaysky AS, 2001, BEHAV ECOL, V12, P619, DOI 10.1093/beheco/12.5.619; Kushlan JA, 1986, WATERBIRDS, V9, P155, DOI DOI 10.2307/1521208; Lieske CL, 2011, ACTA VET SCAND, V53, DOI 10.1186/1751-0147-53-66; LINDQUIST S, 1986, ANNU REV BIOCHEM, V55, P1151, DOI 10.1146/annurev.bi.55.070186.005443; Liu YR, 2010, ENVIRON TOXICOL CHEM, V29, P654, DOI 10.1002/etc.59; Liu ZW, 2009, ECOHYDROLOGY, V2, P182, DOI 10.1002/eco.56; LOCKE M, 1995, CAN J APPL PHYSIOL, V20, P155, DOI 10.1139/h95-011; Loftus W. F., 2000, THESIS FLORIDA INT U; Loiseau C, 2008, GEN COMP ENDOCR, V155, P101, DOI 10.1016/j.ygcen.2007.03.004; Martins TLF, 1997, ANIM BEHAV, V54, P99, DOI 10.1006/anbe.1996.0429; Marvin-DiPasquale MC, 2003, ENVIRON GEOL, V43, P260, DOI 10.1007/s00254-002-0623-y; Mauck RA, 2005, FUNCT ECOL, V19, P73, DOI 10.1111/j.0269-8463.2005.00933.x; Myers GJ, 1998, ENVIRON HEALTH PERSP, V106, P841, DOI 10.2307/3434199; Nakagawa S, 2013, METHODS ECOL EVOL, V4, P133, DOI 10.1111/j.2041-210x.2012.00261.x; Neter J., 1996, APPL LINEAR REGRESSI; Ogden John C., 1994, P533; Papaconstantinou AD, 2003, BIRTH DEFECTS RES B, V68, P456, DOI 10.1002/bdrb.10044; Raberg L, 1998, P ROY SOC B-BIOL SCI, V265, P1637, DOI 10.1098/rspb.1998.0482; Romero LM, 2005, COMP BIOCHEM PHYS A, V142, P65, DOI 10.1016/j.cbpa.2005.07.014; Rumbold DG, 2008, ECOTOXICOLOGY, V17, P632, DOI 10.1007/s10646-008-0234-9; Rumbold DG, 2001, ARCH ENVIRON CON TOX, V41, P501, DOI 10.1007/s002440010277; Schwabl H, 1999, GEN COMP ENDOCR, V116, P403, DOI 10.1006/gcen.1999.7379; Sepulveda MS, 1999, ENVIRON TOXICOL CHEM, V18, P985, DOI [10.1002/etc.5620180525, 10.1897/1551-5028(1999)018&lt;0985:MCIFRG&gt;2.3.CO;2]; Smith JP, 1997, COLON WATERBIRD, V20, P198, DOI 10.2307/1521686; Sorensen JG, 2010, CURR ZOOL, V56, P703; Sorensen JG, 2003, ECOL LETT, V6, P1025, DOI 10.1046/j.1461-0248.2003.00528.x; SUNDLOF SF, 1994, ARCH ENVIRON CON TOX, V27, P299; THOMPSON DR, 1989, MAR POLLUT BULL, V20, P577, DOI 10.1016/0025-326X(89)90361-5; Tomas G, 2004, J FIELD ORNITHOL, V75, P281, DOI 10.1648/0273-8570-75.3.281; U. S. EPA, 2000, 7473 US EPA; Wada H, 2009, ENVIRON SCI TECHNOL, V43, P6031, DOI 10.1021/es803707f; Wasser SK, 2000, GEN COMP ENDOCR, V120, P260, DOI 10.1006/gcen.2000.7557; Wingfield J.C., 1988, P121; Wingfield JC, 2005, FUNCTIONAL AVIAN END; WINGFIELD JC, 1994, PERSPECTIVES COMP EN; Wright J, 2014, P ROYAL SOC LOND B, V273, P1895	81	9	9	1	57	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 3	2014	9	9							e106447	10.1371/journal.pone.0106447	http://dx.doi.org/10.1371/journal.pone.0106447			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3TB	25184221	Green Submitted, Green Published, gold			2022-12-27	WOS:000341257700074
J	Srinivasa, V; Sundaram, MS; Anusha, S; Hemshekhar, M; Nayaka, SC; Kemparaju, K; Basappa; Girish, KS; Rangappa, KS				Srinivasa, Venkatachalaiah; Sundaram, Mahalingam S.; Anusha, Sebastian; Hemshekhar, Mahadevappa; Nayaka, Siddaiah Chandra; Kemparaju, Kempaiah; Basappa; Girish, Kesturu S.; Rangappa, Kanchugarakoppal S.			Novel Apigenin Based Small Molecule that Targets Snake Venom Metalloproteases	PLOS ONE			English	Article							BOTHROPS-JARARACA VENOM; NEGLECTED PROBLEM; INHIBITION; NEUTRALIZATION; COMPONENTS; DAMAGE; VIPER; BITE; NEED	The classical antivenom therapy has appreciably reduced snakebite mortality rate and thus is the only savior drug available. Unfortunately, it considerably fails to shield the viper bite complications like hemorrhage, local tissue degradation and necrosis responsible for severe morbidity. Moreover, the therapy is also tagged with limitations including anaphylaxis, serum sickness and poor availability. Over the last decade, snake venom metalloproteases (SVMPs) are reported to be the primary component responsible for hemorrhage and tissue degradation at bitten site. Thus, antivenom inability to offset viper venom-induced local toxicity has been a basis for an insistent search for SVMP inhibitors. Here we report the inhibitory effect of compound 5d, an apigenin based molecule against SVMPs both in silico and in vivo. Several apigenin analogues are synthesized using multicomponent Ugi reactions. Among them, compound 5d effectively abrogated Echis carinatus (EC) venom-induced local hemorrhage, tissue necrosis and myotoxicity in a dose dependant fashion. The histopathological study further conferred effective inhibition of basement membrane degradation, and accumulation of inflammatory leucocytes at the site of EC venom inoculation. The compound also protected EC venom-induced fibrin and fibrinogen degradation. The molecular docking of compound 5d and bothropasin demonstrated the direct interaction of hydroxyl group of compound with Glu146 present in hydrophobic pocket of active site and does not chelate Zn2+. Hence, it is concluded that compound 5d could be a potent agent in viper bite management.	[Srinivasa, Venkatachalaiah; Anusha, Sebastian; Basappa] Bangalore Univ, Dept Chem, Biol Chem Lab, Bangalore 560056, Karnataka, India; [Sundaram, Mahalingam S.; Hemshekhar, Mahadevappa; Kemparaju, Kempaiah; Girish, Kesturu S.] Univ Mysore, Dept Studies Biochem, Mysore, Karnataka, India; [Nayaka, Siddaiah Chandra] Univ Mysore, Dept Studies Biotechnol, Mysore, Karnataka, India; [Girish, Kesturu S.] Tumkur Univ, Dept Studies & Res Biochem, Tumkur, India; [Rangappa, Kanchugarakoppal S.] Univ Mysore, Dept Studies Chem, Mysore 570006, Karnataka, India	Bangalore University; University of Mysore; University of Mysore; Tumkur University; University of Mysore	Basappa (corresponding author), Bangalore Univ, Dept Chem, Biol Chem Lab, Bangalore 560056, Karnataka, India.	salundibasappa@gmail.com; ksgbaboo@gmail.com; rangappaks@gmail.com	KS, Girish/GWZ-7128-2022	Basappa, Basappa/0000-0002-8844-468X; KS, Girish/0000-0002-7284-3707; /0000-0001-6121-0771	University Grants Commission [41-257-2012-SR]; Vision Group Science and Technology, Department of Science and Technology [SR/FT/LS-142/2012]; UGC-BSR-SAP	University Grants Commission(University Grants Commission, India); Vision Group Science and Technology, Department of Science and Technology; UGC-BSR-SAP	This research was supported by University Grants Commission (41-257-2012-SR), Vision Group Science and Technology, Department of Science and Technology (No. SR/FT/LS-142/2012) to Basappa. MSS thanks UGC-BSR-SAP for the research fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anai K, 2002, TOXICON, V40, P63, DOI 10.1016/S0041-0101(01)00189-1; Baldo C, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000727; Basappa, 2004, BIOORG MED CHEM LETT, V14, P3679, DOI 10.1016/j.bmcl.2004.05.012; Basappa, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039444; Basappa, 2010, CANCER LETT, V297, P231, DOI 10.1016/j.canlet.2010.05.016; Basappa, 2003, BIOORGAN MED CHEM, V11, P4539, DOI 10.1016/j.bmc.2003.08.007; Birt DF, 1997, ANTICANCER RES, V17, P85; Chandramohanadas R, 2014, J INFECT DI IN PRESS; CONDREA E, 1983, THROMB HAEMOSTASIS, V49, P151; Escalante T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028017; Escalante T, 2011, J PROTEOMICS, V74, P1781, DOI 10.1016/j.jprot.2011.03.026; Fonseka CL, 2013, BMC EMERG MED, V13, DOI 10.1186/1471-227X-13-5; Fox JW, 2005, TOXICON, V45, P969, DOI 10.1016/j.toxicon.2005.02.012; Funakoshi-Tago M, 2011, INT IMMUNOPHARMACOL, V11, P1150, DOI 10.1016/j.intimp.2011.03.012; Girish KS, 2011, CURR TOP MED CHEM, V11, P2494; Gutierrez A., 2009, HDB VENOMS TOXINS RE, P115; GUTIERREZ JM, 1990, EXP MOL PATHOL, V52, P25, DOI 10.1016/0014-4800(90)90055-I; Gutierrez JM, 2006, PLOS MED, V3, P727, DOI 10.1371/journal.pmed.0030150; Gutierrez JM, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002162; Hernandez R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019834; HEUSSEN C, 1980, ANAL BIOCHEM, V102, P196, DOI 10.1016/0003-2697(80)90338-3; Howes JM, 2007, TOXICON, V49, P734, DOI 10.1016/j.toxicon.2006.11.020; Hwang YP, 2011, J DERMATOL SCI, V61, P23, DOI 10.1016/j.jdermsci.2010.10.016; Kondo H., 1960, Japanese Journal of Medical Science and Biology, V18, P43; Lim H, 2007, PLANTA MED, V73, P1267, DOI 10.1055/s-2007-990220; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Mahadeswaraswamy YH, 2008, PHYTOTHER RES, V22, P963, DOI 10.1002/ptr.2462; Man MQ, 2012, EVID-BASED COMPL ALT, V2012, DOI 10.1155/2012/912028; Marcaccini S, 2007, NAT PROTOC, V2, P632, DOI 10.1038/nprot.2007.71; Gutierrez JM, 2007, CURR PHARM DESIGN, V13, P2935, DOI 10.2174/138161207782023784; Muniz JRC, 2008, TOXICON, V52, P807, DOI 10.1016/j.toxicon.2008.08.021; Nagaraju S, 2007, BIOCHIMIE, V89, P1322, DOI 10.1016/j.biochi.2007.04.005; OUYANG C, 1976, BIOCHIM BIOPHYS ACTA, V420, P298, DOI 10.1016/0005-2795(76)90321-4; Panfoli I, 2010, TOXINS, V2, P417, DOI 10.3390/toxins2040417; Rangappa KS, 2005, J PHYS ORG CHEM, V18, P773, DOI 10.1002/poc.936; Santhosh MS, 2013, MINI-REV MED CHEM, V13, P106; Segura A, 2013, BIOLOGICALS, V41, P93, DOI 10.1016/j.biologicals.2012.11.001; Sunitha K, 2011, CURR TOP MED CHEM, V11, P2589, DOI 10.2174/156802611797633401; Sunitha K, 2011, BASIC CLIN PHARMACOL, V109, P292, DOI 10.1111/j.1742-7843.2011.00725.x; Thwin MM, 2010, TOXICON, V56, P1275, DOI 10.1016/j.toxicon.2009.12.023; Wagstaff SC, 2006, GENE, V377, P21, DOI 10.1016/j.gene.2006.03.008; Wang W, 2009, J COMB CHEM, V11, P403, DOI 10.1021/cc9000136; Wang YM, 2001, BIOCHEM J, V354, P161, DOI 10.1042/0264-6021:3540161; Warrell DA, 2011, NATL MED J INDIA, V24, P321; Yamagata K, 2011, MICROVASC RES, V81, P60, DOI 10.1016/j.mvr.2010.10.005; Yamakawa M., 1976, P97	46	18	18	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 3	2014	9	9							e106364	10.1371/journal.pone.0106364	http://dx.doi.org/10.1371/journal.pone.0106364			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3TB	25184206	Green Published, Green Submitted, gold, Green Accepted			2022-12-27	WOS:000341257700060
J	Tadesse, M; Abebe, G; Abdissa, K; Bekele, A; Bezabih, M; Apers, L; Colebunders, R; Rigouts, L				Tadesse, Mulualem; Abebe, Gemeda; Abdissa, Ketema; Bekele, Alemayehu; Bezabih, Mesele; Apers, Ludwig; Colebunders, Robert; Rigouts, Leen			Concentration of Lymph Node Aspirate Improves the Sensitivity of Acid Fast Smear Microscopy for the Diagnosis of Tuberculous Lymphadenitis in Jimma, Southwest Ethiopia	PLOS ONE			English	Article							MODIFIED BLEACH METHOD; FAST BACILLI; CYTOLOGY; HIV; PCR	Background: Tuberculous lymphadenitis (TBLN) is the most common form of extrapulmonary tuberculosis. The cytomorphological features of lymph node smears have reduced specificity for the diagnosis of tuberculosis. The diagnosis of TBLN with direct smear microscopy lacks sensitivity due to the limited number of bacilli in lymph node aspirate. Therefore, we aimed to assess whether the concentration of lymph node aspirate improves the sensitivity of acid fast smear microscopy for the diagnosis of tuberculous lymphadenitis. Methods: A cross-sectional comparative study was conducted on 200 patients clinically suspected for tuberculous lymphadenitis in Jimma, Ethiopia. Lymph node aspirate was collected. The first two drops were used for cytomorphological study and direct acid fast staining. The remaining aspirate was treated with N-acetyl-L-cysteine (NALC) and concentrated by centrifugation at 3000 g for 15 minutes. The sediment was used for acid fast staining and culture. Differentiation of M. tuberculosis complex (MTBC) from non-tuberculous mycobacteria (NTM) was done by para-nitrobenzoic acid susceptibility test. Result: Complete data were available for 187 study subjects. 68% (127/187) were positive for M. tuberculosis on culture. Four isolates, 2.1% (4/187), were identified as NTM. The detection rate of direct smear microscopy was 25.1% and that of the concentration method 49.7%. Cytomorphologically, 79.7% of cases were classified as TBLN. The sensitivity of direct smear microscopy was 34.6%, for concentrated smear microscopy 66.1%, and for cytomorphology 89.8%. Two AFB positive cases on concentration method were non-tuberculosis mycobacteria (NTM). The concentration method yielded a positive result from seven cases diagnosed as suppurative abscess by cytology. Both for the direct and concentration methods the highest rate of AFB positivity was observed in smears showing caseous necrosis alone. Smear positivity rate decreased with the appearance of epithelioid cell aggregates. Conclusion: The concentration of lymph node aspirates for acid fast smear microscopy had significantly higher sensitivity than direct microscopy.	[Tadesse, Mulualem; Abebe, Gemeda; Abdissa, Ketema; Bekele, Alemayehu; Bezabih, Mesele] Jimma Univ, Dept Med Lab Sci & Pathol, Jimma, Ethiopia; [Apers, Ludwig; Colebunders, Robert] Inst Trop Med, Dept Clin Sci, B-2000 Antwerp, Belgium; [Colebunders, Robert] Univ Antwerp, Dept Epidemiol & Social Med, B-2020 Antwerp, Belgium; [Rigouts, Leen] Inst Trop Med, Dept Microbiol, Mycobacteriol Unit, B-2000 Antwerp, Belgium	Jimma University; Institute of Tropical Medicine (ITM); University of Antwerp; Institute of Tropical Medicine (ITM)	Abebe, G (corresponding author), Jimma Univ, Dept Med Lab Sci & Pathol, Jimma, Ethiopia.	gemeda.abebe@ju.edu.et	Abebe, Gemeda/AAB-8789-2019	Abebe, Gemeda/0000-0002-7172-9136; Colebunders, Robert/0000-0002-1919-1340	Jimma University; Flemish Universities (VLIR-OUS project)	Jimma University; Flemish Universities (VLIR-OUS project)	Funding for this work was secured from interuniversity cooperation between Jimma University and Flemish Universities (VLIR-OUS project). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aljafari AS, 2004, CYTOPATHOLOGY, V15, P44, DOI 10.1111/j.1365-2303.2003.00119.x; Annam V, 2009, INDIAN J PATHOL MICR, V52, P349, DOI 10.4103/0377-4929.54991; [Anonymous], 2012, GLOBAL TUBERCULOSIS, P1; Bezabih M, 2002, CYTOPATHOLOGY, V13, P284, DOI 10.1046/j.1365-2303.2002.00418.x; Biadglegne F, 2013, JPN J INFECT DIS, V66, P263, DOI 10.7883/yoken.66.263; Bonnet M, 2008, CLIN INFECT DIS, V46, P1710, DOI 10.1086/587891; Derese Y, 2012, J INFECT DEV COUNTR, V6, P53, DOI 10.3855/jidc.2050; Federal Ministry of Health of Ethiopia, 2010, HLTH SECT DEV PROGR; Gangane N, 2008, ACTA CYTOL, V52, P325, DOI 10.1159/000325515; GUPTA AK, 1992, ACTA CYTOL, V36, P391; Iwnetu R, 2009, SCAND J INFECT DIS, V41, P462, DOI 10.1080/00365540902897697; Matee M, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-68; Watterson SA, 2000, J CLIN PATHOL, V53, P727, DOI 10.1136/jcp.53.10.727; *WHO, 1998, WHOTUBERCULOSIS98258	14	11	12	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 3	2014	9	9							e106726	10.1371/journal.pone.0106726	http://dx.doi.org/10.1371/journal.pone.0106726			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3TB	25184279	Green Published, gold, Green Submitted			2022-12-27	WOS:000341257700111
J	Honeyman, MC; Laine, D; Zhan, YF; Londrigan, S; Kirkwood, C; Harrison, LC				Honeyman, Margo C.; Laine, David; Zhan, Yifan; Londrigan, Sarah; Kirkwood, Carl; Harrison, Leonard C.			Rotavirus Infection Induces Transient Pancreatic Involution and Hyperglycemia in Weanling Mice	PLOS ONE			English	Article							DOUBLE-STRANDED-RNA; TOLL-LIKE RECEPTOR-3; T-CELL EPITOPES; EXTRAINTESTINAL SPREAD; INNATE IMMUNITY; TYPE-1; AUTOANTIBODIES; RECOGNITION; ASSOCIATION; ACTIVATION	Rotavirus is a ubiquitous double-stranded RNA virus responsible for most cases of infantile gastroenteritis. It infects pancreatic islets in vitro and is implicated as a trigger of autoimmune destruction of islet beta cells leading to type 1 diabetes, but pancreatic pathology secondary to rotavirus infection in vivo has not been documented. To address this issue, we inoculated 3 week-old C57Bl/6 mice at weaning with rhesus rotavirus, which is closely related to human rotaviruses and known to infect mouse islets in vitro. Virus was quantified in tissues by culture-isolation and enzyme-linked immunosorbent assay. A requirement for viral double stranded RNA was investigated in toll-like receptor 3 (TLR3)-deficient mice. Cell proliferation and apoptosis, and insulin expression, were analyzed by immunohistochemistry. Following rotavirus inoculation by gavage, two phases of mild, transient hyperglycemia were observed beginning after 2 and 8 days. In the first phase, widespread apoptosis of pancreatic cells was associated with a decrease in pancreas mass and insulin production, without detectable virus in the pancreas. These effects were mimicked by injection of the double-stranded RNA mimic, polyinosinic-polycytidylic acid, and were TLR3-dependent. By the second phase, the pancreas had regenerated but islets were smaller than normal and viral antigen was then detected in the pancreas for several days. These findings directly demonstrate pathogenic effects of rotavirus infection on the pancreas in vivo, mediated initially by the interaction of rotavirus double-stranded RNA with TLR3.	[Honeyman, Margo C.; Laine, David; Zhan, Yifan; Londrigan, Sarah; Harrison, Leonard C.] Royal Melbourne Hosp, Walter & Eliza Hall Inst Med Res, Parkville, Vic 3050, Australia; [Honeyman, Margo C.; Laine, David; Zhan, Yifan; Londrigan, Sarah; Harrison, Leonard C.] Univ Melbourne, Dept Med Biol, Parkville, Vic 3052, Australia; [Kirkwood, Carl] Royal Childrens Hosp, Murdoch Childrens Res Inst, Parkville, Vic 3052, Australia	Royal Melbourne Hospital; Walter & Eliza Hall Institute; University of Melbourne; Murdoch Children's Research Institute; Royal Children's Hospital Melbourne	Harrison, LC (corresponding author), Royal Melbourne Hosp, Walter & Eliza Hall Inst Med Res, Parkville, Vic 3050, Australia.	harrison@wehi.edu.au		Zhan, Yifan/0000-0001-6974-0486; Londrigan, Sarah/0000-0003-0989-4971	National Health and Medical Research Council of Australia (NHMRC) [305500]; Juvenile Diabetes Research Foundation	National Health and Medical Research Council of Australia (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation)	This research was supported by a Program Grant (305500) from the National Health and Medical Research Council of Australia (NHMRC) (to LCH). DL was in receipt of a Postdoctoral Fellowship from the Juvenile Diabetes Research Foundation. LCH is a Senior Principal Research Fellow of the NHMRC. This work was made possible through Victorian State Government Operational Infrastructure Support and Australian National Health and Medical Research Council Research Institute Infrastructure Support Scheme. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akira S, 2003, IMMUNOL LETT, V85, P85, DOI 10.1016/S0165-2478(02)00228-6; Alexopoulou L, 2001, NATURE, V413, P732, DOI 10.1038/35099560; Blomqvist M, 2002, CLIN EXP IMMUNOL, V128, P511, DOI 10.1046/j.1365-2249.2002.01842.x; Campbell-Thompson M, 2012, JAMA-J AM MED ASSOC, V308, P2337, DOI 10.1001/jama.2012.15008; Coppieters K. T., 2012, COLD SPRING HARB PER, V2, P1, DOI [10.1101/cshperspect.a007682, DOI 10.1101/cshperspect.a007682]; Coulson BS, 2002, J VIROL, V76, P9537, DOI 10.1128/JVI.76.18.9537-9544.2002; COULSON BS, 1984, J VIROL METHODS, V8, P165, DOI 10.1016/0166-0934(84)90011-9; DelaRubia L, 1996, PANCREAS, V12, P98, DOI 10.1097/00006676-199601000-00013; Dogusan Z, 2008, DIABETES, V57, P1236, DOI 10.2337/db07-0844; Foulis AK, 2008, NOVART FDN SYMP, V292, P13; Foulis AK, 2008, NOVART FDN SYMP, V292, P122; Foulis Alan K, 2008, Novartis Found Symp, V292, P2; Frias AH, 2012, INNATE IMMUN-LONDON, V18, P294, DOI 10.1177/1753425911401930; GEPTS W, 1965, DIABETES, V14, P619, DOI 10.2337/diab.14.10.619; Graham KL, 2008, J VIROL, V82, P6139, DOI 10.1128/JVI.00597-08; Graham KL, 2007, J VIROL, V81, P6446, DOI 10.1128/JVI.00205-07; GROENE WS, 1992, J VIROL METHODS, V38, P93, DOI 10.1016/0166-0934(92)90172-A; Harrison LC, 2008, J AUTOIMMUN, V31, P306, DOI 10.1016/j.jaut.2008.04.026; Holland AM, 2005, DIABETES, V54, P2586, DOI 10.2337/diabetes.54.9.2586; Honeyman M, 2005, CURR OPIN IMMUNOL, V17, P616, DOI 10.1016/j.coi.2005.09.007; Honeyman MC, 2010, J IMMUNOL, V184, P2204, DOI 10.4049/jimmunol.0900709; Honeyman MC, 1998, MOL MED, V4, P231, DOI 10.1007/BF03401920; Honeyman MC, 2000, DIABETES, V49, P1319, DOI 10.2337/diabetes.49.8.1319; Imagawa A, 2011, DIABETES-METAB RES, V27, P959, DOI 10.1002/dmrr.1236; Kumagai H, 2009, INDIAN PEDIATR, V46, P1099; Mossel EC, 2002, J VIROL, V76, P6502, DOI 10.1128/JVI.76.13.6502-6509.2002; Nishio A, 2011, PANCREAS, V40, P95, DOI 10.1097/MPA.0b013e3181f3a5d4; Pane JA, 2013, DIABETOLOGIA, V56, P573, DOI 10.1007/s00125-012-2798-4; Parri N, 2010, PEDIATR EMERG CARE, V26, P592, DOI 10.1097/PEC.0b013e3181ea72a8; Rasschaert J, 2005, J BIOL CHEM, V280, P33984, DOI 10.1074/jbc.M502213200; Rock FL, 1998, P NATL ACAD SCI USA, V95, P588, DOI 10.1073/pnas.95.2.588; Smyth DJ, 2006, NAT GENET, V38, P617, DOI 10.1038/ng1800; Wen L, 2004, J IMMUNOL, V172, P3173, DOI 10.4049/jimmunol.172.5.3173; World Health Organization Department of Immunization Vaccines and Biologicals, 2009, MAN ROT DET CHAR MET, P18; YOON JW, 1978, J EXP MED, V148, P1068, DOI 10.1084/jem.148.4.1068	35	29	29	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2014	9	9							e106560	10.1371/journal.pone.0106560	http://dx.doi.org/10.1371/journal.pone.0106560			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3LR	25181416	Green Published, gold			2022-12-27	WOS:000341231500115
J	Zavyalova, E; Samoylenkova, N; Revishchin, A; Golovin, A; Pavlova, G; Kopylov, A				Zavyalova, Elena; Samoylenkova, Nadezhda; Revishchin, Alexander; Golovin, Andrey; Pavlova, Galina; Kopylov, Alexey			Evaluation of Antithrombotic Activity of Thrombin DNA Aptamers by a Murine Thrombosis Model	PLOS ONE			English	Article							VON-WILLEBRAND-FACTOR; FACTOR XA INHIBITOR; ARTERIAL THROMBOSIS; RAT MODEL; IN-VITRO; COAGULATION; ANTICOAGULANT; ACTIVATION; INITIATION; DISCOVERY	Aptamers are nucleic acid based molecular recognition elements with a high potential for the theranostics. Some of the aptamers are under development for therapeutic applications as promising antithrombotic agents; and G-quadruplex DNA aptamers, which directly inhibit the thrombin activity, are among them. RA-36, the 31-meric DNA aptamer, consists of two thrombin binding pharmacophores joined with the thymine linker. It has been shown earlier that RA-36 directly inhibits thrombin in the reaction of fibrinogen hydrolysis, and also it inhibits plasma and blood coagulation. Studies of both inhibitory and anticoagulation effects had indicated rather high species specificity of the aptamer. Further R&D of RA-36 requires exploring its efficiency in vivo. Therefore the development of a robust and adequate animal model for effective physiological studies of aptamers is in high current demand. This work is devoted to in vivo study of the antithrombotic effect of RA-36 aptamer. A murine model of thrombosis has been applied to reveal a lag and even prevention of thrombus formation when RA-36 was intravenous bolus injected in high doses of 1.4-7.1 mu mol/kg (14-70 mg/kg). A comparative study of RA-36 aptamer and bivalirudin reveals that both direct thrombin inhibitors have similar antithrombotic effects for the murine model of thrombosis; though in vitro bivalirudin has anticoagulation activity several times higher compared to RA-36. The results indicate that both RA-36 aptamer and bivalirudin are direct thrombin inhibitors of different potency, but possible interactions of the thrombin-inhibitor complex with other components of blood coagulation cascade level the physiological effects for both inhibitors.	[Zavyalova, Elena; Kopylov, Alexey] Moscow MV Lomonosov State Univ, Dept Chem, Moscow, Russia; [Zavyalova, Elena; Samoylenkova, Nadezhda; Golovin, Andrey; Pavlova, Galina; Kopylov, Alexey] APTO PHARM LTD, Moscow, Russia; [Samoylenkova, Nadezhda; Revishchin, Alexander; Pavlova, Galina] Russian Acad Sci, Inst Gene Biol, Moscow, Russia; [Golovin, Andrey] Moscow MV Lomonosov State Univ, Dept Bioengn & Bioinformat, Moscow, Russia	Lomonosov Moscow State University; Russian Academy of Sciences; Institute of Gene Biology (IGB) of Russian Academy of Sciences; Lomonosov Moscow State University	Zavyalova, E (corresponding author), Moscow MV Lomonosov State Univ, Dept Chem, Moscow, Russia.	zlenka2006@gmail.com	Golovin, Andrey/ABB-4382-2020; Zavyalova, E./I-1860-2016; Samoylenkova, Nadezhda/AAU-3479-2021; Revishchin, Alexander/AAO-4863-2020; Golovin, Andrey Victorovich/H-3901-2017; Kopylov, Alexey M/B-3907-2015; Pavlova, Galina/AAO-4691-2020	Zavyalova, E./0000-0001-5260-1973; Samoylenkova, Nadezhda/0000-0002-5167-0253; Golovin, Andrey Victorovich/0000-0003-2243-4902; Kopylov, Alexey M/0000-0003-0962-8905; Pavlova, Galina/0000-0002-6885-6601; Revishchin, Alexandr/0000-0002-6007-6440; Golovin, Andrey/0000-0002-8908-4268	Russian Foundation for Basic Research [13 00 40200 K, 13 04 40203 H, 13 04 40200 H, 14-04-32006, 14-04-01757]; RAS Presidium Program 'Molecular and Cell Biology'	Russian Foundation for Basic Research(Russian Foundation for Basic Research (RFBR)); RAS Presidium Program 'Molecular and Cell Biology'	We thank Vladimir E. Babiy for administration and funding. This work was also supported by the Russian Foundation for Basic Research (projects no. 13 00 40200 K, 13 04 40203 H, 13 04 40200 H, 14-04-32006, 14-04-01757), and by RAS Presidium Program 'Molecular and Cell Biology'. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Corral-Rodriguez MA, 2010, J MED CHEM, V53, P3847, DOI 10.1021/jm901743x; Bae ON, 2012, ARCH PHARM RES, V35, P1693, DOI 10.1007/s12272-012-1000-3; Berry CN, 1998, BRIT J PHARMACOL, V125, P29, DOI 10.1038/sj.bjp.0702030; BERRY CN, 1994, BRIT J PHARMACOL, V113, P1209, DOI 10.1111/j.1476-5381.1994.tb17126.x; BOCK LC, 1992, NATURE, V355, P564, DOI 10.1038/355564a0; Bouchard PR, 2010, ANNU REV PHARMACOL, V50, P237, DOI 10.1146/annurev.pharmtox.010909.105547; Brundish D, 1999, J MED CHEM, V42, P4584, DOI 10.1021/jm9811209; Buddai SK, 2010, J BIOL CHEM, V285, P5212, DOI 10.1074/jbc.M109.049833; Cooley BC, 2007, THROMB RES, V119, P747, DOI 10.1016/j.thromres.2006.02.014; DAVIE EW, 1991, BIOCHEMISTRY-US, V30, P10363, DOI 10.1021/bi00107a001; De Cristofaro R, 2003, J THROMB THROMBOLYS, V15, P151, DOI 10.1023/B:THRO.0000011370.80989.7b; DEANDA A, 1994, ANN THORAC SURG, V58, P344, DOI 10.1016/0003-4975(94)92206-3; DEJANA E, 1982, THROMB HAEMOSTASIS, V48, P108; Diaz JA, 2011, JOVE-J VIS EXP, DOI 10.3791/2737; Diener JL, 2009, J THROMB HAEMOST, V7, P1155, DOI 10.1111/j.1538-7836.2009.03459.x; Diener J.L., 2007, Patent No. 2007025049; Farrehi PM, 1998, CIRCULATION, V97, P1002; FREUND M, 1990, THROMB HAEMOSTASIS, V63, P187; Gal SW, 1998, EUR J BIOCHEM, V252, P553, DOI 10.1046/j.1432-1327.1998.2520553.x; Golovin AV, 2011, PCT Patent, Patent No. [2011/075004, 2011075004]; Gopinath SCB, 2006, THROMB HAEMOSTASIS, V95, P767, DOI 10.1160/TH06-01-0047; GRIFFIN LC, 1993, GENE, V137, P25, DOI 10.1016/0378-1119(93)90247-Z; Guarini S, 1996, J PHARMACOL TOXICOL, V35, P101, DOI 10.1016/1056-8719(96)00006-8; Hennan JK, 2008, J THROMB HAEMOST, V6, P1558, DOI 10.1111/j.1538-7836.2008.03063.x; Heran C, 2000, EUR J PHARMACOL, V389, P201, DOI 10.1016/S0014-2999(99)00902-4; HLADOVEC J, 1971, THROMB DIATH HAEMOST, V26, P407, DOI 10.1055/s-0038-1653690; HUGUES J, 1953, ARCH INT PHYS BIOCH, V61, P565, DOI 10.3109/13813455309150870; Kaptanoglui L, 2008, EUR J PHARMACOL, V578, P238, DOI 10.1016/j.ejphar.2007.08.035; Keefe AD, 2008, CURR OPIN PHARMACOL, V8, P147, DOI 10.1016/j.coph.2007.12.005; Krishnan A, 2013, J THROMB THROMBOLYS, V35, P48, DOI 10.1007/s11239-012-0778-7; KURZ KD, 1990, THROMB RES, V60, P269, DOI 10.1016/0049-3848(90)90106-M; Kusada A, 2007, THROMB RES, V121, P103, DOI 10.1016/j.thromres.2007.03.005; Lancellotti Stefano, 2009, Cardiovascular & Hematological Agents in Medicinal Chemistry, V7, P19; MACAYA RF, 1993, P NATL ACAD SCI USA, V90, P3745, DOI 10.1073/pnas.90.8.3745; Mizurini DM, 2013, BIOCHEM BIOPH RES CO, V436, P235, DOI 10.1016/j.bbrc.2013.05.082; Monroe DM, 2006, ARTERIOSCL THROM VAS, V26, P41, DOI 10.1161/01.ATV.0000193624.28251.83; Nimjee SM, 2012, MOL THER, V20, P391, DOI 10.1038/mt.2011.226; Nutescu EA, 2004, ANN PHARMACOTHER, V38, P99, DOI 10.1345/aph.1D066; Nutescu Edith A, 2005, Cleve Clin J Med, V72 Suppl 1, pS2; Parunov LA, 2014, THROMB RES, V133, P112, DOI 10.1016/j.thromres.2013.10.036; Perzborn E, 2005, J THROMB HAEMOST, V3, P514, DOI 10.1111/j.1538-7836.2005.01166.x; PETERS RF, 1991, THROMB HAEMOSTASIS, V65, P268; Ponikova S, 2011, BIOPHYS CHEM, V155, P29, DOI 10.1016/j.bpc.2011.02.004; Pudusseri A, 2013, FRONT PHARMACOL, V4, DOI 10.3389/fphar.2013.00133; ROSENBLUM WI, 1977, CIRC RES, V40, P320, DOI 10.1161/01.RES.40.3.320; Rusconi CP, 2004, NAT BIOTECHNOL, V22, P1423, DOI 10.1038/nbt1023; Rusconi CP, 2000, THROMB HAEMOSTASIS, V84, P841; Sato K, 1998, BRIT J PHARMACOL, V123, P92, DOI 10.1038/sj.bjp.0701566; Serruys PW, 2006, INT J CLIN PRACT, V60, P344, DOI 10.1111/j.1368-5031.2005.00823.x; VALENZENO DP, 1987, PHOTOCHEM PHOTOBIOL, V46, P147, DOI 10.1111/j.1751-1097.1987.tb04749.x; Vavalle JP, 2012, FUTUR CARDIOL, V8, P371, DOI [10.2217/fca.12.5, 10.2217/FCA.12.5]; Wang XK, 2005, THROMB RES, V115, P95, DOI 10.1016/j.thromres.2004.07.009; White R, 2001, MOL THER, V4, P567, DOI 10.1006/mthe.2001.0495; Woodruff RS, 2013, J THROMB HAEMOST, V11, P1364, DOI 10.1111/jth.12302; Xiong J, 2009, J PHARM PHARMACOL, V61, P89, DOI 10.1211/jpp/61.01.0012; Zavyalova E, 2013, CURR MED CHEM, V20, P4836, DOI 10.2174/09298673113206660283; Zavyalova E, 2012, CURR MED CHEM, V19, P5232, DOI 10.2174/092986712803530575; Zavyalova E, 2011, CURR MED CHEM, V18, P3343, DOI 10.2174/092986711796504727; Zavyalova EG, 2012, ANAL BIOCHEM, V421, P234, DOI 10.1016/j.ab.2011.10.015	59	12	12	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2014	9	9							e107113	10.1371/journal.pone.0107113	http://dx.doi.org/10.1371/journal.pone.0107113			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ1IR	25192011	gold, Green Published, Green Submitted			2022-12-27	WOS:000347993600098
J	Bettcher, BM; Watson, CL; Walsh, CM; Lobach, IV; Neuhaus, J; Miller, JW; Green, R; Patel, N; Dutt, S; Busovaca, E; Rosen, HJ; Yaffe, K; Miller, BL; Kramer, JH				Bettcher, Brianne M.; Watson, Christa L.; Walsh, Christine M.; Lobach, Iryna V.; Neuhaus, John; Miller, Joshua W.; Green, Ralph; Patel, Nihar; Dutt, Shubir; Busovaca, Edgar; Rosen, Howard J.; Yaffe, Kristine; Miller, Bruce L.; Kramer, Joel H.			Interleukin-6, Age, and Corpus Callosum Integrity	PLOS ONE			English	Article							WHITE-MATTER ATLAS; COGNITIVE PERFORMANCE; DISEASE; INFLAMMATION; HEALTH; ADULTS; MICROSTRUCTURE; HOMOCYSTEINE; PATHWAYS; BRAIN	The contribution of inflammation to deleterious aging outcomes is increasingly recognized; however, little is known about the complex relationship between interleukin-6 (IL-6) and brain structure, or how this association might change with increasing age. We examined the association between IL-6, white matter integrity, and cognition in 151 community dwelling older adults, and tested whether age moderated these associations. Blood levels of IL-6 and vascular risk (e.g., homocysteine), as well as health history information, were collected. Processing speed assessments were administered to assess cognitive functioning, and we employed tract-based spatial statistics to examine whole brain white matter and regions of interest. Given the association between inflammation, vascular risk, and corpus callosum (CC) integrity, fractional anisotropy (FA) of the genu, body, and splenium represented our primary dependent variables. Whole brain analysis revealed an inverse association between IL-6 and CC fractional anisotropy. Subsequent ROI linear regression and ridge regression analyses indicated that the magnitude of this effect increased with age; thus, older individuals with higher IL-6 levels displayed lower white matter integrity. Finally, higher IL-6 levels were related to worse processing speed; this association was moderated by age, and was not fully accounted for by CC volume. This study highlights that at older ages, the association between higher IL-6 levels and lower white matter integrity is more pronounced; furthermore, it underscores the important, albeit burgeoning role of inflammatory processes in cognitive aging trajectories.	[Bettcher, Brianne M.; Watson, Christa L.; Walsh, Christine M.; Lobach, Iryna V.; Neuhaus, John; Patel, Nihar; Dutt, Shubir; Busovaca, Edgar; Rosen, Howard J.; Miller, Bruce L.; Kramer, Joel H.] Univ Calif San Francisco, Dept Neurol, Memory & Aging Ctr, San Francisco, CA 94143 USA; [Miller, Joshua W.] Rutgers State Univ, Dept Nutr Sci, New Brunswick, NJ 08903 USA; [Miller, Joshua W.; Green, Ralph] Univ Calif Davis, Med Ctr, Dept Pathol, Sacramento, CA 95817 USA; [Miller, Joshua W.; Green, Ralph] Univ Calif Davis, Med Ctr, Lab Med, Sacramento, CA 95817 USA; [Yaffe, Kristine] Univ Calif San Francisco, Dept Psychiat Neurol & Epidemiol & Biostatist, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; Rutgers State University New Brunswick; University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California San Francisco	Bettcher, BM (corresponding author), Univ Calif San Francisco, Dept Neurol, Memory & Aging Ctr, San Francisco, CA 94143 USA.	bbettcher@memory.ucsf.edu			NIH-NINDS [HHSN271200623661C]; NIH-NIA [K23 AG042492-01, R01 AG032289]; Alzheimer's Association New Investigator Grant [NIRP-12-259223]; Larry L. Hillblom Foundation; UCSF Alzheimer's Disease Research Center Resource Allocation Program (RAP); NATIONAL INSTITUTE ON AGING [K23AG042492, P50AG023501, R01AG032289] Funding Source: NIH RePORTER	NIH-NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIH-NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Alzheimer's Association New Investigator Grant; Larry L. Hillblom Foundation; UCSF Alzheimer's Disease Research Center Resource Allocation Program (RAP); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	The study described was supported by grant number HHSN271200623661C from the NIH-NINDS, and numbers K23 AG042492-01 and R01 AG032289 from the NIH-NIA. Its contents are solely the responsibility of the authors and do not necessarily represent the official views of the National Institute of Neurological Disorders and Strokes, National Institute on Aging or NIH. This work was also supported by an Alzheimer's Association New Investigator Grant (NIRP-12-259223), the Larry L. Hillblom Foundation and the UCSF Alzheimer's Disease Research Center Resource Allocation Program (RAP). These funding agencies had no role in the design and conduct of the study; the collection, management, analysis, and interpretation of the data; or the preparation, review, or approval of the manuscript.	Abeywardena MY, 2009, CURR PHARM DESIGN, V15, P1809, DOI 10.2174/138161209788186290; Albani D, 2009, AGE, V31, P155, DOI 10.1007/s11357-009-9092-5; Andersson J.L.R., 2007, TR07JA1 FMRIB; Arfanakis K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073107; Bendlin BB, 2010, DEV NEUROPSYCHOL, V35, P257, DOI 10.1080/87565641003696775; Bettcher BM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077741; Bettcher BM, 2013, NEUROCASE, V19, P182, DOI 10.1080/13554794.2011.654227; Bullmore ET, 1999, IEEE T MED IMAGING, V18, P32, DOI 10.1109/42.750253; CERELLA J, 1994, ACTA PSYCHOL, V86, P109, DOI 10.1016/0001-6918(94)90002-7; Chen J, 2007, PSYCHON B REV, V14, P534, DOI 10.3758/BF03194103; Cosentino C, 2013, CELL MOL LIFE SCI, V70, P1525, DOI 10.1007/s00018-013-1295-3; Crichton GE, 2012, J ALZHEIMERS DIS, V30, pS77, DOI 10.3233/JAD-2011-111022; Cuff CA, 1996, J NEUROIMMUNOL, V70, P21, DOI 10.1016/S0165-5728(96)00103-8; Dale AM, 1999, NEUROIMAGE, V9, P179, DOI 10.1006/nimg.1998.0395; Davis SW, 2009, NEUROIMAGE, V46, P530, DOI 10.1016/j.neuroimage.2009.01.068; Di Paola M, 2010, NEUROLOGY, V74, P1136, DOI 10.1212/WNL.0b013e3181d7d8cb; Eikelenboom P, 2012, ALZHEIMERS RES THER, V4, DOI 10.1186/alzrt118; Friedman J., 2001, ELEMENTS STAT LEARNI, DOI 10.1007/978-0-387-21606-5; Gilfix BM, 1997, CLIN CHEM, V43, P687; Jenny NS, 2012, J GERONTOL A-BIOL, V67, P970, DOI 10.1093/gerona/glr261; Kerchner GA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050425; Lee DY, 2010, STROKE, V41, P1791, DOI 10.1161/STROKEAHA.110.582163; Linton PJ, 2004, NAT IMMUNOL, V5, P133, DOI 10.1038/ni1033; Marsland AL, 2006, PSYCHOSOM MED, V68, P895, DOI 10.1097/01.psy.0000238451.22174.92; Mooijaart SP, 2013, J INTERN MED; Mori S, 2008, NEUROIMAGE, V40, P570, DOI 10.1016/j.neuroimage.2007.12.035; Pawelec G, 2002, FRONT BIOSCI-LANDMRK, V7, pD1056; Refsum H, 1998, ANNU REV MED, V49, P31, DOI 10.1146/annurev.med.49.1.31; Rosano C, 2012, AGING DIS, V3, P16; Segonne F, 2004, NEUROIMAGE, V22, P1060, DOI 10.1016/j.neuroimage.2004.03.032; Segonne F, 2007, IEEE T MED IMAGING, V26, P518, DOI 10.1109/TMI.2006.887364; Sergio G, 2008, INFLAMM RES, V57, P558, DOI 10.1007/s00011-008-7243-2; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Smith SM, 2006, NEUROIMAGE, V31, P1487, DOI 10.1016/j.neuroimage.2006.02.024; Sullivan EV, 2006, CEREB CORTEX, V16, P1030, DOI 10.1093/cercor/bhj045; Terrando N, 2010, CRIT CARE, V14, DOI 10.1186/cc9019; Turken AU, 2008, NEUROIMAGE, V42, P1032, DOI 10.1016/j.neuroimage.2008.03.057; Verstynen TD, 2013, NEUROIMAGE, V79, P129, DOI 10.1016/j.neuroimage.2013.04.075; Wang PJ, 2006, NEUROBIOL AGING, V27, P1613, DOI 10.1016/j.neurobiolaging.2005.09.035; Wersching H, 2010, NEUROLOGY, V74, P1022, DOI 10.1212/WNL.0b013e3181d7b45b; Yaffe K, 2009, NEUROLOGY, V72, P2029, DOI 10.1212/WNL.0b013e3181a92c36; YESAVAGE JA, 1983, J PSYCHIATR RES, V17, P37, DOI 10.1016/0022-3956(82)90033-4; Zhang H, 2010, LECT NOTES COMPUT SC, V6204, P83, DOI 10.1007/978-3-642-14366-3_8; Zheng L, 2012, J AM GERIATR SOC, V60, P499, DOI 10.1111/j.1532-5415.2011.03839.x	44	34	34	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 4	2014	9	9							e106521	10.1371/journal.pone.0106521	http://dx.doi.org/10.1371/journal.pone.0106521			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3XV	25188448	Green Submitted, Green Published, gold			2022-12-27	WOS:000341271500048
J	Cheng, F; Yuan, Q; Yang, J; Wang, WM; Liu, H				Cheng, Feng; Yuan, Qiang; Yang, Jian; Wang, Wenming; Liu, Hua			The Prognostic Value of Serum Neuron-Specific Enolase in Traumatic Brain Injury: Systematic Review and Meta-Analysis	PLOS ONE			English	Review							OUTCOME PREDICTION; PROTEIN-LEVELS; HEAD TRAUMA; MARKERS; BIOMARKERS; MORTALITY; DAMAGE; S100B; S-100	Background: Several studies have suggested that neuron-specific enolase (NSE) in serum may be a biomarker of traumatic brain injury. However, whether serum NSE levels correlate with outcomes remains unclear. The purpose of this review was to evaluate the prognostic value of serum NSE protein after traumatic brain injury. Methods: PubMed and Embase were searched for relevant studies published up to October 2013. Full-text publications on the relationship of NSE to TBI were included if the studies concerned patients with closed head injury, NSE levels in serum after injury, and Glasgow Outcome Scale (GOS) or Extended GOS (GOSE) scores or mortality. Study design, inclusion criteria, assay, blood sample collection time, NSE cutoff, sensitivity and specificity of NSE for mortality prediction (if sufficient information was provided to calculate these values), and main outcomes were recorded. Results: Sixteen studies were eligible for the current meta-analysis. In the six studies comparing NSE concentrations between TBI patients who died and those who survived, NSE concentrations correlated with mortality (M.D. 0.28, 95% confidence interval (CI), 0.21 to 0.34; I-2 55%). In the eight studies evaluating GOS or GOSE, patients with unfavorable outcomes had significantly higher NSE concentrations than those with favorable outcomes (M.D. 0.24, 95% CI, 0.17 to 0.31; I-2 64%). From the studies providing sufficient data, the pooled sensitivity and specificity for mortality were 0.79 and 0.50, and 0.72 and 0.66 for unfavorable neurological prognosis, respectively. The areas under the SROC curve (AUC) of NSE concentrations were 0.73 (95% CI, 0.66-0.80) for unfavorable outcome and 0.76 (95% CI, 0.62-0.90) for mortality. Conclusions: Mortality and unfavorable outcome were significantly associated with greater NSE concentrations. In addition, NSE has moderate discriminatory ability to predict mortality and neurological outcome in TBI patients. The optimal discrimination cutoff values and optimal sampling time remain uncertain because of significant variations between studies.	[Cheng, Feng; Yang, Jian; Wang, Wenming; Liu, Hua] Jiangsu Univ, Peoples Hosp Kunshan 1, Dept Neurosurg, Suzhou, Peoples R China; [Yuan, Qiang] Fudan Univ, Huashan Hosp, Dept Neurosurg, Shanghai 200433, Peoples R China	Jiangsu University; Fudan University	Liu, H (corresponding author), Jiangsu Univ, Peoples Hosp Kunshan 1, Dept Neurosurg, Suzhou, Peoples R China.	wacilii@163.com						Baker AJ, 2009, J NEUROTRAUM, V26, P1227, DOI 10.1089/neu.2008.0868; Begaz T, 2006, J NEUROTRAUM, V23, P1201, DOI 10.1089/neu.2006.23.1201; Bland JM, 1996, BMJ-BRIT MED J, V312, P1153; Bohmer AE, 2011, NEUROSURGERY, V68, P1624, DOI 10.1227/NEU.0b013e318214a81f; Chabok SY, 2012, J TRAUMA ACUTE CARE, V72, P1654, DOI 10.1097/TA.0b013e318246887e; DAUBERSCHMIDT R, 1983, CLIN CHIM ACTA, V131, P165, DOI 10.1016/0009-8981(83)90085-2; de Kruijk JR, 2001, ACTA NEUROL SCAND, V103, P175, DOI 10.1034/j.1600-0404.2001.103003175.x; Giacoppo S, 2012, NEUROCRIT CARE, V16, P470, DOI 10.1007/s12028-012-9707-z; Goncalves CA, 2008, CLIN BIOCHEM, V41, P755, DOI 10.1016/j.clinbiochem.2008.04.003; Gradisek P, 2012, BRAIN INJURY, V26, P1472, DOI 10.3109/02699052.2012.694567; Guan Wei, 2003, Chin J Traumatol, V6, P218; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; Johnsson P, 1996, J CARDIOTHOR VASC AN, V10, P120, DOI 10.1016/S1053-0770(96)80187-X; Li Ning, 2004, Chin J Traumatol, V7, P156; Li XY, 2009, J CLIN NEUROSCI, V16, P614, DOI 10.1016/j.jocn.2008.08.005; McKeating EG, 1998, ACT NEUR S, V71, P117; Meric E, 2010, J EMERG MED, V38, P297, DOI 10.1016/j.jemermed.2007.11.032; Moher D, 2009, BMJ-BRIT MED J, V339, DOI [10.1136/bmj.i4086, 10.1136/bmj.b2535, 10.1186/2046-4053-4-1]; MOORE BW, 1965, J BIOL CHEM, V240, P1647; Olivecrona M, 2009, J NEUROL NEUROSUR PS, V80, P1241, DOI 10.1136/jnnp.2008.158196; Papa Linda, 2008, Expert Opin Med Diagn, V2, P937, DOI 10.1517/17530059.2.8.937; Pelinka LE, 2005, SHOCK, V24, P119, DOI 10.1097/01.shk.0000168876.68154.43; Perel P, 2008, BMJ-BRIT MED J, V336, P425, DOI 10.1136/bmj.39461.643438.25; Raabe A, 1999, BRIT J NEUROSURG, V13, P56, DOI 10.1080/02688699944195; Raabe A, 1998, ACTA NEUROCHIR, V140, P787, DOI 10.1007/s007010050180; Reitsma JB, 2005, J CLIN EPIDEMIOL, V58, P982, DOI 10.1016/j.jclinepi.2005.02.022; Roozenbeek B, 2013, NAT REV NEUROL, V9, P231, DOI 10.1038/nrneurol.2013.22; Ross SA, 1996, BRIT J NEUROSURG, V10, P471, DOI 10.1080/02688699647104; Sogut O, 2010, J INT MED RES, V38, P1708, DOI 10.1177/147323001003800516; Stein DM, 2012, J NEUROTRAUM, V29, P1140, DOI 10.1089/neu.2011.2149; Turgeon AF, 2013, CRIT CARE MED, V41, P1086, DOI 10.1097/CCM.0b013e318275d046; Vos PE, 2004, NEUROLOGY, V62, P1303, DOI 10.1212/01.WNL.0000120550.00643.DC; Whiting PF, 2011, ANN INTERN MED, V155, P529, DOI 10.7326/0003-4819-155-8-201110180-00009; Woertgen C, 1997, ACTA NEUROCHIR, V139, P1161, DOI 10.1007/BF01410977; Wu HM, 2004, J NEUROTRAUM, V21, P149, DOI 10.1089/089771504322778613; YAMAZAKI Y, 1995, SURG NEUROL, V43, P267, DOI 10.1016/0090-3019(95)80012-6; Yokobori S, 2013, CNS NEUROSCI THER, V19, P556, DOI 10.1111/cns.12127; Zitnay GA, 2008, J NEUROTRAUM, V25, P1135, DOI 10.1089/neu.2008.0599; Zurek J, 2012, ACTA NEUROCHIR, V154, P93, DOI 10.1007/s00701-011-1175-2	40	73	78	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 4	2014	9	9							e106680	10.1371/journal.pone.0106680	http://dx.doi.org/10.1371/journal.pone.0106680			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3XV	25188406	Green Published, gold, Green Submitted			2022-12-27	WOS:000341271500069
J	Chou, CH; Sinden, JD; Couraud, PO; Modo, M				Chou, Chung-Hsing; Sinden, John D.; Couraud, Pierre-Olivier; Modo, Michel			In Vitro Modeling of the Neurovascular Environment by Coculturing Adult Human Brain Endothelial Cells with Human Neural Stem Cells	PLOS ONE			English	Article							MOLECULAR-MECHANISMS; BARRIER FUNCTION; RAT-BRAIN; STROKE; ANGIOGENESIS; LINE; VASCULARIZATION; ASTROCYTES; PERICYTES; HYPOXIA	Brain and vascular cells form a functionally integrated signalling network that is known as the neurovascular unit (NVU). The signalling (autocrine, paracrine and juxtacrine) between different elements of this unit, especially in humans, is difficult to disentangle in vivo. Developing representative in vitro models is therefore essential to better understand the cellular interactions that govern the neurovascular environment. We here describe a novel approach to assay these cellular interactions by combining a human adult cerebral microvascular endothelial cell line (hCMEC/D3) with a fetal ganglionic eminence-derived neural stem cell (hNSC) line. These cell lines provide abundant homogeneous populations of cells to produce a consistently reproducible in vitro model of endothelial morphogenesis and the ensuing NVU. Vasculature-like structures (VLS) interspersed with patches of differentiating neural cells only occurred when hNSCs were seeded onto a differentiated endothelium. These VLS emerged within 3 days of coculture and by day 6 were stabilizing. After 7 days of coculture, neuronal differentiation of hNSCs was increased 3-fold, but had no significant effect on astrocyte or oligodendrocyte differentiation. ZO1, a marker of adherens and tight junctions, was highly expressed in both undifferentiated and differentiated endothelial cells, but the adherens junction markers CD31 and VE-cadherin were significantly reduced in coculture by approximately 20%. A basement membrane, consisting of laminin, vitronectin, and collagen I and IV, separated the VLS from neural patches. This simple assay can assist in elucidating the cellular and molecular signaling involved in the formation of VLS, as well as the enhancement of neuronal differentiation through endothelial signaling.	[Chou, Chung-Hsing; Modo, Michel] Univ Pittsburgh, McGowan Inst Regenerat Med, Pittsburgh, PA 15260 USA; [Chou, Chung-Hsing] Kings Coll London, Inst Psychiat, Dept Neurosci, London, England; [Chou, Chung-Hsing] Tri Serv Gen Hosp, Natl Def Med Ctr, Dept Neurol, Taipei, Taiwan; [Sinden, John D.] ReNeuron Ltd, Guildford, Surrey, England; [Couraud, Pierre-Olivier] INSERM, Inst Cochin, U1016, Paris, France; [Couraud, Pierre-Olivier] CNRS, UMR8104, Paris, France; [Couraud, Pierre-Olivier] Univ Paris 05, Sorbonne Paris Cite, Paris, France; [Modo, Michel] Univ Pittsburgh, Dept Radiol, Pittsburgh, PA 15260 USA; [Modo, Michel] Univ Pittsburgh, Dept Bioengn, Pittsburgh, PA USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of London; King's College London; National Defense Medical Center; Tri-Service General Hospital; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Modo, M (corresponding author), Univ Pittsburgh, McGowan Inst Regenerat Med, Pittsburgh, PA 15260 USA.	modomm@upmc.edu		Modo, Michel/0000-0003-4436-735X	Commonwealth of Pennsylvania, Department of Health [4100061184]; National Institute for Neurological Disorders and Stroke [R01NS082226]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS082226] Funding Source: NIH RePORTER	Commonwealth of Pennsylvania, Department of Health; National Institute for Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by the Commonwealth of Pennsylvania, Department of Health (SAP# 4100061184) and the National Institute for Neurological Disorders and Stroke (R01NS082226). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott NJ, 2012, METHODS MOL BIOL, V814, P415, DOI 10.1007/978-1-61779-452-0_28; Albini A, 2010, CURR OPIN CELL BIOL, V22, P677, DOI 10.1016/j.ceb.2010.08.017; Armulik A, 2010, NATURE, V468, P557, DOI 10.1038/nature09522; Arnold T, 2013, VASC CELL, V5, DOI 10.1186/2045-824X-5-4; Auger FA, 2013, ANNU REV BIOMED ENG, V15, P177, DOI 10.1146/annurev-bioeng-071812-152428; Baker BM, 2012, J CELL SCI, V125, P3015, DOI 10.1242/jcs.079509; Bernaudin M, 1998, EXP NEUROL, V150, P30, DOI 10.1006/exnr.1997.6728; Bible E, 2012, BIOMATERIALS, V33, P7435, DOI 10.1016/j.biomaterials.2012.06.085; Bible E, 2012, BIOMATERIALS, V33, P2858, DOI 10.1016/j.biomaterials.2011.12.033; Bible E, 2009, BIOMATERIALS, V30, P2985, DOI 10.1016/j.biomaterials.2009.02.012; Cardoso FL, 2010, BRAIN RES REV, V64, P328, DOI 10.1016/j.brainresrev.2010.05.003; Cecchelli R, 2007, NAT REV DRUG DISCOV, V6, P650, DOI 10.1038/nrd2368; Conway EM, 2001, CARDIOVASC RES, V49, P507, DOI 10.1016/S0008-6363(00)00281-9; Daneman R, 2010, NATURE, V468, P562, DOI 10.1038/nature09513; Eilken HM, 2010, CURR OPIN CELL BIOL, V22, P617, DOI 10.1016/j.ceb.2010.08.010; Emerich DF, 2010, CELL TRANSPLANT, V19, P1063, DOI 10.3727/096368910X498278; Eng G, 2013, P NATL ACAD SCI USA, V110, P4551, DOI 10.1073/pnas.1300569110; Ergul A, 2012, STROKE, V43, P2270, DOI 10.1161/STROKEAHA.111.642710; Gomez-Gaviro MV, 2012, P NATL ACAD SCI USA, V109, P1317, DOI 10.1073/pnas.1016199109; GRANT DS, 1990, ANN NY ACAD SCI, V588, P61, DOI 10.1111/j.1749-6632.1990.tb13197.x; Griep LM, 2013, BIOMED MICRODEVICES, V15, P145, DOI 10.1007/s10544-012-9699-7; Hatherell K, 2011, J NEUROSCI METH, V199, P223, DOI 10.1016/j.jneumeth.2011.05.012; Hawkins BT, 2005, PHARMACOL REV, V57, P173, DOI 10.1124/pr.57.2.4; Hicks C, 2013, CELL TRANSPLANT, V22, P1541, DOI 10.3727/096368912X657936; Horie N, 2011, TRANSPLANTED STEM CE; Jensen RL, 2009, J NEURO-ONCOL, V92, P317, DOI 10.1007/s11060-009-9827-2; Jiang Q, 2005, NEUROIMAGE, V28, P698, DOI 10.1016/j.neuroimage.2005.06.063; Johansson S, 2008, STEM CELLS, V26, P2444, DOI 10.1634/stemcells.2008-0116; Kleinfeld David, 2011, Front Neuroenergetics, V3, P1, DOI 10.3389/fnene.2011.00001; Ko HCH, 2007, EUR CELLS MATER, V14, P1; Lee Hyoshin, 2007, Plant Biology (Rockville), V2007, P156; Li Q, 2011, ANGIOGENESIS, V14, P173, DOI 10.1007/s10456-011-9201-9; Lippmann ES, 2011, J NEUROCHEM, V119, P507, DOI 10.1111/j.1471-4159.2011.07434.x; Liu S, 2012, CURR PHARM DESIGN, V18, P3653, DOI 10.2174/138161212802002706; Luo J, 2012, MICROVASC RES, V83, P138, DOI 10.1016/j.mvr.2011.11.004; Madri JA, 2009, J PHYSIOL PHARMACOL, V60, P95; Maki T, 2013, CNS NEUROL DISORD-DR, V12, P302, DOI 10.2174/1871527311312030004; Mezentsev A, 2005, AM J PHYSIOL-HEART C, V289, pH1106, DOI 10.1152/ajpheart.00265.2005; Moeller BJ, 2004, SEMIN RADIAT ONCOL, V14, P215, DOI 10.1016/j.semradonc.2004.04.005; Montenegro CF, 2012, BIOCHIMIE, V94, P1812, DOI 10.1016/j.biochi.2012.04.020; Nakagawa S, 2009, NEUROCHEM INT, V54, P253, DOI 10.1016/j.neuint.2008.12.002; Pollock K, 2006, EXP NEUROL, V199, P143, DOI 10.1016/j.expneurol.2005.12.011; Quaegebeur A, 2011, NEURON, V71, P406, DOI 10.1016/j.neuron.2011.07.013; ROBINSON KA, 1995, ANGIOLOGY, V46, P107, DOI 10.1177/000331979504600203; Ruhrberg C, 2013, CELL MOL LIFE SCI, V70, P1675, DOI 10.1007/s00018-013-1277-5; Silvestre JS, 2013, PHYSIOL REV, V93, P1743, DOI 10.1152/physrev.00006.2013; Smith EJ, 2012, STEM CELLS, V30, P785, DOI 10.1002/stem.1024; Soares Raquel, 2003, Angiogenesis, V6, P271, DOI 10.1023/B:AGEN.0000029413.32882.dd; Soda Y, 2013, J MOL MED, V91, P439, DOI 10.1007/s00109-013-1019-z; Staton CA, 2009, INT J EXP PATHOL, V90, P195, DOI 10.1111/j.1365-2613.2008.00633.x; Takeshita Y, 2012, IMMUNOL REV, V248, P228, DOI 10.1111/j.1600-065X.2012.01127.x; Terasaki T, 2003, DRUG DISCOV TODAY, V8, P944, DOI 10.1016/S1359-6446(03)02858-7; Weksler B, 2013, FLUIDS BARRIERS CNS, V10, DOI 10.1186/2045-8118-10-16; Weksler BB, 2005, FASEB J, V19, P1872, DOI 10.1096/fj.04-3458fje; Wilhelm I, 2011, ACTA NEUROBIOL EXP, V71, P113; Williams C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0053208; Xue Q, 2013, INT J BIOL SCI, V9, P174, DOI 10.7150/ijbs.5115	57	46	47	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 4	2014	9	9							e106346	10.1371/journal.pone.0106346	http://dx.doi.org/10.1371/journal.pone.0106346			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3XV	25187991	Green Published, gold, Green Accepted			2022-12-27	WOS:000341271500030
J	Gopal, A; Egecioglu, DE; Yoffe, AM; Ben-Shaul, A; Rao, ALN; Knobler, CM; Gelbart, WM				Gopal, Ajaykumar; Egecioglu, Defne E.; Yoffe, Aron M.; Ben-Shaul, Avinoam; Rao, Ayala L. N.; Knobler, Charles M.; Gelbart, William M.			Viral RNAs Are Unusually Compact	PLOS ONE			English	Article							FLUORESCENCE CORRELATION SPECTROSCOPY; SECONDARY STRUCTURE; CAPSID PROTEIN; TETRAHYMENA RIBOZYME; TERTIARY STRUCTURE; VIRUS; CONDENSATION; PRINCIPLES; PREDICTION; SCATTERING	A majority of viruses are composed of long single-stranded genomic RNA molecules encapsulated by protein shells with diameters of just a few tens of nanometers. We examine the extent to which these viral RNAs have evolved to be physically compact molecules to facilitate encapsulation. Measurements of equal-length viral, non-viral, coding and non-coding RNAs show viral RNAs to have among the smallest sizes in solution, i.e., the highest gel-electrophoretic mobilities and the smallest hydrodynamic radii. Using graph-theoretical analyses we demonstrate that their sizes correlate with the compactness of branching patterns in predicted secondary structure ensembles. The density of branching is determined by the number and relative positions of 3-helix junctions, and is highly sensitive to the presence of rare higher-order junctions with 4 or more helices. Compact branching arises from a preponderance of base pairing between nucleotides close to each other in the primary sequence. The density of branching represents a degree of freedom optimized by viral RNA genomes in response to the evolutionary pressure to be packaged reliably. Several families of viruses are analyzed to delineate the effects of capsid geometry, size and charge stabilization on the selective pressure for RNA compactness. Compact branching has important implications for RNA folding and viral assembly.	[Gopal, Ajaykumar; Egecioglu, Defne E.; Yoffe, Aron M.; Knobler, Charles M.; Gelbart, William M.] Univ Calif Los Angeles, Dept Chem & Biochem, Los Angeles, CA 90024 USA; [Ben-Shaul, Avinoam] Hebrew Univ Jerusalem, Inst Chem, IL-91904 Jerusalem, Israel; [Ben-Shaul, Avinoam] Hebrew Univ Jerusalem, Fritz Haber Res Ctr, IL-91904 Jerusalem, Israel; [Rao, Ayala L. N.] Univ Calif Riverside, Dept Plant Pathol, Riverside, CA 92521 USA	University of California System; University of California Los Angeles; Hebrew University of Jerusalem; Hebrew University of Jerusalem; University of California System; University of California Riverside	Gelbart, WM (corresponding author), Univ Calif Los Angeles, Dept Chem & Biochem, 405 Hilgard Ave, Los Angeles, CA 90024 USA.	gelbart@chem.ucla.edu	Gopal, Ajaykumar/C-8886-2009	Gopal, Ajaykumar/0000-0003-4632-4863	U.S. National Science Foundation Division of Chemistry [CHE 0714411, 1051507]; Israel Science Foundation [1448/10]; NIH-NCRR [CJX1-443835-WS-29646]; NSF Major Research Instrumentation grant [CHE-0722519]	U.S. National Science Foundation Division of Chemistry(National Science Foundation (NSF)); Israel Science Foundation(Israel Science Foundation); NIH-NCRR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NSF Major Research Instrumentation grant	This research was supported by the U.S. National Science Foundation Division of Chemistry (http://www.nsf.gov/div/index.jsp?div=CHE) grants CHE 0714411 and 1051507 to WMG and CMK, and the Israel Science Foundation (http://www.isf.org.il/english) grant 1448/10 to ABS. The CNSI Advanced Light Microscopy/Spectroscopy Shared Resource Facility at UCLA was supported by funding from NIH-NCRR shared resources grant (CJX1-443835-WS-29646) and NSF Major Research Instrumentation grant (CHE-0722519). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Mutairy B, 2005, VIRUS GENES, V31, P21, DOI 10.1007/s11262-004-2196-1; Annamalai P, 2005, J VIROL, V79, P3277, DOI 10.1128/JVI.79.6.3277-3288.2005; ARAGON SR, 1976, J CHEM PHYS, V64, P1791, DOI 10.1063/1.432357; Bakhtin Y, 2009, B MATH BIOL, V71, P84, DOI 10.1007/s11538-008-9353-y; Ban N, 2000, SCIENCE, V289, P905, DOI 10.1126/science.289.5481.905; Bao YM, 2004, J VIROL, V78, P7291, DOI 10.1128/JVI.78.14.7291-7298.2004; Basnak G, 2010, J MOL BIOL, V395, P924, DOI 10.1016/j.jmb.2009.11.018; Belyi VA, 2006, P NATL ACAD SCI USA, V103, P17174, DOI 10.1073/pnas.0608311103; Biggs NL, 1976, GRAPH THEORY 1736 19, P1; Bleckley S, 2012, RNA, V18, P1309, DOI 10.1261/rna.032326.112; Bloomfield VA, 1997, BIOPOLYMERS, V44, P269, DOI 10.1002/(SICI)1097-0282(1997)44:3<269::AID-BIP6>3.0.CO;2-T; Bon M, 2013, NUCLEIC ACIDS RES, V41, P1895, DOI 10.1093/nar/gks1204; Bundschuh R, 2002, PHYS REV E, V65, DOI 10.1103/PhysRevE.65.031903; Carrillo-Tripp M, 2009, NUCLEIC ACIDS RES, V37, pD436, DOI 10.1093/nar/gkn840; CASPAR DLD, 1962, COLD SPRING HARB SYM, V27, P1, DOI 10.1101/sqb.1962.027.001.005; Cherry JM, 1997, NATURE, V387, P67, DOI 10.1038/387s067; Choi YG, 2000, VIROLOGY, V270, P377, DOI 10.1006/viro.2000.0312; Choi YG, 2003, J VIROL, V77, P9750, DOI 10.1128/JVI.77.18.9750-9757.2003; Choi YG, 2000, VIROLOGY, V275, P207, DOI 10.1006/viro.2000.0513; Clarke IN, 2000, J INFECT DIS, V181, pS309, DOI 10.1086/315575; COHEN SS, 1981, P NATL ACAD SCI-BIOL, V78, P5470, DOI 10.1073/pnas.78.9.5470; DEGENNES PG, 1968, BIOPOLYMERS, V6, P715, DOI 10.1002/bip.1968.360060508; EECEN HG, 1985, BIOCHEMISTRY-US, V24, P3610, DOI 10.1021/bi00335a032; Euler L., 1736, COMMENTARII ACAD SCI, V8, P128; Fang LT, 2011, J CHEM PHYS, V135, DOI 10.1063/1.3652763; Flinders J, 2006, PROG NUCL MAG RES SP, V48, P137, DOI 10.1016/j.pnmrs.2006.03.001; Freire JJ, 1999, ADV POLYM SCI, V143, P35; Gan HH, 2003, NUCLEIC ACIDS RES, V31, P2926, DOI 10.1093/nar/gkg365; Geis M, 2008, J MOL BIOL, V379, P160, DOI 10.1016/j.jmb.2008.02.064; Gelbart WM, 2000, PHYS TODAY, V53, P38, DOI 10.1063/1.1325230; Glass PJ, 2000, J VIROL, V74, P6581, DOI 10.1128/JVI.74.14.6581-6591.2000; Gopal A, 2012, RNA, V18, P284, DOI 10.1261/rna.027557.111; Hajdin CE, 2010, RNA, V16, P1340, DOI 10.1261/rna.1837410; Heilman-Miller SL, 2001, J MOL BIOL, V306, P1157, DOI 10.1006/jmbi.2001.4437; HOFACKER IL, 1994, MONATSH CHEM, V125, P167, DOI 10.1007/BF00818163; Holbrook SR, 2008, ANNU REV BIOPHYS, V37, P445, DOI 10.1146/annurev.biophys.36.040306.132755; Hyeon C, 2006, J CHEM PHYS, V125, DOI 10.1063/1.2364190; Hyeon C, 2012, BIOPHYS J, V102, pL11, DOI 10.1016/j.bpj.2012.01.003; Izzo JA, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-219; Katz L, 2003, GENOME RES, V13, P2042, DOI 10.1101/gr.1257503; Koculi E, 2004, J MOL BIOL, V341, P27, DOI 10.1016/j.jmb.2004.06.008; Konkolewicz D, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.238301; Krishna NK, 2005, VIRAL IMMUNOL, V18, P17, DOI 10.1089/vim.2005.18.17; Lamb J, 2008, J APPL CRYSTALLOGR, V41, P1046, DOI 10.1107/S0021889808028264; Larson SB, 2001, CURR OPIN STRUC BIOL, V11, P59, DOI 10.1016/S0959-440X(00)00166-4; Li PTX, 2008, ANNU REV BIOCHEM, V77, P77, DOI 10.1146/annurev.biochem.77.061206.174353; Lipfert J, 2007, J MOL BIOL, V365, P1393, DOI 10.1016/j.jmb.2006.10.022; Mathews DH, 2006, CURR OPIN STRUC BIOL, V16, P270, DOI 10.1016/j.sbi.2006.05.010; Mayo MA, 1996, ADV VIRUS RES, V46, P413, DOI 10.1016/S0065-3527(08)60077-9; Pan T, 2006, ANNU REV BIOPH BIOM, V35, P161, DOI 10.1146/annurev.biophys.35.040405.102053; Petrasek Z, 2008, BIOPHYS J, V94, P1437, DOI 10.1529/biophysj.107.108811; PLEIJ CWA, 1985, NUCLEIC ACIDS RES, V13, P1717, DOI 10.1093/nar/13.5.1717; Pristinski D, 2005, J CHEM PHYS, V122, DOI 10.1063/1.1829255; Rao ALN, 2006, ANNU REV PHYTOPATHOL, V44, P61, DOI 10.1146/annurev.phyto.44.070505.143334; Rasband W., 2006, IMAGEJ; RIGLER R, 1993, EUR BIOPHYS J BIOPHY, V22, P169, DOI 10.1007/BF00185777; Sadowy E, 2001, ADV VIRUS RES, V57, P185, DOI 10.1016/S0065-3527(01)57004-9; Sambrook J., 2001, MOL CLONING LAB MANU; Schneemann A, 2006, ANNU REV MICROBIOL, V60, P51, DOI 10.1146/annurev.micro.60.080805.142304; Schultes EA, 2005, NAT STRUCT MOL BIOL, V12, P1130, DOI 10.1038/nsmb1014; Soto AM, 2007, BIOCHEMISTRY-US, V46, P2973, DOI 10.1021/bi0616753; SPEIR JA, 1995, STRUCTURE, V3, P63, DOI 10.1016/S0969-2126(01)00135-6; STRAUSS EG, 1984, VIROLOGY, V133, P92, DOI 10.1016/0042-6822(84)90428-8; Stubbs G, 2012, ADV EXP MED BIOL, V726, P631, DOI 10.1007/978-1-4614-0980-9_28; Svergun DI, 2003, REP PROG PHYS, V66, P1735, DOI 10.1088/0034-4885/66/10/R05; Tamm T, 2000, J VIROL, V74, P6231, DOI 10.1128/JVI.74.14.6231-6241.2000; Tinoco I, 1999, J MOL BIOL, V293, P271, DOI 10.1006/jmbi.1999.3001; Torres MW, 2005, GENET MOL RES, V4, P790; VALEGARD K, 1994, NATURE, V371, P623, DOI 10.1038/371623a0; von Ferber C, 2000, PHYS REV E, V62, P6949, DOI 10.1103/PhysRevE.62.6949; Watts JM, 2009, NATURE, V460, P711, DOI 10.1038/nature08237; Weeks KM, 2010, CURR OPIN STRUC BIOL, V20, P295, DOI 10.1016/j.sbi.2010.04.001; Yoffe AM, 2009, THESIS U CALIFORNIA; Yoffe AM, 2008, P NATL ACAD SCI USA, V105, P16153, DOI 10.1073/pnas.0808089105; Zhang W, 2002, J VIROL, V76, P11645, DOI 10.1128/JVI.76.22.11645-11658.2002; Zipper P, 2007, J APPL CRYSTALLOGR, V40, pS153, DOI 10.1107/S0021889807005936	76	24	24	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 4	2014	9	9							e105875	10.1371/journal.pone.0105875	http://dx.doi.org/10.1371/journal.pone.0105875			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3XV	25188030	gold, Green Published, Green Submitted			2022-12-27	WOS:000341271500016
J	Janssens, X; Decuman, S; De Keyser, F				Janssens, Xavier; Decuman, Saskia; De Keyser, Filip		Belgian Rheumatoid Arthrit	Assessment of Activity Limitations with the Health Assessment Questionnaire Predicts the Need for Support Measures in Patients with Rheumatoid Arthritis: A Multicenter Observational Study	PLOS ONE			English	Article							ASSOCIATION; BENEFITS; PEOPLE; HAQ	Objective: This study investigated whether the Health Assessment Questionnaire (HAQ) can be used as an instrument to assess the need for social support measures that address activity limitations and participation issues in patients with rheumatoid arthritis (RA). Methods: This multicenter observational study included patients with RA and disease duration of at least one year, consulting their rheumatologist for routine evaluation of disease activity. In the single study visit data on demographics, disease history and current treatment were collected. DAS28 values were collected to evaluate current RA disease activity. Patients were asked to fill out the HAQ and SF-36 questionnaires. Receiver Operator Characteristics (ROC) curves were constructed to evaluate the performance of the HAQ, SF-36 and DAS28 in predicting the need for nine supporting measures available for chronically ill patients in the Belgian social security system. The expert opinion of the treating rheumatologist was used as a reference. Results: The study included 316 patients with a mean age of 59.8 +/- 12.6 years, disease duration of 11.4 +/- 9.3 years, mean DAS28 values of 2.83 +/- 1.17. Mean HAQ score was 0.95 +/- 0.73, mean SF-36 score 56.5 +/- 21.3. HAQ scores >1 were observed in 39.4% of patients. The area under the HAQ ROC curve was consistently >0.7 and higher for the HAQ than for SF-36 or DAS28 for all support measures. Rheumatologists on average recommended 3.67 support measures. Conclusion: The HAQ score was found to be a good predictor of the need for social support measures in patients with RA.	[Janssens, Xavier; Decuman, Saskia; De Keyser, Filip] Ghent Univ Hosp, Dept Rheumatol, Ghent, Belgium; [Decuman, Saskia] Univ Ghent, Dept Internal Med, B-9000 Ghent, Belgium	Ghent University; Ghent University Hospital; Ghent University	Janssens, X (corresponding author), Ghent Univ Hosp, Dept Rheumatol, Ghent, Belgium.	janssens.reuma@skynet.be	Verschueren, Patrick/L-6397-2019	Verschueren, Patrick/0000-0002-0340-3580; durez, patrick/0000-0002-7156-2356	Roche; Fonds de la Recherche de l'Association Polyarthrite-FRAP; Fonds voor Wetenschappelijk Reuma Onderzoek/Fonds pour la Recherche Scientifique en Rhumatologie	Roche(Roche Holding); Fonds de la Recherche de l'Association Polyarthrite-FRAP; Fonds voor Wetenschappelijk Reuma Onderzoek/Fonds pour la Recherche Scientifique en Rhumatologie	This work was supported by an unrestricted educational grant from Roche, by the 'Fonds de la Recherche de l'Association Polyarthrite-FRAP' and by the 'Fonds voor Wetenschappelijk Reuma Onderzoek/Fonds pour la Recherche Scientifique en Rhumatologie'. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARNETT FC, 1988, ARTHRITIS RHEUM, V31, P315, DOI 10.1002/art.1780310302; Bendtsen P, DISABIL REHABIL, V17, P94; Bewick V, 2004, CRIT CARE, V8, P508, DOI 10.1186/cc3000; Bruce B, 2003, J RHEUMATOL, V30, P167; Bruce B, 2005, CLIN EXP RHEUMATOL, V23, pS14; Bruce Bonnie, 2003, Health Qual Life Outcomes, V1, P20, DOI 10.1186/1477-7525-1-20; Fruin C, 2008, MUSCULOSKELET CARE, V6, P211, DOI 10.1002/msc.133; Harrison MJ, 2009, ARTHRIT CARE RES, V61, P1297, DOI 10.1002/art.24830; Huscher D, 2006, ANN RHEUM DIS, V65, P1175, DOI 10.1136/ard.2005.046367; Langley C, 2004, RHEUMATOLOGY, V43, P863, DOI 10.1093/rheumatology/keh184; Linde L, 2008, J RHEUMATOL, V35, P1528; Massardo L, 2012, ARTHRIT CARE RES, V64, P1135, DOI 10.1002/acr.21680; Memel DS, 2002, RHEUMATOLOGY, V41, P100, DOI 10.1093/rheumatology/41.1.100; Pincus T, 2006, J RHEUMATOL, V33, P834; Sokka T, 2006, ARTHRITIS RHEUM-US, V54, P3113, DOI 10.1002/art.22130; WOLFE F, 1988, J RHEUMATOL, V15, P1480; Yelin E, 1999, ARTHRITIS RHEUM, V42, P1209, DOI 10.1002/1529-0131(199906)42:6<1209::AID-ANR18>3.0.CO;2-M; YOUDEN W. J., 1950, CANCER, V3, P32, DOI 10.1002/1097-0142(1950)3:1<32::AID-CNCR2820030106>3.0.CO;2-3; Zandbelt MM, 2001, ANN RHEUM DIS, V60, P841	19	6	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 4	2014	9	9							e106749	10.1371/journal.pone.0106749	http://dx.doi.org/10.1371/journal.pone.0106749			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3XV	25188388	gold, Green Published, Green Submitted			2022-12-27	WOS:000341271500082
J	Keikhaee, MR; Nash, EB; O'Rourke, SM; Bowerman, B				Keikhaee, Mohammad R.; Nash, Eric B.; O'Rourke, Sean M.; Bowerman, Bruce			A Semi-Dominant Mutation in the General Splicing Factor SF3a66 Causes Anterior-Posterior Axis Reversal in One-Cell Stage C-elegans Embryos	PLOS ONE			English	Article							CAENORHABDITIS-ELEGANS; PAR PROTEINS; SYMMETRY-BREAKING; MEIOTIC SPINDLE; POLARITY; POLARIZATION; INTERFERENCE; MICROTUBULES; CENTROSOMES; INITIATE	Establishment of anterior-posterior polarity in one-cell stage Caenorhabditis elegans embryos depends in part on astral microtubules. As the zygote enters mitosis, these microtubules promote the establishment of a posterior pole by binding to and protecting a cytoplasmic pool of the posterior polarity protein PAR-2 from phosphorylation by the cortically localized anterior polarity protein PKC-3. Prior to activation of the sperm aster, the oocyte Meiosis I and II spindles assemble and function, usually at the future anterior pole, but these meiotic spindle microtubules fail to establish posterior polarity through PAR-2. Here we show that a semi-dominant mutation in the general splicing factor SF3a66 can lead to a reversed axis of AP polarity that depends on PAR-2 and possibly on close proximity of oocyte meiotic spindles with the cell cortex. One possible explanation is that reduced levels of PKC-3, due to a general splicing defect, can result in axis reversal due to a failure to prevent oocyte meiotic spindle microtubules from interfering with AP axis formation.	[Keikhaee, Mohammad R.; Nash, Eric B.; O'Rourke, Sean M.; Bowerman, Bruce] Univ Oregon, Inst Mol Biol, Eugene, OR 97403 USA	University of Oregon	Bowerman, B (corresponding author), Univ Oregon, Inst Mol Biol, Eugene, OR 97403 USA.	bbowerman@molbio.uoregon.edu			National Institutes of Health [GM049869]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM049869] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by a grant from the National Institutes of Health (GM049869) to BB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bastock R, 2011, DEV CELL, V21, P981, DOI 10.1016/j.devcel.2011.11.015; Bienkowska D, 2012, CURR BIOL, V22, P583, DOI 10.1016/j.cub.2012.01.064; BRENNER S, 1974, GENETICS, V77, P71; Cowan CR, 2004, NATURE, V431, P92, DOI 10.1038/nature02825; De Arras L, 2013, J BIOL CHEM, V288, P1967, DOI 10.1074/jbc.M112.407205; Encalada SE, 2000, DEV BIOL, V228, P225, DOI 10.1006/dbio.2000.9965; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; Goehring NW, 2011, SCIENCE, V334, P1137, DOI 10.1126/science.1208619; Golden A, 2000, J CELL BIOL, V151, P1469, DOI 10.1083/jcb.151.7.1469; Goldstein B, 2007, DEV CELL, V13, P609, DOI 10.1016/j.devcel.2007.10.007; Jenkins N, 2006, SCIENCE, V313, P1298, DOI 10.1126/science.1130291; Kamath RS, 2003, NATURE, V421, P231, DOI 10.1038/nature01278; Motegi F, 2011, NAT CELL BIOL, V13, P1361, DOI 10.1038/ncb2354; Muller-Reichert T, 2010, CELL MOL LIFE SCI, V67, P2195, DOI 10.1007/s00018-010-0324-8; Munro E, 2004, DEV CELL, V7, P413, DOI 10.1016/j.devcel.2004.08.001; Munro E, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a003400; Schneider SQ, 2003, ANNU REV GENET, V37, P221, DOI 10.1146/annurev.genet.37.110801.142443; St Johnston D, 2010, CELL, V141, P757, DOI 10.1016/j.cell.2010.05.011; SULSTON JE, 1983, DEV BIOL, V100, P64, DOI 10.1016/0012-1606(83)90201-4; Takenaka K, 2004, BIOCHEM J, V382, P223, DOI 10.1042/BJ20040521; Timmons L, 1998, NATURE, V395, P854, DOI 10.1038/27579; Tsai MC, 2007, J CELL BIOL, V179, P397, DOI 10.1083/jcb.200708101; van der Voet M, 2009, NAT CELL BIOL, V11, P269, DOI 10.1038/ncb1834; Wallenfang MR, 2000, NATURE, V408, P89, DOI 10.1038/35040562; Yang HY, 2005, J CELL BIOL, V169, P447, DOI 10.1083/jcb.200411132; Zonies S, 2010, DEVELOPMENT, V137, P1669, DOI 10.1242/dev.045823	26	1	1	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 4	2014	9	9							e106484	10.1371/journal.pone.0106484	http://dx.doi.org/10.1371/journal.pone.0106484			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3XV	25188372	Green Submitted, Green Published, gold			2022-12-27	WOS:000341271500040
J	Schlutter, JM; Kirkegaard, I; Petersen, OB; Larsen, N; Christensen, B; Hougaard, DM; Kolvraa, S; Uldbjerg, N				Schlutter, Jacob Morup; Kirkegaard, Ida; Petersen, Olav Bjorn; Larsen, Nanna; Christensen, Britta; Hougaard, David M.; Kolvraa, Steen; Uldbjerg, Niels			Fetal Gender and Several Cytokines Are Associated with the Number of Fetal Cells in Maternal Blood - An Observational Study	PLOS ONE			English	Article							NONINVASIVE PRENATAL-DIAGNOSIS; INFLAMMATORY MARKERS; PERIPHERAL-BLOOD; PROGENITOR CELLS; NUCLEATED CELLS; DNA; MICROCHIMERISM; IDENTIFICATION; PREGNANCY; PLASMA	Objective: To identify factors influencing the number of fetal cells in maternal blood. Methods: A total of 57 pregnant women at a gestational age of weeks 11-14 were included. The number of fetal cells in maternal blood was assessed in 30 ml of blood using specific markers for both enrichment and subsequent identification. Results: Participants carrying male fetuses had a higher median number of fetal cells in maternal blood than those carrying female fetuses (5 vs. 3, p= 0.04). Certain cytokines (RANTES, IL-2 and IL-5) were significantly associated with the number of fetal cells in maternal blood. Conclusion: The number of fetal cells in maternal blood is associated with certain cytokines and fetal gender.	[Schlutter, Jacob Morup; Kirkegaard, Ida; Petersen, Olav Bjorn; Uldbjerg, Niels] Aarhus Univ Hosp, Dept Obstet & Gynecol, Skejby, Denmark; [Larsen, Nanna; Hougaard, David M.] Statens Serum Inst, Dept Clin Biochem & Immunol, DK-2300 Copenhagen, Denmark; [Christensen, Britta] FCMB ApS, Vejle, Denmark; [Kolvraa, Steen] Univ Southern Denmark, Vejle Hosp, Dept Clin Genet, Vejle, Denmark	Aarhus University; Statens Serum Institut; University of Southern Denmark; Lillebaelt Hospital	Kolvraa, S (corresponding author), Univ Southern Denmark, Vejle Hosp, Dept Clin Genet, Vejle, Denmark.	Steen.Koelvraa@rsyd.dk	Hougaard, David/AAD-6368-2019; Petersen, Olav Bjørn/A-1081-2013; Uldbjerg, Niels/O-2038-2016	Petersen, Olav Bjørn/0000-0001-8517-4082; Uldbjerg, Niels/0000-0002-6449-6426	private company FCMB ApS; firm FCMB ApS; Aarhus University; Familien Hede-Nielsens Fond; Aase og Ejner Danielsens Fond; Snedkermester Sophus Jacobsen og hustru Astrid Jacobsens Fond;  [EP13169861];  [EP11785308];  [EP10701193];  [EP10188156];  [EP06818152]	private company FCMB ApS; firm FCMB ApS; Aarhus University; Familien Hede-Nielsens Fond; Aase og Ejner Danielsens Fond; Snedkermester Sophus Jacobsen og hustru Astrid Jacobsens Fond; ; ; ; ; 	The isolation of fetal cells in this article was performed and funded by the private company FCMB ApS, which went into liquidation 18 months ago. FCMB ApS had developed a method for quantifying fetal cells in maternal blood, but for this study FCMB ApS had no role in study design, decision to publish, or preparation of the manuscript. Funders: Two authors (SK and BC) were funders of the firm FCMB ApS, which went into liquidation 18 months ago. The roles of SK and BC in this study were solely related to the counting of fetal cells in the samples. SK and BC filed before the liquidation of FCMB ApS patent applications for the basic methods used for the countings, enrichment and identification of fetal cells in maternal blood and ligants for such use (European application no EP13169861, EP11785308 and EP10701193), and detection of fetal cells from maternal blood (European application no. EP10188156 and EP06818152), but do not own these patent applications at present. With regards to the data in this publication, the patent applications do not alter the authors' adherence to PLOS ONE policies on sharing data and materials. Other funding sources: Aarhus University, Familien Hede-Nielsens Fond, Aase og Ejner Danielsens Fond, and Snedkermester Sophus Jacobsen og hustru Astrid Jacobsens Fond. These funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashoor G, 2013, ULTRASOUND OBST GYN, V41, P26, DOI 10.1002/uog.12331; Athayde N, 1999, AM J OBSTET GYNECOL, V181, P989, DOI 10.1016/S0002-9378(99)70337-6; Bianchi DW, 1996, P NATL ACAD SCI USA, V93, P705, DOI 10.1073/pnas.93.2.705; Bianchi DW, 2002, PRENATAL DIAG, V22, P609, DOI 10.1002/pd.347; Brinch M, 2012, PRENATAL DIAG, V32, P742, DOI 10.1002/pd.3894; Chan KCA, 2006, CLIN CHEM, V52, P2211, DOI 10.1373/clinchem.2006.074997; Christensen B, 2003, FETAL DIAGN THER, V18, P376, DOI 10.1159/000071983; Elsmen E, 2006, ACTA OBSTET GYN SCAN, V85, P1285, DOI 10.1080/00016340600578274; Gammill HS, 2010, BLOOD, V116, P2706, DOI 10.1182/blood-2010-02-270942; Guetta E, 2003, BLOOD CELL MOL DIS, V30, P13, DOI 10.1016/S1079-9796(03)00008-1; Hahn S, 2011, EXPERT REV MOL MED, V13, DOI 10.1017/S1462399411001852; HAMADA H, 1993, HUM GENET, V91, P427; Hatt L, 2014, PRENATAL DIAG, V34, P1066, DOI 10.1002/pd.4429; Hatt L, 2014, FETAL DIAGN THER, V35, P218, DOI 10.1159/000356073; KLEIHAUER E, 1957, KLIN WOCHENSCHR, V35, P637, DOI 10.1007/BF01481043; Kolvraa S, 2005, J HISTOCHEM CYTOCHEM, V53, P331, DOI 10.1369/jhc.4A6396.2005; Krabchi K, 2001, CLIN GENET, V60, P145, DOI 10.1034/j.1399-0004.2001.600209.x; Lo YMD, 1997, LANCET, V350, P485, DOI 10.1016/S0140-6736(97)02174-0; Mujezinovic F, 2007, OBSTET GYNECOL, V110, P687, DOI 10.1097/01.AOG.0000278820.54029.e3; Nielsen HS, 2010, J REPROD IMMUNOL, V87, P67, DOI 10.1016/j.jri.2010.05.006; Oudejans CBM, 2003, PRENATAL DIAG, V23, P111, DOI 10.1002/pd.539; Palomaki GE, 2011, GENET MED, V13, P913, DOI 10.1097/GIM.0b013e3182368a0e; Sharma D, 2010, AM J REPROD IMMUNOL; Skogstrand K, 2005, CLIN CHEM, V51, P1854, DOI 10.1373/clinchem.2005.052241; Taylor JB, 2014, J GENET COUNS, V23, P72, DOI 10.1007/s10897-013-9609-z; Tikkanen M, 2010, ACTA OBSTET GYN SCAN, V89, P916, DOI 10.3109/00016341003605685; Tsaliki E, 2012, PRENATAL DIAG, V32, P996, DOI 10.1002/pd.3947; Vogel I, 2007, J REPROD IMMUNOL, V75, P133, DOI 10.1016/j.jri.2007.02.008; Waldorf KMA, 2010, PLACENTA, V31, P589, DOI 10.1016/j.placenta.2010.04.013	29	11	13	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 4	2014	9	9							e106934	10.1371/journal.pone.0106934	http://dx.doi.org/10.1371/journal.pone.0106934			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3XV	25188498	Green Published, Green Submitted, gold			2022-12-27	WOS:000341271500098
J	Sun, QJ; Xi, TT; Li, Y; Xiong, L				Sun, Qingjie; Xi, Tingting; Li, Ying; Xiong, Liu			Characterization of Corn Starch Films Reinforced with CaCO3 Nanoparticles	PLOS ONE			English	Article							CASSAVA STARCH; MECHANICAL-PROPERTIES; THERMOPLASTIC STARCH; BARRIER	The characterization of corn starch (CS) films impregnated with CaCO3 nanoparticles was investigated. Criteria such as morphology, crystallinity, water vapor permeability (WVP), opacity, and mechanical properties were the focus of the investigation. It was found that the CaCO3 contents had significant effects on the tensile properties of the nanocomposite films. The addition of CaCO3 nanoparticles to the CS films significantly increased tensile strength from 1.40 to 2.24 MPa, elongation from 79.21 to 118.98%, and Young's modulus from 1.82 to 2.41 MPa. The incorporation of CaCO3 nanoparticles increased the opacity of films, lowered the degree of WVP and film solubility value compared to those of the CS films. The results of scanning electron microscopy (SEM) showed that with the increase of CaCO3 nanoparticles content in starch films, the roughness of the films increased, and pores or cavities were found on the surface of the films, while small cracks were observed in the structures of the fractured surfaces. X-ray diffraction showed that the addition of nanoparticles increased the peaks in the intensity of films.	[Sun, Qingjie; Xi, Tingting; Li, Ying; Xiong, Liu] Qingdao Agr Univ, Sch Food Sci & Engn, Qingdao, Shandong, Peoples R China	Qingdao Agricultural University	Sun, QJ (corresponding author), Qingdao Agr Univ, Sch Food Sci & Engn, Qingdao, Shandong, Peoples R China.	phdsun@163.com						Aila-Suarez S, 2013, CARBOHYD POLYM, V98, P102, DOI 10.1016/j.carbpol.2013.05.022; Araujo-Farro PC, 2010, CARBOHYD POLYM, V81, P839, DOI 10.1016/j.carbpol.2010.03.051; Belibi PC, 2013, J FOOD ENG, V115, P339, DOI 10.1016/j.jfoodeng.2012.10.027; Bodirlu R, 2012, MONATSH CHEM, V143, P335, DOI 10.1007/s00706-011-0659-3; Castillo L, 2013, CARBOHYD POLYM, V95, P664, DOI 10.1016/j.carbpol.2013.03.026; Chivrac F, 2008, BIOMACROMOLECULES, V9, P896, DOI 10.1021/bm7012668; Cyras VP, 2008, CARBOHYD POLYM, V73, P55, DOI 10.1016/j.carbpol.2007.11.014; de la Caba K, 2012, J APPL POLYM SCI, V124, P1796, DOI 10.1002/app.35188; de Melo C, 2011, BRAZ ARCH BIOL TECHN, V54, P1223, DOI 10.1590/S1516-89132011000600019; Garcia M, 2009, EDIBLE FILMS COATING; Garg S, 2007, EUR POLYM J, V43, P3976, DOI 10.1016/j.eurpolymj.2007.06.030; Lopez OV, 2008, CARBOHYD POLYM, V73, P573, DOI 10.1016/j.carbpol.2007.12.023; Lopez OV, 2011, J FOOD ENG, V105, P254, DOI 10.1016/j.jfoodeng.2011.02.029; Lopez OV, 2010, J FOOD ENG, V100, P160, DOI 10.1016/j.jfoodeng.2010.03.041; LuEpez O., 2010, POSTHARVEST REV, V6, P1; Mali S, 2002, CARBOHYD POLYM, V50, P379, DOI 10.1016/S0144-8617(02)00058-9; Maran JP, 2013, CARBOHYD POLYM, V92, P1335, DOI 10.1016/j.carbpol.2012.09.069; Mbey JA, 2012, CARBOHYD POLYM, V88, P213, DOI 10.1016/j.carbpol.2011.11.091; Mehyar GF, 2012, J FOOD SCI, V77, pE52, DOI 10.1111/j.1750-3841.2011.02559.x; Muller CMO, 2011, IND CROP PROD, V33, P605, DOI 10.1016/j.indcrop.2010.12.021; Muller CMO, 2009, FOOD HYDROCOLLOID, V23, P1328, DOI 10.1016/j.foodhyd.2008.09.002; Shi AM, 2013, CARBOHYD POLYM, V96, P593, DOI 10.1016/j.carbpol.2012.12.042; Teixeira ED, 2012, IND CROP PROD, V37, P61, DOI 10.1016/j.indcrop.2011.11.036; Ungar T, 2004, SCRIPTA MATER, V51, P777, DOI 10.1016/j.scriptamat.2004.05.007; Wilhelm HM, 2003, CARBOHYD POLYM, V52, P101, DOI 10.1016/S0144-8617(02)00239-4; Wu M, 2009, J TEXT I, V100, P254, DOI 10.1080/00405000701757677; Xie FW, 2013, PROG POLYM SCI, V38, P1590, DOI 10.1016/j.progpolymsci.2013.05.002	27	36	40	1	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 4	2014	9	9							e106727	10.1371/journal.pone.0106727	http://dx.doi.org/10.1371/journal.pone.0106727			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3XV	25188503	Green Published, Green Submitted, gold			2022-12-27	WOS:000341271500077
J	Anton, A; Simpson, MS; Vu, I				Anton, Andrea; Simpson, Michael S.; Vu, Ivana			Environmental and Biotic Correlates to Lionfish Invasion Success in Bahamian Coral Reefs	PLOS ONE			English	Article							INDO-PACIFIC LIONFISH; PTEROIS-VOLITANS; ATLANTIC; DIVERSITY; PATTERNS; DEGRADATION; COMMUNITIES; DISTURBANCE; RESISTANCE; ABUNDANCE	Lionfish (Pterois volitans), venomous predators from the Indo-Pacific, are recent invaders of the Caribbean Basin and southeastern coast of North America. Quantification of invasive lionfish abundances, along with potentially important physical and biological environmental characteristics, permitted inferences about the invasion process of reefs on the island of San Salvador in the Bahamas. Environmental wave-exposure had a large influence on lionfish abundance, which was more than 20 and 120 times greater for density and biomass respectively at sheltered sites as compared with wave-exposed environments. Our measurements of topographic complexity of the reefs revealed that lionfish abundance was not driven by habitat rugosity. Lionfish abundance was not negatively affected by the abundance of large native predators (or large native groupers) and was also unrelated to the abundance of medium prey fishes (total length of 5-10 cm). These relationships suggest that (1) higher-energy environments may impose intrinsic resistance against lionfish invasion, (2) habitat complexity may not facilitate the lionfish invasion process, (3) predation or competition by native fishes may not provide biotic resistance against lionfish invasion, and (4) abundant prey fish might not facilitate lionfish invasion success. The relatively low biomass of large grouper on this island could explain our failure to detect suppression of lionfish abundance and we encourage continuing the preservation and restoration of potential lionfish predators in the Caribbean. In addition, energetic environments might exert direct or indirect resistance to the lionfish proliferation, providing native fish populations with essential refuges.	[Anton, Andrea] Univ N Carolina, Curriculum Environm & Ecol, Chapel Hill, NC USA; [Simpson, Michael S.; Vu, Ivana] Univ N Carolina, Dept Biol, Chapel Hill, NC USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Anton, A (corresponding author), Queens Univ Belfast, Sch Biol Sci, Belfast, Antrim, North Ireland.	androide@live.unc.edu	Anton, Andrea/ABA-3742-2021		PADI Foundation; UNC-Off Campus Fellowship; C.V. STARR Scholarship; Watts Hill Jr. Research Fellowship; NSF OCE [0746164]	PADI Foundation; UNC-Off Campus Fellowship; C.V. STARR Scholarship; Watts Hill Jr. Research Fellowship; NSF OCE(National Science Foundation (NSF))	This project was funded by a PADI Foundation Grant (http://www.padifoundation.org/), a UNC-Off Campus Fellowship (http://gradschool.unc.edu/), and a C.V. STARR Scholarship (http://cgi.unc.edu/awards/cv-starr) to AA, a Watts Hill Jr. Research Fellowship (http://our.unc.edu/) to MSS, and an NSF OCE #0746164 grant (http://www.nsf.gov/) to JF Bruno. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albins MA, 2008, MAR ECOL PROG SER, V367, P233, DOI 10.3354/meps07620; Albins MA, 2013, BIOL INVASIONS, V15, P29, DOI 10.1007/s10530-012-0266-1; Albins MA, 2012, MAR ECOL PROG SER, V448, P1, DOI 10.3354/meps09580; Anton A, 2013, THESIS U N CAROLINA; ARONSON RB, 1995, J EXP MAR BIOL ECOL, V192, P1, DOI 10.1016/0022-0981(95)00052-S; Balasubashini MS, 2006, TOXICOL MECH METHOD, V16, P525, DOI 10.1080/15376510600803573; Barbier EB, 2011, ECOL MONOGR, V81, P169, DOI 10.1890/10-1510.1; Barbour AB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019666; Bariche M, 2013, MEDITERR MAR SCI, V14, P292, DOI 10.12681/mms.428; Bejarano S, 2011, MAR BIOL, V158, P489, DOI 10.1007/s00227-010-1575-5; Bellwood DR, 2002, FUNCT ECOL, V16, P557, DOI 10.1046/j.1365-2435.2002.00655.x; Brokovich E, 2006, ECOL INDIC, V6, P494, DOI 10.1016/j.ecolind.2005.07.002; Cure K, 2012, MAR ECOL PROG SER, V467, P181, DOI 10.3354/meps09942; Darling ES, 2011, BIOL INVASIONS, V13, P2045, DOI 10.1007/s10530-011-0020-0; Davis MA, 2000, J ECOL, V88, P528, DOI 10.1046/j.1365-2745.2000.00473.x; deRivera CE, 2005, ECOLOGY, V86, P3364, DOI 10.1890/05-0479; Diller JL, 2014, J EXP MAR BIOL ECOL, V455, P45, DOI 10.1016/j.jembe.2014.02.014; Elton C., 1958; Fritts TH, 1998, ANNU REV ECOL SYST, V29, P113, DOI 10.1146/annurev.ecolsys.29.1.113; Geraldi NR, 2014, BIOL INVASIONS, V16, P1819, DOI 10.1007/s10530-013-0629-2; GOREAU TF, 1959, ECOLOGY, V40, P67, DOI 10.2307/1929924; Green SJ, 2013, CORAL REEFS, V32, P413, DOI 10.1007/s00338-012-0987-8; Green SJ, 2014, ECOL APPL IN PRESS; Green SJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032596; Hackerott S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068259; Harborne AR, 2006, ECOLOGY, V87, P2871, DOI 10.1890/0012-9658(2006)87[2871:MTBDOC]2.0.CO;2; Human KG, 1996, OECOLOGIA, V105, P405, DOI 10.1007/BF00328744; Karkarey R, 2014, CORAL REEFS, V33, P289, DOI 10.1007/s00338-013-1117-y; Krajewski JP, 2011, ENVIRON BIOL FISH, V92, P25, DOI 10.1007/s10641-011-9813-3; Kulbicki M, 2012, MAR ECOL PROG SER, V446, P189, DOI 10.3354/meps09442; Kundu P. K, 1990, FLUID MECH; Llewelyn J, 2010, BIOL INVASIONS, V12, P1045, DOI 10.1007/s10530-009-9521-5; Lonsdale WM, 1999, ECOLOGY, V80, P1522, DOI 10.2307/176544; Madrigal J, 2011, ECOLOGY, V92, P282, DOI 10.1890/10-0643.1; Martin CW, 2012, MAR ECOL PROG SER, V449, P109, DOI 10.3354/meps09515; Morris JA, 2009, ENVIRON BIOL FISH, V86, P389, DOI 10.1007/s10641-009-9538-8; Mumby PJ, 2016, FISH FISH, V17, P266, DOI 10.1111/faf.12078; Mumby PJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021510; Mumby PJ, 2002, ENVIRON BIOL FISH, V63, P265, DOI 10.1023/A:1014359403167; Mumby PJ, 2004, NATURE, V427, P533, DOI 10.1038/nature02286; Mumby PJ, 2013, PEERJ PREPRINTS, V1, DOI DOI 10.7287/PEERJ.PREPRINTS.45V1; National Marine Fisheries Service, 2008, 2008 STAT US FISH; Pejchar L, 2009, TRENDS ECOL EVOL, V24, P497, DOI 10.1016/j.tree.2009.03.016; POLUNIN NVC, 1993, MAR ECOL PROG SER, V100, P167, DOI 10.3354/meps100167; Risk M.J., 1972, Atoll Res Bull, VNo. 153, P1; Salo P, 2010, ECOL MONOGR, V80, P531, DOI 10.1890/09-1260.1; Sandin SA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001548; Schofield PJ, 2010, AQUAT INVASIONS, V5, pS117, DOI 10.3391/ai.2010.5.S1.024; Shine R, 2010, Q REV BIOL, V85, P253, DOI 10.1086/655116; Stachowicz JJ, 1999, SCIENCE, V286, P1577, DOI 10.1126/science.286.5444.1577; Sutherland WJ, 2010, TRENDS ECOL EVOL, V25, P1, DOI 10.1016/j.tree.2009.10.003; Torres R, 2001, B MAR SCI, V69, P805; Valdivia A, 2014, PEERJ, V2, DOI 10.7717/peerj.348; Venables WN., 2002, MODERN APPL STAT S, V4; Whitfield PE, 2007, BIOL INVASIONS, V9, P53, DOI 10.1007/s10530-006-9005-9; Whitfield PE, 2002, MAR ECOL PROG SER, V235, P289, DOI 10.3354/meps235289; Wolff N, 1997, ENVIRON BIOL FISH, V55, P81; Zeileis A, 2008, J STAT SOFTW, V27, P1, DOI 10.18637/jss.v027.i08; Zuur Alain F., 2009, P1	59	27	27	0	142	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 3	2014	9	9							e106229	10.1371/journal.pone.0106229	http://dx.doi.org/10.1371/journal.pone.0106229			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3TB	25184250	Green Submitted, Green Published, gold			2022-12-27	WOS:000341257700040
J	Bera, A; VenkataSubbaRao, K; Manoharan, MS; Hill, P; Freeman, JW				Bera, Alakesh; VenkataSubbaRao, Kolaparthi; Manoharan, Muthu Saravanan; Hill, Ping; Freeman, James W.			A miRNA Signature of Chemoresistant Mesenchymal Phenotype Identifies Novel Molecular Targets Associated with Advanced Pancreatic Cancer	PLOS ONE			English	Article							MICRORNA EXPRESSION; PROSTATE-CANCER; STEM-CELLS; CHEMOTHERAPEUTIC-AGENTS; REPRESSORS ZEB1; BREAST-CANCER; UP-REGULATION; GEMCITABINE; RESISTANT; MIR-200	In this study a microRNA (miRNA) signature was identified in a gemcitabine resistant pancreatic ductal adenocarcinoma (PDAC) cell line model (BxPC3-GZR) and this signature was further examined in advanced PDAC tumor specimens from The Cancer Genome Atlas (TCGA) database. BxPC3-GZR showed a mesenchymal phenotype, expressed high levels of CD44 and showed a highly significant deregulation of 17 miRNAs. Based on relevance to cancer, a seven-miRNA signature (miR-100, miR-125b, miR-155, miR-21, miR-205, miR-27b and miR-455-3p) was selected for further studies. A strong correlation was observed for six of the seven miRNAs in 43 advanced tumor specimens compared to normal pancreas tissue. To assess the functional relevance we initially focused on miRNA-125b, which is over-expressed in both the BxPC3-GZR model and advanced PDAC tumor specimens. Knockdown of miRNA-125b in BxPC3-GZR and Panc-1 cells caused a partial reversal of the mesenchymal phenotype and enhanced response to gemcitabine. Moreover, RNA-seq data from each of 40 advanced PDAC tumor specimens from the TCGA data base indicate a negative correlation between expression of miRNA-125b and five of six potential target genes (BAP1, BBC3, NEU1, BCL2, STARD13). Thus far, two of these target genes, BBC3 and NEU1, that are tumor suppressor genes but not yet studied in PDAC, appear to be functional targets of miR-125b since knockdown of miR125b caused their up regulation. These miRNAs and their molecular targets may serve as targets to enhance sensitivity to chemotherapy and reduce metastatic spread.	[Bera, Alakesh; VenkataSubbaRao, Kolaparthi; Hill, Ping; Freeman, James W.] Univ Texas Hlth Sci Ctr San Antonio, Dept Med, Div Hematol & Oncol, San Antonio, TX 78229 USA; [Freeman, James W.] Canc Therapy & Res Ctr S Texas, Expt & Dev Therapeut Program, San Antonio, TX 78229 USA; [Manoharan, Muthu Saravanan; Freeman, James W.] Audie L Murphy Mem Vet Adm Med Ctr, San Antonio, TX USA	University of Texas System; University of Texas Health San Antonio; Cancer Therapy & Research Center; University of Texas System; University of Texas Health San Antonio; US Department of Veterans Affairs; Veterans Health Administration (VHA); Audie L. Murphy Memorial Veterans Hospital	Freeman, JW (corresponding author), Univ Texas Hlth Sci Ctr San Antonio, Dept Med, Div Hematol & Oncol, San Antonio, TX 78229 USA.	freemanjw@uthscsa.edu	Manoharan, Muthu Saravanan/L-4851-2019; Bera, Alakesh/J-5429-2019	Bera, Alakesh/0000-0002-2690-8178	National Institutes of Health [RO1CA069122]; Veterans Affairs Merit Award [1I01BX000927]; William and Eula Owens Medical Research Foundation; NATIONAL CANCER INSTITUTE [R01CA069122] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Veterans Affairs Merit Award(US Department of Veterans Affairs); William and Eula Owens Medical Research Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Funding provided by National Institutes of Health-RO1CA069122 to JWF, Veterans Affairs Merit Award 1I01BX000927 to JWF and William and Eula Owens Medical Research Foundation to JWF. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akhavantabasi S, 2012, CELL STRUCT FUNCT, V37, P27; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Bera A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082282; Beumer JH, 2008, CLIN CANCER RES, V14, P3529, DOI 10.1158/1078-0432.CCR-07-4885; Chen Y, 2007, GYNECOL ONCOL, V107, P505, DOI 10.1016/j.ygyno.2007.08.007; Cochrane DR, 2009, MOL CANCER THER, V8, P1055, DOI 10.1158/1535-7163.MCT-08-1046; Collins AT, 2006, EUR J CANCER, V42, P1213, DOI 10.1016/j.ejca.2006.01.037; Cui EH, 2013, ACTA PHARMACOL SIN, V34, P309, DOI 10.1038/aps.2012.125; Danquah M, 2012, EXPERT OPIN DRUG DEL, V9, P1443, DOI 10.1517/17425247.2012.722079; Derynck R, 2001, NAT GENET, V29, P117, DOI 10.1038/ng1001-117; Dong J, 2011, ARCH MED RES, V42, P8, DOI 10.1016/j.arcmed.2011.01.006; Ebert MS, 2007, NAT METHODS, V4, P721, DOI 10.1038/NMETH1079; Hamfjord J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034150; Hu HY, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002327; Huang L, 2011, INT J CANCER, V128, P1758, DOI 10.1002/ijc.25509; Kent OA, 2006, ONCOGENE, V25, P6188, DOI 10.1038/sj.onc.1209913; Korpal M, 2008, J BIOL CHEM, V283, P14910, DOI 10.1074/jbc.C800074200; Le MTN, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002242; Le MTN, 2009, MOL CELL BIOL, V29, P5290, DOI 10.1128/MCB.01694-08; Li YW, 2009, CANCER RES, V69, P6704, DOI 10.1158/0008-5472.CAN-09-1298; Liu C, 2012, CANCER RES, V72, P3393, DOI 10.1158/0008-5472.CAN-11-3864; Ma YX, 2012, J CANCER RES CLIN, V138, P2045, DOI 10.1007/s00432-012-1285-0; Nakanishi H, 2014, ONCOGENE, V33, P702, DOI 10.1038/onc.2013.13; Nakano K, 2001, MOL CELL, V7, P683, DOI 10.1016/S1097-2765(01)00214-3; Niess H, 2015, TARGET ONCOL, V10, P215, DOI 10.1007/s11523-014-0323-z; O'Shea LK, 2014, ONCOTARGETS THER, V7, P117, DOI 10.2147/OTT.S55344; Ozen M, 2008, ONCOGENE, V27, P1788, DOI 10.1038/sj.onc.1210809; Park SM, 2008, GENE DEV, V22, P894, DOI 10.1101/gad.1640608; Peter ME, 2009, CELL CYCLE, V8, P843, DOI 10.4161/cc.8.6.7907; Ricci-Vitiani L, 2007, NATURE, V445, P111, DOI 10.1038/nature05384; Scott GK, 2007, J BIOL CHEM, V282, P1479, DOI 10.1074/jbc.M609383200; Shi XB, 2011, PROSTATE, V71, P538, DOI 10.1002/pros.21270; Siegel R, 2013, CA-CANCER J CLIN, V63, P11, DOI 10.3322/caac.21166; Singh A, 2010, ONCOGENE, V29, P4741, DOI 10.1038/onc.2010.215; Singh S, 2013, CANCER LETT, V334, P211, DOI 10.1016/j.canlet.2012.10.008; Singh S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040021; Song B, 2009, ONCOGENE, V28, P4065, DOI 10.1038/onc.2009.274; Tang F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035435; Thiery JP, 2003, CURR OPIN CELL BIOL, V15, P740, DOI 10.1016/j.ceb.2003.10.006; Uemura T, 2009, ONCOGENE, V28, P1218, DOI 10.1038/onc.2008.471; Van den Broeck A, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-354; Vecchione A, 2013, P NATL ACAD SCI USA, V110, P9845, DOI 10.1073/pnas.1305472110; Venkatasubbarao K, 2005, CANCER RES, V65, P2861, DOI 10.1158/0008-5472.CAN-04-2396; Wang HJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034210; Wang LX, 2012, ONCOL LETT, V3, P119, DOI 10.3892/ol.2011.431; Wang ZW, 2011, NAT REV GASTRO HEPAT, V8, P27, DOI 10.1038/nrgastro.2010.188; Wang ZW, 2009, CANCER RES, V69, P2400, DOI 10.1158/0008-5472.CAN-08-4312; Yang S, 2013, MAR BIOTECHNOL, V15, P540, DOI 10.1007/s10126-013-9503-6; Yu J, 2008, ONCOGENE, V27, pS71, DOI 10.1038/onc.2009.45; Zhao S, 2008, J BIOL CHEM, V283, P11293, DOI 10.1074/jbc.M800154200	50	44	46	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 3	2014	9	9							e106343	10.1371/journal.pone.0106343	http://dx.doi.org/10.1371/journal.pone.0106343			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3TB	25184537	Green Published, Green Submitted, gold			2022-12-27	WOS:000341257700057
J	Xu, FH; Liu, ZX; Xie, HY; Zhu, J; Zhang, JR; Kraus, J; Blaschnig, T; Nehls, R; Wang, H				Xu, Fuhui; Liu, Zhixue; Xie, Hongyan; Zhu, Jian; Zhang, Juren; Kraus, Josef; Blaschnig, Tasja; Nehls, Reinhard; Wang, Hong			Increased Drought Tolerance through the Suppression of ESKMO1 Gene and Overexpression of CBF-Related Genes in Arabidopsis	PLOS ONE			English	Article							STRESS TOLERANCE; LOW-TEMPERATURE; ABSCISIC-ACID; TRANSCRIPTION FACTORS; COLD-ACCLIMATION; ABIOTIC STRESSES; EXPRESSION; REGULATOR; RICE; THALIANA	Improved drought tolerance is always a highly desired trait for agricultural plants. Significantly increased drought tolerance in Arabidopsis thaliana (Columbia-0) has been achieved in our work through the suppression of ESKMO1 (ESK1) gene expression with small-interfering RNA (siRNA) and overexpression of CBF genes with constitutive gene expression. ESK1 has been identified as a gene linked to normal development of the plant vascular system, which is assumed directly related to plant drought response. By using siRNA that specifically targets ESK1, the gene expression has been reduced and drought tolerance of the plant has been enhanced dramatically in the work. However, the plant response to external abscisic acid application has not been changed. ICE1, CBF1, and CBF3 are genes involved in a well-characterized plant stress response pathway, overexpression of them in the plant has demonstrated capable to increase drought tolerance. By overexpression of these genes combining together with suppression of ESK1 gene, the significant increase of plant drought tolerance has been achieved in comparison to single gene manipulation, although the effect is not in an additive way. Accompanying the increase of drought tolerance via suppression of ESK1 gene expression, the negative effect has been observed in seeds yield of transgenic plants in normal watering conditions comparing with wide type plant.	[Xu, Fuhui; Liu, Zhixue; Xie, Hongyan; Zhu, Jian; Wang, Hong] Tongji Univ, Sch Life Sci & Technol, Shanghai 200092, Peoples R China; [Kraus, Josef; Blaschnig, Tasja; Nehls, Reinhard; Wang, Hong] KWS SAAT AG, Einbeck, Germany; [Zhang, Juren] Shandong Univ, Sch Life Sci, Jinan City, Shandong, Peoples R China	Tongji University; KWS Saat AG; Shandong University	Wang, H (corresponding author), Tongji Univ, Sch Life Sci & Technol, Shanghai 200092, Peoples R China.	hong.wang@kws.com			KWS SAAT AG	KWS SAAT AG	The research fund was provided by KWS SAAT AG (www.kws.com) to FX as her PhD project. KWS participated in the study design, data analysis, decision to publish and preparation of manuscript via HW.	Badawi GH, 2004, PHYSIOL PLANTARUM, V121, P231, DOI 10.1111/j.0031-9317.2004.00308.x; BOHNERT HJ, 1995, PLANT CELL, V7, P1099, DOI 10.1105/tpc.7.7.1099; Bouchabke-Coussa O, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-125; BOYER JS, 1982, SCIENCE, V218, P443, DOI 10.1126/science.218.4571.443; Chinnusamy V, 2003, GENE DEV, V17, P1043, DOI 10.1101/gad.1077503; Chinnusamy V, 2007, TRENDS PLANT SCI, V12, P444, DOI 10.1016/j.tplants.2007.07.002; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Duan JL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045117; Dubouzet JG, 2003, PLANT J, V33, P751, DOI 10.1046/j.1365-313X.2003.01661.x; El Kayal W, 2006, J EXP BOT, V57, P2455, DOI 10.1093/jxb/erl019; Gutha LR, 2008, PLANT MOL BIOL, V68, P533, DOI 10.1007/s11103-008-9391-8; Haake V, 2002, PLANT PHYSIOL, V130, P639, DOI 10.1104/pp.006478; Halpin C, 2005, PLANT BIOTECHNOL J, V3, P141, DOI 10.1111/j.1467-7652.2004.00113.x; Hsieh TH, 2002, PLANT PHYSIOL, V130, P618, DOI 10.1104/pp.006783; Jaglo-Ottosen KR, 1998, SCIENCE, V280, P104, DOI 10.1126/science.280.5360.104; Kant S, 2006, PLANT CELL ENVIRON, V29, P1220, DOI 10.1111/j.1365-3040.2006.01502.x; Lata C, 2011, J EXP BOT, V62, P3387, DOI 10.1093/jxb/err016; Lefebvre V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016645; Li HM, 2011, PLANT PHYSIOL, V156, P550, DOI 10.1104/pp.111.176214; Liu Q, 1998, PLANT CELL, V10, P1391, DOI 10.1105/tpc.10.8.1391; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; McBeath Jenifer Huang, 2010, ENV CHANGE FOOD SECU, P112; Medina J, 1999, PLANT PHYSIOL, V119, P463, DOI 10.1104/pp.119.2.463; Miller AK, 2006, MOL GENET GENOMICS, V275, P193, DOI 10.1007/s00438-005-0076-6; Morran S, 2011, PLANT BIOTECHNOL J, V9, P230, DOI 10.1111/j.1467-7652.2010.00547.x; MURASHIGE T, 1962, PHYSIOL PLANTARUM, V15, P473, DOI 10.1111/j.1399-3054.1962.tb08052.x; Nakashima K, 2009, PLANT PHYSIOL, V149, P88, DOI 10.1104/pp.108.129791; Novillo F, 2004, P NATL ACAD SCI USA, V101, P3985, DOI 10.1073/pnas.0303029101; Novillo F, 2007, P NATL ACAD SCI USA, V104, P21002, DOI 10.1073/pnas.0705639105; Oraby H, 2012, PLANT SCI, V185, P331, DOI 10.1016/j.plantsci.2012.01.003; Qin F, 2004, PLANT CELL PHYSIOL, V45, P1042, DOI 10.1093/pcp/pch118; Rao MVR, 2011, PLANT CELL REP, V30, P1241, DOI 10.1007/s00299-011-1033-y; Roychoudhury A, 2013, PLANT CELL REP, V32, P985, DOI 10.1007/s00299-013-1414-5; Sergey M, 2012, NATURAL PROCESES HUM, P113; Shi H, 2013, BMC BIOTECHNOL, V13, DOI 10.1186/1472-6750-13-83; Shinozaki K, 2007, J EXP BOT, V58, P221, DOI 10.1093/jxb/erl164; Siddiqua M, 2011, PLANT CELL ENVIRON, V34, P1345, DOI 10.1111/j.1365-3040.2011.02334.x; Skinner JS, 2005, PLANT MOL BIOL, V59, P533, DOI 10.1007/s11103-005-2498-2; Stockinger EJ, 1997, P NATL ACAD SCI USA, V94, P1035, DOI 10.1073/pnas.94.3.1035; Umezawa T, 2006, CURR OPIN BIOTECH, V17, P113, DOI 10.1016/j.copbio.2006.02.002; van der Weele CM, 2000, J EXP BOT, V51, P1555, DOI 10.1093/jexbot/51.350.1555; Xiao BZ, 2009, MOL PLANT, V2, P73, DOI 10.1093/mp/ssn068; Xin ZG, 1998, P NATL ACAD SCI USA, V95, P7799, DOI 10.1073/pnas.95.13.7799; Xin ZG, 2007, PLANT J, V49, P786, DOI 10.1111/j.1365-313X.2006.02994.x; Ye XD, 2000, SCIENCE, V287, P303, DOI 10.1126/science.287.5451.303; Zarka DG, 2003, PLANT PHYSIOL, V133, P910, DOI 10.1104/pp.103.027169; Zhang M, 2005, PLANT J, V44, P361, DOI 10.1111/j.1365-313X.2005.02536.x; Zhang X, 2004, PLANT J, V39, P905, DOI 10.1111/j.1365-313X.2004.02176.x	48	12	12	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 3	2014	9	9							e106509	10.1371/journal.pone.0106509	http://dx.doi.org/10.1371/journal.pone.0106509			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3TB	25184213	gold, Green Published, Green Submitted			2022-12-27	WOS:000341257700081
J	Abramowski, P; Ogrodowczyk, C; Martin, R; Pongs, O				Abramowski, Pierre; Ogrodowczyk, Christoph; Martin, Roland; Pongs, Olaf			A Truncation Variant of the Cation Channel P2RX5 Is Upregulated during T Cell Activation	PLOS ONE			English	Article							IMMUNOLOGICAL SYNAPSE; DNA MICROARRAYS; P2X RECEPTORS; ION CHANNELS; LYMPHOCYTES; EXPRESSION; COSTIMULATION; STIMULATION; CYTOKINES; RESPONSES	Members of the P2X family of ligand-gated cation channels (P2RX) are expressed by various cell types including neurons, smooth-and cardiac muscle cells, and leukocytes. The channels mediate signalling in response to extracellular ATP. Seven subunit isoforms (P2RX1-P2RX7) have been identified and these can assemble as homo- and heterotrimeric molecules. In humans, P2RX5 exists as a natural deletion mutant lacking amino acids 328-349 of exon 10, which are part of transmembrane (TM) 2 and pre-TM2 regions in other organisms like rat, chicken and zebrafish. We show that P2RX5 gene expression of human T lymphocytes is upregulated during activation. P2RX5 is recruited to the cell surface. P2RX5-siRNA-transfected CD4(+) T cells produced twofold more IL-10 than controls. Surface and intracellular P2RX5 expression was upregulated in activated antigen-specific CD4(+) T cell clones. These data indicate a functional role of the human P2RX5 splice variant in T cell activation and immunoregulation.	[Abramowski, Pierre; Martin, Roland] Univ Med Ctr Hamburg Eppendorf, ZMNH, Inst Neuroimmunol & Clin Multiple Sclerosis Res I, Hamburg, Germany; [Abramowski, Pierre] Univ Med Ctr Hamburg Eppendorf, Clin Stem Cell Transplantat, Res Dept Cell & Gene Therapy, Hamburg, Germany; [Ogrodowczyk, Christoph; Pongs, Olaf] Univ Med Ctr Hamburg Eppendorf, ZMNH, Inst Neural Signaltransduct, Hamburg, Germany; [Martin, Roland] Univ Zurich Hosp, Dept Neurol, CH-8091 Zurich, Switzerland; [Pongs, Olaf] Univ Hamburg Hosp, Inst Physiol, Homburg, Germany	University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Zurich; University Zurich Hospital; University of Hamburg; University Medical Center Hamburg-Eppendorf	Martin, R (corresponding author), Univ Med Ctr Hamburg Eppendorf, ZMNH, Inst Neuroimmunol & Clin Multiple Sclerosis Res I, Hamburg, Germany.	roland.martin@usz.ch		Abramowski, Pierre/0000-0002-7121-6912	Deutsche Forschungsgemeinschaft, DFG [Ma 965/8-1, Po 137/39-1]; Hertie-Stiftung; Fonds der Chemischen Industrie; Gemeinnutzige Hertie Stiftung; Clinical Research Priority Program MS (CRPPMS) of the University Zurich	Deutsche Forschungsgemeinschaft, DFG(German Research Foundation (DFG)); Hertie-Stiftung(Austrian Science Fund (FWF)); Fonds der Chemischen Industrie(Fonds der Chemischen IndustrieEuropean Commission); Gemeinnutzige Hertie Stiftung; Clinical Research Priority Program MS (CRPPMS) of the University Zurich	This work was supported in part by the Deutsche Forschungsgemeinschaft, DFG (Ma 965/8-1, Po 137/39-1) and the Hertie-Stiftung (R.M. and O.P.) and the Fonds der Chemischen Industrie. The inims was supported by the Gemeinnutzige Hertie Stiftung. The Neuroimmunology and MS Research Section (nims) is supported by the Clinical Research Priority Program MS (CRPPMS) of the University Zurich. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alizadeh AA, 2000, CURR OPIN IMMUNOL, V12, P219, DOI 10.1016/S0952-7915(99)00078-3; Aly L, 2011, BRAIN, V134, P2687, DOI 10.1093/brain/awr206; Aschrafi A, 2004, J MOL BIOL, V342, P333, DOI 10.1016/j.jmb.2004.06.092; Balasa B, 2000, J IMMUNOL, V165, P7330, DOI 10.4049/jimmunol.165.12.7330; Banchereau J, 2012, BLOOD, V119, P5742, DOI 10.1182/blood-2011-08-371245; Barrera NP, 2005, J BIOL CHEM, V280, P10759, DOI 10.1074/jbc.M412265200; Battaglia C, 2000, BIOTECHNIQUES, V29, P78, DOI 10.2144/00291st01; Beal AM, 2009, IMMUNITY, V31, P632, DOI 10.1016/j.immuni.2009.09.004; Berger SB, 2005, INT IMMUNOL, V17, P983, DOI 10.1093/intimm/dxh279; Cahalan MD, 2009, IMMUNOL REV, V231, P59, DOI 10.1111/j.1600-065X.2009.00816.x; Detre C, 2006, CELL SIGNAL, V18, P294, DOI 10.1016/j.cellsig.2005.05.012; Diehl F, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/gnf078; Duckwitz W, 2006, J BIOL CHEM, V281, P39561, DOI 10.1074/jbc.M606113200; Dustin ML, 2008, IMMUNOL REV, V221, P77, DOI 10.1111/j.1600-065X.2008.00589.x; Ehrlich LIR, 2002, IMMUNITY, V17, P809, DOI 10.1016/S1074-7613(02)00481-8; Feske S, 2007, NAT REV IMMUNOL, V7, P690, DOI 10.1038/nri2152; Heissmeyer V, 2004, NAT IMMUNOL, V5, P255, DOI 10.1038/ni1047; Huppa JB, 2003, NAT REV IMMUNOL, V3, P973, DOI 10.1038/nri1245; Huppa JB, 2003, NAT IMMUNOL, V4, P749, DOI 10.1038/ni951; Huse M, 2006, NAT IMMUNOL, V7, P247, DOI 10.1038/ni1304; Jiang LH, 2003, J NEUROSCI, V23, P8903; Keller AM, 2007, P NATL ACAD SCI USA, V104, P5989, DOI 10.1073/pnas.0700946104; Kopf M, 1999, IMMUNITY, V11, P699, DOI 10.1016/S1074-7613(00)80144-2; Kummerow C, 2009, IMMUNOL REV, V231, P132, DOI 10.1111/j.1600-065X.2009.00811.x; Kundig TM, 1996, IMMUNITY, V5, P41, DOI 10.1016/S1074-7613(00)80308-8; Kupfer A, 2003, SEMIN IMMUNOL, V15, P295, DOI 10.1016/j.smim.2003.09.001; Le KT, 1997, FEBS LETT, V418, P195, DOI 10.1016/S0014-5793(97)01380-X; Lewis RS, 2001, ANNU REV IMMUNOL, V19, P497, DOI 10.1146/annurev.immunol.19.1.497; Lezzi G, 1998, IMMUNITY, V8, P89, DOI 10.1016/S1074-7613(00)80461-6; Lioudyno MI, 2008, P NATL ACAD SCI USA, V105, P2011, DOI 10.1073/pnas.0706122105; Markovic-Plese S, 2001, J CLIN INVEST, V108, P1185, DOI 10.1172/JCI12516; Nicke A, 1998, EMBO J, V17, P3016, DOI 10.1093/emboj/17.11.3016; Nicke A, 2003, MOL PHARMACOL, V63, P243, DOI 10.1124/mol.63.1.243; Nicolaou SA, 2007, AM J PHYSIOL-CELL PH, V292, pC1431, DOI 10.1152/ajpcell.00376.2006; North RA, 2002, PHYSIOL REV, V82, P1013, DOI 10.1152/physrev.00015.2002; Overes IM, 2008, BRIT J HAEMATOL, V141, P799, DOI 10.1111/j.1365-2141.2008.07125.x; Pestka S, 2004, ANNU REV IMMUNOL, V22, P929, DOI 10.1146/annurev.immunol.22.012703.104622; Rijke BC, 2005, J CLIN INVEST, V115, P3506, DOI 10.1172/JCI24832; Suzuki K, 2007, J SYN ORG CHEM JPN, V65, P1; Szabo SJ, 2002, SCIENCE, V295, P338, DOI 10.1126/science.1065543; Ueda H, 2011, P NATL ACAD SCI USA, V108, P17099, DOI 10.1073/pnas.1113703108; Wenning AS, 2011, BBA-MOL CELL RES, V1813, P412, DOI 10.1016/j.bbamcr.2010.12.022; Whitmire JK, 1999, J IMMUNOL, V163, P3194; Yeh JH, 2008, CELL, V132, P846, DOI 10.1016/j.cell.2008.01.013	44	13	13	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2014	9	9							e104692	10.1371/journal.pone.0104692	http://dx.doi.org/10.1371/journal.pone.0104692			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3LR	25181038	gold, Green Published, Green Submitted, Green Accepted			2022-12-27	WOS:000341231500013
J	Norman, JA; Blackmore, CJ; Rourke, M; Christidis, L				Norman, Janette A.; Blackmore, Caroline J.; Rourke, Meaghan; Christidis, Les			Effects of Mitochondrial DNA Rate Variation on Reconstruction of Pleistocene Demographic History in a Social Avian Species, Pomatostomus superciliosus	PLOS ONE			English	Article							CHESTNUT-CROWNED BABBLER; GENETIC DIVERSITY; ECOLOGICAL CONSTRAINTS; GEOGRAPHIC-VARIATION; COOPERATIVE BREEDER; STATISTICAL TESTS; MOLECULAR CLOCKS; NEUTRALITY TESTS; TIME DEPENDENCY; POPULATION-SIZE	Mitochondrial sequence data is often used to reconstruct the demographic history of Pleistocene populations in an effort to understand how species have responded to past climate change events. However, departures from neutral equilibrium conditions can confound evolutionary inference in species with structured populations or those that have experienced periods of population expansion or decline. Selection can affect patterns of mitochondrial DNA variation and variable mutation rates among mitochondrial genes can compromise inferences drawn from single markers. We investigated the contribution of these factors to patterns of mitochondrial variation and estimates of time to most recent common ancestor (T-MRCA) for two clades in a co-operatively breeding avian species, the white-browed babbler Pomatostomus superciliosus. Both the protein-coding ND3 gene and hypervariable domain I control region sequences showed departures from neutral expectations within the superciliosus clade, and a two-fold difference in T-MRCA estimates. Bayesian phylogenetic analysis provided evidence of departure from a strict clock model of molecular evolution in domain I, leading to an over-estimation of T-MRCA for the superciliosus clade at this marker. Our results suggest mitochondrial studies that attempt to reconstruct Pleistocene demographic histories should rigorously evaluate data for departures from neutral equilibrium expectations, including variation in evolutionary rates across multiple markers. Failure to do so can lead to serious errors in the estimation of evolutionary parameters and subsequent demographic inferences concerning the role of climate as a driver of evolutionary change. These effects may be especially pronounced in species with complex social structures occupying heterogeneous environments. We propose that environmentally driven differences in social structure may explain observed differences in evolutionary rate of domain I sequences, resulting from longer than expected retention times for matriarchal lineages in the superciliosus clade.	[Norman, Janette A.; Blackmore, Caroline J.; Christidis, Les] So Cross Univ, Natl Marine Sci Ctr, Coffs Harbour, NSW, Australia; [Norman, Janette A.] Univ Melbourne, Dept Genet, Parkville, Vic 3052, Australia; [Norman, Janette A.; Rourke, Meaghan] Museum Victoria, Melbourne, Vic, Australia; [Rourke, Meaghan] Deakin Univ, Geelong, Vic 3217, Australia; [Rourke, Meaghan] Narrandera Fisheries Ctr, New South Wales Dept Primary Ind, Narrandera, NSW, Australia	Southern Cross University; University of Melbourne; Museum Victoria; Deakin University; NSW Department of Primary Industries	Norman, JA (corresponding author), So Cross Univ, Natl Marine Sci Ctr, Coffs Harbour, NSW, Australia.	janorman@unimelb.edu.au			School of Science and Engineering, Deakin University, Geelong; Division of Collections Research and Exhibitions, Sciences Department, Museum Victoria	School of Science and Engineering, Deakin University, Geelong; Division of Collections Research and Exhibitions, Sciences Department, Museum Victoria	Financial support was provided by the School of Science and Engineering, Deakin University, Geelong, to MR; and Division of Collections Research and Exhibitions, Sciences Department, Museum Victoria to LC and JAN. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Amos W, 1998, PHILOS T ROY SOC B, V353, P177, DOI 10.1098/rstb.1998.0200; Augustin L, 2004, NATURE, V429, P623, DOI 10.1038/nature02599; Avise J. C., 2000, PHYLOGEOGRAPHY HIST; Ayres DL, 2012, SYST BIOL, V61, P170, DOI [10.1093/sysbio/syr100, 10.1093/sysbio/sys029]; Baele G, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-85; Baele G, 2012, MOL BIOL EVOL, V29, P2157, DOI 10.1093/molbev/mss084; Barker FK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046403; Barrows TT, 2002, QUATERNARY SCI REV, V21, P159, DOI 10.1016/S0277-3791(01)00109-3; Bazin E, 2006, SCIENCE, V312, P570, DOI 10.1126/science.1122033; Blackmore CJ, 2007, J ZOOL, V273, P326, DOI 10.1111/j.1469-7998.2007.00332.x; Cale Peter G., 2002, Corella, V26, P47; Cale PG, 2003, BIOL CONSERV, V109, P237, DOI 10.1016/S0006-3207(02)00152-0; Cale PG, 2002, PAC CONSERV BIOL, V8, P271; Cale PG, 1999, SPATIAL DYNAMICS WHI; CHESSER RK, 1991, GENETICS, V129, P573; Chesser RT, 1999, CONDOR, V101, P439, DOI 10.2307/1370012; Christidis L, 2010, MOL PHYLOGENET EVOL, V57, P868, DOI 10.1016/j.ympev.2010.08.029; Christidis L, 2008, EMU, V108, P275, DOI 10.1071/MU08011; Cockburn A, 1996, FRONTIERS OF POPULATION ECOLOGY, P451; Driskell AC, 2011, MOL PHYLOGENET EVOL, V60, P480, DOI 10.1016/j.ympev.2011.03.030; Drummond A, 2007, TRACER V1 5; Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI [10.1093/molbev/msi103, 10.1093/molbev/mss075]; Duchene S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027138; Edwards SV, 1995, EVOLUTION, V49, P1134, DOI 10.1111/j.1558-5646.1995.tb04440.x; EDWARDS SV, 1993, P ROY SOC B-BIOL SCI, V252, P177, DOI 10.1098/rspb.1993.0063; EDWARDS SV, 1990, GENETICS, V126, P695; EMLEN ST, 1994, TRENDS ECOL EVOL, V9, P282, DOI 10.1016/0169-5347(94)90030-2; EMLEN ST, 1982, AM NAT, V119, P29, DOI 10.1086/283888; Fu YX, 1997, GENETICS, V147, P915; Garnery L, 1992, MOL ECOL, V1, P145, DOI 10.1111/j.1365-294X.1992.tb00170.x; Garrigan D, 2010, MOL BIOL EVOL, V27, P73, DOI 10.1093/molbev/msp209; Gillespie JH, 2001, EVOLUTION, V55, P2161; Haney RA, 2010, MOL PHYLOGENET EVOL, V57, P821, DOI 10.1016/j.ympev.2010.07.014; Hatchwell BJ, 2000, ANIM BEHAV, V59, P1079, DOI 10.1006/anbe.2000.1394; Higgins P.J., 2002, HDB AUSTR NZ ANTARCT; Ho SYW, 2007, SYST BIOL, V56, P515, DOI 10.1080/10635150701435401; Ho SYW, 2007, J AVIAN BIOL, V38, P409, DOI 10.1111/j.2007.0908-8857.04168.x; Ho SYW, 2011, MOL ECOL, V20, P3087, DOI 10.1111/j.1365-294X.2011.05178.x; Ho SYW, 2006, TRENDS GENET, V22, P79, DOI 10.1016/j.tig.2005.11.006; Jobb G, 2004, BMC EVOL BIOL, V4, DOI 10.1186/1471-2148-4-18; Jonsson KA, 2010, J BIOGEOGR, V37, P1767, DOI 10.1111/j.1365-2699.2010.02328.x; Jonsson KA, 2010, ECOGRAPHY, V33, P232, DOI 10.1111/j.1600-0587.2010.06167.x; KASS RE, 1995, J AM STAT ASSOC, V90, P773, DOI 10.1080/01621459.1995.10476572; Kearns AM, 2011, MOL ECOL, V20, P5042, DOI 10.1111/j.1365-294X.2011.05330.x; Kershaw P, 2003, FRESHWATER BIOL, V48, P1274, DOI 10.1046/j.1365-2427.2003.01085.x; Kerth G, 2000, MOL ECOL, V9, P793, DOI 10.1046/j.1365-294x.2000.00934.x; Kimura M., 1983, NEUTRAL THEORY MOL E, DOI [10.1017/CBO9780511623486, DOI 10.1017/CBO9780511623486]; LEHMAN N, 1992, BEHAV ECOL SOCIOBIOL, V30, P83; Lerner HRL, 2011, CURR BIOL, V21, P1838, DOI 10.1016/j.cub.2011.09.039; Lewis AN, 1944, P R SOC, V1943, P41; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Martin HA, 2006, J ARID ENVIRON, V66, P533, DOI 10.1016/j.jaridenv.2006.01.009; McMillan WO, 1997, J MOL EVOL, V45, P473, DOI 10.1007/PL00006252; MENOTTIRAYMOND M, 1993, P NATL ACAD SCI USA, V90, P3172, DOI 10.1073/pnas.90.8.3172; Miura GI, 2001, J AVIAN BIOL, V32, P102, DOI 10.1034/j.1600-048X.2001.320202.x; Norman JA, 1998, EMU, V98, P197, DOI 10.1071/MU98028; Norman JA, 2007, MOL PHYLOGENET EVOL, V42, P80, DOI 10.1016/j.ympev.2006.05.032; Oppenheimer S, 2005, ENDOCRINE CORRELATES; Pereira SL, 2006, MOL BIOL EVOL, V23, P1731, DOI 10.1093/molbev/msl038; Peterson AT, 2006, J AVIAN BIOL, V37, P541, DOI 10.1111/j.0908-8857.2006.04029.x; Portelli DJ, 2009, EMU, V109, P153, DOI 10.1071/MU08065; Rambaut A., 2009, LOGCOMBINER V1 6 2; Ramirez-Soriano A, 2008, GENETICS, V179, P555, DOI 10.1534/genetics.107.083006; Ramos-Onsins SE, 2002, MOL BIOL EVOL, V19, P2092, DOI 10.1093/oxfordjournals.molbev.a004034; Ronquist F, 2011, MRBAYES VER IN PRESS; Ronquist F, 2012, SYST BIOL, V61, P973, DOI 10.1093/sysbio/sys058; Ross KG, 2001, MOL ECOL, V10, P265, DOI 10.1046/j.1365-294x.2001.01191.x; Rubenstein DR, 2007, CURR BIOL, V17, P1414, DOI 10.1016/j.cub.2007.07.032; Ruokonen M, 2002, MOL PHYLOGENET EVOL, V23, P422, DOI 10.1016/S1055-7903(02)00021-0; Russell AF, 2010, EMU, V110, P324, DOI 10.1071/MU10028; Schodde R, 1999, AUSTR BIRDS; SIMONSEN KL, 1995, GENETICS, V141, P413; Sniderman JMK, 2009, QUATERNARY SCI REV, V28, P3185, DOI 10.1016/j.quascirev.2009.08.006; STROBECK C, 1987, GENETICS, V117, P149; Subramanian S, 2011, GENOME BIOL EVOL, V3, P1324, DOI 10.1093/gbe/evr108; Sugg DW, 1996, TRENDS ECOL EVOL, V11, P338, DOI 10.1016/0169-5347(96)20050-3; TAJIMA F, 1989, GENETICS, V123, P585; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tanabe AS, 2011, MOL ECOL RESOUR, V11, P914, DOI 10.1111/j.1755-0998.2011.03021.x; Taylor SG, 2003, HABITAT USE WHITE BR; Thrush M, 2008, PLEISTOCENE GLACIATI; Weir JT, 2008, MOL ECOL, V17, P2321, DOI 10.1111/j.1365-294X.2008.03742.x; Xie WG, 2011, SYST BIOL, V60, P150, DOI 10.1093/sysbio/syq085; Yang ZH, 1996, TRENDS ECOL EVOL, V11, P367, DOI 10.1016/0169-5347(96)10041-0; Zhang YW, 2001, J MOL EVOL, V52, P516, DOI 10.1007/s002390010182	86	5	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2014	9	9							e106267	10.1371/journal.pone.0106267	http://dx.doi.org/10.1371/journal.pone.0106267			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3LR	25181547	Green Published, gold			2022-12-27	WOS:000341231500067
J	Vossen, JM; Guiot, HFL; Lankester, AC; Vossen, ACTM; Bredius, RGM; Wolterbeek, R; Bakker, HDJ; Heidt, PJ				Vossen, Jaak M.; Guiot, Harry F. L.; Lankester, Arjan C.; Vossen, Ann C. T. M.; Bredius, Robbert G. M.; Wolterbeek, Ron; Bakker, Hanny D. J.; Heidt, Peter J.			Complete Suppression of the Gut Microbiome Prevents Acute Graft- Versus-Host Disease following Allogeneic Bone Marrow Transplantation	PLOS ONE			English	Article							STEM-CELL TRANSPLANTATION; MOUSE RADIATION CHIMERAS; TOTAL-BODY IRRADIATION; RISK-FACTORS; INTERLEUKIN-1 RECEPTOR; INTESTINAL MICROFLORA; SECONDARY DISEASE; ACUTE GVHD; MORTALITY; CHILDREN	The hypothesis that elimination of facultative and strict anaerobic microorganisms from the gastro-intestinal tract by antimicrobial drugs in the period of time around allogeneic bone marrow transplantation (BMT) prevents acute graft-versus-host disease (GVHD), was examined in a cohort of 112 children grafted between 1989 and 2002 for hematological malignancies. All patients received T-cell replete marrow from human leukocyte antigens (HLA) matched sibling donors under identical transplantation conditions. To eliminate microorganisms from the gastro-intestinal tract, total gastro-intestinal decontamination (GID) was applied by high doses of non-absorbable antimicrobial drugs while the graft recipient was maintained in strict protective isolation. About half of the children (51%) proved to be successfully decontaminated, and about half (49%) unsuccessfully. One recipient got acute GVHD in the first group and 8 in the second group (p = 0.013). The degree of success of total GID was decisive for the occurrence of acute GVHD, irrespective of the presence of other risk factors such as higher age of recipient and/or donor, female donor for male recipient and carriership or reactivation of herpesviruses. Our results demonstrate that successful total GID of the graft recipient prevents moderate to severe acute GVHD. We suppose that substantial translocation of gastro-intestinal microorganisms or parts of these, functioning as microbial-associated molecular patterns (MAMP's), triggering macrophages/dendritic cells via pattern recognizing receptors (PRR's) is prohibited. As a consequence the initiation and progression of an inflammatory process leading to acute GVHD is inhibited.	[Vossen, Jaak M.; Lankester, Arjan C.; Bredius, Robbert G. M.; Bakker, Hanny D. J.; Heidt, Peter J.] Leiden Univ, Med Ctr, Dept Pediat, Leiden, Netherlands; [Guiot, Harry F. L.; Vossen, Ann C. T. M.] Leiden Univ, Med Ctr, Dept Med Microbiol, Leiden, Netherlands; [Wolterbeek, Ron] Leiden Univ, Med Ctr, Dept Med Stat & Bioinformat, Leiden, Netherlands; [Heidt, Peter J.] Biomed Primate Res Ctr, Rijswijk, Netherlands	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	Vossen, JM (corresponding author), Leiden Univ, Med Ctr, Dept Pediat, Leiden, Netherlands.	j.vossen@lumc.nl	Heidt, Peter/GQQ-8459-2022; Bredius, Robbert/AAF-2592-2019; Vossen, Ann/HIR-2262-2022	Vossen, Ann/0000-0003-1750-2843; Bredius, Robbert/0000-0001-8151-1539				ALEXANDER JW, 1990, ANN SURG, V212, P496, DOI 10.1097/00000658-199010000-00012; Antin JH, 2002, BLOOD, V100, P3479, DOI 10.1182/blood-2002-03-0985; Auletta JJ, 2009, CURR OPIN PEDIATR, V21, P30, DOI 10.1097/MOP.0b013e3283207b2f; BEELEN DW, 1992, BLOOD, V80, P2668; Beelen DW, 1999, BLOOD, V93, P3267, DOI 10.1182/blood.V93.10.3267.410k22_3267_3275; Blom M, 1999, J CLIN MICROBIOL, V37, P2312, DOI 10.1128/JCM.37.7.2312-2316.1999; BOSTROM L, 1988, TRANSPLANTATION, V46, P548, DOI 10.1097/00007890-198810000-00016; Broers AEC, 2000, BLOOD, V95, P2240, DOI 10.1182/blood.V95.7.2240.007k08_2240_2245; Cantoni N, 2010, BIOL BLOOD MARROW TR, V16, P1309, DOI 10.1016/j.bbmt.2010.03.020; D'Orsogna LJA, 2010, TRANSPL IMMUNOL, V23, P149, DOI 10.1016/j.trim.2010.06.008; FEGAN C, 1990, BONE MARROW TRANSPL, V5, P373; Ferrara JLM, 2009, LANCET, V373, P1550, DOI 10.1016/S0140-6736(09)60237-3; GALE RP, 1987, BRIT J HAEMATOL, V67, P397, DOI 10.1111/j.1365-2141.1987.tb06160.x; Gerritsen EJA, 1996, BONE MARROW TRANSPL, V18, P377; GRATAMA JW, 1987, LANCET, V1, P471; Heidt P, 1981, MICROECOL THER, V11, P71; Heidt PJ, 1996, MICROECOLOGY THERAPY, V22, P89; Heit H, 1973, GERMFREE RES BIOL EF, P477; Imado T, 2010, TRANSPLANTATION, V90, P1063, DOI 10.1097/TP.0b013e3181f86947; Jenq RR, 2012, J EXP MED, V209, P902, DOI 10.1084/jem.20112408; Johansson JE, 2007, DIGEST DIS SCI, V52, P2340, DOI 10.1007/s10620-006-9404-x; JONES JM, 1971, RADIAT RES, V45, P577, DOI 10.2307/3573066; Kalpoe JS, 2004, J CLIN MICROBIOL, V42, P1498, DOI 10.1128/JCM.42.4.1498-1504.2004; Kaneko T, 2004, IMMUNITY, V20, P637, DOI 10.1016/S1074-7613(04)00104-9; Lampert I A, 1988, Prog Clin Biol Res, V272, P351; Leung WH, 2001, HUM IMMUNOL, V62, P399, DOI 10.1016/S0198-8859(01)00220-8; Ljungman P, 2003, BLOOD, V102, P4255, DOI 10.1182/blood-2002-10-3263; Maltezou HC, 2000, PEDIATR INFECT DIS J, V19, P307, DOI 10.1097/00006454-200004000-00009; Martin P, 2003, BONE MARROW TRANSPL, V32, P881, DOI 10.1038/sj.bmt.1704239; McCarthy PL, 1996, TRANSPLANTATION, V62, P626, DOI 10.1097/00007890-199609150-00015; Medzhitov R, 2007, NATURE, V449, P819, DOI 10.1038/nature06246; Murphy S, 2011, LEUKEMIA LYMPHOMA, V52, P1844, DOI 10.3109/10428194.2011.580476; Nejdfors P, 2000, DIS COLON RECTUM, V43, P1582, DOI 10.1007/BF02236743; Penack O, 2010, BLOOD, V115, P1865, DOI 10.1182/blood-2009-09-242784; PRZEPIORKA D, 1995, BONE MARROW TRANSPL, V15, P825; Sivula J, 2012, SCAND J IMMUNOL, V76, P336, DOI 10.1111/j.1365-3083.2012.02737.x; STORB R, 1985, IMMUNOL REV, V88, P215, DOI 10.1111/j.1600-065X.1985.tb01160.x; STORB R, 1983, NEW ENGL J MED, V308, P302, DOI 10.1056/NEJM198302103080602; van der Velden WJFM, 2009, BONE MARROW TRANSPL, V44, P243, DOI 10.1038/bmt.2009.21; van Tol MJD, 2005, BONE MARROW TRANSPL, V36, P39, DOI 10.1038/sj.bmt.1705003; VANBEKKU.DW, 1974, J NATL CANCER I, V52, P401, DOI 10.1093/jnci/52.2.401; Vossen J, 1981, RECENT ADV GERMFREE, P573; Vossen J, 1990, GRAFT VS HOST DISEAS, P403; VOSSEN JM, 1972, REV EUR ETUD CL BIOL, V17, P457; VOSSEN JM, 1990, EUR J CLIN MICROBIOL, V9, P14, DOI 10.1007/BF01969527; VRIESENDORP HM, 1981, EXP HEMATOL, V9, P904; Wang LR, 2008, BONE MARROW TRANSPL, V42, P673, DOI 10.1038/bmt.2008.238; Xun CQ, 1997, TRANSPLANTATION, V64, P297, DOI 10.1097/00007890-199707270-00021	48	72	75	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2014	9	9							e105706	10.1371/journal.pone.0105706	http://dx.doi.org/10.1371/journal.pone.0105706			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3LR	25180821	Green Published, Green Submitted, gold			2022-12-27	WOS:000341231500032
J	Woods, ML; Carmona-Fontaine, C; Barnes, CP; Couzin, ID; Mayor, R; Page, KM				Woods, Mae L.; Carmona-Fontaine, Carlos; Barnes, Chris P.; Couzin, Iain D.; Mayor, Roberto; Page, Karen M.			Directional Collective Cell Migration Emerges as a Property of Cell Interactions	PLOS ONE			English	Article							NEURAL CREST CELLS; EPITHELIAL-MESENCHYMAL TRANSITIONS; REGULATES CONTACT INHIBITION; FIBRONECTIN; MECHANISMS; MOVEMENT; BEHAVIOR; LOCOMOTION; MORPHOLOGY; DYNAMICS	Collective cell migration is a fundamental process, occurring during embryogenesis and cancer metastasis. Neural crest cells exhibit such coordinated migration, where aberrant motion can lead to fatality or dysfunction of the embryo. Migration involves at least two complementary mechanisms: contact inhibition of locomotion (a repulsive interaction corresponding to a directional change of migration upon contact with a reciprocating cell), and co-attraction (a mutual chemoattraction mechanism). Here, we develop and employ a parameterized discrete element model of neural crest cells, to investigate how these mechanisms contribute to long-range directional migration during development. Motion is characterized using a coherence parameter and the time taken to reach, collectively, a target location. The simulated cell group is shown to switch from a diffusive to a persistent state as the response-rate to co-attraction is increased. Furthermore, the model predicts that when co-attraction is inhibited, neural crest cells can migrate into restrictive regions. Indeed, inhibition of co-attraction in vivo and in vitro leads to cell invasion into restrictive areas, confirming the prediction of the model. This suggests that the interplay between the complementary mechanisms may contribute to guidance of the neural crest. We conclude that directional migration is a system property and does not require action of external chemoattractants.	[Woods, Mae L.; Page, Karen M.] UCL, Ctr Math & Phys Life Sci & Expt Biol, London, England; [Woods, Mae L.; Carmona-Fontaine, Carlos; Barnes, Chris P.; Mayor, Roberto] UCL, Dept Cell & Dev Biol, London, England; [Couzin, Iain D.] Princeton Univ, Dept Ecol & Evolutionary Biol, Princeton, NJ 08544 USA; [Woods, Mae L.; Page, Karen M.] UCL, Dept Math, London, England	University of London; University College London; University of London; University College London; Princeton University; University of London; University College London	Mayor, R (corresponding author), UCL, Dept Cell & Dev Biol, London, England.	r.mayor@ucl.ac.uk; kpage@math.ucl.ac.uk	Couzin, Iain D./Q-6862-2018	Couzin, Iain D./0000-0001-8556-4558; Barnes, Chris/0000-0002-9459-1395; Mayor, Roberto/0000-0001-9053-9613	Medical Research Council [MR/J000655/1]; Wellcome Trust [WT084247AIA, WT097319/Z/11/Z]; National Science Foundation [PHY-0848755]; Office of Naval Research [N00014-09-1-1074]; Army Research Office [W911NG-11-1-0385]; Engineering and Physical Sciences Research Council Doctoral Training Centre [EP/P505771/1]; Direct For Biological Sciences [1300426] Funding Source: National Science Foundation; MRC [MR/J000655/1] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); National Science Foundation(National Science Foundation (NSF)); Office of Naval Research(Office of Naval Research); Army Research Office; Engineering and Physical Sciences Research Council Doctoral Training Centre(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	RM received funding from the Medical Research Council (MR/J000655/1) www.mrc.ac.uk/index. htm and the Wellcome Trust (WT084247AIA) www.wellcome.ac.uk. CB received funding from the Wellcome Trust (WT097319/Z/11/Z) www.wellcome.ac.uk. IDC received funding from the National Science Foundation (PHY-0848755) www.nsf.gov, Office of Naval Research (N00014-09-1-1074) www.onr.navy.mil, and the Army Research Office (W911NG-11-1-0385) www.arl.army.mil/www/default. cfm. Also MW was funded by the Engineering and Physical Sciences Research Council Doctoral Training Centre (EP/P505771/1) www.epsrc.ac.uk/Pages/default.aspx. In addition, the work made use of the EMERALD High Performanced Computing facility provided by the e-Infrastructure South Centre for Innovation Engineering and Physical Sciences Research Council (EP/K000144/1, EP/K000136/1) www.epsrc.ac.uk/Pages/default.aspx. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABERCROMBIE M, 1953, EXP CELL RES, V5, P111, DOI 10.1016/0014-4827(53)90098-6; ABERCROMBIE M, 1954, EXP CELL RES, V6, P293, DOI 10.1016/0014-4827(54)90176-7; ADAMS JC, 1990, CELL, V63, P425, DOI 10.1016/0092-8674(90)90175-E; Alfandari D, 2003, DEV BIOL, V260, P449, DOI 10.1016/S0012-1606(03)00277-X; Astin JW, 2010, NAT CELL BIOL, V12, P1194, DOI 10.1038/ncb2122; BARD JBL, 1975, J CELL BIOL, V67, P400, DOI 10.1083/jcb.67.2.400; Bindschadler M, 2007, J CELL SCI, V120, P876, DOI 10.1242/jcs.03395; Bracke ME, 1997, EUR J CELL BIOL, V74, P342; Buhl J, 2006, SCIENCE, V312, P1402, DOI 10.1126/science.1125142; Cano A, 2000, NAT CELL BIOL, V2, P76, DOI 10.1038/35000025; Carmona-Fontaine C, 2011, DEV CELL, V21, P1026, DOI 10.1016/j.devcel.2011.10.012; Carmona-Fontaine C, 2008, NATURE, V456, P957, DOI 10.1038/nature07441; Couzin ID, 2002, J THEOR BIOL, V218, P1, DOI 10.1006/jtbi.2002.3065; Cox BN, 2011, J R SOC INTERFACE, V8, P377, DOI 10.1098/rsif.2010.0262; Crosnier C, 2006, NAT REV GENET, V7, P349, DOI 10.1038/nrg1840; CUNDALL PA, 1979, GEOTECHNIQUE, V29, P47, DOI 10.1680/geot.1979.29.1.47; DAVIS EM, 1981, J EMBRYOL EXP MORPH, V63, P29; Douarche C, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.198101; DUFOUR S, 1988, EMBO J, V7, P2661, DOI 10.1002/j.1460-2075.1988.tb03119.x; FLAXMAN BA, 1974, J INVEST DERMATOL, V63, P326, DOI 10.1111/1523-1747.ep12680297; Friedl P, 2004, INT J DEV BIOL, V48, P441, DOI 10.1387/ijdb.041821pf; Fuller D, 2010, P NATL ACAD SCI USA, V107, P9656, DOI 10.1073/pnas.0911178107; Gambardella L, 2003, CURR OPIN CELL BIOL, V15, P771, DOI 10.1016/j.ceb.2003.10.011; GOODAY D, 1985, CELL TISSUE RES, V241, P165, DOI 10.1007/BF00214638; Grossman D, 2008, NEW J PHYS, V10, DOI 10.1088/1367-2630/10/2/023036; Handegard NO, 2012, CURR BIOL, V22, P1213, DOI 10.1016/j.cub.2012.04.050; Hotulainen P, 2006, J CELL BIOL, V173, P383, DOI 10.1083/jcb.200511093; Huttenlocher A, 1998, J CELL BIOL, V141, P515, DOI 10.1083/jcb.141.2.515; Killian ECO, 2009, DEV BIOL, V333, P161, DOI 10.1016/j.ydbio.2009.06.031; Kuriyama S, 2008, PHILOS T R SOC B, V363, P1349, DOI 10.1098/rstb.2007.2252; Ladwein M, 2008, FEBS LETT, V582, P2066, DOI 10.1016/j.febslet.2008.04.033; Landman KA, 2011, J THEOR BIOL, V276, P250, DOI 10.1016/j.jtbi.2011.01.043; Martin P, 1997, SCIENCE, V276, P75, DOI 10.1126/science.276.5309.75; Matthews HK, 2008, DEVELOPMENT, V135, P1771, DOI 10.1242/dev.017350; Mayor R, 2010, TRENDS CELL BIOL, V20, P319, DOI 10.1016/j.tcb.2010.03.005; McLennan R, 2012, DEVELOPMENT, V139, P2935, DOI 10.1242/dev.081471; McLennan R, 2010, DEV BIOL, V339, P114, DOI 10.1016/j.ydbio.2009.12.022; Mogilner A, 2003, J MATH BIOL, V47, P353, DOI 10.1007/s00285-003-0209-7; NEWGREEN DF, 1979, CELL TISSUE RES, V203, P115; ROVASIO RA, 1983, J CELL BIOL, V96, P462, DOI 10.1083/jcb.96.2.462; Serra-Picamal X, 2012, NAT PHYS, V8, P628, DOI [10.1038/NPHYS2355, 10.1038/nphys2355]; Shklarsh A, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002177; Simpson MJ, 2007, DEV BIOL, V302, P553, DOI 10.1016/j.ydbio.2006.10.017; Stramer B, 2010, J CELL BIOL, V189, P681, DOI 10.1083/jcb.200912134; Szabo B, 2006, PHYS REV E, V74, DOI 10.1103/PhysRevE.74.061908; Theveneau E, 2012, DEV BIOL, V366, P34, DOI 10.1016/j.ydbio.2011.12.041; Theveneau Eric, 2010, Small GTPases, V1, P113, DOI 10.4161/sgtp.1.2.13673; Theveneau E, 2011, GENESIS, V49, P164, DOI 10.1002/dvg.20700; Theveneau E, 2010, DEV CELL, V19, P39, DOI 10.1016/j.devcel.2010.06.012; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; TUCKER RP, 1986, J EMBRYOL EXP MORPH, V97, P141; Vedel S, 2013, P NATL ACAD SCI USA, V110, P129, DOI 10.1073/pnas.1204291110; WATSON GN, 1966, TREATISE THEORY BESS, V6; Wynn Michelle L, 2013, Phys Biol, V10, P035003, DOI 10.1088/1478-3975/10/3/035003; Wynn ML, 2012, J R SOC INTERFACE, V9, P1576, DOI 10.1098/rsif.2011.0726; Yamao M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027950; Zhou JA, 2010, DEVELOPMENT, V137, P2785, DOI 10.1242/dev.045997	58	56	56	1	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2014	9	9							e104969	10.1371/journal.pone.0104969	http://dx.doi.org/10.1371/journal.pone.0104969			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3LR	25181349	Green Published, Green Submitted, gold			2022-12-27	WOS:000341231500014
J	Ramirez, O; Motta-Mena, LB; Cordova, A; Garza, KM				Ramirez, Oscar; Motta-Mena, Laura B.; Cordova, Amanda; Garza, Kristine M.			A Small Library of Synthetic Di-Substituted 1, 4-Naphthoquinones Induces ROS-Mediated Cell Death in Murine Fibroblasts	PLOS ONE			English	Article							IN-VITRO; CYCLE ARREST; L929 CELLS; PLUMBAGIN; APOPTOSIS; NAPHTHOQUINONES; CYTOTOXICITY; MENADIONE; 1,4-NAPHTHOQUINONES; MECHANISMS	Synthesis of compound libraries and their concurrent assessment as selective reagents for probing and modulating biological function continues to be an active area of chemical biology. Microwave-assisted solid-phase Dotz benzannulation reactions have been used to inexpensively synthesize 2, 3-disubstituted-1, 4-naphthoquinone derivatives. Herein, we report the biological testing of a small library of such compounds using a murine fibroblast cell line (L929). Assessment of cellular viability identified three categories of cytotoxic compounds: no toxicity, low/intermediate toxicity and high toxicity. Increased levels of Annexin-V-positive staining and of caspase 3 activity confirmed that low, intermediate, and highly toxic compounds promote cell death. The compounds varied in their ability to induce mitochondrial depolarization and formation of reactive oxygen species (ROS). Both cytotoxic and non-cytotoxic compounds triggered mitochondrial depolarization, while one highly cytotoxic compound did not. In addition, all cytotoxic compounds promoted increased intracellular ROS but the cells were only partially protected from compound-induced apoptosis when in the presence of superoxide dismutase, catalase, or ascorbic acid suggesting utilization of additional pro-death mechanisms. In summary, nine of twelve (75%) 1, 4-naphthoquinone synthetic compounds were cytotoxic. Although the mitochondria did not appear to be a central target for induction of cell death, all of the cytotoxic compounds induced ROS formation. Thus, the data demonstrate that the synthesis regime effectively created cytotoxic compounds highlighting the potential use of the regime and its products for the identification of biologically relevant reagents.	[Ramirez, Oscar; Motta-Mena, Laura B.; Cordova, Amanda; Garza, Kristine M.] Univ Texas El Paso, Dept Biol Sci, El Paso, TX 79968 USA; [Ramirez, Oscar; Garza, Kristine M.] Univ Texas El Paso, Border Biomed Res Ctr, El Paso, TX 79968 USA	University of Texas System; University of Texas El Paso; University of Texas System; University of Texas El Paso	Garza, KM (corresponding author), Univ Texas El Paso, Dept Biol Sci, El Paso, TX 79968 USA.	kgarza@utep.edu		Cordova, Amanda/0000-0001-7843-1431	University of Texas at El Paso Border Biomedical Research Center - National Institutes of General Medical Sciences - Research Centers at Minority Institutions [G12RR08124]; National Science Foundation [HRD1202008]; National Institute of General Medical Sciences SCORE Program [2S06GM1008012]; National Institutes of Health [R25GM049011-14]; NATIONAL CENTER FOR RESEARCH RESOURCES [G12RR008124] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R25GM049011] Funding Source: NIH RePORTER	University of Texas at El Paso Border Biomedical Research Center - National Institutes of General Medical Sciences - Research Centers at Minority Institutions; National Science Foundation(National Science Foundation (NSF)); National Institute of General Medical Sciences SCORE Program; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the University of Texas at El Paso Border Biomedical Research Center, funded by the National Institutes of General Medical Sciences - Research Centers at Minority Institutions [G12RR08124]. L. B. M. M. was supported by the National Science Foundation-funded University of Texas at El Paso Model Institution of Excellence Research Experience for Undergraduates Program. K. M. G. and this work was supported by the National Institute of General Medical Sciences SCORE Program [2S06GM1008012]. Undergraduate students who contributed to this work were supported by the National Science Foundation-funded Louis Stokes Alliance for Minority Participation Program [HRD1202008] (B. B) and by the National Institutes of Health-funded Bridges to the Baccalaureate Program [R25GM049011-14] (S. G.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aithal BK, 2009, CELL BIOL INT, V33, P1039, DOI 10.1016/j.cellbi.2009.06.018; BABICH H, 1993, J APPL TOXICOL, V13, P353, DOI 10.1002/jat.2550130510; Babula P, 2009, ENVIRON EXP BOT, V65, P330, DOI 10.1016/j.envexpbot.2008.11.007; Balasubramanian K, 2007, J BIOL CHEM, V282, P18357, DOI 10.1074/jbc.M700202200; Bentinger M, 2010, BIOCHEM BIOPH RES CO, V396, P74, DOI 10.1016/j.bbrc.2010.02.147; Brondani DJ, 2007, MED CHEM, V3, P369; Chen CA, 2009, PANCREATOLOGY, V9, P797, DOI 10.1159/000210028; Chen J, 2004, CELL BIOL TOXICOL, V20, P183, DOI 10.1023/B:CBTO.0000029468.89746.64; Di Rosso ME, 2013, TOXICOL IN VITRO, V27, P2094, DOI 10.1016/j.tiv.2013.08.002; DOHERTY MD, 1987, J APPL TOXICOL, V7, P123, DOI 10.1002/jat.2550070209; HASSAN HM, 1979, ARCH BIOCHEM BIOPHYS, V196, P385, DOI 10.1016/0003-9861(79)90289-3; Hsu YL, 2006, J PHARMACOL EXP THER, V318, P484, DOI 10.1124/jpet.105.098863; Inbaraj JJ, 2004, CHEM RES TOXICOL, V17, P55, DOI 10.1021/tx034132s; Kim YM, 2004, J AGR FOOD CHEM, V52, P6096, DOI 10.1021/jf049379p; Kroemer G, 2009, CELL DEATH DIFFER, V16, P3, DOI 10.1038/cdd.2008.150; Nakato H, 2007, J ANTIMICROB CHEMOTH, V60, P929, DOI 10.1093/jac/dkm337; OBRIEN PJ, 1991, CHEM-BIOL INTERACT, V80, P1, DOI 10.1016/0009-2797(91)90029-7; Ozdemir KG, 2009, J BIOMED MATER RES B, V90B, P82, DOI 10.1002/jbm.b.31256; Patel Samir N, 2005, Expert Rev Anti Infect Ther, V3, P849, DOI 10.1586/14787210.3.6.849; Porter AG, 1999, CELL DEATH DIFFER, V6, P99, DOI 10.1038/sj.cdd.4400476; ROSS D, 1985, CHEM-BIOL INTERACT, V55, P177, DOI 10.1016/S0009-2797(85)80126-5; Shanmugasundaram M, 2005, TETRAHEDRON LETT, V46, P7545, DOI 10.1016/j.tetlet.2005.08.158; Srinivas P, 2004, MOL CARCINOGEN, V40, P201, DOI 10.1002/mc.20031; Suloglu AK, 2014, INT J TOXICOL, V33, P319, DOI 10.1177/1091581814530437; Tasdemir D, 2006, CHEM BIODIVERS, V3, P1230, DOI 10.1002/cbdv.200690124; Ui H, 2007, J ANTIBIOT, V60, P220, DOI 10.1038/ja.2007.27; Verma Rajeshwar P., 2006, Anti-Cancer Agents in Medicinal Chemistry, V6, P41, DOI 10.2174/187152006778226512; Castro FAV, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003999; Wang CCC, 2008, CANCER LETT, V259, P82, DOI 10.1016/j.canlet.2007.10.005; Watanabe N, 2004, METHOD ENZYMOL, V378, P319; Watanabe N, 2003, ARCH BIOCHEM BIOPHYS, V411, P145, DOI 10.1016/S0003-9861(02)00716-6	31	9	9	4	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2014	9	9							e106828	10.1371/journal.pone.0106828	http://dx.doi.org/10.1371/journal.pone.0106828			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4JX	25197824	Green Submitted, Green Published, gold			2022-12-27	WOS:000341304700055
J	Xu, QP; Deller, MC; Nielsen, TK; Grant, JC; Lesley, SA; Elsliger, MA; Deacon, AM; Wilson, IA				Xu, Qingping; Deller, Marc C.; Nielsen, Tine K.; Grant, Joanna C.; Lesley, Scott A.; Elsliger, Marc-Andre; Deacon, Ashley M.; Wilson, Ian A.			Structural Insights into the Recognition of Phosphopeptide by the FHA Domain of Kanadaptin	PLOS ONE			English	Article							PROTEIN-STRUCTURE; CRYSTAL-STRUCTURE; MODEL; PHOSPHORYLATION; REFINEMENT; REVEALS; COMPLEX; BIOLOGY; KIDNEY	Kanadaptin is a nuclear protein of unknown function that is widely expressed in mammalian tissues. The crystal structure of the forkhead-associated (FHA) domain of human kanadaptin was determined to 1.6 angstrom resolution. The structure reveals an asymmetric dimer in which one monomer is complexed with a phosphopeptide mimic derived from a peptide segment from the N-terminus of a symmetry-related molecule as well as a sulfate bound to the structurally conserved phosphothreonine recognition cleft. This structure provides insights into the molecular recognition features utilized by this family of proteins and represents the first evidence that kanadaptin is likely involved in a phosphorylation-mediated signaling pathway. These results will be of use for designing experiments to further probe the function of kanadaptin.	[Xu, Qingping; Deller, Marc C.; Grant, Joanna C.; Lesley, Scott A.; Elsliger, Marc-Andre; Deacon, Ashley M.; Wilson, Ian A.] Joint Ctr Struct Genom, La Jolla, CA 92121 USA; [Xu, Qingping; Deacon, Ashley M.] SLAC Natl Accelerator Lab, Stanford Synchrotron Radiat Lightsource, Menlo Pk, CA USA; [Deller, Marc C.; Lesley, Scott A.; Elsliger, Marc-Andre; Wilson, Ian A.] Scripps Res Inst, Dept Integrat Struct & Computat Biol, La Jolla, CA 92037 USA; [Nielsen, Tine K.] Univ Copenhagen, Fac Hlth Sci, Prot Prod Facil, Novo Nordisk Fdn Ctr Prot Res, Copenhagen, Denmark; [Grant, Joanna C.; Lesley, Scott A.] Novartis Res Fdn, Prot Sci Dept, Genom Inst, San Diego, CA USA	Stanford University; United States Department of Energy (DOE); SLAC National Accelerator Laboratory; Scripps Research Institute; University of Copenhagen; Novartis	Wilson, IA (corresponding author), Joint Ctr Struct Genom, La Jolla, CA 92121 USA.	wilson@scripps.edu		Elsliger, Marc Andre/0000-0002-1989-7626; Deller, Marc/0000-0001-8070-6502	National Institutes of Health (NIH), National Institute of General Medical Sciences (NIGMS), Protein Structure Initiative [U54 GM094586]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103393, U54GM094586] Funding Source: NIH RePORTER	National Institutes of Health (NIH), National Institute of General Medical Sciences (NIGMS), Protein Structure Initiative; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Funding provided by National Institutes of Health (NIH), National Institute of General Medical Sciences (NIGMS), Protein Structure Initiative U54 GM094586. The contents of this publication are solely the responsibility of the authors and do not necessarily represent the official views of NIGMS or NIH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Barthe P, 2009, STRUCTURE, V17, P568, DOI 10.1016/j.str.2009.02.012; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Beitz E, 2000, BIOINFORMATICS, V16, P135, DOI 10.1093/bioinformatics/16.2.135; Blanc E, 2004, ACTA CRYSTALLOGR D, V60, P2210, DOI 10.1107/S0907444904016427; Burkard TR, 2011, BMC SYST BIOL, V5, DOI 10.1186/1752-0509-5-17; Byeon IJL, 2005, NAT STRUCT MOL BIOL, V12, P987, DOI 10.1038/nsmb1008; Chen JH, 1998, J BIOL CHEM, V273, P1038, DOI 10.1074/jbc.273.2.1038; Cohen AE, 2002, J APPL CRYSTALLOGR, V35, P720, DOI 10.1107/S0021889802016709; Davis IW, 2004, NUCLEIC ACIDS RES, V32, pW615, DOI 10.1093/nar/gkh398; Delorenzi M, 2002, BIOINFORMATICS, V18, P617, DOI 10.1093/bioinformatics/18.4.617; Elsliger MA, 2010, ACTA CRYSTALLOGR F, V66, P1137, DOI 10.1107/S1744309110038212; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; HONIG B, 1995, SCIENCE, V268, P1144, DOI 10.1126/science.7761829; Hubner S, 2003, EUR J CELL BIOL, V82, P240, DOI 10.1078/0171-9335-00308; Hubner S, 2002, BIOCHEM J, V361, P287, DOI 10.1042/0264-6021:3610287; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kittanakom S, 2004, MOL MEMBR BIOL, V21, P395, DOI 10.1080/09687860400011365; Langer G, 2008, NAT PROTOC, V3, P1171, DOI 10.1038/nprot.2008.91; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lee H, 2008, MOL CELL, V30, P767, DOI 10.1016/j.molcel.2008.05.013; Lesley SA, 2002, P NATL ACAD SCI USA, V99, P11664, DOI 10.1073/pnas.142413399; Liang XY, 2008, ACCOUNTS CHEM RES, V41, P991, DOI 10.1021/ar700148u; Liu JP, 2012, NUCLEIC ACIDS RES, V40, P3898, DOI 10.1093/nar/gkr1296; LUPAS A, 1991, SCIENCE, V252, P1162, DOI 10.1126/science.252.5009.1162; Machida S, 2013, MOL PLANT, V6, P1290, DOI 10.1093/mp/sst007; Mahajan A, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.151re12; McGuffin LJ, 2000, BIOINFORMATICS, V16, P404, DOI 10.1093/bioinformatics/16.4.404; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Pennell S, 2010, STRUCTURE, V18, P1587, DOI 10.1016/j.str.2010.09.014; Peterson DA, 2007, CELL HOST MICROBE, V2, P328, DOI 10.1016/j.chom.2007.09.013; Roy A, 2010, NAT PROTOC, V5, P725, DOI 10.1038/nprot.2010.5; Santarsiero BD, 2002, J APPL CRYSTALLOGR, V35, P278, DOI 10.1107/S0021889802001474; Saunders LR, 2003, FASEB J, V17, P961, DOI 10.1096/fj.02-0958rev; Schwarzenbacher R, 2004, ACTA CRYSTALLOGR D, V60, P1229, DOI 10.1107/S0907444904010145; Soding J, 2005, NUCLEIC ACIDS RES, V33, pW244, DOI 10.1093/nar/gki408; Stavridi ES, 2002, STRUCTURE, V10, P891, DOI 10.1016/S0969-2126(02)00776-1; Trowitzsch S, 2009, J MOL BIOL, V385, P531, DOI 10.1016/j.jmb.2008.10.087; Vagin A, 2010, ACTA CRYSTALLOGR D, V66, P22, DOI 10.1107/S0907444909042589; Webb Benjamin, 2016, Curr Protoc Protein Sci, V86, DOI [10.1002/cpbi.3, 10.1002/0471250953.bi0506s15, 10.1002/0471140864.ps0209s50, 10.1002/cpps.20]; Xu QP, 2010, ACTA CRYSTALLOGR F, V66, P1354, DOI 10.1107/S1744309110021214	41	6	7	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2014	9	9							e107309	10.1371/journal.pone.0107309	http://dx.doi.org/10.1371/journal.pone.0107309			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4JX	25197798	gold, Green Submitted, Green Published			2022-12-27	WOS:000341304700105
J	Brahmachari, S; Mandal, SK; Das, PK				Brahmachari, Sayanti; Mandal, Subhra Kanti; Das, Prasanta Kumar			Fabrication of SWCNT-Ag Nanoparticle Hybrid Included Self-Assemblies for Antibacterial Applications	PLOS ONE			English	Article							WALLED CARBON NANOTUBES; SILVER NANOPARTICLES; ANTIMICROBIAL ACTIVITY; AMINO-ACID; CATIONIC AMPHIPHILES; ESCHERICHIA-COLI; FUNCTIONALIZATION; BIOCOMPATIBILITY; PEPTIDES; HYDROGEL	The present article reports the development of soft nanohybrids comprising of single walled carbon nanotube (SWCNT) included silver nanoparticles (AgNPs) having superior antibacterial property. In this regard aqueous dispersing agent of carbon nanotube (CNT) containing a silver ion reducing unit was synthesised by the inclusion of tryptophan and tyrosine within the backbone of the amphiphile. The dispersions were characterized spectroscopically and microscopically using TEM, AFM and Raman spectroscopy. The nanotube-nanoparticle conjugates were prepared by the in situ photoreduction of AgNO3. The phenolate residue and the indole moieties of tyrosine and tryptophan, respectively reduces the sliver ion as well as acts as stabilizing agents for the synthesized AgNPs. The nanohybrids were characterized using TEM and AFM. The antibacterial activity of the nanohybrids was studied against Gram-positive (Bacillus subtilis and Micrococcus luteus) and Gram-negative bacteria (Escherichia coli and Klebsiella aerogenes). The SWCNT dispersions showed moderate killing ability (40-60%) against Gram-positive bacteria however no antibacterial activity was observed against the Gram negative ones. Interestingly, the developed SWCNT-amphiphile-AgNP nanohybrids exhibited significant killing ability (, 90%) against all bacteria. Importantly, the cell viability of these newly developed self-assemblies was checked towards chinese hamster ovarian cells and high cell viability was observed after 24 h of incubation. This specific killing of bacterial cells may have been achieved due to the presence of higher -SH containing proteins in the cell walls of the bacteria. The developed nanohybrids were subsequently infused into tissue engineering scaffold agar-gelatin films and the films similarly showed bactericidal activity towards both kinds of bacterial strains while allowing normal growth of eukaryotic cells on the surface of the films.	[Brahmachari, Sayanti; Mandal, Subhra Kanti; Das, Prasanta Kumar] Indian Assoc Cultivat Sci, Dept Biol Chem, Kolkata, India	Department of Science & Technology (India); Indian Association for the Cultivation of Science (IACS) - Jadavpur	Das, PK (corresponding author), Indian Assoc Cultivat Sci, Dept Biol Chem, Kolkata, India.	bcpkd@iacs.res.in			Department of Science and Technology, India [SR/S1/OC-25/2011]; Council of Scientific and Industrial Research, India	Department of Science and Technology, India(Department of Science & Technology (India)); Council of Scientific and Industrial Research, India(Council of Scientific & Industrial Research (CSIR) - India)	P.K.D. is thankful to Department of Science and Technology, India (SR/S1/OC-25/2011) for financial assistance. S.B. and S.K.M. acknowledge the Council of Scientific and Industrial Research, India for Research fellowships. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adhikari B, 2010, CHEM-EUR J, V16, P13698, DOI 10.1002/chem.201001240; Ajayan PM, 1999, CHEM REV, V99, P1787, DOI 10.1021/cr970102g; Arias LR, 2009, LANGMUIR, V25, P3003, DOI 10.1021/la802769m; Backes C, 2010, ADV MATER, V22, P788, DOI 10.1002/adma.200902525; Backes C, 2009, J AM CHEM SOC, V131, P2172, DOI 10.1021/ja805660b; Becraft EJ, 2009, BIOPOLYMERS, V92, P212, DOI 10.1002/bip.21186; Brahmachari S, 2014, J MATER CHEM B, V2, P1160, DOI 10.1039/c3tb21334j; Brahmachari S, 2011, ANGEW CHEM INT EDIT, V50, P11243, DOI 10.1002/anie.201105622; Brahmachari S, 2010, CHEM COMMUN, V46, P8386, DOI 10.1039/c0cc02464c; Brown ED, 2005, CHEM REV, V105, P759, DOI 10.1021/cr030116o; Cousins BG, 2009, SMALL, V5, P587, DOI 10.1002/smll.200801184; Daima HK, 2014, NANOSCALE, V6, P758, DOI 10.1039/c3nr03806h; Daima HK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079676; Das D, 2009, LANGMUIR, V25, P4421, DOI 10.1021/la803753g; Deokar AR, 2013, J MATER CHEM B, V1, P2639, DOI 10.1039/c3tb20188k; Dutta S, 2013, LANGMUIR, V29, P316, DOI 10.1021/la3038389; Dutta S, 2012, J MATER CHEM, V22, P6623, DOI 10.1039/c2jm16585f; Dutta S, 2011, LANGMUIR, V27, P5000, DOI 10.1021/la104903z; Goodwin AP, 2009, J AM CHEM SOC, V131, P289, DOI 10.1021/ja807307e; Gupta A, 1999, NAT MED, V5, P183, DOI 10.1038/5545; Haldar J, 2005, J MED CHEM, V48, P3823, DOI 10.1021/jm049106l; HANSEN MB, 1989, J IMMUNOL METHODS, V119, P203, DOI 10.1016/0022-1759(89)90397-9; Jain J, 2009, MOL PHARMACEUT, V6, P1388, DOI 10.1021/mp900056g; Jung JH, 2011, LANGMUIR, V27, P10256, DOI 10.1021/la201851r; Kang S, 2008, LANGMUIR, V24, P6409, DOI 10.1021/la800951v; Kang S, 2007, LANGMUIR, V23, P8670, DOI 10.1021/la701067r; Kim JS, 2007, NANOMED-NANOTECHNOL, V3, P95, DOI 10.1016/j.nano.2006.12.001; Kumar A, 2008, NAT MATER, V7, P236, DOI 10.1038/nmat2099; Kvitek L, 2008, J PHYS CHEM C, V112, P5825, DOI 10.1021/jp711616v; Lara HH, 2010, WORLD J MICROB BIOT, V26, P615, DOI 10.1007/s11274-009-0211-3; Li XZ, 1997, J BACTERIOL, V179, P6127, DOI 10.1128/JB.179.19.6127-6132.1997; Li YN, 2009, LANGMUIR, V25, P11760, DOI 10.1021/la9011636; Liu SB, 2009, ACS NANO, V3, P3891, DOI 10.1021/nn901252r; Makovitzki A, 2006, P NATL ACAD SCI USA, V103, P15997, DOI 10.1073/pnas.0606129103; Mandal D, 2014, COLLOID SURFACE B, V113, P442, DOI 10.1016/j.colsurfb.2013.09.047; Mitra RN, 2009, ORG BIOMOL CHEM, V7, P94, DOI 10.1039/b815368j; Morones JR, 2005, NANOTECHNOLOGY, V16, P2346, DOI 10.1088/0957-4484/16/10/059; Niu A, 2010, J PHYS CHEM C, V114, P12728, DOI 10.1021/jp104720w; Pal A, 2008, J MATER CHEM, V18, P2593, DOI 10.1039/b719432c; Panacek A, 2006, J PHYS CHEM B, V110, P16248, DOI 10.1021/jp063826h; Pramanik S, 2014, BIOMATER SCI-UK, V2, P192, DOI 10.1039/c3bm60170f; Prato M, 2008, ACCOUNTS CHEM RES, V41, P60, DOI 10.1021/ar700089b; Pritz S, 2007, ORG BIOMOL CHEM, V5, P1789, DOI 10.1039/b702134h; Rai M, 2009, BIOTECHNOL ADV, V27, P76, DOI 10.1016/j.biotechadv.2008.09.002; Roy S, 2008, BIOTECHNOL BIOENG, V100, P756, DOI 10.1002/bit.21803; Salzmann CG, 2008, J MATER CHEM, V18, P1977, DOI 10.1039/b800494c; Salzmann CG, 2007, CARBON, V45, P907, DOI 10.1016/j.carbon.2007.01.009; Shao L, 2007, CHEM COMMUN, P5090, DOI 10.1039/b712614j; Shome A, 2011, SOFT MATTER, V7, P3011, DOI 10.1039/c0sm01087a; Sieber SA, 2005, CHEM REV, V105, P715, DOI 10.1021/cr0301191; Sondi I, 2004, J COLLOID INTERF SCI, V275, P177, DOI 10.1016/j.jcis.2004.02.012; Tiller JC, 2002, BIOTECHNOL BIOENG, V79, P465, DOI 10.1002/bit.10299; Tiller JC, 2003, ANGEW CHEM INT EDIT, V42, P3072, DOI 10.1002/anie.200301647; Usrey ML, 2009, J PHYS CHEM C, V113, P12443, DOI 10.1021/jp902892w; Vargas JH, 2014, J APPL POLYM SCI, DOI [10.1002/APP.40214., DOI 10.1002/APP.40214]; Verma V, 2007, BIOTECHNOL BIOENG, V96, P392, DOI 10.1002/bit.21111; Waschinski CJ, 2008, BIOMACROMOLECULES, V9, P1764, DOI 10.1021/bm7013944; Waschinski CJ, 2008, ADV MATER, V20, P104, DOI 10.1002/adma.200701095; Wigginton NS, 2010, ENVIRON SCI TECHNOL, V44, P2163, DOI 10.1021/es903187s; Witus LS, 2007, J MATER CHEM, V17, P1909, DOI 10.1039/b700174f; Xie H, 2005, J MATER CHEM, V15, P1734, DOI 10.1039/b413262a; Xing BG, 2002, J AM CHEM SOC, V124, P14846, DOI 10.1021/ja028539f; Xu XL, 2008, FIBER POLYM, V9, P685, DOI 10.1007/s12221-008-0108-z; Yang ZM, 2007, ADV MATER, V19, P3152, DOI 10.1002/adma.200701971; Yuan W, 2008, J PHYS CHEM C, V112, P18754, DOI 10.1021/jp807133j; Zhao B, 2005, J AM CHEM SOC, V127, P8197, DOI 10.1021/ja042924i; Zumbuehl A, 2007, P NATL ACAD SCI USA, V104, P12994, DOI 10.1073/pnas.0705250104	67	16	16	0	71	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2014	9	9							e106775	10.1371/journal.pone.0106775	http://dx.doi.org/10.1371/journal.pone.0106775			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ1IR	25191756	Green Submitted, gold, Green Published			2022-12-27	WOS:000347993600060
J	Sabo, RT; Yen, MS; Daniels, S; Sun, SMS				Sabo, Roy T.; Yen, Miao-Shan; Daniels, Stephen; Sun, Shumei S.			Associations between Childhood Body Size, Composition, Blood Pressure and Adult Cardiac Structure: The Fels Longitudinal Study	PLOS ONE			English	Article							LEFT-VENTRICULAR MASS; CARDIOVASCULAR RISK-FACTORS; YOUNG ADULTHOOD; LIFE-STYLE; OBESITY; HYPERTENSION; HYPERTROPHY; ADOLESCENTS; CHILDREN; PREVALENCE	Objectives: To determine whether childhood body size, composition and blood pressure are associated with adult cardiac structure by estimating childhood "age of divergence.'' Methods: 385 female and 312 male participants in the Fels Longitudinal Study had echocardiographic measurements of left ventricular mass, relative wall thickness, and interventricular septal thickness. Also available were anthropometric measurements of body mass index, waist circumference, percentage body fat, fat free mass, total body fat, and systolic and diastolic blood pressures, taken in both childhood and adulthood. The age of divergence is estimated as the lowest age at which childhood measurements are significantly different between patients with low and high measurements of adult cardiac structure. Results: Childhood body mass index is significantly associated with adult left ventricular mass (indexed by height) in men and women (ages of divergence: 7.5 years and 11.5 years, respectively), and with adult interventricular septal thickness in boys (age of divergence: 9 years). Childhood waist circumference indexed by height is associated with left ventricular mass (indexed by height) in boys (age of divergence: 8 years). Cardiac structure was in general not associated with childhood body composition and blood pressure. Conclusions: Though results are affected by adult body size, composition and blood pressure, some aspects of adult cardiac structure may have their genesis in childhood body size.	[Sabo, Roy T.; Yen, Miao-Shan; Sun, Shumei S.] Virginia Commonwealth Univ, Sch Med, Dept Biostat, Richmond, VA 23284 USA; [Daniels, Stephen] Univ Colorado, Sch Med, Dept Pediat, Aurora, CO USA	Virginia Commonwealth University; University of Colorado System; University of Colorado Anschutz Medical Campus	Sabo, RT (corresponding author), Virginia Commonwealth Univ, Sch Med, Dept Biostat, Richmond, VA 23284 USA.	rsabo@vcu.edu			National Heart Lung and Blood Institute [R01HL072838-05]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL072838, R01HL113697] Funding Source: NIH RePORTER	National Heart Lung and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	The research was funded by a grant from the National Heart Lung and Blood Institute (R01HL072838-05). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abel ED, 2008, PHYSIOL REV, V88, P389, DOI 10.1152/physrev.00017.2007; Adolescents. NHBPEPWGoHCiCa, 1996, PEDIATRICS, V98, P649; Amin RS, 2002, AM J RESP CRIT CARE, V165, P1395, DOI 10.1164/rccm.2105118; [Anonymous], 2007, HLTH US 2007 CHARTBO; [Anonymous], 1987, PEDIATRICS, V79, P1; BAECKE JAH, 1982, AM J CLIN NUTR, V36, P936; Chobanian AV, 2003, HYPERTENSION, V42, P1206, DOI 10.1161/01.HYP.0000107251.49515.c2; Coca A, 1999, J HYPERTENS, V17, P1471, DOI 10.1097/00004872-199917100-00016; Cuspidi C, 2012, J HUM HYPERTENS, V26, P343, DOI 10.1038/jhh.2011.104; Daniels SR, 1999, CIRCULATION, V99, P541, DOI 10.1161/01.CIR.99.4.541; DANIELS SR, 1988, J AM COLL CARDIOL, V12, P703, DOI 10.1016/S0735-1097(88)80060-3; de Simone G, 2000, CIRCULATION, V101, P152, DOI 10.1161/01.CIR.101.2.152; de Simone G, 1998, HYPERTENSION, V31, P1077, DOI 10.1161/01.HYP.31.5.1077; Ford ES, 2002, JAMA-J AM MED ASSOC, V287, P356, DOI 10.1001/jama.287.3.356; Frohlich ED, 2009, MED CLIN N AM, V93, pXV, DOI 10.1016/j.mcna.2009.02.016; GOTTDIENER JS, 1994, J AM COLL CARDIOL, V24, P1492, DOI 10.1016/0735-1097(94)90145-7; Guo SM, 1998, AM J HUM BIOL, V10, P589, DOI 10.1002/(SICI)1520-6300(1998)10:5<589::AID-AJHB5>3.0.CO;2-9; Guo SS, 1997, INT J OBESITY, V21, P1167, DOI 10.1038/sj.ijo.0800531; Guo SS, 1999, AM J CLIN NUTR, V70, P405; Guo SS, 1996, AM J CLIN NUTR, V64, P428; Heckbert SR, 2006, J AM COLL CARDIOL, V48, P2285, DOI 10.1016/j.jacc.2006.03.072; HOLM S, 1979, SCAND J STAT, V6, P65; Lang RM, 2005, J AM SOC ECHOCARDIOG, V18, P1440, DOI 10.1016/j.echo.2005.10.005; LAUER MS, 1991, JAMA-J AM MED ASSOC, V266, P231, DOI 10.1001/jama.266.2.231; LAUER MS, 1992, J AM COLL CARDIOL, V19, P130, DOI 10.1016/0735-1097(92)90063-S; LEVY D, 1990, NEW ENGL J MED, V0322; Lieb W, 2009, CIRCULATION, V119, P3085, DOI 10.1161/CIRCULATIONAHA.108.824243; Lohman T. G., 1998, ANTROPOMETRIC STANDA; MALCOLM DD, 1993, PEDIATRICS, V92, P703; McNiece KL, 2007, HYPERTENSION, V50, P392, DOI 10.1161/HYPERTENSIONAHA.107.092197; MUST A, 1992, NEW ENGL J MED, V327, P1350, DOI 10.1056/NEJM199211053271904; Powell BD, 2006, AM J CARDIOL, V98, P116, DOI 10.1016/j.amjcard.2006.01.063; Rademacher ER, 2009, J HYPERTENS, V27, P1766, DOI 10.1097/HJH.0b013e32832e8cfa; Roche A, 1992, GROWTH MATURATION BO; Roche A, 2003, HUMAN GROWTH ASSESSM; Ross R, 2001, MED SCI SPORT EXER, V33, pS521, DOI 10.1097/00005768-200106001-00023; Sabo Roy T, 2012, Open J Endocr Metab Dis, V2, P40; Sabo RT, 2012, OBESITY, V20, P1741, DOI 10.1038/oby.2012.58; Schubert CM, 2006, INT J OBESITY, V30, P251, DOI 10.1038/sj.ijo.0803129; Schussheim AE, 1997, AM J CARDIOL, V79, P1070, DOI 10.1016/S0002-9149(97)00049-0; Singh GK, 2009, J COMMUN HEALTH, V34, P271, DOI 10.1007/s10900-009-9148-6; Toprak A, 2008, AM J CARDIOL, V101, P1621, DOI 10.1016/j.amjcard.2008.01.045; URBINA EM, 1995, CIRCULATION, V91, P2400, DOI 10.1161/01.CIR.91.9.2400; Verdecchia P, 1996, AM J CARDIOL, V78, P197, DOI 10.1016/S0002-9149(96)90395-1	44	11	11	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2014	9	9							e106333	10.1371/journal.pone.0106333	http://dx.doi.org/10.1371/journal.pone.0106333			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ1IR	25191997	gold, Green Published, Green Submitted			2022-12-27	WOS:000347993600020
J	Siqueira, NF; Oliveira, FLBB; Siqueira, JA; de Souza, EAP				Siqueira, Nathalia F.; Oliveira, Fernando L. B. B.; Siqueira, Jorge A.; Pedroso de Souza, Elisabete Abib			Quality of Life in Epilepsy: A Study of Brazilian Adolescents	PLOS ONE			English	Article							VERSION	Objective: Our objectives were: to assess the QOL of Brazilian adolescents with epilepsy with a specific QOL assessment tool; to compare the adolescents with epilepsy and healthy adolescents using a generic QOL assessment tool; to correlate the 2 different QOL assessment tools (the generic and the epilepsy-specific); and to correlate QOL scores of the adolescents with epilepsy obtained by both tools with physical, psychological and social variables of the disease. Methods: Fifty subjects (case group) attending the outpatient clinic of epilepsy of the Clinics Hospital of UNICAMP, Campinas-SP, answered the Brazilian version of the QOL inventory for adolescents with epilepsy - QOLIE-AD-48 and the QOL Questionnaire - WHOQOL - BREF - Portuguese version. Fifty-one subjects (control group) from public schools in Campinas-SP answered only the WHOQOL-BREF. Results: The results showed that adolescents with epilepsy presented a good score of QOL in both tools; overall scores for both groups with WHOQOL-BREF were good, but a statistically significant difference was seen with regards to the Psychological domain of the WHOQOL-BREF favoring the control group. Significant correlations between QOLIE-AD-48 Total and WHOQOL domains were found. Adolescents that were considered seizure-free (P = 0.001), had good perception of seizure control (P = 0.012) and had not had occurrence of seizures in public places (P = 0.001) presented better QOL scores. Conclusions: Brazilian adolescents with epilepsy may present good QOL scores when they themselves consider the disease as under control; physical, social and especially psychological variables associated to the disease may play an important role in these results. As a generic QOL tool, WHOQOL-BREF was sufficient to allow for a comparison between chronic disease bearers and healthy adolescents and showed that the gap in QOL between both populations is not as extensive as once was thought, probably due to better support and adaptation to the disease.	[Siqueira, Nathalia F.; Oliveira, Fernando L. B. B.; Siqueira, Jorge A.; Pedroso de Souza, Elisabete Abib] Univ Estadual Campinas, Dept Neurol, Campinas, SP, Brazil	Universidade Estadual de Campinas	Siqueira, NF (corresponding author), Univ Estadual Campinas, Dept Neurol, Campinas, SP, Brazil.	nfsiqueira@gmail.com	Siqueira, Nathalia F./AGL-3707-2022					BANCAUD J, 1981, EPILEPSIA, V22, P489, DOI 10.1111/j.1528-1157.1981.tb06159.x; Barbosa FD, 2008, EPILEPSY BEHAV, V13, P218, DOI 10.1016/j.yebeh.2008.03.005; Bruck I, 2000, BR J EPILEPSY CLIN N, V6, P193; Cancian F, 2011, THESIS U ESTADUAL CA; de Souza EAP, 2006, EPILEPSY BEHAV, V8, P232, DOI 10.1016/j.yebeh.2005.10.011; de Souza Maia Filho H, 2004, J EPILEPSY CLIN NEUR, V10; Fleck MPA, 2000, REV SAUDE PUBL, V34, P178, DOI 10.1590/S0034-89102000000200012; Funayama SS, 2009, THESIS U SAO PAULO; Gertrudis IJM, 1997, AM J PUBLIC HEALTH, V87, P251; Huang HP, 2011, BIOMED ENVIRON SCI, V24, P228, DOI [10.3967/0895-3988.2011.03.004, 10.3967/0895-3988.2011.03.001]; JACOBY A, 1992, SOC SCI MED, V34, P657, DOI 10.1016/0277-9536(92)90193-T; Liou HH, 2005, EPILEPSY RES, V64, P151, DOI 10.1016/j.eplepsyres.2005.03.006; Martins L M, 1996, Rev Lat Am Enfermagem, V4, P5, DOI 10.1590/S0104-11691996000300002; McEwan MJ, 2004, SEIZURE-EUR J EPILEP, V13, P3, DOI 10.1016/S1059-1311(03)00081-5; Organizacion Mundial de la Salud, 1995, PROGR SAL DES AD INF; Prebianchi HB, 2003, PSICOLOGIA TEORIA PR, V5, P57; Salgado PCB, 2002, ARQ NEURO-PSIQUIAT, V60, P442, DOI 10.1590/S0004-282X2002000300019; Sbarra DA, 2002, EPILEPSY BEHAV, V3, P358, DOI 10.1016/S1525-5050(02)00035-5; Schlindwein-Zanini R, 2007, THESIS U CATOLICA RI; Siqueira NF, 2011, ARQ NEURO-PSIQUIAT, V69, P770, DOI 10.1590/S0004-282X2011000600009; Souza E A, 2001, Arq Neuropsiquiatr, V59, P541; Souza EA, 2002, REV COMCIENCIA, V34, P98; Souza EAP, 2010, EPILEPSIA TRABALHO Q; Souza EAP, 1999, ARQ NEURO-PSIQUIAT, P34; Stevanovic D, 2007, EPILEPSY BEHAV, V10, P571, DOI 10.1016/j.yebeh.2007.02.015; The WHOQOL Group, 1997, WHOQOL MEAS QUAL LIF; Wu DY, 2010, EPILEPSY RES, V90, P16, DOI 10.1016/j.eplepsyres.2010.03.001	27	5	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2014	9	9							e106879	10.1371/journal.pone.0106879	http://dx.doi.org/10.1371/journal.pone.0106879			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AZ1IR	25192176	Green Submitted, Green Published, gold			2022-12-27	WOS:000347993600075
J	Ni, W; Qiao, J; Hu, SW; Zhao, XX; Regouski, M; Yang, M; Polejaeva, IA; Chen, CF				Ni, Wei; Qiao, Jun; Hu, Shengwei; Zhao, Xinxia; Regouski, Misha; Yang, Min; Polejaeva, Irina A.; Chen, Chuangfu			Efficient Gene Knockout in Goats Using CRISPR/Cas9 System	PLOS ONE			English	Article							RNA-GUIDED ENDONUCLEASES; CELL NUCLEAR TRANSFER; ONE-STEP GENERATION; CAENORHABDITIS-ELEGANS; FIBROBLAST CELLS; PRION PROTEIN; GENOME; ZEBRAFISH; MUTATIONS; CATTLE	The CRISPR/Cas9 system has been adapted as an efficient genome editing tool in laboratory animals such as mice, rats, zebrafish and pigs. Here, we report that CRISPR/Cas9 mediated approach can efficiently induce monoallelic and biallelic gene knockout in goat primary fibroblasts. Four genes were disrupted simultaneously in goat fibroblasts by CRISPR/Cas9-mediated genome editing. The single-gene knockout fibroblasts were successfully used for somatic cell nuclear transfer (SCNT) and resulted in live-born goats harboring biallelic mutations. The CRISPR/Cas9 system represents a highly effective and facile platform for targeted editing of large animal genomes, which can be broadly applied to both biomedical and agricultural applications.	[Ni, Wei] Shihezi Univ, Coll Life Sci, Shihezi, Xinjiang, Peoples R China; [Ni, Wei; Hu, Shengwei; Regouski, Misha; Yang, Min; Polejaeva, Irina A.] Utah State Univ, Dept Anim Dairy & Vet Sci, Logan, UT 84322 USA; [Qiao, Jun; Zhao, Xinxia; Chen, Chuangfu] Shihezi Univ, Coll Anim Sci & Technol, Shihezi, Xinjiang, Peoples R China	Shihezi University; Utah System of Higher Education; Utah State University; Shihezi University	Hu, SW (corresponding author), Utah State Univ, Dept Anim Dairy & Vet Sci, Logan, UT 84322 USA.	shengwei.hu@aggiemail.usu.edu; irina.polejaeva@usu.edu; chencf1962@yahoo.com	Yang, Min/AAV-1760-2021; Hu, Shengwei/AGP-1699-2022; Polejaeva, Irina/G-4881-2012	Yang, Min/0000-0002-3880-4843; Polejaeva, Irina/0000-0002-0858-5889	National Basic Research Program of China (973 Program) [2010CB530200]; Bingtuan Twelve Five-Year Special Projects [2012BB051]; National Natural Science Foundation of China [NSFC 31201800, 31260534]; Utah Multidisciplinary Arrhythmia Consortium; Utah Agricultural Experimental Station [1100]	National Basic Research Program of China (973 Program)(National Basic Research Program of China); Bingtuan Twelve Five-Year Special Projects; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Utah Multidisciplinary Arrhythmia Consortium; Utah Agricultural Experimental Station	This work was supported by the National Basic Research Program of China (973 Program 2010CB530200 to CC), the Bingtuan Twelve Five-Year Special Projects (2012BB051 to CC), the National Natural Science Foundation of China (NSFC 31201800 and 31260534 to SH), and Utah Multidisciplinary Arrhythmia Consortium and Utah Agricultural Experimental Station (project1100 to IP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baguisi A, 1999, NAT BIOTECHNOL, V17, P456, DOI 10.1038/8632; Chen CC, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt805; Cho SW, 2014, GENOME RES, V24, P132, DOI 10.1101/gr.162339.113; Cho SW, 2013, NAT BIOTECHNOL, V31, P230, DOI 10.1038/nbt.2507; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Davies B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060216; Delacote F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053217; Deltcheva E, 2011, NATURE, V471, P602, DOI 10.1038/nature09886; Eckstein J, 2011, CARDIOVASC RES, V89, P816, DOI 10.1093/cvr/cvq336; Hai T, 2014, CELL RES, V24, P372, DOI 10.1038/cr.2014.11; Hall J, 2012, REPROD FERT DEVELOP, V25, P162; Hu SW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058521; Huang YJ, 2007, P NATL ACAD SCI USA, V104, P13603, DOI 10.1073/pnas.0702756104; Hwang WY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068708; Jao LE, 2013, P NATL ACAD SCI USA, V110, P13904, DOI 10.1073/pnas.1308335110; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Kling J, 2009, NAT BIOTECHNOL, V27, P302, DOI 10.1038/nbt0409-302; Kuroiwa Y, 2004, NAT GENET, V36, P775, DOI 10.1038/ng1373; Li W, 2013, NAT BIOTECHNOL, V31, P684, DOI 10.1038/nbt.2652; Liu J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065379; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Meng L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077798; Reggio BC, 2001, BIOL REPROD, V65, P1528, DOI 10.1095/biolreprod65.5.1528; Reinwald S, 2008, J BONE MINER RES, V23, P1353, DOI 10.1359/JBMR.080516; Shan QW, 2013, NAT BIOTECHNOL, V31, P686, DOI 10.1038/nbt.2650; Sood R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057239; Sung YH, 2014, GENOME RES, V24, P125, DOI 10.1101/gr.163394.113; Tesson L, 2011, NAT BIOTECHNOL, V29, P695, DOI 10.1038/nbt.1940; Waaijers S, 2013, GENETICS, V195, P1187, DOI 10.1534/genetics.113.156299; Wang HY, 2013, CELL, V153, P910, DOI 10.1016/j.cell.2013.04.025; Wang S, 2009, THERIOGENOLOGY, V72, P535, DOI 10.1016/j.theriogenology.2009.04.009; Watanabe M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076478; Xin JG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084250; Yekta AA, 2013, TRANSGENIC RES, V22, P131, DOI 10.1007/s11248-012-9634-y; Yu GH, 2006, J GEN VIROL, V87, P1019, DOI 10.1099/vir.0.81384-0	35	152	173	12	80	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 4	2014	9	9							e106718	10.1371/journal.pone.0106718	http://dx.doi.org/10.1371/journal.pone.0106718			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3XV	25188313	Green Submitted, gold, Green Published			2022-12-27	WOS:000341271500074
J	Anderson, SG; Dunn, WB; Banerjee, M; Brown, M; Broadhurst, DI; Goodacre, R; Cooper, GJS; Kell, DB; Cruickshank, JK				Anderson, Simon G.; Dunn, Warwick B.; Banerjee, Moulinath; Brown, Marie; Broadhurst, David I.; Goodacre, Royston; Cooper, Garth J. S.; Kell, Douglas B.; Cruickshank, J. Kennedy			Evidence That Multiple Defects in Lipid Regulation Occur before Hyperglycemia during the Prodrome of Type-2 Diabetes	PLOS ONE			English	Article							CONSERVED LYSINE RESIDUES; CORONARY-ARTERY-DISEASE; LOW-DENSITY-LIPOPROTEIN; FATTY-ACID OXIDATION; DIETARY HEME IRON; CARDIOVASCULAR-DISEASE; LIQUID-CHROMATOGRAPHY; INSULIN-RESISTANCE; MASS-SPECTROMETRY; COLLAGENOUS DOMAIN	Background: Blood-vessel dysfunction arises before overt hyperglycemia in type-2 diabetes (T2DM). We hypothesised that a metabolomic approach might identify metabolites/pathways perturbed in this pre-hyperglycemic phase. To test this hypothesis and for specific metabolite hypothesis generation, serum metabolic profiling was performed in young women at increased, intermediate and low risk of subsequent T2DM. Methods: Participants were stratified by glucose tolerance during a previous index pregnancy into three risk-groups: overt gestational diabetes (GDM; n = 18); those with glucose values in the upper quartile but below GDM levels (UQ group; n = 45); and controls (n = 43, below the median glucose values). Follow-up serum samples were collected at a mean 22 months postnatally. Samples were analysed in a random order using Ultra Performance Liquid Chromatography coupled to an electrospray hybrid LTQ-Orbitrap mass spectrometer. Statistical analysis included principal component (PCA) and multivariate methods. Findings: Significant between-group differences were observed at follow-up in waist circumference (86, 95% CI (79-91) vs 80 (76-84) cm for GDM vs controls, p<0.05), adiponectin (about 33% lower in GDM group, p = 0.004), fasting glucose, postprandial glucose and HbA(1c), but the latter 3 all remained within the 'normal' range. Substantial differences in metabolite profiles were apparent between the 2 'at-risk' groups and controls, particularly in concentrations of phospholipids (4 metabolites with p <= 0.01), acylcarnitines (3 with p <= 0.02), short-and long-chain fatty acids (3 with p<=0.03), and diglycerides (4 with p <= 0.05). Interpretation: Defects in adipocyte function from excess energy storage as relatively hypoxic visceral and hepatic fat, and impaired mitochondrial fatty acid oxidation may initiate the observed perturbations in lipid metabolism. Together with evidence from the failure of glucose-directed treatments to improve cardiovascular outcomes, these data and those of others indicate that a new, quite different definition of type-2 diabetes is required. This definition would incorporate disturbed lipid metabolism prior to hyperglycemia.	[Anderson, Simon G.; Banerjee, Moulinath; Cruickshank, J. Kennedy] Univ Manchester, Core Technol Facil, Inst Cardiovasc Sci, Manchester, Lancs, England; [Dunn, Warwick B.; Brown, Marie; Broadhurst, David I.; Goodacre, Royston; Kell, Douglas B.] Univ Manchester, Manchester Inst Biotechnol, Manchester Ctr Integrat Syst Biol, Manchester, Lancs, England; [Dunn, Warwick B.; Cooper, Garth J. S.] Univ Manchester, Manchester Acad Hlth Sci Ctr, CADET, Cent Manchester NHS Fdn Trust, Manchester, Lancs, England; [Dunn, Warwick B.; Cooper, Garth J. S.] Univ Manchester, Manchester Acad Hlth Sci Ctr, Sch Biomed, Manchester, Lancs, England; [Dunn, Warwick B.] Univ Birmingham, Sch Biosci, Birmingham, W Midlands, England; [Broadhurst, David I.] Univ Alberta, Dept Med, Katz Grp Ctr Pharm & Hlth 4126A, Div Gen Internal Med, Edmonton, AB, Canada; [Cooper, Garth J. S.] Univ Auckland, Fac Sci, Maurice Wilkins Ctr Mol Biodiscovery, Auckland 1, New Zealand; [Cooper, Garth J. S.] Univ Oxford, Dept Pharmacol, Oxford OX1 3QT, England; [Cruickshank, J. Kennedy] Kings Coll London, Diabet & Nutr Sci Div, London WC2R 2LS, England	University of Manchester; University of Manchester; University of Manchester; University of Manchester; University of Birmingham; University of Alberta; University of Auckland; University of Oxford; University of London; King's College London	Cruickshank, JK (corresponding author), Univ Manchester, Core Technol Facil, Inst Cardiovasc Sci, Manchester, Lancs, England.	kennedy.cruickshank@kcl.ac.uk	Dunn, Warwick/CAJ-1648-2022; Goodacre, Roy/AAO-3194-2021; Anderson, Simon G/AGM-2359-2022; Cooper, Garth JS/I-3201-2015; Goodacre, Roy/J-1600-2012; Kell, Douglas/E-8318-2011	Dunn, Warwick/0000-0001-6924-0027; Goodacre, Roy/0000-0003-2230-645X; Anderson, Simon G/0000-0002-8896-073X; Cooper, Garth JS/0000-0001-5241-3163; Goodacre, Roy/0000-0003-2230-645X; Banerjee, Moulinath/0000-0003-0456-1967; Kell, Douglas/0000-0001-5838-7963; Broadhurst, David/0000-0003-0775-9581	BBSRC [BB/C008219]; NIHR Manchester Biomedical Research Centre; National Institute for Health Research Academic Clinical Lectureship in Cardiology; BBSRC [BB/G010250/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/G010250/1] Funding Source: researchfish; National Institute for Health Research [ACF-2008-06-003, CL-2012-06-001] Funding Source: researchfish	BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); NIHR Manchester Biomedical Research Centre(National Institute for Health Research (NIHR)); National Institute for Health Research Academic Clinical Lectureship in Cardiology; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); National Institute for Health Research(National Institute for Health Research (NIHR))	WD and RG would like to thank the BBSRC for financial support of The Manchester Centre for Integrative Systems Biology (BB/C008219). This work was supported by the NIHR Manchester Biomedical Research Centre. SA is funded by a National Institute for Health Research Academic Clinical Lectureship in Cardiology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afkhami-Ardekani M, 2009, J DIABETES COMPLICAT, V23, P194, DOI 10.1016/j.jdiacomp.2007.11.006; Aitken JF, 2010, DIABETES, V59, P161, DOI 10.2337/db09-0548; Anderson SG, 2014, ATHEROSCLEROSIS, V236, P62, DOI 10.1016/j.atherosclerosis.2014.06.004; Aregbesola A, 2013, EUR J ENDOCRINOL, V169, P247, DOI 10.1530/EJE-13-0145; Arner P, 2005, CURR MOL MED, V5, P333, DOI 10.2174/1566524053766022; AssimacopoulosJeannet F, 1997, J BIOL CHEM, V272, P1659, DOI 10.1074/jbc.272.3.1659; Banerjee M, 2012, CLIN SCI, V122, P53, DOI 10.1042/CS20110033; Bansal N, 2011, J CLIN ENDOCR METAB, V96, P2567, DOI 10.1210/jc.2011-0046; Bao W, 2012, BMC MED, V10, DOI 10.1186/1741-7015-10-119; Bao YQ, 2009, J PROTEOME RES, V8, P1623, DOI 10.1021/pr800643w; Barallobre-Barreiro J, 2013, REV ESP CARDIOL, V66, P657, DOI [10.1016/j.recesp.2013.04.010, 10.1016/j.rec.2013.04.009]; Bellamy L, 2009, LANCET, V373, P1773, DOI 10.1016/S0140-6736(09)60731-5; BENTLEY R, 1990, CRIT REV BIOCHEM MOL, V25, P307, DOI 10.3109/10409239009090615; Berger K, 2004, PHYSIOL BEHAV, V83, P623, DOI 10.1016/j.physbeh.2004.08.040; Bjorklund A, 1997, DIABETOLOGIA, V40, pB21, DOI 10.1007/s001250051392; Bo S, 2009, AM J OBSTET GYNECOL, V201, DOI 10.1016/j.ajog.2009.04.049; Brown M, 2011, BIOINFORMATICS, V27, P1108, DOI 10.1093/bioinformatics/btr079; Bulbulia R, 2011, LANCET, V378, P2013, DOI 10.1016/S0140-6736(11)61125-2; Colhoun HM, 2004, LANCET, V364, P685, DOI 10.1016/S0140-6736(04)16895-5; Cooper GJS, 2012, CURR MED CHEM, V19, P2828; Cooper GJS, 2005, DIABETES, V54, P1468, DOI 10.2337/diabetes.54.5.1468; Cruickshank K, 2002, CIRCULATION, V106, P2085, DOI 10.1161/01.CIR.0000033824.02722.F7; Dunn WB, 2008, J CHROMATOGR B, V871, P288, DOI 10.1016/j.jchromb.2008.03.021; Dunn WB, 2007, METABOLOMICS, V3, P413, DOI 10.1007/s11306-007-0063-5; Dunn WB, 2011, BIOANALYSIS, V3, P2205, DOI [10.4155/BIO.11.223, 10.4155/bio.11.223]; Dunn WB, 2011, NAT PROTOC, V6, P1060, DOI 10.1038/nprot.2011.335; Dunn WB, 2011, CHEM SOC REV, V40, P387, DOI 10.1039/b906712b; Floegel A, 2013, DIABETES, V62, P639, DOI 10.2337/db12-0495; Gall WE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010883; Gerstein HC, 2008, NEW ENGL J MED, V358, P2545, DOI 10.1056/NEJMoa0802743; Greenstein AS, 2009, CIRCULATION, V119, P1661, DOI 10.1161/CIRCULATIONAHA.108.821181; Griffin JL, 2006, PHARMACOGENOMICS, V7, P1095, DOI 10.2217/14622416.7.7.1095; Griffin JL, 2011, NAT REV CARDIOL, V8, P630, DOI 10.1038/nrcardio.2011.138; Halamkova L, 2012, TALANTA, V100, P7, DOI 10.1016/j.talanta.2012.08.022; Halcox JPJ, 2004, CIRCULATION, V109, P42, DOI 10.1161/01.CIR.0000129500.29229.92; Hedderson MM, 2013, DIABETES CARE; Hemmingsen B, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d6898; Holman RR, 2008, NEW ENGL J MED, V359, P1577, DOI 10.1056/NEJMoa0806470; Holman RR, 2008, NEW ENGL J MED, V359, P1565, DOI 10.1056/NEJMoa0806359; Huang JY, 2011, DIABETES, V60, P80, DOI 10.2337/db10-0593; Ismail-Beigi F, 2010, LANCET, V376, P419, DOI 10.1016/S0140-6736(10)60576-4; Jullig M, 2007, PROTEOM CLIN APPL, V1, P565, DOI 10.1002/prca.200600831; Jullig M, 2007, PROTEOM CLIN APPL, V1, P387, DOI 10.1002/prca.200600770; Kell DB, 2004, BIOESSAYS, V26, P99, DOI 10.1002/bies.10385; Kell DB, 2009, BMC MED GENOMICS, V2, DOI 10.1186/1755-8794-2-2; Kelly A, 2001, MENT RETARD DEV D R, V7, P287, DOI 10.1002/mrdd.1040; Kenny LC, 2010, HYPERTENSION, V56, P741, DOI 10.1161/HYPERTENSIONAHA.110.157297; Kim OY, 2013, EXPERT REV CARDIOVAS, V11, P61, DOI [10.1586/erc.12.121, 10.1586/ERC.12.121]; Koves TR, 2008, CELL METAB, V7, P45, DOI 10.1016/j.cmet.2007.10.013; LENZ ML, 1990, J LIPID RES, V31, P1043; Lewis GD, 2008, J CLIN INVEST, V118, P3503, DOI 10.1172/JCI35111; Li SS, 2009, JAMA-J AM MED ASSOC, V302, P179, DOI 10.1001/jama.2009.976; Li X, 2009, ANAL CHIM ACTA, V633, P257, DOI 10.1016/j.aca.2008.11.058; McGarry JD, 1998, AM J CLIN NUTR, V67, p500S, DOI 10.1093/ajcn/67.3.500S; Meigs JB, 2006, DIABETES, V55, P530, DOI 10.2337/diabetes.55.02.06.db05-1041; Meikle PJ, 2014, PHARMACOL THERAPEUT, V143, P12, DOI 10.1016/j.pharmthera.2014.02.001; Metzger BE, 2008, NEW ENGL J MED, V358, P1991, DOI 10.1056/NEJMoa0707943; Miller M, 2011, CIRCULATION, V123, P2292, DOI 10.1161/CIR.0b013e3182160726; Miyazawa T, 2008, ANN NY ACAD SCI, V1126, P291, DOI 10.1196/annals.1433.033; Mohamed Q, 2007, JAMA-J AM MED ASSOC, V298, P902, DOI 10.1001/jama.298.8.902; Nakashima Y, 2007, ARTERIOSCL THROM VAS, V27, P1159, DOI 10.1161/ATVBAHA.106.134080; Oresic M, 2008, J EXP MED, V205, P2975, DOI 10.1084/jem.20081800; Podrez EA, 2002, J BIOL CHEM, V277, P38517, DOI 10.1074/jbc.M205924200; Preiss D, 2011, JAMA-J AM MED ASSOC, V305, P2556, DOI 10.1001/jama.2011.860; Qiu CF, 2011, DIABETES CARE, V34, P1564, DOI 10.2337/dc11-0135; RANDLE PJ, 1963, LANCET, V1, P785; Ratner RE, 2007, DIABETES CARE, V30, pS242, DOI 10.2337/dc07-s223; Roehrich ME, 2003, J BIOL CHEM, V278, P18368, DOI 10.1074/jbc.M300102200; Sabatine MS, 2005, CIRCULATION, V112, P3868, DOI 10.1161/CIRCULATIONAHA.105.569137; Sattar N, 2010, LANCET, V375, P735, DOI 10.1016/S0140-6736(09)61965-6; Schofield I, 2002, CIRCULATION, V106, P3037, DOI 10.1161/01.CIR.0000041432.80615.A5; Scirica BM, 2013, NEW ENGL J MED, V369, P1317, DOI 10.1056/NEJMoa1307684; Selvin E, 2010, ATHEROSCLEROSIS, V208, P69, DOI 10.1016/j.atherosclerosis.2009.06.025; Stearne MR, 1998, BMJ-BRIT MED J, V317, P703; Sumner LW, 2007, METABOLOMICS, V3, P211, DOI 10.1007/s11306-007-0082-2; Swaminathan S, 2007, DIABETES CARE, V30, P1926, DOI 10.2337/dc06-2625; Turer AT, 2009, CIRCULATION, V119, P1736, DOI 10.1161/CIRCULATIONAHA.108.816116; Undas Anetta, 2002, Clin Lab, V48, P287; Vakkilainen J, 2003, CIRCULATION, V107, P1733, DOI 10.1161/01.CIR.0000057982.50167.6E; Wang TJ, 2011, NAT MED, V17, P448, DOI 10.1038/nm.2307; Wang Y, 2002, J BIOL CHEM, V277, P19521, DOI 10.1074/jbc.M200601200; Wang Y, 2006, J BIOL CHEM, V281, P16391, DOI 10.1074/jbc.M513907200; Wang-Sattler R, 2012, MOL SYST BIOL, V8, DOI 10.1038/msb.2012.43; White DL, 2013, ADV NUTR, V4, P403, DOI 10.3945/an.113.003681; WHO Expert Committee on Physical Status: the Use and Interpretation of Anthropometry (1993: Geneva S Organization WH, 1995, PHYS STAT US INT ANT; Wlazlo N, 2013, DIABETES CARE, V36, P309, DOI 10.2337/dc12-0505; Wong G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076577; Zacharski LR, 2013, AM J PUBLIC HEALTH, V103, pE105, DOI 10.2105/AJPH.2012.301163; Zaharan NL, 2013, BRIT J CLIN PHARMACO, V75, P1118, DOI 10.1111/j.1365-2125.2012.04403.x; Zelena E, 2009, ANAL CHEM, V81, P1357, DOI 10.1021/ac8019366	90	31	31	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 3	2014	9	9							e103217	10.1371/journal.pone.0103217	http://dx.doi.org/10.1371/journal.pone.0103217			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3TB	25184286	Green Published, gold, Green Submitted			2022-12-27	WOS:000341257700006
J	Arrubla, J; Tse, DHY; Amkreutz, C; Neuner, I; Shah, NJ				Arrubla, Jorge; Tse, Desmond H. Y.; Amkreutz, Christin; Neuner, Irene; Shah, N. Jon			GABA Concentration in Posterior Cingulate Cortex Predicts Putamen Response during Resting State fMRI	PLOS ONE			English	Article							DEFAULT-MODE NETWORK; GAMMA-AMINOBUTYRIC-ACID; MAGNETIC-RESONANCE SPECTROSCOPY; INDEPENDENT COMPONENT ANALYSIS; FUNCTIONAL CONNECTIVITY HUBS; HUMAN BRAIN; ALZHEIMERS-DISEASE; MAJOR DEPRESSION; BASAL GANGLIA; BOLD SIGNAL	The role of neurotransmitters in the activity of resting state networks has been gaining attention and has become a field of research with magnetic resonance spectroscopy (MRS) being one of the key techniques. MRS permits the measurement of c-aminobutyric acid (GABA) and glutamate levels, the central biochemical constituents of the excitation-inhibition balance in vivo. The inhibitory effects of GABA in the brain have been largely investigated in relation to the activity of resting state networks in functional magnetic resonance imaging (fMRI). In this study GABA concentration in the posterior cingulate cortex (PCC) was measured using single voxel spectra acquired with standard point resolved spectroscopy (PRESS) from 20 healthy male volunteers at 3 T. Resting state fMRI was consecutively measured and the values of GABA/Creatine+ Phosphocreatine ratio (GABA ratio) were included in a general linear model matrix as a step of dual regression analysis in order to identify voxels whose neuroimaging metrics during rest were related to individual levels of the GABA ratio. Our data show that the connection strength of putamen to the default-mode network during resting state has a negative linear relationship with the GABA ratio measured in the PCC. These findings highlight the role of PCC and GABA in segregation of the motor input, which is an inherent condition that characterises resting state.	[Arrubla, Jorge; Tse, Desmond H. Y.; Amkreutz, Christin; Neuner, Irene; Shah, N. Jon] Forschungszentrum Julich, INM 4, D-52425 Julich, Germany; [Amkreutz, Christin; Neuner, Irene] Rhein Westfal TH Aachen, Dept Psychiat Psychotherapy & Psychosomat, Aachen, Germany; [Neuner, Irene; Shah, N. Jon] Rhein Westfal TH Aachen, JARA BRAIN Translat Med, Aachen, Germany; [Shah, N. Jon] Rhein Westfal TH Aachen, Dept Neurol, Aachen, Germany	Helmholtz Association; Research Center Julich; RWTH Aachen University; RWTH Aachen University; RWTH Aachen University	Shah, NJ (corresponding author), Forschungszentrum Julich, INM 4, D-52425 Julich, Germany.	n.j.shah@fz-juelich.de	Tse, Desmond/D-9586-2017; Shah, N. Jon/H-5849-2013	Tse, Desmond/0000-0003-2559-7707; Shah, N. Jon/0000-0002-8151-6169; Neuner, Irene/0000-0002-5164-8873	Marie Curie Initial Training Network Methods in Neuroimaging [MC-ITN-238593]; Helmholtz Alliance ICEMED - Imaging and Curing Environmental Metabolic Diseases, through Initiative and Network Fund of the Helmholtz Association; EU FP7 project TRIMAGE [602621]	Marie Curie Initial Training Network Methods in Neuroimaging; Helmholtz Alliance ICEMED - Imaging and Curing Environmental Metabolic Diseases, through Initiative and Network Fund of the Helmholtz Association; EU FP7 project TRIMAGE	Jorge Arrubla and Desmond Tse are supported by the Marie Curie Initial Training Network Methods in Neuroimaging (MC-ITN-238593). N. Jon Shah is funded in part by the Helmholtz Alliance ICEMED - Imaging and Curing Environmental Metabolic Diseases, through the Initiative and Network Fund of the Helmholtz Association. Jorge Arrubla, Irene Neuner, and N. Jon Shah are also funded in part through the EU FP7 project TRIMAGE (Grant no. 602621). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beckmann CF, 2004, IEEE T MED IMAGING, V23, P137, DOI 10.1109/TMI.2003.822821; Beckmann CF, 2005, PHILOS T R SOC B, V360, P1001, DOI 10.1098/rstb.2005.1634; BISWAL B, 1995, MAGNET RESON MED, V34, P537, DOI 10.1002/mrm.1910340409; Biswal BB, 1997, NMR BIOMED, V10, P165, DOI 10.1002/(SICI)1099-1492(199706/08)10:4/5<165::AID-NBM454>3.0.CO;2-7; Bluhm RL, 2007, SCHIZOPHRENIA BULL, V33, P1004, DOI 10.1093/schbul/sbm052; Bogner W, 2010, EUR J RADIOL, V73, P526, DOI 10.1016/j.ejrad.2009.01.014; Brooks DJ, 2010, J NUCL MED, V51, P596, DOI 10.2967/jnumed.108.059998; Buckner RL, 2008, ANN NY ACAD SCI, V1124, P1, DOI 10.1196/annals.1440.011; BUERGER AA, 1974, J COMP PHYSIOL PSYCH, V86, P440, DOI 10.1037/h0036142; Cavanna AE, 2006, BRAIN, V129, P564, DOI 10.1093/brain/awl004; Damoiseaux JS, 2008, CEREB CORTEX, V18, P1856, DOI 10.1093/cercor/bhm207; Delaveau P, 2010, EUR NEUROPSYCHOPHARM, V20, P784, DOI 10.1016/j.euroneuro.2010.07.001; DeLong M R, 1984, Hum Neurobiol, V2, P235; Di X, 2014, PEERJ, V2, DOI 10.7717/peerj.367; Donahue MJ, 2010, NEUROIMAGE, V53, P392, DOI 10.1016/j.neuroimage.2010.07.017; Duncan NW, 2014, J NEUROSCI METH, V221, P183, DOI 10.1016/j.jneumeth.2013.10.011; Enzi B, 2012, NEUROSCIENCE, V227, P102, DOI 10.1016/j.neuroscience.2012.09.039; Epperson CN, 2002, ARCH GEN PSYCHIAT, V59, P851, DOI 10.1001/archpsyc.59.9.851; Filippini N, 2009, P NATL ACAD SCI USA, V106, P7209, DOI 10.1073/pnas.0811879106; Fox MD, 2005, P NATL ACAD SCI USA, V102, P9673, DOI 10.1073/pnas.0504136102; Fransson P, 2005, HUM BRAIN MAPP, V26, P15, DOI 10.1002/hbm.20113; Greicius MD, 2004, P NATL ACAD SCI USA, V101, P4637, DOI 10.1073/pnas.0308627101; Greicius MD, 2003, P NATL ACAD SCI USA, V100, P253, DOI 10.1073/pnas.0135058100; Greicius MD, 2009, CEREB CORTEX, V19, P72, DOI 10.1093/cercor/bhn059; Gruetter R, 2000, MAGNET RESON MED, V43, P319, DOI 10.1002/(SICI)1522-2594(200002)43:2<319::AID-MRM22>3.0.CO;2-1; Hagmann P, 2008, PLOS BIOL, V6, P1479, DOI 10.1371/journal.pbio.0060159; Hahn A, 2012, P NATL ACAD SCI USA, V109, P2619, DOI 10.1073/pnas.1117104109; Hasler G, 2007, ARCH GEN PSYCHIAT, V64, P193, DOI 10.1001/archpsyc.64.2.193; Hu S, 2012, HUM BRAIN MAPP, V33, P2785, DOI 10.1002/hbm.21399; Jacob TC, 2008, NAT REV NEUROSCI, V9, P331, DOI 10.1038/nrn2370; Jaffard M, 2008, NEUROIMAGE, V42, P1196, DOI 10.1016/j.neuroimage.2008.05.041; Jenkinson M, 2002, NEUROIMAGE, V17, P825, DOI 10.1006/nimg.2002.1132; Jenkinson M, 2001, MED IMAGE ANAL, V5, P143, DOI 10.1016/S1361-8415(01)00036-6; Kapogiannis D, 2013, NEUROIMAGE, V64, P112, DOI 10.1016/j.neuroimage.2012.09.029; Ke Y, 2000, PSYCHIAT RES-NEUROIM, V100, P169, DOI 10.1016/S0925-4927(00)00075-5; Leech R, 2014, BRAIN, V137, P12, DOI 10.1093/brain/awt162; MAJEWSKA MD, 1986, SCIENCE, V232, P1004, DOI 10.1126/science.2422758; Maudsley AA, 2005, J MAGN RESON, V173, P54, DOI 10.1016/j.jmr.2004.11.018; Mescher M, 1998, NMR BIOMED, V11, P266, DOI 10.1002/(SICI)1099-1492(199810)11:6<266::AID-NBM530>3.0.CO;2-J; Muthukumaraswamy SD, 2009, P NATL ACAD SCI USA, V106, P8356, DOI 10.1073/pnas.0900728106; Napolitano A, 2013, MAGN RESON MED, V69, P1528, DOI 10.1002/mrm.24397; Nichols T, 2003, STAT METHODS MED RES, V12, P419, DOI 10.1191/0962280203sm341ra; Nichols TE, 2002, HUM BRAIN MAPP, V15, P1, DOI 10.1002/hbm.1058; Northoff G, 2007, NAT NEUROSCI, V10, P1515, DOI 10.1038/nn2001; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Packard MG, 2002, ANNU REV NEUROSCI, V25, P563, DOI 10.1146/annurev.neuro.25.112701.142937; Packard MG, 1999, P NATL ACAD SCI USA, V96, P12881, DOI 10.1073/pnas.96.22.12881; Provencher SW, 2001, NMR BIOMED, V14, P260, DOI 10.1002/nbm.698; Puts NAJ, 2012, PROG NUCL MAG RES SP, V60, P29, DOI 10.1016/j.pnmrs.2011.06.001; Quarantelli M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072159; Raichle ME, 2001, P NATL ACAD SCI USA, V98, P676, DOI 10.1073/pnas.98.2.676; Ralchle ME, 2007, NEUROIMAGE, V37, P1083, DOI 10.1016/j.neuroimage.2007.02.041; Robinson S, 2009, BMC NEUROSCI, V10, DOI 10.1186/1471-2202-10-137; Sanacora G, 2004, ARCH GEN PSYCHIAT, V61, P705, DOI 10.1001/archpsyc.61.7.705; SMITH SA, 1994, J MAGN RESON SER A, V106, P75, DOI 10.1006/jmra.1994.1008; Smith SM, 2002, HUM BRAIN MAPP, V17, P143, DOI 10.1002/hbm.10062; Smith SM, 2009, P NATL ACAD SCI USA, V106, P13040, DOI 10.1073/pnas.0905267106; Smith SM, 2009, NEUROIMAGE, V44, P83, DOI 10.1016/j.neuroimage.2008.03.061; Snyder AZ, 2012, NEUROIMAGE, V62, P902, DOI 10.1016/j.neuroimage.2012.01.044; Soher BJ, 1996, MAGNET RESON MED, V35, P356, DOI 10.1002/mrm.1910350313; Sorg C, 2007, P NATL ACAD SCI USA, V104, P18760, DOI 10.1073/pnas.0708803104; Tomasi D, 2011, CEREB CORTEX, V21, P2003, DOI 10.1093/cercor/bhq268; Tomasi D, 2011, NEUROIMAGE, V57, P908, DOI 10.1016/j.neuroimage.2011.05.024; Tomasi D, 2010, P NATL ACAD SCI USA, V107, P9885, DOI 10.1073/pnas.1001414107; Tomasi D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006102; van den Wildenberg WPM, 2010, J COGNITIVE NEUROSCI, V22, P225, DOI 10.1162/jocn.2009.21248; Vogt BA, 2005, PROG BRAIN RES, V150, P205, DOI 10.1016/S0079-6123(05)50015-3; VOGT BA, 1992, CEREB CORTEX, V2, P435, DOI 10.1093/cercor/2.6.435-a; Werner CJ, 2014, HUM BRAIN MAPP, V35, P2582, DOI 10.1002/hbm.22351; Whitfield-Gabrieli S, 2009, P NATL ACAD SCI USA, V106, P1279, DOI 10.1073/pnas.0809141106; Wittchen H-U, 1997, COMMUNICATION; Younes L, 2014, HUM BRAIN MAPP, V35, P792, DOI 10.1002/hbm.22214; Zou QH, 2009, NEUROIMAGE, V48, P515, DOI 10.1016/j.neuroimage.2009.07.006; Zuo XN, 2010, NEUROIMAGE, V49, P2163, DOI 10.1016/j.neuroimage.2009.10.080	74	21	21	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 3	2014	9	9							e106609	10.1371/journal.pone.0106609	http://dx.doi.org/10.1371/journal.pone.0106609			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3TB	25184505	Green Published, gold			2022-12-27	WOS:000341257700092
J	Liu, J; Griesman, J; Nisenbaum, R; Bell, CM				Liu, Jessica; Griesman, Joshua; Nisenbaum, Rosane; Bell, Chaim M.			Quality of Care of Hospitalized Internal Medicine Patients Bedspaced to Non-Internal Medicine Inpatient Units	PLOS ONE			English	Article							HEART-FAILURE; INDICATORS; MANAGEMENT; OUTCOMES; PNEUMONIA; SAFETY; DISEASE; STATES	Background: When the number of patients requiring hospital admission exceeds the number of available department-allotted beds, patients are often placed on a different specialty's inpatient ward, a practice known as "bedspacing''. Whether bedspacing affects quality of patient care has not been previously studied. Methods: We reviewed consecutive general internal medicine (GIM) admissions for congestive heart failure (CHF), chronic obstructive pulmonary disease (COPD), and pneumonia at St. Michael's Hospital in Toronto, Canada, from 2007 to 2011 and examined whether quality of care differs between bedspaced and nonbedspaced patients. We matched each bedspaced patient with a GIM ward patient admitted on the same call shift with the same diagnosis. The primary outcome was the ratio of the actual to the estimated length of stay (ELOS). General and disease specific measures for CHF, COPD, and pneumonia (e. g. fluid restriction) were evaluated, as well as 30-day Emergency Department (ED) and hospital readmissions. Results: Overall, 1639 consecutive admissions were reviewed, and 39 matched pairs for CHF, COPD and pneumonia were studied. Differences in both general and disease specific care measures were not detected between groups. For many disease-specific comparisons, ordering and adherence to quality of care indicators was low in both groups. Conclusions: We were unable to detect differences in quality of care between bedspaced and nonbedspaced patients. As high patient volumes and hospital overcrowding remains, bedspacing will likely continue. More research is required in order to determine if quality of care is compromised by this ongoing practice.	[Liu, Jessica] Univ Hlth Network, Dept Med, Toronto, ON, Canada; [Griesman, Joshua] Royal Coll Surgeons Ireland, Dublin 2, Ireland; [Nisenbaum, Rosane] St Michaels Hosp, Li Ka Shing Knowledge Inst, Toronto, ON M5B 1W8, Canada; [Nisenbaum, Rosane] Univ Toronto, Dalla Lana Sch Publ Hlth, Toronto, ON, Canada; [Bell, Chaim M.] Univ Toronto, Dept Med, Toronto, ON, Canada; [Bell, Chaim M.] Univ Toronto, Inst Hlth Policy Management & Evaluat, Toronto, ON, Canada; [Bell, Chaim M.] Mt Sinai Hosp, Dept Med, Toronto, ON M5G 1X5, Canada	University of Toronto; University Toronto Affiliates; University Health Network Toronto; Royal College of Surgeons - Ireland; University of Toronto; Li Ka Shing Knowledge Institute; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Toronto; University of Toronto; University of Toronto; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute	Bell, CM (corresponding author), Univ Toronto, Dept Med, Toronto, ON, Canada.	cbell@mtsinai.on.ca	Bell, Chaim/C-4611-2015	Bell, Chaim/0000-0002-3778-9469				[Anonymous], 1997, THORAX S5, V52, pS1; Bekmezian A, 2012, PEDIATR EMERG CARE, V28, P236, DOI 10.1097/PEC.0b013e3182494b94; Bell CM, 2001, NEW ENGL J MED, V345, P663, DOI 10.1056/NEJMsa003376; Bond Kenneth, 2007, Healthc Q, V10, P32; Choi PP, 2004, CAN MED ASSOC J, V170, P1409, DOI 10.1503/cmaj.1030713; Dedier J, 2001, ARCH INTERN MED, V161, P2099, DOI 10.1001/archinte.161.17.2099; Fallis BA, 2000, PLOS, V8; Fonarow GC, 2001, ANN INTERN MED, V135, P694, DOI 10.7326/0003-4819-135-8_Part_2-200110161-00008; Fonarow GC, 2007, JAMA-J AM MED ASSOC, V297, P61, DOI 10.1001/jama.297.1.61; Gruneir A, 2011, OPENMEDICINE, V5; Harel Z, 2012, HEMODIAL INT, V16, P286, DOI 10.1111/j.1542-4758.2011.00633.x; Hernandez AF, 2011, CIRCULATION, V124, P712, DOI 10.1161/CIRCULATIONAHA.111.026088; Ko DT, 2005, ARCH INTERN MED, V165, P2486, DOI 10.1001/archinte.165.21.2486; Krumholz HM, 2000, CIRCULATION, V101, pE122, DOI 10.1161/01.CIR.101.12.e122; Lee DS, 2003, CAN J CARDIOL, V19, P357; Liu SW, 2011, ACAD EMERG MED, V18, P1339, DOI 10.1111/j.1553-2712.2011.01082.x; Liu SW, 2011, ACAD EMERG MED, V18, P430, DOI 10.1111/j.1553-2712.2011.01033.x; Maslove DM, 2009, J GEN INTERN MED, V24, P995, DOI 10.1007/s11606-009-1053-2; Meehan TP, 1997, JAMA-J AM MED ASSOC, V278, P2080, DOI 10.1001/jama.278.23.2080; Numminen O, 2013, J CLIN NURS, V22, P1411, DOI 10.1111/j.1365-2702.2012.04334.x; Perry S, 2009, ST HEAL T, V143, P496, DOI 10.3233/978-1-58603-979-0-496; Rhew DC, 2001, ANN INTERN MED, V135, P736, DOI 10.7326/0003-4819-135-8_Part_2-200110161-00013; Salpeter S, 2005, COCHRANE DB SYST REV, V2005; Scott IA, 2003, INTERN MED J, V33, P140, DOI 10.1046/j.1445-5994.2003.00362.x; Sobie J M, 2000, J Emerg Nurs, V26, P549, DOI 10.1067/men.2000.110891; Staggers N, 2013, J ADV NURS, V69, P247, DOI 10.1111/j.1365-2648.2012.06087.x; Stelfox HT, 2003, JAMA-J AM MED ASSOC, V290, P1899, DOI 10.1001/jama.290.14.1899; Trzeciak S, 2003, EMERG MED J, V20, P402, DOI 10.1136/emj.20.5.402; vanWalraven C, 2011, CMAJ, V183, P1067; Viccellio A, 2009, ANN EMERG MED, V54, P487, DOI 10.1016/j.annemergmed.2009.03.005; White BA, 2013, J EMERG MED, V44, P230, DOI 10.1016/j.jemermed.2012.05.007; Wong HJ, 2010, CAN J EMERG MED, V12, P18; Zwar NA, 2012, MED J AUSTRALIA, V197, P394, DOI 10.5694/mja12.10813	34	6	6	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 3	2014	9	9							e106763	10.1371/journal.pone.0106763	http://dx.doi.org/10.1371/journal.pone.0106763			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3TB	25184480	gold, Green Published, Green Submitted			2022-12-27	WOS:000341257700114
J	Miki, Y; Inoue, M; Ikeda, A; Sawada, N; Nakaya, T; Shimazu, T; Iwasaki, M; Yamaji, T; Sasazuki, S; Shibuya, K; Tsugane, S				Miki, Yasuhiro; Inoue, Manami; Ikeda, Ai; Sawada, Norie; Nakaya, Tomoki; Shimazu, Taichi; Iwasaki, Motoki; Yamaji, Taiki; Sasazuki, Shizuka; Shibuya, Kenji; Tsugane, Shoichiro		JPHC Study Grp	Neighborhood Deprivation and Risk of Cancer Incidence, Mortality and Survival: Results from a Population-Based Cohort Study in Japan	PLOS ONE			English	Article							SOCIOECONOMIC-STATUS; WALES; INEQUALITIES; ENGLAND; BREAST	Background: In many developed countries, socioeconomic status is associated with cancer incidence and survival. However, research in Japan is sparse. We examined the association between neighborhood deprivation based on the Japanese Deprivation Index and the risk of incidence, mortality and survival from total and major cancers in the Japan Public Health Center-based Prospective Study. Methods: 86,112 participants were followed through the end of 2009. A total of 10,416 incident cases and 5,510 deaths from cancer were identified among 1,348,437 person-years of follow-up (mean follow-up: 15.7 years). The Japanese deprivation index was used to access neighborhood deprivation. Hazard ratios and 95% confidence intervals were calculated by Cox regression analysis. Results: We found no associations between neighborhood deprivation index and the incidence of total and major cancers. In some cancer risks or deaths, however, we found positive or inverse associations with a higher deprivation index, such as a decreased risk of colorectal cancer incidence and an increased risk of liver cancer incidence and deaths in women. Conclusion: Although some positive or inverse associations were detected for specific sites, the neighborhood deprivation index has no substantial overall association with the risk of incidence, mortality and survival from cancer in the Japanese population.	[Miki, Yasuhiro; Inoue, Manami; Shibuya, Kenji] Univ Tokyo, Grad Sch Med, Tokyo, Japan; [Inoue, Manami; Ikeda, Ai; Sawada, Norie; Shimazu, Taichi; Iwasaki, Motoki; Yamaji, Taiki; Sasazuki, Shizuka; Tsugane, Shoichiro] Natl Canc Ctr, Res Ctr Canc Prevent & Screening, Tokyo 104, Japan; [Nakaya, Tomoki] Ritsumeikan Univ, Dept Geog, Kyoto, Japan	University of Tokyo; National Cancer Center - Japan; Ritsumeikan University	Inoue, M (corresponding author), Univ Tokyo, Grad Sch Med, Tokyo, Japan.	mnminoue@m.u-tokyo.ac.jp	Tsugane, Shoichiro/A-2424-2015; Shimazu, Taichi/A-4470-2015	Tsugane, Shoichiro/0000-0003-4105-2774; Shimazu, Taichi/0000-0001-6000-9830; Shibuya, Kenji/0000-0003-2528-7530; Yamagishi, Kazumasa/0000-0003-3301-5519; Nakaya, Tomoki/0000-0002-3827-1012	National Cancer Centre Research and Development Fund [23-A-31(toku)]	National Cancer Centre Research and Development Fund	The work was supported by National Cancer Centre Research and Development Fund (23-A-31(toku)) http://www.ncc.go.jp. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Coleman MP, 2001, CANCER, V91, P208, DOI 10.1002/1097-0142(20010101)91:1+<208::AID-CNCR6>3.0.CO;2-E; Coleman MP, 2004, BRIT J CANCER, V90, P1367, DOI 10.1038/sj.bjc.6601696; Dalton Susanne Oksbjerg, 2010, Ugeskr Laeger, V172, P691; Dorling D., 2007, POVERTY WEALTH BRITA; Doubeni CA, 2012, CANCER-AM CANCER SOC, V118, P3636, DOI 10.1002/cncr.26677; Gordon D, 1995, J EPIDEMIOL COMMUN H, V49, pS39, DOI 10.1136/jech.49.Suppl_2.S39; Ikegami N, 2011, LANCET, V378, P1106, DOI 10.1016/S0140-6736(11)60828-3; Kuwahara A, 2010, GASTRIC CANCER, V13, P222, DOI 10.1007/s10120-010-0561-4; Major JM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015538; Michikawa T, 2012, PREV MED, V55, P137, DOI 10.1016/j.ypmed.2012.05.017; Ministry of Health Labour and Welfare, 1992, COL CANC SCREEN MAN; Nakaya T., 2011, P I STAT MATH, V59, P239; Nakaya T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097802; Pollock AM, 1997, J PUBLIC HEALTH MED, V19, P288, DOI 10.1093/oxfordjournals.pubmed.a024632; Pornet C, 2012, J EPIDEMIOL COMMUN H, V66, P982, DOI 10.1136/jech-2011-200311; Stata Corporation, 2011, STAT 12; Stuver S O, 1997, IARC Sci Publ, P319; Sundquist J, 2012, BREAST J, V18, P625, DOI 10.1111/tbj.12035; Townsend P, 1988, HLTH DEPRIVATION INQ; Tsugane S, 2001, J Epidemiol, V11, pS24; Ueda K, 2006, CANCER SCI, V97, P283, DOI 10.1111/j.1349-7006.2006.00179.x; Watanabe S, 2001, J Epidemiol, V11, pS3; World Cancer Research Fund and American Institute for Cancer Research, 2007, FOOD NUTR PHYS ACT P; World Health Organization, 2000, INT CLASSIFICATION D; World Health Organization, 1990, INT CLASS DIS HLTH R; Yu XQ, 2008, CANCER CAUSE CONTROL, V19, P1383, DOI 10.1007/s10552-008-9210-1	26	11	11	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 3	2014	9	9							e106729	10.1371/journal.pone.0106729	http://dx.doi.org/10.1371/journal.pone.0106729			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3TB	25184297	Green Submitted, Green Published, gold			2022-12-27	WOS:000341257700112
J	Wang, DD; Bakhotmah, BA; Hu, FB; Alzahrani, HA				Wang, Dong D.; Bakhotmah, Balkees A.; Hu, Frank B.; Alzahrani, Hasan Ali			Prevalence and Correlates of Diabetic Peripheral Neuropathy in a Saudi Arabic Population: A Cross-Sectional Study	PLOS ONE			English	Article							RISK-FACTORS; SENSORY NEUROPATHY; MICROVASCULAR COMPLICATIONS; VASCULAR-DISEASE; NATIONAL-HEALTH; SEVERITY; POLYNEUROPATHY; EPIDEMIOLOGY; INFLAMMATION; PREDICTORS	The purpose of this cross-sectional study was to investigate the prevalence and correlates of diabetic peripheral neuropathy (DPN) in a Saudi population. The study population consisted of 552 diabetic participants with an average age of 53.4 years. Among this population, 62.7% were male and 94.9% had type 2 diabetes. The average body mass index was 31.1 kg/m(2). DPN was diagnosed based on a combination of reduced vibration perception measured by neurothesiometer and/or reduced light touch perception evaluated by the 10-g Semmes-Weinstein monofilament, as well as neurological symptoms. Information on socio-demographic variables, smoking status, duration of diabetes, and medications was obtained through interviews by physicians. Body weight, height, waist circumference, blood pressure and clinical markers were assessed following standard procedures. The prevalence of DPN in this population was 19.9% (95% CI, 16.7%-23.5%). In the multivariable analyses, longer duration of diabetes [odds ratio (OR) for every 5-year increase, 2.49, 95% CI, 1.75-3.53], abdominal obesity (OR, 2.53, 95% CI, 1.41-4.55), and higher levels of fasting blood glucose (OR for every 1 mmol/L increase, 1.05, 95% CI, 0.99-1.12), creatinine (OR for every 10 mmol/L increase, 1.07, 95% CI, 0.99-1.14) and white blood cell count (OR for every 10(6)/L increase, 1.08, 95% CI, 1.01-1.16) were associated with higher odds of DPN, while oral hypoglycemic medication use was associated with a lower odds of DPN (OR, 0.47, 95% CI, 0.26-0.85). In this large Saudi population, several correlates for DPN, in addition to glycemic control and diabetes duration, were identified, including abdominal obesity, creatinine and white blood cell count.	[Wang, Dong D.; Hu, Frank B.] Harvard Univ, Sch Publ Hlth, Dept Nutr, Boston, MA 02115 USA; [Bakhotmah, Balkees A.; Alzahrani, Hasan Ali] King Abdulaziz Univ, Mohammad Hussein Al Amoudi Chair Diabet Foot Res, Art & Design Coll, Jeddah 21413, Saudi Arabia; [Bakhotmah, Balkees A.; Alzahrani, Hasan Ali] King Abdulaziz Univ, Dept Nutr & Food Sci, Art & Design Coll, Jeddah 21413, Saudi Arabia; [Hu, Frank B.] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; [Hu, Frank B.] Brigham & Womens Hosp, Dept Med, Channing Div Network Med, Boston, MA 02115 USA; [Hu, Frank B.] Harvard Univ, Sch Med, Boston, MA USA	Harvard University; Harvard T.H. Chan School of Public Health; King Abdulaziz University; King Abdulaziz University; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School	Hu, FB (corresponding author), Harvard Univ, Sch Publ Hlth, Dept Nutr, Boston, MA 02115 USA.	frank.hu@channing.harvard.edu; haaz59@yahoo.com	Wang, Dong D./AAU-2951-2021	Wang, Dong D./0000-0002-0897-3048	Mohammad Hussein Al-Amoudi Chair for Diabetic Foot Research, Saudi Arabia	Mohammad Hussein Al-Amoudi Chair for Diabetic Foot Research, Saudi Arabia	This study was supported by the Mohammad Hussein Al-Amoudi Chair for Diabetic Foot Research, Saudi Arabia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler AI, 1997, DIABETES CARE, V20, P1162, DOI 10.2337/diacare.20.7.1162; Al-Mahroos F, 2007, ANN SAUDI MED, V27, P25, DOI 10.4103/0256-4947.51536; [Anonymous], 1995, ANN INTERN MED, V122, P561, DOI 10.7326/0003-4819-122-8-199504150-00001; [Anonymous], 2013, DIABETES ATLAS; Boulton AJM, 2005, DIABETES CARE, V28, P956, DOI 10.2337/diacare.28.4.956; Boulton AJM, 2008, DIABETES CARE, V31, P1679, DOI 10.2337/dc08-9021; Bracewell N, 2012, DIABETIC MED, V29, P1553, DOI 10.1111/j.1464-5491.2012.03729.x; Cleeman JI, 2001, JAMA-J AM MED ASSOC, V285, P2486, DOI 10.1001/jama.285.19.2486; Cuddy M, 2005, J PRACT NURS, V55, P22; Davis TME, 2008, DIABETOLOGIA, V51, P562, DOI 10.1007/s00125-007-0919-2; De Block CEM, 2005, DIABETES CARE, V28, P1649, DOI 10.2337/diacare.28.7.1649; Despres JP, 2006, NATURE, V444, P881, DOI 10.1038/nature05488; Dyck PJ, 2006, DIABETES CARE, V29, P2282, DOI 10.2337/dc06-0525; DYCK PJ, 1993, NEUROLOGY, V43, P817, DOI 10.1212/WNL.43.4.817; Dyck PJ, 1999, DIABETES CARE, V22, P1479, DOI 10.2337/diacare.22.9.1479; Elhadd TA, 2007, ANN SAUDI MED, V27, P241; Feng YZ, 2009, J VASC SURG, V50, P675, DOI 10.1016/j.jvs.2009.05.017; Gordois A, 2003, DIABETES CARE, V26, P1790, DOI 10.2337/diacare.26.6.1790; Gregg EW, 2004, DIABETES CARE, V27, P1591, DOI 10.2337/diacare.27.7.1591; Halawa MR, 2010, CURR MED RES OPIN, V26, P337, DOI 10.1185/03007990903471940; Herder C, 2009, DIABETES CARE, V32, P680, DOI 10.2337/dc08-2011; Jambart S, 2011, J INT MED RES, V39, P366, DOI 10.1177/147323001103900204; Kamei N, 2005, J DIABETES COMPLICAT, V19, P47, DOI 10.1016/j.jdiacomp.2003.12.006; Katsilambros NL, 2011, EXP DIABETES RES, DOI 10.1155/2011/607309; Katulanda P, 2012, DIABETOL METAB SYNDR, V4, DOI 10.1186/1758-5996-4-21; Kim ES, 2011, DIABETES CARE, V34, P1403, DOI 10.2337/dc10-2222; Macy EM, 1997, CLIN CHEM, V43, P52; MASER RE, 1989, DIABETES, V38, P1456, DOI 10.2337/diabetes.38.11.1456; Morkrid K, 2010, INT J DIABETES DEV C, V30, P11, DOI 10.4103/0973-3930.60004; Myers GL, 2006, CLIN CHEM, V52, P5, DOI 10.1373/clinchem.2005.0525144; Picon AP, 2012, CLINICS, V67, P151, DOI 10.6061/clinics/2012(02)10; Said G, 2007, NAT CLIN PRACT NEURO, V3, P331, DOI 10.1038/ncpneuro0504; Sone H, 2005, NEW ENGL J MED, V352, P1926; Tapp RJ, 2003, DIABETIC MED, V20, P105, DOI 10.1046/j.1464-5491.2003.00881.x; Tesfaye S, 2012, DIABETES-METAB RES, V28, P8, DOI 10.1002/dmrr.2239; Tesfaye S, 2010, DIABETES CARE, V33, P2285, DOI 10.2337/dc10-1303; Thomas MC, 2003, DIABETES CARE, V26, P1164, DOI 10.2337/diacare.26.4.1164; UBBINK JB, 1991, J CHROMATOGR-BIOMED, V565, P441, DOI 10.1016/0378-4347(91)80407-4; Vincent AM, 2009, J PERIPHER NERV SYST, V14, P257, DOI 10.1111/j.1529-8027.2009.00237.x; Vinik AI, 2013, J DIABETES INVEST, V4, P4, DOI 10.1111/jdi.12042; Weigelt C, 2009, DIABETES CARE, V32, P1491, DOI 10.2337/dc08-2318; WHO, 2000, WHO TECHNICAL REPORT, V894; World Health Organization, 2006, DEF DIAGN DIAB MELL; Ylitalo KR, 2011, DIABETES CARE, V34, P1642, DOI 10.2337/dc10-2150; Ziegler D, 2008, DIABETES CARE, V31, P464, DOI 10.2337/dc07-1796; Ziegler D, 2006, DIABETES CARE, V29, P2365, DOI 10.2337/dc06-1216	46	41	44	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 3	2014	9	9							e106935	10.1371/journal.pone.0106935	http://dx.doi.org/10.1371/journal.pone.0106935			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3TB	25184511	Green Published, Green Submitted, gold			2022-12-27	WOS:000341257700128
J	Zhang, CY; Liu, FF; He, ZH; Deng, QJ; Pan, YQ; Liu, Y; Zhang, CT; Ning, T; Guo, CH; Liang, YM; Xu, RP; Zhang, LX; Cai, H; Ke, Y				Zhang, Chanyuan; Liu, Fangfang; He, Zhonghu; Deng, Qiuju; Pan, Yaqi; Liu, Ying; Zhang, Chaoting; Ning, Tao; Guo, Chuanhai; Liang, Yongmei; Xu, Ruiping; Zhang, Lixin; Cai, Hong; Ke, Yang			Seroprevalence of Merkel Cell Polyomavirus in the General Rural Population of Anyang, China	PLOS ONE			English	Article							GLUTATHIONE-S-TRANSFERASE; CARCINOMA; ANTIBODIES; INFECTION; JC; BK; PROTEINS; SEROLOGY; VIRUS; ELISA	Background: Despite the probably causal link between Merkel cell polyomavirus (MCPyV) infection and Merkel cell carcinoma (MCC), a rare but aggressive skin malignancy, little is known about the seroepidemiology of MCPyV among healthy adults in China. Methods: Serum antibodies against MCPyV were evaluated by multiplex serology in a population-based study of 5548 adults (including 1587 heterosexual couples) aged 25-65 years who were enrolled from rural Anyang, China in 2007-2009. Univariate and multivariate logistic regression analyses were performed to assess the risk factors for the seropositivity of MCPyV. Results: The seroprevalence for MCPyV was 61.0%. MCPyV seropositivity was significantly higher in males than in females (64.5% vs. 57.7%, P < 0.001), and for both genders, showed a trend of increase with age (Male: P-trend < 0.001; Female: P-trend < 0.001). Furthermore, among antibody positives, antibody levels of MCPyV increased with advancing age (P-trend = 0.017). MCPyV seropositivity of one spouse was significantly associated with that of the other partner (Adjusted OR = 1.32, 95% CI: 1.07-1.62). However, there was no association between sexual behaviors and the seropositivity of MCPyV. Conclusions: High seroprevalence of MCPyV was observed in healthy Chinese individuals. Serological evidence suggests that nonsexual horizontal spread of MCPyV can occur among family members, and further research in this regard is needed.	[Zhang, Chanyuan; Liu, Fangfang; He, Zhonghu; Deng, Qiuju; Pan, Yaqi; Liu, Ying; Zhang, Chaoting; Ning, Tao; Guo, Chuanhai; Liang, Yongmei; Cai, Hong; Ke, Yang] Peking Univ, Canc Hosp & Inst, Genet Lab, Key Lab Carcinogenesis & Translat Res,Minist Educ, Beijing 100871, Peoples R China; [Xu, Ruiping; Zhang, Lixin] Anyang Canc Hosp, Anyang, Peoples R China	Peking University	Cai, H (corresponding author), Peking Univ, Canc Hosp & Inst, Genet Lab, Key Lab Carcinogenesis & Translat Res,Minist Educ, Beijing 100871, Peoples R China.	drhcai@gmail.com; keyang@bjmu.edu.com	Zhang, Li/GWM-7501-2022		Natural Science Foundation of China [30872937, 30930102]; "973" Project of National Ministry of Science and Technology Grant [2011CB504300, 2012CB910800]; "863" Key Projects of National Ministry of Science and Technology Grant [2006AA2Z467]; Charity Project of National Ministry of Health [201202014, 200902002]; Natural Science Foundation of Beijing [7100001]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); "973" Project of National Ministry of Science and Technology Grant; "863" Key Projects of National Ministry of Science and Technology Grant; Charity Project of National Ministry of Health; Natural Science Foundation of Beijing(Beijing Natural Science Foundation)	This work was supported by Natural Science Foundation of China [30872937, 30930102]; "973" Project of National Ministry of Science and Technology Grant [2011CB504300, 2012CB910800]; "863" Key Projects of National Ministry of Science and Technology Grant [2006AA2Z467]; Charity Project of National Ministry of Health [201202014, 200902002]; and Natural Science Foundation of Beijing [7100001] to Y.K. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agelli M, 2003, J AM ACAD DERMATOL, V49, P832, DOI 10.1016/S0190-9622(03)02108-X; Antonsson A, 2010, J GEN VIROL, V91, P1849, DOI 10.1099/vir.0.020115-0; Arora R, 2012, CURR OPIN VIROL, V2, P489, DOI 10.1016/j.coviro.2012.05.007; Bouvard V, 2012, LANCET ONCOL, V13, P339, DOI 10.1016/S1470-2045(12)70125-0; Carter JJ, 2009, JNCI-J NATL CANCER I, V101, P1510, DOI 10.1093/jnci/djp332; Chen TT, 2011, J CLIN VIROL, V50, P125, DOI 10.1016/j.jcv.2010.10.015; Faust H, 2014, INT J CANCER, V134, P844, DOI 10.1002/ijc.28419; Feng HC, 2008, SCIENCE, V319, P1096, DOI 10.1126/science.1152586; Foulongne V, 2011, J MED VIROL, V83, P1435, DOI 10.1002/jmv.22110; Foulongne V, 2010, EMERG INFECT DIS, V16, P685, DOI 10.3201/eid1604.091278; He ZH, 2013, EMERG INFECT DIS, V19, P992, DOI 10.3201/eid1906.111597; Kantola K, 2009, J CLIN VIROL, V45, P292, DOI 10.1016/j.jcv.2009.04.008; Kean JM, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000363; Klasse PJ, 2002, J GEN VIROL, V83, P2091, DOI 10.1099/0022-1317-83-9-2091; Lemos B, 2007, J INVEST DERMATOL, V127, P2100, DOI 10.1038/sj.jid.5700925; Li J, 2013, J VIROL, V87, P9173, DOI 10.1128/JVI.01216-13; Liu FF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031602; Nicol JTJ, 2013, CLIN VACCINE IMMUNOL, V20, P363, DOI 10.1128/CVI.00438-12; Pastrana DV, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000578; Robles C, 2013, INT J CANCER, V133, P597, DOI 10.1002/ijc.28053; Rollison DE, 2012, CANCER EPIDEM BIOMAR, V21, P74, DOI 10.1158/1055-9965.EPI-11-0764; Schowalter RM, 2010, CELL HOST MICROBE, V7, P509, DOI 10.1016/j.chom.2010.05.006; Sehr P, 2002, J VIROL METHODS, V106, P61, DOI 10.1016/S0166-0934(02)00134-9; Sehr P, 2001, J IMMUNOL METHODS, V253, P153, DOI 10.1016/S0022-1759(01)00376-3; Shuda M, 2008, P NATL ACAD SCI USA, V105, P16272, DOI 10.1073/pnas.0806526105; Song PI, 2012, INT J DERMATOL, V51, P1054, DOI 10.1111/j.1365-4632.2011.05251.x; Spurgeon ME, 2013, VIROLOGY, V435, P118, DOI 10.1016/j.virol.2012.09.029; Tolstov YL, 2011, EMERG INFECT DIS, V17, P1371, DOI 10.3201/eid1708.110079; Tolstov YL, 2009, INT J CANCER, V125, P1250, DOI 10.1002/ijc.24509; Touze A, 2011, J CLIN ONCOL, V29, P1612, DOI 10.1200/JCO.2010.31.1704; Touze A, 2010, J CLIN MICROBIOL, V48, P1767, DOI 10.1128/JCM.01691-09; van der Meijden E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081078; Viscidi RP, 2011, CLIN VACCINE IMMUNOL, V18, P1737, DOI 10.1128/CVI.05175-11; Waterboer T, 2005, CLIN CHEM, V51, P1845, DOI 10.1373/clinchem.2005.052381; Zeng Q, 2012, VACCINE, V30, P1322, DOI 10.1016/j.vaccine.2011.12.072	35	24	24	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 3	2014	9	9							e106430	10.1371/journal.pone.0106430	http://dx.doi.org/10.1371/journal.pone.0106430			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3TB	25184447	gold, Green Published, Green Submitted			2022-12-27	WOS:000341257700070
J	Huri, HZ; Permalu, V; Vethakkan, SR				Huri, Hasniza Zaman; Permalu, Vishaaliny; Vethakkan, Shireene Ratna			Sliding-Scale versus Basal-Bolus Insulin in the Management of Severe or Acute Hyperglycemia in Type 2 Diabetes Patients: A Retrospective Study	PLOS ONE			English	Article							HOSPITALIZED-PATIENTS; CARE	Sliding-scale and basal-bolus insulin regimens are two options available for the treatment of severe or acute hyperglycemia in type 2 diabetes mellitus patients. Although its use is not recommended, sliding-scale insulin therapy is still being used widely. The aims of the study were to compare the glycemic control achieved by using sliding-scale or basal-bolus regimens for the management of severe or acute hyperglycemia in patients with type 2 diabetes and to analyze factors associated with the types of insulin therapy used in the management of severe or acute hyperglycemia. This retrospective study was conducted using the medical records of patients with acute or severe hyperglycemia admitted to a hospital in Malaysia from January 2008 to December 2012. A total of 202 patients and 247 admissions were included. Patients treated with the basal-bolus insulin regimen attained lower fasting blood glucose (10.8 +/- 2.3 versus 11.6 +/- 3.5 mmol/L; p = 0.028) and mean glucose levels throughout severe/acute hyperglycemia (12.3 +/- 1.9 versus 12.8 +/- 2.2; p = 0.021) compared with sliding-scale insulin regimens. Diabetic ketoacidosis (p = 0.043), cardiovascular diseases (p = 0.005), acute exacerbation of bronchial asthma (p = 0.010), and the use of corticosteroids (p = 0.037) and loop diuretics (p = 0.016) were significantly associated with the type of insulin regimen used. In conclusion, type 2 diabetes patients with severe and acute hyperglycemia achieved better glycemic control with the basal-bolus regimen than with sliding-scale insulin, and factors associated with the insulin regimen used could be identified.	[Huri, Hasniza Zaman; Permalu, Vishaaliny] Univ Malaya, Fac Med, Dept Pharmacol, Kuala Lumpur 50603, Malaysia; [Huri, Hasniza Zaman] Univ Malaya, Med Ctr, Clin Invest Ctr, Kuala Lumpur 50603, Malaysia; [Vethakkan, Shireene Ratna] Univ Malaya, Fac Med, Dept Med, Endocrinol Unit, Kuala Lumpur 50603, Malaysia	Universiti Malaya; Universiti Malaya; Universiti Malaya	Huri, HZ (corresponding author), Univ Malaya, Fac Med, Dept Pharmacol, Kuala Lumpur 50603, Malaysia.	hasnizazh@um.edu.my	HURI, HASNIZA ZAMAN/B-8612-2010; vethakkan, shireene R/P-2214-2016	HURI, HASNIZA ZAMAN/0000-0002-6423-8515; 	Ministry of Science, Technology and Innovation, Malaysia [12-02-03-2097]; University of Malaya, Malaysia [RG428/12HTM, RP024/14HTM, RP024A/14HTM, RP024B/14HTM, RP024C/14HTM]	Ministry of Science, Technology and Innovation, Malaysia(Ministry of Energy, Science, Technology, Environment and Climate Change (MESTECC), Malaysia); University of Malaya, Malaysia(Universiti Malaya)	The authors would like to thank the Ministry of Science, Technology and Innovation, Malaysia (Science fund: 12-02-03-2097) and University of Malaya, Malaysia (RG428/12HTM, RP024/14HTM, RP024A/14HTM, RP024B/14HTM and RP024C/14HTM) for financial and technical support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amer Diabet Assoc, 2013, DIABETES CARE, V36, pS11, DOI 10.2337/dc13-S011; Baldwin D, 2013, CURR DIABETES REP, V13, P114, DOI 10.1007/s11892-012-0339-7; Bonora E, 2001, DIABETOLOGIA, V44, P2107, DOI 10.1007/s001250100020; Dombrowski NC, 2012, METABOLISM; Dungan KM, 2009, LANCET, V373, P1798, DOI 10.1016/S0140-6736(09)60553-5; Huri HZ, 2007, ASIAN BIOMED, V1, P307; Huri HZ, 2013, LAT AM J PHARM, V32, P120; Lutfi MF, 2011, SUDAN J MED SCI, V6, P69; Mafauzy M, 2011, Med J Malaysia, V66, P175; Nau KC, 2010, AM FAM PHYSICIAN, V81, P1130; Shaw JE, 2010, DIABETES RES CLIN PR, V87, P4, DOI 10.1016/j.diabres.2009.10.007; Umpierrez GE, 2012, J CLIN ENDOCR METAB, V97, P16, DOI 10.1210/jc.2011-2098; Umpierrez GE, 2011, DIABETES CARE, V34, P256, DOI 10.2337/dc10-1407; Umpierrez GE, 2007, DIABETES CARE, V30, P2181, DOI 10.2337/dc07-0295; Vasudev M., 2011, CLIN DIABETES, V29, P3, DOI DOI 10.2337/DIACLIN.29.1.3	15	8	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2014	9	9							e106505	10.1371/journal.pone.0106505	http://dx.doi.org/10.1371/journal.pone.0106505			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3LR	25181406	gold, Green Submitted, Green Published			2022-12-27	WOS:000341231500105
J	Sun, Y; Liu, Q; Chen, S; Song, Y; Liu, J; Guo, XJ; Zhu, LW; Ji, X; Xu, LZ; Zhou, W; Qian, J; Feng, SZ				Sun, Yang; Liu, Qi; Chen, Shuo; Song, Yang; Liu, Jun; Guo, Xuejun; Zhu, Lingwei; Ji, Xue; Xu, Lizhi; Zhou, Wei; Qian, Jun; Feng, Shuzhang			Characterization and Plasmid Elimination of NDM-1-Producing Acinetobacter calcoaceticus from China	PLOS ONE			English	Article							BAUMANNII COMPLEX; ESCHERICHIA-COLI; BETA-LACTAMASE; RESISTANCE; IDENTIFICATION; EMERGENCE; CEPHALOSPORINASE; MECHANISM; BACTERIA; NDM-1	The presence of multidrug-resistant bacterial pathogens in the environment poses a serious threat to public health. The opportunistic Acinetobacter spp. are among the most prevalent causes of nosocomial infections. Here, we performed complete genome sequencing of the Acinetobacter calcoaceticus strain XM1570, which was originally cultivated from the sputum of a patient diagnosed with pneumonia in Xiamen in 2010. We identified carbapenem resistance associated gene bla(NDM-1) located on a 47.3-kb plasmid. Three methods - natural reproduction, sodium dodecyl sulfate treatment and nalidixic acid treatment - were used to eliminate the bla(NDM-1)-encoding plasmid, which achieved elimination rates of 3.32% (10/301), 83.78% (278/332), and 84.17% (298/354), respectively. Plasmid elimination dramatically increased antibiotic sensitivity, reducing the minimum bacteriostatic concentration of meropenem from 256 mu g/ml in the clinical strain to 0.125 mu g/ml in the plasmid-eliminated strain. Conjugation transfer assays showed that the bla(NDM-1)- containing plasmid could be transferred into Escherichia coli DH5 alpha: pBR322 in vitro as well as in vivo in mice. The bla(NDM-1) genetic environment was in accordance with that of other bla(NDM-1) genes identified from India, Japan, and Hong-Kong. The multilocus sequence type of the isolate was identified as ST-70. Two novel genes encoding intrinsic OXA and ADC were identified and named as OXA-417 and ADC-72. The finding of bla(NDM-1) in species like A. calcoaceticus demonstrates the wide spread of this gene in gram-negative bacteria which is possible by conjugative plasmid transfer. The results of this study may help in the development of a treatment strategy for controlling NDM-1 bacterial infection and transmission.	[Sun, Yang; Chen, Shuo; Liu, Jun; Guo, Xuejun; Zhu, Lingwei; Ji, Xue; Zhou, Wei; Qian, Jun; Feng, Shuzhang] Acad Mil Med Sci, Inst Mil Vet, Key Lab Jilin Prov Zoonosis Prevent & Control, Changchun, Peoples R China; [Liu, Qi; Song, Yang; Xu, Lizhi] Chinese Acad Sci, Beijing Inst Gen, Beijing, Peoples R China	Academy of Military Medical Sciences - China; Chinese Academy of Sciences; Beijing Institute of Genomics, CAS	Qian, J (corresponding author), Acad Mil Med Sci, Inst Mil Vet, Key Lab Jilin Prov Zoonosis Prevent & Control, Changchun, Peoples R China.	qianj1970@126.com; fengsz@hotmail.com			National Science and Technology Major Project of China [2013ZX10004-217-002]; National 863 Project of China [2012AA022006]	National Science and Technology Major Project of China; National 863 Project of China(National High Technology Research and Development Program of China)	The authors are thankful for research funding from the National Science and Technology Major Project of China (No. 2013ZX10004-217-002) (http://www.nmp.gov.cn/) and National 863 Project of China (No. 2012AA022006) (http://www.863.gov.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams-Haduch JM, 2011, J CLIN MICROBIOL, V49, P3849, DOI 10.1128/JCM.00619-11; Alvarez-Buylla A, 2012, INFECT GENET EVOL, V12, P345, DOI 10.1016/j.meegid.2012.01.002; Bertini A, 2010, ANTIMICROB AGENTS CH, V54, P4168, DOI 10.1128/AAC.00542-10; Carattoli A, 2005, J MICROBIOL METH, V63, P219, DOI 10.1016/j.mimet.2005.03.018; Clinical and Laboratory Standards Institute (CLSI), 2012, M100S22 CLIN LAB S S; Dortet L, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/249856; El-Mansi M, 2000, RES MICROBIOL, V151, P201, DOI 10.1016/S0923-2508(00)00140-6; Ho PL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017989; HOOPER DC, 1984, ANTIMICROB AGENTS CH, V25, P586, DOI 10.1128/AAC.25.5.586; Huang LY, 2010, ANTIMICROB AGENTS CH, V54, P2699, DOI 10.1128/AAC.01624-09; Hujer KM, 2005, ANTIMICROB AGENTS CH, V49, P2941, DOI 10.1128/AAC.49.7.2941-2948.2005; Jacoby GA, 2009, CLIN MICROBIOL REV, V22, P161, DOI 10.1128/CMR.00036-08; Johnson TJ, 2007, APPL ENVIRON MICROB, V73, P1976, DOI 10.1128/AEM.02171-06; Kumarasamy KK, 2010, LANCET INFECT DIS, V10, P597, DOI 10.1016/S1473-3099(10)70143-2; Lopes BS, 2012, J ANTIMICROB CHEMOTH, V67, P59, DOI 10.1093/jac/dkr415; Maltezou HC, 2009, INT J ANTIMICROB AG, V33, DOI 10.1016/j.ijantimicag.2008.09.003; Mishra Shyam Kumar, 2013, BMC Res Notes, V6, P98, DOI 10.1186/1756-0500-6-98; Murray CK, 2005, CURR OPIN INFECT DIS, V18, P502, DOI 10.1097/01.qco.0000185985.64759.41; Rodriguez-Martinez JM, 2010, ANTIMICROB AGENTS CH, V54, P3484, DOI 10.1128/AAC.00050-10; Rolain JM, 2010, CLIN MICROBIOL INFEC, V16, P1699, DOI 10.1111/j.1469-0691.2010.03385.x; Spengler G, 2006, CURR DRUG TARGETS, V7, P823, DOI 10.2174/138945006777709601; Tien N, 2012, ANTIMICROB AGENTS CH, V56, P6267, DOI 10.1128/AAC.01304-12; Walsh TR, 2011, LANCET INFECT DIS, V11, P355, DOI 10.1016/S1473-3099(11)70059-7; Wang Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037152; Yong D, 2009, ANTIMICROB AGENTS CH, V53, P5046, DOI 10.1128/AAC.00774-09; Zhang R, 2014, EUR J CLIN MICROBIOL, V33, P853, DOI 10.1007/s10096-013-2024-4; Zhou WQ, 2013, INDIAN J MED MICROBI, V31, P206, DOI 10.4103/0255-0857.115243	27	10	13	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2014	9	9							e106555	10.1371/journal.pone.0106555	http://dx.doi.org/10.1371/journal.pone.0106555			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3LR	25181293	Green Published, gold, Green Submitted			2022-12-27	WOS:000341231500114
J	Caliskan, M; Pritchard, JK; Ober, C; Gilad, Y				Caliskan, Minal; Pritchard, Jonathan K.; Ober, Carole; Gilad, Yoav			The Effect of Freeze-Thaw Cycles on Gene Expression Levels in Lymphoblastoid Cell Lines	PLOS ONE			English	Article							COPY NUMBER; SENSITIVITY; POPULATION; GENOME; QTLS	Epstein-Barr virus (EBV) transformed lymphoblastoid cell lines (LCLs) are a widely used renewable resource for functional genomic studies in humans. The ability to accumulate multidimensional data pertaining to the same individual cell lines, from complete genomic sequences to detailed gene regulatory profiles, further enhances the utility of LCLs as a model system. However, the extent to which LCLs are a faithful model system is relatively unknown. We have previously shown that gene expression profiles of newly established LCLs maintain a strong individual component. Here, we extend our study to investigate the effect of freeze-thaw cycles on gene expression patterns in mature LCLs, especially in the context of interindividual variation in gene expression. We report a profound difference in the gene expression profiles of newly established and mature LCLs. Once newly established LCLs undergo a freeze-thaw cycle, the individual specific gene expression signatures become much less pronounced as the gene expression levels in LCLs from different individuals converge to a more uniform profile, which reflects a mature transformed B cell phenotype. We found that previously identified eQTLs are enriched among the relatively few genes whose regulations in mature LCLs maintain marked individual signatures. We thus conclude that while insight drawn from gene regulatory studies in mature LCLs may generally not be affected by the artificial nature of the LCL model system, many aspects of primary B cell biology cannot be observed and studied in mature LCL cultures.	[Caliskan, Minal; Ober, Carole; Gilad, Yoav] Univ Chicago, Dept Human Genet, Chicago, IL 60637 USA; [Pritchard, Jonathan K.] Stanford Univ, Dept Genet, Stanford, CA 94305 USA; [Pritchard, Jonathan K.] Stanford Univ, Dept Biol, Stanford, CA 94305 USA; [Pritchard, Jonathan K.] Stanford Univ, Howard Hughes Med Inst, Stanford, CA 94305 USA	University of Chicago; Stanford University; Stanford University; Howard Hughes Medical Institute; Stanford University	Gilad, Y (corresponding author), Univ Chicago, Dept Human Genet, Chicago, IL 60637 USA.	gilad@uchicago.edu		Ober, Carole/0000-0003-4626-9809; Caliskan, Minal/0000-0002-0942-7073	NIH [HG006123, HL085197]; Howard Hughes Medical Institute; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000430] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL085197] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG006123] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI087658] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by NIH grants HG006123 to Y.G. and HL085197 to C.O., as well as by Howard Hughes Medical Institute funded to J.K.P. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akey JM, 2007, NAT GENET, V39, P807, DOI 10.1038/ng0707-807; Bell JT, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-1-r10; Caliskan M, 2011, HUM MOL GENET, V20, P1643, DOI 10.1093/hmg/ddr041; Choy E, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000287; Degner JF, 2012, NATURE, V482, P390, DOI 10.1038/nature10808; Dimas AS, 2009, SCIENCE, V325, P1246, DOI 10.1126/science.1174148; Dolan ME, 2004, CANCER RES, V64, P4353, DOI 10.1158/0008-5472.CAN-04-0340; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Gaffney DJ, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-1-r7; Gruhne B, 2009, ONCOGENE, V28, P3997, DOI 10.1038/onc.2009.258; Grundberg E, 2012, NAT GENET, V44, P1084, DOI 10.1038/ng.2394; Hayashi A, 2009, INT J NEUROPSYCHOPH, V12, P33, DOI 10.1017/S1461145708009358; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Idaghdour Y, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000052; Innocenti F, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002078; Jen KY, 2003, GENOME RES, V13, P2092, DOI 10.1101/gr.1240103; Jeon JP, 2007, CANCER GENET CYTOGEN, V173, P122, DOI 10.1016/j.cancergencyto.2006.10.010; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mangravite LM, 2013, NATURE, V502, P377, DOI 10.1038/nature12508; McVicker G, 2013, SCIENCE, V342, P747, DOI 10.1126/science.1242429; Montgomery SB, 2010, NATURE, V464, P773, DOI 10.1038/nature08903; Myers AJ, 2007, NAT GENET, V39, P1494, DOI 10.1038/ng.2007.16; Nica AC, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002003; Peters EJ, 2011, PHARMACOGENOMICS, V12, P1407, DOI [10.2217/PGS.11.92, 10.2217/pgs.11.92]; Pickrell JK, 2010, NATURE, V464, P768, DOI 10.1038/nature08872; Pique-Regi R, 2011, GENOME RES, V21, P447, DOI 10.1101/gr.112623.110; Redon R, 2006, NATURE, V444, P444, DOI 10.1038/nature05329; Rose S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085436; Sarachana T, 2010, GENOME MED, V2, DOI 10.1186/gm144; Schadt EE, 2008, PLOS BIOL, V6, P1020, DOI 10.1371/journal.pbio.0060107; Stranger BE, 2007, NAT GENET, V39, P1217, DOI 10.1038/ng2142; Veyrieras JB, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000214; Zeller T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010693	33	16	16	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2014	9	9							e107166	10.1371/journal.pone.0107166	http://dx.doi.org/10.1371/journal.pone.0107166			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ1IR	25192014	Green Published, gold, Green Submitted			2022-12-27	WOS:000347993600104
J	Poelmann, RE; Gittenberger-De Groot, AC; Vicente-Steijn, R; Wisse, LJ; Bartelings, MM; Everts, S; Hoppenbrouwers, T; Kruithof, BPT; Jensen, B; de Bruin, PW; Hirasawa, T; Kuratani, S; Vonk, F; van de Put, JMMS; de Bakker, MA; Richardson, MK				Poelmann, Robert E.; Gittenberger-de Groot, Adriana C.; Vicente-Steijn, Rebecca; Wisse, Lambertus J.; Bartelings, Margot M.; Everts, Sonja; Hoppenbrouwers, Tamara; Kruithof, Boudewijn P. T.; Jensen, Bjarke; de Bruin, Paul W.; Hirasawa, Tatsuya; Kuratani, Shigeru; Vonk, Freek; van de Put, Jeanne M. M. S.; de Bakker, Merijn A.; Richardson, Michael K.			Evolution and Development of Ventricular Septation in the Amniote Heart	PLOS ONE			English	Article							EPICARDIUM-DERIVED CELLS; CARDIAC-MALFORMATIONS; REPTILIAN HEART; OUTFLOW TRACT; SMOOTH-MUSCLE; MOUSE HEART; ORIGIN; EMBRYOS; FATE; POPULATION	During cardiogenesis the epicardium, covering the surface of the myocardial tube, has been ascribed several functions essential for normal heart development of vertebrates from lampreys to mammals. We investigated a novel function of the epicardium in ventricular development in species with partial and complete septation. These species include reptiles, birds and mammals. Adult turtles, lizards and snakes have a complex ventricle with three cava, partially separated by the horizontal and vertical septa. The crocodilians, birds and mammals with origins some 100 million years apart, however, have a left and right ventricle that are completely separated, being a clear example of convergent evolution. In specific embryonic stages these species show similarities in development, prompting us to investigate the mechanisms underlying epicardial involvement. The primitive ventricle of early embryos becomes septated by folding and fusion of the anterior ventricular wall, trapping epicardium in its core. This folding septum develops as the horizontal septum in reptiles and the anterior part of the interventricular septum in the other taxa. The mechanism of folding is confirmed using DiI tattoos of the ventricular surface. Trapping of epicardium-derived cells is studied by transplanting embryonic quail pro-epicardial organ into chicken hosts. The effect of decreased epicardium involvement is studied in knock-out mice, and pro-epicardium ablated chicken, resulting in diminished and even absent septum formation. Proper folding followed by diminished ventricular fusion may explain the deep interventricular cleft observed in elephants. The vertical septum, although indistinct in most reptiles except in crocodilians and pythonidsis apparently homologous to the inlet septum. Eventually the various septal components merge to form the completely septated heart. In our attempt to discover homologies between the various septum components we aim to elucidate the evolution and development of this part of the vertebrate heart as well as understand the etiology of septal defects in human congenital heart malformations.	[Poelmann, Robert E.; Vicente-Steijn, Rebecca; Wisse, Lambertus J.; Bartelings, Margot M.; Everts, Sonja] Leiden Univ, Med Ctr, Dept Anat & Embryol, Leiden, Netherlands; [Poelmann, Robert E.; Gittenberger-de Groot, Adriana C.] Leiden Univ, Med Ctr, Dept Cardiol, Leiden, Netherlands; [Kruithof, Boudewijn P. T.] Leiden Univ, Med Ctr, Dept Mol Cell Biol, Leiden, Netherlands; [Jensen, Bjarke] AMC Amsterdam, Dept Anat Embryol & Physiol, Amsterdam, Netherlands; [Jensen, Bjarke] Aarhus Univ, Dept Biosci Zoophysiol, Aarhus, Denmark; [de Bruin, Paul W.] Leiden Univ, Med Ctr, Dept Radiol, Leiden, Netherlands; [Hirasawa, Tatsuya; Kuratani, Shigeru] RIKEN Ctr Dev Biol, Lab Evolutionary Morphol, Kobe, Hyogo, Japan; [Vonk, Freek] Nat Biodivers Ctr, Leiden, Netherlands; [van de Put, Jeanne M. M. S.; de Bakker, Merijn A.; Richardson, Michael K.] Leiden Univ, Sylvius Lab, IBL, Leiden, Netherlands	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; University of Amsterdam; Academic Medical Center Amsterdam; Aarhus University; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; RIKEN; Naturalis Biodiversity Center; Leiden University; Leiden University - Excl LUMC	Poelmann, RE (corresponding author), Leiden Univ, Med Ctr, Dept Anat & Embryol, Leiden, Netherlands.	r.e.poelmann@lumc.nl	Hirasawa, Tatsuya/C-5347-2017; Hoppenbrouwers, Tamara/D-8616-2018; Jensen, Bjarke/I-7490-2019; Kruithof, Boudewijn/C-1718-2014; Jensen, Bjarke/GQI-3989-2022; Kuratani, Shigeru/J-4146-2014	Hirasawa, Tatsuya/0000-0001-6868-3379; Jensen, Bjarke/0000-0002-7750-8035; Kruithof, Boudewijn/0000-0002-9604-4563; Kuratani, Shigeru/0000-0001-9717-7221; de Bakker, Merijn/0000-0002-2061-7986; Hoppenbrouwers, Tamara/0000-0002-1764-9100	Danish Council for Independent Research Natural\Sciences; Netherlands Institute for Regenerative Medicine; BioMedical Materials Institute; AgentschapNL, Smartmix [SSM06010]; Netherlands Heart Foundation [2012T71]	Danish Council for Independent Research Natural\Sciences; Netherlands Institute for Regenerative Medicine; BioMedical Materials Institute; AgentschapNL, Smartmix; Netherlands Heart Foundation(Netherlands Heart Foundation)	B.J. is supported by The Danish Council for Independent Research Natural vertical bar Sciences. B.P.T.K. is supported by the Netherlands Institute for Regenerative Medicine and the BioMedical Materials Institute, M.K.R. is supported by AgentschapNL, Smartmix SSM06010, R.V.-S. receives support from the Netherlands Heart Foundation, 2012T71. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bax NAM, 2010, DEV DYNAM, V239, P2307, DOI 10.1002/dvdy.22363; Bertens LMF, 2010, ANAT REC, V293, P1101, DOI 10.1002/ar.21162; Braitsch CM, 2012, DEV BIOL, V368, P345, DOI 10.1016/j.ydbio.2012.06.002; Darnell DK, 2000, METH MOL B, V135, P305; de Bakker MAG, 2013, NATURE, V500, P445, DOI 10.1038/nature12336; de Boer BA, 2012, DEV BIOL, V368, P203, DOI 10.1016/j.ydbio.2012.05.001; de la Cruz MV, 1998, CARDIOVAS MOL MORPH, P121; Gittenberger-de Groot AC, 2000, CIRC RES, V87, P969, DOI 10.1161/01.RES.87.11.969; Gittenberger-de Groot AC, 1998, CIRC RES, V82, P1043, DOI 10.1161/01.RES.82.10.1043; Gittenberger-de Groot AC, 2012, DIFFERENTIATION, V84, DOI 10.1016/j.diff.2012.05.002; Goodrich ES, 1919, J ANAT, V53, P298; Greulich F, 2011, CARDIOVASC RES, V91, P212, DOI 10.1093/cvr/cvr112; HAMBURGER V, 1951, J MORPHOL, V88, P49, DOI 10.1002/jmor.1050880104; HOLMES EB, 1975, J MORPHOL, V147, P209, DOI 10.1002/jmor.1051470207; Hsu WH, 2013, EXP CELL RES, V319, P1365, DOI 10.1016/j.yexcr.2013.03.027; Huang GN, 2012, SCIENCE, V338, P1599, DOI 10.1126/science.1229765; Jacobs J P, 2000, Ann Thorac Surg, V69, pS18; Jensen B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063651; Jensen B, 2014, BIOL REV, V89, P302, DOI 10.1111/brv.12056; Koshiba-Takeuchi K, 2009, NATURE, V461, P95, DOI 10.1038/nature08324; LAMERS WH, 1992, CIRCULATION, V86, P1194, DOI 10.1161/01.CIR.86.4.1194; Lie-Venema H, 2007, THESCIENTIFICWORLDJO, V7, P1777, DOI 10.1100/tsw.2007.294; Mahtab EAF, 2008, DEV DYNAM, V237, P847, DOI 10.1002/dvdy.21463; Meilhac SM, 2004, DEV CELL, V6, P685, DOI 10.1016/S1534-5807(04)00133-9; Mikawa T, 1996, DEV BIOL, V174, P221, DOI 10.1006/dbio.1996.0068; Moorman AFM, 2001, J HISTOCHEM CYTOCHEM, V49, P1, DOI 10.1177/002215540104900101; POELMANN RE, 1993, CIRC RES, V73, P559, DOI 10.1161/01.RES.73.3.559; Pombal MA, 2008, EVOL DEV, V10, P210, DOI 10.1111/j.1525-142X.2008.00228.x; Rana MS, 2007, CIRC RES, V100, P1000, DOI 10.1161/01.RES.0000262688.14288.b8; Robb JS, 1965, COMP BASIC CARDIOLOG, P212; ROWLATT U, 1990, ZOOL J LINN SOC-LOND, V98, P73, DOI 10.1111/j.1096-3642.1990.tb01220.x; Schlueter J, 2009, P NATL ACAD SCI USA, V106, P7485, DOI 10.1073/pnas.0811944106; Smart N, 2013, VASC PHARMACOL, V58, P164, DOI 10.1016/j.vph.2012.08.001; Van Mierop L H, 1985, Heart Vessels, V1, P114; Van Praagh R, 2011, KARDIOCHIR TORAKOCHI, V8, P1; von Gise A, 2012, CIRC RES, V110, P1628, DOI 10.1161/CIRCRESAHA.111.259960; Wang Z, 2013, NAT GENET, V45, P701, DOI 10.1038/ng.2615; WENINK ACG, 1981, VIRCHOWS ARCH A, V390, P71, DOI 10.1007/BF00443898; Zhou B, 2012, CIRC RES, V111, pE276, DOI 10.1161/CIRCRESAHA.112.275784	39	27	27	1	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2014	9	9							e106569	10.1371/journal.pone.0106569	http://dx.doi.org/10.1371/journal.pone.0106569			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ1IR	25192012	Green Published, Green Submitted, gold			2022-12-27	WOS:000347993600038
J	Salilew-Wondim, D; Ahmad, I; Gebremedhn, S; Sahadevan, S; Hossain, M; Rings, F; Hoelker, M; Tholen, E; Neuhoff, C; Looft, C; Schellander, K; Tesfaye, D				Salilew-Wondim, Dessie; Ahmad, Ijaz; Gebremedhn, Samuel; Sahadevan, Sudeep; Hossain, Munir; Rings, Franca; Hoelker, Michael; Tholen, Ernst; Neuhoff, Christiane; Looft, Christian; Schellander, Karl; Tesfaye, Dawit			The Expression Pattern of microRNAs in Granulosa Cells of Subordinate and Dominant Follicles during the Early Luteal Phase of the Bovine Estrous Cycle	PLOS ONE			English	Article							BETA SUPERFAMILY MEMBERS; SLIT-ROBO PATHWAY; OVARIAN-FOLLICLES; FOLLICULAR DYNAMICS; PROSTATE-CANCER; LACKING COMPLEX; CORPUS-LUTEUM; BREAST-CANCER; GROWTH; GENES	This study aimed to investigate the miRNA expression patterns in granulosa cells of subordinate (SF) and dominant follicle (DF) during the early luteal phase of the bovine estrous cycle. For this, miRNA enriched total RNA isolated from granulosa cells of SF and DF obtained from heifers slaughtered at day 3 and day 7 of the estrous cycle was used for miRNAs deep sequencing. The results revealed that including 17 candidate novel miRNAs, several known miRNAs (n = 291-318) were detected in SF and DF at days 3 and 7 of the estrous cycle of which 244 miRNAs were common to all follicle groups. The let-7 families, bta-miR-10b, bta-miR-26a, bta-miR-99b and bta-miR-27b were among abundantly expressed miRNAs in both SF and DF at both days of the estrous cycle. Further analysis revealed that the expression patterns of 16 miRNAs including bta-miR-449a, bta-miR-449c and bta-miR-222 were differentially expressed between the granulosa cells of SF and DF at day 3 of the estrous cycle. However, at day 7 of the estrous cycle, 108 miRNAs including bta-miR-409a, bta-miR-383 and bta-miR-184 were differentially expressed between the two groups of granulosa cell revealing the presence of distinct miRNA expression profile changes between the two follicular stages at day 7 than day 3 of the estrous cycle. In addition, unlike the SF, marked temporal miRNA expression dynamics was observed in DF groups between day 3 and 7 of the estrous cycle. Target gene prediction and pathway analysis revealed that major signaling associated with follicular development including Wnt signaling, TGF-beta signaling, oocyte meiosis and GnRH signaling were affected by differentially expressed miRNAs. Thus, this study highlights the miRNA expression patterns of granulosa cells in subordinate and dominant follicles that could be associated with follicular recruitment, selection and dominance during the early luteal phase of the bovine estrous cycle.	[Salilew-Wondim, Dessie; Ahmad, Ijaz; Gebremedhn, Samuel; Sahadevan, Sudeep; Rings, Franca; Hoelker, Michael; Tholen, Ernst; Neuhoff, Christiane; Looft, Christian; Schellander, Karl; Tesfaye, Dawit] Univ Bonn, Inst Anim Sci, Anim Breeding & Husb Grp, Bonn, Germany; [Hossain, Munir] Bangladesh Agr Univ, Dept Anim Breeding & Genet, Mymensingh, Bangladesh	University of Bonn; Bangladesh Agricultural University (BAU)	Tesfaye, D (corresponding author), Univ Bonn, Inst Anim Sci, Anim Breeding & Husb Grp, Bonn, Germany.	tesfaye@itw.uni-bonn.de	Gebremedhn, Samuel/AAQ-3139-2020; Hossain, Munir/C-6692-2008	Wondim, Dr. Dessie Salilew/0000-0002-8756-0865; Gebremedhn, Samuel/0000-0002-9977-2347; Hossain, Dr Md Munir/0000-0002-8595-7578	German Research Foundation (DFG) [TE 589/5-1]	German Research Foundation (DFG)(German Research Foundation (DFG))	This work was funded by German Research Foundation (DFG) (Grant number TE 589/5-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Palma GA, 2012, SCI WORLD J, DOI 10.1100/2012/938138; Aerts JMJ, 2010, REPROD DOMEST ANIM, V45, P171, DOI 10.1111/j.1439-0531.2008.01302.x; Ahmad N, 1997, ANIM REPROD SCI, V49, P13, DOI 10.1016/S0378-4320(97)00057-2; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Bao B, 1998, J ANIM SCI, V76, P1903; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bisso A, 2013, CELL CYCLE, V12, P1679, DOI 10.4161/cc.24757; BUCCIONE R, 1990, BIOL REPROD, V43, P543, DOI 10.1095/biolreprod43.4.543; Caraux G, 2005, BIOINFORMATICS, V21, P1280, DOI 10.1093/bioinformatics/bti141; Chen CZ, 2004, SCIENCE, V303, P83, DOI 10.1126/science.1091903; Clement F, 1997, CELL PROLIFERAT, V30, P255, DOI 10.1046/j.1365-2184.1997.00090.x; Craig ZR, 2011, REPRODUCTION, V142, P633, DOI 10.1530/REP-11-0136; Dickinson RE, 2008, ENDOCRINOLOGY, V149, P5024, DOI 10.1210/en.2008-0204; Dickinson RE, 2010, REPRODUCTION, V139, P697, DOI 10.1530/REP-10-0017; Donadeu FX, 2012, J ENDOCRINOL, V215, P323, DOI 10.1530/JOE-12-0252; Evans ACO, 2004, BIOL REPROD, V70, P1475, DOI 10.1095/biolreprod.103.025114; Evans ACO, 1997, ENDOCRINOLOGY, V138, P2963, DOI 10.1210/en.138.7.2963; Fiedler SD, 2008, BIOL REPROD, V79, P1030, DOI 10.1095/biolreprod.108.069690; Fornari F, 2010, CANCER RES, V70, P5184, DOI 10.1158/0008-5472.CAN-10-0145; Friedlander MR, 2012, NUCLEIC ACIDS RES, V40, P37, DOI 10.1093/nar/gkr688; Gad A, 2011, HUM REPROD, V26, P1693, DOI 10.1093/humrep/der110; Galardi S, 2007, J BIOL CHEM, V282, P23716, DOI 10.1074/jbc.M701805200; Ghanem N, 2011, REPRODUCTION, V142, P551, DOI 10.1530/REP-10-0476; Grasa P, 2012, REPRODUCTION, V144, P455, DOI 10.1530/REP-12-0084; Han X., 2014, CANCER GENE THER, V21, P60, DOI [DOI 10.1038/CGT.2013.82, 10.1038/cgt.2013.82]; Hatzirodos N, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-40; Hatzirodos N, 2014, BMC GENOMICS, V15, DOI [10.1186/1471-2164-15-24, 10.1186/1471-2164-15-40]; Hayashi KG, 2010, REPROD BIOL ENDOCRIN, V8, DOI 10.1186/1477-7827-8-11; Hoelker M, 2012, REPROD FERT DEVELOP, V24, P778, DOI 10.1071/RD11171; Hofacker IL, 2003, NUCLEIC ACIDS RES, V31, P3429, DOI 10.1093/nar/gkg599; Hossain MM, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-443; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huminiecki L, 2002, GENOMICS, V79, P547, DOI 10.1006/geno.2002.6745; IRELAND JJ, 1980, J DAIRY SCI, V63, P155, DOI 10.3168/jds.S0022-0302(80)82901-8; Johnson CD, 2007, CANCER RES, V67, P7713, DOI 10.1158/0008-5472.CAN-07-1083; Kheir TB, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-29; Knight PG, 2003, ANIM REPROD SCI, V78, P165, DOI 10.1016/S0378-4320(03)00089-7; Knight PG, 2006, REPRODUCTION, V132, P191, DOI 10.1530/rep.1.01074; Li QJ, 2007, CELL, V129, P147, DOI 10.1016/j.cell.2007.03.008; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mihm M, 2002, REPROD DOMEST ANIM, V37, P191, DOI 10.1046/j.1439-0531.2002.00371.x; Noonan EJ, 2009, ONCOGENE, V28, P1714, DOI 10.1038/onc.2009.19; Noonan EJ, 2010, ONCOTARGET, V1, P349, DOI 10.18632/oncotarget.167; Ouyang YB, 2012, MITOCHONDRION, V12, P213, DOI 10.1016/j.mito.2011.09.001; Qian K, 2009, ENDOCRINOLOGY, V150, P4734, DOI 10.1210/en.2008-1629; Saito Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047396; Salilew-Wondim D, 2013, PHYSIOL GENOMICS, V45, P28, DOI 10.1152/physiolgenomics.00076.2012; Salilew-Wondim D, 2010, PHYSIOL GENOMICS, V42, P201, DOI 10.1152/physiolgenomics.00047.2010; Shi SL, 2004, MOL CELL BIOL, V24, P9920, DOI 10.1128/MCB.24.22.9920-9929.2004; Sirotkin AV, 2009, J CELL PHYSIOL, V219, P415, DOI 10.1002/jcp.21689; Sisco B, 2003, ENDOCRINOLOGY, V144, P3904, DOI 10.1210/en.2003-0485; Spicer LJ, 2011, ANIM REPROD SCI, V124, P19, DOI 10.1016/j.anireprosci.2011.01.005; Su SF, 2013, ONCOGENE, V32, P4694, DOI 10.1038/onc.2012.483; TAYLOR C, 1991, J DAIRY SCI, V74, P115, DOI 10.3168/jds.S0022-0302(91)78151-4; Taylor MA, 2013, J CLIN INVEST, V123, P150, DOI 10.1172/JCI64946; Thomas FH, 2006, REPROD BIOL ENDOCRIN, V4, DOI 10.1186/1477-7827-4-19; Toloubeydokhti T, 2008, SEMIN REPROD MED, V26, P469, DOI 10.1055/s-0028-1096127; Tripurani SK, 2010, ANIM REPROD SCI, V120, P16, DOI 10.1016/j.anireprosci.2010.03.001; Tu F, 2014, GENET MOL RES, V13, P2504, DOI 10.4238/2014.January.14.6; Turcatel G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031032; Vitt UA, 2000, BIOL REPROD, V62, P370, DOI 10.1095/biolreprod62.2.370; Wang JX, 2012, STEM CELLS, V30, P1405, DOI 10.1002/stem.1121; Williams SA, 2009, REPRODUCTION, V137, P321, DOI 10.1530/REP-07-0469; Wong K, 2001, CELL, V107, P209, DOI 10.1016/S0092-8674(01)00530-X; Wong QWL, 2010, CLIN CANCER RES, V16, P867, DOI 10.1158/1078-0432.CCR-09-1840; Xu SY, 2011, ENDOCRINOLOGY, V152, P3941, DOI 10.1210/en.2011-1147; Yada H, 1999, BIOL REPROD, V61, P1480, DOI 10.1095/biolreprod61.6.1480; Yang L, 2014, FEBS LETT, V588, P124, DOI 10.1016/j.febslet.2013.11.019; Zhang CZ, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-229; Zhang Q, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0054250, 10.1371/journal.pone.0059667]; Zhang Y, 2012, NUCLEIC ACIDS RES, V40, P9286, DOI 10.1093/nar/gks667	71	64	74	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2014	9	9							e106795	10.1371/journal.pone.0106795	http://dx.doi.org/10.1371/journal.pone.0106795			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ1IR	25192015	Green Published, Green Submitted, gold			2022-12-27	WOS:000347993600062
J	Chen, CY; Su, CM; Huang, YL; Tsai, CH; Fuh, LJ; Tang, CH				Chen, Cheng-Yu; Su, Chen-Ming; Huang, Yuan-Li; Tsai, Chun-Hao; Fuh, Lih-Jyh; Tang, Chih-Hsin			CCN1 Induces Oncostatin M Production in Osteoblasts via Integrin-Dependent Signal Pathways	PLOS ONE			English	Article							MONOCYTE CHEMOATTRACTANT PROTEIN-1; FIBROBLAST-LIKE SYNOVIOCYTES; NF-KAPPA-B; RHEUMATOID-ARTHRITIS; MATRICELLULAR PROTEIN; SYNOVIAL-FLUID; CELL MOTILITY; IN-VITRO; CYR61; EXPRESSION	Inflammatory response and articular destruction are common symptoms of osteoarthritis. Cysteine-rich 61 (CCN1 or Cyr61), a secreted protein from the CCN family, is associated with the extracellular matrix involved in many cellular activities like growth and differentiation. Yet the mechanism of CCN1 interacting with arthritic inflammatory response is unclear. This study finds CCN1 increasing expression of oncostatin m (OSM) in human osteoblastic cells. Pretreatment of alpha v beta 3 monoclonal antibody and inhibitors of focal adhesion kinase (FAK), c-Src, phosphatidylinositol 3-kinase (PI3K), and NF-kappa B inhibited CCN1-induced OSM expression in osteoblastic cells. Stimulation of cells with CCN1 increased phosphorylation of FAK, c-Src, PI3K, and NF-kappa B via alpha v beta 3 receptor; CCN1 treatment of osteoblasts increased NF-kappa B-luciferase activity and p65 binding to NF-kappa B element on OSM promoter. Results indicate CCN1 heightening OSM expression via alpha v beta 3 receptor, FAK, c-Src, PI3K, and NF-kappa B signal pathway in osteoblastic cells, suggesting CCN1 as a novel target in arthritis treatment.	[Chen, Cheng-Yu; Su, Chen-Ming; Tang, Chih-Hsin] China Med Univ, Grad Inst Basic Med Sci, Taichung, Taiwan; [Huang, Yuan-Li; Tang, Chih-Hsin] Asia Univ, Dept Biotechnol, Coll Hlth Sci, Taichung, Taiwan; [Tsai, Chun-Hao] China Med Univ, Dept Med, Taichung, Taiwan; [Tsai, Chun-Hao] China Med Univ, Grad Inst Clin Med Sci, Taichung, Taiwan; [Tsai, Chun-Hao] China Med Univ Hosp, Dept Orthoped Surg, Taichung, Taiwan; [Fuh, Lih-Jyh] China Med Univ Hosp, Dept Prosthodont, Taichung, Taiwan; [Tang, Chih-Hsin] China Med Univ, Sch Med, Dept Pharmacol, Taichung, Taiwan	China Medical University Taiwan; Asia University Taiwan; China Medical University Taiwan; China Medical University Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan	Tang, CH (corresponding author), China Med Univ Hosp, Dept Prosthodont, Taichung, Taiwan.	ljfuh@mail.cmu.edu.tw; chtang@mail.cmu.edu.tw	Tang, Chih Hsin/O-5212-2015; Fuh, Lih-Jyh/D-1484-2012; Tsai, Chun-Hao/H-3140-2013	Tang, Chih Hsin/0000-0002-7113-8352; Fuh, Lih-Jyh/0000-0003-3008-8165; Tsai, Chun-Hao/0000-0002-4428-3132	National Science Council of Taiwan [100-2320-B-039-028-MY3, 102-2632-B-039-001-MY3, 101-2314-B-039-002-MY3]; China Medical University Hospital [DMR-103-059]	National Science Council of Taiwan(Ministry of Science and Technology, Taiwan); China Medical University Hospital	This work was supported by grants from the National Science Council of Taiwan (100-2320-B-039-028-MY3, 102-2632-B-039-001-MY3, and 101-2314-B-039-002-MY3) and China Medical University Hospital (DMR-103-059). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTMAN R, 1986, ARTHRITIS RHEUM, V29, P1039, DOI 10.1002/art.1780290816; Bai T, 2010, J IMMUNOL, V184, P3223, DOI 10.4049/jimmunol.0902792; Baldwin AS, 1996, ANNU REV IMMUNOL, V14, P649, DOI 10.1146/annurev.immunol.14.1.649; Bamber B, 1998, J MOL MED-JMM, V76, P61, DOI 10.1007/s109-1998-8105-3; Barksby HE, 2006, ARTHRITIS RHEUM-US, V54, P540, DOI 10.1002/art.21574; Bouchard V, 2007, J CELL PHYSIOL, V212, P717, DOI 10.1002/jcp.21096; Bresnihan B, 1999, J RHEUMATOL, V26, P717; Cartmell S, 2012, CELL HLTH CYTOSKELET, V49; Chen CC, 2007, EMBO J, V26, P1257, DOI 10.1038/sj.emboj.7601596; Choi Y, 2009, NAT REV RHEUMATOL, V5, P543, DOI 10.1038/nrrheum.2009.175; Chuang JY, 2012, J CELL BIOCHEM, V113, P1977, DOI 10.1002/jcb.24066; Crockett JC, 2007, ENDOCRINOLOGY, V148, P5761, DOI 10.1210/en.2007-0473; Demyanets S, 2011, BASIC RES CARDIOL, V106, P217, DOI 10.1007/s00395-010-0141-0; Espinoza I, 2013, J CELL COMMUN SIGNAL; Fang MR, 2013, NEUROPHARMACOLOGY, V70, P83, DOI 10.1016/j.neuropharm.2013.01.010; Fearon U, 2006, ARTHRITIS RHEUM-US, V54, P3152, DOI 10.1002/art.22161; Felson DT, 2000, ANN INTERN MED, V133, P635, DOI 10.7326/0003-4819-133-8-200010170-00016; Fromigue O, 2011, J BONE MINER RES, V26, P1533, DOI 10.1002/jbmr.343; Grossman JM, 1997, J WOMENS HEALTH, V6, P627, DOI 10.1089/jwh.1997.6.627; Haque I, 2012, J BIOL CHEM, V287, P38569, DOI 10.1074/jbc.M112.389064; HOUSSIAU FA, 1988, ARTHRITIS RHEUM, V31, P784, DOI 10.1002/art.1780310614; Huang CY, 2012, ARTHRITIS RHEUM-US, V64, P3344, DOI 10.1002/art.34557; Hui W, 1997, ANN RHEUM DIS, V56, P184, DOI 10.1136/ard.56.3.184; Jay PR, 1996, ENDOCRINOLOGY, V137, P1151, DOI 10.1210/en.137.4.1151; Karmakar S, 2010, RHEUM DIS CLIN N AM, V36, P385, DOI 10.1016/j.rdc.2010.03.003; Kastl SP, 2008, ARTERIOSCL THROM VAS, V28, P498, DOI 10.1161/ATVBAHA.107.160580; Kok SH, 2011, ARTHRITIS RHEUM-US, V63, P1010, DOI 10.1002/art.27433; Kotake S, 1996, J BONE MINER RES, V11, P88; Langdon C, 1997, ARTHRITIS RHEUM-US, V40, P2139, DOI 10.1002/art.1780401207; Langdon C, 2000, AM J PATHOL, V157, P1187, DOI 10.1016/S0002-9440(10)64634-2; Lau LF, 2011, CELL MOL LIFE SCI, V68, P3149, DOI 10.1007/s00018-011-0778-3; Leask A, 2011, J CELL COMMUN SIGNAL, V5, P123, DOI 10.1007/s12079-011-0127-1; Lin JP, 2012, J IMMUNOL, V188, P5776, DOI 10.4049/jimmunol.1103201; Lisignoli G, 1999, J RHEUMATOL, V26, P791; Lisignoli G, 2000, CLIN EXP IMMUNOL, V119, P346; Manicourt DH, 2000, ARTHRITIS RHEUM, V43, P281, DOI 10.1002/1529-0131(200002)43:2<281::AID-ANR7>3.0.CO;2-7; Miao F, 2004, J BIOL CHEM, V279, P18091, DOI 10.1074/jbc.M311786200; Mitra SK, 2006, CURR OPIN CELL BIOL, V18, P516, DOI 10.1016/j.ceb.2006.08.011; Mladenovic Z, 2014, J RHEUMATOL; Mo FE, 2002, MOL CELL BIOL, V22, P8709, DOI 10.1128/MCB.22.24.8709-8720.2002; Okutani D, 2006, AM J PHYSIOL-LUNG C, V291, pL129, DOI 10.1152/ajplung.00261.2005; Pala D, 2008, J BIOL CHEM, V283, P9239, DOI 10.1074/jbc.M705175200; Reber L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004393; Richards Carl D, 2013, ISRN Inflamm, V2013, P512103, DOI 10.1155/2013/512103; Schlaepfer DD, 1998, TRENDS CELL BIOL, V8, P151, DOI 10.1016/S0962-8924(97)01172-0; SOLDI R, 1994, ONCOGENE, V9, P2253; Su JL, 2010, J BIOL CHEM, V285, P31325, DOI 10.1074/jbc.M109.087122; Sweeney SE, 2004, CURR OPIN RHEUMATOL, V16, P231, DOI 10.1097/00002281-200405000-00011; Todorovic V, 2005, J CELL BIOL, V171, P559, DOI 10.1083/jcb.200504015; Walsh NC, 2005, IMMUNOL REV, V208, P228, DOI 10.1111/j.0105-2896.2005.00338.x; Wu L, 2008, ONCOGENE, V27, P1439, DOI 10.1038/sj.onc.1210770; Wu PH, 2012, RHEUMATOLOGY, V51, P1953, DOI 10.1093/rheumatology/kes174; Wu XY, 2005, DEV CELL, V9, P185, DOI 10.1016/j.devcel.2005.06.006; Xiong WC, 2003, FRONT BIOSCI-LANDMRK, V8, pD1219, DOI 10.2741/1117; Yi DK, 2003, CHEM COMMUN, P982, DOI 10.1039/b300638g; You JJ, 2014, CELL SIGNAL, V26, P133, DOI 10.1016/j.cellsig.2013.08.026; Zhang QY, 2009, ARTHRITIS RHEUM-US, V60, P3602, DOI 10.1002/art.24999	57	6	6	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 4	2014	9	9							e106632	10.1371/journal.pone.0106632	http://dx.doi.org/10.1371/journal.pone.0106632			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3XV	25187949	Green Submitted, Green Published, gold			2022-12-27	WOS:000341271500064
J	Chen, Q; Liu, XF; Zheng, PS				Chen, Qing; Liu, Xiao-Fang; Zheng, Peng-Sheng			Grape Seed Proanthocyanidins (GSPs) Inhibit the Growth of Cervical Cancer by Inducing Apoptosis Mediated by the Mitochondrial Pathway	PLOS ONE			English	Article							IN-VIVO GROWTH; ANTICANCER PROPERTIES; DIETARY POLYPHENOLS; COLORECTAL-CANCER; CARCINOMA-CELLS; BAX; BCL-2; EXTRACT; P53; MODULATION	Grape seed proanthocyanidins (GSPs), a biologically active component of grape seeds, have been reported to possess a wide array of pharmacological and biochemical properties. Recently, the inhibitory effects of GSPs on various cancers have been reported, but their effects on cervical cancer remain unclear. Here, we explored the effect of GSPs on cervical cancer using in vitro and in vivo models. In vitro, the treatment of HeLa and SiHa cells with GSPs resulted in a significant inhibition of cell viability. Further investigation indicated that GSPs led to the dose-dependent induction of apoptosis in cancer cells. The underlying mechanism was associated with increased expression of the pro-apoptotic protein Bak-1, decreased expression of the anti-apoptotic protein Bcl-2, the loss of mitochondrial membrane potential, and the activation of caspase-3, suggesting that GSPs induced cervical cancer cell apoptosis through the mitochondrial pathway. In addition, the administration of GSPs (0.1%, 0.2%, and 0.4%, w/v) as a supplement in drinking water significantly inhibited the tumor growth of HeLa and SiHa cells in athymic nude mice, and the number of apoptotic cells in those tumors was also increased significantly. Taken together, our studies demonstrated that GSPs could inhibit the growth of cervical cancer by inducing apoptosis through the mitochondrial pathway, which provides evidence indicating that GSPs may be a potential chemopreventive and/or chemotherapeutic agent for cervical cancer.	[Chen, Qing; Liu, Xiao-Fang; Zheng, Peng-Sheng] Xi An Jiao Tong Univ, Affiliated Hosp 1, Dept Reprod Med, Xian 710049, Peoples R China; [Chen, Qing; Zheng, Peng-Sheng] Xi An Jiao Tong Univ, Coll Med, Dept Biochem & Mol Biol, Xian 710049, Peoples R China; [Liu, Xiao-Fang] Xi An Jiao Tong Univ, Coll Med, Dept Pharmacol, Xian 710049, Peoples R China; [Zheng, Peng-Sheng] Minist Educ Peoples Republ China, Key Lab Environm & Genes Related Dis, Sect Canc Res, Xian, Peoples R China	Xi'an Jiaotong University; Xi'an Jiaotong University; Xi'an Jiaotong University; Ministry of Education, China	Zheng, PS (corresponding author), Xi An Jiao Tong Univ, Affiliated Hosp 1, Dept Reprod Med, Xian 710049, Peoples R China.	zpsheng@mail.xjtu.edu.cn			National Natural Science Fund for Distinguished Young Scientists [30725043]; National Natural Science Foundation of China [31201118, 81270715]	National Natural Science Fund for Distinguished Young Scientists(National Natural Science Foundation of China (NSFC)); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	The work was supported by a grant from the National Natural Science Fund for Distinguished Young Scientists (No. 30725043), a general grant (No. 81270715) and a youth grant (No. 31201118) from the National Natural Science Foundation of China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akhtar S, 2009, CLIN CANCER RES, V15, P821, DOI 10.1158/1078-0432.CCR-08-1901; Bagchi DB, 2003, MUTAT RES-FUND MOL M, V523, P87, DOI 10.1016/S0027-5107(02)00324-X; Chipuk JE, 2004, SCIENCE, V303, P1010, DOI 10.1126/science.1092734; Dinicola S, 2012, INT J MOL SCI, V13, P651, DOI 10.3390/ijms13010651; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Fresco P, 2010, CURR PHARM DESIGN, V16, P114, DOI 10.2174/138161210789941856; Gross A, 1999, GENE DEV, V13, P1899, DOI 10.1101/gad.13.15.1899; HOCKENBERY D, 1990, NATURE, V348, P334, DOI 10.1038/348334a0; Isitor GN, 2012, W INDIAN VET J, V9, P27; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Kaur M, 2008, NUTR CANCER, V60, P2, DOI 10.1080/01635580802381295; Kaur M, 2006, CLIN CANCER RES, V12, P6194, DOI 10.1158/1078-0432.CCR-06-1465; Kitamura Y, 1998, BRAIN RES, V780, P260, DOI 10.1016/S0006-8993(97)01202-X; Kluck RM, 1997, SCIENCE, V275, P1132, DOI 10.1126/science.275.5303.1132; Lamoral-Theys D, 2010, CURR MED CHEM, V17, P812, DOI 10.2174/092986710790712183; Mantena SK, 2006, CARCINOGENESIS, V27, P1682, DOI 10.1093/carcin/bgl030; Mathew A, 2009, ASIAN PAC J CANCER P, V10, P645; Mittal A, 2003, CARCINOGENESIS, V24, P1379, DOI 10.1093/carcin/bgg095; Nandakumar V, 2008, CANCER LETT, V269, P378, DOI 10.1016/j.canlet.2008.03.049; OLTVAI ZN, 1993, CELL, V74, P609, DOI 10.1016/0092-8674(93)90509-O; Pandey KB, 2009, CURR NUTR FOOD SCI, V5, P249, DOI 10.2174/157340109790218058; Prasad R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046404; Prasad R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043064; Riboli E, 2003, AM J CLIN NUTR, V78, p559S, DOI 10.1093/ajcn/78.3.559S; Rossi M, 2010, CANCER CAUSE CONTROL, V21, P243, DOI 10.1007/s10552-009-9455-3; Roy AM, 2005, NEOPLASIA, V7, P24, DOI 10.1593/neo.04412; Roy AM, 2005, MOL CANCER THER, V4, P81; Saavedra K, 2012, CLIN EPIGENETICS, V4, DOI 10.1186/1868-7083-4-13; Sharma SD, 2010, MOL CANCER THER, V9, P569, DOI 10.1158/1535-7163.MCT-09-0638; Singh T, 2011, PLOS ONE, V6; Tan J, 2005, CANCER RES, V65, P9012, DOI 10.1158/0008-5472.CAN-05-1226; Vayalil PK, 2004, CARCINOGENESIS, V25, P987, DOI 10.1093/carcin/bgh095; Wolf BB, 1999, J BIOL CHEM, V274, P20049, DOI 10.1074/jbc.274.29.20049; Ye X, 1999, MOL CELL BIOCHEM, V196, P99, DOI 10.1023/A:1006926414683; Zhang Y, 2010, CANCER-AM CANCER SOC, V116, P5207, DOI 10.1002/cncr.25449	35	29	31	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 4	2014	9	9							e107045	10.1371/journal.pone.0107045	http://dx.doi.org/10.1371/journal.pone.0107045			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3XV	25187959	Green Published, Green Submitted, gold			2022-12-27	WOS:000341271500113
J	Huang, ZT; Jiang, PK; Chang, SX; Zhang, Y; Ying, Q				Huang, Zhang-Ting; Jiang, Pei-Kun; Chang, Scott Xiaochuan; Zhang, Yan; Ying, Qi			Production of Carbon Occluded in Phytolith Is Season-Dependent in a Bamboo Forest in Subtropical China	PLOS ONE			English	Article							SOIL ORGANIC-MATTER; BIOGEOCHEMICAL SEQUESTRATION; SILICON; PLANTS	Carbon (C) occluded in phytolith (PhytOC) is a stable form of C; when PhytOC is returned to the soil through litterfall it is stored in the soil which can be an effective way for long-term C sequestration. However, few estimates on the rate of PhytOC input to the soil are available. To better understand the seasonal dynamics of PhytOC production and the annual rate of stable C sequestration through PhytOC input, we quantified the monthly litterfall, phytolith and PhytOC return to the soil over a year in a typical Lei bamboo (Phyllostachys praecox) forest in subtropical China. The monthly litterfall ranged between 14.81 and 131.18 g m(-2), and the phytolith concentration in the monthly litterfall samples ranged between 47.21 and 101.68 g kg(-1) of litter mass, with the PhytOC concentration in the phytolith ranged between 29.4 and 44.9 g kg(-1) of phytolith, equivalent to 1.8-3.6 g kg(-1) of PhytOC in the litterfall (based on litterfall dry mass). The amount of phytolith input to the soil system was 292.21 +/- 69.12 (mean +/- SD) kg ha(-1) yr(-1), sequestering 41.45 +/- 9.32 kg CO2-e ha(-1) yr(-1) of C in the studied Lei bamboo forest. This rate of C sequestration through the formation of PhytOC found in this study falls within the range of rates for other grass-type species reported in the literature. We conclude that return of C occluded in phytolith to the soil can be a substantial source of stable soil C and finding means to increase PhytOC storage in the soil should be able to play a significant role in mitigating the rapidly increasing atmospheric CO2 concentration.	[Huang, Zhang-Ting; Jiang, Pei-Kun; Zhang, Yan; Ying, Qi] Zhejiang A&F Univ, Sch Environm & Resources, Linan, Zhejiang, Peoples R China; [Jiang, Pei-Kun] Zhejiang A&F Univ, Zhejiang Prov Key Lab Carbon Cycling Forest Ecosy, Linan, Zhejiang, Peoples R China; [Chang, Scott Xiaochuan] Univ Alberta, Dept Renewable Resources, Edmonton, AB, Canada	Zhejiang A&F University; Zhejiang A&F University; University of Alberta	Jiang, PK (corresponding author), Zhejiang A&F Univ, Sch Environm & Resources, Linan, Zhejiang, Peoples R China.	jiangpeikun@zafu.edu.cn; scott.chang@ualberta.ca	Chang, Scott X/G-2029-2011	Chang, Scott/0000-0002-7624-439X	Natural Science Foundation of China [31270667]; Zhejiang Province [LZ12C16003]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Zhejiang Province	The authors wish to acknowledge the funding from the Natural Science Foundation of China (No. 31270667), and the key Fund of Science and Technology of Zhejiang Province (No. LZ12C16003). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Avinash Jain, 2010, Journal of Tropical Forestry, V26, P18; DJ He, 2002, ACTA BOT BOREALIOCCI, V23, P291; Hodson MJ, 2005, ANN BOT-LONDON, V96, P1027, DOI 10.1093/aob/mci255; Hodson MJ, 1998, ANN BOT-LONDON, V82, P375, DOI 10.1006/anbo.1998.0694; Huang ZT, 2014, SCI REP-UK, V4, DOI 10.1038/srep03602; Jansson C, 2010, BIOSCIENCE, V60, P685, DOI 10.1525/bio.2010.60.9.6; JONES L. H. P., 1965, Plant and Soil, V23, P79, DOI 10.1007/BF01349120; Kleinhenz V, 2001, ADV AGRON, V74, P99, DOI 10.1016/S0065-2113(01)74032-1; Lal R, 2009, EUR J SOIL SCI, V60, P158, DOI 10.1111/j.1365-2389.2008.01114.x; Li YF, 2013, FOREST ECOL MANAG, V303, P121, DOI 10.1016/j.foreco.2013.04.021; Li ZM, 2013, PLANT SOIL, V370, P615, DOI 10.1007/s11104-013-1661-9; Li ZM, 2013, CHINESE SCI BULL, V58, P2480, DOI 10.1007/s11434-013-5785-3; Ma JF, 2008, CELL MOL LIFE SCI, V65, P3049, DOI 10.1007/s00018-008-7580-x; Ma JianFeng, 2002, Soil, fertilizer and plant silicon research in Japan, DOI 10.1016/B978-044451166-9/50007-5; Nisbet EG, 2014, SCIENCE, V343, P493, DOI 10.1126/science.1247828; Parr J., 2009, Sugar Tech, V11, P17, DOI 10.1007/s12355-009-0003-y; Parr J, 2010, GLOBAL CHANGE BIOL, V16, P2661, DOI 10.1111/j.1365-2486.2009.02118.x; Parr JF, 2011, PLANT SOIL, V342, P165, DOI 10.1007/s11104-010-0680-z; Parr JF, 2005, SOIL BIOL BIOCHEM, V37, P117, DOI 10.1016/j.soilbio.2004.06.013; Parr JF, 2001, REV PALAEOBOT PALYNO, V116, P203, DOI 10.1016/S0034-6667(01)00089-6; PIPERNO DR, 1993, J ARCHAEOL SCI, V20, P337, DOI 10.1006/jasc.1993.1021; Post WM, 2000, GLOB CHANGE BIOL, V6, P317; Santos GM, 2010, RADIOCARBON, V52, P113, DOI 10.1017/S0033822200045070; Skjemstad JO, 1996, AUST J SOIL RES, V34, P251, DOI 10.1071/SR9960251; Sollins P, 2007, BIOGEOCHEMISTRY, V85, P1, DOI 10.1007/s10533-007-9099-x; Song ZL, 2013, GLOBAL CHANGE BIOL, V19, P2907, DOI 10.1111/gcb.12275; Song ZL, 2012, GLOBAL CHANGE BIOL, V18, P3647, DOI 10.1111/gcb.12017; Walkley A, 1934, SOIL SCI, V37, P29, DOI 10.1097/00010694-193401000-00003; Wang YJ, 1993, PHYTOLITH STUDY APPL; Wang YJ, 1992, CHINESE SCI BULL, V37, P342; WILDING LP, 1967, SOIL SCI, V103, P56, DOI 10.1097/00010694-196701000-00009; WILDING LP, 1967, SCIENCE, V156, P66, DOI 10.1126/science.156.3771.66; WILDING LP, 1974, CLAY CLAY MINER, V22, P295, DOI 10.1346/CCMN.1974.0220311; WRB, 2006, FRAM INT CLASS CORR; Zuo XX, 2014, PLANT SOIL, V374, P223, DOI 10.1007/s11104-013-1850-6; Zuo XX, 2011, CHINESE SCI BULL, V56, P3451, DOI 10.1007/s11434-011-4674-x	36	5	7	3	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 4	2014	9	9							e106843	10.1371/journal.pone.0106843	http://dx.doi.org/10.1371/journal.pone.0106843			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3XV	25188462	Green Published, Green Submitted, gold			2022-12-27	WOS:000341271500091
J	Kern, S; Agarwal, S; Huber, K; Gehring, AP; Strodke, B; Wirth, CC; Brugl, T; Abodo, LO; Dandekar, T; Doerig, C; Fischer, R; Tobin, AB; Alam, MM; Bracher, F; Pradel, G				Kern, Selina; Agarwal, Shruti; Huber, Kilian; Gehring, Andre P.; Stroedke, Benjamin; Wirth, Christine C.; Bruegl, Thomas; Abodo, Liliane Onambele; Dandekar, Thomas; Doerig, Christian; Fischer, Rainer; Tobin, Andrew B.; Alam, Mahmood M.; Bracher, Franz; Pradel, Gabriele			Inhibition of the SR Protein-Phosphorylating CLK Kinases of Plasmodium falciparum Impairs Blood Stage Replication and Malaria Transmission	PLOS ONE			English	Article							LACTATE-DEHYDROGENASE; XANTHURENIC ACID; SPLICING FACTORS; PARASITE; EXPRESSION; IDENTIFICATION; TRANSCRIPTOME; REGULATORS; DATABASE; REVEALS	Cyclin-dependent kinase-like kinases (CLKs) are dual specificity protein kinases that phosphorylate Serine/Arginine-rich (SR) proteins involved in pre-mRNA processing. Four CLKs, termed PfCLK-1-4, can be identified in the human malaria parasite Plasmodium falciparum, which show homology with the yeast SR protein kinase Sky1p. The four PfCLKs are present in the nucleus and cytoplasm of the asexual blood stages and of gametocytes, sexual precursor cells crucial for malaria parasite transmission from humans to mosquitoes. We identified three plasmodial SR proteins, PfSRSF12, PfSFRS4 and PfSF-1, which are predominantly present in the nucleus of blood stage trophozoites, PfSRSF12 and PfSF-1 are further detectable in the nucleus of gametocytes. We found that recombinantly expressed SR proteins comprising the Arginine/Serine (RS)-rich domains were phosphorylated by the four PfCLKs in in vitro kinase assays, while a recombinant PfSF-1 peptide lacking the RS-rich domain was not phosphorylated. Since it was hitherto not possible to knock-out the pfclk genes by conventional gene disruption, we aimed at chemical knock-outs for phenotype analysis. We identified five human CLK inhibitors, belonging to the oxo-beta-carbolines and aminopyrimidines, as well as the antiseptic chlorhexidine as PfCLK-targeting compounds. The six inhibitors block P. falciparum blood stage replication in the low micromolar to nanomolar range by preventing the trophozoite-to-schizont transformation. In addition, the inhibitors impair gametocyte maturation and gametogenesis in in vitro assays. The combined data show that the four PfCLKs are involved in phosphorylation of SR proteins with essential functions for the blood and sexual stages of the malaria parasite, thus pointing to the kinases as promising targets for antimalarial and transmission blocking drugs.	[Kern, Selina; Agarwal, Shruti; Bruegl, Thomas] Univ Wurzburg, Res Ctr Infect Dis, D-97070 Wurzburg, Germany; [Kern, Selina; Wirth, Christine C.; Abodo, Liliane Onambele; Fischer, Rainer; Pradel, Gabriele] Rhein Westfal TH Aachen, Inst Mol Biotechnol, Aachen, Germany; [Huber, Kilian; Gehring, Andre P.; Stroedke, Benjamin; Bracher, Franz] Univ Munich, Ctr Drug Res, Dept Pharm, Munich, Germany; [Dandekar, Thomas] Univ Wurzburg, Bioctr, D-97070 Wurzburg, Germany; [Doerig, Christian] Ecole Polytech Fed Lausanne, Global Hlth Inst, INSERM, U609, CH-1015 Lausanne, Switzerland; [Doerig, Christian] Monash Univ, Dept Microbiol, Clayton, Vic 3168, Australia; [Tobin, Andrew B.; Alam, Mahmood M.] Univ Leicester, MRC Toxicol Unit, Dept Cell Physiol & Pharmacol, Leicester, Leics, England	University of Wurzburg; RWTH Aachen University; University of Munich; University of Wurzburg; Institut National de la Sante et de la Recherche Medicale (Inserm); Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Monash University; University of Leicester	Pradel, G (corresponding author), Rhein Westfal TH Aachen, Inst Mol Biotechnol, Aachen, Germany.	gabriele.pradel@molbiotech.rwth-aachen.de	Huber, Kilian V. M./L-6921-2015; Alam, Mahmood/GQQ-9664-2022; Doerig, Christian/Q-9900-2019; Dandekar, Thomas/A-4431-2017	Huber, Kilian V. M./0000-0002-1103-5300; Dandekar, Thomas/0000-0003-1886-7625; Alam, Mahmood M/0000-0003-2148-4887; Doerig, Christian/0000-0002-3188-094X	Emmy Noether programme [PR905/1-2]; Deutsche Forschungsgemeinschaft [SFB630/C6]; MRC-Toxicology Unit programme leader grant; University of Wurzburg; BioMedTec International Graduate School of Science "Lead structures of cell function'' of the Elite Network Bavaria, Germany; EU 7th framework programme (MALSIG); EU 7th framework programme (ANTIMAL); EU 7th framework programme (EVIMALAR); Inserm; Medical Research Council [MC_UP_A600_1110] Funding Source: researchfish; MRC [MC_UP_A600_1110] Funding Source: UKRI	Emmy Noether programme(German Research Foundation (DFG)); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); MRC-Toxicology Unit programme leader grant(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); University of Wurzburg; BioMedTec International Graduate School of Science "Lead structures of cell function'' of the Elite Network Bavaria, Germany; EU 7th framework programme (MALSIG); EU 7th framework programme (ANTIMAL); EU 7th framework programme (EVIMALAR); Inserm(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The project was funded by the EU 7th framework programme (MALSIG (GP, CD), ANTIMAL (CD) and EVIMALAR (CD)) and by the Emmy Noether programme PR905/1-2(GP) and the SFB630/C6 (TD) of the Deutsche Forschungsgemeinschaft. The project was additionally supported by Inserm (CD) and the MRC-Toxicology Unit programme leader grant (ABT and MMA). SK received a fellowship from the program for female scientists of the University of Wurzburg. SA was supported by the BioMedTec International Graduate School of Science "Lead structures of cell function'' of the Elite Network Bavaria, Germany. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal S, 2011, J CELL BIOCHEM, V112, P1295, DOI 10.1002/jcb.23034; ALANO P, 1995, EXP PARASITOL, V81, P227, DOI 10.1006/expr.1995.1112; Aminake MN, 2011, ANTIMICROB AGENTS CH, V55, P1338, DOI 10.1128/AAC.01096-10; Aminake MN, 2012, INT J PARASITOL-DRUG, V2, P1, DOI 10.1016/j.ijpddr.2011.12.001; Anamika, 2005, PROTEINS, V58, P180, DOI 10.1002/prot.20278; Aubol BE, 2003, P NATL ACAD SCI USA, V100, P12601, DOI 10.1073/pnas.1635129100; Aurrecoechea C, 2009, NUCLEIC ACIDS RES, V37, pD539, DOI 10.1093/nar/gkn814; Barthel D, 2008, ANTIMICROB AGENTS CH, V52, P774, DOI 10.1128/AAC.00892-07; Billker O, 1998, NATURE, V392, P289, DOI 10.1038/32667; Bourgeois CF, 2004, PROG NUCLEIC ACID RE, V78, P37, DOI 10.1016/S0079-6603(04)78002-2; Bracchi-Ricard V, 2000, BIOCHEM J, V347, P255, DOI 10.1042/0264-6021:3470255; BRACHER F, 1993, LIEBIGS ANN CHEM, P837; Colwill K, 1996, EMBO J, V15, P265, DOI 10.1002/j.1460-2075.1996.tb00357.x; Cranmer SL, 1997, T ROY SOC TROP MED H, V91, P363, DOI 10.1016/S0035-9203(97)90110-3; Deitsch K, 2007, AM J TROP MED HYG, V77, P201; Dixit A, 2010, J BIOL CHEM, V285, P38315, DOI 10.1074/jbc.M110.119255; Eshar S, 2012, NUCLEIC ACIDS RES, V40, P9903, DOI 10.1093/nar/gks735; Fedorov O, 2011, CHEM BIOL, V18, P67, DOI 10.1016/j.chembiol.2010.11.009; Fraunholz MJ, 2003, REDOX REP, V8, P317, DOI 10.1179/135100003225002961; Garcia GE, 1998, J BIOL CHEM, V273, P12003, DOI 10.1074/jbc.273.20.12003; GEARY TG, 1983, AM J TROP MED HYG, V32, P221, DOI 10.4269/ajtmh.1983.32.221; Gehring AP, 2012, SYNTHESIS-STUTTGART, V44, P2441, DOI 10.1055/s-0032-1316560; GUI JF, 1994, NATURE, V369, P678, DOI 10.1038/369678a0; Higgins DG, 1996, METHOD ENZYMOL, V266, P383; Huber K, 2012, J MED CHEM, V55, P403, DOI 10.1021/jm201286z; Ifediba T, 1981, NATURE, V294, P364, DOI 10.1038/294364a0; Lai MC, 2000, J BIOL CHEM, V275, P7950, DOI 10.1074/jbc.275.11.7950; LAMBROS C, 1979, J PARASITOL, V65, P418, DOI 10.2307/3280287; Lasonder E, 2012, J PROTEOME RES, V11, P5323, DOI 10.1021/pr300557m; Letunic I, 2012, NUCLEIC ACIDS RES, V40, pD302, DOI 10.1093/nar/gkr931; Li JL, 2001, INT J PARASITOL, V31, P387, DOI 10.1016/S0020-7519(01)00126-6; MAKLER MT, 1993, AM J TROP MED HYG, V48, P205, DOI 10.4269/ajtmh.1993.48.205; MAKLER MT, 1993, AM J TROP MED HYG, V48, P739, DOI 10.4269/ajtmh.1993.48.739; Misteli T, 1998, J CELL BIOL, V143, P297, DOI 10.1083/jcb.143.2.297; Ngwa CJ, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-256; Nolen B, 2001, NAT STRUCT BIOL, V8, P176, DOI 10.1038/84178; Otto TD, 2010, MOL MICROBIOL, V76, P12, DOI 10.1111/j.1365-2958.2009.07026.x; Pease BN, 2013, J PROTEOME RES, V12, P4028, DOI 10.1021/pr400394g; PONNUDURAI T, 1981, TROP GEOGR MED, V33, P50; Purcell LA, 2010, INT J PARASITOL, V40, P979, DOI 10.1016/j.ijpara.2010.02.010; Puzik A, 2009, J HETEROCYCLIC CHEM, V46, P770, DOI 10.1002/jhet.126; Sayers EW, 2010, NUCLEIC ACIDS RES, V38, pD5, DOI 10.1093/nar/gkp967; Scholz SM, 2008, INT J PARASITOL, V38, P327, DOI 10.1016/j.ijpara.2007.08.009; Schultz J, 1998, P NATL ACAD SCI USA, V95, P5857, DOI 10.1073/pnas.95.11.5857; Siebel CW, 1999, P NATL ACAD SCI USA, V96, P5440, DOI 10.1073/pnas.96.10.5440; Solyakov L, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1558; Sorber K, 2011, NUCLEIC ACIDS RES, V39, P3820, DOI 10.1093/nar/gkq1223; Stamm S, 2008, J BIOL CHEM, V283, P1223, DOI 10.1074/jbc.R700034200; Templeton TJ, 1997, MOL BIOCHEM PARASIT, V90, P359, DOI 10.1016/S0166-6851(97)00164-3; Tewari R, 2010, CELL HOST MICROBE, V8, P377, DOI 10.1016/j.chom.2010.09.006; TRAGER W, 1976, SCIENCE, V193, P673, DOI 10.1126/science.781840; Treeck M, 2011, CELL HOST MICROBE, V10, P410, DOI 10.1016/j.chom.2011.09.004; Wahl MC, 2009, CELL, V136, P701, DOI 10.1016/j.cell.2009.02.009; WALLIKER D, 1987, SCIENCE, V236, P1661, DOI 10.1126/science.3299700; Ward P, 2004, BMC GENOMICS, V5, DOI 10.1186/1471-2164-5-79; WHO, 2013, WORLD MALARIA REPORT 2013, P1; Williamson KC, 1995, MOL BIOCHEM PARASIT, V75, P33, DOI 10.1016/0166-6851(95)02507-3; Wong R, 2011, RETROVIROLOGY, V8, DOI 10.1186/1742-4690-8-47; Younis I, 2010, MOL CELL BIOL, V30, P1718, DOI 10.1128/MCB.01301-09	59	34	34	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 4	2014	9	9							e105732	10.1371/journal.pone.0105732	http://dx.doi.org/10.1371/journal.pone.0105732			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3XV	25188378	Green Published, Green Accepted, Green Submitted, gold			2022-12-27	WOS:000341271500012
J	Engler, JO; Balkenhol, N; Filz, KJ; Habel, JC; Rodder, D				Engler, Jan O.; Balkenhol, Niko; Filz, Katharina J.; Habel, Jan C.; Roedder, Dennis			Comparative Landscape Genetics of Three Closely Related Sympatric Hesperid Butterflies with Diverging Ecological Traits	PLOS ONE			English	Article							HABITAT FRAGMENTATION; POPULATION-GENETICS; MICROSATELLITE LOCI; CALCAREOUS GRASSLANDS; SPECIES DISTRIBUTIONS; DISPERSAL BEHAVIOR; CIRCUIT-THEORY; SAMPLE-SIZE; DIFFERENTIATION; DIVERSITY	To understand how landscape characteristics affect gene flow in species with diverging ecological traits, it is important to analyze taxonomically related sympatric species in the same landscape using identical methods. Here, we present such a comparative landscape genetic study involving three closely related Hesperid butterflies of the genus Thymelicus that represent a gradient of diverging ecological traits. We analyzed landscape effects on their gene flow by deriving inter-population connectivity estimates based on different species distribution models (SDMs), which were calculated from multiple landscape parameters. We then used SDM output maps to calculate circuit-theoretic connectivity estimates and statistically compared these estimates to actual genetic differentiation in each species. We based our inferences on two different analytical methods and two metrics of genetic differentiation. Results indicate that land use patterns influence population connectivity in the least mobile specialist T. acteon. In contrast, populations of the highly mobile generalist T. lineola were panmictic, lacking any landscape related effect on genetic differentiation. In the species with ecological traits in between those of the congeners, T. sylvestris, climate has a strong impact on inter-population connectivity. However, the relative importance of different landscape factors for connectivity varies when using different metrics of genetic differentiation in this species. Our results show that closely related species representing a gradient of ecological traits also show genetic structures and landscape genetic relationships that gradually change from a geographical macro-to micro-scale. Thus, the type and magnitude of landscape effects on gene flow can differ strongly even among closely related species inhabiting the same landscape, and depend on their relative degree of specialization. In addition, the use of different genetic differentiation metrics makes it possible to detect recent changes in the relative importance of landscape factors affecting gene flow, which likely change as a result of contemporary habitat alterations.	[Engler, Jan O.; Roedder, Dennis] Zool Res Museum Alexander Koenig, Bonn, Germany; [Engler, Jan O.; Balkenhol, Niko] Univ Gottingen, Dept Wildlife Sci, D-37073 Gottingen, Germany; [Filz, Katharina J.] Univ Trier, Dept Biogeog, Trier, Germany; [Filz, Katharina J.] Museum Nat Hist Dortmund, Dortmund, Germany; [Habel, Jan C.] Tech Univ Munich, Dept Ecol & Ecosyst Management, Freising Weihenstephan, Germany	Zoologisches Forschungsmuseum Alexander Koenig (ZFMK); University of Gottingen; Universitat Trier; Technical University of Munich	Engler, JO (corresponding author), Zool Res Museum Alexander Koenig, Bonn, Germany.	j.engler.zfmk@uni-bonn.de	Rödder, Dennis/AAT-8644-2021; Balkenhol, Niko/G-2725-2015; Engler, Jan O/C-3432-2009; Habel, Jan Christian/H-2112-2019	Rödder, Dennis/0000-0002-6108-1639; Habel, Jan Christian/0000-0003-1378-9381	German Federal Environmental Foundation (DBU); Friedrich-Ebert-Stiftung	German Federal Environmental Foundation (DBU); Friedrich-Ebert-Stiftung	JOE received financial support by the German Federal Environmental Foundation (DBU) fellowship programme. KJF was funded by the Friedrich-Ebert-Stiftung. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Araujo MB, 2005, GLOBAL CHANGE BIOL, V11, P1504, DOI 10.1111/j.1365-2486.2005.01000.x; Asher J, 2001, MILLENNIUM ATLAS BUT; Balkenhol N, 2013, CONSERV GENET, V14, P355, DOI 10.1007/s10592-013-0454-2; Beaumont LJ, 2005, ECOL MODEL, V186, P250, DOI 10.1016/j.ecolmodel.2005.01.030; Bell RC, 2010, MOL ECOL, V19, P2531, DOI 10.1111/j.1365-294X.2010.04676.x; Bink F.A., 1992, ECOLOGISCHE ATLAS DA; Brouat C, 2004, MOL ECOL, V13, P1815, DOI 10.1111/j.1365-294X.2004.02206.x; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Conradt L, 2001, OIKOS, V95, P416, DOI 10.1034/j.1600-0706.2001.950306.x; Crawford NG, 2010, MOL ECOL RESOUR, V10, P556, DOI 10.1111/j.1755-0998.2009.02801.x; Dawson MN, 2012, MOL ECOL, V21, P987, DOI 10.1111/j.1365-294X.2011.05417.x; Dennis RLH, 1997, J INSECT CONSERV, V1, P167, DOI 10.1023/A:1018455714879; Devitt TJ, 2013, MOL ECOL, V22, P1650, DOI 10.1111/mec.12196; Elith J, 2006, ECOGRAPHY, V29, P129, DOI 10.1111/j.2006.0906-7590.04596.x; Elith J, 2011, DIVERS DISTRIB, V17, P43, DOI 10.1111/j.1472-4642.2010.00725.x; Ellis JR, 2006, MOL ECOL, V15, P2345, DOI 10.1111/j.1365-294X.2006.02937.x; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Fahrig L, 2003, ANNU REV ECOL EVOL S, V34, P487, DOI 10.1146/annurev.ecolsys.34.011802.132419; Filz KJ, 2013, BIODIVERS CONSERV, V22, P2223, DOI 10.1007/s10531-012-0413-0; Finger A, 2009, ECOGRAPHY, V32, P382, DOI 10.1111/j.1600-0587.2008.05766.x; Gerlach G, 2010, MOL ECOL, V19, P3845, DOI 10.1111/j.1365-294X.2010.04784.x; Gitzendanner MA, 2000, AM J BOT, V87, P783, DOI 10.2307/2656886; Goldberg CS, 2010, MOL ECOL, V19, P3650, DOI 10.1111/j.1365-294X.2010.04673.x; Goodwin BJ, 2003, LANDSCAPE ECOL, V18, P687, DOI 10.1023/B:LAND.0000004184.03500.a8; Goslee SC, 2007, J STAT SOFTW, V22, P1, DOI 10.18637/jss.v022.i07; Groot AT, 2011, MOL ECOL, V20, P2676, DOI 10.1111/j.1365-294X.2011.05129.x; Guillot G, 2009, MOL ECOL RESOUR, V9, P1112, DOI 10.1111/j.1755-0998.2008.02496.x; Habel JC, 2009, B ENTOMOL RES, V99, P513, DOI 10.1017/S0007485308006640; Habel JC, 2008, EUR J ENTOMOL, V105, P361, DOI 10.14411/eje.2008.043; Habel JC, 2013, BIODIVERS CONSERV, V22, P2401, DOI 10.1007/s10531-012-0407-y; Habel JC, 2012, BIOL CONSERV, V147, P270, DOI 10.1016/j.biocon.2011.11.028; Habel JC, 2011, GLOBAL CHANGE BIOL, V17, P194, DOI 10.1111/j.1365-2486.2010.02233.x; Habel JC, 2009, CONSERV GENET, V10, P1659, DOI 10.1007/s10592-008-9744-5; Habel JC, 2009, BIODIVERS CONSERV, V18, P1895, DOI 10.1007/s10531-008-9563-5; Hanski I., 1999, METAPOPULATION ECOLO; Heikkinen RK, 2006, PROG PHYS GEOG, V30, P751, DOI 10.1177/0309133306071957; Heller R, 2009, MOL ECOL, V18, P2080, DOI 10.1111/j.1365-294X.2009.04185.x; Hernandez PA, 2006, ECOGRAPHY, V29, P773, DOI 10.1111/j.0906-7590.2006.04700.x; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Hof C, 2011, GLOBAL CHANGE BIOL, V17, P2987, DOI 10.1111/j.1365-2486.2011.02418.x; Holderegger R, 2008, BIOSCIENCE, V58, P199, DOI 10.1641/B580306; Hu XS, 2006, OIKOS, V113, P548, DOI 10.1111/j.2006.0030-1299.14837.x; Jost L, 2009, MOL ECOL, V18, P2088, DOI 10.1111/j.1365-294X.2009.04186.x; Kadlec T, 2010, ANIM CONSERV, V13, P172, DOI 10.1111/j.1469-1795.2009.00318.x; Kassen R, 2002, J EVOLUTION BIOL, V15, P173, DOI 10.1046/j.1420-9101.2002.00377.x; Kekkonen J, 2011, HEREDITY, V106, P183, DOI 10.1038/hdy.2010.32; Keyghobadi N, 2005, P ROY SOC B-BIOL SCI, V272, P553, DOI 10.1098/rspb.2004.2976; Keyghobadi N, 2007, CAN J ZOOL, V85, P1049, DOI 10.1139/Z07-095; Koh LP, 2007, J APPL ECOL, V44, P703, DOI 10.1111/j.1365-2664.2007.01324.x; Landguth EL, 2012, CONSERV GENET, V13, P1421, DOI 10.1007/s10592-012-0354-x; Laurance WF, 2009, THEORY ISLAND BIOGEO; Lee-Yaw JA, 2009, MOL ECOL, V18, P1863, DOI 10.1111/j.1365-294X.2009.04152.x; Leng L, 2011, MOL ECOL, V20, P2494, DOI 10.1111/j.1365-294X.2011.05108.x; LEVINS R, 1969, Bulletin of the Entomological Society of America, V15, P237; Lichstein JW, 2007, PLANT ECOL, V188, P117, DOI 10.1007/s11258-006-9126-3; Lomolino MV, 2009, Q REV BIOL, V84, P357, DOI 10.1086/648123; Louy D, 2007, CONSERV GENET, V8, P671, DOI 10.1007/s10592-006-9213-y; MAC ARTHUR ROBERT H., 1967; Manel S, 2013, TRENDS ECOL EVOL, V28, P614, DOI 10.1016/j.tree.2013.05.012; Marini L, 2009, BIOL CONSERV, V142, P394, DOI 10.1016/j.biocon.2008.10.034; Mcrae BH, 2008, ECOLOGY, V89, P2712, DOI 10.1890/07-1861.1; Mcrae BH, 2007, P NATL ACAD SCI USA, V104, P19885, DOI 10.1073/pnas.0706568104; McRae BH, 2006, EVOLUTION, V60, P1551, DOI 10.1111/j.0014-3820.2006.tb00500.x; Meglecz E, 1998, HEREDITAS, V128, P95, DOI 10.1111/j.1601-5223.1998.00095.x; Meglecz E, 1998, HEREDITAS, V128, P179, DOI 10.1111/j.1601-5223.1998.00179.x; Meglecz E, 2004, MOL ECOL, V13, P1693, DOI 10.1111/j.1365-294X.2004.02163.x; Meirmans PG, 2011, MOL ECOL RESOUR, V11, P5, DOI 10.1111/j.1755-0998.2010.02927.x; Ortego J, 2012, MOL ECOL, V21, P3210, DOI 10.1111/j.1365-294X.2012.05591.x; Packer L, 2005, CONSERV BIOL, V19, P195, DOI 10.1111/j.1523-1739.2005.00601.x; Pavlacky DC, 2009, MOL ECOL, V18, P2945, DOI 10.1111/j.1365-294X.2009.04226.x; Pe'er G, 2006, LANDSCAPE ECOL, V21, P47, DOI 10.1007/s10980-005-1622-7; Pe'er G, 2004, ANIM BEHAV, V68, P825, DOI 10.1016/j.anbehav.2004.02.006; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Poelchau MF, 2012, MOL ECOL, V21, P4970, DOI 10.1111/j.1365-294X.2012.05755.x; R Development Core Team, 2012, R LANG ENV STAT COMP; Raeymaekers JAM, 2012, MOL ECOL, V21, P3458, DOI 10.1111/j.1365-294X.2012.05628.x; Richards ZT, 2012, ECOL EVOL, V2, P1867, DOI 10.1002/ece3.304; Richardson JL, 2012, MOL ECOL, V21, P4437, DOI 10.1111/j.1365-294X.2012.05708.x; Ryman N, 2009, MOL ECOL, V18, P2084, DOI 10.1111/j.1365-294X.2009.04187.x; Schwenk WS, 2011, CONSERV BIOL, V25, P1010, DOI 10.1111/j.1523-1739.2011.01723.x; Seiferling IS, 2012, CONSERV BIOL, V26, P610, DOI 10.1111/j.1523-1739.2011.01674.x; Severns PM, 2011, CONSERV GENET, V12, P881, DOI 10.1007/s10592-011-0191-3; Spear SF, 2010, MOL ECOL, V19, P3576, DOI 10.1111/j.1365-294X.2010.04657.x; Steele CA, 2009, MOL ECOL, V18, P1629, DOI 10.1111/j.1365-294X.2009.04135.x; Storfer A, 2010, MOL ECOL, V19, P3496, DOI 10.1111/j.1365-294X.2010.04691.x; SWETS JA, 1988, SCIENCE, V240, P1285, DOI 10.1126/science.3287615; Van Dyck H, 2005, BASIC APPL ECOL, V6, P535, DOI 10.1016/j.baae.2005.03.005; van Swaay C. M., 1999, RED DATA BOOK EUROPE; Warren MS, 2001, NATURE, V414, P65, DOI 10.1038/35102054; WEISS SB, 1988, ECOLOGY, V69, P1486, DOI 10.2307/1941646; Wenzel M, 2006, BIOL CONSERV, V128, P542, DOI 10.1016/j.biocon.2005.10.022; Wisz MS, 2008, DIVERS DISTRIB, V14, P763, DOI 10.1111/j.1472-4642.2008.00482.x; Wright S, 1943, GENETICS, V28, P114; Zachos FE, 2007, EUR J WILDLIFE RES, V53, P61, DOI 10.1007/s10344-006-0065-z; Zhang DX, 2004, TRENDS ECOL EVOL, V19, P507, DOI 10.1016/j.tree.2004.07.020	95	34	34	2	82	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 3	2014	9	9							e106526	10.1371/journal.pone.0106526	http://dx.doi.org/10.1371/journal.pone.0106526			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3TB	25184414	Green Published, Green Submitted, gold			2022-12-27	WOS:000341257700084
J	Hennessey, JA; Boczek, NJ; Jiang, YH; Miller, JD; Patrick, W; Pfeiffer, R; Sutphin, BS; Tester, DJ; Barajas-Martinez, H; Ackerman, MJ; Antzelevitch, C; Kanter, R; Pitt, GS				Hennessey, Jessica A.; Boczek, Nicole J.; Jiang, Yong-Hui; Miller, Joelle D.; Patrick, William; Pfeiffer, Ryan; Sutphin, Brittan S.; Tester, David J.; Barajas-Martinez, Hector; Ackerman, Michael J.; Antzelevitch, Charles; Kanter, Ronald; Pitt, Geoffrey S.			A CACNA1C Variant Associated with Reduced Voltage-Dependent Inactivation, Increased Ca(V)1.2 Channel Window Current, and Arrhythmogenesis	PLOS ONE			English	Article							SUDDEN-INFANT-DEATH; LONG QT; CALCIUM-CHANNEL; CARDIAC-ARRHYTHMIA; MUTATIONS; POLYMORPHISM; S1103Y	Mutations in CACNA1C that increase current through the Ca(V)1.2 L-type Ca2+ channel underlie rare forms of long QT syndrome (LQTS), and Timothy syndrome (TS). We identified a variant in CACNA1C in a male child of Filipino descent with arrhythmias and extracardiac features by candidate gene sequencing and performed functional expression studies to electrophysiologically characterize the effects of the variant on Ca(V)1.2 channels. As a baby, the subject developed seizures and displayed developmental delays at 30 months of age. At age 5 years, he displayed a QTc of 520 ms and experienced recurrent VT. Physical exam at 17 years of age was notable for microcephaly, short stature, lower extremity weakness and atrophy with hyperreflexia, spastic diplegia, multiple dental caries and episodes of rhabdomyolysis. Candidate gene sequencing identified a G>C transversion at position 5731 of CACNA1C (rs374528680) predicting a glycine. arginine substitution at residue 1911 (p.G1911R) of Ca(V)1.2. The allele frequency of this variant is 0.01 in Malays, but absent in 984 Caucasian alleles and in the 1000 genomes project. In electrophysiological analyses, the variant decreased voltage-dependent inactivation, thus causing a gain of function of Ca(V)1.2. We also observed a negative shift of V-1/2 of activation and positive shift of V-1/2 of channel inactivation, resulting in an increase of the window current. Together, these suggest a gain-of-function effect on Ca(V)1.2 and suggest increased susceptibility for arrhythmias in certain clinical settings. The p.G1911R variant was also identified in a case of sudden unexplained infant death (SUID), for which an increasing number of clinical observations have demonstrated can be associated with arrhythmogenic mutations in cardiac ion channels. In summary, the combined effects of the CACNA1C variant to diminish voltage-dependent inactivation of Ca(V)1.2 and increase window current expand our appreciation of mechanisms by which a gain of function of Ca(V)1.2 can contribute to QT prolongation.	[Hennessey, Jessica A.; Patrick, William] Duke Univ, Sch Med, Dept Med Cardiol, Durham, NC USA; [Hennessey, Jessica A.; Pitt, Geoffrey S.] Duke Univ, Sch Med, Dept Pharmacol & Canc Biol, Durham, NC 27708 USA; [Jiang, Yong-Hui; Pitt, Geoffrey S.] Duke Univ, Sch Med, Dept Neurobiol, Durham, NC USA; [Jiang, Yong-Hui; Kanter, Ronald] Duke Univ, Dept Pediat, Sch Med, Durham, NC 27706 USA; [Kanter, Ronald] Duke Univ, Sch Med, Dept Pediat Cardiol, Durham, NC USA; [Boczek, Nicole J.; Sutphin, Brittan S.; Tester, David J.; Ackerman, Michael J.] Mayo Clin, Dept Mol Pharmacol, Windland Smith Rice Sudden Death Genom Lab, Rochester, MN USA; [Boczek, Nicole J.; Sutphin, Brittan S.; Tester, David J.; Ackerman, Michael J.] Mayo Clin, Dept Expt Therapeut, Windland Smith Rice Sudden Death Genom Lab, Rochester, MN USA; [Ackerman, Michael J.] Mayo Clin, Dept Internal Med, Div Cardiovasc Dis, Rochester, MN USA; [Ackerman, Michael J.] Mayo Clin, Dept Internal Med, Div Pediat Cardiol, Rochester, MN USA; [Ackerman, Michael J.] Mayo Clin, Dept Pediat & Adolescent Med, Div Cardiovasc Dis, Rochester, MN USA; [Ackerman, Michael J.] Mayo Clin, Dept Pediat & Adolescent Med, Div Pediat Cardiol, Rochester, MN USA; [Miller, Joelle D.] Virginia Tech, Dept Pediat, Caril Sch Med, Roanoke, VA USA; [Pfeiffer, Ryan; Barajas-Martinez, Hector; Antzelevitch, Charles] Masonic Med Res Lab, Utica, NY USA	Duke University; Duke University; Duke University; Duke University; Duke University; Mayo Clinic; Mayo Clinic; Mayo Clinic; Mayo Clinic; Mayo Clinic; Mayo Clinic; Virginia Polytechnic Institute & State University; Masonic Medical Research Laboratory	Pitt, GS (corresponding author), Duke Univ, Sch Med, Dept Pharmacol & Canc Biol, Durham, NC 27708 USA.	geoffrey.pitt@duke.edu	Patrick, William/AAC-8186-2022; Pitt, Geoffrey/L-4927-2019	Patrick, William/0000-0001-6803-6817; Antzelevitch, Charles/0000-0001-7349-1582	National Institutes of Health [R01 HL71165, R01 HL112918, R01 HL47678, R01 HD42569, F30 HL112540]; New York State Stem Cell Science [C026424]; Mason of New York State; Mason of Florida; Mason of Massachusetts Connecticut; Mason of Maryland; Mason of Rhode Island; Mason of Wisconsin; Gertrude Elion Mentored Medical Student Award; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD042569] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL112918, R01HL047678, R01HL071165, F30HL112540] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); New York State Stem Cell Science; Mason of New York State; Mason of Florida; Mason of Massachusetts Connecticut; Mason of Maryland; Mason of Rhode Island; Mason of Wisconsin; Gertrude Elion Mentored Medical Student Award; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was funded by the National Institutes of Health R01 HL71165 and R01 HL112918 (GSP), R01 HL47678 (CA), R01 HD42569 (MJA), and F30 HL112540 (JAH); New York State Stem Cell Science C026424 (CA); the Masons of New York State, Florida, Massachusetts Connecticut, Maryland, Rhode Island and Wisconsin (CA); the Gertrude Elion Mentored Medical Student Award (JAH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Antzelevitch C, 2005, CIRCULATION, V111, P659, DOI 10.1161/01.CIR.0000152479.54298.51; Boczek NJ, 2013, CIRC-CARDIOVASC GENE, V6, P279, DOI 10.1161/CIRCGENETICS.113.000138; Burke A, 2005, CIRCULATION, V112, P798, DOI 10.1161/CIRCULATIONAHA.104.482760; Cohen-Kutner M, 2012, SCI REP-UK, V2, DOI 10.1038/srep00366; CURRAN ME, 1995, CELL, V80, P795, DOI 10.1016/0092-8674(95)90358-5; Dittmer PJ, 2014, CELL REP, V7, P1410, DOI 10.1016/j.celrep.2014.04.039; Fukuyama M, 2014, LONG QT SYNDROME TYP; Gao TY, 2001, J BIOL CHEM, V276, P21089, DOI 10.1074/jbc.M008000200; Gillis J, 2012, AM J MED GENET A, V158A, P182, DOI 10.1002/ajmg.a.34355; JANUARY CT, 1992, ANN NY ACAD SCI, V644, P23, DOI 10.1111/j.1749-6632.1992.tb30999.x; Krous HF, 2004, PEDIATRICS, V114, P234, DOI 10.1542/peds.114.1.234; Plant LD, 2006, J CLIN INVEST, V116, P430, DOI 10.1172/JCI25618; Splawski I, 2002, SCIENCE, V297, P1333, DOI 10.1126/science.1073569; Splawski I, 2004, CELL, V119, P19, DOI 10.1016/j.cell.2004.09.011; Splawski I, 2005, P NATL ACAD SCI USA, V102, P8089, DOI 10.1073/pnas.0502506102; Sun AY, 2011, CIRC-CARDIOVASC GENE, V4, P163, DOI 10.1161/CIRCGENETICS.110.958652; Van Norstrand DW, 2008, HEART RHYTHM, V5, P712, DOI 10.1016/j.hrthm.2008.02.012; WANG Q, 1995, CELL, V80, P805, DOI 10.1016/0092-8674(95)90359-3	19	26	26	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 3	2014	9	9							e106982	10.1371/journal.pone.0106982	http://dx.doi.org/10.1371/journal.pone.0106982			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3TB	25184293	Green Published, Green Submitted, gold			2022-12-27	WOS:000341257700132
J	Astafurov, K; Elhawy, E; Ren, LZ; Dong, CQ; Igboin, C; Hyman, L; Griffen, A; Mittag, T; Danias, J				Astafurov, Konstantin; Elhawy, Eman; Ren, Lizhen; Dong, Cecilia Q.; Igboin, Christina; Hyman, Leslie; Griffen, Ann; Mittag, Thomas; Danias, John			Oral Microbiome Link to Neurodegeneration in Glaucoma	PLOS ONE			English	Article							PRIMARY OPEN-ANGLE; INTRAOCULAR-PRESSURE; NORMAL-TENSION; GENE POLYMORPHISMS; COGNITIVE DECLINE; OPTIC NEUROPATHY; MOUSE MODEL; ASSOCIATION; INFECTION; MICE	Background: Glaucoma is a progressive optic nerve degenerative disease that often leads to blindness. Local inflammatory responses are implicated in the pathology of glaucoma. Although inflammatory episodes outside the CNS, such as those due to acute systemic infections, have been linked to central neurodegeneration, they do not appear to be relevant to glaucoma. Based on clinical observations, we hypothesized that chronic subclinical peripheral inflammation contributes to neurodegeneration in glaucoma. Methods: Mouthwash specimens from patients with glaucoma and control subjects were analyzed for the amount of bacteria. To determine a possible pathogenic mechanism, low-dose subcutaneous lipopolysaccharide (LPS) was administered in two separate animal models of glaucoma. Glaucomatous neurodegeneration was assessed in the retina and optic nerve two months later. Changes in gene expression of toll-like receptor 4 (TLR4) signaling pathway and complement as well as changes in microglial numbers and morphology were analyzed in the retina and optic nerve. The effect of pharmacologic blockade of TLR4 with naloxone was determined. Findings: Patients with glaucoma had higher bacterial oral counts compared to control subjects (p<0.017). Low-dose LPS administration in glaucoma animal models resulted in enhancement of axonal degeneration and neuronal loss. Microglial activation in the optic nerve and retina as well as up regulation of TLR4 signaling and complement system were observed. Pharmacologic blockade of TLR4 partially ameliorated the enhanced damage. Conclusions: The above findings suggest that the oral microbiome contributes to glaucoma pathophysiology. A plausible mechanism by which increased bacterial loads can lead to neurodegeneration is provided by experiments in animal models of the disease and involves activation of microglia in the retina and optic nerve, mediated through TLR4 signaling and complement upregulation. The finding that commensal bacteria may play a role in the development and/or progression of glaucomatous pathology may also be relevant to other chronic neurodegenerative disorders.	[Astafurov, Konstantin; Ren, Lizhen; Danias, John] Suny Downstate Med Ctr, Dept Cell Biol, Brooklyn, NY 11203 USA; [Elhawy, Eman; Dong, Cecilia Q.; Danias, John] Suny Downstate Med Ctr, Dept Ophthalmol, Brooklyn, NY 11203 USA; [Igboin, Christina; Griffen, Ann] Ohio State Univ, Div Pediat Dent, Columbus, OH 43210 USA; [Hyman, Leslie] SUNY Stony Brook, Med Ctr, Dept Prevent Med, Stony Brook, NY USA; [Hyman, Leslie; Danias, John] SUNY, Inst Eye, Brooklyn, NY USA; [Mittag, Thomas] Mt Sinai Sch Med, Dept Ophthalmol, New York, NY USA	State University of New York (SUNY) System; State University of New York (SUNY) Downstate Medical Center; State University of New York (SUNY) System; State University of New York (SUNY) Downstate Medical Center; University System of Ohio; Ohio State University; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; SUNY Maritime College; Icahn School of Medicine at Mount Sinai	Astafurov, K (corresponding author), Suny Downstate Med Ctr, Dept Cell Biol, Brooklyn, NY 11203 USA.	konstantin.astafurov@downstate.edu; john.danias@downstate.edu	Griffen, Ann/AAC-5999-2019	Astafurov, Konstantin/0000-0002-7264-4265	Empire Clinical Research Investigator Program (ECRIP) fellowship; SUNY Eye Institute pilot grant; RPB;  [R01 EY015224]; NATIONAL EYE INSTITUTE [R01EY015224] Funding Source: NIH RePORTER	Empire Clinical Research Investigator Program (ECRIP) fellowship; SUNY Eye Institute pilot grant; RPB; ; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work received financial support from the following sources: R01 EY015224, Unrestricted grant to the Department of Ophthalmology SUNY Downstate and Medical student fellowship from RPB, Empire Clinical Research Investigator Program (ECRIP) fellowship, SUNY Eye Institute pilot grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKIYAMA H, 1990, J NEUROIMMUNOL, V30, P81, DOI 10.1016/0165-5728(90)90055-R; Amor S, 2010, IMMUNOLOGY, V129, P154, DOI 10.1111/j.1365-2567.2009.03225.x; Anderson MG, 2002, NAT GENET, V30, P81, DOI 10.1038/ng794; Bosco A, 2011, J COMP NEUROL, V519, P599, DOI 10.1002/cne.22516; Chen HH, 2011, INVEST OPHTH VIS SCI, V52, P36, DOI 10.1167/iovs.09-5115; Danias J, 2003, INVEST OPHTH VIS SCI, V44, P5151, DOI 10.1167/iovs.02-1101; Danias J, 2003, INVEST OPHTH VIS SCI, V44, P1138, DOI 10.1167/iovs.02-0553; Dunn N, 2005, ALZ DIS ASSOC DIS, V19, P91, DOI 10.1097/01.wad.0000165511.52746.1f; Ebneter A, 2010, INVEST OPHTH VIS SCI, V51, P6448, DOI 10.1167/iovs.10-5284; Engelhart MJ, 2004, ARCH NEUROL-CHICAGO, V61, P668, DOI 10.1001/archneur.61.5.668; Fingert JH, 2011, EYE, V25, P587, DOI 10.1038/eye.2011.97; Gordon MO, 2007, OPHTHALMOLOGY, V114, P10, DOI 10.1016/j.ophtha.2006.08.031; Gross EL, 2010, J CLIN MICROBIOL, V48, P4121, DOI 10.1128/JCM.01232-10; Hirsch EC, 2009, PARKINSONISM RELA S1, V18, pS210; Hofman P, 2001, INVEST OPHTH VIS SCI, V42, P895; Holmes C, 2003, J NEUROL NEUROSUR PS, V74, P788, DOI 10.1136/jnnp.74.6.788; Howell GR, 2012, J CLIN INVEST, V122, P1246, DOI 10.1172/JCI61135; Howell GR, 2011, J CLIN INVEST, V121, P1429, DOI 10.1172/JCI44646; Husain S, 2012, INVEST OPHTH VIS SCI, V53, P4289, DOI 10.1167/iovs.12-9467; Hutchinson MR, 2008, BRAIN BEHAV IMMUN, V22, P1178, DOI 10.1016/j.bbi.2008.05.004; Hutchinson MR, 2008, EUR J NEUROSCI, V28, P20, DOI 10.1111/j.1460-9568.2008.06321.x; Ishida N, 2013, ALZHEIMERS DEMENTI S, V9S, P851, DOI DOI 10.1038/541514-017-0015-X; John SWM, 1998, INVEST OPHTH VIS SCI, V39, P951; Kim JM, 2011, INVEST OPHTH VIS SCI, V52, P665, DOI 10.1167/iovs.10-6096; Kountouras J, 2003, GRAEF ARCH CLIN EXP, V241, P884, DOI 10.1007/s00417-003-0779-5; Krabbe KS, 2005, BRAIN BEHAV IMMUN, V19, P453, DOI 10.1016/j.bbi.2005.04.010; Libby RT, 2005, VISUAL NEUROSCI, V22, P637, DOI 10.1017/S0952523805225130; Luo C, 2010, INVEST OPHTH VIS SCI, V51, P5697, DOI 10.1167/iovs.10-5407; Lyons SR, 2000, J CLIN MICROBIOL, V38, P2362; Marina N, 2010, NAT PROTOC, V5, P1642, DOI 10.1038/nprot.2010.128; MARTIN WR, 1967, PHARMACOL REV, V19, P463; McCusker RH, 2013, J EXP BIOL, V216, P84, DOI 10.1242/jeb.073411; Morrison HW, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-4; Ni YQ, 2008, INVEST OPHTH VIS SCI, V49, P2589, DOI 10.1167/iovs.07-1173; Nissirios N, 2007, J GLAUCOMA, V16, P57, DOI 10.1097/IJG.0b013e31802b3547; Pang IH, 2005, INVEST OPHTH VIS SCI, V46, P1313, DOI 10.1167/iovs.04-0829; Godoy MCP, 2008, BRAIN, V131, P1880, DOI 10.1093/brain/awn101; Quigley HA, 2006, BRIT J OPHTHALMOL, V90, P262, DOI 10.1136/bjo.2005.081224; Rasmussen CA, 2007, T AM OPHTHAL SOC, V105, P238; Rasmussen Carol A, 2007, Trans Am Ophthalmol Soc, V105, P225; Rosenbaum JT, 2008, OPHTHAL RES, V40, P165, DOI 10.1159/000119870; Saito T, 2007, PERIODONTOL 2000, V43, P254, DOI 10.1111/j.1600-0757.2006.00186.x; Schram MT, 2007, J AM GERIATR SOC, V55, P708, DOI 10.1111/j.1532-5415.2007.01159.x; Shibuya E, 2008, INVEST OPHTH VIS SCI, V49, P4453, DOI 10.1167/iovs.07-1575; Stasi K, 2006, INVEST OPHTH VIS SCI, V47, P1024, DOI 10.1167/iovs.05-0830; Takano Y, 2012, AM J OPHTHALMOL, V154, P825, DOI 10.1016/j.ajo.2012.03.050; Wyss-Coray T., 2011, COLD SPRING HARB PER, V2; YOKOCHI T, 1989, INFECT IMMUN, V57, P1786, DOI 10.1128/IAI.57.6.1786-1791.1989; Zoellner H, 2011, SEMIN THROMB HEMOST, V37, P181, DOI 10.1055/s-0031-1273082; Zullo A, 2012, DIGEST LIVER DIS, V44, P627, DOI 10.1016/j.dld.2012.03.011	50	76	80	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2014	9	9							e104416	10.1371/journal.pone.0104416	http://dx.doi.org/10.1371/journal.pone.0104416			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3LR	25180891	gold, Green Published, Green Submitted			2022-12-27	WOS:000341231500012
J	Baliki, MN; Mansour, AR; Baria, AT; Apkarian, AV				Baliki, Marwan N.; Mansour, Ali R.; Baria, Alex T.; Apkarian, A. Vania			Functional Reorganization of the Default Mode Network across Chronic Pain Conditions	PLOS ONE			English	Article							INDEPENDENT COMPONENT ANALYSIS; INTRINSIC BRAIN CONNECTIVITY; RESTING-STATE NETWORKS; FLUCTUATIONS; ORGANIZATION; PERCEPTION; MECHANISMS; PRECUNEUS; PREDICTS; ANATOMY	Chronic pain is associated with neuronal plasticity. Here we use resting-state functional magnetic resonance imaging to investigate functional changes in patients suffering from chronic back pain (CBP), complex regional pain syndrome (CRPS) and knee osteoarthritis (OA). We isolated five meaningful resting-state networks across the groups, of which only the default mode network (DMN) exhibited deviations from healthy controls. All patient groups showed decreased connectivity of medial prefrontal cortex (MPFC) to the posterior constituents of the DMN, and increased connectivity to the insular cortex in proportion to the intensity of pain. Multiple DMN regions, especially the MPFC, exhibited increased high frequency oscillations, conjoined with decreased phase locking with parietal regions involved in processing attention. Both phase and frequency changes correlated to pain duration in OA and CBP patients. Thus chronic pain seems to reorganize the dynamics of the DMN and as such reflect the maladaptive physiology of different types of chronic pain.	[Baliki, Marwan N.; Mansour, Ali R.; Baria, Alex T.; Apkarian, A. Vania] Northwestern Univ, Feinberg Sch Med, Dept Physiol, Chicago, IL 60611 USA; [Apkarian, A. Vania] Northwestern Univ, Feinberg Sch Med, Dept Anesthesia, Chicago, IL 60611 USA; [Apkarian, A. Vania] Rehabil Inst Chicago, Chicago, IL 60611 USA	Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine; Shirley Ryan AbilityLab	Apkarian, AV (corresponding author), Northwestern Univ, Feinberg Sch Med, Dept Physiol, Chicago, IL 60611 USA.	a-apkarian@northwestern.edu	, Ali/ABE-6372-2021; Mansour, Ali/AAP-2422-2020; Mansour, Ali/B-1919-2019	, Ali/0000-0002-2658-074X; Apkarian, A. Vania/0000-0002-9788-7458	NIH NINDS [NS35115]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS035115] Funding Source: NIH RePORTER	NIH NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This study was funded by NIH NINDS NS35115, M.N.B. was funded by an anonymous foundation. The research costs or authors' salaries were not funded, in whole or in part, by a tobacco company. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apkarian AV, 2011, PAIN, V152, pS49, DOI 10.1016/j.pain.2010.11.010; Apkarian AV, 2005, EUR J PAIN, V9, P463, DOI 10.1016/j.ejpain.2004.11.001; Ashburner J, 2000, NEUROIMAGE, V11, P805, DOI 10.1006/nimg.2000.0582; Baliki M, 2007, NEURON UNPUB; Baliki MN, 2009, J NEUROPHYSIOL, V101, P875, DOI 10.1152/jn.91100.2008; Baliki MN, 2008, J NEUROSCI, V28, P1398, DOI 10.1523/JNEUROSCI.4123-07.2008; Baliki MN, 2012, NAT NEUROSCI, V15, P1117, DOI 10.1038/nn.3153; Baliki MN, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026010; Baliki MN, 2011, J NEUROSCI, V31, P13981, DOI 10.1523/JNEUROSCI.1984-11.2011; Baria AT, 2011, J NEUROSCI, V31, P7910, DOI 10.1523/JNEUROSCI.1296-11.2011; Beckmann CF, 2005, NEUROIMAGE, V25, P294, DOI 10.1016/j.neuroimage.2004.10.043; Buckner RL, 2008, ANN NY ACAD SCI, V1124, P1, DOI 10.1196/annals.1440.011; Buckner RL, 2005, J NEUROSCI, V25, P7709, DOI 10.1523/JNEUROSCI.2177-05.2005; Cauda F, 2010, J NEUROL NEUROSUR PS, V81, P806, DOI 10.1136/jnnp.2009.188631; Cauda F, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004542; Cavanna AE, 2006, BRAIN, V129, P564, DOI 10.1093/brain/awl004; Cavanna AE, 2007, CNS SPECTRUMS, V12, P545, DOI 10.1017/S1092852900021295; Damoiseaux JS, 2006, P NATL ACAD SCI USA, V103, P13848, DOI 10.1073/pnas.0601417103; De Luca M, 2006, NEUROIMAGE, V29, P1359, DOI 10.1016/j.neuroimage.2005.08.035; Duff EP, 2008, HUM BRAIN MAPP, V29, P778, DOI 10.1002/hbm.20601; Farmer MA, 2012, NEUROSCI LETT, V520, P197, DOI 10.1016/j.neulet.2012.05.001; Fox MD, 2005, P NATL ACAD SCI USA, V102, P9673, DOI 10.1073/pnas.0504136102; Fox MD, 2007, NEURON, V56, P171, DOI 10.1016/j.neuron.2007.08.023; Fransson P, 2005, HUM BRAIN MAPP, V26, P15, DOI 10.1002/hbm.20113; Good CD, 2001, NEUROIMAGE, V14, P21, DOI 10.1006/nimg.2001.0786; Greicius MD, 2003, P NATL ACAD SCI USA, V100, P253, DOI 10.1073/pnas.0135058100; Gusnard DA, 2001, NAT REV NEUROSCI, V2, P685, DOI 10.1038/35094500; Harden RN, 2005, J PAIN, V6, P364, DOI 10.1016/j.jpain.2005.01.350; Horovitz SG, 2009, P NATL ACAD SCI USA, V106, P11376, DOI 10.1073/pnas.0901435106; Ichesco E, 2012, HEADACHE, V52, P441, DOI 10.1111/j.1526-4610.2011.01998.x; Jenkinson M, 2001, MED IMAGE ANAL, V5, P143, DOI 10.1016/S1361-8415(01)00036-6; Kiviniemi V, 2003, NEUROIMAGE, V19, P253, DOI 10.1016/S1053-8119(03)00097-1; Kucyi A, 2013, P NATL ACAD SCI USA, V110, P18692, DOI 10.1073/pnas.1312902110; Loggia M. L., 2012, PAIN; Malinen S, 2010, P NATL ACAD SCI USA, V107, P6493, DOI 10.1073/pnas.1001504107; McIntosh AR, 2000, NEURAL NETWORKS, V13, P861, DOI 10.1016/S0893-6080(00)00059-9; MELZACK R, 1987, PAIN, V30, P191, DOI 10.1016/0304-3959(87)91074-8; Napadow V, 2012, ARTHRITIS RHEUM-US, V64, P2398, DOI 10.1002/art.34412; Napadow V, 2010, ARTHRITIS RHEUM-US, V62, P2545, DOI 10.1002/art.27497; Otti A, 2010, NEUROSCIENCE, V169, P143, DOI 10.1016/j.neuroscience.2010.04.072; Price DD, 2000, SCIENCE, V288, P1769, DOI 10.1126/science.288.5472.1769; Pyka M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007198; Raichle ME, 2006, ANNU REV NEUROSCI, V29, P449, DOI 10.1146/annurev.neuro.29.051605.112819; Raichle ME, 2001, P NATL ACAD SCI USA, V98, P676, DOI 10.1073/pnas.98.2.676; Scheidegger M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044799; Schmidt-Wilcke T, 2008, CEPHALALGIA, V28, P1, DOI 10.1111/j.1468-2982.2007.01428.x; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Smith SM, 2009, P NATL ACAD SCI USA, V106, P13040, DOI 10.1073/pnas.0905267106; Sporns O, 2004, TRENDS COGN SCI, V8, P418, DOI 10.1016/j.tics.2004.07.008; Tagliazucchi E., 2010, NEUROSCI LETT; Tian LX, 2007, NEUROIMAGE, V36, P684, DOI 10.1016/j.neuroimage.2007.03.044; Tracey I, 2009, J PAIN, V10, P1113, DOI 10.1016/j.jpain.2009.09.001; van den Heuvel MP, 2010, HUM BRAIN MAPP, V31, P631, DOI 10.1002/hbm.20893; Zhou J, 2010, BRAIN, V133, P1352, DOI 10.1093/brain/awq075; Zysset S, 2002, NEUROIMAGE, V15, P983, DOI 10.1006/nimg.2001.1008	55	286	291	3	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2014	9	9							e106133	10.1371/journal.pone.0106133	http://dx.doi.org/10.1371/journal.pone.0106133			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3LR	25180885	Green Published, Green Submitted, gold			2022-12-27	WOS:000341231500052
J	Park, HJ; Yun, J; Jang, SH; Kang, SN; Jeon, BS; Ko, YG; Kim, HD; Won, CK; Kim, GS; Cho, JH				Park, Hyoung Joon; Yun, Jisoo; Jang, Sun-Hee; Kang, Suk Nam; Jeon, Beong-Sam; Ko, Yeoung-Gyu; Kim, Hong-Duck; Won, Chung-Kil; Kim, Gon-Sup; Cho, Jae-Hyeon			Coprinus comatus Cap Inhibits Adipocyte Differentiation via Regulation of PPAR gamma and Akt Signaling Pathway	PLOS ONE			English	Article							MITOTIC CLONAL EXPANSION; GLYCOGEN-SYNTHASE KINASE; BINDING PROTEIN-BETA; ADIPOSE-TISSUE; GENE-EXPRESSION; ADIPOGENESIS; OBESITY; INSULIN; MICE; ACTIVATION	This study assessed the effects of Coprinus comatus cap (CCC) on adipogenesis in 3T3-L1 adipocytes and the effects of CCC on the development of diet-induced obesity in rats. Here, we showed that the CCC has an inhibitory effect on the adipocyte differentiation of 3T3-L1 cells, resulting in a significant decrease in lipid accumulation through the downregulation of several adipocyte specific-transcription factors, including CCAAT/enhancer binding protein beta, C/EBP delta, and peroxisome proliferator-activated receptor gamma (PPAR gamma). Moreover, treatment with CCC during adipocyte differentiation induced a significant down-regulation of PPAR gamma and adipogenic target genes, including adipocyte protein 2, lipoprotein lipase, and adiponectin. Interestingly, the CCC treatment of the 3T3-L1 adipocytes suppressed the insulin-stimulated Akt and GSK3 beta phosphorylation, and these effects were stronger in the presence of an inhibitor of Akt phosphorylation, LY294002, suggesting that CCC inhibited adipocyte differentiation through the down-regulation of Akt signaling. In the animal study, CCC administration significantly reduced the body weight and adipose tissue weight of rats fed a high fat diet (HFD) and attenuated lipid accumulation in the adipose tissues of the HFD-induced obese rats. The size of the adipocyte in the epididymal fat of the CCC fed rats was significantly smaller than in the HFD rats. CCC treatment significantly reduced the total cholesterol and triglyceride levels in the serum of HFD rats. These results strongly indicated that the CCC-mediated decrease in body weight was due to a reduction in adipose tissue mass. The expression level of PPAR gamma and phospho-Akt was significantly lower in the CCC-treated HFD rats than that in the HFD obesity rats. These results suggested that CCC inhibited adipocyte differentiation by the down-regulation of major transcription factor involved in the adipogenesis pathway including PPAR gamma through the regulation of the Akt pathway in 3T3-L1 cells and HFD adipose tissue.	[Park, Hyoung Joon; Jang, Sun-Hee; Jeon, Beong-Sam; Won, Chung-Kil; Kim, Gon-Sup; Cho, Jae-Hyeon] Gyeongsang Natl Univ, Coll Vet Med, Inst Life Sci, Jinju, South Korea; [Yun, Jisoo] Ajou Univ, Dept Mol Sci & Technol, Suwon 441749, South Korea; [Kang, Suk Nam] Gyeongsang Natl Univ, Dept Anim Sci & Biotechnol, Jinju, South Korea; [Ko, Yeoung-Gyu] Natl Inst Anim Sci, RDA, Anim Genet Resources Stn, Namwon, South Korea; [Kim, Hong-Duck] New York Med Coll, Dept Environm Hlth Sci, Valhalla, NY 10595 USA	Gyeongsang National University; Ajou University; Gyeongsang National University; National Institute of Animal Science, Republic of Korea; Rural Development Administration (RDA), Republic of Korea; New York Medical College	Cho, JH (corresponding author), Gyeongsang Natl Univ, Coll Vet Med, Inst Life Sci, Jinju, South Korea.	jaehcho@gnu.ac.kr			Ministry of Education, Basic Science Research Program, National Research Foundation, Korea [20120008419]	Ministry of Education, Basic Science Research Program, National Research Foundation, Korea	This work was supported by the Ministry of Education, Basic Science Research Program, National Research Foundation, Korea (no. 20120008419). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAILEY CJ, 1984, PLANTA MED, V50, P525, DOI 10.1055/s-2007-969791; BRAND-WILLIAMS W, 1995, FOOD SCI TECHNOL-LEB, V28, P25; Chan PT, 1999, J NUTR, V129, P1094, DOI 10.1093/jn/129.6.1094; Chmurzynska A, 2006, J APPL GENET, V47, P39, DOI 10.1007/BF03194597; Christoffersen CT, 1998, BIOCHEM BIOPH RES CO, V246, P426, DOI 10.1006/bbrc.1998.8637; Clarke SL, 1997, BIOCHEM BIOPH RES CO, V240, P99, DOI 10.1006/bbrc.1997.7627; Ding ZY, 2010, FOOD CHEM, V121, P39, DOI 10.1016/j.foodchem.2009.12.001; Fan JM, 2006, CARBOHYD RES, V341, P1130, DOI 10.1016/j.carres.2006.03.039; Fruchart JC, 1998, BIOCHIMIE, V80, P167, DOI 10.1016/S0300-9084(98)80023-0; Gregoire FM, 1998, PHYSIOL REV, V78, P783, DOI 10.1152/physrev.1998.78.3.783; Grimes CA, 2001, PROG NEUROBIOL, V65, P391, DOI 10.1016/S0301-0082(01)00011-9; Hajer GR, 2008, EUR HEART J, V29, P2959, DOI 10.1093/eurheartj/ehn387; Haslam DW, 2005, LANCET, V366, P1197, DOI 10.1016/S0140-6736(05)67483-1; HERBERG L, 1974, COMP BIOCHEM PHYSIOL, V48, P163, DOI 10.1016/0300-9629(74)90864-0; Kim SP, 2010, BIOCHEM BIOPH RES CO, V399, P55, DOI 10.1016/j.bbrc.2010.07.038; Lee H, 2009, J BIOL CHEM, V284, P10601, DOI 10.1074/jbc.M808742200; Liu F, 1997, LIFE SCI, V60, P763, DOI 10.1016/S0024-3205(97)00004-0; Lopes GKB, 1999, BBA-GEN SUBJECTS, V1472, P142, DOI 10.1016/S0304-4165(99)00117-8; Magun R, 1996, ENDOCRINOLOGY, V137, P3590, DOI 10.1210/en.137.8.3590; Manning BD, 2007, CELL, V129, P1261, DOI 10.1016/j.cell.2007.06.009; Meda A, 2005, FOOD CHEM, V91, P571, DOI 10.1016/j.foodchem.2004.10.006; Orena SJ, 2000, J BIOL CHEM, V275, P15765, DOI 10.1074/jbc.M910002199; Otto TC, 2005, CRIT REV BIOCHEM MOL, V40, P229, DOI 10.1080/10409230591008189; Peng XD, 2003, GENE DEV, V17, P1352, DOI 10.1101/gad.1089403; Piwien-Pilipuk G, 2001, J BIOL CHEM, V276, P19664, DOI 10.1074/jbc.M010193200; Prusty D, 2002, J BIOL CHEM, V277, P46226, DOI 10.1074/jbc.M207776200; Rosen ED, 2000, GENE DEV, V14, P1293; Rosen ED, 2006, NATURE, V444, P847, DOI 10.1038/nature05483; Ross SE, 1999, MOL CELL BIOL, V19, P8433; Sakaue H, 1998, J BIOL CHEM, V273, P28945, DOI 10.1074/jbc.273.44.28945; SINGLETON V. L., 1965, AMER J ENOL VITICULT, V16, P144; SPIEGELMAN BM, 1993, J BIOL CHEM, V268, P6823; Strissel KJ, 2007, DIABETES, V56, P2910, DOI 10.2337/db07-0767; Tang QQ, 2005, P NATL ACAD SCI USA, V102, P9766, DOI 10.1073/pnas.0503891102; Tang QQ, 2003, P NATL ACAD SCI USA, V100, P44, DOI 10.1073/pnas.0137044100; Tang QQ, 1999, GENE DEV, V13, P2231, DOI 10.1101/gad.13.17.2231; Tsai SY, 2009, J FOOD BIOCHEM, V33, P368, DOI 10.1111/j.1745-4514.2009.00224.x; Xu JF, 2004, J BIOL CHEM, V279, P35914, DOI 10.1074/jbc.M402297200; Yamaguchi M, 2002, INT J OBESITY, V26, P610, DOI 10.1038/sj.ijo.0801987; Yoon M, 2002, EXP MOL MED, V34, P481, DOI 10.1038/emm.2002.67; Yoshiga D, 2007, MOL ENDOCRINOL, V21, P1120, DOI 10.1210/me.2006-0413; Yu J, 2009, FOOD CHEM, V117, P42, DOI 10.1016/j.foodchem.2009.03.073; Yun SJ, 2008, BIOCHEM BIOPH RES CO, V371, P138, DOI 10.1016/j.bbrc.2008.04.029; Zhang HH, 2009, PLOS ONE, V4, DOI [10.1371/journal.pone.0006189, 10.1371/journal.pone.0007826]; Zou CH, 2005, J BIOCHEM BIOPH METH, V64, P207, DOI 10.1016/j.jbbm.2005.08.001	45	23	24	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2014	9	9							e105809	10.1371/journal.pone.0105809	http://dx.doi.org/10.1371/journal.pone.0105809			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3LR	25181477	gold, Green Submitted, Green Published			2022-12-27	WOS:000341231500036
J	Torres-Kolbus, J; Chou, CJ; Liu, JH; Deiters, A				Torres-Kolbus, Jessica; Chou, Chungjung; Liu, Jihe; Deiters, Alexander			Synthesis of Non-linear Protein Dimers through a Genetically Encoded Thiol-ene Reaction	PLOS ONE			English	Article							TRANSFER-RNA SYNTHETASE; CONTAINING AMINO-ACID; SITE-SPECIFIC INCORPORATION; SODIUM DODECYL-SULFATE; DIELS-ALDER REACTIONS; FREE CLICK CHEMISTRY; RECOMBINANT PROTEINS; ESCHERICHIA-COLI; IN-VIVO; MAMMALIAN-CELLS	Site-specific incorporation of bioorthogonal unnatural amino acids into proteins provides a useful tool for the installation of specific functionalities that will allow for the labeling of proteins with virtually any probe. We demonstrate the genetic encoding of a set of alkene lysines using the orthogonal PylRS/PylT(CUA) pair in Escherichia coli. The installed double bond functionality was then applied in a photoinitiated thiol-ene reaction of the protein with a fluorescent thiol-bearing probe, as well as a cysteine residue of a second protein, showing the applicability of this approach in the formation of heterogeneous non-linear fused proteins.	[Torres-Kolbus, Jessica; Chou, Chungjung; Deiters, Alexander] N Carolina State Univ, Dept Chem, Raleigh, NC 27695 USA; [Liu, Jihe; Deiters, Alexander] Univ Pittsburgh, Dept Chem, Pittsburgh, PA 15260 USA	University of North Carolina; North Carolina State University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Deiters, A (corresponding author), N Carolina State Univ, Dept Chem, Box 8204, Raleigh, NC 27695 USA.	deiters@pitt.edu	Deiters, Alexander/L-3722-2013	Deiters, Alexander/0000-0003-0234-9209; Liu, Jihe/0000-0002-6111-1498	National Science Foundation [CHE-0848398]; National Science Foundation Graduate Research Fellowship [NSF-0750733]	National Science Foundation(National Science Foundation (NSF)); National Science Foundation Graduate Research Fellowship(National Science Foundation (NSF))	This work was supported by the National Science Foundation (CHE-0848398). JTK received support from the National Science Foundation Graduate Research Fellowship (NSF-0750733). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ai HW, 2010, ANGEW CHEM INT EDIT, V49, P935, DOI 10.1002/anie.200905590; Aimetti AA, 2009, BIOMATERIALS, V30, P6048, DOI 10.1016/j.biomaterials.2009.07.043; Andresen M, 2004, MOL BIOL CELL, V15, P5616, DOI 10.1091/mbc.E04-06-0454; Arnaud O, 2010, J MED CHEM, V53, P6720, DOI 10.1021/jm100839w; Atkins JF, 2002, SCIENCE, V296, P1409, DOI 10.1126/science.1073339; Bar-Or R, 2008, RAPID COMMUN MASS SP, V22, P711, DOI 10.1002/rcm.3421; Behbehani GR, 2008, COLLOID SURFACE B, V61, P224, DOI 10.1016/j.colsurfb.2007.08.007; Bianco A, 2012, NAT CHEM BIOL, V8, P748, DOI [10.1038/nchembio.1043, 10.1038/NCHEMBIO.1043]; Blaschke UK, 2000, METHOD ENZYMOL, V328, P478, DOI 10.1016/S0076-6879(00)28414-0; Blight SK, 2004, NATURE, V431, P333, DOI 10.1038/nature02895; Brustad E, 2008, ANGEW CHEM INT EDIT, V47, P8220, DOI 10.1002/anie.200803240; Bundy BC, 2010, BIOCONJUGATE CHEM, V21, P255, DOI 10.1021/bc9002844; Chalker JM, 2011, ACCOUNTS CHEM RES, V44, P730, DOI 10.1021/ar200056q; Chalker JM, 2009, CHEM COMMUN, P3714, DOI 10.1039/b908004j; Chan JW, 2008, CHEM COMMUN, P4959, DOI 10.1039/b813438c; Chan JW, 2009, J AM CHEM SOC, V131, P5751, DOI 10.1021/ja8099135; Chen YX, 2011, ACCOUNTS CHEM RES, V44, P762, DOI 10.1021/ar200046h; Chin JW, 2002, J AM CHEM SOC, V124, P9026, DOI 10.1021/ja027007w; Chou CJ, 2011, CHEM SCI, V2, P480, DOI 10.1039/c0sc00373e; Davis L, 2012, NAT REV MOL CELL BIO, V13, P168, DOI 10.1038/nrm3286; Dawson PE, 2000, ANNU REV BIOCHEM, V69, P923, DOI 10.1146/annurev.biochem.69.1.923; Dawson PE, 2011, ISR J CHEM, V51, P862, DOI 10.1002/ijch.201100128; DeForest CA, 2012, ANGEW CHEM INT EDIT, V51, P1816, DOI 10.1002/anie.201106463; Deiters A, 2005, BIOORG MED CHEM LETT, V15, P1521, DOI 10.1016/j.bmcl.2004.12.065; Deiters A, 2004, BIOORG MED CHEM LETT, V14, P5743, DOI 10.1016/j.bmcl.2004.09.059; Dondoni A, 2012, CHEM SOC REV, V41, P573, DOI 10.1039/c1cs15157f; Durham OZ, 2012, ACS MACRO LETT, V1, P1134, DOI 10.1021/mz300358j; Eger S, 2011, CHEMBIOCHEM, V12, P2807, DOI 10.1002/cbic.201100444; Eger S, 2010, J AM CHEM SOC, V132, P16337, DOI 10.1021/ja1072838; Fekner T, 2011, CURR OPIN CHEM BIOL, V15, P387, DOI 10.1016/j.cbpa.2011.03.007; Flugel V, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096198; Funnell APW, 2012, ADV EXP MED BIOL, V747, P105, DOI 10.1007/978-1-4614-3229-6_7; Garber KCA, 2013, ACS CHEM BIOL, V8, P1671, DOI 10.1021/cb400184v; Gattner MJ, 2013, CHEM COMMUN, V49, P379, DOI 10.1039/c2cc37836a; Giepmans BNG, 2006, SCIENCE, V312, P217, DOI 10.1126/science.1124618; Greiss S, 2011, J AM CHEM SOC, V133, P14196, DOI 10.1021/ja2054034; Gupta N, 2010, NAT CHEM, V2, P138, DOI [10.1038/NCHEM.478, 10.1038/nchem.478]; Hancock SM, 2010, J AM CHEM SOC, V132, P14819, DOI 10.1021/ja104609m; Hao ZY, 2011, CHEM COMMUN, V47, P4502, DOI 10.1039/c1cc00024a; Hinner MJ, 2010, CURR OPIN BIOTECH, V21, P766, DOI 10.1016/j.copbio.2010.09.011; Hoyle CE, 2010, ANGEW CHEM INT EDIT, V49, P1540, DOI 10.1002/anie.200903924; Huang Y, 2010, BIOORG MED CHEM LETT, V20, P878, DOI 10.1016/j.bmcl.2009.12.077; Hudak JE, 2012, ANGEW CHEM INT EDIT, V51, P4161, DOI 10.1002/anie.201108130; Hutchins BM, 2011, CHEM BIOL, V18, P299, DOI 10.1016/j.chembiol.2011.01.006; Jain S, 2004, J CHROMATOGR A, V1035, P83, DOI 10.1016/j.chroma.2004.01.007; Jonkheijm P, 2008, ANGEW CHEM INT EDIT, V47, P4421, DOI 10.1002/anie.200800101; Kavran JM, 2007, P NATL ACAD SCI USA, V104, P11268, DOI 10.1073/pnas.0704769104; Klemm JD, 1998, ANNU REV IMMUNOL, V16, P569, DOI 10.1146/annurev.immunol.16.1.569; Kodama K, 2006, CHEMBIOCHEM, V7, P134, DOI 10.1002/cbic.200500290; Krzycki JA, 2005, CURR OPIN MICROBIOL, V8, P706, DOI 10.1016/j.mib.2005.10.009; Kwon I, 2006, J AM CHEM SOC, V128, P11778, DOI 10.1021/ja0626281; Lang K, 2014, ACS CHEM BIOL, V9, P16, DOI 10.1021/cb4009292; Lang K, 2012, J AM CHEM SOC, V134, P10317, DOI 10.1021/ja302832g; Lang K, 2012, NAT CHEM, V4, P298, DOI 10.1038/nchem.1250; Lee YJ, 2013, ACS CHEM BIOL, V8, P1664, DOI 10.1021/cb400267m; Levary DA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018342; Li X, 2009, ANGEW CHEM INT EDIT, V48, P9184, DOI 10.1002/anie.200904472; Li YM, 2013, ORG BIOMOL CHEM, V11, P2624, DOI 10.1039/c3ob27116a; Li YM, 2012, CHEM SCI, V3, P2766, DOI 10.1039/c2sc20433a; Lim RKV, 2010, CHEM COMMUN, V46, P1589, DOI 10.1039/b925931g; Liu CC, 2010, ANNU REV BIOCHEM, V79, P413, DOI 10.1146/annurev.biochem.052308.105824; Lowe AB, 2010, POLYM CHEM-UK, V1, P17, DOI 10.1039/b9py00216b; Lv YQ, 2012, ANALYST, V137, P4114, DOI 10.1039/c2an35706b; McGinty RK, 2009, ACS CHEM BIOL, V4, P958, DOI 10.1021/cb9002255; Michaux C, 2008, J MOL BIOL, V375, P1477, DOI 10.1016/j.jmb.2007.11.026; Namy O, 2007, FEBS LETT, V581, P5282, DOI 10.1016/j.febslet.2007.10.022; Neumann H, 2008, NAT CHEM BIOL, V4, P232, DOI 10.1038/nchembio.73; Nguyen DP, 2009, J AM CHEM SOC, V131, P8720, DOI 10.1021/ja900553w; Northrop BH, 2012, J AM CHEM SOC, V134, P13804, DOI [10.1021/ja305441d, 10.1021/Ja305441d]; Parrish AR, 2012, ACS CHEM BIOL, V7, P1292, DOI 10.1021/cb200542j; Plass T, 2012, ANGEW CHEM INT EDIT, V51, P4166, DOI 10.1002/anie.201108231; Plass T, 2011, ANGEW CHEM INT EDIT, V50, P3878, DOI 10.1002/anie.201008178; Robinson C, 2008, BIOORG CHEM, V36, P265, DOI 10.1016/j.bioorg.2008.06.004; RYPNIEWSKI WR, 1993, BIOCHEMISTRY-US, V32, P9851, DOI 10.1021/bi00088a041; Seitchik JL, 2012, J AM CHEM SOC, V134, P2898, DOI 10.1021/ja2109745; Sletten EM, 2009, ANGEW CHEM INT EDIT, V48, P6974, DOI 10.1002/anie.200900942; Sommer S, 2011, ANGEW CHEM INT EDIT, V50, P9888, DOI 10.1002/anie.201102531; Song W, 2008, J AM CHEM SOC, V130, P9654, DOI 10.1021/ja803598e; Song WJ, 2010, ACS CHEM BIOL, V5, P875, DOI 10.1021/cb100193h; Stephanopoulos N, 2011, NAT CHEM BIOL, V7, P876, DOI [10.1038/NCHEMBIO.720, 10.1038/nchembio.720]; SURESHCHANDRA BR, 1987, J AGR FOOD CHEM, V35, P244, DOI 10.1021/jf00074a019; Tan JJ, 2014, RSC ADV, V4, P13334, DOI 10.1039/c4ra00203b; Trang VH, 2012, ANGEW CHEM INT EDIT, V51, P13085, DOI 10.1002/anie.201207171; Tsao ML, 2005, CHEMBIOCHEM, V6, P2147, DOI 10.1002/cbic.200500314; Tsien RY, 2009, ANGEW CHEM INT EDIT, V48, P5612, DOI 10.1002/anie.200901916; Valkevich EM, 2012, J AM CHEM SOC, V134, P6916, DOI 10.1021/ja300500a; Virdee S, 2011, J AM CHEM SOC, V133, P10708, DOI 10.1021/ja202799r; Walker JR, 2001, NATURE, V412, P607, DOI 10.1038/35088000; Wan W, 2012, ORGANIC CHEM CURR RE, V1, P1; Wang L, 2003, P NATL ACAD SCI USA, V100, P56, DOI 10.1073/pnas.0234824100; Weinrich D, 2010, ANGEW CHEM INT EDIT, V49, P1252, DOI 10.1002/anie.200906190; WICKNER RB, 1969, J BIOL CHEM, V244, P6550; Wojcik F, 2013, CHEM-EUR J, V19, P3090, DOI 10.1002/chem.201203927; Xiao JP, 2009, ORG LETT, V11, P4144, DOI 10.1021/ol9016468; Yanagisawa T, 2008, J MOL BIOL, V378, P634, DOI 10.1016/j.jmb.2008.02.045; Yanagisawa T, 2008, CHEM BIOL, V15, P1187, DOI 10.1016/j.chembiol.2008.10.004; Ye SX, 2013, CHEMBIOCHEM, V14, P230, DOI 10.1002/cbic.201200515; Yu ZP, 2012, ANGEW CHEM INT EDIT, V51, P10600, DOI 10.1002/anie.201205352; Zeng HQ, 2006, BIOORG MED CHEM LETT, V16, P5356, DOI 10.1016/j.bmcl.2006.07.094; Zhang ZW, 2003, BIOCHEMISTRY-US, V42, P6735, DOI 10.1021/bi0300231	100	11	11	2	54	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2014	9	9							e105467	10.1371/journal.pone.0105467	http://dx.doi.org/10.1371/journal.pone.0105467			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3LR	25181502	Green Accepted, Green Published, gold			2022-12-27	WOS:000341231500026
J	Gautam, M; Izawa, A; Shiba, Y; Motoki, H; Takeuchi, T; Okada, A; Tomita, T; Miyashita, Y; Koyama, J; Ikeda, U				Gautam, Milan; Izawa, Atsushi; Shiba, Yuji; Motoki, Hirohiko; Takeuchi, Takahiro; Okada, Ayako; Tomita, Takeshi; Miyashita, Yusuke; Koyama, Jun; Ikeda, Uichi			Importance of Fatty Acid Compositions in Patients with Peripheral Arterial Disease	PLOS ONE			English	Article							CORONARY-HEART-DISEASE; GAMMA-LINOLENIC ACID; CHRONIC KIDNEY-DISEASE; C-REACTIVE PROTEIN; RISK-FACTORS; EICOSAPENTAENOIC ACID; CARDIOVASCULAR-DISEASE; SERUM N-3; ARACHIDONIC-ACID; EVENING PRIMROSE	Objective: Importance of fatty acid components and imbalances has emerged in coronary heart disease. In this study, we analyzed fatty acids and ankle-brachial index (ABI) in a Japanese cohort. Methods: Peripheral arterial disease (PAD) was diagnosed in 101 patients by ABI <= 0.90 and/or by angiography. Traditional cardiovascular risk factors and components of serum fatty acids were examined in all patients (mean age 73.2 +/- 0.9 years; 81 males), and compared with those in 373 age- and sex-matched control subjects with no evidence of PAD. Results: The presence of PAD (mean ABI: 0.71 +/- 0.02) was independently associated with low levels of gamma-linolenic acid (GLA) (OR: 0.90; 95% CI: 0.85-0.96; P = 0.002), eicosapentaenoic acid: arachidonic acid (EPA: AA) ratio (OR: 0.38; 95% CI: 0.17-0.86; P = 0.021), and estimated glomerular filtration rate (OR: 0.97; 95% CI: 0.96-0.98; P<0.0001), and with a high hemoglobin A1c level (OR: 1.34; 95% CI: 1.06-1.69; P = 0.013). Individuals with lower levels of GLA (<= 7.95 mu g/mL) and a lower EPA: AA ratio (<= 0.55) had the lowest ABI (0.96 +/- 0.02, N = 90), while the highest ABI (1.12 +/- 0.01, N = 78) was observed in individuals with higher values of both GLA and EPA: AA ratio (P<0.0001). Conclusion: A low level of GLA and a low EPA: AA ratio are independently associated with the presence of PAD. Specific fatty acid abnormalities and imbalances could lead to new strategies for risk stratification and prevention in PAD patients.	[Gautam, Milan; Izawa, Atsushi; Shiba, Yuji; Motoki, Hirohiko; Takeuchi, Takahiro; Okada, Ayako; Tomita, Takeshi; Miyashita, Yusuke; Koyama, Jun; Ikeda, Uichi] Shinshu Univ, Sch Med, Dept Cardiovasc Med, Matsumoto, Nagano 390, Japan	Shinshu University	Izawa, A (corresponding author), Shinshu Univ, Sch Med, Dept Cardiovasc Med, Matsumoto, Nagano 390, Japan.	izawa611@shinshu-u.ac.jp		Shiba, Yuji/0000-0002-0311-2919				CRIQUI MH, 1992, NEW ENGL J MED, V326, P381, DOI 10.1056/NEJM199202063260605; Criqui MH, 2008, J AM COLL CARDIOL, V52, P1736, DOI 10.1016/j.jacc.2008.07.060; Domei T, 2012, CIRC J, V76, P423, DOI 10.1253/circj.CJ-11-0941; Eichler K, 2007, AM HEART J, V153, P722, DOI 10.1016/j.ahj.2007.02.027; Endo M, 2010, HYPERTENS RES, V33, P911, DOI 10.1038/hr.2010.93; ENGLER MM, 1993, PROSTAG LEUKOTR ESS, V49, P809, DOI 10.1016/0952-3278(93)90030-Z; Erren M, 1999, ARTERIOSCL THROM VAS, V19, P2355, DOI 10.1161/01.ATV.19.10.2355; Fabsitz RR, 1999, AM J EPIDEMIOL, V149, P330; FAN YY, 1995, ARTERIOSCL THROM VAS, V15, P1397, DOI 10.1161/01.ATV.15.9.1397; Folsom AR, 2001, AM J CARDIOL, V88, P112, DOI 10.1016/S0002-9149(01)01603-4; Fujihara M, 2013, ANGIOLOGY, V64, P112, DOI 10.1177/0003319712437031; Fujiwara T, 2004, ATHEROSCLEROSIS, V177, P83, DOI 10.1016/j.atherosclerosis.2004.05.028; Germano G, 2012, EUR HEART J, V33, P137; Golledge J, 2013, ATHEROSCLEROSIS, V229, P549, DOI 10.1016/j.atherosclerosis.2013.04.030; Harris JI, 2004, PROSTAG LEUKOTR ESS, V71, P263, DOI 10.1016/j.plefa.2004.06.001; Harris WS, 2008, ATHEROSCLEROSIS, V197, P12, DOI 10.1016/j.atherosclerosis.2007.11.008; Harris WS, 2007, ATHEROSCLEROSIS, V193, P1, DOI 10.1016/j.atherosclerosis.2007.03.018; Harris WS, 2009, CIRCULATION, V119, P902, DOI 10.1161/CIRCULATIONAHA.108.191627; Ishikawa Y, 2010, CIRC J, V74, P1451, DOI 10.1253/circj.CJ-09-0520; Jung JY, 2014, ACTA DERM VENEREOL; Kumakura H, 2010, J VASC SURG, V52, P110, DOI 10.1016/j.jvs.2010.02.008; Laaksonen DE, 2005, ARCH INTERN MED, V165, P193, DOI 10.1001/archinte.165.2.193; Leng GC, 1998, CLIN NUTR, V17, P265, DOI 10.1016/S0261-5614(98)80318-X; Marangoni F, 2014, ATHEROSCLEROSIS, V232, P334, DOI 10.1016/j.atherosclerosis.2013.11.048; Matsuo S, 2009, AM J KIDNEY DIS, V53, P982, DOI 10.1053/j.ajkd.2008.12.034; Matsuzaki M, 2009, CIRC J, V73, P1283, DOI 10.1253/circj.CJ-08-1197; McDermott MM, 2003, AM J CARDIOL, V92, P194, DOI 10.1016/S0002-9149(03)00537-X; Micha R, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g2272; Mozaffarian D, 2013, ANN INTERN MED, V158, P515, DOI 10.7326/0003-4819-158-7-201304020-00003; Mozaffarian D, 2011, J AM COLL CARDIOL, V58, P2047, DOI 10.1016/j.jacc.2011.06.063; Ninomiya T, 2013, ATHEROSCLEROSIS, V231, P261, DOI 10.1016/j.atherosclerosis.2013.09.023; Nozue T, 2013, J CARDIOVASC PHARM T, V18, P320, DOI 10.1177/1074248412473202; Ohnishi H, 2010, J ATHEROSCLER THROMB, V17, P751, DOI 10.5551/jat.3731; Rezapour-Firouzi S, 2013, COMPLEMENT THER MED, V21, P473, DOI 10.1016/j.ctim.2013.06.006; Ridker PM, 2001, JAMA-J AM MED ASSOC, V285, P2481, DOI 10.1001/jama.285.19.2481; Rizos EC, 2012, JAMA-J AM MED ASSOC, V308, P1024, DOI 10.1001/2012.jama.11374; Roncaglioni MC, 2013, NEW ENGL J MED, V368, P1800, DOI 10.1056/NEJMoa1205409; Schmitz G, 2008, PROG LIPID RES, V47, P147, DOI 10.1016/j.plipres.2007.12.004; Selvin E, 2004, CIRCULATION, V110, P738, DOI 10.1161/01.CIR.0000137913.26087.F0; Smith SC, 2011, CIRCULATION, V124, P2458, DOI 10.1161/CIR.0b013e318235eb4d; Takai S, 2009, J ATHEROSCLER THROMB, V16, P480, DOI 10.5551/jat.No430; Tavazzi L, 2008, LANCET, V372, P1223, DOI 10.1016/S0140-6736(08)61239-8; Teramoto T, 2013, J ATHEROSCLER THROMB, V20, P517, DOI 10.5551/jat.15792; Thies F, 2003, LANCET, V361, P477, DOI 10.1016/S0140-6736(03)12468-3; Tousoulis D, 2014, ATHEROSCLEROSIS, V232, P10, DOI 10.1016/j.atherosclerosis.2013.10.014; Ueshima H, 2006, CIRC J, V70, P1249; Usui T, 2011, J ATHEROSCLER THROMB, V18, P705, DOI 10.5551/jat.7682; Valagussa F, 1999, LANCET, V354, P447, DOI 10.1016/S0140-6736(99)07072-5; WOOD DA, 1984, LANCET, V2, P117, DOI 10.1016/S0140-6736(84)91044-4; Yamazaki T, 2007, CIRC J, V71, P995, DOI 10.1253/circj.71.995; Yokoyama M, 2007, LANCET, V369, P1090, DOI 10.1016/S0140-6736(07)60527-3	51	11	11	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2014	9	9							e107003	10.1371/journal.pone.0107003	http://dx.doi.org/10.1371/journal.pone.0107003			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ1IR	25191963	Green Published, Green Submitted, gold			2022-12-27	WOS:000347993600086
J	Kuhberger, A; Fritz, A; Scherndl, T				Kuehberger, Anton; Fritz, Astrid; Scherndl, Thomas			Publication Bias in Psychology: A Diagnosis Based on the Correlation between Effect Size and Sample Size	PLOS ONE			English	Article							NULL HYPOTHESIS; CONFIDENCE-INTERVALS; CLINICAL-RESEARCH; P-VALUES; METAANALYSIS; SCIENCE; PREVALENCE; TRIALS; AGGRESSION; INCENTIVES	Background: The p value obtained from a significance test provides no information about the magnitude or importance of the underlying phenomenon. Therefore, additional reporting of effect size is often recommended. Effect sizes are theoretically independent from sample size. Yet this may not hold true empirically: non-independence could indicate publication bias. Methods: We investigate whether effect size is independent from sample size in psychological research. We randomly sampled 1,000 psychological articles from all areas of psychological research. We extracted p values, effect sizes, and sample sizes of all empirical papers, and calculated the correlation between effect size and sample size, and investigated the distribution of p values. Results: We found a negative correlation of r = -.45 [95% CI: -.53; -.35] between effect size and sample size. In addition, we found an inordinately high number of p values just passing the boundary of significance. Additional data showed that neither implicit nor explicit power analysis could account for this pattern of findings. Conclusion: The negative correlation between effect size and samples size, and the biased distribution of p values indicate pervasive publication bias in the entire field of psychology.	[Kuehberger, Anton; Scherndl, Thomas] Salzburg Univ, Dept Psychol, A-5020 Salzburg, Austria; [Kuehberger, Anton] Salzburg Univ, Ctr Cognit Neurosci, A-5020 Salzburg, Austria; [Fritz, Astrid] Osterreich Zentrum Begabtenforderung & Begabungsf, Salzburg, Austria	Salzburg University; Salzburg University	Kuhberger, A (corresponding author), Salzburg Univ, Dept Psychol, A-5020 Salzburg, Austria.	anton.kuehberger@sbg.ac.at		Kuhberger, Anton/0000-0001-5786-5943; Scherndl, Thomas/0000-0001-5755-9073	DOC-fFORTE-fellowship of the Austrian Academy of Sciences	DOC-fFORTE-fellowship of the Austrian Academy of Sciences	This research was supported by a DOC-fFORTE-fellowship of the Austrian Academy of Sciences to Astrid Fritz. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguinis H, 2005, J APPL PSYCHOL, V90, P94, DOI 10.1037/0021-9010.90.1.94; ALLEN M, 1995, HUM COMMUN RES, V22, P258, DOI 10.1111/j.1468-2958.1995.tb00368.x; American Educational Research Association, 2006, ED RES, V35, P33, DOI [10.3102/0013189x035006033?journalCode=e, DOI 10.3102/0013189X035006033]; [Anonymous], ES COMPUTER PROGRAM; APA (American Psychological Association), 2010, PUBL MAN AM PSYCH AS; ATKINSON DR, 1982, J COUNS PSYCHOL, V29, P189, DOI 10.1037/0022-0167.29.2.189; Bakker M, 2012, PERSPECT PSYCHOL SCI, V7, P543, DOI 10.1177/1745691612459060; Brand A, 2011, J GEN PSYCHOL, V138, P281, DOI 10.1080/00221309.2011.604365; Silva-Aycaguer LC, 2010, BMC MED RES METHODOL, V10, DOI 10.1186/1471-2288-10-44; Charles P, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b1732; Cooper H, 1997, PSYCHOL METHODS, V2, P447, DOI 10.1037/1082-989X.2.4.447; COURSOL A, 1986, PROF PSYCHOL-RES PR, V17, P136, DOI 10.1037/0735-7028.17.2.136; Cumming G., 2013, UNDERSTANDING NEW ST; Cumming G, 2009, Z PSYCHOL, V217, P15, DOI 10.1027/0044-3409.217.1.15; De Angelis C, 2004, NEW ENGL J MED, V351, P1250, DOI 10.1056/NEJMe048225; Dubben HH, 2005, BRIT MED J, V331, P433, DOI 10.1136/bmj.38478.497164.F7; Fanelli D, 2013, P NATL ACAD SCI USA, V110, P15031, DOI 10.1073/pnas.1302997110; Fanelli D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010068; Ferguson CJ, 2012, PERSPECT PSYCHOL SCI, V7, P555, DOI 10.1177/1745691612459059; Ferguson CJ, 2012, PSYCHOL METHODS, V17, P120, DOI 10.1037/a0024445; Francis G, 2014, PSYCHONOMIC B REV, P1; Fritz A, 2013, THEOR PSYCHOL, V23, P98, DOI 10.1177/0959354312436870; Gerber A, 2008, Q J POLIT SCI, V3, P313, DOI 10.1561/100.00008024; Gerber AS, 2008, SOCIOL METHOD RES, V37, P3, DOI 10.1177/0049124108318973; GERBER AS, 2001, POLIT ANAL, V0009; Germine L, 2012, PSYCHON B REV, V19, P847, DOI 10.3758/s13423-012-0296-9; Gigerenzer G., 1987, COGNITION INTUITIVE; Gliner JA, 2002, J EXP EDUC, V71, P83, DOI 10.1080/00220970209602058; GREENWALD AG, 1975, PSYCHOL BULL, V82, P1, DOI 10.1037/h0076157; Howard GS, 2009, REV GEN PSYCHOL, V13, P146, DOI 10.1037/a0015319; Ioannidis JPA, 2005, JAMA-J AM MED ASSOC, V294, P218, DOI 10.1001/jama.294.2.218; Ioannidis JPA, 2005, PLOS MED, V2, P696, DOI 10.1371/journal.pmed.0020124; John LK, 2012, PSYCHOL SCI, V23, P524, DOI 10.1177/0956797611430953; La France BH, 2004, COMMUN MONOGR, V71, P28, DOI 10.1080/03634520410001693148; Lecoutre MP, 2003, INT J PSYCHOL, V38, P37, DOI 10.1080/00207590244000250; Leggett NC, 2013, Q J EXP PSYCHOL, V66, P2303, DOI 10.1080/17470218.2013.863371; Levine T, 2009, COMMUN MONOGR, V76, P286, DOI 10.1080/03637750903074685; Levine TR, 2008, HUM COMMUN RES, V34, P171, DOI 10.1111/j.1468-2958.2008.00317.x; Macleod M, 2011, NATURE, V477, P511, DOI 10.1038/477511a; Makel MC, 2012, PERSPECT PSYCHOL SCI, V7, P537, DOI 10.1177/1745691612460688; Masicampo EJ, 2012, Q J EXP PSYCHOL, V65, P2271, DOI 10.1080/17470218.2012.711335; Maxmen A, 2013, PRESERVING RES; Moller AP, 2001, TRENDS ECOL EVOL, V16, P580, DOI 10.1016/S0169-5347(01)02235-2; Morris PE, 2013, PSYCHOLOGIST, V26, P580; Nickerson RS, 2000, PSYCHOL METHODS, V5, P241, DOI 10.1037//1082-989X.5.2.241; Nosek BA, 2012, PERSPECT PSYCHOL SCI, V7, P615, DOI 10.1177/1745691612459058; Odgaard EC, 2010, J CONSULT CLIN PSYCH, V78, P287, DOI 10.1037/a0019294; Peterson RA, 2005, J APPL PSYCHOL, V90, P175, DOI 10.1037/0021-9010.90.1.175; Reysen S, 2006, PSYCHOL REP, V98, P169, DOI 10.2466/PRO.98.1.169-175; Ridley J, 2007, J EVOLUTION BIOL, V20, P1082, DOI 10.1111/j.1420-9101.2006.01291.x; ROTTON J, 1995, J SOC BEHAV PERS, V10, P1; Schooler J, 2011, NATURE, V470, P437, DOI 10.1038/470437a; Schulz KF, 2005, LANCET, V365, P1348, DOI 10.1016/S0140-6736(05)61034-3; Simmons JP, 2011, PSYCHOL SCI, V22, P1359, DOI 10.1177/0956797611417632; Slavin R, 2009, EDUC EVAL POLICY AN, V31, P500, DOI 10.3102/0162373709352369; Stanley TD, 2010, AM STAT, V64, P70, DOI 10.1198/tast.2009.08205; Stern JM, 1997, BMJ-BRIT MED J, V315, P640, DOI 10.1136/bmj.315.7109.640; Thompson B, 2002, J COUNS DEV, V80, P64, DOI 10.1002/j.1556-6678.2002.tb00167.x; Thompson B, 2009, J TEACH PHYS EDUC, V28, P251, DOI 10.1123/jtpe.28.3.251; Wicherts JM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026828; WOOD W, 1991, PSYCHOL BULL, V109, P371, DOI 10.1037/0033-2909.109.3.371	61	175	179	0	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2014	9	9							e105825	10.1371/journal.pone.0105825	http://dx.doi.org/10.1371/journal.pone.0105825			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AZ1IR	25192357	Green Submitted, Green Published, gold			2022-12-27	WOS:000347993600011
J	Kitagawa, Y; Shimodera, S; Togo, F; Okazaki, Y; Nishida, A; Sasaki, T				Kitagawa, Yuko; Shimodera, Shinji; Togo, Fumiharu; Okazaki, Yuji; Nishida, Atsushi; Sasaki, Tsukasa			Suicidal Feelings Interferes with Help-Seeking in Bullied Adolescents	PLOS ONE			English	Article							SELF-HARM; BULLYING VICTIMIZATION; YOUNG-PEOPLE; RISK; POPULATION; DEPRESSION; COHORT; HOPELESSNESS; STRATEGIES; BEHAVIORS	Purpose: Being bullied is associated with the manifestation of suicidal feelings, which sharply increase in middle(-late) adolescence. Whether or not bullied middle(-late) adolescents with suicidal feelings seek help is therefore a critical issue, given that help-seeking plays a key role in the prevention of suicide. The aim of the present study is to investigate the effects of bullying, suicidal feelings and the interaction between these two factors on help-seeking behavior in adolescents. Methods: Japanese middle(-late) adolescents (aged 15-18 years; n = 9484) were studied using self-report questionnaires. The rate of adolescents who actually sought help was examined for bullying status and suicidal feelings. Results: The rate of adolescents who sought help was significantly higher when they were bullied (p<0.001) and also when they had mild suicidal feelings (p<0.001), but not when they displayed serious suicidal feelings. In the case of adolescents who were bullied, however, having suicidal feelings significantly decreased the rate of help-seeking (OR = 0.47, p<0.05 and OR = 0.32, p = 0.002 for having mild and serious suicidal feelings, respectively). The decrease was remarkable when suicidal feelings were serious. Specifically, the decrease was significant in seeking help from peers and family members, who are the most frequent source of the help for adolescents, when they had serious suicidal feelings (OR = 0.21, p<0.01 and OR = 0.13, p<0.001, respectively). Conclusions: Suicidal feelings may interfere with help-seeking behavior, which could be critical in suicide prevention in bullied middle(-late) adolescents.	[Kitagawa, Yuko; Togo, Fumiharu; Sasaki, Tsukasa] Univ Tokyo, Grad Sch Educ, Dept Hlth Educ, Tokyo, Japan; [Shimodera, Shinji] Kochi Univ, Kochi Med Sch, Dept Neuropsychiat, Kochi 780, Japan; [Okazaki, Yuji] Tokyo Metropolitan Matsuzawa Hosp, Tokyo, Japan; [Nishida, Atsushi] Tokyo Metropolitan Inst Med Sci, Dept Psychiat & Behav Sci, Tokyo 113, Japan	University of Tokyo; Kochi University; Tokyo Metropolitan Institute of Medical Science	Nishida, A (corresponding author), Tokyo Metropolitan Inst Med Sci, Dept Psychiat & Behav Sci, Tokyo 113, Japan.	nishida-at@igakuken.or.jp	Andoh, Akira/AAB-9303-2022		Ministry of Health, Labour, and Welfare of Japan Scientific Research Grant [H19-kokoro-ippan-012]; Ministry of Education, Culture, Sports, Science and Technology of Japan Scientific Research Grant on Innovative Area [23118004]; Japanese Society for the Promotion of Science; Research Group for Schizophrenia in Japan; Tokyo Metropolitan Institute of Medical Science Project Grant [Kokoronokenko H21-H26]; JSPS KAKENHI Grant [2612170]	Ministry of Health, Labour, and Welfare of Japan Scientific Research Grant; Ministry of Education, Culture, Sports, Science and Technology of Japan Scientific Research Grant on Innovative Area; Japanese Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Research Group for Schizophrenia in Japan; Tokyo Metropolitan Institute of Medical Science Project Grant; JSPS KAKENHI Grant(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by the Ministry of Health, Labour, and Welfare of Japan Scientific Research Grant (#H19-kokoro-ippan-012), the Ministry of Education, Culture, Sports, Science and Technology of Japan Scientific Research Grant on Innovative Area (23118004; Adolescent Mind & Self-Regulation), the Japanese Society for the Promotion of Science Scientific Research Grant (Strategic Young Researcher Overseas Visits Program for Accelerating Brain Circulation), the Research Group for Schizophrenia in Japan (Award for Research Excellence 2011 to A. N.) and the Tokyo Metropolitan Institute of Medical Science Project Grant (Kokoronokenko H21-H26), and JSPS KAKENHI Grant Number 2612170. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arseneault L, 2006, PEDIATRICS, V118, P130, DOI 10.1542/peds.2005-2388; Arseneault L, 2010, PSYCHOL MED, V40, P717, DOI 10.1017/S0033291709991383; Boulton M, 1992, BRIT J PSYCHOL; Cash SJ, 2009, CURR OPIN PEDIATR, V21, P613, DOI 10.1097/MOP.0b013e32833063e1; Craig W, 2009, INT J PUBLIC HEALTH, V54, P216, DOI 10.1007/s00038-009-5413-9; Deane FP, 2001, J CLIN PSYCHOL, V57, P901, DOI 10.1002/jclp.1058; Eliot M, 2010, J SCHOOL PSYCHOL, V48, P533, DOI 10.1016/j.jsp.2010.07.001; Fisher HL, 2012, BRIT MED J, V344, DOI 10.1136/bmj.e2683; Gould MS, 2004, J AM ACAD CHILD PSY, V43, P1124, DOI 10.1097/01.chi.0000132811.06547.31; Gulliver A, 2012, BMC PSYCHIATRY, V12, DOI 10.1186/1471-244X-12-81; Haavet OR, 2005, J ADOLESCENT HEALTH, V37, P128, DOI 10.1016/j.jadohealth.2004.08.031; Hawton K, 2012, LANCET, V379, P2373, DOI 10.1016/S0140-6736(12)60322-5; Hawton K, 2009, LANCET, V373, P1372, DOI 10.1016/S0140-6736(09)60372-X; Heikkila HK, 2013, EUR CHILD ADOLES PSY, V22, P95, DOI 10.1007/s00787-012-0327-0; Hepburn L, 2012, J ADOLESCENT HEALTH, V51, P93, DOI 10.1016/j.jadohealth.2011.12.014; Hunter SC, 2004, BRIT J EDUC PSYCHOL, V74, P375, DOI 10.1348/0007099041552378; Husky M, 2012, PSYCHIAT SERVICES; Japan Ministry of Health Labour and Welfare, 2011, VIT STAT; Johnson JG, 2002, ARCH GEN PSYCHIAT, V59, P741, DOI 10.1001/archpsyc.59.8.741; Kaltiala-Heino R, 1999, BRIT MED J, V319, P348, DOI 10.1136/bmj.319.7206.348; Kim YS, 2005, PEDIATRICS, V115, P357, DOI 10.1542/peds.2004-0902; King M, 2008, BMC PSYCHIATRY, V8, DOI 10.1186/1471-244X-8-70; Klomek A, 2008, SUICIDE LIFE THREATE, V38; Klomek AB, 2007, J AM ACAD CHILD PSY, V46, P40, DOI 10.1097/01.chi.0000242237.84925.18; Klomek AB, 2009, J AM ACAD CHILD PSY, V48, P254, DOI 10.1097/CHI.0b013e318196b91f; Mann JJ, 2005, JAMA-J AM MED ASSOC, V294, P2064, DOI 10.1001/jama.294.16.2064; Marcel F. van der Wal, 2003, PEDIATRICS, V111, P1312; Michelmore L, 2012, SUICIDE LIFE-THREAT, V42, P507, DOI 10.1111/j.1943-278X.2012.00108.x; Oliver C, 2007, OXFORD REV EDUC, V33, P71, DOI 10.1080/03054980601094594; Patton GC, 2009, LANCET, V374, P881, DOI 10.1016/S0140-6736(09)60741-8; PAYKEL ES, 1974, BRIT J PSYCHIAT, V124, P460, DOI 10.1192/bjp.124.5.460; Pompili M, 2012, J PSYCHOSOM RES, V73, P411, DOI 10.1016/j.jpsychores.2012.09.011; Qin P, 2005, FACTORS CONTRIBUTING, P2; Rickwood D, 2005, AUSTR E J ADV MENTAL, V4; Rickwood D., 2007, MED J AUSTR, V187; Smith PK, 2000, CHILDHOOD, V7, P193, DOI 10.1177/0907568200007002005; WHO,, 2012, PUBL HLTH ACT PREV; Wilson CJ, 2005, J CLIN PSYCHOL, V61, P1525, DOI 10.1002/jclp.20206; Wilson CJ, 2010, J YOUTH ADOLESCENCE, V39, P343, DOI 10.1007/s10964-009-9436-6	39	9	9	2	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 4	2014	9	9							e106031	10.1371/journal.pone.0106031	http://dx.doi.org/10.1371/journal.pone.0106031			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AO3XV	25188324	gold, Green Published			2022-12-27	WOS:000341271500018
J	Pizzatto, L; Both, C; Shine, R				Pizzatto, Ligia; Both, Camila; Shine, Richard			Quantifying Anuran Microhabitat Use to Infer the Potential for Parasite Transmission between Invasive Cane Toads and Two Species of Australian Native Frogs	PLOS ONE			English	Article							BUFO-MARINUS; RHABDIAS-PSEUDOSPHAEROCEPHALA; TREE FROGS; LUNGWORM; HOST; POPULATION; PREDATORS; ECOSYSTEM; DYNAMICS; NEMATODA	Parasites that are carried by invasive species can infect native taxa, with devastating consequences. In Australia, invading cane toads (Rhinella marina) carry lungworm parasites (Rhabdias pseudosphaerocephala) that (based on previous laboratory studies) can infect native treefrogs (Litoria caerulea and L. splendida). To assess the potential of parasite transmission from the invader to the native species (and from one infected native frog to another), we used surveys and radiotelemetry to quantify anuran microhabitat use, and proximity to other anurans, in two sites in tropical Australia. Unsurprisingly, treefrogs spent much of their time off the ground (especially by day, and in undisturbed forests) but terrestrial activity was common at night (especially in anthropogenically modified habitats). Microhabitat overlap between cane toads and frogs was generally low, except at night in disturbed areas, whereas overlap between the two frog species was high. The situations of highest overlap, and hence with the greatest danger of parasite transmission, involve aggregations of frogs within crevices by day, and use of open ground by all three anuran species at night. Overall, microhabitat divergence between toads and frogs should reduce, but not eliminate, the transmission of lungworms from invasive toads to vulnerable native frogs.	[Pizzatto, Ligia; Both, Camila; Shine, Richard] Univ Sydney, Sch Biol Sci, Sydney, NSW 2006, Australia; [Both, Camila] Pontificia Univ Catolica Rio Grande do Sul, Programa Pos Grad Zool, Porto Alegre, RS, Brazil	University of Sydney; Pontificia Universidade Catolica Do Rio Grande Do Sul	Pizzatto, L (corresponding author), Univ Sydney, Sch Biol Sci, Sydney, NSW 2006, Australia.	ligia.oceanica@gmail.com		Both, Camila/0000-0002-4590-7242	Australian Research Council [DP0984888]; Brazilian Conselho Nacional de Pesquisa (CNPq)	Australian Research Council(Australian Research Council); Brazilian Conselho Nacional de Pesquisa (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	Australian Research Council funded the project (grant DP0984888) and Brazilian Conselho Nacional de Pesquisa (CNPq) funded a fellowship to Camila Both. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson CB, 2007, OECOLOGIA, V154, P141, DOI 10.1007/s00442-007-0757-4; BAKER MR, 1979, CAN J ZOOL, V57, P161, DOI 10.1139/z79-014; Brown GP, 2013, J ANIM ECOL, V82, P854, DOI 10.1111/1365-2656.12048; Brown GP, 2011, FUNCT ECOL, V25, P1339, DOI 10.1111/j.1365-2435.2011.01888.x; Burton TC, 1998, J HERPETOL, V32, P611, DOI 10.2307/1565224; Clayton DH, 2003, P NATL ACAD SCI USA, V100, P15694, DOI 10.1073/pnas.2533751100; Combes C., 1991, P62; da Silva Emanuel Teixeira, 2011, South American Journal of Herpetology, V6, P1; Dijkstra JA, 2013, BIOL INVASIONS, V15, P911, DOI 10.1007/s10530-012-0339-1; Dolman PM, 2008, WILDLIFE RES, V35, P202, DOI 10.1071/WR07114; Dubey S, 2008, MOL ECOL, V17, P4418, DOI 10.1111/j.1365-294X.2008.03922.x; Dunn AM, 2009, ADV PARASIT, V68, P161, DOI 10.1016/S0065-308X(08)00607-6; Endlein T, 2013, J R SOC INTERFACE, V10, DOI 10.1098/rsif.2012.0838; Feder M. E., 1992, ENV PHYSL AMPHIBIANS; Federle W, 2006, J R SOC INTERFACE, V3, P689, DOI 10.1098/rsif.2006.0135; Gotelli N., 2001, ECOSIM NULL MODELS S, V78, DOI 10.5281/zenodo.16504; GOWER JC, 1971, BIOMETRICS, V27, P857, DOI 10.2307/2528823; Gozlan RE, 2005, NATURE, V435, P1046, DOI 10.1038/4351046a; Graither M, 2013, PLOS ONE, V8; Gray LA, 1997, J EXP ZOOL, V277, P417, DOI 10.1002/(SICI)1097-010X(19970415)277:6<417::AID-JEZ1>3.0.CO;2-R; Greenlees MJ, 2006, ANIM CONSERV, V9, P431, DOI 10.1111/j.1469-1795.2006.00057.x; Greenlees MJ, 2007, AUSTRAL ECOL, V32, P900, DOI 10.1111/j.1442-9993.2007.01778.x; Greenlees MJ, 2010, BIOL J LINN SOC, V100, P329, DOI 10.1111/j.1095-8312.2010.01432.x; Heym A, 2013, SALAMANDRA, V49, P97; Kelehear C, 2012, CONSERV LETT, V5, P360, DOI 10.1111/j.1755-263X.2012.00251.x; Kelehear C, 2011, HERPETOLOGICA, V67, P378, DOI 10.1655/HERPETOLOGICA-D-11-00027.1; Kilpatrick AM, 2010, TRENDS ECOL EVOL, V25, P109, DOI 10.1016/j.tree.2009.07.011; Kirk RS, 2003, FISHERIES MANAG ECOL, V10, P385, DOI 10.1111/j.1365-2400.2003.00355.x; Langford G, 2010, ECOLOGY RELATIONSHIP; Langford GJ, 2013, J PARASITOL, V99, P277, DOI 10.1645/GE-3217.1; LEVER C., 2001, CANE TOAD HIST ECOLO; McArthur LJ, 2007, SEASONAL ENERGETICS; Nelson DWM, 2011, OIKOS, V120, P152, DOI 10.1111/j.1600-0706.2010.18736.x; Pillar V.P., 2006, MULTIV MULTIVARIATE; Pillar VD, 1996, J VEG SCI, V7, P585, DOI 10.2307/3236308; Pizzatto L, 2012, ANIM CONSERV, V15, P545, DOI 10.1111/j.1469-1795.2012.00564.x; Pizzatto L, 2008, BEHAV ECOL SOCIOBIOL, V63, P123, DOI 10.1007/s00265-008-0642-0; Pizzatto L, 2013, INT J PARASITOL, V43, P753, DOI 10.1016/j.ijpara.2013.05.002; Pizzatto L, 2012, J WILDLIFE DIS, V48, P951, DOI 10.7589/2012-02-050; Pizzatto L, 2011, INT J PARASITOL, V41, P943, DOI 10.1016/j.ijpara.2011.03.013; Pizzatto L, 2011, AUSTRAL ECOL, V36, P954, DOI 10.1111/j.1442-9993.2010.02231.x; Pizzatto L, 2010, J WILDLIFE DIS, V46, P1152, DOI 10.7589/0090-3558-46.4.1152; Planka E.R., 1973, Annual Rev Ecol Syst, V4, P53; Poulin R., 2007, EVOL ECOL, V2; Salo P, 2007, P ROY SOC B-BIOL SCI, V274, P1237, DOI 10.1098/rspb.2006.0444; Shine R, 1996, COPEIA, P290; Shine R, 2014, AUSTRAL ECOL, V39, P1, DOI 10.1111/aec.12066; Shine R, 2009, FRONT ECOL ENVIRON, V7, P359, DOI 10.1890/080081; STRUSSMANN C, 1984, J HERPETOL, V18, P138, DOI 10.2307/1563741; Tingley R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025979; Tracy CR, 2011, AM NAT, V178, P553, DOI 10.1086/661908; Tyler M.J., 2009, FIELD GUIDE FROGS AU; Tyler M. J., 1996, FROGS PETS GUIDE KEE; Tyler M. J., 1983, DIET FEEDING HABITS; Urban MC, 2007, P ROY SOC B-BIOL SCI, V274, P1413, DOI 10.1098/rspb.2007.0114; Wiens JJ, 2010, MOL PHYLOGENET EVOL, V55, P871, DOI 10.1016/j.ympev.2010.03.013; ZUG G.R., 1979, SMITHSON CONTRIB ZOO, V284, P1	57	7	7	0	55	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 4	2014	9	9							e106996	10.1371/journal.pone.0106996	http://dx.doi.org/10.1371/journal.pone.0106996			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3XV	25188421	Green Published, Green Submitted, gold			2022-12-27	WOS:000341271500104
J	Sasportas, LS; Hori, SS; Pratx, G; Gambhir, SS				Sasportas, Laura Sarah; Hori, Sharon Seiko; Pratx, Guillem; Gambhir, Sanjiv Sam			Detection and Quantitation of Circulating Tumor Cell Dynamics by Bioluminescence Imaging in an Orthotopic Mammary Carcinoma Model	PLOS ONE			English	Article							VIVO FLOW-CYTOMETRY; IN-VIVO; BREAST-CANCER; MOUSE MODEL; METASTASIS; BLOOD	Circulating tumor cells (CTCs) have been detected in the bloodstream of both early-stage and advanced cancer patients. However, very little is know about the dynamics of CTCs during cancer progression and the clinical relevance of longitudinal CTC enumeration. To address this, we developed a simple bioluminescence imaging assay to detect CTCs in mouse models of metastasis. In a 4T1 orthotopic metastatic mammary carcinoma mouse model, we demonstrated that this quantitative method offers sensitivity down to 2 CTCs in 0.1-1mL blood samples and high specificity for CTCs originating from the primary tumor, independently of their epithelial status. In this model, we simultaneously monitored blood CTC dynamics, primary tumor growth, and lung metastasis progression over the course of 24 days. Early in tumor development, we observed low numbers of CTCs in blood samples (10-15 cells/100 mu L) and demonstrated that CTC dynamics correlate with viable primary tumor growth. To our knowledge, these data represent the first reported use of bioluminescence imaging to detect CTCs and quantify their dynamics in any cancer mouse model. This new assay is opening the door to the study of CTC dynamics in a variety of animal models. These studies may inform clinical decision on the appropriate timing of blood sampling and value of longitudinal CTC enumeration in cancer patients.	[Sasportas, Laura Sarah; Hori, Sharon Seiko; Gambhir, Sanjiv Sam] Stanford Univ, Sch Med, Dept Radiol, Mol Imaging Program Stanford, Stanford, CA 94305 USA; [Sasportas, Laura Sarah] Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA; [Pratx, Guillem] Stanford Univ, Dept Radiat Oncol, Stanford, CA 94305 USA	Stanford University; Stanford University; Stanford University	Gambhir, SS (corresponding author), Stanford Univ, Sch Med, Dept Radiol, Mol Imaging Program Stanford, Stanford, CA 94305 USA.	sgambhir@stanford.edu	Pratx, Guillem/AAK-8006-2020	Pratx, Guillem/0000-0002-0247-6470	Fulbright Science and Technology Fellowship; Stanford Weiland Fellowship; Howard Hughes Medical Institute (HHMI); Siebel Scholarship; NCI Center for Cancer Nanotechnology Excellence grant (CCNE-T) [U54CA151459]; NCI ICMIC [P50CA114747]; Canary Foundation; Society for Nuclear Medicine (SNM); NATIONAL CANCER INSTITUTE [U01CA188383, P50CA114747, U54CA151459, P30CA124435] Funding Source: NIH RePORTER	Fulbright Science and Technology Fellowship; Stanford Weiland Fellowship; Howard Hughes Medical Institute (HHMI)(Howard Hughes Medical Institute); Siebel Scholarship; NCI Center for Cancer Nanotechnology Excellence grant (CCNE-T); NCI ICMIC; Canary Foundation; Society for Nuclear Medicine (SNM); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	L. S. Sasportas was supported by a Fulbright Science and Technology Fellowship, a Stanford Weiland Fellowship, a Student Fellowship from the Society for Nuclear Medicine (SNM), an International Student Fellowship from the Howard Hughes Medical Institute (HHMI), and a Siebel Scholarship. This work was supported by a NCI Center for Cancer Nanotechnology Excellence grant (CCNE-T) U54CA151459, NCI ICMIC P50CA114747, and the Canary Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Mehdi AB, 2000, NAT MED, V6, P100, DOI 10.1038/71429; Alix-Panabieres C, 2012, CLIN CHEM; Allan AL, 2005, CYTOM PART A, V65A, P4, DOI 10.1002/cyto.a.20132; ASLAKSON CJ, 1992, CANCER RES, V52, P1399; Baccelli I, 2013, NAT BIOTECHNOL, V31, P539, DOI 10.1038/nbt.2576; Bonnomet A, 2012, ONCOGENE, V31, P3741, DOI 10.1038/onc.2011.540; Coumans FA, 2012, THESIS U TWENTE; DONELLI MG, 1969, CANCER RES, V29, P414; Eliane JP, 2008, CANCER RES, V68, P5529, DOI 10.1158/0008-5472.CAN-08-0630; Fan ZC, 2012, CANCER RES, V72, P2683, DOI 10.1158/0008-5472.CAN-11-3733; Georgakoudi I, 2004, CANCER RES, V64, P5044, DOI 10.1158/0008-5472.CAN-04-1058; Gray JW, 2003, CANCER CELL, V4, P4, DOI 10.1016/S1535-6108(03)00167-3; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; He W, 2007, P NATL ACAD SCI USA, V104, P11760, DOI 10.1073/pnas.0703875104; Helzer KT, 2009, CANCER RES, V69, P7860, DOI 10.1158/0008-5472.CAN-09-0801; Howard EW, 2007, CLIN CANCER RES, V13, P1847, DOI 10.1158/1078-0432.CCR-06-2074; James ML, 2012, PHYSIOL REV, V92, P897, DOI 10.1152/physrev.00049.2010; Juratli MA, 2014, CANCERS, V6, P128, DOI 10.3390/cancers6010128; Kammerloher W, 2008, NAT METHODS, V5; Kang JH, 2012, LAB CHIP, V12, P2175, DOI 10.1039/c2lc40072c; Kim JB, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009364; Kolostova K, 2011, ANTICANCER RES, V31, P1535; Krivacic RT, 2004, P NATL ACAD SCI USA, V101, P10501, DOI 10.1073/pnas.0404036101; LEE VW, 1976, CANCER RES, V36, P2053; LIOTTA LA, 1974, CANCER RES, V34, P997; Lucci A, 2012, LANCET ONCOL, V13, P688, DOI 10.1016/S1470-2045(12)70209-7; Mordant P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026073; Nieva J, 2012, PHYS BIOL, V9, DOI 10.1088/1478-3975/9/1/016004; Pages JC, 1996, CANCER LETT, V106, P139, DOI 10.1016/0304-3835(96)04319-4; Pantel K, 2008, NAT REV CANCER, V8, P329, DOI 10.1038/nrc2375; Paterlini-Brechot P, 2007, CANCER LETT, V253, P180, DOI 10.1016/j.canlet.2006.12.014; Paterlini-Brechot P, 2011, FUTURE ONCOL, V7, P849, DOI [10.2217/FON.11.32, 10.2217/fon.11.32]; Rice BW, 2001, J BIOMED OPT, V6, P432, DOI 10.1117/1.1413210; ROMSDAHL MM, 1961, J NATL CANCER I, V26, P19; ROSSO R, 1967, CANCER RES, V27, P1225; SAKO K, 1963, Tech Bull Regist Med Technol, V33, P105; Sasportas LS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086759; Scatton O, 2006, ONCOGENE, V25, P4067, DOI 10.1038/sj.onc.1209430; Schmidt CM, 1999, CLIN EXP METASTAS, V17, P537, DOI 10.1023/A:1006719800907; Sleijfer S, 2011, NAT REV CLIN ONCOL, V8, P696, DOI 10.1038/nrclinonc.2011.167; Sweeney TJ, 1999, P NATL ACAD SCI USA, V96, P12044, DOI 10.1073/pnas.96.21.12044; Tao K, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-228; Tibbe AGJ, 2007, CYTOM PART A, V71A, P154, DOI 10.1002/cyto.a.20369; Tsuji T, 2008, CANCER RES, V68, P10377, DOI 10.1158/0008-5472.CAN-08-1444; Weng DS, 2012, BREAST CANCER RES, V14, DOI 10.1186/bcr3102; Wyckoff JB, 2007, CANCER RES, V67, P2649, DOI 10.1158/0008-5472.CAN-06-1823; Yu M, 2013, SCIENCE, V339, P580, DOI 10.1126/science.1228522; Yu M, 2011, J CELL BIOL, V192, P373, DOI 10.1083/jcb.201010021; Zhang L, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3006376; Zhang LL, 2012, CLIN CANCER RES, V18, P5701, DOI 10.1158/1078-0432.CCR-12-1587; Zhao H, 2005, J BIOMED OPT, V10, DOI 10.1117/1.2032388	51	10	10	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 4	2014	9	9							e105079	10.1371/journal.pone.0105079	http://dx.doi.org/10.1371/journal.pone.0105079			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3XV	25188396	Green Published, Green Submitted, gold			2022-12-27	WOS:000341271500005
J	Boettiger, DC; Kerr, S; Ditangco, R; Merati, TP; Pham, TTT; Chaiwarith, R; Kiertiburanakul, S; Li, CKP; Kumarasamy, N; Vonthanak, S; Lee, C; Kinh, NV; Pujari, S; Wong, WW; Kamarulzaman, A; Zhang, FJ; Yunihastuti, E; Choi, JY; Oka, S; Ng, OT; Kantipong, P; Mustafa, M; Ratanasuwan, W; Sohn, A; Law, M				Boettiger, David Charles; Kerr, Stephen; Ditangco, Rossana; Merati, Tuti Parwati; Thuy Thi Thanh Pham; Chaiwarith, Romanee; Kiertiburanakul, Sasisopin; Li, Chung Ki Patrick; Kumarasamy, Nagalingeswaran; Vonthanak, Saphonn; Lee, Christopher; Nguyen Van Kinh; Pujari, Sanjay; Wong, Wing Wai; Kamarulzaman, Adeeba; Zhang, Fujie; Yunihastuti, Evy; Choi, Jun Yong; Oka, Shinichi; Ng, Oon Tek; Kantipong, Pacharee; Mustafa, Mahiran; Ratanasuwan, Winai; Sohn, Annette; Law, Matthew			Trends in First-Line Antiretroviral Therapy in Asia: Results from the TREAT Asia HIV Observational Database	PLOS ONE			English	Article							COMBINATION; NEVIRAPINE; EFAVIRENZ; TENOFOVIR; EFFICACY; SAFETY; RATES; STAVUDINE; REGIMENS; IMPACT	Background: Antiretroviral therapy (ART) has evolved rapidly since its beginnings. This analysis describes trends in first-line ART use in Asia and their impact on treatment outcomes. Methods: Patients in the TREAT Asia HIV Observational Database receiving first-line ART for >= 6 months were included. Predictors of treatment failure and treatment modification were assessed. Results: Data from 4662 eligible patients was analysed. Patients started ART in 2003-2006 (n = 1419), 2007-2010 (n = 2690) and 2011-2013 (n = 553). During the observation period, tenofovir, zidovudine and abacavir use largely replaced stavudine. Stavudine was prescribed to 5.8% of ART starters in 2012/13. Efavirenz use increased at the expense of nevirapine, although both continue to be used extensively (47.5% and 34.5% of patients in 2012/13, respectively). Protease inhibitor use dropped after 2004. The rate of treatment failure or modification declined over time (22.1 [95% CI 20.7-23.5] events per 100 patient/years in 2003-2006, 15.8 [14.9-16.8] in 2007-2010, and 11.6 [9.4-14.2] in 2011-2013). Adjustment for ART regimen had little impact on the temporal decline in treatment failure rates but substantially attenuated the temporal decline in rates of modification due to adverse event. In the final multivariate model, treatment modification due to adverse event was significantly predicted by earlier period of ART initiation (hazard ratio 0.52 [95% CI 0.33-0.81], p = 0.004 for 2011-2013 versus 2003-2006), older age (1.56 [1.19-2.04], p = 0.001 for >= 50 years versus,<30years), female sex (1.29 [1.11-1.50], p = 0.001 versus male), positive hepatitis C status (1.33 [1.06-1.66], p = 0.013 versus negative), and ART regimen (11.36 [6.28-20.54], p=0.001 for stavudine-based regimens versus tenofovir-based). Conclusions: The observed trends in first-line ART use in Asia reflect changes in drug availability, global treatment recommendations and prescriber preferences over the past decade. These changes have contributed to a declining rate of treatment modification due to adverse event, but not to reductions in treatment failure.	[Boettiger, David Charles; Kerr, Stephen; Law, Matthew] UNSW Australia, Kirby Inst, Sydney, NSW, Australia; [Kerr, Stephen] Thai Red Cross AIDS Res Ctr, HIV NAT, Bangkok, Thailand; [Ditangco, Rossana] Res Inst Trop Med, Manila, Philippines; [Merati, Tuti Parwati] Udayana Univ, Sanglah Hosp, Denpesar, Indonesia; [Thuy Thi Thanh Pham] Bach Mai Hosp, Hanoi, Vietnam; [Chaiwarith, Romanee] Res Inst Hlth Sci, Chiang Mai, Thailand; [Kiertiburanakul, Sasisopin] Mahidol Univ, Ramathibodi Hosp, Fac Med, Bangkok 10400, Thailand; [Li, Chung Ki Patrick] Queen Elizabeth Hosp, Hong Kong, Hong Kong, Peoples R China; [Kumarasamy, Nagalingeswaran] YRG Ctr AIDS Res & Educ, Madras, Tamil Nadu, India; [Vonthanak, Saphonn] Natl Ctr HIV AIDS Dermatol & STDs, Phnom Penh, Cambodia; [Lee, Christopher] Hosp Sungai Buloh, Sungai Buloh, Malaysia; [Nguyen Van Kinh] Natl Hosp Trop Dis, Hanoi, Vietnam; [Pujari, Sanjay] Inst Infect Dis, Pune, Maharashtra, India; [Wong, Wing Wai] Taipei Vet Gen Hosp, Taipei, Taiwan; [Kamarulzaman, Adeeba] Univ Malaya, Med Ctr, Kuala Lumpur, Malaysia; [Zhang, Fujie] Capital Med Univ, Beijing Ditan Hosp, Beijing, Peoples R China; [Yunihastuti, Evy] Univ Indonesia, Working Grp AIDS Fac Med, Cipto Mangunkusumo Hosp, Jakarta, Indonesia; [Choi, Jun Yong] Yonsei Univ, Coll Med, Dept Internal Med, Div Infect Dis, Seoul, South Korea; [Oka, Shinichi] Natl Ctr Global Hlth & Med, Tokyo, Japan; [Ng, Oon Tek] Tan Tock Seng Hosp, Singapore, Singapore; [Kantipong, Pacharee] Chiang Rai Prachanukroh Hosp, Chiang Rai, Thailand; [Mustafa, Mahiran] Hosp Raja Perempuan Zainab II, Kota Baharu, Malaysia; [Ratanasuwan, Winai] Mahidol Univ, Fac Med, Siriraj Hosp, Bangkok 10700, Thailand; [Sohn, Annette] Fdn AIDS Res, TREAT Asia, AmfAR, Bangkok, Thailand	University of New South Wales Sydney; Kirby Institute; Thai Red Cross Society; Research Institute for Tropical Medicine - Philippines; Universitas Udayana; Mahidol University; National Hospital of Tropical Diseases; Taipei Veterans General Hospital; Universiti Malaya; Capital Medical University; University of Indonesia; Yonsei University; Yonsei University Health System; National Center for Global Health & Medicine - Japan; Tan Tock Seng Hospital; Mahidol University	Boettiger, DC (corresponding author), UNSW Australia, Kirby Inst, Sydney, NSW, Australia.	dboettiger@kirby.unsw.edu.au	Kerr, Stephen/J-6126-2012; KAMARULZAMAN, ADEEBA/B-5216-2010; Yunihastuti, Evy/AGD-5382-2022; Kumarasasmy, Nagalingeswaran/AAB-7348-2021; Boettiger, David C/ABB-1694-2021	Kerr, Stephen/0000-0002-1919-4525; Yunihastuti, Evy/0000-0001-6650-0559; Law, Matthew/0000-0002-3540-8837; Boettiger, David/0000-0002-5951-4503; Chaiwarith, Romanee/0000-0002-1241-5954; Choi, Jun Yong/0000-0002-2775-3315; Oka, Shinichi/0000-0002-9283-2167	U.S. National Institutes of Health's National Institute of Allergy and Infectious Diseases; Eunice Kennedy Shriver National Institute of Child Health and Human Development; National Cancer Institute [U01AI069907]; Australian Government Department of Health and Ageing; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI069907] Funding Source: NIH RePORTER	U.S. National Institutes of Health's National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Eunice Kennedy Shriver National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Australian Government Department of Health and Ageing(Australian GovernmentDepartment of Health & Ageing); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The TREAT Asia HIV Observational Database is an initiative of TREAT Asia, a program of amfAR, The Foundation for AIDS Research, with support from the U.S. National Institutes of Health's National Institute of Allergy and Infectious Diseases, Eunice Kennedy Shriver National Institute of Child Health and Human Development, and National Cancer Institute, as part of the International Epidemiologic Databases to Evaluate AIDS (IeDEA; U01AI069907). Further information is available at http://www.iedea.org/. The Kirby Institute is funded by the Australian Government Department of Health and Ageing (http://www.health.gov.au/), and is affiliated with the Faculty of Medicine, UNSW Australia. The content of this publication is solely the responsibility of the authors and does not necessarily represent the official views of any of the governments or institutions mentioned above. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bannister WP, 2006, JAIDS-J ACQ IMM DEF, V42, P229, DOI 10.1097/01.qai.0000214815.95786.31; Bonnet M, 2013, LANCET INFECT DIS, V13, P303, DOI 10.1016/S1473-3099(13)70007-0; Furler MD, 2006, AIDS PATIENT CARE ST, V20, P245, DOI 10.1089/apc.2006.20.245; Gatell J, 2007, CLIN INFECT DIS, V44, P1484, DOI 10.1086/517497; Geng EH, 2011, J INT AIDS SOC, V14, DOI 10.1186/1758-2652-14-46; Gonzalez-Serna A, 2014, J ANTIMICROB CHEMOTH; Hamers RL, 2012, INT J EPIDEMIOL, V41, P43, DOI 10.1093/ije/dyq192; Jimenez-Nacher I, 2008, J ANTIMICROB CHEMOTH, V62, P816, DOI 10.1093/jac/dkn252; Lichterfeld M, 2003, EUR J MED RES, V8, P56; Looby SE, 2014, MENOPAUSE, V21, P403, DOI 10.1097/GME.0b013e31829d4c4c; Mbuagbaw LCE, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004246.pub3; McConnell MS, 2005, JAIDS-J ACQ IMM DEF, V38, P488, DOI 10.1097/01.qai.0000134744.72079.cc; Milinkovic A, 2007, ANTIVIR THER, V12, P407; Molina JM, 2008, LANCET, V372, P646, DOI 10.1016/S0140-6736(08)61081-8; Palmisano L, 2011, ANN I SUPER SANITA, V47, P44, DOI 10.4415/ANN_11_01_10; Ribera E, 2008, HIV CLIN TRIALS, V9, P407, DOI 10.1310/hct0906-407; Shubber Z, 2013, AIDS, V27, P1403, DOI 10.1097/QAD.0b013e32835f1db0; Thompson MA, 2012, JAMA-J AM MED ASSOC, V308, P387, DOI 10.1001/jama.2012.7961; UNAIDS, 2012, GLOBAL REPORT UNAIDS; van den Berg-Wolf M, 2008, HIV CLIN TRIALS, V9, P324, DOI 10.1310/hct0905-324; WHO ART Guidelines Committee, 2013, CONS GUID US ANT DRU; WHO ART Guidelines Committee, 2006, ANT THER HIV INF AD; WHO ART Guidelines Committee, 2010, ANT THER HIV INF AD; Williams I, 2012, HIV MED, V13, P1, DOI [10.1111/j.1468-1293.2012.01029_1.x, 10.1111/j.1468-1293.2012.01029.x]; Wright S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064902; Zhou J, 2005, JAIDS-J ACQ IMM DEF, V38, P174, DOI 10.1097/01.qai.0000145351.96815.d5	26	16	18	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 3	2014	9	9							e106525	10.1371/journal.pone.0106525	http://dx.doi.org/10.1371/journal.pone.0106525			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3TB	25184314	Green Submitted, Green Published, gold			2022-12-27	WOS:000341257700083
J	Harrison, E; Trexler, JC; Collins, TM; Vazquez-Dominguez, E; Razo-Mendivil, U; Matamoros, WA; Barrientos, C				Harrison, Elizabeth; Trexler, Joel C.; Collins, Timothy M.; Vazquez-Dominguez, Ella; Razo-Mendivil, Ulises; Matamoros, Wilfredo A.; Barrientos, Christian			Genetic Evidence for Multiple Sources of the Non-Native Fish Cichlasoma urophthalmus (Gunther; Mayan Cichlids) in Southern Florida	PLOS ONE			English	Article							FRESH-WATER FISHES; CYTONUCLEAR DISEQUILIBRIUM; POPULATION ADMIXTURE; BIOLOGICAL INVASION; MITOCHONDRIAL-DNA; CENTRAL-AMERICA; DIVERSITY; BIOGEOGRAPHY; EVOLUTION; PROGRAM	The number and diversity of source populations may influence the genetic diversity of newly introduced populations and affect the likelihood of their establishment and spread. We used the cytochrome b mitochondrial gene and nuclear microsatellite loci to identify the sources of a successful invader in southern Florida, USA, Cichlasoma urophthalmus (Mayan cichlid). Our cytochrome b data supported an introduction from Guatemala, while our microsatellite data suggested movement of Mayan Cichlids from the upper Yucatan Peninsula to Guatemala and introductions from Guatemala and Belize to Florida. The mismatch between mitochondrial and nuclear genomes suggests admixture of a female lineage from Guatemala, where all individuals were fixed for the mitochondrial haplotype found in the introduced population, and a more diverse but also relatively small number of individuals from Belize. The Florida cytochrome b haplotype appears to be absent from Belize (0 out of 136 fish screened from Belize had this haplotype). Genetic structure within the Florida population was minimal, indicating a panmictic population, while Mexican and Central American samples displayed more genetic subdivision. Individuals from the Upper Yucatan Peninsula and the Peten region of Guatemala were more genetically similar to each other than to fish from nearby sites and movement of Mayan Cichlids between these regions occurred thousands of generations ago, suggestive of pre-Columbian human transportation of Mayan Cichlids through this region. Mayan Cichlids present a rare example of cytonuclear disequilibrium and reduced genetic diversity in the introduced population that persists more than 30 years (at least 7-8 generations) after introduction. We suggest that hybridization occurred in ornamental fish farms in Florida and may contribute their establishment in the novel habitat. Hybridization prior to release may contribute to other successful invasions.	[Harrison, Elizabeth; Trexler, Joel C.; Collins, Timothy M.] Florida Int Univ, Dept Biol Sci, Miami, FL 33199 USA; [Vazquez-Dominguez, Ella] Univ Nacl Autonoma Mexico, Dept Ecol Biodiversidad, Mexico City 04510, DF, Mexico; [Razo-Mendivil, Ulises] Intituto Ecol AC, Xalapa, Veracruz, Mexico; [Matamoros, Wilfredo A.] Univ So Mississippi, Dept Biol Sci, Hattiesburg, MS 39406 USA; [Barrientos, Christian] Univ Florida, Dept Fisheries & Aquat Sci, Gainesville, FL USA	State University System of Florida; Florida International University; Universidad Nacional Autonoma de Mexico; University of Southern Mississippi; State University System of Florida; University of Florida	Harrison, E (corresponding author), Georgia Gwinnett Coll, Sch Sci & Technol, Lawrenceville, GA 30043 USA.	eharrison1@ggc.edu	Matamoros, Wilfredo/CAG-2245-2022; Harrison, Elizabeth/HIK-3787-2022; Trexler, Joel C/I-5265-2012	Matamoros, Wilfredo/0000-0002-6241-5354; Vazquez-Dominguez, Ella/0000-0001-6131-2014	Tinker Fellowship from the Latin American and Caribbean Center at FIU; National Science Foundation through the Florida Coastal Everglades Long-Term Ecological Research program [DEB-9910514]; Sigma Xi; DNA core facility at FIU	Tinker Fellowship from the Latin American and Caribbean Center at FIU; National Science Foundation through the Florida Coastal Everglades Long-Term Ecological Research program; Sigma Xi; DNA core facility at FIU	Funding for travel was provided by a Tinker Fellowship from the Latin American and Caribbean Center at FIU. This material is based upon work supported by the National Science Foundation through the Florida Coastal Everglades Long-Term Ecological Research program under Cooperative Agreement DEB-9910514. Additional funding was provided by Sigma Xi and the DNA core facility at FIU. This is contribution # 279 from the Tropical Biology Program at Florida International University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams AJ, 2007, MAR FRESHWATER RES, V58, P921, DOI 10.1071/MF07086; Allendorf FW, 2003, CONSERV BIOL, V17, P24, DOI 10.1046/j.1523-1739.2003.02365.x; ARNOLD J, 1993, ANNU REV ECOL SYST, V24, P521, DOI 10.1146/annurev.es.24.110193.002513; ASMUSSEN MA, 1987, GENETICS, V115, P755; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Basten CJ, 1997, GENETICS, V146, P1165; Batllori E, 1990, CINVESTAV MER MEX; Beaumont MA, 2010, ANNU REV ECOL EVOL S, V41, P379, DOI 10.1146/annurev-ecolsys-102209-144621; Bermingham E, 1998, MOL ECOL, V7, P499, DOI 10.1046/j.1365-294x.1998.00358.x; Berthier K, 2006, MOL ECOL, V15, P2665, DOI 10.1111/j.1365-294X.2006.02959.x; Boissin E, 2012, MOL ECOL, V21, P5728, DOI 10.1111/mec.12065; BRIGGS JC, 1984, SYST ZOOL, V33, P428, DOI 10.2307/2413095; Capurro FL, 1985, CINVESTAV CONV; Chakrabarty P, 2004, FISH FISH, V5, P97, DOI 10.1111/j.1467-2979.2004.00148.x; Chavez-Lopez Rafael, 2005, Gulf and Caribbean Research, V17, P123; Cornuet JM, 2008, BIOINFORMATICS, V24, P2713, DOI 10.1093/bioinformatics/btn514; Cornuet JM, 1996, GENETICS, V144, P2001; Cornuet JM, 2013, BIOINFORMATICS UNPUB; Courtenay W. R, 1992, DISPERSAL LIVING ORG; Courtenay W. R., 1997, STRANGERS PARADISE I; Crawford KM, 2010, MOL ECOL, V19, P1253, DOI 10.1111/j.1365-294X.2010.04550.x; da Silva AG, 2010, MOL ECOL, V19, P3336, DOI 10.1111/j.1365-294X.2010.04749.x; Darling JA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017828; Dlugosch KM, 2008, MOL ECOL, V17, P431, DOI 10.1111/j.1365-294X.2007.03538.x; Dybdahl MF, 2011, BIOL INVASIONS, V13, P1663, DOI 10.1007/s10530-010-9923-4; Earl DA, 2012, CONSERV GENET RESOUR, V4, P359, DOI 10.1007/s12686-011-9548-7; Ellstrand NC, 2000, P NATL ACAD SCI USA, V97, P7043, DOI 10.1073/pnas.97.13.7043; Engeman R, 2011, CURR ZOOL, V57, P599, DOI 10.1093/czoolo/57.5.599; Erickson CL, 2000, NATURE, V408, P190, DOI 10.1038/35041555; Estoup A, 2002, MOL ECOL, V11, P1591, DOI 10.1046/j.1365-294X.2002.01576.x; Estoup A, 2010, MOL ECOL, V19, P4113, DOI 10.1111/j.1365-294X.2010.04773.x; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Facon B, 2008, CURR BIOL, V18, P363, DOI 10.1016/j.cub.2008.01.063; Faunce CH, 2002, FISH B-NOAA, V100, P42; FERRIS SD, 1983, P NATL ACAD SCI-BIOL, V80, P2290, DOI 10.1073/pnas.80.8.2290; Fields PD, 2014, HEREDITY, V112, P99, DOI 10.1038/hdy.2013.79; Forys EA, 2002, ECOSYSTEMS, V5, P339, DOI 10.1007/s10021-001-0078-0; FOULDS LR, 1979, J MOL EVOL, V13, P127, DOI 10.1007/BF01732868; Fuller P. L., 1999, AM FISHERIES SOC SPE, V27; Fuller PL, 1999, SPECIAL PUBLICATION, V27; Gillis NK, 2009, DIVERS DISTRIB, V15, P784, DOI 10.1111/j.1472-4642.2009.00591.x; GOLDSTEIN DB, 1995, GENETICS, V139, P463; Grapputo A, 2005, MOL ECOL, V14, P4207, DOI 10.1111/j.1365-294X.2005.02740.x; GREENFIELD DW, 1985, COPEIA, P368, DOI 10.2307/1444846; Harrison E, 2013, CONSERV GENET RESOUR, V5, P703, DOI 10.1007/s12686-013-9886-8; Harrison E, 2013, COPEIA, P80, DOI 10.1643/CE-11-182; Howard KS, 1995, THESIS FLORIDA INT U, P83; HUBBS CL, 1936, FISHES YUCATAN PENIN; Huey RB, 2005, SPECIES INVASIONS: INSIGHTS INTO ECOLOGY, EVOLUTION, AND BIOGEORGRAPHY, P139; Hulme PE, 2009, J APPL ECOL, V46, P10, DOI 10.1111/j.1365-2664.2008.01600.x; Hulsey CD, 2011, HISTORICAL BIOGEOGRAPHY OF NEOTROPICAL FRESHWATER FISHES, P279; Hulsey CD, 2011, MOL PHYLOGENET EVOL, V58, P124, DOI 10.1016/j.ympev.2010.11.016; Jakobsson M, 2007, BIOINFORMATICS, V23, P1801, DOI 10.1093/bioinformatics/btm233; Keller SR, 2010, J EVOLUTION BIOL, V23, P1720, DOI 10.1111/j.1420-9101.2010.02037.x; Keller SR, 2012, MOL ECOL, V21, P4721, DOI 10.1111/j.1365-294X.2012.05751.x; Klee A, 1971, AQUARIUM, VIV; Kolar CS, 2002, SCIENCE, V298, P1233, DOI 10.1126/science.1075753; Kolbe JJ, 2008, BIOL LETTERS, V4, P434, DOI 10.1098/rsbl.2008.0205; Kolbe JJ, 2004, NATURE, V431, P177, DOI 10.1038/nature02807; Kolleck J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073647; Kraus F, 2004, INVASIVE SPECIES VEC; Kumar S, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-357; Latta RG, 2001, GENETICS, V158, P843; Lavergne S, 2007, P NATL ACAD SCI USA, V104, P3883, DOI 10.1073/pnas.0607324104; Lee CE, 2002, TRENDS ECOL EVOL, V17, P386, DOI 10.1016/S0169-5347(02)02554-5; Lockwood JL, 2007, INVASION ECOLOGY; Lodge DM, 1998, AUST J ECOL, V23, P53, DOI 10.1111/j.1442-9993.1998.tb00705.x; LOFTUS W F, 1987, Florida Scientist, V50, P1; Lorenz JJ, 1997, WETLANDS, V17, P346, DOI 10.1007/BF03161424; Mann C. C., 2006, 1491 NEW REVELATIONS; MARTINEZPALACIOS CA, 1990, AQUACULTURE, V91, P65, DOI 10.1016/0044-8486(90)90177-O; Matamoros Wilfredo A., 2005, Gulf and Caribbean Research, V17, P113; MILLER RR, 1966, COPEIA, P773, DOI 10.2307/1441406; Monsen KJ, 2007, J HERED, V98, P325, DOI 10.1093/jhered/esm039; Murray J., 1910, REPORTS SCI EXPEDITI, P17; Naranjo-Garcia E, 2003, NONMARINE MOLLUSKS Y; Nickum JG, 2002, GUIDELINE USE FISHES; Nico LG, 2007, AQUAT INVASIONS, V2, P197, DOI 10.3391/ai.2007.2.3.7; Nico LG, 1999, FISHERIES, V24, P16, DOI 10.1577/1548-8446(1999)024<0016:SATPON>2.0.CO;2; NORRIS S. M., 2005, FRESHWATER FISHES ME; OBREGONBARBOZA H, 1994, HYDROBIOLOGIA, V286, P79, DOI 10.1007/BF00008499; Paperno R., 2008, Florida Scientist, V71, P293; Peakall R, 2006, MOL ECOL NOTES, V6, P288, DOI 10.1111/j.1471-8286.2005.01155.x; Peakall R, 2012, BIOINFORMATICS, V28, P2537, DOI 10.1093/bioinformatics/bts460; Peery MZ, 2012, MOL ECOL, V21, P3403, DOI 10.1111/j.1365-294X.2012.05635.x; Perez GAC, 2007, MOL PHYLOGENET EVOL, V43, P91, DOI 10.1016/j.ympev.2006.08.012; Perez-Sanchez E, 2008, AQUAC RES, V39, P777, DOI 10.1111/j.1365-2109.2008.01929.x; Pimentel D, 2005, ECOL ECON, V52, P273, DOI 10.1016/j.ecolecon.2004.10.002; Piry S, 1999, J HERED, V90, P502, DOI 10.1093/jhered/90.4.502; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Pritchard JK, 2000, GENETICS, V155, P945; RATHJE WL, 1971, AM ANTIQUITY, V36, P275, DOI 10.2307/277715; Razo-Mendivil U, 2013, J PARASITOL, V99, P978, DOI 10.1645/13-225.1; RIVAS LR, 1986, SYST ZOOL, V35, P633, DOI 10.2307/2413123; Ronquist F, 2012, SYST BIOL, V61, P539, DOI 10.1093/sysbio/sys029; Rosenberg NA, 2004, MOL ECOL NOTES, V4, P137, DOI 10.1046/j.1471-8286.2003.00566.x; Rosenthal DM, 2008, MOL ECOL, V17, P4657, DOI 10.1111/j.1365-294X.2008.03844.x; Sakai AK, 2001, ANNU REV ECOL SYST, V32, P305, DOI 10.1146/annurev.ecolsys.32.081501.114037; Schmitter-Soto JJ, 2002, HYDROBIOLOGIA, V467, P215, DOI 10.1023/A:1014923217206; Schofield PJ, 2009, J FISH BIOL, V74, P1245, DOI 10.1111/j.1095-8649.2009.02192.x; Simberloff D, 1997, STRANGERS PARADISE I; Solignac M, 2005, P ROY SOC B-BIOL SCI, V272, P411, DOI 10.1098/rspb.2004.2853; Sparks JS, 2004, CLADISTICS, V20, P501, DOI 10.1111/j.1096-0031.2004.00038.x; STAUFFER JR, 1994, T AM FISH SOC, V123, P101, DOI 10.1577/1548-8659(1994)123<0101:EOSOTT>2.3.CO;2; Thierry M, 2011, MOL ECOL, V20, P2172, DOI 10.1111/j.1365-294X.2011.05087.x; Trexler Joel C., 2000, Biological Invasions, V2, P265, DOI 10.1023/A:1011488118444; Tsutsui ND, 2000, PNAS, V97, P5949; Verhoeven KJF, 2011, P ROY SOC B-BIOL SCI, V278, P2, DOI 10.1098/rspb.2010.1272; Wilcove DS, 1998, BIOSCIENCE, V48, P607, DOI 10.2307/1313420; Won Y, 2003, MOL ECOL, V12, P3185, DOI 10.1046/j.1365-294X.2003.01974.x; Zachos FE, 2007, MAMM BIOL, V72, P123, DOI 10.1016/j.mambio.2006.08.005; Zalewski A, 2011, DIVERS DISTRIB, V17, P757, DOI 10.1111/j.1472-4642.2011.00767.x; Zenger KR, 2003, MOL ECOL, V12, P789, DOI 10.1046/j.1365-294X.2003.01759.x	113	10	10	1	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 3	2014	9	9							e104173	10.1371/journal.pone.0104173	http://dx.doi.org/10.1371/journal.pone.0104173			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3TB	25184569	Green Published, gold, Green Submitted			2022-12-27	WOS:000341257700009
J	Hayashi-Takanaka, Y; Stasevich, TJ; Kurumizaka, H; Nozaki, N; Kimura, H				Hayashi-Takanaka, Yoko; Stasevich, Timothy J.; Kurumizaka, Hitoshi; Nozaki, Naohito; Kimura, Hiroshi			Evaluation of Chemical Fluorescent Dyes as a Protein Conjugation Partner for Live Cell Imaging	PLOS ONE			English	Article							IN-VIVO; LIVING CELLS; TIME-LAPSE; TRACKING	To optimize live cell fluorescence imaging, the choice of fluorescent substrate is a critical factor. Although genetically encoded fluorescent proteins have been used widely, chemical fluorescent dyes are still useful when conjugated to proteins or ligands. However, little information is available for the suitability of different fluorescent dyes for live imaging. We here systematically analyzed the property of a number of commercial fluorescent dyes when conjugated with antigen-binding (Fab) fragments directed against specific histone modifications, in particular, phosphorylated H3S28 (H3S28ph) and acetylated H3K9 (H3K9ac). These Fab fragments were conjugated with a fluorescent dye and loaded into living HeLa cells. H3S28ph-specific Fab fragments were expected to be enriched in condensed chromosomes, as H3S28 is phosphorylated during mitosis. However, the degree of Fab fragment enrichment on mitotic chromosomes varied depending on the conjugated dye. In general, green fluorescent dyes showed higher enrichment, compared to red and far-red fluorescent dyes, even when dye: protein conjugation ratios were similar. These differences are partly explained by an altered affinity of Fab fragment after dye-conjugation; some dyes have less effect on the affinity, while others can affect it more. Moreover, red and far-red fluorescent dyes tended to form aggregates in the cytoplasm. Similar results were observed when H3K9ac-specific Fab fragments were used, suggesting that the properties of each dye affect different Fab fragments similarly. According to our analysis, conjugation with green fluorescent dyes, like Alexa Fluor 488 and Dylight 488, has the least effect on Fab affinity and is the best for live cell imaging, although these dyes are less photostable than red fluorescent dyes. When multicolor imaging is required, we recommend the following dye combinations for optimal results: Alexa Fluor 488 (green), Cy3 (red), and Cy5 or CF640 (far-red).	[Hayashi-Takanaka, Yoko; Stasevich, Timothy J.; Kimura, Hiroshi] Osaka Univ, Grad Sch Frontier Biosci, Suita, Osaka, Japan; [Hayashi-Takanaka, Yoko; Kimura, Hiroshi] Tokyo Inst Technol, Grad Sch Biosci & Biotechnol, Yokohama, Kanagawa 227, Japan; [Stasevich, Timothy J.] Colorado State Univ, Dept Biochem & Mol Biol, Ft Collins, CO 80523 USA; [Stasevich, Timothy J.] Howard Hughes Med Inst, Ashburn, VA USA; [Kurumizaka, Hitoshi] Waseda Univ, Grad Sch Adv Sci & Engn, Tokyo, Japan; [Nozaki, Naohito] Mab Inst Inc, Sapporo, Hokkaido, Japan	Osaka University; Tokyo Institute of Technology; Colorado State University; Howard Hughes Medical Institute; Waseda University	Kimura, H (corresponding author), Osaka Univ, Grad Sch Frontier Biosci, Suita, Osaka, Japan.	hkimura@bio.titech.ac.jp	Kimura, Hiroshi/B-9524-2015; Hayashi, Yoko/GPT-4159-2022	Kimura, Hiroshi/0000-0003-0854-083X; Kurumizaka, Hitoshi/0000-0001-7412-3722; HAYASHI, Yoko/0000-0002-0556-6738	Ministry of Education, Culture, Sports, Science and Technology of Japan [25503002, 25118514, 25116005]; Japan Society for the Promotion of Science fellowship; Naito Foundation	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science fellowship(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Naito Foundation(Naito Memorial Foundation)	This work was supported by grants-in-aid from the Ministry of Education, Culture, Sports, Science and Technology of Japan (www.jsps.go.jp/english/e-grants/grants.html): a Grant-in-Aid for Scientific Research (C) #25503002 to Y. Hayashi-Takanaka, a Grant-in-Aid for Scientific Research on Innovative Areas #25118514 to T.J. Stasevich, and a Grant-in-Aid for Scientific Research on Innovative Areas #25116005 to H. Kimura. Y. Hayashi-Takanaka and T.J. Stasevich were supported by Japan Society for the Promotion of Science fellowship. Y. Hayashi-Takanaka was supported by The Naito Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Berlier JE, 2003, J HISTOCHEM CYTOCHEM, V51, P1699, DOI 10.1177/002215540305101214; Hayashi-Takanaka Y, 2011, NUCLEIC ACIDS RES, V39, P6475, DOI 10.1093/nar/gkr343; Hayashi-Takanaka Y, 2009, J CELL BIOL, V187, P781, DOI 10.1083/jcb.200904137; Hinner MJ, 2010, CURR OPIN BIOTECH, V21, P766, DOI 10.1016/j.copbio.2010.09.011; HIRAOKA Y, 1989, NATURE, V342, P293, DOI 10.1038/342293a0; JOHNSON LV, 1980, P NATL ACAD SCI-BIOL, V77, P990, DOI 10.1073/pnas.77.2.990; Jung D, 2013, MOL BIOSYST, V9, P862, DOI 10.1039/c2mb25422k; Keppler A, 2004, P NATL ACAD SCI USA, V101, P9955, DOI 10.1073/pnas.0401923101; Kimura H, 2008, CELL STRUCT FUNCT, V33, P61, DOI 10.1247/csf.07035; Manders EMM, 1999, J CELL BIOL, V144, P813, DOI 10.1083/jcb.144.5.813; Martin-Fernandez ML, 2012, INT J MOL SCI, V13, P14742, DOI 10.3390/ijms131114742; Nienhaus K, 2014, CHEM SOC REV, V43, P1088, DOI 10.1039/c3cs60171d; Paddy MR, 1996, J CELL SCI, V109, P591; Panchuk-Voloshina N, 1999, J HISTOCHEM CYTOCHEM, V47, P1179, DOI 10.1177/002215549904700910; Pellett PA, 2011, BIOMED OPT EXPRESS, V2, P2364, DOI 10.1364/BOE.2.002364; Shaner NC, 2005, NAT METHODS, V2, P905, DOI 10.1038/NMETH819; SWEDLOW JR, 1993, CELL, V73, P97, DOI 10.1016/0092-8674(93)90163-K; Tanaka KAK, 2010, NAT METHODS, V7, P865, DOI 10.1038/nmeth.f.314; Tsien RY, 2005, HDB BIOL CONFOCAL MI, P338; Urano Y, 2012, CURR OPIN CHEM BIOL, V16, P602, DOI 10.1016/j.cbpa.2012.10.023; van de Linde S, 2012, ANNU REV PHYS CHEM, V63, P519, DOI 10.1146/annurev-physchem-032811-112012; Wombacher R, 2011, J BIOPHOTONICS, V4, P391, DOI 10.1002/jbio.201100018; Zanetti-Domingues LC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074200	23	32	33	0	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 3	2014	9	9							e106271	10.1371/journal.pone.0106271	http://dx.doi.org/10.1371/journal.pone.0106271			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3TB	25184362	gold, Green Published, Green Submitted			2022-12-27	WOS:000341257700049
J	Loeffler, CE				Loeffler, Charles E.			Detecting Gunshots Using Wearable Accelerometers	PLOS ONE			English	Article							RECOGNITION	Gun violence continues to be a staggering and seemingly intractable issue in many communities. The prevalence of gun violence among the sub-population of individuals under court-ordered community supervision provides an opportunity for intervention using remote monitoring technology. Existing monitoring systems rely heavily on location-based monitoring methods, which have incomplete geographic coverage and do not provide information on illegal firearm use. This paper presents the first results demonstrating the feasibility of using wearable inertial sensors to recognize wrist movements and other signals corresponding to firearm usage. Data were collected from accelerometers worn on the wrists of subjects shooting a number of different firearms, conducting routine daily activities, and participating in activities and tasks that could be potentially confused with firearm discharges. A training sample was used to construct a combined detector and classifier for individual gunshots, which achieved a classification accuracy of 99.4 percent when tested against a hold-out sample of observations. These results suggest the feasibility of using inexpensive wearable sensors to detect firearm discharges.	Univ Penn, Dept Criminol, Philadelphia, PA 19104 USA	University of Pennsylvania	Loeffler, CE (corresponding author), Univ Penn, Dept Criminol, Philadelphia, PA 19104 USA.	cloef@sas.upenn.edu		Loeffler, Charles/0000-0001-7712-6734				Amft O, 2005, NINTH IEEE INTERNATIONAL SYMPOSIUM ON WEARABLE COMPUTERS, PROCEEDINGS, P160, DOI 10.1109/ISWC.2005.17; Bales W., 2010, QUANTITATIVE QUALITA, DOI 10.1021/jm900298c; Berk R, 2009, J R STAT SOC A STAT, V172, P191, DOI 10.1111/j.1467-985X.2008.00556.x; Blankenship K., 2004, SHOULDER FIRED WEAPO; Braga A.A., 2004, GUN VIOLENCE SERIOUS; Chen J, 2005, PRODUCE DEGRADATION: PATHWAYS AND PREVENTION, P1, DOI 10.1109/iembs.2005.1617246; Chernbumroong S., 2011, P 2011 5 INT C SOFTW, P1, DOI DOI 10.1109/SKIMA.2011.6089975; CLEVELAND WS, 1979, J AM STAT ASSOC, V74, P829, DOI 10.2307/2286407; Friedman J, 2010, J STAT SOFTW, V33, P1, DOI 10.18637/jss.v033.i01; Hall MJ, 2008, INT J IMPACT ENG, V35, P540, DOI 10.1016/j.ijimpeng.2007.03.007; Heard B., 1997, HDB FIREARMS BALLIST; HOSHEN J, 1995, IEEE SPECTRUM, V32, P26, DOI 10.1109/6.343982; Hutchings TD, 1975, STUDY MAN WEAPON REA; Junker H, 2004, EIGHTH INTERNATIONAL SYMPOSIUM ON WEARABLE COMPUTERS, PROCEEDINGS, P188, DOI 10.1109/ISWC.2004.12; Kilmer B, 2008, J DRUG POLICY ANAL, V1, DOI [10.2202/1941-2851.1004, DOI 10.2202/1941-2851.1004]; Klingenberg G, 1989, PROPELLANTS EXPLOS P, V14, P57, DOI [10.1002/prep.19890140204, DOI 10.1002/PREP.19890140204]; Lockman J, 2011, EPILEPSY BEHAV, V20, P638, DOI 10.1016/j.yebeh.2011.01.019; Mares D, 2012, POLIC-J POLICY PRACT, V6, P26, DOI 10.1093/police/par056; Pierce A.D., 1981, ACOUSTICS INTRO ITS, DOI DOI 10.1016/0041-624X(83)90035-5; Renzema M., 2005, J EXPT CRIMINOLOGY, V1, P215, DOI [DOI 10.1007/S11292-005-1615-1, https://doi.org/10.1007/s11292-005-1615-1]; Sallai J, 2011, J SYST ARCHITECT, V57, P869, DOI 10.1016/j.sysarc.2011.04.003; Seisler W, 2006, APPL IM PATT REC WOR, DOI [10.1109/AIPR.2006.31, DOI 10.1109/AIPR.2006.31]; Settles GS, 2005, P SOC PHOTO-OPT INS, V5580, P60, DOI 10.1117/12.580997; Smith Erica L., 2013, HOMICIDE US KNOWN LA; StJohn P, 2014, LOS ANGELES TIMES; Thornton RL, 2009, GUNS SAFETY PROACTIV; Tierney Joseph P., 2001, MURDER IS NO MYSTERY; Varkey JP, 2012, PERS UBIQUIT COMPUT, V16, P897, DOI 10.1007/s00779-011-0455-4; Ward JA, 2006, IEEE T PATTERN ANAL, V28, P1553, DOI 10.1109/TPAMI.2006.197; Wu LC, 2014, IEEE T BIO-MED ENG, V61, P2659, DOI 10.1109/TBME.2014.2320153	30	10	11	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 3	2014	9	9							e106664	10.1371/journal.pone.0106664	http://dx.doi.org/10.1371/journal.pone.0106664			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3TB	25184416	Green Published, gold			2022-12-27	WOS:000341257700098
J	Moreno-Peral, P; Luna, JD; Marston, L; King, M; Nazareth, I; Motrico, E; GildeGomez-Barragan, MJ; Torres-Gonzalez, F; Monton-Franco, C; Sanchez-Celaya, M; Diaz-Barreiros, MA; Vicens, C; Munoz-Bravo, C; Bellon, JA				Moreno-Peral, Patricia; de Dios Luna, Juan; Marston, Louise; King, Michael; Nazareth, Irwin; Motrico, Emma; Josefa GildeGomez-Barragan, Maria; Torres-Gonzalez, Francisco; Monton-Franco, Carmen; Sanchez-Celaya, Marta; Angel Diaz-Barreiros, Miguel; Vicens, Catalina; Munoz-Bravo, Carlos; Angel Bellon, Juan			Predicting the Onset of Anxiety Syndromes at 12 Months in Primary Care Attendees. The PredictA-Spain Study	PLOS ONE			English	Article							GENERAL-PRACTICE ATTENDEES; COMMON MENTAL-DISORDERS; MAJOR DEPRESSION; THREATENING EXPERIENCES; HEALTH SURVEY; LATE-LIFE; RISK; VALIDATION; PREVENTION; PREVALENCE	Background: There are no risk algorithms for the onset of anxiety syndromes at 12 months in primary care. We aimed to develop and validate internally a risk algorithm to predict the onset of anxiety syndromes at 12 months. Methods: A prospective cohort study with evaluations at baseline, 6 and 12 months. We measured 39 known risk factors and used multilevel logistic regression and inverse probability weighting to build the risk algorithm. Our main outcome was generalized anxiety, panic and other non-specific anxiety syndromes as measured by the Primary Care Evaluation of Mental Disorders, Patient Health Questionnaire (PRIME-MD-PHQ). We recruited 3,564 adult primary care attendees without anxiety syndromes from 174 family physicians and 32 health centers in 6 Spanish provinces. Results: The cumulative 12-month incidence of anxiety syndromes was 12.2%. The predictA-Spain risk algorithm included the following predictors of anxiety syndromes: province; sex (female); younger age; taking medicines for anxiety, depression or stress; worse physical and mental quality of life (SF-12); dissatisfaction with paid and unpaid work; perception of financial strain; and the interactions sex*age, sex*perception of financial strain, and age*dissatisfaction with paid work. The C-index was 0.80 (95% confidence interval = 0.78-0.83) and the Hedges' g = 1.17 (95% confidence interval = 1.04-1.29). The Copas shrinkage factor was 0.98 and calibration plots showed an accurate goodness of fit. Conclusions: The predictA-Spain risk algorithm is valid to predict anxiety syndromes at 12 months. Although external validation is required, the predictA-Spain is available for use as a predictive tool in the prevention of anxiety syndromes in primary care.	[Moreno-Peral, Patricia; Motrico, Emma; Angel Bellon, Juan] Inst Invest Biomed Malaga IBIMA, Unidad Invest Dist Sanitario Malaga, Malaga, Spain; [de Dios Luna, Juan] Univ Granada, Dept Bioestadist, Granada, Spain; [Marston, Louise] UCL, Dept Primary Care & Populat Hlth, London, England; [King, Michael] UCL, Fac Brain Sci, London, England; [Nazareth, Irwin] UCL, Dept Primary Care & Populat Hlth, London, England; [Motrico, Emma] Univ Loyola Andalucia, Seville, Spain; [Josefa GildeGomez-Barragan, Maria] Serv Riojano Salud, Unidad Docente Med Familiar & Comunitaria La Rioj, Logrono, La Rioja, Spain; [Torres-Gonzalez, Francisco] Univ Granada, Ctr Invest Biomed Red Salud Mental, Granada, Spain; [Monton-Franco, Carmen] Ctr Salud Casablanca, Inst Aragones Ciencias Salud, Zaragoza, Spain; [Monton-Franco, Carmen] Univ Zaragoza, Dept Med & Psiquiatria, Zaragoza, Spain; [Sanchez-Celaya, Marta] Directora Continuidad Asistencial Hosp Univ Infan, Madrid, Spain; [Angel Diaz-Barreiros, Miguel] Serv Canario Salud, Gerencia Atenc Primaria Gran Canaria, Ctr Salud Vecindario, Las Palmas Gran Canaria, Spain; [Vicens, Catalina] Ctr Salud Son Serra La Vileta, Inst Balear Salud, Unidad Docente Med Familiar & Comunitaria Mallorc, Palma de Mallorca, Illes Balears, Spain; [Munoz-Bravo, Carlos; Angel Bellon, Juan] Univ Malaga, Dept Med Prevent & Salud Publ, E-29071 Malaga, Spain; [Angel Bellon, Juan] Ctr Salud El Palo, Serv Andaluz Salud, Malaga, Spain	Universidad de Malaga; University of Granada; University of London; University College London; University of London; University College London; University of London; University College London; Universidad Loyola Andalucia; CIBER - Centro de Investigacion Biomedica en Red; CIBERSAM; University of Granada; University of Zaragoza; Atencio Primaria de Mallorca; Universidad de Malaga	Bellon, JA (corresponding author), Inst Invest Biomed Malaga IBIMA, Unidad Invest Dist Sanitario Malaga, Malaga, Spain.	jabellon@uma.es	MOTRICO, EMMA/D-2016-2019; Moreno-Peral, Patricia/I-3594-2012; Marston, Louise/A-8535-2012; luna, juan de dios/N-9183-2016	MOTRICO, EMMA/0000-0002-0720-567X; Moreno-Peral, Patricia/0000-0003-4130-9090; Marston, Louise/0000-0002-9973-1131; Bellon Saameno, Juan Angel/0000-0002-4268-4979; Vicens, Caterina/0000-0002-9387-625X; luna, juan de dios/0000-0002-1854-4968	Spanish Ministry of Health [PI041980, PI041771, PI042450, PI06/1442]; Andalusian Council of Health [05/403, 06/278]; Spanish Network of Primary Care Research [RD06/0018, RD06/0018/0020, RD07/0018/0033, RD06/0018/0039]; National Institute for Health Research [NF-SI-0611-10210] Funding Source: researchfish	Spanish Ministry of Health(Instituto de Salud Carlos IIISpanish Government); Andalusian Council of Health; Spanish Network of Primary Care Research; National Institute for Health Research(National Institute for Health Research (NIHR))	This study was supported by the Spanish Ministry of Health (grant FIS references: PI041980, PI041771, PI042450 and PI06/1442) and the Andalusian Council of Health (grant references: 05/403 and 06/278); as well as the Spanish Network of Primary Care Research 'redIAPP' (RD06/0018), the 'Aragon group' (RD06/0018/0020), the 'Baleares group' (RD07/0018/0033), and the 'SAMSERAP group' (RD06/0018/0039). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso J, 2004, ACTA PSYCHIAT SCAND, V109, P21; Alonso J, 2004, ACTA PSYCHIAT SCAND, V109, P55; Altman DG, 2000, STAT MED, V19, P453, DOI 10.1002/(SICI)1097-0258(20000229)19:4<453::AID-SIM350>3.0.CO;2-5; Bellon JA, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-256; Bellon JA, 2010, J EPIDEMIOL COMMUN H, V64, P874, DOI 10.1136/jech.2008.085290; [Anonymous], 1997, COMP INT DIAGN INT C; Arroll B, 2003, BMJ-BRIT MED J, V327, P1144, DOI 10.1136/bmj.327.7424.1144; Baca E, 1999, ACTAS ESP PSIQUIATRI, V27, P375; BARBOR TF, 1989, ALCOHOL USE DISORDER; Barlow DH, 1996, ARCH GEN PSYCHIAT, V53, P727; Bebbington P, 2003, INT REV PSYCHIATR, V15, P74, DOI 10.1080/0954026021000045976; Bellon JA, 2011, PSYCHOL MED, V41, P2075, DOI 10.1017/S0033291711000468; Bellon JA, 2013, BMC PSYCHIATRY, V13, DOI 10.1186/1471-244X-13-171; Blaxter M., 1990, HLTH LIFESTYLES; BRUGHA T, 1985, PSYCHOL MED, V15, P189, DOI 10.1017/S003329170002105X; Calear AL, 2010, MED J AUSTRALIA, V192, pS12; Christensen H, 2010, J PRIM PREV, V31, P139, DOI 10.1007/s10935-010-0214-8; Conroy RM, 2003, EUR HEART J, V24, P987, DOI 10.1016/S0195-668X(03)00114-3; COPAS JB, 1983, J R STAT SOC B, V45, P311; European Commission EUROSTAT, 2013, INC DISTR STAT; Fernandez A, 2007, BRIT J PSYCHIAT, V190, P172, DOI 10.1192/bjp.bp.106.023507; Fernandez A, 2010, BRIT J PSYCHIAT, V196, P302, DOI 10.1192/bjp.bp.109.074211; FINK LA, 1995, AM J PSYCHIAT, V152, P1329, DOI 10.1176/ajp.152.9.1329; Gandek B, 1998, J CLIN EPIDEMIOL, V51, P1171, DOI 10.1016/S0895-4356(98)00109-7; GREENLAND S, 1989, AM J PUBLIC HEALTH, V79, P340, DOI 10.2105/AJPH.79.3.340; Harrell FE, 2001, REGRESSION MODELING; HEATHERTON TF, 1989, BRIT J ADDICT, V84, P791; Hernan MA, 2004, EPIDEMIOLOGY, V15, P615, DOI 10.1097/01.ede.0000135174.63482.43; Hinz Andreas, 2004, Psychosoc Med, V1, pDoc09; Janssen I, 2003, BRIT J PSYCHIAT, V182, P71, DOI 10.1192/bjp.182.1.71; Jenkinson C, 1997, J PUBLIC HEALTH MED, V19, P179, DOI 10.1093/oxfordjournals.pubmed.a024606; Karasek R, 1990, HLTH WORK STRESS PRO; Kessler RC, 1999, AM J PSYCHIAT, V156, P115, DOI 10.1176/ajp.156.1.115; Keyes CLM, 2010, AM J PUBLIC HEALTH, V100, P2366, DOI 10.2105/AJPH.2010.192245; KING M, 1995, PSYCHOL MED, V25, P1125, DOI 10.1017/S0033291700033109; King M, 2011, PSYCHOL MED, V41, P1625, DOI 10.1017/S0033291710002400; King M, 2008, BRIT J PSYCHIAT, V192, P362, DOI 10.1192/bjp.bp.107.039966; King M, 2008, ARCH GEN PSYCHIAT, V65, P1368, DOI 10.1001/archpsyc.65.12.1368; Lee ML, 2002, MED CARE, V40, P761, DOI 10.1097/00005650-200209000-00006; Mennin DS, 2008, DEPRESS ANXIETY, V25, P289, DOI 10.1002/da.20493; Mergl R, 2007, DEPRESS ANXIETY, V24, P185, DOI 10.1002/da.20192; Moons KGM, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b375; Moreno-Peral P, 2014, J AFFECT DISORDERS, V168, P337, DOI 10.1016/j.jad.2014.06.021; Motrico E, 2013, J AFFECT DISORDERS, V150, P931, DOI 10.1016/j.jad.2013.05.017; Orwin R.G., 1994, HDB RES SYNTHESIS; Qureshi N, 2005, FAM PRACT, V22, P663, DOI 10.1093/fampra/cmi073; REYNOLDS CF, 1988, PSYCHIAT RES, V24, P231, DOI 10.1016/0165-1781(88)90106-0; ROBINS LN, 1988, ARCH GEN PSYCHIAT, V45, P1069; Rubio-Stipec M, 1991, Acta Psiquiatr Psicol Am Lat, V37, P191; Schmidt NB, 2007, BEHAV MODIF, V31, P3, DOI 10.1177/0145445506295059; Serrano-Blanco A, 2010, SOC PSYCH PSYCH EPID, V45, P201, DOI 10.1007/s00127-009-0056-y; Snijders T. A. B., 2011, MULTILEVEL ANAL INTR; Somers JM, 2006, CAN J PSYCHIAT, V51, P100, DOI 10.1177/070674370605100206; Spitzer RL, 1999, JAMA-J AM MED ASSOC, V282, P1737, DOI 10.1001/jama.282.18.1737; SPROSTON K, 2003, HLTH SURVEY ENGLAND, V1; StataCorp, 2011, STAT STAT SOFTW REL; Torres LAPD, 2005, MED CLIN-BARCELONA, V125, P727; Tyrer P, 1990, MEASURING HUMAN PROB, P119; Valladolid GR, 1998, REV CLIN ESP, V198, P11; van't Veer-Tazelaar PJ, 2011, AM J GERIAT PSYCHIAT, V19, P230, DOI 10.1097/JGP.0b013e3181faee4d; van't Veer-Tazelaar PJ, 2009, ARCH GEN PSYCHIAT, V66, P297, DOI 10.1001/archgenpsychiatry.2008.555; Weich S, 1998, BMJ-BRIT MED J, V317, P115, DOI 10.1136/bmj.317.7151.115; Wyke Sally, 2003, Eur J Gen Pract, V9, P48	63	9	9	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 3	2014	9	9							e106370	10.1371/journal.pone.0106370	http://dx.doi.org/10.1371/journal.pone.0106370			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3TB	25184313	Green Published, gold, Green Submitted			2022-12-27	WOS:000341257700062
J	Walker, S; Danton, MHD; Lang, AD; Lyall, F				Walker, Susan; Danton, Mark H. D.; Lang, Alexander D.; Lyall, Fiona			RETRACTED: Apelin Receptor (APJ) Expression during Cardiopulmonary Bypass in Children Undergoing Surgical Repair (Retracted article. See vol. 13, art. e0202136, 2018)	PLOS ONE			English	Article; Retracted Publication							CYANOTIC TETRALOGY; FALLOT; SYSTEM; GENE	Background and Aims: In human adults, and animals, the Apelin-APJ ligand-receptor system is emerging as having a role in the pathogenesis of cardiovascular function and heart failure. The aim was to investigate expression, and regulation by oxygen, of the Apelin APJ receptor (APJ) in myocardium obtained from children undergoing corrective surgery with cardiopulmonary bypass for repair of congenital heart defects. Methods: Western blotting and Real-time PCR were used to determine if APJ was expressed in the infant myocardium, if expression was influenced by the duration of myocardial ischemia and if any relationship existed between APJ expression and early post-operative outcome. The next aim was to determine if there was a difference in mRNA expression of APJ in myocardium from cyanotic patients compared with acyanotic patients and if re-perfusing myocardium in vitro with either hypoxic, normoxic or hyperoxic oxygen affected APJ mRNA expression. Results: APJ was expressed in all myocardial samples and myocardium exposed to longer durations of ischemia and cardioplegia expressed higher levels of APJ (p<0.05). There was a significant correlation between APJ expression in myocardium resected after 10 min with both oxygen extraction ratio (p = 0.021, rho = -0.523) and mixed venous oxygen saturation (p = 0.028, rho 0.52). This association did not exist for myocardium collected before 10 min. There was no difference in APJ expression between cyanotic and acyanotic patients. No difference was found in APJ expression whether re-perfused with low, normal or high oxygen. Conclusions: Changes in APJ expression were observed during cardiopulmonary bypass in children and the reasons for this require further investigation.	[Walker, Susan; Lang, Alexander D.; Lyall, Fiona] Univ Glasgow, Sch Med, Royal Hosp Sick Children, Inst Med Genet, Glasgow, Lanark, Scotland; [Danton, Mark H. D.] Royal Hosp Sick Children, Dept Paediat Cardiac Surg, Glasgow G3 8SJ, Lanark, Scotland	University of Glasgow; University of Glasgow	Lyall, F (corresponding author), Univ Glasgow, Sch Med, Royal Hosp Sick Children, Inst Med Genet, Glasgow, Lanark, Scotland.	fiona.lyall@glasgow.ac.uk		Danton, Mark/0000-0003-0866-2394	Yorkhill Children's Foundation	Yorkhill Children's Foundation	The work was supported by Yorkhill Children's Foundation. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdulsid A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054540; Atluri P, 2007, CELL MOL BIOL LETT, V12, P127, DOI 10.2478/s11658-006-0058-7; Berry MF, 2004, CIRCULATION, V110, pII187, DOI 10.1161/01.CIR.0000138382.57325.5c; Castan-Iaurell I, 2012, TRENDS ENDOCRIN MET, V23, P234, DOI 10.1016/j.tem.2012.02.005; Chandrasekaran B, 2010, J CARD FAIL, V16, P556, DOI 10.1016/j.cardfail.2010.02.004; Charo DN, 2009, AM J PHYSIOL-HEART C, V297, pH1904, DOI 10.1152/ajpheart.00686.2009; CULLEN S, 1995, CIRCULATION, V91, P1782, DOI 10.1161/01.CIR.91.6.1782; Falcao-Pires I, 2010, EXPERT OPIN THER TAR, V14, P633, DOI 10.1517/14728221003752743; Farkasfalvi K, 2007, BIOCHEM BIOPH RES CO, V357, P889, DOI 10.1016/j.bbrc.2007.04.017; Guihaire Julien, 2012, J Clin Exp Cardiolog, V8, P1; Iturrioz X, 2010, FASEB J, V24, P1506, DOI 10.1096/fj.09-140715; Japp AG, 2010, CIRCULATION, V121, P1818, DOI 10.1161/CIRCULATIONAHA.109.911339; Japp AG, 2008, BIOCHEM PHARMACOL, V75, P1882, DOI 10.1016/j.bcp.2007.12.015; Kleinz MJ, 2008, REGUL PEPTIDES, V146, P271, DOI 10.1016/j.regpep.2007.10.002; Kleinz MJ, 2005, REGUL PEPTIDES, V126, P233, DOI 10.1016/j.regpep.2004.10.019; Kuklinska AM, 2010, HEART VESSELS, V25, P363, DOI 10.1007/s00380-009-1217-3; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; McCaig D, 2009, HYPERTENS PREGNANCY, V28, P457, DOI 10.3109/10641950802629691; Melgar-Lesmes P, 2011, GUT, V60, P1404, DOI 10.1136/gut.2010.234690; Messari SE, 2004, J NEUROCHEM, V90, P1290, DOI 10.1111/j.1471-4159.2004.02591.x; ODOWD BF, 1993, GENE, V136, P355, DOI 10.1016/0378-1119(93)90495-O; Pchejetski D, 2012, EUR HEART J, V33, P2360, DOI 10.1093/eurheartj/ehr389; Peng EWK, 2011, J THORAC CARDIOV SUR, V141, P1184, DOI 10.1016/j.jtcvs.2011.01.047; Ronkainen VP, 2007, FASEB J, V21, P1821, DOI 10.1096/fj.06-7294com; Siddiquee K, 1998, BRIT J PHARMACOL, V168, P1104; Starr JP, 2010, WORLD J SURG, V34, P658, DOI 10.1007/s00268-009-0296-8; Tao JP, 2011, AM J PHYSIOL-HEART C, V301, pH1471, DOI 10.1152/ajpheart.00097.2011; Tatemoto K, 2001, REGUL PEPTIDES, V99, P87, DOI 10.1016/S0167-0115(01)00236-1; Tatemoto K, 1998, BIOCHEM BIOPH RES CO, V251, P471, DOI 10.1006/bbrc.1998.9489; Tycinska AM, 2012, CLIN CHIM ACTA, V413, P406, DOI 10.1016/j.cca.2011.11.021; Walker S, 2013, THESIS U GLASGOW; Walker S, 2013, CELL STRESS CHAPERON, V18, P269, DOI 10.1007/s12192-012-0379-6	32	3	3	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 3	2014	9	9							e106262	10.1371/journal.pone.0106262	http://dx.doi.org/10.1371/journal.pone.0106262			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3TB	25184296	Green Published, gold			2022-12-27	WOS:000341257700048
J	Wolber, LE; Steves, CJ; Tsai, PC; Deloukas, P; Spector, TD; Bell, JT; Williams, FMK				Wolber, Lisa E.; Steves, Claire J.; Tsai, Pei-Chien; Deloukas, Panos; Spector, Tim D.; Bell, Jordana T.; Williams, Frances M. K.			Epigenome-Wide DNA Methylation in Hearing Ability: New Mechanisms for an Old Problem	PLOS ONE			English	Article							STICKLER-SYNDROME; METHYLTRANSFERASES; ASSOCIATION; TISSUES; MOUSE; CELLS; NULP1	Epigenetic regulation of gene expression has been shown to change over time and may be associated with environmental exposures in common complex traits. Age-related hearing impairment is a complex disorder, known to be heritable, with heritability estimates of 57-70%. Epigenetic regulation might explain the observed difference in age of onset and magnitude of hearing impairment with age. Epigenetic epidemiology studies using unrelated samples can be limited in their ability to detect small effects, and recent epigenetic findings in twins underscore the power of this well matched study design. We investigated the association between venous blood DNA methylation epigenome-wide and hearing ability. Pure-tone audiometry (PTA) and Illumina HumanMethylation array data were obtained from female twin volunteers enrolled in the TwinsUK register. Two study groups were explored: first, an epigenome-wide association scan (EWAS) was performed in a discovery sample (n = 115 subjects, age range: 47-83 years, Illumina 27 k array), then replication of the top ten associated probes from the discovery EWAS was attempted in a second unrelated sample (n = 203, age range: 41-86 years, Illumina 450 k array). Finally, a set of monozygotic (MZ) twin pairs (n = 21 pairs) within the discovery sample (Illumina 27 k array) was investigated in more detail in an MZ discordance analysis. Hearing ability was strongly associated with DNA methylation levels in the promoter regions of several genes, including TCF25 (cg01161216, p = 6.6x10(-6)), FGFR1 (cg15791248, p = 5.7x10(-5)) and POLE (cg18877514, p = 6.3x10(-5)). Replication of these results in a second sample confirmed the presence of differential methylation at TCF25 (p(replication) = 6x10(-5)) and POLE (p(replication) = 0.016). In the MZ discordance analysis, twins' intrapair difference in hearing ability correlated with DNA methylation differences at ACP6 (cg01377755, r = -0.75, p = 1.2x10(-4)) and MEF2D (cg08156349, r = -0.75, p = 1.4x10(-4)). Examination of gene expression in skin, suggests an influence of differential methylation on expression, which may account for the variation in hearing ability with age.	[Wolber, Lisa E.; Steves, Claire J.; Tsai, Pei-Chien; Spector, Tim D.; Bell, Jordana T.; Williams, Frances M. K.] Kings Coll London, Dept Twin Res & Genet Epidemiol, London WC2R 2LS, England; [Deloukas, Panos] Queen Mary Univ London, Barts & London Sch Med & Dent, William Harvey Res Inst, London, England; [Deloukas, Panos] King Abdulaziz Univ, Jeddah 21413, Saudi Arabia; [Deloukas, Panos] Wellcome Trust Sanger Inst, Cambridge, England	University of London; King's College London; University of London; Queen Mary University London; King Abdulaziz University; Wellcome Trust Sanger Institute	Williams, FMK (corresponding author), Kings Coll London, Dept Twin Res & Genet Epidemiol, London WC2R 2LS, England.	frances.williams@kcl.ac.uk	Bell, Jordana/AAH-7312-2019; Deloukas, Panos/B-2922-2013	Deloukas, Panos/0000-0001-9251-070X; Bell, Jordana/0000-0002-3858-5986; Steves, Claire/0000-0002-4910-0489; TSAI, PEI-CHIEN/0000-0003-1575-9020; Williams, Frances/0000-0002-2998-2744	Action on Hearing Loss; AgeUK; Wellcome Trust; European Community; National Institute for Health Research (NIHR) BioResource Clinical Research Facility; Biomedical Research Centre based at Guy's and St Thomas' NHS Foundation Trust; Biomedical Research Centre based at King's College London; ERC	Action on Hearing Loss; AgeUK; Wellcome Trust(Wellcome TrustEuropean Commission); European Community(European Commission); National Institute for Health Research (NIHR) BioResource Clinical Research Facility(National Institute for Health Research (NIHR)); Biomedical Research Centre based at Guy's and St Thomas' NHS Foundation Trust; Biomedical Research Centre based at King's College London; ERC(European Research Council (ERC)European Commission)	This work was funded by Action on Hearing Loss and AgeUK. The authors would like to thank all volunteers from the TwinsUK register, who contributed to this study and acknowledge the work of all researchers who helped in the completion of this work. The study was funded by the Wellcome Trust; European Community's Seventh Framework Programme (FP7/2007-2013). The study also receives support from the National Institute for Health Research (NIHR) BioResource Clinical Research Facility and Biomedical Research Centre based at Guy's and St Thomas' NHS Foundation Trust and King's College London. Tim Spector is holder of an ERC Advanced Principal Investigator award. The funders had no role in study design, data and analysis, decision to publish, or preparation of the manuscript.	Bell JT, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms3978; Bell JT, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-1-r10; Bell JT, 2011, TRENDS GENET, V27, P116, DOI 10.1016/j.tig.2010.12.005; Bestor TH, 2000, HUM MOL GENET, V9, P2395, DOI 10.1093/hmg/9.16.2395; Bibikova M, 2011, GENOMICS, V98, P288, DOI 10.1016/j.ygeno.2011.07.007; Bibikova M, 2009, EPIGENOMICS-UK, V1, P177, DOI [10.2217/epi.09.14, 10.2217/EPI.09.14]; BIRD AP, 1986, NATURE, V321, P209, DOI 10.1038/321209a0; BSA, 2011, REC PROC PUR TON AIR; Buschdorf JP, 2004, J MOL MED, V82, P135, DOI 10.1007/s00109-003-0497-9; Byun HM, 2009, HUM MOL GENET, V18, P4808, DOI 10.1093/hmg/ddp445; Dempster EL, 2011, HUM MOL GENET, V20, P4786, DOI 10.1093/hmg/ddr416; Donoso LA, 2003, SURV OPHTHALMOL, V48, P191, DOI 10.1016/S0039-6257(02)00460-5; Eppig JT, 2012, NUCLEIC ACIDS RES, V40, pD881, DOI 10.1093/nar/gkr974; Fraga MF, 2005, P NATL ACAD SCI USA, V102, P10604, DOI 10.1073/pnas.0500398102; Friedman LM, 2009, MAMM GENOME, V20, P581, DOI 10.1007/s00335-009-9230-5; Grundberg E, 2012, NAT GENET, V44, P1084, DOI 10.1038/ng.2394; HOLLIDAY R, 1990, BIOL REV, V65, P431, DOI 10.1111/j.1469-185X.1990.tb01233.x; Horvath S, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-10-r97; Huyghe JR, 2008, AM J HUM GENET, V83, P401, DOI 10.1016/j.ajhg.2008.08.002; Ladd-Acosta C, 2007, AM J HUM GENET, V81, P1304, DOI 10.1086/524110; Li JY, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002688; Okano M, 1999, CELL, V99, P247, DOI 10.1016/S0092-8674(00)81656-6; Olsson M, 2002, CELL TISSUE RES, V308, P361, DOI 10.1007/s00441-002-0544-9; Pirvola U, 2002, NEURON, V35, P671, DOI 10.1016/S0896-6273(02)00824-3; Provenzano MJ, 2007, HEARING RES, V233, P1, DOI 10.1016/j.heares.2007.07.002; Rakyan VK, 2011, NAT REV GENET, V12, P529, DOI 10.1038/nrg3000; Rakyan VK, 2010, GENOME RES, V20, P434, DOI 10.1101/gr.103101.109; Rosenbloom KR, 2013, NUCLEIC ACIDS RES, V41, pD56, DOI 10.1093/nar/gks1172; Sanchez-Calderon H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008699; Steen H, 2008, BIOCHEM BIOPH RES CO, V366, P432, DOI 10.1016/j.bbrc.2007.11.146; VandenLangenberg GM, 1998, AM J EPIDEMIOL, V148, P204, DOI 10.1093/oxfordjournals.aje.a009625; Waddington C.H., 2012, INT J EPIDEMIOL, V41, P10, DOI DOI 10.1093/ije/dyr184; Wang SJ, 2009, J NEUROSCI RES, V87, P3428, DOI 10.1002/jnr.22164; Wilkin DJ, 2000, AM J MED GENET, V94, P141, DOI 10.1002/1096-8628(20000911)94:2<141::AID-AJMG6>3.0.CO;2-A; Willer CJ, 2010, BIOINFORMATICS, V26, P2190, DOI 10.1093/bioinformatics/btq340; Wong CCY, 2010, EPIGENETICS-US, V5, DOI 10.4161/epi.5.6.12226	36	18	19	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 3	2014	9	9							e105729	10.1371/journal.pone.0105729	http://dx.doi.org/10.1371/journal.pone.0105729			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3TB	25184702	gold, Green Published, Green Submitted			2022-12-27	WOS:000341257700023
J	Odeny, TA; Newman, M; Bukusi, EA; McClelland, RS; Cohen, CR; Camlin, CS				Odeny, Thomas A.; Newman, Maya; Bukusi, Elizabeth A.; McClelland, R. Scott; Cohen, Craig R.; Camlin, Carol S.			Developing Content for a mHealth Intervention to Promote Postpartum Retention in Prevention of Mother-To-Child HIV Transmission Programs and Early Infant Diagnosis of HIV: A Qualitative Study	PLOS ONE			English	Article							HEALTH; MODEL; CARE; BEHAVIOR	Background: Maternal attendance at postnatal clinic visits and timely diagnosis of infant HIV infection are important steps for prevention of mother-to-child transmission (PMTCT) of HIV. We aimed to use theory-informed methods to develop text messages targeted at facilitating these steps. Methods: We conducted five focus group discussions with health workers and women attending antenatal, postnatal, and PMTCT clinics to explore aspects of women's engagement in postnatal HIV care and infant testing. Discussion topics were informed by constructs of the Health Belief Model (HBM) and prior empirical research. Qualitative data were coded and analyzed according to the construct of the HBM to which they related. Themes were extracted and used to draft intervention messages. We carried out two stages of further messaging development: messages were presented in a follow-up focus group in order to develop optimal phrasing in local languages. We then further refined the messages, pretested them in individual cognitive interviews with selected health workers, and finalized the messages for the intervention. Results: Findings indicated that brief, personalized, caring, polite, encouraging, and educational text messages would facilitate women bringing their children to clinic after delivery, suggesting that text messages may serve as an important "cue to action." Participants emphasized that messages should not mention HIV due to fear of HIV testing and disclosure. Participants also noted that text messages could capitalize on women's motivation to attend clinic for childhood immunizations. Conclusions: Applying a multi-stage content development approach to crafting text messages - informed by behavioral theory - resulted in message content that was consistent across different focus groups. This approach could help answer "why" and "how" text messaging may be a useful tool to support maternal and child health. We are evaluating the effect of these messages on improving postpartum PMTCT retention and infant HIV testing in a randomized trial.	[Odeny, Thomas A.; Bukusi, Elizabeth A.] Ctr Microbiol Res, Kenya Med Res Inst, Nairobi, Kenya; [Odeny, Thomas A.; McClelland, R. Scott] Univ Washington, Dept Epidemiol, Seattle, WA 98195 USA; [Newman, Maya] Univ Washington, Sch Med, Seattle, WA 98195 USA; [Bukusi, Elizabeth A.; McClelland, R. Scott] Univ Washington, Dept Global Hlth, Seattle, WA 98195 USA; [Bukusi, Elizabeth A.] Univ Washington, Dept Obstet & Gynecol, Seattle, WA 98195 USA; [McClelland, R. Scott] Univ Washington, Dept Med, Seattle, WA 98195 USA; [McClelland, R. Scott] Univ Nairobi, Inst Trop & Infect Dis, Nairobi, Kenya; [Cohen, Craig R.; Camlin, Carol S.] Univ Calif San Francisco, Dept Obstet Gynecol & Reprod Sci, San Francisco, CA 94143 USA; [Camlin, Carol S.] Univ Calif San Francisco, Ctr AIDS Prevent Studies, San Francisco, CA 94143 USA	Kenya Medical Research Institute; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Nairobi; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Odeny, TA (corresponding author), Ctr Microbiol Res, Kenya Med Res Inst, Nairobi, Kenya.	odeny@uw.edu			National Institutes of Health Office of the Director, Fogarty International Center, Office of AIDS Research; National Cancer Center; National Eye Institute; National Heart, Blood, and Lung Institute; National Institute of Dental and Craniofacial Research; National Institute on Drug Abuse; National Institute of Mental Health; National Institute of Allergy and Infectious Diseases; National Institutes of Health Office of Women's Health and Research through the Fogarty International Clinical Research Scholars and Fellows Program at Vanderbilt University [R24 TW007988]; American Relief and Recovery Act; National Institute of Mental Health [K01MH093205]; FOGARTY INTERNATIONAL CENTER [R24TW007988] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [P30MH062246, K01MH093205] Funding Source: NIH RePORTER	National Institutes of Health Office of the Director, Fogarty International Center, Office of AIDS Research; National Cancer Center; National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); National Heart, Blood, and Lung Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institute of Dental and Craniofacial Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Institutes of Health Office of Women's Health and Research through the Fogarty International Clinical Research Scholars and Fellows Program at Vanderbilt University; American Relief and Recovery Act; National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by the National Institutes of Health Office of the Director, Fogarty International Center, Office of AIDS Research, National Cancer Center, National Eye Institute, National Heart, Blood, and Lung Institute, National Institute of Dental and Craniofacial Research, National Institute on Drug Abuse, National Institute of Mental Health, National Institute of Allergy and Infectious Diseases, and National Institutes of Health Office of Women's Health and Research through the Fogarty International Clinical Research Scholars and Fellows Program at Vanderbilt University (R24 TW007988) and the American Relief and Recovery Act. TAO was a Fogarty International Clinical Research Fellow. CSC was supported by a Research Scientist Development Award from the National Institute of Mental Health (K01MH093205). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2010, KEN DEM HLTH SURV 20; BANDURA A, 1989, PRIM PREV P, V13, P128; Bandura Albert, 1977, SOCIAL LEARNING THEO; CATANIA JA, 1990, HEALTH EDUC QUART, V17, P53, DOI 10.1177/109019819001700107; Chi BH, 2010, LANCET, V376, P1807, DOI 10.1016/S0140-6736(10)62046-6; Coomes CM, 2012, AIDS CARE, V24, P348, DOI 10.1080/09540121.2011.608421; Elhadj As, 2010, OP REM UN REG DIR EL; Glanz K., 1997, THEORY GLANCE GUIDE; Horvath T, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009756; JANZ NK, 1984, HEALTH EDUC QUART, V11, P1, DOI 10.1177/109019818401100101; Kulzer JL, 2012, J INT AIDS SOC, V15, DOI 10.1186/1758-2652-15-8; Lester RT, 2010, LANCET, V376, P1838, DOI 10.1016/S0140-6736(10)61997-6; Manzi M, 2005, TROP MED INT HEALTH, V10, P1242, DOI 10.1111/j.1365-3156.2005.01526.x; Namey E, 2005, QUALITATIVE RES METH; Nassali M, 2009, AIDS CARE, V21, P1124, DOI 10.1080/09540120802707467; Odeny T, 2014, TEXTING IMP IN PRESS; Odeny TA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043832; Perez F, 2004, BRIT MED J, V329, P1147, DOI 10.1136/bmj.329.7475.1147; Pop-Eleches C, 2011, AIDS, V25, P825, DOI 10.1097/QAD.0b013e32834380c1; Rawizza H, 2012, 19 C RETR OPP INF PA; Riley WT, 2011, TRANSL BEHAV MED, V1, P53, DOI 10.1007/s13142-011-0021-7; ROSENSTOCK IM, 1988, HEALTH EDUC QUART, V15, P175, DOI 10.1177/109019818801500203; Rosenstock IM, 1994, HLTH BELIEF MODEL HI; The PME, 2013, PLOS MED, V10; Thirumurthy H, 2012, B WORLD HEALTH ORGAN, V90, P390, DOI 10.2471/BLT.11.099317; Tourangeau R, 1984, COGNITIVE ASPECTS SU, P73; Turan JM, 2011, AIDS BEHAV, V15, P1111, DOI 10.1007/s10461-010-9798-5; UNAIDS, 2011, EP UPD HLTH SECT PRO	28	42	42	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2014	9	9							e106383	10.1371/journal.pone.0106383	http://dx.doi.org/10.1371/journal.pone.0106383			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3LR	25181408	Green Published, Green Submitted, gold			2022-12-27	WOS:000341231500085
J	Wood, R; Morrow, C; Ginsberg, S; Piccoli, E; Kalil, D; Sassi, A; Walensky, RP; Andrews, JR				Wood, Robin; Morrow, Carl; Ginsberg, Samuel; Piccoli, Elizabeth; Kalil, Darryl; Sassi, Angelina; Walensky, Rochelle P.; Andrews, Jason R.			Quantification of Shared Air: A Social and Environmental Determinant of Airborne Disease Transmission	PLOS ONE			English	Article							TUBERCULOSIS TRANSMISSION; CAPE-TOWN; HIGH HIV; INFECTION; PREVALENCE; COMMUNITY; RISK; ADOLESCENTS; HOUSEHOLDS; CHILDREN	Background: Tuberculosis is endemic in Cape Town, South Africa where a majority of the population become tuberculosis infected before adulthood. While social contact patterns impacting tuberculosis and other respiratory disease spread have been studied, the environmental determinants driving airborne transmission have not been quantified. Methods: Indoor carbon dioxide levels above outdoor levels reflect the balance of exhaled breath by room occupants and ventilation. We developed a portable monitor to continuously sample carbon dioxide levels, which were combined with social contact diary records to estimate daily rebreathed litres. A pilot study established the practicality of monitor use up to 48-hours. We then estimated the daily volumes of air rebreathed by adolescents living in a crowded township. Results: One hundred eight daily records were obtained from 63 adolescents aged between 12- and 20-years. Forty-five lived in wooden shacks and 18 in brick-built homes with a median household of 4 members (range 2-9). Mean daily volume of rebreathed air was 120.6 (standard error: 8.0) litres/day, with location contributions from household (48%), school (44%), visited households (4%), transport (0.5%) and other locations (3.4%). Independent predictors of daily rebreathed volumes included household type (p = 0.002), number of household occupants (p = 0.021), number of sleeping space occupants (p = 0.022) and winter season (p<0.001). Conclusions: We demonstrated the practical measurement of carbon dioxide levels to which individuals are exposed in a sequence of non-steady state indoor environments. A novel metric of rebreathed air volume reflects social and environmental factors associated with airborne infection and can identify locations with high transmission potential.	[Wood, Robin; Morrow, Carl; Piccoli, Elizabeth; Kalil, Darryl; Sassi, Angelina] Univ Cape Town, Fac Hlth Sci, Desmond Tutu HIV Ctr, Inst Infect Dis & Mol Med, ZA-7925 Cape Town, South Africa; [Wood, Robin; Morrow, Carl; Piccoli, Elizabeth; Kalil, Darryl; Sassi, Angelina] Univ Cape Town, Fac Hlth Sci, Dept Med, ZA-7925 Cape Town, South Africa; [Ginsberg, Samuel] Univ Cape Town, Fac Engn & Built Environm, Dept Elect Engn, ZA-7925 Cape Town, South Africa; [Walensky, Rochelle P.] Harvard Univ, Sch Med, Ctr AIDS Res, Boston, MA USA; [Andrews, Jason R.] Stanford Univ, Med Ctr, Sch Med, Div Infect Dis & Geog Med, Stanford, CA 94305 USA	University of Cape Town; University of Cape Town; University of Cape Town; Harvard University; Harvard Medical School; Stanford University	Wood, R (corresponding author), Univ Cape Town, Fac Hlth Sci, Desmond Tutu HIV Ctr, Inst Infect Dis & Mol Med, ZA-7925 Cape Town, South Africa.	Robin.Wood@uct.ac.za		Walensky, Rochelle P./0000-0002-8795-379X; Andrews, Jason/0000-0002-5967-251X; Sassi, Angelina/0000-0002-5807-6388	National Institute of Allergy and Infectious Diseases [R01 AI058736, R01 AI093269, U01 AI069519, U01 AI069926, K01 AI104411]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI069519, K01AI104411, R01AI093269, R01AI058736] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the National Institute of Allergy and Infectious Diseases [R01 AI058736 to RW, RPW, CM; R01 AI093269 to RPW, RW; U01 AI069519 and U01 AI069926 to RW; and K01 AI104411 to JRA]. The funders had no role in study design, data collection, analysis, decision to publish, or preparation of the manuscript.	American Society for Testing and Materials, 1998, D624598 ASTM, pD6245; [Anonymous], AV MAX MIN MONTHL TE; Brooks-Pollock E, 2011, J INFECT DIS, V203, P1582, DOI 10.1093/infdis/jir162; CATANZARO A, 1982, AM REV RESPIR DIS, V125, P559, DOI 10.1164/arrd.1982.125.5.559; CHAPMAN JS, 1964, AM REV RESPIR DIS, V90, P48; Chaumont FD, 1874, P R SOC LOND, V23, P187; Emmerlich SJ, 2001, STATE OF THE ART REV; Furuya Hiroyuki, 2009, Environmental Health and Preventive Medicine, V14, P96, DOI 10.1007/s12199-008-0062-9; Guzzetta G, 2011, J THEOR BIOL, V289, P197, DOI 10.1016/j.jtbi.2011.08.032; Ho MJ, 2004, SOC SCI MED, V59, P753, DOI 10.1016/j.socscimed.2003.11.033; Johnstone-Robertson S, 2011, SAMJ S AFR MED J, V101, P809; Johnstone-Robertson SP, 2011, AM J EPIDEMIOL, V174, P1246, DOI 10.1093/aje/kwr251; Ko G, 2004, RISK ANAL, V24, P379, DOI 10.1111/j.0272-4332.2004.00439.x; Kritzinger FE, 2009, TROP MED INT HEALTH, V14, P136, DOI 10.1111/j.1365-3156.2008.02213.x; Martineaua AR, 2011, P NATL ACAD SCI USA, V108, P19013, DOI 10.1073/pnas.1111825108; MENZIES R, 1995, AM J RESP CRIT CARE, V152, P1992, DOI 10.1164/ajrccm.152.6.8520767; Middelkoop K, 2008, CLIN INFECT DIS, V47, P349, DOI 10.1086/589750; Middelkoop K, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-156; Middelkoop K, 2011, JAIDS-J ACQ IMM DEF, V56, P263, DOI 10.1097/QAI.0b013e31820413b3; Murphy S, 2002, INT J EPIDEMIOL, V31, P742, DOI 10.1093/ije/31.4.742; Nakagawa S, 2013, METHODS ECOL EVOL, V4, P133, DOI 10.1111/j.2041-210x.2012.00261.x; Noakes CJ, 2009, J R SOC INTERFACE, V6, pS791, DOI 10.1098/rsif.2009.0305.focus; RAICH JW, 1992, TELLUS B, V44, P81, DOI 10.1034/j.1600-0889.1992.t01-1-00001.x; REIDER HI, 1999, EPIDEMIOLOGICAL BASI; Rieder HL, 1999, INT J TUBERC LUNG D, V3, P177; RILEY RL, 1957, AM REV TUBERC PULM, V75, P420; Rudnick SN, 2003, INDOOR AIR, V13, P237, DOI 10.1034/j.1600-0668.2003.00189.x; South African Weather Service, 2012, CO2 CAP POINT SAWS; Verver S, 2004, LANCET, V363, P212, DOI 10.1016/S0140-6736(03)15332-9; Vittinghoff E, 2005, STAT BIOL HEALTH, pVII; Wells WF, 1955, AIR HYG ECOL STUDY D; WHO, 2012, GLOBAL TUBERCULOSIS REPORT 2012, P1; Wood R, 2010, INT J TUBERC LUNG D, V14, P406; Wood R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039246; Wood R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025098; Wood R, 2011, SAMJ S AFR MED J, V101, P111, DOI 10.7196/SAMJ.4587; Wood R, 2010, CLIN INFECT DIS, V51, P401, DOI 10.1086/655129	37	33	33	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2014	9	9							e106622	10.1371/journal.pone.0106622	http://dx.doi.org/10.1371/journal.pone.0106622			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3LR	25181526	Green Submitted, gold, Green Published			2022-12-27	WOS:000341231500117
J	Cao, JN; Agrawal, A; Sharman, E; Jia, ZY; Gupta, S				Cao, Jia-ning; Agrawal, Anshu; Sharman, Edward; Jia, Zhenyu; Gupta, Sudhir			Alterations in Gene Array Patterns in Dendritic Cells from Aged Humans	PLOS ONE			English	Article							EXPRESSION; INFLAMMATION; PROTEINS; REACTIVITY; IMMUNITY; ANTIGEN; INNATE; DOMAIN; VIRUS; CYCLE	Dendritic cells (DCs) are major antigen-presenting cells that play a key role in initiating and regulating innate and adaptive immune responses. DCs are critical mediators of tolerance and immunity. The functional properties of DCs decline with age. The purpose of this study was to define the age-associated molecular changes in DCs by gene array analysis using Affymatrix GeneChips. The expression levels of a total of 260 genes (1.8%) were significantly different (144 down-regulated and 116 upregulated) in monocyte-derived DCs (MoDCs) from aged compared to young human donors. Of the 260 differentially expressed genes, 24% were down-regulated by more than 3-fold, suggesting that a large reduction in expression occurred for a notable number of genes in the aged. Our results suggest that the genes involved in immune response to pathogens, cell migration and T cell priming display significant age-related changes. Furthermore, downregulated genes involved in cell cycle arrest and DNA replication may play a critical role in aging-associated genetic instability. These changes in gene expression provide molecular based evidence for age-associated functional abnormalities in human DCs that may be responsible for the defects in adaptive immunity observed in the elderly.	[Cao, Jia-ning; Agrawal, Anshu; Gupta, Sudhir] Univ Calif Irvine, Dept Med, Div Basic & Clin Immunol, Irvine, CA 92717 USA; [Sharman, Edward] Univ Calif Irvine, Dept Neurol, Irvine, CA 92717 USA; [Jia, Zhenyu] Univ Akron, Dept Stat, Akron, OH 44325 USA; [Jia, Zhenyu] Northeast Ohio Med Univ, Dept Family & Community Med, Rootstown, OH USA; [Jia, Zhenyu] Univ Calif Irvine, Irvine, CA USA	University of California System; University of California Irvine; University of California System; University of California Irvine; University System of Ohio; University of Akron; Northeast Ohio Medical University (NEOMED); University of California System; University of California Irvine	Gupta, S (corresponding author), Univ Calif Irvine, Dept Med, Div Basic & Clin Immunol, Irvine, CA 92717 USA.	sgupta@uci.edu	Agrawal, Anshu/AAU-6341-2021					Agrawal A, 2007, J IMMUNOL, V178, P6912, DOI 10.4049/jimmunol.178.11.6912; Agrawal A, 2011, AGEING RES REV, V10, P336, DOI 10.1016/j.arr.2010.06.004; Agrawal A, 2010, AGING-US, V2, P93, DOI 10.18632/aging.100121; Agrawal A, 2009, J IMMUNOL, V182, P1138, DOI 10.4049/jimmunol.182.2.1138; Akira S, 2004, NAT REV IMMUNOL, V4, P499, DOI 10.1038/nri1391; Alexander WS, 2004, ANNU REV IMMUNOL, V22, P503, DOI 10.1146/annurev.immunol.22.091003.090312; Banchereau J, 2000, ANNU REV IMMUNOL, V18, P767, DOI 10.1146/annurev.immunol.18.1.767; Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588; Boucheron N, 2012, INT REV IMMUNOL, V31, P133, DOI 10.3109/08830185.2012.664798; Bouvard D, 2006, EUR J CELL BIOL, V85, P275, DOI 10.1016/j.ejcb.2005.10.005; Brass AL, 2009, CELL, V139, P1243, DOI 10.1016/j.cell.2009.12.017; Braun A, 2011, NAT IMMUNOL, V12, P879, DOI 10.1038/ni.2085; Campisi J, 2011, CURR OPIN GENET DEV, V21, P107, DOI 10.1016/j.gde.2010.10.005; Cao JN, 2010, AGING CELL, V9, P19, DOI 10.1111/j.1474-9726.2009.00534.x; Cevenini E, 2013, CURR OPIN CLIN NUTR, V16, P14, DOI 10.1097/MCO.0b013e32835ada13; Cheung CHA, 2011, FRONT BIOSCI-LANDMRK, V16, P952, DOI 10.2741/3728; Chi XJ, 2013, INT J MOL SCI, V14, P7089, DOI 10.3390/ijms14047089; Diamond MS, 2013, NAT REV IMMUNOL, V13, P46, DOI 10.1038/nri3344; Doniger SW, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-1-r7; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Ellison V, 2003, PLOS BIOL, V1, P231, DOI 10.1371/journal.pbio.0000033; Espert L, 2005, J GEN VIROL, V86, P2221, DOI 10.1099/vir.0.81074-0; Forster R, 1999, CELL, V99, P23, DOI 10.1016/S0092-8674(00)80059-8; Fukui R, 2011, IMMUNITY, V35, P69, DOI 10.1016/j.immuni.2011.05.010; Furuya S, 2008, ASIA PAC J CLIN NUTR, V17, P312; Gilli F, 2011, ARCH NEUROL-CHICAGO, V68, P879, DOI 10.1001/archneurol.2011.32; Gollob JA, 1996, ANN NY ACAD SCI, V795, P71, DOI 10.1111/j.1749-6632.1996.tb52656.x; Gruss OJ, 2002, NAT CELL BIOL, V4, P871, DOI 10.1038/ncb870; Haller O, 2007, BIOCHIMIE, V89, P812, DOI 10.1016/j.biochi.2007.04.015; Hlobilkova A, 2006, ANTICANCER RES, V26, P1015; Jonuleit H, 1997, EUR J IMMUNOL, V27, P3135, DOI 10.1002/eji.1830271209; Kim YM, 2008, NATURE, V452, P234, DOI 10.1038/nature06726; Kosar M, 2011, CELL CYCLE, V10, P457, DOI 10.4161/cc.10.3.14707; Kuo AJ, 2012, NATURE, V484, P115, DOI 10.1038/nature10956; Lauper N, 1998, ONCOGENE, V17, P2637, DOI 10.1038/sj.onc.1202477; Lee YM, 2001, BIOCHEM J, V360, P549, DOI 10.1042/0264-6021:3600549; Liu BH, 2012, CURR GENOMICS, V13, P533, DOI 10.2174/138920212803251373; MacDonald KPA, 2002, BLOOD, V100, P4512, DOI 10.1182/blood-2001-11-0097; Maslov AY, 2009, BBA-GEN SUBJECTS, V1790, P963, DOI 10.1016/j.bbagen.2009.03.020; McBerry C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038384; McGeer PL, 2004, ANN NY ACAD SCI, V1035, P104, DOI 10.1196/annals.1332.007; McGlauchlen KS, 2003, MICROBES INFECT, V5, P1279, DOI 10.1016/j.micinf.2003.09.001; Mellor AL, 2004, NAT REV IMMUNOL, V4, P762, DOI 10.1038/nri1457; Michalak M, 1996, J BIOL CHEM, V271, P29436, DOI 10.1074/jbc.271.46.29436; Milne TA, 2002, MOL CELL, V10, P1107, DOI 10.1016/S1097-2765(02)00741-4; Molenaar R, 2011, J IMMUNOL, V186, P1934, DOI 10.4049/jimmunol.1001672; Moon SK, 2004, ARCH BIOCHEM BIOPHYS, V421, P267, DOI 10.1016/j.abb.2003.11.007; Neyt K, 2013, IMMUNOL REV, V255, P57, DOI 10.1111/imr.12100; Nobes C, 2000, CURR BIOL, V10, pR739, DOI 10.1016/S0960-9822(00)00736-3; Panda A, 2010, J IMMUNOL, V184, P2518, DOI 10.4049/jimmunol.0901022; Pichlmair A, 2011, NAT IMMUNOL, V12, P624, DOI 10.1038/ni.2048; Prakash S, 2014, MUCOSAL IMMUNOL; Prakash S, 2013, AGE, V35, P1785, DOI 10.1007/s11357-012-9477-8; Reiner A, 2003, BIOINFORMATICS, V19, P368, DOI 10.1093/bioinformatics/btf877; Scolz M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051259; Sridharan A, 2011, AGE, V33, P363, DOI 10.1007/s11357-010-9191-3; Stark GR, 2006, MOL BIOTECHNOL, V32, P227, DOI 10.1385/MB:32:3:227; Tran DQ, 2009, P NATL ACAD SCI USA, V106, P13445, DOI 10.1073/pnas.0901944106; von Eyss B, 2012, EMBO J, V31, P972, DOI 10.1038/emboj.2011.451; Wick G, 1997, EXP GERONTOL, V32, P401, DOI 10.1016/S0531-5565(96)00152-0; Zhang H, 2008, J BIOL CHEM, V283, P22637, DOI 10.1074/jbc.M802129200; Zheng L, 2011, NUCLEIC ACIDS RES, V39, P781, DOI 10.1093/nar/gkq884; Zhong JX, 2013, DIABETES, V62, P149, DOI 10.2337/db12-0230; Zhou YH, 2010, BIOMARK INSIGHTS, V5, P79, DOI 10.4137/BMI.S5596	64	9	10	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2014	9	9							e106471	10.1371/journal.pone.0106471	http://dx.doi.org/10.1371/journal.pone.0106471			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ1IR	25191744	Green Published, gold			2022-12-27	WOS:000347993600030
J	Leo, F; Noppeney, U				Leo, Fabrizio; Noppeney, Uta			Conditioned Sounds Enhance Visual Processing	PLOS ONE			English	Article							EXPERIENCE-DEPENDENT PLASTICITY; HUMAN AUDITORY-CORTEX; MULTISENSORY INTEGRATION; SUPERIOR COLLICULUS; SPATIAL ATTENTION; AUDIOVISUAL INTEGRATION; MOTION DISCRIMINATION; SPEECH COMPREHENSION; CORTICAL PLASTICITY; SINGLE NEURONS	This psychophysics study investigated whether prior auditory conditioning influences how a sound interacts with visual perception. In the conditioning phase, subjects were presented with three pure tones (= conditioned stimuli, CS) that were paired with positive, negative or neutral unconditioned stimuli. As unconditioned reinforcers we employed pictures (highly pleasant, unpleasant and neutral) or monetary outcomes (+50 euro cents, -50 cents, 0 cents). In the subsequent visual selective attention paradigm, subjects were presented with near-threshold Gabors displayed in their left or right hemifield. Critically, the Gabors were presented in synchrony with one of the conditioned sounds. Subjects discriminated whether the Gabors were presented in their left or right hemifields. Participants determined the location more accurately when the Gabors were presented in synchrony with positive relative to neutral sounds irrespective of reinforcer type. Thus, previously rewarded relative to neutral sounds increased the bottom-up salience of the visual Gabors. Our results are the first demonstration that prior auditory conditioning is a potent mechanism to modulate the effect of sounds on visual perception.	[Leo, Fabrizio; Noppeney, Uta] Max Planck Inst Biol Cybernet, D-72076 Tubingen, Germany; [Leo, Fabrizio] Otto Von Guericke Univ, Inst Biol Psychol, Magdeburg, Germany; [Leo, Fabrizio] Ist Italiano Tecnol, Dept Robot Brain & Cognit Sci, Genoa, Italy; [Noppeney, Uta] Univ Birmingham, Computat Neurosci & Cognit Robot Ctr, Birmingham, W Midlands, England	Max Planck Society; Otto von Guericke University; Istituto Italiano di Tecnologia - IIT; University of Birmingham	Leo, F (corresponding author), Max Planck Inst Biol Cybernet, Spemannstr 38, D-72076 Tubingen, Germany.	Fabrizio.Leo@iit.it	Leo, Fabrizio/AFN-6821-2022	Noppeney, Uta/0000-0002-7697-2290; Leo, Fabrizio/0000-0002-4095-7785	Max Planck Society	Max Planck Society(Max Planck Society)	This study was funded by the Max Planck Society. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AHISSAR E, 1992, SCIENCE, V257, P1412, DOI 10.1126/science.1529342; Bertini C, 2008, BRAIN RES, V1242, P37, DOI 10.1016/j.brainres.2008.03.087; Conrad V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070710; DIAMOND DM, 1984, BEHAV NEUROSCI, V98, P189, DOI 10.1037/0735-7044.98.2.189; Doehrmann O, 2010, J NEUROSCI, V30, P3370, DOI 10.1523/JNEUROSCI.5074-09.2010; Driver J, 1998, PHILOS T R SOC B, V353, P1319, DOI 10.1098/rstb.1998.0286; Falchier A, 2002, J NEUROSCI, V22, P5749; FARAH MJ, 1989, NEUROPSYCHOLOGIA, V27, P461, DOI 10.1016/0028-3932(89)90051-1; Faul F, 2009, BEHAV RES METHODS, V41, P1149, DOI 10.3758/BRM.41.4.1149; Frassinetti F, 2002, EXP BRAIN RES, V147, P332, DOI 10.1007/s00221-002-1262-y; Gao EQ, 2000, P NATL ACAD SCI USA, V97, P8081, DOI 10.1073/pnas.97.14.8081; Hein G, 2007, J NEUROSCI, V27, P7881, DOI 10.1523/JNEUROSCI.1740-07.2007; Honjo K, 2009, J NEUROSCI, V29, P852, DOI 10.1523/JNEUROSCI.1315-08.2009; Irvine DRF, 2007, HEARING RES, V229, P158, DOI 10.1016/j.heares.2007.01.006; Kluge C, 2011, P NATL ACAD SCI USA, V108, P12545, DOI 10.1073/pnas.1016124108; Lang PJ, 2008, INT AFFECTIVE PICTUR; Laurienti PJ, 2004, EXP BRAIN RES, V158, P405, DOI 10.1007/s00221-004-1913-2; Lee H, 2011, J NEUROSCI, V31, P11338, DOI 10.1523/JNEUROSCI.6510-10.2011; Leo F, 2008, EXP BRAIN RES, V186, P67, DOI 10.1007/s00221-007-1204-9; Leo F, 2011, EXP BRAIN RES, V213, P193, DOI 10.1007/s00221-011-2742-8; Lewis R, 2010, J NEUROSCI, V30, P12329, DOI 10.1523/JNEUROSCI.5745-09.2010; Lippert M, 2007, BRAIN RES, V1173, P102, DOI 10.1016/j.brainres.2007.07.050; McDonald JJ, 2000, NATURE, V407, P906, DOI 10.1038/35038085; MEREDITH MA, 1987, J NEUROSCI, V7, P3215; MEREDITH MA, 1986, BRAIN RES, V365, P350; Miller LM, 2005, J NEUROSCI, V25, P5884, DOI 10.1523/JNEUROSCI.0896-05.2005; MOLCHAN SE, 1994, P NATL ACAD SCI USA, V91, P8122, DOI 10.1073/pnas.91.17.8122; Morris JS, 1998, P ROY SOC B-BIOL SCI, V265, P649, DOI 10.1098/rspb.1998.0343; Nakatani Y, 2009, NEUROBIOL LEARN MEM, V92, P370, DOI 10.1016/j.nlm.2009.05.003; Recanzone GH, 2003, J NEUROPHYSIOL, V89, P1078, DOI 10.1152/jn.00706.2002; Rockland KS, 2003, INT J PSYCHOPHYSIOL, V50, P19, DOI 10.1016/S0167-8760(03)00121-1; Ross LA, 2007, CEREB CORTEX, V17, P1147, DOI 10.1093/cercor/bhl024; Sokol-Hessner P, 2009, P NATL ACAD SCI USA, V106, P5035, DOI 10.1073/pnas.0806761106; Spence C, 1996, J EXP PSYCHOL HUMAN, V22, P1005, DOI 10.1037/0096-1523.22.4.1005; Spence C., 2004, HDB MULTISENSORY PRO; Stein BE, 1996, J COGNITIVE NEUROSCI, V8, P497, DOI 10.1162/jocn.1996.8.6.497; STEIN BE, 1988, BRAIN RES, V448, P355, DOI 10.1016/0006-8993(88)91276-0; Stein BE., 1993, MERGING SENSES; Suga N, 2012, NEUROSCI BIOBEHAV R, V36, P969, DOI 10.1016/j.neubiorev.2011.11.006; Takahashi H, 2011, NEUROSCIENCE, V199, P243, DOI 10.1016/j.neuroscience.2011.09.046; TEMPEL BL, 1983, P NATL ACAD SCI-BIOL, V80, P1482, DOI 10.1073/pnas.80.5.1482; Thiel CM, 2002, NEURON, V35, P567, DOI 10.1016/S0896-6273(02)00801-2; Unoki S, 2005, EUR J NEUROSCI, V22, P1409, DOI 10.1111/j.1460-9568.2005.04318.x; Unoki S, 2006, EUR J NEUROSCI, V24, P2031, DOI 10.1111/j.1460-9568.2006.05099.x; von Saldern S, 2013, J NEUROSCI, V33, P8841, DOI 10.1523/JNEUROSCI.3020-12.2013; Vroomen J, 2000, J EXP PSYCHOL HUMAN, V26, P1583, DOI 10.1037/0096-1523.26.5.1583; Weinberger NM, 2004, NAT REV NEUROSCI, V5, P279, DOI 10.1038/nrn1366; Weinberger NM, 2007, LEARN MEMORY, V14, P1, DOI 10.1101/lm.421807; Weis T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052504; Werner S, 2010, J NEUROSCI, V30, P2662, DOI 10.1523/JNEUROSCI.5091-09.2010; Wilson SM, 2008, CEREB CORTEX, V18, P230, DOI 10.1093/cercor/bhm049; Yechiam E, 2013, PSYCHOL BULL, V139, P497, DOI 10.1037/a0029383	52	3	3	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2014	9	9							e106860	10.1371/journal.pone.0106860	http://dx.doi.org/10.1371/journal.pone.0106860			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ1IR	25192387	Green Submitted, Green Published, gold			2022-12-27	WOS:000347993600071
J	Zeng, H; Li, LF; Chen, JX				Zeng, Heng; Li, Lanfang; Chen, Jian-Xiong			Loss of Sirt3 Limits Bone Marrow Cell-Mediated Angiogenesis and Cardiac Repair in Post-Myocardial Infarction	PLOS ONE			English	Article							ACUTE MYOCARDIAL-INFARCTION; ENDOTHELIAL PROGENITOR CELLS; ISCHEMIA/REPERFUSION INJURY; NADPH OXIDASE; CONFERS PROTECTION; AUTOPHAGY; HEART; STRESS; GENE; ACTIVATION	Sirtuin-3 (Sirt3) has a critical role in the regulation of human aging and reactive oxygen species (ROS) formation. A recent study has identified Sirt3 as an essential regulator of stem cell aging. This study investigated whether Sirt3 is necessary for bone marrow cell (BMC)-mediated cardiac repair in post-myocardial infarction (MI). In vitro, BMC-derived endothelial progenitor cells (EPCs) from wild type (WT) and Sirt3KO mice were cultured. EPC angiogenesis, ROS formation and apoptosis were assessed. In vivo, WT and Sirt3 KO mice were subjected to MI and BMCs from WT and Sirt3 KO mice were injected into ischemic area immediately. The expression of VEGF and VEGFR2 was reduced in Sirt3KO-EPCs. Angiogenic capacities and colony formation were significantly impaired in Sirt3KO-EPCs compared to WT-EPCs. Loss of Sirt3 further enhanced ROS formation and apoptosis in EPCs. Overexpression of Sirt3 or treatment with NADPH oxidase inhibitor apocynin (Apo, 200 and 400 microM) rescued these abnormalities. In post-MI mice, BMC treatment increased number of Sca1(+)/c-kit(+) cells; enhanced VEGF expression and angiogenesis whereas Sirt3KO-BMC treatment had little effects. BMC treatment also attenuated NADPH oxidase subunits p47(phox) and gp91(phox) expression, and significantly reduced ROS formation, apoptosis, fibrosis and hypertrophy in post-MI mice. Sirt3KO-BMC treatment did not display these beneficial effects. In contrast, Sirt3KO mice treated with BMCs from WT mice attenuated myocardial apoptosis, fibrosis and improved cardiac function. Our data demonstrate that Sirt3 is essential for BMC therapy; and loss of Sirt3 limits BMC-mediated angiogenesis and cardiac repair in post-MI.	[Zeng, Heng; Li, Lanfang; Chen, Jian-Xiong] Univ Mississippi, Med Ctr, Dept Pharmacol & Toxicol, Jackson, MS 39216 USA	University of Mississippi; University of Mississippi Medical Center	Chen, JX (corresponding author), Univ Mississippi, Med Ctr, Dept Pharmacol & Toxicol, Jackson, MS 39216 USA.	JChen3@umc.edu			National Institutes of Health (NIH) [HL102042]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL102042] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This study was supported by grants from the National Institutes of Health (NIH grant HL102042 to J.X. Chen). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Askari AT, 2003, LANCET, V362, P697, DOI 10.1016/S0140-6736(03)14232-8; Assmus B, 2012, EUR HEART J, V33, P1911, DOI 10.1093/eurheartj/ehr388; Becatti M, 2012, CELL MOL LIFE SCI, V69, P2245, DOI 10.1007/s00018-012-0925-5; Bellizzi D, 2005, GENOMICS, V85, P258, DOI 10.1016/j.ygeno.2004.11.003; Brown K, 2013, CELL REP, V3, P319, DOI 10.1016/j.celrep.2013.01.005; Chen JX, 2007, AM J PHYSIOL-HEART C, V292, pH1664, DOI 10.1152/ajpheart.01138.2006; Chen JX, 2006, AM J PHYSIOL-HEART C, V291, pH1563, DOI 10.1152/ajpheart.01081.2005; Chen JX, 2012, EXP DIABETES RES, DOI 10.1155/2012/836759; Chen JX, 2008, DIABETES, V57, P3335, DOI 10.2337/db08-0503; Chen JX, 2008, LAB INVEST, V88, P1316, DOI 10.1038/labinvest.2008.92; Chen J, 2012, AM J PATHOL, V180, P973, DOI 10.1016/j.ajpath.2011.11.033; Donato AJ, 2011, J PHYSIOL-LONDON, V589, P4545, DOI 10.1113/jphysiol.2011.211219; Edelberg JM, 2002, CIRC RES, V90, pE89, DOI 10.1161/01.RES.0000020861.20064.7E; Fan M, 2010, REJUV RES, V13, P429, DOI 10.1089/rej.2009.0986; Frederick JR, 2010, CIRCULATION, V122, pS107, DOI 10.1161/CIRCULATIONAHA.109.930404; Giralt A, 2012, BIOCHEM J, V444, P1, DOI 10.1042/BJ20120030; Gottlieb RA, 2009, BASIC RES CARDIOL, V104, P169, DOI 10.1007/s00395-009-0011-9; Hamacher-Brady A, 2007, CELL DEATH DIFFER, V14, P146, DOI 10.1038/sj.cdd.4401936; Hamacher-Brady A, 2006, J BIOL CHEM, V281, P29776, DOI 10.1074/jbc.M603783200; Hamacher-Brady A, 2006, AUTOPHAGY, V2, P307, DOI 10.4161/auto.2947; Hu XF, 2007, CIRCULATION, V116, P654, DOI 10.1161/CIRCULATIONAHA.106.672451; Isner JM, 1999, J CLIN INVEST, V103, P1231, DOI 10.1172/JCI6889; Kanamori H, 2011, AM J PHYSIOL-HEART C, V300, pH2261, DOI 10.1152/ajpheart.01056.2010; Khan M, 2011, J CELL MOL MED, V15, P1515, DOI 10.1111/j.1582-4934.2009.00998.x; Kim HS, 2010, CANCER CELL, V17, P41, DOI 10.1016/j.ccr.2009.11.023; Kim I, 2007, ARCH BIOCHEM BIOPHYS, V462, P245, DOI 10.1016/j.abb.2007.03.034; Lee Y, 2013, J CELL BIOCHEM, V114, P79, DOI 10.1002/jcb.24303; Li LF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071041; Li LF, 2012, AM J PHYSIOL-HEART C, V303, pH605, DOI 10.1152/ajpheart.00366.2012; Li LX, 2002, ARTERIOSCL THROM VAS, V22, P249, DOI 10.1161/hq0202.104124; Liu YF, 2011, AGING-US, V3, P1; Massa M, 2005, BLOOD, V105, P199, DOI 10.1182/blood-2004-05-1831; Palacios OM, 2009, AGING-US, V1, P771, DOI 10.18632/aging.100075; Phadwal K, 2013, CELL MOL LIFE SCI, V70, P89, DOI 10.1007/s00018-012-1032-3; Pillai VB, 2010, CARDIOVASC RES, V88, P250, DOI 10.1093/cvr/cvq250; Pillai VB, 2010, J BIOL CHEM, V285, P3133, DOI 10.1074/jbc.M109.077271; Przyklenk K, 2011, AUTOPHAGY, V7, P432, DOI 10.4161/auto.7.4.14395; Rose G, 2003, EXP GERONTOL, V38, P1065, DOI 10.1016/S0531-5565(03)00209-2; Sack MN, 2012, J MOL CELL CARDIOL, V52, P520, DOI 10.1016/j.yjmcc.2011.11.004; Sack MN, 2011, AM J PHYSIOL-HEART C, V301, pH2191, DOI 10.1152/ajpheart.00199.2011; Schachinger V, 2004, J AM COLL CARDIOL, V44, P1690, DOI 10.1016/j.jacc.2004.08.014; Someya S, 2010, CELL, V143, P802, DOI 10.1016/j.cell.2010.10.002; Sundaresan NR, 2008, MOL CELL BIOL, V28, P6384, DOI 10.1128/MCB.00426-08; Sundaresan NR, 2011, J MOL CELL CARDIOL, V51, P614, DOI 10.1016/j.yjmcc.2011.01.008; Sundaresan NR, 2009, J CLIN INVEST, V119, P2758, DOI 10.1172/JCI39162; Tanno M, 2007, J BIOL CHEM, V282, P6823, DOI 10.1074/jbc.M609554200; Tanno M, 2012, BASIC RES CARDIOL, V107, DOI 10.1007/s00395-012-0273-5; Tuo QH, 2008, AM J PHYSIOL-HEART C, V294, pH2547, DOI 10.1152/ajpheart.01250.2007; Vinciguerra M, 2012, AGING CELL, V11, P139, DOI 10.1111/j.1474-9726.2011.00766.x; Wang HJ, 2013, AM J PHYSIOL-CELL PH, V304, pC617, DOI 10.1152/ajpcell.00296.2012; Wojakowski W, 2005, FOLIA HISTOCHEM CYTO, V43, P229; Yoon YS, 2004, MOL CELL BIOCHEM, V264, P63, DOI 10.1023/B:MCBI.0000044375.33928.62; Zeng H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035905; Zhang H, 2005, AM J PHYSIOL-HEART C, V289, pH2089, DOI 10.1152/ajpheart.00019.2005; Zhuang WZ, 2011, INT J CANCER, V129, P2720, DOI 10.1002/ijc.25975; Zu Y, 2010, CIRC RES, V106, P1384, DOI 10.1161/CIRCRESAHA.109.215483	56	26	27	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2014	9	9							e107011	10.1371/journal.pone.0107011	http://dx.doi.org/10.1371/journal.pone.0107011			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ1IR	25192254	gold, Green Published, Green Submitted			2022-12-27	WOS:000347993600088
J	Zheng, YF; Crawford, GW; Chen, XG				Zheng, Yunfei; Crawford, Gary W.; Chen, Xugao			Archaeological Evidence for Peach (Prunus persica) Cultivation and Domestication in China	PLOS ONE			English	Article							EARLY AGRICULTURE; FRUIT	The cultivated/domesticated peach (Prunus persica var. persica; Rosaceae, subgenus Amygdalus; synonym: Amygdalus persica) originated in China, but its wild ancestor, as well as where, when, and under what circumstances the peach was domesticated, is poorly known. Five populations of archaeological peach stones recovered from Zhejiang Province, China, document peach use and evolution beginning ca. 8000 BP. The majority of the archaeological sites from which the earliest peach stones have been recovered are from the Yangzi River valley, indicating that this is where early selection for favorable peach varieties likely took place. Furthermore, peach stone morphology through time is consistent with the hypothesis that an unknown wild P.persica was the ancestor of the cultivated peach. The oldest archaeological peach stones are from the Kuahuqiao (8000-7000 BP) and Tianluoshan (7000-6500 BP) sites and both stone samples segregate into two size groups, suggesting early selection of preferred types. The first peach stones in China most similar to modern cultivated forms are from the Liangzhu culture (ca. 5300 to 4300 BP), where the peach stones are significantly larger and more compressed than earlier stones. Similar peach stones are reported from Japan much earlier (6700-6400 BP). This large, compressed-stone peach was introduced to Japan and indicates a yet unidentified source population in China that was similar to the Liangzhu culture peach. This study proposes that the lower Yangzi River valley is a region, if not the region, of early peach selection and domestication and that the process began at least 7500 years ago.	[Zheng, Yunfei; Chen, Xugao] Zhejiang Prov Inst Rel & Archaeol, Hangzhou, Zhejiang, Peoples R China; [Crawford, Gary W.] Univ Toronto, Dept Anthropol, Mississauga, ON L5L 1C6, Canada	University of Toronto; University Toronto Mississauga	Zheng, YF (corresponding author), Zhejiang Prov Inst Rel & Archaeol, Hangzhou, Zhejiang, Peoples R China.	zhengyunfei@hotmail.com			China State Administration of Cultural Heritage; Social Sciences and Humanities Research Council of Canada (SSHRC)	China State Administration of Cultural Heritage; Social Sciences and Humanities Research Council of Canada (SSHRC)(Social Sciences and Humanities Research Council of Canada (SSHRC)CGIAR)	The Chinese portion of the research was supported by the China State Administration of Cultural Heritage. http://www.china.org.cn/government/2007-02/08/content_1130413.htm. A Social Sciences and Humanities Research Council of Canada (SSHRC) Institutional Grant provided funding for the AMS dates. http://www.sshrc-crsh.gc.ca/home-accueil-eng.aspx. No specific grant number is attached to this. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson K, 2005, TENDING THE WILD; Atahan P, 2008, QUATERNARY SCI REV, V27, P556, DOI 10.1016/j.quascirev.2007.11.003; Bassi D., 2008, The peach: botany, production and uses, P1, DOI 10.1079/9781845933869.0001; Bielenberg Douglas, 2009, V6, P223, DOI 10.1007/978-0-387-77491-6_10; Crawford GW, 2012, HOLOCENE, V22, P613, DOI 10.1177/0959683611424177; Crawford GW, 2006, BLACKW STUD GLOB ARC, P77, DOI 10.1002/9780470774670.ch5; Crawford GW, 2011, CURR ANTHROPOL, V52, pS331, DOI 10.1086/658369; Crawford GW, 2008, WORLD ARCHAEOL, V40, P445, DOI 10.1080/00438240802451181; De Candolle A, 1884, INT SCI SERIES, V49; Ding P., 2010, CULTURAL RELICS, P4; Doebley JF, 2006, CELL, V127, P1309, DOI 10.1016/j.cell.2006.12.006; Faust M., 1995, Horticultural Reviews, V17, P331, DOI 10.1002/9780470650585.ch10; Fuller D. Q., 2001, INDIAN ARCHAEOLOGY R, V2, P317; Fuller DQ, 2009, SCIENCE, V323, P1607, DOI 10.1126/science.1166605; Goldschmidt EE, 2013, ECON BOT, V67, P51, DOI 10.1007/s12231-012-9219-y; Harris D.R., 1977, ORIGINS AGR, P179; Hedrick U.P., 1917, NEW YORK STATE AGR E, DOI [10.5962/bhl.title.55218, DOI 10.5962/BHL.TITLE.55218]; Huang HongWen, 2008, The peach: botany, production and uses, P37, DOI 10.1079/9781845933869.0037; Innes JB, 2009, QUATERNARY SCI REV, V28, P2277, DOI 10.1016/j.quascirev.2009.04.010; Jiang L. -P., 2004, KUAHUQIAO; Kasahara Y, 1982, TOSU SHI KYOIKU IINK, P354; Kislev ME, 2006, SCIENCE, V312, P1372, DOI 10.1126/science.1125910; KISLEV ME, 1992, REV PALAEOBOT PALYNO, V73, P161, DOI 10.1016/0034-6667(92)90054-K; Layne D., 2008, The peach: botany, production and uses, pxiii, DOI 10.1079/9781845933869.0000; Layne D. R., 2008, PEACH BOT PRODUCTION; Lee GA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026720; Lewis H., 1973, PATTERNS INDIAN BURN; Li H-L, 1988, ORIGINS CHINESE CIVI, P21; LI ZL, 1984, HORTSCIENCE, V19, P348; Liu J, 2003, HEMUDU; LIU KB, 1992, QUATERNARY RES, V38, P32, DOI 10.1016/0033-5894(92)90028-H; Liu L, 2012, CAMB WOR ARCHAEOL, P1, DOI 10.1017/CBO9781139015301; Liu L, 2011, J ARCHAEOL SCI, V38, P3524, DOI 10.1016/j.jas.2011.08.015; Loreti F., 2008, The peach: botany, production and uses, P221, DOI 10.1079/9781845933869.0221; Lu L., 2003, FLORA CHINA, P391; Luo GH, 2001, AGR ARCHAEOLOGY NONG, V3, P200; Miller AJ, 2011, AM J BOT, V98, P1389, DOI 10.3732/ajb.1000522; Minaki M, 1986, TARAMI CHO KYOIKU II, P44; Monet R., 1996, Acta Horticulturae, P77; Moore JN, 1990, GENETIC RESOURCES TE; MOWREY BD, 1990, HORTSCIENCE, V25, P219, DOI 10.21273/HORTSCI.25.2.219; Okie WR, 2003, ACTA HORTIC, P261, DOI 10.17660/ActaHortic.2003.622.24; Quilot B, 2004, SCI HORTIC-AMSTERDAM, V99, P387, DOI 10.1016/S0304-4238(03)00110-9; Shu JW, 2010, QUATERN INT, V227, P10, DOI 10.1016/j.quaint.2010.04.010; Smith BD, 2006, DOCUMENTING DOMESTICATION: NEW GENETIC AND ARCHAEOLOGICAL PARADIGMS, P15; Tea Researh Institute Chinese Academy of Agricultural Science, 2013, STON FRUIT SIZ MOD P; Verde I, 2013, NAT GENET, V45, P487, DOI 10.1038/ng.2586; Wang FR, 2006, J PLANT GENETIC RESO, V7, P118; Wang HJ, 1999, J GEOPHYS RES-ATMOS, V104, P9361, DOI 10.1029/1999JD900049; Yang XY, 2012, P NATL ACAD SCI USA, V109, P3726, DOI 10.1073/pnas.1115430109; Yoon J, 2006, J AM HORTICULTURAL S, V131, P531; Zheng YF, 2004, KUAHUQIAO; Zheng YF, 2009, J ARCHAEOL SCI, V36, P2609, DOI 10.1016/j.jas.2009.09.026; ZOHARY D, 1975, SCIENCE, V187, P319, DOI 10.1126/science.187.4174.319; Zong Y, 2007, NATURE, V449, P459, DOI 10.1038/nature06135	55	49	54	7	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2014	9	9							e106595	10.1371/journal.pone.0106595	http://dx.doi.org/10.1371/journal.pone.0106595			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Arts &amp; Humanities Citation Index (A&amp;HCI)	Science & Technology - Other Topics	AZ1IR	25192436	Green Published, gold, Green Submitted			2022-12-27	WOS:000347993600041
J	Al-Jarallah, A; Chen, X; Gonzalez, L; Trigatti, BL				Al-Jarallah, Aishah; Chen, Xing; Gonzalez, Leticia; Trigatti, Bernardo L.			High Density Lipoprotein Stimulated Migration of Macrophages Depends on the Scavenger Receptor Class B, Type I, PDZK1 and Akt1 and Is Blocked by Sphingosine 1 Phosphate Receptor Antagonists	PLOS ONE			English	Article							PROTEIN-KINASE-C; ENDOTHELIAL NITRIC-OXIDE; MONOCYTE-DERIVED CELLS; E-DEFICIENT MICE; SR-BI; ATHEROSCLEROSIS REGRESSION; CHOLESTEROL TRANSPORT; INTERACTING DOMAIN; RECONSTITUTED HDL; PERTUSSIS TOXIN	HDL carries biologically active lipids such as sphingosine-1-phosphate (S1P) and stimulates a variety of cell signaling pathways in diverse cell types, which may contribute to its ability to protect against atherosclerosis. HDL and sphingosine-1-phosphate receptor agonists, FTY720 and SEW2871 triggered macrophage migration. HDL-, but not FTY720-stimulated migration was inhibited by an antibody against the HDL receptor, SR-BI, and an inhibitor of SR-BI mediated lipid transfer. HDL and FTY720-stimulated migration was also inhibited in macrophages lacking either SR-BI or PDZK1, an adaptor protein that binds to SR-BI's C-terminal cytoplasmic tail. Migration in response to HDL and S1P receptor agonists was inhibited by treatment of macrophages with sphingosine-1-phosphate receptor type 1 (S1PR1) antagonists and by pertussis toxin. S1PR1 activates signaling pathways including PI3K-Akt, PKC, p38 MAPK, ERK1/2 and Rho kinases. Using selective inhibitors or macrophages from gene targeted mice, we demonstrated the involvement of each of these pathways in HDL-dependent macrophage migration. These data suggest that HDL stimulates the migration of macrophages in a manner that requires the activities of the HDL receptor SR-BI as well as S1PR1 activity.	[Trigatti, Bernardo L.] McMaster Univ, Dept Biochem & Biomed Sci, Hamilton, ON L8N 3Z5, Canada; McMaster Univ, Thrombosis & Atherosclerosis Res Inst, Hamilton, ON L8N 3Z5, Canada	McMaster University; McMaster University	Trigatti, BL (corresponding author), McMaster Univ, Dept Biochem & Biomed Sci, Hamilton, ON L8N 3Z5, Canada.	trigatt@mcmaster.ca		Trigatti, Bernardo (Dino) L./0000-0002-4556-119X	Heart and Stroke Foundation of Canada [PRG 6502]; Kuwait University, Faculty of Medicine; Equal Opportunities Canada-Chile Program;  [T 7239]	Heart and Stroke Foundation of Canada(Heart & Stroke Foundation of Canada); Kuwait University, Faculty of Medicine; Equal Opportunities Canada-Chile Program; 	This research was supported by a grant in aid (T 7239) and a Program Grant (PRG 6502) from the Heart and Stroke Foundation of Canada. AA is a recipient of a graduate scholarship from Kuwait University, Faculty of Medicine. LG is a recipient of a graduate scholarship from the Equal Opportunities Canada-Chile Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackah E, 2005, J CLIN INVEST, V115, P2119, DOI 10.1172/JCI24726; Acton S, 1996, SCIENCE, V271, P518, DOI 10.1126/science.271.5248.518; Al-Jarallah A, 2010, BBA-MOL CELL BIOL L, V1801, P1239, DOI 10.1016/j.bbalip.2010.08.006; Andreadi CK, 2006, MOL PHARMACOL, V69, P1033, DOI 10.1124/mol.105.018374; Androulidaki A, 2009, IMMUNITY, V31, P220, DOI 10.1016/j.immuni.2009.06.024; Arboleda MJ, 2003, CANCER RES, V63, P196; Argraves KM, 2008, J BIOL CHEM, V283, P25074, DOI 10.1074/jbc.M801214200; Argraves KM, 2007, J LIPID RES; Assanasen C, 2005, J CLIN INVEST, V115, P969, DOI 10.1172/JCI23858; Assmann G, 1996, ATHEROSCLEROSIS, V124, pS11, DOI 10.1016/0021-9150(96)05852-2; Assmann G, 2003, ANNU REV MED, V54, P321, DOI 10.1146/annurev.med.54.101601.152409; ASSMANN G, 1992, AM J CARDIOL, V70, P733, DOI 10.1016/0002-9149(92)90550-I; Ayman S, 2003, BRIT J PHARMACOL, V139, P1532, DOI 10.1038/sj.bjp.0705394; Azhar S, 2002, J LIPID RES, V43, P861; Baranova IN, 2005, J BIOL CHEM, V280, P8031, DOI 10.1074/jbc.M405009200; Billich A, 2003, J BIOL CHEM, V278, P47408, DOI 10.1074/jbc.M307687200; BOCHKOV V, 1992, BIOCHEM BIOPH RES CO, V188, P1295, DOI 10.1016/0006-291X(92)91372-W; Bookout Angie L, 2003, Nucl Recept Signal, V1, pe012; Brunet R, 2011, CHOLESTEROL, DOI 10.1155/2011/687939; BURGERING BMT, 1995, NATURE, V376, P599, DOI 10.1038/376599a0; CHARO IF, 1994, P NATL ACAD SCI USA, V91, P2752, DOI 10.1073/pnas.91.7.2752; Cho KH, 2009, J ATHEROSCLER THROMB, V16, P217, DOI 10.5551/jat.509; Cho KH, 2009, EXP MOL MED, V41, P417, DOI 10.3858/emm.2009.41.6.047; Chodniewicz D, 2003, BLOOD, V101, P1181, DOI 10.1182/blood-2002-05-1435; Chung EY, 2012, J CLIN INVEST, V122, P2257, DOI 10.1172/JCI45851; Covey SD, 2003, ARTERIOSCL THROM VAS, V23, P1589, DOI 10.1161/01.ATV.0000083343.19940.A0; Cuchel M, 2006, CIRCULATION, V113, P2548, DOI 10.1161/CIRCULATIONAHA.104.475715; Davis MD, 2005, J BIOL CHEM, V280, P9833, DOI 10.1074/jbc.M412356200; Feig JE, 2011, P NATL ACAD SCI USA, V108, P7166, DOI 10.1073/pnas.1016086108; Feig JE, 2010, J CLIN INVEST, V120, P4415, DOI 10.1172/JCI38911; Feig JE, 2009, CURR OPIN INVEST DR, V10, P232; Fernandez-Hernando C, 2007, CELL METAB, V6, P446, DOI 10.1016/j.cmet.2007.10.007; Fernandez-Hernando C, 2009, ARTERIOSCL THROM VAS, V29, P2033, DOI 10.1161/ATVBAHA.109.196394; Florentin M, 2008, CURR OPIN CARDIOL, V23, P370, DOI 10.1097/HCO.0b013e3283043806; Frias MA, 2009, CARDIOVASC RES, V82, P313, DOI 10.1093/cvr/cvp024; Gong M, 2003, J CLIN INVEST, V111, P1579, DOI 10.1172/JCI200316777; GORDON DJ, 1989, NEW ENGL J MED, V321, P1311; Gorshkova I, 2008, J BIOL CHEM, V283, P11794, DOI 10.1074/jbc.M800250200; Grewal T, 2005, ONCOGENE, V24, P5809, DOI 10.1038/sj.onc.1208743; Gu XJ, 2000, J BIOL CHEM, V275, P29993, DOI 10.1074/jbc.275.39.29993; Guo H, 2013, J NEUROSCI, V33, P6181, DOI 10.1523/JNEUROSCI.4491-12.2013; Hersberger M, 2005, HANDB EXP PHARM, V170, P537; Honda HM, 1999, ATHEROSCLEROSIS, V143, P299, DOI 10.1016/S0021-9150(98)00302-5; Hughes JE, 2008, CIRC RES, V102, P950, DOI 10.1161/CIRCRESAHA.107.170779; Ikemoto M, 2000, P NATL ACAD SCI USA, V97, P6538, DOI 10.1073/pnas.100114397; Irie HY, 2005, J CELL BIOL, V171, P1023, DOI 10.1083/jcb.200505087; Jajoo S, 2006, J PHARMACOL EXP THER, V317, P1, DOI 10.1124/jpet.105.096255; Ji Y, 1997, J BIOL CHEM, V272, P20982, DOI 10.1074/jbc.272.34.20982; Jones GE, 2000, METHOD ENZYMOL, V325, P449; Jones GE, 2000, J LEUKOCYTE BIOL, V68, P593; Julien B, 2005, GASTROENTEROLOGY, V128, P742, DOI 10.1053/j.gastro.2004.12.050; Katada T, 2012, BIOL PHARM BULL, V35, P2103, DOI 10.1248/bpb.b212024; Keul P, 2011, CIRC RES, V108, P314, DOI 10.1161/CIRCRESAHA.110.235028; Kim SK, 2006, DRUG METAB DISPOS, V34, P683, DOI 10.1124/dmd.105.007666; Kimura T, 2003, ARTERIOSCL THROM VAS, V23, P1283, DOI 10.1161/01.ATV.0000079011.67194.5A; Kimura T, 2000, BIOCHEM J, V348, P71, DOI 10.1042/0264-6021:3480071; Kimura T, 2006, J BIOL CHEM, V281, P37457, DOI 10.1074/jbc.M605823200; Kocher O, 1998, LAB INVEST, V78, P117; Kocher O, 2008, BBA-MOL BASIS DIS, V1782, P310, DOI 10.1016/j.bbadis.2008.02.004; Kocher O, 2011, J BIOL CHEM, V286, P25171, DOI 10.1074/jbc.M111.242362; Kozarsky KF, 1997, NATURE, V387, P414, DOI 10.1038/387414a0; KRIEGER M, 1981, J MOL BIOL, V150, P167, DOI 10.1016/0022-2836(81)90447-2; Li CY, 2012, BIOCHEM BIOPH RES CO, V426, P415, DOI 10.1016/j.bbrc.2012.08.108; Libby P, 2002, NATURE, V420, P868, DOI 10.1161/ATVBAHA.108.179705; Liu F, 2001, AM J RESP CELL MOL, V24, P711, DOI 10.1165/ajrcmb.24.6.4323; Llodra J, 2004, P NATL ACAD SCI USA, V101, P11779, DOI 10.1073/pnas.0403259101; Mair KM, 2010, BRIT J PHARMACOL, V161, P176, DOI 10.1111/j.1476-5381.2010.00878.x; Manning BD, 2007, CELL, V129, P1261, DOI 10.1016/j.cell.2007.06.009; MARTINYBARON G, 1993, J BIOL CHEM, V268, P9194; Matsuo Y, 2007, ATHEROSCLEROSIS, V194, P159, DOI 10.1016/j.atherosclerosis.2006.10.020; MENDEZ AJ, 1991, J BIOL CHEM, V266, P10104; Michaud J, 2010, J IMMUNOL, V184, P1475, DOI 10.4049/jimmunol.0901586; Mineo C, 2003, J BIOL CHEM, V278, P9142, DOI 10.1074/jbc.M211394200; Mineo C, 2006, CIRC RES, V98, P1352, DOI 10.1161/01.RES.0000225982.01988.93; Mineo C, 2012, CURR OPIN LIPIDOL, V23, P487, DOI 10.1097/MOL.0b013e328357ba61; Morales-Ruiz M, 2001, J BIOL CHEM, V276, P19672, DOI 10.1074/jbc.M009993200; Muller H, 2005, EUR J IMMUNOL, V35, P533, DOI 10.1002/eji.200425556; Murakami A, 2010, MOL PHARMACOL, V77, P704, DOI 10.1124/mol.109.061481; Murata N, 2000, BIOCHEM J, V352, P809, DOI 10.1042/0264-6021:3520809; Nagao T, 2007, ARTERIOSCL THROM VAS, V27, P1596, DOI 10.1161/ATVBAHA.107.145086; Nieland TJF, 2004, J LIPID RES, V45, P1256, DOI 10.1194/jlr.M300358-JLR200; Nieland TJF, 2002, P NATL ACAD SCI USA, V99, P15422, DOI 10.1073/pnas.222421399; Nissen SE, 2003, JAMA-J AM MED ASSOC, V290, P2292, DOI 10.1001/jama.290.17.2292; NIXON JS, 1992, BIOCHEM SOC T, V20, P419, DOI 10.1042/bst0200419; Nofer JR, 2004, J CLIN INVEST, V113, P569, DOI 10.1172/JCI200418004; Nofer JR, 2002, ATHEROSCLEROSIS, V161, P1, DOI 10.1016/S0021-9150(01)00651-7; Nofer JR, 2000, BIOCHEMISTRY-US, V39, P15199, DOI 10.1021/bi001162a; Norata GD, 2005, VASC HEALTH RISK MAN, V1, P119, DOI 10.2147/vhrm.1.2.119.64083; Okajima F, 2009, ENDOCR J, V56, P317, DOI 10.1507/endocrj.K08E-228; Park YM, 2012, MOL BIOL CELL, V23, P3057, DOI 10.1091/mbc.E11-12-1051; Pilon A, 2003, BBA-MOL CELL BIOL L, V1631, P218, DOI 10.1016/S1388-1981(03)00020-9; PORN MI, 1991, BIOCHEM J, V279, P29; Qin CB, 2006, ARTERIOSCL THROM VAS, V26, P372, DOI 10.1161/01.ATV.0000197848.67999.e1; Raffai RL, 2005, ARTERIOSCL THROM VAS, V25, P436, DOI 10.1161/01.ATV.0000152613.83243.12; Ramkhelawon B, 2013, ARTERIOSCL THROM VAS, V33, P1180, DOI 10.1161/ATVBAHA.112.301008; Randolph GJ, 2008, CURR OPIN LIPIDOL, V19, P462, DOI 10.1097/MOL.0b013e32830d5f09; Reis ED, 2001, J VASC SURG, V34, P541, DOI 10.1067/mva.2001.115963; Rentero C, 2006, CELL SIGNAL, V18, P1006, DOI 10.1016/j.cellsig.2005.08.008; Ridley AJ, 2004, BREAST CANCER RES TR, V84, P13, DOI 10.1023/B:BREA.0000018423.47497.c6; Ridley AJ, 2001, J CELL SCI, V114, P2713; Ridley AJ, 2001, TRENDS CELL BIOL, V11, P471, DOI 10.1016/S0962-8924(01)02153-5; Ridley AJ, 2001, TRAFFIC, V2, P303, DOI 10.1034/j.1600-0854.2001.002005303.x; Ridley Anne J., 1999, P111; Rikitake Y, 2002, ARTERIOSCL THROM VAS, V22, P108, DOI 10.1161/hq0102.101843; Rivera J, 2008, NAT REV IMMUNOL, V8, P753, DOI 10.1038/nri2400; Rong JX, 2001, CIRCULATION, V104, P2447, DOI 10.1161/hc4501.098952; Ryu Y, 2002, CIRC RES, V90, P325, DOI 10.1161/hh0302.104455; Sanna MG, 2004, J BIOL CHEM, V279, P13839, DOI 10.1074/jbc.M311743200; Sattler K, 2009, CARDIOVASC RES, V82, P201, DOI 10.1093/cvr/cvp070; Seetharam D, 2006, CIRC RES, V98, P63, DOI 10.1161/01.RES.0000199272.59432.5b; Shiratsuchi H, 2007, J CELL BIOCHEM, V102, P353, DOI 10.1002/jcb.21295; Silver DL, 2002, J BIOL CHEM, V277, P34042, DOI 10.1074/jbc.M206584200; Sotsios Y, 2000, IMMUNOL REV, V177, P217, DOI 10.1034/j.1600-065X.2000.17712.x; Steinberg D, 1997, J BIOL CHEM, V272, P20963, DOI 10.1074/jbc.272.34.20963; Stephens L, 2002, CURR OPIN CELL BIOL, V14, P203, DOI 10.1016/S0955-0674(02)00311-3; Tabas I, 2007, CIRCULATION, V116, P1832, DOI 10.1161/CIRCULATIONAHA.106.676890; Takabe K, 2008, PHARMACOL REV, V60, P181, DOI 10.1124/pr.107.07113; Taylor PR, 2005, ANNU REV IMMUNOL, V23, P901, DOI 10.1146/annurev.immunol.23.021704.115816; Theilmeier G, 2000, FASEB J, V14, P2032, DOI 10.1096/fj.99-1029com; Trach CC, 1996, EUR J CELL BIOL, V71, P199; Trigatti B, 1999, P NATL ACAD SCI USA, V96, P9322, DOI 10.1073/pnas.96.16.9322; Trogan E, 2006, P NATL ACAD SCI USA, V103, P3781, DOI 10.1073/pnas.0511043103; Vanhaesebroeck B, 2001, ANNU REV BIOCHEM, V70, P535, DOI 10.1146/annurev.biochem.70.1.535; Verspohl EJ, 1998, J ENDOCRINOL, V159, P287, DOI 10.1677/joe.0.1590287; Williams KJ, 2008, NAT CLIN PRACT CARD, V5, P91, DOI 10.1038/ncpcardio1086; Yesilaltay A, 2006, J BIOL CHEM, V281, P28975, DOI 10.1074/jbc.M603802200; Yoeli-Lerner M, 2005, MOL CELL, V20, P539, DOI 10.1016/j.molcel.2005.10.033; Yuhanna IS, 2001, NAT MED, V7, P853, DOI 10.1038/89986; Zhang X, 2011, ACTA BIOCH BIOPH SIN, V43, P787, DOI 10.1093/abbs/gmr072; Zhang Y, 2007, J LIPID RES, V48, P405, DOI 10.1194/jlr.M600326-JLR200; Zhou GL, 2006, J BIOL CHEM, V281, P36443, DOI 10.1074/jbc.M600788200	131	37	39	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 4	2014	9	9							e106487	10.1371/journal.pone.0106487	http://dx.doi.org/10.1371/journal.pone.0106487			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3XV	25188469	Green Published, gold, Green Submitted			2022-12-27	WOS:000341271500042
J	Allan, RN; Skipp, P; Jefferies, J; Clarke, SC; Faust, SN; Hall-Stoodley, L; Webb, J				Allan, Raymond N.; Skipp, Paul; Jefferies, Johanna; Clarke, Stuart C.; Faust, Saul N.; Hall-Stoodley, Luanne; Webb, Jeremy			Pronounced Metabolic Changes in Adaptation to Biofilm Growth by Streptococcus pneumoniae	PLOS ONE			English	Article							MIDDLE-EAR; IN-VITRO; COLONY MORPHOLOGY; NADH OXIDASE; VIRULENCE; COLONIZATION; PROTEIN; SURFACE; IDENTIFICATION; EXPRESSION	Streptococcus pneumoniae accounts for a significant global burden of morbidity and mortality and biofilm development is increasingly recognised as important for colonization and infection. Analysis of protein expression patterns during biofilm development may therefore provide valuable insights to the understanding of pneumococcal persistence strategies and to improve vaccines. iTRAQ (isobaric tagging for relative and absolute quantification), a high-throughput gel-free proteomic approach which allows high resolution quantitative comparisons of protein profiles between multiple phenotypes, was used to interrogate planktonic and biofilm growth in a clinical serotype 14 strain. Comparative analyses of protein expression between log-phase planktonic and 1-day and 7-day biofilm cultures representing nascent and late phase biofilm growth were carried out. Overall, 244 proteins were identified, of which >80% were differentially expressed during biofilm development. Quantitatively and qualitatively, metabolic regulation appeared to play a central role in the adaptation from the planktonic to biofilm phenotype. Pneumococci adapted to biofilm growth by decreasing enzymes involved in the glycolytic pathway, as well as proteins involved in translation, transcription, and virulence. In contrast, proteins with a role in pyruvate, carbohydrate, and arginine metabolism were significantly increased during biofilm development. Downregulation of glycolytic and translational proteins suggests that pneumococcus adopts a covert phenotype whilst adapting to an adherent lifestyle, while utilization of alternative metabolic pathways highlights the resourcefulness of pneumococcus to facilitate survival in diverse environmental conditions. These metabolic proteins, conserved across both the planktonic and biofilm phenotypes, may also represent target candidates for future vaccine development and treatment strategies. Data are available via ProteomeXchange with identifier PXD001182.	[Allan, Raymond N.; Jefferies, Johanna; Clarke, Stuart C.; Faust, Saul N.; Hall-Stoodley, Luanne] Univ Southampton, Fac Med, Acad Unit Clin & Expt Sci, Southampton SO9 5NH, Hants, England; [Allan, Raymond N.; Jefferies, Johanna; Clarke, Stuart C.; Faust, Saul N.; Hall-Stoodley, Luanne] Univ Southampton, Inst Life Sci, Southampton, Hants, England; [Allan, Raymond N.; Faust, Saul N.; Hall-Stoodley, Luanne] Univ Hosp Southampton NHS Fdn Trust, Southampton NIHR Wellcome Trust Clin Res Facil, Southampton, Hants, England; [Skipp, Paul; Webb, Jeremy] Univ Southampton, Ctr Biol Sci, Southampton, Hants, England; [Skipp, Paul] Univ Southampton, Ctr Prote Res, Inst Life Sci, Southampton, Hants, England; [Jefferies, Johanna; Clarke, Stuart C.] Publ Hlth England, Southampton, Hants, England; [Clarke, Stuart C.; Faust, Saul N.; Webb, Jeremy] Univ Hosp Southampton NHS Fdn Trust, Southampton NIHR Resp Biomed Res Unit, Southampton, Hants, England; [Hall-Stoodley, Luanne] Ohio State Univ, Ctr Microbial Interface Biol, Columbus, OH 43210 USA	University of Southampton; University of Southampton; University of Southampton; University Hospital Southampton NHS Foundation Trust; University of Southampton; University of Southampton; Public Health England; University of Southampton; University Hospital Southampton NHS Foundation Trust; University System of Ohio; Ohio State University	Allan, RN (corresponding author), Univ Southampton, Fac Med, Acad Unit Clin & Expt Sci, Southampton SO9 5NH, Hants, England.	r.allan@soton.ac.uk	Faust, Saul/J-9779-2014; Allan, Raymond/K-2494-2017; Hall-Stoodley, Luanne/AAF-1925-2020	Faust, Saul/0000-0003-3410-7642; Allan, Raymond/0000-0001-7764-4849; Webb, Jeremy/0000-0003-2068-8589; Clarke, Stuart/0000-0002-7009-1548	Bill and Melinda Gates Foundation grant [GCE 1006884]	Bill and Melinda Gates Foundation grant(Bill & Melinda Gates Foundation)	This work was funded by The Bill and Melinda Gates Foundation grant GCE 1006884 (http://www.gatesfoundation.org). Funding was received by JW, SCC, SNF, LHS, and JJ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agafonov DE, 2001, EMBO REP, V2, P399; Allegrucci M, 2006, J BACTERIOL, V188, P2325, DOI 10.1128/JB.188.7.2325-2335.2006; Allegrucci M, 2007, J BACTERIOL, V189, P2030, DOI 10.1128/JB.01369-06; Auzat I, 1999, MOL MICROBIOL, V34, P1018, DOI 10.1046/j.1365-2958.1999.01663.x; Bae SM, 2006, J BIOCHEM MOL BIOL, V39, P703; Bidossi A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033320; Blanchette-Cain K, 2013, MBIO, V4, DOI 10.1128/mBio.00745-13; Buckwalter CM, 2012, TRENDS MICROBIOL, V20, P517, DOI 10.1016/j.tim.2012.08.008; Camilli R, 2011, EUR J CLIN MICROBIOL, V30, P97, DOI 10.1007/s10096-010-1060-6; Carvalho SM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068277; CASIANOCOLON A, 1988, APPL ENVIRON MICROB, V54, P1318; Chhatwal GS, 2002, TRENDS MICROBIOL, V10, P205, DOI 10.1016/S0966-842X(02)02351-X; Cugini C, 2013, MICROBIOL-SGM, V159, P275, DOI 10.1099/mic.0.062695-0; Daniely D, 2006, CLIN EXP IMMUNOL, V144, P254, DOI 10.1111/j.1365-2249.2006.03047.x; Dawid S, 2007, INFECT IMMUN, V75, P443, DOI 10.1128/IAI.01775-05; Degnan BA, 1998, INFECT IMMUN, V66, P3050, DOI 10.1128/IAI.66.7.3050-3058.1998; Ding F, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-158; Encheva V, 2006, PROTEOMICS, V6, P3306, DOI 10.1002/pmic.200500744; Fulde M, 2013, THROMB HAEMOST, V111; Hartel T, 2012, J BIOL CHEM, V287, P4260, DOI 10.1074/jbc.M111.304311; Hakansson AP, 2014, J INFECT DIS; Hall-Stoodley L, 2006, JAMA-J AM MED ASSOC, V296, P202, DOI 10.1001/jama.296.2.202; Hall-Stoodley L, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-173; Hardy GG, 2001, INFECT IMMUN, V69, P2309, DOI 10.1128/IAI.69.4.2309-2317.2001; Hiller NL, 2007, J BACTERIOL, V189, P8186, DOI 10.1128/JB.00690-07; Hoa M, 2009, INT J PEDIATR OTORHI, V73, P1242, DOI 10.1016/j.ijporl.2009.05.016; Kadioglu A, 2008, NAT REV MICROBIOL, V6, P288, DOI 10.1038/nrmicro1871; King SJ, 2004, MOL MICROBIOL, V54, P159, DOI 10.1111/j.1365-2958.2004.04252.x; Kok M, 2003, MICROBIOL-SGM, V149, P2645, DOI 10.1099/mic.0.26406-0; Lee KJ, 2006, PROTEOMICS, V6, P1274, DOI 10.1002/pmic.200500415; Ling E, 2004, CLIN EXP IMMUNOL, V138, P290, DOI 10.1111/j.1365-2249.2004.02628.x; Marion C, 2012, INFECT IMMUN, V80, P1390, DOI 10.1128/IAI.05756-11; Marion C, 2011, INFECT IMMUN, V79, P4193, DOI 10.1128/IAI.05290-11; Marks LR, 2012, MBIO, V3, DOI 10.1128/mBio.00200-12; Marks LR, 2012, INFECT IMMUN, V80, P2744, DOI 10.1128/IAI.00488-12; McCoy LS, 2011, WIRES RNA, V2, P209, DOI 10.1002/wrna.60; Moffitt KL, 2011, CELL HOST MICROBE, V9, P158, DOI 10.1016/j.chom.2011.01.007; Moscoso M, 2006, J BACTERIOL, V188, P7785, DOI 10.1128/JB.00673-06; Muchnik L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061128; Munoz-Elias EJ, 2008, INFECT IMMUN, V76, P5049, DOI 10.1128/IAI.00425-08; Nistico L, 2011, J CLIN MICROBIOL, V49, P1411, DOI 10.1128/JCM.00756-10; Novotny LA, 2013, VACCINE, V31, P3417, DOI 10.1016/j.vaccine.2012.10.033; Oggioni MR, 2006, MOL MICROBIOL, V61, P1196, DOI 10.1111/j.1365-2958.2006.05310.x; Orihuela CJ, 2004, INFECT IMMUN, V72, P5582, DOI 10.1128/IAI.72.10.5582-5596.2004; Regev-Yochay G, 2007, J BACTERIOL, V189, P6532, DOI 10.1128/JB.00813-07; Regev-Yochay G, 2006, J BACTERIOL, V188, P4996, DOI 10.1128/JB.00317-06; Reid SD, 2009, J INFECT DIS, V199, P786, DOI 10.1086/597042; Sanchez CJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028738; Sanchez CJ, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-245; Schultz D, 2013, BMC BIOL, V11, DOI 10.1186/1741-7007-11-120; Syk A., 2014, J INFECT DIS; Trappetti C, 2013, INFECT IMMUN, V81, P505, DOI 10.1128/IAI.01033-12; Weiser JN, 2010, J MOL MED, V88, P97, DOI 10.1007/s00109-009-0557-x; Weiser JN, 1996, INFECT IMMUN, V64, P2240, DOI 10.1128/IAI.64.6.2240-2245.1996; Yang Q, 2011, MICROBES INFECT, V13, P757, DOI 10.1016/j.micinf.2011.03.001; Yu J, 2001, MICROBIOL-UK, V147, P431, DOI 10.1099/00221287-147-2-431	56	37	37	0	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 4	2014	9	9							e107015	10.1371/journal.pone.0107015	http://dx.doi.org/10.1371/journal.pone.0107015			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3XV	25188255	Green Submitted, Green Published, Green Accepted, gold			2022-12-27	WOS:000341271500108
J	Hasegawa, E; Sweigard, H; Husain, D; Olivares, AM; Chang, B; Smith, KE; Birsner, AE; D'Amato, RJ; Michaud, NA; Han, YN; Vavvas, DG; Miller, JW; Haider, NB; Connor, KM				Hasegawa, Eiichi; Sweigard, Harry; Husain, Deeba; Olivares, Ana M.; Chang, Bo; Smith, Kaylee E.; Birsner, Amy E.; D'Amato, Robert J.; Michaud, Norman A.; Han, Yinan; Vavvas, Demetrios G.; Miller, Joan W.; Haider, Neena B.; Connor, Kip M.			Characterization of a Spontaneous Retinal Neovascular Mouse Model	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; MACULAR DEGENERATION; ANGIOMATOUS PROLIFERATION; SUBRETINAL NEOVASCULARIZATION; CHOROIDAL NEOVASCULARIZATION; CHORIORETINAL ANASTOMOSIS; PIGMENT EPITHELIUM; TRANSGENIC MICE; MULLER CELLS; EXPRESSION	Background: Vision loss due to vascular disease of the retina is a leading cause of blindness in the world. Retinal angiomatous proliferation (RAP) is a subgroup of neovascular age-related macular degeneration (AMD), whereby abnormal blood vessels develop in the retina leading to debilitating vision loss and eventual blindness. The novel mouse strain, neoretinal vascularization 2 (NRV2), shows spontaneous fundus changes associated with abnormal neovascularization. The purpose of this study is to characterize the induction of pathologic angiogenesis in this mouse model. Methods: The NRV2 mice were examined from postnatal day 12 (p12) to 3 months. The phenotypic changes within the retina were evaluated by fundus photography, fluorescein angiography, optical coherence tomography, and immunohistochemical and electron microscopic analysis. The pathological neovascularization was imaged by confocal microscopy and reconstructed using three-dimensional image analysis software. Results: We found that NRV2 mice develop multifocal retinal depigmentation in the posterior fundus. Depigmented lesions developed vascular leakage observed by fluorescein angiography. The spontaneous angiogenesis arose from the retinal vascular plexus at postnatal day (p) 15 and extended toward retinal pigment epithelium (RPE). By three months of age, histological analysis revealed encapsulation of the neovascular lesion by the RPE in the photoreceptor cell layer and subretinal space. Conclusions: The NRV2 mouse strain develops early neovascular lesions within the retina, which grow downward towards the RPE beginning at p15. This retinal neovascularization model mimics early stages of human retinal angiomatous proliferation (RAP) and will likely be a useful in elucidating targeted therapeutics for patients with ocular neovascular disease.	[Hasegawa, Eiichi; Sweigard, Harry; Husain, Deeba; Smith, Kaylee E.; Michaud, Norman A.; Vavvas, Demetrios G.; Miller, Joan W.; Connor, Kip M.] Massachusetts Eye & Ear Infirm, Dept Ophthalmol, Angiogenesis Lab, Boston, MA 02114 USA; [Hasegawa, Eiichi; Sweigard, Harry; Husain, Deeba; D'Amato, Robert J.; Vavvas, Demetrios G.; Miller, Joan W.; Haider, Neena B.; Connor, Kip M.] Harvard Univ, Sch Med, Dept Ophthalmol, Boston, MA USA; [Olivares, Ana M.; Han, Yinan; Haider, Neena B.] Massachusetts Eye & Ear Infirm, Schepens Eye Res Inst, Boston, MA 02114 USA; [Chang, Bo] Jackson Lab, Bar Harbor, ME 04609 USA; [Birsner, Amy E.; D'Amato, Robert J.] Harvard Univ, Sch Med, Boston Childrens Hosp, Vasc Biol Program,Dept Surg, Boston, MA USA	Harvard University; Massachusetts Eye & Ear Infirmary; Harvard University; Harvard Medical School; Harvard University; Massachusetts Eye & Ear Infirmary; Schepens Eye Research Institute; Jackson Laboratory; Harvard University; Boston Children's Hospital; Harvard Medical School	Connor, KM (corresponding author), Massachusetts Eye & Ear Infirm, Dept Ophthalmol, Angiogenesis Lab, Boston, MA 02114 USA.	kip_connor@meei.harvard.edu		Husain, Deeba/0000-0002-8494-0950; Chang, Bo/0000-0001-8259-7290; Connor, Kip/0000-0002-2048-9080; Miller, Joan/0000-0003-2046-3996; Vavvas, Demetrios/0000-0002-8622-6478	Research to Prevent Blindness; Bright Focus Foundation; National Eye Institute of the National Institutes of Health [R01EY022084/S1, P30EY014104]; NATIONAL EYE INSTITUTE [R01EY019943, R01EY022084, P30EY014104] Funding Source: NIH RePORTER	Research to Prevent Blindness(Research to Prevent Blindness (RPB)); Bright Focus Foundation(BrightFocus Foundation); National Eye Institute of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	Research reported in this publication was supported by a Special Scholar Award (to KMC) and unrestricted grant (to JM) from Research to Prevent Blindness, as well as a Bright Focus Foundation grant (to KMC and NH). Additionally, research reported in this publication was supported by National Eye Institute of the National Institutes of Health under award numbers R01EY022084/S1 (to KMC) and P30EY014104. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bottoni F, 2005, ARCH OPHTHALMOL-CHIC, V123, P1644, DOI 10.1001/archopht.123.12.1644; BURNS MS, 1992, CURR EYE RES, V11, P863, DOI 10.3109/02713689209033484; Eichler W, 2004, NEUROREPORT, V15, P1633, DOI 10.1097/01.wnr.0000133071.00786.a4; Engelbert M, 2009, RETINA-J RET VIT DIS, V29, P1424, DOI 10.1097/IAE.0b013e3181bfbd46; Gass JDM, 2003, RETINA-J RET VIT DIS, V23, P741, DOI 10.1097/00006982-200312000-00001; Gragoudas ES, 2004, NEW ENGL J MED, V351, P2805, DOI 10.1056/NEJMoa042760; HARTNETT ME, 1992, GRAEF ARCH CLIN EXP, V230, P11, DOI 10.1007/BF00166756; Hartnett ME, 1996, OPHTHALMOLOGY, V103, P2042, DOI 10.1016/S0161-6420(96)30389-8; Heckenlively JR, 2003, RETINA-J RET VIT DIS, V23, P518, DOI 10.1097/00006982-200308000-00012; Hemeida TS, 2010, BRIT J OPHTHALMOL, V94, P701, DOI 10.1136/bjo.2009.167627; Hu WZ, 2008, INVEST OPHTH VIS SCI, V49, P407, DOI 10.1167/iovs.07-0870; Jager RD, 2008, NEW ENGL J MED, V358, P2606, DOI 10.1056/NEJMra0801537; KENDALL RL, 1993, P NATL ACAD SCI USA, V90, P10705, DOI 10.1073/pnas.90.22.10705; Lai CM, 2005, MOL THER, V12, P659, DOI 10.1016/j.ymthe.2005.04.022; Lai CM, 2005, BRIT J OPHTHALMOL, V89, P911, DOI 10.1136/bjo.2004.059089; Liakopoulos S, 2008, INVEST OPHTH VIS SCI, V49, P5048, DOI 10.1167/iovs.08-1877; Lim LS, 2012, LANCET, V379, P1728, DOI 10.1016/S0140-6736(12)60282-7; Lukason M, 2011, MOL THER, V19, P260, DOI 10.1038/mt.2010.230; Luo L, 2013, ELIFE, V2, DOI 10.7554/eLife.00324; Marneros AG, 2005, AM J PATHOL, V167, P1451, DOI 10.1016/S0002-9440(10)61231-X; Miller JW, 2013, OPHTHALMOLOGY, V120, P106, DOI 10.1016/j.ophtha.2012.07.038; Miller JW, 2013, AM J OPHTHALMOL, V155, P1, DOI 10.1016/j.ajo.2012.10.018; Nagai N, 2014, INVEST OPHTH VIS SCI, V55, P3709, DOI 10.1167/iovs.14-13989; Ohno-Matsui K, 2002, AM J PATHOL, V160, P711, DOI 10.1016/S0002-9440(10)64891-2; Okamoto N, 1997, AM J PATHOL, V151, P281; Omarova S, 2012, J CLIN INVEST, V122, P3012, DOI 10.1172/JCI63816; Reichenbach A, 2013, GLIA, V61, P651, DOI 10.1002/glia.22477; Saito M, 2013, JPN J OPHTHALMOL, V57, P211, DOI 10.1007/s10384-012-0215-7; Shen WY, 2012, J NEUROSCI, V32, P15715, DOI 10.1523/JNEUROSCI.2841-12.2012; Shimada H, 2007, GRAEF ARCH CLIN EXP, V245, P295, DOI 10.1007/s00417-006-0367-6; Silva RM, 2007, GRAEF ARCH CLIN EXP, V245, P1131, DOI 10.1007/s00417-006-0532-y; Tobe T, 1998, INVEST OPHTH VIS SCI, V39, P180; Viola F, 2009, RETINA-J RET VIT DIS, V29, P732, DOI 10.1097/IAE.0b013e3181a395cb; Won JY, 2011, J OPHTHALMOL, V2011, DOI 10.1155/2011/391384; Yannuzzi LA, 2001, RETINA-J RET VIT DIS, V21, P416, DOI 10.1097/00006982-200110000-00003; Yetemian RM, 2010, INVEST OPHTH VIS SCI, V51, P6196, DOI 10.1167/iovs.10-5452; Zhang K, 2012, NAT REV DRUG DISCOV, V11, P541, DOI 10.1038/nrd3745	37	26	26	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 4	2014	9	9							e106507	10.1371/journal.pone.0106507	http://dx.doi.org/10.1371/journal.pone.0106507			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3XV	25188381	Green Submitted, Green Published, gold			2022-12-27	WOS:000341271500047
J	Ogun, OA; Janky, KL; Cohn, ES; Buki, B; Lundberg, YW				Ogun, Oluwaseye Ayoola; Janky, Kristen L.; Cohn, Edward S.; Bueki, Bela; Lundberg, Yunxia Wang			Gender-Based Comorbidity in Benign Paroxysmal Positional Vertigo	PLOS ONE			English	Article							SENSORINEURAL HEARING-LOSS; INNER-EAR; FOLLOW-UP; CLINICAL-FEATURES; WHICKHAM SURVEY; DISEASE; POPULATION; PREVALENCE; MIGRAINE; WOMEN	It has been noted that benign paroxysmal positional vertigo (BPPV) may be associated with certain disorders and medical procedures. However, most studies to date were done in Europe, and epidemiological data on the United States (US) population are scarce. Gender-based information is even rarer. Furthermore, it is difficult to assess the relative prevalence of each type of association based solely on literature data, because different comorbidities were reported by various groups from different countries using different patient populations and possibly different inclusion/exclusion criteria. In this study, we surveyed and analyzed a large adult BPPV population (n = 1,360 surveyed, 227 completed, most of which were recurrent BPPV cases) from Omaha, NE, US, and its vicinity, all diagnosed at Boys Town National Research Hospital (BTNRH) over the past decade using established and consistent diagnostic criteria. In addition, we performed a retrospective analysis of patients' diagnostic records (n = 1,377, with 1,360 adults and 17 children). The following comorbidities were found to be significantly more prevalent in the BPPV population when compared to the age- and gender-matched general population: ear/hearing problems, head injury, thyroid problems, allergies, high cholesterol, headaches, and numbness/paralysis. There were gender differences in the comorbidities. In addition, familial predisposition was fairly common among the participants. Thus, the data confirm some previously reported comorbidities, identify new ones (hearing loss, thyroid problems, high cholesterol, and numbness/paralysis), and suggest possible predisposing and triggering factors and events for BPPV.	[Ogun, Oluwaseye Ayoola; Janky, Kristen L.; Cohn, Edward S.; Lundberg, Yunxia Wang] Boys Town Natl Res Hosp, Omaha, NE 68131 USA; [Bueki, Bela] Karl Landsteiner Univ Hosp Krems, Dept Otolaryngol, Krems An Der Donau, Austria	Boys Town National Research Hospital	Lundberg, YW (corresponding author), Boys Town Natl Res Hosp, Omaha, NE 68131 USA.	Yesha.Lundberg@boystown.org			National Institutes of Health [R01DC008603, R01DC008603-S1, P20GM103471, T32DC000013]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR018788] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM109023, P30GM110768, P20GM103471] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [T32DC000013, R01DC008603] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported by grants from the National Institutes of Health, R01DC008603, R01DC008603-S1, and P20GM103471 (formerly P20RR018788) pilot funding to YWL; postdoctoral training grant T32DC000013 to OAO; and P20GM103471 pilot funding to ESC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn SK, 2011, J TRAUMA, V70, P442, DOI 10.1097/TA.0b013e3181d0c3d9; ANDAZ C, 1993, J LARYNGOL OTOL, V107, P1153, DOI 10.1017/S0022215100125538; [Anonymous], 2010, 2010 DEM PROF DAT NE; Atacan E, 2001, LARYNGOSCOPE, V111, P1257, DOI 10.1097/00005537-200107000-00021; BALOH RW, 1987, NEUROLOGY, V37, P371, DOI 10.1212/WNL.37.3.371; Blackwell Debra L, 2002, Vital Health Stat 10, P1; BLESSING R, 1986, LARYNGO RHINO OTOL, V65, P455, DOI 10.1055/s-2007-1008013; Buki B, 2011, J NEUROL NEUROSUR PS, V82, P98, DOI 10.1136/jnnp.2009.199208; Cambi J, 2013, J NEUROL, V260, P1489, DOI 10.1007/s00415-012-6815-9; CDC, 2012, CHOL FACTS; Celebisoy N, 2008, EUR NEUROL, V59, P315, DOI 10.1159/000121422; Chen W, 2008, ALLERGY, V63, P1418, DOI 10.1111/j.1398-9995.2008.01880.x; Christopher and Dana Reeve Foundation, 2013, ON DEGR SEP PAR SPIN; Cohen HS, 2010, ORL-J OTO-RHIN-LARYN, V72, P63, DOI 10.1159/000296304; Cohen HS, 2004, ORL J OTO-RHINO-LARY, V66, P11, DOI 10.1159/000077227; Dispenza F, 2011, AM J OTOLARYNG, V32, P376, DOI 10.1016/j.amjoto.2010.07.009; Dror AA, 2010, J BIOL CHEM, V285, P21724, DOI 10.1074/jbc.M110.120188; Everett LA, 2001, HUM MOL GENET, V10, P153, DOI 10.1093/hmg/10.2.153; Faul M, 2010, TRAUMATIC BRAIN INJU, DOI DOI 10.15620/CDC.5571; Fife TD, 2009, SEMIN NEUROL, V29, P500, DOI 10.1055/s-0029-1241041; Friauf E, 2008, EUR J NEUROSCI, V28, P2371, DOI 10.1111/j.1460-9568.2008.06528.x; FROEHLING DA, 1991, MAYO CLIN PROC, V66, P596, DOI 10.1016/S0025-6196(12)60518-7; Gizzi M, 1998, ACTA OTO-LARYNGOL, V118, P774, DOI 10.1080/00016489850182422; Gross EM, 2000, LARYNGOSCOPE, V110, P655, DOI 10.1097/00005537-200004000-00022; GYO K, 1988, LARYNGOSCOPE, V98, P332; Hain TC, 2000, ARCH OTOLARYNGOL, V126, P617, DOI 10.1001/archotol.126.5.617; Hederstierna C, 2007, ACTA OTO-LARYNGOL, V127, P149, DOI 10.1080/00016480600794446; Hughes CA, 1997, LARYNGOSCOPE, V107, P607, DOI 10.1097/00005537-199705000-00010; Ishiyama A, 2000, ANN OTO RHINOL LARYN, V109, P377, DOI 10.1177/000348940010900407; Jang YS, 2009, OTOL NEUROTOL, V30, P95, DOI 10.1097/MAO.0b013e31818f5777; Jeong SH, 2009, NEUROLOGY, V72, P1069, DOI 10.1212/01.wnl.0000345016.33983.e0; Kaplan DM, 2003, J OTOLARYNGOL, V32, P23, DOI 10.2310/7070.2003.35371; Karlberg M, 2000, ACTA OTO-LARYNGOL, V120, P380; Katsarkas A, 1999, ACTA OTO-LARYNGOL, V119, P745, DOI 10.1080/00016489950180360; Kim MB, 2012, LARYNGOSCOPE, V122, P2832, DOI 10.1002/lary.23607; Kim YH, 2012, OTOLARYNG HEAD NECK, V146, P279, DOI 10.1177/0194599811421733; Kobau Rosemarie, 2008, Morbidity and Mortality Weekly Report, V57, P1; Kozel PJ, 1998, J BIOL CHEM, V273, P18693, DOI 10.1074/jbc.273.30.18693; LANZI G, 1994, CEPHALALGIA, V14, P458, DOI 10.1046/j.1468-2982.1994.1406458.x; Lasisi AO, 2008, J NATL MED ASSOC, V100, P903, DOI 10.1016/S0027-9684(15)31403-6; Lee NH, 2010, OTOLARYNG HEAD NECK, V143, P413, DOI 10.1016/j.otohns.2010.06.905; Lee SH, 2010, J CLIN NEUROL, V6, P51, DOI 10.3988/jcn.2010.6.2.51; Lipton RB, 2001, HEADACHE, V41, P646, DOI 10.1046/j.1526-4610.2001.041007646.x; MacGregor EA, 2011, HEADACHE, V51, P843, DOI 10.1111/j.1526-4610.2011.01904.x; Mandala M, 2010, ACTA OTO-LARYNGOL, V130, P565, DOI 10.3109/00016480903311278; Marcelli V, 2006, BRAIN DEV-JPN, V28, P80, DOI 10.1016/j.braindev.2005.05.003; Meggs WJ, 1996, ARCH ENVIRON HEALTH, V51, P275, DOI 10.1080/00039896.1996.9936026; MIZUKOSHI K, 1988, ACTA OTO-LARYNGOL, P67; Modugno GC, 2000, MED HYPOTHESES, V54, P614, DOI 10.1054/mehy.1999.0905; National Institutes of Health National Heart Lung and Blood Institute, 2012, MORB MORT 2012 CHART; Nunez RA, 2000, OTOLARYNG HEAD NECK, V122, P647, DOI 10.1067/mhn.2000.105185; Ogun OA, 2014, MENOPAUSE, V21, P886, DOI [10.1097/GME.0000000000000190, 10.1097/gme.0000000000000190]; Papi G, 2010, THYROID, V20, P237, DOI 10.1089/thy.2009.0319; Park HM, 2001, ACTA OTO-LARYNGOL, P80; Parnes LS, 2003, CAN MED ASSOC J, V169, P681; Perez P, 2012, OTOL NEUROTOL, V33, P437, DOI 10.1097/MAO.0b013e3182487f78; Rambold H, 2004, EUR J NEUROL, V11, P31, DOI 10.1046/j.1351-5101.2003.00705.x; Scher AI, 1998, HEADACHE, V38, P497, DOI 10.1046/j.1526-4610.1998.3807497.x; Schiller JS, 2012, VITAL HLTH STAT, V10, P252, DOI DOI 10.2105/AJPH.2009.163899; Song JJ, 2012, OTOL NEUROTOL, V33, P137, DOI 10.1097/MAO.0b013e318241c27a; Suarez H, 2011, ACTA OTO-LARYNGOL, V131, P377, DOI 10.3109/00016489.2010.534113; Thakar A, 2001, J LARYNGOL OTOL, V115, P782; TUNBRIDGE WMG, 1977, CLIN ENDOCRINOL, V7, P495, DOI 10.1111/j.1365-2265.1977.tb01341.x; TUNBRIDGE WMG, 1977, CLIN ENDOCRINOL, V7, P481, DOI 10.1111/j.1365-2265.1977.tb01340.x; Uneri Alev, 2004, Ear Nose Throat J, V83, P814; VANDERPUMP MPJ, 1995, CLIN ENDOCRINOL, V43, P55, DOI 10.1111/j.1365-2265.1995.tb01894.x; Vibert D, 2003, ANN OTO RHINOL LARYN, V112, P885, DOI 10.1177/000348940311201010; Viccaro M, 2007, OTOL NEUROTOL, V28, P764, DOI 10.1097/MAO.0b013e318064e8d4; von Brevern M, 2007, J NEUROL NEUROSUR PS, V78, P710, DOI 10.1136/jnnp.2006.100420; Warninghoff JC, 2009, BMC NEUROL, V9, DOI 10.1186/1471-2377-9-29; Wu Zi-Ming, 2007, Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi, V42, P821	71	22	24	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 4	2014	9	9							e105546	10.1371/journal.pone.0105546	http://dx.doi.org/10.1371/journal.pone.0105546			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3XV	25187992	Green Published, gold, Green Submitted			2022-12-27	WOS:000341271500009
J	Candelaria, NR; Addanki, S; Zheng, J; Trang, NV; Karaboga, H; Dey, P; Gabbi, C; Vedin, LL; Liu, K; Wu, WF; Jonsson, PK; Lin, JZ; Su, F; Bollu, LR; Hodges, SE; McElhany, AL; Issazadeh, MA; Fisher, WE; Ittmann, MM; Steffensen, KR; Gustafsson, JA; Lin, CY				Candelaria, Nicholes R.; Addanki, Sridevi; Zheng, Jine; Trang Nguyen-Vu; Karaboga, Husna; Dey, Prasenjit; Gabbi, Chiara; Vedin, Lise-Lotte; Liu, Ka; Wu, Wanfu; Jonsson, Philip K.; Lin, Jean Z.; Su, Fei; Bollu, Lakshmi Reddy; Hodges, Sally E.; McElhany, Amy L.; Issazadeh, Mehdi A.; Fisher, William E.; Ittmann, Michael M.; Steffensen, Knut R.; Gustafsson, Jan-Ake; Lin, Chin-Yo			Antiproliferative Effects and Mechanisms of Liver X Receptor Ligands in Pancreatic Ductal Adenocarcinoma Cells	PLOS ONE			English	Article							GROWTH-FACTOR RECEPTOR; PROSTATE-CANCER CELLS; BREAST-CANCER; PROLIFERATION; GEMCITABINE; THERAPY; TRIAL; MICE; DEGRADATION; INHIBITION	Pancreatic ductal adenocarcinoma (PDAC) is difficult to detect early and is often resistant to standard chemotherapeutic options, contributing to extremely poor disease outcomes. Members of the nuclear receptor superfamily carry out essential biological functions such as hormone signaling and are successfully targeted in the treatment of endocrine-related malignancies. Liver X receptors (LXRs) are nuclear receptors that regulate cholesterol homeostasis, lipid metabolism, and inflammation, and LXR agonists have been developed to regulate LXR function in these processes. Intriguingly, these compounds also exhibit antiproliferative activity in diverse types of cancer cells. In this study, LXR agonist treatments disrupted proliferation, cell-cycle progression, and colony-formation of PDAC cells. At the molecular level, treatments downregulated expression of proteins involved in cell cycle progression and growth factor signaling. Microarray experiments further revealed changes in expression profiles of multiple gene networks involved in biological processes and pathways essential for cell growth and proliferation following LXR activation. These results establish the antiproliferative effects of LXR agonists and potential mechanisms of action in PDAC cells and provide evidence for their potential application in the prevention and treatment of PDAC.	[Candelaria, Nicholes R.; Addanki, Sridevi; Zheng, Jine; Trang Nguyen-Vu; Karaboga, Husna; Dey, Prasenjit; Gabbi, Chiara; Liu, Ka; Wu, Wanfu; Jonsson, Philip K.; Lin, Jean Z.; Su, Fei; Bollu, Lakshmi Reddy; Gustafsson, Jan-Ake; Lin, Chin-Yo] Univ Houston, Dept Biol & Biochem, Ctr Nucl Receptors & Cell Signaling, Houston, TX 77004 USA; [Vedin, Lise-Lotte; Steffensen, Knut R.] Karolinska Inst, Karolinska Univ Hosp Huddinge, Dept Lab Med, Div Clin Chem, Stockholm, Sweden; [Gustafsson, Jan-Ake] Karolinska Inst, Novum, Dept Biosci & Nutr, Huddinge, Sweden; [Lin, Jean Z.] Houston Methodist Res Inst, Ctr Diabet Res, Houston, TX USA; [Hodges, Sally E.; McElhany, Amy L.; Issazadeh, Mehdi A.; Fisher, William E.] Baylor Coll Med, Michael E DeBakey Dept Surg, Houston, TX 77030 USA; [Hodges, Sally E.; McElhany, Amy L.; Issazadeh, Mehdi A.; Fisher, William E.] Baylor Coll Med, Elkins Pancreas Ctr, Houston, TX 77030 USA; [Ittmann, Michael M.] Baylor Coll Med, Dept Pathol & Immunol, Houston, TX 77030 USA	University of Houston System; University of Houston; Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; The Methodist Hospital System; The Methodist Hospital - Houston; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine	Lin, CY (corresponding author), Univ Houston, Dept Biol & Biochem, Ctr Nucl Receptors & Cell Signaling, Houston, TX 77004 USA.	clin23@central.uh.edu	Wu, Wanfu/L-8558-2014; Gabbi, Chiara/AAB-9677-2022; Bollu, Lakshmi/O-4992-2015; Liu, Ka/M-1191-2014	Wu, Wanfu/0000-0002-2231-9528; Gabbi, Chiara/0000-0002-9764-4771; Bollu, Lakshmi/0000-0001-9596-6251; Jonsson, Philip/0000-0002-1537-0624; Liu, Ka/0000-0003-4029-8852; SU, FEI/0000-0001-5834-4074	Golfers Against Cancer; State of Texas Emerging Technologies Fund [300-9-1958]	Golfers Against Cancer; State of Texas Emerging Technologies Fund	This work was supported by an award from Golfers Against Cancer. The Center for Nuclear Receptors and Cell Signaling at the University of Houston is supported by the State of Texas Emerging Technologies Fund (grant number 300-9-1958). No individual employed or contracted by the funders (other than the named authors) played any role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramoff M.D., 2004, BIOPHOT INT, V11, P36, DOI DOI 10.1117/1.3589100; Aranda A, 2001, PHYSIOL REV, V81, P1269, DOI 10.1152/physrev.2001.81.3.1269; Bensinger SJ, 2008, CELL, V134, P97, DOI 10.1016/j.cell.2008.04.052; Bruns CJ, 2000, CANCER RES, V60, P2926; BURRIS H, 1997, EUR J CANCER, V33, P18; Burris HA, 1997, J CLIN ONCOL, V15, P2403, DOI 10.1200/JCO.1997.15.6.2403; Burris TP, 2012, CHEM BIOL, V19, P51, DOI 10.1016/j.chembiol.2011.12.011; Carrano AC, 1999, NAT CELL BIOL, V1, P193, DOI 10.1038/12013; Chuu CP, 2010, ANTICANCER RES, V30, P3643; Deer EL, 2010, PANCREAS, V39, P425, DOI 10.1097/MPA.0b013e3181c15963; Fukuchi J, 2004, CANCER RES, V64, P7686, DOI 10.1158/0008-5472.CAN-04-2332; Gabbi C, 2010, P NATL ACAD SCI USA, V107, P14763, DOI 10.1073/pnas.1009483107; Gabbi C, 2009, MOL ENDOCRINOL, V23, P129, DOI 10.1210/me.2008-0398; Gabbi C, 2008, P NATL ACAD SCI USA, V105, P15052, DOI 10.1073/pnas.0808097105; Guo DL, 2011, CANCER DISCOV, V1, P442, DOI 10.1158/2159-8290.CD-11-0102; Haddow A, 1944, Br Med J, V2, P393; Hopkins AL, 2002, NAT REV DRUG DISCOV, V1, P727, DOI 10.1038/nrd892; Houck KA, 2004, MOL GENET METAB, V83, P184, DOI 10.1016/j.ymgme.2004.07.007; KENNEDY BJ, 1965, CANCER, V18, P1551, DOI 10.1002/1097-0142(196512)18:12<1551::AID-CNCR2820181206>3.0.CO;2-1; Kim HJ, 2009, P NATL ACAD SCI USA, V106, P558, DOI 10.1073/pnas.0811295106; Lim JE, 2003, ANN SURG, V237, P74, DOI 10.1097/00000658-200301000-00011; Logsdon CD, 2003, CANCER RES, V63, P3445; Moore MJ, 2007, J CLIN ONCOL, V25, P1960, DOI 10.1200/JCO.2006.07.9525; Niyazi M, 2007, RADIAT ONCOL, V2, DOI 10.1186/1748-717X-2-4; Olive KP, 2009, SCIENCE, V324, P1457, DOI 10.1126/science.1171362; Pommier AJC, 2010, ONCOGENE, V29, P2712, DOI 10.1038/onc.2010.30; Prufer K, 2007, J CELL BIOCHEM, V100, P69, DOI 10.1002/jcb.21006; Shang YF, 2002, SCIENCE, V295, P2465, DOI 10.1126/science.1068537; Toresson G, 2004, PROTEIN EXPRES PURIF, V35, P190, DOI 10.1016/j.pep.2004.01.007; Nguyen-Vu T, 2013, BREAST CANCER RES, V15, DOI 10.1186/bcr3443; Vedin LL, 2009, CARCINOGENESIS, V30, P575, DOI 10.1093/carcin/bgp029; Vedin LL, 2012, MOL CARCINOG; von der Lehr N, 2003, MOL CELL, V11, P1189, DOI 10.1016/S1097-2765(03)00193-X; Wente W, 2007, ENDOCRINOLOGY, V148, P1843, DOI 10.1210/en.2006-1247; Xiong HQ, 2004, J CLIN ONCOL, V22, P2610, DOI 10.1200/JCO.2004.12.040	35	33	36	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 3	2014	9	9							e106289	10.1371/journal.pone.0106289	http://dx.doi.org/10.1371/journal.pone.0106289			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3TB	25184494	gold, Green Published, Green Submitted			2022-12-27	WOS:000341257700050
J	Chen, SY; Yu, HT; Kao, JP; Yang, CC; Chiang, SS; Mishchuk, DO; Mau, JL; Slupsky, CM				Chen, Shin-Yu; Yu, Hui-Tzu; Kao, Ju-Po; Yang, Chung-Chun; Chiang, Shen-Shih; Mishchuk, Darya O.; Mau, Jeng-Leun; Slupsky, Carolyn M.			An NMR Metabolomic Study on the Effect of Alendronate in Ovariectomized Mice	PLOS ONE			English	Article							BONE-MINERAL DENSITY; POSTMENOPAUSAL WOMEN; GLUCOSE-METABOLISM; DIETARY TAURINE; FRACTURE RISK; SERUM-LEVELS; RATS; OSTEOPOROSIS; TURNOVER; THERAPY	Alendronate sodium (Fosamax) is most widely used for the prevention and treatment of osteoporosis. It is a type of anti-resorptive agent that reduces the risk of fractures by changing bone turnover and bone mineral density. We investigated the effect of Fosamax on a mouse model of osteoporosis. Twenty-seven female C57BL/6JNarl mice were divided into three groups: sham, ovariectomized (OVX) and OVX + Fosamax (Fosamax). After 23 weeks, bone density of femurs was analyzed using microcomputed tomography (micro-CT), and serum was analyzed for osteoblast and osteoclast activity, as well as metabolites using nuclear magnetic resonance (NMR) spectroscopy. Fosamax increased bone mineral density and cortical bone thickness, and decreased osteoblast activity slightly. Fosamax did not significantly change osteoclast activity. Serum metabolomics revealed that Fosamax had profound effects on overall metabolism, as significantly higher concentrations of metabolites associated with energy metabolism (including TCA-cycle intermediates and glucose), 3-hydroxybutyrate, taurine, allantoin, acetate, and ethanol, as well as lower concentrations of aspartate were observed in the Fosamax-treated mice compared with the OVX mice. These results suggest that alendronate may work by increasing bone density through altered metabolic activity.	[Chen, Shin-Yu; Yu, Hui-Tzu; Chiang, Shen-Shih; Mau, Jeng-Leun] Natl Chung Hsing Univ, Dept Food Sci & Biotechnol, Taichung, Taiwan; [Chen, Shin-Yu; Chiang, Shen-Shih; Mau, Jeng-Leun] Natl Chung Hsing Univ, NCHU UCD Plant & Food Biotechnol Ctr, Taichung, Taiwan; [Chen, Shin-Yu] Natl Chung Hsing Univ, Agr Biotechnol Ctr, Taichung, Taiwan; [Kao, Ju-Po; Yang, Chung-Chun] Natl Chung Hsing Univ, Vet Med Teaching Hosp, Coll Vet Med, Taichung, Taiwan; [Mishchuk, Darya O.; Slupsky, Carolyn M.] Univ Calif Davis, Dept Food Sci & Technol, Davis, CA 95616 USA; [Slupsky, Carolyn M.] Univ Calif Davis, Dept Nutr, Davis, CA 95616 USA	National Chung Hsing University; National Chung Hsing University; National Chung Hsing University; National Chung Hsing University; University of California System; University of California Davis; University of California System; University of California Davis	Mau, JL (corresponding author), Natl Chung Hsing Univ, Dept Food Sci & Biotechnol, Taichung, Taiwan.	jlmau@dragon.nchu.edu.tw; cslupsky@ucdavis.edu			National Science Council, Republic of China [NSC-101-2911-I-005-301, NSC-102-2911-I-005-301, NSC 100-2313-B-005-022-MY3]; Ministry of Education, Taiwan, R.O.C., under ATU plan	National Science Council, Republic of China(Ministry of Science and Technology, Taiwan); Ministry of Education, Taiwan, R.O.C., under ATU plan	This study was supported by the National Science Council, Republic of China (NSC-101-2911-I-005-301, NSC-102-2911-I-005-301, NSC 100-2313-B-005-022-MY3) and the Ministry of Education, Taiwan, R.O.C., under the ATU plan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdel-Sater KA, 2012, ACTA ENDOCRINOL-BUCH, V8, P189, DOI 10.4183/aeb.2012.189; Burge R, 2007, J BONE MINER RES, V22, P465, DOI [10.1359/jbmr.061113, 10.1359/JBMR.061113]; Chang KL, 2013, NUTRITION, V29, P250, DOI 10.1016/j.nut.2012.03.009; Cho DC, 2012, ACTA NEUROCHIR, V154, P2215, DOI 10.1007/s00701-012-1516-9; Choi MJ, 2013, ADV EXP MED BIOL, V776, P335, DOI 10.1007/978-1-4614-6093-0_31; Choi MJ, 2009, ADV EXP MED BIOL, V643, P341, DOI 10.1007/978-0-387-75681-3_35; Clemens TL, 2011, J BONE MINER RES, V26, P677, DOI 10.1002/jbmr.321; Clemens TL, 1997, J BONE MINER RES, V12, P1570, DOI 10.1359/jbmr.1997.12.10.1570; Davison KS, 2006, SEMIN ARTHRITIS RHEU, V36, P22, DOI 10.1016/j.semarthrit.2006.04.002; DeBerardinis RJ, 2012, CELL, V148, P1132, DOI 10.1016/j.cell.2012.02.032; Delmas PD, 2004, BONE, V34, P599, DOI 10.1016/j.bone.2003.12.022; Dryland PA, 2008, OPEN BIOACT COMPD J, V1, P1; Faienza MF, 2013, CLIN DEV IMMUNOL, DOI 10.1155/2013/575936; Glatt V, 2007, J BONE MINER RES, V22, P1197, DOI 10.1359/JBMR.070507; Hildebrand TOR, 1997, Comput Methods Biomech Biomed Engin, V1, P15, DOI 10.1080/01495739708936692; Hong Seong-Hun, 2013, J Bone Metab, V20, P37, DOI 10.11005/jbm.2013.20.1.37; Iwamoto J, 2006, EXP ANIM TOKYO, V55, P357, DOI 10.1538/expanim.55.357; Jeon SH, 2007, FEBS LETT, V581, P5929, DOI 10.1016/j.febslet.2007.11.035; Kaji H, 2009, J BONE MINER METAB, V27, P76, DOI 10.1007/s00774-008-0005-y; Kalaiselvi VS, 2013, J CLIN DIAGN RES, V7, P814, DOI 10.7860/JCDR/2013/5370.2946; KANIS JA, 1994, OSTEOPOROSIS INT, V4, P368, DOI 10.1007/BF01622200; Kendler DL, 2010, J BONE MINER RES, V25, P72, DOI 10.1359/jbmr.090716; Khan AA, 2009, J RHEUMATOL, V36, P478, DOI 10.3899/jrheum.080759; Ng KW, 2011, CLIN ENDOCRINOL, V75, P147, DOI 10.1111/j.1365-2265.2011.04133.x; Lacombe J, 2013, MOL METAB, V2, P498, DOI 10.1016/j.molmet.2013.08.004; Lasota A, 2004, Rocz Akad Med Bialymst, V49 Suppl 1, P129; Lee NK, 2007, CELL, V130, P456, DOI 10.1016/j.cell.2007.05.047; Legiran S, 2012, CLIN CASES MINER BON, V9, P145; Neustadt J, 2012, OSTEOPOROSIS BONE MI; Nicholson JK, 2008, NATURE, V455, P1054, DOI 10.1038/4551054a; Notomi T, 2003, J BONE MINER RES, V18, P140, DOI 10.1359/jbmr.2003.18.1.140; O'Sullivan A, 2013, J PROTEOME RES, V12, P481, DOI 10.1021/pr3009176; ODGAARD A, 1993, BONE, V14, P173, DOI 10.1016/8756-3282(93)90245-6; Odvina CV, 2005, J CLIN ENDOCR METAB, V90, P1294, DOI 10.1210/jc.2004-0952; Rendina E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060569; Riggs BL, 2002, ENDOCR REV, V23, P279, DOI 10.1210/er.23.3.279; Russell RGG, 2008, OSTEOPOROSIS INT, V19, P733, DOI 10.1007/s00198-007-0540-8; Sambrook PN, 2004, J INTERN MED, V255, P503, DOI 10.1111/j.1365-2796.2004.01317.x; Schwartz AV, 2013, J BONE MINER RES, V28, P1348, DOI 10.1002/jbmr.1865; Sebastian-Ochoa A, 2012, MENOPAUSE, V19, P172, DOI 10.1097/gme.0b013e31822815c0; Semenkovich CF, 2007, CELL, V130, P409, DOI 10.1016/j.cell.2007.07.031; Sener G, 2005, PROSTAG LEUKOTR ESS, V72, P1, DOI 10.1016/j.plefa.2004.04.005; Senthilkumar R, 2003, POL J PHARMACOL, V55, P603; Seo SK, 2012, GYNECOL OBSTET INVES, V74, P143, DOI 10.1159/000339934; Slupsky CM, 2007, ANAL CHEM, V79, P6995, DOI 10.1021/ac0708588; Talaulikar VS, 2012, J OBSTET GYNAECOL RE, V38, P253, DOI 10.1111/j.1447-0756.2011.01629.x; U.S. Department of Health and Human Services Food and Drug Administration, 2002, EST SAF START DOS CL; Van Ness-Otunnu R, 2013, J EMERG MED, V45, P797, DOI 10.1016/j.jemermed.2013.03.040; Varun Br, 2012, J Oral Maxillofac Pathol, V16, P210, DOI 10.4103/0973-029X.98893; Watts NB, 2010, J CLIN ENDOCR METAB, V95, P1555, DOI 10.1210/jc.2009-1947; Weljie AM, 2006, ANAL CHEM, V78, P4430, DOI 10.1021/ac060209g; Wu N, 2010, CLIN CHIM ACTA, V411, P771, DOI 10.1016/j.cca.2010.02.064; Yamane H, 2009, BONE, V44, P1055, DOI 10.1016/j.bone.2008.05.010; Yamazaki T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079376; Zhao X, 2011, J ETHNOPHARMACOL, V137, P1083, DOI 10.1016/j.jep.2011.07.017; Zhao Y, 2007, BIOMATERIALS, V28, P3063, DOI 10.1016/j.biomaterials.2007.03.003	56	17	18	2	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 3	2014	9	9							e106559	10.1371/journal.pone.0106559	http://dx.doi.org/10.1371/journal.pone.0106559			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3TB	25184758	Green Published, gold			2022-12-27	WOS:000341257700087
J	Harris, LR; Herpers, R; Hofhammer, T; Jenkin, M				Harris, Laurence R.; Herpers, Rainer; Hofhammer, Thomas; Jenkin, Michael			How Much Gravity Is Needed to Establish the Perceptual Upright?	PLOS ONE			English	Article							ORIENTATION; VERTICALITY; STABILIZATION; ACCELERATION; THRESHOLDS; SHAPE	Might the gravity levels found on other planets and on the moon be sufficient to provide an adequate perception of upright for astronauts? Can the amount of gravity required be predicted from the physiological threshold for linear acceleration? The perception of upright is determined not only by gravity but also visual information when available and assumptions about the orientation of the body. Here, we used a human centrifuge to simulate gravity levels from zero to earth gravity along the long-axis of the body and measured observers' perception of upright using the Oriented Character Recognition Test (OCHART) with and without visual cues arranged to indicate a direction of gravity that differed from the body's long axis. This procedure allowed us to assess the relative contribution of the added gravity in determining the perceptual upright. Control experiments off the centrifuge allowed us to measure the relative contributions of normal gravity, vision, and body orientation for each participant. We found that the influence of 1 g in determining the perceptual upright did not depend on whether the acceleration was created by lying on the centrifuge or by normal gravity. The 50% threshold for centrifuge-simulated gravity's ability to influence the perceptual upright was at around 0.15 g, close to the level of moon gravity but much higher than the threshold for detecting linear acceleration along the long axis of the body. This observation may partially explain the instability of moonwalkers but is good news for future missions to Mars.	[Harris, Laurence R.] York Univ, Dept Psychol, Toronto, ON M3J 2R7, Canada; [Herpers, Rainer; Hofhammer, Thomas] Hsch Bonn Rhein Sieg, Dept Comp Sci, St Augustin, Germany; [Jenkin, Michael] York Univ, Dept Elect Engn & Comp Sci, Toronto, ON M3J 2R7, Canada	York University - Canada; Hochschule Bonn Rhein Sieg; York University - Canada	Harris, LR (corresponding author), York Univ, Dept Psychol, Toronto, ON M3J 2R7, Canada.	harris@yorku.ca	Harris, Laurence/AAT-9549-2021	Harris, Laurence/0000-0002-7154-8757; Herpers, Rainer/0000-0002-9712-598X; Jenkin, Michael/0000-0002-2969-0012	DLR Space Administration (National Centrifuge Programme) by NSERC	DLR Space Administration (National Centrifuge Programme) by NSERC	Funding was provided by DLR Space Administration (National Centrifuge Programme) supplemented by NSERC discovery grants held by MJ and LRH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMBLARD B, 1985, EXP BRAIN RES, V61, P21; Barnett-Cowan M, 2010, NEUROSCIENCE, V167, P1138, DOI 10.1016/j.neuroscience.2010.02.065; Benson AJ, 1997, J VESTIBUL RES-EQUIL, V7, P453, DOI 10.1016/S0957-4271(96)00167-X; Clement G, 2001, EXP BRAIN RES, V138, P410, DOI 10.1007/s002210100706; Clement G., 2008, NEUROSCIENCE SPACE; Clement Gilles, 2013, Life-Basel, V3, P524, DOI 10.3390/life3040524; Clement G, 2014, J VESTIBUL RES-EQUIL, V24, P1, DOI 10.3233/VES-130504; CORNSWEET TN, 1962, AM J PSYCHOL, V75, P485, DOI 10.2307/1419876; de Winkel KN, 2012, NEUROSCI LETT, V529, P7, DOI 10.1016/j.neulet.2012.09.026; Dyde RT, 2006, EXP BRAIN RES, V173, P612, DOI 10.1007/s00221-006-0405-y; Gianna C, 1996, BRAIN RES BULL, V40, P443, DOI 10.1016/0361-9230(96)00140-2; Guedry FE, 1974, HDB SENSORY PHYSL, P2; GUNDRY AJ, 1978, AVIAT SPACE ENVIR MD, V49, P679; Harris L, 2012, J GRAVITATIONAL PHYS, V19, P9; Homick JL, 1975, APOLLO FLIGHT CREW V, P323; Isableu B, 1997, EXP BRAIN RES, V114, P584, DOI 10.1007/PL00005667; Jenkin HL, 2004, PERCEPTION, V33, P1453, DOI 10.1068/p5285; Lopez C, 2008, NEUROPHYSIOL CLIN, V38, P149, DOI 10.1016/j.neucli.2007.12.006; Manckoundia P, 2007, CLIN NEUROPHYSIOL, V118, P786, DOI 10.1016/j.clinph.2006.11.274; Mander C, 2013, J VIS, V9, P889; McIntyre J, 2001, NAT NEUROSCI, V4, P693, DOI 10.1038/89477; Mittelstaedt H, 1996, BIOL PSYCHOL, V42, P53, DOI 10.1016/0301-0511(95)05146-5; MITTELSTAEDT H, 1983, NATURWISSENSCHAFTEN, V70, P272, DOI 10.1007/BF00404833; NASA, 1972, 1972779262522 NASA; NASA, 1972, M726 NASA; Paloski W.H., 2018, J GRAVIT PHYSL, V15, P1; PAULUS WM, 1984, BRAIN, V107, P1143, DOI 10.1093/brain/107.4.1143; THOMPSON P, 1980, PERCEPTION, V9, P483, DOI 10.1068/p090483; VALENTINE T, 1988, BRIT J PSYCHOL, V79, P471, DOI 10.1111/j.2044-8295.1988.tb02747.x; WENDEROTH P, 1993, PERCEPTION, V22, P1121, DOI 10.1068/p221121	30	18	18	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 3	2014	9	9							e106207	10.1371/journal.pone.0106207	http://dx.doi.org/10.1371/journal.pone.0106207			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AO3TB	25184481	Green Published, gold			2022-12-27	WOS:000341257700037
J	Li, W; Shi, Q; Wang, WB; Liu, JR; Li, Q; Hou, FG				Li, Wen; Shi, Qi; Wang, Weibing; Liu, Jianrong; Li, Qi; Hou, Fenggang			RETRACTED: Calcium Channel Blockers and Risk of Breast Cancer: A Meta-Analysis of 17 Observational Studies (Retracted article. See vol. 13, pg. 2018)	PLOS ONE			English	Article; Retracted Publication							ANTIHYPERTENSIVE MEDICATIONS; PUBLICATION BIAS; MORTALITY; APOPTOSIS; COHORT; WOMEN; ANTAGONISTS; CARCINOMA; USERS; CELLS	Purpose: Studies on the association between the use of calcium channel blockers (CCBs) and breast cancer risk have reported inconsistent results. We quantitatively assessed this association by conducting a meta-analysis based on the evidence from observational studies. Methods: We searched PubMed, MEDLINE, EMBASE and the Cochrane Library for relevant studies published up to and including December 31, 2013. We calculated pooled risk ratios (RRs) for cancer risk. Results: A total of 17 studies (9 cohort studies, 8 case-control studies) were selected for further study. These studies included 149,607 female subjects, of which 53,812 were CCBs users, who were followed for 2-16 years. The risks of breast cancer among patients receiving CCBs were significantly different for the pooled RRs (95% confidence interval) of cohort studies 1.08 (0.95, 1.20) and case-control studies 0.98 (0.86, 1.09). Differences were also noted for cancer risk, for CCBs use of <5 years 0.96 (0.78, 1.15), and for >5 years 1.01 (0.74, 1.28), as well as for ever used 1.08 (0.95, 1.20), and for current use 1.13 (0.83, 1.42). The RR for studies longer than 10 years was 1.71 (1.01, 2.42), and for studies evaluating nifedipine was 1.10 (0.87, 1.33) and diltiazem was 0.75 (0.40, 1.10). Conclusions: The long-term use of CCBs appears to have a significant relationship with breast cancer. Well-designed clinical trials are needed to optimize the doses and types of these drugs needed to minimize their carcinogenic potential.	[Li, Wen; Shi, Qi; Liu, Jianrong; Hou, Fenggang] Shanghai TCM Univ, Shanghai Municipal Hosp Tradit Chinese Med, Dept Oncol, Shanghai, Peoples R China; [Wang, Weibing] Fudan Univ, Sch Publ Hlth, Dept Epidemiol, Shanghai 200433, Peoples R China; [Li, Qi] Shanghai Univ Tradit Chinese Med, Shuguang Hosp, Dept Oncol, Shanghai, Peoples R China	Fudan University; Shanghai University of Traditional Chinese Medicine	Hou, FG (corresponding author), Shanghai TCM Univ, Shanghai Municipal Hosp Tradit Chinese Med, Dept Oncol, Shanghai, Peoples R China.	fghou555@126.com			Shanghai Municipal Education Commission [12YZ057, 10CG25]; Fundamental Research Funds for the Central Universities [78210021]	Shanghai Municipal Education Commission(Shanghai Municipal Education Commission (SHMEC)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This work is supported by Innovation Project of Shanghai Municipal Education Commission (12YZ057), the Fundamental Research Funds for the Central Universities (78210021) and the Chenguang Program from Shanghai Municipal Education Commission (10CG25). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altamirano F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081222; Assimes TL, 2008, PHARMACOEPIDEM DR S, V17, P1039, DOI 10.1002/pds.1656; Beiderbeck-Noll AB, 2003, EUR J CANCER, V39, P98, DOI 10.1016/S0959-8049(02)00157-0; Braun S, 1998, J AM COLL CARDIOL, V31, P804, DOI 10.1016/S0735-1097(98)00008-4; CARSON DA, 1993, LANCET, V341, P1251, DOI 10.1016/0140-6736(93)91154-E; Chobanian AV, 1996, JAMA-J AM MED ASSOC, V276, P829, DOI 10.1001/jama.276.10.829; Curry MC, 2013, BIOCH BIOPHYSICAL RE; Das A, 2013, PIGM CELL MELANOMA R, V26, DOI 10.1111/pcmr.12155; Davis S, 2007, EUR J EPIDEMIOL, V22, P319, DOI 10.1007/s10654-007-9135-0; Duval S, 2000, BIOMETRICS, V56, P455, DOI 10.1111/j.0006-341X.2000.00455.x; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Fitzpatrick AL, 1997, CANCER, V80, P1438, DOI 10.1002/(SICI)1097-0142(19971015)80:8<1438::AID-CNCR11>3.0.CO;2-6; Fryzek JP, 2006, BREAST CANCER RES TR, V97, P231, DOI 10.1007/s10549-005-9091-x; Gonzalez-Perez A, 2004, PHARMACOEPIDEM DR S, V13, P581, DOI 10.1002/pds.910; Handayani S, 2013, INDONESIAN J PHARM, V23; Hole DJ, 1998, J HYPERTENS, V16, P119, DOI 10.1097/00004872-199816010-00017; Holmes S, 2013, CANCER EPIDEMIOL, V37, P881, DOI 10.1016/j.canep.2013.09.001; Hunter DJ, 2013, NEW ENGL J MED, V369, P1336, DOI 10.1056/NEJMra1109345; Jang SJ, 2013, BIOORG MED CHEM LETT, V23, P6656, DOI 10.1016/j.bmcl.2013.10.049; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Jick H, 1997, LANCET, V349, P525, DOI 10.1016/S0140-6736(97)80084-0; Knobloch K, 2011, J CRANIO MAXILL SURG, V39, P91, DOI 10.1016/j.jcms.2010.11.001; KONRADDALHOFF I, 1991, EUR J CLIN PHARMACOL, V41, P313, DOI 10.1007/BF00314958; Li CI, 2013, JAMA INTERN MED, V173, P1629, DOI 10.1001/jamainternmed.2013.9071; Li CI, 2003, CANCER, V98, P1504, DOI 10.1002/cncr.11663; Lindberg G, 2002, PHARMACOEPIDEM DR S, V11, P493, DOI 10.1002/pds.737; Meier CR, 2000, ARCH INTERN MED, V160, P349, DOI 10.1001/archinte.160.3.349; Michels KB, 1998, CANCER, V83, P2003, DOI 10.1002/(SICI)1097-0142(19981101)83:9<2003::AID-CNCR17>3.3.CO;2-V; Moher David, 2009, Ann Intern Med, V151, P264, DOI [10.1136/bmj.b2535, 10.1016/j.ijsu.2010.02.007]; Moon D, 2013, J SURG RES, V180, P208, DOI 10.1016/j.jss.2012.04.027; Olsen JH, 1997, HYPERTENSION, V29, P1091, DOI 10.1161/01.HYP.29.5.1091; Pahor M, 1996, LANCET, V348, P493, DOI 10.1016/S0140-6736(96)04277-8; Pahor M, 1996, LANCET, V347, P1061, DOI 10.1016/S0140-6736(96)90276-7; PAHOR M, 1994, J AM GERIATR SOC, V42, P50, DOI 10.1111/j.1532-5415.1994.tb06073.x; Peters JL, 2007, STAT MED, V26, P4544, DOI 10.1002/sim.2889; PSATY BM, 1995, JAMA-J AM MED ASSOC, V274, P620, DOI 10.1001/jama.274.8.620; QUINN M, 1995, BRIT MED J, V311, P1391, DOI 10.1136/bmj.311.7017.1391; Rosenberg L, 1998, JAMA-J AM MED ASSOC, V279, P1000, DOI 10.1001/jama.279.13.1000; Saltzman BS, 2013, CANCER CAUSE CONTROL, V24, P365, DOI 10.1007/s10552-012-0122-8; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Sorensen HT, 2000, CANCER-AM CANCER SOC, V89, P165, DOI 10.1002/1097-0142(20000701)89:1<165::AID-CNCR21>3.0.CO;2-G; STEIN G, 1990, ARCH TOXICOL, V64, P623, DOI 10.1007/BF01974690; WAGENKNECHT LE, 1995, BRIT MED J, V310, P776, DOI 10.1136/bmj.310.6982.776	43	14	14	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 3	2014	9	9							e105801	10.1371/journal.pone.0105801	http://dx.doi.org/10.1371/journal.pone.0105801			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3TB	25184210	gold, Green Published, Green Submitted			2022-12-27	WOS:000341257700025
J	Nepal, B; Brown, LJ; Anstey, KJ				Nepal, Binod; Brown, Laurie J.; Anstey, Kaarin J.			Rising Midlife Obesity Will Worsen Future Prevalence of Dementia	PLOS ONE			English	Article							LATE-LIFE; RISK; OVERWEIGHT; AUSTRALIA	Background: Midlife body weight status has been found to affect late life dementia outcomes. A cohort projections model was developed to assess the impact of midlife body mass index (BMI) profile on dementia in older Australians. Methods: A baseline projection using age-sex specific dementia prevalence rates was constructed and the results of scenarios that took account of midlife BMI were compared with those from population ageing only. Results: This modelling predicts that if the rising trend in midlife obesity and declining trend in midlife normal weight in Australia are to be taken into account in projecting future numbers of Australians with dementia then the number of people aged 65 or more years with dementia, by 2050, would be 14% higher than that expected from demographic ageing only. If midlife obesity prevalence was decreased to 20% and normal weight increased to 40% over the period of 2015-2025, then dementia cases among persons aged 65-69 years would be lower by about 10% in 2050 compared with the "doing nothing to stop current trends in obesity" projection. Conclusion: The rising tide of obesity in Australian adults will increase the dementia epidemic expected in future years.	[Nepal, Binod; Brown, Laurie J.] Univ Canberra, Natl Ctr Social & Econ Modelling, Canberra, ACT 2601, Australia; [Anstey, Kaarin J.] Univ Canberra, Ctr Res Ageing Hlth & Wellbeing, Canberra, ACT 2601, Australia	University of Canberra; University of Canberra	Brown, LJ (corresponding author), Univ Canberra, Natl Ctr Social & Econ Modelling, Canberra, ACT 2601, Australia.	laurie.brown@natsem.canberra.edu.au	Anstey, Kaarin/A-3852-2008; Brown, Laurie/G-8745-2017	Anstey, Kaarin/0000-0002-9706-9316; Brown, Laurie/0000-0002-9357-5094	Australian Government Department of Health and Ageing Dementia Collaborative Research Centre initiative	Australian Government Department of Health and Ageing Dementia Collaborative Research Centre initiative(Australian GovernmentDepartment of Health & Ageing)	This work has been funded through the Australian Government Department of Health and Ageing Dementia Collaborative Research Centre initiative. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anstey KJ, 2011, OBES REV, V12, pe426, DOI 10.1111/j.1467-789X.2010.00825.x; Anstey KJ, 2010, BMC NEUROL, V10, DOI 10.1186/1471-2377-10-62; Australian Bureau of Statistics, 2008, POP PROJ AUSTR 2006; Australian Institute of Health and Welfare, 2013, AIHW AN 1980 1983 19; Australian Institute of Health and Welfare, 2007, DEM AUSTR NAT DAT AN; Deloitte Access Economics, 2011, DEM AUSTR 2011 2050; Finucane MM, 2011, LANCET, V377, P557, DOI 10.1016/S0140-6736(10)62037-5; Fitzpatrick AL, 2009, ARCH NEUROL-CHICAGO, V66, P336, DOI 10.1001/archneurol.2008.582; Jorm AF, 2005, AUST NZ J PSYCHIAT, V39, P959, DOI 10.1111/j.1440-1614.2005.01713.x; Kivipelto M, 2006, LANCET NEUROL, V5, P735, DOI 10.1016/S1474-4422(06)70537-3; Lobo A, 2000, NEUROLOGY, V54, pS4; Nepal B, 2013, OBESITY, V21, P2579, DOI 10.1002/oby.20187; Nepal B, 2010, AUSTRALAS J AGEING, V29, P111, DOI 10.1111/j.1741-6612.2010.00392.x; Vickland V, 2010, DEMENT GERIATR COGN, V29, P123, DOI 10.1159/000272436; Xu WL, 2011, NEUROLOGY, V76, P1568, DOI 10.1212/WNL.0b013e3182190d09	15	15	17	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 3	2014	9	9							e99305	10.1371/journal.pone.0099305	http://dx.doi.org/10.1371/journal.pone.0099305			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3TB	25184830	Green Published, gold			2022-12-27	WOS:000341257700002
J	Smith, SM; Lyu, YL; Cai, L				Smith, Shannon M.; Lyu, Yi Lisa; Cai, Li			NF-kappa B Affects Proliferation and Invasiveness of Breast Cancer Cells by Regulating CD44 Expression	PLOS ONE			English	Article							GENE-EXPRESSION; STEM-CELLS; INVASION; ACTIVATION; INHIBITION; MATRIX-METALLOPROTEINASE-9; IDENTIFICATION; SUPPRESSION; RESISTANCE; MIGRATION	NF-kappa B plays an important role in cancer initiation and progression. CD44, a cell surface glycoprotein, is involved in many cellular processes including cell adhesion, migration and proliferation. However, whether and how the two molecules interact in breast cancer is not clear. In recent years, the up-regulation of CD44 has served as a marker for tumor initiating cells in breast cancer and other cancer types. Despite the important role of CD44 in cellular processes and cancer, the mechanism underlying CD44 up-regulation in cancers remains poorly understood. Previously, we have identified a novel cis-element, CR1, located upstream of the CD44 promoter. We demonstrated that NF-kappa B and AP-1 are key trans-acting factors that interact with CR1. Here, we further analyzed the role of NF-kappa B in regulating CD44 expression in triple negative breast cancer cells, MDA-MB-231 and SUM159. Inhibition of NF-kappa B by Bay-11-7082 resulted in a reduction in CD44 expression. CD44 repression via NF-kappa B inhibition consequently decreased proliferation and invasiveness of breast cancer cells. These findings provide not only new insight into the molecular mechanism underlying CD44 regulation but also potential therapeutic targets that may help eliminate chemo-and radiation-resistant cancer cells.	[Smith, Shannon M.; Cai, Li] Rutgers State Univ, Cell & Dev Biol Grad Program, Piscataway, NJ 08854 USA; [Lyu, Yi Lisa] Rutgers State Univ, Robert Wood Johnson Med Sch, Dept Pharmacol, Piscataway, NJ 08854 USA; [Cai, Li] Rutgers State Univ, Dept Biomed Engn, Piscataway, NJ USA	Rutgers State University New Brunswick; Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers State University New Brunswick	Cai, L (corresponding author), Rutgers State Univ, Cell & Dev Biol Grad Program, Piscataway, NJ 08854 USA.	lcai@rutgers.edu		Cai, Li/0000-0003-3344-337X	National Institutes of Health [CA133675]; Busch Biomedical Research Awards; National Science Foundation - IGERT [DGE 0801620]; NATIONAL CANCER INSTITUTE [R21CA133675] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Busch Biomedical Research Awards; National Science Foundation - IGERT(National Science Foundation (NSF)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported in part by the grant CA133675 from the National Institutes of Health and the Busch Biomedical Research Awards. SMS was a fellow of the National Science Foundation - IGERT grant (DGE 0801620). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; Bhat KPL, 2013, CANCER CELL, V24, P331, DOI 10.1016/j.ccr.2013.08.001; Bhola NE, 2013, J CLIN INVEST, V123, P1348, DOI 10.1172/JCI65416; Bourguignon LYW, 2008, J BIOL CHEM, V283, P17635, DOI 10.1074/jbc.M800109200; Charafe-Jauffret E, 2009, CANC RES; Chellaiah MA, 2003, J BIOL CHEM, V278, P29086, DOI 10.1074/jbc.M211074200; Chen L, 2013, J GASTROENTEROL; Cheng CH, 2006, MOL CELL BIOL, V26, P362, DOI 10.1128/MCB.26.1.362-370.2006; Chetty C, 2012, CELL SIGNAL, V24, P549, DOI 10.1016/j.cellsig.2011.10.008; Damm S, 2010, J INVEST DERMATOL, V130, P1893, DOI 10.1038/jid.2010.45; Das S, 2013, J BIOL CHEM, V288, P11824, DOI 10.1074/jbc.M112.432302; Duncan JS, 2012, CELL, V149, P307, DOI 10.1016/j.cell.2012.02.053; Erstad DJ, 2013, SURG ONCOL CLIN N AM, V22, P705, DOI 10.1016/j.soc.2013.06.011; Fillmore C, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1673; Fillmore CM, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr1982; Ghosh G, 2012, IMMUNOL REV, V246, P36, DOI 10.1111/j.1600-065X.2012.01097.x; Ghosh S, 2012, IMMUNOL REV, V246, P5, DOI 10.1111/j.1600-065X.2012.01111.x; Harikumar KB, 2010, MOL CANCER RES, V8, P751, DOI 10.1158/1541-7786.MCR-09-0565; Hebbard L, 2000, J CELL SCI, V113, P2619; Herrlich P, 2000, ANN NY ACAD SCI, V910, P106; Hinz M, 2002, J EXP MED, V196, P605, DOI 10.1084/jem.20020062; Hiraga T, 2013, CANCER RES, V73, P4112, DOI 10.1158/0008-5472.CAN-12-3801; Honeth G, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr2108; Jin LQ, 2006, NAT MED, V12, P1167, DOI 10.1038/nm1483; Kang H, 2012, J CELL BIOCHEM, V113, P2845, DOI 10.1002/jcb.24159; Kendellen MF, 2013, ONCOGENE; Khurana SS, 2013, J BIOL CHEM, V288, P16085, DOI 10.1074/jbc.M112.445551; Krishnan N, 2013, FEBS J, V280, P2830, DOI 10.1111/febs.12283; Lai WW, 2013, ANTICANCER RES, V33, P1941; Liang YJ, 2013, P NATL ACAD SCI USA, V110, P4968, DOI 10.1073/pnas.1302825110; Ling H, 2011, BREAST CANCER RES TR, V126, P609, DOI 10.1007/s10549-010-0929-5; Liu C, 2011, NAT MED, V17, P211, DOI 10.1038/nm.2284; Mandal CC, 2011, J BIOL CHEM, V286, P11314, DOI 10.1074/jbc.M110.193714; Murray D, 2004, ANTICANCER RES, V24, P489; Perkins ND, 2012, NAT REV CANCER, V12, P121, DOI 10.1038/nrc3204; Perrot-Applanat M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021589; Ponta H, 2003, NAT REV MOL CELL BIO, V4, P33, DOI 10.1038/nrm1004; Razani B, 2011, IMMUNOL REV, V244, P44, DOI 10.1111/j.1600-065X.2011.01059.x; Sheridan C, 2006, BREAST CANCER RES, V8, DOI 10.1186/bcr1610; Smale ST, 2012, IMMUNOL REV, V246, P193, DOI 10.1111/j.1600-065X.2011.01091.x; Smith SM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050867; So JY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054020; Su Jing, 2011, Beijing Da Xue Xue Bao Yi Xue Ban, V43, P199; Thirkettle S, 2013, J BIOL CHEM, V288, P16282, DOI 10.1074/jbc.M113.464230; Weedon MN, 2014, NAT GENET, V46, P61, DOI 10.1038/ng.2826; Yang TQ, 2014, CANCER SCI, V105, P265, DOI 10.1111/cas.12351; Yu Q, 1999, GENE DEV, V13, P35, DOI 10.1101/gad.13.1.35; Zhang J, 2011, VIROLOGY, V413, P244, DOI 10.1016/j.virol.2011.02.021; Zoller M, 2011, NAT REV CANCER, V11, P254, DOI 10.1038/nrc3023	49	69	70	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 3	2014	9	9							e106966	10.1371/journal.pone.0106966	http://dx.doi.org/10.1371/journal.pone.0106966			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3TB	25184276	Green Published, Green Submitted, gold			2022-12-27	WOS:000341257700131
J	Swift, BMC; Gerrard, ZE; Huxley, JN; Rees, CED				Swift, Benjamin M. C.; Gerrard, Zara E.; Huxley, Jonathan N.; Rees, Catherine E. D.			Factors Affecting Phage D29 Infection: A Tool to Investigate Different Growth States of Mycobacteria	PLOS ONE			English	Article							AVIUM SUBSP PARATUBERCULOSIS; TUBERCULOSIS; IDENTIFICATION; DORMANCY; HYPOXIA	Bacteriophages D29 and TM4 are able to infect a wide range of mycobacteria, including pathogenic and non-pathogenic species. Successful phage infection of both fast-and slow-growing mycobacteria can be rapidly detected using the phage amplification assay. Using this method, the effect of oxygen limitation during culture of mycobacteria on the success of phage infection was studied. Both D29 and TM4 were able to infect cultures of M. smegmatis and Mycobacterium avium subspecies paratuberculosis (MAP) grown in liquid with aeration. However when cultures were grown under oxygen limiting conditions, only TM4 could productively infect the cells. Cell attachment assays showed that D29 could bind to the cells surface but did not complete the lytic cycle. The ability of D29 to productively infect the cells was rapidly recovered (within 1 day) when the cultures were returned to an aerobic environment and this recovery required de novo RNA synthesis. These results indicated that under oxygen limiting conditions the cells are entering a growth state which inhibits phage D29 replication, and this change in host cell biology which can be detected by using both phage D29 and TM4 in the phage amplification assay.	[Swift, Benjamin M. C.; Gerrard, Zara E.; Rees, Catherine E. D.] Univ Nottingham, Sch Biosci, Loughborough, Leics, England; [Huxley, Jonathan N.] Univ Nottingham, Sch Vet & Med Sci, Loughborough, Leics, England	University of Nottingham; University of Nottingham	Swift, BMC (corresponding author), Univ Nottingham, Sch Biosci, Sutton Bonington Campus, Loughborough, Leics, England.	benjamin.swift@nottingham.ac.uk	Rees, Catherine/AAF-2150-2020; Huxley, Jonathan N/B-7406-2011	Rees, Catherine/0000-0002-5045-8701; Huxley, Jonathan N/0000-0002-1149-2480; Swift, Benjamin/0000-0001-5328-8325				Albert H, 2004, INT J TUBERC LUNG D, V8, P1114; Botsaris G, 2010, DEV EVALUATION RAPID; Botsaris G, 2010, INT J FOOD MICROBIOL, V141, pS87, DOI 10.1016/j.ijfoodmicro.2010.03.016; Cunningham AF, 1998, J BACTERIOL, V180, P801, DOI 10.1128/JB.180.4.801-808.1998; DAVID HL, 1980, ANN INST PASTEUR VIR, V131, P167, DOI 10.1016/0769-2617(80)90031-3; de Siqueira RS, 2006, INT J FOOD MICROBIOL, V111, P259, DOI 10.1016/j.ijfoodmicro.2006.04.047; Dick T, 1998, FEMS MICROBIOL LETT, V163, P159, DOI 10.1111/j.1574-6968.1998.tb13040.x; Dusthackeer A, 2008, J MICROBIOL METH, V73, P18, DOI 10.1016/j.mimet.2008.01.005; Foddai A, 2009, APPL ENVIRON MICROB, V75, P3896, DOI 10.1128/AEM.00294-09; FOLEYTHOMAS EM, 1995, MICROBIOL-SGM, V141, P1173, DOI 10.1099/13500872-141-5-1173; Fullner KJ, 1997, MOL MICROBIOL, V26, P755, DOI 10.1046/j.1365-2958.1997.6111984.x; Gumber S, 2009, VET MICROBIOL, V133, P344, DOI 10.1016/j.vetmic.2008.07.021; Hatfull GF, 2012, ADV VIRUS RES, V82, P179, DOI 10.1016/B978-0-12-394621-8.00015-7; Hatfull GF, 2010, ANNU REV MICROBIOL, V64, P331, DOI 10.1146/annurev.micro.112408.134233; Hutter B, 1999, FEMS MICROBIOL LETT, V178, P63, DOI 10.1016/S0378-1097(99)00348-1; Lacqua A, 2006, APPL ENVIRON MICROB, V72, P956, DOI 10.1128/AEM.72.1.956-959.2006; Lamont EA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030648; Piuri M, 2006, MOL MICROBIOL, V62, P1569, DOI 10.1111/j.1365-2958.2006.05473.x; Rees C, 2012, UNDERSTANDING TUBERCULOSIS - GLOBAL EXPERIENCES AND INNOVATIVE APPROACHES TO THE DIAGNOSIS, P293; Rustad TR, 2009, CELL MICROBIOL, V11, P1151, DOI 10.1111/j.1462-5822.2009.01325.x; Rybniker J, 2006, J MED MICROBIOL, V55, P37, DOI 10.1099/jmm.0.46238-0; Spears PA, 2008, INFECT IMMUN, V76, P4046, DOI 10.1128/IAI.00283-08; Stanley EC, 2007, APPL ENVIRON MICROB, V73, P1851, DOI 10.1128/AEM.01722-06; Swift BMC, 2013, J MICROBIOL METH, V94, P175, DOI 10.1016/j.mimet.2013.06.015; Wayne LG, 1996, INFECT IMMUN, V64, P2062, DOI 10.1128/IAI.64.6.2062-2069.1996; Whittington RJ, 2004, APPL ENVIRON MICROB, V70, P2989, DOI 10.1128/AEM.70.5.2989-3004.2004; Zimmer K, 1999, J VET MED B, V46, P137, DOI 10.1111/j.0931-1793.1999.00214.x	27	15	16	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 3	2014	9	9							e106690	10.1371/journal.pone.0106690	http://dx.doi.org/10.1371/journal.pone.0106690			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3TB	25184428	Green Submitted, Green Accepted, Green Published, gold			2022-12-27	WOS:000341257700105
J	Gu, DM; Wang, SH; Kuiatse, I; Wang, H; He, J; Dai, Y; Jones, RJ; Bjorklund, CC; Yang, J; Grant, S; Orlowski, RZ				Gu, Dongmin; Wang, Shuhong; Kuiatse, Isere; Wang, Hua; He, Jin; Dai, Yun; Jones, Richard J.; Bjorklund, Chad C.; Yang, Jing; Grant, Steven; Orlowski, Robert Z.			Inhibition of the MDM2 E3 Ligase Induces Apoptosis and Autophagy in Wild-Type and Mutant p53 Models of Multiple Myeloma, and Acts Synergistically with ABT-737	PLOS ONE			English	Article							PROTEASOME INHIBITORS; INTERGROUPE FRANCOPHONE; DRUG-RESISTANCE; GENE DELETION; CELL-DEATH; ACTIVATION; SURVIVAL; CANCER; ABNORMALITIES; PATHWAY	Intracellular proteolytic pathways have been validated as rational targets in multiple myeloma with the approval of two proteasome inhibitors in this disease, and with the finding that immunomodulatory agents work through an E3 ubiquitin ligase containing Cereblon. Another E3 ligase that could be a rational target is the murine double minute (MDM) 2 protein, which plays a role in p53 turnover. A novel inhibitor of this complex, MI-63, was found to induce apoptosis in p53 wild-type myeloma models in association with activation of a p53-mediated cell death program. MI-63 overcame adhesion-mediated drug resistance, showed anti-tumor activity in vivo, enhanced the activity of bortezomib and lenalidomide, and also overcame lenalidomide resistance. In mutant p53 models, inhibition of MDM2 with MI-63 also activated apoptosis, albeit at higher concentrations, and this was associated with activation of autophagy. When MI-63 was combined with the BH3 mimetic ABT-737, enhanced activity was seen in both wild-type and mutant p53 models. Finally, this regimen showed efficacy against primary plasma cells from patients with newly diagnosed and relapsed/refractory myeloma. These findings support the translation of novel MDM2 inhibitors both alone, and in combination with other novel agents, to the clinic for patients with multiple myeloma.	[Gu, Dongmin; Kuiatse, Isere; Wang, Hua; He, Jin; Jones, Richard J.; Bjorklund, Chad C.; Yang, Jing; Orlowski, Robert Z.] Univ Texas MD Anderson Canc Ctr, Dept Lymphoma Myeloma, Houston, TX 77030 USA; [Wang, Shuhong] Chinese Peoples Liberat Army Gen Hosp, Dept Hematol, Beijing, Peoples R China; [Dai, Yun; Grant, Steven] Virginia Commonwealth Univ, Dept Med, Richmond, VA 23298 USA; [Orlowski, Robert Z.] Univ Texas MD Anderson Canc Ctr, Dept Expt Therapeut, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center; Chinese People's Liberation Army General Hospital; Virginia Commonwealth University; University of Texas System; UTMD Anderson Cancer Center	Orlowski, RZ (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Lymphoma Myeloma, Houston, TX 77030 USA.	rorlowsk@mdanderson.org	Bjorklund, Chad/G-3645-2013; Dai, Yun/AAG-4040-2019	Dai, Yun/0000-0003-2285-0818; Orlowski, Robert/0000-0002-5723-4129	MD Anderson Cancer Center SPORE in Multiple Myeloma [P50 CA142509]; Florence Maude Thomas Cancer Research Professorship; Brock Family Myeloma Research Fund; Cancer Center Support Grant [CA16672]; NATIONAL CANCER INSTITUTE [P30CA016672, P50CA142509] Funding Source: NIH RePORTER	MD Anderson Cancer Center SPORE in Multiple Myeloma; Florence Maude Thomas Cancer Research Professorship; Brock Family Myeloma Research Fund; Cancer Center Support Grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was supported by The MD Anderson Cancer Center SPORE in Multiple Myeloma (P50 CA142509). R.Z.O. is supported by the Florence Maude Thomas Cancer Research Professorship, and the Brock Family Myeloma Research Fund. The MD Anderson Flow Cytometry and Cellular Imaging Core Facility, the RPPA Core Facility, and the Characterized Cell Line Core Facility are supported by the Cancer Center Support Grant (CA16672). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson KC, 2012, J CLIN ONCOL, V30, P445, DOI 10.1200/JCO.2011.37.8919; Avet-Loiseau H, 2007, BLOOD, V109, P3489, DOI 10.1182/blood-2006-08-040410; Barlogie B, 2010, J CLIN ONCOL, V28, P1209, DOI 10.1200/JCO.2009.25.6081; Bjorklund CC, 2013, LEUKEMIA; Bjorklund CC, 2011, J BIOL CHEM, V286, P11009, DOI 10.1074/jbc.M110.180208; Brenner H, 2009, HAEMATOL-HEMATOL J, V94, P270, DOI 10.3324/haematol.13782; Chang H, 2011, LEUKEMIA RES, V35, P95, DOI 10.1016/j.leukres.2010.05.002; Choi AMK, 2013, NEW ENGL J MED, V368, P651, DOI [10.1056/NEJMra1205406, 10.1056/NEJMc1303158]; Coutts AS, 2007, EMBO REP, V8, P84, DOI 10.1038/sj.embor.7400855; Crighton D, 2007, AUTOPHAGY, V3, P72, DOI 10.4161/auto.3438; Crighton D, 2006, CELL, V126, P121, DOI 10.1016/j.cell.2006.05.034; Davids MS, 2012, J CLIN ONCOL, V30, P3127, DOI 10.1200/JCO.2011.37.0981; Ding K, 2006, J MED CHEM, V49, P3432, DOI 10.1021/jm051122a; Ding WX, 2007, MOL CANCER THER, V6, P1062, DOI 10.1158/1535-7163.MCT-06-0541; Drach J, 1998, BLOOD, V92, P802, DOI 10.1182/blood.V92.3.802.415a17_802_809; Elnenaei MO, 2003, HAEMATOLOGICA, V88, P529; Escoubet-Lozach L, 2009, CANCER RES, V69, P7347, DOI 10.1158/0008-5472.CAN-08-4898; Fahraeus R, 2013, ONCOGENE; Gandhi AK, 2013, BR J HAEMATOL; Ha JH, 2011, J AM CHEM SOC, V133, P1244, DOI 10.1021/ja109521f; Hideshima T, 2001, CANCER RES, V61, P3071; Hideshima T, 2003, BLOOD, V101, P1530, DOI 10.1182/blood-2002-08-2543; Hodge DR, 2005, CANCER RES, V65, P4673, DOI 10.1158/0008-5472.CAN-04-3589; Jones RJ, 2013, J PHARMACOL EXP THER, V346, P381, DOI 10.1124/jpet.113.204958; Jones RJ, 2012, MOL CANCER THER, V11, P2243, DOI 10.1158/1535-7163.MCT-12-0135; Jones RJ, 2011, BLOOD, V118, P4140, DOI 10.1182/blood-2011-03-340323; Kuhn DJ, 2012, BLOOD, V120, P3260, DOI 10.1182/blood-2011-10-386789; Kumar SK, 2008, BLOOD, V111, P2516, DOI 10.1182/blood-2007-10-116129; Kumar SK, 2013, LEUKEMIA; LIN JY, 1994, GENE DEV, V8, P1235, DOI 10.1101/gad.8.10.1235; Lopez-Girona A, 2012, LEUKEMIA, V26, P2326, DOI 10.1038/leu.2012.119; Lu G, 2013, SCIENCE; Mahindra A, 2010, BLOOD REV, V24, pS5, DOI 10.1016/S0268-960X(10)70003-5; Moreau P, 2012, BLOOD, V120, P947, DOI 10.1182/blood-2012-04-403733; Ooi MG, 2009, CLIN CANCER RES, V15, P7153, DOI 10.1158/1078-0432.CCR-09-1071; Orlowski RZ, 2008, CLIN CANCER RES, V14, P1649, DOI 10.1158/1078-0432.CCR-07-2218; Ortega MM, 2003, ANN HEMATOL, V82, P405, DOI 10.1007/s00277-003-0632-2; Pei XY, 2003, LEUKEMIA, V17, P2036, DOI 10.1038/sj.leu.2403109; Perez-Galan P, 2006, BLOOD, V107, P257, DOI 10.1182/blood-2005-05-2091; Pichiorri F, 2010, CANCER CELL, V18, P367, DOI 10.1016/j.ccr.2010.09.005; PICKSLEY SM, 1994, ONCOGENE, V9, P2523; QUESNEL B, 1994, BRIT J HAEMATOL, V88, P415, DOI 10.1111/j.1365-2141.1994.tb05044.x; Rajkumar SV, 2011, NAT REV CLIN ONCOL, V8, P479, DOI 10.1038/nrclinonc.2011.63; Ray-Coquard I, 2012, LANCET ONCOL, V13, P1133, DOI 10.1016/S1470-2045(12)70474-6; Saha MN, 2010, CANCER BIOL THER, V9, P936, DOI 10.4161/cbt.9.11.11882; Shah JJ, 2009, LEUKEMIA, V23, P1964, DOI 10.1038/leu.2009.173; Shangary S, 2008, P NATL ACAD SCI USA, V105, P3933, DOI 10.1073/pnas.0708917105; Shin JS, 2012, BIOCHEM BIOPH RES CO, V420, P48, DOI 10.1016/j.bbrc.2012.02.113; Siegel R, 2013, CA-CANCER J CLIN, V63, P11, DOI 10.3322/caac.21166; Stuhmer T, 2005, BLOOD, V106, P3609, DOI 10.1182/blood-2005-04-1489; Surget S, 2012, CANCER RES, V72, P4562, DOI 10.1158/0008-5472.CAN-12-0487; Tanimura S, 1999, FEBS LETT, V447, P5, DOI 10.1016/S0014-5793(99)00254-9; Tasdemir E, 2008, NAT CELL BIOL, V10, P676, DOI 10.1038/ncb1730; Teoh G, 1997, BLOOD, V90, P1982, DOI 10.1182/blood.V90.5.1982; Thakurta A, 2013, LEUKEMIA; Usmani SZ, 2013, LEUKEMIA, V27, P226, DOI 10.1038/leu.2012.160; Vassilev LT, 2004, SCIENCE, V303, P844, DOI 10.1126/science.1092472; Walker BA, 2010, BLOOD, V116, pE56, DOI 10.1182/blood-2010-04-279596; White E, 2012, NAT REV CANCER, V12, P401, DOI 10.1038/nrc3262; Wu YT, 2010, J BIOL CHEM, V285, P10850, DOI 10.1074/jbc.M109.080796; Xiong W, 2008, BLOOD, V112, P4235, DOI 10.1182/blood-2007-10-119123; Yang L, 2011, ONCOGENE, V30, P1329, DOI 10.1038/onc.2010.515; Zak K, 2013, EXPERT OPIN THER PAT, V23, P425, DOI 10.1517/13543776.2013.765405; Zhu YX, 2011, BLOOD, V118, P4771, DOI 10.1182/blood-2011-05-356063	64	25	26	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2014	9	9							e103015	10.1371/journal.pone.0103015	http://dx.doi.org/10.1371/journal.pone.0103015			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3LR	25181509	Green Published, gold, Green Submitted			2022-12-27	WOS:000341231500006
J	Brudzynski, K; Sjaarda, C				Brudzynski, Katrina; Sjaarda, Calvin			Antibacterial Compounds of Canadian Honeys Target Bacterial Cell Wall Inducing Phenotype Changes, Growth Inhibition and Cell Lysis That Resemble Action of beta-Lactam Antibiotics	PLOS ONE			English	Article							PENICILLIN-BINDING-PROTEINS; ESCHERICHIA-COLI; HYDROGEN-PEROXIDE; MANUKA HONEY; DIVISION; SUSCEPTIBILITY; IDENTIFICATION; MECHANISM; STRAINS; SHAPE	Honeys show a desirable broad spectrum activity against Gram-positive and negative bacteria making antibacterial activity an intrinsic property of honey and a desirable source for new drug development. The cellular targets and underlying mechanism of action of honey antibacterial compounds remain largely unknown. To facilitate the target discovery, we employed a method of phenotypic profiling by directly comparing morphological changes in Escherichia coli induced by honeys to that of ampicillin, the cell wall-active beta-lactam of known mechanism of action. Firstly, we demonstrated the purity of tested honeys from potential beta-lactam contaminations using quantitative LC-ESI-MS. Exposure of log-phase E. coli to honey or ampicillin resulted in time-and concentration-dependent changes in bacterial cell shape with the appearance of filamentous phenotypes at sub-inhibitory concentrations and spheroplasts at the MBC. Cell wall destruction by both agents, clearly visible on microscopic micrographs, was accompanied by increased permeability of the lipopolysaccharide outer membrane as indicated by fluorescence-activated cell sorting (FACS). More than 90% E. coli exposed to honey or ampicillin became permeable to propidium iodide. Consistently with the FACS results, both honey-treated and ampicillin-treated E. coli cells released lipopolysaccharide endotoxins at comparable levels, which were significantly higher than controls (p<0.0001). E. coli cells transformed with the ampicillin-resistance gene (beta-lactamase) remained sensitive to honey, displayed the same level of cytotoxicity, cell shape changes and endotoxin release as ampicillin-sensitive cells. As expected, beta-lactamase protected the host cell from antibacterial action of ampicillin. Thus, both honey and ampicillin induced similar structural changes to the cell wall and LPS and that this ability underlies antibacterial activities of both agents. Since the cell wall is critical for cell growth and survival, honey active compounds would be highly applicable for therapeutic purposes while differences in the mode of action between honey and ampicillin may provide clinical advantage in eradicating beta-lactam- resistant pathogens.	[Brudzynski, Katrina; Sjaarda, Calvin] Bee Biomed Inc, Drug Discovery & Dev Dept, St Catharines, ON, Canada		Brudzynski, K (corresponding author), Bee Biomed Inc, Drug Discovery & Dev Dept, St Catharines, ON, Canada.	beebio@sympatico.ca			Bee-Biomedicals Inc.	Bee-Biomedicals Inc.	Bee-Biomedicals Inc. provided support in the form of salaries for authors KB and CS but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams CJ, 2008, CARBOHYD RES, V343, P651, DOI 10.1016/j.carres.2007.12.011; Balaban NQ, 2004, SCIENCE, V305, P1622, DOI 10.1126/science.1099390; Bayles KW, 2000, TRENDS MICROBIOL, V8, P274, DOI 10.1016/S0966-842X(00)01762-5; Brudzynski K, 2006, CAN J MICROBIOL, V52, P1228, DOI 10.1139/W06-086; Brudzynski K, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00036; Chung HS, 2009, P NATL ACAD SCI USA, V106, P21872, DOI 10.1073/pnas.0911674106; Cooper RA, 2000, LETT APPL MICROBIOL, V31, P20, DOI 10.1046/j.1472-765x.2000.00756.x; Cooper RA, 2002, J APPL MICROBIOL, V93, P857, DOI 10.1046/j.1365-2672.2002.01761.x; Cooper RA, 2002, J BURN CARE REHABIL, V23, P366, DOI 10.1097/00004630-200211000-00002; EVANS ME, 1993, J INFECT DIS, V167, P1336, DOI 10.1093/infdis/167.6.1336; GANT VA, 1993, J MED MICROBIOL, V39, P147, DOI 10.1099/00222615-39-2-147; Henriques AF, 2011, EUR J CLIN MICROBIOL, V30, P167, DOI 10.1007/s10096-010-1065-1; Jenkins R, 2011, J ANTIMICROB CHEMOTH, V66, P2536, DOI 10.1093/jac/dkr340; Kaldalu M, 2004, ANTIMICROB AGENTS CH, V48, P890, DOI 10.1128/AAC.48.3.890-896.2004; Khan MMT, 2010, APPL ENVIRON MICROB, V76, P5088, DOI 10.1128/AEM.02932-09; KITANO K, 1979, ANTIMICROB AGENTS CH, V16, P838, DOI 10.1128/AAC.16.6.838; LEDERBERG J, 1956, P NATL ACAD SCI USA, V42, P574, DOI 10.1073/pnas.42.9.574; Lusby P E, 2002, J Wound Ostomy Continence Nurs, V29, P295, DOI 10.1067/mjw.2002.129073; Lusby PE, 2005, ARCH MED RES, V36, P464, DOI 10.1016/j.arcmed.2005.03.038; Maddocks SE, 2012, MICROBIOL-SGM, V158, P781, DOI 10.1099/mic.0.053959-0; MARTINEZ OV, 1982, CYTOMETRY, V3, P129, DOI 10.1002/cyto.990030211; Mavric E, 2008, MOL NUTR FOOD RES, V52, P483, DOI 10.1002/mnfr.200700282; Oliver JD, 2010, FEMS MICROBIOL REV, V34, P415, DOI 10.1111/j.1574-6976.2009.00200.x; Osborn MJ, 2007, CURR OPIN MICROBIOL, V10, P606, DOI 10.1016/j.mib.2007.09.004; Peach KC, 2013, MOL BIOSYST, V9, P1837, DOI 10.1039/c3mb70027e; PRINS JM, 1994, ANTIMICROB AGENTS CH, V38, P1211, DOI 10.1128/AAC.38.6.1211; Roberts AEL, 2012, MICROBIOL-SGM, V158, P3005, DOI 10.1099/mic.0.062794-0; Roostalu J, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-68; Roth BL, 1997, APPL ENVIRON MICROB, V63, P2421, DOI 10.1128/AEM.63.6.2421-2431.1997; Silhavy TJ, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000414; SPRATT BG, 1983, J GEN MICROBIOL, V129, P1247; SPRATT BG, 1975, P NATL ACAD SCI USA, V72, P2999, DOI 10.1073/pnas.72.8.2999; Taormina PJ, 2001, INT J FOOD MICROBIOL, V69, P217, DOI 10.1016/S0168-1605(01)00505-0; TUOMANEN E, 1986, J GEN MICROBIOL, V132, P1297; TUOMANEN E, 1986, REV INFECT DIS, V8, pS279; Typas A, 2012, NAT REV MICROBIOL, V10, P123, DOI 10.1038/nrmicro2677; WAXMAN DJ, 1983, ANNU REV BIOCHEM, V52, P825, DOI 10.1146/annurev.bi.52.070183.004141; WHITE JW, 1963, BIOCHIM BIOPHYS ACTA, V73, P57; Wilkinson JM, 2005, J MED FOOD, V8, P100, DOI 10.1089/jmf.2005.8.100; Yao ZZ, 2012, MOL CELL, V48, P705, DOI 10.1016/j.molcel.2012.09.016; Young KD, 2008, J BACTERIOL, V190, P1497, DOI 10.1128/JB.01975-07; Young KD, 2007, J BACTERIOL, V189, P6509, DOI 10.1128/JB.01035-07; Young KD, 2006, MICROBIOL MOL BIOL R, V70, P660, DOI 10.1128/MMBR.00001-06	43	34	35	1	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2014	9	9							e106967	10.1371/journal.pone.0106967	http://dx.doi.org/10.1371/journal.pone.0106967			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ1IR	25191847	Green Submitted, Green Published, gold			2022-12-27	WOS:000347993600085
J	Liu, YF; Wang, J; Zhang, LQ; Wang, CX; Wu, JW; Zhou, Y; Gao, X; Wang, AX; Wu, SL; Zhao, XQ				Liu, Yanfang; Wang, Jing; Zhang, Liqun; Wang, Chunxue; Wu, Jianwei; Zhou, Yong; Gao, Xiang; Wang, Anxin; Wu, Shouling; Zhao, Xingquan			Relationship between C-Reactive Protein and Stroke: A Large Prospective Community Based Study	PLOS ONE			English	Article							INTIMA-MEDIA THICKNESS; ISCHEMIC-STROKE; SUBARACHNOID HEMORRHAGE; CARDIOVASCULAR-DISEASE; GLOBAL BURDEN; RISK; CORONARY; ATHEROSCLEROSIS; INFLAMMATION; POPULATION	Objective: Previous studies have suggested that C-reactive protein (CRP) was associated with risk of stroke. There were few studies in Asian population, or on stroke subtypes other than ischemic stroke. We thus investigated the relationship between CRP and the risks of all stroke and its subtypes in a Chinese adult population. Methods: In the current study, we included 90,517 Chinese adults free of stroke and myocardial infarction at baseline (June 2006 to October 2007) in analyses. Strokes were classified as ischemic stroke (IS), intracranial heamorrhage (ICH) and subarachnoid heamorrhage (SAH). High-sensitivity CRP (hs-CRP) were categorized into three groups: <1 mg/L, 1 to 3 mg/L, and >3 mg/L. Cox proportional hazards regression was used to calculate the association between hs-CRP concentrations and all stroke, as well as its subtypes. Results: During a median follow-up time of 49 months, we documented 1,472 incident stroke cases. Of which 1,049 (71.3%) were IS, 383 (26.0%) were ICH, and 40 (2.7%) were SAH. After multivariate adjustment, hs-CRP concentrations >= 1 mg/L were associated with increased risks of all stroke (hs-CRP 1-3 mg/L: hazard ratio (HR) 1.17, 95% confidential interval (CI) 1.03-1.33; hs-CRP>3 mg/L: HR 1.25, 95% CI 1.07-1.46) and IS (hs-CRP 1-3 mg/L: HR 1.17, 95% CI 1.01-1.36; hs-CRP>3 mg/L: HR 1.33, 95% CI 1.11-1.60), but not with ICH and SAH. Subgroup analyses showed that higher hs-CRP concentration was more prone to be a risk factor for all stroke and IS in non-fatal stroke, male and hypertensive participants. Conclusion: We found that higher hs-CRP concentrations were associated with a higher risk of IS, particularly for non-fatal stroke, male and hypertensive subjects. In contrast, we did not observe significant associations between hs-CRP and ICH/SAH.	[Liu, Yanfang; Wang, Jing; Wang, Chunxue; Wu, Jianwei; Zhou, Yong; Wang, Anxin; Zhao, Xingquan] Capital Med Univ, Beijing Tiantan Hosp, Dept Neurol, Beijing, Peoples R China; [Zhang, Liqun] St George Hosp, Dept Neurol, London, England; [Gao, Xiang] Brigham & Womens Hosp, Dept Med, Channing Lab, Boston, MA USA; [Gao, Xiang] Harvard Univ, Sch Med, Boston, MA USA; [Gao, Xiang] Harvard Univ, Sch Publ Hlth, Dept Nutr, Boston, MA 02115 USA; [Wu, Shouling] Hebei United Univ, Kailuan Hosp, Dept Cardiol, Tangshan, Peoples R China	Capital Medical University; St Georges University London; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard T.H. Chan School of Public Health; North China University of Science & Technology	Wu, SL (corresponding author), Hebei United Univ, Kailuan Hosp, Dept Cardiol, Tangshan, Peoples R China.	drwusl@163.com; zxq@vip.163.com	liu, yan/HCI-5542-2022; liu, yan/HGV-1365-2022; Wu, Jian/AAU-5221-2020; Wu, Jian/AAU-5221-2020	Wu, Jian/0000-0001-9933-7364; Wu, Jian/0000-0002-3394-1507; , Xiang/0000-0003-2617-6509; zhang, liqun/0000-0001-6983-7915	Ministry of Science and Technology; Ministry of Health of the People's Republic of China [2008BAI52B03]; National Natural Science Foundation of China [81202279]; Beijing Municipal ST Commission [D101107049310005, Z121100005512016]; National Science and Technology Major Project of China [2011BAI08B02]; Capital Health research and Development of Special [Capital 2011-2004-03]; Beijing Municipal Science & Technology Commission [D111107003111007]	Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea); Ministry of Health of the People's Republic of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Beijing Municipal ST Commission; National Science and Technology Major Project of China; Capital Health research and Development of Special; Beijing Municipal Science & Technology Commission(Beijing Municipal Science & Technology Commission)	This work is supported by grants from the Ministry of Science and Technology and the Ministry of Health of the People's Republic of China (No. 2008BAI52B03), the National Natural Science Foundation of China (No. 81202279), Beijing Municipal S&T Commission (D101107049310005, Z121100005512016), National Science and Technology Major Project of China (2011BAI08B02), the Capital Health research and Development of Special (No. Capital 2011-2004-03) and Beijing Municipal Science & Technology Commission (No. D111107003111007). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS HP, 1993, STROKE, V24, P35, DOI 10.1161/01.STR.24.1.35; [Anonymous], 1989, Stroke, V20, P1407; Badjatia N, 2011, STROKE, V42, P2436, DOI 10.1161/STROKEAHA.111.614685; Ballantyne CM, 2005, ARCH INTERN MED, V165, P2479, DOI 10.1001/archinte.165.21.2479; Bos MJ, 2006, CIRCULATION, V114, P1591, DOI 10.1161/CIRCULATIONAHA.106.619833; Cao JJ, 2003, CIRCULATION, V108, P166, DOI 10.1161/01.CIR.0000079160.07364.6A; CAPLAN LR, 1992, LANCET, V339, P656, DOI 10.1016/0140-6736(92)90804-C; CERMAK J, 1993, BLOOD, V82, P513, DOI 10.1182/blood.V82.2.513.513; Chambers JC, 2001, CIRCULATION, V104, P145, DOI 10.1161/01.CIR.104.2.145; Chei CL, 2011, ATHEROSCLEROSIS, V217, P187, DOI 10.1016/j.atherosclerosis.2011.03.001; Curb JD, 2003, CIRCULATION, V107, P2016, DOI 10.1161/01.CIR.0000065228.20100.F7; Di Napoli M, 2001, STROKE, V32, P917, DOI 10.1161/01.STR.32.4.917; Gabay C, 1999, NEW ENGL J MED, V340, P448, DOI 10.1056/NEJM199902113400607; GILBERT JJ, 1983, STROKE, V14, P915, DOI 10.1161/01.STR.14.6.915; Gussekloo J, 2000, ARTERIOSCL THROM VAS, V20, P1047, DOI 10.1161/01.ATV.20.4.1047; Khera A, 2006, CIRCULATION, V113, P38, DOI 10.1161/CIRCULATIONAHA.105.575241; Libby P, 2002, NATURE, V420, P868, DOI 10.1161/ATVBAHA.108.179705; Linn FHH, 1996, STROKE, V27, P625, DOI 10.1161/01.STR.27.4.625; Lombardo A, 2004, CIRCULATION, V109, P3158, DOI 10.1161/01.CIR.0000130786.28008.56; Miwa K, 2011, STROKE, V42, P3202, DOI 10.1161/STROKEAHA.111.621193; Murray CJL, 2012, LANCET, V380, P2197, DOI 10.1016/S0140-6736(12)61689-4; Paramsothy P, 2010, J AM COLL CARDIOL, V56, P1034, DOI 10.1016/j.jacc.2010.01.073; Pearson TA, 2003, CIRCULATION, V107, P499, DOI 10.1161/01.CIR.0000052939.59093.45; Ridker PM, 2009, LANCET, V373, P1175, DOI 10.1016/S0140-6736(09)60447-5; Rost NS, 2001, STROKE, V32, P2575, DOI 10.1161/hs1101.098151; Teunissen LL, 1996, STROKE, V27, P544, DOI 10.1161/01.STR.27.3.544; Tzoulaki I, 2005, CIRCULATION, V112, P976, DOI 10.1161/CIRCULATIONAHA.104.513085; van Dijk EJ, 2005, CIRCULATION, V112, P900, DOI 10.1161/CIRCULATIONAHA.104.506337; van Gijn J, 2001, BRAIN, V124, P249, DOI 10.1093/brain/124.2.249; Viswanathan A, 2006, STROKE, V37, P550, DOI 10.1161/01.STR.0000199847.96188.12; Wakugawa Y, 2006, STROKE, V37, P27, DOI 10.1161/01.STR.0000194958.88216.87; Welsh P, 2008, STROKE, V39, P2226, DOI 10.1161/STROKEAHA.107.504498; Wilson PWF, 2005, ARCH INTERN MED, V165, P2473, DOI 10.1001/archinte.165.21.2473; Wu SL, 2012, INT J CARDIOL, V157, P75, DOI 10.1016/j.ijcard.2010.12.019; Yang GH, 2013, LANCET, V381, P1987, DOI 10.1016/S0140-6736(13)61097-1; Zhang LF, 2003, STROKE, V34, P2091, DOI 10.1161/01.STR.0000087149.42294.8C; Zhang YX, 1999, ATHEROSCLEROSIS, V145, P375, DOI 10.1016/S0021-9150(99)00105-7	37	38	43	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2014	9	9							e107017	10.1371/journal.pone.0107017	http://dx.doi.org/10.1371/journal.pone.0107017			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ1IR	25191699	Green Published, gold, Green Submitted			2022-12-27	WOS:000347993600090
J	Zakharova, EE; Zaletova, VV; Krivokharchenko, AS				Zakharova, Elena E.; Zaletova, Victoria V.; Krivokharchenko, Alexander S.			Biopsy of Human Morula-Stage Embryos: Outcome of 215 IVF/ICSI Cycles with PGS	PLOS ONE			English	Article							PREIMPLANTATION GENETIC DIAGNOSIS; POLYMERASE-CHAIN-REACTION; BLASTOCYST BIOPSY; CHROMOSOMAL-ABNORMALITIES; BETA-THALASSEMIA; MOUSE EMBRYOS; PREGNANCY; AMPLIFICATION; HYBRIDIZATION; IMPLANTATION	Preimplantation genetic diagnosis (PGD) is commonly performed on biopsies from 6-8-cell-stage embryos or blastocyst trophectoderm obtained on day 3 or 5, respectively. Day 4 human embryos at the morula stage were successfully biopsied. Biopsy was performed on 709 morulae from 215 ICSI cycles with preimplantation genetic screening (PGS), and 3-7 cells were obtained from each embryo. The most common vital aneuploidies (chromosomes X/Y, 21) were screened by fluorescence in situ hybridization (FISH). No aneuploidy was observed in 72.7% of embryos, 91% of those developed to blastocysts. Embryos were transferred on days 5-6. Clinical pregnancy was obtained in 32.8% of cases, and 60 babies were born. Patients who underwent ICSI/PGS treatment were compared with those who underwent standard ICSI treatment by examining the percentage of blastocysts, pregnancy rate, gestational length, birth height and weight. No significant differences in these parameters were observed between the groups. Day 4 biopsy procedure does not adversely affect embryo development in vitro or in vivo. The increased number of cells obtained by biopsy of morulae might facilitate diagnostic screening. There is enough time after biopsy to obtain PGD results for embryo transfer on day 5-6 in the current IVF cycle.	[Zakharova, Elena E.; Zaletova, Victoria V.; Krivokharchenko, Alexander S.] Ctr Reprod Med MAMA, Moscow, Russia		Zakharova, EE (corresponding author), Ctr Reprod Med MAMA, Moscow, Russia.	eezakharova@gmail.com		ZAKHAROVA, ELENA/0000-0002-8003-8636	Center for Reproductive Medicine MAMA, Moscow	Center for Reproductive Medicine MAMA, Moscow	This study was supported by funding from the Center for Reproductive Medicine MAMA, Moscow. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abolfazl Shirazi, 2010, J Reprod Infertil, V11, P25; Alikani M, 2005, HUM REPROD, V20, P3369, DOI 10.1093/humrep/dei242; Ambartsumyan G, 2008, HUM MOL GENET, V17, pR10, DOI 10.1093/hmg/ddn170; Bell CE, 2008, MOL HUM REPROD, V14, P691, DOI 10.1093/molehr/gan063; Brodie D, 2012, J ASSIST REPROD GEN, V29, P821, DOI 10.1007/s10815-012-9782-2; Chavez SL, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2249; Chen YL, 2011, TAIWAN J OBSTET GYNE, V50, P74, DOI 10.1016/j.tjog.2011.01.040; Colls P, 2012, REPROD BIOMED ONLINE, V24, P621, DOI 10.1016/j.rbmo.2012.02.006; De Vos A, 2009, HUM REPROD, V24, P2988, DOI 10.1093/humrep/dep251; Fasouliotis SJ, 1998, HUM REPROD, V13, P2238, DOI 10.1093/humrep/13.8.2238; Findlay I, 2000, BRIT MED BULL, V56, P672, DOI 10.1258/0007142001903463; Fragouli E, 2011, CYTOGENET GENOME RES, V133, P149, DOI 10.1159/000323500; Gardner RJM, 2011, OXFORD MONOGRAPHS ME, V61; Gleicher N, 2012, J ASSIST REPROD GEN, V29, P1159, DOI 10.1007/s10815-012-9871-2; Goossens V, 2008, HUM REPROD, V23, P481, DOI 10.1093/humrep/dem327; Hamatani Toshio, 2006, Hum Cell, V19, P98; HARDY K, 1990, HUM REPROD, V5, P708, DOI 10.1093/oxfordjournals.humrep.a137173; Harper JC, 2012, HUM GENET, V131, P175, DOI 10.1007/s00439-011-1056-z; Hung CC, 2010, ANAL BIOCHEM, V400, P69, DOI 10.1016/j.ab.2009.12.023; Kobielak A, 2004, NAT REV MOL CELL BIO, V5, P614, DOI 10.1038/nrm1433; Kokkali G, 2007, HUM REPROD, V22, P1443, DOI 10.1093/humrep/del506; KRZYMINSKA UB, 1990, HUM REPROD, V5, P203, DOI 10.1093/oxfordjournals.humrep.a137070; Liang L, 2014, PLOS ONE, V8; Liebaers I, 2010, HUM REPROD, V25, P275, DOI 10.1093/humrep/dep298; Liu Jiaen, 2012, Clin Exp Reprod Med, V39, P52, DOI 10.5653/cerm.2012.39.2.52; Mantzouratou A, 2011, CYTOGENET GENOME RES, V133, P141, DOI 10.1159/000323794; McArthur SJ, 2005, FERTIL STERIL, V84, P1628, DOI 10.1016/j.fertnstert.2005.05.063; Moutou C, 2014, HUM REPROD, V29, P880, DOI 10.1093/humrep/deu012; MUGGLETONHARRIS AL, 1993, HUM REPROD, V8, P2197, DOI 10.1093/oxfordjournals.humrep.a138003; NAGASHIMA H, 1989, GAMETE RES, V23, P1, DOI 10.1002/mrd.1120230102; NAGASHIMA H, 1984, J REPROD FERTIL, V70, P357, DOI 10.1530/jrf.0.0700357; Parks JC, 2011, FERTIL STERIL, V95, P1367, DOI 10.1016/j.fertnstert.2010.08.009; Pey R, 1998, P NATL ACAD SCI USA, V95, P12977, DOI 10.1073/pnas.95.22.12977; REICHELT B, 1994, J REPROD FERTIL, V100, P163, DOI 10.1530/jrf.0.1000163; Rubio C, 2007, PRENATAL DIAG, V27, P748, DOI 10.1002/pd.1773; Scott RT, 2013, FERTIL STERIL, V100, P624, DOI 10.1016/j.fertnstert.2013.04.039; SEIKE N, 1989, JPN J VET SCI, V51, P1193; Simpson JL, 2010, PRENATAL DIAG, V30, P682, DOI 10.1002/pd.2552; Swanson Amy, 2007, WMJ, V106, P145; TSUNODA Y, 1985, THERIOGENOLOGY, V24, P337, DOI 10.1016/0093-691X(85)90225-0; VERLINSKY Y, 1991, PREIMPLANTATION GENETICS, P273; Xanthopoulou L, 2012, CYTOGENET GENOME RES, V136, P21, DOI 10.1159/000334836; Xu KP, 2012, SEMIN REPROD MED, V30, P259, DOI 10.1055/s-0032-1313905; Yang ZH, 2012, MOL CYTOGENET, V5, DOI 10.1186/1755-8166-5-24	44	23	25	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2014	9	9							e106433	10.1371/journal.pone.0106433	http://dx.doi.org/10.1371/journal.pone.0106433			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ1IR	25191937	Green Submitted, Green Published, gold			2022-12-27	WOS:000347993600026
J	An, X; Gong, HL; Yin, JP; Wang, XC; Pan, YX; Zhang, X; Lu, YL; Yang, YP; Toth, Z; Schiessl, I; McLoughlin, N; Wang, W				An, Xu; Gong, Hongliang; Yin, Jiapeng; Wang, Xiaochun; Pan, Yanxia; Zhang, Xian; Lu, Yiliang; Yang, Yupeng; Toth, Zoltan; Schiessl, Ingo; McLoughlin, Niall; Wang, Wei			Orientation-Cue Invariant Population Responses to Contrast-Modulated and Phase-Reversed Contour Stimuli in Macaque V1 and V2	PLOS ONE			English	Article							PRIMARY VISUAL-CORTEX; NON-FOURIER MOTION; RECEPTIVE-FIELDS; 2ND-ORDER MOTION; FUNCTIONAL ARCHITECTURE; ILLUSORY CONTOURS; SIMPLE CELLS; AREA V2; FREQUENCY-SELECTIVITY; INTRINSIC CONNECTIONS	Visual scenes can be readily decomposed into a variety of oriented components, the processing of which is vital for object segregation and recognition. In primate V1 and V2, most neurons have small spatio-temporal receptive fields responding selectively to oriented luminance contours (first order), while only a subgroup of neurons signal non-luminance defined contours (second order). So how is the orientation of second-order contours represented at the population level in macaque V1 and V2? Here we compared the population responses in macaque V1 and V2 to two types of second-order contour stimuli generated either by modulation of contrast or phase reversal with those to first-order contour stimuli. Using intrinsic signal optical imaging, we found that the orientation of second-order contour stimuli was represented invariantly in the orientation columns of both macaque V1 and V2. A physiologically constrained spatio-temporal energy model of V1 and V2 neuronal populations could reproduce all the recorded population responses. These findings suggest that, at the population level, the primate early visual system processes the orientation of second-order contours initially through a linear spatio-temporal filter mechanism. Our results of population responses to different second-order contour stimuli support the idea that the orientation maps in primate V1 and V2 can be described as a spatial-temporal energy map.	[An, Xu; Gong, Hongliang; Yin, Jiapeng; Wang, Xiaochun; Pan, Yanxia; Zhang, Xian; Lu, Yiliang; Wang, Wei] Chinese Acad Sci, Inst Neurosci, State Key Lab Neurosci, Shanghai, Peoples R China; [An, Xu; Gong, Hongliang; Yin, Jiapeng; Wang, Xiaochun; Pan, Yanxia; Zhang, Xian; Lu, Yiliang; Wang, Wei] Chinese Acad Sci, Key Lab Primate Neurobiol, Shanghai Inst Biol Sci, Shanghai, Peoples R China; [An, Xu; Zhang, Xian; Yang, Yupeng] Univ Sci & Technol China, Sch Life Sci, Key Lab Brain Funct & Dis, Hefei 230026, Peoples R China; [Toth, Zoltan; Schiessl, Ingo; McLoughlin, Niall] Univ Manchester, Fac Life Sci, Manchester, Lancs, England	Chinese Academy of Sciences; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Chinese Academy of Sciences; University of Science & Technology of China, CAS; University of Manchester	Wang, W (corresponding author), Chinese Acad Sci, Inst Neurosci, State Key Lab Neurosci, Shanghai, Peoples R China.	w.wang@ion.ac.cn	An, Xu/HIK-2020-2022; Yang, Yupeng/G-5107-2018	An, Xu/0000-0003-3386-5521; Yang, Yupeng/0000-0002-9473-9994; McLoughlin, Niall/0000-0002-0138-4312; Schiessl, Ingo/0000-0001-9599-6194	National '973' Programs [2011CBA00400, 2009CB941303]	National '973' Programs(National Basic Research Program of China)	This work was supported by National '973' Programs 2011CBA00400 and 2009CB941303. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aaen-Stockdale C, 2006, VISION RES, V46, P925, DOI 10.1016/j.visres.2005.10.006; ADELSON EH, 1985, J OPT SOC AM A, V2, P284, DOI 10.1364/JOSAA.2.000284; ALBRIGHT TD, 1992, SCIENCE, V255, P1141, DOI 10.1126/science.1546317; Allard R, 2013, J VIS, V13; An X, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093115; An X, 2012, J NEUROSCI, V32, P13363, DOI 10.1523/JNEUROSCI.1900-12.2012; Angelucci A, 2002, J NEUROSCI, V22, P8633; Anzai A, 2007, NAT NEUROSCI, V10, P1313, DOI 10.1038/nn1975; Ayzenshtat I, 2012, J NEUROSCI, V32, P13971, DOI 10.1523/JNEUROSCI.1596-12.2012; Baker CL, 1999, CURR OPIN NEUROBIOL, V9, P461, DOI 10.1016/S0959-4388(99)80069-5; Baker CL, 2001, PROG BRAIN RES, V134, P171; Baker TI, 2005, J NEUROPHYSIOL, V94, P775, DOI 10.1152/jn.01093.2004; Basole A, 2003, NATURE, V423, P986, DOI 10.1038/nature01721; Basole A, 2006, PROG BRAIN RES, V154, P121, DOI 10.1016/S0079-6123(06)54006-3; Benton CP, 2001, J OPT SOC AM A, V18, P2204, DOI 10.1364/JOSAA.18.002204; Benton CP, 1997, VISION RES, V37, P3073, DOI 10.1016/S0042-6989(97)00174-0; Bertone A, 2003, VISION RES, V43, P2591, DOI 10.1016/S0042-6989(03)00465-6; Blasdel G, 2001, J NEUROSCI, V21, P8286, DOI 10.1523/JNEUROSCI.21-20-08286.2001; BONHOEFFER T, 1993, J NEUROSCI, V13, P4157; Bonhoeffer Tobias, 1996, P55; Bosking WH, 1997, J NEUROSCI, V17, P2112; Boynton GM, 1999, VISION RES, V39, P257, DOI 10.1016/S0042-6989(98)00113-8; Bullier J, 2001, BRAIN RES REV, V36, P96, DOI 10.1016/S0165-0173(01)00085-6; Carandini M, 2005, J NEUROSCI, V25, P10577, DOI 10.1523/JNEUROSCI.3726-05.2005; Carandini M, 2012, NAT REV NEUROSCI, V13, P51, DOI 10.1038/nrn3136; CAVANAGH P, 1989, Spatial Vision, V4, P103, DOI 10.1163/156856889X00077; Chaudhuri A, 1997, VISUAL NEUROSCI, V14, P949, DOI 10.1017/S0952523800011664; CHUBB C, 1988, J OPT SOC AM A, V5, P1986, DOI 10.1364/JOSAA.5.001986; COLE LC, 1949, ECOLOGY, V30, P411, DOI 10.2307/1932444; Cox MA, 2013, P NATL ACAD SCI USA, V110, P17095, DOI 10.1073/pnas.1310806110; Crair MC, 1997, J NEUROPHYSIOL, V77, P3381, DOI 10.1152/jn.1997.77.6.3381; Dakin SC, 1999, VISION RES, V39, P2867, DOI 10.1016/S0042-6989(98)00307-1; Dakin SC, 2000, VISION RES, V40, P311, DOI 10.1016/S0042-6989(99)00179-0; Das A, 1999, NATURE, V399, P655, DOI 10.1038/21371; De Valois RL, 2000, VISION RES, V40, P3685, DOI 10.1016/S0042-6989(00)00210-8; DEANGELIS GC, 1993, J NEUROPHYSIOL, V69, P1118, DOI 10.1152/jn.1993.69.4.1118; Demb JB, 2001, NEURON, V32, P711, DOI 10.1016/S0896-6273(01)00484-6; DEVALOIS RL, 1982, VISION RES, V22, P531, DOI 10.1016/0042-6989(82)90112-2; DEVALOIS RL, 1982, VISION RES, V22, P545, DOI 10.1016/0042-6989(82)90113-4; DRESP B, 1995, VISION RES, V35, P1071, DOI 10.1016/0042-6989(94)00204-Y; El-Shamayleh Y, 2011, J NEUROSCI, V31, P8543, DOI 10.1523/JNEUROSCI.5974-10.2011; Ellemberg D, 2004, VISION RES, V44, P1787, DOI 10.1016/j.visres.2004.02.012; FIELD DJ, 1993, VISION RES, V33, P173, DOI 10.1016/0042-6989(93)90156-Q; FLEET DJ, 1994, VISION RES, V34, P3057, DOI 10.1016/0042-6989(94)90278-X; FOSTER KH, 1985, J PHYSIOL-LONDON, V365, P331, DOI 10.1113/jphysiol.1985.sp015776; Frazor RA, 2006, VISION RES, V46, P1585, DOI 10.1016/j.visres.2005.06.038; Geisler WS, 2007, J NEUROSCI, V27, P5063, DOI 10.1523/JNEUROSCI.0835-07.2007; Gharat A, 2012, J NEUROPHYSIOL, V108, P1228, DOI 10.1152/jn.00840.2011; GILBERT CD, 1989, J NEUROSCI, V9, P2432; Gilbert CD, 2013, NAT REV NEUROSCI, V14, P350, DOI 10.1038/nrn3476; Glasser DM, 2011, J VISION, V11, DOI 10.1167/11.13.22; GROSOF DH, 1993, NATURE, V365, P550, DOI 10.1038/365550a0; Hallum LE, 2011, J NEUROPHYSIOL, V105, P2121, DOI 10.1152/jn.01007.2010; Hedges JH, 2011, CURR BIOL, V21, P2023, DOI 10.1016/j.cub.2011.10.049; HUBEL DH, 1968, J PHYSIOL-LONDON, V195, P215, DOI 10.1113/jphysiol.1968.sp008455; HUBEL DH, 1962, J PHYSIOL-LONDON, V160, P106, DOI 10.1113/jphysiol.1962.sp006837; Hupe JM, 1998, NATURE, V394, P784, DOI 10.1038/29537; Ito M, 2004, J NEUROSCI, V24, P3313, DOI 10.1523/JNEUROSCI.4364-03.2004; Jones DG, 2003, VISION RES, V43, P1223, DOI 10.1016/S0042-6989(03)00095-6; KAPADIA MK, 1995, NEURON, V15, P843, DOI 10.1016/0896-6273(95)90175-2; Kastner S, 2000, J NEUROPHYSIOL, V83, P2453, DOI 10.1152/jn.2000.83.4.2453; KIORPES L, 1992, VISUAL NEUROSCI, V9, P243, DOI 10.1017/S0952523800010658; Koivisto M, 2011, J NEUROSCI, V31, P2488, DOI 10.1523/JNEUROSCI.3074-10.2011; Kourtzi Z, 2003, NEURON, V37, P333, DOI 10.1016/S0896-6273(02)01174-1; Kravitz DJ, 2013, TRENDS COGN SCI, V17, P26, DOI 10.1016/j.tics.2012.10.011; LAMME VAF, 1993, NATURE, V363, P541, DOI 10.1038/363541a0; Landy M., 2004, VISUAL NEUROSCIENCES, P1106; LANDY MS, 1991, VISION RES, V31, P679, DOI 10.1016/0042-6989(91)90009-T; Larsson J, 2006, J NEUROPHYSIOL, V95, P862, DOI 10.1152/jn.00668.2005; Ledgeway T, 2006, VISION RES, V46, P556, DOI 10.1016/j.visres.2005.07.008; Lee TS, 2002, NAT NEUROSCI, V5, P589, DOI 10.1038/nn860; Lee TS, 2001, P NATL ACAD SCI USA, V98, P1907, DOI 10.1073/pnas.031579998; Lee TS, 1998, VISION RES, V38, P2429, DOI 10.1016/S0042-6989(97)00464-1; Lennie P, 1998, PERCEPTION, V27, P889, DOI 10.1068/p270889; LEVITT JB, 1994, J NEUROPHYSIOL, V71, P2517, DOI 10.1152/jn.1994.71.6.2517; Li W, 2002, J NEUROPHYSIOL, V88, P2846, DOI 10.1152/jn.00289.2002; Lui LL, 2005, EXP BRAIN RES, V162, P100, DOI 10.1007/s00221-004-2113-9; MALACH R, 1993, P NATL ACAD SCI USA, V90, P10469, DOI 10.1073/pnas.90.22.10469; Maldonado PE, 1997, SCIENCE, V276, P1551, DOI 10.1126/science.276.5318.1551; Manahilov V, 2005, VISION RES, V45, P2759, DOI 10.1016/j.visres.2005.06.004; Mante V, 2005, NAT NEUROSCI, V8, P1690, DOI 10.1038/nn1556; Mante V, 2005, J NEUROPHYSIOL, V94, P788, DOI 10.1152/jn.01094.2004; Mante V, 2003, CURR BIOL, V13, pR906, DOI 10.1016/j.cub.2003.11.010; Marcar VL, 2000, J NEUROPHYSIOL, V84, P2786, DOI 10.1152/jn.2000.84.6.2786; Mareschal I, 1998, NAT NEUROSCI, V1, P150, DOI 10.1038/401; MATHER G, 1993, VISION RES, V33, P1109, DOI 10.1016/0042-6989(93)90243-P; Mc Loughlin NP, 1998, NEUROIMAGE, V7, P326, DOI 10.1006/nimg.1998.0329; Mendola JD, 1999, J NEUROSCI, V19, P8560; MOVSHON JA, 1978, J PHYSIOL-LONDON, V283, P53, DOI 10.1113/jphysiol.1978.sp012488; MOVSHON JA, 1978, J PHYSIOL-LONDON, V283, P101, DOI 10.1113/jphysiol.1978.sp012490; Mysore SG, 2008, CEREB CORTEX, V18, P1429, DOI 10.1093/cercor/bhm176; Mysore SG, 2006, J NEUROPHYSIOL, V95, P1864, DOI 10.1152/jn.00627.2005; Nassi JJ, 2009, NAT REV NEUROSCI, V10, P360, DOI 10.1038/nrn2619; Nauhaus I, 2008, NEURON, V57, P673, DOI 10.1016/j.neuron.2008.01.020; NELSON JI, 1985, EXP BRAIN RES, V61, P54; Nishida S, 2003, J NEUROPHYSIOL, V90, P3242, DOI 10.1152/jn.00693.2003; Nishida S, 1997, VISION RES, V37, P2685, DOI 10.1016/S0042-6989(97)00092-8; O'Keefe LP, 1998, VISUAL NEUROSCI, V15, P305, DOI 10.1017/S0952523898152094; Ohki K, 2006, NATURE, V442, P925, DOI 10.1038/nature05019; Orban GA, 2008, PHYSIOL REV, V88, P59, DOI 10.1152/physrev.00008.2007; Pan YX, 2012, J NEUROSCI, V32, P6760, DOI 10.1523/JNEUROSCI.6140-11.2012; Parkes L, 2001, NAT NEUROSCI, V4, P739, DOI 10.1038/89532; Pavan A, 2009, J VIS, V9, P2721; Polat U, 1998, NATURE, V391, P580, DOI 10.1038/35372; Ramalingam N, 2013, J NEUROSCI, V33, P1773, DOI 10.1523/JNEUROSCI.3825-12.2013; Ramsden BM, 2001, CEREB CORTEX, V11, P648, DOI 10.1093/cercor/11.7.648; Rasch MJ, 2012, J NEUROPHYSIOL; REID RC, 1991, J NEUROPHYSIOL, V66, P505, DOI 10.1152/jn.1991.66.2.505; ROCKLAND KS, 1982, SCIENCE, V215, P1532, DOI 10.1126/science.7063863; Rosenberg A, 2011, NEURON, V71, P348, DOI 10.1016/j.neuron.2011.05.044; Rosenberg A, 2010, J NEUROSCI, V30, P1985, DOI 10.1523/JNEUROSCI.3258-09.2010; Rousselet GA, 2004, TRENDS COGN SCI, V8, P363, DOI 10.1016/j.tics.2004.06.003; Rust NC, 2005, NAT NEUROSCI, V8, P1647, DOI 10.1038/nn1606; Rust NC, 2005, NEURON, V46, P945, DOI 10.1016/j.neuron.2005.05.021; Rust NC, 2006, NAT NEUROSCI, V9, P1421, DOI 10.1038/nn1786; SARY G, 1995, J NEUROPHYSIOL, V73, P1341, DOI 10.1152/jn.1995.73.4.1341; SARY G, 1993, SCIENCE, V260, P995, DOI 10.1126/science.8493538; Sary G, 2008, EUR J NEUROSCI, V28, P2137, DOI 10.1111/j.1460-9568.2008.06499.x; Schiessl I, 2008, NEUROIMAGE, V39, P634, DOI 10.1016/j.neuroimage.2007.09.022; Schwartz GW, 2012, NAT NEUROSCI, V15, P1572, DOI 10.1038/nn.3225; Seiffert AE, 2003, CEREB CORTEX, V13, P340, DOI 10.1093/cercor/13.4.340; SHAPLEY R, 1986, VISION RES, V26, P45, DOI 10.1016/0042-6989(86)90070-2; Shapley R, 1998, NAT NEUROSCI, V1, P95, DOI 10.1038/342; Sheth BR, 1996, SCIENCE, V274, P2110, DOI 10.1126/science.274.5295.2110; Sincich LC, 2005, ANNU REV NEUROSCI, V28, P303, DOI 10.1146/annurev.neuro.28.061604.135731; SKOTTUN BC, 1991, VISION RES, V31, P1079, DOI 10.1016/0042-6989(91)90033-2; Smith AT, 1997, VISION RES, V37, P45, DOI 10.1016/S0042-6989(96)00147-2; Smith AT, 1998, J NEUROSCI, V18, P3816; Stanley DA, 2003, NEURON, V37, P323, DOI 10.1016/S0896-6273(02)01148-0; Super H, 2001, NAT NEUROSCI, V4, P304, DOI 10.1038/85170; Tanaka H, 2009, J NEUROPHYSIOL, V101, P1444, DOI 10.1152/jn.90749.2008; Vaina LM, 1999, HUM BRAIN MAPP, V7, P67, DOI 10.1002/(SICI)1097-0193(1999)7:1<67::AID-HBM6>3.0.CO;2-K; VONDERHEYDT R, 1989, J NEUROSCI, V9, P1731; Wang HX, 2012, VISION RES, V62, P192, DOI 10.1016/j.visres.2012.03.008; Weliky M, 2003, NEURON, V37, P703, DOI 10.1016/S0896-6273(03)00022-9; Westheimer G, 1997, J NEUROPHYSIOL, V77, P2677, DOI 10.1152/jn.1997.77.5.2677; WILSON HR, 1992, VISUAL NEUROSCI, V9, P79, DOI 10.1017/S0952523800006386; Wokke ME, 2013, PSYCHOL SCI, V24, P63, DOI 10.1177/0956797612449175; Zhan CA, 2008, CEREB CORTEX, V18, P1029, DOI 10.1093/cercor/bhm139; Zhan CA, 2006, CEREB CORTEX, V16, P896, DOI 10.1093/cercor/bhj033	140	16	17	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 4	2014	9	9							e106753	10.1371/journal.pone.0106753	http://dx.doi.org/10.1371/journal.pone.0106753			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3XV	25188576	Green Published, gold, Green Submitted			2022-12-27	WOS:000341271500084
J	de Vasconcellos, JF; Fasano, RM; Lee, YT; Kaushal, M; Byrnes, C; Meier, ER; Anderson, M; Rabel, A; Braylan, R; Stroncek, DF; Miller, JL				de Vasconcellos, Jaira F.; Fasano, Ross M.; Lee, Y. Terry; Kaushal, Megha; Byrnes, Colleen; Meier, Emily R.; Anderson, Molly; Rabel, Antoinette; Braylan, Raul; Stroncek, David F.; Miller, Jeffery L.			LIN28A Expression Reduces Sickling of Cultured Human Erythrocytes	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; FETAL-HEMOGLOBIN; GAMMA-GLOBIN; BCL11A; POLYMERIZATION; IDENTIFICATION; REGULATOR; PATIENT; PROTEIN	Induction of fetal hemoglobin (HbF) has therapeutic importance for patients with sickle cell disease (SCD) and the beta-thalassemias. It was recently reported that increased expression of LIN28 proteins or decreased expression of its target let-7 miRNAs enhances HbF levels in cultured primary human erythroblasts from adult healthy donors. Here LIN28A effects were studied further using erythrocytes cultured from peripheral blood progenitor cells of pediatric subjects with SCD. Transgenic expression of LIN28A was accomplished by lentiviral transduction in CD34(+) sickle cells cultivated ex vivo in serum-free medium. LIN28A over-expression (LIN28A-OE) increased HbF, reduced beta (sickle)-globin, and strongly suppressed all members of the let-7 family of miRNAs. LIN28A-OE did not affect erythroblast differentiation or prevent enucleation, but it significantly reduced or ameliorated the sickling morphologies of the enucleated erythrocytes.	[de Vasconcellos, Jaira F.; Lee, Y. Terry; Kaushal, Megha; Byrnes, Colleen; Meier, Emily R.; Anderson, Molly; Rabel, Antoinette; Miller, Jeffery L.] NIDDK, Mol Genom & Therapeut Sect, Mol Med Branch, NIH, Bethesda, MD 20892 USA; [Fasano, Ross M.; Kaushal, Megha; Meier, Emily R.] Childrens Natl Med Ctr, Ctr Canc & Blood Disorders, Washington, DC 20010 USA; [Braylan, Raul] NIH, Dept Lab Med, Ctr Clin, Bethesda, MD 20892 USA; [Stroncek, David F.] NIH, Cell Proc Sect, Dept Transfus Med, Ctr Clin, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); Children's National Health System; National Institutes of Health (NIH) - USA; NIH Clinical Center (CC); National Institutes of Health (NIH) - USA; NIH Clinical Center (CC)	Miller, JL (corresponding author), NIDDK, Mol Genom & Therapeut Sect, Mol Med Branch, NIH, Bethesda, MD 20892 USA.	jm7f@nih.gov		Ferreira de Vasconcellos, Jaira/0000-0001-5011-4493	Intramural Research Programs of the National Institute of Diabetes and Digestive and Kidney Diseases; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL110841] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK025101] Funding Source: NIH RePORTER; CLINICAL CENTER [ZIACL002120, ZIACL060089, ZIACL002119] Funding Source: NIH RePORTER	Intramural Research Programs of the National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); CLINICAL CENTER	The Intramural Research Programs of the National Institute of Diabetes and Digestive and Kidney Diseases supported this work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barabino GA, 2010, ANNU REV BIOMED ENG, V12, P345, DOI 10.1146/annurev-bioeng-070909-105339; BRITTENHAM GM, 1985, BLOOD, V65, P183; CREPEAU RH, 1978, NATURE, V274, P616, DOI 10.1038/274616a0; Flanagan JM, 2012, BRIT J HAEMATOL, V157, P240, DOI 10.1111/j.1365-2141.2012.09061.x; Green NS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055709; He CY, 2009, NAT GENET, V41, P724, DOI 10.1038/ng.385; Holzwarth C, 2010, BMC CELL BIOL, V11, DOI 10.1186/1471-2121-11-11; HORIUCHI K, 1990, J LAB CLIN MED, V115, P613; Lee YT, 2013, BLOOD, V122, P1034, DOI 10.1182/blood-2012-12-472308; Lettre G, 2008, NAT GENET, V40, P584, DOI 10.1038/ng.125; LEY TJ, 1982, NEW ENGL J MED, V307, P1469, DOI 10.1056/NEJM198212093072401; Meier ER, 2011, PEDIATR BLOOD CANCER, V56, P103, DOI 10.1002/pbc.22643; Menzel S, 2007, NAT GENET, V39, P1197, DOI 10.1038/ng2108; Moss EG, 1997, CELL, V88, P637, DOI 10.1016/S0092-8674(00)81906-6; NOGUCHI CT, 1981, BLOOD, V58, P1057; NOGUCHI CT, 1988, NEW ENGL J MED, V318, P96, DOI 10.1056/NEJM198801143180207; Noh SJ, 2009, J TRANSL MED, V7, DOI 10.1186/1479-5876-7-98; Ong KK, 2009, NAT GENET, V41, P729, DOI 10.1038/ng.382; PLATT OS, 1984, J CLIN INVEST, V74, P652, DOI 10.1172/JCI111464; Polesskaya A, 2007, GENE DEV, V21, P1125, DOI 10.1101/gad.415007; Sankaran VG, 2013, CSH PERSPECT MED, V3, DOI 10.1101/cshperspect.a011643; Sankaran VG, 2008, SCIENCE, V322, P1839, DOI 10.1126/science.1165409; Schechter AN, 2008, BLOOD, V112, P3927, DOI 10.1182/blood-2008-04-078188; Sedgewick AE, 2008, BLOOD CELL MOL DIS, V41, P255, DOI 10.1016/j.bcmd.2008.06.007; Spencer JA, 2014, NATURE, V508, P269, DOI 10.1038/nature13034; Sripichai O, 2009, BLOOD, V114, P2299, DOI 10.1182/blood-2009-05-219386; Tanno T, 2009, BLOOD, V114, P181, DOI 10.1182/blood-2008-12-195503; Thein SL, 2007, P NATL ACAD SCI USA, V104, P11346, DOI 10.1073/pnas.0611393104; Uda M, 2008, P NATL ACAD SCI USA, V105, P1620, DOI 10.1073/pnas.0711566105; Viswanathan SR, 2010, CELL, V140, P445, DOI 10.1016/j.cell.2010.02.007; Weatherall DJ, 2013, ANNU REV GENOM HUM G, V14, P1, DOI 10.1146/annurev-genom-091212-153500; Xu J, 2011, SCIENCE, V334, P993, DOI 10.1126/science.1211053; Xu J, 2010, GENE DEV, V24, P783, DOI 10.1101/gad.1897310; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; Zhou DW, 2010, NAT GENET, V42, P742, DOI 10.1038/ng.637	35	14	14	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 4	2014	9	9							e106924	10.1371/journal.pone.0106924	http://dx.doi.org/10.1371/journal.pone.0106924			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3XV	25188417	Green Published, gold, Green Submitted			2022-12-27	WOS:000341271500097
J	Li, Z; Li, W; Li, N; Jiao, YM; Chen, DX; Cui, LX; Hu, Y; Wu, H; He, W				Li, Zhen; Li, Wei; Li, Ning; Jiao, Yanmei; Chen, Dexi; Cui, Lianxian; Hu, Yu; Wu, Hao; He, Wei			gamma delta T Cells Are Involved in Acute HIV Infection and Associated with AIDS Progression	PLOS ONE			English	Article							IMMUNE ACTIVATION; MICROBIAL TRANSLOCATION; DISEASE PROGRESSION; ADOPTIVE IMMUNOTHERAPY; DIFFERENTIATION; LYMPHOCYTES; REPERTOIRE; THERAPY; RESPOND; SUBSETS	Background: Early diagnosis is vital to HIV control. gamma delta T cells play critical roles in viral infections, but their activation in acute HIV infected patients and follow up to 18 months has not been described. Methods: Changes in gamma delta T cells, including subsets, function and activation, in treated and untreated acutely HIV-infected patients (n = 79) were compared by cytotoxicity assay and flow cytometry with healthy controls (n = 21) at month 0, 6, 12 and 18. Results: In acutely HIV-infected patients, V delta 1 cell proportion was elevated (P = 0.027) with V delta 2 population reduced (P = 0.002). Effector and central memory gamma delta T cell factions were decreased (P = 0.006 and P = 0.001, respectively), while proportion of terminal gamma delta T cells increased (P = 0.002). gamma delta T cell cytotoxicity was compromised over time. Fraction of IL-17-producing cells increased (P = 0.008), and IFN-gamma-producing cells were unaffected (P = 0.115). Elevation of a microbial translocation marker, sCD14, was associated with gamma delta T cell activation (P = 0.001), which increased in a time-dependent manner, correlating with CD4/CD8 T cell activation set-points and CD4 counts. Antiretroviral therapy did not affect these changes. Conclusions: gamma delta T cell subpopulation and functions change significantly in acute HIV infection and over time. Early gamma delta T cell activation was associated with CD4/CD8 T cell activation set-points, which predict AIDS progression. Therefore, gamma delta T cell activation represents a potential surrogate marker of AIDS progression.	[Li, Zhen; Cui, Lianxian; Hu, Yu; He, Wei] Chinese Acad Med Sci, Inst Basic Med Sci, Natl Key Lab Med Mol Biol,Dept Immunol, Peking Union Med College,Sch Basic Med, Beijing 100730, Peoples R China; [Li, Wei; Jiao, Yanmei; Chen, Dexi; Wu, Hao] Capital Med Univ, Beijing Youan Hosp, Ctr Infect Dis, Beijing, Peoples R China; [Li, Ning] Capital Med Univ, Beijing Youan Hosp, Beijing, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Basic Medical Sciences - CAMS; Capital Medical University; Capital Medical University	Wu, H (corresponding author), Capital Med Univ, Beijing Youan Hosp, Ctr Infect Dis, Beijing, Peoples R China.	wuhao90000@gmail.com; suprahe@126.com			Twelve-five Project for Control and Prevention of Major Infectious Diseases [2012ZX10001-006]; National Natural Science Foundation of China [81371332]; Beijing Key Laboratory [BZ0089]	Twelve-five Project for Control and Prevention of Major Infectious Diseases; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Beijing Key Laboratory	This work was supported by Twelve-five Project for Control and Prevention of Major Infectious Diseases [2012ZX10001-006], National Natural Science Foundation of China [81371332], and Beijing Key Laboratory [BZ0089]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adib-Conquy M, 2007, FEBS LETT, V581, P3723, DOI 10.1016/j.febslet.2007.03.074; Alunno A, 2012, CLIN DEV IMMUNOL, DOI 10.1155/2012/823085; Battistini L, 1997, J IMMUNOL, V159, P3723; Battistini L, 2005, MICROBES INFECT, V7, P510, DOI 10.1016/j.micinf.2004.12.008; Bordon J, 2004, J INFECT DIS, V189, P1482, DOI 10.1086/382961; Braga WMT, 2012, CLIN DEV IMMUNOL, DOI 10.1155/2012/293479; Brenchley JM, 2006, NAT MED, V12, P1365, DOI 10.1038/nm1511; Brenchley JM, 2012, ANNU REV IMMUNOL, V30, P149, DOI 10.1146/annurev-immunol-020711-075001; Bukowski JF, 1999, IMMUNITY, V11, P57, DOI 10.1016/S1074-7613(00)80081-3; Chevalier MF, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003453; Romero-Sanchez MC, 2012, J INFECTION, V65, P431, DOI 10.1016/j.jinf.2012.06.008; CONSTANT P, 1994, SCIENCE, V264, P267, DOI 10.1126/science.8146660; Deeks SG, 2004, BLOOD, V104, P942, DOI 10.1182/blood-2003-09-3333; Dieli F, 2003, J EXP MED, V198, P391, DOI 10.1084/jem.20030235; Dik WA, 2005, J EXP MED, V201, P1715, DOI 10.1084/jem.20042524; Eberl M, 2002, CELL IMMUNOL, V218, P1, DOI 10.1016/S0008-8749(02)00519-1; Epple HJ, 2009, GUT, V58, P220, DOI 10.1136/gut.2008.150425; Fenoglio D, 2009, BLOOD, V113, P6611, DOI 10.1182/blood-2009-01-198028; Hayday AC, 2000, ANNU REV IMMUNOL, V18, P975, DOI 10.1146/annurev.immunol.18.1.975; Hebbeler AM, 2008, CLIN IMMUNOL, V128, P349, DOI 10.1016/j.clim.2008.04.008; Karim R, 2013, AIDS, V27, P1473, DOI 10.1097/QAD.0b013e3283601bad; Kotler DP, 1984, ANN INTERN MED, V4, P101; Li HS, 2008, CLIN INFECT DIS, V46, P1466, DOI 10.1086/587107; Li HS, 2013, CELL MOL IMMUNOL, V10, P42, DOI 10.1038/cmi.2012.50; MUNOZ C, 1991, J CLIN INVEST, V88, P1747, DOI 10.1172/JCI115493; Qin G, 2012, J INFECT DIS, V205, P1646, DOI 10.1093/infdis/jis253; Ribot JC, 2009, NAT IMMUNOL, V10, P427, DOI 10.1038/ni.1717; Sanders JM, 2004, J MED CHEM, V47, P375, DOI 10.1021/jm0303709; Sandler NG, 2011, J INFECT DIS, V203, P780, DOI 10.1093/infdis/jiq118; Santos-Oliveira JR, 2013, J INFECT DIS, V208, P57, DOI 10.1093/infdis/jit135; Schilbach K, 2001, BLOOD, V97, P2917, DOI 10.1182/blood.V97.9.2917; Shibata K, 2007, J IMMUNOL, V178, P4466, DOI 10.4049/jimmunol.178.7.4466; Sodora DL, 2008, AIDS, V22, P439, DOI 10.1097/QAD.0b013e3282f2dbe7; Thedrez A, 2009, J IMMUNOL, V182, P3423, DOI 10.4049/jimmunol.0803068; Vincent MS, 1998, J IMMUNOL, V161, P5762; Wittkop L, 2013, J INFECT DIS, V207, P622, DOI 10.1093/infdis/jis732; Xi XY, 2009, J BIOL CHEM, V284, P27449, DOI 10.1074/jbc.M109.011684; Zheng NN, 2011, JAIDS-J ACQ IMM DEF, V57, P92, DOI 10.1097/QAI.0b013e318215a877; Zhou JH, 2012, CELL MOL IMMUNOL, V9, P34, DOI 10.1038/cmi.2011.16	39	25	26	2	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 4	2014	9	9							e106064	10.1371/journal.pone.0106064	http://dx.doi.org/10.1371/journal.pone.0106064			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3XV	25188438	Green Submitted, Green Published, gold			2022-12-27	WOS:000341271500020
J	Liu, Y; Huang, XY; Bi, R; Yang, WT; Shao, ZM				Liu, Yin; Huang, Xiaoyan; Bi, Rui; Yang, Wentao; Shao, Zhimin			Similar Prognoses for Invasive Micropapillary Breast Carcinoma and Pure Invasive Ductal Carcinoma: A Retrospectively Matched Cohort Study in China	PLOS ONE			English	Article							EXPRESSION; FEATURES	Purpose: Invasive micropapillary breast carcinoma (IMPC) is a rare pathological finding. Few studies have compared IMPC with invasive ductal breast carcinoma (IDC) according to matched nodal status and age. To better illustrate the difference between IMPC and IDC prognoses, we conducted this cohort study. Methods: 51 mixed or pure IMPC patients and 102 pure IDC patients were matched for nodal status and age. Clinical and biological features as well as disease-free survival (DFS) were compared between groups. Results: More than one-half of IMPC consisted of mostly or exclusively IMPC component (meaning greater than 75%) and these tumors significantly correlated with a higher histologic grade (P = 0.016) and LVI positivity (P = 0.036) compared with mixed IMPC. IMPC displayed a significantly higher rate of estrogen receptor (ER) positivity and lymphovascular invasion (LVI) compared to matched IDC. Women diagnosed with IMPC had a slight, but not significant, reduced frequency for recurrence and metastasis compared to women with IDC (15.7% vs. 21.6%, P = 0.518). In the subgroup analysis, IMPC patients demonstrated significantly reduced survival (P = 0.018) compared to IDC patients in the T1N2-3 subpopulation, whereas IDC patients demonstrated significantly increased recurrence and metastasis (P = 0.024) compared to IMPC patients in the T2N2-3 subgroup. No difference was observed in patients with 3 or less positive lymph nodes (LNs). Conclusion: Although no difference in DFS was observed between IMPC and LN-matched IDC patients, IMPC patients demonstrated a significantly poorer outcome compared to IDC patients with smaller tumors and 4 or more positive LNs. The opposite results were observed in larger tumors and patients with 4 or more positive LNs. Therefore, we might advise more proactive treatment for IMPC patients with a smaller tumor size and extensive LN involvement. Furthermore, correlative IMPC studies should focus on this subset of patients to elucidate the genetic and/or biologic differences that contribute to metastatic potential.	[Liu, Yin; Huang, Xiaoyan; Shao, Zhimin] Fudan Univ, Shanghai Canc Center, Inst Canc, Dept Breast Surg, Shanghai 200433, Peoples R China; [Liu, Yin; Huang, Xiaoyan; Bi, Rui; Yang, Wentao; Shao, Zhimin] Fudan Univ, Shanghai Med Coll, Dept Oncol, Shanghai 200433, Peoples R China; [Bi, Rui; Yang, Wentao] Fudan Univ, Shanghai Canc Center, Inst Canc, Dept Pathol, Shanghai 200433, Peoples R China; [Shao, Zhimin] Fudan Univ, Inst Biomed Sci, Shanghai 200433, Peoples R China	Fudan University; Fudan University; Fudan University; Fudan University	Shao, ZM (corresponding author), Fudan Univ, Shanghai Canc Center, Inst Canc, Dept Breast Surg, Shanghai 200433, Peoples R China.	zhimingshao@yahoo.com			Shanghai Science and Technology [12410707700]	Shanghai Science and Technology(Shanghai Science & Technology Committee)	This study was supported in part by a grant from Shanghai Science and Technology (No. 12410707700). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Acs G, 2010, AM J SURG PATHOL, V34, P1637, DOI 10.1097/PAS.0b013e3181f5539c; Cao AY, 2012, ANN SURG ONCOL, V19, P3019, DOI 10.1245/s10434-012-2322-6; Chen AC, 2013, CLIN BREAST CANCER, V13, P133, DOI 10.1016/j.clbc.2012.10.001; Chen L, 2008, INT J SURG PATHOL, V16, P155, DOI 10.1177/1066896907307047; De La Cruz C, 2004, PATHOL INT, V54, P90, DOI 10.1111/j.1440-1827.2004.01590.x; Elston C W, 2002, Histopathology, V41, P154; Fan L, 2009, BREAST CANCER RES TR, V117, P409, DOI 10.1007/s10549-008-0303-z; Flagella M, 2006, ANAL BIOCHEM, V352, P50, DOI 10.1016/j.ab.2006.02.013; Guo XJ, 2006, AM J CLIN PATHOL, V126, P740, DOI 10.1309/AXYY4AJTMNW6FRMW; Ide Y, 2011, PATHOL INT, V61, P731, DOI 10.1111/j.1440-1827.2011.02735.x; Kim C, 2011, J CLIN ONCOL, V29, P4160, DOI 10.1200/JCO.2010.32.9615; Mahmoud SMA, 2011, J CLIN ONCOL, V29, P1949, DOI 10.1200/JCO.2010.30.5037; Marchio C, 2009, J PATHOL, V218, P301, DOI 10.1002/path.2572; Nassar H, 2001, MODERN PATHOL, V14, P836, DOI 10.1038/modpathol.3880399; Pettinato G, 2004, AM J CLIN PATHOL, V121, P857, DOI 10.1309/XTJ7VHB49UD78X60; SIRIAUNKGUL S, 1993, MODERN PATHOL, V6, P660; Tavassoli FA, 2003, IARC WHO CLASSIFICAT, V4; Vingiani A, 2013, HISTOPATHOLOGY, V63, P217, DOI 10.1111/his.12147; Wo JY, 2011, J CLIN ONCOL, V29, P2619, DOI 10.1200/JCO.2010.29.5907; Wolff AC, 2007, J CLIN ONCOL, V25, P118, DOI 10.1200/JCO.2006.09.2775; Yamaguchi R, 2010, JPN J CLIN ONCOL, V40, P781, DOI 10.1093/jjco/hyq056; Yu JI, 2010, BREAST, V19, P231, DOI 10.1016/j.breast.2010.01.020	22	17	21	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 4	2014	9	9							e106564	10.1371/journal.pone.0106564	http://dx.doi.org/10.1371/journal.pone.0106564			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3XV	25188383	gold, Green Published, Green Submitted			2022-12-27	WOS:000341271500054
J	Yang, XZ; Ma, R; Shi, PJ; Huang, HQ; Bai, YG; Wang, YR; Yang, PL; Fan, YL; Yao, B				Yang, Xinzhuo; Ma, Rui; Shi, Pengjun; Huang, Huoqing; Bai, Yingguo; Wang, Yaru; Yang, Peilong; Fan, Yunliu; Yao, Bin			Molecular Characterization of a Highly-Active Thermophilic beta-Glucosidase from Neosartorya fischeri P1 and Its Application in the Hydrolysis of Soybean Isoflavone Glycosides	PLOS ONE			English	Article							SUBSTRATE-SPECIFICITY; TRICHODERMA-REESEI; PURIFICATION; TOLERANT; EXPRESSION; CLONING	Isoflavone occurs abundantly in leguminous seeds in the form of glycoside and aglycone. However, isoflavone glycoside has anti-nutritional effect and only the free type is beneficial to human health. In the present study we identified a beta-glucosidase from thermophilic Neosartorya fischeri P1, termed NfBGL1, capable of efficiently converting isoflavone glycosides into free isoflavones. The gene, belonging to glycoside hydrolase family 3, was successfully overexpressed in Pichia pastoris at high cell density in a 3.7-l fermentor. Purified recombinant NfBGL1 had higher specific activity (2189 +/- 1.7 U/mg) and temperature optimum (80 degrees C) than other fungal counterparts when using p-nitrophenyl beta-D-glucopyranoside as the substrate. It retained stable at temperatures up to 70 degrees C and over a broad pH range of 3.0-10.0. NfBGL1 had broad substrate specificity including glucosidase, cellobiase, xylanase and glucanase activities, and displayed preference for hydrolysis of beta-1,2 glycosidic bond rather than beta-1,3, beta-1,4, beta-1,6 bonds. The enzyme showed high bioconversion ability for major soybean isoflavone glycosides (daidin, gensitin and glycitin) into free forms. These properties make NfBGL1 potential for the wide use in the food, feed, pharmacy and biofuel industries.	[Yang, Xinzhuo; Ma, Rui; Shi, Pengjun; Huang, Huoqing; Bai, Yingguo; Wang, Yaru; Yang, Peilong; Yao, Bin] Chinese Acad Agr Sci, Feed Res Inst, Minist Agr, Key Lab Feed Biotechnol, Beijing 100193, Peoples R China; [Ma, Rui; Fan, Yunliu] Chinese Acad Agr Sci, Biotechnol Res Inst, Beijing 100193, Peoples R China	Chinese Academy of Agricultural Sciences; Feed Research Institute, CAAS; Ministry of Agriculture & Rural Affairs; Chinese Academy of Agricultural Sciences; Biotechnology Research Institute, CAAS	Yao, B (corresponding author), Chinese Acad Agr Sci, Feed Res Inst, Minist Agr, Key Lab Feed Biotechnol, Beijing 100193, Peoples R China.	binyao@caas.cn			National High Technology Research and Development Program of China [2012AA022208]; National Science Foundation for Distinguished Young Scholars of China [31225026]; National Science and Technology Support Program [2013BAD10B01-2]; China Modern Agriculture Research System [CARS-42]	National High Technology Research and Development Program of China(National High Technology Research and Development Program of China); National Science Foundation for Distinguished Young Scholars of China(National Natural Science Foundation of China (NSFC)National Science Fund for Distinguished Young Scholars); National Science and Technology Support Program; China Modern Agriculture Research System	This work was supported by the National High Technology Research and Development Program of China (2012AA022208), the National Science Foundation for Distinguished Young Scholars of China (31225026), the National Science and Technology Support Program (2013BAD10B01-2), and the China Modern Agriculture Research System (CARS-42). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andric P, 2010, BIOTECHNOL ADV, V28, P308, DOI 10.1016/j.biotechadv.2010.01.003; Badieyan S, 2012, BIOTECHNOL BIOENG, V109, P31, DOI 10.1002/bit.23280; BARNETT CC, 1991, BIO-TECHNOL, V9, P562, DOI 10.1038/nbt0691-562; Cantarel BL, 2009, NUCLEIC ACIDS RES, V37, pD233, DOI 10.1093/nar/gkn663; Chandra M, 2013, MOL BIOTECHNOL, V53, P289, DOI 10.1007/s12033-012-9526-7; Cheng KC, 2013, EUR FOOD RES TECHNOL, V236, P1107, DOI 10.1007/s00217-013-1936-7; Chisti Y, 2007, BIOTECHNOL ADV, V25, P294, DOI 10.1016/j.biotechadv.2007.02.001; Chuankhayan P, 2007, J AGR FOOD CHEM, V55, P2407, DOI 10.1021/jf062885p; DIXON M, 1953, BIOCHEM J, V55, P170, DOI 10.1042/bj0550170; Elshafei AM, 2011, AFR J BIOTECHNOL, V10, P19556, DOI 10.5897/AJB10.2617; FRANKE AA, 1994, J AGR FOOD CHEM, V42, P1905, DOI 10.1021/jf00045a015; Goodman-Gruen D, 2001, J NUTR, V131, P1202, DOI 10.1093/jn/131.4.1202; Kim BN, 2012, BIOTECHNOL LETT, V34, P125, DOI 10.1007/s10529-011-0739-9; Kim YS, 2011, J AGR FOOD CHEM, V59, P11812, DOI 10.1021/jf2025192; Kuo LC, 2006, APPL MICROBIOL BIOT, V73, P314, DOI 10.1007/s00253-006-0474-7; Luo HY, 2009, APPL MICROBIOL BIOT, V82, P453, DOI 10.1007/s00253-008-1766-x; MILLER GL, 1959, ANAL CHEM, V31, P426, DOI 10.1021/ac60147a030; Murray P, 2004, PROTEIN EXPRES PURIF, V38, P248, DOI 10.1016/j.pep.2004.08.006; Pei JJ, 2012, BIOTECHNOL BIOFUELS, V5, DOI 10.1186/1754-6834-5-31; Ramani G, 2012, APPL BIOCHEM BIOTECH, V167, P959, DOI 10.1007/s12010-012-9645-4; Ravindranath MH, 2004, ADV EXP MED BIOL, V546, P121; Riou C, 1998, APPL ENVIRON MICROB, V64, P3607; Saha BC, 1996, APPL ENVIRON MICROB, V62, P3165, DOI 10.1128/AEM.62.9.3165-3170.1996; Saibi W, 2007, APPL MICROBIOL BIOT, V77, P293, DOI 10.1007/s00253-007-1141-3; Soetan K. O., 2009, African Journal of Food Science (ACFS), V3, P223; Suzuki K, 2013, BIOCHEM J, V452, P211, DOI 10.1042/BJ20130054; Uchima CA, 2012, APPL ENVIRON MICROB, V78, P4288, DOI 10.1128/AEM.07718-11; Uchiyama T, 2013, J BIOL CHEM, V288, P18325, DOI 10.1074/jbc.M113.471342; Varghese JN, 1999, STRUCTURE, V7, P179, DOI 10.1016/S0969-2126(99)80024-0; Venturi LL, 2002, J BASIC MICROB, V42, P55, DOI 10.1002/1521-4028(200203)42:1<55::AID-JOBM55>3.0.CO;2-#; Wang HM, 2014, BIORESOURCE TECHNOL, V153, P361, DOI 10.1016/j.biortech.2013.11.078; WOOD TM, 1982, J GEN MICROBIOL, V128, P2973; Xue YM, 2009, J IND MICROBIOL BIOT, V36, P1401, DOI 10.1007/s10295-009-0626-8; Yang SQ, 2008, J AGR FOOD CHEM, V56, P602, DOI 10.1021/jf072279+; Yang SQ, 2009, FOOD CHEM, V115, P1247, DOI 10.1016/j.foodchem.2009.01.038; Yoon JJ, 2008, J MICROBIOL, V46, P51, DOI 10.1007/s12275-007-0230-4; Yoshida E, 2010, BIOCHEM J, V431, P39, DOI 10.1042/BJ20100351	37	23	26	1	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 4	2014	9	9							e106785	10.1371/journal.pone.0106785	http://dx.doi.org/10.1371/journal.pone.0106785			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3XV	25188254	gold, Green Submitted, Green Published			2022-12-27	WOS:000341271500087
J	Blumenberg, M				Blumenberg, Miroslav			Differential Transcriptional Effects of EGFR Inhibitors	PLOS ONE			English	Article							GROWTH-FACTOR RECEPTOR; CELL LUNG-CANCER; ACTIVATION; LIGANDS; BINDING	EGF and its receptor EGFR serve as a paradigm for signaling in cell, molecular and tumor biology. EGFR inhibitors, drugs targeting the intracellular kinase activity and antibodies targeting the extracellular ligand binding, are used to treat breast, lung, colon and other cancers. Nominally affecting the same target, inhibitors have different effects, suggesting that use of inhibitor combinations may provide beneficial in cancer treatment. To explore the specific and the common transcriptional effects of EGFR inhibitors, we present metaanalysis of 20 individual studies comprising 346 microarrays. We identified specific gene subsets regulated by kinase inhibitors, those regulated using antibodies and by suppressing EGFR expression using miR-7. Unreported before, the inhibitors prominently induce lysosome components. All inhibitors rely on related sets of transcription factors and protein kinases, both for transcriptional induction and suppression. However, we find that Gefitinib suppresses apoptosis inhibitors, while inducing cell-cycle inhibitors; conversely, Erlotinib suppresses cell-cycle and cell migration genes, while inducing proapoptotic genes. EGFR-targeting antibodies specifically suppress cell motility, developmental and differentiation processes, while inducing the contractile apparatus. miR-7, distinctively, suppresses cell-cycle genes, while inducing transcription machinery. These metaanalysis results suggest that different inhibitors have overlapping but quite distinct effects in target cells. Judicial use of EGFR-targeting combinations, i.e., simultaneous use of antibodies and multiple kinase inhibitors, may provide more effective cancer treatments with fewer side-effects and avoid development of resistance. We expect, moreover, that specific drug combination treatments can be fine-tuned to achieve specific, personalized results.	[Blumenberg, Miroslav] NYU, Langone Med Ctr, Dept Biochem & Mol Pharmacol, RO Perelman Dept Dermatol, New York, NY 10012 USA; [Blumenberg, Miroslav] NYU, Langone Med Ctr, Inst Canc, New York, NY USA	New York University; NYU Langone Medical Center; New York University; NYU Langone Medical Center	Blumenberg, M (corresponding author), NYU, Langone Med Ctr, Dept Biochem & Mol Pharmacol, RO Perelman Dept Dermatol, New York, NY 10012 USA.	Miroslav.Blumenberg@nyumc.org		Blumenberg, Miroslav/0000-0002-8672-7774	RO Perelman Department of Dermatology, NYU Langone Medical Center	RO Perelman Department of Dermatology, NYU Langone Medical Center	Supported by the RO Perelman Department of Dermatology, NYU Langone Medical Center. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali A, 2001, CHEM REV, V101, P2527, DOI 10.1021/cr000110o; Bae JH, 2010, MOL CELLS, V29, P443, DOI 10.1007/s10059-010-0080-5; Casas-Selves M, 2012, CANCER RES, V72, P4154, DOI 10.1158/0008-5472.CAN-11-2848; Chung I, 2010, NATURE, V464, P783, DOI 10.1038/nature08827; Ciardiello F, 2008, NEW ENGL J MED, V358, P1160, DOI 10.1056/NEJMra0707704; Clayton AHA, 2007, BIOCHEMISTRY-US, V46, P4589, DOI 10.1021/bi700002b; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Dragowska WH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076503; Gautier L, 2004, BIOINFORMATICS, V20, P307, DOI 10.1093/bioinformatics/btg405; Hong FX, 2006, BIOINFORMATICS, V22, P2825, DOI 10.1093/bioinformatics/btl476; Kalinowski FC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047067; Kuo LC, 2011, MED ONCOL, V28, P79, DOI 10.1007/s12032-010-9424-4; Lachmann A, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-87; Liu YB, 2005, CANCER RES, V65, P3404, DOI 10.1158/0008-5472.CAN-04-4292; Mimoso C, 2013, METHOD MOL BIOL, V3, P3; Pao W, 2010, NAT REV CANCER, V10, P760, DOI 10.1038/nrc2947; Perera RM, 2005, CLIN CANCER RES, V11, P6390, DOI 10.1158/1078-0432.CCR-04-2653; Pomerantz RG, 2010, J DRUGS DERMATOL, V9, P1229; RUFFJAMISON S, 1993, SCIENCE, V261, P1733, DOI 10.1126/science.8378774; Schneider MR, 2008, AM J PATHOL, V173, P14, DOI 10.2353/ajpath.2008.070942; Singh AB, 2005, CELL SIGNAL, V17, P1183, DOI 10.1016/j.cellsig.2005.03.026; Stabile LP, 2005, CANCER RES, V65, P1459, DOI 10.1158/0008-5472.CAN-04-1872; Takeuchi K, 2010, FEBS J, V277, P316, DOI 10.1111/j.1742-4658.2009.07450.x; ULLRICH A, 1990, CELL, V61, P203, DOI 10.1016/0092-8674(90)90801-K; Wheeler DL, 2010, NAT REV CLIN ONCOL, V7, P493, DOI 10.1038/nrclinonc.2010.97; Wood ER, 2004, CANCER RES, V64, P6652, DOI 10.1158/0008-5472.CAN-04-1168; Zheng Y, 2013, NATURE, V499, P166, DOI 10.1038/nature12308	27	11	11	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 3	2014	9	9							e102466	10.1371/journal.pone.0102466	http://dx.doi.org/10.1371/journal.pone.0102466			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3TB	25184905	Green Submitted, Green Published, gold			2022-12-27	WOS:000341257700003
J	Cheng, GY; Liu, CC; Wang, X; Ma, HM; Pan, YH; Huang, LL; Hao, HH; Dai, MH; Yuan, ZH				Cheng, Guyue; Liu, Changcun; Wang, Xu; Ma, Hongmin; Pan, Yuanhu; Huang, Lingli; Hao, Haihong; Dai, Menghong; Yuan, Zonghui			Structure-Function Analysis of Porcine Cytochrome P450 3A29 in the Hydroxylation of T-2 Toxin as Revealed by Docking and Mutagenesis Studies	PLOS ONE			English	Article							SUBSTRATE-SPECIFICITY; METABOLIC PATHWAYS; LIVER MICROSOMES; P450 3A; SITE; BINDING; TRICHOTHECENES; COOPERATIVITY; MYCOTOXINS; EXPRESSION	T-2 toxin, one of the type A trichothecenes, presents a potential hazard to human and animal health. Our previous work demonstrated that porcine cytochrome P450 3A29 (CYP3A29) played an important role in the hydroxylation of T-2 toxin. To identify amino acids involved in this metabolic process, T-2 toxin was docked into a homology model of CYP3A29 based on a crystal structure of CYP3A4 using AutoDock 4.0. Nine residues of CYP3A29, Arg105, Arg106, Phe108, Ser119, Lys212, Phe213, Phe215, Arg372 and Glu374, which were found within 5 angstrom around T-2 toxin were subjected to site-directed mutagenesis. In the oxidation of nifedipine, the CLint value of R106A was increased by nearly two-folds compared with the wild-type CYP3A29, while the substrate affinities and CLint values of S119A and K212A were significantly reduced. In the hydroxylation of T-2 toxin, the generation of 3'-OH-T-2 by R105A, S119A and K212A was significantly less than that by the wild-type, whereas R106A slightly increased the generation of 3'-OH-T-2. These results were further confirmed by isothermal titration calorimetry analysis, suggesting that these four residues are important in the hydroxylation of T-2 toxin and Arg105 may be a specific recognition site for the toxin. Our study suggests a possible structure-function relationship of CYP3A29 in the hydroxylation of T-2 toxin, providing with new insights into the mechanism of CYP3A enzymes in the biotransformation of T-2 toxin.	[Cheng, Guyue; Wang, Xu; Hao, Haihong; Dai, Menghong; Yuan, Zonghui] Huazhong Agr Univ, MOA Lab Risk Assessment Qual & Safety Livestock &, Wuhan, Peoples R China; [Liu, Changcun; Pan, Yuanhu; Huang, Lingli; Yuan, Zonghui] Huazhong Agr Univ, MOA Key Lab Detect Vet Drug Residues, Natl Reference Lab Vet Drug Residues HZAU, Wuhan, Peoples R China; [Ma, Hongmin] Wuhan Univ, Sch Pharmaceut Sci, Minist Educ, Key Lab Combinatorial Biosynth & Drug Discovery, Wuhan 430072, Peoples R China	Huazhong Agricultural University; Huazhong Agricultural University; Wuhan University	Yuan, ZH (corresponding author), Huazhong Agr Univ, MOA Lab Risk Assessment Qual & Safety Livestock &, Wuhan, Peoples R China.	yuan5802@mail.hzau.edu.cn	DAI, M/GPS-8291-2022; yuan, zonghui/A-1158-2017; Hao, Haihong/E-2789-2019	Ma, Hongmin/0000-0003-2268-1436; Hao, Haihong/0000-0003-0199-5700	National Natural Science Foundation of China [31272614]; Fundamental Research Funds for the Central Universities [2013QC002]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This work was supported by the National Natural Science Foundation of China (grant no. 31272614) and the Fundamental Research Funds for the Central Universities (program no. 2013QC002). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	ANDERSON DW, 1989, J MED CHEM, V32, P555, DOI 10.1021/jm00123a008; Chen R, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.006445; Chenna R, 2003, NUCLEIC ACIDS RES, V31, P3497, DOI 10.1093/nar/gkg500; Dohnal V, 2008, CURR DRUG METAB, V9, P77; Domanski TL, 2000, J PHARMACOL EXP THER, V293, P585; Ekroos M, 2006, P NATL ACAD SCI USA, V103, P13682, DOI 10.1073/pnas.0603236103; Fowler SM, 2000, BIOCHEMISTRY-US, V39, P4406, DOI 10.1021/bi992372u; Ge XH, 2010, CATAL COMMUN, V12, P71, DOI 10.1016/j.catcom.2010.08.003; Guengerich FP, 2005, BIOCHEM BIOPH RES CO, V338, P465, DOI 10.1016/j.bbrc.2005.08.079; Harlow GR, 1997, J BIOL CHEM, V272, P5396, DOI 10.1074/jbc.272.9.5396; Harlow GR, 1998, P NATL ACAD SCI USA, V95, P6636, DOI 10.1073/pnas.95.12.6636; He JW, 2010, TRENDS FOOD SCI TECH, V21, P67, DOI 10.1016/j.tifs.2009.08.002; He YA, 2003, ARCH BIOCHEM BIOPHYS, V409, P92, DOI 10.1016/S0003-9861(02)00484-8; HOLMANS PL, 1994, ARCH BIOCHEM BIOPHYS, V312, P554, DOI 10.1006/abbi.1994.1345; Islam Z, 1998, BIOSCI BIOTECH BIOCH, V62, P1492, DOI 10.1271/bbb.62.1492; Khan KK, 2000, ARCH BIOCHEM BIOPHYS, V373, P335, DOI 10.1006/abbi.1999.1578; KING J, 1971, J MOL BIOL, V62, P465, DOI 10.1016/0022-2836(71)90148-3; Kirton SB, 2005, PROTEINS, V58, P836, DOI 10.1002/prot.20389; KOBAYASHI J, 1987, FOOD CHEM TOXICOL, V25, P539, DOI 10.1016/0278-6915(87)90206-7; Konigs M, 2009, TOXICOLOGY, V258, P106, DOI 10.1016/j.tox.2009.01.012; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; Lewis DFV, 2005, DRUG DEVELOP RES, V66, P19, DOI 10.1002/ddr.20040; Lewis DFV, 2004, DRUG DISCOV TODAY, V9, P530, DOI 10.1016/S1359-6446(04)03115-0; Li HY, 2004, CURR TOP MED CHEM, V4, P1789, DOI 10.2174/1568026043387205; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Moore CD, 2010, BIOCHEMISTRY-US, V49, P9011, DOI 10.1021/bi101139q; Morris GM, 2009, J COMPUT CHEM, V30, P2785, DOI 10.1002/jcc.21256; OMURA T, 1964, J BIOL CHEM, V239, P2370; Park H, 2005, J AM CHEM SOC, V127, P13634, DOI 10.1021/ja053809q; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Scott EE, 2005, TRENDS BIOCHEM SCI, V30, P5, DOI 10.1016/j.tibs.2004.11.004; Strobel H W, 1978, Methods Enzymol, V52, P89; SWANSON SP, 1988, FOOD CHEM TOXICOL, V26, P823, DOI 10.1016/0278-6915(88)90021-X; THOMPSON WL, 1986, TOXICON, V24, P985, DOI 10.1016/0041-0101(86)90004-8; Torimoto N, 2007, DRUG METAB DISPOS, V35, P484, DOI 10.1124/dmd.106.011304; Wang HF, 1998, BIOCHEMISTRY-US, V37, P12536, DOI 10.1021/bi980895g; Wang JF, 2007, BIOCHEM BIOPH RES CO, V355, P513, DOI 10.1016/j.bbrc.2007.01.185; Williams PA, 2004, SCIENCE, V305, P683, DOI 10.1126/science.1099736; Wu QH, 2013, CURR DRUG METAB, V14, P641, DOI 10.2174/1389200211314060002; Wu QH, 2011, XENOBIOTICA, V41, P863, DOI 10.3109/00498254.2011.593206; Wu QH, 2010, DRUG METAB REV, V42, P250, DOI [10.3109/03602530903125807, 10.1080/03602530903125807]; Yang DF, 2009, TOXICOL APPL PHARM, V237, P49, DOI 10.1016/j.taap.2009.02.012; Yano JK, 2004, J BIOL CHEM, V279, P38091, DOI 10.1074/jbc.C400293200; Yao M, 2012, RES VET SCI, V93, P360, DOI 10.1016/j.rvsc.2011.06.013; Yao M, 2011, BIOSCIENCE REP, V31, P211, DOI 10.1042/BSR20100084; Zhang DL, 2009, DRUG METAB DISPOS, V37, P710, DOI 10.1124/dmd.108.024398; Zhao CS, 2012, BIOCHEMISTRY-US, V51, P9488, DOI 10.1021/bi301069r; Zheng L, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh110	48	11	11	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 3	2014	9	9							e106769	10.1371/journal.pone.0106769	http://dx.doi.org/10.1371/journal.pone.0106769			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3TB	25184434	gold, Green Submitted, Green Published			2022-12-27	WOS:000341257700118
J	Guagliano, JM; Lonsdale, C; Rosenkranz, RR; Kolt, GS; George, ES				Guagliano, Justin M.; Lonsdale, Chris; Rosenkranz, Richard R.; Kolt, Gregory S.; George, Emma S.			Do Coaches Perceive Themselves as Influential on Physical Activity for Girls in Organised Youth Sport?	PLOS ONE			English	Article							QUALITATIVE RESEARCH; ADOLESCENT GIRLS; DECLINE; HEALTH; CLUB; STRATEGY; CHILDREN; BEHAVIOR; ROLES	Participation in organised youth sports (OYS) has been recommended as an opportunity to increase young peoples' physical activity (PA) levels. While coaches can potentially influence athletes' PA levels, what has not been explored is the question; do coaches perceive themselves as influential on PA for girls in OYS? Participants were 30 coaches of girls OYS teams aged 9-17 years in the Greater Sydney Metropolitan Area, Australia. Participants took part in a semi-structured interview that lasted approximately 30 minutes. They responded to questions regarding their perceived role as coaches, their perceptions of themselves as role models for PA, their views on their athletes' current PA levels, their opinions on improving their athletes' PA levels, and their perceived challenges as coaches in OYS. Many coaches considered themselves role models for PA due to their own involvement in organised sports. Coaches felt that they were conscious of girls' PA levels during training and could accurately gauge how active girls were. Coaches perceived their training sessions to provide sufficient PA and thus, did not feel the need to try to increase PA during training. Many coaches were cautious about conducting training sessions where the PA intensity was high for prolonged periods because they believed that it could potentially result in dropout from OYS. Coaches' perceived time commitment to OYS, variability of skill/experience amongst girls, and poor parental support as major challenges they experienced in OYS. This study provided a unique insight from the perspective of coaches in OYS. Most coaches felt that they had the potential to influence PA for girls in OYS; however, coaches may underestimate or not fully realise the impact they can have on the girls they coach. Future research should focus on educating coaches to capitalise on the opportunity they have to promote PA through OYS.	[Guagliano, Justin M.; Rosenkranz, Richard R.; Kolt, Gregory S.; George, Emma S.] Univ Western Sydney, Sch Sci & Hlth, Sydney, NSW, Australia; [Lonsdale, Chris] Australian Catholic Univ, Inst Posit Psychol & Educ, Sydney, NSW, Australia; [Rosenkranz, Richard R.] Kansas State Univ, Dept Human Nutr, Manhattan, KS 66506 USA	Western Sydney University; Australian Catholic University; Kansas State University	Guagliano, JM (corresponding author), Univ Western Sydney, Sch Sci & Hlth, Sydney, NSW, Australia.	j.guagliano@uws.edu.au	Rosenkranz, Richard/AAL-6154-2021; Kolt, Gregory/W-1342-2019; George, Emma/AAU-4754-2021; Lonsdale, Chris/T-8710-2017	Rosenkranz, Richard/0000-0002-8242-3546; Kolt, Gregory/0000-0002-9223-3324; George, Emma/0000-0001-9936-1911; Lonsdale, Chris/0000-0002-2523-5565; Guagliano, Justin/0000-0002-4450-5700	School of Science and Health at the University of Western Sydney	School of Science and Health at the University of Western Sydney	This study was funded by the School of Science and Health at the University of Western Sydney. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Active Healthy Kids Australia, 2014, IS SPORT EN 2014 AUS, P1; Ajzen I, 2011, BASIC APPL SOC PSYCH, V33, P101, DOI 10.1080/01973533.2011.568834; Armentrout S. M., 2011, Journal of Sport Behavior, V34, P121; Australian Bureau of Statistics, 2009, CHILDR PART ORG SPOR; Australian Bureau of Statistics, 2012, CHILDR PART SPORT LE; Bauer KW, 2008, INT J BEHAV NUTR PHY, V5, DOI 10.1186/1479-5868-5-12; Belanger M, 2011, INT J BEHAV NUTR PHY, V8, DOI 10.1186/1479-5868-8-117; Blomquist K B, 1986, Health Educ, V17, P8; Boeije H., 2009, ANAL QUALITATIVE RES; Bradley RH, 2011, INT J BEHAV NUTR PHY, V8, DOI 10.1186/1479-5868-8-33; Bryman A., 2012, SOCIAL RES METHODS, DOI DOI 10.1007/978-1-349-21149-4_10; C?t? J.\, 2006, ATHLETIC INSIGHT, V8, P12; Camacho-Minano MJ, 2011, HEALTH EDUC RES, V26, P1025, DOI 10.1093/her/cyr040; Conroy DE, 2006, SPORT PSYCHOL, V20, P128, DOI 10.1123/tsp.20.2.128; COTE J, 1993, SPORT PSYCHOL, V7, P127, DOI 10.1123/tsp.7.2.127; COTE J, 1994, PERCEPT MOTOR SKILL, V78, P465, DOI 10.2466/pms.1994.78.2.465; Cox M, 2010, J SCI MED SPORT, V13, P46, DOI 10.1016/j.jsams.2009.02.006; Creswell J, 2012, QUALITATIVE INQUIRY; Department of Health and Ageing, 2014, AUSTR PHYS ACT SED B; Drummond J.L., 2002, HEALTH EDUC J, V61, P78, DOI DOI 10.1177/001789690206100108; Dudley DA, 2012, J SCI MED SPORT, V15, P231, DOI 10.1016/j.jsams.2011.10.005; Eime RM, 2013, INT J BEHAV NUTR PHY, V10, DOI 10.1186/1479-5868-10-50; Fitzgerald A, 2012, J ADOLESCENCE, V35, P941, DOI 10.1016/j.adolescence.2012.01.002; Fraser-Thomas J. L., 2005, Physical Education and Sport Pedagogy, V10, P19, DOI 10.1080/1740898042000334890; Fraser-Thomas J, 2008, PSYCHOL SPORT EXERC, V9, P645, DOI 10.1016/j.psychsport.2007.08.003; Geidne S, 2013, SCAND J PUBLIC HEALT, V41, P269, DOI 10.1177/1403494812473204; Guagliano JM, 2013, MED SCI SPORT EXER, V45, P116, DOI 10.1249/MSS.0b013e31826a0a73; Hardy LL, 2008, MED SCI SPORT EXER, V40, P835, DOI 10.1249/MSS.0b013e318163f286; Hedstrom R, 2004, RES YOUTH SPORTS CRI; Janssen I, 2014, CAN J PUBLIC HEALTH, V105, pE22, DOI 10.17269/cjph.105.4154; Kelder SH, 2003, HEALTH EDUC BEHAV, V30, P463, DOI 10.1177/1090198103253538; Kelly B, 2014, J SCI MED SPORT, V17, P61, DOI 10.1016/j.jsams.2013.02.011; Kimm SYS, 2002, NEW ENGL J MED, V347, P709, DOI 10.1056/NEJMoa003277; Kokko S, 2009, HEALTH PROMOT INT, V24, P26, DOI 10.1093/heapro/dan040; KREFTING L, 1991, AM J OCCUP THER, V45, P214, DOI 10.5014/ajot.45.3.214; Leberman SI, 2011, J SPORT MANAGE, V25, P474, DOI 10.1123/jsm.25.5.474; Leek D, 2011, ARCH PEDIAT ADOL MED, V165, P294, DOI 10.1001/archpediatrics.2010.252; Lincoln Y.S., 1985, NATURALISTIC ENQUIRY; Lubans DR, 2007, AUST J EDUC DEV PSYC, V7, P22; Mandic S, 2012, INT J BEHAV NUTR PHY, V9, DOI 10.1186/1479-5868-9-86; McDavid L, 2012, PSYCHOL SPORT EXERC, V13, P99, DOI 10.1016/j.psychsport.2011.10.003; MCKENZIE TL, 1992, J TEACH PHYS EDUC, V11, P195, DOI 10.1123/jtpe.11.2.195; Patton M. Q., 2001, QUALITATIVE RES EVAL; Rink J., 2010, SCHOOLWIDE PHYS ACTI; Rottensteiner C, 2013, INT J SPORTS SCI COA, V8, P19, DOI 10.1260/1747-9541.8.1.19; Sacheck JM, 2011, PEDIATR EXERC SCI, V23, P281, DOI 10.1123/pes.23.2.281; Sallis JF, 2000, MED SCI SPORT EXER, V32, P963, DOI 10.1097/00005768-200009000-00012; Smith RE, 1997, CURR DIR PSYCHOL SCI, V6, P16, DOI 10.1111/1467-8721.ep11512606; Smoll FL, 2002, CHILDREN YOUTH SPORT; Strong WB, 2005, J PEDIATR-US, V146, P732, DOI 10.1016/j.jpeds.2005.01.055; Tesch R., 1990, QUALITATIVE RES ANAL; Timperio AF, 2013, INT J BEHAV NUTR PHY, V10, DOI 10.1186/1479-5868-10-15; Tong A, 2007, INT J QUAL HEALTH C, V19, P349, DOI 10.1093/intqhc/mzm042; Tremblay MS, 2014, J PHYS ACT HEALTH, V11, pS113, DOI 10.1123/jpah.2014-0177; Troiano RP, 2008, MED SCI SPORT EXER, V40, P181, DOI 10.1249/mss.0b013e31815a51b3; Trost SG, 2003, AM J PREV MED, V25, P277, DOI 10.1016/S0749-3797(03)00217-4; Vella S, 2011, J APPL SPORT PSYCHOL, V23, P33, DOI 10.1080/10413200.2010.511423; WHO, 2010, GLOB REC PHYS ACT HL, V1st, P15; Wickel EE, 2007, MED SCI SPORT EXER, V39, P1493, DOI 10.1249/mss.0b013e318093f56a	59	18	18	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 3	2014	9	9							e105960	10.1371/journal.pone.0105960	http://dx.doi.org/10.1371/journal.pone.0105960			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AO3TB	25184413	gold, Green Published, Green Submitted			2022-12-27	WOS:000341257700029
J	Lothery, CJ; Thompson, CF; Lawler, ML; Sakaluk, SK				Lothery, Cassie J.; Thompson, Charles F.; Lawler, Megan L.; Sakaluk, Scott K.			Food Supplementation Fails to Reveal a Trade-Off between Incubation and Self-Maintenance in Female House Wrens	PLOS ONE			English	Article							BASE-LINE GLUCOCORTICOIDS; CLUTCH-SIZE; ENERGETIC CONSTRAINT; INDIVIDUAL QUALITY; NEST PREDATION; GREAT TITS; CORTICOSTERONE; STRESS; FITNESS; TEMPERATURE	Incubating birds must allocate their time and energy between maintaining egg temperature and obtaining enough food to meet their own metabolic demands. We tested the hypothesis that female house wrens (Troglodytes aedon) face a trade-off between incubation and self-maintenance by providing females with supplemental food during incubation. We predicted that food supplementation would increase the amount of time females devoted to incubating their eggs, lower their baseline plasma corticosterone levels (a measure of chronic stress), and increase their body mass, haematocrit (a measure of anaemia), and reproductive success relative to control females. As predicted, food-supplemented females spent a greater proportion of time incubating their eggs than control females. Contrary to expectation, however, there was no evidence that food supplementation significantly influenced female baseline plasma corticosterone levels, body mass, haematocrit, or reproductive success. However, females with high levels of corticosterone at the beginning of incubation were more likely to abandon their nesting attempt after capture than females with low levels. Corticosterone significantly increased between the early incubation and early nestling stages of the breeding cycle in all females. These results suggest that although food supplementation results in a modest increase in incubation effort, it does not lead to significantly lower levels of chronic stress as reflected in lower baseline corticosterone levels. We conclude that female house wrens that begin the incubation period with low levels of plasma corticosterone can easily meet their own nutritional needs while incubating their eggs, and that any trade-off between incubation and self-feeding does not influence female reproductive success under the conditions at the time of our study.	[Lothery, Cassie J.; Thompson, Charles F.; Lawler, Megan L.; Sakaluk, Scott K.] Illinois State Univ, Sch Biol Sci, Behav Ecol Evolut & Systemat Sect, Normal, IL 61761 USA	Illinois State University	Sakaluk, SK (corresponding author), Illinois State Univ, Sch Biol Sci, Behav Ecol Evolut & Systemat Sect, Normal, IL 61761 USA.	sksakal@ilstu.edu			National Science Foundation [IBN-0316580, IOS-0718140]; National Institutes of Health [R15HD076308-01]; German Academic Exchange Service; Beta Lambda Chapter of the Phi Sigma Biological Sciences Honor Society; Illinois State University; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R15HD076308] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); German Academic Exchange Service(Deutscher Akademischer Austausch Dienst (DAAD)); Beta Lambda Chapter of the Phi Sigma Biological Sciences Honor Society(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Illinois State University; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported by the National Science Foundation (IBN-0316580 and IOS-0718140) (http://www.nsf.gov/), National Institutes of Health (R15HD076308-01) (http://www.nih.gov/), German Academic Exchange Service (https://www.daad.de/rise/en/), Beta Lambda Chapter of the Phi Sigma Biological Sciences Honor Society (http://bio.illinoisstate.edu/studentorgs/phisigma/index.shtml), and Illinois State University (http://illinoisstate.edu/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angelier F, 2010, BIOL LETTERS, V6, P846, DOI 10.1098/rsbl.2010.0376; Ardia DR, 2007, BEHAV ECOL, V18, P259, DOI 10.1093/beheco/arl078; Ardia DR, 2009, J ANIM ECOL, V78, P4, DOI 10.1111/j.1365-2656.2008.01453.x; Barnett CA, 2011, ANIM BEHAV, V81, P113, DOI 10.1016/j.anbehav.2010.09.019; Barnett CA, 2010, IBIS, V152, P169, DOI 10.1111/j.1474-919X.2009.00970.x; Bonier F, 2011, BIOL LETTERS, V7, P944, DOI 10.1098/rsbl.2011.0391; Bonier F, 2009, TRENDS ECOL EVOL, V24, P634, DOI 10.1016/j.tree.2009.04.013; Bonier F, 2009, GEN COMP ENDOCR, V163, P208, DOI 10.1016/j.ygcen.2008.12.013; Bryan SM, 1999, P ROY SOC B-BIOL SCI, V266, P157, DOI 10.1098/rspb.1999.0616; Cavitt JF, 1997, ECOLOGY, V78, P2512; Chalfoun AD, 2007, ANIM BEHAV, V73, P579, DOI 10.1016/j.anbehav.2006.09.010; CHARNOV EL, 1974, IBIS, V116, P217, DOI 10.1111/j.1474-919X.1974.tb00241.x; Clinchy M, 2004, P ROY SOC B-BIOL SCI, V271, P2473, DOI 10.1098/rspb.2004.2913; CODY ML, 1966, EVOLUTION, V20, P174, DOI 10.1111/j.1558-5646.1966.tb03353.x; Criscuolo F, 2005, J AVIAN BIOL, V36, P306, DOI 10.1111/j.0908-8857.2005.03371.x; de Heij ME, 2006, P ROY SOC B-BIOL SCI, V273, P2353, DOI 10.1098/rspb.2006.3584; DeMory ML, 2010, BEHAV ECOL, V21, P1156, DOI 10.1093/beheco/arq123; Dobbs RC, 2006, BEHAV ECOL, V17, P849, DOI 10.1093/beheco/arl019; DYKSTRA CR, 1993, AUK, V110, P481, DOI 10.2307/4088412; Eikenaar C, 2003, J AVIAN BIOL, V34, P419, DOI 10.1111/j.0908-8857.2003.03147.x; Fontaine JJ, 2011, CONDOR, V113, P825, DOI 10.1525/cond.2011.110027; Gill SA, 2008, HORM BEHAV, V54, P115, DOI 10.1016/j.yhbeh.2008.02.003; Jenni-Eiermann S, 2008, GEN COMP ENDOCR, V155, P558, DOI 10.1016/j.ygcen.2007.08.011; Johnson L. S., 1998, BIRDS N AM, V380, P32; JOHNSON LS, 1992, AM MIDL NAT, V127, P200, DOI 10.2307/2426336; Jonsson KI, 1997, OIKOS, V78, P57, DOI 10.2307/3545800; KACELNIK A, 1984, J ANIM ECOL, V53, P283, DOI 10.2307/4357; Lambrechts MM, 2010, ACTA ORNITHOL, V45, P1, DOI 10.3161/000164510X516047; Landys MM, 2006, GEN COMP ENDOCR, V148, P132, DOI 10.1016/j.ygcen.2006.02.013; Lendvai AZ, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.1734; Love OP, 2014, GEN COMP ENDOCR, V199, P65, DOI 10.1016/j.ygcen.2014.01.001; Love OP, 2004, HORM BEHAV, V46, P59, DOI 10.1016/j.yhbeh.2004.02.001; Martin TE, 2000, P ROY SOC B-BIOL SCI, V267, P2287, DOI 10.1098/rspb.2000.1281; MARTIN TE, 1987, ANNU REV ECOL SYST, V18, P453, DOI 10.1146/annurev.ecolsys.18.1.453; Monaghan P, 1997, TRENDS ECOL EVOL, V12, P270, DOI 10.1016/S0169-5347(97)01094-X; Monaghan P, 2014, CURR BIOL, V24, pR408, DOI 10.1016/j.cub.2014.04.017; MORENO J, 1989, ARDEA, V77, P107; MORENO J, 1991, IBIS, V133, P186, DOI 10.1111/j.1474-919X.1991.tb04830.x; Nelson R.J., 2011, INTRO BEHAV ENDOCRIN; Nord A, 2011, AM NAT, V178, P639, DOI 10.1086/662172; Nord A, 2010, FUNCT ECOL, V24, P1031, DOI 10.1111/j.1365-2435.2010.01719.x; Nordlund CA, 2005, NORTHEAST NAT, V12, P425, DOI 10.1656/1092-6194(2005)012[0425:PPIMMS]2.0.CO;2; Ouyang JQ, 2013, HORM BEHAV, V63, P776, DOI 10.1016/j.yhbeh.2013.03.002; Ouyang JQ, 2011, P ROY SOC B-BIOL SCI, V278, P2537, DOI 10.1098/rspb.2010.2490; Pearse AT, 2004, WILSON BULL, V116, P23, DOI 10.1676/0043-5643(2004)116[0023:EOFSOF]2.0.CO;2; Pereyra ME, 2003, GEN COMP ENDOCR, V130, P222, DOI 10.1016/S0016-6480(02)00568-3; Reid JM, 2000, P ROY SOC B-BIOL SCI, V267, P37, DOI 10.1098/rspb.2000.0963; Roff Derek, 2002, pi; Romero LM, 2005, COMP BIOCHEM PHYS A, V140, P73, DOI 10.1016/j.cbpb.2004.11.004; Sanz JJ, 1996, AUK, V113, P249; Scheiner Samuel M., 1993, P94; Schoech SJ, 2007, GEN COMP ENDOCR, V154, P150, DOI 10.1016/j.ygcen.2007.05.027; Schoech SJ, 2011, CURR ZOOL, V57, P514, DOI 10.1093/czoolo/57.4.514; Schoech SJ, 2009, GEN COMP ENDOCR, V163, P201, DOI 10.1016/j.ygcen.2008.09.009; Stearns S.C., 1992, pi; Suarez ME, 1996, POULTRY SCI, V75, P924, DOI 10.3382/ps.0750924; Thomson DL, 1998, BIOL REV, V73, P293, DOI 10.1017/S0006323198005180; VLECK CM, 1981, CONDOR, V83, P229, DOI 10.2307/1367313; Wada H, 2007, GEN COMP ENDOCR, V150, P405, DOI 10.1016/j.ygcen.2006.10.002; Walsberg G.E., 1983, P161; WEBB DR, 1987, CONDOR, V89, P874, DOI 10.2307/1368537; WESOLOWSKI T, 1994, AM NAT, V143, P39, DOI 10.1086/285595; Williams T., 2012, PHYSL ADAPTATIONS BR	63	21	21	0	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 3	2014	9	9							e106260	10.1371/journal.pone.0106260	http://dx.doi.org/10.1371/journal.pone.0106260			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3TB	25184281	Green Published, gold, Green Submitted			2022-12-27	WOS:000341257700047
J	Meng, YL; Chopp, M; Zhang, YL; Liu, ZW; An, A; Mahmood, A; Xiong, Y				Meng, Yuling; Chopp, Michael; Zhang, Yanlu; Liu, Zhongwu; An, Aaron; Mahmood, Asim; Xiong, Ye			Subacute Intranasal Administration of Tissue Plasminogen Activator Promotes Neuroplasticity and Improves Functional Recovery following Traumatic Brain Injury in Rats	PLOS ONE			English	Article							CONTROLLED CORTICAL IMPACT; FOCAL CEREBRAL-ISCHEMIA; CENTRAL-NERVOUS-SYSTEM; MARROW STROMAL CELLS; NEUROTROPHIC FACTOR; INFARCT VOLUME; DENTATE GYRUS; UP-REGULATION; SPINAL-CORD; ERYTHROPOIETIN RECEPTOR	Traumatic brain injury (TBI) is a major cause of death and long-term disability worldwide. To date, there are no effective pharmacological treatments for TBI. Recombinant human tissue plasminogen activator (tPA) is the effective drug for the treatment of acute ischemic stroke. In addition to its thrombolytic effect, tPA is also involved in neuroplasticity in the central nervous system. However, tPA has potential adverse side effects when administered intravenously including brain edema and hemorrhage. Here we report that tPA, administered by intranasal delivery during the subacute phase after TBI, provides therapeutic benefit. Animals with TBI were treated intranasally with saline or tPA initiated 7 days after TBI. Compared with saline treatment, subacute intranasal tPA treatment significantly 1) improved cognitive (Morris water maze test) and sensorimotor (footfault and modified neurological severity score) functional recovery in rats after TBI, 2) reduced the cortical stimulation threshold evoking ipsilateral forelimb movement, 3) enhanced neurogenesis in the dentate gyrus and axonal sprouting of the corticospinal tract originating from the contralesional cortex into the denervated side of the cervical gray matter, and 4) increased the level of mature brain-derived neurotrophic factor. Our data suggest that subacute intranasal tPA treatment improves functional recovery and promotes brain neurogenesis and spinal cord axonal sprouting after TBI, which may be mediated, at least in part, by tPA/plasmin-dependent maturation of brain-derived neurotrophic factor.	[Meng, Yuling; Zhang, Yanlu; An, Aaron; Mahmood, Asim; Xiong, Ye] Henry Ford Hosp, Dept Neurosurg, Detroit, MI 48202 USA; [Chopp, Michael; Liu, Zhongwu] Henry Ford Hosp, Dept Neurol, Detroit, MI 48202 USA; [Chopp, Michael] Oakland Univ, Dept Phys, Rochester, MI USA	Henry Ford Health System; Henry Ford Hospital; Henry Ford Health System; Henry Ford Hospital; Oakland University	Xiong, Y (corresponding author), Henry Ford Hosp, Dept Neurosurg, Detroit, MI 48202 USA.	yxiong1@hfhs.org		Xiong, Ye/0000-0001-9770-6031	National Institute of Neurological Disorders and Stroke [RO1 NS062002]; National Institute on Aging [RO1 AG037506]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS062002] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG037506] Funding Source: NIH RePORTER	National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	The research presented herein was supported by National Institute of Neurological Disorders and Stroke RO1 NS062002 (YX), and National Institute on Aging RO1 AG037506 (MC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adibhatla RM, 2008, CNS NEUROL DISORD-DR, V7, P243, DOI 10.2174/187152708784936608; Ahn MY, 1999, BRAIN RES, V837, P169, DOI 10.1016/S0006-8993(99)01645-5; Armstead WM, 2013, J NEUROTRAUM, V30, P1898, DOI 10.1089/neu.2013.2962; Armstead WM, 2012, J NEUROTRAUM, V29, P1794, DOI 10.1089/neu.2012.2328; Armstead WM, 2011, NEUROL RES, V33, P726, DOI 10.1179/016164110X12807570509853; Barha CK, 2011, EXP NEUROL, V231, P72, DOI 10.1016/j.expneurol.2011.05.016; Barnes P, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003248; Baskin YK, 2003, J NEUROSCI METH, V129, P87, DOI 10.1016/S0165-0270(03)00212-7; Bukhari N, 2011, J NEUROSCI, V31, P14931, DOI 10.1523/JNEUROSCI.3339-11.2011; Chen JL, 2005, J CEREBR BLOOD F MET, V25, P281, DOI 10.1038/sj.jcbfm.9600034; Chen JL, 2001, STROKE, V32, P2682, DOI 10.1161/hs1101.098367; Cho E, 2012, NEUROBIOL DIS, V46, P215, DOI 10.1016/j.nbd.2012.01.010; Choi SH, 2006, J NEUROSCI METH, V156, P182, DOI 10.1016/j.jneumeth.2006.03.002; Cutler SM, 2007, J NEUROTRAUM, V24, P1475, DOI 10.1089/neu.2007.0294; Dhuria SV, 2010, J PHARM SCI-US, V99, P1654, DOI 10.1002/jps.21924; Ding Q, 2011, NEUROSCIENCE, V192, P773, DOI 10.1016/j.neuroscience.2011.06.032; DIXON CE, 1991, J NEUROSCI METH, V39, P253; FESTOFF BW, 1994, J CELL PHYSIOL, V159, P11, DOI 10.1002/jcp.1041590103; Figurov A, 1996, NATURE, V381, P706, DOI 10.1038/381706a0; Fox GB, 1998, J NEUROTRAUM, V15, P599, DOI 10.1089/neu.1998.15.599; FRIBERGER P, 1978, HAEMOSTASIS, V7, P138; Gao X, 2009, J NEUROTRAUM, V26, P1325, DOI [10.1089/neu.2008.0744, 10.1089/neu.2008-0744]; Garcia AN, 2011, PM&R, V3, pS18, DOI 10.1016/j.pmrj.2011.03.017; Gean AD, 2010, NEUROIMAG CLIN N AM, V20, P527, DOI 10.1016/j.nic.2010.08.001; Glover LE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033646; Goto H, 2007, J NEUROTRAUM, V24, P745, DOI 10.1089/neu.2006.0183; Greenberg ME, 2009, J NEUROSCI, V29, P12764, DOI 10.1523/JNEUROSCI.3566-09.2009; Griesbach GS, 2004, NEUROSCIENCE, V125, P129, DOI 10.1016/j.neuroscience.2004.01.030; Hall ED, 2005, J NEUROTRAUM, V22, P252, DOI 10.1089/neu.2005.22.252; Han XD, 2011, J NEUROTRAUM, V28, P995, DOI 10.1089/neu.2010.1563; Je HS, 2012, P NATL ACAD SCI USA, V109, P15924, DOI 10.1073/pnas.1207767109; Kaplan GB, 2010, BEHAV PHARMACOL, V21, P427, DOI 10.1097/FBP.0b013e32833d8bc9; KARTJETILLOTSON G, 1985, BRAIN RES, V332, P103, DOI 10.1016/0006-8993(85)90393-2; Khan M, 2009, J NEUROINFLAMM, V6, DOI 10.1186/1742-2094-6-32; KORTE M, 1995, P NATL ACAD SCI USA, V92, P8856, DOI 10.1073/pnas.92.19.8856; Koshimizu H, 2009, MOL BRAIN, V2, DOI 10.1186/1756-6606-2-27; Levin HS, 2003, BRAIN INJURY, V17, P665, DOI 10.1080/0269905031000107151; LIN TN, 1993, STROKE, V24, P117, DOI 10.1161/01.STR.24.1.117; Liu ZW, 2008, STROKE, V39, P2571, DOI 10.1161/STROKEAHA.107.511659; Liu ZW, 2007, BRAIN RES, V1149, P172, DOI 10.1016/j.brainres.2007.02.047; Liu ZW, 2012, NEUROBIOL DIS, V45, P804, DOI 10.1016/j.nbd.2011.11.004; Loane DJ, 2010, TRENDS PHARMACOL SCI, V31, P596, DOI 10.1016/j.tips.2010.09.005; Lu B, 2005, NAT REV NEUROSCI, V6, P603, DOI 10.1038/nrn1726; Lu DY, 2007, NEUROSURGERY, V61, P596, DOI 10.1227/01.NEU.0000290908.38438.B2; Lu DY, 2003, J NEUROSURG, V99, P351, DOI 10.3171/jns.2003.99.2.0351; Mahmood A, 2007, NEUROSURGERY, V60, P546, DOI 10.1227/01.NEU.0000255346.25959.99; Mahmood A, 2011, J NEUROTRAUM, V28, P1199, DOI 10.1089/neu.2010.1694; Marklund N, 2009, NEUROSCIENCE, V163, P540, DOI 10.1016/j.neuroscience.2009.06.042; Mast TG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031978; Meng YL, 2011, J NEUROSURG, V115, P550, DOI 10.3171/2011.3.JNS101721; Minor K, 2009, J NEUROCHEM, V109, P706, DOI 10.1111/j.1471-4159.2009.05977.x; MISKIN R, 1981, ANAL BIOCHEM, V118, P252, DOI 10.1016/0003-2697(81)90187-1; Mori T, 2001, NEUROREPORT, V12, P4117, DOI 10.1097/00001756-200112210-00051; MORRIS RGM, 1982, NATURE, V297, P681, DOI 10.1038/297681a0; Nagai T, 2004, P NATL ACAD SCI USA, V101, P10554, DOI 10.1073/pnas.0400417101; Narayan RK, 2002, J NEUROTRAUM, V19, P503, DOI 10.1089/089771502753754037; NEAFSEY EJ, 1986, BRAIN RES REV, V11, P77, DOI 10.1016/0165-0173(86)90011-1; Ning RZ, 2011, BRAIN RES, V1384, P140, DOI 10.1016/j.brainres.2011.01.099; Obiang P, 2011, NEUROBIOL LEARN MEM, V96, P121, DOI 10.1016/j.nlm.2011.03.004; Pang PT, 2004, SCIENCE, V306, P487, DOI 10.1126/science.1100135; Qu CS, 2010, J NEUROTRAUM, V27, P1625, DOI 10.1089/neu.2010.1359; Richardson RM, 2007, NEUROSURG CLIN N AM, V18, P169, DOI 10.1016/j.nec.2006.10.007; Rodier M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092416; Samson AL, 2006, NEURON, V50, P673, DOI 10.1016/j.neuron.2006.04.013; Sashindranath M, 2012, BRAIN, V135, P3251, DOI 10.1093/brain/aws178; Shen LH, 2011, STROKE, V42, P459, DOI 10.1161/STROKEAHA.110.593863; Singleton RH, 2010, J NEUROTRAUM, V27, P1091, DOI 10.1089/neu.2010.1291; Stein SC, 2009, J NEUROTRAUM, V26, P1585, DOI [10.1089/neu.2008.0720, 10.1089/neu.2008-0720]; Sun D, 2005, J NEUROTRAUM, V22, P95, DOI 10.1089/neu.2005.22.95; Sun Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035883; SWANSON LW, 1980, NEUROENDOCRINOLOGY, V31, P410, DOI 10.1159/000123111; SWANSON RA, 1990, J CEREBR BLOOD F MET, V10, P290, DOI 10.1038/jcbfm.1990.47; Tamas A, 2006, J NEUROTRAUM, V23, P686, DOI 10.1089/neu.2006.23.686; Thau-Zuchman O, 2010, J CEREBR BLOOD F MET, V30, P1008, DOI 10.1038/jcbfm.2009.271; Thorne RG, 2004, NEUROSCIENCE, V127, P481, DOI 10.1016/j.neuroscience.2004.05.029; Toni N, 2007, NAT NEUROSCI, V10, P727, DOI 10.1038/nn1908; Vivar C, 2013, FRONT NEURAL CIRCUIT, V7, DOI 10.3389/fncir.2013.00015; Vivien D, 2000, J CEREBR BLOOD F MET, V20, P755, DOI 10.1097/00004647-200005000-00001; Wang Y, 2007, BRIT J PHARMACOL, V151, P1377, DOI 10.1038/sj.bjp.0707285; Wu HT, 2008, J NEUROTRAUM, V25, P130, DOI 10.1089/neu.2007.0369; Wu YP, 2000, J CELL BIOL, V148, P1295, DOI 10.1083/jcb.148.6.1295; Xin HQ, 2011, J CEREBR BLOOD F MET, V31, P2181, DOI 10.1038/jcbfm.2011.116; Xin HQ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009027; Xiong Y, 2008, BRAIN RES, V1230, P247, DOI 10.1016/j.brainres.2008.06.127; Xiong Y, 2008, J NEUROSURG, V109, P510, DOI 10.3171/JNS/2008/109/9/0510; Xiong Y, 2013, NAT REV NEUROSCI, V14, P128, DOI 10.1038/nrn3407; Xiong Y, 2012, J NEUROSURG, V116, P1081, DOI 10.3171/2012.1.JNS111729; Xiong Y, 2011, J NEUROSURG, V114, P102, DOI 10.3171/2010.4.JNS10118; Xiong Y, 2010, J NEUROSURG, V113, P598, DOI 10.3171/2009.9.JNS09844; Xiong Y, 2010, J NEUROTRAUM, V27, P205, DOI 10.1089/neu.2009.1001; Yang JM, 2014, CELL REP, V7, P796, DOI 10.1016/j.celrep.2014.03.040; Yepes M, 2004, EXP BIOL MED, V229, P1097, DOI 10.1177/153537020422901103; Yi JH, 2012, J COMP NEUROL, V520, P3295, DOI 10.1002/cne.23156; Zhang C, 1998, J NEUROSCI RES, V52, P342, DOI 10.1002/(SICI)1097-4547(19980501)52:3<342::AID-JNR10>3.0.CO;2-8; Zhang RL, 2002, STROKE, V33, P2675, DOI 10.1161/01.STR.0000034399.95249.59; Zhang RL, 1998, J NEUROL SCI, V160, P1, DOI 10.1016/S0022-510X(98)00155-5; Zhang YL, 2010, BRAIN RES, V1353, P249, DOI 10.1016/j.brainres.2010.07.046; Zhang YL, 2009, BRAIN RES, V1294, P153, DOI 10.1016/j.brainres.2009.07.077; Zhang Y, 2006, BRAIN RES, V1111, P227, DOI 10.1016/j.brainres.2006.07.005; Zhao CM, 2008, CELL, V132, P645, DOI 10.1016/j.cell.2008.01.033; Zhao CM, 2006, J NEUROSCI, V26, P3, DOI 10.1523/JNEUROSCI.3648-05.2006; Zheng WM, 2013, J NEUROTRAUM, V30, P1872, DOI 10.1089/neu.2010.1579	102	25	28	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 3	2014	9	9							e106238	10.1371/journal.pone.0106238	http://dx.doi.org/10.1371/journal.pone.0106238			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3TB	25184365	Green Published, Green Submitted, gold			2022-12-27	WOS:000341257700043
J	Grabowska, AD; Wywial, E; Dunin-Horkawicz, S; Lasica, AM; Wosten, MMSM; Nagy-Staron, A; Godlewska, R; Bocian-Ostrzycka, K; Pienkowska, K; Laniewski, P; Bujnicki, JM; van Putten, JPM; Jagusztyn-Krynicka, EK				Grabowska, Anna D.; Wywial, Ewa; Dunin-Horkawicz, Stanislaw; Lasica, Anna M.; Woesten, Marc M. S. M.; Nagy-Staron, Anna; Godlewska, Renata; Bocian-Ostrzycka, Katarzyna; Pienkowska, Katarzyna; Laniewski, Pawel; Bujnicki, Janusz M.; van Putten, Jos P. M.; Jagusztyn-Krynicka, E. Katarzyna			Functional and Bioinformatics Analysis of Two Campylobacter jejuni Homologs of the Thiol-Disulfide Oxidoreductase, DsbA	PLOS ONE			English	Article							CIS-PROLINE RESIDUE; BOND FORMATION; ARYLSULFATE SULFOTRANSFERASE; HELICOBACTER-PYLORI; PERIPLASMIC SPACE; CXXC-MOTIF; PROTEIN; SYSTEM; EXPRESSION; ISOMERASE	Background: Bacterial Dsb enzymes are involved in the oxidative folding of many proteins, through the formation of disulfide bonds between their cysteine residues. The Dsb protein network has been well characterized in cells of the model microorganism Escherichia coli. To gain insight into the functioning of the Dsb system in epsilon-Proteobacteria, where it plays an important role in the colonization process, we studied two homologs of the main Escherichia coli Dsb oxidase (EcDsbA) that are present in the cells of the enteric pathogen Campylobacter jejuni, the most frequently reported bacterial cause of human enteritis in the world. Methods and Results: Phylogenetic analysis suggests the horizontal transfer of the epsilon-Proteobacterial DsbAs from a common ancestor to gamma-Proteobacteria, which then gave rise to the DsbL lineage. Phenotype and enzymatic assays suggest that the two C. jejuni DsbAs play different roles in bacterial cells and have divergent substrate spectra. CjDsbA1 is essential for the motility and autoagglutination phenotypes, while CjDsbA2 has no impact on those processes. CjDsbA1 plays a critical role in the oxidative folding that ensures the activity of alkaline phosphatase CjPhoX, whereas CjDsbA2 is crucial for the activity of arylsulfotransferase CjAstA, encoded within the dsbA2-dsbB-astA operon. Conclusions: Our results show that CjDsbA1 is the primary thiol-oxidoreductase affecting life processes associated with bacterial spread and host colonization, as well as ensuring the oxidative folding of particular protein substrates. In contrast, CjDsbA2 activity does not affect the same processes and so far its oxidative folding activity has been demonstrated for one substrate, arylsulfotransferase CjAstA. The results suggest the cooperation between CjDsbA2 and CjDsbB. In the case of the CjDsbA1, this cooperation is not exclusive and there is probably another protein to be identified in C. jejuni cells that acts to re-oxidize CjDsbA1. Altogether the data presented here constitute the considerable insight to the Epsilonproteobacterial Dsb systems, which have been poorly understood so far.	[Grabowska, Anna D.; Lasica, Anna M.; Godlewska, Renata; Bocian-Ostrzycka, Katarzyna; Pienkowska, Katarzyna; Laniewski, Pawel; Jagusztyn-Krynicka, E. Katarzyna] Warsaw Univ, Inst Microbiol, Dept Bacterial Genet, Warsaw, Poland; [Wywial, Ewa; Dunin-Horkawicz, Stanislaw; Bujnicki, Janusz M.] Int Inst Mol & Cell Biol, Lab Bioinformat & Prot Engn, Warsaw, Poland; [Woesten, Marc M. S. M.; van Putten, Jos P. M.] Univ Utrecht, Dept Infect Dis & Immunol, Utrecht, Netherlands; [Woesten, Marc M. S. M.; van Putten, Jos P. M.] WOH, Collaborating Ctr Reference & Res Campylobacter, World Org Anim Hlth Reference Lab Campylobacterio, Utrecht, Netherlands; [Nagy-Staron, Anna] IST Austria, Klosterneuburg, Austria; [Bujnicki, Janusz M.] Adam Mickiewicz Univ, Fac Biol, Inst Mol Biol & Biotechnol, Poznan, Poland	University of Warsaw; Miedzynarodowy Instytut Biologii Molekularnej i Komorkowej; Utrecht University; Institute of Science & Technology - Austria; Adam Mickiewicz University	Grabowska, AD (corresponding author), Univ Toulouse, Univ Paul Sabatier, Inst Pharmacol & Struct Biol, Natl Ctr Sci Res, Toulouse, France.	anna.grabowska@ipbs.fr	Godlewska, Renata/O-8781-2017; Staron, Anna/AAN-2969-2021; Lasica, Anna/N-3453-2019; Godlewska, Renata/AAO-8705-2020; Dunin-Horkawicz, Stanislaw/Z-4153-2019; Lasica, Anna M/J-7083-2012	Godlewska, Renata/0000-0001-7810-8482; Staron, Anna/0000-0002-1391-8377; Lasica, Anna/0000-0003-0516-9959; Godlewska, Renata/0000-0001-7810-8482; Dunin-Horkawicz, Stanislaw/0000-0002-4581-1558; Laniewski, Pawel/0000-0002-5190-2173; van Putten, Jos/0000-0002-4126-8172; Bocian-Ostrzycka, Katarzyna Marta/0000-0003-3271-0325; Wosten, Marc/0000-0002-7464-7232; Jagusztyn-Krynicka, Elzbieta/0000-0003-0484-9290; , Anna D./0000-0003-1633-6345	Polish Ministry of Science and Higher Education [N401 183 31/3968, N N303 550 439, POIG. 02.03.00-00-003/09]; National Science Centre (NCN) [2011/03/D/NZ8/03011]; EU [229676]; IIMCB	Polish Ministry of Science and Higher Education(Ministry of Science and Higher Education, Poland); National Science Centre (NCN)(National Science Centre, Poland); EU(European Commission); IIMCB	This work was funded by the grant of Polish Ministry of Science and Higher Education (grant No. N401 183 31/3968 and N N303 550 439). EW has been supported by the Polish Ministry of Science and Higher Education (grant POIG. 02.03.00-00-003/09). SDH has been supported by the National Science Centre (NCN, grant 2011/03/D/NZ8/03011) and by the Polish Ministry of Science and Higher Education (MNiSW, fellowship for outstanding young scientists). JMB has been supported by the 7th Framework Programme of the EU (grant HEALTHPROT, contract number 229676) and by the statutory funds of IIMCB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; BARDWELL JCA, 1991, CELL, V67, P581, DOI 10.1016/0092-8674(91)90532-4; Brady C, 2013, SYST APPL MICROBIOL, V36, P309, DOI 10.1016/j.syapm.2013.03.005; Carrillo CD, 2004, J BIOL CHEM, V279, P20327, DOI 10.1074/jbc.M401134200; Charbonnier JB, 1999, PROTEIN SCI, V8, P96; Chivers PT, 1996, EMBO J, V15, P2659, DOI 10.1002/j.1460-2075.1996.tb00626.x; Chng SS, 2012, MOL MICROBIOL, V85, P996, DOI 10.1111/j.1365-2958.2012.08157.x; Choi JH, 2004, APPL MICROBIOL BIOT, V64, P625, DOI 10.1007/s00253-004-1559-9; Collet JF, 2005, PROTEIN SCI, V14, P1863, DOI 10.1110/ps.051464705; DAILEY FE, 1993, P NATL ACAD SCI USA, V90, P1043, DOI 10.1073/pnas.90.3.1043; Dartigalongue C, 2000, EMBO J, V19, P5980, DOI 10.1093/emboj/19.22.5980; Debarbieux L, 1998, P NATL ACAD SCI USA, V95, P10751, DOI 10.1073/pnas.95.18.10751; DeLano WL, 2002, CURR OPIN STRUC BIOL, V12, P14, DOI 10.1016/S0959-440X(02)00283-X; Denoncin K, 2013, ANTIOXID REDOX SIGN, V19, P63, DOI 10.1089/ars.2012.4864; Denoncin Katleen, 2013, Methods Mol Biol, V966, P325, DOI 10.1007/978-1-62703-245-2_20; Depuydt M, 2009, SCIENCE, V326, P1109, DOI 10.1126/science.1179557; Duan QD, 2013, J BASIC MICROB, V53, P1, DOI [10.1002/jobm.201100335, 10.1002/jobm.201370001]; Dutton RJ, 2008, P NATL ACAD SCI USA, V105, P11933, DOI 10.1073/pnas.0804621105; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Ferre F, 2005, NUCLEIC ACIDS RES, V33, pW230, DOI 10.1093/nar/gki412; Frickey T, 2004, BIOINFORMATICS, V20, P3702, DOI 10.1093/bioinformatics/bth444; Gleiter S, 2008, BBA-MOL CELL RES, V1783, P530, DOI 10.1016/j.bbamcr.2008.02.009; Goemans C, 2014, BBA-MOL CELL RES, V1843, P1517, DOI 10.1016/j.bbamcr.2013.10.014; Golden NJ, 2002, INFECT IMMUN, V70, P1761, DOI 10.1128/IAI.70.4.1761-1771.2002; Grabowska AD, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-166; Grimshaw JPA, 2008, J MOL BIOL, V380, P667, DOI 10.1016/j.jmb.2008.05.031; Guddat LW, 1997, PROTEIN SCI, V6, P1893, DOI 10.1002/pro.5560060910; Hendrixson DR, 2003, MOL MICROBIOL, V50, P687, DOI 10.1046/j.1365-2958.2003.03731.x; Heras B, 2010, J BIOL CHEM, V285, P18423, DOI 10.1074/jbc.M110.101360; Heras B, 2009, NAT REV MICROBIOL, V7, P215, DOI 10.1038/nrmicro2087; Hiniker A, 2007, P NATL ACAD SCI USA, V104, P11670, DOI 10.1073/pnas.0704692104; Inaba K, 2009, J BIOCHEM, V146, P591, DOI 10.1093/jb/mvp102; Ito K, 2008, CURR OPIN STRUC BIOL, V18, P450, DOI 10.1016/j.sbi.2008.02.002; Jo S, 2008, J COMPUT CHEM, V29, P1859, DOI 10.1002/jcc.20945; Jonda S, 1999, EMBO J, V18, P3271, DOI 10.1093/emboj/18.12.3271; Kadokura H, 2005, J BACTERIOL, V187, P1519, DOI 10.1128/JB.187.4.1519-1522.2005; Kadokura H, 2004, SCIENCE, V303, P534, DOI 10.1126/science.1091724; Kadokura H, 2009, CELL, V138, P1164, DOI 10.1016/j.cell.2009.07.030; KIM DH, 1986, BIOCHIM BIOPHYS ACTA, V872, P33, DOI 10.1016/0167-4838(86)90144-5; KIM DH, 1986, BIOCHEM PHARMACOL, V35, P3507, DOI 10.1016/0006-2952(86)90619-2; KORLATH JA, 1985, J INFECT DIS, V152, P592, DOI 10.1093/infdis/152.3.592; Kosinski J, 2005, PROTEINS, V61, P106, DOI 10.1002/prot.20726; Kouwen TRHM, 2007, MOL MICROBIOL, V64, P984, DOI 10.1111/j.1365-2958.2007.05707.x; Kpadeh ZZ, 2013, J BACTERIOL, V195, P1825, DOI 10.1128/JB.01949-12; Kurowski MA, 2003, NUCLEIC ACIDS RES, V31, P3305, DOI 10.1093/nar/gkg557; Kwon AR, 2005, ARCH PHARM RES, V28, P561, DOI 10.1007/BF02977759; Lafaye C, 2009, J MOL BIOL, V392, P952, DOI 10.1016/j.jmb.2009.07.056; Lasica AM, 2010, J APPL GENET, V51, P383, DOI 10.1007/BF03208868; Leach S, 1997, J APPL MICROBIOL, V82, P631; LEYLAND ML, 1991, EUR J BIOCHEM, V202, P85, DOI 10.1111/j.1432-1033.1991.tb16347.x; Macnab RM, 2003, ANNU REV MICROBIOL, V57, P77, DOI 10.1146/annurev.micro.57.030502.090832; Malojcic G, 2008, P NATL ACAD SCI USA, V105, P19217, DOI 10.1073/pnas.0806997105; Masip L, 2004, SCIENCE, V303, P1185, DOI 10.1126/science.1092612; Matias VRF, 2006, J BACTERIOL, V188, P1011, DOI 10.1128/JB.188.3.1011-1021.2006; Matias VRF, 2005, MOL MICROBIOL, V56, P240, DOI 10.1111/j.1365-2958.2005.04535.x; MAYER MP, 1995, GENE, V163, P41, DOI 10.1016/0378-1119(95)00389-N; McMahon RM, 2014, BBA-PROTEINS PROTEOM, V1844, P1391, DOI 10.1016/j.bbapap.2014.01.013; Messens J, 2006, INT J BIOCHEM CELL B, V38, P1050, DOI 10.1016/j.biocel.2005.12.011; Myers JD, 2005, MICROBIOL-SGM, V151, P233, DOI 10.1099/mic.0.27573-0; PALMER SR, 1983, LANCET, V1, P287, DOI 10.1016/S0140-6736(83)91698-7; Pawlowski M, 2009, POL J MICROBIOL, V58, P181; Pawlowski M, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-403; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Price MN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009490; Quan S, 2007, J BIOL CHEM, V282, P28823, DOI 10.1074/jbc.M705291200; Raczko AM, 2005, MICROBIOL-SGM, V151, P219, DOI 10.1099/mic.0.27483-0; Ren GP, 2009, J BIOL CHEM, V284, P10150, DOI 10.1074/jbc.M809509200; Rinaldi FC, 2009, BIOCHEMISTRY-US, V48, P3508, DOI 10.1021/bi801899x; Roszczenko P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046563; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Sambrook J., 2001, MOL CLONING LAB MANU; Soding J, 2005, BIOINFORMATICS, V21, P951, DOI 10.1093/bioinformatics/bti125; Sone M, 1997, J BIOL CHEM, V272, P6174, DOI 10.1074/jbc.272.10.6174; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; Teramoto T, 2009, FEBS LETT, V583, P3091, DOI 10.1016/j.febslet.2009.08.016; Testerman TL, 2001, J CLIN MICROBIOL, V39, P3842, DOI 10.1128/JCM.39.11.3842-3850.2001; Tinsley CR, 2004, J BIOL CHEM, V279, P27078, DOI 10.1074/jbc.M313404200; Totsika M, 2009, J BACTERIOL, V191, P3901, DOI 10.1128/JB.00143-09; van Mourik A, 2008, MICROBIOL-SGM, V154, P584, DOI 10.1099/mic.0.2007/012120-0; Vertommen D, 2008, MOL MICROBIOL, V67, P336, DOI 10.1111/j.1365-2958.2007.06030.x; Wosten MMSM, 2006, MOL MICROBIOL, V62, P278, DOI 10.1111/j.1365-2958.2006.05372.x; YAO RJ, 1993, GENE, V130, P127, DOI 10.1016/0378-1119(93)90355-7; Yao RJ, 1996, J BACTERIOL, V178, P3335, DOI 10.1128/jb.178.11.3335-3338.1996	83	12	12	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2014	9	9							e106247	10.1371/journal.pone.0106247	http://dx.doi.org/10.1371/journal.pone.0106247			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3LR	25181355	gold, Green Submitted, Green Published, Green Accepted			2022-12-27	WOS:000341231500064
J	Kubota, H; Nagao, S; Obata, K; Hirono, M				Kubota, Hideo; Nagao, Soichi; Obata, Kunihiko; Hirono, Moritoshi			mGluR1-Mediated Excitation of Cerebellar GABAergic Interneurons Requires Both G Protein-Dependent and Src-ERK1/2-Dependent Signaling Pathways	PLOS ONE			English	Article							METABOTROPIC GLUTAMATE RECEPTORS; LONG-TERM DEPRESSION; PURKINJE-CELLS; SYNAPTIC INHIBITION; MOUSE CEREBELLUM; TYROSINE KINASE; ORIENS/ALVEUS INTERNEURONS; DOPAMINE NEURONS; TRPC3 CHANNELS; INWARD CURRENT	Stimulation of type I metabotropic glutamate receptors (mGluR1/5) in several neuronal types induces slow excitatory responses through activation of transient receptor potential canonical (TRPC) channels. GABAergic cerebellar molecular layer interneurons (MLIs) modulate firing patterns of Purkinje cells (PCs), which play a key role in cerebellar information processing. MLIs express mGluR1, and activation of mGluR1 induces an inward current, but its precise intracellular signaling pathways are unknown. We found that mGluR1 activation facilitated spontaneous firing of mouse cerebellar MLIs through an inward current mediated by TRPC1 channels. This mGluR1-mediated inward current depends on both G protein-dependent and -independent pathways. The nonselective protein tyrosine kinase inhibitors genistein and AG490 as well as the selective extracellular signal-regulated kinase 1/2 (ERK1/2) inhibitors PD98059 and SL327 suppressed the mGluR1-mediated current responses. Following G protein blockade, the residual mGluR1-mediated inward current was significantly reduced by the selective Src tyrosine kinase inhibitor PP2. In contrast to cerebellar PCs, GABA(B) receptor activation in MLIs did not alter the mGluR1-mediated inward current, suggesting that there is no cross-talk between mGluR1 and GABA(B) receptors in MLIs. Thus, activation of mGluR1 facilitates firing of MLIs through the TRPC1-mediated inward current, which depends on not only G protein-dependent but also Src-ERK1/2-dependent signaling pathways, and consequently depresses the excitability of cerebellar PCs.	[Kubota, Hideo] TMDU, Hosp Med, Bunkyo Ku, Tokyo, Japan; [Nagao, Soichi; Hirono, Moritoshi] RIKEN, Brain Sci Inst, Lab Motor Learning Control, Wako, Saitama, Japan; [Obata, Kunihiko; Hirono, Moritoshi] RIKEN, Brain Sci Inst, Obata Res Unit, Wako, Saitama, Japan	Tokyo Medical & Dental University (TMDU); RIKEN; RIKEN	Kubota, H (corresponding author), TMDU, Hosp Med, Bunkyo Ku, Tokyo, Japan.	hkubota.supp@tmd.ac.jp; mhirono@mail.doshisha.ac.jp		Hirono, Moritoshi/0000-0001-6068-1045	Ministry of Education, Culture, Sports, Science and Technology, Japan [16700344]; RIKEN	Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); RIKEN	This work was supported by Grants-in-Aid for Young Scientists (B) 16700344 (M.H.) from the Ministry of Education, Culture, Sports, Science and Technology, Japan, and by the Special Postdoctoral Researchers Program (M.H.) from RIKEN. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ady V, 2014, EMBO REP, V15, P103, DOI 10.1002/embr.201337371; Atkins CM, 1998, NAT NEUROSCI, V1, P602, DOI 10.1038/2836; Auger C, 2010, J PHYSIOL-LONDON, V588, P3063, DOI 10.1113/jphysiol.2010.191080; Barmack NH, 2008, J NEUROSCI, V28, P1140, DOI 10.1523/JNEUROSCI.3942-07.2008; Bartos M, 2007, NAT REV NEUROSCI, V8, P45, DOI 10.1038/nrn2044; Becker EBE, 2009, P NATL ACAD SCI USA, V106, P6706, DOI 10.1073/pnas.0810599106; Benquet P, 2002, J NEUROSCI, V22, P9679; Bichet D, 2003, NAT REV NEUROSCI, V4, P957, DOI 10.1038/nrn1244; Camire O, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00259; Canepari M, 2003, J NEUROSCI, V23, P4066; Collin T, 2009, J NEUROSCI, V29, P9281, DOI 10.1523/JNEUROSCI.1865-09.2009; De Zeeuw CI, 2011, NAT REV NEUROSCI, V12, P327, DOI 10.1038/nrn3011; Dietrich A, 2005, PFLUG ARCH EUR J PHY, V451, P72, DOI 10.1007/s00424-005-1460-0; Dizon MJ, 2011, J NEUROSCI, V31, P10463, DOI 10.1523/JNEUROSCI.1350-11.2011; Endo S, 2003, NEUROPHARMACOLOGY, V45, P863, DOI 10.1016/S0028-3908(03)00210-7; Gee CE, 2004, BRAIN RES, V1000, P92, DOI 10.1016/j.brainres.2003.11.046; Gee CE, 2003, J PHYSIOL-LONDON, V546, P655, DOI 10.1113/jphysiol.2002.032961; Gerber U, 2007, CURR OPIN PHARMACOL, V7, P56, DOI 10.1016/j.coph.2006.08.008; Glitsch MD, 2010, FASEB J, V24, P318, DOI 10.1096/fj.09-134973; Hartmann J, 2009, ACTA PHYSIOL, V195, P79, DOI 10.1111/j.1748-1716.2008.01923.x; Hartmann J, 2008, NEURON, V59, P392, DOI 10.1016/j.neuron.2008.06.009; Hausser M, 1997, NEURON, V19, P665, DOI 10.1016/S0896-6273(00)80379-7; Heuss C, 1999, NAT NEUROSCI, V2, P1070, DOI 10.1038/15996; Hirono M, 2001, NAT NEUROSCI, V4, P1207, DOI 10.1038/nn764; Hirono M, 1998, BIOCHEM BIOPH RES CO, V251, P753, DOI 10.1006/bbrc.1998.9465; Huang WC, 2007, CELL CALCIUM, V42, P1, DOI 10.1016/j.ceca.2006.11.002; Ireland DR, 2002, J NEUROPHYSIOL, V88, P107, DOI 10.1152/jn.2002.88.1.107; Ito M, 2006, PROG NEUROBIOL, V78, P272, DOI 10.1016/j.pneurobio.2006.02.006; Ito-Ishida A, 2006, EUR J NEUROSCI, V24, P1617, DOI 10.1111/j.1460-9568.2006.05055.x; Karakossian MH, 2004, J NEUROPHYSIOL, V92, P1558, DOI 10.1152/jn.00300.2004; Kawasaki H, 1999, J BIOL CHEM, V274, P13498, DOI 10.1074/jbc.274.19.13498; Kelly L, 2009, NAT NEUROSCI, V12, P593, DOI 10.1038/nn.2309; Kiyonaka S, 2009, P NATL ACAD SCI USA, V106, P5400, DOI 10.1073/pnas.0808793106; Kubota H, 2007, NEUROSCI RES, V58, pS196, DOI 10.1016/j.neures.2007.06.877; Kullmann DM, 2007, NAT REV NEUROSCI, V8, P687, DOI 10.1038/nrn2207; Leftowitz RJ, 2005, SCIENCE, V308, P512, DOI 10.1126/science.1109237; LLANO I, 1995, J PHYSIOL-LONDON, V486, P163, DOI 10.1113/jphysiol.1995.sp020800; Luscher C, 2010, NEURON, V65, P445, DOI 10.1016/j.neuron.2010.01.016; Luttrell LM, 1999, SCIENCE, V283, P655, DOI 10.1126/science.283.5402.655; Mittmann W, 2005, J PHYSIOL-LONDON, V563, P369, DOI 10.1113/jphysiol.2004.075028; Nelson C, 2012, J BIOL CHEM, V287, P6326, DOI 10.1074/jbc.M111.246553; Obata K, 2008, BIOCHEM BIOPH RES CO, V370, P429, DOI 10.1016/j.bbrc.2008.03.110; Rancillac A, 2004, J PHYSIOL-LONDON, V554, P707, DOI 10.1113/jphysiol.2003.055871; Saleh SN, 2008, J PHYSIOL-LONDON, V586, P2463, DOI 10.1113/jphysiol.2008.152157; Sansone A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087721; Smith SL, 2005, P NATL ACAD SCI USA, V102, P14901, DOI 10.1073/pnas.0505028102; Sugiyama T, 1999, BIOCHEM BIOPH RES CO, V265, P473, DOI 10.1006/bbrc.1999.1628; Sweatt JD, 2004, CURR OPIN NEUROBIOL, V14, P311, DOI 10.1016/j.conb.2004.04.001; Tempia F, 1998, J NEUROPHYSIOL, V80, P520, DOI 10.1152/jn.1998.80.2.520; Topolnik L, 2006, J PHYSIOL-LONDON, V575, P115, DOI 10.1113/jphysiol.2006.112896; Tozzi A, 2003, EUR J NEUROSCI, V18, P2133, DOI 10.1046/j.1460-9568.2003.02936.x; Tozzi A, 2001, J NEUROPHYSIOL, V85, P2490, DOI 10.1152/jn.2001.85.6.2490; Umemori H, 1997, SCIENCE, V276, P1878, DOI 10.1126/science.276.5320.1878; Wulff P, 2009, NAT NEUROSCI, V12, P1042, DOI 10.1038/nn.2348	54	10	10	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2014	9	9							e106316	10.1371/journal.pone.0106316	http://dx.doi.org/10.1371/journal.pone.0106316			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3LR	25181481	Green Published, Green Submitted, gold			2022-12-27	WOS:000341231500076
J	Zilinskas, J; Lancinskas, A; Guarracino, MR				Zilinskas, Julius; Lancinskas, Algirdas; Guarracino, Mario Rosario			Application of Multi-Objective Optimization to Pooled Experiments of Next Generation Sequencing for Detection of Rare Mutations	PLOS ONE			English	Article								In this paper we propose some mathematical models to plan a Next Generation Sequencing experiment to detect rare mutations in pools of patients. A mathematical optimization problem is formulated for optimal pooling, with respect to minimization of the experiment cost. Then, two different strategies to replicate patients in pools are proposed, which have the advantage to decrease the overall costs. Finally, a multi-objective optimization formulation is proposed, where the trade-off between the probability to detect a mutation and overall costs is taken into account. The proposed solutions are devised in pursuance of the following advantages: (i) the solution guarantees mutations are detectable in the experimental setting, and (ii) the cost of the NGS experiment and its biological validation using Sanger sequencing is minimized. Simulations show replicating pools can decrease overall experimental cost, thus making pooling an interesting option.	[Zilinskas, Julius; Lancinskas, Algirdas] Vilnius Univ, Inst Math & Informat, Vilnius, Lithuania; [Guarracino, Mario Rosario] High Performance Comp & Networking Inst, Natl Res Council, Naples, Italy	Vilnius University	Zilinskas, J (corresponding author), Vilnius Univ, Inst Math & Informat, Vilnius, Lithuania.	julius.zilinskas@mii.vu.lt	Guarracino, Mario Rosario/L-3815-2013	Guarracino, Mario Rosario/0000-0003-2870-8134; Lancinskas, Algirdas/0000-0002-9403-4978	Research Council of Lithuania [MIP-063/2012]; Italian Flagship Project Interomics; Italian projects [PON02_00619]	Research Council of Lithuania(Research Council of Lithuania (LMTLT)); Italian Flagship Project Interomics; Italian projects	This research was funded by a grant (No. MIP-063/2012) from the Research Council of Lithuania. This work has been partially funded by the Italian Flagship Project Interomics, The Italian PON02_00619 projects, and F.A.R. LAB-GTP initiative. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Calvo SE, 2010, NAT GENET, V42, P851, DOI 10.1038/ng.659; Chinchuluun A, 2008, SPRINGER SER OPTIM A, V17, P1, DOI 10.1007/978-0-387-77247-9; Chinchuluun A, 2007, ANN OPER RES, V154, P29, DOI 10.1007/s10479-007-0186-0; Deb K., 2005, MULTIOBJECTIVE OPTIM, P273, DOI [10.1007/0-387-28356-0_10., DOI 10.1007/0-387-28356-0_10]; Doumpos M, 2010, APPL OPTIM, V103, P215, DOI 10.1007/978-3-540-92828-7_7; Ferraro MB, 2013, LECT NOTES BIOINFORM; Kaplan JC, 2013, NEUROMUSCULAR DISORD, V23, P1081, DOI 10.1016/j.nmd.2013.10.006; Luc DT, 2008, SPRINGER SER OPTIM A, V17, P481; Wang Tao, 2011, Frontiers in Genetics, V2, P51, DOI 10.3389/fgene.2011.00051	10	4	4	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2014	9	9							e104992	10.1371/journal.pone.0104992	http://dx.doi.org/10.1371/journal.pone.0104992			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3LR	25181462	Green Published, gold, Green Submitted			2022-12-27	WOS:000341231500015
J	Hu, GZ; Lou, ZK; Gupta, M				Hu, Guangzhen; Lou, Zhenkun; Gupta, Mamta			The Long Non-Coding RNA GAS5 Cooperates with the Eukaryotic Translation Initiation Factor 4E to Regulate c-Myc Translation	PLOS ONE			English	Article							ONCOGENIC TRANSCRIPTION FACTOR; MULTIPLE-MYELOMA CELLS; RIBOSOME ENTRY SITE; DENDRITIC BC1 RNA; MESSENGER-RNA; GROWTH-ARREST; MOLECULAR-MECHANISMS; BINDING SITES; PROTEIN; INHIBITION	Long noncoding RNAs (lncRNAs) are important regulators of transcription; however, their involvement in protein translation is not well known. Here we explored whether the lncRNA GAS5 is associated with translation initiation machinery and regulates translation. GAS5 was enriched with eukaryotic translation initiation factor-4E (eIF4E) in an RNA-immunoprecipitation assay using lymphoma cell lines. We identified two RNA binding motifs within eIF4E protein and the deletion of each motif inhibited the binding of GAS5 with eIF4E. To confirm the role of GAS5 in translation regulation, GAS5 siRNA and in vitro transcribed GAS5 RNA were used to knock down or overexpress GAS5, respectively. GAS5 siRNA had no effect on global protein translation but did specifically increase c-Myc protein level without an effect on c-Myc mRNA. The mechanism of this increase in c-Myc protein was enhanced association of c-Myc mRNA with the polysome without any effect on protein stability. In contrast, overexpression of in vitro transcribed GAS5 RNA suppressed c-Myc protein without affecting c-Myc mRNA. Interestingly, GAS5 was found to be bound with c-Myc mRNA, suggesting that GAS5 regulates c-Myc translation through lncRNA-mRNA interaction. Our findings have uncovered a role of GAS5 lncRNA in translation regulation through its interactions with eIF4E and c-Myc mRNA.	[Gupta, Mamta] Mayo Clin, Dept Internal Med, Div Hematol, Rochester, MN 55905 USA; Mayo Clin, Dept Internal Med, Div Oncol Res, Rochester, MN USA	Mayo Clinic; Mayo Clinic	Gupta, M (corresponding author), Mayo Clin, Dept Internal Med, Div Hematol, Rochester, MN 55905 USA.	gupta.mamta@mayo.edu	Hu, Guangzhen/B-2240-2015		National Cancer Institute (NCI) Lymphoma SPORE [P50 CA97274]; NATIONAL CANCER INSTITUTE [R01CA130996, R01CA189666, P50CA097274] Funding Source: NIH RePORTER	National Cancer Institute (NCI) Lymphoma SPORE; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study is supported by National Cancer Institute (NCI) Lymphoma SPORE (P50 CA97274) to MG. The funder had no role in the design or data collection and analysis, decision to publish, or preparation of the manuscript.	AMATI B, 1994, CURR OPIN GENET DEV, V4, P102, DOI 10.1016/0959-437X(94)90098-1; Bert AG, 2006, RNA, V12, P1074, DOI 10.1261/rna.2320506; Carrieri C, 2012, NATURE, V491, P454, DOI 10.1038/nature11508; Dang CV, 1997, J BIOMED SCI, V4, P269, DOI 10.1007/BF02258350; Dang CV, 1999, EXP CELL RES, V253, P63, DOI 10.1006/excr.1999.4686; Flintoft L, 2013, NAT REV GENET, V14, P3534, DOI 10.1038/nrg3534; Gee HE, 2011, BRIT J CANCER, V104, P1168, DOI 10.1038/sj.bjc.6606076; Gumireddy K, 2013, EMBO J, V32, P2672, DOI 10.1038/emboj.2013.188; Gupta M, 2012, BLOOD, V120, P4400, DOI 10.1182/blood-2012-05-428466; Guttman M, 2013, CELL, V154, P240, DOI 10.1016/j.cell.2013.06.009; HANN SR, 1984, MOL CELL BIOL, V4, P2486, DOI 10.1128/MCB.4.11.2486; Hansson MD, 2008, ANAL BIOCHEM, V375, P373, DOI 10.1016/j.ab.2007.12.005; Holcik M, 2005, NAT REV MOL CELL BIO, V6, P318, DOI 10.1038/nrm1618; Hu GZ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067851; Ingolia NT, 2011, CELL, V147, P789, DOI 10.1016/j.cell.2011.10.002; Jefferies HBJ, 1997, EMBO J, V16, P3693, DOI 10.1093/emboj/16.12.3693; Kino T, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000568; Kondrashov AV, 2005, J MOL BIOL, V353, P88, DOI 10.1016/j.jmb.2005.07.049; Kornienko AE, 2013, BMC BIOL, V11, DOI 10.1186/1741-7007-11-59; KOROMILAS AE, 1992, EMBO J, V11, P4153, DOI 10.1002/j.1460-2075.1992.tb05508.x; Kumar M, 2008, PROTEINS, V71, P189, DOI 10.1002/prot.21677; LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y; Liao BS, 2007, NAT STRUCT MOL BIOL, V14, P511, DOI 10.1038/nsmb1249; Lin D, 2008, MOL CELL BIOL, V28, P3008, DOI 10.1128/MCB.01800-07; Liu ZH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073991; Lu XX, 2013, CELL TISSUE RES, V354, P891, DOI 10.1007/s00441-013-1711-x; Ma XJM, 2009, NAT REV MOL CELL BIO, V10, P307, DOI 10.1038/nrm2672; Mourtada-Maarabouni M, 2008, J CELL SCI, V121, P939, DOI 10.1242/jcs.024646; Mourtada-Maarabouni M, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/358015; Mourtada-Maarabouni M, 2010, MOL PHARMACOL, V78, P19, DOI 10.1124/mol.110.064055; Nanbru C, 2001, ONCOGENE, V20, P4270, DOI 10.1038/sj.onc.1204548; Nanbru C, 1997, J BIOL CHEM, V272, P32061, DOI 10.1074/jbc.272.51.32061; Pichon X, 2012, CURR PROTEIN PEPT SC, V13, P294, DOI 10.2174/138920312801619475; Qiao HP, 2013, ASIAN PAC J CANCER P, V14, P1077, DOI 10.7314/APJCP.2013.14.2.1077; Raho G, 2000, GENE, V256, P13, DOI 10.1016/S0378-1119(00)00363-2; Shi X, 2013, MOL CARCINOGENESIS; Shi YJ, 2011, J BIOL CHEM, V286, P67, DOI 10.1074/jbc.M110.153221; Shi YJ, 2008, CANCER RES, V68, P10215, DOI 10.1158/0008-5472.CAN-08-1066; Sonenberg N, 2009, CELL, V136, P731, DOI 10.1016/j.cell.2009.01.042; Thoma C, 2008, RNA, V14, P1579, DOI 10.1261/rna.1043908; Wang HD, 2005, J CELL BIOL, V171, P811, DOI 10.1083/jcb.200506006; Wang KC, 2011, MOL CELL, V43, P904, DOI 10.1016/j.molcel.2011.08.018; Wang LJ, 2006, NUCLEIC ACIDS RES, V34, pW243, DOI 10.1093/nar/gkl298; Wierstra I, 2008, ADV CANCER RES, V99, P113, DOI 10.1016/S0065-230X(07)99004-1; WIGHTMAN B, 1993, CELL, V75, P855, DOI 10.1016/0092-8674(93)90530-4; Williams GT, 2011, BIOCHEM SOC T, V39, P482, DOI 10.1042/BST0390482; Yoon JH, 2012, MOL CELL, V47, P648, DOI 10.1016/j.molcel.2012.06.027; Zalfa F, 2003, CELL, V112, P317, DOI 10.1016/S0092-8674(03)00079-5	48	94	98	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2014	9	9							e107016	10.1371/journal.pone.0107016	http://dx.doi.org/10.1371/journal.pone.0107016			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4JX	25197831	Green Published, gold, Green Submitted			2022-12-27	WOS:000341304700075
J	Soumya, SS; Sthanam, LK; Padinhateeri, R; Inamdar, MM; Sen, S				Soumya, S. S.; Sthanam, Lakshmi Kavitha; Padinhateeri, Ranjith; Inamdar, Mandar M.; Sen, Shamik			Probing Cellular Mechanoadaptation Using Cell-Substrate De-Adhesion Dynamics: Experiments and Model	PLOS ONE			English	Article							MATRIX-RIGIDITY; FOCAL ADHESIONS; LIGAND DENSITY; ELASTICITY; CONTRACTILITY; STIFFNESS; MOTILITY; POLARIZATION; MECHANICS; PHYSICS	Physical properties of the extracellular matrix (ECM) are known to regulate cellular processes ranging from spreading to differentiation, with alterations in cell phenotype closely associated with changes in physical properties of cells themselves. When plated on substrates of varying stiffness, fibroblasts have been shown to exhibit stiffness matching property, wherein cell cortical stiffness increases in proportion to substrate stiffness up to 5 kPa, and subsequently saturates. Similar mechanoadaptation responses have also been observed in other cell types. Trypsin de-adhesion represents a simple experimental framework for probing the contractile mechanics of adherent cells, with de-adhesion timescales shown to scale inversely with cortical stiffness values. In this study, we combine experiments and computation in deciphering the influence of substrate properties in regulating de-adhesion dynamics of adherent cells. We first show that NIH 3T3 fibroblasts cultured on collagen-coated polyacrylamide hydrogels de-adhere faster on stiffer substrates. Using a simple computational model, we qualitatively show how substrate stiffness and cell-substrate bond breakage rate collectively influence de-adhesion timescales, and also obtain analytical expressions of de-adhesion timescales in certain regimes of the parameter space. Finally, by comparing stiffness-dependent experimental and computational de-adhesion responses, we show that faster de-adhesion on stiffer substrates arises due to force-dependent breakage of cell-matrix adhesions. In addition to illustrating the utility of employing trypsin de-adhesion as a biophysical tool for probing mechanoadaptation, our computational results highlight the collective interplay of substrate properties and bond breakage rate in setting de-adhesion timescales.	[Soumya, S. S.; Inamdar, Mandar M.] Indian Inst Technol, Dept Civil Engn, Bombay 400076, Maharashtra, India; [Sthanam, Lakshmi Kavitha; Padinhateeri, Ranjith; Sen, Shamik] Indian Inst Technol, Dept Biosci & Bioengn, Bombay 400076, Maharashtra, India	Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Bombay; Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Bombay	Padinhateeri, R (corresponding author), Indian Inst Technol, Dept Biosci & Bioengn, Bombay 400076, Maharashtra, India.	ranjithp@iitb.ac.in; minamdar@civil.iitb.ac.in; shamiks@iitb.ac.in	Sthanam, Lakshmi Kavitha/AAY-4326-2020	Sen, Shamik/0000-0002-8639-8659	Department of Science and Technology, India [SR/FTP/ETA-45/2012]; Department of Biotechnology, India, IYBA	Department of Science and Technology, India(Department of Science & Technology (India)); Department of Biotechnology, India, IYBA	MMI gratefully acknowledges financial support from the Department of Science and Technology, India, grant no. SR/FTP/ETA-45/2012 and the Department of Biotechnology, India, IYBA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balaban NQ, 2001, NAT CELL BIOL, V3, P466, DOI 10.1038/35074532; Banerjee S, 2013, NEW J PHYS, V15, DOI 10.1088/1367-2630/15/3/035015; Banerjee S, 2012, PHYS REV LETT, V109, DOI 10.1103/PhysRevLett.109.108101; BELL GI, 1984, BIOPHYS J, V45, P1051, DOI 10.1016/S0006-3495(84)84252-6; BELL GI, 1978, SCIENCE, V200, P618, DOI 10.1126/science.347575; Cavalcanti-Adam EA, 2007, BIOPHYS J, V92, P2964, DOI 10.1529/biophysj.106.089730; Coskun H, 2007, J THEOR BIOL, V244, P169, DOI 10.1016/j.jtbi.2006.07.025; Das A, 2013, J CARCINOGENESIS MUT, VS13; Discher DE, 2005, SCIENCE, V310, P1139, DOI 10.1126/science.1116995; Dowling EP, 2014, ANN BIOMED ENG, V42, P1037, DOI 10.1007/s10439-013-0965-5; Doyle AD, 2009, J CELL BIOL, V184, P481, DOI 10.1083/jcb.200810041; Edwards CM, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.128101; Engler A, 2004, BIOPHYS J, V86, P617, DOI 10.1016/S0006-3495(04)74140-5; Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044; Engler AJ, 2004, J CELL BIOL, V166, P877, DOI 10.1083/jcb.200405004; Erdmann T, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.108102; Evans E, 1997, BIOPHYS J, V72, P1541, DOI 10.1016/S0006-3495(97)78802-7; Evans EA, 2007, SCIENCE, V316, P1148, DOI 10.1126/science.1137592; Friedrich BM, 2012, SOFT MATTER, V8, P3223, DOI 10.1039/c2sm06450b; Gao HJ, 2011, J R SOC INTERFACE, V8, P1217, DOI 10.1098/rsif.2011.0157; HAMMER DA, 1987, BIOPHYS J, V52, P475, DOI 10.1016/S0006-3495(87)83236-8; Harland B, 2011, PHYS BIOL, V8, DOI 10.1088/1478-3975/8/1/015011; He SJ, 2014, J MECH PHYS SOLIDS, V70, P116, DOI 10.1016/j.jmps.2014.05.016; Isabey D, 2013, J BIOMECH, V46, P307, DOI 10.1016/j.jbiomech.2012.10.039; Jamali Y, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012097; Kapoor A, 2012, INT J CELL BIO, V471591; Karcher H, 2003, BIOPHYS J, V85, P3336, DOI 10.1016/S0006-3495(03)74753-5; Kong HJ, 2005, P NATL ACAD SCI USA, V102, P4300, DOI 10.1073/pnas.0405873102; LANDAU LD, 2005, THEORY ELASTICITY; Larripa K, 2006, PHYSICA A, V372, P113, DOI 10.1016/j.physa.2006.05.008; Levental KR, 2009, CELL, V139, P891, DOI 10.1016/j.cell.2009.10.027; Lin YC, 2010, PHYS REV E, V82, DOI 10.1103/PhysRevE.82.041918; Lo CM, 2000, BIOPHYS J, V79, P144, DOI 10.1016/S0006-3495(00)76279-5; Mesquita AD, 2003, ENG ANAL BOUND ELEM, V27, P885, DOI 10.1016/S0955-7997(03)00060-2; Oberhauser AF, 2002, J MOL BIOL, V319, P433, DOI 10.1016/S0022-2836(02)00306-6; Park S, 2005, BIOPHYS J, V89, P4330, DOI 10.1529/biophysj.104.053462; Pelham RJ, 1997, P NATL ACAD SCI USA, V94, P13661, DOI 10.1073/pnas.94.25.13661; Prager-Khoutorsky M, 2011, NAT CELL BIOL, V13, P1457, DOI 10.1038/ncb2370; Rebelo LM, 2013, NANOTECHNOLOGY, V24, DOI 10.1088/0957-4484/24/5/055102; Reinhart-King CA, 2005, BIOPHYS J, V89, P676, DOI 10.1529/biophysj.104.054320; Ronan W, 2014, BIOMECH MODEL MECHAN, V13, P417, DOI 10.1007/s10237-013-0506-z; Safran SA, 2005, PHYSICA A, V352, P171, DOI 10.1016/j.physa.2004.12.035; Schwarz US, 2013, REV MOD PHYS, V85, P1327, DOI 10.1103/RevModPhys.85.1327; Schwarz US, 2006, BIOSYSTEMS, V83, P225, DOI 10.1016/j.biosystems.2005.05.019; Sen S, 2012, J R SOC INTERFACE, V9, P1311, DOI 10.1098/rsif.2011.0567; Sen S, 2011, ANN BIOMED ENG, V39, P1163, DOI 10.1007/s10439-010-0195-z; Sen S, 2011, EUR J CELL BIOL, V90, P249, DOI 10.1016/j.ejcb.2010.06.005; Sen S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008427; Sen S, 2009, CELL MOL BIOENG, V2, P218, DOI 10.1007/s12195-009-0057-7; Sen S, 2009, CELL MOL BIOENG, V2, P39, DOI 10.1007/s12195-009-0052-z; Sens P, 2013, EPL-EUROPHYS LETT, V104, DOI 10.1209/0295-5075/104/38003; Solon J, 2007, BIOPHYS J, V93, P4453, DOI 10.1529/biophysj.106.101386; Soumya SS, 2014, APPL PHYS LETT, V104, DOI 10.1063/1.4866797; Tse J.R., 2010, CURR PROTOC CELL BIO, V10, pUnit, DOI [DOI 10.1002/0471143030.CB1016S47, 10.1002/0471143030.cb1016s47]; Ulrich TA, 2009, CANCER RES, V69, P4167, DOI 10.1158/0008-5472.CAN-08-4859; Walcott S, 2010, P NATL ACAD SCI USA, V107, P7757, DOI 10.1073/pnas.0912739107; Yamada S, 2000, BIOPHYS J, V78, P1736, DOI 10.1016/S0006-3495(00)76725-7; Yoon SH, 2011, BIOMATERIALS, V32, P7286, DOI 10.1016/j.biomaterials.2011.05.077; Yoon SH, 2011, APPL PHYS LETT, V98, DOI 10.1063/1.3556557; Zemel A, 2010, NAT PHYS, V6, P468, DOI 10.1038/NPHYS1613; Zeng XW, 2014, J ENG MECH, V140, DOI 10.1061/(ASCE)EM.1943-7889.0000735	61	8	8	2	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2014	9	9							e106915	10.1371/journal.pone.0106915	http://dx.doi.org/10.1371/journal.pone.0106915			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4JX	25197799	Green Submitted, Green Published, gold			2022-12-27	WOS:000341304700065
J	Dormontt, EE; Gardner, MG; Breed, MF; Rodger, JG; Prentis, PJ; Lowe, AJ				Dormontt, Eleanor E.; Gardner, Michael G.; Breed, Martin F.; Rodger, James G.; Prentis, Peter J.; Lowe, Andrew J.			Genetic Bottlenecks in Time and Space: Reconstructing Invasions from Contemporary and Historical Collections	PLOS ONE			English	Article							SENECIO-MADAGASCARIENSIS POIR.; AMBROSIA-ARTEMISIIFOLIA; BIOLOGICAL INVASIONS; ADAPTIVE EVOLUTION; SPECIES INVASIONS; COUNTING ALLELES; RAPID EVOLUTION; COMMON RAGWEED; SOUTH-AFRICAN; DIVERSITY	Herbarium accession data offer a useful historical botanical perspective and have been used to track the spread of plant invasions through time and space. Nevertheless, few studies have utilised this resource for genetic analysis to reconstruct a more complete picture of historical invasion dynamics, including the occurrence of separate introduction events. In this study, we combined nuclear and chloroplast microsatellite analyses of contemporary and historical collections of Senecio madagascariensis, a globally invasive weed first introduced to Australia c. 1918 from its native South Africa. Analysis of nuclear microsatellites, together with temporal spread data and simulations of herbarium voucher sampling, revealed distinct introductions to south-eastern Australia and mid-eastern Australia. Genetic diversity of the south-eastern invasive population was lower than in the native range, but higher than in the mid-eastern invasion. In the invasive range, despite its low resolution, our chloroplast microsatellite data revealed the occurrence of new haplotypes over time, probably as the result of subsequent introduction(s) to Australia from the native range during the latter half of the 20th century. Our work demonstrates how molecular studies of contemporary and historical field collections can be combined to reconstruct a more complete picture of the invasion history of introduced taxa. Further, our study indicates that a survey of contemporary samples only (as undertaken for the majority of invasive species studies) would be insufficient to identify potential source populations and occurrence of multiple introductions.	[Dormontt, Eleanor E.; Breed, Martin F.; Lowe, Andrew J.] Univ Adelaide, Australian Ctr Evolutionary Biol & Biodivers, Adelaide, SA, Australia; [Gardner, Michael G.] Flinders Univ S Australia, Sch Biol Sci, Adelaide, SA 5001, Australia; [Gardner, Michael G.] S Australian Museum, Evolutionary Biol Unit, Adelaide, SA 5000, Australia; [Rodger, James G.] Univ KwaZulu Natal, Ctr Invas Biol, Pietermaritzburg, South Africa; [Prentis, Peter J.] Queensland Univ Technol, Sch Earth Environm & Biol Sci, Brisbane, Qld 4001, Australia	University of Adelaide; Flinders University South Australia; University of Kwazulu Natal; Queensland University of Technology (QUT)	Lowe, AJ (corresponding author), Univ Adelaide, Australian Ctr Evolutionary Biol & Biodivers, Adelaide, SA, Australia.	andrew.lowe@adelaide.edu.au	Gardner, Michael G/A-8280-2011; Breed, Martin/G-5482-2011; Rodger, James/R-7093-2016	Gardner, Michael G/0000-0002-8629-354X; Breed, Martin/0000-0001-7810-9696; Rodger, James/0000-0002-9878-3247; Lowe, Andrew/0000-0003-1139-2516; Prentis, Peter/0000-0001-6587-8875	Australian Research Council [DP0664967]	Australian Research Council(Australian Research Council)	This work was supported by Australian Research Council Discovery project (www.arc.gov.au/, DP0664967) awarded to AL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALI SI, 1966, AUST J BOT, V14, P317, DOI 10.1071/BT9660317; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Bartle K, 2013, AUSTRAL ECOL, V38, P915, DOI 10.1111/aec.12032; BLOSSEY B, 1995, J ECOL, V83, P887, DOI 10.2307/2261425; Bossdorf O, 2005, OECOLOGIA, V144, P1, DOI 10.1007/s00442-005-0070-z; Buswell JM, 2011, J ECOL, V99, P214, DOI 10.1111/j.1365-2745.2010.01759.x; Chauvel B, 2006, J BIOGEOGR, V33, P665, DOI 10.1111/j.1365-2699.2005.01401.x; Chun YJ, 2010, NEW PHYTOL, V185, P1100, DOI 10.1111/j.1469-8137.2009.03129.x; Chybicki IJ, 2009, J HERED, V100, P106, DOI 10.1093/jhered/esn088; COCKERHAM CC, 1973, GENETICS, V74, P679; Crawford KM, 2010, MOL ECOL, V19, P1253, DOI 10.1111/j.1365-294X.2010.04550.x; Crawford NG, 2010, MOL ECOL RESOUR, V10, P556, DOI 10.1111/j.1755-0998.2009.02801.x; Crawford PHC, 2009, J BIOGEOGR, V36, P651, DOI 10.1111/j.1365-2699.2008.02043.x; Dlugosch KM, 2008, MOL ECOL, V17, P431, DOI 10.1111/j.1365-294X.2007.03538.x; Earl DA, 2012, CONSERV GENET RESOUR, V4, P359, DOI 10.1007/s12686-011-9548-7; Estoup A, 2010, MOL ECOL, V19, P4113, DOI 10.1111/j.1365-294X.2010.04773.x; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Facon B, 2008, CURR BIOL, V18, P363, DOI 10.1016/j.cub.2008.01.063; Fluxus TL, 2010, NETWORK V4 6 0 0; FREEMAN GH, 1951, BIOMETRIKA, V38, P141, DOI 10.2307/2332323; Genton BJ, 2005, MOL ECOL, V14, P4275, DOI 10.1111/j.1365-294X.2005.02750.x; Gerlach G, 2010, MOL ECOL, V19, P3845, DOI 10.1111/j.1365-294X.2010.04784.x; Goudet J, 1995, J HERED, V86, P485, DOI 10.1093/oxfordjournals.jhered.a111627; Harvey KJ, 2013, OECOLOGIA, V173, P493, DOI 10.1007/s00442-013-2633-8; Harvey KJ-M, 2012, ROLE PHYLOGENY HERBI; Hilliard O.M., 1977, COMPOSITAE NATAL; Jakobsson M, 2007, BIOINFORMATICS, V23, P1801, DOI 10.1093/bioinformatics/btm233; Jost L, 2008, MOL ECOL, V17, P4015, DOI 10.1111/j.1365-294X.2008.03887.x; Kalinowski ST, 2004, CONSERV GENET, V5, P539, DOI 10.1023/B:COGE.0000041021.91777.1a; Kang M, 2007, MOL ECOL, V16, P4662, DOI 10.1111/j.1365-294X.2007.03536.x; Keller SR, 2010, J EVOLUTION BIOL, V23, P1720, DOI 10.1111/j.1420-9101.2010.02037.x; Lachmuth S, 2010, MOL ECOL, V19, P3952, DOI 10.1111/j.1365-294X.2010.04797.x; Lafuma L, 2007, OIKOS, V116, P201, DOI 10.1111/j.0030-1299.2007.15220.x; Lavergne S, 2007, P NATL ACAD SCI USA, V104, P3883, DOI 10.1073/pnas.0607324104; Lavoie C, 2005, ECOSCIENCE, V12, P366, DOI 10.2980/i1195-6860-12-3-366.1; Le Roux JJ, 2007, MOL ECOL NOTES, V7, P327, DOI 10.1111/j.1471-8286.2006.01596.x; Roux JJ, 2010, BIOL INVASIONS, V12, P2251, DOI 10.1007/s10530-009-9635-9; Leng L, 2011, MOL ECOL, V20, P2494, DOI 10.1111/j.1365-294X.2011.05108.x; MANN HB, 1947, ANN MATH STAT, V18, P50, DOI 10.1214/aoms/1177730491; MAROHASY J J, 1989, Plant Protection Quarterly, V4, P139; Marsico TD, 2010, EVOL APPL, V3, P203, DOI 10.1111/j.1752-4571.2009.00101.x; Martin MD, 2014, MOL ECOL, V23, P1701, DOI 10.1111/mec.12675; Meirmans PG, 2006, EVOLUTION, V60, P2399, DOI 10.1111/j.0014-3820.2006.tb01874.x; Meirmans PG, 2011, MOL ECOL RESOUR, V11, P5, DOI 10.1111/j.1755-0998.2010.02927.x; Michel A, 2004, MOL ECOL, V13, P3229, DOI 10.1111/j.1365-294X.2004.02280.x; Muirhead JR, 2008, MOL ECOL, V17, P1020, DOI 10.1111/j.1365-294X.2008.03669.x; Neve P, 2009, NEW PHYTOL, V184, P783, DOI 10.1111/j.1469-8137.2009.03034.x; Page A.R., 2006, EC IMPACT ASSESSMENT; Pairon M, 2010, ANN BOT-LONDON, V105, P881, DOI 10.1093/aob/mcq065; Peakall R, 2006, MOL ECOL NOTES, V6, P288, DOI 10.1111/j.1471-8286.2005.01155.x; Peakall R, 2012, BIOINFORMATICS, V28, P2537, DOI 10.1093/bioinformatics/bts460; Petit RJ, 1998, CONSERV BIOL, V12, P844, DOI 10.1046/j.1523-1739.1998.96489.x; PONS O, 1995, THEOR APPL GENET, V90, P462, DOI 10.1007/BF00221991; Prentis PJ, 2009, DIVERS DISTRIB, V15, P822, DOI 10.1111/j.1472-4642.2009.00592.x; Prentis PJ, 2008, TRENDS PLANT SCI, V13, P288, DOI 10.1016/j.tplants.2008.03.004; Prentis PJ, 2010, ANN BOT-LONDON, V106, P1009, DOI 10.1093/aob/mcq201; Pritchard JK, 2000, GENETICS, V155, P945; Provan J, 2008, DIVERS DISTRIB, V14, P343, DOI 10.1111/j.1472-4642.2007.00420.x; Radford IJ, 2000, AUST SYST BOT, V13, P409, DOI 10.1071/SB98029; Radford IJ, 1995, AUST SYST BOT, V8, P1029, DOI 10.1071/SB9951029; RADFORD IJ, 1997, THESIS U SYDNEY; Roman J, 2007, TRENDS ECOL EVOL, V22, P454, DOI 10.1016/j.tree.2007.07.002; Rosenberg NA, 2004, MOL ECOL NOTES, V4, P137, DOI 10.1046/j.1471-8286.2003.00566.x; Scott LJ, 1998, PLANT SYST EVOL, V213, P251, DOI 10.1007/BF00985204; Simberloff D, 2009, ANNU REV ECOL EVOL S, V40, P81, DOI 10.1146/annurev.ecolsys.110308.120304; SINDEL B M, 1986, Plant Protection Quarterly, V1, P163; SINDEL B M, 1988, Plant Protection Quarterly, V3, P22; Sindel B.M., 1998, PLANT PROT Q, V13, P2; SINDEL BM, 1992, AUST J ECOL, V17, P21, DOI 10.1111/j.1442-9993.1992.tb00776.x; Solignac M, 2005, P ROY SOC B-BIOL SCI, V272, P411, DOI 10.1098/rspb.2004.2853; Szpiech ZA, 2008, BIOINFORMATICS, V24, P2498, DOI 10.1093/bioinformatics/btn478; Vandepitte K, 2014, MOL ECOL, V23, P2157, DOI 10.1111/mec.12683; Verhoeven KJF, 2011, P ROY SOC B-BIOL SCI, V278, P2, DOI 10.1098/rspb.2010.1272; Weising K, 1999, GENOME, V42, P9, DOI 10.1139/gen-42-1-9; Whitlock MC, 2011, MOL ECOL, V20, P1083, DOI 10.1111/j.1365-294X.2010.04996.x; Wilson JRU, 2009, TRENDS ECOL EVOL, V24, P136, DOI 10.1016/j.tree.2008.10.007; Zangerl AR, 2005, P NATL ACAD SCI USA, V102, P15529, DOI 10.1073/pnas.0507805102	77	13	13	2	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2014	9	9							e106874	10.1371/journal.pone.0106874	http://dx.doi.org/10.1371/journal.pone.0106874			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ1IR	25192006	Green Published, gold, Green Submitted			2022-12-27	WOS:000347993600074
J	Stepanyuk, AR; Belan, PV; Kononenko, NI				Stepanyuk, Andrey R.; Belan, Pavel V.; Kononenko, Nikolai I.			A Model for the Fast Synchronous Oscillations of Firing Rate in Rat Suprachiasmatic Nucleus Neurons Cultured in a Multielectrode Array Dish	PLOS ONE			English	Article							GONADOTROPIN-RELEASING-HORMONE; CYCLIC-AMP; INTERCELLULAR SYNCHRONIZATION; CIRCADIAN-RHYTHMS; CLOCK; RECEPTOR; DESENSITIZATION; VIP; INTERNALIZATION; PERIOD	When dispersed and cultured in a multielectrode dish (MED), suprachiasmatic nucleus (SCN) neurons express fast oscillations of firing rate (FOFR; fast relative to the circadian cycle), with burst duration, similar to 10 min, and interburst interval varying from 20 to 60 min in different cells but remaining nevertheless rather regular in individual cells. In many cases, separate neurons in distant parts of the 1 mm recording area of a MED exhibited correlated FOFR. Neither the mechanism of FOFR nor the mechanism of their synchronization among neurons is known. Based on recent data implicating vasoactive intestinal polypeptide (VIP) as a key intercellular synchronizing agent, we built a model in which VIP acts as both a feedback regulator to generate FOFR in individual neurons, and a diffusible synchronizing agent to produce coherent electrical output of a neuronal network. In our model, VIP binding to its (VPAC(2)) receptors acts through G(s) G-proteins to activate adenylyl cyclase (AC), increase intracellular cAMP, and open cyclic-nucleotide-gated (CNG) cation channels, thus depolarizing the cell and generating neuronal firing to release VIP. In parallel, slowly developing homologous desensitization and internalization of VPAC(2) receptors terminates elevation of cAMP and thereby provides an interpulse silent interval. Through mathematical modeling, we show that this VIP/VPAC(2)/AC/cAMP/CNG-channel mechanism is sufficient for generating reliable FOFR in single neurons. When our model for FOFR is combined with a published model of synchronization of circadian rhythms based on VIP/VPAC(2) and Per gene regulation synchronization of circadian rhythms is significantly accelerated. These results suggest that (a) auto/paracrine regulation by VIP/VPAC(2) and intracellular AC/cAMP/CNG-channels are sufficient to provide robust FOFR and synchrony among neurons in a heterogeneous network, and (b) this system may also participate in synchronization of circadian rhythms.	[Stepanyuk, Andrey R.; Belan, Pavel V.; Kononenko, Nikolai I.] Bogomoletz Inst Physiol, Kiev, Ukraine; [Stepanyuk, Andrey R.; Belan, Pavel V.; Kononenko, Nikolai I.] State Key Lab Mol & Cellular Biol, Kiev, Ukraine	National Academy of Sciences Ukraine; A.A. Bogomoletz Institute of Physiology	Stepanyuk, AR (corresponding author), Bogomoletz Inst Physiol, Kiev, Ukraine.	standrey@biph.kiev.ua	Belan, Pavel/AAV-3522-2021	Belan, Pavel/0000-0001-5429-3716	government of Ukraine	government of Ukraine	This work was supported by the government of Ukraine. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An SW, 2011, J NEUROPHYSIOL, V105, P2289, DOI 10.1152/jn.00966.2010; Aton SJ, 2006, P NATL ACAD SCI USA, V103, P19188, DOI 10.1073/pnas.0607466103; Aton SJ, 2005, NAT NEUROSCI, V8, P476, DOI 10.1038/nn1419; Bhalla US, 2002, METHOD ENZYMOL, V345, P3; Brancaccio M, 2013, NEURON, V78, P714, DOI 10.1016/j.neuron.2013.03.011; Brown TM, 2007, J NEUROPHYSIOL, V97, P2553, DOI 10.1152/jn.01206.2006; Couvineau A, 2012, BRIT J PHARMACOL, V166, P42, DOI 10.1111/j.1476-5381.2011.01676.x; Gerard C, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002516; Goldbeter A, 2006, B MATH BIOL, V68, P1095, DOI 10.1007/s11538-006-9090-z; Govaerts W, 2006, NEURAL COMPUT, V18, P817, DOI 10.1162/089976606775774688; Hamada T, 2001, J NEUROSCI, V21, P7742, DOI 10.1523/JNEUROSCI.21-19-07742.2001; Hao HP, 2006, BIOPHYS J, V90, P1560, DOI 10.1529/biophysj.105.065250; Herzog ED, 2004, J BIOL RHYTHM, V19, P35, DOI 10.1177/0748730403260776; Herzog ED, 1998, NAT NEUROSCI, V1, P708, DOI 10.1038/3708; Honma S, 1998, NEUROSCI LETT, V250, P157, DOI 10.1016/S0304-3940(98)00464-9; Hughes ATL, 2008, J NEUROCHEM, V106, P1646, DOI 10.1111/j.1471-4159.2008.05520.x; Idevall-Hagren O, 2010, J BIOL CHEM, V285, P23005, DOI 10.1074/jbc.M109.095992; Khadra A, 2006, BIOPHYS J, V91, P74, DOI 10.1529/biophysj.105.080630; Kononenko NI, 2004, NEUROSCIENCE, V129, P85, DOI 10.1016/j.neuroscience.2004.06.080; Kononenko NI, 2012, CIRCADIAN RHYTHMS BI, P29; Kononenko NI, 2013, NEUROSCI RES, V75, P218, DOI 10.1016/j.neures.2013.01.003; Kori H, 2012, J THEOR BIOL, V297, P61, DOI 10.1016/j.jtbi.2011.12.007; Krsmanovic LZ, 2009, TRENDS ENDOCRIN MET, V20, P402, DOI 10.1016/j.tem.2009.05.002; Krsmanovic LZ, 2003, P NATL ACAD SCI USA, V100, P2969, DOI 10.1073/pnas.0535708100; Kuhlman SJ, 2003, J NEUROSCI, V23, P1441, DOI 10.1523/JNEUROSCI.23-04-01441.2003; Langlet C, 2004, PEPTIDES, V25, P2079, DOI 10.1016/j.peptides.2004.08.017; Lee HS, 2003, J BIOL RHYTHM, V18, P435, DOI 10.1177/0748730403259106; Leloup JC, 2003, P NATL ACAD SCI USA, V100, P7051, DOI 10.1073/pnas.1132112100; Long MA, 2005, NAT NEUROSCI, V8, P61, DOI 10.1038/nn1361; Loomis WF, 2008, ADV EXP MED BIOL, V641, P39; Luo X, 1999, J BIOL CHEM, V274, P17684, DOI 10.1074/jbc.274.25.17684; Marie JC, 2003, MOL PHARMACOL, V64, P1565, DOI 10.1124/mol.64.6.1565; MARTIEL JL, 1987, BIOPHYS J, V52, P807, DOI 10.1016/S0006-3495(87)83275-7; Maywood ES, 2011, P NATL ACAD SCI USA, V108, P14306, DOI 10.1073/pnas.1101767108; MIROLLO RE, 1990, J STAT PHYS, V60, P245, DOI 10.1007/BF01013676; Murthy KS, 2008, AM J PHYSIOL-CELL PH, V294, pC477, DOI 10.1152/ajpcell.00229.2007; Nakamura W, 2002, NAT NEUROSCI, V5, P399, DOI 10.1038/nn843; Pakhotin P, 2006, PFLUG ARCH EUR J PHY, V452, P7, DOI 10.1007/s00424-005-0003-z; REA MA, 1990, BRAIN RES BULL, V25, P843, DOI 10.1016/0361-9230(90)90179-4; Reppert SM, 2002, NATURE, V418, P935, DOI 10.1038/nature00965; ROBBERECHT P, 1989, PEPTIDES, V10, P441, DOI 10.1016/0196-9781(89)90056-9; Rubin J, 2007, BIOL CYBERN, V97, P5, DOI 10.1007/s00422-007-0153-5; Strecker GJ, 1997, J NEUROPHYSIOL, V78, P2217, DOI 10.1152/jn.1997.78.4.2217; To TL, 2007, BIOPHYS J, V92, P3792, DOI 10.1529/biophysj.106.094086; Vanecek J, 1998, NEUROSCI LETT, V252, P21, DOI 10.1016/S0304-3940(98)00530-8; Vasalou C, 2011, BIOPHYS J, V101, P12, DOI 10.1016/j.bpj.2011.04.051; Vasalou C, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000706; Wagenaar DA, 2006, BMC NEUROSCI, V7, DOI 10.1186/1471-2202-7-11; Wagenaar DA, 2005, J NEUROSCI, V25, P680, DOI 10.1523/JNEUROSCI.4209-04.2005; Webb AB, 2009, P NATL ACAD SCI USA, V106, P16493, DOI 10.1073/pnas.0902768106; Welsh DK, 2010, ANNU REV PHYSIOL, V72, P551, DOI 10.1146/annurev-physiol-021909-135919; WELSH DK, 1995, NEURON, V14, P697, DOI 10.1016/0896-6273(95)90214-7	53	2	2	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2014	9	9							e106152	10.1371/journal.pone.0106152	http://dx.doi.org/10.1371/journal.pone.0106152			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ1IR	25192180	Green Published, gold, Green Submitted			2022-12-27	WOS:000347993600015
J	Asanuma, M; Miyazaki, I; Murakami, S; Diaz-Corrales, FJ; Ogawa, N				Asanuma, Masato; Miyazaki, Ikuko; Murakami, Shinki; Diaz-Corrales, Francisco J.; Ogawa, Norio			Striatal Astrocytes Act as a Reservoir for L-DOPA	PLOS ONE			English	Article							CULTURED RAT; TERMINALS; RECEPTORS; TRANSPORT; TURNOVER; NEURONS	L-DOPA is therapeutically efficacious in patients with Parkinson's disease (PD), although dopamine (DA) neurons are severely degenerated. Since cortical astrocytes express neutral amino acid transporter (LAT) and DA transporter (DAT), the uptake and metabolism of L-DOPA and DA in striatal astrocytes may influence their availability in the dopaminergic system of PD. To assess possible L-DOPA-and DA-uptake and metabolic properties of striatal astrocytes, we examined the expression of L-DOPA, DA and DAT in striatal astrocytes of hemi-parkinsonian model rats after repeated L-DOPA administration, and measured the contents of L-DOPA, DA and their metabolite in primary cultured striatal astrocytes after L-DOPA/DA treatment. Repeated injections of L-DOPA induced apparent L-DOPA-and DA-immunoreactivities and marked expression of DAT in reactive astrocytes on the lesioned side of the striatum in hemi-parkinsonian rats. Exposure to DA for 4 h significantly increased the levels of DA and its metabolite DOPAC in cultured striatal astrocytes. L-DOPA was also markedly increased in cultured striatal astrocytes after 4-h L-DOPA exposure, but DA was not detected 4 or 8 h after L-DOPA treatment, despite the expression of aromatic amino acid decarboxylase in astrocytes. Furthermore, the intracellular level of L-DOPA in cultured striatal astrocytes decreased rapidly after removal of extracellular L-DOPA. The results suggest that DA uptaken into striatal astrocytes is rapidly metabolized and that striatal astrocytes act as a reservoir of L-DOPA that govern the uptake or release of L-DOPA depending on extracellular L-DOPA concentration, but are less capable of converting L-DOPA to DA.	[Asanuma, Masato; Miyazaki, Ikuko; Murakami, Shinki; Diaz-Corrales, Francisco J.; Ogawa, Norio] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Brain Sci, Okayama, Japan	Okayama University	Asanuma, M (corresponding author), Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Brain Sci, Okayama, Japan.	asachan@cc.okayama-u.ac.jp	Diaz-Corrales, Francisco/L-7559-2014	Diaz-Corrales, Francisco/0000-0002-5752-0205	Japanese Ministry of Education, Culture, Sports, Science and Technology [24111533, 21591082, 22590934, 25461279]; Health and Labour Sciences Research Grant for Research on Measures for Intractable Diseases; Health and Labour Sciences Research Grant for Research on Psychiatric and Neurological Diseases and Mental Health; Health and Labour Sciences Research Grant for Comprehensive Research on Aging and Health from the Japanese Ministry of Health, Labour and Welfare; Grants-in-Aid for Scientific Research [24659431] Funding Source: KAKEN	Japanese Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Health and Labour Sciences Research Grant for Research on Measures for Intractable Diseases; Health and Labour Sciences Research Grant for Research on Psychiatric and Neurological Diseases and Mental Health; Health and Labour Sciences Research Grant for Comprehensive Research on Aging and Health from the Japanese Ministry of Health, Labour and Welfare; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported, in part, by Grants-in-aid for Scientific Research on Innovative Areas "Brain Environment'' (KAKENHI #24111533; MA) and for Scientific Research (C) (KAKENHI #21591082; MA and #22590934, #25461279; IM) from the Japanese Ministry of Education, Culture, Sports, Science and Technology. Additional funding came from Health and Labour Sciences Research Grants for Research on Measures for Intractable Diseases (MA), for Research on Psychiatric and Neurological Diseases and Mental Health (MA and NO), and for Comprehensive Research on Aging and Health (MA and NO) from the Japanese Ministry of Health, Labour and Welfare. The funders had no role in study design, data collection, analyses, decision to prepare or submit the manuscript.	Allaman I, 2011, TRENDS NEUROSCI, V34, P76, DOI 10.1016/j.tins.2010.12.001; Asanuma M, 2010, ANN NEUROL, V67, P239, DOI 10.1002/ana.21885; Carta M, 2007, BRAIN, V130, P1819, DOI 10.1093/brain/awm082; Diaz-Corrales FJ, 2005, NEUROSCIENCE, V133, P117, DOI 10.1016/j.neuroscience.2005.01.044; Hamby ME, 2010, NEUROTHERAPEUTICS, V7, P494, DOI 10.1016/j.nurt.2010.07.003; Inazu M, 1999, NEUROSCI RES, V34, P235, DOI 10.1016/S0168-0102(99)00053-X; Inazu M, 1999, LIFE SCI, V64, P2239, DOI 10.1016/S0024-3205(99)00175-7; Inyushin MY, 2012, PARKINSONS DIS-US, V2012, DOI 10.1155/2012/321406; Iwata-Ichikawa E, 1999, J NEUROCHEM, V72, P2334, DOI 10.1046/j.1471-4159.1999.0722334.x; Kim DK, 2004, NEUROSCI RES, V50, P437, DOI 10.1016/j.neures.2004.08.003; Kimelberg HK, 2010, NEUROTHERAPEUTICS, V7, P338, DOI 10.1016/j.nurt.2010.07.006; Lee J, 2008, BRAIN, V131, P1574, DOI 10.1093/brain/awn085; Megyeri K, 2007, BRAIN RES BULL, V71, P501, DOI 10.1016/j.brainresbull.2006.11.003; Miyazaki I, 2004, BRAIN RES, V1029, P120, DOI 10.1016/j.brainres.2004.09.014; Miyazaki I, 2011, GLIA, V59, P435, DOI 10.1002/glia.21112; Ogawa N, 2000, NEUROCHEM RES, V25, P755, DOI 10.1023/A:1007530720544; Pellegrino L. J., 1979, STEREOTAXIC ATLAS RA; Perea G, 2009, TRENDS NEUROSCI, V32, P421, DOI 10.1016/j.tins.2009.05.001; Rylander D, 2010, ANN NEUROL, V68, P619, DOI 10.1002/ana.22097; Tanaka H, 1999, NEUROREPORT, V10, P631, DOI 10.1097/00001756-199902250-00034; Tsai MJ, 1996, J NEUROSCI RES, V43, P490, DOI 10.1002/(SICI)1097-4547(19960215)43:4<490::AID-JNR10>3.3.CO;2-K; Xie GX, 1998, BRAIN RES, V785, P129, DOI 10.1016/S0006-8993(97)01394-2	22	34	34	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 4	2014	9	9							e106362	10.1371/journal.pone.0106362	http://dx.doi.org/10.1371/journal.pone.0106362			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3XV	25188235	Green Submitted, Green Published, gold			2022-12-27	WOS:000341271500031
J	Fogarty, SW; Patel, II; Martin, FL; Fullwood, NJ				Fogarty, Simon W.; Patel, Imran I.; Martin, Francis L.; Fullwood, Nigel J.			Surface-Enhanced Raman Spectroscopy of the Endothelial Cell Membrane	PLOS ONE			English	Article							IMMUNO-PCR; GOLD; SPECTRA; SILVER; NANOPARTICLES; CHOLESTEROL; SCATTERING; DYNAMICS; CANCERS; SERS	We applied surface-enhanced Raman spectroscopy (SERS) to cationic gold-labeled endothelial cells to derive SERS-enhanced spectra of the bimolecular makeup of the plasma membrane. A two-step protocol with cationic charged gold nanoparticles followed by silver-intensification to generate silver nanoparticles on the cell surface was employed. This protocol of post-labelling silver-intensification facilitates the collection of SERS-enhanced spectra from the cell membrane without contribution from conjugated antibodies or other molecules. This approach generated a 100-fold SERS-enhancement of the spectral signal. The SERS spectra exhibited many vibrational peaks that can be assigned to components of the cell membrane. We were able to carry out spectral mapping using some of the enhanced wavenumbers. Significantly, the spectral maps suggest the distribution of some membrane components are was not evenly distributed over the cells plasma membrane. These results provide some possible evidence for the existence of lipid rafts in the plasma membrane and show that SERS has great potential for the study and characterization of cell surfaces.	[Fogarty, Simon W.; Fullwood, Nigel J.] Univ Lancaster, Div Biomed & Life Sci, Lancaster, Lancs, England; [Fogarty, Simon W.; Patel, Imran I.; Martin, Francis L.] Univ Lancaster, Lancaster Environm Ctr, Ctr Biophoton, Lancaster, Lancs, England; [Patel, Imran I.] Univ Cambridge, Cavendish Lab, Cambridge CB3 0HE, Cambs, England	Lancaster University; Lancaster University; University of Cambridge	Fullwood, NJ (corresponding author), Univ Lancaster, Div Biomed & Life Sci, Lancaster, Lancs, England.	n.fullwood@lancaster.ac.uk	Martin, Francis L/J-4585-2019	Martin, Francis L/0000-0001-8562-4944; Fullwood, Nigel James/0000-0002-9405-8515	Biotechnology and Biological Sciences Research Council; BBSRC doctoral training grant [BB/F017111/1]; Natural Environment Research Council [ceh010010] Funding Source: researchfish	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC doctoral training grant(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	Funding provided by Biotechnology and Biological Sciences Research Council http://www.bbsrc.ac.uk/home/home.aspx. Simon Fogarty was supported by BBSRC doctoral training grant BB/F017111/1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arkill KP, 2012, MICROCIRCULATION, V19, P343, DOI 10.1111/j.1549-8719.2012.00168.x; Austin LA, 2014, ARCH TOXICOL, V88, P1391, DOI 10.1007/s00204-014-1245-3; Baker MJ, 2014, NAT PROTOC, V9, P1771, DOI 10.1038/nprot.2014.110; Berkowitz ML, 2009, BBA-BIOMEMBRANES, V1788, P86, DOI 10.1016/j.bbamem.2008.09.009; Chen LY, 2009, J IMMUNOL METHODS, V346, P64, DOI 10.1016/j.jim.2009.05.007; Chen XD, 2009, ACS NANO, V3, P87, DOI 10.1021/nn800695u; de Meyer F, 2009, P NATL ACAD SCI USA, V106, P3654, DOI 10.1073/pnas.0809959106; Dieringer JA, 2006, FARADAY DISCUSS, V132, P9, DOI 10.1039/b513431p; Dodelet-Devillers A, 2009, J MOL MED, V87, P765, DOI 10.1007/s00109-009-0488-6; Festag G, 2007, NANOTECHNOLOGY, V18, DOI 10.1088/0957-4484/18/1/015502; FLEISCHMANN M, 1974, CHEM PHYS LETT, V26, P163, DOI 10.1016/0009-2614(74)85388-1; Fullwood NJ, 1996, INVEST OPHTH VIS SCI, V37, P1256; Herpers B, 2010, NAT PROTOC, V5, P678, DOI 10.1038/nprot.2010.12; Hodges MD, 2011, ACS NANO, V5, P9535, DOI 10.1021/nn202652h; Kang B, 2014, ACS NANO, V8, P4883, DOI 10.1021/nn500840x; Krafft C, 2005, SPECTROCHIM ACTA A, V61, P1529, DOI 10.1016/j.saa.2004.11.017; Mackey MA, 2014, J PHYS CHEM B, V118, P1319, DOI 10.1021/jp409298f; Mahmoud MA, 2014, NANO LETT, V14, P743, DOI 10.1021/nl4040362; Margueritat J, 2011, ACS NANO, V5, P1630, DOI 10.1021/nn103256t; Martin FL, 2010, NAT PROTOC, V5, P1748, DOI 10.1038/nprot.2010.133; Martin Francis L, 2007, Proc Natl Acad Sci U S A, V104, pE1, DOI 10.1073/pnas.0710307105; Meyer MW, 2011, ANALYST, V136, P3542, DOI 10.1039/c0an00851f; Movasaghi Z, 2007, APPL SPECTROSC REV, V42, P493, DOI 10.1080/05704920701551530; Nie SM, 1997, SCIENCE, V275, P1102, DOI 10.1126/science.275.5303.1102; Notingher I, 2003, BIOPOLYMERS, V72, P230, DOI 10.1002/bip.10378; Potuckova L, 2011, J IMMUNOL METHODS, V371, P38, DOI 10.1016/j.jim.2011.06.012; Selvakannan PR, 2013, PHYS CHEM CHEM PHYS, V15, P12920, DOI 10.1039/c3cp51646f; Shegai T, 2011, ACS NANO, V5, P2036, DOI 10.1021/nn1031406; Stone N, 2004, FARADAY DISCUSS, V126, P141, DOI 10.1039/b304992b; Stone N, 2002, J RAMAN SPECTROSC, V33, P564, DOI 10.1002/jrs.882; Tong LM, 2008, J PHYS CHEM C, V112, P7119, DOI 10.1021/jp7102484; Trevisan J, 2013, BIOINFORMATICS, V29, P1095, DOI 10.1093/bioinformatics/btt084; Xie JP, 2008, ACS NANO, V2, P2473, DOI 10.1021/nn800442q; Zhang AY, 2006, HYPERTENSION, V47, P74, DOI 10.1161/01.HYP.0000196727.53300.62	34	16	16	4	66	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 4	2014	9	9							e106283	10.1371/journal.pone.0106283	http://dx.doi.org/10.1371/journal.pone.0106283			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3XV	25188340	Green Accepted, gold, Green Published			2022-12-27	WOS:000341271500026
J	Fowler, AK; Thompson, J; Chen, LX; Dagda, M; Dertien, J; Dossou, KSS; Moaddel, R; Bergeson, SE; Kruman, II				Fowler, Anna-Kate; Thompson, Jeremy; Chen, Lixia; Dagda, Marisela; Dertien, Janet; Dossou, Katina Sylvestre S.; Moaddel, Ruin; Bergeson, Susan E.; Kruman, Inna I.			Differential Sensitivity of Prefrontal Cortex and Hippocampus to Alcohol-Induced Toxicity	PLOS ONE			English	Article							BASE EXCISION-REPAIR; FUTURE CONSEQUENCES; ETHANOL EXPOSURE; DECISION-MAKING; DRUG-DEPENDENCE; RAT CEREBELLUM; DNA-DAMAGE; CELL-DEATH; BRAIN; STRESS	The prefrontal cortex (PFC) is a brain region responsible for executive functions including working memory, impulse control and decision making. The loss of these functions may ultimately lead to addiction. Using histological analysis combined with stereological technique, we demonstrated that the PFC is more vulnerable to chronic alcohol-induced oxidative stress and neuronal cell death than the hippocampus. This increased vulnerability is evidenced by elevated oxidative stress-induced DNA damage and enhanced expression of apoptotic markers in PFC neurons. We also found that one-carbon metabolism (OCM) impairment plays a significant role in alcohol toxicity to the PFC seen from the difference in the effects of acute and chronic alcohol exposure on DNA repair and from exaggeration of the damaging effects upon additional OCM impairment in mice deficient in a key OCM enzyme, methylenetetrahydrofolate reductase (MTHFR). Given that damage to the PFC leads to loss of executive function and addiction, our study may shed light on the mechanism of alcohol addiction.	[Fowler, Anna-Kate; Thompson, Jeremy; Chen, Lixia; Dagda, Marisela; Dertien, Janet; Bergeson, Susan E.; Kruman, Inna I.] Texas Tech Univ, Hlth Sci Ctr, Dept Pharmacol & Neurosci, Lubbock, TX 79430 USA; [Dossou, Katina Sylvestre S.; Moaddel, Ruin] NIA, Lab Clin Invest, NIH, Baltimore, MD 21224 USA	Texas Tech University System; Texas Tech University; Texas Tech University Health Science Center; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA)	Kruman, II (corresponding author), Texas Tech Univ, Hlth Sci Ctr, Dept Pharmacol & Neurosci, Lubbock, TX 79430 USA.	inna.kruman@ttuhsc.edu	Moaddel, Ruin/AAE-3378-2020	Thompson, Jeremy/0000-0002-8917-7894; Moaddel, Ruin/0000-0002-6812-0127	Foundation for Alcohol Research; South Plains Alcohol and Addiction Research Center; National Institutes of Health Intramural Research Program	Foundation for Alcohol Research; South Plains Alcohol and Addiction Research Center; National Institutes of Health Intramural Research Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by the Foundation for Alcohol Research (to I. I. K.), the South Plains Alcohol and Addiction Research Center and in part, by National Institutes of Health Intramural Research Program (to R. M.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnsten AFT, 2009, NAT REV NEUROSCI, V10, P410, DOI 10.1038/nrn2648; Bechara A, 2002, NEUROPSYCHOLOGIA, V40, P1675, DOI 10.1016/S0028-3932(02)00015-5; Bechara A, 2001, NEUROPSYCHOLOGIA, V39, P376, DOI 10.1016/S0028-3932(00)00136-6; Bechara A, 2002, NEUROPSYCHOLOGIA, V40, P1690, DOI 10.1016/S0028-3932(02)00016-7; BECHARA A, 1994, COGNITION, V50, P7, DOI 10.1016/0010-0277(94)90018-3; Berlin HA, 2004, BRAIN, V127, P1108, DOI 10.1093/brain/awh135; Bjork JM, 2014, NEUROPHARMACOLOGY, V84, P101, DOI 10.1016/j.neuropharm.2013.07.039; Bleich S, 2000, ADV RES NEURODEGENER, V8, P187; Chen ZT, 2001, HUM MOL GENET, V10, P433, DOI 10.1093/hmg/10.5.433; Choi DH, 2012, ANTIOXID REDOX SIGN, V16, P1033, DOI 10.1089/ars.2011.3960; Cravo ML, 2000, NUTRITION, V16, P296, DOI 10.1016/S0899-9007(99)00297-X; Crews FT, 2009, PHARMACOL BIOCHEM BE, V93, P237, DOI 10.1016/j.pbb.2009.04.018; Cunha-Oliveira T, 2008, BRAIN RES REV, V58, P192, DOI 10.1016/j.brainresrev.2008.03.002; Davis CD, 2004, EXP BIOL MED, V229, P988, DOI 10.1177/153537020422901002; Domazet-Damjanov D., 2009, OPEN BIOL J, V2, P149; Elmore S, 2007, TOXICOL PATHOL, V35, P495, DOI 10.1080/01926230701320337; Ersche KD, 2011, BRAIN, V134, P2013, DOI 10.1093/brain/awr138; Filipovic D, 2011, J NEUROSCI RES, V89, P1461, DOI 10.1002/jnr.22687; Finckbone V, 2009, FRONT NEUROANAT, V3, DOI 10.3389/neuro.05.003.2009; Fowler AK, 2014, J NEUROCHEM; Fowler AK, 2012, J BIOL CHEM, V287, P43533, DOI 10.1074/jbc.M112.401497; Franklin TR, 2002, BIOL PSYCHIAT, V51, P134, DOI 10.1016/S0006-3223(01)01269-0; Garcia-Bueno B, 2007, NEUROPSYCHOPHARMACOL, V32, P1251, DOI 10.1038/sj.npp.1301252; George O, 2010, NEUROSCI BIOBEHAV R, V35, P232, DOI 10.1016/j.neubiorev.2010.05.002; Harper C, 2009, ALCOHOL ALCOHOLISM, V44, P136, DOI 10.1093/alcalc/agn102; Hashimoto E, 2013, WORLD J BIOL PSYCHIA, V14, P549, DOI 10.3109/15622975.2013.838302; Jacintho JD, 2003, CURR MED CHEM, V10, P2693, DOI 10.2174/0929867033456404; Job MO, 2007, BIOL PSYCHIAT, V62, P627, DOI 10.1016/j.biopsych.2006.11.016; Kanoh M, 1999, CIRCULATION, V99, P2757, DOI 10.1161/01.CIR.99.21.2757; Kolodner RD, 2002, SCIENCE, V297, P552, DOI 10.1126/science.1075277; Koob G, 2007, AM J PSYCHIAT, V164, P1149, DOI 10.1176/appi.ajp.2007.05030503; Koob GF, 2010, NEUROPSYCHOPHARMACOL, V35, P217, DOI 10.1038/npp.2009.110; Kruman II, 2012, EXP BIOL MED, V237, P740, DOI 10.1258/ebm.2012.011421; LINDAHL T, 1993, NATURE, V362, P709, DOI 10.1038/362709a0; Ljungman M, 2005, MUTAT RES-FUND MOL M, V577, P203, DOI 10.1016/j.mrfmmm.2005.02.014; Loo DT, 2011, METHODS MOL BIOL, V682, P3, DOI 10.1007/978-1-60327-409-8_1; Luhar RB, 2013, NEUROPSYCH DIS TREAT, V9, P1767, DOI 10.2147/NDT.S52298; Marinkovic K, 2012, HUM BRAIN MAPP, V33, P319, DOI 10.1002/hbm.21213; Mathur P, 2011, BEHAV BRAIN RES, V219, P234, DOI 10.1016/j.bbr.2011.01.019; Meyerhoff DJ, 2004, ALCOHOL CLIN EXP RES, V28, P650, DOI 10.1097/01.ALC.0000121805.12350.CA; Oomman S, 2005, DEV BRAIN RES, V160, P130, DOI 10.1016/j.devbrainres.2005.07.010; Pau CWH, 2002, ARCH CLIN NEUROPSYCH, V17, P663, DOI 10.1016/S0887-6177(01)00169-X; Pelloux Y., 2013, EUR J NEUROSCI; Ramalingam M, 2012, J NEURAL TRANSM, V119, P891, DOI 10.1007/s00702-011-0758-7; Rudebeck PH, 2006, NAT NEUROSCI, V9, P1161, DOI 10.1038/nn1756; Schulte T, 2012, ALCOHOL CLIN EXP RES, V36, P2017, DOI 10.1111/j.1530-0277.2012.01831.x; Schweizer TA, 2006, NEUROPSYCHOPHARMACOL, V31, P1301, DOI 10.1038/sj.npp.1300941; Sieber OM, 2003, NAT REV CANCER, V3, P701, DOI 10.1038/nrc1170; Singh NP, 1995, MUTAT RES-GENET TOX, V345, P191, DOI 10.1016/0165-1218(95)90054-3; Sinha R, 2008, ANN NY ACAD SCI, V1141, P105, DOI 10.1196/annals.1441.030; Sircar R, 2009, BEHAV BRAIN RES, V202, P225, DOI 10.1016/j.bbr.2009.03.036; Spanagel R, 2009, PHYSIOL REV, V89, P649, DOI 10.1152/physrev.00013.2008; Stover PJ, 2009, J NUTR, V139, P2402, DOI 10.3945/jn.109.113670; Sunkesula SRB, 2008, NEUROCHEM RES, V33, P1117, DOI 10.1007/s11064-007-9560-1; Ventura I, 2010, MUTAT RES-GEN TOX EN, V703, P59, DOI 10.1016/j.mrgentox.2010.06.008; Zhang HH, 2010, DNA REPAIR, V9, P898, DOI 10.1016/j.dnarep.2010.06.003; Zlatkovic J, 2014, MOL CELL BIOCH	57	49	49	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 4	2014	9	9							e106945	10.1371/journal.pone.0106945	http://dx.doi.org/10.1371/journal.pone.0106945			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3XV	25188266	gold, Green Submitted, Green Published			2022-12-27	WOS:000341271500101
J	Moser, B; Megerle, A; Bekos, C; Janik, S; Szerafin, T; Birner, P; Schiefer, AI; Mildner, M; Lang, I; Skoro-Sajer, N; Sadushi-Kolici, R; Taghavi, S; Klepetko, W; Ankersmit, HJ				Moser, Bernhard; Megerle, Anna; Bekos, Christine; Janik, Stefan; Szerafin, Tamas; Birner, Peter; Schiefer, Ana-Iris; Mildner, Michael; Lang, Irene; Skoro-Sajer, Nika; Sadushi-Kolici, Roela; Taghavi, Shahrokh; Klepetko, Walter; Ankersmit, Hendrik Jan			Local and Systemic RAGE Axis Changes in Pulmonary Hypertension: CTEPH and iPAH	PLOS ONE			English	Article							GLYCATION END-PRODUCTS; CELL-SURFACE RECEPTOR; SOLUBLE RECEPTOR; HEART-FAILURE; ENDARTERECTOMIZED TISSUES; INFLAMMATORY MEDIATORS; PROGENITOR CELLS; RISK-FACTORS; EXPRESSION; BIOMARKERS	Objective: The molecular determinants of chronic thromboembolic pulmonary hypertension (CTEPH) and idiopathic pulmonary arterial hypertension (iPAH) remain poorly understood. The receptor for advanced glycation endproducts (RAGE) and its ligands: HMGB1 and S100A9 are involved in inflammatory disorders. We sought to investigate the role of the RAGE axis in patients with CTEPH undergoing pulmonary endarterectomy (PEA), iPAH undergoing lung transplantation (LuTX). The high pulmonary vascular resistance in CTEPH/iPAH results in pressure overload of the right ventricle. We compared sRAGE measurements to that of patients with aortic valve stenosis (AVS) - pressure overload of the left ventricle. Methods: We enrolled patients with CTEPH(26), iPAH(15), AVS(15) and volunteers(33). Immunohistochemistry with antibodies to RAGE and HMGB1 was performed on PEA specimens and lung tissues. We employed enzyme-linked immunosorbent assays to determine the concentrations of sRAGE, esRAGE, HMGB1 and S100A9 in serum of volunteers and patients with CTEPH, iPAH, AVS before and after PEA, LuTX and aortic valve replacement (AVR). Results: In endarterectomised tissues from patients with CTEPH RAGE and HMGB1 were identified in myofibroblasts (alpha-SMA(+) vimentin(+)CD34(-)), recanalizing vessel-like structures of distal myofibrotic tissues and endothelium of neointima. RAGE was differentially expressed in prototypical Heath Edwards lesions in iPAH. We found significantly increased serum concentrations of sRAGE, esRAGE and HMGB1 in CTEPH. In iPAH, sRAGE and esRAGE were significantly higher than in controls. Serum concentrations of sRAGE were significantly elevated in iPAH(p < 0.001) and CTEPH(p = 0.001) compared to AVS. Serum sRAGE was significantly higher in iPAH compared to CTEPH(p = 0.042) and significantly reduced in AVS compared to controls(p = 0.001). There were no significant differences in sRAGE serum concentrations before and after surgical therapy for CTEPH, iPAH or AVS. Conclusions: Our data suggest a role for the RAGE pathway in the pathophysiology of CTEPH and iPAH. PEA improves the local control of disease but may not influence the systemic inflammatory mechanisms in CTEPH patients through the RAGE pathway.	[Moser, Bernhard; Megerle, Anna; Bekos, Christine; Janik, Stefan; Taghavi, Shahrokh; Klepetko, Walter; Ankersmit, Hendrik Jan] Med Univ Vienna, Div Surg, Dept Thorac Surg, Vienna, Austria; [Bekos, Christine; Ankersmit, Hendrik Jan] Med Univ Vienna, Christian Doppler Lab Diag & Regenerat Cardiac &, Vienna, Austria; [Szerafin, Tamas] Univ Debrecen, Dept Cardiac Surg, H-4012 Debrecen, Hungary; [Birner, Peter; Schiefer, Ana-Iris] Med Univ Vienna, Dept Pathol, Vienna, Austria; [Mildner, Michael] Med Univ Vienna, Dept Dermatol, Vienna, Austria; [Lang, Irene; Skoro-Sajer, Nika; Sadushi-Kolici, Roela] Med Univ Vienna, Div Cardiol, Dept Internal Med 2, Vienna, Austria	Medical University of Vienna; Medical University of Vienna; University of Debrecen; Medical University of Vienna; Medical University of Vienna; Medical University of Vienna	Moser, B (corresponding author), Med Univ Vienna, Div Surg, Dept Thorac Surg, Vienna, Austria.	bernhard.moser@meduniwien.ac.at	Schiefer, Ana-Iris/AAX-8123-2020; Moser, Bernhard/ABA-9436-2020	Moser, Bernhard/0000-0002-6037-5475; Lang, Irene/0000-0003-0485-2692; Ankersmit, Hendrik Jan/0000-0002-8761-3517; Bekos, Christine/0000-0003-4038-6860; Mildner, Michael/0000-0002-6892-925X	Research laboratories of the Department of Surgery (FOLAB ARGE Moser) of the Medical University Vienna; Christian Doppler laboratory for the Diagnosis and Regeneration of Cardiac and Thoracic Diseases	Research laboratories of the Department of Surgery (FOLAB ARGE Moser) of the Medical University Vienna; Christian Doppler laboratory for the Diagnosis and Regeneration of Cardiac and Thoracic Diseases	The study was funded by the Research laboratories of the Department of Surgery (FOLAB ARGE Moser) of the Medical University Vienna and the Christian Doppler laboratory for the Diagnosis and Regeneration of Cardiac and Thoracic Diseases. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anker SD, 2004, HEART, V90, P464, DOI 10.1136/hrt.2002.007005; Basta G, 2010, ATHEROSCLEROSIS, V210, P614, DOI 10.1016/j.atherosclerosis.2009.12.029; Bauer EM, 2012, MOL MED, V18, P1509, DOI 10.2119/molmed.2012.00283; Bauer EM, 2013, J BIOL CHEM, V288, P1365, DOI 10.1074/jbc.M112.434142; Bogaard HJ, 2009, CHEST, V135, P794, DOI 10.1378/chest.08-0492; Bucciarelli LG, 2002, CIRCULATION, V106, P2827, DOI 10.1161/01.CIR.0000039325.03698.36; Calfee CS, 2007, J HEART LUNG TRANSPL, V26, P675, DOI 10.1016/j.healun.2007.04.002; Carlsen J, 2013, J HEART LUNG TRANSPL, V32, P347, DOI 10.1016/j.healun.2012.11.014; Cheng CM, 2005, MODERN PATHOL, V18, P1385, DOI 10.1038/modpathol.3800450; Cheng DT, 2013, AM J RESP CRIT CARE, V188, P948, DOI 10.1164/rccm.201302-0247OC; Christie JD, 2009, AM J RESP CRIT CARE, V180, P1010, DOI 10.1164/rccm.200901-0118OC; Cockayne DA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038629; Delcroix M, 2013, EUR RESPIR J, V41, P224, DOI 10.1183/09031936.00047712; Farmer DGS, 2014, PULM PHARMACOL THER, V29, P7, DOI 10.1016/j.pupt.2014.01.002; Farmer DGS, 2009, PHARMACOL THERAPEUT, V124, P185, DOI 10.1016/j.pharmthera.2009.06.013; Firth AL, 2010, AM J PHYSIOL-CELL PH, V298, pC1217, DOI 10.1152/ajpcell.00416.2009; Foris V, 2013, CHEST, V144, P274, DOI 10.1378/chest.12-1246; Galie N, 2009, EUR RESPIR J, V34, P1219, DOI 10.1183/09031936.00139009; Hartupee J, 2013, J CARDIOVASC TRANSL, V6, P485, DOI 10.1007/s12265-013-9467-y; HEATH D, 1958, CIRCULATION, V18, P533, DOI 10.1161/01.CIR.18.4.533; Hofmann MA, 2002, GENES IMMUN, V3, P123, DOI 10.1038/sj.gene.6363861; Hofmann MA, 1999, CELL, V97, P889, DOI 10.1016/S0092-8674(00)80801-6; HORI O, 1995, J BIOL CHEM, V270, P25752, DOI 10.1074/jbc.270.43.25752; Hudson BI, 2008, FASEB J, V22, P1572, DOI 10.1096/fj.07-9909com; Jujo T, 2012, INT J ONCOL, V41, P701, DOI 10.3892/ijo.2012.1493; Kalea AZ, 2011, FRONT BIOSCI-LANDMRK, V16, P2756, DOI 10.2741/3884; Kang R, 2013, CLIN CANCER RES, V19, P4046, DOI 10.1158/1078-0432.CCR-13-0495; Kasimir MT, 2004, EUR J CARDIO-THORAC, V26, P776, DOI 10.1016/j.ejcts.2004.05.057; Kim NH, 2012, EUR RESPIR REV, V21, P27, DOI 10.1183/09059180.00009111; Kim NHS, 2004, CIRCULATION, V109, P18, DOI 10.1161/01.CIR.0000111841.28126.D4; Koyama H, 2007, BIOMARK INSIGHTS, V2, P331; Lalla E, 2001, Ann Periodontol, V6, P113, DOI 10.1902/annals.2001.6.1.113; Lang IM, 2008, CURR OPIN CARDIOL, V23, P555, DOI 10.1097/HCO.0b013e328311f254; Lang IM, 2013, EUR RESPIR J, V41, P462, DOI 10.1183/09031936.00049312; Liu XW, 2012, CRIT CARE, V16, DOI 10.1186/cc11354; Lu L, 2010, CHINESE MED J-PEKING, V123, P594, DOI 10.3760/cma.j.issn.0366-6999.2010.05.017; Maillard-Lefebvre H, 2009, RHEUMATOLOGY, V48, P1190, DOI 10.1093/rheumatology/kep199; Mann DL, 2002, CIRC RES, V91, P988, DOI 10.1161/01.RES.0000043825.01705.1B; Maruoka M, 2012, INT J CARDIOL, V159, P119, DOI 10.1016/j.ijcard.2011.02.037; Meloche J, 2013, J AM HEART ASSOC, V2, DOI 10.1161/JAHA.112.005157; Morbini P, 2006, MODERN PATHOL, V19, P1437, DOI 10.1038/modpathol.3800661; Moser B, 2007, AM J TRANSPLANT, V7, P293, DOI 10.1111/j.1600-6143.2006.01617.x; Moser B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094118; MOSER KM, 1993, CHEST, V103, P685, DOI 10.1378/chest.103.3.685; Naka Y, 2004, ARTERIOSCL THROM VAS, V24, P1342, DOI 10.1161/01.ATV.0000133191.71196.90; NEEPER M, 1992, J BIOL CHEM, V267, P14998; Park HY, 2009, J CLIN NEUROL, V5, P126, DOI 10.3988/jcn.2009.5.3.126; Prasad K, 2014, INT J ANGIOL, V23, P11, DOI 10.1055/s-0033-1363423; Ramasamy R, 2008, ANN NY ACAD SCI, V1126, P7, DOI 10.1196/annals.1433.056; Raucci A, 2008, FASEB J, V22, P3716, DOI 10.1096/fj.08-109033; Sanz J, 2007, AM J CARDIOL, V100, P731, DOI 10.1016/j.amjcard.2007.03.094; Scheiber-Camoretti R, 2013, AM J CARDIOVASC DIS, V3, P85; Seta Y, 1996, J Card Fail, V2, P243, DOI 10.1016/S1071-9164(96)80047-9; Shah RJ, 2013, AM J TRANSPLANT, V13, P754, DOI 10.1111/ajt.12062; Sims GP, 2010, ANNU REV IMMUNOL, V28, P367, DOI 10.1146/annurev.immunol.021908.132603; Smith DJ, 2011, EUR RESPIR J, V37, P516, DOI 10.1183/09031936.00029310; Thistlethwaite PA, 2002, J THORAC CARDIOV SUR, V124, P1203, DOI 10.1067/mtc.2002.127313; van de Veerdonk MC, 2011, J AM COLL CARDIOL, V58, P2511, DOI 10.1016/j.jacc.2011.06.068; von Haehling S, 2010, INT J CARDIOL, V144, P206, DOI 10.1016/j.ijcard.2009.04.019; Vonk-Noordegraaf A, 2013, J AM COLL CARDIOL, V62, pD22, DOI 10.1016/j.jacc.2013.10.027; Wendt TM, 2003, AM J PATHOL, V162, P1123, DOI 10.1016/S0002-9440(10)63909-0; Wu Y, 2014, RES J BIOTECHNOL, V9, P1; Yan L, 2014, ARTERIOSCL THROM VAS, V34, P1399, DOI 10.1161/ATVBAHA.114.303508; Yan SF, 2003, CIRC RES, V93, P1159, DOI 10.1161/01.RES.0000103862.26506.3D; Yan Shi-Fang, 2004, Diab Vasc Dis Res, V1, P10, DOI 10.3132/dvdr.2004.001; Yao WJ, 2009, AM J PHYSIOL-LUNG C, V296, pL870, DOI 10.1152/ajplung.90413.2008; Zabini D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043793; Zhang L, 2008, J BIOL CHEM, V283, P35507, DOI 10.1074/jbc.M806948200	68	23	25	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 4	2014	9	9							e106440	10.1371/journal.pone.0106440	http://dx.doi.org/10.1371/journal.pone.0106440			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3XV	25188497	Green Published, gold, Green Submitted			2022-12-27	WOS:000341271500035
J	Takahashi, A; Nakayama, R; Ishibashi, N; Doi, A; Ichinohe, R; Ikuyo, Y; Takahashi, T; Marui, S; Yasuhara, K; Nakamura, T; Sugita, S; Sakamoto, H; Yoshida, T; Hasegawa, T; Takahashi, H				Takahashi, Anna; Nakayama, Robert; Ishibashi, Nanako; Doi, Ayano; Ichinohe, Risa; Ikuyo, Yoriko; Takahashi, Teruyoshi; Marui, Shigetaka; Yasuhara, Koji; Nakamura, Tetsuro; Sugita, Shintaro; Sakamoto, Hiromi; Yoshida, Teruhiko; Hasegawa, Tadashi; Takahashi, Hiro			Analysis of Gene Expression Profiles of Soft Tissue Sarcoma Using a Combination of Knowledge-Based Filtering with Integration of Multiple Statistics	PLOS ONE			English	Article							ADAPTIVE RESONANCE THEORY; MALIGNANT FIBROUS HISTIOCYTOMA; BOOSTED FUZZY CLASSIFIER; PROGNOSTIC RELEVANCE; CANCER; IDENTIFICATION; PROTEIN; PREDICTION; DIAGNOSIS; PATHWAY	The diagnosis and treatment of soft tissue sarcomas (STS) have been difficult. Of the diverse histological subtypes, undifferentiated pleomorphic sarcoma (UPS) is particularly difficult to diagnose accurately, and its classification per se is still controversial. Recent advances in genomic technologies provide an excellent way to address such problems. However, it is often difficult, if not impossible, to identify definitive disease-associated genes using genome-wide analysis alone, primarily because of multiple testing problems. In the present study, we analyzed microarray data from 88 STS patients using a combination method that used knowledge-based filtering and a simulation based on the integration of multiple statistics to reduce multiple testing problems. We identified 25 genes, including hypoxia-related genes (e.g., MIF, SCD1, P4HA1, ENO1, and STAT1) and cell cycle- and DNA repair-related genes (e.g., TACC3, PRDX1, PRKDC, and H2AFY). These genes showed significant differential expression among histological subtypes, including UPS, and showed associations with overall survival. STAT1 showed a strong association with overall survival in UPS patients (logrank p = 1.84x10(-6) and adjusted p value 2.99x10(-3) after the permutation test). According to the literature, the 25 genes selected are useful not only as markers of differential diagnosis but also as prognostic/predictive markers and/or therapeutic targets for STS. Our combination method can identify genes that are potential prognostic/predictive factors and/or therapeutic targets in STS and possibly in other cancers. These disease-associated genes deserve further preclinical and clinical validation.	[Takahashi, Anna; Takahashi, Hiro] Chubu Univ, Plant Biol Res Ctr, Kasugai, Aichi 487, Japan; [Nakayama, Robert; Doi, Ayano; Ichinohe, Risa; Sakamoto, Hiromi; Yoshida, Teruhiko; Takahashi, Hiro] Natl Canc Ctr, Res Inst, Div Genet, Tokyo 104, Japan; [Nakayama, Robert] Keio Univ, Sch Med, Dept Orthopaed Surg, Tokyo, Japan; [Ishibashi, Nanako] Nagoya Univ, Grad Sch Sci, Div Biol Sci, Nagoya, Aichi 4648601, Japan; [Doi, Ayano; Ichinohe, Risa] Chiba Univ, Fac Hort, Matsudo, Chiba 271, Japan; [Takahashi, Hiro] Chiba Univ, Grad Sch Hort, Matsudo, Chiba, Japan; [Ikuyo, Yoriko; Takahashi, Teruyoshi; Marui, Shigetaka; Yasuhara, Koji; Nakamura, Tetsuro] Chubu Univ, Grad Sch Biosci & Biotechnol, Kasugai, Aichi 487, Japan; [Sugita, Shintaro; Hasegawa, Tadashi] Sapporo Med Univ, Sch Med, Dept Surg Pathol, Sapporo, Hokkaido, Japan; [Hasegawa, Tadashi] Natl Canc Ctr, Div Pathol, Tokyo, Japan	Chubu University; National Cancer Center - Japan; Keio University; Nagoya University; Chiba University; Chiba University; Chubu University; Sapporo Medical University; National Cancer Center - Japan	Hasegawa, T (corresponding author), Sapporo Med Univ, Sch Med, Dept Surg Pathol, Sapporo, Hokkaido, Japan.	hasetada@sapmed.ac.jp; hiro.takahashi@chiba-u.jp	Takahashi, Hiro/E-6746-2013	Takahashi, Hiro/0000-0002-8230-9524	Ministry of Education, Culture, Sports, Science, and Technology of Japan (MEXT) [21710211, 24710222, 26114703]; Advanced Research for Medical Products Mining Program of the National Institute of Biomedical Innovation (NIBIO) [10-41]; Futaba Electronics Memorial Foundation; Research Foundation for the Electrotechnology of Chubu; Nakajima Foundation; Grants-in-Aid for Scientific Research [26114703] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science, and Technology of Japan (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Advanced Research for Medical Products Mining Program of the National Institute of Biomedical Innovation (NIBIO); Futaba Electronics Memorial Foundation; Research Foundation for the Electrotechnology of Chubu(Research Foundation for the Electrotechnology of Chubu); Nakajima Foundation; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by the Ministry of Education, Culture, Sports, Science, and Technology of Japan (MEXT): Grants-in-Aid for Scientific Research for Young Scientists (B) (nos. 21710211 and 24710222 to H. T.) and Grant-in-Aid for Scientific Research on Innovative Areas (no. 26114703 to H. T.). This work was also supported by the Advanced Research for Medical Products Mining Program of the National Institute of Biomedical Innovation (NIBIO ID10-41), the Futaba Electronics Memorial Foundation, the Research Foundation for the Electrotechnology of Chubu, and the Nakajima Foundation. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of this manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Ando T, 2002, JPN J CANCER RES, V93, P1207, DOI 10.1111/j.1349-7006.2002.tb01225.x; Antonescu CR, 2000, J MOL DIAGN, V2, P132, DOI 10.1016/S1525-1578(10)60628-9; Arima C, 2008, J BIOSCI BIOENG, V105, P273, DOI 10.1263/jbb.105.273; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Chiba Y, 2013, PLANT CELL PHYSIOL, V54, P180, DOI 10.1093/pcp/pcs164; Chibon F, 2010, NAT MED, V16, P781, DOI 10.1038/nm.2174; CLARK J, 1994, NAT GENET, V7, P502, DOI 10.1038/ng0894-502; Ding L, 2008, NATURE, V455, P1069, DOI 10.1038/nature07423; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Fletcher CDM, 2001, J CLIN ONCOL, V19, P3045, DOI 10.1200/JCO.2001.19.12.3045; FLETCHER CDM, 1992, AM J SURG PATHOL, V16, P213, DOI 10.1097/00000478-199203000-00001; Fletcher CDM., 2002, WHO CLASSIFICATION T; Flicek P, 2014, NUCLEIC ACIDS RES, V42, pD749, DOI 10.1093/nar/gkt1196; Franceschini A, 2013, NUCLEIC ACIDS RES, V41, pD808, DOI 10.1093/nar/gks1094; Guillou L, 1997, J CLIN ONCOL, V15, P350, DOI 10.1200/JCO.1997.15.1.350; Hasegawa T, 2000, ONCOLOGY-BASEL, V58, P66, DOI 10.1159/000012081; Hasegawa T, 2002, HUM PATHOL, V33, P111, DOI 10.1053/hupa.2002.30184; Helman LJ, 2003, NAT REV CANCER, V3, P685, DOI 10.1038/nrc1168; HOLLOWOOD K, 1995, SEMIN DIAGN PATHOL, V12, P210; Iwasaki M, 2013, DEVELOPMENT, V140, P1958, DOI 10.1242/dev.085365; KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868; Kawamura T, 2008, J BIOSCI BIOENG, V105, P81, DOI 10.1263/jbb.105.81; Kohno T, 2012, NAT MED, V18, P375, DOI 10.1038/nm.2644; Kojima S, 2011, PLANT CELL PHYSIOL, V52, P1259, DOI 10.1093/pcp/pcr083; Kotooka N, 2013, INT J CARDIOL, V167, P1068, DOI 10.1016/j.ijcard.2012.10.066; Lux ML, 2000, AM J PATHOL, V156, P791, DOI 10.1016/S0002-9440(10)64946-2; MANTEL NATHAN, 1966, CANCERCHEMOTHERAP REP, V50, P163; Matsuo N, 2009, PLANT BIOTECHNOL-NAR, V26, P385, DOI 10.5511/plantbiotechnology.26.385; Nakagawa A, 2012, PLANT MOL BIOL, V79, P569, DOI 10.1007/s11103-012-9929-7; Nakayama R, 2007, MODERN PATHOL, V20, P749, DOI 10.1038/modpathol.3800794; Pearson K, 1901, PHILOS MAG, V2, P559, DOI 10.1080/14786440109462720; Portal D, 2013, P NATL ACAD SCI USA, V110, P18537, DOI 10.1073/pnas.1317608110; Sano M, 2010, INT J ONCOL, V36, P321, DOI 10.3892/ijo_00000503; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Takahashi H, 2004, J BIOSCI BIOENG, V98, P193, DOI 10.1263/jbb.98.193; Takahashi H, 2003, J BIOSCI BIOENG, V96, P154, DOI 10.1263/jbb.96.154; Takahashi H, 2005, BIOINFORMATICS, V21, P179, DOI 10.1093/bioinformatics/bth473; Takahashi H, 2006, J BIOSCI BIOENG, V101, P137, DOI 10.1263/jbb.101.137; Takahashi H, 2005, J CHEM ENG JPN, V38, P763, DOI 10.1252/jcej.38.763; Takahashi H, 2008, J BIOSCI BIOENG, V106, P587, DOI 10.1263/jbb.106.587; Takahashi H, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-399; Takahashi H, 2007, BIOCHEM ENG J, V33, P100, DOI 10.1016/j.bej.2006.08.004; Takahashi H, 2006, J BIOSCI BIOENG, V102, P46, DOI 10.1263/jbb.102.46; Takahashi H, 2006, BIOINFORMATICS, V22, P1662, DOI 10.1093/bioinformatics/btl156; Takahashi H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105160; Takahashi H, 2013, J BIOSCI BIOENG, V116, P768, DOI 10.1016/j.jbiosc.2013.05.021; Takahashi H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078250; Takahashi H, 2013, PLANT CELL PHYSIOL, V54, P418, DOI 10.1093/pcp/pct027; Takahashi H, 2012, J BIOSCI BIOENG, V114, P570, DOI 10.1016/j.jbiosc.2012.05.017; Takahashi H, 2012, BIOINFORMATICS, V28, P2231, DOI 10.1093/bioinformatics/bts303; Takahashi H, 2006, J CHEM ENG JPN, V39, P767, DOI 10.1252/jcej.39.767; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Tomida S, 2002, BIOINFORMATICS, V18, P1073, DOI 10.1093/bioinformatics/18.8.1073; TROJANI M, 1984, INT J CANCER, V33, P37, DOI 10.1002/ijc.2910330108; Yajima I, 2012, AM J CANCER RES, V2, P322; Yoshida T, 2010, CANCER SCI, V101, P1582, DOI 10.1111/j.1349-7006.2010.01590.x; Yoshimura K, 2011, PLANT CELL PHYSIOL, V52, P1786, DOI 10.1093/pcp/pcr115; Zhou HF, 2014, BIOL DIRECT, V9, DOI 10.1186/1745-6150-9-5; Zhou HF, 2013, BMC SYST BIOL, V7, DOI 10.1186/1752-0509-7-S6-S6; Zhou HF, 2012, BMC SYST BIOL, V6, DOI 10.1186/1752-0509-6-S2-S2; Zhou HF, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-S3-S20	62	24	25	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 4	2014	9	9							e106801	10.1371/journal.pone.0106801	http://dx.doi.org/10.1371/journal.pone.0106801			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3XV	25188299	Green Submitted, Green Published, gold			2022-12-27	WOS:000341271500088
J	Barberis, C; Almuzara, M; Join-Lambert, O; Ramirez, MS; Famiglietti, A; Vay, C				Barberis, Claudia; Almuzara, Marisa; Join-Lambert, Olivier; Soledad Ramirez, Maria; Famiglietti, Angela; Vay, Carlos			Comparison of the Bruker MALDI-TOF Mass Spectrometry System and Conventional Phenotypic Methods for Identification of Gram-Positive Rods	PLOS ONE			English	Article							DESORPTION IONIZATION-TIME; CORYNEFORM BACTERIA; CORYNEBACTERIUM; RPOB	In recent years, MALDI-TOF Mass Spectrometry (MS) method has emerged as a promising and a reliable tool for bacteria identification. In this study we compared Bruker MALDI-TOF MS and conventional phenotypic methods to identify a collection of 333 Gram-positive clinical isolates comprising 22 genera and 60 species. 16S rRNA sequencing was the reference molecular technique, and rpoB gene sequecing was used as a secondary gene target when 16Sr RNA did not allow species identification of Corynebacterium spp. We also investigate if score cut-offs values of >= 1,5 and >= 1,7 were accurate for genus and species-level identification using the Bruker system. Identification at species level was obtained for 92,49% of Gram-positive rods by MALDI-TOF MS compared to 85,89% by phenotypic method. Our data validates the score >= 1,5 for genus level and >= 1,7 for species-level identification in a large and diverse collection of Gram-positive rods. The present study has proved the accuracy of MALDI-TOF MS as an identification method in Gram-positive rods compared to currently used methods in routine laboratories.	[Barberis, Claudia; Almuzara, Marisa; Famiglietti, Angela; Vay, Carlos] Univ Buenos Aires, Fac Farm & Bioquim, Hosp Clin Jose de San Martin, Inst Fisiopatol & Bioquim Clin, RA-1113 Buenos Aires, DF, Argentina; [Join-Lambert, Olivier] Univ Paris 05, Paris, France; [Join-Lambert, Olivier] Hop Necker Enfants Malad, Microbiol Lab, Paris, France; [Soledad Ramirez, Maria] Univ Buenos Aires, Consejo Nacl Invest Cient & Tecn, Inst Microbiol & Parasitol Med, Buenos Aires, DF, Argentina	University of Buenos Aires; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University of Buenos Aires	Barberis, C (corresponding author), Univ Buenos Aires, Fac Farm & Bioquim, Hosp Clin Jose de San Martin, Inst Fisiopatol & Bioquim Clin, RA-1113 Buenos Aires, DF, Argentina.	claudiabar07@gmail.com	Join-Lambert, Olivier/AAE-5205-2019		Secretaria de Ciencia y Tecnica de la Universidad de Buenos Aires (UBACyT)	Secretaria de Ciencia y Tecnica de la Universidad de Buenos Aires (UBACyT)(Secretaria de Ciencia y Tecnologia (SECYT))	This work was supported by grants from the Secretaria de Ciencia y Tecnica de la Universidad de Buenos Aires (UBACyT) to C.V. M.S.R. is a member of the CONICET research career. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adderson EE, 2008, PEDIATR INFECT DIS J, V27, P136, DOI [10.1097/INF.0b013e31814fab12, 10.1097/INF.0b0113e31814fab12]; Alatoom AA, 2012, J CLIN MICROBIOL, V50, P160, DOI 10.1128/JCM.05889-11; Bernard K.A., 2012, BERGEYS MANUAL SYSTE, P245; Bernard K, 2012, J CLIN MICROBIOL, V50, P3152, DOI 10.1128/JCM.00796-12; Farfour E, 2012, J CLIN MICROBIOL, V50, P2702, DOI 10.1128/JCM.00368-12; Funke G, 1997, CLIN MICROBIOL REV, V10, P125, DOI 10.1128/CMR.10.1.125; Funke G., 2011, MANUAL CLIN MICROBIO, V10th ed; Gaillot O, 2011, J CLIN MICROBIOL, V49, P4412, DOI 10.1128/JCM.05429-11; Khamis A, 2005, J CLIN MICROBIOL, V43, P1934, DOI 10.1128/JCM.43.4.1934-1936.2005; Khamis A, 2004, J CLIN MICROBIOL, V42, P3925, DOI 10.1128/JCM.42.9.3925-3931.2004; Konrad R, 2010, EURO SURVEILL, V15, P19699; Mackinnon A, 2000, COMPUT BIOL MED, V30, P127, DOI 10.1016/S0010-4825(00)00006-8; Saffert RT, 2011, J CLIN MICROBIOL, V49, P887, DOI 10.1128/JCM.01890-10; Seng P, 2009, CLIN INFECT DIS, V49, P543, DOI 10.1086/600885; Stackebrandt E, 2006, MICROBIOLOGY TODAY, V06, P152, DOI DOI 10.1038/MSB.2013.22; Theel ES, 2012, J CLIN MICROBIOL, V50, P3093, DOI 10.1128/JCM.01045-12; Vila J, 2012, J CLIN MICROBIOL, V50, P1745, DOI 10.1128/JCM.05821-11; WEISBURG WG, 1991, J BACTERIOL, V173, P697, DOI 10.1128/JB.173.2.697-703.1991	18	49	51	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 3	2014	9	9							e106303	10.1371/journal.pone.0106303	http://dx.doi.org/10.1371/journal.pone.0106303			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3TB	25184254	gold, Green Submitted, Green Published			2022-12-27	WOS:000341257700054
J	Blauenfeldt, T; Heyckendorf, J; Jensen, SG; Lange, C; Drabe, C; Hermansen, TS; de Thurah, L; Lillebaek, T; Eugen-Olsen, J; Seersholm, N; Hoff, S; Bonde, J; Ruhwald, M				Blauenfeldt, Thomas; Heyckendorf, Jan; Jensen, Sidse Graff; Lange, Christoph; Drabe, Camilla; Hermansen, Thomas S.; de Thurah, Lena; Lillebaek, Troels; Eugen-Olsen, Jesper; Seersholm, Niels; Hoff, Soren; Bonde, Jesper; Ruhwald, Morten			Development of a One-Step Probe Based Molecular Assay for Rapid Immunodiagnosis of Infection with M. tuberculosis Using Dried Blood Spots	PLOS ONE			English	Article							INTERFERON-GAMMA ASSAY; ACTIVE TUBERCULOSIS; LATENT INFECTION; PREDICTIVE-VALUE; RELEASE ASSAY; DIAGNOSIS; PCR; RNA; EXPRESSION; RESPONSES	Background: Antigen specific release of IP-10 is the most promising alternative marker to IFN-gamma for infection with M. tuberculosis. Compared to Interferon-c release assays (IGRA), IP-10 is released in high levels enabling novel approaches such as field friendly dried blood spots (DBS) and molecular detection. Aim: To develop a robust IP-10 based molecular assay for the diagnosis of infection with M. tubercuolsis from whole blood and DBS. Method: We developed a one-step probe based multiplex RT-qPCR assay for detecting IP-10 and IFN-gamma mRNA expression from whole blood and DBS samples. The assay was validated and applied for the diagnosis of M. tuberculosis infection in DBS samples from 43 patients with confirmed TB, 13 patients with latent TB and 96 presumed uninfected controls. In parallel, IP-10 and INF-gamma levels were measured in Quantiferon (QFT-TB) plasma supernatants. Results: IP-10 mRNA upregulation was detectable at 4 hours after stimulation (6 fold upregulation) peaking at 8 hours (108 fold upregulation). IFN-gamma expression occurred in concert but levels were lower (peak 6.7 fold upregulation). IP-10 gene expression level was significantly higher in patients with tuberculosis (median 31.2, IQR 10.7-67.0) and persons with latent tuberculosis infection (LTBI) (41.2, IQR 9.8-64.9) compared to healthy controls (1.6, IQR 1.1-2.4; p<0.0001). The IP-10 mRNA and protein based tests had comparable diagnostic accuracy to QFT-TB, sensitivity (85% and 88% vs 85%) and specificity (96% and 96% vs 97%, p = ns.). Conclusion: We developed a rapid, robust and accurate molecular immunodiagnostic test for M. tuberculosis infection. By combining DBS based sample acquisition, mail or currier based sample transport with centralized molecular detection, this immunodiagnostic test concept can reduce the local technological requirements everywhere and make it possible to offer highly accurate immunodiagnostic tests in low resource settings.	[Blauenfeldt, Thomas; de Thurah, Lena; Hoff, Soren; Ruhwald, Morten] Statens Serum Inst, Dept Infect Dis Immunol, DK-2300 Copenhagen, Denmark; [Heyckendorf, Jan; Lange, Christoph] Res Ctr Borstel, TB Unit, German Ctr Infect Res DZIF, Borstel, Germany; [Jensen, Sidse Graff; Seersholm, Niels] Univ Copenhagen, Gentofte Hosp, Dept Pulm Med, Copenhagen, Denmark; [Hermansen, Thomas S.; Lillebaek, Troels] Statens Serum Inst, Int Reference Lab Mycobacteriol, DK-2300 Copenhagen, Denmark; [Blauenfeldt, Thomas; Drabe, Camilla; de Thurah, Lena; Eugen-Olsen, Jesper; Bonde, Jesper; Ruhwald, Morten] Univ Copenhagen, Clin Res Ctr, Hvidovre Hosp, Copenhagen, Denmark; [Bonde, Jesper] Univ Copenhagen, Hvidovre Hosp, Dept Pathol, Copenhagen, Denmark; [Lange, Christoph] Univ Namibia, Sch Med, Dept Med, Windhoek, Namibia	Statens Serum Institut; Forschungszentrum Borstel; German Center for Infection Research; University of Copenhagen; Herlev & Gentofte Hospital; Statens Serum Institut; University of Copenhagen; University of Copenhagen; University of Namibia	Ruhwald, M (corresponding author), Statens Serum Inst, Dept Infect Dis Immunol, DK-2300 Copenhagen, Denmark.	moru@ssi.dk	Bonde, Jesper/AAN-5930-2020; Heyckendorf, Jan/AAA-8782-2021; Lange, Christoph/J-6289-2012	Lange, Christoph/0000-0002-9691-4741; Drabe, Camilla Heldbjerg/0000-0002-9053-9047; Bonde, Jesper/0000-0003-4853-6747; Lillebaek, Troels/0000-0002-2601-2718; Eugen-Olsen, Jesper/0000-0002-4630-4275	Roche Denmark; infectious disease outpatients clinic at Copenhagen University Hospital, Hvidovre, Denmark; Medical Clinic of the Research Center Borstel, Borstel, Germany	Roche Denmark(Roche Holding); infectious disease outpatients clinic at Copenhagen University Hospital, Hvidovre, Denmark; Medical Clinic of the Research Center Borstel, Borstel, Germany	Thanks to Katja Bogebjerg Carlsen for excellent technical assistance. To the staff at the TB outpatient clinic at Copenhagen University Hospital, Gentofte and the infectious disease outpatients clinic at Copenhagen University Hospital, Hvidovre, Denmark and the Medical Clinic of the Research Center Borstel, Borstel, Germany for support and inclusion of patients. To Miki Hansen and Ronni Bertelsen from Roche Denmark for providing input to probe and primer design and for providing PCR reagents at reduced cost.	Aabye MG, 2010, EUR RESPIR J, V36, P1488, DOI 10.1183/09031936.00039010; Aabye MG, 2013, EUR RESPIR J, V42, P495, DOI 10.1183/09031936.00129412; Aabye MG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039228; Bibova I, 2012, DIAGN MICR INFEC DIS, V72, P68, DOI 10.1016/j.diagmicrobio.2011.09.024; Chakera A, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-143; Chee CBE, 2013, RESPIROLOGY, V18, P205, DOI 10.1111/resp.12002; Chegou NN, 2013, EUR RESPIR J; Connell TG, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002624; Diel R, 2011, AM J RESP CRIT CARE, V183, P88, DOI 10.1164/rccm.201006-0974OC; Fietta A, 2003, AM J INFECT CONTROL, V31, P347, DOI 10.1016/S0196-6553(02)48240-5; Gauffin F, 2009, CLIN CHEM LAB MED, V47, P1467, DOI 10.1515/CCLM.2009.351; Harari A, 2011, NAT MED, V17, P372, DOI 10.1038/nm.2299; Herzmann C, 2012, J INFECT DIS, V206, P1630, DOI 10.1093/infdis/jis557; HUEBNER RE, 1993, CLIN INFECT DIS, V17, P968, DOI 10.1093/clinids/17.6.968; Kabeer BSA, 2010, AIDS, V24, P323, DOI 10.1097/QAD.0b013e328334895e; Karlsson H, 2003, CLIN CHEM, V49, P979, DOI 10.1373/49.6.979; Kasprowicz VO, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020606; Kik SV, 2010, EUR RESPIR J, V35, P1346, DOI 10.1183/09031936.00098509; Kim S, 2012, DIAGN MICROBIOL INFE; Kreuzer KA, 1999, CLIN CHEM, V45, P297; KROUWER JS, 1984, CLIN CHEM, V30, P290; Lalvani A, 2010, ENFERM INFEC MICR CL, V28, P245, DOI 10.1016/j.eimc.2009.05.012; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; LUSTER AD, 1987, J EXP MED, V166, P1084, DOI 10.1084/jem.166.4.1084; Mack U, 2009, EUR RESPIR J, V33, P956, DOI 10.1183/09031936.00120908; MATSUBARA Y, 1992, NUCLEIC ACIDS RES, V20, P1998, DOI 10.1093/nar/20.8.1998; Mazurek GH, 2001, JAMA-J AM MED ASSOC, V286, P1740, DOI 10.1001/jama.286.14.1740; Mei JV, 2001, J NUTR, V131, p1631S, DOI 10.1093/jn/131.5.1631S; O'Garra A, 2013, ANNU REV IMMUNOL, V31, P475, DOI 10.1146/annurev-immunol-032712-095939; Provenzano Maurizio, 2003, J Transl Med, V1, P12, DOI 10.1186/1479-5876-1-12; Ruhwald M, 2011, TUBERCULOSIS; Ruhwald M, 2012, EXPERT REV MOL DIAGN, V12, P175, DOI [10.1586/ERM.11.97, 10.1586/erm.11.97]; Schultz-Thater E, 2008, J TRANSL MED, V6, DOI 10.1186/1479-5876-6-58; Suthanthiran M, 2013, NEW ENGL J MED, V369, P20, DOI 10.1056/NEJMoa1215555; Tuuminen T, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2012-001751; van Dissel JT, 2011, VACCINE, V29, P2100, DOI 10.1016/j.vaccine.2010.12.135; Wang S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051338; WHO, 2014, GLOB TUB REP 2013; Wu B, 2007, J IMMUNOL, V178, P3688, DOI 10.4049/jimmunol.178.6.3688; Yang S, 2004, LANCET INFECT DIS, V4, P337, DOI 10.1016/S1473-3099(04)01044-8; Young JM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011237	41	12	14	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 3	2014	9	9							e105628	10.1371/journal.pone.0105628	http://dx.doi.org/10.1371/journal.pone.0105628			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3TB	25184553	Green Published, gold, Green Submitted			2022-12-27	WOS:000341257700022
J	Dean, DA; Adler, GK; Nguyen, DP; Klerman, EB				Dean, Dennis A., II; Adler, Gail K.; Nguyen, David P.; Klerman, Elizabeth B.			Biological Time Series Analysis Using a Context Free Language: Applicability to Pulsatile Hormone Data	PLOS ONE			English	Article							SECRETORY ACTIVITY; CIRCADIAN-RHYTHMS; STATISTICAL-MODEL; CORTISOL; SLEEP; ALGORITHM; ACTH; ENTRAINMENT; DEPRESSION; DISORDER	We present a novel approach for analyzing biological time-series data using a context-free language (CFL) representation that allows the extraction and quantification of important features from the time-series. This representation results in Hierarchically AdaPtive (HAP) analysis, a suite of multiple complementary techniques that enable rapid analysis of data and does not require the user to set parameters. HAP analysis generates hierarchically organized parameter distributions that allow multi-scale components of the time-series to be quantified and includes a data analysis pipeline that applies recursive analyses to generate hierarchically organized results that extend traditional outcome measures such as pharmacokinetics and inter-pulse interval. Pulsicons, a novel text-based time-series representation also derived from the CFL approach, are introduced as an objective qualitative comparison nomenclature. We apply HAP to the analysis of 24 hours of frequently sampled pulsatile cortisol hormone data, which has known analysis challenges, from 14 healthy women. HAP analysis generated results in seconds and produced dozens of figures for each participant. The results quantify the observed qualitative features of cortisol data as a series of pulse clusters, each consisting of one or more embedded pulses, and identify two ultradian phenotypes in this dataset. HAP analysis is designed to be robust to individual differences and to missing data and may be applied to other pulsatile hormones. Future work can extend HAP analysis to other time-series data types, including oscillatory and other periodic physiological signals.	[Dean, Dennis A., II; Klerman, Elizabeth B.] Brigham & Womens Hosp, Div Sleep & Circadian Disorders, Boston, MA 02115 USA; [Dean, Dennis A., II] MIT, Neurosci Stat Res Lab, Cambridge, MA 02139 USA; [Dean, Dennis A., II] Univ Massachusetts, Biomed Engn & Biotechnol Program, Lowell, MA USA; [Dean, Dennis A., II; Adler, Gail K.; Klerman, Elizabeth B.] Harvard Univ, Sch Med, Boston, MA USA; [Adler, Gail K.; Klerman, Elizabeth B.] Brigham & Womens Hosp, Div Endocrinol Diabet & Hypertens, Boston, MA 02115 USA; [Nguyen, David P.] NIA, NIH, Baltimore, MD 21224 USA	Harvard University; Brigham & Women's Hospital; Massachusetts Institute of Technology (MIT); University of Massachusetts System; University of Massachusetts Lowell; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA)	Dean, DA (corresponding author), Brigham & Womens Hosp, Div Sleep & Circadian Disorders, 75 Francis St, Boston, MA 02115 USA.	ddean@research.bwh.harvard.edu			AFOSR [F49620-95-1-0388, FA9550-06-0080]; NIH [NCRR-GCRC-M01-RR-02635, P01-AG09975, T32 HL07901-10, F31-GM095340-01, K24-HL105664, K02-HD045459, RC2-HL101340, R01-AR43130, K24-HL103845, R01-MH071847, R01 HL098433, R01 HL098433-02S1]; NSBRI through NASA NCC [9-58 HFP01603, HPF00405]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [K02HD045459] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR002635, UL1RR025758] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K24HL105664, R01HL098433, T32HL007901, K24HL103845, R01HL114088, RC2HL101340] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR043130] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F31GM095340] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH071847] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG009975] Funding Source: NIH RePORTER	AFOSR(United States Department of DefenseAir Force Office of Scientific Research (AFOSR)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSBRI through NASA NCC; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work received funding from the following sources: AFOSR F49620-95-1-0388, FA9550-06-0080; NIH NCRR-GCRC-M01-RR-02635, P01-AG09975, T32 HL07901-10 (DAD), F31-GM095340-01 (DAD), K24-HL105664 (EBK), K02-HD045459 (EBK), RC2-HL101340, R01-AR43130 (GKA), K24-HL103845 (GKA), R01-MH071847, R01 HL098433, and R01 HL098433-02S1(DAD), NSBRI through NASA NCC 9-58 HFP01603 and HPF00405. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achermann P, 2004, AVIAT SPACE ENVIR MD, V75, pA37; Almajai I, 2007, INT CONF ACOUST SPEE, P585; Barrett C., 2003, DISCRETE MATH THEOR, P69; Barrett CL, 1999, APPL MATH COMPUT, V98, P241, DOI 10.1016/S0096-3003(97)10166-7; BECKFRIIS J, 1985, PSYCHONEUROENDOCRINO, V10, P173, DOI 10.1016/0306-4530(85)90055-1; Brown EM, 1988, BINDING SITES INOSIT, pS75; Brown EN, 2001, AM J PHYSIOL-ENDOC M, V280, pE450, DOI 10.1152/ajpendo.2001.280.3.E450; Brown EN, 2000, AM J PHYSIOL-ENDOC M, V279, pE669, DOI 10.1152/ajpendo.2000.279.3.E669; Buckley TM, 2005, J CLIN ENDOCR METAB, V90, P3106, DOI 10.1210/jc.2004-1056; CHOMSKY N, 1956, IRE T INFORM THEOR, V2, P113; Clifton DK, 1987, EPISODIC HORMONE SEC, P35; De Kloet ER, 2010, J NEUROENDOCRINOL, V20, P885; Du D-Z, 2001, PROBLEM SOLVING AUTO, P1; Duffy JF, 2005, J BIOL RHYTHM, V20, P326, DOI 10.1177/0748730405277983; Gupta S, 2007, THEOR BIOL MED MODEL, V4, DOI 10.1186/1742-4682-4-8; Haefner JW, 2008, MODELING BIOL SYSTEM, P1; Johnson ML, 2008, ANAL BIOCHEM, V381, P8, DOI 10.1016/j.ab.2008.07.001; JUSKO WJ, 1975, J CLIN ENDOCR METAB, V40, P278, DOI 10.1210/jcem-40-2-278; Keenan DM, 2009, ENDOCRINOLOGY, V150, P1941, DOI 10.1210/en.2008-1249; Keenan DM, 1998, AM J PHYSIOL-ENDOC M, V275, pE157, DOI 10.1152/ajpendo.1998.275.1.E157; Keller-Wood M, 1998, AM J PHYSIOL-REG I, V274, pR1762, DOI 10.1152/ajpregu.1998.274.6.R1762; Klerman EB, 2003, AM J PHYSIOL-ENDOC M, V285, pE1118, DOI 10.1152/ajpendo.00562.2002; Klerman EB, 2001, J CLIN ENDOCR METAB, V86, P1034, DOI 10.1210/jc.86.3.1034; Koenigsberg HW, 2009, J PSYCHIATR RES, V38, P503; Lambalk CB, 1987, EPISODIC SECRETION H, P67; Lewis HR, 1998, CONTEXT FREE LANGUAG, P113; Lewis RD, 1997, J THEOR BIOL, V185, P503, DOI 10.1006/jtbi.1996.0330; Lopowski ZJ, 2010, ANN MED, V22, P213; Magalooikonomou V, 2005, MULTIRESOLUTION SYMB, P668; Mattews SG, 2009, ENDOCRINE, V6, P293; MATTHEWS SG, 1995, AM J PHYSIOL-ENDOC M, V268, pE1096, DOI 10.1152/ajpendo.1995.268.6.E1096; McEwen BS, 2007, PHYSIOL REV, V87, P873, DOI 10.1152/physrev.00041.2006; MERRIAM GR, 1982, AM J PHYSIOL, V243, pE310, DOI 10.1152/ajpendo.1982.243.4.E310; MILLS JN, 1974, J PHYSIOL-LONDON, V240, P567, DOI 10.1113/jphysiol.1974.sp010623; MINORS D S, 1984, Chronobiology International, V1, P205, DOI 10.3109/07420528409063897; MORTOLA JF, 1987, J CLIN ENDOCR METAB, V65, P962, DOI 10.1210/jcem-65-5-962; Mortveit HS, 2008, INTRO SEQUENTIAL DYN, P1; Mullington JM, 2009, PROG CARDIOVASC DIS, V51, P294, DOI 10.1016/j.pcad.2008.10.003; Naska A, 2007, ARCH INTERN MED, V167, P296, DOI 10.1001/archinte.167.3.296; OSULLIVAN F, 1988, BIOMETRICS, V44, P339, DOI 10.2307/2531849; Phanindra G, 2007, INT J COMPUT SCI NET, V7, P231; Pollmacher T, 1996, J INFECT DIS, V174, P1040, DOI 10.1093/infdis/174.5.1040; Proschak E, 2010, J CHEM INF MODEL, V47, P295; PULLUM GK, 1982, LINGUIST PHILOS, V4, P471, DOI 10.1007/BF00360802; Rubin RT, 1996, BIOL PSYCHIAT, V40, P89, DOI 10.1016/0006-3223(95)00358-4; SANTEN RJ, 1973, J CLIN INVEST, V52, P2617, DOI 10.1172/JCI107454; Schweinhardt P, 2008, NEUROSCIENTIST, V14, P415, DOI 10.1177/1073858407312521; Sharpe M, 1997, GEN HOSP PSYCHIAT, V19, P185, DOI 10.1016/S0163-8343(97)80315-5; Sipser M, 1997, INTRO THEORY COMPUTA, P1; Stephenson R, 2012, J BIOL RHYTHM, V27, P490, DOI 10.1177/0748730412461247; STEWART PM, 2008, WILLIAMS TXB ENDOCRI, P445; U.S Food & Drug Administration (FDA), 2007, GUIDANCE IND FDA STA, P1; URBAN RJ, 1988, AM J PHYSIOL, V254, pE113, DOI 10.1152/ajpendo.1988.254.1.E113; Van Cauter E, 2004, CHRONOBIOLGICAL SERI; VANCAUTER E, 1974, J INTERDISCIPL CYCLE, V5, P131; VELDHUIS JD, 1990, J BIOL RHYTHM, V5, P247, DOI 10.1177/074873049000500306; VELDHUIS JD, 1994, NEUROSCI BIOBEHAV R, V18, P605, DOI 10.1016/0149-7634(94)90019-1; VELDHUIS JD, 1986, AM J PHYSIOL, V250, pE486, DOI 10.1152/ajpendo.1986.250.4.E486; Veldhuis JD, 2008, ENDOCR REV, V29, P823, DOI 10.1210/er.2008-0005; Walker JJ, 2010, P ROY SOC B-BIOL SCI, V277, P1627, DOI 10.1098/rspb.2009.2148; Wang D, 2008, J CLIN SLEEP MED, V4, P557; Wang W, 2007, STOCHASTIC CONTEXT F; Wehr TA, 2001, J BIOL RHYTHM, V16, P348, DOI 10.1177/074873001129002060; Wilkinson L, 2005, GRAMMAR GRAPHICS, P1; Zarchan P, 2011, FUNDAMENTALS KALMAN, P1	66	4	4	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 3	2014	9	9							e104087	10.1371/journal.pone.0104087	http://dx.doi.org/10.1371/journal.pone.0104087			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3TB	25184442	Green Published, Green Submitted, gold			2022-12-27	WOS:000341257700008
J	Pointin, F; Payne, MR				Pointin, Fabien; Payne, Mark R.			A Resolution to the Blue Whiting (Micromesistius poutassou) Population Paradox?	PLOS ONE			English	Article							VERTICAL-DISTRIBUTION; PORCUPINE BANK; SUBPOLAR GYRE; LARVAE; PLANKTON; RISSO; EGGS; DISTRIBUTIONS; HYDROGRAPHY; PREDICTION	We provide the strongest evidence to date supporting the existence of two independent blue whiting (Micromesistius poutassou (Risso, 1827)) populations in the North Atlantic. In spite of extensive data collected in conjunction with the fishery, the population structure of blue whiting is poorly understood. On one hand, genetic, morphometric, otolith and drift modelling studies point towards the existence of two populations, but, on the other hand, observations of adult distributions point towards a single population. A paradox therefore arises in attempting to reconcile these two sets of information. Here we analyse 1100 observations of blue whiting larvae from the Continuous Plankton Recorder (CPR) from 1948-2005 using modern statistical techniques. We show a clear spatial separation between a northern spawning area, in the Rockall Trough, and a southern one, off the Porcupine Seabight. We further show a difference in the timing of spawning between these sites of at least a month, and meaningful differences in interannual variability. The results therefore support the two-population hypothesis. Furthermore, we resolve the paradox by showing that the acoustic observations cited in support of the single-population model are not capable of resolving both populations, as they occur too late in the year and do not extend sufficiently far south to cover the southern population: the confusion is the result of a simple observational artefact. We conclude that blue whiting in the North Atlantic comprises two populations.	[Pointin, Fabien; Payne, Mark R.] Tech Univ Denmark, Ctr Ocean Life, Natl Inst Aquat Resources DTU Aqua, Charlottenlund, Denmark	Technical University of Denmark	Payne, MR (corresponding author), Tech Univ Denmark, Ctr Ocean Life, Natl Inst Aquat Resources DTU Aqua, Charlottenlund, Denmark.	mpay@aqua.dtu.dk	Payne, Mark/C-6844-2008	Payne, Mark/0000-0001-5795-2481	European Union [264933, 308299]; United Kingdom Department of Environment, Fisheries and Rural Affairs (Defra) [MF1101]	European Union(European Commission); United Kingdom Department of Environment, Fisheries and Rural Affairs (Defra)	The research leading to these results has received funding from the European Union 7th Framework Programme (FP7 2007-2013) under grant agreement numbers 264933 (Euro-Basin project) and 308299 (NACLIM). Analysis of the CPR fish larval samples from 1979 to 2005 was funded by the United Kingdom Department of Environment, Fisheries and Rural Affairs (Defra) through project MF1101. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adlandsvik B, 2001, FISH RES, V50, P59, DOI 10.1016/S0165-7836(00)00242-3; Agresti A., 2010, ANAL ORDINAL CATEGOR, DOI [DOI 10.1002/9780470594001, 10.1002/9780470594001]; [Anonymous], 2012, TECHNICAL REPORT; [Anonymous], 2013, MAPTOOLS TOOLS READI; Bailey MC, 2001, FISH RES, V50, P73, DOI 10.1016/S0165-7836(00)00243-5; BAILEY RS, 1982, ADV MAR BIOL, V19, P257, DOI 10.1016/S0065-2881(08)60089-9; BAINBRIDGE V, 1973, Bulletins of Marine Ecology, V8, P99; Bartsch J, 1997, FISH OCEANOGR, V6, P141, DOI 10.1046/j.1365-2419.1997.00036.x; Brophy D, 2007, ICES J MAR SCI, V64, P1136, DOI 10.1093/icesjms/fsm080; Burnham KP, 2011, BEHAV ECOL SOCIOBIOL, V65, P23, DOI 10.1007/s00265-010-1029-6; Burnham KP, 2002, MODEL SELECTION MULT, V2nd, DOI [DOI 10.1007/B97636, 10.1007/978-1-4757-2917-7, DOI 10.1007/978-1-4757-2917-7]; CONWAY DVP, 1980, J FISH BIOL, V16, P709, DOI 10.1111/j.1095-8649.1980.tb03750.x; COOMBS S H, 1980, Bulletins of Marine Ecology, V8, P229; COOMBS SH, 1979, J FISH BIOL, V14, P111; Corten A, 2003, PROG OCEANOGR, V58, P285, DOI 10.1016/j.pocean.2003.08.008; Edwards M., 2011, FISH LARVAE ATLAS NE; Elith J, 2006, ECOGRAPHY, V29, P129, DOI 10.1111/j.2006.0906-7590.04596.x; Gerber E, 1993, J ICHTHYOL+, V33, P26; Gerber YM, 1993, J ICHTHYOL, V33, P77; Giaever M, 1998, J FISH BIOL, V52, P782, DOI 10.1111/j.1095-8649.1998.tb00820.x; Hatun H, 2009, PROG OCEANOGR, V80, P149, DOI 10.1016/j.pocean.2009.03.001; Hatun H, 2009, CAN J FISH AQUAT SCI, V66, P759, DOI 10.1139/F09-037; Heino M, 2008, FISH OCEANOGR, V17, P153, DOI 10.1111/j.1365-2419.2008.00472.x; HENDERSON G. T. D., 1957, BULL MARINE ECOL, V4, P179; Henderson GTD, 1961, YOUNG FISH B MARINE, V5, P105; Huse G, 2012, MAR BIOL RES, V8, P488, DOI 10.1080/17451000.2011.639779; ICES, 1986, 1986ASSESS3 ICES CM; ICES, 2013, REP ICES ADV COMM 20; ICES, 2012, 2012ACOM47 ICES CM; ICES, 2014, 2014SSGESST01 ICES C; ICES (International Council for the Exploration of the Sea), 2010, REP ICES ADV COMM 20; Isaev NA, 1991, J ICHTHYOLOGY, V31, P45; Jansen T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051541; Jones MC, 2012, ECOL MODEL, V225, P133, DOI 10.1016/j.ecolmodel.2011.11.003; Kell LT, 2009, ICES J MAR SCI, V66, P1776, DOI 10.1093/icesjms/fsp181; Kloppmann M, 2001, FISH RES, V50, P89, DOI 10.1016/S0165-7836(00)00244-7; Lobo JM, 2008, GLOBAL ECOL BIOGEOGR, V17, P145, DOI 10.1111/j.1466-8238.2007.00358.x; Lynam CP, 2013, ICES J MAR SCI, V70, P540, DOI 10.1093/icesjms/fst006; McPherson AA, 2001, J FISH BIOL, V59, P356, DOI 10.1006/jfbi.2001.1769; Monstad Terje, 2004, P263; MORK J, 1995, J FISH BIOL, V46, P462, DOI 10.1111/j.1095-8649.1995.tb05987.x; NCAR, 2012, VER FOR VER UT; Payne MR, 2012, MAR BIOL RES, V8, P475, DOI 10.1080/17451000.2011.639778; Pitois SG, 2012, MAR ECOL PROG SER, V456, P169, DOI 10.3354/meps09710; Reiss H, 2009, FISH FISH, V10, P361, DOI 10.1111/j.1467-2979.2008.00324.x; Richardson AJ, 2006, PROG OCEANOGR, V68, P27, DOI 10.1016/j.pocean.2005.09.011; Ryan AW, 2005, ICES J MAR SCI, V62, P948, DOI 10.1016/j.icesjms.2005.03.006; Schmidt J., 1909, RAPPORTS PROCES VERB, V10, P1; Secor DH, 2009, ICES J MAR SCI, V66, P1726, DOI 10.1093/icesjms/fsp154; Skogen MD, 1999, FISH RES, V41, P119, DOI 10.1016/S0165-7836(99)00019-3; Svendsen E., 1996, 1996S31 ICES CM; Trenkel VM, 2014, PROGR OCEAN IN PRESS; Was A, 2008, ICES J MAR SCI, V65, P216, DOI 10.1093/icesjms/fsm187; Wood S, 2017, GEN ADDITIVE MODELS, DOI 10.1201/9781315370279; Wood SN, 2006, BIOMETRICS, V62, P1025, DOI 10.1111/j.1541-0420.2006.00574.x; Wood SN, 2011, J R STAT SOC B, V73, P3, DOI 10.1111/j.1467-9868.2010.00749.x	56	10	10	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 3	2014	9	9							e106237	10.1371/journal.pone.0106237	http://dx.doi.org/10.1371/journal.pone.0106237			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3TB	25184302	gold, Green Published, Green Submitted			2022-12-27	WOS:000341257700042
J	Sahu, BD; Kalvala, AK; Koneru, M; Kumar, JM; Kuncha, M; Rachamalla, SS; Sistla, R				Sahu, Bidya Dhar; Kalvala, Anil Kumar; Koneru, Meghana; Kumar, Jerald Mahesh; Kuncha, Madhusudana; Rachamalla, Shyam Sunder; Sistla, Ramakrishna			Ameliorative Effect of Fisetin on Cisplatin-Induced Nephrotoxicity in Rats via Modulation of NF-kappa B Activation and Antioxidant Defence	PLOS ONE			English	Article							ACUTE KIDNEY INJURY; OXIDATIVE STRESS; MITOCHONDRIAL DYSFUNCTION; PATHOLOGICAL ROLE; RENAL INJURY; CELL-DEATH; INFLAMMATION; MECHANISMS; PROTECTS; MICE	Nephrotoxicity is a dose-dependent side effect of cisplatin limiting its clinical usage in the field of cancer chemotherapy. Fisetin is a bioactive flavonoid with recognized antioxidant and anti-inflammatory properties. In the present study, we investigated the potential renoprotective effect and underlying mechanism of fisetin using rat model of cisplatin-induced nephrotoxicity. The elevation in serum biomarkers of renal damage (blood urea nitrogen and creatinine); degree of histopathological alterations and oxidative stress were significantly restored towards normal in fisetin treated, cisplatin challenged animals. Fisetin treatment also significantly attenuated the cisplatin-induced I kappa B alpha degradation and phosphorylation and blocked the NF-kappa B (p65) nuclear translocation, with subsequent elevation of pro-inflammatory cytokine, TNF-alpha, protein expression of iNOS and myeloperoxidase activities. Furthermore, fisetin markedly attenuated the translocation of cytochrome c protein from the mitochondria to the cytosol; decreased the expression of pro-apoptotic proteins including Bax, cleaved caspase-3, cleaved caspase-9 and p53; and prevented the decline of anti-apoptotic protein, Bcl-2. The cisplatin-induced mRNA expression of NOX2/gp91phox and NOX4/RENOX and the NADPH oxidase enzyme activity were also significantly lowered by fisetin treatment. Moreover, the evaluated mitochondrial respiratory enzyme activities and mitochondrial antioxidants were restored by fisetin treatment. Estimation of platinum concentration in kidney tissues revealed that fisetin treatment along with cisplatin did not alter the cisplatin uptake in kidney tissues. In conclusion, these findings suggest that fisetin may be used as a promising adjunct candidate for cisplatin use.	[Sahu, Bidya Dhar; Koneru, Meghana; Kuncha, Madhusudana; Sistla, Ramakrishna] CSIR Indian Inst Chem Technol IICT, Med Chem & Pharmacol Div, Hyderabad, Andhra Pradesh, India; [Kalvala, Anil Kumar] NIPER, Dept Pharmacol & Toxicol, Hyderabad, Andhra Pradesh, India; [Kumar, Jerald Mahesh] CSIR Ctr Cellular & Mol Biol CCMB, Hyderabad, Andhra Pradesh, India; [Rachamalla, Shyam Sunder] Osmania Univ, Fac Pharm, Hyderabad 500007, Andhra Pradesh, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Indian Institute of Chemical Technology (IICT); National Institute of Pharmaceutical Education & Research, Hyderabad; National Institute of Pharmaceutical Education & Research (NIPER); Council of Scientific & Industrial Research (CSIR) - India; CSIR - Centre for Cellular & Molecular Biology (CCMB); Osmania University	Sistla, R (corresponding author), CSIR Indian Inst Chem Technol IICT, Med Chem & Pharmacol Div, Hyderabad, Andhra Pradesh, India.	sistla@iict.res.in	Kalvala, Anil/AFT-4757-2022	Kalvala, Anil/0000-0003-4500-1472	CSIR [CSC 0111]; CSIR, India	CSIR(Council of Scientific & Industrial Research (CSIR) - India); CSIR, India(Council of Scientific & Industrial Research (CSIR) - India)	This work was supported by research grant from CSIR project 'SMiLE' (CSC 0111). Senior Research Fellowship to BDS from CSIR, India, is gratefully acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aebi H., 1974, METHODS ENZYMATIC AN, P673, DOI [10.1016/B978-0-12-091302-2.50032-3, DOI 10.1016/B978-0-12-091302-2.50032-3]; CARLBERG I, 1975, J BIOL CHEM, V250, P5475; Chou RH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071983; El-Naga RN, 2014, TOXICOL APPL PHARM, V274, P87, DOI 10.1016/j.taap.2013.10.031; ELLMAN GL, 1959, ARCH BIOCHEM BIOPHYS, V82, P70, DOI 10.1016/0003-9861(59)90090-6; Gelderblom M, 2012, J CEREBR BLOOD F MET, V32, P835, DOI 10.1038/jcbfm.2011.189; Goh FY, 2012, EUR J PHARMACOL, V679, P109, DOI 10.1016/j.ejphar.2012.01.002; dos Santos NAG, 2012, ARCH TOXICOL, V86, P1233, DOI 10.1007/s00204-012-0821-7; HABIG WH, 1974, J BIOL CHEM, V249, P7130; Jaiman S, 2013, EUR J CLIN PHARMACOL, V69, P1863, DOI 10.1007/s00228-013-1568-7; Jeon TI, 2013, MOL NUTR FOOD RES, V57, P1931, DOI 10.1002/mnfr.201300071; Jiang M, 2008, J PHARMACOL EXP THER, V327, P300, DOI 10.1124/jpet.108.139162; Kang KP, 2011, NEPHROL DIAL TRANSPL, V26, P814, DOI 10.1093/ndt/gfq528; Kim Hye Joo, 2012, Evid Based Complement Alternat Med, V2012, P639469, DOI 10.1155/2012/639469; King T.E., 1967, METHOD ENZYMOL, V10, P322, DOI DOI 10.1016/0076-6879(67)10061-X; King T.E., 1967, METHOD ENZYMOL, V10, P275, DOI DOI 10.1016/0076-6879(67)10055-4; Kruidering M, 1997, J PHARMACOL EXP THER, V280, P638; Lee IC, 2014, FOOD CHEM TOXICOL, V63, P174, DOI 10.1016/j.fct.2013.11.006; Lee Y, 2013, ARCH PHARM RES, V36, P1377, DOI 10.1007/s12272-013-0226-z; Leotoing L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068388; Liu H, 1997, J BIOL CHEM, V272, P21751, DOI 10.1074/jbc.272.35.21751; Luo JH, 2008, NEPHROL DIAL TRANSPL, V23, P2198, DOI 10.1093/ndt/gfn090; Maher P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021226; Maher P, 2009, GENES NUTR, V4, P297, DOI 10.1007/s12263-009-0142-5; Marullo R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081162; Miller RP, 2010, TOXINS, V2, P2490, DOI 10.3390/toxins2112490; Mitazaki S, 2013, LIFE SCI, V92, P694, DOI 10.1016/j.lfs.2013.01.026; Mukhopadhyay P, 2012, FREE RADICAL BIO MED, V52, P497, DOI 10.1016/j.freeradbiomed.2011.11.001; Mukhopadhyay P, 2010, BRIT J PHARMACOL, V160, P657, DOI 10.1111/j.1476-5381.2010.00769.x; Oh GS, 2014, KIDNEY INT, V85, P547, DOI 10.1038/ki.2013.330; OHKAWA H, 1979, ANAL BIOCHEM, V95, P351, DOI 10.1016/0003-2697(79)90738-3; Omaye S T, 1979, Methods Enzymol, V62, P3, DOI 10.1016/0076-6879(79)62181-X; Pabla N, 2008, KIDNEY INT, V73, P994, DOI 10.1038/sj.ki.5002786; Park H, 2008, IEEE COMPUT INTELL M, V3, P76; Rubera I, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.355; Sahu BD, 2014, TOXICOL APPL PHARM, V277, P8, DOI 10.1016/j.taap.2014.02.022; Sahu BD, 2013, PHYTOMEDICINE, V20, P453, DOI 10.1016/j.phymed.2012.12.001; Sahu BD, 2011, FOOD CHEM TOXICOL, V49, P3090, DOI 10.1016/j.fct.2011.08.018; Santos NAG, 2007, ARCH TOXICOL, V81, P495, DOI 10.1007/s00204-006-0173-2; Satoh M, 2003, J PHARMACOL EXP THER, V305, P1183, DOI 10.1124/jpet.102.047522; Sung MJ, 2008, KIDNEY INT, V74, P1538, DOI 10.1038/ki.2008.409; Thippeswamy BS, 2011, EUR J PHARMACOL, V654, P100, DOI 10.1016/j.ejphar.2010.12.012; Touil YS, 2011, BIOCHEM PHARMACOL, V82, P1731, DOI 10.1016/j.bcp.2011.07.097; Tripathi R, 2011, MOL CANCER THER, V10, P255, DOI 10.1158/1535-7163.MCT-10-0606; van Angelen AA, 2013, NEPHROL DIAL TRANSPL, V28, P879, DOI 10.1093/ndt/gfs499; Wei Q, 2007, KIDNEY INT, V72, P53, DOI 10.1038/sj.ki.5002256; Zhu H, 2005, FEBS LETT, V579, P3029, DOI 10.1016/j.febslet.2005.04.058	47	134	138	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 3	2014	9	9							e105070	10.1371/journal.pone.0105070	http://dx.doi.org/10.1371/journal.pone.0105070			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3TB	25184746	Green Submitted, Green Published, gold			2022-12-27	WOS:000341257700016
J	Chang, YX; Liu, J; Bai, Y; Li, J; Liu, EW; He, J; Jiao, XC; Wang, ZZ; Gao, XM; Zhang, BL; Xiao, W				Chang, Yan-xu; Liu, Jiao; Bai, Yang; Li, Jin; Liu, Er-wei; He, Jun; Jiao, Xiu-cheng; Wang, Zhen-zhong; Gao, Xiu-Mei; Zhang, Bo-li; Xiao, Wei			The Activity-Integrated Method for Quality Assessment of Reduning Injection by On-Line DPPH-CE-DAD	PLOS ONE			English	Article							MICELLAR ELECTROKINETIC CHROMATOGRAPHY; RADICAL-SCAVENGING ACTIVITY; CARBON NANOTUBES; ORGANIC-SOLVENTS; HPLC; CONSTITUENTS; COMPONENTS; SEPARATION; PHASE	A sensitive on-line DPPH-CE-DAD method was developed and validated for both screening and determining the concentration of seven antioxidants of Reduning injection. The pH and concentrations of buffer solution, SDS, beta-CD and organic modifier were studied for the detection of DPPH and seven antioxidants. By on-line mixing DPPH and sample solution, a DPPH-CE method for testing the antioxidant activity of the complex matrix was successfully established and used to screen the antioxidant components of Reduning injection. Then, antioxidant components including caffeic acid, isochlorogenic acid A, isochlorogenic acid B, isochlorogenic acid C, chlorogenic acid, neochlorogenic acid and cryptochlorogenic acid were quantified by the newly established CE-DAD method. Finally, the total antioxidant activity and the multiple active components were selected as markers to evaluate the quality of Reduning injection. The results demonstrated that the on-line DPPH-CE-DAD method was reagent-saving, rapid and feasible for on-line simultaneous determination of total pharmacological activity and contents of multi-components samples. It was also a powerful method for evaluating the quality control and mechanism of action of TCM injection.	[Chang, Yan-xu; Liu, Jiao; Bai, Yang; Li, Jin; Liu, Er-wei; He, Jun; Jiao, Xiu-cheng; Gao, Xiu-Mei; Zhang, Bo-li] Tianjin Univ Tradit Chinese Med, Tianjin State Key Lab Modern Chinese Med, Tianjin, Peoples R China; [Chang, Yan-xu; Wang, Zhen-zhong; Xiao, Wei] Kanion Pharmaceut Co Ltd, State Key Lab New Tech Chinese Med Pharmaceut Pro, Lianyungang, Peoples R China	Tianjin University of Traditional Chinese Medicine	Chang, YX (corresponding author), Tianjin Univ Tradit Chinese Med, Tianjin State Key Lab Modern Chinese Med, Tianjin, Peoples R China.	Tcmcyx@126.com; Xiaowei@163.com		chang, yanxu/0000-0002-4198-374X; Li, Jin/0000-0003-3094-4777	National Natural Science Foundation of China [81374050]; Program for Innovative Research Team in Universities of Tianjin [TD12-5033]; Tianjin Research Program of Application Foundation Advanced Technology [12JCQNJC08800]; Stated Key Development Program for Basic Research of China [973:2012CB723504]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Program for Innovative Research Team in Universities of Tianjin; Tianjin Research Program of Application Foundation Advanced Technology; Stated Key Development Program for Basic Research of China	This research was supported National Natural Science Foundation of China (81374050) and Program for Innovative Research Team in Universities of Tianjin (TD12-5033) and Tianjin Research Program of Application Foundation Advanced Technology (12JCQNJC08800) and Stated Key Development Program for Basic Research of China (No. 973:2012CB723504). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cao J, 2013, ELECTROPHORESIS, V34, P324, DOI 10.1002/elps.201200101; Cao J, 2011, J CHROMATOGR A, V1218, P9428, DOI 10.1016/j.chroma.2011.11.013; Cao J, 2010, ELECTROPHORESIS, V31, P3492, DOI 10.1002/elps.201000168; Chandrasekar D, 2006, J PHARMACEUT BIOMED, V40, P460, DOI 10.1016/j.jpba.2005.07.042; Ciesla L, 2012, J PHARMACEUT BIOMED, V70, P126, DOI 10.1016/j.jpba.2012.06.007; de Oliveira RG, 2013, J YOUNG PHARM, V5, P102, DOI 10.1016/j.jyp.2013.08.005; Gasic U, 2014, FOOD CHEM, V145, P599, DOI 10.1016/j.foodchem.2013.08.088; Gottardo R, 2012, J CHROMATOGR A, V1267, P198, DOI 10.1016/j.chroma.2012.08.085; Hu YC, 2014, J SEP SCI, V37, P404, DOI 10.1002/jssc.201301102; Huie CW, 2003, ELECTROPHORESIS, V24, P1508, DOI 10.1002/elps.200305396; Iwai K, 2004, J AGR FOOD CHEM, V52, P4893, DOI 10.1021/jf040048m; Jian ZY, 2013, NUTR HOSP, V28, P1681, DOI 10.3305/nh.2013.28.5.6587; Li TX, 2014, J CHROMATOGR B, V944, P90, DOI 10.1016/j.jchromb.2013.11.015; Li XH, 2014, EVID-BASED COMPL ALT, V2014, DOI 10.1155/2014/140764; Liang J, 2013, J CHROMATOGR A, V1294, P58, DOI 10.1016/j.chroma.2013.04.016; Naldi M, 2014, J PHARMACEUT BIOMED, V88, P307, DOI 10.1016/j.jpba.2013.08.054; Orlandini S, 2014, J PHARMACEUT BIOMED, V87, P290, DOI 10.1016/j.jpba.2013.04.014; Rodriguez J, 2012, J CHROMATOGR A, V1231, P66, DOI 10.1016/j.chroma.2012.02.003; Takeoka GR, 2003, J AGR FOOD CHEM, V51, P496, DOI 10.1021/jf020660i; Tang LP, 2014, CHIN J INTEGR MED, V20, P591, DOI 10.1007/s11655-014-1758-x; Tian SG, 2012, PHARMACOGN MAG, V8, P280, DOI 10.4103/0973-1296.103653; Yamaguchi T, 1998, BIOSCI BIOTECH BIOCH, V62, P1201, DOI 10.1271/bbb.62.1201; Zhao LS, 2014, NAT PROD RES, V28, P500, DOI 10.1080/14786419.2013.877904	23	13	14	1	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2014	9	9							e106254	10.1371/journal.pone.0106254	http://dx.doi.org/10.1371/journal.pone.0106254			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3LR	25181475	Green Published, Green Submitted, gold			2022-12-27	WOS:000341231500065
J	Dai, XJ; Gao, SX; Liu, DG				Dai, Xinjia; Gao, Suxia; Liu, Deguang			Genetic Basis and Selection for Life-History Trait Plasticity on Alternative Host Plants for the Cereal Aphid Sitobion avenae	PLOS ONE			English	Article							PHENOTYPIC PLASTICITY; DIFFERENTIAL PERFORMANCE; EVOLUTION; SPECIALIZATION; ADAPTATION; HOMOPTERA; POPULATIONS; ENVIRONMENT; CLONES; COSTS	Sitobion avenae (F.) can survive on various plants in the Poaceae, which may select for highly plastic genotypes. But phenotypic plasticity was often thought to be non-genetic, and of little evolutionary significance historically, and many problems related to adaptive plasticity, its genetic basis and natural selection for plasticity have not been well documented. To address these questions, clones of S. avenae were collected from three plants, and their phenotypic plasticity under alternative environments was evaluated. Our results demonstrated that nearly all tested life-history traits showed significant plastic changes for certain S. avenae clones with the total developmental time of nymphs and fecundity tending to have relatively higher plasticity for most clones. Overall, the level of plasticity for S. avenae clones' life-history traits was unexpectedly low. The factor 'clone' alone explained 27.7-62.3% of the total variance for trait plasticities. The heritability of plasticity was shown to be significant in nearly all the cases. Many significant genetic correlations were found between trait plasticities with a majority of them being positive. Therefore, it is evident that life-history trait plasticity involved was genetically based. There was a high degree of variation in selection coefficients for life-history trait plasticity of different S. avenae clones. Phenotypic plasticity for barley clones, but not for oat or wheat clones, was frequently found to be under significant selection. The directional selection of alternative environments appeared to act to decrease the plasticity of S. avenae clones in most cases. G-matrix comparisons showed significant differences between S. avenae clones, as well as quite a few negative covariances (i.e., trade-offs) between trait plasticities. Genetic basis and evolutionary significance of life-history trait plasticity were discussed.	[Dai, Xinjia; Gao, Suxia; Liu, Deguang] Northwest A&F Univ, State Key Lab Crop Stress Biol Arid Areas, Yangling, Shaanxi, Peoples R China; [Dai, Xinjia; Gao, Suxia; Liu, Deguang] Minist Agr, Key Lab Integrated Pest Management Crops Northwes, Yangling, Shaanxi, Peoples R China; [Dai, Xinjia; Gao, Suxia; Liu, Deguang] Northwest A&F Univ, Coll Plant Protect, Yangling, Shaanxi, Peoples R China	Northwest A&F University - China; Ministry of Agriculture & Rural Affairs; Northwest A&F University - China	Liu, DG (corresponding author), Northwest A&F Univ, State Key Lab Crop Stress Biol Arid Areas, Yangling, Shaanxi, Peoples R China.	dgliu@nwsuaf.edu.cn			Ministry of Education of China [20110204120001]; Northwest AF University [QN2011059]	Ministry of Education of China(Ministry of Education, China); Northwest AF University	This research was supported by the Specialized Research Fund for the Doctoral Program of Higher Education from Ministry of Education of China (No. 20110204120001) (http://www.moe.edu.cn/), and a grant from Northwest A&F University (No. QN2011059) (http://www.nwsuaf.edu.cn). DL received the funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS JB, 1964, CAN J ZOOLOG, V42, P741, DOI 10.1139/z64-072; Agarwala BK, 2007, CURR SCI INDIA, V93, P308; [Anonymous], 2017, ANIM COGN, DOI DOI 10.1007/s10071-016-1007-0; BLACKMAN R.L., 2006, APHIDS WORLDS HERBAC; Borges RM, 2008, PLANT SIGNAL BEHAV, V3, P367, DOI 10.4161/psb.3.6.5823; BRADSHAW A. D., 1965, ADVANCE GENET, V13, P115, DOI 10.1016/S0065-2660(08)60048-6; Bradshaw AD, 2006, NEW PHYTOL, V170, P644, DOI 10.1111/j.1469-8137.2006.01761.x; Carter MJ, 2012, ECOL EVOL, V2, P1414, DOI 10.1002/ece3.247; Chevin LM, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000357; DEAN GJW, 1973, ANN APPL BIOL, V73, P127, DOI 10.1111/j.1744-7348.1973.tb01317.x; Fordyce JA, 2005, INSECT PHENOTYPIC PLASTICITY: DIVERSITY OF RESPONSES, P125; Gao SX, 2014, INSECT SCI, V21, P352, DOI 10.1111/1744-7917.12085; Gao SX, 2013, J ECON ENTOMOL, V106, P1294, DOI 10.1603/EC13017; Ghalambor CK, 2007, FUNCT ECOL, V21, P394, DOI 10.1111/j.1365-2435.2007.01283.x; Godfrey L. D., 2001, Journal of Cotton Science, V5, P22; Gorur G, 2007, ARTHROPOD-PLANT INTE, V1, P187, DOI 10.1007/s11829-007-9017-0; Gorur G, 2005, ECOL ENTOMOL, V30, P657, DOI 10.1111/j.0307-6946.2005.00742.x; Huang XL, 2013, ENVIRON ENTOMOL, V42, P1174, DOI 10.1603/EN13132; Kelly SA, 2012, COMPR PHYSIOL, V2, P1417, DOI 10.1002/cphy.c110008; LANDE R, 1983, EVOLUTION, V37, P1210, DOI 10.1111/j.1558-5646.1983.tb00236.x; Lande R, 2009, J EVOLUTION BIOL, V22, P1435, DOI 10.1111/j.1420-9101.2009.01754.x; Nespolo RF, 2009, EVOLUTION, V63, P2402, DOI 10.1111/j.1558-5646.2009.00706.x; Neumaier A, 1998, GENET SEL EVOL, V30, P3, DOI 10.1051/gse:19980101; Nylin S, 1998, ANNU REV ENTOMOL, V43, P63, DOI 10.1146/annurev.ento.43.1.63; Orr HA, 2005, NAT REV GENET, V6, P119, DOI 10.1038/nrg1523; Papura D, 2003, HEREDITY, V90, P397, DOI 10.1038/sj.hdy.6800262; Phillips PC, 1999, EVOLUTION, V53, P1506, DOI 10.2307/2640896; Pigliucci M, 2005, TRENDS ECOL EVOL, V20, P481, DOI 10.1016/j.tree.2005.06.001; Pitchers WR, 2013, J EVOLUTION BIOL, V26, P1060, DOI 10.1111/jeb.12120; Price TD, 2003, P ROY SOC B-BIOL SCI, V270, P1433, DOI 10.1098/rspb.2003.2372; Relyea RA, 2002, AM NAT, V159, P272, DOI 10.1086/338540; SAS, 1998, SAS SYST VERS 6 12; SCHEINER SM, 1993, ANNU REV ECOL SYST, V24, P35, DOI 10.1146/annurev.es.24.110193.000343; SCHLICHTING CD, 1986, ANNU REV ECOL SYST, V17, P667, DOI 10.1146/annurev.es.17.110186.003315; Simon JC, 1999, MOL ECOL, V8, P531, DOI 10.1046/j.1365-294x.1999.00583.x; Sultan SE, 1995, ACTA BOT NEERL, V44, P363; SULTAN SE, 1987, EVOL BIOL, V21, P127; Sultan SE, 2000, TRENDS PLANT SCI, V5, P537, DOI 10.1016/S1360-1385(00)01797-0; Sultan SE, 2007, TRENDS ECOL EVOL, V22, P575, DOI 10.1016/j.tree.2007.06.014; Sunnucks P, 1997, MOL ECOL, V6, P1059, DOI 10.1046/j.1365-294X.1997.00280.x; Svensson EI, 2004, HEREDITY, V93, P423, DOI 10.1038/sj.hdy.6800519; VIA S, 1985, EVOLUTION, V39, P505, DOI [10.2307/2408649, 10.1111/j.1558-5646.1985.tb00391.x]; VIA S, 1991, ECOLOGY, V72, P1420, DOI 10.2307/1941114; WATSON SJ, 1984, CROP PROT, V3, P67, DOI 10.1016/0261-2194(84)90008-5; West-Eberhard Mary Jane, 2003, pi; WESTEBERHARD MJ, 1989, ANNU REV ECOL SYST, V20, P249, DOI 10.1146/annurev.es.20.110189.001341; Whitman D.W., 2009, PHENOTYPIC PLASTICIT, V1st; Wool D, 1997, ANN ENTOMOL SOC AM, V90, P316, DOI 10.1093/aesa/90.3.316; Xu ZH, 2011, J ECON ENTOMOL, V104, P1080, DOI 10.1603/EC10204	49	18	19	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2014	9	9							e106179	10.1371/journal.pone.0106179	http://dx.doi.org/10.1371/journal.pone.0106179			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3LR	25181493	Green Published, gold, Green Submitted			2022-12-27	WOS:000341231500056
J	Jerman, S; Ward, HH; Lee, R; Lopes, CAM; Fry, AM; MacDougall, M; Wandinger-Ness, A				Jerman, Stephanie; Ward, Heather H.; Lee, Rebecca; Lopes, Carla A. M.; Fry, Andrew M.; MacDougall, Mary; Wandinger-Ness, Angela			OFD1 and Flotillins Are Integral Components of a Ciliary Signaling Protein Complex Organized by Polycystins in Renal Epithelia and Odontoblasts	PLOS ONE			English	Article							RECEPTOR TYROSINE KINASE; GROWTH-FACTOR RECEPTOR; VESICLE DOCKING; PRIMARY CILIUM; UP-REGULATION; MEMBRANE; LOCALIZATION; REGGIE-1/FLOTILLIN-2; ASSOCIATION; REQUIRES	Mutation of the X-linked oral-facial-digital syndrome type 1 (OFD1) gene is embryonic lethal in males and results in craniofacial malformations and adult onset polycystic kidney disease in females. While the OFD1 protein localizes to centriolar satellites, centrosomes and basal bodies, its cellular function and how it relates to cystic kidney disease is largely unknown. Here, we demonstrate that OFD1 is assembled into a protein complex that is localized to the primary cilium and contains the epidermal growth factor receptor (EGFR) and domain organizing flotillin proteins. This protein complex, which has similarity to a basolateral adhesion domain formed during cell polarization, also contains the polycystin proteins that when mutant cause autosomal dominant polycystic kidney disease (ADPKD). Importantly, in human ADPKD cells where mutant polycystin-1 fails to localize to cilia, there is a concomitant loss of localization of polycystin-2, OFD1, EGFR and flotillin-1 to cilia. Together, these data suggest that polycystins are necessary for assembly of a novel flotillin-containing ciliary signaling complex and provide a molecular rationale for the common renal pathologies caused by OFD1 and PKD mutations.	[Jerman, Stephanie; Lee, Rebecca; Wandinger-Ness, Angela] Univ New Mexico Hlth Sci Ctr, Canc Res & Treatment Ctr, Dept Pathol MSC08 4640, Albuquerque, NM 87131 USA; [Ward, Heather H.] Univ New Mexico Hlth Sci Ctr, Dept Internal Med, Div Nephrol MSC10 5550, Albuquerque, NM USA; [Lopes, Carla A. M.; Fry, Andrew M.] Univ Leicester, Dept Biochem, Leicester LE1 7RH, Leics, England; [MacDougall, Mary] Univ Alabama Birmingham, Sch Dent, Inst Oral Hlth Res, Birmingham, AL 35294 USA; [MacDougall, Mary] Univ Alabama Birmingham, Sch Dent, Dept Oral & Maxillofacial Surg, Birmingham, AL 35294 USA	University of New Mexico; University of New Mexico's Health Sciences Center; University of New Mexico; University of New Mexico's Health Sciences Center; University of Leicester; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham	Wandinger-Ness, A (corresponding author), Univ New Mexico Hlth Sci Ctr, Canc Res & Treatment Ctr, Dept Pathol MSC08 4640, Albuquerque, NM 87131 USA.	wness@unm.edu	Ward, Heather/R-7785-2016; MacDougall, Mary/ABG-8212-2021	Ward, Heather/0000-0002-8502-3679; Lopes, Carla A. M./0000-0003-3182-8305	National Institute of Dental and Craniofacial Research [F31 DE023483-01]; National Institute of General Medical Sciences (NIGMS) Spatio Temporal Modeling Center Fellowship (STMC) [P50 GM085273]; Wellcome Trust; National Institute of Diabetes and Digestive and Kidney Diseases [R01 DK050141]; NIGMS [K12 GM088021]; Kidney Research UK; NATIONAL CANCER INSTITUTE [P30CA118100] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [F31DE023483] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK050141] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM085273, K12GM088021] Funding Source: NIH RePORTER; Kidney Research UK [RP2/2013] Funding Source: researchfish; Worldwide Cancer Research [13-0042] Funding Source: researchfish	National Institute of Dental and Craniofacial Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); National Institute of General Medical Sciences (NIGMS) Spatio Temporal Modeling Center Fellowship (STMC); Wellcome Trust(Wellcome TrustEuropean Commission); National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Kidney Research UK(Kidney Research UK (KRUK)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Kidney Research UK(Kidney Research UK (KRUK)); Worldwide Cancer Research	These studies were supported in part by: grants from the National Institute of Dental and Craniofacial Research F31 DE023483-01 (SJ); a National Institute of General Medical Sciences (NIGMS) Spatio Temporal Modeling Center Fellowship (STMC) P50 GM085273 (SJ, PI-Wilson, B.); The Wellcome Trust and Kidney Research UK (AMF); the National Institute of Diabetes and Digestive and Kidney Diseases R01 DK050141 (AWN); NIGMS K12 GM088021 (AWN; HHW scholar). The content is solely the responsibility of the authors and does not necessarily represent the official views from the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amaddii M, 2012, J BIOL CHEM, V287, P7265, DOI 10.1074/jbc.M111.287599; Baldari CT, 2010, CURR OPIN CELL BIOL, V22, P75, DOI 10.1016/j.ceb.2009.10.010; Banning A, 2011, CURR PROTEIN PEPT SC, V12, P725, DOI 10.2174/138920311798841708; Benvenuti S, 2011, CANCER RES, V71, P1945, DOI 10.1158/0008-5472.CAN-10-2100; Boucher CA, 2011, BBA-MOL BASIS DIS, V1812, P1225, DOI 10.1016/j.bbadis.2010.11.006; Christensen ST, 2012, J PATHOL, V226, P172, DOI 10.1002/path.3004; Feather SA, 1997, NEPHROL DIAL TRANSPL, V12, P1354, DOI 10.1093/ndt/12.7.1354; Geng L, 2000, BBA-MOL BASIS DIS, V1535, P21, DOI 10.1016/S0925-4439(00)00079-X; Giorgio G, 2007, MOL BIOL CELL, V18, P4397, DOI 10.1091/mbc.E07-03-0198; Goetz SC, 2010, NAT REV GENET, V11, P331, DOI 10.1038/nrg2774; Griffiths GM, 2010, J CELL BIOL, V189, P397, DOI 10.1083/jcb.201002027; Hanaoka K, 2000, NATURE, V408, P990, DOI 10.1038/35050128; Herbert BS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055191; HORIE S, 1994, LANCET, V344, P789, DOI 10.1016/S0140-6736(94)92344-2; Ishikawa H, 2012, CURR BIOL, V22, P414, DOI 10.1016/j.cub.2012.01.031; Jerman S, 2013, POLYCYSTIC KIDNEY DI; Joo K, 2013, P NATL ACAD SCI USA, V110, P5987, DOI 10.1073/pnas.1220927110; Kang Richard S, 2009, F1000 Biol Rep, V1, P83, DOI 10.3410/B1-83; Kim J, 2008, HUM MOL GENET, V17, P3796, DOI 10.1093/hmg/ddn277; Kurrle N, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-575; Lechguer AN, 2011, J DENT RES, V90, P583, DOI 10.1177/0022034510391796; Liu HS, 2010, CARCINOGENESIS, V31, P1456, DOI 10.1093/carcin/bgq100; Lopes CAM, 2011, J CELL SCI, V124, P600, DOI 10.1242/jcs.077156; Lui-Roberts WWY, 2012, EUR J IMMUNOL, V42, P2132, DOI 10.1002/eji.201242525; Ma R, 2005, MOL CELL BIOL, V25, P8285, DOI 10.1128/MCB.25.18.8285-8298.2005; MacDougall M, 1995, Connect Tissue Res, V33, P97, DOI 10.3109/03008209509016988; Manzanares D, 2007, AM J RESP CELL MOL, V37, P160, DOI 10.1165/rcmb.2006-0413OC; Marley A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070857; McCleese JK, 2013, VET COMP ONCOL, V11, P124, DOI 10.1111/j.1476-5829.2011.00309.x; Meister M, 2013, INT J MOL SCI, V14, P4854, DOI 10.3390/ijms14034854; Merrick D, 2013, PEDIAT NEPHROL; Miettinen PJ, 1999, NAT GENET, V22, P69, DOI 10.1038/8773; Nauli SM, 2003, NAT GENET, V33, P129, DOI 10.1038/ng1076; NELSON DL, 1995, METHOD CELL BIOL, V47, P17, DOI 10.1016/S0091-679X(08)60785-2; Neumann-Giesen C, 2004, BIOCHEM J, V378, P509, DOI 10.1042/BJ20031100; Neumann-Giesen C, 2007, J CELL SCI, V120, P395, DOI 10.1242/jcs.03336; Ohazama A, 2009, DEVELOPMENT, V136, P897, DOI 10.1242/dev.027979; Otto EA, 2011, J MED GENET, V48, P105, DOI 10.1136/jmg.2010.082552; Peace BE, 2003, EXP CELL RES, V289, P317, DOI 10.1016/S0014-4827(03)00280-5; Qian F, 2002, P NATL ACAD SCI USA, V99, P16981, DOI 10.1073/pnas.252484899; Qin S, 2012, J AM SOC NEPHROL, V23, P1309, DOI 10.1681/ASN.2011030277; Rajendran L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008290; Roitbak T, 2005, BIOCHEM J, V392, P29, DOI 10.1042/BJ20050645; Romio L, 2004, J AM SOC NEPHROL, V15, P2556, DOI 10.1097/01.ASN.0000140220.46477.5C; Salzer U, 2001, BLOOD, V97, P1141, DOI 10.1182/blood.V97.4.1141; Sillibourne JE, 2013, BIOL OPEN, V2, P535, DOI 10.1242/bio.20134457; Singla V, 2010, DEV CELL, V18, P410, DOI 10.1016/j.devcel.2009.12.022; Suda N, 2006, Orthod Craniofac Res, V9, P52, DOI 10.1111/j.1601-6343.2006.00337.x; Tang PF, 2014, MOL NEUROBIOL, V49, P276, DOI 10.1007/s12035-013-8518-3; Tanos BE, 2013, GENE DEV, V27, P163, DOI 10.1101/gad.207043.112; Thivichon-Prince B, 2009, J DENT RES, V88, P910, DOI 10.1177/0022034509345822; Thymiakou E, 2011, JOVE-J VIS EXP, DOI 10.3791/2631; Tran PV, 2014, J AM SOC NEPHROL; vanAdelsberg J, 1997, AM J PHYSIOL-RENAL, V272, pF602, DOI 10.1152/ajprenal.1997.272.5.F602; Vieira OV, 2006, P NATL ACAD SCI USA, V103, P18556, DOI 10.1073/pnas.0608291103; Ward HH, 2011, MOL BIOL CELL, V22, P3289, DOI 10.1091/mbc.E11-01-0082; Xu C, 2007, AM J PHYSIOL-RENAL, V292, pF930, DOI 10.1152/ajprenal.00285.2006; Ye X, 2014, P NATL ACAD SCI USA, V111, P2164, DOI 10.1073/pnas.1318737111; Yoder BK, 2002, J AM SOC NEPHROL, V13, P2508, DOI 10.1097/01.ASN.0000029587.47950.25; Yoder BK, 2002, AM J PHYSIOL-RENAL, V282, pF541, DOI 10.1152/ajprenal.00273.2001; Zhang ZR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073424; Zheleznova NN, 2011, BBA-MOL BASIS DIS, V1812, P1301, DOI 10.1016/j.bbadis.2010.10.004; Zullo A, 2010, HUM MOL GENET, V19, P2792, DOI 10.1093/hmg/ddq180	63	10	11	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2014	9	9							e106330	10.1371/journal.pone.0106330	http://dx.doi.org/10.1371/journal.pone.0106330			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3LR	25180832	Green Published, gold, Green Submitted			2022-12-27	WOS:000341231500082
J	Loyau, T; Metayer-Coustard, S; Berri, C; Crochet, S; Cailleau-Audouin, E; Sannier, M; Chartrin, P; Praud, C; Hennequet-Antier, C; Rideau, N; Courousse, N; Mignon-Grasteau, S; Everaert, N; Duclos, MJ; Yahav, S; Tesseraud, S; Collin, A				Loyau, Thomas; Metayer-Coustard, Sonia; Berri, Cecile; Crochet, Sabine; Cailleau-Audouin, Estelle; Sannier, Melanie; Chartrin, Pascal; Praud, Christophe; Hennequet-Antier, Christelle; Rideau, Nicole; Courousse, Nathalie; Mignon-Grasteau, Sandrine; Everaert, Nadia; Duclos, Michel Jacques; Yahav, Shlomo; Tesseraud, Sophie; Collin, Anne			Thermal Manipulation during Embryogenesis Has Long-Term Effects on Muscle and Liver Metabolism in Fast-Growing Chickens	PLOS ONE			English	Article							CHRONIC HEAT-EXPOSURE; AVIAN UNCOUPLING PROTEIN; MESSENGER-RNA EXPRESSION; SKELETAL-MUSCLE; BROILER CHICKS; SUPEROXIDE-PRODUCTION; BODY-TEMPERATURE; FAT DEPOSITION; STRESS; PERFORMANCE	Fast-growing chickens have a limited ability to tolerate high temperatures. Thermal manipulation during embryogenesis (TM) has previously been shown to lower chicken body temperature (T-b) at hatching and to improve thermotolerance until market age, possibly resulting from changes in metabolic regulation. The aim of this study was to evaluate the long-term effects of TM (12 h/d, 39.5 degrees C, 65% RH from d 7 to 16 of embryogenesis vs. 37.8 degrees C, 56% RH continuously) and of a subsequent heat challenge (32 degrees C for 5 h at 34 d) on the mRNA expression of metabolic genes and cell signaling in the Pectoralis major muscle and the liver. Gene expression was analyzed by RT-qPCR in 8 chickens per treatment, characterized by low T-b in the TM groups and high T-b in the control groups. Data were analyzed using the general linear model of SAS considering TM and heat challenge within TM as main effects. TM had significant long-term effects on thyroid hormone metabolism by decreasing the muscle mRNA expression of deiodinase DIO3. Under standard rearing conditions, the expression of several genes involved in the regulation of energy metabolism, such as transcription factor PGC-1 alpha, was affected by TM in the muscle, whereas for other genes regulating mitochondrial function and muscle growth, TM seemed to mitigate the decrease induced by the heat challenge. TM increased DIO2 mRNA expression in the liver (only at 21 degrees C) and reduced the citrate synthase activity involved in the Krebs cycle. The phosphorylation level of p38 Mitogen-activated-protein kinase regulating the cell stress response was higher in the muscle of TM groups compared to controls. In conclusion, markers of energy utilization and growth were either changed by TM in the Pectoralis major muscle and the liver by thermal manipulation during incubation as a possible long-term adaptation limiting energy metabolism, or mitigated during heat challenge.	[Loyau, Thomas; Metayer-Coustard, Sonia; Berri, Cecile; Crochet, Sabine; Cailleau-Audouin, Estelle; Sannier, Melanie; Chartrin, Pascal; Praud, Christophe; Hennequet-Antier, Christelle; Rideau, Nicole; Courousse, Nathalie; Mignon-Grasteau, Sandrine; Duclos, Michel Jacques; Tesseraud, Sophie; Collin, Anne] INRA, Rech Avicoles UR83, F-37380 Nouzilly, France; [Everaert, Nadia] Katholieke Univ Leuven, Dept Biosyst, Leuven, Belgium; [Everaert, Nadia] Univ Liege, Gembloux Agrobio Tech, Anim Sci Unit, Gembloux, Belgium; [Yahav, Shlomo] Agr Res Org, Volcani Ctr, Inst Anim Sci, IL-50250 Bet Dagan, Israel	INRAE; KU Leuven; University of Liege; VOLCANI INSTITUTE OF AGRICULTURAL RESEARCH	Collin, A (corresponding author), INRA, Rech Avicoles UR83, F-37380 Nouzilly, France.	anne.collin@tours.inra.fr	Berri, Cécile/H-6409-2016; Metayer-Coustard, Sonia/AAO-7503-2020; DUCLOS, Michel/AAQ-3957-2021; Everaert, Nadia/AAJ-7714-2021; Praud, Christophe/AAT-9553-2020	Berri, Cécile/0000-0002-3613-1825; DUCLOS, Michel/0000-0002-9305-3982; Everaert, Nadia/0000-0001-9282-6288	French Agence Nationale de la Recherche, Project Jeunes Chercheuses et Jeunes Chercheurs [ANR-09-JCJC-0015-01]; Ministere de l'Enseignement Superieur et de la Recherche; Agence Nationale de la Recherche [ANR-09-JCJC-0015-01]	French Agence Nationale de la Recherche, Project Jeunes Chercheuses et Jeunes Chercheurs(French National Research Agency (ANR)); Ministere de l'Enseignement Superieur et de la Recherche(Estonian Research CouncilEuropean Commission); Agence Nationale de la Recherche(French National Research Agency (ANR))	This study was performed with the financial support of the French Agence Nationale de la Recherche (http://www.agence-nationale-recherche.fr/), Project "Jeunes Chercheuses et Jeunes Chercheurs", ANR-09-JCJC-0015-01, THERMOCHICK. T Loyau is a PhD student supported by a grant from the Ministere de l'Enseignement Superieur et de la Recherche (http://www.enseignementsup-recherche.gouv.fr/) and Agence Nationale de la Recherche (http://www.agencenationale-recherche.fr/), Project "Jeunes Chercheuses et Jeunes Chercheurs", ANR-09-JCJC-0015-01, THERMOCHICK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARAD Z, 1983, COMP BIOCHEM PHYS A, V74, P125, DOI 10.1016/0300-9629(83)90722-3; Azad MAK, 2010, COMP BIOCHEM PHYS A, V155, P401, DOI 10.1016/j.cbpa.2009.12.011; BASS A, 1969, EUR J BIOCHEM, V10, P198, DOI 10.1111/j.1432-1033.1969.tb00674.x; Baziz HA, 1996, POULTRY SCI, V75, P505, DOI 10.3382/ps.0750505; Beattie J, 2006, BIOCHEM J, V395, P1, DOI 10.1042/BJ20060086; Boussaid-Om Ezzine S, 2010, COMP BIOCHEM PHYS B, V157, P281, DOI 10.1016/j.cbpb.2010.07.001; Bruzual JJ, 2000, POULTRY SCI, V79, P1385, DOI 10.1093/ps/79.10.1385; Collin A, 2009, ENDOCR RES CLIN DEV, P93; Collin A, 2003, BRIT J NUTR, V90, P261, DOI 10.1079/BJN2003910; Collin A, 2003, AM J PHYSIOL-ENDOC M, V284, pE771, DOI 10.1152/ajpendo.00478.2002; Collin A, 2003, GEN COMP ENDOCR, V130, P70, DOI 10.1016/S0016-6480(02)00571-3; Collin A, 2002, REPROD NUTR DEV, V42, P45, DOI 10.1051/rnd:2002005; Collin A, 2009, COMP BIOCHEM PHYS B, V153, P171, DOI 10.1016/j.cbpb.2009.02.012; Darras VM, 2006, THYROID, V16, P25, DOI 10.1089/thy.2006.16.25; De Basilio V, 2003, POULTRY SCI, V82, P1235, DOI 10.1093/ps/82.8.1235; Dridi S, 2008, J EXP ZOOL PART A, V309A, P381, DOI 10.1002/jez.461; Duchene S, 2008, DOMEST ANIM ENDOCRIN, V34, P63, DOI 10.1016/j.domaniend.2006.11.001; Geraert PA, 1996, BRIT J NUTR, V75, P205, DOI 10.1079/BJN19960125; GROSS WB, 1983, AVIAN DIS, V27, P972, DOI 10.2307/1590198; Gutierrez-Uzquiza A, 2012, J BIOL CHEM, V287, P2632, DOI 10.1074/jbc.M111.323709; Halevy O, 2001, AM J PHYSIOL-REG I, V281, pR302, DOI 10.1152/ajpregu.2001.281.1.R302; Holmes BF, 1999, J APPL PHYSIOL, V87, P1990, DOI 10.1152/jappl.1999.87.5.1990; Joubert R, 2010, DOMEST ANIM ENDOCRIN, V38, P115, DOI 10.1016/j.domaniend.2009.08.002; Joubert R, 2011, AM J PHYSIOL-REG I, V301, pR201, DOI 10.1152/ajpregu.00087.2010; KLANDORF H, 1981, GEN COMP ENDOCR, V45, P513, DOI 10.1016/0016-6480(81)90056-3; LEVEILLE GA, 1968, P SOC EXP BIOL MED, V128, P398; Loyau T, 2013, J ANIM SCI, V91, P3674, DOI 10.2527/jas.2013-6445; Lu Q, 2007, POULTRY SCI, V86, P1059, DOI 10.1093/ps/86.6.1059; Mujahid A, 2006, POULTRY SCI, V85, P1259, DOI 10.1093/ps/85.7.1259; Mujahid A, 2007, FEBS LETT, V581, P3461, DOI 10.1016/j.febslet.2007.06.051; Mujahid A, 2009, AM J PHYSIOL-REG I, V297, pR690, DOI 10.1152/ajpregu.90974.2008; Piestun Y, 2008, POULTRY SCI, V87, P1516, DOI 10.3382/ps.2008-00030; Piestun Y, 2013, POULTRY SCI, V92, P1155, DOI 10.3382/ps.2012-02609; Piestun Y, 2011, J THERM BIOL, V36, P469, DOI 10.1016/j.jtherbio.2011.08.003; Piestun Y, 2009, POULTRY SCI, V88, P2677, DOI 10.3382/ps.2009-00231; Piestun Y, 2009, J APPL PHYSIOL, V106, P233, DOI 10.1152/japplphysiol.91090.2008; Rolfe DFS, 1996, AM J PHYSIOL-CELL PH, V271, pC1380, DOI 10.1152/ajpcell.1996.271.4.C1380; Seebacher F, 2006, P ROY SOC B-BIOL SCI, V273, P565, DOI 10.1098/rspb.2005.3333; Sibut V, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-112; St-Pierre NR, 2003, J DAIRY SCI, V86, pE52, DOI 10.3168/jds.S0022-0302(03)74040-5; Tan GY, 2010, POULTRY SCI, V89, P115, DOI 10.3382/ps.2009-00318; Taouis M, 2002, POULTRY SCI, V81, P1640, DOI 10.1093/ps/81.11.1640; Temim S, 2000, J NUTR, V130, P813, DOI 10.1093/jn/130.4.813; Tona K, 2008, ARCH GEFLUGELKD, V72, P75; Ueda M, 2005, FEBS LETT, V579, P11, DOI 10.1016/j.febslet.2004.11.039; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Walter I, 2007, AM J PHYSIOL-REG I, V293, pR2315, DOI 10.1152/ajpregu.00505.2007; Walter I, 2010, J EXP BIOL, V213, P3167, DOI 10.1242/jeb.043349; Walter I, 2009, J EXP BIOL, V212, P2328, DOI 10.1242/jeb.029009; WEINTRAUB H, 1993, CELL, V75, P1241, DOI 10.1016/0092-8674(93)90610-3; Wulf A, 2008, MOL CELL ENDOCRINOL, V287, P90, DOI 10.1016/j.mce.2008.01.017; Yahav S, 2004, POULTRY SCI, V83, P1959, DOI 10.1093/ps/83.12.1959; Yahav S, 2009, WORLD POULTRY SCI J, V65, P719, DOI 10.1017/S004393390900049X	53	44	45	0	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2014	9	9							e105339	10.1371/journal.pone.0105339	http://dx.doi.org/10.1371/journal.pone.0105339			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3LR	25180913	Green Published, Green Submitted, gold			2022-12-27	WOS:000341231500022
J	Vanzo, E; Ghirardo, A; Merl-Pham, J; Lindermayr, C; Heller, W; Hauck, SM; Durner, J; Schnitzler, JP				Vanzo, Elisa; Ghirardo, Andrea; Merl-Pham, Juliane; Lindermayr, Christian; Heller, Werner; Hauck, Stefanie M.; Durner, Joerg; Schnitzler, Joerg-Peter			S-Nitroso-Proteome in Poplar Leaves in Response to Acute Ozone Stress	PLOS ONE			English	Article							BIOCHEMICAL-PLANT RESPONSES; PHENYLALANINE AMMONIA-LYASE; NITRIC-OXIDE PRODUCTION; INDUCED CELL-DEATH; NITROSYLATED PROTEINS; CARBOXYLASE/OXYGENASE ACTIVITY; ARABIDOPSIS-THALIANA; TRANSGENIC POPLARS; OXIDATIVE BURST; NORWAY SPRUCE	Protein S-nitrosylation, the covalent binding of nitric oxide (NO) to protein cysteine residues, is one of the main mechanisms of NO signaling in plant and animal cells. Using a combination of the biotin switch assay and label-free LC-MS/MS analysis, we revealed the S-nitroso-proteome of the woody model plant Populus x canescens. Under normal conditions, constitutively S-nitrosylated proteins in poplar leaves and calli comprise all aspects of primary and secondary metabolism. Acute ozone fumigation was applied to elicit ROS-mediated changes of the S-nitroso-proteome. This treatment changed the total nitrite and nitrosothiol contents of poplar leaves and affected the homeostasis of 32 S-nitrosylated proteins. Multivariate data analysis revealed that ozone exposure negatively affected the S-nitrosylation status of leaf proteins: 23 proteins were de-nitrosylated and 9 proteins had increased S-nitrosylation content compared to the control. Phenylalanine ammonia-lyase 2 (log2[ozone/control] = -3.6) and caffeic acid O-methyltransferase (-3.4), key enzymes catalyzing important steps in the phenylpropanoid and subsequent lignin biosynthetic pathways, respectively, were de-nitrosylated upon ozone stress. Measuring the in vivo and in vitro phenylalanine ammonia-lyase activity indicated that the increase of the phenylalanine ammonia-lyase activity in response to acute ozone is partly regulated by de-nitrosylation, which might favor a higher metabolic flux through the phenylpropanoid pathway within minutes after ozone exposure.	[Vanzo, Elisa; Ghirardo, Andrea; Schnitzler, Joerg-Peter] Helmholtz Zentrum Munchen, Inst Biochem Plant Pathol, Res Unit Environm Simulat, Neuherberg, Germany; [Merl-Pham, Juliane; Hauck, Stefanie M.] Helmholtz Zentrum Munchen, Res Unit Prot Sci, Neuherberg, Germany; [Lindermayr, Christian; Heller, Werner; Durner, Joerg] Helmholtz Zentrum Munchen, Inst Biochem Plant Pathol, Neuherberg, Germany	Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health	Schnitzler, JP (corresponding author), Helmholtz Zentrum Munchen, Inst Biochem Plant Pathol, Res Unit Environm Simulat, Neuherberg, Germany.	jp.schnitzler@helmholtz-muenchen.de	Hauck, Stefanie/B-3300-2013; Ghirardo, Andrea/P-1764-2019; Schnitzler, Joerg-Peter/C-5268-2011; Merl-Pham, Juliane/N-7258-2014; Lindermayr, Christian/M-7338-2014	Hauck, Stefanie/0000-0002-1630-6827; Ghirardo, Andrea/0000-0003-1973-4007; Schnitzler, Joerg-Peter/0000-0002-9825-867X; Merl-Pham, Juliane/0000-0002-3422-4083; Lindermayr, Christian/0000-0002-9343-4996				Abat JK, 2008, FEBS J, V275, P2862, DOI 10.1111/j.1742-4658.2008.06425.x; Abat JK, 2009, PROTEOMICS, V9, P4368, DOI 10.1002/pmic.200800985; Agarwal GK, 2002, PROTEOMICS, V2, P947, DOI 10.1002/1615-9861(200208)2:8<947::AID-PROT947>3.0.CO;2-J; Agati G, 2011, J PLANT PHYSIOL, V168, P204, DOI 10.1016/j.jplph.2010.07.016; Ahlfors R, 2009, PLANT J, V58, P1, DOI 10.1111/j.1365-313X.2008.03756.x; Ainsworth EA, 2008, PLANT PHYSIOL, V147, P13, DOI 10.1104/pp.108.117101; Allwood EG, 1999, FEBS LETT, V457, P47, DOI 10.1016/S0014-5793(99)00998-9; Allwood EG, 2002, PLANT MOL BIOL, V49, P533, DOI 10.1023/A:1015502117870; Andoh T, 2003, J BIOL CHEM, V278, P885, DOI 10.1074/jbc.M209914200; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Astier J, 2012, FREE RADICAL BIO MED, V53, P1101, DOI 10.1016/j.freeradbiomed.2012.06.032; Aylott MJ, 2008, NEW PHYTOL, V178, P358, DOI 10.1111/j.1469-8137.2008.02396.x; Barglow KT, 2011, P NATL ACAD SCI USA, V108, pE600, DOI 10.1073/pnas.1110736108; Beauchamp J, 2005, PLANT CELL ENVIRON, V28, P1334, DOI 10.1111/j.1365-3040.2005.01383.x; Behnke K, 2007, PLANT J, V51, P485, DOI 10.1111/j.1365-313X.2007.03157.x; Behnke K, 2009, TREE PHYSIOL, V29, P725, DOI 10.1093/treephys/tpp009; Belenghi B, 2007, J BIOL CHEM, V282, P1352, DOI 10.1074/jbc.M608931200; Beligni MV, 2000, PLANTA, V210, P215, DOI 10.1007/PL00008128; Benhar M, 2009, NAT REV MOL CELL BIO, V10, P721, DOI 10.1038/nrm2764; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Benjamini Y, 2006, BIOMETRIKA, V93, P491, DOI 10.1093/biomet/93.3.491; Bohler S, 2007, PROTEOMICS, V7, P1584, DOI 10.1002/pmic.200600822; Brosch M, 2009, J PROTEOME RES, V8, P3176, DOI 10.1021/pr800982s; Cabane M, 2004, PLANT PHYSIOL, V134, P586, DOI 10.1104/pp.103.031765; Chaki M, 2009, PLANT CELL PHYSIOL, V50, P265, DOI 10.1093/pcp/pcn196; Cho K, 2008, J PROTEOME RES, V7, P2980, DOI 10.1021/pr800128q; Corpas FJ, 2011, PLANT SCI, V181, P604, DOI 10.1016/j.plantsci.2011.04.005; Davin LB, 2008, NAT PROD REP, V25, P1015, DOI 10.1039/b510386j; Dempsey D'Maris Amick, 2011, Arabidopsis Book, V9, pe0156, DOI 10.1199/tab.0156; Dong JF, 2012, FOOD CHEM, V135, P1220, DOI 10.1016/j.foodchem.2012.05.055; Durner J, 1998, P NATL ACAD SCI USA, V95, P10328, DOI 10.1073/pnas.95.17.10328; ECKEYKALTENBACH H, 1994, PLANT PHYSIOL, V104, P67, DOI 10.1104/pp.104.1.67; Ederli L, 2006, PLANT PHYSIOL, V142, P595, DOI 10.1104/pp.106.085472; EFRON B, 1983, AM STAT, V37, P36, DOI 10.2307/2685844; Emberson LD, 2000, ENVIRON POLLUT, V109, P393, DOI 10.1016/S0269-7491(00)00042-7; Eriksson L., 2006, MULTI MEGAVARIATE 1; Erwin PA, 2005, J BIOL CHEM, V280, P19888, DOI 10.1074/jbc.M413058200; Fares A, 2011, BIOCHEM BIOPH RES CO, V416, P331, DOI 10.1016/j.bbrc.2011.11.036; Fares S, 2013, GLOBAL CHANGE BIOL, V19, P2427, DOI 10.1111/gcb.12222; Fares S, 2010, J EXP BOT, V61, P629, DOI 10.1093/jxb/erp336; Francini A, 2008, ENVIRON POLLUT, V151, P272, DOI 10.1016/j.envpol.2007.07.007; Galant A, 2012, NEW PHYTOL, V194, P220, DOI 10.1111/j.1469-8137.2011.04037.x; Godon C, 1998, J BIOL CHEM, V273, P22480, DOI 10.1074/jbc.273.35.22480; Gould KS, 2003, PLANT CELL ENVIRON, V26, P1851, DOI 10.1046/j.1365-3040.2003.01101.x; Gow AJ, 2004, AM J PHYSIOL-LUNG C, V287, pL262, DOI 10.1152/ajplung.00295.2003; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Hauck SM, 2010, MOL CELL PROTEOMICS, V9, P2292, DOI 10.1074/mcp.M110.001073; He YK, 2004, SCIENCE, V305, P1968, DOI 10.1126/science.1098837; HEIDE L, 1989, PHYTOCHEMISTRY, V28, P1873, DOI 10.1016/S0031-9422(00)97877-4; HELLER W, 1990, ENVIRON POLLUT, V64, P353, DOI 10.1016/0269-7491(90)90057-J; Hess DT, 2005, NAT REV MOL CELL BIO, V6, P150, DOI 10.1038/nrm1569; Hogg N, 1999, ANAL BIOCHEM, V272, P257, DOI 10.1006/abio.1999.4199; Holtgrefe S, 2008, PHYSIOL PLANTARUM, V133, P211, DOI 10.1111/j.1399-3054.2008.01066.x; Hu SQ, 2012, J BIOL CHEM, V287, P2364, DOI 10.1074/jbc.M111.227124; Huang B, 2006, FREE RADICAL BIO MED, V41, P562, DOI 10.1016/j.freeradbiomed.2006.03.006; Huang WH, 2013, MOL PLANT, V6, P1673, DOI 10.1093/mp/sst069; Jaffrey S R, 2001, Sci STKE, V2001, ppl1, DOI 10.1126/stke.2001.86.pl1; JANERO DR, 1994, AM J PHYSIOL, V266, pC179, DOI 10.1152/ajpcell.1994.266.1.C179; Jansson S, 2007, ANNU REV PLANT BIOL, V58, P435, DOI 10.1146/annurev.arplant.58.032806.103956; Jeandet P, 2010, BIOFACTORS, V36, P331, DOI 10.1002/biof.108; Jouanin L, 2000, PLANT PHYSIOL, V123, P1363, DOI 10.1104/pp.123.4.1363; Kallakunta VM, 2010, BBA-GEN SUBJECTS, V1800, P23, DOI 10.1016/j.bbagen.2009.10.004; Kangasjarvi J, 2005, PLANT CELL ENVIRON, V28, P1021, DOI 10.1111/j.1365-3040.2005.01325.x; Kato H, 2013, PHYSIOL PLANTARUM, V148, P371, DOI 10.1111/j.1399-3054.2012.01684.x; Kovacik J, 2009, FREE RADICAL BIO MED, V46, P1686, DOI 10.1016/j.freeradbiomed.2009.03.020; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lai YC, 2011, CIRC RES, V109, P1375, DOI 10.1161/CIRCRESAHA.111.256479; Lamb C, 1997, ANNU REV PLANT PHYS, V48, P251, DOI 10.1146/annurev.arplant.48.1.251; Lane P, 2001, Sci STKE, V2001, pre1, DOI 10.1126/stke.2001.86.re1; Langebartels C, 2002, PLANT PHYSIOL BIOCH, V40, P567, DOI 10.1016/S0981-9428(02)01416-X; Laureysens I, 2005, ENVIRON POLLUT, V133, P541, DOI 10.1016/j.envpol.2004.06.013; LEPLE JC, 1992, PLANT CELL REP, V11, P137, DOI 10.1007/BF00232166; Lindermayr C, 2006, J BIOL CHEM, V281, P4285, DOI 10.1074/jbc.M511635200; Lindermayr C, 2005, PLANT PHYSIOL, V137, P921, DOI 10.1104/pp.104.058719; Liu DH, 2013, NEUROSCIENCE, V229, P36, DOI 10.1016/j.neuroscience.2012.10.055; Liu L, 2004, CELL, V116, P617, DOI 10.1016/S0092-8674(04)00131-X; Liu LM, 2001, NATURE, V410, P490, DOI 10.1038/35068596; Mahalingam R, 2006, PLANT CELL ENVIRON, V29, P1357, DOI 10.1111/j.1365-3040.2006.01516.x; Mannick JB, 1999, SCIENCE, V284, P651, DOI 10.1126/science.284.5414.651; Marcus Y, 2003, J BACTERIOL, V185, P1509, DOI 10.1128/JB.185.5.1509-1517.2003; Merl J, 2012, PROTEOMICS, V12, P1902, DOI 10.1002/pmic.201100549; MEYER DJ, 1994, FEBS LETT, V345, P177, DOI 10.1016/0014-5793(94)00429-3; Mohr S, 1999, J BIOL CHEM, V274, P9427, DOI 10.1074/jbc.274.14.9427; Neill SJ, 2002, PLANT PHYSIOL, V128, P13, DOI 10.1104/pp.010707; NOGAE I, 1990, GENE, V96, P161, DOI 10.1016/0378-1119(90)90248-P; Ortega-Galisteo AP, 2012, J EXP BOT, V63, P2089, DOI 10.1093/jxb/err414; PADGETT CM, 1995, AM J PHYSIOL-CELL PH, V269, pC739, DOI 10.1152/ajpcell.1995.269.3.C739; Pagnussat GC, 2002, PLANT PHYSIOL, V129, P954, DOI 10.1104/pp.004036; Palmieri MC, 2010, PLANT PHYSIOL, V152, P1514, DOI 10.1104/pp.109.152579; Pasqualini S, 2003, PLANT PHYSIOL, V133, P1122, DOI 10.1104/pp.103.026591; Pasqualini S, 2002, PLANT PHYSIOL BIOCH, V40, P599, DOI 10.1016/S0981-9428(02)01426-2; Pollak N, 2007, BIOCHEM J, V402, P205, DOI 10.1042/BJ20061638; Prado AM, 2004, DEVELOPMENT, V131, P2707, DOI 10.1242/dev.01153; Qiu QS, 2008, PHOTOSYNTH RES, V97, P155, DOI 10.1007/s11120-008-9310-5; Qu J, 2011, P NATL ACAD SCI USA, V108, P14330, DOI 10.1073/pnas.1105172108; Ralser M., 2007, J BIOL, V6, P10, DOI [DOI 10.1186/jbiol61, 10.1186/jbiol61]; Rao MV, 2001, PLANTA, V213, P682, DOI 10.1007/s004250100618; Renaut J, 2009, MASS SPECTROM REV, V28, P495, DOI 10.1002/mas.20202; Richter AS, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00371; Ritter H, 2004, PLANT CELL, V16, P3426, DOI 10.1105/tpc.104.025288; Rockel P, 2002, J EXP BOT, V53, P103, DOI 10.1093/jexbot/53.366.103; Romero-Puertas MC, 2008, PROTEOMICS, V8, P1459, DOI 10.1002/pmic.200700536; Romero-Puertas MC, 2007, PLANT CELL, V19, P4120, DOI 10.1105/tpc.107.055061; ROSEMANN D, 1991, PLANT PHYSIOL, V97, P1280, DOI 10.1104/pp.97.4.1280; Samouilov A, 1998, ARCH BIOCHEM BIOPHYS, V357, P1, DOI 10.1006/abbi.1998.0785; Schulze PC, 2006, ARTERIOSCL THROM VAS, V26, P2666, DOI 10.1161/01.ATV.0000248914.21018.f1; Sengupta R, 2007, BIOCHEMISTRY-US, V46, P8472, DOI 10.1021/bi700449x; Serpa V, 2007, BIOCHEM BIOPH RES CO, V361, P1048, DOI 10.1016/j.bbrc.2007.07.133; SHARMA YK, 1994, PLANT PHYSIOL, V105, P1089, DOI 10.1104/pp.105.4.1089; SINGH RJ, 1995, FEBS LETT, V360, P47, DOI 10.1016/0014-5793(95)00065-H; Strohm M, 1999, J EXP BOT, V50, P365, DOI 10.1093/jexbot/50.332.363; Tanou G, 2010, J PROTEOME RES, V9, P5994, DOI 10.1021/pr100782h; Tanou G, 2009, PLANT J, V60, P795, DOI 10.1111/j.1365-313X.2009.04000.x; Tuskan GA, 2006, SCIENCE, V313, P1596, DOI 10.1126/science.1128691; Vainonen JP, 2014, PLANT CELL ENVIRON, DOI 10.1111/pce.12273; Velikova V, 2014, J PROTEOME RES; Wang YQ, 2013, J INTEGR PLANT BIOL, V55, P202, DOI 10.1111/jipb.12032; Wendehenne D, 2001, TRENDS PLANT SCI, V6, P177, DOI 10.1016/S1360-1385(01)01893-3; Wisniewski JR, 2009, NAT METHODS, V6, P359, DOI [10.1038/NMETH.1322, 10.1038/nmeth.1322]; Xiao WH, 2009, J BIOTECHNOL, V139, P222, DOI 10.1016/j.jbiotec.2008.11.005; Xue Y, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011290; Yu CKY, 2005, PLANT PHYSIOL, V138, P393, DOI 10.1104/pp.105.059337; Yu MD, 2012, CURR OPIN PLANT BIOL, V15, P424, DOI 10.1016/j.pbi.2012.03.005; Yun BW, 2011, NATURE, V478, P264, DOI 10.1038/nature10427; Ziogas V, 2013, PLANT PHYSIOL BIOCH, V68, P118, DOI 10.1016/j.plaphy.2013.04.004; ZWEIER JL, 1995, NAT MED, V1, P804, DOI 10.1038/nm0895-804	126	32	32	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2014	9	9							e106886	10.1371/journal.pone.0106886	http://dx.doi.org/10.1371/journal.pone.0106886			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ1IR	25192423	Green Published, gold, Green Submitted			2022-12-27	WOS:000347993600077
J	Yu, ZG; Chen, WT; Kong, Y; Sun, XAL; Zheng, J				Yu, Zhonggen; Chen, Wentao; Kong, Yong; Sun, Xiao Ling; Zheng, Jing			The Impact of Clickers Instruction on Cognitive Loads and Listening and Speaking Skills in College English Class	PLOS ONE			English	Article							AUDIENCE RESPONSE SYSTEMS	Clickers might own a bright future in China if properly introduced although they have not been widely acknowledged as an effective tool to facilitate English learning and teaching in Chinese contexts. By randomly selecting participants from undergraduates in a university in China over four academic years, this study aims to identify the impact of clickers on college English listening and speaking skills, and differences in cognitive loads between clickers and traditional multimedia assisted instruction modes. It was concluded that in China's college English class, compared with multimedia assisted instruction, (1) clickers could improve college English listening skills; (2) clickers could improve college English speaking skills; and (3) clickers could reduce undergraduates' cognitive loads in College English Class. Reasons for the results and defects in this study were also explored and discussed, based on learning, teaching and cognitive load theories. Some Suggestions for future research were also raised.	[Yu, Zhonggen; Sun, Xiao Ling; Zheng, Jing] Hohai Univ, Sch Foreign Languages, Nanjing, Jiangsu, Peoples R China; [Yu, Zhonggen; Chen, Wentao; Kong, Yong] Zhejiang Yuexiu Univ Foreign Languages, Sch English, Shaoxing City, Zhejiang, Peoples R China	Hohai University; Zhejiang Yuexiu University	Yu, ZG (corresponding author), Hohai Univ, Sch Foreign Languages, Nanjing, Jiangsu, Peoples R China.	18951801880@189.cn	Zhonggen, Yu/AAE-5514-2020; Yu, Zhonggen/AAJ-3063-2020	Zhonggen, Yu/0000-0002-3873-980X; 	Findings of Research Project of Philosophy and Social Sciences of Zhejiang Province [14NDJC245YB]; Humanities and Social Sciences of Ministry of Education of China [11YJC740138]; Second Batch of Post-doctoral Research Fund of Jiangsu Province [1202112C]; Philosophy and Social Science Guidance Research Project of Education Bureau of Jiangsu Province [2013SJD740005]; Special Fundamental Research Fund for the Central Universities [2013B33914]; Shaoxing Important Research Project of Higher Education Reform; Zhejiang Yuexiu University of Foreign Languages [N2014013]	Findings of Research Project of Philosophy and Social Sciences of Zhejiang Province; Humanities and Social Sciences of Ministry of Education of China(Ministry of Education, China); Second Batch of Post-doctoral Research Fund of Jiangsu Province; Philosophy and Social Science Guidance Research Project of Education Bureau of Jiangsu Province; Special Fundamental Research Fund for the Central Universities; Shaoxing Important Research Project of Higher Education Reform; Zhejiang Yuexiu University of Foreign Languages	The authors wish to thank the people who help this study and the projects which financially support this study: Findings of 2014 Research Project of Philosophy and Social Sciences of Zhejiang Province "Use of Clickers in College English Class in Zhejiang Province" (14NDJC245YB), 2011 Youth Fund of Humanities and Social Sciences of Ministry of Education of China "The Regression and Threshold Hypotheses of English Negative Sentences Attrition among English Learners in China" (Project No.: 11YJC740138), The Second Batch of Post-doctoral Research Fund of Jiangsu Province in 2012 "The Regression and Threshold Hypotheses of English Language Attrition among Students in China" (Project No.: 1202112C)", 2013 Philosophy and Social Science Guidance Research Project of Education Bureau of Jiangsu Province (Project No.: 2013SJD740005), Special Fundamental Research Fund for the Central Universities (Project No.: 2013B33914), 2013 Shaoxing Important Research Project of Higher Education Reform, and 2014 Research Project of Zhejiang Yuexiu University of Foreign Languages (Project No.: N2014013). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beatty ID, 2006, AM J PHYS, V74, P31, DOI 10.1119/1.2121753; Cain J, 2008, AM J PHARM EDUC, V72, DOI 10.5688/aj720110; Caldwell Jane E, 2007, CBE Life Sci Educ, V6, P9, DOI 10.1187/cbe.06-12-0205; Chen JC, 2010, J ENG EDUC, V99, P159, DOI 10.1002/j.2168-9830.2010.tb01052.x; Collins Jannette, 2008, J Am Coll Radiol, V5, P993, DOI 10.1016/j.jacr.2008.04.008; Collins Linda J., 2007, Medical Reference Services Quarterly, V26, P81, DOI 10.1300/J115v26n01_08; Crossgrove K, 2008, CBE-LIFE SCI EDUC, V7, P146, DOI 10.1187/cbe.07-08-0060; Dalkilic N, 2001, THESIS UKUROVA U ADA; Draper SW, 2004, J COMPUT ASSIST LEAR, V20, P81, DOI 10.1111/j.1365-2729.2004.00074.x; HART S G, 1988, P139; HORWITZ EK, 1986, MOD LANG J, V70, P125, DOI 10.2307/327317; King DB, 2011, J CHEM EDUC, V88, P1485, DOI 10.1021/ed1004799; Knight Jennifer K, 2005, Cell Biol Educ, V4, P298, DOI 10.1187/05-06-0082; MACINTYRE PD, 1991, LANG LEARN, V41, P85, DOI 10.1111/j.1467-1770.1991.tb00677.x; Marcus N, 1996, J EDUC PSYCHOL, V88, P49, DOI 10.1037/0022-0663.88.1.49; Mayer R. E., 2003, Journal of Educational Computing Research, V29, P297, DOI 10.2190/YJLG-09F9-XKAX-753D; Mazur E., 1997, PEER INSTRUCTION USE; Paas F, 2003, EDUC PSYCHOL-US, V38, P63, DOI 10.1207/S15326985EP3801_8; Porter Leo, 2011, P 7 INT WORKSHOP COM, p45aAS52, DOI [DOI 10.1145/2016911.2016923, 10.1145/2016911.2016923]; Preszler Ralph W, 2007, CBE Life Sci Educ, V6, P29, DOI 10.1187/cbe.06-09-0190; Reay NW, 2008, AM J PHYS, V76, P171, DOI 10.1119/1.2820392; Smith MK, 2009, SCIENCE, V323, P122, DOI 10.1126/science.1165919; Smith MK, 2011, CBE-LIFE SCI EDUC, V10, P14, DOI 10.1187/cbe.10-09-0114; Sweller J, 1998, EDUC PSYCHOL REV, V10, P251, DOI 10.1023/A:1022193728205; Sweller J., 1994, LEARN INSTR, V4, P295, DOI DOI 10.1016/0959-4752(94)90003-5; Sweller J, 2011, EXPLOR LEARN SCI, P3, DOI 10.1007/978-1-4419-8126-4; Sweller J, 2010, EDUC PSYCHOL REV, V22, P123, DOI 10.1007/s10648-010-9128-5; van Merrienboer JJG, 2005, ETR&D-EDUC TECH RES, V53, P5, DOI 10.1007/BF02504793; Wiebe EN, 2010, COMPUT HUM BEHAV, V26, P474, DOI 10.1016/j.chb.2009.12.006; Wong A, 2012, LEARN INSTR, V22, P449, DOI 10.1016/j.learninstruc.2012.05.004; Yang HZ, 2003, J FOREIGN LANGUAGES, V145, P21	31	15	15	6	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2014	9	9							e106626	10.1371/journal.pone.0106626	http://dx.doi.org/10.1371/journal.pone.0106626			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Arts &amp; Humanities Citation Index (A&amp;HCI)	Science & Technology - Other Topics	AZ1IR	25192424	gold, Green Published, Green Submitted			2022-12-27	WOS:000347993600047
J	Bertuzzi, R; Pasqua, LA; Bueno, S; Lima-Silva, AE; Matsuda, M; Marquezini, M; Saldiva, PH				Bertuzzi, Romulo; Pasqua, Leonardo A.; Bueno, Salomao; Lima-Silva, Adriano Eduardo; Matsuda, Monique; Marquezini, Monica; Saldiva, Paulo H.			Is the COL5A1 rs12722 Gene Polymorphism Associated with Running Economy?	PLOS ONE			English	Article							PHYSICAL-ACTIVITY QUESTIONNAIRE; DEMOGRAPHIC CHARACTERISTICS; PERFORMANCE; RANGE; VARIANTS; TESTS; POWER; MEN	The COL5A1 rs12722 polymorphism is considered to be a novel genetic marker for endurance running performance. It has been postulated that COL5A1 rs12722 may influence the elasticity of tendons and the energetic cost of running. To date, there are no experimental data in the literature supporting the relationship between range of motion, running economy, and the COL5A1 rs12722 gene polymorphism. Therefore, the main purpose of the current study was to analyze the influence of the COL5A1rs12722 polymorphism on running economy and range of motion. One hundred and fifty (n = 150) physically active young men performed the following tests: a) a maximal incremental treadmill test, b) two constant-speed running tests (10 km.h(-1) and 12 km.h(-1)) to determine the running economy, and c) a sit-and-reach test to determine the range of motion. All of the subjects were genotyped for the COL5A1 rs12722 single-nucleotide polymorphism. The genotype frequencies were TT = 27.9%, CT = 55.8%, and CC = 16.3%. There were no significant differences between COL5A1 genotypes for running economy measured at 10 km.h(-1) (p = 0.232) and 12 km.h(-1) (p = 0.259). Similarly, there were no significant differences between COL5A1 genotypes for range of motion (p = 0.337). These findings suggest that the previous relationship reported between COL5A1 rs12722 genotypes and running endurance performance might not be mediated by the energetic cost of running.	[Bertuzzi, Romulo; Marquezini, Monica; Saldiva, Paulo H.] Univ Sao Paulo, Sch Med, Dept Pathol, Lab Expt Air Pollut, Sao Paulo, Brazil; [Bertuzzi, Romulo; Pasqua, Leonardo A.; Bueno, Salomao] Univ Sao Paulo, Sch Phys Educ & Sport, Endurance Sports Res Grp, Sao Paulo, Brazil; [Lima-Silva, Adriano Eduardo] Univ Fed Pernambuco, Acad Ctr Vitoria, Sports Sci Res Grp, Vitoria De Santo Antao, Brazil; [Matsuda, Monique] Univ Sao Paulo, Fac Med, Sao Paulo, Brazil	Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade Federal de Pernambuco; Universidade de Sao Paulo	Bertuzzi, R (corresponding author), Univ Sao Paulo, Sch Med, Dept Pathol, Lab Expt Air Pollut, Sao Paulo, Brazil.	bertuzzi@usp.br	Lima-Silva, Adriano/Y-2404-2019; Matsuda, Monique/J-4646-2013; Lima-Silva, Adriano Eduardo/C-2800-2013; Bertuzzi, Romulo/E-7048-2012; Saldiva, Paulo HN/D-7385-2012	Lima-Silva, Adriano/0000-0002-0613-5104; Matsuda, Monique/0000-0003-4451-9712; Lima-Silva, Adriano Eduardo/0000-0002-0613-5104; Saldiva, Paulo HN/0000-0003-2005-8253	CAPES [23038.000486/2011-15, 1182744]; FAPESP [2010/13913-6]	CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	Romulo Bertuzzi is supported by CAPES (grant 23038.000486/2011-15). Leonardo A. Pasqua is supported by FAPESP (grant 2010/13913-6). Salomao Bueno is supported by CAPES (grant 1182744). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrahams S, 2014, INT J SPORT PHYSIOL, V9, P583, DOI [10.1123/IJSPP.2013-0222, 10.1123/ijspp.2013-0222]; Arampatzis A, 2006, J EXP BIOL, V209, P3345, DOI 10.1242/jeb.02340; Ariens GAM, 1997, EUR J APPL PHYSIOL O, V76, P214, DOI 10.1007/s004210050239; Baltaci G, 2003, BRIT J SPORT MED, V37, P59, DOI 10.1136/bjsm.37.1.59; Bojsen-Moller J, 2005, J APPL PHYSIOL, V99, P986, DOI 10.1152/japplphysiol.01305.2004; BRANSFORD DR, 1977, MED SCI SPORT EXER, V9, P41; Brown JC, 2011, SCAND J MED SCI SPOR, V21, pE266, DOI 10.1111/j.1600-0838.2010.01271.x; Brown JC, 2011, INT J SPORT PHYSIOL, V6, P485, DOI 10.1123/ijspp.6.4.485; BROZEK J, 1963, ANN NY ACAD SCI, V110, P113, DOI 10.1111/j.1749-6632.1963.tb17079.x; Chanock SJ, 2007, NAT GENET, V39, P283, DOI 10.1038/ng0307-283; Collins M, 2009, SCAND J MED SCI SPOR, V19, P803, DOI 10.1111/j.1600-0838.2009.00915.x; Collins M, 2011, EXERC SPORT SCI REV, V39, P191, DOI 10.1097/JES.0b013e318224e853; Craig CL, 2003, MED SCI SPORT EXER, V35, P1381, DOI 10.1249/01.MSS.0000078924.61453.FB; Cupeiro R, 2010, J SCI MED SPORT, V15, P541; Eynon N, 2009, INT J SPORTS MED, V30, P695, DOI 10.1055/s-0029-1220731; Eynon N, 2013, SPORTS MED, V43, P803, DOI 10.1007/s40279-013-0059-4; Ficek K, 2013, J SCI MED SPORT, V16, P396, DOI 10.1016/j.jsams.2012.10.004; Fogelholm M, 2006, MED SCI SPORT EXER, V38, P753, DOI 10.1249/01.mss.0000194075.16960.20; Gomez-Gallego F, 2009, EUR J APPL PHYSIOL, V107, P565, DOI 10.1007/s00421-009-1166-7; Helgerud J, 2010, EUR J APPL PHYSIOL, V108, P1099, DOI 10.1007/s00421-009-1218-z; HOWLEY ET, 1995, MED SCI SPORT EXER, V27, P1292; JACKSON AS, 1985, PHYSICIAN SPORTSMED, V13, P76, DOI 10.1080/00913847.1985.11708790; KOMI PV, 1978, MED SCI SPORT EXER, V10, P261; Kubo K, 2013, SPRINGERPLUS, V2, DOI 10.1186/2193-1801-2-343; Kyrolainen H, 2003, MED SCI SPORT EXER, V35, P45, DOI 10.1249/01.MSS.0000046149.03322.BB; Kyrolainen H, 2001, MED SCI SPORT EXER, V33, P1330; Laguette MJ, 2011, MATRIX BIOL, V30, P338, DOI 10.1016/j.matbio.2011.05.001; Nummela A, 2007, INT J SPORTS MED, V28, P655, DOI 10.1055/s-2007-964896; Olds Norton, 1996, ANTHROPOMETRICA; Onywera VO, 2006, J SPORT SCI, V24, P415, DOI 10.1080/02640410500189033; Posthumus M, 2011, MED SCI SPORT EXER, V43, P584, DOI 10.1249/MSS.0b013e3181f34f4d; Ramsbottom R, 1987, Br J Sports Med, V21, P9; Lopes FAS, 2010, J STRENGTH COND RES, V24, P1650, DOI 10.1519/JSC.0b013e3181d32f7b; Saunders PU, 2004, SPORTS MED, V34, P465, DOI 10.2165/00007256-200434070-00005; Scott RA, 2003, MED SCI SPORT EXER, V35, P1727, DOI 10.1249/01.MSS.0000089335.85254.89; Silva-Batista C, 2013, J STRENGTH COND RES, V27, P3481, DOI 10.1519/JSC.0b013e31828f1efa; Wenstrup RJ, 2011, J BIOL CHEM, V286, P20455, DOI 10.1074/jbc.M111.223693; Wenstrup RJ, 2006, J BIOL CHEM, V281, P12888, DOI 10.1074/jbc.M511528200; WILLIAMS TJ, 1991, MED SCI SPORT EXER, V23, P944	39	9	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 4	2014	9	9							e106581	10.1371/journal.pone.0106581	http://dx.doi.org/10.1371/journal.pone.0106581			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3XV	25188268	gold, Green Published, Green Submitted			2022-12-27	WOS:000341271500059
J	Guerin, F; Galimand, M; Tuambilangana, F; Courvalin, P; Cattoir, V				Guerin, Francois; Galimand, Marc; Tuambilangana, Fabrice; Courvalin, Patrice; Cattoir, Vincent			Overexpression of the Novel MATE Fluoroquinolone Efflux Pump FepA in Listeria monocytogenes Is Driven by Inactivation of Its Local Repressor FepR	PLOS ONE			English	Article							FIELD GEL-ELECTROPHORESIS; STAPHYLOCOCCUS-AUREUS; MULTIDRUG-RESISTANCE; FAMILY; TRANSPORTER; EXPRESSION; PROTEIN; SUSCEPTIBILITY; MOXIFLOXACIN; MENINGITIS	Whereas fluoroquinolone resistance mainly results from target modifications in gram-positive bacteria, it is primarily due to active efflux in Listeria monocytogenes. The aim of this study was to dissect a novel molecular mechanism of fluoroquinolone resistance in this important human pathogen. Isogenic L. monocytogenes clinical isolates BM4715 and BM4716, respectively susceptible and resistant to fluoroquinolones, were studied. MICs of norfloxacin and ciprofloxacin were determined in the presence or in the absence of reserpine (10 mg/L). Strain BM4715 was susceptible to norfloxacin (MIC, 4 mg/L) and ciprofloxacin (MIC, 0.5 mg/L) whereas BM4716 was highly resistant to both drugs (MICs 128 and 32 mg/L, respectively). Reserpine was responsible for a 16-fold decrease in both norfloxacin and ciprofloxacin MICs against BM4716 suggesting efflux associated resistance. Whole-genome sequencing of the strains followed by comparative genomic analysis revealed a single point mutation in the gene for a transcriptional regulator, designated fepR (for fluoroquinolone efflux protein regulator) belonging to the TetR family. The frame-shift mutation was responsible for the introduction of a premature stop codon resulting in an inactive truncated protein. Just downstream from fepR, the structural gene for an efflux pump of the MATE family (named FepA) was identified. Gene expression was quantified by qRT-PCR and demonstrated that fepA expression was more than 64-fold higher in BM4716 than in BM4715. The clean deletion of the fepR gene from BM4715 was responsible for an overexpression of fepA with resistance to norfloxacin and ciprofloxacin, confirming the role of FepR as a local repressor of fepA. In conclusion, we demonstrated that overexpression of the new MATE efflux pump FepA is responsible for fluoroquinolone resistance in L. monocytogenes and secondary to inactivation of the FepR repressor.	[Guerin, Francois; Tuambilangana, Fabrice; Cattoir, Vincent] CHU Caen, Microbiol Serv, F-14033 Caen, France; [Guerin, Francois; Cattoir, Vincent] Univ Caen Basse Normandie, EA4655 Equipe Antibio Resistance, F-14032 Caen, France; [Galimand, Marc; Courvalin, Patrice] Inst Pasteur, Unite Agents Antibacteriens, Paris, France	CHU de Caen NORMANDIE; Universite de Caen Normandie; Universite de Caen Normandie; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Cattoir, V (corresponding author), CHU Caen, Microbiol Serv, F-14033 Caen, France.	cattoir-v@chu-caen.fr	Cattoir, Vincent/AAD-8353-2019	GUERIN, Francois/0000-0001-6821-3131	Ministere de l'Enseignement Superieur et de la Recherche [EA4655]; Universite Caen Basse-Normandie, France	Ministere de l'Enseignement Superieur et de la Recherche; Universite Caen Basse-Normandie, France	This research was funded by a grant from the Ministere de l'Enseignement Superieur et de la Recherche (EA4655), Universite Caen Basse-Normandie, France. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brown MH, 1999, MOL MICROBIOL, V31, P394, DOI 10.1046/j.1365-2958.1999.01162.x; BUCHRIESER C, 1993, CAN J MICROBIOL, V39, P395, DOI 10.1139/m93-058; Dridi L, 2004, MICROB DRUG RESIST, V10, P191, DOI 10.1089/1076629041939391; FARBER JM, 1991, MICROBIOL REV, V55, P476, DOI 10.1128/MMBR.55.3.476-511.1991; Glaser P, 2001, SCIENCE, V294, P849; Godreuil S, 2003, ANTIMICROB AGENTS CH, V47, P704, DOI 10.1128/AAC.47.2.704-708.2003; Grayo S, 2008, ANTIMICROB AGENTS CH, V52, P3210, DOI 10.1128/AAC.00177-08; Grkovic S, 2002, MICROBIOL MOL BIOL R, V66, P671, DOI 10.1128/MMBR.66.4.671-701.2002; Hashimoto K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059525; Hof H, 1997, CLIN MICROBIOL REV, V10, P345, DOI 10.1128/CMR.10.2.345; Hooper DC, 2002, LANCET INFECT DIS, V2, P530, DOI 10.1016/S1473-3099(02)00369-9; Jiang XB, 2012, MICROBIOL IMMUNOL, V56, P843, DOI 10.1111/j.1348-0421.2012.00506.x; Kaatz GW, 2005, ANTIMICROB AGENTS CH, V49, P1857, DOI 10.1128/AAC.49.5.1857-1864.2005; KAATZ GW, 1995, ANTIMICROB AGENTS CH, V39, P2650, DOI 10.1128/AAC.39.12.2650; Kuroda T, 2009, BBA-PROTEINS PROTEOM, V1794, P763, DOI 10.1016/j.bbapap.2008.11.012; Lampidis R, 2002, J ANTIMICROB CHEMOTH, V49, P917, DOI 10.1093/jac/dkf065; Lorber B, 1997, CLIN INFECT DIS, V24, P1, DOI 10.1093/clinids/24.1.1; Mata MT, 2000, FEMS MICROBIOL LETT, V187, P185, DOI 10.1111/j.1574-6968.2000.tb09158.x; McAleese F, 2005, ANTIMICROB AGENTS CH, V49, P1865, DOI 10.1128/AAC.49.5.1865-1871.2005; Morita Y, 1998, ANTIMICROB AGENTS CH, V42, P1778, DOI 10.1128/AAC.42.7.1778; Morvan A, 2010, ANTIMICROB AGENTS CH, V54, P2728, DOI 10.1128/AAC.01557-09; Piddock LJV, 2006, NAT REV MICROBIOL, V4, P629, DOI 10.1038/nrmicro1464; Poole K, 2005, J ANTIMICROB CHEMOTH, V56, P20, DOI 10.1093/jac/dki171; Ramos JL, 2005, MICROBIOL MOL BIOL R, V69, P326, DOI 10.1128/MMBR.69.2.326-356.2005; Rosenfeld N, 2012, ANTIMICROB AGENTS CH, V56, P2504, DOI 10.1128/AAC.06422-11; Sipahi OR, 2008, J ANTIMICROB CHEMOTH, V61, P670, DOI 10.1093/jac/dkn001; Tasara T, 2007, FEMS MICROBIOL LETT, V269, P265, DOI 10.1111/j.1574-6968.2007.00633.x; Temple ME, 2000, ANN PHARMACOTHER, V34, P656, DOI 10.1345/aph.19315; TENOVER FC, 1995, J CLIN MICROBIOL, V33, P2233, DOI 10.1128/JCM.33.9.2233-2239.1995; Tocci N, 2013, ANTIMICROB AGENTS CH, V57, P248, DOI 10.1128/AAC.01298-12; Viale P, 2007, DIAGN MICR INFEC DIS, V58, P137, DOI 10.1016/j.diagmicrobio.2006.11.010; Wiegand I, 2008, NAT PROTOC, V3, P163, DOI 10.1038/nprot.2007.521; Zhang XL, 2011, ENVIRON MICROBIOL, V13, P518, DOI 10.1111/j.1462-2920.2010.02355.x	33	22	25	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 4	2014	9	9							e106340	10.1371/journal.pone.0106340	http://dx.doi.org/10.1371/journal.pone.0106340			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3XV	25188450	Green Published, gold, Green Submitted			2022-12-27	WOS:000341271500028
J	Hsu, PJ; Wu, FJ; Kudo, M; Hsiao, CL; Hsueh, AJW; Luo, CW				Hsu, Pei-Jen; Wu, Fang-Ju; Kudo, Masataka; Hsiao, Chih-Lun; Hsueh, Aaron J. W.; Luo, Ching-Wei			A Naturally Occurring Lgr4 Splice Variant Encodes a Soluble Antagonist Useful for Demonstrating the Gonadal Roles of Lgr4 in Mammals	PLOS ONE			English	Article							ESTROGEN-RECEPTOR-ALPHA; MALE REPRODUCTIVE-TRACT; STEM-CELLS; SERTOLI-CELLS; TRANSMEMBRANE DOMAIN; HORMONE-RECEPTOR; HAIR FOLLICLE; IN-VITRO; EXPRESSION; PROTEIN	Leucine-rich repeat containing G protein-coupled receptor 4 (LGR4) promotes the Wnt signaling through interaction with R-spondins or norrin. Using PCR amplification from rat ovarian cDNAs, we identified a naturally occurring Lgr4 splice variant encoding only the ectodomain of Lgr4, which was named Lgr4-ED. Lgr4-ED can be detected as a secreted protein in the extracts from rodent and bovine postnatal gonads, suggesting conservation of Lgr4-ED in mammals. Recombinant Lgr4-ED purified from the conditioned media of transfected 293T cells was found to dose-dependently inhibit the LGR4-mediated Wnt signaling induced by RSPO2 or norrin, suggesting that it is capable of ligand absorption and could have a potential role as an antagonist. Intraperitoneal injection of purified recombinant Lgr4-ED into newborn mice was found to significantly decrease the testicular expression of estrogen receptor alpha and aquaporin 1, which is similar to the phenotype found in Lgr4-null mice. Administration of recombinant Lgr4-ED to superovulated female rats can also decrease the expression of estrogen receptor alpha, aquaporin 1, LH receptor and other key steroidogenic genes as well as bring about the suppression of progesterone production. Thus, these findings suggest that endogenously expressed Lgr4-ED may act as an antagonist molecule and help to fine-tune the R-spondin/norrin-mediated Lgr4-Wnt signaling during gonadal development.	[Hsu, Pei-Jen; Wu, Fang-Ju; Hsiao, Chih-Lun; Luo, Ching-Wei] Natl Yang Ming Univ, Dept Life Sci, Taipei 112, Taiwan; [Hsu, Pei-Jen; Wu, Fang-Ju; Hsiao, Chih-Lun; Luo, Ching-Wei] Natl Yang Ming Univ, Inst Genome Sci, Taipei 112, Taiwan; [Kudo, Masataka; Hsueh, Aaron J. W.] Stanford Univ, Sch Med, Dept Obstet & Gynecol, Div Reprod & Stem Cell Biol, Stanford, CA 94305 USA	National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; Stanford University	Luo, CW (corresponding author), Natl Yang Ming Univ, Dept Life Sci, Taipei 112, Taiwan.	cwluo@ym.edu.tw			National Science Council in Taiwan [NSC99-2628-B-010-014-MY3, NSC102-2320-B-010-026]	National Science Council in Taiwan(Ministry of Science and Technology, Taiwan)	This work was supported by National Science Council (NSC99-2628-B-010-014-MY3 and NSC102-2320-B-010-026) in Taiwan for CWL. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arrighi S, 2014, REPROD DOMEST ANIM, V49, P17, DOI 10.1111/rda.12213; Barker N, 2007, NATURE, V449, P1003, DOI 10.1038/nature06196; Barker N, 2012, CELL REP, V2, P540, DOI 10.1016/j.celrep.2012.08.018; Barker N, 2010, CELL STEM CELL, V6, P25, DOI 10.1016/j.stem.2009.11.013; Boyer A, 2008, BIOL REPROD, V79, P475, DOI 10.1095/biolreprod.108.068627; Carmon KS, 2011, P NATL ACAD SCI USA, V108, P11452, DOI 10.1073/pnas.1106083108; de Lau W, 2011, NATURE, V476, P293, DOI 10.1038/nature10337; Deng C, 2013, J CELL SCI, V126, P2060, DOI 10.1242/jcs.123471; Eddy EM, 1996, ENDOCRINOLOGY, V137, P4796, DOI 10.1210/en.137.11.4796; Fisher JS, 1998, ENDOCRINOLOGY, V139, P3935, DOI 10.1210/en.139.9.3935; Grammatopoulos DK, 1999, MOL ENDOCRINOL, V13, P2189, DOI 10.1210/me.13.12.2189; GRAVES PN, 1992, BIOCHEM BIOPH RES CO, V187, P1135, DOI 10.1016/0006-291X(92)91315-H; Han J, 2009, J APPL TOXICOL, V29, P446, DOI 10.1002/jat.1417; Hoshii T, 2006, BIOL REPROD; Hsu SY, 2000, MOL ENDOCRINOL, V14, P1257, DOI 10.1210/me.14.8.1257; Jaks V, 2008, NAT GENET, V40, P1291, DOI 10.1038/ng.239; KHAN H, 1993, BIOCHEM BIOPH RES CO, V190, P888, DOI 10.1006/bbrc.1993.1132; Kubota H, 2003, P NATL ACAD SCI USA, V100, P6487, DOI 10.1073/pnas.0631767100; Li XY, 2010, DEVELOPMENT, V137, P151, DOI 10.1242/dev.040659; Lin J, 2014, REPROD SCI; Lu DY, 2008, ANAT HISTOL EMBRYOL, V37, P1, DOI 10.1111/j.1439-0264.2007.00827.x; Lucas TFG, 2008, BIOL REPROD, V78, P101, DOI 10.1095/biolreprod.107.063909; Luo Ching-Wei, 2006, Chang Gung Med J, V29, P2; Luo CW, 2005, P NATL ACAD SCI USA, V102, P2820, DOI 10.1073/pnas.0409916102; Luo W, 2013, STEM CELLS; Malherbe P, 1999, MOL BRAIN RES, V67, P201, DOI 10.1016/S0169-328X(99)00050-9; Mazerbourg S, 2004, MOL ENDOCRINOL, V18, P2241, DOI 10.1210/me.2004-0133; Mendive F, 2006, DEV BIOL, V290, P421, DOI 10.1016/j.ydbio.2005.11.043; Mizutani T, 1997, LIFE SCI, V61, P1497, DOI 10.1016/S0024-3205(97)00709-1; Mustata RC, 2011, EMBO REP, V12, P558, DOI 10.1038/embor.2011.52; Parr BA, 1998, NATURE, V395, P707, DOI 10.1038/27221; PULAK R, 1993, GENE DEV, V7, P1885, DOI 10.1101/gad.7.10.1885; Qian Y, 2013, DEVELOPMENT, V140, P1751, DOI 10.1242/dev.093641; Schwarz DA, 2000, J BIOL CHEM, V275, P32174, DOI 10.1074/jbc.M005333200; Scott DJ, 2005, ANN NY ACAD SCI, V1041, P22, DOI 10.1196/annals.1282.005; Snippert HJ, 2010, SCIENCE, V327, P1385, DOI 10.1126/science.1184733; Tanwar PS, 2010, BIOL REPROD, V82, P422, DOI 10.1095/biolreprod.109.079335; Vainio S, 1999, NATURE, V397, P405, DOI 10.1038/17068; Valerio A, 2001, GENE, V262, P99, DOI 10.1016/S0378-1119(00)00547-3; Van Schoore G, 2005, HISTOCHEM CELL BIOL, V124, P35, DOI 10.1007/s00418-005-0002-3; Wang Y, 2013, STEM CELLS, V31, P1921, DOI 10.1002/stem.1438; Yamaguchi TP, 1999, DEVELOPMENT, V126, P1211; You S, 2000, BIOL REPROD, V62, P108, DOI 10.1095/biolreprod62.1.108	43	9	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 4	2014	9	9							e106804	10.1371/journal.pone.0106804	http://dx.doi.org/10.1371/journal.pone.0106804			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3XV	25188337	Green Published, Green Submitted, gold			2022-12-27	WOS:000341271500089
J	Cao, Y; Roursgaard, M; Danielsen, PH; Moller, P; Loft, S				Cao, Yi; Roursgaard, Martin; Danielsen, Pernille Hogh; Moller, Peter; Loft, Steffen			Carbon Black Nanoparticles Promote Endothelial Activation and Lipid Accumulation in Macrophages Independently of Intracellular ROS Production	PLOS ONE			English	Article							ADHESION MOLECULE EXPRESSION; DIESEL EXHAUST PARTICLE; REACTIVE OXYGEN; OXIDATIVE DAMAGE; WOOD SMOKE; MOUSE LUNG; CELLS; EXPOSURE; INFLAMMATION; CYTOTOXICITY	Exposure to nanoparticles (NPs) may cause vascular effects including endothelial dysfunction and foam cell formation, with oxidative stress and inflammation as supposed central mechanisms. We investigated oxidative stress, endothelial dysfunction and lipid accumulation caused by nano-sized carbon black (CB) exposure in cultured human umbilical vein endothelial cells (HUVECs), THP-1 (monocytes) and THP-1 derived macrophages (THP-1a). The proliferation of HUVECs or co-cultures of HUVECs and THP-1 cells were unaffected by CB exposure, whereas there was increased cytotoxicity, assessed by the LDH and WST-1 assays, especially in THP-1 and THP-1a cells. The CB exposure decreased the glutathione (GSH) content in THP-1 and THP-1a cells, whereas GSH was increased in HUVECs. The reactive oxygen species (ROS) production was increased in all cell types after CB exposure. A reduction of the intracellular GSH concentration by buthionine sulfoximine (BSO) pre-treatment further increased the CB-induced ROS production in THP-1 cells and HUVECs. The expression of adhesion molecules ICAM-1 and VCAM-1, but not adhesion of THP-1 to HUVECs or culture dishes, was elevated by CB exposure, whereas these effects were unaffected by BSO pre-treatment. qRT-PCR showed increased VCAM1 expression, but no change in GCLM and HMOX1 expression in CB-exposed HUVECs. Pre-exposure to CB induced lipid accumulation in THP-1a cells, which was not affected by the presence of the antioxidant N-acetylcysteine. In addition, the concentrations of CB to induce lipid accumulation were lower than the concentrations to promote intracellular ROS production in THP-1a cells. In conclusion, exposure to nano-sized CB induced endothelial dysfunction and foam cell formation, which was not dependent on intracellular ROS production.	[Cao, Yi; Roursgaard, Martin; Danielsen, Pernille Hogh; Moller, Peter; Loft, Steffen] Univ Copenhagen, Dept Publ Hlth, Environm Hlth Sect, Copenhagen, Denmark	University of Copenhagen	Roursgaard, M (corresponding author), Univ Copenhagen, Dept Publ Hlth, Environm Hlth Sect, Copenhagen, Denmark.	mwro@sund.ku.dk	Roursgaard, Martin/D-7320-2016	Roursgaard, Martin/0000-0002-7206-0032; Loft, Steffen/0000-0001-9552-8518; Danielsen, Pernille Hogh/0000-0001-7212-7818	Centre for Pharmaceutical Nanoscience and Nanotoxicology - Danish Strategic Research Council; Lundbeck Foundation Center for Biomembranes in Nanomedicine (CBN)	Centre for Pharmaceutical Nanoscience and Nanotoxicology - Danish Strategic Research Council; Lundbeck Foundation Center for Biomembranes in Nanomedicine (CBN)	This work was supported by the Centre for Pharmaceutical Nanoscience and Nanotoxicology financed by the Danish Strategic Research Council and by the Lundbeck Foundation Center for Biomembranes in Nanomedicine (CBN). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson CP, 2002, BONE MARROW TRANSPL, V30, P135, DOI 10.1038/sj.bmt.1703605; Bourdon JA, 2012, PART FIBRE TOXICOL, V9, DOI 10.1186/1743-8977-9-5; Cao Y, 2014, TOXICOL SCI, V138, P104, DOI 10.1093/toxsci/kft328; Cao Y, 2011, ENVIRON TOXICOL, V26, P279, DOI 10.1002/tox.20554; Chen XP, 2010, FREE RADICAL RES, V44, P587, DOI 10.3109/10715761003709802; Cook-Mills JM, 2011, ANTIOXID REDOX SIGN, V15, P1607, DOI 10.1089/ars.2010.3522; Danielsen PH, 2011, CHEM RES TOXICOL, V24, P168, DOI 10.1021/tx100407m; Danielsen PH, 2009, MUTAT RES-GEN TOX EN, V674, P116, DOI 10.1016/j.mrgentox.2008.10.014; Danielsen PH, 2008, PART FIBRE TOXICOL, V5, DOI 10.1186/1743-8977-5-6; Dikalov S, 2007, HYPERTENSION, V49, P717, DOI 10.1161/01.HYP.0000258594.87211.6b; Forchhammer L, 2012, TOXICOL LETT, V209, P121, DOI 10.1016/j.toxlet.2011.12.003; Forman HJ, 2004, AM J PHYSIOL-CELL PH, V287, pC246, DOI 10.1152/ajpcell.00516.2003; Frikke-Schmidt H, 2011, TOXICOL LETT, V203, P181, DOI 10.1016/j.toxlet.2011.03.011; Gangwal S, 2011, ENVIRON HEALTH PERSP, V119, P1539, DOI 10.1289/ehp.1103750; Gojova A, 2007, ENVIRON HEALTH PERSP, V115, P403, DOI 10.1289/ehp.8497; Hemmingsen JG, 2011, ENVIRON SCI TECHNOL, V45, P8545, DOI 10.1021/es200956p; Hussain S, 2010, PART FIBRE TOXICOL, V7, DOI 10.1186/1743-8977-7-10; Jackson P, 2012, NANOTOXICOLOGY, V6, P486, DOI 10.3109/17435390.2011.587902; Jacobsen NR, 2008, ENVIRON MOL MUTAGEN, V49, P476, DOI 10.1002/em.20406; Jacobsen NR, 2007, ENVIRON MOL MUTAGEN, V48, P451, DOI 10.1002/em.20300; Jantzen K, 2012, MUTAGENESIS, V27, P693, DOI 10.1093/mutage/ges035; Karlsson M, 2010, BIOCHEM J, V428, P183, DOI 10.1042/BJ20100208; Kensler TW, 2007, ANNU REV PHARMACOL, V47, P89, DOI 10.1146/annurev.pharmtox.46.120604.141046; Khatchadourian A, 2009, MOL PHARMACEUT, V6, P1125, DOI 10.1021/mp900098p; LEBEL CP, 1992, CHEM RES TOXICOL, V5, P227, DOI 10.1021/tx00026a012; McLaughlin AP, 2001, AM J PHYSIOL-CELL PH, V281, pC1448, DOI 10.1152/ajpcell.2001.281.5.C1448; Mikkelsen L, 2013, NANOTOXICOLOGY, V7, P117, DOI 10.3109/17435390.2011.641604; Moller P, 2011, CRIT REV TOXICOL, V41, P339, DOI 10.3109/10408444.2010.533152; Moller P, 2010, FREE RADICAL RES, V44, P1, DOI 10.3109/10715760903300691; Montiel-Davalos A, 2010, TOXICOL IN VITRO, V24, P135, DOI 10.1016/j.tiv.2009.08.004; Murphy FA, 2012, PART FIBRE TOXICOL, V9, DOI 10.1186/1743-8977-9-8; Niwa Y, 2007, CIRC J, V71, P1157, DOI 10.1253/circj.71.1157; Ohashi T, 2002, FEBS LETT, V511, P21, DOI 10.1016/S0014-5793(01)03262-8; Packard RRS, 2008, CLIN CHEM, V54, P24, DOI 10.1373/clinchem.2007.097360; Peebles BC, 2011, ENVIRON SCI TECHNOL, V45, P10668, DOI 10.1021/es202984t; Przybytkowski E, 2009, FEBS J, V276, P6204, DOI 10.1111/j.1742-4658.2009.07324.x; Speciale A, 2011, TOXICOL LETT, V207, P291, DOI 10.1016/j.toxlet.2011.09.017; Traore K, 2005, LEUKEMIA RES, V29, P863, DOI 10.1016/j.leukres.2004.12.011; Tsukahara T, 2011, BIOCHEM BIOPH RES CO, V406, P558, DOI 10.1016/j.bbrc.2011.02.090; Vesterdal LK, 2012, TOXICOL LETT, V214, P19, DOI 10.1016/j.toxlet.2012.07.022; Vesterdal LK, 2010, PART FIBRE TOXICOL, V7, DOI 10.1186/1743-8977-7-33; Vesterdal LK, 2013, TOXICOL APPL PHARM, V10; Willett NJ, 2011, ANTIOXID REDOX SIGN, V15, P1369, DOI 10.1089/ars.2010.3550; ZHU H, 1994, ARCH TOXICOL, V68, P582, DOI 10.1007/s002040050118	44	50	51	1	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 3	2014	9	9							e106711	10.1371/journal.pone.0106711	http://dx.doi.org/10.1371/journal.pone.0106711			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3TB	25184212	Green Published, Green Submitted, gold			2022-12-27	WOS:000341257700109
J	Li, JH; Huang, QY; Zeng, FF; Li, WX; He, ZN; Chen, W; Zhu, W; Zhang, B				Li, Jinhui; Huang, Qingyuan; Zeng, Fangfang; Li, Wenxue; He, Zhini; Chen, Wen; Zhu, Wei; Zhang, Bo			The Prognostic Value of Global DNA Hypomethylation in Cancer: A Meta-Analysis	PLOS ONE			English	Article							LINE-1 HYPOMETHYLATION; POOR-PROGNOSIS; PYROSEQUENCING ASSAY; METHYLATION LEVELS; SEQUENCES; GENES; TUMOR; EPIGENETICS; SURGERY; LEVEL	Background: Aberrant methylation of the global genome has been investigated as a prognostic indicator in various cancers, but the results are controversial and ambiguous. Methods and Findings: This meta-analysis presents pooled estimates of the evidence to elucidate this issue. We searched the electronic databases: PubMed, Embase, ISI Web of Science and the Cochrane library (up to August 2013) to identify all of the relevant studies. The association between the level of surrogates' indexes of genome-wide hypomethylation (LINE-1, Alu and Sat-alpha) and the overall survival (OS) of cancer patients was examined. In addition, the pooled hazard ratios (HRs) with their 95% confidence interval (95% CI) were calculated to estimate the influences through fixed-effects and random-effects model. Finally, twenty studies with total population of 5447 met the inclusion criteria. The results indicate that the summary HRs for the studies employing LINE-1, Alu, and Sat-a repetitive elements also show that the global DNA hypomethylation have significant desirable effects on the tumour prognostic value. The pooled HRs (and CIs) of LINE-1, Alu and Sat-a were 1.83 (1.38-2.44), 2.00 (1.16-3.45), and 2.92 (1.04-8.25), with a heterogeneity measure index of I-2 (and p-value) shows of 66.6% (p = 0.001), 57.1% (p = 0.053) and 68.2% (p = 0.076) respectively. The meta-regression and subgroup analysis indicated that the percentage of hypomethylated sample of cancer patients is one source of heterogeneity. Conclusion: Our meta-analysis findings support the hypothesis that the global DNA hypomethylation is associated with a detrimental prognosis in tumour patients.	[Li, Jinhui; He, Zhini; Chen, Wen; Zhang, Bo] Sun Yat Sen Univ, Sch Publ Hlth, Dept Prevent Med, Guangzhou 510275, Guangdong, Peoples R China; [Li, Jinhui; Li, Wenxue; Zhu, Wei] Guangzhou Ctr Dis Control & Prevent, Dept Toxicol, Guangzhou, Guangdong, Peoples R China; [Huang, Qingyuan] Sun Yat Sen Univ, Ctr Canc, State Key Lab Oncol South China, Dept Thorac Oncol, Guangzhou 510275, Guangdong, Peoples R China; [Zeng, Fangfang] Sun Yat Sen Univ, Affiliated Hosp 1, Dept Epidemiol, Guangzhou 510275, Guangdong, Peoples R China; [Zeng, Fangfang] Sun Yat Sen Univ, Sch Publ Hlth, Dept Med Stat & Epidemiol, Guangdong Prov Key Lab Food Nutr & Hlth, Guangzhou 510275, Guangdong, Peoples R China	Sun Yat Sen University; State Key Lab Oncology South China; Sun Yat Sen University; Sun Yat Sen University; Sun Yat Sen University	Zhu, W (corresponding author), Guangzhou Ctr Dis Control & Prevent, Dept Toxicol, Guangzhou, Guangdong, Peoples R China.	zhuyc126@126.com; zhangb65@mail.sysu.edu.cn	Huang, Qingyuan/AAC-7164-2019; li, wenxue/K-7505-2014	li, wenxue/0000-0002-0346-5300; He, Zhini/0000-0002-9185-5500	National Natural Science Foundation of China [81101562, 81273099]; Fundamental Research Funds for the Central Universities [12ykpy13]; Foundation of Natural Science of Guangdong Province [S2012010009633]; Science and Technology Planning Project of Guangdong Province [2012B060300005]; Key Project of Guangzhou Medical and Health Science and Technology [20121A021018]; Project for Key Medicine Discipline Construction of Guangzhou Municipality [2013-2015-07]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Foundation of Natural Science of Guangdong Province; Science and Technology Planning Project of Guangdong Province; Key Project of Guangzhou Medical and Health Science and Technology; Project for Key Medicine Discipline Construction of Guangzhou Municipality	This work was supported by the National Natural Science Foundation of China (81101562, 81273099), Fundamental Research Funds for the Central Universities (12ykpy13), Foundation of Natural Science of Guangdong Province (S2012010009633), Science and Technology Planning Project of Guangdong Province (2012B060300005), Key Project of Guangzhou Medical and Health Science and Technology (20121A021018), The Project for Key Medicine Discipline Construction of Guangzhou Municipality (2013-2015-07). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ando N, 2003, J CLIN ONCOL, V21, P4592, DOI 10.1200/JCO.2003.12.095; Aoki Y, 2013, GENOME MED, V5, DOI 10.1186/gm491; Aoki Y, 2012, GENOME MED, V4, DOI 10.1186/gm402; Bae JM, 2012, INT J CANCER, V131, P1323, DOI 10.1002/ijc.27369; Banelli B, 2012, LAB INVEST, V92, P458, DOI 10.1038/labinvest.2011.169; Belinsky SA, 2002, CARCINOGENESIS, V23, P335, DOI 10.1093/carcin/23.2.335; Bird A, 2002, GENE DEV, V16, P6, DOI 10.1101/gad.947102; Chalitchagorn K, 2004, ONCOGENE, V23, P8841, DOI 10.1038/sj.onc.1208137; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Doi T, 2011, TOXICOL SCI, V120, P475, DOI 10.1093/toxsci/kfr022; Duthie SJ, 2002, J NUTR; Ehrlich M, 2009, EPIGENOMICS, V1, P1750; Esteller M, 2008, NEW ENGL J MED, V358, P1148, DOI 10.1056/NEJMra072067; Fabris S, 2011, EPIGENETICS-US, V6, P188, DOI 10.4161/epi.6.2.13528; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Furniss CS, 2008, CANCER EPIDEM BIOMAR, V17, P966, DOI 10.1158/1055-9965.EPI-07-2775; Gilbert J, 2004, CLIN CANCER RES, V10, P4589, DOI 10.1158/1078-0432.CCR-03-0297; Hartman M, 2010, LANCET ONCOL, V11, P383, DOI 10.1016/S1470-2045(10)70005-X; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Hoshimoto S, 2012, J INVEST DERMATOL, V132, P1689, DOI 10.1038/jid.2012.36; Hou LF, 2011, PART FIBRE TOXICOL, V8, DOI 10.1186/1743-8977-8-25; Intarasunanont P, 2012, INTARASUNANONT ENV H, V11; Irahara N, 2010, J MOL DIAGN, V12, P177, DOI 10.2353/jmoldx.2010.090106; Iwagami S, 2013, ANN SURG, V257, P449, DOI 10.1097/SLA.0b013e31826d8602; Klek S, 2013, WORLD J SURG; Liberati Alessandro, 2009, J Clin Epidemiol, V62, pe1, DOI 10.1016/j.jclinepi.2009.06.006; Macdonald JS, 2001, NEW ENGL J MED, V345, P725, DOI 10.1056/NEJMoa010187; Maio M, 2003, ONCOGENE, V22, P6484, DOI 10.1038/sj.onc.1206956; MANTEL N, 1959, J NATL CANCER I, V22, P719; McDermott U, 2011, NEW ENGL J MED, V364, P340, DOI 10.1056/NEJMra0907178; Murata A, 2013, BRIT J CANCER, V109, P408, DOI 10.1038/bjc.2013.289; Nosho K, 2009, GASTROENTEROLOGY, V137, P1609, DOI 10.1053/j.gastro.2009.08.002; Ogino S, 2008, J NATL CANCER I, V100, P1734, DOI 10.1093/jnci/djn359; Ohka F, 2011, GLOBAL DNA METHYLATI; Pattamadilok J, 2008, INT J GYNECOL CANCER, V18, P711, DOI 10.1111/j.1525-1438.2007.01117.x; Renehan AG, 2008, LANCET, V371, P569, DOI 10.1016/S0140-6736(08)60269-X; Rhee I, 2002, NATURE, V416, P552, DOI 10.1038/416552a; Rhee Y, 2012, ANN SURG ONCOL, V19, P3441, DOI 10.1245/s10434-012-2410-7; Ross JP, 2010, EPIGENOMICS-UK, V2, P245, DOI 10.2217/EPI.10.2; Saito K, 2010, CLIN CANCER RES, V16, P2418, DOI 10.1158/1078-0432.CCR-09-2819; Shigaki H, 2012, GASTRIC CANC; Sigalotti L, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-78; Sigalotti L, 2010, J TRANSL MED, V8, DOI 10.1186/1479-5876-8-56; Sincic N, 2011, CURR OPIN ONCOL, V23, P69, DOI 10.1097/CCO.0b013e3283412eb4; Stroup DF, 2000, JAMA-J AM MED ASSOC, V283, P2008, DOI 10.1001/jama.283.15.2008; Tao LH, 2005, TOXICOL SCI, V87, P344, DOI 10.1093/toxsci/kfi257; Tierney JF, 2007, TRIALS, V8, DOI 10.1186/1745-6215-8-16; van Hoesel AQ, 2012, BREAST CANCER RES TR, V134, P1103, DOI 10.1007/s10549-012-2038-0; Wilson AS, 2007, BBA-REV CANCER, V1775, P138, DOI 10.1016/j.bbcan.2006.08.007; Wu H, 2011, GENE DEV, V25, P2436, DOI 10.1101/gad.179184.111; Yoshida T, 2011, INT J CANCER, V128, P33, DOI 10.1002/ijc.25534; Zan X, 2010, LINE METHYLATION LEV; Zhang CS, 2011, ANN SURG ONCOL, V18, P2373, DOI 10.1245/s10434-011-1599-1; Zhu ZZ, 2011, CANCER CAUSE CONTROL, V22, P437, DOI 10.1007/s10552-010-9715-2	54	41	41	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 3	2014	9	9							e106290	10.1371/journal.pone.0106290	http://dx.doi.org/10.1371/journal.pone.0106290			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3TB	25184628	Green Published, Green Submitted, gold			2022-12-27	WOS:000341257700051
J	Overman, JP; Preisinger, C; Prummel, K; Bonetti, M; Giansanti, P; Heck, A; den Hertog, J				Overman, Jeroen Paardekooper; Preisinger, Christian; Prummel, Karin; Bonetti, Monica; Giansanti, Piero; Heck, Albert; den Hertog, Jeroen			Phosphoproteomics-Mediated Identification of Fer Kinase as a Target of Mutant Shp2 in Noonan and LEOPARD Syndrome	PLOS ONE			English	Article							NONRECEPTOR TYROSINE-KINASE; PHOSPHATASE SHP-2; ZEBRAFISH EMBRYOS; BETA-CATENIN; PROTEIN; PHOSPHORYLATION; MUTATIONS; CELLS; ACTIVATION; DROSOPHILA	Noonan syndrome (NS) and LEOPARD syndrome (LS) cause congenital afflictions such as short stature, hypertelorism and heart defects. More than 50% of NS and almost all of LS cases are caused by activating and inactivating mutations of the phosphatase Shp2, respectively. How these biochemically opposing mutations lead to similar clinical outcomes is not clear. Using zebrafish models of NS and LS and mass spectrometry-based phosphotyrosine proteomics, we identified a down-regulated peptide of Fer kinase in both NS and LS. Further investigation showed a role for Fer during development, where morpholino-based knockdown caused craniofacial defects, heart edema and short stature. During gastrulation, loss of Fer caused convergence and extension defects without affecting cell fate. Moreover, Fer knockdown cooperated with NS and LS, but not wild type Shp2 to induce developmental defects, suggesting a role for Fer in the pathogenesis of both NS and LS.	[Overman, Jeroen Paardekooper; Prummel, Karin; Bonetti, Monica; den Hertog, Jeroen] Koninklijke Nederlandse Akad Wetenschappen, Hubrecht Inst, Utrecht, Netherlands; [Overman, Jeroen Paardekooper; Prummel, Karin; Bonetti, Monica; den Hertog, Jeroen] Univ Med Ctr Utrecht, Utrecht, Netherlands; [Preisinger, Christian; Giansanti, Piero; Heck, Albert] Univ Utrecht, Bijvoet Ctr Biomol Res, Utrecht, Netherlands; [Preisinger, Christian; Giansanti, Piero; Heck, Albert] Univ Utrecht, Utrecht Inst Pharmaceut Res, Utrecht, Netherlands; [Preisinger, Christian; Giansanti, Piero; Heck, Albert] Netherlands Prote Ctr, Utrecht, Netherlands; [Preisinger, Christian] Univ Aachen, Prote Facil, Interdisciplinary Ctr Clin Res Aachen, Aachen, Germany; [Heck, Albert] Ctr Biomed Genet, Utrecht, Netherlands; [den Hertog, Jeroen] Inst Biol Leiden, Leiden, Netherlands	Royal Netherlands Academy of Arts & Sciences; Hubrecht Institute (KNAW); Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University; RWTH Aachen University; Leiden University	den Hertog, J (corresponding author), Koninklijke Nederlandse Akad Wetenschappen, Hubrecht Inst, Utrecht, Netherlands.	j.denhertog@hubrecht.eu	Prummel, Karin/U-5095-2017; Heck, Albert/D-7098-2011	Heck, Albert/0000-0002-2405-4404; Giansanti, Piero/0000-0003-2857-0841; Prummel, Karin/0000-0001-6077-6407	Research Council for Earth and Life Sciences [ALW 819.02.021]; Netherlands Organisation for Scientific Research (NWO)	Research Council for Earth and Life Sciences(Netherlands Organization for Scientific Research (NWO)); Netherlands Organisation for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO))	This work was funded, in part, by a grant to JdH from the Research Council for Earth and Life Sciences (ALW 819.02.021) with financial aid from the Netherlands Organisation for Scientific Research (NWO). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aoki Y, 2013, AM J HUM GENET, V93, P173, DOI 10.1016/j.ajhg.2013.05.021; Ben-Dor I, 1999, CELL GROWTH DIFFER, V10, P113; Boersema PJ, 2010, MOL CELL PROTEOMICS, V9, P84, DOI 10.1074/mcp.M900291-MCP200; Boersema PJ, 2009, NAT PROTOC, V4, P484, DOI 10.1038/nprot.2009.21; Bonetti M, 2014, DEVELOPMENT, V141, P1961, DOI 10.1242/dev.106310; Carney TJ, 2006, DEVELOPMENT, V133, P4619, DOI 10.1242/dev.02668; Craig AWB, 2002, MOL CELL BIOL, V22, P6363, DOI 10.1128/MCB.22.18.6363-6374.2002; Craig AWB, 2001, MOL CELL BIOL, V21, P603, DOI 10.1128/MCB.21.2.603-613.2001; Darian E, 2011, PROTEINS, V79, P1573, DOI 10.1002/prot.22984; Ding VMY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017538; Eminaga S, 2008, J BIOL CHEM, V283, P15328, DOI 10.1074/jbc.M801382200; FELDMAN RA, 1986, MOL CELL BIOL, V6, P1065, DOI 10.1128/MCB.6.4.1065; Gebriel M, 2014, J NEUROSCI RES, V92, P104, DOI 10.1002/jnr.23297; Gelb BD, 2006, HUM MOL GENET, V15, pR220, DOI 10.1093/hmg/ddl197; Greer P, 2002, NAT REV MOL CELL BIO, V3, P278, DOI 10.1038/nrm783; Hof P, 1998, CELL, V92, P441, DOI 10.1016/S0092-8674(00)80938-1; Jia DS, 2014, CELL RES, V24, P204, DOI 10.1038/cr.2013.158; Jopling C, 2007, PLOS GENET, V3, P2468, DOI 10.1371/journal.pgen.0030225; KATZEN AL, 1991, MOL CELL BIOL, V11, P226, DOI 10.1128/MCB.11.1.226; Kessels MY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090568; KIM L, 1995, MOL CELL BIOL, V15, P4553; Kogata N, 2003, MOL BIOL CELL, V14, P3553, DOI 10.1091/mbc.E03-02-0080; Kontaridis MI, 2006, J BIOL CHEM, V281, P6785, DOI 10.1074/jbc.M513068200; Lee SH, 2008, J CELL BIOL, V183, P893, DOI 10.1083/jcb.200807188; Lemeer S, 2008, MOL CELL PROTEOMICS, V7, P2176, DOI 10.1074/mcp.M800081-MCP200; Lemeer S, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000581; Li C, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000044; Link V, 2006, BMC DEV BIOL, V6, DOI 10.1186/1471-213X-6-1; Muller PJ, 2013, J PROTEOMICS, V84, P132, DOI 10.1016/j.jprot.2013.04.005; Murray MJ, 2006, DEVELOPMENT, V133, P3063, DOI 10.1242/dev.02467; Neel BG, 2003, TRENDS BIOCHEM SCI, V28, P284, DOI 10.1016/S0968-0004(03)00091-4; Oishi K, 2009, HUM MOL GENET, V18, P193, DOI 10.1093/hmg/ddn336; Paardekooper Overman J, 2014, MOL CELL BI IN PRESS; PAWSON T, 1989, MOL CELL BIOL, V9, P5722, DOI 10.1128/MCB.9.12.5722; Preisinger C, 2013, LEUKEMIA, V27, P743, DOI 10.1038/leu.2012.243; Putzke AP, 2005, DEVELOPMENT, V132, P3185, DOI 10.1242/dev.01900; Robu ME, 2007, PLOS GENET, V3, P787, DOI 10.1371/journal.pgen.0030078; Ronnstrand L, 1999, ONCOGENE, V18, P3696, DOI 10.1038/sj.onc.1202705; Roszko I, 2009, SEMIN CELL DEV BIOL, V20, P986, DOI 10.1016/j.semcdb.2009.09.004; Runtuwene V, 2011, DIS MODEL MECH, V4, P393, DOI 10.1242/dmm.007112; Salem Y, 2005, CELL SIGNAL, V17, P341, DOI 10.1016/j.cellsig.2004.08.001; Saxton TM, 1999, P NATL ACAD SCI USA, V96, P3790, DOI 10.1073/pnas.96.7.3790; Saxton TM, 2000, NAT GENET, V24, P420, DOI 10.1038/74279; Saxton TM, 1997, EMBO J, V16, P2352, DOI 10.1093/emboj/16.9.2352; Singh SK, 2010, ZEBRAFISH, V7, P169, DOI 10.1089/zeb.2010.0657; Stewart RA, 2010, DEV CELL, V18, P750, DOI [10.1016/j.devcel.2010.03.009, 10.1016/j.devce1.2010.03.009]; Westerfield M, 1995, ZEBRAFISH BOOK; Xu G, 2004, J CELL SCI, V117, P3207, DOI 10.1242/jcs.01174; Yu ZH, 2013, J BIOL CHEM, V288, P10472, DOI 10.1074/jbc.M113.450023	50	5	5	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 3	2014	9	9							e106682	10.1371/journal.pone.0106682	http://dx.doi.org/10.1371/journal.pone.0106682			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3TB	25184253	Green Submitted, Green Published, gold			2022-12-27	WOS:000341257700103
J	Ramos, BCR; Moraes, MNCM; Poletini, MO; Lima, LHRG; Castrucci, AML				Ramos, Bruno C. R.; Moraes, Maria Nathalia C. M.; Poletini, Maristela O.; Lima, Leonardo H. R. G.; Castrucci, Ana Maria L.			From Blue Light to Clock Genes in Zebrafish ZEM-2S Cells	PLOS ONE			English	Article							NITRIC-OXIDE SYNTHASE; MAMMALIAN CIRCADIAN CLOCK; ACTIVATED PROTEIN-KINASE; EXPRESSION PATTERN; PHOTIC REGULATION; BIOLOGICAL CLOCK; GANGLION-CELLS; MESSENGER-RNA; VA-OPSIN; MELANOPSIN	Melanopsin has been implicated in the mammalian photoentrainment by blue light. This photopigment, which maximally absorbs light at wavelengths between 470 and 480 nm depending on the species, is found in the retina of all classes of vertebrates so far studied. In mammals, melanopsin activation triggers a signaling pathway which resets the circadian clock in the suprachiasmatic nucleus (SCN). Unlike mammals, Drosophila melanogaster and Danio rerio do not rely only on their eyes to perceive light, in fact their whole body may be capable of detecting light and entraining their circadian clock. Melanopsin, teleost multiple tissue (tmt) opsin and others such as neuropsin and va-opsin, are found in the peripheral tissues of Danio rerio, however, there are limited data concerning the photopigment/s or the signaling pathway/s directly involved in light detection. Here, we demonstrate that melanopsin is a strong candidate to mediate synchronization of zebrafish cells. The deduced amino acid sequence of melanopsin, although being a vertebrate opsin, is more similar to invertebrate than vertebrate photopigments, and melanopsin photostimulation triggers the phosphoinositide pathway through activation of a G(q/11)-type G protein. We stimulated cultured ZEM-2S cells with blue light at wavelengths consistent with melanopsin maximal absorption, and evaluated the time course expression of per1b, cry1b, per2 and cry1a. Using quantitative PCR, we showed that blue light is capable of slightly modulating per1b and cry1b genes, and drastically increasing per2 and cry1a expression. Pharmacological assays indicated that per2 and cry1a responses to blue light are evoked through the activation of the phosphoinositide pathway, which crosstalks with nitric oxide (NO) and mitogen activated protein MAP kinase (MAPK) to activate the clock genes. Our results suggest that melanopsin may be important in mediating the photoresponse in Danio rerio ZEM-2S cells, and provide new insights about the modulation of clock genes in peripheral clocks.	[Ramos, Bruno C. R.; Moraes, Maria Nathalia C. M.; Poletini, Maristela O.; Lima, Leonardo H. R. G.; Castrucci, Ana Maria L.] Univ Sao Paulo, Dept Physiol, Inst Biosci, Sao Paulo, Brazil; [Poletini, Maristela O.] Univ Fed Minas Gerais, Inst Biol Sci, Dept Physiol, Belo Horizonte, MG, Brazil	Universidade de Sao Paulo; Universidade Federal de Minas Gerais	Castrucci, AML (corresponding author), Univ Sao Paulo, Dept Physiol, Inst Biosci, Sao Paulo, Brazil.	amdlcast@ib.usp.br	Lima, Leonardo HRG/A-2652-2015; Poletini, Maristela O/D-5855-2015	Poletini, Maristela O/0000-0003-4917-889X; Castrucci, Ana Maria/0000-0002-2065-8198; Moraes, Maria Nathalia/0000-0003-2479-4477	BCRR Coordenacao de Aperfeicoamento de Pessoal de Ensino Superior; LHRGL Fundacao de Amparo a Pesquisa do Estado de Sao Paulo [2011/23930-8]; AMLC Fundacao de Amparo a Pesquisa do Estado de Sao Paulo [2012-50214-4]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico [301293/2011-2]; MNCMM Fundacao de Amparo a Pesquisa do Estado de Sao Paulo [2010/51374-0]	BCRR Coordenacao de Aperfeicoamento de Pessoal de Ensino Superior; LHRGL Fundacao de Amparo a Pesquisa do Estado de Sao Paulo; AMLC Fundacao de Amparo a Pesquisa do Estado de Sao Paulo; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); MNCMM Fundacao de Amparo a Pesquisa do Estado de Sao Paulo	BCRR Coordenacao de Aperfeicoamento de Pessoal de Ensino Superior, LHRGL Fundacao de Amparo a Pesquisa do Estado de Sao Paulo(#2011/23930-8), AMLC Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (#2012-50214-4) and Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (301293/2011-2), MNCMM Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (2010/51374-0). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aerts JL, 2004, BIOTECHNIQUES, V36, P84, DOI 10.2144/04361ST04; Agostino PV, 2004, NEUROCHEM INT, V44, P617, DOI 10.1016/j.neuint.2003.09.005; Akashi M, 2008, J NEUROSCI, V28, P4619, DOI 10.1523/JNEUROSCI.3410-07.2008; Bailey MJ, 2005, MOL BRAIN RES, V134, P345, DOI 10.1016/j.molbrainres.2004.11.003; Balsalobre A, 1998, CELL, V93, P929, DOI 10.1016/S0092-8674(00)81199-X; Bass J, 2010, SCIENCE, V330, P1349, DOI 10.1126/science.1195027; Bellingham J, 2006, PLOS BIOL, V4, P1334, DOI 10.1371/journal.pbio.0040254; Berridge G, 2002, BIOCHEM J, V365, P295, DOI 10.1042/BJ20020180; Berson DM, 2002, SCIENCE, V295, P1070, DOI 10.1126/science.1067262; Bilotta J, 2001, INT J DEV NEUROSCI, V19, P621, DOI 10.1016/S0736-5748(01)00050-8; Blum ID, 2012, NEUROSCI BIOBEHAV R, V36, P254, DOI 10.1016/j.neubiorev.2011.06.003; Buhr ED, 2010, SCIENCE, V330, P379, DOI 10.1126/science.1195262; Butcher GQ, 2003, J NEUROPHYSIOL, V90, P3854, DOI 10.1152/jn.00524.2003; Butcher GQ, 2002, J BIOL CHEM, V277, P29519, DOI 10.1074/jbc.M203301200; Cahill GM, 2002, CELL TISSUE RES, V309, P27, DOI 10.1007/s00441-002-0570-7; Cavallari N, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001142; Ceriani MF, 1999, SCIENCE, V285, P553, DOI 10.1126/science.285.5427.553; Cermakian N, 2002, CURR BIOL, V12, P844, DOI 10.1016/S0960-9822(02)00835-7; Chakraborty C, 2009, CURR DRUG METAB, V10, P116, DOI 10.2174/138920009787522197; Chansard M, 2007, NEUROSCIENCE, V145, P812, DOI 10.1016/j.neuroscience.2006.12.037; Chaurasia SS, 2005, J NEUROCHEM, V92, P158, DOI 10.1111/j.1471-4159.2004.02874.x; Contin MA, 2006, FASEB J, V20, P2648, DOI 10.1096/fj.06-6133fje; Davies WIL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051276; Davies WIL, 2011, CELL MOL LIFE SCI, V68, P4115, DOI 10.1007/s00018-011-0785-4; Davies WL, 2010, PHOTOCH PHOTOBIO SCI, V9, P1444, DOI 10.1039/c0pp00203h; Ding JM, 1997, J NEUROSCI, V17, P667; DING JM, 1994, SCIENCE, V266, P1713, DOI 10.1126/science.7527589; Drivenes O, 2003, J COMP NEUROL, V456, P84, DOI 10.1002/cne.10523; Dunlap JC, 1999, CELL, V96, P271, DOI 10.1016/S0092-8674(00)80566-8; Dziema H, 2003, EUR J NEUROSCI, V17, P1617, DOI 10.1046/j.1460-9568.2003.02592.x; Emery P, 1998, CELL, V95, P669, DOI 10.1016/S0092-8674(00)81637-2; Farhat FP, 2009, CHRONOBIOL INT, V26, P1090, DOI 10.1080/07420520903249005; Ferreyra GA, 2000, BRAIN RES, V858, P33, DOI 10.1016/S0006-8993(99)02390-2; Ferreyra GA, 1998, BRAIN RES, V797, P190, DOI 10.1016/S0006-8993(98)00376-X; Fukushima T, 1997, NEUROSCI LETT, V227, P45, DOI 10.1016/S0304-3940(97)00297-8; Goidin D, 2001, ANAL BIOCHEM, V295, P17, DOI 10.1006/abio.2001.5171; GOLOMBEK DA, 1995, NEUROSCI LETT, V192, P101, DOI 10.1016/0304-3940(95)99209-N; GOLOMBEK DA, 1994, NEUROREPORT, V5, P1638, DOI 10.1097/00001756-199408150-00024; Golombek DA, 2010, PHYSIOL REV, V90, P1063, DOI 10.1152/physrev.00009.2009; Gonzalez-Nunez V, 2009, ILAR J, V50, P373, DOI 10.1093/ilar.50.4.373; Graham DM, 2008, J NEUROPHYSIOL, V99, P2522, DOI 10.1152/jn.01066.2007; Hankins MW, 2008, TRENDS NEUROSCI, V31, P27, DOI 10.1016/j.tins.2007.11.002; Hardie RC, 2001, NATURE, V413, P186, DOI 10.1038/35093002; Hayashi Y, 1999, J BIOL CHEM, V274, P20597, DOI 10.1074/jbc.274.29.20597; Hess DT, 2005, NAT REV MOL CELL BIO, V6, P150, DOI 10.1038/nrm1569; Hirayama J, 2007, P NATL ACAD SCI USA, V104, P15747, DOI 10.1073/pnas.0705614104; Hirayama J, 2009, CELL CYCLE, V8, P2794, DOI 10.4161/cc.8.17.9447; Huang WY, 2011, J CLIN INVEST, V121, P2133, DOI 10.1172/JCI46043; Hughes S, 2012, PROG BRAIN RES, V199, P19, DOI 10.1016/B978-0-444-59427-3.00002-2; Idda ML, 2012, PROG BRAIN RES, V199, P41, DOI 10.1016/B978-0-444-59427-3.00003-4; Isoldi MC, 2005, P NATL ACAD SCI USA, V102, P1217, DOI 10.1073/pnas.0409252102; Jenkins A, 2003, CURR BIOL, V13, P1269, DOI 10.1016/S0960-9822(03)00509-8; Koyanagi M, 2014, BBA-BIOENERGETICS, V1837, P710, DOI 10.1016/j.bbabio.2013.09.003; Koyanagi M, 2013, P NATL ACAD SCI USA, V110, P4998, DOI 10.1073/pnas.1219416110; Krishna M, 2008, CELL MOL LIFE SCI, V65, P3525, DOI 10.1007/s00018-008-8170-7; Kumbalasiri T, 2007, PHOTOCHEM PHOTOBIOL, V83, P273, DOI 10.1562/2006-07-11-RA-964; Lima LHRG, 2006, BIOL RHYTHM RES, V37, P393, DOI 10.1080/09291010600870230; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lucas RJ, 2003, SCIENCE, V299, P245, DOI 10.1126/science.1077293; Martinez-Ruiz A, 2011, FREE RADICAL BIO MED, V51, P17, DOI 10.1016/j.freeradbiomed.2011.04.010; McCurley AT, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-102; Melo L, 1997, J BIOL RHYTHM, V12, P319, DOI 10.1177/074873049701200404; Melyan Z, 2005, NATURE, V433, P741, DOI 10.1038/nature03344; Moutsaki P, 2003, MOL BRAIN RES, V112, P135, DOI 10.1016/S0169-328X(03)00059-7; Mracek P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067858; Newman LA, 2003, BIOCHEMISTRY-US, V42, P12734, DOI 10.1021/bi035418z; NISHIZUKA Y, 1988, Biofactors, V1, P17; O'Neill JS, 2008, SCIENCE, V320, P949, DOI 10.1126/science.1152506; Obrietan K, 1998, NAT NEUROSCI, V1, P693, DOI 10.1038/3695; Obrietan K, 1999, J BIOL CHEM, V274, P17748, DOI 10.1074/jbc.274.25.17748; Okamura H, 2002, CELL TISSUE RES, V309, P47, DOI 10.1007/s00441-002-0572-5; Ozturk N, 2014, J BIOL CHEM, V289, P4634, DOI 10.1074/jbc.M113.542498; Panda S, 2002, CELL, V109, P307, DOI 10.1016/S0092-8674(02)00722-5; Panda S, 2005, SCIENCE, V307, P600, DOI 10.1126/science.1105121; Panda S, 2003, SCIENCE, V301, P525, DOI 10.1126/science.1086179; Pando MP, 2002, CELL, V110, P107, DOI 10.1016/S0092-8674(02)00803-6; Patten SA, 2007, INT J DEV NEUROSCI, V25, P155, DOI 10.1016/j.ijdevneu.2007.02.003; Peirson SN, 2007, CURR BIOL, V17, P1363, DOI 10.1016/j.cub.2007.07.045; PITTENDRIGH CS, 1993, ANNU REV PHYSIOL, V55, P16; Pizzio GA, 2003, NEUROREPORT, V14, P1417, DOI 10.1097/00001756-200308060-00002; Plautz JD, 1997, SCIENCE, V278, P1632, DOI 10.1126/science.278.5343.1632; PROSSER RA, 1991, BRAIN RES, V568, P185, DOI 10.1016/0006-8993(91)91396-I; PROSSER RA, 1989, J NEUROSCI, V9, P1073; Provencio I, 2002, NATURE, V415, P493, DOI 10.1038/415493a; Provencio I, 1998, P NATL ACAD SCI USA, V95, P340, DOI 10.1073/pnas.95.1.340; Qiu XD, 2005, NATURE, V433, P745, DOI 10.1038/nature03345; Rollag MD, 2000, METHOD ENZYMOL, V316, P291; Ruby NF, 2002, SCIENCE, V298, P2211, DOI 10.1126/science.1076701; Sekaran S, 2003, CURR BIOL, V13, P1290, DOI 10.1016/S0960-9822(03)00510-4; Shearman LP, 2000, SCIENCE, V288, P1013, DOI 10.1126/science.288.5468.1013; Stokkan KA, 2001, SCIENCE, V291, P490, DOI 10.1126/science.291.5503.490; Tamai TK, 2007, P NATL ACAD SCI USA, V104, P14712, DOI 10.1073/pnas.0704588104; Tamai TK, 2005, BIOCHEM SOC T, V33, P962, DOI 10.1042/BST0330962; Tomonari S, 2007, GENE EXPR PATTERNS, V7, P746, DOI 10.1016/j.modgep.2007.06.001; Uchida Y, 2010, BIOL PHARM BULL, V33, P535, DOI 10.1248/bpb.33.535; Vatine G, 2011, FEBS LETT, V585, P1485, DOI 10.1016/j.febslet.2011.04.007; WATANABE A, 1995, NEUROSCI LETT, V192, P25, DOI 10.1016/0304-3940(95)11599-R; Whitmore D, 2000, NATURE, V404, P87, DOI 10.1038/35003589; Yun HY, 1998, P NATL ACAD SCI USA, V95, P5773, DOI 10.1073/pnas.95.10.5773; Zhang EE, 2010, NAT REV MOL CELL BIO, V11, P764, DOI 10.1038/nrm2995; Zhu LJ, 2005, ANAL BIOCHEM, V345, P102, DOI 10.1016/j.ab.2005.07.028; Ziv L, 2006, CHRONOBIOL INT, V23, P101, DOI 10.1080/07420520500464551	102	25	25	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 3	2014	9	9							e106252	10.1371/journal.pone.0106252	http://dx.doi.org/10.1371/journal.pone.0106252			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3TB	25184495	Green Published, gold, Green Submitted			2022-12-27	WOS:000341257700044
J	Renna, NF; Diez, EA; Miatello, RM				Renna, Nicolas F.; Diez, Emiliano A.; Miatello, Roberto M.			Effects of Dipeptidyl-Peptidase 4 Inhibitor about Vascular Inflammation in a Metabolic Syndrome Model	PLOS ONE			English	Article							GLUCAGON-LIKE PEPTIDE-1; ENDOTHELIAL FUNCTION; RELAXATION; RECEPTOR; GLUCOSE; MUSCLE; ARTERY; GLP-1; DPP-4	Background: In this study, we used vidagliptin(V) to examine the role of the DDP-IV, incretin system component, in the activation of different molecular inflammatory cytokines, NF-kB and VCAM-1 to generate a microenvironment that supports cardiovascular remodeling. Methods: Male WKY and SHR were separated into five groups: Control, FFR: WKY rats receiving a 10% (w/v) fructose solution during all 12 weeks, SHR, FFHR: SHR receiving a 10% (w/v) fructose solution during all 12 weeks and FFHR+V: (5 mg/kg per day for 6 weeks) (n = 8 each group). Metabolic variables and systolic blood pressure were measured. The TBRAS, eNOS activity, and NAD(P) H oxidase activity were estimated to evaluate oxidative stress. Cardiac and vascular remodeling were evaluated. To assess the cytokine, NF-kB and VCAM-1 immunostaining techniques were used. Results: The FFHR experimental model presents metabolic syndrome criteria, vascular and cardiac remodeling, vascular inflammation due to increased expression of NF-kB, VCAM-1, and pro-atherogenic cytokines. Chronic treatment with V was able to reverse total or partiality of variables studied. Conclusions: Data demonstrated an important effect of DDP-IV in reducing vascular inflammation, accompanied by a favorable reduction in metabolic and structural parameters.	[Renna, Nicolas F.; Miatello, Roberto M.] Natl Univ Cuyo, Sch Med, Dept Pathol, Mendoza, Argentina; [Renna, Nicolas F.; Diez, Emiliano A.; Miatello, Roberto M.] Consejo Nacl Invest Cient & Tecn, Lab Cardiovasc Physiopathol, Inst Expt Med & Biol Cuyo IMBECU, Mendoza, Argentina	University Nacional Cuyo Mendoza; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)	Renna, NF (corresponding author), Natl Univ Cuyo, Sch Med, Dept Pathol, Mendoza, Argentina.	nicolasrenna@fcm.uncu.edu.ar		Diez, Emiliano/0000-0001-5163-3703	Consejo Nacional de Investigaciones Cientificas y Tecnicas	Consejo Nacional de Investigaciones Cientificas y Tecnicas(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET))	This work was supported by Consejo Nacional de Investigaciones Cientificas y Tecnicas (http://www.conicet.gov.ar). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahren B, 2004, J CLIN ENDOCR METAB, V89, P2078, DOI 10.1210/jc.2003-031907; Ban K, 2008, CIRCULATION, V117, P2340, DOI 10.1161/CIRCULATIONAHA.107.739938; Barnett A, 2006, INT J CLIN PRACT, V60, P1454, DOI 10.1111/j.1742-1241.2006.01178.x; Basu A, 2007, AM J PHYSIOL-ENDOC M, V293, pE1289, DOI 10.1152/ajpendo.00373.2007; Carretero OA, 2000, CIRCULATION, V101, P329, DOI 10.1161/01.CIR.101.3.329; Dong AL, 2011, P NATL ACAD SCI USA, V108, P14614, DOI 10.1073/pnas.1012859108; Drucker DJ, 2006, LANCET, V368, P1696, DOI 10.1016/S0140-6736(06)69705-5; Fleming I, 1999, CARDIOVASC RES, V43, P532, DOI 10.1016/S0008-6363(99)00094-2; FURCHGOTT RF, 1980, NATURE, V288, P373, DOI 10.1038/288373a0; IGNARRO LJ, 1987, CIRC RES, V61, P866, DOI 10.1161/01.RES.61.6.866; KEANEY JF, 1993, P NATL ACAD SCI USA, V90, P11880, DOI 10.1073/pnas.90.24.11880; Michel JB, 1997, J BIOL CHEM, V272, P25907, DOI 10.1074/jbc.272.41.25907; Muniyappa R, 2007, ENDOCR REV, V28, P463, DOI 10.1210/er.2007-0006; Nikolaidis LA, 2004, CIRCULATION, V109, P962, DOI 10.1161/01.CIR.0000120505.91348.58; Nystrom T, 2004, AM J PHYSIOL-ENDOC M, V287, pE1209, DOI 10.1152/ajpendo.00237.2004; Panchapakesan U, 2013, CLIN SCI, V124, P17, DOI 10.1042/CS20120167; Peairs AD, 2011, NUTR J, V10, DOI 10.1186/1475-2891-10-122; Renna N, 2012, HDB METABOLIC SYNDRO; Renna N F, 2013, Int J Hypertens, V2013, P420979, DOI 10.1155/2013/420979; Renna Nicolas F, 2013, Int J Hypertens, V2013, P808353, DOI 10.1155/2013/808353; Renna NF, 2013, MEDIAT INFLAMM, V2013, DOI 10.1155/2013/513251; Renna NF, 2009, CLIN EXP PHARMACOL P, V36, P162, DOI 10.1111/j.1440-1681.2008.05042.x; Shah Z, 2011, CIRCULATION, V124, P2339, DOI 10.1161/CIRCULATIONAHA.111.041418; Siegel David, 2007, Metabolic Syndrome and Related Disorders, V5, P211, DOI 10.1089/met.2007.0016; Timper K, 2013, AM J PHYSIOL-ENDOC M, V1, P304; Ussher JR, 2012, ENDOCR REV, V33, P187, DOI 10.1210/er.2011-1052; Valerio A, 2006, J CLIN INVEST, V116, P2791, DOI [10.1172/JCI28570, 10.1172/JCI28570.]; Vilsboll T, 2003, J CLIN ENDOCR METAB, V88, P4897, DOI 10.1210/jc.2003-030738; Vomhof-DeKrey EE, 2012, FREE RADICAL BIO MED, V53, P690, DOI 10.1016/j.freeradbiomed.2012.05.047	29	7	7	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 3	2014	9	9							e106563	10.1371/journal.pone.0106563	http://dx.doi.org/10.1371/journal.pone.0106563			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3TB	25184237	Green Published, gold, Green Submitted			2022-12-27	WOS:000341257700088
J	Wang, F; Long, GW; Zhao, CX; Li, HP; Chaugai, S; Wang, Y; Chen, C; Wang, DW				Wang, Feng; Long, Guangwen; Zhao, Chunxia; Li, Huaping; Chaugai, Sandip; Wang, Yan; Chen, Chen; Wang, Dao Wen			Atherosclerosis-Related Circulating miRNAs as Novel and Sensitive Predictors for Acute Myocardial Infarction	PLOS ONE			English	Article							TROPONIN-T; MICRORNAS; BIOMARKERS; SERUM; PLASMA; EXPRESSION; DISEASE; CANCER	Background: The dysregulated expressions of circulating miRNAs have been detected in various cardiovascular diseases. In our previous experiments, the altered expressions of circulating miRNA-21-5p, miRNA-361-5p and miRNA-519e-5p were confirmed in patients with coronary atherosclerosis by miRNA microarrays. However, the expression levels of these circulating miRNAs in the early phase of acute myocardial infarction (AMI) are still unknown. In the present study, our aims were to examine the expressions of circulating miR-21-5p, miR-361-5p and miR-519e-5p in AMI patients, and assess their clinical applications for diagnosing and monitoring AMI. Results: Two different cohorts were enrolled in this study. The first cohort included 17 AMI patients and 28 healthy volunteers, and the second cohort included 9 AMI patients, 9 ischemic stroke patients, 8 patients with pulmonary embolism, and 12 healthy volunteers. Quantitative real-time PCR and ELISA assays were preformed to detect the concentrations of plasma miRNAs and cardiac troponin I (cTnI), respectively. The results showed that the plasma levels of miR-21-5p and miR-361-5p were significantly increased in AMI patients, whereas the concentration of circulating miR-519e-5p was reduced. Interestingly, the levels of these circulating miRNAs correlated with the concentrations of plasma cTnI. Receiver operating characteristic (ROC) analysis revealed that these three circulating miRNAs had considerable diagnostic accuracy for AMI with high values of area under ROC curve (AUC). Importantly, combining the three miRNAs significantly increased the diagnostic accuracy. Furthermore, cell experiments demonstrated that these plasma miRNAs may originate from injured cardiomyocytes induced by hypoxia. In addition, the levels of all the three circulating miRNAs in ischemic stroke (IS) and pulmonary embolism (PE) were elevated, whereas the decreased level of plasma miR-519e-5p was only detected in AMI. ROC analysis demonstrated that circulating miR-519e-5p may be a useful biomarker for distinguishing AMI from other ischemic diseases. Conclusions: Circulating miRNAs may be novel and powerful biomarkers for AMI and they could be potential diagnostic tool for AMI.	[Chen, Chen] Huazhong Univ Sci & Technol, Inst Hypertens, Wuhan 430074, Peoples R China; Huazhong Univ Sci & Technol, Tongji Med Coll, Tongji Hosp, Dept Internal Med, Wuhan 430074, Peoples R China	Huazhong University of Science & Technology; Huazhong University of Science & Technology	Chen, C (corresponding author), Huazhong Univ Sci & Technol, Inst Hypertens, Wuhan 430074, Peoples R China.	chenchen@tjh.tjmu.edu.cn	, Chen/R-4321-2019	chunxia, Zhao/0000-0001-6134-4251; , Chen/0000-0001-5080-9383	National Natural Science Foundation of China [31200594, 81070236]; Research Fund for the Doctoral Program of Higher Education of China [20120142120056]; Ministry of Health of the People's Republic of China; Key Project from Hubei Province [JX6A02]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Research Fund for the Doctoral Program of Higher Education of China(Research Fund for the Doctoral Program of Higher Education of China (RFDP)Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); Ministry of Health of the People's Republic of China; Key Project from Hubei Province	This work was supported by grant from the National Natural Science Foundation of China (No. 31200594 and No. 81070236), Research Fund for the Doctoral Program of Higher Education of China (No. 20120142120056), Key Project of Ministry of Health of the People's Republic of China and Key Project from Hubei Province (JX6A02). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbas NA, 2005, CLIN CHEM, V51, P2059, DOI 10.1373/clinchem.2005.055665; Adachi T, 2010, CLIN CHEM, V56, P1183, DOI 10.1373/clinchem.2010.144121; Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Boeckel JN, 2013, CLIN CHEM, V59, P1125, DOI 10.1373/clinchem.2012.199505; Brase JC, 2011, INT J CANCER, V128, P608, DOI 10.1002/ijc.25376; Cheng YH, 2010, J CARDIOVASC TRANSL, V3, P251, DOI 10.1007/s12265-010-9169-7; Creemers EE, 2012, CIRC RES, V110, P483, DOI 10.1161/CIRCRESAHA.111.247452; Cui LB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027071; D'Alessandra Y, 2010, EUR HEART J, V31, P2765, DOI 10.1093/eurheartj/ehq167; DEWINTER RJ, 1995, CIRCULATION, V92, P3401, DOI 10.1161/01.CIR.92.12.3401; Dong SM, 2009, J BIOL CHEM, V284, P29514, DOI 10.1074/jbc.M109.027896; Fichtlscherer S, 2010, CIRC RES, V107, P677, DOI 10.1161/CIRCRESAHA.109.215566; Finn NA, 2013, FEBS LETT; Finsterer J, 2007, NETH J MED, V65, P289; Gilad S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003148; Gupta SK, 2010, CIRC-CARDIOVASC GENE, V3, P484, DOI 10.1161/CIRCGENETICS.110.958363; Jaffe AS, 2000, CIRCULATION, V102, P1216, DOI 10.1161/01.CIR.102.11.1216; Jickling GC, 2011, NEUROTHERAPEUTICS, V8, P349, DOI 10.1007/s13311-011-0050-4; Kanitz A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049568; Kotlabova K, 2011, J REPROD IMMUNOL, V89, P185, DOI 10.1016/j.jri.2011.02.006; Kroh EM, 2010, METHODS, V50, P298, DOI 10.1016/j.ymeth.2010.01.032; Kumarswamy R, 2011, RNA BIOL, V8, P706, DOI 10.4161/rna.8.5.16154; Kuwabara Y, 2011, CIRC-CARDIOVASC GENE, V4, P446, DOI 10.1161/CIRCGENETICS.110.958975; Lawrie CH, 2008, BRIT J HAEMATOL, V141, P672, DOI 10.1111/j.1365-2141.2008.07077.x; Li SQ, 2011, CIRCULATION, V124, P175, DOI 10.1161/CIRCULATIONAHA.110.012237; Liu DC, 2014, BIOCHEM BIOPH RES CO, V445, P151, DOI 10.1016/j.bbrc.2014.01.140; Long GW, 2012, INT J BIOL SCI, V8, P811, DOI 10.7150/ijbs.4439; Mitchell PS, 2008, P NATL ACAD SCI USA, V105, P10513, DOI 10.1073/pnas.0804549105; Mouillet JF, 2010, PLACENTA, V31, P781, DOI 10.1016/j.placenta.2010.07.001; Oerlemans MIFJ, 2012, EMBO MOL MED, V4, P1176, DOI 10.1002/emmm.201201749; Plasterk RHA, 2006, CELL, V124, P877, DOI 10.1016/j.cell.2006.02.030; Rhodes CJ, 2013, AM J RESP CRIT CARE, V187, P294, DOI 10.1164/rccm.201205-0839OC; Rosjo H, 2011, INTENS CARE MED, V37, P77, DOI 10.1007/s00134-010-2051-x; SCHWABBAUER ML, 1975, AM J MED TECHNOL, V41, P457; Shi WT, 2012, J PSYCHIATR RES, V46, P198, DOI 10.1016/j.jpsychires.2011.09.010; Thygesen K, 2012, CIRCULATION, V126, P2020, DOI 10.1161/CIR.0b013e31826e1058; Tijsen AJ, 2010, CIRC RES, V106, P1035, DOI 10.1161/CIRCRESAHA.110.218297; van Rooij E, 2008, P NATL ACAD SCI USA, V105, P13027, DOI 10.1073/pnas.0805038105; Vickers KC, 2011, NAT CELL BIOL, V13, P423, DOI 10.1038/ncb2210; Wang F, 2013, J TRANSL MED, V11, DOI 10.1186/1479-5876-11-222; Wang GK, 2010, EUR HEART J, V31, P659, DOI 10.1093/eurheartj/ehq013; White HD, 2008, LANCET, V372, P570, DOI 10.1016/S0140-6736(08)61237-4; Zampetaki A, 2012, J AM COLL CARDIOL, V60, P290, DOI 10.1016/j.jacc.2012.03.056; Zhang YJ, 2010, MOL CELL, V39, P133, DOI 10.1016/j.molcel.2010.06.010	45	57	64	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 3	2014	9	9							e105734	10.1371/journal.pone.0105734	http://dx.doi.org/10.1371/journal.pone.0105734			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3TB	25184815	gold, Green Published, Green Submitted			2022-12-27	WOS:000341257700024
J	Bijos, DA; Drake, MJ; Vahabi, B				Bijos, Dominika A.; Drake, Marcus J.; Vahabi, Bahareh			Anoctamin-1 in the Juvenile Rat Urinary Bladder	PLOS ONE			English	Article							ACTIVATED CHLORIDE CHANNELS; GUINEA-PIG BLADDER; INTERSTITIAL-CELLS; SMOOTH-MUSCLE; CL-CHANNELS; EXPRESSION; DETRUSOR; IDENTIFICATION; LOCALIZATION; CONTRACTIONS	Purpose: To investigate presence, location and functional role of calcium-activated chloride channel (CaCC) Anoctamin-1 (Ano1) in rat urinary bladder. Materials and Methods: Bladders from 3 week old 1Wistar rats were studied. End-point PCR on total mRNA was used to assess the expression of Ano1. Immunofluorescent labelling of whole mount bladder tissue imaged with confocal microscope allowed localization of Ano1 and vimentin immunopositive cells. The effects of CaCC blockers: niflumic acid (NFA) (3,10,30 mu M) and 5-Nitro-2-(3-phenylpropylamino)benzoic acid (NPPB) (10, 30 mu M) on spontaneous phasic contractile activity of intact (with mucosa) and denuded (without mucosa) detrusor strips were measured under isometric tension in organ baths (n = 141, N = 60). Results: Ano1 expression was found at mRNA level in mucosa and detrusor layers. Confocal microscopy revealed presence of Ano1 immunopositive cells in mucosa and in detrusor layers; a subpopulation of vimentin positive cells expressed Ano1. Both chloride channel blockers reduced the amplitude and frequency of phasic contractions in denuded and intact strips. Conclusions: Ano1 is expressed in rat urinary bladder and is present in cells sharing markers with interstitial cells. CaCC blockers reduced phasic activity of the bladder tissue. Ano1 is expressed in the bladder and plays a role in its spontaneous phasic contractile activity.	[Bijos, Dominika A.; Drake, Marcus J.] Univ Bristol, Sch Clin Sci, Bristol, Avon, England; [Bijos, Dominika A.; Drake, Marcus J.; Vahabi, Bahareh] North Bristol NHS Trust, Bristol Urol Inst, Bristol, Avon, England; [Vahabi, Bahareh] Univ W England, Dept Biol Biomed & Analyt Sci, Bristol BS16 1QY, Avon, England	University of Bristol; North Bristol NHS Trust; University of West England	Drake, MJ (corresponding author), Univ Bristol, Sch Clin Sci, Bristol, Avon, England.	Marcus.drake@nbt.nhs.uk	Drake, Marcus/C-4542-2014	Drake, Marcus/0000-0002-6230-2552	European Union Framework 7 Programme TRUST (Training Urological Scientists) Grant	European Union Framework 7 Programme TRUST (Training Urological Scientists) Grant	The research was funded by the European Union Framework 7 Programme TRUST (Training Urological Scientists) Grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balderas E, 2012, J CELL PHYSIOL, V227, P2542, DOI 10.1002/jcp.22992; Berg J, 2012, J CELL SCI, V125, P1367, DOI 10.1242/jcs.093260; Bijos D, 2012, NEUROUROL URODYNAM, V31, P1043; Davidson RA, 2005, J UROLOGY, V173, P1385, DOI 10.1097/01.ju.0000146272.80848.37; Drake MJ, 2003, EXP PHYSIOL, V88, P19, DOI 10.1113/eph8802473; Elble RC, 2002, J BIOL CHEM, V277, P18586, DOI 10.1074/jbc.M200829200; Finney SM, 2007, BJU INT, V100, P668, DOI 10.1111/j.1464-410X.2007.07021.x; Forrest AS, 2012, AM J PHYSIOL-CELL PH, V303, pC1229, DOI 10.1152/ajpcell.00044.2012; Gallos G, 2013, AM J PHYSIOL-LUNG C, V305, pL625, DOI 10.1152/ajplung.00068.2013; Gomez-Pinilla PJ, 2009, AM J PHYSIOL-GASTR L, V296, pG1370, DOI 10.1152/ajpgi.00074.2009; Hashitani H, 2004, J PHYSIOL-LONDON, V559, P567, DOI 10.1113/jphysiol.2004.065136; Hwang SJ, 2009, J PHYSIOL-LONDON, V587, P4887, DOI 10.1113/jphysiol.2009.176198; Imai T, 2001, ACTA PHYSIOL SCAND, V173, P323, DOI 10.1046/j.1365-201X.2001.00908.x; Johnston L, 2012, J CELL MOL MED, V16, P1533, DOI 10.1111/j.1582-4934.2011.01410.x; Kanai A, 2007, AM J PHYSIOL-RENAL, V292, pF1065, DOI 10.1152/ajprenal.00229.2006; Kanai A, 2014, NEUROUROL URODYN; Lam WP, 2014, INT UROL NEPHROL, V46, P349, DOI 10.1007/s11255-013-0550-8; Li L, 2008, ACTA PHARMACOL SIN, V29, P789, DOI 10.1111/j.1745-7254.2008.00803.x; Li LK, 2008, BJU INT, V101, P1588, DOI 10.1111/j.1464-410X.2008.07522.x; McCloskey KD, 2013, ACTA PHYSIOL, V207, P7, DOI 10.1111/apha.12009; McCloskey KD, 2010, NEUROUROL URODYNAM, V29, P82, DOI 10.1002/nau.20739; Monaghan KP, 2012, J UROLOGY, V188, P639, DOI 10.1016/j.juro.2012.03.117; Namkung W, 2011, J BIOL CHEM, V286, P2365, DOI 10.1074/jbc.M110.175109; Sancho M, 2012, AM J PHYSIOL-RENAL, V302, pF390, DOI 10.1152/ajprenal.00344.2011; Sanders KM, 2012, EXP PHYSIOL, V97, P200, DOI 10.1113/expphysiol.2011.058248; Sugaya K, 2000, AM J PHYSIOL-REG I, V278, pR238, DOI 10.1152/ajpregu.2000.278.1.R238; Szell EA, 2003, AM J PHYSIOL-REG I, V285, pR809, DOI 10.1152/ajpregu.00641.2002; Vahabi B, 2011, BJU INT, V107, P1480, DOI 10.1111/j.1464-410X.2010.09507.x; Wu C, 2004, J PHYSIOL-LONDON, V559, P231, DOI 10.1113/jphysiol.2004.067934; Yu WQ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048897	30	19	19	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2014	9	9							e106190	10.1371/journal.pone.0106190	http://dx.doi.org/10.1371/journal.pone.0106190			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3LR	25181534	Green Published, Green Submitted, gold			2022-12-27	WOS:000341231500057
J	Moldobaeva, A; Rentsendorj, O; Jenkins, J; Wagner, EM				Moldobaeva, Aigul; Rentsendorj, Otgonchimeg; Jenkins, John; Wagner, Elizabeth M.			Nitric Oxide Synthase Promotes Distension-Induced Tracheal Venular Leukocyte Adherence	PLOS ONE			English	Article							P-SELECTIN EXPRESSION; INDUCED LUNG INJURY; AIRWAY DISTENSION; ISCHEMIA-REPERFUSION; ENDOTHELIAL-CELLS; OXIDATIVE STRESS; SENSITIVE FACTOR; CYCLIC STRETCH; EXOCYTOSIS; PERMEABILITY	The process of leukocyte recruitment to the airways in real time has not been extensively studied, yet airway inflammation persists as a major contributor to lung pathology. We showed previously in vivo, that neutrophils are recruited acutely to the large airways after periods of airway distension imposed by the application of positive end-expiratory pressure (PEEP). Given extensive literature implicating products of nitric oxide synthase (NOS) in lung injury after ventilatory over-distension, we questioned whether similar mechanisms exist in airway post-capillary venules. Yet, endothelial nitric oxide has been shown to be largely anti-inflammatory in other systemic venules. Using intravital microscopy to visualize post-capillary tracheal venules in anesthetized, ventilated mice, the number of adherent leukocytes was significantly decreased in eNOS(-/-) mice under baseline conditions (2 +/- 1 cell/60 min observation) vs wild type (WT) C57BL/6 mice (7 +/- 2 cells). After exposure to PEEP (8 cmH(2)O for 1 min; 5 times), adherent cells increased significantly (29 +/- 5 cells) in WT mice while eNOS(-/-) mice demonstrated a significantly decreased number of adherent cells (11 +/- 4 cells) after PEEP. A similar response was seen when thrombin was used as the pro-inflammatory stimulus. In addition, mouse tracheal venular endothelial cells studied in vitro after exposure to cyclic stretch (18% elongation) or thrombin both demonstrated increased p-selectin expression that was significantly attenuated by N-G-nitro-L-arginine methyl ester, N-acetylcysteine amide (NACA) and excess BH4. In vivo treatment with the ROS inhibitor NACA or co-factor BH4 abolished completely the PEEP-induced leukocyte adherence. These results suggest that pro-inflammatory stimuli cause leukocyte recruitment to tracheal endothelium in part due to eNOS uncoupling.	[Moldobaeva, Aigul; Rentsendorj, Otgonchimeg; Jenkins, John; Wagner, Elizabeth M.] Johns Hopkins Univ, Dept Med, Baltimore, MD 21218 USA	Johns Hopkins University	Wagner, EM (corresponding author), Johns Hopkins Univ, Dept Med, Baltimore, MD 21218 USA.	wagnerem@jhmi.edu			National Institutes of Health, Heart, Lung, and Blood Institute [HL10342]; flow cytometry core, National Institutes of Health [P30AR053503]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL010342] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P30AR053503] Funding Source: NIH RePORTER	National Institutes of Health, Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); flow cytometry core, National Institutes of Health; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported by National Institutes of Health, Heart, Lung, and Blood Institute, HL10342 (Project 3-Wagner) and funding of the flow cytometry core, National Institutes of Health, P30AR053503 (Soloski). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amer J, 2008, BBA-GEN SUBJECTS, V1780, P249, DOI 10.1016/j.bbagen.2007.11.009; Birukov KG, 2003, AM J PHYSL LUNG CELL; DAVENPECK KL, 1994, GASTROENTEROLOGY, V107, P1050, DOI 10.1016/0016-5085(94)90229-1; Davidovich N, 2013, AM J RESP CELL MOL, V49, P156, DOI 10.1165/rcmb.2012-0252OC; Forstermann U, 2011, BRIT J PHARMACOL, V164, P213, DOI 10.1111/j.1476-5381.2010.01196.x; Forbes SP, 2013, ATHEROSCLEROSIS, V230, P23, DOI 10.1016/j.atherosclerosis.2013.06.002; Fulton D, 1999, NATURE, V399, P597, DOI 10.1038/21218; GAUTHIER TW, 1994, AM J PHYSIOL-GASTR L, V267, pG562, DOI 10.1152/ajpgi.1994.267.4.G562; Hu ZQ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071359; Ichimura H, 2003, J CLIN INVEST, V111, P691, DOI 10.1172/JCI200317271; Jones SP, 1999, AM J PHYSIOL-HEART C, V276, pH1567, DOI 10.1152/ajpheart.1999.276.5.H1567; KUBES P, 1991, P NATL ACAD SCI USA, V88, P4651, DOI 10.1073/pnas.88.11.4651; Kuebler WM, 2003, AM J RESP CRIT CARE, V168, P1391, DOI 10.1164/rccm.200304-562OC; Lim LHK, 2003, AM J RESP CRIT CARE, V168, P1068, DOI 10.1164/rccm.200207-690OC; Lowenstein CJ, 2005, TRENDS CARDIOVAS MED, V15, P302, DOI 10.1016/j.tcm.2005.09.005; Matsushita K, 2005, J CELL BIOL, V170, P73, DOI 10.1083/jcb.200502031; Matsushita K, 2003, CELL, V115, P139, DOI 10.1016/S0092-8674(03)00803-1; Matthay MA, 2012, J CLIN INVEST, V122, P2731, DOI 10.1172/JCI60331; MCDONALD DM, 1994, AM J PHYSIOL, V266, pL61, DOI 10.1152/ajplung.1994.266.1.L61; Moldobaeva A, 2008, AM J PHYSIOL-LUNG C, V295, pL941, DOI 10.1152/ajplung.90447.2008; Nickles HT, 2014, AM J PHYSIOL-LUNG C, V307, pL27, DOI 10.1152/ajplung.00288.2013; Rondaij MG, 2006, ARTERIOSCL THROM VAS, V26, P1002, DOI 10.1161/01.ATV.0000209501.56852.6c; Sanz MJ, 2001, BRIT J PHARMACOL, V134, P305, DOI 10.1038/sj.bjp.0704234; Stalker TJ, 2001, BRIT J PHARMACOL, V133, P406, DOI 10.1038/sj.bjp.0704070; Su Y, 2013, BIOCH PHARM; Takeda H, 2006, LIFE SCI, V79, P233, DOI 10.1016/j.lfs.2005.12.051; Tschumperlin DJ, 2000, AM J RESP CRIT CARE, V162, P357, DOI 10.1164/ajrccm.162.2.9807003; Vaporidi K, 2010, AM J PHYSIOL-LUNG C, V299, pL150, DOI 10.1152/ajplung.00341.2009; Wagner EM, 2007, J APPL PHYSIOL, V102, P1528, DOI 10.1152/japplphysiol.01054.2006; Ware LB, 2010, AM J PHYSIOL-LUNG C, V299, pL147, DOI 10.1152/ajplung.00179.2010; Yan JL, 2012, MOL MED, V18, P1220, DOI 10.2119/molmed.2011.00103.revised	31	3	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2014	9	9							e106092	10.1371/journal.pone.0106092	http://dx.doi.org/10.1371/journal.pone.0106092			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3LR	25181540	gold, Green Published, Green Submitted			2022-12-27	WOS:000341231500047
J	Robertson, SM; Medina, J; Lin, RL				Robertson, Scott M.; Medina, Jessica; Lin, Rueyling			Uncoupling Different Characteristics of the C. elegans E Lineage from Differentiation of Intestinal Markers	PLOS ONE			English	Article							NEMATODE CAENORHABDITIS-ELEGANS; DNA-BINDING DOMAIN; GATA FACTOR; RECIPROCAL ASYMMETRY; CELL-INTERACTIONS; SPECIFY ENDODERM; MAP KINASE; EMBRYOS; SPECIFICATION; GENE	In the 4-cell C. elegans embryo, a signal from P-2 to its anterior sister, EMS, specifies the posterior daughter of EMS, E, as the sole founder cell for intestine. The P-2-to-EMS signal restricts high level zygotic expression of the redundant GATA transcription factors, END-1 and END-3, to only the E lineage. Expression of END-1 or END-3 in early blastomeres is sufficient to drive intestinal differentiation. We show here that a number of E lineage characteristics, which are also regulated through P-2-EMS signaling, can be uncoupled from intestine development, and each with a different sensitivity to specific perturbations of the P-2-EMS signal. For example, we show that the extended cell cycle in Ea and Ep depends on the P-2-induced high level expression of the cell cycle regulator, WEE-1.1, in E. A mutation in wee-1.1 results in shortened Ea and Ep cell cycles, but has no effect upon intestinal differentiation or embryogenesis. Furthermore, it has been shown previously that the total number of E lineage cell divisions is regulated by a mechanism dependent upon E being specified as the intestinal founder cell. We now show, however, that cell division counting can be uncoupled from intestine differentiation in the E lineage. Many mutations in P-2-EMS signal genes exhibit nonfully-penetrant defects in intestinal differentiation. When embryos with those mutations generate intestinal cells, they often make too many intestinal cells. In addition, at the level of individual embryos, expression of end-1 and end-3, and another very early E-specific zygotic gene, sdz-23, exhibit stochastic and discordant defects in P-2-EMS signaling mutants. We show here that sdz-23 is expressed close to wildtype levels in embryos deleted of both end-1 and end-3. sdz-23 does not appear to function in intestine development, raising the intriguing possibility that the P-2-EMS interaction has downstream molecular consequences within the E lineage independent of end-1/3 and intestinal development.	[Robertson, Scott M.; Medina, Jessica; Lin, Rueyling] Univ Texas SW Med Ctr Dallas, Dept Mol Biol, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas	Robertson, SM (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Mol Biol, Dallas, TX 75390 USA.	scott.robertson@utsouthwestern.edu			National Institutes of Health Eunice Kennedy Shriver National Institute of Child Health and Human Development [R01HD037933]; National Institutes of Health, National Institute of General Medical Sciences [R01GM084198]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD037933] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM084198] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P40OD010440] Funding Source: NIH RePORTER	National Institutes of Health Eunice Kennedy Shriver National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); National Institutes of Health, National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	National Institutes of Health Eunice Kennedy Shriver National Institute of Child Health and Human Development Grant # R01HD037933 to RL (https://www.nichd.nih.gov/). National Institutes of Health, National Institute of General Medical Sciences Grant # R01GM084198 to RL (http://www.nigms.nih.gov/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atcha FA, 2007, MOL CELL BIOL, V27, P8352, DOI 10.1128/MCB.02132-06; Bei YX, 2002, DEV CELL, V3, P113, DOI 10.1016/S1534-5807(02)00185-5; Bhambhani C, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004133; BLACKWELL TK, 1994, SCIENCE, V266, P621, DOI 10.1126/science.7939715; Boeck ME, 2011, DEV BIOL, V358, P345, DOI 10.1016/j.ydbio.2011.08.002; BOWERMAN B, 1992, CELL, V68, P1061, DOI 10.1016/0092-8674(92)90078-Q; BOWERMAN B, 1992, DEVELOPMENT, V116, P1113; BRADY G, 1993, METHOD ENZYMOL, V225, P611; Broitman-Maduro G, 2005, DEV CELL, V8, P427, DOI 10.1016/j.devcel.2005.01.014; Calvo D, 2001, EMBO J, V20, P7197, DOI 10.1093/emboj/20.24.7197; Captan VV, 2007, GENETICS, V175, P969, DOI 10.1534/genetics.106.066662; Clucas C, 2002, EMBO J, V21, P665, DOI 10.1093/emboj/21.4.665; DEPPE U, 1978, P NATL ACAD SCI USA, V75, P376, DOI 10.1073/pnas.75.1.376; Fukuyama M, 2003, DEV BIOL, V260, P273, DOI 10.1016/S0012-1606(03)00239-2; GOLDSTEIN B, 1993, DEVELOPMENT, V118, P1267; GOLDSTEIN B, 1995, DEVELOPMENT, V121, P1227; GOLDSTEIN B, 1992, NATURE, V357, P255, DOI 10.1038/357255a0; Goszczynski B, 2005, GENETICS, V171, P545, DOI 10.1534/genetics.105.044909; Hebeisen M, 2008, DEVELOPMENT, V135, P1259, DOI 10.1242/dev.014969; Hermann GJ, 2000, DEVELOPMENT, V127, P3429; Huang SY, 2007, DEVELOPMENT, V134, P2685, DOI 10.1242/dev.008268; KEMPHUES KJ, 1988, CELL, V52, P311, DOI 10.1016/S0092-8674(88)80024-2; Korswagen HC, 2000, NATURE, V406, P527, DOI 10.1038/35020099; Kostic I, 2002, DEVELOPMENT, V129, P2155; LAUFER JS, 1980, CELL, V19, P569, DOI 10.1016/S0092-8674(80)80033-X; Lee JY, 2006, CURR BIOL, V16, P1986, DOI 10.1016/j.cub.2006.08.090; Leung B, 1999, DEV BIOL, V216, P114, DOI 10.1006/dbio.1999.9471; LIN RL, 1995, CELL, V83, P599, DOI 10.1016/0092-8674(95)90100-0; Lo MC, 2004, CELL, V117, P95, DOI 10.1016/S0092-8674(04)00203-X; Maduro MF, 2005, DEV BIOL, V284, P509, DOI 10.1016/j.ydbio.2005.05.016; Maduro MF, 2001, MOL CELL, V7, P475, DOI 10.1016/S1097-2765(01)00195-2; Maduro MF, 2007, DEV BIOL, V301, P590, DOI 10.1016/j.ydbio.2006.08.029; Maduro MF, 2010, DEV DYNAM, V239, P1315, DOI 10.1002/dvdy.22233; McGhee JD, 2013, WIRES DEV BIOL, V2, P347, DOI 10.1002/wdev.93; McGhee James D, 2007, WormBook, P1; Meneghini MD, 1999, NATURE, V399, P793, DOI 10.1038/21666; Owraghi M, 2010, DEV BIOL, V340, P209, DOI 10.1016/j.ydbio.2009.09.042; Phillips BT, 2007, P NATL ACAD SCI USA, V104, P3231, DOI 10.1073/pnas.0611507104; Raj A, 2010, NATURE, V463, P913, DOI 10.1038/nature08781; Robertson SM, 2011, DEV BIOL, V355, P115, DOI 10.1016/j.ydbio.2011.04.012; Robertson SM, 2000, DEVELOPMENT, V127, P2447; Robertson SM, 2004, DEV BIOL, V276, P493, DOI 10.1016/j.ydbio.2004.09.015; Rocheleau CE, 1997, CELL, V90, P707, DOI 10.1016/S0092-8674(00)80531-0; Rogers E, 2002, J CELL BIOL, V157, P219, DOI 10.1083/jcb.200110045; Sawyer JM, 2011, GENETICS, V188, P549, DOI 10.1534/genetics.111.129486; Schnabel R, 1997, DEV BIOL, V184, P234, DOI 10.1006/dbio.1997.8509; Shetty P, 2005, DEV BIOL, V285, P584, DOI 10.1016/j.ydbio.2005.07.008; Shin TH, 1999, MOL CELL, V4, P275, DOI 10.1016/S1097-2765(00)80375-5; SULSTON JE, 1983, DEV BIOL, V100, P64, DOI 10.1016/0012-1606(83)90201-4; Thorpe CJ, 1997, CELL, V90, P695, DOI 10.1016/S0092-8674(00)80530-9; Timmons L, 1998, NATURE, V395, P854, DOI 10.1038/27579; Wilson MA, 1999, BBA-GENE STRUCT EXPR, V1445, P99, DOI 10.1016/S0167-4781(99)00027-5; Zhu JW, 1998, GENE DEV, V12, P3809, DOI 10.1101/gad.12.24.3809; Zhu JW, 1997, GENE DEV, V11, P2883, DOI 10.1101/gad.11.21.2883	54	9	11	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2014	9	9							e106309	10.1371/journal.pone.0106309	http://dx.doi.org/10.1371/journal.pone.0106309			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3LR	25181289	Green Published, gold, Green Submitted			2022-12-27	WOS:000341231500074
J	Bo, V; Curtis, T; Lysenko, A; Saqi, M; Swift, S; Tucker, A				Bo, Valeria; Curtis, Tanya; Lysenko, Artem; Saqi, Mansoor; Swift, Stephen; Tucker, Allan			Discovering Study-Specific Gene Regulatory Networks	PLOS ONE			English	Article							COMBINING MULTIPLE MICROARRAY; GLYCERALDEHYDE-3-PHOSPHATE DEHYDROGENASE; BAYESIAN NETWORKS; PHOTOSYSTEM-I; PSI-K; EXPRESSION; ARABIDOPSIS; PROTEIN; SUBUNIT; COMPLEX	Microarrays are commonly used in biology because of their ability to simultaneously measure thousands of genes under different conditions. Due to their structure, typically containing a high amount of variables but far fewer samples, scalable network analysis techniques are often employed. In particular, consensus approaches have been recently used that combine multiple microarray studies in order to find networks that are more robust. The purpose of this paper, however, is to combine multiple microarray studies to automatically identify subnetworks that are distinctive to specific experimental conditions rather than common to them all. To better understand key regulatory mechanisms and how they change under different conditions, we derive unique networks from multiple independent networks built using glasso which goes beyond standard correlations. This involves calculating cluster prediction accuracies to detect the most predictive genes for a specific set of conditions. We differentiate between accuracies calculated using cross-validation within a selected cluster of studies (the intra prediction accuracy) and those calculated on a set of independent studies belonging to different study clusters (inter prediction accuracy). Finally, we compare our method's results to related state-of-the art techniques. We explore how the proposed pipeline performs on both synthetic data and real data (wheat and Fusarium). Our results show that subnetworks can be identified reliably that are specific to subsets of studies and that these networks reflect key mechanisms that are fundamental to the experimental conditions in each of those subsets.	[Bo, Valeria; Swift, Stephen; Tucker, Allan] Brunel Univ, Dept Informat Syst & Comp, London, England; [Curtis, Tanya; Lysenko, Artem; Saqi, Mansoor] Rothamsted Res, Harpenden, Herts, England	Brunel University; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Rothamsted Research	Bo, V (corresponding author), Brunel Univ, Dept Informat Syst & Comp, London, England.	Valeria.Bo@brunel.ac.uk	Swift, Stephen/AAE-6174-2020	Swift, Stephen/0000-0001-8918-3365; Lysenko, Artem/0000-0002-1441-0604; Tucker, Allan/0000-0001-5105-3506; Saqi, Mansoor/0000-0003-1222-475X	BBSRC [BBS/E/C/00005205, BB/I020918/1] Funding Source: UKRI	BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))		Alakwaa FM, 2011, THEOR BIOL MED MODEL, V8, DOI 10.1186/1742-4682-8-39; Andersson U, 2003, PLANT PHYSIOL, V132, P811, DOI 10.1104/pp.102.019281; Ando K, 2010, J AM SOC HORTIC SCI, V135, P291, DOI 10.21273/JASHS.135.4.291; Anvar SY, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-32; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Baalmann E, 1996, PLANT MOL BIOL, V32, P505, DOI 10.1007/BF00019102; Baek D, 2008, PHYTOCHEMISTRY, V69, P333, DOI 10.1016/j.phytochem.2007.07.027; Bang WY, 2008, PLANT CELL PHYSIOL, V49, P1350, DOI 10.1093/pcp/pcn111; Barabasi AL, 1999, SCIENCE, V286, P509, DOI 10.1126/science.286.5439.509; Beinlich IA, 1989, ALARM MONITORING SYS; Binder J., 1997, MACHINE LEARNING, V29; Bo V, 2013, LECT NOTES COMPUT SC, V8207, P104, DOI 10.1007/978-3-642-41398-8_10; Cheng Y, 2000, Proc Int Conf Intell Syst Mol Biol, V8, P93; Choi JK, 2003, BIOINFORMATICS, V19, pi84, DOI 10.1093/bioinformatics/btg1010; Damkjaer JT, 2009, PLANT CELL, V21, P3245, DOI 10.1105/tpc.108.064006; Dash S, 2012, NUCLEIC ACIDS RES, V40, pD1194, DOI 10.1093/nar/gkr938; Friedman J, 2008, BIOSTATISTICS, V9, P432, DOI 10.1093/biostatistics/kxm045; Friedman N, 2000, J COMPUT BIOL, V7, P601, DOI 10.1089/106652700750050961; Grigorova B, 2011, ACTA PHYSIOL PLANT, V33, P2041, DOI 10.1007/s11738-011-0733-9; Hartigan J. A., 1979, Applied Statistics, V28, P100, DOI 10.2307/2346830; HECKERMAN D, 1995, MACH LEARN, V20, P197, DOI 10.1007/BF00994016; Hojsgaard S, 2012, GRAPHICAL INDEPENDEN; Ihalainen JA, 2002, BIOPHYS J, V83, P2190, DOI 10.1016/S0006-3495(02)73979-9; Infanger S, 2011, MOL PLANT, V4, P252, DOI 10.1093/mp/ssq071; Irizarry RA, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng015; Jensen PE, 2000, J BIOL CHEM, V275, P24701, DOI 10.1074/jbc.M000550200; Kaiser S, 2009, BICLUST BICLUSTER AL; Kim YJ, 2010, J GINSENG RES, V34, P296, DOI 10.5142/jgr.2010.34.4.296; Kirk P, 2012, BIOINFORMATICS, V28, P3290, DOI 10.1093/bioinformatics/bts595; Kluger Y, 2003, GENOME RES, V13, P703, DOI 10.1101/gr.648603; Kwon Y, 2013, J EXP BOT, V64, P3911, DOI 10.1093/jxb/ert223; Langfelder P, 2012, J STAT SOFTWARE, V46; Langfelder P, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-559; Llorente F, 2002, PLANT J, V32, P13, DOI 10.1046/j.1365-313X.2002.01398.x; Lysenko A, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-203; Madeira SC, 2004, IEEE ACM T COMPUT BI, V1, P24, DOI 10.1109/TCBB.2004.2; Marri L, 2005, J EXP BOT, V56, P73, DOI 10.1093/jxb/eri020; Marri L, 2008, J BIOL CHEM, V283, P1831, DOI 10.1074/jbc.M705650200; Meinshausen N, 2006, ANN STAT, V34, P1436, DOI 10.1214/009053606000000281; Mochizuki N, 2001, P NATL ACAD SCI USA, V98, P2053, DOI 10.1073/pnas.98.4.2053; Murali T M, 2003, Pac Symp Biocomput, P77; Obayashi T, 2011, PLANT CELL PHYSIOL, V52, P213, DOI 10.1093/pcp/pcq203; Parkinson H, 2007, NUCLEIC ACIDS RES, V35, pD747, DOI 10.1093/nar/gkl995; Renyi A., 1959, PUBL MATH-DEBRECEN, V6, P290, DOI DOI 10.2307/1999405; Russell S.J., 2016, ARTIF INTELL; SAMAC DA, 1990, PLANT PHYSIOL, V93, P907, DOI 10.1104/pp.93.3.907; Scutari M, 2012, PACKAGE BNLEARN; Scutari M, 2010, J STAT SOFTW, V35, P1, DOI 10.18637/jss.v035.i03; Segal E, 2003, NAT GENET, V34, P166, DOI 10.1038/ng1165; Sengupta U, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008100; Spiegelhalter D. J., 1992, BAYESIAN STAT, V4, P447; SRINIVASAN R, 1995, PLANT PHYSIOL, V109, P161, DOI 10.1104/pp.109.1.161; Steele E, 2008, J BIOMED INFORM, V41, P914, DOI 10.1016/j.jbi.2008.01.011; Swift S, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-11-r94; Thimm O, 2004, PLANT J, V37, P914, DOI 10.1111/j.1365-313X.2004.02016.x; Wientjes E, 2011, BIOCHEM J, V433, P477, DOI 10.1042/BJ20101538; Zhang B, 2005, STAT APPL GENET MOL, V4, DOI 10.2202/1544-6115.1128; Zhang J, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002656; Zhang SP, 2004, J BIOL CHEM, V279, P3180, DOI 10.1074/jbc.M311640200	59	5	5	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2014	9	9							e106524	10.1371/journal.pone.0106524	http://dx.doi.org/10.1371/journal.pone.0106524			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ1IR	25191999	Green Published, Green Submitted, gold			2022-12-27	WOS:000347993600032
J	Dabravolski, A; Batenburg, KJ; Sijbers, J				Dabravolski, Andrei; Batenburg, Kees Joost; Sijbers, Jan			A Multiresolution Approach to Discrete Tomography Using DART	PLOS ONE			English	Article							ELECTRON TOMOGRAPHY; RECONSTRUCTION	In discrete tomography, a scanned object is assumed to consist of only a few different materials. This prior knowledge can be effectively exploited by a specialized discrete reconstruction algorithm such as the Discrete Algebraic Reconstruction Technique (DART), which is capable of providing more accurate reconstructions from limited data compared to conventional reconstruction algorithms. However, like most iterative reconstruction algorithms, DART suffers from long computation times. To increase the computational efficiency as well as the reconstruction quality of DART, a multiresolution version of DART (MDART) is proposed, in which the reconstruction starts on a coarse grid with big pixel (voxel) size. The resulting reconstruction is then resampled on a finer grid and used as an initial point for a subsequent DART reconstruction. This process continues until the target pixel size is reached. Experiments show that MDART can provide a significant speed-up, reduce missing wedge artefacts and improve feature reconstruction in the object compared with DART within the same time, making its use with large datasets more feasible.	[Dabravolski, Andrei; Batenburg, Kees Joost; Sijbers, Jan] Univ Antwerp, iMinds Vis lab, B-2020 Antwerp, Belgium; [Batenburg, Kees Joost] CWI, Amsterdam, Netherlands; [Batenburg, Kees Joost] Leiden Univ, Math Inst, Leiden, Netherlands	IMEC; University of Antwerp; Leiden University; Leiden University - Excl LUMC	Dabravolski, A (corresponding author), Univ Antwerp, iMinds Vis lab, B-2020 Antwerp, Belgium.	andrei.dabravolski@uantwerpen.be	Dabravolski, Andrei/G-3059-2014; Sijbers, Jan/H-4324-2015; Sijbers, Jan/A-5531-2012; Sijbers, Jan/C-4214-2011	Sijbers, Jan/0000-0003-4225-2487; Sijbers, Jan/0000-0003-4225-2487; Sijbers, Jan/0000-0003-4225-2487	BOF project from the University of Antwerp [25778]; SBO project TomFood from the Agency for Innovation by Science and Technology in Flanders (IWT); Netherlands Organisation for Scientific Research (NWO) [639.072.005]; EXTREMA COST Action [MP1207]	BOF project from the University of Antwerp; SBO project TomFood from the Agency for Innovation by Science and Technology in Flanders (IWT); Netherlands Organisation for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); EXTREMA COST Action	This work was financially supported by the BOF project 25778 from the University of Antwerp (www.uantwerp.be) and the SBO project TomFood from the Agency for Innovation by Science and Technology in Flanders (IWT, www.iwt.be). KJB was supported by the Netherlands Organisation for Scientific Research (NWO, www.nwo.nl), programme 639.072.005. Networking support was provided by the EXTREMA COST Action MP1207 (www.cost.eu). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Batenburg KJ, 2006, PROC SPIE, V6142, DOI 10.1117/12.652603; Batenburg KJ, 2009, ULTRAMICROSCOPY, V109, P730, DOI 10.1016/j.ultramic.2009.01.009; Batenburg KJ, 2011, IEEE T IMAGE PROCESS, V20, P2542, DOI 10.1109/TIP.2011.2131661; Brabant L, 2014, J X-RAY SCI TECHNOL, V22, P47, DOI 10.3233/XST-130408; Butala MD, 2010, SOL PHYS, V262, P495, DOI 10.1007/s11207-010-9536-1; Buzug T.M., 2008, COMPUTED TOMOGRAPHY; Fedrigo M, 2012, J X-RAY SCI TECHNOL, V20, P1, DOI 10.3233/XST-2012-0314; Gregor J, 2008, IEEE T MED IMAGING, V27, P918, DOI 10.1109/TMI.2008.923696; Maestre-Deusto FJ, 2011, IEEE T IMAGE PROCESS, V20, P2146, DOI 10.1109/TIP.2011.2114894; Joseph P M, 1982, IEEE Trans Med Imaging, V1, P192, DOI 10.1109/TMI.1982.4307572; Kuba A., 1999, DISCRETE TOMOGRAPHY; Maire E, 2014, INT MATER REV, V59, P1, DOI 10.1179/1743280413Y.0000000023; Masschaele B, 2013, J PHYS CONF SER, V463, DOI 10.1088/1742-6596/463/1/012012; Midgley PA, 2009, NAT MATER, V8, P271, DOI 10.1038/nmat2406; Nagy A, 2014, LECT NOTES COMPUT SC, V8466, P224, DOI 10.1007/978-3-319-07148-0_20; OTSU N, 1979, IEEE T SYST MAN CYB, V9, P62, DOI 10.1109/TSMC.1979.4310076; Palenstijn WJ, 2011, J STRUCT BIOL, V176, P250, DOI 10.1016/j.jsb.2011.07.017; Palenstijn W. J., 2013, 13 INT C COMP MATH M; Segers H, 2013, FUND INFORM, V125, P223, DOI 10.3233/FI-2013-861; Sidky EY, 2006, J X-RAY SCI TECHNOL, V14, P119; Stampanoni M., 2006, P SPIE, V6318; van Aarle W, 2014, IEEE T IMAGE PROCESS, V23, P1181, DOI 10.1109/TIP.2013.2297025; van Aarle W, 2012, IEEE T IMAGE PROCESS, V21, P4608, DOI 10.1109/TIP.2012.2206042; Varga L, 2011, GRAPH MODELS, V73, P365, DOI 10.1016/j.gmod.2011.06.006; Zurner A, 2012, ULTRAMICROSCOPY, V115, P41, DOI 10.1016/j.ultramic.2012.01.015	25	14	14	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2014	9	9							e106090	10.1371/journal.pone.0106090	http://dx.doi.org/10.1371/journal.pone.0106090			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ1IR	25192003	Green Submitted, Green Published, gold			2022-12-27	WOS:000347993600014
J	De Moura, DC; Bryksa, BC; Yada, RY				De Moura, Dref C.; Bryksa, Brian C.; Yada, Rickey Y.			In Silico Insights into Protein-Protein Interactions and Folding Dynamics of the Saposin-Like Domain of Solanum tuberosum Aspartic Protease	PLOS ONE			English	Article							MOLECULAR-DYNAMICS; CRYSTAL-STRUCTURE; FREE-ENERGY; FUSION; SIMULATION; GROMACS; FLOWERS; GENE	The plant-specific insert is an approximately 100-residue domain found exclusively within the C-terminal lobe of some plant aspartic proteases. Structurally, this domain is a member of the saposin-like protein family, and is involved in plant pathogen defense as well as vacuolar targeting of the parent protease molecule. Similar to other members of the saposin-like protein family, most notably saposins A and C, the recently resolved crystal structure of potato (Solanum tuberosum) plant-specific insert has been shown to exist in a substrate-bound open conformation in which the plant-specific insert oligomerizes to form homodimers. In addition to the open structure, a closed conformation also exists having the classic saposin fold of the saposin-like protein family as observed in the crystal structure of barley (Hordeum vulgare L.) plant-specific insert. In the present study, the mechanisms of tertiary and quaternary conformation changes of potato plant-specific insert were investigated in silico as a function of pH. Umbrella sampling and determination of the free energy change of dissociation of the plant-specific insert homodimer revealed that increasing the pH of the system to near physiological levels reduced the free energy barrier to dissociation. Furthermore, principal component analysis was used to characterize conformational changes at both acidic and neutral pH. The results indicated that the plant-specific insert may adopt a tertiary structure similar to the characteristic saposin fold and suggest a potential new structural motif among saposin-like proteins. To our knowledge, this acidified PSI structure presents the first example of an alternative saposin-fold motif for any member of the large and diverse SAPLIP family.	[De Moura, Dref C.; Yada, Rickey Y.] Univ Guelph, Biophys Interdepartmental Grp, Guelph, ON N1G 2W1, Canada; [De Moura, Dref C.; Bryksa, Brian C.; Yada, Rickey Y.] Univ Guelph, Dept Food Sci, Guelph, ON N1G 2W1, Canada	University of Guelph; University of Guelph	Yada, RY (corresponding author), Univ Guelph, Biophys Interdepartmental Grp, Guelph, ON N1G 2W1, Canada.	ryada@uoguelph.ca	Bryksa, Brian/A-8281-2013	Bryksa, Brian/0000-0001-5626-8012; Yada, Rickey/0000-0002-8648-2156	Natural Sciences and Engineering Research Council of Canada; Canada Research Chairs Program	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Canada Research Chairs Program(Canada Research Chairs)	This work was supported by the Natural Sciences and Engineering Research Council of Canada and the Canada Research Chairs Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn VE, 2003, P NATL ACAD SCI USA, V100, P38, DOI 10.1073/pnas.0136947100; Ahn VE, 2006, PROTEIN SCI, V15, P1849, DOI 10.1110/ps.062256606; AMADEI A, 1993, PROTEINS, V17, P412, DOI 10.1002/prot.340170408; Anandakrishnan R, 2012, NUCLEIC ACIDS RES, V40, pW537, DOI 10.1093/nar/gks375; Anderson DH, 2003, J MOL BIOL, V325, P355, DOI 10.1016/S0022-2836(02)01234-2; ASHKIN A, 1986, OPT LETT, V11, P288, DOI 10.1364/OL.11.000288; Baoukina S, 2011, BIOPHYS J, V100, P1678, DOI 10.1016/j.bpj.2011.02.019; Baoukina S, 2010, BIOPHYS J, V99, P2134, DOI 10.1016/j.bpj.2010.07.049; Barrett CP, 2004, ACTA CRYSTALLOGR D, V60, P2280, DOI 10.1107/S0907444904019171; Berendsen HJC, 2000, CURR OPIN STRUC BIOL, V10, P165, DOI 10.1016/S0959-440X(00)00061-0; BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; BINNIG G, 1986, PHYS REV LETT, V56, P930, DOI 10.1103/PhysRevLett.56.930; Bruhn H, 2005, BIOCHEM J, V389, P249, DOI 10.1042/BJ20050051; Bryksa BC, 2011, J BIOL CHEM, V286, P28265, DOI 10.1074/jbc.M111.252619; Bussi G, 2007, J CHEM PHYS, V126, DOI 10.1063/1.2408420; Chen PC, 2011, BIOPHYS J, V100, P2466, DOI 10.1016/j.bpj.2011.03.052; CORDEIRO MC, 1994, PLANT MOL BIOL, V24, P733, DOI 10.1007/BF00029855; Cuendet MA, 2008, BIOPHYS J, V95, P3575, DOI 10.1529/biophysj.108.131383; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; DAVIES DR, 1990, ANNU REV BIOPHYS BIO, V19, P189, DOI 10.1146/annurev.bb.19.060190.001201; de Alba E, 2003, BIOCHEMISTRY-US, V42, P14729, DOI 10.1021/bi0301338; Egas C, 2000, J BIOL CHEM, V275, P38190, DOI 10.1074/jbc.M006093200; Fiser A, 2000, PROTEIN SCI, V9, P1753, DOI 10.1110/ps.9.9.1753; Frazao C, 1999, J BIOL CHEM, V274, P27694, DOI 10.1074/jbc.274.39.27694; Gonzalez A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023815; Gordon JC, 2005, NUCLEIC ACIDS RES, V33, pW368, DOI 10.1093/nar/gki464; Guevara MG, 2004, J PLANT PATHOL, V86, P233; GURUPRASAD K, 1994, FEBS LETT, V352, P131, DOI 10.1016/0014-5793(94)00935-X; Hawkins CA, 2005, J MOL BIOL, V346, P1381, DOI 10.1016/j.jmb.2004.12.045; Hess B, 1997, J COMPUT CHEM, V18, P1463, DOI 10.1002/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H; Hess B, 2008, J CHEM THEORY COMPUT, V4, P435, DOI 10.1021/ct700301q; Izrailev S., 1999, COMPUTATIONAL MOL DY, P39, DOI DOI 10.1007/978-3-642-58360-5_2; JONGSTRA J, 1987, J EXP MED, V165, P601, DOI 10.1084/jem.165.3.601; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Kastner J, 2011, WIRES COMPUT MOL SCI, V1, P932, DOI 10.1002/wcms.66; Kalikka J, 2011, EUR BIOPHYS J BIOPHY, V40, P181, DOI 10.1007/s00249-010-0638-3; Kervinen J, 1999, EMBO J, V18, P3947, DOI 10.1093/emboj/18.14.3947; Kosztin I, 2006, J CHEM PHYS, V124, DOI 10.1063/1.2166379; KUMAR S, 1992, J COMPUT CHEM, V13, P1011, DOI 10.1002/jcc.540130812; Lemkul JA, 2010, J PHYS CHEM B, V114, P1652, DOI 10.1021/jp9110794; Li DW, 2010, ANGEW CHEM INT EDIT, V49, P6778, DOI 10.1002/anie.201001898; Liepinsh E, 1997, NAT STRUCT BIOL, V4, P793, DOI 10.1038/nsb1097-793; Lindorff-Larsen K, 2010, PROTEINS, V78, P1950, DOI 10.1002/prot.22711; Long D, 2011, BIOPHYS J, V101, P910, DOI 10.1016/j.bpj.2011.06.053; Matsuda J, 2001, HUM MOL GENET, V10, P1191, DOI 10.1093/hmg/10.11.1191; Mendieta JR, 2010, FITOTERAPIA, V81, P329, DOI 10.1016/j.fitote.2009.10.004; Myers J, 2006, PROTEINS, V63, P928, DOI 10.1002/prot.20922; NategholEslam M, 2011, PHYS REV E, V83, DOI 10.1103/PhysRevE.83.021114; NOSE S, 1983, MOL PHYS, V50, P1055, DOI 10.1080/00268978300102851; PARRINELLO M, 1981, J APPL PHYS, V52, P7182, DOI 10.1063/1.328693; Popovic K, 2012, P NATL ACAD SCI USA, V109, P2908, DOI 10.1073/pnas.1115743109; Pronk S, 2013, BIOINFORMATICS, V29, P845, DOI 10.1093/bioinformatics/btt055; Rawlings ND, 2010, NUCLEIC ACIDS RES, V38, pD227, DOI 10.1093/nar/gkp971; Rossmann M, 2008, STRUCTURE, V16, P809, DOI 10.1016/j.str.2008.02.016; ROUX B, 1995, COMPUT PHYS COMMUN, V91, P275, DOI 10.1016/0010-4655(95)00053-I; RUNEBERGROOS P, 1991, EUR J BIOCHEM, V202, P1021, DOI 10.1111/j.1432-1033.1991.tb16465.x; Simoes I, 2004, EUR J BIOCHEM, V271, P2067, DOI 10.1111/j.1432-1033.2004.04136.x; Sotomayor M, 2007, SCIENCE, V316, P1144, DOI 10.1126/science.1137591; TORMAKANGAS K, 1994, PLANTA, V195, P116, DOI 10.1007/BF00206299; Tormakangas K, 2001, PLANT CELL, V13, P2021, DOI 10.1105/tpc.13.9.2021; TORRIE GM, 1977, J COMPUT PHYS, V23, P187, DOI 10.1016/0021-9991(77)90121-8; VACCARO AM, 1994, FEBS LETT, V349, P181, DOI 10.1016/0014-5793(94)00659-8; Van der Spoel D, 2005, J COMPUT CHEM, V26, P1701, DOI 10.1002/jcc.20291; Wang Y, 2003, ARCH BIOCHEM BIOPHYS, V415, P43, DOI 10.1016/S0003-9861(03)00219-4; Webb Benjamin, 2016, Curr Protoc Protein Sci, V86, DOI [10.1002/cpbi.3, 10.1002/0471250953.bi0506s15, 10.1002/0471140864.ps0209s50, 10.1002/cpps.20]; West DK, 2006, BIOPHYS J, V90, P287, DOI 10.1529/biophysj.105.071035; Willis C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025369; Zhang BW, 2011, J AM CHEM SOC, V133, P19393, DOI 10.1021/ja2060066	68	14	14	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 4	2014	9	9							e104315	10.1371/journal.pone.0104315	http://dx.doi.org/10.1371/journal.pone.0104315			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3XV	25188221	Green Submitted, gold, Green Published			2022-12-27	WOS:000341271500002
J	Igland, J; Vollset, SE; Nygard, OK; Sulo, G; Ebbing, M; Tell, GS				Igland, Jannicke; Vollset, Stein Emil; Nygard, Ottar K.; Sulo, Gerhard; Ebbing, Marta; Tell, Grethe S.			Educational Inequalities in Acute Myocardial Infarction Incidence in Norway: A Nationwide Cohort Study	PLOS ONE			English	Article							CORONARY-HEART-DISEASE; SOCIOECONOMIC INEQUALITIES; CASE-FATALITY; MORTALITY; RISK; HEALTH; TRENDS; SWEDEN; WOMEN; MANAGEMENT	Background: Increasing differences in cardiovascular disease (CVD) mortality across levels of education have been reported in Norway. The aim of the study was to investigate educational inequalities in acute myocardial infarction (AMI) incidence and whether such inequalities have changed during the past decade using a nationwide longitudinal study design. Methods: Data on 141 332 incident (first) AMIs in Norway during 2001-2009 were obtained through the Cardiovascular Disease in Norway (CVDNOR) project. Educational inequalities in AMI incidence were assessed in terms of age-standardised incidence rates stratified on educational level, incidence rate ratios (IRR), relative index of inequality (RII) and slope index of inequality (SII). All calculations were conducted in four gender and age strata: Men and women aged 35-69 and 70-94 years. Results: AMI Incidence rates decreased during 2001-2009 for all educational levels except in women aged 35-69 among whom only those with basic education had a significant decrease. In all gender and age groups; those with the highest educational level had the lowest rates. The strongest relative difference was found among women aged 35-69, with IRR (95% CI) for basic versus tertiary education 3.04 (2.85-3.24)) and RII (95% CI) equal to 4.36 (4.03-4.71). The relative differences did not change during 2001-2009 in any of the four gender and age groups, but absolute inequalities measured as SII decreased among the oldest men and women. Conclusions: There are substantial educational inequalities in AMI incidence in Norway, especially for women aged 35-69. Relative inequalities did not change from 2001 to 2009.	[Igland, Jannicke; Vollset, Stein Emil; Sulo, Gerhard; Tell, Grethe S.] Univ Bergen, Dept Global Publ Hlth & Primary Care, Bergen, Norway; [Vollset, Stein Emil; Ebbing, Marta; Tell, Grethe S.] Norwegian Inst Publ Hlth, Dept Hlth Registries, Bergen, Norway; [Nygard, Ottar K.] Univ Bergen, Cardiol Sect, Dept Clin Sci, Bergen, Norway; [Nygard, Ottar K.] Haukeland Hosp, Dept Heart Dis, N-5021 Bergen, Norway	University of Bergen; Norwegian Institute of Public Health (NIPH); University of Bergen; University of Bergen; Haukeland University Hospital	Igland, J (corresponding author), Univ Bergen, Dept Global Publ Hlth & Primary Care, Bergen, Norway.	Jannicke.igland@igs.uib.no	Tell, Grethe/G-5639-2015	Tell, Grethe/0000-0003-1386-1638	University of Bergen	University of Bergen	This study was funded by a PhD scholarship from the University of Bergen. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alter DA, 2006, ANN INTERN MED, V144, P82, DOI 10.7326/0003-4819-144-2-200601170-00005; [Anonymous], 2011, ED GLANC 2011 OECD I; Baldi I, 2013, INT J CARDIOL; Capewell S, 2000, EUR HEART J, V21, P1833, DOI 10.1053/euhj.2000.2318; Clench-Aas J, 2005, METHODOLOGICAL DEV E; Davies CA, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-134; Ernstsen L, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-266; Ernstsen L, 2010, SCAND J PUBLIC HEALT, V38, P678, DOI 10.1177/1403494810380300; Gallo V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039013; Geyer S, 2006, J EPIDEMIOL COMMUN H, V60, P804, DOI 10.1136/jech.2005.041319; Goldman DP, 2002, P NATL ACAD SCI USA, V99, P10929, DOI 10.1073/pnas.162086599; Hallqvist J, 1998, INT J EPIDEMIOL, V27, P410, DOI 10.1093/ije/27.3.410; Huisman M, 2008, SOC SCI MED, V66, P2240, DOI 10.1016/j.socscimed.2008.01.049; Igland J, 2013, CARDIOVASCULAR DIS N; Kelly MP, 2007, SOCIAL DETERMINANTS; King NB, 2012, BMJ, V345; Kuper H, 2003, J EPIDEMIOL COMMUN H, V57, P147, DOI 10.1136/jech.57.2.147; Kuper H, 2006, AM J EPIDEMIOL, V164, P349, DOI 10.1093/aje/kwj212; Lammintausta A, 2012, ANN EPIDEMIOL, V22, P87, DOI 10.1016/j.annepidem.2011.10.012; Langorgen J, 2013, EUR J PREV CARDIOL; Langorgen J, 2009, EUR J CARDIOV PREV R, V16, P621, DOI 10.1097/HJR.0b013e32832e096b; Levi F, 2009, EUR J CARDIOV PREV R, V16, P333, DOI 10.1097/HJR.0b013e328325d67d; Mackenbach JP, 2008, NEW ENGL J MED, V358, P2468, DOI 10.1056/NEJMsa0707519; Mackenbach JP, 1997, SOC SCI MED, V44, P757, DOI 10.1016/S0277-9536(96)00073-1; Manrique-Garcia E, 2011, J EPIDEMIOL COMMUN H, V65, P301, DOI 10.1136/jech.2009.104075; McKee MM, 2012, J AM BOARD FAM MED, V25, P416, DOI 10.3122/jabfm.2012.04.110282; Moe JO, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-911; Morrison C, 1997, BMJ-BRIT MED J, V314, P541, DOI 10.1136/bmj.314.7080.541; OECD, 2005, ED GLANC 2005 OECD I; Peterson LM, 2012, PSYCHOL HEALTH, V27, P737, DOI 10.1080/08870446.2011.626856; Petrelli A, 2006, SOC SCI MED, V63, P446, DOI 10.1016/j.socscimed.2006.01.018; Qureshi Adnan I, 2003, Med Sci Monit, V9, pCR466; Rasmussen JN, 2006, J EPIDEMIOL COMMUN H, V60, P351, DOI 10.1136/jech.200X.040972; Rosengren A, 2009, HEART, V95, P2014, DOI 10.1136/hrt.2009.182436; Schmidt M., 2012, BMJ, V344, P356; Sergeant JC, 2006, BIOSTATISTICS, V7, P213, DOI 10.1093/biostatistics/kxj002; Shavers VL, 2007, J NATL MED ASSOC, V99, P1013; Statistics Norway, 2006, IND BAS ED STAT DOC; Statistics Norway, 2012, HLTH CAR SOC REL SUR; Strand BH, 2010, BRIT MED J, V340, DOI 10.1136/bmj.c654; Sulo G., 2013, Norsk Epidemiologi, V23, P101; Sulo G, 2013, EUR J PREV CARDIOL; Williams R, 2012, STATA J, V12, P308, DOI 10.1177/1536867X1201200209; Yang D, 2012, EUR J PREV CARDIOL, V19, P1304, DOI 10.1177/1741826711425340; Yarnell J, 2005, INT J EPIDEMIOL, V34, P268, DOI 10.1093/ije/dyh267	45	21	22	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 4	2014	9	9							e106898	10.1371/journal.pone.0106898	http://dx.doi.org/10.1371/journal.pone.0106898			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AO3XV	25188248	Green Published, gold, Green Submitted			2022-12-27	WOS:000341271500094
J	Medina-Navarro, R; Corona-Candelas, I; Barajas-Gonzalez, S; Diaz-Flores, M; Duran-Reyes, G				Medina-Navarro, Rafael; Corona-Candelas, Itzia; Barajas-Gonzalez, Saul; Diaz-Flores, Margarita; Duran-Reyes, Genoveva			Albumin Antioxidant Response to Stress in Diabetic Nephropathy Progression	PLOS ONE			English	Article							BOVINE SERUM-ALBUMIN; HUMAN PLASMA; ISOMERIZATION; REACTIVITY; MORTALITY; OXIDATION; LYSOZYME; GLUCOSE; BINDING	Background: A new component of the protein antioxidant capacity, designated Response Surplus (RS), was recently described. A major feature of this component is the close relationship between protein antioxidant capacity and molecular structure. Oxidative stress is associated with renal dysfunction in patients with renal failure, and plasma albumin is the target of massive oxidation in nephrotic syndrome and diabetic nephropathy. The aim of the present study was to explore the albumin redox state and the RS component of human albumin isolated from diabetic patients with progressive renal damage. Methods/Principal Findings: Serum aliquots were collected and albumin isolated from 125 diabetic patients divided into 5 groups according to their estimated glomerular filtration rate (GFR). In addition to clinical and biochemical variables, the albumin redox state, including antioxidant capacity, thiol group content, and RS component, were evaluated. The albumin antioxidant capacity and thiol group content were reciprocally related to the RS component in association with GFR reduction. The GFR decline and RS component were significantly negatively correlated (R = -0.83, p < 0.0001). Age, creatinine, thiol groups, and antioxidant capacity were also significantly related to the GFR decline (R = -0.47, p < 0.001; R = -0.68, p < 0.0001; R = 0.44, p < 0.001; and R = 0.72, p < 0.0001). Conclusion/Significance: The response of human albumin to stress in relation to the progression of diabetic renal disease was evaluated. The findings confirm that the albumin molecular structure is closely related to its redox state, and is a key factor in the progression of diabetes nephropathy.	[Medina-Navarro, Rafael] Ctr Biomed Res Michoacan CIBIMI, IMSS, Dept Expt Metab, Morelia, Michoacan, Mexico; [Corona-Candelas, Itzia; Barajas-Gonzalez, Saul] IMSS, Dept Nephrol, Morelia, Michoacan, Mexico; [Diaz-Flores, Margarita; Duran-Reyes, Genoveva] Natl Med Ctr, IMSS, Biochem Med Res Unit, Mexico City, DF, Mexico	Instituto Mexicano del Seguro Social	Medina-Navarro, R (corresponding author), Ctr Biomed Res Michoacan CIBIMI, IMSS, Dept Expt Metab, Morelia, Michoacan, Mexico.	cibimirmn@gmail.com		Medina-Navarro, Rafael/0000-0002-7183-6126; DIAZ-FLORES, MARGARITA/0000-0001-9764-2701	Consejo Nacional de Ciencia y Tecnologia (CONACYT) [SALUD-2010-01-141937/CONACYT- FIS/IMSS/PROT/896]; Fondo de Investigacion en Salud [FIS/IMSS/PROT/G10/854]	Consejo Nacional de Ciencia y Tecnologia (CONACYT)(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); Fondo de Investigacion en Salud	This study was supported by a grant from Consejo Nacional de Ciencia y Tecnologia (CONACYT) SALUD-2010-01-141937/CONACYT- FIS/IMSS/PROT/896 and a grant from the Fondo de Investigacion en Salud FIS/IMSS/PROT/G10/854. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Diabetes Association, 2013, DIABETES CARE S1, V36, pS12, DOI DOI 10.2337/DC12-1218; Anraku M, 2013, BBA-GEN SUBJECTS, V1830, P5465, DOI 10.1016/j.bbagen.2013.04.036; Barzegar A, 2007, PROTEIN PEPTIDE LETT, V14, P13, DOI 10.2174/092986607779117191; Bourdon E, 1999, FASEB J, V13, P233, DOI 10.1096/fasebj.13.2.233; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Candiano G, 2009, J PROTEOMICS, V73, P188, DOI 10.1016/j.jprot.2009.06.006; COCKCROFT DW, 1976, NEPHRON, V16, P31, DOI 10.1159/000180580; Coussons PJ, 1997, FREE RADICAL BIO MED, V22, P1217, DOI 10.1016/S0891-5849(96)00557-6; EFTINK MR, 1981, ANAL BIOCHEM, V114, P199, DOI 10.1016/0003-2697(81)90474-7; Faure P, 2005, DIABETES METAB, V31, P169, DOI 10.1016/S1262-3636(07)70183-0; Gabaldon M, 2002, INT J BIOL MACROMOL, V30, P259, DOI 10.1016/S0141-8130(02)00040-5; Gabaldon M, 2009, INT J BIOL MACROMOL, V44, P43, DOI 10.1016/j.ijbiomac.2008.09.020; Goldwasser P, 1997, J CLIN EPIDEMIOL, V50, P693, DOI 10.1016/S0895-4356(97)00015-2; Halliwell B, 1996, ANNU REV NUTR, V16, P33, DOI 10.1146/annurev.nu.16.070196.000341; ISEKI K, 1993, KIDNEY INT, V44, P115, DOI 10.1038/ki.1993.220; KALYANARAMAN B, 1985, J BIOL CHEM, V260, P4003; Kawakami A, 2006, FEBS J, V273, P3346, DOI 10.1111/j.1742-4658.2006.05341.x; Khodarahmi R, 2012, SPECTROCHIM ACTA A, V89, P177, DOI 10.1016/j.saa.2011.12.058; Kouoh F, 1999, FARMACO, V54, P695, DOI 10.1016/S0014-827X(99)00082-8; Lamprecht M, 2018, J APPL PHYSL, V104, P1611; Lim PS, 2007, NEPHROLOGY, V12, P18, DOI 10.1111/j.1440-1797.2006.00745.x; Medina-Navarro R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008971; MORENO SNJ, 1988, ARCH BIOCHEM BIOPHYS, V265, P267, DOI 10.1016/0003-9861(88)90127-0; Musante L, 2006, BIOCHEM BIOPH RES CO, V349, P668, DOI 10.1016/j.bbrc.2006.08.079; Otagiri M, 2009, BIOL PHARM BULL, V32, P527, DOI 10.1248/bpb.32.527; OWEN WF, 1993, NEW ENGL J MED, V329, P1001, DOI 10.1056/NEJM199309303291404; PETERMAN BF, 1980, ARCH BIOCHEM BIOPHYS, V199, P158, DOI 10.1016/0003-9861(80)90268-4; PHILLIPS A, 1989, LANCET, V2, P1434; Pierce A, 2006, BIOCHEMISTRY-US, V45, P3077, DOI 10.1021/bi052031i; Riener CK, 2002, ANAL BIOANAL CHEM, V373, P266, DOI 10.1007/s00216-002-1347-2; Roche M, 2008, FEBS LETT, V582, P1783, DOI 10.1016/j.febslet.2008.04.057; Shaw AK, 2008, J PHOTOCH PHOTOBIO B, V90, P69, DOI 10.1016/j.jphotobiol.2007.11.003; SMITHIES O, 1965, SCIENCE, V150, P1595, DOI 10.1126/science.150.3703.1595; SORIANI M, 1994, ARCH BIOCHEM BIOPHYS, V312, P180, DOI 10.1006/abbi.1994.1297; Takeda N, 2013, AM J PATHOL, V183, P774, DOI 10.1016/j.ajpath.2013.05.026; Terawaki H, 2004, KIDNEY INT, V66, P1988, DOI 10.1111/j.1523-1755.2004.00969.x; Turell L, 2008, BIOCHEMISTRY-US, V47, P358, DOI 10.1021/bi701520y; Turell L, 2013, FREE RADICAL BIO MED, V65, P244, DOI 10.1016/j.freeradbiomed.2013.05.050; Vaidya V, 2009, ANGEW CHEM INT EDIT, V48, P157, DOI 10.1002/anie.200804560; WALLEVIK K, 1976, J CLIN INVEST, V57, P398, DOI 10.1172/JCI108291; WALLEVIK K, 1976, BIOCHIM BIOPHYS ACTA, V420, P42, DOI 10.1016/0005-2795(76)90343-3; Weber J, 2000, BIOCHEMISTRY-US, V39, P5287, DOI 10.1021/bi992730t; WELLS TA, 1994, BIOCHEMISTRY-US, V33, P708, DOI 10.1021/bi00169a012; WHITEHEAD TP, 1992, ANAL CHIM ACTA, V266, P265, DOI 10.1016/0003-2670(92)85052-8; Wu XW, 2010, OMICS, V14, P61, DOI 10.1089/omi.2009.0073; Xie JB, 2011, PROTEINS, V79, P2505, DOI 10.1002/prot.23074; Yamada Naoyuki, 2008, Rinsho Byori, V56, P409	47	17	17	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 4	2014	9	9							e106490	10.1371/journal.pone.0106490	http://dx.doi.org/10.1371/journal.pone.0106490			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3XV	25187963	Green Submitted, Green Published, gold			2022-12-27	WOS:000341271500043
J	Sun, HY; Guan, L; Feng, HL; Yin, J; Cao, YZ; Xi, JH; Li, KB				Sun, Hongyan; Guan, Li; Feng, Honglin; Yin, Jiao; Cao, Yazhong; Xi, Jinghui; Li, Kebin			Functional Characterization of Chemosensory Proteins in the Scarab Beetle, Holotrichia oblita Faldermann (Coleoptera: Scarabaeida)	PLOS ONE			English	Article							ODORANT-BINDING-PROTEINS; EXPRESSION PATTERN; IMMUNOCYTOCHEMICAL LOCALIZATION; BEHAVIORAL-RESPONSES; HELIOTHIS-VIRESCENS; MAMESTRA-BRASSICAE; MOLECULAR-CLONING; LIGAND-BINDING; GENE FAMILIES; MOTH	Chemosensory proteins (CSPs) play important roles in chemical communication by insects, as they recognize and transport environmental chemical signals to receptors within sensilla. In this study, we identified HoblCSP1 and HoblCSP2 from a cDNA library of Holotrichia oblita antennae, successfully expressed them in E. coli and purified them by Ni ion affinity chromatography. We then measured the ligand-binding specificities of HoblCSP1 and HoblCSP2 to 50 selected ligands in a competitive binding assay. These results demonstrated that HoblCSP1 and HoblCSP2 have similar ligand-binding spectra. Both proteins displayed the highest affinity for beta-ionone, alpha-ionone and cinnamaldehyde, indicating that they prefer binding to odorants other than sex pheromones. Additionally, immuno-localization revealed that HoblCSP1 is highly concentrated in sensilla basiconica, while HoblCSP2 is specifically localized to sensilla placodea. In conclusion, HoblCSP1 and HoblCSP2 are responsible for binding to general odorants with slightly different specificities due to their different in vivo environments.	[Sun, Hongyan; Guan, Li; Feng, Honglin; Yin, Jiao; Cao, Yazhong; Li, Kebin] Chinese Acad Agr Sci, Inst Plant Protect, State Key Lab Biol Plant Dis & Insect Pests, Beijing 100193, Peoples R China; [Sun, Hongyan; Guan, Li; Feng, Honglin; Xi, Jinghui] Jilin Univ, Coll Plant Sci, Changchun 130023, Jilin Province, Peoples R China	Chinese Academy of Agricultural Sciences; Institute of Plant Protection, CAAS; Jilin University	Li, KB (corresponding author), Chinese Acad Agr Sci, Inst Plant Protect, State Key Lab Biol Plant Dis & Insect Pests, Beijing 100193, Peoples R China.	likebin54@163.com	Feng, Honglin/J-1298-2019	Feng, Honglin/0000-0001-6803-3413	Special Fund for Agro-Scientific Research in the Public Interest [201003025]; National Natural Science Foundation of China [31371997]	Special Fund for Agro-Scientific Research in the Public Interest; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the Special Fund for Agro-Scientific Research in the Public Interest (No. 201003025) and the National Natural Science Foundation of China (No. 31371997) to KL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson MN, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-198; Angeli S, 1999, EUR J BIOCHEM, V262, P745, DOI 10.1046/j.1432-1327.1999.00438.x; Apweiler R, 2014, NUCLEIC ACIDS RES, V42, pD191, DOI 10.1093/nar/gkt1140; Ban L, 2003, INSECT MOL BIOL, V12, P125, DOI 10.1046/j.1365-2583.2003.00394.x; Bendtsen JD, 2004, J MOL BIOL, V340, P783, DOI 10.1016/j.jmb.2004.05.028; Briand L, 2002, EUR J BIOCHEM, V269, P4586, DOI 10.1046/j.1432-1033.2002.03156.x; BROEKAERT WF, 1988, PHYSIOL MOL PLANT P, V33, P319, DOI 10.1016/0885-5765(88)90001-X; BROEKAERT WF, 1988, PLANT PHYSIOL, V86, P569, DOI 10.1104/pp.86.2.569; Campanacci V, 2001, J BIOL CHEM, V276, P20078, DOI 10.1074/jbc.M100713200; Campanacci V, 2001, EUR J BIOCHEM, V268, P4731, DOI 10.1046/j.1432-1327.2001.02398.x; Capella-Gutierrez S, 2009, BIOINFORMATICS, V25, P1972, DOI 10.1093/bioinformatics/btp348; Danty E, 1999, J NEUROSCI, V19, P7468, DOI 10.1523/JNEUROSCI.19-17-07468.1999; Das A, 2013, PLANT BIOTECHNOL REP, V7, P9, DOI 10.1007/s11816-012-0236-1; Deng SS, 2012, CHEM SENSES, V37, P141, DOI 10.1093/chemse/bjr084; Du Yong-Jun, 1994, Acta Entomologica Sinica, V37, P233; Field LM, 2000, INSECT MOL BIOL, V9, P545, DOI 10.1046/j.1365-2583.2000.00221.x; Foret S, 2007, INSECT BIOCHEM MOLEC, V37, P19, DOI 10.1016/j.ibmb.2006.09.009; Gong DP, 2007, INSECT BIOCHEM MOLEC, V37, P266, DOI 10.1016/j.ibmb.2006.11.012; Gonzalez D, 2009, INSECT MOL BIOL, V18, P395, DOI 10.1111/j.1365-2583.2009.00883.x; HARARI AR, 1994, J CHEM ECOL, V20, P361, DOI 10.1007/BF02064443; Iovinella I, 2013, CHEM SENSES, V38, P409, DOI 10.1093/chemse/bjt012; Jacquin-Joly E, 2002, EUR J BIOCHEM, V269, P2133, DOI 10.1046/j.1432-1033.2002.02863.x; Jacquin-Joly E, 2001, CHEM SENSES, V26, P833, DOI 10.1093/chemse/26.7.833; Jansen S, 2007, ARCH INSECT BIOCHEM, V66, P135, DOI 10.1002/arch.20205; Jiang QY, 2009, INSECT BIOCHEM MOLEC, V39, P440, DOI 10.1016/j.ibmb.2009.04.004; Jin X, 2005, CELL MOL LIFE SCI, V62, P1156, DOI 10.1007/s00018-005-5014-6; JONES DT, 1992, COMPUT APPL BIOSCI, V8, P275, DOI 10.1093/bioinformatics/8.3.275; Kim JY, 2000, ARTHROPOD STRUCT DEV, V29, P121, DOI 10.1016/S1467-8039(00)00022-0; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Larsson MC, 2001, J INSECT PHYSIOL, V47, P1065, DOI 10.1016/S0022-1910(01)00087-7; Lartigue A, 2002, J BIOL CHEM, V277, P32094, DOI 10.1074/jbc.M204371200; Li H, 2012, J APPL ENTOMOL, V136, P781, DOI 10.1111/j.1439-0418.2012.01712.x; Li HL, 2013, INT J BIOL MACROMOL, V56, P114, DOI 10.1016/j.ijbiomac.2013.01.032; Li Weizheng, 2013, Acta Ecologica Sinica, V33, P6895; Liu Jin-Xiang, 2005, Acta Entomologica Sinica, V48, P418; Luo SL, 2011, ENTOMOL SCI, V14, P359, DOI 10.1111/j.1479-8298.2011.00442.x; Maleszka R, 1997, GENE, V202, P39, DOI 10.1016/S0378-1119(97)00448-4; MCKENNA MP, 1994, J BIOL CHEM, V269, P16340; Monteforti G, 2002, ARTHROPOD STRUCT DEV, V30, P195, DOI 10.1016/S1467-8039(01)00036-6; Nagnan-Le Meillour P, 2000, CHEM SENSES, V25, P541, DOI 10.1093/chemse/25.5.541; NOMURA A, 1992, INT J DEV BIOL, V36, P391; Ozaki K, 2008, INSECT BIOCHEM MOLEC, V38, P969, DOI 10.1016/j.ibmb.2008.07.010; Pelosi P, 2006, CELL MOL LIFE SCI, V63, P1658, DOI 10.1007/s00018-005-5607-0; Picimbon JF, 2000, ARCH INSECT BIOCHEM, V44, P120, DOI 10.1002/1520-6327(200007)44:3&lt;120::AID-ARCH3&gt;3.0.CO;2-H; Picimbon JF, 2000, INSECT BIOCHEM MOLEC, V30, P233, DOI 10.1016/S0965-1748(99)00121-6; Picimbon JF, 2001, INSECT BIOCHEM MOLEC, V31, P1173, DOI 10.1016/S0965-1748(01)00063-7; PIKIELNY CW, 1994, NEURON, V12, P35, DOI 10.1016/0896-6273(94)90150-3; Qiao HL, 2013, J INSECT PHYSIOL, V59, P667, DOI 10.1016/j.jinsphys.2013.04.004; Richards S, 2008, NATURE, V452, P949, DOI 10.1038/nature06784; Robertson HM, 1999, INSECT MOL BIOL, V8, P501, DOI 10.1046/j.1365-2583.1999.00146.x; Sanchez-Gracia A, 2009, HEREDITY, V103, P208, DOI 10.1038/hdy.2009.55; Sandler BH, 2000, CHEM BIOL, V7, P143, DOI 10.1016/S1074-5521(00)00078-8; Sun F, 2008, J NE FORESTRY U, V36, DOI [10.3969/j.issn.1000-5382.2008.3905.3021, DOI 10.3969/J.ISSN.1000-5382.2008.3905.3021]; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; TINGLE FC, 1991, J CHEM ECOL, V17, P1621, DOI 10.1007/BF00984693; Tomaselli S, 2006, BIOCHEMISTRY-US, V45, P10606, DOI 10.1021/bi060998w; VISSER JH, 1983, ACS SYM SER, V208, P215; Vogt RG, 2003, BIOCH DIVERSITY ODOR, P392; Vosshall LB, 2000, CELL, V102, P147, DOI 10.1016/S0092-8674(00)00021-0; Wang B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084795; Wang GL, 2006, THESIS NE FORESTRY U; Wang J, 2014, COMP BIOCHEM PHYS D, V11, P1, DOI 10.1016/j.cbd.2014.05.001; Wanner KW, 2004, J CHEM ECOL, V30, P889, DOI 10.1023/B:JOEC.0000028457.51147.d4; Wojtasek H, 1998, BIOCHEM BIOPH RES CO, V250, P217, DOI 10.1006/bbrc.1998.9278; Xu YL, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-632; Yan Shanchun, 2003, Yingyong Shengtai Xuebao, V14, P310; Yin J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033589; Zhang Y, 2005, NATURE, V438, P179, DOI 10.1038/nature04216; [张艳玲 ZHANG Yanling], 2006, [河南农业大学学报, JOURNAL OF HENAN AGRICULTURAL UNIVERSITY], V40, P53; Zhou JJ, 2010, INSECT MOL BIOL, V19, P113, DOI 10.1111/j.1365-2583.2009.00919.x; Zubkov S, 2005, J MOL BIOL, V354, P1081, DOI 10.1016/j.jmb.2005.10.015	71	17	21	2	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 4	2014	9	9							e107059	10.1371/journal.pone.0107059	http://dx.doi.org/10.1371/journal.pone.0107059			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3XV	25188038	Green Published, Green Submitted, gold			2022-12-27	WOS:000341271500114
J	Carta, V; Pangerl, M; Baur, R; Puthenkalam, R; Ernst, M; Trauner, D; Sigel, E				Carta, Valentina; Pangerl, Michael; Baur, Roland; Puthenkalam, Roshan; Ernst, Margot; Trauner, Dirk; Sigel, Erwin			A Pentasymmetric Open Channel Blocker for Cys-Loop Receptor Channels	PLOS ONE			English	Article							GABA(A) RECEPTOR; SUBUNIT COMPOSITION; SODIUM-CHANNELS; STOICHIOMETRY; PHARMACOLOGY; CONFERS	gamma-Aminobutyric acid type A receptors (GABA(A) receptors) are chloride ion channels composed of five subunits, mediating fast synaptic and tonic inhibition in the mammalian brain. These receptors show near five-fold symmetry that is most pronounced in the second trans-membrane domain M2 lining the Cl- ion channel. To take advantage of this inherent symmetry, we screened a variety of aromatic anions with matched symmetry and found an inhibitor, pentacyanocyclopentdienyl anion (PCCP-) that exhibited all characteristics of an open channel blocker. Inhibition was strongly dependent on the membrane potential. Through mutagenesis and covalent modification, we identified the region alpha(1)V256-alpha(1)T261 in the rat recombinant GABA(A) receptor to be important for PCCP- action. Introduction of positive charges into M2 increased the affinity for PCCP- while PCCP- prevented the access of a positively charged molecule into M2. Interestingly, other anion selective cys-loop receptors were also inhibited by PCCP-, among them the Drosophila RDL GABA(A) receptor carrying an insecticide resistance mutation, suggesting that PCCP- could serve as an insecticide.	[Carta, Valentina; Baur, Roland; Sigel, Erwin] Univ Bern, Inst Biochem & Mol Med, Bern, Switzerland; [Pangerl, Michael; Trauner, Dirk] Univ Munich, Dept Chem, Munich, Germany; [Pangerl, Michael; Trauner, Dirk] Ctr Integrated Prot Sci, Munich, Germany; [Puthenkalam, Roshan; Ernst, Margot] Med Univ Vienna, Ctr Brain Res, Dept Biochem & Mol Biol, Vienna, Austria	University of Bern; University of Munich; University of Munich; Medical University of Vienna	Trauner, D (corresponding author), Univ Munich, Dept Chem, Munich, Germany.	dirk.trauner@lmu.de; erwin.sigel@ibmm.unibe.ch	Sigel, Erwin/F-7736-2015	Ernst, Margot/0000-0002-9809-2649	Deutsche Forschungsgemeinschaft [SFB 749]; Swiss National Science Foundation [31003A_132806/1]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	D.T.: Deutsche Forschungsgemeinschaft (www.dfg.de) (SFB 749). E.S.: Swiss National Science Foundation (www.snf.ch) grant No. 31003A_132806/1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baumann SW, 2002, J BIOL CHEM, V277, P46020, DOI 10.1074/jbc.M207663200; Baumann SW, 2001, J BIOL CHEM, V276, P36275, DOI 10.1074/jbc.M105240200; Baur R, 2006, FEBS LETT, V580, P1616, DOI 10.1016/j.febslet.2006.02.002; Betz H, 2006, J NEUROCHEM, V97, P1600, DOI 10.1111/j.1471-4159.2006.03908.x; Chang YC, 1996, J NEUROSCI, V16, P5415; Chisari M, 2011, BRIT J PHARMACOL, V164, P667, DOI 10.1111/j.1476-5381.2011.01396.x; Cole JC, 2005, VIRTUAL SCREENING IN DRUG DISCOVERY, P379; FFRENCHCONSTANT RH, 1993, NATURE, V363, P449, DOI 10.1038/363449a0; FFRENCHCONSTANT RH, 1993, P NATL ACAD SCI USA, V90, P1957, DOI 10.1073/pnas.90.5.1957; Goff E. L., 1964, J ORG CHEM, V29, P423; Hargittai I., 1994, SYMMETRY UNIFYING CO; Hibbs RE, 2011, NATURE, V474, P54, DOI 10.1038/nature10139; Hilf RJC, 2008, NATURE, V452, P375, DOI 10.1038/nature06717; Karginov VA, 2006, BIOORGAN MED CHEM, V14, P33, DOI 10.1016/j.bmc.2005.07.054; Korshoej AR, 2010, BRIT J PHARMACOL, V159, P636, DOI 10.1111/j.1476-5381.2009.00542.x; Less RJ, 2010, CHEM-EUR J, V16, P13723, DOI 10.1002/chem.201001980; MACDONALD RL, 1994, ANNU REV NEUROSCI, V17, P569, DOI 10.1146/annurev.neuro.17.1.569; Mammen M, 1998, ANGEW CHEM INT EDIT, V37, P2755; Martos V, 2009, P NATL ACAD SCI USA, V106, P10482, DOI 10.1073/pnas.0813396106; Martos V, 2008, CURR OPIN CHEM BIOL, V12, P698, DOI 10.1016/j.cbpa.2008.08.024; Minier F, 2004, P NATL ACAD SCI USA, V101, P7769, DOI 10.1073/pnas.0400220101; Olsen RW, 2008, PHARMACOL REV, V60, P243, DOI 10.1124/pr.108.00505; Perret P, 1999, J BIOL CHEM, V274, P25350, DOI 10.1074/jbc.274.36.25350; Prasad BVV, 2012, ADV EXPT MED BIOL, V726; Raymond-Delpech Valerie, 2005, Invertebrate Neuroscience, V5, P119; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Sieghart W., 2002, Current Topics in Medicinal Chemistry, V2, P795, DOI 10.2174/1568026023393507; SIEGHART W, 1995, PHARMACOL REV, V47, P181; SIGEL E, 1987, J PHYSIOL-LONDON, V386, P73, DOI 10.1113/jphysiol.1987.sp016523; SIGEL E, 1990, NEURON, V5, P703, DOI 10.1016/0896-6273(90)90224-4; Sigel E, 2012, J BIOL CHEM, V287, P40224, DOI 10.1074/jbc.R112.386664; SIMMONS HE, 1980, J ORG CHEM, V45, P5113, DOI 10.1021/jo01313a019; Tretter V, 1997, J NEUROSCI, V17, P2728; UNWIN N, 1989, NEURON, V3, P665, DOI 10.1016/0896-6273(89)90235-3; WOODHULL AM, 1973, J GEN PHYSIOL, V61, P687, DOI 10.1085/jgp.61.6.687; Xu M, 1995, BIOPHYS J, V69, P1858, DOI 10.1016/S0006-3495(95)80056-1; Xu M, 1996, J GEN PHYSIOL, V107, P195, DOI 10.1085/jgp.107.2.195	37	6	6	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 3	2014	9	9							e106688	10.1371/journal.pone.0106688	http://dx.doi.org/10.1371/journal.pone.0106688			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3TB	25184303	gold, Green Published, Green Submitted			2022-12-27	WOS:000341257700104
J	Liu, B; Xu, JH; Lan, X; Xu, RF; Zhou, JY; Wang, XL; Chou, KC				Liu, Bin; Xu, Jinghao; Lan, Xun; Xu, Ruifeng; Zhou, Jiyun; Wang, Xiaolong; Chou, Kuo-Chen			iDNA-Prot vertical bar dis: Identifying DNA-Binding Proteins by Incorporating Amino Acid Distance-Pairs and Reduced Alphabet Profile into the General Pseudo Amino Acid Composition	PLOS ONE			English	Article							SUPPORT VECTOR MACHINES; REMOTE HOMOLOGY DETECTION; SUBCELLULAR LOCATION PREDICTION; FUNCTIONAL DOMAIN COMPOSITION; TUPLE NUCLEOTIDE COMPOSITION; SECONDARY STRUCTURE-CONTENT; STRUCTURAL CLASSES; SIGNAL PEPTIDES; CHOUS PSEAAC; PHYSICOCHEMICAL PROPERTIES	Playing crucial roles in various cellular processes, such as recognition of specific nucleotide sequences, regulation of transcription, and regulation of gene expression, DNA-binding proteins are essential ingredients for both eukaryotic and prokaryotic proteomes. With the avalanche of protein sequences generated in the postgenomic age, it is a critical challenge to develop automated methods for accurate and rapidly identifying DNA-binding proteins based on their sequence information alone. Here, a novel predictor, called "iDNA-Prot|dis'', was established by incorporating the amino acid distance-pair coupling information and the amino acid reduced alphabet profile into the general pseudo amino acid composition (PseAAC) vector. The former can capture the characteristics of DNA-binding proteins so as to enhance its prediction quality, while the latter can reduce the dimension of PseAAC vector so as to speed up its prediction process. It was observed by the rigorous jackknife and independent dataset tests that the new predictor outperformed the existing predictors for the same purpose. As a user-friendly web-server, iDNA-Prot|dis is accessible to the public at http://bioinformatics.hitsz.edu.cn/iDNA-Prot_dis/. Moreover, for the convenience of the vast majority of experimental scientists, a step-by-step protocol guide is provided on how to use the web-server to get their desired results without the need to follow the complicated mathematic equations that are presented in this paper just for the integrity of its developing process. It is anticipated that the iDNA-Prot| dis predictor may become a useful high throughput tool for large-scale analysis of DNA-binding proteins, or at the very least, play a complementary role to the existing predictors in this regard.	[Liu, Bin; Xu, Jinghao; Xu, Ruifeng; Zhou, Jiyun; Wang, Xiaolong] Harbin Inst Technol, Shenzhen Grad Sch, Sch Comp Sci & Technol, Shenzhen, Guangdong, Peoples R China; [Liu, Bin; Xu, Ruifeng; Wang, Xiaolong] Harbin Inst Technol, Shenzhen Grad Sch, Key Lab Network Oriented Intelligent Computat, Shenzhen, Guangdong, Peoples R China; [Liu, Bin] Shanghai Key Lab Intelligent Informat Proc, Shanghai, Peoples R China; [Liu, Bin; Chou, Kuo-Chen] Gordon Life Sci Inst, Belmont, MA USA; [Lan, Xun] Stanford Univ, Stanford, CA 94305 USA; [Chou, Kuo-Chen] King Abdulaziz Univ, CEGMR, Jeddah 21413, Saudi Arabia	Harbin Institute of Technology; University Town of Shenzhen; Harbin Institute of Technology; University Town of Shenzhen; Gordon Life Science Institute; Stanford University; King Abdulaziz University	Liu, B (corresponding author), Harbin Inst Technol, Shenzhen Grad Sch, Sch Comp Sci & Technol, Shenzhen, Guangdong, Peoples R China.	bliu@gordonlifescience.org; kcchou@gordonlifescience.org	Liu, Bin/E-9480-2013; xu, rui/GRX-5734-2022; Chou, Kuo-Chen/A-8340-2009	Liu, Bin/0000-0002-8520-8374; Lan, Xun/0000-0002-6523-046X	National Natural Science Foundation of China [61300112]; Natural Science Foundation of Guangdong Province [S2012040007390]; Scientific Research Innovation Foundation in Harbin Institute of Technology [HIT.NSRIF.2013103]; Shanghai Key Laboratory of Intelligent Information Processing, China [IIPL-2012-002]; Scientific Research Foundation for the Returned Overseas Chinese Scholars, State Education Ministry; National Natural Science Foundation of China [61300112]; Natural Science Foundation of Guangdong Province [S2012040007390]; Scientific Research Innovation Foundation in Harbin Institute of Technology [HIT.NSRIF.2013103]; Shanghai Key Laboratory of Intelligent Information Processing, China [IIPL-2012-002]; Scientific Research Foundation for the Returned Overseas Chinese Scholars, State Education Ministry	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Guangdong Province(National Natural Science Foundation of Guangdong Province); Scientific Research Innovation Foundation in Harbin Institute of Technology; Shanghai Key Laboratory of Intelligent Information Processing, China; Scientific Research Foundation for the Returned Overseas Chinese Scholars, State Education Ministry(Scientific Research Foundation for the Returned Overseas Chinese Scholars); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Guangdong Province(National Natural Science Foundation of Guangdong Province); Scientific Research Innovation Foundation in Harbin Institute of Technology; Shanghai Key Laboratory of Intelligent Information Processing, China; Scientific Research Foundation for the Returned Overseas Chinese Scholars, State Education Ministry(Scientific Research Foundation for the Returned Overseas Chinese Scholars)	This work was supported by the National Natural Science Foundation of China (No. 61300112), the Natural Science Foundation of Guangdong Province (No. S2012040007390), the Scientific Research Innovation Foundation in Harbin Institute of Technology (Project No. HIT.NSRIF.2013103), the Shanghai Key Laboratory of Intelligent Information Processing, China (Grant No. IIPL-2012-002), the Scientific Research Foundation for the Returned Overseas Chinese Scholars, State Education Ministry. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad S, 2004, J MOL BIOL, V341, P65, DOI 10.1016/j.jmb.2004.05.058; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Cai YD, 2003, BBA-PROTEINS PROTEOM, V1648, P127, DOI 10.1016/S1570-9639(03)00112-2; Cai YD, 2003, BIOPHYS J, V84, P3257, DOI 10.1016/S0006-3495(03)70050-2; Cai YD, 2009, J PROTEOME RES, V8, P999, DOI 10.1021/pr800717y; Cao DS, 2013, BIOINFORMATICS, V29, P960, DOI 10.1093/bioinformatics/btt072; Chang C.- C., 2009, LIBSVM LIB SUPPORT V; Chen W, 2014, ANAL BIOCHEM, V462, P76, DOI 10.1016/j.ab.2014.06.022; Chen W, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/623149; Chen W, 2014, ANAL BIOCHEM, V456, P53, DOI 10.1016/j.ab.2014.04.001; Chen W, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gks1450; Chen W, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047843; Chen YK, 2013, J THEOR BIOL, V318, P1, DOI 10.1016/j.jtbi.2012.10.033; Chou KC, 2006, BIOCHEM BIOPH RES CO, V339, P1015, DOI 10.1016/j.bbrc.2005.10.196; Chou KC, 2005, J PROTEOME RES, V4, P1413, DOI 10.1021/pr050087t; Chou KC, 2005, BIOINFORMATICS, V21, P10, DOI 10.1093/bioinformatics/bth466; Chou KC, 1997, FEBS LETT, V419, P49, DOI 10.1016/S0014-5793(97)01246-5; Chou KC, 2002, J BIOL CHEM, V277, P45765, DOI 10.1074/jbc.M204161200; Chou KC, 2001, PEPTIDES, V22, P1973, DOI 10.1016/S0196-9781(01)00540-X; CHOU KC, 1995, CRIT REV BIOCHEM MOL, V30, P275, DOI 10.3109/10409239509083488; CHOU KC, 1995, PROTEINS, V21, P319, DOI 10.1002/prot.340210406; Chou KC, 2001, PROTEINS, V43, P246, DOI 10.1002/prot.1035; Chou KC, 2001, PROTEIN ENG, V14, P75, DOI 10.1093/protein/14.2.75; Chou KC, 1999, J PROTEIN CHEM, V18, P473, DOI 10.1023/A:1020696810938; Chou KC, 2009, NAT SCI, V2, P63, DOI DOI 10.4236/NS.2009.12011; Chou KC, 2007, ANAL BIOCHEM, V370, P1, DOI 10.1016/j.ab.2007.07.006; Chou KC, 2007, J PROTEOME RES, V6, P1728, DOI 10.1021/pr060635i; Chou KC, 2006, J PROTEOME RES, V5, P1888, DOI 10.1021/pr060167c; Chou KC, 2013, MOL BIOSYST, V9, P1092, DOI 10.1039/c3mb25555g; Chou KC, 2011, J THEOR BIOL, V273, P236, DOI 10.1016/j.jtbi.2010.12.024; Chou KC, 2009, CURR PROTEOMICS, V6, P262, DOI 10.2174/157016409789973707; Cristianini N, 2000, INTRO SUPPORT VECTOR; Ding H, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/286419; Du PF, 2014, INT J MOL SCI, V15, P3495, DOI 10.3390/ijms15033495; Du PF, 2012, ANAL BIOCHEM, V425, P117, DOI 10.1016/j.ab.2012.03.015; Du ZM, 2011, J BIOL CHEM, V286, P38638, DOI 10.1074/jbc.M111.290569; Esmaeili M, 2010, J THEOR BIOL, V263, P203, DOI 10.1016/j.jtbi.2009.11.016; Fan YN, 2014, INT J MOL SCI, V15, P4915, DOI 10.3390/ijms15034915; Fang Y, 2008, AMINO ACIDS, V34, P103, DOI 10.1007/s00726-007-0568-2; Feng KY, 2005, BIOCHEM BIOPH RES CO, V334, P213, DOI 10.1016/j.bbrc.2005.06.075; Feng PM, 2013, ANAL BIOCHEM, V442, P118, DOI 10.1016/j.ab.2013.05.024; Gao M, 2008, NUCLEIC ACIDS RES, V36, P3978, DOI 10.1093/nar/gkn332; Gao M, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000567; Georgiou D.N., 2013, OPEN BIOINF J, V7, P41, DOI DOI 10.2174/1875036201307010041; Guo SH, 2014, BIOINFORMATICS, V30, P1522, DOI 10.1093/bioinformatics/btu083; Hajisharifi Z, 2014, J THEOR BIOL, V341, P34, DOI 10.1016/j.jtbi.2013.08.037; Hayat M, 2014, COMPUT METHODS PROGR; Hayat M, 2012, PROTEIN PEPTIDE LETT, V19, P411, DOI 10.2174/092986612799789387; Ho SY, 2007, BIOSYSTEMS, V90, P234, DOI 10.1016/j.biosystems.2006.08.007; Kandaswamy KK, 2011, J THEOR BIOL, V270, P56, DOI 10.1016/j.jtbi.2010.10.037; Kandaswamy KK, 2010, PROTEIN PEPTIDE LETT, V17, P1473; Khosravian M, 2013, PROTEIN PEPTIDE LETT, V20, P180, DOI 10.2174/092986613804725307; Kong L, 2014, J THEOR BIOL, V344, P12, DOI 10.1016/j.jtbi.2013.11.021; Kumar KK, 2009, J BIOMOL STRUCT DYN, V26, P679, DOI 10.1080/07391102.2009.10507281; Kumar M, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-463; Langlois RE, 2010, NUCLEIC ACIDS RES, V38, P3149, DOI 10.1093/nar/gkq061; LIN SX, 2013, J BIOMED SCI JBISE, V6, P435, DOI DOI 10.4236/JBISE.2013.64054; Lin WZ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024756; Liu B, 2014, BIOINFORMATICS, V30, P472, DOI 10.1093/bioinformatics/btt709; Liu B, 2013, MOL INFORM, V32, P775, DOI 10.1002/minf.201300084; Liu B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046633; Liu H, 2005, BIOCHEM BIOPH RES CO, V336, P737, DOI 10.1016/j.bbrc.2005.08.160; Liu WM, 1999, PROTEIN ENG, V12, P1041, DOI 10.1093/protein/12.12.1041; Lou WC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086703; Min JL, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/701317; Mohabatkar H, 2013, MED CHEM, V9, P133, DOI 10.2174/157340613804488341; Mohabatkar H, 2011, J THEOR BIOL, V281, P18, DOI 10.1016/j.jtbi.2011.04.017; Mohabatkar H, 2010, PROTEIN PEPTIDE LETT, V17, P1207, DOI 10.2174/092986610792231564; Mohammad Beigi Majid, 2011, J Struct Funct Genomics, V12, P191, DOI 10.1007/s10969-011-9120-4; Mondal S, 2014, J THEOR BIOL, V356, P30, DOI 10.1016/j.jtbi.2014.04.006; Nanni L, 2008, AMINO ACIDS, V34, P653, DOI 10.1007/s00726-007-0018-1; Nanni L, 2012, IEEE ACM T COMPUT BI, V9, P467, DOI 10.1109/TCBB.2011.117; Nanni L, 2009, AMINO ACIDS, V36, P167, DOI 10.1007/s00726-008-0044-7; Noble WS, 1999, SUPPORT VECTOR MACHI; Ogul H, 2007, BIOSYSTEMS, V87, P75, DOI 10.1016/j.biosystems.2006.03.006; Peterson EL, 2009, BIOINFORMATICS, V25, P1356, DOI 10.1093/bioinformatics/btp164; Qiu WR, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/947416; Qiu WR, 2014, INT J MOL SCI, V15, P1746, DOI 10.3390/ijms15021746; Shen HB, 2006, J THEOR BIOL, V240, P9, DOI 10.1016/j.jtbi.2005.08.016; Shen HB, 2009, ANAL BIOCHEM, V394, P269, DOI 10.1016/j.ab.2009.07.046; Stawiski EW, 2003, J MOL BIOL, V326, P1065, DOI 10.1016/S0022-2836(03)00031-7; Sun XY, 2012, MOL BIOSYST, V8, P3178, DOI 10.1039/c2mb25280e; Szaboova A, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-S10-S3; Szilagyi A, 2006, J MOL BIOL, V358, P922, DOI 10.1016/j.jmb.2006.02.053; Tanaka Y, 2001, EMBO J, V20, P6612, DOI 10.1093/emboj/20.23.6612; Tjong H, 2007, NUCLEIC ACIDS RES, V35, P1465, DOI 10.1093/nar/gkm008; Wan SB, 2013, J THEOR BIOL, V323, P40, DOI 10.1016/j.jtbi.2013.01.012; Wang GL, 2005, NUCLEIC ACIDS RES, V33, pW94, DOI 10.1093/nar/gki402; Wang M, 2005, J THEOR BIOL, V232, P7, DOI 10.1016/j.jtbi.2004.07.023; Wang T, 2008, PROTEIN PEPTIDE LETT, V15, P915, DOI 10.2174/092986608785849308; Xiao X, 2013, J THEOR BIOL, V337, P71, DOI 10.1016/j.jtbi.2013.08.013; Xiao X, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072234; Xiao X, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030869; Xu Y, 2014, PLOS ONE; Xu Y, 2014, INT J MOL SCI, V15, P7594, DOI 10.3390/ijms15057594; Xu Y, 2013, PEERJ, V1, DOI 10.7717/peerj.171; Xu Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055844; Zhang SW, 2008, AMINO ACIDS, V34, P565, DOI 10.1007/s00726-007-0010-9; Zia-ur-Rehman, 2012, PROTEIN PEPTIDE LETT, V19, P890; Zou CX, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-90; Zou DS, 2011, J COMPUT CHEM, V32, P271, DOI 10.1002/jcc.21616	101	234	236	1	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 3	2014	9	9							e106691	10.1371/journal.pone.0106691	http://dx.doi.org/10.1371/journal.pone.0106691			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3TB	25184541	Green Submitted, Green Published, gold			2022-12-27	WOS:000341257700106
J	Yang, XX; Morris, SM; Gearhart, JM; Ruark, CD; Paule, MG; Slikker, W; Mattison, DR; Vitiello, B; Twaddle, NC; Doerge, DR; Young, JF; Fisher, JW				Yang, Xiaoxia; Morris, Suzanne M.; Gearhart, Jeffery M.; Ruark, Christopher D.; Paule, Merle G.; Slikker, William, Jr.; Mattison, Donald R.; Vitiello, Benedetto; Twaddle, Nathan C.; Doerge, Daniel R.; Young, John F.; Fisher, Jeffrey W.			Development of a Physiologically Based Model to Describe the Pharmacokinetics of Methylphenidate in Juvenile and Adult Humans and Nonhuman Primates	PLOS ONE			English	Article							ATTENTION-DEFICIT/HYPERACTIVITY DISORDER; SINGLE-DOSE PHARMACOKINETICS; DL-THREO-METHYLPHENIDATE; DEFICIT HYPERACTIVITY DISORDER; MASS-SPECTROMETRIC ANALYSIS; ROUTE DEPENDENT DOSIMETRY; RELEASE METHYLPHENIDATE; HEALTHY-SUBJECTS; RITALINIC ACID; RHESUS-MONKEYS	The widespread usage of methylphenidate (MPH) in the pediatric population has received considerable attention due to its potential effect on child development. For the first time a physiologically based pharmacokinetic (PBPK) model has been developed in juvenile and adult humans and nonhuman primates to quantitatively evaluate species-and age-dependent enantiomer specific pharmacokinetics of MPH and its primary metabolite ritalinic acid. The PBPK model was first calibrated in adult humans using in vitro enzyme kinetic data of MPH enantiomers, together with plasma and urine pharmacokinetic data with MPH in adult humans. Metabolism of MPH in the small intestine was assumed to account for the low oral bioavailability of MPH. Due to lack of information, model development for children and juvenile and adult nonhuman primates primarily relied on intra-and interspecies extrapolation using allometric scaling. The juvenile monkeys appear to metabolize MPH more rapidly than adult monkeys and humans, both adults and children. Model prediction performance is comparable between juvenile monkeys and children, with average root mean squared error values of 4.1 and 2.1, providing scientific basis for interspecies extrapolation of toxicity findings. Model estimated human equivalent doses in children that achieve similar internal dose metrics to those associated with pubertal delays in juvenile monkeys were found to be close to the therapeutic doses of MPH used in pediatric patients. This computational analysis suggests that continued pharmacovigilance assessment is prudent for the safe use of MPH.	[Yang, Xiaoxia; Morris, Suzanne M.; Paule, Merle G.; Slikker, William, Jr.; Twaddle, Nathan C.; Doerge, Daniel R.; Young, John F.; Fisher, Jeffrey W.] US FDA, Natl Ctr Toxicol Res, Jefferson, AR 72079 USA; [Gearhart, Jeffery M.; Ruark, Christopher D.] Henry M Jackson Fdn Adv Mil Med, Wright Patterson AFB, OH USA; [Mattison, Donald R.] Risk Sci Int, Ottawa, ON, Canada; [Mattison, Donald R.] Univ Ottawa, Ottawa, ON, Canada; [Vitiello, Benedetto] NIMH, Bethesda, MD 20892 USA	US Food & Drug Administration (FDA); Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc; University of Ottawa; National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH)	Yang, XX (corresponding author), US FDA, Natl Ctr Toxicol Res, Jefferson, AR 72079 USA.	xiaoxia.yang@fda.hhs.gov	Vitiello, Benedetto/AAC-1758-2022; Mattison, Donald/L-4661-2013	Mattison, Donald/0000-0001-5623-0874; Ruark, Christopher/0000-0003-1032-5696	NCTR/FDA; FDA Commissioner's Program	NCTR/FDA; FDA Commissioner's Program	This work was supported by NCTR/FDA and the FDA Commissioner's Program. These sponsors had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The views presented here do not necessarily reflect the position or opinions of the FDA/NIH nor does mention of trade names or commercial products constitute endorsement or recommendation for use. The findings and conclusions in this manuscript are those of the authors and do not necessarily represent the views of the FDA/NIH.	Akabane T, 2010, DRUG METAB DISPOS, V38, P308, DOI 10.1124/dmd.109.028829; American Psychiatric Association (APA), 2013, DIAGN STAT MAN MENT; Amos-Kroohs RM, 2011, NEUROSCI LETT, V502, P152, DOI 10.1016/j.neulet.2011.07.013; [Anonymous], 1987, Pediatrics, V80, P758; [Anonymous], VITAL HLTH STAT; AOYAMA T, 1993, EUR J CLIN PHARMACOL, V44, P79, DOI 10.1007/BF00315285; AOYAMA T, 1990, J PHARM SCI, V79, P465, DOI 10.1002/jps.2600790602; AOYAMA T, 1994, CLIN PHARMACOL THER, V55, P270, DOI 10.1038/clpt.1994.27; Barter ZE, 2008, DRUG METAB DISPOS, V36, P2405, DOI 10.1124/dmd.108.021311; Bjorkman S, 2005, BRIT J CLIN PHARMACO, V59, P691, DOI 10.1111/j.1365-2125.2004.02225.x; Brown RP, 1997, TOXICOL IND HEALTH, V13, P407, DOI 10.1177/074823379701300401; CHAN YM, 1980, CLIN BIOCHEM, V13, P266, DOI 10.1016/S0009-9120(80)80007-5; CHAN YPM, 1983, PEDIATRICS, V72, P56; Chavez B, 2009, ANN PHARMACOTHER, V43, P1084, DOI 10.1345/aph.1L523; Childress AC, 2010, POSTGRAD MED, V122, P35, DOI 10.3810/pgm.2010.09.2199; Ciccone PE, 2006, J AM PHARM ASSOC, V46, P472, DOI 10.1331/154434506778073600; CLEWELL HJ, 1994, RISK ANAL, V14, P521, DOI 10.1111/j.1539-6924.1994.tb00268.x; CROPP GJA, 1971, J PEDIATR-US, V78, P220, DOI 10.1016/S0022-3476(71)80004-5; Dai D, 2001, J PHARMACOL EXP THER, V299, P825; DAVIES B, 1993, PHARMACEUT RES, V10, P1093, DOI 10.1023/A:1018943613122; DeVane CL, 2000, J CLIN PSYCHOPHARM, V20, P347, DOI 10.1097/00004714-200006000-00009; Ding YS, 1997, PSYCHOPHARMACOLOGY, V131, P71, DOI 10.1007/s002130050267; Dopfner Manfred, 2011, Eur Child Adolesc Psychiatry, V20 Suppl 2, pS243, DOI 10.1007/s00787-011-0202-4; Edginton AN, 2006, CLIN PHARMACOKINET, V45, P1013, DOI 10.2165/00003088-200645100-00005; EGGER H, 1981, DRUG METAB DISPOS, V9, P415; FARAJ BA, 1974, J PHARMACOL EXP THER, V191, P535; Fisher JW, 2011, TOXICOL APPL PHARM, V257, P122, DOI 10.1016/j.taap.2011.08.026; FRIISHANSEN BJ, 1951, PEDIATRICS, V7, P321; Fukami T, 2008, PHARMACOGENET GENOM, V18, P911, DOI 10.1097/FPC.0b013e32830b0c5e; Gaub M, 1997, J AM ACAD CHILD PSY, V36, P1036, DOI 10.1097/00004583-199708000-00011; Godfrey J, 2009, J PSYCHOPHARMACOL, V23, P194, DOI 10.1177/0269881108089809; Godin SJ, 2006, DRUG METAB DISPOS, V34, P1764, DOI 10.1124/dmd.106.010058; Golub M, 2005, BIRTH DEFECTS RES B, V74, P300, DOI 10.1002/bdrb.20049; Gouras P, 2008, GRAEF ARCH CLIN EXP, V246, P1395, DOI 10.1007/s00417-008-0910-8; Haddad S, 2001, J TOXICOL ENV HEAL A, V64, P453, DOI 10.1080/152873901753215911; Hibel LC, 2007, CHILD DEV, V78, P927, DOI 10.1111/j.1467-8624.2007.01041.x; Hosokawa M, 2008, MOLECULES, V13, P412, DOI 10.3390/molecules13020412; Inchem website, CHAR APPL PHYS BAS P; JOYCE PR, 1984, LIFE SCI, V34, P1707, DOI 10.1016/0024-3205(84)90568-X; Kimko HC, 1999, CLIN PHARMACOKINET, V37, P457, DOI 10.2165/00003088-199937060-00002; Koehm M, 2010, ARZNEIMITTEL-FORSCH, V60, P238; Kortejarvi H, 2007, EUR J PHARM SCI, V30, P155, DOI 10.1016/j.ejps.2006.10.011; KOTAKI H, 1988, CHEM PHARM BULL, V36, P3190; Lacroix D, 1997, EUR J BIOCHEM, V247, P625, DOI 10.1111/j.1432-1033.1997.00625.x; LIM HK, 1986, J CHROMATOGR, V378, P109, DOI 10.1016/S0378-4347(00)80704-5; Maldonado R, 2013, EXPERT OPIN DRUG MET, V9, P1001, DOI 10.1517/17425255.2013.786041; Manjanatha MG, 2008, ENVIRON MOL MUTAGEN, V49, P585, DOI 10.1002/em.20407; Marchei E, 2010, CLIN CHEM, V56, P585, DOI 10.1373/clinchem.2009.138396; Markowitz JS, 2003, CLIN PHARMACOKINET, V42, P393, DOI 10.2165/00003088-200342040-00007; Martignoni M, 2006, EXPERT OPIN DRUG MET, V2, P875, DOI 10.1517/17425255.2.6.875; Mattison DR, 2011, P NATL ACAD SCI USA, V108, P16301, DOI 10.1073/pnas.1102187108; Meyer MC, 2000, PHARMACEUT RES, V17, P381, DOI 10.1023/A:1007560500301; Midha KK, 2001, PHARMACEUT RES, V18, P1185, DOI 10.1023/A:1010987212724; Modi NB, 2000, BIOPHARM DRUG DISPOS, V21, P23, DOI 10.1002/1099-081X(200001)21:1&lt;23::AID-BDD212&gt;3.0.CO;2-V; Modi NB, 2000, J CLIN PHARMACOL, V40, P379, DOI 10.1177/00912700022009080; Morris SA, 2009, MUTAT RES-GEN TOX EN, V673, P59, DOI 10.1016/j.mrgentox.2008.12.001; Nemoda Z, 2009, NEUROPHARMACOLOGY, V57, P731, DOI 10.1016/j.neuropharm.2009.08.014; Parasrampuria DA, 2007, J CLIN PHARMACOL, V47, P1476, DOI 10.1177/0091270007308615; Parrott N, 2011, CLIN PHARMACOKINET, V50, P613, DOI 10.2165/11592640-000000000-00000; Patrick KS, 2007, CLIN PHARMACOL THER, V81, P346, DOI 10.1038/sj.clpt.6100082; Patrick Kennerly S, 2005, Expert Opin Drug Deliv, V2, P121; Patrick KS, 2013, DRUG METAB DISPOS, V41, P197, DOI 10.1124/dmd.112.048595; PATRICK KS, 1987, J PHARMACOL EXP THER, V241, P152; PATRICK KS, 1981, J MED CHEM, V24, P1237, DOI 10.1021/jm00142a021; PATRICK KS, 1989, BIOPHARM DRUG DISPOS, V10, P165, DOI 10.1002/bdd.2510100206; PATRICK KS, 1985, J CHROMATOGR, V343, P329, DOI 10.1016/S0378-4347(00)84601-0; PATRICK KS, 1984, J PHARMACOL EXP THER, V231, P61; Prashad M, 2001, ADV SYNTH CATAL, V343, P379, DOI 10.1002/1615-4169(200107)343:5<379::AID-ADSC379>3.0.CO;2-4; Price K, 2003, J TOXICOL ENV HEAL A, V66, P417, DOI 10.1080/15287390306450; Quinn D, 2004, J AM ACAD CHILD PSY, V43, P1422, DOI 10.1097/01.chi.0000140455.96946.2b; Quinn D, 2007, J CLIN PHARMACOL, V47, P760, DOI 10.1177/0091270007299759; Quinney SK, 2005, J PHARMACOL EXP THER, V313, P1011, DOI 10.1124/jpet.104.081265; Raman A, 2005, J GERONTOL A-BIOL, V60, P1518, DOI 10.1093/gerona/60.12.1518; REDALIEU E, 1982, DRUG METAB DISPOS, V10, P708; Rodriguez JS, 2010, NEUROTOXICOL TERATOL, V32, P142, DOI 10.1016/j.ntt.2009.08.011; Roth GS, 2004, SCIENCE, V305, P1423, DOI 10.1126/science.1102541; Salonen JS, 2003, DRUG METAB DISPOS, V31, P1093, DOI 10.1124/dmd.31.9.1093; Satoh T, 2002, DRUG METAB DISPOS, V30, P488, DOI 10.1124/dmd.30.5.488; Schmitt W, 2008, TOXICOL IN VITRO, V22, P457, DOI 10.1016/j.tiv.2007.09.010; Shader RI, 1999, J CLIN PHARMACOL, V39, P775, DOI 10.1177/00912709922008425; SHAYWITZ SE, 1982, PEDIATRICS, V69, P688; Soto PL, 2012, NEUROPSYCHOPHARMACOL; Spencer TJ, 2006, AM J PSYCHIAT, V163, P387, DOI 10.1176/appi.ajp.163.3.387; SRINIVAS NR, 1992, CLIN PHARMACOL THER, V52, P561, DOI 10.1038/clpt.1992.185; SRINIVAS NR, 1987, J PHARMACOL EXP THER, V241, P300; SRINIVAS NR, 1993, PHARMACEUT RES, V10, P14, DOI 10.1023/A:1018956526016; SRINIVAS NR, 1992, J PHARM SCI, V81, P747, DOI 10.1002/jps.2600810805; Stein MA, 2008, CHILD ADOL PSYCH CL, V17, P475, DOI 10.1016/j.chc.2007.11.009; Sun ZJ, 2004, J PHARMACOL EXP THER, V310, P469, DOI 10.1124/jpet.104.067116; Swanson JM, 2003, NEUROSCI BIOBEHAV R, V27, P615, DOI 10.1016/j.neubiorev.2003.08.013; SZANTAY V, 1974, REV ROUM MED-MED INT, V11, P91; Taketani M, 2007, LIFE SCI, V81, P924, DOI 10.1016/j.lfs.2007.07.026; Teeguarden JG, 2005, TOXICOL SCI, V85, P823, DOI 10.1093/toxsci/kfi135; Teo SK, 2004, J CLIN PHARMACOL, V44, P173, DOI 10.1177/0091270003261899; Thai DL, 1999, DRUG METAB DISPOS, V27, P645; Thelen K, 2009, J PHARM PHARMACOL, V61, P541, DOI [10.1211/jpp.61.05.0002, 10.1211/jpp/61.05.0002]; USEPA, EXP FACT HDB; Visser SN, 2013, J AM ACAD CHILD ADOL, P2003; WARGIN W, 1983, J PHARMACOL EXP THER, V226, P382; Watanabe A, 2010, DRUG METAB DISPOS, V38, P1532, DOI 10.1124/dmd.110.033720; Wells JCK, 2005, ARCH DIS CHILD, V90, P965, DOI 10.1136/adc.2004.067538; Wigal SB, 2007, J CHILD ADOL PSYCHOP, V17, P153, DOI 10.1089/cap.2007.0043; Wigal SB, 2011, J CHILD ADOL PSYCHOP, V21, P255, DOI 10.1089/cap.2010.0083; Wong YN, 1998, J CLIN PHARMACOL, V38, P276, DOI 10.1002/j.1552-4604.1998.tb04425.x; Yang XX, 2013, TOXICOL APPL PHARM, V270, P45, DOI 10.1016/j.taap.2013.03.022; Zhang DL, 2012, ACTA PHARM SIN B, V2, P549, DOI 10.1016/j.apsb.2012.10.004; Zhu HJ, 2008, AM J HUM GENET, V82, P1241, DOI 10.1016/j.ajhg.2008.04.015; Zhu HJ, 2009, DRUG METAB DISPOS, V37, P1819, DOI 10.1124/dmd.109.028209	108	14	15	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 3	2014	9	9							e106101	10.1371/journal.pone.0106101	http://dx.doi.org/10.1371/journal.pone.0106101			30	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3TB	25184666	Green Published, gold			2022-12-27	WOS:000341257700031
J	McDonald, MA; Braga, JR; Li, J; Manlhiot, C; Ross, HJ; Redington, AN				McDonald, Michael A.; Braga, Juarez R.; Li, Jing; Manlhiot, Cedric; Ross, Heather J.; Redington, Andrew N.			A Randomized Pilot Trial of Remote Ischemic Preconditioning in Heart Failure with Reduced Ejection Fraction	PLOS ONE			English	Article							SKELETAL-MUSCLE; AMBULATORY PATIENTS; OXYGEN-CONSUMPTION; LIMB ISCHEMIA; EXERCISE; ABNORMALITIES	Background: Remote ischemic preconditioning (RIPC) induced by transient limb ischemia confers multi-organ protection and improves exercise performance in the setting of tissue hypoxia. We aimed to evaluate the effect of RIPC on exercise capacity in heart failure patients. Methods: We performed a randomized crossover trial of RIPC (4x5-minutes limb ischemia) compared to sham control in heart failure patients undergoing exercise testing. Patients were randomly allocated to either RIPC or sham prior to exercise, then crossed over and completed the alternate intervention with repeat testing. The primary outcome was peak VO2, RIPC versus sham. A mechanistic substudy was performed using dialysate from study patient blood samples obtained after sham and RIPC. This dialysate was used to test for a protective effect of RIPC in a mouse heart Langendorff model of infarction. Mouse heart infarct size with RIPC or sham dialysate exposure was also compared with historical control data. Results: Twenty patients completed the study. RIPC was not associated with improvements in peak VO2 (15.6+/-4.2 vs 15.3+/-4.6mL/kg/min; p = 0.53, sham and RIPC, respectively). In our Langendorff sub-study, infarct size was similar between RIPC and sham dialysate groups from our study patients, but was smaller than expected compared to healthy controls (29.0%, 27.9% [sham, RIPC] vs 51.2% [controls]. We observed less preconditioning among the subgroup of patients with increased exercise performance following RIPC (p<0.04). Conclusion: In this pilot study of RIPC in heart failure patients, RIPC was not associated with improvements in exercise capacity overall. However, the degree of effect of RIPC may be inversely related to the degree of baseline preconditioning. These data provide the basis for a larger randomized trial to test the potential benefits of RIPC in patients with heart failure.	[McDonald, Michael A.; Braga, Juarez R.; Ross, Heather J.] Univ Toronto, Peter Munk Cardiac Ctr, Div Cardiol, Toronto, ON, Canada; [Li, Jing; Manlhiot, Cedric; Redington, Andrew N.] Univ Toronto, Hosp Sick Children, Div Cardiol, Toronto, ON M5G 1X8, Canada	University of Toronto; Peter Munk Cardiac Centre; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids)	McDonald, MA (corresponding author), Univ Toronto, Peter Munk Cardiac Ctr, Div Cardiol, Toronto, ON, Canada.	Michael.mcdonald@uhn.on.ca						Aaronson KD, 1997, CIRCULATION, V95, P2660, DOI 10.1161/01.CIR.95.12.2660; Ali ZA, 2007, CIRCULATION, V116, pI98, DOI 10.1161/circulationaha.106.679167; Botker HE, 2010, LANCET, V375, P727, DOI 10.1016/S0140-6736(09)62001-8; Cheung MMH, 2006, J AM COLL CARDIOL, V47, P2277, DOI 10.1016/j.jacc.2006.01.066; de Groot PCE, 2010, EUR J APPL PHYSIOL, V108, P141, DOI 10.1007/s00421-009-1195-2; Dickson EW, 1999, AM J PHYSIOL-HEART C, V277, pH2451, DOI 10.1152/ajpheart.1999.277.6.H2451; Ferdinandy P, 2007, PHARMACOL REV, V59, P418, DOI 10.1124/pr.107.06002; Giricz Z, 2014, J MOL CELL CARDIOL, V68, P75, DOI 10.1016/j.yjmcc.2014.01.004; Hambrecht R, 1997, J AM COLL CARDIOL, V29, P1067, DOI 10.1016/S0735-1097(97)00015-6; HAMBRECHT R, 1995, J AM COLL CARDIOL, V25, P1239, DOI 10.1016/0735-1097(94)00568-B; Hausenloy DJ, 2013, CARDIOVASC RES, V98, P7, DOI 10.1093/cvr/cvt004; Haykowsky MJ, 2007, J AM COLL CARDIOL, V49, P2329, DOI 10.1016/j.jacc.2007.02.055; Hoole SP, 2009, CIRCULATION, V119, P820, DOI 10.1161/CIRCULATIONAHA.108.809723; Jean-St-Michel E, 2011, MED SCI SPORT EXER, V43, P1280, DOI 10.1249/MSS.0b013e318206845d; Kharbanda RK, 2009, LANCET, V374, P1557, DOI 10.1016/S0140-6736(09)61421-5; Maack C, 2009, CIRC RES, V105, P811, DOI 10.1161/CIRCRESAHA.109.206359; MANCINI DM, 1989, CIRCULATION, V80, P1338, DOI 10.1161/01.CIR.80.5.1338; MANCINI DM, 1991, CIRCULATION, V83, P778, DOI 10.1161/01.CIR.83.3.778; MCELROY PA, 1988, AM J CARDIOL, V62, pA35, DOI 10.1016/S0002-9149(88)80083-3; Michelsen MM, 2012, BASIC RES CARDIOL, V107, DOI 10.1007/s00395-012-0260-x; O'Connor CM, 2009, JAMA-J AM MED ASSOC, V301, P1439, DOI 10.1001/jama.2009.454; O'Neill JO, 2005, CIRCULATION, V111, P2313, DOI 10.1161/01.CIR.0000164270.72123.18; Ostadal B, 2009, PHYSIOL RES, V58, pS1, DOI 10.33549/physiolres.931920; Pardaens K, 2000, CIRCULATION, V101, P1152, DOI 10.1161/01.CIR.101.10.1152; Rajabi M, 2007, HEART FAIL REV, V12, P331, DOI 10.1007/s10741-007-9034-1; Redington KL, 2012, BASIC RES CARDIOL, V107, DOI 10.1007/s00395-011-0241-5; Shimizu M, 2009, CLIN SCI, V117, P191, DOI 10.1042/CS20080523; Steensrud T, 2010, AM J PHYSIOL-HEART C, V299, pH1598, DOI 10.1152/ajpheart.00396.2010; STEVENSON LW, 1995, J AM COLL CARDIOL, V25, P163, DOI 10.1016/0735-1097(94)00357-V; Venugopal V, 2009, HEART, V95, P1567, DOI 10.1136/hrt.2008.155770; WILSON JR, 1984, AM J CARDIOL, V53, P1308, DOI 10.1016/0002-9149(84)90085-7; Zhu J, 2010, J GERONTOL A-BIOL, V65, P611, DOI 10.1093/gerona/glq035	32	15	16	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2014	9	9							e105361	10.1371/journal.pone.0105361	http://dx.doi.org/10.1371/journal.pone.0105361			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3LR	25181050	gold, Green Published, Green Submitted			2022-12-27	WOS:000341231500023
J	Pandita, A; Kumar, B; Manvati, S; Vaishnavi, S; Singh, SK; Bamezai, RNK				Pandita, Archana; Kumar, Bhupender; Manvati, Siddharth; Vaishnavi, Samantha; Singh, Shashank K.; Bamezai, Rameshwar N. K.			Synergistic Combination of Gemcitabine and Dietary Molecule Induces Apoptosis in Pancreatic Cancer Cells and Down Regulates PKM2 Expression	PLOS ONE			English	Article							LEUKEMIA HL-60 CELLS; M2 PYRUVATE-KINASE; BETULINIC ACID; ANTITUMOR-ACTIVITY; COLORECTAL-CANCER; ORTHOTOPIC MODEL; NIGELLA-SATIVA; ESSENTIAL OIL; TUMOR-GROWTH; IN-VITRO	Gemcitabine, an effective agent in treatment of cancer of pancreas, has undergone failures in many instances after multiple cycles of therapy due to emergence of drug resistance. Combination of dietary compounds with clinically validated drugs has emerged as an effective therapeutic approach to treat pancreatic tumors, refractory to gemcitabine therapy. In order to optimize a possible synergistic combination of Gemcitabine (GCB) with dietary molecules, Betuilnic acid (BA) and Thymoquinone (TQ), stand-alone IC50 dose of GCB, BA and TQ was calculated for pancreatic cancer cell lines. Fixed IC50 dose ratio of the dietary molecules in combination with reduced IC50 dose of GCB was tested on GCB resistant PANC-1 and sensitive MIA PaCa-2 cells for synergism, additive response and antagonism, using calcusyn. Combination index (CI) revealed that pre-treatment of BA and TQ along with GCB synergistically inhibited the cancer cell proliferation in in-vitro experiments. Pyruvate kinase (PK) M2 isoform, a promising target involved in cancer cell metabolism, showed down-regulation in presence of TQ or BA in combination with GCB. GCB with BA acted preferentially on tumor mitochondria and triggered mitochondrial permeability transition. Pre-exposure of the cell lines, MIA PaCa-2 and PANC-1, to TQ in combination with GCB induced apoptosis. Thus, the effectiveness of BA or TQ in combination with GCB to inhibit cell proliferation, induce apoptosis and down-regulate the expression of PKM2, reflects promise in pancreatic cancer treatment.	[Pandita, Archana; Manvati, Siddharth; Vaishnavi, Samantha] Shri Mata Vaishno Devi Univ, Sch Biotechnol, Katra, Jammu & Kashmir, India; [Kumar, Bhupender; Bamezai, Rameshwar N. K.] Jawaharlal Nehru Univ, Sch Life Sci, New Delhi 110067, India; [Singh, Shashank K.] CSIR, Indian Inst Integrat Med, Jammu, Jammu & Kashmir, India	Shri Mata Vaishno Devi University; Jawaharlal Nehru University, New Delhi; Council of Scientific & Industrial Research (CSIR) - India; CSIR - Indian Institute of Integrative Medicine (IIIM)	Singh, SK (corresponding author), CSIR, Indian Inst Integrat Med, Jammu, Jammu & Kashmir, India.	shashankksingh@gmail.com; bamezai@hotmail.com	Kumar, Bhupender/GLR-8413-2022	Kumar, Bhupender/0000-0003-3887-5040; singh, shashank/0000-0001-8532-7421; Bamezai, R.N.K/0000-0002-5128-2859				Banerjee S, 2005, CANCER RES, V65, P9064, DOI 10.1158/0008-5472.CAN-05-1330; Banerjee S, 2009, CANCER RES, V69, P5575, DOI 10.1158/0008-5472.CAN-08-4235; Bhushan S, 2007, APOPTOSIS, V12, P1911, DOI 10.1007/s10495-007-0105-5; Bluemlein K, 2011, ONCOTARGET, V2, P393; BRINCK U, 1994, VIRCHOWS ARCH, V424, P177; CHOU TC, 1984, ADV ENZYME REGUL, V22, P27, DOI 10.1016/0065-2571(84)90007-4; Chou TC, 2010, CANCER RES, V70, P440, DOI 10.1158/0008-5472.CAN-09-1947; Christofk HR, 2008, NATURE, V452, P230, DOI 10.1038/nature06734; CURI R, 1988, BIOCHEM J, V250, P383, DOI 10.1042/bj2500383; El Kamar FG, 2003, ONCOLOGIST, V8, P18, DOI 10.1634/theoncologist.8-1-18; El-Mahdy MA, 2005, INT J CANCER, V117, P409, DOI 10.1002/ijc.21205; Fulda S, 2009, MOL NUTR FOOD RES, V53, P140, DOI 10.1002/mnfr.200700491; Fulda S, 2008, INT J MOL SCI, V9, P1096, DOI 10.3390/ijms9061096; Fulda S, 2009, DRUG DISCOV TODAY, V14, P885, DOI 10.1016/j.drudis.2009.05.015; Gali-Muhtasib H, 2008, CANCER RES, V68, P5609, DOI 10.1158/0008-5472.CAN-08-0884; Hardt PD, 2003, ANTICANCER RES, V23, P851; Iqbal MA, 2013, MOL CANCER, V12, DOI 10.1186/1476-4598-12-72; Kacem R, 2009, NAT PROD RES, V23, P1168, DOI 10.1080/14786410802228611; Kang SP, 2008, J PANCREAS, V9, P251; Kumar A, 2008, CHEM-BIOL INTERACT, V171, P332, DOI 10.1016/j.cbi.2007.10.003; Kunnumakkara AB, 2007, CANCER RES, V67, P3853, DOI 10.1158/0008-5472.CAN-06-4257; Lemasters JJ, 1997, BIOSCIENCE REP, V17, P281, DOI 10.1023/A:1027332611839; Luftner D, 2000, ANTICANCER RES, V20, P5077; Luo WB, 2012, TRENDS ENDOCRIN MET, V23, P560, DOI 10.1016/j.tem.2012.06.010; Mazurek S, 2005, SEMIN CANCER BIOL, V15, P300, DOI 10.1016/j.semcancer.2005.04.009; Norwood AA, 2006, BIOMED SCI INSTRUM, V42, P350; Oremek GM, 1999, ANTICANCER RES, V19, P2599; Padhye Subhash, 2008, Cancer Ther, V6, P495; Parasramka MA, 2013, MOL NUTR FOOD RES, V57, P235, DOI 10.1002/mnfr.201200297; Pfeiffer T, 2001, SCIENCE, V292, P504, DOI 10.1126/science.1058079; Plunkett W, 1995, ANTI-CANCER DRUG, V6, P7, DOI 10.1097/00001813-199512006-00002; Pottek T, 2000, ANTICANCER RES, V20, P5029; Rabi T, 2008, MOL CARCINOGEN, V47, P964, DOI 10.1002/mc.20447; Rajendran P, 2011, CLIN EPIGENETICS, V3, DOI 10.1186/1868-7083-3-4; Roepke M, 2007, CANCER BIOL THER, V6, P160, DOI 10.4161/cbt.6.2.3575; Roigas J, 2001, TUMOR BIOL, V22, P282, DOI 10.1159/000050628; Rooney S, 2005, ANTICANCER RES, V25, P2199; Schneider J, 2002, ANTICANCER RES, V22, P311; Shoieb AM, 2003, INT J ONCOL, V22, P107; Tempero MA, 2011, ANN ONCOL, V22, P1500, DOI 10.1093/annonc/mdq545; WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309; Warburg O, 1927, J GEN PHYSIOL, V8, P519, DOI 10.1085/jgp.8.6.519; Wechsel HW, 1999, ANTICANCER RES, V19, P2583; Wilson-Simpson F, 2007, BIOMED SCI INSTRUM, V43, P378; Wong Nicholas, 2013, Int J Cell Biol, V2013, P242513, DOI 10.1155/2013/242513; Wu Zhi-hao, 2011, Yaoxue Xuebao, V46, P910; Zhao L, 2004, CLIN CANCER RES, V10, P7994, DOI 10.1158/1078-0432.CCR-04-1087; Zuco V, 2002, CANCER LETT, V175, P17, DOI 10.1016/S0304-3835(01)00718-2	48	36	39	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2014	9	9							e107154	10.1371/journal.pone.0107154	http://dx.doi.org/10.1371/journal.pone.0107154			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4JX	25197966	Green Published, Green Submitted, gold			2022-12-27	WOS:000341304700086
J	Ramsby, BD; Shirur, KP; Iglesias-Prieto, R; Goulet, TL				Ramsby, Blake D.; Shirur, Kartick P.; Iglesias-Prieto, Roberto; Goulet, Tamar L.			Symbiodinium Photosynthesis in Caribbean Octocorals	PLOS ONE			English	Article							CORAL PSEUDOPLEXAURA-FLAGELLOSA; NATURAL PHYTOPLANKTON; MARINE INVERTEBRATE; GORGONIAN OCTOCORAL; COMMUNITY STRUCTURE; GENUS SYMBIODINIUM; CNIDARIA-ANTHOZOA; SPICULE FORMATION; LIGHT LEVELS; REEF CORALS	Symbioses with the dinoflagellate Symbiodinium form the foundation of tropical coral reef communities. Symbiodinium photosynthesis fuels the growth of an array of marine invertebrates, including cnidarians such as scleractinian corals and octocorals (e.g., gorgonian and soft corals). Studies examining the symbioses between Caribbean gorgonian corals and Symbiodinium are sparse, even though gorgonian corals blanket the landscape of Caribbean coral reefs. The objective of this study was to compare photosynthetic characteristics of Symbiodinium in four common Caribbean gorgonian species: Pterogorgia anceps, Eunicea tourneforti, Pseudoplexaura porosa, and Pseudoplexaura wagenaari. Symbiodinium associated with these four species exhibited differences in Symbiodinium density, chlorophyll a per cell, light absorption by chlorophyll a, and rates of photosynthetic oxygen production. The two Pseudoplexaura species had higher Symbiodinium densities and chlorophyll a per Symbiodinium cell but lower chlorophyll a specific absorption compared to P. anceps and E. tourneforti. Consequently, P. porosa and P. wagenaari had the highest average photosynthetic rates per cm 2 but the lowest average photosynthetic rates per Symbiodinium cell or chlorophyll a. With the exception of Symbiodinium from E. tourneforti, isolated Symbiodinium did not photosynthesize at the same rate as Symbiodinium in hospite. Differences in Symbiodinium photosynthetic performance could not be attributed to Symbiodinium type. All P. anceps (n = 9) and P. wagenaari (n = 6) colonies, in addition to one E. tourneforti and three P. porosa colonies, associated with Symbiodinium type B1. The B1 Symbiodinium from these four gorgonian species did not cluster with lineages of B1 Symbiodinium from scleractinian corals. The remaining eight E. tourneforti colonies harbored Symbiodinium type B1L, while six P. porosa colonies harbored type B1i. Understanding the symbioses between gorgonian corals and Symbiodinium will aid in deciphering why gorgonian corals dominate many Caribbean reefs.	[Ramsby, Blake D.; Shirur, Kartick P.; Goulet, Tamar L.] Univ Mississippi, Dept Biol, University, MS 38677 USA; [Iglesias-Prieto, Roberto] Univ Nacl Autonoma Mexico, Inst Ciencias Mar & Limnol, Unidad Acad Sistemas Arrecifales Puerto Morelos, Cancun, Mexico	University of Mississippi; Universidad Autonoma del Estado de Morelos; Universidad Nacional Autonoma de Mexico	Goulet, TL (corresponding author), Univ Mississippi, Dept Biol, University, MS 38677 USA.	tlgoulet@olemiss.edu		Ramsby, Blake/0000-0001-9961-945X	National Science Foundation [IOS 0747205]; National Science Foundation Research Experience for Undergraduates (REU) supplements [1038291, 0936630]; Explorers Club Exploration Fund; University of Mississippi Graduate Student Council Research Grant	National Science Foundation(National Science Foundation (NSF)); National Science Foundation Research Experience for Undergraduates (REU) supplements(National Science Foundation (NSF)); Explorers Club Exploration Fund; University of Mississippi Graduate Student Council Research Grant	This material is based upon work supported by the National Science Foundation under Grant No. IOS 0747205 and National Science Foundation Research Experience for Undergraduates (REU) supplements (No. 1038291 and 0936630) to the above grant (TLG). Any opinions, findings, and conclusions or recommendations expressed in this material are those of the authors and do not necessarily reflect the views of the National Science Foundation. The work was also funded by the Explorers Club Exploration Fund, and a University of Mississippi Graduate Student Council Research Grant (BDR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aizenberg J, 2004, P NATL ACAD SCI USA, V101, P3358, DOI 10.1073/pnas.0307843101; [Anonymous], 2006, THESIS U TEXAS AUSTI; Baker DM, 2011, CORAL REEFS, V30, P709, DOI 10.1007/s00338-011-0759-x; Bayer, 1961, STUD FAUNA CURACAO, V12, P1; Brading P, 2013, NEW PHYTOL, V200, P432, DOI 10.1111/nph.12379; BRAZEAU DA, 1992, BIOL BULL, V183, P269, DOI 10.2307/1542214; BRICAUD A, 1995, J GEOPHYS RES-OCEANS, V100, P13321, DOI 10.1029/95JC00463; Brummer F, 2008, J EXP MAR BIOL ECOL, V367, P61, DOI 10.1016/j.jembe.2008.06.036; BURKHOLDER PR, 1960, AM J BOT, V47, P866, DOI 10.2307/2446584; Cary LR, 1918, GORGONACEAE FACTOR F; Colvard NB, 2011, J EXP MAR BIOL ECOL, V397, P153, DOI 10.1016/j.jembe.2010.11.015; DAHLGREN EJ, 1989, B MAR SCI, V45, P678; Drohan AF, 2005, B MAR SCI, V77, P257; Edmunds PJ, 2007, ECOL MONOGR, V77, P3, DOI 10.1890/05-1081; Edmunds PJ, 2011, OECOLOGIA, V167, P379, DOI 10.1007/s00442-011-2004-2; Enriquez S, 2005, LIMNOL OCEANOGR, V50, P1025, DOI 10.4319/lo.2005.50.4.1025; Ezzat L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064370; FABRICIUS KE, 1995, MAR ECOL PROG SER, V125, P195, DOI 10.3354/meps125195; FARRANT PA, 1987, MAR BIOL, V95, P565, DOI 10.1007/BF00393100; Ferrier-Pages C, 2009, J EXP BIOL, V212, P3007, DOI 10.1242/jeb.031823; Finney JC, 2010, MICROB ECOL, V60, P250, DOI 10.1007/s00248-010-9681-y; Fitt WK, 2001, J EXP MAR BIOL ECOL, V256, P15, DOI 10.1016/S0022-0981(00)00302-6; Gardner TA, 2003, SCIENCE, V301, P958, DOI 10.1126/science.1086050; Goiran C, 1996, J EXP MAR BIOL ECOL, V199, P207, DOI 10.1016/0022-0981(95)00201-4; Goiran C, 1997, MAR BIOL, V129, P581, DOI 10.1007/s002270050199; GOLDBERG WM, 1987, B MAR SCI, V40, P287; GOLDBERG WM, 1987, B MAR SCI, V40, P304; Goulet TL, 2008, MAR ECOL PROG SER, V355, P45, DOI 10.3354/meps07214; Goulet TL, 2005, LIMNOL OCEANOGR, V50, P1490, DOI 10.4319/lo.2005.50.5.1490; Goulet TL, 2004, CORAL REEFS, V23, P465, DOI 10.1007/s00338-004-0408-8; Hennige SJ, 2009, CORAL REEFS, V28, P179, DOI 10.1007/s00338-008-0444-x; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; HUGHES TP, 1994, SCIENCE, V265, P1547, DOI 10.1126/science.265.5178.1547; Iglesias-Prieto R, 2004, P ROY SOC B-BIOL SCI, V271, P1757, DOI 10.1098/rspb.2004.2757; IGLESIASPRIETO R, 1994, MAR ECOL PROG SER, V113, P163, DOI 10.3354/meps113163; Imbs AB, 2010, MAR ECOL PROG SER, V409, P65, DOI 10.3354/meps08622; JEFFREY SW, 1975, BIOCHEM PHYSIOL PFL, V167, P191, DOI 10.1016/s0015-3796(17)30778-3; Jeong HJ, 2014, J EUKARYOT MICROBIOL, V61, P75, DOI 10.1111/jeu.12088; Kaniewska P, 2008, MAR BIOL, V155, P649, DOI 10.1007/s00227-008-1061-5; Kaniewska P, 2011, J PHYCOL, V47, P846, DOI 10.1111/j.1529-8817.2011.01021.x; KANWISHER JW, 1967, BIOL BULL-US, V133, P378, DOI 10.2307/1539833; Khalesi MK, 2011, MAR BIOTECHNOL, V13, P1092, DOI 10.1007/s10126-011-9373-8; Kinzie I, 1973, B MAR SCI, V23, P93; KUHL M, 1995, MAR ECOL PROG SER, V117, P159, DOI 10.3354/meps117159; LaJeunesse TC, 2002, MAR BIOL, V141, P387, DOI 10.1007/s00227-002-0829-2; LaJeunesse TC, 2001, J PHYCOL, V37, P866, DOI 10.1046/j.1529-8817.2001.01031.x; Lasker HR, 2003, BIOL BULL-US, V205, P319, DOI 10.2307/1543295; LASKER HR, 1988, BIOL BULL, V174, P254, DOI 10.2307/1541952; LASKER HR, 1985, MAR ECOL PROG SER, V21, P213, DOI 10.3354/meps021213; LASKER HR, 1981, MAR ECOL PROG SER, V5, P61, DOI 10.3354/meps005061; LEWIS JB, 1982, COMP BIOCHEM PHYS A, V71, P457, DOI 10.1016/0300-9629(82)90434-0; MERGNER H, 1977, HELGOLAND WISS MEER, V30, P383, DOI 10.1007/BF02207849; Miller SL, 2009, LARGE SCALE ASSESSME; MURDOCK GR, 1978, B MAR SCI, V28, P354; MURDOCK GR, 1978, B MAR SCI, V28, P363; Mydlarz LD, 2006, MAR FRESHW BEHAV PHY, V39, P143, DOI 10.1080/10236240600708512; Pandolfi JM, 2005, SCIENCE, V307, P1725, DOI 10.1126/science.1104258; Pettay DT, 2007, MOL ECOL NOTES, V7, P1271, DOI 10.1111/j.1471-8286.2007.01852.x; PLATT T, 1980, J MAR RES, V38, P687; Pochon X, 2010, MOL PHYLOGENET EVOL, V56, P492, DOI 10.1016/j.ympev.2010.03.040; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Posada D, 2009, METHODS MOL BIOL, V537, P93, DOI 10.1007/978-1-59745-251-9_5; RAMUS J, 1976, MAR BIOL, V37, P231, DOI 10.1007/BF00387608; Ribes M, 1998, LIMNOL OCEANOGR, V43, P1170, DOI 10.4319/lo.1998.43.6.1170; Rodriguez AD, 1995, TETRAHEDRON, V51, P4751; Ruzicka RR, 2013, MAR ECOL PROG SER, V489, P125, DOI 10.3354/meps10427; Sampayo EM, 2008, P NATL ACAD SCI USA, V105, P10444, DOI 10.1073/pnas.0708049105; Sampayo EM, 2007, MOL ECOL, V16, P3721, DOI 10.1111/j.1365-294X.2007.03403.x; Santos SR, 2004, MOL ECOL, V13, P459, DOI 10.1046/j.1365-294X.2003.02058.x; Santos SR, 2001, J PHYCOL, V37, P900, DOI 10.1046/j.1529-8817.2001.00194.x; Seibt C, 2001, NATURWISSENSCHAFTEN, V88, P382, DOI 10.1007/s001140100240; SUTTON DC, 1990, BIOL BULL, V178, P175, DOI 10.2307/1541975; Thornhill DJ, 2013, MOL ECOL, V22, P4499, DOI 10.1111/mec.12416; Tunn KPP, 1996, MARINE BIOL S CHINA, P275; VREELAND HV, 1989, J EXP MAR BIOL ECOL, V129, P265, DOI 10.1016/0022-0981(89)90108-1; Wang JT, 2011, MAR ECOL PROG SER, V422, P51, DOI 10.3354/meps08913	76	13	13	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2014	9	9							e106419	10.1371/journal.pone.0106419	http://dx.doi.org/10.1371/journal.pone.0106419			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ1IR	25192405	Green Submitted, Green Published, gold			2022-12-27	WOS:000347993600023
J	Kraus, C; Baldinger, P; Rami-Mark, C; Gryglewsky, G; Kranz, GS; Haeusler, D; Hahn, A; Wadsak, W; Mitterhauser, M; Rujescu, D; Kasper, S; Lanzenberger, R				Kraus, Christoph; Baldinger, Pia; Rami-Mark, Christina; Gryglewsky, Gregor; Kranz, Georg S.; Haeusler, Daniela; Hahn, Andreas; Wadsak, Wolfgang; Mitterhauser, Markus; Rujescu, Dan; Kasper, Siegfried; Lanzenberger, Rupert			Exploring the Impact of BDNF Val66Met Genotype on Serotonin Transporter and Serotonin-1A Receptor Binding	PLOS ONE			English	Article							NEUROTROPHIC FACTOR BDNF; MAJOR DEPRESSION; IN-VIVO; BRAIN; POLYMORPHISM; EXPRESSION; ALTERS; CELLS; MICE	Background: The brain-derived neurotrophic factor (BDNF) Val66Met polymorphism (rs6265) may impact on the in-vivo binding of important serotonergic structures such as the serotonin transporter (5-HTT) and the serotonin-1A (5-HT1A) receptor. Previous positron emission tomography (PET) studies on the association between Val66Met and 5-HTT and 5-HT1A binding potential (BPND) have demonstrated equivocal results. Methods: We conducted an imaging genetics study investigating the effect of Val66Met genotype on 5-HTT or 5-HT1A BPND in 92 subjects. Forty-one subjects (25 healthy subjects and 16 depressive patients) underwent genotyping for Val66Met and PET imaging with the 5-HTT specific radioligand [C-11]DASB. Additionally, in 51 healthy subjects Val66Met genotypes and 5-HT1A binding with the radioligand [carbonyl-C-11]WAY-100635 were ascertained. Voxel-wise and region of interest-based analyses of variance were used to examine the influence of Val66Met on 5-HTT and 5-HT1A BPND. Results: No significant differences of 5-HTT nor 5-HT1A BPND between BDNF Val66Met genotype groups (val/val vs. met-carrier) were detected. There was no interaction between depression and Val66Met genotype status. Conclusion: In line with previous data, our work confirms an absent effect of BDNF Val66Met on two major serotonergic structures. These results could suggest that altered protein expression associated with genetic variants, might be compensated in vivo by several levels of unknown feedback mechanisms. In conclusion, Val66Met genotype status is not associated with changes of in-vivo binding of 5-HTT and 5-HT1A receptors in human subjects.	[Kraus, Christoph; Baldinger, Pia; Gryglewsky, Gregor; Kranz, Georg S.; Hahn, Andreas; Kasper, Siegfried; Lanzenberger, Rupert] Med Univ Vienna, Dept Psychiat & Psychotherapy, Vienna, Austria; [Rami-Mark, Christina; Haeusler, Daniela; Wadsak, Wolfgang; Mitterhauser, Markus] Med Univ Vienna, Div Nucl Med, Dept Biomed Imaging & Image Guided Therapy, Vienna, Austria; [Rujescu, Dan] Med Univ Halle, Dept Psychiat, Halle, Germany	Medical University of Vienna; Medical University of Vienna	Lanzenberger, R (corresponding author), Med Univ Vienna, Dept Psychiat & Psychotherapy, Vienna, Austria.	rupert.lanzenberger@meduniwien.ac.at	Rujescu, Dan/GRS-3875-2022; Lanzenberger, Rupert/I-5438-2019; Wadsak, Wolfgang/K-7408-2019; Kranz, Georg S./T-8981-2019; Gryglewski, Gregor/U-5155-2017	Lanzenberger, Rupert/0000-0003-4641-9539; Hahn, Andreas/0000-0001-9727-7580; Gryglewski, Gregor/0000-0002-7344-8071; Kraus, Christoph/0000-0002-7144-2282; Kranz, Georg/0000-0002-3892-1804; Wadsak, Wolfgang/0000-0003-4479-8053; Kasper, Siegfried/0000-0001-8278-191X; Baldinger-Melich, Pia/0000-0001-8382-6665; Mitterhauser, Markus/0000-0003-3173-5272	Oesterreichische Nationalbank (Anniversary Fund) [11468, 12809, 13675]; Austrian Science Fund [FWF P16549]	Oesterreichische Nationalbank (Anniversary Fund); Austrian Science Fund(Austrian Science Fund (FWF))	This research was conducted by pooling data from studies supported by grants of the Oesterreichische Nationalbank (Anniversary Fund, project numbers: 11468, 12809, 13675) and the Austrian Science Fund (FWF P16549). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baldinger P., 2013, BRAIN STRUCT FUNCT; Black IB, 1999, J NEUROBIOL, V41, P108, DOI 10.1002/(SICI)1097-4695(199910)41:1<108::AID-NEU14>3.0.CO;2-U; Castren E, 2005, NAT REV NEUROSCI, V6, P241, DOI 10.1038/nrn1629; Castren E, 2013, JAMA PSYCHIAT, V70, P983, DOI 10.1001/jamapsychiatry.2013.1; Chao MV, 2003, NAT REV NEUROSCI, V4, P299, DOI 10.1038/nrn1078; Chen ZY, 2004, J NEUROSCI, V24, P4401, DOI 10.1523/JNEUROSCI.0348-04.2004; Cole J, 2011, GENES BRAIN BEHAV, V10, P756, DOI 10.1111/j.1601-183X.2011.00714.x; Coppell AL, 2003, NEUROPHARMACOLOGY, V44, P903, DOI 10.1016/S0028-3908(03)00077-7; Daws LC, 2007, J NEUROCHEM, V101, P641, DOI 10.1111/j.1471-4159.2006.04392.x; Djalali S, 2005, J NEUROCHEM, V92, P616, DOI 10.1111/j.1471-4159.2004.02911.x; Gan WB, 1999, NEURON, V24, P491, DOI 10.1016/S0896-6273(00)81100-9; Gentry JJ, 2004, PROG BRAIN RES, V146, P25, DOI 10.1016/S0079-6123(03)46002-0; Guiard BP, 2008, INT J NEUROPSYCHOPH, V11, P79, DOI 10.1017/S1461145707007857; Gyekis JP, 2013, AM J MED GENET B, V162B, P61, DOI 10.1002/ajmg.b.32122; Haeusler D, 2009, APPL RADIAT ISOTOPES, V67, P1654, DOI 10.1016/j.apradiso.2009.03.005; Hahn A, 2014, HUM BRAIN MAPP; Hajek T, 2012, WORLD J BIOL PSYCHIA, V13, P178, DOI 10.3109/15622975.2011.580005; Henningsson S, 2009, BIOL PSYCHIAT, V66, P477, DOI 10.1016/j.biopsych.2009.04.009; Ichise M, 2003, J CEREBR BLOOD F MET, V23, P1096, DOI 10.1097/01.WCB.0000085441.37552.CA; Ichise M, 2001, J NUCL MED, V42, P755; Innis RB, 2007, J CEREBR BLOOD F MET, V27, P1533, DOI 10.1038/sj.jcbfm.9600493; JOHNSON JE, 1986, J NEUROSCI, V6, P3031; Khundakar AA, 2006, BRAIN RES, V1106, P12, DOI 10.1016/j.brainres.2006.05.063; Klein AB, 2010, J CEREBR BLOOD F MET, V30, pE1, DOI 10.1038/jcbfm.2010.114; Lan MJ, 2014, NEUROIMAGE; Lanzenberger R, 2012, NEUROIMAGE; Lanzenberger R, 2010, INT J NEUROPSYCHOPH, P1; Laruelle Marc, 2003, Mol Imaging Biol, V5, P363, DOI 10.1016/j.mibio.2003.09.009; Liu QR, 2005, AM J MED GENET B, V134B, P93, DOI 10.1002/ajmg.b.30109; Martinowich K, 2008, NEUROPSYCHOPHARMACOL, V33, P73, DOI 10.1038/sj.npp.1301571; Meyer JH, 2007, J PSYCHIATR NEUROSCI, V32, P86; Molendijk ML, 2012, TRANSL PSYCHIAT, V2, DOI 10.1038/tp.2011.72; Molendijk ML, 2013, MOL PSYCHIAT; NIBUYA M, 1995, J NEUROSCI, V15, P7539; Oeth P, 2006, IPLEXTM ASSAY INCREA; Parsey RV, 2010, BIOL PSYCHIAT, V68, P170, DOI 10.1016/j.biopsych.2010.03.023; Parsey RV, 2006, BIOL PSYCHIAT, V59, P821, DOI 10.1016/j.biopsych.2005.08.010; Rami-Mark C, 2013, APPL RADIAT ISOTOPES, V82, P75, DOI 10.1016/j.apradiso.2013.07.023; Savli M, 2012, NEUROIMAGE, V63, P447, DOI 10.1016/j.neuroimage.2012.07.001; Szapacs ME, 2004, J NEUROSCI METH, V140, P81, DOI 10.1016/j.jneumeth.2004.03.026; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; Verhagen M, 2010, MOL PSYCHIATR, V15, P260, DOI 10.1038/mp.2008.109; Wadsak W, 2007, RADIOCHIM ACTA, V95, P33, DOI 10.1524/ract.2007.95.1.33; Willeit M, 2010, NEUROIMAGE, P1; Yu H, 2012, J NEUROSCI, V32, P4092, DOI 10.1523/JNEUROSCI.5048-11.2012; Zou YF, 2010, EUR NEUROPSYCHOPHARM, V20, P535, DOI 10.1016/j.euroneuro.2009.12.005	46	10	10	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 4	2014	9	9							e106810	10.1371/journal.pone.0106810	http://dx.doi.org/10.1371/journal.pone.0106810			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3XV	25188405	Green Published, Green Submitted, gold			2022-12-27	WOS:000341271500090
J	Melaku, YA; Sahle, BW; Tesfay, FH; Bezabih, AM; Aregay, A; Abera, SF; Abreha, L; Zello, GA				Melaku, Yohannes Adama; Sahle, Berhe Weldearegawi; Tesfay, Fisaha Haile; Bezabih, Afework Mulugeta; Aregay, Alemseged; Abera, Semaw Ferede; Abreha, Loko; Zello, Gordon Alexander			Causes of Death among Adults in Northern Ethiopia: Evidence from Verbal Autopsy Data in Health and Demographic Surveillance System	PLOS ONE			English	Article							YOUNG-PEOPLE; MORTALITY TRENDS; AIDS MORTALITY; INTERVA MODEL; MIDDLE-INCOME; SOUTH-AFRICA; POPULATION; BURDEN; DISEASE	Background: In countries where registration of vital events is lacking and the proportion of people who die at home without medical care is high, verbal autopsy is used to determine and estimate causes of death. Methods: We conducted 723 verbal autopsy interviews of adult (15 years of age and above) deaths from September 2009 to January 2013. Trained physicians interpreted the collected verbal autopsy data, and assigned causes of death according to the international classification of diseases (ICD-10). We did analysis of specific as well as broad causes of death (i.e. non-communicable diseases, communicable diseases and external causes of death) by sex and age using Stata version 11.1. We performed logistic regression to identify socio-demographic predictors using odds ratio with 95% confidence interval and a p-value of 0.05. Findings: Tuberculosis, cerebrovascular diseases and accidental falls were leading specific causes of death accounting for 15.9%, 7.3% and 3.9% of all deaths. Two hundred sixty three (36.4% [95% CI: 32.9, 39.9]), 252 (34.9% [95% CI: 31.4, 38.4]) and 89 (12.3% [95% CI: 10.1, 14.9]) deaths were due to non-communicable, communicable diseases, and external causes, respectively. Females had 1.5 times (AOR = 1.53 [95% CI: 1.10, 2.15]) higher odds of dying due to communicable diseases than males. The odds of dying due to external causes were 4 times higher among 15-49 years of age (AOR = 4.02 [95% CI: 2.25, 7.18]) compared to older ages. Males also had 1.7 times (AOR = 1.70 [95% CI: 1.01, 2.85]) higher odds of dying due to external causes than females. Conclusion: Tuberculosis, cerebrovascular diseases and accidental falls were the top three causes of death among adults. Efforts to prevent tuberculosis and cerebrovascular diseases related deaths should be improved and safety efforts to reduce accidents should also receive attention.	[Melaku, Yohannes Adama; Sahle, Berhe Weldearegawi; Tesfay, Fisaha Haile; Bezabih, Afework Mulugeta; Aregay, Alemseged; Abera, Semaw Ferede] Mekelle Univ, Dept Publ Hlth, Coll Hlth Sci, Mekelle, Ethiopia; [Abreha, Loko] Mekelle Univ, Sch Med, Coll Hlth Sci, Mekelle, Ethiopia; [Zello, Gordon Alexander] Univ Saskatchewan, Coll Pharm & Nutr, Saskatoon, SK, Canada	Mekelle University; Mekelle University; University of Saskatchewan	Melaku, YA (corresponding author), Mekelle Univ, Dept Publ Hlth, Coll Hlth Sci, Mekelle, Ethiopia.	adamayohannes@gmail.com	Melaku, Yohannes Adama/S-2451-2019	Melaku, Yohannes Adama/0000-0002-3051-7313; Tesfay (PhD), Fisaha Haile/0000-0003-0399-1711; Mulugeta, Afework/0000-0003-0707-4363	Centers for Disease Control and Prevention (CDC) through Ethiopian Public Health Association (EPHA); EPHA-CDC [5U22/PS022179_10]; Mekelle University	Centers for Disease Control and Prevention (CDC) through Ethiopian Public Health Association (EPHA)(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); EPHA-CDC; Mekelle University	The surveillance system was funded by Centers for Disease Control and Prevention (CDC) through Ethiopian Public Health Association (EPHA) in accordance with the EPHA-CDC Cooperative Agreement No. 5U22/PS022179_10 and Mekelle University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbas SM, 2011, J PAK MED ASSOC, V61, P235; Abegunde DO, 2007, LANCET, V370, P1929, DOI 10.1016/S0140-6736(07)61696-1; Araya T, 2012, WORLD J AIDS, V2, P89; Dongre AR, 2009, ONLINE J HLTH ALLIED, V7, P1; Edmond KM, 2008, PAEDIATR PERINAT EP, V22, P417, DOI 10.1111/j.1365-3016.2008.00962.x; Ethiopia Ministry of Health and Federal HIV/AIDS prevention and Control Office (FHAPCO), 2007, SINGL POINT HIV PREV; Ethiopian Ministry of Health Ethiopian, 2009, POP BAS NAT TB PREV; Federal Democratic Republic of Ethiopia: Ministry of Finance and Economic Development, 2013, 201112 FY FED DEM RE; Federal Democratic Republic of Ethiopia: Ministry of Health (FMoH), 2012, HLTH STAT IND FACT S; Federal Ministry of Health Ethiopia (FMoH-HEP), 2007, HLTH EXT ED CTR HLTH; FMOH, 2010, HLTH SECT DEV PROGR; Fottrell E, 2010, EPIDEMIOL REV, V32, P38, DOI 10.1093/epirev/mxq003; Gajalakshmi V, 2004, BMC PUBLIC HEALTH, V4, DOI 10.1186/1471-2458-4-47; Gargano JW, 2012, ADULT POPULATION IMP; Gore FM, 2011, LANCET, V377, P2093, DOI 10.1016/S0140-6736(11)60512-6; Herbst AJ, 2011, POPUL HEALTH METR, V9, DOI 10.1186/1478-7954-9-47; Hernandez B, 2011, POPUL HEALTH METR, V9, DOI 10.1186/1478-7954-9-38; Hoog van't A, 2012, INT J TB LU IN PRESS, V8, P231; Kahn K, 1999, TROP MED INT HEALTH, V4, P433, DOI 10.1046/j.1365-3156.1999.00415.x; Khademi H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011183; Kobusingye O, 2001, Inj Prev, V7, P46, DOI 10.1136/ip.7.1.46; Lopez AD, 2006, GLOBAL BURDEN OF DISEASE AND RISK FACTORS, P1, DOI 10.1596/978-0-8213-6262-4; Lulu K, 2005, BMC PUBLIC HEALTH, V5, DOI 10.1186/1471-2458-5-58; Mamo Y, 2007, CLIN MED, V7, P228, DOI 10.7861/clinmedicine.7-3-228; Mathers CD, 2006, PLOS MED, V3, DOI 10.1371/journal.pmed.0030442; Misganaw A, 2012, BMC PUBLIC HEALTH, V12, P2458; Morris SK, 2010, PLOS ONE, V5, pA170, DOI 10.1371/journal.pone.0009583; Mwagomba B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010452; Oti SO, 2010, POPUL HEALTH METR, V8, DOI 10.1186/1478-7954-8-21; Pagano M., 2018, PRINCIPLES BIOSTATIS; Patton GC, 2009, LANCET, V374, P881, DOI 10.1016/S0140-6736(09)60741-8; Prevett M, 2012, ETHIOP J HEALTH SCI, V22, P1; Quigley MA, 1996, B WORLD HEALTH ORGAN, V74, P147; RAO C, 2006, CAUSES DEATH DIS MOR, P43; Reniers G, 2009, AIDS, V23, P511, DOI 10.1097/QAD.0b013e32832403d0; Ronsmans C, 1998, INT J EPIDEMIOL, V27, P660, DOI 10.1093/ije/27.4.660; Setel PW, 2006, TROP MED INT HEALTH, V11, P681, DOI 10.1111/j.1365-3156.2006.01603.x; Tadesse S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073463; Tensou B, 2010, TROP MED INT HEALTH, V15, P547, DOI 10.1111/j.1365-3156.2010.02484.x; van der Sande MAB, 2001, B WORLD HEALTH ORGAN, V79, P133; Van Ness PH, 2007, 10531 SUGI 31, P1; Viner RM, 2011, LANCET, V377, P1162, DOI 10.1016/S0140-6736(11)60106-2; Weldearegawi B, 2013, HLTH POLICY PLANN, P1, DOI DOI 10.1093/HEAP0L/CZS135; Weldearegawi B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093099; WHO, 2011, GLOB TUB CONTR REP; WHO, 2010, INT STAT CLASS DIS R; World Health Organization, 2008, WORLD REPORT CHILD I	47	17	17	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 4	2014	9	9							e106781	10.1371/journal.pone.0106781	http://dx.doi.org/10.1371/journal.pone.0106781			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3XV	25188025	Green Published, gold			2022-12-27	WOS:000341271500086
J	Tong, XH; Xu, B; Zhang, YW; Liu, YS; Ma, CH				Tong, Xian-Hong; Xu, Bo; Zhang, Yuan-Wei; Liu, Yu-Sheng; Ma, Chun-Hong			Research Resources: Comparative MicroRNA Profiles in Human Corona Radiata Cells and Cumulus Oophorus Cells Detected by Next-Generation Small RNA Sequencing	PLOS ONE			English	Article							COMPANION GRANULOSA-CELLS; METABOLIC COOPERATIVITY; IN-VITRO; GENE-EXPRESSION; OOCYTE CONTROL; MOUSE OOCYTES; FERTILIZATION; DICER; COMPLEX; MIRNAS	During folliculogenesis, cumulus cells surrounding the oocyte differentiate into corona radiata cells (CRCs) and cumulus oophorus cells (COCs), which are involved in gonadal steroidogenesis and the development of germ cells. Several studies suggested that microRNAs (miRNAs) play an important regulatory role at the post-transcriptional level in cumulus cells. However, comparative miRNA profiles and associated processes in human CRCs and COCs have not been reported before. In this study, miRNA profiles were obtained from CRCs and COCs using next generation sequencing in women undergoing controlled ovarian stimulation for IVF. A total of 785 and 799 annotated miRNAs were identified in CRCs and COCs, while high expression levels of six novel miRNAs were detected both in CRCs and in COCs. In addition, different expression patterns in CRCs and COCs were detected in 72 annotated miRNAs. To confirm the miRNA profile in COCs and CRCs, quantitative real-time PCR was used to validate the expression of annotated miRNAs, differentially expressed miRNAs, and novel miRNAs. The miRNAs in the let-7 family were found to be involved in the regulation of a broad range of biological processes in both cumulus cell populations, which was accompanied by a large amount of miRNA editing. Bioinformatics analysis showed that amino acid and energy metabolism were targeted significantly by miRNAs that were differentially expressed between CRCs and COCs. Our work extends the current knowledge of the regulatory role of miRNAs and their targeted pathways in folliculogenesis, and provides novel candidates for molecular biomarkers in the research of female infertility.	[Tong, Xian-Hong; Ma, Chun-Hong] Shandong Univ, Coll Med, Inst Immunol, Jinan 250100, Peoples R China; [Tong, Xian-Hong; Xu, Bo; Liu, Yu-Sheng] Anhui Med Univ, Anhui Prov Hosp, Ctr Reprod Med, Hefei, Peoples R China; [Zhang, Yuan-Wei] Univ Sci & Technol China, Hefei Natl Lab Phys Sci Microscale, Hefei 230026, Peoples R China; [Zhang, Yuan-Wei] Univ Sci & Technol China, Sch Life Sci, Hefei 230026, Peoples R China	Shandong University; Anhui Medical University; Chinese Academy of Sciences; University of Science & Technology of China, CAS; Chinese Academy of Sciences; University of Science & Technology of China, CAS	Xu, B (corresponding author), Anhui Med Univ, Anhui Prov Hosp, Ctr Reprod Med, Hefei, Peoples R China.	bio_xubo@163.com; machunhong@sdu.edu.cn	Zhang, Yuanwei/C-7695-2016	Zhang, Yuanwei/0000-0002-2814-8061	Natural Science Foundation of Anhui Provincial of China [1308085QH131]; Natural Science Research Project of Anhui Provincial Education Department [KJ2013Z134]; National Natural Science Foundation of China [81000237]	Natural Science Foundation of Anhui Provincial of China; Natural Science Research Project of Anhui Provincial Education Department; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This research was supported by the Natural Science Foundation of Anhui Provincial of China (1308085QH131), Natural Science Research Project of Anhui Provincial Education Department (KJ2013Z134), and the National Natural Science Foundation of China (81000237). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adriaenssens T, 2011, J ASSIST REPROD GEN, V28, P31, DOI 10.1007/s10815-010-9481-9; Albertini DF, 2001, REPRODUCTION, V121, P647, DOI 10.1530/rep.0.1210647; Anderson RA, 2009, REPRODUCTION, V138, P629, DOI 10.1530/REP-09-0144; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Assou S, 2006, HUM REPROD, V21, P1705, DOI 10.1093/humrep/del065; Azuma-Mukai A, 2008, P NATL ACAD SCI USA, V105, P7964, DOI 10.1073/pnas.0800334105; Downs SM, 1999, BIOL REPROD, V60, P1446, DOI 10.1095/biolreprod60.6.1446; Ebhardt HA, 2009, NUCLEIC ACIDS RES, V37, P2461, DOI 10.1093/nar/gkp093; Eppig JJ, 2002, P NATL ACAD SCI USA, V99, P2890, DOI 10.1073/pnas.052658699; Eppig JJ, 2005, BIOL REPROD, V73, P351, DOI 10.1095/biolreprod.105.041798; FAGBOHUN CF, 1992, J REPROD FERTIL, V96, P681, DOI 10.1530/jrf.0.0960681; Familiari G, 1996, MOL REPROD DEV, V43, P392, DOI 10.1002/(SICI)1098-2795(199603)43:3<392::AID-MRD14>3.0.CO;2-3; Fernandez-Valverde SL, 2010, RNA, V16, P1881, DOI 10.1261/rna.2379610; Gilchrist RB, 2008, HUM REPROD UPDATE, V14, P159, DOI 10.1093/humupd/dmm040; Gonzalez G, 2009, MOL REPROD DEV, V76, P678, DOI 10.1002/mrd.21010; GREGORY L, 1994, HUM REPROD, V9, P1308, DOI 10.1093/oxfordjournals.humrep.a138700; Griffiths-Jones S, 2008, NUCLEIC ACIDS RES, V36, pD154, DOI 10.1093/nar/gkm952; Grondahl ML, 2012, MOL HUM REPROD, V18, P572, DOI 10.1093/molehr/gas035; Hong SJ, 2004, HUM REPROD, V19, P1562, DOI 10.1093/humrep/deh281; Hong XM, 2008, ENDOCRINOLOGY, V149, P6207, DOI 10.1210/en.2008-0294; Huang JM, 2011, INT J BIOL SCI, V7, P1016, DOI 10.7150/ijbs.7.1016; Huang ZW, 2010, MOL HUM REPROD, V16, P715, DOI 10.1093/molehr/gaq031; Hussein TS, 2005, J CELL SCI, V118, P5257, DOI 10.1242/jcs.02644; IMOEDEMHE DG, 1992, J ASSIST REPROD GEN, V9, P323, DOI 10.1007/BF01203954; Jepsen K, 2000, CELL, V102, P753, DOI 10.1016/S0092-8674(00)00064-7; Kanehisa M, 2010, NUCLEIC ACIDS RES, V38, pD355, DOI 10.1093/nar/gkp896; Kanellopoulou C, 2005, GENE DEV, V19, P489, DOI 10.1101/gad.1248505; Kim YJ, 2010, REPROD SCI, V17, P1081, DOI 10.1177/1933719110377663; Koks S, 2010, MOL HUM REPROD, V16, P229, DOI 10.1093/molehr/gap103; Lei L, 2010, MOL CELL ENDOCRINOL, V315, P63, DOI 10.1016/j.mce.2009.09.021; Lewis BP, 2003, CELL, V115, P787, DOI 10.1016/S0092-8674(03)01018-3; Li JJ, 2005, CURR BIOL, V15, P1501, DOI 10.1016/j.cub.2005.07.029; Li RQ, 2009, BIOINFORMATICS, V25, P1966, DOI 10.1093/bioinformatics/btp336; Li Y, 2012, NUCLEIC ACIDS RES, V40, P4298, DOI 10.1093/nar/gks043; Lu SF, 2009, NUCLEIC ACIDS RES, V37, P1878, DOI 10.1093/nar/gkp031; Ma TH, 2011, J APPL GENET, V52, P481, DOI 10.1007/s13353-011-0055-z; Mase Y, 2012, REPROD SCI, V19, P1030, DOI 10.1177/1933719112442245; Miles JR, 2012, ANIM REPROD SCI, V130, P16, DOI 10.1016/j.anireprosci.2011.12.021; Morin RD, 2008, GENOME RES, V18, P610, DOI 10.1101/gr.7179508; Murchison EP, 2007, GENE DEV, V21, P682, DOI 10.1101/gad.1521307; Nagaraja AK, 2008, MOL ENDOCRINOL, V22, P2336, DOI 10.1210/me.2008-0142; Nakanishi T, 2001, J PHYSIOL-LONDON, V532, P297, DOI 10.1111/j.1469-7793.2001.0297f.x; Oktem O, 2008, ANN NY ACAD SCI, V1127, P1, DOI 10.1196/annals.1434.009; Ouandaogo ZG, 2012, HUM REPROD, V27, P2438, DOI 10.1093/humrep/des172; Pastorelli LM, 2009, MAMM GENOME, V20, P140, DOI 10.1007/s00335-008-9169-y; Perez-Schindler J, 2012, MOL CELL BIOL, V32, P4913, DOI 10.1128/MCB.00877-12; Sang Q, 2013, J CLIN ENDOCR METAB, V98, P3068, DOI 10.1210/jc.2013-1715; Shibahara Y, 2012, J PATHOL, V227, P357, DOI 10.1002/path.4019; Shirasuna K, 2012, DOMEST ANIM ENDOCRIN, V43, P198, DOI 10.1016/j.domaniend.2012.03.007; Su YQ, 2008, DEVELOPMENT, V135, P111, DOI 10.1242/dev.009068; Su YQ, 2009, SEMIN REPROD MED, V27, P32, DOI 10.1055/s-0028-1108008; Sugiura K, 2005, REPROD FERT DEVELOP, V17, P667, DOI 10.1071/RD05071; Sugiura K, 2005, DEV BIOL, V279, P20, DOI 10.1016/j.ydbio.2004.11.027; Thomas FH, 2005, ENDOCRINOLOGY, V146, P941, DOI 10.1210/en.2004-0826; Tong XH, 2012, HUM REPROD, V27, P3208, DOI 10.1093/humrep/des295; Velthut-Meikas A, 2013, MOL ENDOCRINOL, V27, P1128, DOI 10.1210/me.2013-1058; Yao N, 2009, FRONT BIOSCI-LANDMRK, V14, P3239, DOI 10.2741/3447; Yin MM, 2012, MOL ENDOCRINOL, V26, P1129, DOI 10.1210/me.2011-1341; Zhang XD, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-157; Zhang YW, 2012, BIOINFORMATICS, V28, P1925, DOI 10.1093/bioinformatics/bts282; Zhang YW, 2011, BIOINFORMATICS, V27, P1436, DOI 10.1093/bioinformatics/btr148	61	21	22	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 4	2014	9	9							e106706	10.1371/journal.pone.0106706	http://dx.doi.org/10.1371/journal.pone.0106706			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3XV	25188034	Green Submitted, Green Published, gold			2022-12-27	WOS:000341271500072
J	Bolick, DT; Chen, TF; Alves, LAO; Tong, YX; Wu, D; Joyner, LT; Oria, RB; Guerrant, RL; Fu, Z				Bolick, David T.; Chen, Tufeng; Alves, Luis Antonio O.; Tong, Yixin; Wu, Di; Joyner, Linwood T., II; Oria, Reinaldo B.; Guerrant, Richard L.; Fu, Zheng			Intestinal Cell Kinase Is a Novel Participant in Intestinal Cell Signaling Responses to Protein Malnutrition	PLOS ONE			English	Article							EPITHELIAL-CELLS; CRYPTOSPORIDIUM INFECTION; CYCLE PROGRESSION; ACTIVATING KINASE; STEM-CELLS; IN-VIVO; F-BOX; ADAPTATION; STARVATION; DIFFERENTIATION	Nutritional deficiency and stress can severely impair intestinal architecture, integrity and host immune defense, leading to increased susceptibility to infection and cancer. Although the intestine has an inherent capability to adapt to environmental stress, the molecular mechanisms by which the intestine senses and responds to malnutrition are not completely understood. We hereby report that intestinal cell kinase (ICK), a highly conserved serine/threonine protein kinase, is a novel component of the adaptive cell signaling responses to protein malnutrition in murine small intestine. Using an experimental mouse model, we demonstrated that intestinal ICK protein level was markedly and transiently elevated upon protein deprivation, concomitant with activation of prominent pro-proliferation and pro-survival pathways of Wnt/beta-catenin, mammalian target of rapamycin (mTOR), mitogen-activated protein kinase (MAPK), and protein kinase B (PKB/Akt) as well as increased expression of intestinal stem cell markers. Using the human ileocecal epithelial cell line HCT-8 as an in vitro model, we further demonstrated that serum starvation was able to induce up-regulation of ICK protein in intestinal epithelial cells in a reversible manner, and that serum albumin partially contributed to this effect. Knockdown of ICK expression in HCT-8 cells significantly impaired cell proliferation and down-regulated active beta-catenin signal. Furthermore, reduced ICK expression in HCT-8 cells induced apoptosis through a caspase-dependent mechanism. Taken together, our findings suggest that increased ICK expression/activity in response to protein deprivation likely provides a novel protective mechanism to limit apoptosis and support compensatory mucosal growth under nutritional stress.	[Bolick, David T.; Chen, Tufeng; Alves, Luis Antonio O.; Tong, Yixin; Wu, Di; Joyner, Linwood T., II; Oria, Reinaldo B.; Guerrant, Richard L.; Fu, Zheng] Univ Virginia, Dept Med, Ctr Global Hlth, Digest Res Ctr Excellence, Charlottesville, VA 22903 USA; [Chen, Tufeng] Sun Yat Sen Univ, Dept Gastrointestinal Surg, Affiliated Hosp 3, Guangzhou, Guangdong, Peoples R China; [Tong, Yixin] Huazhong Univ Sci & Technol, Gastrointestinal Surg Ctr, Tongji Hosp, Wuhan, Hubei, Peoples R China	University of Virginia; Sun Yat Sen University; Huazhong University of Science & Technology	Guerrant, RL (corresponding author), Univ Virginia, Dept Med, Ctr Global Hlth, Digest Res Ctr Excellence, Charlottesville, VA 22903 USA.	rlg9a@virginia.edu; zf6n@virginia.edu	Oria, Reinaldo B/D-6440-2014; Bolick, David/A-3467-2017	Oria, Reinaldo/0000-0002-6914-5481	National Institutes of Health [DK082614, U54 AI057168, D43 TW006578]; FOGARTY INTERNATIONAL CENTER [D43TW006578] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U54AI057168] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K01DK082614] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institutes of Health grants DK082614 (to Z.F.) and U54 AI057168 and D43 TW006578 (to R. L. G.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aliaga JC, 1999, AM J PHYSIOL-GASTR L, V277, pG631, DOI 10.1152/ajpgi.1999.277.3.G631; Barker N, 2007, NATURE, V449, P1003, DOI 10.1038/nature06196; Chappell VL, 2003, DIGEST DIS SCI, V48, P765, DOI 10.1023/A:1022849112100; Chen TF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079359; Costa LB, 2012, J INFECT DIS, V205, P1464, DOI 10.1093/infdis/jis216; Costa LB, 2011, J PARASITOL, V97, P1113, DOI 10.1645/GE-2848.1; Coutinho BP, 2008, J PARASITOL, V94, P1225, DOI 10.1645/GE-1411.1; DEO MG, 1965, GASTROENTEROLOGY, V49, P150; Drozdowski L, 2006, WORLD J GASTROENTERO, V12, P4614, DOI 10.3748/wjg.v12.i29.4614; Fu Z, 2005, MOL CELL BIOL, V25, P6047, DOI 10.1128/MCB.25.14.6047-6064.2005; Fu Z, 2006, MOL CELL BIOL, V26, P8639, DOI 10.1128/MCB.00816-06; Fu Z, 2009, AM J PHYSIOL-GASTR L, V297, pG632, DOI 10.1152/ajpgi.00066.2009; HILL RB, 1968, EXP MOL PATHOL, V8, P66, DOI 10.1016/0014-4800(68)90006-3; HOOPER CS, 1958, EXP CELL RES, V14, P175, DOI 10.1016/0014-4827(58)90224-6; JENKINS AP, 1994, GUT, V35, P1765, DOI 10.1136/gut.35.12.1765; JOHNSON LR, 1988, PHYSIOL REV, V68, P456, DOI 10.1152/physrev.1988.68.2.456; Lee KW, 2013, BIOCHEM BIOPH RES CO, V435, P239, DOI 10.1016/j.bbrc.2013.04.072; LIPKIN M, 1962, J CLIN INVEST, V41, P646, DOI 10.1172/JCI104520; Liu Y, 2004, J BIOL CHEM, V279, P4507, DOI 10.1074/jbc.M309995200; Manning BD, 2007, CELL, V129, P1261, DOI 10.1016/j.cell.2007.06.009; MURAMATSU K, 1963, J NUTR, V81, P427, DOI 10.1093/jn/81.4.427; Nicholson JP, 2000, BRIT J ANAESTH, V85, P599, DOI 10.1093/bja/85.4.599; Pinto D, 2003, GENE DEV, V17, P1709, DOI 10.1101/gad.267103; Raul F, 1996, P NUTR SOC, V55, P279, DOI 10.1079/PNS19960029; Sangiorgi E, 2008, NAT GENET, V40, P915, DOI 10.1038/ng.165; Sheng H, 2003, GUT, V52, P1472, DOI 10.1136/gut.52.10.1472; Sokolovic M, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-361; Sturgill TW, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-104; Tappenden KA, 2006, GASTROENTEROLOGY, V130, pS93, DOI 10.1053/j.gastro.2005.11.051; Togawa K, 2000, J CELL PHYSIOL, V183, P129, DOI 10.1002/(SICI)1097-4652(200004)183:1<129::AID-JCP15>3.0.CO;2-S; TOMPKINS WA, 1974, J NATL CANCER I, V52, P1101, DOI 10.1093/jnci/52.4.1101; Yilmaz OH, 2012, NATURE, V486, P490, DOI 10.1038/nature11163	33	13	13	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 3	2014	9	9							e106902	10.1371/journal.pone.0106902	http://dx.doi.org/10.1371/journal.pone.0106902			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3TB	25184386	Green Submitted, gold, Green Published			2022-12-27	WOS:000341257700127
J	Itoh, M; Nakadate, K; Horibata, Y; Matsusaka, T; Xu, JL; Hunziker, W; Sugimoto, H				Itoh, Masahiko; Nakadate, Kazuhiko; Horibata, Yasuhiro; Matsusaka, Taiji; Xu, Jianliang; Hunziker, Walter; Sugimoto, Hiroyuki			The Structural and Functional Organization of the Podocyte Filtration Slits Is Regulated by Tjp1/ZO-1	PLOS ONE			English	Article							AMINONUCLEOSIDE NEPHROSIS; GLOMERULAR PROTEIN; NEPHRIN; CELL; JUNCTION; KIDNEY; ACTIN; DEFICIENT; DIAPHRAGM; GENE	Blood filtration in the kidney glomerulus is essential for physiological homeostasis. The filtration apparatus of the kidney glomerulus is composed of three distinct components: the fenestrated endothelial cells, the glomerular basement membrane, and interdigitating foot processes of podocytes that form the slit diaphragm. Recent studies have demonstrated that podocytes play a crucial role in blood filtration and in the pathogenesis of proteinuria and glomerular sclerosis; however, the molecular mechanisms that organize the podocyte filtration barrier are not fully understood. In this study, we suggest that tight junction protein 1 (Tjp1 or ZO-1), which is encoded by Tjp1 gene, plays an essential role in establishing the podocyte filtration barrier. The podocyte-specific deletion of Tjp1 down-regulated the expression of podocyte membrane proteins, impaired the interdigitation of the foot processes and the formation of the slit diaphragm, resulting in glomerular dysfunction. We found the possibility that podocyte filtration barrier requires the integration of two independent units, the pre-existing epithelial junction components and the newly synthesized podocyte-specific components, at the final stage in glomerular morphogenesis, for which Tjp1 is indispensable. Together with previous findings that Tjp1 expression was decreased in glomerular diseases in human and animal models, our results indicate that the suppression of Tjp1 could directly aggravate glomerular disorders, highlights Tjp1 as a potential therapeutic target.	[Itoh, Masahiko; Horibata, Yasuhiro; Sugimoto, Hiroyuki] Dokkyo Med Univ, Sch Med, Dept Biochem, Mibu, Tochigi, Japan; [Nakadate, Kazuhiko] Meiji Pharmaceut Univ, Dept Basic Biol, Educ & Res Ctr Pharm, Tokyo, Japan; [Matsusaka, Taiji] Tokai Univ, Sch Med, Dept Internal Med, Isehara, Kanagawa 25911, Japan; [Xu, Jianliang; Hunziker, Walter] Natl Univ Singapore, Inst Mol & Cell Biol, Epithelial Cell Biol Lab, Singapore 117548, Singapore	Dokkyo Medical University; Meiji Pharmaceutical University; Tokai University; Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Molecular & Cell Biology (IMCB); National University of Singapore	Itoh, M (corresponding author), Dokkyo Med Univ, Sch Med, Dept Biochem, Mibu, Tochigi, Japan.	mitoh@dokkyomed.ac.jp; hunziker@imcb.a-star.edu.sg	Hunziker, Walter/B-3140-2010; Hunziker, Walter/GSM-8190-2022	Hunziker, Walter/0000-0002-5265-4933; Xu, Jianliang/0000-0002-2277-2197	JSPS KAKENHI [23590242]; Grants-in-Aid for Scientific Research [25870668] Funding Source: KAKEN	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by JSPS KAKENHI to M.I. (Grant Number 23590242). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asano T, 2005, J AM SOC NEPHROL, V16, P2257, DOI 10.1681/ASN.2004121134; Asanuma K, 2006, NAT CELL BIOL, V8, P485, DOI 10.1038/ncb1400; Boute N, 2000, NAT GENET, V24, P349, DOI 10.1038/74166; Brinkkoetter PT, 2013, NAT REV NEPHROL, V9, P328, DOI 10.1038/nrneph.2013.78; CAULFIELD JP, 1976, LAB INVEST, V34, P43; D'Agati V, 2003, SEMIN NEPHROL, V23, P117, DOI 10.1053/snep.2003.50012; D'Agati VD, 2011, NEW ENGL J MED, V365, P2398, DOI 10.1056/NEJMra1106556; Dai CS, 2009, J AM SOC NEPHROL, V20, P1997, DOI 10.1681/ASN.2009010019; Fukasawa H, 2009, J AM SOC NEPHROL, V20, P1491, DOI 10.1681/ASN.2008101117; George B, 2012, SEMIN NEPHROL, V32, P307, DOI 10.1016/j.semnephrol.2012.06.002; George B, 2012, J CLIN INVEST, V122, P674, DOI 10.1172/JCI60070; Grahammer F, 2013, NAT REV NEPHROL, V9, P587, DOI 10.1038/nrneph.2013.169; Haraldsson B, 2008, PHYSIOL REV, V88, P451, DOI 10.1152/physrev.00055.2006; Jones N, 2006, NATURE, V440, P818, DOI 10.1038/nature04662; Kaplan JM, 2000, NAT GENET, V24, P251, DOI 10.1038/73456; Katsuno T, 2008, MOL BIOL CELL, V19, P2465, DOI 10.1091/mbc.E07-12-1215; Kestila M, 1998, MOL CELL, V1, P575, DOI 10.1016/S1097-2765(00)80057-X; Kilkenny C, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000412; Kim JM, 2003, SCIENCE, V300, P1298, DOI 10.1126/science.1081068; Kos CH, 2003, J CLIN INVEST, V111, P1683, DOI 10.1172/JCI200317988; KURIHARA H, 1992, AM J PATHOL, V141, P805; Li H, 2004, J AM SOC NEPHROL, V15, P3006, DOI 10.1097/01.ASN.0000146689.88078.80; Li YJ, 2008, AM J PATHOL, V172, P299, DOI 10.2353/ajpath.2008.070057; Ma H, 2010, J AM SOC NEPHROL, V21, P1145, DOI 10.1681/ASN.2009090991; Miner JH, 2002, J CLIN INVEST, V109, P1065, DOI 10.1172/JCi200213954; Mundel P, 1997, EXP CELL RES, V236, P248, DOI 10.1006/excr.1997.3739; Niimura F, 1995, J CLIN INVEST, V96, P2947, DOI 10.1172/JCI118366; Pavenstadt H, 2003, PHYSIOL REV, V83, P253, DOI 10.1152/physrev.00020.2002; Putaala H, 2001, HUM MOL GENET, V10, P1, DOI 10.1093/hmg/10.1.1; Radice GL, 1997, J CELL BIOL, V139, P1025, DOI 10.1083/jcb.139.4.1025; Reiser J, 2000, J AM SOC NEPHROL, V11, P1, DOI 10.1681/ASN.V1111; Rincon-Choles H, 2006, DIABETES, V55, P894, DOI 10.2337/diabetes.55.04.06.db05-0355; Rohr C, 2002, J CLIN INVEST, V109, P1073, DOI 10.1172/JCI200213961; Roselli S, 2004, MOL CELL BIOL, V24, P550, DOI 10.1128/MCB.24.2.550-560.2004; SCHNABEL E, 1990, J CELL BIOL, V111, P1255, DOI 10.1083/jcb.111.3.1255; Shih NY, 1999, SCIENCE, V286, P312, DOI 10.1126/science.286.5438.312; Shono A, 2007, J AM SOC NEPHROL, V18, P2525, DOI 10.1681/ASN.2006101084; Tryggvason K, 2006, CELL, V125, P221, DOI 10.1016/j.cell.2006.04.002; Tsukita S, 2001, NAT REV MOL CELL BIO, V2, P285, DOI 10.1038/35067088; Weavers H, 2009, NATURE, V457, P322, DOI 10.1038/nature07526	40	43	43	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 3	2014	9	9							e106621	10.1371/journal.pone.0106621	http://dx.doi.org/10.1371/journal.pone.0106621			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3TB	25184792	gold, Green Submitted, Green Published			2022-12-27	WOS:000341257700094
J	Liao, L; Yang, S; Miron, RJ; Wei, JC; Zhang, YF; Zhang, M				Liao, Lan; Yang, Shuang; Miron, Richard J.; Wei, Junchao; Zhang, Yufeng; Zhang, Meng			Osteogenic Properties of PBLG-g-HA/PLLA Nanocomposites	PLOS ONE			English	Article							MODIFIED HYDROXYAPATITE/POLY(L-LACTIDE) NANOCOMPOSITES; IN-VIVO; HYDROXYAPATITE; SCAFFOLDS; CELLS; POLYLACTIDE; REPAIR; DIFFERENTIATION; MINERALIZATION; NANOPARTICLES	New development of biomaterial scaffolds remains a prominent issue for the regeneration of lost or fractured bone. Of these scaffolds, a number of bioactive polymers have been synthesized and fabricated for diverse biological roles. Although recent evidence has demonstrated that composite scaffolds such as HA/PLLA have improved properties when compared to either HA or PLLA alone, recent investigations have demonstrated that the phase compatibility between HA and PLLA layers is weak preventing optimal enhancement of the mechanical properties and making the composites prone to breakdown. In the present study, poly (gamma-benzyl-L-glutamate) modified hydroxyapatite/(poly (L-lactic acid)) (PBLG-g-HA/PLLA) composite scaffolds were fabricated with improved phase compatibility and tested for their osteogenic properties in 18 Wistar female rats by analyzing new bone formation in 3 mm bilateral femur defects in vivo. At time points, 2, 4 and 8 weeks post surgery, bone formation was evaluated by mu-CT and histological analysis by comparing 4 treatment groups; 1) blank defect, 2) PLLA, 3) HA/PLLA and 4) PBLG-g-HA/PLLA scaffolds. The in vivo analysis demonstrated that new bone formation was much more prominent in HA/PLLA and PBLG-g-HA/PLLA groups as depicted by mu-CT, H&E staining and immunohistochemistry for collagen I. TRAP staining was also utilized to determine the influence of osteoclast cell number and staining intensity to the various scaffolds. No significant differences in either staining intensity or osteoclast numbers between all treatment modalities was observed, however blank defects did contain a higher number of osteoclast-like cells. The results from the present study illustrate the potential of PBLG-g-HA/PLLA scaffolds for bone tissue engineering applications by demonstrating favorable osteogenic properties.	[Liao, Lan; Wei, Junchao; Zhang, Meng] Nanchang Univ, Sch Mat Sci & Engn, Nanchang, Peoples R China; [Liao, Lan] Nanchang Univ, Sch Stomatol, Nanchang, Peoples R China; [Yang, Shuang; Miron, Richard J.; Zhang, Yufeng] Wuhan Univ, State Key Lab Breeding Base Basic Sci Stomatol Hu, Sch & Hosp Stomatol, Minist Educ, Wuhan 430072, Peoples R China; [Yang, Shuang; Miron, Richard J.; Zhang, Yufeng] Wuhan Univ, Key Lab Oral Biomed, Sch & Hosp Stomatol, Minist Educ, Wuhan 430072, Peoples R China; [Zhang, Yufeng] Wuhan Univ, Sch Stomatol, Dept Oral Implantol, Wuhan 430072, Peoples R China	Nanchang University; Nanchang University; Wuhan University; Wuhan University; Wuhan University	Wei, JC (corresponding author), Nanchang Univ, Sch Mat Sci & Engn, Nanchang, Peoples R China.	weijunchao@ncu.edu.cn; zyf@whu.edu.cn; zhhmeng@ncu.edu.cn	Zhang, Mengzhi/GRX-6466-2022	Zhang, Yufeng/0000-0001-8702-5291	Program for New Century Excellent Talents in University [NCET-11-0414]; Excellent Youth Foundation of Hubei; National Natural Science Foundation of China [81271108, 51203073]; education department of Jiangxi province [GJJ13107]	Program for New Century Excellent Talents in University(Program for New Century Excellent Talents in University (NCET)); Excellent Youth Foundation of Hubei; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); education department of Jiangxi province	This project was supported by Program for New Century Excellent Talents in University (NCET-11-0414), Excellent Youth Foundation of Hubei and the funds of the National Natural Science Foundation of China (81271108& amp; 51203073). The authors are also grateful for the project from education department of Jiangxi province (GJJ13107). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boccaccini A.R., 2005, BIOACTIVE COMPOSITE; Cai Q, 2002, BIOMATERIALS, V23, P4483, DOI 10.1016/S0142-9612(02)00168-0; Charles LF, 2013, J MECH BEHAV BIOMED, V17, P269, DOI 10.1016/j.jmbbm.2012.09.007; Cheng N, 2013, J MATER SCI-MATER M, V24, P1963, DOI 10.1007/s10856-013-4945-y; Costantino PD, 2000, OTOLARYNG HEAD NECK, V123, P409, DOI 10.1067/mhn.2000.107679; Dinaryand P, 2011, ACS APPL MATER INTER, V3, P4518, DOI 10.1021/am201212u; Dugard MN, 2005, CLIN CHIM ACTA, V356, P154, DOI 10.1016/j.cccn.2005.01.020; Durrieu MC, 2004, J MATER SCI-MATER M, V15, P779, DOI 10.1023/B:JMSM.0000032818.09569.d9; Fuchs S, 2006, BIOMATERIALS, V27, P5399, DOI 10.1016/j.biomaterials.2006.06.015; Giannoudis PV, 2005, INJURY, V36, P20, DOI 10.1016/j.injury.2005.07.029; Gupta AP, 2007, EUR POLYM J, V43, P4053, DOI 10.1016/j.eurpolymj.2007.06.045; Hartgerink JD, 2001, SCIENCE, V294, P1684, DOI 10.1126/science.1063187; Hasegawa S, 2006, BIOMATERIALS, V27, P1327, DOI 10.1016/j.biomaterials.2005.09.003; Hayashi M, 2013, J CRANIOMAXILLOFAC S; Komlev VS, 2006, TISSUE ENG, V12, P3449, DOI 10.1089/ten.2006.12.3449; Li XM, 2006, MAT SCI ENG C-BIO S, V26, P716, DOI 10.1016/j.msec.2005.06.062; Li XM, 2007, J CELL BIOCHEM, V100, P527, DOI 10.1002/jcb.21017; Ludwig SC, 2000, EUR SPINE J; Matsuo A, 2010, ODONTOLOGY, V98, P85, DOI 10.1007/s10266-009-0111-x; MCCONNELL D, 1961, SCIENCE, V133, P281, DOI 10.1126/science.133.3448.281; Mei F, 2007, BIOMACROMOLECULES, V8, P3729, DOI 10.1021/bm7006295; Miron RJ, 2012, J DENT RES, V91, P736, DOI 10.1177/0022034511435260; Ngiam M, 2009, TISSUE ENG PT A, V15, P535, DOI 10.1089/ten.tea.2008.0011; Supova M, 2009, J MAT SCI MAT MED; Supova M, 2009, J MATER SCI-MATER M, V20, P1201, DOI 10.1007/s10856-009-3696-2; Takayama T, 2009, J MAT SCI; Wei JC, 2011, CHEM J CHINESE U, V32, P2674; Wei JC, 2011, SCI CHINA CHEM, V54, P431, DOI 10.1007/s11426-011-4221-2; Wei JC, 2009, MACROMOL BIOSCI, V9, P631, DOI 10.1002/mabi.200800324; Wei L., 2013, CLIN IMPLANT DENT RE; Wildemann B, 2004, J CONTROL RELEASE, V95, P249, DOI 10.1016/j.jconrel.2003.11.014; Wu CT, 2011, BIOMATERIALS, V32, P7068, DOI 10.1016/j.biomaterials.2011.06.009; Zhang YF, 2012, BIOMATERIALS, V33, P6698, DOI 10.1016/j.biomaterials.2012.06.021	33	20	21	2	59	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 3	2014	9	9							e105876	10.1371/journal.pone.0105876	http://dx.doi.org/10.1371/journal.pone.0105876			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3TB	25184285	Green Published, gold, Green Submitted			2022-12-27	WOS:000341257700027
J	Ng, HP; Zhou, Y; Song, KJ; Hodges, CA; Drumm, ML; Wang, GS				Ng, Hang Pong; Zhou, Yun; Song, Kejing; Hodges, Craig A.; Drumm, Mitchell L.; Wang, Guoshun			Neutrophil-Mediated Phagocytic Host Defense Defect in Myeloid Cftr-Inactivated Mice	PLOS ONE			English	Article							FIBROSIS LUNG-DISEASE; CYSTIC-FIBROSIS; PSEUDOMONAS-AERUGINOSA; HYPOCHLOROUS ACID; LEUKOCYTE MYELOPEROXIDASE; STAPHYLOCOCCUS-AUREUS; BACTERICIDAL ACTIVITY; INNATE IMMUNITY; CHLORINATION; DEFICIENT	Cystic fibrosis (CF) is a common and deadly inherited disease, caused by mutations in the CFTR gene that encodes a cAMP-activated chloride channel. One outstanding manifestation of the disease is the persistent bacterial infection and inflammation in the lung, which claims over 90% of CF mortality. It has been debated whether neutrophil-mediated phagocytic innate immunity has any intrinsic defect that contributes to the host lung defense failure. Here we compared phagosomal CFTR targeting, hypochlorous acid (HOCl) production, and microbial killing of the neutrophils from myeloid Cftr-inactivated (Myeloid-Cftr-/-) mice and the non-inactivated control (Cftr(fl10)) mice. We found that the mutant CFTR that lacked Exon-10 failed to target to the neutrophil phagosomes. This dysfunction resulted in impaired intraphagosomal HOCl production and neutrophil microbial killing. In vivo lung infection with a lethal dose of Pseudomonas aeruginosa caused significantly higher mortality in the myeloid CF mice than in the controls. The myeloid-Cftr-/- lungs were deficient in bacterial clearance, and had sustained neutrophilic inflammation and stalled transition from early to late immunity. These manifestations recapitulated the symptoms of human CF lungs. The data altogether suggest that myeloid CFTR expression is critical to normal host lung defense. CFTR dysfunction in neutrophils compromises the phagocytic innate immunity, which may predispose CF lungs to infection.	[Ng, Hang Pong; Zhou, Yun; Song, Kejing; Wang, Guoshun] Louisiana State Univ, Hlth Sci Ctr, Dept Microbiol & Immunol, New Orleans, LA 70112 USA; [Hodges, Craig A.; Drumm, Mitchell L.] Case Western Reserve Univ, Sch Med, Dept Pediat, Cleveland, OH 44106 USA; [Hodges, Craig A.; Drumm, Mitchell L.] Case Western Reserve Univ, Sch Med, Dept Genet & Genome Sci, Cleveland, OH USA; [Wang, Guoshun] Louisiana State Univ, Hlth Sci Ctr, Dept Genet, New Orleans, LA USA; [Wang, Guoshun] Louisiana State Univ, Hlth Sci Ctr, Dept Med, New Orleans, LA USA	Louisiana State University System; Louisiana State University Health Sciences Center New Orleans; Case Western Reserve University; Case Western Reserve University; Louisiana State University System; Louisiana State University Health Sciences Center New Orleans; Louisiana State University System; Louisiana State University Health Sciences Center New Orleans	Wang, GS (corresponding author), Louisiana State Univ, Hlth Sci Ctr, Dept Microbiol & Immunol, New Orleans, LA 70112 USA.	gwang@lsuhsc.edu	NG, Hang Pong/AAB-2427-2020		LSUHSC research grant; NIH [R01AI72327]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI072327] Funding Source: NIH RePORTER	LSUHSC research grant; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by a LSUHSC research grant and an NIH grant (R01AI72327) to GW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adib-Conquy M, 2008, MOL MED, V14, P36, DOI 10.2119/2007-00081.Adib-Conquy; Aiken ML, 2012, FREE RADICAL BIO MED, V53, P2308, DOI 10.1016/j.freeradbiomed.2012.10.542; ALBRICH JM, 1981, P NATL ACAD SCI-BIOL, V78, P210, DOI 10.1073/pnas.78.1.210; Aratani Y, 1999, INFECT IMMUN, V67, P1828; Aratani Y, 2000, J INFECT DIS, V182, P1276, DOI 10.1086/315843; Aratani Y, 2006, J MED MICROBIOL, V55, P1291, DOI 10.1099/jmm.0.46620-0; Babaev VR, 2005, ARTERIOSCL THROM VAS, V25, P1647, DOI 10.1161/01.ATV.0000173413.31789.1a; BABIOR BM, 1978, NEW ENGL J MED, V298, P659, DOI 10.1056/NEJM197803232981205; BODEY GP, 1966, ANN INTERN MED, V64, P328, DOI 10.7326/0003-4819-64-2-328; Bonfield TL, 2012, J LEUKOCYTE BIOL, V92, P1111, DOI 10.1189/jlb.0412188; Boxio R, 2004, J LEUKOCYTE BIOL, V75, P604, DOI 10.1189/jlb.0703340; Bruscia EM, 2009, AM J RESP CELL MOL, V40, P295, DOI 10.1165/rcmb.2008-0170OC; Chapman ALP, 2002, J BIOL CHEM, V277, P9757, DOI 10.1074/jbc.M106134200; Chen X, 2011, CHEM COMMUN, V47, P4373, DOI 10.1039/c1cc10589b; Cohen TS, 2012, NAT MED, V18, P509, DOI 10.1038/nm.2715; COLLINS FS, 1992, SCIENCE, V256, P774, DOI 10.1126/science.1375392; Corvol H, 2003, AM J PHYSIOL-LUNG C, V284, pL997, DOI 10.1152/ajplung.00156.2002; Cui LY, 2007, J MOL BIOL, V365, P981, DOI 10.1016/j.jmb.2006.10.086; Davis PB, 1996, AM J RESP CRIT CARE, V154, P1229, DOI 10.1164/ajrccm.154.5.8912731; DEIMANN W, 1984, PROG HISTOCHEM CYTOC, V15, P1; Del Porto P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019970; Deriy LV, 2009, J BIOL CHEM, V284, P35926, DOI 10.1074/jbc.M109.057372; Di A, 2006, NAT CELL BIOL, V8, P933, DOI 10.1038/ncb1456; Downey DG, 2009, THORAX, V64, P81, DOI 10.1136/thx.2007.082388; FOOTE CS, 1983, NATURE, V301, P715, DOI 10.1038/301715a0; Hampton MB, 1996, INFECT IMMUN, V64, P3512, DOI 10.1128/IAI.64.9.3512-3517.1996; HARRISON JE, 1976, J BIOL CHEM, V251, P1371; Hartl D, 2012, J CYST FIBROS, V11, P363, DOI 10.1016/j.jcf.2012.07.003; Hartl D, 2007, NAT MED, V13, P1423, DOI 10.1038/nm1690; Hayes E, 2011, ARCH IMMUNOL THER EX, V59, P97, DOI 10.1007/s00005-011-0113-6; Hodges CA, 2008, GENESIS, V46, P546, DOI 10.1002/dvg.20433; Jiang Q, 1997, CHEM RES TOXICOL, V10, P1080, DOI 10.1021/tx9700984; Kantari Chahrazade, 2008, V15, P118, DOI 10.1159/000136335; Kettle A. J., 2014, EUR RESP J; Kim J, 2001, J IMMUNOL, V167, P2808, DOI 10.4049/jimmunol.167.5.2808; Klebanoff SJ, 2013, J LEUKOCYTE BIOL, V93, P185, DOI 10.1189/jlb.0712349; KLEBANOFF SJ, 1968, J BACTERIOL, V95, P2131, DOI 10.1128/JB.95.6.2131-2138.1968; KLEBANOFF SJ, 1970, SCIENCE, V169, P1095, DOI 10.1126/science.169.3950.1095; Klein C, 2011, ANNU REV IMMUNOL, V29, P399, DOI 10.1146/annurev-immunol-030409-101259; Kukavica-Ibrulj I, 2008, J BACTERIOL, V190, P2804, DOI 10.1128/JB.01572-07; Leguit RJ, 2010, HISTOPATHOLOGY, V57, P655, DOI 10.1111/j.1365-2559.2010.03612.x; LEHRER RI, 1969, J CLIN INVEST, V48, P1478, DOI 10.1172/JCI106114; LEHRER RI, 1969, NATURE, V223, P78, DOI 10.1038/223078a0; Luo Yi, 2001, Curr Protoc Immunol, VChapter 3, DOI 10.1002/0471142735.im0320s22; Malech HL, 1997, SEMIN HEMATOL, V34, P279; Marcos V, 2010, NAT MED, V16, P1018, DOI 10.1038/nm.2209; Moriceau S, 2010, J INNATE IMMUN, V2, P260, DOI 10.1159/000295791; Nauseef WM, 2007, IMMUNOL REV, V219, P88, DOI 10.1111/j.1600-065X.2007.00550.x; Painter RG, 2008, J LEUKOCYTE BIOL, V83, P1345, DOI 10.1189/jlb.0907658; Painter RG, 2006, BIOCHEMISTRY-US, V45, P10260, DOI 10.1021/bi060490t; Painter RG, 2010, J LEUKOCYTE BIOL, V87, P933, DOI 10.1189/jlb.1009655; Pohl K, 2014, BLOOD; Reeves EP, 2011, AM J RESP CRIT CARE, V183, P1517, DOI 10.1164/rccm.201101-0072OC; Rieber N, 2014, INT J BIOCH CELL BIO; Sajjan U, 2001, J MED MICROBIOL, V50, P535, DOI 10.1099/0022-1317-50-6-535; Stoltz DA, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000928; Su X, 2011, INFLAMM RES; Tirouvanziam R, 2008, P NATL ACAD SCI USA, V105, P4335, DOI 10.1073/pnas.0712386105; van Heeckeren AM, 2002, LAB ANIM-UK, V36, P291, DOI 10.1258/002367702320162405; WEISS SJ, 1982, J CLIN INVEST, V70, P598, DOI 10.1172/JCI110652; Welsh MJ, 2001, METABOLIC MOL BASES, P5121; Winterbourn CC, 2006, J BIOL CHEM, V281, P39860, DOI 10.1074/jbc.M605898200; Witko-Sarsat V, 1999, MEDIAT INFLAMM, V8, P7, DOI 10.1080/09629359990658; WitkoSarsat V, 1996, J IMMUNOL, V157, P2728; YOSHIMURA K, 1991, NUCLEIC ACIDS RES, V19, P5417, DOI 10.1093/nar/19.19.5417; Zhou Y, 2013, J INNATE IMMUN, V5, P219, DOI 10.1159/000346568	66	42	43	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 3	2014	9	9							e106813	10.1371/journal.pone.0106813	http://dx.doi.org/10.1371/journal.pone.0106813			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3TB	25184794	Green Published, gold, Green Submitted			2022-12-27	WOS:000341257700121
J	Stefanini, GG; Taniwaki, M; Kalesan, B; Raber, L; Stortecky, S; Pilgrim, T; Onuma, Y; Silber, S; Serruys, PW; Meier, B; Juni, P; Windecker, S				Stefanini, Giulio G.; Taniwaki, Masanori; Kalesan, Bindu; Raeber, Lorenz; Stortecky, Stefan; Pilgrim, Thomas; Onuma, Yoshinobu; Silber, Sigmund; Serruys, Patrick W.; Meier, Bernhard; Jueni, Peter; Windecker, Stephan			The Impact of Renal Impairment on Long-Term Safety and Effectiveness of Drug-Eluting Stents	PLOS ONE			English	Article							CHRONIC KIDNEY-DISEASE; PERCUTANEOUS CORONARY INTERVENTION; ADVERSE CLINICAL EVENTS; HEART-DISEASE; OUTCOMES; INSUFFICIENCY; REVASCULARIZATION; RESTENOSIS; MODERATE; IMPLANTATION	Background: Renal impairment (RI) is associated with impaired prognosis in patients with coronary artery disease. Clinical and angiographic outcomes of patients undergoing percutaneous coronary intervention (PCI) with the use of drug-eluting stents (DES) in this patient population are not well established. Methods: We pooled individual data for 5,011 patients from 3 trials with the exclusive and unrestricted use of DES (SIRTAX - N = 1,012, LEADERS - N = 1,707, RESOLUTE AC - N = 2,292). Angiographic follow-up was available for 1,544 lesions. Outcomes through 2 years were stratified according to glomerular filtration rate (normal renal function: GFR >= 90 ml/min; mild RI: 90, GFR >= 60 ml/min; moderate/severe RI GFR<60 ml/min). Results: Patients with moderate/severe RI had an increased risk of cardiac death or myocardial infarction ([MI], OR 2.14, 95%CI 1.36-3.36), cardiac death (OR 2.21, 95%CI 1.10-4.46), and MI (OR 2.02, 95%CI 1.19-3.43) compared with patients with normal renal function at 2 years follow-up. There was no difference in cardiac death or MI between patients with mild RI compared to those with normal renal function (OR 1.10, 95%CI 0.75-1.61). The risk of target-lesion revascularization was similar for patients with moderate/severe RI (OR 1.17, 95%CI 0.70-1.95) and mild RI (OR 1.16, 95%CI 0.81-1.64) compared with patients with normal renal function. In-stent late loss and in-segment restenosis were not different for patients with moderate/severe RI, mild RI, and normal renal function. Conclusions: Renal function does not affect clinical and angiographic effectiveness of DES. However, prognosis remains impaired among patients with moderate/severe RI.	[Stefanini, Giulio G.; Taniwaki, Masanori; Raeber, Lorenz; Stortecky, Stefan; Pilgrim, Thomas; Meier, Bernhard; Windecker, Stephan] Univ Hosp Bern, Dept Cardiol, CH-3010 Bern, Switzerland; [Kalesan, Bindu; Jueni, Peter; Windecker, Stephan] Univ Hosp Bern, Clin Trials Unit, CH-3010 Bern, Switzerland; [Kalesan, Bindu; Jueni, Peter] Univ Bern, Inst Social & Prevent Med, Bern, Switzerland; [Onuma, Yoshinobu; Serruys, Patrick W.] Erasmus MC, Thoraxctr, Rotterdam, Netherlands; [Silber, Sigmund] Heart Ctr Isar, Munich, Germany	University of Bern; University Hospital of Bern; University of Bern; University Hospital of Bern; University of Bern; Erasmus University Rotterdam; Erasmus MC	Windecker, S (corresponding author), Univ Hosp Bern, Dept Cardiol, CH-3010 Bern, Switzerland.	stephan.windecker@insel.ch	Stefanini, Giulio G/K-7406-2016; Juni, Peter/Q-8700-2016; Onuma, Yoshinobu/AHB-6273-2022; Stefanini, Giulio/GZG-4754-2022; Stortecky, Stefan/AAS-9140-2021; Pilgrim, Thomas/AAS-9120-2021	Stefanini, Giulio G/0000-0002-3558-6967; Juni, Peter/0000-0002-5985-0670; Onuma, Yoshinobu/0000-0001-7702-0649; Stefanini, Giulio/0000-0002-3558-6967; Pilgrim, Thomas/0000-0001-8721-4068; Stortecky, Stefan/0000-0002-5076-0177	Swiss National Science Foundation [33CM30-140336]; Swiss National Science Foundation	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	Funding for the current analysis was provided in part by a grant of the Swiss National Science Foundation (grant 33CM30-140336). Dr. Stefanini is the recipient of a research fellowship (SPUM) of the Swiss National Science Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Appleby CE, 2009, CIRC-CARDIOVASC INTE, V2, P309, DOI 10.1161/CIRCINTERVENTIONS.108.828954; Berl T, 2006, CLIN J AM SOC NEPHRO, V1, P8, DOI 10.2215/CJN.00730805; Best PJM, 2002, J AM COLL CARDIOL, V39, P1113, DOI 10.1016/S0735-1097(02)01745-X; Best PJM, 2004, J AM COLL CARDIOL, V44, P1786, DOI 10.1016/j.jacc.2004.07.052; Collins Allan J, 2012, Am J Kidney Dis, V59, pe1, DOI 10.1053/j.ajkd.2011.11.015; Cutlip DE, 2007, CIRCULATION, V115, P2344, DOI 10.1161/CIRCULATIONAHA.106.685313; Eknoyan G, 2002, AM J KIDNEY DIS, V39, pS14, DOI 10.1053/ajkd.2002.30939; Garg P, 2010, AM J CARDIOL, V106, P1436, DOI 10.1016/j.amjcard.2010.07.011; Go AS, 2004, NEW ENGL J MED, V351, P1296, DOI 10.1056/NEJMoa041031; Hage FG, 2009, J AM COLL CARDIOL, V53, P2129, DOI 10.1016/j.jacc.2009.02.047; Halkin A, 2005, AM HEART J, V150, P1163, DOI 10.1016/j.ahj.2005.01.032; Iakovou I, 2005, JAMA-J AM MED ASSOC, V293, P2126, DOI 10.1001/jama.293.17.2126; Kimura T, 2010, CIRCULATION, V122, P52, DOI 10.1161/CIRCULATIONAHA.109.903955; Koyanagi T, 1996, ANN THORAC SURG, V61, P1793, DOI 10.1016/0003-4975(96)00170-1; Kuchulakanti PK, 2006, AM J CARDIOL, V97, P792, DOI 10.1016/j.amjcard.2005.10.018; Latif F, 2009, JACC-CARDIOVASC INTE, V2, P37, DOI 10.1016/j.jcin.2008.06.012; Lemos PA, 2005, AM J CARDIOL, V95, P167, DOI 10.1016/j.amjcard.2004.08.089; Levey AS, 2003, ANN INTERN MED, V139, P137, DOI 10.7326/0003-4819-139-2-200307150-00013; Roger VL, 2012, CIRCULATION, V125, pE2, DOI 10.1161/CIR.0b013e31823ac046; Rosenblum MA, 2009, NEPHRON CLIN PRACT, V113, pC198, DOI 10.1159/000232602; Rubenstein MH, 2000, CIRCULATION, V102, P2966; Saltzman AJ, 2011, JACC-CARDIOVASC INTE, V4, P1011, DOI 10.1016/j.jcin.2011.06.012; Schoebel FC, 1997, HEART, V78, P337, DOI 10.1136/hrt.78.4.337; Serruys PW, 2010, NEW ENGL J MED, V363, P136, DOI 10.1056/NEJMoa1004130; Stefanini GG, 2013, LANCET, V382, P1879, DOI 10.1016/S0140-6736(13)61782-1; Stefanini GG, 2013, NEW ENGL J MED, V368, P254, DOI 10.1056/NEJMra1210816; Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS), 2010, Eur Heart J, V31, P2501, DOI 10.1093/eurheartj/ehq277; Tomai F, 2014, CIRCULATION, V129, P1104, DOI 10.1161/CIRCULATIONAHA.113.005186; Tonelli M, 2006, J AM SOC NEPHROL, V17, P2034, DOI 10.1681/ASN.2005101085; Tsai TT, 2011, J AM COLL CARDIOL, V58, P1859, DOI 10.1016/j.jacc.2011.06.056; Vranckx P, 2010, EUROINTERVENTION, V5, P871, DOI 10.4244/EIJV5I7A146; Wenaweser P, 2008, J AM COLL CARDIOL, V52, P1134, DOI 10.1016/j.jacc.2008.07.006; Windecker S, 2005, NEW ENGL J MED, V353, P653, DOI 10.1056/NEJMoa051175; Windecker S, 2008, LANCET, V372, P1163, DOI 10.1016/S0140-6736(08)61244-1; Zhang RY, 2009, INT J CARDIOL, V136, P72, DOI 10.1016/j.ijcard.2008.04.028	35	9	9	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 3	2014	9	9							e106450	10.1371/journal.pone.0106450	http://dx.doi.org/10.1371/journal.pone.0106450			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3TB	25184244	Green Published, Green Submitted, gold			2022-12-27	WOS:000341257700075
J	Swennes, AG; Sheh, A; Parry, NMA; Muthupalani, S; Lertpiriyapong, K; Garcia, A; Fox, JG				Swennes, Alton G.; Sheh, Alexander; Parry, Nicola M. A.; Muthupalani, Sureshkumar; Lertpiriyapong, Kvin; Garcia, Alexis; Fox, James G.			Helicobacter hepaticus Infection Promotes Hepatitis and Preneoplastic Foci in Farnesoid X Receptor (FXR) Deficient Mice	PLOS ONE			English	Article							BILE-ACID RECEPTOR; VITAMIN-D-RECEPTOR; HEPATOCELLULAR-CARCINOMA; NUCLEAR RECEPTOR; LITHOCHOLIC ACID; COLON CARCINOGENESIS; LIVER-TUMORS; A/JCR MICE; HEPATOCARCINOGENESIS; EXPRESSION	Farnesoid X receptor (FXR) is a nuclear receptor that regulates bile acid metabolism and transport. Mice lacking expression of FXR (FXR KO) have a high incidence of foci of cellular alterations (FCA) and liver tumors. Here, we report that Helicobacter hepaticus infection is necessary for the development of increased hepatitis scores and FCA in previously Helicobacter-free FXR KO mice. FXR KO and wild-type (WT) mice were sham-treated or orally inoculated with H. hepaticus. At 12 months post-infection, mice were euthanized and liver pathology, gene expression, and the cecal microbiome were analyzed. H. hepaticus induced significant increases hepatitis scores and FCA numbers in FXR KO mice (P<0.01 and P<0.05, respectively). H. hepaticus altered the beta diversity of cecal microbiome in both WT and FXR KO mice compared to uninfected mice (P<0.05). Significant upregulation of beta-catenin, Rela, Slc10a1, Tlr2, Nos2, Vdr, and Cyp3a11 was observed in all FXR KO mice compared to controls (P< 0.05). Importantly, H. hepaticus and FXR deficiency were necessary to significantly upregulate Cyp2b10 (P< 0.01). FXR deficiency was also a potent modulator of the cecal microbiota, as observed by a strong decrease in alpha diversity. A significant decrease in Firmicutes, particularly members of the order Clostridiales, was observed in FXR KO mice (P< 0.05 and FDR<5%, ANOVA). While FXR deficiency strongly affects expression of genes related to immunity and bile acid metabolism, as well as the composition of the microbiome; however, its deficiency was not able to produce significant histopathological changes in the absence of H. hepaticus infection.	[Swennes, Alton G.; Sheh, Alexander; Parry, Nicola M. A.; Muthupalani, Sureshkumar; Lertpiriyapong, Kvin; Garcia, Alexis; Fox, James G.] MIT, Div Comparat Med, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT)	Fox, JG (corresponding author), MIT, Div Comparat Med, Cambridge, MA 02139 USA.	jgfox@mit.edu	Muthupalani, Sureshkumar/C-7244-2015	Parry, Nicola/0000-0002-0446-5249	NIH [R01 OD011141, T32 OD010978, P30 ES002109, P01 CA026731]; NATIONAL CANCER INSTITUTE [P01CA026731] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES002109] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [T32OD010978, R01OD011141] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by NIH R01 OD011141 (JGF), NIH T32 OD010978 (JGF), NIH P30 ES002109 (JGF), and P01 CA026731. The NIH website is at www.nih.gov. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atarashi K, 2011, SCIENCE, V331, P337, DOI 10.1126/science.1198469; Berr F, 1996, GASTROENTEROLOGY, V111, P1611, DOI 10.1016/S0016-5085(96)70024-0; Boutin SR, 2004, TOXICOL PATHOL, V32, P678, DOI 10.1080/01926230490524058; Caporaso JG, 2011, P NATL ACAD SCI USA, V108, P4516, DOI 10.1073/pnas.1000080107; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Chichlowski M, 2008, COMPARATIVE MED, V58, P534; Chichlowski M, 2009, COMPARATIVE MED, V59, P10; Denson LA, 2001, GASTROENTEROLOGY, V121, P140, DOI 10.1053/gast.2001.25503; Dufer M, 2012, ISLETS, V4, P333, DOI [10.4161/islets.22383, 10.4161/isl.22383]; Elinav E, 2011, CELL, V145, P745, DOI 10.1016/j.cell.2011.04.022; Fox JG, 2011, MUCOSAL IMMUNOL, V4, P22, DOI 10.1038/mi.2010.61; Fox JG, 1998, GASTROENTEROLOGY, V114, P755, DOI 10.1016/S0016-5085(98)70589-X; Fox JG, 1996, INFECT IMMUN, V64, P3673, DOI 10.1128/IAI.64.9.3673-3681.1996; Fox JG, 1996, INFECT IMMUN, V64, P1548, DOI 10.1128/IAI.64.5.1548-1558.1996; FOX JG, 1994, J CLIN MICROBIOL, V32, P1238, DOI 10.1128/JCM.32.5.1238-1245.1994; Fox JG, 1999, INFECT IMMUN, V67, P1757; Garcia A, 2008, INFECT IMMUN, V76, P1866, DOI 10.1128/IAI.01044-07; Garcia A, 2011, CANCER RES, V71, P2529, DOI 10.1158/0008-5472.CAN-10-1975; Ge ZM, 2007, CELL MICROBIOL, V9, P2070, DOI 10.1111/j.1462-5822.2007.00939.x; Ge ZM, 2001, J CLIN MICROBIOL, V39, P2598, DOI 10.1128/JCM.39.7.2598-2602.2001; Gonzalez FJ, 2012, COMPR PHYSIOL, V2, P2811, DOI 10.1002/cphy.c120007; Hailey JR, 1998, TOXICOL PATHOL, V26, P602, DOI 10.1177/019262339802600503; Hamady M, 2009, GENOME RES, V19, P1141, DOI 10.1101/gr.085464.108; Huang WD, 2006, SCIENCE, V312, P233, DOI 10.1126/science.1121435; Inagaki T, 2006, P NATL ACAD SCI USA, V103, P3920, DOI 10.1073/pnas.0509592103; Ishizawa M, 2008, J LIPID RES, V49, P763, DOI 10.1194/jlr.M700293-JLR200; Kim I, 2007, CARCINOGENESIS, V28, P940, DOI 10.1093/carcin/bgl249; Kozoni V, 2000, CARCINOGENESIS, V21, P999, DOI 10.1093/carcin/21.5.999; Kuczynski J, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-5-210; Kuehl CJ, 2005, INFECT IMMUN, V73, P6952, DOI 10.1128/IAI.73.10.6852-6961.2005; Liu NA, 2012, MOL ENDOCRINOL, V26, P775, DOI 10.1210/me.2011-1383; Lozupone C, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-371; Makishima M, 2002, SCIENCE, V296, P1313, DOI 10.1126/science.1070477; MALLONEE DH, 1990, J BACTERIOL, V172, P7011, DOI 10.1128/jb.172.12.7011-7019.1990; Marschall HU, 2006, J LIPID RES, V47, P582, DOI 10.1194/jlr.M500427-JLR200; Matsukura N, 2002, JPN J CANCER RES, V93, P842, DOI 10.1111/j.1349-7006.2002.tb01327.x; Nagalingam NA, 2013, MICROBIOME, V1, DOI 10.1186/2049-2618-1-15; Nishida S, 2009, DRUG METAB DISPOS, V37, P2037, DOI 10.1124/dmd.109.027334; Rajilic-Stojanovic M, 2011, GASTROENTEROLOGY, V141, P1792, DOI 10.1053/j.gastro.2011.07.043; REDDY BS, 1979, CANCER RES, V39, P1521; Ridlon JM, 2010, ANAEROBE, V16, P137, DOI 10.1016/j.anaerobe.2009.05.004; Rodrigue S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011840; Rogers AB, 2007, CANCER RES, V67, P11536, DOI 10.1158/0008-5472.CAN-07-1479; Rowan F, 2010, DIS COLON RECTUM, V53, P1530, DOI 10.1007/DCR.0b013e3181f1e620; Taylor NS, 2007, J CLIN MICROBIOL, V45, P2166, DOI 10.1128/JCM.00137-07; Thoolen B, 2010, TOXICOL PATHOL, V38, p5S, DOI 10.1177/0192623310386499; Vorobjova T, 2006, DIGEST LIVER DIS, V38, P171, DOI 10.1016/j.dld.2005.12.008; Wagner M, 2005, HEPATOLOGY, V42, P420, DOI 10.1002/hep.20784; WARD JM, 1994, JNCI-J NATL CANCER I, V86, P1222, DOI 10.1093/jnci/86.16.1222; Wells JE, 2000, APPL ENVIRON MICROB, V66, P1107, DOI 10.1128/AEM.66.3.1107-1113.2000; Whary MT, 2004, COMPARATIVE MED, V54, P128; Wolfe A, 2011, J PHARMACOL EXP THER, V338, P12, DOI 10.1124/jpet.111.179390; Yang F, 2007, CANCER RES, V67, P863, DOI 10.1158/0008-5472.CAN-06-1078; Yang I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070783; Yuan JS, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-85	55	12	12	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 3	2014	9	9							e106764	10.1371/journal.pone.0106764	http://dx.doi.org/10.1371/journal.pone.0106764			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3TB	25184625	Green Published, gold, Green Submitted			2022-12-27	WOS:000341257700115
J	Tantawy, MA; Hatesuer, B; Wilk, E; Dengler, L; Kasnitz, N; Weiss, S; Schughart, K				Tantawy, Mohamed A.; Hatesuer, Bastian; Wilk, Esther; Dengler, Leonie; Kasnitz, Nadine; Weiss, Siegfried; Schughart, Klaus			The Interferon-Induced Gene Ifi27l2a is Active in Lung Macrophages and Lymphocytes After Influenza A Infection but Deletion of Ifi27l2a in Mice Does Not Increase Susceptibility to Infection	PLOS ONE			English	Article							VIRUS-INFECTION; IMMUNE-RESPONSES; INNATE IMMUNITY; HOST-DEFENSE; EXPRESSION; MECHANISMS; FAMILY; RECEPTORS; MORTALITY; PROTEINS	Interferons represent one of the first and essential host defense mechanisms after infection, and the activation of the IFN-pathway results in the transcriptional activation of hundreds of interferon-stimulated genes. The alpha-inducible protein 27 like 2A (Ifi27l2a) gene (human synonym: ISG12) is strongly up-regulated in the lung after influenza A infection in mice and has been shown in gene expression studies to be highly correlated to other activated genes. Therefore, we investigated the role of Ifi27l2a for the host defense to influenza A infections in more detail. RT-PCR analyses in non-infected mice demonstrated that Ifi27l2a was expressed in several tissues, including the lung. Detailed analyses of reporter gene expression in lungs from Ifi27l2a-LacZ mice revealed that Ifi27l2a was expressed in macrophages and lymphocytes but not in alveolar cells or bronchiolar epithelium cells. The number of macrophages and lymphocyte strongly increased in the lung after infection, but no significant increase in expression levels of the LacZ reporter gene was found within individual immune cells. Also, no reporter gene expression was found in bronchiolar epithelial cells, alveolar cells or infiltrating neutrophils after infection. Thus, up-regulation of Ifi27l2a in infected lungs is mainly due to the infiltration of macrophages and lymphocytes. Most surprisingly, deletion of Ifi27l2a in mouse knock-out lines did not result in increased susceptibility to infections with H1N1 or H7N7 influenza A virus compared to wild type C57BL/6N mice, suggesting a less important role of the gene for the host response to influenza infections than for bacterial infections.	[Tantawy, Mohamed A.; Hatesuer, Bastian; Wilk, Esther; Dengler, Leonie; Schughart, Klaus] Helmholtz Ctr Infect Res, Dept Infect Genet, Potsdam, Germany; [Tantawy, Mohamed A.; Hatesuer, Bastian; Wilk, Esther; Dengler, Leonie; Schughart, Klaus] Univ Vet Med Hannover, Hannover, Germany; [Kasnitz, Nadine; Weiss, Siegfried] Helmholtz Ctr Infect Res, Dept Mol Immunol, Hannover, Germany; [Schughart, Klaus] Univ Tennessee, Ctr Hlth Sci, Memphis, TN 38163 USA	Helmholtz Association; Helmholtz-Center for Infection Research; University of Veterinary Medicine Hannover, Foundation; Helmholtz Association; Helmholtz-Center for Infection Research; University of Tennessee System; University of Tennessee Health Science Center	Schughart, K (corresponding author), Helmholtz Ctr Infect Res, Dept Infect Genet, Potsdam, Germany.	klaus.schughart@helmholtz-hzi.de	tantawy, mohamed/AAD-3542-2020	tantawy, mohamed/0000-0003-4014-6074; Schughart, Klaus/0000-0002-6824-7523	Helmholtz-Association (Program Infection and Immunity) the research grants FluResearchNet [01KI07137]; German Ministry of Education and Research; Deutsche Akademische Austauschdienst (DAAD); German-Egyptian Research Long-term Scholarship (GERLS) [A/10/92653]	Helmholtz-Association (Program Infection and Immunity) the research grants FluResearchNet; German Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); Deutsche Akademische Austauschdienst (DAAD)(Deutscher Akademischer Austausch Dienst (DAAD)); German-Egyptian Research Long-term Scholarship (GERLS)	This work was supported by intra-mural grants from the Helmholtz-Association (Program Infection and Immunity) the research grants FluResearchNet (No. 01KI07137) and 'Infection challenge in the German Mouse Clinic' from the German Ministry of Education and Research to KS. MT was supported by a fellowship from the Deutsche Akademische Austauschdienst (DAAD) and by a German-Egyptian Research Long-term Scholarship (GERLS, award no. A/10/92653). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benoit M, 2008, J IMMUNOL, V181, P3733, DOI 10.4049/jimmunol.181.6.3733; Bergmann M, 2000, J VIROL, V74, P6203, DOI 10.1128/JVI.74.13.6203-6206.2000; Blazejewska P, 2011, VIROLOGY, V412, P36, DOI 10.1016/j.virol.2010.12.047; Borden EC, 2007, NAT REV DRUG DISCOV, V6, P975, DOI 10.1038/nrd2422; Bottomly D, 2012, G3-GENES GENOM GENET, V2, P213, DOI 10.1534/g3.111.001800; Cheriyath V, 2011, J INTERF CYTOK RES, V31, P173, DOI 10.1089/jir.2010.0105; Davidson S, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4864; de Veer MJ, 2001, J LEUKOCYTE BIOL, V69, P912; Diamond MS, 2013, NAT REV IMMUNOL, V13, P46, DOI 10.1038/nri3344; Everitt AR, 2012, NATURE, V484, P519, DOI 10.1038/nature10921; Fauci AS, 2006, J INFECT DIS, V194, pS73, DOI 10.1086/507550; Feeley EM, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002337; Fitzgerald KA, 2011, J INTERF CYTOK RES, V31, P131, DOI 10.1089/jir.2010.0127; Fraser C, 2009, SCIENCE, V324, P1557, DOI 10.1126/science.1176062; Gabriel G, 2005, P NATL ACAD SCI USA, V102, P18590, DOI 10.1073/pnas.0507415102; Haller O, 2009, Verh K Acad Geneeskd Belg, V71, P73; Haller O, 2007, BIOCHIMIE, V89, P812, DOI 10.1016/j.biochi.2007.04.015; Holler O, 2009, REV SCI TECH OIE, V28, P219, DOI 10.20506/rst.28.1.1867; Johnson NPAS, 2002, B HIST MED, V76, P105, DOI 10.1353/bhm.2002.0022; Julkunen I, 2000, VACCINE, V19, pS32, DOI 10.1016/S0264-410X(00)00275-9; Julkunen I, 2001, CYTOKINE GROWTH F R, V12, P171, DOI 10.1016/S1359-6101(00)00026-5; Kato A, 2007, CURR OPIN IMMUNOL, V19, P711, DOI 10.1016/j.coi.2007.08.004; Kilbourne ED, 2006, EMERG INFECT DIS, V12, P9, DOI 10.3201/eid1201.051254; Klenk HD, 2011, BIOESSAYS, V33, P180, DOI 10.1002/bies.201000118; Kohlmeier JE, 2009, ANNU REV IMMUNOL, V27, P61, DOI 10.1146/annurev.immunol.021908.132625; Lai C, 2009, J VIROL, V83, P1147, DOI 10.1128/JVI.00105-08; Lim JK, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000321; Limberis Maria, 2007, V411, P25, DOI 10.1007/978-1-59745-549-7_3; Liu SY, 2011, CURR OPIN IMMUNOL, V23, P57, DOI 10.1016/j.coi.2010.11.003; MacMicking JD, 2012, NAT REV IMMUNOL, V12, P367, DOI 10.1038/nri3210; Martensen PM, 2001, EUR J BIOCHEM, V268, P5947, DOI 10.1046/j.0014-2956.2001.02545.x; Mordstein M, 2010, J VIROL, V84, P5670, DOI 10.1128/JVI.00272-10; Mordstein M, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000151; Moritoh K, 2009, JPN J VET RES, V57, P89; Murray PJ, 2011, NAT REV IMMUNOL, V11, P723, DOI 10.1038/nri3073; Neumann G, 2009, NATURE, V459, P931, DOI 10.1038/nature08157; Papac-Milicevic N, 2012, CIRC RES, V110, pE50, DOI 10.1161/CIRCRESAHA.111.258814; Pestka S, 2004, IMMUNOL REV, V202, P8, DOI 10.1111/j.0105-2896.2004.00204.x; Pichlmair A, 2007, IMMUNITY, V27, P370, DOI 10.1016/j.immuni.2007.08.012; Platanias LC, 2005, NAT REV IMMUNOL, V5, P375, DOI 10.1038/nri1604; Pommerenke C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041169; Rittirsch D, 2008, NAT REV IMMUNOL, V8, P776, DOI 10.1038/nri2402; Russell CJ, 2005, CELL, V123, P368, DOI 10.1016/j.cell.2005.10.019; Sadler AJ, 2008, NAT REV IMMUNOL, V8, P559, DOI 10.1038/nri2314; Skarnes WC, 2011, NATURE, V474, P337, DOI 10.1038/nature10163; Srivastava B, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004857; Takaoka A, 2006, CELL MICROBIOL, V8, P907, DOI 10.1111/j.1462-5822.2006.00716.x; Takeuchi O, 2009, IMMUNOL REV, V227, P75, DOI 10.1111/j.1600-065X.2008.00737.x; Taniguchi T, 2001, ANNU REV IMMUNOL, V19, P623, DOI 10.1146/annurev.immunol.19.1.623; Toapanta FR, 2009, RESP RES, V10, DOI 10.1186/1465-9921-10-112; Uhrin P, 2013, IMMUNOBIOLOGY, V218, P1207, DOI 10.1016/j.imbio.2013.04.009; Wang JR, 2011, AM J RESP CELL MOL, V45, P582, DOI 10.1165/rcmb.2010-0108OC; Wang TT, 2009, CELL, V137, P983, DOI 10.1016/j.cell.2009.05.032; Weiss DJ, 1997, HUM GENE THER, V8, P1545, DOI 10.1089/hum.1997.8.13-1545; Wilk Esther, 2012, Curr Protoc Mouse Biol, V2, P177, DOI 10.1002/9780470942390.mo110173; Yang YL, 1995, EMBO J, V14, P6095, DOI 10.1002/j.1460-2075.1995.tb00300.x; Zhou X, 2013, INT J BIOL SCI, V9, P200, DOI 10.7150/ijbs.5613	58	13	14	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 3	2014	9	9							e106392	10.1371/journal.pone.0106392	http://dx.doi.org/10.1371/journal.pone.0106392			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3TB	25184786	Green Published, gold, Green Submitted			2022-12-27	WOS:000341257700066
J	Tchalla, AE; Dufour, AB; Travison, TG; Habtemariam, D; Iloputaife, I; Manor, B; Lipsitz, LA				Tchalla, Achille E.; Dufour, Alyssa B.; Travison, Thomas G.; Habtemariam, Daniel; Iloputaife, Ikechukwu; Manor, Brad; Lipsitz, Lewis A.			Patterns, Predictors, and Outcomes of Falls Trajectories in Older Adults: The MOBILIZE Boston Study with 5 Years of Follow-Up	PLOS ONE			English	Article							MINI-MENTAL-STATE; RESTRICTED ACTIVITY; COMMUNITY; HOSPITALIZATION; POPULATION; DISABILITY; INJURIES; PEOPLE	Background: Falls may occur as unpredictable events or in patterns indicative of potentially modifiable risks and predictive of adverse outcomes. Knowing the patterns, risks, and outcomes of falls trajectories may help clinicians plan appropriate preventive measures. We hypothesized that clinically distinct trajectories of falls progression, baseline predictors and their coincident clinical outcomes could be identified. Methods: We studied 765 community-dwelling participants in the MOBILIZE Boston Study, who were aged 70 and older and followed prospectively for falls over 5 years. Baseline demographic and clinical data were collected by questionnaire and a comprehensive clinic examination. Falls, injuries, and hospitalizations were recorded prospectively on daily calendars. Group-Based Trajectory Modeling (GBTM) was used to identify trajectories. Results: We identified 4 distinct trajectories: No Falls (30.1%), Cluster Falls (46.1%), Increasing Falls (5.8%) and Chronic Recurring Falls (18.0%). Predictors of Cluster Falls were faster gait speed (OR 1.69 (95CI, 1.50-2.56)) and fall in the past year (OR 3.52 (95CI, 2.16-6.34)). Predictors of Increasing Falls were Diabetes Mellitus (OR 4.3 (95CI, 1.4-13.3)) and Cognitive Impairment (OR 2.82 (95CI, 1.34-5.82)). Predictors of Chronic Recurring Falls were multi-morbidity (OR 2.24 (95CI, 1.60-3.16)) and fall in the past year (OR 3.82 (95CI, 2.34-6.23)). Symptoms of depression were predictive of all falls trajectories. In the Chronic Recurring Falls trajectory group the incidence rate of Hospital visits was 121 (95% CI 63-169) per 1,000 person-years; Injurious falls 172 (95% CI 111-237) per 1,000 person-years and Fractures 41 (95% CI 9-78) per 1,000 person-years. Conclusions: Falls may occur in clusters over discrete intervals in time, or as chronically increasing or recurring events that have a relatively greater risk of adverse outcomes. Patients with multiple falls, multimorbidity, and depressive symptoms should be targeted for preventive measures.	[Tchalla, Achille E.; Dufour, Alyssa B.; Travison, Thomas G.; Manor, Brad; Lipsitz, Lewis A.] Harvard Univ, Sch Med, Boston, MA USA; [Tchalla, Achille E.; Dufour, Alyssa B.; Travison, Thomas G.; Manor, Brad; Lipsitz, Lewis A.] Beth Israel Deaconess Med Ctr, Div Gerontol, Boston, MA 02215 USA; [Tchalla, Achille E.; Dufour, Alyssa B.; Travison, Thomas G.; Habtemariam, Daniel; Iloputaife, Ikechukwu; Manor, Brad; Lipsitz, Lewis A.] Hebrew SeniorLife, Inst Aging Res, Boston, MA USA; [Tchalla, Achille E.] Univ Limoges, Univ Hosp Ctr Limoges, Dept Geriatr Med, EA HAVAE Disabil Act Aging Auton & Environm 6310, Limoges, France	Harvard University; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Hebrew SeniorLife; CHU Limoges; Universite de Limoges	Lipsitz, LA (corresponding author), Harvard Univ, Sch Med, Boston, MA USA.	lipsitz@hsl.harvard.edu		Dufour, Alyssa/0000-0001-8061-9599; Tchalla, Achille/0000-0003-3457-5219	US National-Institute on Aging [P01 AG04390, R37 AG25037]; NATIONAL INSTITUTE ON AGING [R01AG041785, P01AG004390, R37AG025037] Funding Source: NIH RePORTER	US National-Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Grant P01 AG04390 and R37 AG25037 from the US National-Institute on Aging. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cohen J., 2003, APPL MULTIPLE REGRES; ESCOBAR JI, 1986, J NERV MENT DIS, V174, P607, DOI 10.1097/00005053-198610000-00005; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Gates S, 2008, BRIT MED J, V336, P130, DOI 10.1136/bmj.39412.525243.BE; GIBSON MJ, 1987, DAN MED BULL, V34, P1; Gill TM, 2010, JAMA-J AM MED ASSOC, V304, P1919, DOI 10.1001/jama.2010.1568; Gill TM, 2004, JAMA-J AM MED ASSOC, V292, P2115, DOI 10.1001/jama.292.17.2115; Gillespie L. D., 2012, COCHRANE DB SYST REV, V9, DOI DOI 10.1002/14651858.CD007146; Gorina Yelena, 2005, Aging Trends, P1; GURALNIK JM, 1995, NEW ENGL J MED, V332, P556, DOI 10.1056/NEJM199503023320902; Jones BL, 2001, SOCIOL METHOD RES, V29, P374, DOI 10.1177/0049124101029003005; Jones DJ, 2010, J CLIN CHILD ADOLESC, V39, P667, DOI 10.1080/15374416.2010.501286; Kohout F J, 1993, J Aging Health, V5, P179, DOI 10.1177/089826439300500202; Leveille Suzanne G, 2008, BMC Geriatr, V8, P16, DOI 10.1186/1471-2318-8-16; LIPSITZ LA, 1991, J GERONTOL, V46, pM114, DOI 10.1093/geronj/46.4.M114; Marengoni A, 2011, AGEING RES REV, V10, P430, DOI 10.1016/j.arr.2011.03.003; NAGELKERKE NJD, 1991, BIOMETRIKA, V78, P691, DOI 10.1093/biomet/78.3.691; Nagin D. S., 2005, GROUP BASED MODELING, DOI DOI 10.4159/9780674041318; Nagin DS, 2010, ANNU REV CLIN PSYCHO, V6, P109, DOI 10.1146/annurev.clinpsy.121208.131413; Nagin DS, 2005, ANN AM ACAD POLIT SS, V602, P82, DOI 10.1177/0002716205280565; Pepe M. S., 2003, STAT EVALUATION MED; Rubenstein LZ, 2006, AGE AGEING, V35, P37, DOI 10.1093/ageing/afl084; Samelson EJ, 2008, AM J EPIDEMIOL, V168, P1444, DOI 10.1093/aje/kwn277; Sibley KM, 2014, BMC GERIATR, V14, DOI 10.1186/1471-2318-14-22; Stevens JA, 2006, INJURY PREV, V12, P290, DOI 10.1136/ip.2005.011015; Tinetti ME, 2008, NEW ENGL J MED, V359, P252, DOI 10.1056/NEJMoa0801748; TINETTI ME, 1993, JAMA-J AM MED ASSOC, V269, P65, DOI 10.1001/jama.269.1.65; TINETTI ME, 1989, NEW ENGL J MED, V320, P1055; WASHBURN RA, 1993, J CLIN EPIDEMIOL, V46, P153, DOI 10.1016/0895-4356(93)90053-4	29	24	24	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 3	2014	9	9							e106363	10.1371/journal.pone.0106363	http://dx.doi.org/10.1371/journal.pone.0106363			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3TB	25184785	Green Published, gold			2022-12-27	WOS:000341257700059
J	Moldenhauer, H; Latorre, R; Grandl, J				Moldenhauer, Hans; Latorre, Ramon; Grandl, Joerg			The Pore-Domain of TRPA1 Mediates the Inhibitory Effect of the Antagonist 6-Methyl-5-(2-(trifluoromethyl)phenyl)-1H-indazole	PLOS ONE			English	Article							ION-CHANNEL; ACTIVATION; SENSITIVITY; PAIN	The transient receptor potential ion channel TRPA1 confers the ability to detect tissue damaging chemicals to sensory neurons and as a result mediates chemical nociception in vivo. Mouse TRPA1 is activated by electrophilic compounds such as mustard-oil and several physical stimuli such as cold temperature. Due to its sensory function inhibition of TRPA1 activity might provide an effective treatment against chronic and inflammatory pain. Therefore, TRPA1 has become a target for the development of analgesic drugs. 6-Methyl-5-(2-(trifluoromethyl) phenyl)-1H-indazole (Compound 31) has been identified by a chemical screen and lead optimization as an inhibitor of chemical activation of TRPA1. However, the structures or domains of TRPA1 that mediate the inhibitory effect of Compound 31 are unknown. Here, we screened 12,000 random mutant clones of mouse TRPA1 for their sensitivity to mustard-oil and the ability of Compound 31 to inhibit chemical activation by mustard-oil. In addition, we separately screened this mutant library while stimulating it with cold temperatures. We found that the single-point mutation I624N in the N-terminus of TRPA1 specifically affects the sensitivity to mustard-oil, but not to cold temperatures. This is evidence that sensitivity of TRPA1 to chemicals and cold temperatures is conveyed by separable mechanisms. We also identified five mutations located within the pore domain that cause loss of inhibition by Compound 31. This result demonstrates that the pore-domain is a regulator of chemical activation and suggests that Compound 31 might be acting directly on the pore-domain.	[Moldenhauer, Hans; Latorre, Ramon] Univ Valparaiso, Fac Ciencias, Ctr Interdisciplinario Neurociencias Valparaiso, Valparaiso, Chile; [Grandl, Joerg] Duke Univ, Med Ctr, Dept Neurobiol, Durham, NC 27710 USA	Universidad de Valparaiso; Duke University	Grandl, J (corresponding author), Duke Univ, Med Ctr, Dept Neurobiol, Durham, NC 27710 USA.	grandl@neuro.duke.edu		Grandl, Jorg/0000-0001-7179-7609	FONDECYT [1110430]; Millenium Scientific Initiative of the Ministerio de Economia, Fomento y Turismo; NIH NRSA award [F32NS062515]; Duke Whitehead Scholarship; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [F32NS062515] Funding Source: NIH RePORTER	FONDECYT(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); Millenium Scientific Initiative of the Ministerio de Economia, Fomento y Turismo; NIH NRSA award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Duke Whitehead Scholarship; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	RL was supported by FONDECYT Grant 1110430 and The Centro Interdisciplinario de Neurociencia de Valparaiso is a Millennium Institute supported by the Millenium Scientific Initiative of the Ministerio de Economia, Fomento y Turismo. JG was supported by NIH NRSA award F32NS062515 and a Duke Whitehead Scholarship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bandell M, 2006, NAT NEUROSCI, V9, P493, DOI 10.1038/nn1665; Bautista DM, 2006, CELL, V124, P1269, DOI 10.1016/j.cell.2006.02.023; Bianchi BR, 2012, J PHARMACOL EXP THER, V341, P360, DOI 10.1124/jpet.111.189902; Chen J, 2008, J NEUROSCI, V28, P5063, DOI 10.1523/JNEUROSCI.0047-08.2008; Chen J, 2009, J GEN PHYSIOL, V133, P623, DOI 10.1085/jgp.200910246; Cordero-Morales JF, 2011, P NATL ACAD SCI USA, V108, pE1184, DOI 10.1073/pnas.1114124108; Doerner JF, 2007, J BIOL CHEM, V282, P13180, DOI 10.1074/jbc.M607849200; Garrison SR, 2011, CURR PHARM BIOTECHNO, V12, P1689; Grandl J, 2008, NAT NEUROSCI, V11, P1007, DOI 10.1038/nn.2169; Hinman A, 2006, P NATL ACAD SCI USA, V103, P19564, DOI 10.1073/pnas.0609598103; Hu HZ, 2009, NAT CHEM BIOL, V5, P183, DOI 10.1038/nchembio.146; Jabba S, 2014, NEURON, V82, P1017, DOI 10.1016/j.neuron.2014.04.016; Jordt SE, 2002, CELL, V108, P421, DOI 10.1016/S0092-8674(02)00637-2; Jordt SE, 2004, NATURE, V427, P260, DOI 10.1038/nature02282; Karashima Y, 2009, P NATL ACAD SCI USA, V106, P1273, DOI 10.1073/pnas.0808487106; Laliberte S, 2014, BIOORG MED CHEM LETT; Macpherson LJ, 2007, NATURE, V445, P541, DOI 10.1038/nature05544; McNamara CR, 2007, P NATL ACAD SCI USA, V104, P13525, DOI 10.1073/pnas.0705924104; Nagatomo K, 2010, BIOPHYS J, V99, P3609, DOI 10.1016/j.bpj.2010.10.014; Patapoutian A, 2009, NAT REV DRUG DISCOV, V8, P55, DOI 10.1038/nrd2757; Rooney L, 2014, J MED CHEM; Sawada Y, 2007, BRAIN RES, V1160, P39, DOI 10.1016/j.brainres.2007.05.047; Story GM, 2003, CELL, V112, P819, DOI 10.1016/S0092-8674(03)00158-2; Wang Su-Fang, 2012, Enzyme Res, V2012, P192867, DOI 10.1155/2012/192867; Xiao B, 2008, J NEUROSCI, V28, P9640, DOI 10.1523/JNEUROSCI.2772-08.2008	25	8	8	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2014	9	9							e106776	10.1371/journal.pone.0106776	http://dx.doi.org/10.1371/journal.pone.0106776			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3LR	25181545	gold, Green Submitted, Green Published			2022-12-27	WOS:000341231500127
J	Guo, JQ; Durdagi, S; Changalov, M; Perissinotti, LL; Hargreaves, JM; Back, TG; Noskov, SY; Duff, HJ				Guo, Jiqing; Durdagi, Serdar; Changalov, Mohamed; Perissinotti, Laura L.; Hargreaves, Jason M.; Back, Thomas G.; Noskov, Sergei Y.; Duff, Henry J.			Structure Driven Design of Novel Human Ether-A-Go-Go-Related-Gene Channel (hERG1) Activators	PLOS ONE			English	Article							MOLECULAR DETERMINANTS; POTASSIUM CHANNELS; BINDING; MECHANISM; ANALOGS; MODEL; KCNH2; PORE	One of the main culprits in modern drug discovery is apparent cardiotoxicity of many lead-candidates via inadvertent pharmacologic blockade of K+, Ca2+ and Na+ currents. Many drugs inadvertently block hERG1 leading to an acquired form of the Long QT syndrome and potentially lethal polymorphic ventricular tachycardia. An emerging strategy is to rely on interventions with a drug that may proactively activate hERG1 channels reducing cardiovascular risks. Small molecules-activators have a great potential for co-therapies where the risk of hERG-related QT prolongation is significant and rehabilitation of the drug is impractical. Although a number of hERG1 activators have been identified in the last decade, their binding sites, functional moieties responsible for channel activation and thus mechanism of action, have yet to be established. Here, we present a proof-of-principle study that combines de-novo drug design, molecular modeling, chemical synthesis with whole cell electrophysiology and Action Potential (AP) recordings in fetal mouse ventricular myocytes to establish basic chemical principles required for efficient activator of hERG1 channel. In order to minimize the likelihood that these molecules would also block the hERG1 channel they were computationally engineered to minimize interactions with known intra-cavitary drug binding sites. The combination of experimental and theoretical studies led to identification of functional elements (functional groups, flexibility) underlying efficiency of hERG1 activators targeting binding pocket located in the S4-S5 linker, as well as identified potential side-effects in this promising line of drugs, which was associated with multi-channel targeting of the developed drugs.	[Guo, Jiqing; Duff, Henry J.] Univ Calgary, Libin Cardiovasc Inst Alberta, Calgary, AB, Canada; [Durdagi, Serdar; Perissinotti, Laura L.; Noskov, Sergei Y.] Univ Calgary, Dept Biol Sci, Ctr Mol Simulat, Calgary, AB T2N 1N4, Canada; [Durdagi, Serdar] Bahcesehir Univ, Sch Med, Dept Biophys, Istanbul, Turkey; [Changalov, Mohamed; Hargreaves, Jason M.; Back, Thomas G.] Univ Calgary, Dept Chem, Calgary, AB T2N 1N4, Canada	Libin Cardiovascular Institute Of Alberta; University of Calgary; University of Calgary; Bahcesehir University; University of Calgary	Back, TG (corresponding author), Univ Calgary, Dept Chem, Calgary, AB T2N 1N4, Canada.	tgback@ucalgary.ca; snoskov@ucalgary.ca; hduff@ucalgary.ca	Durdagi, Serdar/B-6862-2009; Durdagi, Serdar/J-1904-2018	Noskov, Sergei/0000-0001-7769-335X; Durdagi, Serdar/0000-0002-0426-0905	Canadian Institutes of Health Research [201103MOP-CSA-244888]; Heart and Stroke Foundation of Alberta [2010HSF-2013DUFF, 2011HSF-2014NOSKOV]; Canadian Institutes of Health Research; Alberta Innovates Health Solutions; West-Grid Canada; Scientific and Technological Research Council of Turkey (TUBITAK); EU 7th Framework Marie Curie Actions under Co-Funded Brain Circulation Scheme [TUBITAK2236 112C017]; Bilim Akademisi - The Science Academy, Turkey, under the BAGEP program	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Heart and Stroke Foundation of Alberta; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Alberta Innovates Health Solutions; West-Grid Canada; Scientific and Technological Research Council of Turkey (TUBITAK)(Turkiye Bilimsel ve Teknolojik Arastirma Kurumu (TUBITAK)); EU 7th Framework Marie Curie Actions under Co-Funded Brain Circulation Scheme; Bilim Akademisi - The Science Academy, Turkey, under the BAGEP program	This work was supported by the Canadian Institutes of Health Research [Grant 201103MOP-CSA-244888] (to S.Y.N. and H.J.D.); and the Heart and Stroke Foundation of Alberta [Grants 2010HSF-2013DUFF; 2011HSF-2014NOSKOV] (to H.J.D. and S.Y.N.). S.Y.N. is an Alberta Heritage Foundation for Medical Research Scholar. H.J.D. is an Alberta Heritage Foundation for Medical Research Medical Scientist. S.D. is supported by postdoctoral fellowships from the Canadian Institutes of Health Research and Alberta Innovates Health Solutions. The computational support for this work was provided by West-Grid Canada through a resource allocation award to S.Y.N. S.D. was supported in part by The Scientific and Technological Research Council of Turkey (TUBITAK) and EU 7th Framework Marie Curie Actions under Co-Funded Brain Circulation Scheme (TUBITAK2236 112C017). S.D. also acknowledges support from Bilim Akademisi - The Science Academy, Turkey, under the BAGEP program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1989, NEW ENGL J MED, V321, P406; Asayama M, 2013, J PHARMACOL SCI, V121, P1, DOI 10.1254/jphs.12220FP; Bentzen BH, 2011, J CARDIOVASC PHARM, V57, P223, DOI 10.1097/FJC.0b013e318203a44d; Bilet A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050886; Carvalho JFS, 2013, J MED CHEM, V56, P2828, DOI 10.1021/jm301564f; Casis O, 2006, MOL PHARMACOL, V69, P658, DOI 10.1124/mol.105.019943; Durdagi S, 2014, BMC PHARMACOL TOXICO, V15, DOI 10.1186/2050-6511-15-14; Durdagi S, 2012, J CHEM INF MODEL, V52, P2760, DOI 10.1021/ci300353u; Durdagi S, 2012, J PHARMACOL EXP THER, V342, P441, DOI 10.1124/jpet.111.189159; Durdagi S, 2011, J CHEM INF MODEL, V51, P463, DOI 10.1021/ci100409y; Fernandez D, 2008, MOL PHARMACOL, V73, P1159, DOI 10.1124/mol.107.043505; Friesner RA, 2006, J MED CHEM, V49, P6177, DOI 10.1021/jm051256o; Garg V, 2011, MOL PHARMACOL, V80, P630, DOI 10.1124/mol.111.073809; Grunnet M, 2011, MOL PHARMACOL, V79, P1, DOI 10.1124/mol.110.067728; Guo JQ, 2005, HEART RHYTHM, V2, P860, DOI 10.1016/j.hrthm.2005.04.029; Hansen RS, 2005, CIRCULATION, V112, pU87; Jones G, 1997, ABSTR PAP AM CHEM S, V214, P154; Kang JS, 2005, MOL PHARMACOL, V67, P827, DOI 10.1124/mol.104.006577; Kell DB, 2013, DRUG DISCOV TODAY, V18, P218, DOI 10.1016/j.drudis.2012.11.008; Kramer J, 2013, SCI REP-UK, V3, DOI 10.1038/srep02100; Lees-Miller JP, 2009, BIOPHYS J, V96, P3600, DOI 10.1016/j.bpj.2009.01.028; Patel C, 2008, HEART RHYTHM, V5, P585, DOI 10.1016/j.hrthm.2008.01.022; Payandeh J, 2011, NATURE, V475, P353, DOI 10.1038/nature10238; Perry M, 2007, P NATL ACAD SCI USA, V104, P13827, DOI 10.1073/pnas.0703934104; Sanguinetti MC, 2006, NATURE, V440, P463, DOI 10.1038/nature04710; Sanguinetti MC, 2014, CURR OPIN PHARMACOL, V15, P22, DOI 10.1016/j.coph.2013.11.006; Seebohm G, 2005, MOL PHARMACOL, V67, P585, DOI 10.1124/mol.104.010173; Smith PL, 1996, NATURE, V379, P833, DOI 10.1038/379833a0; Subbotina J, 2010, PROTEINS, V78, P2922, DOI 10.1002/prot.22815; Tristani-Firouzi M, 2002, J BIOL CHEM, V277, P18994, DOI 10.1074/jbc.M200410200; Vandenberg JI, 2012, PHYSIOL REV, V92, P1393, DOI 10.1152/physrev.00036.2011; Zachariae U, 2009, J MED CHEM, V52, P4266, DOI 10.1021/jm900002x	32	16	16	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2014	9	9							e105553	10.1371/journal.pone.0105553	http://dx.doi.org/10.1371/journal.pone.0105553			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ1IR	25191697	Green Published, gold, Green Submitted			2022-12-27	WOS:000347993600006
J	Liu, J; Mei, DS; Li, YC; Huang, SM; Hu, Q				Liu, Jia; Mei, Desheng; Li, Yunchang; Huang, Shunmou; Hu, Qiong			Deep RNA-Seq to Unlock the Gene Bank of Floral Development in Sinapis arvensis	PLOS ONE			English	Article							MICROSATELLITE MARKERS; BRASSICA-NAPUS; GENOME; GROWTH; LINES; RAPA; TOOL	Sinapis arvensis is a weed with strong biological activity. Despite being a problematic annual weed that contaminates agricultural crop yield, it is a valuable alien germplasm resource. It can be utilized for broadening the genetic background of Brassica crops with desirable agricultural traits like resistance to blackleg (Leptosphaeria maculans), stem rot (Sclerotinia sclerotium) and pod shatter (caused by FRUITFULL gene). However, few genetic studies of S. arvensis were reported because of the lack of genomic resources. In the present study, we performed de novo transcriptome sequencing to produce a comprehensive dataset for S. arvensis for the first time. We used Illumina paired-end sequencing technology to sequence the S. arvensis flower transcriptome and generated 40,981,443 reads that were assembled into 131,278 transcripts. We de novo assembled 96,562 high quality unigenes with an average length of 832 bp. A total of 33,662 full-length ORF complete sequences were identified, and 41,415 unigenes were mapped onto 128 pathways using the KEGG Pathway database. The annotated unigenes were compared against Brassica rapa, B. oleracea, B. napus and Arabidopsis thaliana. Among these unigenes, 76,324 were identified as putative homologs of annotated sequences in the public protein databases, of which 1194 were associated with plant hormone signal transduction and 113 were related to gibberellin homeostasis/signaling. Unigenes that did not match any of those sequence datasets were considered to be unique to S. arvensis. Furthermore, 21,321 simple sequence repeats were found. Our study will enhance the currently available resources for Brassicaceae and will provide a platform for future genomic studies for genetic improvement of Brassica crops.	[Liu, Jia; Mei, Desheng; Li, Yunchang; Huang, Shunmou; Hu, Qiong] Chinese Acad Agr Sci, Oil Crops Res Inst, Minist Agr, Key Lab Biol & Genet Improvement Oil Crops, Wuhan, Hubei, Peoples R China	Chinese Academy of Agricultural Sciences; Oil Crops Research Institute, CAAS; Ministry of Agriculture & Rural Affairs	Hu, Q (corresponding author), Chinese Acad Agr Sci, Oil Crops Res Inst, Minist Agr, Key Lab Biol & Genet Improvement Oil Crops, Wuhan, Hubei, Peoples R China.	huqiong@oilcrops.cn			National Natural Science Foundation of China [31000725, 30871553]; National High Technology Research and Development Program of China [2011CB109302]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National High Technology Research and Development Program of China(National High Technology Research and Development Program of China)	This work was financially supported by the National Natural Science Foundation of China (grant nos. 31000725 and 30871553) and the National High Technology Research and Development Program of China (grant no. 2011CB109302). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Shehbaz IA, 2012, TAXON, V61, P931, DOI 10.1002/tax.615002; Bancroft I, 2011, NAT BIOTECHNOL, V29, P762, DOI 10.1038/nbt.1926; Cheng H, 2004, DEVELOPMENT, V131, P1055, DOI 10.1242/dev.00992; Egan AN, 2012, AM J BOT, V99, P175, DOI 10.3732/ajb.1200020; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Hails RS, 2005, TRENDS ECOL EVOL, V20, P245, DOI 10.1016/j.tree.2005.02.006; Hu JH, 2008, PLANT CELL, V20, P320, DOI 10.1105/tpc.107.057752; Hu Q, 2002, PLANT CELL REP, V21, P147, DOI 10.1007/s00299-002-0491-7; Iseli C, 1999, Proc Int Conf Intell Syst Mol Biol, P138; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kolb LN, 2013, WEED RES, V53, P201, DOI 10.1111/wre.12018; Lysak MA, 2005, GENOME RES, V15, P516, DOI 10.1101/gr.3531105; Ma HY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089134; Min XJ, 2005, NUCLEIC ACIDS RES, V33, pW669, DOI 10.1093/nar/gki436; Moriya Y, 2007, NUCLEIC ACIDS RES, V35, pW182, DOI 10.1093/nar/gkm321; Pankin AA, 2011, AM J BOT, V98, pE54, DOI 10.3732/ajb.1000422; Paritosh K, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-463; Powell W, 1996, TRENDS PLANT SCI, V1, P215, DOI 10.1016/1360-1385(96)86898-1; Ramchiary N, 2011, DNA RES, V18, P305, DOI 10.1093/dnares/dsr017; Rieu I, 2008, PLANT J, V53, P488, DOI 10.1111/j.1365-313X.2007.03356.x; Silverstone AL, 2007, PLANT PHYSIOL, V143, P987, DOI 10.1104/pp.106.091025; Snowdon RJ, 2000, THEOR APPL GENET, V101, P1008, DOI 10.1007/s001220051574; Strickler SR, 2012, AM J BOT, V99, P257, DOI 10.3732/ajb.1100292; Tatusov RL, 2000, NUCLEIC ACIDS RES, V28, P33, DOI 10.1093/nar/28.1.33; Varshney RK, 2005, TRENDS BIOTECHNOL, V23, P48, DOI 10.1016/j.tibtech.2004.11.005; Wang F, 2012, MOL BREEDING, V30, P731, DOI 10.1007/s11032-011-9658-7; Wang XW, 2011, NAT GENET, V43, P1035, DOI 10.1038/ng.919; Wang Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066539; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Warwick SI, 2000, CAN J PLANT SCI, V80, P939, DOI 10.4141/P99-139; Wei WH, 2010, THEOR APPL GENET, V120, P1089, DOI 10.1007/s00122-009-1236-6; Zhang YY, 2008, J INTEGR PLANT BIOL, V50, P1327, DOI 10.1111/j.1744-7909.2008.00740.x; Zhao QH, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0057333, 10.1371/journal.pone.0061140]	33	7	7	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2014	9	9							e105775	10.1371/journal.pone.0105775	http://dx.doi.org/10.1371/journal.pone.0105775			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ1IR	25192023	Green Submitted, Green Published, gold			2022-12-27	WOS:000347993600009
J	Ortega-Egea, JM; Garcia-de-Frutos, N; Antolin-Lopez, R				Manuel Ortega-Egea, Jose; Garcia-de-Frutos, Nieves; Antolin-Lopez, Raquel			Why Do Some People Do "More" to Mitigate Climate Change than Others? Exploring Heterogeneity in Psycho-Social Associations	PLOS ONE			English	Article							ENVIRONMENTAL ATTITUDES; MULTILEVEL ANALYSIS; VALUE ORIENTATIONS; PLANNED BEHAVIOR; RISK PERCEPTION; VALUES; GENDER; DETERMINANTS; WILLINGNESS; BELIEFS	The urgency of climate change mitigation calls for a profound shift in personal behavior. This paper investigates psychosocial correlates of extra mitigation behavior in response to climate change, while also testing for potential (unobserved) heterogeneity in European citizens' decision-making. A person's extra mitigation behavior in response to climate change is conceptualized-and differentiated from common mitigation behavior-as some people's broader and greater levels of behavioral engagement (compared to others) across specific self-reported mitigation actions and behavioral domains. Regression analyses highlight the importance of environmental psychographics (i.e., attitudes, motivations, and knowledge about climate change) and socio-demographics (especially country-level variables) in understanding extra mitigation behavior. By looking at the data through the lens of segmentation, significant heterogeneity is uncovered in the associations of attitudes and knowledge about climate change-but not in motivational or socio-demographic links-with extra mitigation behavior in response to climate change, across two groups of environmentally active respondents. The study has implications for promoting more ambitious behavioral responses to climate change, both at the individual level and across countries.	[Manuel Ortega-Egea, Jose; Garcia-de-Frutos, Nieves; Antolin-Lopez, Raquel] Univ Almeria CeiA3, Dept Econ & Business, Almeria, Spain		Ortega-Egea, JM (corresponding author), Univ Almeria CeiA3, Dept Econ & Business, Almeria, Spain.	jmortega@ual.es	Antolin-Lopez, Raquel/AAB-1024-2019; de Frutos, Nieves García/AAQ-7444-2021; Egea, José Manuel Ortega/AAA-2816-2019; Antolín-López, Raquel/AAP-5321-2020	Egea, José Manuel Ortega/0000-0002-2255-5897; 	Spanish Ministry of Economy and Science [ECO2011-24921]; European Regional Development Fund (ERDF/FEDER); University of Almerias (UAL) [ceiA3]; CySOC	Spanish Ministry of Economy and Science(Spanish Government); European Regional Development Fund (ERDF/FEDER)(European Commission); University of Almerias (UAL); CySOC	The authors acknowledge financial support from the Spanish Ministry of Economy and Science (National R&D Project ECO2011-24921 and predoctoral grant program) and the European Regional Development Fund (ERDF/FEDER), from the University of Almerias (UAL, ceiA3) predoctoral grant program, and CySOC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrahamse W, 2009, TRANSPORT RES F-TRAF, V12, P317, DOI 10.1016/j.trf.2009.04.004; AJZEN I, 1991, ORGAN BEHAV HUM DEC, V50, P179, DOI 10.1016/0749-5978(91)90020-T; Ajzen I, 2010, FRONT SOC PSYCHOL, P289; Aldrich GA, 2007, ENVIRON RESOUR ECON, V37, P757, DOI 10.1007/s10640-006-9054-7; [Anonymous], 2008, EUR ATT CLIM CHANG; Aoyagi-Usui M., 2003, HUM ECOL REV, V10, P23, DOI DOI 10.1177/0013916505285933; Bamberg S, 2003, ENVIRON BEHAV, V35, P264, DOI 10.1177/0013916502250134; Bamberg S, 2007, J ENVIRON PSYCHOL, V27, P14, DOI 10.1016/j.jenvp.2006.12.002; Barr S, 2011, GLOBAL ENVIRON CHANG, V21, P1234, DOI 10.1016/j.gloenvcha.2011.07.011; Bhat CR, 2000, TRANSPORT SCI, V34, P228, DOI 10.1287/trsc.34.2.228.12306; Bin S, 2005, ENERG POLICY, V33, P197, DOI 10.1016/S0301-4215(03)00210-6; Bodur M, 2005, ENVIRON BEHAV, V37, P487, DOI 10.1177/0013916504269666; BOOTHKEWLEY S, 1994, J PERS, V62, P282; Bord RJ, 1998, CLIMATE RES, V11, P75, DOI 10.3354/cr011075; Brechin S. R., 2003, INT J SOCIOLOGY SOCI, V23, P106, DOI DOI 10.1108/01443330310790318; BRECHIN SR, 1994, SOC SCI QUART, V75, P245; Cheung SF, 1999, ENVIRON BEHAV, V31, P587, DOI 10.1177/00139169921972254; Clark CF, 2003, J ENVIRON PSYCHOL, V23, P237, DOI 10.1016/S0272-4944(02)00105-6; Cottrell SP, 2003, ENVIRON BEHAV, V35, P347, DOI 10.1177/0013916503035003003; Davidson DJ, 1996, ENVIRON BEHAV, V28, P302, DOI 10.1177/0013916596283003; de Groot JIM, 2008, ENVIRON BEHAV, V40, P330, DOI 10.1177/0013916506297831; De Young R, 2000, J SOC ISSUES, V56, P509, DOI 10.1111/0022-4537.00181; Diamantopoulos A, 2003, J BUS RES, V56, P465, DOI 10.1016/S0148-2963(01)00241-7; Diekmann A, 1999, ENVIRON BEHAV, V31, P540, DOI 10.1177/00139169921972227; Dietz T, 1998, ENVIRON BEHAV, V30, P450, DOI 10.1177/001391659803000402; Dolnicar S, 2009, ENVIRON BEHAV, V41, P693, DOI 10.1177/0013916508319448; Dunlap RE, 1995, J SOC ISSUES, V51, P121, DOI 10.1111/j.1540-4560.1995.tb01351.x; ELLEN PS, 1994, J BUS RES, V30, P43, DOI 10.1016/0148-2963(94)90067-1; EPSTEIN S, 1983, J PERS, V51, P360, DOI 10.1111/j.1467-6494.1983.tb00338.x; European Commission, 2011, CLIMATE CHANGE; European Environment Agency, 2013, FIN EN CONS SECT; FAZIO RH, 1990, ADV EXP SOC PSYCHOL, V23, P75, DOI 10.1016/S0065-2601(08)60318-4; Fishbein M., 1975, BELIEF ATTITUDE INTE; Franzen A, 2003, SOC SCI QUART, V84, P297, DOI 10.1111/1540-6237.8402005; Franzen A, 2010, EUR SOCIOL REV, V26, P219, DOI 10.1093/esr/jcp018; Frick J, 2004, PERS INDIV DIFFER, V37, P1597, DOI 10.1016/j.paid.2004.02.015; Gelissen J, 2007, ENVIRON BEHAV, V39, P392, DOI 10.1177/0013916506292014; Gifford R, 2009, J ENVIRON PSYCHOL, V29, P1, DOI 10.1016/j.jenvp.2008.06.001; Guerin D, 2001, SOC SCI RES, V30, P195, DOI 10.1006/ssre.2000.0694; Hines J.M., 1987, J ENVIRON EDUC, V18, P1, DOI [DOI 10.1080/00958964.1987.9943482, 10.1080/00958964.1987.9943482]; HOPPER JR, 1991, ENVIRON BEHAV, V23, P195, DOI 10.1177/0013916591232004; Howell RA, 2011, GLOBAL ENVIRON CHANG, V21, P177, DOI 10.1016/j.gloenvcha.2010.09.004; Hunter LM, 2004, SOC SCI QUART, V85, P677, DOI 10.1111/j.0038-4941.2004.00239.x; IMMERWAHR J, 1999, WAITING SIGNAL PUBLI; Inglehart R., 1997, MODERNIZATION POSTMO; Iyer EaswarS., 2007, J CONSUM BEHAV, V6, P32, DOI [DOI 10.1002/CB.206, 10.1002/CB.206]; JONES RE, 1992, RURAL SOCIOL, V57, P28; Junta de AndalucuUa, 2010, AND INN ESP CAMB CLI; Kaiser FG, 1999, J ENVIRON PSYCHOL, V19, P1, DOI 10.1006/jevp.1998.0107; Kaiser FG, 2003, APPL PSYCHOL-INT REV, V52, P598, DOI 10.1111/1464-0597.00153; Kaiser FG, 2001, EUR J PSYCHOL ASSESS, V17, P212, DOI 10.1027//1015-5759.17.3.212; Kemmelmeier M, 2002, CROSS-CULT RES, V36, P256, DOI 10.1177/10697102036003004; Kollmuss A., 2002, ENVIRON EDUC RES, V8, P239, DOI [10.1080/1350462022014540, DOI 10.1080/1350462022014540, 10.1080/13504620220145401, DOI 10.1080/13504620220145401]; Leiserowitz A, 2006, CLIMATIC CHANGE, V77, P45, DOI 10.1007/s10584-006-9059-9; Lorenzoni I, 2007, GLOBAL ENVIRON CHANG, V17, P445, DOI 10.1016/j.gloenvcha.2007.01.004; Magidson J., 2004, SAGE HDB QUANTITATIV, P175; McCright AM, 2011, GLOBAL ENVIRON CHANG, V21, P1163, DOI 10.1016/j.gloenvcha.2011.06.003; Mobley C, 2010, ENVIRON BEHAV, V42, P420, DOI 10.1177/0013916508325002; MOHAI P, 1987, SOC SCI QUART, V68, P798; Moisander J., 2007, INT J CONSUM STUD, V31, P404, DOI DOI 10.1111/J.1470-6431.2007.00586.X; Moors G, 2007, ACTA SOCIOL, V50, P147, DOI 10.1177/0001699307077656; NEUMAN K, 1986, ENVIRON BEHAV, V18, P53, DOI 10.1177/0013916586181003; Nordlund AM, 2002, ENVIRON BEHAV, V34, P740, DOI 10.1177/001391602237244; O'Connor RE, 1999, RISK ANAL, V19, P461, DOI 10.1111/j.1539-6924.1999.tb00421.x; Ojea E, 2007, ECOL ECON, V63, P807, DOI 10.1016/j.ecolecon.2007.02.003; Oreg S, 2006, ENVIRON BEHAV, V38, P462, DOI 10.1177/0013916505286012; Parker SK, 2006, J APPL PSYCHOL, V91, P636, DOI 10.1037/0021-9010.91.3.636; Poortinga W, 2011, GLOBAL ENVIRON CHANG, V21, P1015, DOI 10.1016/j.gloenvcha.2011.03.001; Roberts JA, 1996, BUS HORIZONS, V39, P79, DOI DOI 10.1016/S0007-6813(96)90087-7; Sarigollu E, 2009, ENVIRON BEHAV, V41, P365, DOI 10.1177/0013916507313920; Schultz PW, 1999, J ENVIRON PSYCHOL, V19, P255; Schwartz S. H., 1977, ADV EXP SOC PSYCHOL, V10, P221, DOI [10.1016/s0065-2601(08)60358-5, 10.1016/S0065-2601(08) 60358-5, DOI 10.1016/S0065-2601(08)60358-5]; SCOTT D, 1994, ENVIRON BEHAV, V26, P239, DOI 10.1177/001391659402600206; Semenza JC, 2008, AM J PREV MED, V35, P479, DOI 10.1016/j.amepre.2008.08.020; Slimak MW, 2006, RISK ANAL, V26, P1689, DOI 10.1111/j.1539-6924.2006.00832.x; Smith S.M., 1994, PSYCHOL MARKET, V11, P359, DOI [10.1002/mar.4220110405, DOI 10.1002/MAR.4220110405]; Spence A, 2011, NAT CLIM CHANGE, V1, P46, DOI [10.1038/NCLIMATE1059, 10.1038/nclimate1059]; Stern PC, 2000, J SOC ISSUES, V56, P407, DOI 10.1111/0022-4537.00175; STERN PC, 1993, ENVIRON BEHAV, V25, P322, DOI 10.1177/0013916593255002; STERN PC, 1995, ENVIRON BEHAV, V27, P723, DOI 10.1177/0013916595276001; Sutton SG, 2011, GLOBAL ENVIRON CHANG, V21, P894, DOI 10.1016/j.gloenvcha.2011.05.006; Tay L, 2011, ORGAN RES METHODS, V14, P177, DOI 10.1177/1094428110372674; Thogersen J, 2009, J CONSUM POLICY, V32, P141, DOI 10.1007/s10603-009-9101-1; Thogersen J, 2009, BASIC APPL SOC PSYCH, V31, P348, DOI 10.1080/01973530903317144; THOMPSON SCG, 1994, J ENVIRON PSYCHOL, V14, P149; Vermunt JK, 2002, APPL LATENT CLASS AN, P89, DOI DOI 10.1017/CBO9780511499531.004; VINING J, 1990, ENVIRON BEHAV, V22, P55, DOI 10.1177/0013916590221003; Vinzi VE, 2007, 07019 ESSEC; Webb TL, 2006, PSYCHOL BULL, V132, P249, DOI 10.1037/0033-2909.132.2.249; WHITMARSH L, 2011, GLOBAL ENVIRON CHANG, V21, P690, DOI [DOI 10.1016/J.GLOENVCHA.2011.01.016, DOI 10.1016/j.gloenvcha.2011.01.016]; Whitmarsh L, 2008, J RISK RES, V11, P351, DOI 10.1080/13669870701552235; Whitmarsh L, 2011, GLOBAL ENVIRON CHANG, V21, P56, DOI 10.1016/j.gloenvcha.2010.07.011; Whitmarsh L, 2010, J ENVIRON PSYCHOL, V30, P305, DOI 10.1016/j.jenvp.2010.01.003; Whitmarsh L, 2009, J ENVIRON PSYCHOL, V29, P13, DOI 10.1016/j.jenvp.2008.05.003; Xiao Chenyang, 2007, J ENVIRON EDUC, V38, P3, DOI DOI 10.3200/JOEE.38.1.3-14; Zelezny LC, 2000, J SOC ISSUES, V56, P443, DOI 10.1111/0022-4537.00177	97	51	52	2	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2014	9	9							e106645	10.1371/journal.pone.0106645	http://dx.doi.org/10.1371/journal.pone.0106645			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AZ1IR	25191841	gold, Green Submitted, Green Published			2022-12-27	WOS:000347993600049
J	Peng, LL; Xie, NZ; Guo, L; Wang, LM; Yu, B; Ma, YH				Peng, Lili; Xie, Nengzhong; Guo, Ling; Wang, Limin; Yu, Bo; Ma, Yanhe			Efficient Open Fermentative Production of Polymer-Grade L-Lactate from Sugarcane Bagasse Hydrolysate by Thermotolerant Bacillus sp Strain P38	PLOS ONE			English	Article							LACTIC-ACID PRODUCTION; SIMULTANEOUS SACCHARIFICATION; HEMICELLULOSE HYDROLYSATE; LACTOBACILLUS-CASEI; L(+)-LACTIC ACID; NITROGEN-SOURCES; CELLULOSE	Lactic acid is one of the top 30 potential building-block chemicals from biomass, of which the most extensive use is in the polymerization of lactic acid to poly-lactic-acid (PLA). To reduce the cost of PLA, the search for cheap raw materials and low-cost process for lactic acid production is highly desired. In this study, the final titer of produced L-lactic acid reached a concentration of 185 g.L-1 with a volumetric productivity of 1.93 g.L-1.h(-1) by using sugarcane bagasse hydrolysate as the sole carbon source simultaneously with cottonseed meal as cheap nitrogen sources under the open fed-batch fermentation process. Furthermore, a lactic acid yield of 0.99 g per g of total reducing sugars was obtained, which is very close to the theoretical value (1.0 g.g(-1)). No D-isomer of lactic acid was detected in the broth, and thereafter resulted in an optical purity of 100%, which exceeds the requirement of lactate polymerization process. To our knowledge, this is the best performance of fermentation on polymer-grade L-lactic acid production totally using lignocellulosic sources. The high levels of optically pure L-lactic acid produced, combined with the ease of handling and low costs associated with the open fermentation strategy, indicated the thermotolerant Bacillus sp. P38 could be an excellent candidate strain with great industrial potential for polymer-grade L-lactic acid production from various cellulosic biomasses.	[Peng, Lili; Wang, Limin; Yu, Bo] Chinese Acad Sci, Inst Microbiol, CAS Key Lab Microbial Physiol & Metab Engn, Beijing, Peoples R China; [Xie, Nengzhong; Guo, Ling] Guangxi Acad Sci, Natl Engn Res Ctr Nonfood Biorefinery, Nanning, Peoples R China; [Ma, Yanhe] Chinese Acad Sci, Tianjin Inst Ind Biotechnol, Tianjin, Peoples R China	Chinese Academy of Sciences; Institute of Microbiology, CAS; Chinese Academy of Sciences; Tianjin Institute of Industrial Biotechnology, CAS	Yu, B (corresponding author), Chinese Acad Sci, Inst Microbiol, CAS Key Lab Microbial Physiol & Metab Engn, Beijing, Peoples R China.	yub@im.ac.cn	MA, YAN/HHN-2912-2022		Chinese National Programs for High Technology Research Development [2011AA02A202]; Key Deployment Projects of Chinese Academy of Sciences [KSZD-EW-Z-016-3]; Industrial Biotechnology Program of Tianjin Municipal Science and Technology Commission [11ZCZDSY08900]	Chinese National Programs for High Technology Research Development; Key Deployment Projects of Chinese Academy of Sciences; Industrial Biotechnology Program of Tianjin Municipal Science and Technology Commission	This work was supported by grants from the Chinese National Programs for High Technology Research & Development (2011AA02A202), the Key Deployment Projects of Chinese Academy of Sciences (KSZD-EW-Z-016-3), and the Industrial Biotechnology Program of Tianjin Municipal Science and Technology Commission (11ZCZDSY08900). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adsul MG, 2007, GREEN CHEM, V9, P58, DOI 10.1039/B605839F; Altaf M, 2007, BIORESOURCE TECHNOL, V98, P498, DOI 10.1016/j.biortech.2006.02.013; EINARSSON H, 1983, J AGR FOOD CHEM, V31, P1043, DOI 10.1021/jf00119a031; Gorke B, 2008, NAT REV MICROBIOL, V6, P613, DOI 10.1038/nrmicro1932; Hsieh CM, 1999, PROCESS BIOCHEM, V34, P173, DOI 10.1016/S0032-9592(98)00081-8; Jiang X, 2013, BIORESOURCE TECHNOL, V143, P665, DOI 10.1016/j.biortech.2013.06.049; John RP, 2007, APPL MICROBIOL BIOT, V74, P524, DOI 10.1007/s00253-006-0779-6; Laopaiboon P, 2010, BIORESOURCE TECHNOL, V101, P1036, DOI 10.1016/j.biortech.2009.08.091; Liguori R, 2013, APPL MICROBIOL BIOT, V97, P6129, DOI 10.1007/s00253-013-5014-7; Maeda RN, 2011, PROCESS BIOCHEM, V46, P1196, DOI 10.1016/j.procbio.2011.01.022; Nancib A, 2005, BIORESOURCE TECHNOL, V96, P63, DOI 10.1016/j.biortech.2003.09.018; Patel M, 2004, BIOTECHNOL LETT, V26, P865, DOI 10.1023/B:bile.0000025893.27700.5c; Patel MA, 2005, BIOTECHNOL PROGR, V21, P1453, DOI 10.1021/bp0400339; Peng LL, 2013, BIORESOURCE TECHNOL, V149, P169, DOI 10.1016/j.biortech.2013.09.047; Rojan PJ, 2005, BIOTECHNOL LETT, V27, P1685, DOI 10.1007/s10529-005-2731-8; Schepers AW, 2002, ENZYME MICROB TECH, V30, P176, DOI 10.1016/S0141-0229(01)00465-3; Sodergard A, 2002, PROG POLYM SCI, V27, P1123, DOI 10.1016/s0079-6700(02)00012-6; Sun JX, 2004, POLYM DEGRAD STABIL, V84, P331, DOI [10.1016/j.polymdegradstab.2004.02.008, 10.1016/S0141-3910(04)00045-X]; Tanaka T, 2006, BIORESOURCE TECHNOL, V97, P211, DOI 10.1016/j.biortech.2005.02.025; Travaini R, 2013, BIORESOURCE TECHNOL, V133, P332, DOI 10.1016/j.biortech.2013.01.133; Wang LM, 2013, BIORESOURCE TECHNOL, V130, P174, DOI 10.1016/j.biortech.2012.11.144; Xu K, 2014, BIORESOURCE TECHNOL, V153, P23, DOI 10.1016/j.biortech.2013.11.057; Yang XF, 2013, BIOTECHNOL BIOFUELS, V6, DOI 10.1186/1754-6834-6-124; Zhao K, 2013, BIORESOURCE TECHNOL, V135, P481, DOI 10.1016/j.biortech.2012.09.063	24	21	21	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2014	9	9							e107143	10.1371/journal.pone.0107143	http://dx.doi.org/10.1371/journal.pone.0107143			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ1IR	25192451	Green Published, gold, Green Submitted			2022-12-27	WOS:000347993600101
J	Sabbagh, JJ; O'Leary, JC; Blair, LJ; Klengel, T; Nordhues, BA; Fontaine, SN; Binder, EB; Dickey, CA				Sabbagh, Jonathan J.; O'Leary, John C., III; Blair, Laura J.; Klengel, Torsten; Nordhues, Bryce A.; Fontaine, Sarah N.; Binder, Elisabeth B.; Dickey, Chad A.			Age-Associated Epigenetic Upregulation of the FKBP5 Gene Selectively Impairs Stress Resiliency	PLOS ONE			English	Article							PROTEIN 51 FKBP5; GLUCOCORTICOID-RECEPTOR; CHRONIC CORTICOSTERONE; DEPRESSIVE SYMPTOMS; IMMUNOPHILIN FKBP51; ALZHEIMERS-DISEASE; METABOLIC SYNDROME; MAJOR DEPRESSION; DISORDERS; RATS	Single nucleotide polymorphisms (SNPs) in the FK506 binding protein 5 (FKBP5) gene combine with traumatic events to increase risk for post-traumatic stress and major depressive disorders (PTSD and MDD). These SNPs increase FKBP51 protein expression through a mechanism involving demethylation of the gene and altered glucocorticoid signaling. Aged animals also display elevated FKBP51 levels, which contribute to impaired resiliency to depressive-like behaviors through impaired glucocorticoid signaling, a phenotype that is abrogated in FKBP5 2/2 mice. But the age of onset and progressive stability of these phenotypes remain unknown. Moreover, it is unclear how FKBP5 deletion affects other glucocorticoid-dependent processes or if age-associated increases in FKBP51 expression are mediated through a similar epigenetic process caused by SNPs in the FKBP5 gene. Here, we show that FKBP51-mediated impairment in stress resiliency and glucocorticoid signaling occurs by 10 months of age and this increased over their lifespan. Surprisingly, despite these progressive changes in glucocorticoid responsiveness, FKBP5 2/2 mice displayed normal longevity, glucose tolerance, blood composition and cytokine profiles across lifespan, phenotypes normally associated with glucocorticoid signaling. We also found that methylation of Fkbp5 decreased with age in mice, a process that likely explains the age-associated increases in FKBP51 levels. Thus, epigenetic upregulation of FKBP51 with age can selectively impair psychological stress-resiliency, but does not affect other glucocorticoid-mediated physiological processes. This makes FKBP51 a unique and attractive therapeutic target to treat PTSD and MDD. In addition, aged wild-type mice may be a useful model for investigating the mechanisms of FKBP5 SNPs associated with these disorders.	[Sabbagh, Jonathan J.; O'Leary, John C., III; Blair, Laura J.; Nordhues, Bryce A.; Fontaine, Sarah N.; Dickey, Chad A.] Univ S Florida, Byrd Alzheimers Res Inst, Dept Mol Med, Tampa, FL 33620 USA; [Klengel, Torsten; Binder, Elisabeth B.] Emory Univ, Sch Med, Dept Psychiat & Behav Sci, Atlanta, GA USA; [Klengel, Torsten; Binder, Elisabeth B.] Max Planck Inst Psychiat, Dept Translat Res, D-80804 Munich, Germany	State University System of Florida; University of South Florida; Emory University; Max Planck Society	Dickey, CA (corresponding author), Univ S Florida, Byrd Alzheimers Res Inst, Dept Mol Med, Tampa, FL 33620 USA.	cdickey@health.usf.edu	Fontaine, Sarah/P-6536-2016; Klengel, Torsten/E-5629-2010	Klengel, Torsten/0000-0001-7045-9229; Blair, Laura/0000-0002-4981-5564	National Institutes of Health/National Institutes of Neurological Disease and Stroke [R01 NS073899]; American Federation for Aging Research; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH103848] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS073899] Funding Source: NIH RePORTER	National Institutes of Health/National Institutes of Neurological Disease and Stroke; American Federation for Aging Research; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by the National Institutes of Health/National Institutes of Neurological Disease and Stroke R01 NS073899 and the American Federation for Aging Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alamed J, 2006, NAT PROTOC, V1, P1671, DOI 10.1038/nprot.2006.275; Appelhof BC, 2006, BIOL PSYCHIAT, V59, P696, DOI 10.1016/j.biopsych.2005.09.008; Attwood BK, 2011, NATURE, V473, P372, DOI 10.1038/nature09938; Beas BS, 2013, NEUROBIOL AGING, V34, P2164, DOI 10.1016/j.neurobiolaging.2013.03.019; Binder EB, 2004, NAT GENET, V36, P1319, DOI 10.1038/ng1479; Binder EB, 2008, JAMA-J AM MED ASSOC, V299, P1291, DOI 10.1001/jama.299.11.1291; Blair LJ, 2013, J CLIN INVEST, V123, P4158, DOI 10.1172/JCI69003; Chanson P, 2010, NEUROENDOCRINOLOGY, V92, P96, DOI 10.1159/000314272; Denny WB, 2000, ENDOCRINOLOGY, V141, P4107, DOI 10.1210/en.141.11.4107; Epel ES, 2004, P NATL ACAD SCI USA, V101, P17312, DOI 10.1073/pnas.0407162101; Fani N, 2013, JAMA PSYCHIAT, V70, P392, DOI 10.1001/2013.jamapsychiatry.210; Freret T., 2014, J NEURAL TRANSM; Galigniana NM, 2012, J NEUROCHEM, V122, P4, DOI 10.1111/j.1471-4159.2012.07775.x; GILAD GM, 1995, MECH AGEING DEV, V78, P75, DOI 10.1016/0047-6374(94)01529-U; Gump BB, 2005, STROKE, V36, P98, DOI 10.1161/01.STR.0000149626.50127.d0; Hartmann J, 2012, NEUROPHARMACOLOGY, V62, P332, DOI 10.1016/j.neuropharm.2011.07.041; Jinwal UK, 2010, J NEUROSCI, V30, P591, DOI 10.1523/JNEUROSCI.4815-09.2010; Karatsoreos IN, 2010, ENDOCRINOLOGY, V151, P2117, DOI 10.1210/en.2009-1436; Klengel T, 2013, NAT NEUROSCI, V16, P33, DOI 10.1038/nn.3275; Lee RS, 2010, ENDOCRINOLOGY, V151, P4332, DOI 10.1210/en.2010-0225; Lenze EJ, 2005, J AM GERIATR SOC, V53, P569, DOI 10.1111/j.1532-5415.2005.53202.x; Lok A, 2012, PSYCHONEUROENDOCRINO, V37, P892, DOI 10.1016/j.psyneuen.2011.10.005; Luijendijk HJ, 2008, ARCH GEN PSYCHIAT, V65, P1394, DOI 10.1001/archpsyc.65.12.1394; Magee JA, 2006, ENDOCRINOLOGY, V147, P590, DOI 10.1210/en.2005-1001; Minelli A, 2013, DEPRESS ANXIETY, V30, P1170, DOI 10.1002/da.22158; Naegeli KJ, 2013, EUR J PHARMACOL, V703, P62, DOI 10.1016/j.ejphar.2013.02.006; Naismith SL, 2012, PROG NEUROBIOL, V98, P99, DOI 10.1016/j.pneurobio.2012.05.009; O'Leary JC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024840; Ohira H, 2011, NEUROSCIENCE, V193, P193, DOI 10.1016/j.neuroscience.2011.07.014; Palmer K, 2010, J ALZHEIMERS DIS, V20, P175, DOI 10.3233/JAD-2010-1352; Romano S, 2011, CURR OPIN PHARMACOL, V11, P288, DOI 10.1016/j.coph.2011.04.011; Schmidt MV, 2012, CHEMMEDCHEM, V7, P1351, DOI 10.1002/cmdc.201200137; Simon NM, 2006, BIOL PSYCHIAT, V60, P432, DOI 10.1016/j.biopsych.2006.02.004; Starkstein SE, 2008, INT REV PSYCHIATR, V20, P382, DOI 10.1080/09540260802094480; Sterner EY, 2010, PROG NEURO-PSYCHOPH, V34, P777, DOI 10.1016/j.pnpbp.2010.03.005; Storer CL, 2011, TRENDS ENDOCRIN MET, V22, P481, DOI 10.1016/j.tem.2011.08.001; Touma C, 2011, BIOL PSYCHIAT, V70, P928, DOI 10.1016/j.biopsych.2011.07.023; Weber B, 2000, EXP CLIN ENDOCR DIAB, V108, P187, DOI 10.1055/s-2000-7742; West RL, 1996, PSYCHOL BULL, V120, P272, DOI 10.1037/0033-2909.120.2.272; Wochnik GM, 2005, J BIOL CHEM, V280, P4609, DOI 10.1074/jbc.M407498200; Wolkowitz OM, 2010, DEPRESS ANXIETY, V27, P327, DOI 10.1002/da.20686; Yang L, 2012, AM J PHYSIOL-ENDOC M, V302, pE987, DOI 10.1152/ajpendo.00474.2011; Yang XJ, 2012, BIOCHEM BIOPH RES CO, V420, P570, DOI 10.1016/j.bbrc.2012.03.035; Zobel AW, 2001, J PSYCHIAT RES, V35, P83, DOI 10.1016/S0022-3956(01)00013-9	44	58	60	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2014	9	9							e107241	10.1371/journal.pone.0107241	http://dx.doi.org/10.1371/journal.pone.0107241			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ1IR	25191701	gold, Green Submitted, Green Published			2022-12-27	WOS:000347993600108
J	Tradtrantip, L; Asavapanumas, N; Phuan, PW; Verkman, AS				Tradtrantip, Lukmanee; Asavapanumas, Nithi; Phuan, Puay-Wah; Verkman, A. S.			Potential Therapeutic Benefit of C1-Esterase Inhibitor in Neuromyelitis Optica Evaluated In Vitro and in an Experimental Rat Model	PLOS ONE			English	Article							COMPLEMENT-DEPENDENT CYTOTOXICITY; C1 INHIBITOR; IMMUNOGLOBULIN-G; AQUAPORIN-4; SPECTRUM; ACTIVATION; MECHANISMS; SERPIN; AUTOANTIBODIES; PATHOGENICITY	Neuromyelitis optica (NMO) is an autoimmune demyelinating disease of the central nervous system in which binding of anti-aquaporin-4 (AQP4) autoantibodies (NMO-IgG) to astrocytes causes complement-dependent cytotoxicity (CDC) and inflammation resulting in oligodendrocyte and neuronal injury. There is compelling evidence for a central role of complement in NMO pathogenesis. Here, we evaluated the potential of C1-esterase inhibitor (C1-inh) for complement-targeted therapy of NMO. C1-inh is an anti-inflammatory plasma protein with serine protease inhibition activity that has a broad range of biological activities on the contact (kallikrein), coagulation, fibrinolytic and complement systems. C1-inh is approved for therapy of hereditary angioedema (HAE) and has been studied in a small safety trial in acute NMO relapses (NCT 01759602). In vitro assays of NMO-IgG-dependent CDC showed C1-inh inhibition of human and rat complement, but with predicted minimal complement inhibition activity at a dose of 2000 units in humans. Inhibition of complement by C1-inh was potentiated by similar to 10-fold by polysulfated macromolecules including heparin and dextran sulfate. In rats, intravenous C1-inh at a dose 30-fold greater than that approved to treat HAE inhibited serum complement activity by <5%, even when supplemented with heparin. Also, high-dose C1-inh did not reduce pathology in a rat model of NMO produced by intracerebral injection of NMO-IgG. Therefore, although C1r and C1s are targets of C1-inh, our in vitro data with human serum and in vivo data in rats suggest that the complement inhibition activity of C1-inh in serum is too low to confer clinical benefit in NMO.	[Tradtrantip, Lukmanee; Asavapanumas, Nithi; Phuan, Puay-Wah; Verkman, A. S.] Univ Calif San Francisco, Dept Physiol & Med, San Francisco, CA 94143 USA	University of California System; University of California San Francisco	Verkman, AS (corresponding author), Univ Calif San Francisco, Dept Physiol & Med, San Francisco, CA 94143 USA.	Alan.Verkman@ucsf.edu		Asavapanumas, Nithi/0000-0002-5362-2124	National Institutes of Health [EY13574, DK35124, EB00415, DK72517]; Guthy-Jackson Charitable Foundation; CSL Behring (Kankakee, IL); NATIONAL EYE INSTITUTE [R01EY013574] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB000415, R37EB000415] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK072517, R37DK035124, R01DK035124] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Guthy-Jackson Charitable Foundation; CSL Behring (Kankakee, IL); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by grants EY13574, DK35124, EB00415 and DK72517 from the National Institutes of Health, a grant from the Guthy-Jackson Charitable Foundation, and a sponsored research agreement from CSL Behring (Kankakee, IL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asavapanumas N, 2014, ACTA NEUROPATHOL, V127, P539, DOI 10.1007/s00401-013-1204-8; Ayzenberg I, 2013, JAMA NEUROL, V70, P394, DOI 10.1001/jamaneurol.2013.1246; Beinrohr L, 2007, J BIOL CHEM, V282, P21100, DOI 10.1074/jbc.M700841200; Bennett JL, 2009, ANN NEUROL, V66, P617, DOI 10.1002/ana.21802; BIANCHINO AC, 1988, J IMMUNOL, V141, P3930; Caliezi C, 2000, PHARMACOL REV, V52, P91; Cicardi M, 1998, IMMUNOBIOLOGY, V199, P366, DOI 10.1016/S0171-2985(98)80041-7; Collongues Nicolas, 2011, Ther Adv Neurol Disord, V4, P111, DOI 10.1177/1756285611398939; Crane JM, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M111.227298; Cree B, 2008, CURR NEUROL NEUROSCI, V8, P427, DOI 10.1007/s11910-008-0066-2; Cugno M, 2009, TRENDS MOL MED, V15, P69, DOI 10.1016/j.molmed.2008.12.001; Garlatti V, 2010, J IMMUNOL, V185, P808, DOI 10.4049/jimmunol.1000184; Gettins PGW, 2002, CHEM REV, V102, P4751, DOI 10.1021/cr010170+; Hinson SR, 2007, NEUROLOGY, V69, P2221, DOI 10.1212/01.WNL.0000289761.64862.ce; Hinson SR, 2009, ARCH NEUROL-CHICAGO, V66, P1164, DOI 10.1001/archneurol.2009.188; HUGHESJONES NC, 1978, IMMUNOLOGY, V34, P459; Jacob A, 2013, J NEUROL NEUROSUR PS, V84, P922, DOI 10.1136/jnnp-2012-302310; Jarius S, 2008, NAT CLIN PRACT NEURO, V4, P202, DOI 10.1038/ncpneuro0764; Karnaukhova E, 2013, J HEMATOL THROMB DIS, V1, P3; Kerr FK, 2008, MOL IMMUNOL, V45, P670, DOI 10.1016/j.molimm.2007.07.008; Kim SH, 2013, J CLIN NEUROL, V9, P36, DOI 10.3988/jcn.2013.9.1.36; Kira J, 2011, J NEUROL SCI, V311, P69, DOI 10.1016/j.jns.2011.08.043; Kunschak M, 1998, TRANSFUSION, V38, P540, DOI 10.1046/j.1537-2995.1998.38698326333.x; Lennon VA, 2005, J EXP MED, V202, P473, DOI 10.1084/jem.20050304; Levy M, 2014, NEUROL-NEUROIMMUNOL, V1, DOI 10.1212/NXI.0000000000000005; Lucchinetti CF, 2002, BRAIN, V125, P1450, DOI 10.1093/brain/awf151; Misu T, 2007, BRAIN, V130, P1224, DOI 10.1093/brain/awm047; Nielsen EW, 2007, MOL IMMUNOL, V44, P1819, DOI 10.1016/j.molimm.2006.10.003; Papadopoulos MC, 2013, NAT REV NEUROSCI, V14, P265, DOI 10.1038/nrn3468; Papadopoulos MC, 2012, LANCET NEUROL, V11, P535, DOI 10.1016/S1474-4422(12)70133-3; Parker C, 2009, LANCET, V373, P759, DOI 10.1016/S0140-6736(09)60001-5; Phuan PW, 2013, ACTA NEUROPATHOL, V125, P829, DOI 10.1007/s00401-013-1128-3; Phuan PW, 2012, J BIOL CHEM, V287, P13829, DOI 10.1074/jbc.M112.344325; Pittock SJ, 2013, LANCET NEUROL, V12, P554, DOI 10.1016/S1474-4422(13)70076-0; Prematta Michael J, 2008, Ther Clin Risk Manag, V4, P975; Ratelade J, 2014, MOL IMMUNOL, V62, P104, DOI 10.1016/j.molimm.2014.06.003; Ratelade J, 2014, EXP NEUROL, V255, P145, DOI 10.1016/j.expneurol.2014.03.004; Roemer SF, 2007, BRAIN, V130, P1194, DOI 10.1093/brain/awl371; Saadoun S, 2012, ANN NEUROL, V71, P323, DOI 10.1002/ana.22686; Saadoun S, 2010, BRAIN, V133, P349, DOI 10.1093/brain/awp309; Sabater L, 2009, J NEUROIMMUNOL, V215, P31, DOI 10.1016/j.jneuroim.2009.07.014; TENNER AJ, 1986, J IMMUNOL, V137, P625; Tradtrantip L, 2012, ANN NEUROL, V71, P314, DOI 10.1002/ana.22657; WEILER JM, 1992, J IMMUNOL, V148, P3210; Wingerchuk DM, 2007, LANCET NEUROL, V6, P805, DOI 10.1016/S1474-4422(07)70216-8; Wouters D, 2013, BLOOD, V121, P1242, DOI 10.1182/blood-2012-11-467209; Wuillemin WA, 1997, J IMMUNOL, V159, P1953; Zhang H, 2013, J CLIN INVEST, V123, P2306, DOI 10.1172/JCI67554; Zhang H, 2011, ANN NEUROL, V70, P943, DOI 10.1002/ana.22551; ZICCARDI RJ, 1979, J IMMUNOL, V123, P788	50	15	20	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2014	9	9							e106824	10.1371/journal.pone.0106824	http://dx.doi.org/10.1371/journal.pone.0106824			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ1IR	25191939	Green Published, Green Submitted, gold			2022-12-27	WOS:000347993600068
J	Ursinus, WW; Van Reenen, CG; Reimert, I; Bolhuis, JE				Ursinus, Winanda W.; Van Reenen, Cornelis G.; Reimert, Inonge; Bolhuis, J. Elizabeth			Tail Biting in Pigs: Blood Serotonin and Fearfulness as Pieces of the Puzzle?	PLOS ONE			English	Article							INDIVIDUAL COPING CHARACTERISTICS; OBSESSIVE-COMPULSIVE DISORDER; ENVIRONMENTAL ENRICHMENT; FEATHER PECKING; LAYING HENS; PERIPHERAL SEROTONIN; BEHAVIORAL-RESPONSES; PLATELET SEROTONIN; GROWTH-PERFORMANCE; CIRCADIAN-RHYTHM	Tail biting in pigs is a widespread problem in intensive pig farming. The tendency to develop this damaging behaviour has been suggested to relate to serotonergic functioning and personality characteristics of pigs. We investigated whether tail biting in pigs can be associated with blood serotonin and with their behavioural and physiological responses to novelty. Pigs (n = 480) were born in conventional farrowing pens and after weaning at four weeks of age they were either housed barren (B) or in straw-enriched (E) pens. Individual pigs were exposed to a back test and novel environment test before weaning, and after weaning to a novel object (i.e. bucket) test in an unfamiliar arena. A Principal Component Analysis on behaviours during the tests and salivary cortisol (novel object test only) revealed five factors for both housing systems, labeled 'Early life exploration', 'Near bucket', 'Cortisol', 'Vocalizations & standing alert', and 'Back test activity'. Blood samples were taken at 8, 9 and 22 weeks of age to determine blood platelet serotonin. In different phases of life, pigs were classified as tail biter/non-tail biter based on tail biting behaviour, and as victim/non-victim based on tail wounds. A combination of both classifications resulted in four pig types: biters, victims, biter/victims, and neutrals. Generally, only in phases of life during which pigs were classified as tail biters, they seemed to have lower blood platelet serotonin storage and higher blood platelet uptake velocities. Victims also seemed to have lower blood serotonin storage. Additionally, in B housing, tail biters seemed to consistently have lower scores of the factor 'Near bucket', possibly indicating a higher fearfulness in tail biters. Further research is needed to elucidate the nature of the relationship between peripheral 5-HT, fearfulness and tail biting, and to develop successful strategies and interventions to prevent and reduce tail biting.	[Ursinus, Winanda W.; Reimert, Inonge; Bolhuis, J. Elizabeth] Wageningen Univ, Dept Anim Sci, Adaptat Physiol Grp, NL-6700 AP Wageningen, Netherlands; [Ursinus, Winanda W.; Van Reenen, Cornelis G.] Wageningen UR Livestock Res, Anim Behav & Welf, Wageningen, Netherlands	Wageningen University & Research; Wageningen University & Research	Ursinus, WW (corresponding author), Wageningen Univ, Dept Anim Sci, Adaptat Physiol Grp, NL-6700 AP Wageningen, Netherlands.	nanda.ursinus@wur.nl	Bolhuis, J. Elizabeth/P-7978-2015	Bolhuis, J. Elizabeth/0000-0002-5172-7635; Ursinus, Winanda/0000-0002-3186-6793	Dutch Ministry of Economic Affairs	Dutch Ministry of Economic Affairs(Ministry of Economic Affairs, Netherlands)	This research was financed by the Dutch Ministry of Economic Affairs. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashwani A, 2011, IRJP, V2, P18; Azmitia EC, 2010, HBK BEHAV NEUROSCI, V21, P3, DOI 10.1016/S1569-7339(10)70069-2; Beattie VE, 1996, APPL ANIM BEHAV SCI, V48, P151, DOI 10.1016/0168-1591(96)01031-3; Bell AM, 2007, ECOL LETT, V10, P828, DOI 10.1111/j.1461-0248.2007.01081.x; Bolhuis JE, 2009, PHYSIOL BEHAV, V97, P470, DOI 10.1016/j.physbeh.2009.03.021; Bolhuis JE, 2004, BEHAV BRAIN RES, V152, P351, DOI 10.1016/j.bbr.2003.10.024; Bolhuis JE, 2003, PHYSIOL BEHAV, V79, P289, DOI 10.1016/S0031-9384(03)00090-8; Bolhuis JE, 2000, PSYCHOPHARMACOLOGY, V152, P24, DOI 10.1007/s002130000516; Brunberg E, 2013, GENES BRAIN BEHAV, V12, P275, DOI 10.1111/gbb.12002; Brunberg E, 2011, POULTRY SCI, V90, P1145, DOI 10.3382/ps.2010-00961; Brunberg E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066513; BUTLER J, 1992, J AFFECT DISORDERS, V26, P89, DOI 10.1016/0165-0327(92)90039-9; Camerlink I, 2014, BEHAV GENET IN PRESS; Camerlink I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065136; Carver CS, 2006, PSYCHIAT RES, V144, P1, DOI 10.1016/j.psychres.2006.03.013; CELADA P, 1994, LIFE SCI, V55, P1237, DOI 10.1016/0024-3205(94)00663-6; Cleare A J, 1997, Depress Anxiety, V5, P108, DOI 10.1002/(SICI)1520-6394(1997)5:2<108::AID-DA8>3.0.CO;2-B; COPPEN A, 1976, POSTGRAD MED J, V52, P156, DOI 10.1136/pgmj.52.605.156; Crespi BJ, 2000, HEREDITY, V84, P623, DOI 10.1046/j.1365-2540.2000.00746.x; CURZON G, 1970, BRIT J PHARMACOL, V39, P653, DOI 10.1111/j.1476-5381.1970.tb10373.x; da Silva CS, 2014, ANIMAL, V8, P1402, DOI 10.1017/S1751731114001116; DAPRADA M, 1979, BRIT J PHARMACOL, V65, P653; de Haas EN, 2013, POULTRY SCI, V92, P2259, DOI 10.3382/ps.2012-02996; de Haas EN, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090577; de Jong IC, 2000, PHYSIOL BEHAV, V68, P571, DOI 10.1016/S0031-9384(99)00212-7; Delorme R, 2005, NEUROPSYCHOPHARMACOL, V30, P1539, DOI 10.1038/sj.npp.1300752; Dickerson SS, 2004, PSYCHOL BULL, V130, P355, DOI 10.1037/0033-2909.130.3.355; European Food Safety Authority, 2007, EFSA J, V572, P1, DOI DOI 10.2903/J.EFSA.2007.572; European Food Safety Authority (EFSA), 2007, EFSA J, V611, P1, DOI DOI 10.2903/J.EFSA.2007.611; FICHTNER CG, 1995, LIFE SCI, V57, pPL37, DOI 10.1016/0024-3205(95)00262-5; Forkman B, 2007, PHYSIOL BEHAV, V92, P340, DOI 10.1016/j.physbeh.2007.03.016; Friedman BH, 1998, BIOL PSYCHOL, V49, P303; Gershenfeld HK, 1997, GENOMICS, V46, P1, DOI 10.1006/geno.1997.5002; Ghaffari M. S., 2010, Comparative Clinical Pathology, V19, P317, DOI 10.1007/s00580-009-0878-8; Hashimoto S, 1999, EUR J PHARMACOL, V378, P23, DOI 10.1016/S0014-2999(99)00441-0; Hyun Y, 1998, J ANIM SCI, V76, P721; Jansen J, 2009, ANIM COGN, V12, P303, DOI 10.1007/s10071-008-0191-y; JERNEJ B, 1990, PSYCHIAT RES, V32, P167, DOI 10.1016/0165-1781(90)90083-H; Jernej B, 2000, PSYCHIAT RES, V94, P153, DOI 10.1016/S0165-1781(00)00129-3; Jolliffe I.T., 2002, PRINCIPAL COMPONENT, V87, P513; Kallai J, 2007, BEHAV NEUROSCI, V121, P21, DOI 10.1037/0735-7044.121.1.21; Kemperman Ramses F. J., 2007, Biogenic Amines, V21, P260; Keszthelyi D, 2012, AM J CLIN NUTR, V95, P603, DOI 10.3945/ajcn.111.028589; Kluge H, 1999, J LAB MED, V23, P360, DOI DOI 10.1515/LABM.1999.23.6.360]; KOE BK, 1966, J PHARMACOL EXP THER, V154, P499; Koolhaas JM, 2010, FRONT NEUROENDOCRIN, V31, P307, DOI 10.1016/j.yfrne.2010.04.001; Koolhaas JM, 1999, NEUROSCI BIOBEHAV R, V23, P925, DOI 10.1016/S0149-7634(99)00026-3; Koolhaas JM, 1997, NEUROSCI BIOBEHAV R, V21, P775, DOI 10.1016/S0149-7634(96)00057-7; Kops MS, 2013, PHYSIOL BEHAV, V120, P77, DOI 10.1016/j.physbeh.2013.07.007; Kops MS, 2014, THESIS UTRECHT U UTR; Korte SM, 2009, VET J, V182, P378, DOI 10.1016/j.tvjl.2009.08.023; Korte SM, 1999, PHYSIOL BEHAV, V65, P649; Korte SM, 2003, EUR J PHARMACOL, V463, P163, DOI 10.1016/S0014-2999(03)01279-2; Leon-Ponte M, 2007, BLOOD, V109, P3139, DOI 10.1182/blood-2006-10-052787; Martinez-Trejo G, 2009, J ANIM VET ADV, V8, P608; Melotti L, 2011, APPL ANIM BEHAV SCI, V133, P144, DOI 10.1016/j.applanim.2011.05.018; Mills DS, 2003, APPL ANIM BEHAV SCI, V81, P265, DOI 10.1016/S0168-1591(02)00286-1; Morgan KN, 2007, APPL ANIM BEHAV SCI, V102, P262, DOI 10.1016/j.applanim.2006.05.032; Morrison RS, 2007, APPL ANIM BEHAV SCI, V103, P12, DOI 10.1016/j.applanim.2006.04.002; Naesh O, 2001, CLIN PHYSIOL, V21, P39, DOI 10.1046/j.1365-2281.2001.00303.x; Pearish S, 2013, BEHAV ECOL SOCIOBIOL, V67, P765, DOI 10.1007/s00265-013-1500-2; POND WG, 1987, J ANIM SCI, V65, P497, DOI 10.2527/jas1987.652497x; Reimert I, 2013, J ANIM SCI, V91, P4589, DOI 10.2527/jas.2013-6673; Reimert I, 2014, APPL ANIM BEHAV SCI, V151, P24, DOI 10.1016/j.applanim.2013.11.015; Reimert I, 2013, PHYSIOL BEHAV, V109, P42, DOI 10.1016/j.physbeh.2012.11.002; Rodenburg TB, 2010, APPL ANIM BEHAV SCI, V128, P91, DOI 10.1016/j.applanim.2010.09.017; Rodenburg TB, 2009, PHYSIOL BEHAV, V98, P519, DOI 10.1016/j.physbeh.2009.08.006; Ruis MAW, 1997, PHYSIOL BEHAV, V62, P623, DOI 10.1016/S0031-9384(97)00177-7; Seksel K, 2001, AUST VET J, V79, P252, DOI 10.1111/j.1751-0813.2001.tb11976.x; Spiller R, 2008, NEUROPHARMACOLOGY, V55, P1072, DOI 10.1016/j.neuropharm.2008.07.016; Studnitz M, 2007, APPL ANIM BEHAV SCI, V107, P183, DOI 10.1016/j.applanim.2006.11.013; Taylor NR, 2010, VET J, V186, P137, DOI 10.1016/j.tvjl.2009.08.028; THIESFLECHTNER K, 1994, PHARMACOPSYCHIATRY, V27, P4, DOI 10.1055/s-2007-1014316; Torres AR, 2006, AM J PSYCHIAT, V163, P1978, DOI 10.1176/appi.ajp.163.11.1978; Uitdehaag KA, 2011, POULTRY SCI, V90, P1629, DOI 10.3382/ps.2010-01292; Ursinus WW, 2014, APPL ANIM BEHAV SCI, V156, P22, DOI 10.1016/j.applanim.2014.04.001; Ursinus WW, 2013, PHYSIOL BEHAV, V118, P88, DOI 10.1016/j.physbeh.2013.05.018; Valros A, 2013, P 47 C INT SOC APPL, P105; Van de Weerd HA, 2005, ANIM SCI, V80, P289, DOI 10.1079/ASC40450289; Van Reenen CG, 2009, PHYSIOL BEHAV, V96, P307, DOI 10.1016/j.physbeh.2008.10.016; Van Reenen CG, 2004, APPL ANIM BEHAV SCI, V85, P11, DOI 10.1016/j.applanim.2003.09.007; van Zeeland YRA, 2013, APPL ANIM BEHAV SCI, V148, P218, DOI 10.1016/j.applanim.2013.08.004; van Zeeland YRA, 2009, APPL ANIM BEHAV SCI, V121, P75, DOI 10.1016/j.applanim.2009.09.006; Vicens-Costa E, 2011, PHYSIOL BEHAV, V103, P148, DOI 10.1016/j.physbeh.2010.12.009; YUWILER A, 1981, ARCH GEN PSYCHIAT, V38, P619; Zonderland JJ, 2008, APPL ANIM BEHAV SCI, V110, P269, DOI 10.1016/j.applanim.2007.04.005; Zupan M, 2012, PHYSIOL BEHAV, V106, P638, DOI 10.1016/j.physbeh.2012.04.025	87	26	27	0	61	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 4	2014	9	9							e107040	10.1371/journal.pone.0107040	http://dx.doi.org/10.1371/journal.pone.0107040			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3XV	25188502	Green Published, gold, Green Submitted			2022-12-27	WOS:000341271500112
J	Li, M; Yang, DB; Mei, L; Yuan, L; Xie, A; Yuan, JL				Li, Ming; Yang, Dianbin; Mei, Lu; Yuan, Lin; Xie, Ao; Yuan, Jieli			Screening and Characterization of Purine Nucleoside Degrading Lactic Acid Bacteria Isolated from Chinese Sauerkraut and Evaluation of the Serum Uric Acid Lowering Effect in Hyperuricemic Rats	PLOS ONE			English	Article							ASSOCIATION; PROGRESSION; STRAINS	Hyperuricemia is well known as the cause of gout. In recent years, it has also been recognized as a risk factor for arteriosclerosis, cerebrovascular and cardiovascular diseases, and nephropathy in diabetic patients. Foods high in purine compounds are more potent in exacerbating hyperuricemia. Therefore, the development of probiotics that efficiently degrade purine compounds is a promising potential therapy for the prevention of hyperuricemia. In this study, fifty-five lactic acid bacteria isolated from Chinese sauerkraut were evaluated for the ability to degrade inosine and guanosine, the two key intermediates in purine metabolism. After a preliminary screening based on HPLC, three candidate strains with the highest nucleoside degrading rates were selected for further characterization. The tested biological characteristics of candidate strains included acid tolerance, bile tolerance, anti-pathogenic bacteria activity, cell adhesion ability, resistance to antibiotics and the ability to produce hydrogen peroxide. Among the selected strains, DM9218 showed the best probiotic potential compared with other strains despite its poor bile resistance. Analysis of 16S rRNA sequences showed that DM9218 has the highest similarity (99%) to Lactobacillus plantarum WCFS1. The acclimated strain DM9218-A showed better resistance to 0.3% bile salt, and its survival in gastrointestinal tract of rats was proven by PCR-DGGE. Furthermore, the effects of DM9218-A in a hyperuricemia rat model were evaluated. The level of serum uric acid in hyperuricemic rat can be efficiently reduced by the intragastric administration of DM9218-A (P<0.05). The preventive treatment of DM9218-A caused a greater reduction in serum uric acid concentration in hyperuricemic rats than the later treatment (P<0.05). Our results suggest that DM9218-A may be a promising candidate as an adjunctive treatment in patients with hyperuricemia during the onset period of disease. DM9218-A also has potential as a probiotic in the prevention of hyperuricemia in the normal population.	[Li, Ming; Yang, Dianbin; Mei, Lu; Xie, Ao; Yuan, Jieli] Dalian Med Univ, Sch Basic Med Sci, Dept Microecol, Dalian, Liaoning, Peoples R China; [Mei, Lu] Zhengzhou Univ, Affiliated Hosp 2, Dept Gastroenterol, Zhengzhou 450052, Henan, Peoples R China; [Yuan, Lin] Univ Alberta, Fac Agr Life & Environm Sci, Edmonton, AB, Canada	Dalian Medical University; Zhengzhou University; University of Alberta	Yuan, JL (corresponding author), Dalian Med Univ, Sch Basic Med Sci, Dept Microecol, Dalian, Liaoning, Peoples R China.	jieli_yuan_dmu@163.com			Key Project of the National Twelfth-Five Year Research Program of China [2012BAI35B02]; National Program on Key Basic Research Project (973 Program) [2013CB531405]; Research Fund for the Doctoral Program of Higher Education, China (RFDP) [20132105120012]	Key Project of the National Twelfth-Five Year Research Program of China; National Program on Key Basic Research Project (973 Program)(National Basic Research Program of China); Research Fund for the Doctoral Program of Higher Education, China (RFDP)(Research Fund for the Doctoral Program of Higher Education of China (RFDP))	This work was supported by the Key Project of the National Twelfth-Five Year Research Program of China (2012BAI35B02), the National Program on Key Basic Research Project (973 Program, 2013CB531405), and the Research Fund for the Doctoral Program of Higher Education, China (RFDP, 20132105120012). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmadzadeh A, 2011, SAUDI J KIDNEY DIS T, V22, P497; BRULE D, 1992, J AM COLL NUTR, V11, P353; Chang JH, 2010, J APPL MICROBIOL, V109, P220, DOI 10.1111/j.1365-2672.2009.04648.x; Chizynski Krzysztof, 2005, Pol Merkur Lekarski, V19, P693; Doghramji PP, 2012, POSTGRAD MED, V124, P98, DOI 10.3810/pgm.2012.11.2616; Dubernet S, 2002, FEMS MICROBIOL LETT, V214, P271, DOI [10.1111/j.1574-6968.2002.tb11358.x, 10.1016/S0378-1097(02)00895-9]; Feliu JX, 1998, BIOTECHNOL BIOENG, V58, P536, DOI 10.1002/(SICI)1097-0290(19980605)58:5<536::AID-BIT10>3.0.CO;2-9; Fuller R, 1997, SCAND J GASTROENTERO, V32, P28, DOI 10.1080/00365521.1997.11720714; Guimaraes AP, 2011, J MOL MODEL, V17, P2939, DOI 10.1007/s00894-011-0968-9; Isolauri E, 2001, AM J CLIN NUTR, V73, p444S, DOI 10.1093/ajcn/73.2.444s; Jacobsen CN, 1999, APPL ENVIRON MICROB, V65, P4949; Johnson RJ, 2008, MED HYPOTHESES, V71, P22, DOI 10.1016/j.mehy.2008.01.017; Joossens M, 2011, GUT, V60, P631, DOI 10.1136/gut.2010.223263; Kang DH, 2002, J AM SOC NEPHROL, V13, P2888, DOI 10.1097/01.ASN.0000034910.58454.FD; Kankainen M, 2009, P NATL ACAD SCI USA, V106, P17193, DOI 10.1073/pnas.0908876106; Kanmani P, 2013, CRIT REV FOOD SCI, V53, P641, DOI 10.1080/10408398.2011.553752; Kim SM, 2012, NEPHRON EXP NEPHROL, V121, pE109, DOI 10.1159/000343567; Klaenhammer TR, 2005, FEMS MICROBIOL REV, V29, P393, DOI 10.1016/j.femsre.2005.04.007; Kosugi T, 2009, AM J PHYSIOL-RENAL, V297, pF481, DOI 10.1152/ajprenal.00092.2009; Lv Q, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056864; Maccaferri S, 2012, APPL ENVIRON MICROB, V78, P956, DOI 10.1128/AEM.06385-11; Makarova K, 2006, P NATL ACAD SCI USA, V103, P15611, DOI 10.1073/pnas.0607117103; Mazzali M, 2001, HYPERTENSION, V38, P1101, DOI 10.1161/hy1101.092839; Minelli EB, 2004, INT DAIRY J, V14, P723, DOI 10.1016/j.idairyj.2004.01.007; Nakagawa T, 2003, AM J NEPHROL, V23, P2, DOI 10.1159/000066303; Ndrepepa G, 2013, NUTR METAB CARDIOVAS, V23, P1195, DOI 10.1016/j.numecd.2013.03.005; Ostlie HM, 2003, INT J FOOD MICROBIOL, V87, P17, DOI 10.1016/S0168-1605(03)00044-8; Perelmuter K, 2008, J APPL MICROBIOL, V104, P1718, DOI 10.1111/j.1365-2672.2007.03702.x; Sanchez-Lozada LG, 2008, AM J PHYSIOL-RENAL, V295, pF1134, DOI 10.1152/ajprenal.00104.2008; Shcherbak AV, 2013, TERAPEVT ARKH, V85, P100; Siezen RJ, 2012, J BACTERIOL, V194, P195, DOI 10.1128/JB.06275-11; Soltani Z, 2013, CURR HYPERTENS REP, V15, P175, DOI 10.1007/s11906-013-0344-5; Sun SZ, 2010, NUTR METAB, V7, DOI 10.1186/1743-7075-7-16; Villegas E, 1998, J FOOD SCI, V63, P1070, DOI 10.1111/j.1365-2621.1998.tb15857.x; Wang CY, 2010, ANAEROBE, V16, P578, DOI 10.1016/j.anaerobe.2010.10.003; Wikler M, 2010, M100S20 NAT COMM CLI; Xiong T, 2012, FOOD CONTROL, V26, P178, DOI 10.1016/j.foodcont.2012.01.027; Yun J, 2013, CLIN EXP ALLERGY, V43, P1246, DOI 10.1111/cea.12184; Zgaga L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038123; Zoccali C, 2013, CURR HYPERTENS REP, V15, P531, DOI 10.1007/s11906-013-0391-y	40	42	48	23	124	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 3	2014	9	9							e105577	10.1371/journal.pone.0105577	http://dx.doi.org/10.1371/journal.pone.0105577			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3TB	25184445	Green Submitted, Green Published, gold			2022-12-27	WOS:000341257700021
J	Li, YY; Xu, CQ; Lin, XG; Cui, BB; Wu, RL; Pang, XM				Li, Yingyue; Xu, Chaoqun; Lin, Xinggu; Cui, Binbin; Wu, Rongling; Pang, Xiaoming			De Novo Assembly and Characterization of the Fruit Transcriptome of Chinese Jujube (Ziziphus jujuba Mill.) Using 454 Pyrosequencing and the Development of Novel Tri-Nucleotide SSR Markers	PLOS ONE			English	Article							EXPRESSED SEQUENCE TAGS; MICROSATELLITE MARKERS; EST-SSRS; HIGH-THROUGHPUT; CANDIDATE GENES; VITAMIN-C; PLANT; ANNOTATION; DISCOVERY; DATABASE	Chinese jujube (Ziziphus jujuba Mill.) is an economically important deciduous tree that has high therapeutic value and health benefits. However, a lack of sequence data and molecular markers have constrained genetic and breeding studies for better fruit quality and other traits in Chinese jujube. In this study, two combined cDNA libraries of 'Dongzao' fruit representing the early and late stages of fruit development were constructed and sequenced on the 454 GS FLX Titanium platform. In total, 1,124,197 reads were generated and then de novo assembled into 97,479 unigenes. A total of 52,938 unigenes were homologous to genes in the NCBI non-redundant sequence database. A total of 33,123 unigenes were assigned to one or more Gene Ontology terms, and 16,693 unigenes were classified into 319 Kyoto Encyclopedia of Genes and Genomes pathways. The results showed that the Smirnoff-Wheeler pathway was the main pathway for the biosynthesis of ascorbic acid in Chinese jujube. The number of differentially expressed genes between the two stages of fruit development was 1,764, among which 974 and 790 genes were up-regulated and down-regulated, respectively. Furthermore, 9,893 sequences were identified containing SSRs. 93 primer pairs designed from the sequences with a tri-nucleotide repeat showed successful PCR amplification and could be validated in Chinese jujube accessions and Z. mauritiana Lam and Z. acidojujuba as well, of which 71 primer pairs were polymorphic. The obtained transcriptome provides a most comprehensive resource currently available for gene discovery and the development of functional markers in Z. jujuba. The newly developed microsatellite markers could be used in applications such as genetic linkage analysis and association studies, diversity analysis, and marker-assisted selection in Chinese jujube and related species.	[Li, Yingyue; Xu, Chaoqun; Lin, Xinggu; Cui, Binbin; Wu, Rongling; Pang, Xiaoming] Beijing Forestry Univ, Key Lab Genet & Breeding Forest Trees & Ornamenta, Natl Engn Lab Tree Breeding, Minist Educ,Coll Biol Sci & Biotechnol, Beijing, Peoples R China; [Wu, Rongling; Pang, Xiaoming] Beijing Forestry Univ, Ctr Computat Biol, Beijing, Peoples R China	Beijing Forestry University; Beijing Forestry University	Pang, XM (corresponding author), Beijing Forestry Univ, Key Lab Genet & Breeding Forest Trees & Ornamenta, Natl Engn Lab Tree Breeding, Minist Educ,Coll Biol Sci & Biotechnol, Beijing, Peoples R China.	xmpang@bjfu.edu.cn			Projects in the National Science & Technology Pillar Program [2013BAD14B0302]; National Natural Science Foundation of China [31372019]; Special Fund for Forestry-Scientific Research in the Public welfare [201004017]; 'Thousand-person Plan' Award	Projects in the National Science & Technology Pillar Program; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Special Fund for Forestry-Scientific Research in the Public welfare; 'Thousand-person Plan' Award(Chinese Academy of Sciences)	This work was supported by Projects in the National Science & Technology Pillar Program (2013BAD14B0302), the National Natural Science Foundation of China (31372019), Special Fund for Forestry-Scientific Research in the Public welfare (201004017) and a 'Thousand-person Plan' Award to Dr. Rongling Wu. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agius F, 2003, NAT BIOTECHNOL, V21, P177, DOI 10.1038/nbt777; Amos W, 2007, MOL ECOL NOTES, V7, P10, DOI 10.1111/j.1471-8286.2006.01560.x; [Anonymous], 1997, MOL BIOL BIOTECHNOLO; [Anonymous], 2014, CELL SIGNAL BIOL; Appleby Nikki, 2009, V513, P19, DOI 10.1007/978-1-59745-427-8_2; Barata-Soares Anderson D., 2004, Braz. J. Plant Physiol., V16, P147, DOI 10.1590/S1677-04202004000300004; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bi P, 1990, SHANXI FRUIT, V4, P24; BOTSTEIN D, 1980, AM J HUM GENET, V32, P314; Breiteneder H, 2004, ALLERGY, V59, P479, DOI 10.1046/j.1398-9995.2003.00421.x; Ceresini PC, 2005, GENET MOL BIOL, V28, P589, DOI 10.1590/S1415-47572005000400014; Cho YG, 2000, THEOR APPL GENET, V100, P713, DOI 10.1007/s001220051343; Cipriani G, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-127; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Crowhurst RN, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-351; CYONG JC, 1980, PHYTOCHEMISTRY, V19, P2747, DOI 10.1016/S0031-9422(00)83955-2; Diwan N, 1997, THEOR APPL GENET, V95, P723, DOI 10.1007/s001220050618; Dutta S, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-17; Edwards CE, 2012, DNA RES, V19, P1, DOI 10.1093/dnares/dsr037; Edwards KJ, 1996, BIOTECHNIQUES, V20, P758; Eujayl I, 2004, THEOR APPL GENET, V108, P414, DOI 10.1007/s00122-003-1450-6; Feng C, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-19; Gao QH, 2013, J AGR FOOD CHEM, V61, P3351, DOI 10.1021/jf4007032; Giovannoni JJ, 2004, PLANT CELL, V16, pS170, DOI 10.1105/tpc.019158; Guo SG, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-384; HANABUSA K, 1981, PLANTA MED, V42, P380, DOI 10.1055/s-2007-971659; Handa AK, 2012, PLANT BIOTECHNOLOGY AND AGRICULTURE: PROSPECTS FOR THE 21ST CENTURY, P405, DOI 10.1016/B978-0-12-381466-1.00026-2; HEARNE CM, 1992, TRENDS GENET, V8, P288, DOI 10.1016/0168-9525(92)90256-4; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kaur S, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-265; Li CQ, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-552; Li DJ, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-192; Li JW, 2007, FOOD CHEM, V103, P454, DOI 10.1016/j.foodchem.2006.08.016; Li XB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0085480; Li XY, 2010, BMC GENET, V11, DOI 10.1186/1471-2156-11-66; Lin XY, 2013, ADV DIFFER EQU-NY, P1, DOI 10.1186/1687-1847-2013-154; Liu J, 2014, SCI HORTIC-AMSTERDAM, V165, P99, DOI 10.1016/j.scienta.2013.10.033; Liu M, 2008, INT JUJUBE S, V840, P25; Liu M.J., 2009, GERMPLASM RESOURCES; Liu MengJun, 2006, Horticultural Reviews, V32, P229; [刘学生 Liu Xuesheng], 2013, [园艺学报, Acta Horticulturae Sinica], V40, P426; Lorence A, 2004, PLANT PHYSIOL, V134, P1200, DOI 10.1104/pp.103.033936; Luro FL, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-287; Ma KY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039727; Ma QH, 2011, SCI HORTIC-AMSTERDAM, V129, P597, DOI 10.1016/j.scienta.2011.04.032; Mammadov J, 2012, INT J PLANT GENOMICS, V2012; Mammadov JA, 2010, THEOR APPL GENET, V121, P577, DOI 10.1007/s00122-010-1331-8; Mardis ER, 2008, TRENDS GENET, V24, P133, DOI 10.1016/j.tig.2007.12.007; Meldgaard M, 1997, ELECTROPHORESIS, V18, P1928, DOI 10.1002/elps.1150181107; Metzker ML, 2010, NAT REV GENET, V11, P31, DOI 10.1038/nrg2626; Meyer E, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-219; Morgante M, 2002, NAT GENET, V30, P194, DOI 10.1038/ng822; Morozova O, 2008, GENOMICS, V92, P255, DOI 10.1016/j.ygeno.2008.07.001; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Mounet F, 2009, PLANT PHYSIOL, V149, P1505, DOI 10.1104/pp.108.133967; MURRAY MG, 1980, NUCLEIC ACIDS RES, V8, P4321, DOI 10.1093/nar/8.19.4321; Novaes E, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-312; Nyberg KG, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-287; Palmieri DA, 2007, GENET MOL BIOL, V30, P1009, DOI 10.1590/S1415-47572007000500029; Pan L, 2010, LEGUME GENOMICS GENE, V1; Pang Xiao-Ming, 2003, Acta Genetica Sinica, V30, P81; Parchman TL, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-180; Peng JianYing, 2005, Acta Horticulturae Sinica, V32, P798; Poncet V, 2006, MOL GENET GENOMICS, V276, P436, DOI 10.1007/s00438-006-0153-5; Qu LJ, 2003, PLANT PHYSIOL, V133, P560, DOI 10.1104/pp.103.024810; Qu Z., 1963, J HEBEI AGR U, V2, P1; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Schlotterer C, 2004, NAT REV GENET, V5, P63, DOI 10.1038/nrg1249; Seymour GB, 2013, ANNU REV PLANT BIOL, V64, P219, DOI 10.1146/annurev-arplant-050312-120057; SFA (State Forestry Administration), 2011, CHIN FOR STAT YB; Sharma RK, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-53; Shi CY, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-131; Tan LQ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081611; TAUTZ D, 1989, NUCLEIC ACIDS RES, V17, P6463, DOI 10.1093/nar/17.16.6463; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Vera JC, 2008, MOL ECOL, V17, P1636, DOI 10.1111/j.1365-294X.2008.03666.x; Wagner C, 2003, PHYTOCHEMISTRY, V62, P887, DOI 10.1016/S0031-9422(02)00703-3; Wang C., 2013, J FOOD AGRIC ENVIRON, V11, P469; Wang R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060449; Wang SQ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099842; Wang XW, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-400; WEBER JL, 1990, GENOMICS, V7, P524, DOI 10.1016/0888-7543(90)90195-Z; Wei WL, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-451; Wheeler GL, 1998, NATURE, V393, P365, DOI 10.1038/30728; Wu LiPing, 2013, Journal of Beijing Forestry University, V35, P77; Xia ZH, 2011, PLANT MOL BIOL, V77, P299, DOI 10.1007/s11103-011-9811-z; Yang T, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-602; Yonghui LMW, 1991, J AGR U HEBEI, V4, P004; Zane L, 2002, MOL ECOL, V11, P1, DOI 10.1046/j.0962-1083.2001.01418.x; Zeng SH, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-94; Zhang CM, 2013, INDIAN J GENET PL BR, V73, P338, DOI 10.5958/j.0975-6906.73.3.052; Zhang JA, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-90; Zhang XM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042082; Zheng XF, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-490	94	13	14	0	54	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 3	2014	9	9							e106438	10.1371/journal.pone.0106438	http://dx.doi.org/10.1371/journal.pone.0106438			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3TB	25184704	Green Submitted, Green Published, gold			2022-12-27	WOS:000341257700072
J	Pardha-Saradhi, P; Yamal, G; Peddisetty, T; Sharmila, P; Nagar, S; Singh, J; Nagarajan, R; Rao, KS				Pardha-Saradhi, Peddisetty; Yamal, Gupta; Peddisetty, Tanuj; Sharmila, Peddisetty; Nagar, Shilpi; Singh, Jyoti; Nagarajan, Rajamani; Rao, Kottapalli S.			Reducing Strength Prevailing at Root Surface of Plants Promotes Reduction of Ag+ and Generation of Ag-0/Ag2O Nanoparticles Exogenously in Aqueous Phase	PLOS ONE			English	Article							SILVER NANOPARTICLES; GOLD NANOPARTICLES; SOLVOTHERMAL SYNTHESIS; METAL NANOPARTICLES; OPTICAL-PROPERTIES; GREEN SYNTHESIS; BACTERIA; IRON; CHEMISTRY; TRANSPORT	Potential of root system of plants from wide range of families to effectively reduce membrane impermeable ferricyanide to ferrocyanide and blue coloured 2,6-dichlorophenol indophenol (DCPIP) to colourless DCPIPH2 both under non-sterile and sterile conditions, revealed prevalence of immense reducing strength at root surface. As generation of silver nanoparticles (NPs) from Ag+ involves reduction, present investigations were carried to evaluate if reducing strength prevailing at surface of root system can be exploited for reduction of Ag+ and exogenous generation of silver-NPs. Root system of intact plants of 16 species from 11 diverse families of angiosperms turned clear colorless AgNO3 solutions, turbid brown. Absorption spectra of these turbid brown solutions showed silver-NPs specific surface plasmon resonance peak. Transmission electron microscope coupled with energy dispersive X-ray confirmed the presence of distinct NPs in the range of 5-50 nm containing Ag. Selected area electron diffraction and powder X-ray diffraction patterns of the silver NPs showed Bragg reflections, characteristic of crystalline face-centered cubic structure of Ag-0 and cubic structure of Ag2O. Root system of intact plants raised under sterile conditions also generated Ag-0/Ag2O-NPs under strict sterile conditions in a manner similar to that recorded under non-sterile conditions. This revealed the inbuilt potential of root system to generate Ag-0/Ag2O-NPs independent of any microorganism. Roots of intact plants reduced triphenyltetrazolium to triphenylformazon and impermeable ferricyanide to ferrocyanide, suggesting involvement of plasma membrane bound dehydrogenases in reduction of Ag+ and formation of Ag-0/Ag2O-NPs. Root enzyme extract reduced triphenyltetrazolium to triphenylformazon and Ag+ to Ag-0 in presence of NADH, clearly establishing potential of dehydrogenases to reduce Ag+ to Ag-0, which generate Ag-0/Ag2O-NPs. Findings presented in this manuscript put forth a novel, simple, economically viable and green protocol for synthesis of silver-NPs under ambient conditions in aqueous phase, using root system of intact plants.	[Pardha-Saradhi, Peddisetty; Yamal, Gupta; Nagar, Shilpi] Univ Delhi, Dept Environm Studies, Delhi 110007, India; [Yamal, Gupta; Rao, Kottapalli S.] Univ Delhi, Dept Bot, Delhi 110007, India; [Peddisetty, Tanuj] Univ Petr & Energy Studies, Dept Petr Engn & Earth Sci, Dehra Dun, Uttarakhand, India; [Sharmila, Peddisetty] Indian Inst Technol Delhi, Dept Chem, New Delhi, India; [Singh, Jyoti; Nagarajan, Rajamani] Univ Delhi, Dept Chem, Delhi 110007, India	University of Delhi; University of Delhi; University of Petroleum & Energy Studies (UPES); Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Delhi; University of Delhi	Pardha-Saradhi, P (corresponding author), Univ Delhi, Dept Environm Studies, Delhi 110007, India.	ppsaradhi@gmail.com	Rao, K S/I-7548-2012; Kottapalli, Rao S/D-5278-2009	Rao, K S/0000-0003-4919-5067; Kottapalli, Rao S/0000-0003-4919-5067	Council for Scientific and Industrial Research (Govt. of India); Department of Biotechnology (Govt. of India) under Bio-CARe Women Scientist Scheme	Council for Scientific and Industrial Research (Govt. of India)(Council of Scientific & Industrial Research (CSIR) - India); Department of Biotechnology (Govt. of India) under Bio-CARe Women Scientist Scheme	Yamal and Shilpi thank Council for Scientific and Industrial Research (Govt. of India) for providing research fellowship. Sharmila thanks the Department of Biotechnology (Govt. of India) for financial support under Bio-CARe Women Scientist Scheme. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ainsworth EA, 2007, NAT PROTOC, V2, P875, DOI 10.1038/nprot.2007.102; Alvarez-Puebla RA, 2009, ANAL CHEM, V81, P2280, DOI 10.1021/ac8024416; ARORA S, 1995, AUST J PLANT PHYSIOL, V22, P383, DOI 10.1071/PP9950383; Beattie IR, 2011, METALLOMICS, V3, P628, DOI 10.1039/c1mt00044f; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; CRANE FL, 1991, J BIOENERG BIOMEMBR, V23, P773, DOI 10.1007/BF00786001; Dahl JA, 2007, CHEM REV, V107, P2228, DOI 10.1021/cr050943k; Daniel MC, 2004, CHEM REV, V104, P293, DOI 10.1021/cr030698+; Darroudi M, 2011, INT J NANOMED, V6, P569, DOI 10.2147/IJN.S16867; Deshmukh RD, 2007, CHEM MATER, V19, P745, DOI 10.1021/cm062030s; Dong J, 2007, PLANT SOIL ENVIRON, V53, P193, DOI 10.17221/2205-PSE; Evanoff DD, 2005, CHEMPHYSCHEM, V6, P1221, DOI 10.1002/cphc.200500113; Gan PP, 2012, REV ENVIRON SCI BIO, V11, P169, DOI 10.1007/s11157-012-9278-7; Gardea-Torresdey JL, 2003, LANGMUIR, V19, P1357, DOI 10.1021/la020835i; Harris AT, 2008, J NANOPART RES, V10, P691, DOI 10.1007/s11051-007-9288-5; Huang TH, 2007, J CHEM EDUC, V84, P1461, DOI 10.1021/ed084p1461; Iravani S, 2011, GREEN CHEM, V13, P2638, DOI 10.1039/c1gc15386b; Jain D, 2009, DIG J NANOMATER BIOS, V4, P557; Kim SH, 2007, J ALLOY COMPD, V433, P261, DOI 10.1016/j.jallcom.2006.06.053; Klaus-Joerger T, 2001, TRENDS BIOTECHNOL, V19, P15, DOI 10.1016/S0167-7799(00)01514-6; Kumar V, 2009, J CHEM TECHNOL BIOT, V84, P151, DOI 10.1002/jctb.2023; Leela A, 2008, AFR J BIOTECHNOL, V7, P3162; Levard C, 2012, ENVIRON SCI TECHNOL, V46, P6900, DOI 10.1021/es2037405; Masala O, 2004, ANNU REV MATER RES, V34, P41, DOI 10.1146/annurev.matsci.34.052803.090949; Mittal AK, 2013, BIOTECHNOL ADV, V31, P346, DOI 10.1016/j.biotechadv.2013.01.003; Mohanpuria P, 2008, J NANOPART RES, V10, P507, DOI 10.1007/s11051-007-9275-x; Narayanan KB, 2010, ADV COLLOID INTERFAC, V156, P1, DOI 10.1016/j.cis.2010.02.001; Navaladian S, 2008, NANOTECHNOLOGY, V19, DOI 10.1088/0957-4484/19/04/045603; Njagi EC, 2011, LANGMUIR, V27, P264, DOI 10.1021/la103190n; Pardha-Saradhi P, 2014, BIOMETALS, V27, P97, DOI 10.1007/s10534-013-9690-7; Pardha-Saradhi P, 2014, RSC ADV, V4, P7361, DOI 10.1039/c3ra45370g; QIU ZS, 1985, PLANTA, V165, P383, DOI 10.1007/BF00392236; RUBINSTEIN B, 1984, PLANT PHYSIOL, V76, P386, DOI 10.1104/pp.76.2.386; Rycenga M, 2011, CHEM REV, V111, P3669, DOI 10.1021/cr100275d; Shabnam N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085242; Shabnam N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071123; Singh N, 2009, BIOMATERIALS, V30, P3891, DOI 10.1016/j.biomaterials.2009.04.009; Song JY, 2010, BIOPROC BIOSYST ENG, V33, P159, DOI 10.1007/s00449-009-0373-2; Starcher B, 2001, ANAL BIOCHEM, V292, P125, DOI 10.1006/abio.2001.5050; Tolaymat TM, 2010, SCI TOTAL ENVIRON, V408, P999, DOI 10.1016/j.scitotenv.2009.11.003; Vuletic M, 2005, ANN NY ACAD SCI, V1048, P244, DOI 10.1196/annals.1342.022; Wang WX, 2007, COLLOID SURFACE A, V301, P73, DOI 10.1016/j.colsurfa.2006.12.037; Wani IA, 2010, MATER RES BULL, V45, P1033, DOI 10.1016/j.materresbull.2010.03.028; Weiss JV, 2003, BIOGEOCHEMISTRY, V64, P77, DOI 10.1023/A:1024953027726; Wiley BJ, 2007, NANO LETT, V7, P1032, DOI 10.1021/nl070214f; Xia YN, 2009, ANGEW CHEM INT EDIT, V48, P60, DOI 10.1002/anie.200802248; Yamal G, 2013, PROCESS BIOCHEM, V48, P532, DOI 10.1016/j.procbio.2013.02.011; Yamal G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061750; Yamauchi T, 2014, J EXP BOT, V65, P261, DOI 10.1093/jxb/ert371; Yang Y, 2007, J PHYS CHEM C, V111, P9095, DOI 10.1021/jp068859b; Zhang XL, 2011, CHEMOSPHERE, V82, P489, DOI 10.1016/j.chemosphere.2010.10.023	52	22	22	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 3	2014	9	9							e106715	10.1371/journal.pone.0106715	http://dx.doi.org/10.1371/journal.pone.0106715			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3TB	25184239	Green Published, gold, Green Submitted			2022-12-27	WOS:000341257700110
J	Stillwell, RC; Daws, A; Davidowitz, G				Stillwell, R. Craig; Daws, Andrew; Davidowitz, Goggy			The Ontogeny of Sexual Size Dimorphism of a Moth: When Do Males and Females Grow Apart?	PLOS ONE			English	Article							BODY-SIZE; PHENOTYPIC PLASTICITY; TOBACCO HORNWORM; MECHANISM; CONSEQUENCES; PERSPECTIVE; EVOLUTION; PATTERNS; INSECTS; WEIGHT	Sexual dimorphism in body size (sexual size dimorphism) is common in many species. The sources of selection that generate the independent evolution of adult male and female size have been investigated extensively by evolutionary biologists, but how and when females and males grow apart during ontogeny is poorly understood. Here we use the hawkmoth, Manduca sexta, to examine when sexual size dimorphism arises by measuring body mass every day during development. We further investigated whether environmental variables influence the ontogeny of sexual size dimorphism by raising moths on three different diet qualities (poor, medium and high). We found that size dimorphism arose during early larval development on the highest quality food treatment but it arose late in larval development when raised on the medium quality food. This female-biased dimorphism (females larger) increased substantially from the pupal-to-adult stage in both treatments, a pattern that appears to be common in Lepidopterans. Although dimorphism appeared in a few stages when individuals were raised on the poorest quality diet, it did not persist such that male and female adults were the same size. This demonstrates that the environmental conditions that insects are raised in can affect the growth trajectories of males and females differently and thus when dimorphism arises or disappears during development. We conclude that the development of sexual size dimorphism in M. sexta occurs during larval development and continues to accumulate during the pupal/adult stages, and that environmental variables such as diet quality can influence patterns of dimorphism in adults.	[Stillwell, R. Craig] Univ Lausanne, Dept Ecol & Evolut, Lausanne, Switzerland; [Daws, Andrew; Davidowitz, Goggy] Univ Arizona, Dept Entomol, Tucson, AZ 85721 USA	University of Lausanne; University of Arizona	Stillwell, RC (corresponding author), Univ Lausanne, Dept Ecol & Evolut, Lausanne, Switzerland.	roger.stillwell@unil.ch			NSF-USA [IBN 9975168, IOS-1053318]; Postdoctoral Excellence in Research and Teaching fellowship through NIH-USA [1 K12 GM00708]; SNSF; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [K12GM000708] Funding Source: NIH RePORTER	NSF-USA(National Science Foundation (NSF)); Postdoctoral Excellence in Research and Teaching fellowship through NIH-USA; SNSF(Swiss National Science Foundation (SNSF)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by NSF-USA (http://www.nsf.gov/) grant numbers IBN 9975168 and IOS-1053318 to Goggy Davidowitz and by a Postdoctoral Excellence in Research and Teaching fellowship to R. Craig Stillwell through NIH-USA (http://www.nih.gov/) Training Grant #1 K12 GM00708 to the Center for Insect Science, University of Arizona. This work was also supported (the data analysis and writing were done during R. Craig Stillwell's time in this current postdoc) by an SNSF (http://www.snf.ch/) grant to Tadeusz Kawecki. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott JK, 2008, EVOL ECOL, V22, P103, DOI 10.1007/s10682-007-9161-0; Andersson Malte, 1994; Badyaev AV, 2002, TRENDS ECOL EVOL, V17, P369, DOI 10.1016/S0169-5347(02)02569-7; Benbow ME, 2008, ENVIRON ENTOMOL, V37, P1162, DOI 10.1603/0046-225X(2008)37[1162:ROLSDB]2.0.CO;2; Blanckenhorn WU, 2007, AM NAT, V169, P245, DOI 10.1086/510597; Blanckenhorn WU, 2006, EVOLUTION, V60, P2004, DOI 10.1111/j.0014-3820.2006.tb01838.x; Cox RM, 2007, HERPETOLOGICA, V63, P245, DOI 10.1655/0018-0831(2007)63[245:GATTDO]2.0.CO;2; Davidowitz G, 2004, EVOL ECOL RES, V6, P49; Davidowitz G, 2003, EVOL DEV, V5, P188, DOI 10.1046/j.1525-142X.2003.03026.x; Esperk T, 2007, J ECON ENTOMOL, V100, P627, DOI 10.1603/0022-0493(2007)100[627:IVINOL]2.0.CO;2; Esperk T, 2007, ECOL ENTOMOL, V32, P243, DOI 10.1111/j.1365-2311.2007.00872.x; Etile E, 2008, OIKOS, V117, P135, DOI 10.1111/j.2007.0030-1299.16114.x; Fairbairn DJ, 1997, ANNU REV ECOL SYST, V28, P659, DOI 10.1146/annurev.ecolsys.28.1.659; Fairburn Daphne J., 2007, P97; Fairburn Daphne J., 2007, P1; Fischer K, 2001, J EVOLUTION BIOL, V14, P210, DOI 10.1046/j.1420-9101.2001.00280.x; Frynta D, 2010, ZOOL SCI, V27, P917, DOI 10.2108/zsj.27.917; Howard RD, 2009, CAN J ZOOL, V87, P573, DOI 10.1139/Z09-043; Hu YW, 2011, ECOL ENTOMOL, V36, P111, DOI 10.1111/j.1365-2311.2010.01251.x; Karl I, 2008, OECOLOGIA, V155, P215, DOI 10.1007/s00442-007-0902-0; Kingsolver JG, 2007, P ROY SOC B-BIOL SCI, V274, P977, DOI 10.1098/rspb.2006.0036; Lindenfors Patrik, 2007, P16; LOVICH JE, 1992, GROWTH DEVELOP AGING, V56, P269; Madden AH, 1945, USDA TECH B, V896; Molleman F, 2011, J INSECT PHYSIOL, V57, P712, DOI 10.1016/j.jinsphys.2011.02.009; NIJHOUT HF, 1974, J EXP BIOL, V61, P481; Parker TH, 2005, HEREDITY, V95, P401, DOI 10.1038/sj.hdy.6800742; RANTA E, 1994, OIKOS, V70, P313, DOI 10.2307/3545768; ROTHSCHILD LW, 1903, NOV ZOOL S, V9, P1; Serrano-Meneses MA, 2007, EUR J ENTOMOL, V104, P453, DOI 10.14411/eje.2007.065; Stillwell RC, 2007, OECOLOGIA, V153, P273, DOI 10.1007/s00442-007-0724-0; Stillwell RC, 2010, P ROY SOC B-BIOL SCI, V277, P3819, DOI 10.1098/rspb.2010.0895; Stillwell RC, 2010, P ROY SOC B-BIOL SCI, V277, P2069, DOI 10.1098/rspb.2009.2277; Stillwell RC, 2010, ANNU REV ENTOMOL, V55, P227, DOI 10.1146/annurev-ento-112408-085500; Tammaru T, 1998, ECOL ENTOMOL, V23, P80, DOI 10.1046/j.1365-2311.1998.00106.x; Tammaru T, 2010, EVOL ECOL, V24, P161, DOI 10.1007/s10682-009-9297-1; Teder T, 2014, FUNCT ECOL, V28, P479, DOI 10.1111/1365-2435.12172; Testa ND, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058936; Tomovic LM, 2010, J ZOOL SYST EVOL RES, V48, P279, DOI 10.1111/j.1439-0469.2009.00556.x; TUTTLE JP, 2007, HAWK MOTHS N AM; YAMAMOTO RT, 1968, J ECON ENTOMOL, V61, P170, DOI 10.1093/jee/61.1.170; Yasuda H, 2002, ECOL ENTOMOL, V27, P493, DOI 10.1046/j.1365-2311.2002.00428.x	42	16	16	0	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 3	2014	9	9							e106548	10.1371/journal.pone.0106548	http://dx.doi.org/10.1371/journal.pone.0106548			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3TB	25184664	Green Published, gold			2022-12-27	WOS:000341257700086
J	Fan, YP; Marcy, G; Lee, ESM; Rozen, S; Mattar, CNZ; Waddington, SN; Goh, ELK; Choolani, M; Chan, JKY				Fan, Yiping; Marcy, Guillaume; Lee, Eddy S. M.; Rozen, Steve; Mattar, Citra N. Z.; Waddington, Simon N.; Goh, Eyleen L. K.; Choolani, Mahesh; Chan, Jerry K. Y.			Regionally-Specified Second Trimester Fetal Neural Stem Cells Reveals Differential Neurogenic Programming	PLOS ONE			English	Article							CENTRAL-NERVOUS-SYSTEM; MIDBRAIN DOPAMINE NEURONS; ADULT HUMAN HIPPOCAMPUS; HUMAN SPINAL-CORD; HUMAN BRAIN; HUNTINGTONS-DISEASE; PROGENITOR CELLS; FUNCTIONAL RECOVERY; PARKINSONS-DISEASE; HUMAN NEUROSPHERES	Neural stem/progenitor cells (NSC) have the potential for treatment of a wide range of neurological diseases such as Parkinson Disease and multiple sclerosis. Currently, NSC have been isolated only from hippocampus and subventricular zone (SVZ) of the adult brain. It is not known whether NSC can be found in all parts of the developing mid-trimester central nervous system (CNS) when the brain undergoes massive transformation and growth. Multipotent NSC from the mid-trimester cerebra, thalamus, SVZ, hippocampus, thalamus, cerebellum, brain stem and spinal cord can be derived and propagated as clonal neurospheres with increasing frequencies with increasing gestations. These NSC can undergo multi-lineage differentiation both in vitro and in vivo, and engraft in a developmental murine model. Regionally-derived NSC are phenotypically distinct, with hippocampal NSC having a significantly higher neurogenic potential (53.6%) over other sources (range of 0%-27.5%, p<0.004). Whole genome expression analysis showed differential gene expression between these regionally-derived NSC, which involved the Notch, epidermal growth factor as well as interleukin pathways. We have shown the presence of phenotypically-distinct regionally-derived NSC from the mid-trimester CNS, which may reflect the ontological differences occurring within the CNS. Aside from informing on the role of such cells during fetal growth, they may be useful for different cellular therapy applications.	[Fan, Yiping; Chan, Jerry K. Y.] KK Womens & Childrens Hosp, Dept Reprod Med, Singapore, Singapore; [Fan, Yiping; Mattar, Citra N. Z.; Choolani, Mahesh; Chan, Jerry K. Y.] Natl Univ Hlth Syst, Yong Loo Lin Sch Med, Dept Obstet & Gynaecol, Expt Fetal Med Grp, Singapore, Singapore; [Marcy, Guillaume; Goh, Eyleen L. K.] Duke NUS Grad Med Sch, Neurosci & Behav Disorder Program, Singapore, Singapore; [Lee, Eddy S. M.] Stanford Univ, Dept Radiol, Richard M Lucas Ctr Imaging, Stanford, CA 94305 USA; [Rozen, Steve; Chan, Jerry K. Y.] Duke NUS Grad Med Sch, Canc & Stem Cell Biol Program, Singapore, Singapore; [Waddington, Simon N.] UCL, Inst Womens Hlth, Gene Transfer Technol Grp, London, England; [Waddington, Simon N.] Univ Witwatersrand, Fac Hlth Sci, Johannesburg, South Africa	KK Women's & Children's Hospital; National University of Singapore; National University of Singapore; Stanford University; National University of Singapore; University of London; University College London; University of Witwatersrand	Choolani, M (corresponding author), Natl Univ Hlth Syst, Yong Loo Lin Sch Med, Dept Obstet & Gynaecol, Expt Fetal Med Grp, Singapore, Singapore.	maheshchoolani@nus.edu.sg; jerrychan@nus.edu.sg	Marcy, Geoff/AAC-6050-2019; Marcy, Guillaume/M-8063-2014; Waddington, Simon/G-3778-2011; Rozen, Steven G./J-5939-2013	Waddington, Simon/0000-0003-4970-4730; Rozen, Steven G./0000-0002-4288-0056; Mattar, Citra Nurfarah/0000-0003-0068-6957; Goh, Eyleen/0000-0002-8244-6959; Marcy, Guillaume/0000-0002-3469-8131	Clinician Scientist Unit, NUS; National Research Foundation, Singapore; Clinician Scientist Award; National Medical Research Council, Singapore [NMRC/CSA/009/2009, NMRC/CSA/043/2012]	Clinician Scientist Unit, NUS; National Research Foundation, Singapore(National Research Foundation, Singapore); Clinician Scientist Award; National Medical Research Council, Singapore(National Medical Research Council, SingaporeUK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was funded by a grant from the Clinician Scientist Unit, NUS to J.K.Y. Chan, and Competitive Research Program (CRP) funds from National Research Foundation, Singapore to E.L.K. Goh. J.K.Y. Chan and M.A. Choolani received salary support from Clinician Scientist Award, National Medical Research Council, Singapore (NMRC/CSA/009/2009 and NMRC/CSA/043/2012). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez-Buylla A, 2001, NAT REV NEUROSCI, V2, P287, DOI 10.1038/35067582; Andersson E, 2006, CELL, V124, P393, DOI [10.1016/j.cell.2005.10.037, 10.1016/J.CELL.2005.10.037]; AWATSUJI H, 1993, J NEUROSCI RES, V35, P305, DOI 10.1002/jnr.490350310; Bachoud-Levi A, 2000, LANCET, V356, P1975, DOI 10.1016/S0140-6736(00)03310-9; Barami K, 2001, NEUROL RES, V23, P260, DOI 10.1179/016164101101198406; BENVENISTE EN, 1986, NATURE, V321, P610, DOI 10.1038/321610a0; Bez A, 2003, BRAIN RES, V993, P18, DOI 10.1016/j.brainres.2003.08.061; Briata P, 1996, MECH DEVELOP, V57, P169, DOI 10.1016/0925-4773(96)00544-8; Brundin P, 2000, BRAIN, V123, P1380, DOI 10.1093/brain/123.7.1380; Brustle O, 1998, NAT BIOTECHNOL, V16, P1040, DOI 10.1038/3481; Burbach JPH, 2003, ANN NY ACAD SCI, V991, P61; Chong MSK, 2010, METHODS MOL BIOL, V614, P135, DOI 10.1007/978-1-60761-533-0_9; Cooper JA, 2013, J CELL BIOL, V202, P725, DOI 10.1083/jcb.201305021; Draberova E, 2008, J NEUROPATH EXP NEUR, V67, P341, DOI 10.1097/NEN.0b013e31816a686d; Ellisor D, 2012, DEV BIOL, V372, P249, DOI 10.1016/j.ydbio.2012.09.019; Eriksson PS, 1998, NAT MED, V4, P1313, DOI 10.1038/3305; Falk R, 2012, METHODS; Flax JD, 1998, NAT BIOTECHNOL, V16, P1033, DOI 10.1038/3473; Gage FH, 2000, SCIENCE, V287, P1433, DOI 10.1126/science.287.5457.1433; Gupta N, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004373; Gustafsson MV, 2005, DEV CELL, V9, P617, DOI 10.1016/j.devcel.2005.09.010; Huang H, 2009, J NEUROSCI, V29, P4263, DOI 10.1523/JNEUROSCI.2769-08.2009; Hutton SR, 2011, DEV BIOL, V352, P40, DOI 10.1016/j.ydbio.2011.01.015; Johansson CB, 1999, EXP CELL RES, V253, P733, DOI 10.1006/excr.1999.4678; Kallur T, 2006, J NEUROSCI RES, V84, P1630, DOI 10.1002/jnr.21066; Kalyani A, 1997, DEV BIOL, V186, P202, DOI 10.1006/dbio.1997.8592; Kalyani AJ, 1998, J NEUROSCI, V18, P7856; Kennea NL, 2009, CELL CYCLE, V8, P1069, DOI 10.4161/cc.8.7.8121; Kesner R, 1991, Hippocampus, V1, P279, DOI 10.1002/hipo.450010316; Kim HJ, 2009, STEM CELLS, V27, P390, DOI 10.1634/stemcells.2007-1047; Kim SU, 2006, NEUROPATHOLOGY, V26, P129, DOI 10.1111/j.1440-1789.2006.00688.x; Kim YT, 2006, EXP NEUROL, V199, P222, DOI 10.1016/j.expneurol.2006.03.015; Le Belle JE, 2002, BIODRUGS, V16, P389, DOI 10.2165/00063030-200216060-00001; Lee HJ, 2007, STEM CELLS, V25, P1204, DOI 10.1634/stemcells.2006-0409; Lee JP, 2007, NAT MED, V13, P439, DOI 10.1038/nm1548; Lee ST, 2005, NEUROSCI RES, V52, P243, DOI 10.1016/j.neures.2005.03.016; Liu B, 2007, J NEUROSCI RES, V85, P3523, DOI 10.1002/jnr.21364; Maisel M, 2007, STEM CELLS, V25, P1231, DOI 10.1634/stemcells.2006-0617; Michaelson MD, 1996, DEV BIOL, V179, P251, DOI 10.1006/dbio.1996.0255; Mo ZC, 2007, J NEUROSCI, V27, P4132, DOI 10.1523/JNEUROSCI.0111-07.2007; Nakao N, 2000, PROG NEUROBIOL, V61, P313, DOI 10.1016/S0301-0082(99)00058-1; Oosterveen T, 2003, EMBO J, V22, P262, DOI 10.1093/emboj/cdg029; Orvis GD, 2012, DEV BIOL, V367, P25, DOI 10.1016/j.ydbio.2012.04.018; Ostenfeld T, 2002, DEV BRAIN RES, V134, P43, DOI 10.1016/S0165-3806(01)00291-7; OTERO GC, 1994, GLIA, V11, P117, DOI 10.1002/glia.440110207; Palmer TD, 2001, NATURE, V411, P42, DOI 10.1038/35075141; Piao JH, 2006, J NEUROSCI RES, V84, P471, DOI 10.1002/jnr.20955; Piccini P, 1999, NAT NEUROSCI, V2, P1137, DOI 10.1038/16060; Pilcher H, 2009, NATURE; Quinn SM, 1999, J NEUROSCI RES, V57, P590, DOI 10.1002/(SICI)1097-4547(19990901)57:5<590::AID-JNR2>3.0.CO;2-X; RAY J, 1993, P NATL ACAD SCI USA, V90, P3602, DOI 10.1073/pnas.90.8.3602; ReNeuron, 2009, RENEURON GAINS UK RE; REYNOLDS BA, 1992, SCIENCE, V255, P1707, DOI 10.1126/science.1553558; Roy NS, 2000, NAT MED, V6, P271; SARDER M, 1993, BRAIN RES, V625, P347, DOI 10.1016/0006-8993(93)91080-C; Shikanai Mima, 2011, Commun Integr Biol, V4, P326, DOI 10.4161/cib.4.3.14886; SIDMAN RL, 1973, BRAIN RES, V62, P1, DOI 10.1016/0006-8993(73)90617-3; Smidt MP, 2003, EUR J PHARMACOL, V480, P75, DOI 10.1016/j.ejphar.2003.08.094; Sottile V, 2006, BRAIN RES, V1099, P8, DOI 10.1016/j.brainres.2006.04.127; Sun D, 2010, J NEUROTRAUM, V27, P923, DOI 10.1089/neu.2009.1209; Sun YE, 2003, SEMIN CELL DEV BIOL, V14, P161, DOI 10.1016/S1084-9521(03)00007-7; Suslov ON, 2002, P NATL ACAD SCI USA, V99, P14506, DOI 10.1073/pnas.212525299; Svendsen CN, 2004, NAT MED, V10, P224, DOI 10.1038/nm0304-224; Tchorz JS, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.65; Temple S, 2001, NATURE, V414, P112, DOI 10.1038/35102174; Uchida N, 2000, P NATL ACAD SCI USA, V97, P14720, DOI 10.1073/pnas.97.26.14720; UEMURA T, 1989, CELL, V58, P349, DOI 10.1016/0092-8674(89)90849-0; Watanabe K, 2004, DEV NEUROSCI-BASEL, V26, P275, DOI 10.1159/000082144; Wernig M, 2008, P NATL ACAD SCI USA, V105, P5856, DOI 10.1073/pnas.0801677105; Wu P, 2002, NAT NEUROSCI, V5, P1271, DOI 10.1038/nn974; Yan J, 2007, PLOS MED, V4, P318, DOI 10.1371/journal.pmed.0040039; Yandava BD, 1999, P NATL ACAD SCI USA, V96, P7029, DOI 10.1073/pnas.96.12.7029; Ye WL, 1998, CELL, V93, P755, DOI 10.1016/S0092-8674(00)81437-3; Zecevic N, 2004, GLIA, V48, P27, DOI 10.1002/glia.20044	75	2	3	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2014	9	9							e105985	10.1371/journal.pone.0105985	http://dx.doi.org/10.1371/journal.pone.0105985			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3LR	25181041	Green Published, Green Submitted, gold			2022-12-27	WOS:000341231500043
J	Kim, JB; Hong, S; Park, JW; Cho, DH; Park, KJ; Kim, BJ				Kim, Jung Bin; Hong, Soonwoong; Park, Jin-Woo; Cho, Dong-Hyuk; Park, Ki-Jong; Kim, Byung-Jo			Utility of Corrected QT Interval in Orthostatic Intolerance	PLOS ONE			English	Article							POSTURAL TACHYCARDIA SYNDROME; HEART-RATE-VARIABILITY; ABNORMALITIES; DISPERSION; SYNCOPE; TILT; HYPOTENSION; MANAGEMENT; DISORDERS; SUDOMOTOR	We performed this study to determine whether electrocardiographic corrected QT (QTc) interval predicts alterations in sympathovagal balance during orthostatic intolerance (OI). We reviewed 1,368 patients presenting with symptoms suggestive of OI who underwent electrocardiography and composite autonomic function tests (AFTs). Patients with a positive response to the head-up tilt test were classified into orthostatic hypotension (OH), neurocardiogenic syncope (NCS), or postural orthostatic tachycardia syndrome (POTS) groups. A total of 275 patients (159 OH, 54 NCS, and 62 POTS) were included in the final analysis. Between-group comparisons of OI symptom grade, QTc interval, QTc dispersion, and each AFT measure were performed. QTc interval and dispersion were correlated with AFT measures. OH Patients had the most severe OI symptom grade and NCS patients the mildest. Patients with OH showed the longest QTc interval (448.8 +/- 33.6 msec), QTc dispersion (59.5 +/- 30.3 msec) and the lowest values in heart rate response to deep breathing (HRDB) (10.3 +/- 6.0 beats/min) and Valsalva ratio (1.3 +/- 0.2). Patients with POTS showed the shortest QTc interval (421.7 +/- 28.6 msec), the highest HRDB values (24.5 +/- 9.2 beats/min), Valsalva ratio (1.8 +/- 0.3), and proximal and distal leg sweat volumes in the quantitative sudomotor axon reflex test. QTc interval correlated negatively with HRDB (r = -0.443, p<0.001) and Valsalva ratio (r = -0.425, p<0.001). We found negative correlations between QTc interval and AFT values representing cardiovagal function in patients with OI. Our findings suggest that prolonged QTc interval may be considered to be a biomarker for detecting alterations in sympathovagal balance, especially cardiovagal dysfunction in OH.	[Kim, Jung Bin; Hong, Soonwoong; Park, Jin-Woo; Kim, Byung-Jo] Korea Univ, Coll Med, Med Ctr, Dept Neurol, Seoul 136705, South Korea; [Cho, Dong-Hyuk] Korea Univ, Coll Med, Med Ctr, Dept Cardiol, Seoul 136705, South Korea; [Park, Ki-Jong] Kyungsang Univ, Med Ctr, Dept Neurol, Jinjoo, South Korea	Korea University; Korea University Medicine (KU Medicine); Korea University; Korea University Medicine (KU Medicine)	Kim, BJ (corresponding author), Korea Univ, Coll Med, Med Ctr, Dept Neurol, Seoul 136705, South Korea.	nukbj@korea.ac.kr	Park, Jin-Woo/AAD-1328-2022; Kim, Byung-Jo/A-5943-2012	Park, Jin-Woo/0000-0001-5548-3378; Kim, Byung-Jo/0000-0002-0445-7185; Kim, Jung Bin/0000-0002-8013-9349				ABBOUD FM, 1993, NEW ENGL J MED, V328, P1117, DOI 10.1056/NEJM199304153281510; Arai K, 2013, AUTON NEUROSCI-BASIC, V173, P53, DOI 10.1016/j.autneu.2012.11.006; Axelrod FB, 1997, CARDIOLOGY, V88, P133, DOI 10.1159/000177319; Bednar MM, 2001, PROG CARDIOVASC DIS, V43, P1, DOI 10.1053/pcad.2001.21469; Bradbury S, 1925, AM HEART J, V1, P73, DOI 10.1016/S0002-8703(25)90007-5; BRIGNOLE M, 1991, AM HEART J, V122, P1644, DOI 10.1016/0002-8703(91)90282-M; Choy AMJ, 1998, AM HEART J, V136, P664, DOI 10.1016/S0002-8703(98)70014-6; DAY CP, 1990, BRIT HEART J, V63, P342; Deguchi K, 2002, J NEUROL SCI, V199, P31, DOI 10.1016/S0022-510X(02)00079-5; DEKKER JM, 1994, CIRCULATION, V90, P779, DOI 10.1161/01.CIR.90.2.779; deLuna AB, 1996, EUR HEART J, V17, P165; Furlan R, 2001, AUTON NEUROSCI-BASIC, V90, P83, DOI 10.1016/S1566-0702(01)00271-5; Garland EM, 2007, NEUROLOGY, V69, P790, DOI 10.1212/01.wnl.0000267663.05398.40; GLICKSTEIN JS, 1993, J PEDIATR-US, V122, P925, DOI 10.1016/S0022-3476(09)90022-1; Goldstein DS, 2005, CIRCULATION, V111, P839, DOI 10.1161/01.CIR.0000155613.20376.CA; Grubb BP, 2005, CIRCULATION, V111, P2997, DOI 10.1161/CIRCULATIONAHA.104.482018; Grubb BP, 1997, PACE, V20, P2205, DOI 10.1111/j.1540-8159.1997.tb04238.x; Jacob G, 2000, NEW ENGL J MED, V343, P1008, DOI 10.1056/NEJM200010053431404; KAPOOR WN, 1994, AM J MED, V97, P78, DOI 10.1016/0002-9343(94)90051-5; Karatas Z, 2012, EUR J PAEDIATR NEURO, V16, P469, DOI 10.1016/j.ejpn.2011.12.009; KAUFMANN H, 1995, NEUROLOGY, V45, pS12; KOLLAI M, 1979, J AUTONOM NERV SYST, V1, P33, DOI 10.1016/0165-1838(79)90004-3; Koo YS, 2012, J CLIN NEUROL, V8, P1, DOI 10.3988/jcn.2012.8.1.1; Lo SSS, 1996, HEART, V75, P498, DOI 10.1136/hrt.75.5.498; Low PA, 1997, MUSCLE NERVE, V20, P1561, DOI 10.1002/(SICI)1097-4598(199712)20:12<1561::AID-MUS11>3.0.CO;2-3; LOW PA, 1995, MAYO CLIN PROC, V70, P617, DOI 10.4065/70.7.617; LOW PA, 1995, NEUROLOGY, V45, pS19; LOW PA, 1993, J CLIN NEUROPHYSIOL, V10, P14, DOI 10.1097/00004691-199301000-00003; Low PA, 2008, LANCET NEUROL, V7, P451, DOI 10.1016/S1474-4422(08)70088-7; Low PA, 2013, J CLIN NEUROL, V9, P1, DOI 10.3988/jcn.2013.9.1.1; Low PA, 2009, J CARDIOVASC ELECTR, V20, P352, DOI 10.1111/j.1540-8167.2008.01407.x; Macfarlane PW, 1998, CIRCULATION, V98, P2160, DOI 10.1161/01.CIR.98.20.2160; Malik M, 2000, J AM COLL CARDIOL, V36, P1749, DOI 10.1016/S0735-1097(00)00962-1; MALLIANI A, 1991, CIRCULATION, V84, P482, DOI 10.1161/01.CIR.84.2.482; Mathias CJ, 2012, NAT REV NEUROL, V8, P22, DOI 10.1038/nrneurol.2011.187; Moak JP, 2002, J AM COLL CARDIOL, V40, P1466, DOI 10.1016/S0735-1097(02)02273-8; Mosqueda-Garcia R, 2000, CIRCULATION, V102, P2898; Moya A, 2009, EUR HEART J, V30, P2631, DOI 10.1093/eurheartj/ehp298; MURAKAWA Y, 1992, AM J CARDIOL, V69, P339, DOI 10.1016/0002-9149(92)90230-V; Park KM, 2013, J CLIN NEUROL, V9, P186, DOI 10.3988/jcn.2013.9.3.186; Peltier AC, 2010, CLIN AUTON RES, V20, P93, DOI 10.1007/s10286-009-0045-y; Piccirillo G, 1999, HYPERTENSION, V34, P242, DOI 10.1161/01.HYP.34.2.242; Raj SR, 2007, AM J MED SCI, V334, P57, DOI 10.1097/MAJ.0b013e318063c6c0; Schatz IJ, 1996, NEUROLOGY, V46, P1470, DOI 10.1212/wnl.46.5.1470; Shannon JR, 2000, NEW ENGL J MED, V342, P541, DOI 10.1056/NEJM200002243420803; Shibao C, 2005, HYPERTENSION, V45, P385, DOI 10.1161/01.HYP.0000158259.68614.40; Stewart JM, 2002, CIRCULATION, V105, P2274, DOI 10.1161/01.CIR.0000016348.55378.C4; Veglio M, 1996, CLIN AUTON RES, V6, P309, DOI 10.1007/BF02556300	48	11	12	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2014	9	9							e106417	10.1371/journal.pone.0106417	http://dx.doi.org/10.1371/journal.pone.0106417			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3LR	25180969	Green Published, gold			2022-12-27	WOS:000341231500093
J	Steele, SE; Lopez-Fernandez, H				Steele, Sarah E.; Lopez-Fernandez, Hernan			Body Size Diversity and Frequency Distributions of Neotropical Cichlid Fishes (Cichliformes: Cichlidae: Cichlinae)	PLOS ONE			English	Article							FRESH-WATER FISHES; ADAPTIVE RADIATIONS; SCALE FACTORS; COPES RULE; EVOLUTION; PATTERNS; DIVERSIFICATION; MAMMALS; MINIATURIZATION; MASS	Body size is an important correlate of life history, ecology and distribution of species. Despite this, very little is known about body size evolution in fishes, particularly freshwater fishes of the Neotropics where species and body size diversity are relatively high. Phylogenetic history and body size data were used to explore body size frequency distributions in Neotropical cichlids, a broadly distributed and ecologically diverse group of fishes that is highly representative of body size diversity in Neotropical freshwater fishes. We test for divergence, phylogenetic autocorrelation and among-clade partitioning of body size space. Neotropical cichlids show low phylogenetic autocorrelation and divergence within and among taxonomic levels. Three distinct regions of body size space were identified from body size frequency distributions at various taxonomic levels corresponding to subclades of the most diverse tribe, Geophagini. These regions suggest that lineages may be evolving towards particular size optima that may be tied to specific ecological roles. The diversification of Geophagini appears to constrain the evolution of body size among other Neotropical cichlid lineages; non-Geophagini clades show lower species-richness in body size regions shared with Geophagini. Neotropical cichlid genera show less divergence and extreme body size than expected within and among tribes. Body size divergence among species may instead be present or linked to ecology at the community assembly scale.	[Steele, Sarah E.; Lopez-Fernandez, Hernan] Univ Toronto, Dept Ecol & Evolutionary Biol, Toronto, ON, Canada; [Lopez-Fernandez, Hernan] Royal Ontario Museum, Dept Nat Hist, Toronto, ON M5S 2C6, Canada	University of Toronto; Royal Ontario Museum	Steele, SE (corresponding author), Univ Toronto, Dept Ecol & Evolutionary Biol, 100 Coll St, Toronto, ON, Canada.	sarah.steele@utoronto.ca		Lopez-Fernandez, Hernan/0000-0003-0270-1671	Discovery Grant; Natural Sciences and Engineering Research Council of Canada	Discovery Grant; Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	Research for this paper was funded by a Discovery Grant to Hernan Lopez-Fernandez and by a Canada Graduate Scholarship to Sarah E. Steele from the Natural Sciences and Engineering Research Council of Canada (http://www.nserc-crsng.gc.ca/index_eng.asp). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert JS, 2012, EVOL BIOL, V39, P324, DOI 10.1007/s11692-011-9149-0; Albert JS, 2009, ACTA ZOOL-STOCKHOLM, V90, P357, DOI 10.1111/j.1463-6395.2008.00364.x; Allen CR, 2006, ECOL LETT, V9, P630, DOI 10.1111/j.1461-0248.2006.00902.x; Arbour JH, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.0849; Arita HT, 1999, OIKOS, V85, P310, DOI 10.2307/3546497; Bakker VJ, 2000, ECOLOGY, V81, P3530, DOI 10.1890/0012-9658(2000)081[3530:SDPIBS]2.0.CO;2; Belk MC, 2002, AM NAT, V160, P803, DOI 10.1086/343880; Bennett MG, 2010, ICHTHYOL EXPLOR FRES, V21, P63; Blackburn Tim M., 1999, Diversity and Distributions, V5, P165, DOI 10.1046/j.1472-4642.1999.00046.x; BROWN JH, 1993, AM NAT, V142, P573, DOI 10.1086/285558; BROWN JH, 1991, AM NAT, V138, P1478, DOI 10.1086/285297; Cardillo M, 2005, SCIENCE, V309, P1239, DOI 10.1126/science.1116030; Clauset A, 2008, SCIENCE, V321, P399, DOI 10.1126/science.1157534; Collar DC, 2011, EVOLUTION, V65, P2664, DOI 10.1111/j.1558-5646.2011.01335.x; Cox CL, 2011, EVOL BIOL, V38, P453, DOI 10.1007/s11692-011-9132-9; Diniz JAF, 2009, GENET MOL BIOL, V32, P170, DOI 10.1590/S1415-47572009005000004; FELSENSTEIN J, 1985, AM NAT, V125, P1, DOI 10.1086/284325; Fu CZ, 2004, GLOBAL ECOL BIOGEOGR, V13, P543, DOI 10.1111/j.1466-822X.2004.00122.x; GRIFFITHS D, 1986, AM NAT, V127, P140, DOI 10.1086/284475; Griffiths D, 2006, J ANIM ECOL, V75, P734, DOI 10.1111/j.1365-2656.2006.01094.x; Griffiths D, 2013, ECOL FRESHW FISH, V22, P257, DOI 10.1111/eff.12023; Griffiths D, 2012, GLOBAL ECOL BIOGEOGR, V21, P383, DOI 10.1111/j.1466-8238.2011.00680.x; Griffiths D, 2010, BIOL J LINN SOC, V100, P46, DOI 10.1111/j.1095-8312.2010.01404.x; HANKEN J, 1993, ANNU REV ECOL SYST, V24, P501, DOI 10.1146/annurev.es.24.110193.002441; Hardman M, 2008, SYST BIOL, V57, P116, DOI 10.1080/10635150801902193; HARTIGAN JA, 1985, ANN STAT, V13, P70, DOI 10.1214/aos/1176346577; Harvey P.H., 1991, COMP METHOD EVOLUTIO; Kelt DA, 1999, OIKOS, V85, P320, DOI 10.2307/3546498; Kingsolver JG, 2004, EVOLUTION, V58, P1608; Knouft JH, 2004, OECOLOGIA, V139, P408, DOI 10.1007/s00442-004-1510-x; Knouft JH, 2003, AM NAT, V161, P413, DOI 10.1086/346133; Kozlowski J, 2002, FUNCT ECOL, V16, P419, DOI 10.1046/j.1365-2435.2002.00646.x; Kullander S. O., 1983, REVISION S AM CICHLI; Lavoue S, 2010, MOL PHYLOGENET EVOL, V56, P480, DOI 10.1016/j.ympev.2009.11.022; LINDSEY CC, 1966, EVOLUTION, V20, P456, DOI 10.1111/j.1558-5646.1966.tb03380.x; Lopez-Fernandez H, 2013, EVOLUTION, V67, P1321, DOI 10.1111/evo.12038; Lopez-Fernandez H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033997; Lopez-Fernandez H, 2010, MOL PHYLOGENET EVOL, V55, P1070, DOI 10.1016/j.ympev.2010.02.020; Lucena, 1998, PHYLOGENY CLASSIFICA; Mahler DL, 2010, EVOLUTION, V64, P2731, DOI 10.1111/j.1558-5646.2010.01026.x; MAHON R, 1984, CAN J FISH AQUAT SCI, V41, P330, DOI 10.1139/f84-037; Monroe MJ, 2009, AM NAT, V174, P912, DOI 10.1086/646606; Polo V, 1999, J ANIM ECOL, V68, P324, DOI 10.1046/j.1365-2656.1999.00282.x; Reis RE., 2003, CLOFFSCA CHECK LIST; Rican O, 2011, MOL PHYLOGENET EVOL, V62, P46; Romanuk TN, 2011, GLOBAL ECOL BIOGEOGR, V20, P231, DOI 10.1111/j.1466-8238.2010.00579.x; Salzburger W, 2004, NATURWISSENSCHAFTEN, V91, P277, DOI 10.1007/s00114-004-0528-6; Salzburger W, 2009, MOL ECOL, V18, P169, DOI 10.1111/j.1365-294X.2008.03981.x; Schutz D, 2000, J FISH BIOL, V57, P1254, DOI 10.1006/jfbi.2000.1388; Seehausen O, 2006, P ROY SOC B-BIOL SCI, V273, P1987, DOI 10.1098/rspb.2006.3539; Smith FA, 2004, AM NAT, V163, P672, DOI 10.1086/382898; Smith FA, 2011, PHILOS T R SOC B, V366, P2364, DOI 10.1098/rstb.2011.0067; Stiassny M.L.J., 1991, CICHLID FISHES BEHAV, P1; Thomas GH, 2009, EVOLUTION, V63, P2017, DOI 10.1111/j.1558-5646.2009.00694.x; WAINWRIGHT PC, 1995, ENVIRON BIOL FISH, V44, P97, DOI 10.1007/BF00005909; WEITZMAN SH, 1988, P BIOL SOC WASH, V101, P444; WINEMILLER KO, 1992, CAN J FISH AQUAT SCI, V49, P2196, DOI 10.1139/f92-242; Woodward G, 2002, J ANIM ECOL, V71, P1063, DOI 10.1046/j.1365-2656.2002.00669.x	58	18	19	2	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2014	9	9							e106336	10.1371/journal.pone.0106336	http://dx.doi.org/10.1371/journal.pone.0106336			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3LR	25180970	Green Published, Green Submitted, gold			2022-12-27	WOS:000341231500083
J	Marchal, E; Hult, EF; Huang, J; Pang, ZG; Stay, B; Tobe, SS				Marchal, Elisabeth; Hult, Ekaterina F.; Huang, Juan; Pang, Zhenguo; Stay, Barbara; Tobe, Stephen S.			Methoprene-Tolerant (Met) Knockdown in the Adult Female Cockroach, Diploptera punctata Completely Inhibits Ovarian Development	PLOS ONE			English	Article							JUVENILE-HORMONE BIOSYNTHESIS; RED FLOUR BEETLE; KRUPPEL HOMOLOG 1; BHLH-PAS FAMILY; CORPORA-ALLATA; VIVIPAROUS COCKROACH; REPRODUCTIVE-CYCLE; SIGNALING PATHWAY; INSECT METAMORPHOSIS; GONADOTROPIC CYCLE	Independent of the design of the life cycle of any insect, their growth and reproduction are highly choreographed through the action of two versatile hormones: ecdysteroids and juvenile hormones (JH). However, the means by which JH can target tissues and exert its pleiotropic physiological effects is currently still not completely elucidated. Although the identity of the one JH receptor is currently still elusive, recent evidence seems to point to the product of the Methoprene-tolerant gene (Met) as the most likely contender in transducing the action of JH. Studies on the role of this transcription factor have mostly been focused on immature insect stages. In this study we used the viviparous cockroach Diploptera punctata, a favorite model in studying JH endocrinology, to examine the role of Met during reproduction. A tissue distribution and developmental profile of transcript levels was determined for Met and its downstream partners during the first gonadotropic cycle of this cockroach. Using RNA interference, our study shows that silencing Met results in an arrest of basal oocyte development; vitellogenin is no longer transcribed in the fat body and no longer taken up by the ovary. Patency is not induced in these animals which fail to produce the characteristic profile of JH biosynthesis typical of the first gonadotropic cycle. Moreover, the ultrastructure of the follicle cells showed conspicuous whorls of rough endoplasmic reticulum and a failure to form chorion. Our study describes the role of Met on a cellular and physiological level during insect reproduction, and confirms the role of Met as a key factor in the JH signaling pathway.	[Marchal, Elisabeth; Hult, Ekaterina F.; Huang, Juan; Pang, Zhenguo; Tobe, Stephen S.] Univ Toronto, Dept Cell & Syst Biol, Toronto, ON, Canada; [Stay, Barbara] Univ Iowa, Dept Biol, Iowa City, IA 52242 USA	University of Toronto; University of Iowa	Tobe, SS (corresponding author), Univ Toronto, Dept Cell & Syst Biol, Toronto, ON, Canada.	stephen.tobe@utoronto.ca	Tobe, Stephen S./A-1445-2008	Marchal, Elisabeth/0000-0003-1310-4792	Natural Science and Engineering Research Council of Canada; China Scholarship Council	Natural Science and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); China Scholarship Council(China Scholarship Council)	This work was supported by a Natural Science and Engineering Research Council of Canada grant to SST. JH was supported by a China Scholarship Council doctoral award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdou MA, 2011, INSECT BIOCHEM MOLEC, V41, P938, DOI 10.1016/j.ibmb.2011.09.003; Ashok M, 1998, P NATL ACAD SCI USA, V95, P2761, DOI 10.1073/pnas.95.6.2761; Badisco L, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00202; Badisco L, 2011, PEPTIDES, V32, P573, DOI 10.1016/j.peptides.2010.11.008; Baumann AA, 2013, MOL CELL ENDOCRINOL, V372, P30, DOI 10.1016/j.mce.2013.02.019; Bilen J, 2013, P NATL ACAD SCI USA, V110, P18321, DOI 10.1073/pnas.1318119110; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Charles JP, 2011, P NATL ACAD SCI USA, V108, P21128, DOI 10.1073/pnas.1116123109; Cruz J, 2006, DEV BIOL, V297, P158, DOI 10.1016/j.ydbio.2006.06.048; Elliott KL, 2006, J INSECT PHYSIOL, V52, P929, DOI 10.1016/j.jinsphys.2006.05.012; Engelmann F, 1979, ADV INSECT PHYSL, V14, P59; Erezyilmaz DF, 2009, DEV GENES EVOL, V219, P535, DOI 10.1007/s00427-009-0315-7; Erezyilmaz DF, 2006, P NATL ACAD SCI USA, V103, P6925, DOI 10.1073/pnas.0509983103; FEYEREISEN R, 1981, ANAL BIOCHEM, V111, P372, DOI 10.1016/0003-2697(81)90575-3; Girardie J, 1998, ANN NY ACAD SCI, V839, P118, DOI 10.1111/j.1749-6632.1998.tb10742.x; Huang JH, 2013, BBA-GEN SUBJECTS, V1830, P2178, DOI 10.1016/j.bbagen.2012.09.025; Jindra M, 2013, ANNU REV ENTOMOL, V58, P181, DOI 10.1146/annurev-ento-120811-153700; JOHNSON GD, 1993, CELL TISSUE RES, V274, P279, DOI 10.1007/BF00318747; JOHNSON GD, 1985, CELL TISSUE RES, V239, P317, DOI 10.1007/BF00218010; Kayukawa T, 2012, P NATL ACAD SCI USA, V109, P11729, DOI 10.1073/pnas.1204951109; Konopova B, 2008, DEVELOPMENT, V135, P559, DOI 10.1242/dev.016097; Konopova B, 2007, P NATL ACAD SCI USA, V104, P10488, DOI 10.1073/pnas.0703719104; Konopova B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028728; Konopova B, 2009, MECH DEVELOP, V126, pS68, DOI 10.1016/j.mod.2009.06.059; Lindsey BW, 2012, J COMP NEUROL, V520, P2275, DOI 10.1002/cne.23065; Lozano J, 2011, SCI REP-UK, V1, DOI 10.1038/srep00163; Maestro JL, 2009, J BIOL CHEM, V284, P5506, DOI 10.1074/jbc.M807042200; Marchal Elisabeth, 2013, BMC Res Notes, V6, P237, DOI 10.1186/1756-0500-6-237; Marchal E, 2013, GEN COMP ENDOCR, V188, P85, DOI 10.1016/j.ygcen.2013.04.018; Minakuchi C, 2009, DEV BIOL, V325, P341, DOI 10.1016/j.ydbio.2008.10.016; Minakuchi C, 2008, MECH DEVELOP, V125, P91, DOI 10.1016/j.mod.2007.10.002; Minakuchi C, 2011, INSECT BIOCHEM MOLEC, V41, P125, DOI 10.1016/j.ibmb.2010.11.004; Miura K, 2005, FEBS J, V272, P1169, DOI 10.1111/j.1742-4658.2005.04552.x; MUNDALL EC, 1979, NATURE, V282, P97, DOI 10.1038/282097a0; MUNDALL EC, 1981, J INSECT PHYSIOL, V27, P821, DOI 10.1016/0022-1910(81)90083-4; Parthasarathy R, 2008, MECH DEVELOP, V125, P601, DOI 10.1016/j.mod.2008.03.004; Parthasarathy R, 2008, MECH DEVELOP, V125, P299, DOI 10.1016/j.mod.2007.11.001; Parthasarathy R, 2011, INSECT BIOCHEM MOLEC, V41, P294, DOI 10.1016/j.ibmb.2011.01.006; Parthasarathy R, 2010, INSECT BIOCHEM MOLEC, V40, P405, DOI 10.1016/j.ibmb.2010.03.006; PASCUAL N, 1992, J INSECT PHYSIOL, V38, P339, DOI 10.1016/0022-1910(92)90058-L; Perez-Hedo M, 2013, INSECT BIOCHEM MOLEC, V43, P495, DOI 10.1016/j.ibmb.2013.03.008; Piulachs MD, 2010, INSECT BIOCHEM MOLEC, V40, P468, DOI 10.1016/j.ibmb.2010.04.006; PRATT GE, 1974, LIFE SCI, V14, P575, DOI 10.1016/0024-3205(74)90372-5; RANKIN SM, 1984, GEN COMP ENDOCR, V54, P382, DOI 10.1016/0016-6480(84)90151-5; Riddiford LM, 2012, GEN COMP ENDOCR, V179, P477, DOI 10.1016/j.ygcen.2012.06.001; ROTH LM, 1961, J INSECT PHYSIOL, V7, P186, DOI 10.1016/0022-1910(61)90071-3; Sheng ZT, 2011, J BIOL CHEM, V286, P41924, DOI 10.1074/jbc.M111.269845; Shpigler H, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-120; Smykal V, 2014, INSECT BIOCHEM MOLEC, V45, P69, DOI 10.1016/j.ibmb.2013.12.003; STAY B, 1977, GEN COMP ENDOCR, V33, P531, DOI 10.1016/0016-6480(77)90113-7; STAY B, 1983, GEN COMP ENDOCR, V52, P341, DOI 10.1016/0016-6480(83)90171-5; STAY B, 1978, GEN COMP ENDOCR, V34, P276, DOI 10.1016/0016-6480(78)90249-6; STAY B, 1984, J INSECT PHYSIOL, V30, P643, DOI 10.1016/0022-1910(84)90049-0; Stoltzman CA, 1997, EUR J ENTOMOL, V94, P335; Suren-Castillo S, 2012, INSECT BIOCHEM MOLEC, V42, P491, DOI 10.1016/j.ibmb.2012.03.006; Suzuki Y, 2008, DEVELOPMENT, V135, P569, DOI 10.1242/dev.015263; TOBE SS, 1985, INSECT BIOCHEM, V15, P175, DOI 10.1016/0020-1790(85)90005-8; TOBE SS, 1974, BIOCHEM J, V144, P107, DOI 10.1042/bj1440107; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; WILSON TG, 1986, DEV BIOL, V118, P190, DOI 10.1016/0012-1606(86)90087-4; Woodhead AP, 2003, J INSECT PHYSIOL, V49, P1103, DOI 10.1016/j.jinsphys.2003.08.006; Zou Z, 2013, P NATL ACAD SCI USA, V110, pE2173, DOI 10.1073/pnas.1305293110	62	56	60	1	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2014	9	9							e106737	10.1371/journal.pone.0106737	http://dx.doi.org/10.1371/journal.pone.0106737			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4JX	25197795	Green Submitted, gold, Green Published			2022-12-27	WOS:000341304700045
J	Rindi, L; Medici, C; Bimbi, N; Buzzigoli, A; Lari, N; Garzelli, C				Rindi, Laura; Medici, Chiara; Bimbi, Nicola; Buzzigoli, Andrea; Lari, Nicoletta; Garzelli, Carlo			Genomic Variability of Mycobacterium tuberculosis Strains of the Euro-American Lineage Based on Large Sequence Deletions and 15-Locus MIRU-VNTR Polymorphism	PLOS ONE			English	Article							COMPLEX; FAMILY; RECONSTRUCTION; SUBLINEAGE; PHYLOGENY; DIVERSITY; EVOLUTION; DATABASE; COUNTRY	A sample of 260 Mycobacterium tuberculosis strains assigned to the Euro-American family was studied to identify phylogenetically informative genomic regions of difference (RD). Mutually exclusive deletions of regions RD115, RD122, RD174, RD182, RD183, RD193, RD219, RD726 and RD761 were found in 202 strains; the RDRio deletion was detected exclusively among the RD174-deleted strains. Although certain deletions were found more frequently in certain spoligotype families (i.e., deletion RD115 in T and LAM, RD174 in LAM, RD182 in Haarlem, RD219 in T and RD726 in the "Cameroon'' family), the RD-defined sublineages did not specifically match with spoligotype-defined families, thus arguing against the use of spoligotyping for establishing exact phylogenetic relationships between strains. Notably, when tested for katG463/gyrA95 polymorphism, all the RD-defined sublineages belonged to Principal Genotypic Group (PGG) 2, except sublineage RD219 exclusively belonging to PGG3; the 58 Euro-American strains with no deletion were of either PGG2 or 3. A representative sample of 197 isolates was then analyzed by standard 15-locus MIRU-VNTR typing, a suitable approach to independently assess genetic relationships among the strains. Analysis of the MIRU-VNTR typing results by using a minimum spanning tree (MST) and a classical dendrogram showed groupings that were largely concordant with those obtained by RD-based analysis. Isolates of a given RD profile show, in addition to closely related MIRU-VNTR profiles, related spoligotype profiles that can serve as a basis for better spoligotype-based classification.	[Rindi, Laura; Medici, Chiara; Bimbi, Nicola; Buzzigoli, Andrea; Lari, Nicoletta; Garzelli, Carlo] Univ Pisa, Dipartimento Ric Traslaz & Nuove Tecnol Med & Chi, Pisa, Italy	University of Pisa	Rindi, L (corresponding author), Univ Pisa, Dipartimento Ric Traslaz & Nuove Tecnol Med & Chi, Pisa, Italy.	laura.rindi@med.unipi.it	MEDICI, CHIARA/AAC-8734-2022	Medici, Chiara/0000-0002-7348-9674	University of Pisa, Grant "Fondi di Ateneo"	University of Pisa, Grant "Fondi di Ateneo"	This work was financially supported by the University of Pisa, Grant "Fondi di Ateneo, 2013". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allix-Beguec C, 2008, J CLIN MICROBIOL, V46, P2692, DOI 10.1128/JCM.00540-08; Brosch R, 2002, P NATL ACAD SCI USA, V99, P3684, DOI 10.1073/pnas.052548299; Brudey K, 2006, BMC MICROBIOL, V6, DOI 10.1186/1471-2180-6-23; Comas I, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007815; Comas I, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000600; David S, 2012, INFECT GENET EVOL, V12, P1362, DOI 10.1016/j.meegid.2012.04.021; de Jong BC, 2009, J CLIN MICROBIOL, V47, P994, DOI 10.1128/JCM.01216-08; Demay C, 2012, INFECT GENET EVOL, V12, P755, DOI 10.1016/j.meegid.2012.02.004; Fenner L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024737; Flores L, 2007, J CLIN MICROBIOL, V45, P3393, DOI 10.1128/JCM.00828-07; Gagneux S, 2006, P NATL ACAD SCI USA, V103, P2869, DOI 10.1073/pnas.0511240103; Gagneux S, 2007, LANCET INFECT DIS, V7, P328, DOI 10.1016/S1473-3099(07)70108-1; Gibson AL, 2008, J CLIN MICROBIOL, V46, P1259, DOI 10.1128/JCM.02231-07; Hershberg R, 2008, PLOS BIOL, V6, P2658, DOI 10.1371/journal.pbio.0060311; Hirsh AE, 2004, P NATL ACAD SCI USA, V101, P4871, DOI 10.1073/pnas.0305627101; Homolka S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039855; Kamerbeek J, 1997, J CLIN MICROBIOL, V35, P907, DOI 10.1128/JCM.35.4.907-914.1997; Kato-Maeda M, 2011, INT J TUBERC LUNG D, V15, P131; Lari N, 2007, J CLIN MICROBIOL, V45, P1851, DOI 10.1128/JCM.00170-07; Marmiesse M, 2004, MICROBIOL-SGM, V150, P483, DOI 10.1099/mic.0.26662-0; Mokrousov I, 2014, J BACTERIOL, V196, P1833, DOI 10.1128/JB.01485-13; Niobe-Eyangoh SN, 2004, J CLIN MICROBIOL, V42, P5029, DOI 10.1128/JCM.42.11.5029-5035.2004; Niobe-Eyangoh SN, 2003, J CLIN MICROBIOL, V41, P2547, DOI 10.1128/JCM.41.6.2547-2553.2003; Oelemann MC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018256; Rastogi N., 2007, TUBERCULOSIS 2007 BA, V2007, P53; Reed MB, 2009, J CLIN MICROBIOL, V47, P1119, DOI 10.1128/JCM.02142-08; Reyes JF, 2012, INFECT GENET EVOL, V12, P811, DOI 10.1016/j.meegid.2011.05.018; Rindi L, 2004, J MICROBIOL METH, V59, P283, DOI 10.1016/j.mimet.2004.06.012; Rindi L, 2012, INFECT GENET EVOL, V12, P1551, DOI 10.1016/j.meegid.2012.06.008; SELANDER RK, 1986, APPL ENVIRON MICROB, V51, P873, DOI 10.1128/AEM.51.5.873-884.1986; Sola C, 2001, J MOL EVOL, V53, P680, DOI 10.1007/s002390010255; Sreevatsan S, 1997, P NATL ACAD SCI USA, V94, P9869, DOI 10.1073/pnas.94.18.9869; Streicher EM, 2007, J CLIN MICROBIOL, V45, P237, DOI 10.1128/JCM.01429-06; Supply P, 2000, MOL MICROBIOL, V36, P762, DOI 10.1046/j.1365-2958.2000.01905.x; Supply P, 2003, MOL MICROBIOL, V47, P529, DOI 10.1046/j.1365-2958.2003.03315.x; Supply P, 2006, J CLIN MICROBIOL, V44, P4498, DOI 10.1128/JCM.01392-06; Thorne N, 2011, INFECT GENET EVOL, V11, P132, DOI 10.1016/j.meegid.2010.09.011; Tsolaki AG, 2004, P NATL ACAD SCI USA, V101, P4865, DOI 10.1073/pnas.0305634101; Warren RM, 2002, J CLIN MICROBIOL, V40, P4457, DOI 10.1128/JCM.40.12.4457-4465.2002; Weisenberg SA, 2012, INFECT GENET EVOL, V12, P664, DOI 10.1016/j.meegid.2011.07.018; Weniger T, 2010, NUCLEIC ACIDS RES, V38, pW326, DOI 10.1093/nar/gkq351; Wirth T, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000160	42	11	11	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2014	9	9							e107150	10.1371/journal.pone.0107150	http://dx.doi.org/10.1371/journal.pone.0107150			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4JX	25197794	gold, Green Published, Green Submitted			2022-12-27	WOS:000341304700085
J	Trentini, B; Steindel, M; Marlow, MA				Trentini, Bruno; Steindel, Mario; Marlow, Mariel A.			Low Quality Evidence of Epidemiological Observational Studies on Leishmaniasis in Brazil	PLOS ONE			English	Article							HEALTH; AREA; IMPACT; DOGS	Background: Brazil has implemented systematic control methods for leishmaniasis for the past 30 years, despite an increase in cases and continued spread of the disease to new regions. A lack high quality evidence from epidemiological observational studies impedes the development of novel control methods to prevent disease transmission among the population. Here, we have evaluated the quality of observational studies on leishmaniasis conducted in Brazil to highlight this issue. Methods/Principal Findings: For this systematic review, all publications on leishmaniasis conducted in Brazil from January 1st, 2002 to December 31st, 2012 were screened via Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) checklist to select observational studies involving human subjects. The 283 included studies, representing only 14.1% of articles screened, were then further evaluated for quality of epidemiological methods and study design based on the STROBE (Strengthening the Reporting of Observational studies in Epidemiology) checklists. Over half of these studies were descriptive or case reports (53.4%, 151), followed by cross-sectional (20.8%, n=59), case-control (8.5%, n=24), and cohort (6.0%, n=17). Study design was not stated in 46.6% (n=181) and incorrectly stated in 17.5% (n=24). Comparison groups were utilized in just 39.6% (n=112) of the publications, and only 13.4% (n=38) employed healthy controls. Majority of studies were performed at the city-level (62.9%, n=178), in contrast with two (0.7%) studies performed at the national-level. Coauthorship networks showed the number of author collaborations rapidly decreased after three collaborations, with 70.9% (n=659/929) of coauthors publishing only one article during the study period. Conclusions/Significance: A review of epidemiological research in Brazil revealed a major lack of quality and evidence. While certain indicators suggested research methods may have improved in the last two years, an emphasis on observational research which employs comparison groups and representative samples is urgently needed.	[Trentini, Bruno] Univ Fed Santa Catarina, Sch Med, Florianopolis, SC, Brazil; [Steindel, Mario] Univ Fed Santa Catarina, Dept Microbiol Immunol & Parasitol, Florianopolis, SC, Brazil; [Marlow, Mariel A.] Univ Calif Berkeley, Sch Publ Hlth, Div Infect Dis & Vaccinol, Berkeley, CA 94720 USA	Universidade Federal de Santa Catarina (UFSC); Universidade Federal de Santa Catarina (UFSC); University of California System; University of California Berkeley	Marlow, MA (corresponding author), Univ Calif Berkeley, Sch Publ Hlth, Div Infect Dis & Vaccinol, Berkeley, CA 94720 USA.	mmarlow@berkeley.edu	Steindel, Mario/N-2040-2018; Steindel, Mario/H-2945-2015	Steindel, Mario/0000-0002-2768-7469; Steindel, Mario/0000-0002-2768-7469	NIH - Fogarty International Center [R25 TW009338]; Office of AIDS Research at the National Institutes of Health; FOGARTY INTERNATIONAL CENTER [R25TW009338] Funding Source: NIH RePORTER	NIH - Fogarty International Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); Office of AIDS Research at the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC))	MM was supported by NIH Research Training Grant #R25 TW009338 funded by the Fogarty International Center and the Office of AIDS Research at the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvar J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035671; Barros AJD, 2006, REV SAUDE PUBL, V40, P43, DOI 10.1590/S0034-89102006000400007; Batagelj V., 1998, CONNECTIONS, V21, P47, DOI DOI 10.1017/CB09780511996368; Cameron C, 2011, J CANCER EDUC, V26, P72, DOI 10.1007/s13187-010-0143-5; Casadevall A, 2014, MBIO, V5, DOI 10.1128/mBio.00064-14; Costa DNCC, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002355; Cummins P, 2013, EUROINTERVENTION, V9, P294, DOI 10.4244/EIJV9I3A48; Ghafouri HB, 2014, EMERG MED J, V31, P619, DOI 10.1136/emermed-2012-201781; Grimaldi G, 2012, AM J TROP MED HYG, V86, P966, DOI 10.4269/ajtmh.2012.12-0040; Grimes DA, 2002, LANCET, V359, P57, DOI 10.1016/S0140-6736(02)07283-5; Grimes DA, 2002, LANCET, V359, P145, DOI 10.1016/S0140-6736(02)07373-7; Israel BA, 1998, ANNU REV PUBL HEALTH, V19, P173, DOI 10.1146/annurev.publhealth.19.1.173; Kishore SP, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000635; Marlow MA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056177; McDowell MA, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001219; Meneghini R, 2007, EMBO REP, V8, P112, DOI 10.1038/sj.embor.7400906; Ministerio da Saude, 2007, SIST INF AGR NOT; Ministerio da Saude, 2007, MAN VIG LEISHM TEG A; Ministerio da Saude, 2013, MAN VIG LEISHM TEG A; Moher D, 2009, PLOS MED, V6, DOI [10.1136/bmj.b4037, 10.1371/journal.pmed.1000097]; Murray CJL, 2012, LANCET, V380, P2197, DOI 10.1016/S0140-6736(12)61689-4; Pang T, 2003, B WORLD HEALTH ORGAN, V81, P815; Reithinger R, 2007, LANCET INFECT DIS, V7, P581, DOI 10.1016/S1473-3099(07)70209-8; Romero GAS, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000584; Rychetnik L, 2002, J EPIDEMIOL COMMUN H, V56, P119, DOI 10.1136/jech.56.2.119; Schneider J.W, 2009, CELEBRATING SCHOLARL, V5, P9, DOI DOI 1458990/FILE/1458992.PDF#PAGE=11; Schonian G, 2011, PARASITOLOGY, V138, P405, DOI 10.1017/S0031182010001538; Soccol VT, 2009, ACTA TROP, V111, P308, DOI 10.1016/j.actatropica.2009.05.013; von Elm E, 2007, LANCET, V370, P1453, DOI 10.1016/S0140-6736(07)61602-X	29	1	1	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2014	9	9							e106635	10.1371/journal.pone.0106635	http://dx.doi.org/10.1371/journal.pone.0106635			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4JX	25197965	Green Submitted, gold, Green Published			2022-12-27	WOS:000341304700036
J	Al-Sabah, S; Al-Fulaij, M; Shaaban, G; Ahmed, HA; Mann, RJ; Donnelly, D; Bunemann, M; Krasel, C				Al-Sabah, Suleiman; Al-Fulaij, Munya; Shaaban, Ghina; Ahmed, Hanadi A.; Mann, Rosalind J.; Donnelly, Dan; Buenemann, Moritz; Krasel, Cornelius			The GIP Receptor Displays Higher Basal Activity than the GLP-1 Receptor but Does Not Recruit GRK2 or Arrestin3 Effectively	PLOS ONE			English	Article							GLUCAGON-LIKE PEPTIDE-1; PROTEIN-COUPLED RECEPTORS; BETA-ARRESTIN; CONSTITUTIVE ACTIVITY; POLYPEPTIDE; CELLS; ACTIVATION; BETA-ARRESTIN2; IDENTIFICATION; PHYSIOLOGY	Background and Objectives: Glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP) are important regulators of insulin secretion, and their functional loss is an early characteristic of type 2 diabetes mellitus (T2DM). Pharmacological levels of GLP-1, but not GIP, can overcome this loss. GLP-1 and GIP exert their insulinotropic effects through their respective receptors expressed on pancreatic beta-cells. Both the GLP-1 receptor (GLP-1R) and the GIP receptor (GIPR) are members of the secretin family of G protein-coupled receptors (GPCRs) and couple positively to adenylate cyclase. We compared the signalling properties of these two receptors to gain further insight into why GLP-1, but not GIP, remains insulinotropic in T2DM patients. Methods: GLP-1R and GIPR were transiently expressed in HEK-293 cells, and basal and ligand-induced cAMP production were investigated using a cAMP-responsive luciferase reporter gene assay. Arrestin3 (Arr3) recruitment to the two receptors was investigated using enzyme fragment complementation, confocal microscopy and fluorescence resonance energy transfer (FRET). Results: GIPR displayed significantly higher (P<0.05) ligand-independent activity than GLP-1R. Arr3 displayed a robust translocation to agonist-stimulated GLP-1R but not to GIPR. These observations were confirmed in FRET experiments, in which GLP-1 stimulated the recruitment of both GPCR kinase 2 (GRK2) and Arr3 to GLP-1R. These interactions were not reversed upon agonist washout. In contrast, GIP did not stimulate recruitment of either GRK2 or Arr3 to its receptor. Interestingly, arrestin remained at the plasma membrane even after prolonged (30 min) stimulation with GLP-1. Although the GLP-1R/arrestin interaction could not be reversed by agonist washout, GLP-1R and arrestin did not co-internalise, suggesting that GLP-1R is a class A receptor with regard to arrestin binding. Conclusions: GIPR displays higher basal activity than GLP-1R but does not effectively recruit GRK2 or Arr3.	[Al-Sabah, Suleiman; Al-Fulaij, Munya; Shaaban, Ghina; Ahmed, Hanadi A.] Kuwait Univ, Fac Med, Dept Pharmacol & Toxicol, Safat, Kuwait; [Mann, Rosalind J.; Donnelly, Dan] Univ Leeds, Sch Biomed Sci, Leeds, W Yorkshire, England; [Buenemann, Moritz; Krasel, Cornelius] Univ Marburg, Inst Pharmacol & Toxicol, Sch Pharm, Marburg, Germany	Kuwait University; University of Leeds; Philipps University Marburg	Al-Sabah, S (corresponding author), Kuwait Univ, Fac Med, Dept Pharmacol & Toxicol, Safat, Kuwait.	Suleiman@hsc.edu.kw	Donnelly, Dan/O-5374-2015; Krasel, Cornelius/AAH-7074-2019	Donnelly, Dan/0000-0001-6048-6995; Krasel, Cornelius/0000-0001-8309-8696; Al-Sabah, Suleiman/0000-0002-9808-7866	Kuwait University [MR02/12]; BBSRC [BB/E003583/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/E003583/1] Funding Source: researchfish	Kuwait University; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by Kuwait University grant No. MR02/12. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahren B, 2011, DIABETES OBES METAB, V13, P158, DOI 10.1111/j.1463-1326.2011.01457.x; Akhtar S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067813; Al-Fulaij MA, 2007, J PHARMACOL EXP THER, V321, P298, DOI 10.1124/jpet.106.116384; Almind K, 1998, DIABETOLOGIA, V41, P1194, DOI 10.1007/s001250051051; Amisten S, 2013, PHARMACOL THERAPEUT, V139, P359, DOI 10.1016/j.pharmthera.2013.05.004; Baggio LL, 2007, GASTROENTEROLOGY, V132, P2131, DOI 10.1053/j.gastro.2007.03.054; Campbell JE, 2013, CELL METAB, V17, P819, DOI 10.1016/j.cmet.2013.04.008; Ceperuelo-Mallafre V, 2014, J CLIN ENDOCR METAB, V99, pE908, DOI 10.1210/jc.2013-3350; Engelhardt S, 2001, MOL PHARMACOL, V60, P712; Finan B, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3007218; Fortin JP, 2010, J PHARMACOL EXP THER, V332, P274, DOI 10.1124/jpet.109.160531; Holst B, 2003, MOL ENDOCRINOL, V17, P2201, DOI 10.1210/me.2003-0069; Holst JJ, 2011, DIABETES CARE, V34, pS251, DOI 10.2337/dc11-s227; Holst JJ, 2007, PHYSIOL REV, V87, P1409, DOI 10.1152/physrev.00034.2006; Holst JJ, 2013, TRENDS ENDOCRIN MET, V24, P145, DOI 10.1016/j.tem.2013.01.004; Huang Y, 2010, BRIT J PHARMACOL, V159, P237, DOI 10.1111/j.1476-5381.2009.00517.x; Jorgensen R, 2005, MOL ENDOCRINOL, V19, P812, DOI 10.1210/me.2004-0312; Jorgensen R, 2007, J PHARMACOL EXP THER, V322, P148, DOI 10.1124/jpet.107.120006; Jorgensen R, 2011, PHARMACOLOGY, V88, P174, DOI 10.1159/000330742; Kim W, 2008, PHARMACOL REV, V60, P470, DOI 10.1124/pr.108.000604; Krasel C, 2005, J BIOL CHEM, V280, P9528, DOI 10.1074/jbc.M413078200; Krasel C, 2008, J BIOL CHEM, V283, P31840, DOI 10.1074/jbc.M806086200; Luttrell LM, 2010, PHARMACOL REV, V62, P305, DOI 10.1124/pr.109.002436; McIntosh CHS, 2010, VITAM HORM, V84, P21, DOI [10.1016/S0083-6729(10)84016-6, 10.1016/B978-0-12-381517-0.00002-3]; NAUCK MA, 1993, J CLIN INVEST, V91, P301, DOI 10.1172/JCI116186; Pierce KL, 2001, NAT REV NEUROSCI, V2, P727, DOI 10.1038/35094577; Ravier MA, 2014, DIABETOLOGIA, V57, P532, DOI 10.1007/s00125-013-3130-7; Schelshorn D, 2012, MOL PHARMACOL, V81, P309, DOI 10.1124/mol.111.074757; Seifert R, 2002, N-S ARCH PHARMACOL, V366, P381, DOI 10.1007/s00210-002-0588-0; Sonoda N, 2008, P NATL ACAD SCI USA, V105, P6614, DOI 10.1073/pnas.0710402105; Syme CA, 2006, MOL ENDOCRINOL, V20, P3400, DOI 10.1210/me.2006-0178; Talbot J, 2012, MOL CELL ENDOCRINOL, V364, P65, DOI 10.1016/j.mce.2012.08.010; Torekov SS, 2014, J CLIN ENDOCR METAB, V99, pE729, DOI 10.1210/jc.2013-3766; Tseng CC, 2000, ENDOCRINOLOGY, V141, P947, DOI 10.1210/en.141.3.947; Ussher JR, 2012, ENDOCR REV, V33, P187, DOI 10.1210/er.2011-1052; Vilardaga JP, 2003, NAT BIOTECHNOL, V21, P807, DOI 10.1038/nbt838; Whitaker GM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032675	37	29	31	4	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2014	9	9							e106890	10.1371/journal.pone.0106890	http://dx.doi.org/10.1371/journal.pone.0106890			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ1IR	25191754	Green Published, gold			2022-12-27	WOS:000347993600078
J	Baskaran, K; Pugazhendhi, S; Ramakrishna, BS				Baskaran, Kirankumar; Pugazhendhi, Srinivasan; Ramakrishna, Balakrishnan S.			Association of IRGM Gene Mutations with Inflammatory Bowel Disease in the Indian Population	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; CROHNS-DISEASE; NOD2 GENE; VARIANTS; SUSCEPTIBILITY; AUTOPHAGY; POLYMORPHISM; UPSTREAM; NKX2-3; RISK	Background: Mutations in the IRGM gene have been associated with Crohn's disease in several populations but have not been explored in Indian patients with this disease. This study examined the association of IRGM mutations with ulcerative colitis and Crohn's disease in Indian patients with inflammatory bowel disease. Methods: The IRGM gene was amplified in four segments and Sanger-sequenced in 101 participants (42 Crohn's disease, 39 ulcerative colitis, and 20 healthy controls). Ten single nucleotide polymorphisms (SNP) were genotyped in 1200 participants (352 Crohn's disease, 400 ulcerative colitis, and 448 healthy controls) using Sequenom MassARRAY iPLEX. Disease associations were evaluated for each of the ten SNPs. Results: Thirty one mutations were identified in the IRGM gene, of which two had not hitherto been reported (150226250-ss947429272 & 150227858-ss947429273). Ten SNPs (6 from the above and 4 from the literature) were evaluated. Significant associations with Crohn's disease were noted with the T allele of rs1000113 (OR 1.46, 95% CI 1.12-1.90), T allele of rs9637876 (OR 1.25, 95% CI 1.005-1.561) and C allele of rs 13361189 (OR 1.33, 95% CI 1.07-1.669). Two SNPs - rs11747270 and rs180802994 - did not exhibit Hardy-Weinberg equilibrium but were associated with both Crohn's disease and ulcerative colitis in this population. The remaining SNPs did not show significant associations with either Crohn's disease or ulcerative colitis. Conclusions: Association of IRGM gene SNPs with Crohn's disease is reported for the first time in Indian patients. We also report, for the first time, an association of rs 9637876 in the IRGM gene with Crohn's disease.	[Baskaran, Kirankumar; Pugazhendhi, Srinivasan; Ramakrishna, Balakrishnan S.] Christian Med Coll & Hosp, Wellcome Trust Res Lab, Vellore, Tamil Nadu, India; [Ramakrishna, Balakrishnan S.] SRM Inst Med Sci, Madras, Tamil Nadu, India	Christian Medical College & Hospital (CMCH) Vellore; SRM Institute of Science & Technology Chennai	Ramakrishna, BS (corresponding author), Christian Med Coll & Hosp, Wellcome Trust Res Lab, Vellore, Tamil Nadu, India.	wurama@hotmail.com	Srinivasan, Pugazhendhi/M-5184-2019; Ramakrishna, Balakrishnan/D-6808-2015	Srinivasan, Pugazhendhi/0000-0002-1748-1416; Ramakrishna, Balakrishnan/0000-0001-5090-9501	Department of Science and Technology, Government of India	Department of Science and Technology, Government of India(Department of Science & Technology (India))	This work was supported by the Department of Science and Technology, Government of India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Barrett JC, 2008, NAT GENET, V40, P955, DOI 10.1038/ng.175; Billmann-Born S, 2011, EUR J CELL BIOL, V90, P593, DOI 10.1016/j.ejcb.2010.10.015; Brest P, 2011, NAT GENET, V43, P242, DOI 10.1038/ng.762; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; De Rijk Peter, 2007, V396, P331; Gabriel Stacey, 2009, Curr Protoc Hum Genet, VChapter 2, DOI 10.1002/0471142905.hg0212s60; Giegerich R, 1996, Proc Int Conf Intell Syst Mol Biol, V4, P68; Glas J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054338; Hampe J, 2001, LANCET, V357, P1925, DOI 10.1016/S0140-6736(00)05063-7; Intemann CD, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000577; Jostins L, 2012, NATURE, V491, P119, DOI 10.1038/nature11582; Lapaquette P, 2010, CELL MICROBIOL, V12, P99, DOI 10.1111/j.1462-5822.2009.01381.x; Latiano A, 2009, AM J GASTROENTEROL, V104, P110, DOI 10.1038/ajg.2008.3; McCarroll SA, 2008, NAT GENET, V40, P1107, DOI 10.1038/ng.215; Meggyesi N, 2010, WORLD J GASTROENTERO, V16, P5233, DOI 10.3748/wjg.v16.i41.5233; Molodecky NA, 2012, GASTROENTEROLOGY, V142, P46, DOI 10.1053/j.gastro.2011.10.001; Moon CM, 2013, INFLAMM BOWEL DIS, V19, P106, DOI 10.1002/ibd.22972; Moore JH, 2006, J THEOR BIOL, V241, P252, DOI 10.1016/j.jtbi.2005.11.036; Murdoch TB, 2012, INFLAMM BOWEL DIS, V18, P1743, DOI 10.1002/ibd.22884; Ogura Y, 2001, NATURE, V411, P603, DOI 10.1038/35079114; Packey CD, 2008, J INTERN MED, V263, P597, DOI 10.1111/j.1365-2796.2008.01962.x; Palomino-Morales RJ, 2009, GENES IMMUN, V10, P356, DOI 10.1038/gene.2009.25; Parkes M, 2007, NAT GENET, V39, P830, DOI 10.1038/ng2061; Peter I, 2011, BMC MED GENET, V12, DOI 10.1186/1471-2350-12-63; Prescott NJ, 2010, HUM MOL GENET, V19, P1828, DOI 10.1093/hmg/ddq041; Pugazhendhi Srinivasan, 2008, Indian J Gastroenterol, V27, P201; Pugazhendhi S, 2013, GENE, V512, P309, DOI 10.1016/j.gene.2012.10.015; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Qin OY, 2006, J GASTROEN HEPATOL, V21, P1772, DOI 10.1111/j.1440-1746.2006.04674.x; Ramakrishna BS, 2012, INDIAN J GASTROENTER, V31, P307, DOI 10.1007/s12664-012-0259-0; Schaid DJ, 1999, AM J EPIDEMIOL, V149, P706; Sehgal R, 2012, DIS COLON RECTUM, V55, P115, DOI 10.1097/DCR.0b013e31823ccea8; Singh SB, 2006, SCIENCE, V313, P1438, DOI 10.1126/science.1129577; Taylor GA, 2007, CELL MICROBIOL, V9, P1099, DOI 10.1111/j.1462-5822.2007.00916.x; Ward LD, 2012, NUCLEIC ACIDS RES, V40, pD930, DOI 10.1093/nar/gkr917; Yamazaki K, 2009, GUT, V58, P228, DOI 10.1136/gut.2007.140764	37	18	19	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2014	9	9							e106863	10.1371/journal.pone.0106863	http://dx.doi.org/10.1371/journal.pone.0106863			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ1IR	25191865	Green Published, gold, Green Submitted			2022-12-27	WOS:000347993600073
J	Healey, B; Hoek, J; Edwards, R				Healey, Benjamin; Hoek, Janet; Edwards, Richard			Posting Behaviour Patterns in an Online Smoking Cessation Social Network: Implications for Intervention Design and Development	PLOS ONE			English	Article							ADOLESCENT SMOKING; YOUTH SMOKING	Objectives: Online Cessation Support Networks (OCSNs) are associated with increased quit success rates, but few studies have examined their use over time. We identified usage patterns in New Zealand's largest OCSN over two years and explored implications for OCSN intervention design and evaluation. Methods: We analysed metadata relating to 133,096 OCSN interactions during 2011 and 2012. Metrics covered aggregate network activity, user posting activity and longevity, and between-user commenting. Binary logistic regression models were estimated to investigate the feasibility of predicting low user engagement using early interaction data. Results: Repeating periodic peaks and troughs in aggregate activity related not only to seasonality (e.g., New Year), but also to day of the week. Out of 2,062 unique users, 69 Highly Engaged Users (180+ interactions each) contributed 69% of all OCSN interactions in 2012 compared to 1.3% contributed by 864 Minimally Engaged Users (< = 2 items each). The proportion of Highly Engaged Users increased with network growth between 2011 and 2012 (with marginal significance), but the proportion of Minimally Engaged Users did not decline substantively. First week interaction data enabled identification of Minimally Engaged Users with high specificity and sensitivity (AUROC = 0.94). Implications: Results suggest future research should develop and test interventions that promote activity, and hence cessation support, amongst specific user groups or at key time points. For example, early usage information could help identify Minimally Engaged Users for tests of targeted messaging designed to improve their integration into, or re-engagement with, the OCSN. Furthermore, although we observed strong growth over time on varied metrics including posts and comments, this change did not coincide with large gains in first-time user persistence. Researchers assessing intervention effects should therefore examine multiple measures when evaluating changes in network dynamics over time.	[Healey, Benjamin; Hoek, Janet] Univ Otago, Dept Mkt, Dunedin, New Zealand; [Edwards, Richard] Univ Otago, Dept Publ Hlth, Wellington, New Zealand	University of Otago; University of Otago	Healey, B (corresponding author), Univ Otago, Dept Mkt, Dunedin, New Zealand.	ben.healey@otago.ac.nz	Hoek, Janet/A-5186-2010; Edwards, Richard/O-4771-2017	Hoek, Janet/0000-0003-4362-1539; Edwards, Richard/0000-0003-2264-9823				Anderson CM, 2007, TOB CONTROL, V16, pI81, DOI 10.1136/tc.2007.020701; [Anonymous], 2011, 2010 NAT DRUG STRAT; Ayers JW, 2014, AM J PREV MED, V47, P73, DOI 10.1016/j.amepre.2014.02.003; Ayers JW, 2014, JAMA INTERN MED, V174, P146, DOI 10.1001/jamainternmed.2013.11933; Benowitz NL, 1996, ANNU REV PHARMACOL, V36, P597, DOI 10.1146/annurev.pa.36.040196.003121; Bewick V, 2004, CRIT CARE, V8, P508, DOI 10.1186/cc3000; Biener L, 2000, AM J PUBLIC HEALTH, V90, P407, DOI 10.2105/AJPH.90.3.407; Blok DJ, 2013, EPIDEMIOL INFECT, V141, P667, DOI 10.1017/S0950268812000891; Brandtzaeg Petter Bae, 2011, International Journal of Web Based Communities, V7, P28, DOI 10.1504/IJWBC.2011.038124; Canty A, 2014, BOOT BOOTSTRAP R S P; Christakis NA, 2008, NEW ENGL J MED, V358, P2249, DOI 10.1056/NEJMsa0706154; Christakis NA, 2013, STAT MED, V32, P556, DOI 10.1002/sim.5408; Civljak M, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007078.pub4; Cobb NK, 2011, J MED INTERNET RES, V13, DOI 10.2196/jmir.1911; Cobb NK, 2010, AM J PUBLIC HEALTH, V100, P1282, DOI 10.2105/AJPH.2009.165449; Couper MP, 2010, J MED INTERNET RES, V12, P41, DOI 10.2196/jmir.1430; Fichtenberg CM, 2002, BMJ-BRIT MED J, V325, P188, DOI 10.1136/bmj.325.7357.188; Gartner CE, 2009, TOB CONTROL, V18, P183, DOI 10.1136/tc.2008.027615; Gravitas Research and Strategy Limited, 2012, QUIT GROUP SERV LONG; Halekoh U, 2006, J STAT SOFTW, V15, P1, DOI 10.18637/jss.v015.i02; Huett JB, 2008, AM J DISTANCE EDUC, V22, P159, DOI 10.1080/08923640802224451; Ikeda T, 2015, TOB CONTROL, V24, P139, DOI 10.1136/tobaccocontrol-2013-051196; Kobus K, 2003, ADDICTION, V98, P37, DOI 10.1046/j.1360-0443.98.s1.4.x; Levy DT, 2000, PREV MED, V31, P279, DOI 10.1006/pmed.2000.0696; McClure JB, 2014, NICOTINE TOB RES, V16, P1129, DOI 10.1093/ntr/ntu057; McClure JB, 2013, J MED INTERNET RES, V15, P88, DOI 10.2196/jmir.2508; Ministry of Health, 2012, HLTH NZ AD 2011 12 K; Nielsen J, 2013, FEMS YEAST RES, V13, P1, DOI 10.1111/1567-1364.12026; Oracle Corporation, 2012, DOWNL MYSQL COMM SER; Organization WH, 2009, GLOB HLTH RISKS MORT; Prochaska JJ, 2012, TOB CONTROL, V21, P447, DOI 10.1136/tc.2010.042507; Python Software Foundation, 2007, PYTH PROGR LANG; Quit Group, 2013, QUITL ANN REV 2012 2; R Core Team, 2012, R LANG ENV STAT COMP; Richardson A, 2012, NAT C HLTH COMM MARK; Richardson A, 2013, J MED INTERNET RES, V15, DOI 10.2196/jmir.2277; Ross H, 2003, HEALTH ECON, V12, P217, DOI 10.1002/hec.709; RStudio Inc, 2012, RSTUDIO IDE; Schwarzer R, 2012, PREV MED, V55, P233, DOI 10.1016/j.ypmed.2012.07.006; Scrapy Development Community, 2012, SCRAP OP SOURC WEB S; Selby P, 2010, J MED INTERNET RES, V12, DOI 10.2196/jmir.1340; Simons-Morton B, 2013, HEALTH EDUC BEHAV, V40, P6, DOI 10.1177/1090198112464494; Simpson O., 2004, OPEN LEARN, V19, P79, DOI [10.1080/0268051042000177863, DOI 10.1080/0268051042000177863]; van Mierlo T, 2012, J MED INTERNET RES, V14, P45, DOI 10.2196/jmir.1854; van Mierlo T, 2014, J MED INTERNET RES, V16, DOI 10.2196/jmir.2966; VanderWeele TJ, 2011, SOCIOL METHOD RES, V40, P240, DOI 10.1177/0049124111404821; Wilcox P, 2003, ADDICTION, V98, P57, DOI 10.1046/j.1360-0443.98.s1.5.x	47	12	12	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2014	9	9							e106603	10.1371/journal.pone.0106603	http://dx.doi.org/10.1371/journal.pone.0106603			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AZ1IR	25192174	Green Published, Green Submitted, gold			2022-12-27	WOS:000347993600045
J	Mirajkar, NS; Gebhart, CJ				Mirajkar, Nandita S.; Gebhart, Connie J.			Understanding the Molecular Epidemiology and Global Relationships of Brachyspira hyodysenteriae from Swine Herds in the United States: A Multi-Locus Sequence Typing Approach	PLOS ONE			English	Article							SERPULINA-HYODYSENTERIAE; DYSENTERY; NUMBER; GENE	Outbreaks of mucohemorrhagic diarrhea in pigs caused by Brachyspira hyodysenteriae in the late 2000s indicated the reemergence of Swine Dysentery (SD) in the U.S. Although the clinical disease was absent in the U.S. since the early 1990s, it continued to cause significant economic losses to other swine rearing countries worldwide. This study aims to fill the gap in knowledge pertaining to the re-emergence and epidemiology of B. hyodysenteriae in the U.S. and its global relationships using a multi-locus sequence typing (MLST) approach. Fifty-nine post re-emergent isolates originating from a variety of sources in the U.S. were characterized by MLST, analyzed for epidemiological relationships (within and between multiple sites of swine systems), and were compared with pre re-emergent isolates from the U.S. Information for an additional 272 global isolates from the MLST database was utilized for international comparisons. Thirteen nucleotide sequence types (STs) including a predominant genotype (ST93) were identified in the post re-emergent U.S. isolates; some of which showed genetic similarity to the pre re-emergent STs thereby suggesting its likely role in the re-emergence of SD. In the U.S., in general, no more than one ST was found on a site; multiple sites of a common system shared a ST; and STs found in the U.S. were distinct from those identified globally. Of the 110 STs characterized from ten countries, only two were found in more than one country. The U.S. and global populations, identified as clonal and heterogeneous based on STs, showed close relatedness based on amino acid types (AATs). One predicted founder type (AAT9) and multiple predicted subgroup founder types identified for both the U.S. and the global population indicate the potential microevolution of this pathogen. This study elucidates the strain diversity and microevolution of B. hyodysenteriae, and highlights the utility of MLST for epidemiological and surveillance studies.	[Mirajkar, Nandita S.; Gebhart, Connie J.] Univ Minnesota, Coll Vet Med, Dept Vet & Biomed Sci, St Paul, MN 55108 USA; [Gebhart, Connie J.] Univ Minnesota, Coll Vet Med, Vet Diagnost Lab, St Paul, MN 55108 USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities	Mirajkar, NS (corresponding author), Univ Minnesota, Coll Vet Med, Dept Vet & Biomed Sci, St Paul, MN 55108 USA.	miraj001@umn.edu			Novartis Animal Health US, Inc. [3000-11651-UMSPR-0026522-1]	Novartis Animal Health US, Inc.	CJG received funding (#3000-11651-UMSPR-0026522-1) from Novartis Animal Health US, Inc. (url:http://www.ah.novartis.us/) for a portion of this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atyeo RF, 1999, VET MICROBIOL, V67, P47, DOI 10.1016/S0378-1135(99)00030-9; Atyeo RF, 1999, EPIDEMIOL INFECT, V123, P133, DOI 10.1017/S0950268899002691; Backhans A, 2010, ENV MICROBIOL REP, V2, P720, DOI 10.1111/j.1758-2229.2010.00165.x; COMBS BG, 1992, VET MICROBIOL, V31, P273, DOI 10.1016/0378-1135(92)90085-8; Dugourd D, 1996, VET MICROBIOL, V48, P305, DOI 10.1016/0378-1135(95)00149-2; Feil EJ, 2004, J BACTERIOL, V186, P1518, DOI 10.1128/JB.186.5.1518-1530.2004; Fellstrom C, 1999, VET MICROBIOL, V70, P225, DOI 10.1016/S0378-1135(99)00146-7; Fisher LN, 1997, CLIN DIAGN LAB IMMUN, V4, P681, DOI 10.1128/CDLI.4.6.681-686.1997; GOJOBORI T, 1982, J MOL EVOL, V18, P414, DOI 10.1007/BF01840889; Hampson DJ, 2012, DIS SWINE, P680; HAREL J, 1994, CAN J VET RES, V58, P302; Hidalgo A, 2010, EPIDEMIOL INFECT, V138, P76, DOI 10.1017/S0950268809002817; Hidalgo A, 2010, J CLIN MICROBIOL, V48, P2859, DOI 10.1128/JCM.00348-10; HUNTER PR, 1988, J CLIN MICROBIOL, V26, P2465, DOI 10.1128/JCM.26.11.2465-2466.1988; Jolley KA, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-595; Karlsson M., 2001, Animal Health Research Reviews, V2, P59; La T, 2011, VET MICROBIOL, V153, P150, DOI 10.1016/j.vetmic.2011.02.053; La T, 2009, VET MICROBIOL, V138, P330, DOI 10.1016/j.vetmic.2009.03.025; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; LEE JI, 1993, VET MICROBIOL, V34, P35, DOI 10.1016/0378-1135(93)90005-R; Maiden MCJ, 1998, P NATL ACAD SCI USA, V95, P3140, DOI 10.1073/pnas.95.6.3140; Morschhauser J, 2000, PHILOS T R SOC B, V355, P695, DOI 10.1098/rstb.2000.0609; Osorio J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039082; Rasback T, 2007, MICROBIOL-SGM, V153, P4074, DOI 10.1099/mic.0.2007/008540-0; SMITH JM, 1993, P NATL ACAD SCI USA, V90, P4384, DOI 10.1073/pnas.90.10.4384; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; TAYLOR DJ, 1971, BRIT VET J, V127, pR58, DOI 10.1016/S0007-1935(17)37282-2; TERHUURNE AAHM, 1995, VET MICROBIOL, V46, P347, DOI 10.1016/0378-1135(95)00049-G; Trott DJ, 1997, MICROBIOL-SGM, V143, P3357, DOI 10.1099/00221287-143-10-3357; Trott DJ, 1996, LETT APPL MICROBIOL, V23, P431, DOI 10.1111/j.1472-765X.1996.tb01352.x; Urwin R, 2003, TRENDS MICROBIOL, V11, P479, DOI 10.1016/j.tim.2003.08.006	31	21	21	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2014	9	9							e107176	10.1371/journal.pone.0107176	http://dx.doi.org/10.1371/journal.pone.0107176			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ1IR	25192199	Green Published, Green Submitted, gold			2022-12-27	WOS:000347993600105
J	Pilbrow, J; Sabherwal, M; Garama, D; Carne, A				Pilbrow, Jodi; Sabherwal, Manya; Garama, Daniel; Carne, Alan			A Novel Fatty Acid-Binding Protein-Like Carotenoid-Binding Protein from the Gonad of the New Zealand Sea Urchin Evechinus chloroticus	PLOS ONE			English	Article							CIRCULAR-DICHROISM SPECTRA; MULTIPLE SEQUENCE ALIGNMENT; SECONDARY STRUCTURE; LIGAND-BINDING; CHEMICAL-COMPOSITION; ESCHERICHIA-COLI; VITAMIN-A; PURIFICATION; STRONGYLOCENTROTUS; EXPRESSION	A previously uncharacterized protein with a carotenoid-binding function has been isolated and characterized from the gonad of the New Zealand sea urchin Evechinus chloroticus. The main carotenoid bound to the protein was determined by reversed phase-high performance liquid chromatography to be 9'-cis-echinenone and hence this 15 kDa protein has been called an echinenone-binding protein (EBP). Purification of the EBP in quantity from the natural source proved to be challenging. However, analysis of EBP by mass spectrometry combined with information from the Strongylocentrotus purpuratus genome sequence and the recently published E. chloroticus transcriptome database, enabled recombinant expression of wild type EBP and also of a cysteine61 to serine mutant that had improved solubility characteristics. Circular dichroism data and ab initio structure prediction suggests that the EBP adopts a 10-stranded beta-barrel fold consistent with that of fatty acid-binding proteins. Therefore, EBP may represent the first report of a fatty acid-binding protein in complex with a carotenoid.	[Pilbrow, Jodi; Carne, Alan] Univ Otago, Dept Biochem, Dunedin, New Zealand; [Sabherwal, Manya] Univ Otago, Dept Biochem, Ctr Prot Res, Dunedin, New Zealand; [Garama, Daniel] Monash Univ, Monash Inst Med Res, Prince Henrys Inst, Melbourne, Vic 3004, Australia	University of Otago; University of Otago; Monash University; Prince Henry's Institute of Medical Research	Pilbrow, J (corresponding author), Univ Otago, Dept Biochem, Dunedin, New Zealand.	jodi.pilbrow@otago.ac.nz; Daniel.garama@monash.edu.au	Carne, Alan/R-6260-2019; Brewster, Jodi/AAP-6952-2021	Brewster, Jodi/0000-0001-8569-1813; Carne, Alan/0000-0003-3665-1940	University of Otago, New Zealand	University of Otago, New Zealand	JP acknowledges the receipt of a Doctoral Scholarship from the University of Otago, New Zealand. http://www.otago.ac.nz/study/scholarships/database/otago014687.html. The funding body had no influence upon experimental design, data collection, analysis or reporting.	Akerstrom B, 2000, BBA-PROTEIN STRUCT M, V1482, P1, DOI 10.1016/S0167-4838(00)00137-0; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Andrew NL, 2002, OCEANOGR MAR BIOL, V40, P343; Apweiler R, 2013, NUCLEIC ACIDS RES, V41, pD43, DOI 10.1093/nar/gks1068; AVIRAM M, 1983, BIOCHEM MED METAB B, V30, P111, DOI 10.1016/0006-2944(83)90013-3; BANASZAK L, 1994, ADV PROTEIN CHEM, V45, P89; Bhosale P, 2004, J BIOL CHEM, V279, P49447, DOI 10.1074/jbc.M405334200; Billsten HH, 2003, PHOTOCHEM PHOTOBIOL, V78, P138, DOI 10.1562/0031-8655(2003)078<0138:PPOXIC>2.0.CO;2; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Borisovets EE, 2002, COMP BIOCHEM PHYS B, V132, P779, DOI 10.1016/S1096-4959(02)00099-4; Bornhorst JA, 2000, METHOD ENZYMOL, V326, P245; BRITTON G, 2006, CAROTENOIDS, V4; Cianci M, 2002, P NATL ACAD SCI USA, V99, P9795, DOI 10.1073/pnas.152088999; Cianci M, 2001, ACTA CRYSTALLOGR D, V57, P1219, DOI 10.1107/S0907444901009350; Davidson E, 2006, DEV BIOL, V300, P1, DOI 10.1016/j.ydbio.2006.10.036; de Marco A, 2009, MICROB CELL FACT, V8, DOI 10.1186/1475-2859-8-26; Dincer T, 2007, CRIT REV FOOD SCI, V47, P21, DOI 10.1080/10408390600550265; Edgar RC, 2004, BMC BIOINFORMATICS, V5, P1, DOI 10.1186/1471-2105-5-113; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; ENGLE JM, 1991, ARCH MICROBIOL, V155, P453, DOI 10.1007/BF00244961; Ernst SG, 2011, DEV BIOL, V358, P285, DOI 10.1016/j.ydbio.2011.06.021; Faraggi E, 2012, J COMPUT CHEM, V33, P259, DOI 10.1002/jcc.21968; FLOWER DR, 1993, FEBS LETT, V333, P99, DOI 10.1016/0014-5793(93)80382-5; FLOWER DR, 1993, PROTEIN SCI, V2, P753, DOI 10.1002/pro.5560020507; FLOWER DR, 1995, J MOL RECOGNIT, V8, P185, DOI 10.1002/jmr.300080304; Flower DR, 1996, BIOCHEM J, V318, P1; Flower DR, 2000, BBA-PROTEIN STRUCT M, V1482, P9, DOI 10.1016/S0167-4838(00)00148-5; FRANK HA, 1993, ANN NY ACAD SCI, V691, P1, DOI 10.1111/j.1749-6632.1993.tb26152.x; Gao Y, 2001, J BIOCHEM-TOKYO, V129, P179, DOI 10.1093/oxfordjournals.jbchem.a002830; Garama D, 2012, ACTA BIOCHIM POL, V59, P83; Giese AC, 1938, BIOL BULL-US, V75, P238, DOI 10.2307/1537731; Gillard GB, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-45; Goodwin TW, 1984, BIOCH CAROTENOIDS, VII; GRIFFITHS M, 1976, COMP BIOCHEM PHYS B, V55, P435, DOI 10.1016/0305-0491(76)90317-5; Grzyb J, 2006, J PLANT PHYSIOL, V163, P895, DOI 10.1016/j.jplph.2005.12.007; Guidice G, 1973, DEV BIOL SEA URCHIN; Hagen NT, 2008, AQUAT BIOL, V3, P227, DOI 10.3354/ab00084; Haunerland NH, 2004, PROG LIPID RES, V43, P328, DOI 10.1016/j.plipres.2004.05.001; HAVEL RJ, 1955, J CLIN INVEST, V34, P1345, DOI 10.1172/JCI103182; He Y, 2007, BIOCHEMISTRY-US, V46, P12543, DOI 10.1021/bi701092r; HOLLANDER D, 1978, AM J PHYSIOL, V235, pE686, DOI 10.1152/ajpendo.1978.235.6.E686; Johnson WC, 1999, PROTEINS, V35, P307, DOI 10.1002/(SICI)1097-0134(19990515)35:3<307::AID-PROT4>3.0.CO;2-3; Jones DT, 1999, J MOL BIOL, V292, P195, DOI 10.1006/jmbi.1999.3091; Jouni ZE, 1996, J BIOL CHEM, V271, P14722, DOI 10.1074/jbc.271.25.14722; Kane CD, 1996, BIOCHEMISTRY-US, V35, P2894, DOI 10.1021/bi952476e; Kelly SM, 2005, BBA-PROTEINS PROTEOM, V1751, P119, DOI 10.1016/j.bbapap.2005.06.005; KRINSKY NI, 1958, ARCH BIOCHEM BIOPHYS, V73, P233, DOI 10.1016/0003-9861(58)90259-5; Lamare MD, 2004, J EXP MAR BIOL ECOL, V312, P215, DOI 10.1016/j.jembe.2004.02.016; Lin K, 2005, BIOINFORMATICS, V21, P152, DOI 10.1093/bioinformatics/bth487; Liu HT, 2008, BMC BIOTECHNOL, V8, DOI 10.1186/1472-6750-8-91; McClay DR, 2011, DEVELOPMENT, V138, P2639, DOI 10.1242/dev.048967; McShane PE, 1996, NEW ZEAL J MAR FRESH, V30, P333; Miller SL, 2011, CHRACTERISATION NZ K; Moran NA, 2010, SCIENCE, V328, P624, DOI 10.1126/science.1187113; MULLER HN, 1993, J MOL BIOL, V230, P725, DOI 10.1006/jmbi.1993.1194; Nahon S, 2009, SCI TOTAL ENVIRON, V407, P1892, DOI 10.1016/j.scitotenv.2008.11.044; OKOH C, 1993, J NUTR BIOCHEM, V4, P569, DOI 10.1016/0955-2863(93)90025-R; Petersen B, 2009, BMC STRUCT BIOL, V9, DOI 10.1186/1472-6807-9-51; Plank LR, 2002, J WORLD AQUACULT SOC, V33, P127, DOI 10.1111/j.1749-7345.2002.tb00487.x; POWLS R, 1976, BIOCHIM BIOPHYS ACTA, V453, P270, DOI 10.1016/0005-2795(76)90273-7; PROVENCHER SW, 1981, BIOCHEMISTRY-US, V20, P33, DOI 10.1021/bi00504a006; Rao MN, 1997, J BIOL CHEM, V272, P24455, DOI 10.1074/jbc.272.39.24455; REDGRAVE TG, 1975, ANAL BIOCHEM, V65, P42, DOI 10.1016/0003-2697(75)90488-1; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Richardson J S, 1981, Adv Protein Chem, V34, P167, DOI 10.1016/S0065-3233(08)60520-3; Richieri GV, 1999, MOL CELL BIOCHEM, V192, P77, DOI 10.1023/A:1006826405151; Rost B, 1996, METHOD ENZYMOL, V266, P525; Schmidt AM, 1998, PROTEIN ENG, V11, P601, DOI 10.1093/protein/11.7.601; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; Shukolyukov SA, 2001, BIOCHEMISTRY-MOSCOW+, V66, P535, DOI 10.1023/A:1010263003330; Sodergren E, 2006, SCIENCE, V314, P941, DOI 10.1126/science.1133609; Sreerama N, 2000, ANAL BIOCHEM, V287, P243, DOI 10.1006/abio.2000.4879; Sreerama N, 2000, ANAL BIOCHEM, V287, P252, DOI 10.1006/abio.2000.4880; Sreerama N, 1999, PROTEIN SCI, V8, P370; SREERAMA N, 1993, ANAL BIOCHEM, V209, P32, DOI 10.1006/abio.1993.1079; Sreerama N, CDPRO; Storch J, 2008, ANNU REV NUTR, V28, P73, DOI 10.1146/annurev.nutr.27.061406.093710; Storch J, 2009, J LIPID RES, V50, pS126, DOI 10.1194/jlr.R800084-JLR200; Symonds RC, 2007, COMP BIOCHEM PHYS B, V148, P432, DOI 10.1016/j.cbpb.2007.07.012; Symonds RC, 2009, AQUACULTURE, V288, P120, DOI 10.1016/j.aquaculture.2008.11.018; Tabunoki H, 2002, J BIOL CHEM, V277, P32133, DOI 10.1074/jbc.M204507200; Tropea Joseph E., 2009, V498, P297, DOI 10.1007/978-1-59745-196-3_19; TSUSHIMA M, 1990, COMP BIOCHEM PHYS B, V96, P801, DOI 10.1016/0305-0491(90)90235-L; TSUSHIMA M, 1993, COMP BIOCHEM PHYS B, V106, P737, DOI 10.1016/0305-0491(93)90156-Y; Tsushima M, 1997, COMP BIOCHEM PHYS B, V118, P921, DOI 10.1016/S0305-0491(97)00302-7; Tu Q, 2012, GENOME RES, V22, P2079, DOI 10.1101/gr.139170.112; Whitaker R., 1997, Bulletin of the Aquaculture Association of Canada, P42; Williams H, 2002, SEA URCHIN FISHERIES; WILMOT CM, 1988, J MOL BIOL, V203, P221, DOI 10.1016/0022-2836(88)90103-9; Wilson A, 2006, PLANT CELL, V18, P992, DOI 10.1105/tpc.105.040121; Yemelyanov AY, 2001, EXP EYE RES, V72, P381, DOI 10.1006/exer.2000.0965	91	9	9	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2014	9	9							e106465	10.1371/journal.pone.0106465	http://dx.doi.org/10.1371/journal.pone.0106465			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ1IR	25192378	Green Published, gold, Green Submitted			2022-12-27	WOS:000347993600029
J	Wei, QQ; Xiao, X; Fogle, P; Dong, Z				Wei, Qingqing; Xiao, Xiao; Fogle, Paul; Dong, Zheng			Changes in Metabolic Profiles during Acute Kidney Injury and Recovery following Ischemia/Reperfusion	PLOS ONE			English	Article							REGULATES RENAL EXPRESSION; INDOXYL SULFATE; TUBULAR INJURY; 3-INDOXYL SULFATE; ISCHEMIA; SPHINGOSINE; ACTIVATION; CERAMIDE; RECEPTOR; NEPHROTOXICITY	Changes of metabolism have been implicated in renal ischemia/reperfusion injury (IRI). However, a global analysis of the metabolic changes in renal IRI is lacking and the association of the changes with ischemic kidney injury and subsequent recovery are unclear. In this study, mice were subjected to 25 minutes of bilateral renal IRI followed by 2 hours to 7 days of reperfusion. Kidney injury and subsequent recovery was verified by serum creatinine and blood urea nitrogen measurements. The metabolome of plasma, kidney cortex, and medulla were profiled by the newly developed global metabolomics analysis. Renal IRI induced overall changes of the metabolome in plasma and kidney tissues. The changes started in renal cortex, followed by medulla and plasma. In addition, we identified specific metabolites that may contribute to early renal injury response, perturbed energy metabolism, impaired purine metabolism, impacted osmotic regulation and the induction of inflammation. Some metabolites, such as 3-indoxyl sulfate, were induced at the earliest time point of renal IRI, suggesting the potential of being used as diagnostic biomarkers. There was a notable switch of energy source from glucose to lipids, implicating the importance of appropriate nutrition supply during treatment. In addition, we detected the depressed polyols for osmotic regulation which may contribute to the loss of kidney function. Several pathways involved in inflammation regulation were also induced. Finally, there was a late induction of prostaglandins, suggesting their possible involvement in kidney recovery. In conclusion, this study demonstrates significant changes of metabolome kidney tissues and plasma in renal IRI. The changes in specific metabolites are associated with and may contribute to early injury, shift of energy source, inflammation, and late phase kidney recovery.	[Wei, Qingqing; Xiao, Xiao; Dong, Zheng] Georgia Regents Univ, Med Coll Georgia, Dept Cellular Biol & Anat, Augusta, GA 30912 USA; [Wei, Qingqing; Xiao, Xiao; Dong, Zheng] Charlie Norwood VA Med Ctr, Augusta, GA USA; [Xiao, Xiao] Wuhan Univ, Wuhan 430072, Hubei, Peoples R China; [Fogle, Paul] Metabolon Inc, Durham, NC USA; [Dong, Zheng] Cent S Univ, Xiangya Hosp 2, Dept Nephrol, Changsha, Hunan, Peoples R China	University System of Georgia; Augusta University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Wuhan University; Metabolon; Central South University	Dong, Z (corresponding author), Georgia Regents Univ, Med Coll Georgia, Dept Cellular Biol & Anat, Augusta, GA 30912 USA.	zdong@gru.edu			National Natural Science Foundation of China [81370791]; National Basic Research Program of China 973 Program [2012CB517600, 2012CB517601]; American Heart Association; National Institutes of Health and Department of Veterans Administration of the USA; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK087843, R01DK058831] Funding Source: NIH RePORTER; Veterans Affairs [I01BX000319] Funding Source: NIH RePORTER	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China 973 Program(National Basic Research Program of China); American Heart Association(American Heart Association); National Institutes of Health and Department of Veterans Administration of the USA; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Veterans Affairs(US Department of Veterans Affairs)	The study was supported in part by grants from National Natural Science Foundation of China (81370791), National Basic Research Program of China 973 Program No. 2012CB517600 (No. 2012CB517601), American Heart Association, and the National Institutes of Health and Department of Veterans Administration of the USA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agatsuma S, 1996, CLIN NEPHROL, V45, P250; Atzori L, 2011, J MATERN-FETAL NEO M, V24, P41, DOI 10.3109/14767058.2011.606678; Bolati D, 2013, BMC NEPHROL, V14, DOI 10.1186/1471-2369-14-56; Bonventre JV, 2011, J CLIN INVEST, V121, P4210, DOI 10.1172/JCI45161; FITZPATRICK JM, 1981, BRIT J UROL, V53, P524, DOI 10.1111/j.1464-410X.1981.tb03253.x; Hanna MH, 2013, PEDIATR RES, V73, P585, DOI 10.1038/pr.2013.34; Hauet T, 2000, CLIN CHEM LAB MED, V38, P1093, DOI 10.1515/CCLM.2000.162; IWATA M, 1995, P NATL ACAD SCI USA, V92, P8970, DOI 10.1073/pnas.92.19.8970; Kelly KJ, 2003, J AM SOC NEPHROL, V14, P128, DOI 10.1097/01.ASN.0000040596.23073.01; Kinsey GR, 2013, J AM SOC NEPHROL, V24, P1720, DOI 10.1681/ASN.2013050502; Lau T, 2000, J CLIN INVEST, V105, P1217, DOI 10.1172/JCI7199; Lee HT, 2001, AM J KIDNEY DIS, V38, P610, DOI 10.1053/ajkd.2001.26888; Liu Y, 2012, KIDNEY BLOOD PRESS R, V35, P373, DOI 10.1159/000336171; Noto A, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/612032; OGATA F, 1981, CLIN EXP DIAL A, V5, P361, DOI 10.3109/08860228109076027; PALLER MS, 1992, KIDNEY INT, V42, P1345, DOI 10.1038/ki.1992.426; Park SW, 2010, SHOCK, V33, P31, DOI 10.1097/SHK.0b013e3181c02c1f; Portilla D, 2007, SEMIN NEPHROL, V27, P609, DOI 10.1016/j.semnephrol.2007.09.006; Saito S, 2014, ENDOCRINOLOGY, V155, P1899, DOI 10.1210/en.2013-1937; Schnackenberg LK, 2012, FOOD CHEM TOXICOL, V50, P3978, DOI 10.1016/j.fct.2012.08.010; Schulman G, 2012, J RENAL NUTR, V22, P107, DOI 10.1053/j.jrn.2011.10.035; Shimizu H, 2013, AM J NEPHROL, V37, P97, DOI 10.1159/000346420; Shimizu H, 2013, LIFE SCI, V92, P143, DOI 10.1016/j.lfs.2012.11.012; Sun JC, 2012, J CHROMATOGR B, V893, P107, DOI 10.1016/j.jchromb.2012.02.042; Uehara T., 2013, J APPL TOXICOL; VARY TC, 1979, CIRC RES, V45, P218, DOI 10.1161/01.RES.45.2.218; Wang J, 2011, TRANSPL P, V43, P3738, DOI 10.1016/j.transproceed.2011.08.109; Wei Q, 2013, KIDNEY INT, V84, P138, DOI 10.1038/ki.2013.68; Wei QQ, 2012, AM J PHYSIOL-RENAL, V303, pF1487, DOI 10.1152/ajprenal.00352.2012; Weiss RH, 2012, NAT REV NEPHROL, V8, P22, DOI 10.1038/nrneph.2011.152; Woodcock J, 2006, IUBMB LIFE, V58, P462, DOI 10.1080/15216540600871118; Wu VC, 2013, ANGIOGENESIS, V16, P609, DOI 10.1007/s10456-013-9339-8; Xie GX, 2010, J PROTEOME RES, V9, P125, DOI 10.1021/pr900333h; Yagihashi S, 2010, J PATHOL, V220, P530, DOI 10.1002/path.2671; Yisireyili M, 2013, LIFE SCI, V92, P1180, DOI 10.1016/j.lfs.2013.05.008; Zager RA, 1998, J AM SOC NEPHROL, V9, P1670; Zager RA, 1997, KIDNEY INT, V52, P60, DOI 10.1038/ki.1997.304; Zgoda-Pols JR, 2011, TOXICOL APPL PHARM, V255, P48, DOI 10.1016/j.taap.2011.05.015; Zhan M, 2013, KIDNEY INT, V83, P568, DOI 10.1038/ki.2012.441; Zhang A, 2013, INT UROL NEPHROL; Zhang D, 2014, J AM SOC NEPHROL	41	77	79	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2014	9	9							e106647	10.1371/journal.pone.0106647	http://dx.doi.org/10.1371/journal.pone.0106647			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ1IR	25191961	gold, Green Published, Green Submitted			2022-12-27	WOS:000347993600050
J	Curtis, JA; Flint, LE; Flint, AL; Lundquist, JD; Hudgens, B; Boydston, EE; Young, JK				Curtis, Jennifer A.; Flint, Lorraine E.; Flint, Alan L.; Lundquist, Jessica D.; Hudgens, Brian; Boydston, Erin E.; Young, Julie K.			Incorporating Cold-Air Pooling into Downscaled Climate Models Increases Potential Refugia for Snow-Dependent Species within the Sierra Nevada Ecoregion, CA	PLOS ONE			English	Article							MOUNTAIN SNOWPACK; CALIFORNIA; TEMPERATURE; WOLVERINE; ACCUMULATION; DISTRIBUTIONS; STREAMFLOW; BALANCE; TRENDS; ONSET	We present a unique water-balance approach for modeling snowpack under historic, current and future climates throughout the Sierra Nevada Ecoregion. Our methodology uses a finer scale (270 m) than previous regional studies and incorporates cold-air pooling, an atmospheric process that sustains cooler temperatures in topographic depressions thereby mitigating snowmelt. Our results are intended to support management and conservation of snow-dependent species, which requires characterization of suitable habitat under current and future climates. We use the wolverine (Gulo gulo) as an example species and investigate potential habitat based on the depth and extent of spring snowpack within four National Park units with proposed wolverine reintroduction programs. Our estimates of change in spring snowpack conditions under current and future climates are consistent with recent studies that generally predict declining snowpack. However, model development at a finer scale and incorporation of cold-air pooling increased the persistence of April 1st snowpack. More specifically, incorporation of cold-air pooling into future climate projections increased April 1st snowpack by 6.5% when spatially averaged over the study region and the trajectory of declining April 1st snowpack reverses at mid-elevations where snow pack losses are mitigated by topographic shading and cold-air pooling. Under future climates with sustained or increased precipitation, our results indicate a high likelihood for the persistence of late spring snowpack at elevations above approximately 2,800 m and identify potential climate refugia sites for snow-dependent species at mid-elevations, where significant topographic shading and cold-air pooling potential exist.	[Curtis, Jennifer A.] US Geol Survey, Calif Water Sci Ctr, Eureka, CA 95501 USA; [Flint, Lorraine E.] US Geol Survey, Calif Water Sci Ctr, Sacramento, CA USA; [Flint, Alan L.] US Geol Survey, Calif Water Sci Ctr, Placer Hall, CA USA; [Lundquist, Jessica D.] Univ Washington, Dept Civil & Environm Engn, Seattle, WA 98195 USA; [Hudgens, Brian] Inst Wildlife Studies, Arcata, CA USA; [Boydston, Erin E.] US Geol Survey, Western Ecol Res Ctr, Thousand Oaks, CA USA; [Young, Julie K.] Wildlife Serv, USDA, Natl Wildlife Res Ctr, Logan, UT USA; [Young, Julie K.] Utah State Univ, Wildland Resources Dept, Logan, UT 84322 USA	United States Department of the Interior; United States Geological Survey; United States Department of the Interior; United States Geological Survey; United States Department of the Interior; United States Geological Survey; University of Washington; University of Washington Seattle; United States Department of the Interior; United States Geological Survey; United States Department of Agriculture (USDA); Utah System of Higher Education; Utah State University	Curtis, JA (corresponding author), US Geol Survey, Calif Water Sci Ctr, Eureka, CA 95501 USA.	jacurtis@usgs.gov		Young, Julie/0000-0003-4522-0157; Curtis, Jennifer/0000-0001-7766-994X	Park Oriented Biologic Support; National Park Service; United States Geological Survey	Park Oriented Biologic Support; National Park Service; United States Geological Survey(United States Geological Survey)	Funding provided by Park Oriented Biologic Support, a program funded jointly by the National Park Service and United States Geological Survey. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackerly DD, 2010, DIVERS DISTRIB, V16, P476, DOI 10.1111/j.1472-4642.2010.00654.x; Anderson E.A., 1973, NATL WEATHER SERVICE; Anderson E.A, 1976, 19 NOAA US DEP COMM; Anderson RS, 2006, J GEOPHYS RES-EARTH, V111, DOI 10.1029/2005JF000344; Andrews E.D., 2012, NPSSIENNRR2012500; Aubry KB, 2007, J WILDLIFE MANAGE, V71, P2147, DOI 10.2193/2006-548; BARR S, 1989, J APPL METEOROL, V28, P497, DOI 10.1175/1520-0450(1989)028<0497:IOEMON>2.0.CO;2; Blennow K, 1998, AGR FOREST METEOROL, V91, P223, DOI 10.1016/S0168-1923(98)00069-0; Cayan Dan, 2006, CLIMATE SCENARIOS CA; Cayan DR, 2008, CLIMATIC CHANGE, V87, pS21, DOI 10.1007/s10584-007-9377-6; Cayan DR, 2001, B AM METEOROL SOC, V82, P399, DOI 10.1175/1520-0477(2001)082<0399:CITOOS>2.3.CO;2; Chung U, 2006, AGR FOREST METEOROL, V137, P15, DOI 10.1016/j.agrformet.2005.12.011; Copeland JP, 2010, CAN J ZOOL, V88, P233, DOI 10.1139/Z09-136; Daly C, 2008, INT J CLIMATOL, V28, P2031, DOI 10.1002/joc.1688; Daly C, 2010, INT J CLIMATOL, V30, P1857, DOI 10.1002/joc.2007; Delworth TL, 2006, J CLIMATE, V19, P643, DOI 10.1175/JCLI3629.1; Dettinger MD, 2004, CLIMATIC CHANGE, V62, P283, DOI 10.1023/B:CLIM.0000013683.13346.4f; Flint L.E., 2013, ECOL PROCESS, V2, P1, DOI [DOI 10.1186/2192-1709-2-25, 10.1186/2192-1709-2-25]; Flint L.E., 2012, 20125132 US GEOL SUR; Flint R.F., 1957, GLACIAL PLEISTOCENE; Garcelon DK, 2009, FEASIBILITY ASSESSME; Garen DC, 2005, J HYDROL, V315, P126, DOI 10.1016/j.jhydrol.2005.03.026; Gillespie AR, 2004, DEV QUA SCI, V2, P51, DOI 10.1016/S1571-0866(04)80185-4; Grinnell J., 1937, FUR BEARING MAMMALS; Gustavsson T, 1998, J APPL METEOROL, V37, P559, DOI 10.1175/1520-0450(1998)037<0559:DOTPDC>2.0.CO;2; Halley V, 2003, AUST GEOGR STUD, V41, P287, DOI 10.1046/j.1467-8470.2003.00235.x; Hidalgo H. G., 2008, CEC5002007123; Howat IM, 2005, ANN GLACIOL-SER, V40, P151, DOI 10.3189/172756405781813816; Hunsaker CT, 2012, J AM WATER RESOUR AS, V48, P667, DOI 10.1111/j.1752-1688.2012.00641.x; Inman RM, 2007, GREATER YELLOWSTONE, P55; Knowles N, 2002, GEOPHYS RES LETT, V29, DOI 10.1029/2001GL014339; Lindkvist L, 2000, AGR FOREST METEOROL, V102, P51, DOI 10.1016/S0168-1923(99)00087-8; Lundquist JD, 2006, J HYDROMETEOROL, V7, P1199, DOI 10.1175/JHM539.1; Lundquist JD, 2008, J GEOPHYS RES-ATMOS, V113, DOI 10.1029/2008JD009879; MacGregor KR, 2000, GEOLOGY, V28, P1031, DOI 10.1130/0091-7613(2000)28<1031:NSOGLP>2.0.CO;2; Magoun AJ, 1998, J WILDLIFE MANAGE, V62, P1313, DOI 10.2307/3801996; Marvin, 1914, MONTHLY WEATHER REV, V42, P583, DOI [10.1175/1520-0493(1914)42%3c583:ADE%3-2.0.CO;2, DOI 10.1175/1520-0493(1914)42<583:ADE>2.0.C0;2]; McKelvey KS, 2011, ECOL APPL, V21, P2882, DOI 10.1890/10-2206.1; Meehl GA, 2003, J CLIMATE, V16, P426, DOI [10.1175/1520-0442(2003)016<0426:SAGGFA>2.0.CO;2, 10.1175/1520-0442(2003)016&lt;0426:SAGGFA&gt;2.0.CO;2]; Mills LS, 2013, P NATL ACAD SCI USA, V110, P7360, DOI 10.1073/pnas.1222724110; Moriarty KM, 2009, NORTHWEST SCI, V83, P154, DOI 10.3955/046.083.0207; Mote PW, 2006, J CLIMATE, V19, P6209, DOI 10.1175/JCLI3971.1; Mote PW, 2005, B AM METEOROL SOC, V86, P39, DOI 10.1175/BAMS-86-1-39; NEFF WD, 1989, J APPL METEOROL, V28, P518, DOI 10.1175/1520-0450(1989)028<0518:TAAPOD>2.0.CO;2; Ohmura A, 1996, J CLIMATE, V9, P2124, DOI 10.1175/1520-0442(1996)009<2124:APCIMB>2.0.CO;2; Peacock S, 2011, ENVIRON RES LETT, V6, DOI 10.1088/1748-9326/6/1/014007; Penck A, 1905, J GEOL, V13, P1, DOI 10.1086/621202; Pepin NC, 2011, J GEOPHYS RES-ATMOS, V116, DOI 10.1029/2010JD014769; Powell R.A., 2003, WILD MAMMALS N AM, P635; Raleigh MS, 2012, WATER RESOUR RES, V48, DOI 10.1029/2011WR010542; Rice R, 2011, WATER RESOUR RES, V47, DOI 10.1029/2010WR009278; Schwartz MK, 2007, J WILDLIFE MANAGE, V71, P2170, DOI 10.2193/2007-026; Shamir E, 2006, ADV WATER RESOUR, V29, P558, DOI 10.1016/j.advwatres.2005.06.010; Solomon S, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P1; Stewart IT, 2005, J CLIMATE, V18, P1136, DOI 10.1175/JCLI3321.1; Stocker TF, 2014, CLIMATE CHANGE 2013: THE PHYSICAL SCIENCE BASIS, P1, DOI 10.1017/cbo9781107415324; Stouffer RJ, 2006, J CLIMATE, V19, P723, DOI 10.1175/JCLI3632.1; Sugden D. E., 1976, GLACIERS LANDSCAPE G; Warhaftig C., 1965, QUATERNARY US, P299; Washington WM, 2000, CLIM DYNAM, V16, P755, DOI 10.1007/s003820000079; Whiteman CD, 1999, J APPL METEOROL, V38, P1103, DOI 10.1175/1520-0450(1999)038<1103:WEOTTI>2.0.CO;2; Wilson D.E., 1982, P644; Young CA, 2009, J AM WATER RESOUR AS, V45, P1409, DOI 10.1111/j.1752-1688.2009.00375.x; Zielinski WJ, 2005, J BIOGEOGR, V32, P1385, DOI 10.1111/j.1365-2699.2005.01234.x; [No title captured]	65	34	34	1	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 4	2014	9	9							e106984	10.1371/journal.pone.0106984	http://dx.doi.org/10.1371/journal.pone.0106984			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3XV	25188379	Green Published, gold			2022-12-27	WOS:000341271500103
J	Garcia-Cerro, S; Martinez, P; Vidal, V; Corrales, A; Florez, J; Vidal, R; Rueda, N; Arbones, ML; Martinez-Cue, C				Garcia-Cerro, Susana; Martinez, Paula; Vidal, Veronica; Corrales, Andrea; Florez, Jesus; Vidal, Rebeca; Rueda, Noemi; Arbones, Maria L.; Martinez-Cue, Carmen			Overexpression of Dyrk1A Is Implicated in Several Cognitive, Electrophysiological and Neuromorphological Alterations Found in a Mouse Model of Down Syndrome	PLOS ONE			English	Article							ADULT HIPPOCAMPAL NEUROGENESIS; TS65DN MOUSE; SYNAPTIC PLASTICITY; NEURONAL DIFFERENTIATION; INHIBITS PROLIFERATION; WORKING-MEMORY; CELL-SURVIVAL; MURINE MODEL; WATER-MAZE; EXPRESSION	Down syndrome (DS) phenotypes result from the overexpression of several dosage-sensitive genes. The DYRK1A (dual-specificity tyrosine-(Y)-phosphorylation regulated kinase 1A) gene, which has been implicated in the behavioral and neuronal alterations that are characteristic of DS, plays a role in neuronal progenitor proliferation, neuronal differentiation and long-term potentiation (LTP) mechanisms that contribute to the cognitive deficits found in DS. The purpose of this study was to evaluate the effect of Dyrk1A overexpression on the behavioral and cognitive alterations in the Ts65Dn (TS) mouse model, which is the most commonly utilized mouse model of DS, as well as on several neuromorphological and electrophysiological properties proposed to underlie these deficits. In this study, we analyzed the phenotypic differences in the progeny obtained from crosses of TS females and heterozygous Dyrk1A (+/-) male mice. Our results revealed that normalization of the Dyrk1A copy number in TS mice improved working and reference memory based on the Morris water maze and contextual conditioning based on the fear conditioning test and rescued hippocampal LTP. Concomitant with these functional improvements, normalization of the Dyrk1A expression level in TS mice restored the proliferation and differentiation of hippocampal cells in the adult dentate gyrus (DG) and the density of GABAergic and glutamatergic synapse markers in the molecular layer of the hippocampus. However, normalization of the Dyrk1A gene dosage did not affect other structural (e.g., the density of mature hippocampal granule cells, the DG volume and the subgranular zone area) or behavioral (i.e., hyperactivity/attention) alterations found in the TS mouse. These results suggest that Dyrk1A overexpression is involved in some of the cognitive, electrophysiological and neuromorphological alterations, but not in the structural alterations found in DS, and suggest that pharmacological strategies targeting this gene may improve the treatment of DS-associated learning disabilities.	[Garcia-Cerro, Susana; Martinez, Paula; Vidal, Veronica; Corrales, Andrea; Florez, Jesus; Vidal, Rebeca; Rueda, Noemi; Martinez-Cue, Carmen] Univ Cantabria, Fac Med, Dept Physiol & Pharmacol, E-39005 Santander, Spain; [Vidal, Rebeca] Univ Cantabria, CSIC, Inst Biomed & Biotechnol IBBITEC, E-39005 Santander, Spain; [Vidal, Rebeca] Invest Desarrollo & Invest Cantabria IDICAN, Santander, Spain; [Vidal, Rebeca] Inst Salud Carlos III, Ctr Invest Biomed Red Salud Mental CIBERSAM, Madrid, Spain; [Arbones, Maria L.] CSIC, Barcelona Inst Mol Biol, Barcelona, Spain; [Arbones, Maria L.] Ctr Invest Biomed Red Enfermedades Raras CIBERER, Barcelona, Spain	Universidad de Cantabria; Consejo Superior de Investigaciones Cientificas (CSIC); Universidad de Cantabria; CSIC - Instituto de Biomedicina y Biotecnologia de Cantabria (IBBTEC); CIBER - Centro de Investigacion Biomedica en Red; CIBERSAM; Instituto de Salud Carlos III; Consejo Superior de Investigaciones Cientificas (CSIC); CIBER - Centro de Investigacion Biomedica en Red; CIBERER	Martinez-Cue, C (corresponding author), Univ Cantabria, Fac Med, Dept Physiol & Pharmacol, E-39005 Santander, Spain.	martinec@unican.es	García-Cerro, Susana/ABC-9675-2021; Arbones, Maria/D-4668-2016; Cue, Carmen Martinez/AAA-2850-2019; Vidal, Rebeca/AAN-7295-2020	García-Cerro, Susana/0000-0002-6091-2824; Arbones, Maria/0000-0002-6035-0235; Martinez-Cue, Carmen/0000-0002-2137-1156; Vidal, Rebeca/0000-0002-3339-5681; /0000-0002-1512-2671	Jerome Lejeune Foundation; Spanish Ministry of Economy and Competitiveness [PSI2012-33652, SAF2010-17004]	Jerome Lejeune Foundation; Spanish Ministry of Economy and Competitiveness(Spanish Government)	This work was supported by grants from the Jerome Lejeune Foundation (www.fondationlejeune.org/en/) and the Spanish Ministry of Economy and Competitiveness (www.mineco.gob.es/) ( Grant numbers: PSI2012-33652 and SAF2010-17004). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn KJ, 2006, NEUROBIOL DIS, V22, P463, DOI 10.1016/j.nbd.2005.12.006; Altafaj X, 2001, HUM MOL GENET, V10, P1915, DOI 10.1093/hmg/10.18.1915; Altafaj X, 2013, NEUROBIOL DIS, V52, P117, DOI 10.1016/j.nbd.2012.11.017; Anagnostaras SG, 2001, HIPPOCAMPUS, V11, P8; Bartesaghi R, 2011, REV NEUROSCIENCE, V22, P419, DOI 10.1515/RNS.2011.037; Baxter LL, 2000, HUM MOL GENET, V9, P195, DOI 10.1093/hmg/9.2.195; Becker W, 2011, FEBS J, V278, P246, DOI 10.1111/j.1742-4658.2010.07956.x; Belichenko PV, 2009, J COMP NEUROL, V512, P453, DOI 10.1002/cne.21895; Bianchi P, 2010, J NEUROSCI, V30, P8769, DOI 10.1523/JNEUROSCI.0534-10.2010; Biedenkapp JC, 2009, LEARN MEMORY, V16, P38, DOI 10.1101/lm.1099109; Bortone D, 2009, NEURON, V62, P53, DOI 10.1016/j.neuron.2009.01.034; BOWES C, 1993, P NATL ACAD SCI USA, V90, P2955, DOI 10.1073/pnas.90.7.2955; Branchi I, 2004, J NEUROPATH EXP NEUR, V63, P429, DOI 10.1093/jnen/63.5.429; Braudeau J, 2011, J PSYCHOPHARMACOL, V25, P1030, DOI 10.1177/0269881111405366; CAMPEAU S, 1995, J NEUROSCI, V15, P2312, DOI 10.1523/JNEUROSCI.15-03-02312.1995; Chakrabarti L, 2010, NAT NEUROSCI, V13, P927, DOI 10.1038/nn.2600; Chen GQ, 2000, NATURE, V408, P975, DOI 10.1038/35050103; Colas D, 2013, BRIT J PHARMACOL, V169, P963, DOI 10.1111/bph.12169; Contestabile A, 2013, J CLIN INVEST, V123, P348, DOI 10.1172/JCI64650; Costa ACS, 1999, PHYSIOL BEHAV, V68, P211, DOI 10.1016/S0031-9384(99)00178-X; Crnic LS, 2000, PROGRESS INFANCY RES, V1, P69; De la Torre R, 2014, MOL NUTR FOOD RES, V58, P278, DOI 10.1002/mnfr.201300325; Duchon A, 2011, MAMM GENOME, V22, P674, DOI 10.1007/s00335-011-9356-0; Earnheart JC, 2007, J NEUROSCI, V27, P3845, DOI 10.1523/JNEUROSCI.3609-06.2007; ESCORIHUELA RM, 1995, NEUROSCI LETT, V199, P143, DOI 10.1016/0304-3940(95)12052-6; Fernandez F, 2007, NAT NEUROSCI, V10, P411, DOI 10.1038/nn1860; Fotaki V, 2002, MOL CELL BIOL, V22, P6636, DOI 10.1128/MCB.22.18.6636-6647.2002; Garthe A, 2013, FRONT NEUROSCI-SWITZ, V7, DOI 10.3389/fnins.2013.00063; Ge SY, 2006, NATURE, V439, P589, DOI 10.1038/nature04404; Goldman-Rakic PS, 1999, BIOL PSYCHIAT, V46, P650, DOI 10.1016/S0006-3223(99)00130-4; Goosens KA, 2001, LEARN MEMORY, V8, P148, DOI 10.1101/lm.37601; Goto Y, 2010, BIOL PSYCHIAT, V67, P199, DOI 10.1016/j.biopsych.2009.08.026; Guedj F, 2009, PLOS ONE, V4, P1; Guedj F, 2012, NEUROBIOL DIS, V46, P190, DOI 10.1016/j.nbd.2012.01.007; Guo XM, 2010, J BIOL CHEM, V285, P13223, DOI 10.1074/jbc.M110.102574; Hibaoui Y, 2014, EMBO MOL MED, V6, P259, DOI 10.1002/emmm.201302848; Imayoshi I, 2008, NAT NEUROSCI, V11, P1153, DOI 10.1038/nn.2185; Kholodar-Smith DB, 2008, BEHAV NEUROSCI, V122, P1178, DOI 10.1037/a0012902; Kleschevnikov AM, 2004, J NEUROSCI, V24, P8153, DOI 10.1523/JNEUROSCI.1766-04.2004; Laguna A, 2013, HUM MOL GENET, V22, P2775, DOI 10.1093/hmg/ddt125; Laguna A, 2008, DEV CELL, V15, P841, DOI 10.1016/j.devcel.2008.10.014; Liu DP, 2003, BIOTECHNIQUES, V35, P1170, DOI 10.2144/03356st02; Llorens-Martin M, 2006, HIPPOCAMPUS, V16, P480, DOI 10.1002/hipo.20175; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Martinez-Cue C, 2006, GENES BRAIN BEHAV, V5, P413, DOI 10.1111/j.1601-183X.2005.00175.x; Martinez-Cue C, 2014, NEUROSCI BI IN PRESS, DOI [10.1016/jneurobiorev.2013.12.008, DOI 10.1016/JNEUROBIOREV.2013.12.008]; Martinez-Cue C, 2013, J NEUROSCI, V33, P3953, DOI 10.1523/JNEUROSCI.1203-12.2013; McKay SM, 2006, INFANT BEHAV DEV, V29, P153, DOI 10.1016/j.infbeh.2005.09.004; MORRIS R, 1984, J NEUROSCI METH, V11, P47, DOI 10.1016/0165-0270(84)90007-4; Nishizawa Y, 2006, PEDIATR INT, V48, P484, DOI 10.1111/j.1442-200X.2006.02258.x; OLTON DS, 1979, NEUROPSYCHOLOGIA, V17, P669, DOI 10.1016/0028-3932(79)90042-3; Ortiz-Abalia J, 2008, AM J HUM GENET, V83, P479, DOI 10.1016/j.ajhg.2008.09.010; Park J, 2010, J BIOL CHEM, V285, P31895, DOI 10.1074/jbc.M110.147520; Pereira K, 2013, RES DEV DISABIL, V34, P894, DOI 10.1016/j.ridd.2012.11.021; Perez-Cremades D, 2010, J NEURAL TRANSM, V117, P445, DOI 10.1007/s00702-010-0376-9; Perez-Domper P, 2013, AGEING RES REV, V12, P777, DOI 10.1016/j.arr.2013.06.001; Rueda N, 2013, APOPTOSIS, V18, P121, DOI 10.1007/s10495-012-0785-3; Rueda N, 2012, NEURAL PLAST, V2012, DOI 10.1155/2012/584071; Rueda N, 2011, INT J DEV NEUROSCI, V29, P711, DOI 10.1016/j.ijdevneu.2011.06.001; Saab BJ, 2011, J NEUROSCI METH, V198, P44, DOI 10.1016/j.jneumeth.2011.03.008; Sacchetti B, 2002, P NATL ACAD SCI USA, V99, P8406, DOI 10.1073/pnas.112660399; Salehi A, 2009, SCI TRANSL MED, V1, DOI 10.1126/scitranslmed.3000258; Savonenko A, 2005, NEUROBIOL DIS, V18, P602, DOI 10.1016/j.nbd.2004.10.022; Schebesta M, 2009, DEV DYNAM, V238, P887, DOI 10.1002/dvdy.21909; Seamans JK, 1995, BEHAV NEUROSCI, V109, P1063, DOI 10.1037/0735-7044.109.6.1063; Sebrie C, 2008, ANAT REC, V291, P254, DOI 10.1002/ar.20640; Shors TJ, 2002, HIPPOCAMPUS, V12, P578, DOI 10.1002/hipo.10103; Shors TJ, 2001, NATURE, V410, P372, DOI 10.1038/35066584; Smith DJ, 1997, NAT GENET, V16, P28, DOI 10.1038/ng0597-28; Souchet B, 2014, NEUROBIOL DIS, V69, P65, DOI 10.1016/j.nbd.2014.04.016; Steele RJ, 1999, HIPPOCAMPUS, V9, P118, DOI 10.1002/(SICI)1098-1063(1999)9:2<118::AID-HIPO4>3.0.CO;2-8; Sturgeon X, 2011, MAMM GENOME, V22, P261, DOI 10.1007/s00335-011-9321-y; Tejedor FJ, 2011, FEBS J, V278, P223, DOI 10.1111/j.1742-4658.2010.07954.x; Thomazeau A, 2014, J NEUROSCI, V34, P1138, DOI 10.1523/JNEUROSCI.2852-13.2014; Tiso N, 2009, J COMP NEUROL, V515, P378, DOI 10.1002/cne.22054; Tozuka Y, 2005, NEURON, V47, P803, DOI 10.1016/j.neuron.2005.08.023; Wang GW, 2006, BEHAV BRAIN RES, V175, P329, DOI 10.1016/j.bbr.2006.09.002; Xie W, 2008, NEUROCHEM RES, V33, P776, DOI 10.1007/s11064-007-9494-7; Yabut O, 2010, J NEUROSCI, V30, P4004, DOI 10.1523/JNEUROSCI.4711-09.2010	79	61	61	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 4	2014	9	9							e106572	10.1371/journal.pone.0106572	http://dx.doi.org/10.1371/journal.pone.0106572			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3XV	25188425	Green Published, Green Submitted, gold			2022-12-27	WOS:000341271500055
J	Mei, SC; Brenner, C				Mei, Szu-Chieh; Brenner, Charles			Quantification of Protein Copy Number in Yeast: The NAD(+) Metabolome	PLOS ONE			English	Article							LIFE-SPAN EXTENSION; SACCHAROMYCES-CEREVISIAE; CALORIE RESTRICTION; NICOTINAMIDE RIBOSIDE; DIPHOSPHOPYRIDINE NUCLEOTIDE; DIFFERENT MECHANISMS; DAMAGED PROTEINS; RHESUS-MONKEYS; SIR2; LONGEVITY	Saccharomyces cerevisiae is calorie-restricted by lowering glucose from 2% to 0.5%. Under low glucose conditions, replicative lifespan is extended in a manner that depends on the NAD(+)-dependent protein lysine deacetylase Sir2 and NAD(+) salvage enzymes. Because NAD(+) is required for glucose utilization and Sir2 function, it was postulated that glucose levels alter the levels of NAD(+) metabolites that tune Sir2 function. Though NAD(+) precursor vitamins, which increase the levels of all NAD(+) metabolites, can extend yeast replicative lifespan, glucose restriction does not significantly change the levels or ratios of intracellular NAD(+) metabolites. To test whether glucose restriction affects protein copy numbers, we developed a technology that combines the measurement of Urh1 specific activity and quantification of relative expression between Urh1 and any other protein. The technology was applied to obtain the protein copy numbers of enzymes involved in NAD(+) metabolism in rich and synthetic yeast media. Our data indicated that Sir2 and Pnc1, two enzymes that sequentially convert NAD(+) to nicotinamide and then to nicotinic acid, are up-regulated by glucose restriction in rich media, and that Pnc1 alone is up-regulated in synthetic media while levels of all other enzymes are unchanged. These data suggest that production or export of nicotinic acid might be a connection between NAD(+) and calorie restriction-mediated lifespan extension in yeast.	[Mei, Szu-Chieh; Brenner, Charles] Univ Iowa, Carver Coll Med, Dept Biochem, Iowa City, IA 52242 USA	University of Iowa	Brenner, C (corresponding author), Univ Iowa, Carver Coll Med, Dept Biochem, Iowa City, IA 52242 USA.	charles-brenner@uiowa.edu	Brenner, Charles/D-6339-2014	Brenner, Charles/0000-0002-4955-3226	National Science Foundation [MCB1322118]; Div Of Molecular and Cellular Bioscience [1322118] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); Div Of Molecular and Cellular Bioscience(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	Work was supported by grant MCB1322118 from the National Science Foundation to CB. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilaniu H, 2003, SCIENCE, V299, P1751, DOI 10.1126/science.1080418; Anderson RM, 2003, SCIENCE, V302, P2124, DOI 10.1126/science.1088697; Anderson RM, 2003, NATURE, V423, P181, DOI 10.1038/nature01578; Anderson RM, 2002, J BIOL CHEM, V277, P18881, DOI 10.1074/jbc.M111773200; Belenky P, 2007, TRENDS BIOCHEM SCI, V32, P12, DOI 10.1016/j.tibs.2006.11.006; Belenky P, 2007, CELL, V129, P473, DOI 10.1016/j.cell.2007.03.024; Belenky P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019710; Belenky P, 2009, J BIOL CHEM, V284, P158, DOI 10.1074/jbc.M807976200; Bieganowski P, 2004, CELL, V117, P495, DOI 10.1016/S0092-8674(04)00416-7; Bieganowski P, 2003, J BIOL CHEM, V278, P33049, DOI 10.1074/jbc.M302257200; Bieganowski P, 2006, J BIOL CHEM, V281, P22439, DOI 10.1074/jbc.M513919200; Bogan KL, 2009, J BIOL CHEM, V284, P34861, DOI 10.1074/jbc.M109.056689; Colman RJ, 2009, SCIENCE, V325, P201, DOI 10.1126/science.1173635; Dang WW, 2009, NATURE, V459, P802, DOI 10.1038/nature08085; Erjavec N, 2007, GENE DEV, V21, P2410, DOI 10.1101/gad.439307; Erjavec N, 2007, P NATL ACAD SCI USA, V104, P10877, DOI 10.1073/pnas.0701634104; Evans Charles, 2010, BMC Chemical Biology, V10, P2, DOI 10.1186/1472-6769-10-2; Fontana L, 2010, SCIENCE, V328, P321, DOI 10.1126/science.1172539; Ghislain M, 2002, YEAST, V19, P215, DOI 10.1002/yea.810; Imai S, 2000, NATURE, V403, P795, DOI 10.1038/35001622; Jiang JC, 2000, FASEB J, V14, P2135; Jiang JC, 2002, EXP GERONTOL, V37, P1023, DOI 10.1016/S0531-5565(02)00064-5; Kaeberlein M, 1999, GENE DEV, V13, P2570, DOI 10.1101/gad.13.19.2570; Koubova J, 2003, GENE DEV, V17, P313, DOI 10.1101/gad.1052903; Lamming DW, 2005, SCIENCE, V309, P1861, DOI 10.1126/science.1113611; Lin SJ, 2004, GENE DEV, V18, P12, DOI 10.1101/gad.1164804; Lin SJ, 2000, SCIENCE, V289, P2126, DOI 10.1126/science.289.5487.2126; Lin SJ, 2002, NATURE, V418, P344, DOI 10.1038/nature00829; Mattison JA, 2012, NATURE, V489, P318, DOI 10.1038/nature11432; Medvedik O, 2007, PLOS BIOL, V5, P2330, DOI 10.1371/journal.pbio.0050261; Michel AH, 2005, GENE DEV, V19, P1199, DOI 10.1101/gad.340205; PREISS J, 1958, J BIOL CHEM, V233, P488; PREISS J, 1958, J BIOL CHEM, V233, P493; Schmidt MT, 2004, J BIOL CHEM, V279, P40122, DOI 10.1074/jbc.M407484200; Sherman F, 2002, METHOD ENZYMOL, V350, P3, DOI 10.1016/S0076-6879(02)50954-X; Smith JS, 2000, P NATL ACAD SCI USA, V97, P6658, DOI 10.1073/pnas.97.12.6658; Tempel W, 2007, PLOS BIOL, V5, P2220, DOI 10.1371/journal.pbio.0050263; Trammell SAJ, 2013, COMPUT STRUCT BIOTEC, V4, DOI 10.5936/csbj.201301012; Winzeler EA, 1999, SCIENCE, V285, P901, DOI 10.1126/science.285.5429.901; Wojcik M, 2006, J BIOL CHEM, V281, P33395, DOI 10.1074/jbc.M607111200	40	10	10	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 4	2014	9	9							e106496	10.1371/journal.pone.0106496	http://dx.doi.org/10.1371/journal.pone.0106496			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3XV	25188219	Green Submitted, Green Published, gold			2022-12-27	WOS:000341271500044
J	Ode, A; Duda, GN; Geissler, S; Pauly, S; Ode, JE; Perka, C; Strube, P				Ode, Andrea; Duda, Georg N.; Geissler, Sven; Pauly, Stephan; Ode, Jan-Erik; Perka, Carsten; Strube, Patrick			Interaction of Age and Mechanical Stability on Bone Defect Healing: An Early Transcriptional Analysis of Fracture Hematoma in Rat	PLOS ONE			English	Article							GENE-EXPRESSION; MATRIX METALLOPROTEINASES; MOLECULAR ASPECTS; CELL; PATHOPHYSIOLOGY; ANGIOGENESIS	Among other stressors, age and mechanical constraints significantly influence regeneration cascades in bone healing. Here, our aim was to identify genes and, through their functional annotation, related biological processes that are influenced by an interaction between the effects of mechanical fixation stability and age. Therefore, at day three post-osteotomy, chip-based whole-genome gene expression analyses of fracture hematoma tissue were performed for four groups of Sprague-Dawley rats with a 1.5-mm osteotomy gap in the femora with varying age (12 vs. 52 weeks - biologically challenging) and external fixator stiffness (mechanically challenging). From 31099 analysed genes, 1103 genes were differentially expressed between the six possible combinations of the four groups and from those 144 genes were identified as statistically significantly influenced by the interaction between age and fixation stability. Functional annotation of these differentially expressed genes revealed an association with extracellular space, cell migration or vasculature development. The chip-based whole-genome gene expression data was validated by q-RT-PCR at days three and seven post-osteotomy for MMP-9 and MMP-13, members of the mechanosensitive matrix metalloproteinase family and key players in cell migration and angiogenesis. Furthermore, we observed an interaction of age and mechanical stimuli in vitro on cell migration of mesenchymal stromal cells. These cells are a subpopulation of the fracture hematoma and are known to be key players in bone regeneration. In summary, these data correspond to and might explain our previously described biomechanical healing outcome after six weeks in response to fixation stiffness variation. In conclusion, our data highlight the importance of analysing the influence of risk factors of fracture healing (e.g. advanced age, suboptimal fixator stability) in combination rather than alone.	[Ode, Andrea; Duda, Georg N.; Geissler, Sven; Pauly, Stephan; Ode, Jan-Erik; Perka, Carsten; Strube, Patrick] Charite, Julius Wolff Inst, D-13353 Berlin, Germany; [Ode, Andrea; Duda, Georg N.; Geissler, Sven; Perka, Carsten] Berlin Brandenburg Ctr Regenerat Therapies, Berlin, Germany; [Duda, Georg N.; Pauly, Stephan; Perka, Carsten; Strube, Patrick] Charite, Ctr Muskuloskeletale Chirurg, Klin Orthopadie, D-13353 Berlin, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Duda, GN (corresponding author), Charite, Julius Wolff Inst, D-13353 Berlin, Germany.	Georg.Duda@charite.de	Perka, Carsten/ABG-6505-2021; Strube, Patrick/AAH-5408-2019; Ode, Andrea/B-6805-2015; Geißler, Sven/J-7275-2013; Duda, Georg N/H-2085-2016	Strube, Patrick/0000-0003-3210-5301; Geißler, Sven/0000-0002-8750-6324; Duda, Georg N/0000-0001-7605-3908; Ode, Jan-Erik/0000-0002-8762-5796; Perka, Carsten/0000-0002-0993-581X	Federal Ministry of Education and Research (BMBF) [0315848A]; Berlin-Brandenburg Center for Regenerative Therapies; German Research Foundation [DFG SFB 760]	Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); Berlin-Brandenburg Center for Regenerative Therapies; German Research Foundation(German Research Foundation (DFG))	This study was supported partly by the Federal Ministry of Education and Research (BMBF, Grant 0315848A) excellence cluster, Berlin-Brandenburg Center for Regenerative Therapies, and partly by the German Research Foundation (DFG SFB 760). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barnes GL, 1999, J BONE MINER RES, V14, P1805, DOI 10.1359/jbmr.1999.14.11.1805; Bloomfield SA, 2002, CLIN ORTHOP RELAT R, P248, DOI 10.1097/00003086-200203000-00036; Carano RAD, 2003, DRUG DISCOV TODAY, V8, P980, DOI 10.1016/S1359-6446(03)02866-6; Claes LE, 1998, CLIN ORTHOP RELAT R, pS132; Claes L, 2009, J ORTHOP RES, V27, P22, DOI 10.1002/jor.20712; Colnot C, 2003, DEVELOPMENT, V130, P4123, DOI 10.1242/dev.00559; Dimitriou R, 2005, INJURY, V36, P1392, DOI 10.1016/j.injury.2005.07.019; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Einhorn TA, 1998, CLIN ORTHOP RELAT R, pS7; Fujisawa T, 1999, J BIOCHEM-TOKYO, V125, P966, DOI 10.1093/oxfordjournals.jbchem.a022376; Gerstenfeld LC, 2003, J CELL BIOCHEM, V88, P873, DOI 10.1002/jcb.10435; Groothuis A, 2010, BONE, V47, P438, DOI 10.1016/j.bone.2010.05.026; Hayda RA, 1998, CLIN ORTHOP RELAT R, pS31; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Kaspar K, 2007, BIOMED TECH, V52, P383, DOI 10.1515/BMT.2007.063; Kasper G, 2007, STEM CELLS, V25, P903, DOI 10.1634/stemcells.2006-0432; Kasper G, 2009, STEM CELLS, V27, P1288, DOI 10.1002/stem.49; Klein P, 2003, J ORTHOP RES, V21, P662, DOI 10.1016/S0736-0266(02)00259-0; Le AX, 2001, J ORTHOPAED RES, V19, P78, DOI 10.1016/S0736-0266(00)00006-1; Lienau J, 2010, TISSUE ENG PT A, V16, P191, DOI [10.1089/ten.tea.2009.0187, 10.1089/ten.TEA.2009.0187]; Mehta M, 2010, BONE, V47, P219, DOI 10.1016/j.bone.2010.05.029; Meyer RA, 2003, J BONE JOINT SURG AM, V85A, P1243, DOI 10.2106/00004623-200307000-00010; Meyer RA, 2001, J ORTHOP RES, V19, P428, DOI 10.1016/S0736-0266(00)90034-2; Ode A, 2011, EUR CELLS MATER, V22, P26, DOI 10.22203/eCM.v022a03; Ortega N, 2003, ANN NY ACAD SCI, V995, P109, DOI 10.1111/j.1749-6632.2003.tb03214.x; Panagiotis M, 2005, INJURY, V36, pS30, DOI 10.1016/j.injury.2005.10.008; Phillips AM, 2005, INJURY, V36, P5, DOI 10.1016/j.injury.2005.07.027; RUBIN CT, 1992, CALCIFIED TISSUE INT, V50, P306, DOI 10.1007/BF00301627; SKAK SV, 1988, ACTA ORTHOP SCAND, V59, P704, DOI 10.3109/17453678809149430; Sternlicht MD, 2001, ANNU REV CELL DEV BI, V17, P463, DOI 10.1146/annurev.cellbio.17.1.463; Stickens D, 2004, DEVELOPMENT, V131, P5883, DOI 10.1242/dev.01461; Strube P, 2008, J BIOMECH, V41, P2696, DOI 10.1016/j.jbiomech.2008.06.009; Strube P, 2008, BONE, V42, P758, DOI 10.1016/S0021-9290(08)70350-6; Supek F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021800; TURNER CH, 1995, J BONE MINER RES, V10, P1544; Uusitalo H, 2000, CALCIFIED TISSUE INT, V67, P382, DOI 10.1007/s002230001152; Yang CM, 2004, J BIOL CHEM, V279, P22158, DOI 10.1074/jbc.M401343200	37	20	20	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 4	2014	9	9							e106462	10.1371/journal.pone.0106462	http://dx.doi.org/10.1371/journal.pone.0106462			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3XV	25187955	Green Published, Green Submitted, gold			2022-12-27	WOS:000341271500036
J	Singh, BN; Rawat, AKS; Khan, W; Naqvi, AH; Singh, BR				Singh, Brahma Nand; Rawat, Ajay Kumar Singh; Khan, Wasi; Naqvi, Alim H.; Singh, Braj Raj			Biosynthesis of Stable Antioxidant ZnO Nanoparticles by Pseudomonas aeruginosa Rhamnolipids	PLOS ONE			English	Article							RADICAL-SCAVENGING ACTIVITIES; OXIDE NANOPARTICLES; BAND-GAP; FUNGUS; ASSAY; CELLS	During the last several years, various chemical methods have been used for synthesis of a variety of metal nanoparticles. Most of these methods pose severe environmental problems and biological risks; therefore the present study reports a biological route for synthesis of zinc oxide nanoparticles using Pseudomonas aeruginosa rhamnolipids (RLs) (denoted as "RL@ZnO'') and their antioxidant property. Formation of stable RL@ZnO nanoparticles gave mostly spherical particles with a particle size ranging from 35 to 80 nm. The RL@ZnO nanoparticles were characterized by UV-visible (UV-vis) spectroscopy, scanning electron microscopy, transmission electron microscopy, dynamic light scattering, Fourier transform infrared spectroscopy, X-ray diffraction (XRD), and thermal gravimetric analysis. The UV-vis spectra presented a characteristic absorbance peak at similar to 360 nm for synthesized RL@ZnO nanoparticles. The XRD spectrum showed that RL@ZnO nanoparticles are crystalline in nature and have typical wurtzite type polycrystals. Antioxidant potential of RL@ZnO nanoparticles was assessed through 2,2-diphenyl-1-picrylhydrazyl (DPPH), hydroxyl, and superoxide anion free radicals with varying concentration and time of the storage up to 15 months, while it was found to decline in bare ZnO nanoparticles. Similarly, the inhibitory effects on beta-carotene oxidation and lipid peroxidation were also observed. These results elucidate the significance of P. aeruginosa RL as effective stabilizing agents to develop surface protective ZnO nanoparticles, which can be used as promising antioxidants in biological system.	[Singh, Brahma Nand; Rawat, Ajay Kumar Singh] Natl Bot Res Inst, CSIR, Pharmacognosy & Ethnopharmacol Div, Lucknow 226001, Uttar Pradesh, India; [Khan, Wasi; Naqvi, Alim H.; Singh, Braj Raj] Aligarh Muslim Univ, Ctr Excellence Mat Sci Nanomat, Dept Appl Phys, ZH Coll Engn & Technol, Aligarh, Uttar Pradesh, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - National Botanical Research Institute (NBRI); Aligarh Muslim University; Zakir Husain College Of Engineering & Technology	Singh, BR (corresponding author), Aligarh Muslim Univ, Ctr Excellence Mat Sci Nanomat, Dept Appl Phys, ZH Coll Engn & Technol, Aligarh, Uttar Pradesh, India.	brajviro@gmail.com						Ahmed AS, 2011, J LUMIN, V131, P1, DOI 10.1016/j.jlumin.2010.07.017; Ansari SA, 2011, FOOD CHEM TOXICOL, V49, P2107, DOI 10.1016/j.fct.2011.05.025; Apati P, 2003, J PHARMACEUT BIOMED, V32, P1045, DOI 10.1016/S0731-7085(03)00207-3; AVOURIS P, 1995, ACCOUNTS CHEM RES, V28, P95, DOI 10.1021/ar00051a002; Banat IM, 2010, APPL MICROBIOL BIOT, V87, P427, DOI 10.1007/s00253-010-2589-0; Bansal V, 2005, J MATER CHEM, V15, P2583, DOI 10.1039/b503008k; Bansal V, 2004, J MATER CHEM, V14, P3303, DOI 10.1039/b407904c; Bansal V, 2006, J AM CHEM SOC, V128, P11958, DOI 10.1021/ja063011m; Bansal V, 2014, INT J PHARMACEUT, V471, P377, DOI 10.1016/j.ijpharm.2014.05.061; BEAUCHAM.C, 1971, ANAL BIOCHEM, V44, P276, DOI 10.1016/0003-2697(71)90370-8; Bowen WR, 2000, BIOTECHNOL LETT, V22, P893, DOI 10.1023/A:1005604028444; Das D, 2013, COLLOID SURFACE B, V111, P556, DOI 10.1016/j.colsurfb.2013.06.041; HALLIWELL B, 1995, CRIT REV FOOD SCI, V35, P7, DOI 10.1080/10408399509527682; HALLIWELL B, 1987, ANAL BIOCHEM, V165, P215, DOI 10.1016/0003-2697(87)90222-3; Hazra C, 2013, J CHEM TECHNOL BIOT, V88, P1039, DOI 10.1002/jctb.3934; Kathiravan A, 2009, J MOL STRUCT, V934, P129, DOI 10.1016/j.molstruc.2009.06.032; Kharissova OV, 2013, TRENDS BIOTECHNOL, V31, P240, DOI 10.1016/j.tibtech.2013.01.003; Li JY, 2010, NANOSCALE RES LETT, V5, P1063, DOI 10.1007/s11671-010-9603-4; Mehta SK, 2009, NANOSCALE RES LETT, V4, P17, DOI 10.1007/s11671-008-9196-3; Nel A, 2006, SCIENCE, V311, P622, DOI 10.1126/science.1114397; OHKAWA H, 1979, ANAL BIOCHEM, V95, P351, DOI 10.1016/0003-2697(79)90738-3; Prakash D, 2007, FOOD CHEM, V104, P783, DOI 10.1016/j.foodchem.2006.12.029; Prakash D, 2007, INT J FOOD SCI NUTR, V58, P18, DOI 10.1080/09637480601093269; Premanathan M, 2011, NANOMED-NANOTECHNOL, V7, P184, DOI 10.1016/j.nano.2010.10.001; Saikia JP, 2013, COLLOID SURFACE B, V104, P330, DOI 10.1016/j.colsurfb.2012.10.069; Sangeetha J, 2013, J BIOMED NANOTECHNOL, V9, P751, DOI 10.1166/jbn.2013.1590; Sanyal A, 2005, LANGMUIR, V21, P7220, DOI 10.1021/la047132g; Shoeb M, 2013, ADV NAT SCI-NANOSCI, V4, DOI 10.1088/2043-6262/4/3/035015; Singh BN, 2009, CHEM-BIOL INTERACT, V181, P20, DOI 10.1016/j.cbi.2009.05.007; Singh BN, 2009, FOOD CHEM TOXICOL, V47, P1161, DOI 10.1016/j.fct.2009.02.004; Singh BN, 2009, FOOD CHEM TOXICOL, V47, P1109, DOI 10.1016/j.fct.2009.01.034; Singh BN, 2009, FOOD CHEM TOXICOL, V47, P778, DOI 10.1016/j.fct.2009.01.009; Singh BR, 2012, BIOMATERIALS, V33, P5753, DOI 10.1016/j.biomaterials.2012.04.045; Singh BR, 2011, COLLOID SURFACE B, V85, P207, DOI 10.1016/j.colsurfb.2011.02.030; Singh HB, 2010, BIORESOURCE TECHNOL, V101, P6444, DOI 10.1016/j.biortech.2010.03.057; Singla ML, 2009, J LUMIN, V129, P434, DOI 10.1016/j.jlumin.2008.11.021; Zak AK, 2011, CERAM INT, V37, P393, DOI 10.1016/j.ceramint.2010.08.017; Zhang HY, 2012, ACS NANO, V6, P4349, DOI 10.1021/nn3010087	38	98	102	2	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 4	2014	9	9							e106937	10.1371/journal.pone.0106937	http://dx.doi.org/10.1371/journal.pone.0106937			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3XV	25187953	Green Submitted, Green Published, gold			2022-12-27	WOS:000341271500099
J	Yu, XM; Li, YM; Zhang, C; Liu, HY; Liu, J; Zheng, WW; Kang, X; Leng, XJ; Zhao, K; Gu, YF; Zhang, XP; Xiang, QJ; Chen, Q				Yu, Xiumei; Li, Yanmei; Zhang, Chu; Liu, Huiying; Liu, Jin; Zheng, Wenwen; Kang, Xia; Leng, Xuejun; Zhao, Ke; Gu, Yunfu; Zhang, Xiaoping; Xiang, Quanju; Chen, Qiang			Culturable Heavy Metal-Resistant and Plant Growth Promoting Bacteria in V-Ti Magnetite Mine Tailing Soil from Panzhihua, China	PLOS ONE			English	Article							INDOLEACETIC-ACID; COMMUNITY STRUCTURE; CONTAMINATED SOIL; LEGUMINOUS PLANT; BIOREMEDIATION; STRAINS; RHIZOBACTERIA; PHYTOREMEDIATION; REMEDIATION; SYMBIOSIS	To provide a basis for using indigenous bacteria for bioremediation of heavy metal contaminated soil, the heavy metal resistance and plant growth-promoting activity of 136 isolates from V-Ti magnetite mine tailing soil were systematically analyzed. Among the 13 identified bacterial genera, the most abundant genus was Bacillus (79 isolates) out of which 32 represented B. subtilis and 14 B. pumilus, followed by Rhizobium sp. (29 isolates) and Ochrobactrum intermedium (13 isolates). Altogether 93 isolates tolerated the highest concentration (1000 mg kg(-1)) of at least one of the six tested heavy metals. Five strains were tolerant against all the tested heavy metals, 71 strains tolerated 1,000 mg kg(-1) cadmium whereas only one strain tolerated 1,000 mg kg(-1) cobalt. Altogether 67% of the bacteria produced indoleacetic acid (IAA), a plant growth-promoting phytohormone. The concentration of IAA produced by 53 isolates was higher than 20 mu g ml(-1). In total 21% of the bacteria produced siderophore (5.50-167.67 mu g ml(-1)) with two Bacillus sp. producing more than 100 mu g ml(-1). Eighteen isolates produced both IAA and siderophore. The results suggested that the indigenous bacteria in the soil have beneficial characteristics for remediating the contaminated mine tailing soil.	[Yu, Xiumei; Li, Yanmei; Zhang, Chu; Liu, Huiying; Liu, Jin; Zheng, Wenwen; Kang, Xia; Leng, Xuejun; Zhao, Ke; Gu, Yunfu; Zhang, Xiaoping; Xiang, Quanju; Chen, Qiang] Sichuan Agr Univ, Coll Resource & Environm Sci, Dept Microbiol, Chengdu, Peoples R China; [Leng, Xuejun] Panzhihua Municipal Environm Protect Bur, Environm Monitoring Stn, Panzhihua, Peoples R China	Sichuan Agricultural University	Yu, XM (corresponding author), Sichuan Agr Univ, Coll Resource & Environm Sci, Dept Microbiol, Chengdu, Peoples R China.	yuxiumeicool@163.com; cqiang@sicau.edu.cn	chen, qiang/HGU-5418-2022		National Natural Science Foundation of China [31300461]; Doctoral Fund of Ministry of Education of China [20135103120003]; Research Foundation for the Introduction of Talent of Sichuan Agricultural University	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Doctoral Fund of Ministry of Education of China(Ministry of Education, China); Research Foundation for the Introduction of Talent of Sichuan Agricultural University	This work was financially supported by National Natural Science Foundation of China (NO. 31300461), Doctoral Fund of Ministry of Education of China (NO. 20135103120003), and Research Foundation for the Introduction of Talent of Sichuan Agricultural University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046754; Ahmad F, 2008, MICROBIOL RES, V163, P173, DOI 10.1016/j.micres.2006.04.001; Bafana A, 2010, J HAZARD MATER, V177, P481, DOI 10.1016/j.jhazmat.2009.12.058; Benson DA, 2012, GENBANK; Boularbah A, 2006, CHEMOSPHERE, V63, P802, DOI 10.1016/j.chemosphere.2005.07.079; Brady N. C., 1984, The nature and properties of soils.; Braud A, 2009, CHEMOSPHERE, V74, P280, DOI 10.1016/j.chemosphere.2008.09.013; BRIC JM, 1991, APPL ENVIRON MICROB, V57, P535, DOI 10.1128/AEM.57.2.535-538.1991; Chang SS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020303; Cheng YJ, 2010, ENVIRON SCI TECHNOL, V44, P6357, DOI 10.1021/es100198v; Das S, 2014, CHEMOSPHERE, V96, P112, DOI 10.1016/j.chemosphere.2013.08.080; de Abreu CA, 2005, SCI AGR, V62, P564, DOI 10.1590/S0103-90162005000600009; Eckardt NA, 2012, PLANT CELL, V24, P3855, DOI 10.1105/tpc.112.241010; FUENTESRAMIREZ LE, 1993, PLANT SOIL, V154, P145, DOI 10.1007/BF00012519; Glick BR, 2010, BIOTECHNOL ADV, V28, P367, DOI 10.1016/j.biotechadv.2010.02.001; Govarthanan M, 2013, CHEMOSPHERE, V90, P2267, DOI 10.1016/j.chemosphere.2012.10.038; Gupta AK, 2013, ENVIRON SCI TECHNOL, V47, P10115, DOI 10.1021/es403469c; Ike A, 2007, CHEMOSPHERE, V66, P1670, DOI 10.1016/j.chemosphere.2006.07.058; Jaroszuk-Scisel J, 2014, BIOLOGIA, V69, P281, DOI 10.2478/s11756-013-0328-6; Joseph B, 2007, INT J PLANT PROD, V1, P141; Khan MS, 2009, ENVIRON CHEM LETT, V7, P1, DOI 10.1007/s10311-008-0155-0; Kuffner M, 2010, J APPL MICROBIOL, V108, P1471, DOI 10.1111/j.1365-2672.2010.04670.x; Kuzel S, 2003, BIOL TRACE ELEM RES, V91, P179, DOI 10.1385/BTER:91:2:179; Larsson MA, 2013, ENVIRON TOXICOL CHEM, V32, P2266, DOI 10.1002/etc.2322; Lauber CL, 2009, APPL ENVIRON MICROB, V75, P5111, DOI 10.1128/AEM.00335-09; LEINHOS V, 1995, ANGEW BOT, V69, P37; Leinhos V, 1995, ANGEW BOT GERMANY; Li ZY, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0056412, 10.1371/journal.pone.0075856]; Lippmann B, 1995, ANGEW BOT GERMANY; Ma Y, 2011, BIOTECHNOL ADV, V29, P248, DOI 10.1016/j.biotechadv.2010.12.001; MARTIN B, 1992, NUCLEIC ACIDS RES, V20, P3479, DOI 10.1093/nar/20.13.3479; Mazej Z, 2010, ARCH ENVIRON CON TOX, V58, P998, DOI 10.1007/s00244-009-9417-5; Miller CS, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0056018, 10.1371/journal.pone.0081692]; Mishra VK, 2008, BIORESOURCE TECHNOL, V99, P930, DOI 10.1016/j.biortech.2007.03.010; Murugappan R. M., 2006, Pakistan Journal of Biological Sciences, V9, P437, DOI 10.3923/pjbs.2006.437.440; NEUBERGER JS, 1990, SCI TOTAL ENVIRON, V94, P261, DOI 10.1016/0048-9697(90)90175-T; Nielsen MN, 2002, MICROORGANISMS INDIC; Ohlander J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079756; Olson JW, 2001, MOL MICROBIOL, V39, P176, DOI 10.1046/j.1365-2958.2001.02244.x; Pandey S, 2013, J MICROBIOL, V51, P11, DOI 10.1007/s12275-013-2330-7; Patten CL, 2002, APPL ENVIRON MICROB, V68, P3795, DOI 10.1128/AEM.68.8.3795-3801.2002; Peralta-Videa JR, 2002, ENVIRON POLLUT, V119, P291, DOI 10.1016/S0269-7491(02)00105-7; Pumpel T, 2001, ADV APPL MICROBIOL, V48, P135, DOI 10.1016/S0065-2164(01)48002-6; Rajkumar M, 2008, CHEMOSPHERE, V71, P834, DOI 10.1016/j.chemosphere.2007.11.038; Rajkumar M, 2010, TRENDS BIOTECHNOL, V28, P142, DOI 10.1016/j.tibtech.2009.12.002; Rodriguez L, 2009, J ENVIRON MANAGE, V90, P1106, DOI 10.1016/j.jenvman.2008.04.007; ROSZAK DB, 1987, MICROBIOL REV, V51, P365, DOI 10.1128/MMBR.51.3.365-379.1987; Sakamoto T, 2001, PLANT CELL PHYSL, V42, P186; Saunders JE, 2013, AUDIOL NEURO-OTOL, V18, P101, DOI 10.1159/000345470; Sayyed R Z, 2010, Indian J Microbiol, V50, P179, DOI 10.1007/s12088-010-0021-1; Shacklette H. T., 1984, 1270 US GEOL SURV; Sriprang R, 2002, J BIOTECHNOL, V99, P279, DOI 10.1016/S0168-1656(02)00219-5; Tacao M, 2005, ANTON LEEUW INT J G, V88, P173, DOI 10.1007/s10482-005-3450-9; Tak HI, 2013, REV ENVIRON CONTAM T, V223, P33, DOI 10.1007/978-1-4614-5577-6_2; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tripathi BM, 2012, MICROB ECOL, V64, P474, DOI 10.1007/s00248-012-0028-8; Valverde A, 2011, CHEMOSPHERE, V85, P129, DOI 10.1016/j.chemosphere.2011.06.025; Venail PA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072561; Wasi S, 2013, ENVIRON MONIT ASSESS, V185, P8147, DOI 10.1007/s10661-013-3163-x; Weyens N, 2009, TRENDS BIOTECHNOL, V27, P591, DOI 10.1016/j.tibtech.2009.07.006; WILSON KH, 1990, J CLIN MICROBIOL, V28, P1942, DOI 10.1128/JCM.28.9.1942-1946.1990; Xie H, 1996, CURR MICROBIOL, V32, P67, DOI 10.1007/s002849900012; Xie XH, 2010, AFR J BIOTECHNOL, V9, P4056; Yanguo T, 2002, CHINESE J GEOCHEMIST, V21, P274, DOI DOI 10.1007/BF02831093; Yanguo T, 2003, CHIN J GEOCHEM, V22, P253, DOI DOI 10.1007/BF02842869; Zhang SR, 2010, J HAZARD MATER, V173, P705, DOI 10.1016/j.jhazmat.2009.08.142; Zhou MF, 2005, J PETROL, V46, P2253, DOI 10.1093/petrology/egi054; Zhuang P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094484	68	27	30	2	75	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 4	2014	9	9							e106618	10.1371/journal.pone.0106618	http://dx.doi.org/10.1371/journal.pone.0106618			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3XV	25188470	gold, Green Submitted, Green Published			2022-12-27	WOS:000341271500063
J	Cassim, R; Talcott, JB; Moores, E				Cassim, Rizan; Talcott, Joel B.; Moores, Elisabeth			Adults with Dyslexia Demonstrate Large Effects of Crowding and Detrimental Effects of Distractors in a Visual Tilt Discrimination Task	PLOS ONE			English	Article							DEVELOPMENTAL DYSLEXIA; VISUOSPATIAL ATTENTION; SPATIAL ATTENTION; DEFICITS; CHILDREN; PERCEPTION; MODELS; WORDS; NOISE	Previous research has shown that adults with dyslexia (AwD) are disproportionately impacted by close spacing of stimuli and increased numbers of distractors in a visual search task compared to controls [1]. Using an orientation discrimination task, the present study extended these findings to show that even in conditions where target search was not required: (i) AwD had detrimental effects of both crowding and increased numbers of distractors; (ii) AwD had more pronounced difficulty with distractor exclusion in the left visual field and (iii) measures of crowding and distractor exclusion correlated significantly with literacy measures. Furthermore, such difficulties were not accounted for by the presence of covarying symptoms of ADHD in the participant groups. These findings provide further evidence to suggest that the ability to exclude distracting stimuli likely contributes to the reported visual attention difficulties in AwD and to the aetiology of literacy difficulties. The pattern of results is consistent with weaker and asymmetric attention in AwD.	[Cassim, Rizan; Talcott, Joel B.; Moores, Elisabeth] Aston Univ, Sch Life & Hlth Sci, Birmingham B4 7ET, W Midlands, England	Aston University	Moores, E (corresponding author), Aston Univ, Sch Life & Hlth Sci, Birmingham B4 7ET, W Midlands, England.	e.j.moores@aston.ac.uk		moores, elisabeth/0000-0003-3997-0832	Aston University	Aston University	This work constitutes part of RC's PhD thesis for which he received a scholarship from Aston University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American psychiatric association, 2013, DIAGNOSTIC STAT MANU, DOI 10.1176/appi.books.9780890425596; Barkley RA, 1997, PSYCHOL BULL, V121, P65, DOI 10.1037/0033-2909.121.1.65; Barkley RA, 2006, ATTENTION DEFICIT HY; Bosse ML, 2007, COGNITION, V104, P198, DOI 10.1016/j.cognition.2006.05.009; BOUMA H, 1977, NEUROPSYCHOLOGIA, V15, P69, DOI 10.1016/0028-3932(77)90116-6; Callens M, 2013, Q J EXP PSYCHOL, V66, P1803, DOI 10.1080/17470218.2013.766898; COHEN A, 1991, J EXP PSYCHOL HUMAN, V17, P891, DOI 10.1037/0096-1523.17.4.891; Cohen J.E., 1988, STAT POWER ANAL BEHA; Dakin SC, 2009, J VISION, V9, DOI [10.1167/9.4.2, 10.1167/9.11.28]; Facoetti A, 2000, CORTEX, V36, P109, DOI 10.1016/S0010-9452(08)70840-2; Facoetti A, 2000, EXP BRAIN RES, V132, P531, DOI 10.1007/s002219900330; Facoetti A, 2001, EXP BRAIN RES, V138, P46, DOI 10.1007/s002210100700; Facoetti A, 2001, NEUROPSYCHOLOGIA, V39, P352, DOI 10.1016/S0028-3932(00)00138-X; Facoetti A, 2000, NEUROSCI LETT, V290, P216, DOI 10.1016/S0304-3940(00)01354-9; Facoetti A, 2006, COGN NEUROPSYCHOL, V23, P841, DOI 10.1080/02643290500483090; Franceschini S, 2012, CURR BIOL, V22, P814, DOI 10.1016/j.cub.2012.03.013; Freeman J, 2007, J VISION, V7, DOI 10.1167/7.2.22; Hari R, 2001, BRAIN, V124, P1373, DOI 10.1093/brain/124.7.1373; He S, 1996, NATURE, V383, P334, DOI 10.1038/383334a0; Kevan A, 2009, NEUROPSYCHOLOGIA, V47, P3174, DOI 10.1016/j.neuropsychologia.2009.07.016; Ladavas E, 1997, NEUROPSYCHOLOGIA, V35, P257, DOI 10.1016/S0028-3932(96)00066-8; Ladavas E, 1997, NEUROPSYCHOLOGIA, V35, P1075, DOI 10.1016/S0028-3932(97)00032-8; Martelli M, 2009, J VISION, V9, DOI 10.1167/9.4.14; Moores E, 2011, NEUROPSYCHOLOGIA, V49, P3881, DOI 10.1016/j.neuropsychologia.2011.10.005; Pelli DG, 2007, J VISION, V7, DOI 10.1167/7.2.20; Pennington BF, 2006, COGNITION, V101, P385, DOI 10.1016/j.cognition.2006.04.008; Pernet C, 2006, NEUROPSYCHOLOGIA, V44, P2374, DOI 10.1016/j.neuropsychologia.2006.05.003; Plaza M, 2007, DYSLEXIA, V13, P67, DOI 10.1002/dys.330; Roach NW, 2008, VISION RES, V48, P193, DOI 10.1016/j.visres.2007.11.001; Roach NW, 2007, BRAIN, V130, P771, DOI 10.1093/brain/awl353; Roach NW, 2004, PSYCHOL SCI, V15, P650, DOI 10.1111/j.0956-7976.2004.00735.x; Rochelle KSH, 2009, EXP BRAIN RES, V192, P627, DOI 10.1007/s00221-008-1568-5; Schneider W., 2002, E PRIME USERS GUIDE; SHAYWITZ SE, 1994, TOP LANG DISORD, V14, P1, DOI 10.1097/00011363-199408000-00003; Sireteanu R, 2005, VISION RES, V45, P3075, DOI 10.1016/j.visres.2005.07.030; Snowling M., 2005, DYSLEXIA COGNITIVE D, V17, P4; Sonuga-Barke EJS, 2005, BIOL PSYCHIAT, V57, P1231, DOI 10.1016/j.biopsych.2004.09.008; Sperling AJ, 2005, NAT NEUROSCI, V8, P862, DOI 10.1038/nn1474; Sperling AJ, 2006, PSYCHOL SCI, V17, P1047, DOI 10.1111/j.1467-9280.2006.01825.x; Spinelli D, 2002, CORTEX, V38, P179, DOI 10.1016/S0010-9452(08)70649-X; STANOVICH KE, 1988, J LEARN DISABIL-US, V21, P590, DOI 10.1177/002221948802101003; Torgesen J.K., 1999, COMPREHENSIVE TEST P; Vellutino F.R., 1979, DYSLEXIA THEORY RES; Vidyasagar TR, 2010, TRENDS COGN SCI, V14, P57, DOI 10.1016/j.tics.2009.12.003; Waldie KE, 2010, NEUROPSYCHOLOGIA, V48, P3650, DOI 10.1016/j.neuropsychologia.2010.08.023; Wechsler D., 2011, WASI 2 WECHSLER ABBR; Wechsler D, 1999, WECHSLER ADULT INTEL; Wechsler D., 2002, WECHSLER INDIVIDUAL; Whitney D, 2011, TRENDS COGN SCI, V15, P160, DOI 10.1016/j.tics.2011.02.005; Yeshurun Y, 2010, J VISION, V10, DOI 10.1167/10.10.16; Zorzi M, 2012, P NATL ACAD SCI USA, V109, P11455, DOI 10.1073/pnas.1205566109	51	12	12	0	78	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 3	2014	9	9							e106191	10.1371/journal.pone.0106191	http://dx.doi.org/10.1371/journal.pone.0106191			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AO3TB	25184299	Green Published, Green Accepted, Green Submitted, gold			2022-12-27	WOS:000341257700035
J	Cornelissen, JBWJ; van der Giessen, JWB; Takumi, K; Teunis, PFM; Wisselink, HJ				Cornelissen, Jan B. W. J.; van der Giessen, Joke W. B.; Takumi, Katsuhisa; Teunis, Peter F. M.; Wisselink, Henk J.			An Experimental Toxoplasma gondii Dose Response Challenge Model to Study Therapeutic or Vaccine Efficacy in Cats	PLOS ONE			English	Article							CRUDE RHOPTRY PROTEINS; OOCYSTS; INFECTIVITY; TISSUE; BRADYZOITES; OUTBREAK; ANIMALS; TACHYZOITES; SURVIVAL; IMMUNITY	High numbers of Toxoplasma gondii oocysts in the environment are a risk factor to humans. The environmental contamination might be reduced by vaccinating the definitive host, cats. An experimental challenge model is necessary to quantitatively assess the efficacy of a vaccine or drug treatment. Previous studies have indicated that bradyzoites are highly infectious for cats. To infect cats, tissue cysts were isolated from the brains of mice infected with oocysts of T. gondii M4 strain, and bradyzoites were released by pepsin digestion. Free bradyzoites were counted and graded doses (1000, 100, 50, 10), and 250 intact tissue cysts were inoculated orally into three cats each. Oocysts shed by these five groups of cats were collected from faeces by flotation techniques, counted microscopically and estimated by real time PCR. Additionally, the number of T. gondii in heart, tongue and brains were estimated, and serology for anti T. gondii antibodies was performed. A Beta-Poisson dose-response model was used to estimate the infectivity of single bradyzoites and linear regression was used to determine the relation between inoculated dose and numbers of oocyst shed. We found that real time PCR was more sensitive than microscopic detection of oocysts, and oocysts were detected by PCR in faeces of cats fed 10 bradyzoites but by microscopic examination. Real time PCR may only detect fragments of T. gondii DNA without the presence of oocysts in low doses. Prevalence of tissue cysts of T. gondii in tongue, heart and brains, and anti T. gondii antibody concentrations were all found to depend on the inoculated bradyzoite dose. The combination of the experimental challenge model and the dose response analysis provides a suitable reference for quantifying the potential reduction in human health risk due to a treatment of domestic cats by vaccination or by therapeutic drug application.	[Cornelissen, Jan B. W. J.; Wisselink, Henk J.] Cent Vet Inst Wageningen UR, Dept Infect Biol, Lelystad, Netherlands; [van der Giessen, Joke W. B.] Cent Vet Inst Wageningen UR, Dept Bacteriol & TSEs, Lelystad, Netherlands; [van der Giessen, Joke W. B.; Takumi, Katsuhisa] Natl Inst Publ Hlth & Environm RIVM, Ctr Zoonoses & Environm Microbiol, Bilthoven, Netherlands; [Teunis, Peter F. M.] Natl Inst Publ Hlth & Environm RIVM, Ctr Epidemiol, Bilthoven, Netherlands	Wageningen University & Research; Wageningen University & Research; Netherlands National Institute for Public Health & the Environment; Netherlands National Institute for Public Health & the Environment	Cornelissen, JBWJ (corresponding author), Cent Vet Inst Wageningen UR, Dept Infect Biol, Lelystad, Netherlands.	jan.cornelissen@wur.nl	Wisselink, Henk/AAL-6283-2020	Wisselink, Henk/0000-0002-3747-8054				Ajzenberg D, 2009, J INFECT DIS, V199, P1155, DOI 10.1086/597477; Bahia-Oliveira LMG, 2003, EMERG INFECT DIS, V9, P55; Batz MB, 2012, J FOOD PROTECT, V75, P1278, DOI 10.4315/0362-028X.JFP-11-418; Bowie WR, 1997, LANCET, V350, P173, DOI 10.1016/S0140-6736(96)11105-3; CORNELISSEN AWCA, 1981, PARASITOLOGY, V83, P103, DOI 10.1017/S0031182000050071; Dabritz HA, 2010, ZOONOSES PUBLIC HLTH, V57, P34, DOI 10.1111/j.1863-2378.2009.01273.x; Dubey JP, 2008, INT J PARASITOL, V38, P1257, DOI 10.1016/j.ijpara.2008.03.007; Dubey JP, 2006, VET PARASITOL, V140, P69, DOI 10.1016/j.vetpar.2006.03.018; Dubey J.P., 1988, TOXOPLASMOSIS ANIMAL; DUBEY JP, 1972, J PROTOZOOL, V19, P155, DOI 10.1111/j.1550-7408.1972.tb03431.x; DUBEY JP, 1995, J PARASITOL, V81, P410, DOI 10.2307/3283823; Dubey JP, 1996, VET PARASITOL, V64, P65, DOI 10.1016/0304-4017(96)00961-2; Dubey JP, 2005, VET PARASITOL, V133, P289, DOI 10.1016/j.vetpar.2005.06.007; Dubey JP, 1997, PARASITOLOGY, V115, P15, DOI 10.1017/S0031182097008949; DUBEY JP, 1994, J AM VET MED ASSOC, V205, P1593; Dubey JP, 1998, J PARASITOL, V84, P862, DOI 10.2307/3284606; Dubey JP, 1996, J PARASITOL, V82, P957, DOI 10.2307/3284206; Dubey JP, 2001, J PARASITOL, V87, P215, DOI 10.1645/0022-3395(2001)087[0215:OSBCFI]2.0.CO;2; Dubey JP, 1998, CLIN MICROBIOL REV, V11, P267, DOI 10.1128/CMR.11.2.267; Dubey JP, 1995, J PARASITOL, V81, P887, DOI 10.2307/3284035; Dubey JP, 2010, TOXOPLASMOSIS ANIMAL, V38; Dumetre A, 2008, VET PARASITOL, V153, P209, DOI 10.1016/j.vetpar.2008.02.004; FRENKEL JK, 1991, AM J VET RES, V52, P759; FREYRE A, 1993, J PARASITOL, V79, P716, DOI 10.2307/3283610; FREYRE A, 1989, J PARASITOL, V75, P750, DOI 10.2307/3283060; Fritz H, 2012, J MICROBIOL METH, V88, P47, DOI 10.1016/j.mimet.2011.10.010; Garcia JL, 2007, VET PARASITOL, V145, P197, DOI 10.1016/j.vetpar.2007.01.007; Havelaar AH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013965; Hill Dolores E., 2005, Animal Health Research Reviews, V6, P41, DOI 10.1079/AHR2005100; Homan WL, 2000, INT J PARASITOL, V30, P69, DOI 10.1016/S0020-7519(99)00170-8; Innes EA, 2009, MEM I OSWALDO CRUZ, V104, P246, DOI 10.1590/S0074-02762009000200018; Lindsay DS, 2009, J PARASITOL, V95, P1019, DOI 10.1645/GE-1919.1; Mateus-Pinilla NE, 1999, J PARASITOL, V85, P855, DOI 10.2307/3285821; Mishima M, 2002, PARASITOL RES, V88, P144, DOI 10.1007/s004360100429; Omata Y, 1996, VET PARASITOL, V65, P173, DOI 10.1016/S0304-4017(96)00973-9; Pfaff A. W., 2008, Parassitologia (Rome), V50, P55; Popiel I, 1996, J PARASITOL, V82, P330, DOI 10.2307/3284172; Reischl U, 2003, BMC INFECT DIS, V3, DOI 10.1186/1471-2334-3-7; Tenter AM, 2000, INT J PARASITOL, V30, P1217, DOI 10.1016/S0020-7519(00)00124-7; Teunis P, 2004, RISK ANAL, V24, P401, DOI 10.1111/j.0272-4332.2004.00441.x; Torgerson PR, 2013, B WORLD HEALTH ORGAN, V91, P501, DOI 10.2471/BLT.12.111732; Verma R, 2013, HUM VACC IMMUNOTHER, V9, P291, DOI 10.4161/hv.22474; Wainwright KE, 2007, J PARASITOL, V93, P925, DOI 10.1645/GE-1063R.1; Zulpo DL, 2012, EXP PARASITOL, V131, P223, DOI 10.1016/j.exppara.2012.04.006	44	15	15	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 3	2014	9	9							e104740	10.1371/journal.pone.0104740	http://dx.doi.org/10.1371/journal.pone.0104740			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3TB	25184619	Green Submitted, Green Published, gold			2022-12-27	WOS:000341257700015
J	Furuse, Y; Finethy, R; Saka, HA; Xet-Mull, AM; Sisk, DM; Smith, KLJ; Lee, S; Coers, J; Valdivia, RH; Tobin, DM; Cullen, BR				Furuse, Yuki; Finethy, Ryan; Saka, Hector A.; Xet-Mull, Ana M.; Sisk, Dana M.; Smith, Kristen L. Jurcic; Lee, Sunhee; Coers, Joern; Valdivia, Raphael H.; Tobin, David M.; Cullen, Bryan R.			Search for MicroRNAs Expressed by Intracellular Bacterial Pathogens in Infected Mammalian Cells	PLOS ONE			English	Article							MYCOBACTERIUM-TUBERCULOSIS; RNA INTERFERENCE; IMMUNE-SYSTEM; TARGETS; MARINUM; DNA; MODULATION; CHLAMYDIA; EVOLUTION; VIRULENCE	MicroRNAs are expressed by all multicellular organisms and play a critical role as post-transcriptional regulators of gene expression. Moreover, different microRNA species are known to influence the progression of a range of different diseases, including cancer and microbial infections. A number of different human viruses also encode microRNAs that can attenuate cellular innate immune responses and promote viral replication, and a fungal pathogen that infects plants has recently been shown to express microRNAs in infected cells that repress host cell immune responses and promote fungal pathogenesis. Here, we have used deep sequencing of total expressed small RNAs, as well as small RNAs associated with the cellular RNA-induced silencing complex RISC, to search for microRNAs that are potentially expressed by intracellular bacterial pathogens and translocated into infected animal cells. In the case of Legionella and Chlamydia and the two mycobacterial species M. smegmatis and M. tuberculosis, we failed to detect any bacterial small RNAs that had the characteristics expected for authentic microRNAs, although large numbers of small RNAs of bacterial origin could be recovered. However, a third mycobacterial species, M. marinum, did express an similar to 23-nt small RNA that was bound by RISC and derived from an RNA stem-loop with the characteristics expected for a pre-microRNA. While intracellular expression of this candidate bacterial microRNA was too low to effectively repress target mRNA species in infected cultured cells in vitro, artificial overexpression of this potential bacterial pre-microRNA did result in the efficient repression of a target mRNA. This bacterial small RNA therefore represents the first candidate microRNA of bacterial origin.	[Furuse, Yuki; Finethy, Ryan; Saka, Hector A.; Xet-Mull, Ana M.; Sisk, Dana M.; Smith, Kristen L. Jurcic; Lee, Sunhee; Coers, Joern; Valdivia, Raphael H.; Tobin, David M.; Cullen, Bryan R.] Duke Univ, Med Ctr, Dept Mol Genet & Microbiol, Durham, NC 27708 USA	Duke University	Cullen, BR (corresponding author), Duke Univ, Med Ctr, Dept Mol Genet & Microbiol, Durham, NC 27708 USA.	bryan.cullen@duke.edu	Saka, Hector Alex/AAQ-2424-2021; Valdivia, Raphael/R-5377-2019	Valdivia, Raphael/0000-0003-0961-073X; Tobin, David/0000-0003-3465-5518; Coers, Jorn/0000-0001-8707-4608; Finethy, Ryan/0000-0001-5110-7172	Japan Society for the Promotion of Science; National Institutes of Health [R01-AI100759]; National Science Foundation; Mallinckrodt Scholar Award; Searle Scholar Award; National Institutes of Health Director's New Innovator Award [1DP2-OD008614-01]; Duke University Center for AIDS Research [P30-AI064518]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI100759, P30AI064518] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007184] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD008614] Funding Source: NIH RePORTER	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); Mallinckrodt Scholar Award; Searle Scholar Award; National Institutes of Health Director's New Innovator Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Duke University Center for AIDS Research; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	YF is a recipient of a Postdoctoral Fellowship for Research Abroad (Japan Society for the Promotion of Science, http://www.jsps.go.jp/english/). RHV and SAK were supported by National Institutes of Health grant R01-AI100759 and RF is the recipient of an National Science Foundation predoctoral fellowship. DMT is funded through a Mallinckrodt Scholar Award (http://www.emallinckrodtfoundation.org/), a Searle Scholar Award (http://www.searlescholars.net/), a National Institutes of Health Director's New Innovator Award (1DP2-OD008614-01) and the Duke University Center for AIDS Research (P30-AI064518). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Babiarz JE, 2008, GENE DEV, V22, P2773, DOI 10.1101/gad.1705308; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Belland R, 2004, NAT REV MICROBIOL, V2, P530, DOI 10.1038/nrmicro931; Bernstein E, 2001, NATURE, V409, P363, DOI 10.1038/35053110; Brummelkamp TR, 2002, SCIENCE, V296, P550, DOI 10.1126/science.1068999; Coers J, 1999, NAT CELL BIOL, V1, P451, DOI 10.1038/15687; Cullen BR, 2004, MOL CELL, V16, P861, DOI 10.1016/j.molcel.2004.12.002; Cullen BR, 2013, NAT IMMUNOL, V14, P205, DOI 10.1038/ni.2537; Driessen AJM, 2008, ANNU REV BIOCHEM, V77, P643, DOI 10.1146/annurev.biochem.77.061606.160747; Elbashir SM, 2001, GENE DEV, V15, P188, DOI 10.1101/gad.862301; Fasold M, 2011, NUCLEIC ACIDS RES, V39, pW112, DOI 10.1093/nar/gkr357; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; Flores O, 2013, J VIROL, V87, P6589, DOI 10.1128/JVI.00504-13; Friedman Herman, 2002, Semin Pediatr Infect Dis, V13, P273, DOI 10.1053/spid.2002.127206; Garneau JE, 2010, NATURE, V468, P67, DOI 10.1038/nature09523; Gottwein E, 2006, J VIROL, V80, P5321, DOI 10.1128/JVI.02734-05; Gripenland J, 2010, NAT REV MICROBIOL, V8, P857, DOI 10.1038/nrmicro2457; Grundhoff A, 2011, VIROLOGY, V411, P325, DOI 10.1016/j.virol.2011.01.002; Hammond SM, 2000, NATURE, V404, P293, DOI 10.1038/35005107; Hoe CH, 2013, INT J MED MICROBIOL, V303, P217, DOI 10.1016/j.ijmm.2013.04.002; Hubber A, 2010, ANNU REV CELL DEV BI, V26, P261, DOI 10.1146/annurev-cellbio-100109-104034; Isaac DT, 2014, FUTURE MICROBIOL, V9, P343, DOI 10.2217/fmb.13.162; Lalaouna D, 2013, BBA-GENE REGUL MECH, V1829, P742, DOI 10.1016/j.bbagrm.2013.02.013; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Marraffini LA, 2010, NAT REV GENET, V11, P181, DOI 10.1038/nrg2749; Martinez J, 2002, CELL, V110, P563, DOI 10.1016/S0092-8674(02)00908-X; Mueller KE, 2014, INFECT IMMUN, V82, P2, DOI 10.1128/IAI.00917-13; Mullokandov G, 2012, NAT METHODS, V9, P840, DOI [10.1038/nmeth.2078, 10.1038/NMETH.2078]; Okamura K, 2008, NAT STRUCT MOL BIOL, V15, P354, DOI 10.1038/nsmb.1409; Philips JA, 2012, ANNU REV PATHOL-MECH, V7, P353, DOI 10.1146/annurev-pathol-011811-132458; Sampson TR, 2013, NATURE, V497, P254, DOI 10.1038/nature12048; SHEPARD CC, 1957, J EXP MED, V105, P39, DOI 10.1084/jem.105.1.39; Skalsky RL, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002484; Smith KLJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094953; Stamm LM, 2003, J EXP MED, V198, P1361, DOI 10.1084/jem.20031072; Stinear TP, 2008, GENOME RES, V18, P729, DOI 10.1101/gr.075069.107; Tobin DM, 2008, CELL MICROBIOL, V10, P1027, DOI 10.1111/j.1462-5822.2008.01133.x; Umbach JL, 2010, J VIROL, V84, P695, DOI 10.1128/JVI.02013-09; van der Wel N, 2007, CELL, V129, P1287, DOI 10.1016/j.cell.2007.05.059; van der Woude AD, 2014, CURR TOP MICROBIOL, V374, P109, DOI 10.1007/82_2012_298; Wang HW, 2009, NAT STRUCT MOL BIOL, V16, P1148, DOI 10.1038/nsmb.1673; Watson RO, 2012, CELL, V150, P803, DOI 10.1016/j.cell.2012.06.040; Weiberg A, 2013, SCIENCE, V342, P118, DOI 10.1126/science.1239705; Zhao YG, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001305; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	45	46	48	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 3	2014	9	9							e106434	10.1371/journal.pone.0106434	http://dx.doi.org/10.1371/journal.pone.0106434			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3TB	25184567	Green Published, gold, Green Submitted			2022-12-27	WOS:000341257700071
J	Suenaga, K; Kitahara, S; Suzuki, Y; Kobayashi, M; Horie, S; Sugawara, J; Yaegashi, N; Sato, Y				Suenaga, Kaori; Kitahara, Shuji; Suzuki, Yasuhiro; Kobayashi, Miho; Horie, Sachiko; Sugawara, Junichi; Yaegashi, Nobuo; Sato, Yasufumi			Role of the Vasohibin Family in the Regulation of Fetoplacental Vascularization and Syncytiotrophoblast Formation	PLOS ONE			English	Article							NEGATIVE FEEDBACK REGULATOR; CELL-FUSION; ANGIOGENESIS INHIBITOR; HUMAN PLACENTA; SYNCYTIN; ENDOTHELIUM; GROWTH; GENES; EXPRESSION; DIFFERENTIATION	Vasohibin-1 (VASH1) and vasohibin-2 (VASH2), the 2 members of the vasohibin family, have been identified as novel regulators of angiogenesis. VASH1 ceases angiogenesis, whereas VASH2 stimulates sprouting. Here we characterized their functional role in the placenta. Immunohistochemical analysis of human placental tissue clarified their distinctive localization; VASH1 in endothelial cells and VASH2 in trophoblasts. We then used a mouse model to explore their function. Wild-type, Vash1((-/-)), and Vash2((-/-)) mice on a C57BL6 background were used in their first pregnancy. As expected, the fetal vascular area was increased in the Vash1((-/-)) mice, whereas it was decreased in the Vash2((-/-)) mice relative to wildtype. In addition, we noticed that the Vash2((-/-)) mice at 18.5dpc displayed thinner villi of the labyrinth and larger maternal lacunae. Careful observation by an electron microscopy revealed that the syncytiotrophoblast formation was defective in the Vash2((-/-)) mice. To test the possible involvement of VASH2 in the syncytiotrophoblast formation, we examined the fusion of BeWo cells, a human trophoblastoid choriocarcinoma cell line. The forskolin treatment induced the fusion of BeWo cells, and the knockdown of VASH2 expression significantly inhibited this cell fusion. Conversely, the overexpression of VASH2 by the infection with adenovirus vector encoding human VASH2 gene significantly increased the fusion of BeWo cells. Glial cell missing-1 and endogenous retrovirus envelope glycoprotein Syncytin 1 and Syncytin 2 are known to be involved in the fusion of trophoblasts. However, VASH2 did not alter their expression in BeWo cells. These results indicate that VASH1 and VASH2 showed distinctive localization and opposing function on the fetoplacental vascularization. Moreover, our study shows for the first time that VASH2 expressed in trophoblasts is involved in the regulation of cell fusion for syncytiotrophoblast formation.	[Suenaga, Kaori; Suzuki, Yasuhiro; Kobayashi, Miho; Horie, Sachiko; Sato, Yasufumi] Tohoku Univ, Inst Dev Aging & Canc, Dept Vasc Biol, Aoba Ku, Sendai, Miyagi 980, Japan; [Suenaga, Kaori; Sugawara, Junichi; Yaegashi, Nobuo] Tohoku Univ, Sch Med, Dept Obstet & Gynecol, Aoba Ku, Sendai, Miyagi 980, Japan; [Kitahara, Shuji] Tokyo Womens Med Univ, Dept Anat & Dev Biol, Shinjuku Ku, Tokyo, Japan; [Sugawara, Junichi; Yaegashi, Nobuo] Tohoku Univ, Tohoku Med Megabank Org, Aoba Ku, Sendai, Miyagi 980, Japan	Tohoku University; Tohoku University; Tokyo Women's Medical University; Tohoku University	Sato, Y (corresponding author), Tohoku Univ, Inst Dev Aging & Canc, Dept Vasc Biol, Aoba Ku, Sendai, Miyagi 980, Japan.	y-sato@idac.tohoku.ac.jp	Suzuki, Yasuhiro/GOE-4553-2022; Kobayashi, Miho/AAD-1801-2022; Sugawara, Junichi/O-2190-2013; Sato, Yasufumi/AAF-3367-2019; Kitahara, Shuji/AAA-4632-2020	Suzuki, Yasuhiro/0000-0001-9046-5466; Kobayashi, Miho/0000-0003-2548-4120; Kitahara, Shuji/0000-0002-2904-0319	Global COE for Conquest of Signal Transduction Diseases with Network Medicine, Tohoku University; Grants-in-Aid for Scientific Research [26860205] Funding Source: KAKEN	Global COE for Conquest of Signal Transduction Diseases with Network Medicine, Tohoku University; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by a grant from the Global COE for Conquest of Signal Transduction Diseases with Network Medicine, Tohoku University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arroyo JA, 2008, SEMIN PERINATOL, V32, P172, DOI 10.1053/j.semperi.2008.02.006; Barut F, 2010, DIAGN PATHOL, V5, DOI 10.1186/1746-1596-5-24; Bulmer JN, 2012, FASEB J, V26, P2975, DOI 10.1096/fj.12-203679; Burton GJ, 2009, REPRODUCTION, V138, P895, DOI 10.1530/REP-09-0092; Chen CP, 2008, BIOL REPROD, V79, P815, DOI 10.1095/biolreprod.108.069765; Dittmar T, 2013, CURR MOL MED, V13, P735, DOI 10.2174/1566524011313050005; Dupressoir A, 2005, P NATL ACAD SCI USA, V102, P725, DOI 10.1073/pnas.0406509102; Dupressoir A, 2012, PLACENTA, V33, P663, DOI 10.1016/j.placenta.2012.05.005; Dupressoir A, 2011, P NATL ACAD SCI USA, V108, pE1164, DOI 10.1073/pnas.1112304108; Frendo JL, 2003, MOL CELL BIOL, V23, P3566, DOI 10.1128/MCB.23.10.3566-3574.2003; Holder BS, 2012, PLACENTA, V33, P460, DOI 10.1016/j.placenta.2012.02.012; Hosaka T, 2009, AM J PATHOL, V175, P430, DOI 10.2353/ajpath.2009.080788; Kimura H, 2009, BLOOD, V113, P4810, DOI 10.1182/blood-2008-07-170316; Kitahara S, 2010, MED MOL MORPHOL, V43, P26, DOI 10.1007/s00795-009-0481-8; Larsson LI, 2008, HISTOCHEM CELL BIOL, V129, P551, DOI 10.1007/s00418-008-0411-1; Lavialle C, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2012.0507; Matsuura K, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1551; Mi S, 2000, NATURE, V403, P785, DOI 10.1038/35001608; Potgens AJG, 2004, HUM REPROD UPDATE, V10, P487, DOI 10.1093/humupd/dmh039; Sato H, 2009, DIABETOLOGIA, V52, P359, DOI 10.1007/s00125-008-1229-z; Sato Y, 2013, J BIOCHEM, V153, P5, DOI 10.1093/jb/mvs128; Schubert SW, 2008, J BIOL CHEM, V283, P5460, DOI 10.1074/jbc.M710110200; Shibuya T, 2006, ARTERIOSCL THROM VAS, V26, P1051, DOI 10.1161/01.ATV.0000216747.66660.26; Simmons DG, 2008, DEVELOPMENT, V135, P2083, DOI 10.1242/dev.020099; Suzuki Y, 2010, J CELL SCI, V123, P3094, DOI 10.1242/jcs.067538; Takahashi Y, 2012, MOL CANCER RES, V10, P1135, DOI 10.1158/1541-7786.MCR-12-0098-T; Tamaki K, 2009, CANCER SCI, V100, P88, DOI 10.1111/j.1349-7006.2008.01015.x; Wakusawa R, 2008, AM J OPHTHALMOL, V146, P235, DOI 10.1016/j.ajo.2008.03.019; Wang A, 2009, PHYSIOLOGY, V24, P147, DOI 10.1152/physiol.00043.2008; Watanabe K, 2004, J CLIN INVEST, V114, P898, DOI 10.1172/JC1200421152; Xue X, 2013, ONCOGENE, V32, P1724, DOI 10.1038/onc.2012.177; Yamashita H, 2006, BIOCHEM BIOPH RES CO, V345, P919, DOI 10.1016/j.bbrc.2006.04.176; Yoshie M, 2010, HUM REPROD, V25, P2229, DOI 10.1093/humrep/deq190; Yoshinaga K, 2008, CANCER SCI, V99, P914, DOI 10.1111/j.1349-7006.2008.00777.x; Yu CC, 2002, J BIOL CHEM, V277, P50062, DOI 10.1074/jbc.M209316200	35	11	12	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 3	2014	9	9							e104728	10.1371/journal.pone.0104728	http://dx.doi.org/10.1371/journal.pone.0104728			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3TB	25184477	Green Published, Green Submitted, gold			2022-12-27	WOS:000341257700014
J	White, S; de Prado, BM; Russo, AF; Hammond, DL				White, Stephanie; de Prado, Blanca Marquez; Russo, Andrew F.; Hammond, Donna L.			Heat Hyperalgesia and Mechanical Hypersensitivity Induced by Calcitonin Gene-Related Peptide in a Mouse Model of Neurofibromatosis	PLOS ONE			English	Article							SENSORY NEURONS; NOCICEPTIVE NEURONS; CGRP; TYPE-1; MICE; CAPSAICIN; RELEASE; PAIN; NEUROPEPTIDES; SENSITIZATION	This study examined whether mice with a deficiency of neurofibromin, a Ras GTPase activating protein, exhibit a nociceptive phenotype and probed a possible contribution by calcitonin gene-related peptide. In the absence of inflammation, Nf1(+/-) mice (B6.129S6 Nf1 < tm1Fcr >/J) and wild type littermates responded comparably to heat or mechanical stimuli, except for a subtle enhanced mechanical sensitivity in female Nf1(+/-) mice. Nociceptive phenotype was also examined after inflammation induced by capsaicin and formalin, which release endogenous calcitonin gene-related peptide. Intraplantar injection of capsaicin evoked comparable heat hyperalgesia and mechanical hypersensitivity in Nf1(+/-) and wild type mice of both genders. Formalin injection caused a similar duration of licking in male Nf1(+/-) and wild type mice. Female Nf1(+/-) mice licked less than wild type mice, but displayed other nociceptive behaviors. In contrast, intraplantar injection of CGRP caused greater heat hyperalgesia in Nf1(+/-) mice of both genders compared to wild type mice. Male Nf1(+/-) mice also exhibited greater mechanical hypersensitivity; however, female Nf1(+/-) mice exhibited less mechanical hypersensitivity than their wild type littermates. Transcripts for calcitonin gene-related peptide were similar in the dorsal root ganglia of both genotypes and genders. Transcripts for receptor activity-modifying protein-1, which is rate-limiting for the calcitonin gene-related peptide receptor, in the spinal cord were comparable for both genotypes and genders. The increased responsiveness to intraplantar calcitonin gene-related peptide suggests that the peripheral actions of calcitonin gene-related peptide are enhanced as a result of the neurofibromin deficit. The analgesic efficacy of calcitonin gene-related peptide receptor antagonists may therefore merit investigation in neurofibromatosis patients.	[White, Stephanie; de Prado, Blanca Marquez; Hammond, Donna L.] Univ Iowa, Dept Anesthesia, Iowa City, IA 52242 USA; [de Prado, Blanca Marquez; Russo, Andrew F.] Univ Iowa, Dept Mol Physiol & Biophys, Iowa City, IA 52242 USA; [Hammond, Donna L.] Univ Iowa, Dept Pharmacol, Iowa City, IA 52242 USA	University of Iowa; University of Iowa; University of Iowa	Hammond, DL (corresponding author), Univ Iowa, Dept Anesthesia, Iowa City, IA 52242 USA.	Donna-hammond@uiowa.edu	; Hammond, Donna/C-6508-2009	Russo, Andrew/0000-0002-8156-5649; Hammond, Donna/0000-0002-2537-0441	Department of Defense [NF073016, NF100114]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS075599] Funding Source: NIH RePORTER	Department of Defense(United States Department of Defense); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by the Department of Defense through Grant NF073016 to DLH and Grant NF100114 to BMdP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartley EJ, 2013, BRIT J ANAESTH, V111, P52, DOI 10.1093/bja/aet127; Benemei S, 2009, CURR OPIN PHARMACOL, V9, P9, DOI 10.1016/j.coph.2008.12.007; BRANNAN CI, 1994, GENE DEV, V8, P1019, DOI 10.1101/gad.8.9.1019; Creange A, 1999, BRAIN, V122, P473, DOI 10.1093/brain/122.3.473; Drouet A, 2004, BRAIN, V127, P1993, DOI 10.1093/brain/awh234; Duan JH, 2014, NEUROSCIENCE, V270, P192, DOI 10.1016/j.neuroscience.2014.04.021; Duarte DB, 2011, J NEUROPHYSIOL, V106, P309, DOI 10.1152/jn.00963.2010; Fillingim RB, 2009, J PAIN, V10, P447, DOI 10.1016/j.jpain.2008.12.001; Hay DL, 2006, PHARMACOL THERAPEUT, V109, P173, DOI 10.1016/j.pharmthera.2005.06.015; Hingtgen CM, 2006, NEUROSCIENCE, V137, P637, DOI 10.1016/j.neuroscience.2005.09.030; HIRATA H, 1990, PAIN, V42, P253, DOI 10.1016/0304-3959(90)91169-J; Hodgdon KE, 2012, NEUROSCIENCE, V206, P237, DOI 10.1016/j.neuroscience.2011.12.045; JACKS T, 1994, NAT GENET, V7, P353, DOI 10.1038/ng0794-353; Kilo S, 1997, PAIN, V73, P201, DOI 10.1016/S0304-3959(97)00108-5; Lakkis MM, 2000, J NEUROSCI RES, V62, P755, DOI 10.1002/1097-4547(20001215)62:6<755::AID-JNR1>3.3.CO;2-N; Lee MJ, 2007, CURR OPIN NEUROL, V20, P135, DOI 10.1097/WCO.0b013e3280895da8; Li DG, 2008, J PAIN, V9, P1155, DOI 10.1016/j.jpain.2008.06.011; LUNDBERG JM, 1992, ANN NY ACAD SCI, V657, P187, DOI 10.1111/j.1749-6632.1992.tb22767.x; Ma WY, 2006, J NEUROCHEM, V98, P180, DOI 10.1111/j.1471-4159.2006.03856.x; Macpherson LJ, 2007, J NEUROSCI, V27, P11412, DOI 10.1523/JNEUROSCI.3600-07.2007; Malin S, 2011, J NEUROSCI, V31, P10516, DOI 10.1523/JNEUROSCI.2992-10.2011; McClatchey AI, 2007, ANNU REV PATHOL-MECH, V2, P191, DOI 10.1146/annurev.pathol.2.010506.091940; McMullan S, 2004, J NEUROSCI METH, V138, P133, DOI 10.1016/j.jneumeth.2004.03.020; McNamara CR, 2007, P NATL ACAD SCI USA, V104, P13525, DOI 10.1073/pnas.0705924104; Moore EL, 2012, BRIT J PHARMACOL, V166, P66, DOI 10.1111/j.1476-5381.2011.01633.x; O'Brien DE, 2013, J PAIN, V14, P628, DOI 10.1016/j.jpain.2013.01.770; Riccardi V M, 1992, Curr Probl Pediatr, V22, P66, DOI 10.1016/0045-9380(92)90053-2; RICCARDI VM, 1994, AM J PATHOL, V145, P994; RICCARDI VM, 1992, CURR PROBL PEDIATR, V22, P107; Salmon AM, 2001, NAT NEUROSCI, V4, P357, DOI 10.1038/86001; Seybold V S, 2009, Handb Exp Pharmacol, P451, DOI 10.1007/978-3-540-79090-7_13; Story GM, 2003, CELL, V112, P819, DOI 10.1016/S0092-8674(03)00158-2; Sun RQ, 2003, PAIN, V104, P201, DOI 10.1016/S0304-3959(03)00008-3; Theos A, 2006, ANN INTERN MED, V144, P842, DOI 10.7326/0003-4819-144-11-200606060-00010; Tian Li-Juan, 2009, Shengli Xuebao, V61, P404; VAALASTI A, 1990, J CUTAN PATHOL, V17, P371, DOI 10.1111/j.1600-0560.1990.tb00114.x; VANCE JM, 1989, AM J HUM GENET, V44, P25; VanRossum D, 1997, NEUROSCI BIOBEHAV R, V21, P649, DOI 10.1016/S0149-7634(96)00023-1; Von Banchet GS, 2002, NEUROSCIENCE, V110, P131, DOI 10.1016/S0306-4522(01)00547-4; Wang Y, 2005, J NEUROPHYSIOL, V94, P3670, DOI 10.1152/jn.00489.2005; Wang Y, 2010, J NEUROPHYSIOL, V103, P2085, DOI 10.1152/jn.01010.2009; Wolkenstein P, 2001, ARCH DERMATOL, V137, P1421, DOI 10.1001/archderm.137.11.1421; Yeomans DC, 1996, PAIN, V68, P141, DOI 10.1016/S0304-3959(96)03177-6; YEOMANS DC, 1994, PAIN, V59, P85, DOI 10.1016/0304-3959(94)90051-5; Yu LC, 2009, NEUROSCI BIOBEHAV R, V33, P1185, DOI 10.1016/j.neubiorev.2009.03.009; Zhang ZM, 2007, J NEUROSCI, V27, P2693, DOI 10.1523/JNEUROSCI.4542-06.2007	46	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 3	2014	9	9							e106767	10.1371/journal.pone.0106767	http://dx.doi.org/10.1371/journal.pone.0106767			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3TB	25184332	gold, Green Published, Green Submitted			2022-12-27	WOS:000341257700117
J	Yadav, S; Gupta, S; Selvaraj, C; Doharey, PK; Verma, A; Singh, SK; Saxena, JK				Yadav, Sunita; Gupta, Smita; Selvaraj, Chandrabose; Doharey, Pawan Kumar; Verma, Anita; Singh, Sanjeev Kumar; Saxena, Jitendra Kumar			In Silico and In Vitro Studies on the Protein-Protein Interactions between Brugia malayi Immunomodulatory Protein Calreticulin and Human C1q	PLOS ONE			English	Article							CLASSICAL COMPLEMENT PATHWAY; FASCIOLA-HEPATICA; NIPPOSTRONGYLUS-BRASILIENSIS; HAEMONCHUS-CONTORTUS; STRUCTURAL BIOLOGY; MEMBRANE-PROTEINS; FILARIAL PARASITE; GLOBULAR DOMAIN; 1ST COMPONENT; A-CHAIN	Filarial parasites modulate effective immune response of their host by releasing a variety of immunomodulatory molecules, which help in the long persistence of the parasite within the host. The present study was aimed to characterize an immunomodulatory protein of Brugia malayi and its interaction with the host immune component at the structural and functional level. Our findings showed that Brugia malayi Calreticulin (BmCRT) is responsible for the prevention of classical complement pathway activation via its interaction with the first component C1q of the human host. This was confirmed by inhibition of C1q dependent lysis of immunoglobulin-sensitized Red Blood Cells (S-RBCs). This is possibly the first report which predicts CRT-C1q interaction on the structural content of proteins to explain how BmCRT inhibits this pathway. The molecular docking of BmCRT-C1q complex indicated that C1qB chain (IgG/M and CRP binding sites on C1q) played a major role in the interaction with conserved and non-conserved regions of N and P domain of BmCRT. Out of 37 amino acids of BmCRT involved in the interaction, nine amino acids (Pro(126), Glu(132), His(147), Arg(151), His(153), Met(154), Lys(156), Ala(196) and Lys(212)) are absent in human CRT. Both ELISA and in silico analysis showed the significant role of Ca+2 in BmCRT-HuC1q complex formation and deactivation of C1r(2)-C1s(2). Molecular dynamics studies of BmCRT-HuC1q complex showed a deviation from similar to 0.4 nm to similar to 1.0 nm. CD analyses indicated that BmCRT is composed of 49.6% alpha helix, 9.6% beta sheet and 43.6% random coil. These findings provided valuable information on the architecture and chemistry of BmCRT-C1q interaction and supported the hypothesis that BmCRT binds with huC1q at their targets (IgG/M, CRP) binding sites. This interaction enables the parasite to interfere with the initial stage of host complement activation, which might be helpful in parasites establishment. These results might be utilized for help in blocking the C1q/CRT interaction and preventing parasite infection.	[Yadav, Sunita; Gupta, Smita; Doharey, Pawan Kumar; Verma, Anita; Saxena, Jitendra Kumar] Cent Drug Res Inst, CSIR, Div Biochem, Lucknow 226001, Uttar Pradesh, India; [Selvaraj, Chandrabose; Singh, Sanjeev Kumar] Alagappa Univ, Dept Bioinformat, Comp Aided Drug Design & Mol Modeling Lab, Karaikkudi, Tamil Nadu, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Central Drug Research Institute (CDRI); Alagappa University	Saxena, JK (corresponding author), Cent Drug Res Inst, CSIR, Div Biochem, BS10-1,Sect 10, Lucknow 226001, Uttar Pradesh, India.	jkscdri@yahoo.com	Singh, Kumar/AAP-1954-2020; Yadav, Sunita/ABG-3222-2020; Singh, Sanjeev Kumar/GZG-9941-2022; Chandrabose, Selvaraj/N-6961-2017; Selvaraj, Chandrabose/F-4168-2012	Singh, Kumar/0000-0003-4153-6437; Chandrabose, Selvaraj/0000-0002-8115-0486; Selvaraj, Chandrabose/0000-0002-8115-0486	University Grants Commission (UGC); Council for Scientific and Industrial Research (CSIR); Indian Council of Medical Research (ICMR), New Delhi, India	University Grants Commission (UGC)(University Grants Commission, India); Council for Scientific and Industrial Research (CSIR)(Council of Scientific & Industrial Research (CSIR) - India); Indian Council of Medical Research (ICMR), New Delhi, India(Indian Council of Medical Research (ICMR))	The financial support was received in the form of research fellowships to the research students from University Grants Commission (UGC), Council for Scientific and Industrial Research (CSIR) and Indian Council of Medical Research (ICMR), New Delhi, India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aliev AE, 2007, J PHYS CHEM B, V111, P14034, DOI 10.1021/jp076729c; Allen JE, 1998, PARASITE IMMUNOL, V20, P241, DOI 10.1046/j.1365-3024.1998.00151.x; ANDRADE MA, 1993, PROTEIN ENG, V6, P383, DOI 10.1093/protein/6.4.383; [Anonymous], 2012, PRIM VERS 3 0; Arlaud GJ, 2002, BIOCHEM SOC T, V30, P1001, DOI 10.1042/bst0301001; Arlaud GJ, 2002, MOL IMMUNOL, V39, P383, DOI 10.1016/S0161-5890(02)00143-8; Bernauer J, 2008, BIOINFORMATICS, V24, P652, DOI 10.1093/bioinformatics/btn022; Bockarie MJ, 2010, CURR OPIN INFECT DIS, V23, P617, DOI 10.1097/QCO.0b013e32833fdee5; Castillo C, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002376; Cervi L, 1999, PARASITOLOGY, V119, P627, DOI 10.1017/S003118209900517X; COOPER NR, 1985, ADV IMMUNOL, V37, P151, DOI 10.1016/S0065-2776(08)60340-5; Dainichi T, 2001, INFECT IMMUN, V69, P7380, DOI 10.1128/IAI.69.12.7380-7386.2001; Eggleton P, 1999, SCAND J IMMUNOL, V49, P466; Fazil MHUT, 2012, J BIOMOL STRUCT DYN, V30, P574, DOI 10.1080/07391102.2012.687523; Ferreira V, 2004, J IMMUNOL, V172, P3042, DOI 10.4049/jimmunol.172.5.3042; FLIEGEL L, 1989, J BIOL CHEM, V264, P21522; Flynn RJ, 2007, INFECT IMMUN, V75, P1373, DOI 10.1128/IAI.01445-06; Gaboriaud C, 2003, J BIOL CHEM, V278, P46974, DOI 10.1074/jbc.M307764200; Gadjeva MG, 2008, BIOCHEMISTRY-US, V47, P13093, DOI 10.1021/bi801131h; Gasque P, 2004, MOL IMMUNOL, V41, P1089, DOI 10.1016/j.molimm.2004.06.011; Ghebrehiwet B, 1997, J IMMUNOL, V159, P1429; Ghebrehiwet B, 2004, MOL IMMUNOL, V41, P173, DOI 10.1016/j.molimm.2004.03.014; Ghebrehiwet B, 2003, INT IMMUNOPHARMACOL, V3, P299, DOI 10.1016/S1567-5769(02)00270-9; Graham AL, 2005, J INFECT DIS, V191, P410, DOI 10.1086/426871; Guo L, 2003, J BIOL CHEM, V278, P50645, DOI 10.1074/jbc.M309497200; Helenius A, 1997, TRENDS CELL BIOL, V7, P193; Hewitson JR, 2008, MOL BIOCHEM PARASIT, V160, P8, DOI 10.1016/j.molbiopara.2008.02.007; Hoerauf A, 2011, CLIN MICROBIOL INFEC, V17, P977, DOI 10.1111/j.1469-0691.2011.03586.x; Holland MJ, 2000, EUR J IMMUNOL, V30, P1977, DOI 10.1002/1521-4141(200007)30:7&lt;1977::AID-IMMU1977&gt;3.0.CO;2-3; Johnson S, 2001, TRENDS CELL BIOL, V11, P122, DOI 10.1016/S0962-8924(01)01926-2; Jorgensen CS, 2003, EUR J BIOCHEM, V270, P4140, DOI 10.1046/j.1432-1033.2003.03808.x; Joshi P, 2000, INDIAN J BIOCHEM BIO, V37, P192; KARANU FN, 1993, EXP PARASITOL, V77, P362, DOI 10.1006/expr.1993.1093; Kasper G, 2001, PARASITE IMMUNOL, V23, P141, DOI 10.1046/j.1365-3024.2001.00366.x; Kim KY, 2008, BIOCHEM BIOPH RES CO, V371, P600, DOI 10.1016/j.bbrc.2008.03.126; Kishore U, 1997, BIOCHEM J, V322, P543, DOI 10.1042/bj3220543; Kishore U, 1997, CLIN EXP IMMUNOL, V108, P181, DOI 10.1046/j.1365-2249.1997.3761273.x; Kishore W, 2004, IMMUNOL LETT, V95, P113, DOI 10.1016/j.imlet.2004.06.015; Kovacs H, 1998, BIOCHEMISTRY-US, V37, P17865, DOI 10.1021/bi973197p; Kozlov G, 2010, J BIOL CHEM, V285, P35551, DOI 10.1074/jbc.M110.160101; KUWABARA K, 1995, J BIOL CHEM, V270, P8179, DOI 10.1074/jbc.270.14.8179; Kwon MS, 2000, MOL BIOL CELL, V11, P1433, DOI 10.1091/mbc.11.4.1433; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Lyne PD, 2006, J MED CHEM, V49, P4805, DOI 10.1021/jm060522a; Maizels RM, 2003, NAT REV IMMUNOL, V3, P733, DOI 10.1038/nri1183; Mary KA, 2007, J IMMUNOASS IMMUNOCH, V28, P343, DOI 10.1080/15321810701603484; Mery L, 1996, J BIOL CHEM, V271, P9332, DOI 10.1074/jbc.271.16.9332; Michalak M, 1999, BIOCHEM J, V344, P281, DOI 10.1042/0264-6021:3440281; Michalak M, 2002, CELL CALCIUM, V32, P269, DOI 10.1016/S0143416002001884; MILBOURNE EA, 1993, INT J PARASITOL, V23, P1005, DOI 10.1016/0020-7519(93)90120-N; MILBOURNE EA, 1990, INT J PARASITOL, V20, P705, DOI 10.1016/0020-7519(90)90135-A; Murthy P.K., 1995, Journal of Parasitic Diseases, V19, P135; Naresha S, 2009, MOL BIOCHEM PARASIT, V166, P42, DOI 10.1016/j.molbiopara.2009.02.007; Newlands GFJ, 2001, PARASITOLOGY, V122, P371, DOI 10.1017/S0031182001007302; Nisbet AJ, 2010, PARASITE IMMUNOL, V32, P503, DOI 10.1111/j.1365-3024.2010.01215.x; Ogden CA, 2001, J EXP MED, V194, P781, DOI 10.1084/jem.194.6.781; Osei-Atweneboana MY, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0000998; Paidassi H, 2011, J MOL BIOL, V408, P277, DOI 10.1016/j.jmb.2011.02.029; Peng GP, 2008, J VIROL, V82, P12487, DOI 10.1128/JVI.00877-08; Peterson KL, 1997, CLIN IMMUNOL IMMUNOP, V84, P17, DOI 10.1006/clin.1997.4374; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pronk S, 2013, BIOINFORMATICS, V29, P845, DOI 10.1093/bioinformatics/btt055; Prowse RK, 2002, PARASITE IMMUNOL, V24, P57, DOI 10.1046/j.0141-9838.2001.00438.x; Racila DM, 1999, LUPUS, V8, P300, DOI 10.1191/096120399678847849; Roumenina LT, 2006, BIOCHEMISTRY-US, V45, P4093, DOI 10.1021/bi052646f; Roumenina LT, 2005, BIOCHEMISTRY-US, V44, P14097, DOI 10.1021/bi051186n; Roumenina L, 2007, J MOL RECOGNIT, V20, P405, DOI 10.1002/jmr.853; Rzepecka J, 2009, MOL IMMUNOL, V46, P1109, DOI 10.1016/j.molimm.2008.10.032; Schneidman-Duhovny D, 2005, NUCLEIC ACIDS RES, V33, pW363, DOI 10.1093/nar/gki481; SCHUMAKER VN, 1987, ANNU REV IMMUNOL, V5, P21, DOI 10.1146/annurev.iy.05.040187.000321; Selvaraj C, 2012, MED CHEM RES, V21, P4060, DOI 10.1007/s00044-011-9941-5; Shafreen RMB, 2013, J MOL RECOGNIT, V26, P276, DOI 10.1002/jmr.2270; Sim RB, 1998, IMMUNOBIOLOGY, V199, P208, DOI 10.1016/S0171-2985(98)80028-4; SMITH MJ, 1989, EMBO J, V8, P3581, DOI 10.1002/j.1460-2075.1989.tb08530.x; Spiegel A, 2003, T ROY SOC TROP MED H, V97, P198, DOI 10.1016/S0035-9203(03)90117-9; Steino A, 2004, SCAND J IMMUNOL, V59, P485, DOI 10.1111/j.0300-9475.2004.01425.x; Stuart GR, 1996, FEBS LETT, V397, P245, DOI 10.1016/S0014-5793(96)01156-8; Stuart GR, 1997, IMMUNOPHARMACOLOGY, V38, P73, DOI 10.1016/S0162-3109(97)00076-3; Suchitra S, 2005, BBA-GEN SUBJECTS, V1722, P293, DOI 10.1016/j.bbagen.2004.12.020; Taylor MJ, 2010, LANCET, V376, P1175, DOI 10.1016/S0140-6736(10)60586-7; Thermo scientific, INSTRUCTIONS PROF PU; Trombetta ES, 2003, GLYCOBIOLOGY, V13, p77R, DOI 10.1093/glycob/cwg075; Urban JF, 2007, VET PARASITOL, V148, P14, DOI 10.1016/j.vetpar.2007.05.006; Valck C, 2010, MOL IMMUNOL, V47, P1516, DOI 10.1016/j.molimm.2010.01.019; van Riet E, 2007, IMMUNOBIOLOGY, V212, P475, DOI 10.1016/j.imbio.2007.03.009; Vandivier RW, 2002, J IMMUNOL, V169, P3978, DOI 10.4049/jimmunol.169.7.3978; Vegh Z, 2006, MOL IMMUNOL, V43, P1402, DOI 10.1016/j.molimm.2005.07.030; Winger M, 2009, PHYS CHEM CHEM PHYS, V11, P1934, DOI 10.1039/b818713d; YING SC, 1993, J IMMUNOL, V150, P169; Zlatarova AS, 2006, BIOCHEMISTRY-US, V45, P9979, DOI 10.1021/bi060539v	91	30	32	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 3	2014	9	9							e106413	10.1371/journal.pone.0106413	http://dx.doi.org/10.1371/journal.pone.0106413			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3TB	25184227	Green Submitted, Green Published, gold			2022-12-27	WOS:000341257700067
J	Gaythri, T; Suresh, K; Subha, B; Kalyani, R				Gaythri, T.; Suresh, K.; Subha, B.; Kalyani, R.			Identification and Characterisation of Heat Shock Protein 70 in Thermal Stressed Blastocystis sp.	PLOS ONE			English	Article							NITRIC-OXIDE PRODUCTION; HEAT-SHOCK; HOST-DEFENSE; HOMINIS; HSP70; EXPRESSION; SYNTHASE; ARGININE	Protistan parasites in order to ensure their viability and demonstrate successful progression in their life cycle need to respond towards various environmental stressors. Blastocystis sp. is known to be the most commonly found intestinal protistan parasite in any human stool surveys and has been incriminated to be responsible for diarrhea and bloating stomach. The present study demonstrates for the first time the presence of HSP70 in subtypes of Blastocystis sp. when the cultures were subjected to temperature of 39 and 41 degrees C where the growth of parasites was reduced to a minimum to majority being granular forms. The growth of parasites exposed to higher temperatures however doubled compared to the controls when the parasites were re- cultured back at 37 degrees C. Upon thermal stress at 41 degrees C, subtype 3 and subtype 5 isolates' growth reached up to 2.97x10(6) and 3.05x10 6 cells/ml compared to their respective controlled culture tubes at 37 degrees C which peaked only at 1.34x10(6) and 1.70x10(6) cells/ml respectively. The designed primer set that amplified Blastocystis sp. subtype 7 HSP70 gene in subtypes 1, 3 and 5 was against a conserved region. The gene was amplified at 318 bp. The multiple sequence alignment showed that the targeted sequence length ranges from 291-295 bp. The pair wise alignment result showed that the sequence identity among the four sequence ranges from 88% to 96%. These findings were further evidenced by the up regulation of HSP70 gene in thermal stressed isolates of subtype 3 and 5 at 41 degrees C. Higher number of granular forms was significantly found in thermal stressed isolates of subtype 3 and 5 which implicates that this life cycle stage has a role in responding to thermal stress.	[Gaythri, T.; Suresh, K.; Kalyani, R.] Univ Malaya, Dept Parasitol, Kuala Lumpur, Malaysia; [Subha, B.] Univ Malaya, Dept Genet & Mol Biol, Kuala Lumpur, Malaysia	Universiti Malaya; Universiti Malaya	Suresh, K (corresponding author), Univ Malaya, Dept Parasitol, Kuala Lumpur, Malaysia.	suresh@um.edu.my	BHASSU, SUBHA/B-9843-2010	BHASSU, SUBHA/0000-0001-8658-6900	High Impact Research Grant (HIR) [UM.C/HIR/MOHE/MED/44]; University of Malaya Postgraduate Research Grant (PPP) [PG108-2012B]	High Impact Research Grant (HIR); University of Malaya Postgraduate Research Grant (PPP)	This work was supported by High Impact Research Grant (HIR) (UM.C/HIR/MOHE/MED/44) and University of Malaya Postgraduate Research Grant (PPP) (PG108-2012B). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akide-Ndunge OB, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-113; Babbitt SE, 2012, PLASMODIUM FALCIPARU; Deane EE, 2004, AM J PHYSIOL-REG I, V287, pR1054, DOI 10.1152/ajpregu.00347.2004; Denoeud F, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-3-r29; Eckmann L, 2000, J IMMUNOL, V164, P1478, DOI 10.4049/jimmunol.164.3.1478; Elnekave K, 2003, PARASITE IMMUNOL, V25, P597, DOI 10.1111/j.0141-9838.2004.00669.x; Evans CG, 2010, J MED CHEM PERSPECTI; Govind SK, 2002, TRENDS PARASITOL, V18, P528, DOI 10.1016/S1471-4922(02)02402-9; JONES WR, 1946, ANN TROP MED PARASIT, V40, P130, DOI 10.1080/00034983.1946.11685270; Krebs RA, 1998, J INSECT PHYSIOL, V44, P1091, DOI 10.1016/S0022-1910(98)00059-6; Lewis ND, 2010, J IMMUNOL, V184, P2572, DOI 10.4049/jimmunol.0902436; LINDLEY TA, 1988, MOL BIOCHEM PARASIT, V28, P135, DOI 10.1016/0166-6851(88)90061-8; Mirza H, 2011, INFECT IMMUN, V79, P5019, DOI 10.1128/IAI.05632-11; Nakano K, 2004, ENVIRON BIOL FISH, V70, P321, DOI 10.1023/B:EBFI.0000035425.08566.9f; Rajah S, 1997, INT MED RES J, V1, P93; Roberts SP, 1999, OECOLOGIA, V121, P323, DOI 10.1007/s004420050935; Sorensen JG, 2003, ECOL LETT, V6, P1025, DOI 10.1046/j.1461-0248.2003.00528.x; Stenzel DJ, 1996, CLIN MICROBIOL REV, V9, P563, DOI 10.1128/CMR.9.4.563; SURESH K, 1994, INT J PARASITOL, V24, P605, DOI 10.1016/0020-7519(94)90152-X; SURESH K, 1994, PARASITOL RES, V80, P327, DOI 10.1007/BF02351875; TAN HK, 1973, Z PARASITENKD, V42, P315, DOI 10.1007/BF00328892; Tan KSW, 2003, TRENDS PARASITOL, V19, P290, DOI 10.1016/S1471-4922(03)00119-3; Tan TC, 2008, PARASITOL RES, V104, P85, DOI 10.1007/s00436-008-1163-5; Zaman V, 1997, PARASITOL RES, V83, P731, DOI 10.1007/s004360050329; Zhang YL, 1998, INFECT IMMUN, V66, P3106, DOI 10.1128/IAI.66.7.3106-3112.1998; ZIERDT CH, 1967, AM J CLIN PATHOL, V48, P495	26	4	4	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2014	9	9							e95608	10.1371/journal.pone.0095608	http://dx.doi.org/10.1371/journal.pone.0095608			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3LR	25180903	gold, Green Published, Green Submitted			2022-12-27	WOS:000341231500002
J	Xu, CG; Kou, YH; Zhang, PX; Han, N; Yin, XF; Deng, JX; Chen, B; Jiang, BG				Xu, Chungui; Kou, Yuhui; Zhang, Peixun; Han, Na; Yin, Xiaofeng; Deng, Jiuxu; Chen, Bo; Jiang, Baoguo			Electrical Stimulation Promotes Regeneration of Defective Peripheral Nerves after Delayed Repair Intervals Lasting under One Month	PLOS ONE			English	Article							SCHWANN-CELL DENERVATION; RAT FEMORAL MOTONEURONS; NEUROTROPHIC FACTOR; MUSCLE REINNERVATION; AXONAL REGENERATION; SPINAL MOTONEURONS; GENE-EXPRESSION; MOTOR-NEURONS; ADULT RATS; IN-VIVO	Background: Electrical stimulation (ES) has been proven to be an effective means of enhancing the speed and accuracy of nerve regeneration. However, these results were recorded when the procedure was performed almost immediately after nerve injury. In clinical settings, most patients cannot be treated immediately. Some patients with serious trauma or contaminated wounds need to wait for nerve repair surgery. Delays in nerve repair have been shown to be associated with poorer results than immediate surgery. It is not clear whether electrical stimulation still has any effect on nerve regeneration after enough time has elapsed. Methods: A delayed nerve repair model in which the rats received delayed nerve repair after 1 day, 1 week, 1 month, and 2 months was designed. At each point in time, the nerve stumps of half the rats were bridged with an absorbable conduit and the rats were given 1 h of weak electrical stimulation. The other half was not treated. In order to analyzethe morphological and molecular differences among these groups, 6 ES rats and 6 sham ES rats per point in time were killed 5 days after surgery. The other rats in each group were allowed to recover for 6 weeks before the final functional test and tissue observation. Results: The amounts of myelinated fibers in the distal nerve stumps decreased as the delay in repair increased for both ES rats and sham ES rats. In the 1-day-delay and 1-week-delay groups, there were more fibers in ES rats than in sham ES rats. And the compound muscle action potential (CMAP) and motor nerve conduction velocity (MNCV) results were better for ES rats in these two groups. In order to analyze the mechanisms underlying these differences, Masson staining was performed on the distal nerves and quantitative PCR on the spinal cords. Results showed that, after delays in repair of 1 month and 2 months, there was more collagen tissue hyperplasia in the distal nerve in all rats. The brain-derived neurotrophic factor (BDNF) and trkB expression levels in the spinal cords of ES rats were higher than in sham ES rats. However, these differences decreased as the delay in repair increased. Conclusions: Electrical stimulation does not continue to promote nerve regeneration after long delays in nerve repair. The effective interval for nerve regeneration after delayed repair was found to be less than 1 month. The mechanism seemed to be related to the expression of nerve growth factors and regeneration environment in the distal nerves.	[Xu, Chungui; Kou, Yuhui; Zhang, Peixun; Han, Na; Yin, Xiaofeng; Deng, Jiuxu; Chen, Bo; Jiang, Baoguo] Peking Univ, Dept Trauma & Orthopaed, Peoples Hosp, Beijing 100871, Peoples R China	Peking University	Jiang, BG (corresponding author), Peking Univ, Dept Trauma & Orthopaed, Peoples Hosp, Beijing 100871, Peoples R China.	zhangpeixun@126.com; hanna@bjmu.edu.cn; jiangbaoguo@vip.sina.com		Han, Na/0000-0002-2472-8245; Yin, Xiaofeng/0000-0001-9932-642X; Kou, Yuhui/0000-0003-1523-825X; Jiang, Baoguo/0000-0001-8436-5266	Chinese National Ministry of Science and Technology 973 Project Planning [2014CB542200]; National Natural Science Fund [31271284, 31171150, 81171146, 30971526, 31100860, 31040043]; Educational Ministry New Century Excellent Talents Support Project [BMU20110270]; Beijing City Science and Technology New Star Classification [A-2008-10]	Chinese National Ministry of Science and Technology 973 Project Planning; National Natural Science Fund(National Natural Science Foundation of China (NSFC)); Educational Ministry New Century Excellent Talents Support Project; Beijing City Science and Technology New Star Classification	This research project was funded by the Chinese National Ministry of Science and Technology 973 Project Planning (No. 2014CB542200); The ministry of education innovation team(IRT1201); the National Natural Science Fund (No. 31271284, 31171150, 81171146, 30971526, 31100860, 31040043); the Educational Ministry New Century Excellent Talents Support Project (No. BMU20110270); and Beijing City Science and Technology New Star Classification (A-2008-10). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Majed AA, 2004, CELL MOL NEUROBIOL, V24, P379, DOI 10.1023/B:CEMN.0000022770.66463.f7; Al-Majed AA, 2000, EUR J NEUROSCI, V12, P4381, DOI 10.1046/j.1460-9568.2000.01341.x; Al-Majed AA, 2000, J NEUROSCI, V20, P2602; Brushart TM, 2005, EXP NEUROL, V194, P221, DOI 10.1016/j.expneurol.2005.02.007; BRUSHART TM, 1983, J HAND SURG-AM, V8, P248, DOI 10.1016/S0363-5023(83)80152-X; Diao E, 2000, HAND CLIN, V16, P53; Dvali L, 2003, CLIN PLAST SURG, V30, P203, DOI 10.1016/S0094-1298(02)00096-2; Fernandes KJL, 1998, J NEUROSCI, V18, P9936; FRIEDMAN B, 1995, J NEUROSCI, V15, P1044; Geremia NM, 2007, EXP NEUROL, V205, P347, DOI 10.1016/j.expneurol.2007.01.040; Gordon T, 2010, EXP NEUROL, V223, P192, DOI 10.1016/j.expneurol.2009.09.020; Gordon T, 2009, INT REV NEUROBIOL, V87, P433, DOI 10.1016/S0074-7742(09)87024-4; GULATI AK, 1988, J NEUROSURG, V68, P117, DOI 10.3171/jns.1988.68.1.0117; Gutmann E, 1942, J EXP BIOL, V19, P14; Hoke A, 2002, EXP NEUROL, V173, P77, DOI 10.1006/exnr.2001.7826; Huang JH, 2013, EUR J NEUROSCI, V38, P3691, DOI 10.1111/ejn.12370; Jivan S, 2006, EXP BRAIN RES, V170, P245, DOI 10.1007/s00221-005-0207-7; Jonsson S, 2012, PLOS ONE, V8; Li H, 1997, GLIA, V20, P333, DOI 10.1002/(SICI)1098-1136(199708)20:4<333::AID-GLIA6>3.0.CO;2-6; Ma JJ, 2001, EXP BRAIN RES, V139, P216, DOI 10.1007/s002210100769; NADIM W, 1990, NEUROPATH APPL NEURO, V16, P411, DOI 10.1111/j.1365-2990.1990.tb01277.x; Noble J, 1998, J TRAUMA, V45, P116, DOI 10.1097/00005373-199807000-00025; NOVIKOV L, 1995, NEUROSCI LETT, V200, P45, DOI 10.1016/0304-3940(95)12078-I; Ramon Y., 1928, DEGENERATION REGENER; Saito H, 2009, NEUROSCI LETT, V456, P30, DOI 10.1016/j.neulet.2009.03.075; Saito H, 2008, BMC NEUROSCI, V9, DOI 10.1186/1471-2202-9-88; Siemionow M, 2004, NEUROL RES, V26, P218, DOI 10.1179/016164104225013860; Spinner RJ, 2000, MUSCLE NERVE, V23, P680, DOI 10.1002/(SICI)1097-4598(200005)23:5<680::AID-MUS4>3.0.CO;2-H; Stauch B, 2000, HAND CLIN, V16, P123; Sulaiman OAR, 2000, GLIA, V32, P234, DOI 10.1002/1098-1136(200012)32:3<234::AID-GLIA40>3.0.CO;2-3; Sunderland S, 1978, NERV NERV INJ; Taylor CA, 2008, AM J PHYS MED REHAB, V87, P381, DOI 10.1097/PHM.0b013e31815e6370; THOMAS PK, 1964, J ANAT, V98, P175; Tohill M, 2004, NEUROSCI LETT, V362, P200, DOI 10.1016/j.neulet.2004.03.077; Trumble TE, 2000, HAND CLIN, V16, P105; Wang W, 1997, J NEUROSCI RES, V47, P134, DOI 10.1002/(SICI)1097-4547(19970115)47:2<134::AID-JNR2>3.0.CO;2-G; YAN Q, 1994, J NEUROSCI, V14, P5281; Yeh CC, 2010, NEUROREHAB NEURAL RE, V24, P730, DOI 10.1177/1545968310376758; Zhang PX, 2005, J RECONSTR MICROSURG, V21, P565, DOI 10.1055/s-2005-922437	39	26	31	3	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2014	9	9							e105045	10.1371/journal.pone.0105045	http://dx.doi.org/10.1371/journal.pone.0105045			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3LR	25181499	Green Published, Green Submitted, gold			2022-12-27	WOS:000341231500016
J	Zhang, QZ; Dijkstra, FA; Liu, XR; Wang, YD; Huang, J; Lu, N				Zhang, Qing-zhong; Dijkstra, Feike A.; Liu, Xing-ren; Wang, Yi-ding; Huang, Jian; Lu, Ning			Effects of Biochar on Soil Microbial Biomass after Four Years of Consecutive Application in the North China Plain	PLOS ONE			English	Article							FUMIGATION-EXTRACTION; MINERALIZATION; CARBON; DECOMPOSITION; CALIBRATION; COMMUNITY; NITROGEN; RELEASE; RESIDUE; IMPACT	The long term effect of biochar application on soil microbial biomass is not well understood. We measured soil microbial biomass carbon (MBC) and nitrogen (MBN) in a field experiment during a winter wheat growing season after four consecutive years of no (CK), 4.5 (B4.5) and 9.0 t biochar ha(-1) yr(-1) (B9.0) applied. For comparison, a treatment with wheat straw residue incorporation (SR) was also included. Results showed that biochar application increased soil MBC significantly compared to the CK treatment, and that the effect size increased with biochar application rate. The B9.0 treatment showed the same effect on MBC as the SR treatment. Treatments effects on soil MBN were less strong than for MBC. The microbial biomass C:N ratio was significantly increased by biochar. Biochar might decrease the fraction of biomass N mineralized (K-N), which would make the soil MBN for biochar treatments underestimated, and microbial biomass C: N ratios overestimated. Seasonal fluctuation in MBC was less for biochar amended soils than for CK and SR treatments, suggesting that biochar induced a less extreme environment for microorganisms throughout the season. There was a significant positive correlation between MBC and soil water content (SWC), but there was no significant correlation between MBC and soil temperature. Biochar amendments may therefore reduce temporal variability in environmental conditions for microbial growth in this system thereby reducing temporal fluctuations in C and N dynamics.	[Zhang, Qing-zhong; Liu, Xing-ren; Wang, Yi-ding; Huang, Jian; Lu, Ning] Chinese Acad Agr Sci, Key Lab Agr Environm, Sinoaustralian Joint Lab Sustainable Agroecosyst, Minist Agr,Inst Environm & Sustainable Dev Agr, Beijing 100193, Peoples R China; [Dijkstra, Feike A.] Univ Sydney, Ctr Carbon Water & Food, Dept Environm Sci, Camden, NSW, Australia	Chinese Academy of Agricultural Sciences; Institute of Environment & Sustainable Development in Agriculture, CAAS; Ministry of Agriculture & Rural Affairs; University of Sydney	Zhang, QZ (corresponding author), Chinese Acad Agr Sci, Key Lab Agr Environm, Sinoaustralian Joint Lab Sustainable Agroecosyst, Minist Agr,Inst Environm & Sustainable Dev Agr, Beijing 100193, Peoples R China.	ecologyouth@126.com	Dijkstra, Feike A/H-2182-2012	Dijkstra, Feike A/0000-0002-6191-6018; Zhang, Yunchun/0000-0001-8259-5850	S & T Innovation Program of Chinese Academy of Agricultural Sciences	S & T Innovation Program of Chinese Academy of Agricultural Sciences	This work was supported by the S & T Innovation Program of Chinese Academy of Agricultural Sciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BROOKES PC, 1985, SOIL BIOL BIOCHEM, V17, P837, DOI 10.1016/0038-0717(85)90144-0; Castaldi S, 2011, CHEMOSPHERE, V85, P1464, DOI 10.1016/j.chemosphere.2011.08.031; Chen Y, 2010, AUST J SOIL RES, V48, P526, DOI 10.1071/SR10011; Contin M, 2000, SOIL BIOL BIOCHEM, V32, P1219, DOI 10.1016/S0038-0717(00)00038-9; Cross A, 2011, SOIL BIOL BIOCHEM, V43, P2127, DOI 10.1016/j.soilbio.2011.06.016; Dempster DN, 2012, PLANT SOIL, V354, P311, DOI 10.1007/s11104-011-1067-5; GREENFIELD LG, 1995, SOIL BIOL BIOCHEM, V27, P1235, DOI 10.1016/0038-0717(95)00023-8; [郭伟 GUO Wei], 2011, [生态环境学报, Ecology and Environmental Sciences], V20, P425; Joergensen RG, 1996, SOIL BIOL BIOCHEM, V28, P25, DOI 10.1016/0038-0717(95)00102-6; JOERGENSEN RG, 1990, SOIL BIOL BIOCHEM, V22, P1129, DOI 10.1016/0038-0717(90)90039-3; Kallenbach C, 2011, AGR ECOSYST ENVIRON, V144, P241, DOI 10.1016/j.agee.2011.08.020; Keith A, 2011, ENVIRON SCI TECHNOL, V45, P9611, DOI 10.1021/es202186j; Kolb SE, 2009, SOIL SCI SOC AM J, V73, P1173, DOI 10.2136/sssaj2008.0232; Kumar K, 2000, ADV AGRON, V68, P197; Kushwaha CP, 2000, SOIL TILL RES, V56, P153, DOI 10.1016/S0167-1987(00)00135-5; Lehmann J, 2009, EARTHSCAN, DOI [10.4324/9780203762264, DOI 10.4324/9780203762264]; Lehmann J, 2007, NATURE, V447, P143, DOI 10.1038/447143a; Lehmann J, 2011, SOIL BIOL BIOCHEM, V43, P1812, DOI 10.1016/j.soilbio.2011.04.022; Liang BQ, 2010, ORG GEOCHEM, V41, P206, DOI 10.1016/j.orggeochem.2009.09.007; Lou YS, 2004, SOIL BIOL BIOCHEM, V36, P1835, DOI 10.1016/j.soilbio.2004.05.006; Luo Y, 2013, SOIL BIOL BIOCHEM, V57, P513, DOI 10.1016/j.soilbio.2012.10.033; Luo Y, 2011, SOIL BIOL BIOCHEM, V43, P2304, DOI 10.1016/j.soilbio.2011.07.020; Nicolardot B, 2001, PLANT SOIL, V228, P83, DOI 10.1023/A:1004813801728; O'Neill B, 2009, MICROB ECOL, V58, P23, DOI 10.1007/s00248-009-9515-y; Piccolo A, 1996, SOIL USE MANAGE, V12, P209, DOI 10.1111/j.1475-2743.1996.tb00545.x; SPARLING G, 1993, SOIL BIOL BIOCHEM, V25, P1793, DOI 10.1016/0038-0717(93)90185-E; Steinbeiss S, 2009, SOIL BIOL BIOCHEM, V41, P1301, DOI 10.1016/j.soilbio.2009.03.016; Steiner C, 2008, PEDOBIOLOGIA, V51, P359, DOI 10.1016/j.pedobi.2007.08.002; Thiessen S, 2013, SOIL BIOL BIOCHEM, V57, P739, DOI 10.1016/j.soilbio.2012.10.029; WARDLE DA, 1992, BIOL REV, V67, P321, DOI 10.1111/j.1469-185X.1992.tb00728.x; WU J, 1990, SOIL BIOL BIOCHEM, V22, P1167, DOI 10.1016/0038-0717(90)90046-3; Zavalloni C, 2011, APPL SOIL ECOL, V50, P45, DOI 10.1016/j.apsoil.2011.07.012; Zhang QZ, 2013, SOIL RES, V51, P521, DOI 10.1071/SR13153; Zhang QZ, 2013, SOIL SCI SOC AM J, V77, P1478, DOI 10.2136/sssaj2012.0180; Zimmerman AR, 2011, SOIL BIOL BIOCHEM, V43, P1169, DOI 10.1016/j.soilbio.2011.02.005	35	79	90	12	141	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2014	9	7							e102062	10.1371/journal.pone.0102062	http://dx.doi.org/10.1371/journal.pone.0102062			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6RN	25184224	gold, Green Submitted, Green Published			2022-12-27	WOS:000339992400041
J	Sharfi, K; Rosenblum, S				Sharfi, Kineret; Rosenblum, Sara			Activity and Participation Characteristics of Adults with Learning Disabilities - A Systematic Review	PLOS ONE			English	Article							SOCIAL-EMOTIONAL SIDE; YOUNG-ADULTS; FOLLOW-UP; POSTSECONDARY EDUCATION; EMPLOYMENT OUTCOMES; LITERACY SURVEY; SCHOOL-AGE; STUDENTS; LANGUAGE; SELF	Background: 'Learning disabilities' (LD) refer to a wide group of neurological disorders caused by deficits in the central nervous system which influence the individual's ability to maintain-, process or convey information to others in an efficient way. A worldwide discussion about the definitions of LD continues while a conceptual framework for studying the diverse life outcomes of adults with LD is still missing. Objective: The aim was to review the literature on the activity and participation of adults with LD based on the International Classification of Functioning, Disability and Health (ICF) concepts. Methods: "PsychInfo'', "Eric'' and "PubMed'' were searched for relevant literature according to the guidelines of Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA). After a three-stage process, 62 articles relevant for domains of activity and participation of adults with LD were included in the review. Results: Thirty-two articles focused on the domain of major life areas of education, work and employment and twelve articles focused on the domain of learning and applying knowledge. Limitations in activity and participation of the population with LD in these domains are recognized and discussed. Eighteen additional articles demonstrated that adults with LD confront difficulties in various life domains (e.g., communication, interpersonal interactions, mobility, and domestic life), however literature concerning these domains is scarce. Conclusions: The ICF can be useful for further exploration of activity and participation characteristics of adults with LD in various life domains. Such exploration is required in order to gain a wider perspective of their functional characteristics and daily needs.	[Sharfi, Kineret; Rosenblum, Sara] Univ Haifa, Lab Complex Human Act & Participat, Dept Occupat Therapy, IL-31999 Haifa, Israel	University of Haifa	Sharfi, K (corresponding author), Univ Haifa, Lab Complex Human Act & Participat, Dept Occupat Therapy, IL-31999 Haifa, Israel.	kineretsharfi@gmail.com	Smith, Matthew E./A-8115-2012	Smith, Matthew E./0000-0002-0878-0932	Israeli Ministry of Science and Technology	Israeli Ministry of Science and Technology(Ministry of Science, Technology and Space (MOST), Israel)	This work was supported by the Israeli Ministry of Science and Technology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADELMAN PB, 1993, LEARN DISABILITY Q, V16, P219, DOI 10.2307/1511328; American Psychiatric Association, 1994, DIAGN STAT MAN MENT; Bahl M, 2009, J COMMUN DISORD, V42, P313, DOI 10.1016/j.jcomdis.2009.02.001; Brueggemann AE, 2008, PROF PSYCHOL-RES PR, V39, P424, DOI 10.1037/0735-7028.39.4.424; Bryan T, 2004, LEARN DISABILITY Q, V27, P45, DOI 10.2307/1593631; BUTLER DL, 1995, J LEARN DISABIL-US, V28, P170, DOI 10.1177/002221949502800306; Cameto R, 2011, LEARN DISABIL-MULTI, V17, P45; Cavendish W, 2013, J LEARN DISABIL-US, V46, P52, DOI 10.1177/0022219412464352; Chapman JW, 2003, DYSLEXIA, V9, P75, DOI 10.1002/dys.238; CLEMENTHEIST K, 1992, EXCEPT CHILDREN, V58, P336, DOI 10.1177/001440299205800406; Coleman C, 2009, ASSES EFF INTERV, V34, P94, DOI 10.1177/1534508408318808; Dickinson DL, 2002, J LEARN DISABIL-US, V35, P175, DOI 10.1177/002221940203500208; Dijkers MP, 2010, ARCH PHYS MED REHAB, V91, pS5, DOI 10.1016/j.apmr.2009.10.036; Dombrowski SC, 2004, PROF PSYCHOL-RES PR, V35, P364, DOI 10.1037/0735-7028.35.4.364; Doren B, 2007, CAREER DEV TRANSIT E, V30, P171, DOI 10.1177/08857288070300030601; Duquette C, 2009, EXCEPTIONALITY ED IN, V19, P51; Einat T, 2008, INT J OFFENDER THER, V52, P416, DOI 10.1177/0306624X07307352; Elksnin LK, 2004, LEARN DISABILITY Q, V27, P3, DOI 10.2307/1593627; FAFARD MB, 1981, LEARN DISABILITY Q, V4, P122, DOI 10.2307/1510997; FOURQUREAN JM, 1991, J LEARN DISABIL, V24, P400, DOI 10.1177/002221949102400704; Gerber P.J., 2003, LEARN DISABIL RES PR, V18, P132; Gerber P. J., 2008, LEARNING DISABILITIE, V15, P21; Gerber PJ, 2012, J LEARN DISABIL-US, V45, P31, DOI 10.1177/0022219411426858; GERBER PJ, 1990, J LEARN DISABIL, V23, P570, DOI 10.1177/002221949002300907; Gerber PJ, 2004, J LEARN DISABIL-US, V37, P283, DOI 10.1177/00222194040370040101; Gilger JW, 2001, DEV NEUROPSYCHOL, V20, P465, DOI 10.1207/S15326942DN2002_2; Goldstein DE, 1998, LEARNING DISABILITIE, V13, P53; GOODMAN NC, 1987, J CLIN CHILD PSYCHOL, V16, P290, DOI 10.1207/s15374424jccp1604_1; Greenbaum B, 1996, J LEARN DISABIL, V29, P167, DOI 10.1177/002221949602900206; Gregg N, 2008, REM SPEC EDUC, V29, P175, DOI 10.1177/0741932508315951; Grunow H, 2006, J COMMUN DISORD, V39, P158, DOI 10.1016/j.jcomdis.2005.11.004; HARING KA, 1990, J SPEC EDUC, V23, P463, DOI 10.1177/002246699002300409; HARING KA, 1990, J LEARN DISABIL, V23, P108, DOI 10.1177/002221949002300206; Heiman T, 2006, LEARN DISABILITY Q, V29, P55, DOI 10.2307/30035532; HOFFMANN FJ, 1987, J LEARN DISABIL, V20, P43, DOI 10.1177/002221948702000107; Hutchinson N. L., 2004, ALBERTA J EDUC RES, V50, P5; HYND GW, 1991, LEARN DISABILITY Q, V14, P283, DOI 10.2307/1510664; Isaki E, 2008, J COMMUN DISORD, V41, P512, DOI 10.1016/j.jcomdis.2008.03.006; JARVIS PA, 1992, ADOLESCENCE, V27, P977; Jongmans MJ, 2003, J LEARN DISABIL-US, V36, P528, DOI 10.1177/00222194030360060401; Josman  N., 2011, COGNITION OCCUPATION, P223; Kavale KA, 2000, J LEARN DISABIL-US, V33, P239, DOI 10.1177/002221940003300303; Kavale KA, 2009, LEARN DISABILITY Q, V32, P39, DOI 10.2307/25474661; KLEIN HB, 1988, J COMMUN DISORD, V21, P423, DOI 10.1016/0021-9924(88)90027-5; Learning Disabilities Association of Canada (LDA Canada), 2002, OFF DEF LEARN DIS; LEVINE P, 1995, EXCEPT CHILDREN, V61, P282; Luftig RL, 2005, RES DEV DISABIL, V26, P317, DOI 10.1016/j.ridd.2003.08.001; Macdonald SJ, 2009, DYSLEXIA, V15, P347, DOI 10.1002/dys.391; Madaus J.W., 2008, LEARN DISABIL RES PR, V23, P148, DOI [DOI 10.1111/J.1540-5826.2008.00272, 10.1111/j.1540-5826.2008.00272.x, DOI 10.1111/J.1540-5826.2008.00272.X]; Madaus JW, 2008, REM SPEC EDUC, V29, P323, DOI 10.1177/0741932507312012; Madaus JW, 2006, LEARN DISABILITY Q, V29, P19, DOI 10.2307/30035529; Magajna L, 2003, DYSLEXIA, V9, P229, DOI 10.1002/dys.242; MALCOLM CB, 1990, J LEARN DISABIL, V23, P518, DOI 10.1177/002221949002300811; Mangina CA, 2009, INT J PSYCHOPHYSIOL, V73, P170, DOI 10.1016/j.ijpsycho.2009.03.008; Mathis L.M., 2010, J APPL REHABIL COUNS, V41, P3, DOI [10.1891/0047-2220.41.1.3, DOI 10.1891/0047-2220.41.1.3]; McCue M, 1986, Arch Clin Neuropsychol, V1, P13, DOI 10.1016/0887-6177(86)90022-3; Mellard DF, 2008, REM SPEC EDUC, V29, P133, DOI 10.1177/0741932508315053; MELLARD DF, 1992, LEARN DISABILITY Q, V15, P251, DOI 10.2307/1511317; MILLER RJ, 1990, J LEARN DISABIL, V23, P349, DOI 10.1177/002221949002300605; MILLER RJ, 1991, J LEARN DISABIL, V24, P188, DOI 10.1177/002221949102400307; Murray C., 2000, LEARN DISABIL RES PR, V15, P119, DOI DOI 10.1207/SLDRP1503_1; Patterson ML, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2012-001586; POSTHILL SM, 1991, J LEARN DISABIL, V24, P619, DOI 10.1177/002221949102401005; Raskind M.H., 1999, LEARN DISABIL RES PR, V14, P35, DOI [10.1207/sldrp1401_4, DOI 10.1207/SLDRP1401_4]; Reis SM, 2000, GIFTED CHILD QUART, V44, P123, DOI 10.1177/001698620004400205; Resnik L, 2009, ARCH PHYS MED REHAB, V90, P856, DOI 10.1016/j.apmr.2008.11.010; Richardson J, 2006, J SPEECH LANG HEAR R, V49, P1257, DOI 10.1044/1092-4388(2006/090); Roffman AJ, 2000, M CHALLENGES LEARNIN; Scanlon D, 2002, EXCEPT CHILDREN, V68, P239, DOI 10.1177/001440290206800206; Scanlon D, 2013, J LEARN DISABIL-US, V46, P26, DOI 10.1177/0022219412464342; Seo Y, 2008, J LEARN DISABIL-US, V41, P300, DOI 10.1177/0022219407311308; SHAFRIR U, 1994, J LEARN DISABIL-US, V27, P123, DOI 10.1177/002221949402700207; SHAPIRO ES, 1991, EXCEPT CHILDREN, V58, P47, DOI 10.1177/001440299105800105; Shessel I, 1999, LEARN DISABILITY Q, V22, P305, DOI 10.2307/1511264; SIEGEL S, 1991, J LEARN DISABIL, V24, P40, DOI 10.1177/002221949102400108; SITLINGTON PL, 1993, EXCEPT CHILDREN, V59, P221; Sitlington PL, 1996, J LEARN DISABIL, V29, P31, DOI 10.1177/002221949602900106; Sparks RL, 2009, J LEARN DISABIL-US, V42, P230, DOI 10.1177/0022219408331040; WELLER C, 1994, LEARN DISABILITY Q, V17, P282, DOI 10.2307/1511125; Werner EE, 1993, LEARNING DISABILITIE, V8, P28; WHITE WJ, 1992, J LEARN DISABIL, V25, P448, DOI 10.1177/002221949202500705; WHO, 2001, WHO INT CLASS FUNCT; Wilson AM, 2009, J LEARN DISABIL-US, V42, P24, DOI 10.1177/0022219408326216; World Health Organization, 2019, INT STAT CLASS DIS R, V11th Edn; Young AR, 2002, J CHILD PSYCHOL PSYC, V43, P635, DOI 10.1111/1469-7610.00052	85	18	19	0	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 3	2014	9	9							e106657	10.1371/journal.pone.0106657	http://dx.doi.org/10.1371/journal.pone.0106657			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AO3TB	25285444	Green Published, gold, Green Submitted			2022-12-27	WOS:000341257700097
J	Zhang, XX; Wang, GJ; Gurley, EC; Zhou, HP				Zhang, Xiaoxuan; Wang, Guangji; Gurley, Emily C.; Zhou, Huiping			Flavonoid Apigenin Inhibits Lipopolysaccharide-Induced Inflammatory Response through Multiple Mechanisms in Macrophages	PLOS ONE			English	Article							NF-KAPPA-B; ACTIVATED PROTEIN-KINASES; TNF-ALPHA; PROINFLAMMATORY CYTOKINES; IL-6 PRODUCTION; POSTTRANSCRIPTIONAL REGULATION; CANCER CHEMOPREVENTION; SIGNALING PATHWAYS; NATURAL-PRODUCTS; RAW264.7 CELLS	Background: Apigenin is a non-toxic natural flavonoid that is abundantly present in common fruits and vegetables. It has been reported that apigenin has various beneficial health effects such as anti-inflammation and chemoprevention. Multiple studies have shown that inflammation is an important risk factor for atherosclerosis, diabetes, sepsis, various liver diseases, and other metabolic diseases. Although it has been long realized that apigenin has anti-inflammatory activities, the underlying functional mechanisms are still not fully understood. Methodology and Principal Findings: In the present study, we examined the effect of apigenin on LPS-induced inflammatory response and further elucidated the potential underlying mechanisms in human THP-1-induced macrophages and mouse J774A.1 macrophages. By using the PrimePCR array, we were able to identify the major target genes regulated by apigenin in LPS-mediated immune response. The results indicated that apigenin significantly inhibited LPS-induced production of pro-inflammatory cytokines, such as IL-6, IL-1 beta, and TNF-alpha through modulating multiple intracellular signaling pathways in macrophages. Apigenin inhibited LPS-induced IL-1 beta production by inhibiting caspase-1 activation through the disruption of the NLRP3 inflammasome assembly. Apigenin also prevented LPS-induced IL-6 and IL-1 beta production by reducing the mRNA stability via inhibiting ERK1/2 activation. In addition, apigenin significantly inhibited TNF-alpha and IL-1 beta-induced activation of NF-kappa B. Conclusion and Significance: Apigenin Inhibits LPS-induced Inflammatory Response through multiple mechanisms in macrophages. These results provided important scientific evidences for the potential application of apigenin as a therapeutic agent for inflammatory diseases.	[Zhang, Xiaoxuan; Wang, Guangji] China Pharmaceut Univ, Ctr Drug Metab & Pharmacokinet, Nanjing, Jiangsu, Peoples R China; [Zhang, Xiaoxuan; Gurley, Emily C.; Zhou, Huiping] Virginia Commonwealth Univ, Dept Microbiol & Immunol, Richmond, VA 23298 USA; [Zhou, Huiping] Dept Internal Med Gastroenterol, Richmond, VA USA; [Zhou, Huiping] McGuire Vet Affairs Med Ctr, Richmond, VA USA; [Zhou, Huiping] Wenzhou Med Univ, Sch Pharm, Wenzhou, Peoples R China	China Pharmaceutical University; Virginia Commonwealth University; Hunter Holmes McGuire Veterinary Affairs Medical Center; Wenzhou Medical University	Wang, GJ (corresponding author), China Pharmaceut Univ, Ctr Drug Metab & Pharmacokinet, Nanjing, Jiangsu, Peoples R China.	wangguangji01@gmail.com; hzhou@vcu.edu	Zhou, Huiping/H-6875-2019; Zhou, Huiping/J-3639-2015; Suinesiaputra, Avan/W-6730-2019; Bluemke, David/GYU-8169-2022	Zhou, Huiping/0000-0002-0050-372X; Lee, Daniel/0000-0001-9447-4175; Suinesiaputra, Avan/0000-0003-1165-458X; Medrano-Gracia, Pau/0000-0002-6255-4864; Young, Alistair/0000-0001-5702-4220; Zhang, Xingyu/0000-0001-8108-1997; Bluemke, David/0000-0002-8323-8086	NIH [R01 DK-057543, R01AT004148]; VA Merit Award [1I01BX001390]; National Science Foundation of China [81070245, 81270489, 81273589, 81202591]; Jiangsu province promotion foundation for the key lab of drug metabolism and pharmacokinetics [NM2012012]; Project for international S&T cooperation program of China [2011DFG333380]; NATIONAL CENTER FOR COMPLEMENTARY &ALTERNATIVE MEDICINE [R01AT004148] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK057543] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); VA Merit Award(US Department of Veterans Affairs); National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Jiangsu province promotion foundation for the key lab of drug metabolism and pharmacokinetics; Project for international S&T cooperation program of China; NATIONAL CENTER FOR COMPLEMENTARY &ALTERNATIVE MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Complementary & Alternative Medicine); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported in part by NIH grants R01 DK-057543 and R01AT004148, VA Merit Award 1I01BX001390, National Science Foundation of China Grants (81070245, 81270489, 81273589, and 81202591), Jiangsu province promotion foundation for the key lab of drug metabolism and pharmacokinetics (NM2012012), and Project for international S&T cooperation program of China (2011DFG333380). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chahar Maheep K, 2011, Pharmacogn Rev, V5, P1, DOI 10.4103/0973-7847.79093; Chawla A, 2010, CIRC RES, V106, P1559, DOI 10.1161/CIRCRESAHA.110.216523; Chen AY, 2013, FOOD CHEM, V138, P2099, DOI 10.1016/j.foodchem.2012.11.139; Chen L, 2009, BIOCHEM PHARMACOL, V78, P70, DOI 10.1016/j.bcp.2009.03.022; Chen R, 2014, MOL VIS, V20, P242; Cho SY, 2003, MOL CELL BIOCHEM, V243, P153, DOI 10.1023/A:1021624520740; Costa SS, 2012, EXPERT OPIN THER PAT, V22, P1111, DOI 10.1517/13543776.2012.724062; Cragg GM, 2013, BBA-GEN SUBJECTS, V1830, P3670, DOI 10.1016/j.bbagen.2013.02.008; Cragg GM, 2009, CHEM REV, V109, P3012, DOI 10.1021/cr900019j; De Nardo D, 2011, TRENDS IMMUNOL, V32, P373, DOI 10.1016/j.it.2011.05.004; Desai P, 2011, EUR J IMMUNOL, V41, P1764, DOI 10.1002/eji.201040932; Dinarello CA, 2000, CHEST, V118, P503, DOI 10.1378/chest.118.2.503; Dinarello CA, 2009, ANNU REV IMMUNOL, V27, P519, DOI 10.1146/annurev.immunol.021908.132612; Duarte S, 2013, INT J MOL SCI, V14, P17664, DOI 10.3390/ijms140917664; Feghali Carol A., 1997, Frontiers in Bioscience (online), V2, pD12; Galleano M, 2012, ANN NY ACAD SCI, V1259, P87, DOI 10.1111/j.1749-6632.2012.06511.x; Garcia-Lafuente A, 2009, INFLAMM RES, V58, P537, DOI 10.1007/s00011-009-0037-3; Gonzalez R, 2011, CRIT REV FOOD SCI, V51, P331, DOI 10.1080/10408390903584094; Han JM, 2010, BIOL PHARM BULL, V33, P1019, DOI 10.1248/bpb.33.1019; Hotamisligil GS, 2006, NATURE, V444, P860, DOI 10.1038/nature05485; Huang TT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041383; Izzi V, 2012, FRONT BIOSCI-LANDMRK, V17, P2396, DOI 10.2741/4061; Jang CH, 2006, RHEUMATOLOGY, V45, P703, DOI 10.1093/rheumatology/kei282; Johnson JL, 2013, MOL NUTR FOOD RES, V57, P2112, DOI 10.1002/mnfr.201300307; Kim AR, 2005, ARCH PHARM RES, V28, P297, DOI 10.1007/BF02977796; Kim HP, 2004, J PHARMACOL SCI, V96, P229, DOI 10.1254/jphs.CRJ04003X; Kim Seewan, 2011, Chonnam Med J, V47, P104, DOI 10.4068/cmj.2011.47.2.104; Knekt P, 2002, AM J CLIN NUTR, V76, P560, DOI 10.1093/ajcn/76.3.560; Koga T, 2011, CLIN EXP RHEUMATOL, V29, P906; Kowalski J, 2005, PHARMACOL REP, V57, P390; Li RR, 2010, IMMUNOPHARM IMMUNOT, V32, P364, DOI 10.3109/08923970903420566; Lund S, 2006, J NEUROIMMUNOL, V180, P71, DOI 10.1016/j.jneuroim.2006.07.007; Menu P, 2011, CLIN EXP IMMUNOL, V166, P1, DOI 10.1111/j.1365-2249.2011.04440.x; Mulvihill Erin E., 2012, Cardiovascular & Hematological Disorders - Drug Targets, V12, P84; Nicholas C, 2007, J IMMUNOL, V179, P7121, DOI 10.4049/jimmunol.179.10.7121; Nijveldt RJ, 2001, AM J CLIN NUTR, V74, P418; Nurmi K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078537; Park BS, 2013, EXP MOL MED, V45, DOI 10.1038/emm.2013.97; Park EJ, 2012, ANTI-CANCER AGENT ME, V12, P836, DOI 10.2174/187152012802650075; Patel D, 2007, INT J ONCOL, V30, P233; Pereira SG, 2008, INT J BIOCHEM CELL B, V40, P1425, DOI 10.1016/j.biocel.2007.05.004; Prasad S, 2010, PLANTA MED, V76, P1044, DOI 10.1055/s-0030-1250111; RAMBALDI A, 1993, BRIT J HAEMATOL, V83, P204, DOI 10.1111/j.1365-2141.1993.tb08273.x; Romagnolo Donato F., 2012, Journal of Nutrition in Gerontology and Geriatrics, V31, P206, DOI 10.1080/21551197.2012.702534; Romano B, 2013, PHYTOTHER RES, V27, P1588, DOI 10.1002/ptr.5023; Satoh T, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.169; Schmidt B, 2008, METABOLISM, V57, pS3, DOI 10.1016/j.metabol.2008.03.001; Schroder K, 2010, CELL, V140, P821, DOI 10.1016/j.cell.2010.01.040; Serafini M, 2010, P NUTR SOC, V69, P273, DOI 10.1017/S002966511000162X; Sharma H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091588; Shukla S, 2010, PHARM RES-DORDR, V27, P962, DOI 10.1007/s11095-010-0089-7; Sucher NJ, 2013, EXPERT OPIN DRUG DIS, V8, P21, DOI 10.1517/17460441.2013.739602; Takano-Ishikawa Y, 2006, PHYTOMEDICINE, V13, P310, DOI 10.1016/j.phymed.2005.01.016; Tanaka T, 2013, NUTRIENTS, V5, P2128, DOI 10.3390/nu5062128; Wang J, 2012, INFLAMMATION, V35, P1466, DOI 10.1007/s10753-012-9460-7; WEINSTEIN SL, 1992, J BIOL CHEM, V267, P14955; Weiss U, 2008, NATURE, V454, P427, DOI 10.1038/454427a; Xagorari A, 2002, BRIT J PHARMACOL, V136, P1058, DOI 10.1038/sj.bjp.0704803; Xie CH, 2012, J NUTR BIOCHEM, V23, P1184, DOI 10.1016/j.jnutbio.2011.06.013; Yamamoto M, 2004, GENES CELLS, V9, P1055, DOI 10.1111/j.1365-2443.2004.00789.x; Yu HB, 2008, CELL HOST MICROBE, V4, P198, DOI 10.1016/j.chom.2008.08.007; Zha WB, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009069; Zhang AH, 2013, EVID-BASED COMPL ALT, V2013, DOI 10.1155/2013/257909; Zhou Huiping, 2007, Atherosclerosis, V195, pe134, DOI 10.1016/j.atherosclerosis.2007.04.008	64	123	132	4	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2014	9	9							e107072	10.1371/journal.pone.0107072	http://dx.doi.org/10.1371/journal.pone.0107072			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ1IR	25360520	Green Published, Green Submitted, gold			2022-12-27	WOS:000347993600095
J	Filho, MAM; Dutra, JDL; Rocha, GB; Simas, AM; Freire, RO				Filho, Manoel A. M.; Dutra, Jose Diogo L.; Rocha, Gerd B.; Simas, Alfredo M.; Freire, Ricardo O.			Semiempirical Quantum Chemistry Model for the Lanthanides: RM1 (Recife Model 1) Parameters for Dysprosium, Holmium and Erbium	PLOS ONE			English	Article							CAMBRIDGE STRUCTURAL DATABASE; CHEMICAL AM1 CALCULATION; SINGLE-MOLECULE MAGNET; SPARKLE MODEL; COORDINATION POLYHEDRON; COMPLEXES; EUROPIUM(III); PHOTOLUMINESCENCE; PSEUDOPOTENTIALS; PREDICTION	Complexes of dysprosium, holmium, and erbium find many applications as single-molecule magnets, as contrast agents for magnetic resonance imaging, as anti-cancer agents, in optical telecommunications, etc. Therefore, the development of tools that can be proven helpful to complex design is presently an active area of research. In this article, we advance a major improvement to the semiempirical description of lanthanide complexes: the Recife Model 1, RM1, model for the lanthanides, parameterized for the trications of Dy, Ho, and Er. By representing such lanthanide in the RM1 calculation as a three-electron atom with a set of 5 d, 6 s, and 6 p semiempirical orbitals, the accuracy of the previous sparkle models, mainly concentrated on lanthanide-oxygen and lanthanide-nitrogen distances, is extended to other types of bonds in the trication complexes' coordination polyhedra, such as lanthanide-carbon, lanthanide-chlorine, etc. This is even more important as, for example, lanthanide-carbon atom distances in the coordination polyhedra of the complexes comprise about 30% of all distances for all complexes of Dy, Ho, and Er considered. Our results indicate that the average unsigned mean error for the lanthanide-carbon distances dropped from an average of 0.30 angstrom, for the sparkle models, to 0.04 angstrom for the RM1 model for the lanthanides; for a total of 509 such distances for the set of all Dy, Ho, and Er complexes considered. A similar behavior took place for the other distances as well, such as lanthanide-chlorine, lanthanide-bromine, lanthanide, phosphorus and lanthanide-sulfur. Thus, the RM1 model for the lanthanides, being advanced in this article, broadens the range of application of semiempirical models to lanthanide complexes by including comprehensively many other types of bonds not adequately described by the previous models.	[Filho, Manoel A. M.; Dutra, Jose Diogo L.; Freire, Ricardo O.] Univ Fed Sergipe, Dept Quim, Pople Computat Chem Lab, Sao Cristovao, SE, Brazil; [Rocha, Gerd B.] Univ Fed Paraiba, CCEN, Dept Quim, BR-58059900 Joao Pessoa, Paraiba, Brazil; [Simas, Alfredo M.] Univ Fed Pernambuco, Dept Quim Fundamental, Recife, PE, Brazil	Universidade Federal de Sergipe; Universidade Federal da Paraiba; Universidade Federal de Pernambuco	Freire, RO (corresponding author), Univ Fed Sergipe, Dept Quim, Pople Computat Chem Lab, Sao Cristovao, SE, Brazil.	rfreire@ufs.br	Lisboa Dutra, José Diogo/I-7088-2013; Freire, Ricardo O/B-7685-2008; Rocha, Gerd B/G-5115-2010; Freire, Ricardo/AGR-4537-2022; Filho, Manoel Alves Machado/R-2505-2019; DUTRA, JOSE DIOGO LISBOA/AAJ-9870-2021; Simas, Alfredo M/B-1096-2008; Cominetti, Marcia Regina/B-8080-2012; Vieira, Paulo Cezar/B-9504-2012; Franceschini Sarria, Andre Lucio/C-8189-2012	Freire, Ricardo O/0000-0002-3603-3184; Rocha, Gerd B/0000-0001-9805-9497; Freire, Ricardo/0000-0002-3603-3184; DUTRA, JOSE DIOGO LISBOA/0000-0003-2123-2209; Simas, Alfredo M/0000-0003-3653-6328; Cominetti, Marcia Regina/0000-0001-6385-7392; Vieira, Paulo Cezar/0000-0003-4207-6217; Paranhos, Caio M./0000-0002-2261-0585; Franceschini Sarria, Andre Lucio/0000-0003-0616-624X; Blanque Becceneri, Amanda/0000-0001-5223-961X	CNPq; FAPITEC-SE; FACEPE (Pronex); INAMI	CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); FAPITEC-SE; FACEPE (Pronex)(Fundacao de Amparo a Ciencia e Tecnologia do Estado de Pernambuco (FACEPE)); INAMI	This work received financial support from the Brazilian agencies, institutes and networks: CNPq, FAPITEC-SE, FACEPE (Pronex), and INAMI. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AlDamen MA, 2009, INORG CHEM, V48, P3467, DOI 10.1021/ic801630z; Allen FH, 2002, ACTA CRYSTALLOGR B, V58, P407, DOI 10.1107/S0108768102004895; Allen FH, 2002, ACTA CRYSTALLOGR B, V58, P380, DOI 10.1107/S0108768102003890; BAYOUTH JE, 1995, J NUCL MED, V36, P730; Conover WJ, 1999, PRACTICAL NONPARAMET; da Costa NB, 2005, POLYHEDRON, V24, P3046, DOI 10.1016/j.poly.2005.06.027; da Costa NB, 2005, INORG CHEM COMMUN, V8, P831, DOI 10.1016/j.inoche.2005.06.014; DEANDRADE AVM, 1994, CHEM PHYS LETT, V227, P349, DOI 10.1016/0009-2614(94)00829-9; deAndrade AVM, 1996, J CHEM SOC FARADAY T, V92, P1835, DOI 10.1039/ft9969201835; DEANDRADE AVM, 1995, J ALLOY COMPD, V225, P55, DOI 10.1016/0925-8388(94)07009-1; DEWAR MJS, 1985, J AM CHEM SOC, V107, P3902, DOI 10.1021/ja00299a024; DOLG M, 1989, THEOR CHIM ACTA, V75, P173, DOI 10.1007/BF00528565; DOLG M, 1989, J CHEM PHYS, V90, P1730, DOI 10.1063/1.456066; Dolg M, 2012, CHEM REV, V112, P403, DOI 10.1021/cr2001383; Dutra JDL, 2013, J CHEM THEORY COMPUT, V9, P3333, DOI 10.1021/ct301012h; Ertl P, 2003, J CHEM INF COMP SCI, V43, P374, DOI 10.1021/ci0255782; Faustino WM, 2006, J PHYS CHEM A, V110, P2510, DOI 10.1021/jp056180m; Faustino WM, 2000, J MOL STRUC-THEOCHEM, V527, P245, DOI 10.1016/S0166-1280(00)00497-8; Filho MAM, 2013, RSC ADV, V3, P16747, DOI 10.1039/c3ra41406j; Freire RO, 2006, J ORGANOMET CHEM, V691, P2584, DOI 10.1016/j.jorganchem.2006.01.044; Freire RO, 2006, CHEM PHYS LETT, V425, P138, DOI 10.1016/j.cplett.2006.04.103; Freire RO, 2010, J CHEM THEORY COMPUT, V6, P2019, DOI 10.1021/ct100192c; Freire RO, 2009, J BRAZIL CHEM SOC, V20, P1638, DOI 10.1590/S0103-50532009000900011; Freire RO, 2006, J MOL MODEL, V12, P373, DOI 10.1007/s00894-005-0027-5; Freire RO, 2005, J COMPUT CHEM, V26, P1524, DOI 10.1002/jcc.20288; Freire RO, 2005, INORG CHEM, V44, P3299, DOI 10.1021/ic048530+; Freire RO, 2005, J LUMIN, V111, P81, DOI 10.1016/j.jlumin.2004.07.001; Ishikawa N, 2003, J AM CHEM SOC, V125, P8694, DOI 10.1021/ja029629n; Ishikawa N, 2008, INORG CHEM, V47, P10217, DOI 10.1021/ic8014892; Kaufman L., 2009, FINDING GROUPS DATA; Lin PH, 2009, ANGEW CHEM INT EDIT, V48, P9489, DOI 10.1002/anie.200903199; Nilsson S, 1996, ACTA RADIOL, V37, P27; Norek M, 2011, PROG NUCL MAG RES SP, V59, P64, DOI 10.1016/j.pnmrs.2010.08.002; Orpen AG, 2002, ACTA CRYSTALLOGR B, V58, P398, DOI 10.1107/S0108768102002446; Park OH, 2003, J MATER RES, V18, P1039, DOI 10.1557/JMR.2003.0143; Rinehart JD, 2011, NAT CHEM, V3, P538, DOI 10.1038/nchem.1063; Rocha GB, 2004, INORG CHEM, V43, P2346, DOI 10.1021/ic034882p; Rocha GB, 2006, J COMPUT CHEM, V27, P1101, DOI 10.1002/jcc.20425; Simas AM, 2008, J ORGANOMET CHEM, V693, P1952, DOI 10.1016/j.jorganchem.2008.01.029; Stewart J. J. P., 2012, MOPAC2012; STEWART JPP, 2007, MOPAC2007; Sun LN, 2005, ADV FUNCT MATER, V15, P1041, DOI 10.1002/adfm.200400386; TSALLIS C, 1988, J STAT PHYS, V52, P479, DOI 10.1007/BF01016429; WIKSTROM M, 1992, ACTA RADIOL, V33, P1; Zhang P, 2013, COORDIN CHEM REV, V257, P1728, DOI 10.1016/j.ccr.2013.01.012	45	28	29	1	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2014	9	1							e86376	10.1371/journal.pone.0086376	http://dx.doi.org/10.1371/journal.pone.0086376			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302RF	24497945	gold, Green Published, Green Submitted			2022-12-27	WOS:000330621900023
J	Liu, HN; Gao, LD; Chowell, G; Hu, SX; Lin, XL; Li, XJ; Ma, GH; Huang, R; Yang, HS; Tian, HY; Xiao, H				Liu, Hai-Ning; Gao, Li-Dong; Chowell, Gerardo; Hu, Shi-Xiong; Lin, Xiao-Ling; Li, Xiu-Jun; Ma, Gui-Hua; Huang, Ru; Yang, Hui-Suo; Tian, Huaiyu; Xiao, Hong			Time-Specific Ecologic Niche Models Forecast the Risk of Hemorrhagic Fever with Renal Syndrome in Dongting Lake District, China, 2005-2010	PLOS ONE			English	Article							NEPHROPATHIA-EPIDEMICA; HANTAVIRUS INFECTION; TEMPORAL DYNAMICS; HANTAAN VIRUS; AREAS; PREDICTION; DISTRIBUTIONS; TRANSMISSION; VARIABILITY; POPULATIONS	Background: Hemorrhagic fever with renal syndrome (HFRS), a rodent-borne infectious disease, is one of the most serious public health threats in China. Increasing our understanding of the spatial and temporal patterns of HFRS infections could guide local prevention and control strategies. Methodology/Principal Findings: We employed statistical models to analyze HFRS case data together with environmental data from the Dongting Lake district during 2005-2010. Specifically, time-specific ecologic niche models (ENMs) were used to quantify and identify risk factors associated with HFRS transmission as well as forecast seasonal variation in risk across geographic areas. Results showed that the Maximum Entropy model provided the best predictive ability (AUC = 0.755). Time-specific Maximum Entropy models showed that the potential risk areas of HFRS significantly varied across seasons. High-risk areas were mainly found in the southeastern and southwestern areas of the Dongting Lake district. Our findings based on models focused on the spring and winter seasons showed particularly good performance. The potential risk areas were smaller in March, May and August compared with those identified for June, July and October to December. Both normalized difference vegetation index (NDVI) and land use types were found to be the dominant risk factors. Conclusions/Significance: Our findings indicate that time-specific ENMs provide a useful tool to forecast the spatial and temporal risk of HFRS.	[Liu, Hai-Ning; Lin, Xiao-Ling; Ma, Gui-Hua; Huang, Ru; Tian, Huaiyu; Xiao, Hong] Hunan Normal Univ, Coll Resources & Environm Sci, Changsha, Peoples R China; [Gao, Li-Dong; Hu, Shi-Xiong] Hunan Prov Ctr Dis Control & Prevent, Changsha, Peoples R China; [Chowell, Gerardo] NIH, Div Int Epidemiol & Populat Studies, Fogarty Int Ctr, Bethesda, MD 20892 USA; [Chowell, Gerardo] Arizona State Univ, Sch Human Evolut & Social Change, Simon A Levin Math Computat & Modeling Sci Ctr, Tempe, AZ USA; [Li, Xiu-Jun] Shandong Univ, Sch Publ Hlth, Jinan 250100, Peoples R China; [Yang, Hui-Suo] Ctr Dis Control & Prevent Beijing Mil Reg, Beijing, Peoples R China	Hunan Normal University; National Institutes of Health (NIH) - USA; NIH Fogarty International Center (FIC); Arizona State University; Arizona State University-Tempe; Shandong University	Xiao, H (corresponding author), Hunan Normal Univ, Coll Resources & Environm Sci, Changsha, Peoples R China.	xiaohong.hnnu@gmail.com	Tian, Huaiyu/G-1934-2016	Tian, Huaiyu/0000-0002-4466-0858	Hunan Provincial Education Department [13A051]; Construct Program of the Key Discipline in Hunan Province, China; National Institute of General Medical Sciences (NIGMS) at the National Institutes of Health [1R01GM100471-01]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM100471] Funding Source: NIH RePORTER	Hunan Provincial Education Department(Hunan Provincial Education Department); Construct Program of the Key Discipline in Hunan Province, China; National Institute of General Medical Sciences (NIGMS) at the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This research was supported by the Scientific Research Fund of Hunan Provincial Education Department (13A051) (http://gov.hnedu.cn/), Construct Program of the Key Discipline in Hunan Province (http://gov.hnedu.cn/), China. G.C. acknowledges support from grant number 1R01GM100471-01 from the National Institute of General Medical Sciences (NIGMS) at the National Institutes of Health (http://www.nigms.nih.gov/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson RP, 2003, ECOL MODEL, V162, P211, DOI 10.1016/S0304-3800(02)00349-6; Andreo V, 2009, POPUL ECOL, V51, P297, DOI 10.1007/s10144-008-0123-3; Bi P, 1998, AM J EPIDEMIOL, V148, P276, DOI 10.1093/oxfordjournals.aje.a009636; BRUMMERKORVENKONTIO M, 1980, J INFECT DIS, V141, P131, DOI 10.1093/infdis/141.2.131; Cao Xiang-feng, 2010, Yingyong Shengtai Xuebao, V21, P3063; CARPENTER G, 1993, BIODIVERS CONSERV, V2, P667, DOI 10.1007/BF00051966; China TMoHoPR, 2007, EXP NAT IMM IMPL PRO; Ernest SKM, 2000, OIKOS, V88, P470, DOI 10.1034/j.1600-0706.2000.880302.x; Glass GE, 2000, EMERG INFECT DIS, V6, P238, DOI 10.3201/eid0603.000303; Glass GE, 2007, ECOL APPL, V17, P129, DOI 10.1890/1051-0761(2007)017[0129:PHRAFH]2.0.CO;2; Hardestam J, 2007, APPL ENVIRON MICROB, V73, P2547, DOI 10.1128/AEM.02869-06; Li FF, 2009, ROTATING MACHINERY H; [李惠敏 LI Hui-min], 2010, [地理科学, Scientia Geographica Sinica], V30, P119; Li Shuang-cheng, 2008, Shengtaixue Zazhi, V27, P1531; Liu FQ, 2008, CHIN J NATURAL MED, V10, P199; [刘静 Liu Jing], 2006, [中国卫生统计, Chinese Journal of Health Statistics], V23, P326; Luo XW, 2008, CHINESE J PREVENTIVE, V29, P1017; MILLS JN, 1991, J MAMMAL, V72, P470, DOI 10.2307/1382129; MILLS JN, 1992, AM J TROP MED HYG, V47, P749, DOI 10.4269/ajtmh.1992.47.749; NIKLASSON B, 1995, AM J TROP MED HYG, V53, P134, DOI 10.4269/ajtmh.1995.53.134; Peterson A Townsend, 2007, Vet Ital, V43, P393; Peterson AT, 2006, AM J TROP MED HYG, V75, P9, DOI 10.4269/ajtmh.2006.75.1.0750009; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; PHILLIPS SJ, 2004, MAXIMUM ENTROPY APPR, P83; Previtali MA, 2009, ECOLOGY, V90, P1996, DOI 10.1890/08-0405.1; Stockwell D, 1999, INT J GEOGR INF SCI, V13, P143, DOI 10.1080/136588199241391; Wang Yong, 2003, Changjiang Liuyu Ziyuan Yu Huanjing, V12, P265; Wei L, 2011, AM J TROP MED HYG, V84, P497, DOI 10.4269/ajtmh.2011.10-0314; Williams RAJ, 2008, T ROY SOC TROP MED H, V102, P471, DOI 10.1016/j.trstmh.2008.01.016; Xiao H, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-305; [肖洪 Xiao Hong], 2013, [地理科学, Scientia Geographica Sinica], V33, P123; Yahnke CJ, 2001, AM J TROP MED HYG, V65, P768, DOI 10.4269/ajtmh.2001.65.768; Yan L, 2007, EMERG INFECT DIS, V13, P1301, DOI 10.3201/eid1309.061481; Yang ZX, 2007, CHINESE AGR SCINCE B, V23, P193; Zhang WY, 2010, ENVIRON HEALTH PERSP, V118, P915, DOI 10.1289/ehp.0901504; Zhang WY, 2009, AM J TROP MED HYG, V80, P678, DOI 10.4269/ajtmh.2009.80.678	36	31	32	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 3	2014	9	9							e106839	10.1371/journal.pone.0106839	http://dx.doi.org/10.1371/journal.pone.0106839			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3TB	25184252	Green Published, Green Submitted, gold			2022-12-27	WOS:000341257700124
